id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
164188630|NCT00463801|593060308|FG000|Overall Study|Protocol Violation|1|||
164188631|NCT00463801|593060308|FG000|Overall Study|Lack of Efficacy|2|||
164188632|NCT00463801|593060308|FG000|Overall Study|Adverse Event|4|||
164188633|NCT00463801|593060308|FG000|Overall Study|Lost to Follow-up|5|||
164188634|NCT00463801|593060308|FG000|Overall Study|No longer require therapy|1|||
164188635|NCT01073163|593060309|FG000|Overall Study|Adverse Event|1|||
164188636|NCT01073163|593060309|FG000|Overall Study|Disease Progression|1|||
164188637|NCT01073163|593060309|FG000|Overall Study|Early termination|1|||
164188638|NCT00802672|593060310|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
164188639|NCT00802672|593060311|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
164188640|NCT00802672|593060312|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
164188641|NCT00802672|593060310|FG000|Overall Study|Adverse Event|1|||
164188642|NCT00802672|593060311|FG001|Overall Study|Adverse Event|1|||
164188643|NCT00802672|593060312|FG002|Overall Study|Adverse Event|1|||
164188644|NCT00802672|593060310|FG000|Overall Study|Protocol Violation|2|||
164188645|NCT00802672|593060311|FG001|Overall Study|Protocol Violation|1|||
164188646|NCT00802672|593060312|FG002|Overall Study|Protocol Violation|1|||
164188647|NCT00802672|593060310|FG000|Overall Study|Lost to Follow-up|5|||
164188648|NCT00802672|593060311|FG001|Overall Study|Lost to Follow-up|5|||
164188649|NCT00802672|593060312|FG002|Overall Study|Lost to Follow-up|3|||
164188650|NCT00802672|593060310|FG000|Overall Study|Withdrawal by Subject|1|||
164188651|NCT00802672|593060311|FG001|Overall Study|Withdrawal by Subject|1|||
164188652|NCT00802672|593060312|FG002|Overall Study|Withdrawal by Subject|2|||
164073741|NCT00563524|592635004|FG000|Overall Study|Adverse Event|0|||
164188653|NCT00802672|593060310|FG000|Overall Study|other|3|||
164188654|NCT00802672|593060311|FG001|Overall Study|other|1|||
164188655|NCT00802672|593060312|FG002|Overall Study|other|2|||
164188656|NCT00703677|593060313|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
164188657|NCT04441788|593060316|FG000|Overall Study|Voluntary Withdrawl|0|||
164188658|NCT04441788|593060317|FG001|Overall Study|Voluntary Withdrawl|1|||
164188659|NCT04441788|593060318|FG002|Overall Study|Voluntary Withdrawl|0|||
164188660|NCT04441788|593060316|FG000|Overall Study|Ineligibility|1|||
164188661|NCT04441788|593060317|FG001|Overall Study|Ineligibility|0|||
164188662|NCT04441788|593060318|FG002|Overall Study|Ineligibility|0|||
164188663|NCT04441788|593060316|FG000|Overall Study|Adverse Event|0|||
164188664|NCT04441788|593060317|FG001|Overall Study|Adverse Event|0|||
164188665|NCT04441788|593060318|FG002|Overall Study|Adverse Event|4|||
164188666|NCT04441788|593060316|FG000|Overall Study|Study Terminated by Sponsor|16|||
164188667|NCT04441788|593060317|FG001|Overall Study|Study Terminated by Sponsor|16|||
164188668|NCT04441788|593060318|FG002|Overall Study|Study Terminated by Sponsor|12|||
164188669|NCT02793947|593060324|FG000|Overall Study|Death|1|||
164188670|NCT02793947|593060325|FG001|Overall Study|Death|0|||
164188671|NCT02793947|593060324|FG000|Overall Study|Physician Decision|1|||
164188672|NCT02793947|593060325|FG001|Overall Study|Physician Decision|5|||
164188673|NCT02959918|593060326|FG000|Overall Study|Adverse Event|1|||
164188674|NCT02959918|593060327|FG001|Overall Study|Adverse Event|1|||
164188675|NCT02959918|593060328|FG002|Overall Study|Adverse Event|2|||
164188676|NCT02959918|593060329|FG003|Overall Study|Adverse Event|0|||
164188677|NCT02959918|593060330|FG004|Overall Study|Adverse Event|0|||
164188678|NCT02959918|593060331|FG005|Overall Study|Adverse Event|2|||
164188679|NCT02959918|593060332|FG006|Overall Study|Adverse Event|2|||
164188680|NCT02959918|593060333|FG007|Overall Study|Adverse Event|1|||
164188681|NCT02959918|593060334|FG008|Overall Study|Adverse Event|2|||
164188682|NCT02959918|593060335|FG009|Overall Study|Adverse Event|1|||
164188683|NCT02959918|593060336|FG010|Overall Study|Adverse Event|1|||
164188684|NCT02959918|593060337|FG011|Overall Study|Adverse Event|3|||
164188685|NCT02959918|593060338|FG012|Overall Study|Adverse Event|2|||
164188686|NCT02959918|593060339|FG013|Overall Study|Adverse Event|4|||
164188687|NCT02959918|593060326|FG000|Overall Study|Lost to Follow-up|0|||
164188688|NCT02959918|593060327|FG001|Overall Study|Lost to Follow-up|0|||
164188689|NCT02959918|593060328|FG002|Overall Study|Lost to Follow-up|0|||
164188690|NCT02959918|593060329|FG003|Overall Study|Lost to Follow-up|0|||
164188691|NCT02959918|593060330|FG004|Overall Study|Lost to Follow-up|0|||
164188692|NCT02959918|593060331|FG005|Overall Study|Lost to Follow-up|0|||
164188693|NCT02959918|593060332|FG006|Overall Study|Lost to Follow-up|0|||
164188694|NCT02959918|593060333|FG007|Overall Study|Lost to Follow-up|0|||
164188695|NCT02959918|593060334|FG008|Overall Study|Lost to Follow-up|0|||
164188696|NCT02959918|593060335|FG009|Overall Study|Lost to Follow-up|1|||
164188697|NCT02959918|593060336|FG010|Overall Study|Lost to Follow-up|0|||
164188698|NCT02959918|593060337|FG011|Overall Study|Lost to Follow-up|0|||
164188699|NCT02959918|593060338|FG012|Overall Study|Lost to Follow-up|1|||
164188700|NCT02959918|593060339|FG013|Overall Study|Lost to Follow-up|0|||
164188701|NCT02959918|593060326|FG000|Overall Study|Withdrawal by Subject|0|||
164188702|NCT02959918|593060327|FG001|Overall Study|Withdrawal by Subject|0|||
164188703|NCT02959918|593060328|FG002|Overall Study|Withdrawal by Subject|1|||
164188704|NCT02959918|593060329|FG003|Overall Study|Withdrawal by Subject|2|||
164188705|NCT02959918|593060330|FG004|Overall Study|Withdrawal by Subject|0|||
164188706|NCT02959918|593060331|FG005|Overall Study|Withdrawal by Subject|0|||
164188707|NCT02959918|593060332|FG006|Overall Study|Withdrawal by Subject|1|||
164188708|NCT02959918|593060333|FG007|Overall Study|Withdrawal by Subject|0|||
164188709|NCT02959918|593060334|FG008|Overall Study|Withdrawal by Subject|1|||
164188710|NCT02959918|593060335|FG009|Overall Study|Withdrawal by Subject|1|||
164188711|NCT02959918|593060336|FG010|Overall Study|Withdrawal by Subject|2|||
164188712|NCT02959918|593060337|FG011|Overall Study|Withdrawal by Subject|3|||
164188713|NCT02959918|593060338|FG012|Overall Study|Withdrawal by Subject|1|||
164188714|NCT02959918|593060339|FG013|Overall Study|Withdrawal by Subject|1|||
164188715|NCT02959918|593060326|FG000|Overall Study|Protocol Violation|0|||
164188716|NCT02959918|593060327|FG001|Overall Study|Protocol Violation|0|||
164188717|NCT02959918|593060328|FG002|Overall Study|Protocol Violation|1|||
164188718|NCT02959918|593060329|FG003|Overall Study|Protocol Violation|0|||
164188719|NCT02959918|593060330|FG004|Overall Study|Protocol Violation|0|||
164188720|NCT02959918|593060331|FG005|Overall Study|Protocol Violation|1|||
164188721|NCT02959918|593060332|FG006|Overall Study|Protocol Violation|0|||
164188722|NCT02959918|593060333|FG007|Overall Study|Protocol Violation|0|||
164188723|NCT02959918|593060334|FG008|Overall Study|Protocol Violation|2|||
164188724|NCT02959918|593060335|FG009|Overall Study|Protocol Violation|1|||
164188725|NCT02959918|593060336|FG010|Overall Study|Protocol Violation|0|||
164188726|NCT02959918|593060337|FG011|Overall Study|Protocol Violation|1|||
164188727|NCT02959918|593060338|FG012|Overall Study|Protocol Violation|1|||
164188728|NCT02959918|593060339|FG013|Overall Study|Protocol Violation|0|||
164188729|NCT02959918|593060326|FG000|Overall Study|Stopping Rule Met|1|||
164188730|NCT02959918|593060327|FG001|Overall Study|Stopping Rule Met|0|||
164188731|NCT02959918|593060328|FG002|Overall Study|Stopping Rule Met|3|||
164188732|NCT02959918|593060329|FG003|Overall Study|Stopping Rule Met|4|||
164188733|NCT02959918|593060330|FG004|Overall Study|Stopping Rule Met|5|||
164188734|NCT02959918|593060331|FG005|Overall Study|Stopping Rule Met|3|||
164188735|NCT02959918|593060332|FG006|Overall Study|Stopping Rule Met|2|||
164188736|NCT02959918|593060333|FG007|Overall Study|Stopping Rule Met|4|||
164188737|NCT02959918|593060334|FG008|Overall Study|Stopping Rule Met|1|||
164188738|NCT02959918|593060335|FG009|Overall Study|Stopping Rule Met|1|||
164188739|NCT02959918|593060336|FG010|Overall Study|Stopping Rule Met|3|||
164188740|NCT02959918|593060337|FG011|Overall Study|Stopping Rule Met|5|||
164188741|NCT02959918|593060338|FG012|Overall Study|Stopping Rule Met|2|||
164188742|NCT02959918|593060339|FG013|Overall Study|Stopping Rule Met|1|||
164188743|NCT02959918|593060326|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
164188744|NCT02959918|593060327|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
164188745|NCT02959918|593060328|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
164188746|NCT02959918|593060329|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
164188747|NCT02959918|593060330|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188748|NCT02959918|593060331|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188749|NCT02959918|593060332|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188750|NCT02959918|593060333|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188751|NCT02959918|593060334|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188752|NCT02959918|593060335|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188753|NCT02959918|593060336|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188754|NCT02959918|593060337|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188755|NCT02959918|593060338|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188756|NCT02959918|593060339|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
164188757|NCT02959918|593060326|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188758|NCT02959918|593060327|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188759|NCT02959918|593060328|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188760|NCT02959918|593060329|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188761|NCT02959918|593060330|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188762|NCT02959918|593060331|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188763|NCT02959918|593060332|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
163958914|NCT05199571|592221739|FG000|Treatment period|Participant decision|3|||
163958915|NCT05199571|592221739|FG000|Treatment period|Physician Decision|1|||
163958916|NCT05199571|592221739|FG000|Post-treatment follow up period|Participant decision|3|||
163958917|NCT02892344|592221740|FG000|Overall Study|Protocol deviation|3|||
164073742|NCT00563524|592635005|FG001|Overall Study|Adverse Event|1|||
164073743|NCT00563524|592635006|FG002|Overall Study|Adverse Event|0|||
164073744|NCT00563524|592635007|FG003|Overall Study|Adverse Event|0|||
164073745|NCT00563524|592635008|FG004|Overall Study|Adverse Event|2|||
164073746|NCT00563524|592635009|FG005|Overall Study|Adverse Event|0|||
164073747|NCT00563524|592635004|FG000|Overall Study|Lost to Follow-up|1|||
164073748|NCT00563524|592635005|FG001|Overall Study|Lost to Follow-up|0|||
164073749|NCT00563524|592635006|FG002|Overall Study|Lost to Follow-up|0|||
164073750|NCT00563524|592635007|FG003|Overall Study|Lost to Follow-up|0|||
164073751|NCT00563524|592635008|FG004|Overall Study|Lost to Follow-up|0|||
164073752|NCT00563524|592635009|FG005|Overall Study|Lost to Follow-up|0|||
164073753|NCT00563524|592635004|FG000|Overall Study|Protocol Violation|0|||
164188764|NCT02959918|593060333|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
164188765|NCT02959918|593060334|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188766|NCT02959918|593060335|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188767|NCT02959918|593060336|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188768|NCT02959918|593060337|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188769|NCT02959918|593060338|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188770|NCT02959918|593060339|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
164188771|NCT02959918|593060326|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188772|NCT02959918|593060327|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164073754|NCT00563524|592635005|FG001|Overall Study|Protocol Violation|1|||
164073755|NCT00563524|592635006|FG002|Overall Study|Protocol Violation|0|||
164073756|NCT00563524|592635007|FG003|Overall Study|Protocol Violation|0|||
164073757|NCT00563524|592635008|FG004|Overall Study|Protocol Violation|0|||
164073758|NCT00563524|592635009|FG005|Overall Study|Protocol Violation|0|||
164073759|NCT00563524|592635004|FG000|Overall Study|Withdrawal by Subject|1|||
164188773|NCT02959918|593060328|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188774|NCT02959918|593060329|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188775|NCT02959918|593060330|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164073760|NCT00563524|592635005|FG001|Overall Study|Withdrawal by Subject|1|||
164073761|NCT00563524|592635006|FG002|Overall Study|Withdrawal by Subject|3|||
164073762|NCT00563524|592635007|FG003|Overall Study|Withdrawal by Subject|0|||
164073763|NCT00563524|592635008|FG004|Overall Study|Withdrawal by Subject|0|||
164073764|NCT00563524|592635009|FG005|Overall Study|Withdrawal by Subject|1|||
164073765|NCT01467570|592635011|FG000|Overall Study|Lost to Follow-up|8|||
164073766|NCT01467570|592635012|FG001|Overall Study|Lost to Follow-up|9|||
164073767|NCT03836729|592635016|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
164073768|NCT01392170|592635019|FG000|Overall Study|Withdrawal by Subject|1|||
164073769|NCT01392170|592635019|FG000|Overall Study|Ineligible|1|||
164073770|NCT00467818|592635029|FG000|Overall Study|Adverse Event|1|||
164073771|NCT00467818|592635030|FG001|Overall Study|Adverse Event|0|||
164073772|NCT00467818|592635029|FG000|Overall Study|Lost to Follow-up|2|||
164073773|NCT00467818|592635030|FG001|Overall Study|Lost to Follow-up|2|||
164073774|NCT01313728|592635032|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
164073775|NCT02216214|592635033|FG000|Overall Study|Randomized Never Received Study Drug|1|||
164073776|NCT02216214|592635034|FG001|Overall Study|Randomized Never Received Study Drug|0|||
164073777|NCT02216214|592635033|FG000|Overall Study|Adverse Event|10|||
164073778|NCT02216214|592635034|FG001|Overall Study|Adverse Event|8|||
164073779|NCT02216214|592635033|FG000|Overall Study|Lack of Efficacy|2|||
164073780|NCT02216214|592635034|FG001|Overall Study|Lack of Efficacy|2|||
164073781|NCT02216214|592635033|FG000|Overall Study|Lost to Follow-up|3|||
164073782|NCT02216214|592635034|FG001|Overall Study|Lost to Follow-up|2|||
164073783|NCT02216214|592635033|FG000|Overall Study|Protocol Violation|4|||
164188776|NCT02959918|593060331|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188777|NCT02959918|593060332|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188778|NCT02959918|593060333|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164073784|NCT02216214|592635034|FG001|Overall Study|Protocol Violation|2|||
164073785|NCT02216214|592635033|FG000|Overall Study|Withdrawal by Subject|22|||
164073786|NCT02216214|592635034|FG001|Overall Study|Withdrawal by Subject|20|||
164073787|NCT02216214|592635033|FG000|Overall Study|Study Terminated By Sponsor|0|||
164073788|NCT02216214|592635034|FG001|Overall Study|Study Terminated By Sponsor|1|||
164073789|NCT02216214|592635033|FG000|Overall Study|Miscellaneous|1|||
164073790|NCT02216214|592635034|FG001|Overall Study|Miscellaneous|1|||
164073791|NCT05354206|592635036|FG000|Overall Study|Withdrawal by Subject|1|||
164073792|NCT05354206|592635037|FG001|Overall Study|Withdrawal by Subject|0|||
164073793|NCT00713830|592635040|FG000|Overall Study|Adverse Event|23|||
164073794|NCT00713830|592635041|FG001|Overall Study|Adverse Event|71|||
164073795|NCT00713830|592635040|FG000|Overall Study|Lack of Efficacy|24|||
164073796|NCT00713830|592635041|FG001|Overall Study|Lack of Efficacy|16|||
164073797|NCT00713830|592635040|FG000|Overall Study|Lost to Follow-up|2|||
164073798|NCT00713830|592635041|FG001|Overall Study|Lost to Follow-up|9|||
164073799|NCT00713830|592635040|FG000|Overall Study|Withdrawal by Subject|13|||
164073800|NCT00713830|592635041|FG001|Overall Study|Withdrawal by Subject|23|||
164073801|NCT00713830|592635040|FG000|Overall Study|Poor Compliance to Protocol|7|||
164188779|NCT02959918|593060334|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
164188780|NCT02959918|593060335|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188781|NCT02959918|593060336|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164073802|NCT00713830|592635041|FG001|Overall Study|Poor Compliance to Protocol|14|||
164073803|NCT00713830|592635040|FG000|Overall Study|Familial and Personal Reasons|9|||
164073804|NCT00713830|592635041|FG001|Overall Study|Familial and Personal Reasons|34|||
164188782|NCT02959918|593060337|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188783|NCT02959918|593060338|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
164188784|NCT02959918|593060339|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
163958918|NCT02892344|592221741|FG001|Overall Study|Protocol deviation|4|||
164188785|NCT02959918|593060326|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188786|NCT02959918|593060327|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188787|NCT02959918|593060328|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188788|NCT02959918|593060329|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188789|NCT02959918|593060330|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188790|NCT02959918|593060331|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188791|NCT02959918|593060332|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188792|NCT02959918|593060333|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188793|NCT02959918|593060334|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188794|NCT02959918|593060335|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
164188795|NCT02959918|593060336|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188796|NCT02959918|593060337|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188797|NCT02959918|593060338|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188798|NCT02959918|593060339|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
164188799|NCT03173456|593060341|FG000|Baseline|Medication dispensing system malfunction'|0|||
164188800|NCT03173456|593060342|FG001|Baseline|Medication dispensing system malfunction'|1|||
164188801|NCT03173456|593060343|FG002|Baseline|Medication dispensing system malfunction'|0|||
164188802|NCT03173456|593060344|FG003|Baseline|Medication dispensing system malfunction'|0|||
164188803|NCT03173456|593060345|FG004|Baseline|Medication dispensing system malfunction'|2|||
164188804|NCT03173456|593060341|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
164188805|NCT03173456|593060342|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
164188806|NCT03173456|593060343|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
164188807|NCT03173456|593060344|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
164188808|NCT03173456|593060345|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
164188809|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
164188810|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
164188811|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
164188812|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
164188813|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
164188814|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
164188815|NCT01733121|593060346|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
164188816|NCT01733121|593060347|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
164188817|NCT03061188|593060348|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
164188818|NCT03061188|593060349|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
164188819|NCT03061188|593060350|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
164188820|NCT03061188|593060351|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
164188821|NCT03061188|593060348|FG000|On Follow-up for 3 Years|Death|0|||
164188822|NCT03061188|593060349|FG001|On Follow-up for 3 Years|Death|3|||
164188823|NCT03061188|593060350|FG002|On Follow-up for 3 Years|Death|5|||
164188824|NCT03061188|593060351|FG003|On Follow-up for 3 Years|Death|4|||
164188825|NCT03061188|593060348|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
164188826|NCT03061188|593060349|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
164188827|NCT03061188|593060350|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
164188828|NCT03061188|593060351|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
164188829|NCT04865419|593060354|FG000|Overall Study|Other|1|||
164188830|NCT04865419|593060355|FG001|Overall Study|Other|2|||
164188831|NCT04865419|593060356|FG002|Overall Study|Other|2|||
164188832|NCT04865419|593060357|FG003|Overall Study|Other|1|||
164188833|NCT04865419|593060358|FG004|Overall Study|Other|3|||
164188834|NCT04865419|593060359|FG005|Overall Study|Other|0|||
164188835|NCT04865419|593060360|FG006|Overall Study|Other|0|||
164188836|NCT04865419|593060361|FG007|Overall Study|Other|1|||
164188837|NCT04865419|593060362|FG008|Overall Study|Other|0|||
164188838|NCT04865419|593060363|FG009|Overall Study|Other|0|||
164188839|NCT04865419|593060364|FG010|Overall Study|Other|0|||
164188840|NCT04865419|593060354|FG000|Overall Study|Withdrawal by Subject|0|||
164188841|NCT04865419|593060355|FG001|Overall Study|Withdrawal by Subject|1|||
164188842|NCT04865419|593060356|FG002|Overall Study|Withdrawal by Subject|1|||
164188843|NCT04865419|593060357|FG003|Overall Study|Withdrawal by Subject|0|||
164188844|NCT04865419|593060358|FG004|Overall Study|Withdrawal by Subject|0|||
164188845|NCT04865419|593060359|FG005|Overall Study|Withdrawal by Subject|0|||
164188846|NCT04865419|593060360|FG006|Overall Study|Withdrawal by Subject|0|||
164188847|NCT04865419|593060361|FG007|Overall Study|Withdrawal by Subject|1|||
163958919|NCT02892344|592221740|FG000|Overall Study|Adverse Event|1|||
164188848|NCT04865419|593060362|FG008|Overall Study|Withdrawal by Subject|2|||
164188849|NCT04865419|593060363|FG009|Overall Study|Withdrawal by Subject|1|||
164188850|NCT04865419|593060364|FG010|Overall Study|Withdrawal by Subject|0|||
164188851|NCT04865419|593060354|FG000|Overall Study|Study terminated by Sponsor|0|||
164188852|NCT04865419|593060355|FG001|Overall Study|Study terminated by Sponsor|0|||
164188853|NCT04865419|593060356|FG002|Overall Study|Study terminated by Sponsor|0|||
164188854|NCT04865419|593060357|FG003|Overall Study|Study terminated by Sponsor|2|||
164188855|NCT04865419|593060358|FG004|Overall Study|Study terminated by Sponsor|2|||
164188856|NCT04865419|593060359|FG005|Overall Study|Study terminated by Sponsor|0|||
164188857|NCT04865419|593060360|FG006|Overall Study|Study terminated by Sponsor|0|||
164188858|NCT04865419|593060361|FG007|Overall Study|Study terminated by Sponsor|0|||
164188859|NCT04865419|593060362|FG008|Overall Study|Study terminated by Sponsor|0|||
164188860|NCT04865419|593060363|FG009|Overall Study|Study terminated by Sponsor|0|||
164188861|NCT04865419|593060364|FG010|Overall Study|Study terminated by Sponsor|1|||
164188862|NCT04865419|593060354|FG000|Overall Study|Death|3|||
164188863|NCT04865419|593060355|FG001|Overall Study|Death|1|||
164188864|NCT04865419|593060356|FG002|Overall Study|Death|4|||
164188865|NCT04865419|593060357|FG003|Overall Study|Death|2|||
164188866|NCT04865419|593060358|FG004|Overall Study|Death|5|||
164188867|NCT04865419|593060359|FG005|Overall Study|Death|2|||
164188868|NCT04865419|593060360|FG006|Overall Study|Death|1|||
164188869|NCT04865419|593060361|FG007|Overall Study|Death|1|||
164188870|NCT04865419|593060362|FG008|Overall Study|Death|2|||
164188871|NCT04865419|593060363|FG009|Overall Study|Death|2|||
164188872|NCT04865419|593060364|FG010|Overall Study|Death|1|||
164188873|NCT04865419|593060354|FG000|Overall Study|Lost to Follow-up|0|||
164188874|NCT04865419|593060355|FG001|Overall Study|Lost to Follow-up|0|||
164188875|NCT04865419|593060356|FG002|Overall Study|Lost to Follow-up|0|||
164188876|NCT04865419|593060357|FG003|Overall Study|Lost to Follow-up|0|||
164188877|NCT04865419|593060358|FG004|Overall Study|Lost to Follow-up|0|||
164188878|NCT04865419|593060359|FG005|Overall Study|Lost to Follow-up|0|||
164188879|NCT04865419|593060360|FG006|Overall Study|Lost to Follow-up|0|||
164188880|NCT04865419|593060361|FG007|Overall Study|Lost to Follow-up|0|||
164188881|NCT04865419|593060362|FG008|Overall Study|Lost to Follow-up|0|||
164188882|NCT04865419|593060363|FG009|Overall Study|Lost to Follow-up|1|||
164188883|NCT04865419|593060364|FG010|Overall Study|Lost to Follow-up|0|||
164188884|NCT05446142|593060365|FG000|Period 2|Adverse Event|1|||
164188885|NCT05446142|593060366|FG001|Period 2|Adverse Event|0|||
164188886|NCT05446142|593060367|FG002|Period 2|Adverse Event|0|||
164188887|NCT05446142|593060368|FG003|Period 2|Adverse Event|0|||
164188888|NCT05446142|593060369|FG004|Period 2|Adverse Event|0|||
164188889|NCT05446142|593060370|FG005|Period 2|Adverse Event|0|||
164188890|NCT00547157|593060375|FG000|Overall Study|Other|1|||
164188891|NCT00547157|593060376|FG001|Overall Study|Other|0|||
164188892|NCT00547157|593060375|FG000|Overall Study|Death|38|||
164188893|NCT00547157|593060376|FG001|Overall Study|Death|18|||
164188894|NCT00547157|593060375|FG000|Overall Study|Withdrawal by Subject|3|||
164188895|NCT00547157|593060376|FG001|Overall Study|Withdrawal by Subject|1|||
164188896|NCT00547157|593060375|FG000|Overall Study|Administrative decision|3|||
164188897|NCT00547157|593060376|FG001|Overall Study|Administrative decision|2|||
164188898|NCT00547157|593060375|FG000|Overall Study|Lost to Follow-up|4|||
164188899|NCT00547157|593060376|FG001|Overall Study|Lost to Follow-up|2|||
164188900|NCT01151345|593060378|FG000|First Intervention Period|Protocol Violation|0|||
164188901|NCT01151345|593060379|FG001|First Intervention Period|Protocol Violation|1|||
164188902|NCT03883477|593060381|FG000|Overall Study|Death|1|||
164188903|NCT03883477|593060382|FG001|Overall Study|Death|0|||
164188904|NCT03883477|593060381|FG000|Overall Study|Protocol Violation|0|||
164188905|NCT03883477|593060382|FG001|Overall Study|Protocol Violation|1|||
164188906|NCT03853291|593060383|FG000|Overall Study|Lost to Follow-up|1|||
164188907|NCT03853291|593060384|FG001|Overall Study|Lost to Follow-up|2|||
164188908|NCT03853291|593060385|FG002|Overall Study|Lost to Follow-up|0|||
164188909|NCT03853291|593060386|FG003|Overall Study|Lost to Follow-up|0|||
164188910|NCT03853291|593060387|FG004|Overall Study|Lost to Follow-up|0|||
164188911|NCT03853291|593060388|FG005|Overall Study|Lost to Follow-up|0|||
164188912|NCT03853291|593060383|FG000|Overall Study|Determined to be ineligible|1|||
164188913|NCT03853291|593060384|FG001|Overall Study|Determined to be ineligible|1|||
164188914|NCT03853291|593060385|FG002|Overall Study|Determined to be ineligible|0|||
164188915|NCT03853291|593060386|FG003|Overall Study|Determined to be ineligible|0|||
164188916|NCT03853291|593060387|FG004|Overall Study|Determined to be ineligible|0|||
164188917|NCT03853291|593060388|FG005|Overall Study|Determined to be ineligible|0|||
164188918|NCT04186221|593060390|FG000|Overall Study|Death|1|||
164188919|NCT01658904|593060391|FG000|Overall Study|Principal Investigator discretion|2|||
163958920|NCT02892344|592221741|FG001|Overall Study|Adverse Event|8|||
163958921|NCT02892344|592221740|FG000|Overall Study|Lost to Follow-up|0|||
164188920|NCT01658904|593060392|FG001|Overall Study|Principal Investigator discretion|0|||
164188921|NCT01658904|593060393|FG002|Overall Study|Principal Investigator discretion|0|||
164188922|NCT02998996|593060398|FG000|Overall Study|Lost to Follow-up|0|||
164188923|NCT02998996|593060399|FG001|Overall Study|Lost to Follow-up|0|||
164188924|NCT02998996|593060400|FG002|Overall Study|Lost to Follow-up|1|||
164188925|NCT02998996|593060401|FG003|Overall Study|Lost to Follow-up|0|||
164188926|NCT02998996|593060402|FG004|Overall Study|Lost to Follow-up|0|||
164188927|NCT02998996|593060403|FG005|Overall Study|Lost to Follow-up|0|||
164188928|NCT02998996|593060398|FG000|Overall Study|Pregnancy|0|||
164188929|NCT02998996|593060399|FG001|Overall Study|Pregnancy|1|||
164188930|NCT02998996|593060400|FG002|Overall Study|Pregnancy|0|||
164188931|NCT02998996|593060401|FG003|Overall Study|Pregnancy|0|||
164188932|NCT02998996|593060402|FG004|Overall Study|Pregnancy|0|||
164188933|NCT02998996|593060403|FG005|Overall Study|Pregnancy|0|||
164188934|NCT02998996|593060398|FG000|Overall Study|Family reasons|0|||
164188935|NCT02998996|593060399|FG001|Overall Study|Family reasons|0|||
164188936|NCT02998996|593060400|FG002|Overall Study|Family reasons|0|||
164188937|NCT02998996|593060401|FG003|Overall Study|Family reasons|0|||
164188938|NCT02998996|593060402|FG004|Overall Study|Family reasons|1|||
164188939|NCT02998996|593060403|FG005|Overall Study|Family reasons|0|||
164188940|NCT01087203|593060404|FG000|Overall Study|Lost to Follow-up|2|||
164188941|NCT01087203|593060405|FG001|Overall Study|Lost to Follow-up|0|||
164188942|NCT01087203|593060404|FG000|Overall Study|Withdrawal by Subject|2|||
164188943|NCT01087203|593060405|FG001|Overall Study|Withdrawal by Subject|6|||
164188944|NCT01087203|593060404|FG000|Overall Study|Lack of Efficacy|1|||
164188945|NCT01087203|593060405|FG001|Overall Study|Lack of Efficacy|2|||
164188946|NCT01087203|593060404|FG000|Overall Study|Study terminated by sponsor|27|||
164188947|NCT01087203|593060405|FG001|Overall Study|Study terminated by sponsor|27|||
164188948|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
164188949|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
164188950|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
164188951|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
164188952|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
164188953|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
164188954|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
164188955|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
164188956|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
164301366|NCT01709084|593480138|FG000|Overall Study|Not Treated|0|||
164301367|NCT01709084|593480139|FG001|Overall Study|Not Treated|2|||
164073805|NCT00713830|592635040|FG000|Overall Study|Sponsor Decision|4|||
164073806|NCT00713830|592635041|FG001|Overall Study|Sponsor Decision|10|||
164073807|NCT02261974|592635044|FG000|Overall Study|Withdrawal by Subject|3|||
164073808|NCT02261974|592635045|FG001|Overall Study|Withdrawal by Subject|2|||
164073809|NCT02261974|592635044|FG000|Overall Study|Pregnancy|0|||
164073810|NCT02261974|592635045|FG001|Overall Study|Pregnancy|1|||
164073811|NCT02261974|592635044|FG000|Overall Study|Missed treatment cut-off date|6|||
164073812|NCT02261974|592635045|FG001|Overall Study|Missed treatment cut-off date|3|||
164073813|NCT02261974|592635044|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
164073814|NCT02261974|592635045|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
164073815|NCT02261974|592635044|FG000|Overall Study|Lost to Follow-up|2|||
164073816|NCT02261974|592635045|FG001|Overall Study|Lost to Follow-up|0|||
164073817|NCT02261974|592635044|FG000|Overall Study|Adverse Event|1|||
164073818|NCT02261974|592635045|FG001|Overall Study|Adverse Event|0|||
164073819|NCT02030834|592635046|FG000|Overall Study|Death|4|||
164073820|NCT02030834|592635047|FG001|Overall Study|Death|0|||
164073821|NCT02030834|592635048|FG002|Overall Study|Death|0|||
164090380|NCT00306384|592693426|FG001|Overall Study|Pregnancy|1|||
164301368|NCT00214201|593480140|FG000|Overall Study|Withdrawal by Subject|2|||
164301369|NCT00214201|593480141|FG001|Overall Study|Withdrawal by Subject|0|||
164301370|NCT00214201|593480140|FG000|Overall Study|Death|0|||
164301371|NCT00214201|593480141|FG001|Overall Study|Death|2|||
164301372|NCT00463567|593480145|FG000|Overall Study|Adverse Event|29|||
164301373|NCT00463567|593480146|FG001|Overall Study|Adverse Event|26|||
164301374|NCT00463567|593480147|FG002|Overall Study|Adverse Event|17|||
164301375|NCT00463567|593480148|FG003|Overall Study|Adverse Event|46|||
164301376|NCT00463567|593480149|FG004|Overall Study|Adverse Event|10|||
164301377|NCT00463567|593480150|FG005|Overall Study|Adverse Event|10|||
164301378|NCT00463567|593480151|FG006|Overall Study|Adverse Event|4|||
164301379|NCT00463567|593480145|FG000|Overall Study|Withdrawal by Subject|29|||
164301380|NCT00463567|593480146|FG001|Overall Study|Withdrawal by Subject|22|||
164301381|NCT00463567|593480147|FG002|Overall Study|Withdrawal by Subject|20|||
164301382|NCT00463567|593480148|FG003|Overall Study|Withdrawal by Subject|37|||
164301383|NCT00463567|593480149|FG004|Overall Study|Withdrawal by Subject|6|||
164301384|NCT00463567|593480150|FG005|Overall Study|Withdrawal by Subject|5|||
164301385|NCT00463567|593480151|FG006|Overall Study|Withdrawal by Subject|1|||
164301386|NCT00463567|593480145|FG000|Overall Study|Protocol Deviation|13|||
164301387|NCT00463567|593480146|FG001|Overall Study|Protocol Deviation|9|||
164301388|NCT00463567|593480147|FG002|Overall Study|Protocol Deviation|14|||
164301389|NCT00463567|593480148|FG003|Overall Study|Protocol Deviation|11|||
164301390|NCT00463567|593480149|FG004|Overall Study|Protocol Deviation|1|||
164301391|NCT00463567|593480150|FG005|Overall Study|Protocol Deviation|1|||
164301392|NCT00463567|593480151|FG006|Overall Study|Protocol Deviation|2|||
164301393|NCT00463567|593480145|FG000|Overall Study|Lost to Follow-up|12|||
164301394|NCT00463567|593480146|FG001|Overall Study|Lost to Follow-up|6|||
164301395|NCT00463567|593480147|FG002|Overall Study|Lost to Follow-up|13|||
164301396|NCT00463567|593480148|FG003|Overall Study|Lost to Follow-up|8|||
164301397|NCT00463567|593480149|FG004|Overall Study|Lost to Follow-up|1|||
164301398|NCT00463567|593480150|FG005|Overall Study|Lost to Follow-up|1|||
164301399|NCT00463567|593480151|FG006|Overall Study|Lost to Follow-up|1|||
164301400|NCT00463567|593480145|FG000|Overall Study|Administrative problems|5|||
164301401|NCT00463567|593480146|FG001|Overall Study|Administrative problems|3|||
164301402|NCT00463567|593480147|FG002|Overall Study|Administrative problems|6|||
164301403|NCT00463567|593480148|FG003|Overall Study|Administrative problems|9|||
164188957|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
164188958|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188959|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188960|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188961|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
164188962|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188963|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188964|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
164188965|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
164188966|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188967|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
164188968|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188969|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188970|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
164188971|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188972|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164301989|NCT00248040|593482502|FG002|Overall Study|Death|1|||
164301990|NCT03847896|593482504|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164301991|NCT03847896|593482505|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164073822|NCT02030834|592635046|FG000|Overall Study|Manufacturing failure|2|||
164073823|NCT02030834|592635047|FG001|Overall Study|Manufacturing failure|0|||
164301992|NCT03847896|593482506|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
164301993|NCT03847896|593482507|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164073824|NCT02030834|592635048|FG002|Overall Study|Manufacturing failure|1|||
164073825|NCT02030834|592635046|FG000|Overall Study|Disease progression|2|||
164073826|NCT02030834|592635047|FG001|Overall Study|Disease progression|0|||
164073827|NCT02030834|592635048|FG002|Overall Study|Disease progression|2|||
164073828|NCT02030834|592635046|FG000|Overall Study|Lost to Follow-up|1|||
164073829|NCT02030834|592635047|FG001|Overall Study|Lost to Follow-up|0|||
164301994|NCT03847896|593482508|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
164301995|NCT03847896|593482504|FG000|Overall Study|Withdrawal by Subject|2|||
164301996|NCT03847896|593482505|FG001|Overall Study|Withdrawal by Subject|10|||
164301997|NCT03847896|593482506|FG002|Overall Study|Withdrawal by Subject|5|||
164301998|NCT03847896|593482507|FG003|Overall Study|Withdrawal by Subject|9|||
164301999|NCT03847896|593482508|FG004|Overall Study|Withdrawal by Subject|8|||
164302000|NCT03847896|593482504|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164302001|NCT03847896|593482505|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164302002|NCT03847896|593482506|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164302003|NCT03847896|593482507|FG003|Overall Study|Withdrawal by parent/guardian|0|||
164302004|NCT03847896|593482508|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164302005|NCT03847896|593482504|FG000|Overall Study|Adverse Event|2|||
164302006|NCT03847896|593482505|FG001|Overall Study|Adverse Event|1|||
164302007|NCT03847896|593482506|FG002|Overall Study|Adverse Event|3|||
164302008|NCT03847896|593482507|FG003|Overall Study|Adverse Event|2|||
164302009|NCT03847896|593482508|FG004|Overall Study|Adverse Event|4|||
164302010|NCT03847896|593482504|FG000|Overall Study|A severe exacerbation event|0|||
164302011|NCT03847896|593482505|FG001|Overall Study|A severe exacerbation event|0|||
164302012|NCT03847896|593482506|FG002|Overall Study|A severe exacerbation event|0|||
164302013|NCT03847896|593482507|FG003|Overall Study|A severe exacerbation event|0|||
164302014|NCT03847896|593482508|FG004|Overall Study|A severe exacerbation event|3|||
164302015|NCT03847896|593482504|FG000|Overall Study|Protocol Violation|0|||
164302016|NCT03847896|593482505|FG001|Overall Study|Protocol Violation|2|||
164302017|NCT03847896|593482506|FG002|Overall Study|Protocol Violation|1|||
164302018|NCT03847896|593482507|FG003|Overall Study|Protocol Violation|0|||
164302019|NCT03847896|593482508|FG004|Overall Study|Protocol Violation|2|||
164302020|NCT03847896|593482504|FG000|Overall Study|Lost to Follow-up|0|||
164302021|NCT03847896|593482505|FG001|Overall Study|Lost to Follow-up|0|||
164302022|NCT03847896|593482506|FG002|Overall Study|Lost to Follow-up|0|||
164302023|NCT03847896|593482507|FG003|Overall Study|Lost to Follow-up|1|||
164302024|NCT03847896|593482508|FG004|Overall Study|Lost to Follow-up|0|||
164302025|NCT03847896|593482504|FG000|Overall Study|Condition under investigation worsened|0|||
164302026|NCT03847896|593482505|FG001|Overall Study|Condition under investigation worsened|0|||
164302027|NCT03847896|593482506|FG002|Overall Study|Condition under investigation worsened|0|||
164302028|NCT03847896|593482507|FG003|Overall Study|Condition under investigation worsened|1|||
164302029|NCT03847896|593482508|FG004|Overall Study|Condition under investigation worsened|1|||
164302030|NCT03847896|593482504|FG000|Overall Study|Lack of Efficacy|0|||
164302031|NCT03847896|593482505|FG001|Overall Study|Lack of Efficacy|0|||
164302032|NCT03847896|593482506|FG002|Overall Study|Lack of Efficacy|0|||
164302033|NCT03847896|593482507|FG003|Overall Study|Lack of Efficacy|2|||
164303069|NCT00775190|593486416|FG000|Overall Study|Lost to Follow-up|2|||
164303070|NCT00775190|593486417|FG001|Overall Study|Lost to Follow-up|3|||
164303071|NCT00775190|593486416|FG000|Overall Study|Withdrawal by Subject|1|||
164303072|NCT00775190|593486417|FG001|Overall Study|Withdrawal by Subject|2|||
164303073|NCT00775190|593486416|FG000|Overall Study|Protocol Violation|1|||
164303074|NCT00775190|593486417|FG001|Overall Study|Protocol Violation|0|||
164303075|NCT01710501|593486418|FG000|Overall Study|Lost to Follow-up|2|||
164303076|NCT01710501|593486419|FG001|Overall Study|Lost to Follow-up|0|||
164303077|NCT01710501|593486420|FG002|Overall Study|Lost to Follow-up|0|||
164303078|NCT01376804|593486421|FG000|Treatment Period|Withdrawal by Subject|1|||
164303079|NCT01376804|593486421|FG000|Treatment Period|Adverse Event|6|||
164303080|NCT01376804|593486421|FG000|Treatment Period|Patient did not receive study drug|1|||
164303081|NCT01281124|593486422|FG000|Overall Study|Death|1|||
164303082|NCT05097963|593486423|FG000|Overall Study|Protocol Violation|13|||
164303083|NCT05097963|593486423|FG000|Overall Study|Withdrawal by Subject|21|||
164303084|NCT02492763|593486424|FG000|Overall Study|Withdrawal by Subject|0|||
164303085|NCT02492763|593486425|FG001|Overall Study|Withdrawal by Subject|2|||
164303086|NCT02492763|593486426|FG002|Overall Study|Withdrawal by Subject|1|||
164303087|NCT02492763|593486427|FG003|Overall Study|Withdrawal by Subject|0|||
164303088|NCT02492763|593486424|FG000|Overall Study|Adverse Event|3|||
164303089|NCT02492763|593486425|FG001|Overall Study|Adverse Event|1|||
164303090|NCT02492763|593486426|FG002|Overall Study|Adverse Event|1|||
164303091|NCT02492763|593486427|FG003|Overall Study|Adverse Event|2|||
164303092|NCT02492763|593486424|FG000|Overall Study|Death|0|||
164303093|NCT02492763|593486425|FG001|Overall Study|Death|0|||
164303094|NCT02492763|593486426|FG002|Overall Study|Death|1|||
164303095|NCT02492763|593486427|FG003|Overall Study|Death|0|||
164303096|NCT02492763|593486424|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
164303097|NCT02492763|593486425|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
164303098|NCT02492763|593486426|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
164303099|NCT02492763|593486427|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
164303100|NCT02492763|593486424|FG000|Overall Study|Lost to Follow-up|0|||
164303101|NCT02492763|593486425|FG001|Overall Study|Lost to Follow-up|0|||
164303102|NCT02492763|593486426|FG002|Overall Study|Lost to Follow-up|1|||
164303103|NCT02492763|593486427|FG003|Overall Study|Lost to Follow-up|0|||
164303104|NCT02492763|593486424|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164303105|NCT02492763|593486425|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164303106|NCT02492763|593486426|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164303107|NCT02492763|593486427|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164303108|NCT02492763|593486424|FG000|Overall Study|Screen Failure|0|||
164303109|NCT02492763|593486425|FG001|Overall Study|Screen Failure|0|||
164303110|NCT02492763|593486426|FG002|Overall Study|Screen Failure|0|||
164303111|NCT02492763|593486427|FG003|Overall Study|Screen Failure|1|||
164303112|NCT02492763|593486424|FG000|Overall Study|Study Terminated by Sponsor|13|||
164303113|NCT02492763|593486425|FG001|Overall Study|Study Terminated by Sponsor|10|||
163958922|NCT02892344|592221741|FG001|Overall Study|Lost to Follow-up|1|||
163958923|NCT02892344|592221740|FG000|Overall Study|Non-compliance with study treatment|0|||
163958924|NCT02892344|592221741|FG001|Overall Study|Non-compliance with study treatment|1|||
163958925|NCT02892344|592221740|FG000|Overall Study|Physician Decision|0|||
163958926|NCT02892344|592221741|FG001|Overall Study|Physician Decision|2|||
163958927|NCT02892344|592221740|FG000|Overall Study|Subject/guardian decision|0|||
163958928|NCT02892344|592221741|FG001|Overall Study|Subject/guardian decision|4|||
163958929|NCT02892344|592221740|FG000|Overall Study|Technical problems|0|||
163958930|NCT02892344|592221741|FG001|Overall Study|Technical problems|1|||
163958931|NCT03938454|592221742|FG000|Overall Study|Protocol Violation|1|||
163958932|NCT03938454|592221742|FG000|Overall Study|Withdrawal by Subject|2|||
163958933|NCT03938454|592221742|FG000|Overall Study|Lost to Follow-up|3|||
163958934|NCT05888103|592221743|FG000|Overall Study|Participant decision|3|||
163958935|NCT05888103|592221744|FG001|Overall Study|Participant decision|3|||
163958936|NCT01028222|592221751|FG000|Overall Study|Protocol deviation|1|||
163958937|NCT01028222|592221752|FG001|Overall Study|Protocol deviation|0|||
163958938|NCT01028222|592221751|FG000|Overall Study|Disease progression|33|||
163958939|NCT01028222|592221752|FG001|Overall Study|Disease progression|9|||
163958940|NCT01028222|592221751|FG000|Overall Study|Administrative problems|1|||
163844474|NCT00581113|591800033|FG000|Overall Study|Withdrawal by Subject|0|||
163844475|NCT00581113|591800034|FG001|Overall Study|Withdrawal by Subject|1|||
163958941|NCT01028222|592221752|FG001|Overall Study|Administrative problems|1|||
164303114|NCT02492763|593486426|FG002|Overall Study|Study Terminated by Sponsor|6|||
164303115|NCT02492763|593486427|FG003|Overall Study|Study Terminated by Sponsor|10|||
164303116|NCT02446899|593486428|FG000|Overall Study|Adverse Event|4|||
164303117|NCT02446899|593486429|FG001|Overall Study|Adverse Event|7|||
164303118|NCT02446899|593486428|FG000|Overall Study|Condition Under Investigation Worsened|1|||
164303119|NCT02446899|593486429|FG001|Overall Study|Condition Under Investigation Worsened|4|||
164303120|NCT02446899|593486428|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
164303121|NCT02446899|593486429|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
164303122|NCT02446899|593486428|FG000|Overall Study|Lack of Efficacy|2|||
163844476|NCT04834362|591800035|FG000|Overall Study|Death|1|||
163844477|NCT04834362|591800036|FG001|Overall Study|Death|2|||
163844478|NCT00329719|591800039|FG000|Overall Study|Lost to Follow-up|0|||
163844479|NCT00329719|591800040|FG001|Overall Study|Lost to Follow-up|0|||
163844480|NCT00329719|591800041|FG002|Overall Study|Lost to Follow-up|0|||
163844481|NCT00329719|591800042|FG003|Overall Study|Lost to Follow-up|1|||
163844482|NCT06017999|591800043|FG000|Overall Study|Withdrawal by Subject|0|||
163844483|NCT06017999|591800044|FG001|Overall Study|Withdrawal by Subject|4|||
163844484|NCT06017999|591800045|FG002|Overall Study|Withdrawal by Subject|3|||
163844485|NCT06017999|591800043|FG000|Overall Study|Adverse Event|2|||
163844486|NCT06017999|591800044|FG001|Overall Study|Adverse Event|1|||
163844487|NCT06017999|591800045|FG002|Overall Study|Adverse Event|1|||
163958942|NCT01028222|592221751|FG000|Overall Study|Lost to Follow-up|0|||
163958943|NCT01028222|592221752|FG001|Overall Study|Lost to Follow-up|1|||
163958944|NCT01028222|592221751|FG000|Overall Study|Withdrawal by Subject|1|||
163958945|NCT01028222|592221752|FG001|Overall Study|Withdrawal by Subject|0|||
163958946|NCT01028222|592221751|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
163958947|NCT01028222|592221752|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
163958948|NCT01028222|592221751|FG000|Overall Study|Adverse Event|2|||
163958949|NCT01028222|592221752|FG001|Overall Study|Adverse Event|0|||
163958950|NCT00146328|592221753|FG000|Overall Study|Adverse Event|39|||
163958951|NCT00146328|592221754|FG001|Overall Study|Adverse Event|48|||
163958952|NCT00146328|592221755|FG002|Overall Study|Adverse Event|79|||
163958953|NCT00146328|592221753|FG000|Overall Study|Protocol Violation|11|||
163958954|NCT00146328|592221754|FG001|Overall Study|Protocol Violation|6|||
163958955|NCT00146328|592221755|FG002|Overall Study|Protocol Violation|12|||
163958956|NCT00146328|592221753|FG000|Overall Study|Lost to Follow-up|7|||
163958957|NCT00146328|592221754|FG001|Overall Study|Lost to Follow-up|4|||
163958958|NCT00146328|592221755|FG002|Overall Study|Lost to Follow-up|7|||
164303123|NCT02446899|593486429|FG001|Overall Study|Lack of Efficacy|8|||
164303124|NCT02446899|593486428|FG000|Overall Study|Lost to Follow-up|1|||
164303125|NCT02446899|593486429|FG001|Overall Study|Lost to Follow-up|3|||
164303126|NCT02446899|593486428|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
164303127|NCT02446899|593486429|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
164303128|NCT02446899|593486428|FG000|Overall Study|Withdrawal by Subject|11|||
164303129|NCT02446899|593486429|FG001|Overall Study|Withdrawal by Subject|19|||
164303130|NCT02446899|593486428|FG000|Overall Study|Miscellaneous|5|||
164303131|NCT02446899|593486429|FG001|Overall Study|Miscellaneous|4|||
164303132|NCT02446899|593486428|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164303133|NCT02446899|593486429|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
164303134|NCT01002339|593486430|FG000|Overall Study|Withdrawal by Subject|0|||
164303135|NCT01002339|593486431|FG001|Overall Study|Withdrawal by Subject|1|||
164303136|NCT01002339|593486432|FG002|Overall Study|Withdrawal by Subject|0|||
164303137|NCT01002339|593486430|FG000|Overall Study|Incorrect treatment assignment|0|||
164303138|NCT01002339|593486431|FG001|Overall Study|Incorrect treatment assignment|0|||
164303139|NCT01002339|593486432|FG002|Overall Study|Incorrect treatment assignment|1|||
164303140|NCT01002339|593486430|FG000|Overall Study|Protocol Violation|0|||
164303141|NCT01002339|593486431|FG001|Overall Study|Protocol Violation|0|||
164303142|NCT01002339|593486432|FG002|Overall Study|Protocol Violation|2|||
164303143|NCT01002339|593486430|FG000|Overall Study|Lung cancer detected before transplant|0|||
164303144|NCT01002339|593486431|FG001|Overall Study|Lung cancer detected before transplant|0|||
164303145|NCT01002339|593486432|FG002|Overall Study|Lung cancer detected before transplant|1|||
164303146|NCT01002339|593486430|FG000|Overall Study|Randomized. Not transplanted|0|||
164303147|NCT01002339|593486431|FG001|Overall Study|Randomized. Not transplanted|0|||
163958959|NCT00146328|592221753|FG000|Overall Study|Withdrawal by Subject|16|||
164303148|NCT01002339|593486432|FG002|Overall Study|Randomized. Not transplanted|1|||
164303149|NCT02215252|593486433|FG000|Overall Study|Adverse Event|1|||
163844488|NCT06017999|591800043|FG000|Overall Study|Lost to Follow-up|0|||
163958960|NCT00146328|592221754|FG001|Overall Study|Withdrawal by Subject|16|||
163958961|NCT00146328|592221755|FG002|Overall Study|Withdrawal by Subject|22|||
163958962|NCT00146328|592221753|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
164303150|NCT02215252|593486434|FG001|Overall Study|Adverse Event|5|||
164303151|NCT02215252|593486435|FG002|Overall Study|Adverse Event|2|||
164303152|NCT02215252|593486433|FG000|Overall Study|Lost to Follow-up|0|||
164303153|NCT02215252|593486434|FG001|Overall Study|Lost to Follow-up|0|||
164303154|NCT02215252|593486435|FG002|Overall Study|Lost to Follow-up|1|||
164303155|NCT02215252|593486433|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
164303156|NCT02215252|593486434|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
164303157|NCT02215252|593486435|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
164303158|NCT02215252|593486433|FG000|Overall Study|Protocol Violation|0|||
164303159|NCT02215252|593486434|FG001|Overall Study|Protocol Violation|1|||
164303160|NCT02215252|593486435|FG002|Overall Study|Protocol Violation|0|||
164303161|NCT02215252|593486433|FG000|Overall Study|Withdrawal by Subject|1|||
163958963|NCT00146328|592221754|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
163958964|NCT00146328|592221755|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
163958965|NCT00146328|592221753|FG000|Overall Study|Trial ended/site closed|8|||
163958966|NCT00146328|592221754|FG001|Overall Study|Trial ended/site closed|2|||
163958967|NCT00146328|592221755|FG002|Overall Study|Trial ended/site closed|19|||
163958968|NCT00146328|592221753|FG000|Overall Study|Patient decision to end|0|||
163958969|NCT00146328|592221754|FG001|Overall Study|Patient decision to end|1|||
163958970|NCT00146328|592221755|FG002|Overall Study|Patient decision to end|6|||
163958971|NCT00146328|592221753|FG000|Overall Study|Enroll into other trial|2|||
163958972|NCT00146328|592221754|FG001|Overall Study|Enroll into other trial|4|||
163958973|NCT00146328|592221755|FG002|Overall Study|Enroll into other trial|2|||
163958974|NCT00146328|592221753|FG000|Overall Study|Death|0|||
163958975|NCT00146328|592221754|FG001|Overall Study|Death|1|||
163958976|NCT00146328|592221755|FG002|Overall Study|Death|1|||
163958977|NCT00146328|592221753|FG000|Overall Study|Moved|2|||
163958978|NCT00146328|592221754|FG001|Overall Study|Moved|0|||
163958979|NCT00146328|592221755|FG002|Overall Study|Moved|0|||
163958980|NCT00146328|592221753|FG000|Overall Study|Interaction with other medication|2|||
163958981|NCT00146328|592221754|FG001|Overall Study|Interaction with other medication|0|||
163958982|NCT00146328|592221755|FG002|Overall Study|Interaction with other medication|1|||
163958983|NCT01717989|592221756|FG000|Overall Study|Ineligibility determined|6|||
163958984|NCT01717989|592221756|FG000|Overall Study|Protocol deviation|6|||
163958985|NCT01717989|592221756|FG000|Overall Study|Withdrawal by Subject|11|||
163958986|NCT01717989|592221756|FG000|Overall Study|Physician Decision|2|||
163958987|NCT01717989|592221756|FG000|Overall Study|Lost to Follow-up|11|||
163958988|NCT01717989|592221756|FG000|Overall Study|Death|439|||
163958989|NCT01717989|592221756|FG000|Overall Study|Protocol-specified criteria|551|||
163958990|NCT01717989|592221756|FG000|Overall Study|Other|40|||
163958991|NCT03224325|592221757|FG000|Overall Study|Adverse Event|1|||
163958992|NCT03224325|592221758|FG001|Overall Study|Adverse Event|0|||
163958993|NCT03224325|592221759|FG002|Overall Study|Adverse Event|0|||
163958994|NCT03224325|592221760|FG003|Overall Study|Adverse Event|0|||
163958995|NCT03224325|592221761|FG004|Overall Study|Adverse Event|0|||
163958996|NCT03224325|592221762|FG005|Overall Study|Adverse Event|0|||
163958997|NCT03224325|592221763|FG006|Overall Study|Adverse Event|1|||
163958998|NCT03224325|592221757|FG000|Overall Study|Withdrawal by Subject|0|||
163958999|NCT03224325|592221758|FG001|Overall Study|Withdrawal by Subject|0|||
163959000|NCT03224325|592221759|FG002|Overall Study|Withdrawal by Subject|0|||
163959001|NCT03224325|592221760|FG003|Overall Study|Withdrawal by Subject|1|||
163959002|NCT03224325|592221761|FG004|Overall Study|Withdrawal by Subject|0|||
163959003|NCT03224325|592221762|FG005|Overall Study|Withdrawal by Subject|0|||
163959004|NCT03224325|592221763|FG006|Overall Study|Withdrawal by Subject|0|||
163959005|NCT02072434|592221767|FG000|Overall Study|Protocol Violation|10|||
163959006|NCT02072434|592221768|FG001|Overall Study|Protocol Violation|9|||
163959007|NCT02072434|592221767|FG000|Overall Study|Physician Decision|5|||
163959008|NCT02072434|592221768|FG001|Overall Study|Physician Decision|10|||
163959009|NCT02072434|592221767|FG000|Overall Study|Adverse event, serious fatal|1|||
163959010|NCT02072434|592221768|FG001|Overall Study|Adverse event, serious fatal|6|||
163959011|NCT02072434|592221767|FG000|Overall Study|Adverse Event|7|||
163959012|NCT02072434|592221768|FG001|Overall Study|Adverse Event|6|||
163959013|NCT02072434|592221767|FG000|Overall Study|Withdrawal by Subject|17|||
163959014|NCT02072434|592221768|FG001|Overall Study|Withdrawal by Subject|29|||
163959015|NCT02072434|592221767|FG000|Overall Study|Other|14|||
163959016|NCT02072434|592221768|FG001|Overall Study|Other|29|||
163959017|NCT02072434|592221767|FG000|Overall Study|Lost to Follow-up|0|||
163959018|NCT02072434|592221768|FG001|Overall Study|Lost to Follow-up|1|||
163959019|NCT01117454|592221771|FG000|Overall Study|Pregnancy|0|||
163959020|NCT01117454|592221772|FG001|Overall Study|Pregnancy|1|||
164303162|NCT02215252|593486434|FG001|Overall Study|Withdrawal by Subject|0|||
163959021|NCT00888433|592221775|FG000|Overall Study|Withdrawal by Subject|1|||
163959022|NCT00888433|592221776|FG001|Overall Study|Withdrawal by Subject|2|||
163959023|NCT00888433|592221775|FG000|Overall Study|Missed Visit|2|||
163959024|NCT00888433|592221776|FG001|Overall Study|Missed Visit|1|||
163959025|NCT04452877|592221777|FG000|Overall Study|Adverse Event|5|||
163959026|NCT04452877|592221777|FG000|Overall Study|Lost to Follow-up|1|||
163959027|NCT04452877|592221777|FG000|Overall Study|Physician Decision|4|||
163959028|NCT04452877|592221777|FG000|Overall Study|Progressive Disease|18|||
163959029|NCT04452877|592221777|FG000|Overall Study|Withdrawal by Subject|3|||
163959030|NCT02276872|592221778|FG000|Overall Study|Adverse Event|1|||
163959031|NCT02276872|592221779|FG001|Overall Study|Adverse Event|0|||
163959032|NCT02276872|592221780|FG002|Overall Study|Adverse Event|0|||
163959033|NCT04175808|592221781|FG000|Part A|Miscellaneous|2|||
163959034|NCT04175808|592221782|FG001|Part A|Miscellaneous|0|||
163959035|NCT04175808|592221783|FG002|Part A|Miscellaneous|0|||
163959036|NCT04175808|592221784|FG003|Part A|Miscellaneous|0|||
164303163|NCT02215252|593486435|FG002|Overall Study|Withdrawal by Subject|0|||
164303164|NCT02215252|593486433|FG000|Overall Study|Other|0|||
164303165|NCT02215252|593486434|FG001|Overall Study|Other|1|||
164303166|NCT02215252|593486435|FG002|Overall Study|Other|1|||
163959037|NCT04175808|592221785|FG004|Part A|Miscellaneous|0|||
163959038|NCT04175808|592221786|FG005|Part A|Miscellaneous|0|||
163959039|NCT04175808|592221787|FG006|Part A|Miscellaneous|0|||
163959040|NCT02544217|592221789|FG000|Overall Study|Withdrawal by Subject|1|||
163959041|NCT02544217|592221790|FG001|Overall Study|Withdrawal by Subject|1|||
163959042|NCT02544217|592221791|FG002|Overall Study|Withdrawal by Subject|0|||
163959043|NCT02544217|592221792|FG003|Overall Study|Withdrawal by Subject|0|||
163959044|NCT02544217|592221793|FG004|Overall Study|Withdrawal by Subject|0|||
163959045|NCT02544217|592221794|FG005|Overall Study|Withdrawal by Subject|0|||
163959046|NCT03278106|592221795|FG000|Overall Study|No protocol treatment|1|||
163959047|NCT03952806|592221800|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
163959048|NCT03952806|592221801|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
163959049|NCT03952806|592221800|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
163959050|NCT03952806|592221801|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
163959051|NCT03952806|592221800|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
163959052|NCT03952806|592221801|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
163959053|NCT03952806|592221800|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
163959054|NCT03952806|592221801|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
163959055|NCT03952806|592221800|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
163959056|NCT03952806|592221801|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
163959057|NCT03952806|592221800|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
163959058|NCT03952806|592221801|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
163959059|NCT03952806|592221800|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
163959060|NCT03952806|592221801|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
163959061|NCT03952806|592221800|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
163959062|NCT03952806|592221801|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
163959063|NCT03952806|592221800|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
163959064|NCT03952806|592221801|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
163959065|NCT03952806|592221800|FG000|OLE Phase (48 Weeks)|Other|16|||
163959066|NCT03952806|592221801|FG001|OLE Phase (48 Weeks)|Other|13|||
163959067|NCT00068588|592221802|FG000|Overall Study|Adverse Event|0|||
163959068|NCT00068588|592221803|FG001|Overall Study|Adverse Event|0|||
163959069|NCT00068588|592221804|FG002|Overall Study|Adverse Event|2|||
163959070|NCT00068588|592221802|FG000|Overall Study|Withdrawal by Subject|0|||
163959071|NCT00068588|592221803|FG001|Overall Study|Withdrawal by Subject|0|||
163959072|NCT00068588|592221804|FG002|Overall Study|Withdrawal by Subject|1|||
163959073|NCT00068588|592221802|FG000|Overall Study|Poor KPS|0|||
163959074|NCT00068588|592221803|FG001|Overall Study|Poor KPS|0|||
163959075|NCT00068588|592221804|FG002|Overall Study|Poor KPS|1|||
163959076|NCT02027701|592221808|FG000|Overall Study|Adverse Event|3|||
163959077|NCT02027701|592221808|FG000|Overall Study|Lack of Efficacy|8|||
163959078|NCT02027701|592221808|FG000|Overall Study|Physician Decision|2|||
163959079|NCT02027701|592221808|FG000|Overall Study|Withdrawal by Subject|3|||
163959080|NCT02875977|592221809|FG000|Overall Study|Lost to Follow-up|42|||
163959081|NCT02875977|592221810|FG001|Overall Study|Lost to Follow-up|29|||
163959082|NCT00820027|592221811|FG000|Overall Study|Adverse Event|15|||
163959083|NCT00820027|592221812|FG001|Overall Study|Adverse Event|8|||
163959084|NCT00820027|592221813|FG002|Overall Study|Adverse Event|10|||
163959085|NCT00820027|592221814|FG003|Overall Study|Adverse Event|5|||
163959086|NCT00820027|592221811|FG000|Overall Study|Lack of Efficacy|2|||
163959087|NCT00820027|592221812|FG001|Overall Study|Lack of Efficacy|1|||
163959088|NCT00820027|592221813|FG002|Overall Study|Lack of Efficacy|2|||
163959089|NCT00820027|592221814|FG003|Overall Study|Lack of Efficacy|2|||
163959090|NCT00820027|592221811|FG000|Overall Study|Physician Decision|0|||
163959091|NCT00820027|592221812|FG001|Overall Study|Physician Decision|1|||
163959092|NCT00820027|592221813|FG002|Overall Study|Physician Decision|1|||
163959093|NCT00820027|592221814|FG003|Overall Study|Physician Decision|0|||
163959094|NCT00820027|592221811|FG000|Overall Study|Protocol Violation|3|||
163959095|NCT00820027|592221812|FG001|Overall Study|Protocol Violation|0|||
163959096|NCT00820027|592221813|FG002|Overall Study|Protocol Violation|4|||
163959097|NCT00820027|592221814|FG003|Overall Study|Protocol Violation|0|||
164303167|NCT00892099|593486436|FG000|Overall Study|Death|1|||
163959098|NCT00820027|592221811|FG000|Overall Study|Withdrawal by Subject|6|||
163959099|NCT00820027|592221812|FG001|Overall Study|Withdrawal by Subject|4|||
163959100|NCT00820027|592221813|FG002|Overall Study|Withdrawal by Subject|4|||
164073830|NCT02030834|592635048|FG002|Overall Study|Lost to Follow-up|0|||
164303168|NCT00892099|593486437|FG001|Overall Study|Death|0|||
164303169|NCT00892099|593486438|FG002|Overall Study|Death|1|||
164303170|NCT00892099|593486436|FG000|Overall Study|Adverse Event|1|||
164303171|NCT00892099|593486437|FG001|Overall Study|Adverse Event|0|||
164303172|NCT00892099|593486438|FG002|Overall Study|Adverse Event|0|||
164303173|NCT00892099|593486436|FG000|Overall Study|replocated|1|||
164303174|NCT00892099|593486437|FG001|Overall Study|replocated|0|||
164303175|NCT00892099|593486438|FG002|Overall Study|replocated|2|||
164303176|NCT00892099|593486436|FG000|Overall Study|Prolonged hospitalization|1|||
164303177|NCT00892099|593486437|FG001|Overall Study|Prolonged hospitalization|0|||
164303178|NCT00892099|593486438|FG002|Overall Study|Prolonged hospitalization|1|||
164303179|NCT00892099|593486436|FG000|Overall Study|no further details|1|||
164303180|NCT00892099|593486437|FG001|Overall Study|no further details|0|||
164303181|NCT00892099|593486438|FG002|Overall Study|no further details|1|||
164303182|NCT00892099|593486436|FG000|Overall Study|kidney function recovered|0|||
164303183|NCT00892099|593486437|FG001|Overall Study|kidney function recovered|1|||
164303184|NCT00892099|593486438|FG002|Overall Study|kidney function recovered|0|||
164303185|NCT00892099|593486436|FG000|Overall Study|investigator decision|0|||
164303186|NCT00892099|593486437|FG001|Overall Study|investigator decision|0|||
164303187|NCT00892099|593486438|FG002|Overall Study|investigator decision|1|||
164303188|NCT00892099|593486436|FG000|Overall Study|Lost to Follow-up|0|||
164303189|NCT00892099|593486437|FG001|Overall Study|Lost to Follow-up|0|||
164303190|NCT00892099|593486438|FG002|Overall Study|Lost to Follow-up|1|||
164303191|NCT03910244|593486439|FG000|Overall Study|Adverse Event|14|||
164303192|NCT03910244|593486440|FG001|Overall Study|Adverse Event|0|||
164303193|NCT03910244|593486439|FG000|Overall Study|Death|1|||
164303194|NCT03910244|593486440|FG001|Overall Study|Death|0|||
164303195|NCT03910244|593486439|FG000|Overall Study|Lost to Follow-up|0|||
164303196|NCT03910244|593486440|FG001|Overall Study|Lost to Follow-up|2|||
164303197|NCT03910244|593486439|FG000|Overall Study|Joint withdrawal decision|1|||
164303198|NCT03910244|593486440|FG001|Overall Study|Joint withdrawal decision|0|||
164303199|NCT03910244|593486439|FG000|Overall Study|Study Terminated by Sponsor|7|||
164303200|NCT03910244|593486440|FG001|Overall Study|Study Terminated by Sponsor|4|||
164303201|NCT03910244|593486439|FG000|Overall Study|Physician Decision|1|||
164303202|NCT03910244|593486440|FG001|Overall Study|Physician Decision|0|||
164303203|NCT03910244|593486439|FG000|Overall Study|Protocol Violation|1|||
164303204|NCT03910244|593486440|FG001|Overall Study|Protocol Violation|0|||
164303205|NCT03910244|593486439|FG000|Overall Study|Withdrawal by Subject|7|||
164303206|NCT03910244|593486440|FG001|Overall Study|Withdrawal by Subject|2|||
164303207|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
164303208|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
164303209|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
164303210|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
164303211|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
164303212|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
164303213|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
164303214|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
164303215|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
164303216|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
164303217|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
164303218|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
164303219|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
164303220|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
164303221|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
164303222|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164303223|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164303224|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164303225|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
164303226|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164303227|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164303228|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
164303229|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164303230|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164303231|NCT01106690|593486441|FG000|Core Period: Baseline to Week 26|Other|10|||
164303232|NCT01106690|593486442|FG001|Core Period: Baseline to Week 26|Other|2|||
164303233|NCT01106690|593486443|FG002|Core Period: Baseline to Week 26|Other|6|||
164303234|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164303235|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164303236|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164303237|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
163959101|NCT00820027|592221814|FG003|Overall Study|Withdrawal by Subject|6|||
163959102|NCT02604433|592221815|FG000|Overall Study|Withdrawal by Subject|37|||
163959103|NCT02604433|592221816|FG001|Overall Study|Withdrawal by Subject|16|||
163959104|NCT02604433|592221815|FG000|Overall Study|Adverse Event|4|||
163959105|NCT02604433|592221816|FG001|Overall Study|Adverse Event|0|||
163959106|NCT02604433|592221815|FG000|Overall Study|Other reasons|3|||
163959107|NCT02604433|592221816|FG001|Overall Study|Other reasons|5|||
163959108|NCT02604433|592221815|FG000|Overall Study|Death|4|||
163959109|NCT02604433|592221816|FG001|Overall Study|Death|1|||
163959110|NCT02604433|592221815|FG000|Overall Study|Transition to Rollover Protocol|169|||
163959111|NCT02604433|592221816|FG001|Overall Study|Transition to Rollover Protocol|82|||
163959112|NCT02604433|592221815|FG000|Overall Study|Physician Decision|1|||
163959113|NCT02604433|592221816|FG001|Overall Study|Physician Decision|1|||
163959114|NCT02604433|592221815|FG000|Overall Study|Lack of Efficacy|0|||
163959115|NCT02604433|592221816|FG001|Overall Study|Lack of Efficacy|1|||
163959116|NCT03285178|592221817|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
163959117|NCT03285178|592221818|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163959118|NCT03285178|592221819|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163959119|NCT03285178|592221820|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163959120|NCT03285178|592221821|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163959121|NCT03285178|592221822|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163959122|NCT03285178|592221823|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
163959123|NCT03285178|592221817|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
163959124|NCT03285178|592221818|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163959125|NCT03285178|592221819|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163959126|NCT03285178|592221820|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163959127|NCT03285178|592221821|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163959128|NCT03285178|592221822|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163959129|NCT03285178|592221823|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
163959130|NCT03285178|592221817|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
163959131|NCT03285178|592221818|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
163959132|NCT03285178|592221819|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
163959133|NCT03285178|592221820|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
163959134|NCT03285178|592221821|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
163959135|NCT03285178|592221822|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
163959136|NCT03285178|592221823|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
163959137|NCT03285178|592221817|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
163959138|NCT03285178|592221818|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163959139|NCT03285178|592221819|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163959140|NCT03285178|592221820|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163959141|NCT03285178|592221821|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163959142|NCT03285178|592221822|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163959143|NCT03285178|592221823|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
163959144|NCT03285178|592221817|FG000|Single-Blind Run-In Period|Physician Decision|2|||
163959145|NCT03285178|592221818|FG001|Single-Blind Run-In Period|Physician Decision|0|||
163959146|NCT03285178|592221819|FG002|Single-Blind Run-In Period|Physician Decision|0|||
163959147|NCT03285178|592221820|FG003|Single-Blind Run-In Period|Physician Decision|0|||
163959148|NCT03285178|592221821|FG004|Single-Blind Run-In Period|Physician Decision|0|||
163959149|NCT03285178|592221822|FG005|Single-Blind Run-In Period|Physician Decision|0|||
163959150|NCT03285178|592221823|FG006|Single-Blind Run-In Period|Physician Decision|0|||
163959151|NCT03285178|592221817|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163959152|NCT03285178|592221818|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
163959153|NCT03285178|592221819|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
163959154|NCT03285178|592221820|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163959155|NCT03285178|592221821|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163959156|NCT03285178|592221822|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163959157|NCT03285178|592221823|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
163959158|NCT03285178|592221817|FG000|Double-Blind Treatment Period|Adverse Event|0|||
163959159|NCT03285178|592221818|FG001|Double-Blind Treatment Period|Adverse Event|0|||
163959160|NCT03285178|592221819|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163959161|NCT03285178|592221820|FG003|Double-Blind Treatment Period|Adverse Event|0|||
163959162|NCT03285178|592221821|FG004|Double-Blind Treatment Period|Adverse Event|0|||
164090381|NCT00306384|592693427|FG002|Overall Study|Pregnancy|1|||
163959163|NCT03285178|592221822|FG005|Double-Blind Treatment Period|Adverse Event|0|||
163959164|NCT03285178|592221823|FG006|Double-Blind Treatment Period|Adverse Event|2|||
163959165|NCT03285178|592221817|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163959166|NCT03285178|592221818|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163959167|NCT03285178|592221819|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
163959168|NCT03285178|592221820|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
163959169|NCT03285178|592221821|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
163959170|NCT03285178|592221822|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
163959171|NCT03285178|592221823|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
163959172|NCT03285178|592221817|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163959173|NCT03285178|592221818|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163959174|NCT03285178|592221819|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163959175|NCT03285178|592221820|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163959176|NCT03285178|592221821|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163959177|NCT03285178|592221822|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163959178|NCT03285178|592221823|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
163959179|NCT03285178|592221817|FG000|Double-Blind Treatment Period|COVID-19|0|||
163959180|NCT03285178|592221818|FG001|Double-Blind Treatment Period|COVID-19|0|||
163959181|NCT03285178|592221819|FG002|Double-Blind Treatment Period|COVID-19|1|||
163959182|NCT03285178|592221820|FG003|Double-Blind Treatment Period|COVID-19|0|||
163959183|NCT03285178|592221821|FG004|Double-Blind Treatment Period|COVID-19|0|||
163959184|NCT03285178|592221822|FG005|Double-Blind Treatment Period|COVID-19|0|||
163959185|NCT03285178|592221823|FG006|Double-Blind Treatment Period|COVID-19|0|||
163959186|NCT01128894|592221824|FG000|Overall Study|Adverse Event|31|||
163959187|NCT01128894|592221825|FG001|Overall Study|Adverse Event|41|||
163959188|NCT01128894|592221824|FG000|Overall Study|Protocol Violation|2|||
163959189|NCT01128894|592221825|FG001|Overall Study|Protocol Violation|1|||
163959190|NCT01128894|592221824|FG000|Overall Study|Noncompliance|4|||
163959191|NCT01128894|592221825|FG001|Overall Study|Noncompliance|5|||
163959192|NCT01128894|592221824|FG000|Overall Study|Lost to Follow-up|8|||
163959193|NCT01128894|592221825|FG001|Overall Study|Lost to Follow-up|8|||
163959194|NCT01128894|592221824|FG000|Overall Study|Withdrawal by Subject|10|||
163959195|NCT01128894|592221825|FG001|Overall Study|Withdrawal by Subject|12|||
163959196|NCT01128894|592221824|FG000|Overall Study|Physician Decision|2|||
163959197|NCT01128894|592221825|FG001|Overall Study|Physician Decision|1|||
163959198|NCT01128894|592221824|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
163959199|NCT01128894|592221825|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
163959200|NCT01128738|592221826|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
163959201|NCT01128738|592221827|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
163959202|NCT01128738|592221826|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
163959203|NCT01128738|592221827|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
163959204|NCT01128738|592221826|FG000|Second TP|Lost to Follow-up|0|||
163959205|NCT01128738|592221827|FG001|Second TP|Lost to Follow-up|1|||
163959206|NCT01128738|592221826|FG000|Second TP|Withdrawal by Subject|0|||
163959207|NCT01128738|592221827|FG001|Second TP|Withdrawal by Subject|2|||
163959208|NCT00973362|592221828|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
163959209|NCT00973362|592221829|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
163959210|NCT00973362|592221828|FG000|Baseline Evaluation|No colposcopy visit|62|||
163959211|NCT00973362|592221829|FG001|Baseline Evaluation|No colposcopy visit|0|||
163959212|NCT00973362|592221828|FG000|Baseline Evaluation|Inevaluable|686|||
163959213|NCT00973362|592221829|FG001|Baseline Evaluation|Inevaluable|223|||
163959214|NCT00973362|592221828|FG000|3-Year Follow-up|Lost to Follow-up|17|||
163959215|NCT00973362|592221829|FG001|3-Year Follow-up|Lost to Follow-up|0|||
163959216|NCT00887679|592221832|FG000|Overall Study|Withdrawal by Subject|1|||
163959217|NCT00887679|592221832|FG000|Overall Study|Lost to Follow-up|4|||
163959218|NCT00887679|592221832|FG000|Overall Study|Physician Decision|5|||
163959219|NCT02683941|592221833|FG000|Double-blind Phase|Adverse Event|0|||
163959220|NCT02683941|592221834|FG001|Double-blind Phase|Adverse Event|1|||
163959221|NCT02683941|592221833|FG000|Double-blind Phase|Withdrawal by Subject|4|||
163959222|NCT02683941|592221834|FG001|Double-blind Phase|Withdrawal by Subject|2|||
163959223|NCT02683941|592221833|FG000|Double-blind Phase|Lost to Follow-up|1|||
163959224|NCT02683941|592221834|FG001|Double-blind Phase|Lost to Follow-up|0|||
163959225|NCT02683941|592221833|FG000|Double-blind Phase|Disease Progression|5|||
163959226|NCT02683941|592221834|FG001|Double-blind Phase|Disease Progression|2|||
163959227|NCT02683941|592221833|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
163959228|NCT02683941|592221834|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
163959229|NCT02683941|592221833|FG000|Open-label Treatment Phase|Disease Progression|1|||
163959230|NCT02683941|592221834|FG001|Open-label Treatment Phase|Disease Progression|2|||
163959231|NCT02683941|592221833|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
164303238|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164303239|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
163959232|NCT02683941|592221834|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
164303240|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
163959233|NCT02683941|592221833|FG000|Open-label Treatment Phase|Other|1|||
163959234|NCT02683941|592221834|FG001|Open-label Treatment Phase|Other|0|||
163959235|NCT02683941|592221833|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
163959236|NCT02683941|592221834|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
163959237|NCT02683941|592221833|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
163959238|NCT02683941|592221834|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
163959239|NCT02683941|592221833|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
163959240|NCT02683941|592221834|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
163959241|NCT02683941|592221833|FG000|Open-label Follow-up Phase|Other|8|||
163959242|NCT02683941|592221834|FG001|Open-label Follow-up Phase|Other|1|||
163959243|NCT00146757|592221835|FG000|Overall Study|Death|1|||
163959244|NCT00146757|592221836|FG001|Overall Study|Death|0|||
163959245|NCT00146757|592221835|FG000|Overall Study|Adverse Event|1|||
163959246|NCT00146757|592221836|FG001|Overall Study|Adverse Event|0|||
163959247|NCT01971203|592221842|FG000|Overall Study|Protocol Violation|3|||
163959248|NCT01971203|592221843|FG001|Overall Study|Protocol Violation|2|||
163959249|NCT01971203|592221842|FG000|Overall Study|Withdrawal by Subject|5|||
163959250|NCT01971203|592221843|FG001|Overall Study|Withdrawal by Subject|6|||
163959251|NCT01971203|592221842|FG000|Overall Study|Adverse Event|1|||
163959252|NCT01971203|592221843|FG001|Overall Study|Adverse Event|0|||
163959253|NCT03037619|592221844|FG000|Overall Study|Lost to Follow-up|0|||
163959254|NCT03037619|592221845|FG001|Overall Study|Lost to Follow-up|1|||
163959255|NCT00307125|592221846|FG000|Screening Phase|Adverse Event|1|||
163959256|NCT00307125|592221847|FG001|Screening Phase|Adverse Event|0|||
163959257|NCT00307125|592221848|FG002|Screening Phase|Adverse Event|0|||
163959258|NCT00307125|592221846|FG000|Screening Phase|Protocol Violation|27|||
163959259|NCT00307125|592221847|FG001|Screening Phase|Protocol Violation|0|||
163959260|NCT00307125|592221848|FG002|Screening Phase|Protocol Violation|0|||
163959261|NCT00307125|592221846|FG000|Screening Phase|Lost to Follow-up|87|||
163959262|NCT00307125|592221847|FG001|Screening Phase|Lost to Follow-up|0|||
163959263|NCT00307125|592221848|FG002|Screening Phase|Lost to Follow-up|0|||
163959264|NCT00307125|592221846|FG000|Screening Phase|Death|10|||
163959265|NCT00307125|592221847|FG001|Screening Phase|Death|0|||
163959266|NCT00307125|592221848|FG002|Screening Phase|Death|0|||
163959267|NCT00307125|592221846|FG000|Screening Phase|Withdrawal by Subject|77|||
163959268|NCT00307125|592221847|FG001|Screening Phase|Withdrawal by Subject|0|||
163959269|NCT00307125|592221848|FG002|Screening Phase|Withdrawal by Subject|0|||
163959270|NCT00307125|592221846|FG000|Screening Phase|Physician Decision|26|||
163959271|NCT00307125|592221847|FG001|Screening Phase|Physician Decision|0|||
163959272|NCT00307125|592221848|FG002|Screening Phase|Physician Decision|0|||
163959273|NCT00307125|592221846|FG000|Screening Phase|Sponsor Decision|4|||
163959274|NCT00307125|592221847|FG001|Screening Phase|Sponsor Decision|0|||
163959275|NCT00307125|592221848|FG002|Screening Phase|Sponsor Decision|0|||
163959276|NCT00307125|592221846|FG000|Screening Phase|Study Terminated|17|||
163959277|NCT00307125|592221847|FG001|Screening Phase|Study Terminated|0|||
163959278|NCT00307125|592221848|FG002|Screening Phase|Study Terminated|0|||
163959279|NCT00307125|592221846|FG000|Screening Phase|Graft Loss|3|||
163959280|NCT00307125|592221847|FG001|Screening Phase|Graft Loss|0|||
163959281|NCT00307125|592221848|FG002|Screening Phase|Graft Loss|0|||
163959282|NCT00307125|592221846|FG000|Screening Phase|Graft Failure|8|||
163959283|NCT00307125|592221847|FG001|Screening Phase|Graft Failure|0|||
163959284|NCT00307125|592221848|FG002|Screening Phase|Graft Failure|0|||
163959285|NCT00307125|592221846|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
163959286|NCT00307125|592221847|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
163959287|NCT00307125|592221848|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
163959288|NCT00307125|592221846|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
163959289|NCT00307125|592221847|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
163959290|NCT00307125|592221848|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
163959291|NCT00307125|592221846|FG000|Screening Phase|Moved or transferred facilities|34|||
163959292|NCT00307125|592221847|FG001|Screening Phase|Moved or transferred facilities|0|||
163959293|NCT00307125|592221848|FG002|Screening Phase|Moved or transferred facilities|0|||
163959294|NCT00307125|592221846|FG000|Screening Phase|Received Pancreas Transplant|8|||
163959295|NCT00307125|592221847|FG001|Screening Phase|Received Pancreas Transplant|0|||
163959296|NCT00307125|592221848|FG002|Screening Phase|Received Pancreas Transplant|0|||
163959297|NCT00307125|592221846|FG000|Screening Phase|Ineligible for pilot|4|||
163959298|NCT00307125|592221847|FG001|Screening Phase|Ineligible for pilot|0|||
163959299|NCT00307125|592221848|FG002|Screening Phase|Ineligible for pilot|0|||
164303241|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164303242|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164303243|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
163959300|NCT00307125|592221846|FG000|Screening Phase|Try to get pregnant|1|||
163959301|NCT00307125|592221847|FG001|Screening Phase|Try to get pregnant|0|||
163959302|NCT00307125|592221848|FG002|Screening Phase|Try to get pregnant|0|||
163959303|NCT00307125|592221846|FG000|Screening Phase|Developed acute leukemia|1|||
163959304|NCT00307125|592221847|FG001|Screening Phase|Developed acute leukemia|0|||
163959305|NCT00307125|592221848|FG002|Screening Phase|Developed acute leukemia|0|||
163959306|NCT00307125|592221846|FG000|Screening Phase|Metastatic colon cancer|1|||
163959307|NCT00307125|592221847|FG001|Screening Phase|Metastatic colon cancer|0|||
163959308|NCT00307125|592221848|FG002|Screening Phase|Metastatic colon cancer|0|||
163959309|NCT00307125|592221846|FG000|Screening Phase|Malignancy|1|||
163959310|NCT00307125|592221847|FG001|Screening Phase|Malignancy|0|||
163959311|NCT00307125|592221848|FG002|Screening Phase|Malignancy|0|||
163959312|NCT00307125|592221846|FG000|Screening Phase|PAK|1|||
163959313|NCT00307125|592221847|FG001|Screening Phase|PAK|0|||
163959314|NCT00307125|592221848|FG002|Screening Phase|PAK|0|||
163959315|NCT00307125|592221846|FG000|Screening Phase|Ineligible|1|||
163959316|NCT00307125|592221847|FG001|Screening Phase|Ineligible|0|||
163959317|NCT00307125|592221848|FG002|Screening Phase|Ineligible|0|||
163959318|NCT00307125|592221846|FG000|Screening Phase|Screen Error|1|||
163959319|NCT00307125|592221847|FG001|Screening Phase|Screen Error|0|||
163959320|NCT00307125|592221848|FG002|Screening Phase|Screen Error|0|||
163959321|NCT00307125|592221846|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
163959322|NCT00307125|592221847|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
163959323|NCT00307125|592221848|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
163959324|NCT00307125|592221846|FG000|Screening Phase|AMR and treated with rituximab|1|||
163959325|NCT00307125|592221847|FG001|Screening Phase|AMR and treated with rituximab|0|||
163959326|NCT00307125|592221848|FG002|Screening Phase|AMR and treated with rituximab|0|||
163959327|NCT00307125|592221846|FG000|Screening Phase|Coronary artery bypass|1|||
163959328|NCT00307125|592221847|FG001|Screening Phase|Coronary artery bypass|0|||
163959329|NCT00307125|592221848|FG002|Screening Phase|Coronary artery bypass|0|||
163959330|NCT00307125|592221846|FG000|Pilot Phase|Lost to Follow-up|0|||
163959331|NCT00307125|592221847|FG001|Pilot Phase|Lost to Follow-up|1|||
163959332|NCT00307125|592221848|FG002|Pilot Phase|Lost to Follow-up|0|||
163959333|NCT00307125|592221846|FG000|Pilot Phase|Withdrawal by Subject|0|||
163959334|NCT00307125|592221847|FG001|Pilot Phase|Withdrawal by Subject|1|||
163959335|NCT00307125|592221848|FG002|Pilot Phase|Withdrawal by Subject|1|||
163959336|NCT02571049|592221849|FG000|Screening|Did not meet entry criteria|2|||
163959337|NCT02571049|592221850|FG001|Screening|Did not meet entry criteria|2|||
163959338|NCT02571049|592221849|FG000|Randomization|No migraine attack|0|||
163959339|NCT02571049|592221850|FG001|Randomization|No migraine attack|1|||
163959340|NCT02571049|592221849|FG000|Randomization|Adverse Event|0|||
163959341|NCT02571049|592221850|FG001|Randomization|Adverse Event|1|||
163959342|NCT01055262|592221853|FG000|Overall Study|Adverse Event|5|||
163959343|NCT01055262|592221853|FG000|Overall Study|Protocol Violation|3|||
163959344|NCT01055262|592221853|FG000|Overall Study|Uncooperativeness|1|||
163959345|NCT00561951|592221855|FG000|Overall Study|Adverse Event|11|||
163959346|NCT00561951|592221856|FG001|Overall Study|Adverse Event|14|||
163959347|NCT00561951|592221857|FG002|Overall Study|Adverse Event|14|||
163959348|NCT00561951|592221855|FG000|Overall Study|Lack of Efficacy|5|||
164073831|NCT02030834|592635046|FG000|Overall Study|Withdrawal by Subject|1|||
164073832|NCT02030834|592635047|FG001|Overall Study|Withdrawal by Subject|0|||
164073833|NCT02030834|592635048|FG002|Overall Study|Withdrawal by Subject|0|||
164073834|NCT02030834|592635046|FG000|Overall Study|Lack of funding|1|||
164073835|NCT02030834|592635047|FG001|Overall Study|Lack of funding|0|||
164073836|NCT02030834|592635048|FG002|Overall Study|Lack of funding|0|||
164073837|NCT04440007|592635049|FG000|Overall Study|Adverse Event|0|||
164073838|NCT04440007|592635050|FG001|Overall Study|Adverse Event|1|||
164073839|NCT04440007|592635049|FG000|Overall Study|Lost to Follow-up|1|||
164073840|NCT04440007|592635050|FG001|Overall Study|Lost to Follow-up|3|||
164073841|NCT04440007|592635049|FG000|Overall Study|Death|7|||
164073842|NCT04440007|592635050|FG001|Overall Study|Death|2|||
164073843|NCT04440007|592635049|FG000|Overall Study|Physician Decision|1|||
164073844|NCT04440007|592635050|FG001|Overall Study|Physician Decision|1|||
164073845|NCT04440007|592635049|FG000|Overall Study|Withdrawal by Subject|2|||
164073846|NCT04440007|592635050|FG001|Overall Study|Withdrawal by Subject|1|||
164073847|NCT04440007|592635049|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
164073848|NCT04440007|592635050|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
164303244|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164073849|NCT04440007|592635049|FG000|Overall Study|Discontinued prior to dosing|0|||
164073850|NCT04440007|592635050|FG001|Overall Study|Discontinued prior to dosing|2|||
164073851|NCT01466673|592635051|FG000|Overall Study|Non-compliance with study treatment|2|||
164073852|NCT01466673|592635052|FG001|Overall Study|Non-compliance with study treatment|0|||
164073853|NCT01466673|592635051|FG000|Overall Study|Lost to Follow-up|3|||
163959349|NCT00561951|592221856|FG001|Overall Study|Lack of Efficacy|3|||
163959350|NCT00561951|592221857|FG002|Overall Study|Lack of Efficacy|2|||
163959351|NCT00561951|592221855|FG000|Overall Study|Lost to Follow-up|1|||
164073854|NCT01466673|592635052|FG001|Overall Study|Lost to Follow-up|5|||
164073855|NCT01466673|592635051|FG000|Overall Study|Adverse Event|2|||
164073856|NCT01466673|592635052|FG001|Overall Study|Adverse Event|1|||
164073857|NCT02164539|592635053|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
164073858|NCT02164539|592635054|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
164073859|NCT02164539|592635055|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
163959352|NCT00561951|592221856|FG001|Overall Study|Lost to Follow-up|1|||
163959353|NCT00561951|592221857|FG002|Overall Study|Lost to Follow-up|0|||
163959354|NCT00561951|592221855|FG000|Overall Study|Withdrawal by Subject|10|||
163959355|NCT00561951|592221856|FG001|Overall Study|Withdrawal by Subject|9|||
163959356|NCT00561951|592221857|FG002|Overall Study|Withdrawal by Subject|10|||
163959357|NCT00561951|592221855|FG000|Overall Study|Protocol Violation|4|||
163959358|NCT00561951|592221856|FG001|Overall Study|Protocol Violation|3|||
163959359|NCT00561951|592221857|FG002|Overall Study|Protocol Violation|4|||
163959360|NCT00561951|592221855|FG000|Overall Study|Physician Decision|1|||
163959361|NCT00561951|592221856|FG001|Overall Study|Physician Decision|0|||
163959362|NCT00561951|592221857|FG002|Overall Study|Physician Decision|0|||
163959363|NCT00561951|592221855|FG000|Overall Study|Pregnancy|0|||
163959364|NCT00561951|592221856|FG001|Overall Study|Pregnancy|1|||
163959365|NCT00561951|592221857|FG002|Overall Study|Pregnancy|0|||
163959366|NCT00561951|592221855|FG000|Overall Study|Meet Withdrawal Criterion|0|||
163959367|NCT00561951|592221856|FG001|Overall Study|Meet Withdrawal Criterion|1|||
163959368|NCT00561951|592221857|FG002|Overall Study|Meet Withdrawal Criterion|1|||
163959369|NCT00561951|592221855|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
163959370|NCT00561951|592221856|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
163959371|NCT00561951|592221857|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
163959372|NCT01596621|592221858|FG000|Overall Study|Death|4|||
163959373|NCT01596621|592221858|FG000|Overall Study|Withdrawal by Subject|9|||
163959374|NCT01596621|592221858|FG000|Overall Study|Disease Progression|49|||
163959375|NCT01596621|592221858|FG000|Overall Study|Lost to Follow-up|3|||
163959376|NCT01596621|592221858|FG000|Overall Study|Other than specified|13|||
163959377|NCT00421707|592221859|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
163959378|NCT00421707|592221860|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
163959379|NCT00421707|592221859|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
163959380|NCT00421707|592221860|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
163959381|NCT00421707|592221859|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
163959382|NCT00421707|592221860|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
163959383|NCT00421707|592221859|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
163959384|NCT00421707|592221860|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
163959385|NCT00421707|592221859|FG000|Period 2: Washout|Adverse Event|1|||
163959386|NCT00421707|592221860|FG001|Period 2: Washout|Adverse Event|1|||
163959387|NCT00421707|592221859|FG000|Period 2: Washout|Withdrawal by Subject|0|||
163959388|NCT00421707|592221860|FG001|Period 2: Washout|Withdrawal by Subject|1|||
163959389|NCT00421707|592221859|FG000|Period 2: Washout|Lost to Follow-up|0|||
163959390|NCT00421707|592221860|FG001|Period 2: Washout|Lost to Follow-up|1|||
163959391|NCT00421707|592221859|FG000|Period 2: Washout|Other: Pregnancy|0|||
163959392|NCT00421707|592221860|FG001|Period 2: Washout|Other: Pregnancy|1|||
163959393|NCT00421707|592221859|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
163959394|NCT00421707|592221860|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
163959395|NCT00421707|592221859|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
163959396|NCT00421707|592221860|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
163959397|NCT00421707|592221859|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
163959398|NCT00421707|592221860|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
163959399|NCT01201265|592221861|FG000|Overall Study|Death|14|||
163959400|NCT01201265|592221861|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163959401|NCT01201265|592221861|FG000|Overall Study|Lost to Follow-up|10|||
163959402|NCT01201265|592221861|FG000|Overall Study|Withdrawal by Subject|7|||
163959403|NCT01201265|592221861|FG000|Overall Study|Disease Progression|4|||
163959404|NCT01898923|592221864|FG000|Overall Study|Lack of Efficacy|5|||
163959405|NCT01898923|592221865|FG001|Overall Study|Lack of Efficacy|6|||
164303245|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
164303246|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
163959406|NCT01898923|592221864|FG000|Overall Study|Adverse Event|3|||
163959407|NCT01898923|592221865|FG001|Overall Study|Adverse Event|1|||
163959408|NCT01898923|592221864|FG000|Overall Study|Lost to Follow-up|0|||
163959409|NCT01898923|592221865|FG001|Overall Study|Lost to Follow-up|1|||
163959410|NCT01898923|592221864|FG000|Overall Study|Withdrawal by Subject|4|||
163959411|NCT01898923|592221865|FG001|Overall Study|Withdrawal by Subject|7|||
163959412|NCT01898923|592221864|FG000|Overall Study|Physician Decision|3|||
163959413|NCT01898923|592221865|FG001|Overall Study|Physician Decision|4|||
163959414|NCT01898923|592221864|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
163959415|NCT01898923|592221865|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
163959416|NCT00723021|592221866|FG000|Intervention Period 4|Adverse Event|0|||
163959417|NCT00723021|592221867|FG001|Intervention Period 4|Adverse Event|0|||
163959418|NCT00723021|592221868|FG002|Intervention Period 4|Adverse Event|0|||
163959419|NCT00723021|592221869|FG003|Intervention Period 4|Adverse Event|0|||
163959420|NCT00723021|592221870|FG004|Intervention Period 4|Adverse Event|1|||
163959421|NCT02975700|592221875|FG000|Overall Study|Adverse Event|1|||
163959422|NCT02975700|592221875|FG000|Overall Study|Progressive disease|3|||
163959423|NCT02975700|592221875|FG000|Overall Study|Failed screening criteria|2|||
164303247|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164303248|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164303249|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Other|8|||
164303250|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Other|3|||
164303251|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Other|4|||
164303252|NCT01106690|593486441|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
164303253|NCT01106690|593486442|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164303254|NCT01106690|593486443|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164303255|NCT04455815|593486444|FG000|Randomisation Phase|Adverse Event|1|||
164303256|NCT04455815|593486445|FG001|Randomisation Phase|Adverse Event|0|||
164303257|NCT04455815|593486444|FG000|Treatment Phase|Adverse Event|0|||
164303258|NCT04455815|593486445|FG001|Treatment Phase|Adverse Event|1|||
164303259|NCT04455815|593486444|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
164303260|NCT04455815|593486445|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
164303261|NCT04455815|593486444|FG000|Treatment Phase|Withdrawal by Subject|1|||
164303262|NCT04455815|593486445|FG001|Treatment Phase|Withdrawal by Subject|1|||
164303263|NCT03219528|593486450|FG000|Overall Study|Lost to Follow-up|5|||
164303264|NCT03219528|593486451|FG001|Overall Study|Lost to Follow-up|4|||
164303265|NCT03219528|593486450|FG000|Overall Study|Withdrawal by Subject|4|||
164303266|NCT03219528|593486451|FG001|Overall Study|Withdrawal by Subject|4|||
164303267|NCT03809104|593486452|FG000|Overall Study|Withdrawal by Subject|3|||
164303268|NCT00790842|593486453|FG000|Dose Level 1|Adverse Event|1|||
164303269|NCT00790842|593486454|FG001|Dose Level 1|Adverse Event|0|||
164303270|NCT00790842|593486455|FG002|Dose Level 1|Adverse Event|0|||
164303271|NCT00790842|593486456|FG003|Dose Level 1|Adverse Event|2|||
164303272|NCT00790842|593486457|FG004|Dose Level 1|Adverse Event|0|||
164303273|NCT00790842|593486458|FG005|Dose Level 1|Adverse Event|0|||
163959424|NCT02441686|592221876|FG000|Induction|Adverse Event|4|||
163959425|NCT02441686|592221876|FG000|Induction|Complicating disease|1|||
163959426|NCT02441686|592221876|FG000|Induction|Physician Decision|1|||
163959427|NCT02441686|592221876|FG000|Induction|Withdrawal by Subject|1|||
163959428|NCT02441686|592221876|FG000|Induction|Did not receive treatment|1|||
163959429|NCT02441686|592221876|FG000|Maintenance|Remaining on Treatment|23|||
163959430|NCT02441686|592221876|FG000|Maintenance|Physician Decision|1|||
163959431|NCT02441686|592221876|FG000|Maintenance|Adverse Event|3|||
163959432|NCT02441686|592221876|FG000|Maintenance|Progressive Disease|10|||
163959433|NCT02441686|592221876|FG000|Maintenance|Withdrawal by Subject|1|||
163959434|NCT05497284|592221877|FG000|Overall Study|Adverse Event|1|||
163959435|NCT05497284|592221878|FG001|Overall Study|Adverse Event|0|||
163959436|NCT05497284|592221877|FG000|Overall Study|Physician Decision|0|||
163959437|NCT05497284|592221878|FG001|Overall Study|Physician Decision|1|||
163959438|NCT05497284|592221877|FG000|Overall Study|Study terminated by sponsor|7|||
163959439|NCT05497284|592221878|FG001|Overall Study|Study terminated by sponsor|4|||
163959440|NCT05497284|592221877|FG000|Overall Study|Subject Decision|0|||
163959441|NCT05497284|592221878|FG001|Overall Study|Subject Decision|1|||
163959442|NCT02254278|592221896|FG000|Overall Study|Protocol Violation|1|||
163959443|NCT02254278|592221897|FG001|Overall Study|Protocol Violation|1|||
163959444|NCT02903368|592221898|FG000|Part 1|Adverse Event|3|||
163959445|NCT02903368|592221899|FG001|Part 1|Adverse Event|0|||
163959446|NCT02903368|592221900|FG002|Part 1|Adverse Event|0|||
163959447|NCT02903368|592221901|FG003|Part 1|Adverse Event|0|||
163959448|NCT02903368|592221898|FG000|Part 1|Withdrawal by Subject|1|||
163959449|NCT02903368|592221899|FG001|Part 1|Withdrawal by Subject|0|||
163959450|NCT02903368|592221900|FG002|Part 1|Withdrawal by Subject|0|||
163959451|NCT02903368|592221901|FG003|Part 1|Withdrawal by Subject|0|||
163959452|NCT02903368|592221898|FG000|Part 2|Adverse Event|0|||
163959453|NCT02903368|592221899|FG001|Part 2|Adverse Event|0|||
163959454|NCT02903368|592221900|FG002|Part 2|Adverse Event|5|||
163959455|NCT02903368|592221901|FG003|Part 2|Adverse Event|0|||
163959456|NCT02903368|592221898|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
163959457|NCT02903368|592221899|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
163959458|NCT02903368|592221900|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
163959459|NCT02903368|592221901|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
164303274|NCT00790842|593486459|FG006|Dose Level 1|Adverse Event|0|||
164303275|NCT00790842|593486460|FG007|Dose Level 1|Adverse Event|1|||
164303276|NCT00790842|593486461|FG008|Dose Level 1|Adverse Event|0|||
164303277|NCT00790842|593486462|FG009|Dose Level 1|Adverse Event|0|||
164303278|NCT00790842|593486463|FG010|Dose Level 1|Adverse Event|0|||
164303279|NCT00790842|593486453|FG000|Dose Level 1|Physician Decision|1|||
164303280|NCT00790842|593486454|FG001|Dose Level 1|Physician Decision|0|||
164303281|NCT00790842|593486455|FG002|Dose Level 1|Physician Decision|0|||
163959460|NCT02903368|592221898|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
163959461|NCT02903368|592221899|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
163959462|NCT02903368|592221900|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
163959463|NCT02903368|592221901|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
163959464|NCT02903368|592221898|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
163959465|NCT02903368|592221899|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
163959466|NCT02903368|592221900|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
163959467|NCT02903368|592221901|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
163959468|NCT05437510|592221902|FG000|Overall Study|Adverse Event|2|||
163959469|NCT05437510|592221903|FG001|Overall Study|Adverse Event|1|||
163959470|NCT05437510|592221902|FG000|Overall Study|Protocol Deviation|1|||
163959471|NCT05437510|592221903|FG001|Overall Study|Protocol Deviation|6|||
163959472|NCT05437510|592221902|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
163959473|NCT05437510|592221903|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
163959474|NCT05437510|592221902|FG000|Overall Study|Lost to Follow-up|265|||
163959475|NCT05437510|592221903|FG001|Overall Study|Lost to Follow-up|358|||
163959476|NCT00147823|592221906|FG000|Overall Study|Lost to Follow-up|6|||
163959477|NCT00147823|592221907|FG001|Overall Study|Lost to Follow-up|12|||
163959478|NCT00147823|592221906|FG000|Overall Study|Physician Decision|1|||
163959479|NCT00147823|592221907|FG001|Overall Study|Physician Decision|0|||
163959480|NCT00147823|592221906|FG000|Overall Study|Withdrawal by Subject|0|||
163959481|NCT00147823|592221907|FG001|Overall Study|Withdrawal by Subject|1|||
163959482|NCT00147823|592221906|FG000|Overall Study|Did not receive vitoss due to infection|6|||
163959483|NCT00147823|592221907|FG001|Overall Study|Did not receive vitoss due to infection|2|||
164006433|NCT02158533|592390962|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
164006434|NCT02158533|592390963|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
164006435|NCT02158533|592390964|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
164006436|NCT02158533|592390965|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
164006437|NCT02158533|592390966|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
164006438|NCT02158533|592390967|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
164006439|NCT02158533|592390962|FG000|Stage 1|Non-compliance with study visits|1|||
164006440|NCT02158533|592390963|FG001|Stage 1|Non-compliance with study visits|0|||
164006441|NCT02158533|592390964|FG002|Stage 1|Non-compliance with study visits|0|||
164006442|NCT02158533|592390965|FG003|Stage 1|Non-compliance with study visits|0|||
164006443|NCT02158533|592390966|FG004|Stage 1|Non-compliance with study visits|0|||
164006444|NCT02158533|592390967|FG005|Stage 1|Non-compliance with study visits|0|||
164006445|NCT02158533|592390962|FG000|Stage 2|Adverse Event|0|||
164073860|NCT02164539|592635056|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
164073861|NCT02164539|592635057|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
164006446|NCT02158533|592390963|FG001|Stage 2|Adverse Event|0|||
164073862|NCT02164539|592635058|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
164073863|NCT02164539|592635059|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
164073864|NCT02164539|592635053|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
164073865|NCT02164539|592635054|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
164073866|NCT02164539|592635055|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
164073867|NCT02164539|592635056|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
164073868|NCT02164539|592635057|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
164073869|NCT02164539|592635058|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
164073870|NCT02164539|592635059|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
164073871|NCT02164539|592635053|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
164073872|NCT02164539|592635054|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
164073873|NCT02164539|592635055|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
164073874|NCT02164539|592635056|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
164073875|NCT02164539|592635057|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
164073876|NCT02164539|592635058|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
164073877|NCT02164539|592635059|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
164006447|NCT02158533|592390964|FG002|Stage 2|Adverse Event|0|||
164006448|NCT02158533|592390965|FG003|Stage 2|Adverse Event|0|||
164006449|NCT02158533|592390966|FG004|Stage 2|Adverse Event|0|||
164073878|NCT02164539|592635053|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
164073879|NCT02164539|592635054|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164006450|NCT02158533|592390967|FG005|Stage 2|Adverse Event|1|||
164006451|NCT02158533|592390962|FG000|Stage 2|Lack of Efficacy|0|||
164006452|NCT02158533|592390963|FG001|Stage 2|Lack of Efficacy|0|||
164006453|NCT02158533|592390964|FG002|Stage 2|Lack of Efficacy|0|||
164006454|NCT02158533|592390965|FG003|Stage 2|Lack of Efficacy|0|||
164073880|NCT02164539|592635055|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164073881|NCT02164539|592635056|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164006455|NCT02158533|592390966|FG004|Stage 2|Lack of Efficacy|1|||
164006456|NCT02158533|592390967|FG005|Stage 2|Lack of Efficacy|0|||
164006457|NCT02158533|592390962|FG000|Stage 2|Lost to Follow-up|0|||
164006458|NCT02158533|592390963|FG001|Stage 2|Lost to Follow-up|0|||
164006459|NCT02158533|592390964|FG002|Stage 2|Lost to Follow-up|0|||
164006460|NCT02158533|592390965|FG003|Stage 2|Lost to Follow-up|1|||
164006461|NCT02158533|592390966|FG004|Stage 2|Lost to Follow-up|1|||
164006462|NCT02158533|592390967|FG005|Stage 2|Lost to Follow-up|2|||
164073882|NCT02164539|592635057|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164073883|NCT02164539|592635058|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
163959484|NCT04441905|592224006|FG000|Overall Study|Lost to Follow-up|1|||
163959485|NCT04441905|592224007|FG001|Overall Study|Lost to Follow-up|0|||
163959486|NCT04441905|592224008|FG002|Overall Study|Lost to Follow-up|0|||
163959487|NCT04441905|592224009|FG003|Overall Study|Lost to Follow-up|0|||
163959488|NCT04441905|592224010|FG004|Overall Study|Lost to Follow-up|0|||
163959489|NCT04441905|592224011|FG005|Overall Study|Lost to Follow-up|0|||
163959490|NCT04441905|592224006|FG000|Overall Study|Enrolled but treatment not administered|0|||
163959491|NCT04441905|592224007|FG001|Overall Study|Enrolled but treatment not administered|1|||
163959492|NCT04441905|592224008|FG002|Overall Study|Enrolled but treatment not administered|0|||
163959493|NCT04441905|592224009|FG003|Overall Study|Enrolled but treatment not administered|0|||
163959494|NCT04441905|592224010|FG004|Overall Study|Enrolled but treatment not administered|0|||
163959495|NCT04441905|592224011|FG005|Overall Study|Enrolled but treatment not administered|0|||
163959496|NCT04441905|592224006|FG000|Overall Study|Became ineligible after enrollment|0|||
163959497|NCT04441905|592224007|FG001|Overall Study|Became ineligible after enrollment|0|||
163959498|NCT04441905|592224008|FG002|Overall Study|Became ineligible after enrollment|0|||
163959499|NCT04441905|592224009|FG003|Overall Study|Became ineligible after enrollment|0|||
163959500|NCT04441905|592224010|FG004|Overall Study|Became ineligible after enrollment|1|||
163959501|NCT04441905|592224011|FG005|Overall Study|Became ineligible after enrollment|0|||
163959502|NCT03922802|592224012|FG000|Overall Study|Withdrawal by Subject|4|||
163959503|NCT04486716|592224013|FG000|Core Phase|Subject decision|6|||
163959504|NCT04486716|592224013|FG000|Core Phase|Adverse Event|5|||
163959505|NCT04486716|592224013|FG000|Core Phase|Lost to Follow-up|1|||
163959506|NCT04486716|592224013|FG000|Core Phase|Physician Decision|1|||
163959507|NCT04486716|592224013|FG000|Core Phase|Enrolled subjects not treated|9|||
163959508|NCT04987307|592224014|FG000|Overall Study|Protocol-specified criteria|2|||
163959509|NCT04987307|592224015|FG001|Overall Study|Protocol-specified criteria|0|||
163959510|NCT04987307|592224016|FG002|Overall Study|Protocol-specified criteria|0|||
163959511|NCT04987307|592224017|FG003|Overall Study|Protocol-specified criteria|3|||
163959512|NCT04987307|592224014|FG000|Overall Study|Withdrawal by Subject|34|||
163959513|NCT04987307|592224015|FG001|Overall Study|Withdrawal by Subject|30|||
163959514|NCT04987307|592224016|FG002|Overall Study|Withdrawal by Subject|29|||
164073884|NCT02164539|592635059|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
164073885|NCT02164539|592635053|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
164073886|NCT02164539|592635054|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
164073887|NCT02164539|592635055|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
163959515|NCT04987307|592224017|FG003|Overall Study|Withdrawal by Subject|35|||
163959516|NCT04987307|592224014|FG000|Overall Study|Decision by sponsor|10|||
163959517|NCT04987307|592224015|FG001|Overall Study|Decision by sponsor|13|||
163959518|NCT04987307|592224016|FG002|Overall Study|Decision by sponsor|11|||
163959519|NCT04987307|592224017|FG003|Overall Study|Decision by sponsor|9|||
163959520|NCT04987307|592224014|FG000|Overall Study|Lost to Follow-up|1|||
163959521|NCT04987307|592224015|FG001|Overall Study|Lost to Follow-up|0|||
163959522|NCT04987307|592224016|FG002|Overall Study|Lost to Follow-up|0|||
163959523|NCT04987307|592224017|FG003|Overall Study|Lost to Follow-up|0|||
163959524|NCT03650400|592224018|FG000|Overall Study|Study terminated by sponsor|0|||
163959525|NCT03650400|592224019|FG001|Overall Study|Study terminated by sponsor|5|||
163959526|NCT00792805|592224021|FG000|Overall Study|Adverse Event|12|||
163959527|NCT00792805|592224022|FG001|Overall Study|Adverse Event|10|||
164073888|NCT02164539|592635056|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
164073889|NCT02164539|592635057|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
164073890|NCT02164539|592635058|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
164073891|NCT02164539|592635059|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
164073892|NCT02164539|592635053|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
164073893|NCT02164539|592635054|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
164073894|NCT02164539|592635055|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
164073895|NCT02164539|592635056|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
164073896|NCT02164539|592635057|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
164073897|NCT02164539|592635058|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
164073898|NCT02164539|592635059|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
164073899|NCT01255722|592635060|FG000|Overall Study|Adverse Event|0|||
164073900|NCT01255722|592635061|FG001|Overall Study|Adverse Event|1|||
164073901|NCT01255722|592635062|FG002|Overall Study|Adverse Event|1|||
164073902|NCT01255722|592635060|FG000|Overall Study|asymptomatic patient|1|||
163959528|NCT00792805|592224023|FG002|Overall Study|Adverse Event|10|||
164073903|NCT01255722|592635061|FG001|Overall Study|asymptomatic patient|0|||
164073904|NCT01255722|592635062|FG002|Overall Study|asymptomatic patient|0|||
164073905|NCT01255722|592635060|FG000|Overall Study|beta-blocker contraindicated|2|||
164073906|NCT01255722|592635061|FG001|Overall Study|beta-blocker contraindicated|0|||
163959529|NCT00792805|592224021|FG000|Overall Study|Subject withdrew consent|5|||
163959530|NCT00792805|592224022|FG001|Overall Study|Subject withdrew consent|6|||
163959531|NCT00792805|592224023|FG002|Overall Study|Subject withdrew consent|5|||
163959532|NCT00792805|592224021|FG000|Overall Study|Administrative problems|2|||
164073907|NCT01255722|592635062|FG002|Overall Study|beta-blocker contraindicated|0|||
164073908|NCT04529499|592635066|FG000|Overall Study|Withdrawal by Subject|9|||
164073909|NCT04529499|592635067|FG001|Overall Study|Withdrawal by Subject|11|||
163959533|NCT00792805|592224022|FG001|Overall Study|Administrative problems|0|||
163959534|NCT00792805|592224023|FG002|Overall Study|Administrative problems|4|||
163959535|NCT00792805|592224021|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163959536|NCT00792805|592224022|FG001|Overall Study|Abnormal test procedure result(s)|2|||
163959537|NCT00792805|592224023|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163959538|NCT00792805|592224021|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163959539|NCT00792805|592224022|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
163959540|NCT00792805|592224023|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163959541|NCT00792805|592224021|FG000|Overall Study|Lost to Follow-up|1|||
163959542|NCT00792805|592224022|FG001|Overall Study|Lost to Follow-up|1|||
163959543|NCT00792805|592224023|FG002|Overall Study|Lost to Follow-up|6|||
163959544|NCT00792805|592224021|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163959545|NCT00792805|592224022|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163959546|NCT00792805|592224023|FG002|Overall Study|Abnormal laboratory value(s)|1|||
163959547|NCT00792805|592224021|FG000|Overall Study|Protocol deviation|0|||
163959548|NCT00792805|592224022|FG001|Overall Study|Protocol deviation|1|||
163959549|NCT00792805|592224023|FG002|Overall Study|Protocol deviation|1|||
163959550|NCT05541861|592224024|FG000|Overall Study|Withdrawal by Subject|0|||
163959551|NCT05541861|592224025|FG001|Overall Study|Withdrawal by Subject|0|||
163959552|NCT05541861|592224026|FG002|Overall Study|Withdrawal by Subject|0|||
163959553|NCT05541861|592224027|FG003|Overall Study|Withdrawal by Subject|0|||
163959554|NCT05541861|592224028|FG004|Overall Study|Withdrawal by Subject|0|||
164073910|NCT04529499|592635066|FG000|Overall Study|Physician Decision|1|||
164073911|NCT04529499|592635067|FG001|Overall Study|Physician Decision|2|||
164073912|NCT04529499|592635066|FG000|Overall Study|Adverse Event|4|||
164073913|NCT04529499|592635067|FG001|Overall Study|Adverse Event|4|||
164073914|NCT04529499|592635066|FG000|Overall Study|Death|14|||
164073915|NCT04529499|592635067|FG001|Overall Study|Death|11|||
164073916|NCT04529499|592635066|FG000|Overall Study|Lost to Follow-up|1|||
164073917|NCT04529499|592635067|FG001|Overall Study|Lost to Follow-up|1|||
164073918|NCT04529499|592635066|FG000|Overall Study|Others|7|||
164073919|NCT04529499|592635067|FG001|Overall Study|Others|11|||
164073920|NCT00683904|592635068|FG000|Dose Level 1|Disease progression|2|||
164073921|NCT00683904|592635069|FG001|Dose Level 1|Disease progression|0|||
164073922|NCT00683904|592635068|FG000|Dose Level 1|Adverse Event|1|||
164073923|NCT00683904|592635069|FG001|Dose Level 1|Adverse Event|0|||
164073924|NCT00683904|592635068|FG000|Dose Level 2|Adverse Event|0|||
164073925|NCT00683904|592635069|FG001|Dose Level 2|Adverse Event|2|||
164073926|NCT02702271|592635070|FG000|Overall Study|Death|36|||
164073927|NCT02702271|592635071|FG001|Overall Study|Death|7|||
164073928|NCT02702271|592635070|FG000|Overall Study|Lost to Follow-up|12|||
164073929|NCT02702271|592635071|FG001|Overall Study|Lost to Follow-up|0|||
164073930|NCT02702271|592635070|FG000|Overall Study|Withdrawal by Subject|8|||
164073931|NCT02702271|592635071|FG001|Overall Study|Withdrawal by Subject|1|||
164073932|NCT02702271|592635070|FG000|Overall Study|Physician Decision|2|||
164073933|NCT02702271|592635071|FG001|Overall Study|Physician Decision|0|||
164073934|NCT02702271|592635070|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
164073935|NCT02702271|592635071|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
164073936|NCT01494649|592635072|FG000|Overall Study|Lost to Follow-up|0|||
164073937|NCT01494649|592635073|FG001|Overall Study|Lost to Follow-up|1|||
164073938|NCT03091400|592635074|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
164073939|NCT03091400|592635075|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
164303282|NCT00790842|593486456|FG003|Dose Level 1|Physician Decision|0|||
164073940|NCT00975884|592635076|FG000|Overall Study|Adverse Event|1|||
164073941|NCT00975884|592635077|FG001|Overall Study|Adverse Event|0|||
164073942|NCT00975884|592635076|FG000|Overall Study|Lost to Follow-up|5|||
164073943|NCT00975884|592635077|FG001|Overall Study|Lost to Follow-up|3|||
164073944|NCT00975884|592635076|FG000|Overall Study|Withdrawal by Subject|9|||
164073945|NCT00975884|592635077|FG001|Overall Study|Withdrawal by Subject|9|||
164073946|NCT00975884|592635076|FG000|Overall Study|Other|1|||
164073947|NCT00975884|592635077|FG001|Overall Study|Other|3|||
164073948|NCT03707522|592635080|FG000|Overall Study|Lost to Follow-up|24|||
164073949|NCT03707522|592635081|FG001|Overall Study|Lost to Follow-up|27|||
164073950|NCT03707522|592635082|FG002|Overall Study|Lost to Follow-up|41|||
164073951|NCT03707522|592635083|FG003|Overall Study|Lost to Follow-up|36|||
164073952|NCT00383019|592635084|FG000|Overall Study|Adverse Event|5|||
164073953|NCT00383019|592635085|FG001|Overall Study|Adverse Event|1|||
164073954|NCT00383019|592635084|FG000|Overall Study|Withdrawal by Subject|0|||
164073955|NCT00383019|592635085|FG001|Overall Study|Withdrawal by Subject|1|||
164073956|NCT05473247|592635089|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
164073957|NCT00000135|592635090|FG000|Overall Study|Death|27|||
164073958|NCT00000135|592635091|FG001|Overall Study|Death|14|||
164073959|NCT01831596|592635092|FG000|Overall Study|Other|8|||
164073960|NCT02508649|592635095|FG000|Overall Study|Withdrawal by Subject|4|||
164073961|NCT02508649|592635096|FG001|Overall Study|Withdrawal by Subject|6|||
164073962|NCT02508649|592635097|FG002|Overall Study|Withdrawal by Subject|5|||
164073963|NCT02508649|592635098|FG003|Overall Study|Withdrawal by Subject|6|||
164073964|NCT02508649|592635095|FG000|Overall Study|Investigator withdrew the subject|1|||
163959555|NCT05541861|592224029|FG005|Overall Study|Withdrawal by Subject|0|||
163959556|NCT05541861|592224030|FG006|Overall Study|Withdrawal by Subject|2|||
163959557|NCT05541861|592224031|FG007|Overall Study|Withdrawal by Subject|0|||
163959558|NCT05541861|592224032|FG008|Overall Study|Withdrawal by Subject|0|||
163959559|NCT05541861|592224024|FG000|Overall Study|Randomized but not dosed|0|||
163959560|NCT05541861|592224025|FG001|Overall Study|Randomized but not dosed|1|||
163959561|NCT05541861|592224026|FG002|Overall Study|Randomized but not dosed|1|||
163959562|NCT05541861|592224027|FG003|Overall Study|Randomized but not dosed|0|||
163959563|NCT05541861|592224028|FG004|Overall Study|Randomized but not dosed|0|||
163959564|NCT05541861|592224029|FG005|Overall Study|Randomized but not dosed|0|||
163959565|NCT05541861|592224030|FG006|Overall Study|Randomized but not dosed|1|||
163959566|NCT05541861|592224031|FG007|Overall Study|Randomized but not dosed|0|||
163959567|NCT05541861|592224032|FG008|Overall Study|Randomized but not dosed|1|||
163959568|NCT05678959|592224033|FG000|Overall Study|Study Terminated by Sponsor|76|||
163959569|NCT05678959|592224034|FG001|Overall Study|Study Terminated by Sponsor|76|||
163959570|NCT05678959|592224033|FG000|Overall Study|Physician Decision|2|||
163959571|NCT05678959|592224034|FG001|Overall Study|Physician Decision|3|||
163959572|NCT05678959|592224033|FG000|Overall Study|Adverse Event|1|||
164073965|NCT02508649|592635096|FG001|Overall Study|Investigator withdrew the subject|2|||
164073966|NCT02508649|592635097|FG002|Overall Study|Investigator withdrew the subject|1|||
164073967|NCT02508649|592635098|FG003|Overall Study|Investigator withdrew the subject|0|||
164073968|NCT02508649|592635095|FG000|Overall Study|Post randomization screening failure|12|||
164073969|NCT02508649|592635096|FG001|Overall Study|Post randomization screening failure|4|||
164073970|NCT02508649|592635097|FG002|Overall Study|Post randomization screening failure|9|||
164073971|NCT02508649|592635098|FG003|Overall Study|Post randomization screening failure|3|||
163959573|NCT05678959|592224034|FG001|Overall Study|Adverse Event|1|||
163959574|NCT05678959|592224033|FG000|Overall Study|Guardian Decision|1|||
163959575|NCT05678959|592224034|FG001|Overall Study|Guardian Decision|0|||
163959576|NCT05678959|592224033|FG000|Overall Study|Protocol Deviation|0|||
163959577|NCT05678959|592224034|FG001|Overall Study|Protocol Deviation|1|||
163959578|NCT05678959|592224033|FG000|Overall Study|Subject Decision|1|||
163959579|NCT05678959|592224034|FG001|Overall Study|Subject Decision|0|||
163959580|NCT05678959|592224033|FG000|Overall Study|Technical Problem|0|||
163959581|NCT05678959|592224034|FG001|Overall Study|Technical Problem|1|||
163959582|NCT02065336|592224035|FG000|Extension Phase|Study Terminated by Sponsor|0|||
163959583|NCT02065336|592224036|FG001|Extension Phase|Study Terminated by Sponsor|0|||
163959584|NCT02065336|592224037|FG002|Extension Phase|Study Terminated by Sponsor|0|||
163959585|NCT02065336|592224038|FG003|Extension Phase|Study Terminated by Sponsor|0|||
163959586|NCT02065336|592224039|FG004|Extension Phase|Study Terminated by Sponsor|0|||
163959587|NCT02065336|592224040|FG005|Extension Phase|Study Terminated by Sponsor|0|||
163959588|NCT02065336|592224041|FG006|Extension Phase|Study Terminated by Sponsor|0|||
163959589|NCT02065336|592224042|FG007|Extension Phase|Study Terminated by Sponsor|0|||
163959590|NCT02065336|592224043|FG008|Extension Phase|Study Terminated by Sponsor|2|||
163959591|NCT02065336|592224044|FG009|Extension Phase|Study Terminated by Sponsor|8|||
163959592|NCT03226392|592224045|FG000|Overall Study|Protocol Deviation|1|||
163959593|NCT03226392|592224046|FG001|Overall Study|Protocol Deviation|0|||
164073972|NCT02508649|592635095|FG000|Overall Study|Lost to Follow-up|1|||
164073973|NCT02508649|592635096|FG001|Overall Study|Lost to Follow-up|1|||
164303283|NCT00790842|593486457|FG004|Dose Level 1|Physician Decision|0|||
164303284|NCT00790842|593486458|FG005|Dose Level 1|Physician Decision|0|||
164303285|NCT00790842|593486459|FG006|Dose Level 1|Physician Decision|0|||
164303286|NCT00790842|593486460|FG007|Dose Level 1|Physician Decision|1|||
164303287|NCT00790842|593486461|FG008|Dose Level 1|Physician Decision|0|||
164303288|NCT00790842|593486462|FG009|Dose Level 1|Physician Decision|0|||
164303289|NCT00790842|593486463|FG010|Dose Level 1|Physician Decision|0|||
164303290|NCT00790842|593486453|FG000|Dose Level 1|Withdrawal by Subject|1|||
164073974|NCT02508649|592635097|FG002|Overall Study|Lost to Follow-up|0|||
164073975|NCT02508649|592635098|FG003|Overall Study|Lost to Follow-up|1|||
164303291|NCT00790842|593486454|FG001|Dose Level 1|Withdrawal by Subject|0|||
164303292|NCT00790842|593486455|FG002|Dose Level 1|Withdrawal by Subject|0|||
164303293|NCT00790842|593486456|FG003|Dose Level 1|Withdrawal by Subject|0|||
164073976|NCT00446134|592635099|FG000|Overall Study|Adverse Event|7|||
164073977|NCT00446134|592635100|FG001|Overall Study|Adverse Event|17|||
164073978|NCT00446134|592635101|FG002|Overall Study|Adverse Event|13|||
164073979|NCT00446134|592635102|FG003|Overall Study|Adverse Event|18|||
164073980|NCT00446134|592635099|FG000|Overall Study|Lack of Efficacy|19|||
164073981|NCT00446134|592635100|FG001|Overall Study|Lack of Efficacy|19|||
164073982|NCT00446134|592635101|FG002|Overall Study|Lack of Efficacy|24|||
164303294|NCT00790842|593486457|FG004|Dose Level 1|Withdrawal by Subject|0|||
164303295|NCT00790842|593486458|FG005|Dose Level 1|Withdrawal by Subject|0|||
164303296|NCT00790842|593486459|FG006|Dose Level 1|Withdrawal by Subject|0|||
164073983|NCT00446134|592635102|FG003|Overall Study|Lack of Efficacy|19|||
164303297|NCT00790842|593486460|FG007|Dose Level 1|Withdrawal by Subject|0|||
164073984|NCT00446134|592635099|FG000|Overall Study|Protocol Violation|0|||
164073985|NCT00446134|592635100|FG001|Overall Study|Protocol Violation|2|||
164073986|NCT00446134|592635101|FG002|Overall Study|Protocol Violation|1|||
164073987|NCT00446134|592635102|FG003|Overall Study|Protocol Violation|0|||
164073988|NCT00446134|592635099|FG000|Overall Study|Lost to Follow-up|1|||
164303298|NCT00790842|593486461|FG008|Dose Level 1|Withdrawal by Subject|0|||
164303299|NCT00790842|593486462|FG009|Dose Level 1|Withdrawal by Subject|0|||
164303300|NCT00790842|593486463|FG010|Dose Level 1|Withdrawal by Subject|0|||
164303301|NCT00790842|593486453|FG000|Dose Level 2|Death|0|||
164303302|NCT00790842|593486454|FG001|Dose Level 2|Death|1|||
164303303|NCT00790842|593486455|FG002|Dose Level 2|Death|0|||
164303304|NCT00790842|593486456|FG003|Dose Level 2|Death|0|||
164303305|NCT00790842|593486457|FG004|Dose Level 2|Death|1|||
164303306|NCT00790842|593486458|FG005|Dose Level 2|Death|0|||
164303307|NCT00790842|593486459|FG006|Dose Level 2|Death|0|||
164303308|NCT00790842|593486460|FG007|Dose Level 2|Death|0|||
164303309|NCT00790842|593486461|FG008|Dose Level 2|Death|0|||
164303310|NCT00790842|593486462|FG009|Dose Level 2|Death|0|||
164303311|NCT00790842|593486463|FG010|Dose Level 2|Death|0|||
164303312|NCT00790842|593486453|FG000|Dose Level 2|Physician Decision|0|||
164303313|NCT00790842|593486454|FG001|Dose Level 2|Physician Decision|1|||
164303314|NCT00790842|593486455|FG002|Dose Level 2|Physician Decision|0|||
164303315|NCT00790842|593486456|FG003|Dose Level 2|Physician Decision|0|||
164303316|NCT00790842|593486457|FG004|Dose Level 2|Physician Decision|0|||
164303317|NCT00790842|593486458|FG005|Dose Level 2|Physician Decision|0|||
164303318|NCT00790842|593486459|FG006|Dose Level 2|Physician Decision|0|||
164303319|NCT00790842|593486460|FG007|Dose Level 2|Physician Decision|0|||
164303320|NCT00790842|593486461|FG008|Dose Level 2|Physician Decision|0|||
164303321|NCT00790842|593486462|FG009|Dose Level 2|Physician Decision|0|||
164303322|NCT00790842|593486463|FG010|Dose Level 2|Physician Decision|0|||
164303323|NCT00790842|593486453|FG000|Dose Level 2|Withdrawal by Subject|0|||
164303324|NCT00790842|593486454|FG001|Dose Level 2|Withdrawal by Subject|1|||
164303325|NCT00790842|593486455|FG002|Dose Level 2|Withdrawal by Subject|0|||
164303326|NCT00790842|593486456|FG003|Dose Level 2|Withdrawal by Subject|0|||
164303327|NCT00790842|593486457|FG004|Dose Level 2|Withdrawal by Subject|0|||
164303328|NCT00790842|593486458|FG005|Dose Level 2|Withdrawal by Subject|0|||
164303329|NCT00790842|593486459|FG006|Dose Level 2|Withdrawal by Subject|0|||
164303330|NCT00790842|593486460|FG007|Dose Level 2|Withdrawal by Subject|0|||
164303331|NCT00790842|593486461|FG008|Dose Level 2|Withdrawal by Subject|0|||
164303332|NCT00790842|593486462|FG009|Dose Level 2|Withdrawal by Subject|0|||
164303333|NCT00790842|593486463|FG010|Dose Level 2|Withdrawal by Subject|0|||
164303334|NCT00790842|593486453|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303335|NCT00790842|593486454|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303336|NCT00790842|593486455|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303337|NCT00790842|593486456|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303338|NCT00790842|593486457|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303339|NCT00790842|593486458|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303340|NCT00790842|593486459|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303341|NCT00790842|593486460|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303342|NCT00790842|593486461|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
164303343|NCT00790842|593486462|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303344|NCT00790842|593486463|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
164303345|NCT00790842|593486453|FG000|Dose Level 3|Adverse Event|0|||
164303346|NCT00790842|593486454|FG001|Dose Level 3|Adverse Event|0|||
164303347|NCT00790842|593486455|FG002|Dose Level 3|Adverse Event|1|||
164303348|NCT00790842|593486456|FG003|Dose Level 3|Adverse Event|0|||
164073989|NCT00446134|592635100|FG001|Overall Study|Lost to Follow-up|3|||
164073990|NCT00446134|592635101|FG002|Overall Study|Lost to Follow-up|1|||
164073991|NCT00446134|592635102|FG003|Overall Study|Lost to Follow-up|1|||
164073992|NCT00446134|592635099|FG000|Overall Study|Withdrawal by Subject|3|||
164073993|NCT00446134|592635100|FG001|Overall Study|Withdrawal by Subject|3|||
164073994|NCT00446134|592635101|FG002|Overall Study|Withdrawal by Subject|1|||
164073995|NCT00446134|592635102|FG003|Overall Study|Withdrawal by Subject|3|||
164073996|NCT00446134|592635099|FG000|Overall Study|Physician Decision|0|||
164073997|NCT00446134|592635100|FG001|Overall Study|Physician Decision|0|||
164073998|NCT00446134|592635101|FG002|Overall Study|Physician Decision|0|||
164073999|NCT00446134|592635102|FG003|Overall Study|Physician Decision|2|||
164074000|NCT00446134|592635099|FG000|Overall Study|Adverse Event-Diarrhea|1|||
164074001|NCT00446134|592635100|FG001|Overall Study|Adverse Event-Diarrhea|1|||
164303349|NCT00790842|593486457|FG004|Dose Level 3|Adverse Event|0|||
164303350|NCT00790842|593486458|FG005|Dose Level 3|Adverse Event|0|||
164303351|NCT00790842|593486459|FG006|Dose Level 3|Adverse Event|0|||
164303352|NCT00790842|593486460|FG007|Dose Level 3|Adverse Event|0|||
164303353|NCT00790842|593486461|FG008|Dose Level 3|Adverse Event|0|||
164303354|NCT00790842|593486462|FG009|Dose Level 3|Adverse Event|0|||
164303355|NCT00790842|593486463|FG010|Dose Level 3|Adverse Event|0|||
164303356|NCT00790842|593486453|FG000|Dose Level 3|Withdrawal by Subject|0|||
164303357|NCT00790842|593486454|FG001|Dose Level 3|Withdrawal by Subject|0|||
164303358|NCT00790842|593486455|FG002|Dose Level 3|Withdrawal by Subject|3|||
164074002|NCT00446134|592635101|FG002|Overall Study|Adverse Event-Diarrhea|2|||
164303359|NCT00790842|593486456|FG003|Dose Level 3|Withdrawal by Subject|0|||
164074003|NCT00446134|592635102|FG003|Overall Study|Adverse Event-Diarrhea|0|||
164074004|NCT00446134|592635099|FG000|Overall Study|Reason Not Completed|3|||
164074005|NCT00446134|592635100|FG001|Overall Study|Reason Not Completed|0|||
164074006|NCT00446134|592635101|FG002|Overall Study|Reason Not Completed|1|||
164074007|NCT00446134|592635102|FG003|Overall Study|Reason Not Completed|2|||
164074008|NCT00567996|592635106|FG000|Overall Study|Adverse Event|18|||
164074009|NCT00567996|592635107|FG001|Overall Study|Adverse Event|16|||
164074010|NCT00567996|592635108|FG002|Overall Study|Adverse Event|13|||
164074011|NCT00567996|592635106|FG000|Overall Study|Protocol Deviation|9|||
164074012|NCT00567996|592635107|FG001|Overall Study|Protocol Deviation|11|||
164074013|NCT00567996|592635108|FG002|Overall Study|Protocol Deviation|13|||
164074014|NCT00567996|592635106|FG000|Overall Study|Withdrawal by Subject|8|||
164074015|NCT00567996|592635107|FG001|Overall Study|Withdrawal by Subject|12|||
164074016|NCT00567996|592635108|FG002|Overall Study|Withdrawal by Subject|22|||
164074017|NCT00567996|592635106|FG000|Overall Study|Abnormal Lab value(s)|2|||
164074018|NCT00567996|592635107|FG001|Overall Study|Abnormal Lab value(s)|1|||
164074019|NCT00567996|592635108|FG002|Overall Study|Abnormal Lab value(s)|2|||
164074020|NCT00567996|592635106|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164074021|NCT00567996|592635107|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164074022|NCT00567996|592635108|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164074023|NCT00567996|592635106|FG000|Overall Study|Lost to Follow-up|2|||
164074024|NCT00567996|592635107|FG001|Overall Study|Lost to Follow-up|5|||
164303360|NCT00790842|593486457|FG004|Dose Level 3|Withdrawal by Subject|0|||
164303361|NCT00790842|593486458|FG005|Dose Level 3|Withdrawal by Subject|0|||
164303362|NCT00790842|593486459|FG006|Dose Level 3|Withdrawal by Subject|0|||
164303363|NCT00790842|593486460|FG007|Dose Level 3|Withdrawal by Subject|0|||
164303364|NCT00790842|593486461|FG008|Dose Level 3|Withdrawal by Subject|0|||
164303365|NCT00790842|593486462|FG009|Dose Level 3|Withdrawal by Subject|2|||
164303366|NCT00790842|593486463|FG010|Dose Level 3|Withdrawal by Subject|0|||
164303367|NCT00790842|593486453|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303368|NCT00790842|593486454|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303369|NCT00790842|593486455|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303370|NCT00790842|593486456|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303371|NCT00790842|593486457|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303372|NCT00790842|593486458|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
164303373|NCT00790842|593486459|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303374|NCT00790842|593486460|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303375|NCT00790842|593486461|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303376|NCT00790842|593486462|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303377|NCT00790842|593486463|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
164303378|NCT00790842|593486453|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303379|NCT00790842|593486454|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164074025|NCT00567996|592635108|FG002|Overall Study|Lost to Follow-up|2|||
164074026|NCT00567996|592635106|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164074027|NCT00567996|592635107|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164074028|NCT00567996|592635108|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
164074029|NCT00567996|592635106|FG000|Overall Study|Administrative problems|1|||
164074030|NCT00567996|592635107|FG001|Overall Study|Administrative problems|1|||
164074031|NCT00567996|592635108|FG002|Overall Study|Administrative problems|0|||
164074032|NCT00567996|592635106|FG000|Overall Study|Death|1|||
164074033|NCT00567996|592635107|FG001|Overall Study|Death|0|||
164074034|NCT00567996|592635108|FG002|Overall Study|Death|2|||
164074035|NCT00567996|592635106|FG000|Overall Study|Patient's inability to use the device|0|||
164074036|NCT00567996|592635107|FG001|Overall Study|Patient's inability to use the device|1|||
164074037|NCT00567996|592635108|FG002|Overall Study|Patient's inability to use the device|0|||
164074038|NCT02956005|592635110|FG000|Overall Study|Not eligible|1|||
164074039|NCT02956005|592635110|FG000|Overall Study|Withdrawal by Subject|3|||
164074040|NCT02956005|592635110|FG000|Overall Study|Physician Decision|12|||
164074041|NCT03125629|592635111|FG000|Overall Study|Withdrawal by Subject|2|||
164074042|NCT03125629|592635111|FG000|Overall Study|Equipment malfunction|1|||
164074043|NCT00743119|592635112|FG000|Overall Study|unreliable|3|||
164074044|NCT00743119|592635112|FG000|Overall Study|Withdrawal by Subject|1|||
164074045|NCT02524665|592635113|FG000|Overall Study|Lost to Follow-up|1|||
164074046|NCT02989610|592635114|FG000|Overall Study|Withdrawal by Subject|20|||
164074047|NCT02989610|592635114|FG000|Overall Study|Departure of PI from Site|8|||
164074048|NCT02989610|592635114|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
164074049|NCT02989610|592635114|FG000|Overall Study|Lost to Follow-up|3|||
164074050|NCT02989610|592635114|FG000|Overall Study|Death|3|||
164074051|NCT02989610|592635114|FG000|Overall Study|System Explant|3|||
164074052|NCT02989610|592635114|FG000|Overall Study|Subject Non-Compliance|2|||
164074053|NCT02989610|592635114|FG000|Overall Study|System Revision|2|||
164303380|NCT00790842|593486455|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
164303381|NCT00790842|593486456|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303382|NCT00790842|593486457|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303383|NCT00790842|593486458|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303384|NCT00790842|593486459|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303385|NCT00790842|593486460|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164074054|NCT02989610|592635114|FG000|Overall Study|PI Left, Study Closing|1|||
164074055|NCT02989610|592635114|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
164303386|NCT00790842|593486461|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303387|NCT00790842|593486462|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303388|NCT00790842|593486463|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
164303389|NCT00790842|593486453|FG000|Dose Level 4|Adverse Event|0|||
164303390|NCT00790842|593486454|FG001|Dose Level 4|Adverse Event|0|||
164303391|NCT00790842|593486455|FG002|Dose Level 4|Adverse Event|0|||
164303392|NCT00790842|593486456|FG003|Dose Level 4|Adverse Event|0|||
164303393|NCT00790842|593486457|FG004|Dose Level 4|Adverse Event|0|||
164303394|NCT00790842|593486458|FG005|Dose Level 4|Adverse Event|0|||
164303395|NCT00790842|593486459|FG006|Dose Level 4|Adverse Event|1|||
164303396|NCT00790842|593486460|FG007|Dose Level 4|Adverse Event|0|||
164303397|NCT00790842|593486461|FG008|Dose Level 4|Adverse Event|0|||
164303398|NCT00790842|593486462|FG009|Dose Level 4|Adverse Event|0|||
164303399|NCT00790842|593486463|FG010|Dose Level 4|Adverse Event|0|||
164303400|NCT00790842|593486453|FG000|Dose Level 4|Physician Decision|0|||
164303401|NCT00790842|593486454|FG001|Dose Level 4|Physician Decision|0|||
164303402|NCT00790842|593486455|FG002|Dose Level 4|Physician Decision|0|||
164303403|NCT00790842|593486456|FG003|Dose Level 4|Physician Decision|0|||
164303404|NCT00790842|593486457|FG004|Dose Level 4|Physician Decision|0|||
164303405|NCT00790842|593486458|FG005|Dose Level 4|Physician Decision|0|||
164303406|NCT00790842|593486459|FG006|Dose Level 4|Physician Decision|1|||
164303407|NCT00790842|593486460|FG007|Dose Level 4|Physician Decision|0|||
164303408|NCT00790842|593486461|FG008|Dose Level 4|Physician Decision|0|||
164303409|NCT00790842|593486462|FG009|Dose Level 4|Physician Decision|0|||
164303410|NCT00790842|593486463|FG010|Dose Level 4|Physician Decision|1|||
164303411|NCT00790842|593486453|FG000|Dose Level 4|Withdrawal by Subject|0|||
164303412|NCT00790842|593486454|FG001|Dose Level 4|Withdrawal by Subject|0|||
164303413|NCT00790842|593486455|FG002|Dose Level 4|Withdrawal by Subject|0|||
164303414|NCT00790842|593486456|FG003|Dose Level 4|Withdrawal by Subject|0|||
164303415|NCT00790842|593486457|FG004|Dose Level 4|Withdrawal by Subject|0|||
164303416|NCT00790842|593486458|FG005|Dose Level 4|Withdrawal by Subject|0|||
164303417|NCT00790842|593486459|FG006|Dose Level 4|Withdrawal by Subject|0|||
164303418|NCT00790842|593486460|FG007|Dose Level 4|Withdrawal by Subject|0|||
164303419|NCT00790842|593486461|FG008|Dose Level 4|Withdrawal by Subject|0|||
164303420|NCT00790842|593486462|FG009|Dose Level 4|Withdrawal by Subject|0|||
164303421|NCT00790842|593486463|FG010|Dose Level 4|Withdrawal by Subject|1|||
164303422|NCT00790842|593486453|FG000|Expansion Cohort|Adverse Event|0|||
164303423|NCT00790842|593486454|FG001|Expansion Cohort|Adverse Event|0|||
164303424|NCT00790842|593486455|FG002|Expansion Cohort|Adverse Event|0|||
164303425|NCT00790842|593486456|FG003|Expansion Cohort|Adverse Event|0|||
164303426|NCT00790842|593486457|FG004|Expansion Cohort|Adverse Event|0|||
164303427|NCT00790842|593486458|FG005|Expansion Cohort|Adverse Event|0|||
164303428|NCT00790842|593486459|FG006|Expansion Cohort|Adverse Event|1|||
164303429|NCT00790842|593486460|FG007|Expansion Cohort|Adverse Event|0|||
164303430|NCT00790842|593486461|FG008|Expansion Cohort|Adverse Event|0|||
164303431|NCT00790842|593486462|FG009|Expansion Cohort|Adverse Event|0|||
164303432|NCT00790842|593486463|FG010|Expansion Cohort|Adverse Event|0|||
164303433|NCT00790842|593486453|FG000|Expansion Cohort|Death|0|||
164303434|NCT00790842|593486454|FG001|Expansion Cohort|Death|0|||
164303435|NCT00790842|593486455|FG002|Expansion Cohort|Death|2|||
164303436|NCT00790842|593486456|FG003|Expansion Cohort|Death|0|||
164303437|NCT00790842|593486457|FG004|Expansion Cohort|Death|0|||
164303438|NCT00790842|593486458|FG005|Expansion Cohort|Death|0|||
164303439|NCT00790842|593486459|FG006|Expansion Cohort|Death|0|||
164188973|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188974|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188975|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188976|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188977|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
164188978|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164074056|NCT02989610|592635114|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
164074057|NCT02602080|592635120|FG000|Overall Study|Protocol Violation|6|||
164188979|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188980|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188981|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188982|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188983|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
164188984|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164303440|NCT00790842|593486460|FG007|Expansion Cohort|Death|0|||
164303441|NCT00790842|593486461|FG008|Expansion Cohort|Death|0|||
164188985|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
164188986|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164188987|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
164303442|NCT00790842|593486462|FG009|Expansion Cohort|Death|0|||
164303443|NCT00790842|593486463|FG010|Expansion Cohort|Death|0|||
164303444|NCT00790842|593486453|FG000|Expansion Cohort|Physician Decision|0|||
164303445|NCT00790842|593486454|FG001|Expansion Cohort|Physician Decision|0|||
164188988|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188989|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188990|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188991|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188992|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
164188993|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
164188994|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188995|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188996|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188997|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
164188998|NCT04074330|593060413|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164188999|NCT04074330|593060414|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189000|NCT04074330|593060415|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189001|NCT04074330|593060416|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189002|NCT04074330|593060417|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189003|NCT04074330|593060418|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
164189004|NCT04074330|593060419|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189005|NCT04074330|593060420|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189006|NCT04074330|593060421|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189007|NCT04074330|593060422|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
164189008|NCT04074330|593060413|FG000|Dose Expansion (up to 42 Months)|Death|0|||
164189009|NCT04074330|593060414|FG001|Dose Expansion (up to 42 Months)|Death|0|||
164189010|NCT04074330|593060415|FG002|Dose Expansion (up to 42 Months)|Death|0|||
164189011|NCT04074330|593060416|FG003|Dose Expansion (up to 42 Months)|Death|0|||
164303446|NCT00790842|593486455|FG002|Expansion Cohort|Physician Decision|1|||
164303447|NCT00790842|593486456|FG003|Expansion Cohort|Physician Decision|0|||
164303448|NCT00790842|593486457|FG004|Expansion Cohort|Physician Decision|0|||
164303449|NCT00790842|593486458|FG005|Expansion Cohort|Physician Decision|0|||
164303450|NCT00790842|593486459|FG006|Expansion Cohort|Physician Decision|0|||
164303451|NCT00790842|593486460|FG007|Expansion Cohort|Physician Decision|0|||
164303452|NCT00790842|593486461|FG008|Expansion Cohort|Physician Decision|0|||
164303453|NCT00790842|593486462|FG009|Expansion Cohort|Physician Decision|0|||
164303454|NCT00790842|593486463|FG010|Expansion Cohort|Physician Decision|0|||
164303455|NCT00790842|593486453|FG000|Expansion Cohort|Withdrawal by Subject|0|||
164303456|NCT00790842|593486454|FG001|Expansion Cohort|Withdrawal by Subject|0|||
164303457|NCT00790842|593486455|FG002|Expansion Cohort|Withdrawal by Subject|3|||
164303458|NCT00790842|593486456|FG003|Expansion Cohort|Withdrawal by Subject|0|||
164303459|NCT00790842|593486457|FG004|Expansion Cohort|Withdrawal by Subject|0|||
164303460|NCT00790842|593486458|FG005|Expansion Cohort|Withdrawal by Subject|0|||
164303461|NCT00790842|593486459|FG006|Expansion Cohort|Withdrawal by Subject|0|||
164303462|NCT00790842|593486460|FG007|Expansion Cohort|Withdrawal by Subject|0|||
164303463|NCT00790842|593486461|FG008|Expansion Cohort|Withdrawal by Subject|0|||
164303464|NCT00790842|593486462|FG009|Expansion Cohort|Withdrawal by Subject|0|||
164303465|NCT00790842|593486463|FG010|Expansion Cohort|Withdrawal by Subject|0|||
164303466|NCT00790842|593486453|FG000|Expansion Cohort|Study Closure|0|||
164303467|NCT00790842|593486454|FG001|Expansion Cohort|Study Closure|0|||
164303468|NCT00790842|593486455|FG002|Expansion Cohort|Study Closure|1|||
164303469|NCT00790842|593486456|FG003|Expansion Cohort|Study Closure|0|||
164303470|NCT00790842|593486457|FG004|Expansion Cohort|Study Closure|0|||
164303471|NCT00790842|593486458|FG005|Expansion Cohort|Study Closure|0|||
164303472|NCT00790842|593486459|FG006|Expansion Cohort|Study Closure|0|||
164303473|NCT00790842|593486460|FG007|Expansion Cohort|Study Closure|0|||
164303474|NCT00790842|593486461|FG008|Expansion Cohort|Study Closure|0|||
164303475|NCT00790842|593486462|FG009|Expansion Cohort|Study Closure|0|||
164303476|NCT00790842|593486463|FG010|Expansion Cohort|Study Closure|0|||
164189012|NCT04074330|593060417|FG004|Dose Expansion (up to 42 Months)|Death|0|||
164189013|NCT04074330|593060418|FG005|Dose Expansion (up to 42 Months)|Death|0|||
164303477|NCT02504151|593486464|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
164303478|NCT02504151|593486465|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
164303479|NCT02504151|593486464|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
164303480|NCT02504151|593486465|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
164303481|NCT02504151|593486464|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164303482|NCT02504151|593486465|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164303483|NCT02504151|593486464|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
164303484|NCT02504151|593486465|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
164303485|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
164303486|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
164303487|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
164303488|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
164303489|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
164303490|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
164303491|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
164303492|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
164303493|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
164303494|NCT00538902|593486466|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
164303495|NCT00538902|593486467|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
164303496|NCT00538902|593486468|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
164303497|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
164303498|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
164303499|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
164303500|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
164303501|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
164303502|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
164303503|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
164303504|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
164303505|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
164303506|NCT00538902|593486466|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
164074058|NCT02602080|592635121|FG001|Overall Study|Protocol Violation|1|||
164303507|NCT00538902|593486467|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
164303508|NCT00538902|593486468|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
164303509|NCT01454102|593486469|FG000|Overall Study|Continuing in the treatment period|0|||
164303510|NCT01454102|593486470|FG001|Overall Study|Continuing in the treatment period|0|||
164303511|NCT01454102|593486471|FG002|Overall Study|Continuing in the treatment period|0|||
164303512|NCT01454102|593486472|FG003|Overall Study|Continuing in the treatment period|0|||
164303513|NCT01454102|593486473|FG004|Overall Study|Continuing in the treatment period|3|||
164303514|NCT01454102|593486474|FG005|Overall Study|Continuing in the treatment period|3|||
164303515|NCT01454102|593486475|FG006|Overall Study|Continuing in the treatment period|2|||
164303516|NCT01454102|593486476|FG007|Overall Study|Continuing in the treatment period|0|||
164303517|NCT01454102|593486477|FG008|Overall Study|Continuing in the treatment period|1|||
164303518|NCT01454102|593486478|FG009|Overall Study|Continuing in the treatment period|0|||
164303519|NCT01454102|593486479|FG010|Overall Study|Continuing in the treatment period|0|||
164303520|NCT01454102|593486480|FG011|Overall Study|Continuing in the treatment period|4|||
164303521|NCT01454102|593486481|FG012|Overall Study|Continuing in the treatment period|7|||
164303522|NCT01454102|593486482|FG013|Overall Study|Continuing in the treatment period|4|||
164303523|NCT01454102|593486483|FG014|Overall Study|Continuing in the treatment period|3|||
164303524|NCT01454102|593486484|FG015|Overall Study|Continuing in the treatment period|1|||
164303525|NCT00705016|593486487|FG000|Overall Study|Adverse Event|6|||
164303526|NCT00705016|593486488|FG001|Overall Study|Adverse Event|11|||
164303527|NCT00705016|593486489|FG002|Overall Study|Adverse Event|10|||
164303528|NCT00705016|593486487|FG000|Overall Study|Death|5|||
164303529|NCT00705016|593486488|FG001|Overall Study|Death|7|||
164303530|NCT00705016|593486489|FG002|Overall Study|Death|5|||
164303531|NCT00705016|593486487|FG000|Overall Study|Protocol Violation|0|||
164303532|NCT00705016|593486488|FG001|Overall Study|Protocol Violation|1|||
164303533|NCT00705016|593486489|FG002|Overall Study|Protocol Violation|1|||
164074059|NCT02602080|592635122|FG002|Overall Study|Protocol Violation|3|||
164303534|NCT00705016|593486487|FG000|Overall Study|Withdrawal by Subject|4|||
164074060|NCT01066039|592635127|FG000|Overall Study|Adverse Event|6|||
164303535|NCT00705016|593486488|FG001|Overall Study|Withdrawal by Subject|3|||
164303536|NCT00705016|593486489|FG002|Overall Study|Withdrawal by Subject|2|||
164303537|NCT00705016|593486487|FG000|Overall Study|Progressive Disease|33|||
164303538|NCT00705016|593486488|FG001|Overall Study|Progressive Disease|29|||
164303539|NCT00705016|593486489|FG002|Overall Study|Progressive Disease|33|||
164303540|NCT00705016|593486487|FG000|Overall Study|Symptomatic Deterioration|3|||
164303541|NCT00705016|593486488|FG001|Overall Study|Symptomatic Deterioration|1|||
164303542|NCT00705016|593486489|FG002|Overall Study|Symptomatic Deterioration|1|||
164303543|NCT00705016|593486487|FG000|Overall Study|Other|9|||
164303544|NCT00705016|593486488|FG001|Overall Study|Other|6|||
164303545|NCT00705016|593486489|FG002|Overall Study|Other|6|||
164303546|NCT00942604|593486490|FG000|Overall Study|Protocol Violation|1|||
164303547|NCT00942604|593486491|FG001|Overall Study|Protocol Violation|1|||
164303548|NCT00942604|593486490|FG000|Overall Study|Adverse Event|0|||
164303549|NCT00942604|593486491|FG001|Overall Study|Adverse Event|1|||
164303550|NCT00942604|593486490|FG000|Overall Study|Withdrawal by Subject|0|||
164303551|NCT00942604|593486491|FG001|Overall Study|Withdrawal by Subject|1|||
164303552|NCT00942604|593486490|FG000|Overall Study|Patient relocation|1|||
164303553|NCT00942604|593486491|FG001|Overall Study|Patient relocation|1|||
164303554|NCT01188343|593486492|FG000|Overall Study|Not vaccinated|0|||
164303555|NCT01188343|593486493|FG001|Overall Study|Not vaccinated|2|||
164303556|NCT01188343|593486494|FG002|Overall Study|Not vaccinated|1|||
164303557|NCT01188343|593486492|FG000|Overall Study|Withdrawal by Subject|1|||
164303558|NCT01188343|593486493|FG001|Overall Study|Withdrawal by Subject|24|||
164303559|NCT01188343|593486494|FG002|Overall Study|Withdrawal by Subject|0|||
164303560|NCT04109547|593486495|FG000|Overall Study|Withdrawal by Subject|3|||
164303561|NCT04109547|593486496|FG001|Overall Study|Withdrawal by Subject|2|||
164303562|NCT04109547|593486497|FG002|Overall Study|Withdrawal by Subject|6|||
164303563|NCT04109547|593486498|FG003|Overall Study|Withdrawal by Subject|6|||
164303564|NCT04109547|593486495|FG000|Overall Study|Lost to Follow-up|0|||
164303565|NCT04109547|593486496|FG001|Overall Study|Lost to Follow-up|0|||
164303566|NCT04109547|593486497|FG002|Overall Study|Lost to Follow-up|0|||
164303567|NCT04109547|593486498|FG003|Overall Study|Lost to Follow-up|1|||
164303568|NCT04109547|593486495|FG000|Overall Study|Physician Decision|1|||
164303569|NCT04109547|593486496|FG001|Overall Study|Physician Decision|2|||
164303570|NCT04109547|593486497|FG002|Overall Study|Physician Decision|0|||
164303571|NCT04109547|593486498|FG003|Overall Study|Physician Decision|0|||
164303572|NCT01499355|593486501|FG000|Run-In Period|Study Termination|15|||
164303573|NCT01499355|593486502|FG001|Run-In Period|Study Termination|0|||
164303574|NCT01499355|593486503|FG002|Run-In Period|Study Termination|0|||
164303575|NCT01499355|593486504|FG003|Run-In Period|Study Termination|0|||
164303576|NCT01499355|593486501|FG000|Run-In Period|Other|3|||
164303577|NCT01499355|593486502|FG001|Run-In Period|Other|0|||
164303578|NCT01499355|593486503|FG002|Run-In Period|Other|0|||
164303579|NCT01499355|593486504|FG003|Run-In Period|Other|0|||
164303580|NCT01499355|593486501|FG000|Run-In Period|Death|2|||
164303581|NCT01499355|593486502|FG001|Run-In Period|Death|0|||
164303582|NCT01499355|593486503|FG002|Run-In Period|Death|0|||
164303583|NCT01499355|593486504|FG003|Run-In Period|Death|0|||
164303584|NCT01499355|593486501|FG000|Run-In Period|Investigator Decision|2|||
164303585|NCT01499355|593486502|FG001|Run-In Period|Investigator Decision|0|||
164303586|NCT01499355|593486503|FG002|Run-In Period|Investigator Decision|0|||
164303587|NCT01499355|593486504|FG003|Run-In Period|Investigator Decision|0|||
164303588|NCT01499355|593486501|FG000|Run-In Period|Consent Withdrawn|1|||
164303589|NCT01499355|593486502|FG001|Run-In Period|Consent Withdrawn|0|||
164303590|NCT01499355|593486503|FG002|Run-In Period|Consent Withdrawn|0|||
164303591|NCT01499355|593486504|FG003|Run-In Period|Consent Withdrawn|0|||
164303592|NCT01499355|593486501|FG000|Run-In Period|Adverse Event|8|||
164303593|NCT01499355|593486502|FG001|Run-In Period|Adverse Event|0|||
164303594|NCT01499355|593486503|FG002|Run-In Period|Adverse Event|0|||
164303595|NCT01499355|593486504|FG003|Run-In Period|Adverse Event|0|||
164303596|NCT01499355|593486501|FG000|Double-Blind Period|Adverse Event|0|||
164303597|NCT01499355|593486502|FG001|Double-Blind Period|Adverse Event|2|||
164303598|NCT01499355|593486503|FG002|Double-Blind Period|Adverse Event|3|||
164303599|NCT01499355|593486504|FG003|Double-Blind Period|Adverse Event|2|||
164303600|NCT01499355|593486501|FG000|Double-Blind Period|Study Termination|0|||
164303601|NCT01499355|593486502|FG001|Double-Blind Period|Study Termination|18|||
164303602|NCT01499355|593486503|FG002|Double-Blind Period|Study Termination|16|||
164303603|NCT01499355|593486504|FG003|Double-Blind Period|Study Termination|14|||
164303604|NCT01499355|593486501|FG000|Double-Blind Period|Other|0|||
164303605|NCT01499355|593486502|FG001|Double-Blind Period|Other|1|||
164303606|NCT01499355|593486503|FG002|Double-Blind Period|Other|2|||
164303607|NCT01499355|593486504|FG003|Double-Blind Period|Other|2|||
164303608|NCT01499355|593486501|FG000|Double-Blind Period|Death|0|||
164303609|NCT01499355|593486502|FG001|Double-Blind Period|Death|1|||
164303610|NCT01499355|593486503|FG002|Double-Blind Period|Death|0|||
164303611|NCT01499355|593486504|FG003|Double-Blind Period|Death|0|||
164303612|NCT01499355|593486501|FG000|Double-Blind Period|Investigator Decision|0|||
164303613|NCT01499355|593486502|FG001|Double-Blind Period|Investigator Decision|0|||
164303614|NCT01499355|593486503|FG002|Double-Blind Period|Investigator Decision|3|||
164303615|NCT01499355|593486504|FG003|Double-Blind Period|Investigator Decision|3|||
164303616|NCT01499355|593486501|FG000|Double-Blind Period|Consent Withdrawn|0|||
164303617|NCT01499355|593486502|FG001|Double-Blind Period|Consent Withdrawn|0|||
164303618|NCT01499355|593486503|FG002|Double-Blind Period|Consent Withdrawn|1|||
164303619|NCT01499355|593486504|FG003|Double-Blind Period|Consent Withdrawn|2|||
164303620|NCT01499355|593486501|FG000|Double-Blind Period|Lost to Follow-up|0|||
164303621|NCT01499355|593486502|FG001|Double-Blind Period|Lost to Follow-up|1|||
164303622|NCT01499355|593486503|FG002|Double-Blind Period|Lost to Follow-up|0|||
164303623|NCT01499355|593486504|FG003|Double-Blind Period|Lost to Follow-up|0|||
164303624|NCT02668653|593486505|FG000|Overall Study|Refractory disease|41|||
164303625|NCT02668653|593486506|FG001|Overall Study|Refractory disease|70|||
164303626|NCT02668653|593486505|FG000|Overall Study|Relapse|44|||
164303627|NCT02668653|593486506|FG001|Overall Study|Relapse|65|||
164303628|NCT02668653|593486505|FG000|Overall Study|Adverse Event|58|||
164303629|NCT02668653|593486506|FG001|Overall Study|Adverse Event|23|||
164303630|NCT02668653|593486505|FG000|Overall Study|Subject decision to stop study drug|25|||
164303631|NCT02668653|593486506|FG001|Overall Study|Subject decision to stop study drug|23|||
164303632|NCT02668653|593486505|FG000|Overall Study|Other reasons not specified|16|||
164303633|NCT02668653|593486506|FG001|Overall Study|Other reasons not specified|11|||
164303634|NCT02668653|593486505|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
164303635|NCT02668653|593486506|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
164303636|NCT02668653|593486505|FG000|Overall Study|Investigator decision|10|||
164303637|NCT02668653|593486506|FG001|Overall Study|Investigator decision|7|||
164303638|NCT02668653|593486505|FG000|Overall Study|Failure to meet continuation criteria|5|||
164303639|NCT02668653|593486506|FG001|Overall Study|Failure to meet continuation criteria|12|||
164303640|NCT02668653|593486505|FG000|Overall Study|Lost to Follow-up|1|||
164303641|NCT02668653|593486506|FG001|Overall Study|Lost to Follow-up|0|||
164303642|NCT02668653|593486505|FG000|Overall Study|Pregnancy|0|||
164303643|NCT02668653|593486506|FG001|Overall Study|Pregnancy|1|||
164303644|NCT02668653|593486505|FG000|Overall Study|Death|0|||
164303645|NCT02668653|593486506|FG001|Overall Study|Death|1|||
164303646|NCT00686712|593486508|FG000|Overall Study|Protocol Violation|8|||
164303647|NCT00686712|593486509|FG001|Overall Study|Protocol Violation|8|||
164303648|NCT00686712|593486510|FG002|Overall Study|Protocol Violation|10|||
164303649|NCT00686712|593486508|FG000|Overall Study|Lost to Follow-up|1|||
164303650|NCT00686712|593486509|FG001|Overall Study|Lost to Follow-up|2|||
164303651|NCT00686712|593486510|FG002|Overall Study|Lost to Follow-up|3|||
164303652|NCT00686712|593486508|FG000|Overall Study|Adverse Event|1|||
164303653|NCT00686712|593486509|FG001|Overall Study|Adverse Event|1|||
164303654|NCT00686712|593486510|FG002|Overall Study|Adverse Event|0|||
164303655|NCT01318915|593486511|FG000|Overall Study|Lost to Follow-up|1|||
164303656|NCT03987503|593486512|FG000|Overall Study|Lost to Follow-up|20|||
164303657|NCT03987503|593486512|FG000|Overall Study|Withdrawal by Subject|2|||
164303658|NCT04119414|593486513|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
164303659|NCT01929317|593486527|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
164303660|NCT01929317|593486528|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
164303661|NCT01929317|593486527|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
164303662|NCT01929317|593486528|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
164303663|NCT01929317|593486527|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
164303664|NCT01929317|593486528|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
164303665|NCT01929317|593486527|FG000|Long-term Phase|Adverse Event|5|||
164303666|NCT01929317|593486528|FG001|Long-term Phase|Adverse Event|1|||
164303667|NCT01929317|593486527|FG000|Long-term Phase|Physician Decision|3|||
164303668|NCT01929317|593486528|FG001|Long-term Phase|Physician Decision|0|||
164303669|NCT01929317|593486527|FG000|Long-term Phase|Withdrawal by Subject|4|||
164303670|NCT01929317|593486528|FG001|Long-term Phase|Withdrawal by Subject|0|||
164303671|NCT01929317|593486527|FG000|Long-term Phase|Protocol Violation|1|||
164303672|NCT01929317|593486528|FG001|Long-term Phase|Protocol Violation|0|||
164303673|NCT01929317|593486527|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
164303674|NCT01929317|593486528|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
164303675|NCT01929317|593486527|FG000|Long-term Phase|Study Closed/Terminated|5|||
164303676|NCT01929317|593486528|FG001|Long-term Phase|Study Closed/Terminated|3|||
164303677|NCT01588522|593486548|FG000|Overall Study|Withdrawal by Subject|1|||
164303678|NCT01588522|593486549|FG001|Overall Study|Withdrawal by Subject|5|||
164303679|NCT01588522|593486550|FG002|Overall Study|Withdrawal by Subject|3|||
164303680|NCT01588522|593486551|FG003|Overall Study|Withdrawal by Subject|1|||
164303681|NCT01588522|593486552|FG004|Overall Study|Withdrawal by Subject|2|||
164303682|NCT01588522|593486553|FG005|Overall Study|Withdrawal by Subject|0|||
164303683|NCT01588522|593486548|FG000|Overall Study|Lack of Efficacy|0|||
164303684|NCT01588522|593486549|FG001|Overall Study|Lack of Efficacy|0|||
164303685|NCT01588522|593486550|FG002|Overall Study|Lack of Efficacy|0|||
164303686|NCT01588522|593486551|FG003|Overall Study|Lack of Efficacy|0|||
164303687|NCT01588522|593486552|FG004|Overall Study|Lack of Efficacy|1|||
164303688|NCT01588522|593486553|FG005|Overall Study|Lack of Efficacy|0|||
164303689|NCT01588522|593486548|FG000|Overall Study|Adverse Event|0|||
163844489|NCT06017999|591800044|FG001|Overall Study|Lost to Follow-up|0|||
164303690|NCT01588522|593486549|FG001|Overall Study|Adverse Event|0|||
164303691|NCT01588522|593486550|FG002|Overall Study|Adverse Event|0|||
164303692|NCT01588522|593486551|FG003|Overall Study|Adverse Event|1|||
164303693|NCT01588522|593486552|FG004|Overall Study|Adverse Event|0|||
164303694|NCT01588522|593486553|FG005|Overall Study|Adverse Event|0|||
164303695|NCT01588522|593486548|FG000|Overall Study|Grade 2 alopecia|1|||
164303696|NCT01588522|593486549|FG001|Overall Study|Grade 2 alopecia|0|||
164303697|NCT01588522|593486550|FG002|Overall Study|Grade 2 alopecia|0|||
164303698|NCT01588522|593486551|FG003|Overall Study|Grade 2 alopecia|0|||
164303699|NCT01588522|593486552|FG004|Overall Study|Grade 2 alopecia|0|||
164303700|NCT01588522|593486553|FG005|Overall Study|Grade 2 alopecia|0|||
164303701|NCT01588522|593486548|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
164303702|NCT01588522|593486549|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
164303703|NCT01588522|593486550|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
164303704|NCT01588522|593486551|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
164303705|NCT01588522|593486552|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
164303706|NCT01588522|593486553|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
164303707|NCT01588522|593486548|FG000|Overall Study|Taken off taxane-based regimen|0|||
164303708|NCT01588522|593486549|FG001|Overall Study|Taken off taxane-based regimen|0|||
164303709|NCT01588522|593486550|FG002|Overall Study|Taken off taxane-based regimen|0|||
164303710|NCT01588522|593486551|FG003|Overall Study|Taken off taxane-based regimen|1|||
164303711|NCT01588522|593486552|FG004|Overall Study|Taken off taxane-based regimen|0|||
164303712|NCT01588522|593486553|FG005|Overall Study|Taken off taxane-based regimen|0|||
164303713|NCT01588522|593486548|FG000|Overall Study|Did not initiate chemotherapy|0|||
164303714|NCT01588522|593486549|FG001|Overall Study|Did not initiate chemotherapy|0|||
164303715|NCT01588522|593486550|FG002|Overall Study|Did not initiate chemotherapy|0|||
164303716|NCT01588522|593486551|FG003|Overall Study|Did not initiate chemotherapy|0|||
164303717|NCT01588522|593486552|FG004|Overall Study|Did not initiate chemotherapy|1|||
164303718|NCT01588522|593486553|FG005|Overall Study|Did not initiate chemotherapy|0|||
164303719|NCT02855125|593486558|FG000|Overall Study|Withdrawal by Subject|2|||
164303720|NCT02855125|593486559|FG001|Overall Study|Withdrawal by Subject|2|||
164303721|NCT02855125|593486558|FG000|Overall Study|Clinical Disease Progression|5|||
164303722|NCT02855125|593486559|FG001|Overall Study|Clinical Disease Progression|4|||
164303723|NCT02855125|593486558|FG000|Overall Study|Radiologic Disease Progression|36|||
164303724|NCT02855125|593486559|FG001|Overall Study|Radiologic Disease Progression|39|||
164303725|NCT02855125|593486558|FG000|Overall Study|Adverse Event|11|||
164303726|NCT02855125|593486559|FG001|Overall Study|Adverse Event|7|||
164303727|NCT02855125|593486558|FG000|Overall Study|Physician Decision|1|||
164303728|NCT02855125|593486559|FG001|Overall Study|Physician Decision|0|||
164303729|NCT02855125|593486558|FG000|Overall Study|On Treatment|9|||
164303730|NCT02855125|593486559|FG001|Overall Study|On Treatment|11|||
164303731|NCT02855125|593486558|FG000|Overall Study|Randomized but not treated|0|||
164303732|NCT02855125|593486559|FG001|Overall Study|Randomized but not treated|1|||
164303733|NCT01899040|593486561|FG000|Overall Study|Randomized in error|0|||
164303734|NCT01899040|593486562|FG001|Overall Study|Randomized in error|1|||
164303735|NCT01899040|593486563|FG002|Overall Study|Randomized in error|1|||
164303736|NCT01899040|593486561|FG000|Overall Study|Adverse Event|3|||
164303737|NCT01899040|593486562|FG001|Overall Study|Adverse Event|1|||
164303738|NCT01899040|593486563|FG002|Overall Study|Adverse Event|2|||
164303739|NCT01899040|593486561|FG000|Overall Study|Unspecified reasons|4|||
164303740|NCT01899040|593486562|FG001|Overall Study|Unspecified reasons|4|||
164303741|NCT01899040|593486563|FG002|Overall Study|Unspecified reasons|0|||
164303742|NCT01899040|593486561|FG000|Overall Study|Compliance issues|1|||
164303743|NCT01899040|593486562|FG001|Overall Study|Compliance issues|2|||
164303744|NCT01899040|593486563|FG002|Overall Study|Compliance issues|0|||
164303745|NCT02638220|593486569|FG000|Overall Study|Lost to Follow-up|6|||
164303746|NCT02638220|593486569|FG000|Overall Study|Withdrawal by Subject|3|||
164303747|NCT02638220|593486569|FG000|Overall Study|Physician Decision|1|||
164303748|NCT02638220|593486569|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
164355601|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
164355602|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
164355603|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
164355604|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
164355605|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
164355606|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
164355607|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
164355608|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
164355609|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
163844490|NCT06017999|591800045|FG002|Overall Study|Lost to Follow-up|1|||
164355610|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
164355611|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
164355612|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
164303749|NCT02083354|593488356|FG000|Overall Study|Withdrawal by Subject|9|||
164303750|NCT02083354|593488356|FG000|Overall Study|Lost to Follow-up|1|||
164303751|NCT02083354|593488356|FG000|Overall Study|Adverse Event|3|||
164303752|NCT02083354|593488356|FG000|Overall Study|Disease progression|46|||
164303753|NCT02083354|593488356|FG000|Overall Study|Study closed/terminated|5|||
164303754|NCT01646125|593488357|FG000|Overall Study|Untreated|2|||
164189014|NCT04074330|593060419|FG006|Dose Expansion (up to 42 Months)|Death|0|||
164189015|NCT04074330|593060420|FG007|Dose Expansion (up to 42 Months)|Death|0|||
164189016|NCT04074330|593060421|FG008|Dose Expansion (up to 42 Months)|Death|1|||
164189017|NCT04074330|593060422|FG009|Dose Expansion (up to 42 Months)|Death|0|||
164189018|NCT04074330|593060413|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189019|NCT04074330|593060414|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189020|NCT04074330|593060415|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189021|NCT04074330|593060416|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189022|NCT04074330|593060417|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189023|NCT04074330|593060418|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189024|NCT04074330|593060419|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189025|NCT04074330|593060420|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
164189026|NCT04074330|593060421|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
164189027|NCT04074330|593060422|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
164189028|NCT01429298|593060427|FG000|Overall Study|Protocol Violation|4|||
164189029|NCT01429298|593060428|FG001|Overall Study|Protocol Violation|6|||
164189030|NCT02903420|593060429|FG000|Overall Study|Death|3|||
164189031|NCT00181883|593060432|FG000|Overall Study|Lack of Efficacy|2|||
164189032|NCT00181883|593060432|FG000|Overall Study|Treatment Limiting AEs|3|||
164189033|NCT00181883|593060432|FG000|Overall Study|Withdrawal by Subject|4|||
164189034|NCT00181883|593060432|FG000|Overall Study|Lost to Follow-up|1|||
164189035|NCT05305989|593060433|FG000|Overall Study|Other|3|||
164189036|NCT05305989|593060434|FG001|Overall Study|Other|2|||
164189037|NCT05305989|593060435|FG002|Overall Study|Other|0|||
164189038|NCT05305989|593060433|FG000|Overall Study|Sponsor decision|2|||
164189039|NCT05305989|593060434|FG001|Overall Study|Sponsor decision|1|||
164189040|NCT05305989|593060435|FG002|Overall Study|Sponsor decision|0|||
164303755|NCT01646125|593488358|FG001|Overall Study|Untreated|5|||
164303756|NCT01646125|593488357|FG000|Overall Study|Adverse Event|2|||
164303757|NCT01646125|593488358|FG001|Overall Study|Adverse Event|1|||
164303758|NCT01646125|593488357|FG000|Overall Study|Death|1|||
164303759|NCT01646125|593488358|FG001|Overall Study|Death|1|||
164303760|NCT01646125|593488357|FG000|Overall Study|Physician Decision|1|||
164303761|NCT01646125|593488358|FG001|Overall Study|Physician Decision|3|||
164303762|NCT01646125|593488357|FG000|Overall Study|Progressive disease|22|||
164303763|NCT01646125|593488358|FG001|Overall Study|Progressive disease|16|||
164303764|NCT01646125|593488357|FG000|Overall Study|Study terminated by sponsor|2|||
164303765|NCT01646125|593488358|FG001|Overall Study|Study terminated by sponsor|1|||
164303766|NCT01646125|593488357|FG000|Overall Study|Subject/Guardian decision|1|||
164303767|NCT01646125|593488358|FG001|Overall Study|Subject/Guardian decision|1|||
164303768|NCT02105662|593488359|FG000|Overall Study|Lost to Follow-up|5|||
164303769|NCT02105662|593488359|FG000|Overall Study|Withdrawal by Subject|1|||
164303770|NCT01417377|593488362|FG000|Overall Study|Lost to Follow-up|12|||
164303771|NCT01417377|593488362|FG000|Overall Study|Enrolled, but not treated|1|||
164303772|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
164303773|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
164303774|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
164303775|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
164303776|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
164303777|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
164303778|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
164303779|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
164303780|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
164303781|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
164303782|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
164303783|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
164303784|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
164303785|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
164189041|NCT05305989|593060433|FG000|Overall Study|Protocol Violation|0|||
164189042|NCT05305989|593060434|FG001|Overall Study|Protocol Violation|1|||
164189043|NCT05305989|593060435|FG002|Overall Study|Protocol Violation|0|||
164189044|NCT05305989|593060433|FG000|Overall Study|Investigator decision|1|||
164189045|NCT05305989|593060434|FG001|Overall Study|Investigator decision|2|||
164303786|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
164303787|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
164303788|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
164303789|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
164303790|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
164303791|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
164303792|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
164303793|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
164303794|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
164303795|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
164303796|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
164303797|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
164303798|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
164303799|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
164303800|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303801|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303802|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303803|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303804|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303805|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303806|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
164303807|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303808|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303809|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303810|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303811|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303812|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303813|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
164303814|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Transplant|0|||
164303815|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Transplant|1|||
164303816|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Transplant|0|||
164303817|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Transplant|0|||
164303818|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Transplant|0|||
164303819|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Transplant|1|||
164303820|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Transplant|0|||
164303821|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Transplant|0|||
164303822|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Transplant|0|||
164303823|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Transplant|0|||
164303824|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Transplant|0|||
164303825|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Transplant|0|||
164303826|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Transplant|0|||
164303827|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Transplant|0|||
163844491|NCT06017999|591800043|FG000|Overall Study|Physician Decision|1|||
163844492|NCT06017999|591800044|FG001|Overall Study|Physician Decision|1|||
163844493|NCT06017999|591800045|FG002|Overall Study|Physician Decision|0|||
163844494|NCT06017999|591800043|FG000|Overall Study|Non-Compliance|0|||
163844495|NCT06017999|591800044|FG001|Overall Study|Non-Compliance|0|||
163844496|NCT06017999|591800045|FG002|Overall Study|Non-Compliance|1|||
163844497|NCT06017999|591800043|FG000|Overall Study|Lack of Efficacy|1|||
163844498|NCT06017999|591800044|FG001|Overall Study|Lack of Efficacy|0|||
163844499|NCT06017999|591800045|FG002|Overall Study|Lack of Efficacy|7|||
163844500|NCT06017999|591800043|FG000|Overall Study|COVID Positive|0|||
163844501|NCT06017999|591800044|FG001|Overall Study|COVID Positive|1|||
164074061|NCT01066039|592635127|FG000|Overall Study|Withdrawal by Subject|17|||
164074062|NCT01066039|592635127|FG000|Overall Study|Protocol Violation|2|||
164074063|NCT01066039|592635127|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
164074064|NCT01066039|592635127|FG000|Overall Study|Investigator's Request|1|||
164074065|NCT01066039|592635127|FG000|Overall Study|Dropout due to Insulin Administration|1|||
164074066|NCT01066039|592635127|FG000|Overall Study|Additional Antihypertensive Required|4|||
164074067|NCT01066039|592635127|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
163844502|NCT06017999|591800045|FG002|Overall Study|COVID Positive|0|||
164074068|NCT01066039|592635127|FG000|Overall Study|Failure to Control Blood Pressure|1|||
164074069|NCT01066039|592635127|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
164303828|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
164303829|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
164303830|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
163844503|NCT06017999|591800043|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
164303831|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
164303832|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
164303833|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
164303834|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
164303835|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
164303836|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
164303837|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
164303838|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
164303839|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
164303840|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
164303841|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
163844504|NCT06017999|591800044|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
163844505|NCT06017999|591800045|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
163844506|NCT01155388|591800046|FG000|Overall Study|Adverse Event|1|||
163844507|NCT01155388|591800047|FG001|Overall Study|Adverse Event|0|||
163844508|NCT03943589|591800048|FG000|Overall Study|Death|1|||
163844509|NCT03943589|591800048|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
163844510|NCT04329104|591800049|FG000|Efficacy Study|Withdrawal by Subject|0|||
163844511|NCT04329104|591800050|FG001|Efficacy Study|Withdrawal by Subject|0|||
163844512|NCT04329104|591800051|FG002|Efficacy Study|Withdrawal by Subject|0|||
163844513|NCT04329104|591800052|FG003|Efficacy Study|Withdrawal by Subject|5|||
163844514|NCT04329104|591800053|FG004|Efficacy Study|Withdrawal by Subject|6|||
163844515|NCT04329104|591800054|FG005|Efficacy Study|Withdrawal by Subject|8|||
163844516|NCT01702428|591800055|FG000|Overall Study|Adverse Event|2|||
163844517|NCT01702428|591800056|FG001|Overall Study|Adverse Event|0|||
163844518|NCT01702428|591800057|FG002|Overall Study|Adverse Event|0|||
163844519|NCT01702428|591800058|FG003|Overall Study|Adverse Event|0|||
163844520|NCT01702428|591800055|FG000|Overall Study|Lost to Follow-up|33|||
163844521|NCT01702428|591800056|FG001|Overall Study|Lost to Follow-up|41|||
163844522|NCT01702428|591800057|FG002|Overall Study|Lost to Follow-up|37|||
163844523|NCT01702428|591800058|FG003|Overall Study|Lost to Follow-up|44|||
163844524|NCT01702428|591800055|FG000|Overall Study|Parents cannot assist to site|1|||
163844525|NCT01702428|591800056|FG001|Overall Study|Parents cannot assist to site|0|||
163844526|NCT01702428|591800057|FG002|Overall Study|Parents cannot assist to site|1|||
164074070|NCT02574260|592635128|FG000|Overall Study|Disease Progression|1|||
163844527|NCT01702428|591800058|FG003|Overall Study|Parents cannot assist to site|0|||
163844528|NCT01702428|591800055|FG000|Overall Study|Lost Coverage|0|||
163844529|NCT01702428|591800056|FG001|Overall Study|Lost Coverage|0|||
163844530|NCT01702428|591800057|FG002|Overall Study|Lost Coverage|0|||
163844531|NCT01702428|591800058|FG003|Overall Study|Lost Coverage|1|||
163844532|NCT01702428|591800055|FG000|Overall Study|Lost Health Plan|3|||
163844533|NCT01702428|591800056|FG001|Overall Study|Lost Health Plan|5|||
163844534|NCT01702428|591800057|FG002|Overall Study|Lost Health Plan|0|||
163844535|NCT01702428|591800058|FG003|Overall Study|Lost Health Plan|2|||
163844536|NCT01702428|591800055|FG000|Overall Study|Mother transferred care|0|||
163844537|NCT01702428|591800056|FG001|Overall Study|Mother transferred care|1|||
163844538|NCT01702428|591800057|FG002|Overall Study|Mother transferred care|0|||
163844539|NCT01702428|591800058|FG003|Overall Study|Mother transferred care|0|||
163844540|NCT01702428|591800055|FG000|Overall Study|Parents too busy|1|||
163844541|NCT01702428|591800056|FG001|Overall Study|Parents too busy|0|||
163844542|NCT01702428|591800057|FG002|Overall Study|Parents too busy|0|||
163844543|NCT01702428|591800058|FG003|Overall Study|Parents too busy|0|||
163844544|NCT01702428|591800055|FG000|Overall Study|Protocol Violation|3|||
163844545|NCT01702428|591800056|FG001|Overall Study|Protocol Violation|0|||
163844546|NCT01702428|591800057|FG002|Overall Study|Protocol Violation|1|||
163844547|NCT01702428|591800058|FG003|Overall Study|Protocol Violation|0|||
163844548|NCT01702428|591800055|FG000|Overall Study|Withdrawal by Subject|21|||
163844549|NCT01702428|591800056|FG001|Overall Study|Withdrawal by Subject|23|||
163844550|NCT01702428|591800057|FG002|Overall Study|Withdrawal by Subject|14|||
163844551|NCT01702428|591800058|FG003|Overall Study|Withdrawal by Subject|10|||
163844552|NCT02091869|591800059|FG000|Overall Study|Withdrawal by Subject|0|||
163844553|NCT02091869|591800060|FG001|Overall Study|Withdrawal by Subject|3|||
163844554|NCT03685708|591800064|FG000|Overall Study|Withdrawal by Subject|0|||
163844555|NCT03685708|591800065|FG001|Overall Study|Withdrawal by Subject|0|||
164074071|NCT04508621|592635129|FG000|Overall Study|Adverse Event|39|||
164074072|NCT04508621|592635130|FG001|Overall Study|Adverse Event|16|||
164074073|NCT04508621|592635129|FG000|Overall Study|Lack of Efficacy|2|||
164074074|NCT04508621|592635130|FG001|Overall Study|Lack of Efficacy|8|||
163844556|NCT03685708|591800066|FG002|Overall Study|Withdrawal by Subject|1|||
163844557|NCT03685708|591800064|FG000|Overall Study|Screen Fail|0|||
163844558|NCT03685708|591800065|FG001|Overall Study|Screen Fail|1|||
163844559|NCT03685708|591800066|FG002|Overall Study|Screen Fail|1|||
163844560|NCT03685708|591800064|FG000|Overall Study|COVID 19 Pandemic|1|||
164074075|NCT04508621|592635129|FG000|Overall Study|Physician Decision|0|||
164303842|NCT02113982|593488363|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
163844561|NCT03685708|591800065|FG001|Overall Study|COVID 19 Pandemic|1|||
163844562|NCT03685708|591800066|FG002|Overall Study|COVID 19 Pandemic|6|||
163844563|NCT03685708|591800064|FG000|Overall Study|Disease Progression|0|||
164303843|NCT02113982|593488364|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
164303844|NCT02113982|593488365|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
164303845|NCT02113982|593488366|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
164303846|NCT02113982|593488367|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
164303847|NCT02113982|593488368|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
164303848|NCT02113982|593488369|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
164303849|NCT02113982|593488370|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
164303850|NCT02113982|593488371|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
164303851|NCT02113982|593488372|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
164303852|NCT02113982|593488373|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
164303853|NCT02113982|593488374|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
164303854|NCT02113982|593488375|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
164303855|NCT02113982|593488376|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
164303856|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
164303857|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
164303858|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
164303859|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
164303860|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
164303861|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
164303862|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
164303863|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
164303864|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
164303865|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
164303866|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
164303867|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
164303868|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
164303869|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
164303870|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
164303871|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
164303872|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
164303873|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
164303874|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
164303875|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
164303876|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
164303877|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
164303878|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
164303879|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
164303880|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
164303881|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
164303882|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
164303883|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
164303884|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303885|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303886|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303887|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303888|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303889|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303890|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303891|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
164303892|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303893|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
164303894|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
164303895|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303896|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303897|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
164303898|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303899|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303900|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303901|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303902|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303903|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303904|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303905|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
164303906|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303907|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
164303908|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303909|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303910|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303911|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
164303912|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
163959594|NCT03226392|592224045|FG000|Overall Study|Physician Decision|1|||
164303913|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303914|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303915|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303916|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303917|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303918|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303919|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
164303920|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303921|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303922|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303923|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303924|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303925|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
164303926|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Transplant|0|||
164303927|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Transplant|0|||
164303928|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Transplant|0|||
164303929|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Transplant|0|||
164303930|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Transplant|0|||
164303931|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Transplant|0|||
164303932|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Transplant|0|||
164303933|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Transplant|0|||
164303934|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Transplant|0|||
164303935|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Transplant|4|||
164303936|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Transplant|2|||
164303937|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Transplant|0|||
164303938|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Transplant|0|||
164303939|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Transplant|0|||
164303940|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
164303941|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
164303942|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
164303943|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
164303944|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
164303945|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
164303946|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
164303947|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
164303948|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
164303949|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
164303950|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
164303951|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
164303952|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
164303953|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
164303954|NCT02113982|593488363|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
164303955|NCT02113982|593488364|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
164303956|NCT02113982|593488365|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
164303957|NCT02113982|593488366|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
164074076|NCT04508621|592635130|FG001|Overall Study|Physician Decision|1|||
164074077|NCT04508621|592635129|FG000|Overall Study|Withdrawal by Subject|10|||
164074078|NCT04508621|592635130|FG001|Overall Study|Withdrawal by Subject|14|||
164074079|NCT04508621|592635129|FG000|Overall Study|Lost to Follow-up|12|||
164074080|NCT04508621|592635130|FG001|Overall Study|Lost to Follow-up|9|||
164074081|NCT04508621|592635129|FG000|Overall Study|COVID-19 related crisis|3|||
163959595|NCT03226392|592224046|FG001|Overall Study|Physician Decision|0|||
164189046|NCT05305989|593060435|FG002|Overall Study|Investigator decision|0|||
164189047|NCT05305989|593060433|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
164189048|NCT05305989|593060434|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
164189049|NCT05305989|593060435|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
164189050|NCT05305989|593060433|FG000|Overall Study|Adverse Event|1|||
164189051|NCT05305989|593060434|FG001|Overall Study|Adverse Event|1|||
164189052|NCT05305989|593060435|FG002|Overall Study|Adverse Event|0|||
164189053|NCT05305989|593060433|FG000|Overall Study|Enrolled but never dosed|3|||
164189054|NCT05305989|593060434|FG001|Overall Study|Enrolled but never dosed|2|||
164189055|NCT05305989|593060435|FG002|Overall Study|Enrolled but never dosed|1|||
164189056|NCT03162328|593060436|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
164189057|NCT03162328|593060437|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
164189058|NCT03162328|593060438|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
164189059|NCT03162328|593060436|FG000|Screening Period|Withdrawal by Subject|1|||
164189060|NCT03162328|593060437|FG001|Screening Period|Withdrawal by Subject|0|||
164189061|NCT03162328|593060438|FG002|Screening Period|Withdrawal by Subject|0|||
164189062|NCT03162328|593060436|FG000|Study Period|Withdrawal by Subject|0|||
164189063|NCT03162328|593060437|FG001|Study Period|Withdrawal by Subject|0|||
164189064|NCT03162328|593060438|FG002|Study Period|Withdrawal by Subject|1|||
164189065|NCT00913770|593060439|FG000|Overall Study|Unable to contact|24|||
164189066|NCT00913770|593060440|FG001|Overall Study|Unable to contact|19|||
164189067|NCT00913770|593060441|FG002|Overall Study|Unable to contact|13|||
164189068|NCT00913770|593060439|FG000|Overall Study|Refused|11|||
164189069|NCT00913770|593060440|FG001|Overall Study|Refused|10|||
164189070|NCT00913770|593060441|FG002|Overall Study|Refused|8|||
164189071|NCT01990768|593060442|FG000|Intervention Started|Found to be ineligible|14|||
164189072|NCT01990768|593060443|FG001|Intervention Started|Found to be ineligible|13|||
164189073|NCT01990768|593060444|FG002|Intervention Started|Found to be ineligible|11|||
164189074|NCT01990768|593060442|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
164189075|NCT01990768|593060443|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
164189076|NCT01990768|593060444|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
164189077|NCT01990768|593060442|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
164189078|NCT01990768|593060443|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
164189079|NCT01990768|593060444|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
164189080|NCT01990768|593060442|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
164189081|NCT01990768|593060443|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
164189082|NCT01990768|593060444|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
164189083|NCT01990768|593060442|FG000|Intervention Started|Patient care priority|1|||
164074082|NCT04508621|592635130|FG001|Overall Study|COVID-19 related crisis|0|||
164074083|NCT04508621|592635129|FG000|Overall Study|Subject non-compliance|1|||
164074084|NCT04508621|592635130|FG001|Overall Study|Subject non-compliance|0|||
164074085|NCT00752895|592635131|FG000|Overall Study|Withdrawal by Subject|8|||
164074086|NCT00752895|592635132|FG001|Overall Study|Withdrawal by Subject|3|||
164074087|NCT03022799|592635133|FG000|Overall Study|Adverse Event|0|||
164074088|NCT03022799|592635134|FG001|Overall Study|Adverse Event|0|||
164074089|NCT03022799|592635135|FG002|Overall Study|Adverse Event|0|||
164074090|NCT03022799|592635136|FG003|Overall Study|Adverse Event|0|||
164074091|NCT03022799|592635137|FG004|Overall Study|Adverse Event|0|||
164074092|NCT03022799|592635138|FG005|Overall Study|Adverse Event|0|||
164074093|NCT03022799|592635139|FG006|Overall Study|Adverse Event|0|||
164074094|NCT03022799|592635140|FG007|Overall Study|Adverse Event|0|||
164074095|NCT03022799|592635141|FG008|Overall Study|Adverse Event|0|||
164074096|NCT03022799|592635142|FG009|Overall Study|Adverse Event|1|||
164074097|NCT03022799|592635143|FG010|Overall Study|Adverse Event|1|||
164074098|NCT03022799|592635144|FG011|Overall Study|Adverse Event|0|||
164074099|NCT03022799|592635145|FG012|Overall Study|Adverse Event|0|||
164074100|NCT04881448|592635146|FG000|Overall Study|Study cancelled by sponsor|220|||
164074101|NCT04881448|592635146|FG000|Overall Study|Withdrawal by Subject|2|||
164074102|NCT04881448|592635146|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
164074103|NCT01966107|592635148|FG000|Overall Study|excluded from FAS|21|||
164074104|NCT01966107|592635149|FG001|Overall Study|excluded from FAS|20|||
164074105|NCT01966107|592635148|FG000|Overall Study|discontinued treatment|345|||
164074106|NCT01966107|592635149|FG001|Overall Study|discontinued treatment|372|||
164074107|NCT01966107|592635148|FG000|Overall Study|due to study closure|164|||
164074108|NCT01966107|592635149|FG001|Overall Study|due to study closure|186|||
164074109|NCT01966107|592635148|FG000|Overall Study|withdrew from the study|272|||
164074110|NCT01966107|592635149|FG001|Overall Study|withdrew from the study|303|||
164074111|NCT02200614|592635150|FG000|Double Blind Treatment|Adverse Event|86|||
164074112|NCT02200614|592635151|FG001|Double Blind Treatment|Adverse Event|48|||
164074113|NCT02200614|592635150|FG000|Double Blind Treatment|Confirmed metastasis|120|||
164074114|NCT02200614|592635151|FG001|Double Blind Treatment|Confirmed metastasis|140|||
164074115|NCT02200614|592635150|FG000|Double Blind Treatment|Judgment of the investigator|59|||
164074116|NCT02200614|592635151|FG001|Double Blind Treatment|Judgment of the investigator|99|||
164074117|NCT02200614|592635150|FG000|Double Blind Treatment|Metastasis by local reading|1|||
164074118|NCT02200614|592635151|FG001|Double Blind Treatment|Metastasis by local reading|3|||
164074119|NCT02200614|592635150|FG000|Double Blind Treatment|Other reason|6|||
164074120|NCT02200614|592635151|FG001|Double Blind Treatment|Other reason|2|||
164074121|NCT02200614|592635150|FG000|Double Blind Treatment|Personal reason|77|||
164074122|NCT02200614|592635151|FG001|Double Blind Treatment|Personal reason|85|||
164074123|NCT02200614|592635150|FG000|Double Blind Treatment|Protocol deviation|14|||
164074124|NCT02200614|592635151|FG001|Double Blind Treatment|Protocol deviation|7|||
164074125|NCT02200614|592635150|FG000|Double Blind Treatment|Not treated|1|||
164074126|NCT02200614|592635151|FG001|Double Blind Treatment|Not treated|0|||
164074127|NCT02200614|592635150|FG000|Open Label|Adverse Event|41|||
164074128|NCT02200614|592635151|FG001|Open Label|Adverse Event|11|||
164074129|NCT02200614|592635150|FG000|Open Label|Confirmed metastasis|1|||
164074130|NCT02200614|592635151|FG001|Open Label|Confirmed metastasis|0|||
164074131|NCT02200614|592635150|FG000|Open Label|Judgment of the investigator|29|||
164074132|NCT02200614|592635151|FG001|Open Label|Judgment of the investigator|2|||
164074133|NCT02200614|592635150|FG000|Open Label|Metastasis by local reading|138|||
164074134|NCT02200614|592635151|FG001|Open Label|Metastasis by local reading|27|||
164074135|NCT02200614|592635150|FG000|Open Label|Other reason|22|||
164074136|NCT02200614|592635151|FG001|Open Label|Other reason|4|||
164074137|NCT02200614|592635150|FG000|Open Label|Personal reason|60|||
164074138|NCT02200614|592635151|FG001|Open Label|Personal reason|8|||
164074139|NCT02200614|592635150|FG000|Open Label|Protocol deviation|3|||
164074140|NCT02200614|592635151|FG001|Open Label|Protocol deviation|2|||
164074141|NCT02200614|592635150|FG000|Open Label|Missing|2|||
164074142|NCT02200614|592635151|FG001|Open Label|Missing|2|||
164074143|NCT02531698|592635155|FG000|Overall Study|Adverse Event|2|||
164074144|NCT02531698|592635156|FG001|Overall Study|Adverse Event|1|||
164074145|NCT02531698|592635155|FG000|Overall Study|Withdrawal by Subject|6|||
164074146|NCT02531698|592635156|FG001|Overall Study|Withdrawal by Subject|1|||
164074147|NCT02531698|592635155|FG000|Overall Study|Protocol Violation|2|||
164074148|NCT02531698|592635156|FG001|Overall Study|Protocol Violation|0|||
164074149|NCT02531698|592635155|FG000|Overall Study|Lost to Follow-up|1|||
164074150|NCT02531698|592635156|FG001|Overall Study|Lost to Follow-up|0|||
164074151|NCT01861717|592635157|FG000|Overall Study|Lost to Follow-up|1|||
164074152|NCT01861717|592635157|FG000|Overall Study|Withdrawal by Subject|1|||
164074153|NCT02395536|592635163|FG000|Overall Study|Lost to Follow-up|4|||
164074154|NCT02395536|592635164|FG001|Overall Study|Lost to Follow-up|4|||
164074155|NCT02395536|592635163|FG000|Overall Study|Death|2|||
164074156|NCT02395536|592635164|FG001|Overall Study|Death|0|||
164074157|NCT02395536|592635163|FG000|Overall Study|Physician Decision|4|||
164074158|NCT02395536|592635164|FG001|Overall Study|Physician Decision|6|||
164074159|NCT02395536|592635163|FG000|Overall Study|Withdrawal by Subject|9|||
164074160|NCT02395536|592635164|FG001|Overall Study|Withdrawal by Subject|17|||
164074161|NCT02395536|592635163|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
164074162|NCT02395536|592635164|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
164074163|NCT02395536|592635163|FG000|Overall Study|Insurance issue|0|||
164074164|NCT02395536|592635164|FG001|Overall Study|Insurance issue|1|||
164074165|NCT00701558|592635165|FG000|Overall Study|Death|7|||
164074166|NCT00701558|592635165|FG000|Overall Study|Lost to Follow-up|8|||
164090382|NCT00306384|592693425|FG000|Overall Study|Lack of Efficacy|26|||
164090383|NCT00306384|592693426|FG001|Overall Study|Lack of Efficacy|40|||
164090384|NCT00306384|592693427|FG002|Overall Study|Lack of Efficacy|38|||
164090385|NCT00306384|592693425|FG000|Overall Study|Investigator discretion|28|||
164090386|NCT00306384|592693426|FG001|Overall Study|Investigator discretion|31|||
164090387|NCT00306384|592693427|FG002|Overall Study|Investigator discretion|21|||
164090388|NCT00306384|592693425|FG000|Overall Study|Other|80|||
164090389|NCT00306384|592693426|FG001|Overall Study|Other|70|||
164090390|NCT00306384|592693427|FG002|Overall Study|Other|32|||
164090391|NCT00306384|592693425|FG000|Overall Study|Site closure|2|||
164090392|NCT00306384|592693426|FG001|Overall Study|Site closure|0|||
164090393|NCT00306384|592693427|FG002|Overall Study|Site closure|0|||
164090394|NCT02275364|592693428|FG000|Period 1|Withdrawal by Subject|1|||
164090395|NCT02275364|592693429|FG001|Period 1|Withdrawal by Subject|0|||
164090396|NCT02275364|592693428|FG000|Period 1|Other reason|1|||
163844564|NCT03685708|591800065|FG001|Overall Study|Disease Progression|0|||
164189084|NCT01990768|593060443|FG001|Intervention Started|Patient care priority|2|||
164189085|NCT01990768|593060444|FG002|Intervention Started|Patient care priority|3|||
164189086|NCT01990768|593060442|FG000|Intervention Started|IV lost|2|||
164189087|NCT01990768|593060443|FG001|Intervention Started|IV lost|2|||
164074167|NCT02598622|592637114|FG000|Overall Study|Withdrawal by Subject|3|||
164074168|NCT02598622|592637115|FG001|Overall Study|Withdrawal by Subject|0|||
164074169|NCT02598622|592637114|FG000|Overall Study|Physician Decision|3|||
164074170|NCT02598622|592637115|FG001|Overall Study|Physician Decision|0|||
164074171|NCT01416142|592637118|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
164074172|NCT01416142|592637119|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
164074173|NCT01416142|592637120|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
164074174|NCT02464059|592637121|FG000|Overall Study|Lost to Follow-up|6|||
164074175|NCT02499406|592637124|FG000|Overall Study|missed 3 treatment sessions|4|||
164074176|NCT03591107|592637128|FG000|Overall Study|Same patient in both arms|1|||
164074177|NCT03591107|592637129|FG001|Overall Study|Same patient in both arms|1|||
164074178|NCT03591107|592637128|FG000|Overall Study|Sought care at other clinics|0|||
164074179|NCT03591107|592637129|FG001|Overall Study|Sought care at other clinics|2|||
164074180|NCT03591107|592637128|FG000|Overall Study|Discharged from clinic|0|||
164074181|NCT03591107|592637129|FG001|Overall Study|Discharged from clinic|1|||
164074182|NCT03591107|592637128|FG000|Overall Study|Withdrawal by Subject|0|||
164074183|NCT03591107|592637129|FG001|Overall Study|Withdrawal by Subject|1|||
164074184|NCT00304954|592637130|FG000|Overall Study|Withdrawal by Subject|0|||
164074185|NCT00304954|592637131|FG001|Overall Study|Withdrawal by Subject|0|||
164074186|NCT00304954|592637132|FG002|Overall Study|Withdrawal by Subject|1|||
164074187|NCT00304954|592637133|FG003|Overall Study|Withdrawal by Subject|0|||
164074188|NCT00304954|592637130|FG000|Overall Study|Adverse Event|1|||
164074189|NCT00304954|592637131|FG001|Overall Study|Adverse Event|0|||
164074190|NCT00304954|592637132|FG002|Overall Study|Adverse Event|0|||
164074191|NCT00304954|592637133|FG003|Overall Study|Adverse Event|0|||
164074192|NCT00736099|592637136|FG000|Overall Study|Adverse Event|61|||
164074193|NCT00736099|592637137|FG001|Overall Study|Adverse Event|18|||
164074194|NCT00736099|592637136|FG000|Overall Study|Protocol Violation|10|||
164074195|NCT00736099|592637137|FG001|Overall Study|Protocol Violation|4|||
164074196|NCT00736099|592637136|FG000|Overall Study|Lost to Follow-up|12|||
164074197|NCT00736099|592637137|FG001|Overall Study|Lost to Follow-up|5|||
164074198|NCT00736099|592637136|FG000|Overall Study|Withdrawal by Subject|42|||
164074199|NCT00736099|592637137|FG001|Overall Study|Withdrawal by Subject|13|||
164074200|NCT00736099|592637136|FG000|Overall Study|Lack of Efficacy|15|||
164074201|NCT00736099|592637137|FG001|Overall Study|Lack of Efficacy|8|||
164074202|NCT00736099|592637136|FG000|Overall Study|Other reason|43|||
164074203|NCT00736099|592637137|FG001|Overall Study|Other reason|10|||
164074204|NCT01222715|592637138|FG000|Overall Study|Adverse Event|0|||
164074205|NCT01222715|592637139|FG001|Overall Study|Adverse Event|4|||
164074206|NCT01222715|592637138|FG000|Overall Study|Death|0|||
164074207|NCT01222715|592637139|FG001|Overall Study|Death|1|||
164074208|NCT01222715|592637138|FG000|Overall Study|Lack of Efficacy|22|||
164074209|NCT01222715|592637139|FG001|Overall Study|Lack of Efficacy|14|||
164074210|NCT01222715|592637138|FG000|Overall Study|Physician Decision|12|||
164074211|NCT01222715|592637139|FG001|Overall Study|Physician Decision|2|||
164074212|NCT01222715|592637138|FG000|Overall Study|Refusal of further protocol therapy|0|||
164074213|NCT01222715|592637139|FG001|Overall Study|Refusal of further protocol therapy|4|||
164074214|NCT01222715|592637138|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
164189088|NCT01990768|593060444|FG002|Intervention Started|IV lost|2|||
164189089|NCT01990768|593060442|FG000|Intervention Started|Required CPR|1|||
164189090|NCT01990768|593060443|FG001|Intervention Started|Required CPR|1|||
164189091|NCT01990768|593060444|FG002|Intervention Started|Required CPR|0|||
164303958|NCT02113982|593488367|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
164189092|NCT01990768|593060442|FG000|Intervention Started|Seizure or hx of seizure|0|||
164074215|NCT01222715|592637139|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
164074216|NCT01222715|592637138|FG000|Overall Study|Ineligible|0|||
164074217|NCT01222715|592637139|FG001|Overall Study|Ineligible|1|||
164074218|NCT01222715|592637138|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
164074219|NCT01222715|592637139|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
164074220|NCT00948025|592637141|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
164074221|NCT00948025|592637142|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
164074222|NCT00948025|592637141|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
164074223|NCT00948025|592637142|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
164074224|NCT00948025|592637141|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
164074225|NCT00948025|592637142|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
164074226|NCT04006847|592637143|FG000|Overall Study|Product issue|1|||
164074227|NCT03555890|592637148|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164074228|NCT03555890|592637149|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164074229|NCT03555890|592637150|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164074230|NCT03555890|592637151|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164074231|NCT03372369|592637152|FG000|Qualification Period|Withdrawal by Subject|16|||
164074232|NCT03372369|592637153|FG001|Qualification Period|Withdrawal by Subject|13|||
164074233|NCT03372369|592637152|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
164074234|NCT03372369|592637153|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
164074235|NCT03372369|592637152|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
164074236|NCT03372369|592637153|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
164074237|NCT01383954|592637154|FG000|Overall Study|Lack of Efficacy|2|||
164074238|NCT01383954|592637154|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
164074239|NCT01383954|592637154|FG000|Overall Study|Adverse Event|1|||
164074240|NCT01383954|592637154|FG000|Overall Study|Reason Not Specified|9|||
164074241|NCT01791127|592637155|FG000|Overall Study|Death|356|||
164074242|NCT01791127|592637155|FG000|Overall Study|Patient has withdrawn from study|293|||
164074243|NCT01791127|592637155|FG000|Overall Study|Lost to Follow-up|42|||
164074244|NCT01791127|592637155|FG000|Overall Study|All Siello leads are explanted|31|||
164074245|NCT01791127|592637155|FG000|Overall Study|Completion of 30 day safety registry|1|||
164074246|NCT01791127|592637155|FG000|Overall Study|Study terminated for EP Passion|749|||
164074247|NCT00520494|592637156|FG000|Overall Study|Withdrawal by Subject|1|||
164074248|NCT04023994|592637162|FG000|Overall Study|Lost to Follow-up|0|||
164074249|NCT04023994|592637163|FG001|Overall Study|Lost to Follow-up|1|||
164074250|NCT04023994|592637164|FG002|Overall Study|Lost to Follow-up|2|||
164074251|NCT04023994|592637165|FG003|Overall Study|Lost to Follow-up|0|||
164189093|NCT01990768|593060443|FG001|Intervention Started|Seizure or hx of seizure|0|||
164189094|NCT01990768|593060444|FG002|Intervention Started|Seizure or hx of seizure|2|||
164189095|NCT01990768|593060442|FG000|Intervention Started|Discovered to be pregnant|0|||
164189096|NCT01990768|593060443|FG001|Intervention Started|Discovered to be pregnant|1|||
164189097|NCT01990768|593060444|FG002|Intervention Started|Discovered to be pregnant|0|||
164189098|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
164189099|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
164189100|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
164189101|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
164189102|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
164189103|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
164189104|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
164189105|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
164189106|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
164189107|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
164189108|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
164189109|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
164189110|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Death|3|||
164189111|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Death|1|||
164189112|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Death|1|||
164189113|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Discharged|2|||
164189114|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Discharged|1|||
164189115|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Discharged|0|||
164189116|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
164189117|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
164189118|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
164189119|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
164189120|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
164189121|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
164189122|NCT01990768|593060442|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
164189123|NCT01990768|593060443|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
164189124|NCT01990768|593060444|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
164189125|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
164074252|NCT04023994|592637166|FG004|Overall Study|Lost to Follow-up|0|||
164074253|NCT04023994|592637167|FG005|Overall Study|Lost to Follow-up|0|||
164074254|NCT04023994|592637162|FG000|Overall Study|Withdrawal by Subject|0|||
164074255|NCT04023994|592637163|FG001|Overall Study|Withdrawal by Subject|0|||
164074256|NCT04023994|592637164|FG002|Overall Study|Withdrawal by Subject|0|||
164074257|NCT04023994|592637165|FG003|Overall Study|Withdrawal by Subject|1|||
164074258|NCT04023994|592637166|FG004|Overall Study|Withdrawal by Subject|0|||
164074259|NCT04023994|592637167|FG005|Overall Study|Withdrawal by Subject|0|||
164074260|NCT00707174|592637168|FG000|Overall Study|Adverse Event|1|||
164074261|NCT00707174|592637169|FG001|Overall Study|Adverse Event|6|||
164074262|NCT00707174|592637168|FG000|Overall Study|Withdrawal by Subject|4|||
164074263|NCT00707174|592637169|FG001|Overall Study|Withdrawal by Subject|1|||
164074264|NCT00544557|592637170|FG000|Overall Study|Adverse Event|140|||
164074265|NCT00544557|592637170|FG000|Overall Study|Lack of Efficacy|196|||
164074266|NCT00544557|592637170|FG000|Overall Study|Other|98|||
164074267|NCT01017029|592637171|FG000|Overall Study|Lost to Follow-up|1|||
164074268|NCT01017029|592637172|FG001|Overall Study|Lost to Follow-up|0|||
164074269|NCT01017029|592637171|FG000|Overall Study|Administrative problem|0|||
164074270|NCT01017029|592637172|FG001|Overall Study|Administrative problem|1|||
164074271|NCT01017029|592637171|FG000|Overall Study|Death|3|||
164074272|NCT01017029|592637172|FG001|Overall Study|Death|1|||
164074273|NCT01830920|592637173|FG000|Overall Study|Adverse Event|1|||
164074274|NCT01830920|592637174|FG001|Overall Study|Adverse Event|0|||
164074275|NCT01830920|592637175|FG002|Overall Study|Adverse Event|1|||
164074276|NCT01830920|592637176|FG003|Overall Study|Adverse Event|0|||
164074277|NCT01830920|592637177|FG004|Overall Study|Adverse Event|0|||
164074278|NCT01830920|592637173|FG000|Overall Study|Withdrawal by Subject|2|||
164074279|NCT01830920|592637174|FG001|Overall Study|Withdrawal by Subject|2|||
164074280|NCT01830920|592637175|FG002|Overall Study|Withdrawal by Subject|1|||
164074281|NCT01830920|592637176|FG003|Overall Study|Withdrawal by Subject|7|||
164074282|NCT01830920|592637177|FG004|Overall Study|Withdrawal by Subject|1|||
164074283|NCT01830920|592637173|FG000|Overall Study|Death|3|||
164074284|NCT01830920|592637174|FG001|Overall Study|Death|3|||
164074285|NCT01830920|592637175|FG002|Overall Study|Death|5|||
164074286|NCT01830920|592637176|FG003|Overall Study|Death|4|||
164074287|NCT01830920|592637177|FG004|Overall Study|Death|4|||
164074288|NCT01830920|592637173|FG000|Overall Study|Other|15|||
164074289|NCT01830920|592637174|FG001|Overall Study|Other|1|||
164074290|NCT01830920|592637175|FG002|Overall Study|Other|1|||
164074291|NCT01830920|592637176|FG003|Overall Study|Other|5|||
164074292|NCT01830920|592637177|FG004|Overall Study|Other|3|||
164074293|NCT00422058|592637178|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
164074294|NCT00422058|592637179|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
164074295|NCT00422058|592637180|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
164074296|NCT00422058|592637181|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
164074297|NCT00422058|592637182|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
164074298|NCT00422058|592637183|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
164074299|NCT00422058|592637178|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
164074300|NCT00422058|592637179|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
164074301|NCT00422058|592637180|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
164074302|NCT00422058|592637181|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
164074303|NCT00422058|592637182|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
164074304|NCT00422058|592637183|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
164074305|NCT00422058|592637178|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
164074306|NCT00422058|592637179|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
164074307|NCT00422058|592637180|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
164074308|NCT00422058|592637181|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
164074309|NCT00422058|592637182|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
164074310|NCT00422058|592637183|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
164074311|NCT00422058|592637178|FG000|Double-Blind, Week 0-20|Other|11|||
164074312|NCT00422058|592637179|FG001|Double-Blind, Week 0-20|Other|3|||
164074313|NCT00422058|592637180|FG002|Double-Blind, Week 0-20|Other|8|||
164074314|NCT00422058|592637181|FG003|Double-Blind, Week 0-20|Other|8|||
164074315|NCT00422058|592637182|FG004|Double-Blind, Week 0-20|Other|4|||
163844565|NCT03685708|591800066|FG002|Overall Study|Disease Progression|1|||
164074316|NCT00422058|592637183|FG005|Double-Blind, Week 0-20|Other|10|||
164074317|NCT00422058|592637178|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
164074318|NCT00422058|592637179|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
164074319|NCT00422058|592637180|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
164074320|NCT00422058|592637181|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
164074321|NCT00422058|592637182|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
164074322|NCT00422058|592637183|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
164074323|NCT00422058|592637178|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
164074324|NCT00422058|592637179|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
164074325|NCT00422058|592637180|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
163844566|NCT02771210|591800069|FG000|Period 1|Adverse Event|5|||
164074326|NCT00422058|592637181|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
164074327|NCT00422058|592637182|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
164074328|NCT00422058|592637183|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
164074329|NCT00422058|592637178|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
164074330|NCT00422058|592637179|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
164074331|NCT00422058|592637180|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
164074332|NCT00422058|592637181|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
164074333|NCT00422058|592637182|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
164074334|NCT00422058|592637183|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
164074335|NCT00422058|592637178|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
164074336|NCT00422058|592637179|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
164074337|NCT00422058|592637180|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
164074338|NCT00422058|592637181|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
164074339|NCT00422058|592637182|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
164074340|NCT00422058|592637183|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
164074341|NCT00422058|592637178|FG000|Open-Label Extension, Week 20-104|Other|13|||
164074342|NCT00422058|592637179|FG001|Open-Label Extension, Week 20-104|Other|14|||
164074343|NCT00422058|592637180|FG002|Open-Label Extension, Week 20-104|Other|6|||
164074344|NCT00422058|592637181|FG003|Open-Label Extension, Week 20-104|Other|13|||
164074345|NCT00422058|592637182|FG004|Open-Label Extension, Week 20-104|Other|16|||
164074346|NCT00422058|592637183|FG005|Open-Label Extension, Week 20-104|Other|18|||
164074347|NCT00572156|592637184|FG000|Overall Study|Adverse Event|3|||
164074348|NCT00572156|592637185|FG001|Overall Study|Adverse Event|1|||
164074349|NCT00572156|592637186|FG002|Overall Study|Adverse Event|5|||
164074350|NCT00572156|592637187|FG003|Overall Study|Adverse Event|1|||
164074351|NCT00572156|592637184|FG000|Overall Study|Lost to Follow-up|1|||
164074352|NCT00572156|592637185|FG001|Overall Study|Lost to Follow-up|1|||
164074353|NCT00572156|592637186|FG002|Overall Study|Lost to Follow-up|1|||
164074354|NCT00572156|592637187|FG003|Overall Study|Lost to Follow-up|0|||
164074355|NCT00572156|592637184|FG000|Overall Study|Protocol Violation|1|||
164074356|NCT00572156|592637185|FG001|Overall Study|Protocol Violation|2|||
164074357|NCT00572156|592637186|FG002|Overall Study|Protocol Violation|0|||
164074358|NCT00572156|592637187|FG003|Overall Study|Protocol Violation|2|||
164074359|NCT00572156|592637184|FG000|Overall Study|Patient/Parent Decision|1|||
164074360|NCT00572156|592637185|FG001|Overall Study|Patient/Parent Decision|6|||
164074361|NCT00572156|592637186|FG002|Overall Study|Patient/Parent Decision|4|||
164074362|NCT00572156|592637187|FG003|Overall Study|Patient/Parent Decision|3|||
164074363|NCT00572156|592637184|FG000|Overall Study|Sponsor Decision|20|||
164074364|NCT00572156|592637185|FG001|Overall Study|Sponsor Decision|16|||
164074365|NCT00572156|592637186|FG002|Overall Study|Sponsor Decision|17|||
164074366|NCT00572156|592637187|FG003|Overall Study|Sponsor Decision|19|||
164074367|NCT03216954|592637190|FG000|Overall Study|Adverse Event|0|||
164074368|NCT03216954|592637191|FG001|Overall Study|Adverse Event|0|||
164074369|NCT03216954|592637192|FG002|Overall Study|Adverse Event|1|||
164074370|NCT03216954|592637193|FG003|Overall Study|Adverse Event|0|||
164074371|NCT03216954|592637194|FG004|Overall Study|Adverse Event|1|||
164074372|NCT03216954|592637190|FG000|Overall Study|Withdrawal by Subject|2|||
164074373|NCT03216954|592637191|FG001|Overall Study|Withdrawal by Subject|0|||
164074374|NCT03216954|592637192|FG002|Overall Study|Withdrawal by Subject|0|||
164074375|NCT03216954|592637193|FG003|Overall Study|Withdrawal by Subject|0|||
164074376|NCT03216954|592637194|FG004|Overall Study|Withdrawal by Subject|0|||
164074377|NCT03216954|592637190|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164074378|NCT03216954|592637191|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
164074379|NCT03216954|592637192|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164074380|NCT03216954|592637193|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164074381|NCT03216954|592637194|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
164074382|NCT04333199|592637197|FG000|Evaluated Patients|Lost to Follow-up|0|||
164074383|NCT04333199|592637198|FG001|Evaluated Patients|Lost to Follow-up|1|||
164074384|NCT04333199|592637199|FG002|Evaluated Patients|Lost to Follow-up|2|||
164074385|NCT01333475|592637201|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
164074386|NCT01333475|592637202|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
164074387|NCT01333475|592637201|FG000|Overall Study|Toxicity|1|||
164074388|NCT01333475|592637202|FG001|Overall Study|Toxicity|3|||
164074389|NCT02981602|592637203|FG000|Overall Study|Adverse Event|0|||
164074390|NCT02981602|592637204|FG001|Overall Study|Adverse Event|0|||
164074391|NCT02981602|592637205|FG002|Overall Study|Adverse Event|0|||
164074392|NCT02981602|592637206|FG003|Overall Study|Adverse Event|1|||
164074393|NCT02981602|592637207|FG004|Overall Study|Adverse Event|0|||
164074394|NCT00666718|592637208|FG000|Overall Study|Adverse Event|0|||
164074395|NCT00666718|592637209|FG001|Overall Study|Adverse Event|1|||
164074396|NCT00666718|592637208|FG000|Overall Study|Death|1|||
164074397|NCT00666718|592637209|FG001|Overall Study|Death|0|||
164074398|NCT00666718|592637208|FG000|Overall Study|Lost to Follow-up|1|||
164074399|NCT00666718|592637209|FG001|Overall Study|Lost to Follow-up|0|||
164074400|NCT00666718|592637208|FG000|Overall Study|Entry Criteria Not Met|2|||
164074401|NCT00666718|592637209|FG001|Overall Study|Entry Criteria Not Met|0|||
164074402|NCT00666718|592637208|FG000|Overall Study|Protocol Violation|1|||
164074403|NCT00666718|592637209|FG001|Overall Study|Protocol Violation|3|||
164074404|NCT00666718|592637208|FG000|Overall Study|Withdrawal by Subject|7|||
164074405|NCT00666718|592637209|FG001|Overall Study|Withdrawal by Subject|12|||
164074406|NCT00666718|592637208|FG000|Overall Study|Physician Decision|0|||
164074407|NCT00666718|592637209|FG001|Overall Study|Physician Decision|2|||
164074408|NCT02567266|592637219|FG000|Overall Study|Withdrawal by Subject|10|||
164074409|NCT02567266|592637220|FG001|Overall Study|Withdrawal by Subject|7|||
164074410|NCT02567266|592637221|FG002|Overall Study|Withdrawal by Subject|6|||
164074411|NCT02567266|592637219|FG000|Overall Study|Lost to Follow-up|13|||
164074412|NCT02567266|592637220|FG001|Overall Study|Lost to Follow-up|8|||
164074413|NCT02567266|592637221|FG002|Overall Study|Lost to Follow-up|10|||
164074414|NCT02983227|592637222|FG000|Overall Study|Adverse Event|21|||
164074415|NCT02983227|592637223|FG001|Overall Study|Adverse Event|3|||
164074416|NCT02983227|592637222|FG000|Overall Study|Death|3|||
164074417|NCT02983227|592637223|FG001|Overall Study|Death|0|||
164074418|NCT02983227|592637222|FG000|Overall Study|Lack of Efficacy|8|||
164074419|NCT02983227|592637223|FG001|Overall Study|Lack of Efficacy|1|||
164074420|NCT02983227|592637222|FG000|Overall Study|Lost to Follow-up|3|||
164074421|NCT02983227|592637223|FG001|Overall Study|Lost to Follow-up|0|||
164074422|NCT02983227|592637222|FG000|Overall Study|Multiple Reasons|2|||
164074423|NCT02983227|592637223|FG001|Overall Study|Multiple Reasons|1|||
164074424|NCT02983227|592637222|FG000|Overall Study|Physician Decision|3|||
164074425|NCT02983227|592637223|FG001|Overall Study|Physician Decision|1|||
164074426|NCT02983227|592637222|FG000|Overall Study|Withdrawal by Subject|19|||
164074427|NCT02983227|592637223|FG001|Overall Study|Withdrawal by Subject|8|||
164074428|NCT00527397|592637228|FG000|Overall Study|Adverse Event|3|||
164074429|NCT00527397|592637228|FG000|Overall Study|Lack of Efficacy|1|||
164074430|NCT00527397|592637228|FG000|Overall Study|Protocol Violation|1|||
164074431|NCT00527397|592637228|FG000|Overall Study|Withdrawal by Subject|6|||
164074432|NCT00527397|592637228|FG000|Overall Study|Study terminated by sponsor|13|||
164074433|NCT02065791|592637232|FG000|Overall Study|Closed Site|1|||
164074434|NCT02065791|592637233|FG001|Overall Study|Closed Site|1|||
164074435|NCT02065791|592637232|FG000|Overall Study|Withdrawal by Subject|11|||
164074436|NCT02065791|592637233|FG001|Overall Study|Withdrawal by Subject|5|||
164074437|NCT02065791|592637232|FG000|Overall Study|Lost to Follow-up|13|||
164074438|NCT02065791|592637233|FG001|Overall Study|Lost to Follow-up|9|||
164074439|NCT04529096|592637234|FG000|Overall Study|Adverse Event|6|||
164074440|NCT04529096|592637235|FG001|Overall Study|Adverse Event|1|||
164074441|NCT04529096|592637234|FG000|Overall Study|Lack of Efficacy|1|||
164074442|NCT04529096|592637235|FG001|Overall Study|Lack of Efficacy|0|||
164074443|NCT04529096|592637234|FG000|Overall Study|Lost to Follow-up|1|||
164074444|NCT04529096|592637235|FG001|Overall Study|Lost to Follow-up|1|||
164074445|NCT04529096|592637234|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164074446|NCT04529096|592637235|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164074447|NCT04529096|592637234|FG000|Overall Study|Physician Decision|1|||
164074448|NCT04529096|592637235|FG001|Overall Study|Physician Decision|3|||
164074449|NCT04529096|592637234|FG000|Overall Study|Withdrawal by Subject|5|||
164074450|NCT04529096|592637235|FG001|Overall Study|Withdrawal by Subject|0|||
164074451|NCT03467971|592637236|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164074452|NCT03467971|592637237|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164074453|NCT01619085|592637238|FG000|Overall Study|Adverse Event|231|||
164074454|NCT01619085|592637238|FG000|Overall Study|Protocol Violation|4|||
164074455|NCT01619085|592637238|FG000|Overall Study|Lost to Follow-up|3|||
164074456|NCT01619085|592637238|FG000|Overall Study|Withdrawal by Subject|45|||
164074457|NCT01619085|592637238|FG000|Overall Study|Other than specified|96|||
164074458|NCT01619085|592637238|FG000|Overall Study|Not treated|1|||
164074459|NCT01619085|592637238|FG000|Overall Study|Death|145|||
164074460|NCT00883129|592637241|FG000|Overall Study|Adverse Event|7|||
164074461|NCT00883129|592637242|FG001|Overall Study|Adverse Event|15|||
164074462|NCT00883129|592637241|FG000|Overall Study|Withdrawal by Subject|8|||
164074463|NCT00883129|592637242|FG001|Overall Study|Withdrawal by Subject|9|||
164074464|NCT00883129|592637241|FG000|Overall Study|Non-compliance|3|||
164074465|NCT00883129|592637242|FG001|Overall Study|Non-compliance|6|||
164074466|NCT00883129|592637241|FG000|Overall Study|Lost to Follow-up|1|||
164074467|NCT00883129|592637242|FG001|Overall Study|Lost to Follow-up|2|||
164074468|NCT00883129|592637241|FG000|Overall Study|Death|1|||
164074469|NCT00883129|592637242|FG001|Overall Study|Death|2|||
164074470|NCT00883129|592637241|FG000|Overall Study|Defined Treatment Failure|0|||
164074471|NCT00883129|592637242|FG001|Overall Study|Defined Treatment Failure|2|||
164074472|NCT03273257|592637243|FG000|Overall Study|Death|0|||
164074473|NCT03273257|592637244|FG001|Overall Study|Death|1|||
164074474|NCT03273257|592637243|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
164074475|NCT03273257|592637244|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
164074476|NCT03273257|592637243|FG000|Overall Study|Study terminated|3|||
164074477|NCT03273257|592637244|FG001|Overall Study|Study terminated|2|||
164074478|NCT01898884|592637245|FG000|Multiple Dose Period|Adverse Event|0|||
164074479|NCT01898884|592637246|FG001|Multiple Dose Period|Adverse Event|0|||
164074480|NCT01898884|592637247|FG002|Multiple Dose Period|Adverse Event|0|||
164074481|NCT01898884|592637248|FG003|Multiple Dose Period|Adverse Event|0|||
164074482|NCT01898884|592637249|FG004|Multiple Dose Period|Adverse Event|0|||
164074483|NCT01898884|592637250|FG005|Multiple Dose Period|Adverse Event|0|||
164074484|NCT01898884|592637251|FG006|Multiple Dose Period|Adverse Event|1|||
164074485|NCT01898884|592637252|FG007|Multiple Dose Period|Adverse Event|0|||
164074486|NCT01898884|592637253|FG008|Multiple Dose Period|Adverse Event|0|||
164074487|NCT01898884|592637245|FG000|Multiple Dose Period|Randomized Not Treated|0|||
164074488|NCT01898884|592637246|FG001|Multiple Dose Period|Randomized Not Treated|0|||
164074489|NCT01898884|592637247|FG002|Multiple Dose Period|Randomized Not Treated|0|||
164074490|NCT01898884|592637248|FG003|Multiple Dose Period|Randomized Not Treated|0|||
164074491|NCT01898884|592637249|FG004|Multiple Dose Period|Randomized Not Treated|0|||
164074492|NCT01898884|592637250|FG005|Multiple Dose Period|Randomized Not Treated|0|||
164074493|NCT01898884|592637251|FG006|Multiple Dose Period|Randomized Not Treated|0|||
164074494|NCT01898884|592637252|FG007|Multiple Dose Period|Randomized Not Treated|0|||
164074495|NCT01898884|592637253|FG008|Multiple Dose Period|Randomized Not Treated|1|||
164074496|NCT00434148|592637254|FG000|Overall Study|Adverse Event|18|||
164074497|NCT00434148|592637255|FG001|Overall Study|Adverse Event|18|||
164074498|NCT00434148|592637254|FG000|Overall Study|Lack of Efficacy|25|||
164074499|NCT00434148|592637255|FG001|Overall Study|Lack of Efficacy|28|||
164074500|NCT00434148|592637254|FG000|Overall Study|Withdrawal by Subject|15|||
164074501|NCT00434148|592637255|FG001|Overall Study|Withdrawal by Subject|15|||
164074502|NCT00434148|592637254|FG000|Overall Study|Protocol Violation|4|||
164074503|NCT00434148|592637255|FG001|Overall Study|Protocol Violation|0|||
164074504|NCT00434148|592637254|FG000|Overall Study|Administrative problems|6|||
164074505|NCT00434148|592637255|FG001|Overall Study|Administrative problems|10|||
164074506|NCT00434148|592637254|FG000|Overall Study|Lost to Follow-up|0|||
164074507|NCT00434148|592637255|FG001|Overall Study|Lost to Follow-up|1|||
164074508|NCT00434148|592637254|FG000|Overall Study|Condition no longer requires study drug|1|||
164074509|NCT00434148|592637255|FG001|Overall Study|Condition no longer requires study drug|0|||
164074510|NCT00434148|592637254|FG000|Overall Study|Abnormal test procedure result|0|||
164074511|NCT00434148|592637255|FG001|Overall Study|Abnormal test procedure result|1|||
164074512|NCT00759759|592637256|FG000|Overall Study|didn't return for period 2|1|||
164074513|NCT00759759|592637257|FG001|Overall Study|didn't return for period 2|0|||
164074514|NCT00759759|592637256|FG000|Overall Study|Didn't receive drug in period 2|1|||
164074515|NCT00759759|592637257|FG001|Overall Study|Didn't receive drug in period 2|0|||
164074516|NCT00759759|592637256|FG000|Overall Study|Withdrawal by Subject|2|||
164074517|NCT00759759|592637257|FG001|Overall Study|Withdrawal by Subject|1|||
164074518|NCT01556165|592637258|FG000|Overall Study|Adverse Event|5|||
164074519|NCT01556165|592637259|FG001|Overall Study|Adverse Event|3|||
164074520|NCT01556165|592637258|FG000|Overall Study|Protocol Violation|0|||
164074521|NCT01556165|592637259|FG001|Overall Study|Protocol Violation|3|||
164074522|NCT01556165|592637258|FG000|Overall Study|Withdrawal of Consent|7|||
164074523|NCT01556165|592637259|FG001|Overall Study|Withdrawal of Consent|1|||
164074524|NCT01640964|592637262|FG000|Overall Study|Lost to Follow-up|0|||
164074525|NCT01640964|592637263|FG001|Overall Study|Lost to Follow-up|0|||
164074526|NCT01640964|592637264|FG002|Overall Study|Lost to Follow-up|1|||
164074527|NCT01640964|592637262|FG000|Overall Study|Protocol Deviation|1|||
164074528|NCT01640964|592637263|FG001|Overall Study|Protocol Deviation|1|||
164074529|NCT01640964|592637264|FG002|Overall Study|Protocol Deviation|2|||
164074530|NCT00833976|592638700|FG000|Overall Study|Withdrawal by Subject|5|||
164074531|NCT00833976|592638700|FG000|Overall Study|Lost to Follow-up|4|||
164074532|NCT00833976|592638700|FG000|Overall Study|Did not meet eligibility criteria|41|||
164074533|NCT00833976|592638700|FG000|Overall Study|Physician Decision|1|||
164074534|NCT01246973|592638705|FG000|Overall Study|Other|38|||
164074535|NCT01246973|592638706|FG001|Overall Study|Other|25|||
164074536|NCT01246973|592638705|FG000|Overall Study|Adverse Event|16|||
164074537|NCT01246973|592638706|FG001|Overall Study|Adverse Event|9|||
164074538|NCT01246973|592638705|FG000|Overall Study|Withdrawal by Subject|7|||
164074539|NCT01246973|592638706|FG001|Overall Study|Withdrawal by Subject|13|||
164074540|NCT00678379|592638707|FG000|Overall Study|Injection performed after tonsillectomy|2|||
164074541|NCT00678379|592638708|FG001|Overall Study|Injection performed after tonsillectomy|0|||
164074542|NCT00678379|592638709|FG002|Overall Study|Injection performed after tonsillectomy|1|||
164074543|NCT00678379|592638707|FG000|Overall Study|Incomplete Data|4|||
164074544|NCT00678379|592638708|FG001|Overall Study|Incomplete Data|3|||
164074545|NCT00678379|592638709|FG002|Overall Study|Incomplete Data|3|||
164074546|NCT01835470|592638710|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
164074547|NCT01835470|592638710|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
164074548|NCT01011907|592638711|FG000|Overall Study|Withdrawal by Subject|13|||
164074549|NCT01011907|592638712|FG001|Overall Study|Withdrawal by Subject|11|||
164074550|NCT01011907|592638711|FG000|Overall Study|Adverse Event|1|||
164074551|NCT01011907|592638712|FG001|Overall Study|Adverse Event|4|||
164074552|NCT00350519|592638717|FG000|Overall Study|Death|0|||
164074553|NCT00350519|592638718|FG001|Overall Study|Death|1|||
164074554|NCT00350519|592638717|FG000|Overall Study|Physician Decision|0|||
164074555|NCT00350519|592638718|FG001|Overall Study|Physician Decision|1|||
164074556|NCT00350519|592638717|FG000|Overall Study|Protocol Violation|1|||
164074557|NCT00350519|592638718|FG001|Overall Study|Protocol Violation|2|||
164074558|NCT00350519|592638717|FG000|Overall Study|Withdrawal by Subject|3|||
164074559|NCT00350519|592638718|FG001|Overall Study|Withdrawal by Subject|2|||
164074560|NCT01637961|592638720|FG000|Overall Study|Ineligible: wrong primary|1|||
164074561|NCT01637961|592638720|FG000|Overall Study|Ineligible: inadequate pathology|1|||
164074562|NCT02239601|592638726|FG000|Overall Study|Withdrawal by Subject|3|||
164074563|NCT02239601|592638727|FG001|Overall Study|Withdrawal by Subject|4|||
164074564|NCT02239601|592638726|FG000|Overall Study|Protocol Violation|4|||
164074565|NCT02239601|592638727|FG001|Overall Study|Protocol Violation|2|||
164074566|NCT04682639|592638728|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
164074567|NCT04682639|592638729|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
164074568|NCT04682639|592638730|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
164074569|NCT04682639|592638731|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
164074570|NCT04682639|592638732|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
164074571|NCT04682639|592638728|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164074572|NCT04682639|592638729|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164074573|NCT04682639|592638730|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164074574|NCT04682639|592638731|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164074575|NCT04682639|592638732|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164074576|NCT04682639|592638728|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
164074577|NCT04682639|592638729|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164074578|NCT04682639|592638730|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164074579|NCT04682639|592638731|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164074580|NCT04682639|592638732|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164074581|NCT04682639|592638728|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164074582|NCT04682639|592638729|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
164074583|NCT04682639|592638730|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164074584|NCT04682639|592638731|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164074585|NCT04682639|592638732|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
164074586|NCT04682639|592638728|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
164074587|NCT04682639|592638729|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164074588|NCT04682639|592638730|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164074589|NCT04682639|592638731|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164074590|NCT04682639|592638732|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
164074591|NCT04682639|592638728|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
164074592|NCT04682639|592638729|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
164074593|NCT04682639|592638730|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
164074594|NCT04682639|592638731|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164074595|NCT04682639|592638732|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164074596|NCT04682639|592638728|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
164074597|NCT04682639|592638729|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
164074598|NCT04682639|592638730|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
164074599|NCT04682639|592638731|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
164074600|NCT04682639|592638732|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
164074601|NCT04682639|592638728|FG000|OLE Period (28 Weeks)|Other|1|||
164074602|NCT04682639|592638729|FG001|OLE Period (28 Weeks)|Other|2|||
164074603|NCT04682639|592638730|FG002|OLE Period (28 Weeks)|Other|0|||
164074604|NCT04682639|592638731|FG003|OLE Period (28 Weeks)|Other|0|||
164074605|NCT04682639|592638732|FG004|OLE Period (28 Weeks)|Other|1|||
164074606|NCT04682639|592638728|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
164074607|NCT04682639|592638729|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
164074608|NCT04682639|592638730|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
164074609|NCT04682639|592638731|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
164074610|NCT04682639|592638732|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
164074611|NCT04682639|592638728|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
164074612|NCT04682639|592638729|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
164074613|NCT04682639|592638730|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164074614|NCT04682639|592638731|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164074615|NCT04682639|592638732|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164074616|NCT04682639|592638728|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
164074617|NCT04682639|592638729|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
164074618|NCT04682639|592638730|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164074619|NCT04682639|592638731|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164074620|NCT04682639|592638732|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164074621|NCT04682639|592638728|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
164074622|NCT04682639|592638729|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
164090397|NCT02275364|592693429|FG001|Period 1|Other reason|0|||
164074623|NCT04682639|592638730|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
164074624|NCT04682639|592638731|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
164074625|NCT04682639|592638732|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
164074626|NCT04388527|592638733|FG000|Overall Study|Death|14|||
164074627|NCT04388527|592638733|FG000|Overall Study|Withdrawal by Subject|2|||
164074628|NCT04388527|592638733|FG000|Overall Study|Lost to Follow-up|1|||
164074629|NCT00331773|592638737|FG000|Overall Study|Withdrawal by Subject|6|||
164074630|NCT00331773|592638738|FG001|Overall Study|Withdrawal by Subject|4|||
164074631|NCT00331773|592638737|FG000|Overall Study|Protocol Violation|10|||
164074632|NCT00331773|592638738|FG001|Overall Study|Protocol Violation|3|||
164074633|NCT02773446|592638739|FG000|First Admission|Withdrawal by Subject|0|||
164074634|NCT02773446|592638740|FG001|First Admission|Withdrawal by Subject|0|||
164074635|NCT02773446|592638741|FG002|First Admission|Withdrawal by Subject|0|||
164074636|NCT02773446|592638742|FG003|First Admission|Withdrawal by Subject|1|||
164074637|NCT02773446|592638743|FG004|First Admission|Withdrawal by Subject|0|||
164074638|NCT02773446|592638744|FG005|First Admission|Withdrawal by Subject|0|||
164074639|NCT02773446|592638739|FG000|First Admission|Lost to Follow-up|1|||
164074640|NCT02773446|592638740|FG001|First Admission|Lost to Follow-up|0|||
164074641|NCT02773446|592638741|FG002|First Admission|Lost to Follow-up|0|||
164074642|NCT02773446|592638742|FG003|First Admission|Lost to Follow-up|0|||
164074643|NCT02773446|592638743|FG004|First Admission|Lost to Follow-up|0|||
164074644|NCT02773446|592638744|FG005|First Admission|Lost to Follow-up|0|||
164074645|NCT02513459|592638745|FG000|Overall Study|Adverse Event|7|||
164074646|NCT02513459|592638745|FG000|Overall Study|Withdrew consent|5|||
164074647|NCT02513459|592638745|FG000|Overall Study|Loss of efficacy|2|||
164074648|NCT02513459|592638745|FG000|Overall Study|Pregnancy|2|||
164074649|NCT02513459|592638745|FG000|Overall Study|Subject decision|2|||
164074650|NCT02513459|592638745|FG000|Overall Study|Lack of response|1|||
164074651|NCT02513459|592638745|FG000|Overall Study|Reproductive plans|1|||
164074652|NCT02513459|592638745|FG000|Overall Study|Surgery planned-- not done|1|||
164074653|NCT00923195|592638746|FG000|Overall Study|Death|0|||
164074654|NCT00923195|592638747|FG001|Overall Study|Death|1|||
164074655|NCT00525031|592638748|FG000|Overall Study|Disease Progression|1|||
164074656|NCT00525031|592638749|FG001|Overall Study|Disease Progression|1|||
164074657|NCT01613131|592638750|FG000|Overall Study|Withdrawal by Subject|3|||
164074658|NCT01613131|592638751|FG001|Overall Study|Withdrawal by Subject|5|||
164074659|NCT02454972|592638754|FG000|Overall Study|Progressive disease|17|||
164074660|NCT02454972|592638755|FG001|Overall Study|Progressive disease|16|||
164074661|NCT02454972|592638756|FG002|Overall Study|Progressive disease|59|||
164074662|NCT02454972|592638757|FG003|Overall Study|Progressive disease|23|||
164074663|NCT02454972|592638758|FG004|Overall Study|Progressive disease|16|||
164074664|NCT02454972|592638759|FG005|Overall Study|Progressive disease|12|||
164074665|NCT02454972|592638760|FG006|Overall Study|Progressive disease|19|||
164074666|NCT02454972|592638761|FG007|Overall Study|Progressive disease|27|||
164074667|NCT02454972|592638762|FG008|Overall Study|Progressive disease|0|||
164074668|NCT02454972|592638754|FG000|Overall Study|Death|0|||
164074669|NCT02454972|592638755|FG001|Overall Study|Death|0|||
164074670|NCT02454972|592638756|FG002|Overall Study|Death|5|||
164074671|NCT02454972|592638757|FG003|Overall Study|Death|1|||
164074672|NCT02454972|592638758|FG004|Overall Study|Death|0|||
164074673|NCT02454972|592638759|FG005|Overall Study|Death|0|||
164074674|NCT02454972|592638760|FG006|Overall Study|Death|0|||
164074675|NCT02454972|592638761|FG007|Overall Study|Death|0|||
164074676|NCT02454972|592638762|FG008|Overall Study|Death|95|||
164074677|NCT02454972|592638754|FG000|Overall Study|Physician Decision|0|||
164074678|NCT02454972|592638755|FG001|Overall Study|Physician Decision|1|||
164074679|NCT02454972|592638756|FG002|Overall Study|Physician Decision|2|||
164074680|NCT02454972|592638757|FG003|Overall Study|Physician Decision|1|||
164074681|NCT02454972|592638758|FG004|Overall Study|Physician Decision|2|||
164074682|NCT02454972|592638759|FG005|Overall Study|Physician Decision|0|||
164074683|NCT02454972|592638760|FG006|Overall Study|Physician Decision|0|||
164074684|NCT02454972|592638761|FG007|Overall Study|Physician Decision|1|||
164074685|NCT02454972|592638762|FG008|Overall Study|Physician Decision|0|||
164074686|NCT02454972|592638754|FG000|Overall Study|Non treatment-related adverse event|2|||
164074687|NCT02454972|592638755|FG001|Overall Study|Non treatment-related adverse event|0|||
164074688|NCT02454972|592638756|FG002|Overall Study|Non treatment-related adverse event|1|||
164074689|NCT02454972|592638757|FG003|Overall Study|Non treatment-related adverse event|0|||
164074690|NCT02454972|592638758|FG004|Overall Study|Non treatment-related adverse event|0|||
164074691|NCT02454972|592638759|FG005|Overall Study|Non treatment-related adverse event|1|||
164074692|NCT02454972|592638760|FG006|Overall Study|Non treatment-related adverse event|0|||
164074693|NCT02454972|592638761|FG007|Overall Study|Non treatment-related adverse event|1|||
164074694|NCT02454972|592638762|FG008|Overall Study|Non treatment-related adverse event|0|||
164074695|NCT02454972|592638754|FG000|Overall Study|Treatment-related adverse events|0|||
164074696|NCT02454972|592638755|FG001|Overall Study|Treatment-related adverse events|1|||
164074697|NCT02454972|592638756|FG002|Overall Study|Treatment-related adverse events|1|||
164074698|NCT02454972|592638757|FG003|Overall Study|Treatment-related adverse events|0|||
164074699|NCT02454972|592638758|FG004|Overall Study|Treatment-related adverse events|2|||
164074700|NCT02454972|592638759|FG005|Overall Study|Treatment-related adverse events|0|||
164133264|NCT02283983|592852718|FG001|Overall Study|Relapse|0|||
164074701|NCT02454972|592638760|FG006|Overall Study|Treatment-related adverse events|0|||
164074702|NCT02454972|592638761|FG007|Overall Study|Treatment-related adverse events|2|||
164074703|NCT02454972|592638762|FG008|Overall Study|Treatment-related adverse events|0|||
164074704|NCT02454972|592638754|FG000|Overall Study|Patient moves to compassionate use|0|||
164074705|NCT02454972|592638755|FG001|Overall Study|Patient moves to compassionate use|0|||
164074706|NCT02454972|592638756|FG002|Overall Study|Patient moves to compassionate use|0|||
164074707|NCT02454972|592638757|FG003|Overall Study|Patient moves to compassionate use|0|||
164074708|NCT02454972|592638758|FG004|Overall Study|Patient moves to compassionate use|0|||
164074709|NCT02454972|592638759|FG005|Overall Study|Patient moves to compassionate use|0|||
164074710|NCT02454972|592638760|FG006|Overall Study|Patient moves to compassionate use|2|||
164074711|NCT02454972|592638761|FG007|Overall Study|Patient moves to compassionate use|0|||
164074712|NCT02454972|592638762|FG008|Overall Study|Patient moves to compassionate use|0|||
164074713|NCT02454972|592638754|FG000|Overall Study|Withdrawal by Subject|0|||
164074714|NCT02454972|592638755|FG001|Overall Study|Withdrawal by Subject|1|||
164074715|NCT02454972|592638756|FG002|Overall Study|Withdrawal by Subject|5|||
164074716|NCT02454972|592638757|FG003|Overall Study|Withdrawal by Subject|2|||
164074717|NCT02454972|592638758|FG004|Overall Study|Withdrawal by Subject|3|||
164074718|NCT02454972|592638759|FG005|Overall Study|Withdrawal by Subject|2|||
164074719|NCT02454972|592638760|FG006|Overall Study|Withdrawal by Subject|0|||
164074720|NCT02454972|592638761|FG007|Overall Study|Withdrawal by Subject|1|||
164074721|NCT02454972|592638762|FG008|Overall Study|Withdrawal by Subject|2|||
164074722|NCT02454972|592638754|FG000|Overall Study|Multiple delay/holds on treatment|0|||
164074723|NCT02454972|592638755|FG001|Overall Study|Multiple delay/holds on treatment|0|||
164074724|NCT02454972|592638756|FG002|Overall Study|Multiple delay/holds on treatment|0|||
164074725|NCT02454972|592638757|FG003|Overall Study|Multiple delay/holds on treatment|1|||
164074726|NCT02454972|592638758|FG004|Overall Study|Multiple delay/holds on treatment|0|||
164074727|NCT02454972|592638759|FG005|Overall Study|Multiple delay/holds on treatment|0|||
164074728|NCT02454972|592638760|FG006|Overall Study|Multiple delay/holds on treatment|0|||
164074729|NCT02454972|592638761|FG007|Overall Study|Multiple delay/holds on treatment|0|||
164074730|NCT02454972|592638762|FG008|Overall Study|Multiple delay/holds on treatment|0|||
164074731|NCT02454972|592638754|FG000|Overall Study|Never treated|0|||
164074732|NCT02454972|592638755|FG001|Overall Study|Never treated|0|||
164074733|NCT02454972|592638756|FG002|Overall Study|Never treated|3|||
164074734|NCT02454972|592638757|FG003|Overall Study|Never treated|1|||
164074735|NCT02454972|592638758|FG004|Overall Study|Never treated|1|||
164074736|NCT02454972|592638759|FG005|Overall Study|Never treated|0|||
164074737|NCT02454972|592638760|FG006|Overall Study|Never treated|0|||
164074738|NCT02454972|592638761|FG007|Overall Study|Never treated|0|||
164074739|NCT02454972|592638762|FG008|Overall Study|Never treated|5|||
164074740|NCT02454972|592638754|FG000|Overall Study|Lost to Follow-up|0|||
164074741|NCT02454972|592638755|FG001|Overall Study|Lost to Follow-up|0|||
164074742|NCT02454972|592638756|FG002|Overall Study|Lost to Follow-up|0|||
164074743|NCT02454972|592638757|FG003|Overall Study|Lost to Follow-up|0|||
164074744|NCT02454972|592638758|FG004|Overall Study|Lost to Follow-up|0|||
164074745|NCT02454972|592638759|FG005|Overall Study|Lost to Follow-up|0|||
164074746|NCT02454972|592638760|FG006|Overall Study|Lost to Follow-up|0|||
164074747|NCT02454972|592638761|FG007|Overall Study|Lost to Follow-up|0|||
164074748|NCT02454972|592638762|FG008|Overall Study|Lost to Follow-up|2|||
164074749|NCT02454972|592638754|FG000|Overall Study|Study termination|0|||
164074750|NCT02454972|592638755|FG001|Overall Study|Study termination|0|||
164074751|NCT02454972|592638756|FG002|Overall Study|Study termination|0|||
164074752|NCT02454972|592638757|FG003|Overall Study|Study termination|0|||
164074753|NCT02454972|592638758|FG004|Overall Study|Study termination|0|||
164074754|NCT02454972|592638759|FG005|Overall Study|Study termination|0|||
164074755|NCT02454972|592638760|FG006|Overall Study|Study termination|0|||
164074756|NCT02454972|592638761|FG007|Overall Study|Study termination|0|||
164074757|NCT02454972|592638762|FG008|Overall Study|Study termination|6|||
164074758|NCT00787566|592638763|FG000|Overall Study|AE related to chemotherapy|0|||
164074759|NCT00787566|592638764|FG001|Overall Study|AE related to chemotherapy|1|||
164074760|NCT00787566|592638765|FG002|Overall Study|AE related to chemotherapy|0|||
164074761|NCT02140164|592638766|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
164074762|NCT01814761|592638771|FG000|Overall Study|Other Reasons|1|||
164074763|NCT01814761|592638772|FG001|Overall Study|Other Reasons|10|||
164074764|NCT01814761|592638771|FG000|Overall Study|Ocular Adverse Event|6|||
164074765|NCT01814761|592638772|FG001|Overall Study|Ocular Adverse Event|15|||
164074766|NCT01814761|592638771|FG000|Overall Study|Lost to Follow-up|1|||
164074767|NCT01814761|592638772|FG001|Overall Study|Lost to Follow-up|5|||
164074768|NCT00775983|592638773|FG000|Overall Study|Protocol Violation|1|||
164074769|NCT00775983|592638774|FG001|Overall Study|Protocol Violation|2|||
164074770|NCT01020305|592638777|FG000|Overall Study|Adverse Event|2|||
164074771|NCT01070966|592638780|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
164074772|NCT01070966|592638780|FG000|Participants for Safety Evaluation|Off-label use|9|||
164074773|NCT01070966|592638780|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
164074774|NCT01070966|592638780|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
164074775|NCT01070966|592638780|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
164074776|NCT01070966|592638780|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
164074777|NCT01070966|592638780|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
164074778|NCT01070966|592638780|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
164074779|NCT01725113|592638781|FG000|Overall Study|Kidney Transplant|1|||
164074780|NCT01725113|592638782|FG001|Overall Study|Kidney Transplant|1|||
164074781|NCT01725113|592638781|FG000|Overall Study|Withdrawal by Subject|0|||
164074782|NCT01725113|592638782|FG001|Overall Study|Withdrawal by Subject|1|||
164074783|NCT02753400|592638784|FG000|Overall Study|Adverse Event|3|||
164074784|NCT02753400|592638785|FG001|Overall Study|Adverse Event|0|||
164074785|NCT02753400|592638784|FG000|Overall Study|Withdrawal by Subject|2|||
164074786|NCT02753400|592638785|FG001|Overall Study|Withdrawal by Subject|1|||
164074787|NCT03989115|592638786|FG000|Overall Study|Withdrawal by Subject|2|||
164074788|NCT03989115|592638787|FG001|Overall Study|Withdrawal by Subject|1|||
164074789|NCT03989115|592638788|FG002|Overall Study|Withdrawal by Subject|3|||
164074790|NCT03989115|592638789|FG003|Overall Study|Withdrawal by Subject|0|||
164074791|NCT03989115|592638790|FG004|Overall Study|Withdrawal by Subject|17|||
164074792|NCT03989115|592638791|FG005|Overall Study|Withdrawal by Subject|1|||
164074793|NCT03989115|592638792|FG006|Overall Study|Withdrawal by Subject|0|||
164074794|NCT03989115|592638793|FG007|Overall Study|Withdrawal by Subject|0|||
164074795|NCT03989115|592638786|FG000|Overall Study|Sponsor decision to terminate the study|1|||
164074796|NCT03989115|592638787|FG001|Overall Study|Sponsor decision to terminate the study|1|||
164074797|NCT03989115|592638788|FG002|Overall Study|Sponsor decision to terminate the study|0|||
164074798|NCT03989115|592638789|FG003|Overall Study|Sponsor decision to terminate the study|1|||
164074799|NCT03989115|592638790|FG004|Overall Study|Sponsor decision to terminate the study|11|||
164074800|NCT03989115|592638791|FG005|Overall Study|Sponsor decision to terminate the study|0|||
164074801|NCT03989115|592638792|FG006|Overall Study|Sponsor decision to terminate the study|2|||
164074802|NCT03989115|592638793|FG007|Overall Study|Sponsor decision to terminate the study|1|||
164074803|NCT03989115|592638786|FG000|Overall Study|Lost to Follow-up|2|||
164074804|NCT03989115|592638787|FG001|Overall Study|Lost to Follow-up|0|||
164074805|NCT03989115|592638788|FG002|Overall Study|Lost to Follow-up|0|||
164074806|NCT03989115|592638789|FG003|Overall Study|Lost to Follow-up|0|||
164074807|NCT03989115|592638790|FG004|Overall Study|Lost to Follow-up|1|||
164074808|NCT03989115|592638791|FG005|Overall Study|Lost to Follow-up|0|||
164074809|NCT03989115|592638792|FG006|Overall Study|Lost to Follow-up|0|||
164074810|NCT03989115|592638793|FG007|Overall Study|Lost to Follow-up|0|||
164074811|NCT03989115|592638786|FG000|Overall Study|Death|2|||
164074812|NCT03989115|592638787|FG001|Overall Study|Death|2|||
164074813|NCT03989115|592638788|FG002|Overall Study|Death|9|||
164074814|NCT03989115|592638789|FG003|Overall Study|Death|6|||
164074815|NCT03989115|592638790|FG004|Overall Study|Death|31|||
164074816|NCT03989115|592638791|FG005|Overall Study|Death|6|||
164074817|NCT03989115|592638792|FG006|Overall Study|Death|2|||
164074818|NCT03989115|592638793|FG007|Overall Study|Death|3|||
164074819|NCT03989115|592638786|FG000|Overall Study|Other|1|||
164074820|NCT03989115|592638787|FG001|Overall Study|Other|2|||
164074821|NCT03989115|592638788|FG002|Overall Study|Other|0|||
164074822|NCT03989115|592638789|FG003|Overall Study|Other|0|||
164074823|NCT03989115|592638790|FG004|Overall Study|Other|5|||
164074824|NCT03989115|592638791|FG005|Overall Study|Other|0|||
164074825|NCT03989115|592638792|FG006|Overall Study|Other|0|||
164074826|NCT03989115|592638793|FG007|Overall Study|Other|0|||
164074827|NCT01415921|592638794|FG000|Overall Study|Adverse Event|0|||
164074828|NCT01415921|592638795|FG001|Overall Study|Adverse Event|1|||
164074829|NCT01415921|592638794|FG000|Overall Study|Physician Decision|1|||
164074830|NCT01415921|592638795|FG001|Overall Study|Physician Decision|1|||
164074831|NCT01415921|592638794|FG000|Overall Study|Withdrawal by Subject|0|||
164074832|NCT01415921|592638795|FG001|Overall Study|Withdrawal by Subject|1|||
164074833|NCT01415921|592638794|FG000|Overall Study|Other|2|||
164074834|NCT01415921|592638795|FG001|Overall Study|Other|0|||
164074835|NCT00697112|592638800|FG000|Overall Study|Adverse Event|8|||
164074836|NCT00697112|592638800|FG000|Overall Study|Lost to Follow-up|1|||
164074837|NCT00697112|592638800|FG000|Overall Study|Did not meet inclusion criteria|1|||
164074838|NCT00720304|592638803|FG000|Overall Study|Withdrawal by Subject|14|||
164074839|NCT00720304|592638804|FG001|Overall Study|Withdrawal by Subject|1|||
164074840|NCT00720304|592638803|FG000|Overall Study|Death|1|||
164074841|NCT00720304|592638804|FG001|Overall Study|Death|0|||
164074842|NCT00720304|592638803|FG000|Overall Study|Physician Decision|5|||
164074843|NCT00720304|592638804|FG001|Overall Study|Physician Decision|2|||
164074844|NCT00720304|592638803|FG000|Overall Study|Adverse Event|3|||
164074845|NCT00720304|592638804|FG001|Overall Study|Adverse Event|1|||
164074846|NCT00720304|592638803|FG000|Overall Study|Disease progression|6|||
164074847|NCT00720304|592638804|FG001|Overall Study|Disease progression|1|||
164074848|NCT04330482|592638807|FG000|Overall Study|Lost to Follow-up|2|||
164074849|NCT04330482|592638808|FG001|Overall Study|Lost to Follow-up|1|||
164074850|NCT04330482|592638807|FG000|Overall Study|Withdrawal by Subject|0|||
164074851|NCT04330482|592638808|FG001|Overall Study|Withdrawal by Subject|3|||
164074852|NCT02725671|592638810|FG000|Overall Study|Lost to Follow-up|1|||
164074853|NCT02354976|592638813|FG000|Overall Study|Other - reason not specified|1|||
164074854|NCT02354976|592638814|FG001|Overall Study|Other - reason not specified|0|||
164074855|NCT02354976|592638815|FG002|Overall Study|Other - reason not specified|1|||
164074856|NCT02354976|592638813|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
164074857|NCT02354976|592638814|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
164074858|NCT02354976|592638815|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
164074859|NCT02354976|592638813|FG000|Overall Study|Adverse Event|1|||
164074860|NCT02354976|592638814|FG001|Overall Study|Adverse Event|0|||
164074861|NCT02354976|592638815|FG002|Overall Study|Adverse Event|2|||
164074862|NCT01706770|592638816|FG000|Overall Study|Lost to Follow-up|1|||
164074863|NCT01706770|592638817|FG001|Overall Study|Lost to Follow-up|0|||
164074864|NCT01706770|592638816|FG000|Overall Study|Physician Decision|1|||
164074865|NCT01706770|592638817|FG001|Overall Study|Physician Decision|0|||
164074866|NCT00068445|592638818|FG000|Randomization|Cancel|1|||
164074867|NCT00068445|592638819|FG001|Randomization|Cancel|3|||
164074868|NCT00068445|592638818|FG000|Randomization|Ineligible|1|||
164074869|NCT00068445|592638819|FG001|Randomization|Ineligible|1|||
164074870|NCT00068445|592638818|FG000|Treatment|Refused Further Treatment|13|||
164074871|NCT00068445|592638819|FG001|Treatment|Refused Further Treatment|10|||
164074872|NCT00068445|592638818|FG000|Treatment|Adverse Event|7|||
164074873|NCT00068445|592638819|FG001|Treatment|Adverse Event|1|||
164074874|NCT00068445|592638818|FG000|Treatment|Other (Specifics not available)|9|||
164074875|NCT00068445|592638819|FG001|Treatment|Other (Specifics not available)|5|||
164074876|NCT01155284|592638820|FG000|Overall Study|Withdrawal by Subject|4|||
164074877|NCT01155284|592638821|FG001|Overall Study|Withdrawal by Subject|3|||
164074878|NCT01155284|592638820|FG000|Overall Study|Lost to Follow-up|1|||
164074879|NCT01155284|592638821|FG001|Overall Study|Lost to Follow-up|2|||
164074880|NCT01155284|592638820|FG000|Overall Study|Physician Decision|1|||
164074881|NCT01155284|592638821|FG001|Overall Study|Physician Decision|0|||
164074882|NCT01155284|592638820|FG000|Overall Study|Adverse Event|1|||
164074883|NCT01155284|592638821|FG001|Overall Study|Adverse Event|0|||
164074884|NCT01896700|592638822|FG000|Overall Study|Adverse Event|4|||
164074885|NCT01896700|592638823|FG001|Overall Study|Adverse Event|5|||
164074886|NCT01896700|592638822|FG000|Overall Study|Withdrawal by Subject|0|||
164074887|NCT01896700|592638823|FG001|Overall Study|Withdrawal by Subject|1|||
164074888|NCT00123487|592638824|FG000|Randomized|Death prior to starting treatment|0|||
164074889|NCT00123487|592638825|FG001|Randomized|Death prior to starting treatment|1|||
164074890|NCT00123487|592638824|FG000|Randomized|SAE prior to starting treatment|1|||
164074891|NCT00123487|592638825|FG001|Randomized|SAE prior to starting treatment|0|||
164074892|NCT00123487|592638824|FG000|Treated With Study Drug|Adverse Event|23|||
164074893|NCT00123487|592638825|FG001|Treated With Study Drug|Adverse Event|22|||
164074894|NCT00123487|592638824|FG000|Treated With Study Drug|Disease Progression|141|||
164074895|NCT00123487|592638825|FG001|Treated With Study Drug|Disease Progression|122|||
164074896|NCT00123487|592638824|FG000|Treated With Study Drug|Physician Decision|8|||
164074897|NCT00123487|592638825|FG001|Treated With Study Drug|Physician Decision|9|||
164074898|NCT00123487|592638824|FG000|Treated With Study Drug|Other|59|||
164074899|NCT00123487|592638825|FG001|Treated With Study Drug|Other|58|||
164074900|NCT00123487|592638824|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
164074901|NCT00123487|592638825|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
164074902|NCT00123487|592638824|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
164074903|NCT00123487|592638825|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
164074904|NCT00123487|592638824|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
164074905|NCT00123487|592638825|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
164074906|NCT01656967|592638828|FG000|Overall Study|faulty monitor|1|||
164074907|NCT01656967|592638829|FG001|Overall Study|faulty monitor|0|||
164074908|NCT01656967|592638828|FG000|Overall Study|unsuccessful ETT insertion|3|||
164074909|NCT01656967|592638829|FG001|Overall Study|unsuccessful ETT insertion|2|||
164074910|NCT05788237|592638836|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
164074911|NCT05788237|592638837|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
164074912|NCT05788237|592638838|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
164074913|NCT05788237|592638839|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
164074914|NCT05788237|592638836|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
164074915|NCT05788237|592638837|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
164074916|NCT05788237|592638838|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
164074917|NCT05788237|592638839|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
164074918|NCT05788237|592638836|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
164074919|NCT05788237|592638837|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
164074920|NCT05788237|592638838|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
164074921|NCT05788237|592638839|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
164074922|NCT05788237|592638836|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
164074923|NCT05788237|592638837|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
164074924|NCT05788237|592638838|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
164074925|NCT05788237|592638839|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
164074926|NCT05788237|592638836|FG000|SSA (Approximately 2 Months)|Death|0|||
164074927|NCT05788237|592638837|FG001|SSA (Approximately 2 Months)|Death|1|||
164074928|NCT05788237|592638838|FG002|SSA (Approximately 2 Months)|Death|0|||
164074929|NCT05788237|592638839|FG003|SSA (Approximately 2 Months)|Death|0|||
164074930|NCT05788237|592638836|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
164074931|NCT05788237|592638837|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
164074932|NCT05788237|592638838|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
164074933|NCT05788237|592638839|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
164074934|NCT05788237|592638836|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
164074935|NCT05788237|592638837|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
164074936|NCT05788237|592638838|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
164074937|NCT05788237|592638839|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
164074938|NCT05788237|592638836|FG000|SSB (Approximately 1 Month)|Other|0|||
164074939|NCT05788237|592638837|FG001|SSB (Approximately 1 Month)|Other|0|||
164074940|NCT05788237|592638838|FG002|SSB (Approximately 1 Month)|Other|0|||
164074941|NCT05788237|592638839|FG003|SSB (Approximately 1 Month)|Other|1|||
164074942|NCT00681824|592640158|FG000|Overall Study|withdrawn by investigator|0|||
164074943|NCT00681824|592640159|FG001|Overall Study|withdrawn by investigator|0|||
164074944|NCT00681824|592640160|FG002|Overall Study|withdrawn by investigator|1|||
164074945|NCT00681824|592640158|FG000|Overall Study|scheduling conflict|1|||
164074946|NCT00681824|592640159|FG001|Overall Study|scheduling conflict|0|||
164074947|NCT00681824|592640160|FG002|Overall Study|scheduling conflict|0|||
164074948|NCT00681824|592640158|FG000|Overall Study|Death|0|||
164074949|NCT00681824|592640159|FG001|Overall Study|Death|1|||
164074950|NCT00681824|592640160|FG002|Overall Study|Death|0|||
164074951|NCT03724916|592640161|FG000|Overall Study|Withdrawal by Subject|0|||
164074952|NCT03724916|592640162|FG001|Overall Study|Withdrawal by Subject|1|||
164074953|NCT03724916|592640163|FG002|Overall Study|Withdrawal by Subject|1|||
164074954|NCT03724916|592640164|FG003|Overall Study|Withdrawal by Subject|2|||
164074955|NCT03724916|592640161|FG000|Overall Study|Randomized but not Treated|1|||
164074956|NCT03724916|592640162|FG001|Overall Study|Randomized but not Treated|0|||
164074957|NCT03724916|592640163|FG002|Overall Study|Randomized but not Treated|0|||
164074958|NCT03724916|592640164|FG003|Overall Study|Randomized but not Treated|0|||
164074959|NCT04575038|592640165|FG000|Overall Study|Withdrawal by Subject|1|||
164074960|NCT04575038|592640166|FG001|Overall Study|Withdrawal by Subject|1|||
164074961|NCT04335110|592640173|FG000|Overall Study|Withdrawal by Subject|1|||
164074962|NCT04335110|592640174|FG001|Overall Study|Withdrawal by Subject|1|||
164074963|NCT04335110|592640173|FG000|Overall Study|Death|0|||
164074964|NCT04335110|592640174|FG001|Overall Study|Death|1|||
164074965|NCT03101293|592640177|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
164074966|NCT03101293|592640178|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
164074967|NCT03333382|592640185|FG000|Overall Study|Lost to Follow-up|1|||
164074968|NCT03333382|592640186|FG001|Overall Study|Lost to Follow-up|0|||
164074969|NCT00660790|592640195|FG000|Baseline to 3 Months|Death|1|||
164074970|NCT00660790|592640195|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
164074971|NCT00660790|592640195|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
164074972|NCT00686374|592640201|FG000|Overall Study|Lack of Efficacy|10|||
164074973|NCT00686374|592640201|FG000|Overall Study|Adverse Event|8|||
164074974|NCT00686374|592640201|FG000|Overall Study|Withdrew consent|5|||
164074975|NCT00686374|592640201|FG000|Overall Study|Lost to Follow-up|1|||
164074976|NCT00686374|592640201|FG000|Overall Study|Missing reason|33|||
164074977|NCT00686374|592640201|FG000|Overall Study|Other, not specified|4|||
164074978|NCT00618774|592640202|FG000|Overall Study|Adverse Event|5|||
164074979|NCT00618774|592640203|FG001|Overall Study|Adverse Event|3|||
164074980|NCT00618774|592640202|FG000|Overall Study|Withdrawal by Subject|1|||
164074981|NCT00618774|592640203|FG001|Overall Study|Withdrawal by Subject|0|||
164074982|NCT02424565|592640205|FG000|Period 1 (D0)|Protocol Violation|0|||
164074983|NCT02424565|592640206|FG001|Period 1 (D0)|Protocol Violation|1|||
164074984|NCT02143947|592640207|FG000|Overall Study|Lost to Follow-up|4|||
164074985|NCT02143947|592640208|FG001|Overall Study|Lost to Follow-up|2|||
164074986|NCT01808209|592640209|FG000|Overall Study|Lost to Follow-up|0|||
164074987|NCT01808209|592640210|FG001|Overall Study|Lost to Follow-up|1|||
164074988|NCT00685919|592640217|FG000|Overall Study|Withdrawal by Subject|0|||
164074989|NCT00685919|592640218|FG001|Overall Study|Withdrawal by Subject|0|||
164074990|NCT00685919|592640219|FG002|Overall Study|Withdrawal by Subject|1|||
164074991|NCT00685919|592640220|FG003|Overall Study|Withdrawal by Subject|0|||
164074992|NCT00685919|592640217|FG000|Overall Study|Physician Decision|1|||
164074993|NCT00685919|592640218|FG001|Overall Study|Physician Decision|0|||
164074994|NCT00685919|592640219|FG002|Overall Study|Physician Decision|0|||
164074995|NCT00685919|592640220|FG003|Overall Study|Physician Decision|0|||
164074996|NCT04228302|592640221|FG000|Overall Study|Adverse Event|0|||
164074997|NCT04228302|592640222|FG001|Overall Study|Adverse Event|0|||
164074998|NCT04228302|592640223|FG002|Overall Study|Adverse Event|0|||
164074999|NCT04228302|592640224|FG003|Overall Study|Adverse Event|0|||
164075000|NCT04228302|592640225|FG004|Overall Study|Adverse Event|1|||
164075001|NCT04228302|592640226|FG005|Overall Study|Adverse Event|0|||
164075002|NCT02732561|592640227|FG000|Overall Study|Lost to Follow-up|1|||
164075003|NCT02732561|592640228|FG001|Overall Study|Lost to Follow-up|1|||
164075004|NCT02732561|592640227|FG000|Overall Study|Withdrawal by Subject|1|||
164075005|NCT02732561|592640228|FG001|Overall Study|Withdrawal by Subject|0|||
164075006|NCT04736576|592640229|FG000|Overall Study|Progressive disease|3|||
164075007|NCT04736576|592640230|FG001|Overall Study|Progressive disease|1|||
164075008|NCT04736576|592640229|FG000|Overall Study|Death|1|||
164075009|NCT04736576|592640230|FG001|Overall Study|Death|0|||
164075010|NCT05180630|592640231|FG000|First Intervention|Physician Decision|0|||
164075011|NCT05180630|592640232|FG001|First Intervention|Physician Decision|0|||
164075012|NCT05180630|592640233|FG002|First Intervention|Physician Decision|3|||
164075013|NCT00709735|592640236|FG000|Overall Study|Lost to Follow-up|1|||
164075014|NCT00709735|592640237|FG001|Overall Study|Lost to Follow-up|1|||
164075015|NCT00709735|592640236|FG000|Overall Study|Relapse into Opioid Abuse|0|||
164075016|NCT00709735|592640237|FG001|Overall Study|Relapse into Opioid Abuse|1|||
164075017|NCT00709735|592640236|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
164075018|NCT00709735|592640237|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
164075019|NCT00963599|592640238|FG000|Overall Study|Adverse Event|2|||
164075020|NCT00963599|592640239|FG001|Overall Study|Adverse Event|0|||
164075021|NCT00963599|592640240|FG002|Overall Study|Adverse Event|1|||
164075022|NCT00963599|592640241|FG003|Overall Study|Adverse Event|2|||
164075023|NCT00963599|592640238|FG000|Overall Study|Lack of Efficacy|0|||
164075024|NCT00963599|592640239|FG001|Overall Study|Lack of Efficacy|2|||
164075025|NCT00963599|592640240|FG002|Overall Study|Lack of Efficacy|1|||
164075026|NCT00963599|592640241|FG003|Overall Study|Lack of Efficacy|4|||
164075027|NCT00963599|592640238|FG000|Overall Study|Lost to Follow-up|0|||
164075028|NCT00963599|592640239|FG001|Overall Study|Lost to Follow-up|1|||
164075029|NCT00963599|592640240|FG002|Overall Study|Lost to Follow-up|1|||
164075030|NCT00963599|592640241|FG003|Overall Study|Lost to Follow-up|1|||
164075031|NCT00963599|592640238|FG000|Overall Study|Protocol Violation|2|||
164075032|NCT00963599|592640239|FG001|Overall Study|Protocol Violation|2|||
164075033|NCT00963599|592640240|FG002|Overall Study|Protocol Violation|3|||
164075034|NCT00963599|592640241|FG003|Overall Study|Protocol Violation|4|||
164075035|NCT00963599|592640238|FG000|Overall Study|Withdrawal by Subject|2|||
164075036|NCT00963599|592640239|FG001|Overall Study|Withdrawal by Subject|1|||
164075037|NCT00963599|592640240|FG002|Overall Study|Withdrawal by Subject|3|||
164075038|NCT00963599|592640241|FG003|Overall Study|Withdrawal by Subject|3|||
164075039|NCT00190684|592640244|FG000|Overall Study|Adverse Event|86|||
164075040|NCT00190684|592640244|FG000|Overall Study|Satisfactory response|80|||
164075041|NCT00190684|592640244|FG000|Overall Study|Lack of efficacy|204|||
164075042|NCT00190684|592640244|FG000|Overall Study|Lost to Follow-up|232|||
164075043|NCT00190684|592640244|FG000|Overall Study|Patient moved|60|||
164075044|NCT00190684|592640244|FG000|Overall Study|Patient Decision|432|||
163959596|NCT03226392|592224045|FG000|Overall Study|Lost to Follow-up|1|||
164075045|NCT00190684|592640244|FG000|Overall Study|Clinical relapse|67|||
164075046|NCT00190684|592640244|FG000|Overall Study|Sponsor's decision|17|||
164075047|NCT00190684|592640244|FG000|Overall Study|Physician Decision|84|||
164075048|NCT00190684|592640244|FG000|Overall Study|Protocol Violation|123|||
164075049|NCT00190684|592640244|FG000|Overall Study|Study Period III Completed|103|||
164075050|NCT00190684|592640244|FG000|Overall Study|Study Period V Completed|1|||
164075051|NCT00423488|592640248|FG000|Overall Study|No evidence of study drug intake|2|||
164075052|NCT00423488|592640249|FG001|Overall Study|No evidence of study drug intake|1|||
164075053|NCT00423488|592640248|FG000|Overall Study|No post baseline data|3|||
164075054|NCT00423488|592640249|FG001|Overall Study|No post baseline data|0|||
164075055|NCT03118765|592640250|FG000|Overall Study|Withdrawal by Subject|0|||
164075056|NCT03118765|592640251|FG001|Overall Study|Withdrawal by Subject|0|||
164075057|NCT03118765|592640252|FG002|Overall Study|Withdrawal by Subject|1|||
164075058|NCT03118765|592640253|FG003|Overall Study|Withdrawal by Subject|0|||
164075059|NCT03118765|592640254|FG004|Overall Study|Withdrawal by Subject|0|||
164075060|NCT03118765|592640250|FG000|Overall Study|Adverse Event|1|||
164075061|NCT03118765|592640251|FG001|Overall Study|Adverse Event|1|||
164075062|NCT03118765|592640252|FG002|Overall Study|Adverse Event|1|||
164075063|NCT03118765|592640253|FG003|Overall Study|Adverse Event|1|||
164075064|NCT03118765|592640254|FG004|Overall Study|Adverse Event|1|||
164075065|NCT03118765|592640250|FG000|Overall Study|Non compliance with Study Procedures|0|||
164075066|NCT03118765|592640251|FG001|Overall Study|Non compliance with Study Procedures|0|||
164075067|NCT03118765|592640252|FG002|Overall Study|Non compliance with Study Procedures|0|||
164075068|NCT03118765|592640253|FG003|Overall Study|Non compliance with Study Procedures|1|||
164075069|NCT03118765|592640254|FG004|Overall Study|Non compliance with Study Procedures|0|||
164075070|NCT03118765|592640250|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
164075071|NCT03118765|592640251|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
164075072|NCT03118765|592640252|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
164075073|NCT03118765|592640253|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
164075074|NCT03118765|592640254|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
164075075|NCT03118765|592640250|FG000|Overall Study|COPD Exacerbation|1|||
164075076|NCT03118765|592640251|FG001|Overall Study|COPD Exacerbation|0|||
164075077|NCT03118765|592640252|FG002|Overall Study|COPD Exacerbation|0|||
164075078|NCT03118765|592640253|FG003|Overall Study|COPD Exacerbation|1|||
164075079|NCT03118765|592640254|FG004|Overall Study|COPD Exacerbation|0|||
164075080|NCT03118765|592640250|FG000|Overall Study|Lost to Follow-up|1|||
164075081|NCT03118765|592640251|FG001|Overall Study|Lost to Follow-up|0|||
164075082|NCT03118765|592640252|FG002|Overall Study|Lost to Follow-up|1|||
164075083|NCT03118765|592640253|FG003|Overall Study|Lost to Follow-up|0|||
164075084|NCT03118765|592640254|FG004|Overall Study|Lost to Follow-up|0|||
164075085|NCT03118765|592640250|FG000|Overall Study|Sponsor Decision|1|||
164075086|NCT03118765|592640251|FG001|Overall Study|Sponsor Decision|0|||
164075087|NCT03118765|592640252|FG002|Overall Study|Sponsor Decision|1|||
164075088|NCT03118765|592640253|FG003|Overall Study|Sponsor Decision|0|||
164075089|NCT03118765|592640254|FG004|Overall Study|Sponsor Decision|1|||
164075090|NCT02643966|592640255|FG000|First Screening Round|ineligible|1|||
164075091|NCT02643966|592640255|FG000|First Screening Round|excluded from analysis|2|||
164075092|NCT02643966|592640255|FG000|First Screening Round|Lost to Follow-up|56|||
164075093|NCT02643966|592640255|FG000|First Screening Round|Withdrawal by Subject|28|||
164075094|NCT02643966|592640255|FG000|First Screening Round|Death|1|||
164075095|NCT02643966|592640255|FG000|Between First and Second Screening|Lost to Follow-up|65|||
164075096|NCT02643966|592640255|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
164075097|NCT02643966|592640255|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
164075098|NCT02643966|592640255|FG000|Second Screening Round|Withdrawal by Subject|20|||
164075099|NCT02643966|592640255|FG000|Second Screening Round|Lost to Follow-up|57|||
164189126|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
164189127|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
164189128|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
164189129|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
164189130|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
164189131|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
164189132|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
164189133|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
164189134|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
164189135|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
164189136|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
164189137|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
164189138|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
164189139|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
164189140|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
164189141|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
164075100|NCT02643966|592640255|FG000|Second Screening Round|Physician Decision|2|||
164189142|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
164189143|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
164189144|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
164189145|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
164075101|NCT02643966|592640255|FG000|Second Screening Round|Death|4|||
164075102|NCT02643966|592640255|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
164075103|NCT02643966|592640255|FG000|Between Second and Third Screening|Death|1|||
164075104|NCT02643966|592640255|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
164189146|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
164189147|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
164189148|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
164189149|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
164189150|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
164189151|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
164189152|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
164189153|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
164189154|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
164189155|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
164189156|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
164189157|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
164075105|NCT02643966|592640255|FG000|Third Screening Round|PI excluded|2|||
164075106|NCT02643966|592640255|FG000|Third Screening Round|Lost to Follow-up|241|||
164075107|NCT01493531|592640256|FG000|Overall Study|Adverse Event|4|||
164075108|NCT01493531|592640257|FG001|Overall Study|Adverse Event|12|||
164075109|NCT01493531|592640258|FG002|Overall Study|Adverse Event|9|||
164075110|NCT01493531|592640256|FG000|Overall Study|Gout flare|3|||
164075111|NCT01493531|592640257|FG001|Overall Study|Gout flare|0|||
164075112|NCT01493531|592640258|FG002|Overall Study|Gout flare|2|||
164075113|NCT01493531|592640256|FG000|Overall Study|Protocol Violation|8|||
164075114|NCT01493531|592640257|FG001|Overall Study|Protocol Violation|15|||
164075115|NCT01493531|592640258|FG002|Overall Study|Protocol Violation|12|||
164075116|NCT01493531|592640256|FG000|Overall Study|Sponsor terminated study|5|||
164075117|NCT01493531|592640257|FG001|Overall Study|Sponsor terminated study|2|||
164075118|NCT01493531|592640258|FG002|Overall Study|Sponsor terminated study|3|||
164075119|NCT01493531|592640256|FG000|Overall Study|Lost to Follow-up|5|||
164075120|NCT01493531|592640257|FG001|Overall Study|Lost to Follow-up|7|||
164075121|NCT01493531|592640258|FG002|Overall Study|Lost to Follow-up|11|||
164075122|NCT01493531|592640256|FG000|Overall Study|Withdrawal by Subject|16|||
164075123|NCT01493531|592640257|FG001|Overall Study|Withdrawal by Subject|13|||
164075124|NCT01493531|592640258|FG002|Overall Study|Withdrawal by Subject|11|||
164075125|NCT01493531|592640256|FG000|Overall Study|Death|0|||
164075126|NCT01493531|592640257|FG001|Overall Study|Death|1|||
164075127|NCT01493531|592640258|FG002|Overall Study|Death|0|||
164075128|NCT03835975|592640263|FG000|Overall Study|Lost to Follow-up|1|||
164075129|NCT03835975|592640264|FG001|Overall Study|Lost to Follow-up|1|||
164075130|NCT03835975|592640265|FG002|Overall Study|Lost to Follow-up|0|||
164075131|NCT03835975|592640266|FG003|Overall Study|Lost to Follow-up|0|||
164075132|NCT03835975|592640267|FG004|Overall Study|Lost to Follow-up|0|||
164075133|NCT03835975|592640263|FG000|Overall Study|No longer met eligibility criteria|0|||
164075134|NCT03835975|592640264|FG001|Overall Study|No longer met eligibility criteria|1|||
164075135|NCT03835975|592640265|FG002|Overall Study|No longer met eligibility criteria|0|||
164075136|NCT03835975|592640266|FG003|Overall Study|No longer met eligibility criteria|0|||
164075137|NCT03835975|592640267|FG004|Overall Study|No longer met eligibility criteria|0|||
164075138|NCT03835975|592640263|FG000|Overall Study|Protocol Violation|1|||
164075139|NCT03835975|592640264|FG001|Overall Study|Protocol Violation|1|||
164075140|NCT03835975|592640265|FG002|Overall Study|Protocol Violation|2|||
164075141|NCT03835975|592640266|FG003|Overall Study|Protocol Violation|0|||
164075142|NCT03835975|592640267|FG004|Overall Study|Protocol Violation|0|||
164075143|NCT03835975|592640263|FG000|Overall Study|Withdrawal by Subject|1|||
164075144|NCT03835975|592640264|FG001|Overall Study|Withdrawal by Subject|0|||
164075145|NCT03835975|592640265|FG002|Overall Study|Withdrawal by Subject|1|||
164075146|NCT03835975|592640266|FG003|Overall Study|Withdrawal by Subject|1|||
164075147|NCT03835975|592640267|FG004|Overall Study|Withdrawal by Subject|0|||
164075148|NCT01612702|592640268|FG000|Overall Study|Protocol Violation|11|||
164075149|NCT01612702|592640269|FG001|Overall Study|Protocol Violation|11|||
164075150|NCT03070431|592640270|FG000|Overall Study|Withdrawal by Subject|2|||
164075151|NCT03070431|592640270|FG000|Overall Study|Lost to Follow-up|2|||
164075152|NCT00370396|592640273|FG000|Overall Study|Withdrawal by Subject|0|||
164075153|NCT00370396|592640274|FG001|Overall Study|Withdrawal by Subject|0|||
164189158|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
164189159|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
164189160|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
164189161|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
164189162|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
164189163|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
164189164|NCT01990768|593060442|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
164189165|NCT01990768|593060443|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
164189166|NCT01990768|593060444|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
164189167|NCT01990768|593060442|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
164189168|NCT01990768|593060443|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
164075154|NCT00370396|592640275|FG002|Overall Study|Withdrawal by Subject|1|||
164075155|NCT00370396|592640273|FG000|Overall Study|Lost to Follow-up|11|||
164075156|NCT00370396|592640274|FG001|Overall Study|Lost to Follow-up|1|||
164075157|NCT00370396|592640275|FG002|Overall Study|Lost to Follow-up|0|||
164075158|NCT00051636|592640279|FG000|Period 1 - Core|Adverse Event|2|||
164075159|NCT00051636|592640280|FG001|Period 1 - Core|Adverse Event|2|||
164075160|NCT00051636|592640279|FG000|Period 1 - Core|Protocol Violation|1|||
164075161|NCT00051636|592640280|FG001|Period 1 - Core|Protocol Violation|0|||
164075162|NCT00051636|592640279|FG000|Period 1 - Core|Withdrawal by Subject|1|||
164075163|NCT00051636|592640280|FG001|Period 1 - Core|Withdrawal by Subject|2|||
164075164|NCT00051636|592640279|FG000|Period 1 - Core|Lost to Follow-up|0|||
164075165|NCT00051636|592640280|FG001|Period 1 - Core|Lost to Follow-up|2|||
164075166|NCT00051636|592640279|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
164075167|NCT00051636|592640280|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
164075168|NCT00051636|592640279|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
164075169|NCT00051636|592640280|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
164075170|NCT00051636|592640279|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
164075171|NCT00051636|592640280|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
164075172|NCT00051636|592640279|FG000|Period 2- Extended Observation Period|Death|4|||
164075173|NCT00051636|592640280|FG001|Period 2- Extended Observation Period|Death|5|||
164075174|NCT00051636|592640279|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
164075175|NCT00051636|592640280|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
164075176|NCT02340078|592640281|FG000|Overall Study|Protocol Violation|1|||
164075177|NCT00944125|592640284|FG000|3 to 6 Months|Withdrawal by Subject|0|||
164075178|NCT00944125|592640285|FG001|3 to 6 Months|Withdrawal by Subject|2|||
164075179|NCT00944125|592640284|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
164075180|NCT00944125|592640285|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
164075181|NCT02176642|592640286|FG000|Overall Study|Withdrawal by Subject|0|||
164075182|NCT02176642|592640287|FG001|Overall Study|Withdrawal by Subject|1|||
164075183|NCT03471182|592641779|FG000|Overall Study|Withdrawal by Subject|1|||
164075184|NCT03471182|592641780|FG001|Overall Study|Withdrawal by Subject|1|||
164075185|NCT03471182|592641781|FG002|Overall Study|Withdrawal by Subject|0|||
164075186|NCT03471182|592641779|FG000|Overall Study|Technical failure|2|||
164075187|NCT03471182|592641780|FG001|Overall Study|Technical failure|0|||
164075188|NCT03471182|592641781|FG002|Overall Study|Technical failure|0|||
164075189|NCT03451331|592641785|FG000|Overall Study|Withdrawal by Subject|1|||
164075190|NCT03451331|592641786|FG001|Overall Study|Withdrawal by Subject|0|||
164075191|NCT03451331|592641785|FG000|Overall Study|Unable to start treatment.|1|||
164075192|NCT03451331|592641786|FG001|Overall Study|Unable to start treatment.|1|||
164075193|NCT00289731|592641787|FG000|Overall Study|Adverse Event|1|||
164075194|NCT00289731|592641788|FG001|Overall Study|Adverse Event|2|||
164075195|NCT00289731|592641789|FG002|Overall Study|Adverse Event|2|||
164075196|NCT00289731|592641787|FG000|Overall Study|Other|1|||
164075197|NCT00289731|592641788|FG001|Overall Study|Other|0|||
164075198|NCT00289731|592641789|FG002|Overall Study|Other|0|||
164075199|NCT01170364|592641792|FG000|Overall Study|Protocol Violation|4|||
164075200|NCT01170364|592641793|FG001|Overall Study|Protocol Violation|1|||
164075201|NCT00368537|592641795|FG000|Randomization|No study drug dosed|13|||
164075202|NCT00368537|592641796|FG001|Randomization|No study drug dosed|6|||
164075203|NCT00368537|592641795|FG000|Baseline Participants|Lost to Follow-up|16|||
164075204|NCT00368537|592641796|FG001|Baseline Participants|Lost to Follow-up|17|||
164075205|NCT00368537|592641795|FG000|Baseline Participants|Withdrawal by Subject|6|||
164189169|NCT01990768|593060444|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
164189170|NCT01990768|593060442|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
164075206|NCT00368537|592641796|FG001|Baseline Participants|Withdrawal by Subject|4|||
164075207|NCT00368537|592641795|FG000|Baseline Participants|Death|1|||
164075208|NCT00368537|592641796|FG001|Baseline Participants|Death|2|||
164075209|NCT00368537|592641795|FG000|Baseline Participants|No susceptibility|1|||
164075210|NCT00368537|592641796|FG001|Baseline Participants|No susceptibility|0|||
164075211|NCT00368537|592641795|FG000|Baseline Participants|Patient uncompliant|0|||
164075212|NCT00368537|592641796|FG001|Baseline Participants|Patient uncompliant|1|||
164075213|NCT01368276|592641808|FG000|Overall Study|Death|1|||
164075214|NCT01368276|592641809|FG001|Overall Study|Death|10|||
164075215|NCT01427920|592641810|FG000|Overall Study|Adverse Event|1|||
164075216|NCT01427920|592641811|FG001|Overall Study|Adverse Event|2|||
164075217|NCT01427920|592641810|FG000|Overall Study|Lack of Efficacy|1|||
164075218|NCT01427920|592641811|FG001|Overall Study|Lack of Efficacy|0|||
164075219|NCT01427920|592641810|FG000|Overall Study|Protocol Violation|1|||
164075220|NCT01427920|592641811|FG001|Overall Study|Protocol Violation|3|||
164075221|NCT01427920|592641810|FG000|Overall Study|Withdrawal Criteria|4|||
164075222|NCT01427920|592641811|FG001|Overall Study|Withdrawal Criteria|4|||
164075223|NCT01427920|592641810|FG000|Overall Study|Unclassified|2|||
164075224|NCT01427920|592641811|FG001|Overall Study|Unclassified|8|||
164075225|NCT03341273|592641812|FG000|Overall Study|Lost to Follow-up|7|||
164075226|NCT03341273|592641813|FG001|Overall Study|Lost to Follow-up|7|||
164075227|NCT03341273|592641812|FG000|Overall Study|Withdrawal by Subject|4|||
164075228|NCT03341273|592641813|FG001|Overall Study|Withdrawal by Subject|2|||
164075229|NCT03341273|592641812|FG000|Overall Study|Physician Decision|1|||
164075230|NCT03341273|592641813|FG001|Overall Study|Physician Decision|0|||
164075231|NCT03341273|592641812|FG000|Overall Study|Protocol Violation|0|||
164075232|NCT03341273|592641813|FG001|Overall Study|Protocol Violation|1|||
164075233|NCT03341273|592641812|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
164075234|NCT03341273|592641813|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
164075235|NCT03341273|592641812|FG000|Overall Study|Became ineligible after enrollment|1|||
164075236|NCT03341273|592641813|FG001|Overall Study|Became ineligible after enrollment|0|||
164075237|NCT03341273|592641812|FG000|Overall Study|Not Eligible at Enrollment|0|||
164075238|NCT03341273|592641813|FG001|Overall Study|Not Eligible at Enrollment|1|||
164075239|NCT03341273|592641812|FG000|Overall Study|Participant incarcerated|1|||
164189171|NCT01990768|593060443|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
164189172|NCT01990768|593060444|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
164075240|NCT03341273|592641813|FG001|Overall Study|Participant incarcerated|0|||
164075241|NCT01717456|592641816|FG000|End of Treatment|Physician Decision|0|||
164075242|NCT01717456|592641817|FG001|End of Treatment|Physician Decision|1|||
164075243|NCT01717456|592641816|FG000|End of Treatment|Lost to Follow-up|0|||
164075244|NCT01717456|592641817|FG001|End of Treatment|Lost to Follow-up|1|||
164189173|NCT01990768|593060442|FG000|6-Month Follow-up|No contact information|5|||
164189174|NCT01990768|593060443|FG001|6-Month Follow-up|No contact information|6|||
164189175|NCT01990768|593060444|FG002|6-Month Follow-up|No contact information|5|||
164189176|NCT01990768|593060442|FG000|6-Month Follow-up|Homeless|4|||
164189177|NCT01990768|593060443|FG001|6-Month Follow-up|Homeless|3|||
164189178|NCT01990768|593060444|FG002|6-Month Follow-up|Homeless|6|||
164189179|NCT01990768|593060442|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
164189180|NCT01990768|593060443|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
164075245|NCT01717456|592641816|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
164075246|NCT01717456|592641817|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
164075247|NCT03066440|592641824|FG000|Overall Study|Physician Decision|1|||
164075248|NCT03066440|592641825|FG001|Overall Study|Physician Decision|1|||
164075249|NCT03066440|592641824|FG000|Overall Study|Protocol Violation|0|||
164075250|NCT03066440|592641825|FG001|Overall Study|Protocol Violation|2|||
164075251|NCT00736333|592641826|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
164075252|NCT00736333|592641826|FG000|Overall Study|Data Missing|2|||
164075253|NCT00736333|592641826|FG000|Overall Study|Tumor Progression|75|||
164075254|NCT00736333|592641826|FG000|Overall Study|Toxicity|6|||
164075255|NCT00736333|592641826|FG000|Overall Study|Withdrawal by Subject|10|||
164075256|NCT00736333|592641826|FG000|Overall Study|Death|7|||
164075257|NCT00736333|592641826|FG000|Overall Study|Other|4|||
164075258|NCT04991311|592641828|FG000|Overall Study|Adverse Event|1|||
164075259|NCT00054275|592641830|FG000|Overall Study|Withdrawal by Subject|4|||
164075260|NCT00054275|592641830|FG000|Overall Study|Adverse Event|5|||
164075261|NCT00054275|592641830|FG000|Overall Study|Progressive disease in cycle 1|1|||
164075262|NCT00054275|592641830|FG000|Overall Study|Physician Decision|1|||
164189181|NCT01990768|593060444|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
164189182|NCT01990768|593060442|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
164189183|NCT01990768|593060443|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
164189184|NCT01990768|593060444|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
164189185|NCT01990768|593060442|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
164189186|NCT01990768|593060443|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
164189187|NCT01990768|593060444|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
164189188|NCT02348008|593060445|FG000|Overall Study|Adverse Event|2|||
164189189|NCT02348008|593060446|FG001|Overall Study|Adverse Event|3|||
164189190|NCT02348008|593060447|FG002|Overall Study|Adverse Event|3|||
164189191|NCT02348008|593060445|FG000|Overall Study|Disease Progression|1|||
164075263|NCT01106352|592641831|FG000|Overall Study|Subjects untreated|0|||
164075264|NCT01106352|592641832|FG001|Overall Study|Subjects untreated|0|||
164075265|NCT01106352|592641833|FG002|Overall Study|Subjects untreated|0|||
164075266|NCT01106352|592641834|FG003|Overall Study|Subjects untreated|3|||
164075267|NCT01106352|592641835|FG004|Overall Study|Subjects untreated|4|||
164075268|NCT01106352|592641831|FG000|Overall Study|Sponsor Decision|1|||
164075269|NCT01106352|592641832|FG001|Overall Study|Sponsor Decision|0|||
164075270|NCT01106352|592641833|FG002|Overall Study|Sponsor Decision|0|||
164075271|NCT01106352|592641834|FG003|Overall Study|Sponsor Decision|0|||
164075272|NCT01106352|592641835|FG004|Overall Study|Sponsor Decision|0|||
164075273|NCT01106352|592641831|FG000|Overall Study|Too ill to come in for the visit|0|||
164075274|NCT01106352|592641832|FG001|Overall Study|Too ill to come in for the visit|0|||
164075275|NCT01106352|592641833|FG002|Overall Study|Too ill to come in for the visit|1|||
164075276|NCT01106352|592641834|FG003|Overall Study|Too ill to come in for the visit|0|||
164075277|NCT01106352|592641835|FG004|Overall Study|Too ill to come in for the visit|0|||
164075278|NCT01106352|592641831|FG000|Overall Study|Lost to Follow-up|0|||
164075279|NCT01106352|592641832|FG001|Overall Study|Lost to Follow-up|0|||
164075280|NCT01106352|592641833|FG002|Overall Study|Lost to Follow-up|0|||
164189192|NCT02348008|593060446|FG001|Overall Study|Disease Progression|5|||
164075281|NCT01106352|592641834|FG003|Overall Study|Lost to Follow-up|0|||
164075282|NCT01106352|592641835|FG004|Overall Study|Lost to Follow-up|1|||
164075283|NCT01106352|592641831|FG000|Overall Study|Death|0|||
164075284|NCT01106352|592641832|FG001|Overall Study|Death|0|||
164075285|NCT01106352|592641833|FG002|Overall Study|Death|1|||
164075286|NCT01106352|592641834|FG003|Overall Study|Death|3|||
164075287|NCT01106352|592641835|FG004|Overall Study|Death|1|||
164075288|NCT01106352|592641831|FG000|Overall Study|Disease progression|0|||
164075289|NCT01106352|592641832|FG001|Overall Study|Disease progression|0|||
164075290|NCT01106352|592641833|FG002|Overall Study|Disease progression|0|||
164075291|NCT01106352|592641834|FG003|Overall Study|Disease progression|1|||
164075292|NCT01106352|592641835|FG004|Overall Study|Disease progression|0|||
164075293|NCT01106352|592641831|FG000|Overall Study|Withdrawal by Subject|0|||
164075294|NCT01106352|592641832|FG001|Overall Study|Withdrawal by Subject|0|||
164075295|NCT01106352|592641833|FG002|Overall Study|Withdrawal by Subject|0|||
164075296|NCT01106352|592641834|FG003|Overall Study|Withdrawal by Subject|3|||
164075297|NCT01106352|592641835|FG004|Overall Study|Withdrawal by Subject|2|||
164075298|NCT01106352|592641831|FG000|Overall Study|Went on hospice|0|||
164075299|NCT01106352|592641832|FG001|Overall Study|Went on hospice|0|||
164075300|NCT01106352|592641833|FG002|Overall Study|Went on hospice|0|||
164075301|NCT01106352|592641834|FG003|Overall Study|Went on hospice|1|||
164075302|NCT01106352|592641835|FG004|Overall Study|Went on hospice|0|||
164075303|NCT01106352|592641831|FG000|Overall Study|Subject entered hospice|0|||
164075304|NCT01106352|592641832|FG001|Overall Study|Subject entered hospice|0|||
164075305|NCT01106352|592641833|FG002|Overall Study|Subject entered hospice|0|||
164075306|NCT01106352|592641834|FG003|Overall Study|Subject entered hospice|1|||
164075307|NCT01106352|592641835|FG004|Overall Study|Subject entered hospice|0|||
164075308|NCT01106352|592641831|FG000|Overall Study|Home hospice since July 2013|0|||
164075309|NCT01106352|592641832|FG001|Overall Study|Home hospice since July 2013|0|||
164075310|NCT01106352|592641833|FG002|Overall Study|Home hospice since July 2013|0|||
164075311|NCT01106352|592641834|FG003|Overall Study|Home hospice since July 2013|1|||
164075312|NCT01106352|592641835|FG004|Overall Study|Home hospice since July 2013|0|||
164075313|NCT03944707|592641836|FG000|Overall Study|Adverse Event|0|||
164075314|NCT03944707|592641837|FG001|Overall Study|Adverse Event|2|||
164075315|NCT03944707|592641836|FG000|Overall Study|Study terminated by sponsor|12|||
164075316|NCT03944707|592641837|FG001|Overall Study|Study terminated by sponsor|7|||
164075317|NCT03944707|592641836|FG000|Overall Study|Subject decision|0|||
164075318|NCT03944707|592641837|FG001|Overall Study|Subject decision|1|||
164075319|NCT02444182|592641839|FG000|Overall Study|non-compliance|2|||
164075320|NCT02444182|592641840|FG001|Overall Study|non-compliance|1|||
164075321|NCT02444182|592641839|FG000|Overall Study|Lost to Follow-up|0|||
164075322|NCT02444182|592641840|FG001|Overall Study|Lost to Follow-up|4|||
164075323|NCT01959230|592641841|FG000|Overall Study|Failure to follow study procedures|0|||
164075324|NCT01959230|592641842|FG001|Overall Study|Failure to follow study procedures|1|||
164075325|NCT01959230|592641841|FG000|Overall Study|Administrative reasons|2|||
164075326|NCT01959230|592641842|FG001|Overall Study|Administrative reasons|0|||
164075327|NCT01959230|592641841|FG000|Overall Study|Withdrawal by Subject|2|||
164075328|NCT01959230|592641842|FG001|Overall Study|Withdrawal by Subject|0|||
164075329|NCT01453374|592641843|FG000|Overall Study|Adverse Event|7|||
164075330|NCT01453374|592641843|FG000|Overall Study|Lack of Efficacy|1|||
164075331|NCT01453374|592641843|FG000|Overall Study|Lost to Follow-up|3|||
164075332|NCT01453374|592641843|FG000|Overall Study|Withdrawal by Subject|5|||
164075333|NCT01453374|592641843|FG000|Overall Study|Incarcerated|2|||
164075334|NCT00751998|592641844|FG000|Overall Study|Lost to Follow-up|7|||
164075335|NCT00751998|592641844|FG000|Overall Study|Death|11|||
164075336|NCT00751998|592641844|FG000|Overall Study|Withdrawal by Subject|2|||
164075337|NCT00996918|592641848|FG000|Overall Study|Lack of Efficacy|1|||
164075338|NCT00996918|592641849|FG001|Overall Study|Lack of Efficacy|1|||
164075339|NCT00996918|592641850|FG002|Overall Study|Lack of Efficacy|2|||
164075340|NCT00996918|592641851|FG003|Overall Study|Lack of Efficacy|2|||
164075341|NCT00996918|592641852|FG004|Overall Study|Lack of Efficacy|0|||
163844567|NCT02771210|591800070|FG001|Period 1|Adverse Event|3|||
164075342|NCT00996918|592641848|FG000|Overall Study|Adverse Event|2|||
164075343|NCT00996918|592641849|FG001|Overall Study|Adverse Event|5|||
164075344|NCT00996918|592641850|FG002|Overall Study|Adverse Event|2|||
164075345|NCT00996918|592641851|FG003|Overall Study|Adverse Event|6|||
164075346|NCT00996918|592641852|FG004|Overall Study|Adverse Event|0|||
164075347|NCT00996918|592641848|FG000|Overall Study|Withdrawal by Subject|1|||
164075348|NCT00996918|592641849|FG001|Overall Study|Withdrawal by Subject|4|||
164075349|NCT00996918|592641850|FG002|Overall Study|Withdrawal by Subject|3|||
164075350|NCT00996918|592641851|FG003|Overall Study|Withdrawal by Subject|3|||
164075351|NCT00996918|592641852|FG004|Overall Study|Withdrawal by Subject|2|||
164075352|NCT00996918|592641848|FG000|Overall Study|Physician Decision|1|||
164075353|NCT00996918|592641849|FG001|Overall Study|Physician Decision|0|||
164075354|NCT00996918|592641850|FG002|Overall Study|Physician Decision|0|||
164075355|NCT00996918|592641851|FG003|Overall Study|Physician Decision|0|||
164075356|NCT00996918|592641852|FG004|Overall Study|Physician Decision|0|||
164075357|NCT00996918|592641848|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
164075358|NCT00996918|592641849|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
164075359|NCT00996918|592641850|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
164075360|NCT00996918|592641851|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
164075361|NCT00996918|592641852|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
164075362|NCT00996918|592641848|FG000|Overall Study|Loss of Caregiver|0|||
164075363|NCT00996918|592641849|FG001|Overall Study|Loss of Caregiver|1|||
164075364|NCT00996918|592641850|FG002|Overall Study|Loss of Caregiver|0|||
164075365|NCT00996918|592641851|FG003|Overall Study|Loss of Caregiver|0|||
164075366|NCT00996918|592641852|FG004|Overall Study|Loss of Caregiver|0|||
164075367|NCT00996918|592641848|FG000|Overall Study|Other|3|||
164075368|NCT00996918|592641849|FG001|Overall Study|Other|1|||
164075369|NCT00996918|592641850|FG002|Overall Study|Other|0|||
164075370|NCT00996918|592641851|FG003|Overall Study|Other|0|||
164075371|NCT00996918|592641852|FG004|Overall Study|Other|0|||
164075372|NCT01965535|592641855|FG000|Overall Study|Lack of Efficacy|2|||
164075373|NCT01965535|592641856|FG001|Overall Study|Lack of Efficacy|1|||
164075374|NCT00829439|592641858|FG000|Overall Study|Adverse Event|0|||
164075375|NCT00829439|592641859|FG001|Overall Study|Adverse Event|0|||
164075376|NCT00829439|592641860|FG002|Overall Study|Adverse Event|1|||
164075377|NCT00829439|592641861|FG003|Overall Study|Adverse Event|0|||
164075378|NCT02525562|592641862|FG000|Overall Study|Death|9|||
164075379|NCT02525562|592641863|FG001|Overall Study|Death|0|||
164075380|NCT02525562|592641864|FG002|Overall Study|Death|0|||
164075381|NCT02525562|592641862|FG000|Overall Study|Lost to Follow-up|19|||
164189193|NCT02348008|593060447|FG002|Overall Study|Disease Progression|16|||
164075382|NCT02525562|592641863|FG001|Overall Study|Lost to Follow-up|0|||
164075383|NCT02525562|592641864|FG002|Overall Study|Lost to Follow-up|0|||
164075384|NCT02525562|592641862|FG000|Overall Study|Withdrawal by Subject|37|||
164075385|NCT02525562|592641863|FG001|Overall Study|Withdrawal by Subject|0|||
164075386|NCT02525562|592641864|FG002|Overall Study|Withdrawal by Subject|0|||
164075387|NCT02525562|592641862|FG000|Overall Study|Revision/Removal of Study Device|4|||
164075388|NCT02525562|592641863|FG001|Overall Study|Revision/Removal of Study Device|0|||
164075389|NCT02525562|592641864|FG002|Overall Study|Revision/Removal of Study Device|0|||
164075390|NCT02525562|592641862|FG000|Overall Study|Study Closed by Sponsor|154|||
164075391|NCT02525562|592641863|FG001|Overall Study|Study Closed by Sponsor|0|||
164075392|NCT02525562|592641864|FG002|Overall Study|Study Closed by Sponsor|0|||
164075393|NCT00886782|592641865|FG000|Overall Study|Disease progression|3|||
164189194|NCT02348008|593060445|FG000|Overall Study|Withdrawal by Subject|0|||
164189195|NCT02348008|593060446|FG001|Overall Study|Withdrawal by Subject|1|||
164189196|NCT02348008|593060447|FG002|Overall Study|Withdrawal by Subject|0|||
164189197|NCT02348008|593060445|FG000|Overall Study|Symptomatic Deterioration|0|||
164189198|NCT02348008|593060446|FG001|Overall Study|Symptomatic Deterioration|1|||
164189199|NCT02348008|593060447|FG002|Overall Study|Symptomatic Deterioration|0|||
164189200|NCT02029274|593060449|FG000|Overall Study|Adverse Event|1|||
164189201|NCT02029274|593060450|FG001|Overall Study|Adverse Event|0|||
164189202|NCT02029274|593060451|FG002|Overall Study|Adverse Event|2|||
164189203|NCT02029274|593060452|FG003|Overall Study|Adverse Event|2|||
164189204|NCT01249833|593060454|FG000|Overall Study|Lost to Follow-up|0|||
164189205|NCT01249833|593060455|FG001|Overall Study|Lost to Follow-up|1|||
164299660|NCT01075243|593472886|FG002|Overall Study|Withdrawal by Subject|0|||
164299661|NCT00627393|593472887|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
164299662|NCT00627393|593472888|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
164299663|NCT00627393|593472887|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
164299664|NCT00627393|593472888|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
164299665|NCT00627393|593472887|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
164299666|NCT00627393|593472888|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
164299667|NCT00627393|593472887|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
164299668|NCT00627393|593472888|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
164299669|NCT00551642|593472891|FG000|Treatment Period|Protocol Deviation|6|||
164299670|NCT00551642|593472892|FG001|Treatment Period|Protocol Deviation|11|||
164299671|NCT00551642|593472891|FG000|Treatment Period|Delivery device failure|1|||
164299672|NCT00551642|593472892|FG001|Treatment Period|Delivery device failure|3|||
164299673|NCT00551642|593472891|FG000|Treatment Period|Physician Decision|0|||
164299674|NCT00551642|593472892|FG001|Treatment Period|Physician Decision|1|||
164299675|NCT00551642|593472891|FG000|Treatment Period|Death|33|||
164299676|NCT00551642|593472892|FG001|Treatment Period|Death|31|||
164299677|NCT00551642|593472891|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
164299678|NCT00551642|593472892|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
164299679|NCT00551642|593472891|FG000|Treatment Period|Adverse Event|15|||
164075394|NCT00886782|592641866|FG001|Overall Study|Disease progression|3|||
164075395|NCT00886782|592641867|FG002|Overall Study|Disease progression|3|||
164299680|NCT00551642|593472892|FG001|Treatment Period|Adverse Event|12|||
164189206|NCT00669318|593062042|FG000|Overall Study|Withdrawal by Subject|2|||
164189207|NCT02315664|593062043|FG000|Overall Study|Lost to Follow-up|1|||
164189208|NCT02315664|593062044|FG001|Overall Study|Lost to Follow-up|1|||
164189209|NCT02315664|593062043|FG000|Overall Study|Withdrawal by Subject|0|||
164189210|NCT02315664|593062044|FG001|Overall Study|Withdrawal by Subject|3|||
164189211|NCT01677182|593062045|FG000|Overall Study|Adverse Event|2|||
164189212|NCT01677182|593062046|FG001|Overall Study|Adverse Event|1|||
164189213|NCT01677182|593062047|FG002|Overall Study|Adverse Event|8|||
164189214|NCT01677182|593062045|FG000|Overall Study|Protocol Violation|5|||
164189215|NCT01677182|593062046|FG001|Overall Study|Protocol Violation|1|||
164189216|NCT01677182|593062047|FG002|Overall Study|Protocol Violation|4|||
164189217|NCT01677182|593062045|FG000|Overall Study|Lost to Follow-up|4|||
164189218|NCT01677182|593062046|FG001|Overall Study|Lost to Follow-up|0|||
164189219|NCT01677182|593062047|FG002|Overall Study|Lost to Follow-up|3|||
164189220|NCT01677182|593062045|FG000|Overall Study|Withdrawal by Subject|7|||
164189221|NCT01677182|593062046|FG001|Overall Study|Withdrawal by Subject|12|||
164189222|NCT01677182|593062047|FG002|Overall Study|Withdrawal by Subject|10|||
164189223|NCT01677182|593062045|FG000|Overall Study|Study termination|12|||
164189224|NCT01677182|593062046|FG001|Overall Study|Study termination|9|||
164189225|NCT01677182|593062047|FG002|Overall Study|Study termination|11|||
164189226|NCT01677182|593062045|FG000|Overall Study|Lack of Efficacy|3|||
164189227|NCT01677182|593062046|FG001|Overall Study|Lack of Efficacy|0|||
164189228|NCT01677182|593062047|FG002|Overall Study|Lack of Efficacy|1|||
164189229|NCT01677182|593062045|FG000|Overall Study|Other reasons|1|||
164189230|NCT01677182|593062046|FG001|Overall Study|Other reasons|5|||
164189231|NCT01677182|593062047|FG002|Overall Study|Other reasons|2|||
164189232|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
164189233|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
164189234|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
164189235|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
164189236|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
164189237|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
164189238|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
164189239|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
164189240|NCT00667992|593062050|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
164189241|NCT00667992|593062051|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
164189242|NCT00667992|593062050|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
164189243|NCT00667992|593062051|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
164189244|NCT00667992|593062050|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
164189245|NCT00667992|593062051|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
164189246|NCT00667992|593062050|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
164189247|NCT00667992|593062051|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
164189248|NCT00667992|593062050|FG000|Wash-out|Not within one doubling dilution|4|||
164189249|NCT00667992|593062051|FG001|Wash-out|Not within one doubling dilution|3|||
164189250|NCT00667992|593062050|FG000|Wash-out|Failure to wash-out|2|||
164189251|NCT00667992|593062051|FG001|Wash-out|Failure to wash-out|2|||
164189252|NCT00667992|593062050|FG000|Wash-out|Withdrawal by Subject|1|||
164189253|NCT00667992|593062051|FG001|Wash-out|Withdrawal by Subject|0|||
164189254|NCT00667992|593062050|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
164189255|NCT00667992|593062051|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
164189256|NCT00667992|593062050|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
164189257|NCT00667992|593062051|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
164189258|NCT02748057|593062055|FG000|Overall Study|Adverse Event|1|||
164189259|NCT02748057|593062056|FG001|Overall Study|Adverse Event|0|||
164075396|NCT00886782|592641865|FG000|Overall Study|Study drug toxicity|0|||
164075397|NCT00886782|592641866|FG001|Overall Study|Study drug toxicity|0|||
164075398|NCT00886782|592641867|FG002|Overall Study|Study drug toxicity|1|||
164075399|NCT00886782|592641865|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
164075400|NCT00886782|592641866|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
164075401|NCT00886782|592641867|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
164075402|NCT01946282|592641868|FG000|Year 1|Did not return FIT kit|4186|||
164075403|NCT01946282|592641869|FG001|Year 1|Did not return FIT kit|608|||
164075404|NCT01946282|592641870|FG002|Year 1|Did not return FIT kit|654|||
164075405|NCT01946282|592641868|FG000|Year 2|Did not return FIT kit|803|||
164189260|NCT02748057|593062055|FG000|Overall Study|Physician Decision|0|||
164075406|NCT01946282|592641869|FG001|Year 2|Did not return FIT kit|131|||
164075407|NCT01946282|592641870|FG002|Year 2|Did not return FIT kit|115|||
164189261|NCT02748057|593062056|FG001|Overall Study|Physician Decision|1|||
164189262|NCT02748057|593062055|FG000|Overall Study|Protocol Violation|2|||
164189263|NCT02748057|593062056|FG001|Overall Study|Protocol Violation|1|||
164189264|NCT02748057|593062055|FG000|Overall Study|Participant Moved|1|||
164189265|NCT02748057|593062056|FG001|Overall Study|Participant Moved|0|||
164189266|NCT02748057|593062055|FG000|Overall Study|Withdrawal by Subject|1|||
164075408|NCT01946282|592641868|FG000|Year 3|Did not return FIT kit|288|||
164075409|NCT01946282|592641869|FG001|Year 3|Did not return FIT kit|43|||
164075410|NCT01946282|592641870|FG002|Year 3|Did not return FIT kit|30|||
164075411|NCT03031431|592641871|FG000|Overall Study|Infant removed by maternal request|1|||
164189267|NCT02748057|593062056|FG001|Overall Study|Withdrawal by Subject|0|||
164189268|NCT03512353|593062058|FG000|Overall Study|Sponsor Decision|3|||
164189269|NCT03512353|593062058|FG000|Overall Study|Death|1|||
164189270|NCT02090283|593062059|FG000|Overall Study|Withdrawal by Subject|6|||
164189271|NCT02090283|593062060|FG001|Overall Study|Withdrawal by Subject|6|||
164189272|NCT02090283|593062061|FG002|Overall Study|Withdrawal by Subject|6|||
164189273|NCT02090283|593062059|FG000|Overall Study|Sponsor Terminated Study|6|||
164189274|NCT02090283|593062060|FG001|Overall Study|Sponsor Terminated Study|6|||
164189275|NCT02090283|593062061|FG002|Overall Study|Sponsor Terminated Study|1|||
164189276|NCT02090283|593062059|FG000|Overall Study|Lost to Follow-up|2|||
164189277|NCT02090283|593062060|FG001|Overall Study|Lost to Follow-up|2|||
164189278|NCT02090283|593062061|FG002|Overall Study|Lost to Follow-up|3|||
164189279|NCT02090283|593062059|FG000|Overall Study|Adverse Event|1|||
164189280|NCT02090283|593062060|FG001|Overall Study|Adverse Event|1|||
164189281|NCT02090283|593062061|FG002|Overall Study|Adverse Event|0|||
164189282|NCT02090283|593062059|FG000|Overall Study|Protocol Violation|2|||
164303959|NCT02113982|593488368|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
164303960|NCT02113982|593488369|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
164303961|NCT02113982|593488370|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
164303962|NCT02113982|593488371|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
164303963|NCT02113982|593488372|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
164303964|NCT02113982|593488373|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
164303965|NCT02113982|593488374|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
164303966|NCT02113982|593488375|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
164303967|NCT02113982|593488376|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
164303968|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303969|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303970|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303971|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303972|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303973|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303974|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303975|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303976|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303977|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303978|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303979|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
164303980|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303981|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
164303982|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303983|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303984|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303985|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
164075412|NCT04130919|592641872|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
164075413|NCT04130919|592641873|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
164075414|NCT04130919|592641874|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
164075415|NCT04130919|592641875|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
164075416|NCT04130919|592641876|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
164075417|NCT04130919|592641877|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
164075418|NCT04130919|592641872|FG000|Blinded Treatment Phase|Adverse Event|0|||
164075419|NCT04130919|592641873|FG001|Blinded Treatment Phase|Adverse Event|0|||
164075420|NCT04130919|592641874|FG002|Blinded Treatment Phase|Adverse Event|1|||
164075421|NCT04130919|592641875|FG003|Blinded Treatment Phase|Adverse Event|0|||
164075422|NCT04130919|592641876|FG004|Blinded Treatment Phase|Adverse Event|0|||
164075423|NCT04130919|592641877|FG005|Blinded Treatment Phase|Adverse Event|0|||
164075424|NCT04130919|592641872|FG000|Blinded Treatment Phase|Disease worsening|0|||
164075425|NCT04130919|592641873|FG001|Blinded Treatment Phase|Disease worsening|0|||
164075426|NCT04130919|592641874|FG002|Blinded Treatment Phase|Disease worsening|1|||
164075427|NCT04130919|592641875|FG003|Blinded Treatment Phase|Disease worsening|0|||
164075428|NCT04130919|592641876|FG004|Blinded Treatment Phase|Disease worsening|0|||
164189283|NCT02090283|593062060|FG001|Overall Study|Protocol Violation|0|||
164303986|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303987|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
163844568|NCT02771210|591800069|FG000|Period 1|Lack of Efficacy|3|||
164303988|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303989|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303990|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303991|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303992|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
163844569|NCT02771210|591800070|FG001|Period 1|Lack of Efficacy|6|||
164075429|NCT04130919|592641877|FG005|Blinded Treatment Phase|Disease worsening|0|||
164075430|NCT04130919|592641872|FG000|Blinded Treatment Phase|Investigator's decision|0|||
164075431|NCT04130919|592641873|FG001|Blinded Treatment Phase|Investigator's decision|1|||
164075432|NCT04130919|592641874|FG002|Blinded Treatment Phase|Investigator's decision|0|||
164075433|NCT04130919|592641875|FG003|Blinded Treatment Phase|Investigator's decision|0|||
164075434|NCT04130919|592641876|FG004|Blinded Treatment Phase|Investigator's decision|0|||
164075435|NCT04130919|592641877|FG005|Blinded Treatment Phase|Investigator's decision|0|||
164075436|NCT04130919|592641872|FG000|Blinded Treatment Phase|Withdrew consent|1|||
164075437|NCT04130919|592641873|FG001|Blinded Treatment Phase|Withdrew consent|0|||
164075438|NCT04130919|592641874|FG002|Blinded Treatment Phase|Withdrew consent|0|||
164075439|NCT04130919|592641875|FG003|Blinded Treatment Phase|Withdrew consent|0|||
164075440|NCT04130919|592641876|FG004|Blinded Treatment Phase|Withdrew consent|0|||
164075441|NCT04130919|592641877|FG005|Blinded Treatment Phase|Withdrew consent|0|||
164075442|NCT04130919|592641872|FG000|Open-label Treatment Phase|Withdrew consent|0|||
164075443|NCT04130919|592641873|FG001|Open-label Treatment Phase|Withdrew consent|0|||
164075444|NCT04130919|592641874|FG002|Open-label Treatment Phase|Withdrew consent|0|||
164303993|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
164303994|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303995|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
164303996|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164303997|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164303998|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164303999|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304000|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304001|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304002|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304003|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304004|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304005|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304006|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304007|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
164304008|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304009|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
164304010|NCT02113982|593488363|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
164304011|NCT02113982|593488364|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
164304012|NCT02113982|593488365|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
164304013|NCT02113982|593488366|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
164304014|NCT02113982|593488367|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
164304015|NCT02113982|593488368|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
164304016|NCT02113982|593488369|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
164304017|NCT02113982|593488370|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
164304018|NCT02113982|593488371|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
164304019|NCT02113982|593488372|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
164304020|NCT02113982|593488373|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
164304021|NCT02113982|593488374|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
164304022|NCT02113982|593488375|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
164304023|NCT02113982|593488376|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
164304024|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304025|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304026|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304027|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304028|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304029|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304030|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304031|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304032|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304033|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304034|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304035|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304036|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
164304037|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
164304038|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164075445|NCT04130919|592641875|FG003|Open-label Treatment Phase|Withdrew consent|1|||
164075446|NCT04130919|592641876|FG004|Open-label Treatment Phase|Withdrew consent|1|||
164304039|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304040|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163844570|NCT02771210|591800069|FG000|Period 1|Lost to Follow-up|2|||
164075447|NCT04130919|592641877|FG005|Open-label Treatment Phase|Withdrew consent|1|||
164304041|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
163844571|NCT02771210|591800070|FG001|Period 1|Lost to Follow-up|0|||
164075448|NCT04130919|592641872|FG000|Open-label Treatment Phase|Disease worsening|0|||
164075449|NCT04130919|592641873|FG001|Open-label Treatment Phase|Disease worsening|0|||
164075450|NCT04130919|592641874|FG002|Open-label Treatment Phase|Disease worsening|0|||
164075451|NCT04130919|592641875|FG003|Open-label Treatment Phase|Disease worsening|1|||
164075452|NCT04130919|592641876|FG004|Open-label Treatment Phase|Disease worsening|0|||
164075453|NCT04130919|592641877|FG005|Open-label Treatment Phase|Disease worsening|1|||
164075454|NCT04130919|592641872|FG000|Open-label Treatment Phase|Investigator's decision|0|||
164075455|NCT04130919|592641873|FG001|Open-label Treatment Phase|Investigator's decision|0|||
164075456|NCT04130919|592641874|FG002|Open-label Treatment Phase|Investigator's decision|0|||
164075457|NCT04130919|592641875|FG003|Open-label Treatment Phase|Investigator's decision|1|||
164075458|NCT04130919|592641876|FG004|Open-label Treatment Phase|Investigator's decision|0|||
164075459|NCT04130919|592641877|FG005|Open-label Treatment Phase|Investigator's decision|0|||
164075460|NCT04130919|592641872|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
164075461|NCT04130919|592641873|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
164075462|NCT04130919|592641874|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
164075463|NCT04130919|592641875|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
164075464|NCT04130919|592641876|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
164075465|NCT04130919|592641877|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
164075466|NCT04130919|592641872|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164075467|NCT04130919|592641873|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164075468|NCT04130919|592641874|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164075469|NCT04130919|592641875|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164075470|NCT04130919|592641876|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
164075471|NCT04130919|592641877|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
164075472|NCT02400905|592641879|FG000|Overall Study|Death|24|||
164189284|NCT02090283|593062061|FG002|Overall Study|Protocol Violation|0|||
164189285|NCT02171429|593062066|FG000|Overall Study|Other|0|||
164189286|NCT02171429|593062067|FG001|Overall Study|Other|1|||
164189287|NCT02171429|593062068|FG002|Overall Study|Other|1|||
164189288|NCT02171429|593062066|FG000|Overall Study|Non-Compliance|0|||
164189289|NCT02171429|593062067|FG001|Overall Study|Non-Compliance|0|||
164189290|NCT02171429|593062068|FG002|Overall Study|Non-Compliance|1|||
164189291|NCT02171429|593062066|FG000|Overall Study|Physician Decision|0|||
164189292|NCT02171429|593062067|FG001|Overall Study|Physician Decision|0|||
164189293|NCT02171429|593062068|FG002|Overall Study|Physician Decision|1|||
164189294|NCT02171429|593062066|FG000|Overall Study|Withdrawal by Subject|1|||
164189295|NCT02171429|593062067|FG001|Overall Study|Withdrawal by Subject|1|||
164189296|NCT02171429|593062068|FG002|Overall Study|Withdrawal by Subject|1|||
164189297|NCT02171429|593062066|FG000|Overall Study|Lost to Follow-up|0|||
164189298|NCT02171429|593062067|FG001|Overall Study|Lost to Follow-up|1|||
164189299|NCT02171429|593062068|FG002|Overall Study|Lost to Follow-up|0|||
164189300|NCT02171429|593062066|FG000|Overall Study|Death|0|||
164189301|NCT02171429|593062067|FG001|Overall Study|Death|0|||
164189302|NCT02171429|593062068|FG002|Overall Study|Death|1|||
164189303|NCT00281697|593062069|FG000|Overall Study|> 60 days since last dose of study drug|4|||
164189304|NCT00281697|593062070|FG001|Overall Study|> 60 days since last dose of study drug|4|||
164189305|NCT00281697|593062069|FG000|Overall Study|Adverse Event|54|||
164189306|NCT00281697|593062070|FG001|Overall Study|Adverse Event|15|||
164189307|NCT00281697|593062069|FG000|Overall Study|Death|8|||
164189308|NCT00281697|593062070|FG001|Overall Study|Death|3|||
164189309|NCT00281697|593062069|FG000|Overall Study|Disease progression|279|||
164189310|NCT00281697|593062070|FG001|Overall Study|Disease progression|149|||
164189311|NCT00281697|593062069|FG000|Overall Study|Other|5|||
164189312|NCT00281697|593062070|FG001|Overall Study|Other|6|||
164189313|NCT00281697|593062069|FG000|Overall Study|Physician's decision to withdraw|15|||
164189314|NCT00281697|593062070|FG001|Overall Study|Physician's decision to withdraw|12|||
164189315|NCT00281697|593062069|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
164189316|NCT00281697|593062070|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
164189317|NCT00281697|593062069|FG000|Overall Study|Did not receive study drug|3|||
164189318|NCT00281697|593062070|FG001|Overall Study|Did not receive study drug|2|||
164189319|NCT00632125|593062071|FG000|Overall Study|Death|82|||
164189320|NCT00632125|593062071|FG000|Overall Study|Withdrawal by Subject|44|||
164189321|NCT00632125|593062071|FG000|Overall Study|Adverse Event|36|||
164189322|NCT00632125|593062071|FG000|Overall Study|Renal transplantation|17|||
164189323|NCT00632125|593062071|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
164189324|NCT00632125|593062071|FG000|Overall Study|Non-compliance|8|||
164189325|NCT00632125|593062071|FG000|Overall Study|Development of uncontrolled hypertension|5|||
164189326|NCT00632125|593062071|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
164189327|NCT00577772|593062074|FG000|Overall Study|Lost to Follow-up|0|||
164189328|NCT00577772|593062075|FG001|Overall Study|Lost to Follow-up|1|||
164189329|NCT00540644|593062079|FG000|Overall Study|Adverse Event|3|||
164189330|NCT00540644|593062080|FG001|Overall Study|Adverse Event|1|||
164189331|NCT00540644|593062079|FG000|Overall Study|Disease Progression|3|||
164075473|NCT02400905|592641879|FG000|Overall Study|Lost to Follow-up|18|||
164075474|NCT02400905|592641879|FG000|Overall Study|Withdrawal by Subject|16|||
164075475|NCT02400905|592641879|FG000|Overall Study|Physician Decision|4|||
164075476|NCT02400905|592641879|FG000|Overall Study|Other|1|||
164075477|NCT03196791|592641882|FG000|Overall Study|Protocol Violation|7|||
164075478|NCT03196791|592641883|FG001|Overall Study|Protocol Violation|3|||
164075479|NCT03196791|592641882|FG000|Overall Study|Withdrawal by Subject|3|||
164075480|NCT03196791|592641883|FG001|Overall Study|Withdrawal by Subject|2|||
164075481|NCT01749033|592641887|FG000|Overall Study|Did not receive allocated intervention|3|||
164075482|NCT01749033|592641888|FG001|Overall Study|Did not receive allocated intervention|3|||
164075483|NCT01749033|592641889|FG002|Overall Study|Did not receive allocated intervention|0|||
164075484|NCT01749033|592641887|FG000|Overall Study|Lost to Follow-up|0|||
164075485|NCT01749033|592641888|FG001|Overall Study|Lost to Follow-up|2|||
164075486|NCT01749033|592641889|FG002|Overall Study|Lost to Follow-up|1|||
164075487|NCT01256398|592641891|FG000|Overall Study|Withdrawal by Subject|1|||
164075488|NCT00995488|592641892|FG000|Overall Study|Withdrawal by Subject|1|||
164075489|NCT01039584|592641893|FG000|Overall Study|Withdrawal by Subject|4|||
164075490|NCT01039584|592641894|FG001|Overall Study|Withdrawal by Subject|2|||
164075491|NCT01039584|592641895|FG002|Overall Study|Withdrawal by Subject|1|||
164189332|NCT00540644|593062080|FG001|Overall Study|Disease Progression|1|||
164189333|NCT00540644|593062079|FG000|Overall Study|Physician Decision|0|||
164189334|NCT00540644|593062080|FG001|Overall Study|Physician Decision|5|||
164189335|NCT00540644|593062079|FG000|Overall Study|Withdrawal by Subject|2|||
164189336|NCT00540644|593062080|FG001|Overall Study|Withdrawal by Subject|2|||
164189337|NCT00540644|593062079|FG000|Overall Study|Noncomplilance|1|||
164189338|NCT00540644|593062080|FG001|Overall Study|Noncomplilance|0|||
164189339|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
164189340|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
164189341|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
164189342|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
164189343|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
164189344|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
164189345|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
164189346|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
164189347|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
164189348|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
164189349|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
164189350|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
164189351|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
164189352|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
164189353|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Death|1|||
164189354|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Death|0|||
164189355|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
164189356|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
164189357|NCT00105989|593062081|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
164189358|NCT00105989|593062082|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
164189359|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
164189360|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
164189361|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
164189362|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
164189363|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
164189364|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
164189365|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
164189366|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
164189367|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
164189368|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
164189369|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
164189370|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
164189371|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
164189372|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
164189373|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Death|0|||
164189374|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Death|0|||
164189375|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
164189376|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
164189377|NCT00105989|593062081|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
164189378|NCT00105989|593062082|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
164189379|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
164189380|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
164189381|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
164189382|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
164189383|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
164189384|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
164189385|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
164189386|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
164189387|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
164189388|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
164189389|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
164189390|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
164189391|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
164189392|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
164189393|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
164189394|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
164189395|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
164189396|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
164189397|NCT00105989|593062081|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
164189398|NCT00105989|593062082|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
164189399|NCT01716663|593062083|FG000|Overall Study|Withdrawn prior to procedure|4|||
164189400|NCT01716663|593062083|FG000|Overall Study|Treated with non-study catheter|2|||
164189401|NCT01059773|593062084|FG000|Overall Study|Adverse Event|2|||
164189402|NCT01059773|593062085|FG001|Overall Study|Adverse Event|2|||
164189403|NCT01059773|593062084|FG000|Overall Study|Withdrawal by Subject|1|||
164189404|NCT01059773|593062085|FG001|Overall Study|Withdrawal by Subject|5|||
164189405|NCT01059773|593062084|FG000|Overall Study|Lost to Follow-up|1|||
164189406|NCT01059773|593062085|FG001|Overall Study|Lost to Follow-up|1|||
164189407|NCT01059773|593062084|FG000|Overall Study|Pregnancy|1|||
164189408|NCT01059773|593062085|FG001|Overall Study|Pregnancy|1|||
164189409|NCT01059773|593062084|FG000|Overall Study|Protocol Violation|6|||
164189410|NCT01059773|593062085|FG001|Overall Study|Protocol Violation|2|||
164189411|NCT01059773|593062084|FG000|Overall Study|Physician Decision|5|||
164189412|NCT01059773|593062085|FG001|Overall Study|Physician Decision|4|||
164189413|NCT01059773|593062084|FG000|Overall Study|Lack of Efficacy|3|||
164189414|NCT01059773|593062085|FG001|Overall Study|Lack of Efficacy|3|||
164189415|NCT01059773|593062084|FG000|Overall Study|Death|0|||
164189416|NCT01059773|593062085|FG001|Overall Study|Death|1|||
164189417|NCT01059773|593062084|FG000|Overall Study|Malignancy including squamous cell skin|0|||
164189418|NCT01059773|593062085|FG001|Overall Study|Malignancy including squamous cell skin|1|||
164189419|NCT01059773|593062084|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
164189420|NCT01059773|593062085|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
164189421|NCT01059773|593062084|FG000|Overall Study|Other|1|||
164189422|NCT01059773|593062085|FG001|Overall Study|Other|3|||
164189423|NCT01806168|593062088|FG000|Overall Study|Adverse Event|1|||
164189424|NCT01806168|593062089|FG001|Overall Study|Adverse Event|0|||
164189425|NCT01806168|593062090|FG002|Overall Study|Adverse Event|0|||
164189426|NCT01806168|593062088|FG000|Overall Study|Withdrawal by Subject|0|||
164189427|NCT01806168|593062089|FG001|Overall Study|Withdrawal by Subject|1|||
164189428|NCT01806168|593062090|FG002|Overall Study|Withdrawal by Subject|2|||
164189429|NCT01806168|593062088|FG000|Overall Study|Protocol Violation|0|||
164189430|NCT01806168|593062089|FG001|Overall Study|Protocol Violation|0|||
164189431|NCT01806168|593062090|FG002|Overall Study|Protocol Violation|1|||
164189432|NCT02620787|593062093|FG000|Overall Study|Adverse Event|1|||
164189433|NCT02620787|593062094|FG001|Overall Study|Adverse Event|0|||
164189434|NCT02620787|593062093|FG000|Overall Study|Eligibility Criteria Not Met|1|||
164189435|NCT02620787|593062094|FG001|Overall Study|Eligibility Criteria Not Met|0|||
164189436|NCT01462630|593062097|FG000|Overall Study|Did not initiate therapy|3|||
164189437|NCT01462630|593062097|FG000|Overall Study|Death|1|||
164189438|NCT01462630|593062097|FG000|Overall Study|Protocol Violation|2|||
164189439|NCT01462630|593062097|FG000|Overall Study|Adverse Event|1|||
164189440|NCT03665077|593062098|FG000|Overall Study|Lost to Follow-up|2|||
164189441|NCT03665077|593062098|FG000|Overall Study|Physician Decision|2|||
164189442|NCT02364388|593062099|FG000|Overall Study|Protocol Violation|1|||
164189443|NCT02364388|593062099|FG000|Overall Study|Technical Failure|3|||
164189444|NCT02364388|593062099|FG000|Overall Study|No OA/US data|2|||
164189445|NCT02364388|593062099|FG000|Overall Study|No Biopsy|2|||
164189446|NCT00837967|593062100|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
164189447|NCT00837967|593062101|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
164189448|NCT02504320|593062105|FG000|Treatment Period 1|Positive Drug Screen|0|||
164189449|NCT02504320|593062106|FG001|Treatment Period 1|Positive Drug Screen|0|||
164189450|NCT02504320|593062107|FG002|Treatment Period 1|Positive Drug Screen|1|||
164189451|NCT02504320|593062108|FG003|Treatment Period 1|Positive Drug Screen|0|||
164189452|NCT02504320|593062105|FG000|Treatment Period 2|Positive Drug Screen|0|||
164189453|NCT02504320|593062106|FG001|Treatment Period 2|Positive Drug Screen|1|||
164189454|NCT02504320|593062107|FG002|Treatment Period 2|Positive Drug Screen|0|||
164189455|NCT02504320|593062108|FG003|Treatment Period 2|Positive Drug Screen|0|||
164304042|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304043|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304044|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304045|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304046|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304047|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304048|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304049|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
164304050|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
164304051|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
164304052|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304053|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304054|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304055|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304056|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304057|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304058|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304059|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304060|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304061|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304062|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304063|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
164304064|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
164304065|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
164304066|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304067|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304068|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304069|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304070|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304071|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304072|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304073|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304074|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304075|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304076|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304077|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
164304078|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
164304079|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
164304080|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304081|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304082|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304083|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304084|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304085|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304086|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304087|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304088|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304089|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304090|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304091|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304092|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
164304093|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
164304094|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304095|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304096|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304097|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304098|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304099|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304100|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304101|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304102|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304103|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304104|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304105|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
163844572|NCT02771210|591800069|FG000|Period 1|Physician Decision|0|||
163844573|NCT02771210|591800070|FG001|Period 1|Physician Decision|1|||
164304106|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
164304107|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
164304108|NCT02113982|593488363|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164189456|NCT02504320|593062105|FG000|Treatment Period 3|Positive Drug Screen|0|||
164189457|NCT02504320|593062106|FG001|Treatment Period 3|Positive Drug Screen|0|||
164189458|NCT02504320|593062107|FG002|Treatment Period 3|Positive Drug Screen|0|||
164189459|NCT02504320|593062108|FG003|Treatment Period 3|Positive Drug Screen|1|||
164189460|NCT02504320|593062105|FG000|Treatment Period 3|Adverse Event|0|||
164189461|NCT02504320|593062106|FG001|Treatment Period 3|Adverse Event|0|||
164189462|NCT02504320|593062107|FG002|Treatment Period 3|Adverse Event|1|||
164189463|NCT02504320|593062108|FG003|Treatment Period 3|Adverse Event|0|||
164189464|NCT02306850|593062111|FG000|Overall Study|Lack of Efficacy|2|||
164189465|NCT02420262|593062112|FG000|Overall Study|Adverse Event|1|||
164189466|NCT02420262|593062113|FG001|Overall Study|Adverse Event|0|||
164189467|NCT02420262|593062112|FG000|Overall Study|Withdrawal by Subject|1|||
164189468|NCT02420262|593062113|FG001|Overall Study|Withdrawal by Subject|4|||
164189469|NCT02420262|593062112|FG000|Overall Study|Unclassified|0|||
164189470|NCT02420262|593062113|FG001|Overall Study|Unclassified|1|||
164189471|NCT02497404|593062114|FG000|Overall Study|Adverse Event|1|||
164189472|NCT01408901|593062115|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
164189473|NCT01408901|593062116|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
164189474|NCT01408901|593062117|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
164189475|NCT01408901|593062118|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
164189476|NCT01408901|593062115|FG000|6-Week Follow-Up|Death|1|||
164189477|NCT01408901|593062116|FG001|6-Week Follow-Up|Death|0|||
164189478|NCT01408901|593062117|FG002|6-Week Follow-Up|Death|0|||
164189479|NCT01408901|593062118|FG003|6-Week Follow-Up|Death|0|||
164189480|NCT01408901|593062115|FG000|6-Week Follow-Up|Cancelled visit|0|||
164189481|NCT01408901|593062116|FG001|6-Week Follow-Up|Cancelled visit|1|||
164189482|NCT01408901|593062117|FG002|6-Week Follow-Up|Cancelled visit|0|||
164189483|NCT01408901|593062118|FG003|6-Week Follow-Up|Cancelled visit|2|||
164189484|NCT01408901|593062115|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
164189485|NCT01408901|593062116|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
164189486|NCT01408901|593062117|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
164189487|NCT01408901|593062118|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
164189488|NCT01408901|593062115|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
164189489|NCT01408901|593062116|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
164189490|NCT01408901|593062117|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
164189491|NCT01408901|593062118|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
164189492|NCT01408901|593062115|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
164189493|NCT01408901|593062116|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
164189494|NCT01408901|593062117|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
164189495|NCT01408901|593062118|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
164189496|NCT01408901|593062115|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
164189497|NCT01408901|593062116|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
164189498|NCT01408901|593062117|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
164189499|NCT01408901|593062118|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
164189500|NCT01408901|593062115|FG000|26-Week Follow-Up|Death|0|||
164189501|NCT01408901|593062116|FG001|26-Week Follow-Up|Death|1|||
164189502|NCT01408901|593062117|FG002|26-Week Follow-Up|Death|0|||
164189503|NCT01408901|593062118|FG003|26-Week Follow-Up|Death|0|||
164189504|NCT02098395|593062121|FG000|Overall Study|Protocol Violation|2|||
164189505|NCT02098395|593062122|FG001|Overall Study|Protocol Violation|2|||
164189506|NCT02098395|593062123|FG002|Overall Study|Protocol Violation|0|||
164189507|NCT02098395|593062124|FG003|Overall Study|Protocol Violation|7|||
164189508|NCT02098395|593062121|FG000|Overall Study|Withdrawal by Subject|10|||
164189509|NCT02098395|593062122|FG001|Overall Study|Withdrawal by Subject|10|||
164189510|NCT02098395|593062123|FG002|Overall Study|Withdrawal by Subject|5|||
164189511|NCT02098395|593062124|FG003|Overall Study|Withdrawal by Subject|13|||
164189512|NCT02098395|593062121|FG000|Overall Study|Adverse Event|12|||
164189513|NCT02098395|593062122|FG001|Overall Study|Adverse Event|19|||
164189514|NCT02098395|593062123|FG002|Overall Study|Adverse Event|34|||
164189515|NCT02098395|593062124|FG003|Overall Study|Adverse Event|2|||
164189516|NCT02098395|593062121|FG000|Overall Study|Lost to Follow-up|2|||
164189517|NCT02098395|593062122|FG001|Overall Study|Lost to Follow-up|1|||
164189518|NCT02098395|593062123|FG002|Overall Study|Lost to Follow-up|0|||
164189519|NCT02098395|593062124|FG003|Overall Study|Lost to Follow-up|3|||
164189520|NCT02098395|593062121|FG000|Overall Study|Unclassified|0|||
164189521|NCT02098395|593062122|FG001|Overall Study|Unclassified|0|||
164189522|NCT02098395|593062123|FG002|Overall Study|Unclassified|3|||
164189523|NCT02098395|593062124|FG003|Overall Study|Unclassified|2|||
164189524|NCT00110357|593062130|FG000|Overall Study|Deterioration without progression|2|||
164189525|NCT00110357|593062131|FG001|Overall Study|Deterioration without progression|0|||
164189526|NCT00110357|593062130|FG000|Overall Study|Disease progression/relapse|20|||
164189527|NCT00110357|593062131|FG001|Overall Study|Disease progression/relapse|15|||
164189528|NCT00110357|593062130|FG000|Overall Study|Study Closure|1|||
164189529|NCT00110357|593062131|FG001|Overall Study|Study Closure|0|||
164189530|NCT00110357|593062130|FG000|Overall Study|Study Drug Toxicity|1|||
164189531|NCT00110357|593062131|FG001|Overall Study|Study Drug Toxicity|3|||
164189532|NCT00110357|593062130|FG000|Overall Study|Withdrawal by Subject|3|||
163844574|NCT02771210|591800069|FG000|Period 1|Withdrawal by Subject|0|||
163844575|NCT02771210|591800070|FG001|Period 1|Withdrawal by Subject|3|||
164189533|NCT00110357|593062131|FG001|Overall Study|Withdrawal by Subject|1|||
164189534|NCT05285787|593062132|FG000|Overall Study|Withdrawal by Subject|1|||
164189535|NCT04004260|593062133|FG000|Overall Study|Withdrawal by Subject|7|||
164189536|NCT04004260|593062134|FG001|Overall Study|Withdrawal by Subject|3|||
164189537|NCT04004260|593062133|FG000|Overall Study|Lost to Follow-up|22|||
164189538|NCT04004260|593062134|FG001|Overall Study|Lost to Follow-up|12|||
164189539|NCT04004260|593062133|FG000|Overall Study|Did not engage in intervention|13|||
164189540|NCT04004260|593062134|FG001|Overall Study|Did not engage in intervention|17|||
164189541|NCT02360280|593062138|FG000|Overall Study|Withdrawal by Subject|2|||
164189542|NCT02360280|593062139|FG001|Overall Study|Withdrawal by Subject|0|||
164189543|NCT02360280|593062138|FG000|Overall Study|Adverse Event|0|||
164189544|NCT02360280|593062139|FG001|Overall Study|Adverse Event|1|||
164189545|NCT02360280|593062138|FG000|Overall Study|Lost to Follow-up|1|||
164189546|NCT02360280|593062139|FG001|Overall Study|Lost to Follow-up|0|||
164189547|NCT04633226|593062141|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164189548|NCT04633226|593062141|FG000|Overall Study|Randomized by mistake without study treatment|1|||
164189549|NCT01765569|593062143|FG000|Period B|Withdrawal by Subject|1|||
164189550|NCT01765569|593062143|FG000|Period C|Death|1|||
164189551|NCT05415462|593062147|FG000|Overall Study|Death|18|||
164189552|NCT05415462|593062148|FG001|Overall Study|Death|10|||
164189553|NCT05415462|593062147|FG000|Overall Study|Lost to Follow-up|72|||
164189554|NCT05415462|593062148|FG001|Overall Study|Lost to Follow-up|64|||
164189555|NCT05415462|593062147|FG000|Overall Study|Physician Decision|5|||
164189556|NCT05415462|593062148|FG001|Overall Study|Physician Decision|5|||
164189557|NCT05415462|593062147|FG000|Overall Study|Protocol Deviation|1|||
164189558|NCT05415462|593062148|FG001|Overall Study|Protocol Deviation|0|||
164189559|NCT05415462|593062147|FG000|Overall Study|Withdrawal by Subject|129|||
164189560|NCT05415462|593062148|FG001|Overall Study|Withdrawal by Subject|101|||
164189561|NCT05415462|593062147|FG000|Overall Study|Other Than Specified|8|||
164189562|NCT05415462|593062148|FG001|Overall Study|Other Than Specified|8|||
164189563|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
164189564|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
164189565|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
164189566|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
164189567|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
164189568|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
164189569|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|Death|0|||
164189570|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|Death|1|||
164189571|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|Death|0|||
164189572|NCT01030718|593062149|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
164189573|NCT01030718|593062150|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
164189574|NCT01030718|593062151|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
164189575|NCT01030718|593062149|FG000|Study CA180-036 Only|insufficient effect|1|||
164189576|NCT01030718|593062150|FG001|Study CA180-036 Only|insufficient effect|1|||
164189577|NCT01030718|593062151|FG002|Study CA180-036 Only|insufficient effect|5|||
164189578|NCT01030718|593062149|FG000|Study CA180-036 Only|Adverse Event|2|||
164189579|NCT01030718|593062150|FG001|Study CA180-036 Only|Adverse Event|3|||
164189580|NCT01030718|593062151|FG002|Study CA180-036 Only|Adverse Event|0|||
164189581|NCT01030718|593062149|FG000|Study CA180-036 Only|Death|0|||
164189582|NCT01030718|593062150|FG001|Study CA180-036 Only|Death|1|||
164189583|NCT01030718|593062151|FG002|Study CA180-036 Only|Death|0|||
164189584|NCT01030718|593062149|FG000|Study CA180-036 Only|Other Reasons|0|||
164189585|NCT01030718|593062150|FG001|Study CA180-036 Only|Other Reasons|2|||
164189586|NCT01030718|593062151|FG002|Study CA180-036 Only|Other Reasons|0|||
164189587|NCT00423813|593062152|FG000|Overall Study|Adverse Event|11|||
164189588|NCT00423813|593062153|FG001|Overall Study|Adverse Event|30|||
164189589|NCT00423813|593062154|FG002|Overall Study|Adverse Event|40|||
164189590|NCT00423813|593062152|FG000|Overall Study|Withdrawal by Subject|6|||
164189591|NCT00423813|593062153|FG001|Overall Study|Withdrawal by Subject|8|||
164189592|NCT00423813|593062154|FG002|Overall Study|Withdrawal by Subject|5|||
164189593|NCT00423813|593062152|FG000|Overall Study|Lost to Follow-up|5|||
164189594|NCT00423813|593062153|FG001|Overall Study|Lost to Follow-up|4|||
164189595|NCT00423813|593062154|FG002|Overall Study|Lost to Follow-up|4|||
164189596|NCT00423813|593062152|FG000|Overall Study|Lack of Efficacy|23|||
164189597|NCT00423813|593062153|FG001|Overall Study|Lack of Efficacy|18|||
164189598|NCT00423813|593062154|FG002|Overall Study|Lack of Efficacy|19|||
164189599|NCT00423813|593062152|FG000|Overall Study|Physician Decision|2|||
164189600|NCT00423813|593062153|FG001|Overall Study|Physician Decision|0|||
164189601|NCT00423813|593062154|FG002|Overall Study|Physician Decision|0|||
164189602|NCT00423813|593062152|FG000|Overall Study|Sponsor Decision|0|||
164189603|NCT00423813|593062153|FG001|Overall Study|Sponsor Decision|1|||
164189604|NCT00423813|593062154|FG002|Overall Study|Sponsor Decision|0|||
164189605|NCT00423813|593062152|FG000|Overall Study|Protocol Violation|9|||
164189606|NCT00423813|593062153|FG001|Overall Study|Protocol Violation|4|||
164189607|NCT00423813|593062154|FG002|Overall Study|Protocol Violation|4|||
164189608|NCT00423813|593062152|FG000|Overall Study|Pregnancy|0|||
164189609|NCT00423813|593062153|FG001|Overall Study|Pregnancy|0|||
164189610|NCT00423813|593062154|FG002|Overall Study|Pregnancy|1|||
164189611|NCT00423813|593062152|FG000|Overall Study|Subject started night shift work|1|||
164189612|NCT00423813|593062153|FG001|Overall Study|Subject started night shift work|0|||
164189613|NCT00423813|593062154|FG002|Overall Study|Subject started night shift work|0|||
164189614|NCT00423813|593062152|FG000|Overall Study|Will start exclusionary medications|0|||
164189615|NCT00423813|593062153|FG001|Overall Study|Will start exclusionary medications|1|||
164189616|NCT00423813|593062154|FG002|Overall Study|Will start exclusionary medications|0|||
164189617|NCT00423813|593062152|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
164189618|NCT00423813|593062153|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
164189619|NCT00423813|593062154|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
164189620|NCT01904032|593062156|FG000|Overall Study|Adverse Event|3|||
164189621|NCT01904032|593062157|FG001|Overall Study|Adverse Event|1|||
164189622|NCT01904032|593062156|FG000|Overall Study|Lost to Follow-up|4|||
164189623|NCT01904032|593062157|FG001|Overall Study|Lost to Follow-up|2|||
164189624|NCT00003896|593062170|FG000|Overall Study|Adverse Event|16|||
164189625|NCT00003896|593062170|FG000|Overall Study|Withdrawal by Subject|1|||
164189626|NCT00003896|593062170|FG000|Overall Study|Lack of Efficacy|1|||
163959597|NCT03226392|592224046|FG001|Overall Study|Lost to Follow-up|0|||
164189627|NCT00003896|593062170|FG000|Overall Study|Death|3|||
164189628|NCT00003896|593062170|FG000|Overall Study|not protocol specified|3|||
164189629|NCT00003896|593062170|FG000|Overall Study|ineligible|5|||
163844576|NCT02771210|591800069|FG000|Period 1|Withdrawal of informed consent|1|||
163844577|NCT02771210|591800070|FG001|Period 1|Withdrawal of informed consent|5|||
163844578|NCT02771210|591800069|FG000|Period 2|Adverse Event|1|||
163844579|NCT02771210|591800070|FG001|Period 2|Adverse Event|0|||
163844580|NCT02771210|591800069|FG000|Period 2|Lack of Efficacy|0|||
163844581|NCT02771210|591800070|FG001|Period 2|Lack of Efficacy|1|||
163844582|NCT02771210|591800069|FG000|Period 2|Withdrawal by Subject|1|||
164189630|NCT01398358|593062171|FG000|Overall Study|Lost to Follow-up|11|||
163844583|NCT02771210|591800070|FG001|Period 2|Withdrawal by Subject|0|||
163844584|NCT02771210|591800069|FG000|Period 2|Withdrawal of informed consent|0|||
163844585|NCT02771210|591800070|FG001|Period 2|Withdrawal of informed consent|2|||
163844586|NCT04397523|591800072|FG000|Overall Study|Lost to Follow-up|3|||
164189631|NCT01398358|593062172|FG001|Overall Study|Lost to Follow-up|21|||
164189632|NCT01398358|593062173|FG002|Overall Study|Lost to Follow-up|18|||
164189633|NCT01398358|593062171|FG000|Overall Study|Withdrawal by Subject|3|||
164189634|NCT01398358|593062172|FG001|Overall Study|Withdrawal by Subject|2|||
164189635|NCT01398358|593062173|FG002|Overall Study|Withdrawal by Subject|2|||
164189636|NCT01398358|593062171|FG000|Overall Study|no longer eligible|1|||
164189637|NCT01398358|593062172|FG001|Overall Study|no longer eligible|0|||
164189638|NCT01398358|593062173|FG002|Overall Study|no longer eligible|1|||
164189639|NCT02559570|593062175|FG000|Overall Study|Adverse Event|0|||
164189640|NCT02559570|593062176|FG001|Overall Study|Adverse Event|2|||
164189641|NCT02559570|593062177|FG002|Overall Study|Adverse Event|0|||
164189642|NCT02559570|593062178|FG003|Overall Study|Adverse Event|1|||
164189643|NCT02559570|593062179|FG004|Overall Study|Adverse Event|0|||
164189644|NCT02559570|593062175|FG000|Overall Study|Withdrawal of Consent|0|||
164189645|NCT02559570|593062176|FG001|Overall Study|Withdrawal of Consent|0|||
164189646|NCT02559570|593062177|FG002|Overall Study|Withdrawal of Consent|1|||
164189647|NCT02559570|593062178|FG003|Overall Study|Withdrawal of Consent|2|||
164189648|NCT02559570|593062179|FG004|Overall Study|Withdrawal of Consent|1|||
164189649|NCT02559570|593062175|FG000|Overall Study|Lost to Follow-up|1|||
164189650|NCT02559570|593062176|FG001|Overall Study|Lost to Follow-up|0|||
164189651|NCT02559570|593062177|FG002|Overall Study|Lost to Follow-up|0|||
164189652|NCT02559570|593062178|FG003|Overall Study|Lost to Follow-up|0|||
164189653|NCT02559570|593062179|FG004|Overall Study|Lost to Follow-up|0|||
164189654|NCT02559570|593062175|FG000|Overall Study|Protocol Violation|1|||
164189655|NCT02559570|593062176|FG001|Overall Study|Protocol Violation|0|||
164189656|NCT02559570|593062177|FG002|Overall Study|Protocol Violation|0|||
164189657|NCT02559570|593062178|FG003|Overall Study|Protocol Violation|0|||
164189658|NCT02559570|593062179|FG004|Overall Study|Protocol Violation|1|||
164189659|NCT02559570|593062175|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164189660|NCT02559570|593062176|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164189661|NCT02559570|593062177|FG002|Overall Study|Other Miscellaneous Reasons|1|||
164189662|NCT02559570|593062178|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164189663|NCT02559570|593062179|FG004|Overall Study|Other Miscellaneous Reasons|0|||
164189664|NCT01066871|593062184|FG000|Overall Study|Lost to Follow-up|0|||
164189665|NCT01066871|593062185|FG001|Overall Study|Lost to Follow-up|2|||
164189666|NCT01066871|593062186|FG002|Overall Study|Lost to Follow-up|2|||
164189667|NCT01066871|593062187|FG003|Overall Study|Lost to Follow-up|0|||
164189668|NCT01066871|593062184|FG000|Overall Study|Protocol Violation|1|||
164189669|NCT01066871|593062185|FG001|Overall Study|Protocol Violation|0|||
164189670|NCT01066871|593062186|FG002|Overall Study|Protocol Violation|3|||
163844587|NCT04397523|591800072|FG000|Overall Study|Transfer from/to other hospital|8|||
163844588|NCT01275196|591800073|FG000|Overall Study|Adverse Event|3|||
164189671|NCT01066871|593062187|FG003|Overall Study|Protocol Violation|2|||
164189672|NCT01066871|593062184|FG000|Overall Study|Lack of Efficacy|0|||
164189673|NCT01066871|593062185|FG001|Overall Study|Lack of Efficacy|0|||
164189674|NCT01066871|593062186|FG002|Overall Study|Lack of Efficacy|0|||
164189675|NCT01066871|593062187|FG003|Overall Study|Lack of Efficacy|1|||
164189676|NCT01066871|593062184|FG000|Overall Study|Withdrawal by Subject|3|||
164189677|NCT01066871|593062185|FG001|Overall Study|Withdrawal by Subject|1|||
164189678|NCT01066871|593062186|FG002|Overall Study|Withdrawal by Subject|0|||
164189679|NCT01066871|593062187|FG003|Overall Study|Withdrawal by Subject|0|||
164189680|NCT01066871|593062184|FG000|Overall Study|Other|0|||
164189681|NCT01066871|593062185|FG001|Overall Study|Other|2|||
164189682|NCT01066871|593062186|FG002|Overall Study|Other|1|||
164189683|NCT01066871|593062187|FG003|Overall Study|Other|2|||
164189684|NCT00845676|593062192|FG000|Overall Study|Virologic breakthrough at week 20|1|||
164189685|NCT00845676|593062192|FG000|Overall Study|Adverse Event|1|||
164189686|NCT00248833|593062197|FG000|Overall Study|Adverse Event|2|||
164189687|NCT00248833|593062198|FG001|Overall Study|Adverse Event|0|||
164189688|NCT00248833|593062199|FG002|Overall Study|Adverse Event|0|||
164189689|NCT00248833|593062197|FG000|Overall Study|Withdrawal by Subject|0|||
164189690|NCT00248833|593062198|FG001|Overall Study|Withdrawal by Subject|1|||
164189691|NCT00248833|593062199|FG002|Overall Study|Withdrawal by Subject|1|||
164189692|NCT00248833|593062197|FG000|Overall Study|Lost to Follow-up|1|||
164189693|NCT00248833|593062198|FG001|Overall Study|Lost to Follow-up|1|||
164189694|NCT00248833|593062199|FG002|Overall Study|Lost to Follow-up|1|||
164189695|NCT00248833|593062197|FG000|Overall Study|Other|0|||
164189696|NCT00248833|593062198|FG001|Overall Study|Other|1|||
164189697|NCT00248833|593062199|FG002|Overall Study|Other|0|||
164189698|NCT01554163|593062200|FG000|Overall Study|Adverse Event|3|||
164189699|NCT01554163|593062201|FG001|Overall Study|Adverse Event|0|||
164189700|NCT01554163|593062200|FG000|Overall Study|Lack of Efficacy|1|||
164189701|NCT01554163|593062201|FG001|Overall Study|Lack of Efficacy|0|||
164189702|NCT01554163|593062200|FG000|Overall Study|Lost to Follow-up|1|||
164189703|NCT01554163|593062201|FG001|Overall Study|Lost to Follow-up|0|||
164189704|NCT01554163|593062200|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164189705|NCT01554163|593062201|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164189706|NCT01554163|593062200|FG000|Overall Study|Protocol Violation|0|||
164189707|NCT01554163|593062201|FG001|Overall Study|Protocol Violation|4|||
164189708|NCT01554163|593062200|FG000|Overall Study|Withdrawal by Subject|1|||
164189709|NCT01554163|593062201|FG001|Overall Study|Withdrawal by Subject|5|||
164189710|NCT01554163|593062200|FG000|Overall Study|Not Treated|1|||
164189711|NCT01554163|593062201|FG001|Overall Study|Not Treated|0|||
164189712|NCT01941537|593062202|FG000|Overall Study|Lack of Efficacy|1|||
164189713|NCT01941537|593062203|FG001|Overall Study|Lack of Efficacy|2|||
164189714|NCT01941537|593062202|FG000|Overall Study|Lost to Follow-up|1|||
164189715|NCT01941537|593062203|FG001|Overall Study|Lost to Follow-up|0|||
164189716|NCT01941537|593062202|FG000|Overall Study|Pregnancy|1|||
164189717|NCT01941537|593062203|FG001|Overall Study|Pregnancy|0|||
164189718|NCT01941537|593062202|FG000|Overall Study|Adverse Event|1|||
164189719|NCT01941537|593062203|FG001|Overall Study|Adverse Event|0|||
164189720|NCT01941537|593062202|FG000|Overall Study|Withdrawal by Subject|0|||
164189721|NCT01941537|593062203|FG001|Overall Study|Withdrawal by Subject|1|||
164189722|NCT02634983|593062205|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
164189723|NCT02634983|593062206|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
164189724|NCT00762762|593063942|FG000|Overall Study|Did not return for appointments|6|||
164189725|NCT00762762|593063943|FG001|Overall Study|Did not return for appointments|8|||
164189726|NCT02489448|593063944|FG000|Overall Study|Death|3|||
164189727|NCT02489448|593063944|FG000|Overall Study|Withdrawal by Subject|2|||
164189728|NCT00215644|593063947|FG000|Overall Study|Disease Progression|28|||
164189729|NCT00215644|593063948|FG001|Overall Study|Disease Progression|10|||
164304109|NCT02113982|593488364|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304110|NCT02113982|593488365|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304111|NCT02113982|593488366|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304112|NCT02113982|593488367|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304113|NCT02113982|593488368|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304114|NCT02113982|593488369|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304115|NCT02113982|593488370|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304116|NCT02113982|593488371|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304117|NCT02113982|593488372|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304118|NCT02113982|593488373|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304119|NCT02113982|593488374|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304120|NCT02113982|593488375|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
164304121|NCT02113982|593488376|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
164304122|NCT01772316|593488378|FG000|Overall Study|Serious adverse event|1|||
164304123|NCT01772316|593488378|FG000|Overall Study|Inform consent withdrawn|1|||
164304124|NCT01772316|593488378|FG000|Overall Study|Withdrawn by sponsor decision|5|||
164304125|NCT02085161|593488379|FG000|Overall Study|Not Treated|1|||
164304126|NCT02085161|593488380|FG001|Overall Study|Not Treated|0|||
164304127|NCT02085161|593488381|FG002|Overall Study|Not Treated|0|||
164304128|NCT02085161|593488382|FG003|Overall Study|Not Treated|0|||
164189730|NCT00215644|593063947|FG000|Overall Study|Adverse Event|2|||
164189731|NCT00215644|593063948|FG001|Overall Study|Adverse Event|9|||
164189732|NCT00215644|593063947|FG000|Overall Study|Death|1|||
163844589|NCT01275196|591800074|FG001|Overall Study|Adverse Event|5|||
164189733|NCT00215644|593063948|FG001|Overall Study|Death|2|||
164304129|NCT02085161|593488379|FG000|Overall Study|Adverse Event|8|||
164304130|NCT02085161|593488380|FG001|Overall Study|Adverse Event|5|||
164304131|NCT02085161|593488381|FG002|Overall Study|Adverse Event|4|||
164304132|NCT02085161|593488382|FG003|Overall Study|Adverse Event|5|||
164304133|NCT02085161|593488379|FG000|Overall Study|Protocol Violation|0|||
164304134|NCT02085161|593488380|FG001|Overall Study|Protocol Violation|1|||
164304135|NCT02085161|593488381|FG002|Overall Study|Protocol Violation|0|||
164304136|NCT02085161|593488382|FG003|Overall Study|Protocol Violation|1|||
164304137|NCT02085161|593488379|FG000|Overall Study|Withdrawal by Subject|2|||
164304138|NCT02085161|593488380|FG001|Overall Study|Withdrawal by Subject|4|||
164304139|NCT02085161|593488381|FG002|Overall Study|Withdrawal by Subject|0|||
164304140|NCT02085161|593488382|FG003|Overall Study|Withdrawal by Subject|3|||
164304141|NCT02085161|593488379|FG000|Overall Study|Other Reason|1|||
164304142|NCT02085161|593488380|FG001|Overall Study|Other Reason|0|||
164304143|NCT02085161|593488381|FG002|Overall Study|Other Reason|1|||
164304144|NCT02085161|593488382|FG003|Overall Study|Other Reason|1|||
164304145|NCT00068692|593488393|FG000|Step 1: Registration|Disese progression/relapse|5|||
164304146|NCT00068692|593488394|FG001|Step 1: Registration|Disese progression/relapse|0|||
164304147|NCT00068692|593488395|FG002|Step 1: Registration|Disese progression/relapse|0|||
164304148|NCT00068692|593488396|FG003|Step 1: Registration|Disese progression/relapse|0|||
164304149|NCT00068692|593488397|FG004|Step 1: Registration|Disese progression/relapse|0|||
164304150|NCT00068692|593488398|FG005|Step 1: Registration|Disese progression/relapse|0|||
164304151|NCT00068692|593488399|FG006|Step 1: Registration|Disese progression/relapse|0|||
164304152|NCT00068692|593488400|FG007|Step 1: Registration|Disese progression/relapse|0|||
164304153|NCT00068692|593488393|FG000|Step 1: Registration|Adverse Event|7|||
164304154|NCT00068692|593488394|FG001|Step 1: Registration|Adverse Event|0|||
164304155|NCT00068692|593488395|FG002|Step 1: Registration|Adverse Event|0|||
164304156|NCT00068692|593488396|FG003|Step 1: Registration|Adverse Event|0|||
164304157|NCT00068692|593488397|FG004|Step 1: Registration|Adverse Event|0|||
164304158|NCT00068692|593488398|FG005|Step 1: Registration|Adverse Event|0|||
164304159|NCT00068692|593488399|FG006|Step 1: Registration|Adverse Event|0|||
164304160|NCT00068692|593488400|FG007|Step 1: Registration|Adverse Event|0|||
164304161|NCT00068692|593488393|FG000|Step 1: Registration|Death|1|||
164304162|NCT00068692|593488394|FG001|Step 1: Registration|Death|0|||
164304163|NCT00068692|593488395|FG002|Step 1: Registration|Death|0|||
164304164|NCT00068692|593488396|FG003|Step 1: Registration|Death|0|||
164304165|NCT00068692|593488397|FG004|Step 1: Registration|Death|0|||
164304166|NCT00068692|593488398|FG005|Step 1: Registration|Death|0|||
164304167|NCT00068692|593488399|FG006|Step 1: Registration|Death|0|||
163844590|NCT01275196|591800073|FG000|Overall Study|Withdrawal by Subject|4|||
163844591|NCT01275196|591800074|FG001|Overall Study|Withdrawal by Subject|5|||
163844592|NCT01275196|591800073|FG000|Overall Study|Lost to Follow-up|1|||
163844593|NCT01275196|591800074|FG001|Overall Study|Lost to Follow-up|0|||
163844594|NCT01275196|591800073|FG000|Overall Study|Disease Progression|6|||
163844595|NCT01275196|591800074|FG001|Overall Study|Disease Progression|5|||
163844596|NCT01275196|591800073|FG000|Overall Study|Protocol Violation|1|||
163844597|NCT01275196|591800074|FG001|Overall Study|Protocol Violation|0|||
163844598|NCT01275196|591800073|FG000|Overall Study|Suboptimal response/treatment failure|5|||
163844599|NCT01275196|591800074|FG001|Overall Study|Suboptimal response/treatment failure|6|||
163844600|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
163844601|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
163844602|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
163844603|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
163844604|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163844605|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
163844606|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163844607|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
163844608|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
163844609|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
163844610|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163844611|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
163844612|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
163844613|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
163844614|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163844615|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
163844616|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
163844617|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
163844618|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
163844619|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
163844620|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
163844621|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
163844622|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
163844623|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
163844624|NCT03230864|591800075|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
163844625|NCT03230864|591800076|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
163844626|NCT03230864|591800077|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
163844627|NCT03230864|591800078|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
163844628|NCT03230864|591800075|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
163844629|NCT03230864|591800076|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
163844630|NCT03230864|591800077|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
163844631|NCT03230864|591800078|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
163844632|NCT03230864|591800075|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163844633|NCT03230864|591800076|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
163844634|NCT03230864|591800077|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
163844635|NCT03230864|591800078|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
163844636|NCT03230864|591800075|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
163844637|NCT03230864|591800076|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
163844638|NCT03230864|591800077|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
163844639|NCT03230864|591800078|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
163844640|NCT01744496|591800081|FG000|Titration Period|Adverse Event|2|||
163844641|NCT01744496|591800082|FG001|Titration Period|Adverse Event|1|||
163844642|NCT01744496|591800081|FG000|Titration Period|Personal reasons|0|||
163844643|NCT01744496|591800082|FG001|Titration Period|Personal reasons|1|||
163844644|NCT01744496|591800081|FG000|Maintenance Period|Adverse Event|1|||
163844645|NCT01744496|591800082|FG001|Maintenance Period|Adverse Event|3|||
163844646|NCT01744496|591800081|FG000|Maintenance Period|Protocol Violation|1|||
163844647|NCT01744496|591800082|FG001|Maintenance Period|Protocol Violation|0|||
163844648|NCT01744496|591800081|FG000|Maintenance Period|Withdrawal by Subject|1|||
163844649|NCT01744496|591800082|FG001|Maintenance Period|Withdrawal by Subject|1|||
163844650|NCT01744496|591800081|FG000|Maintenance Period|Subject left town|1|||
163844651|NCT01744496|591800082|FG001|Maintenance Period|Subject left town|0|||
163844652|NCT01284140|591800083|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
163844653|NCT01284140|591800084|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
163844654|NCT01284140|591800083|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
163844655|NCT01284140|591800084|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
163844656|NCT05033080|591800095|FG000|Overall Study|Adverse Event|4|||
163844657|NCT05033080|591800096|FG001|Overall Study|Adverse Event|4|||
163844658|NCT05033080|591800095|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
163844659|NCT05033080|591800096|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
163844660|NCT05033080|591800095|FG000|Overall Study|Lost to Follow-up|1|||
163844661|NCT05033080|591800096|FG001|Overall Study|Lost to Follow-up|0|||
163844662|NCT05033080|591800095|FG000|Overall Study|Other non-compliance|0|||
163844663|NCT05033080|591800096|FG001|Overall Study|Other non-compliance|1|||
163844664|NCT05033080|591800095|FG000|Overall Study|Physician Decision|0|||
163844665|NCT05033080|591800096|FG001|Overall Study|Physician Decision|1|||
163844666|NCT05033080|591800095|FG000|Overall Study|Other|1|||
163844667|NCT05033080|591800096|FG001|Overall Study|Other|1|||
163844668|NCT05376371|591800097|FG000|Overall Study|change in release date|10|||
163844669|NCT04159415|591800098|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844670|NCT04159415|591800099|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844671|NCT04159415|591800100|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844672|NCT04159415|591800101|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844673|NCT04159415|591800102|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844674|NCT04159415|591800103|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844675|NCT04159415|591800104|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
163844676|NCT04159415|591800105|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
163844677|NCT04159415|591800106|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844678|NCT04159415|591800107|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
163844679|NCT04159415|591800098|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844680|NCT04159415|591800099|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844681|NCT04159415|591800100|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844682|NCT04159415|591800101|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844683|NCT04159415|591800102|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844684|NCT04159415|591800103|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844685|NCT04159415|591800104|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844686|NCT04159415|591800105|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
163844687|NCT04159415|591800106|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844688|NCT04159415|591800107|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
163844689|NCT04159415|591800098|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844690|NCT04159415|591800099|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844691|NCT04159415|591800100|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844692|NCT04159415|591800101|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844693|NCT04159415|591800102|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844694|NCT04159415|591800103|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844695|NCT04159415|591800104|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844696|NCT04159415|591800105|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
163844697|NCT04159415|591800106|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844698|NCT04159415|591800107|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
163844699|NCT04159415|591800098|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844700|NCT04159415|591800099|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844701|NCT04159415|591800100|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844702|NCT04159415|591800101|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844703|NCT04159415|591800102|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844704|NCT04159415|591800103|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844705|NCT04159415|591800104|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844706|NCT04159415|591800105|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844707|NCT04159415|591800106|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
163844708|NCT04159415|591800107|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
163844709|NCT03560245|591800108|FG000|Overall Study|Withdrawal by Subject|3|||
163844710|NCT03560245|591800109|FG001|Overall Study|Withdrawal by Subject|2|||
163844711|NCT03560245|591800108|FG000|Overall Study|Adverse Event|1|||
163844712|NCT03560245|591800109|FG001|Overall Study|Adverse Event|1|||
163844713|NCT03560245|591800108|FG000|Overall Study|Protocol Violation|1|||
163844714|NCT03560245|591800109|FG001|Overall Study|Protocol Violation|0|||
163844715|NCT03560245|591800108|FG000|Overall Study|Death|0|||
163844716|NCT03560245|591800109|FG001|Overall Study|Death|1|||
163844717|NCT03560245|591800108|FG000|Overall Study|Lost to Follow-up|0|||
163844718|NCT03560245|591800109|FG001|Overall Study|Lost to Follow-up|1|||
163844719|NCT03560245|591800108|FG000|Overall Study|Physician Decision|0|||
163844720|NCT03560245|591800109|FG001|Overall Study|Physician Decision|1|||
163844721|NCT03560245|591800108|FG000|Overall Study|Other|0|||
163844722|NCT03560245|591800109|FG001|Overall Study|Other|1|||
163844723|NCT00960752|591800117|FG000|Overall Study|Adverse Event|0|||
163844724|NCT00960752|591800118|FG001|Overall Study|Adverse Event|0|||
163844725|NCT00960752|591800119|FG002|Overall Study|Adverse Event|1|||
163844726|NCT00960752|591800117|FG000|Overall Study|Progression|0|||
163844727|NCT00960752|591800118|FG001|Overall Study|Progression|0|||
163844728|NCT00960752|591800119|FG002|Overall Study|Progression|1|||
163844729|NCT02058290|591800123|FG000|Overall Study|Protocol Violation|2|||
163844730|NCT02058290|591800124|FG001|Overall Study|Protocol Violation|1|||
163844731|NCT02058290|591800123|FG000|Overall Study|Physician Decision|1|||
163844732|NCT02058290|591800124|FG001|Overall Study|Physician Decision|0|||
163844733|NCT02058290|591800123|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
163844734|NCT02058290|591800124|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
163844735|NCT02058290|591800123|FG000|Overall Study|Withdrawal by Subject|0|||
163844736|NCT02058290|591800124|FG001|Overall Study|Withdrawal by Subject|1|||
163844737|NCT00105586|591800128|FG000|Overall Study|Adverse Event|4|||
163844738|NCT00105586|591800129|FG001|Overall Study|Adverse Event|3|||
163844739|NCT00105586|591800128|FG000|Overall Study|Physician Decision|13|||
163844740|NCT00105586|591800129|FG001|Overall Study|Physician Decision|13|||
163844741|NCT02262260|591800132|FG000|Overall Study|Adverse Event|4|||
163844742|NCT02262260|591800133|FG001|Overall Study|Adverse Event|1|||
163844743|NCT02262260|591800132|FG000|Overall Study|Withdrawal of consent|4|||
163844744|NCT02262260|591800133|FG001|Overall Study|Withdrawal of consent|2|||
164304168|NCT00068692|593488400|FG007|Step 1: Registration|Death|0|||
164304169|NCT00068692|593488393|FG000|Step 1: Registration|Withdrawal by Subject|11|||
164304170|NCT00068692|593488394|FG001|Step 1: Registration|Withdrawal by Subject|0|||
164304171|NCT00068692|593488395|FG002|Step 1: Registration|Withdrawal by Subject|0|||
163844745|NCT02262260|591800132|FG000|Overall Study|Lost to Follow-up|1|||
163844746|NCT02262260|591800133|FG001|Overall Study|Lost to Follow-up|2|||
163844747|NCT02262260|591800132|FG000|Overall Study|Protocol deviation|2|||
164304172|NCT00068692|593488396|FG003|Step 1: Registration|Withdrawal by Subject|0|||
164304173|NCT00068692|593488397|FG004|Step 1: Registration|Withdrawal by Subject|0|||
163844748|NCT02262260|591800133|FG001|Overall Study|Protocol deviation|5|||
163844749|NCT01794117|591800134|FG000|Overall Study|Adverse Event|1|||
163844750|NCT01794117|591800135|FG001|Overall Study|Adverse Event|0|||
163844751|NCT01794117|591800136|FG002|Overall Study|Adverse Event|0|||
163844752|NCT01794117|591800137|FG003|Overall Study|Adverse Event|0|||
163844753|NCT01794117|591800134|FG000|Overall Study|Participant noncompliance|0|||
163844754|NCT01794117|591800135|FG001|Overall Study|Participant noncompliance|1|||
163844755|NCT01794117|591800136|FG002|Overall Study|Participant noncompliance|0|||
163844756|NCT01794117|591800137|FG003|Overall Study|Participant noncompliance|0|||
163844757|NCT01794117|591800134|FG000|Overall Study|Refused further treatment|0|||
163844758|NCT01794117|591800135|FG001|Overall Study|Refused further treatment|2|||
163844759|NCT01794117|591800136|FG002|Overall Study|Refused further treatment|0|||
163844760|NCT01794117|591800137|FG003|Overall Study|Refused further treatment|0|||
163844761|NCT03406702|591800138|FG000|Overall Study|Missed Day 27 Dosing|1|||
163844762|NCT00735644|591800141|FG000|Overall Study|Did not receive study vaccine|0|||
163844763|NCT00735644|591800142|FG001|Overall Study|Did not receive study vaccine|1|||
163844764|NCT00735644|591800143|FG002|Overall Study|Did not receive study vaccine|0|||
163844765|NCT00735644|591800144|FG003|Overall Study|Did not receive study vaccine|0|||
163844766|NCT00735644|591800145|FG004|Overall Study|Did not receive study vaccine|0|||
163844767|NCT00735644|591800141|FG000|Overall Study|Withdrawal by Subject|0|||
163844768|NCT00735644|591800142|FG001|Overall Study|Withdrawal by Subject|1|||
163844769|NCT00735644|591800143|FG002|Overall Study|Withdrawal by Subject|1|||
163844770|NCT00735644|591800144|FG003|Overall Study|Withdrawal by Subject|1|||
163844771|NCT00735644|591800145|FG004|Overall Study|Withdrawal by Subject|0|||
163844772|NCT00514046|591800146|FG000|Overall Study|transferred to another protocol|2|||
163844773|NCT00514046|591800147|FG001|Overall Study|transferred to another protocol|1|||
163844774|NCT00514046|591800148|FG002|Overall Study|transferred to another protocol|3|||
163844775|NCT00514046|591800149|FG003|Overall Study|transferred to another protocol|0|||
163844776|NCT00514046|591800150|FG004|Overall Study|transferred to another protocol|1|||
163844777|NCT00514046|591800151|FG005|Overall Study|transferred to another protocol|0|||
163844778|NCT00514046|591800152|FG006|Overall Study|transferred to another protocol|0|||
163844779|NCT00514046|591800153|FG007|Overall Study|transferred to another protocol|0|||
163844780|NCT00514046|591800154|FG008|Overall Study|transferred to another protocol|0|||
163844781|NCT00514046|591800146|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
163844782|NCT00514046|591800147|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
163844783|NCT00514046|591800148|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
163844784|NCT00514046|591800149|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
163844785|NCT00514046|591800150|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
163844786|NCT00514046|591800151|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
163844787|NCT00514046|591800152|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
163844788|NCT00514046|591800153|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
163844789|NCT00514046|591800154|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
163844790|NCT00514046|591800146|FG000|Overall Study|Disease progression on study|0|||
163844791|NCT00514046|591800147|FG001|Overall Study|Disease progression on study|0|||
163844792|NCT00514046|591800148|FG002|Overall Study|Disease progression on study|2|||
163844793|NCT00514046|591800149|FG003|Overall Study|Disease progression on study|0|||
163844794|NCT00514046|591800150|FG004|Overall Study|Disease progression on study|0|||
163844795|NCT00514046|591800151|FG005|Overall Study|Disease progression on study|1|||
163844796|NCT00514046|591800152|FG006|Overall Study|Disease progression on study|0|||
163844797|NCT00514046|591800153|FG007|Overall Study|Disease progression on study|0|||
163844798|NCT00514046|591800154|FG008|Overall Study|Disease progression on study|0|||
163844799|NCT00655551|591800155|FG000|All Periods Combined|Adverse Event|0|||
163844800|NCT00655551|591800156|FG001|All Periods Combined|Adverse Event|3|||
163844801|NCT00655551|591800157|FG002|All Periods Combined|Adverse Event|4|||
163844802|NCT00655551|591800155|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
163844803|NCT00655551|591800156|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
163844804|NCT00655551|591800157|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
163844805|NCT00655551|591800155|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
163844806|NCT00655551|591800156|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
163844807|NCT00655551|591800157|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
163844808|NCT00655551|591800155|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
163844809|NCT00655551|591800156|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
163844810|NCT00655551|591800157|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
163844811|NCT02855164|591800159|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163844812|NCT02855164|591800160|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163844813|NCT02855164|591800161|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
163844814|NCT02855164|591800162|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
163844815|NCT02855164|591800163|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
163959598|NCT03226392|592224045|FG000|Overall Study|Adverse Event|1|||
163844816|NCT02855164|591800164|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163844817|NCT02855164|591800165|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163959599|NCT03226392|592224046|FG001|Overall Study|Adverse Event|0|||
163844818|NCT02855164|591800166|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
163844819|NCT02855164|591800159|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
163844820|NCT02855164|591800160|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
163844821|NCT02855164|591800161|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
163844822|NCT02855164|591800162|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
163844823|NCT02855164|591800163|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
163844824|NCT02855164|591800164|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
163844825|NCT02855164|591800165|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
163844826|NCT02855164|591800166|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
163844827|NCT02855164|591800159|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
163844828|NCT02855164|591800160|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
163844829|NCT02855164|591800161|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
163844830|NCT02855164|591800162|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
163844831|NCT02855164|591800163|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
163844832|NCT02855164|591800164|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
163844833|NCT02855164|591800165|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
163844834|NCT02855164|591800166|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
163844835|NCT02855164|591800159|FG000|Part C (Randomized Set)|Adverse Event|0|||
163844836|NCT02855164|591800160|FG001|Part C (Randomized Set)|Adverse Event|0|||
163844837|NCT02855164|591800161|FG002|Part C (Randomized Set)|Adverse Event|0|||
163844838|NCT02855164|591800162|FG003|Part C (Randomized Set)|Adverse Event|0|||
163844839|NCT02855164|591800163|FG004|Part C (Randomized Set)|Adverse Event|0|||
163844840|NCT02855164|591800164|FG005|Part C (Randomized Set)|Adverse Event|5|||
163844841|NCT02855164|591800165|FG006|Part C (Randomized Set)|Adverse Event|9|||
163844842|NCT02855164|591800166|FG007|Part C (Randomized Set)|Adverse Event|2|||
163844843|NCT02855164|591800159|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
163844844|NCT02855164|591800160|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
163844845|NCT02855164|591800161|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
163844846|NCT02855164|591800162|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
163844847|NCT02855164|591800163|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
163844848|NCT02855164|591800164|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
163844849|NCT02855164|591800165|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
163844850|NCT02855164|591800166|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
163844851|NCT02855164|591800159|FG000|Part C (Randomized Set)|Physician Decision|0|||
163844852|NCT02855164|591800160|FG001|Part C (Randomized Set)|Physician Decision|0|||
163844853|NCT02855164|591800161|FG002|Part C (Randomized Set)|Physician Decision|0|||
163844854|NCT02855164|591800162|FG003|Part C (Randomized Set)|Physician Decision|0|||
163844855|NCT02855164|591800163|FG004|Part C (Randomized Set)|Physician Decision|0|||
163844856|NCT02855164|591800164|FG005|Part C (Randomized Set)|Physician Decision|1|||
163844857|NCT02855164|591800165|FG006|Part C (Randomized Set)|Physician Decision|0|||
163844858|NCT02855164|591800166|FG007|Part C (Randomized Set)|Physician Decision|1|||
163844859|NCT02855164|591800159|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
163844860|NCT02855164|591800160|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
163844861|NCT02855164|591800161|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
163844862|NCT02855164|591800162|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
163844863|NCT02855164|591800163|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
163844864|NCT02855164|591800164|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
163844865|NCT02855164|591800165|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
163844866|NCT02855164|591800166|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
163844867|NCT00383240|591800167|FG000|Overall Study|Adverse Event|4|||
163844868|NCT00383240|591800168|FG001|Overall Study|Adverse Event|6|||
163844869|NCT00383240|591800169|FG002|Overall Study|Adverse Event|9|||
163844870|NCT00383240|591800170|FG003|Overall Study|Adverse Event|7|||
163844871|NCT00383240|591800167|FG000|Overall Study|Treatment Failure|8|||
163844872|NCT00383240|591800168|FG001|Overall Study|Treatment Failure|13|||
163844873|NCT00383240|591800169|FG002|Overall Study|Treatment Failure|47|||
163844874|NCT00383240|591800170|FG003|Overall Study|Treatment Failure|46|||
163844875|NCT00383240|591800167|FG000|Overall Study|Lost to Follow-up|3|||
163844876|NCT00383240|591800168|FG001|Overall Study|Lost to Follow-up|0|||
163844877|NCT00383240|591800169|FG002|Overall Study|Lost to Follow-up|0|||
163844878|NCT00383240|591800170|FG003|Overall Study|Lost to Follow-up|2|||
163844879|NCT00383240|591800167|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
163844880|NCT00383240|591800168|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
163844881|NCT00383240|591800169|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
163844882|NCT00383240|591800170|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
163844883|NCT00383240|591800167|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
163844884|NCT00383240|591800168|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
163844885|NCT00383240|591800169|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
163844886|NCT00383240|591800170|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
163844887|NCT00383240|591800167|FG000|Overall Study|Protocol Violation|4|||
163844888|NCT00383240|591800168|FG001|Overall Study|Protocol Violation|5|||
163844889|NCT00383240|591800169|FG002|Overall Study|Protocol Violation|9|||
163844890|NCT00383240|591800170|FG003|Overall Study|Protocol Violation|6|||
163844891|NCT00383240|591800167|FG000|Overall Study|Did not meet protocol eligibility|9|||
163844892|NCT00383240|591800168|FG001|Overall Study|Did not meet protocol eligibility|4|||
163844893|NCT00383240|591800169|FG002|Overall Study|Did not meet protocol eligibility|9|||
163844894|NCT00383240|591800170|FG003|Overall Study|Did not meet protocol eligibility|3|||
163844895|NCT00383240|591800167|FG000|Overall Study|Administrative|1|||
163844896|NCT00383240|591800168|FG001|Overall Study|Administrative|1|||
163844897|NCT00383240|591800169|FG002|Overall Study|Administrative|0|||
163844898|NCT00383240|591800170|FG003|Overall Study|Administrative|0|||
163844899|NCT02049710|591800171|FG000|Overall Study|Lost to Follow-up|319|||
163844900|NCT02049710|591800172|FG001|Overall Study|Lost to Follow-up|324|||
163844901|NCT06385483|591800173|FG000|Overall Study|Withdrawal by Subject|2|||
163844902|NCT06385483|591800173|FG000|Overall Study|Never start protocol therapy|2|||
163844903|NCT06385483|591800173|FG000|Overall Study|Disease progression|15|||
163899994|NCT01961609|592005595|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
163899995|NCT01961609|592005596|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
163899996|NCT01961609|592005593|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
163899997|NCT01961609|592005594|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
163899998|NCT01961609|592005595|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
163899999|NCT01961609|592005596|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
163900000|NCT01961609|592005593|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
163900001|NCT01961609|592005594|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
163900002|NCT01961609|592005595|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
163900003|NCT01961609|592005596|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
163900004|NCT01961609|592005593|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
163900005|NCT01961609|592005594|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
163900006|NCT01961609|592005595|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
163900007|NCT01961609|592005596|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
163900008|NCT01961609|592005593|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
163900009|NCT01961609|592005594|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
163900010|NCT01961609|592005595|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
163900011|NCT01961609|592005596|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
163900012|NCT01961609|592005593|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
163900013|NCT01961609|592005594|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
163900014|NCT01961609|592005595|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
163900015|NCT01961609|592005596|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
163900016|NCT01961609|592005593|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
163900017|NCT01961609|592005594|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
163900018|NCT01961609|592005595|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
163900019|NCT01961609|592005596|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
163900020|NCT01212744|592005599|FG000|Overall Study|Withdrawal by Subject|1|||
163900021|NCT02167451|592005600|FG000|Overall Study|Withdrawal by Subject|1|||
163900022|NCT00571649|592005601|FG000|Treatment Period|Adverse Event|438|||
163900023|NCT00571649|592005602|FG001|Treatment Period|Adverse Event|385|||
163900024|NCT00571649|592005601|FG000|Treatment Period|Clinical endpoint reached|50|||
163900025|NCT00571649|592005602|FG001|Treatment Period|Clinical endpoint reached|56|||
163900026|NCT00571649|592005601|FG000|Treatment Period|Withdrawal by Subject|285|||
163900027|NCT00571649|592005602|FG001|Treatment Period|Withdrawal by Subject|255|||
163900028|NCT00571649|592005601|FG000|Treatment Period|Death|76|||
163900029|NCT00571649|592005602|FG001|Treatment Period|Death|59|||
163900030|NCT00571649|592005601|FG000|Treatment Period|Physician Decision|8|||
163900031|NCT00571649|592005602|FG001|Treatment Period|Physician Decision|9|||
163900032|NCT00571649|592005601|FG000|Treatment Period|Lost to Follow-up|43|||
163900033|NCT00571649|592005602|FG001|Treatment Period|Lost to Follow-up|41|||
163900034|NCT00571649|592005601|FG000|Treatment Period|Non-compliant with study medication|88|||
163900035|NCT00571649|592005602|FG001|Treatment Period|Non-compliant with study medication|89|||
163900036|NCT00571649|592005601|FG000|Treatment Period|Patient convenience|11|||
163900037|NCT00571649|592005602|FG001|Treatment Period|Patient convenience|13|||
163900038|NCT00571649|592005601|FG000|Treatment Period|Protocol Violation|90|||
163900039|NCT00571649|592005602|FG001|Treatment Period|Protocol Violation|92|||
163900040|NCT00571649|592005601|FG000|Treatment Period|Technical problems|3|||
163900041|NCT00571649|592005602|FG001|Treatment Period|Technical problems|5|||
163900042|NCT00571649|592005601|FG000|Follow-up Period|Adverse Event|46|||
163900043|NCT00571649|592005602|FG001|Follow-up Period|Adverse Event|40|||
163900044|NCT00571649|592005601|FG000|Follow-up Period|Clinical endpoint reached|5|||
164189734|NCT00215644|593063947|FG000|Overall Study|Withdrawal by Subject|1|||
163900045|NCT00571649|592005602|FG001|Follow-up Period|Clinical endpoint reached|2|||
163900046|NCT00571649|592005601|FG000|Follow-up Period|Withdrawal by Subject|119|||
163900047|NCT00571649|592005602|FG001|Follow-up Period|Withdrawal by Subject|115|||
163900048|NCT00571649|592005601|FG000|Follow-up Period|Death|132|||
163900049|NCT00571649|592005602|FG001|Follow-up Period|Death|133|||
163900050|NCT00571649|592005601|FG000|Follow-up Period|Physician Decision|7|||
163900051|NCT00571649|592005602|FG001|Follow-up Period|Physician Decision|13|||
163844904|NCT01818141|591801702|FG000|Overall Study|Withdrawal by Subject|2|||
163844905|NCT01818141|591801703|FG001|Overall Study|Withdrawal by Subject|0|||
163844906|NCT01818141|591801702|FG000|Overall Study|No baseline C.diff colonies|1|||
163844907|NCT01818141|591801703|FG001|Overall Study|No baseline C.diff colonies|1|||
163844908|NCT01818141|591801702|FG000|Overall Study|Lost to Follow-up|0|||
163844909|NCT01818141|591801703|FG001|Overall Study|Lost to Follow-up|2|||
163844910|NCT04781647|591801707|FG000|Overall Study|Study terminated by Sponsor|11|||
163844911|NCT04781647|591801708|FG001|Overall Study|Study terminated by Sponsor|9|||
163844912|NCT04781647|591801709|FG002|Overall Study|Study terminated by Sponsor|9|||
163844913|NCT04781647|591801707|FG000|Overall Study|Withdrawal by Subject|1|||
163844914|NCT04781647|591801708|FG001|Overall Study|Withdrawal by Subject|2|||
163844915|NCT04781647|591801709|FG002|Overall Study|Withdrawal by Subject|0|||
163844916|NCT04781647|591801707|FG000|Overall Study|Adverse Event|0|||
163844917|NCT04781647|591801708|FG001|Overall Study|Adverse Event|1|||
163844918|NCT04781647|591801709|FG002|Overall Study|Adverse Event|1|||
163844919|NCT04781647|591801707|FG000|Overall Study|Protocol Violation|1|||
163844920|NCT04781647|591801708|FG001|Overall Study|Protocol Violation|0|||
164189735|NCT00215644|593063948|FG001|Overall Study|Withdrawal by Subject|0|||
164189736|NCT00215644|593063947|FG000|Overall Study|Other|3|||
164189737|NCT00215644|593063948|FG001|Overall Study|Other|15|||
164189738|NCT00215644|593063947|FG000|Overall Study|Randomized but Not Treated|1|||
164189739|NCT00215644|593063948|FG001|Overall Study|Randomized but Not Treated|0|||
164189740|NCT02861664|593063949|FG000|Overall Study|Withdrawal of Consent|0|||
164189741|NCT02861664|593063950|FG001|Overall Study|Withdrawal of Consent|1|||
164189742|NCT02542397|593063951|FG000|Overall Study|Death|2|||
164189743|NCT02542397|593063951|FG000|Overall Study|Physician Decision|6|||
164189744|NCT02542397|593063951|FG000|Overall Study|Withdrawal by Subject|6|||
164189745|NCT02542397|593063951|FG000|Overall Study|Lost to Follow-up|2|||
164189746|NCT00493012|593063954|FG000|Overall Study|Lost to Follow-up|18|||
164189747|NCT00493012|593063955|FG001|Overall Study|Lost to Follow-up|17|||
164189748|NCT04147247|593063957|FG000|Overall Study|Progressive disease|3|||
164189749|NCT04147247|593063958|FG001|Overall Study|Progressive disease|3|||
164189750|NCT04147247|593063959|FG002|Overall Study|Progressive disease|4|||
164189751|NCT04147247|593063960|FG003|Overall Study|Progressive disease|4|||
164189752|NCT04147247|593063961|FG004|Overall Study|Progressive disease|3|||
164189753|NCT04147247|593063957|FG000|Overall Study|Physician Decision|0|||
164189754|NCT04147247|593063958|FG001|Overall Study|Physician Decision|1|||
164189755|NCT04147247|593063959|FG002|Overall Study|Physician Decision|0|||
164189756|NCT04147247|593063960|FG003|Overall Study|Physician Decision|0|||
163844921|NCT04781647|591801709|FG002|Overall Study|Protocol Violation|0|||
163844922|NCT04781647|591801707|FG000|Overall Study|Pregnancy|0|||
163844923|NCT04781647|591801708|FG001|Overall Study|Pregnancy|0|||
163844924|NCT04781647|591801709|FG002|Overall Study|Pregnancy|1|||
163844925|NCT04781647|591801707|FG000|Overall Study|Virology rebounded|1|||
163844926|NCT04781647|591801708|FG001|Overall Study|Virology rebounded|0|||
163844927|NCT04781647|591801709|FG002|Overall Study|Virology rebounded|0|||
163844928|NCT01668147|591801712|FG000|Overall Study|Withdrawal by Subject|6|||
163844929|NCT00224133|591801715|FG000|Overall Study|Adverse Event|93|||
163844930|NCT00224133|591801715|FG000|Overall Study|Protocol Violation|6|||
163844931|NCT00224133|591801715|FG000|Overall Study|Withdrawal by Subject|33|||
163844932|NCT00224133|591801715|FG000|Overall Study|Lack of Efficacy|58|||
163844933|NCT00224133|591801715|FG000|Overall Study|Lost to Follow-up|21|||
163844934|NCT00224133|591801715|FG000|Overall Study|Physician Decision|1|||
163844935|NCT00224133|591801715|FG000|Overall Study|Other|14|||
163844936|NCT01238575|591801717|FG000|Overall Study|Lack of Efficacy|2|||
163844937|NCT01238575|591801718|FG001|Overall Study|Lack of Efficacy|4|||
163844938|NCT01238575|591801717|FG000|Overall Study|Adverse Event|2|||
163844939|NCT01238575|591801718|FG001|Overall Study|Adverse Event|0|||
163844940|NCT00593554|591801720|FG000|Overall Study|Death|1|||
163844941|NCT00593554|591801721|FG001|Overall Study|Death|2|||
163844942|NCT00593554|591801720|FG000|Overall Study|Physician Decision|0|||
163844943|NCT00593554|591801721|FG001|Overall Study|Physician Decision|1|||
163844944|NCT00593554|591801720|FG000|Overall Study|Withdrawal by Subject|1|||
163844945|NCT00593554|591801721|FG001|Overall Study|Withdrawal by Subject|0|||
163844946|NCT00593554|591801720|FG000|Overall Study|Disease Progression|1|||
163844947|NCT00593554|591801721|FG001|Overall Study|Disease Progression|2|||
163844948|NCT00795132|591801724|FG000|Overall Study|Death|1|||
163844949|NCT00795132|591801724|FG000|Overall Study|Relapse|2|||
163844950|NCT00358150|591801729|FG000|Overall Study|Adverse Event|3|||
163844951|NCT00358150|591801729|FG000|Overall Study|Withdrawal by Subject|1|||
163844952|NCT00358150|591801729|FG000|Overall Study|Undefined|3|||
163844953|NCT04254679|591801750|FG000|Overall Study|Protocol Violation|1|||
163844954|NCT04254679|591801751|FG001|Overall Study|Protocol Violation|1|||
164189757|NCT04147247|593063961|FG004|Overall Study|Physician Decision|0|||
164189758|NCT04147247|593063957|FG000|Overall Study|Clinical Disease Progression|0|||
164189759|NCT04147247|593063958|FG001|Overall Study|Clinical Disease Progression|0|||
163844955|NCT04254679|591801750|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
163844956|NCT04254679|591801751|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
163844957|NCT04076020|591801760|FG000|Overall Study|Death|4|||
164304174|NCT00068692|593488398|FG005|Step 1: Registration|Withdrawal by Subject|0|||
164304175|NCT00068692|593488399|FG006|Step 1: Registration|Withdrawal by Subject|0|||
164304176|NCT00068692|593488400|FG007|Step 1: Registration|Withdrawal by Subject|0|||
164304177|NCT00068692|593488393|FG000|Step 1: Registration|Alternative therapy|2|||
164304178|NCT00068692|593488394|FG001|Step 1: Registration|Alternative therapy|0|||
164304179|NCT00068692|593488395|FG002|Step 1: Registration|Alternative therapy|0|||
164304180|NCT00068692|593488396|FG003|Step 1: Registration|Alternative therapy|0|||
164304181|NCT00068692|593488397|FG004|Step 1: Registration|Alternative therapy|0|||
163844958|NCT04076020|591801761|FG001|Overall Study|Death|6|||
164304182|NCT00068692|593488398|FG005|Step 1: Registration|Alternative therapy|0|||
164304183|NCT00068692|593488399|FG006|Step 1: Registration|Alternative therapy|0|||
164304184|NCT00068692|593488400|FG007|Step 1: Registration|Alternative therapy|0|||
164304185|NCT00068692|593488393|FG000|Step 1: Registration|Complicating disease|2|||
164304186|NCT00068692|593488394|FG001|Step 1: Registration|Complicating disease|0|||
164304187|NCT00068692|593488395|FG002|Step 1: Registration|Complicating disease|0|||
164304188|NCT00068692|593488396|FG003|Step 1: Registration|Complicating disease|0|||
163844959|NCT04076020|591801760|FG000|Overall Study|Withdrawal by Subject|12|||
163844960|NCT04076020|591801761|FG001|Overall Study|Withdrawal by Subject|8|||
163844961|NCT00502996|591801778|FG000|Overall Study|Lost to Follow-up|9|||
163844962|NCT00502996|591801778|FG000|Overall Study|Protocol Violation|2|||
163844963|NCT00502996|591801778|FG000|Overall Study|Treatment failure|25|||
163844964|NCT00502996|591801778|FG000|Overall Study|Withdrawal Informed Consent|6|||
163844965|NCT00502996|591801778|FG000|Overall Study|Adverse Event|2|||
163844966|NCT01729728|591801779|FG000|Overall Study|Adverse Event|0|||
163844967|NCT01729728|591801780|FG001|Overall Study|Adverse Event|6|||
163844968|NCT01729728|591801781|FG002|Overall Study|Adverse Event|0|||
163844969|NCT01729728|591801779|FG000|Overall Study|Protocol Violation|1|||
163844970|NCT01729728|591801780|FG001|Overall Study|Protocol Violation|0|||
163844971|NCT01729728|591801781|FG002|Overall Study|Protocol Violation|1|||
163844972|NCT01316692|591801782|FG000|Overall Study|Adverse Event|5|||
163844973|NCT01316692|591801782|FG000|Overall Study|Disease Progression|7|||
163844974|NCT02001974|591801795|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
163844975|NCT02001974|591801796|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
163844976|NCT02001974|591801797|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
163844977|NCT02001974|591801795|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
163844978|NCT02001974|591801796|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
163844979|NCT02001974|591801797|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
163844980|NCT02001974|591801795|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
163844981|NCT02001974|591801796|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
163844982|NCT02001974|591801797|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
163844983|NCT02001974|591801795|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
163844984|NCT02001974|591801796|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
163844985|NCT02001974|591801797|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
163844986|NCT00993317|591801798|FG000|Overall Study|Adverse Event|2|||
163844987|NCT00993317|591801799|FG001|Overall Study|Adverse Event|4|||
163844988|NCT00993317|591801798|FG000|Overall Study|Lack of Efficacy|18|||
163844989|NCT00993317|591801799|FG001|Overall Study|Lack of Efficacy|18|||
163844990|NCT00993317|591801798|FG000|Overall Study|Withdrawal by Subject|0|||
163844991|NCT00993317|591801799|FG001|Overall Study|Withdrawal by Subject|2|||
163844992|NCT00993317|591801798|FG000|Overall Study|Investigator's opinion|0|||
163844993|NCT00993317|591801799|FG001|Overall Study|Investigator's opinion|1|||
163844994|NCT00993317|591801798|FG000|Overall Study|Early study termination at the site|1|||
163844995|NCT00993317|591801799|FG001|Overall Study|Early study termination at the site|0|||
163844996|NCT00672958|591801800|FG000|Overall Study|Adverse Event|11|||
163844997|NCT00672958|591801801|FG001|Overall Study|Adverse Event|9|||
163844998|NCT00672958|591801800|FG000|Overall Study|Lack of Efficacy|6|||
163844999|NCT00672958|591801801|FG001|Overall Study|Lack of Efficacy|11|||
163845000|NCT00672958|591801800|FG000|Overall Study|Non-compliance with study drug|2|||
163845001|NCT00672958|591801801|FG001|Overall Study|Non-compliance with study drug|3|||
163845002|NCT00672958|591801800|FG000|Overall Study|Protocol deviations|11|||
163845003|NCT00672958|591801801|FG001|Overall Study|Protocol deviations|5|||
163845004|NCT00672958|591801800|FG000|Overall Study|Voluntary withdrawal|12|||
163845005|NCT00672958|591801801|FG001|Overall Study|Voluntary withdrawal|8|||
163845006|NCT00672958|591801800|FG000|Overall Study|Lost to Follow-up|22|||
163845007|NCT00672958|591801801|FG001|Overall Study|Lost to Follow-up|17|||
163845008|NCT00672958|591801800|FG000|Overall Study|Reason not specified|0|||
163845009|NCT00672958|591801801|FG001|Overall Study|Reason not specified|3|||
163845010|NCT01380990|591801802|FG000|Overall Study|Treatment Failure|1|||
164304189|NCT00068692|593488397|FG004|Step 1: Registration|Complicating disease|0|||
163845011|NCT01380990|591801803|FG001|Overall Study|Treatment Failure|0|||
163845012|NCT01380990|591801802|FG000|Overall Study|Death|0|||
163845013|NCT01380990|591801803|FG001|Overall Study|Death|1|||
163845014|NCT04422639|591801804|FG000|Overall Study|Death|1|||
163845015|NCT04422639|591801805|FG001|Overall Study|Death|0|||
163845016|NCT04422639|591801804|FG000|Overall Study|study closed prior to completion of FU visits|0|||
163845017|NCT04422639|591801805|FG001|Overall Study|study closed prior to completion of FU visits|2|||
163845018|NCT01964521|591801806|FG000|Overall Study|Lost to Follow-up|4|||
163845019|NCT02374593|591801807|FG000|Overall Study|non-compliant|2|||
163845020|NCT02374593|591801808|FG001|Overall Study|non-compliant|0|||
163845021|NCT01463293|591801810|FG000|Overall Study|Lost to Follow-up|1|||
163845022|NCT01463293|591801811|FG001|Overall Study|Lost to Follow-up|4|||
163845023|NCT01463293|591801812|FG002|Overall Study|Lost to Follow-up|5|||
163845024|NCT01463293|591801810|FG000|Overall Study|Adverse Event|1|||
163845025|NCT01463293|591801811|FG001|Overall Study|Adverse Event|2|||
163845026|NCT01463293|591801812|FG002|Overall Study|Adverse Event|0|||
163845027|NCT01463293|591801810|FG000|Overall Study|Withdrawal by Subject|4|||
163845028|NCT01463293|591801811|FG001|Overall Study|Withdrawal by Subject|10|||
163845029|NCT01463293|591801812|FG002|Overall Study|Withdrawal by Subject|5|||
164189760|NCT04147247|593063959|FG002|Overall Study|Clinical Disease Progression|0|||
164189761|NCT04147247|593063960|FG003|Overall Study|Clinical Disease Progression|0|||
164189762|NCT04147247|593063961|FG004|Overall Study|Clinical Disease Progression|1|||
164189763|NCT04147247|593063957|FG000|Overall Study|Adverse Event|0|||
164189764|NCT04147247|593063958|FG001|Overall Study|Adverse Event|0|||
164189765|NCT04147247|593063959|FG002|Overall Study|Adverse Event|1|||
164189766|NCT04147247|593063960|FG003|Overall Study|Adverse Event|0|||
164189767|NCT04147247|593063961|FG004|Overall Study|Adverse Event|1|||
164189768|NCT01724177|593063962|FG000|Overall Study|Adverse Event|8|||
164189769|NCT01724177|593063962|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
163845030|NCT01463293|591801810|FG000|Overall Study|Other|0|||
163845031|NCT01463293|591801811|FG001|Overall Study|Other|0|||
164189770|NCT01724177|593063962|FG000|Overall Study|Nervous participant|1|||
164189771|NCT01724177|593063962|FG000|Overall Study|Serious Adverse Event Related|1|||
164189772|NCT00327340|593063967|FG000|Overall Study|Withdrawal by Subject|1|||
164189773|NCT00327340|593063968|FG001|Overall Study|Withdrawal by Subject|5|||
164189774|NCT00327340|593063967|FG000|Overall Study|Physician Decision|1|||
164189775|NCT00327340|593063968|FG001|Overall Study|Physician Decision|1|||
164189776|NCT00327340|593063967|FG000|Overall Study|Disease Progression|10|||
164189777|NCT00327340|593063968|FG001|Overall Study|Disease Progression|19|||
164189778|NCT00327340|593063967|FG000|Overall Study|Symptomatic Disease|0|||
164189779|NCT00327340|593063968|FG001|Overall Study|Symptomatic Disease|2|||
164189780|NCT00327340|593063967|FG000|Overall Study|Adverse Event|3|||
164189781|NCT00327340|593063968|FG001|Overall Study|Adverse Event|3|||
164189782|NCT00206427|593063972|FG000|Overall Study|Adverse Event|2|||
164189783|NCT04085601|593063973|FG000|Overall Study|Lost to Follow-up|1|||
164189784|NCT04085601|593063974|FG001|Overall Study|Lost to Follow-up|0|||
164189785|NCT04085601|593063973|FG000|Overall Study|Death|1|||
164189786|NCT04085601|593063974|FG001|Overall Study|Death|1|||
164189787|NCT03492437|593063975|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164189788|NCT03492437|593063976|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164189789|NCT02915159|593063978|FG000|Overall Study|Participant no longer meets criteria|2|||
164189790|NCT02915159|593063979|FG001|Overall Study|Participant no longer meets criteria|0|||
164189791|NCT02915159|593063978|FG000|Overall Study|poor/non-compliance|1|||
164189792|NCT02915159|593063979|FG001|Overall Study|poor/non-compliance|0|||
164189793|NCT02915159|593063978|FG000|Overall Study|Participant withdrew consent|5|||
164189794|NCT02915159|593063979|FG001|Overall Study|Participant withdrew consent|1|||
164189795|NCT02915159|593063978|FG000|Overall Study|Request to discontinue treatment|1|||
164189796|NCT02915159|593063979|FG001|Overall Study|Request to discontinue treatment|2|||
164189797|NCT02915159|593063978|FG000|Overall Study|Adverse Event|2|||
164189798|NCT02915159|593063979|FG001|Overall Study|Adverse Event|2|||
164189799|NCT02915159|593063978|FG000|Overall Study|Lack of Efficacy|0|||
164189800|NCT02915159|593063979|FG001|Overall Study|Lack of Efficacy|3|||
164189801|NCT04534517|593063980|FG000|Overall Study|Adverse Event|1|||
164189802|NCT04534517|593063980|FG000|Overall Study|Withdrawal by Subject|1|||
164189803|NCT04534517|593063980|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164189804|NCT04534517|593063980|FG000|Overall Study|COVID-19 Related|1|||
164304190|NCT00068692|593488398|FG005|Step 1: Registration|Complicating disease|0|||
164304191|NCT00068692|593488399|FG006|Step 1: Registration|Complicating disease|0|||
164304192|NCT00068692|593488400|FG007|Step 1: Registration|Complicating disease|0|||
164304193|NCT00068692|593488393|FG000|Step 1: Registration|Protocol Violation|1|||
164304194|NCT00068692|593488394|FG001|Step 1: Registration|Protocol Violation|0|||
164304195|NCT00068692|593488395|FG002|Step 1: Registration|Protocol Violation|0|||
164304196|NCT00068692|593488396|FG003|Step 1: Registration|Protocol Violation|0|||
164304197|NCT00068692|593488397|FG004|Step 1: Registration|Protocol Violation|0|||
163845032|NCT01463293|591801812|FG002|Overall Study|Other|2|||
163845033|NCT02796963|591801813|FG000|Overall Study|Lost to Follow-up|89|||
163845034|NCT02796963|591801814|FG001|Overall Study|Lost to Follow-up|76|||
163845035|NCT02796963|591801815|FG002|Overall Study|Lost to Follow-up|69|||
163845036|NCT02796963|591801816|FG003|Overall Study|Lost to Follow-up|72|||
163845037|NCT03192215|591801817|FG000|Overall Study|Death|28|||
164189805|NCT02121795|593063981|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
164189806|NCT02121795|593063982|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
164189807|NCT02121795|593063981|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
164304198|NCT00068692|593488398|FG005|Step 1: Registration|Protocol Violation|0|||
164304199|NCT00068692|593488399|FG006|Step 1: Registration|Protocol Violation|0|||
164304200|NCT00068692|593488400|FG007|Step 1: Registration|Protocol Violation|0|||
164304201|NCT00068692|593488393|FG000|Step 1: Registration|Not eligible|6|||
164304202|NCT00068692|593488394|FG001|Step 1: Registration|Not eligible|0|||
164304203|NCT00068692|593488395|FG002|Step 1: Registration|Not eligible|0|||
164304204|NCT00068692|593488396|FG003|Step 1: Registration|Not eligible|0|||
164304205|NCT00068692|593488397|FG004|Step 1: Registration|Not eligible|0|||
164304206|NCT00068692|593488398|FG005|Step 1: Registration|Not eligible|0|||
164304207|NCT00068692|593488399|FG006|Step 1: Registration|Not eligible|0|||
164304208|NCT00068692|593488400|FG007|Step 1: Registration|Not eligible|0|||
164304209|NCT00068692|593488393|FG000|Step 1: Registration|Other|2|||
164304210|NCT00068692|593488394|FG001|Step 1: Registration|Other|0|||
164304211|NCT00068692|593488395|FG002|Step 1: Registration|Other|0|||
164304212|NCT00068692|593488396|FG003|Step 1: Registration|Other|0|||
164304213|NCT00068692|593488397|FG004|Step 1: Registration|Other|0|||
164304214|NCT00068692|593488398|FG005|Step 1: Registration|Other|0|||
164304215|NCT00068692|593488399|FG006|Step 1: Registration|Other|0|||
163845038|NCT03192215|591801818|FG001|Overall Study|Death|23|||
163845039|NCT03192215|591801817|FG000|Overall Study|Lost to Follow-up|10|||
163845040|NCT03192215|591801818|FG001|Overall Study|Lost to Follow-up|15|||
163845041|NCT03192215|591801817|FG000|Overall Study|Withdrawal by Subject|49|||
163845042|NCT03192215|591801818|FG001|Overall Study|Withdrawal by Subject|48|||
163845043|NCT03192215|591801817|FG000|Overall Study|Other as reported in analysis|4|||
163845044|NCT03192215|591801818|FG001|Overall Study|Other as reported in analysis|1|||
163845045|NCT04844918|591801821|FG000|Overall Study|Adverse Event|7|||
163845046|NCT04844918|591801822|FG001|Overall Study|Adverse Event|8|||
163845047|NCT04844918|591801823|FG002|Overall Study|Adverse Event|5|||
163845048|NCT04844918|591801821|FG000|Overall Study|Physician Decision|0|||
164304216|NCT00068692|593488400|FG007|Step 1: Registration|Other|0|||
164304217|NCT00068692|593488393|FG000|Step 1: Registration|Not start protocol therapy|3|||
164304218|NCT00068692|593488394|FG001|Step 1: Registration|Not start protocol therapy|0|||
164304219|NCT00068692|593488395|FG002|Step 1: Registration|Not start protocol therapy|0|||
164304220|NCT00068692|593488396|FG003|Step 1: Registration|Not start protocol therapy|0|||
164304221|NCT00068692|593488397|FG004|Step 1: Registration|Not start protocol therapy|0|||
164304222|NCT00068692|593488398|FG005|Step 1: Registration|Not start protocol therapy|0|||
164304223|NCT00068692|593488399|FG006|Step 1: Registration|Not start protocol therapy|0|||
164304224|NCT00068692|593488400|FG007|Step 1: Registration|Not start protocol therapy|0|||
164304225|NCT00068692|593488393|FG000|Step 1: Registration|Registered but not randomized|0|||
163845049|NCT04844918|591801822|FG001|Overall Study|Physician Decision|1|||
163845050|NCT04844918|591801823|FG002|Overall Study|Physician Decision|0|||
163845051|NCT04844918|591801821|FG000|Overall Study|Withdrawal by Subject|6|||
163845052|NCT04844918|591801822|FG001|Overall Study|Withdrawal by Subject|3|||
163845053|NCT04844918|591801823|FG002|Overall Study|Withdrawal by Subject|3|||
163845054|NCT04844918|591801821|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
163845055|NCT04844918|591801822|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
163845056|NCT04844918|591801823|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
163845057|NCT01009047|591801827|FG000|Overall Study|Adverse Event|5|||
163845058|NCT01009047|591801828|FG001|Overall Study|Adverse Event|0|||
163845059|NCT01009047|591801827|FG000|Overall Study|Lost to Follow-up|0|||
163845060|NCT01009047|591801828|FG001|Overall Study|Lost to Follow-up|2|||
163845061|NCT01009047|591801827|FG000|Overall Study|Lack of Efficacy|4|||
163845062|NCT01009047|591801828|FG001|Overall Study|Lack of Efficacy|11|||
163845063|NCT01009047|591801827|FG000|Overall Study|Withdrawal by consent|16|||
163845064|NCT01009047|591801828|FG001|Overall Study|Withdrawal by consent|11|||
163845065|NCT01009047|591801827|FG000|Overall Study|Other|3|||
163845066|NCT01009047|591801828|FG001|Overall Study|Other|2|||
163845067|NCT01146574|591801834|FG000|Overall Study|Death|0|||
164304226|NCT00068692|593488394|FG001|Step 1: Registration|Registered but not randomized|1|||
164304227|NCT00068692|593488395|FG002|Step 1: Registration|Registered but not randomized|0|||
164304228|NCT00068692|593488396|FG003|Step 1: Registration|Registered but not randomized|0|||
164304229|NCT00068692|593488397|FG004|Step 1: Registration|Registered but not randomized|0|||
164304230|NCT00068692|593488398|FG005|Step 1: Registration|Registered but not randomized|0|||
163845068|NCT01146574|591801835|FG001|Overall Study|Death|1|||
163845069|NCT01146574|591801836|FG002|Overall Study|Death|1|||
163845070|NCT01146574|591801837|FG003|Overall Study|Death|0|||
163845071|NCT01146574|591801838|FG004|Overall Study|Death|0|||
163845072|NCT01146574|591801839|FG005|Overall Study|Death|0|||
163845073|NCT01146574|591801840|FG006|Overall Study|Death|0|||
163845074|NCT01146574|591801834|FG000|Overall Study|Other reasons|0|||
164304231|NCT00068692|593488399|FG006|Step 1: Registration|Registered but not randomized|0|||
164304232|NCT00068692|593488400|FG007|Step 1: Registration|Registered but not randomized|0|||
164304233|NCT00068692|593488393|FG000|Step 2: Randomization|Disesae progression/replase|0|||
163845075|NCT01146574|591801835|FG001|Overall Study|Other reasons|0|||
163845076|NCT01146574|591801836|FG002|Overall Study|Other reasons|3|||
163845077|NCT01146574|591801837|FG003|Overall Study|Other reasons|0|||
164304234|NCT00068692|593488394|FG001|Step 2: Randomization|Disesae progression/replase|0|||
164304235|NCT00068692|593488395|FG002|Step 2: Randomization|Disesae progression/replase|1|||
164304236|NCT00068692|593488396|FG003|Step 2: Randomization|Disesae progression/replase|1|||
164304237|NCT00068692|593488397|FG004|Step 2: Randomization|Disesae progression/replase|0|||
164304238|NCT00068692|593488398|FG005|Step 2: Randomization|Disesae progression/replase|0|||
164304239|NCT00068692|593488399|FG006|Step 2: Randomization|Disesae progression/replase|0|||
164304240|NCT00068692|593488400|FG007|Step 2: Randomization|Disesae progression/replase|0|||
164304241|NCT00068692|593488393|FG000|Step 2: Randomization|Adverse Event|0|||
164304242|NCT00068692|593488394|FG001|Step 2: Randomization|Adverse Event|0|||
164304243|NCT00068692|593488395|FG002|Step 2: Randomization|Adverse Event|4|||
164304244|NCT00068692|593488396|FG003|Step 2: Randomization|Adverse Event|2|||
164304245|NCT00068692|593488397|FG004|Step 2: Randomization|Adverse Event|2|||
164304246|NCT00068692|593488398|FG005|Step 2: Randomization|Adverse Event|3|||
164304247|NCT00068692|593488399|FG006|Step 2: Randomization|Adverse Event|4|||
164304248|NCT00068692|593488400|FG007|Step 2: Randomization|Adverse Event|4|||
164304249|NCT00068692|593488393|FG000|Step 2: Randomization|Death|0|||
164304250|NCT00068692|593488394|FG001|Step 2: Randomization|Death|0|||
164304251|NCT00068692|593488395|FG002|Step 2: Randomization|Death|0|||
164304252|NCT00068692|593488396|FG003|Step 2: Randomization|Death|0|||
164304253|NCT00068692|593488397|FG004|Step 2: Randomization|Death|1|||
164304254|NCT00068692|593488398|FG005|Step 2: Randomization|Death|0|||
164304255|NCT00068692|593488399|FG006|Step 2: Randomization|Death|0|||
164304256|NCT00068692|593488400|FG007|Step 2: Randomization|Death|1|||
164304257|NCT00068692|593488393|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
164304258|NCT00068692|593488394|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
164304259|NCT00068692|593488395|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
164304260|NCT00068692|593488396|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
164304261|NCT00068692|593488397|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
164304262|NCT00068692|593488398|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
164304263|NCT00068692|593488399|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
164304264|NCT00068692|593488400|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
164304265|NCT00068692|593488393|FG000|Step 2: Randomization|alternative therapy|0|||
164304266|NCT00068692|593488394|FG001|Step 2: Randomization|alternative therapy|0|||
164304267|NCT00068692|593488395|FG002|Step 2: Randomization|alternative therapy|0|||
164304268|NCT00068692|593488396|FG003|Step 2: Randomization|alternative therapy|1|||
164304269|NCT00068692|593488397|FG004|Step 2: Randomization|alternative therapy|1|||
164304270|NCT00068692|593488398|FG005|Step 2: Randomization|alternative therapy|0|||
164304271|NCT00068692|593488399|FG006|Step 2: Randomization|alternative therapy|0|||
164304272|NCT00068692|593488400|FG007|Step 2: Randomization|alternative therapy|0|||
164304273|NCT00068692|593488393|FG000|Step 2: Randomization|Physician Decision|0|||
164304274|NCT00068692|593488394|FG001|Step 2: Randomization|Physician Decision|0|||
164304275|NCT00068692|593488395|FG002|Step 2: Randomization|Physician Decision|0|||
164304276|NCT00068692|593488396|FG003|Step 2: Randomization|Physician Decision|1|||
164304277|NCT00068692|593488397|FG004|Step 2: Randomization|Physician Decision|1|||
164304278|NCT00068692|593488398|FG005|Step 2: Randomization|Physician Decision|0|||
164304279|NCT00068692|593488399|FG006|Step 2: Randomization|Physician Decision|0|||
164304280|NCT00068692|593488400|FG007|Step 2: Randomization|Physician Decision|0|||
164304281|NCT00068692|593488393|FG000|Step 2: Randomization|Other|0|||
164304282|NCT00068692|593488394|FG001|Step 2: Randomization|Other|0|||
164304283|NCT00068692|593488395|FG002|Step 2: Randomization|Other|0|||
164304284|NCT00068692|593488396|FG003|Step 2: Randomization|Other|1|||
164304285|NCT00068692|593488397|FG004|Step 2: Randomization|Other|0|||
164304286|NCT00068692|593488398|FG005|Step 2: Randomization|Other|1|||
164304287|NCT00068692|593488399|FG006|Step 2: Randomization|Other|0|||
164304288|NCT00068692|593488400|FG007|Step 2: Randomization|Other|0|||
164304289|NCT00068692|593488393|FG000|Step 2: Randomization|never start protocol therapy|0|||
164304290|NCT00068692|593488394|FG001|Step 2: Randomization|never start protocol therapy|0|||
164304291|NCT00068692|593488395|FG002|Step 2: Randomization|never start protocol therapy|1|||
164304292|NCT00068692|593488396|FG003|Step 2: Randomization|never start protocol therapy|0|||
164304293|NCT00068692|593488397|FG004|Step 2: Randomization|never start protocol therapy|1|||
164304294|NCT00068692|593488398|FG005|Step 2: Randomization|never start protocol therapy|0|||
164304295|NCT00068692|593488399|FG006|Step 2: Randomization|never start protocol therapy|0|||
164304296|NCT00068692|593488400|FG007|Step 2: Randomization|never start protocol therapy|0|||
164304297|NCT01600716|593488402|FG000|Overall Study|Other Reasons|3|||
164304298|NCT01600716|593488403|FG001|Overall Study|Other Reasons|1|||
164304299|NCT01600716|593488402|FG000|Overall Study|Personal Reasons|0|||
164304300|NCT01600716|593488403|FG001|Overall Study|Personal Reasons|2|||
164304301|NCT01600716|593488402|FG000|Overall Study|Lost to Follow-up|0|||
164304302|NCT01600716|593488403|FG001|Overall Study|Lost to Follow-up|2|||
164304303|NCT01600716|593488402|FG000|Overall Study|Pregnancy|1|||
164304304|NCT01600716|593488403|FG001|Overall Study|Pregnancy|0|||
164304305|NCT01600716|593488402|FG000|Overall Study|Lack of Efficacy|2|||
164304306|NCT01600716|593488403|FG001|Overall Study|Lack of Efficacy|1|||
164304307|NCT01600716|593488402|FG000|Overall Study|Adverse Event|1|||
164304308|NCT01600716|593488403|FG001|Overall Study|Adverse Event|1|||
164304309|NCT03557034|593488406|FG000|Overall Study|Withdrawal by Subject|1|||
164304310|NCT03557034|593488407|FG001|Overall Study|Withdrawal by Subject|0|||
164304311|NCT03349034|593488410|FG000|Overall Study|catheters dislodged during transport|2|||
164304312|NCT03349034|593488411|FG001|Overall Study|catheters dislodged during transport|0|||
164304313|NCT03349034|593488410|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
164304314|NCT03349034|593488411|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
164304315|NCT03349034|593488410|FG000|Overall Study|soft tissue flap used|1|||
164304316|NCT03349034|593488411|FG001|Overall Study|soft tissue flap used|0|||
164304317|NCT03349034|593488410|FG000|Overall Study|Other|0|||
164304318|NCT03349034|593488411|FG001|Overall Study|Other|1|||
164304319|NCT00123422|593488412|FG000|Overall Study|Physician Decision|2|||
164304320|NCT00123422|593488413|FG001|Overall Study|Physician Decision|2|||
164304321|NCT00123422|593488414|FG002|Overall Study|Physician Decision|6|||
164304322|NCT00123422|593488412|FG000|Overall Study|Withdrawal by Subject|1|||
164304323|NCT00123422|593488413|FG001|Overall Study|Withdrawal by Subject|2|||
164304324|NCT00123422|593488414|FG002|Overall Study|Withdrawal by Subject|2|||
164304325|NCT00123422|593488412|FG000|Overall Study|Lost to Follow-up|1|||
164304326|NCT00123422|593488413|FG001|Overall Study|Lost to Follow-up|2|||
164304327|NCT00123422|593488414|FG002|Overall Study|Lost to Follow-up|2|||
164304328|NCT00602472|593488419|FG000|Overall Study|Adverse Event|5|||
164304329|NCT00602472|593488420|FG001|Overall Study|Adverse Event|23|||
164304330|NCT00602472|593488419|FG000|Overall Study|Protocol Violation|4|||
164304331|NCT00602472|593488420|FG001|Overall Study|Protocol Violation|19|||
164304332|NCT00602472|593488419|FG000|Overall Study|Withdrawal by Subject|8|||
164304333|NCT00602472|593488420|FG001|Overall Study|Withdrawal by Subject|14|||
164304334|NCT00602472|593488419|FG000|Overall Study|Other incl. lack of efficacy|4|||
164304335|NCT00602472|593488420|FG001|Overall Study|Other incl. lack of efficacy|2|||
164304336|NCT01938716|593488421|FG000|Overall Study|Physician Decision|2|||
164304337|NCT01938716|593488421|FG000|Overall Study|Withdrawal by Subject|2|||
164304338|NCT01908803|593488422|FG000|Overall Study|Adverse Event|1|||
164304339|NCT01908803|593488423|FG001|Overall Study|Adverse Event|0|||
164304340|NCT01908803|593488422|FG000|Overall Study|Physician Decision|0|||
164304341|NCT01908803|593488423|FG001|Overall Study|Physician Decision|1|||
164304342|NCT01908803|593488422|FG000|Overall Study|Withdrawal by Subject|1|||
164304343|NCT01908803|593488423|FG001|Overall Study|Withdrawal by Subject|0|||
164304344|NCT01908803|593488422|FG000|Overall Study|Randomization Error|1|||
164304345|NCT01908803|593488423|FG001|Overall Study|Randomization Error|0|||
164304346|NCT01908803|593488422|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
164304347|NCT01908803|593488423|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
164304348|NCT00823615|593488424|FG000|Period 2|Lost to Follow-up|2|||
164304349|NCT00823615|593488425|FG001|Period 2|Lost to Follow-up|0|||
164304350|NCT00823615|593488424|FG000|Period 2|Time/Job Conflict|1|||
164304351|NCT00823615|593488425|FG001|Period 2|Time/Job Conflict|2|||
164304352|NCT00098813|593488426|FG000|Overall Study|Death|8|||
164304353|NCT00098813|593488426|FG000|Overall Study|Protocol Violation|1|||
164304354|NCT00098813|593488426|FG000|Overall Study|Withdrawal by Subject|7|||
164304355|NCT00098813|593488426|FG000|Overall Study|Progression of Disease|1|||
164304356|NCT00098813|593488426|FG000|Overall Study|Other complicating disease|1|||
164304357|NCT00098813|593488426|FG000|Overall Study|Reversal of RAI resistance|1|||
164304358|NCT00433004|593488428|FG000|Overall Study|Lost to Follow-up|5|||
164304359|NCT00433004|593488429|FG001|Overall Study|Lost to Follow-up|7|||
164304360|NCT04730271|593488431|FG000|Overall Study|Adverse Event|0|||
164304361|NCT04730271|593488432|FG001|Overall Study|Adverse Event|2|||
164304362|NCT04730271|593488431|FG000|Overall Study|Withdrawal by Subject|1|||
164304363|NCT04730271|593488432|FG001|Overall Study|Withdrawal by Subject|1|||
164304364|NCT04730271|593488431|FG000|Overall Study|Protocol Violation|7|||
164304365|NCT04730271|593488432|FG001|Overall Study|Protocol Violation|13|||
164304366|NCT04730271|593488431|FG000|Overall Study|Lost to Follow-up|3|||
164304367|NCT04730271|593488432|FG001|Overall Study|Lost to Follow-up|3|||
164304368|NCT04730271|593488431|FG000|Overall Study|Death|1|||
164304369|NCT04730271|593488432|FG001|Overall Study|Death|0|||
164304370|NCT00998296|593488433|FG000|Overall Study|Progressive disease|0|||
164304371|NCT00998296|593488434|FG001|Overall Study|Progressive disease|1|||
164304372|NCT00998296|593488435|FG002|Overall Study|Progressive disease|0|||
164304373|NCT00998296|593488436|FG003|Overall Study|Progressive disease|0|||
164304374|NCT00998296|593488437|FG004|Overall Study|Progressive disease|0|||
164304375|NCT00998296|593488438|FG005|Overall Study|Progressive disease|0|||
164304376|NCT00998296|593488439|FG006|Overall Study|Progressive disease|1|||
164304377|NCT00998296|593488440|FG007|Overall Study|Progressive disease|0|||
164304378|NCT00998296|593488441|FG008|Overall Study|Progressive disease|0|||
164304379|NCT00998296|593488442|FG009|Overall Study|Progressive disease|14|||
164304380|NCT00998296|593488443|FG010|Overall Study|Progressive disease|5|||
164304381|NCT00998296|593488433|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304382|NCT00998296|593488434|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304383|NCT00998296|593488435|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304384|NCT00998296|593488436|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304385|NCT00998296|593488437|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
164189808|NCT02121795|593063982|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
164189809|NCT02121795|593063981|FG000|Double-Blind Phase|Lost to Follow-up|7|||
164189810|NCT02121795|593063982|FG001|Double-Blind Phase|Lost to Follow-up|4|||
164189811|NCT02121795|593063981|FG000|Double-Blind Phase|Physician Decision|2|||
164189812|NCT02121795|593063982|FG001|Double-Blind Phase|Physician Decision|5|||
164189813|NCT02121795|593063981|FG000|Double-Blind Phase|Adverse Event|5|||
164189814|NCT02121795|593063982|FG001|Double-Blind Phase|Adverse Event|0|||
164189815|NCT02121795|593063981|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
164189816|NCT02121795|593063982|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164189817|NCT02121795|593063981|FG000|Double-Blind Phase|Protocol Violation|0|||
164189818|NCT02121795|593063982|FG001|Double-Blind Phase|Protocol Violation|3|||
164189819|NCT02121795|593063981|FG000|Double-Blind Phase|Death|1|||
164189820|NCT02121795|593063982|FG001|Double-Blind Phase|Death|1|||
164189821|NCT02121795|593063981|FG000|Open-Label Phase|Physician Decision|8|||
164189822|NCT02121795|593063982|FG001|Open-Label Phase|Physician Decision|8|||
164189823|NCT02121795|593063981|FG000|Open-Label Phase|Withdrawal by Subject|3|||
164189824|NCT02121795|593063982|FG001|Open-Label Phase|Withdrawal by Subject|2|||
164189825|NCT02121795|593063981|FG000|Open-Label Phase|Lost to Follow-up|1|||
164189826|NCT02121795|593063982|FG001|Open-Label Phase|Lost to Follow-up|0|||
164189827|NCT01914393|593063983|FG000|Overall Study|Protocol Violation|11|||
164189828|NCT01914393|593063984|FG001|Overall Study|Protocol Violation|3|||
164189829|NCT01914393|593063985|FG002|Overall Study|Protocol Violation|19|||
164189830|NCT01914393|593063983|FG000|Overall Study|Lack of Efficacy|11|||
164189831|NCT01914393|593063984|FG001|Overall Study|Lack of Efficacy|16|||
164189832|NCT01914393|593063985|FG002|Overall Study|Lack of Efficacy|5|||
164189833|NCT01914393|593063983|FG000|Overall Study|no reason given|14|||
164189834|NCT01914393|593063984|FG001|Overall Study|no reason given|8|||
164189835|NCT01914393|593063985|FG002|Overall Study|no reason given|16|||
164189836|NCT01914393|593063983|FG000|Overall Study|Adverse Event|29|||
164189837|NCT01914393|593063984|FG001|Overall Study|Adverse Event|18|||
164189838|NCT01914393|593063985|FG002|Overall Study|Adverse Event|31|||
164189839|NCT01914393|593063983|FG000|Overall Study|Withdrawal by Subject|38|||
164189840|NCT01914393|593063984|FG001|Overall Study|Withdrawal by Subject|20|||
164189841|NCT01914393|593063985|FG002|Overall Study|Withdrawal by Subject|47|||
164189842|NCT01914393|593063983|FG000|Overall Study|Lost to Follow-up|12|||
164189843|NCT01914393|593063984|FG001|Overall Study|Lost to Follow-up|6|||
164189844|NCT01914393|593063985|FG002|Overall Study|Lost to Follow-up|19|||
164189845|NCT01914393|593063983|FG000|Overall Study|subject never dosed|0|||
164189846|NCT01914393|593063984|FG001|Overall Study|subject never dosed|0|||
164189847|NCT01914393|593063985|FG002|Overall Study|subject never dosed|1|||
164189848|NCT00572455|593063986|FG000|Stage I (14 Days)|Adverse Event|0|||
164189849|NCT00572455|593063987|FG001|Stage I (14 Days)|Adverse Event|0|||
164189850|NCT00572455|593063988|FG002|Stage I (14 Days)|Adverse Event|0|||
164189851|NCT00572455|593063989|FG003|Stage I (14 Days)|Adverse Event|0|||
164189852|NCT00572455|593063990|FG004|Stage I (14 Days)|Adverse Event|0|||
164189853|NCT00572455|593063991|FG005|Stage I (14 Days)|Adverse Event|3|||
164189854|NCT00572455|593063992|FG006|Stage I (14 Days)|Adverse Event|0|||
164189855|NCT00572455|593063993|FG007|Stage I (14 Days)|Adverse Event|0|||
164189856|NCT00572455|593063994|FG008|Stage I (14 Days)|Adverse Event|0|||
164189857|NCT00572455|593063995|FG009|Stage I (14 Days)|Adverse Event|0|||
164189858|NCT00572455|593063996|FG010|Stage I (14 Days)|Adverse Event|0|||
164189859|NCT00572455|593063997|FG011|Stage I (14 Days)|Adverse Event|0|||
164189860|NCT00572455|593063998|FG012|Stage I (14 Days)|Adverse Event|0|||
164189861|NCT00572455|593063999|FG013|Stage I (14 Days)|Adverse Event|0|||
164189862|NCT00572455|593063986|FG000|Stage I (14 Days)|Other|0|||
164189863|NCT00572455|593063987|FG001|Stage I (14 Days)|Other|0|||
164189864|NCT00572455|593063988|FG002|Stage I (14 Days)|Other|0|||
164189865|NCT00572455|593063989|FG003|Stage I (14 Days)|Other|0|||
164189866|NCT00572455|593063990|FG004|Stage I (14 Days)|Other|1|||
164189867|NCT00572455|593063991|FG005|Stage I (14 Days)|Other|0|||
164189868|NCT00572455|593063992|FG006|Stage I (14 Days)|Other|0|||
164189869|NCT00572455|593063993|FG007|Stage I (14 Days)|Other|0|||
164189870|NCT00572455|593063994|FG008|Stage I (14 Days)|Other|0|||
164189871|NCT00572455|593063995|FG009|Stage I (14 Days)|Other|0|||
164189872|NCT00572455|593063996|FG010|Stage I (14 Days)|Other|0|||
164189873|NCT00572455|593063997|FG011|Stage I (14 Days)|Other|0|||
164189874|NCT00572455|593063998|FG012|Stage I (14 Days)|Other|0|||
164189875|NCT00572455|593063999|FG013|Stage I (14 Days)|Other|0|||
164189876|NCT00572455|593063986|FG000|Stage II (28 Days)|Adverse Event|0|||
164189877|NCT00572455|593063987|FG001|Stage II (28 Days)|Adverse Event|0|||
164189878|NCT00572455|593063988|FG002|Stage II (28 Days)|Adverse Event|0|||
164189879|NCT00572455|593063989|FG003|Stage II (28 Days)|Adverse Event|0|||
164189880|NCT00572455|593063990|FG004|Stage II (28 Days)|Adverse Event|0|||
164189881|NCT00572455|593063991|FG005|Stage II (28 Days)|Adverse Event|0|||
164189882|NCT00572455|593063992|FG006|Stage II (28 Days)|Adverse Event|0|||
164189883|NCT00572455|593063993|FG007|Stage II (28 Days)|Adverse Event|0|||
164189884|NCT00572455|593063994|FG008|Stage II (28 Days)|Adverse Event|1|||
164189885|NCT00572455|593063995|FG009|Stage II (28 Days)|Adverse Event|3|||
164189886|NCT00572455|593063996|FG010|Stage II (28 Days)|Adverse Event|3|||
164189887|NCT00572455|593063997|FG011|Stage II (28 Days)|Adverse Event|4|||
164189888|NCT00572455|593063998|FG012|Stage II (28 Days)|Adverse Event|5|||
164304386|NCT00998296|593488438|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304387|NCT00998296|593488439|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304388|NCT00998296|593488440|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
164304389|NCT00998296|593488441|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
164304390|NCT00998296|593488442|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304391|NCT00998296|593488443|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
164304392|NCT00998296|593488433|FG000|Overall Study|Other adverse event|0|||
164304393|NCT00998296|593488434|FG001|Overall Study|Other adverse event|0|||
164304394|NCT00998296|593488435|FG002|Overall Study|Other adverse event|0|||
164304395|NCT00998296|593488436|FG003|Overall Study|Other adverse event|0|||
164304396|NCT00998296|593488437|FG004|Overall Study|Other adverse event|1|||
164304397|NCT00998296|593488438|FG005|Overall Study|Other adverse event|0|||
164304398|NCT00998296|593488439|FG006|Overall Study|Other adverse event|0|||
164304399|NCT00998296|593488440|FG007|Overall Study|Other adverse event|0|||
164304400|NCT00998296|593488441|FG008|Overall Study|Other adverse event|0|||
164304401|NCT00998296|593488442|FG009|Overall Study|Other adverse event|1|||
163845078|NCT01146574|591801838|FG004|Overall Study|Other reasons|0|||
163845079|NCT01146574|591801839|FG005|Overall Study|Other reasons|0|||
163845080|NCT01146574|591801840|FG006|Overall Study|Other reasons|0|||
163845081|NCT01146574|591801834|FG000|Overall Study|Kidney transplant|0|||
163845082|NCT01146574|591801835|FG001|Overall Study|Kidney transplant|0|||
163845083|NCT01146574|591801836|FG002|Overall Study|Kidney transplant|1|||
163845084|NCT01146574|591801837|FG003|Overall Study|Kidney transplant|1|||
163845085|NCT01146574|591801838|FG004|Overall Study|Kidney transplant|0|||
163845086|NCT01146574|591801839|FG005|Overall Study|Kidney transplant|0|||
163845087|NCT01146574|591801840|FG006|Overall Study|Kidney transplant|0|||
163845088|NCT01146574|591801834|FG000|Overall Study|Withdrew consent|0|||
163845089|NCT01146574|591801835|FG001|Overall Study|Withdrew consent|0|||
163845090|NCT01146574|591801836|FG002|Overall Study|Withdrew consent|1|||
163845091|NCT01146574|591801837|FG003|Overall Study|Withdrew consent|1|||
163845092|NCT01146574|591801838|FG004|Overall Study|Withdrew consent|2|||
163845093|NCT01146574|591801839|FG005|Overall Study|Withdrew consent|1|||
163845094|NCT01146574|591801840|FG006|Overall Study|Withdrew consent|1|||
163845095|NCT00876460|591801844|FG000|Combination Therapy Phase|Progressive disease|2|||
163845096|NCT00876460|591801845|FG001|Combination Therapy Phase|Progressive disease|3|||
163845097|NCT00876460|591801846|FG002|Combination Therapy Phase|Progressive disease|3|||
163845098|NCT00876460|591801847|FG003|Combination Therapy Phase|Progressive disease|3|||
163845099|NCT00876460|591801848|FG004|Combination Therapy Phase|Progressive disease|3|||
163845100|NCT00876460|591801849|FG005|Combination Therapy Phase|Progressive disease|1|||
163845101|NCT00876460|591801850|FG006|Combination Therapy Phase|Progressive disease|1|||
163845102|NCT00876460|591801851|FG007|Combination Therapy Phase|Progressive disease|1|||
163845103|NCT00876460|591801844|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
163845104|NCT00876460|591801845|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
163845105|NCT00876460|591801846|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
163845106|NCT00876460|591801847|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
163845107|NCT00876460|591801848|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
163845108|NCT00876460|591801849|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
163845109|NCT00876460|591801850|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
163845110|NCT00876460|591801851|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
163845111|NCT00876460|591801844|FG000|Combination Therapy Phase|Adverse Event|0|||
164304402|NCT00998296|593488443|FG010|Overall Study|Other adverse event|2|||
164304403|NCT00998296|593488433|FG000|Overall Study|Refused to continue taking trial med.|0|||
164304404|NCT00998296|593488434|FG001|Overall Study|Refused to continue taking trial med.|0|||
164304405|NCT00998296|593488435|FG002|Overall Study|Refused to continue taking trial med.|0|||
164304406|NCT00998296|593488436|FG003|Overall Study|Refused to continue taking trial med.|0|||
164304407|NCT00998296|593488437|FG004|Overall Study|Refused to continue taking trial med.|0|||
163845112|NCT00876460|591801845|FG001|Combination Therapy Phase|Adverse Event|2|||
163845113|NCT00876460|591801846|FG002|Combination Therapy Phase|Adverse Event|0|||
163845114|NCT00876460|591801847|FG003|Combination Therapy Phase|Adverse Event|2|||
163845115|NCT00876460|591801848|FG004|Combination Therapy Phase|Adverse Event|2|||
163845116|NCT00876460|591801849|FG005|Combination Therapy Phase|Adverse Event|0|||
163845117|NCT00876460|591801850|FG006|Combination Therapy Phase|Adverse Event|3|||
164304408|NCT00998296|593488438|FG005|Overall Study|Refused to continue taking trial med.|0|||
164304409|NCT00998296|593488439|FG006|Overall Study|Refused to continue taking trial med.|0|||
164304410|NCT00998296|593488440|FG007|Overall Study|Refused to continue taking trial med.|0|||
163845118|NCT00876460|591801851|FG007|Combination Therapy Phase|Adverse Event|2|||
163845119|NCT00876460|591801844|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
163845120|NCT00876460|591801845|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
163845121|NCT00876460|591801846|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
163845122|NCT00876460|591801847|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
163845123|NCT00876460|591801848|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
163845124|NCT00876460|591801849|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
163959600|NCT03226392|592224045|FG000|Overall Study|Technical Problems|0|||
164304411|NCT00998296|593488441|FG008|Overall Study|Refused to continue taking trial med.|0|||
164304412|NCT00998296|593488442|FG009|Overall Study|Refused to continue taking trial med.|2|||
164304413|NCT00998296|593488443|FG010|Overall Study|Refused to continue taking trial med.|0|||
164304414|NCT00998296|593488433|FG000|Overall Study|Reason other than those specified above|0|||
164304415|NCT00998296|593488434|FG001|Overall Study|Reason other than those specified above|0|||
164304416|NCT00998296|593488435|FG002|Overall Study|Reason other than those specified above|0|||
164304417|NCT00998296|593488436|FG003|Overall Study|Reason other than those specified above|0|||
164304418|NCT00998296|593488437|FG004|Overall Study|Reason other than those specified above|0|||
164304419|NCT00998296|593488438|FG005|Overall Study|Reason other than those specified above|0|||
164304420|NCT00998296|593488439|FG006|Overall Study|Reason other than those specified above|0|||
164304421|NCT00998296|593488440|FG007|Overall Study|Reason other than those specified above|0|||
164304422|NCT00998296|593488441|FG008|Overall Study|Reason other than those specified above|0|||
164304423|NCT00998296|593488442|FG009|Overall Study|Reason other than those specified above|1|||
164304424|NCT00998296|593488443|FG010|Overall Study|Reason other than those specified above|0|||
164304425|NCT04396639|593488446|FG000|Overall Study|Withdrawal by Subject|1|||
164304426|NCT04396639|593488446|FG000|Overall Study|Other|1|||
164304427|NCT02106390|593488447|FG000|Overall Study|Withdrawal by Subject|15|||
164304428|NCT02106390|593488448|FG001|Overall Study|Withdrawal by Subject|16|||
164304429|NCT02106390|593488449|FG002|Overall Study|Withdrawal by Subject|15|||
164304430|NCT02106390|593488447|FG000|Overall Study|Lost to Follow-up|25|||
164304431|NCT02106390|593488448|FG001|Overall Study|Lost to Follow-up|20|||
164304432|NCT02106390|593488449|FG002|Overall Study|Lost to Follow-up|13|||
164304433|NCT02106390|593488447|FG000|Overall Study|Other: Administrative Reason|8|||
164304434|NCT02106390|593488448|FG001|Overall Study|Other: Administrative Reason|5|||
164304435|NCT02106390|593488449|FG002|Overall Study|Other: Administrative Reason|12|||
164304436|NCT02106390|593488447|FG000|Overall Study|Other: Unspecified|1|||
164304437|NCT02106390|593488448|FG001|Overall Study|Other: Unspecified|4|||
164304438|NCT02106390|593488449|FG002|Overall Study|Other: Unspecified|2|||
164304439|NCT02106390|593488447|FG000|Overall Study|Adverse Event|0|||
164304440|NCT02106390|593488448|FG001|Overall Study|Adverse Event|2|||
164304441|NCT02106390|593488449|FG002|Overall Study|Adverse Event|1|||
164304442|NCT02106390|593488447|FG000|Overall Study|Protocol Violation|0|||
164304443|NCT02106390|593488448|FG001|Overall Study|Protocol Violation|1|||
164304444|NCT02106390|593488449|FG002|Overall Study|Protocol Violation|0|||
164304445|NCT05029362|593488450|FG000|Overall Study|Lost to Follow-up|9|||
164304446|NCT00419952|593488454|FG000|Overall Study|Adverse Event|8|||
164304447|NCT00419952|593488455|FG001|Overall Study|Adverse Event|10|||
164304448|NCT00419952|593488454|FG000|Overall Study|Withdrawal by Subject|44|||
164304449|NCT00419952|593488455|FG001|Overall Study|Withdrawal by Subject|43|||
164304450|NCT00419952|593488454|FG000|Overall Study|Lost to Follow-up|43|||
164304451|NCT00419952|593488455|FG001|Overall Study|Lost to Follow-up|34|||
164304452|NCT00419952|593488454|FG000|Overall Study|Protocol Violation|32|||
164304453|NCT00419952|593488455|FG001|Overall Study|Protocol Violation|24|||
164304454|NCT00419952|593488454|FG000|Overall Study|Pregnancy|4|||
164304455|NCT00419952|593488455|FG001|Overall Study|Pregnancy|2|||
164304456|NCT00419952|593488454|FG000|Overall Study|Physician Decision|1|||
164304457|NCT00419952|593488455|FG001|Overall Study|Physician Decision|3|||
164304458|NCT00419952|593488454|FG000|Overall Study|Incorrectly enrolled|10|||
164304459|NCT00419952|593488455|FG001|Overall Study|Incorrectly enrolled|3|||
164304460|NCT00419952|593488454|FG000|Overall Study|Intake of prohibited medication|2|||
164304461|NCT00419952|593488455|FG001|Overall Study|Intake of prohibited medication|2|||
164304462|NCT00419952|593488454|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
164304463|NCT00419952|593488455|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
164304464|NCT00419952|593488454|FG000|Overall Study|Diary or medication non-compliance|2|||
164304465|NCT00419952|593488455|FG001|Overall Study|Diary or medication non-compliance|4|||
164304466|NCT00419952|593488454|FG000|Overall Study|Abnormal ECG|1|||
164304467|NCT00419952|593488455|FG001|Overall Study|Abnormal ECG|0|||
164304468|NCT03126591|593488460|FG000|Overall Study|Death|6|||
164304469|NCT03126591|593488461|FG001|Overall Study|Death|3|||
164304470|NCT03126591|593488462|FG002|Overall Study|Death|17|||
164304471|NCT03126591|593488460|FG000|Overall Study|Progressive Disease|0|||
164304472|NCT03126591|593488461|FG001|Overall Study|Progressive Disease|1|||
164304473|NCT03126591|593488462|FG002|Overall Study|Progressive Disease|2|||
164304474|NCT03126591|593488460|FG000|Overall Study|Terminated by Sponsor|0|||
164304475|NCT03126591|593488461|FG001|Overall Study|Terminated by Sponsor|1|||
164304476|NCT03126591|593488462|FG002|Overall Study|Terminated by Sponsor|4|||
164304477|NCT03126591|593488460|FG000|Overall Study|Withdrawal by Subject|1|||
164304478|NCT03126591|593488461|FG001|Overall Study|Withdrawal by Subject|1|||
164304479|NCT03126591|593488462|FG002|Overall Study|Withdrawal by Subject|4|||
164304480|NCT03722238|593488465|FG000|Overall Study|Protocol Violation|1|||
164304481|NCT03722238|593488466|FG001|Overall Study|Protocol Violation|0|||
164304482|NCT03722238|593488465|FG000|Overall Study|Physician Decision|1|||
164304483|NCT03722238|593488466|FG001|Overall Study|Physician Decision|0|||
164304484|NCT03722238|593488465|FG000|Overall Study|Death|1|||
164304485|NCT03722238|593488466|FG001|Overall Study|Death|0|||
164304486|NCT03722238|593488465|FG000|Overall Study|Lost to Follow-up|6|||
164304487|NCT03722238|593488466|FG001|Overall Study|Lost to Follow-up|0|||
164304488|NCT03722238|593488465|FG000|Overall Study|Partial missing data|44|||
164304489|NCT03722238|593488466|FG001|Overall Study|Partial missing data|1|||
164304490|NCT03722238|593488465|FG000|Overall Study|Withdrawal by Subject|2|||
164304491|NCT03722238|593488466|FG001|Overall Study|Withdrawal by Subject|0|||
164304492|NCT03722238|593488465|FG000|Overall Study|Other|4|||
164304493|NCT03722238|593488466|FG001|Overall Study|Other|0|||
164304494|NCT03722238|593488465|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
164304495|NCT03722238|593488466|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
164304496|NCT03722238|593488465|FG000|Overall Study|Did not meet risk classification group criteria|90|||
164304497|NCT03722238|593488466|FG001|Overall Study|Did not meet risk classification group criteria|0|||
164304498|NCT03722238|593488465|FG000|Overall Study|Did not sign consent|17|||
164304499|NCT03722238|593488466|FG001|Overall Study|Did not sign consent|0|||
164304500|NCT03722238|593488465|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
164304501|NCT03722238|593488466|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
164304502|NCT03722238|593488465|FG000|Overall Study|Not willing to purchase study medication|142|||
164304503|NCT03722238|593488466|FG001|Overall Study|Not willing to purchase study medication|0|||
164304504|NCT03722238|593488465|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
164304505|NCT03722238|593488466|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
164304506|NCT02085460|593488467|FG000|Overall Study|Adverse Event|2|||
164304507|NCT02085460|593488468|FG001|Overall Study|Adverse Event|2|||
164304508|NCT02085460|593488469|FG002|Overall Study|Adverse Event|1|||
164304509|NCT02085460|593488467|FG000|Overall Study|Physician Decision|1|||
164304510|NCT02085460|593488468|FG001|Overall Study|Physician Decision|1|||
164304511|NCT02085460|593488469|FG002|Overall Study|Physician Decision|2|||
164304512|NCT02085460|593488467|FG000|Overall Study|Withdrawal by Subject|11|||
164304513|NCT02085460|593488468|FG001|Overall Study|Withdrawal by Subject|5|||
164304514|NCT02085460|593488469|FG002|Overall Study|Withdrawal by Subject|7|||
164304515|NCT01285323|593488470|FG000|Overall Study|Adverse Event|9|||
164304516|NCT01285323|593488471|FG001|Overall Study|Adverse Event|8|||
164304517|NCT01285323|593488470|FG000|Overall Study|Lack of Efficacy|4|||
164304518|NCT01285323|593488471|FG001|Overall Study|Lack of Efficacy|2|||
164304519|NCT01285323|593488470|FG000|Overall Study|Withdrawal by Subject|15|||
164304520|NCT01285323|593488471|FG001|Overall Study|Withdrawal by Subject|11|||
164304521|NCT01285323|593488470|FG000|Overall Study|Protocol Violation|1|||
164304522|NCT01285323|593488471|FG001|Overall Study|Protocol Violation|2|||
164304523|NCT01285323|593488470|FG000|Overall Study|Non-compliance with study procedures|2|||
164304524|NCT01285323|593488471|FG001|Overall Study|Non-compliance with study procedures|3|||
164304525|NCT01285323|593488470|FG000|Overall Study|Lost to Follow-up|1|||
164304526|NCT01285323|593488471|FG001|Overall Study|Lost to Follow-up|1|||
164304527|NCT01285323|593488470|FG000|Overall Study|Other|1|||
164304528|NCT01285323|593488471|FG001|Overall Study|Other|3|||
164304529|NCT02606643|593488472|FG000|Overall Study|did not meet inclusion criteria|1|||
164304530|NCT02606643|593488473|FG001|Overall Study|did not meet inclusion criteria|3|||
164304531|NCT02158546|593488480|FG000|Overall Study|Physician Decision|0|||
164304532|NCT02158546|593488481|FG001|Overall Study|Physician Decision|1|||
164304533|NCT02158546|593488482|FG002|Overall Study|Physician Decision|0|||
164304534|NCT02158546|593488483|FG003|Overall Study|Physician Decision|0|||
164304535|NCT02158546|593488480|FG000|Overall Study|Non-compliance|0|||
164304536|NCT02158546|593488481|FG001|Overall Study|Non-compliance|1|||
164304537|NCT02158546|593488482|FG002|Overall Study|Non-compliance|0|||
164304538|NCT02158546|593488483|FG003|Overall Study|Non-compliance|1|||
164304539|NCT02158546|593488480|FG000|Overall Study|Failure to meet eligibility criteria|0|||
164304540|NCT02158546|593488481|FG001|Overall Study|Failure to meet eligibility criteria|1|||
164304541|NCT02158546|593488482|FG002|Overall Study|Failure to meet eligibility criteria|0|||
164304542|NCT02158546|593488483|FG003|Overall Study|Failure to meet eligibility criteria|0|||
164304543|NCT02158546|593488480|FG000|Overall Study|Lack of Efficacy|1|||
164304544|NCT02158546|593488481|FG001|Overall Study|Lack of Efficacy|1|||
164304545|NCT02158546|593488482|FG002|Overall Study|Lack of Efficacy|0|||
164304546|NCT02158546|593488483|FG003|Overall Study|Lack of Efficacy|0|||
164304547|NCT02158546|593488480|FG000|Overall Study|Adverse Event|2|||
164304548|NCT02158546|593488481|FG001|Overall Study|Adverse Event|2|||
164304549|NCT02158546|593488482|FG002|Overall Study|Adverse Event|0|||
164304550|NCT02158546|593488483|FG003|Overall Study|Adverse Event|0|||
164304551|NCT02158546|593488480|FG000|Overall Study|Withdrawal by Subject|6|||
164304552|NCT02158546|593488481|FG001|Overall Study|Withdrawal by Subject|2|||
164304553|NCT02158546|593488482|FG002|Overall Study|Withdrawal by Subject|1|||
164304554|NCT02158546|593488483|FG003|Overall Study|Withdrawal by Subject|0|||
164304555|NCT02158546|593488480|FG000|Overall Study|Lost to Follow-up|5|||
164304556|NCT02158546|593488481|FG001|Overall Study|Lost to Follow-up|4|||
164304557|NCT02158546|593488482|FG002|Overall Study|Lost to Follow-up|0|||
164304558|NCT02158546|593488483|FG003|Overall Study|Lost to Follow-up|1|||
164304559|NCT02158546|593488480|FG000|Overall Study|Site Excluded|5|||
164304560|NCT02158546|593488481|FG001|Overall Study|Site Excluded|5|||
164304561|NCT02158546|593488482|FG002|Overall Study|Site Excluded|3|||
164304562|NCT02158546|593488483|FG003|Overall Study|Site Excluded|4|||
164304563|NCT02351817|593488485|FG000|Period 1|Adverse Event|1|||
164304564|NCT02351817|593488486|FG001|Period 1|Adverse Event|2|||
164304565|NCT02351817|593488485|FG000|Period 1|Lack of Efficacy|0|||
164304566|NCT02351817|593488486|FG001|Period 1|Lack of Efficacy|1|||
164304567|NCT02351817|593488485|FG000|Period 2|Adverse Event|0|||
164304568|NCT02351817|593488486|FG001|Period 2|Adverse Event|2|||
164304569|NCT02351817|593488485|FG000|Period 2|Protocol Violation|1|||
164304570|NCT02351817|593488486|FG001|Period 2|Protocol Violation|0|||
164304571|NCT00561925|593488491|FG000|14 Day Lead-In Period|Adverse Event|38|||
164304572|NCT00561925|593488492|FG001|14 Day Lead-In Period|Adverse Event|0|||
164304573|NCT00561925|593488493|FG002|14 Day Lead-In Period|Adverse Event|0|||
164304574|NCT00561925|593488494|FG003|14 Day Lead-In Period|Adverse Event|0|||
164304575|NCT00561925|593488495|FG004|14 Day Lead-In Period|Adverse Event|0|||
164304576|NCT00561925|593488491|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
164304577|NCT00561925|593488492|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304578|NCT00561925|593488493|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304579|NCT00561925|593488494|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304580|NCT00561925|593488495|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
164304581|NCT00561925|593488491|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
164304582|NCT00561925|593488492|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
164304583|NCT00561925|593488493|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
164304584|NCT00561925|593488494|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
164304585|NCT00561925|593488495|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
164304586|NCT00561925|593488491|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
164304587|NCT00561925|593488492|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304588|NCT00561925|593488493|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304589|NCT00561925|593488494|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304590|NCT00561925|593488495|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
164304591|NCT00561925|593488491|FG000|14 Day Lead-In Period|Other|5|||
164304592|NCT00561925|593488492|FG001|14 Day Lead-In Period|Other|0|||
164304593|NCT00561925|593488493|FG002|14 Day Lead-In Period|Other|0|||
164304594|NCT00561925|593488494|FG003|14 Day Lead-In Period|Other|0|||
164304595|NCT00561925|593488495|FG004|14 Day Lead-In Period|Other|0|||
164304596|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
164304597|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
164304598|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
164304599|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
164304600|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
164304601|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
164304602|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
164304603|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
164304604|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
164304605|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
164304606|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
164304607|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
164304608|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
164304609|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
164304610|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
164304611|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
164304612|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
164304613|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
164304614|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
164304615|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
164304616|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
164304617|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
164304618|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
164304619|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
164304620|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
164304621|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
164304622|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
164304623|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
164304624|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
164304625|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
164304626|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Death|0|||
164304627|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Death|6|||
164304628|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Death|3|||
164304629|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Death|0|||
164304630|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Death|0|||
164304631|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304632|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
164304633|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304634|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304635|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
164304636|NCT00561925|593488491|FG000|144-week Double-blind, Double-dummy|Other|0|||
164304637|NCT00561925|593488492|FG001|144-week Double-blind, Double-dummy|Other|8|||
164304638|NCT00561925|593488493|FG002|144-week Double-blind, Double-dummy|Other|11|||
164304639|NCT00561925|593488494|FG003|144-week Double-blind, Double-dummy|Other|0|||
164304640|NCT00561925|593488495|FG004|144-week Double-blind, Double-dummy|Other|0|||
164304641|NCT00561925|593488491|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
164304642|NCT00561925|593488492|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
164304643|NCT00561925|593488493|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
164304644|NCT00561925|593488494|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
164304645|NCT00561925|593488495|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
164304646|NCT00684021|593488498|FG000|Overall Study|MRI Contraindicated|1|||
164304647|NCT00684021|593488499|FG001|Overall Study|MRI Contraindicated|1|||
164304648|NCT00684021|593488500|FG002|Overall Study|MRI Contraindicated|1|||
164304649|NCT00684021|593488501|FG003|Overall Study|MRI Contraindicated|0|||
164304650|NCT00684021|593488498|FG000|Overall Study|MRI not performed|0|||
164304651|NCT00684021|593488499|FG001|Overall Study|MRI not performed|1|||
164304652|NCT00684021|593488500|FG002|Overall Study|MRI not performed|1|||
164304653|NCT00684021|593488501|FG003|Overall Study|MRI not performed|2|||
164304654|NCT00684021|593488498|FG000|Overall Study|Death|1|||
164304655|NCT00684021|593488499|FG001|Overall Study|Death|0|||
164304656|NCT00684021|593488500|FG002|Overall Study|Death|0|||
164304657|NCT00684021|593488501|FG003|Overall Study|Death|0|||
164304658|NCT00891904|593488502|FG000|Overall Study|Death|1|||
164304659|NCT00891904|593488502|FG000|Overall Study|Adverse Event|1|||
164304660|NCT01208207|593488503|FG000|Part I|Adverse Event|19|||
164304661|NCT01208207|593488504|FG001|Part I|Adverse Event|2|||
164304662|NCT01208207|593488505|FG002|Part I|Adverse Event|6|||
164304663|NCT01208207|593488506|FG003|Part I|Adverse Event|0|||
164304664|NCT01208207|593488507|FG004|Part I|Adverse Event|0|||
164304665|NCT01208207|593488508|FG005|Part I|Adverse Event|0|||
164304666|NCT01208207|593488509|FG006|Part I|Adverse Event|0|||
164304667|NCT01208207|593488503|FG000|Part I|Lack of Efficacy|21|||
164304668|NCT01208207|593488504|FG001|Part I|Lack of Efficacy|3|||
164304669|NCT01208207|593488505|FG002|Part I|Lack of Efficacy|2|||
164304670|NCT01208207|593488506|FG003|Part I|Lack of Efficacy|0|||
164304671|NCT01208207|593488507|FG004|Part I|Lack of Efficacy|0|||
164304672|NCT01208207|593488508|FG005|Part I|Lack of Efficacy|0|||
164304673|NCT01208207|593488509|FG006|Part I|Lack of Efficacy|0|||
164304674|NCT01208207|593488503|FG000|Part I|Lost to Follow-up|6|||
164304675|NCT01208207|593488504|FG001|Part I|Lost to Follow-up|1|||
164304676|NCT01208207|593488505|FG002|Part I|Lost to Follow-up|0|||
164304677|NCT01208207|593488506|FG003|Part I|Lost to Follow-up|0|||
164304678|NCT01208207|593488507|FG004|Part I|Lost to Follow-up|0|||
164304679|NCT01208207|593488508|FG005|Part I|Lost to Follow-up|0|||
164304680|NCT01208207|593488509|FG006|Part I|Lost to Follow-up|0|||
164304681|NCT01208207|593488503|FG000|Part I|Non-Compliance With Study Drug|1|||
164304682|NCT01208207|593488504|FG001|Part I|Non-Compliance With Study Drug|0|||
164304683|NCT01208207|593488505|FG002|Part I|Non-Compliance With Study Drug|1|||
164304684|NCT01208207|593488506|FG003|Part I|Non-Compliance With Study Drug|0|||
164304685|NCT01208207|593488507|FG004|Part I|Non-Compliance With Study Drug|0|||
164304686|NCT01208207|593488508|FG005|Part I|Non-Compliance With Study Drug|0|||
164304687|NCT01208207|593488509|FG006|Part I|Non-Compliance With Study Drug|0|||
164304688|NCT01208207|593488503|FG000|Part I|Physician Decision|0|||
164304689|NCT01208207|593488504|FG001|Part I|Physician Decision|1|||
164304690|NCT01208207|593488505|FG002|Part I|Physician Decision|0|||
164304691|NCT01208207|593488506|FG003|Part I|Physician Decision|0|||
164304692|NCT01208207|593488507|FG004|Part I|Physician Decision|0|||
164304693|NCT01208207|593488508|FG005|Part I|Physician Decision|0|||
164304694|NCT01208207|593488509|FG006|Part I|Physician Decision|0|||
164304695|NCT01208207|593488503|FG000|Part I|Progressive Disease|1|||
164304696|NCT01208207|593488504|FG001|Part I|Progressive Disease|0|||
164304697|NCT01208207|593488505|FG002|Part I|Progressive Disease|0|||
164304698|NCT01208207|593488506|FG003|Part I|Progressive Disease|0|||
164304699|NCT01208207|593488507|FG004|Part I|Progressive Disease|0|||
164304700|NCT01208207|593488508|FG005|Part I|Progressive Disease|0|||
164304701|NCT01208207|593488509|FG006|Part I|Progressive Disease|0|||
164304702|NCT01208207|593488503|FG000|Part I|Protocol Violation|8|||
164304703|NCT01208207|593488504|FG001|Part I|Protocol Violation|0|||
164304704|NCT01208207|593488505|FG002|Part I|Protocol Violation|2|||
164304705|NCT01208207|593488506|FG003|Part I|Protocol Violation|0|||
164304706|NCT01208207|593488507|FG004|Part I|Protocol Violation|0|||
164304707|NCT01208207|593488508|FG005|Part I|Protocol Violation|0|||
164304708|NCT01208207|593488509|FG006|Part I|Protocol Violation|0|||
164304709|NCT01208207|593488503|FG000|Part I|Withdrawal by Subject|14|||
164304710|NCT01208207|593488504|FG001|Part I|Withdrawal by Subject|4|||
164304711|NCT01208207|593488505|FG002|Part I|Withdrawal by Subject|4|||
164304712|NCT01208207|593488506|FG003|Part I|Withdrawal by Subject|0|||
164304713|NCT01208207|593488507|FG004|Part I|Withdrawal by Subject|0|||
164304714|NCT01208207|593488508|FG005|Part I|Withdrawal by Subject|0|||
164304715|NCT01208207|593488509|FG006|Part I|Withdrawal by Subject|0|||
164304716|NCT01208207|593488503|FG000|Part II|Withdrawal by Subject|0|||
164304717|NCT01208207|593488504|FG001|Part II|Withdrawal by Subject|0|||
164304718|NCT01208207|593488505|FG002|Part II|Withdrawal by Subject|0|||
164304719|NCT01208207|593488506|FG003|Part II|Withdrawal by Subject|10|||
164304720|NCT01208207|593488507|FG004|Part II|Withdrawal by Subject|9|||
164304721|NCT01208207|593488508|FG005|Part II|Withdrawal by Subject|3|||
164304722|NCT01208207|593488509|FG006|Part II|Withdrawal by Subject|5|||
164304723|NCT01208207|593488503|FG000|Part II|Adverse Event|0|||
164304724|NCT01208207|593488504|FG001|Part II|Adverse Event|0|||
164304725|NCT01208207|593488505|FG002|Part II|Adverse Event|0|||
164304726|NCT01208207|593488506|FG003|Part II|Adverse Event|5|||
164304727|NCT01208207|593488507|FG004|Part II|Adverse Event|9|||
164304728|NCT01208207|593488508|FG005|Part II|Adverse Event|4|||
164304729|NCT01208207|593488509|FG006|Part II|Adverse Event|2|||
164304730|NCT01208207|593488503|FG000|Part II|Lack of Efficacy|0|||
164304731|NCT01208207|593488504|FG001|Part II|Lack of Efficacy|0|||
164304732|NCT01208207|593488505|FG002|Part II|Lack of Efficacy|0|||
164304733|NCT01208207|593488506|FG003|Part II|Lack of Efficacy|6|||
164304734|NCT01208207|593488507|FG004|Part II|Lack of Efficacy|4|||
164304735|NCT01208207|593488508|FG005|Part II|Lack of Efficacy|3|||
164304736|NCT01208207|593488509|FG006|Part II|Lack of Efficacy|3|||
164304737|NCT01208207|593488503|FG000|Part II|Lost to Follow-up|0|||
164304738|NCT01208207|593488504|FG001|Part II|Lost to Follow-up|0|||
164304739|NCT01208207|593488505|FG002|Part II|Lost to Follow-up|0|||
164304740|NCT01208207|593488506|FG003|Part II|Lost to Follow-up|4|||
164304741|NCT01208207|593488507|FG004|Part II|Lost to Follow-up|0|||
164304742|NCT01208207|593488508|FG005|Part II|Lost to Follow-up|2|||
164304743|NCT01208207|593488509|FG006|Part II|Lost to Follow-up|1|||
164304744|NCT01208207|593488503|FG000|Part II|Non-Compliance With Study Drug|0|||
164304745|NCT01208207|593488504|FG001|Part II|Non-Compliance With Study Drug|0|||
164304746|NCT01208207|593488505|FG002|Part II|Non-Compliance With Study Drug|0|||
164304747|NCT01208207|593488506|FG003|Part II|Non-Compliance With Study Drug|4|||
164304748|NCT01208207|593488507|FG004|Part II|Non-Compliance With Study Drug|1|||
164304749|NCT01208207|593488508|FG005|Part II|Non-Compliance With Study Drug|1|||
164304750|NCT01208207|593488509|FG006|Part II|Non-Compliance With Study Drug|0|||
164304751|NCT01208207|593488503|FG000|Part II|Physician Decision|0|||
164304752|NCT01208207|593488504|FG001|Part II|Physician Decision|0|||
164304753|NCT01208207|593488505|FG002|Part II|Physician Decision|0|||
164304754|NCT01208207|593488506|FG003|Part II|Physician Decision|1|||
164304755|NCT01208207|593488507|FG004|Part II|Physician Decision|0|||
164304756|NCT01208207|593488508|FG005|Part II|Physician Decision|2|||
164304757|NCT01208207|593488509|FG006|Part II|Physician Decision|0|||
164304758|NCT01208207|593488503|FG000|Part II|Protocol Violation|0|||
164304759|NCT01208207|593488504|FG001|Part II|Protocol Violation|0|||
164304760|NCT01208207|593488505|FG002|Part II|Protocol Violation|0|||
164304761|NCT01208207|593488506|FG003|Part II|Protocol Violation|1|||
164304762|NCT01208207|593488507|FG004|Part II|Protocol Violation|0|||
164304763|NCT01208207|593488508|FG005|Part II|Protocol Violation|0|||
164304764|NCT01208207|593488509|FG006|Part II|Protocol Violation|0|||
164304765|NCT01208207|593488503|FG000|Part II|Technical Problems|0|||
164304766|NCT01208207|593488504|FG001|Part II|Technical Problems|0|||
164304767|NCT01208207|593488505|FG002|Part II|Technical Problems|0|||
164304768|NCT01208207|593488506|FG003|Part II|Technical Problems|1|||
164304769|NCT01208207|593488507|FG004|Part II|Technical Problems|0|||
164304770|NCT01208207|593488508|FG005|Part II|Technical Problems|1|||
164304771|NCT01208207|593488509|FG006|Part II|Technical Problems|0|||
164304772|NCT04041414|593488512|FG000|Overall Study|Lost to Follow-up|1|||
164304773|NCT04041414|593488513|FG001|Overall Study|Lost to Follow-up|2|||
164304774|NCT00665652|593488514|FG000|Overall Study|Adverse Event|4|||
164304775|NCT00665652|593488514|FG000|Overall Study|Death|1|||
164304776|NCT00665652|593488514|FG000|Overall Study|No longer met inclusion criteria.|1|||
164304777|NCT02556177|593488518|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
164304778|NCT02556177|593488519|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
164304779|NCT01055197|593488532|FG000|Overall Study|Protocol Violation|7|||
164304780|NCT01055197|593488533|FG001|Overall Study|Protocol Violation|2|||
164304781|NCT01055197|593488532|FG000|Overall Study|Withdrawal by Subject|2|||
164304782|NCT01055197|593488533|FG001|Overall Study|Withdrawal by Subject|0|||
164304783|NCT00734539|593488534|FG000|Main Study|Death|33|||
164304784|NCT00734539|593488535|FG001|Main Study|Death|32|||
164304785|NCT00734539|593488534|FG000|Main Study|Physician Decision|2|||
164304786|NCT00734539|593488535|FG001|Main Study|Physician Decision|0|||
164304787|NCT00734539|593488534|FG000|Main Study|Withdrawal by Subject|1|||
164304788|NCT00734539|593488535|FG001|Main Study|Withdrawal by Subject|3|||
164304789|NCT00734539|593488534|FG000|Main Study|Enrolled in error; ineligible|1|||
164304790|NCT00734539|593488535|FG001|Main Study|Enrolled in error; ineligible|0|||
164304791|NCT01782378|593488536|FG000|First Series|Lost to Follow-up|7|||
164304792|NCT01782378|593488537|FG001|First Series|Lost to Follow-up|8|||
164304793|NCT01782378|593488536|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
164304794|NCT01782378|593488537|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
164304795|NCT01782378|593488536|FG000|Second Series|Lost to Follow-up|8|||
164304796|NCT01782378|593488537|FG001|Second Series|Lost to Follow-up|7|||
164304797|NCT01782378|593488536|FG000|Second Series|Did not choose to complete S2 Optional|18|||
164304798|NCT01782378|593488537|FG001|Second Series|Did not choose to complete S2 Optional|0|||
164304799|NCT00830440|593488538|FG000|Overall Study|Protocol Violation|1|||
164304800|NCT00830440|593488539|FG001|Overall Study|Protocol Violation|0|||
164304801|NCT00830440|593488538|FG000|Overall Study|Withdrawal by Subject|1|||
164304802|NCT00830440|593488539|FG001|Overall Study|Withdrawal by Subject|0|||
164304803|NCT00830440|593488538|FG000|Overall Study|unsuccessful procedure|4|||
164304804|NCT00830440|593488539|FG001|Overall Study|unsuccessful procedure|0|||
164304805|NCT00830440|593488538|FG000|Overall Study|Adverse Event|2|||
164304806|NCT00830440|593488539|FG001|Overall Study|Adverse Event|0|||
164304807|NCT01663103|593488542|FG000|Overall Study|Withdrawal by Subject|1|||
164304808|NCT01663103|593488543|FG001|Overall Study|Withdrawal by Subject|2|||
164304809|NCT01663103|593488542|FG000|Overall Study|Adverse Event|1|||
164304810|NCT01663103|593488543|FG001|Overall Study|Adverse Event|0|||
164304811|NCT01663103|593488542|FG000|Overall Study|dog bite|1|||
164304812|NCT01663103|593488543|FG001|Overall Study|dog bite|0|||
164304813|NCT01721044|593488548|FG000|Treatment Period|Adverse Event|7|||
164304814|NCT01721044|593488549|FG001|Treatment Period|Adverse Event|7|||
164304815|NCT01721044|593488550|FG002|Treatment Period|Adverse Event|10|||
164304816|NCT01721044|593488548|FG000|Treatment Period|Death|0|||
164304817|NCT01721044|593488549|FG001|Treatment Period|Death|0|||
164304818|NCT01721044|593488550|FG002|Treatment Period|Death|1|||
164304819|NCT01721044|593488548|FG000|Treatment Period|Lack of Efficacy|16|||
164304820|NCT01721044|593488549|FG001|Treatment Period|Lack of Efficacy|4|||
164304821|NCT01721044|593488550|FG002|Treatment Period|Lack of Efficacy|4|||
164304822|NCT01721044|593488548|FG000|Treatment Period|Lost to Follow-up|0|||
164304823|NCT01721044|593488549|FG001|Treatment Period|Lost to Follow-up|0|||
164304824|NCT01721044|593488550|FG002|Treatment Period|Lost to Follow-up|1|||
164304825|NCT01721044|593488548|FG000|Treatment Period|Physician Decision|1|||
164304826|NCT01721044|593488549|FG001|Treatment Period|Physician Decision|0|||
164304827|NCT01721044|593488550|FG002|Treatment Period|Physician Decision|2|||
164304828|NCT01721044|593488548|FG000|Treatment Period|Protocol Violation|1|||
164304829|NCT01721044|593488549|FG001|Treatment Period|Protocol Violation|0|||
164304830|NCT01721044|593488550|FG002|Treatment Period|Protocol Violation|0|||
164304831|NCT01721044|593488548|FG000|Treatment Period|Withdrawal by Subject|7|||
164304832|NCT01721044|593488549|FG001|Treatment Period|Withdrawal by Subject|6|||
164304833|NCT01721044|593488550|FG002|Treatment Period|Withdrawal by Subject|1|||
164304834|NCT02420821|593488559|FG000|Overall Study|Lost to Follow-up|6|||
164304835|NCT02420821|593488560|FG001|Overall Study|Lost to Follow-up|6|||
164304836|NCT02420821|593488559|FG000|Overall Study|Non-compliance|0|||
164304837|NCT02420821|593488560|FG001|Overall Study|Non-compliance|2|||
164304838|NCT02420821|593488559|FG000|Overall Study|Physician Decision|6|||
164304839|NCT02420821|593488560|FG001|Overall Study|Physician Decision|2|||
164304840|NCT02420821|593488559|FG000|Overall Study|Withdrawal by Subject|32|||
164304841|NCT02420821|593488560|FG001|Overall Study|Withdrawal by Subject|25|||
164304842|NCT02420821|593488559|FG000|Overall Study|Death|270|||
164304843|NCT02420821|593488560|FG001|Overall Study|Death|263|||
164304844|NCT02420821|593488559|FG000|Overall Study|Study Terminated By Sponsor|145|||
164304845|NCT02420821|593488560|FG001|Overall Study|Study Terminated By Sponsor|149|||
164304846|NCT02420821|593488559|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
164304847|NCT02420821|593488560|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
164304848|NCT02420821|593488559|FG000|Overall Study|Adverse Event|0|||
164304849|NCT02420821|593488560|FG001|Overall Study|Adverse Event|1|||
164304850|NCT02420821|593488559|FG000|Overall Study|Protinuria|0|||
164304851|NCT02420821|593488560|FG001|Overall Study|Protinuria|1|||
164304852|NCT02420821|593488559|FG000|Overall Study|Progressive Disease|1|||
164304853|NCT02420821|593488560|FG001|Overall Study|Progressive Disease|1|||
164304854|NCT02420821|593488559|FG000|Overall Study|Disease Progression|0|||
164304855|NCT02420821|593488560|FG001|Overall Study|Disease Progression|1|||
164304856|NCT02420821|593488559|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
163959601|NCT03226392|592224046|FG001|Overall Study|Technical Problems|2|||
164304857|NCT02420821|593488560|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
164304858|NCT04467905|593488561|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
164304859|NCT04467905|593488562|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
164304860|NCT04467905|593488563|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
164304861|NCT04467905|593488561|FG000|Overall Study|Conversion to SR|0|||
164304862|NCT04467905|593488562|FG001|Overall Study|Conversion to SR|0|||
164304863|NCT04467905|593488563|FG002|Overall Study|Conversion to SR|3|||
164304864|NCT04467905|593488561|FG000|Overall Study|Technical issue with Holter ECG|0|||
164304865|NCT04467905|593488562|FG001|Overall Study|Technical issue with Holter ECG|0|||
164304866|NCT04467905|593488563|FG002|Overall Study|Technical issue with Holter ECG|3|||
164304867|NCT04467905|593488561|FG000|Overall Study|Hemodynamic instability|0|||
164304868|NCT04467905|593488562|FG001|Overall Study|Hemodynamic instability|0|||
164304869|NCT04467905|593488563|FG002|Overall Study|Hemodynamic instability|1|||
164304870|NCT04467905|593488561|FG000|Overall Study|Site misinterpretation of protocol|0|||
164304871|NCT04467905|593488562|FG001|Overall Study|Site misinterpretation of protocol|0|||
164304872|NCT04467905|593488563|FG002|Overall Study|Site misinterpretation of protocol|1|||
164304873|NCT02202759|593490476|FG000|Overall Study|Study Terminated by Sponsor|3|||
164304874|NCT02202759|593490477|FG001|Overall Study|Study Terminated by Sponsor|3|||
164304875|NCT02202759|593490478|FG002|Overall Study|Study Terminated by Sponsor|3|||
164304876|NCT02202759|593490476|FG000|Overall Study|Withdrawal by Subject|2|||
164304877|NCT02202759|593490477|FG001|Overall Study|Withdrawal by Subject|1|||
164304878|NCT02202759|593490478|FG002|Overall Study|Withdrawal by Subject|1|||
164304879|NCT02202759|593490476|FG000|Overall Study|Reason not Specified|4|||
164304880|NCT02202759|593490477|FG001|Overall Study|Reason not Specified|11|||
164304881|NCT02202759|593490478|FG002|Overall Study|Reason not Specified|10|||
164304882|NCT01590888|593490479|FG000|Overall Study|Adverse Event|3|||
164304883|NCT01590888|593490480|FG001|Overall Study|Adverse Event|0|||
164304884|NCT01590888|593490481|FG002|Overall Study|Adverse Event|1|||
164304885|NCT01590888|593490479|FG000|Overall Study|Lost to Follow-up|1|||
164304886|NCT01590888|593490480|FG001|Overall Study|Lost to Follow-up|0|||
164304887|NCT01590888|593490481|FG002|Overall Study|Lost to Follow-up|0|||
164304888|NCT04953728|593490482|FG000|Overall Study|Withdrawal by Subject|3|||
164304889|NCT04953728|593490482|FG000|Overall Study|Physician Decision|1|||
164304890|NCT02331277|593490483|FG000|Overall Study|Withdrawal by Subject|1|||
164304891|NCT02331277|593490484|FG001|Overall Study|Withdrawal by Subject|0|||
164304892|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
164304893|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
164304894|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Patient requirement|20|||
164304895|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Death|5|||
164304896|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Change of therapy|6|||
164304897|NCT01071798|593490486|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
164304898|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
164304899|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
164304900|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
164304901|NCT01071798|593490486|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
164304902|NCT01759446|593490489|FG000|Overall Study|Protocol Violation|1|||
164304903|NCT01759446|593490490|FG001|Overall Study|Protocol Violation|0|||
164304904|NCT01759446|593490491|FG002|Overall Study|Protocol Violation|1|||
164304905|NCT01759446|593490492|FG003|Overall Study|Protocol Violation|0|||
164304906|NCT01759446|593490493|FG004|Overall Study|Protocol Violation|0|||
164304907|NCT01759446|593490489|FG000|Overall Study|Withdrawal by Subject|0|||
164304908|NCT01759446|593490490|FG001|Overall Study|Withdrawal by Subject|1|||
164304909|NCT01759446|593490491|FG002|Overall Study|Withdrawal by Subject|0|||
164304910|NCT01759446|593490492|FG003|Overall Study|Withdrawal by Subject|1|||
164304911|NCT01759446|593490493|FG004|Overall Study|Withdrawal by Subject|0|||
164304912|NCT01760733|593490494|FG000|Waiting List|Death|18|||
164304913|NCT01760733|593490494|FG000|Waiting List|Removed from waiting list|41|||
164304914|NCT01760733|593490494|FG000|Waiting List|Not received a transplant yet|13|||
164304915|NCT01760733|593490494|FG000|Transplanted|Not reached 10 years post transplant|184|||
164304916|NCT01760733|593490494|FG000|Transplanted|Death|26|||
164304917|NCT01760733|593490494|FG000|Transplanted|Graft loss|7|||
164304918|NCT00815659|593490497|FG000|Overall Study|Adverse Event|9|||
164304919|NCT00815659|593490497|FG000|Overall Study|Withdrawal by Subject|9|||
164304920|NCT00815659|593490497|FG000|Overall Study|Lost to Follow-up|4|||
164304921|NCT00815659|593490497|FG000|Overall Study|Protocol Violation|1|||
164304922|NCT00719472|593490498|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
164304923|NCT00719472|593490498|FG000|Enrolled in Study|Subject decision to withdraw|8|||
164304924|NCT00719472|593490498|FG000|Enrolled in Study|Various Reasons|17|||
164304925|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
164304926|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Death|5|||
164304927|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
164304928|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
164304929|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
164304930|NCT00719472|593490498|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
164304931|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
164304932|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Death|6|||
164304933|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Disease progression|3|||
164304934|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
164304935|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
164304936|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
164304937|NCT00719472|593490498|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
164304938|NCT03584789|593490502|FG000|Overall Study|refused EHR permission|19|||
164304939|NCT03584789|593490503|FG001|Overall Study|refused EHR permission|28|||
164304940|NCT03584789|593490504|FG002|Overall Study|refused EHR permission|23|||
164304941|NCT03584789|593490502|FG000|Overall Study|patients tied to a provider who retired|0|||
164304942|NCT03584789|593490503|FG001|Overall Study|patients tied to a provider who retired|0|||
164304943|NCT03584789|593490504|FG002|Overall Study|patients tied to a provider who retired|3|||
164304944|NCT04646044|593490506|FG000|Overall Study|Lost to Follow-up|0|||
164304945|NCT04646044|593490507|FG001|Overall Study|Lost to Follow-up|0|||
164304946|NCT04646044|593490508|FG002|Overall Study|Lost to Follow-up|1|||
164304947|NCT04646044|593490509|FG003|Overall Study|Lost to Follow-up|0|||
164304948|NCT04646044|593490506|FG000|Overall Study|Withdrawal by Subject|0|||
164304949|NCT04646044|593490507|FG001|Overall Study|Withdrawal by Subject|1|||
164304950|NCT04646044|593490508|FG002|Overall Study|Withdrawal by Subject|0|||
164304951|NCT04646044|593490509|FG003|Overall Study|Withdrawal by Subject|0|||
164304952|NCT00742235|593490510|FG000|Overall Study|Lost to Follow-up|0|||
164304953|NCT00742235|593490511|FG001|Overall Study|Lost to Follow-up|31|||
164304954|NCT02346721|593490514|FG000|Overall Study|Withdrew Consent|3|||
164304955|NCT02346721|593490514|FG000|Overall Study|Lack of Efficacy|1|||
164304956|NCT01544335|593490515|FG000|Overall Study|Lost to Follow-up|27|||
164304957|NCT01544335|593490515|FG000|Overall Study|Death|4|||
164304958|NCT01544335|593490515|FG000|Overall Study|Disease progression|3|||
164304959|NCT01544335|593490515|FG000|Overall Study|Baseline Measurements not Available|19|||
164304960|NCT02488915|593490523|FG000|Overall Study|Death|21|||
164304961|NCT02488915|593490523|FG000|Overall Study|Lost to Follow-up|4|||
164304962|NCT02488915|593490523|FG000|Overall Study|Withdrawal by Subject|1|||
164304963|NCT01532986|593490524|FG000|Overall Study|Death|9|||
164304964|NCT01532986|593490525|FG001|Overall Study|Death|9|||
164304965|NCT01532986|593490524|FG000|Overall Study|Withdrawal by Subject|7|||
164304966|NCT01532986|593490525|FG001|Overall Study|Withdrawal by Subject|10|||
164304967|NCT01532986|593490524|FG000|Overall Study|Physician Decision|7|||
164304968|NCT01532986|593490525|FG001|Overall Study|Physician Decision|5|||
164304969|NCT00885170|593490530|FG000|Overall Study|Adverse Event|12|||
164304970|NCT00885170|593490531|FG001|Overall Study|Adverse Event|4|||
164304971|NCT00885170|593490530|FG000|Overall Study|Excessive bone loss|6|||
164304972|NCT00885170|593490531|FG001|Overall Study|Excessive bone loss|3|||
164304973|NCT00885170|593490530|FG000|Overall Study|Lost to Follow-up|2|||
164304974|NCT00885170|593490531|FG001|Overall Study|Lost to Follow-up|1|||
164304975|NCT00885170|593490530|FG000|Overall Study|Physician Decision|2|||
164304976|NCT00885170|593490531|FG001|Overall Study|Physician Decision|1|||
164304977|NCT00885170|593490530|FG000|Overall Study|Protocol Violation|3|||
164304978|NCT00885170|593490531|FG001|Overall Study|Protocol Violation|1|||
164304979|NCT00885170|593490530|FG000|Overall Study|Withdrawal by Subject|13|||
164304980|NCT00885170|593490531|FG001|Overall Study|Withdrawal by Subject|13|||
164304981|NCT03771664|593490532|FG000|Overall Study|Adverse Event|1|||
164304982|NCT03771664|593490533|FG001|Overall Study|Adverse Event|0|||
164304983|NCT03771664|593490532|FG000|Overall Study|Lost to Follow-up|1|||
164304984|NCT03771664|593490533|FG001|Overall Study|Lost to Follow-up|0|||
164304985|NCT03771664|593490532|FG000|Overall Study|Withdrawal by Participant|1|||
164304986|NCT03771664|593490533|FG001|Overall Study|Withdrawal by Participant|4|||
164304987|NCT03771664|593490532|FG000|Overall Study|Randomized but not Treated|0|||
164304988|NCT03771664|593490533|FG001|Overall Study|Randomized but not Treated|1|||
164304989|NCT02120898|593490534|FG000|Overall Study|Withdrawal by Subject|4|||
164304990|NCT02120898|593490535|FG001|Overall Study|Withdrawal by Subject|2|||
164304991|NCT02120898|593490536|FG002|Overall Study|Withdrawal by Subject|2|||
164304992|NCT02120898|593490534|FG000|Overall Study|Non-compliance with study drug|3|||
164304993|NCT02120898|593490535|FG001|Overall Study|Non-compliance with study drug|0|||
164304994|NCT02120898|593490536|FG002|Overall Study|Non-compliance with study drug|0|||
164304995|NCT02120898|593490534|FG000|Overall Study|Adverse Event|1|||
164304996|NCT02120898|593490535|FG001|Overall Study|Adverse Event|2|||
164304997|NCT02120898|593490536|FG002|Overall Study|Adverse Event|1|||
164304998|NCT02120898|593490534|FG000|Overall Study|Protocol Violation|1|||
164304999|NCT02120898|593490535|FG001|Overall Study|Protocol Violation|2|||
164305000|NCT02120898|593490536|FG002|Overall Study|Protocol Violation|0|||
164305001|NCT02120898|593490534|FG000|Overall Study|Lost to Follow-up|0|||
163959602|NCT03226392|592224045|FG000|Overall Study|Subject/Guardian Decision|7|||
164006463|NCT02158533|592390962|FG000|Stage 2|Withdrawal by Subject|0|||
164305002|NCT02120898|593490535|FG001|Overall Study|Lost to Follow-up|0|||
164305003|NCT02120898|593490536|FG002|Overall Study|Lost to Follow-up|1|||
164305004|NCT01046396|593490537|FG000|Overall Study|Withdrawal by Subject|5|||
164305005|NCT02161016|593490541|FG000|Overall Study|withdrawn by IRB|1|||
164305006|NCT03818321|593490542|FG000|Overall Study|Withdrawal by Subject|1|||
164305007|NCT03818321|593490543|FG001|Overall Study|Withdrawal by Subject|2|||
164305008|NCT00275509|593490544|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
164305009|NCT00275509|593490545|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
164305010|NCT00380367|593490548|FG000|Overall Study|Lost to Follow-up|1|||
164305011|NCT00380367|593490548|FG000|Overall Study|Withdrawal by Subject|1|||
164305012|NCT01605799|593490549|FG000|Overall Study|Withdrawal by Subject|2|||
164305013|NCT01605799|593490550|FG001|Overall Study|Withdrawal by Subject|1|||
164305014|NCT00499083|593490552|FG000|Overall Study|Not evaluable|3|||
164305015|NCT00477386|593490556|FG000|Overall Study|Adverse Event|4|||
164305016|NCT00477386|593490557|FG001|Overall Study|Adverse Event|8|||
163845125|NCT00876460|591801850|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
163845126|NCT00876460|591801851|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
163845127|NCT00876460|591801844|FG000|Combination Therapy Phase|Other reason not defined above|0|||
163845128|NCT00876460|591801845|FG001|Combination Therapy Phase|Other reason not defined above|0|||
163845129|NCT00876460|591801846|FG002|Combination Therapy Phase|Other reason not defined above|0|||
163845130|NCT00876460|591801847|FG003|Combination Therapy Phase|Other reason not defined above|0|||
163845131|NCT00876460|591801848|FG004|Combination Therapy Phase|Other reason not defined above|0|||
163845132|NCT00876460|591801849|FG005|Combination Therapy Phase|Other reason not defined above|0|||
163845133|NCT00876460|591801850|FG006|Combination Therapy Phase|Other reason not defined above|1|||
163845134|NCT00876460|591801851|FG007|Combination Therapy Phase|Other reason not defined above|2|||
163845135|NCT00876460|591801844|FG000|Combination Therapy Phase|Not treated|0|||
163845136|NCT00876460|591801845|FG001|Combination Therapy Phase|Not treated|0|||
163845137|NCT00876460|591801846|FG002|Combination Therapy Phase|Not treated|0|||
164305017|NCT00477386|593490556|FG000|Overall Study|Disease progression, relapse|3|||
164305018|NCT00477386|593490557|FG001|Overall Study|Disease progression, relapse|4|||
164305019|NCT00477386|593490556|FG000|Overall Study|Disease progression, refractory|1|||
164305020|NCT00477386|593490557|FG001|Overall Study|Disease progression, refractory|3|||
164305021|NCT00477386|593490556|FG000|Overall Study|Other|1|||
164305022|NCT00477386|593490557|FG001|Overall Study|Other|2|||
164305023|NCT00477386|593490556|FG000|Overall Study|Physician Decision|1|||
164305024|NCT00477386|593490557|FG001|Overall Study|Physician Decision|0|||
164305025|NCT00477386|593490556|FG000|Overall Study|Withdrawal by Subject|1|||
164305026|NCT00477386|593490557|FG001|Overall Study|Withdrawal by Subject|0|||
164305027|NCT01254422|593490558|FG000|Overall Study|Protocol Violation|1|||
164305028|NCT01254422|593490559|FG001|Overall Study|Protocol Violation|0|||
164305029|NCT01254422|593490558|FG000|Overall Study|Adverse Event|1|||
164305030|NCT01254422|593490559|FG001|Overall Study|Adverse Event|0|||
164305031|NCT01254422|593490558|FG000|Overall Study|Serious adverse event|0|||
164305032|NCT01254422|593490559|FG001|Overall Study|Serious adverse event|1|||
164305033|NCT01254422|593490558|FG000|Overall Study|Lost to Follow-up|1|||
164305034|NCT01254422|593490559|FG001|Overall Study|Lost to Follow-up|0|||
164305035|NCT00643162|593490560|FG000|Overall Study|Withdrawal by Subject|1|||
164305036|NCT00643162|593490561|FG001|Overall Study|Withdrawal by Subject|1|||
164305037|NCT01812252|593490568|FG000|Overall Study|Persistent Disease|1|||
163845138|NCT00876460|591801847|FG003|Combination Therapy Phase|Not treated|0|||
163845139|NCT00876460|591801848|FG004|Combination Therapy Phase|Not treated|0|||
163845140|NCT00876460|591801849|FG005|Combination Therapy Phase|Not treated|0|||
163845141|NCT00876460|591801850|FG006|Combination Therapy Phase|Not treated|1|||
163845142|NCT00876460|591801851|FG007|Combination Therapy Phase|Not treated|0|||
163845143|NCT00876460|591801844|FG000|Mono Therapy Phase|Progressive disease|0|||
163845144|NCT00876460|591801845|FG001|Mono Therapy Phase|Progressive disease|0|||
163845145|NCT00876460|591801846|FG002|Mono Therapy Phase|Progressive disease|0|||
163845146|NCT00876460|591801847|FG003|Mono Therapy Phase|Progressive disease|0|||
163845147|NCT00876460|591801848|FG004|Mono Therapy Phase|Progressive disease|2|||
163845148|NCT00876460|591801849|FG005|Mono Therapy Phase|Progressive disease|0|||
163845149|NCT00876460|591801850|FG006|Mono Therapy Phase|Progressive disease|1|||
163845150|NCT00876460|591801851|FG007|Mono Therapy Phase|Progressive disease|3|||
163845151|NCT00876460|591801844|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
163845152|NCT00876460|591801845|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
163845153|NCT00876460|591801846|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
163845154|NCT00876460|591801847|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
163845155|NCT00876460|591801848|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
163845156|NCT00876460|591801849|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
163845157|NCT00876460|591801850|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
163845158|NCT00876460|591801851|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
163845159|NCT00876460|591801844|FG000|Mono Therapy Phase|Adverse Event|0|||
163845160|NCT00876460|591801845|FG001|Mono Therapy Phase|Adverse Event|0|||
163845161|NCT00876460|591801846|FG002|Mono Therapy Phase|Adverse Event|0|||
163845162|NCT00876460|591801847|FG003|Mono Therapy Phase|Adverse Event|1|||
163845163|NCT00876460|591801848|FG004|Mono Therapy Phase|Adverse Event|0|||
164305038|NCT01812252|593490569|FG001|Overall Study|Persistent Disease|0|||
163845164|NCT00876460|591801849|FG005|Mono Therapy Phase|Adverse Event|0|||
163845165|NCT00876460|591801850|FG006|Mono Therapy Phase|Adverse Event|0|||
163845166|NCT00876460|591801851|FG007|Mono Therapy Phase|Adverse Event|0|||
163845167|NCT01216293|591801859|FG000|Main Study|Adverse Event|1|||
163845168|NCT01216293|591801860|FG001|Main Study|Adverse Event|4|||
164305039|NCT01812252|593490568|FG000|Overall Study|Not transplanted|11|||
163845169|NCT01216293|591801861|FG002|Main Study|Adverse Event|2|||
164006464|NCT02158533|592390963|FG001|Stage 2|Withdrawal by Subject|0|||
164305040|NCT01812252|593490569|FG001|Overall Study|Not transplanted|11|||
163845170|NCT01216293|591801859|FG000|Main Study|Major Protocol Deviation|1|||
164305041|NCT01812252|593490568|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
164305042|NCT01812252|593490569|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
164305043|NCT01812252|593490568|FG000|Overall Study|Withdrawal by Subject|1|||
164305044|NCT01812252|593490569|FG001|Overall Study|Withdrawal by Subject|1|||
164305045|NCT01812252|593490568|FG000|Overall Study|Screen Failure|1|||
163845171|NCT01216293|591801860|FG001|Main Study|Major Protocol Deviation|0|||
163845172|NCT01216293|591801861|FG002|Main Study|Major Protocol Deviation|1|||
163845173|NCT01216293|591801859|FG000|Main Study|Lost to Follow-up|3|||
163845174|NCT01216293|591801860|FG001|Main Study|Lost to Follow-up|1|||
163845175|NCT01216293|591801861|FG002|Main Study|Lost to Follow-up|0|||
163845176|NCT01216293|591801859|FG000|Main Study|Voluntary Withdrawal|2|||
163845177|NCT01216293|591801860|FG001|Main Study|Voluntary Withdrawal|2|||
163845178|NCT01216293|591801861|FG002|Main Study|Voluntary Withdrawal|2|||
163845179|NCT01216293|591801859|FG000|Main Study|Other Reason Not Specified|0|||
163845180|NCT01216293|591801860|FG001|Main Study|Other Reason Not Specified|1|||
163845181|NCT01216293|591801861|FG002|Main Study|Other Reason Not Specified|1|||
163845182|NCT01216293|591801859|FG000|Main Study|Randomized, Not Treated|1|||
163845183|NCT01216293|591801860|FG001|Main Study|Randomized, Not Treated|0|||
163845184|NCT01216293|591801861|FG002|Main Study|Randomized, Not Treated|0|||
163845185|NCT01216293|591801859|FG000|Calcium Absorption Substudy|Adverse Event|0|||
163845186|NCT01216293|591801860|FG001|Calcium Absorption Substudy|Adverse Event|2|||
163845187|NCT01216293|591801861|FG002|Calcium Absorption Substudy|Adverse Event|0|||
163845188|NCT01216293|591801859|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
163845189|NCT01216293|591801860|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
164305046|NCT01812252|593490569|FG001|Overall Study|Screen Failure|0|||
164305047|NCT01656408|593490570|FG000|Overall Study|Adverse Event|0|||
164305048|NCT01656408|593490571|FG001|Overall Study|Adverse Event|0|||
164305049|NCT01656408|593490572|FG002|Overall Study|Adverse Event|1|||
164305050|NCT01656408|593490573|FG003|Overall Study|Adverse Event|0|||
164305051|NCT01656408|593490574|FG004|Overall Study|Adverse Event|0|||
164305052|NCT01656408|593490575|FG005|Overall Study|Adverse Event|1|||
164305053|NCT01656408|593490576|FG006|Overall Study|Adverse Event|1|||
164305054|NCT01656408|593490577|FG007|Overall Study|Adverse Event|0|||
164305055|NCT01656408|593490578|FG008|Overall Study|Adverse Event|1|||
164305056|NCT01656408|593490579|FG009|Overall Study|Adverse Event|0|||
164305057|NCT01656408|593490570|FG000|Overall Study|Physician Decision|1|||
164305058|NCT01656408|593490571|FG001|Overall Study|Physician Decision|0|||
164305059|NCT01656408|593490572|FG002|Overall Study|Physician Decision|1|||
164305060|NCT01656408|593490573|FG003|Overall Study|Physician Decision|0|||
164305061|NCT01656408|593490574|FG004|Overall Study|Physician Decision|1|||
164305062|NCT01656408|593490575|FG005|Overall Study|Physician Decision|1|||
164305063|NCT01656408|593490576|FG006|Overall Study|Physician Decision|0|||
163845190|NCT01216293|591801861|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
163845191|NCT01216293|591801859|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
163845192|NCT01216293|591801860|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
163845193|NCT01216293|591801861|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
163845194|NCT01040780|591803666|FG000|Overall Study|Protocol Violation|1|||
163845195|NCT01040780|591803667|FG001|Overall Study|Protocol Violation|3|||
163845196|NCT03681639|591803668|FG000|Overall Study|Death|4|||
163845197|NCT03681639|591803668|FG000|Overall Study|Lost to Follow-up|2|||
163845198|NCT03681639|591803668|FG000|Overall Study|Withdrawal by Subject|1|||
163845199|NCT03681639|591803668|FG000|Overall Study|Adverse Event|2|||
163845200|NCT00654940|591803669|FG000|Period 1|Adverse Event|0|||
163845201|NCT00654940|591803670|FG001|Period 1|Adverse Event|1|||
163845202|NCT00654940|591803669|FG000|Period 1|Intolerable Pain Level|1|||
163845203|NCT00654940|591803670|FG001|Period 1|Intolerable Pain Level|0|||
163845204|NCT02169830|591803671|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
163845205|NCT02169830|591803672|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
163845206|NCT02169830|591803673|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
163845207|NCT02169830|591803671|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
163845208|NCT02169830|591803672|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
164305064|NCT01656408|593490577|FG007|Overall Study|Physician Decision|1|||
164305065|NCT01656408|593490578|FG008|Overall Study|Physician Decision|1|||
163845209|NCT02169830|591803673|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163845210|NCT02169830|591803671|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
163845211|NCT02169830|591803672|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
164305066|NCT01656408|593490579|FG009|Overall Study|Physician Decision|3|||
164305067|NCT04634253|593490582|FG000|Overall Study|Adverse Event|1|||
164305068|NCT04634253|593490583|FG001|Overall Study|Adverse Event|1|||
164305069|NCT04634253|593490584|FG002|Overall Study|Adverse Event|0|||
164305070|NCT04634253|593490582|FG000|Overall Study|Physician Decision|0|||
164305071|NCT04634253|593490583|FG001|Overall Study|Physician Decision|1|||
164305072|NCT04634253|593490584|FG002|Overall Study|Physician Decision|0|||
164305073|NCT04634253|593490582|FG000|Overall Study|Withdrawal by Subject|1|||
164305074|NCT04634253|593490583|FG001|Overall Study|Withdrawal by Subject|0|||
163845212|NCT02169830|591803673|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164305075|NCT04634253|593490584|FG002|Overall Study|Withdrawal by Subject|3|||
164305076|NCT01457703|593490585|FG000|Overall Study|Screen Failure|5|||
164305077|NCT01457703|593490586|FG001|Overall Study|Screen Failure|7|||
164305078|NCT01457703|593490585|FG000|Overall Study|Withdrawal by Subject|1|||
164305079|NCT01457703|593490586|FG001|Overall Study|Withdrawal by Subject|4|||
164305080|NCT01658436|593490587|FG000|Overall Study|Adverse Event|6|||
164305081|NCT01658436|593490588|FG001|Overall Study|Adverse Event|5|||
164305082|NCT01658436|593490587|FG000|Overall Study|Physician Decision|1|||
164305083|NCT01658436|593490588|FG001|Overall Study|Physician Decision|0|||
164305084|NCT01658436|593490587|FG000|Overall Study|Progressive disease|12|||
164305085|NCT01658436|593490588|FG001|Overall Study|Progressive disease|4|||
163845213|NCT02169830|591803671|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
163845214|NCT02169830|591803672|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
164305086|NCT01658436|593490587|FG000|Overall Study|Study terminated by sponsor|0|||
164305087|NCT01658436|593490588|FG001|Overall Study|Study terminated by sponsor|1|||
164305088|NCT01658436|593490587|FG000|Overall Study|Subject/guardian decision|0|||
164305089|NCT01658436|593490588|FG001|Overall Study|Subject/guardian decision|1|||
164305090|NCT01658436|593490587|FG000|Overall Study|Death|1|||
163845215|NCT02169830|591803673|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
163845216|NCT02169830|591803671|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
163845217|NCT02169830|591803672|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
163845218|NCT02169830|591803673|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
163845219|NCT03204695|591803674|FG000|Overall Study|Death|1|||
163845220|NCT03204695|591803674|FG000|Overall Study|Participant was treated with another device|1|||
163845221|NCT03204695|591803674|FG000|Overall Study|Physician Decision|2|||
163845222|NCT00777803|591803678|FG000|Overall Study|Lost to Follow-up|12|||
163845223|NCT00777803|591803679|FG001|Overall Study|Lost to Follow-up|5|||
163845224|NCT00777803|591803678|FG000|Overall Study|Adverse Event|1|||
163845225|NCT00777803|591803679|FG001|Overall Study|Adverse Event|0|||
163845226|NCT00777803|591803678|FG000|Overall Study|Non-compliance|2|||
163845227|NCT00777803|591803679|FG001|Overall Study|Non-compliance|2|||
163845228|NCT01755689|591803680|FG000|Overall Study|Withdrawal by Subject|1|||
163845229|NCT01755689|591803681|FG001|Overall Study|Withdrawal by Subject|3|||
163845230|NCT01755689|591803682|FG002|Overall Study|Withdrawal by Subject|2|||
164305091|NCT01658436|593490588|FG001|Overall Study|Death|0|||
164305092|NCT00926237|593490589|FG000|Overall Study|Withdrawal by Subject|2|||
164305093|NCT00926237|593490590|FG001|Overall Study|Withdrawal by Subject|1|||
164305094|NCT03133793|593490591|FG000|Overall Study|Withdrawal by Subject|0|||
164305095|NCT03133793|593490592|FG001|Overall Study|Withdrawal by Subject|4|||
164305096|NCT03133793|593490593|FG002|Overall Study|Withdrawal by Subject|2|||
164305097|NCT03133793|593490594|FG003|Overall Study|Withdrawal by Subject|4|||
164305098|NCT03133793|593490591|FG000|Overall Study|Lost to Follow-up|1|||
164305099|NCT03133793|593490592|FG001|Overall Study|Lost to Follow-up|0|||
164305100|NCT03133793|593490593|FG002|Overall Study|Lost to Follow-up|2|||
164305101|NCT03133793|593490594|FG003|Overall Study|Lost to Follow-up|0|||
164305102|NCT03133793|593490591|FG000|Overall Study|Death|0|||
164305103|NCT03133793|593490592|FG001|Overall Study|Death|0|||
164305104|NCT03133793|593490593|FG002|Overall Study|Death|0|||
163845231|NCT01755689|591803683|FG003|Overall Study|Withdrawal by Subject|1|||
163845232|NCT01755689|591803684|FG004|Overall Study|Withdrawal by Subject|1|||
163845233|NCT01755689|591803680|FG000|Overall Study|Migrated/moved from study area|0|||
163845234|NCT01755689|591803681|FG001|Overall Study|Migrated/moved from study area|1|||
163845235|NCT01755689|591803682|FG002|Overall Study|Migrated/moved from study area|1|||
163845236|NCT01755689|591803683|FG003|Overall Study|Migrated/moved from study area|1|||
163845237|NCT01755689|591803684|FG004|Overall Study|Migrated/moved from study area|1|||
163845238|NCT01755689|591803680|FG000|Overall Study|Lost to Follow-up|1|||
163845239|NCT01755689|591803681|FG001|Overall Study|Lost to Follow-up|0|||
163845240|NCT01755689|591803682|FG002|Overall Study|Lost to Follow-up|1|||
163845241|NCT01755689|591803683|FG003|Overall Study|Lost to Follow-up|0|||
163845242|NCT01755689|591803684|FG004|Overall Study|Lost to Follow-up|2|||
163845243|NCT01755689|591803680|FG000|Overall Study|Pregnancy|1|||
163845244|NCT01755689|591803681|FG001|Overall Study|Pregnancy|1|||
163845245|NCT01755689|591803682|FG002|Overall Study|Pregnancy|2|||
163845246|NCT01755689|591803683|FG003|Overall Study|Pregnancy|4|||
164305105|NCT03133793|593490594|FG003|Overall Study|Death|1|||
164305106|NCT03486834|593490595|FG000|Overall Study|Withdrawal by Subject|46|||
164305107|NCT03486834|593490596|FG001|Overall Study|Withdrawal by Subject|46|||
164305108|NCT03486834|593490597|FG002|Overall Study|Withdrawal by Subject|52|||
164305109|NCT03486834|593490595|FG000|Overall Study|Adverse Event|8|||
164305110|NCT03486834|593490596|FG001|Overall Study|Adverse Event|7|||
164305111|NCT03486834|593490597|FG002|Overall Study|Adverse Event|0|||
164305112|NCT03486834|593490595|FG000|Overall Study|Lost to Follow-up|41|||
164305113|NCT03486834|593490596|FG001|Overall Study|Lost to Follow-up|24|||
163845247|NCT01755689|591803684|FG004|Overall Study|Pregnancy|2|||
163845248|NCT02930122|591803687|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
164305114|NCT03486834|593490597|FG002|Overall Study|Lost to Follow-up|39|||
164305115|NCT03486834|593490595|FG000|Overall Study|Non-compliance with Study Drug|2|||
164305116|NCT03486834|593490596|FG001|Overall Study|Non-compliance with Study Drug|2|||
164305117|NCT03486834|593490597|FG002|Overall Study|Non-compliance with Study Drug|0|||
164305118|NCT03486834|593490595|FG000|Overall Study|Physician Decision|5|||
164305119|NCT03486834|593490596|FG001|Overall Study|Physician Decision|2|||
164305120|NCT03486834|593490597|FG002|Overall Study|Physician Decision|3|||
164305121|NCT03486834|593490595|FG000|Overall Study|Pregnancy|10|||
164305122|NCT03486834|593490596|FG001|Overall Study|Pregnancy|12|||
164305123|NCT03486834|593490597|FG002|Overall Study|Pregnancy|12|||
164305124|NCT03486834|593490595|FG000|Overall Study|Protocol Deviation|2|||
164305125|NCT03486834|593490596|FG001|Overall Study|Protocol Deviation|3|||
164305126|NCT03486834|593490597|FG002|Overall Study|Protocol Deviation|3|||
164305127|NCT03486834|593490595|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163845249|NCT02930122|591803688|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
163845250|NCT01995357|591803689|FG000|Period 5|Lack of Efficacy|1|||
163845251|NCT01995357|591803690|FG001|Period 5|Lack of Efficacy|0|||
163845252|NCT01995357|591803691|FG002|Period 5|Lack of Efficacy|0|||
163845253|NCT01995357|591803692|FG003|Period 5|Lack of Efficacy|0|||
163845254|NCT01995357|591803693|FG004|Period 5|Lack of Efficacy|0|||
164305128|NCT03486834|593490596|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164305129|NCT03486834|593490597|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164305130|NCT03486834|593490595|FG000|Overall Study|Randomized but not treated|4|||
164305131|NCT03486834|593490596|FG001|Overall Study|Randomized but not treated|4|||
164305132|NCT03486834|593490597|FG002|Overall Study|Randomized but not treated|1|||
164305133|NCT00888940|593490598|FG000|Overall Study|Adverse Event|12|||
164305134|NCT00888940|593490599|FG001|Overall Study|Adverse Event|3|||
164305135|NCT00888940|593490598|FG000|Overall Study|Lost to Follow-up|5|||
164305136|NCT00888940|593490599|FG001|Overall Study|Lost to Follow-up|5|||
164305137|NCT00888940|593490598|FG000|Overall Study|Randomized Not Treated|11|||
164305138|NCT00888940|593490599|FG001|Overall Study|Randomized Not Treated|13|||
164305139|NCT00432172|593490600|FG000|Overall Study|Physician Decision|0|||
164305140|NCT00432172|593490601|FG001|Overall Study|Physician Decision|0|||
164305141|NCT00432172|593490602|FG002|Overall Study|Physician Decision|2|||
164305142|NCT00432172|593490603|FG003|Overall Study|Physician Decision|0|||
164305143|NCT00432172|593490600|FG000|Overall Study|Adverse Event|4|||
164305144|NCT00432172|593490601|FG001|Overall Study|Adverse Event|2|||
164305145|NCT00432172|593490602|FG002|Overall Study|Adverse Event|4|||
164305146|NCT00432172|593490603|FG003|Overall Study|Adverse Event|3|||
164305147|NCT00432172|593490600|FG000|Overall Study|Disease progression|0|||
164305148|NCT00432172|593490601|FG001|Overall Study|Disease progression|2|||
164305149|NCT00432172|593490602|FG002|Overall Study|Disease progression|5|||
164305150|NCT00432172|593490603|FG003|Overall Study|Disease progression|1|||
164305151|NCT00432172|593490600|FG000|Overall Study|Withdrawal by Subject|0|||
164305152|NCT00432172|593490601|FG001|Overall Study|Withdrawal by Subject|1|||
164305153|NCT00432172|593490602|FG002|Overall Study|Withdrawal by Subject|0|||
164305154|NCT00432172|593490603|FG003|Overall Study|Withdrawal by Subject|2|||
164305155|NCT00432172|593490600|FG000|Overall Study|No treatment received|2|||
164305156|NCT00432172|593490601|FG001|Overall Study|No treatment received|2|||
163845255|NCT01995357|591803694|FG005|Period 5|Lack of Efficacy|0|||
163845256|NCT01995357|591803689|FG000|Period 5|Adverse Event|1|||
163845257|NCT01995357|591803690|FG001|Period 5|Adverse Event|0|||
163845258|NCT01995357|591803691|FG002|Period 5|Adverse Event|1|||
163845259|NCT01995357|591803692|FG003|Period 5|Adverse Event|0|||
163845260|NCT01995357|591803693|FG004|Period 5|Adverse Event|0|||
163845261|NCT01995357|591803694|FG005|Period 5|Adverse Event|0|||
163845262|NCT02609659|591803695|FG000|Overall Study|Adverse Event|1|||
163845263|NCT02609659|591803695|FG000|Overall Study|Lost to Follow-up|6|||
163845264|NCT02609659|591803695|FG000|Overall Study|Other|1|||
163845265|NCT01004250|591803698|FG000|Induction Therapy Period|Adverse Event|10|||
163845266|NCT01004250|591803698|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
163845267|NCT01004250|591803698|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
163845268|NCT01004250|591803698|FG000|Induction Therapy Period|Physician Decision|2|||
163845269|NCT01004250|591803698|FG000|Maintenance Therapy Period|Adverse Event|15|||
163845270|NCT01004250|591803698|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
163845271|NCT01004250|591803698|FG000|Maintenance Therapy Period|Protocol Violation|1|||
163845272|NCT01004250|591803698|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
163845273|NCT01004250|591803698|FG000|Maintenance Therapy Period|Physician Decision|4|||
163845274|NCT01004250|591803698|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
163845275|NCT01853254|591803699|FG000|Overall Study|Abnormal Laboratory Test|1|||
163845276|NCT01853254|591803699|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
163845277|NCT01853254|591803699|FG000|Overall Study|Death|1|||
163845278|NCT01853254|591803699|FG000|Overall Study|Failure to Return|43|||
163845279|NCT01853254|591803699|FG000|Overall Study|Insufficient Therapeutic Response|22|||
163845280|NCT01853254|591803699|FG000|Overall Study|Refusal of Treatment|1|||
163845281|NCT01853254|591803699|FG000|Overall Study|Other Protocol Violation|1|||
163845282|NCT01853254|591803699|FG000|Overall Study|Withdrawal of Consent|16|||
164305157|NCT00432172|593490602|FG002|Overall Study|No treatment received|0|||
164305158|NCT00432172|593490603|FG003|Overall Study|No treatment received|1|||
164305159|NCT00515619|593490604|FG000|Overall Study|Adverse Event|34|||
164305160|NCT00515619|593490604|FG000|Overall Study|Lack of Efficacy|92|||
164305161|NCT00515619|593490604|FG000|Overall Study|Withdrawal by Subject|66|||
164305162|NCT00515619|593490604|FG000|Overall Study|Protocol Violation|3|||
164305163|NCT00515619|593490604|FG000|Overall Study|Lost to Follow-up|4|||
164305164|NCT00515619|593490604|FG000|Overall Study|Unsatisfactory compliance|6|||
163845283|NCT01853254|591803699|FG000|Overall Study|Administrative/Other|16|||
164305165|NCT00515619|593490604|FG000|Overall Study|Other: Site discontinuing trials|2|||
164305166|NCT00515619|593490604|FG000|Overall Study|Other: Subject cannot attend visits|2|||
164305167|NCT00515619|593490604|FG000|Overall Study|Other: Subject required surgery|1|||
164305168|NCT00515619|593490604|FG000|Overall Study|Other: Subject moved to another country|1|||
164305169|NCT00515619|593490604|FG000|Overall Study|Other: Investigator decision|1|||
164305170|NCT00515619|593490604|FG000|Overall Study|Other: Subject became pregnant|1|||
164305171|NCT00515619|593490604|FG000|Overall Study|Other: Request from sponsor|1|||
164305172|NCT00515619|593490604|FG000|Overall Study|Other: Drug available on license|1|||
164305173|NCT00515619|593490604|FG000|Overall Study|Other: Subject interested in other AED|1|||
164305174|NCT02379091|593490605|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164305175|NCT02379091|593490606|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164305176|NCT02379091|593490607|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164305177|NCT02379091|593490608|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
164305178|NCT02379091|593490605|FG000|Overall Study|Principal Investigator Discretion|0|||
164305179|NCT02379091|593490606|FG001|Overall Study|Principal Investigator Discretion|1|||
164305180|NCT02379091|593490607|FG002|Overall Study|Principal Investigator Discretion|0|||
164305181|NCT02379091|593490608|FG003|Overall Study|Principal Investigator Discretion|0|||
164305182|NCT02379091|593490605|FG000|Overall Study|Lost to Follow-up|0|||
164305183|NCT02379091|593490606|FG001|Overall Study|Lost to Follow-up|0|||
164305184|NCT02379091|593490607|FG002|Overall Study|Lost to Follow-up|0|||
164305185|NCT02379091|593490608|FG003|Overall Study|Lost to Follow-up|1|||
164305186|NCT02379091|593490605|FG000|Overall Study|Voluntary Withdrawal|2|||
164305187|NCT02379091|593490606|FG001|Overall Study|Voluntary Withdrawal|5|||
164305188|NCT02379091|593490607|FG002|Overall Study|Voluntary Withdrawal|2|||
164305189|NCT02379091|593490608|FG003|Overall Study|Voluntary Withdrawal|4|||
164305190|NCT02379091|593490605|FG000|Overall Study|Study Termination|7|||
164305191|NCT02379091|593490606|FG001|Overall Study|Study Termination|2|||
164305192|NCT02379091|593490607|FG002|Overall Study|Study Termination|5|||
164305193|NCT02379091|593490608|FG003|Overall Study|Study Termination|8|||
164305194|NCT02379091|593490605|FG000|Overall Study|Lack of Efficacy|3|||
164305195|NCT02379091|593490606|FG001|Overall Study|Lack of Efficacy|0|||
164305196|NCT02379091|593490607|FG002|Overall Study|Lack of Efficacy|0|||
164305197|NCT02379091|593490608|FG003|Overall Study|Lack of Efficacy|0|||
164305198|NCT03326713|593490610|FG000|Overall Study|Death|2|||
163845284|NCT02462083|591803700|FG000|Overall Study|Sponsor request|39|||
163845285|NCT02462083|591803700|FG000|Overall Study|Withdrawal by Subject|87|||
163845286|NCT02462083|591803700|FG000|Overall Study|Lost to Follow-up|41|||
163845287|NCT02462083|591803700|FG000|Overall Study|Lack of Efficacy|151|||
163845288|NCT02462083|591803700|FG000|Overall Study|Pregnancy|1|||
163845289|NCT02462083|591803700|FG000|Overall Study|Protocol Violation|6|||
163845290|NCT02462083|591803700|FG000|Overall Study|Adverse Event|33|||
163845291|NCT02462083|591803700|FG000|Overall Study|Worsening condition|16|||
163845292|NCT02462083|591803700|FG000|Overall Study|Other than specified|45|||
163845293|NCT02711995|591803703|FG000|Washout (90 Days)|Conflicting medication|1|||
163845294|NCT01809210|591803706|FG000|Overall Study|Withdrawal by Subject|0|||
163845295|NCT01809210|591803707|FG001|Overall Study|Withdrawal by Subject|0|||
163845296|NCT01809210|591803708|FG002|Overall Study|Withdrawal by Subject|1|||
163845297|NCT01809210|591803709|FG003|Overall Study|Withdrawal by Subject|1|||
163845298|NCT01809210|591803710|FG004|Overall Study|Withdrawal by Subject|1|||
163845299|NCT01809210|591803711|FG005|Overall Study|Withdrawal by Subject|0|||
163845300|NCT01809210|591803712|FG006|Overall Study|Withdrawal by Subject|4|||
163845301|NCT01809210|591803706|FG000|Overall Study|Death|1|||
163845302|NCT01809210|591803707|FG001|Overall Study|Death|1|||
163845303|NCT01809210|591803708|FG002|Overall Study|Death|2|||
163845304|NCT01809210|591803709|FG003|Overall Study|Death|0|||
163845305|NCT01809210|591803710|FG004|Overall Study|Death|1|||
163845306|NCT01809210|591803711|FG005|Overall Study|Death|3|||
163845307|NCT01809210|591803712|FG006|Overall Study|Death|1|||
163845308|NCT01115998|591803713|FG000|Overall Study|Lost to Follow-up|6|||
163845309|NCT01115998|591803714|FG001|Overall Study|Lost to Follow-up|6|||
163845310|NCT01383993|591803720|FG000|Overall Study|Adverse Event|1|||
163845311|NCT01383993|591803721|FG001|Overall Study|Adverse Event|1|||
163845312|NCT01383993|591803722|FG002|Overall Study|Adverse Event|0|||
163845313|NCT01383993|591803720|FG000|Overall Study|Withdrawal by Subject|0|||
163845314|NCT01383993|591803721|FG001|Overall Study|Withdrawal by Subject|0|||
163845315|NCT01383993|591803722|FG002|Overall Study|Withdrawal by Subject|1|||
163845316|NCT01383993|591803720|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
164305199|NCT03326713|593490611|FG001|Overall Study|Death|1|||
164305200|NCT03326713|593490612|FG002|Overall Study|Death|0|||
164305201|NCT03326713|593490610|FG000|Overall Study|Lost to Follow-up|20|||
164305202|NCT03326713|593490611|FG001|Overall Study|Lost to Follow-up|21|||
164305203|NCT03326713|593490612|FG002|Overall Study|Lost to Follow-up|33|||
164305204|NCT03326713|593490610|FG000|Overall Study|Withdrawal by Subject|1|||
164305205|NCT03326713|593490611|FG001|Overall Study|Withdrawal by Subject|2|||
164305206|NCT03326713|593490612|FG002|Overall Study|Withdrawal by Subject|11|||
164305207|NCT03326713|593490610|FG000|Overall Study|Found Ineligible|11|||
163845317|NCT01383993|591803721|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
163845318|NCT01383993|591803722|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
163845319|NCT01489020|591803727|FG000|Overall Study|Withdrawal by Subject|1|||
163845320|NCT01489020|591803728|FG001|Overall Study|Withdrawal by Subject|0|||
163845321|NCT01489020|591803729|FG002|Overall Study|Withdrawal by Subject|0|||
163845322|NCT01489020|591803730|FG003|Overall Study|Withdrawal by Subject|0|||
163845323|NCT01489020|591803731|FG004|Overall Study|Withdrawal by Subject|0|||
163845324|NCT01489020|591803732|FG005|Overall Study|Withdrawal by Subject|0|||
163845325|NCT01489020|591803727|FG000|Overall Study|Adverse Event|0|||
163845326|NCT01489020|591803728|FG001|Overall Study|Adverse Event|0|||
163845327|NCT01489020|591803729|FG002|Overall Study|Adverse Event|3|||
163845328|NCT01489020|591803730|FG003|Overall Study|Adverse Event|0|||
163845329|NCT01489020|591803731|FG004|Overall Study|Adverse Event|3|||
163845330|NCT01489020|591803732|FG005|Overall Study|Adverse Event|0|||
163845331|NCT01489020|591803727|FG000|Overall Study|Concomitant disease|0|||
163845332|NCT01489020|591803728|FG001|Overall Study|Concomitant disease|0|||
164305208|NCT03326713|593490611|FG001|Overall Study|Found Ineligible|11|||
163845333|NCT01489020|591803729|FG002|Overall Study|Concomitant disease|0|||
163845334|NCT01489020|591803730|FG003|Overall Study|Concomitant disease|0|||
163845335|NCT01489020|591803731|FG004|Overall Study|Concomitant disease|3|||
163845336|NCT01489020|591803732|FG005|Overall Study|Concomitant disease|0|||
163845337|NCT00262743|591803736|FG000|Overall Study|Adverse Event|0|||
163845338|NCT00262743|591803737|FG001|Overall Study|Adverse Event|9|||
164305209|NCT03326713|593490612|FG002|Overall Study|Found Ineligible|8|||
164305210|NCT00771758|593490613|FG000|Overall Study|Adverse Event|2|||
164305211|NCT00771758|593490614|FG001|Overall Study|Adverse Event|8|||
164305212|NCT00771758|593490615|FG002|Overall Study|Adverse Event|1|||
164305213|NCT00771758|593490613|FG000|Overall Study|Lack of Efficacy|0|||
164305214|NCT00771758|593490614|FG001|Overall Study|Lack of Efficacy|2|||
164305215|NCT00771758|593490615|FG002|Overall Study|Lack of Efficacy|1|||
164305216|NCT00771758|593490613|FG000|Overall Study|Lost to Follow-up|1|||
164305217|NCT00771758|593490614|FG001|Overall Study|Lost to Follow-up|0|||
164305218|NCT00771758|593490615|FG002|Overall Study|Lost to Follow-up|0|||
164305219|NCT00771758|593490613|FG000|Overall Study|Protocol Violation|1|||
164305220|NCT00771758|593490614|FG001|Overall Study|Protocol Violation|0|||
164305221|NCT00771758|593490615|FG002|Overall Study|Protocol Violation|0|||
164305222|NCT00771758|593490613|FG000|Overall Study|Withdrawal by Subject|1|||
164305223|NCT00771758|593490614|FG001|Overall Study|Withdrawal by Subject|0|||
164305224|NCT00771758|593490615|FG002|Overall Study|Withdrawal by Subject|0|||
164305225|NCT00771758|593490613|FG000|Overall Study|Other|3|||
164305226|NCT00771758|593490614|FG001|Overall Study|Other|2|||
163845339|NCT00262743|591803736|FG000|Overall Study|Disease progression|0|||
163845340|NCT00262743|591803737|FG001|Overall Study|Disease progression|3|||
163845341|NCT02485353|591803738|FG000|Overall Study|Death|1|||
163845342|NCT02485353|591803738|FG000|Overall Study|Disease Progression|1|||
163845343|NCT01950273|591803743|FG000|Overall Study|Protocol Violation|1|||
163845344|NCT01950273|591803744|FG001|Overall Study|Protocol Violation|0|||
163845345|NCT01950273|591803743|FG000|Overall Study|Withdrawal by Subject|2|||
163845346|NCT01950273|591803744|FG001|Overall Study|Withdrawal by Subject|0|||
163845347|NCT01950273|591803743|FG000|Overall Study|Other not defined above|1|||
164305227|NCT00771758|593490615|FG002|Overall Study|Other|0|||
164305228|NCT03067077|593490616|FG000|Overall Study|Did not receive surgery|4|||
164305229|NCT03067077|593490617|FG001|Overall Study|Did not receive surgery|5|||
164305230|NCT03067077|593490616|FG000|Overall Study|Lost to Follow-up|3|||
164305231|NCT03067077|593490617|FG001|Overall Study|Lost to Follow-up|2|||
164305232|NCT00935584|593490620|FG000|Overall Study|Withdrawal by Subject|9|||
163845348|NCT01950273|591803744|FG001|Overall Study|Other not defined above|0|||
163845349|NCT04430335|591803745|FG000|Overall Study|Withdrawal by Subject|1|||
163845350|NCT00179010|591803746|FG000|Overall Study|Muscle probe defective|1|||
163845351|NCT00179010|591803747|FG001|Overall Study|Muscle probe defective|1|||
163845352|NCT00179010|591803746|FG000|Overall Study|Failure to place arterial line|0|||
163845353|NCT00179010|591803747|FG001|Overall Study|Failure to place arterial line|1|||
163845354|NCT04747275|591803759|FG000|Overall Study|Study terminated|0|||
163845355|NCT04747275|591803760|FG001|Overall Study|Study terminated|1|||
163845356|NCT00531011|591803763|FG000|Overall Study|Withdrawal by Subject|2|||
163845357|NCT00531011|591803764|FG001|Overall Study|Withdrawal by Subject|4|||
163845358|NCT00531011|591803763|FG000|Overall Study|Death|1|||
163845359|NCT00531011|591803764|FG001|Overall Study|Death|0|||
163845360|NCT00531011|591803763|FG000|Overall Study|Lost to Follow-up|1|||
163845361|NCT00531011|591803764|FG001|Overall Study|Lost to Follow-up|0|||
163845362|NCT00531011|591803763|FG000|Overall Study|Physician Decision|0|||
163845363|NCT00531011|591803764|FG001|Overall Study|Physician Decision|3|||
163845364|NCT03268590|591803765|FG000|Overall Study|Previously unknown exclusion criteria|1|||
164305233|NCT00935584|593490621|FG001|Overall Study|Withdrawal by Subject|0|||
163845365|NCT02823964|591803768|FG000|Overall Study|Adverse Event|2|||
163845366|NCT02823964|591803768|FG000|Overall Study|Physician Decision|1|||
163845367|NCT02823964|591803768|FG000|Overall Study|Lack of Efficacy|1|||
164305234|NCT00935584|593490620|FG000|Overall Study|Death|3|||
164305235|NCT00935584|593490621|FG001|Overall Study|Death|0|||
164305236|NCT00935584|593490620|FG000|Overall Study|Lost to Follow-up|8|||
164305237|NCT00935584|593490621|FG001|Overall Study|Lost to Follow-up|0|||
163845368|NCT02823964|591803768|FG000|Overall Study|Withdrawal by Subject|1|||
164305238|NCT00935584|593490620|FG000|Overall Study|No show|9|||
163845369|NCT03537261|591803772|FG000|Overall Study|Lost to Follow-up|4|||
163845370|NCT03537261|591803773|FG001|Overall Study|Lost to Follow-up|5|||
163845371|NCT03537261|591803772|FG000|Overall Study|Withdrawal by Subject|4|||
163845372|NCT03537261|591803773|FG001|Overall Study|Withdrawal by Subject|6|||
163845373|NCT03537261|591803772|FG000|Overall Study|Did not return study questionnaires|0|||
163845374|NCT03537261|591803773|FG001|Overall Study|Did not return study questionnaires|1|||
163845375|NCT00610675|591803774|FG000|Overall Study|Untreated|4|||
163845376|NCT00610675|591803774|FG000|Overall Study|Adverse Event|67|||
163845377|NCT00610675|591803774|FG000|Overall Study|Insufficient Effect|31|||
163845378|NCT00610675|591803774|FG000|Overall Study|Withdrawal by Subject|28|||
163845379|NCT00610675|591803774|FG000|Overall Study|Reasons unrelated to trial|27|||
163845380|NCT00610675|591803774|FG000|Overall Study|Lack of Compliance|7|||
163845381|NCT00610675|591803774|FG000|Overall Study|Lost to Follow-up|31|||
163845382|NCT00610675|591803774|FG000|Overall Study|Other reason (not specified)|25|||
163845383|NCT01458249|591803775|FG000|Overall Study|Not treated|1|||
163845384|NCT01458249|591803775|FG000|Overall Study|Adverse Event|4|||
163845385|NCT01458249|591803775|FG000|Overall Study|Other|2|||
163845386|NCT01458249|591803775|FG000|Overall Study|Ongoing|1|||
163845387|NCT02056119|591803778|FG000|Overall Study|Death|1|||
163845388|NCT02056119|591803779|FG001|Overall Study|Death|2|||
163845389|NCT02056119|591803778|FG000|Overall Study|Intubated for less than 24 hrs|2|||
163845390|NCT02056119|591803779|FG001|Overall Study|Intubated for less than 24 hrs|7|||
163845391|NCT02056119|591803778|FG000|Overall Study|No aerosol treatments were given.|3|||
163845392|NCT02056119|591803779|FG001|Overall Study|No aerosol treatments were given.|2|||
163845393|NCT02056119|591803778|FG000|Overall Study|Received Metaneb treatment|0|||
163845394|NCT02056119|591803779|FG001|Overall Study|Received Metaneb treatment|2|||
163845395|NCT02056119|591803778|FG000|Overall Study|Protocol Violation|4|||
164305239|NCT00935584|593490621|FG001|Overall Study|No show|0|||
164305240|NCT00935584|593490620|FG000|Overall Study|Relocated|3|||
164305241|NCT00935584|593490621|FG001|Overall Study|Relocated|0|||
164305242|NCT00935584|593490620|FG000|Overall Study|Patient changed provider|3|||
164305243|NCT00935584|593490621|FG001|Overall Study|Patient changed provider|0|||
164305244|NCT00935584|593490620|FG000|Overall Study|Provider dropped out of study|14|||
164305245|NCT00935584|593490621|FG001|Overall Study|Provider dropped out of study|4|||
164305246|NCT00687193|593490622|FG000|Overall Study|Adverse Event|0|||
164305247|NCT00687193|593490623|FG001|Overall Study|Adverse Event|1|||
164305248|NCT00687193|593490624|FG002|Overall Study|Adverse Event|2|||
164305249|NCT00687193|593490625|FG003|Overall Study|Adverse Event|3|||
164305250|NCT00687193|593490626|FG004|Overall Study|Adverse Event|0|||
164305251|NCT00687193|593490627|FG005|Overall Study|Adverse Event|2|||
164305252|NCT00687193|593490622|FG000|Overall Study|Lack of Efficacy|1|||
164305253|NCT00687193|593490623|FG001|Overall Study|Lack of Efficacy|1|||
163845396|NCT02056119|591803779|FG001|Overall Study|Protocol Violation|7|||
163845397|NCT01348854|591803780|FG000|Overall Study|Lost to Follow-up|2|||
163845398|NCT01348854|591803781|FG001|Overall Study|Lost to Follow-up|1|||
164305254|NCT00687193|593490624|FG002|Overall Study|Lack of Efficacy|0|||
164305255|NCT00687193|593490625|FG003|Overall Study|Lack of Efficacy|0|||
164305256|NCT00687193|593490626|FG004|Overall Study|Lack of Efficacy|0|||
164305257|NCT00687193|593490627|FG005|Overall Study|Lack of Efficacy|2|||
164305258|NCT00687193|593490622|FG000|Overall Study|Protocol Violation|1|||
164305259|NCT00687193|593490623|FG001|Overall Study|Protocol Violation|2|||
164305260|NCT00687193|593490624|FG002|Overall Study|Protocol Violation|0|||
164305261|NCT00687193|593490625|FG003|Overall Study|Protocol Violation|1|||
164305262|NCT00687193|593490626|FG004|Overall Study|Protocol Violation|2|||
164305263|NCT00687193|593490627|FG005|Overall Study|Protocol Violation|0|||
164305264|NCT02514083|593490632|FG000|Overall Study|Adverse Event|1|||
164305265|NCT02017405|593490633|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305266|NCT02017405|593490634|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305267|NCT02017405|593490635|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305268|NCT02017405|593490636|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305269|NCT02017405|593490637|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
164305270|NCT02017405|593490638|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
164305271|NCT02017405|593490633|FG000|Open-label Phase|Adverse Event|1|||
164305272|NCT02017405|593490634|FG001|Open-label Phase|Adverse Event|1|||
164305273|NCT02017405|593490635|FG002|Open-label Phase|Adverse Event|0|||
164305274|NCT02017405|593490636|FG003|Open-label Phase|Adverse Event|0|||
164305275|NCT02017405|593490637|FG004|Open-label Phase|Adverse Event|0|||
163845399|NCT01348854|591803780|FG000|Overall Study|Withdrawal by Subject|1|||
163845400|NCT01348854|591803781|FG001|Overall Study|Withdrawal by Subject|0|||
163845401|NCT00983619|591803784|FG000|Overall Study|Lost to Follow-up|0|||
163845402|NCT00983619|591803785|FG001|Overall Study|Lost to Follow-up|1|||
163845403|NCT00983619|591803786|FG002|Overall Study|Lost to Follow-up|0|||
164305276|NCT02017405|593490638|FG005|Open-label Phase|Adverse Event|0|||
163845404|NCT00983619|591803787|FG003|Overall Study|Lost to Follow-up|0|||
164305277|NCT02273596|593491684|FG000|24-Week Treatment Period|Adverse Event|3|||
164305278|NCT02273596|593491684|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
164305279|NCT02273596|593491684|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
163845405|NCT00983619|591803788|FG004|Overall Study|Lost to Follow-up|0|||
163845406|NCT00983619|591803789|FG005|Overall Study|Lost to Follow-up|2|||
163845407|NCT00983619|591803790|FG006|Overall Study|Lost to Follow-up|0|||
163845408|NCT00983619|591803791|FG007|Overall Study|Lost to Follow-up|0|||
163845409|NCT00983619|591803792|FG008|Overall Study|Lost to Follow-up|0|||
163845410|NCT00983619|591803793|FG009|Overall Study|Lost to Follow-up|0|||
163845411|NCT00983619|591803794|FG010|Overall Study|Lost to Follow-up|0|||
163845412|NCT00983619|591803795|FG011|Overall Study|Lost to Follow-up|2|||
163845413|NCT00983619|591803784|FG000|Overall Study|Withdrawal by Subject|2|||
163845414|NCT00983619|591803785|FG001|Overall Study|Withdrawal by Subject|1|||
164305280|NCT02273596|593491684|FG000|24-Week Treatment Period|Physician Decision|1|||
164305281|NCT02273596|593491684|FG000|24-Week Treatment Period|Protocol Deviation|1|||
164305282|NCT02273596|593491684|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
164305283|NCT02273596|593491684|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
164305284|NCT02273596|593491684|FG000|Extension Period|Lost to Follow-up|1|||
164305285|NCT02273596|593491684|FG000|Extension Period|Protocol Deviation|1|||
164305286|NCT02139592|593491686|FG000|Overall Study|Case Report Forms Uncollected|8|||
164305287|NCT02873702|593491691|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
164305288|NCT02873702|593491692|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
164305289|NCT02873702|593491693|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
164305290|NCT02873702|593491694|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
164305291|NCT02873702|593491691|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
164305292|NCT02873702|593491692|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
164305293|NCT02873702|593491693|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
164305294|NCT02873702|593491694|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
164305295|NCT02873702|593491691|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
164305296|NCT02873702|593491692|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
163845415|NCT00983619|591803786|FG002|Overall Study|Withdrawal by Subject|1|||
163845416|NCT00983619|591803787|FG003|Overall Study|Withdrawal by Subject|3|||
163845417|NCT00983619|591803788|FG004|Overall Study|Withdrawal by Subject|1|||
163845418|NCT00983619|591803789|FG005|Overall Study|Withdrawal by Subject|23|||
163845419|NCT00983619|591803790|FG006|Overall Study|Withdrawal by Subject|0|||
163845420|NCT00983619|591803791|FG007|Overall Study|Withdrawal by Subject|0|||
163845421|NCT00983619|591803792|FG008|Overall Study|Withdrawal by Subject|0|||
163845422|NCT00983619|591803793|FG009|Overall Study|Withdrawal by Subject|0|||
163845423|NCT00983619|591803794|FG010|Overall Study|Withdrawal by Subject|1|||
163845424|NCT00983619|591803795|FG011|Overall Study|Withdrawal by Subject|1|||
163845425|NCT00983619|591803784|FG000|Overall Study|Death|0|||
163845426|NCT00983619|591803785|FG001|Overall Study|Death|2|||
163845427|NCT00983619|591803786|FG002|Overall Study|Death|2|||
163845428|NCT00983619|591803787|FG003|Overall Study|Death|1|||
163845429|NCT00983619|591803788|FG004|Overall Study|Death|2|||
163845430|NCT00983619|591803789|FG005|Overall Study|Death|30|||
163845431|NCT00983619|591803790|FG006|Overall Study|Death|1|||
163845432|NCT00983619|591803791|FG007|Overall Study|Death|0|||
163845433|NCT00983619|591803792|FG008|Overall Study|Death|1|||
163845434|NCT00983619|591803793|FG009|Overall Study|Death|2|||
163845435|NCT00983619|591803794|FG010|Overall Study|Death|9|||
163845436|NCT00983619|591803795|FG011|Overall Study|Death|8|||
163845437|NCT00983619|591803784|FG000|Overall Study|Other|1|||
163845438|NCT00983619|591803785|FG001|Overall Study|Other|0|||
163845439|NCT00983619|591803786|FG002|Overall Study|Other|0|||
163845440|NCT00983619|591803787|FG003|Overall Study|Other|1|||
163845441|NCT00983619|591803788|FG004|Overall Study|Other|0|||
164305297|NCT02873702|593491693|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
164305298|NCT02873702|593491694|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
164305299|NCT02873702|593491691|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
164305300|NCT02873702|593491692|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
164305301|NCT02873702|593491693|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
164305302|NCT02873702|593491694|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
164305303|NCT02873702|593491691|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
164305304|NCT02873702|593491692|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
164305305|NCT02873702|593491693|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
163845442|NCT00983619|591803789|FG005|Overall Study|Other|12|||
163845443|NCT00983619|591803790|FG006|Overall Study|Other|2|||
163845444|NCT00983619|591803791|FG007|Overall Study|Other|2|||
163845445|NCT00983619|591803792|FG008|Overall Study|Other|0|||
163845446|NCT00983619|591803793|FG009|Overall Study|Other|1|||
163845447|NCT00983619|591803794|FG010|Overall Study|Other|1|||
163845448|NCT00983619|591803795|FG011|Overall Study|Other|0|||
163845449|NCT02443103|591803797|FG000|Overall Study|Adverse Event|2|||
163845450|NCT02443103|591803797|FG000|Overall Study|Noncompliance|1|||
163845451|NCT02366936|591803799|FG000|Overall Study|Withdrawal by Subject|2|||
163845452|NCT02366936|591803799|FG000|Overall Study|Lost to Follow-up|4|||
163845453|NCT02366936|591803799|FG000|Overall Study|Physician Decision|2|||
163845454|NCT02878213|591803800|FG000|Overall Study|Withdrawal by Subject|2|||
163845455|NCT02878213|591803800|FG000|Overall Study|Adverse Event|1|||
163845456|NCT01558674|591803801|FG000|Part 1|Study Terminated by Sponsor|10|||
163845457|NCT01558674|591803802|FG001|Part 1|Study Terminated by Sponsor|0|||
163845458|NCT01558674|591803801|FG000|Part 1|Withdrawal by Subject|1|||
163845459|NCT01558674|591803802|FG001|Part 1|Withdrawal by Subject|0|||
163845460|NCT01555021|591803805|FG000|Overall Study|Lost to Follow-up|1|||
163845461|NCT01555021|591803806|FG001|Overall Study|Lost to Follow-up|2|||
163845462|NCT01313923|591803807|FG000|Overall Study|Physician Decision|3|||
163845463|NCT01388530|591803808|FG000|Overall Study|Lost to Follow-up|5|||
163845464|NCT02420327|591803809|FG000|Overall Study|Adverse Event|7|||
163845465|NCT02420327|591803809|FG000|Overall Study|Pregnancy|1|||
163845466|NCT02420327|591803809|FG000|Overall Study|Withdrawal by Subject|6|||
163845467|NCT02420327|591803809|FG000|Overall Study|Lost to Follow-up|1|||
163845468|NCT02420327|591803809|FG000|Overall Study|Protocol Violation|1|||
163845469|NCT02204293|591803810|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
163845470|NCT02204293|591803811|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
163845471|NCT02204293|591803812|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
163845472|NCT02204293|591803813|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
163845473|NCT02204293|591803814|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
163845474|NCT02204293|591803815|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
163845475|NCT02204293|591803810|FG000|Core Study Part I|Adverse Event|1|||
163845476|NCT02204293|591803811|FG001|Core Study Part I|Adverse Event|0|||
163845477|NCT02204293|591803812|FG002|Core Study Part I|Adverse Event|0|||
163845478|NCT02204293|591803813|FG003|Core Study Part I|Adverse Event|0|||
163845479|NCT02204293|591803814|FG004|Core Study Part I|Adverse Event|0|||
163845480|NCT02204293|591803815|FG005|Core Study Part I|Adverse Event|0|||
163845481|NCT02204293|591803810|FG000|Core Study Part I|Physician Decision|0|||
163845482|NCT02204293|591803811|FG001|Core Study Part I|Physician Decision|3|||
163845483|NCT02204293|591803812|FG002|Core Study Part I|Physician Decision|0|||
163845484|NCT02204293|591803813|FG003|Core Study Part I|Physician Decision|0|||
163845485|NCT02204293|591803814|FG004|Core Study Part I|Physician Decision|0|||
163845486|NCT02204293|591803815|FG005|Core Study Part I|Physician Decision|0|||
163845487|NCT02204293|591803810|FG000|LTE Phase|Study Suspended|0|||
163845488|NCT02204293|591803811|FG001|LTE Phase|Study Suspended|0|||
163845489|NCT02204293|591803812|FG002|LTE Phase|Study Suspended|0|||
163845490|NCT02204293|591803813|FG003|LTE Phase|Study Suspended|0|||
163845491|NCT02204293|591803814|FG004|LTE Phase|Study Suspended|0|||
163845492|NCT02204293|591803815|FG005|LTE Phase|Study Suspended|7|||
163845493|NCT01225835|591803818|FG000|Overall Study|Completed protocol|2|||
163845494|NCT01225835|591803819|FG001|Overall Study|Completed protocol|1|||
163845495|NCT01225835|591803818|FG000|Overall Study|Did not meet hCG criterion|2|||
163845496|NCT01225835|591803819|FG001|Overall Study|Did not meet hCG criterion|0|||
163845497|NCT01225835|591803818|FG000|Overall Study|Adverse Event|2|||
163845498|NCT01225835|591803819|FG001|Overall Study|Adverse Event|1|||
163845499|NCT01225835|591803818|FG000|Overall Study|Other|1|||
163845500|NCT01225835|591803819|FG001|Overall Study|Other|1|||
163845501|NCT01266993|591803820|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
163845502|NCT01266993|591803821|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
163845503|NCT01266993|591803820|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
163845504|NCT01266993|591803821|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
163845505|NCT03051659|591803822|FG000|Treatment Period|Withdrawal by Subject|0|||
163845506|NCT03051659|591803823|FG001|Treatment Period|Withdrawal by Subject|2|||
163845507|NCT03051659|591803822|FG000|Survival Follow-up|Lost to Follow-up|23|||
163845508|NCT03051659|591803823|FG001|Survival Follow-up|Lost to Follow-up|22|||
163845509|NCT04779242|591803824|FG000|Overall Study|Adverse Event|1|||
163845510|NCT04779242|591803825|FG001|Overall Study|Adverse Event|1|||
163845511|NCT04779242|591803824|FG000|Overall Study|Lost to Follow-up|2|||
163845512|NCT04779242|591803825|FG001|Overall Study|Lost to Follow-up|4|||
163845513|NCT04779242|591803824|FG000|Overall Study|Withdrawal by Subject|7|||
163845514|NCT04779242|591803825|FG001|Overall Study|Withdrawal by Subject|9|||
163845515|NCT04779242|591803824|FG000|Overall Study|Death|6|||
163845516|NCT04779242|591803825|FG001|Overall Study|Death|6|||
163845517|NCT04779242|591803824|FG000|Overall Study|COVID-19 related reasons|2|||
163845518|NCT04779242|591803825|FG001|Overall Study|COVID-19 related reasons|1|||
163845519|NCT04779242|591803824|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
163845520|NCT04779242|591803825|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
163845521|NCT04779242|591803824|FG000|Overall Study|Martial Law in Ukraine|2|||
163845522|NCT04779242|591803825|FG001|Overall Study|Martial Law in Ukraine|3|||
163845523|NCT00849680|591803830|FG000|Overall Study|Adverse Event|0|||
163845524|NCT00849680|591803831|FG001|Overall Study|Adverse Event|0|||
163845525|NCT00849680|591803832|FG002|Overall Study|Adverse Event|0|||
163845526|NCT00849680|591803833|FG003|Overall Study|Adverse Event|0|||
163845527|NCT00849680|591803834|FG004|Overall Study|Adverse Event|0|||
163845528|NCT00849680|591803835|FG005|Overall Study|Adverse Event|0|||
163845529|NCT00849680|591803836|FG006|Overall Study|Adverse Event|2|||
163845530|NCT00849680|591803837|FG007|Overall Study|Adverse Event|0|||
163845531|NCT00849680|591803830|FG000|Overall Study|Lost to Follow-up|7|||
163845532|NCT00849680|591803831|FG001|Overall Study|Lost to Follow-up|3|||
163845533|NCT00849680|591803832|FG002|Overall Study|Lost to Follow-up|12|||
163845534|NCT00849680|591803833|FG003|Overall Study|Lost to Follow-up|11|||
163845535|NCT00849680|591803834|FG004|Overall Study|Lost to Follow-up|8|||
163845536|NCT00849680|591803835|FG005|Overall Study|Lost to Follow-up|11|||
164305306|NCT02873702|593491694|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
164305307|NCT01177397|593491695|FG000|Overall Study|Protocol Violation|0|||
164305308|NCT01177397|593491696|FG001|Overall Study|Protocol Violation|0|||
164305309|NCT01177397|593491697|FG002|Overall Study|Protocol Violation|0|||
164305310|NCT01177397|593491698|FG003|Overall Study|Protocol Violation|0|||
164305311|NCT01177397|593491699|FG004|Overall Study|Protocol Violation|0|||
164305312|NCT01177397|593491700|FG005|Overall Study|Protocol Violation|1|||
164305313|NCT01177397|593491701|FG006|Overall Study|Protocol Violation|0|||
164305314|NCT01177397|593491702|FG007|Overall Study|Protocol Violation|0|||
164305315|NCT01177397|593491703|FG008|Overall Study|Protocol Violation|0|||
164305316|NCT01177397|593491704|FG009|Overall Study|Protocol Violation|0|||
164305317|NCT01177397|593491705|FG010|Overall Study|Protocol Violation|0|||
164305318|NCT01177397|593491706|FG011|Overall Study|Protocol Violation|0|||
164305319|NCT01177397|593491695|FG000|Overall Study|Lost to Follow-up|0|||
163845537|NCT00849680|591803836|FG006|Overall Study|Lost to Follow-up|12|||
163845538|NCT00849680|591803837|FG007|Overall Study|Lost to Follow-up|5|||
164305320|NCT01177397|593491696|FG001|Overall Study|Lost to Follow-up|0|||
164305321|NCT01177397|593491697|FG002|Overall Study|Lost to Follow-up|0|||
164305322|NCT01177397|593491698|FG003|Overall Study|Lost to Follow-up|0|||
164305323|NCT01177397|593491699|FG004|Overall Study|Lost to Follow-up|1|||
164305324|NCT01177397|593491700|FG005|Overall Study|Lost to Follow-up|0|||
164305325|NCT01177397|593491701|FG006|Overall Study|Lost to Follow-up|0|||
164305326|NCT01177397|593491702|FG007|Overall Study|Lost to Follow-up|2|||
164305327|NCT01177397|593491703|FG008|Overall Study|Lost to Follow-up|0|||
164305328|NCT01177397|593491704|FG009|Overall Study|Lost to Follow-up|0|||
164305329|NCT01177397|593491705|FG010|Overall Study|Lost to Follow-up|0|||
164305330|NCT01177397|593491706|FG011|Overall Study|Lost to Follow-up|0|||
164305331|NCT01177397|593491695|FG000|Overall Study|Death|0|||
164305332|NCT01177397|593491696|FG001|Overall Study|Death|0|||
164305333|NCT01177397|593491697|FG002|Overall Study|Death|1|||
164305334|NCT01177397|593491698|FG003|Overall Study|Death|1|||
164305335|NCT01177397|593491699|FG004|Overall Study|Death|0|||
164305336|NCT01177397|593491700|FG005|Overall Study|Death|0|||
164305337|NCT01177397|593491701|FG006|Overall Study|Death|0|||
164305338|NCT01177397|593491702|FG007|Overall Study|Death|5|||
164305339|NCT01177397|593491703|FG008|Overall Study|Death|2|||
164305340|NCT01177397|593491704|FG009|Overall Study|Death|1|||
164305341|NCT01177397|593491705|FG010|Overall Study|Death|0|||
164305342|NCT01177397|593491706|FG011|Overall Study|Death|0|||
164305343|NCT01177397|593491695|FG000|Overall Study|Withdrawal by Subject|0|||
164305344|NCT01177397|593491696|FG001|Overall Study|Withdrawal by Subject|0|||
164305345|NCT01177397|593491697|FG002|Overall Study|Withdrawal by Subject|1|||
164305346|NCT01177397|593491698|FG003|Overall Study|Withdrawal by Subject|1|||
164305347|NCT01177397|593491699|FG004|Overall Study|Withdrawal by Subject|1|||
164305348|NCT01177397|593491700|FG005|Overall Study|Withdrawal by Subject|2|||
164305349|NCT01177397|593491701|FG006|Overall Study|Withdrawal by Subject|0|||
164305350|NCT01177397|593491702|FG007|Overall Study|Withdrawal by Subject|5|||
164305351|NCT01177397|593491703|FG008|Overall Study|Withdrawal by Subject|9|||
164305352|NCT01177397|593491704|FG009|Overall Study|Withdrawal by Subject|1|||
164305353|NCT01177397|593491705|FG010|Overall Study|Withdrawal by Subject|1|||
164305354|NCT01177397|593491706|FG011|Overall Study|Withdrawal by Subject|0|||
164305355|NCT01177397|593491695|FG000|Overall Study|Adverse Event|0|||
164305356|NCT01177397|593491696|FG001|Overall Study|Adverse Event|0|||
164305357|NCT01177397|593491697|FG002|Overall Study|Adverse Event|1|||
164305358|NCT01177397|593491698|FG003|Overall Study|Adverse Event|2|||
164305359|NCT01177397|593491699|FG004|Overall Study|Adverse Event|0|||
164305360|NCT01177397|593491700|FG005|Overall Study|Adverse Event|12|||
164305361|NCT01177397|593491701|FG006|Overall Study|Adverse Event|1|||
164305362|NCT01177397|593491702|FG007|Overall Study|Adverse Event|14|||
164305363|NCT01177397|593491703|FG008|Overall Study|Adverse Event|8|||
164305364|NCT01177397|593491704|FG009|Overall Study|Adverse Event|6|||
164305365|NCT01177397|593491705|FG010|Overall Study|Adverse Event|3|||
164305366|NCT01177397|593491706|FG011|Overall Study|Adverse Event|7|||
164305367|NCT01177397|593491695|FG000|Overall Study|Disease progression|1|||
163845539|NCT00849680|591803830|FG000|Overall Study|Subject moved|1|||
163845540|NCT00849680|591803831|FG001|Overall Study|Subject moved|0|||
164305368|NCT01177397|593491696|FG001|Overall Study|Disease progression|2|||
164305369|NCT01177397|593491697|FG002|Overall Study|Disease progression|5|||
164305370|NCT01177397|593491698|FG003|Overall Study|Disease progression|5|||
164305371|NCT01177397|593491699|FG004|Overall Study|Disease progression|4|||
164305372|NCT01177397|593491700|FG005|Overall Study|Disease progression|10|||
164305373|NCT01177397|593491701|FG006|Overall Study|Disease progression|10|||
164305374|NCT01177397|593491702|FG007|Overall Study|Disease progression|21|||
164305375|NCT01177397|593491703|FG008|Overall Study|Disease progression|18|||
164305376|NCT01177397|593491704|FG009|Overall Study|Disease progression|12|||
164305377|NCT01177397|593491705|FG010|Overall Study|Disease progression|10|||
164305378|NCT01177397|593491706|FG011|Overall Study|Disease progression|8|||
164305379|NCT01177397|593491695|FG000|Overall Study|Other reasons|0|||
164305380|NCT01177397|593491696|FG001|Overall Study|Other reasons|0|||
164305381|NCT01177397|593491697|FG002|Overall Study|Other reasons|1|||
164305382|NCT01177397|593491698|FG003|Overall Study|Other reasons|0|||
164305383|NCT01177397|593491699|FG004|Overall Study|Other reasons|1|||
164305384|NCT01177397|593491700|FG005|Overall Study|Other reasons|1|||
164305385|NCT01177397|593491701|FG006|Overall Study|Other reasons|2|||
164305386|NCT01177397|593491702|FG007|Overall Study|Other reasons|6|||
164305387|NCT01177397|593491703|FG008|Overall Study|Other reasons|10|||
164305388|NCT01177397|593491704|FG009|Overall Study|Other reasons|8|||
164305389|NCT01177397|593491705|FG010|Overall Study|Other reasons|0|||
164305390|NCT01177397|593491706|FG011|Overall Study|Other reasons|2|||
164305391|NCT01528969|593491707|FG000|Overall Study|absent from the school at baseline|2|||
164305392|NCT01528969|593491708|FG001|Overall Study|absent from the school at baseline|0|||
164305393|NCT03085797|593491709|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
164305394|NCT03085797|593491710|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
164305395|NCT03085797|593491709|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
164305396|NCT03085797|593491710|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
164305397|NCT03085797|593491709|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
164305398|NCT03085797|593491710|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
164305399|NCT04050202|593491717|FG000|Overall Study|Lost to Follow-up|2|||
164305400|NCT01554241|593491718|FG000|Overall Study|Death|3|||
164305401|NCT01554241|593491719|FG001|Overall Study|Death|1|||
164305402|NCT01554241|593491720|FG002|Overall Study|Death|1|||
164305403|NCT01554241|593491721|FG003|Overall Study|Death|0|||
164305404|NCT01554241|593491718|FG000|Overall Study|protocol specified renal stone|0|||
164305405|NCT01554241|593491719|FG001|Overall Study|protocol specified renal stone|0|||
164305406|NCT01554241|593491720|FG002|Overall Study|protocol specified renal stone|0|||
164305407|NCT01554241|593491721|FG003|Overall Study|protocol specified renal stone|1|||
164305408|NCT01554241|593491718|FG000|Overall Study|protocol specified change in eGFR|0|||
164305409|NCT01554241|593491719|FG001|Overall Study|protocol specified change in eGFR|0|||
164305410|NCT01554241|593491720|FG002|Overall Study|protocol specified change in eGFR|1|||
164305411|NCT01554241|593491721|FG003|Overall Study|protocol specified change in eGFR|0|||
164305412|NCT01554241|593491718|FG000|Overall Study|Withdrawal by Subject|0|||
164305413|NCT01554241|593491719|FG001|Overall Study|Withdrawal by Subject|0|||
164305414|NCT01554241|593491720|FG002|Overall Study|Withdrawal by Subject|2|||
164305415|NCT01554241|593491721|FG003|Overall Study|Withdrawal by Subject|0|||
164305416|NCT05661409|593491722|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
164305417|NCT05661409|593491723|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
164305418|NCT05661409|593491724|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
164305419|NCT05661409|593491725|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
164305420|NCT05661409|593491726|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
164305421|NCT05661409|593491727|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
164305422|NCT05661409|593491722|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
164305423|NCT05661409|593491723|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
164305424|NCT05661409|593491724|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
164305425|NCT05661409|593491725|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
164305426|NCT05661409|593491726|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
164305427|NCT05661409|593491727|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
164305428|NCT05661409|593491722|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
164305429|NCT05661409|593491723|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
164305430|NCT05661409|593491724|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
164305431|NCT05661409|593491725|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
164305432|NCT05661409|593491726|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
164305433|NCT05661409|593491727|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
164305434|NCT05661409|593491722|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305435|NCT05661409|593491723|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305436|NCT05661409|593491724|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305437|NCT05661409|593491725|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305438|NCT05661409|593491726|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
164305439|NCT05661409|593491727|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
164305440|NCT05661409|593491722|FG000|Overall Study|Miscommu-nication about administration|0|||
164305441|NCT05661409|593491723|FG001|Overall Study|Miscommu-nication about administration|0|||
164305442|NCT05661409|593491724|FG002|Overall Study|Miscommu-nication about administration|0|||
164305443|NCT05661409|593491725|FG003|Overall Study|Miscommu-nication about administration|0|||
164305444|NCT05661409|593491726|FG004|Overall Study|Miscommu-nication about administration|0|||
164305445|NCT05661409|593491727|FG005|Overall Study|Miscommu-nication about administration|1|||
164305446|NCT03198507|593491728|FG000|Overall Study|Withdrawal by Subject|1|||
164305447|NCT03198507|593491729|FG001|Overall Study|Withdrawal by Subject|0|||
164305448|NCT00724698|593491730|FG000|Overall Study|Adverse Event|9|||
164305449|NCT00724698|593491730|FG000|Overall Study|Failure of Therapy|4|||
164305450|NCT00724698|593491730|FG000|Overall Study|Poor Compliance|16|||
164305451|NCT00724698|593491730|FG000|Overall Study|Lost to Follow-up|36|||
164305452|NCT00724698|593491730|FG000|Overall Study|No Info|25|||
164305453|NCT01411891|593491733|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
164305454|NCT01411891|593491734|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
164305455|NCT04614974|593491735|FG000|Overall Study|Lost to Follow-up|14|||
164305456|NCT04614974|593491736|FG001|Overall Study|Lost to Follow-up|11|||
164305457|NCT00658359|593491738|FG000|Overall Study|Death|3|||
164305458|NCT00658359|593491739|FG001|Overall Study|Death|1|||
164305459|NCT00658359|593491740|FG002|Overall Study|Death|2|||
164305460|NCT00658359|593491738|FG000|Overall Study|Adverse Event|13|||
164305461|NCT00658359|593491739|FG001|Overall Study|Adverse Event|6|||
164305462|NCT00658359|593491740|FG002|Overall Study|Adverse Event|9|||
164305463|NCT00658359|593491738|FG000|Overall Study|Protocol Violation|1|||
164305464|NCT00658359|593491739|FG001|Overall Study|Protocol Violation|0|||
164305465|NCT00658359|593491740|FG002|Overall Study|Protocol Violation|0|||
164305466|NCT00658359|593491738|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
164305467|NCT00658359|593491739|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
164305468|NCT00658359|593491740|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
164305469|NCT00658359|593491738|FG000|Overall Study|Withdrawal by Subject|7|||
164305470|NCT00658359|593491739|FG001|Overall Study|Withdrawal by Subject|4|||
164305471|NCT00658359|593491740|FG002|Overall Study|Withdrawal by Subject|2|||
164305472|NCT00658359|593491738|FG000|Overall Study|Lost to Follow-up|2|||
164305473|NCT00658359|593491739|FG001|Overall Study|Lost to Follow-up|2|||
164305474|NCT00658359|593491740|FG002|Overall Study|Lost to Follow-up|4|||
164305475|NCT00658359|593491738|FG000|Overall Study|Lack of Efficacy|0|||
164305476|NCT00658359|593491739|FG001|Overall Study|Lack of Efficacy|1|||
164305477|NCT00658359|593491740|FG002|Overall Study|Lack of Efficacy|0|||
164305478|NCT01075685|593491741|FG000|Overall Study|Protocol Violation|9|||
164305479|NCT01075685|593491742|FG001|Overall Study|Protocol Violation|1|||
164305480|NCT01075685|593491741|FG000|Overall Study|Withdrawal by Subject|20|||
164305481|NCT01075685|593491742|FG001|Overall Study|Withdrawal by Subject|5|||
164305482|NCT01075685|593491741|FG000|Overall Study|Lost to Follow-up|563|||
164305483|NCT01075685|593491742|FG001|Overall Study|Lost to Follow-up|220|||
164305484|NCT03196349|593491745|FG000|Overall Study|Did not receive study drug|0|||
164305485|NCT03196349|593491746|FG001|Overall Study|Did not receive study drug|1|||
164305486|NCT03196349|593491747|FG002|Overall Study|Did not receive study drug|2|||
164305487|NCT03196349|593491745|FG000|Overall Study|No data entered|2|||
164305488|NCT03196349|593491746|FG001|Overall Study|No data entered|4|||
164305489|NCT03196349|593491747|FG002|Overall Study|No data entered|0|||
164305490|NCT03196349|593491745|FG000|Overall Study|Study Terminated early|15|||
164305491|NCT03196349|593491746|FG001|Overall Study|Study Terminated early|9|||
164305492|NCT03196349|593491747|FG002|Overall Study|Study Terminated early|11|||
164305493|NCT03388164|593491752|FG000|Overall Study|Withdrawal by Subject|3|||
164305494|NCT03388164|593491753|FG001|Overall Study|Withdrawal by Subject|1|||
164305495|NCT03023397|593491754|FG000|Run-In|Failed screening allergen challenge|1|||
164305496|NCT03023397|593491755|FG001|Run-In|Failed screening allergen challenge|0|||
164305497|NCT03023397|593491756|FG002|Run-In|Failed screening allergen challenge|0|||
164305498|NCT03023397|593491754|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
164305499|NCT03023397|593491755|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
164305500|NCT03023397|593491756|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
164305501|NCT00363480|593491757|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
164305502|NCT00363480|593491757|FG000|Overall Study|Adverse Event|4|||
164305503|NCT00363480|593491757|FG000|Overall Study|Lost to Follow-up|5|||
164305504|NCT00363480|593491757|FG000|Overall Study|Withdrawal by Subject|5|||
164305505|NCT00363480|593491757|FG000|Overall Study|Non-compliance of subject|1|||
164305506|NCT00363480|593491757|FG000|Overall Study|Participant discontinued on its own|1|||
164305507|NCT02129699|593491764|FG000|Overall Study|Did not start treatment|3|||
164305508|NCT02129699|593491765|FG001|Overall Study|Did not start treatment|2|||
164305509|NCT01394016|593491766|FG000|Overall Study|Progressive Disease|2|||
164305510|NCT01394016|593491767|FG001|Overall Study|Progressive Disease|0|||
164305511|NCT01394016|593491768|FG002|Overall Study|Progressive Disease|0|||
164305512|NCT01394016|593491769|FG003|Overall Study|Progressive Disease|0|||
164305513|NCT01394016|593491770|FG004|Overall Study|Progressive Disease|0|||
164305514|NCT01394016|593491771|FG005|Overall Study|Progressive Disease|0|||
164305515|NCT01394016|593491772|FG006|Overall Study|Progressive Disease|0|||
164305516|NCT01394016|593491773|FG007|Overall Study|Progressive Disease|0|||
164305517|NCT01394016|593491774|FG008|Overall Study|Progressive Disease|0|||
164305518|NCT01394016|593491775|FG009|Overall Study|Progressive Disease|0|||
164305519|NCT01394016|593491776|FG010|Overall Study|Progressive Disease|0|||
164305520|NCT01394016|593491777|FG011|Overall Study|Progressive Disease|0|||
164305521|NCT01394016|593491778|FG012|Overall Study|Progressive Disease|0|||
164305522|NCT01394016|593491779|FG013|Overall Study|Progressive Disease|0|||
164305523|NCT01394016|593491780|FG014|Overall Study|Progressive Disease|0|||
164305524|NCT01394016|593491781|FG015|Overall Study|Progressive Disease|0|||
163845541|NCT00849680|591803832|FG002|Overall Study|Subject moved|3|||
164305525|NCT01394016|593491782|FG016|Overall Study|Progressive Disease|0|||
164305526|NCT01394016|593491783|FG017|Overall Study|Progressive Disease|0|||
164305527|NCT01394016|593491784|FG018|Overall Study|Progressive Disease|0|||
164305528|NCT01394016|593491766|FG000|Overall Study|Withdrawal by Subject|0|||
164305529|NCT01394016|593491767|FG001|Overall Study|Withdrawal by Subject|0|||
164305530|NCT01394016|593491768|FG002|Overall Study|Withdrawal by Subject|0|||
164305531|NCT01394016|593491769|FG003|Overall Study|Withdrawal by Subject|0|||
164305532|NCT01394016|593491770|FG004|Overall Study|Withdrawal by Subject|0|||
164305533|NCT01394016|593491771|FG005|Overall Study|Withdrawal by Subject|0|||
164305534|NCT01394016|593491772|FG006|Overall Study|Withdrawal by Subject|0|||
164305535|NCT01394016|593491773|FG007|Overall Study|Withdrawal by Subject|1|||
164305536|NCT01394016|593491774|FG008|Overall Study|Withdrawal by Subject|1|||
164305537|NCT01394016|593491775|FG009|Overall Study|Withdrawal by Subject|1|||
164305538|NCT01394016|593491776|FG010|Overall Study|Withdrawal by Subject|4|||
164305539|NCT01394016|593491777|FG011|Overall Study|Withdrawal by Subject|0|||
164305540|NCT01394016|593491778|FG012|Overall Study|Withdrawal by Subject|0|||
164305541|NCT01394016|593491779|FG013|Overall Study|Withdrawal by Subject|3|||
164305542|NCT01394016|593491780|FG014|Overall Study|Withdrawal by Subject|1|||
164305543|NCT01394016|593491781|FG015|Overall Study|Withdrawal by Subject|3|||
164305544|NCT01394016|593491782|FG016|Overall Study|Withdrawal by Subject|1|||
164305545|NCT01394016|593491783|FG017|Overall Study|Withdrawal by Subject|1|||
164305546|NCT01394016|593491784|FG018|Overall Study|Withdrawal by Subject|2|||
164305547|NCT01394016|593491766|FG000|Overall Study|Adverse Event|0|||
164305548|NCT01394016|593491767|FG001|Overall Study|Adverse Event|0|||
164305549|NCT01394016|593491768|FG002|Overall Study|Adverse Event|0|||
164305550|NCT01394016|593491769|FG003|Overall Study|Adverse Event|0|||
164305551|NCT01394016|593491770|FG004|Overall Study|Adverse Event|0|||
164305552|NCT01394016|593491771|FG005|Overall Study|Adverse Event|0|||
164305553|NCT01394016|593491772|FG006|Overall Study|Adverse Event|0|||
164305554|NCT01394016|593491773|FG007|Overall Study|Adverse Event|0|||
164305555|NCT01394016|593491774|FG008|Overall Study|Adverse Event|0|||
164305556|NCT01394016|593491775|FG009|Overall Study|Adverse Event|1|||
164305557|NCT01394016|593491776|FG010|Overall Study|Adverse Event|0|||
164305558|NCT01394016|593491777|FG011|Overall Study|Adverse Event|0|||
164305559|NCT01394016|593491778|FG012|Overall Study|Adverse Event|0|||
164305560|NCT01394016|593491779|FG013|Overall Study|Adverse Event|0|||
164305561|NCT01394016|593491780|FG014|Overall Study|Adverse Event|0|||
164305562|NCT01394016|593491781|FG015|Overall Study|Adverse Event|0|||
164305563|NCT01394016|593491782|FG016|Overall Study|Adverse Event|1|||
164305564|NCT01394016|593491783|FG017|Overall Study|Adverse Event|1|||
164305565|NCT01394016|593491784|FG018|Overall Study|Adverse Event|0|||
164305566|NCT01394016|593491766|FG000|Overall Study|Sponsor Decision|0|||
164305567|NCT01394016|593491767|FG001|Overall Study|Sponsor Decision|0|||
164305568|NCT01394016|593491768|FG002|Overall Study|Sponsor Decision|0|||
164305569|NCT01394016|593491769|FG003|Overall Study|Sponsor Decision|0|||
164305570|NCT01394016|593491770|FG004|Overall Study|Sponsor Decision|0|||
164305571|NCT01394016|593491771|FG005|Overall Study|Sponsor Decision|0|||
164305572|NCT01394016|593491772|FG006|Overall Study|Sponsor Decision|0|||
164305573|NCT01394016|593491773|FG007|Overall Study|Sponsor Decision|0|||
164305574|NCT01394016|593491774|FG008|Overall Study|Sponsor Decision|0|||
164305575|NCT01394016|593491775|FG009|Overall Study|Sponsor Decision|0|||
164305576|NCT01394016|593491776|FG010|Overall Study|Sponsor Decision|0|||
164305577|NCT01394016|593491777|FG011|Overall Study|Sponsor Decision|0|||
164305578|NCT01394016|593491778|FG012|Overall Study|Sponsor Decision|1|||
164305579|NCT01394016|593491779|FG013|Overall Study|Sponsor Decision|0|||
164305580|NCT01394016|593491780|FG014|Overall Study|Sponsor Decision|0|||
164305581|NCT01394016|593491781|FG015|Overall Study|Sponsor Decision|0|||
164305582|NCT01394016|593491782|FG016|Overall Study|Sponsor Decision|0|||
164305583|NCT01394016|593491783|FG017|Overall Study|Sponsor Decision|0|||
164305584|NCT01394016|593491784|FG018|Overall Study|Sponsor Decision|0|||
164305585|NCT01394016|593491766|FG000|Overall Study|Lost to Follow-up|0|||
164305586|NCT01394016|593491767|FG001|Overall Study|Lost to Follow-up|0|||
164305587|NCT01394016|593491768|FG002|Overall Study|Lost to Follow-up|0|||
164305588|NCT01394016|593491769|FG003|Overall Study|Lost to Follow-up|0|||
164305589|NCT01394016|593491770|FG004|Overall Study|Lost to Follow-up|0|||
164305590|NCT01394016|593491771|FG005|Overall Study|Lost to Follow-up|0|||
163845542|NCT00849680|591803833|FG003|Overall Study|Subject moved|1|||
163845543|NCT00849680|591803834|FG004|Overall Study|Subject moved|0|||
164305591|NCT01394016|593491772|FG006|Overall Study|Lost to Follow-up|0|||
164305592|NCT01394016|593491773|FG007|Overall Study|Lost to Follow-up|0|||
164305593|NCT01394016|593491774|FG008|Overall Study|Lost to Follow-up|0|||
164305594|NCT01394016|593491775|FG009|Overall Study|Lost to Follow-up|0|||
164305595|NCT01394016|593491776|FG010|Overall Study|Lost to Follow-up|0|||
164305596|NCT01394016|593491777|FG011|Overall Study|Lost to Follow-up|0|||
164305597|NCT01394016|593491778|FG012|Overall Study|Lost to Follow-up|0|||
164305598|NCT01394016|593491779|FG013|Overall Study|Lost to Follow-up|0|||
164305599|NCT01394016|593491780|FG014|Overall Study|Lost to Follow-up|0|||
164305600|NCT01394016|593491781|FG015|Overall Study|Lost to Follow-up|0|||
164305601|NCT01394016|593491782|FG016|Overall Study|Lost to Follow-up|0|||
164305602|NCT01394016|593491783|FG017|Overall Study|Lost to Follow-up|0|||
164305603|NCT01394016|593491784|FG018|Overall Study|Lost to Follow-up|1|||
164305604|NCT03534804|593491785|FG000|Overall Study|Withdrawal by Subject|1|||
164305605|NCT04161157|593491789|FG000|Overall Study|Lost to Follow-up|4|||
164305606|NCT04161157|593491789|FG000|Overall Study|Death|3|||
164305607|NCT04161157|593491789|FG000|Overall Study|Ineligible|2|||
164305608|NCT04161157|593491789|FG000|Overall Study|Withdrawal by Subject|4|||
164305609|NCT02991768|593491798|FG000|Overall Study|Physician Decision|4|||
164305610|NCT05786651|593491801|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
164305611|NCT01442103|593493143|FG000|Overall Study|Lost to Follow-up|2|||
164305612|NCT02605122|593493146|FG000|Overall Study|Withdrawal by Subject|4|||
164305613|NCT02605122|593493147|FG001|Overall Study|Withdrawal by Subject|1|||
164305614|NCT02605122|593493146|FG000|Overall Study|Lost to Follow-up|1|||
164305615|NCT02605122|593493147|FG001|Overall Study|Lost to Follow-up|1|||
164305616|NCT00807001|593493149|FG000|Overall Study|Non-compliance|0|||
164305617|NCT00807001|593493150|FG001|Overall Study|Non-compliance|1|||
164305618|NCT00807001|593493151|FG002|Overall Study|Non-compliance|0|||
164305619|NCT00807001|593493152|FG003|Overall Study|Non-compliance|0|||
164305620|NCT00807001|593493153|FG004|Overall Study|Non-compliance|0|||
164305621|NCT01399372|593493155|FG000|Overall Study|Protocol Violation|3|||
164305622|NCT01399372|593493156|FG001|Overall Study|Protocol Violation|1|||
164305623|NCT01027273|593493159|FG000|Overall Study|Lost to Follow-up|57|||
163845544|NCT00849680|591803835|FG005|Overall Study|Subject moved|2|||
163845545|NCT00849680|591803836|FG006|Overall Study|Subject moved|2|||
163845546|NCT00849680|591803837|FG007|Overall Study|Subject moved|2|||
163845547|NCT00849680|591803830|FG000|Overall Study|Withdrawal by Subject|2|||
163845548|NCT00849680|591803831|FG001|Overall Study|Withdrawal by Subject|0|||
163845549|NCT00849680|591803832|FG002|Overall Study|Withdrawal by Subject|0|||
163845550|NCT00849680|591803833|FG003|Overall Study|Withdrawal by Subject|2|||
163845551|NCT00849680|591803834|FG004|Overall Study|Withdrawal by Subject|2|||
164305624|NCT01027273|593493160|FG001|Overall Study|Lost to Follow-up|31|||
164305625|NCT01027273|593493159|FG000|Overall Study|Death|2|||
164305626|NCT01027273|593493160|FG001|Overall Study|Death|2|||
164305627|NCT04313244|593493161|FG000|Overall Study|Withdrawal of Consent|3|||
164305628|NCT04313244|593493162|FG001|Overall Study|Withdrawal of Consent|3|||
164305629|NCT04313244|593493161|FG000|Overall Study|Met Exclusion Criteria|1|||
164305630|NCT04313244|593493162|FG001|Overall Study|Met Exclusion Criteria|0|||
164305631|NCT04313244|593493161|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
164305632|NCT04313244|593493162|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
164305633|NCT00043979|593493163|FG000|Period 1|recipient with progressive disease|7|||
164305634|NCT00043979|593493164|FG001|Period 1|recipient with progressive disease|4|||
164305635|NCT00043979|593493165|FG002|Period 1|recipient with progressive disease|3|||
164305636|NCT03096288|593493167|FG000|Overall Study|Withdrawal by Subject|0|||
164305637|NCT03096288|593493168|FG001|Overall Study|Withdrawal by Subject|1|||
164305638|NCT03096288|593493169|FG002|Overall Study|Withdrawal by Subject|0|||
164305639|NCT03096288|593493170|FG003|Overall Study|Withdrawal by Subject|1|||
164305640|NCT02560558|593493171|FG000|Overall Study|Adverse Event|1|||
164305641|NCT02560558|593493172|FG001|Overall Study|Adverse Event|0|||
164305642|NCT02560558|593493171|FG000|Overall Study|Death|0|||
164305643|NCT02560558|593493172|FG001|Overall Study|Death|2|||
164305644|NCT02560558|593493171|FG000|Overall Study|Lost to Follow-up|0|||
164305645|NCT02560558|593493172|FG001|Overall Study|Lost to Follow-up|4|||
164305646|NCT02560558|593493171|FG000|Overall Study|Protocol Violation|3|||
164305647|NCT02560558|593493172|FG001|Overall Study|Protocol Violation|0|||
164305648|NCT02560558|593493171|FG000|Overall Study|Withdrawal by Subject|3|||
164305649|NCT02560558|593493172|FG001|Overall Study|Withdrawal by Subject|0|||
164305650|NCT02819804|593493173|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
164305651|NCT03967444|593493174|FG000|Overall Study|Lost to Follow-up|1|||
164305652|NCT03967444|593493175|FG001|Overall Study|Lost to Follow-up|2|||
164305653|NCT02858362|593493176|FG000|Overall Study|Protocol Violation|0|||
164305654|NCT02858362|593493177|FG001|Overall Study|Protocol Violation|1|||
164305655|NCT02858362|593493178|FG002|Overall Study|Protocol Violation|0|||
164305656|NCT02858362|593493176|FG000|Overall Study|Withdrawal by Subject|1|||
164305657|NCT02858362|593493177|FG001|Overall Study|Withdrawal by Subject|0|||
164305658|NCT02858362|593493178|FG002|Overall Study|Withdrawal by Subject|0|||
164305659|NCT02858362|593493176|FG000|Overall Study|Early Study Termination|0|||
164305660|NCT02858362|593493177|FG001|Overall Study|Early Study Termination|0|||
164305661|NCT02858362|593493178|FG002|Overall Study|Early Study Termination|3|||
164305662|NCT02858362|593493176|FG000|Overall Study|Lost to Follow-up|1|||
164305663|NCT02858362|593493177|FG001|Overall Study|Lost to Follow-up|0|||
163845552|NCT00849680|591803835|FG005|Overall Study|Withdrawal by Subject|2|||
163845553|NCT00849680|591803836|FG006|Overall Study|Withdrawal by Subject|1|||
163845554|NCT00849680|591803837|FG007|Overall Study|Withdrawal by Subject|1|||
164305664|NCT02858362|593493178|FG002|Overall Study|Lost to Follow-up|0|||
164305665|NCT01821118|593493184|FG000|Overall Study|Death|0|||
164305666|NCT01821118|593493185|FG001|Overall Study|Death|1|||
164305667|NCT00686686|593493186|FG000|Overall Study|Non-compliance|1|||
164305668|NCT00686686|593493186|FG000|Overall Study|Adverse Event|2|||
164305669|NCT00686686|593493186|FG000|Overall Study|Lost to Follow-up|3|||
164305670|NCT00131248|593493187|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
164305671|NCT00131248|593493188|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
164305672|NCT00318643|593493193|FG000|Overall Study|Adverse Event|0|||
164305673|NCT00318643|593493194|FG001|Overall Study|Adverse Event|0|||
164305674|NCT00318643|593493195|FG002|Overall Study|Adverse Event|0|||
164305675|NCT00318643|593493196|FG003|Overall Study|Adverse Event|0|||
164305676|NCT00318643|593493197|FG004|Overall Study|Adverse Event|1|||
164305677|NCT00318643|593493193|FG000|Overall Study|Participant's Decision|0|||
164305678|NCT00318643|593493194|FG001|Overall Study|Participant's Decision|0|||
164305679|NCT00318643|593493195|FG002|Overall Study|Participant's Decision|0|||
164305680|NCT00318643|593493196|FG003|Overall Study|Participant's Decision|0|||
164305681|NCT00318643|593493197|FG004|Overall Study|Participant's Decision|1|||
164305682|NCT00318643|593493193|FG000|Overall Study|Investigator's Decision|0|||
164305683|NCT00318643|593493194|FG001|Overall Study|Investigator's Decision|0|||
164305684|NCT00318643|593493195|FG002|Overall Study|Investigator's Decision|0|||
164305685|NCT00318643|593493196|FG003|Overall Study|Investigator's Decision|0|||
164305686|NCT00318643|593493197|FG004|Overall Study|Investigator's Decision|1|||
164305687|NCT05038982|593493198|FG000|Overall Study|Withdrawal by Subject|0|||
164305688|NCT05038982|593493199|FG001|Overall Study|Withdrawal by Subject|2|||
164305689|NCT02691507|593493202|FG000|Overall Study|Missed Visit 3|0|||
164305690|NCT02691507|593493203|FG001|Overall Study|Missed Visit 3|1|||
164305691|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
164305692|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
164305693|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
164305694|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164305695|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164305696|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164305697|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
164305698|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
164305699|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
164305700|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
164305701|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
164305702|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
164305703|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
164305704|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
164305705|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
164305706|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
164305707|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
164305708|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
164305709|NCT03739203|593493210|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
164305710|NCT03739203|593493211|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
164305711|NCT03739203|593493212|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
164305712|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
164305713|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
164305714|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
164305715|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
164305716|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
164305717|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
164305718|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
164305719|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
164305720|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
164305721|NCT03739203|593493210|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
164305722|NCT03739203|593493211|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
164305723|NCT03739203|593493212|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
164305724|NCT01519921|593493216|FG000|Overall Study|Adverse Event|10|||
164305725|NCT01519921|593493217|FG001|Overall Study|Adverse Event|9|||
164305726|NCT01519921|593493216|FG000|Overall Study|Lack of Efficacy|4|||
164305727|NCT01519921|593493217|FG001|Overall Study|Lack of Efficacy|3|||
164305728|NCT01519921|593493216|FG000|Overall Study|Withdrawal by Subject|3|||
164305729|NCT01519921|593493217|FG001|Overall Study|Withdrawal by Subject|0|||
164305730|NCT01519921|593493216|FG000|Overall Study|Lost to Follow-up|2|||
164305731|NCT01519921|593493217|FG001|Overall Study|Lost to Follow-up|1|||
164305732|NCT01519921|593493216|FG000|Overall Study|Treatment refusal|2|||
164305733|NCT01519921|593493217|FG001|Overall Study|Treatment refusal|1|||
164305734|NCT01519921|593493216|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
164305735|NCT01519921|593493217|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
164305736|NCT01216189|593493218|FG000|Overall Study|Lost to Follow-up|21|||
164305737|NCT01216189|593493219|FG001|Overall Study|Lost to Follow-up|3|||
164305738|NCT01216189|593493218|FG000|Overall Study|Death|4|||
164305739|NCT01216189|593493219|FG001|Overall Study|Death|2|||
164305740|NCT01143246|593493220|FG000|Overall Study|Adverse Event|24|||
164305741|NCT01143246|593493221|FG001|Overall Study|Adverse Event|28|||
164305742|NCT01143246|593493220|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
164305743|NCT01143246|593493221|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
164305744|NCT01143246|593493220|FG000|Overall Study|Lost to Follow-up|0|||
164305745|NCT01143246|593493221|FG001|Overall Study|Lost to Follow-up|1|||
164305746|NCT01143246|593493220|FG000|Overall Study|Death|16|||
164305747|NCT01143246|593493221|FG001|Overall Study|Death|15|||
164305748|NCT01143246|593493220|FG000|Overall Study|Reason not Specified|3|||
164305749|NCT01143246|593493221|FG001|Overall Study|Reason not Specified|5|||
164305750|NCT01146795|593493222|FG000|Overall Study|Withdrawal by Subject|4|||
164305751|NCT01146795|593493222|FG000|Overall Study|Adverse Event|6|||
164305752|NCT01146795|593493222|FG000|Overall Study|Still in treatment at study closure|10|||
164305753|NCT05375760|593493223|FG000|Overall Study|Adverse Event|1|||
164305754|NCT05375760|593493224|FG001|Overall Study|Adverse Event|0|||
164305755|NCT05375760|593493223|FG000|Overall Study|Death|0|||
164305756|NCT05375760|593493224|FG001|Overall Study|Death|1|||
164305757|NCT05375760|593493223|FG000|Overall Study|Lost to Follow-up|6|||
164305758|NCT05375760|593493224|FG001|Overall Study|Lost to Follow-up|6|||
164305759|NCT05375760|593493223|FG000|Overall Study|Withdrawal by Subject|17|||
164305760|NCT05375760|593493224|FG001|Overall Study|Withdrawal by Subject|19|||
164305761|NCT05375760|593493223|FG000|Overall Study|Dosing halted by FDA|96|||
164305762|NCT05375760|593493224|FG001|Overall Study|Dosing halted by FDA|100|||
164305763|NCT05375760|593493223|FG000|Overall Study|Not compliant with study visit|2|||
164305764|NCT05375760|593493224|FG001|Overall Study|Not compliant with study visit|0|||
164305765|NCT05375760|593493223|FG000|Overall Study|Physician Decision|1|||
164305766|NCT05375760|593493224|FG001|Overall Study|Physician Decision|0|||
164305767|NCT05375760|593493223|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
164305768|NCT05375760|593493224|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
164305769|NCT05375760|593493223|FG000|Overall Study|Participant moved|1|||
164305770|NCT05375760|593493224|FG001|Overall Study|Participant moved|0|||
164305771|NCT03853109|593493225|FG000|Overall Study|Withdrawal by Subject|0|||
164305772|NCT03853109|593493226|FG001|Overall Study|Withdrawal by Subject|0|||
164305773|NCT03853109|593493227|FG002|Overall Study|Withdrawal by Subject|1|||
164305774|NCT03853109|593493228|FG003|Overall Study|Withdrawal by Subject|2|||
164305775|NCT03853109|593493229|FG004|Overall Study|Withdrawal by Subject|1|||
164305776|NCT03853109|593493230|FG005|Overall Study|Withdrawal by Subject|4|||
164305777|NCT03853109|593493231|FG006|Overall Study|Withdrawal by Subject|5|||
164305778|NCT03853109|593493232|FG007|Overall Study|Withdrawal by Subject|3|||
164305779|NCT03853109|593493225|FG000|Overall Study|Decision by Sponsor|0|||
164305780|NCT03853109|593493226|FG001|Overall Study|Decision by Sponsor|0|||
164305781|NCT03853109|593493227|FG002|Overall Study|Decision by Sponsor|1|||
164305782|NCT03853109|593493228|FG003|Overall Study|Decision by Sponsor|0|||
164305783|NCT03853109|593493229|FG004|Overall Study|Decision by Sponsor|1|||
164305784|NCT03853109|593493230|FG005|Overall Study|Decision by Sponsor|1|||
164305785|NCT03853109|593493231|FG006|Overall Study|Decision by Sponsor|10|||
164305786|NCT03853109|593493232|FG007|Overall Study|Decision by Sponsor|2|||
164305787|NCT03853109|593493225|FG000|Overall Study|Lost to Follow-up|0|||
164305788|NCT03853109|593493226|FG001|Overall Study|Lost to Follow-up|0|||
164305789|NCT03853109|593493227|FG002|Overall Study|Lost to Follow-up|0|||
164305790|NCT03853109|593493228|FG003|Overall Study|Lost to Follow-up|0|||
164305791|NCT03853109|593493229|FG004|Overall Study|Lost to Follow-up|1|||
164305792|NCT03853109|593493230|FG005|Overall Study|Lost to Follow-up|3|||
164305793|NCT03853109|593493231|FG006|Overall Study|Lost to Follow-up|0|||
164305794|NCT03853109|593493232|FG007|Overall Study|Lost to Follow-up|0|||
164305795|NCT03853109|593493225|FG000|Overall Study|Death|2|||
164305796|NCT03853109|593493226|FG001|Overall Study|Death|5|||
164305797|NCT03853109|593493227|FG002|Overall Study|Death|8|||
164305798|NCT03853109|593493228|FG003|Overall Study|Death|10|||
164305799|NCT03853109|593493229|FG004|Overall Study|Death|3|||
164305800|NCT03853109|593493230|FG005|Overall Study|Death|20|||
164305801|NCT03853109|593493231|FG006|Overall Study|Death|10|||
164305802|NCT03853109|593493232|FG007|Overall Study|Death|5|||
164305803|NCT04032093|593493235|FG000|Overall Study|Lost to Follow-up|7|||
164305804|NCT04032093|593493236|FG001|Overall Study|Lost to Follow-up|7|||
164305805|NCT04032093|593493237|FG002|Overall Study|Lost to Follow-up|6|||
164305806|NCT04032093|593493238|FG003|Overall Study|Lost to Follow-up|10|||
164305807|NCT04032093|593493239|FG004|Overall Study|Lost to Follow-up|13|||
164305808|NCT04032093|593493240|FG005|Overall Study|Lost to Follow-up|7|||
164305809|NCT04032093|593493241|FG006|Overall Study|Lost to Follow-up|7|||
164305810|NCT04032093|593493242|FG007|Overall Study|Lost to Follow-up|5|||
164305811|NCT04032093|593493243|FG008|Overall Study|Lost to Follow-up|9|||
164305812|NCT04032093|593493244|FG009|Overall Study|Lost to Follow-up|12|||
164305813|NCT04032093|593493235|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305814|NCT04032093|593493236|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305815|NCT04032093|593493237|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305816|NCT04032093|593493238|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
164305817|NCT04032093|593493239|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
164305818|NCT04032093|593493240|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305819|NCT04032093|593493241|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305820|NCT04032093|593493242|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164305821|NCT04032093|593493243|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
164305822|NCT04032093|593493244|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
164305823|NCT04032093|593493235|FG000|Overall Study|Other|1|||
164305824|NCT04032093|593493236|FG001|Overall Study|Other|0|||
164305825|NCT04032093|593493237|FG002|Overall Study|Other|0|||
164305826|NCT04032093|593493238|FG003|Overall Study|Other|1|||
164305827|NCT04032093|593493239|FG004|Overall Study|Other|1|||
164305828|NCT04032093|593493240|FG005|Overall Study|Other|0|||
164305829|NCT04032093|593493241|FG006|Overall Study|Other|0|||
164305830|NCT04032093|593493242|FG007|Overall Study|Other|0|||
164305831|NCT04032093|593493243|FG008|Overall Study|Other|0|||
164305832|NCT04032093|593493244|FG009|Overall Study|Other|1|||
164305833|NCT04032093|593493235|FG000|Overall Study|Withdrawal by Subject|1|||
164305834|NCT04032093|593493236|FG001|Overall Study|Withdrawal by Subject|3|||
164305835|NCT04032093|593493237|FG002|Overall Study|Withdrawal by Subject|2|||
164305836|NCT04032093|593493238|FG003|Overall Study|Withdrawal by Subject|2|||
164305837|NCT04032093|593493239|FG004|Overall Study|Withdrawal by Subject|3|||
164305838|NCT04032093|593493240|FG005|Overall Study|Withdrawal by Subject|0|||
164305839|NCT04032093|593493241|FG006|Overall Study|Withdrawal by Subject|0|||
164305840|NCT04032093|593493242|FG007|Overall Study|Withdrawal by Subject|0|||
164305841|NCT04032093|593493243|FG008|Overall Study|Withdrawal by Subject|0|||
164305842|NCT04032093|593493244|FG009|Overall Study|Withdrawal by Subject|0|||
164305843|NCT04032093|593493235|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164305844|NCT04032093|593493236|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164305845|NCT04032093|593493237|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164305846|NCT04032093|593493238|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164305847|NCT04032093|593493239|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164305848|NCT04032093|593493240|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164305849|NCT04032093|593493241|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
164305850|NCT04032093|593493242|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
164305851|NCT04032093|593493243|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
164305852|NCT04032093|593493244|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
164305853|NCT04032093|593493235|FG000|Overall Study|Adverse Event|0|||
164305854|NCT04032093|593493236|FG001|Overall Study|Adverse Event|0|||
164305855|NCT04032093|593493237|FG002|Overall Study|Adverse Event|0|||
164305856|NCT04032093|593493238|FG003|Overall Study|Adverse Event|0|||
164305857|NCT04032093|593493239|FG004|Overall Study|Adverse Event|0|||
164305858|NCT04032093|593493240|FG005|Overall Study|Adverse Event|0|||
164305859|NCT04032093|593493241|FG006|Overall Study|Adverse Event|0|||
164305860|NCT04032093|593493242|FG007|Overall Study|Adverse Event|0|||
164305861|NCT04032093|593493243|FG008|Overall Study|Adverse Event|0|||
164305862|NCT04032093|593493244|FG009|Overall Study|Adverse Event|1|||
164305863|NCT04032093|593493235|FG000|Overall Study|Physician Decision|0|||
164305864|NCT04032093|593493236|FG001|Overall Study|Physician Decision|0|||
164305865|NCT04032093|593493237|FG002|Overall Study|Physician Decision|0|||
164305866|NCT04032093|593493238|FG003|Overall Study|Physician Decision|0|||
164305867|NCT04032093|593493239|FG004|Overall Study|Physician Decision|0|||
164305868|NCT04032093|593493240|FG005|Overall Study|Physician Decision|1|||
164305869|NCT04032093|593493241|FG006|Overall Study|Physician Decision|0|||
164305870|NCT04032093|593493242|FG007|Overall Study|Physician Decision|0|||
164305871|NCT04032093|593493243|FG008|Overall Study|Physician Decision|0|||
164305872|NCT04032093|593493244|FG009|Overall Study|Physician Decision|0|||
164305873|NCT02565108|593493247|FG000|Overall Study|Adverse Event|1|||
164305874|NCT02565108|593493248|FG001|Overall Study|Adverse Event|0|||
164305875|NCT02565108|593493247|FG000|Overall Study|Withdrew Consent|1|||
164305876|NCT02565108|593493248|FG001|Overall Study|Withdrew Consent|0|||
164305877|NCT01310075|593493249|FG000|Overall Study|Lost to Follow-up|1|||
164305878|NCT01310075|593493250|FG001|Overall Study|Lost to Follow-up|0|||
164305879|NCT01310075|593493249|FG000|Overall Study|Physician Decision|10|||
164305880|NCT01310075|593493250|FG001|Overall Study|Physician Decision|7|||
164305881|NCT01310075|593493249|FG000|Overall Study|Protocol Violation|2|||
164305882|NCT01310075|593493250|FG001|Overall Study|Protocol Violation|2|||
164305883|NCT01310075|593493249|FG000|Overall Study|Withdrawal by Subject|1|||
164305884|NCT01310075|593493250|FG001|Overall Study|Withdrawal by Subject|1|||
164305885|NCT02745119|593493255|FG000|Overall Study|Adverse Event|1|||
164305886|NCT02745119|593493256|FG001|Overall Study|Adverse Event|0|||
164305887|NCT02745119|593493257|FG002|Overall Study|Adverse Event|1|||
164305888|NCT02745119|593493258|FG003|Overall Study|Adverse Event|3|||
164305889|NCT02745119|593493255|FG000|Overall Study|Death|3|||
164305890|NCT02745119|593493256|FG001|Overall Study|Death|3|||
164305891|NCT02745119|593493257|FG002|Overall Study|Death|0|||
164305892|NCT02745119|593493258|FG003|Overall Study|Death|4|||
164305893|NCT02745119|593493255|FG000|Overall Study|Lost to Follow-up|0|||
164305894|NCT02745119|593493256|FG001|Overall Study|Lost to Follow-up|0|||
164305895|NCT02745119|593493257|FG002|Overall Study|Lost to Follow-up|0|||
164305896|NCT02745119|593493258|FG003|Overall Study|Lost to Follow-up|1|||
164305897|NCT02745119|593493255|FG000|Overall Study|Protocol Deviation|0|||
164305898|NCT02745119|593493256|FG001|Overall Study|Protocol Deviation|0|||
164305899|NCT02745119|593493257|FG002|Overall Study|Protocol Deviation|0|||
164305900|NCT02745119|593493258|FG003|Overall Study|Protocol Deviation|1|||
164305901|NCT02745119|593493255|FG000|Overall Study|Withdrawal by Subject|7|||
164305902|NCT02745119|593493256|FG001|Overall Study|Withdrawal by Subject|15|||
164305903|NCT02745119|593493257|FG002|Overall Study|Withdrawal by Subject|8|||
164305904|NCT02745119|593493258|FG003|Overall Study|Withdrawal by Subject|14|||
164305905|NCT02745119|593493255|FG000|Overall Study|Study Terminated by Sponsor|134|||
164305906|NCT02745119|593493256|FG001|Overall Study|Study Terminated by Sponsor|252|||
164305907|NCT02745119|593493257|FG002|Overall Study|Study Terminated by Sponsor|135|||
164305908|NCT02745119|593493258|FG003|Overall Study|Study Terminated by Sponsor|251|||
164305909|NCT02745119|593493255|FG000|Overall Study|Physician Decision|0|||
164305910|NCT02745119|593493256|FG001|Overall Study|Physician Decision|2|||
164305911|NCT02745119|593493257|FG002|Overall Study|Physician Decision|2|||
164305912|NCT02745119|593493258|FG003|Overall Study|Physician Decision|2|||
164305913|NCT02745119|593493255|FG000|Overall Study|Reason Not Specified|0|||
164305914|NCT02745119|593493256|FG001|Overall Study|Reason Not Specified|2|||
164305915|NCT02745119|593493257|FG002|Overall Study|Reason Not Specified|0|||
164305916|NCT02745119|593493258|FG003|Overall Study|Reason Not Specified|1|||
164305917|NCT00960999|593493259|FG000|Overall Study|Withdrawal by Subject|1|||
164305918|NCT00960999|593493260|FG001|Overall Study|Withdrawal by Subject|0|||
164305919|NCT00960999|593493259|FG000|Overall Study|Protocol Violation|5|||
164305920|NCT00960999|593493260|FG001|Overall Study|Protocol Violation|2|||
164305921|NCT00960999|593493259|FG000|Overall Study|RT dose constraints not met|2|||
164305922|NCT00960999|593493260|FG001|Overall Study|RT dose constraints not met|0|||
164305923|NCT02536963|593493261|FG000|Overall Study|Withdrawal by Subject|18|||
164305924|NCT02425943|593493262|FG000|Overall Study|Adverse Event|3|||
164305925|NCT02425943|593493263|FG001|Overall Study|Adverse Event|1|||
164305926|NCT02425943|593493262|FG000|Overall Study|Lost to Follow-up|59|||
164305927|NCT02425943|593493263|FG001|Overall Study|Lost to Follow-up|37|||
164305928|NCT02425943|593493262|FG000|Overall Study|Protocol Violation|4|||
164305929|NCT02425943|593493263|FG001|Overall Study|Protocol Violation|1|||
164305930|NCT02425943|593493262|FG000|Overall Study|Withdrawal by Subject|64|||
164305931|NCT02425943|593493263|FG001|Overall Study|Withdrawal by Subject|31|||
164305932|NCT02425943|593493262|FG000|Overall Study|Other|6|||
164305933|NCT02425943|593493263|FG001|Overall Study|Other|0|||
164305934|NCT02141204|593493264|FG000|Overall Study|Lost to Follow-up|2|||
164305935|NCT02141204|593493265|FG001|Overall Study|Lost to Follow-up|1|||
164305936|NCT02141204|593493264|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
164305937|NCT02141204|593493265|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
164305938|NCT02141204|593493264|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
164305939|NCT02141204|593493265|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
164305940|NCT02141204|593493264|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
164305941|NCT02141204|593493265|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
164305942|NCT01209325|593493266|FG000|Overall Study|Lost to Follow-up|24|||
164305943|NCT01209325|593493266|FG000|Overall Study|Adverse Event|1|||
164305944|NCT01209325|593493266|FG000|Overall Study|Relocated|3|||
164305945|NCT01209325|593493266|FG000|Overall Study|Refusal after starting therapy|8|||
164305946|NCT01209325|593493266|FG000|Overall Study|Protocol Violation|4|||
164305947|NCT01209325|593493266|FG000|Overall Study|Refusal prior to therapy|1|||
164305948|NCT01209325|593493266|FG000|Overall Study|Incarceration|2|||
164305949|NCT03529422|593493275|FG000|Overall Study|Withdrawal by Subject|1|||
164305950|NCT03529422|593493275|FG000|Overall Study|Protocol Violation|1|||
164305951|NCT03529422|593493275|FG000|Overall Study|Disease progression|2|||
164305952|NCT02484391|593493276|FG000|Overall Study|Lack of Efficacy|15|||
164305953|NCT02484391|593493277|FG001|Overall Study|Lack of Efficacy|14|||
164305954|NCT02484391|593493278|FG002|Overall Study|Lack of Efficacy|3|||
164305955|NCT02484391|593493276|FG000|Overall Study|Lost to Follow-up|0|||
164305956|NCT02484391|593493277|FG001|Overall Study|Lost to Follow-up|0|||
164305957|NCT02484391|593493278|FG002|Overall Study|Lost to Follow-up|2|||
164305958|NCT02484391|593493276|FG000|Overall Study|Physician Decision|1|||
164305959|NCT02484391|593493277|FG001|Overall Study|Physician Decision|3|||
164305960|NCT02484391|593493278|FG002|Overall Study|Physician Decision|0|||
164305961|NCT02484391|593493276|FG000|Overall Study|Went to Transplant|5|||
164305962|NCT02484391|593493277|FG001|Overall Study|Went to Transplant|3|||
164305963|NCT02484391|593493278|FG002|Overall Study|Went to Transplant|2|||
164305964|NCT04922216|593493279|FG000|Overall Study|Withdrawal by Subject|0|||
164305965|NCT04922216|593493280|FG001|Overall Study|Withdrawal by Subject|1|||
164305966|NCT04922216|593493281|FG002|Overall Study|Withdrawal by Subject|0|||
164305967|NCT04922216|593493282|FG003|Overall Study|Withdrawal by Subject|0|||
164305968|NCT04922216|593493283|FG004|Overall Study|Withdrawal by Subject|0|||
164305969|NCT04922216|593493284|FG005|Overall Study|Withdrawal by Subject|0|||
164305970|NCT04922216|593493285|FG006|Overall Study|Withdrawal by Subject|0|||
164305971|NCT04922216|593493286|FG007|Overall Study|Withdrawal by Subject|2|||
164305972|NCT04922216|593493287|FG008|Overall Study|Withdrawal by Subject|0|||
164305973|NCT04922216|593493288|FG009|Overall Study|Withdrawal by Subject|0|||
164305974|NCT04922216|593493289|FG010|Overall Study|Withdrawal by Subject|0|||
164305975|NCT04922216|593493290|FG011|Overall Study|Withdrawal by Subject|0|||
164305976|NCT04922216|593493291|FG012|Overall Study|Withdrawal by Subject|1|||
164305977|NCT04922216|593493292|FG013|Overall Study|Withdrawal by Subject|1|||
164305978|NCT04922216|593493293|FG014|Overall Study|Withdrawal by Subject|1|||
164305979|NCT04922216|593493294|FG015|Overall Study|Withdrawal by Subject|0|||
164305980|NCT04922216|593493295|FG016|Overall Study|Withdrawal by Subject|0|||
164305981|NCT04922216|593493296|FG017|Overall Study|Withdrawal by Subject|1|||
164305982|NCT04922216|593493297|FG018|Overall Study|Withdrawal by Subject|1|||
164305983|NCT04922216|593493298|FG019|Overall Study|Withdrawal by Subject|1|||
164305984|NCT04922216|593493299|FG020|Overall Study|Withdrawal by Subject|1|||
164305985|NCT04922216|593493300|FG021|Overall Study|Withdrawal by Subject|0|||
164305986|NCT04922216|593493301|FG022|Overall Study|Withdrawal by Subject|0|||
164305987|NCT04922216|593493302|FG023|Overall Study|Withdrawal by Subject|2|||
163845555|NCT00849680|591803830|FG000|Overall Study|Subject unable to comply with protocol|1|||
163845556|NCT00849680|591803831|FG001|Overall Study|Subject unable to comply with protocol|0|||
163845557|NCT00849680|591803832|FG002|Overall Study|Subject unable to comply with protocol|0|||
163845558|NCT00849680|591803833|FG003|Overall Study|Subject unable to comply with protocol|0|||
163845559|NCT00849680|591803834|FG004|Overall Study|Subject unable to comply with protocol|0|||
163845560|NCT00849680|591803835|FG005|Overall Study|Subject unable to comply with protocol|0|||
163845561|NCT00849680|591803836|FG006|Overall Study|Subject unable to comply with protocol|0|||
163845562|NCT00849680|591803837|FG007|Overall Study|Subject unable to comply with protocol|0|||
163845563|NCT00003458|591803842|FG000|Overall Study|Not evaluable|4|||
163845564|NCT04714216|591805695|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
163845565|NCT04714216|591805695|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
163845566|NCT01349829|591805696|FG000|Overall Study|Lost to Follow-up|4|||
163845567|NCT01349829|591805697|FG001|Overall Study|Lost to Follow-up|8|||
163845568|NCT01349829|591805696|FG000|Overall Study|Consent withdrawal|3|||
163845569|NCT01349829|591805697|FG001|Overall Study|Consent withdrawal|8|||
163845570|NCT01349829|591805696|FG000|Overall Study|Migrated/moved|2|||
163845571|NCT01349829|591805697|FG001|Overall Study|Migrated/moved|7|||
163845572|NCT02555371|591805698|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
163845573|NCT02555371|591805699|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163845574|NCT02555371|591805700|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163845575|NCT02555371|591805701|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163845576|NCT02555371|591805702|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
163845577|NCT02555371|591805698|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
163845578|NCT02555371|591805699|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163845579|NCT02555371|591805700|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163845580|NCT02555371|591805701|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163845581|NCT02555371|591805702|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
163845582|NCT02555371|591805698|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
163845583|NCT02555371|591805699|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163845584|NCT02555371|591805700|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163845585|NCT02555371|591805701|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163845586|NCT02555371|591805702|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
163845587|NCT02555371|591805698|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
163845588|NCT02555371|591805699|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163845589|NCT02555371|591805700|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163845590|NCT02555371|591805701|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163845591|NCT02555371|591805702|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
163845592|NCT02555371|591805698|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
163845593|NCT02555371|591805699|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163845594|NCT02555371|591805700|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163845595|NCT02555371|591805701|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163845596|NCT02555371|591805702|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
163845597|NCT02555371|591805698|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
163845598|NCT02555371|591805699|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
163845599|NCT02555371|591805700|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
163845600|NCT02555371|591805701|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
163845601|NCT02555371|591805702|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
164305988|NCT04922216|593493303|FG024|Overall Study|Withdrawal by Subject|0|||
164305989|NCT04922216|593493304|FG025|Overall Study|Withdrawal by Subject|0|||
164305990|NCT04922216|593493305|FG026|Overall Study|Withdrawal by Subject|1|||
164305991|NCT04922216|593493306|FG027|Overall Study|Withdrawal by Subject|0|||
164305992|NCT04922216|593493307|FG028|Overall Study|Withdrawal by Subject|0|||
164305993|NCT04922216|593493308|FG029|Overall Study|Withdrawal by Subject|0|||
164305994|NCT04922216|593493309|FG030|Overall Study|Withdrawal by Subject|1|||
164305995|NCT04922216|593493310|FG031|Overall Study|Withdrawal by Subject|0|||
164305996|NCT04922216|593493279|FG000|Overall Study|Lost to Follow-up|1|||
164305997|NCT04922216|593493280|FG001|Overall Study|Lost to Follow-up|0|||
164305998|NCT04922216|593493281|FG002|Overall Study|Lost to Follow-up|2|||
164305999|NCT04922216|593493282|FG003|Overall Study|Lost to Follow-up|0|||
164306000|NCT04922216|593493283|FG004|Overall Study|Lost to Follow-up|0|||
164306001|NCT04922216|593493284|FG005|Overall Study|Lost to Follow-up|2|||
164306002|NCT04922216|593493285|FG006|Overall Study|Lost to Follow-up|0|||
164306003|NCT04922216|593493286|FG007|Overall Study|Lost to Follow-up|1|||
164306004|NCT04922216|593493287|FG008|Overall Study|Lost to Follow-up|1|||
164306005|NCT04922216|593493288|FG009|Overall Study|Lost to Follow-up|2|||
164306006|NCT04922216|593493289|FG010|Overall Study|Lost to Follow-up|2|||
164306007|NCT04922216|593493290|FG011|Overall Study|Lost to Follow-up|1|||
164306008|NCT04922216|593493291|FG012|Overall Study|Lost to Follow-up|1|||
164306009|NCT04922216|593493292|FG013|Overall Study|Lost to Follow-up|0|||
164306010|NCT04922216|593493293|FG014|Overall Study|Lost to Follow-up|1|||
164306011|NCT04922216|593493294|FG015|Overall Study|Lost to Follow-up|0|||
164306012|NCT04922216|593493295|FG016|Overall Study|Lost to Follow-up|0|||
164306013|NCT04922216|593493296|FG017|Overall Study|Lost to Follow-up|2|||
164306014|NCT04922216|593493297|FG018|Overall Study|Lost to Follow-up|1|||
164306015|NCT04922216|593493298|FG019|Overall Study|Lost to Follow-up|0|||
164306016|NCT04922216|593493299|FG020|Overall Study|Lost to Follow-up|1|||
164306017|NCT04922216|593493300|FG021|Overall Study|Lost to Follow-up|0|||
164306018|NCT04922216|593493301|FG022|Overall Study|Lost to Follow-up|2|||
164306019|NCT04922216|593493302|FG023|Overall Study|Lost to Follow-up|1|||
164306020|NCT04922216|593493303|FG024|Overall Study|Lost to Follow-up|0|||
164306021|NCT04922216|593493304|FG025|Overall Study|Lost to Follow-up|2|||
164306022|NCT04922216|593493305|FG026|Overall Study|Lost to Follow-up|0|||
164006465|NCT02158533|592390964|FG002|Stage 2|Withdrawal by Subject|0|||
164306023|NCT04922216|593493306|FG027|Overall Study|Lost to Follow-up|0|||
164306024|NCT04922216|593493307|FG028|Overall Study|Lost to Follow-up|1|||
164306025|NCT04922216|593493308|FG029|Overall Study|Lost to Follow-up|0|||
164306026|NCT04922216|593493309|FG030|Overall Study|Lost to Follow-up|2|||
164306027|NCT04922216|593493310|FG031|Overall Study|Lost to Follow-up|1|||
164306028|NCT03207763|593494660|FG000|Overall Study|Lost to Follow-up|1|||
164306029|NCT03207763|593494661|FG001|Overall Study|Lost to Follow-up|0|||
164306030|NCT02102204|593494662|FG000|Overall Study|Withdrawal by Subject|137|||
164306031|NCT02102204|593494662|FG000|Overall Study|Death|92|||
164306032|NCT02102204|593494662|FG000|Overall Study|Lost to Follow-up|65|||
164306033|NCT02102204|593494662|FG000|Overall Study|Sponsor Decision|5|||
164306034|NCT02102204|593494662|FG000|Overall Study|Ongoing|5|||
164306035|NCT03751657|593494663|FG000|Overall Study|Physician Decision|0|||
164306036|NCT03751657|593494664|FG001|Overall Study|Physician Decision|1|||
164306037|NCT03751657|593494663|FG000|Overall Study|Withdrawal by Subject|1|||
164306038|NCT03751657|593494664|FG001|Overall Study|Withdrawal by Subject|1|||
164306039|NCT03751657|593494663|FG000|Overall Study|Lost to Follow-up|2|||
164306040|NCT03751657|593494664|FG001|Overall Study|Lost to Follow-up|1|||
164306041|NCT00990704|593494665|FG000|Overall Study|Adverse Event|1|||
164306042|NCT00990704|593494666|FG001|Overall Study|Adverse Event|1|||
164306043|NCT00990704|593494665|FG000|Overall Study|Physician Decision|0|||
164306044|NCT00990704|593494666|FG001|Overall Study|Physician Decision|1|||
164306045|NCT03894813|593494673|FG000|Overall Study|Adverse Event|1|||
164306046|NCT03894813|593494674|FG001|Overall Study|Adverse Event|1|||
164306047|NCT03894813|593494673|FG000|Overall Study|Lack of Efficacy|3|||
164306048|NCT03894813|593494674|FG001|Overall Study|Lack of Efficacy|3|||
164306049|NCT03894813|593494673|FG000|Overall Study|Lost to Follow-up|1|||
164306050|NCT03894813|593494674|FG001|Overall Study|Lost to Follow-up|0|||
164306051|NCT03894813|593494673|FG000|Overall Study|Pregnancy|2|||
164306052|NCT03894813|593494674|FG001|Overall Study|Pregnancy|1|||
164306053|NCT03894813|593494673|FG000|Overall Study|Protocol Violation|3|||
164306054|NCT03894813|593494674|FG001|Overall Study|Protocol Violation|7|||
164306055|NCT03894813|593494673|FG000|Overall Study|Withdrawal by Subject|1|||
164306056|NCT03894813|593494674|FG001|Overall Study|Withdrawal by Subject|3|||
164306057|NCT03894813|593494673|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
164306058|NCT03894813|593494674|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
164306059|NCT02269267|593494676|FG000|Overall Study|Death|5|||
164306060|NCT03773796|593494677|FG000|Overall Study|Adverse Event|1|||
164306061|NCT03773796|593494677|FG000|Overall Study|Withdrawal by Subject|1|||
164306062|NCT03773796|593494677|FG000|Overall Study|Lack of Efficacy|1|||
164306063|NCT03805659|593494678|FG000|Overall Study|Withdrawal by Subject|0|||
164306064|NCT03805659|593494679|FG001|Overall Study|Withdrawal by Subject|1|||
164306065|NCT00145158|593494682|FG000|Overall Study|premature withdrawal|2|||
164306066|NCT00145158|593494683|FG001|Overall Study|premature withdrawal|3|||
164306067|NCT02741518|593494684|FG000|Overall Study|Withdrawal by Subject|1|||
164306068|NCT02741518|593494685|FG001|Overall Study|Withdrawal by Subject|1|||
164306069|NCT00476008|593494686|FG000|Overall Study|Adverse Event|4|||
164306070|NCT00476008|593494687|FG001|Overall Study|Adverse Event|4|||
164306071|NCT00476008|593494686|FG000|Overall Study|Placebo concerns|2|||
164306072|NCT00476008|593494687|FG001|Overall Study|Placebo concerns|2|||
164306073|NCT00476008|593494686|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
164306074|NCT00476008|593494687|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
164306075|NCT00476008|593494686|FG000|Overall Study|Withdrawal by Subject|0|||
164306076|NCT00476008|593494687|FG001|Overall Study|Withdrawal by Subject|1|||
164306077|NCT00476008|593494686|FG000|Overall Study|Death|1|||
164306078|NCT00476008|593494687|FG001|Overall Study|Death|0|||
164306079|NCT01788358|593494688|FG000|Overall Study|Other|11|||
164306080|NCT01788358|593494688|FG000|Overall Study|Logistical difficulties|1|||
164306081|NCT01788358|593494688|FG000|Overall Study|Lost to Follow-up|5|||
164306082|NCT01788358|593494688|FG000|Overall Study|Protocol Violation|3|||
164306083|NCT01788358|593494688|FG000|Overall Study|Withdrawal by Subject|26|||
164306084|NCT01788358|593494688|FG000|Overall Study|Lack of Efficacy|1|||
164306085|NCT01788358|593494688|FG000|Overall Study|Adverse Event|51|||
164306086|NCT01227018|593494689|FG000|Overall Study|Disease progression|9|||
164306087|NCT01227018|593494689|FG000|Overall Study|Toxicity|2|||
164306088|NCT01227018|593494689|FG000|Overall Study|Withdrew after beginning treatment|4|||
164306089|NCT00499616|593494697|FG000|Overall Study|Death|1|||
164306090|NCT00499616|593494698|FG001|Overall Study|Death|5|||
164306091|NCT00499616|593494699|FG002|Overall Study|Death|3|||
164306092|NCT00499616|593494700|FG003|Overall Study|Death|1|||
164306093|NCT00499616|593494697|FG000|Overall Study|Lack of Efficacy|5|||
164306094|NCT00499616|593494698|FG001|Overall Study|Lack of Efficacy|0|||
164306095|NCT00499616|593494699|FG002|Overall Study|Lack of Efficacy|19|||
164306096|NCT00499616|593494700|FG003|Overall Study|Lack of Efficacy|0|||
164306097|NCT00499616|593494697|FG000|Overall Study|Lost to Follow-up|0|||
164306098|NCT00499616|593494698|FG001|Overall Study|Lost to Follow-up|0|||
164306099|NCT00499616|593494699|FG002|Overall Study|Lost to Follow-up|1|||
164306100|NCT00499616|593494700|FG003|Overall Study|Lost to Follow-up|0|||
164306101|NCT00499616|593494697|FG000|Overall Study|Physician Decision|6|||
164306102|NCT00499616|593494698|FG001|Overall Study|Physician Decision|16|||
164306103|NCT00499616|593494699|FG002|Overall Study|Physician Decision|9|||
164306104|NCT00499616|593494700|FG003|Overall Study|Physician Decision|0|||
164306105|NCT00499616|593494697|FG000|Overall Study|Withdrawal by Subject|1|||
164306106|NCT00499616|593494698|FG001|Overall Study|Withdrawal by Subject|0|||
164306107|NCT00499616|593494699|FG002|Overall Study|Withdrawal by Subject|1|||
164306108|NCT00499616|593494700|FG003|Overall Study|Withdrawal by Subject|0|||
164306109|NCT00499616|593494697|FG000|Overall Study|Ineligible|1|||
164306110|NCT00499616|593494698|FG001|Overall Study|Ineligible|2|||
164306111|NCT00499616|593494699|FG002|Overall Study|Ineligible|0|||
164306112|NCT00499616|593494700|FG003|Overall Study|Ineligible|15|||
164306113|NCT00499616|593494697|FG000|Overall Study|Not evaluable|0|||
164306114|NCT00499616|593494698|FG001|Overall Study|Not evaluable|0|||
164306115|NCT00499616|593494699|FG002|Overall Study|Not evaluable|0|||
164306116|NCT00499616|593494700|FG003|Overall Study|Not evaluable|41|||
164306117|NCT00499616|593494697|FG000|Overall Study|Patient/Parent Refusal|1|||
164306118|NCT00499616|593494698|FG001|Overall Study|Patient/Parent Refusal|5|||
164306119|NCT00499616|593494699|FG002|Overall Study|Patient/Parent Refusal|3|||
164306120|NCT00499616|593494700|FG003|Overall Study|Patient/Parent Refusal|0|||
164306121|NCT00808080|593494703|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
164306122|NCT02803580|593494706|FG000|Overall Study|Death|13|||
164306123|NCT02803580|593494706|FG000|Overall Study|Lost to Follow-up|19|||
164306124|NCT02803580|593494706|FG000|Overall Study|Withdrawal by Subject|3|||
164306125|NCT02803580|593494706|FG000|Overall Study|Inclusion in clinical trial|1|||
164306126|NCT01837823|593494707|FG000|Overall Study|Lost to Follow-up|6|||
164306127|NCT03052400|593494708|FG000|Overall Study|Lost to Follow-up|1|||
164306128|NCT03052400|593494709|FG001|Overall Study|Lost to Follow-up|0|||
164306129|NCT03052400|593494708|FG000|Overall Study|Withdrawal by Subject|0|||
164306130|NCT03052400|593494709|FG001|Overall Study|Withdrawal by Subject|1|||
164306131|NCT01358721|593494710|FG000|Overall Study|Withdrawal by Subject|0|||
164306132|NCT01358721|593494711|FG001|Overall Study|Withdrawal by Subject|0|||
164306133|NCT01358721|593494712|FG002|Overall Study|Withdrawal by Subject|0|||
164306134|NCT01358721|593494713|FG003|Overall Study|Withdrawal by Subject|1|||
164306135|NCT01358721|593494710|FG000|Overall Study|Death|0|||
164306136|NCT01358721|593494711|FG001|Overall Study|Death|2|||
164306137|NCT01358721|593494712|FG002|Overall Study|Death|0|||
164306138|NCT01358721|593494713|FG003|Overall Study|Death|0|||
164306139|NCT01358721|593494710|FG000|Overall Study|Study Drug Toxicity|1|||
164306140|NCT01358721|593494711|FG001|Overall Study|Study Drug Toxicity|3|||
164306141|NCT01358721|593494712|FG002|Overall Study|Study Drug Toxicity|4|||
164306142|NCT01358721|593494713|FG003|Overall Study|Study Drug Toxicity|5|||
164306143|NCT01358721|593494710|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
164306144|NCT01358721|593494711|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
164306145|NCT01358721|593494712|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
164306146|NCT01358721|593494713|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
164306147|NCT01358721|593494710|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164306148|NCT01358721|593494711|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
164306149|NCT01358721|593494712|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
164306150|NCT01358721|593494713|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
164306151|NCT01358721|593494710|FG000|Overall Study|Adverse Event related to study drug|1|||
164306152|NCT01358721|593494711|FG001|Overall Study|Adverse Event related to study drug|0|||
164306153|NCT01358721|593494712|FG002|Overall Study|Adverse Event related to study drug|0|||
164306154|NCT01358721|593494713|FG003|Overall Study|Adverse Event related to study drug|1|||
164306155|NCT01358721|593494710|FG000|Overall Study|Disease Progression|19|||
164306156|NCT01358721|593494711|FG001|Overall Study|Disease Progression|15|||
164306157|NCT01358721|593494712|FG002|Overall Study|Disease Progression|17|||
164306158|NCT01358721|593494713|FG003|Overall Study|Disease Progression|15|||
164306159|NCT01358721|593494710|FG000|Overall Study|Out of State/Unmet Criteria|0|||
164306160|NCT01358721|593494711|FG001|Overall Study|Out of State/Unmet Criteria|0|||
164306161|NCT01358721|593494712|FG002|Overall Study|Out of State/Unmet Criteria|1|||
164306162|NCT01358721|593494713|FG003|Overall Study|Out of State/Unmet Criteria|0|||
164306163|NCT00867815|593494714|FG000|Overall Study|Lost to Follow-up|1|||
164306164|NCT00001213|593494715|FG000|Overall Study|Death|18|||
164306165|NCT02636595|593494716|FG000|Overall Study|Lost to Follow-up|1|||
164306166|NCT02636595|593494716|FG000|Overall Study|Other|1|||
164306167|NCT05782179|593494718|FG000|Overall Study|Adverse Event|0|||
164306168|NCT05782179|593494719|FG001|Overall Study|Adverse Event|0|||
164306169|NCT05782179|593494720|FG002|Overall Study|Adverse Event|2|||
164306170|NCT05782179|593494721|FG003|Overall Study|Adverse Event|0|||
164306171|NCT05782179|593494722|FG004|Overall Study|Adverse Event|0|||
164306172|NCT05782179|593494723|FG005|Overall Study|Adverse Event|0|||
164306173|NCT00831181|593494726|FG000|Overall Study|Adverse Event|12|||
164306174|NCT05021978|593494729|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
164306175|NCT05021978|593494730|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
164306176|NCT05021978|593494731|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
164306177|NCT05021978|593494732|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
164306178|NCT05021978|593494729|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
164306179|NCT05021978|593494730|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
164306180|NCT05021978|593494731|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
164306181|NCT05021978|593494732|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
164306182|NCT00196313|593494733|FG000|Overall Study|Protocol Violation|2|||
164306183|NCT00196313|593494734|FG001|Overall Study|Protocol Violation|3|||
164306184|NCT00196313|593494733|FG000|Overall Study|Withdrawal by Subject|3|||
164306185|NCT00196313|593494734|FG001|Overall Study|Withdrawal by Subject|1|||
164306186|NCT00196313|593494733|FG000|Overall Study|Adverse Event|3|||
164306187|NCT00196313|593494734|FG001|Overall Study|Adverse Event|1|||
164306188|NCT00196313|593494733|FG000|Overall Study|Subject Pregnant|1|||
164306189|NCT00196313|593494734|FG001|Overall Study|Subject Pregnant|1|||
164306190|NCT00196313|593494733|FG000|Overall Study|Lost to Follow-up|2|||
164306191|NCT00196313|593494734|FG001|Overall Study|Lost to Follow-up|2|||
164306192|NCT04639258|593494735|FG000|Overall Study|Screen failure|5|||
164306193|NCT04639258|593494735|FG000|Overall Study|Physician Decision|2|||
164306194|NCT04639258|593494735|FG000|Overall Study|Early study termination|3|||
164306195|NCT04639258|593494735|FG000|Overall Study|Withdrawal by Subject|1|||
164306196|NCT00414596|593494737|FG000|Overall Study|Protocol Violation|2|||
164306197|NCT01635153|593494739|FG000|Overall Study|Lost to Follow-up|40|||
164306198|NCT01635153|593494740|FG001|Overall Study|Lost to Follow-up|43|||
164306199|NCT02754440|593494741|FG000|Overall Study|Protocol Violation|3|||
164306200|NCT02754440|593494742|FG001|Overall Study|Protocol Violation|2|||
164306201|NCT02754440|593494743|FG002|Overall Study|Protocol Violation|2|||
164306202|NCT02754440|593494744|FG003|Overall Study|Protocol Violation|6|||
164306203|NCT02754440|593494741|FG000|Overall Study|Adverse Event|3|||
164306204|NCT02754440|593494742|FG001|Overall Study|Adverse Event|1|||
164306205|NCT02754440|593494743|FG002|Overall Study|Adverse Event|0|||
164306206|NCT02754440|593494744|FG003|Overall Study|Adverse Event|9|||
164306207|NCT02754440|593494741|FG000|Overall Study|Withdrawal by Subject|0|||
164306208|NCT02754440|593494742|FG001|Overall Study|Withdrawal by Subject|0|||
164306209|NCT02754440|593494743|FG002|Overall Study|Withdrawal by Subject|0|||
164306210|NCT02754440|593494744|FG003|Overall Study|Withdrawal by Subject|1|||
164306211|NCT02754440|593494741|FG000|Overall Study|Equipment failure|0|||
164306212|NCT02754440|593494742|FG001|Overall Study|Equipment failure|5|||
164306213|NCT02754440|593494743|FG002|Overall Study|Equipment failure|5|||
164306214|NCT02754440|593494744|FG003|Overall Study|Equipment failure|7|||
164306215|NCT02754440|593494741|FG000|Overall Study|Subject issues not resulting in AE|0|||
164306216|NCT02754440|593494742|FG001|Overall Study|Subject issues not resulting in AE|0|||
164306217|NCT02754440|593494743|FG002|Overall Study|Subject issues not resulting in AE|0|||
164306218|NCT02754440|593494744|FG003|Overall Study|Subject issues not resulting in AE|12|||
164306219|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Adverse Event|9|||
164306220|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Adverse Event|3|||
164306221|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Death|7|||
164306222|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Death|7|||
164306223|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
164306224|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
164306225|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Physician Decision|1|||
164306226|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Physician Decision|0|||
164306227|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
164306228|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
164306229|NCT02558296|593494745|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
164306230|NCT02558296|593494746|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
164306231|NCT02558296|593494745|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
164306232|NCT02558296|593494746|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
164306233|NCT02558296|593494745|FG000|Completed the Study|Adverse Event|14|||
164306234|NCT02558296|593494746|FG001|Completed the Study|Adverse Event|5|||
164306235|NCT02558296|593494745|FG000|Completed the Study|Death|39|||
164306236|NCT02558296|593494746|FG001|Completed the Study|Death|25|||
164306237|NCT02558296|593494745|FG000|Completed the Study|Lost to Follow-up|31|||
164306238|NCT02558296|593494746|FG001|Completed the Study|Lost to Follow-up|23|||
164306239|NCT02558296|593494745|FG000|Completed the Study|Physician Decision|6|||
164306240|NCT02558296|593494746|FG001|Completed the Study|Physician Decision|0|||
164306241|NCT02558296|593494745|FG000|Completed the Study|Protocol Violation|2|||
164306242|NCT02558296|593494746|FG001|Completed the Study|Protocol Violation|1|||
164306243|NCT02558296|593494745|FG000|Completed the Study|Withdrawal by Subject|53|||
164306244|NCT02558296|593494746|FG001|Completed the Study|Withdrawal by Subject|31|||
164306245|NCT02558296|593494745|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
164306246|NCT02558296|593494746|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
164306247|NCT01189032|593494751|FG000|Overall Study|Adverse Event|1|||
164306248|NCT01189032|593494752|FG001|Overall Study|Adverse Event|3|||
164306249|NCT01189032|593494753|FG002|Overall Study|Adverse Event|4|||
164306250|NCT01189032|593494751|FG000|Overall Study|Lack of Efficacy|2|||
164306251|NCT01189032|593494752|FG001|Overall Study|Lack of Efficacy|3|||
164306252|NCT01189032|593494753|FG002|Overall Study|Lack of Efficacy|0|||
164306253|NCT01189032|593494751|FG000|Overall Study|Withdrawal by Subject|1|||
164306254|NCT01189032|593494752|FG001|Overall Study|Withdrawal by Subject|0|||
164306255|NCT01189032|593494753|FG002|Overall Study|Withdrawal by Subject|1|||
164306256|NCT01189032|593494751|FG000|Overall Study|Protocol Violation|1|||
164306257|NCT01189032|593494752|FG001|Overall Study|Protocol Violation|1|||
164306258|NCT01189032|593494753|FG002|Overall Study|Protocol Violation|1|||
164306259|NCT01995838|593494758|FG000|Overall Study|Lost to Follow-up|0|||
164306260|NCT01995838|593494759|FG001|Overall Study|Lost to Follow-up|1|||
164306261|NCT01995838|593494760|FG002|Overall Study|Lost to Follow-up|0|||
164306262|NCT01995838|593494761|FG003|Overall Study|Lost to Follow-up|0|||
164306263|NCT01995838|593494762|FG004|Overall Study|Lost to Follow-up|0|||
164306264|NCT01995838|593494763|FG005|Overall Study|Lost to Follow-up|0|||
164306265|NCT01995838|593494764|FG006|Overall Study|Lost to Follow-up|1|||
164306266|NCT01995838|593494758|FG000|Overall Study|Participant choice|2|||
164306267|NCT01995838|593494759|FG001|Overall Study|Participant choice|0|||
164306268|NCT01995838|593494760|FG002|Overall Study|Participant choice|0|||
164306269|NCT01995838|593494761|FG003|Overall Study|Participant choice|0|||
164306270|NCT01995838|593494762|FG004|Overall Study|Participant choice|0|||
164306271|NCT01995838|593494763|FG005|Overall Study|Participant choice|1|||
164306272|NCT01995838|593494764|FG006|Overall Study|Participant choice|1|||
164306273|NCT01995838|593494758|FG000|Overall Study|Adverse Event|0|||
164306274|NCT01995838|593494759|FG001|Overall Study|Adverse Event|0|||
164306275|NCT01995838|593494760|FG002|Overall Study|Adverse Event|0|||
164306276|NCT01995838|593494761|FG003|Overall Study|Adverse Event|0|||
164306277|NCT01995838|593494762|FG004|Overall Study|Adverse Event|0|||
164306278|NCT01995838|593494763|FG005|Overall Study|Adverse Event|0|||
164306279|NCT01995838|593494764|FG006|Overall Study|Adverse Event|1|||
164306280|NCT01995838|593494758|FG000|Overall Study|Withdrawal by Subject|0|||
164306281|NCT01995838|593494759|FG001|Overall Study|Withdrawal by Subject|0|||
164306282|NCT01995838|593494760|FG002|Overall Study|Withdrawal by Subject|0|||
164306283|NCT01995838|593494761|FG003|Overall Study|Withdrawal by Subject|0|||
164306284|NCT01995838|593494762|FG004|Overall Study|Withdrawal by Subject|1|||
164306285|NCT01995838|593494763|FG005|Overall Study|Withdrawal by Subject|0|||
164306286|NCT01995838|593494764|FG006|Overall Study|Withdrawal by Subject|0|||
164306287|NCT01995838|593494758|FG000|Overall Study|Other|3|||
164306288|NCT01995838|593494759|FG001|Overall Study|Other|1|||
164306289|NCT01995838|593494760|FG002|Overall Study|Other|0|||
164306290|NCT01995838|593494761|FG003|Overall Study|Other|2|||
164306291|NCT01995838|593494762|FG004|Overall Study|Other|1|||
164306292|NCT01995838|593494763|FG005|Overall Study|Other|1|||
164306293|NCT01995838|593494764|FG006|Overall Study|Other|2|||
164306294|NCT01967576|593494765|FG000|Overall Study|Withdrawal by Subject|3|||
164306295|NCT01967576|593494765|FG000|Overall Study|Progressed/Removed from treatment|1|||
164306296|NCT01967576|593494765|FG000|Overall Study|Study closing at site|1|||
164306297|NCT01967576|593494765|FG000|Overall Study|Adverse Event|1|||
164306298|NCT01967576|593494765|FG000|Overall Study|Refused further treatment|1|||
164306299|NCT00345358|593494766|FG000|Primary Vaccination Phase|Other|0|||
164306300|NCT00345358|593494767|FG001|Primary Vaccination Phase|Other|1|||
164306301|NCT00345358|593494768|FG002|Primary Vaccination Phase|Other|1|||
164306302|NCT00345358|593494769|FG003|Primary Vaccination Phase|Other|0|||
164306303|NCT00345358|593494766|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
164306304|NCT00345358|593494767|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
164306305|NCT00345358|593494768|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
164306306|NCT00345358|593494769|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
164306307|NCT00345358|593494766|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
164306308|NCT00345358|593494767|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
164306309|NCT00345358|593494768|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
164306310|NCT00345358|593494769|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
164306311|NCT00345358|593494766|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
164306312|NCT00345358|593494767|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
164306313|NCT00345358|593494768|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
164306314|NCT00345358|593494769|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
164306315|NCT00345358|593494766|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
164306316|NCT00345358|593494767|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164306317|NCT00345358|593494768|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
164306318|NCT00345358|593494769|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
164306319|NCT00345358|593494766|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
164306320|NCT00345358|593494767|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
164306321|NCT00345358|593494768|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
164306322|NCT00345358|593494769|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
164306323|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
164306324|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
164306325|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
164306326|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
164306327|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
164306328|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
164306329|NCT02592798|593494770|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
164306330|NCT02592798|593494771|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
164306331|NCT02592798|593494770|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
164006466|NCT02158533|592390965|FG003|Stage 2|Withdrawal by Subject|0|||
164306332|NCT02592798|593494771|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
164306333|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
164306334|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
164306335|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
164306336|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
164306337|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
164306338|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
164306339|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
164306340|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
164306341|NCT02592798|593494770|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
164306342|NCT02592798|593494771|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
164306343|NCT02592798|593494770|FG000|Transition From DB2 to OLE|Other reasons|1|||
164306344|NCT02592798|593494771|FG001|Transition From DB2 to OLE|Other reasons|0|||
164306345|NCT02592798|593494770|FG000|Open Label Period (OLE)|Other reasons|0|||
164306346|NCT02592798|593494771|FG001|Open Label Period (OLE)|Other reasons|2|||
164306347|NCT02592798|593494770|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
163845602|NCT02555371|591805698|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
163845603|NCT02555371|591805699|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
163845604|NCT02555371|591805700|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
164306348|NCT02592798|593494771|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
164306349|NCT02592798|593494770|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
164306350|NCT02592798|593494771|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
164306351|NCT02592798|593494770|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
164306352|NCT02592798|593494771|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
164306353|NCT02592798|593494770|FG000|Open Label Period (OLE)|Adverse Event|0|||
164306354|NCT02592798|593494771|FG001|Open Label Period (OLE)|Adverse Event|1|||
164306355|NCT01696188|593494772|FG000|Overall Study|Protocol Violation|1|||
164306356|NCT01696188|593494773|FG001|Overall Study|Protocol Violation|1|||
164306357|NCT02668393|593494774|FG000|Overall Study|Progressive disease|6|||
164306358|NCT02668393|593494775|FG001|Overall Study|Progressive disease|3|||
164189889|NCT00572455|593063999|FG013|Stage II (28 Days)|Adverse Event|1|||
164306359|NCT02668393|593494774|FG000|Overall Study|Adverse Event|0|||
164306360|NCT02668393|593494775|FG001|Overall Study|Adverse Event|2|||
163845605|NCT02555371|591805701|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
164306361|NCT02668393|593494774|FG000|Overall Study|Withdrawal from the trial|0|||
164306362|NCT02668393|593494775|FG001|Overall Study|Withdrawal from the trial|1|||
164306363|NCT02668393|593494774|FG000|Overall Study|Lack of benefit and side effects|1|||
164306364|NCT02668393|593494775|FG001|Overall Study|Lack of benefit and side effects|0|||
164306365|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
164306366|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
164306367|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
164306368|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
164306369|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
164306370|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
164306371|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
164306372|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
164306373|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
164306374|NCT00174187|593494778|FG000|Period 1 (up to 3 Years)|Other|0|||
164306375|NCT00174187|593494779|FG001|Period 1 (up to 3 Years)|Other|1|||
164306376|NCT00174187|593494780|FG002|Period 1 (up to 3 Years)|Other|0|||
164306377|NCT00174187|593494778|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
164306378|NCT00174187|593494779|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
164306379|NCT00174187|593494780|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
164306380|NCT00174187|593494778|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
164306381|NCT00174187|593494779|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
164306382|NCT00174187|593494780|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
164306383|NCT00174187|593494778|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
164306384|NCT00174187|593494779|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
164306385|NCT00174187|593494780|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
164306386|NCT00174187|593494778|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
164306387|NCT00174187|593494779|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
164306388|NCT00174187|593494780|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
164306389|NCT00174187|593494778|FG000|Period 2 (After 3 Years)|Other|0|||
164306390|NCT00174187|593494779|FG001|Period 2 (After 3 Years)|Other|0|||
164306391|NCT00174187|593494780|FG002|Period 2 (After 3 Years)|Other|5|||
164306392|NCT01285557|593494781|FG000|Overall Study|Death|173|||
164306393|NCT01285557|593494782|FG001|Overall Study|Death|90|||
164306394|NCT01285557|593494781|FG000|Overall Study|Lost to Follow-up|6|||
164306395|NCT01285557|593494782|FG001|Overall Study|Lost to Follow-up|2|||
164306396|NCT01285557|593494781|FG000|Overall Study|Withdrew Consent|6|||
164306397|NCT01285557|593494782|FG001|Overall Study|Withdrew Consent|1|||
164306398|NCT01285557|593494781|FG000|Overall Study|Sponsor Study Termination|23|||
164306399|NCT01285557|593494782|FG001|Overall Study|Sponsor Study Termination|13|||
164306400|NCT01285557|593494781|FG000|Overall Study|Randomized but not treated|1|||
164306401|NCT01285557|593494782|FG001|Overall Study|Randomized but not treated|1|||
164306402|NCT01285557|593494781|FG000|Overall Study|Study follow-up ongoing|28|||
164306403|NCT01285557|593494782|FG001|Overall Study|Study follow-up ongoing|14|||
164306404|NCT01285557|593494781|FG000|Overall Study|Sponsor Decision|2|||
164306405|NCT01285557|593494782|FG001|Overall Study|Sponsor Decision|1|||
164306406|NCT02000115|593494783|FG000|Overall Study|Death|56|||
164306407|NCT02000115|593494784|FG001|Overall Study|Death|45|||
164306408|NCT02000115|593494785|FG002|Overall Study|Death|0|||
164306409|NCT02000115|593494786|FG003|Overall Study|Death|0|||
164306410|NCT02000115|593494783|FG000|Overall Study|Missed Visit|6|||
164306411|NCT02000115|593494784|FG001|Overall Study|Missed Visit|8|||
164306412|NCT02000115|593494785|FG002|Overall Study|Missed Visit|1|||
164306413|NCT02000115|593494786|FG003|Overall Study|Missed Visit|0|||
164306414|NCT02000115|593494783|FG000|Overall Study|Protocol Violation|2|||
164306415|NCT02000115|593494784|FG001|Overall Study|Protocol Violation|1|||
164306416|NCT02000115|593494785|FG002|Overall Study|Protocol Violation|0|||
164306417|NCT02000115|593494786|FG003|Overall Study|Protocol Violation|0|||
164306418|NCT02000115|593494783|FG000|Overall Study|Physician Decision|2|||
164306419|NCT02000115|593494784|FG001|Overall Study|Physician Decision|0|||
164306420|NCT02000115|593494785|FG002|Overall Study|Physician Decision|0|||
164306421|NCT02000115|593494786|FG003|Overall Study|Physician Decision|0|||
164306422|NCT02000115|593494783|FG000|Overall Study|Withdrawal by Subject|11|||
164306423|NCT02000115|593494784|FG001|Overall Study|Withdrawal by Subject|11|||
164306424|NCT02000115|593494785|FG002|Overall Study|Withdrawal by Subject|0|||
164306425|NCT02000115|593494786|FG003|Overall Study|Withdrawal by Subject|0|||
164306426|NCT02000115|593494783|FG000|Overall Study|Lost to Follow-up|0|||
164306427|NCT02000115|593494784|FG001|Overall Study|Lost to Follow-up|1|||
164306428|NCT02000115|593494785|FG002|Overall Study|Lost to Follow-up|0|||
164306429|NCT02000115|593494786|FG003|Overall Study|Lost to Follow-up|0|||
164306430|NCT02000115|593494783|FG000|Overall Study|Non-compliance|2|||
164306431|NCT02000115|593494784|FG001|Overall Study|Non-compliance|1|||
164306432|NCT02000115|593494785|FG002|Overall Study|Non-compliance|0|||
164306433|NCT02000115|593494786|FG003|Overall Study|Non-compliance|0|||
164306434|NCT02000115|593494783|FG000|Overall Study|Withdrawn on day of randomization|0|||
164306435|NCT02000115|593494784|FG001|Overall Study|Withdrawn on day of randomization|1|||
164306436|NCT02000115|593494785|FG002|Overall Study|Withdrawn on day of randomization|0|||
164306437|NCT02000115|593494786|FG003|Overall Study|Withdrawn on day of randomization|0|||
164306438|NCT02000115|593494783|FG000|Overall Study|Still on Study|0|||
164306439|NCT02000115|593494784|FG001|Overall Study|Still on Study|0|||
163845606|NCT02555371|591805702|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
163845607|NCT02555371|591805698|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
164306440|NCT02000115|593494785|FG002|Overall Study|Still on Study|0|||
164306441|NCT02000115|593494786|FG003|Overall Study|Still on Study|53|||
164306442|NCT03278249|593494789|FG000|Overall Study|Withdrawal by Subject|2|||
164306443|NCT03278249|593494789|FG000|Overall Study|Lost to Follow-up|1|||
164306444|NCT02656693|593496776|FG000|Overall Study|Pregnancy|1|||
164306445|NCT02656693|593496777|FG001|Overall Study|Pregnancy|1|||
164306446|NCT02656693|593496778|FG002|Overall Study|Pregnancy|1|||
164306447|NCT02656693|593496776|FG000|Overall Study|Bariatric surgery|0|||
164306448|NCT02656693|593496777|FG001|Overall Study|Bariatric surgery|1|||
164306449|NCT02656693|593496778|FG002|Overall Study|Bariatric surgery|2|||
164306450|NCT02565784|593496779|FG000|First Treatment|Adverse Event|1|||
164306451|NCT02565784|593496779|FG000|First Treatment|Withdrawal by Subject|1|||
164306452|NCT02565784|593496779|FG000|Second Treatment|Withdrawal by Subject|2|||
164306453|NCT02948634|593496784|FG000|Overall Study|Lack of efficacy and study suspended|10|||
164306454|NCT02948634|593496785|FG001|Overall Study|Lack of efficacy and study suspended|2|||
164306455|NCT00753649|593496790|FG000|Overall Study|Migrated/moved from study area|1|||
164306456|NCT00753649|593496791|FG001|Overall Study|Migrated/moved from study area|0|||
164306457|NCT00753649|593496790|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
164306458|NCT00753649|593496791|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
164306459|NCT00753649|593496790|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
164306460|NCT00753649|593496791|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
164306461|NCT00753649|593496790|FG000|Overall Study|Protocol Violation|2|||
164306462|NCT00753649|593496791|FG001|Overall Study|Protocol Violation|0|||
164306463|NCT01039519|593496797|FG000|Treatment|Progressive disease|20|||
164306464|NCT01039519|593496797|FG000|Treatment|Treatment failure|2|||
164306465|NCT01039519|593496797|FG000|Treatment|Adverse Event|3|||
164306466|NCT01039519|593496797|FG000|Treatment|Physician Decision|2|||
164306467|NCT01039519|593496797|FG000|Survival Follow-up|Death|23|||
164306468|NCT01039519|593496797|FG000|Survival Follow-up|Sponsor decision|4|||
164306469|NCT01255436|593496800|FG000|Overall Study|Lost to Follow-up|178|||
164306470|NCT01255436|593496801|FG001|Overall Study|Lost to Follow-up|191|||
164306471|NCT01255436|593496800|FG000|Overall Study|Death, stroke, or MI|4|||
164306472|NCT01255436|593496801|FG001|Overall Study|Death, stroke, or MI|3|||
164306473|NCT04816669|593496802|FG000|Part 1|Adverse Event|1|||
164306474|NCT04816669|593496803|FG001|Part 1|Adverse Event|1|||
164306475|NCT04816669|593496804|FG002|Part 1|Adverse Event|0|||
164306476|NCT04816669|593496805|FG003|Part 1|Adverse Event|0|||
164306477|NCT04816669|593496802|FG000|Part 1|Lost to Follow-up|2|||
164306478|NCT04816669|593496803|FG001|Part 1|Lost to Follow-up|2|||
164306479|NCT04816669|593496804|FG002|Part 1|Lost to Follow-up|0|||
164306480|NCT04816669|593496805|FG003|Part 1|Lost to Follow-up|0|||
164306481|NCT04816669|593496802|FG000|Part 1|Protocol Violation|0|||
164306482|NCT04816669|593496803|FG001|Part 1|Protocol Violation|1|||
164306483|NCT04816669|593496804|FG002|Part 1|Protocol Violation|0|||
164306484|NCT04816669|593496805|FG003|Part 1|Protocol Violation|0|||
164306485|NCT04816669|593496802|FG000|Part 1|Withdrawal by Subject|1|||
164306486|NCT04816669|593496803|FG001|Part 1|Withdrawal by Subject|2|||
164306487|NCT04816669|593496804|FG002|Part 1|Withdrawal by Subject|0|||
164306488|NCT04816669|593496805|FG003|Part 1|Withdrawal by Subject|0|||
164306489|NCT04816669|593496802|FG000|Part 2|Other|0|||
164306490|NCT04816669|593496803|FG001|Part 2|Other|0|||
164306491|NCT04816669|593496804|FG002|Part 2|Other|1|||
164306492|NCT04816669|593496805|FG003|Part 2|Other|0|||
164306493|NCT04816669|593496802|FG000|Part 2|Withdrawal by Subject|0|||
164306494|NCT04816669|593496803|FG001|Part 2|Withdrawal by Subject|0|||
164306495|NCT04816669|593496804|FG002|Part 2|Withdrawal by Subject|0|||
164306496|NCT04816669|593496805|FG003|Part 2|Withdrawal by Subject|1|||
164306497|NCT04816669|593496802|FG000|Part 2|Lost to Follow-up|0|||
164306498|NCT04816669|593496803|FG001|Part 2|Lost to Follow-up|0|||
164306499|NCT04816669|593496804|FG002|Part 2|Lost to Follow-up|1|||
164306500|NCT04816669|593496805|FG003|Part 2|Lost to Follow-up|0|||
164306501|NCT01229267|593496806|FG000|Overall Study|Adverse Event|4|||
164306502|NCT01229267|593496807|FG001|Overall Study|Adverse Event|6|||
164306503|NCT01229267|593496808|FG002|Overall Study|Adverse Event|3|||
164306504|NCT01229267|593496809|FG003|Overall Study|Adverse Event|2|||
164306505|NCT01229267|593496810|FG004|Overall Study|Adverse Event|10|||
164306506|NCT01229267|593496806|FG000|Overall Study|Death|40|||
164306507|NCT01229267|593496807|FG001|Overall Study|Death|37|||
164306508|NCT01229267|593496808|FG002|Overall Study|Death|35|||
164306509|NCT01229267|593496809|FG003|Overall Study|Death|13|||
164306510|NCT01229267|593496810|FG004|Overall Study|Death|103|||
164306511|NCT01229267|593496806|FG000|Overall Study|Withdrawal by Subject|23|||
164306512|NCT01229267|593496807|FG001|Overall Study|Withdrawal by Subject|22|||
164306513|NCT01229267|593496808|FG002|Overall Study|Withdrawal by Subject|32|||
164306514|NCT01229267|593496809|FG003|Overall Study|Withdrawal by Subject|14|||
164306515|NCT01229267|593496810|FG004|Overall Study|Withdrawal by Subject|59|||
164306516|NCT01229267|593496806|FG000|Overall Study|Protocol Violation|0|||
164306517|NCT01229267|593496807|FG001|Overall Study|Protocol Violation|1|||
164306518|NCT01229267|593496808|FG002|Overall Study|Protocol Violation|0|||
163845608|NCT02555371|591805699|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
163845609|NCT02555371|591805700|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163845610|NCT02555371|591805701|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163845611|NCT02555371|591805702|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
163845612|NCT02555371|591805698|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
163845613|NCT02555371|591805699|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
163845614|NCT02555371|591805700|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
163845615|NCT02555371|591805701|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
163845616|NCT02555371|591805702|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
163845617|NCT02555371|591805698|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163845618|NCT02555371|591805699|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163845619|NCT02555371|591805700|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163845620|NCT02555371|591805701|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
163845621|NCT02555371|591805702|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
163845622|NCT02555371|591805698|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163845623|NCT02555371|591805699|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163845624|NCT02555371|591805700|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163845625|NCT02555371|591805701|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
163845626|NCT02555371|591805702|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
163845627|NCT02555371|591805698|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163845628|NCT02555371|591805699|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163845629|NCT02555371|591805700|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163845630|NCT02555371|591805701|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
163845631|NCT02555371|591805702|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
163845632|NCT02555371|591805698|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163845633|NCT02555371|591805699|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163845634|NCT02555371|591805700|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163845635|NCT02555371|591805701|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
163845636|NCT02555371|591805702|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
163845637|NCT02555371|591805698|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163845638|NCT02555371|591805699|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163845639|NCT02555371|591805700|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163845640|NCT02555371|591805701|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
163845641|NCT02555371|591805702|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
163845642|NCT03095599|591805703|FG000|Overall Study|Withdrawal by Subject|1|||
163845643|NCT03095599|591805704|FG001|Overall Study|Withdrawal by Subject|0|||
163845644|NCT03095599|591805703|FG000|Overall Study|Lost to Follow-up|1|||
163845645|NCT03095599|591805704|FG001|Overall Study|Lost to Follow-up|0|||
163845646|NCT03095599|591805703|FG000|Overall Study|Withdrawal prior to vaccination|1|||
163845647|NCT03095599|591805704|FG001|Overall Study|Withdrawal prior to vaccination|0|||
163845648|NCT00513019|591805706|FG000|Overall Study|Adverse Event|1|||
163845649|NCT00513019|591805707|FG001|Overall Study|Adverse Event|0|||
163845650|NCT00513019|591805706|FG000|Overall Study|Withdrawal by Subject|4|||
163845651|NCT00513019|591805707|FG001|Overall Study|Withdrawal by Subject|5|||
163845652|NCT00742885|591805708|FG000|Overall Study|Lost to Follow-up|1|||
164306519|NCT01229267|593496809|FG003|Overall Study|Protocol Violation|0|||
164306520|NCT01229267|593496810|FG004|Overall Study|Protocol Violation|0|||
164306521|NCT01229267|593496806|FG000|Overall Study|Progressive disease|0|||
164306522|NCT01229267|593496807|FG001|Overall Study|Progressive disease|0|||
164306523|NCT01229267|593496808|FG002|Overall Study|Progressive disease|0|||
164306524|NCT01229267|593496809|FG003|Overall Study|Progressive disease|0|||
164306525|NCT01229267|593496810|FG004|Overall Study|Progressive disease|1|||
164306526|NCT01229267|593496806|FG000|Overall Study|Physician Decision|8|||
164306527|NCT01229267|593496807|FG001|Overall Study|Physician Decision|11|||
164306528|NCT01229267|593496808|FG002|Overall Study|Physician Decision|8|||
164306529|NCT01229267|593496809|FG003|Overall Study|Physician Decision|3|||
164306530|NCT01229267|593496810|FG004|Overall Study|Physician Decision|25|||
164306531|NCT01229267|593496806|FG000|Overall Study|Lost to Follow-up|6|||
164306532|NCT01229267|593496807|FG001|Overall Study|Lost to Follow-up|5|||
164306533|NCT01229267|593496808|FG002|Overall Study|Lost to Follow-up|8|||
164306534|NCT01229267|593496809|FG003|Overall Study|Lost to Follow-up|3|||
164306535|NCT01229267|593496810|FG004|Overall Study|Lost to Follow-up|22|||
164306536|NCT02223858|593496812|FG000|Overall Study|Death|1|||
164306537|NCT02223858|593496813|FG001|Overall Study|Death|1|||
164306538|NCT02223858|593496812|FG000|Overall Study|Lost to Follow-up|6|||
164306539|NCT02223858|593496813|FG001|Overall Study|Lost to Follow-up|11|||
164306540|NCT02223858|593496812|FG000|Overall Study|Withdrawal by Subject|8|||
164306541|NCT02223858|593496813|FG001|Overall Study|Withdrawal by Subject|5|||
164306542|NCT02223858|593496812|FG000|Overall Study|Refused|9|||
164306543|NCT02223858|593496813|FG001|Overall Study|Refused|9|||
164306544|NCT00241839|593496814|FG000|Overall Study|Withdrawal by Subject|18|||
164306545|NCT00241839|593496815|FG001|Overall Study|Withdrawal by Subject|17|||
164306546|NCT00241839|593496814|FG000|Overall Study|Adverse Event|1|||
164306547|NCT00241839|593496815|FG001|Overall Study|Adverse Event|1|||
164306548|NCT06170242|593496816|FG000|Overall Study|Lost to Follow-up|0|||
164306549|NCT06170242|593496817|FG001|Overall Study|Lost to Follow-up|0|||
164306550|NCT06170242|593496818|FG002|Overall Study|Lost to Follow-up|1|||
164306551|NCT06170242|593496819|FG003|Overall Study|Lost to Follow-up|1|||
164306552|NCT02976038|593496820|FG000|Overall Study|Physician Decision|22|||
164306553|NCT02976038|593496820|FG000|Overall Study|Withdrawal by Subject|3|||
164306554|NCT02976038|593496820|FG000|Overall Study|Lost to Follow-up|2|||
164306555|NCT02976038|593496820|FG000|Overall Study|Adverse Event|1|||
164306556|NCT02919995|593496823|FG000|Overall Study|Adverse Event|0|||
164306557|NCT02919995|593496824|FG001|Overall Study|Adverse Event|0|||
164306558|NCT02919995|593496825|FG002|Overall Study|Adverse Event|0|||
164306559|NCT02919995|593496826|FG003|Overall Study|Adverse Event|0|||
164306560|NCT02919995|593496827|FG004|Overall Study|Adverse Event|0|||
164306561|NCT02919995|593496828|FG005|Overall Study|Adverse Event|1|||
164306562|NCT01263197|593496840|FG000|First Intervention (Period 1)|Adverse Event|0|||
164306563|NCT01263197|593496841|FG001|First Intervention (Period 1)|Adverse Event|0|||
164306564|NCT01263197|593496842|FG002|First Intervention (Period 1)|Adverse Event|0|||
163845653|NCT00742885|591805709|FG001|Overall Study|Lost to Follow-up|0|||
164306565|NCT01263197|593496843|FG003|First Intervention (Period 1)|Adverse Event|0|||
164306566|NCT01263197|593496844|FG004|First Intervention (Period 1)|Adverse Event|0|||
164306567|NCT01263197|593496845|FG005|First Intervention (Period 1)|Adverse Event|1|||
164306568|NCT01263197|593496840|FG000|Washout Period 1|Protocol Violation|0|||
164306569|NCT01263197|593496841|FG001|Washout Period 1|Protocol Violation|0|||
164306570|NCT01263197|593496842|FG002|Washout Period 1|Protocol Violation|0|||
164306571|NCT01263197|593496843|FG003|Washout Period 1|Protocol Violation|0|||
164306572|NCT01263197|593496844|FG004|Washout Period 1|Protocol Violation|1|||
164306573|NCT01263197|593496845|FG005|Washout Period 1|Protocol Violation|0|||
164306574|NCT01263197|593496840|FG000|Washout Period 2|Physician Decision|0|||
164306575|NCT01263197|593496841|FG001|Washout Period 2|Physician Decision|0|||
164306576|NCT01263197|593496842|FG002|Washout Period 2|Physician Decision|0|||
164306577|NCT01263197|593496843|FG003|Washout Period 2|Physician Decision|0|||
164306578|NCT01263197|593496844|FG004|Washout Period 2|Physician Decision|0|||
164306579|NCT01263197|593496845|FG005|Washout Period 2|Physician Decision|1|||
164306580|NCT01263197|593496840|FG000|Washout Period 2|Protocol Violation|0|||
164306581|NCT01263197|593496841|FG001|Washout Period 2|Protocol Violation|0|||
164306582|NCT01263197|593496842|FG002|Washout Period 2|Protocol Violation|0|||
164306583|NCT01263197|593496843|FG003|Washout Period 2|Protocol Violation|1|||
164306584|NCT01263197|593496844|FG004|Washout Period 2|Protocol Violation|0|||
164306585|NCT01263197|593496845|FG005|Washout Period 2|Protocol Violation|0|||
164306586|NCT01263197|593496840|FG000|Third Intervention (Period 3)|Adverse Event|0|||
164306587|NCT01263197|593496841|FG001|Third Intervention (Period 3)|Adverse Event|1|||
164306588|NCT01263197|593496842|FG002|Third Intervention (Period 3)|Adverse Event|0|||
164306589|NCT01263197|593496843|FG003|Third Intervention (Period 3)|Adverse Event|0|||
164306590|NCT01263197|593496844|FG004|Third Intervention (Period 3)|Adverse Event|0|||
164306591|NCT01263197|593496845|FG005|Third Intervention (Period 3)|Adverse Event|0|||
164306592|NCT02577718|593496846|FG000|Overall Study|Death|6|||
164306593|NCT02577718|593496846|FG000|Overall Study|Withdrawal by Subject|2|||
164306594|NCT02194985|593496847|FG000|Overall Study|Adverse Event|1|||
164306595|NCT02194985|593496847|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
163845654|NCT04129580|591805712|FG000|Overall Study|Lost to Follow-up|14|||
163845655|NCT04129580|591805713|FG001|Overall Study|Lost to Follow-up|25|||
163845656|NCT03615482|591805714|FG000|Overall Study|Death|1|||
163845657|NCT03615482|591805715|FG001|Overall Study|Death|0|||
163845658|NCT03615482|591805714|FG000|Overall Study|Lost to Follow-up|7|||
163845659|NCT03615482|591805715|FG001|Overall Study|Lost to Follow-up|7|||
163845660|NCT03615482|591805714|FG000|Overall Study|Physician Decision|2|||
163845661|NCT03615482|591805715|FG001|Overall Study|Physician Decision|3|||
163845662|NCT03615482|591805714|FG000|Overall Study|Withdrawal by Subject|7|||
163845663|NCT03615482|591805715|FG001|Overall Study|Withdrawal by Subject|7|||
163845664|NCT00322868|591805716|FG000|Overall Study|disease progression|1|||
163845665|NCT01852162|591805718|FG000|Overall Study|Adverse Event|1|||
163845666|NCT01852162|591805719|FG001|Overall Study|Adverse Event|0|||
163845667|NCT01852162|591805718|FG000|Overall Study|Withdrawal by Subject|3|||
163845668|NCT01852162|591805719|FG001|Overall Study|Withdrawal by Subject|1|||
163845669|NCT01500226|591805722|FG000|Overall Study|Adverse Event|31|||
163845670|NCT01500226|591805723|FG001|Overall Study|Adverse Event|38|||
163845671|NCT01500226|591805722|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
163845672|NCT01500226|591805723|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
163845673|NCT01500226|591805722|FG000|Overall Study|Withdrawal by Subject|93|||
163845674|NCT01500226|591805723|FG001|Overall Study|Withdrawal by Subject|96|||
163845675|NCT01500226|591805722|FG000|Overall Study|Death|12|||
163845676|NCT01500226|591805723|FG001|Overall Study|Death|4|||
163845677|NCT01500226|591805722|FG000|Overall Study|Disease Progression|16|||
163845678|NCT01500226|591805723|FG001|Overall Study|Disease Progression|14|||
163845679|NCT01500226|591805722|FG000|Overall Study|Protocol Violation|53|||
163845680|NCT01500226|591805723|FG001|Overall Study|Protocol Violation|39|||
163845681|NCT01500226|591805722|FG000|Overall Study|Physician Decision|17|||
163845682|NCT01500226|591805723|FG001|Overall Study|Physician Decision|15|||
163845683|NCT01500226|591805722|FG000|Overall Study|Lack of Efficacy|14|||
163845684|NCT01500226|591805723|FG001|Overall Study|Lack of Efficacy|30|||
163845685|NCT01500226|591805722|FG000|Overall Study|Lost to Follow-up|9|||
163845686|NCT01500226|591805723|FG001|Overall Study|Lost to Follow-up|5|||
163845687|NCT01500226|591805722|FG000|Overall Study|Other Reasons|19|||
163845688|NCT01500226|591805723|FG001|Overall Study|Other Reasons|16|||
163845689|NCT02955277|591805724|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
163845690|NCT02955277|591805725|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
163845691|NCT02955277|591805724|FG000|Post to Follow-up|Lost to Follow-up|8|||
163845692|NCT02955277|591805725|FG001|Post to Follow-up|Lost to Follow-up|11|||
163845693|NCT04212169|591805728|FG000|Overall Study|Adverse Event|0|||
163845694|NCT04212169|591805729|FG001|Overall Study|Adverse Event|0|||
163845695|NCT04212169|591805730|FG002|Overall Study|Adverse Event|0|||
163845696|NCT04212169|591805731|FG003|Overall Study|Adverse Event|2|||
163845697|NCT04212169|591805728|FG000|Overall Study|Lost to Follow-up|1|||
163845698|NCT04212169|591805729|FG001|Overall Study|Lost to Follow-up|0|||
164306596|NCT02194985|593496847|FG000|Overall Study|Physician Decision|4|||
164306597|NCT02194985|593496847|FG000|Overall Study|Lost to Follow-up|1|||
164306598|NCT02194985|593496847|FG000|Overall Study|Withdrawal by Subject|2|||
164306599|NCT00346697|593496851|FG000|Overall Study|Lost to Follow-up|0|||
164306600|NCT00346697|593496852|FG001|Overall Study|Lost to Follow-up|1|||
164306601|NCT01012440|593496853|FG000|Overall Study|Withdrawal by Subject|2|||
164306602|NCT00594815|593496854|FG000|Overall Study|Never Treated|3|||
164306603|NCT00594815|593496854|FG000|Overall Study|Withdrawal by Subject|2|||
164306604|NCT00594815|593496854|FG000|Overall Study|Toxicity|4|||
164306605|NCT02557139|593496855|FG000|Overall Study|Significant liver elevation|1|||
164306606|NCT02557139|593496856|FG001|Overall Study|Significant liver elevation|0|||
164306607|NCT02557139|593496857|FG002|Overall Study|Significant liver elevation|1|||
164306608|NCT02557139|593496855|FG000|Overall Study|Withdrawal by Subject|1|||
164306609|NCT02557139|593496856|FG001|Overall Study|Withdrawal by Subject|0|||
164306610|NCT02557139|593496857|FG002|Overall Study|Withdrawal by Subject|0|||
164306611|NCT02557139|593496855|FG000|Overall Study|Illness of prohibited medication|0|||
164306612|NCT02557139|593496856|FG001|Overall Study|Illness of prohibited medication|0|||
164306613|NCT02557139|593496857|FG002|Overall Study|Illness of prohibited medication|1|||
164306614|NCT02284243|593496858|FG000|Overall Study|Lack of Efficacy|3|||
164306615|NCT02284243|593496859|FG001|Overall Study|Lack of Efficacy|3|||
164306616|NCT02284243|593496858|FG000|Overall Study|Adverse Event|1|||
164306617|NCT02284243|593496859|FG001|Overall Study|Adverse Event|0|||
164306618|NCT01932437|593496861|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306619|NCT01932437|593496862|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306620|NCT01932437|593496863|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306621|NCT01932437|593496864|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306622|NCT01932437|593496865|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
164306623|NCT01932437|593496866|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
164306624|NCT04269889|593496867|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
164306625|NCT00949702|593496872|FG000|Overall Study|Death|40|||
164306626|NCT00949702|593496872|FG000|Overall Study|Disease progression|7|||
164306627|NCT00949702|593496872|FG000|Overall Study|Withdrawal of consent|1|||
164306628|NCT01654302|593496873|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
164306629|NCT01654302|593496874|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
164306630|NCT02699749|593496877|FG000|Overall Study|Other|0|||
164306631|NCT02699749|593496878|FG001|Overall Study|Other|0|||
164306632|NCT02699749|593496879|FG002|Overall Study|Other|2|||
164306633|NCT02699749|593496880|FG003|Overall Study|Other|0|||
164306634|NCT02699749|593496881|FG004|Overall Study|Other|0|||
164306635|NCT02699749|593496882|FG005|Overall Study|Other|1|||
164306636|NCT02699749|593496883|FG006|Overall Study|Other|1|||
164306637|NCT02699749|593496884|FG007|Overall Study|Other|0|||
164306638|NCT02699749|593496885|FG008|Overall Study|Other|0|||
164306639|NCT02699749|593496886|FG009|Overall Study|Other|0|||
164306640|NCT02699749|593496887|FG010|Overall Study|Other|1|||
164306641|NCT02699749|593496888|FG011|Overall Study|Other|0|||
164306642|NCT02699749|593496889|FG012|Overall Study|Other|0|||
164306643|NCT02699749|593496890|FG013|Overall Study|Other|0|||
164306644|NCT02699749|593496877|FG000|Overall Study|Progressive Disease|3|||
164306645|NCT02699749|593496878|FG001|Overall Study|Progressive Disease|3|||
164306646|NCT02699749|593496879|FG002|Overall Study|Progressive Disease|14|||
164306647|NCT02699749|593496880|FG003|Overall Study|Progressive Disease|3|||
164306648|NCT02699749|593496881|FG004|Overall Study|Progressive Disease|3|||
163845699|NCT04212169|591805730|FG002|Overall Study|Lost to Follow-up|0|||
163845700|NCT04212169|591805731|FG003|Overall Study|Lost to Follow-up|2|||
163845701|NCT04212169|591805728|FG000|Overall Study|Withdrawal by Subject|10|||
163845702|NCT04212169|591805729|FG001|Overall Study|Withdrawal by Subject|2|||
163845703|NCT04212169|591805730|FG002|Overall Study|Withdrawal by Subject|5|||
163845704|NCT04212169|591805731|FG003|Overall Study|Withdrawal by Subject|7|||
163845705|NCT04212169|591805728|FG000|Overall Study|Other reason, unspecified|3|||
163845706|NCT04212169|591805729|FG001|Overall Study|Other reason, unspecified|1|||
163845707|NCT04212169|591805730|FG002|Overall Study|Other reason, unspecified|0|||
163845708|NCT04212169|591805731|FG003|Overall Study|Other reason, unspecified|2|||
163845709|NCT02176928|591805732|FG000|Overall Study|Lost to Follow-up|2|||
163845710|NCT02176928|591805733|FG001|Overall Study|Lost to Follow-up|4|||
163845711|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163845712|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
163845713|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
163845714|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
163845715|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
163845716|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
163845717|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163845718|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163845719|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163845720|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
163845721|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845722|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845723|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845724|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
163845725|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
163845726|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845727|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845728|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845729|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845730|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
163845731|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163845732|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
163845733|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
163845734|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
163845735|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
163845736|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
163845737|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163845738|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163845739|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
164306649|NCT02699749|593496882|FG005|Overall Study|Progressive Disease|7|||
164306650|NCT02699749|593496883|FG006|Overall Study|Progressive Disease|5|||
164306651|NCT02699749|593496884|FG007|Overall Study|Progressive Disease|5|||
164306652|NCT02699749|593496885|FG008|Overall Study|Progressive Disease|6|||
164306653|NCT02699749|593496886|FG009|Overall Study|Progressive Disease|6|||
164306654|NCT02699749|593496887|FG010|Overall Study|Progressive Disease|5|||
164306655|NCT02699749|593496888|FG011|Overall Study|Progressive Disease|4|||
164306656|NCT02699749|593496889|FG012|Overall Study|Progressive Disease|3|||
164306657|NCT02699749|593496890|FG013|Overall Study|Progressive Disease|5|||
164306658|NCT02699749|593496877|FG000|Overall Study|Death|0|||
164306659|NCT02699749|593496878|FG001|Overall Study|Death|0|||
164306660|NCT02699749|593496879|FG002|Overall Study|Death|0|||
164306661|NCT02699749|593496880|FG003|Overall Study|Death|0|||
164306662|NCT02699749|593496881|FG004|Overall Study|Death|0|||
164306663|NCT02699749|593496882|FG005|Overall Study|Death|0|||
164306664|NCT02699749|593496883|FG006|Overall Study|Death|0|||
164306665|NCT02699749|593496884|FG007|Overall Study|Death|0|||
164306666|NCT02699749|593496885|FG008|Overall Study|Death|0|||
164306667|NCT02699749|593496886|FG009|Overall Study|Death|0|||
164306668|NCT02699749|593496887|FG010|Overall Study|Death|0|||
164306669|NCT02699749|593496888|FG011|Overall Study|Death|0|||
163845740|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
163845741|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
164306670|NCT02699749|593496889|FG012|Overall Study|Death|0|||
163845742|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
164306671|NCT02699749|593496890|FG013|Overall Study|Death|1|||
164306672|NCT02699749|593496877|FG000|Overall Study|Lost to Follow-up|0|||
164306673|NCT02699749|593496878|FG001|Overall Study|Lost to Follow-up|0|||
164306674|NCT02699749|593496879|FG002|Overall Study|Lost to Follow-up|0|||
164306675|NCT02699749|593496880|FG003|Overall Study|Lost to Follow-up|0|||
164306676|NCT02699749|593496881|FG004|Overall Study|Lost to Follow-up|0|||
164306677|NCT02699749|593496882|FG005|Overall Study|Lost to Follow-up|1|||
164306678|NCT02699749|593496883|FG006|Overall Study|Lost to Follow-up|0|||
164306679|NCT02699749|593496884|FG007|Overall Study|Lost to Follow-up|1|||
164306680|NCT02699749|593496885|FG008|Overall Study|Lost to Follow-up|0|||
164306681|NCT02699749|593496886|FG009|Overall Study|Lost to Follow-up|0|||
164306682|NCT02699749|593496887|FG010|Overall Study|Lost to Follow-up|0|||
164306683|NCT02699749|593496888|FG011|Overall Study|Lost to Follow-up|0|||
164306684|NCT02699749|593496889|FG012|Overall Study|Lost to Follow-up|0|||
164306685|NCT02699749|593496890|FG013|Overall Study|Lost to Follow-up|0|||
164306686|NCT02377817|593496892|FG000|Overall Study|Transportation/childcare barriers.|2|||
164306687|NCT02377817|593496893|FG001|Overall Study|Transportation/childcare barriers.|0|||
164306688|NCT02377817|593496892|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
164306689|NCT02377817|593496893|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
164306690|NCT04139018|593496894|FG000|Overall Study|Screen fail|1|||
164306691|NCT04139018|593496895|FG001|Overall Study|Screen fail|0|||
164306692|NCT04139018|593496894|FG000|Overall Study|Withdrawal by Subject|2|||
164306693|NCT04139018|593496895|FG001|Overall Study|Withdrawal by Subject|0|||
164306694|NCT04139018|593496894|FG000|Overall Study|Lost to Follow-up|0|||
164306695|NCT04139018|593496895|FG001|Overall Study|Lost to Follow-up|1|||
164306696|NCT03614156|593496912|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
164306697|NCT03614156|593496913|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
164306698|NCT03614156|593496914|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
164306699|NCT03614156|593496915|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
164306700|NCT03614156|593496912|FG000|Open-Label Treatment Period|Adverse Event|7|||
164306701|NCT03614156|593496913|FG001|Open-Label Treatment Period|Adverse Event|0|||
164306702|NCT03614156|593496914|FG002|Open-Label Treatment Period|Adverse Event|0|||
164306703|NCT03614156|593496915|FG003|Open-Label Treatment Period|Adverse Event|0|||
164306704|NCT03614156|593496912|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
164306705|NCT03614156|593496913|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164306706|NCT03614156|593496914|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164306707|NCT03614156|593496915|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
164306708|NCT03614156|593496912|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
164306709|NCT03614156|593496913|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
164306710|NCT03614156|593496914|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
164306711|NCT03614156|593496915|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
164306712|NCT03614156|593496912|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
164306713|NCT03614156|593496913|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
164306714|NCT03614156|593496914|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
164306715|NCT03614156|593496915|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
164306716|NCT03614156|593496912|FG000|Open-Label Treatment Period|Protocol Violation|2|||
164306717|NCT03614156|593496913|FG001|Open-Label Treatment Period|Protocol Violation|0|||
164306718|NCT03614156|593496914|FG002|Open-Label Treatment Period|Protocol Violation|0|||
164306719|NCT03614156|593496915|FG003|Open-Label Treatment Period|Protocol Violation|0|||
164306720|NCT03614156|593496912|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
164306721|NCT03614156|593496913|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
164306722|NCT03614156|593496914|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
164306723|NCT03614156|593496915|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
164306724|NCT03614156|593496912|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
164306725|NCT03614156|593496913|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
164306726|NCT03614156|593496914|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
164306727|NCT03614156|593496915|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
164306728|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
164306729|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
164306730|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
164306731|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
164306732|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164306733|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
164306734|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164306735|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164306736|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164306737|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163845743|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163845744|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
163845745|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
163845746|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163845747|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163845748|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163959603|NCT03226392|592224046|FG001|Overall Study|Subject/Guardian Decision|6|||
164306738|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
164306739|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
164306740|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
164306741|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
164306742|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
164306743|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
164306744|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
164306745|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
164306746|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
164306747|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
164306748|NCT03614156|593496912|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
164306749|NCT03614156|593496913|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
164306750|NCT03614156|593496914|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
164306751|NCT03614156|593496915|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
164306752|NCT03614156|593496912|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
164306753|NCT03614156|593496913|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
164306754|NCT03614156|593496914|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
164306755|NCT03614156|593496915|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
164306756|NCT03614156|593496912|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
164306757|NCT03614156|593496913|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
164306758|NCT03614156|593496914|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
164306759|NCT03614156|593496915|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
164306760|NCT03614156|593496912|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
164306761|NCT03614156|593496913|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
164306762|NCT03614156|593496914|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
164306763|NCT03614156|593496915|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
164306764|NCT01094119|593496916|FG000|Overall Study|Lack of Efficacy|2|||
164306765|NCT01094119|593496917|FG001|Overall Study|Lack of Efficacy|4|||
164306766|NCT01106248|593496920|FG000|Overall Study|Adverse Event|1|||
164306767|NCT01106248|593496920|FG000|Overall Study|Administrative|2|||
164306768|NCT00357903|593496921|FG000|Overall Study|Adverse Event|87|||
164306769|NCT00357903|593496922|FG001|Overall Study|Adverse Event|4|||
164306770|NCT00357903|593496921|FG000|Overall Study|Death|33|||
164306771|NCT00357903|593496922|FG001|Overall Study|Death|0|||
164306772|NCT00357903|593496921|FG000|Overall Study|Lost to Follow-up|23|||
164306773|NCT00357903|593496922|FG001|Overall Study|Lost to Follow-up|4|||
164306774|NCT00357903|593496921|FG000|Overall Study|Physician Decision|39|||
164306775|NCT00357903|593496922|FG001|Overall Study|Physician Decision|5|||
164306776|NCT00357903|593496921|FG000|Overall Study|Withdrawal by Subject|57|||
164306777|NCT00357903|593496922|FG001|Overall Study|Withdrawal by Subject|7|||
164306778|NCT00357903|593496921|FG000|Overall Study|Completed month 12 only|0|||
164306779|NCT00357903|593496922|FG001|Overall Study|Completed month 12 only|1|||
164306780|NCT00357903|593496921|FG000|Overall Study|Protocol issues|14|||
164306781|NCT00357903|593496922|FG001|Overall Study|Protocol issues|3|||
164306782|NCT00357903|593496921|FG000|Overall Study|Response status|61|||
164306783|NCT00357903|593496922|FG001|Overall Study|Response status|9|||
164306784|NCT00357903|593496921|FG000|Overall Study|Other|49|||
164306785|NCT00357903|593496922|FG001|Overall Study|Other|10|||
164306786|NCT00606593|593496923|FG000|Overall Study|Adverse Event|0|||
164306787|NCT00606593|593496924|FG001|Overall Study|Adverse Event|0|||
164306788|NCT00606593|593496925|FG002|Overall Study|Adverse Event|0|||
164306789|NCT00606593|593496926|FG003|Overall Study|Adverse Event|1|||
164306790|NCT00606593|593496927|FG004|Overall Study|Adverse Event|1|||
164306791|NCT00606593|593496928|FG005|Overall Study|Adverse Event|0|||
164306792|NCT00606593|593496929|FG006|Overall Study|Adverse Event|1|||
164306793|NCT00606593|593496930|FG007|Overall Study|Adverse Event|2|||
164306794|NCT00606593|593496931|FG008|Overall Study|Adverse Event|1|||
164306795|NCT00606593|593496932|FG009|Overall Study|Adverse Event|0|||
164306796|NCT00606593|593496923|FG000|Overall Study|Withdrawal of consent|1|||
164306797|NCT00606593|593496924|FG001|Overall Study|Withdrawal of consent|0|||
164306798|NCT00606593|593496925|FG002|Overall Study|Withdrawal of consent|1|||
164306799|NCT00606593|593496926|FG003|Overall Study|Withdrawal of consent|0|||
164306800|NCT00606593|593496927|FG004|Overall Study|Withdrawal of consent|0|||
164306801|NCT00606593|593496928|FG005|Overall Study|Withdrawal of consent|0|||
164306802|NCT00606593|593496929|FG006|Overall Study|Withdrawal of consent|0|||
164306803|NCT00606593|593496930|FG007|Overall Study|Withdrawal of consent|0|||
164306804|NCT00606593|593496931|FG008|Overall Study|Withdrawal of consent|0|||
164306805|NCT00606593|593496932|FG009|Overall Study|Withdrawal of consent|0|||
164306806|NCT00606593|593496923|FG000|Overall Study|Administrative/Other|0|||
164306807|NCT00606593|593496924|FG001|Overall Study|Administrative/Other|0|||
164306808|NCT00606593|593496925|FG002|Overall Study|Administrative/Other|1|||
164306809|NCT00606593|593496926|FG003|Overall Study|Administrative/Other|0|||
163959604|NCT03056755|592224047|FG000|Core Phase|Progressive disease|89|||
164306810|NCT00606593|593496927|FG004|Overall Study|Administrative/Other|0|||
164306811|NCT00606593|593496928|FG005|Overall Study|Administrative/Other|0|||
164306812|NCT00606593|593496929|FG006|Overall Study|Administrative/Other|0|||
164306813|NCT00606593|593496930|FG007|Overall Study|Administrative/Other|0|||
164306814|NCT00606593|593496931|FG008|Overall Study|Administrative/Other|0|||
163845749|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163845750|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
163845751|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845752|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845753|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
164306815|NCT00606593|593496932|FG009|Overall Study|Administrative/Other|0|||
164306816|NCT01160822|593496933|FG000|Overall Study|Adverse Event|0|||
164306817|NCT01160822|593496934|FG001|Overall Study|Adverse Event|0|||
164306818|NCT01160822|593496935|FG002|Overall Study|Adverse Event|0|||
164306819|NCT01160822|593496936|FG003|Overall Study|Adverse Event|0|||
164306820|NCT01160822|593496937|FG004|Overall Study|Adverse Event|1|||
164306821|NCT01160822|593496938|FG005|Overall Study|Adverse Event|2|||
164306822|NCT01160822|593496939|FG006|Overall Study|Adverse Event|5|||
164306823|NCT01160822|593496933|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164306824|NCT01160822|593496934|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164306825|NCT01160822|593496935|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164306826|NCT01160822|593496936|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164306827|NCT01160822|593496937|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
164306828|NCT01160822|593496938|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
164306829|NCT01160822|593496939|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
164306830|NCT01160822|593496933|FG000|Overall Study|Withdrawal by Subject|0|||
164306831|NCT01160822|593496934|FG001|Overall Study|Withdrawal by Subject|0|||
164306832|NCT01160822|593496935|FG002|Overall Study|Withdrawal by Subject|0|||
164306833|NCT01160822|593496936|FG003|Overall Study|Withdrawal by Subject|0|||
164306834|NCT01160822|593496937|FG004|Overall Study|Withdrawal by Subject|0|||
164306835|NCT01160822|593496938|FG005|Overall Study|Withdrawal by Subject|0|||
164306836|NCT01160822|593496939|FG006|Overall Study|Withdrawal by Subject|1|||
164306837|NCT01160822|593496933|FG000|Overall Study|Lost to Follow-up|0|||
164306838|NCT01160822|593496934|FG001|Overall Study|Lost to Follow-up|0|||
164306839|NCT01160822|593496935|FG002|Overall Study|Lost to Follow-up|0|||
164306840|NCT01160822|593496936|FG003|Overall Study|Lost to Follow-up|0|||
164306841|NCT01160822|593496937|FG004|Overall Study|Lost to Follow-up|1|||
164306842|NCT01160822|593496938|FG005|Overall Study|Lost to Follow-up|0|||
164306843|NCT01160822|593496939|FG006|Overall Study|Lost to Follow-up|0|||
164306844|NCT01160822|593496933|FG000|Overall Study|Administrative problems|0|||
164306845|NCT01160822|593496934|FG001|Overall Study|Administrative problems|0|||
164306846|NCT01160822|593496935|FG002|Overall Study|Administrative problems|0|||
164306847|NCT01160822|593496936|FG003|Overall Study|Administrative problems|0|||
164306848|NCT01160822|593496937|FG004|Overall Study|Administrative problems|1|||
164306849|NCT01160822|593496938|FG005|Overall Study|Administrative problems|0|||
164306850|NCT01160822|593496939|FG006|Overall Study|Administrative problems|0|||
164306851|NCT01160822|593496933|FG000|Overall Study|Protocol deviation|0|||
164306852|NCT01160822|593496934|FG001|Overall Study|Protocol deviation|0|||
164306853|NCT01160822|593496935|FG002|Overall Study|Protocol deviation|0|||
164306854|NCT01160822|593496936|FG003|Overall Study|Protocol deviation|0|||
164306855|NCT01160822|593496937|FG004|Overall Study|Protocol deviation|2|||
164306856|NCT01160822|593496938|FG005|Overall Study|Protocol deviation|0|||
164306857|NCT01160822|593496939|FG006|Overall Study|Protocol deviation|0|||
164306858|NCT00759941|593496947|FG000|Overall Study|Use of medication|1|||
164306859|NCT00759941|593496948|FG001|Overall Study|Use of medication|0|||
164306860|NCT00759941|593496947|FG000|Overall Study|Adverse Event|1|||
164306861|NCT00759941|593496948|FG001|Overall Study|Adverse Event|0|||
164306862|NCT00759941|593496947|FG000|Overall Study|Exited in error by site|1|||
164306863|NCT00759941|593496948|FG001|Overall Study|Exited in error by site|1|||
164306864|NCT00354432|593496949|FG000|Overall Study|Adverse Event|3|||
164306865|NCT00354432|593496950|FG001|Overall Study|Adverse Event|1|||
164306866|NCT00354432|593496951|FG002|Overall Study|Adverse Event|5|||
164306867|NCT00354432|593496952|FG003|Overall Study|Adverse Event|5|||
164306868|NCT00354432|593496949|FG000|Overall Study|Off/Toxicity|3|||
164306869|NCT00354432|593496950|FG001|Overall Study|Off/Toxicity|7|||
164306870|NCT00354432|593496951|FG002|Overall Study|Off/Toxicity|5|||
164306871|NCT00354432|593496952|FG003|Overall Study|Off/Toxicity|5|||
164306872|NCT03863080|593496953|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
164306873|NCT03863080|593496954|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
164306874|NCT03863080|593496955|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
164306875|NCT03863080|593496956|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
164306876|NCT03863080|593496953|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
164306877|NCT03863080|593496954|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
164306878|NCT03863080|593496955|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
164306879|NCT03863080|593496956|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
164306880|NCT03863080|593496953|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
164306881|NCT03863080|593496954|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
164306882|NCT03863080|593496955|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
164306883|NCT03863080|593496956|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
163845754|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
163845755|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845756|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845757|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845758|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845759|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845760|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
163845761|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845762|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845763|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845764|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845765|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
163845766|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845767|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845768|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845769|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845770|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
163845771|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845772|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845773|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845774|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
163845775|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
163845776|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
163845777|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845778|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845779|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845780|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
163845781|NCT02018861|591805741|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845782|NCT02018861|591805742|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845783|NCT02018861|591805743|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845784|NCT02018861|591805744|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
163845785|NCT02018861|591805745|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
163845786|NCT02018861|591805746|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845787|NCT02018861|591805747|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845788|NCT02018861|591805748|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845789|NCT02018861|591805749|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845790|NCT02018861|591805750|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
163845791|NCT02018861|591805741|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845792|NCT02018861|591805742|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845793|NCT02018861|591805743|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845794|NCT02018861|591805744|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845795|NCT02018861|591805745|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845796|NCT02018861|591805746|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845797|NCT02018861|591805747|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
163845798|NCT02018861|591805748|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
163845799|NCT02018861|591805749|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845800|NCT02018861|591805750|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
163845801|NCT02018861|591805741|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845802|NCT02018861|591805742|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845803|NCT02018861|591805743|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845804|NCT02018861|591805744|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845805|NCT02018861|591805745|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845806|NCT02018861|591805746|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845807|NCT02018861|591805747|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
163845808|NCT02018861|591805748|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
163845809|NCT02018861|591805749|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845810|NCT02018861|591805750|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
163845811|NCT02018861|591805741|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845812|NCT02018861|591805742|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845813|NCT02018861|591805743|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163959605|NCT03056755|592224048|FG001|Core Phase|Progressive disease|88|||
163959606|NCT03056755|592224049|FG002|Core Phase|Progressive disease|90|||
163845814|NCT02018861|591805744|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845815|NCT02018861|591805745|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845816|NCT02018861|591805746|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845817|NCT02018861|591805747|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845818|NCT02018861|591805748|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845819|NCT02018861|591805749|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
163845820|NCT02018861|591805750|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
163845821|NCT02018861|591805741|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845822|NCT02018861|591805742|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845823|NCT02018861|591805743|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845824|NCT02018861|591805744|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845825|NCT02018861|591805745|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845826|NCT02018861|591805746|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845827|NCT02018861|591805747|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845828|NCT02018861|591805748|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845829|NCT02018861|591805749|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
163845830|NCT02018861|591805750|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
163845831|NCT02018861|591805741|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845832|NCT02018861|591805742|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845833|NCT02018861|591805743|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845834|NCT02018861|591805744|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845835|NCT02018861|591805745|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845836|NCT02018861|591805746|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845837|NCT02018861|591805747|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845838|NCT02018861|591805748|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845839|NCT02018861|591805749|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
163845840|NCT02018861|591805750|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
163845841|NCT01642186|591805751|FG000|Overall Study|Death|0|||
163845842|NCT01642186|591805752|FG001|Overall Study|Death|2|||
163845843|NCT01642186|591805753|FG002|Overall Study|Death|2|||
163845844|NCT01642186|591805751|FG000|Overall Study|Lost to Follow-up|0|||
163845845|NCT01642186|591805752|FG001|Overall Study|Lost to Follow-up|0|||
163845846|NCT01642186|591805753|FG002|Overall Study|Lost to Follow-up|1|||
163845847|NCT00163215|591805754|FG000|Overall Study|Lack of Efficacy|3|||
163845848|NCT00163215|591805754|FG000|Overall Study|Withdrawal by Subject|5|||
163845849|NCT00163215|591805754|FG000|Overall Study|Other|7|||
163845850|NCT00590980|591805757|FG000|Overall Study|Did not meet all inclusion criteria|10|||
163845851|NCT00504348|591805758|FG000|Overall Study|Adverse Event|3|||
163845852|NCT00504348|591805758|FG000|Overall Study|Lack of Efficacy|4|||
163845853|NCT00504348|591805758|FG000|Overall Study|Physician Decision|1|||
163845854|NCT01023308|591805760|FG000|Overall Study|Abnormal test proceedure results|3|||
163845855|NCT01023308|591805761|FG001|Overall Study|Abnormal test proceedure results|8|||
163845856|NCT01023308|591805760|FG000|Overall Study|Administrative problems|2|||
163845857|NCT01023308|591805761|FG001|Overall Study|Administrative problems|1|||
163845858|NCT01023308|591805760|FG000|Overall Study|Adverse Event|130|||
163845859|NCT01023308|591805761|FG001|Overall Study|Adverse Event|66|||
163845860|NCT01023308|591805760|FG000|Overall Study|Death|21|||
163845861|NCT01023308|591805761|FG001|Overall Study|Death|17|||
163845862|NCT01023308|591805760|FG000|Overall Study|Disease progression|82|||
163845863|NCT01023308|591805761|FG001|Overall Study|Disease progression|153|||
163845864|NCT01023308|591805760|FG000|Overall Study|New Cancer therapy|4|||
163845865|NCT01023308|591805761|FG001|Overall Study|New Cancer therapy|7|||
163845866|NCT01023308|591805760|FG000|Overall Study|Protocol Violation|3|||
163845867|NCT01023308|591805761|FG001|Overall Study|Protocol Violation|4|||
163845868|NCT01023308|591805760|FG000|Overall Study|Untreated|5|||
163845869|NCT01023308|591805761|FG001|Overall Study|Untreated|5|||
163845870|NCT01023308|591805760|FG000|Overall Study|Lost to Follow-up|1|||
163845871|NCT01023308|591805761|FG001|Overall Study|Lost to Follow-up|0|||
163845872|NCT01023308|591805760|FG000|Overall Study|Withdrawal by Subject|34|||
163845873|NCT01023308|591805761|FG001|Overall Study|Withdrawal by Subject|18|||
163845874|NCT01646320|591805762|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
163845875|NCT01646320|591805763|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
163845876|NCT01646320|591805762|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
163845877|NCT01646320|591805763|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
163845878|NCT01646320|591805762|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
163845879|NCT01646320|591805763|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
163845880|NCT01646320|591805762|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
163845881|NCT01646320|591805763|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
163845882|NCT01646320|591805762|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
163845883|NCT01646320|591805763|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
163845884|NCT01646320|591805762|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
163845885|NCT01646320|591805763|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
163845886|NCT01646320|591805762|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
163845887|NCT01646320|591805763|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
163845888|NCT01646320|591805762|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
163845889|NCT01646320|591805763|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
163845890|NCT01646320|591805762|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
163845891|NCT01646320|591805763|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
163845892|NCT01646320|591805762|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
163845893|NCT01646320|591805763|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
163845894|NCT01646320|591805762|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
163845895|NCT01646320|591805763|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
163845896|NCT02451930|591805766|FG000|Overall Study|Death|0|||
163845897|NCT02451930|591805767|FG001|Overall Study|Death|15|||
163845898|NCT02451930|591805766|FG000|Overall Study|Lost to Follow-up|0|||
163845899|NCT02451930|591805767|FG001|Overall Study|Lost to Follow-up|3|||
163845900|NCT02451930|591805766|FG000|Overall Study|Sponsor Decision|2|||
163845901|NCT02451930|591805767|FG001|Overall Study|Sponsor Decision|10|||
163845902|NCT02451930|591805766|FG000|Overall Study|Withdrawal by Subject|0|||
163845903|NCT02451930|591805767|FG001|Overall Study|Withdrawal by Subject|1|||
163845904|NCT02451930|591805766|FG000|Overall Study|Other|0|||
163845905|NCT02451930|591805767|FG001|Overall Study|Other|1|||
163845906|NCT00962585|591805768|FG000|Overall Study|Adverse Event|0|||
163845907|NCT00962585|591805769|FG001|Overall Study|Adverse Event|2|||
163845908|NCT00962585|591805770|FG002|Overall Study|Adverse Event|1|||
163845909|NCT00962585|591805771|FG003|Overall Study|Adverse Event|0|||
163845910|NCT00962585|591805768|FG000|Overall Study|Lost to Follow-up|3|||
163845911|NCT00962585|591805769|FG001|Overall Study|Lost to Follow-up|0|||
163845912|NCT00962585|591805770|FG002|Overall Study|Lost to Follow-up|1|||
163845913|NCT00962585|591805771|FG003|Overall Study|Lost to Follow-up|0|||
163845914|NCT00962585|591805768|FG000|Overall Study|Protocol Violation|0|||
163845915|NCT00962585|591805769|FG001|Overall Study|Protocol Violation|0|||
163845916|NCT00962585|591805770|FG002|Overall Study|Protocol Violation|1|||
163845917|NCT00962585|591805771|FG003|Overall Study|Protocol Violation|0|||
163845918|NCT00962585|591805768|FG000|Overall Study|Withdrawal by Subject|1|||
163845919|NCT00962585|591805769|FG001|Overall Study|Withdrawal by Subject|0|||
163845920|NCT00962585|591805770|FG002|Overall Study|Withdrawal by Subject|0|||
163845921|NCT00962585|591805771|FG003|Overall Study|Withdrawal by Subject|0|||
163845922|NCT00962585|591805768|FG000|Overall Study|Withdrew Consent|2|||
163845923|NCT00962585|591805769|FG001|Overall Study|Withdrew Consent|0|||
163845924|NCT00962585|591805770|FG002|Overall Study|Withdrew Consent|0|||
163845925|NCT00962585|591805771|FG003|Overall Study|Withdrew Consent|0|||
163845926|NCT02254421|591805774|FG000|Overall Study|Randomized but Not Treated|1|||
163845927|NCT02254421|591805775|FG001|Overall Study|Randomized but Not Treated|0|||
163845928|NCT02254421|591805774|FG000|Overall Study|Death|0|||
163845929|NCT02254421|591805775|FG001|Overall Study|Death|2|||
163845930|NCT02254421|591805774|FG000|Overall Study|Withdrew Consent|1|||
163845931|NCT02254421|591805775|FG001|Overall Study|Withdrew Consent|1|||
163845932|NCT03249376|591805789|FG000|Overall Study|Adverse Event|11|||
163845933|NCT03249376|591805790|FG001|Overall Study|Adverse Event|5|||
163845934|NCT03249376|591805789|FG000|Overall Study|Lack of Efficacy|2|||
163845935|NCT03249376|591805790|FG001|Overall Study|Lack of Efficacy|4|||
163845936|NCT03249376|591805789|FG000|Overall Study|Protocol Violation|3|||
163845937|NCT03249376|591805790|FG001|Overall Study|Protocol Violation|2|||
163845938|NCT03249376|591805789|FG000|Overall Study|Physician Decision|0|||
163845939|NCT03249376|591805790|FG001|Overall Study|Physician Decision|2|||
163845940|NCT03249376|591805789|FG000|Overall Study|Withdrawal by Subject|3|||
163845941|NCT03249376|591805790|FG001|Overall Study|Withdrawal by Subject|9|||
163845942|NCT03249376|591805789|FG000|Overall Study|LTFU|2|||
163845943|NCT03249376|591805790|FG001|Overall Study|LTFU|1|||
163845944|NCT00627042|591805794|FG000|Overall Study|Withdrawal by Subject|2|||
163845945|NCT00794820|591805799|FG000|Overall Study|Adverse Event|11|||
163845946|NCT00794820|591805799|FG000|Overall Study|Secondary Malignancies|2|||
163845947|NCT00794820|591805799|FG000|Overall Study|Resistant Disease|2|||
163845948|NCT00794820|591805799|FG000|Overall Study|Ineligible/Screen Failure|1|||
163845949|NCT00432679|591805803|FG000|Overall Study|Adverse Event|2|||
163845950|NCT00432679|591805804|FG001|Overall Study|Adverse Event|1|||
163845951|NCT00432679|591805803|FG000|Overall Study|Withdrawal by Subject|3|||
163845952|NCT00432679|591805804|FG001|Overall Study|Withdrawal by Subject|2|||
163845953|NCT03405662|591805806|FG000|Overall Study|COVID-19 restriction|1|||
163845954|NCT03405662|591805807|FG001|Overall Study|COVID-19 restriction|0|||
163845955|NCT03405662|591805806|FG000|Overall Study|unblinding|0|||
163845956|NCT03405662|591805807|FG001|Overall Study|unblinding|1|||
163845957|NCT03405662|591805806|FG000|Overall Study|placement in memory care facility|0|||
163845958|NCT03405662|591805807|FG001|Overall Study|placement in memory care facility|2|||
163845959|NCT00280293|591805808|FG000|Overall Study|Protocol Violation|3|||
163845960|NCT00280293|591805809|FG001|Overall Study|Protocol Violation|0|||
163845961|NCT00280293|591805808|FG000|Overall Study|Physician Decision|5|||
163845962|NCT00280293|591805809|FG001|Overall Study|Physician Decision|4|||
163845963|NCT00280293|591805808|FG000|Overall Study|Lost to Follow-up|14|||
163845964|NCT00280293|591805809|FG001|Overall Study|Lost to Follow-up|12|||
163845965|NCT00280293|591805808|FG000|Overall Study|Withdrawal by Subject|3|||
163845966|NCT00280293|591805809|FG001|Overall Study|Withdrawal by Subject|5|||
163845967|NCT00280293|591805808|FG000|Overall Study|Incarceration/Legal Reasons|1|||
163845968|NCT00280293|591805809|FG001|Overall Study|Incarceration/Legal Reasons|1|||
163845969|NCT00280293|591805808|FG000|Overall Study|Adverse Event|0|||
163845970|NCT00280293|591805809|FG001|Overall Study|Adverse Event|1|||
163845971|NCT01177813|591805810|FG000|Overall Study|Adverse Event|8|||
163845972|NCT01177813|591805811|FG001|Overall Study|Adverse Event|2|||
163845973|NCT01177813|591805812|FG002|Overall Study|Adverse Event|4|||
163845974|NCT01177813|591805813|FG003|Overall Study|Adverse Event|6|||
163845975|NCT01177813|591805814|FG004|Overall Study|Adverse Event|3|||
163845976|NCT01177813|591805810|FG000|Overall Study|Lack of Efficacy|1|||
163845977|NCT01177813|591805811|FG001|Overall Study|Lack of Efficacy|0|||
163845978|NCT01177813|591805812|FG002|Overall Study|Lack of Efficacy|0|||
163845979|NCT01177813|591805813|FG003|Overall Study|Lack of Efficacy|0|||
163845980|NCT01177813|591805814|FG004|Overall Study|Lack of Efficacy|0|||
163845981|NCT01177813|591805810|FG000|Overall Study|Protocol Violation|3|||
163845982|NCT01177813|591805811|FG001|Overall Study|Protocol Violation|2|||
163845983|NCT01177813|591805812|FG002|Overall Study|Protocol Violation|2|||
163845984|NCT01177813|591805813|FG003|Overall Study|Protocol Violation|0|||
163845985|NCT01177813|591805814|FG004|Overall Study|Protocol Violation|1|||
163845986|NCT01177813|591805810|FG000|Overall Study|Lost to Follow-up|12|||
163845987|NCT01177813|591805811|FG001|Overall Study|Lost to Follow-up|5|||
163845988|NCT01177813|591805812|FG002|Overall Study|Lost to Follow-up|6|||
163845989|NCT01177813|591805813|FG003|Overall Study|Lost to Follow-up|3|||
163845990|NCT01177813|591805814|FG004|Overall Study|Lost to Follow-up|0|||
163845991|NCT01177813|591805810|FG000|Overall Study|Withdrawal by Subject|12|||
163845992|NCT01177813|591805811|FG001|Overall Study|Withdrawal by Subject|7|||
163845993|NCT01177813|591805812|FG002|Overall Study|Withdrawal by Subject|6|||
163845994|NCT01177813|591805813|FG003|Overall Study|Withdrawal by Subject|5|||
163845995|NCT01177813|591805814|FG004|Overall Study|Withdrawal by Subject|3|||
163845996|NCT01177813|591805810|FG000|Overall Study|Other reason not defined above|5|||
163845997|NCT01177813|591805811|FG001|Overall Study|Other reason not defined above|2|||
163845998|NCT01177813|591805812|FG002|Overall Study|Other reason not defined above|2|||
163845999|NCT01177813|591805813|FG003|Overall Study|Other reason not defined above|3|||
163846000|NCT01177813|591805814|FG004|Overall Study|Other reason not defined above|2|||
163846001|NCT03220737|591805817|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
163846002|NCT03220737|591805818|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
163846003|NCT03220737|591805819|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
163846004|NCT03220737|591805820|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
163846005|NCT03220737|591805821|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
163846006|NCT03220737|591805822|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
163846007|NCT03220737|591805823|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
163846008|NCT03220737|591805817|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
163846009|NCT03220737|591805818|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
163846010|NCT03220737|591805819|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
163846011|NCT03220737|591805820|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
163846012|NCT03220737|591805821|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
163846013|NCT03220737|591805822|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
163846014|NCT03220737|591805823|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
163846015|NCT03220737|591805817|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
163846016|NCT03220737|591805818|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
163846017|NCT03220737|591805819|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
163846018|NCT03220737|591805820|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
163846019|NCT03220737|591805821|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
163846020|NCT03220737|591805822|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
163846021|NCT03220737|591805823|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
163846022|NCT03220737|591805817|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163846023|NCT03220737|591805818|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163846024|NCT03220737|591805819|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
163846025|NCT03220737|591805820|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163846026|NCT03220737|591805821|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163846027|NCT03220737|591805822|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163846028|NCT03220737|591805823|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
163846029|NCT03220737|591805817|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163846030|NCT03220737|591805818|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163846031|NCT03220737|591805819|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163846032|NCT03220737|591805820|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163846033|NCT03220737|591805821|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
163846034|NCT03220737|591805822|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163846035|NCT03220737|591805823|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
163846036|NCT03220737|591805817|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
163846037|NCT03220737|591805818|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163846038|NCT03220737|591805819|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163846039|NCT03220737|591805820|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163846040|NCT03220737|591805821|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163846041|NCT03220737|591805822|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163846042|NCT03220737|591805823|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
163846043|NCT03220737|591805817|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
163846044|NCT03220737|591805818|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163846045|NCT03220737|591805819|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163846046|NCT03220737|591805820|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163846047|NCT03220737|591805821|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163846048|NCT03220737|591805822|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163846049|NCT03220737|591805823|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
163846050|NCT03220737|591805817|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
163846051|NCT03220737|591805818|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163846052|NCT03220737|591805819|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163846053|NCT03220737|591805820|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163846054|NCT03220737|591805821|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163846055|NCT03220737|591805822|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163846056|NCT03220737|591805823|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
163846057|NCT04011384|591805829|FG000|Overall Study|Withdrawal by Subject|2|||
163846058|NCT04011384|591805830|FG001|Overall Study|Withdrawal by Subject|0|||
163846059|NCT04716881|591805831|FG000|Overall Study|Adverse Event|1|||
163846060|NCT04716881|591805831|FG000|Overall Study|Lost to Follow-up|1|||
163846061|NCT01630590|591805832|FG000|Overall Study|Adverse Event|9|||
163846062|NCT01630590|591805832|FG000|Overall Study|Lack of Efficacy|37|||
163846063|NCT01630590|591805832|FG000|Overall Study|Withdrawal by Subject|4|||
163846064|NCT01630590|591805832|FG000|Overall Study|2nd primary tumor|2|||
163846065|NCT01630590|591805832|FG000|Overall Study|Automobile accident|1|||
163846066|NCT01630590|591805832|FG000|Overall Study|Maximum benefit|4|||
163846067|NCT01751113|591805833|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163846068|NCT01751113|591805834|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163846069|NCT01751113|591805835|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163846070|NCT01751113|591805836|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
163846071|NCT01751113|591805837|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
163846072|NCT01751113|591805838|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
163846073|NCT01751113|591805833|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163846074|NCT01751113|591805834|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163846075|NCT01751113|591805835|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163846076|NCT01751113|591805836|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163846077|NCT01751113|591805837|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
163846078|NCT01751113|591805838|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
163846079|NCT00363896|591805839|FG000|Overall Study|Withdrawal by Subject|29|||
163846080|NCT00363896|591805840|FG001|Overall Study|Withdrawal by Subject|16|||
163846081|NCT00363896|591805839|FG000|Overall Study|Adverse Event|24|||
163846082|NCT00363896|591805840|FG001|Overall Study|Adverse Event|13|||
163846083|NCT00363896|591805839|FG000|Overall Study|COPD exacerbation|13|||
163846084|NCT00363896|591805840|FG001|Overall Study|COPD exacerbation|7|||
163846085|NCT00363896|591805839|FG000|Overall Study|Lack of Efficacy|12|||
163846086|NCT00363896|591805840|FG001|Overall Study|Lack of Efficacy|8|||
163846087|NCT00363896|591805839|FG000|Overall Study|Protocol Violation|6|||
163846088|NCT00363896|591805840|FG001|Overall Study|Protocol Violation|1|||
163846089|NCT00363896|591805839|FG000|Overall Study|Lost to Follow-up|3|||
163846090|NCT00363896|591805840|FG001|Overall Study|Lost to Follow-up|0|||
163846091|NCT00363896|591805839|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
163846092|NCT00363896|591805840|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
163846093|NCT00363896|591805839|FG000|Overall Study|Other|1|||
163846094|NCT00363896|591805840|FG001|Overall Study|Other|2|||
163846095|NCT04147260|591805841|FG000|Overall Study|Adverse Event|1|||
163846096|NCT04147260|591805842|FG001|Overall Study|Adverse Event|0|||
163846097|NCT04147260|591805843|FG002|Overall Study|Adverse Event|1|||
163846098|NCT04147260|591805844|FG003|Overall Study|Adverse Event|2|||
163846099|NCT04147260|591805845|FG004|Overall Study|Adverse Event|0|||
163846100|NCT04147260|591805841|FG000|Overall Study|Withdrawal by Subject|0|||
163846101|NCT04147260|591805842|FG001|Overall Study|Withdrawal by Subject|0|||
163846102|NCT04147260|591805843|FG002|Overall Study|Withdrawal by Subject|1|||
163846103|NCT04147260|591805844|FG003|Overall Study|Withdrawal by Subject|1|||
163846104|NCT04147260|591805845|FG004|Overall Study|Withdrawal by Subject|0|||
163846105|NCT02471404|591805853|FG000|Overall Study|Adverse Event|7|||
163846106|NCT02471404|591805854|FG001|Overall Study|Adverse Event|1|||
163846107|NCT02471404|591805855|FG002|Overall Study|Adverse Event|2|||
163846108|NCT02471404|591805853|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
163846109|NCT02471404|591805854|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
164306884|NCT01967238|593496958|FG000|Overall Study|Adverse Event|1|||
164306885|NCT01967238|593496959|FG001|Overall Study|Adverse Event|1|||
164306886|NCT01967238|593496960|FG002|Overall Study|Adverse Event|0|||
164306887|NCT01967238|593496958|FG000|Overall Study|Lost to Follow-up|1|||
164306888|NCT01967238|593496959|FG001|Overall Study|Lost to Follow-up|0|||
164306889|NCT01967238|593496960|FG002|Overall Study|Lost to Follow-up|1|||
164306890|NCT01967238|593496958|FG000|Overall Study|Withdrawal by Subject|0|||
164306891|NCT01967238|593496959|FG001|Overall Study|Withdrawal by Subject|0|||
164306892|NCT01967238|593496960|FG002|Overall Study|Withdrawal by Subject|1|||
164306893|NCT03493464|593496961|FG000|Overall Study|Surgery not performed|1|||
164306894|NCT04949490|593496965|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306895|NCT04949490|593496966|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306896|NCT04949490|593496967|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306897|NCT04949490|593496968|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
164306898|NCT04949490|593496969|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306899|NCT04949490|593496970|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
164306900|NCT04949490|593496965|FG000|Group A and Group B|Withdrawal by Subject|0|||
164306901|NCT04949490|593496966|FG001|Group A and Group B|Withdrawal by Subject|0|||
164306902|NCT04949490|593496967|FG002|Group A and Group B|Withdrawal by Subject|1|||
164306903|NCT04949490|593496968|FG003|Group A and Group B|Withdrawal by Subject|0|||
164306904|NCT04949490|593496969|FG004|Group A and Group B|Withdrawal by Subject|0|||
164306905|NCT04949490|593496970|FG005|Group A and Group B|Withdrawal by Subject|0|||
164306906|NCT04949490|593496965|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306907|NCT04949490|593496966|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306908|NCT04949490|593496967|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306909|NCT04949490|593496968|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306910|NCT04949490|593496969|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
164306911|NCT04949490|593496970|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
164306912|NCT04949490|593496965|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306913|NCT04949490|593496966|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306914|NCT04949490|593496967|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306915|NCT04949490|593496968|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306916|NCT04949490|593496969|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
164306917|NCT04949490|593496970|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
164306918|NCT02864394|593496972|FG000|Overall Study|Death|184|||
164306919|NCT02864394|593496973|FG001|Overall Study|Death|189|||
164306920|NCT02864394|593496972|FG000|Overall Study|Lost to Follow-up|0|||
164306921|NCT02864394|593496973|FG001|Overall Study|Lost to Follow-up|2|||
164306922|NCT02864394|593496972|FG000|Overall Study|Sponsor Decision|26|||
164306923|NCT02864394|593496973|FG001|Overall Study|Sponsor Decision|11|||
164306924|NCT02864394|593496972|FG000|Overall Study|Withdrawal by Subject|3|||
164306925|NCT02864394|593496973|FG001|Overall Study|Withdrawal by Subject|10|||
164306926|NCT05232682|593496974|FG000|Overall Study|Lost to Follow-up|2|||
164306927|NCT02604160|593499134|FG000|Overall Study|Protocol Violation|0|||
164306928|NCT02604160|593499135|FG001|Overall Study|Protocol Violation|1|||
164306929|NCT02604160|593499134|FG000|Overall Study|Physician Decision|0|||
164306930|NCT02604160|593499135|FG001|Overall Study|Physician Decision|1|||
164306931|NCT01596062|593499136|FG000|Overall Study|Adverse Event|1|||
164306932|NCT01596062|593499137|FG001|Overall Study|Adverse Event|0|||
164306933|NCT01596062|593499138|FG002|Overall Study|Adverse Event|2|||
164306934|NCT01596062|593499136|FG000|Overall Study|Lack of Efficacy|0|||
164306935|NCT01596062|593499137|FG001|Overall Study|Lack of Efficacy|0|||
164306936|NCT01596062|593499138|FG002|Overall Study|Lack of Efficacy|1|||
164306937|NCT01069900|593499139|FG000|Overall Study|Technical problems|0|||
164306938|NCT01069900|593499140|FG001|Overall Study|Technical problems|1|||
164306939|NCT01069900|593499139|FG000|Overall Study|Lost to Follow-up|7|||
164306940|NCT01069900|593499140|FG001|Overall Study|Lost to Follow-up|1|||
164306941|NCT01069900|593499139|FG000|Overall Study|Withdrawal by Subject|6|||
164306942|NCT01069900|593499140|FG001|Overall Study|Withdrawal by Subject|1|||
164306943|NCT01069900|593499139|FG000|Overall Study|Protocol Violation|4|||
164306944|NCT01069900|593499140|FG001|Overall Study|Protocol Violation|1|||
164306945|NCT01069900|593499139|FG000|Overall Study|Insufficient Therapeutic effect|1|||
164306946|NCT01069900|593499140|FG001|Overall Study|Insufficient Therapeutic effect|0|||
164306947|NCT03180840|593499141|FG000|Overall Study|Withdrawal by Subject|1|||
164306948|NCT01168219|593499145|FG000|Overall Study|off study before starting treatment|2|||
164306949|NCT01168219|593499145|FG000|Overall Study|withdrew before transplant|1|||
164306950|NCT01168219|593499145|FG000|Overall Study|ineligible due to CML|2|||
164306951|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
164306952|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
164306953|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
164306954|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
164306955|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
164306956|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
163846110|NCT02471404|591805855|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
163846111|NCT02471404|591805853|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
163846112|NCT02471404|591805854|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163846113|NCT02471404|591805855|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
163846114|NCT02471404|591805853|FG000|Overall Study|Lost to Follow-up|1|||
163846115|NCT02471404|591805854|FG001|Overall Study|Lost to Follow-up|1|||
163846116|NCT02471404|591805855|FG002|Overall Study|Lost to Follow-up|3|||
163846117|NCT02471404|591805853|FG000|Overall Study|Protocol Violation|1|||
163846118|NCT02471404|591805854|FG001|Overall Study|Protocol Violation|0|||
163846119|NCT02471404|591805855|FG002|Overall Study|Protocol Violation|0|||
163846120|NCT02471404|591805853|FG000|Overall Study|Withdrawal by Subject|8|||
163846121|NCT02471404|591805854|FG001|Overall Study|Withdrawal by Subject|4|||
163846122|NCT02471404|591805855|FG002|Overall Study|Withdrawal by Subject|5|||
163846123|NCT02471404|591805853|FG000|Overall Study|Other reasons not specified|10|||
163846124|NCT02471404|591805854|FG001|Overall Study|Other reasons not specified|7|||
163846125|NCT02471404|591805855|FG002|Overall Study|Other reasons not specified|12|||
163846126|NCT02207374|591805856|FG000|Overall Study|Withdrawal by Subject|5|||
163846127|NCT02207374|591805857|FG001|Overall Study|Withdrawal by Subject|9|||
163846128|NCT02207374|591805858|FG002|Overall Study|Withdrawal by Subject|4|||
163846129|NCT02207374|591805856|FG000|Overall Study|Death|1|||
163846130|NCT02207374|591805857|FG001|Overall Study|Death|0|||
163846131|NCT02207374|591805858|FG002|Overall Study|Death|1|||
163846132|NCT02207374|591805856|FG000|Overall Study|Missing follow-up information|0|||
163846133|NCT02207374|591805857|FG001|Overall Study|Missing follow-up information|1|||
163846134|NCT02207374|591805858|FG002|Overall Study|Missing follow-up information|1|||
163846135|NCT02087150|591805859|FG000|Overall Study|Death|0|||
163846136|NCT02087150|591805860|FG001|Overall Study|Death|1|||
163846137|NCT02087150|591805861|FG002|Overall Study|Death|0|||
163846138|NCT02087150|591805859|FG000|Overall Study|Lost to Follow-up|6|||
163846139|NCT02087150|591805860|FG001|Overall Study|Lost to Follow-up|13|||
163846140|NCT02087150|591805861|FG002|Overall Study|Lost to Follow-up|7|||
163846141|NCT02087150|591805859|FG000|Overall Study|Withdrawal by Subject|2|||
163846142|NCT02087150|591805860|FG001|Overall Study|Withdrawal by Subject|5|||
163846143|NCT02087150|591805861|FG002|Overall Study|Withdrawal by Subject|3|||
163846144|NCT02087150|591805859|FG000|Overall Study|Physician Decision|0|||
163846145|NCT02087150|591805860|FG001|Overall Study|Physician Decision|1|||
163846146|NCT02087150|591805861|FG002|Overall Study|Physician Decision|0|||
163846147|NCT02087150|591805859|FG000|Overall Study|Procedure not done|1|||
163846148|NCT02087150|591805860|FG001|Overall Study|Procedure not done|13|||
163846149|NCT02087150|591805861|FG002|Overall Study|Procedure not done|0|||
163846150|NCT02087150|591805859|FG000|Overall Study|F/U not completed w/in study window|0|||
163846151|NCT02087150|591805860|FG001|Overall Study|F/U not completed w/in study window|0|||
163846152|NCT02087150|591805861|FG002|Overall Study|F/U not completed w/in study window|1|||
163846153|NCT02087150|591805859|FG000|Overall Study|Other|1|||
163846154|NCT02087150|591805860|FG001|Overall Study|Other|0|||
163846155|NCT02087150|591805861|FG002|Overall Study|Other|0|||
163846156|NCT02087150|591805859|FG000|Overall Study|Pt moved out of town|0|||
163846157|NCT02087150|591805860|FG001|Overall Study|Pt moved out of town|1|||
163846158|NCT02087150|591805861|FG002|Overall Study|Pt moved out of town|0|||
163846159|NCT00785538|591805862|FG000|Treatment Period|Adverse Event|1|||
163846160|NCT00785538|591805863|FG001|Treatment Period|Adverse Event|2|||
163846161|NCT00785538|591805864|FG002|Treatment Period|Adverse Event|2|||
163846162|NCT00785538|591805865|FG003|Treatment Period|Adverse Event|0|||
163846163|NCT00785538|591805862|FG000|Treatment Period|Withdrawal by Subject|0|||
163846164|NCT00785538|591805863|FG001|Treatment Period|Withdrawal by Subject|0|||
163846165|NCT00785538|591805864|FG002|Treatment Period|Withdrawal by Subject|0|||
163846166|NCT00785538|591805865|FG003|Treatment Period|Withdrawal by Subject|1|||
163846167|NCT00683449|591805866|FG000|Overall Study|Lost to Follow-up|0|||
163846168|NCT00683449|591805867|FG001|Overall Study|Lost to Follow-up|1|||
163846169|NCT00683449|591805868|FG002|Overall Study|Lost to Follow-up|0|||
163846170|NCT00683449|591805869|FG003|Overall Study|Lost to Follow-up|0|||
163846171|NCT00683449|591805870|FG004|Overall Study|Lost to Follow-up|0|||
163846172|NCT01000376|591805876|FG000|Cycle 1 Day 1|Adverse Event|1|||
163846173|NCT01000376|591805877|FG001|Cycle 1 Day 1|Adverse Event|0|||
163846174|NCT01000376|591805876|FG000|Cycle 1 Day 1|Progressive Disease|1|||
163846175|NCT01000376|591805877|FG001|Cycle 1 Day 1|Progressive Disease|0|||
163846176|NCT00507026|591805878|FG000|Overall Study|Lack of Efficacy|6|||
163846177|NCT00507026|591805879|FG001|Overall Study|Lack of Efficacy|4|||
163846178|NCT00507026|591805880|FG002|Overall Study|Lack of Efficacy|21|||
163846179|NCT00507026|591805878|FG000|Overall Study|Withdrawal by Subject|2|||
163846180|NCT00507026|591805879|FG001|Overall Study|Withdrawal by Subject|0|||
163846181|NCT00507026|591805880|FG002|Overall Study|Withdrawal by Subject|0|||
163846182|NCT00507026|591805878|FG000|Overall Study|Investigator Decision|1|||
163846183|NCT00507026|591805879|FG001|Overall Study|Investigator Decision|0|||
163846184|NCT00507026|591805880|FG002|Overall Study|Investigator Decision|0|||
163846185|NCT00507026|591805878|FG000|Overall Study|Adverse Event|2|||
163846186|NCT00507026|591805879|FG001|Overall Study|Adverse Event|0|||
163846187|NCT00507026|591805880|FG002|Overall Study|Adverse Event|0|||
163846188|NCT00507026|591805878|FG000|Overall Study|Protocol Violation|1|||
163846189|NCT00507026|591805879|FG001|Overall Study|Protocol Violation|0|||
163846190|NCT00507026|591805880|FG002|Overall Study|Protocol Violation|0|||
163846191|NCT00507026|591805878|FG000|Overall Study|Other|1|||
163846192|NCT00507026|591805879|FG001|Overall Study|Other|0|||
163846193|NCT00507026|591805880|FG002|Overall Study|Other|0|||
163846194|NCT04230980|591805881|FG000|Overall Study|Lost to Follow-up|1|||
163846195|NCT04230980|591805882|FG001|Overall Study|Lost to Follow-up|2|||
163846196|NCT04230980|591805881|FG000|Overall Study|Adverse Event|0|||
163846197|NCT04230980|591805882|FG001|Overall Study|Adverse Event|1|||
163846198|NCT04285229|591805883|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
163846199|NCT04285229|591805884|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163846200|NCT04285229|591805885|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163846201|NCT04285229|591805886|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163846202|NCT04285229|591805887|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163846203|NCT04285229|591805888|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163846204|NCT04285229|591805883|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
163846205|NCT04285229|591805884|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
164306957|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
164306958|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
164306959|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
164306960|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
164306961|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
164306962|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
164306963|NCT02405442|593499147|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
164306964|NCT02405442|593499148|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
164306965|NCT02405442|593499149|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
164306966|NCT02405442|593499150|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
164306967|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
164306968|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
164306969|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
164306970|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
164306971|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
164306972|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
164306973|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
164306974|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
164306975|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
164306976|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
164306977|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
164306978|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
164306979|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
164306980|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
164306981|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
164306982|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
164306983|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
164306984|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
163959607|NCT03056755|592224047|FG000|Core Phase|Adverse Event|20|||
164306985|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
164306986|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
164306987|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
164306988|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
164306989|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
164306990|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
164306991|NCT02405442|593499147|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
164306992|NCT02405442|593499148|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
164306993|NCT02405442|593499149|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
164306994|NCT02405442|593499150|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
164306995|NCT02405442|593499147|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
164306996|NCT02405442|593499148|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
164306997|NCT02405442|593499149|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
164306998|NCT02405442|593499150|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
164306999|NCT02405442|593499147|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
164307000|NCT02405442|593499148|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
164307001|NCT02405442|593499149|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
164307002|NCT02405442|593499150|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
164307003|NCT02405442|593499147|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
164307004|NCT02405442|593499148|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
164307005|NCT02405442|593499149|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
164307006|NCT02405442|593499150|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
164307007|NCT00337675|593499153|FG000|Overall Study|Adverse Event|10|||
164307008|NCT00337675|593499154|FG001|Overall Study|Adverse Event|9|||
164307009|NCT00337675|593499155|FG002|Overall Study|Adverse Event|19|||
164307010|NCT00337675|593499153|FG000|Overall Study|Lack of Efficacy|10|||
164307011|NCT00337675|593499154|FG001|Overall Study|Lack of Efficacy|7|||
164307012|NCT00337675|593499155|FG002|Overall Study|Lack of Efficacy|9|||
164307013|NCT00337675|593499153|FG000|Overall Study|Lost to Follow-up|22|||
164307014|NCT00337675|593499154|FG001|Overall Study|Lost to Follow-up|19|||
164307015|NCT00337675|593499155|FG002|Overall Study|Lost to Follow-up|17|||
164307016|NCT00337675|593499153|FG000|Overall Study|Physician Decision|9|||
164307017|NCT00337675|593499154|FG001|Overall Study|Physician Decision|17|||
164307018|NCT00337675|593499155|FG002|Overall Study|Physician Decision|14|||
164307019|NCT00337675|593499153|FG000|Overall Study|Protocol Violation|21|||
164307020|NCT00337675|593499154|FG001|Overall Study|Protocol Violation|24|||
164307021|NCT00337675|593499155|FG002|Overall Study|Protocol Violation|19|||
164307022|NCT00337675|593499153|FG000|Overall Study|Withdrawal by Subject|25|||
164307023|NCT00337675|593499154|FG001|Overall Study|Withdrawal by Subject|25|||
164307024|NCT00337675|593499155|FG002|Overall Study|Withdrawal by Subject|19|||
164307025|NCT00337675|593499153|FG000|Overall Study|Progressive Disease|0|||
164307026|NCT00337675|593499154|FG001|Overall Study|Progressive Disease|2|||
164307027|NCT00337675|593499155|FG002|Overall Study|Progressive Disease|0|||
164307028|NCT00337675|593499153|FG000|Overall Study|Trial Terminated|0|||
164307029|NCT00337675|593499154|FG001|Overall Study|Trial Terminated|0|||
164307030|NCT00337675|593499155|FG002|Overall Study|Trial Terminated|2|||
164307031|NCT00859456|593499156|FG000|Overall Study|Adverse Event|3|||
164307032|NCT00859456|593499156|FG000|Overall Study|Progressive disease|2|||
164307033|NCT00859456|593499156|FG000|Overall Study|Non-compliance|3|||
164307034|NCT02015637|593499161|FG000|Overall Study|Lost to Follow-up|3|||
164307035|NCT02015637|593499162|FG001|Overall Study|Lost to Follow-up|5|||
164307036|NCT02015637|593499161|FG000|Overall Study|Adverse Event|3|||
164307037|NCT02015637|593499162|FG001|Overall Study|Adverse Event|0|||
164307038|NCT02015637|593499161|FG000|Overall Study|Did not take study drug|2|||
164307039|NCT02015637|593499162|FG001|Overall Study|Did not take study drug|0|||
163846206|NCT04285229|591805885|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
163846207|NCT04285229|591805886|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
163846208|NCT04285229|591805887|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
163846209|NCT04285229|591805888|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
163846210|NCT04285229|591805883|FG000|Extended Treatment Period|Adverse Event|0|||
163846211|NCT04285229|591805884|FG001|Extended Treatment Period|Adverse Event|0|||
163846212|NCT04285229|591805885|FG002|Extended Treatment Period|Adverse Event|0|||
163846213|NCT04285229|591805886|FG003|Extended Treatment Period|Adverse Event|1|||
163846214|NCT04285229|591805887|FG004|Extended Treatment Period|Adverse Event|0|||
163846215|NCT04285229|591805888|FG005|Extended Treatment Period|Adverse Event|0|||
163846216|NCT04285229|591805883|FG000|Extended Treatment Period|Physician Decision|0|||
163846217|NCT04285229|591805884|FG001|Extended Treatment Period|Physician Decision|0|||
163846218|NCT04285229|591805885|FG002|Extended Treatment Period|Physician Decision|1|||
163846219|NCT04285229|591805886|FG003|Extended Treatment Period|Physician Decision|0|||
163846220|NCT04285229|591805887|FG004|Extended Treatment Period|Physician Decision|0|||
163846221|NCT04285229|591805888|FG005|Extended Treatment Period|Physician Decision|0|||
163846222|NCT04285229|591805883|FG000|Follow-up Period|Adverse Event|0|||
163846223|NCT04285229|591805884|FG001|Follow-up Period|Adverse Event|0|||
163846224|NCT04285229|591805885|FG002|Follow-up Period|Adverse Event|0|||
163846225|NCT04285229|591805886|FG003|Follow-up Period|Adverse Event|0|||
163846226|NCT04285229|591805887|FG004|Follow-up Period|Adverse Event|1|||
163846227|NCT04285229|591805888|FG005|Follow-up Period|Adverse Event|4|||
163846228|NCT04285229|591805883|FG000|Follow-up Period|Withdrawal by Subject|0|||
163846229|NCT04285229|591805884|FG001|Follow-up Period|Withdrawal by Subject|0|||
163846230|NCT04285229|591805885|FG002|Follow-up Period|Withdrawal by Subject|0|||
163846231|NCT04285229|591805886|FG003|Follow-up Period|Withdrawal by Subject|0|||
163846232|NCT04285229|591805887|FG004|Follow-up Period|Withdrawal by Subject|0|||
163846233|NCT04285229|591805888|FG005|Follow-up Period|Withdrawal by Subject|5|||
163846234|NCT04285229|591805883|FG000|Follow-up Period|Covid-19|0|||
163846235|NCT04285229|591805884|FG001|Follow-up Period|Covid-19|0|||
163846236|NCT04285229|591805885|FG002|Follow-up Period|Covid-19|0|||
163846237|NCT04285229|591805886|FG003|Follow-up Period|Covid-19|0|||
163846238|NCT04285229|591805887|FG004|Follow-up Period|Covid-19|0|||
163846239|NCT04285229|591805888|FG005|Follow-up Period|Covid-19|2|||
163846240|NCT04285229|591805883|FG000|Follow-up Period|Physician Decision|0|||
163846241|NCT04285229|591805884|FG001|Follow-up Period|Physician Decision|0|||
163846242|NCT04285229|591805885|FG002|Follow-up Period|Physician Decision|0|||
163846243|NCT04285229|591805886|FG003|Follow-up Period|Physician Decision|0|||
163846244|NCT04285229|591805887|FG004|Follow-up Period|Physician Decision|0|||
163846245|NCT04285229|591805888|FG005|Follow-up Period|Physician Decision|1|||
163846246|NCT02819479|591808335|FG000|Overall Study|Adverse Event|2|||
163846247|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
163846248|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
163846249|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
163846250|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
163846251|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
163846252|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
163846253|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
163846254|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
163846255|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
163846256|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
163846257|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
163846258|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
163846259|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
163846260|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
163846261|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
163846262|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
163846263|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
163846264|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
163846265|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
163846266|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
163846267|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
163846268|NCT02718417|591808337|FG000|Chemotherapy Phase (CP)|Other|2|||
163846269|NCT02718417|591808338|FG001|Chemotherapy Phase (CP)|Other|0|||
163846270|NCT02718417|591808339|FG002|Chemotherapy Phase (CP)|Other|1|||
163846271|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Adverse Event|21|||
163846272|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Adverse Event|26|||
163846273|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Adverse Event|0|||
163846274|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
163846275|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
163846276|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
163846277|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
163846278|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
163846279|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
163846280|NCT02718417|591808337|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
163846281|NCT02718417|591808338|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
163846282|NCT02718417|591808339|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
163846283|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Physician's decision|6|||
163846284|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Physician's decision|7|||
163846285|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Physician's decision|0|||
163846286|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Progressive disease|100|||
163846287|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Progressive disease|88|||
163846288|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Progressive disease|0|||
163846289|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Other|2|||
163846290|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Other|1|||
163846291|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Other|0|||
163846292|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
163846293|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
163846294|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
163846295|NCT02718417|591808337|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
163846296|NCT02718417|591808338|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
163846297|NCT02718417|591808339|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
163846298|NCT02718417|591808337|FG000|Observation Phase (OP)|Adverse Event|0|||
163846299|NCT02718417|591808338|FG001|Observation Phase (OP)|Adverse Event|0|||
163846300|NCT02718417|591808339|FG002|Observation Phase (OP)|Adverse Event|1|||
163846301|NCT02718417|591808337|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
163846302|NCT02718417|591808338|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
163846303|NCT02718417|591808339|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
163846304|NCT02718417|591808337|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
163846305|NCT02718417|591808338|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
163846306|NCT02718417|591808339|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
163846307|NCT02718417|591808337|FG000|Observation Phase (OP)|Physician Decision|0|||
163846308|NCT02718417|591808338|FG001|Observation Phase (OP)|Physician Decision|0|||
163846309|NCT02718417|591808339|FG002|Observation Phase (OP)|Physician Decision|9|||
163846310|NCT02718417|591808337|FG000|Observation Phase (OP)|Progressive disease|0|||
163846311|NCT02718417|591808338|FG001|Observation Phase (OP)|Progressive disease|0|||
163846312|NCT02718417|591808339|FG002|Observation Phase (OP)|Progressive disease|92|||
163846313|NCT02718417|591808337|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
163846314|NCT02718417|591808338|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
163846315|NCT02718417|591808339|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
163846316|NCT02718417|591808337|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
163846317|NCT02718417|591808338|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
163846318|NCT02718417|591808339|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
163846319|NCT02718417|591808337|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
163846320|NCT02718417|591808338|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
163846321|NCT02718417|591808339|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
163846322|NCT02718417|591808337|FG000|Observation Phase (OP)|Other|0|||
163846323|NCT02718417|591808338|FG001|Observation Phase (OP)|Other|0|||
163846324|NCT02718417|591808339|FG002|Observation Phase (OP)|Other|7|||
163846325|NCT02718417|591808337|FG000|Follow-up Phase|Adverse Event|3|||
163846326|NCT02718417|591808338|FG001|Follow-up Phase|Adverse Event|1|||
163846327|NCT02718417|591808339|FG002|Follow-up Phase|Adverse Event|1|||
163846328|NCT02718417|591808337|FG000|Follow-up Phase|Other|4|||
163846329|NCT02718417|591808338|FG001|Follow-up Phase|Other|6|||
163846330|NCT02718417|591808339|FG002|Follow-up Phase|Other|4|||
163846331|NCT02718417|591808337|FG000|Follow-up Phase|Withdrawal by Subject|19|||
163846332|NCT02718417|591808338|FG001|Follow-up Phase|Withdrawal by Subject|17|||
163846333|NCT02718417|591808339|FG002|Follow-up Phase|Withdrawal by Subject|5|||
163846334|NCT02718417|591808337|FG000|Follow-up Phase|Study terminated by sponsor|100|||
163846335|NCT02718417|591808338|FG001|Follow-up Phase|Study terminated by sponsor|138|||
163846336|NCT02718417|591808339|FG002|Follow-up Phase|Study terminated by sponsor|6|||
163846337|NCT02718417|591808337|FG000|Follow-up Phase|Lost to Follow-up|2|||
163846338|NCT02718417|591808338|FG001|Follow-up Phase|Lost to Follow-up|3|||
163846339|NCT02718417|591808339|FG002|Follow-up Phase|Lost to Follow-up|0|||
163846340|NCT02718417|591808337|FG000|Follow-up Phase|Death leading to discontinuation|7|||
163846341|NCT02718417|591808338|FG001|Follow-up Phase|Death leading to discontinuation|7|||
163846342|NCT02718417|591808339|FG002|Follow-up Phase|Death leading to discontinuation|3|||
163846343|NCT02718417|591808337|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
163846344|NCT02718417|591808338|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
163846345|NCT02718417|591808339|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
163846346|NCT02718417|591808337|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
163846347|NCT02718417|591808338|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
164307040|NCT00927953|593499167|FG000|Overall Study|Death|2|||
164307041|NCT00927953|593499168|FG001|Overall Study|Death|1|||
163846348|NCT02718417|591808339|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
163846349|NCT02718417|591808337|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
163846350|NCT02718417|591808338|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
163846351|NCT02718417|591808339|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
163846352|NCT02718417|591808337|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
163846353|NCT02718417|591808338|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
163846354|NCT02718417|591808339|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
163846355|NCT02718417|591808337|FG000|Long-term Follow-up Phase|Other|0|||
163846356|NCT02718417|591808338|FG001|Long-term Follow-up Phase|Other|2|||
163846357|NCT02718417|591808339|FG002|Long-term Follow-up Phase|Other|0|||
163846358|NCT00506285|591808340|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
163846359|NCT00506285|591808341|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
163846360|NCT00506285|591808340|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
163846361|NCT00506285|591808341|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
163846362|NCT00506285|591808340|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
163846363|NCT00506285|591808341|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
163846364|NCT00506285|591808340|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
163846365|NCT00506285|591808341|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
163846366|NCT00506285|591808340|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
163846367|NCT00506285|591808341|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
163846368|NCT00551213|591808344|FG000|Overall Study|Adverse Event|6|||
163846369|NCT00551213|591808345|FG001|Overall Study|Adverse Event|3|||
163846370|NCT00551213|591808344|FG000|Overall Study|Progressive Disease|41|||
163846371|NCT00551213|591808345|FG001|Overall Study|Progressive Disease|12|||
163846372|NCT00551213|591808344|FG000|Overall Study|Withdrawal by Subject|2|||
163846373|NCT00551213|591808345|FG001|Overall Study|Withdrawal by Subject|0|||
163846374|NCT00551213|591808344|FG000|Overall Study|Not Treated|1|||
163846375|NCT00551213|591808345|FG001|Overall Study|Not Treated|2|||
163846376|NCT01890967|591808346|FG000|Overall Study|Adverse Event|3|||
163846377|NCT01890967|591808347|FG001|Overall Study|Adverse Event|3|||
164307042|NCT02863419|593499169|FG000|Overall Study|Lost to Follow-up|0|||
164307043|NCT02863419|593499170|FG001|Overall Study|Lost to Follow-up|1|||
163846378|NCT01890967|591808348|FG002|Overall Study|Adverse Event|3|||
163846379|NCT01890967|591808349|FG003|Overall Study|Adverse Event|2|||
163846380|NCT01890967|591808350|FG004|Overall Study|Adverse Event|1|||
164307044|NCT02863419|593499171|FG002|Overall Study|Lost to Follow-up|4|||
164307045|NCT02863419|593499169|FG000|Overall Study|Withdrawal by Subject|5|||
164307046|NCT02863419|593499170|FG001|Overall Study|Withdrawal by Subject|5|||
164307047|NCT02863419|593499171|FG002|Overall Study|Withdrawal by Subject|3|||
164307048|NCT02863419|593499169|FG000|Overall Study|Died|3|||
164307049|NCT02863419|593499170|FG001|Overall Study|Died|4|||
164307050|NCT02863419|593499171|FG002|Overall Study|Died|1|||
164307051|NCT01491607|593499174|FG000|Overall Study|Lost to Follow-up|7|||
164307052|NCT01491607|593499174|FG000|Overall Study|Withdrawal by Subject|3|||
164307053|NCT01317277|593499175|FG000|Overall Study|Lost to Follow-up|3|||
164307054|NCT01317277|593499176|FG001|Overall Study|Lost to Follow-up|1|||
164307055|NCT01317277|593499175|FG000|Overall Study|Lost MEMS|1|||
164307056|NCT01317277|593499176|FG001|Overall Study|Lost MEMS|1|||
164307057|NCT01317277|593499175|FG000|Overall Study|Unable to comply with intervention|1|||
164307058|NCT01317277|593499176|FG001|Overall Study|Unable to comply with intervention|0|||
164307059|NCT01317277|593499175|FG000|Overall Study|Withdrawal by Subject|1|||
164307060|NCT01317277|593499176|FG001|Overall Study|Withdrawal by Subject|0|||
164307061|NCT01317277|593499175|FG000|Overall Study|Adverse Event|1|||
164307062|NCT01317277|593499176|FG001|Overall Study|Adverse Event|0|||
164307063|NCT00297258|593499183|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
164307064|NCT00297258|593499183|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
164307065|NCT00297258|593499183|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
164307066|NCT00297258|593499183|FG000|Overall Study|Intercurrent Illness|3|||
164307067|NCT00297258|593499183|FG000|Overall Study|Intercurrent Death|2|||
164307068|NCT00297258|593499183|FG000|Overall Study|Deteriorization of General Condition|1|||
164307069|NCT00297258|593499183|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
164307070|NCT00297258|593499183|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
164307071|NCT00297258|593499183|FG000|Overall Study|Switch to Commercial Treatment|1|||
164307072|NCT00297258|593499183|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
164307073|NCT02454517|593499184|FG000|Overall Study|Withdrawal by Subject|3|||
164307074|NCT02454517|593499185|FG001|Overall Study|Withdrawal by Subject|0|||
163846381|NCT01890967|591808351|FG005|Overall Study|Adverse Event|7|||
163846382|NCT01890967|591808346|FG000|Overall Study|Death|1|||
164307075|NCT02454517|593499184|FG000|Overall Study|Lost to Follow-up|4|||
164307076|NCT02454517|593499185|FG001|Overall Study|Lost to Follow-up|7|||
164307077|NCT02454517|593499184|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
164307078|NCT02454517|593499185|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
164307079|NCT00473382|593499186|FG000|Core Study|Adverse Event|3|||
163846383|NCT01890967|591808347|FG001|Overall Study|Death|0|||
163846384|NCT01890967|591808348|FG002|Overall Study|Death|0|||
163846385|NCT01890967|591808349|FG003|Overall Study|Death|0|||
164307080|NCT00473382|593499187|FG001|Core Study|Adverse Event|1|||
164307081|NCT00473382|593499188|FG002|Core Study|Adverse Event|1|||
164307082|NCT00473382|593499186|FG000|Core Study|Death|3|||
164307083|NCT00473382|593499187|FG001|Core Study|Death|5|||
164307084|NCT00473382|593499188|FG002|Core Study|Death|10|||
164307085|NCT00473382|593499186|FG000|Core Study|Lost to Follow-up|3|||
164307086|NCT00473382|593499187|FG001|Core Study|Lost to Follow-up|3|||
164307087|NCT00473382|593499188|FG002|Core Study|Lost to Follow-up|3|||
164307088|NCT00473382|593499186|FG000|Core Study|Physician Decision|1|||
164307089|NCT00473382|593499187|FG001|Core Study|Physician Decision|2|||
164307090|NCT00473382|593499188|FG002|Core Study|Physician Decision|2|||
164307091|NCT00473382|593499186|FG000|Core Study|Subject non-compliance|5|||
164307092|NCT00473382|593499187|FG001|Core Study|Subject non-compliance|2|||
164307093|NCT00473382|593499188|FG002|Core Study|Subject non-compliance|1|||
164307094|NCT00473382|593499186|FG000|Core Study|Subject needed other treatment|1|||
164307095|NCT00473382|593499187|FG001|Core Study|Subject needed other treatment|3|||
164307096|NCT00473382|593499188|FG002|Core Study|Subject needed other treatment|2|||
164307097|NCT00473382|593499186|FG000|Core Study|Subject's decision|12|||
164307098|NCT00473382|593499187|FG001|Core Study|Subject's decision|11|||
164307099|NCT00473382|593499188|FG002|Core Study|Subject's decision|10|||
164307100|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
164307101|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
164307102|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
164307103|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Death|1|||
164307104|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Death|3|||
164307105|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Death|3|||
164307106|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
164307107|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
164307108|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
164307109|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
164307110|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
164307111|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
164307112|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
164307113|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
164307114|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
164307115|NCT00473382|593499186|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
164307116|NCT00473382|593499187|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
164307117|NCT00473382|593499188|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
164307118|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
164307119|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
164307120|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
164307121|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Death|1|||
164307122|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Death|7|||
164307123|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Death|4|||
163846386|NCT01890967|591808350|FG004|Overall Study|Death|0|||
163846387|NCT01890967|591808351|FG005|Overall Study|Death|0|||
163846388|NCT01890967|591808346|FG000|Overall Study|Lost to Follow-up|1|||
163846389|NCT01890967|591808347|FG001|Overall Study|Lost to Follow-up|1|||
163846390|NCT01890967|591808348|FG002|Overall Study|Lost to Follow-up|1|||
163846391|NCT01890967|591808349|FG003|Overall Study|Lost to Follow-up|1|||
163846392|NCT01890967|591808350|FG004|Overall Study|Lost to Follow-up|0|||
163846393|NCT01890967|591808351|FG005|Overall Study|Lost to Follow-up|1|||
163846394|NCT01890967|591808346|FG000|Overall Study|Protocol Violation|0|||
163846395|NCT01890967|591808347|FG001|Overall Study|Protocol Violation|3|||
163846396|NCT01890967|591808348|FG002|Overall Study|Protocol Violation|3|||
163846397|NCT01890967|591808349|FG003|Overall Study|Protocol Violation|2|||
163846398|NCT01890967|591808350|FG004|Overall Study|Protocol Violation|4|||
163846399|NCT01890967|591808351|FG005|Overall Study|Protocol Violation|1|||
163846400|NCT01890967|591808346|FG000|Overall Study|Sponsor Decision|2|||
163846401|NCT01890967|591808347|FG001|Overall Study|Sponsor Decision|0|||
163846402|NCT01890967|591808348|FG002|Overall Study|Sponsor Decision|1|||
163846403|NCT01890967|591808349|FG003|Overall Study|Sponsor Decision|3|||
163846404|NCT01890967|591808350|FG004|Overall Study|Sponsor Decision|2|||
163846405|NCT01890967|591808351|FG005|Overall Study|Sponsor Decision|3|||
163846406|NCT01890967|591808346|FG000|Overall Study|Withdrawal by Subject|3|||
163846407|NCT01890967|591808347|FG001|Overall Study|Withdrawal by Subject|4|||
163846408|NCT01890967|591808348|FG002|Overall Study|Withdrawal by Subject|2|||
163846409|NCT01890967|591808349|FG003|Overall Study|Withdrawal by Subject|3|||
163846410|NCT01890967|591808350|FG004|Overall Study|Withdrawal by Subject|3|||
163846411|NCT01890967|591808351|FG005|Overall Study|Withdrawal by Subject|1|||
163846412|NCT02892409|591808352|FG000|Overall Study|Adverse Event|1|||
163846413|NCT02892409|591808353|FG001|Overall Study|Adverse Event|0|||
163846414|NCT02892409|591808352|FG000|Overall Study|Withdrawal by Subject|2|||
163846415|NCT02892409|591808353|FG001|Overall Study|Withdrawal by Subject|1|||
163846416|NCT01154036|591808362|FG000|Phase I|Physician Decision|0|||
163846417|NCT01154036|591808363|FG001|Phase I|Physician Decision|1|||
163846418|NCT01154036|591808364|FG002|Phase I|Physician Decision|0|||
163846419|NCT01154036|591808365|FG003|Phase I|Physician Decision|0|||
163846420|NCT01154036|591808366|FG004|Phase I|Physician Decision|0|||
163846421|NCT01154036|591808367|FG005|Phase I|Physician Decision|0|||
163846422|NCT01154036|591808368|FG006|Phase I|Physician Decision|0|||
163846423|NCT01154036|591808369|FG007|Phase I|Physician Decision|0|||
164307124|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
164307125|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
164307126|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
164307127|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
164307128|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
164307129|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
164307130|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
164307131|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
164307132|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
164307133|NCT00473382|593499186|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
164307134|NCT00473382|593499187|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
164307135|NCT00473382|593499188|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
164307136|NCT02999672|593499189|FG000|Overall Study|Death|0|||
164307137|NCT02999672|593499190|FG001|Overall Study|Death|1|||
164307138|NCT02999672|593499189|FG000|Overall Study|Study Terminated by Sponsor|0|||
164307139|NCT02999672|593499190|FG001|Overall Study|Study Terminated by Sponsor|1|||
164307140|NCT02999672|593499189|FG000|Overall Study|Progressive Disease|9|||
164307141|NCT02999672|593499190|FG001|Overall Study|Progressive Disease|5|||
163846424|NCT01154036|591808362|FG000|Phase I|Lost to Follow-up|0|||
164307142|NCT02999672|593499189|FG000|Overall Study|Adverse Event|4|||
163846425|NCT01154036|591808363|FG001|Phase I|Lost to Follow-up|3|||
163846426|NCT01154036|591808364|FG002|Phase I|Lost to Follow-up|6|||
163846427|NCT01154036|591808365|FG003|Phase I|Lost to Follow-up|0|||
163846428|NCT01154036|591808366|FG004|Phase I|Lost to Follow-up|0|||
163846429|NCT01154036|591808367|FG005|Phase I|Lost to Follow-up|0|||
163846430|NCT01154036|591808368|FG006|Phase I|Lost to Follow-up|0|||
163846431|NCT01154036|591808369|FG007|Phase I|Lost to Follow-up|0|||
163846432|NCT01154036|591808362|FG000|Phase I|Protocol Violation|0|||
163846433|NCT01154036|591808363|FG001|Phase I|Protocol Violation|3|||
163846434|NCT01154036|591808364|FG002|Phase I|Protocol Violation|9|||
163846435|NCT01154036|591808365|FG003|Phase I|Protocol Violation|0|||
163846436|NCT01154036|591808366|FG004|Phase I|Protocol Violation|0|||
163846437|NCT01154036|591808367|FG005|Phase I|Protocol Violation|0|||
163846438|NCT01154036|591808368|FG006|Phase I|Protocol Violation|0|||
163846439|NCT01154036|591808369|FG007|Phase I|Protocol Violation|0|||
163846440|NCT01154036|591808362|FG000|Phase I|Withdrawal by Subject|2|||
163846441|NCT01154036|591808363|FG001|Phase I|Withdrawal by Subject|10|||
163846442|NCT01154036|591808364|FG002|Phase I|Withdrawal by Subject|29|||
163846443|NCT01154036|591808365|FG003|Phase I|Withdrawal by Subject|0|||
163846444|NCT01154036|591808366|FG004|Phase I|Withdrawal by Subject|0|||
163846445|NCT01154036|591808367|FG005|Phase I|Withdrawal by Subject|0|||
163846446|NCT01154036|591808368|FG006|Phase I|Withdrawal by Subject|0|||
163846447|NCT01154036|591808369|FG007|Phase I|Withdrawal by Subject|0|||
163846448|NCT01154036|591808362|FG000|Phase I|Adverse Event|1|||
163846449|NCT01154036|591808363|FG001|Phase I|Adverse Event|11|||
163846450|NCT01154036|591808364|FG002|Phase I|Adverse Event|12|||
163846451|NCT01154036|591808365|FG003|Phase I|Adverse Event|0|||
163846452|NCT01154036|591808366|FG004|Phase I|Adverse Event|0|||
163846453|NCT01154036|591808367|FG005|Phase I|Adverse Event|0|||
163846454|NCT01154036|591808368|FG006|Phase I|Adverse Event|0|||
163846455|NCT01154036|591808369|FG007|Phase I|Adverse Event|0|||
163846456|NCT01154036|591808362|FG000|Phase II|Adverse Event|0|||
163846457|NCT01154036|591808363|FG001|Phase II|Adverse Event|0|||
163846458|NCT01154036|591808364|FG002|Phase II|Adverse Event|0|||
163846459|NCT01154036|591808365|FG003|Phase II|Adverse Event|0|||
163846460|NCT01154036|591808366|FG004|Phase II|Adverse Event|1|||
163846461|NCT01154036|591808367|FG005|Phase II|Adverse Event|1|||
163846462|NCT01154036|591808368|FG006|Phase II|Adverse Event|1|||
163846463|NCT01154036|591808369|FG007|Phase II|Adverse Event|1|||
163846464|NCT01154036|591808362|FG000|Phase II|Physician Decision|0|||
163846465|NCT01154036|591808363|FG001|Phase II|Physician Decision|0|||
163846466|NCT01154036|591808364|FG002|Phase II|Physician Decision|0|||
163846467|NCT01154036|591808365|FG003|Phase II|Physician Decision|0|||
163846468|NCT01154036|591808366|FG004|Phase II|Physician Decision|0|||
163846469|NCT01154036|591808367|FG005|Phase II|Physician Decision|0|||
163846470|NCT01154036|591808368|FG006|Phase II|Physician Decision|1|||
163846471|NCT01154036|591808369|FG007|Phase II|Physician Decision|0|||
164307143|NCT02999672|593499190|FG001|Overall Study|Adverse Event|0|||
164307144|NCT03565497|593499191|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
164307145|NCT03565497|593499192|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
164307146|NCT03565497|593499193|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
164307147|NCT03565497|593499191|FG000|Overall Study|Lost to Follow-up|1|||
164307148|NCT03565497|593499192|FG001|Overall Study|Lost to Follow-up|1|||
164307149|NCT03565497|593499193|FG002|Overall Study|Lost to Follow-up|2|||
164307150|NCT03565497|593499191|FG000|Overall Study|Withdrawal by Subject|1|||
164307151|NCT03565497|593499192|FG001|Overall Study|Withdrawal by Subject|1|||
164307152|NCT03565497|593499193|FG002|Overall Study|Withdrawal by Subject|1|||
164307153|NCT01470326|593499194|FG000|Overall Study|Protocol Violation|32|||
164307154|NCT01470326|593499194|FG000|Overall Study|No Drug Administration Information|2|||
164307155|NCT01470326|593499194|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
164307156|NCT01166282|593499195|FG000|Open-label Period|Adverse Event|0|||
164307157|NCT01166282|593499196|FG001|Open-label Period|Adverse Event|0|||
163846472|NCT01154036|591808362|FG000|Phase II|Lost to Follow-up|0|||
163846473|NCT01154036|591808363|FG001|Phase II|Lost to Follow-up|0|||
163846474|NCT01154036|591808364|FG002|Phase II|Lost to Follow-up|0|||
164307158|NCT01166282|593499197|FG002|Open-label Period|Adverse Event|6|||
164307159|NCT01166282|593499195|FG000|Open-label Period|Withdrawal by Subject|0|||
164307160|NCT01166282|593499196|FG001|Open-label Period|Withdrawal by Subject|0|||
163846475|NCT01154036|591808365|FG003|Phase II|Lost to Follow-up|1|||
163846476|NCT01154036|591808366|FG004|Phase II|Lost to Follow-up|2|||
163846477|NCT01154036|591808367|FG005|Phase II|Lost to Follow-up|0|||
163846478|NCT01154036|591808368|FG006|Phase II|Lost to Follow-up|2|||
163846479|NCT01154036|591808369|FG007|Phase II|Lost to Follow-up|1|||
163846480|NCT01154036|591808362|FG000|Phase II|Protocol Violation|0|||
163846481|NCT01154036|591808363|FG001|Phase II|Protocol Violation|0|||
163846482|NCT01154036|591808364|FG002|Phase II|Protocol Violation|0|||
163846483|NCT01154036|591808365|FG003|Phase II|Protocol Violation|0|||
163846484|NCT01154036|591808366|FG004|Phase II|Protocol Violation|1|||
163846485|NCT01154036|591808367|FG005|Phase II|Protocol Violation|2|||
163846486|NCT01154036|591808368|FG006|Phase II|Protocol Violation|0|||
163846487|NCT01154036|591808369|FG007|Phase II|Protocol Violation|0|||
163846488|NCT01154036|591808362|FG000|Phase II|Withdrawal by Subject|0|||
163846489|NCT01154036|591808363|FG001|Phase II|Withdrawal by Subject|0|||
163846490|NCT01154036|591808364|FG002|Phase II|Withdrawal by Subject|0|||
163846491|NCT01154036|591808365|FG003|Phase II|Withdrawal by Subject|0|||
163846492|NCT01154036|591808366|FG004|Phase II|Withdrawal by Subject|4|||
163846493|NCT01154036|591808367|FG005|Phase II|Withdrawal by Subject|2|||
163846494|NCT01154036|591808368|FG006|Phase II|Withdrawal by Subject|5|||
163846495|NCT01154036|591808369|FG007|Phase II|Withdrawal by Subject|4|||
163846496|NCT02264574|591808370|FG000|Overall Study|Death|21|||
163846497|NCT02264574|591808371|FG001|Overall Study|Death|21|||
163846498|NCT02264574|591808370|FG000|Overall Study|Withdrawal by Subject|8|||
163846499|NCT02264574|591808371|FG001|Overall Study|Withdrawal by Subject|6|||
163846500|NCT02264574|591808370|FG000|Overall Study|Other, Not Specified|0|||
163846501|NCT02264574|591808371|FG001|Overall Study|Other, Not Specified|3|||
163846502|NCT02080520|591808372|FG000|Overall Study|Self-reported symptoms|5|||
163846503|NCT02080520|591808373|FG001|Overall Study|Self-reported symptoms|6|||
163846504|NCT02080520|591808372|FG000|Overall Study|Unable to contact|2|||
163846505|NCT02080520|591808373|FG001|Overall Study|Unable to contact|1|||
163846506|NCT02080520|591808372|FG000|Overall Study|Initiated aspirin|2|||
163846507|NCT02080520|591808373|FG001|Overall Study|Initiated aspirin|0|||
163846508|NCT02080520|591808372|FG000|Overall Study|Atrial fibrillation|1|||
163846509|NCT02080520|591808373|FG001|Overall Study|Atrial fibrillation|1|||
163846510|NCT02080520|591808372|FG000|Overall Study|Cancer|1|||
163846511|NCT02080520|591808373|FG001|Overall Study|Cancer|2|||
163846512|NCT02080520|591808372|FG000|Overall Study|Not interested in study|1|||
163846513|NCT02080520|591808373|FG001|Overall Study|Not interested in study|3|||
163846514|NCT02080520|591808372|FG000|Overall Study|Too busy|1|||
163846515|NCT02080520|591808373|FG001|Overall Study|Too busy|1|||
163846516|NCT02080520|591808372|FG000|Overall Study|Work-related injury|1|||
163846517|NCT02080520|591808373|FG001|Overall Study|Work-related injury|0|||
163846518|NCT02080520|591808372|FG000|Overall Study|Personal reasons|0|||
163846519|NCT02080520|591808373|FG001|Overall Study|Personal reasons|3|||
163846520|NCT00390455|591808374|FG000|Overall Study|Adverse Event|17|||
163846521|NCT00390455|591808375|FG001|Overall Study|Adverse Event|3|||
163846522|NCT00390455|591808374|FG000|Overall Study|Withdrawal by Subject|8|||
163846523|NCT00390455|591808375|FG001|Overall Study|Withdrawal by Subject|8|||
163846524|NCT00390455|591808374|FG000|Overall Study|Alternate Treatment|0|||
163846525|NCT00390455|591808375|FG001|Overall Study|Alternate Treatment|1|||
163846526|NCT00390455|591808374|FG000|Overall Study|Other Medical Reasons|7|||
163846527|NCT00390455|591808375|FG001|Overall Study|Other Medical Reasons|11|||
163846528|NCT01591460|591808381|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
163846529|NCT01591460|591808381|FG000|Overall Study|Futility Rule (Week 12)|7|||
163846530|NCT01591460|591808381|FG000|Overall Study|Futility Rule (Week 24)|3|||
163846531|NCT01591460|591808381|FG000|Overall Study|Rebound or Breakthrough|3|||
163846532|NCT01591460|591808381|FG000|Overall Study|Treatment Discontinued by Error|1|||
163846533|NCT01591460|591808381|FG000|Overall Study|Lost to Follow-up|1|||
163959608|NCT03056755|592224048|FG001|Core Phase|Adverse Event|14|||
163846534|NCT01591460|591808381|FG000|Overall Study|Noncompliance|1|||
163846535|NCT01591460|591808381|FG000|Overall Study|Participant Refusal|3|||
163846536|NCT01591460|591808381|FG000|Overall Study|Withdrawal by Subject|1|||
163846537|NCT01591460|591808381|FG000|Overall Study|Protocol Violation|1|||
163846538|NCT04102540|591808386|FG000|Overall Study|Withdrawn by PI|2|||
163846539|NCT04102540|591808386|FG000|Overall Study|Lost to Follow-up|6|||
163846540|NCT01720797|591808387|FG000|Overall Study|Withdrawal by Subject|3|||
163846541|NCT01720797|591808388|FG001|Overall Study|Withdrawal by Subject|0|||
164307161|NCT01166282|593499197|FG002|Open-label Period|Withdrawal by Subject|4|||
164307162|NCT01166282|593499195|FG000|Open-label Period|Lack of Efficacy|0|||
164307163|NCT01166282|593499196|FG001|Open-label Period|Lack of Efficacy|0|||
164307164|NCT01166282|593499197|FG002|Open-label Period|Lack of Efficacy|2|||
164307165|NCT01166282|593499195|FG000|Open-label Period|Remission|0|||
164307166|NCT01166282|593499196|FG001|Open-label Period|Remission|0|||
164307167|NCT01166282|593499197|FG002|Open-label Period|Remission|4|||
164307168|NCT01166282|593499195|FG000|Open-label Period|Irregular Compliance|0|||
164307169|NCT01166282|593499196|FG001|Open-label Period|Irregular Compliance|0|||
164307170|NCT01166282|593499197|FG002|Open-label Period|Irregular Compliance|1|||
164307171|NCT02561832|593499206|FG000|Overall Study|Withdrawal by Subject|1|||
164307172|NCT02561832|593499207|FG001|Overall Study|Withdrawal by Subject|1|||
164307173|NCT02561832|593499206|FG000|Overall Study|Adverse Event|3|||
164307174|NCT02561832|593499207|FG001|Overall Study|Adverse Event|0|||
164307175|NCT02561832|593499206|FG000|Overall Study|Disease progression|3|||
164307176|NCT02561832|593499207|FG001|Overall Study|Disease progression|3|||
164307177|NCT02892448|593499208|FG000|Overall Study|Screening failure|2|||
164307178|NCT02892448|593499209|FG001|Overall Study|Screening failure|2|||
164307179|NCT02892448|593499210|FG002|Overall Study|Screening failure|1|||
164307180|NCT03214666|593499211|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307181|NCT03214666|593499212|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307182|NCT03214666|593499213|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307183|NCT03214666|593499214|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307184|NCT03214666|593499215|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
164307185|NCT03214666|593499216|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
164307186|NCT03048578|593499217|FG000|Overall Study|Withdrawal by Subject|5|||
164307187|NCT03048578|593499218|FG001|Overall Study|Withdrawal by Subject|6|||
164307188|NCT03048578|593499217|FG000|Overall Study|Lost to Follow-up|22|||
164307189|NCT03048578|593499218|FG001|Overall Study|Lost to Follow-up|10|||
164307190|NCT03048578|593499217|FG000|Overall Study|Adverse Event|1|||
164307191|NCT03048578|593499218|FG001|Overall Study|Adverse Event|2|||
164307192|NCT03048578|593499217|FG000|Overall Study|Terminated|3|||
164307193|NCT03048578|593499218|FG001|Overall Study|Terminated|2|||
164307194|NCT02023697|593499223|FG000|Treatment Period|Radiological progression|13|||
164307195|NCT02023697|593499224|FG001|Treatment Period|Radiological progression|17|||
164307196|NCT02023697|593499225|FG002|Treatment Period|Radiological progression|26|||
164307197|NCT02023697|593499223|FG000|Treatment Period|Never Treated|5|||
164307198|NCT02023697|593499224|FG001|Treatment Period|Never Treated|6|||
164307199|NCT02023697|593499225|FG002|Treatment Period|Never Treated|10|||
164307200|NCT02023697|593499223|FG000|Treatment Period|Adverse Event|13|||
164307201|NCT02023697|593499224|FG001|Treatment Period|Adverse Event|25|||
164307202|NCT02023697|593499225|FG002|Treatment Period|Adverse Event|23|||
164307203|NCT02023697|593499223|FG000|Treatment Period|Logistical difficulties|1|||
164307204|NCT02023697|593499224|FG001|Treatment Period|Logistical difficulties|1|||
164307205|NCT02023697|593499225|FG002|Treatment Period|Logistical difficulties|1|||
164307206|NCT02023697|593499223|FG000|Treatment Period|Clinical progression|10|||
164307207|NCT02023697|593499224|FG001|Treatment Period|Clinical progression|8|||
164307208|NCT02023697|593499225|FG002|Treatment Period|Clinical progression|28|||
164307209|NCT02023697|593499223|FG000|Treatment Period|Withdrawal by Subject|4|||
164307210|NCT02023697|593499224|FG001|Treatment Period|Withdrawal by Subject|5|||
164307211|NCT02023697|593499225|FG002|Treatment Period|Withdrawal by Subject|13|||
164307212|NCT02023697|593499223|FG000|Treatment Period|Safety outcome reached|0|||
164307213|NCT02023697|593499224|FG001|Treatment Period|Safety outcome reached|1|||
164307214|NCT02023697|593499225|FG002|Treatment Period|Safety outcome reached|0|||
164307215|NCT02023697|593499223|FG000|Treatment Period|Physician Decision|0|||
164307216|NCT02023697|593499224|FG001|Treatment Period|Physician Decision|0|||
164307217|NCT02023697|593499225|FG002|Treatment Period|Physician Decision|1|||
164307218|NCT02023697|593499223|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
164307219|NCT02023697|593499224|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
164307220|NCT02023697|593499225|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
164307221|NCT02023697|593499223|FG000|Active Follow-up Period|Lost to Follow-up|1|||
164307222|NCT02023697|593499224|FG001|Active Follow-up Period|Lost to Follow-up|1|||
164307223|NCT02023697|593499225|FG002|Active Follow-up Period|Lost to Follow-up|1|||
163846542|NCT01686932|591808391|FG000|Period 1|Adverse Event|1|||
164307224|NCT02023697|593499223|FG000|Active Follow-up Period|Deterioration of general condition|1|||
164307225|NCT02023697|593499224|FG001|Active Follow-up Period|Deterioration of general condition|1|||
164307226|NCT02023697|593499225|FG002|Active Follow-up Period|Deterioration of general condition|1|||
164307227|NCT02023697|593499223|FG000|Active Follow-up Period|Other unspecified|2|||
164307228|NCT02023697|593499224|FG001|Active Follow-up Period|Other unspecified|0|||
164307229|NCT02023697|593499225|FG002|Active Follow-up Period|Other unspecified|1|||
164307230|NCT02023697|593499223|FG000|Active Follow-up Period|Clinical progression|0|||
164307231|NCT02023697|593499224|FG001|Active Follow-up Period|Clinical progression|2|||
164307232|NCT02023697|593499225|FG002|Active Follow-up Period|Clinical progression|1|||
164307233|NCT02023697|593499223|FG000|Active Follow-up Period|Radiological progression|0|||
163846543|NCT01686932|591808392|FG001|Period 1|Adverse Event|1|||
164307234|NCT02023697|593499224|FG001|Active Follow-up Period|Radiological progression|0|||
164307235|NCT02023697|593499225|FG002|Active Follow-up Period|Radiological progression|1|||
164307236|NCT02023697|593499223|FG000|Active Follow-up Period|Death|83|||
164307237|NCT02023697|593499224|FG001|Active Follow-up Period|Death|82|||
164307238|NCT02023697|593499225|FG002|Active Follow-up Period|Death|87|||
164307239|NCT02023697|593499223|FG000|Long-term Follow-up Period|Death|9|||
164307240|NCT02023697|593499224|FG001|Long-term Follow-up Period|Death|6|||
164307241|NCT02023697|593499225|FG002|Long-term Follow-up Period|Death|4|||
164307242|NCT02023697|593499223|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
164307243|NCT02023697|593499224|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
164307244|NCT02023697|593499225|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
164307245|NCT02023697|593499223|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
164307246|NCT02023697|593499224|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
164307247|NCT02023697|593499225|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
164307248|NCT02023697|593499223|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
163846544|NCT04827134|591808395|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
163846545|NCT04827134|591808396|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
163846546|NCT04827134|591808397|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
163846547|NCT04827134|591808398|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
163846548|NCT00924469|591808408|FG000|Overall Study|Adverse Event|2|||
163846549|NCT00924469|591808409|FG001|Overall Study|Adverse Event|0|||
163846550|NCT00924469|591808408|FG000|Overall Study|Withdrawal by Subject|0|||
163846551|NCT00924469|591808409|FG001|Overall Study|Withdrawal by Subject|1|||
163846552|NCT00924469|591808408|FG000|Overall Study|Lost to Follow-up|0|||
163846553|NCT00924469|591808409|FG001|Overall Study|Lost to Follow-up|1|||
163846554|NCT01651936|591808410|FG000|Base Study|Adverse Event|3|||
163846555|NCT01651936|591808411|FG001|Base Study|Adverse Event|0|||
163846556|NCT01651936|591808412|FG002|Base Study|Adverse Event|0|||
163846557|NCT01651936|591808410|FG000|Base Study|Withdrawal by Subject|1|||
163846558|NCT01651936|591808411|FG001|Base Study|Withdrawal by Subject|1|||
163846559|NCT01651936|591808412|FG002|Base Study|Withdrawal by Subject|0|||
163846560|NCT01651936|591808410|FG000|Base Study|Early Escape|2|||
163846561|NCT01651936|591808411|FG001|Base Study|Early Escape|8|||
163846562|NCT01651936|591808412|FG002|Base Study|Early Escape|0|||
163846563|NCT01651936|591808410|FG000|Base Study|Study terminated by sponsor|21|||
163846564|NCT01651936|591808411|FG001|Base Study|Study terminated by sponsor|16|||
163846565|NCT01651936|591808412|FG002|Base Study|Study terminated by sponsor|0|||
163846566|NCT01651936|591808410|FG000|Extension Study|Lack of Efficacy|0|||
163846567|NCT01651936|591808411|FG001|Extension Study|Lack of Efficacy|0|||
163846568|NCT01651936|591808412|FG002|Extension Study|Lack of Efficacy|1|||
163846569|NCT01651936|591808410|FG000|Extension Study|Study terminated by sponsor|0|||
163846570|NCT01651936|591808411|FG001|Extension Study|Study terminated by sponsor|0|||
163846571|NCT01651936|591808412|FG002|Extension Study|Study terminated by sponsor|13|||
163846572|NCT03044353|591808413|FG000|Overall Study|Adverse Event|0|||
163846573|NCT03044353|591808414|FG001|Overall Study|Adverse Event|1|||
163846574|NCT03044353|591808415|FG002|Overall Study|Adverse Event|0|||
163846575|NCT03358329|591808416|FG000|Overall Study|Lost to Follow-up|2|||
163846576|NCT03358329|591808416|FG000|Overall Study|Withdrawal by Subject|2|||
163846577|NCT03875911|591808419|FG000|Overall Study|Lost to Follow-up|3|||
163846578|NCT03875911|591808420|FG001|Overall Study|Lost to Follow-up|6|||
163846579|NCT03875911|591808421|FG002|Overall Study|Lost to Follow-up|2|||
163846580|NCT03875911|591808419|FG000|Overall Study|Surgery cancelled|1|||
163846581|NCT03875911|591808420|FG001|Overall Study|Surgery cancelled|0|||
163846582|NCT03875911|591808421|FG002|Overall Study|Surgery cancelled|1|||
163846583|NCT03875911|591808419|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
163846584|NCT03875911|591808420|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
163846585|NCT03875911|591808421|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
163846586|NCT05284019|591808422|FG000|Overall Study|Study terminated|2|||
163846587|NCT05284019|591808423|FG001|Overall Study|Study terminated|2|||
163846588|NCT05284019|591808424|FG002|Overall Study|Study terminated|2|||
163846589|NCT05284019|591808425|FG003|Overall Study|Study terminated|5|||
163846590|NCT05284019|591808426|FG004|Overall Study|Study terminated|15|||
163846591|NCT05284019|591808422|FG000|Overall Study|Withdrawal by Subject|0|||
163846592|NCT05284019|591808423|FG001|Overall Study|Withdrawal by Subject|0|||
163846593|NCT05284019|591808424|FG002|Overall Study|Withdrawal by Subject|0|||
163846594|NCT05284019|591808425|FG003|Overall Study|Withdrawal by Subject|1|||
163846595|NCT05284019|591808426|FG004|Overall Study|Withdrawal by Subject|1|||
163846596|NCT05284019|591808422|FG000|Overall Study|Lost to Follow-up|1|||
163846597|NCT05284019|591808423|FG001|Overall Study|Lost to Follow-up|0|||
163846598|NCT05284019|591808424|FG002|Overall Study|Lost to Follow-up|0|||
163846599|NCT05284019|591808425|FG003|Overall Study|Lost to Follow-up|2|||
163846600|NCT05284019|591808426|FG004|Overall Study|Lost to Follow-up|1|||
163846601|NCT01990300|591808427|FG000|Overall Study|Case Report Forms Uncollected|89|||
163846602|NCT01990300|591808427|FG000|Overall Study|Protocol Deviation|53|||
163846603|NCT01231503|591808428|FG000|Overall Study|Adverse Event|0|||
163846604|NCT01231503|591808429|FG001|Overall Study|Adverse Event|0|||
163846605|NCT01231503|591808430|FG002|Overall Study|Adverse Event|0|||
163846606|NCT01231503|591808431|FG003|Overall Study|Adverse Event|0|||
163846607|NCT01231503|591808432|FG004|Overall Study|Adverse Event|0|||
163846608|NCT01231503|591808433|FG005|Overall Study|Adverse Event|1|||
163846609|NCT01231503|591808434|FG006|Overall Study|Adverse Event|0|||
163846610|NCT01231503|591808435|FG007|Overall Study|Adverse Event|0|||
163846611|NCT01231503|591808428|FG000|Overall Study|Adverse event, serious fatal|0|||
163846612|NCT01231503|591808429|FG001|Overall Study|Adverse event, serious fatal|0|||
163846613|NCT01231503|591808430|FG002|Overall Study|Adverse event, serious fatal|1|||
163846614|NCT01231503|591808431|FG003|Overall Study|Adverse event, serious fatal|1|||
163846615|NCT01231503|591808432|FG004|Overall Study|Adverse event, serious fatal|0|||
163846616|NCT01231503|591808433|FG005|Overall Study|Adverse event, serious fatal|1|||
163846617|NCT01231503|591808434|FG006|Overall Study|Adverse event, serious fatal|0|||
163846618|NCT01231503|591808435|FG007|Overall Study|Adverse event, serious fatal|0|||
163846619|NCT01231503|591808428|FG000|Overall Study|Withdrawal by Subject|6|||
163846620|NCT01231503|591808429|FG001|Overall Study|Withdrawal by Subject|3|||
163846621|NCT01231503|591808430|FG002|Overall Study|Withdrawal by Subject|3|||
163846622|NCT01231503|591808431|FG003|Overall Study|Withdrawal by Subject|1|||
163846623|NCT01231503|591808432|FG004|Overall Study|Withdrawal by Subject|3|||
163846624|NCT01231503|591808433|FG005|Overall Study|Withdrawal by Subject|5|||
163846625|NCT01231503|591808434|FG006|Overall Study|Withdrawal by Subject|1|||
163846626|NCT01231503|591808435|FG007|Overall Study|Withdrawal by Subject|2|||
163846627|NCT01231503|591808428|FG000|Overall Study|Lost to Follow-up|8|||
163846628|NCT01231503|591808429|FG001|Overall Study|Lost to Follow-up|10|||
163846629|NCT01231503|591808430|FG002|Overall Study|Lost to Follow-up|8|||
163846630|NCT01231503|591808431|FG003|Overall Study|Lost to Follow-up|5|||
163846631|NCT01231503|591808432|FG004|Overall Study|Lost to Follow-up|7|||
163846632|NCT01231503|591808433|FG005|Overall Study|Lost to Follow-up|9|||
163846633|NCT01231503|591808434|FG006|Overall Study|Lost to Follow-up|6|||
163846634|NCT01231503|591808435|FG007|Overall Study|Lost to Follow-up|6|||
163846635|NCT01231503|591808428|FG000|Overall Study|Protocol Violation|0|||
163846636|NCT01231503|591808429|FG001|Overall Study|Protocol Violation|0|||
163846637|NCT01231503|591808430|FG002|Overall Study|Protocol Violation|0|||
163846638|NCT01231503|591808431|FG003|Overall Study|Protocol Violation|1|||
163846639|NCT01231503|591808432|FG004|Overall Study|Protocol Violation|0|||
163846640|NCT01231503|591808433|FG005|Overall Study|Protocol Violation|0|||
163959609|NCT03056755|592224049|FG002|Core Phase|Adverse Event|13|||
163846641|NCT01231503|591808434|FG006|Overall Study|Protocol Violation|0|||
163846642|NCT01231503|591808435|FG007|Overall Study|Protocol Violation|0|||
163846643|NCT02293837|591808436|FG000|Overall Study|Lost to Follow-up|0|||
163846644|NCT02293837|591808437|FG001|Overall Study|Lost to Follow-up|2|||
163846645|NCT02293837|591808438|FG002|Overall Study|Lost to Follow-up|1|||
163959610|NCT03056755|592224047|FG000|Core Phase|Physician Decision|7|||
163959611|NCT03056755|592224048|FG001|Core Phase|Physician Decision|13|||
163959612|NCT03056755|592224049|FG002|Core Phase|Physician Decision|5|||
163959613|NCT03056755|592224047|FG000|Core Phase|Subject/guardian decision|5|||
163959614|NCT03056755|592224048|FG001|Core Phase|Subject/guardian decision|8|||
163959615|NCT03056755|592224049|FG002|Core Phase|Subject/guardian decision|4|||
163959616|NCT03056755|592224047|FG000|Core Phase|Death|3|||
163959617|NCT03056755|592224048|FG001|Core Phase|Death|2|||
163959618|NCT03056755|592224049|FG002|Core Phase|Death|4|||
163959619|NCT03056755|592224047|FG000|Core Phase|Protocol deviation|1|||
163959620|NCT03056755|592224048|FG001|Core Phase|Protocol deviation|1|||
163959621|NCT03056755|592224049|FG002|Core Phase|Protocol deviation|0|||
163959622|NCT03056755|592224047|FG000|Core Phase|Technical problems|1|||
163959623|NCT03056755|592224048|FG001|Core Phase|Technical problems|0|||
163959624|NCT03056755|592224049|FG002|Core Phase|Technical problems|0|||
163959625|NCT03056755|592224047|FG000|Extension Phase|Physician Decision|1|||
163959626|NCT03056755|592224048|FG001|Extension Phase|Physician Decision|0|||
163959627|NCT03056755|592224049|FG002|Extension Phase|Physician Decision|3|||
163959628|NCT03056755|592224047|FG000|Extension Phase|Adverse Event|0|||
163959629|NCT03056755|592224048|FG001|Extension Phase|Adverse Event|0|||
163959630|NCT03056755|592224049|FG002|Extension Phase|Adverse Event|1|||
163959631|NCT03056755|592224047|FG000|Extension Phase|Subject/guardian decision|0|||
163959632|NCT03056755|592224048|FG001|Extension Phase|Subject/guardian decision|0|||
163959633|NCT03056755|592224049|FG002|Extension Phase|Subject/guardian decision|1|||
163959634|NCT00402363|592224050|FG000|Overall Study|Adverse Event|9|||
163959635|NCT00402363|592224051|FG001|Overall Study|Adverse Event|14|||
163959636|NCT00402363|592224052|FG002|Overall Study|Adverse Event|2|||
163959637|NCT00402363|592224053|FG003|Overall Study|Adverse Event|2|||
163959638|NCT00402363|592224050|FG000|Overall Study|Withdrew Consent|10|||
163959639|NCT00402363|592224051|FG001|Overall Study|Withdrew Consent|5|||
163959640|NCT00402363|592224052|FG002|Overall Study|Withdrew Consent|2|||
163959641|NCT00402363|592224053|FG003|Overall Study|Withdrew Consent|1|||
163846646|NCT02293837|591808439|FG003|Overall Study|Lost to Follow-up|0|||
163846647|NCT02293837|591808436|FG000|Overall Study|Withdrawal by Subject|2|||
163846648|NCT02293837|591808437|FG001|Overall Study|Withdrawal by Subject|1|||
163846649|NCT02293837|591808438|FG002|Overall Study|Withdrawal by Subject|2|||
163846650|NCT02293837|591808439|FG003|Overall Study|Withdrawal by Subject|1|||
163846651|NCT02293837|591808436|FG000|Overall Study|COVID-19 Related|1|||
163846652|NCT02293837|591808437|FG001|Overall Study|COVID-19 Related|1|||
163846653|NCT02293837|591808438|FG002|Overall Study|COVID-19 Related|0|||
163846654|NCT02293837|591808439|FG003|Overall Study|COVID-19 Related|0|||
163846655|NCT02293837|591808436|FG000|Overall Study|Participant ill and could not be infused|0|||
163846656|NCT02293837|591808437|FG001|Overall Study|Participant ill and could not be infused|0|||
163846657|NCT02293837|591808438|FG002|Overall Study|Participant ill and could not be infused|1|||
163846658|NCT02293837|591808439|FG003|Overall Study|Participant ill and could not be infused|0|||
163846659|NCT01076088|591808440|FG000|Overall Study|Adverse Event|1|||
163846660|NCT01076088|591808441|FG001|Overall Study|Adverse Event|6|||
163846661|NCT01076088|591808442|FG002|Overall Study|Adverse Event|3|||
163846662|NCT01076088|591808443|FG003|Overall Study|Adverse Event|2|||
163846663|NCT01076088|591808444|FG004|Overall Study|Adverse Event|3|||
163846664|NCT01076088|591808445|FG005|Overall Study|Adverse Event|3|||
163846665|NCT01076088|591808440|FG000|Overall Study|Lost to Follow-up|1|||
163846666|NCT01076088|591808441|FG001|Overall Study|Lost to Follow-up|1|||
163846667|NCT01076088|591808442|FG002|Overall Study|Lost to Follow-up|0|||
163846668|NCT01076088|591808443|FG003|Overall Study|Lost to Follow-up|1|||
163846669|NCT01076088|591808444|FG004|Overall Study|Lost to Follow-up|1|||
163846670|NCT01076088|591808445|FG005|Overall Study|Lost to Follow-up|2|||
163846671|NCT01076088|591808440|FG000|Overall Study|Non-compliance with study drug|0|||
163846672|NCT01076088|591808441|FG001|Overall Study|Non-compliance with study drug|0|||
163846673|NCT01076088|591808442|FG002|Overall Study|Non-compliance with study drug|0|||
163846674|NCT01076088|591808443|FG003|Overall Study|Non-compliance with study drug|1|||
163846675|NCT01076088|591808444|FG004|Overall Study|Non-compliance with study drug|0|||
163846676|NCT01076088|591808445|FG005|Overall Study|Non-compliance with study drug|0|||
163846677|NCT01076088|591808440|FG000|Overall Study|Physician Decision|1|||
163846678|NCT01076088|591808441|FG001|Overall Study|Physician Decision|3|||
163846679|NCT01076088|591808442|FG002|Overall Study|Physician Decision|0|||
163846680|NCT01076088|591808443|FG003|Overall Study|Physician Decision|1|||
163846681|NCT01076088|591808444|FG004|Overall Study|Physician Decision|1|||
163846682|NCT01076088|591808445|FG005|Overall Study|Physician Decision|0|||
163846683|NCT01076088|591808440|FG000|Overall Study|Withdrawal by Subject|8|||
163846684|NCT01076088|591808441|FG001|Overall Study|Withdrawal by Subject|8|||
163846685|NCT01076088|591808442|FG002|Overall Study|Withdrawal by Subject|14|||
163959642|NCT00402363|592224050|FG000|Overall Study|Protocol Violation|3|||
163959643|NCT00402363|592224051|FG001|Overall Study|Protocol Violation|5|||
163959644|NCT00402363|592224052|FG002|Overall Study|Protocol Violation|0|||
163959645|NCT00402363|592224053|FG003|Overall Study|Protocol Violation|3|||
163959646|NCT00402363|592224050|FG000|Overall Study|Lost to Follow-up|5|||
163959647|NCT00402363|592224051|FG001|Overall Study|Lost to Follow-up|4|||
163959648|NCT00402363|592224052|FG002|Overall Study|Lost to Follow-up|0|||
163959649|NCT00402363|592224053|FG003|Overall Study|Lost to Follow-up|2|||
163959650|NCT00402363|592224050|FG000|Overall Study|"Captured as Other"|6|||
163959651|NCT00402363|592224051|FG001|Overall Study|"Captured as Other"|2|||
163959652|NCT00402363|592224052|FG002|Overall Study|"Captured as Other"|2|||
163846686|NCT01076088|591808443|FG003|Overall Study|Withdrawal by Subject|10|||
163846687|NCT01076088|591808444|FG004|Overall Study|Withdrawal by Subject|11|||
163846688|NCT01076088|591808445|FG005|Overall Study|Withdrawal by Subject|17|||
163846689|NCT01076088|591808440|FG000|Overall Study|Other protocol specified criteria|0|||
163846690|NCT01076088|591808441|FG001|Overall Study|Other protocol specified criteria|0|||
163846691|NCT01076088|591808442|FG002|Overall Study|Other protocol specified criteria|0|||
163846692|NCT01076088|591808443|FG003|Overall Study|Other protocol specified criteria|0|||
163959653|NCT00402363|592224053|FG003|Overall Study|"Captured as Other"|2|||
163959654|NCT04667949|592224069|FG000|Overall Study|Adverse Event|0|||
163959655|NCT04667949|592224070|FG001|Overall Study|Adverse Event|2|||
163959656|NCT04667949|592224069|FG000|Overall Study|Lost to Follow-up|0|||
163959657|NCT04667949|592224070|FG001|Overall Study|Lost to Follow-up|1|||
163959658|NCT04667949|592224069|FG000|Overall Study|Physician Decision|0|||
163959659|NCT04667949|592224070|FG001|Overall Study|Physician Decision|2|||
163959660|NCT04667949|592224069|FG000|Overall Study|Subject decision|1|||
163959661|NCT04667949|592224070|FG001|Overall Study|Subject decision|7|||
163959662|NCT04504630|592224071|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
163959663|NCT04504630|592224072|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
163959664|NCT04504630|592224071|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
163959665|NCT04504630|592224072|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
163959666|NCT00568321|592224073|FG000|Overall Study|Adverse Event|1|||
163959667|NCT00568321|592224074|FG001|Overall Study|Adverse Event|0|||
163959668|NCT00568321|592224075|FG002|Overall Study|Adverse Event|0|||
163959669|NCT00568321|592224073|FG000|Overall Study|Lack of Efficacy|8|||
163959670|NCT00568321|592224074|FG001|Overall Study|Lack of Efficacy|5|||
163959671|NCT00568321|592224075|FG002|Overall Study|Lack of Efficacy|6|||
163959672|NCT00568321|592224073|FG000|Overall Study|Lost to Follow-up|0|||
163959673|NCT00568321|592224074|FG001|Overall Study|Lost to Follow-up|0|||
163959674|NCT00568321|592224075|FG002|Overall Study|Lost to Follow-up|1|||
163959675|NCT00568321|592224073|FG000|Overall Study|Withdrawal by Subject|2|||
163959676|NCT00568321|592224074|FG001|Overall Study|Withdrawal by Subject|0|||
163959677|NCT00568321|592224075|FG002|Overall Study|Withdrawal by Subject|0|||
163959678|NCT00568321|592224073|FG000|Overall Study|Protocol Violation|0|||
163959679|NCT00568321|592224074|FG001|Overall Study|Protocol Violation|0|||
163959680|NCT00568321|592224075|FG002|Overall Study|Protocol Violation|1|||
163959681|NCT00568321|592224073|FG000|Overall Study|Randomized, not treated|2|||
163959682|NCT00568321|592224074|FG001|Overall Study|Randomized, not treated|0|||
163959683|NCT00568321|592224075|FG002|Overall Study|Randomized, not treated|1|||
163959684|NCT00937833|592224077|FG000|Overall Study|Protocol Violation|1|||
163959685|NCT00937833|592224078|FG001|Overall Study|Protocol Violation|2|||
163959686|NCT00937833|592224077|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
163959687|NCT00937833|592224078|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
163959688|NCT00937833|592224077|FG000|Overall Study|Lost to Follow-up|10|||
163959689|NCT00937833|592224078|FG001|Overall Study|Lost to Follow-up|8|||
163959690|NCT00937833|592224077|FG000|Overall Study|Withdrawal by Subject|4|||
163959691|NCT00937833|592224078|FG001|Overall Study|Withdrawal by Subject|6|||
163959692|NCT04266301|592224079|FG000|Overall Study|Progressive Disease|111|||
163959693|NCT04266301|592224080|FG001|Overall Study|Progressive Disease|92|||
163959694|NCT04266301|592224079|FG000|Overall Study|Adverse Event|41|||
163959695|NCT04266301|592224080|FG001|Overall Study|Adverse Event|43|||
163959696|NCT04266301|592224079|FG000|Overall Study|Death|26|||
163959697|NCT04266301|592224080|FG001|Overall Study|Death|35|||
163959698|NCT04266301|592224079|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
163959699|NCT04266301|592224080|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
163959700|NCT04266301|592224079|FG000|Overall Study|Study Terminated by Sponsor|22|||
163959701|NCT04266301|592224080|FG001|Overall Study|Study Terminated by Sponsor|27|||
163959702|NCT04266301|592224079|FG000|Overall Study|Participant Decision|22|||
163959703|NCT04266301|592224080|FG001|Overall Study|Participant Decision|28|||
163959704|NCT04266301|592224079|FG000|Overall Study|Physician Decision|14|||
163959705|NCT04266301|592224080|FG001|Overall Study|Physician Decision|9|||
163959706|NCT04266301|592224079|FG000|Overall Study|New Therapy for Study Indication|2|||
163959707|NCT04266301|592224080|FG001|Overall Study|New Therapy for Study Indication|4|||
163959708|NCT04266301|592224079|FG000|Overall Study|Protocol Deviation|2|||
163959709|NCT04266301|592224080|FG001|Overall Study|Protocol Deviation|4|||
163959710|NCT04266301|592224079|FG000|Overall Study|Guardian Decision|1|||
163959711|NCT04266301|592224080|FG001|Overall Study|Guardian Decision|0|||
163959712|NCT04266301|592224079|FG000|Overall Study|Lost to Follow-up|1|||
163959713|NCT04266301|592224080|FG001|Overall Study|Lost to Follow-up|0|||
163846693|NCT01076088|591808444|FG004|Overall Study|Other protocol specified criteria|0|||
163846694|NCT01076088|591808445|FG005|Overall Study|Other protocol specified criteria|1|||
163846695|NCT03285113|591808446|FG000|Overall Study|Unable to implant leads|2|||
163846696|NCT03053492|591808447|FG000|Overall Study|Adverse Event|1|||
163846697|NCT03053492|591808448|FG001|Overall Study|Adverse Event|1|||
163846698|NCT03053492|591808447|FG000|Overall Study|Withdrawal by Subject|7|||
163846699|NCT03053492|591808448|FG001|Overall Study|Withdrawal by Subject|5|||
163846700|NCT01448044|591808453|FG000|Treatment Period|Adverse Event|4|||
163846701|NCT01448044|591808454|FG001|Treatment Period|Adverse Event|3|||
163959714|NCT04266301|592224079|FG000|Overall Study|Participants Not Treated|1|||
163959715|NCT04266301|592224080|FG001|Overall Study|Participants Not Treated|1|||
163959716|NCT03215758|592224081|FG000|Overall Study|Technical Problems|1|||
163959717|NCT03215758|592224082|FG001|Overall Study|Technical Problems|0|||
163846702|NCT01448044|591808453|FG000|Treatment Period|Lack of Efficacy|5|||
163846703|NCT01448044|591808454|FG001|Treatment Period|Lack of Efficacy|12|||
163959718|NCT03215758|592224081|FG000|Overall Study|Protocol deviation|0|||
163959719|NCT03215758|592224082|FG001|Overall Study|Protocol deviation|1|||
163959720|NCT03215758|592224081|FG000|Overall Study|Physician Decision|0|||
163846704|NCT01448044|591808453|FG000|Treatment Period|Subject requested discontinue study drug|1|||
163959721|NCT03215758|592224082|FG001|Overall Study|Physician Decision|1|||
163846705|NCT01448044|591808454|FG001|Treatment Period|Subject requested discontinue study drug|0|||
163846706|NCT01448044|591808453|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
163846707|NCT01448044|591808454|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
163846708|NCT01448044|591808453|FG000|Treatment Period|Participant does not meet study criteria|1|||
163846709|NCT01448044|591808454|FG001|Treatment Period|Participant does not meet study criteria|0|||
163846710|NCT01448044|591808453|FG000|Treatment Period|Lost to Follow-up|2|||
163846711|NCT01448044|591808454|FG001|Treatment Period|Lost to Follow-up|1|||
163846712|NCT01448044|591808453|FG000|Treatment Period|Other reason|2|||
163846713|NCT01448044|591808454|FG001|Treatment Period|Other reason|0|||
163846714|NCT01448044|591808453|FG000|Follow Up Period|Withdrawal by Subject|1|||
163846715|NCT01448044|591808454|FG001|Follow Up Period|Withdrawal by Subject|1|||
163846716|NCT01448044|591808453|FG000|Follow Up Period|Lost to Follow-up|6|||
163846717|NCT01448044|591808454|FG001|Follow Up Period|Lost to Follow-up|2|||
163846718|NCT01448044|591808453|FG000|Follow Up Period|Other|5|||
163846719|NCT01448044|591808454|FG001|Follow Up Period|Other|11|||
163846720|NCT03018106|591808456|FG000|Overall Study|Lost to Follow-up|0|||
163846721|NCT03018106|591808457|FG001|Overall Study|Lost to Follow-up|1|||
163846722|NCT01994720|591808458|FG000|Overall Study|Withdrawal by Subject|46|||
163846723|NCT01994720|591808459|FG001|Overall Study|Withdrawal by Subject|56|||
163846724|NCT01010217|591808461|FG000|Overall Study|Lost to Follow-up|4|||
163846725|NCT01010217|591808462|FG001|Overall Study|Lost to Follow-up|5|||
163846726|NCT01010217|591808463|FG002|Overall Study|Lost to Follow-up|1|||
163846727|NCT01010217|591808464|FG003|Overall Study|Lost to Follow-up|0|||
163846728|NCT01010217|591808465|FG004|Overall Study|Lost to Follow-up|0|||
163846729|NCT01010217|591808461|FG000|Overall Study|Withdrawal by Subject|1|||
163846730|NCT01010217|591808462|FG001|Overall Study|Withdrawal by Subject|0|||
163846731|NCT01010217|591808463|FG002|Overall Study|Withdrawal by Subject|0|||
163846732|NCT01010217|591808464|FG003|Overall Study|Withdrawal by Subject|0|||
163846733|NCT01010217|591808465|FG004|Overall Study|Withdrawal by Subject|0|||
163846734|NCT01010217|591808461|FG000|Overall Study|Physician Decision|0|||
163846735|NCT01010217|591808462|FG001|Overall Study|Physician Decision|0|||
163846736|NCT01010217|591808463|FG002|Overall Study|Physician Decision|0|||
163846737|NCT01010217|591808464|FG003|Overall Study|Physician Decision|6|||
163846738|NCT01010217|591808465|FG004|Overall Study|Physician Decision|3|||
163846739|NCT02213055|591808466|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
163846740|NCT02213055|591808467|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
163846741|NCT02213055|591808466|FG000|Overall Study|Protocol was not Followed during Study|1|||
163846742|NCT02213055|591808467|FG001|Overall Study|Protocol was not Followed during Study|0|||
163846743|NCT02213055|591808466|FG000|Overall Study|Documentation Issue at Enrollment|1|||
163846744|NCT02213055|591808467|FG001|Overall Study|Documentation Issue at Enrollment|0|||
163846745|NCT02213055|591808466|FG000|Overall Study|Documentation Issue during Study|10|||
163846746|NCT02213055|591808467|FG001|Overall Study|Documentation Issue during Study|0|||
163846747|NCT02213055|591808466|FG000|Overall Study|Did not have Live Lice|8|||
163846748|NCT02213055|591808467|FG001|Overall Study|Did not have Live Lice|0|||
163846749|NCT02213055|591808466|FG000|Overall Study|Had another Treatment during the Study|3|||
163846750|NCT02213055|591808467|FG001|Overall Study|Had another Treatment during the Study|0|||
163846751|NCT02213055|591808466|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
163846752|NCT02213055|591808467|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
163846753|NCT02213055|591808466|FG000|Overall Study|Did not Return to School|5|||
163846754|NCT02213055|591808467|FG001|Overall Study|Did not Return to School|0|||
163846755|NCT02061761|591808468|FG000|Overall Study|Disease progression|2|||
163846756|NCT02061761|591808469|FG001|Overall Study|Disease progression|8|||
163846757|NCT02061761|591808470|FG002|Overall Study|Disease progression|4|||
163846758|NCT02061761|591808471|FG003|Overall Study|Disease progression|5|||
163846759|NCT02061761|591808472|FG004|Overall Study|Disease progression|9|||
163846760|NCT02061761|591808473|FG005|Overall Study|Disease progression|3|||
163846761|NCT02061761|591808474|FG006|Overall Study|Disease progression|1|||
163846762|NCT02061761|591808475|FG007|Overall Study|Disease progression|2|||
163846763|NCT02061761|591808476|FG008|Overall Study|Disease progression|28|||
163846764|NCT02061761|591808468|FG000|Overall Study|Study Drug toxicity|0|||
163846765|NCT02061761|591808469|FG001|Overall Study|Study Drug toxicity|0|||
163846766|NCT02061761|591808470|FG002|Overall Study|Study Drug toxicity|0|||
163846767|NCT02061761|591808471|FG003|Overall Study|Study Drug toxicity|0|||
163846768|NCT02061761|591808472|FG004|Overall Study|Study Drug toxicity|0|||
163846769|NCT02061761|591808473|FG005|Overall Study|Study Drug toxicity|1|||
163846770|NCT02061761|591808474|FG006|Overall Study|Study Drug toxicity|0|||
163846771|NCT02061761|591808475|FG007|Overall Study|Study Drug toxicity|2|||
163846772|NCT02061761|591808476|FG008|Overall Study|Study Drug toxicity|6|||
163846773|NCT02061761|591808468|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
163846774|NCT02061761|591808469|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
163846775|NCT02061761|591808470|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
163846776|NCT02061761|591808471|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
163846777|NCT02061761|591808472|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
163846778|NCT02061761|591808473|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
163846779|NCT02061761|591808474|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
163846780|NCT02061761|591808475|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
163846781|NCT02061761|591808476|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
163846782|NCT02061761|591808468|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163846783|NCT02061761|591808469|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163846784|NCT02061761|591808470|FG002|Overall Study|Participant request to discontinue study treatment|2|||
163846785|NCT02061761|591808471|FG003|Overall Study|Participant request to discontinue study treatment|2|||
163846786|NCT02061761|591808472|FG004|Overall Study|Participant request to discontinue study treatment|0|||
163846787|NCT02061761|591808473|FG005|Overall Study|Participant request to discontinue study treatment|1|||
163846788|NCT02061761|591808474|FG006|Overall Study|Participant request to discontinue study treatment|0|||
163846789|NCT02061761|591808475|FG007|Overall Study|Participant request to discontinue study treatment|0|||
163846790|NCT02061761|591808476|FG008|Overall Study|Participant request to discontinue study treatment|2|||
163846791|NCT02061761|591808468|FG000|Overall Study|Withdrawal by Subject|0|||
163846792|NCT02061761|591808469|FG001|Overall Study|Withdrawal by Subject|0|||
163846793|NCT02061761|591808470|FG002|Overall Study|Withdrawal by Subject|0|||
163846794|NCT02061761|591808471|FG003|Overall Study|Withdrawal by Subject|0|||
163846795|NCT02061761|591808472|FG004|Overall Study|Withdrawal by Subject|0|||
163846796|NCT02061761|591808473|FG005|Overall Study|Withdrawal by Subject|0|||
163846797|NCT02061761|591808474|FG006|Overall Study|Withdrawal by Subject|0|||
163846798|NCT02061761|591808475|FG007|Overall Study|Withdrawal by Subject|0|||
163846799|NCT02061761|591808476|FG008|Overall Study|Withdrawal by Subject|2|||
163846800|NCT02061761|591808468|FG000|Overall Study|Maximum clinical benefit|0|||
163846801|NCT02061761|591808469|FG001|Overall Study|Maximum clinical benefit|0|||
163846802|NCT02061761|591808470|FG002|Overall Study|Maximum clinical benefit|0|||
163846803|NCT02061761|591808471|FG003|Overall Study|Maximum clinical benefit|1|||
163846804|NCT02061761|591808472|FG004|Overall Study|Maximum clinical benefit|0|||
163846805|NCT02061761|591808473|FG005|Overall Study|Maximum clinical benefit|0|||
163846806|NCT02061761|591808474|FG006|Overall Study|Maximum clinical benefit|0|||
163846807|NCT02061761|591808475|FG007|Overall Study|Maximum clinical benefit|0|||
163846808|NCT02061761|591808476|FG008|Overall Study|Maximum clinical benefit|6|||
163846809|NCT02061761|591808468|FG000|Overall Study|Participant no longer meets study criteria|0|||
163846810|NCT02061761|591808469|FG001|Overall Study|Participant no longer meets study criteria|0|||
163846811|NCT02061761|591808470|FG002|Overall Study|Participant no longer meets study criteria|0|||
163846812|NCT02061761|591808471|FG003|Overall Study|Participant no longer meets study criteria|0|||
163846813|NCT02061761|591808472|FG004|Overall Study|Participant no longer meets study criteria|0|||
163846814|NCT02061761|591808473|FG005|Overall Study|Participant no longer meets study criteria|0|||
163846815|NCT02061761|591808474|FG006|Overall Study|Participant no longer meets study criteria|0|||
163846816|NCT02061761|591808475|FG007|Overall Study|Participant no longer meets study criteria|0|||
163846817|NCT02061761|591808476|FG008|Overall Study|Participant no longer meets study criteria|1|||
163846818|NCT02061761|591808468|FG000|Overall Study|Other reasons|0|||
163846819|NCT02061761|591808469|FG001|Overall Study|Other reasons|0|||
163846820|NCT02061761|591808470|FG002|Overall Study|Other reasons|0|||
163846821|NCT02061761|591808471|FG003|Overall Study|Other reasons|0|||
163846822|NCT02061761|591808472|FG004|Overall Study|Other reasons|2|||
163846823|NCT02061761|591808473|FG005|Overall Study|Other reasons|0|||
163846824|NCT02061761|591808474|FG006|Overall Study|Other reasons|0|||
163846825|NCT02061761|591808475|FG007|Overall Study|Other reasons|0|||
163846826|NCT02061761|591808476|FG008|Overall Study|Other reasons|6|||
163846827|NCT01024751|591808477|FG000|Enrolled Participants|Ineligible at baseline|3|||
163846828|NCT01024751|591808478|FG001|Enrolled Participants|Ineligible at baseline|4|||
163846829|NCT01024751|591808477|FG000|Eligible Participants|Withdrawal by Subject|0|||
163846830|NCT01024751|591808478|FG001|Eligible Participants|Withdrawal by Subject|1|||
163846831|NCT01024751|591808477|FG000|Eligible Participants|Lost to Follow-up|0|||
163846832|NCT01024751|591808478|FG001|Eligible Participants|Lost to Follow-up|1|||
163846833|NCT01024751|591808477|FG000|Eligible Participants|Ineligible|0|||
163846834|NCT01024751|591808478|FG001|Eligible Participants|Ineligible|1|||
163846835|NCT00577720|591808483|FG000|Overall Study|Adverse Event|2|||
163846836|NCT00577720|591808484|FG001|Overall Study|Adverse Event|1|||
163846837|NCT00577720|591808485|FG002|Overall Study|Adverse Event|0|||
163846838|NCT00577720|591808486|FG003|Overall Study|Adverse Event|4|||
163846839|NCT00577720|591808483|FG000|Overall Study|Lost to Follow-up|0|||
163846840|NCT00577720|591808484|FG001|Overall Study|Lost to Follow-up|0|||
163846841|NCT00577720|591808485|FG002|Overall Study|Lost to Follow-up|1|||
163846842|NCT00577720|591808486|FG003|Overall Study|Lost to Follow-up|0|||
163846843|NCT00577720|591808483|FG000|Overall Study|Protocol Violation|0|||
163846844|NCT00577720|591808484|FG001|Overall Study|Protocol Violation|0|||
163846845|NCT00577720|591808485|FG002|Overall Study|Protocol Violation|0|||
163846846|NCT00577720|591808486|FG003|Overall Study|Protocol Violation|1|||
163846847|NCT00577720|591808483|FG000|Overall Study|Withdrawal by Subject|2|||
163846848|NCT00577720|591808484|FG001|Overall Study|Withdrawal by Subject|0|||
163846849|NCT00577720|591808485|FG002|Overall Study|Withdrawal by Subject|0|||
163846850|NCT00577720|591808486|FG003|Overall Study|Withdrawal by Subject|2|||
163846851|NCT03246672|591808487|FG000|Overall Study|Lost to Follow-up|2|||
163846852|NCT03260504|591808488|FG000|Overall Study|Adverse Event|0|||
163846853|NCT03260504|591808489|FG001|Overall Study|Adverse Event|1|||
163846854|NCT00967018|591808490|FG000|Overall Study|Adverse Event|2|||
163846855|NCT00967018|591808490|FG000|Overall Study|Physician Decision|7|||
163846856|NCT00967018|591808490|FG000|Overall Study|Lost to Follow-up|2|||
163846857|NCT00967018|591808490|FG000|Overall Study|Withdrawal by Subject|1|||
163846858|NCT00967018|591808490|FG000|Overall Study|Miscellaneous Reasons|9|||
163846859|NCT05868954|591808496|FG000|Overall Study|Lost to Follow-up|0|||
163846860|NCT05868954|591808497|FG001|Overall Study|Lost to Follow-up|1|||
163846861|NCT05868954|591808496|FG000|Overall Study|Withdrawal by Subject|2|||
163846862|NCT05868954|591808497|FG001|Overall Study|Withdrawal by Subject|2|||
163846863|NCT05868954|591808496|FG000|Overall Study|Participant delivered|1|||
163846864|NCT05868954|591808497|FG001|Overall Study|Participant delivered|1|||
163846865|NCT05868954|591808496|FG000|Overall Study|Miscarriage|0|||
163846866|NCT05868954|591808497|FG001|Overall Study|Miscarriage|1|||
163846867|NCT01680458|591808507|FG000|Overall Study|Protocol Violation|3|||
163846868|NCT02138747|591808508|FG000|Treatment Period 1|Adverse Event|10|||
163846869|NCT02138747|591808509|FG001|Treatment Period 1|Adverse Event|14|||
163846870|NCT02138747|591808510|FG002|Treatment Period 1|Adverse Event|2|||
163846871|NCT02138747|591808511|FG003|Treatment Period 1|Adverse Event|1|||
163846872|NCT02138747|591808508|FG000|Treatment Period 1|Lost to Follow-up|0|||
163846873|NCT02138747|591808509|FG001|Treatment Period 1|Lost to Follow-up|1|||
163846874|NCT02138747|591808510|FG002|Treatment Period 1|Lost to Follow-up|1|||
163846875|NCT02138747|591808511|FG003|Treatment Period 1|Lost to Follow-up|0|||
163846876|NCT02138747|591808508|FG000|Treatment Period 1|Protocol Violation|0|||
163846877|NCT02138747|591808509|FG001|Treatment Period 1|Protocol Violation|2|||
163846878|NCT02138747|591808510|FG002|Treatment Period 1|Protocol Violation|0|||
163846879|NCT02138747|591808511|FG003|Treatment Period 1|Protocol Violation|0|||
163846880|NCT02138747|591808508|FG000|Treatment Period 1|Withdrawal by Subject|8|||
163846881|NCT02138747|591808509|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163846882|NCT02138747|591808510|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163846883|NCT02138747|591808511|FG003|Treatment Period 1|Withdrawal by Subject|3|||
163846884|NCT02138747|591808508|FG000|Treatment Period 1|Other - Miscellaneous|2|||
163846885|NCT02138747|591808509|FG001|Treatment Period 1|Other - Miscellaneous|4|||
163846886|NCT02138747|591808510|FG002|Treatment Period 1|Other - Miscellaneous|0|||
163846887|NCT02138747|591808511|FG003|Treatment Period 1|Other - Miscellaneous|0|||
163846888|NCT02138747|591808508|FG000|Treatment Period 2|Adverse Event|6|||
163846889|NCT02138747|591808509|FG001|Treatment Period 2|Adverse Event|3|||
163846890|NCT02138747|591808510|FG002|Treatment Period 2|Adverse Event|1|||
163846891|NCT02138747|591808511|FG003|Treatment Period 2|Adverse Event|1|||
163846892|NCT02138747|591808508|FG000|Treatment Period 2|Lost to Follow-up|2|||
163846893|NCT02138747|591808509|FG001|Treatment Period 2|Lost to Follow-up|0|||
163846894|NCT02138747|591808510|FG002|Treatment Period 2|Lost to Follow-up|0|||
163846895|NCT02138747|591808511|FG003|Treatment Period 2|Lost to Follow-up|0|||
163846896|NCT02138747|591808508|FG000|Treatment Period 2|Protocol Violation|1|||
163846897|NCT02138747|591808509|FG001|Treatment Period 2|Protocol Violation|0|||
163846898|NCT02138747|591808510|FG002|Treatment Period 2|Protocol Violation|0|||
163846899|NCT02138747|591808511|FG003|Treatment Period 2|Protocol Violation|0|||
163846900|NCT02138747|591808508|FG000|Treatment Period 2|Withdrawal by Subject|5|||
163846901|NCT02138747|591808509|FG001|Treatment Period 2|Withdrawal by Subject|4|||
163846902|NCT02138747|591808510|FG002|Treatment Period 2|Withdrawal by Subject|1|||
163846903|NCT02138747|591808511|FG003|Treatment Period 2|Withdrawal by Subject|2|||
163846904|NCT02138747|591808508|FG000|Treatment Period 2|Other - Miscellaneous|3|||
163846905|NCT02138747|591808509|FG001|Treatment Period 2|Other - Miscellaneous|0|||
163846906|NCT02138747|591808510|FG002|Treatment Period 2|Other - Miscellaneous|0|||
163846907|NCT02138747|591808511|FG003|Treatment Period 2|Other - Miscellaneous|0|||
163846908|NCT02302066|591808512|FG000|Overall Study|Adverse Event|1|||
163846909|NCT02302066|591808513|FG001|Overall Study|Adverse Event|1|||
163846910|NCT02302066|591808514|FG002|Overall Study|Adverse Event|3|||
163846911|NCT02302066|591808515|FG003|Overall Study|Adverse Event|0|||
163846912|NCT02302066|591808512|FG000|Overall Study|Lost to Follow-up|4|||
163846913|NCT02302066|591808513|FG001|Overall Study|Lost to Follow-up|5|||
163846914|NCT02302066|591808514|FG002|Overall Study|Lost to Follow-up|24|||
163846915|NCT02302066|591808515|FG003|Overall Study|Lost to Follow-up|7|||
163846916|NCT02302066|591808512|FG000|Overall Study|Withdrawal by Subject|25|||
163846917|NCT02302066|591808513|FG001|Overall Study|Withdrawal by Subject|58|||
163846918|NCT02302066|591808514|FG002|Overall Study|Withdrawal by Subject|124|||
163846919|NCT02302066|591808515|FG003|Overall Study|Withdrawal by Subject|33|||
163846920|NCT02302066|591808512|FG000|Overall Study|Pregnancy|2|||
163846921|NCT02302066|591808513|FG001|Overall Study|Pregnancy|10|||
163846922|NCT02302066|591808514|FG002|Overall Study|Pregnancy|12|||
163846923|NCT02302066|591808515|FG003|Overall Study|Pregnancy|0|||
163846924|NCT02302066|591808512|FG000|Overall Study|Reason Not Specified|1|||
163846925|NCT02302066|591808513|FG001|Overall Study|Reason Not Specified|1|||
163846926|NCT02302066|591808514|FG002|Overall Study|Reason Not Specified|9|||
163846927|NCT02302066|591808515|FG003|Overall Study|Reason Not Specified|1|||
163846928|NCT04793464|591808520|FG000|Overall Study|Lost to Follow-up|458|||
163846929|NCT04793464|591808521|FG001|Overall Study|Lost to Follow-up|168|||
163846930|NCT04793464|591808522|FG002|Overall Study|Lost to Follow-up|5|||
163846931|NCT04793464|591808520|FG000|Overall Study|Withdrawal by Subject|43|||
163846932|NCT04793464|591808521|FG001|Overall Study|Withdrawal by Subject|15|||
163846933|NCT04793464|591808522|FG002|Overall Study|Withdrawal by Subject|0|||
163846934|NCT02696902|591808526|FG000|Overall Study|Lost to Follow-up|0|||
163846935|NCT02696902|591808527|FG001|Overall Study|Lost to Follow-up|1|||
163846936|NCT02696902|591808528|FG002|Overall Study|Lost to Follow-up|1|||
163846937|NCT02696902|591808526|FG000|Overall Study|Withdrawal by Subject|0|||
163846938|NCT02696902|591808527|FG001|Overall Study|Withdrawal by Subject|0|||
163846939|NCT02696902|591808528|FG002|Overall Study|Withdrawal by Subject|1|||
163846940|NCT02696902|591808526|FG000|Overall Study|Death|19|||
163846941|NCT02696902|591808527|FG001|Overall Study|Death|3|||
163846942|NCT02696902|591808528|FG002|Overall Study|Death|24|||
163846943|NCT02696902|591808526|FG000|Overall Study|Participant not fit post-randomization|0|||
163846944|NCT02696902|591808527|FG001|Overall Study|Participant not fit post-randomization|0|||
163846945|NCT02696902|591808528|FG002|Overall Study|Participant not fit post-randomization|1|||
163846946|NCT02696902|591808526|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
163846947|NCT02696902|591808527|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
163846948|NCT02696902|591808528|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
163846949|NCT02696902|591808526|FG000|Overall Study|Principal investigator's decision|1|||
163846950|NCT02696902|591808527|FG001|Overall Study|Principal investigator's decision|0|||
163846951|NCT02696902|591808528|FG002|Overall Study|Principal investigator's decision|0|||
163846952|NCT02696902|591808526|FG000|Overall Study|Sponsor's decision|1|||
163846953|NCT02696902|591808527|FG001|Overall Study|Sponsor's decision|0|||
163846954|NCT02696902|591808528|FG002|Overall Study|Sponsor's decision|0|||
163846955|NCT02696902|591808526|FG000|Overall Study|Transferred to other hospital|1|||
163846956|NCT02696902|591808527|FG001|Overall Study|Transferred to other hospital|0|||
163846957|NCT02696902|591808528|FG002|Overall Study|Transferred to other hospital|0|||
163846958|NCT00845871|591808532|FG000|Assessment Period|Adverse Event|2|||
163846959|NCT00845871|591808532|FG000|Assessment Period|Abnormal laboratory values|1|||
163846960|NCT00845871|591808532|FG000|Assessment Period|Abnormal test procedure results|1|||
163846961|NCT00845871|591808532|FG000|Assessment Period|Patient withdrew consent|3|||
163846962|NCT01857622|591808533|FG000|Overall Study|Adverse Event|5|||
163846963|NCT01857622|591808534|FG001|Overall Study|Adverse Event|0|||
163846964|NCT01857622|591808535|FG002|Overall Study|Adverse Event|2|||
163846965|NCT01857622|591808533|FG000|Overall Study|Physician Decision|1|||
163846966|NCT01857622|591808534|FG001|Overall Study|Physician Decision|0|||
163846967|NCT01857622|591808535|FG002|Overall Study|Physician Decision|0|||
163846968|NCT01857622|591808533|FG000|Overall Study|Protocol Violation|4|||
163846969|NCT01857622|591808534|FG001|Overall Study|Protocol Violation|1|||
163846970|NCT01857622|591808535|FG002|Overall Study|Protocol Violation|0|||
163846971|NCT01857622|591808533|FG000|Overall Study|Withdrawal by Subject|1|||
163846972|NCT01857622|591808534|FG001|Overall Study|Withdrawal by Subject|0|||
163846973|NCT01857622|591808535|FG002|Overall Study|Withdrawal by Subject|0|||
163846974|NCT01291225|591808538|FG000|Overall Study|Lost to Follow-up|85|||
163846975|NCT01291225|591808539|FG001|Overall Study|Lost to Follow-up|39|||
163846976|NCT01734434|591808540|FG000|Overall Study|Death Infant|3|||
163846977|NCT01734434|591808541|FG001|Overall Study|Death Infant|1|||
163846978|NCT01734434|591808542|FG002|Overall Study|Death Infant|17|||
163846979|NCT01734434|591808543|FG003|Overall Study|Death Infant|5|||
163846980|NCT01734434|591808540|FG000|Overall Study|Lost to Follow-up|2|||
163846981|NCT01734434|591808541|FG001|Overall Study|Lost to Follow-up|9|||
163846982|NCT01734434|591808542|FG002|Overall Study|Lost to Follow-up|67|||
163846983|NCT01734434|591808543|FG003|Overall Study|Lost to Follow-up|11|||
163846984|NCT01734434|591808540|FG000|Overall Study|No Live Birth|1|||
163846985|NCT01734434|591808541|FG001|Overall Study|No Live Birth|2|||
163846986|NCT01734434|591808542|FG002|Overall Study|No Live Birth|32|||
163846987|NCT01734434|591808543|FG003|Overall Study|No Live Birth|6|||
163846988|NCT01734434|591808540|FG000|Overall Study|Withdrawal by Subject|4|||
163846989|NCT01734434|591808541|FG001|Overall Study|Withdrawal by Subject|0|||
163846990|NCT01734434|591808542|FG002|Overall Study|Withdrawal by Subject|8|||
163846991|NCT01734434|591808543|FG003|Overall Study|Withdrawal by Subject|1|||
163846992|NCT01734434|591808540|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
163846993|NCT01734434|591808541|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
163846994|NCT01734434|591808542|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
163846995|NCT01734434|591808543|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
163846996|NCT01734434|591808540|FG000|Overall Study|Subject Not Reachable|0|||
163846997|NCT01734434|591808541|FG001|Overall Study|Subject Not Reachable|0|||
163846998|NCT01734434|591808542|FG002|Overall Study|Subject Not Reachable|1|||
163846999|NCT01734434|591808543|FG003|Overall Study|Subject Not Reachable|0|||
163847000|NCT01734434|591808540|FG000|Overall Study|Treatment Defaulter|0|||
163847001|NCT01734434|591808541|FG001|Overall Study|Treatment Defaulter|0|||
163847002|NCT01734434|591808542|FG002|Overall Study|Treatment Defaulter|1|||
163847003|NCT01734434|591808543|FG003|Overall Study|Treatment Defaulter|0|||
163847004|NCT01734434|591808540|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
163847005|NCT01734434|591808541|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
163847006|NCT01734434|591808542|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
163847007|NCT01734434|591808543|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
163847008|NCT01734434|591808540|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
163847009|NCT01734434|591808541|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
163847010|NCT01734434|591808542|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
163847011|NCT01734434|591808543|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
163847012|NCT00867490|591809962|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
163847013|NCT00867490|591809962|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
163847014|NCT00867490|591809962|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
163847015|NCT00867490|591809962|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
163847016|NCT00867490|591809962|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
163847017|NCT02406261|591809963|FG000|Period 1|Lost to Follow-up|2|||
163847018|NCT02406261|591809964|FG001|Period 1|Lost to Follow-up|0|||
163847019|NCT02406261|591809963|FG000|Period 1|Adverse Event|1|||
163847020|NCT02406261|591809964|FG001|Period 1|Adverse Event|0|||
163847021|NCT02406261|591809963|FG000|Period 2|Physician Decision|0|||
163847022|NCT02406261|591809964|FG001|Period 2|Physician Decision|1|||
163847023|NCT02406261|591809963|FG000|Period 2|Protocol Violation|0|||
163847024|NCT02406261|591809964|FG001|Period 2|Protocol Violation|1|||
163847025|NCT02406261|591809963|FG000|Period 2|Withdrawal by Subject|0|||
163847026|NCT02406261|591809964|FG001|Period 2|Withdrawal by Subject|1|||
163847027|NCT01567163|591809965|FG000|Overall Study|Progressive Disease|2|||
163847028|NCT01567163|591809965|FG000|Overall Study|Lost to Follow-up|2|||
163847029|NCT00393094|591809969|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
163847030|NCT00393094|591809969|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
163847031|NCT02019602|591809970|FG000|Screening Period|Ineligibility|4|||
163847032|NCT02019602|591809971|FG001|Screening Period|Ineligibility|0|||
163847033|NCT02019602|591809970|FG000|Screening Period|Adverse Event|1|||
163847034|NCT02019602|591809971|FG001|Screening Period|Adverse Event|0|||
163847035|NCT03207711|591809974|FG000|Overall Study|Withdrawal by Subject|1|||
163847036|NCT03207711|591809975|FG001|Overall Study|Withdrawal by Subject|2|||
163847037|NCT02372058|591809978|FG000|Overall Study|Withdrawal by Subject|3|||
163847038|NCT02788006|591809982|FG000|Overall Study|Patient not treated|1|||
163847039|NCT00318149|591809983|FG000|Overall Study|Adverse Event|0|||
163847040|NCT00318149|591809984|FG001|Overall Study|Adverse Event|0|||
163847041|NCT00318149|591809985|FG002|Overall Study|Adverse Event|0|||
163847042|NCT00318149|591809986|FG003|Overall Study|Adverse Event|0|||
163847043|NCT00318149|591809987|FG004|Overall Study|Adverse Event|0|||
163847044|NCT00318149|591809988|FG005|Overall Study|Adverse Event|2|||
163847045|NCT03541642|591809991|FG000|Overall Study|Withdrawal by Subject|1|||
163847046|NCT03541642|591809992|FG001|Overall Study|Withdrawal by Subject|2|||
163847047|NCT03541642|591809991|FG000|Overall Study|Lost to Follow-up|16|||
163847048|NCT03541642|591809992|FG001|Overall Study|Lost to Follow-up|12|||
163847049|NCT03541642|591809991|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
163847050|NCT03541642|591809992|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
163847051|NCT03050398|591809997|FG000|Overall Study|Study terminated by sponsor|8|||
163847052|NCT05108649|591809998|FG000|Overall Study|Lost to Follow-up|0|||
163847053|NCT05108649|591809999|FG001|Overall Study|Lost to Follow-up|4|||
163847054|NCT05108649|591810000|FG002|Overall Study|Lost to Follow-up|3|||
163847055|NCT05108649|591810001|FG003|Overall Study|Lost to Follow-up|6|||
163847056|NCT05108649|591809998|FG000|Overall Study|Not Interested|1|||
163847057|NCT05108649|591809999|FG001|Overall Study|Not Interested|1|||
163847058|NCT05108649|591810000|FG002|Overall Study|Not Interested|0|||
163847059|NCT05108649|591810001|FG003|Overall Study|Not Interested|1|||
163847060|NCT05108649|591809998|FG000|Overall Study|Out of area|0|||
163847061|NCT05108649|591809999|FG001|Overall Study|Out of area|0|||
163847062|NCT05108649|591810000|FG002|Overall Study|Out of area|0|||
163847063|NCT05108649|591810001|FG003|Overall Study|Out of area|1|||
163847064|NCT05108649|591809998|FG000|Overall Study|PI decision|1|||
163847065|NCT05108649|591809999|FG001|Overall Study|PI decision|0|||
163847066|NCT05108649|591810000|FG002|Overall Study|PI decision|0|||
163847067|NCT05108649|591810001|FG003|Overall Study|PI decision|0|||
163847068|NCT05108649|591809998|FG000|Overall Study|Significant Non-Compliance|0|||
163847069|NCT05108649|591809999|FG001|Overall Study|Significant Non-Compliance|1|||
163847070|NCT05108649|591810000|FG002|Overall Study|Significant Non-Compliance|0|||
163847071|NCT05108649|591810001|FG003|Overall Study|Significant Non-Compliance|0|||
163847072|NCT05108649|591809998|FG000|Overall Study|Unable to adhere to study protocol|0|||
163847073|NCT05108649|591809999|FG001|Overall Study|Unable to adhere to study protocol|2|||
163847074|NCT05108649|591810000|FG002|Overall Study|Unable to adhere to study protocol|0|||
163847075|NCT05108649|591810001|FG003|Overall Study|Unable to adhere to study protocol|0|||
163847076|NCT03523871|591810002|FG000|Overall Study|Death|1|||
163847077|NCT01083160|591810003|FG000|Overall Study|Adverse Event|1|||
163847078|NCT00918749|591810004|FG000|Overall Study|Adverse Event|1|||
163847079|NCT00918749|591810005|FG001|Overall Study|Adverse Event|0|||
163847080|NCT00918749|591810006|FG002|Overall Study|Adverse Event|1|||
163847081|NCT00918749|591810004|FG000|Overall Study|Lost to Follow-up|0|||
163847082|NCT00918749|591810005|FG001|Overall Study|Lost to Follow-up|0|||
163847083|NCT00918749|591810006|FG002|Overall Study|Lost to Follow-up|1|||
163847084|NCT00918749|591810004|FG000|Overall Study|Withdrawal by Subject|5|||
163847085|NCT00918749|591810005|FG001|Overall Study|Withdrawal by Subject|3|||
163847086|NCT00918749|591810006|FG002|Overall Study|Withdrawal by Subject|5|||
163847087|NCT00918749|591810004|FG000|Overall Study|No Study Medication Taken|1|||
163847088|NCT00918749|591810005|FG001|Overall Study|No Study Medication Taken|0|||
163847089|NCT00918749|591810006|FG002|Overall Study|No Study Medication Taken|0|||
163847090|NCT01951092|591810007|FG000|Overall Study|Lost to Follow-up|10|||
163847091|NCT01951092|591810007|FG000|Overall Study|Incarceration|1|||
163847092|NCT01951092|591810007|FG000|Overall Study|Transfer of Care|1|||
163847093|NCT01712789|591810008|FG000|Overall Study|Lack of Efficacy|2|||
163847094|NCT01712789|591810008|FG000|Overall Study|Lost to Follow-up|1|||
163847095|NCT01712789|591810008|FG000|Overall Study|Progressive Disease|504|||
163847096|NCT01712789|591810008|FG000|Overall Study|Death|57|||
163847097|NCT01712789|591810008|FG000|Overall Study|Adverse Event|52|||
163847098|NCT01712789|591810008|FG000|Overall Study|Miscellaneous|31|||
163847099|NCT01712789|591810008|FG000|Overall Study|Withdrawal by Subject|21|||
163847100|NCT01712789|591810008|FG000|Overall Study|Transition to Commercial Treatment|8|||
163847101|NCT01712789|591810008|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
163847102|NCT00219141|591810009|FG000|Overall Study|Adverse Event|4|||
163847103|NCT00219141|591810010|FG001|Overall Study|Adverse Event|10|||
163847104|NCT00219141|591810011|FG002|Overall Study|Adverse Event|5|||
163847105|NCT00219141|591810009|FG000|Overall Study|Lack of Efficacy|3|||
163847106|NCT00219141|591810010|FG001|Overall Study|Lack of Efficacy|2|||
163847107|NCT00219141|591810011|FG002|Overall Study|Lack of Efficacy|0|||
163847108|NCT00219141|591810009|FG000|Overall Study|Administrative problems|0|||
163847109|NCT00219141|591810010|FG001|Overall Study|Administrative problems|1|||
163847110|NCT00219141|591810011|FG002|Overall Study|Administrative problems|0|||
163847111|NCT00219141|591810009|FG000|Overall Study|Lost to Follow-up|2|||
163847112|NCT00219141|591810010|FG001|Overall Study|Lost to Follow-up|4|||
163847113|NCT00219141|591810011|FG002|Overall Study|Lost to Follow-up|1|||
163847114|NCT00219141|591810009|FG000|Overall Study|Protocol Violation|3|||
163847115|NCT00219141|591810010|FG001|Overall Study|Protocol Violation|1|||
163847116|NCT00219141|591810011|FG002|Overall Study|Protocol Violation|1|||
163847117|NCT00219141|591810009|FG000|Overall Study|Withdrawal by Subject|1|||
163847118|NCT00219141|591810010|FG001|Overall Study|Withdrawal by Subject|3|||
163847119|NCT00219141|591810011|FG002|Overall Study|Withdrawal by Subject|5|||
163847120|NCT00219141|591810009|FG000|Overall Study|Condition no longer requires study drug|1|||
163847121|NCT00219141|591810010|FG001|Overall Study|Condition no longer requires study drug|0|||
163847122|NCT00219141|591810011|FG002|Overall Study|Condition no longer requires study drug|0|||
163847123|NCT00972179|591810012|FG000|Overall Study|Noncompliance|1|||
163847124|NCT00972179|591810013|FG001|Overall Study|Noncompliance|0|||
163847125|NCT00972179|591810014|FG002|Overall Study|Noncompliance|0|||
163847126|NCT00972179|591810015|FG003|Overall Study|Noncompliance|0|||
163847127|NCT00972179|591810016|FG004|Overall Study|Noncompliance|1|||
163847128|NCT00972179|591810017|FG005|Overall Study|Noncompliance|0|||
163847129|NCT00972179|591810018|FG006|Overall Study|Noncompliance|1|||
163847130|NCT00972179|591810012|FG000|Overall Study|Withdrawal by Subject|0|||
163847131|NCT00972179|591810013|FG001|Overall Study|Withdrawal by Subject|3|||
163847132|NCT00972179|591810014|FG002|Overall Study|Withdrawal by Subject|0|||
163847133|NCT00972179|591810015|FG003|Overall Study|Withdrawal by Subject|1|||
163847134|NCT00972179|591810016|FG004|Overall Study|Withdrawal by Subject|0|||
163847135|NCT00972179|591810017|FG005|Overall Study|Withdrawal by Subject|0|||
163847136|NCT00972179|591810018|FG006|Overall Study|Withdrawal by Subject|2|||
163847137|NCT00972179|591810012|FG000|Overall Study|Administrative Decision|0|||
163847138|NCT00972179|591810013|FG001|Overall Study|Administrative Decision|0|||
163847139|NCT00972179|591810014|FG002|Overall Study|Administrative Decision|0|||
163847140|NCT00972179|591810015|FG003|Overall Study|Administrative Decision|0|||
163847141|NCT00972179|591810016|FG004|Overall Study|Administrative Decision|1|||
163847142|NCT00972179|591810017|FG005|Overall Study|Administrative Decision|0|||
163847143|NCT00972179|591810018|FG006|Overall Study|Administrative Decision|0|||
163847144|NCT00972179|591810012|FG000|Overall Study|Lost to Follow-up|0|||
163847145|NCT00972179|591810013|FG001|Overall Study|Lost to Follow-up|0|||
163847146|NCT00972179|591810014|FG002|Overall Study|Lost to Follow-up|1|||
163847147|NCT00972179|591810015|FG003|Overall Study|Lost to Follow-up|0|||
163847148|NCT00972179|591810016|FG004|Overall Study|Lost to Follow-up|0|||
163847149|NCT00972179|591810017|FG005|Overall Study|Lost to Follow-up|3|||
163847150|NCT00972179|591810018|FG006|Overall Study|Lost to Follow-up|1|||
163847151|NCT03055832|591810019|FG000|Week 2|Withdrawal by Subject|1|||
163847152|NCT03055832|591810020|FG001|Week 2|Withdrawal by Subject|0|||
163847153|NCT00136916|591810021|FG000|Overall Study|Never received study treatment|3|||
163847154|NCT00136916|591810022|FG001|Overall Study|Never received study treatment|5|||
163847155|NCT00136916|591810021|FG000|Overall Study|Death|1|||
163847156|NCT00136916|591810022|FG001|Overall Study|Death|3|||
163847157|NCT00136916|591810021|FG000|Overall Study|Adverse Event|27|||
163847158|NCT00136916|591810022|FG001|Overall Study|Adverse Event|8|||
163847159|NCT00136916|591810021|FG000|Overall Study|Laboratory abnormality|0|||
163847160|NCT00136916|591810022|FG001|Overall Study|Laboratory abnormality|1|||
163847161|NCT00136916|591810021|FG000|Overall Study|Lack of Efficacy|13|||
163847162|NCT00136916|591810022|FG001|Overall Study|Lack of Efficacy|3|||
163847163|NCT00136916|591810021|FG000|Overall Study|Lost to Follow-up|12|||
163847164|NCT00136916|591810022|FG001|Overall Study|Lost to Follow-up|14|||
163847165|NCT00136916|591810021|FG000|Overall Study|Withdrawal by Subject|44|||
163847166|NCT00136916|591810022|FG001|Overall Study|Withdrawal by Subject|46|||
163847167|NCT00136916|591810021|FG000|Overall Study|Other|22|||
163847168|NCT00136916|591810022|FG001|Overall Study|Other|24|||
163847169|NCT00136916|591810021|FG000|Overall Study|Discontinued in follow up period|3|||
163847170|NCT00136916|591810022|FG001|Overall Study|Discontinued in follow up period|0|||
163847171|NCT01991197|591810023|FG000|Overall Study|Lost to Follow-up|1|||
163847172|NCT01991197|591810024|FG001|Overall Study|Lost to Follow-up|1|||
163847173|NCT01991197|591810023|FG000|Overall Study|Physician Decision|0|||
163847174|NCT01991197|591810024|FG001|Overall Study|Physician Decision|2|||
163847175|NCT01991197|591810023|FG000|Overall Study|Withdrawal by Subject|2|||
163847176|NCT01991197|591810024|FG001|Overall Study|Withdrawal by Subject|0|||
163847177|NCT01012973|591810025|FG000|Overall Study|Adverse Event|5|||
163847178|NCT01012973|591810026|FG001|Overall Study|Adverse Event|5|||
163847179|NCT01012973|591810025|FG000|Overall Study|Lack of Efficacy|0|||
163847180|NCT01012973|591810026|FG001|Overall Study|Lack of Efficacy|5|||
163847181|NCT01012973|591810025|FG000|Overall Study|Lost to Follow-up|1|||
163847182|NCT01012973|591810026|FG001|Overall Study|Lost to Follow-up|0|||
163847183|NCT01012973|591810025|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
163847184|NCT01012973|591810026|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
163847185|NCT01012973|591810025|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
163847186|NCT01012973|591810026|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
163847187|NCT01012973|591810025|FG000|Overall Study|Protocol Violation|5|||
163847188|NCT01012973|591810026|FG001|Overall Study|Protocol Violation|2|||
163847189|NCT01012973|591810025|FG000|Overall Study|Withdrawal by Subject|4|||
163847190|NCT01012973|591810026|FG001|Overall Study|Withdrawal by Subject|6|||
163847191|NCT01932996|591810027|FG000|Overall Study|Protocol Violation|2|||
163847192|NCT01932996|591810028|FG001|Overall Study|Protocol Violation|0|||
163847193|NCT00846742|591810031|FG000|Overall Study|Withdrawal by Subject|1|||
163847194|NCT01435798|591810036|FG000|Overall Study|Withdrawal by Subject|1|||
163847195|NCT03257995|591810040|FG000|Overall Study|Adverse Event|0|||
163847196|NCT03257995|591810041|FG001|Overall Study|Adverse Event|1|||
163847197|NCT03257995|591810042|FG002|Overall Study|Adverse Event|0|||
163847198|NCT03257995|591810043|FG003|Overall Study|Adverse Event|0|||
163847199|NCT03257995|591810044|FG004|Overall Study|Adverse Event|0|||
163847200|NCT03257995|591810045|FG005|Overall Study|Adverse Event|0|||
163847201|NCT03257995|591810040|FG000|Overall Study|Protocol deviation|0|||
163847202|NCT03257995|591810041|FG001|Overall Study|Protocol deviation|0|||
163847203|NCT03257995|591810042|FG002|Overall Study|Protocol deviation|0|||
163847204|NCT03257995|591810043|FG003|Overall Study|Protocol deviation|0|||
163847205|NCT03257995|591810044|FG004|Overall Study|Protocol deviation|0|||
163847206|NCT03257995|591810045|FG005|Overall Study|Protocol deviation|2|||
163847207|NCT04170296|591810050|FG000|Overall Study|Adverse Event|1|||
163847208|NCT04170296|591810051|FG001|Overall Study|Adverse Event|0|||
163847209|NCT04170296|591810050|FG000|Overall Study|Withdrawal by Subject|3|||
163847210|NCT04170296|591810051|FG001|Overall Study|Withdrawal by Subject|2|||
163847211|NCT04170296|591810050|FG000|Overall Study|Lost to Follow-up|4|||
163847212|NCT04170296|591810051|FG001|Overall Study|Lost to Follow-up|2|||
163847213|NCT03567993|591810052|FG000|Overall Study|Lost to Follow-up|4|||
163847214|NCT03567993|591810053|FG001|Overall Study|Lost to Follow-up|2|||
163847215|NCT03567993|591810052|FG000|Overall Study|Death|1|||
163847216|NCT03567993|591810053|FG001|Overall Study|Death|1|||
163847217|NCT03567993|591810052|FG000|Overall Study|Withdrawal by Subject|1|||
163847218|NCT03567993|591810053|FG001|Overall Study|Withdrawal by Subject|0|||
163847219|NCT00903786|591810057|FG000|Overall Study|Physician Decision|6|||
163847220|NCT00903786|591810057|FG000|Overall Study|Lack of Efficacy|5|||
163847221|NCT00903786|591810057|FG000|Overall Study|Reason other than lack of efficacy|4|||
163847222|NCT02285595|591810058|FG000|Overall Study|Lost to Follow-up|14|||
163847223|NCT02285595|591810058|FG000|Overall Study|Withdrawal by Subject|1|||
163847224|NCT01960790|591810059|FG000|Overall Study|Survey forms could not be recovered|3|||
163847225|NCT01960790|591810059|FG000|Overall Study|Treat with Humira outside survey period|3|||
163847226|NCT01960790|591810059|FG000|Overall Study|Transferred to another hospital|4|||
163847227|NCT01960790|591810059|FG000|Overall Study|Unevaluable for safety|1|||
163847228|NCT04318093|591810061|FG000|Overall Study|Adverse Event|2|||
163847229|NCT04318093|591810062|FG001|Overall Study|Adverse Event|2|||
163847230|NCT04318093|591810061|FG000|Overall Study|Participant withdrew consent|1|||
163847231|NCT04318093|591810062|FG001|Overall Study|Participant withdrew consent|0|||
163847232|NCT04318093|591810061|FG000|Overall Study|Other reasons|0|||
163847233|NCT04318093|591810062|FG001|Overall Study|Other reasons|1|||
163847234|NCT01370603|591810063|FG000|Period 1|Adverse Event|5|||
163847235|NCT01370603|591810064|FG001|Period 1|Adverse Event|3|||
163847236|NCT01370603|591810063|FG000|Period 1|Lost to Follow-up|2|||
163847237|NCT01370603|591810064|FG001|Period 1|Lost to Follow-up|0|||
163847238|NCT01370603|591810063|FG000|Period 1|Protocol Violation|2|||
163847239|NCT01370603|591810064|FG001|Period 1|Protocol Violation|2|||
163847240|NCT01370603|591810063|FG000|Period 1|Withdrawal by Subject|5|||
163959722|NCT03215758|592224081|FG000|Overall Study|Death|0|||
163959723|NCT03215758|592224082|FG001|Overall Study|Death|1|||
163847241|NCT01370603|591810064|FG001|Period 1|Withdrawal by Subject|5|||
163847242|NCT01370603|591810063|FG000|Crossover Washout|Adverse Event|2|||
163847243|NCT01370603|591810064|FG001|Crossover Washout|Adverse Event|1|||
163847244|NCT01370603|591810063|FG000|Crossover Washout|Lost to Follow-up|2|||
163847245|NCT01370603|591810064|FG001|Crossover Washout|Lost to Follow-up|0|||
163847246|NCT01370603|591810063|FG000|Crossover Washout|Protocol Violation|1|||
163847247|NCT01370603|591810064|FG001|Crossover Washout|Protocol Violation|0|||
163847248|NCT01370603|591810063|FG000|Crossover Washout|Withdrawal by Subject|4|||
163847249|NCT01370603|591810064|FG001|Crossover Washout|Withdrawal by Subject|1|||
163847250|NCT01370603|591810063|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
163847251|NCT01370603|591810064|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
163847252|NCT01370603|591810063|FG000|Period 2|Adverse Event|1|||
163847253|NCT01370603|591810064|FG001|Period 2|Adverse Event|4|||
163847254|NCT01370603|591810063|FG000|Period 2|Lost to Follow-up|1|||
163847255|NCT01370603|591810064|FG001|Period 2|Lost to Follow-up|0|||
163847256|NCT01370603|591810063|FG000|Period 2|Withdrawal by Subject|1|||
163847257|NCT01370603|591810064|FG001|Period 2|Withdrawal by Subject|0|||
163847258|NCT02133924|591810065|FG000|Overall Study|Death|38|||
163847259|NCT02133924|591810065|FG000|Overall Study|Physician Decision|1|||
163847260|NCT02133924|591810065|FG000|Overall Study|Withdrawal by Subject|3|||
163847261|NCT01644474|591810067|FG000|Overall Study|Poor compliance to protocol|1|||
163847262|NCT01644474|591810068|FG001|Overall Study|Poor compliance to protocol|0|||
163847263|NCT01644474|591810067|FG000|Overall Study|Consent withdrawn by participant|0|||
163847264|NCT01644474|591810068|FG001|Overall Study|Consent withdrawn by participant|1|||
163847265|NCT01644474|591810067|FG000|Overall Study|Participant moved|0|||
163847266|NCT01644474|591810068|FG001|Overall Study|Participant moved|1|||
163847267|NCT01644474|591810067|FG000|Overall Study|Adverse Event|4|||
163847268|NCT01644474|591810068|FG001|Overall Study|Adverse Event|5|||
163847269|NCT01644474|591810067|FG000|Overall Study|Site scheduling error|1|||
163959724|NCT03215758|592224081|FG000|Overall Study|Adverse Event|1|||
163959725|NCT03215758|592224082|FG001|Overall Study|Adverse Event|2|||
163959726|NCT03215758|592224081|FG000|Overall Study|Subject/Guardian Decision|3|||
163959727|NCT03215758|592224082|FG001|Overall Study|Subject/Guardian Decision|3|||
163847270|NCT01644474|591810068|FG001|Overall Study|Site scheduling error|1|||
163847271|NCT01644474|591810067|FG000|Overall Study|Protocol Violation|1|||
163847272|NCT01644474|591810068|FG001|Overall Study|Protocol Violation|0|||
163847273|NCT04039503|591810073|FG000|Overall Study|Adverse Event|3|||
163847274|NCT04039503|591810074|FG001|Overall Study|Adverse Event|0|||
163847275|NCT04039503|591810075|FG002|Overall Study|Adverse Event|2|||
163959728|NCT02175004|592224086|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
163959729|NCT02175004|592224087|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
163847276|NCT04039503|591810076|FG003|Overall Study|Adverse Event|0|||
163847277|NCT04039503|591810073|FG000|Overall Study|Lost to Follow-up|0|||
163847278|NCT04039503|591810074|FG001|Overall Study|Lost to Follow-up|0|||
163959730|NCT02175004|592224086|FG000|Overall Study|Investigator Judgment|1|||
163959731|NCT02175004|592224087|FG001|Overall Study|Investigator Judgment|4|||
163959732|NCT02175004|592224086|FG000|Overall Study|Voluntary Withdrawal|6|||
163959733|NCT02175004|592224087|FG001|Overall Study|Voluntary Withdrawal|19|||
163959734|NCT02175004|592224086|FG000|Overall Study|Liver Transplant|1|||
163959735|NCT02175004|592224087|FG001|Overall Study|Liver Transplant|0|||
163959736|NCT02175004|592224086|FG000|Overall Study|Disease Progression|1|||
163959737|NCT02175004|592224087|FG001|Overall Study|Disease Progression|0|||
163959738|NCT02175004|592224086|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
163959739|NCT02175004|592224087|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
163959740|NCT00162032|592224088|FG000|Overall Study|Lost to Follow-up|4|||
163959741|NCT00162032|592224089|FG001|Overall Study|Lost to Follow-up|2|||
163959742|NCT00162032|592224088|FG000|Overall Study|Reason not specified|1|||
163959743|NCT00162032|592224089|FG001|Overall Study|Reason not specified|0|||
163959744|NCT01137955|592224090|FG000|Overall Study|Withdrawal by Subject|5|||
163959745|NCT01137955|592224091|FG001|Overall Study|Withdrawal by Subject|4|||
163959746|NCT02977988|592224093|FG000|Overall Study|Lost to Follow-up|13|||
163959747|NCT02977988|592224094|FG001|Overall Study|Lost to Follow-up|7|||
163959748|NCT05341115|592224095|FG000|Overall Study|Adverse Event|1|||
163959749|NCT05341115|592224095|FG000|Overall Study|Lost to Follow-up|1|||
163959750|NCT04263909|592224101|FG000|Overall Study|Physician Decision|1|||
163959751|NCT04263909|592224102|FG001|Overall Study|Physician Decision|0|||
163959752|NCT04263909|592224103|FG002|Overall Study|Physician Decision|0|||
163959753|NCT04263909|592224101|FG000|Overall Study|Adverse Event|3|||
163959754|NCT04263909|592224102|FG001|Overall Study|Adverse Event|0|||
163959755|NCT04263909|592224103|FG002|Overall Study|Adverse Event|0|||
163959756|NCT04263909|592224101|FG000|Overall Study|Protocol Violation|5|||
163959757|NCT04263909|592224102|FG001|Overall Study|Protocol Violation|0|||
163959758|NCT04263909|592224103|FG002|Overall Study|Protocol Violation|0|||
163959759|NCT05630001|592224104|FG000|Overall Study|Adverse Event|1|||
163959760|NCT05386680|592224105|FG000|Overall Study|Guardian decision|2|||
163959761|NCT03946670|592224106|FG000|Overall Study|Progressive Disease|34|||
163959762|NCT03946670|592224107|FG001|Overall Study|Progressive Disease|27|||
163847279|NCT04039503|591810075|FG002|Overall Study|Lost to Follow-up|1|||
163959763|NCT03946670|592224106|FG000|Overall Study|Adverse Event|7|||
163959764|NCT03946670|592224107|FG001|Overall Study|Adverse Event|10|||
163959765|NCT03946670|592224106|FG000|Overall Study|Physician Decision|6|||
163959766|NCT03946670|592224107|FG001|Overall Study|Physician Decision|5|||
163959767|NCT03946670|592224106|FG000|Overall Study|Death|5|||
163959768|NCT03946670|592224107|FG001|Overall Study|Death|8|||
163959769|NCT03946670|592224106|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
163959770|NCT03946670|592224107|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
163959771|NCT03946670|592224106|FG000|Overall Study|Subject Decision|4|||
163959772|NCT03946670|592224107|FG001|Overall Study|Subject Decision|5|||
163959773|NCT03946670|592224106|FG000|Overall Study|Study Terminated By Sponsor|2|||
163959774|NCT03946670|592224107|FG001|Overall Study|Study Terminated By Sponsor|0|||
163847280|NCT04039503|591810076|FG003|Overall Study|Lost to Follow-up|0|||
163847281|NCT04039503|591810073|FG000|Overall Study|Protocol Violation|0|||
163847282|NCT04039503|591810074|FG001|Overall Study|Protocol Violation|1|||
163847283|NCT04039503|591810075|FG002|Overall Study|Protocol Violation|2|||
163847284|NCT04039503|591810076|FG003|Overall Study|Protocol Violation|1|||
163847285|NCT04039503|591810073|FG000|Overall Study|Withdrawal by Subject|4|||
163847286|NCT04039503|591810074|FG001|Overall Study|Withdrawal by Subject|3|||
163847287|NCT04039503|591810075|FG002|Overall Study|Withdrawal by Subject|5|||
163847288|NCT04039503|591810076|FG003|Overall Study|Withdrawal by Subject|2|||
163847289|NCT01163747|591810078|FG000|Overall Study|Adverse Event|0|||
163847290|NCT01163747|591810079|FG001|Overall Study|Adverse Event|5|||
163847291|NCT01163747|591810078|FG000|Overall Study|Insufficient Therapeutic Response|0|||
163847292|NCT01163747|591810079|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163847293|NCT01163747|591810078|FG000|Overall Study|Protocol Violation|0|||
163847294|NCT01163747|591810079|FG001|Overall Study|Protocol Violation|1|||
163847295|NCT01163747|591810078|FG000|Overall Study|Refused Treatment|6|||
163847296|NCT01163747|591810079|FG001|Overall Study|Refused Treatment|4|||
163847297|NCT02044458|591810086|FG000|Overall Study|Protocol Violation|3|||
163847298|NCT02044458|591810087|FG001|Overall Study|Protocol Violation|8|||
163847299|NCT02924389|591810090|FG000|Overall Study|Lost to Follow-up|1|||
163847300|NCT02924389|591810091|FG001|Overall Study|Lost to Follow-up|0|||
163847301|NCT02924389|591810090|FG000|Overall Study|Physician Decision|2|||
163959775|NCT03946670|592224106|FG000|Overall Study|New Therapy For Study Indication|1|||
163959776|NCT03946670|592224107|FG001|Overall Study|New Therapy For Study Indication|0|||
163959777|NCT03946670|592224106|FG000|Overall Study|Not Treated|1|||
163959778|NCT03946670|592224107|FG001|Overall Study|Not Treated|1|||
163847302|NCT02924389|591810091|FG001|Overall Study|Physician Decision|0|||
163847303|NCT02924389|591810090|FG000|Overall Study|Withdrawal by Subject|3|||
163847304|NCT02924389|591810091|FG001|Overall Study|Withdrawal by Subject|0|||
163959779|NCT03840486|592224108|FG000|Overall Study|Withdrawal by Subject|0|||
163959780|NCT03840486|592224109|FG001|Overall Study|Withdrawal by Subject|1|||
163847305|NCT02924389|591810090|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
163847306|NCT02924389|591810091|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
163847307|NCT05567952|591811403|FG000|Overall Study|Lost to Follow-up|3|||
163847308|NCT05567952|591811404|FG001|Overall Study|Lost to Follow-up|2|||
163847309|NCT05567952|591811403|FG000|Overall Study|Withdrawal by Subject|6|||
163847310|NCT05567952|591811404|FG001|Overall Study|Withdrawal by Subject|3|||
163847311|NCT05567952|591811403|FG000|Overall Study|Other|3|||
163847312|NCT05567952|591811404|FG001|Overall Study|Other|1|||
163847313|NCT05220501|591811405|FG000|Overall Study|Withdrawal by Subject|11|||
163847314|NCT05220501|591811406|FG001|Overall Study|Withdrawal by Subject|21|||
163847315|NCT05220501|591811407|FG002|Overall Study|Withdrawal by Subject|32|||
163847316|NCT05220501|591811405|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
163847317|NCT05220501|591811406|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
163847318|NCT05220501|591811407|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
163847319|NCT02692235|591811408|FG000|Overall Study|Withdrawal by Subject|2|||
163847320|NCT02692235|591811409|FG001|Overall Study|Withdrawal by Subject|1|||
163847321|NCT02692235|591811408|FG000|Overall Study|Adverse Event|1|||
163847322|NCT02692235|591811409|FG001|Overall Study|Adverse Event|2|||
163847323|NCT00802841|591811410|FG000|Overall Study|Administrative problems|1|||
163847324|NCT00802841|591811411|FG001|Overall Study|Administrative problems|0|||
163847325|NCT00802841|591811410|FG000|Overall Study|Lost to Follow-up|2|||
163847326|NCT00802841|591811411|FG001|Overall Study|Lost to Follow-up|1|||
163847327|NCT00802841|591811410|FG000|Overall Study|Death|1|||
163847328|NCT00802841|591811411|FG001|Overall Study|Death|2|||
163847329|NCT00802841|591811410|FG000|Overall Study|Adverse Event|8|||
163847330|NCT00802841|591811411|FG001|Overall Study|Adverse Event|2|||
163847331|NCT00802841|591811410|FG000|Overall Study|Disease progression|7|||
163847332|NCT00802841|591811411|FG001|Overall Study|Disease progression|3|||
163847333|NCT00802841|591811410|FG000|Overall Study|Withdrawal by Subject|9|||
163847334|NCT00802841|591811411|FG001|Overall Study|Withdrawal by Subject|5|||
163847335|NCT00802841|591811410|FG000|Overall Study|Protocol deviation|2|||
163847336|NCT00802841|591811411|FG001|Overall Study|Protocol deviation|6|||
163847337|NCT00802841|591811410|FG000|Overall Study|Treatment duration completed|66|||
163847338|NCT00802841|591811411|FG001|Overall Study|Treatment duration completed|76|||
163847339|NCT01268059|591811412|FG000|Overall Study|Lost to Follow-up|0|||
163847340|NCT01268059|591811413|FG001|Overall Study|Lost to Follow-up|1|||
163847341|NCT01268059|591811414|FG002|Overall Study|Lost to Follow-up|0|||
163847342|NCT01268059|591811415|FG003|Overall Study|Lost to Follow-up|0|||
163847343|NCT01268059|591811412|FG000|Overall Study|Withdrawal by Subject|7|||
163847344|NCT01268059|591811413|FG001|Overall Study|Withdrawal by Subject|4|||
163847345|NCT01268059|591811414|FG002|Overall Study|Withdrawal by Subject|0|||
163847346|NCT01268059|591811415|FG003|Overall Study|Withdrawal by Subject|0|||
163847347|NCT01268059|591811412|FG000|Overall Study|Death|20|||
163847348|NCT01268059|591811413|FG001|Overall Study|Death|30|||
163847349|NCT01268059|591811414|FG002|Overall Study|Death|3|||
163847350|NCT01268059|591811415|FG003|Overall Study|Death|5|||
163847351|NCT01268059|591811412|FG000|Overall Study|Progression of disease|1|||
163847352|NCT01268059|591811413|FG001|Overall Study|Progression of disease|0|||
163847353|NCT01268059|591811414|FG002|Overall Study|Progression of disease|0|||
163847354|NCT01268059|591811415|FG003|Overall Study|Progression of disease|0|||
163847355|NCT03660943|591811416|FG000|Overall Study|Adverse Event|5|||
163847356|NCT03660943|591811417|FG001|Overall Study|Adverse Event|3|||
163847357|NCT03660943|591811416|FG000|Overall Study|Death|0|||
163847358|NCT03660943|591811417|FG001|Overall Study|Death|2|||
163847359|NCT03660943|591811416|FG000|Overall Study|Lost to Follow-up|7|||
163847360|NCT03660943|591811417|FG001|Overall Study|Lost to Follow-up|3|||
163847361|NCT03660943|591811416|FG000|Overall Study|Protocol Violation|3|||
163847362|NCT03660943|591811417|FG001|Overall Study|Protocol Violation|5|||
163847363|NCT03660943|591811416|FG000|Overall Study|Withdrawal by Subject|8|||
163847364|NCT03660943|591811417|FG001|Overall Study|Withdrawal by Subject|15|||
163847365|NCT03660943|591811416|FG000|Overall Study|Lack of Efficacy|9|||
163847366|NCT03660943|591811417|FG001|Overall Study|Lack of Efficacy|12|||
163847367|NCT03660943|591811416|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
163847368|NCT03660943|591811417|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
163847369|NCT03699124|591811418|FG000|Overall Study|Adverse Event|6|||
163847370|NCT03699124|591811419|FG001|Overall Study|Adverse Event|5|||
163847371|NCT03699124|591811420|FG002|Overall Study|Adverse Event|2|||
163847372|NCT03699124|591811418|FG000|Overall Study|Death|0|||
163847373|NCT03699124|591811419|FG001|Overall Study|Death|2|||
163847374|NCT03699124|591811420|FG002|Overall Study|Death|0|||
163847375|NCT03699124|591811418|FG000|Overall Study|Lost to Follow-up|20|||
163847376|NCT03699124|591811419|FG001|Overall Study|Lost to Follow-up|16|||
163847377|NCT03699124|591811420|FG002|Overall Study|Lost to Follow-up|15|||
163847378|NCT03699124|591811418|FG000|Overall Study|Protocol Violation|1|||
163847379|NCT03699124|591811419|FG001|Overall Study|Protocol Violation|0|||
163847380|NCT03699124|591811420|FG002|Overall Study|Protocol Violation|0|||
164006467|NCT02158533|592390966|FG004|Stage 2|Withdrawal by Subject|1|||
163847381|NCT03699124|591811418|FG000|Overall Study|Withdrawal by Subject|13|||
163847382|NCT03699124|591811419|FG001|Overall Study|Withdrawal by Subject|14|||
163847383|NCT03699124|591811420|FG002|Overall Study|Withdrawal by Subject|13|||
163847384|NCT03699124|591811418|FG000|Overall Study|Other reasons|5|||
163847385|NCT03699124|591811419|FG001|Overall Study|Other reasons|3|||
163847386|NCT03699124|591811420|FG002|Overall Study|Other reasons|10|||
163847387|NCT00472186|591811424|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
163847388|NCT00472186|591811425|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
163847389|NCT00997243|591811426|FG000|Overall Study|Early termination of study by sponsor|7|||
163847390|NCT02086552|591811431|FG000|Overall Study|Withdrawal by Subject|1|||
163847391|NCT00724061|591811434|FG000|Dose Escalation Phase|Adverse Event|2|||
163847392|NCT00724061|591811434|FG000|Dose Escalation Phase|Disease Progression|3|||
163847393|NCT00594932|591811437|FG000|First 3 Months|Withdrawal by Subject|1|||
163847394|NCT00594932|591811438|FG001|First 3 Months|Withdrawal by Subject|3|||
163847395|NCT00594932|591811437|FG000|Final 3 Months|Withdrawal by Subject|4|||
163847396|NCT00594932|591811438|FG001|Final 3 Months|Withdrawal by Subject|3|||
163847397|NCT01536145|591811439|FG000|Overall Study|Progressive disease|3|||
163847398|NCT01536145|591811440|FG001|Overall Study|Progressive disease|4|||
163847399|NCT01536145|591811441|FG002|Overall Study|Progressive disease|1|||
163847400|NCT01536145|591811442|FG003|Overall Study|Progressive disease|2|||
163847401|NCT01536145|591811443|FG004|Overall Study|Progressive disease|1|||
163847402|NCT01536145|591811444|FG005|Overall Study|Progressive disease|2|||
163847403|NCT01536145|591811445|FG006|Overall Study|Progressive disease|1|||
163847404|NCT01536145|591811446|FG007|Overall Study|Progressive disease|2|||
163847405|NCT01536145|591811447|FG008|Overall Study|Progressive disease|1|||
163847406|NCT01536145|591811448|FG009|Overall Study|Progressive disease|3|||
163847407|NCT01536145|591811449|FG010|Overall Study|Progressive disease|3|||
163847408|NCT01536145|591811439|FG000|Overall Study|Withdrawal by Subject|0|||
163847409|NCT01536145|591811440|FG001|Overall Study|Withdrawal by Subject|0|||
163847410|NCT01536145|591811441|FG002|Overall Study|Withdrawal by Subject|1|||
163847411|NCT01536145|591811442|FG003|Overall Study|Withdrawal by Subject|0|||
163847412|NCT01536145|591811443|FG004|Overall Study|Withdrawal by Subject|0|||
163847413|NCT01536145|591811444|FG005|Overall Study|Withdrawal by Subject|1|||
163847414|NCT01536145|591811445|FG006|Overall Study|Withdrawal by Subject|0|||
163847415|NCT01536145|591811446|FG007|Overall Study|Withdrawal by Subject|0|||
163847416|NCT01536145|591811447|FG008|Overall Study|Withdrawal by Subject|2|||
163847417|NCT01536145|591811448|FG009|Overall Study|Withdrawal by Subject|0|||
163847418|NCT01536145|591811449|FG010|Overall Study|Withdrawal by Subject|2|||
163847419|NCT01536145|591811439|FG000|Overall Study|Other|0|||
163847420|NCT01536145|591811440|FG001|Overall Study|Other|0|||
163847421|NCT01536145|591811441|FG002|Overall Study|Other|0|||
163847422|NCT01536145|591811442|FG003|Overall Study|Other|0|||
163847423|NCT01536145|591811443|FG004|Overall Study|Other|1|||
163847424|NCT01536145|591811444|FG005|Overall Study|Other|0|||
163847425|NCT01536145|591811445|FG006|Overall Study|Other|0|||
163847426|NCT01536145|591811446|FG007|Overall Study|Other|0|||
163847427|NCT01536145|591811447|FG008|Overall Study|Other|0|||
163847428|NCT01536145|591811448|FG009|Overall Study|Other|3|||
163847429|NCT01536145|591811449|FG010|Overall Study|Other|2|||
163847430|NCT01536145|591811439|FG000|Overall Study|Death|0|||
163847431|NCT01536145|591811440|FG001|Overall Study|Death|0|||
163847432|NCT01536145|591811441|FG002|Overall Study|Death|0|||
163847433|NCT01536145|591811442|FG003|Overall Study|Death|0|||
163847434|NCT01536145|591811443|FG004|Overall Study|Death|0|||
163847435|NCT01536145|591811444|FG005|Overall Study|Death|0|||
163847436|NCT01536145|591811445|FG006|Overall Study|Death|1|||
163847437|NCT01536145|591811446|FG007|Overall Study|Death|0|||
163847438|NCT01536145|591811447|FG008|Overall Study|Death|0|||
163847439|NCT01536145|591811448|FG009|Overall Study|Death|0|||
163847440|NCT01536145|591811449|FG010|Overall Study|Death|0|||
163847441|NCT01536145|591811439|FG000|Overall Study|Adverse Event|0|||
163847442|NCT01536145|591811440|FG001|Overall Study|Adverse Event|0|||
163847443|NCT01536145|591811441|FG002|Overall Study|Adverse Event|0|||
163847444|NCT01536145|591811442|FG003|Overall Study|Adverse Event|0|||
163847445|NCT01536145|591811443|FG004|Overall Study|Adverse Event|0|||
163847446|NCT01536145|591811444|FG005|Overall Study|Adverse Event|0|||
163847447|NCT01536145|591811445|FG006|Overall Study|Adverse Event|0|||
163847448|NCT01536145|591811446|FG007|Overall Study|Adverse Event|2|||
163847449|NCT01536145|591811447|FG008|Overall Study|Adverse Event|0|||
163847450|NCT01536145|591811448|FG009|Overall Study|Adverse Event|0|||
163847451|NCT01536145|591811449|FG010|Overall Study|Adverse Event|3|||
163847452|NCT00688259|591811452|FG000|Overall Study|Lost to Follow-up|2|||
163847453|NCT00688259|591811453|FG001|Overall Study|Lost to Follow-up|4|||
163847454|NCT00688259|591811452|FG000|Overall Study|Physician Decision|1|||
163847455|NCT00688259|591811453|FG001|Overall Study|Physician Decision|0|||
163847456|NCT00688259|591811452|FG000|Overall Study|Withdrawal by Subject|2|||
163847457|NCT00688259|591811453|FG001|Overall Study|Withdrawal by Subject|0|||
163847458|NCT00688259|591811452|FG000|Overall Study|Declined Interview|2|||
163847459|NCT00688259|591811453|FG001|Overall Study|Declined Interview|3|||
163847460|NCT00688259|591811452|FG000|Overall Study|Hospitalized at Follow-up|0|||
163847461|NCT00688259|591811453|FG001|Overall Study|Hospitalized at Follow-up|1|||
163847462|NCT02982720|591811456|FG000|Overall Study|Adverse Event|3|||
163847463|NCT02982720|591811456|FG000|Overall Study|Death|1|||
163847464|NCT01734850|591811461|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
163847465|NCT01734850|591811462|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
163847466|NCT01734850|591811463|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
163847467|NCT01734850|591811461|FG000|Overall Study|Not infused due to manufacturing failure|0|||
163847468|NCT01734850|591811462|FG001|Overall Study|Not infused due to manufacturing failure|0|||
163847469|NCT01734850|591811463|FG002|Overall Study|Not infused due to manufacturing failure|1|||
163847470|NCT03824938|591811464|FG000|Overall Study|Withdrawal by Subject|2|||
163847471|NCT03824938|591811465|FG001|Overall Study|Withdrawal by Subject|1|||
163847472|NCT03824938|591811466|FG002|Overall Study|Withdrawal by Subject|0|||
163847473|NCT03824938|591811467|FG003|Overall Study|Withdrawal by Subject|2|||
163847474|NCT03824938|591811468|FG004|Overall Study|Withdrawal by Subject|0|||
163847475|NCT03824938|591811469|FG005|Overall Study|Withdrawal by Subject|1|||
163847476|NCT03824938|591811464|FG000|Overall Study|Lost to Follow-up|0|||
163847477|NCT03824938|591811465|FG001|Overall Study|Lost to Follow-up|1|||
163847478|NCT03824938|591811466|FG002|Overall Study|Lost to Follow-up|0|||
163847479|NCT03824938|591811467|FG003|Overall Study|Lost to Follow-up|0|||
163847480|NCT03824938|591811468|FG004|Overall Study|Lost to Follow-up|1|||
163847481|NCT03824938|591811469|FG005|Overall Study|Lost to Follow-up|0|||
163847482|NCT00287469|591811473|FG000|Overall Study|serious adverse event|1|||
163847483|NCT00287469|591811474|FG001|Overall Study|serious adverse event|6|||
163847484|NCT00287469|591811473|FG000|Overall Study|Adverse Event|1|||
163847485|NCT00287469|591811474|FG001|Overall Study|Adverse Event|1|||
163847486|NCT00287469|591811473|FG000|Overall Study|moved from area|144|||
163847487|NCT00287469|591811474|FG001|Overall Study|moved from area|138|||
163847488|NCT00287469|591811473|FG000|Overall Study|Lost to Follow-up|74|||
163847489|NCT00287469|591811474|FG001|Overall Study|Lost to Follow-up|69|||
163959781|NCT03840486|592224110|FG002|Overall Study|Withdrawal by Subject|0|||
163959782|NCT03840486|592224111|FG003|Overall Study|Withdrawal by Subject|0|||
163959783|NCT03840486|592224112|FG004|Overall Study|Withdrawal by Subject|0|||
163959784|NCT03840486|592224113|FG005|Overall Study|Withdrawal by Subject|0|||
163959785|NCT03840486|592224114|FG006|Overall Study|Withdrawal by Subject|0|||
163959786|NCT03840486|592224115|FG007|Overall Study|Withdrawal by Subject|0|||
163959787|NCT03840486|592224116|FG008|Overall Study|Withdrawal by Subject|0|||
163959788|NCT03840486|592224117|FG009|Overall Study|Withdrawal by Subject|0|||
163959789|NCT03840486|592224118|FG010|Overall Study|Withdrawal by Subject|0|||
163959790|NCT03840486|592224119|FG011|Overall Study|Withdrawal by Subject|0|||
163959791|NCT03780725|592224120|FG000|Overall Study|Progression of disease|3|||
163959792|NCT03780725|592224121|FG001|Overall Study|Progression of disease|4|||
163959793|NCT03780725|592224120|FG000|Overall Study|Adverse Event|0|||
163959794|NCT03780725|592224121|FG001|Overall Study|Adverse Event|1|||
163959795|NCT03437278|592224122|FG000|Overall Study|Adverse Event|0|||
163959796|NCT03437278|592224123|FG001|Overall Study|Adverse Event|0|||
163959797|NCT03437278|592224124|FG002|Overall Study|Adverse Event|1|||
163959798|NCT03437278|592224122|FG000|Overall Study|Progressive disease|1|||
163959799|NCT03437278|592224123|FG001|Overall Study|Progressive disease|0|||
163959800|NCT03437278|592224124|FG002|Overall Study|Progressive disease|0|||
163959801|NCT03437278|592224122|FG000|Overall Study|Physician Decision|1|||
163959802|NCT03437278|592224123|FG001|Overall Study|Physician Decision|0|||
163959803|NCT03437278|592224124|FG002|Overall Study|Physician Decision|1|||
163959804|NCT05116046|592224125|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163959805|NCT05116046|592224126|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163959806|NCT05116046|592224127|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163959807|NCT05116046|592224125|FG000|Overall Study|Study terminated by sponsor|14|||
163959808|NCT05116046|592224126|FG001|Overall Study|Study terminated by sponsor|16|||
163959809|NCT05116046|592224127|FG002|Overall Study|Study terminated by sponsor|1|||
163959810|NCT04328727|592224129|FG000|Overall Study|Guardian Decision|1|||
163959811|NCT04328727|592224129|FG000|Overall Study|Participant decision|4|||
163959812|NCT04328727|592224129|FG000|Overall Study|Death|3|||
163959813|NCT02604199|592224137|FG000|Overall Study|Pregnancy|0|||
163959814|NCT02604199|592224138|FG001|Overall Study|Pregnancy|0|||
163959815|NCT02604199|592224139|FG002|Overall Study|Pregnancy|0|||
163959816|NCT02604199|592224140|FG003|Overall Study|Pregnancy|1|||
163847490|NCT01058863|591811475|FG000|Overall Study|Lost to Follow-up|1|||
163847491|NCT01058863|591811475|FG000|Overall Study|Withdrawal by Subject|1|||
163847492|NCT01058863|591811475|FG000|Overall Study|Sponsor requested withdrawal|1|||
163847493|NCT01058863|591811475|FG000|Overall Study|Randomized in error|1|||
163847494|NCT00681187|591811476|FG000|Overall Study|Withdrawal by Subject|1|||
163959817|NCT02604199|592224137|FG000|Overall Study|Study terminated by sponsor|0|||
163959818|NCT02604199|592224138|FG001|Overall Study|Study terminated by sponsor|2|||
163959819|NCT02604199|592224139|FG002|Overall Study|Study terminated by sponsor|0|||
163959820|NCT02604199|592224140|FG003|Overall Study|Study terminated by sponsor|2|||
163847495|NCT00681187|591811477|FG001|Overall Study|Withdrawal by Subject|0|||
163959821|NCT02604199|592224137|FG000|Overall Study|Withdrawal by Subject|0|||
163959822|NCT02604199|592224138|FG001|Overall Study|Withdrawal by Subject|1|||
163847496|NCT00681187|591811476|FG000|Overall Study|Death|0|||
163847497|NCT00681187|591811477|FG001|Overall Study|Death|1|||
163847498|NCT00681187|591811476|FG000|Overall Study|Adverse Event|0|||
163847499|NCT00681187|591811477|FG001|Overall Study|Adverse Event|1|||
163847500|NCT03653416|591811478|FG000|Overall Study|Protocol Violation|6|||
163847501|NCT03653416|591811479|FG001|Overall Study|Protocol Violation|1|||
163847502|NCT03619174|591811480|FG000|Overall Study|Lost to Follow-up|3|||
163847503|NCT03619174|591811481|FG001|Overall Study|Lost to Follow-up|0|||
163847504|NCT03619174|591811480|FG000|Overall Study|Withdrawal by Subject|4|||
163847505|NCT03619174|591811481|FG001|Overall Study|Withdrawal by Subject|3|||
163847506|NCT03619174|591811480|FG000|Overall Study|Pregnancy|1|||
163847507|NCT03619174|591811481|FG001|Overall Study|Pregnancy|1|||
163847508|NCT03619174|591811480|FG000|Overall Study|Discomfort during treatment|1|||
163847509|NCT03619174|591811481|FG001|Overall Study|Discomfort during treatment|0|||
163847510|NCT01556763|591811484|FG000|Overall Study|Withdrawal by Subject|0|||
163847511|NCT01556763|591811485|FG001|Overall Study|Withdrawal by Subject|1|||
163847512|NCT01556763|591811486|FG002|Overall Study|Withdrawal by Subject|0|||
163847513|NCT02258464|591811487|FG000|Overall Study|Progressive disease (PD)|9|||
163847514|NCT02258464|591811488|FG001|Overall Study|Progressive disease (PD)|17|||
163847515|NCT02258464|591811487|FG000|Overall Study|Study drug never administered|1|||
163847516|NCT02258464|591811488|FG001|Overall Study|Study drug never administered|1|||
163847517|NCT02258464|591811487|FG000|Overall Study|AE not related to clinical PD|1|||
163847518|NCT02258464|591811488|FG001|Overall Study|AE not related to clinical PD|3|||
163847519|NCT02258464|591811487|FG000|Overall Study|Withdrawal by Subject|5|||
163847520|NCT02258464|591811488|FG001|Overall Study|Withdrawal by Subject|4|||
163847521|NCT02258464|591811487|FG000|Overall Study|AE related to clinical PD|1|||
163847522|NCT02258464|591811488|FG001|Overall Study|AE related to clinical PD|0|||
163847523|NCT00932646|591811489|FG000|Overall Study|Adverse Event|2|||
163847524|NCT00932646|591811490|FG001|Overall Study|Adverse Event|1|||
163847525|NCT00932646|591811491|FG002|Overall Study|Adverse Event|1|||
163847526|NCT00932646|591811492|FG003|Overall Study|Adverse Event|1|||
163847527|NCT00932646|591811489|FG000|Overall Study|Lost to Follow-up|2|||
163847528|NCT00932646|591811490|FG001|Overall Study|Lost to Follow-up|1|||
163847529|NCT00932646|591811491|FG002|Overall Study|Lost to Follow-up|0|||
163847530|NCT00932646|591811492|FG003|Overall Study|Lost to Follow-up|0|||
163847531|NCT00932646|591811489|FG000|Overall Study|Withdrawal by Subject|1|||
163847532|NCT00932646|591811490|FG001|Overall Study|Withdrawal by Subject|1|||
163847533|NCT00932646|591811491|FG002|Overall Study|Withdrawal by Subject|3|||
163847534|NCT00932646|591811492|FG003|Overall Study|Withdrawal by Subject|0|||
163847535|NCT00776100|591811493|FG000|Overall Study|Disease Progression|1|||
163847536|NCT00776100|591811494|FG001|Overall Study|Disease Progression|0|||
163847537|NCT04759885|591811499|FG000|Overall Study|Other|1|||
163847538|NCT04759885|591811500|FG001|Overall Study|Other|0|||
163847539|NCT04759885|591811501|FG002|Overall Study|Other|2|||
163847540|NCT04759885|591811502|FG003|Overall Study|Other|0|||
163847541|NCT04759885|591811503|FG004|Overall Study|Other|0|||
163847542|NCT04759885|591811499|FG000|Overall Study|Withdrawal by Subject|0|||
163847543|NCT04759885|591811500|FG001|Overall Study|Withdrawal by Subject|0|||
163847544|NCT04759885|591811501|FG002|Overall Study|Withdrawal by Subject|1|||
163847545|NCT04759885|591811502|FG003|Overall Study|Withdrawal by Subject|9|||
163847546|NCT04759885|591811503|FG004|Overall Study|Withdrawal by Subject|6|||
163847547|NCT04759885|591811499|FG000|Overall Study|Adverse Event|0|||
163847548|NCT04759885|591811500|FG001|Overall Study|Adverse Event|0|||
163847549|NCT04759885|591811501|FG002|Overall Study|Adverse Event|0|||
163847550|NCT04759885|591811502|FG003|Overall Study|Adverse Event|3|||
163847551|NCT04759885|591811503|FG004|Overall Study|Adverse Event|0|||
163847552|NCT04759885|591811499|FG000|Overall Study|Physician Decision|0|||
163847553|NCT04759885|591811500|FG001|Overall Study|Physician Decision|0|||
163847554|NCT04759885|591811501|FG002|Overall Study|Physician Decision|0|||
163847555|NCT04759885|591811502|FG003|Overall Study|Physician Decision|2|||
163847556|NCT04759885|591811503|FG004|Overall Study|Physician Decision|0|||
163847557|NCT00195715|591811504|FG000|Overall Study|Adverse Event|122|||
163959823|NCT02604199|592224139|FG002|Overall Study|Withdrawal by Subject|0|||
163959824|NCT02604199|592224140|FG003|Overall Study|Withdrawal by Subject|0|||
163847558|NCT00195715|591811504|FG000|Overall Study|Withdrawal by Subject|58|||
163959825|NCT02604212|592224141|FG000|Overall Study|Study Terminated by Sponsor|2|||
163959826|NCT02604212|592224142|FG001|Overall Study|Study Terminated by Sponsor|1|||
163847559|NCT00195715|591811504|FG000|Overall Study|Lost to Follow-up|27|||
163847560|NCT00195715|591811504|FG000|Overall Study|Protocol Violation|13|||
163847561|NCT00195715|591811504|FG000|Overall Study|Lack of Efficacy|93|||
163847562|NCT00195715|591811504|FG000|Overall Study|Pregnancy|14|||
163847563|NCT00195715|591811504|FG000|Overall Study|Investigative site closure|8|||
163847564|NCT00195715|591811504|FG000|Overall Study|Subject moved/relocated|7|||
163847565|NCT00195715|591811504|FG000|Overall Study|Subject non-compliance|6|||
164006468|NCT02158533|592390967|FG005|Stage 2|Withdrawal by Subject|2|||
163847566|NCT00195715|591811504|FG000|Overall Study|Subject started commercial Humira|5|||
163847567|NCT00195715|591811504|FG000|Overall Study|Subject choice|3|||
163847568|NCT00195715|591811504|FG000|Overall Study|Loss of response/no improvement|3|||
163847569|NCT00195715|591811504|FG000|Overall Study|Sponsor stopped study|1|||
163847570|NCT00195715|591811504|FG000|Overall Study|Administrative reasons|2|||
163847571|NCT00195715|591811504|FG000|Overall Study|Investigator's decision|2|||
163847572|NCT00195715|591811504|FG000|Overall Study|Subject wants to get pregnant|4|||
163847573|NCT00195715|591811504|FG000|Overall Study|Use of prohibited medication|2|||
163847574|NCT00195715|591811504|FG000|Overall Study|Planned surgery|2|||
163847575|NCT00195715|591811504|FG000|Overall Study|Increased infection rate|1|||
163847576|NCT00195715|591811504|FG000|Overall Study|Ineligible|1|||
163847577|NCT00195715|591811504|FG000|Overall Study|Colonic stricture|1|||
163847578|NCT00195715|591811504|FG000|Overall Study|Sponsor discontinued trial|1|||
163847579|NCT00195715|591811504|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
163847580|NCT05822921|591811509|FG000|Overall Study|Lost to Follow-up|1|||
163847581|NCT05822921|591811510|FG001|Overall Study|Lost to Follow-up|1|||
163847582|NCT01267253|591811513|FG000|Overall Study|Ineligible - required test not done|1|||
163847583|NCT01267253|591811513|FG000|Overall Study|Inevaluable-never received study treatme|2|||
163847584|NCT00996580|591811514|FG000|Overall Study|Adverse Event|466|||
163847585|NCT00996580|591811514|FG000|Overall Study|Lost to Follow-up|480|||
163847586|NCT00996580|591811514|FG000|Overall Study|Noncompliance with the protocol|137|||
163847587|NCT00996580|591811514|FG000|Overall Study|Physician Decision|5|||
163847588|NCT00996580|591811514|FG000|Overall Study|Pregnancy|68|||
163847589|NCT00996580|591811514|FG000|Overall Study|Protocol Violation|16|||
163847590|NCT00996580|591811514|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
163847591|NCT00996580|591811514|FG000|Overall Study|Withdrawal by Subject|217|||
163847592|NCT00996580|591811514|FG000|Overall Study|Other|29|||
163847593|NCT00064025|591811515|FG000|Overall Study|Ineligible|4|||
163847594|NCT00064025|591811515|FG000|Overall Study|Inevaluable|3|||
163847595|NCT02468934|591811516|FG000|Overall Study|Withdrawal by Subject|4|||
163847596|NCT02468934|591811516|FG000|Overall Study|Screen Failure|3|||
163847597|NCT02036515|591811521|FG000|Overall Study|Adverse Event|1|||
163847598|NCT02036515|591811522|FG001|Overall Study|Adverse Event|1|||
163847599|NCT02036515|591811523|FG002|Overall Study|Adverse Event|2|||
163847600|NCT02036515|591811521|FG000|Overall Study|Lost to Follow-up|0|||
163847601|NCT02036515|591811522|FG001|Overall Study|Lost to Follow-up|2|||
163959827|NCT02604212|592224143|FG002|Overall Study|Study Terminated by Sponsor|3|||
163959828|NCT02604212|592224144|FG003|Overall Study|Study Terminated by Sponsor|3|||
163959829|NCT02604212|592224141|FG000|Overall Study|Withdrawal by Subject|0|||
163959830|NCT02604212|592224142|FG001|Overall Study|Withdrawal by Subject|0|||
163959831|NCT02604212|592224143|FG002|Overall Study|Withdrawal by Subject|1|||
163959832|NCT02604212|592224144|FG003|Overall Study|Withdrawal by Subject|0|||
163959833|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
163959834|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
163959835|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Death|0|||
163959836|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Death|2|||
163959837|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163959838|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
163959839|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
163959840|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
163959841|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
163959842|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
163959843|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
163959844|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
163959845|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
163959846|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
163959847|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
163959848|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
163959849|NCT00343252|592224153|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
163959850|NCT00343252|592224154|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
163959851|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
163959852|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
163959853|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Death|3|||
163959854|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Death|3|||
163959855|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163959856|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163959857|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
163847602|NCT02036515|591811523|FG002|Overall Study|Lost to Follow-up|0|||
163847603|NCT02036515|591811521|FG000|Overall Study|Non-compliance with study drug|0|||
163847604|NCT02036515|591811522|FG001|Overall Study|Non-compliance with study drug|0|||
163847605|NCT02036515|591811523|FG002|Overall Study|Non-compliance with study drug|2|||
163847606|NCT02036515|591811521|FG000|Overall Study|Screen failure|0|||
163959858|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
163847607|NCT02036515|591811522|FG001|Overall Study|Screen failure|2|||
163847608|NCT02036515|591811523|FG002|Overall Study|Screen failure|0|||
163847609|NCT02036515|591811521|FG000|Overall Study|Withdrawal by Subject|4|||
163847610|NCT02036515|591811522|FG001|Overall Study|Withdrawal by Subject|7|||
163847611|NCT02036515|591811523|FG002|Overall Study|Withdrawal by Subject|9|||
163847612|NCT02036515|591811521|FG000|Overall Study|Hyperglycemia|0|||
163847613|NCT02036515|591811522|FG001|Overall Study|Hyperglycemia|0|||
163847614|NCT02036515|591811523|FG002|Overall Study|Hyperglycemia|1|||
163847615|NCT02218489|591811530|FG000|Overall Study|Withdrawal by Subject|4|||
163847616|NCT02218489|591811531|FG001|Overall Study|Withdrawal by Subject|3|||
163847617|NCT02218489|591811530|FG000|Overall Study|Lost to Follow-up|1|||
163847618|NCT02218489|591811531|FG001|Overall Study|Lost to Follow-up|0|||
163847619|NCT00547911|591811532|FG000|Overall Study|Adverse Event|0|||
163847620|NCT00547911|591811533|FG001|Overall Study|Adverse Event|0|||
163847621|NCT00547911|591811534|FG002|Overall Study|Adverse Event|0|||
163847622|NCT00547911|591811535|FG003|Overall Study|Adverse Event|1|||
163847623|NCT00547911|591811536|FG004|Overall Study|Adverse Event|0|||
163847624|NCT00547911|591811537|FG005|Overall Study|Adverse Event|0|||
163847625|NCT02601937|591811538|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847626|NCT02601937|591811539|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847627|NCT02601937|591811540|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847628|NCT02601937|591811541|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847629|NCT02601937|591811542|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847630|NCT02601937|591811543|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
163847631|NCT02601937|591811544|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847632|NCT02601937|591811545|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847633|NCT02601937|591811546|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847634|NCT02601937|591811547|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847635|NCT02601937|591811548|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
163847636|NCT02601937|591811538|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
163847637|NCT02601937|591811539|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847638|NCT02601937|591811540|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847639|NCT02601937|591811541|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847640|NCT02601937|591811542|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847641|NCT02601937|591811543|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847642|NCT02601937|591811544|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
163847643|NCT02601937|591811545|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847644|NCT02601937|591811546|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847645|NCT02601937|591811547|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847646|NCT02601937|591811548|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
163847647|NCT02601937|591811538|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847648|NCT02601937|591811539|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847649|NCT02601937|591811540|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
163847650|NCT02601937|591811541|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847651|NCT02601937|591811542|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847652|NCT02601937|591811543|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847653|NCT02601937|591811544|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847654|NCT02601937|591811545|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847655|NCT02601937|591811546|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847656|NCT02601937|591811547|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847657|NCT02601937|591811548|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
163847658|NCT02601937|591811538|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
163847659|NCT02601937|591811539|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
163847660|NCT02601937|591811540|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
163847661|NCT02601937|591811541|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
163847662|NCT02601937|591811542|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
163847663|NCT02601937|591811543|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
163847664|NCT02601937|591811544|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
163847665|NCT02601937|591811545|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
163847666|NCT02601937|591811546|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
163847667|NCT02601937|591811547|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
163847668|NCT02601937|591811548|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
163847669|NCT02601937|591811538|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847670|NCT02601937|591811539|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847671|NCT02601937|591811540|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847672|NCT02601937|591811541|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847673|NCT02601937|591811542|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847674|NCT02601937|591811543|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847675|NCT02601937|591811544|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847676|NCT02601937|591811545|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847677|NCT02601937|591811546|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163959859|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
163959860|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
163959861|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
163959862|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
163959863|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
163959864|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
163959865|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
163959866|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
163959867|NCT00343252|592224153|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
163959868|NCT00343252|592224154|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
163959869|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
163959870|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
163959871|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Death|4|||
163959872|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Death|5|||
163959873|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
163959874|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
163959875|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
163959876|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
163959877|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
163959878|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
163959879|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
163847678|NCT02601937|591811547|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
163847679|NCT02601937|591811548|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
163847680|NCT02601937|591811538|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847681|NCT02601937|591811539|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847682|NCT02601937|591811540|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847683|NCT02601937|591811541|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847684|NCT02601937|591811542|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847685|NCT02601937|591811543|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847686|NCT02601937|591811544|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847687|NCT02601937|591811545|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
163847688|NCT02601937|591811546|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847689|NCT02601937|591811547|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847690|NCT02601937|591811548|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
163847691|NCT02601937|591811538|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847692|NCT02601937|591811539|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847693|NCT02601937|591811540|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847694|NCT02601937|591811541|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847695|NCT02601937|591811542|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847696|NCT02601937|591811543|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847697|NCT02601937|591811544|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847698|NCT02601937|591811545|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847699|NCT02601937|591811546|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
163847700|NCT02601937|591811547|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
163847701|NCT02601937|591811548|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
163847702|NCT02601937|591811538|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847703|NCT02601937|591811539|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847704|NCT02601937|591811540|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847705|NCT02601937|591811541|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847706|NCT02601937|591811542|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847707|NCT02601937|591811543|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847708|NCT02601937|591811544|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
163847709|NCT02601937|591811545|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
163847710|NCT02601937|591811546|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
163847711|NCT02601937|591811547|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
163847712|NCT02601937|591811548|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
163847713|NCT02601937|591811538|FG000|Period 2: Dose Expansion Cohort|Other|0|||
163847714|NCT02601937|591811539|FG001|Period 2: Dose Expansion Cohort|Other|0|||
163847715|NCT02601937|591811540|FG002|Period 2: Dose Expansion Cohort|Other|0|||
163847716|NCT02601937|591811541|FG003|Period 2: Dose Expansion Cohort|Other|0|||
163847717|NCT02601937|591811542|FG004|Period 2: Dose Expansion Cohort|Other|0|||
163959880|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
163959881|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
163847718|NCT02601937|591811543|FG005|Period 2: Dose Expansion Cohort|Other|0|||
163847719|NCT02601937|591811544|FG006|Period 2: Dose Expansion Cohort|Other|0|||
163847720|NCT02601937|591811545|FG007|Period 2: Dose Expansion Cohort|Other|0|||
163847721|NCT02601937|591811546|FG008|Period 2: Dose Expansion Cohort|Other|2|||
163847722|NCT02601937|591811547|FG009|Period 2: Dose Expansion Cohort|Other|2|||
163847723|NCT02601937|591811548|FG010|Period 2: Dose Expansion Cohort|Other|0|||
163847724|NCT02601937|591811538|FG000|Period 2: Dose Expansion Cohort|Death|0|||
163847725|NCT02601937|591811539|FG001|Period 2: Dose Expansion Cohort|Death|0|||
163847726|NCT02601937|591811540|FG002|Period 2: Dose Expansion Cohort|Death|0|||
163847727|NCT02601937|591811541|FG003|Period 2: Dose Expansion Cohort|Death|0|||
163847728|NCT02601937|591811542|FG004|Period 2: Dose Expansion Cohort|Death|0|||
163847729|NCT02601937|591811543|FG005|Period 2: Dose Expansion Cohort|Death|0|||
163847730|NCT02601937|591811544|FG006|Period 2: Dose Expansion Cohort|Death|0|||
163847731|NCT02601937|591811545|FG007|Period 2: Dose Expansion Cohort|Death|0|||
163847732|NCT02601937|591811546|FG008|Period 2: Dose Expansion Cohort|Death|1|||
163847733|NCT02601937|591811547|FG009|Period 2: Dose Expansion Cohort|Death|0|||
163847734|NCT02601937|591811548|FG010|Period 2: Dose Expansion Cohort|Death|0|||
163847735|NCT04145349|591813412|FG000|Overall Study|Withdrawal by Subject|3|||
163847736|NCT04145349|591813413|FG001|Overall Study|Withdrawal by Subject|0|||
163847737|NCT04145349|591813412|FG000|Overall Study|Lost to Follow-up|0|||
163847738|NCT04145349|591813413|FG001|Overall Study|Lost to Follow-up|1|||
163847739|NCT04145349|591813412|FG000|Overall Study|On study treatment (Ongoing)|0|||
163847740|NCT04145349|591813413|FG001|Overall Study|On study treatment (Ongoing)|1|||
163847741|NCT03280563|591813415|FG000|Stage 1|Death|2|||
163847742|NCT03280563|591813416|FG001|Stage 1|Death|1|||
163847743|NCT03280563|591813417|FG002|Stage 1|Death|0|||
163847744|NCT03280563|591813418|FG003|Stage 1|Death|0|||
163847745|NCT03280563|591813419|FG004|Stage 1|Death|0|||
163847746|NCT03280563|591813420|FG005|Stage 1|Death|3|||
163847747|NCT03280563|591813421|FG006|Stage 1|Death|0|||
163847748|NCT03280563|591813422|FG007|Stage 1|Death|0|||
163847749|NCT03280563|591813423|FG008|Stage 1|Death|0|||
163847750|NCT03280563|591813415|FG000|Stage 1|Study Ended by Sponsor|0|||
163847751|NCT03280563|591813416|FG001|Stage 1|Study Ended by Sponsor|0|||
163847752|NCT03280563|591813417|FG002|Stage 1|Study Ended by Sponsor|1|||
163847753|NCT03280563|591813418|FG003|Stage 1|Study Ended by Sponsor|0|||
163847754|NCT03280563|591813419|FG004|Stage 1|Study Ended by Sponsor|0|||
163847755|NCT03280563|591813420|FG005|Stage 1|Study Ended by Sponsor|1|||
163847756|NCT03280563|591813421|FG006|Stage 1|Study Ended by Sponsor|0|||
163847757|NCT03280563|591813422|FG007|Stage 1|Study Ended by Sponsor|0|||
163847758|NCT03280563|591813423|FG008|Stage 1|Study Ended by Sponsor|0|||
163847759|NCT03280563|591813415|FG000|Stage 1|Withdrawal by Subject|5|||
163847760|NCT03280563|591813416|FG001|Stage 1|Withdrawal by Subject|1|||
163847761|NCT03280563|591813417|FG002|Stage 1|Withdrawal by Subject|2|||
163847762|NCT03280563|591813418|FG003|Stage 1|Withdrawal by Subject|0|||
163847763|NCT03280563|591813419|FG004|Stage 1|Withdrawal by Subject|0|||
163847764|NCT03280563|591813420|FG005|Stage 1|Withdrawal by Subject|2|||
163847765|NCT03280563|591813421|FG006|Stage 1|Withdrawal by Subject|0|||
163847766|NCT03280563|591813422|FG007|Stage 1|Withdrawal by Subject|0|||
163847767|NCT03280563|591813423|FG008|Stage 1|Withdrawal by Subject|0|||
163847768|NCT03280563|591813415|FG000|Stage 1|Reason Not Specified|0|||
163847769|NCT03280563|591813416|FG001|Stage 1|Reason Not Specified|0|||
163847770|NCT03280563|591813417|FG002|Stage 1|Reason Not Specified|0|||
163847771|NCT03280563|591813418|FG003|Stage 1|Reason Not Specified|0|||
163847772|NCT03280563|591813419|FG004|Stage 1|Reason Not Specified|0|||
163847773|NCT03280563|591813420|FG005|Stage 1|Reason Not Specified|1|||
163847774|NCT03280563|591813421|FG006|Stage 1|Reason Not Specified|0|||
163847775|NCT03280563|591813422|FG007|Stage 1|Reason Not Specified|0|||
163847776|NCT03280563|591813423|FG008|Stage 1|Reason Not Specified|0|||
163847777|NCT03280563|591813415|FG000|Stage 1|Physician Decision|0|||
163847778|NCT03280563|591813416|FG001|Stage 1|Physician Decision|1|||
163847779|NCT03280563|591813417|FG002|Stage 1|Physician Decision|0|||
163847780|NCT03280563|591813418|FG003|Stage 1|Physician Decision|0|||
163847781|NCT03280563|591813419|FG004|Stage 1|Physician Decision|0|||
163847782|NCT03280563|591813420|FG005|Stage 1|Physician Decision|0|||
163847783|NCT03280563|591813421|FG006|Stage 1|Physician Decision|0|||
163847784|NCT03280563|591813422|FG007|Stage 1|Physician Decision|0|||
163847785|NCT03280563|591813423|FG008|Stage 1|Physician Decision|0|||
163959882|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
163847786|NCT03280563|591813415|FG000|Stage 2|Death|0|||
163847787|NCT03280563|591813416|FG001|Stage 2|Death|0|||
163847788|NCT03280563|591813417|FG002|Stage 2|Death|0|||
163847789|NCT03280563|591813418|FG003|Stage 2|Death|0|||
163847790|NCT03280563|591813419|FG004|Stage 2|Death|0|||
163847791|NCT03280563|591813420|FG005|Stage 2|Death|0|||
163847792|NCT03280563|591813421|FG006|Stage 2|Death|0|||
163847793|NCT03280563|591813422|FG007|Stage 2|Death|1|||
163847794|NCT03280563|591813423|FG008|Stage 2|Death|0|||
163847795|NCT03280563|591813415|FG000|Stage 2|Progressive Disease|0|||
163847796|NCT03280563|591813416|FG001|Stage 2|Progressive Disease|0|||
163847797|NCT03280563|591813417|FG002|Stage 2|Progressive Disease|0|||
163847798|NCT03280563|591813418|FG003|Stage 2|Progressive Disease|0|||
163847799|NCT03280563|591813419|FG004|Stage 2|Progressive Disease|0|||
163847800|NCT03280563|591813420|FG005|Stage 2|Progressive Disease|0|||
163847801|NCT03280563|591813421|FG006|Stage 2|Progressive Disease|2|||
163847802|NCT03280563|591813422|FG007|Stage 2|Progressive Disease|0|||
163847803|NCT03280563|591813423|FG008|Stage 2|Progressive Disease|0|||
163847804|NCT03280563|591813415|FG000|Long-term Survival Follow-up|Death|10|||
163847805|NCT03280563|591813416|FG001|Long-term Survival Follow-up|Death|14|||
163847806|NCT03280563|591813417|FG002|Long-term Survival Follow-up|Death|15|||
163847807|NCT03280563|591813418|FG003|Long-term Survival Follow-up|Death|3|||
163847808|NCT03280563|591813419|FG004|Long-term Survival Follow-up|Death|6|||
163847809|NCT03280563|591813420|FG005|Long-term Survival Follow-up|Death|18|||
163847810|NCT03280563|591813421|FG006|Long-term Survival Follow-up|Death|11|||
163847811|NCT03280563|591813422|FG007|Long-term Survival Follow-up|Death|1|||
163847812|NCT03280563|591813423|FG008|Long-term Survival Follow-up|Death|3|||
163847813|NCT03280563|591813415|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
163847814|NCT03280563|591813416|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
163847815|NCT03280563|591813417|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
163847816|NCT03280563|591813418|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163847817|NCT03280563|591813419|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163847818|NCT03280563|591813420|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
163847819|NCT03280563|591813421|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163847820|NCT03280563|591813422|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
163847821|NCT03280563|591813423|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
163847822|NCT03280563|591813415|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163847823|NCT03280563|591813416|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163847824|NCT03280563|591813417|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163847825|NCT03280563|591813418|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163847826|NCT03280563|591813419|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
163959883|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
163959884|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
163959885|NCT00343252|592224153|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
163959886|NCT00343252|592224154|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
163959887|NCT01026454|592224155|FG000|Second Intervention|Pregnancy|1|||
163959888|NCT01026454|592224156|FG001|Second Intervention|Pregnancy|1|||
163959889|NCT02893930|592224157|FG000|Overall Study|Adverse Event|3|||
163959890|NCT02893930|592224157|FG000|Overall Study|Death|1|||
163959891|NCT02893930|592224157|FG000|Overall Study|Disease progression|5|||
163959892|NCT02893930|592224157|FG000|Overall Study|Withdrawal by Subject|2|||
163959893|NCT02893930|592224157|FG000|Overall Study|Physician Decision|1|||
163959894|NCT02893930|592224157|FG000|Overall Study|Ineligible|1|||
163959895|NCT01592864|592224160|FG000|Overall Study|Withdrawal by Subject|0|||
163959896|NCT01592864|592224161|FG001|Overall Study|Withdrawal by Subject|1|||
163959897|NCT04150029|592224170|FG000|Overall Study|Disease Relapse|0|||
163959898|NCT04150029|592224171|FG001|Overall Study|Disease Relapse|18|||
163959899|NCT04150029|592224170|FG000|Overall Study|Progressive Disease|2|||
163959900|NCT04150029|592224171|FG001|Overall Study|Progressive Disease|16|||
163959901|NCT04150029|592224170|FG000|Overall Study|Adverse Event|1|||
163959902|NCT04150029|592224171|FG001|Overall Study|Adverse Event|11|||
163959903|NCT04150029|592224170|FG000|Overall Study|Physician Decision|0|||
163959904|NCT04150029|592224171|FG001|Overall Study|Physician Decision|10|||
163959905|NCT04150029|592224170|FG000|Overall Study|Study Terminated by Sponsor|1|||
163959906|NCT04150029|592224171|FG001|Overall Study|Study Terminated by Sponsor|10|||
163959907|NCT04150029|592224170|FG000|Overall Study|Death|0|||
163959908|NCT04150029|592224171|FG001|Overall Study|Death|8|||
163959909|NCT04150029|592224170|FG000|Overall Study|Participant Decision|0|||
163959910|NCT04150029|592224171|FG001|Overall Study|Participant Decision|7|||
163959911|NCT04150029|592224170|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
163959912|NCT04150029|592224171|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
163959913|NCT02577029|592224172|FG000|Overall Study|Adverse Event|1|||
163959914|NCT02577029|592224173|FG001|Overall Study|Adverse Event|0|||
163959915|NCT02577029|592224174|FG002|Overall Study|Adverse Event|2|||
163959916|NCT02577029|592224175|FG003|Overall Study|Adverse Event|0|||
163959917|NCT02577029|592224176|FG004|Overall Study|Adverse Event|1|||
163959918|NCT02577029|592224177|FG005|Overall Study|Adverse Event|0|||
163959919|NCT02577029|592224178|FG006|Overall Study|Adverse Event|0|||
163959920|NCT02577029|592224179|FG007|Overall Study|Adverse Event|0|||
163847827|NCT03280563|591813420|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163847828|NCT03280563|591813421|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163847829|NCT03280563|591813422|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163959921|NCT02577029|592224172|FG000|Overall Study|Withdrawal by Subject|0|||
163959922|NCT02577029|592224173|FG001|Overall Study|Withdrawal by Subject|0|||
163959923|NCT02577029|592224174|FG002|Overall Study|Withdrawal by Subject|0|||
163959924|NCT02577029|592224175|FG003|Overall Study|Withdrawal by Subject|0|||
163959925|NCT02577029|592224176|FG004|Overall Study|Withdrawal by Subject|0|||
163959926|NCT02577029|592224177|FG005|Overall Study|Withdrawal by Subject|1|||
163959927|NCT02577029|592224178|FG006|Overall Study|Withdrawal by Subject|0|||
163959928|NCT02577029|592224179|FG007|Overall Study|Withdrawal by Subject|0|||
163959929|NCT02577029|592224172|FG000|Overall Study|Sponsor Termination of the Study|9|||
163959930|NCT02577029|592224173|FG001|Overall Study|Sponsor Termination of the Study|2|||
163959931|NCT02577029|592224174|FG002|Overall Study|Sponsor Termination of the Study|5|||
163959932|NCT02577029|592224175|FG003|Overall Study|Sponsor Termination of the Study|12|||
163959933|NCT02577029|592224176|FG004|Overall Study|Sponsor Termination of the Study|10|||
163959934|NCT02577029|592224177|FG005|Overall Study|Sponsor Termination of the Study|12|||
163959935|NCT02577029|592224178|FG006|Overall Study|Sponsor Termination of the Study|12|||
163959936|NCT02577029|592224179|FG007|Overall Study|Sponsor Termination of the Study|12|||
163959937|NCT04379518|592224180|FG000|Overall Study|Physician Decision|2|||
163959938|NCT04379518|592224181|FG001|Overall Study|Physician Decision|0|||
163959939|NCT04379518|592224182|FG002|Overall Study|Physician Decision|0|||
163959940|NCT04379518|592224183|FG003|Overall Study|Physician Decision|0|||
163959941|NCT04379518|592224184|FG004|Overall Study|Physician Decision|0|||
163959942|NCT04379518|592224180|FG000|Overall Study|Withdrawal by Subject|1|||
163959943|NCT04379518|592224181|FG001|Overall Study|Withdrawal by Subject|0|||
163959944|NCT04379518|592224182|FG002|Overall Study|Withdrawal by Subject|0|||
163959945|NCT04379518|592224183|FG003|Overall Study|Withdrawal by Subject|0|||
163959946|NCT04379518|592224184|FG004|Overall Study|Withdrawal by Subject|0|||
163959947|NCT05135000|592224185|FG000|Overall Study|Adverse Event|2|||
163959948|NCT05135000|592224186|FG001|Overall Study|Adverse Event|0|||
163959949|NCT05135000|592224185|FG000|Overall Study|Lost to Follow-up|1|||
163959950|NCT05135000|592224186|FG001|Overall Study|Lost to Follow-up|0|||
163959951|NCT05135000|592224185|FG000|Overall Study|Study Terminated by Sponsor|6|||
163959952|NCT05135000|592224186|FG001|Overall Study|Study Terminated by Sponsor|3|||
163959953|NCT04652726|592225366|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
163959954|NCT04652726|592225367|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
163959955|NCT04652726|592225368|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
163959956|NCT04652726|592225366|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
163959957|NCT04652726|592225367|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
163959958|NCT04652726|592225368|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
163959959|NCT02738008|592225369|FG000|Overall Study|Study Terminated by Sponsor|1|||
163959960|NCT02738008|592225370|FG001|Overall Study|Study Terminated by Sponsor|5|||
163959961|NCT02738008|592225371|FG002|Overall Study|Study Terminated by Sponsor|3|||
163959962|NCT02738008|592225369|FG000|Overall Study|Adverse Event|0|||
163959963|NCT02738008|592225370|FG001|Overall Study|Adverse Event|1|||
163959964|NCT02738008|592225371|FG002|Overall Study|Adverse Event|2|||
163959965|NCT05192382|592225372|FG000|RC Phase (Up to Week 24)|Adverse Event|1|||
163959966|NCT05192382|592225373|FG001|RC Phase (Up to Week 24)|Adverse Event|1|||
163959967|NCT05192382|592225374|FG002|RC Phase (Up to Week 24)|Adverse Event|0|||
163959968|NCT05192382|592225372|FG000|RC Phase (Up to Week 24)|Withdrawal by Subject|1|||
163959969|NCT05192382|592225373|FG001|RC Phase (Up to Week 24)|Withdrawal by Subject|2|||
163959970|NCT05192382|592225374|FG002|RC Phase (Up to Week 24)|Withdrawal by Subject|0|||
163959971|NCT05192382|592225372|FG000|OLE Phase (Up to Week 200)|Discontinued|1|||
163959972|NCT05192382|592225373|FG001|OLE Phase (Up to Week 200)|Discontinued|4|||
163959973|NCT05192382|592225374|FG002|OLE Phase (Up to Week 200)|Discontinued|1|||
163959974|NCT05192382|592225372|FG000|OLE Phase (Up to Week 200)|Ongoing|49|||
163959975|NCT05192382|592225373|FG001|OLE Phase (Up to Week 200)|Ongoing|48|||
163959976|NCT05192382|592225374|FG002|OLE Phase (Up to Week 200)|Ongoing|10|||
163959977|NCT04702776|592225377|FG000|Overall Study|Adverse Event|1|||
163959978|NCT04702776|592225378|FG001|Overall Study|Adverse Event|2|||
163959979|NCT04702776|592225379|FG002|Overall Study|Adverse Event|1|||
163959980|NCT04702776|592225377|FG000|Overall Study|Lost to Follow-up|2|||
163959981|NCT04702776|592225378|FG001|Overall Study|Lost to Follow-up|1|||
163959982|NCT04702776|592225379|FG002|Overall Study|Lost to Follow-up|4|||
163959983|NCT04702776|592225377|FG000|Overall Study|Protocol Violation|2|||
163959984|NCT04702776|592225378|FG001|Overall Study|Protocol Violation|2|||
163959985|NCT04702776|592225379|FG002|Overall Study|Protocol Violation|3|||
163959986|NCT02076178|592225380|FG000|Oral Phase|Adverse Event|0|||
163959987|NCT02076178|592225381|FG001|Oral Phase|Adverse Event|7|||
163959988|NCT02076178|592225380|FG000|Oral Phase|Withdrawal by Subject|0|||
163959989|NCT02076178|592225381|FG001|Oral Phase|Withdrawal by Subject|4|||
163959990|NCT02076178|592225380|FG000|Oral Phase|Physician Decision|0|||
163959991|NCT02076178|592225381|FG001|Oral Phase|Physician Decision|1|||
163959992|NCT02076178|592225380|FG000|Injection Phase|Protocol defined stopping criteria|1|||
163959993|NCT02076178|592225381|FG001|Injection Phase|Protocol defined stopping criteria|0|||
163959994|NCT02076178|592225380|FG000|Injection Phase|Withdrawal by Subject|0|||
163959995|NCT02076178|592225381|FG001|Injection Phase|Withdrawal by Subject|3|||
163959996|NCT02076178|592225380|FG000|Injection Phase|Physician Decision|0|||
163959997|NCT02076178|592225381|FG001|Injection Phase|Physician Decision|3|||
163959998|NCT02076178|592225380|FG000|Injection Phase|Lost to Follow-up|0|||
163959999|NCT02076178|592225381|FG001|Injection Phase|Lost to Follow-up|1|||
163960000|NCT00051363|592225384|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
163960001|NCT00051363|592225385|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
163847830|NCT03280563|591813423|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
163847831|NCT03280563|591813415|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
163847832|NCT03280563|591813416|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
163847833|NCT03280563|591813417|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
163847834|NCT03280563|591813418|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
163847835|NCT03280563|591813419|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
163847836|NCT03280563|591813420|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
163847837|NCT03280563|591813421|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
163847838|NCT03280563|591813422|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
163847839|NCT03280563|591813423|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
163847840|NCT03038672|591813424|FG000|Initial Treatment|Unacceptable chemistry|0|||
163847841|NCT03038672|591813425|FG001|Initial Treatment|Unacceptable chemistry|1|||
163847842|NCT03038672|591813424|FG000|Initial Treatment|Progression prior to treatment|1|||
163847843|NCT03038672|591813425|FG001|Initial Treatment|Progression prior to treatment|0|||
163847844|NCT03038672|591813424|FG000|Initial Treatment|No treatment per protocol|1|||
163847845|NCT03038672|591813425|FG001|Initial Treatment|No treatment per protocol|0|||
163847846|NCT04423393|591813426|FG000|Overall Study|Withdrawal by Subject|0|||
163847847|NCT04423393|591813427|FG001|Overall Study|Withdrawal by Subject|0|||
163847848|NCT04423393|591813428|FG002|Overall Study|Withdrawal by Subject|0|||
163847849|NCT04423393|591813429|FG003|Overall Study|Withdrawal by Subject|0|||
163847850|NCT04423393|591813430|FG004|Overall Study|Withdrawal by Subject|0|||
163847851|NCT04423393|591813431|FG005|Overall Study|Withdrawal by Subject|1|||
163847852|NCT04423393|591813432|FG006|Overall Study|Withdrawal by Subject|0|||
163847853|NCT04423393|591813433|FG007|Overall Study|Withdrawal by Subject|0|||
163847854|NCT04423393|591813434|FG008|Overall Study|Withdrawal by Subject|0|||
163847855|NCT04423393|591813435|FG009|Overall Study|Withdrawal by Subject|0|||
163847856|NCT04423393|591813436|FG010|Overall Study|Withdrawal by Subject|0|||
163847857|NCT04423393|591813437|FG011|Overall Study|Withdrawal by Subject|0|||
163847858|NCT04423393|591813438|FG012|Overall Study|Withdrawal by Subject|0|||
163847859|NCT04423393|591813439|FG013|Overall Study|Withdrawal by Subject|1|||
163847860|NCT04423393|591813440|FG014|Overall Study|Withdrawal by Subject|0|||
163847861|NCT04423393|591813441|FG015|Overall Study|Withdrawal by Subject|0|||
163847862|NCT04423393|591813442|FG016|Overall Study|Withdrawal by Subject|0|||
163847863|NCT04423393|591813443|FG017|Overall Study|Withdrawal by Subject|0|||
163847864|NCT04423393|591813426|FG000|Overall Study|Sponsor Decision|0|||
163847865|NCT04423393|591813427|FG001|Overall Study|Sponsor Decision|0|||
163847866|NCT04423393|591813428|FG002|Overall Study|Sponsor Decision|0|||
163847867|NCT04423393|591813429|FG003|Overall Study|Sponsor Decision|0|||
163847868|NCT04423393|591813430|FG004|Overall Study|Sponsor Decision|0|||
163847869|NCT04423393|591813431|FG005|Overall Study|Sponsor Decision|0|||
163847870|NCT04423393|591813432|FG006|Overall Study|Sponsor Decision|0|||
163847871|NCT04423393|591813433|FG007|Overall Study|Sponsor Decision|0|||
163847872|NCT04423393|591813434|FG008|Overall Study|Sponsor Decision|0|||
163847873|NCT04423393|591813435|FG009|Overall Study|Sponsor Decision|0|||
163847874|NCT04423393|591813436|FG010|Overall Study|Sponsor Decision|0|||
163847875|NCT04423393|591813437|FG011|Overall Study|Sponsor Decision|0|||
163847876|NCT04423393|591813438|FG012|Overall Study|Sponsor Decision|0|||
163847877|NCT04423393|591813439|FG013|Overall Study|Sponsor Decision|1|||
163847878|NCT04423393|591813440|FG014|Overall Study|Sponsor Decision|0|||
163847879|NCT04423393|591813441|FG015|Overall Study|Sponsor Decision|0|||
163847880|NCT04423393|591813442|FG016|Overall Study|Sponsor Decision|0|||
163847881|NCT04423393|591813443|FG017|Overall Study|Sponsor Decision|0|||
163847882|NCT00432159|591813444|FG000|Overall Study|Death|0|||
163847883|NCT00432159|591813445|FG001|Overall Study|Death|1|||
163847884|NCT00432159|591813446|FG002|Overall Study|Death|0|||
163847885|NCT00432159|591813447|FG003|Overall Study|Death|0|||
163847886|NCT00432159|591813448|FG004|Overall Study|Death|0|||
163847887|NCT00432159|591813444|FG000|Overall Study|Failure|9|||
163847888|NCT00432159|591813445|FG001|Overall Study|Failure|5|||
163847889|NCT00432159|591813446|FG002|Overall Study|Failure|3|||
163847890|NCT00432159|591813447|FG003|Overall Study|Failure|2|||
163847891|NCT00432159|591813448|FG004|Overall Study|Failure|3|||
163847892|NCT00432159|591813444|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
163847893|NCT00432159|591813445|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
163847894|NCT00432159|591813446|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
163847895|NCT00432159|591813447|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
163847896|NCT00432159|591813448|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
163847897|NCT01929993|591813450|FG000|Overall Study|Protocol Violation|4|||
163847898|NCT01929993|591813451|FG001|Overall Study|Protocol Violation|6|||
163847899|NCT01929993|591813450|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
163847900|NCT01929993|591813451|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
163847901|NCT00107380|591813452|FG000|Overall Study|Adverse Event|7|||
163847902|NCT00107380|591813452|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
163847903|NCT00107380|591813452|FG000|Overall Study|Progression/relapse|4|||
163847904|NCT00107380|591813452|FG000|Overall Study|Death|3|||
163847905|NCT00107380|591813452|FG000|Overall Study|Other - not protocol specified|7|||
163847906|NCT00107380|591813452|FG000|Overall Study|Ineligible|2|||
163847907|NCT03673098|591813453|FG000|Overall Study|Lost to Follow-up|2|||
163847908|NCT03673098|591813454|FG001|Overall Study|Lost to Follow-up|3|||
163847909|NCT03673098|591813453|FG000|Overall Study|Withdrawal by Subject|6|||
163847910|NCT03673098|591813454|FG001|Overall Study|Withdrawal by Subject|1|||
163847911|NCT03673098|591813453|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
163847912|NCT03673098|591813454|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
163847913|NCT03850444|591813455|FG000|Overall Study|Adverse Event|16|||
163847914|NCT03850444|591813456|FG001|Overall Study|Adverse Event|10|||
163960002|NCT00051363|592225384|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
163960003|NCT00051363|592225385|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
163960004|NCT00051363|592225384|FG000|Overall Study|Death|2|||
163960005|NCT00051363|592225385|FG001|Overall Study|Death|2|||
163960006|NCT00051363|592225384|FG000|Overall Study|Excluded Pre-Randomization|2|||
163960007|NCT00051363|592225385|FG001|Overall Study|Excluded Pre-Randomization|5|||
163960008|NCT03370471|592225386|FG000|Overall Study|Withdrawal by Subject|6|||
163960009|NCT03370471|592225387|FG001|Overall Study|Withdrawal by Subject|1|||
163960010|NCT03370471|592225386|FG000|Overall Study|Unable to access veins for blood draw|0|||
163960011|NCT03370471|592225387|FG001|Overall Study|Unable to access veins for blood draw|1|||
163960012|NCT03370471|592225386|FG000|Overall Study|Screen fail|1|||
163960013|NCT03370471|592225387|FG001|Overall Study|Screen fail|0|||
163960014|NCT01765179|592225389|FG000|Overall Study|Adverse Event|3|||
163960015|NCT01765179|592225389|FG000|Overall Study|Lost to Follow-up|5|||
163960016|NCT01765179|592225389|FG000|Overall Study|Non-compliance with study drug|2|||
163960017|NCT01765179|592225389|FG000|Overall Study|Protocol Violation|1|||
163960018|NCT01765179|592225389|FG000|Overall Study|Withdrawal by Subject|8|||
163960019|NCT01765179|592225389|FG000|Overall Study|Hematocrit >54%|3|||
163960020|NCT01765179|592225389|FG000|Overall Study|prohibited med|1|||
163960021|NCT01765179|592225389|FG000|Overall Study|Out of country unable to finish study|1|||
163960022|NCT01765179|592225389|FG000|Overall Study|lack of venous access|1|||
163960023|NCT01765179|592225389|FG000|Overall Study|work conflict|1|||
163960024|NCT01765179|592225389|FG000|Overall Study|Ca elevated 10.6|1|||
163960025|NCT05358717|592225390|FG000|Overall Study|Adverse Event|0|||
163960026|NCT05358717|592225391|FG001|Overall Study|Adverse Event|1|||
163960027|NCT05358717|592225392|FG002|Overall Study|Adverse Event|1|||
163960028|NCT05358717|592225390|FG000|Overall Study|Death|1|||
163960029|NCT05358717|592225391|FG001|Overall Study|Death|1|||
163960030|NCT05358717|592225392|FG002|Overall Study|Death|0|||
163960031|NCT05358717|592225390|FG000|Overall Study|Withdrawal by Subject|1|||
163960032|NCT05358717|592225391|FG001|Overall Study|Withdrawal by Subject|1|||
163960033|NCT05358717|592225392|FG002|Overall Study|Withdrawal by Subject|2|||
163960034|NCT05358717|592225390|FG000|Overall Study|Study Paused by Sponsor in United States|0|||
163960035|NCT05358717|592225391|FG001|Overall Study|Study Paused by Sponsor in United States|2|||
163960036|NCT05358717|592225392|FG002|Overall Study|Study Paused by Sponsor in United States|0|||
163960037|NCT02640157|592225393|FG000|Overall Study|Adverse Event|2|||
163960038|NCT02640157|592225394|FG001|Overall Study|Adverse Event|2|||
163960039|NCT02640157|592225395|FG002|Overall Study|Adverse Event|1|||
163960040|NCT02640157|592225393|FG000|Overall Study|Withdrew consent|2|||
163960041|NCT02640157|592225394|FG001|Overall Study|Withdrew consent|0|||
163960042|NCT02640157|592225395|FG002|Overall Study|Withdrew consent|2|||
163960043|NCT02640157|592225393|FG000|Overall Study|Lost to Follow-up|9|||
163960044|NCT02640157|592225394|FG001|Overall Study|Lost to Follow-up|2|||
163960045|NCT02640157|592225395|FG002|Overall Study|Lost to Follow-up|7|||
163960046|NCT02640157|592225393|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
163960047|NCT02640157|592225394|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
163960048|NCT02640157|592225395|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
163960049|NCT00710021|592225396|FG000|Overall Study|Lost to Follow-up|1|||
163960050|NCT00710021|592225397|FG001|Overall Study|Lost to Follow-up|0|||
163847915|NCT03850444|591813455|FG000|Overall Study|Death|87|||
163960051|NCT00710021|592225398|FG002|Overall Study|Lost to Follow-up|0|||
163960052|NCT00710021|592225396|FG000|Overall Study|Subject's Decision|0|||
163960053|NCT00710021|592225397|FG001|Overall Study|Subject's Decision|1|||
163960054|NCT00710021|592225398|FG002|Overall Study|Subject's Decision|0|||
163960055|NCT00710021|592225396|FG000|Overall Study|Subject misrandomized|0|||
163960056|NCT00710021|592225397|FG001|Overall Study|Subject misrandomized|1|||
163960057|NCT00710021|592225398|FG002|Overall Study|Subject misrandomized|1|||
163960058|NCT00710021|592225396|FG000|Overall Study|Physician Decision|0|||
163960059|NCT00710021|592225397|FG001|Overall Study|Physician Decision|1|||
163960060|NCT00710021|592225398|FG002|Overall Study|Physician Decision|0|||
163960061|NCT00026208|592225399|FG000|Overall Study|Complications of auto accident|1|||
163960062|NCT00026208|592225400|FG001|Overall Study|Complications of auto accident|0|||
163960063|NCT04837040|592225404|FG000|RC Phase (Up to Week 36)|Withdrawal by Subject|0|||
163960064|NCT04837040|592225405|FG001|RC Phase (Up to Week 36)|Withdrawal by Subject|1|||
163960065|NCT02961218|592225406|FG000|Overall Study|Lost to Follow-up|0|||
163960066|NCT02961218|592225407|FG001|Overall Study|Lost to Follow-up|2|||
163960067|NCT02961218|592225406|FG000|Overall Study|Physician Decision|0|||
163960068|NCT02961218|592225407|FG001|Overall Study|Physician Decision|2|||
163960069|NCT02961218|592225406|FG000|Overall Study|Subject/Guardian Decision|3|||
163960070|NCT02961218|592225407|FG001|Overall Study|Subject/Guardian Decision|1|||
163960071|NCT00602667|592225408|FG000|Overall Study|Still on Therapy|0|||
163960072|NCT00602667|592225409|FG001|Overall Study|Still on Therapy|2|||
163960073|NCT00602667|592225410|FG002|Overall Study|Still on Therapy|2|||
163960074|NCT00602667|592225408|FG000|Overall Study|Death|0|||
163960075|NCT00602667|592225409|FG001|Overall Study|Death|1|||
163960076|NCT00602667|592225410|FG002|Overall Study|Death|1|||
163960077|NCT00602667|592225408|FG000|Overall Study|Family request|3|||
163960078|NCT00602667|592225409|FG001|Overall Study|Family request|25|||
163960079|NCT00602667|592225410|FG002|Overall Study|Family request|6|||
163960080|NCT00602667|592225408|FG000|Overall Study|Excessive toxicity|1|||
163960081|NCT00602667|592225409|FG001|Overall Study|Excessive toxicity|1|||
163960082|NCT00602667|592225410|FG002|Overall Study|Excessive toxicity|0|||
163960083|NCT00602667|592225408|FG000|Overall Study|Second malignancy|0|||
163960084|NCT00602667|592225409|FG001|Overall Study|Second malignancy|1|||
163960085|NCT00602667|592225410|FG002|Overall Study|Second malignancy|0|||
163960086|NCT00602667|592225408|FG000|Overall Study|Physician Decision|2|||
163960087|NCT00602667|592225409|FG001|Overall Study|Physician Decision|3|||
163960088|NCT00602667|592225410|FG002|Overall Study|Physician Decision|8|||
163960089|NCT00602667|592225408|FG000|Overall Study|Progressive disease|13|||
163960090|NCT00602667|592225409|FG001|Overall Study|Progressive disease|48|||
163960091|NCT00602667|592225410|FG002|Overall Study|Progressive disease|45|||
163960092|NCT00602667|592225408|FG000|Overall Study|Progressive disease prior to therapy|0|||
163960093|NCT00602667|592225409|FG001|Overall Study|Progressive disease prior to therapy|0|||
163960094|NCT00602667|592225410|FG002|Overall Study|Progressive disease prior to therapy|1|||
163960095|NCT04765059|592225411|FG000|Overall Study|Failure to meet randomization criteria|1|||
163960096|NCT04765059|592225412|FG001|Overall Study|Failure to meet randomization criteria|0|||
163960097|NCT04765059|592225411|FG000|Overall Study|Withdrawal by Subject|1|||
163960098|NCT04765059|592225412|FG001|Overall Study|Withdrawal by Subject|4|||
163960099|NCT04765059|592225411|FG000|Overall Study|Lost to Follow-up|1|||
163960100|NCT04765059|592225412|FG001|Overall Study|Lost to Follow-up|1|||
163960101|NCT04765059|592225411|FG000|Overall Study|Death|25|||
163960102|NCT04765059|592225412|FG001|Overall Study|Death|28|||
163960103|NCT04765059|592225411|FG000|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|21|||
163960104|NCT04765059|592225412|FG001|Overall Study|Participants ongoing study at data cutoff date of 28-Oct-24|16|||
163960105|NCT04300309|592225413|FG000|Overall Study|Lost to Follow-up|1|||
163960106|NCT04300309|592225414|FG001|Overall Study|Lost to Follow-up|0|||
163960107|NCT04647526|592225415|FG000|Overall Study|Death|13|||
163960108|NCT04647526|592225416|FG001|Overall Study|Death|76|||
163960109|NCT04647526|592225417|FG002|Overall Study|Death|32|||
163960110|NCT04647526|592225418|FG003|Overall Study|Death|0|||
163960111|NCT04647526|592225415|FG000|Overall Study|Lost to Follow-up|1|||
163960112|NCT04647526|592225416|FG001|Overall Study|Lost to Follow-up|0|||
163960113|NCT04647526|592225417|FG002|Overall Study|Lost to Follow-up|1|||
163960114|NCT04647526|592225418|FG003|Overall Study|Lost to Follow-up|0|||
163960115|NCT04647526|592225415|FG000|Overall Study|Withdrawal by Subject|4|||
163960116|NCT04647526|592225416|FG001|Overall Study|Withdrawal by Subject|15|||
163960117|NCT04647526|592225417|FG002|Overall Study|Withdrawal by Subject|8|||
163960118|NCT04647526|592225418|FG003|Overall Study|Withdrawal by Subject|1|||
163960119|NCT04647526|592225415|FG000|Overall Study|Incorrect enrollment|0|||
163960120|NCT04647526|592225416|FG001|Overall Study|Incorrect enrollment|1|||
163960121|NCT04647526|592225417|FG002|Overall Study|Incorrect enrollment|1|||
163960122|NCT04647526|592225418|FG003|Overall Study|Incorrect enrollment|0|||
163960123|NCT04647526|592225415|FG000|Overall Study|Physician Decision|0|||
163960124|NCT04647526|592225416|FG001|Overall Study|Physician Decision|1|||
163960125|NCT04647526|592225417|FG002|Overall Study|Physician Decision|1|||
163960126|NCT04647526|592225418|FG003|Overall Study|Physician Decision|0|||
163960127|NCT04647526|592225415|FG000|Overall Study|Ongoing|9|||
163960128|NCT04647526|592225416|FG001|Overall Study|Ongoing|183|||
163960129|NCT04647526|592225417|FG002|Overall Study|Ongoing|93|||
163960130|NCT04647526|592225418|FG003|Overall Study|Ongoing|15|||
163960131|NCT03282240|592225419|FG000|Overall Study|Adverse Event|2|||
163960132|NCT03282240|592225420|FG001|Overall Study|Adverse Event|2|||
163960133|NCT03282240|592225421|FG002|Overall Study|Adverse Event|0|||
163960134|NCT03282240|592225419|FG000|Overall Study|Lost to Follow-up|3|||
163960135|NCT03282240|592225420|FG001|Overall Study|Lost to Follow-up|0|||
163960136|NCT03282240|592225421|FG002|Overall Study|Lost to Follow-up|0|||
163960137|NCT03282240|592225419|FG000|Overall Study|Protocol Deviation|4|||
163960138|NCT03282240|592225420|FG001|Overall Study|Protocol Deviation|1|||
163960139|NCT03282240|592225421|FG002|Overall Study|Protocol Deviation|2|||
163960140|NCT03282240|592225419|FG000|Overall Study|Withdrawal by Subject|1|||
163960141|NCT03282240|592225420|FG001|Overall Study|Withdrawal by Subject|0|||
163960142|NCT03282240|592225421|FG002|Overall Study|Withdrawal by Subject|1|||
163960143|NCT01675479|592225422|FG000|Overall Study|Lost to Follow-up|11|||
163960144|NCT02910739|592225423|FG000|Overall Study|Adverse Event|1|||
163960145|NCT02910739|592225424|FG001|Overall Study|Adverse Event|0|||
163960146|NCT02910739|592225425|FG002|Overall Study|Adverse Event|0|||
163847916|NCT03850444|591813456|FG001|Overall Study|Death|107|||
163847917|NCT03850444|591813455|FG000|Overall Study|Lost to Follow-up|1|||
163847918|NCT03850444|591813456|FG001|Overall Study|Lost to Follow-up|1|||
163847919|NCT03850444|591813455|FG000|Overall Study|Withdrawal by Subject|1|||
163847920|NCT03850444|591813456|FG001|Overall Study|Withdrawal by Subject|5|||
163847921|NCT03850444|591813455|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
163847922|NCT03850444|591813456|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
163847923|NCT03595683|591813457|FG000|Overall Study|Adverse Event|1|||
163847924|NCT03595683|591813458|FG001|Overall Study|Adverse Event|0|||
163847925|NCT03595683|591813457|FG000|Overall Study|Pursue alternative therapy|1|||
163847926|NCT03595683|591813458|FG001|Overall Study|Pursue alternative therapy|1|||
163847927|NCT03595683|591813457|FG000|Overall Study|Progressive disease|1|||
163847928|NCT03595683|591813458|FG001|Overall Study|Progressive disease|3|||
163847929|NCT01021878|591813459|FG000|Overall Study|Lost to Follow-up|4|||
163847930|NCT01021878|591813460|FG001|Overall Study|Lost to Follow-up|3|||
163847931|NCT01021878|591813459|FG000|Overall Study|Death|0|||
163847932|NCT01021878|591813460|FG001|Overall Study|Death|1|||
163847933|NCT01021878|591813459|FG000|Overall Study|Adverse Event|6|||
163847934|NCT01021878|591813460|FG001|Overall Study|Adverse Event|5|||
163847935|NCT01021878|591813459|FG000|Overall Study|Transplantation|6|||
163847936|NCT01021878|591813460|FG001|Overall Study|Transplantation|1|||
163847937|NCT03158948|591813462|FG000|Overall Study|Death|1|||
163847938|NCT03158948|591813463|FG001|Overall Study|Death|1|||
163847939|NCT03158948|591813464|FG002|Overall Study|Death|3|||
163847940|NCT03158948|591813465|FG003|Overall Study|Death|2|||
163847941|NCT03158948|591813462|FG000|Overall Study|Physician Decision|0|||
163847942|NCT03158948|591813463|FG001|Overall Study|Physician Decision|0|||
163847943|NCT03158948|591813464|FG002|Overall Study|Physician Decision|0|||
163847944|NCT03158948|591813465|FG003|Overall Study|Physician Decision|1|||
163847945|NCT03468426|591813468|FG000|Overall Study|Progressive disease|3|||
163847946|NCT03468426|591813469|FG001|Overall Study|Progressive disease|0|||
163847947|NCT03468426|591813470|FG002|Overall Study|Progressive disease|4|||
163847948|NCT03468426|591813471|FG003|Overall Study|Progressive disease|20|||
163847949|NCT03468426|591813472|FG004|Overall Study|Progressive disease|23|||
163847950|NCT03468426|591813473|FG005|Overall Study|Progressive disease|15|||
163847951|NCT03468426|591813474|FG006|Overall Study|Progressive disease|24|||
163847952|NCT03468426|591813475|FG007|Overall Study|Progressive disease|27|||
163847953|NCT03468426|591813476|FG008|Overall Study|Progressive disease|13|||
163847954|NCT03468426|591813477|FG009|Overall Study|Progressive disease|13|||
163847955|NCT03468426|591813478|FG010|Overall Study|Progressive disease|0|||
163847956|NCT03468426|591813468|FG000|Overall Study|Other adverse event or clinical progression|0|||
163847957|NCT03468426|591813469|FG001|Overall Study|Other adverse event or clinical progression|1|||
163847958|NCT03468426|591813470|FG002|Overall Study|Other adverse event or clinical progression|3|||
163847959|NCT03468426|591813471|FG003|Overall Study|Other adverse event or clinical progression|14|||
163847960|NCT03468426|591813472|FG004|Overall Study|Other adverse event or clinical progression|10|||
163847961|NCT03468426|591813473|FG005|Overall Study|Other adverse event or clinical progression|8|||
163847962|NCT03468426|591813474|FG006|Overall Study|Other adverse event or clinical progression|5|||
163847963|NCT03468426|591813475|FG007|Overall Study|Other adverse event or clinical progression|4|||
163847964|NCT03468426|591813476|FG008|Overall Study|Other adverse event or clinical progression|6|||
163847965|NCT03468426|591813477|FG009|Overall Study|Other adverse event or clinical progression|11|||
163847966|NCT03468426|591813478|FG010|Overall Study|Other adverse event or clinical progression|0|||
163847967|NCT03468426|591813468|FG000|Overall Study|Refused to continue taking trial medication|0|||
163847968|NCT03468426|591813469|FG001|Overall Study|Refused to continue taking trial medication|0|||
163847969|NCT03468426|591813470|FG002|Overall Study|Refused to continue taking trial medication|0|||
163847970|NCT03468426|591813471|FG003|Overall Study|Refused to continue taking trial medication|2|||
163847971|NCT03468426|591813472|FG004|Overall Study|Refused to continue taking trial medication|0|||
163847972|NCT03468426|591813473|FG005|Overall Study|Refused to continue taking trial medication|3|||
163847973|NCT03468426|591813474|FG006|Overall Study|Refused to continue taking trial medication|0|||
163847974|NCT03468426|591813475|FG007|Overall Study|Refused to continue taking trial medication|0|||
163847975|NCT03468426|591813476|FG008|Overall Study|Refused to continue taking trial medication|1|||
163847976|NCT03468426|591813477|FG009|Overall Study|Refused to continue taking trial medication|0|||
163847977|NCT03468426|591813478|FG010|Overall Study|Refused to continue taking trial medication|0|||
163847978|NCT03468426|591813468|FG000|Overall Study|Other than listed|0|||
163847979|NCT03468426|591813469|FG001|Overall Study|Other than listed|1|||
163847980|NCT03468426|591813470|FG002|Overall Study|Other than listed|0|||
163847981|NCT03468426|591813471|FG003|Overall Study|Other than listed|0|||
163847982|NCT03468426|591813472|FG004|Overall Study|Other than listed|2|||
163847983|NCT03468426|591813473|FG005|Overall Study|Other than listed|2|||
163847984|NCT03468426|591813474|FG006|Overall Study|Other than listed|0|||
163847985|NCT03468426|591813475|FG007|Overall Study|Other than listed|0|||
163847986|NCT03468426|591813476|FG008|Overall Study|Other than listed|4|||
163847987|NCT03468426|591813477|FG009|Overall Study|Other than listed|4|||
163847988|NCT03468426|591813478|FG010|Overall Study|Other than listed|1|||
163847989|NCT03468426|591813468|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847990|NCT03468426|591813469|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847991|NCT03468426|591813470|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163847992|NCT03468426|591813471|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847993|NCT03468426|591813472|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847994|NCT03468426|591813473|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847995|NCT03468426|591813474|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847996|NCT03468426|591813475|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847997|NCT03468426|591813476|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847998|NCT03468426|591813477|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163847999|NCT03468426|591813478|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163848000|NCT03468426|591813468|FG000|Overall Study|missing reason|0|||
163848001|NCT03468426|591813469|FG001|Overall Study|missing reason|0|||
163848002|NCT03468426|591813470|FG002|Overall Study|missing reason|0|||
163848003|NCT03468426|591813471|FG003|Overall Study|missing reason|0|||
163848004|NCT03468426|591813472|FG004|Overall Study|missing reason|0|||
163848005|NCT03468426|591813473|FG005|Overall Study|missing reason|0|||
163848006|NCT03468426|591813474|FG006|Overall Study|missing reason|0|||
163848007|NCT03468426|591813475|FG007|Overall Study|missing reason|0|||
163848008|NCT03468426|591813476|FG008|Overall Study|missing reason|0|||
163848009|NCT03468426|591813477|FG009|Overall Study|missing reason|1|||
163848010|NCT03468426|591813478|FG010|Overall Study|missing reason|0|||
163848011|NCT05876351|591813480|FG000|Overall Study|Other than specified|2|||
163848012|NCT05876351|591813480|FG000|Overall Study|Study specific discontinuation criteria|1|||
163848013|NCT03415022|591813481|FG000|Overall Study|Withdrawal by Subject|1|||
163848014|NCT03415022|591813482|FG001|Overall Study|Withdrawal by Subject|2|||
163848015|NCT03415022|591813481|FG000|Overall Study|COVID-19 Suspension|2|||
163848016|NCT03415022|591813482|FG001|Overall Study|COVID-19 Suspension|3|||
163848017|NCT03415022|591813481|FG000|Overall Study|Lost to Follow-up|2|||
163848018|NCT03415022|591813482|FG001|Overall Study|Lost to Follow-up|0|||
163848019|NCT02206152|591813483|FG000|Pre-Randomization|Withdrawal by Subject|2|||
163848020|NCT00478608|591813484|FG000|Overall Study|Adverse Event|1|||
163848021|NCT00478608|591813484|FG000|Overall Study|Serious Adverse Event|14|||
163848022|NCT00478608|591813484|FG000|Overall Study|Withdrawal by Subject|2|||
163848023|NCT00478608|591813484|FG000|Overall Study|Protocol Violation|3|||
163848024|NCT01349907|591813485|FG000|Overall Study|Adverse Event|37|||
163848025|NCT01349907|591813486|FG001|Overall Study|Adverse Event|11|||
163848026|NCT01349907|591813485|FG000|Overall Study|Treatment failure|13|||
163848027|NCT01349907|591813486|FG001|Overall Study|Treatment failure|4|||
163848028|NCT01349907|591813485|FG000|Overall Study|Lost to Follow-up|25|||
163848029|NCT01349907|591813486|FG001|Overall Study|Lost to Follow-up|6|||
163848030|NCT01349907|591813485|FG000|Overall Study|Withdrawal by Subject|30|||
163848031|NCT01349907|591813486|FG001|Overall Study|Withdrawal by Subject|8|||
163848032|NCT01349907|591813485|FG000|Overall Study|Protocol Violation|33|||
163848033|NCT01349907|591813486|FG001|Overall Study|Protocol Violation|13|||
163848034|NCT01349907|591813485|FG000|Overall Study|Administrative|1|||
163848035|NCT01349907|591813486|FG001|Overall Study|Administrative|1|||
163960147|NCT02910739|592225426|FG003|Overall Study|Adverse Event|0|||
163960148|NCT03816891|592225427|FG000|Double-Blind Period|Withdrawal by Subject|1|||
163960149|NCT03816891|592225428|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163960150|NCT03816891|592225429|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163960151|NCT03816891|592225430|FG003|Double-Blind Period|Withdrawal by Subject|2|||
163960152|NCT03816891|592225431|FG004|Double-Blind Period|Withdrawal by Subject|0|||
163960153|NCT03816891|592225432|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163960154|NCT03816891|592225427|FG000|Double-Blind Period|Adverse Event|0|||
163848036|NCT03583541|591813494|FG000|Overall Study|Lost to Follow-up|31|||
163848037|NCT03583541|591813495|FG001|Overall Study|Lost to Follow-up|65|||
163848038|NCT00884286|591813496|FG000|Overall Study|Progressive disease|21|||
163848039|NCT00884286|591813497|FG001|Overall Study|Progressive disease|28|||
163848040|NCT00884286|591813496|FG000|Overall Study|Toxicity|4|||
163848041|NCT00884286|591813497|FG001|Overall Study|Toxicity|1|||
163848042|NCT00884286|591813496|FG000|Overall Study|Death|2|||
163848043|NCT00884286|591813497|FG001|Overall Study|Death|2|||
163848044|NCT00884286|591813496|FG000|Overall Study|Physician Decision|1|||
163848045|NCT00884286|591813497|FG001|Overall Study|Physician Decision|0|||
163848046|NCT00884286|591813496|FG000|Overall Study|Septic shock|1|||
163848047|NCT00884286|591813497|FG001|Overall Study|Septic shock|0|||
163848048|NCT00884286|591813496|FG000|Overall Study|Thrombus in right auricle|1|||
163848049|NCT00884286|591813497|FG001|Overall Study|Thrombus in right auricle|0|||
163848050|NCT00884286|591813496|FG000|Overall Study|Not treated|2|||
163848051|NCT00884286|591813497|FG001|Overall Study|Not treated|1|||
163960155|NCT03816891|592225428|FG001|Double-Blind Period|Adverse Event|0|||
163960156|NCT03816891|592225429|FG002|Double-Blind Period|Adverse Event|2|||
163848052|NCT00884286|591813496|FG000|Overall Study|Comprised lung carcinoma|0|||
163848053|NCT00884286|591813497|FG001|Overall Study|Comprised lung carcinoma|1|||
163848054|NCT00088205|591813499|FG000|Overall Study|Adverse Event|4|||
163848055|NCT00088205|591813499|FG000|Overall Study|Progressive Disease|51|||
163848056|NCT00088205|591813499|FG000|Overall Study|Physician Decision|1|||
163848057|NCT00088205|591813499|FG000|Overall Study|Death Due to Study Disease|4|||
163848058|NCT05199233|591813500|FG000|Overall Study|Lack of Efficacy|1|||
163848059|NCT02491892|591813505|FG000|Overall Study|Adverse Event|1|||
163848060|NCT02491892|591813506|FG001|Overall Study|Adverse Event|1|||
163848061|NCT02491892|591813505|FG000|Overall Study|Death|1|||
163848062|NCT02491892|591813506|FG001|Overall Study|Death|1|||
163848063|NCT02491892|591813505|FG000|Overall Study|Lack of Efficacy|37|||
163848064|NCT02491892|591813506|FG001|Overall Study|Lack of Efficacy|36|||
163848065|NCT02491892|591813505|FG000|Overall Study|Refused Treatment|1|||
163848066|NCT02491892|591813506|FG001|Overall Study|Refused Treatment|0|||
163848067|NCT02491892|591813505|FG000|Overall Study|Lost to Follow-up|1|||
163848068|NCT02491892|591813506|FG001|Overall Study|Lost to Follow-up|0|||
163848069|NCT00065468|591813507|FG000|Overall Study|Death|172|||
163848070|NCT00065468|591813508|FG001|Overall Study|Death|169|||
163848071|NCT00065468|591813509|FG002|Overall Study|Death|171|||
163848072|NCT00065468|591813507|FG000|Overall Study|Withdrawal by Subject|3|||
163848073|NCT00065468|591813508|FG001|Overall Study|Withdrawal by Subject|4|||
163848074|NCT00065468|591813509|FG002|Overall Study|Withdrawal by Subject|5|||
163848075|NCT00065468|591813507|FG000|Overall Study|Lost to Follow-up|5|||
163848076|NCT00065468|591813508|FG001|Overall Study|Lost to Follow-up|3|||
163848077|NCT00065468|591813509|FG002|Overall Study|Lost to Follow-up|2|||
163848078|NCT00065468|591813507|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
163848079|NCT00065468|591813508|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
163848080|NCT00065468|591813509|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
163848081|NCT00065468|591813507|FG000|Overall Study|Disease progression|0|||
163848082|NCT00065468|591813508|FG001|Overall Study|Disease progression|0|||
163848083|NCT00065468|591813509|FG002|Overall Study|Disease progression|1|||
163848084|NCT00065468|591813507|FG000|Overall Study|Other|14|||
163848085|NCT00065468|591813508|FG001|Overall Study|Other|24|||
163848086|NCT00065468|591813509|FG002|Overall Study|Other|18|||
163848087|NCT02117544|591813510|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
163848088|NCT02117544|591813511|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
163848089|NCT00231894|591813516|FG000|Overall Study|Withdrawal by Subject|1|||
163848090|NCT00231894|591813517|FG001|Overall Study|Withdrawal by Subject|1|||
163848091|NCT02448719|591813520|FG000|Overall Study|Withdrawal by Subject|0|||
163848092|NCT02448719|591813521|FG001|Overall Study|Withdrawal by Subject|0|||
163848093|NCT02448719|591813522|FG002|Overall Study|Withdrawal by Subject|0|||
163848094|NCT02448719|591813523|FG003|Overall Study|Withdrawal by Subject|0|||
163848095|NCT02448719|591813524|FG004|Overall Study|Withdrawal by Subject|1|||
163848096|NCT02448719|591813525|FG005|Overall Study|Withdrawal by Subject|0|||
163848097|NCT02448719|591813526|FG006|Overall Study|Withdrawal by Subject|0|||
163848098|NCT02448719|591813527|FG007|Overall Study|Withdrawal by Subject|0|||
163848099|NCT02448719|591813528|FG008|Overall Study|Withdrawal by Subject|0|||
163848100|NCT02448719|591813529|FG009|Overall Study|Withdrawal by Subject|0|||
163848101|NCT02448719|591813530|FG010|Overall Study|Withdrawal by Subject|0|||
163848102|NCT04707391|591813533|FG000|Overall Study|Adverse Event|5|||
163848103|NCT04707391|591813534|FG001|Overall Study|Adverse Event|8|||
163848104|NCT04707391|591813533|FG000|Overall Study|Lost to Follow-up|44|||
163848105|NCT04707391|591813534|FG001|Overall Study|Lost to Follow-up|31|||
163848106|NCT04707391|591813533|FG000|Overall Study|Protocol Violation|1|||
163848107|NCT04707391|591813534|FG001|Overall Study|Protocol Violation|5|||
163848108|NCT04707391|591813533|FG000|Overall Study|Withdrawal by Subject|27|||
163848109|NCT04707391|591813534|FG001|Overall Study|Withdrawal by Subject|25|||
163848110|NCT04707391|591813533|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
163848111|NCT04707391|591813534|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
163848112|NCT04707391|591813533|FG000|Overall Study|Other|0|||
163848113|NCT04707391|591813534|FG001|Overall Study|Other|2|||
163848114|NCT01848834|591813535|FG000|Overall Study|Adverse Event|3|||
163848115|NCT01848834|591813536|FG001|Overall Study|Adverse Event|11|||
163848116|NCT01848834|591813537|FG002|Overall Study|Adverse Event|3|||
163960157|NCT03816891|592225430|FG003|Double-Blind Period|Adverse Event|0|||
163960158|NCT03816891|592225431|FG004|Double-Blind Period|Adverse Event|0|||
163960159|NCT03816891|592225432|FG005|Double-Blind Period|Adverse Event|0|||
163960160|NCT03816891|592225427|FG000|Double-Blind Period|Lost to Follow-up|2|||
163960161|NCT03816891|592225428|FG001|Double-Blind Period|Lost to Follow-up|0|||
163848117|NCT01848834|591813538|FG003|Overall Study|Adverse Event|5|||
163848118|NCT01848834|591813539|FG004|Overall Study|Adverse Event|9|||
163848119|NCT01848834|591813535|FG000|Overall Study|Death|2|||
163848120|NCT01848834|591813536|FG001|Overall Study|Death|11|||
163848121|NCT01848834|591813537|FG002|Overall Study|Death|1|||
163848122|NCT01848834|591813538|FG003|Overall Study|Death|8|||
163848123|NCT01848834|591813539|FG004|Overall Study|Death|27|||
163848124|NCT01848834|591813535|FG000|Overall Study|Excluded Medication|5|||
163848125|NCT01848834|591813536|FG001|Overall Study|Excluded Medication|4|||
163848126|NCT01848834|591813537|FG002|Overall Study|Excluded Medication|3|||
163848127|NCT01848834|591813538|FG003|Overall Study|Excluded Medication|6|||
163848128|NCT01848834|591813539|FG004|Overall Study|Excluded Medication|6|||
163848129|NCT01848834|591813535|FG000|Overall Study|Lost to Follow-up|5|||
163848130|NCT01848834|591813536|FG001|Overall Study|Lost to Follow-up|5|||
163848131|NCT01848834|591813537|FG002|Overall Study|Lost to Follow-up|3|||
163848132|NCT01848834|591813538|FG003|Overall Study|Lost to Follow-up|0|||
164006469|NCT02158533|592390962|FG000|Stage 2|Physician Decision|0|||
163848133|NCT01848834|591813539|FG004|Overall Study|Lost to Follow-up|3|||
163848134|NCT01848834|591813535|FG000|Overall Study|Physician Decision|1|||
163848135|NCT01848834|591813536|FG001|Overall Study|Physician Decision|3|||
163848136|NCT01848834|591813537|FG002|Overall Study|Physician Decision|4|||
163848137|NCT01848834|591813538|FG003|Overall Study|Physician Decision|0|||
163848138|NCT01848834|591813539|FG004|Overall Study|Physician Decision|11|||
163848139|NCT01848834|591813535|FG000|Overall Study|Protocol Violation|0|||
163848140|NCT01848834|591813536|FG001|Overall Study|Protocol Violation|0|||
163848141|NCT01848834|591813537|FG002|Overall Study|Protocol Violation|0|||
163848142|NCT01848834|591813538|FG003|Overall Study|Protocol Violation|0|||
163848143|NCT01848834|591813539|FG004|Overall Study|Protocol Violation|1|||
163848144|NCT01848834|591813535|FG000|Overall Study|Sponsor Decision|1|||
163848145|NCT01848834|591813536|FG001|Overall Study|Sponsor Decision|1|||
163848146|NCT01848834|591813537|FG002|Overall Study|Sponsor Decision|0|||
163848147|NCT01848834|591813538|FG003|Overall Study|Sponsor Decision|1|||
163848148|NCT01848834|591813539|FG004|Overall Study|Sponsor Decision|1|||
163848149|NCT01848834|591813535|FG000|Overall Study|Withdrawal by Subject|2|||
163848150|NCT01848834|591813536|FG001|Overall Study|Withdrawal by Subject|13|||
163848151|NCT01848834|591813537|FG002|Overall Study|Withdrawal by Subject|10|||
163848152|NCT01848834|591813538|FG003|Overall Study|Withdrawal by Subject|6|||
163848153|NCT01848834|591813539|FG004|Overall Study|Withdrawal by Subject|36|||
163848154|NCT01406717|591813542|FG000|Overall Study|Subject non-compliance|4|||
163848155|NCT01406717|591813543|FG001|Overall Study|Subject non-compliance|3|||
163848156|NCT01406717|591813542|FG000|Overall Study|Protocol Violation|5|||
163848157|NCT01406717|591813543|FG001|Overall Study|Protocol Violation|1|||
163848158|NCT01406717|591813542|FG000|Overall Study|Lost to Follow-up|14|||
163848159|NCT01406717|591813543|FG001|Overall Study|Lost to Follow-up|8|||
163848160|NCT01406717|591813542|FG000|Overall Study|Withdrawal by Subject|19|||
163848161|NCT01406717|591813543|FG001|Overall Study|Withdrawal by Subject|15|||
163848162|NCT01406717|591813542|FG000|Overall Study|Adverse Event|1|||
163848163|NCT01406717|591813543|FG001|Overall Study|Adverse Event|2|||
163848164|NCT01406717|591813542|FG000|Overall Study|Lack of Efficacy|0|||
163848165|NCT01406717|591813543|FG001|Overall Study|Lack of Efficacy|1|||
163848166|NCT01406717|591813542|FG000|Overall Study|Non-completion of visit activity|0|||
163848167|NCT01406717|591813543|FG001|Overall Study|Non-completion of visit activity|1|||
163848168|NCT02040090|591813544|FG000|Overall Study|Adverse Event|2|||
163848169|NCT02040090|591813545|FG001|Overall Study|Adverse Event|0|||
163848170|NCT02040090|591813544|FG000|Overall Study|Physician Decision|1|||
163848171|NCT02040090|591813545|FG001|Overall Study|Physician Decision|0|||
163848172|NCT02040090|591813544|FG000|Overall Study|Withdrawal by Subject|0|||
163848173|NCT02040090|591813545|FG001|Overall Study|Withdrawal by Subject|1|||
163848174|NCT02040090|591813544|FG000|Overall Study|Lost to Follow-up|0|||
163848175|NCT02040090|591813545|FG001|Overall Study|Lost to Follow-up|1|||
163848176|NCT02275533|591813548|FG000|Overall Study|Protocol Violation|2|||
163848177|NCT02275533|591813549|FG001|Overall Study|Protocol Violation|0|||
163848178|NCT02275533|591813548|FG000|Overall Study|Never received study treatment|1|||
163848179|NCT02275533|591813549|FG001|Overall Study|Never received study treatment|0|||
163848180|NCT01570868|591813550|FG000|Overall Study|Adverse Event|8|||
163848181|NCT01570868|591813551|FG001|Overall Study|Adverse Event|1|||
163848182|NCT01570868|591813550|FG000|Overall Study|FDA Recommendation|23|||
163848183|NCT01570868|591813551|FG001|Overall Study|FDA Recommendation|3|||
163848184|NCT01570868|591813550|FG000|Overall Study|Physician Decision|10|||
163848185|NCT01570868|591813551|FG001|Overall Study|Physician Decision|4|||
163848186|NCT01570868|591813550|FG000|Overall Study|Lost to Follow-up|1|||
163848187|NCT01570868|591813551|FG001|Overall Study|Lost to Follow-up|0|||
163848188|NCT01570868|591813550|FG000|Overall Study|Withdrawal by Subject|1|||
163848189|NCT01570868|591813551|FG001|Overall Study|Withdrawal by Subject|0|||
163848190|NCT03370276|591813552|FG000|Overall Study|Death|0|||
163848191|NCT03370276|591813553|FG001|Overall Study|Death|2|||
163848192|NCT03370276|591813554|FG002|Overall Study|Death|5|||
163848193|NCT02584855|591813560|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
163848194|NCT02584855|591813561|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
163848195|NCT02584855|591813562|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
163848196|NCT02584855|591813563|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
163848197|NCT02584855|591813564|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
163848198|NCT02584855|591813565|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
163848199|NCT02584855|591813560|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
163848200|NCT02584855|591813561|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
163848201|NCT02584855|591813562|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
163848202|NCT02584855|591813563|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
163848203|NCT02584855|591813564|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
163848204|NCT02584855|591813565|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
163848205|NCT02584855|591813560|FG000|Open-Label Treatment Period|Adverse Event|14|||
163848206|NCT02584855|591813561|FG001|Open-Label Treatment Period|Adverse Event|0|||
163848207|NCT02584855|591813562|FG002|Open-Label Treatment Period|Adverse Event|0|||
163848208|NCT02584855|591813563|FG003|Open-Label Treatment Period|Adverse Event|0|||
163848209|NCT02584855|591813564|FG004|Open-Label Treatment Period|Adverse Event|0|||
163848210|NCT02584855|591813565|FG005|Open-Label Treatment Period|Adverse Event|0|||
163848211|NCT02584855|591813560|FG000|Open-Label Treatment Period|Death|2|||
163848212|NCT02584855|591813561|FG001|Open-Label Treatment Period|Death|0|||
163848213|NCT02584855|591813562|FG002|Open-Label Treatment Period|Death|0|||
163848214|NCT02584855|591813563|FG003|Open-Label Treatment Period|Death|0|||
163848215|NCT02584855|591813564|FG004|Open-Label Treatment Period|Death|0|||
163848216|NCT02584855|591813565|FG005|Open-Label Treatment Period|Death|0|||
163848217|NCT02584855|591813560|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
163848218|NCT02584855|591813561|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
163848219|NCT02584855|591813562|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
163848220|NCT02584855|591813563|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
163848221|NCT02584855|591813564|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
163848222|NCT02584855|591813565|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
163848223|NCT02584855|591813560|FG000|Open-Label Treatment Period|Protocol Violation|1|||
163848224|NCT02584855|591813561|FG001|Open-Label Treatment Period|Protocol Violation|0|||
163848225|NCT02584855|591813562|FG002|Open-Label Treatment Period|Protocol Violation|0|||
163848226|NCT02584855|591813563|FG003|Open-Label Treatment Period|Protocol Violation|0|||
163848227|NCT02584855|591813564|FG004|Open-Label Treatment Period|Protocol Violation|0|||
163848228|NCT02584855|591813565|FG005|Open-Label Treatment Period|Protocol Violation|0|||
163848229|NCT02584855|591813560|FG000|Open-Label Treatment Period|No PI Available|2|||
163848230|NCT02584855|591813561|FG001|Open-Label Treatment Period|No PI Available|0|||
163848231|NCT02584855|591813562|FG002|Open-Label Treatment Period|No PI Available|0|||
163848232|NCT02584855|591813563|FG003|Open-Label Treatment Period|No PI Available|0|||
163848233|NCT02584855|591813564|FG004|Open-Label Treatment Period|No PI Available|0|||
163848234|NCT02584855|591813565|FG005|Open-Label Treatment Period|No PI Available|0|||
163848235|NCT02584855|591813560|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
163848236|NCT02584855|591813561|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
163848237|NCT02584855|591813562|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
163848238|NCT02584855|591813563|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
163848239|NCT02584855|591813564|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
163848240|NCT02584855|591813565|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
163848241|NCT02584855|591813560|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163848242|NCT02584855|591813561|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163848243|NCT02584855|591813562|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
163848244|NCT02584855|591813563|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163848245|NCT02584855|591813564|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163848246|NCT02584855|591813565|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
163848247|NCT02584855|591813560|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
163848248|NCT02584855|591813561|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
163848249|NCT02584855|591813562|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
163848250|NCT02584855|591813563|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
163848251|NCT02584855|591813564|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
163848252|NCT02584855|591813565|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
163848253|NCT02584855|591813560|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163848254|NCT02584855|591813561|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
163848255|NCT02584855|591813562|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163848256|NCT02584855|591813563|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163848257|NCT02584855|591813564|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163848258|NCT02584855|591813565|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
163848259|NCT02584855|591813560|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163848260|NCT02584855|591813561|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
163848261|NCT02584855|591813562|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163848262|NCT02584855|591813563|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163848263|NCT02584855|591813564|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163848264|NCT02584855|591813565|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
163848265|NCT02584855|591813560|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163848266|NCT02584855|591813561|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163848267|NCT02584855|591813562|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163848268|NCT02584855|591813563|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163848269|NCT02584855|591813564|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
163848270|NCT02584855|591813565|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
163848271|NCT02584855|591813560|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
163848272|NCT02584855|591813561|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
163848273|NCT02584855|591813562|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
163848274|NCT02584855|591813563|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
163848275|NCT02584855|591813564|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
163848276|NCT02584855|591813565|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
163848277|NCT00653263|591813566|FG000|Overall Study|Withdrawal by Subject|1|||
163848278|NCT00653263|591813566|FG000|Overall Study|Physician Decision|1|||
163848279|NCT00895843|591813567|FG000|Overall Study|Protocol Violation|12|||
163848280|NCT00895843|591813568|FG001|Overall Study|Protocol Violation|12|||
163848281|NCT02611830|591813569|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
163848282|NCT02611830|591813570|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
163848283|NCT02611830|591813571|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
163848284|NCT02611830|591813572|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
163848285|NCT02611830|591813569|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
163848286|NCT02611830|591813570|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
163848287|NCT02611830|591813571|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
163848288|NCT02611830|591813572|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
163848289|NCT02611830|591813569|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
163848290|NCT02611830|591813570|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
163848291|NCT02611830|591813571|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
163848292|NCT02611830|591813572|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
163848293|NCT02611830|591813569|FG000|OL Induction Phase|Lack of Efficacy|9|||
163848294|NCT02611830|591813570|FG001|OL Induction Phase|Lack of Efficacy|0|||
163848295|NCT02611830|591813571|FG002|OL Induction Phase|Lack of Efficacy|0|||
163848296|NCT02611830|591813572|FG003|OL Induction Phase|Lack of Efficacy|0|||
163848297|NCT02611830|591813569|FG000|OL Induction Phase|Reason not specified|3|||
163848298|NCT02611830|591813570|FG001|OL Induction Phase|Reason not specified|0|||
163848299|NCT02611830|591813571|FG002|OL Induction Phase|Reason not specified|0|||
163848300|NCT02611830|591813572|FG003|OL Induction Phase|Reason not specified|0|||
163848301|NCT02611830|591813569|FG000|Maintenance Phase|Lack of Efficacy|0|||
163848302|NCT02611830|591813570|FG001|Maintenance Phase|Lack of Efficacy|29|||
163848303|NCT02611830|591813571|FG002|Maintenance Phase|Lack of Efficacy|18|||
163848304|NCT02611830|591813572|FG003|Maintenance Phase|Lack of Efficacy|6|||
163848305|NCT02611830|591813569|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
163848306|NCT02611830|591813570|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
163848307|NCT02611830|591813571|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
163848308|NCT02611830|591813572|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
163848309|NCT02611830|591813569|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
163848310|NCT02611830|591813570|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
163848311|NCT02611830|591813571|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
163848312|NCT02611830|591813572|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
163848313|NCT02611830|591813569|FG000|Maintenance Phase|Lost to Follow-up|0|||
163848314|NCT02611830|591813570|FG001|Maintenance Phase|Lost to Follow-up|0|||
163848315|NCT02611830|591813571|FG002|Maintenance Phase|Lost to Follow-up|0|||
163848316|NCT02611830|591813572|FG003|Maintenance Phase|Lost to Follow-up|1|||
163848317|NCT02611830|591813569|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
163848318|NCT02611830|591813570|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
163848319|NCT02611830|591813571|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
163848320|NCT02611830|591813572|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
163848321|NCT02611830|591813569|FG000|Maintenance Phase|Pregnancy|0|||
163848322|NCT02611830|591813570|FG001|Maintenance Phase|Pregnancy|0|||
163848323|NCT02611830|591813571|FG002|Maintenance Phase|Pregnancy|1|||
163848324|NCT02611830|591813572|FG003|Maintenance Phase|Pregnancy|0|||
163848325|NCT02611830|591813569|FG000|Maintenance Phase|Reason not specified|0|||
163848326|NCT02611830|591813570|FG001|Maintenance Phase|Reason not specified|1|||
163848327|NCT02611830|591813571|FG002|Maintenance Phase|Reason not specified|4|||
163848328|NCT02611830|591813572|FG003|Maintenance Phase|Reason not specified|0|||
163848329|NCT04963062|591813578|FG000|Overall Study|withdrew by the study team|4|||
163848330|NCT04963062|591813579|FG001|Overall Study|withdrew by the study team|2|||
163848331|NCT01518257|591815321|FG000|Overall Study|Lost to Follow-up|1|||
163848332|NCT01518257|591815322|FG001|Overall Study|Lost to Follow-up|0|||
163848333|NCT01518257|591815321|FG000|Overall Study|Other Miscellaneous Reason|1|||
163848334|NCT01518257|591815322|FG001|Overall Study|Other Miscellaneous Reason|0|||
163848335|NCT01155726|591815326|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
163848336|NCT01155726|591815327|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
163848337|NCT01155726|591815328|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
163848338|NCT01155726|591815329|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
163848339|NCT05257837|591815333|FG000|Overall Study|Excluded (did not find the guns)|4|||
163848340|NCT05257837|591815334|FG001|Overall Study|Excluded (did not find the guns)|2|||
163848341|NCT05257837|591815335|FG002|Overall Study|Excluded (did not find the guns)|4|||
163848342|NCT05257837|591815336|FG003|Overall Study|Excluded (did not find the guns)|0|||
163848343|NCT05675709|591815339|FG000|Overall Study|incomplete outcome data|2|||
163848344|NCT05675709|591815340|FG001|Overall Study|incomplete outcome data|8|||
163848345|NCT01254565|591815344|FG000|Overall Study|Non-compliance to Study Procedures|0|||
163848346|NCT01254565|591815345|FG001|Overall Study|Non-compliance to Study Procedures|0|||
163848347|NCT01254565|591815346|FG002|Overall Study|Non-compliance to Study Procedures|0|||
163848348|NCT01254565|591815347|FG003|Overall Study|Non-compliance to Study Procedures|0|||
163848349|NCT01254565|591815348|FG004|Overall Study|Non-compliance to Study Procedures|1|||
163848350|NCT01254565|591815349|FG005|Overall Study|Non-compliance to Study Procedures|0|||
163848351|NCT01254565|591815344|FG000|Overall Study|Did not Receive Treatment|1|||
163848352|NCT01254565|591815345|FG001|Overall Study|Did not Receive Treatment|1|||
163848353|NCT01254565|591815346|FG002|Overall Study|Did not Receive Treatment|0|||
163848354|NCT01254565|591815347|FG003|Overall Study|Did not Receive Treatment|0|||
163848355|NCT01254565|591815348|FG004|Overall Study|Did not Receive Treatment|3|||
163848356|NCT01254565|591815349|FG005|Overall Study|Did not Receive Treatment|4|||
163848357|NCT01254565|591815344|FG000|Overall Study|Other|0|||
163848358|NCT01254565|591815345|FG001|Overall Study|Other|0|||
163848359|NCT01254565|591815346|FG002|Overall Study|Other|0|||
163848360|NCT01254565|591815347|FG003|Overall Study|Other|1|||
163848361|NCT01254565|591815348|FG004|Overall Study|Other|0|||
163848362|NCT01254565|591815349|FG005|Overall Study|Other|0|||
163848363|NCT02726399|591815354|FG000|Overall Study|Participant Non-Compliance|1|||
163848364|NCT02726399|591815354|FG000|Overall Study|Adverse Event|2|||
163848365|NCT02726399|591815354|FG000|Overall Study|Progression of disease|4|||
163848366|NCT01440049|591815357|FG000|Overall Study|Adverse Event|5|||
163848367|NCT02268552|591815358|FG000|Part 1|Death|1|||
163848368|NCT02268552|591815359|FG001|Part 1|Death|1|||
163848369|NCT02268552|591815360|FG002|Part 1|Death|1|||
163848370|NCT02268552|591815361|FG003|Part 1|Death|2|||
163848371|NCT02268552|591815362|FG004|Part 1|Death|0|||
163848372|NCT02268552|591815363|FG005|Part 1|Death|0|||
163848373|NCT02268552|591815364|FG006|Part 1|Death|0|||
163848374|NCT02268552|591815358|FG000|Part 1|Subject/guardian decision|0|||
163848375|NCT02268552|591815359|FG001|Part 1|Subject/guardian decision|0|||
163848376|NCT02268552|591815360|FG002|Part 1|Subject/guardian decision|0|||
163848377|NCT02268552|591815361|FG003|Part 1|Subject/guardian decision|1|||
163848378|NCT02268552|591815362|FG004|Part 1|Subject/guardian decision|0|||
163848379|NCT02268552|591815363|FG005|Part 1|Subject/guardian decision|0|||
163848380|NCT02268552|591815364|FG006|Part 1|Subject/guardian decision|0|||
163848381|NCT02268552|591815358|FG000|Part 2|Death|0|||
163848382|NCT02268552|591815359|FG001|Part 2|Death|0|||
163848383|NCT02268552|591815360|FG002|Part 2|Death|0|||
163848384|NCT02268552|591815361|FG003|Part 2|Death|0|||
163848385|NCT02268552|591815362|FG004|Part 2|Death|0|||
163848386|NCT02268552|591815363|FG005|Part 2|Death|0|||
163848387|NCT02268552|591815364|FG006|Part 2|Death|2|||
163848388|NCT02268552|591815358|FG000|Part 2|Subject/guardian decision|0|||
163848389|NCT02268552|591815359|FG001|Part 2|Subject/guardian decision|0|||
163848390|NCT02268552|591815360|FG002|Part 2|Subject/guardian decision|0|||
163848391|NCT02268552|591815361|FG003|Part 2|Subject/guardian decision|0|||
163848392|NCT02268552|591815362|FG004|Part 2|Subject/guardian decision|0|||
163848393|NCT02268552|591815363|FG005|Part 2|Subject/guardian decision|0|||
163848394|NCT02268552|591815364|FG006|Part 2|Subject/guardian decision|1|||
163848395|NCT02268552|591815358|FG000|Part 3 Extension|Death|0|||
163848396|NCT02268552|591815359|FG001|Part 3 Extension|Death|1|||
163848397|NCT02268552|591815360|FG002|Part 3 Extension|Death|1|||
163848398|NCT02268552|591815361|FG003|Part 3 Extension|Death|1|||
163848399|NCT02268552|591815362|FG004|Part 3 Extension|Death|1|||
163848400|NCT02268552|591815363|FG005|Part 3 Extension|Death|1|||
163848401|NCT02268552|591815364|FG006|Part 3 Extension|Death|0|||
163848402|NCT02268552|591815358|FG000|Part 3 Extension|Early termination of trial|1|||
163848403|NCT02268552|591815359|FG001|Part 3 Extension|Early termination of trial|0|||
163848404|NCT02268552|591815360|FG002|Part 3 Extension|Early termination of trial|0|||
163848405|NCT02268552|591815361|FG003|Part 3 Extension|Early termination of trial|0|||
163848406|NCT02268552|591815362|FG004|Part 3 Extension|Early termination of trial|2|||
163848407|NCT02268552|591815363|FG005|Part 3 Extension|Early termination of trial|9|||
163848408|NCT02268552|591815364|FG006|Part 3 Extension|Early termination of trial|11|||
163848409|NCT02268552|591815358|FG000|Part 3 Extension|Subject/guardian decision|0|||
163848410|NCT02268552|591815359|FG001|Part 3 Extension|Subject/guardian decision|0|||
163848411|NCT02268552|591815360|FG002|Part 3 Extension|Subject/guardian decision|0|||
163848412|NCT02268552|591815361|FG003|Part 3 Extension|Subject/guardian decision|0|||
163848413|NCT02268552|591815362|FG004|Part 3 Extension|Subject/guardian decision|0|||
163848414|NCT02268552|591815363|FG005|Part 3 Extension|Subject/guardian decision|0|||
163960162|NCT03816891|592225429|FG002|Double-Blind Period|Lost to Follow-up|0|||
163848415|NCT02268552|591815364|FG006|Part 3 Extension|Subject/guardian decision|1|||
163848416|NCT04168385|591815366|FG000|Overall Study|Withdrawal by Subject|1|||
163848417|NCT04168385|591815367|FG001|Overall Study|Withdrawal by Subject|0|||
163848418|NCT04168385|591815366|FG000|Overall Study|Adverse Event|2|||
163848419|NCT04168385|591815367|FG001|Overall Study|Adverse Event|1|||
163848420|NCT04168385|591815366|FG000|Overall Study|Liver transplant|3|||
163848421|NCT04168385|591815367|FG001|Overall Study|Liver transplant|1|||
163848422|NCT04168385|591815366|FG000|Overall Study|Listed for liver transplant|1|||
163848423|NCT04168385|591815367|FG001|Overall Study|Listed for liver transplant|0|||
163848424|NCT02139982|591815368|FG000|Overall Study|Lack of Efficacy|0|||
163848425|NCT02139982|591815369|FG001|Overall Study|Lack of Efficacy|1|||
163848426|NCT02139982|591815370|FG002|Overall Study|Lack of Efficacy|0|||
163848427|NCT02139982|591815371|FG003|Overall Study|Lack of Efficacy|1|||
163848428|NCT02139982|591815372|FG004|Overall Study|Lack of Efficacy|0|||
163848429|NCT02139982|591815373|FG005|Overall Study|Lack of Efficacy|0|||
163848430|NCT02139982|591815374|FG006|Overall Study|Lack of Efficacy|0|||
163848431|NCT02139982|591815375|FG007|Overall Study|Lack of Efficacy|0|||
163848432|NCT02139982|591815376|FG008|Overall Study|Lack of Efficacy|0|||
163848433|NCT02139982|591815377|FG009|Overall Study|Lack of Efficacy|0|||
163848434|NCT02748512|591815380|FG000|Overall Study|Lost to Follow-up|1|||
163848435|NCT02748512|591815381|FG001|Overall Study|Lost to Follow-up|1|||
163848436|NCT01196104|591815395|FG000|Overall Study|Lost to Follow-up|1|||
163848437|NCT01196104|591815396|FG001|Overall Study|Lost to Follow-up|0|||
163848438|NCT01196104|591815395|FG000|Overall Study|Physician Decision|0|||
163848439|NCT01196104|591815396|FG001|Overall Study|Physician Decision|1|||
163848440|NCT01196104|591815395|FG000|Overall Study|Withdrawal by Subject|3|||
163848441|NCT01196104|591815396|FG001|Overall Study|Withdrawal by Subject|3|||
163848442|NCT01196104|591815395|FG000|Overall Study|Various|0|||
163848443|NCT01196104|591815396|FG001|Overall Study|Various|1|||
163848444|NCT01094171|591815403|FG000|Overall Study|Lost to Follow-up|2|||
163848445|NCT01094171|591815403|FG000|Overall Study|Informed consent withdrawal|4|||
163848446|NCT01094171|591815403|FG000|Overall Study|Migration from the study area|3|||
163848447|NCT01094171|591815403|FG000|Overall Study|Other|1|||
163848448|NCT01310868|591815404|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
163848449|NCT04496167|591815405|FG000|Overall Study|Adverse Event|6|||
163848450|NCT04496167|591815406|FG001|Overall Study|Adverse Event|2|||
163848451|NCT04496167|591815405|FG000|Overall Study|Withdrawal by Subject|7|||
163848452|NCT04496167|591815406|FG001|Overall Study|Withdrawal by Subject|6|||
163848453|NCT04496167|591815405|FG000|Overall Study|Lost to Follow-up|3|||
163848454|NCT04496167|591815406|FG001|Overall Study|Lost to Follow-up|5|||
163848455|NCT04496167|591815405|FG000|Overall Study|Not Treated|1|||
163848456|NCT04496167|591815406|FG001|Overall Study|Not Treated|2|||
163848457|NCT04496167|591815405|FG000|Overall Study|Other Than Specified|1|||
163848458|NCT04496167|591815406|FG001|Overall Study|Other Than Specified|1|||
163848459|NCT00598481|591815407|FG000|Treatment|Physician Decision|1|||
163848460|NCT01708187|591815410|FG000|Overall Study|Lost to Follow-up|0|||
163848461|NCT01708187|591815411|FG001|Overall Study|Lost to Follow-up|1|||
163848462|NCT02408549|591815413|FG000|Overall Study|Adverse Event|15|||
163848463|NCT02408549|591815413|FG000|Overall Study|Death|4|||
163848464|NCT02408549|591815413|FG000|Overall Study|Lack of Efficacy|17|||
163848465|NCT02408549|591815413|FG000|Overall Study|Protocol Violation|4|||
163848466|NCT02408549|591815413|FG000|Overall Study|Lost to Follow-up|6|||
163848467|NCT02408549|591815413|FG000|Overall Study|Consent withdrawn|30|||
163848468|NCT02408549|591815413|FG000|Overall Study|Neurology research program closing at site|1|||
163848469|NCT02408549|591815413|FG000|Overall Study|Site closure|1|||
163848470|NCT02408549|591815413|FG000|Overall Study|Pregnancy|1|||
163848471|NCT02408549|591815413|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
163848472|NCT02408549|591815413|FG000|Overall Study|Subject moved to another place, far from site|1|||
163848473|NCT02408549|591815413|FG000|Overall Study|Study terminated at site|1|||
163848474|NCT02025205|591815414|FG000|Overall Study|Withdrawal by Subject|1|||
163848475|NCT02025205|591815415|FG001|Overall Study|Withdrawal by Subject|1|||
163848476|NCT02025205|591815414|FG000|Overall Study|Protocol Violation|2|||
163848477|NCT02025205|591815415|FG001|Overall Study|Protocol Violation|1|||
163848478|NCT02025205|591815414|FG000|Overall Study|Death|0|||
163848479|NCT02025205|591815415|FG001|Overall Study|Death|1|||
163848480|NCT01232556|591815418|FG000|Overall Study|Withdrawal by Subject|21|||
163848481|NCT01232556|591815419|FG001|Overall Study|Withdrawal by Subject|17|||
163848482|NCT01232556|591815418|FG000|Overall Study|Death|97|||
163848483|NCT01232556|591815419|FG001|Overall Study|Death|97|||
163848484|NCT01232556|591815418|FG000|Overall Study|Lost to Follow-up|0|||
163848485|NCT01232556|591815419|FG001|Overall Study|Lost to Follow-up|2|||
163848486|NCT01232556|591815418|FG000|Overall Study|Terminated by Sponsor|35|||
163848487|NCT01232556|591815419|FG001|Overall Study|Terminated by Sponsor|51|||
163848488|NCT01232556|591815418|FG000|Overall Study|Other|6|||
163848489|NCT01232556|591815419|FG001|Overall Study|Other|4|||
163848490|NCT04172987|591815420|FG000|Lead In Period|Adverse Event|1|||
163848491|NCT04172987|591815420|FG000|Lead In Period|Protocol Violation|1|||
163848492|NCT04172987|591815420|FG000|Period 1|Physician Decision|1|||
163848493|NCT04172987|591815420|FG000|Period 2|Adverse Event|5|||
163848494|NCT04172987|591815420|FG000|Period 2|Dosing Termination by Sponsor|4|||
163848495|NCT03785340|591815422|FG000|Overall Study|Lost to Follow-up|2|||
163848496|NCT03785340|591815423|FG001|Overall Study|Lost to Follow-up|0|||
163848497|NCT03785340|591815422|FG000|Overall Study|Adverse Event|1|||
163848498|NCT03785340|591815423|FG001|Overall Study|Adverse Event|0|||
163848499|NCT02500316|591815424|FG000|Overall Study|Adverse Event|3|||
163848500|NCT02500316|591815424|FG000|Overall Study|Lost to Follow-up|2|||
163848501|NCT02500316|591815424|FG000|Overall Study|Protocol Violation|1|||
163848502|NCT02500316|591815424|FG000|Overall Study|Withdrawal by Subject|15|||
163848503|NCT02500316|591815424|FG000|Overall Study|Final height achieved|5|||
163848504|NCT02500316|591815424|FG000|Overall Study|Due to war activity|1|||
163848505|NCT02337478|591815425|FG000|Overall Study|Lack of Efficacy|5|||
163848506|NCT01513967|591815433|FG000|Overall Study|Pregnancy|0|||
163848507|NCT01513967|591815434|FG001|Overall Study|Pregnancy|0|||
163848508|NCT01513967|591815435|FG002|Overall Study|Pregnancy|0|||
163848509|NCT01513967|591815436|FG003|Overall Study|Pregnancy|0|||
163848510|NCT01513967|591815437|FG004|Overall Study|Pregnancy|0|||
163848511|NCT01513967|591815438|FG005|Overall Study|Pregnancy|0|||
163848512|NCT01513967|591815439|FG006|Overall Study|Pregnancy|1|||
163848513|NCT01513967|591815440|FG007|Overall Study|Pregnancy|0|||
163848514|NCT01513967|591815433|FG000|Overall Study|missed a study visit|0|||
163848515|NCT01513967|591815434|FG001|Overall Study|missed a study visit|0|||
163848516|NCT01513967|591815435|FG002|Overall Study|missed a study visit|0|||
163848517|NCT01513967|591815436|FG003|Overall Study|missed a study visit|0|||
163848518|NCT01513967|591815437|FG004|Overall Study|missed a study visit|0|||
163848519|NCT01513967|591815438|FG005|Overall Study|missed a study visit|0|||
163848520|NCT01513967|591815439|FG006|Overall Study|missed a study visit|1|||
163848521|NCT01513967|591815440|FG007|Overall Study|missed a study visit|0|||
163848522|NCT01513967|591815433|FG000|Overall Study|excluded due to positive drug screen|0|||
163848523|NCT01513967|591815434|FG001|Overall Study|excluded due to positive drug screen|0|||
163848524|NCT01513967|591815435|FG002|Overall Study|excluded due to positive drug screen|0|||
163848525|NCT01513967|591815436|FG003|Overall Study|excluded due to positive drug screen|0|||
163848526|NCT01513967|591815437|FG004|Overall Study|excluded due to positive drug screen|0|||
163848527|NCT01513967|591815438|FG005|Overall Study|excluded due to positive drug screen|0|||
163848528|NCT01513967|591815439|FG006|Overall Study|excluded due to positive drug screen|0|||
163848529|NCT01513967|591815440|FG007|Overall Study|excluded due to positive drug screen|2|||
163848530|NCT01513967|591815433|FG000|Overall Study|Physician Decision|0|||
163848531|NCT01513967|591815434|FG001|Overall Study|Physician Decision|0|||
163848532|NCT01513967|591815435|FG002|Overall Study|Physician Decision|0|||
163848533|NCT01513967|591815436|FG003|Overall Study|Physician Decision|0|||
163848534|NCT01513967|591815437|FG004|Overall Study|Physician Decision|0|||
163848535|NCT01513967|591815438|FG005|Overall Study|Physician Decision|1|||
163848536|NCT01513967|591815439|FG006|Overall Study|Physician Decision|0|||
163848537|NCT01513967|591815440|FG007|Overall Study|Physician Decision|0|||
163848538|NCT01987830|591815441|FG000|Overall Study|Never received baseline scan|1|||
163848539|NCT05294419|591815442|FG000|Overall Study|Protocol Violation|4|||
163848540|NCT05294419|591815443|FG001|Overall Study|Protocol Violation|0|||
163848541|NCT05294419|591815444|FG002|Overall Study|Protocol Violation|0|||
163848542|NCT05294419|591815442|FG000|Overall Study|Lost to Follow-up|6|||
163848543|NCT05294419|591815443|FG001|Overall Study|Lost to Follow-up|0|||
163848544|NCT05294419|591815444|FG002|Overall Study|Lost to Follow-up|0|||
163848545|NCT05294419|591815442|FG000|Overall Study|Results voided after publishing|2|||
163848546|NCT05294419|591815443|FG001|Overall Study|Results voided after publishing|0|||
163848547|NCT05294419|591815444|FG002|Overall Study|Results voided after publishing|0|||
163848548|NCT00544544|591815445|FG000|Overall Study|Withdrawal by Subject|1|||
163848549|NCT00544544|591815445|FG000|Overall Study|Adverse Event|1|||
163848550|NCT00544544|591815445|FG000|Overall Study|Lost to Follow-up|1|||
163848551|NCT00442286|591815449|FG000|Overall Study|Death|2|||
163848552|NCT00442286|591815450|FG001|Overall Study|Death|2|||
163848553|NCT00442286|591815449|FG000|Overall Study|Lost to Follow-up|1|||
163848554|NCT00442286|591815450|FG001|Overall Study|Lost to Follow-up|0|||
163848555|NCT00442286|591815449|FG000|Overall Study|Withdrawal by Subject|2|||
163848556|NCT00442286|591815450|FG001|Overall Study|Withdrawal by Subject|0|||
163848557|NCT00442286|591815449|FG000|Overall Study|System explanted|1|||
163848558|NCT00442286|591815450|FG001|Overall Study|System explanted|0|||
163848559|NCT00442286|591815449|FG000|Overall Study|Patient Injury|1|||
163848560|NCT00442286|591815450|FG001|Overall Study|Patient Injury|0|||
163848561|NCT05221749|591815451|FG000|Overall Study|Lost to Follow-up|2|||
163848562|NCT05221749|591815452|FG001|Overall Study|Lost to Follow-up|3|||
163848563|NCT03428815|591815453|FG000|Overall Study|Lost to Follow-up|2|||
163848564|NCT03428815|591815454|FG001|Overall Study|Lost to Follow-up|2|||
163848565|NCT03428815|591815453|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
163848566|NCT03428815|591815454|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
163848567|NCT03428815|591815453|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
163848568|NCT03428815|591815454|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
163848569|NCT02102464|591815455|FG000|Randomized Study|Withdrawal by Subject|0|||
163960163|NCT03816891|592225430|FG003|Double-Blind Period|Lost to Follow-up|0|||
163960164|NCT03816891|592225431|FG004|Double-Blind Period|Lost to Follow-up|0|||
163960165|NCT03816891|592225432|FG005|Double-Blind Period|Lost to Follow-up|1|||
163960166|NCT03816891|592225427|FG000|Double-Blind Period|Physician Decision|0|||
163960167|NCT03816891|592225428|FG001|Double-Blind Period|Physician Decision|0|||
163960168|NCT03816891|592225429|FG002|Double-Blind Period|Physician Decision|0|||
163960169|NCT03816891|592225430|FG003|Double-Blind Period|Physician Decision|1|||
163960170|NCT03816891|592225431|FG004|Double-Blind Period|Physician Decision|0|||
163960171|NCT03816891|592225432|FG005|Double-Blind Period|Physician Decision|0|||
163960172|NCT03816891|592225427|FG000|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163960173|NCT03816891|592225428|FG001|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163960174|NCT03816891|592225429|FG002|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163960175|NCT03816891|592225430|FG003|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163960176|NCT03816891|592225431|FG004|Double-Blind Period|Coronavirus Disease (COVID-19)|0|||
163960177|NCT03816891|592225432|FG005|Double-Blind Period|Coronavirus Disease (COVID-19)|1|||
163960178|NCT03816891|592225427|FG000|Double-Blind Period|Other|1|||
163960179|NCT03816891|592225428|FG001|Double-Blind Period|Other|0|||
163960180|NCT03816891|592225429|FG002|Double-Blind Period|Other|0|||
163848570|NCT02102464|591815456|FG001|Randomized Study|Withdrawal by Subject|1|||
163848571|NCT02102464|591815457|FG002|Randomized Study|Withdrawal by Subject|0|||
163848572|NCT01700348|591815458|FG000|Overall Study|Withdrawal by Subject|22|||
163848573|NCT01700348|591815458|FG000|Overall Study|Lost to Follow-up|1|||
163848574|NCT04140890|591815461|FG000|Overall Study|Withdrawal by Subject|0|||
163848575|NCT04140890|591815462|FG001|Overall Study|Withdrawal by Subject|1|||
163848576|NCT02404493|591815463|FG000|Overall Study|Adverse Event|1|||
163848577|NCT02404493|591815464|FG001|Overall Study|Adverse Event|1|||
163848578|NCT02388074|591815465|FG000|Overall Study|Lost in Transit|2|||
163848579|NCT02388074|591815465|FG000|Overall Study|Sample Not Returned|1|||
163848580|NCT01778062|591815468|FG000|Overall Study|Adverse Event|1|||
163848581|NCT01778062|591815469|FG001|Overall Study|Adverse Event|3|||
163848582|NCT01778062|591815468|FG000|Overall Study|Consent Withdrawal|1|||
163848583|NCT01778062|591815469|FG001|Overall Study|Consent Withdrawal|5|||
163848584|NCT01778062|591815468|FG000|Overall Study|major protocol deviation|4|||
163848585|NCT01778062|591815469|FG001|Overall Study|major protocol deviation|3|||
163848586|NCT03958630|591815472|FG000|Overall Study|Withdrawal by Subject|0|||
163848587|NCT03958630|591815473|FG001|Overall Study|Withdrawal by Subject|0|||
163848588|NCT03958630|591815474|FG002|Overall Study|Withdrawal by Subject|1|||
163848589|NCT03958630|591815472|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
163848590|NCT03958630|591815473|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
163848591|NCT03958630|591815474|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
163848592|NCT03317379|591815480|FG000|Overall Study|Lost to Follow-up|0|||
163848593|NCT03317379|591815481|FG001|Overall Study|Lost to Follow-up|3|||
163848594|NCT03317379|591815482|FG002|Overall Study|Lost to Follow-up|2|||
163848595|NCT04157686|591815483|FG000|Overall Study|Adverse Event|1|||
163848596|NCT04157686|591815484|FG001|Overall Study|Adverse Event|0|||
163848597|NCT04157686|591815485|FG002|Overall Study|Adverse Event|1|||
163848598|NCT04157686|591815486|FG003|Overall Study|Adverse Event|0|||
163848599|NCT04157686|591815487|FG004|Overall Study|Adverse Event|1|||
163848600|NCT04157686|591815488|FG005|Overall Study|Adverse Event|0|||
163848601|NCT04157686|591815489|FG006|Overall Study|Adverse Event|0|||
163848602|NCT04157686|591815490|FG007|Overall Study|Adverse Event|0|||
163848603|NCT04157686|591815483|FG000|Overall Study|Pregnancy|0|||
163848604|NCT04157686|591815484|FG001|Overall Study|Pregnancy|1|||
163848605|NCT04157686|591815485|FG002|Overall Study|Pregnancy|3|||
163848606|NCT04157686|591815486|FG003|Overall Study|Pregnancy|0|||
163848607|NCT04157686|591815487|FG004|Overall Study|Pregnancy|0|||
163848608|NCT04157686|591815488|FG005|Overall Study|Pregnancy|0|||
163848609|NCT04157686|591815489|FG006|Overall Study|Pregnancy|3|||
163848610|NCT04157686|591815490|FG007|Overall Study|Pregnancy|0|||
163848611|NCT04157686|591815483|FG000|Overall Study|Lost to Follow-up|1|||
163848612|NCT04157686|591815484|FG001|Overall Study|Lost to Follow-up|2|||
163848613|NCT04157686|591815485|FG002|Overall Study|Lost to Follow-up|8|||
163848614|NCT04157686|591815486|FG003|Overall Study|Lost to Follow-up|6|||
163848615|NCT04157686|591815487|FG004|Overall Study|Lost to Follow-up|6|||
163848616|NCT04157686|591815488|FG005|Overall Study|Lost to Follow-up|3|||
163848617|NCT04157686|591815489|FG006|Overall Study|Lost to Follow-up|7|||
163848618|NCT04157686|591815490|FG007|Overall Study|Lost to Follow-up|9|||
163848619|NCT04157686|591815483|FG000|Overall Study|Lack of Efficacy|0|||
163848620|NCT04157686|591815484|FG001|Overall Study|Lack of Efficacy|0|||
163848621|NCT04157686|591815485|FG002|Overall Study|Lack of Efficacy|0|||
163848622|NCT04157686|591815486|FG003|Overall Study|Lack of Efficacy|0|||
163848623|NCT04157686|591815487|FG004|Overall Study|Lack of Efficacy|0|||
163848624|NCT04157686|591815488|FG005|Overall Study|Lack of Efficacy|2|||
163848625|NCT04157686|591815489|FG006|Overall Study|Lack of Efficacy|0|||
163848626|NCT04157686|591815490|FG007|Overall Study|Lack of Efficacy|1|||
163848627|NCT04157686|591815483|FG000|Overall Study|Withdrawal by Subject|10|||
163848628|NCT04157686|591815484|FG001|Overall Study|Withdrawal by Subject|10|||
163848629|NCT04157686|591815485|FG002|Overall Study|Withdrawal by Subject|12|||
163848630|NCT04157686|591815486|FG003|Overall Study|Withdrawal by Subject|20|||
163848631|NCT04157686|591815487|FG004|Overall Study|Withdrawal by Subject|12|||
163848632|NCT04157686|591815488|FG005|Overall Study|Withdrawal by Subject|11|||
163848633|NCT04157686|591815489|FG006|Overall Study|Withdrawal by Subject|18|||
163848634|NCT04157686|591815490|FG007|Overall Study|Withdrawal by Subject|24|||
163848635|NCT04157686|591815483|FG000|Overall Study|Physician Decision|0|||
163848636|NCT04157686|591815484|FG001|Overall Study|Physician Decision|0|||
163848637|NCT04157686|591815485|FG002|Overall Study|Physician Decision|1|||
163848638|NCT04157686|591815486|FG003|Overall Study|Physician Decision|0|||
163848639|NCT04157686|591815487|FG004|Overall Study|Physician Decision|1|||
163848640|NCT04157686|591815488|FG005|Overall Study|Physician Decision|0|||
163848641|NCT04157686|591815489|FG006|Overall Study|Physician Decision|3|||
163848642|NCT04157686|591815490|FG007|Overall Study|Physician Decision|0|||
163848643|NCT04157686|591815483|FG000|Overall Study|Death|0|||
163848644|NCT04157686|591815484|FG001|Overall Study|Death|0|||
163848645|NCT04157686|591815485|FG002|Overall Study|Death|0|||
163848646|NCT04157686|591815486|FG003|Overall Study|Death|2|||
163848647|NCT04157686|591815487|FG004|Overall Study|Death|0|||
163960181|NCT03816891|592225430|FG003|Double-Blind Period|Other|0|||
163848648|NCT04157686|591815488|FG005|Overall Study|Death|0|||
163848649|NCT04157686|591815489|FG006|Overall Study|Death|0|||
163848650|NCT04157686|591815490|FG007|Overall Study|Death|0|||
163848651|NCT04157686|591815483|FG000|Overall Study|Protocol Violation|0|||
163848652|NCT04157686|591815484|FG001|Overall Study|Protocol Violation|0|||
163848653|NCT04157686|591815485|FG002|Overall Study|Protocol Violation|0|||
163848654|NCT04157686|591815486|FG003|Overall Study|Protocol Violation|0|||
163848655|NCT04157686|591815487|FG004|Overall Study|Protocol Violation|1|||
163848656|NCT04157686|591815488|FG005|Overall Study|Protocol Violation|0|||
163848657|NCT04157686|591815489|FG006|Overall Study|Protocol Violation|0|||
163848658|NCT04157686|591815490|FG007|Overall Study|Protocol Violation|0|||
163848659|NCT04157686|591815483|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
163848660|NCT04157686|591815484|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
163848661|NCT04157686|591815485|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
163848662|NCT04157686|591815486|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
163848663|NCT04157686|591815487|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
163848664|NCT04157686|591815488|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
163848665|NCT04157686|591815489|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
163848666|NCT04157686|591815490|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
163848667|NCT04445155|591815491|FG000|Overall Study|Lost to Follow-up|11|||
163848668|NCT04445155|591815492|FG001|Overall Study|Lost to Follow-up|2|||
163848669|NCT04445155|591815493|FG002|Overall Study|Lost to Follow-up|3|||
163848670|NCT04445155|591815494|FG003|Overall Study|Lost to Follow-up|0|||
163848671|NCT04445155|591815491|FG000|Overall Study|Withdrawal by Subject|8|||
163848672|NCT04445155|591815492|FG001|Overall Study|Withdrawal by Subject|0|||
163848673|NCT04445155|591815493|FG002|Overall Study|Withdrawal by Subject|0|||
163848674|NCT04445155|591815494|FG003|Overall Study|Withdrawal by Subject|0|||
163848675|NCT04445155|591815491|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
163848676|NCT04445155|591815492|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
163848677|NCT04445155|591815493|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
163848678|NCT04445155|591815494|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
163848679|NCT04445155|591815491|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
163848680|NCT04445155|591815492|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
163848681|NCT04445155|591815493|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
163848682|NCT04445155|591815494|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
163848683|NCT04191135|591815496|FG000|Induction Treatment|Not Treated|2|||
163848684|NCT04191135|591815497|FG001|Induction Treatment|Not Treated|0|||
163848685|NCT04191135|591815498|FG002|Induction Treatment|Not Treated|0|||
163848686|NCT04191135|591815496|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
163848687|NCT04191135|591815497|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
163848688|NCT04191135|591815498|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
163848689|NCT04191135|591815496|FG000|Induction Treatment|Adverse Event|25|||
163848690|NCT04191135|591815497|FG001|Induction Treatment|Adverse Event|0|||
163848691|NCT04191135|591815498|FG002|Induction Treatment|Adverse Event|0|||
163848692|NCT04191135|591815496|FG000|Induction Treatment|Clinical Progression|8|||
163848693|NCT04191135|591815497|FG001|Induction Treatment|Clinical Progression|0|||
163848694|NCT04191135|591815498|FG002|Induction Treatment|Clinical Progression|0|||
163848695|NCT04191135|591815496|FG000|Induction Treatment|Excluded Medication|1|||
163848696|NCT04191135|591815497|FG001|Induction Treatment|Excluded Medication|0|||
163848697|NCT04191135|591815498|FG002|Induction Treatment|Excluded Medication|0|||
163848698|NCT04191135|591815496|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
163848699|NCT04191135|591815497|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
163848700|NCT04191135|591815498|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
163848701|NCT04191135|591815496|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
163848702|NCT04191135|591815497|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
163848703|NCT04191135|591815498|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
163848704|NCT04191135|591815496|FG000|Induction Treatment|Physician Decision|2|||
163848705|NCT04191135|591815497|FG001|Induction Treatment|Physician Decision|0|||
163848706|NCT04191135|591815498|FG002|Induction Treatment|Physician Decision|0|||
163848707|NCT04191135|591815496|FG000|Induction Treatment|Progressive Disease|135|||
163848708|NCT04191135|591815497|FG001|Induction Treatment|Progressive Disease|0|||
163848709|NCT04191135|591815498|FG002|Induction Treatment|Progressive Disease|0|||
163848710|NCT04191135|591815496|FG000|Induction Treatment|Protocol Violation|10|||
163848711|NCT04191135|591815497|FG001|Induction Treatment|Protocol Violation|0|||
163848712|NCT04191135|591815498|FG002|Induction Treatment|Protocol Violation|0|||
163848713|NCT04191135|591815496|FG000|Induction Treatment|Withdrawal by Subject|4|||
163848714|NCT04191135|591815497|FG001|Induction Treatment|Withdrawal by Subject|0|||
163848715|NCT04191135|591815498|FG002|Induction Treatment|Withdrawal by Subject|0|||
163848716|NCT04191135|591815496|FG000|Randomized Treatment|Death|0|||
163848717|NCT04191135|591815497|FG001|Randomized Treatment|Death|50|||
163848718|NCT04191135|591815498|FG002|Randomized Treatment|Death|54|||
163848719|NCT04191135|591815496|FG000|Randomized Treatment|Lost to Follow-up|0|||
163848720|NCT04191135|591815497|FG001|Randomized Treatment|Lost to Follow-up|0|||
163848721|NCT04191135|591815498|FG002|Randomized Treatment|Lost to Follow-up|1|||
163848722|NCT04191135|591815496|FG000|Randomized Treatment|Withdrawal by Subject|0|||
163848723|NCT04191135|591815497|FG001|Randomized Treatment|Withdrawal by Subject|2|||
163848724|NCT04191135|591815498|FG002|Randomized Treatment|Withdrawal by Subject|0|||
163848725|NCT04191135|591815496|FG000|Randomized Treatment|Ongoing in Trial|0|||
163848726|NCT04191135|591815497|FG001|Randomized Treatment|Ongoing in Trial|83|||
163848727|NCT04191135|591815498|FG002|Randomized Treatment|Ongoing in Trial|81|||
163848728|NCT02107274|591816843|FG000|Treatment vs. Placebo|Adverse Event|3|||
163848729|NCT02107274|591816844|FG001|Treatment vs. Placebo|Adverse Event|0|||
163848730|NCT02107274|591816843|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
163848731|NCT02107274|591816844|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
163848732|NCT02107274|591816843|FG000|Control Phase|Lost to Follow-up|1|||
163848733|NCT02107274|591816844|FG001|Control Phase|Lost to Follow-up|1|||
163848734|NCT02107274|591816843|FG000|Control Phase|Death|2|||
163848735|NCT02107274|591816844|FG001|Control Phase|Death|0|||
163848736|NCT02107274|591816843|FG000|Control Phase|Adverse Event|0|||
163848737|NCT02107274|591816844|FG001|Control Phase|Adverse Event|1|||
163848738|NCT05305040|591816847|FG000|Overall Study|Not Dosed|37|||
163848739|NCT05305040|591816848|FG001|Overall Study|Not Dosed|37|||
163848740|NCT05305040|591816847|FG000|Overall Study|Study Closure|34|||
163848741|NCT05305040|591816848|FG001|Overall Study|Study Closure|46|||
163848742|NCT05305040|591816847|FG000|Overall Study|Death|14|||
163848743|NCT05305040|591816848|FG001|Overall Study|Death|13|||
163848744|NCT05305040|591816847|FG000|Overall Study|Withdrawal by Subject|15|||
163848745|NCT05305040|591816848|FG001|Overall Study|Withdrawal by Subject|10|||
163848746|NCT05305040|591816847|FG000|Overall Study|Other|13|||
163848747|NCT05305040|591816848|FG001|Overall Study|Other|10|||
163848748|NCT05305040|591816847|FG000|Overall Study|Primary Malignancy Relapse|3|||
163848749|NCT05305040|591816848|FG001|Overall Study|Primary Malignancy Relapse|4|||
163848750|NCT05305040|591816847|FG000|Overall Study|Adverse Event|3|||
163848751|NCT05305040|591816848|FG001|Overall Study|Adverse Event|3|||
163848752|NCT05305040|591816847|FG000|Overall Study|Lost to Follow-up|2|||
163848753|NCT05305040|591816848|FG001|Overall Study|Lost to Follow-up|1|||
163848754|NCT05305040|591816847|FG000|Overall Study|Graft versus host disease|2|||
163848755|NCT05305040|591816848|FG001|Overall Study|Graft versus host disease|0|||
163848756|NCT05305040|591816847|FG000|Overall Study|Investigator's Decision|1|||
163848757|NCT05305040|591816848|FG001|Overall Study|Investigator's Decision|1|||
163848758|NCT05305040|591816847|FG000|Overall Study|COVID-19 Reasons|1|||
163848759|NCT05305040|591816848|FG001|Overall Study|COVID-19 Reasons|0|||
163848760|NCT02206685|591816849|FG000|Overall Study|Surgery cancelled/changed|2|||
163848761|NCT02206685|591816850|FG001|Overall Study|Surgery cancelled/changed|3|||
163848762|NCT02206685|591816849|FG000|Overall Study|Withdrawal by Subject|1|||
163848763|NCT02206685|591816850|FG001|Overall Study|Withdrawal by Subject|2|||
163848764|NCT02206685|591816849|FG000|Overall Study|Protocol Violation|2|||
163848765|NCT02206685|591816850|FG001|Overall Study|Protocol Violation|2|||
163848766|NCT01195675|591816851|FG000|Overall Study|Adverse Event|1|||
163848767|NCT01195675|591816851|FG000|Overall Study|Withdrawal by Subject|2|||
163848768|NCT02424344|591816852|FG000|Overall Study|Lack of Efficacy|0|||
163848769|NCT02424344|591816853|FG001|Overall Study|Lack of Efficacy|1|||
163848770|NCT02424344|591816852|FG000|Overall Study|Withdrawal by Subject|2|||
163848771|NCT02424344|591816853|FG001|Overall Study|Withdrawal by Subject|1|||
163848772|NCT02424344|591816852|FG000|Overall Study|Lost to Follow-up|1|||
163848773|NCT02424344|591816853|FG001|Overall Study|Lost to Follow-up|0|||
163848774|NCT02424344|591816852|FG000|Overall Study|Adverse Event|4|||
163848775|NCT02424344|591816853|FG001|Overall Study|Adverse Event|8|||
163848776|NCT04730947|591816854|FG000|Overall Study|Withdrawal by Subject|0|||
163848777|NCT04730947|591816855|FG001|Overall Study|Withdrawal by Subject|1|||
163848778|NCT01174550|591816856|FG000|Overall Study|Death|75|||
163848779|NCT01174550|591816857|FG001|Overall Study|Death|74|||
163848780|NCT01174550|591816856|FG000|Overall Study|Lost to Follow-up|652|||
163848781|NCT01174550|591816857|FG001|Overall Study|Lost to Follow-up|510|||
163848782|NCT01174550|591816856|FG000|Overall Study|Withdrawal by Subject|543|||
163960182|NCT03816891|592225431|FG004|Double-Blind Period|Other|0|||
163960183|NCT03816891|592225432|FG005|Double-Blind Period|Other|0|||
163960184|NCT03816891|592225427|FG000|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
163848783|NCT01174550|591816857|FG001|Overall Study|Withdrawal by Subject|289|||
163848784|NCT02123966|591816858|FG000|Overall Study|Intercurrent Illness|1|||
163848785|NCT01536262|591816859|FG000|Overall Study|Adverse Event|6|||
163848786|NCT01536262|591816860|FG001|Overall Study|Adverse Event|1|||
163848787|NCT01536262|591816861|FG002|Overall Study|Adverse Event|2|||
163848788|NCT01536262|591816859|FG000|Overall Study|Withdrawal by Subject|1|||
163848789|NCT01536262|591816860|FG001|Overall Study|Withdrawal by Subject|1|||
163848790|NCT01536262|591816861|FG002|Overall Study|Withdrawal by Subject|0|||
163848791|NCT01536262|591816859|FG000|Overall Study|Other than stated above|1|||
164006470|NCT02158533|592390963|FG001|Stage 2|Physician Decision|0|||
163848792|NCT01536262|591816860|FG001|Overall Study|Other than stated above|0|||
163848793|NCT01536262|591816861|FG002|Overall Study|Other than stated above|0|||
163848794|NCT01460381|591816865|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
163848795|NCT01460381|591816866|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
163848796|NCT01097655|591816867|FG000|Overall Study|Withdrawal by Subject|1|||
163848797|NCT01097655|591816867|FG000|Overall Study|Subject Documented Twice|1|||
163848798|NCT01097655|591816867|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
163848799|NCT02561455|591816868|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
163848800|NCT02561455|591816869|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
163848801|NCT02561455|591816870|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
163848802|NCT02561455|591816871|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
163848803|NCT02561455|591816868|FG000|Overall Study|Withdrawal by Subject|1|||
163848804|NCT02561455|591816869|FG001|Overall Study|Withdrawal by Subject|0|||
163848805|NCT02561455|591816870|FG002|Overall Study|Withdrawal by Subject|1|||
163848806|NCT02561455|591816871|FG003|Overall Study|Withdrawal by Subject|0|||
163848807|NCT02561455|591816868|FG000|Overall Study|Disease Progression|0|||
163848808|NCT02561455|591816869|FG001|Overall Study|Disease Progression|1|||
163848809|NCT02561455|591816870|FG002|Overall Study|Disease Progression|0|||
163848810|NCT02561455|591816871|FG003|Overall Study|Disease Progression|0|||
163848811|NCT03639675|591816872|FG000|Overall Study|Withdrawal by Subject|1|||
163848812|NCT01021332|591816873|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
163848813|NCT01021332|591816873|FG000|Overall Study|Adverse Event|43|||
163848814|NCT01021332|591816873|FG000|Overall Study|Lack of Efficacy|19|||
163848815|NCT01021332|591816873|FG000|Overall Study|Withdrawal of Consent|23|||
163848816|NCT01021332|591816873|FG000|Overall Study|Lost to Follow-up|4|||
163848817|NCT01021332|591816873|FG000|Overall Study|Protocol Violation|9|||
163848818|NCT01021332|591816873|FG000|Overall Study|Miscellaneous|3|||
163848819|NCT00826280|591816874|FG000|Overall Study|Randomized but drug not received|1|||
163848820|NCT00826280|591816875|FG001|Overall Study|Randomized but drug not received|0|||
163848821|NCT00826280|591816876|FG002|Overall Study|Randomized but drug not received|1|||
163848822|NCT00826280|591816874|FG000|Overall Study|Adverse Event|1|||
163848823|NCT00826280|591816875|FG001|Overall Study|Adverse Event|3|||
163848824|NCT00826280|591816876|FG002|Overall Study|Adverse Event|0|||
163848825|NCT00826280|591816874|FG000|Overall Study|Lost to Follow-up|0|||
163848826|NCT00826280|591816875|FG001|Overall Study|Lost to Follow-up|1|||
163848827|NCT00826280|591816876|FG002|Overall Study|Lost to Follow-up|0|||
163848828|NCT00826280|591816874|FG000|Overall Study|Sponsor discontinued subject or study|1|||
163848829|NCT00826280|591816875|FG001|Overall Study|Sponsor discontinued subject or study|0|||
163848830|NCT00826280|591816876|FG002|Overall Study|Sponsor discontinued subject or study|0|||
163848831|NCT00826280|591816874|FG000|Overall Study|Reversible ischemic defect not present|43|||
163848832|NCT00826280|591816875|FG001|Overall Study|Reversible ischemic defect not present|40|||
163848833|NCT00826280|591816876|FG002|Overall Study|Reversible ischemic defect not present|44|||
163848834|NCT00826280|591816874|FG000|Overall Study|Interpretation Failure|1|||
163848835|NCT00826280|591816875|FG001|Overall Study|Interpretation Failure|0|||
163848836|NCT00826280|591816876|FG002|Overall Study|Interpretation Failure|0|||
163848837|NCT00826280|591816874|FG000|Overall Study|Machine Failure|1|||
163848838|NCT00826280|591816875|FG001|Overall Study|Machine Failure|1|||
163848839|NCT00826280|591816876|FG002|Overall Study|Machine Failure|0|||
163848840|NCT00826280|591816874|FG000|Overall Study|One or more non-interpretable scan|0|||
163848841|NCT00826280|591816875|FG001|Overall Study|One or more non-interpretable scan|1|||
163848842|NCT00826280|591816876|FG002|Overall Study|One or more non-interpretable scan|1|||
163848843|NCT05343455|591816879|FG000|Overall Study|Withdrawal by Subject|4|||
163848844|NCT05343455|591816880|FG001|Overall Study|Withdrawal by Subject|9|||
163848845|NCT05343455|591816881|FG002|Overall Study|Withdrawal by Subject|7|||
163848846|NCT05343455|591816879|FG000|Overall Study|Adverse Event|2|||
163848847|NCT05343455|591816880|FG001|Overall Study|Adverse Event|1|||
163848848|NCT05343455|591816881|FG002|Overall Study|Adverse Event|2|||
163848849|NCT05343455|591816879|FG000|Overall Study|Lost to Follow-up|1|||
163848850|NCT05343455|591816880|FG001|Overall Study|Lost to Follow-up|1|||
163848851|NCT05343455|591816881|FG002|Overall Study|Lost to Follow-up|3|||
163848852|NCT05343455|591816879|FG000|Overall Study|Pregnancy|1|||
163848853|NCT05343455|591816880|FG001|Overall Study|Pregnancy|0|||
163848854|NCT05343455|591816881|FG002|Overall Study|Pregnancy|0|||
163848855|NCT05343455|591816879|FG000|Overall Study|Physician Decision|0|||
163848856|NCT05343455|591816880|FG001|Overall Study|Physician Decision|0|||
163848857|NCT05343455|591816881|FG002|Overall Study|Physician Decision|1|||
163848858|NCT05343455|591816879|FG000|Overall Study|Protocol Violation|0|||
163848859|NCT05343455|591816880|FG001|Overall Study|Protocol Violation|1|||
163848860|NCT05343455|591816881|FG002|Overall Study|Protocol Violation|1|||
163848861|NCT03354637|591816884|FG000|Double-blind Period|Protocol Violation|2|||
163848862|NCT03354637|591816885|FG001|Double-blind Period|Protocol Violation|0|||
163848863|NCT03354637|591816886|FG002|Double-blind Period|Protocol Violation|0|||
163848864|NCT03354637|591816884|FG000|Double-blind Period|Adverse Event|1|||
163848865|NCT03354637|591816885|FG001|Double-blind Period|Adverse Event|2|||
163848866|NCT03354637|591816886|FG002|Double-blind Period|Adverse Event|0|||
163848867|NCT03354637|591816884|FG000|Double-blind Period|Lost to Follow-up|3|||
163848868|NCT03354637|591816885|FG001|Double-blind Period|Lost to Follow-up|4|||
163848869|NCT03354637|591816886|FG002|Double-blind Period|Lost to Follow-up|3|||
163848870|NCT03354637|591816884|FG000|Double-blind Period|Withdrawal by Subject|10|||
163848871|NCT03354637|591816885|FG001|Double-blind Period|Withdrawal by Subject|6|||
163848872|NCT03354637|591816886|FG002|Double-blind Period|Withdrawal by Subject|4|||
163848873|NCT03354637|591816884|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
163848874|NCT03354637|591816885|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
163848875|NCT03354637|591816886|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
163848876|NCT03354637|591816884|FG000|Open Label Extension|Adverse Event|0|||
163848877|NCT03354637|591816885|FG001|Open Label Extension|Adverse Event|0|||
163848878|NCT03354637|591816886|FG002|Open Label Extension|Adverse Event|1|||
163848879|NCT03354637|591816884|FG000|Open Label Extension|Lost to Follow-up|0|||
163848880|NCT03354637|591816885|FG001|Open Label Extension|Lost to Follow-up|0|||
163848881|NCT03354637|591816886|FG002|Open Label Extension|Lost to Follow-up|2|||
163848882|NCT03354637|591816884|FG000|Open Label Extension|Withdrawal by Subject|0|||
163848883|NCT03354637|591816885|FG001|Open Label Extension|Withdrawal by Subject|0|||
163848884|NCT03354637|591816886|FG002|Open Label Extension|Withdrawal by Subject|5|||
163848885|NCT03354637|591816884|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
163848886|NCT03354637|591816885|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
163848887|NCT03354637|591816886|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
163848888|NCT03354637|591816884|FG000|Open Label Extension|Subject Noncompliance|0|||
163848889|NCT03354637|591816885|FG001|Open Label Extension|Subject Noncompliance|0|||
163848890|NCT03354637|591816886|FG002|Open Label Extension|Subject Noncompliance|1|||
163848891|NCT03354637|591816884|FG000|Open Label Extension|Lack of Efficacy|0|||
163848892|NCT03354637|591816885|FG001|Open Label Extension|Lack of Efficacy|0|||
163848893|NCT03354637|591816886|FG002|Open Label Extension|Lack of Efficacy|1|||
163848894|NCT03354637|591816884|FG000|Open Label Extension|Physician Decision|0|||
163848895|NCT03354637|591816885|FG001|Open Label Extension|Physician Decision|0|||
163848896|NCT03354637|591816886|FG002|Open Label Extension|Physician Decision|1|||
163848897|NCT04006366|591816887|FG000|Overall Study|Withdrawal by Subject|1|||
163848898|NCT01123161|591816890|FG000|Overall Study|Lost to Follow-up|1|||
163848899|NCT01123161|591816891|FG001|Overall Study|Lost to Follow-up|0|||
163848900|NCT01123161|591816890|FG000|Overall Study|Withdrawal by Subject|1|||
163848901|NCT01123161|591816891|FG001|Overall Study|Withdrawal by Subject|0|||
163848902|NCT00873093|591816892|FG000|Overall Study|Adverse Event|0|||
163848903|NCT00873093|591816893|FG001|Overall Study|Adverse Event|2|||
163848904|NCT00873093|591816894|FG002|Overall Study|Adverse Event|0|||
163848905|NCT00873093|591816895|FG003|Overall Study|Adverse Event|0|||
163848906|NCT00873093|591816896|FG004|Overall Study|Adverse Event|0|||
163848907|NCT00873093|591816892|FG000|Overall Study|Death|0|||
163848908|NCT00873093|591816893|FG001|Overall Study|Death|3|||
163848909|NCT00873093|591816894|FG002|Overall Study|Death|2|||
163848910|NCT00873093|591816895|FG003|Overall Study|Death|0|||
163848911|NCT00873093|591816896|FG004|Overall Study|Death|0|||
163848912|NCT00873093|591816892|FG000|Overall Study|Physician Decision|0|||
163848913|NCT00873093|591816893|FG001|Overall Study|Physician Decision|17|||
163848914|NCT00873093|591816894|FG002|Overall Study|Physician Decision|10|||
163848915|NCT00873093|591816895|FG003|Overall Study|Physician Decision|10|||
163848916|NCT00873093|591816896|FG004|Overall Study|Physician Decision|2|||
163848917|NCT00873093|591816892|FG000|Overall Study|Withdrawal by Subject|1|||
163848918|NCT00873093|591816893|FG001|Overall Study|Withdrawal by Subject|4|||
163848919|NCT00873093|591816894|FG002|Overall Study|Withdrawal by Subject|4|||
163848920|NCT00873093|591816895|FG003|Overall Study|Withdrawal by Subject|0|||
163848921|NCT00873093|591816896|FG004|Overall Study|Withdrawal by Subject|0|||
163848922|NCT00873093|591816892|FG000|Overall Study|Ineligible|0|||
163848923|NCT00873093|591816893|FG001|Overall Study|Ineligible|1|||
163848924|NCT00873093|591816894|FG002|Overall Study|Ineligible|0|||
163848925|NCT00873093|591816895|FG003|Overall Study|Ineligible|1|||
163848926|NCT00873093|591816896|FG004|Overall Study|Ineligible|0|||
163848927|NCT01152554|591816898|FG000|Overall Study|Withdrawal by Subject|73|||
163848928|NCT01152554|591816899|FG001|Overall Study|Withdrawal by Subject|28|||
163848929|NCT01152554|591816898|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
163848930|NCT01152554|591816899|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
163848931|NCT01152554|591816898|FG000|Overall Study|Adverse Event|67|||
163848932|NCT01152554|591816899|FG001|Overall Study|Adverse Event|14|||
163848933|NCT01152554|591816898|FG000|Overall Study|Severe non-compliance to protocol|36|||
163848934|NCT01152554|591816899|FG001|Overall Study|Severe non-compliance to protocol|14|||
163848935|NCT01152554|591816898|FG000|Overall Study|Condition under investigation worsened|5|||
163848936|NCT01152554|591816899|FG001|Overall Study|Condition under investigation worsened|2|||
163848937|NCT01152554|591816898|FG000|Overall Study|Lack of Efficacy|20|||
163848938|NCT01152554|591816899|FG001|Overall Study|Lack of Efficacy|3|||
163848939|NCT01152554|591816898|FG000|Overall Study|Study-specific withdrawal criteria|17|||
163848940|NCT01152554|591816899|FG001|Overall Study|Study-specific withdrawal criteria|8|||
163848941|NCT01152554|591816898|FG000|Overall Study|Lost to Follow-up|87|||
163848942|NCT01152554|591816899|FG001|Overall Study|Lost to Follow-up|32|||
163848943|NCT01152554|591816898|FG000|Overall Study|Other|28|||
163848944|NCT01152554|591816899|FG001|Overall Study|Other|8|||
163848945|NCT01152554|591816898|FG000|Overall Study|Death|1|||
163848946|NCT01152554|591816899|FG001|Overall Study|Death|1|||
163848947|NCT00146640|591816902|FG000|Overall Study|Adverse Event|12|||
163848948|NCT00146640|591816903|FG001|Overall Study|Adverse Event|10|||
163848949|NCT00146640|591816902|FG000|Overall Study|Medical Reasons|3|||
163848950|NCT00146640|591816903|FG001|Overall Study|Medical Reasons|0|||
163848951|NCT00146640|591816902|FG000|Overall Study|Non-Medical Reasons|8|||
163848952|NCT00146640|591816903|FG001|Overall Study|Non-Medical Reasons|4|||
163848953|NCT03486899|591816904|FG000|Overall Study|Lost to Follow-up|4|||
163848954|NCT03486899|591816905|FG001|Overall Study|Lost to Follow-up|1|||
163848955|NCT03486899|591816906|FG002|Overall Study|Lost to Follow-up|4|||
163848956|NCT03486899|591816907|FG003|Overall Study|Lost to Follow-up|3|||
163848957|NCT03486899|591816904|FG000|Overall Study|Death|1|||
163848958|NCT03486899|591816905|FG001|Overall Study|Death|0|||
163848959|NCT03486899|591816906|FG002|Overall Study|Death|0|||
163848960|NCT03486899|591816907|FG003|Overall Study|Death|1|||
163848961|NCT03486899|591816904|FG000|Overall Study|Adverse Event|0|||
163848962|NCT03486899|591816905|FG001|Overall Study|Adverse Event|2|||
163848963|NCT03486899|591816906|FG002|Overall Study|Adverse Event|0|||
163848964|NCT03486899|591816907|FG003|Overall Study|Adverse Event|2|||
163848965|NCT03486899|591816904|FG000|Overall Study|Withdrawal by Subject|3|||
163848966|NCT03486899|591816905|FG001|Overall Study|Withdrawal by Subject|7|||
163848967|NCT03486899|591816906|FG002|Overall Study|Withdrawal by Subject|4|||
163848968|NCT03486899|591816907|FG003|Overall Study|Withdrawal by Subject|3|||
163848969|NCT03486899|591816904|FG000|Overall Study|Other Reasons|0|||
163848970|NCT03486899|591816905|FG001|Overall Study|Other Reasons|1|||
163848971|NCT03486899|591816906|FG002|Overall Study|Other Reasons|0|||
163848972|NCT03486899|591816907|FG003|Overall Study|Other Reasons|1|||
163848973|NCT01439711|591816908|FG000|Overall Study|Ineligible|13|||
163848974|NCT01439711|591816908|FG000|Overall Study|Cancel|3|||
163848975|NCT01439711|591816908|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
163848976|NCT01439711|591816908|FG000|Overall Study|Adverse Event|5|||
163848977|NCT01439711|591816908|FG000|Overall Study|Withdrawal by Subject|3|||
163848978|NCT01439711|591816908|FG000|Overall Study|Progression During Active Tx|3|||
163848979|NCT01439711|591816908|FG000|Overall Study|Noncompliance|3|||
163848980|NCT01439711|591816908|FG000|Overall Study|No MRI|9|||
163848981|NCT04242875|591816909|FG000|Overall Study|Adverse Event|2|||
163848982|NCT02397460|591816910|FG000|Treatment Period 2|Adverse Event|0|||
163848983|NCT02397460|591816911|FG001|Treatment Period 2|Adverse Event|0|||
163848984|NCT02397460|591816912|FG002|Treatment Period 2|Adverse Event|0|||
163848985|NCT02397460|591816913|FG003|Treatment Period 2|Adverse Event|0|||
163848986|NCT02397460|591816914|FG004|Treatment Period 2|Adverse Event|0|||
163848987|NCT02397460|591816915|FG005|Treatment Period 2|Adverse Event|0|||
163848988|NCT02397460|591816916|FG006|Treatment Period 2|Adverse Event|0|||
163848989|NCT02397460|591816917|FG007|Treatment Period 2|Adverse Event|1|||
163848990|NCT02397460|591816910|FG000|Treatment Period 4|Adverse Event|0|||
163848991|NCT02397460|591816911|FG001|Treatment Period 4|Adverse Event|1|||
163848992|NCT02397460|591816912|FG002|Treatment Period 4|Adverse Event|0|||
163848993|NCT02397460|591816913|FG003|Treatment Period 4|Adverse Event|0|||
163848994|NCT02397460|591816914|FG004|Treatment Period 4|Adverse Event|0|||
163848995|NCT02397460|591816915|FG005|Treatment Period 4|Adverse Event|0|||
163848996|NCT02397460|591816916|FG006|Treatment Period 4|Adverse Event|0|||
163848997|NCT02397460|591816917|FG007|Treatment Period 4|Adverse Event|0|||
163848998|NCT02397460|591816910|FG000|Treatment Period 4|Physician Decision|0|||
163848999|NCT02397460|591816911|FG001|Treatment Period 4|Physician Decision|0|||
163849000|NCT02397460|591816912|FG002|Treatment Period 4|Physician Decision|0|||
163849001|NCT02397460|591816913|FG003|Treatment Period 4|Physician Decision|0|||
163849002|NCT02397460|591816914|FG004|Treatment Period 4|Physician Decision|1|||
163849003|NCT02397460|591816915|FG005|Treatment Period 4|Physician Decision|0|||
163849004|NCT02397460|591816916|FG006|Treatment Period 4|Physician Decision|0|||
163849005|NCT02397460|591816917|FG007|Treatment Period 4|Physician Decision|0|||
163849006|NCT01723826|591816921|FG000|Overall Study|Adverse Event|4|||
163849007|NCT01723826|591816922|FG001|Overall Study|Adverse Event|1|||
163849008|NCT01723826|591816923|FG002|Overall Study|Adverse Event|4|||
163849009|NCT01723826|591816924|FG003|Overall Study|Adverse Event|5|||
163960185|NCT03816891|592225428|FG001|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
163960186|NCT03816891|592225429|FG002|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|4|||
163849010|NCT01723826|591816921|FG000|Overall Study|Death according to AE eCRF|2|||
163849011|NCT01723826|591816922|FG001|Overall Study|Death according to AE eCRF|3|||
163849012|NCT01723826|591816923|FG002|Overall Study|Death according to AE eCRF|3|||
163849013|NCT01723826|591816924|FG003|Overall Study|Death according to AE eCRF|7|||
163960187|NCT03816891|592225430|FG003|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|3|||
163849014|NCT01723826|591816921|FG000|Overall Study|Lost to Follow-up|1|||
163849015|NCT01723826|591816922|FG001|Overall Study|Lost to Follow-up|3|||
163849016|NCT01723826|591816923|FG002|Overall Study|Lost to Follow-up|1|||
163849017|NCT01723826|591816924|FG003|Overall Study|Lost to Follow-up|1|||
163849018|NCT01723826|591816921|FG000|Overall Study|Non-compliance|0|||
163849019|NCT01723826|591816922|FG001|Overall Study|Non-compliance|1|||
163849020|NCT01723826|591816923|FG002|Overall Study|Non-compliance|3|||
163849021|NCT01723826|591816924|FG003|Overall Study|Non-compliance|3|||
163849022|NCT01723826|591816921|FG000|Overall Study|Non-compliance With Study Drug|0|||
163849023|NCT01723826|591816922|FG001|Overall Study|Non-compliance With Study Drug|1|||
163849024|NCT01723826|591816923|FG002|Overall Study|Non-compliance With Study Drug|0|||
163849025|NCT01723826|591816924|FG003|Overall Study|Non-compliance With Study Drug|0|||
163849026|NCT01723826|591816921|FG000|Overall Study|Other Reason|8|||
163849027|NCT01723826|591816922|FG001|Overall Study|Other Reason|6|||
163849028|NCT01723826|591816923|FG002|Overall Study|Other Reason|12|||
163849029|NCT01723826|591816924|FG003|Overall Study|Other Reason|14|||
163849030|NCT01723826|591816921|FG000|Overall Study|Physician Decision|1|||
163849031|NCT01723826|591816922|FG001|Overall Study|Physician Decision|3|||
163849032|NCT01723826|591816923|FG002|Overall Study|Physician Decision|4|||
163849033|NCT01723826|591816924|FG003|Overall Study|Physician Decision|11|||
163849034|NCT01723826|591816921|FG000|Overall Study|Protocol Violation|1|||
163849035|NCT01723826|591816922|FG001|Overall Study|Protocol Violation|1|||
163849036|NCT01723826|591816923|FG002|Overall Study|Protocol Violation|3|||
163849037|NCT01723826|591816924|FG003|Overall Study|Protocol Violation|1|||
163849038|NCT01723826|591816921|FG000|Overall Study|Withdrawal by Subject|10|||
163849039|NCT01723826|591816922|FG001|Overall Study|Withdrawal by Subject|17|||
163849040|NCT01723826|591816923|FG002|Overall Study|Withdrawal by Subject|27|||
163849041|NCT01723826|591816924|FG003|Overall Study|Withdrawal by Subject|48|||
163849042|NCT01767129|591816925|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
163849043|NCT01767129|591816926|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
163849044|NCT01603121|591816930|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
163849045|NCT01603121|591816931|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
163849046|NCT00738530|591816932|FG000|Overall Study|Death|220|||
163849047|NCT00738530|591816933|FG001|Overall Study|Death|224|||
163849048|NCT00738530|591816932|FG000|Overall Study|Lost to Follow-up|8|||
163849049|NCT00738530|591816933|FG001|Overall Study|Lost to Follow-up|6|||
163849050|NCT00738530|591816932|FG000|Overall Study|Withdrawal by Subject|6|||
163849051|NCT00738530|591816933|FG001|Overall Study|Withdrawal by Subject|8|||
163849052|NCT01656759|591816934|FG000|Overall Study|Protocol Violation|2|||
163849053|NCT01656759|591816935|FG001|Overall Study|Protocol Violation|3|||
163849054|NCT01628510|591816936|FG000|Overall Study|Withdrawal by Subject|0|||
163849055|NCT01628510|591816937|FG001|Overall Study|Withdrawal by Subject|4|||
163849056|NCT01628510|591816936|FG000|Overall Study|Death|3|||
163849057|NCT01628510|591816937|FG001|Overall Study|Death|1|||
163849058|NCT04179461|591816938|FG000|Overall Study|Lost to Follow-up|4|||
163849059|NCT03160079|591816946|FG000|Overall Study|Adverse Event|2|||
163849060|NCT03160079|591816947|FG001|Overall Study|Adverse Event|0|||
163849061|NCT03160079|591816946|FG000|Overall Study|Disease Progression|1|||
163849062|NCT03160079|591816947|FG001|Overall Study|Disease Progression|0|||
163849063|NCT03160079|591816946|FG000|Overall Study|Physician Decision|1|||
163849064|NCT03160079|591816947|FG001|Overall Study|Physician Decision|0|||
163849065|NCT03259373|591816959|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
163849066|NCT03259373|591816960|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
163849067|NCT03259373|591816959|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
163849068|NCT03259373|591816960|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
163849069|NCT03259373|591816959|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
163849070|NCT03259373|591816960|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
163849071|NCT03259373|591816959|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
163849072|NCT03259373|591816960|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
163849073|NCT03259373|591816959|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
163849074|NCT03259373|591816960|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
163849075|NCT03259373|591816959|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
163849076|NCT03259373|591816960|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
163849077|NCT05764239|591816966|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
163849078|NCT05764239|591816966|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
163849079|NCT05764239|591816966|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
163849080|NCT05764239|591816966|FG000|DEP (Part 1)|Adverse Event|1|||
163849081|NCT05764239|591816966|FG000|DEP (Part 1)|Lost to Follow-up|1|||
163849082|NCT05764239|591816966|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
163849083|NCT05764239|591816966|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
163849084|NCT05764239|591816966|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
163849085|NCT05764239|591816966|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
163849086|NCT00057811|591816970|FG000|Overall Study|Lack of Efficacy|1|||
163849087|NCT00057811|591816971|FG001|Overall Study|Lack of Efficacy|4|||
163960188|NCT03816891|592225431|FG004|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|2|||
163849088|NCT00057811|591816970|FG000|Overall Study|Physician Decision|1|||
163849089|NCT00057811|591816971|FG001|Overall Study|Physician Decision|0|||
163849090|NCT00057811|591816970|FG000|Overall Study|Withdrawal by Subject|3|||
163849091|NCT00057811|591816971|FG001|Overall Study|Withdrawal by Subject|4|||
163849092|NCT00057811|591816970|FG000|Overall Study|Ineligible|4|||
163849093|NCT00057811|591816971|FG001|Overall Study|Ineligible|2|||
163849094|NCT00057811|591816970|FG000|Overall Study|Inevaluable|1|||
163849095|NCT00057811|591816971|FG001|Overall Study|Inevaluable|2|||
163849096|NCT00556374|591816972|FG000|Overall Study|Withdrawal by Subject|235|||
163849097|NCT00556374|591816973|FG001|Overall Study|Withdrawal by Subject|205|||
163849098|NCT00556374|591816972|FG000|Overall Study|Death|158|||
163849099|NCT00556374|591816973|FG001|Overall Study|Death|127|||
163849100|NCT00556374|591816972|FG000|Overall Study|Lost to Follow-up|24|||
163849101|NCT00556374|591816973|FG001|Overall Study|Lost to Follow-up|17|||
163849102|NCT00556374|591816972|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
163849103|NCT00556374|591816973|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
163849104|NCT04131907|591816974|FG000|Overall Study|Adverse Event|2|||
163849105|NCT04131907|591816975|FG001|Overall Study|Adverse Event|0|||
163849106|NCT04131907|591816976|FG002|Overall Study|Adverse Event|0|||
163849107|NCT04131907|591816974|FG000|Overall Study|Physician Decision|4|||
163849108|NCT04131907|591816975|FG001|Overall Study|Physician Decision|22|||
163849109|NCT04131907|591816976|FG002|Overall Study|Physician Decision|0|||
163849110|NCT04131907|591816974|FG000|Overall Study|Withdrawal by Subject|2|||
163849111|NCT04131907|591816975|FG001|Overall Study|Withdrawal by Subject|0|||
163849112|NCT04131907|591816976|FG002|Overall Study|Withdrawal by Subject|1|||
163849113|NCT04131907|591816974|FG000|Overall Study|Treatment failure|2|||
163849114|NCT04131907|591816975|FG001|Overall Study|Treatment failure|0|||
163849115|NCT04131907|591816976|FG002|Overall Study|Treatment failure|1|||
163849116|NCT00847301|591816977|FG000|Overall Study|Adverse Event|35|||
163849117|NCT00847301|591816977|FG000|Overall Study|Switch to other anticoagulants|16|||
163849118|NCT00847301|591816977|FG000|Overall Study|Lost to Follow-up|1|||
163849119|NCT00847301|591816977|FG000|Overall Study|No prescription after hospital discharge|1|||
163849120|NCT00847301|591816977|FG000|Overall Study|Other reason not defined above|1|||
163849121|NCT00641186|591816978|FG000|Overall Study|Adverse Event|3|||
163849122|NCT01388543|591816983|FG000|Day 14|Adverse Event|1|||
163849123|NCT01388543|591816984|FG001|Day 14|Adverse Event|4|||
163849124|NCT03363659|591816985|FG000|Overall Study|Adverse Event|1|||
163849125|NCT03363659|591816985|FG000|Overall Study|Screen fail|1|||
163849126|NCT03363659|591816985|FG000|Overall Study|Withdrawal by Subject|1|||
163849127|NCT00904150|591816986|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
163849128|NCT00904150|591816987|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
163849129|NCT00904150|591816986|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
163849130|NCT00904150|591816987|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
163849131|NCT01671748|591816988|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
163849132|NCT01671748|591816989|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
163849133|NCT01671748|591816988|FG000|4 Week run-in Phase|Adverse Event|1|||
163960189|NCT03816891|592225432|FG005|Open-Label Period (Phase 2b Only)|Withdrawal by Subject|0|||
163960190|NCT03816891|592225427|FG000|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
163849134|NCT01671748|591816989|FG001|4 Week run-in Phase|Adverse Event|0|||
163849135|NCT01671748|591816988|FG000|4 Week run-in Phase|Not eligible|9|||
163849136|NCT01671748|591816989|FG001|4 Week run-in Phase|Not eligible|0|||
163849137|NCT03872388|591816990|FG000|Overall Study|Disease Progression|0|||
163849138|NCT03872388|591816991|FG001|Overall Study|Disease Progression|0|||
163849139|NCT03872388|591816992|FG002|Overall Study|Disease Progression|0|||
163849140|NCT03872388|591816993|FG003|Overall Study|Disease Progression|0|||
163849141|NCT03872388|591816994|FG004|Overall Study|Disease Progression|0|||
163849142|NCT03872388|591816995|FG005|Overall Study|Disease Progression|0|||
163849143|NCT03872388|591816996|FG006|Overall Study|Disease Progression|1|||
163849144|NCT03872388|591816997|FG007|Overall Study|Disease Progression|1|||
163849145|NCT00394095|591818579|FG000|Screening|Withdrawal by Subject|1|||
163849146|NCT00394095|591818580|FG001|Screening|Withdrawal by Subject|0|||
163849147|NCT00394095|591818579|FG000|Randomized|Withdrawal by Subject|5|||
163960191|NCT03816891|592225428|FG001|Open-Label Period (Phase 2b Only)|Adverse Event|0|||
163960192|NCT03816891|592225429|FG002|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163960193|NCT03816891|592225430|FG003|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163849148|NCT00394095|591818580|FG001|Randomized|Withdrawal by Subject|1|||
163849149|NCT00394095|591818579|FG000|Randomized|Adverse Event|1|||
163849150|NCT00394095|591818580|FG001|Randomized|Adverse Event|1|||
163849151|NCT00394095|591818579|FG000|Randomized|Overdose|1|||
163849152|NCT00394095|591818580|FG001|Randomized|Overdose|0|||
163849153|NCT00394095|591818579|FG000|Randomized|Lost to Follow-up|1|||
163849154|NCT00394095|591818580|FG001|Randomized|Lost to Follow-up|2|||
163849155|NCT04213846|591818581|FG000|Overall Study|Withdrawal by Subject|7|||
163849156|NCT04213846|591818582|FG001|Overall Study|Withdrawal by Subject|6|||
163849157|NCT04213846|591818581|FG000|Overall Study|Lost to Follow-up|15|||
163849158|NCT04213846|591818582|FG001|Overall Study|Lost to Follow-up|21|||
163849159|NCT01036087|591818589|FG000|Overall Study|Adverse Event|2|||
163849160|NCT01036087|591818589|FG000|Overall Study|Lack of Efficacy|1|||
163849161|NCT03527277|591818590|FG000|Overall Study|Withdrawal by Subject|5|||
163849162|NCT03527277|591818591|FG001|Overall Study|Withdrawal by Subject|0|||
163960194|NCT03816891|592225431|FG004|Open-Label Period (Phase 2b Only)|Adverse Event|2|||
163849163|NCT03527277|591818590|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
163849164|NCT03527277|591818591|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
163849165|NCT03527277|591818590|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
163849166|NCT03527277|591818591|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
163849167|NCT01781611|591818592|FG000|Overall Study|Adverse Event|4|||
163849168|NCT01781611|591818593|FG001|Overall Study|Adverse Event|0|||
163849169|NCT01333943|591818597|FG000|Overall Study|Known neuropathy|1|||
163849170|NCT01333943|591818598|FG001|Overall Study|Known neuropathy|0|||
163849171|NCT02459587|591818605|FG000|3-Month Follow-up Assessment|Death|0|||
163960195|NCT03816891|592225432|FG005|Open-Label Period (Phase 2b Only)|Adverse Event|1|||
163960196|NCT03816891|592225427|FG000|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163960197|NCT03816891|592225428|FG001|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163960198|NCT03816891|592225429|FG002|Open-Label Period (Phase 2b Only)|Lack of Efficacy|1|||
163960199|NCT03816891|592225430|FG003|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163960200|NCT03816891|592225431|FG004|Open-Label Period (Phase 2b Only)|Lack of Efficacy|3|||
163960201|NCT03816891|592225432|FG005|Open-Label Period (Phase 2b Only)|Lack of Efficacy|0|||
163960202|NCT03816891|592225427|FG000|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163960203|NCT03816891|592225428|FG001|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163960204|NCT03816891|592225429|FG002|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163960205|NCT03816891|592225430|FG003|Open-Label Period (Phase 2b Only)|Lost to Follow-up|0|||
163960206|NCT03816891|592225431|FG004|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
163960207|NCT03816891|592225432|FG005|Open-Label Period (Phase 2b Only)|Lost to Follow-up|1|||
163960208|NCT03816891|592225427|FG000|Open-Label Period (Phase 2b Only)|Other|0|||
163960209|NCT03816891|592225428|FG001|Open-Label Period (Phase 2b Only)|Other|0|||
163960210|NCT03816891|592225429|FG002|Open-Label Period (Phase 2b Only)|Other|0|||
163960211|NCT03816891|592225430|FG003|Open-Label Period (Phase 2b Only)|Other|0|||
163960212|NCT03816891|592225431|FG004|Open-Label Period (Phase 2b Only)|Other|0|||
163960213|NCT03816891|592225432|FG005|Open-Label Period (Phase 2b Only)|Other|1|||
163960214|NCT05666505|592225433|FG000|Overall Study|Withdrawn due to caregiver consent obtained from non-legal guardian|1|||
163960215|NCT04751656|592226792|FG000|Overall Study|Lost to Follow-up|1|||
163960216|NCT01485354|592226798|FG000|Overall Study|Withdrawal by Subject|5|||
163960217|NCT03566810|592226799|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
163960218|NCT03566810|592226800|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
163960219|NCT03566810|592226801|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
163960220|NCT03566810|592226802|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
163960221|NCT01444651|592226805|FG000|Overall Study|Adverse Event|3|||
163960222|NCT01444651|592226806|FG001|Overall Study|Adverse Event|2|||
163960223|NCT01444651|592226805|FG000|Overall Study|Lost to Follow-up|5|||
163960224|NCT01444651|592226806|FG001|Overall Study|Lost to Follow-up|5|||
163960225|NCT01444651|592226805|FG000|Overall Study|Non-fasting|2|||
163960226|NCT01444651|592226806|FG001|Overall Study|Non-fasting|1|||
163960227|NCT01444651|592226805|FG000|Overall Study|Missing data|1|||
163960228|NCT01444651|592226806|FG001|Overall Study|Missing data|1|||
163960229|NCT03338192|592226807|FG000|Year One to Year Two|High Blood Pressure|7|||
163960230|NCT03338192|592226808|FG001|Year One to Year Two|High Blood Pressure|1|||
163960231|NCT03338192|592226807|FG000|Year One to Year Two|HIV +|1|||
163960232|NCT03338192|592226808|FG001|Year One to Year Two|HIV +|0|||
163960233|NCT03338192|592226807|FG000|Year Two to Year Four|High Blood Pressure|1|||
163960234|NCT03338192|592226808|FG001|Year Two to Year Four|High Blood Pressure|0|||
163960235|NCT03338192|592226807|FG000|Year Two to Year Four|HIV +|2|||
163960236|NCT03338192|592226808|FG001|Year Two to Year Four|HIV +|0|||
163960237|NCT03338192|592226807|FG000|Year Four to Year Six|High Blood Pressure|2|||
163960238|NCT03338192|592226808|FG001|Year Four to Year Six|High Blood Pressure|1|||
163960239|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
163960240|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
163960241|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
163960242|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
163960243|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
163960244|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
163960245|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
163960246|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
163960247|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
163960248|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
163960249|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
163849172|NCT02459587|591818606|FG001|3-Month Follow-up Assessment|Death|2|||
163960250|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
163960251|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Death|3|||
163849173|NCT02459587|591818605|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
163849174|NCT02459587|591818606|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
163960252|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Death|1|||
164006471|NCT02158533|592390964|FG002|Stage 2|Physician Decision|0|||
163849175|NCT02459587|591818605|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
163849176|NCT02459587|591818606|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
163849177|NCT02459587|591818605|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
163849178|NCT02459587|591818606|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
163849179|NCT02459587|591818605|FG000|6-month Follow-up Assessment|Death|2|||
163849180|NCT02459587|591818606|FG001|6-month Follow-up Assessment|Death|1|||
163849181|NCT02459587|591818605|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
163849182|NCT02459587|591818606|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
163849183|NCT02459587|591818605|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
163849184|NCT02459587|591818606|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
163849185|NCT02459587|591818605|FG000|12-month Follow-up Assessment|Death|2|||
163849186|NCT02459587|591818606|FG001|12-month Follow-up Assessment|Death|0|||
163849187|NCT02459587|591818605|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
163849188|NCT02459587|591818606|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
163849189|NCT02459587|591818605|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
163849190|NCT02459587|591818606|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
163849191|NCT02459587|591818605|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
163849192|NCT02459587|591818606|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
163849193|NCT02652130|591818609|FG000|Overall Study|Death|1|||
163849194|NCT02028884|591818610|FG000|Double-blind Period|Adverse Event|5|||
163849195|NCT02028884|591818611|FG001|Double-blind Period|Adverse Event|3|||
163849196|NCT02028884|591818612|FG002|Double-blind Period|Adverse Event|0|||
163849197|NCT02028884|591818610|FG000|Double-blind Period|Eligibility Violation|1|||
163849198|NCT02028884|591818611|FG001|Double-blind Period|Eligibility Violation|0|||
163849199|NCT02028884|591818612|FG002|Double-blind Period|Eligibility Violation|0|||
163849200|NCT02028884|591818610|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
163849201|NCT02028884|591818611|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
163849202|NCT02028884|591818612|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
163849203|NCT02028884|591818610|FG000|Double-blind Period|Withdrawal by Subject|2|||
163849204|NCT02028884|591818611|FG001|Double-blind Period|Withdrawal by Subject|0|||
163849205|NCT02028884|591818612|FG002|Double-blind Period|Withdrawal by Subject|0|||
163849206|NCT02028884|591818610|FG000|Open-label Extension Period|Adverse Event|3|||
163849207|NCT02028884|591818611|FG001|Open-label Extension Period|Adverse Event|1|||
163849208|NCT02028884|591818612|FG002|Open-label Extension Period|Adverse Event|0|||
163849209|NCT02028884|591818610|FG000|Open-label Extension Period|Lack of Efficacy|3|||
163849210|NCT02028884|591818611|FG001|Open-label Extension Period|Lack of Efficacy|0|||
163849211|NCT02028884|591818612|FG002|Open-label Extension Period|Lack of Efficacy|0|||
163849212|NCT02028884|591818610|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
163849213|NCT02028884|591818611|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
163849214|NCT02028884|591818612|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
163849215|NCT02028884|591818610|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163849216|NCT02028884|591818611|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
163849217|NCT02028884|591818612|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
163849218|NCT02028884|591818610|FG000|Open-label Extension Period|Switched to another treatment option|3|||
163849219|NCT02028884|591818611|FG001|Open-label Extension Period|Switched to another treatment option|0|||
163849220|NCT02028884|591818612|FG002|Open-label Extension Period|Switched to another treatment option|0|||
163849221|NCT00354029|591818613|FG000|Overall Study|Protocol Violation|4|||
163849222|NCT00354029|591818614|FG001|Overall Study|Protocol Violation|2|||
163849223|NCT04466618|591818623|FG000|Overall Study|Withdrawal by Subject|0|||
163849224|NCT04466618|591818624|FG001|Overall Study|Withdrawal by Subject|1|||
163849225|NCT02800928|591818625|FG000|Overall Study|Withdrawal by Subject|1|||
163849226|NCT02800928|591818626|FG001|Overall Study|Withdrawal by Subject|1|||
163849227|NCT02800928|591818625|FG000|Overall Study|Protocol Violation|1|||
163849228|NCT02800928|591818626|FG001|Overall Study|Protocol Violation|1|||
163849229|NCT02886728|591818634|FG000|Overall Study|Withdrew Consent|31|||
163849230|NCT02886728|591818635|FG001|Overall Study|Withdrew Consent|13|||
163849231|NCT02886728|591818636|FG002|Overall Study|Withdrew Consent|11|||
163849232|NCT02886728|591818637|FG003|Overall Study|Withdrew Consent|47|||
163849233|NCT02886728|591818634|FG000|Overall Study|Lost to Follow-up|12|||
163849234|NCT02886728|591818635|FG001|Overall Study|Lost to Follow-up|6|||
163849235|NCT02886728|591818636|FG002|Overall Study|Lost to Follow-up|13|||
163849236|NCT02886728|591818637|FG003|Overall Study|Lost to Follow-up|12|||
163849237|NCT02886728|591818634|FG000|Overall Study|Adverse Event|13|||
163849238|NCT02886728|591818635|FG001|Overall Study|Adverse Event|5|||
163849239|NCT02886728|591818636|FG002|Overall Study|Adverse Event|5|||
163849240|NCT02886728|591818637|FG003|Overall Study|Adverse Event|11|||
163849241|NCT02886728|591818634|FG000|Overall Study|Investigator's Discretion|11|||
163849242|NCT02886728|591818635|FG001|Overall Study|Investigator's Discretion|7|||
163849243|NCT02886728|591818636|FG002|Overall Study|Investigator's Discretion|5|||
163849244|NCT02886728|591818637|FG003|Overall Study|Investigator's Discretion|11|||
163849245|NCT02886728|591818634|FG000|Overall Study|Death|3|||
163849246|NCT02886728|591818635|FG001|Overall Study|Death|1|||
163849247|NCT02886728|591818636|FG002|Overall Study|Death|0|||
163849248|NCT02886728|591818637|FG003|Overall Study|Death|0|||
163849249|NCT02886728|591818634|FG000|Overall Study|Protocol Violation|0|||
163849250|NCT02886728|591818635|FG001|Overall Study|Protocol Violation|0|||
163849251|NCT02886728|591818636|FG002|Overall Study|Protocol Violation|0|||
163849252|NCT02886728|591818637|FG003|Overall Study|Protocol Violation|4|||
163849253|NCT02886728|591818634|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163849254|NCT02886728|591818635|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163849255|NCT02886728|591818636|FG002|Overall Study|Non-Compliance with Study Drug|1|||
163849256|NCT02886728|591818637|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163849257|NCT02886728|591818634|FG000|Overall Study|Pregnancy|0|||
163849258|NCT02886728|591818635|FG001|Overall Study|Pregnancy|0|||
163849259|NCT02886728|591818636|FG002|Overall Study|Pregnancy|1|||
163849260|NCT02886728|591818637|FG003|Overall Study|Pregnancy|0|||
163849261|NCT02886728|591818634|FG000|Overall Study|Randomized but Not Dosed|1|||
163849262|NCT02886728|591818635|FG001|Overall Study|Randomized but Not Dosed|0|||
163849263|NCT02886728|591818636|FG002|Overall Study|Randomized but Not Dosed|0|||
163849264|NCT02886728|591818637|FG003|Overall Study|Randomized but Not Dosed|2|||
163849265|NCT00109928|591818638|FG000|Overall Study|Adverse Event|2|||
163849266|NCT00109928|591818638|FG000|Overall Study|Progression|6|||
163849267|NCT00109928|591818638|FG000|Overall Study|Death|2|||
163849268|NCT00109928|591818638|FG000|Overall Study|not protocol specified|2|||
163849269|NCT00109928|591818638|FG000|Overall Study|not eligible|1|||
163849270|NCT01364727|591818642|FG000|Overall Study|Not Eligible|2|||
163849271|NCT01676220|591818643|FG000|Overall Study|Randomized But Not Treated|4|||
163849272|NCT01676220|591818644|FG001|Overall Study|Randomized But Not Treated|1|||
163849273|NCT01676220|591818643|FG000|Overall Study|Adverse Event|10|||
163849274|NCT01676220|591818644|FG001|Overall Study|Adverse Event|8|||
163849275|NCT01676220|591818643|FG000|Overall Study|Lack of Efficacy|2|||
163849276|NCT01676220|591818644|FG001|Overall Study|Lack of Efficacy|5|||
163849277|NCT01676220|591818643|FG000|Overall Study|Protocol Violation|11|||
163849278|NCT01676220|591818644|FG001|Overall Study|Protocol Violation|12|||
163849279|NCT01676220|591818643|FG000|Overall Study|Received Rescue Therapy|14|||
163849280|NCT01676220|591818644|FG001|Overall Study|Received Rescue Therapy|22|||
163849281|NCT01676220|591818643|FG000|Overall Study|Personal Reason|34|||
163849282|NCT01676220|591818644|FG001|Overall Study|Personal Reason|45|||
163849283|NCT01676220|591818643|FG000|Overall Study|Lost to Follow-up|11|||
163849284|NCT01676220|591818644|FG001|Overall Study|Lost to Follow-up|18|||
163849285|NCT01676220|591818643|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
163849286|NCT01676220|591818644|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
163849287|NCT01676220|591818643|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
163849288|NCT01676220|591818644|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
163849289|NCT01676220|591818643|FG000|Overall Study|Perceived Lack of Efficacy|3|||
163849290|NCT01676220|591818644|FG001|Overall Study|Perceived Lack of Efficacy|1|||
163849291|NCT01676220|591818643|FG000|Overall Study|Non Serious Hypoglycemia|2|||
163849292|NCT01676220|591818644|FG001|Overall Study|Non Serious Hypoglycemia|0|||
163849293|NCT01676220|591818643|FG000|Overall Study|No More Need of Insulin|1|||
163849294|NCT01676220|591818644|FG001|Overall Study|No More Need of Insulin|0|||
163849295|NCT02411591|591818645|FG000|Overall Study|Adverse Event|0|||
163849296|NCT02411591|591818646|FG001|Overall Study|Adverse Event|4|||
163849297|NCT02411591|591818647|FG002|Overall Study|Adverse Event|2|||
163849298|NCT02411591|591818645|FG000|Overall Study|Withdrawal by Subject|0|||
163849299|NCT02411591|591818646|FG001|Overall Study|Withdrawal by Subject|3|||
163849300|NCT02411591|591818647|FG002|Overall Study|Withdrawal by Subject|0|||
163849301|NCT02411591|591818645|FG000|Overall Study|Physician Decision|0|||
163849302|NCT02411591|591818646|FG001|Overall Study|Physician Decision|3|||
163849303|NCT02411591|591818647|FG002|Overall Study|Physician Decision|1|||
163849304|NCT00750893|591818650|FG000|Overall Study|Adverse Event|5|||
163960253|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
163960254|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
163960255|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Adverse Event|7|||
163960256|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Adverse Event|8|||
163960257|NCT03236246|592226813|FG000|24-Week Dose Titration Period|Captured as Other|1|||
163960258|NCT03236246|592226814|FG001|24-Week Dose Titration Period|Captured as Other|2|||
163849305|NCT00750893|591818650|FG000|Overall Study|Withdrawal by Subject|10|||
163849306|NCT00750893|591818650|FG000|Overall Study|Lost to Follow-up|510|||
163849307|NCT00750893|591818650|FG000|Overall Study|Other|17|||
163849308|NCT00661258|591818658|FG000|Overall Study|Death|1|||
163849309|NCT00661258|591818659|FG001|Overall Study|Death|0|||
163849310|NCT00661258|591818658|FG000|Overall Study|caught by police and in detox center|2|||
163849311|NCT00661258|591818659|FG001|Overall Study|caught by police and in detox center|1|||
163849312|NCT01628874|591818660|FG000|Overall Study|Physician Decision|1|||
163849313|NCT01628874|591818661|FG001|Overall Study|Physician Decision|1|||
163849314|NCT01628874|591818660|FG000|Overall Study|Age >4 months|4|||
163849315|NCT01628874|591818661|FG001|Overall Study|Age >4 months|2|||
163849316|NCT01473420|591818662|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
163849317|NCT01473420|591818663|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
163849318|NCT01473420|591818662|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
163849319|NCT01473420|591818663|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
163849320|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
163849321|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
163849322|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
163849323|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
163849324|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
163849325|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
163849326|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
163849327|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
163849328|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
163849329|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
163849330|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
163849331|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
163849332|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
163849333|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
163849334|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
163849335|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
163849336|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
163849337|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
163849338|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
163849339|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
163849340|NCT01473420|591818662|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
163849341|NCT01473420|591818663|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
163849342|NCT02906202|591818670|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
163849343|NCT03990363|591818672|FG000|Overall Study|Withdrawal by Subject|10|||
163849344|NCT03990363|591818673|FG001|Overall Study|Withdrawal by Subject|9|||
163849345|NCT03990363|591818674|FG002|Overall Study|Withdrawal by Subject|18|||
163849346|NCT03990363|591818675|FG003|Overall Study|Withdrawal by Subject|11|||
163849347|NCT03990363|591818676|FG004|Overall Study|Withdrawal by Subject|9|||
163849348|NCT03990363|591818672|FG000|Overall Study|Physician Decision|1|||
163849349|NCT03990363|591818673|FG001|Overall Study|Physician Decision|0|||
163849350|NCT03990363|591818674|FG002|Overall Study|Physician Decision|0|||
163849351|NCT03990363|591818675|FG003|Overall Study|Physician Decision|0|||
163849352|NCT03990363|591818676|FG004|Overall Study|Physician Decision|0|||
163849353|NCT03990363|591818672|FG000|Overall Study|Adverse Event|1|||
163849354|NCT03990363|591818673|FG001|Overall Study|Adverse Event|3|||
163849355|NCT03990363|591818674|FG002|Overall Study|Adverse Event|2|||
163849356|NCT03990363|591818675|FG003|Overall Study|Adverse Event|2|||
163849357|NCT03990363|591818676|FG004|Overall Study|Adverse Event|0|||
163849358|NCT03990363|591818672|FG000|Overall Study|Death|14|||
163849359|NCT03990363|591818673|FG001|Overall Study|Death|8|||
163849360|NCT03990363|591818674|FG002|Overall Study|Death|14|||
163849361|NCT03990363|591818675|FG003|Overall Study|Death|10|||
163849362|NCT03990363|591818676|FG004|Overall Study|Death|11|||
163849363|NCT03990363|591818672|FG000|Overall Study|Failure to meet randomization criteria|0|||
163849364|NCT03990363|591818673|FG001|Overall Study|Failure to meet randomization criteria|1|||
163849365|NCT03990363|591818674|FG002|Overall Study|Failure to meet randomization criteria|1|||
163849366|NCT03990363|591818675|FG003|Overall Study|Failure to meet randomization criteria|0|||
163849367|NCT03990363|591818676|FG004|Overall Study|Failure to meet randomization criteria|0|||
163849368|NCT03990363|591818672|FG000|Overall Study|Lost to Follow-up|0|||
163849369|NCT03990363|591818673|FG001|Overall Study|Lost to Follow-up|0|||
163849370|NCT03990363|591818674|FG002|Overall Study|Lost to Follow-up|0|||
163849371|NCT03990363|591818675|FG003|Overall Study|Lost to Follow-up|1|||
163960259|NCT03236246|592226813|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
163849372|NCT03990363|591818676|FG004|Overall Study|Lost to Follow-up|2|||
163849373|NCT03990363|591818672|FG000|Overall Study|Non-compliance with study drug|2|||
163960260|NCT03236246|592226814|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
163960261|NCT03236246|592226813|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
163960262|NCT03236246|592226814|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
163960263|NCT03236246|592226813|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
163960264|NCT03236246|592226814|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
163960265|NCT03236246|592226813|FG000|24-Week Dose Maintenance Period|Death|0|||
163960266|NCT03236246|592226814|FG001|24-Week Dose Maintenance Period|Death|1|||
163960267|NCT03236246|592226813|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
163960268|NCT03236246|592226814|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
163849374|NCT03990363|591818673|FG001|Overall Study|Non-compliance with study drug|1|||
163849375|NCT03990363|591818674|FG002|Overall Study|Non-compliance with study drug|2|||
163849376|NCT03990363|591818675|FG003|Overall Study|Non-compliance with study drug|0|||
163849377|NCT03990363|591818676|FG004|Overall Study|Non-compliance with study drug|0|||
163849378|NCT03990363|591818672|FG000|Overall Study|Study terminated by sponsor|0|||
163849379|NCT03990363|591818673|FG001|Overall Study|Study terminated by sponsor|1|||
163849380|NCT03990363|591818674|FG002|Overall Study|Study terminated by sponsor|0|||
163960269|NCT02952001|592226815|FG000|Overall Study|Adverse Event|3|||
163960270|NCT02952001|592226816|FG001|Overall Study|Adverse Event|0|||
163960271|NCT02952001|592226815|FG000|Overall Study|Prohibited therapy|10|||
163960272|NCT02952001|592226816|FG001|Overall Study|Prohibited therapy|3|||
163960273|NCT02952001|592226815|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
163960274|NCT02952001|592226816|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
163960275|NCT01681628|592226819|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
163849381|NCT03990363|591818675|FG003|Overall Study|Study terminated by sponsor|0|||
163849382|NCT03990363|591818676|FG004|Overall Study|Study terminated by sponsor|0|||
163849383|NCT03990363|591818672|FG000|Overall Study|Site terminated by sponsor|2|||
163849384|NCT03990363|591818673|FG001|Overall Study|Site terminated by sponsor|1|||
163849385|NCT03990363|591818674|FG002|Overall Study|Site terminated by sponsor|2|||
163849386|NCT03990363|591818675|FG003|Overall Study|Site terminated by sponsor|0|||
163849387|NCT03990363|591818676|FG004|Overall Study|Site terminated by sponsor|2|||
163849388|NCT03990363|591818672|FG000|Overall Study|Not categorized|5|||
163849389|NCT03990363|591818673|FG001|Overall Study|Not categorized|5|||
163849390|NCT03990363|591818674|FG002|Overall Study|Not categorized|3|||
163849391|NCT03990363|591818675|FG003|Overall Study|Not categorized|2|||
163849392|NCT03990363|591818676|FG004|Overall Study|Not categorized|2|||
163849393|NCT01563978|591818682|FG000|Overall Study|Physician Decision|1|||
163849394|NCT01563978|591818683|FG001|Overall Study|Physician Decision|0|||
163849395|NCT01563978|591818682|FG000|Overall Study|Lost to Follow-up|1|||
163849396|NCT01563978|591818683|FG001|Overall Study|Lost to Follow-up|0|||
163849397|NCT01563978|591818682|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
163849398|NCT01563978|591818683|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
163849399|NCT01563978|591818682|FG000|Overall Study|Adverse Event|1|||
163849400|NCT01563978|591818683|FG001|Overall Study|Adverse Event|2|||
163849401|NCT04630756|591818684|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
163849402|NCT04630756|591818685|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
163849403|NCT04630756|591818686|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
163849404|NCT01824472|591818690|FG000|Overall Study|Lost to Follow-up|0|||
163849405|NCT01824472|591818691|FG001|Overall Study|Lost to Follow-up|0|||
163849406|NCT01824472|591818692|FG002|Overall Study|Lost to Follow-up|1|||
163849407|NCT01824472|591818690|FG000|Overall Study|Withdrawal by Subject|1|||
163849408|NCT01824472|591818691|FG001|Overall Study|Withdrawal by Subject|5|||
163849409|NCT01824472|591818692|FG002|Overall Study|Withdrawal by Subject|3|||
163849410|NCT01824472|591818690|FG000|Overall Study|Ineligible post randomization&screening|0|||
163849411|NCT01824472|591818691|FG001|Overall Study|Ineligible post randomization&screening|2|||
163849412|NCT01824472|591818692|FG002|Overall Study|Ineligible post randomization&screening|0|||
163849413|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
163849414|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
163849415|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
163849416|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
163849417|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
163849418|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
163849419|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
163849420|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
163849421|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
163849422|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
163849423|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
163849424|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
163849425|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
163849426|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
163849427|NCT01815736|591818693|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
163849428|NCT01815736|591818694|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
163849429|NCT01815736|591818693|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
163849430|NCT01815736|591818694|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
163849431|NCT01815736|591818693|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
163849432|NCT01815736|591818694|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
163849433|NCT01815736|591818693|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
163849434|NCT01815736|591818694|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
163849435|NCT01815736|591818693|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
163849436|NCT01815736|591818694|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
163849437|NCT01815736|591818693|FG000|Extension Treatment Phase- After Week 96|Death|1|||
163960276|NCT01681628|592226820|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
163960277|NCT01681628|592226819|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
163849438|NCT01815736|591818694|FG001|Extension Treatment Phase- After Week 96|Death|0|||
163849439|NCT03387514|591818697|FG000|Overall Study|Withdrawal by Subject|2|||
163960278|NCT01681628|592226820|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
163960279|NCT01681628|592226819|FG000|19 Months Follow-up|Death|1|||
163849440|NCT03387514|591818697|FG000|Overall Study|Physician Decision|1|||
163849441|NCT03387514|591818697|FG000|Overall Study|Lost to Follow-up|2|||
163849442|NCT03040687|591818698|FG000|Overall Study|Withdrawal by Subject|1|||
163849443|NCT03040687|591818699|FG001|Overall Study|Withdrawal by Subject|0|||
163849444|NCT03040687|591818700|FG002|Overall Study|Withdrawal by Subject|0|||
163849445|NCT02846558|591818701|FG000|Overall Study|Adverse Event|1|||
163849446|NCT02846558|591818702|FG001|Overall Study|Adverse Event|0|||
163849447|NCT02846558|591818703|FG002|Overall Study|Adverse Event|0|||
163849448|NCT02846558|591818704|FG003|Overall Study|Adverse Event|0|||
163849449|NCT02846558|591818701|FG000|Overall Study|Withdrawal by Subject|5|||
163849450|NCT02846558|591818702|FG001|Overall Study|Withdrawal by Subject|4|||
163849451|NCT02846558|591818703|FG002|Overall Study|Withdrawal by Subject|2|||
163849452|NCT02846558|591818704|FG003|Overall Study|Withdrawal by Subject|2|||
163849453|NCT02846558|591818701|FG000|Overall Study|Lost to Follow-up|2|||
163849454|NCT02846558|591818702|FG001|Overall Study|Lost to Follow-up|0|||
163849455|NCT02846558|591818703|FG002|Overall Study|Lost to Follow-up|0|||
163849456|NCT02846558|591818704|FG003|Overall Study|Lost to Follow-up|0|||
163849457|NCT01556243|591818708|FG000|Overall Study|Ineligible|34|||
163849458|NCT01556243|591818708|FG000|Overall Study|Converted to mastectomy|14|||
163849459|NCT01556243|591818708|FG000|Overall Study|Unable to achieve negative margins|2|||
163849460|NCT01556243|591818708|FG000|Overall Study|Withdrawal by Subject|16|||
163849461|NCT04684914|591818709|FG000|Overall Study|Withdrawal by Subject|1|||
163849462|NCT04684914|591818710|FG001|Overall Study|Withdrawal by Subject|0|||
163849463|NCT04684914|591818709|FG000|Overall Study|Discontinued before receiving study treatment|1|||
163849464|NCT04684914|591818710|FG001|Overall Study|Discontinued before receiving study treatment|2|||
163849465|NCT02353832|591818711|FG000|Overall Study|Ineligible after enrollment|1|||
163849466|NCT02353832|591818711|FG000|Overall Study|Lost to Follow-up|1|||
163849467|NCT04096365|591820395|FG000|Overall Study|Adverse Event|1|||
163849468|NCT02401529|591820398|FG000|Overall Study|Lost to Follow-up|2|||
163849469|NCT02401529|591820399|FG001|Overall Study|Lost to Follow-up|1|||
163849470|NCT02401529|591820398|FG000|Overall Study|Physician Decision|2|||
163849471|NCT02401529|591820399|FG001|Overall Study|Physician Decision|6|||
163849472|NCT02401529|591820398|FG000|Overall Study|Protocol Violation|5|||
163849473|NCT02401529|591820399|FG001|Overall Study|Protocol Violation|0|||
163849474|NCT01939158|591820402|FG000|Overall Study|Adverse Event|1|||
163849475|NCT01939158|591820403|FG001|Overall Study|Adverse Event|0|||
163849476|NCT01939158|591820404|FG002|Overall Study|Adverse Event|0|||
163849477|NCT01939158|591820405|FG003|Overall Study|Adverse Event|0|||
163849478|NCT01939158|591820402|FG000|Overall Study|Withdrawal by Subject|22|||
163960280|NCT01681628|592226820|FG001|19 Months Follow-up|Death|0|||
163960281|NCT01681628|592226819|FG000|19 Months Follow-up|Lost to Follow-up|61|||
163960282|NCT01681628|592226820|FG001|19 Months Follow-up|Lost to Follow-up|43|||
163960283|NCT01794520|592226821|FG000|Overall Study|Adverse events- related to progression|0|||
163960284|NCT01794520|592226822|FG001|Overall Study|Adverse events- related to progression|0|||
163960285|NCT01794520|592226823|FG002|Overall Study|Adverse events- related to progression|1|||
163849479|NCT01939158|591820403|FG001|Overall Study|Withdrawal by Subject|25|||
163849480|NCT01939158|591820404|FG002|Overall Study|Withdrawal by Subject|15|||
163849481|NCT01939158|591820405|FG003|Overall Study|Withdrawal by Subject|17|||
163849482|NCT01939158|591820402|FG000|Overall Study|Migrated/moved from study area|5|||
163849483|NCT01939158|591820403|FG001|Overall Study|Migrated/moved from study area|7|||
163849484|NCT01939158|591820404|FG002|Overall Study|Migrated/moved from study area|3|||
163849485|NCT01939158|591820405|FG003|Overall Study|Migrated/moved from study area|6|||
163849486|NCT01939158|591820402|FG000|Overall Study|Lost to Follow-up|18|||
163849487|NCT01939158|591820403|FG001|Overall Study|Lost to Follow-up|17|||
163849488|NCT01939158|591820404|FG002|Overall Study|Lost to Follow-up|17|||
163849489|NCT01939158|591820405|FG003|Overall Study|Lost to Follow-up|17|||
163849490|NCT01939158|591820402|FG000|Overall Study|Death|0|||
163849491|NCT01939158|591820403|FG001|Overall Study|Death|0|||
163849492|NCT01939158|591820404|FG002|Overall Study|Death|1|||
163849493|NCT01939158|591820405|FG003|Overall Study|Death|1|||
163849494|NCT01939158|591820402|FG000|Overall Study|No longer meets eligibility criteria|0|||
163849495|NCT01939158|591820403|FG001|Overall Study|No longer meets eligibility criteria|0|||
163849496|NCT01939158|591820404|FG002|Overall Study|No longer meets eligibility criteria|1|||
163849497|NCT01939158|591820405|FG003|Overall Study|No longer meets eligibility criteria|0|||
163849498|NCT01939158|591820402|FG000|Overall Study|Other|1|||
163849499|NCT01939158|591820403|FG001|Overall Study|Other|3|||
163849500|NCT01939158|591820404|FG002|Overall Study|Other|4|||
163849501|NCT01939158|591820405|FG003|Overall Study|Other|3|||
163849502|NCT05310084|591820406|FG000|Overall Study|Withdrawal by Subject|2|||
163849503|NCT05310084|591820407|FG001|Overall Study|Withdrawal by Subject|3|||
163849504|NCT05310084|591820406|FG000|Overall Study|Participant availability|0|||
163849505|NCT05310084|591820407|FG001|Overall Study|Participant availability|4|||
163849506|NCT05310084|591820406|FG000|Overall Study|Lost to Follow-up|1|||
163849507|NCT05310084|591820407|FG001|Overall Study|Lost to Follow-up|1|||
163849508|NCT05310084|591820406|FG000|Overall Study|Adverse Event|1|||
163960286|NCT01794520|592226824|FG003|Overall Study|Adverse events- related to progression|2|||
163960287|NCT01794520|592226825|FG004|Overall Study|Adverse events- related to progression|0|||
163960288|NCT01794520|592226826|FG005|Overall Study|Adverse events- related to progression|1|||
163849509|NCT05310084|591820407|FG001|Overall Study|Adverse Event|1|||
163849510|NCT05310084|591820406|FG000|Overall Study|Randomized but not vaccinated|4|||
163849511|NCT05310084|591820407|FG001|Overall Study|Randomized but not vaccinated|2|||
163849512|NCT02065245|591820409|FG000|Infusion 1|Lost to Follow-up|0|||
163849513|NCT02065245|591820410|FG001|Infusion 1|Lost to Follow-up|0|||
163849514|NCT02065245|591820411|FG002|Infusion 1|Lost to Follow-up|0|||
163849515|NCT02065245|591820412|FG003|Infusion 1|Lost to Follow-up|0|||
163849516|NCT02065245|591820413|FG004|Infusion 1|Lost to Follow-up|0|||
163849517|NCT02065245|591820414|FG005|Infusion 1|Lost to Follow-up|0|||
163849518|NCT02065245|591820415|FG006|Infusion 1|Lost to Follow-up|1|||
163849519|NCT02065245|591820409|FG000|Infusion 1|Death|0|||
163849520|NCT02065245|591820410|FG001|Infusion 1|Death|0|||
163849521|NCT02065245|591820411|FG002|Infusion 1|Death|1|||
163849522|NCT02065245|591820412|FG003|Infusion 1|Death|0|||
163849523|NCT02065245|591820413|FG004|Infusion 1|Death|1|||
163849524|NCT02065245|591820414|FG005|Infusion 1|Death|0|||
163849525|NCT02065245|591820415|FG006|Infusion 1|Death|0|||
163849526|NCT02065245|591820409|FG000|Infusion 2|Death|0|||
163849527|NCT02065245|591820410|FG001|Infusion 2|Death|0|||
163849528|NCT02065245|591820411|FG002|Infusion 2|Death|0|||
163849529|NCT02065245|591820412|FG003|Infusion 2|Death|0|||
163849530|NCT02065245|591820413|FG004|Infusion 2|Death|0|||
163849531|NCT02065245|591820414|FG005|Infusion 2|Death|0|||
163849532|NCT02065245|591820415|FG006|Infusion 2|Death|1|||
163849533|NCT02065245|591820409|FG000|Infusion 3|Lost to Follow-up|1|||
163849534|NCT02065245|591820410|FG001|Infusion 3|Lost to Follow-up|1|||
163849535|NCT02065245|591820411|FG002|Infusion 3|Lost to Follow-up|0|||
163849536|NCT02065245|591820412|FG003|Infusion 3|Lost to Follow-up|0|||
163849537|NCT02065245|591820413|FG004|Infusion 3|Lost to Follow-up|0|||
163849538|NCT02065245|591820414|FG005|Infusion 3|Lost to Follow-up|0|||
163849539|NCT02065245|591820415|FG006|Infusion 3|Lost to Follow-up|0|||
163849540|NCT00924664|591820416|FG000|Overall Study|Adverse Event|23|||
163849541|NCT00924664|591820417|FG001|Overall Study|Adverse Event|39|||
163849542|NCT00924664|591820416|FG000|Overall Study|Lack of Efficacy|10|||
163849543|NCT00924664|591820417|FG001|Overall Study|Lack of Efficacy|15|||
163849544|NCT00924664|591820416|FG000|Overall Study|Lost to Follow-up|10|||
163849545|NCT00924664|591820417|FG001|Overall Study|Lost to Follow-up|12|||
163849546|NCT00924664|591820416|FG000|Overall Study|Withdrawal by Subject|47|||
163849547|NCT00924664|591820417|FG001|Overall Study|Withdrawal by Subject|71|||
163849548|NCT00924664|591820416|FG000|Overall Study|Protocol Violation|2|||
163849549|NCT00924664|591820417|FG001|Overall Study|Protocol Violation|5|||
163849550|NCT00924664|591820416|FG000|Overall Study|Pregnancy|1|||
163849551|NCT00924664|591820417|FG001|Overall Study|Pregnancy|1|||
163849552|NCT00924664|591820416|FG000|Overall Study|Death|0|||
163849553|NCT00924664|591820417|FG001|Overall Study|Death|2|||
163960289|NCT01794520|592226827|FG006|Overall Study|Adverse events- related to progression|0|||
163960290|NCT01794520|592226821|FG000|Overall Study|Adverse event- not related to progression|1|||
163960291|NCT01794520|592226822|FG001|Overall Study|Adverse event- not related to progression|1|||
163960292|NCT01794520|592226823|FG002|Overall Study|Adverse event- not related to progression|0|||
163960293|NCT01794520|592226824|FG003|Overall Study|Adverse event- not related to progression|0|||
163960294|NCT01794520|592226825|FG004|Overall Study|Adverse event- not related to progression|2|||
163960295|NCT01794520|592226826|FG005|Overall Study|Adverse event- not related to progression|0|||
163960296|NCT01794520|592226827|FG006|Overall Study|Adverse event- not related to progression|0|||
163960297|NCT01794520|592226821|FG000|Overall Study|Progressive disease|5|||
163960298|NCT01794520|592226822|FG001|Overall Study|Progressive disease|6|||
163960299|NCT01794520|592226823|FG002|Overall Study|Progressive disease|2|||
163960300|NCT01794520|592226824|FG003|Overall Study|Progressive disease|5|||
163960301|NCT01794520|592226825|FG004|Overall Study|Progressive disease|27|||
163849554|NCT00924664|591820416|FG000|Overall Study|Study terminated by sponsor|199|||
163849555|NCT00924664|591820417|FG001|Overall Study|Study terminated by sponsor|330|||
163849556|NCT00924664|591820416|FG000|Overall Study|Other|29|||
163849557|NCT00924664|591820417|FG001|Overall Study|Other|52|||
163849558|NCT00924664|591820416|FG000|Overall Study|Randomized but not Treated|1|||
163849559|NCT00924664|591820417|FG001|Overall Study|Randomized but not Treated|0|||
163849560|NCT01598987|591820418|FG000|Baseline to Month 12|Administrative problems|2|||
163849561|NCT01598987|591820418|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
163849562|NCT01598987|591820418|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
163849563|NCT01598987|591820418|FG000|Baseline to 24 Month|Administrative problems|2|||
163849564|NCT01598987|591820418|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
163849565|NCT03531905|591820419|FG000|Overall Study|Withdrawal by Subject|3|||
163849566|NCT03531905|591820420|FG001|Overall Study|Withdrawal by Subject|3|||
163849567|NCT03531905|591820421|FG002|Overall Study|Withdrawal by Subject|2|||
163849568|NCT03531905|591820419|FG000|Overall Study|Lost to Follow-up|2|||
163849569|NCT03531905|591820420|FG001|Overall Study|Lost to Follow-up|2|||
163849570|NCT03531905|591820421|FG002|Overall Study|Lost to Follow-up|1|||
163849571|NCT03531905|591820419|FG000|Overall Study|Participant was out of town|1|||
163849572|NCT03531905|591820420|FG001|Overall Study|Participant was out of town|0|||
163960302|NCT01794520|592226826|FG005|Overall Study|Progressive disease|18|||
163960303|NCT01794520|592226827|FG006|Overall Study|Progressive disease|0|||
163849573|NCT03531905|591820421|FG002|Overall Study|Participant was out of town|0|||
163849574|NCT03531905|591820419|FG000|Overall Study|Could not speak with the participant|1|||
163849575|NCT03531905|591820420|FG001|Overall Study|Could not speak with the participant|0|||
163849576|NCT03531905|591820421|FG002|Overall Study|Could not speak with the participant|0|||
163849577|NCT01616563|591820424|FG000|Overall Study|Lost to Follow-up|40|||
163849578|NCT00072475|591820425|FG000|Overall Study|Adverse Event|44|||
163849579|NCT00072475|591820425|FG000|Overall Study|Death|3|||
163849580|NCT00072475|591820425|FG000|Overall Study|Withdrawal by Subject|46|||
163849581|NCT00072475|591820425|FG000|Overall Study|Patient/Investigator Decision|4|||
163849582|NCT03303105|591820428|FG000|Overall Study|Adverse Event|0|||
163849583|NCT03303105|591820429|FG001|Overall Study|Adverse Event|2|||
163849584|NCT03303105|591820428|FG000|Overall Study|Lack of Efficacy|1|||
163849585|NCT03303105|591820429|FG001|Overall Study|Lack of Efficacy|0|||
163849586|NCT03303105|591820428|FG000|Overall Study|Protocol Violation|1|||
163849587|NCT03303105|591820429|FG001|Overall Study|Protocol Violation|0|||
163849588|NCT03303105|591820428|FG000|Overall Study|Withdrawal by Subject|0|||
163849589|NCT03303105|591820429|FG001|Overall Study|Withdrawal by Subject|2|||
163849590|NCT01033643|591820433|FG000|Overall Study|Withdrew Consent|0|||
163849591|NCT01033643|591820434|FG001|Overall Study|Withdrew Consent|3|||
163849592|NCT01033643|591820435|FG002|Overall Study|Withdrew Consent|0|||
163849593|NCT01033643|591820436|FG003|Overall Study|Withdrew Consent|0|||
163849594|NCT01033643|591820437|FG004|Overall Study|Withdrew Consent|0|||
163849595|NCT01033643|591820438|FG005|Overall Study|Withdrew Consent|1|||
163960304|NCT01794520|592226821|FG000|Overall Study|Withdrew consent|0|||
163960305|NCT01794520|592226822|FG001|Overall Study|Withdrew consent|0|||
163849596|NCT00839917|591820440|FG000|Overall Study|Lost to Follow-up|1|||
163849597|NCT00839917|591820441|FG001|Overall Study|Lost to Follow-up|0|||
163849598|NCT00839917|591820440|FG000|Overall Study|Did not receive vaccine|0|||
163849599|NCT00839917|591820441|FG001|Overall Study|Did not receive vaccine|1|||
163849600|NCT02297503|591820442|FG000|Overall Study|Withdrawal by Subject|1|||
163849601|NCT02297503|591820443|FG001|Overall Study|Withdrawal by Subject|1|||
163849602|NCT02297503|591820442|FG000|Overall Study|Protocol Violation|1|||
163849603|NCT02297503|591820443|FG001|Overall Study|Protocol Violation|0|||
163849604|NCT02297503|591820442|FG000|Overall Study|Pregnancy|0|||
163849605|NCT02297503|591820443|FG001|Overall Study|Pregnancy|1|||
163849606|NCT02297503|591820442|FG000|Overall Study|Lost to Follow-up|0|||
163849607|NCT02297503|591820443|FG001|Overall Study|Lost to Follow-up|1|||
163849608|NCT02297503|591820442|FG000|Overall Study|Medical reason|0|||
163849609|NCT02297503|591820443|FG001|Overall Study|Medical reason|1|||
163849610|NCT00765362|591820444|FG000|Overall Study|Death|9|||
163849611|NCT00765362|591820444|FG000|Overall Study|Adverse Event|2|||
163849612|NCT00765362|591820444|FG000|Overall Study|Protocol Violation|18|||
163849613|NCT00765362|591820444|FG000|Overall Study|Withdrawal by Subject|13|||
163849614|NCT00765362|591820444|FG000|Overall Study|Lost to Follow-up|95|||
163849615|NCT00519779|591820447|FG000|Overall Study|Withdrawal by Subject|0|||
163849616|NCT00519779|591820448|FG001|Overall Study|Withdrawal by Subject|1|||
163849617|NCT02724020|591820463|FG000|Overall Study|Death|16|||
163849618|NCT02724020|591820464|FG001|Overall Study|Death|18|||
163849619|NCT02724020|591820465|FG002|Overall Study|Death|19|||
163849620|NCT02724020|591820463|FG000|Overall Study|Lost to Follow-up|0|||
163849621|NCT02724020|591820464|FG001|Overall Study|Lost to Follow-up|3|||
163849622|NCT02724020|591820465|FG002|Overall Study|Lost to Follow-up|0|||
163849623|NCT02724020|591820463|FG000|Overall Study|Site Terminated by Sponsor|15|||
163849624|NCT02724020|591820464|FG001|Overall Study|Site Terminated by Sponsor|8|||
163849625|NCT02724020|591820465|FG002|Overall Study|Site Terminated by Sponsor|8|||
163849626|NCT02724020|591820463|FG000|Overall Study|Withdrawal by Subject|1|||
163849627|NCT02724020|591820464|FG001|Overall Study|Withdrawal by Subject|3|||
163849628|NCT02724020|591820465|FG002|Overall Study|Withdrawal by Subject|5|||
163849629|NCT02179918|591820466|FG000|Overall Study|Death|0|||
163849630|NCT02179918|591820467|FG001|Overall Study|Death|0|||
163849631|NCT02179918|591820468|FG002|Overall Study|Death|0|||
163849632|NCT02179918|591820469|FG003|Overall Study|Death|1|||
163849633|NCT02179918|591820470|FG004|Overall Study|Death|0|||
163849634|NCT02179918|591820466|FG000|Overall Study|Lost to Follow-up|0|||
163849635|NCT02179918|591820467|FG001|Overall Study|Lost to Follow-up|0|||
163849636|NCT02179918|591820468|FG002|Overall Study|Lost to Follow-up|1|||
163849637|NCT02179918|591820469|FG003|Overall Study|Lost to Follow-up|0|||
163849638|NCT02179918|591820470|FG004|Overall Study|Lost to Follow-up|0|||
163849639|NCT02179918|591820466|FG000|Overall Study|Progressive Disease|4|||
163849640|NCT02179918|591820467|FG001|Overall Study|Progressive Disease|1|||
163849641|NCT02179918|591820468|FG002|Overall Study|Progressive Disease|1|||
163849642|NCT02179918|591820469|FG003|Overall Study|Progressive Disease|2|||
163849643|NCT02179918|591820470|FG004|Overall Study|Progressive Disease|6|||
163849644|NCT02179918|591820466|FG000|Overall Study|Other|0|||
163849645|NCT02179918|591820467|FG001|Overall Study|Other|1|||
163849646|NCT02179918|591820468|FG002|Overall Study|Other|0|||
163849647|NCT02179918|591820469|FG003|Overall Study|Other|0|||
163849648|NCT02179918|591820470|FG004|Overall Study|Other|1|||
163849649|NCT02179918|591820466|FG000|Overall Study|Subject refused further follow-up|0|||
163849650|NCT02179918|591820467|FG001|Overall Study|Subject refused further follow-up|1|||
163960306|NCT01794520|592226823|FG002|Overall Study|Withdrew consent|1|||
163960307|NCT01794520|592226824|FG003|Overall Study|Withdrew consent|1|||
163960308|NCT01794520|592226825|FG004|Overall Study|Withdrew consent|0|||
163960309|NCT01794520|592226826|FG005|Overall Study|Withdrew consent|0|||
163960310|NCT01794520|592226827|FG006|Overall Study|Withdrew consent|0|||
163960311|NCT01794520|592226821|FG000|Overall Study|Lost to Follow-up|0|||
163960312|NCT01794520|592226822|FG001|Overall Study|Lost to Follow-up|0|||
163960313|NCT01794520|592226823|FG002|Overall Study|Lost to Follow-up|0|||
163960314|NCT01794520|592226824|FG003|Overall Study|Lost to Follow-up|0|||
163960315|NCT01794520|592226825|FG004|Overall Study|Lost to Follow-up|1|||
163960316|NCT01794520|592226826|FG005|Overall Study|Lost to Follow-up|0|||
163960317|NCT01794520|592226827|FG006|Overall Study|Lost to Follow-up|0|||
163960318|NCT01794520|592226821|FG000|Overall Study|Toxicity|0|||
163960319|NCT01794520|592226822|FG001|Overall Study|Toxicity|2|||
163960320|NCT01794520|592226823|FG002|Overall Study|Toxicity|0|||
163960321|NCT01794520|592226824|FG003|Overall Study|Toxicity|0|||
163960322|NCT01794520|592226825|FG004|Overall Study|Toxicity|0|||
163960323|NCT01794520|592226826|FG005|Overall Study|Toxicity|0|||
163960324|NCT01794520|592226827|FG006|Overall Study|Toxicity|0|||
163960325|NCT01794520|592226821|FG000|Overall Study|Study terminated by sponsor|0|||
163960326|NCT01794520|592226822|FG001|Overall Study|Study terminated by sponsor|0|||
163960327|NCT01794520|592226823|FG002|Overall Study|Study terminated by sponsor|1|||
163960328|NCT01794520|592226824|FG003|Overall Study|Study terminated by sponsor|0|||
163960329|NCT01794520|592226825|FG004|Overall Study|Study terminated by sponsor|1|||
163960330|NCT01794520|592226826|FG005|Overall Study|Study terminated by sponsor|0|||
163960331|NCT01794520|592226827|FG006|Overall Study|Study terminated by sponsor|7|||
163960332|NCT01794520|592226821|FG000|Overall Study|Death|0|||
163960333|NCT01794520|592226822|FG001|Overall Study|Death|0|||
163960334|NCT01794520|592226823|FG002|Overall Study|Death|0|||
163960335|NCT01794520|592226824|FG003|Overall Study|Death|0|||
163960336|NCT01794520|592226825|FG004|Overall Study|Death|1|||
163960337|NCT01794520|592226826|FG005|Overall Study|Death|0|||
163960338|NCT01794520|592226827|FG006|Overall Study|Death|22|||
163960339|NCT01794520|592226821|FG000|Overall Study|Other, not specified|0|||
163960340|NCT01794520|592226822|FG001|Overall Study|Other, not specified|0|||
163960341|NCT01794520|592226823|FG002|Overall Study|Other, not specified|1|||
163960342|NCT01794520|592226824|FG003|Overall Study|Other, not specified|1|||
163960343|NCT01794520|592226825|FG004|Overall Study|Other, not specified|4|||
163960344|NCT01794520|592226826|FG005|Overall Study|Other, not specified|1|||
163960345|NCT01794520|592226827|FG006|Overall Study|Other, not specified|2|||
163960346|NCT04796896|592226828|FG000|Overall Study|Adverse Event|1|||
163960347|NCT04796896|592226829|FG001|Overall Study|Adverse Event|0|||
163960348|NCT04796896|592226830|FG002|Overall Study|Adverse Event|0|||
163960349|NCT04796896|592226831|FG003|Overall Study|Adverse Event|0|||
163960350|NCT04796896|592226832|FG004|Overall Study|Adverse Event|0|||
163960351|NCT04796896|592226833|FG005|Overall Study|Adverse Event|1|||
163960352|NCT04796896|592226834|FG006|Overall Study|Adverse Event|1|||
163960353|NCT04796896|592226835|FG007|Overall Study|Adverse Event|0|||
163960354|NCT04796896|592226836|FG008|Overall Study|Adverse Event|1|||
163960355|NCT04796896|592226837|FG009|Overall Study|Adverse Event|1|||
163960356|NCT04796896|592226838|FG010|Overall Study|Adverse Event|1|||
163960357|NCT04796896|592226839|FG011|Overall Study|Adverse Event|0|||
163960358|NCT04796896|592226828|FG000|Overall Study|Lost to Follow-up|24|||
163960359|NCT04796896|592226829|FG001|Overall Study|Lost to Follow-up|15|||
163960360|NCT04796896|592226830|FG002|Overall Study|Lost to Follow-up|6|||
163960361|NCT04796896|592226831|FG003|Overall Study|Lost to Follow-up|4|||
163960362|NCT04796896|592226832|FG004|Overall Study|Lost to Follow-up|21|||
163960363|NCT04796896|592226833|FG005|Overall Study|Lost to Follow-up|55|||
163960364|NCT04796896|592226834|FG006|Overall Study|Lost to Follow-up|237|||
163960365|NCT04796896|592226835|FG007|Overall Study|Lost to Follow-up|52|||
163960366|NCT04796896|592226836|FG008|Overall Study|Lost to Follow-up|221|||
163960367|NCT04796896|592226837|FG009|Overall Study|Lost to Follow-up|43|||
163960368|NCT04796896|592226838|FG010|Overall Study|Lost to Follow-up|142|||
163960369|NCT04796896|592226839|FG011|Overall Study|Lost to Follow-up|18|||
163960370|NCT04796896|592226828|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
163960371|NCT04796896|592226829|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
163960372|NCT04796896|592226830|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
163960373|NCT04796896|592226831|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
163960374|NCT04796896|592226832|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
163960375|NCT04796896|592226833|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
163960376|NCT04796896|592226834|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
163960377|NCT04796896|592226835|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
163960378|NCT04796896|592226836|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
163960379|NCT04796896|592226837|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
163960380|NCT04796896|592226838|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
163960381|NCT04796896|592226839|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
163960382|NCT04796896|592226828|FG000|Overall Study|Physician Decision|1|||
163960383|NCT04796896|592226829|FG001|Overall Study|Physician Decision|0|||
163960384|NCT04796896|592226830|FG002|Overall Study|Physician Decision|0|||
163960385|NCT04796896|592226831|FG003|Overall Study|Physician Decision|0|||
163960386|NCT04796896|592226832|FG004|Overall Study|Physician Decision|0|||
163960387|NCT04796896|592226833|FG005|Overall Study|Physician Decision|3|||
163960388|NCT04796896|592226834|FG006|Overall Study|Physician Decision|18|||
163960389|NCT04796896|592226835|FG007|Overall Study|Physician Decision|1|||
163960390|NCT04796896|592226836|FG008|Overall Study|Physician Decision|7|||
163960391|NCT04796896|592226837|FG009|Overall Study|Physician Decision|0|||
163960392|NCT04796896|592226838|FG010|Overall Study|Physician Decision|5|||
163960393|NCT04796896|592226839|FG011|Overall Study|Physician Decision|0|||
163960394|NCT04796896|592226828|FG000|Overall Study|Withdrawal by Subject|36|||
163960395|NCT04796896|592226829|FG001|Overall Study|Withdrawal by Subject|31|||
163960396|NCT04796896|592226830|FG002|Overall Study|Withdrawal by Subject|11|||
163960397|NCT04796896|592226831|FG003|Overall Study|Withdrawal by Subject|8|||
163960398|NCT04796896|592226832|FG004|Overall Study|Withdrawal by Subject|16|||
163960399|NCT04796896|592226833|FG005|Overall Study|Withdrawal by Subject|162|||
163960400|NCT04796896|592226834|FG006|Overall Study|Withdrawal by Subject|299|||
163960401|NCT04796896|592226835|FG007|Overall Study|Withdrawal by Subject|149|||
163960402|NCT04796896|592226836|FG008|Overall Study|Withdrawal by Subject|303|||
163960403|NCT04796896|592226837|FG009|Overall Study|Withdrawal by Subject|94|||
163960404|NCT04796896|592226838|FG010|Overall Study|Withdrawal by Subject|192|||
163960405|NCT04796896|592226839|FG011|Overall Study|Withdrawal by Subject|16|||
163960406|NCT04796896|592226828|FG000|Overall Study|Other Than Specified|6|||
163960407|NCT04796896|592226829|FG001|Overall Study|Other Than Specified|5|||
163960408|NCT04796896|592226830|FG002|Overall Study|Other Than Specified|3|||
163960409|NCT04796896|592226831|FG003|Overall Study|Other Than Specified|2|||
163960410|NCT04796896|592226832|FG004|Overall Study|Other Than Specified|6|||
163960411|NCT04796896|592226833|FG005|Overall Study|Other Than Specified|31|||
163960412|NCT04796896|592226834|FG006|Overall Study|Other Than Specified|86|||
163960413|NCT04796896|592226835|FG007|Overall Study|Other Than Specified|66|||
163960414|NCT04796896|592226836|FG008|Overall Study|Other Than Specified|388|||
163960415|NCT04796896|592226837|FG009|Overall Study|Other Than Specified|48|||
163960416|NCT04796896|592226838|FG010|Overall Study|Other Than Specified|258|||
163960417|NCT04796896|592226839|FG011|Overall Study|Other Than Specified|4|||
163960418|NCT04796896|592226828|FG000|Overall Study|Protocol Deviation|0|||
163960419|NCT04796896|592226829|FG001|Overall Study|Protocol Deviation|0|||
163960420|NCT04796896|592226830|FG002|Overall Study|Protocol Deviation|0|||
163960421|NCT04796896|592226831|FG003|Overall Study|Protocol Deviation|1|||
163960422|NCT04796896|592226832|FG004|Overall Study|Protocol Deviation|1|||
163960423|NCT04796896|592226833|FG005|Overall Study|Protocol Deviation|2|||
163960424|NCT04796896|592226834|FG006|Overall Study|Protocol Deviation|2|||
163960425|NCT04796896|592226835|FG007|Overall Study|Protocol Deviation|2|||
163960426|NCT04796896|592226836|FG008|Overall Study|Protocol Deviation|2|||
163960427|NCT04796896|592226837|FG009|Overall Study|Protocol Deviation|1|||
163960428|NCT04796896|592226838|FG010|Overall Study|Protocol Deviation|0|||
163960429|NCT04796896|592226839|FG011|Overall Study|Protocol Deviation|0|||
163960430|NCT04796896|592226828|FG000|Overall Study|Missing|0|||
163960431|NCT04796896|592226829|FG001|Overall Study|Missing|0|||
163960432|NCT04796896|592226830|FG002|Overall Study|Missing|0|||
163960433|NCT04796896|592226831|FG003|Overall Study|Missing|0|||
163960434|NCT04796896|592226832|FG004|Overall Study|Missing|0|||
163960435|NCT04796896|592226833|FG005|Overall Study|Missing|0|||
163960436|NCT04796896|592226834|FG006|Overall Study|Missing|2|||
163960437|NCT04796896|592226835|FG007|Overall Study|Missing|1|||
163960438|NCT04796896|592226836|FG008|Overall Study|Missing|2|||
163960439|NCT04796896|592226837|FG009|Overall Study|Missing|1|||
163960440|NCT04796896|592226838|FG010|Overall Study|Missing|1|||
163960441|NCT04796896|592226839|FG011|Overall Study|Missing|0|||
163960442|NCT04796896|592226828|FG000|Overall Study|Death|0|||
163960443|NCT04796896|592226829|FG001|Overall Study|Death|0|||
163960444|NCT04796896|592226830|FG002|Overall Study|Death|0|||
163960445|NCT04796896|592226831|FG003|Overall Study|Death|0|||
163960446|NCT04796896|592226832|FG004|Overall Study|Death|0|||
163960447|NCT04796896|592226833|FG005|Overall Study|Death|0|||
163960448|NCT04796896|592226834|FG006|Overall Study|Death|0|||
163960449|NCT04796896|592226835|FG007|Overall Study|Death|0|||
163960450|NCT04796896|592226836|FG008|Overall Study|Death|1|||
163960451|NCT04796896|592226837|FG009|Overall Study|Death|0|||
163960452|NCT04796896|592226838|FG010|Overall Study|Death|0|||
163960453|NCT04796896|592226839|FG011|Overall Study|Death|0|||
163960454|NCT02021292|592226840|FG000|Overall Study|Physician Decision|0|||
163960455|NCT02021292|592226841|FG001|Overall Study|Physician Decision|1|||
163960456|NCT02021292|592226840|FG000|Overall Study|Lost to Follow-up|0|||
163960457|NCT02021292|592226841|FG001|Overall Study|Lost to Follow-up|1|||
163960458|NCT02021292|592226840|FG000|Overall Study|Death|0|||
163960459|NCT02021292|592226841|FG001|Overall Study|Death|1|||
163960460|NCT04356183|592226842|FG000|Overall Study|Lost to Follow-up|1|||
163960461|NCT04356183|592226843|FG001|Overall Study|Lost to Follow-up|0|||
163960462|NCT04356183|592226842|FG000|Overall Study|Withdrawal by Subject|1|||
163960463|NCT04356183|592226843|FG001|Overall Study|Withdrawal by Subject|1|||
163960464|NCT01637623|592226844|FG000|Overall Study|Lost to Follow-up|0|||
163960465|NCT01637623|592226845|FG001|Overall Study|Lost to Follow-up|0|||
163960466|NCT01637623|592226846|FG002|Overall Study|Lost to Follow-up|2|||
163960467|NCT01637623|592226844|FG000|Overall Study|Physician Decision|1|||
163960468|NCT01637623|592226845|FG001|Overall Study|Physician Decision|0|||
163960469|NCT01637623|592226846|FG002|Overall Study|Physician Decision|1|||
163960470|NCT02824263|592226849|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
163960471|NCT02824263|592226850|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
163960472|NCT02824263|592226849|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
163960473|NCT02824263|592226850|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
163960474|NCT01676909|592226851|FG000|Overall Study|Withdrawal by Subject|3|||
163960475|NCT01676909|592226852|FG001|Overall Study|Withdrawal by Subject|5|||
163960476|NCT01676909|592226851|FG000|Overall Study|Lost to Follow-up|15|||
163960477|NCT01676909|592226852|FG001|Overall Study|Lost to Follow-up|9|||
163960478|NCT04615247|592226853|FG000|Overall Study|Adverse Event|0|||
163960479|NCT04615247|592226854|FG001|Overall Study|Adverse Event|2|||
163960480|NCT04615247|592226853|FG000|Overall Study|Withdrawal by Subject|1|||
163960481|NCT04615247|592226854|FG001|Overall Study|Withdrawal by Subject|1|||
163960482|NCT00823901|592226857|FG000|Overall Study|Adverse Event|1|||
163960483|NCT00823901|592226858|FG001|Overall Study|Adverse Event|1|||
163960484|NCT00823901|592226857|FG000|Overall Study|Lack of Efficacy|1|||
163960485|NCT00823901|592226858|FG001|Overall Study|Lack of Efficacy|0|||
163960486|NCT00823901|592226857|FG000|Overall Study|Lost to Follow-up|2|||
163960487|NCT00823901|592226858|FG001|Overall Study|Lost to Follow-up|1|||
163960488|NCT01369511|592226859|FG000|Overall Study|Adverse Event|1|||
163960489|NCT01369511|592226860|FG001|Overall Study|Adverse Event|1|||
163960490|NCT01369511|592226861|FG002|Overall Study|Adverse Event|5|||
163960491|NCT01369511|592226862|FG003|Overall Study|Adverse Event|0|||
163960492|NCT01369511|592226859|FG000|Overall Study|Entry criteria not met|2|||
163960493|NCT01369511|592226860|FG001|Overall Study|Entry criteria not met|0|||
163960494|NCT01369511|592226861|FG002|Overall Study|Entry criteria not met|0|||
163960495|NCT01369511|592226862|FG003|Overall Study|Entry criteria not met|1|||
163960496|NCT01369511|592226859|FG000|Overall Study|Lost to Follow-up|0|||
163960497|NCT01369511|592226860|FG001|Overall Study|Lost to Follow-up|1|||
163960498|NCT01369511|592226861|FG002|Overall Study|Lost to Follow-up|1|||
163960499|NCT01369511|592226862|FG003|Overall Study|Lost to Follow-up|2|||
163960500|NCT01369511|592226859|FG000|Overall Study|Protocol Violation|0|||
163960501|NCT01369511|592226860|FG001|Overall Study|Protocol Violation|1|||
163960502|NCT01369511|592226861|FG002|Overall Study|Protocol Violation|0|||
163960503|NCT01369511|592226862|FG003|Overall Study|Protocol Violation|2|||
163960504|NCT01369511|592226859|FG000|Overall Study|Physician Decision|3|||
163960505|NCT01369511|592226860|FG001|Overall Study|Physician Decision|4|||
163960506|NCT01369511|592226861|FG002|Overall Study|Physician Decision|0|||
163960507|NCT01369511|592226862|FG003|Overall Study|Physician Decision|0|||
163960508|NCT01369511|592226859|FG000|Overall Study|Sponsor decision|2|||
163960509|NCT01369511|592226860|FG001|Overall Study|Sponsor decision|0|||
163960510|NCT01369511|592226861|FG002|Overall Study|Sponsor decision|1|||
163960511|NCT01369511|592226862|FG003|Overall Study|Sponsor decision|0|||
163960512|NCT01369511|592226859|FG000|Overall Study|Withdrawal by Subject|5|||
163960513|NCT01369511|592226860|FG001|Overall Study|Withdrawal by Subject|6|||
163960514|NCT01369511|592226861|FG002|Overall Study|Withdrawal by Subject|4|||
163960515|NCT01369511|592226862|FG003|Overall Study|Withdrawal by Subject|6|||
163960516|NCT01376349|592226863|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
163960517|NCT01376349|592226864|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
163960518|NCT01376349|592226865|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
163960519|NCT01376349|592226863|FG000|Raondomized Treatment|Adverse Event|13|||
163960520|NCT01376349|592226864|FG001|Raondomized Treatment|Adverse Event|17|||
163960521|NCT01376349|592226865|FG002|Raondomized Treatment|Adverse Event|14|||
163960522|NCT01376349|592226863|FG000|Raondomized Treatment|Unkown|1|||
163960523|NCT01376349|592226864|FG001|Raondomized Treatment|Unkown|2|||
163960524|NCT01376349|592226865|FG002|Raondomized Treatment|Unkown|1|||
163960525|NCT01376349|592226863|FG000|Raondomized Treatment|Alternative Treatment|0|||
163960526|NCT01376349|592226864|FG001|Raondomized Treatment|Alternative Treatment|0|||
163960527|NCT01376349|592226865|FG002|Raondomized Treatment|Alternative Treatment|1|||
163960528|NCT00718640|592226866|FG000|Overall Study|Adverse Event|4|||
163960529|NCT00718640|592226866|FG000|Overall Study|Death|1|||
163960530|NCT00718640|592226866|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
163960531|NCT02147353|592226867|FG000|Overall Study|Lost to Follow-up|2|||
163960532|NCT02147353|592226868|FG001|Overall Study|Lost to Follow-up|0|||
163960533|NCT02147353|592226867|FG000|Overall Study|unable to make visits|4|||
163960534|NCT02147353|592226868|FG001|Overall Study|unable to make visits|0|||
163960535|NCT02147353|592226867|FG000|Overall Study|medication noncompliance|3|||
163960536|NCT02147353|592226868|FG001|Overall Study|medication noncompliance|0|||
163960537|NCT02121834|592226873|FG000|Overall Study|Protocol Violation|0|||
163960538|NCT02121834|592226874|FG001|Overall Study|Protocol Violation|1|||
163960539|NCT02121834|592226875|FG002|Overall Study|Protocol Violation|0|||
163960540|NCT02121834|592226876|FG003|Overall Study|Protocol Violation|0|||
163960541|NCT02121834|592226877|FG004|Overall Study|Protocol Violation|0|||
163960542|NCT02121834|592226878|FG005|Overall Study|Protocol Violation|0|||
163960543|NCT02121834|592226879|FG006|Overall Study|Protocol Violation|0|||
163960544|NCT02121834|592226873|FG000|Overall Study|Withdrawal by Subject|0|||
163960545|NCT02121834|592226874|FG001|Overall Study|Withdrawal by Subject|1|||
163960546|NCT02121834|592226875|FG002|Overall Study|Withdrawal by Subject|1|||
163960547|NCT02121834|592226876|FG003|Overall Study|Withdrawal by Subject|0|||
163960548|NCT02121834|592226877|FG004|Overall Study|Withdrawal by Subject|0|||
163960549|NCT02121834|592226878|FG005|Overall Study|Withdrawal by Subject|0|||
163960550|NCT02121834|592226879|FG006|Overall Study|Withdrawal by Subject|0|||
163960551|NCT02121834|592226873|FG000|Overall Study|Lost to Follow-up|0|||
163960552|NCT02121834|592226874|FG001|Overall Study|Lost to Follow-up|0|||
163960553|NCT02121834|592226875|FG002|Overall Study|Lost to Follow-up|1|||
163960554|NCT02121834|592226876|FG003|Overall Study|Lost to Follow-up|0|||
163960555|NCT02121834|592226877|FG004|Overall Study|Lost to Follow-up|0|||
163960556|NCT02121834|592226878|FG005|Overall Study|Lost to Follow-up|0|||
163960557|NCT02121834|592226879|FG006|Overall Study|Lost to Follow-up|0|||
163960558|NCT02578862|592226880|FG000|Overall Study|Withdrawal by Subject|0|||
163960559|NCT02578862|592226881|FG001|Overall Study|Withdrawal by Subject|1|||
163960560|NCT02578862|592226880|FG000|Overall Study|Unplanned unilateral procedure|0|||
163960561|NCT02578862|592226881|FG001|Overall Study|Unplanned unilateral procedure|1|||
163960562|NCT01230788|592226889|FG000|Overall Study|Prescribed exclusion drug|1|||
163960563|NCT01142596|592226890|FG000|Overall Study|Withdrawal by Subject|9|||
163960564|NCT01142596|592226891|FG001|Overall Study|Withdrawal by Subject|35|||
163960565|NCT01142596|592226890|FG000|Overall Study|Adverse Event|8|||
163960566|NCT01142596|592226891|FG001|Overall Study|Adverse Event|35|||
163960567|NCT01142596|592226890|FG000|Overall Study|Lack of Efficacy|5|||
163960568|NCT01142596|592226891|FG001|Overall Study|Lack of Efficacy|9|||
163960569|NCT01142596|592226890|FG000|Overall Study|Lost to Follow-up|2|||
163960570|NCT01142596|592226891|FG001|Overall Study|Lost to Follow-up|3|||
163960571|NCT01142596|592226890|FG000|Overall Study|Other reason (not specified)|5|||
163960572|NCT01142596|592226891|FG001|Overall Study|Other reason (not specified)|4|||
163960573|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
163960574|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
163960575|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
163960576|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
163960577|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
163960578|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
163960579|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
163960580|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
163960581|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
163960582|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
163960583|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
163960584|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
163960585|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
163960586|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
163960587|NCT01294683|592226894|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
163960588|NCT01294683|592226895|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
163960589|NCT01294683|592226894|FG000|Post Crossover (Period III)|Adverse Event|6|||
163960590|NCT01294683|592226895|FG001|Post Crossover (Period III)|Adverse Event|6|||
163960591|NCT01294683|592226894|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
163960592|NCT01294683|592226895|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
163960593|NCT01294683|592226894|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
163960594|NCT01294683|592226895|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
163960595|NCT01294683|592226894|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
163960596|NCT01294683|592226895|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
163960597|NCT01794923|592226896|FG000|Overall Study|Adverse Event|0|||
163960598|NCT01794923|592226897|FG001|Overall Study|Adverse Event|0|||
163960599|NCT01794923|592226898|FG002|Overall Study|Adverse Event|1|||
163960600|NCT01881750|592226899|FG000|Overall Study|Changes in concomitant therapies|2|||
163960601|NCT01881750|592226900|FG001|Overall Study|Changes in concomitant therapies|3|||
163960602|NCT01881750|592226899|FG000|Overall Study|Lost to Follow-up|0|||
163960603|NCT01881750|592226900|FG001|Overall Study|Lost to Follow-up|1|||
163960604|NCT01572922|592226909|FG000|Overall Study|Adverse Event|1|||
163960605|NCT01572922|592226909|FG000|Overall Study|Protocol Violation|1|||
163960606|NCT01572922|592226909|FG000|Overall Study|Death|1|||
163960607|NCT01103245|592228649|FG000|Overall Study|Withdrawal by Subject|1|||
163960608|NCT01103245|592228650|FG001|Overall Study|Withdrawal by Subject|0|||
163960609|NCT01103245|592228651|FG002|Overall Study|Withdrawal by Subject|3|||
163960610|NCT01103245|592228652|FG003|Overall Study|Withdrawal by Subject|0|||
163960611|NCT01103245|592228649|FG000|Overall Study|Inadequate IV access|1|||
163960612|NCT01103245|592228650|FG001|Overall Study|Inadequate IV access|0|||
163960613|NCT01103245|592228651|FG002|Overall Study|Inadequate IV access|0|||
163960614|NCT01103245|592228652|FG003|Overall Study|Inadequate IV access|0|||
163960615|NCT01103245|592228649|FG000|Overall Study|Adverse Event|0|||
163960616|NCT01103245|592228650|FG001|Overall Study|Adverse Event|2|||
163960617|NCT01103245|592228651|FG002|Overall Study|Adverse Event|1|||
163960618|NCT01103245|592228652|FG003|Overall Study|Adverse Event|0|||
163960619|NCT01103245|592228649|FG000|Overall Study|Physician Decision|1|||
163960620|NCT01103245|592228650|FG001|Overall Study|Physician Decision|0|||
163960621|NCT01103245|592228651|FG002|Overall Study|Physician Decision|0|||
163960622|NCT01103245|592228652|FG003|Overall Study|Physician Decision|0|||
163960623|NCT03078907|592228657|FG000|Overall Study|Adverse Event|2|||
163960624|NCT03078907|592228658|FG001|Overall Study|Adverse Event|0|||
163960625|NCT03078907|592228657|FG000|Overall Study|Other|1|||
163960626|NCT03078907|592228658|FG001|Overall Study|Other|0|||
163960627|NCT03078907|592228657|FG000|Overall Study|Protocol Violation|0|||
163960628|NCT03078907|592228658|FG001|Overall Study|Protocol Violation|1|||
163960629|NCT01955122|592228659|FG000|Overall Study|Physician Decision|5|||
163960630|NCT01955122|592228660|FG001|Overall Study|Physician Decision|5|||
163960631|NCT01672788|592228661|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
163960632|NCT01672788|592228662|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
163960633|NCT01672788|592228663|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
163960634|NCT01672788|592228664|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
163960635|NCT01128361|592228674|FG000|Overall Study|Lost to Follow-up|0|||
163960636|NCT01128361|592228675|FG001|Overall Study|Lost to Follow-up|1|||
163960637|NCT01128361|592228674|FG000|Overall Study|Withdrawal by Subject|5|||
163960638|NCT01128361|592228675|FG001|Overall Study|Withdrawal by Subject|2|||
163960639|NCT02464228|592228676|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
163960640|NCT02464228|592228677|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
163960641|NCT02464228|592228678|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
163960642|NCT02464228|592228679|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
163960643|NCT02464228|592228676|FG000|Overall Study|Physician Decision|2|||
163960644|NCT02464228|592228677|FG001|Overall Study|Physician Decision|0|||
163960645|NCT02464228|592228678|FG002|Overall Study|Physician Decision|1|||
163960646|NCT02464228|592228679|FG003|Overall Study|Physician Decision|0|||
163960647|NCT02464228|592228676|FG000|Overall Study|Miscellaneous|1|||
163960648|NCT02464228|592228677|FG001|Overall Study|Miscellaneous|0|||
163960649|NCT02464228|592228678|FG002|Overall Study|Miscellaneous|1|||
163960650|NCT02464228|592228679|FG003|Overall Study|Miscellaneous|0|||
163960651|NCT02464228|592228676|FG000|Overall Study|Adverse Event|9|||
163960652|NCT02464228|592228677|FG001|Overall Study|Adverse Event|0|||
163960653|NCT02464228|592228678|FG002|Overall Study|Adverse Event|3|||
163960654|NCT02464228|592228679|FG003|Overall Study|Adverse Event|0|||
163960655|NCT02464228|592228676|FG000|Overall Study|Withdrawal by Subject|1|||
163960656|NCT02464228|592228677|FG001|Overall Study|Withdrawal by Subject|1|||
163960657|NCT02464228|592228678|FG002|Overall Study|Withdrawal by Subject|1|||
163960658|NCT02464228|592228679|FG003|Overall Study|Withdrawal by Subject|0|||
163960659|NCT02464228|592228676|FG000|Overall Study|Disease Progression|22|||
163960660|NCT02464228|592228677|FG001|Overall Study|Disease Progression|12|||
163960661|NCT02464228|592228678|FG002|Overall Study|Disease Progression|5|||
163960662|NCT02464228|592228679|FG003|Overall Study|Disease Progression|2|||
163960663|NCT05972733|592228690|FG000|Overall Study|Lost to Follow-up|2|||
163960664|NCT05972733|592228690|FG000|Overall Study|Withdrawal by Subject|1|||
163960665|NCT01177787|592228691|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
163960666|NCT01177787|592228691|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
163960667|NCT01177787|592228691|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
163960668|NCT00818389|592228694|FG000|Overall Study|Death|1|||
163960669|NCT00818389|592228695|FG001|Overall Study|Death|3|||
163960670|NCT00818389|592228694|FG000|Overall Study|ALS Disease Progression|1|||
163960671|NCT00818389|592228695|FG001|Overall Study|ALS Disease Progression|0|||
163960672|NCT00818389|592228694|FG000|Overall Study|Withdrawal by Subject|2|||
163960673|NCT00818389|592228695|FG001|Overall Study|Withdrawal by Subject|2|||
163960674|NCT00818389|592228694|FG000|Overall Study|Adverse Event|0|||
163960675|NCT00818389|592228695|FG001|Overall Study|Adverse Event|1|||
163960676|NCT05193500|592228698|FG000|Overall Study|Withdrawal by Subject|7|||
163960677|NCT05193500|592228699|FG001|Overall Study|Withdrawal by Subject|4|||
163960678|NCT05193500|592228700|FG002|Overall Study|Withdrawal by Subject|3|||
163960679|NCT05193500|592228701|FG003|Overall Study|Withdrawal by Subject|5|||
163960680|NCT03871829|592228702|FG000|Overall Study|Lost to Follow-up|0|||
163960681|NCT03871829|592228703|FG001|Overall Study|Lost to Follow-up|1|||
163960682|NCT03871829|592228702|FG000|Overall Study|Withdrawal by Subject|1|||
163960683|NCT03871829|592228703|FG001|Overall Study|Withdrawal by Subject|1|||
163960684|NCT03871829|592228702|FG000|Overall Study|Death|12|||
163960685|NCT03871829|592228703|FG001|Overall Study|Death|8|||
163960686|NCT03871829|592228702|FG000|Overall Study|Study terminated by sponsor|31|||
163960687|NCT03871829|592228703|FG001|Overall Study|Study terminated by sponsor|34|||
163960688|NCT02993523|592228704|FG000|Overall Study|Withdrew Consent|0|||
163960689|NCT02993523|592228705|FG001|Overall Study|Withdrew Consent|0|||
163960690|NCT02993523|592228706|FG002|Overall Study|Withdrew Consent|2|||
163960691|NCT02993523|592228707|FG003|Overall Study|Withdrew Consent|9|||
163960692|NCT02993523|592228708|FG004|Overall Study|Withdrew Consent|0|||
163960693|NCT02993523|592228704|FG000|Overall Study|Lost to Follow-up|0|||
163960694|NCT02993523|592228705|FG001|Overall Study|Lost to Follow-up|0|||
163960695|NCT02993523|592228706|FG002|Overall Study|Lost to Follow-up|3|||
163960696|NCT02993523|592228707|FG003|Overall Study|Lost to Follow-up|6|||
163960697|NCT02993523|592228708|FG004|Overall Study|Lost to Follow-up|0|||
163960698|NCT02993523|592228704|FG000|Overall Study|Death|1|||
163960699|NCT02993523|592228705|FG001|Overall Study|Death|1|||
163960700|NCT02993523|592228706|FG002|Overall Study|Death|138|||
163960701|NCT02993523|592228707|FG003|Overall Study|Death|222|||
163960702|NCT02993523|592228708|FG004|Overall Study|Death|6|||
163960703|NCT02993523|592228704|FG000|Overall Study|Reason not Specified|0|||
163960704|NCT02993523|592228705|FG001|Overall Study|Reason not Specified|0|||
163960705|NCT02993523|592228706|FG002|Overall Study|Reason not Specified|1|||
163960706|NCT02993523|592228707|FG003|Overall Study|Reason not Specified|1|||
163960707|NCT02993523|592228708|FG004|Overall Study|Reason not Specified|0|||
163960708|NCT03694418|592228709|FG000|Overall Study|Lost to Follow-up|115|||
163960709|NCT03694418|592228710|FG001|Overall Study|Lost to Follow-up|23|||
163960710|NCT03694418|592228711|FG002|Overall Study|Lost to Follow-up|12|||
163960711|NCT03694418|592228712|FG003|Overall Study|Lost to Follow-up|12|||
163960712|NCT03694418|592228713|FG004|Overall Study|Lost to Follow-up|13|||
163960713|NCT04288778|592228716|FG000|Overall Study|Withdrawal by Subject|2|||
163960714|NCT04288778|592228716|FG000|Overall Study|Adverse Event|5|||
163960715|NCT04288778|592228716|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163960716|NCT04288778|592228716|FG000|Overall Study|Other|1|||
163960717|NCT04288778|592228716|FG000|Overall Study|Started but not treated|2|||
163960718|NCT04442737|592228717|FG000|Overall Study|Lost to Follow-up|1|||
163960719|NCT04442737|592228718|FG001|Overall Study|Lost to Follow-up|3|||
163960720|NCT04442737|592228717|FG000|Overall Study|Withdrawal by Subject|3|||
163960721|NCT04442737|592228718|FG001|Overall Study|Withdrawal by Subject|2|||
163960722|NCT04442737|592228717|FG000|Overall Study|Adverse Event|3|||
163960723|NCT04442737|592228718|FG001|Overall Study|Adverse Event|2|||
163960724|NCT04442737|592228717|FG000|Overall Study|Death|0|||
163960725|NCT04442737|592228718|FG001|Overall Study|Death|1|||
163960726|NCT04442737|592228717|FG000|Overall Study|Protocol Violation|0|||
163960727|NCT04442737|592228718|FG001|Overall Study|Protocol Violation|2|||
163960728|NCT04442737|592228717|FG000|Overall Study|Other|1|||
163960729|NCT04442737|592228718|FG001|Overall Study|Other|1|||
163960730|NCT01139021|592228719|FG000|Overall Study|Adverse Event|0|||
163960731|NCT01139021|592228720|FG001|Overall Study|Adverse Event|0|||
163960732|NCT01139021|592228721|FG002|Overall Study|Adverse Event|0|||
163960733|NCT01139021|592228722|FG003|Overall Study|Adverse Event|0|||
163960734|NCT01139021|592228723|FG004|Overall Study|Adverse Event|1|||
163960735|NCT01139021|592228724|FG005|Overall Study|Adverse Event|0|||
163960736|NCT01139021|592228719|FG000|Overall Study|Lost to Follow-up|0|||
163960737|NCT01139021|592228720|FG001|Overall Study|Lost to Follow-up|0|||
163960738|NCT01139021|592228721|FG002|Overall Study|Lost to Follow-up|0|||
163960739|NCT01139021|592228722|FG003|Overall Study|Lost to Follow-up|0|||
163960740|NCT01139021|592228723|FG004|Overall Study|Lost to Follow-up|2|||
163960741|NCT01139021|592228724|FG005|Overall Study|Lost to Follow-up|0|||
163960742|NCT01139021|592228719|FG000|Overall Study|Protocol Violation|1|||
163960743|NCT01139021|592228720|FG001|Overall Study|Protocol Violation|0|||
163960744|NCT01139021|592228721|FG002|Overall Study|Protocol Violation|0|||
163960745|NCT01139021|592228722|FG003|Overall Study|Protocol Violation|0|||
163960746|NCT01139021|592228723|FG004|Overall Study|Protocol Violation|2|||
163960747|NCT01139021|592228724|FG005|Overall Study|Protocol Violation|0|||
163960748|NCT01139021|592228719|FG000|Overall Study|Withdrawal by Subject|0|||
163960749|NCT01139021|592228720|FG001|Overall Study|Withdrawal by Subject|0|||
163960750|NCT01139021|592228721|FG002|Overall Study|Withdrawal by Subject|0|||
163960751|NCT01139021|592228722|FG003|Overall Study|Withdrawal by Subject|1|||
163960752|NCT01139021|592228723|FG004|Overall Study|Withdrawal by Subject|4|||
163960753|NCT01139021|592228724|FG005|Overall Study|Withdrawal by Subject|0|||
163960754|NCT05458479|592228729|FG000|Overall Study|Lost to Follow-up|1|||
163960755|NCT00784693|592228730|FG000|Overall Study|Lost to Follow-up|0|||
163960756|NCT00784693|592228731|FG001|Overall Study|Lost to Follow-up|1|||
163960757|NCT00784693|592228730|FG000|Overall Study|Lack of Efficacy|1|||
163960758|NCT00784693|592228731|FG001|Overall Study|Lack of Efficacy|1|||
163960759|NCT00784693|592228730|FG000|Overall Study|Withdrawal by Subject|0|||
163960760|NCT00784693|592228731|FG001|Overall Study|Withdrawal by Subject|4|||
163960761|NCT00784693|592228730|FG000|Overall Study|Randomized but not Treated|1|||
163960762|NCT00784693|592228731|FG001|Overall Study|Randomized but not Treated|0|||
163960763|NCT00784693|592228730|FG000|Overall Study|Other|1|||
163960764|NCT00784693|592228731|FG001|Overall Study|Other|0|||
163960765|NCT01978262|592228732|FG000|Overall Study|Withdrawal by Subject|9|||
163960766|NCT01978262|592228732|FG000|Overall Study|Lost to Follow-up|2|||
163960767|NCT02982187|592228733|FG000|Overall Study|Withdrawal by Subject|0|||
163960768|NCT02982187|592228734|FG001|Overall Study|Withdrawal by Subject|0|||
163960769|NCT02982187|592228735|FG002|Overall Study|Withdrawal by Subject|0|||
163960770|NCT02982187|592228736|FG003|Overall Study|Withdrawal by Subject|0|||
163960771|NCT02982187|592228737|FG004|Overall Study|Withdrawal by Subject|0|||
163960772|NCT02982187|592228738|FG005|Overall Study|Withdrawal by Subject|0|||
163960773|NCT02982187|592228739|FG006|Overall Study|Withdrawal by Subject|1|||
163960774|NCT02982187|592228740|FG007|Overall Study|Withdrawal by Subject|0|||
163960775|NCT02202551|592228741|FG000|Overall Study|Adverse Event|8|||
163960776|NCT02202551|592228742|FG001|Overall Study|Adverse Event|19|||
163960777|NCT02202551|592228743|FG002|Overall Study|Adverse Event|5|||
163960778|NCT02202551|592228744|FG003|Overall Study|Adverse Event|9|||
163960779|NCT02202551|592228741|FG000|Overall Study|Death|3|||
163960780|NCT02202551|592228742|FG001|Overall Study|Death|2|||
163960781|NCT02202551|592228743|FG002|Overall Study|Death|1|||
163960782|NCT02202551|592228744|FG003|Overall Study|Death|1|||
163960783|NCT02202551|592228741|FG000|Overall Study|Lost to Follow-up|0|||
163960784|NCT02202551|592228742|FG001|Overall Study|Lost to Follow-up|1|||
163960785|NCT02202551|592228743|FG002|Overall Study|Lost to Follow-up|0|||
163960786|NCT02202551|592228744|FG003|Overall Study|Lost to Follow-up|1|||
163960787|NCT02202551|592228741|FG000|Overall Study|Needed to take excluded medication|0|||
163960788|NCT02202551|592228742|FG001|Overall Study|Needed to take excluded medication|2|||
163960789|NCT02202551|592228743|FG002|Overall Study|Needed to take excluded medication|0|||
163960790|NCT02202551|592228744|FG003|Overall Study|Needed to take excluded medication|1|||
163960791|NCT02202551|592228741|FG000|Overall Study|Subject moved away|0|||
163960792|NCT02202551|592228742|FG001|Overall Study|Subject moved away|1|||
163960793|NCT02202551|592228743|FG002|Overall Study|Subject moved away|0|||
163960794|NCT02202551|592228744|FG003|Overall Study|Subject moved away|0|||
163960795|NCT02202551|592228741|FG000|Overall Study|DBS surgery|3|||
163960796|NCT02202551|592228742|FG001|Overall Study|DBS surgery|0|||
163960797|NCT02202551|592228743|FG002|Overall Study|DBS surgery|0|||
163960798|NCT02202551|592228744|FG003|Overall Study|DBS surgery|0|||
163960799|NCT02202551|592228741|FG000|Overall Study|Dyskinesia upon taper|1|||
163960800|NCT02202551|592228742|FG001|Overall Study|Dyskinesia upon taper|0|||
163960801|NCT02202551|592228743|FG002|Overall Study|Dyskinesia upon taper|0|||
163960802|NCT02202551|592228744|FG003|Overall Study|Dyskinesia upon taper|0|||
163960803|NCT02202551|592228741|FG000|Overall Study|Lack of Efficacy|0|||
163960804|NCT02202551|592228742|FG001|Overall Study|Lack of Efficacy|1|||
163960805|NCT02202551|592228743|FG002|Overall Study|Lack of Efficacy|0|||
163960806|NCT02202551|592228744|FG003|Overall Study|Lack of Efficacy|0|||
163960807|NCT02202551|592228741|FG000|Overall Study|Physician Decision|1|||
163960808|NCT02202551|592228742|FG001|Overall Study|Physician Decision|0|||
163960809|NCT02202551|592228743|FG002|Overall Study|Physician Decision|0|||
163960810|NCT02202551|592228744|FG003|Overall Study|Physician Decision|0|||
163960811|NCT02202551|592228741|FG000|Overall Study|Site closure|3|||
163960812|NCT02202551|592228742|FG001|Overall Study|Site closure|0|||
163960813|NCT02202551|592228743|FG002|Overall Study|Site closure|0|||
163960814|NCT02202551|592228744|FG003|Overall Study|Site closure|1|||
163960815|NCT02202551|592228741|FG000|Overall Study|Unable to complete visits per protocol|1|||
163960816|NCT02202551|592228742|FG001|Overall Study|Unable to complete visits per protocol|0|||
163960817|NCT02202551|592228743|FG002|Overall Study|Unable to complete visits per protocol|0|||
163960818|NCT02202551|592228744|FG003|Overall Study|Unable to complete visits per protocol|0|||
163960819|NCT02202551|592228741|FG000|Overall Study|Worsening Dyskinesia|0|||
163960820|NCT02202551|592228742|FG001|Overall Study|Worsening Dyskinesia|0|||
163960821|NCT02202551|592228743|FG002|Overall Study|Worsening Dyskinesia|0|||
163960822|NCT02202551|592228744|FG003|Overall Study|Worsening Dyskinesia|1|||
163960823|NCT02202551|592228741|FG000|Overall Study|Protocol Violation|0|||
163960824|NCT02202551|592228742|FG001|Overall Study|Protocol Violation|1|||
163960825|NCT02202551|592228743|FG002|Overall Study|Protocol Violation|0|||
163960826|NCT02202551|592228744|FG003|Overall Study|Protocol Violation|0|||
163960827|NCT02202551|592228741|FG000|Overall Study|Sponsor's decision|2|||
163960828|NCT02202551|592228742|FG001|Overall Study|Sponsor's decision|0|||
163960829|NCT02202551|592228743|FG002|Overall Study|Sponsor's decision|0|||
163960830|NCT02202551|592228744|FG003|Overall Study|Sponsor's decision|0|||
163960831|NCT02202551|592228741|FG000|Overall Study|Subject unwilling to proceed|1|||
163960832|NCT02202551|592228742|FG001|Overall Study|Subject unwilling to proceed|5|||
163960833|NCT02202551|592228743|FG002|Overall Study|Subject unwilling to proceed|3|||
163960834|NCT02202551|592228744|FG003|Overall Study|Subject unwilling to proceed|5|||
163960835|NCT02202551|592228741|FG000|Overall Study|Subject consent withdrawn|0|||
163960836|NCT02202551|592228742|FG001|Overall Study|Subject consent withdrawn|3|||
163960837|NCT02202551|592228743|FG002|Overall Study|Subject consent withdrawn|1|||
163960838|NCT02202551|592228744|FG003|Overall Study|Subject consent withdrawn|2|||
163960839|NCT02202551|592228741|FG000|Overall Study|eGFR<50mL/min/m2|2|||
163960840|NCT02202551|592228742|FG001|Overall Study|eGFR<50mL/min/m2|2|||
163960841|NCT02202551|592228743|FG002|Overall Study|eGFR<50mL/min/m2|0|||
163960842|NCT02202551|592228744|FG003|Overall Study|eGFR<50mL/min/m2|1|||
163960843|NCT02349451|592228748|FG000|Overall Study|Withdrawal by Subject|0|||
163960844|NCT02349451|592228749|FG001|Overall Study|Withdrawal by Subject|1|||
163960845|NCT02349451|592228750|FG002|Overall Study|Withdrawal by Subject|2|||
163960846|NCT02349451|592228751|FG003|Overall Study|Withdrawal by Subject|1|||
163960847|NCT02168842|592228752|FG000|Overall Study|Withdrawal by Subject|5|||
163960848|NCT02168842|592228753|FG001|Overall Study|Withdrawal by Subject|3|||
163960849|NCT02168842|592228752|FG000|Overall Study|Lost to Follow-up|0|||
163960850|NCT02168842|592228753|FG001|Overall Study|Lost to Follow-up|2|||
163960851|NCT02168842|592228752|FG000|Overall Study|Death|2|||
163960852|NCT02168842|592228753|FG001|Overall Study|Death|1|||
163960853|NCT02168842|592228752|FG000|Overall Study|Physician Decision|1|||
163960854|NCT02168842|592228753|FG001|Overall Study|Physician Decision|2|||
163960855|NCT01423253|592228758|FG000|Overall Study|Adverse Event|2|||
163960856|NCT01423253|592228758|FG000|Overall Study|Lack of Efficacy|2|||
163960857|NCT01423253|592228758|FG000|Overall Study|Lost to Follow-up|1|||
163960858|NCT01423253|592228758|FG000|Overall Study|Protocol Violation|2|||
163960859|NCT01423253|592228758|FG000|Overall Study|Withdrawal by Subject|2|||
163960860|NCT00392327|592228759|FG000|Overall Study|Death|1|||
163960861|NCT00392327|592228760|FG001|Overall Study|Death|0|||
163960862|NCT00392327|592228761|FG002|Overall Study|Death|1|||
163960863|NCT00392327|592228762|FG003|Overall Study|Death|0|||
163960864|NCT00392327|592228763|FG004|Overall Study|Death|0|||
163960865|NCT00392327|592228764|FG005|Overall Study|Death|0|||
163960866|NCT00392327|592228765|FG006|Overall Study|Death|0|||
163960867|NCT00392327|592228766|FG007|Overall Study|Death|0|||
163960868|NCT00392327|592228759|FG000|Overall Study|Lack of Efficacy|8|||
163960869|NCT00392327|592228760|FG001|Overall Study|Lack of Efficacy|8|||
163960870|NCT00392327|592228761|FG002|Overall Study|Lack of Efficacy|9|||
163960871|NCT00392327|592228762|FG003|Overall Study|Lack of Efficacy|6|||
163960872|NCT00392327|592228763|FG004|Overall Study|Lack of Efficacy|3|||
163960873|NCT00392327|592228764|FG005|Overall Study|Lack of Efficacy|3|||
163960874|NCT00392327|592228765|FG006|Overall Study|Lack of Efficacy|3|||
163960875|NCT00392327|592228766|FG007|Overall Study|Lack of Efficacy|3|||
163960876|NCT00392327|592228759|FG000|Overall Study|Physician Decision|3|||
163960877|NCT00392327|592228760|FG001|Overall Study|Physician Decision|5|||
163960878|NCT00392327|592228761|FG002|Overall Study|Physician Decision|2|||
163960879|NCT00392327|592228762|FG003|Overall Study|Physician Decision|2|||
163960880|NCT00392327|592228763|FG004|Overall Study|Physician Decision|0|||
163960881|NCT00392327|592228764|FG005|Overall Study|Physician Decision|1|||
163960882|NCT00392327|592228765|FG006|Overall Study|Physician Decision|5|||
163960883|NCT00392327|592228766|FG007|Overall Study|Physician Decision|3|||
163960884|NCT00392327|592228759|FG000|Overall Study|Protocol Violation|0|||
163960885|NCT00392327|592228760|FG001|Overall Study|Protocol Violation|0|||
163960886|NCT00392327|592228761|FG002|Overall Study|Protocol Violation|1|||
163960887|NCT00392327|592228762|FG003|Overall Study|Protocol Violation|0|||
163960888|NCT00392327|592228763|FG004|Overall Study|Protocol Violation|0|||
163960889|NCT00392327|592228764|FG005|Overall Study|Protocol Violation|0|||
163960890|NCT00392327|592228765|FG006|Overall Study|Protocol Violation|0|||
163960891|NCT00392327|592228766|FG007|Overall Study|Protocol Violation|0|||
163960892|NCT00392327|592228759|FG000|Overall Study|Withdrawal by Subject|3|||
163960893|NCT00392327|592228760|FG001|Overall Study|Withdrawal by Subject|2|||
163960894|NCT00392327|592228761|FG002|Overall Study|Withdrawal by Subject|4|||
163960895|NCT00392327|592228762|FG003|Overall Study|Withdrawal by Subject|6|||
163960896|NCT00392327|592228763|FG004|Overall Study|Withdrawal by Subject|0|||
163960897|NCT00392327|592228764|FG005|Overall Study|Withdrawal by Subject|1|||
163960898|NCT00392327|592228765|FG006|Overall Study|Withdrawal by Subject|1|||
163960899|NCT00392327|592228766|FG007|Overall Study|Withdrawal by Subject|5|||
163960900|NCT00392327|592228759|FG000|Overall Study|Ineligible|0|||
163960901|NCT00392327|592228760|FG001|Overall Study|Ineligible|4|||
163960902|NCT00392327|592228761|FG002|Overall Study|Ineligible|3|||
163960903|NCT00392327|592228762|FG003|Overall Study|Ineligible|2|||
163849651|NCT02179918|591820468|FG002|Overall Study|Subject refused further follow-up|0|||
163849652|NCT02179918|591820469|FG003|Overall Study|Subject refused further follow-up|0|||
163849653|NCT02179918|591820470|FG004|Overall Study|Subject refused further follow-up|1|||
163849654|NCT02954575|591820472|FG000|Overall Study|Withdrawal by Subject|2|||
163849655|NCT02954575|591820472|FG000|Overall Study|Adverse Event|1|||
163849656|NCT00570661|591820475|FG000|Overall Study|Disease worsening|5|||
163849657|NCT00570661|591820475|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
163849658|NCT00570661|591820475|FG000|Overall Study|Adverse Event|1|||
163849659|NCT01734382|591820479|FG000|Part 1|Adverse Event|2|||
163849660|NCT01734382|591820480|FG001|Part 1|Adverse Event|0|||
163849661|NCT01734382|591820481|FG002|Part 1|Adverse Event|0|||
163849662|NCT01734382|591820479|FG000|Part 2|Adverse Event|0|||
163849663|NCT01734382|591820480|FG001|Part 2|Adverse Event|0|||
163849664|NCT01734382|591820481|FG002|Part 2|Adverse Event|1|||
163849665|NCT01734382|591820479|FG000|Part 2|Lack of Efficacy|0|||
163849666|NCT01734382|591820480|FG001|Part 2|Lack of Efficacy|1|||
163849667|NCT01734382|591820481|FG002|Part 2|Lack of Efficacy|1|||
163960904|NCT00392327|592228763|FG004|Overall Study|Ineligible|0|||
163960905|NCT00392327|592228764|FG005|Overall Study|Ineligible|0|||
163960906|NCT00392327|592228765|FG006|Overall Study|Ineligible|0|||
163960907|NCT00392327|592228766|FG007|Overall Study|Ineligible|0|||
163960908|NCT00894686|592228767|FG000|Overall Study|Withdrawal by Subject|50|||
163849668|NCT01734382|591820479|FG000|Part 2|Other|0|||
163849669|NCT01734382|591820480|FG001|Part 2|Other|0|||
163849670|NCT01734382|591820481|FG002|Part 2|Other|1|||
163960909|NCT00894686|592228767|FG000|Overall Study|Physician Decision|1|||
163960910|NCT00894686|592228767|FG000|Overall Study|Other|5|||
163849671|NCT01734382|591820479|FG000|Part 2|Physician Decision|0|||
163849672|NCT01734382|591820480|FG001|Part 2|Physician Decision|0|||
163849673|NCT01734382|591820481|FG002|Part 2|Physician Decision|3|||
163849674|NCT01734382|591820479|FG000|Part 2|Protocol Violation|0|||
163960911|NCT03267940|592228768|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
163960912|NCT03267940|592228769|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
163960913|NCT03267940|592228770|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163960914|NCT03267940|592228771|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163960915|NCT03267940|592228772|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163960916|NCT03267940|592228773|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
163960917|NCT03267940|592228768|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163960918|NCT03267940|592228769|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
163960919|NCT03267940|592228770|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163960920|NCT03267940|592228771|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163960921|NCT03267940|592228772|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163960922|NCT03267940|592228773|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
163960923|NCT03267940|592228768|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163960924|NCT03267940|592228769|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
163960925|NCT03267940|592228770|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163960926|NCT03267940|592228771|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163960927|NCT03267940|592228772|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163960928|NCT03267940|592228773|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
163960929|NCT03267940|592228768|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
163960930|NCT03267940|592228769|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
163960931|NCT03267940|592228770|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163960932|NCT03267940|592228771|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163960933|NCT03267940|592228772|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163960934|NCT03267940|592228773|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
163960935|NCT03267940|592228768|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163960936|NCT03267940|592228769|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163960937|NCT03267940|592228770|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163960938|NCT03267940|592228771|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
163960939|NCT03267940|592228772|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
163960940|NCT03267940|592228773|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
163960941|NCT03267940|592228768|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
163960942|NCT03267940|592228769|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
163960943|NCT03267940|592228770|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
163960944|NCT03267940|592228771|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
163960945|NCT03267940|592228772|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
163960946|NCT03267940|592228773|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
163960947|NCT03267940|592228768|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
163960948|NCT03267940|592228769|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
163960949|NCT03267940|592228770|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
163960950|NCT03267940|592228771|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
163960951|NCT03267940|592228772|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
163960952|NCT03267940|592228773|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
163960953|NCT03267940|592228768|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
163960954|NCT03267940|592228769|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
163960955|NCT03267940|592228770|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
163960956|NCT03267940|592228771|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
163960957|NCT03267940|592228772|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
163960958|NCT03267940|592228773|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
163960959|NCT03267940|592228768|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
163960960|NCT03267940|592228769|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
163960961|NCT03267940|592228770|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
163960962|NCT03267940|592228771|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
163960963|NCT03267940|592228772|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
163960964|NCT03267940|592228773|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
163960965|NCT01759407|592228783|FG000|Overall Study|Protocol Violation|0|||
163960966|NCT01759407|592228784|FG001|Overall Study|Protocol Violation|2|||
163960967|NCT04526197|592228787|FG000|Period 1|Adverse Event|0|||
163960968|NCT04526197|592228788|FG001|Period 1|Adverse Event|1|||
163960969|NCT04526197|592228787|FG000|Period 1|Withdrawal by Subject|1|||
163960970|NCT04526197|592228788|FG001|Period 1|Withdrawal by Subject|0|||
163960971|NCT04526197|592228787|FG000|Period 2|Adverse Event|0|||
163960972|NCT04526197|592228788|FG001|Period 2|Adverse Event|1|||
163960973|NCT04526197|592228787|FG000|Period 2|Withdrawal by Subject|0|||
163960974|NCT04526197|592228788|FG001|Period 2|Withdrawal by Subject|1|||
163960975|NCT01209143|592228789|FG000|Overall Study|Adverse Event|2|||
163960976|NCT01209143|592228790|FG001|Overall Study|Adverse Event|1|||
163960977|NCT01209143|592228789|FG000|Overall Study|Death|0|||
163960978|NCT01209143|592228790|FG001|Overall Study|Death|1|||
163960979|NCT01209143|592228789|FG000|Overall Study|Physician Decision|3|||
163960980|NCT01209143|592228790|FG001|Overall Study|Physician Decision|1|||
163960981|NCT01209143|592228789|FG000|Overall Study|Lost to Follow-up|1|||
163960982|NCT01209143|592228790|FG001|Overall Study|Lost to Follow-up|0|||
163960983|NCT01209143|592228789|FG000|Overall Study|Withdrawal by Subject|2|||
163960984|NCT01209143|592228790|FG001|Overall Study|Withdrawal by Subject|1|||
163960985|NCT01209143|592228789|FG000|Overall Study|Disease progression|11|||
163960986|NCT01209143|592228790|FG001|Overall Study|Disease progression|16|||
163960987|NCT01136811|592228791|FG000|Overall Study|Physician Decision|11|||
163960988|NCT01116882|592228800|FG000|30-day|Lost to Follow-up|50|||
163960989|NCT01116882|592228801|FG001|30-day|Lost to Follow-up|21|||
163960990|NCT01116882|592228800|FG000|30-day|Withdrawal by Subject|2|||
163960991|NCT01116882|592228801|FG001|30-day|Withdrawal by Subject|4|||
163960992|NCT01116882|592228800|FG000|30-day|Other Reasons|16|||
163960993|NCT01116882|592228801|FG001|30-day|Other Reasons|6|||
163960994|NCT01116882|592228800|FG000|12-month|Lost to Follow-up|111|||
163960995|NCT01116882|592228801|FG001|12-month|Lost to Follow-up|42|||
163960996|NCT01116882|592228800|FG000|12-month|Other Reasons|151|||
163960997|NCT01116882|592228801|FG001|12-month|Other Reasons|49|||
163960998|NCT01116882|592228800|FG000|12-month|Withdrawal by Subject|5|||
163960999|NCT01116882|592228801|FG001|12-month|Withdrawal by Subject|8|||
163961000|NCT00547365|592228802|FG000|Overall Study|Physician Decision|1|||
163961001|NCT00547365|592228802|FG000|Overall Study|Lost to Follow-up|1|||
163961002|NCT00547365|592228802|FG000|Overall Study|Protocol Violation|2|||
163961003|NCT00547365|592228802|FG000|Overall Study|death (not related to study)|4|||
163961004|NCT01139658|592228805|FG000|Overall Study|Adverse Event|10|||
163961005|NCT01139658|592228806|FG001|Overall Study|Adverse Event|27|||
163961006|NCT01139658|592228805|FG000|Overall Study|Lack of Efficacy|15|||
163961007|NCT01139658|592228806|FG001|Overall Study|Lack of Efficacy|7|||
163961008|NCT01139658|592228805|FG000|Overall Study|Withdrawal by Subject|2|||
163961009|NCT01139658|592228806|FG001|Overall Study|Withdrawal by Subject|4|||
163961010|NCT01139658|592228805|FG000|Overall Study|No documentation of treatment|1|||
163961011|NCT01139658|592228806|FG001|Overall Study|No documentation of treatment|0|||
163961012|NCT01139658|592228805|FG000|Overall Study|Other|28|||
163961013|NCT01139658|592228806|FG001|Overall Study|Other|75|||
163961014|NCT00753272|592228814|FG000|Overall Study|Adverse Event|878|||
163961015|NCT00753272|592228815|FG001|Overall Study|Adverse Event|869|||
163961016|NCT00753272|592228814|FG000|Overall Study|Protocol Violation|28|||
163961017|NCT00753272|592228815|FG001|Overall Study|Protocol Violation|46|||
163961018|NCT00753272|592228814|FG000|Overall Study|Withdrawal by Subject|2481|||
163961019|NCT00753272|592228815|FG001|Overall Study|Withdrawal by Subject|2407|||
163961020|NCT00753272|592228814|FG000|Overall Study|Lost to Follow-up|491|||
163961021|NCT00753272|592228815|FG001|Overall Study|Lost to Follow-up|497|||
163961022|NCT00753272|592228814|FG000|Overall Study|Other|1104|||
163961023|NCT00753272|592228815|FG001|Overall Study|Other|1088|||
163961024|NCT02092220|592228818|FG000|Period 1|Unrelated Illness|0|||
163961025|NCT02092220|592228819|FG001|Period 1|Unrelated Illness|2|||
163961026|NCT02092220|592228818|FG000|Period 2|Severe Hypoglycaemia|1|||
163961027|NCT02092220|592228819|FG001|Period 2|Severe Hypoglycaemia|0|||
163961028|NCT02092220|592228818|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
163961029|NCT02092220|592228819|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
163961030|NCT00960531|592228820|FG000|Overall Study|Lack of Efficacy|1|||
163961031|NCT00960531|592228821|FG001|Overall Study|Lack of Efficacy|0|||
163961032|NCT00960531|592228822|FG002|Overall Study|Lack of Efficacy|0|||
163961033|NCT00960531|592228823|FG003|Overall Study|Lack of Efficacy|0|||
163961034|NCT00960531|592228824|FG004|Overall Study|Lack of Efficacy|0|||
163961035|NCT00960531|592228825|FG005|Overall Study|Lack of Efficacy|0|||
163961036|NCT00960531|592228826|FG006|Overall Study|Lack of Efficacy|0|||
163961037|NCT00960531|592228827|FG007|Overall Study|Lack of Efficacy|0|||
163961038|NCT00960531|592228828|FG008|Overall Study|Lack of Efficacy|0|||
163961039|NCT00960531|592228829|FG009|Overall Study|Lack of Efficacy|0|||
163961040|NCT00960531|592228820|FG000|Overall Study|Withdrawal by Subject|1|||
163961041|NCT00960531|592228821|FG001|Overall Study|Withdrawal by Subject|0|||
163961042|NCT00960531|592228822|FG002|Overall Study|Withdrawal by Subject|5|||
163961043|NCT00960531|592228823|FG003|Overall Study|Withdrawal by Subject|2|||
163961044|NCT00960531|592228824|FG004|Overall Study|Withdrawal by Subject|0|||
163961045|NCT00960531|592228825|FG005|Overall Study|Withdrawal by Subject|0|||
163961046|NCT00960531|592228826|FG006|Overall Study|Withdrawal by Subject|2|||
163961047|NCT00960531|592228827|FG007|Overall Study|Withdrawal by Subject|0|||
163961048|NCT00960531|592228828|FG008|Overall Study|Withdrawal by Subject|1|||
163961049|NCT00960531|592228829|FG009|Overall Study|Withdrawal by Subject|0|||
163961050|NCT00960531|592228820|FG000|Overall Study|Caregiver Request|2|||
163961051|NCT00960531|592228821|FG001|Overall Study|Caregiver Request|0|||
163961052|NCT00960531|592228822|FG002|Overall Study|Caregiver Request|6|||
163961053|NCT00960531|592228823|FG003|Overall Study|Caregiver Request|5|||
163961054|NCT00960531|592228824|FG004|Overall Study|Caregiver Request|0|||
163961055|NCT00960531|592228825|FG005|Overall Study|Caregiver Request|2|||
163961056|NCT00960531|592228826|FG006|Overall Study|Caregiver Request|3|||
163961057|NCT00960531|592228827|FG007|Overall Study|Caregiver Request|1|||
163849675|NCT01734382|591820480|FG001|Part 2|Protocol Violation|1|||
163849676|NCT01734382|591820481|FG002|Part 2|Protocol Violation|0|||
163849677|NCT01734382|591820479|FG000|Part 2|Withdrawal by Subject|0|||
163849678|NCT01734382|591820480|FG001|Part 2|Withdrawal by Subject|0|||
163849679|NCT01734382|591820481|FG002|Part 2|Withdrawal by Subject|1|||
163849680|NCT04537949|591820482|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
163849681|NCT04537949|591820483|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
163849682|NCT04537949|591820484|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
163849683|NCT04537949|591820485|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
163849684|NCT04537949|591820486|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
163849685|NCT04537949|591820487|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
163849686|NCT04537949|591820488|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
163849687|NCT04537949|591820489|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
163849688|NCT04537949|591820482|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
163849689|NCT04537949|591820483|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
163849690|NCT04537949|591820484|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
163849691|NCT04537949|591820485|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
163849692|NCT04537949|591820486|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
163849693|NCT04537949|591820487|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
163849694|NCT04537949|591820488|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
163849695|NCT04537949|591820489|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
163849696|NCT04537949|591820482|FG000|Follow-up Phase|Lost to Follow-up|0|||
163849697|NCT04537949|591820483|FG001|Follow-up Phase|Lost to Follow-up|3|||
163849698|NCT04537949|591820484|FG002|Follow-up Phase|Lost to Follow-up|0|||
163849699|NCT04537949|591820485|FG003|Follow-up Phase|Lost to Follow-up|0|||
163849700|NCT04537949|591820486|FG004|Follow-up Phase|Lost to Follow-up|0|||
163849701|NCT04537949|591820487|FG005|Follow-up Phase|Lost to Follow-up|0|||
163849702|NCT04537949|591820488|FG006|Follow-up Phase|Lost to Follow-up|0|||
163849703|NCT04537949|591820489|FG007|Follow-up Phase|Lost to Follow-up|0|||
163849704|NCT04537949|591820482|FG000|Follow-up Phase|personal reasons|0|||
163849705|NCT04537949|591820483|FG001|Follow-up Phase|personal reasons|0|||
163849706|NCT04537949|591820484|FG002|Follow-up Phase|personal reasons|0|||
163849707|NCT04537949|591820485|FG003|Follow-up Phase|personal reasons|1|||
163849708|NCT04537949|591820486|FG004|Follow-up Phase|personal reasons|1|||
163849709|NCT04537949|591820487|FG005|Follow-up Phase|personal reasons|0|||
163849710|NCT04537949|591820488|FG006|Follow-up Phase|personal reasons|0|||
163849711|NCT04537949|591820489|FG007|Follow-up Phase|personal reasons|0|||
163849712|NCT04537949|591820482|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163849713|NCT04537949|591820483|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163849714|NCT04537949|591820484|FG002|Follow-up Phase|Withdrawal by Subject|0|||
163849715|NCT04537949|591820485|FG003|Follow-up Phase|Withdrawal by Subject|0|||
163849716|NCT04537949|591820486|FG004|Follow-up Phase|Withdrawal by Subject|1|||
163849717|NCT04537949|591820487|FG005|Follow-up Phase|Withdrawal by Subject|0|||
163849718|NCT04537949|591820488|FG006|Follow-up Phase|Withdrawal by Subject|0|||
163849719|NCT04537949|591820489|FG007|Follow-up Phase|Withdrawal by Subject|0|||
163849720|NCT01349660|591820491|FG000|Overall Study|Still Receiving Study Treatment|0|||
163849721|NCT01349660|591820492|FG001|Overall Study|Still Receiving Study Treatment|0|||
163849722|NCT01349660|591820493|FG002|Overall Study|Still Receiving Study Treatment|1|||
163849723|NCT01349660|591820491|FG000|Overall Study|Disease Progression|2|||
163849724|NCT01349660|591820492|FG001|Overall Study|Disease Progression|4|||
163849725|NCT01349660|591820493|FG002|Overall Study|Disease Progression|50|||
163849726|NCT01349660|591820491|FG000|Overall Study|Adverse Event|1|||
163849727|NCT01349660|591820492|FG001|Overall Study|Adverse Event|1|||
163849728|NCT01349660|591820493|FG002|Overall Study|Adverse Event|12|||
163849729|NCT01349660|591820491|FG000|Overall Study|Withdrawal by Subject|2|||
163849730|NCT01349660|591820492|FG001|Overall Study|Withdrawal by Subject|0|||
163849731|NCT01349660|591820493|FG002|Overall Study|Withdrawal by Subject|9|||
163849732|NCT01349660|591820491|FG000|Overall Study|Death|1|||
163849733|NCT01349660|591820492|FG001|Overall Study|Death|1|||
163849734|NCT01349660|591820493|FG002|Overall Study|Death|0|||
163849735|NCT01349660|591820491|FG000|Overall Study|Non-Permitted Interventions|0|||
163849736|NCT01349660|591820492|FG001|Overall Study|Non-Permitted Interventions|0|||
163849737|NCT01349660|591820493|FG002|Overall Study|Non-Permitted Interventions|2|||
163849738|NCT01349660|591820491|FG000|Overall Study|Study Compliance|0|||
163849739|NCT01349660|591820492|FG001|Overall Study|Study Compliance|0|||
163849740|NCT01349660|591820493|FG002|Overall Study|Study Compliance|1|||
163849741|NCT01349660|591820491|FG000|Overall Study|Declining Performance Status|0|||
163849742|NCT01349660|591820492|FG001|Overall Study|Declining Performance Status|0|||
163849743|NCT01349660|591820493|FG002|Overall Study|Declining Performance Status|1|||
163849744|NCT05593211|591820494|FG000|Overall Study|Withdrawal by Subject|1|||
163849745|NCT03225846|591820495|FG000|Overall Study|Adverse Event|0|||
163849746|NCT03225846|591820496|FG001|Overall Study|Adverse Event|0|||
163849747|NCT03225846|591820497|FG002|Overall Study|Adverse Event|0|||
163961058|NCT00960531|592228828|FG008|Overall Study|Caregiver Request|3|||
163961059|NCT00960531|592228829|FG009|Overall Study|Caregiver Request|0|||
163961060|NCT00960531|592228820|FG000|Overall Study|Investigator Request|0|||
163961061|NCT00960531|592228821|FG001|Overall Study|Investigator Request|0|||
163961062|NCT00960531|592228822|FG002|Overall Study|Investigator Request|1|||
163961063|NCT00960531|592228823|FG003|Overall Study|Investigator Request|0|||
163961064|NCT00960531|592228824|FG004|Overall Study|Investigator Request|0|||
163961065|NCT00960531|592228825|FG005|Overall Study|Investigator Request|0|||
163961066|NCT00960531|592228826|FG006|Overall Study|Investigator Request|0|||
163961067|NCT00960531|592228827|FG007|Overall Study|Investigator Request|0|||
163961068|NCT00960531|592228828|FG008|Overall Study|Investigator Request|0|||
163961069|NCT00960531|592228829|FG009|Overall Study|Investigator Request|0|||
163961070|NCT00960531|592228820|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
163961071|NCT00960531|592228821|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163961072|NCT00960531|592228822|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
163961073|NCT00960531|592228823|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
163961074|NCT00960531|592228824|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
163961075|NCT00960531|592228825|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
163961076|NCT00960531|592228826|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
163961077|NCT00960531|592228827|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
163961078|NCT00960531|592228828|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
163961079|NCT00960531|592228829|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
163961080|NCT00960531|592228820|FG000|Overall Study|Lost to Follow-up|0|||
163961081|NCT00960531|592228821|FG001|Overall Study|Lost to Follow-up|0|||
163961082|NCT00960531|592228822|FG002|Overall Study|Lost to Follow-up|1|||
163961083|NCT00960531|592228823|FG003|Overall Study|Lost to Follow-up|0|||
163961084|NCT00960531|592228824|FG004|Overall Study|Lost to Follow-up|0|||
163961085|NCT00960531|592228825|FG005|Overall Study|Lost to Follow-up|0|||
163961086|NCT00960531|592228826|FG006|Overall Study|Lost to Follow-up|1|||
163961087|NCT00960531|592228827|FG007|Overall Study|Lost to Follow-up|0|||
163961088|NCT00960531|592228828|FG008|Overall Study|Lost to Follow-up|0|||
163961089|NCT00960531|592228829|FG009|Overall Study|Lost to Follow-up|0|||
163961090|NCT00960531|592228820|FG000|Overall Study|Failed to Return|2|||
163961091|NCT00960531|592228821|FG001|Overall Study|Failed to Return|0|||
163961092|NCT00960531|592228822|FG002|Overall Study|Failed to Return|0|||
163961093|NCT00960531|592228823|FG003|Overall Study|Failed to Return|0|||
163961094|NCT00960531|592228824|FG004|Overall Study|Failed to Return|0|||
163961095|NCT00960531|592228825|FG005|Overall Study|Failed to Return|0|||
163961096|NCT00960531|592228826|FG006|Overall Study|Failed to Return|0|||
163961097|NCT00960531|592228827|FG007|Overall Study|Failed to Return|2|||
163961098|NCT00960531|592228828|FG008|Overall Study|Failed to Return|0|||
163961099|NCT00960531|592228829|FG009|Overall Study|Failed to Return|0|||
163961100|NCT00960531|592228820|FG000|Overall Study|Adverse Event (AE)|2|||
163961101|NCT00960531|592228821|FG001|Overall Study|Adverse Event (AE)|0|||
163961102|NCT00960531|592228822|FG002|Overall Study|Adverse Event (AE)|0|||
163961103|NCT00960531|592228823|FG003|Overall Study|Adverse Event (AE)|0|||
163961104|NCT00960531|592228824|FG004|Overall Study|Adverse Event (AE)|0|||
163961105|NCT00960531|592228825|FG005|Overall Study|Adverse Event (AE)|1|||
163961106|NCT00960531|592228826|FG006|Overall Study|Adverse Event (AE)|2|||
163961107|NCT00960531|592228827|FG007|Overall Study|Adverse Event (AE)|0|||
163961108|NCT00960531|592228828|FG008|Overall Study|Adverse Event (AE)|2|||
163961109|NCT00960531|592228829|FG009|Overall Study|Adverse Event (AE)|0|||
163961110|NCT00960531|592228820|FG000|Overall Study|Reason not Specified|2|||
163961111|NCT00960531|592228821|FG001|Overall Study|Reason not Specified|1|||
163961112|NCT00960531|592228822|FG002|Overall Study|Reason not Specified|13|||
163961113|NCT00960531|592228823|FG003|Overall Study|Reason not Specified|1|||
163961114|NCT00960531|592228824|FG004|Overall Study|Reason not Specified|2|||
163961115|NCT00960531|592228825|FG005|Overall Study|Reason not Specified|0|||
163961116|NCT00960531|592228826|FG006|Overall Study|Reason not Specified|16|||
163961117|NCT00960531|592228827|FG007|Overall Study|Reason not Specified|0|||
163961118|NCT00960531|592228828|FG008|Overall Study|Reason not Specified|8|||
163961119|NCT00960531|592228829|FG009|Overall Study|Reason not Specified|1|||
163961120|NCT00593957|592228830|FG000|Overall Study|Physician Decision|0|||
163961121|NCT00593957|592228831|FG001|Overall Study|Physician Decision|1|||
163961122|NCT00593957|592228832|FG002|Overall Study|Physician Decision|2|||
163961123|NCT00494481|592228835|FG000|Overall Study|Condition under investigation worsened|11|||
163961124|NCT00494481|592228836|FG001|Overall Study|Condition under investigation worsened|13|||
163961125|NCT00494481|592228835|FG000|Overall Study|Adverse Event|15|||
163961126|NCT00494481|592228836|FG001|Overall Study|Adverse Event|11|||
163961127|NCT00494481|592228835|FG000|Overall Study|Other|1|||
163961128|NCT00494481|592228836|FG001|Overall Study|Other|0|||
163961129|NCT00494481|592228835|FG000|Overall Study|Never received IP|2|||
163961130|NCT00494481|592228836|FG001|Overall Study|Never received IP|0|||
163961131|NCT01030198|592228837|FG000|Overall Study|Could not measure efficacy accurately|0|||
163961132|NCT01030198|592228838|FG001|Overall Study|Could not measure efficacy accurately|7|||
163961133|NCT01411839|592228840|FG000|Overall Study|Lost to Follow-up|4|||
163961134|NCT01411839|592228841|FG001|Overall Study|Lost to Follow-up|3|||
163961135|NCT05089656|592228842|FG000|Period 1 - First Intervention (52 weeks)|Physician Decision|1|||
163961136|NCT05089656|592228843|FG001|Period 1 - First Intervention (52 weeks)|Physician Decision|0|||
163961137|NCT05089656|592228842|FG000|Period 1 - First Intervention (52 weeks)|Guardian decision|1|||
163961138|NCT05089656|592228843|FG001|Period 1 - First Intervention (52 weeks)|Guardian decision|0|||
163961139|NCT05089656|592228842|FG000|Period 1 - First Intervention (52 weeks)|Adverse Event|0|||
163961140|NCT05089656|592228843|FG001|Period 1 - First Intervention (52 weeks)|Adverse Event|1|||
163961141|NCT05089656|592228842|FG000|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|6|||
163961142|NCT05089656|592228843|FG001|Period 1 - First Intervention (52 weeks)|Protocol-specified withdrawal criterion met|4|||
163961143|NCT02535416|592228844|FG000|Overall Study|Family bereavement overseas|1|||
163961144|NCT02535416|592228845|FG001|Overall Study|Family bereavement overseas|0|||
163961145|NCT02535416|592228846|FG002|Overall Study|Family bereavement overseas|0|||
163961146|NCT02535416|592228847|FG003|Overall Study|Family bereavement overseas|0|||
163961147|NCT02535416|592228848|FG004|Overall Study|Family bereavement overseas|0|||
163961148|NCT02535416|592228849|FG005|Overall Study|Family bereavement overseas|0|||
163961149|NCT02535416|592228850|FG006|Overall Study|Family bereavement overseas|0|||
163961150|NCT02535416|592228851|FG007|Overall Study|Family bereavement overseas|0|||
163961151|NCT02535416|592228852|FG008|Overall Study|Family bereavement overseas|0|||
163961152|NCT04641299|592230477|FG000|Overall Study|Adverse Event|0|||
163961153|NCT04641299|592230478|FG001|Overall Study|Adverse Event|0|||
163961154|NCT04641299|592230479|FG002|Overall Study|Adverse Event|2|||
163961155|NCT04641299|592230480|FG003|Overall Study|Adverse Event|0|||
163961156|NCT04641299|592230477|FG000|Overall Study|Lost to Follow-up|0|||
163961157|NCT04641299|592230478|FG001|Overall Study|Lost to Follow-up|1|||
163961158|NCT04641299|592230479|FG002|Overall Study|Lost to Follow-up|0|||
163961159|NCT04641299|592230480|FG003|Overall Study|Lost to Follow-up|0|||
163961160|NCT04641299|592230477|FG000|Overall Study|Withdrawal by Subject|1|||
163961161|NCT04641299|592230478|FG001|Overall Study|Withdrawal by Subject|0|||
163961162|NCT04641299|592230479|FG002|Overall Study|Withdrawal by Subject|0|||
163961163|NCT04641299|592230480|FG003|Overall Study|Withdrawal by Subject|0|||
163961164|NCT04641299|592230477|FG000|Overall Study|Reason not given|1|||
163961165|NCT04641299|592230478|FG001|Overall Study|Reason not given|0|||
163961166|NCT04641299|592230479|FG002|Overall Study|Reason not given|0|||
163961167|NCT04641299|592230480|FG003|Overall Study|Reason not given|0|||
163961168|NCT01890148|592230483|FG000|Overall Study|Adverse Event|1|||
163961169|NCT05736211|592230495|FG000|Overall Study|Lost to Follow-up|6|||
163961170|NCT05736211|592230496|FG001|Overall Study|Lost to Follow-up|0|||
163961171|NCT05104476|592230499|FG000|Overall Study|Randomized But Not Treated|1|||
163961172|NCT05104476|592230500|FG001|Overall Study|Randomized But Not Treated|2|||
163961173|NCT05104476|592230499|FG000|Overall Study|Adverse Event|2|||
163961174|NCT05104476|592230500|FG001|Overall Study|Adverse Event|2|||
163961175|NCT05104476|592230499|FG000|Overall Study|Withdrawal by Subject|3|||
163961176|NCT05104476|592230500|FG001|Overall Study|Withdrawal by Subject|3|||
163961177|NCT05104476|592230499|FG000|Overall Study|Other Than Specified|0|||
163961178|NCT05104476|592230500|FG001|Overall Study|Other Than Specified|3|||
163961179|NCT01176968|592230504|FG000|Overall Study|Adverse Event|10|||
163961180|NCT01176968|592230505|FG001|Overall Study|Adverse Event|11|||
163961181|NCT01176968|592230504|FG000|Overall Study|Death|2|||
163961182|NCT01176968|592230505|FG001|Overall Study|Death|3|||
163961183|NCT01176968|592230504|FG000|Overall Study|Lack of Efficacy|0|||
163961184|NCT01176968|592230505|FG001|Overall Study|Lack of Efficacy|1|||
163961185|NCT01176968|592230504|FG000|Overall Study|Lost to Follow-up|16|||
163961186|NCT01176968|592230505|FG001|Overall Study|Lost to Follow-up|14|||
163961187|NCT01176968|592230504|FG000|Overall Study|Withdrawal by Subject|48|||
163961188|NCT01176968|592230505|FG001|Overall Study|Withdrawal by Subject|48|||
163961189|NCT01176968|592230504|FG000|Overall Study|Protocol Violation|2|||
163961190|NCT01176968|592230505|FG001|Overall Study|Protocol Violation|1|||
163961191|NCT01176968|592230504|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
163961192|NCT01176968|592230505|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
163961193|NCT01176968|592230504|FG000|Overall Study|Study terminated by sponsor|0|||
163961194|NCT01176968|592230505|FG001|Overall Study|Study terminated by sponsor|1|||
163961195|NCT01176968|592230504|FG000|Overall Study|Reason not defined|5|||
163961196|NCT01176968|592230505|FG001|Overall Study|Reason not defined|3|||
163961197|NCT04658186|592230506|FG000|Overall Study|Adverse Event|4|||
163961198|NCT04658186|592230507|FG001|Overall Study|Adverse Event|18|||
163961199|NCT04658186|592230508|FG002|Overall Study|Adverse Event|15|||
163961200|NCT04658186|592230506|FG000|Overall Study|Lack of Efficacy|1|||
163961201|NCT04658186|592230507|FG001|Overall Study|Lack of Efficacy|1|||
163961202|NCT04658186|592230508|FG002|Overall Study|Lack of Efficacy|0|||
163961203|NCT04658186|592230506|FG000|Overall Study|Protocol Violation|0|||
163961204|NCT04658186|592230507|FG001|Overall Study|Protocol Violation|0|||
163961205|NCT04658186|592230508|FG002|Overall Study|Protocol Violation|1|||
163961206|NCT04658186|592230506|FG000|Overall Study|Lost to Follow-up|0|||
163961207|NCT04658186|592230507|FG001|Overall Study|Lost to Follow-up|0|||
163961208|NCT04658186|592230508|FG002|Overall Study|Lost to Follow-up|2|||
163961209|NCT04658186|592230506|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
163849748|NCT03225846|591820498|FG003|Overall Study|Adverse Event|0|||
163849749|NCT03225846|591820499|FG004|Overall Study|Adverse Event|0|||
163849750|NCT03225846|591820500|FG005|Overall Study|Adverse Event|0|||
163849751|NCT03225846|591820501|FG006|Overall Study|Adverse Event|6|||
163849752|NCT03225846|591820495|FG000|Overall Study|Withdrawal by Subject|0|||
163849753|NCT03225846|591820496|FG001|Overall Study|Withdrawal by Subject|1|||
163849754|NCT03225846|591820497|FG002|Overall Study|Withdrawal by Subject|0|||
163849755|NCT03225846|591820498|FG003|Overall Study|Withdrawal by Subject|0|||
163849756|NCT03225846|591820499|FG004|Overall Study|Withdrawal by Subject|0|||
163849757|NCT03225846|591820500|FG005|Overall Study|Withdrawal by Subject|0|||
163849758|NCT03225846|591820501|FG006|Overall Study|Withdrawal by Subject|0|||
163849759|NCT03225846|591820495|FG000|Overall Study|Death|0|||
163849760|NCT03225846|591820496|FG001|Overall Study|Death|1|||
163849761|NCT03225846|591820497|FG002|Overall Study|Death|0|||
163849762|NCT03225846|591820498|FG003|Overall Study|Death|0|||
163849763|NCT03225846|591820499|FG004|Overall Study|Death|0|||
163849764|NCT03225846|591820500|FG005|Overall Study|Death|0|||
163849765|NCT03225846|591820501|FG006|Overall Study|Death|0|||
163849766|NCT03225846|591820495|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
163849767|NCT03225846|591820496|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
163849768|NCT03225846|591820497|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
163849769|NCT03225846|591820498|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
163849770|NCT03225846|591820499|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
163849771|NCT03225846|591820500|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
163849772|NCT03225846|591820501|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
163849773|NCT03225846|591820495|FG000|Overall Study|Patient decision|0|||
163849774|NCT03225846|591820496|FG001|Overall Study|Patient decision|0|||
163849775|NCT03225846|591820497|FG002|Overall Study|Patient decision|0|||
163849776|NCT03225846|591820498|FG003|Overall Study|Patient decision|0|||
163849777|NCT03225846|591820499|FG004|Overall Study|Patient decision|0|||
163849778|NCT03225846|591820500|FG005|Overall Study|Patient decision|0|||
163849779|NCT03225846|591820501|FG006|Overall Study|Patient decision|1|||
163849780|NCT04248465|591820502|FG000|Randomized-Controlled Period|Death|12|||
163849781|NCT04248465|591820503|FG001|Randomized-Controlled Period|Death|5|||
163849782|NCT04248465|591820502|FG000|Randomized-Controlled Period|Adverse Event|2|||
163849783|NCT04248465|591820503|FG001|Randomized-Controlled Period|Adverse Event|0|||
163849784|NCT04248465|591820502|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
163849785|NCT04248465|591820503|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
163849786|NCT04248465|591820502|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
163849787|NCT04248465|591820503|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
163849788|NCT04248465|591820502|FG000|Randomized-Controlled Period|Physician Decision|1|||
163849789|NCT04248465|591820503|FG001|Randomized-Controlled Period|Physician Decision|1|||
163849790|NCT04248465|591820502|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
163849791|NCT04248465|591820503|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
163849792|NCT04248465|591820502|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
163849793|NCT04248465|591820503|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
163849794|NCT04248465|591820502|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163849795|NCT04248465|591820503|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
163849796|NCT00810641|591820511|FG000|Overall Study|Withdrawal by Subject|0|||
163849797|NCT00810641|591820512|FG001|Overall Study|Withdrawal by Subject|1|||
163849798|NCT00810641|591820513|FG002|Overall Study|Withdrawal by Subject|2|||
163849799|NCT01213173|591820517|FG000|Overall Study|Protocol Violation|2|||
163849800|NCT01213173|591820518|FG001|Overall Study|Protocol Violation|0|||
163849801|NCT01213173|591820517|FG000|Overall Study|Adverse Event|4|||
163849802|NCT01213173|591820518|FG001|Overall Study|Adverse Event|8|||
163849803|NCT01213173|591820517|FG000|Overall Study|Withdrawal by Subject|5|||
163849804|NCT01213173|591820518|FG001|Overall Study|Withdrawal by Subject|5|||
163849805|NCT01213173|591820517|FG000|Overall Study|Incorrect Enrollment|1|||
163849806|NCT01213173|591820518|FG001|Overall Study|Incorrect Enrollment|3|||
163849807|NCT02253316|591820519|FG000|Consolidation|Progression|4|||
163849808|NCT02253316|591820520|FG001|Consolidation|Progression|0|||
163849809|NCT02253316|591820521|FG002|Consolidation|Progression|0|||
163849810|NCT02253316|591820519|FG000|Consolidation|Non-Compliance|1|||
163849811|NCT02253316|591820520|FG001|Consolidation|Non-Compliance|0|||
163849812|NCT02253316|591820521|FG002|Consolidation|Non-Compliance|0|||
163849813|NCT02253316|591820519|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
163849814|NCT02253316|591820520|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
163849815|NCT02253316|591820521|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
163849816|NCT02253316|591820519|FG000|Consolidation|Secondary Malignancy|2|||
163849817|NCT02253316|591820520|FG001|Consolidation|Secondary Malignancy|0|||
163849818|NCT02253316|591820521|FG002|Consolidation|Secondary Malignancy|0|||
163849819|NCT02253316|591820519|FG000|Consolidation|Adverse Event|7|||
163849820|NCT02253316|591820520|FG001|Consolidation|Adverse Event|0|||
163849821|NCT02253316|591820521|FG002|Consolidation|Adverse Event|0|||
163849822|NCT02253316|591820519|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
163961210|NCT04658186|592230507|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
163961211|NCT04658186|592230508|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
163961212|NCT04658186|592230506|FG000|Overall Study|Participant is Moving in Another Province|0|||
163961213|NCT04658186|592230507|FG001|Overall Study|Participant is Moving in Another Province|1|||
163961214|NCT04658186|592230508|FG002|Overall Study|Participant is Moving in Another Province|0|||
163961215|NCT04658186|592230506|FG000|Overall Study|Non-Compliance|0|||
163961216|NCT04658186|592230507|FG001|Overall Study|Non-Compliance|1|||
163961217|NCT04658186|592230508|FG002|Overall Study|Non-Compliance|1|||
163961218|NCT04658186|592230506|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
163961219|NCT04658186|592230507|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
163961220|NCT04658186|592230508|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
163961221|NCT04658186|592230506|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
163961222|NCT04658186|592230507|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
163961223|NCT04658186|592230508|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
163961224|NCT04658186|592230506|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
163961225|NCT04658186|592230507|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
163961226|NCT04658186|592230508|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
163961227|NCT04658186|592230506|FG000|Overall Study|PI Decision due to Participant Safety|0|||
163961228|NCT04658186|592230507|FG001|Overall Study|PI Decision due to Participant Safety|0|||
163961229|NCT04658186|592230508|FG002|Overall Study|PI Decision due to Participant Safety|1|||
163961230|NCT04658186|592230506|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
163961231|NCT04658186|592230507|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
163961232|NCT04658186|592230508|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
163961233|NCT05057247|592230523|FG000|Overall Study|Death|4|||
163961234|NCT05057247|592230523|FG000|Overall Study|Physician Decision|3|||
163961235|NCT05057247|592230523|FG000|Overall Study|Progressive Disease|7|||
163961236|NCT05057247|592230523|FG000|Overall Study|Withdrawal by Subject|3|||
163961237|NCT05057247|592230523|FG000|Overall Study|Adverse Event|6|||
163961238|NCT05057247|592230523|FG000|Overall Study|Subject Non-Compliance|1|||
163961239|NCT05057247|592230523|FG000|Overall Study|On treatment|2|||
163961240|NCT00528866|592230524|FG000|Overall Study|Protocol Violation|6|||
163961241|NCT00993915|592230525|FG000|Overall Study|Insufficient clinical response|3|||
163961242|NCT00993915|592230525|FG000|Overall Study|Withdrawal by Subject|2|||
163961243|NCT00993915|592230525|FG000|Overall Study|Other|1|||
163961244|NCT00993915|592230525|FG000|Overall Study|Ongoing|3|||
163961245|NCT02465463|592230526|FG000|Overall Study|Lost to Follow-up|2|||
163961246|NCT02465463|592230527|FG001|Overall Study|Lost to Follow-up|1|||
163961247|NCT02465463|592230526|FG000|Overall Study|Death|1|||
163961248|NCT02465463|592230527|FG001|Overall Study|Death|0|||
163961249|NCT02465463|592230526|FG000|Overall Study|Protocol Violation|1|||
163961250|NCT02465463|592230527|FG001|Overall Study|Protocol Violation|0|||
163961251|NCT01067326|592230532|FG000|Overall Study|Adverse Event|0|||
163961252|NCT01067326|592230533|FG001|Overall Study|Adverse Event|2|||
163961253|NCT01067326|592230532|FG000|Overall Study|Withdrawal by Subject|1|||
163961254|NCT01067326|592230533|FG001|Overall Study|Withdrawal by Subject|0|||
163961255|NCT01067326|592230532|FG000|Overall Study|Early Study Termination|1|||
163961256|NCT01067326|592230533|FG001|Overall Study|Early Study Termination|1|||
163961257|NCT00323297|592230534|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
163961258|NCT00323297|592230535|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
163961259|NCT00323297|592230534|FG000|Part A (Double Blind Randomized)|Death|0|||
163961260|NCT00323297|592230535|FG001|Part A (Double Blind Randomized)|Death|1|||
163961261|NCT00323297|592230534|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
163961262|NCT00323297|592230535|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
163961263|NCT00323297|592230534|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
163961264|NCT00323297|592230535|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
163961265|NCT00323297|592230534|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
163961266|NCT00323297|592230535|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
163961267|NCT00323297|592230534|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
163961268|NCT00323297|592230535|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
163961269|NCT00323297|592230534|FG000|Part B (Open-label)|Death|0|||
163961270|NCT00323297|592230535|FG001|Part B (Open-label)|Death|1|||
163961271|NCT00323297|592230534|FG000|Part B (Open-label)|Reason unspecified|0|||
163961272|NCT00323297|592230535|FG001|Part B (Open-label)|Reason unspecified|1|||
163961273|NCT00323297|592230534|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
163961274|NCT00323297|592230535|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
163961275|NCT00323297|592230534|FG000|Part B (Open-label)|Lack of Efficacy|3|||
163961276|NCT00323297|592230535|FG001|Part B (Open-label)|Lack of Efficacy|1|||
163961277|NCT00323297|592230534|FG000|Part B (Open-label)|Adverse Event|5|||
163961278|NCT00323297|592230535|FG001|Part B (Open-label)|Adverse Event|5|||
163961279|NCT00323297|592230534|FG000|Part B (Open-label)|Protocol Violation|0|||
163961280|NCT00323297|592230535|FG001|Part B (Open-label)|Protocol Violation|1|||
163961281|NCT01176773|592230536|FG000|Overall Study|Screen Failure|2|||
163849823|NCT02253316|591820520|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
163849824|NCT02253316|591820521|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
163849825|NCT02253316|591820519|FG000|Maintenance|Physician Decision|0|||
163849826|NCT02253316|591820520|FG001|Maintenance|Physician Decision|7|||
163849827|NCT02253316|591820521|FG002|Maintenance|Physician Decision|16|||
163849828|NCT02253316|591820519|FG000|Maintenance|Non-Compliance|0|||
163849829|NCT02253316|591820520|FG001|Maintenance|Non-Compliance|1|||
163849830|NCT02253316|591820521|FG002|Maintenance|Non-Compliance|1|||
163849831|NCT02253316|591820519|FG000|Maintenance|Secondary Malignancy|0|||
163849832|NCT02253316|591820520|FG001|Maintenance|Secondary Malignancy|2|||
163849833|NCT02253316|591820521|FG002|Maintenance|Secondary Malignancy|6|||
163849834|NCT02253316|591820519|FG000|Maintenance|Adverse Event|0|||
163849835|NCT02253316|591820520|FG001|Maintenance|Adverse Event|8|||
163849836|NCT02253316|591820521|FG002|Maintenance|Adverse Event|12|||
163849837|NCT02253316|591820519|FG000|Maintenance|Still receiving active treatment|0|||
163849838|NCT02253316|591820520|FG001|Maintenance|Still receiving active treatment|4|||
163849839|NCT02253316|591820521|FG002|Maintenance|Still receiving active treatment|0|||
163849840|NCT02684903|591820522|FG000|Overall Study|COVID-19 shutdown of lab|4|||
163849841|NCT02684903|591820523|FG001|Overall Study|COVID-19 shutdown of lab|6|||
163849842|NCT02684903|591820522|FG000|Overall Study|Lost to Follow-up|31|||
163849843|NCT02684903|591820523|FG001|Overall Study|Lost to Follow-up|41|||
163849844|NCT06403605|591820528|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
163849845|NCT06403605|591820529|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
163849846|NCT06403605|591820528|FG000|Follow-up|Adverse Event|4|||
163849847|NCT06403605|591820529|FG001|Follow-up|Adverse Event|2|||
163849848|NCT06403605|591820528|FG000|Follow-up|Withdrawal by Subject|2|||
163849849|NCT06403605|591820529|FG001|Follow-up|Withdrawal by Subject|3|||
163849850|NCT06403605|591820528|FG000|Follow-up|Lost to Follow-up|1|||
163849851|NCT06403605|591820529|FG001|Follow-up|Lost to Follow-up|0|||
163849852|NCT06403605|591820528|FG000|Follow-up|Death|1|||
163849853|NCT06403605|591820529|FG001|Follow-up|Death|0|||
163849854|NCT06403605|591820528|FG000|Follow-up|Other reasons|0|||
163849855|NCT06403605|591820529|FG001|Follow-up|Other reasons|4|||
163849856|NCT07083843|591820530|FG000|Intervention period.|Withdrawal by Subject|1|||
163849857|NCT07083843|591820531|FG001|Intervention period.|Withdrawal by Subject|0|||
163849858|NCT07083843|591820530|FG000|Intervention period.|Death|0|||
163849859|NCT07083843|591820531|FG001|Intervention period.|Death|1|||
163849860|NCT02153788|591822378|FG000|Overall Study|Physician Decision|2|||
163849861|NCT02153788|591822379|FG001|Overall Study|Physician Decision|1|||
163849862|NCT01106287|591822380|FG000|Overall Study|Adverse Event|1|||
163849863|NCT01106287|591822381|FG001|Overall Study|Adverse Event|0|||
163849864|NCT01106287|591822382|FG002|Overall Study|Adverse Event|0|||
163849865|NCT01106287|591822383|FG003|Overall Study|Adverse Event|0|||
163849866|NCT01450943|591822386|FG000|Overall Study|Screen failure, loss to follow-up|2|||
163849867|NCT01450943|591822387|FG001|Overall Study|Screen failure, loss to follow-up|7|||
163849868|NCT01450943|591822388|FG002|Overall Study|Screen failure, loss to follow-up|6|||
163849869|NCT00557505|591822389|FG000|Overall Study|Death|0|||
163849870|NCT00557505|591822390|FG001|Overall Study|Death|0|||
163849871|NCT00557505|591822391|FG002|Overall Study|Death|0|||
163849872|NCT00557505|591822392|FG003|Overall Study|Death|0|||
163849873|NCT00557505|591822393|FG004|Overall Study|Death|0|||
163849874|NCT00557505|591822394|FG005|Overall Study|Death|0|||
163849875|NCT00557505|591822395|FG006|Overall Study|Death|0|||
163849876|NCT00557505|591822396|FG007|Overall Study|Death|0|||
163849877|NCT00557505|591822397|FG008|Overall Study|Death|1|||
163849878|NCT00557505|591822389|FG000|Overall Study|Adverse Event|0|||
163849879|NCT00557505|591822390|FG001|Overall Study|Adverse Event|0|||
163849880|NCT00557505|591822391|FG002|Overall Study|Adverse Event|1|||
163849881|NCT00557505|591822392|FG003|Overall Study|Adverse Event|0|||
163849882|NCT00557505|591822393|FG004|Overall Study|Adverse Event|0|||
163849883|NCT00557505|591822394|FG005|Overall Study|Adverse Event|0|||
163849884|NCT00557505|591822395|FG006|Overall Study|Adverse Event|1|||
163849885|NCT00557505|591822396|FG007|Overall Study|Adverse Event|0|||
163849886|NCT00557505|591822397|FG008|Overall Study|Adverse Event|0|||
163849887|NCT00557505|591822389|FG000|Overall Study|Global deterioration of health|1|||
163849888|NCT00557505|591822390|FG001|Overall Study|Global deterioration of health|0|||
163849889|NCT00557505|591822391|FG002|Overall Study|Global deterioration of health|0|||
163849890|NCT00557505|591822392|FG003|Overall Study|Global deterioration of health|0|||
163849891|NCT00557505|591822393|FG004|Overall Study|Global deterioration of health|0|||
163849892|NCT00557505|591822394|FG005|Overall Study|Global deterioration of health|0|||
163849893|NCT00557505|591822395|FG006|Overall Study|Global deterioration of health|0|||
163849894|NCT00557505|591822396|FG007|Overall Study|Global deterioration of health|0|||
163849895|NCT00557505|591822397|FG008|Overall Study|Global deterioration of health|0|||
163961282|NCT01176773|592230536|FG000|Overall Study|Withdrew consent|1|||
163849896|NCT00557505|591822389|FG000|Overall Study|Objective progression or relapse|2|||
163849897|NCT00557505|591822390|FG001|Overall Study|Objective progression or relapse|3|||
163849898|NCT00557505|591822391|FG002|Overall Study|Objective progression or relapse|3|||
163849899|NCT00557505|591822392|FG003|Overall Study|Objective progression or relapse|2|||
163961283|NCT01498289|592230541|FG000|Overall Study|Adverse Event|16|||
163961284|NCT01498289|592230542|FG001|Overall Study|Adverse Event|18|||
163961285|NCT01498289|592230541|FG000|Overall Study|Death|6|||
163961286|NCT01498289|592230542|FG001|Overall Study|Death|8|||
163961287|NCT01498289|592230541|FG000|Overall Study|Withdrawal unrelated to AE|16|||
163961288|NCT01498289|592230542|FG001|Overall Study|Withdrawal unrelated to AE|16|||
163961289|NCT01498289|592230541|FG000|Overall Study|Progression/relapse|53|||
163961290|NCT01498289|592230542|FG001|Overall Study|Progression/relapse|59|||
163961291|NCT01498289|592230541|FG000|Overall Study|Not protocol specified|7|||
163961292|NCT01498289|592230542|FG001|Overall Study|Not protocol specified|2|||
163961293|NCT01498289|592230541|FG000|Overall Study|Reason under review|0|||
163961294|NCT01498289|592230542|FG001|Overall Study|Reason under review|1|||
163961295|NCT01290601|592230550|FG000|Overall Study|Adverse Event|0|||
163961296|NCT01290601|592230551|FG001|Overall Study|Adverse Event|2|||
163961297|NCT01290601|592230552|FG002|Overall Study|Adverse Event|0|||
163961298|NCT01290601|592230553|FG003|Overall Study|Adverse Event|0|||
163961299|NCT01290601|592230550|FG000|Overall Study|Lack of Efficacy|2|||
163961300|NCT01290601|592230551|FG001|Overall Study|Lack of Efficacy|1|||
163961301|NCT01290601|592230552|FG002|Overall Study|Lack of Efficacy|0|||
163961302|NCT01290601|592230553|FG003|Overall Study|Lack of Efficacy|0|||
163961303|NCT01290601|592230550|FG000|Overall Study|Lost to Follow-up|7|||
163961304|NCT01290601|592230551|FG001|Overall Study|Lost to Follow-up|2|||
163961305|NCT01290601|592230552|FG002|Overall Study|Lost to Follow-up|0|||
163961306|NCT01290601|592230553|FG003|Overall Study|Lost to Follow-up|0|||
163961307|NCT01290601|592230550|FG000|Overall Study|Other|1|||
163961308|NCT01290601|592230551|FG001|Overall Study|Other|0|||
163961309|NCT01290601|592230552|FG002|Overall Study|Other|0|||
163961310|NCT01290601|592230553|FG003|Overall Study|Other|0|||
163961311|NCT01290601|592230550|FG000|Overall Study|Protocol Violation|1|||
163961312|NCT01290601|592230551|FG001|Overall Study|Protocol Violation|0|||
163961313|NCT01290601|592230552|FG002|Overall Study|Protocol Violation|0|||
163961314|NCT01290601|592230553|FG003|Overall Study|Protocol Violation|0|||
163961315|NCT00775450|592230554|FG000|Overall Study|Serious Adverse Event|2|||
163961316|NCT00775450|592230555|FG001|Overall Study|Serious Adverse Event|0|||
163961317|NCT00775450|592230556|FG002|Overall Study|Serious Adverse Event|0|||
163961318|NCT00775450|592230557|FG003|Overall Study|Serious Adverse Event|0|||
163961319|NCT00775450|592230558|FG004|Overall Study|Serious Adverse Event|0|||
163961320|NCT00775450|592230554|FG000|Overall Study|Protocol Violation|0|||
163961321|NCT00775450|592230555|FG001|Overall Study|Protocol Violation|0|||
163961322|NCT00775450|592230556|FG002|Overall Study|Protocol Violation|0|||
163961323|NCT00775450|592230557|FG003|Overall Study|Protocol Violation|0|||
163961324|NCT00775450|592230558|FG004|Overall Study|Protocol Violation|1|||
163961325|NCT00775450|592230554|FG000|Overall Study|Withdrawal by Subject|1|||
163961326|NCT00775450|592230555|FG001|Overall Study|Withdrawal by Subject|0|||
163961327|NCT00775450|592230556|FG002|Overall Study|Withdrawal by Subject|0|||
163961328|NCT00775450|592230557|FG003|Overall Study|Withdrawal by Subject|0|||
163961329|NCT00775450|592230558|FG004|Overall Study|Withdrawal by Subject|1|||
163961330|NCT01749540|592230566|FG000|Overall Study|Protocol Violation|0|||
163961331|NCT01749540|592230567|FG001|Overall Study|Protocol Violation|0|||
163961332|NCT01749540|592230568|FG002|Overall Study|Protocol Violation|0|||
163961333|NCT01749540|592230569|FG003|Overall Study|Protocol Violation|0|||
163961334|NCT01749540|592230570|FG004|Overall Study|Protocol Violation|0|||
163961335|NCT01749540|592230571|FG005|Overall Study|Protocol Violation|1|||
163961336|NCT01749540|592230572|FG006|Overall Study|Protocol Violation|1|||
163961337|NCT01749540|592230566|FG000|Overall Study|Withdrawal by Subject|0|||
163961338|NCT01749540|592230567|FG001|Overall Study|Withdrawal by Subject|0|||
163961339|NCT01749540|592230568|FG002|Overall Study|Withdrawal by Subject|0|||
163961340|NCT01749540|592230569|FG003|Overall Study|Withdrawal by Subject|1|||
163961341|NCT01749540|592230570|FG004|Overall Study|Withdrawal by Subject|0|||
163961342|NCT01749540|592230571|FG005|Overall Study|Withdrawal by Subject|0|||
163961343|NCT01749540|592230572|FG006|Overall Study|Withdrawal by Subject|0|||
163961344|NCT01749540|592230566|FG000|Overall Study|Initiated into extension study A536-06|0|||
163961345|NCT01749540|592230567|FG001|Overall Study|Initiated into extension study A536-06|0|||
163961346|NCT01749540|592230568|FG002|Overall Study|Initiated into extension study A536-06|0|||
163961347|NCT01749540|592230569|FG003|Overall Study|Initiated into extension study A536-06|0|||
163961348|NCT01749540|592230570|FG004|Overall Study|Initiated into extension study A536-06|0|||
163961349|NCT01749540|592230571|FG005|Overall Study|Initiated into extension study A536-06|2|||
163961350|NCT01749540|592230572|FG006|Overall Study|Initiated into extension study A536-06|24|||
163961351|NCT00752622|592230584|FG000|Induction Phase|Adverse Event|3|||
163961352|NCT00752622|592230584|FG000|Induction Phase|Other|3|||
163961353|NCT00752622|592230584|FG000|Induction Phase|Non-responder|14|||
163961354|NCT00752622|592230584|FG000|Induction Phase|Withdrawal by Subject|1|||
163961355|NCT00752622|592230584|FG000|Induction Phase|Premature study termination|14|||
163961356|NCT00752622|592230584|FG000|Observational Phase|Premature Study Termination|36|||
163961357|NCT00752622|592230584|FG000|Observational Phase|Non-responder|2|||
163961358|NCT00752622|592230584|FG000|Observational Phase|Withdrawal by Subject|2|||
163961359|NCT00752622|592230584|FG000|Observational Phase|Adverse Event|1|||
163961360|NCT00752622|592230584|FG000|Observational Phase|Other|2|||
163961361|NCT00752622|592230584|FG000|Interventional Phase|Non-responder|2|||
163961362|NCT00752622|592230584|FG000|Interventional Phase|Physician Decision|1|||
163961363|NCT00752622|592230584|FG000|Interventional Phase|Premature Study Termination|5|||
163961364|NCT00576836|592230586|FG000|Overall Study|Death|0|||
163961365|NCT00576836|592230587|FG001|Overall Study|Death|1|||
163961366|NCT00576836|592230586|FG000|Overall Study|Physician Decision|0|||
163961367|NCT00576836|592230587|FG001|Overall Study|Physician Decision|1|||
163961368|NCT00132496|592230591|FG000|Overall Study|Withdrawal by Subject|1|||
163961369|NCT00132496|592230592|FG001|Overall Study|Withdrawal by Subject|2|||
163961370|NCT00132496|592230591|FG000|Overall Study|Physician Decision|1|||
163961371|NCT00132496|592230592|FG001|Overall Study|Physician Decision|0|||
163961372|NCT00986440|592230595|FG000|Overall Study|Progressive disease|27|||
163961373|NCT00986440|592230596|FG001|Overall Study|Progressive disease|37|||
163961374|NCT00986440|592230595|FG000|Overall Study|Serious adverse event or adverse event|9|||
163961375|NCT00986440|592230596|FG001|Overall Study|Serious adverse event or adverse event|2|||
163961376|NCT00986440|592230595|FG000|Overall Study|Withdrawal by Subject|1|||
163961377|NCT00986440|592230596|FG001|Overall Study|Withdrawal by Subject|2|||
163961378|NCT00986440|592230595|FG000|Overall Study|Screen failure (not dosed)|4|||
163961379|NCT00986440|592230596|FG001|Overall Study|Screen failure (not dosed)|2|||
163961380|NCT00388154|592230597|FG000|Overall Study|Withdrawal by Subject|1|||
163961381|NCT00178126|592230598|FG000|Overall Study|Lost to Follow-up|21|||
163961382|NCT00178126|592230599|FG001|Overall Study|Lost to Follow-up|21|||
163961383|NCT00178126|592230598|FG000|Overall Study|did not receive intervention|4|||
163961384|NCT00178126|592230599|FG001|Overall Study|did not receive intervention|6|||
163961385|NCT01074216|592230600|FG000|Overall Study|Physician Decision|1|||
163961386|NCT01074216|592230600|FG000|Overall Study|Not Treated|12|||
163961387|NCT01323634|592230603|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
163961388|NCT01323634|592230604|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
163961389|NCT01323634|592230605|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
163961390|NCT01323634|592230603|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
163961391|NCT01323634|592230604|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
163961392|NCT01323634|592230605|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
163961393|NCT01323634|592230603|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
163961394|NCT01323634|592230604|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163961395|NCT01323634|592230605|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163961396|NCT01323634|592230603|FG000|2-week Run-in Period|Physician Decision|5|||
163961397|NCT01323634|592230604|FG001|2-week Run-in Period|Physician Decision|0|||
163961398|NCT01323634|592230605|FG002|2-week Run-in Period|Physician Decision|0|||
163961399|NCT01323634|592230603|FG000|2-week Run-in Period|Protocol Violation|1|||
163961400|NCT01323634|592230604|FG001|2-week Run-in Period|Protocol Violation|0|||
163961401|NCT01323634|592230605|FG002|2-week Run-in Period|Protocol Violation|0|||
163961402|NCT01323634|592230603|FG000|2-week Run-in Period|Adverse Event|1|||
163961403|NCT01323634|592230604|FG001|2-week Run-in Period|Adverse Event|0|||
163961404|NCT01323634|592230605|FG002|2-week Run-in Period|Adverse Event|0|||
163961405|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
163961406|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
163961407|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
163961408|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
163961409|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
163961410|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
163961411|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
163961412|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
163961413|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
163961414|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163961415|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163961416|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163961417|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
163961418|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
163961419|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
163961420|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163961421|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
163961422|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
163961423|NCT01323634|592230603|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
163961424|NCT01323634|592230604|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
163961425|NCT01323634|592230605|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
163961426|NCT05056987|592230606|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
163961427|NCT05056987|592230607|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
163961428|NCT05056987|592230606|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
163961429|NCT05056987|592230607|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
163961430|NCT01575028|592230608|FG000|Overall Study|Physician Decision|0|||
163961431|NCT01575028|592230609|FG001|Overall Study|Physician Decision|1|||
163961432|NCT01182194|592230610|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
163961433|NCT01182194|592230611|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
163961434|NCT01948908|592230612|FG000|Overall Study|Protocol Violation|1|||
163961435|NCT01948908|592230613|FG001|Overall Study|Protocol Violation|0|||
163961436|NCT01948908|592230614|FG002|Overall Study|Protocol Violation|2|||
163961437|NCT01585987|592230615|FG000|Randomized|Withdrawal by Subject|0|||
163961438|NCT01585987|592230616|FG001|Randomized|Withdrawal by Subject|4|||
163961439|NCT01585987|592230615|FG000|Randomized|No longer met criteria|0|||
163961440|NCT01585987|592230616|FG001|Randomized|No longer met criteria|2|||
163961441|NCT01585987|592230615|FG000|Treated|Disease Progression|39|||
163961442|NCT01585987|592230616|FG001|Treated|Disease Progression|36|||
163961443|NCT01585987|592230615|FG000|Treated|Study Drug Toxicity|9|||
163961444|NCT01585987|592230616|FG001|Treated|Study Drug Toxicity|5|||
163961445|NCT01585987|592230615|FG000|Treated|Adverse Event|3|||
163961446|NCT01585987|592230616|FG001|Treated|Adverse Event|0|||
163961447|NCT01585987|592230615|FG000|Treated|Withdrawal by Subject|1|||
163961448|NCT01585987|592230616|FG001|Treated|Withdrawal by Subject|2|||
163961449|NCT01585987|592230615|FG000|Treated|Death|1|||
163961450|NCT01585987|592230616|FG001|Treated|Death|0|||
163961451|NCT01585987|592230615|FG000|Treated|Lost to Follow-up|0|||
163961452|NCT01585987|592230616|FG001|Treated|Lost to Follow-up|1|||
163961453|NCT01585987|592230615|FG000|Treated|Maximum Clinical Benefit|0|||
163961454|NCT01585987|592230616|FG001|Treated|Maximum Clinical Benefit|1|||
163961455|NCT01585987|592230615|FG000|Treated|Non-Specified|1|||
163961456|NCT01585987|592230616|FG001|Treated|Non-Specified|2|||
163961457|NCT01585987|592230615|FG000|Treated|Subject Request|0|||
163961458|NCT01585987|592230616|FG001|Treated|Subject Request|1|||
163961459|NCT01585987|592230615|FG000|Treated|Poor/Non-Compliance|0|||
163961460|NCT01585987|592230616|FG001|Treated|Poor/Non-Compliance|1|||
163961461|NCT03291587|592230617|FG000|Overall Study|Lost to Follow-up|62|||
163961462|NCT03291587|592230618|FG001|Overall Study|Lost to Follow-up|43|||
163961463|NCT03291587|592230617|FG000|Overall Study|Refused to Answer|5|||
163961464|NCT03291587|592230618|FG001|Overall Study|Refused to Answer|2|||
163961465|NCT03291587|592230617|FG000|Overall Study|Death|2|||
163961466|NCT03291587|592230618|FG001|Overall Study|Death|4|||
163961467|NCT03291587|592230617|FG000|Overall Study|Not interested in participating|8|||
163961468|NCT03291587|592230618|FG001|Overall Study|Not interested in participating|6|||
163961469|NCT03291587|592230617|FG000|Overall Study|Too busy to participate|4|||
163961470|NCT03291587|592230618|FG001|Overall Study|Too busy to participate|2|||
163961471|NCT00796120|592230619|FG000|Overall Study|Death|3|||
163961472|NCT00796120|592230620|FG001|Overall Study|Death|0|||
163961473|NCT00796120|592230619|FG000|Overall Study|Adverse Event|11|||
163961474|NCT00796120|592230620|FG001|Overall Study|Adverse Event|6|||
163961475|NCT00796120|592230619|FG000|Overall Study|Progressive disease|22|||
163961476|NCT00796120|592230620|FG001|Overall Study|Progressive disease|13|||
163961477|NCT00796120|592230619|FG000|Overall Study|Participant refusal|3|||
163961478|NCT00796120|592230620|FG001|Overall Study|Participant refusal|4|||
163961479|NCT00796120|592230619|FG000|Overall Study|Other|6|||
163961480|NCT00796120|592230620|FG001|Overall Study|Other|17|||
163961481|NCT00796120|592230619|FG000|Overall Study|Physician Decision|16|||
163961482|NCT00796120|592230620|FG001|Overall Study|Physician Decision|17|||
163961483|NCT00796120|592230619|FG000|Overall Study|Randomized but not treated|0|||
163961484|NCT00796120|592230620|FG001|Overall Study|Randomized but not treated|3|||
163961485|NCT02520284|592230621|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
163961486|NCT02520284|592230622|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
163961487|NCT02520284|592230623|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
163961488|NCT02520284|592230621|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
163961489|NCT02520284|592230622|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
163961490|NCT02520284|592230623|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
163961491|NCT02520284|592230621|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
163961492|NCT02520284|592230622|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
163961493|NCT02520284|592230623|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
163961494|NCT02520284|592230621|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
163961495|NCT02520284|592230622|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
163961496|NCT02520284|592230623|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
163961497|NCT02520284|592230621|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
163961498|NCT02520284|592230622|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
163961499|NCT02520284|592230623|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
163961500|NCT02520284|592230621|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
163961501|NCT02520284|592230622|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
163961502|NCT02520284|592230623|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
163961503|NCT02520284|592230621|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
163961504|NCT02520284|592230622|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
163961505|NCT02520284|592230623|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
163961506|NCT02520284|592230621|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
163961507|NCT02520284|592230622|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
163961508|NCT02520284|592230623|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
163961509|NCT02520284|592230621|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
163961510|NCT02520284|592230622|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
163961511|NCT02520284|592230623|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
163961512|NCT02520284|592230621|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
163961513|NCT02520284|592230622|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
163961514|NCT02520284|592230623|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
163961515|NCT02520284|592230621|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
163961516|NCT02520284|592230622|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
163961517|NCT02520284|592230623|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
163961518|NCT03737474|592230624|FG000|Overall Study|Adverse Event|18|||
163961519|NCT03737474|592230625|FG001|Overall Study|Adverse Event|48|||
163961520|NCT03737474|592230624|FG000|Overall Study|Lack of Efficacy|1|||
163961521|NCT03737474|592230625|FG001|Overall Study|Lack of Efficacy|3|||
163961522|NCT03737474|592230624|FG000|Overall Study|Protocol Violation|0|||
163961523|NCT03737474|592230625|FG001|Overall Study|Protocol Violation|8|||
163961524|NCT03737474|592230624|FG000|Overall Study|Withdrawal by Subject|5|||
163961525|NCT03737474|592230625|FG001|Overall Study|Withdrawal by Subject|20|||
163961526|NCT03737474|592230624|FG000|Overall Study|Non-compliance With Study Drug|0|||
163961527|NCT03737474|592230625|FG001|Overall Study|Non-compliance With Study Drug|1|||
163961528|NCT03737474|592230624|FG000|Overall Study|Physician Decision|1|||
163961529|NCT03737474|592230625|FG001|Overall Study|Physician Decision|4|||
163961530|NCT00803270|592230626|FG000|Overall Study|Lost to Follow-up|1|||
163961531|NCT00803270|592230627|FG001|Overall Study|Lost to Follow-up|2|||
163961532|NCT01966471|592230628|FG000|Overall Study|Death|44|||
163961533|NCT01966471|592230629|FG001|Overall Study|Death|56|||
163961534|NCT01966471|592230628|FG000|Overall Study|Lost to Follow-up|46|||
163961535|NCT01966471|592230629|FG001|Overall Study|Lost to Follow-up|39|||
163961536|NCT01966471|592230628|FG000|Overall Study|Various reasons|4|||
163961537|NCT01966471|592230629|FG001|Overall Study|Various reasons|4|||
163961538|NCT01966471|592230628|FG000|Overall Study|Physician Decision|7|||
163961539|NCT01966471|592230629|FG001|Overall Study|Physician Decision|5|||
163961540|NCT01966471|592230628|FG000|Overall Study|Study Terminated By Sponsor|758|||
163961541|NCT01966471|592230629|FG001|Overall Study|Study Terminated By Sponsor|773|||
163961542|NCT01966471|592230628|FG000|Overall Study|Withdrawal by Subject|59|||
163961543|NCT01966471|592230629|FG001|Overall Study|Withdrawal by Subject|51|||
163961544|NCT04223856|592230630|FG000|Overall Study|Progressive disease|153|||
163961545|NCT04223856|592230631|FG001|Overall Study|Progressive disease|73|||
163961546|NCT04223856|592230630|FG000|Overall Study|Adverse Event|97|||
163961547|NCT04223856|592230631|FG001|Overall Study|Adverse Event|62|||
163961548|NCT04223856|592230630|FG000|Overall Study|Physician Decision|9|||
163961549|NCT04223856|592230631|FG001|Overall Study|Physician Decision|28|||
163961550|NCT04223856|592230630|FG000|Overall Study|Withdrawal by Subject|22|||
163961551|NCT04223856|592230631|FG001|Overall Study|Withdrawal by Subject|24|||
163961552|NCT04223856|592230630|FG000|Overall Study|Other|7|||
163961553|NCT04223856|592230631|FG001|Overall Study|Other|2|||
163961554|NCT04223856|592230630|FG000|Overall Study|Randomized but not treated|2|||
163961555|NCT04223856|592230631|FG001|Overall Study|Randomized but not treated|11|||
163961556|NCT04223856|592230630|FG000|Overall Study|On-treatment|144|||
163961557|NCT04223856|592230631|FG001|Overall Study|On-treatment|0|||
163961558|NCT00992511|592232704|FG000|Overall Study|Migrated/moved from study area|1|||
163961559|NCT00992511|592232705|FG001|Overall Study|Migrated/moved from study area|0|||
163961560|NCT00992511|592232706|FG002|Overall Study|Migrated/moved from study area|1|||
163961561|NCT00992511|592232707|FG003|Overall Study|Migrated/moved from study area|2|||
163961562|NCT00992511|592232704|FG000|Overall Study|Lost to Follow-up|1|||
163961563|NCT00992511|592232705|FG001|Overall Study|Lost to Follow-up|0|||
163961564|NCT00992511|592232706|FG002|Overall Study|Lost to Follow-up|0|||
163961565|NCT00992511|592232707|FG003|Overall Study|Lost to Follow-up|2|||
163961566|NCT00992511|592232704|FG000|Overall Study|Withdrawal by Subject|0|||
163961567|NCT00992511|592232705|FG001|Overall Study|Withdrawal by Subject|0|||
163961568|NCT00992511|592232706|FG002|Overall Study|Withdrawal by Subject|1|||
163961569|NCT00992511|592232707|FG003|Overall Study|Withdrawal by Subject|1|||
163961570|NCT01180998|592232708|FG000|Overall Study|Poor Vision|0|||
163961571|NCT01180998|592232709|FG001|Overall Study|Poor Vision|2|||
163961572|NCT01180998|592232710|FG002|Overall Study|Poor Vision|2|||
163961573|NCT01180998|592232708|FG000|Overall Study|Lost to Follow-up|0|||
163961574|NCT01180998|592232709|FG001|Overall Study|Lost to Follow-up|0|||
163961575|NCT01180998|592232710|FG002|Overall Study|Lost to Follow-up|1|||
163961576|NCT01180998|592232708|FG000|Overall Study|Protocol Violation|1|||
163961577|NCT01180998|592232709|FG001|Overall Study|Protocol Violation|2|||
163961578|NCT01180998|592232710|FG002|Overall Study|Protocol Violation|0|||
163961579|NCT01180998|592232708|FG000|Overall Study|Withdrawal by Subject|0|||
163961580|NCT01180998|592232709|FG001|Overall Study|Withdrawal by Subject|0|||
163961581|NCT01180998|592232710|FG002|Overall Study|Withdrawal by Subject|1|||
163961582|NCT01180998|592232708|FG000|Overall Study|Poor comfort|3|||
163961583|NCT01180998|592232709|FG001|Overall Study|Poor comfort|0|||
163849900|NCT00557505|591822393|FG004|Overall Study|Objective progression or relapse|2|||
163849901|NCT00557505|591822394|FG005|Overall Study|Objective progression or relapse|3|||
163849902|NCT00557505|591822395|FG006|Overall Study|Objective progression or relapse|2|||
163849903|NCT00557505|591822396|FG007|Overall Study|Objective progression or relapse|5|||
163849904|NCT00557505|591822397|FG008|Overall Study|Objective progression or relapse|15|||
163849905|NCT00557505|591822389|FG000|Overall Study|Withdrawal by Subject|0|||
163849906|NCT00557505|591822390|FG001|Overall Study|Withdrawal by Subject|0|||
163849907|NCT00557505|591822391|FG002|Overall Study|Withdrawal by Subject|0|||
163849908|NCT00557505|591822392|FG003|Overall Study|Withdrawal by Subject|1|||
163849909|NCT00557505|591822393|FG004|Overall Study|Withdrawal by Subject|0|||
163849910|NCT00557505|591822394|FG005|Overall Study|Withdrawal by Subject|0|||
163849911|NCT00557505|591822395|FG006|Overall Study|Withdrawal by Subject|0|||
163849912|NCT00557505|591822396|FG007|Overall Study|Withdrawal by Subject|0|||
163849913|NCT00557505|591822397|FG008|Overall Study|Withdrawal by Subject|1|||
163849914|NCT01244763|591822398|FG000|Overall Study|Adverse Event|1|||
163849915|NCT01244763|591822399|FG001|Overall Study|Adverse Event|0|||
163849916|NCT01244763|591822400|FG002|Overall Study|Adverse Event|0|||
163849917|NCT01244763|591822401|FG003|Overall Study|Adverse Event|0|||
163849918|NCT01244763|591822402|FG004|Overall Study|Adverse Event|0|||
163849919|NCT01244763|591822403|FG005|Overall Study|Adverse Event|1|||
163849920|NCT01244763|591822398|FG000|Overall Study|Death|1|||
163849921|NCT01244763|591822399|FG001|Overall Study|Death|0|||
163849922|NCT01244763|591822400|FG002|Overall Study|Death|1|||
163849923|NCT01244763|591822401|FG003|Overall Study|Death|0|||
163849924|NCT01244763|591822402|FG004|Overall Study|Death|2|||
163849925|NCT01244763|591822403|FG005|Overall Study|Death|0|||
163849926|NCT01244763|591822398|FG000|Overall Study|Physician Decision|0|||
163849927|NCT01244763|591822399|FG001|Overall Study|Physician Decision|0|||
163849928|NCT01244763|591822400|FG002|Overall Study|Physician Decision|1|||
163849929|NCT01244763|591822401|FG003|Overall Study|Physician Decision|0|||
163849930|NCT01244763|591822402|FG004|Overall Study|Physician Decision|0|||
163961584|NCT01180998|592232710|FG002|Overall Study|Poor comfort|4|||
163961585|NCT01180998|592232708|FG000|Overall Study|Poor lens handling|0|||
163961586|NCT01180998|592232709|FG001|Overall Study|Poor lens handling|0|||
163961587|NCT01180998|592232710|FG002|Overall Study|Poor lens handling|2|||
163961588|NCT04098068|592232711|FG000|Overall Study|Disease Progression|7|||
163961589|NCT04098068|592232711|FG000|Overall Study|Withdrawal by Subject|2|||
163961590|NCT04098068|592232711|FG000|Overall Study|New Cancer Diagnosis|1|||
163961591|NCT00744523|592232712|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
163961592|NCT00744523|592232713|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
163961593|NCT03588728|592232717|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
163961594|NCT03588728|592232718|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
163961595|NCT03588728|592232719|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
163961596|NCT03588728|592232720|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
163961597|NCT03588728|592232717|FG000|Overall Study|Lab shut down due to COVID-19|0|||
163961598|NCT03588728|592232718|FG001|Overall Study|Lab shut down due to COVID-19|0|||
163961599|NCT03588728|592232719|FG002|Overall Study|Lab shut down due to COVID-19|0|||
163961600|NCT03588728|592232720|FG003|Overall Study|Lab shut down due to COVID-19|1|||
163961601|NCT03588728|592232717|FG000|Overall Study|multiple technical issues|1|||
163961602|NCT03588728|592232718|FG001|Overall Study|multiple technical issues|0|||
163961603|NCT03588728|592232719|FG002|Overall Study|multiple technical issues|0|||
163961604|NCT03588728|592232720|FG003|Overall Study|multiple technical issues|0|||
163961605|NCT03588728|592232717|FG000|Overall Study|Hospitalized for COVID|1|||
163961606|NCT03588728|592232718|FG001|Overall Study|Hospitalized for COVID|0|||
163961607|NCT03588728|592232719|FG002|Overall Study|Hospitalized for COVID|0|||
163961608|NCT03588728|592232720|FG003|Overall Study|Hospitalized for COVID|0|||
163961609|NCT03588728|592232717|FG000|Overall Study|Schedule change unable to attend sessions|1|||
163961610|NCT03588728|592232718|FG001|Overall Study|Schedule change unable to attend sessions|0|||
163961611|NCT03588728|592232719|FG002|Overall Study|Schedule change unable to attend sessions|0|||
163961612|NCT03588728|592232720|FG003|Overall Study|Schedule change unable to attend sessions|0|||
163961613|NCT01388790|592232721|FG000|Overall Study|Ongoing at data cut-off date|8|||
163961614|NCT01386658|592232722|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
163961615|NCT01386658|592232723|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
163961616|NCT01386658|592232722|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
163961617|NCT01386658|592232723|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
163961618|NCT02513745|592232724|FG000|Overall Study|Criteria at time of surgery not met.|3|||
164006472|NCT02158533|592390965|FG003|Stage 2|Physician Decision|0|||
163849931|NCT01244763|591822403|FG005|Overall Study|Physician Decision|0|||
163849932|NCT01244763|591822398|FG000|Overall Study|Withdrawal by Subject|1|||
163849933|NCT01244763|591822399|FG001|Overall Study|Withdrawal by Subject|2|||
163849934|NCT01244763|591822400|FG002|Overall Study|Withdrawal by Subject|0|||
163849935|NCT01244763|591822401|FG003|Overall Study|Withdrawal by Subject|1|||
163849936|NCT01244763|591822402|FG004|Overall Study|Withdrawal by Subject|1|||
163849937|NCT01244763|591822403|FG005|Overall Study|Withdrawal by Subject|2|||
163961619|NCT02513745|592232725|FG001|Overall Study|Criteria at time of surgery not met.|3|||
163961620|NCT00381303|592232726|FG000|Overall Study|Lost to Follow-up|25|||
163961621|NCT00381303|592232727|FG001|Overall Study|Lost to Follow-up|9|||
163961622|NCT00381303|592232726|FG000|Overall Study|AE/HIV-related event|22|||
163961623|NCT00381303|592232727|FG001|Overall Study|AE/HIV-related event|6|||
163961624|NCT00381303|592232726|FG000|Overall Study|Non-Adherence|13|||
163961625|NCT00381303|592232727|FG001|Overall Study|Non-Adherence|6|||
163961626|NCT00381303|592232726|FG000|Overall Study|Withdrawal by Subject|13|||
163961627|NCT00381303|592232727|FG001|Overall Study|Withdrawal by Subject|6|||
163961628|NCT00381303|592232726|FG000|Overall Study|Virologic failure|6|||
163961629|NCT00381303|592232727|FG001|Overall Study|Virologic failure|4|||
163961630|NCT00381303|592232726|FG000|Overall Study|Ineligible to continue the trial|2|||
163961631|NCT00381303|592232727|FG001|Overall Study|Ineligible to continue the trial|1|||
163961632|NCT00381303|592232726|FG000|Overall Study|Pregnancy|2|||
163961633|NCT00381303|592232727|FG001|Overall Study|Pregnancy|0|||
163961634|NCT00381303|592232726|FG000|Overall Study|Physician Decision|1|||
163961635|NCT00381303|592232727|FG001|Overall Study|Physician Decision|0|||
163961636|NCT00381303|592232726|FG000|Overall Study|Physician's decision to close the site|3|||
163961637|NCT00381303|592232727|FG001|Overall Study|Physician's decision to close the site|1|||
163961638|NCT00381303|592232726|FG000|Overall Study|Subject moved out of state|2|||
163961639|NCT00381303|592232727|FG001|Overall Study|Subject moved out of state|0|||
163961640|NCT00381303|592232726|FG000|Overall Study|Subject taking too many different meds|1|||
163961641|NCT00381303|592232727|FG001|Overall Study|Subject taking too many different meds|0|||
163961642|NCT00381303|592232726|FG000|Overall Study|No virologic response by week 12|1|||
163961643|NCT00381303|592232727|FG001|Overall Study|No virologic response by week 12|0|||
163961644|NCT00381303|592232726|FG000|Overall Study|Subject was too busy for appointments|1|||
163961645|NCT00381303|592232727|FG001|Overall Study|Subject was too busy for appointments|0|||
163961646|NCT00381303|592232726|FG000|Overall Study|Subject did not continue visits|1|||
163961647|NCT00381303|592232727|FG001|Overall Study|Subject did not continue visits|0|||
163961648|NCT00381303|592232726|FG000|Overall Study|Subject primary physician's decision|1|||
163961649|NCT00381303|592232727|FG001|Overall Study|Subject primary physician's decision|0|||
163961650|NCT01211522|592232728|FG000|Overall Study|Withdrawal by Subject|3|||
163961651|NCT01211522|592232729|FG001|Overall Study|Withdrawal by Subject|7|||
163961652|NCT01211522|592232730|FG002|Overall Study|Withdrawal by Subject|5|||
163961653|NCT01777269|592232731|FG000|Overall Study|Adverse Event|24|||
163961654|NCT01777269|592232732|FG001|Overall Study|Adverse Event|33|||
163961655|NCT01777269|592232731|FG000|Overall Study|Lack of Efficacy|8|||
163961656|NCT01777269|592232732|FG001|Overall Study|Lack of Efficacy|10|||
163961657|NCT01777269|592232731|FG000|Overall Study|Protocol Violation|4|||
163961658|NCT01777269|592232732|FG001|Overall Study|Protocol Violation|4|||
163961659|NCT01777269|592232731|FG000|Overall Study|Participants reached stopping criteria|1|||
163961660|NCT01777269|592232732|FG001|Overall Study|Participants reached stopping criteria|1|||
163961661|NCT01777269|592232731|FG000|Overall Study|Lost to Follow-up|4|||
163961662|NCT01777269|592232732|FG001|Overall Study|Lost to Follow-up|0|||
163961663|NCT01777269|592232731|FG000|Overall Study|Physician Decision|5|||
163961664|NCT01777269|592232732|FG001|Overall Study|Physician Decision|2|||
163961665|NCT01777269|592232731|FG000|Overall Study|Withdrawal by Subject|9|||
163961666|NCT01777269|592232732|FG001|Overall Study|Withdrawal by Subject|9|||
163961667|NCT00504881|592232733|FG000|Overall Study|Lack of Efficacy|1|||
163961668|NCT00504881|592232734|FG001|Overall Study|Lack of Efficacy|5|||
163961669|NCT00504881|592232733|FG000|Overall Study|Lost to Follow-up|0|||
163961670|NCT00504881|592232734|FG001|Overall Study|Lost to Follow-up|2|||
163961671|NCT00504881|592232733|FG000|Overall Study|Withdrawal by Subject|1|||
163961672|NCT00504881|592232734|FG001|Overall Study|Withdrawal by Subject|4|||
163961673|NCT00504881|592232733|FG000|Overall Study|Non-Compliance|1|||
163961674|NCT00504881|592232734|FG001|Overall Study|Non-Compliance|0|||
163961675|NCT00504881|592232733|FG000|Overall Study|No Birth Control|0|||
163961676|NCT00504881|592232734|FG001|Overall Study|No Birth Control|1|||
163961677|NCT00504881|592232733|FG000|Overall Study|Safety Visit not performed|0|||
163961678|NCT00504881|592232734|FG001|Overall Study|Safety Visit not performed|1|||
163961679|NCT00504881|592232733|FG000|Overall Study|AE, serious fatal|0|||
163961680|NCT00504881|592232734|FG001|Overall Study|AE, serious fatal|1|||
163961681|NCT00504881|592232733|FG000|Overall Study|SAE, non-fatal|2|||
163961682|NCT00504881|592232734|FG001|Overall Study|SAE, non-fatal|6|||
163961683|NCT00504881|592232733|FG000|Overall Study|AE, non-serious non-fatal|4|||
163961684|NCT00504881|592232734|FG001|Overall Study|AE, non-serious non-fatal|14|||
163961685|NCT00504881|592232733|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163961686|NCT00504881|592232734|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
163961687|NCT00504881|592232733|FG000|Overall Study|AE of unknown type|1|||
163961688|NCT00504881|592232734|FG001|Overall Study|AE of unknown type|0|||
163961689|NCT02411578|592232737|FG000|Crossover Trial Phase|Pregnancy|0|||
163961690|NCT02411578|592232738|FG001|Crossover Trial Phase|Pregnancy|1|||
163961691|NCT02973048|592232739|FG000|Overall Study|Epidural catheter insertion failure|1|||
163961692|NCT02973048|592232740|FG001|Overall Study|Epidural catheter insertion failure|0|||
164189890|NCT00572455|593063986|FG000|Stage II (28 Days)|Death|0|||
164189891|NCT00572455|593063987|FG001|Stage II (28 Days)|Death|0|||
163961693|NCT02973048|592232739|FG000|Overall Study|Withdrawal by Subject|0|||
163961694|NCT02973048|592232740|FG001|Overall Study|Withdrawal by Subject|3|||
163961695|NCT00332189|592232741|FG000|Overall Study|Adverse Event|3|||
163961696|NCT00332189|592232741|FG000|Overall Study|Uncooperative/Noncompliant|3|||
163961697|NCT00332189|592232741|FG000|Overall Study|Withdrawal by Subject|9|||
163961698|NCT00332189|592232741|FG000|Overall Study|Lack of Efficacy|4|||
163961699|NCT00332189|592232741|FG000|Overall Study|Moved out of country|2|||
163961700|NCT02370043|592232742|FG000|Overall Study|Withdrawal by Subject|0|||
163961701|NCT02370043|592232743|FG001|Overall Study|Withdrawal by Subject|0|||
163961702|NCT02370043|592232744|FG002|Overall Study|Withdrawal by Subject|0|||
163961703|NCT02370043|592232745|FG003|Overall Study|Withdrawal by Subject|0|||
163961704|NCT02370043|592232746|FG004|Overall Study|Withdrawal by Subject|1|||
163961705|NCT02370043|592232747|FG005|Overall Study|Withdrawal by Subject|1|||
163961706|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
163961707|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
163961708|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
163961709|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
163961710|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
163961711|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
163961712|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
163961713|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
163961714|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
163961715|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
163961716|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
163961717|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
163961718|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
163961719|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
163961720|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
163961721|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
163961722|NCT01231516|592232748|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
163961723|NCT01231516|592232749|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
163961724|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
163961725|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
163961726|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
163961727|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
163961728|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
163961729|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
163961730|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
163961731|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
163961732|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
163961733|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
163961734|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
163849938|NCT01244763|591822398|FG000|Overall Study|Lost to Follow-up|0|||
163849939|NCT01244763|591822399|FG001|Overall Study|Lost to Follow-up|1|||
163849940|NCT01244763|591822400|FG002|Overall Study|Lost to Follow-up|0|||
163849941|NCT01244763|591822401|FG003|Overall Study|Lost to Follow-up|0|||
163849942|NCT01244763|591822402|FG004|Overall Study|Lost to Follow-up|0|||
163849943|NCT01244763|591822403|FG005|Overall Study|Lost to Follow-up|0|||
163849944|NCT01244763|591822398|FG000|Overall Study|Enrolled into the Extension Study|0|||
163849945|NCT01244763|591822399|FG001|Overall Study|Enrolled into the Extension Study|0|||
163849946|NCT01244763|591822400|FG002|Overall Study|Enrolled into the Extension Study|0|||
163849947|NCT01244763|591822401|FG003|Overall Study|Enrolled into the Extension Study|0|||
163849948|NCT01244763|591822402|FG004|Overall Study|Enrolled into the Extension Study|0|||
163849949|NCT01244763|591822403|FG005|Overall Study|Enrolled into the Extension Study|1|||
163849950|NCT00550732|591822408|FG000|Overall Study|Death|4|||
163849951|NCT00550732|591822408|FG000|Overall Study|Withdrawal by Subject|2|||
163849952|NCT00550732|591822408|FG000|Overall Study|Physician Decision|2|||
163849953|NCT00550732|591822408|FG000|Overall Study|Lost to Follow-up|1|||
163849954|NCT00550732|591822408|FG000|Overall Study|Palliative care|1|||
163849955|NCT00550732|591822408|FG000|Overall Study|Adverse Event|1|||
163849956|NCT01323660|591822409|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
163849957|NCT01323660|591822410|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163849958|NCT01323660|591822411|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
163849959|NCT01323660|591822412|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163849960|NCT01323660|591822413|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
163849961|NCT01323660|591822414|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
163849962|NCT01323660|591822409|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
163849963|NCT01323660|591822410|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
163961735|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
163961736|NCT01231516|592232748|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
163961737|NCT01231516|592232749|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
163961738|NCT04427501|592232750|FG000|Overall Study|Death|0|||
163961739|NCT04427501|592232751|FG001|Overall Study|Death|0|||
163961740|NCT04427501|592232752|FG002|Overall Study|Death|0|||
163961741|NCT04427501|592232753|FG003|Overall Study|Death|0|||
163961742|NCT04427501|592232754|FG004|Overall Study|Death|0|||
163961743|NCT04427501|592232755|FG005|Overall Study|Death|15|||
163961744|NCT04427501|592232756|FG006|Overall Study|Death|0|||
163961745|NCT04427501|592232757|FG007|Overall Study|Death|0|||
163961746|NCT04427501|592232758|FG008|Overall Study|Death|0|||
163961747|NCT04427501|592232759|FG009|Overall Study|Death|0|||
163961748|NCT04427501|592232760|FG010|Overall Study|Death|0|||
163961749|NCT04427501|592232761|FG011|Overall Study|Death|0|||
163961750|NCT04427501|592232750|FG000|Overall Study|Lost to Follow-up|5|||
163961751|NCT04427501|592232751|FG001|Overall Study|Lost to Follow-up|1|||
163961752|NCT04427501|592232752|FG002|Overall Study|Lost to Follow-up|2|||
163961753|NCT04427501|592232753|FG003|Overall Study|Lost to Follow-up|0|||
163961754|NCT04427501|592232754|FG004|Overall Study|Lost to Follow-up|2|||
163961755|NCT04427501|592232755|FG005|Overall Study|Lost to Follow-up|11|||
163961756|NCT04427501|592232756|FG006|Overall Study|Lost to Follow-up|10|||
163961757|NCT04427501|592232757|FG007|Overall Study|Lost to Follow-up|10|||
163961758|NCT04427501|592232758|FG008|Overall Study|Lost to Follow-up|2|||
163961759|NCT04427501|592232759|FG009|Overall Study|Lost to Follow-up|5|||
163961760|NCT04427501|592232760|FG010|Overall Study|Lost to Follow-up|2|||
163961761|NCT04427501|592232761|FG011|Overall Study|Lost to Follow-up|0|||
163961762|NCT04427501|592232750|FG000|Overall Study|Physician Decision|0|||
163961763|NCT04427501|592232751|FG001|Overall Study|Physician Decision|3|||
163961764|NCT04427501|592232752|FG002|Overall Study|Physician Decision|0|||
163961765|NCT04427501|592232753|FG003|Overall Study|Physician Decision|0|||
163961766|NCT04427501|592232754|FG004|Overall Study|Physician Decision|0|||
163961767|NCT04427501|592232755|FG005|Overall Study|Physician Decision|0|||
163961768|NCT04427501|592232756|FG006|Overall Study|Physician Decision|2|||
163961769|NCT04427501|592232757|FG007|Overall Study|Physician Decision|0|||
163961770|NCT04427501|592232758|FG008|Overall Study|Physician Decision|0|||
163961771|NCT04427501|592232759|FG009|Overall Study|Physician Decision|0|||
163961772|NCT04427501|592232760|FG010|Overall Study|Physician Decision|0|||
163961773|NCT04427501|592232761|FG011|Overall Study|Physician Decision|0|||
163961774|NCT04427501|592232750|FG000|Overall Study|Withdrawal by Subject|9|||
163961775|NCT04427501|592232751|FG001|Overall Study|Withdrawal by Subject|2|||
163961776|NCT04427501|592232752|FG002|Overall Study|Withdrawal by Subject|2|||
163961777|NCT04427501|592232753|FG003|Overall Study|Withdrawal by Subject|3|||
163961778|NCT04427501|592232754|FG004|Overall Study|Withdrawal by Subject|7|||
163961779|NCT04427501|592232755|FG005|Overall Study|Withdrawal by Subject|25|||
163961780|NCT04427501|592232756|FG006|Overall Study|Withdrawal by Subject|15|||
163961781|NCT04427501|592232757|FG007|Overall Study|Withdrawal by Subject|7|||
163961782|NCT04427501|592232758|FG008|Overall Study|Withdrawal by Subject|4|||
163961783|NCT04427501|592232759|FG009|Overall Study|Withdrawal by Subject|1|||
163961784|NCT04427501|592232760|FG010|Overall Study|Withdrawal by Subject|4|||
163961785|NCT04427501|592232761|FG011|Overall Study|Withdrawal by Subject|0|||
163961786|NCT04427501|592232750|FG000|Overall Study|Other - as reported by the investigator|1|||
163961787|NCT04427501|592232751|FG001|Overall Study|Other - as reported by the investigator|0|||
163961788|NCT04427501|592232752|FG002|Overall Study|Other - as reported by the investigator|0|||
163961789|NCT04427501|592232753|FG003|Overall Study|Other - as reported by the investigator|0|||
163961790|NCT04427501|592232754|FG004|Overall Study|Other - as reported by the investigator|0|||
163961791|NCT04427501|592232755|FG005|Overall Study|Other - as reported by the investigator|6|||
163961792|NCT04427501|592232756|FG006|Overall Study|Other - as reported by the investigator|6|||
163961793|NCT04427501|592232757|FG007|Overall Study|Other - as reported by the investigator|0|||
163961794|NCT04427501|592232758|FG008|Overall Study|Other - as reported by the investigator|0|||
163961795|NCT04427501|592232759|FG009|Overall Study|Other - as reported by the investigator|0|||
163961796|NCT04427501|592232760|FG010|Overall Study|Other - as reported by the investigator|0|||
163961797|NCT04427501|592232761|FG011|Overall Study|Other - as reported by the investigator|0|||
163961798|NCT04427501|592232750|FG000|Overall Study|Other|0|||
163961799|NCT04427501|592232751|FG001|Overall Study|Other|0|||
163961800|NCT04427501|592232752|FG002|Overall Study|Other|0|||
163961801|NCT04427501|592232753|FG003|Overall Study|Other|0|||
163961802|NCT04427501|592232754|FG004|Overall Study|Other|0|||
163961803|NCT04427501|592232755|FG005|Overall Study|Other|0|||
163961804|NCT04427501|592232756|FG006|Overall Study|Other|0|||
163961805|NCT04427501|592232757|FG007|Overall Study|Other|0|||
164189892|NCT00572455|593063988|FG002|Stage II (28 Days)|Death|0|||
163961806|NCT04427501|592232758|FG008|Overall Study|Other|0|||
163961807|NCT04427501|592232759|FG009|Overall Study|Other|0|||
163961808|NCT04427501|592232760|FG010|Overall Study|Other|0|||
163961809|NCT04427501|592232761|FG011|Overall Study|Other|1|||
163961810|NCT03170154|592232762|FG000|Overall Study|Lost to Follow-up|4|||
163961811|NCT03170154|592232762|FG000|Overall Study|Death|2|||
164189893|NCT00572455|593063989|FG003|Stage II (28 Days)|Death|0|||
163961812|NCT03170154|592232762|FG000|Overall Study|Withdrawal by Subject|2|||
163961813|NCT01906346|592232763|FG000|Overall Study|AEs|1|||
163961814|NCT04936841|592232766|FG000|Overall Study|Death|1|||
163961815|NCT02279862|592232767|FG000|Overall Study|Study drug toxicity|3|||
163961816|NCT02279862|592232768|FG001|Overall Study|Study drug toxicity|6|||
163961817|NCT02279862|592232767|FG000|Overall Study|No longer meets criteria|0|||
163961818|NCT02279862|592232768|FG001|Overall Study|No longer meets criteria|1|||
163961819|NCT02279862|592232767|FG000|Overall Study|Administrative reason by sponsor|0|||
163961820|NCT02279862|592232768|FG001|Overall Study|Administrative reason by sponsor|1|||
163961821|NCT02279862|592232767|FG000|Overall Study|Disease progression|5|||
163961822|NCT02279862|592232768|FG001|Overall Study|Disease progression|2|||
163961823|NCT02279862|592232767|FG000|Overall Study|Study closed by sponsor|16|||
163961824|NCT02279862|592232768|FG001|Overall Study|Study closed by sponsor|13|||
163961825|NCT02279862|592232767|FG000|Overall Study|Other|1|||
163961826|NCT02279862|592232768|FG001|Overall Study|Other|2|||
163961827|NCT02279862|592232767|FG000|Overall Study|Withdrawal by Subject|1|||
163961828|NCT02279862|592232768|FG001|Overall Study|Withdrawal by Subject|0|||
163961829|NCT05266586|592232772|FG000|Overall Study|Adverse Event|2|||
163961830|NCT05266586|592232773|FG001|Overall Study|Adverse Event|2|||
163961831|NCT05266586|592232774|FG002|Overall Study|Adverse Event|1|||
163961832|NCT05266586|592232772|FG000|Overall Study|Withdrawal by Subject|1|||
163961833|NCT05266586|592232773|FG001|Overall Study|Withdrawal by Subject|0|||
163961834|NCT05266586|592232774|FG002|Overall Study|Withdrawal by Subject|1|||
163961835|NCT05266586|592232772|FG000|Overall Study|Non-compliance with study drug|0|||
163961836|NCT05266586|592232773|FG001|Overall Study|Non-compliance with study drug|1|||
163961837|NCT05266586|592232774|FG002|Overall Study|Non-compliance with study drug|0|||
163961838|NCT05266586|592232772|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
163961839|NCT05266586|592232773|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
163961840|NCT05266586|592232774|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
163961841|NCT02225353|592232775|FG000|Overall Study|Lost to Follow-up|0|||
163961842|NCT02225353|592232776|FG001|Overall Study|Lost to Follow-up|1|||
163961843|NCT02225353|592232777|FG002|Overall Study|Lost to Follow-up|3|||
163961844|NCT02225353|592232775|FG000|Overall Study|Protocol Violation|4|||
163961845|NCT02225353|592232776|FG001|Overall Study|Protocol Violation|5|||
163961846|NCT02225353|592232777|FG002|Overall Study|Protocol Violation|12|||
163961847|NCT03707925|592232778|FG000|Overall Study|Inevaluable|1|||
163961848|NCT01193920|592232779|FG000|Overall Study|Withdrawal by Subject|1|||
163961849|NCT01193920|592232780|FG001|Overall Study|Withdrawal by Subject|0|||
163961850|NCT01193920|592232781|FG002|Overall Study|Withdrawal by Subject|5|||
163961851|NCT01193920|592232782|FG003|Overall Study|Withdrawal by Subject|1|||
163961852|NCT01193920|592232783|FG004|Overall Study|Withdrawal by Subject|3|||
163961853|NCT01193920|592232784|FG005|Overall Study|Withdrawal by Subject|1|||
163961854|NCT01193920|592232785|FG006|Overall Study|Withdrawal by Subject|3|||
163961855|NCT01193920|592232786|FG007|Overall Study|Withdrawal by Subject|0|||
163961856|NCT01193920|592232787|FG008|Overall Study|Withdrawal by Subject|1|||
163961857|NCT01193920|592232788|FG009|Overall Study|Withdrawal by Subject|0|||
163961858|NCT01193920|592232779|FG000|Overall Study|Lost to Follow-up|1|||
163961859|NCT01193920|592232780|FG001|Overall Study|Lost to Follow-up|0|||
163961860|NCT01193920|592232781|FG002|Overall Study|Lost to Follow-up|1|||
163961861|NCT01193920|592232782|FG003|Overall Study|Lost to Follow-up|1|||
163961862|NCT01193920|592232783|FG004|Overall Study|Lost to Follow-up|3|||
163961863|NCT01193920|592232784|FG005|Overall Study|Lost to Follow-up|3|||
163961864|NCT01193920|592232785|FG006|Overall Study|Lost to Follow-up|1|||
163961865|NCT01193920|592232786|FG007|Overall Study|Lost to Follow-up|0|||
163961866|NCT01193920|592232787|FG008|Overall Study|Lost to Follow-up|2|||
163961867|NCT01193920|592232788|FG009|Overall Study|Lost to Follow-up|3|||
163961868|NCT01193920|592232779|FG000|Overall Study|Protocol Violation|1|||
163961869|NCT01193920|592232780|FG001|Overall Study|Protocol Violation|0|||
163961870|NCT01193920|592232781|FG002|Overall Study|Protocol Violation|0|||
163961871|NCT01193920|592232782|FG003|Overall Study|Protocol Violation|0|||
163961872|NCT01193920|592232783|FG004|Overall Study|Protocol Violation|0|||
163961873|NCT01193920|592232784|FG005|Overall Study|Protocol Violation|0|||
163961874|NCT01193920|592232785|FG006|Overall Study|Protocol Violation|0|||
163961875|NCT01193920|592232786|FG007|Overall Study|Protocol Violation|0|||
163961876|NCT01193920|592232787|FG008|Overall Study|Protocol Violation|0|||
163961877|NCT01193920|592232788|FG009|Overall Study|Protocol Violation|0|||
163961878|NCT01193920|592232779|FG000|Overall Study|Death|0|||
163961879|NCT01193920|592232780|FG001|Overall Study|Death|0|||
163961880|NCT01193920|592232781|FG002|Overall Study|Death|0|||
163961881|NCT01193920|592232782|FG003|Overall Study|Death|1|||
163961882|NCT01193920|592232783|FG004|Overall Study|Death|0|||
163961883|NCT01193920|592232784|FG005|Overall Study|Death|0|||
163961884|NCT01193920|592232785|FG006|Overall Study|Death|2|||
163961885|NCT01193920|592232786|FG007|Overall Study|Death|3|||
163961886|NCT01193920|592232787|FG008|Overall Study|Death|2|||
163961887|NCT01193920|592232788|FG009|Overall Study|Death|4|||
163961888|NCT01193920|592232779|FG000|Overall Study|Unable to classify|0|||
163961889|NCT01193920|592232780|FG001|Overall Study|Unable to classify|0|||
163961890|NCT01193920|592232781|FG002|Overall Study|Unable to classify|0|||
163961891|NCT01193920|592232782|FG003|Overall Study|Unable to classify|1|||
163961892|NCT01193920|592232783|FG004|Overall Study|Unable to classify|0|||
163961893|NCT01193920|592232784|FG005|Overall Study|Unable to classify|0|||
163961894|NCT01193920|592232785|FG006|Overall Study|Unable to classify|0|||
163961895|NCT01193920|592232786|FG007|Overall Study|Unable to classify|1|||
163961896|NCT01193920|592232787|FG008|Overall Study|Unable to classify|0|||
163961897|NCT01193920|592232788|FG009|Overall Study|Unable to classify|0|||
163961898|NCT03431857|592232789|FG000|Overall Study|Death|6|||
163961899|NCT03431857|592232789|FG000|Overall Study|Lost to Follow-up|41|||
163961900|NCT03431857|592232789|FG000|Overall Study|Adverse Event|6|||
163961901|NCT03431857|592232789|FG000|Overall Study|Withdrawal by Subject|1|||
163961902|NCT01323621|592232790|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
163961903|NCT01323621|592232791|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
163961904|NCT01323621|592232792|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
163961905|NCT01323621|592232790|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
163961906|NCT01323621|592232791|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
163961907|NCT01323621|592232792|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
163961908|NCT01323621|592232790|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
163961909|NCT01323621|592232791|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
163961910|NCT01323621|592232792|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
163961911|NCT01323621|592232790|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
163961912|NCT01323621|592232791|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
163961913|NCT01323621|592232792|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
163961914|NCT01323621|592232790|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
163961915|NCT01323621|592232791|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
163961916|NCT01323621|592232792|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
163961917|NCT01323621|592232790|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
163961918|NCT01323621|592232791|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
163961919|NCT01323621|592232792|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
163961920|NCT01323621|592232790|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
163961921|NCT01323621|592232791|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
163961922|NCT01323621|592232792|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
163961923|NCT01323621|592232790|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
163961924|NCT01323621|592232791|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
163961925|NCT01323621|592232792|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
163961926|NCT01323621|592232790|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
163961927|NCT01323621|592232791|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
163961928|NCT01323621|592232792|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
163961929|NCT01323621|592232790|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163961930|NCT01323621|592232791|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
163961931|NCT01323621|592232792|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
163961932|NCT01323621|592232790|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
163961933|NCT01323621|592232791|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
163961934|NCT01323621|592232792|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
163961935|NCT01323621|592232790|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163961936|NCT01323621|592232791|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
163961937|NCT01323621|592232792|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
163961938|NCT01117857|592232793|FG000|Overall Study|Lost to Follow-up|4|||
163961939|NCT01117857|592232793|FG000|Overall Study|Withdrawal by Subject|4|||
163961940|NCT01117857|592232793|FG000|Overall Study|Physician Decision|1|||
163961941|NCT01119001|592232794|FG000|Overall Study|Withdrawal by Subject|2|||
163961942|NCT00954421|592232795|FG000|Screening|screen failures|3|||
163961943|NCT00954421|592232795|FG000|6 Months of DBS|Withdrawal by Subject|1|||
163961944|NCT00954421|592232795|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
163961945|NCT00403754|592232796|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
163961946|NCT00403754|592232797|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
163961947|NCT00403754|592232798|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
163961948|NCT00403754|592232799|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
163961949|NCT00403754|592232796|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
163961950|NCT00403754|592232797|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
163961951|NCT00403754|592232798|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
163961952|NCT00403754|592232799|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
163961953|NCT04343248|592232802|FG000|Overall Study|Withdrawal by Subject|5|||
163961954|NCT04343248|592232803|FG001|Overall Study|Withdrawal by Subject|6|||
163961955|NCT04343248|592232802|FG000|Overall Study|Death|1|||
163961956|NCT04343248|592232803|FG001|Overall Study|Death|2|||
163961957|NCT04343248|592232802|FG000|Overall Study|Lost to Follow-up|9|||
163961958|NCT04343248|592232803|FG001|Overall Study|Lost to Follow-up|6|||
163961959|NCT04343248|592232802|FG000|Overall Study|Physician Decision|0|||
163961960|NCT04343248|592232803|FG001|Overall Study|Physician Decision|1|||
163961961|NCT04343248|592232802|FG000|Overall Study|Adverse Event|1|||
163961962|NCT04343248|592232803|FG001|Overall Study|Adverse Event|0|||
163961963|NCT03951220|592232808|FG000|Overall Study|Withdrawal by Subject|9|||
163961964|NCT03951220|592232809|FG001|Overall Study|Withdrawal by Subject|2|||
163961965|NCT03951220|592232810|FG002|Overall Study|Withdrawal by Subject|0|||
163961966|NCT05245097|592232811|FG000|Overall Study|Adverse Event|13|||
163961967|NCT05245097|592232812|FG001|Overall Study|Adverse Event|2|||
163961968|NCT05245097|592232811|FG000|Overall Study|Protocol Violation|8|||
163961969|NCT05245097|592232812|FG001|Overall Study|Protocol Violation|6|||
163961970|NCT05245097|592232811|FG000|Overall Study|Withdrawal by Subject|18|||
163961971|NCT05245097|592232812|FG001|Overall Study|Withdrawal by Subject|0|||
163961972|NCT05245097|592232811|FG000|Overall Study|Death|6|||
163961973|NCT05245097|592232812|FG001|Overall Study|Death|7|||
163961974|NCT05245097|592232811|FG000|Overall Study|Physician Decision|6|||
163961975|NCT05245097|592232812|FG001|Overall Study|Physician Decision|0|||
163961976|NCT05245097|592232811|FG000|Overall Study|Relocation|4|||
163961977|NCT05245097|592232812|FG001|Overall Study|Relocation|3|||
163961978|NCT04683731|592232815|FG000|Overall Study|Withdrawal by Subject|1|||
163961979|NCT04683731|592232816|FG001|Overall Study|Withdrawal by Subject|0|||
163961980|NCT04683731|592232817|FG002|Overall Study|Withdrawal by Subject|3|||
163961981|NCT04683731|592232818|FG003|Overall Study|Withdrawal by Subject|2|||
163961982|NCT04683731|592232815|FG000|Overall Study|Determined patient was not eligible|3|||
163961983|NCT04683731|592232816|FG001|Overall Study|Determined patient was not eligible|3|||
163961984|NCT04683731|592232817|FG002|Overall Study|Determined patient was not eligible|12|||
163961985|NCT04683731|592232818|FG003|Overall Study|Determined patient was not eligible|3|||
163961986|NCT00883051|592232819|FG000|Overall Study|Lost to Follow-up|0|||
163961987|NCT00883051|592232820|FG001|Overall Study|Lost to Follow-up|0|||
163961988|NCT00883051|592232821|FG002|Overall Study|Lost to Follow-up|0|||
163961989|NCT00883051|592232822|FG003|Overall Study|Lost to Follow-up|0|||
163961990|NCT00883051|592232823|FG004|Overall Study|Lost to Follow-up|1|||
163961991|NCT00883051|592232819|FG000|Overall Study|Did not use study medication|24|||
163961992|NCT00883051|592232820|FG001|Overall Study|Did not use study medication|22|||
163961993|NCT00883051|592232821|FG002|Overall Study|Did not use study medication|29|||
163961994|NCT00883051|592232822|FG003|Overall Study|Did not use study medication|29|||
163961995|NCT00883051|592232823|FG004|Overall Study|Did not use study medication|17|||
163961996|NCT03604523|592232826|FG000|Overall Study|Physician Decision|1|||
163961997|NCT03604523|592232827|FG001|Overall Study|Physician Decision|0|||
163961998|NCT00458341|592232828|FG000|Cycle 1|Adverse Event|1|||
163961999|NCT00458341|592232829|FG001|Cycle 1|Adverse Event|0|||
163962000|NCT05461794|592232830|FG000|Overall Study|Withdrawal by Subject|1|||
163962001|NCT05461794|592232831|FG001|Overall Study|Withdrawal by Subject|1|||
163962002|NCT05461794|592232832|FG002|Overall Study|Withdrawal by Subject|3|||
163962003|NCT05461794|592232830|FG000|Overall Study|Study Terminated By Sponsor|18|||
163962004|NCT05461794|592232831|FG001|Overall Study|Study Terminated By Sponsor|13|||
163962005|NCT05461794|592232832|FG002|Overall Study|Study Terminated By Sponsor|16|||
163962006|NCT05461794|592232830|FG000|Overall Study|Death|20|||
163962007|NCT05461794|592232831|FG001|Overall Study|Death|5|||
163962008|NCT05461794|592232832|FG002|Overall Study|Death|19|||
163962009|NCT02730598|592232835|FG000|Overall Study|Withdrawal by Subject|3|||
163962010|NCT02730598|592232836|FG001|Overall Study|Withdrawal by Subject|3|||
163962011|NCT02730598|592232835|FG000|Overall Study|Protocol Violation|0|||
163962012|NCT02730598|592232836|FG001|Overall Study|Protocol Violation|1|||
163962013|NCT02730598|592232835|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
163962014|NCT02730598|592232836|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
163962015|NCT00810394|592232837|FG000|Overall Study|Withdrawal by Subject|3|||
163962016|NCT00467285|592232840|FG000|Overall Study|Lost to Follow-up|4|||
163962017|NCT00467285|592232841|FG001|Overall Study|Lost to Follow-up|4|||
163962018|NCT03891524|592232842|FG000|Overall Study|Death|0|||
163962019|NCT03891524|592232843|FG001|Overall Study|Death|0|||
163962020|NCT03891524|592232844|FG002|Overall Study|Death|0|||
163962021|NCT03891524|592232845|FG003|Overall Study|Death|0|||
163962022|NCT03891524|592232846|FG004|Overall Study|Death|0|||
163962023|NCT03891524|592232847|FG005|Overall Study|Death|0|||
163962024|NCT03891524|592232848|FG006|Overall Study|Death|0|||
163962025|NCT03891524|592232849|FG007|Overall Study|Death|1|||
163962026|NCT03891524|592232842|FG000|Overall Study|Withdrawal by Subject|0|||
163962027|NCT03891524|592232843|FG001|Overall Study|Withdrawal by Subject|1|||
163962028|NCT03891524|592232844|FG002|Overall Study|Withdrawal by Subject|2|||
163962029|NCT03891524|592232845|FG003|Overall Study|Withdrawal by Subject|1|||
163962030|NCT03891524|592232846|FG004|Overall Study|Withdrawal by Subject|2|||
163962031|NCT03891524|592232847|FG005|Overall Study|Withdrawal by Subject|2|||
163962032|NCT03891524|592232848|FG006|Overall Study|Withdrawal by Subject|2|||
163962033|NCT03891524|592232849|FG007|Overall Study|Withdrawal by Subject|1|||
163962034|NCT01210118|592232850|FG000|Overall Study|Lost to Follow-up|1|||
163962035|NCT01210118|592232851|FG001|Overall Study|Lost to Follow-up|1|||
163962036|NCT01210118|592232850|FG000|Overall Study|Protocol Violation|1|||
163962037|NCT01210118|592232851|FG001|Overall Study|Protocol Violation|1|||
163962038|NCT01210118|592232850|FG000|Overall Study|Spontaneous abortion|1|||
163962039|NCT01210118|592232851|FG001|Overall Study|Spontaneous abortion|3|||
163962040|NCT01079130|592232852|FG000|Overall Study|Adverse Event|1|||
163962041|NCT01079130|592232853|FG001|Overall Study|Adverse Event|1|||
163962042|NCT01079130|592232854|FG002|Overall Study|Adverse Event|0|||
163962043|NCT01079130|592232855|FG003|Overall Study|Adverse Event|1|||
163962044|NCT01079130|592232856|FG004|Overall Study|Adverse Event|5|||
163962045|NCT01079130|592232857|FG005|Overall Study|Adverse Event|1|||
163962046|NCT01079130|592232852|FG000|Overall Study|Administrative problems|1|||
163962047|NCT01079130|592232853|FG001|Overall Study|Administrative problems|3|||
163962048|NCT01079130|592232854|FG002|Overall Study|Administrative problems|0|||
163962049|NCT01079130|592232855|FG003|Overall Study|Administrative problems|0|||
163962050|NCT01079130|592232856|FG004|Overall Study|Administrative problems|0|||
163962051|NCT01079130|592232857|FG005|Overall Study|Administrative problems|1|||
163962052|NCT01079130|592232852|FG000|Overall Study|Withdrawal by Subject|0|||
163962053|NCT01079130|592232853|FG001|Overall Study|Withdrawal by Subject|1|||
163962054|NCT01079130|592232854|FG002|Overall Study|Withdrawal by Subject|0|||
163962055|NCT01079130|592232855|FG003|Overall Study|Withdrawal by Subject|0|||
163962056|NCT01079130|592232856|FG004|Overall Study|Withdrawal by Subject|1|||
163962057|NCT01079130|592232857|FG005|Overall Study|Withdrawal by Subject|3|||
163962058|NCT01079130|592232852|FG000|Overall Study|Protocol deviation|0|||
163962059|NCT01079130|592232853|FG001|Overall Study|Protocol deviation|2|||
163962060|NCT01079130|592232854|FG002|Overall Study|Protocol deviation|1|||
163962061|NCT01079130|592232855|FG003|Overall Study|Protocol deviation|2|||
163962062|NCT01079130|592232856|FG004|Overall Study|Protocol deviation|0|||
163962063|NCT01079130|592232857|FG005|Overall Study|Protocol deviation|0|||
163962064|NCT01079130|592232852|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163962065|NCT01079130|592232853|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163962066|NCT01079130|592232854|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163962067|NCT01079130|592232855|FG003|Overall Study|Abnormal test procedure result(s)|0|||
163962068|NCT01079130|592232856|FG004|Overall Study|Abnormal test procedure result(s)|1|||
163962069|NCT01079130|592232857|FG005|Overall Study|Abnormal test procedure result(s)|0|||
163962070|NCT01079130|592232852|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163962071|NCT01079130|592232853|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163962072|NCT01079130|592232854|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163962073|NCT01079130|592232855|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163962074|NCT01079130|592232856|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
163962075|NCT01079130|592232857|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
163962076|NCT01079130|592232852|FG000|Overall Study|Lost to Follow-up|0|||
163962077|NCT01079130|592232853|FG001|Overall Study|Lost to Follow-up|0|||
163962078|NCT01079130|592232854|FG002|Overall Study|Lost to Follow-up|0|||
163962079|NCT01079130|592232855|FG003|Overall Study|Lost to Follow-up|0|||
163962080|NCT01079130|592232856|FG004|Overall Study|Lost to Follow-up|1|||
163962081|NCT01079130|592232857|FG005|Overall Study|Lost to Follow-up|0|||
163962082|NCT01696942|592232864|FG000|Overall Study|Withdrawal by Subject|1|||
163962083|NCT01696942|592232865|FG001|Overall Study|Withdrawal by Subject|0|||
163962084|NCT01696942|592232864|FG000|Overall Study|Protocol Violation|1|||
163962085|NCT01696942|592232865|FG001|Overall Study|Protocol Violation|2|||
163962086|NCT01696942|592232864|FG000|Overall Study|screen failure|0|||
163962087|NCT01696942|592232865|FG001|Overall Study|screen failure|1|||
163962088|NCT01598311|592232866|FG000|Overall Study|Physician Decision|4|||
163962089|NCT01598311|592232867|FG001|Overall Study|Physician Decision|5|||
163962090|NCT01598311|592232866|FG000|Overall Study|Adverse Event|9|||
163962091|NCT01598311|592232867|FG001|Overall Study|Adverse Event|13|||
163962092|NCT01598311|592232866|FG000|Overall Study|Lost to Follow-up|7|||
163962093|NCT01598311|592232867|FG001|Overall Study|Lost to Follow-up|12|||
163962094|NCT01598311|592232866|FG000|Overall Study|Withdrawal by Subject|9|||
163962095|NCT01598311|592232867|FG001|Overall Study|Withdrawal by Subject|13|||
163962096|NCT01598311|592232866|FG000|Overall Study|No reason provided.|0|||
163962097|NCT01598311|592232867|FG001|Overall Study|No reason provided.|5|||
163962098|NCT01598311|592232866|FG000|Overall Study|Randomized but never treated|8|||
163962099|NCT01598311|592232867|FG001|Overall Study|Randomized but never treated|5|||
163962100|NCT01598311|592232866|FG000|Overall Study|Treated but no confirmed CDAD|9|||
163962101|NCT01598311|592232867|FG001|Overall Study|Treated but no confirmed CDAD|8|||
163962102|NCT01598311|592232866|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
163962103|NCT01598311|592232867|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
163962104|NCT03144804|592232868|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
163962105|NCT00959647|592232869|FG000|Overall Study|Adverse Event|2|||
163962106|NCT00959647|592232869|FG000|Overall Study|Progressive disease|6|||
163962107|NCT00959647|592232869|FG000|Overall Study|Study terminated by sponsor|4|||
163962108|NCT00959647|592232869|FG000|Overall Study|Withdrawal by Subject|7|||
163962109|NCT06515483|592232870|FG000|Overall Study|Subject withdraw due to family issues|1|||
163962110|NCT06515483|592232871|FG001|Overall Study|Subject withdraw due to family issues|0|||
163962111|NCT00523718|592234354|FG000|Overall Study|Withdrawal by Subject|1|||
163962112|NCT00523718|592234355|FG001|Overall Study|Withdrawal by Subject|0|||
163962113|NCT00523718|592234354|FG000|Overall Study|Protocol Violation|2|||
163962114|NCT00523718|592234355|FG001|Overall Study|Protocol Violation|0|||
163962115|NCT01306890|592234356|FG000|Overall Study|Adverse Event|2|||
163962116|NCT01306890|592234356|FG000|Overall Study|Death|1223|||
163962117|NCT01306890|592234356|FG000|Overall Study|Lost to Follow-up|58|||
163962118|NCT01306890|592234356|FG000|Overall Study|Withdrawal by Subject|88|||
163962119|NCT01306890|592234356|FG000|Overall Study|Unspecified reasons|104|||
163962120|NCT01306890|592234356|FG000|Overall Study|Study Termination|3|||
163962121|NCT01306890|592234356|FG000|Overall Study|No discontinuation documentation|41|||
163962122|NCT02217436|592234357|FG000|Overall Study|Protocol Violation|1|||
163962123|NCT02217436|592234358|FG001|Overall Study|Protocol Violation|1|||
163962124|NCT02217436|592234357|FG000|Overall Study|Incomplete data|0|||
163962125|NCT02217436|592234358|FG001|Overall Study|Incomplete data|1|||
163962126|NCT00234494|592234363|FG000|Overall Study|Protocol Violation|2|||
163962127|NCT02634346|592234367|FG000|Overall Study|Withdrawal by Subject|8|||
163962128|NCT02634346|592234368|FG001|Overall Study|Withdrawal by Subject|9|||
163962129|NCT02634346|592234369|FG002|Overall Study|Withdrawal by Subject|8|||
163962130|NCT02634346|592234367|FG000|Overall Study|Adverse Event|2|||
163962131|NCT02634346|592234368|FG001|Overall Study|Adverse Event|2|||
163962132|NCT02634346|592234369|FG002|Overall Study|Adverse Event|7|||
163962133|NCT02634346|592234367|FG000|Overall Study|Lack of Efficacy|1|||
163962134|NCT02634346|592234368|FG001|Overall Study|Lack of Efficacy|2|||
163962135|NCT02634346|592234369|FG002|Overall Study|Lack of Efficacy|8|||
163962136|NCT02634346|592234367|FG000|Overall Study|Lost to Follow-up|1|||
163962137|NCT02634346|592234368|FG001|Overall Study|Lost to Follow-up|0|||
163962138|NCT02634346|592234369|FG002|Overall Study|Lost to Follow-up|0|||
163962139|NCT02634346|592234367|FG000|Overall Study|Protocol Violation|0|||
163962140|NCT02634346|592234368|FG001|Overall Study|Protocol Violation|1|||
163962141|NCT02634346|592234369|FG002|Overall Study|Protocol Violation|0|||
163962142|NCT02170389|592234370|FG000|Overall Study|Study terminated prior to start of treat|1|||
163962143|NCT03801902|592234376|FG000|Overall Study|Did not receive protocol treatment.|1|||
163962144|NCT03801902|592234377|FG001|Overall Study|Did not receive protocol treatment.|0|||
163962145|NCT03801902|592234378|FG002|Overall Study|Did not receive protocol treatment.|0|||
163962146|NCT03801902|592234379|FG003|Overall Study|Did not receive protocol treatment.|0|||
163962147|NCT04485104|592234382|FG000|Overall Study|Physician Decision|2|||
163962148|NCT04485104|592234383|FG001|Overall Study|Physician Decision|0|||
163962149|NCT04485104|592234382|FG000|Overall Study|Decision by sponsor|0|||
163962150|NCT04485104|592234383|FG001|Overall Study|Decision by sponsor|1|||
163962151|NCT00908232|592234384|FG000|Cycle 1 to 4|Death|5|||
163962152|NCT00908232|592234385|FG001|Cycle 1 to 4|Death|0|||
163962153|NCT00908232|592234386|FG002|Cycle 1 to 4|Death|0|||
163962154|NCT00908232|592234387|FG003|Cycle 1 to 4|Death|0|||
163962155|NCT00908232|592234384|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
163962156|NCT00908232|592234385|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
163962157|NCT00908232|592234386|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
163962158|NCT00908232|592234387|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
163962159|NCT00908232|592234384|FG000|Cycle 1 to 4|Progressive Disease|6|||
163962160|NCT00908232|592234385|FG001|Cycle 1 to 4|Progressive Disease|0|||
163962161|NCT00908232|592234386|FG002|Cycle 1 to 4|Progressive Disease|0|||
163962162|NCT00908232|592234387|FG003|Cycle 1 to 4|Progressive Disease|0|||
163962163|NCT00908232|592234384|FG000|Cycle 1 to 4|Adverse Event|12|||
163962164|NCT00908232|592234385|FG001|Cycle 1 to 4|Adverse Event|0|||
163962165|NCT00908232|592234386|FG002|Cycle 1 to 4|Adverse Event|0|||
163962166|NCT00908232|592234387|FG003|Cycle 1 to 4|Adverse Event|0|||
163962167|NCT00908232|592234384|FG000|Cycle 1 to 4|Other|1|||
163962168|NCT00908232|592234385|FG001|Cycle 1 to 4|Other|0|||
163962169|NCT00908232|592234386|FG002|Cycle 1 to 4|Other|0|||
163962170|NCT00908232|592234387|FG003|Cycle 1 to 4|Other|0|||
163962171|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
163962172|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
163962173|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
163962174|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
163962175|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
163962176|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
163962177|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
163962178|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
163962179|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
163962180|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
163962181|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
163962182|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
163962183|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
163962184|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
163962185|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
163962186|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
163962187|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
163962188|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
163962189|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
163962190|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
163962191|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
163962192|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
163962193|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
163962194|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
163962195|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
163962196|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
163962197|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
163962198|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
163962199|NCT00908232|592234384|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
163962200|NCT00908232|592234385|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
163962201|NCT00908232|592234386|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
163962202|NCT00908232|592234387|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
163962203|NCT03153137|592234388|FG000|Overall Study|Lost to Follow-up|1|||
163962204|NCT03153137|592234389|FG001|Overall Study|Lost to Follow-up|0|||
163962205|NCT03153137|592234388|FG000|Overall Study|Withdrawal by Subject|2|||
163962206|NCT03153137|592234389|FG001|Overall Study|Withdrawal by Subject|1|||
163962207|NCT03153137|592234388|FG000|Overall Study|Physician Decision|0|||
163962208|NCT03153137|592234389|FG001|Overall Study|Physician Decision|3|||
163962209|NCT00195507|592234393|FG000|Overall Study|Adverse Event|24|||
163962210|NCT00195507|592234394|FG001|Overall Study|Adverse Event|13|||
163962211|NCT00195507|592234393|FG000|Overall Study|Death|0|||
163962212|NCT00195507|592234394|FG001|Overall Study|Death|1|||
163962213|NCT00195507|592234393|FG000|Overall Study|Failed to Return|4|||
163962214|NCT00195507|592234394|FG001|Overall Study|Failed to Return|3|||
163962215|NCT00195507|592234393|FG000|Overall Study|Physician Decision|1|||
163962216|NCT00195507|592234394|FG001|Overall Study|Physician Decision|2|||
163962217|NCT00195507|592234393|FG000|Overall Study|Lost to Follow-up|3|||
163962218|NCT00195507|592234394|FG001|Overall Study|Lost to Follow-up|2|||
163962219|NCT00195507|592234393|FG000|Overall Study|Protocol Violation|5|||
163962220|NCT00195507|592234394|FG001|Overall Study|Protocol Violation|4|||
163962221|NCT00195507|592234393|FG000|Overall Study|Lack of Efficacy|40|||
163962222|NCT00195507|592234394|FG001|Overall Study|Lack of Efficacy|67|||
163962223|NCT00195507|592234393|FG000|Overall Study|Withdrawal by Subject|16|||
163962224|NCT00195507|592234394|FG001|Overall Study|Withdrawal by Subject|23|||
163962225|NCT00195507|592234393|FG000|Overall Study|Protocol Deviation|6|||
163962226|NCT00195507|592234394|FG001|Overall Study|Protocol Deviation|3|||
163962227|NCT02260882|592234395|FG000|Overall Study|Protocol Violation|0|||
163962228|NCT02260882|592234396|FG001|Overall Study|Protocol Violation|1|||
163962229|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
163962230|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
163962231|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
163962232|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
163962233|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
163962234|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
163962235|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
163962236|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
163962237|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Death|1|||
163962238|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Death|1|||
163962239|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
163962240|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
163962241|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
163962242|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
163962243|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
163962244|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
163962245|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
163962246|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
163962247|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
163962248|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
163962249|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
163962250|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
163962251|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
163962252|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
163962253|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
163962254|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
163962255|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
163962256|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
163962257|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
163962258|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
163962259|NCT00559585|592234402|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
164006473|NCT02158533|592390966|FG004|Stage 2|Physician Decision|1|||
163962260|NCT00559585|592234403|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
163962261|NCT00559585|592234402|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
163962262|NCT00559585|592234403|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
163962263|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
163962264|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
163962265|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
163962266|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
163962267|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
163962268|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
163962269|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
163962270|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
163962271|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
163962272|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
163962273|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
163962274|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
163962275|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
163962276|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
163962277|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
163962278|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
163962279|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
163962280|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
163962281|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
163962282|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
163962283|NCT00559585|592234402|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
163962284|NCT00559585|592234403|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
163962285|NCT04209621|592234404|FG000|Overall Study|Death|1|||
163962286|NCT04209621|592234404|FG000|Overall Study|Study Terminated Early|2|||
163962287|NCT00769860|592234407|FG000|Overall Study|Withdrawal by Subject|2|||
163962288|NCT00769860|592234408|FG001|Overall Study|Withdrawal by Subject|0|||
163962289|NCT01106404|592234411|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
163962290|NCT01106404|592234412|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
163962291|NCT01106404|592234411|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
163962292|NCT01106404|592234412|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
163962293|NCT01106404|592234411|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
163962294|NCT01106404|592234412|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
163962295|NCT01106404|592234411|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
163962296|NCT01106404|592234412|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
163962297|NCT01774084|592234413|FG000|Overall Study|Personal reasons|1|||
163962298|NCT01774084|592234414|FG001|Overall Study|Personal reasons|0|||
163962299|NCT03026127|592234418|FG000|CRISP R61|Adverse Event|5|||
163962300|NCT03026127|592234419|FG001|CRISP R61|Adverse Event|0|||
163962301|NCT03026127|592234420|FG002|CRISP R61|Adverse Event|0|||
163962302|NCT03026127|592234418|FG000|CRISP R61|Lost to Follow-up|2|||
163962303|NCT03026127|592234419|FG001|CRISP R61|Lost to Follow-up|0|||
163962304|NCT03026127|592234420|FG002|CRISP R61|Lost to Follow-up|0|||
163962305|NCT03026127|592234418|FG000|CRISP R61|Dropped before therapy|5|||
163962306|NCT03026127|592234419|FG001|CRISP R61|Dropped before therapy|0|||
163962307|NCT03026127|592234420|FG002|CRISP R61|Dropped before therapy|0|||
163962308|NCT03026127|592234418|FG000|CRISP R33|Lost to Follow-up|0|||
163962309|NCT03026127|592234419|FG001|CRISP R33|Lost to Follow-up|5|||
163962310|NCT03026127|592234420|FG002|CRISP R33|Lost to Follow-up|4|||
163962311|NCT03026127|592234418|FG000|CRISP R33|Adverse Event|0|||
163962312|NCT03026127|592234419|FG001|CRISP R33|Adverse Event|9|||
163962313|NCT03026127|592234420|FG002|CRISP R33|Adverse Event|5|||
163962314|NCT03026127|592234418|FG000|CRISP R33|Withdrawal by Subject|0|||
163962315|NCT03026127|592234419|FG001|CRISP R33|Withdrawal by Subject|9|||
163962316|NCT03026127|592234420|FG002|CRISP R33|Withdrawal by Subject|1|||
163962317|NCT03026127|592234418|FG000|CRISP R33|Lack of Efficacy|0|||
163962318|NCT03026127|592234419|FG001|CRISP R33|Lack of Efficacy|3|||
163962319|NCT03026127|592234420|FG002|CRISP R33|Lack of Efficacy|2|||
163962320|NCT03026127|592234418|FG000|CRISP R33|Physician Decision|0|||
163962321|NCT03026127|592234419|FG001|CRISP R33|Physician Decision|3|||
163962322|NCT03026127|592234420|FG002|CRISP R33|Physician Decision|1|||
163962323|NCT03026127|592234418|FG000|CRISP R33|Transportation|0|||
163962324|NCT03026127|592234419|FG001|CRISP R33|Transportation|2|||
163962325|NCT03026127|592234420|FG002|CRISP R33|Transportation|1|||
163962326|NCT01182766|592234421|FG000|Overall Study|Lost to Follow-up|32|||
163962327|NCT01182766|592234422|FG001|Overall Study|Lost to Follow-up|36|||
163962328|NCT01182766|592234423|FG002|Overall Study|Lost to Follow-up|29|||
163962329|NCT01182766|592234421|FG000|Overall Study|Withdrawal by Subject|14|||
163962330|NCT01182766|592234422|FG001|Overall Study|Withdrawal by Subject|3|||
163962331|NCT01182766|592234423|FG002|Overall Study|Withdrawal by Subject|6|||
163962332|NCT01182766|592234421|FG000|Overall Study|Physician Decision|1|||
163962333|NCT01182766|592234422|FG001|Overall Study|Physician Decision|0|||
163962334|NCT01182766|592234423|FG002|Overall Study|Physician Decision|0|||
163962335|NCT01182766|592234421|FG000|Overall Study|Non-compliance|1|||
163962336|NCT01182766|592234422|FG001|Overall Study|Non-compliance|1|||
163962337|NCT01182766|592234423|FG002|Overall Study|Non-compliance|1|||
163962338|NCT03027557|592234424|FG000|Overall Study|Adverse Event|1|||
163962339|NCT03027557|592234425|FG001|Overall Study|Adverse Event|0|||
163962340|NCT03027557|592234426|FG002|Overall Study|Adverse Event|0|||
163962341|NCT02430051|592234429|FG000|Overall Study|Withdrawal by Subject|6|||
163962342|NCT02430051|592234430|FG001|Overall Study|Withdrawal by Subject|3|||
163962343|NCT02430051|592234429|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
163962344|NCT02430051|592234430|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
163962345|NCT02430051|592234429|FG000|Overall Study|Protocol Violation|1|||
163962346|NCT02430051|592234430|FG001|Overall Study|Protocol Violation|0|||
163962347|NCT02030405|592234434|FG000|Overall Study|Withdrawal by Subject|1|||
163962348|NCT02030405|592234434|FG000|Overall Study|Lost to Follow-up|1|||
163962349|NCT00564018|592234435|FG000|Overall Study|Withdrawal by Subject|2|||
163962350|NCT00564018|592234436|FG001|Overall Study|Withdrawal by Subject|3|||
163962351|NCT00564018|592234437|FG002|Overall Study|Withdrawal by Subject|1|||
163962352|NCT01145755|592234445|FG000|Overall Study|Adverse Event|2|||
163962353|NCT01145755|592234446|FG001|Overall Study|Adverse Event|4|||
163962354|NCT01145755|592234447|FG002|Overall Study|Adverse Event|2|||
163962355|NCT01145755|592234445|FG000|Overall Study|Withdrawal by Subject|2|||
163962356|NCT01145755|592234446|FG001|Overall Study|Withdrawal by Subject|2|||
163962357|NCT01145755|592234447|FG002|Overall Study|Withdrawal by Subject|2|||
163962358|NCT01145755|592234445|FG000|Overall Study|Lost to Follow-up|2|||
163962359|NCT01145755|592234446|FG001|Overall Study|Lost to Follow-up|3|||
163962360|NCT01145755|592234447|FG002|Overall Study|Lost to Follow-up|1|||
163962361|NCT01145755|592234445|FG000|Overall Study|Protocol Violation|0|||
163962362|NCT01145755|592234446|FG001|Overall Study|Protocol Violation|3|||
163962363|NCT01145755|592234447|FG002|Overall Study|Protocol Violation|1|||
163962364|NCT01145755|592234445|FG000|Overall Study|Study Closure|14|||
163962365|NCT01145755|592234446|FG001|Overall Study|Study Closure|14|||
163962366|NCT01145755|592234447|FG002|Overall Study|Study Closure|17|||
163962367|NCT01145755|592234445|FG000|Overall Study|Lack of Efficacy|0|||
163962368|NCT01145755|592234446|FG001|Overall Study|Lack of Efficacy|1|||
163962369|NCT01145755|592234447|FG002|Overall Study|Lack of Efficacy|0|||
163962370|NCT01145755|592234445|FG000|Overall Study|Patient could not swollow medication|0|||
163962371|NCT01145755|592234446|FG001|Overall Study|Patient could not swollow medication|0|||
163962372|NCT01145755|592234447|FG002|Overall Study|Patient could not swollow medication|1|||
163962373|NCT01145755|592234445|FG000|Overall Study|Withdrawal by Subject|0|||
163962374|NCT01145755|592234446|FG001|Overall Study|Withdrawal by Subject|0|||
163962375|NCT01145755|592234447|FG002|Overall Study|Withdrawal by Subject|1|||
163962376|NCT01145755|592234445|FG000|Overall Study|Positive urine ethanol|0|||
163962377|NCT01145755|592234446|FG001|Overall Study|Positive urine ethanol|1|||
163962378|NCT01145755|592234447|FG002|Overall Study|Positive urine ethanol|0|||
163962379|NCT00372385|592234448|FG000|Overall Study|Adverse Event|6|||
163962380|NCT00372385|592234449|FG001|Overall Study|Adverse Event|11|||
163962381|NCT00372385|592234450|FG002|Overall Study|Adverse Event|9|||
163962382|NCT00372385|592234451|FG003|Overall Study|Adverse Event|7|||
163962383|NCT00372385|592234448|FG000|Overall Study|Noncompliance|0|||
163962384|NCT00372385|592234449|FG001|Overall Study|Noncompliance|1|||
163962385|NCT00372385|592234450|FG002|Overall Study|Noncompliance|1|||
163962386|NCT00372385|592234451|FG003|Overall Study|Noncompliance|1|||
163962387|NCT00372385|592234448|FG000|Overall Study|Physician Decision|1|||
163962388|NCT00372385|592234449|FG001|Overall Study|Physician Decision|0|||
163962389|NCT00372385|592234450|FG002|Overall Study|Physician Decision|0|||
163962390|NCT00372385|592234451|FG003|Overall Study|Physician Decision|0|||
163962391|NCT00372385|592234448|FG000|Overall Study|Lost to Follow-up|2|||
163962392|NCT00372385|592234449|FG001|Overall Study|Lost to Follow-up|0|||
163962393|NCT00372385|592234450|FG002|Overall Study|Lost to Follow-up|0|||
163962394|NCT00372385|592234451|FG003|Overall Study|Lost to Follow-up|0|||
163962395|NCT00372385|592234448|FG000|Overall Study|Withdrawal by Subject|2|||
163962396|NCT00372385|592234449|FG001|Overall Study|Withdrawal by Subject|1|||
163962397|NCT00372385|592234450|FG002|Overall Study|Withdrawal by Subject|0|||
163962398|NCT00372385|592234451|FG003|Overall Study|Withdrawal by Subject|0|||
163962399|NCT00372385|592234448|FG000|Overall Study|Refusal of Treatment|3|||
163962400|NCT00372385|592234449|FG001|Overall Study|Refusal of Treatment|6|||
163962401|NCT00372385|592234450|FG002|Overall Study|Refusal of Treatment|0|||
163962402|NCT00372385|592234451|FG003|Overall Study|Refusal of Treatment|0|||
163962403|NCT00372385|592234448|FG000|Overall Study|No Response|1|||
163962404|NCT00372385|592234449|FG001|Overall Study|No Response|1|||
163962405|NCT00372385|592234450|FG002|Overall Study|No Response|0|||
163962406|NCT00372385|592234451|FG003|Overall Study|No Response|0|||
163962407|NCT00372385|592234448|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
163962408|NCT00372385|592234449|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
163962409|NCT00372385|592234450|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
163962410|NCT00372385|592234451|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
163962411|NCT00372385|592234448|FG000|Overall Study|Virologic Stopping Rule|17|||
163962412|NCT00372385|592234449|FG001|Overall Study|Virologic Stopping Rule|0|||
163962413|NCT00372385|592234450|FG002|Overall Study|Virologic Stopping Rule|0|||
163849964|NCT01323660|591822411|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
163849965|NCT01323660|591822412|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
163849966|NCT01323660|591822413|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
163849967|NCT01323660|591822414|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
163849968|NCT01323660|591822409|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163849969|NCT01323660|591822410|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
163849970|NCT01323660|591822411|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163849971|NCT01323660|591822412|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163849972|NCT01323660|591822413|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
163849973|NCT01323660|591822414|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
163849974|NCT01323660|591822409|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163962414|NCT00372385|592234451|FG003|Overall Study|Virologic Stopping Rule|0|||
163962415|NCT01009554|592234454|FG000|Overall Study|Adverse Event|1|||
163962416|NCT01009554|592234455|FG001|Overall Study|Adverse Event|1|||
163962417|NCT01009554|592234454|FG000|Overall Study|Withdrawal by Subject|1|||
163962418|NCT01009554|592234455|FG001|Overall Study|Withdrawal by Subject|3|||
163962419|NCT01009554|592234454|FG000|Overall Study|Noncompliant with Study Product|0|||
163962420|NCT01009554|592234455|FG001|Overall Study|Noncompliant with Study Product|3|||
163962421|NCT01605253|592234456|FG000|Overall Study|Physician Decision|3|||
163962422|NCT01605253|592234457|FG001|Overall Study|Physician Decision|2|||
163962423|NCT01605253|592234456|FG000|Overall Study|Lost to Follow-up|3|||
163962424|NCT01605253|592234457|FG001|Overall Study|Lost to Follow-up|1|||
163962425|NCT02554903|592234458|FG000|Overall Study|Death|1|||
163962426|NCT02554903|592234459|FG001|Overall Study|Death|1|||
163962427|NCT02554903|592234458|FG000|Overall Study|Physician Decision|2|||
163962428|NCT02554903|592234459|FG001|Overall Study|Physician Decision|2|||
163962429|NCT02554903|592234458|FG000|Overall Study|Heart Transplant|1|||
163962430|NCT02554903|592234459|FG001|Overall Study|Heart Transplant|2|||
163962431|NCT04226833|592234471|FG000|Overall Study|Death|0|||
163962432|NCT04226833|592234472|FG001|Overall Study|Death|0|||
163962433|NCT04226833|592234473|FG002|Overall Study|Death|1|||
163962434|NCT04226833|592234474|FG003|Overall Study|Death|0|||
163962435|NCT02876835|592234477|FG000|Treatment Period (51.1 Month)|Other|1|||
163962436|NCT02876835|592234478|FG001|Treatment Period (51.1 Month)|Other|0|||
163962437|NCT02876835|592234477|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
163962438|NCT02876835|592234478|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
163962439|NCT02876835|592234477|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
163962440|NCT02876835|592234478|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
163962441|NCT02876835|592234477|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
163962442|NCT02876835|592234478|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
163962443|NCT00475033|592234479|FG000|Infant Series|Failed to return|3|||
163962444|NCT00475033|592234480|FG001|Infant Series|Failed to return|4|||
163962445|NCT00475033|592234479|FG000|Infant Series|Parent or legal guardian request|1|||
163962446|NCT00475033|592234480|FG001|Infant Series|Parent or legal guardian request|5|||
163962447|NCT00475033|592234479|FG000|Infant Series|Protocol Violation|1|||
163962448|NCT00475033|592234480|FG001|Infant Series|Protocol Violation|2|||
163962449|NCT00475033|592234479|FG000|Infant Series|Lost to Follow-up|2|||
163962450|NCT00475033|592234480|FG001|Infant Series|Lost to Follow-up|0|||
163962451|NCT00475033|592234479|FG000|Infant Series|Adverse Event|0|||
163962452|NCT00475033|592234480|FG001|Infant Series|Adverse Event|2|||
163962453|NCT00475033|592234479|FG000|After the Infant Series|Adverse Event|0|||
163962454|NCT00475033|592234480|FG001|After the Infant Series|Adverse Event|4|||
163962455|NCT00475033|592234479|FG000|After the Infant Series|Parent or legal guardian request|2|||
163962456|NCT00475033|592234480|FG001|After the Infant Series|Parent or legal guardian request|2|||
163962457|NCT00475033|592234479|FG000|After the Infant Series|Failed to return|2|||
163962458|NCT00475033|592234480|FG001|After the Infant Series|Failed to return|1|||
163962459|NCT00475033|592234479|FG000|After the Infant Series|Protocol Violation|1|||
163962460|NCT00475033|592234480|FG001|After the Infant Series|Protocol Violation|0|||
163962461|NCT00475033|592234479|FG000|After the Infant Series|Lost to Follow-up|1|||
163962462|NCT00475033|592234480|FG001|After the Infant Series|Lost to Follow-up|0|||
163962463|NCT00475033|592234479|FG000|After the Infant Series|Other|0|||
163962464|NCT00475033|592234480|FG001|After the Infant Series|Other|1|||
163962465|NCT00475033|592234479|FG000|Toddler Dose|Parent or legal guardian request|2|||
163962466|NCT00475033|592234480|FG001|Toddler Dose|Parent or legal guardian request|0|||
163962467|NCT00475033|592234479|FG000|Toddler Dose|Failed to return|1|||
163962468|NCT00475033|592234480|FG001|Toddler Dose|Failed to return|0|||
163962469|NCT00475033|592234479|FG000|Toddler Dose|Lost to Follow-up|1|||
163962470|NCT00475033|592234480|FG001|Toddler Dose|Lost to Follow-up|0|||
163962471|NCT01335009|592234483|FG000|Overall Study|Too ill to travel to study sites|1|||
163962472|NCT01335009|592234484|FG001|Overall Study|Too ill to travel to study sites|0|||
163962473|NCT01335009|592234483|FG000|Overall Study|Death|28|||
163962474|NCT01335009|592234484|FG001|Overall Study|Death|32|||
163962475|NCT01335009|592234483|FG000|Overall Study|Withdrawal by Subject|1|||
163962476|NCT01335009|592234484|FG001|Overall Study|Withdrawal by Subject|1|||
163962477|NCT01335009|592234483|FG000|Overall Study|Lost to Follow-up|1|||
163962478|NCT01335009|592234484|FG001|Overall Study|Lost to Follow-up|0|||
163962479|NCT04824521|592234485|FG000|Overall Study|Lost to Follow-up|1|||
163962480|NCT01920594|592236570|FG000|Overall Study|Adverse Event|4|||
163962481|NCT01920594|592236571|FG001|Overall Study|Adverse Event|2|||
163962482|NCT01920594|592236570|FG000|Overall Study|Lost to Follow-up|1|||
163962483|NCT01920594|592236571|FG001|Overall Study|Lost to Follow-up|0|||
163962484|NCT01920594|592236570|FG000|Overall Study|Recovery|2|||
163962485|NCT01920594|592236571|FG001|Overall Study|Recovery|0|||
163962486|NCT01920594|592236570|FG000|Overall Study|Investigator discretion|0|||
163962487|NCT01920594|592236571|FG001|Overall Study|Investigator discretion|1|||
163962488|NCT04906616|592236572|FG000|Overall Study|Divorce|3|||
163962489|NCT04906616|592236573|FG001|Overall Study|Divorce|2|||
163962490|NCT01521897|592236574|FG000|Overall Study|Protocol Violation|18|||
163962491|NCT01521897|592236574|FG000|Overall Study|Lost to Follow-up|5|||
163962492|NCT02194062|592236575|FG000|Overall Study|Lost to Follow-up|2|||
163962493|NCT02194062|592236576|FG001|Overall Study|Lost to Follow-up|2|||
163962494|NCT02194062|592236577|FG002|Overall Study|Lost to Follow-up|5|||
163962495|NCT04147234|592236578|FG000|Overall Study|Clinical deterioration|0|||
163962496|NCT04147234|592236579|FG001|Overall Study|Clinical deterioration|0|||
163962497|NCT04147234|592236580|FG002|Overall Study|Clinical deterioration|1|||
163962498|NCT04147234|592236581|FG003|Overall Study|Clinical deterioration|0|||
163962499|NCT04147234|592236582|FG004|Overall Study|Clinical deterioration|0|||
163962500|NCT04147234|592236583|FG005|Overall Study|Clinical deterioration|0|||
163962501|NCT04147234|592236584|FG006|Overall Study|Clinical deterioration|0|||
163962502|NCT04147234|592236578|FG000|Overall Study|Withdrawal by Subject|0|||
163962503|NCT04147234|592236579|FG001|Overall Study|Withdrawal by Subject|1|||
163962504|NCT04147234|592236580|FG002|Overall Study|Withdrawal by Subject|1|||
163962505|NCT04147234|592236581|FG003|Overall Study|Withdrawal by Subject|0|||
163962506|NCT04147234|592236582|FG004|Overall Study|Withdrawal by Subject|0|||
163962507|NCT04147234|592236583|FG005|Overall Study|Withdrawal by Subject|0|||
163962508|NCT04147234|592236584|FG006|Overall Study|Withdrawal by Subject|0|||
163962509|NCT04147234|592236578|FG000|Overall Study|Clinical disease progression|1|||
163962510|NCT04147234|592236579|FG001|Overall Study|Clinical disease progression|3|||
163962511|NCT04147234|592236580|FG002|Overall Study|Clinical disease progression|1|||
163962512|NCT04147234|592236581|FG003|Overall Study|Clinical disease progression|1|||
163962513|NCT04147234|592236582|FG004|Overall Study|Clinical disease progression|0|||
163962514|NCT04147234|592236583|FG005|Overall Study|Clinical disease progression|1|||
163962515|NCT04147234|592236584|FG006|Overall Study|Clinical disease progression|0|||
163962516|NCT04147234|592236578|FG000|Overall Study|Objective disease progression|6|||
163962517|NCT04147234|592236579|FG001|Overall Study|Objective disease progression|4|||
163962518|NCT04147234|592236580|FG002|Overall Study|Objective disease progression|3|||
163962519|NCT04147234|592236581|FG003|Overall Study|Objective disease progression|3|||
163962520|NCT04147234|592236582|FG004|Overall Study|Objective disease progression|5|||
163962521|NCT04147234|592236583|FG005|Overall Study|Objective disease progression|2|||
163962522|NCT04147234|592236584|FG006|Overall Study|Objective disease progression|3|||
163962523|NCT04147234|592236578|FG000|Overall Study|Adverse Event|0|||
163962524|NCT04147234|592236579|FG001|Overall Study|Adverse Event|0|||
163962525|NCT04147234|592236580|FG002|Overall Study|Adverse Event|0|||
163962526|NCT04147234|592236581|FG003|Overall Study|Adverse Event|0|||
163962527|NCT04147234|592236582|FG004|Overall Study|Adverse Event|1|||
163962528|NCT04147234|592236583|FG005|Overall Study|Adverse Event|0|||
163962529|NCT04147234|592236584|FG006|Overall Study|Adverse Event|0|||
163962530|NCT04498169|592236589|FG000|Study Completion|Adverse Event|1|||
163962531|NCT04498169|592236590|FG001|Study Completion|Adverse Event|1|||
163962532|NCT01754857|592236591|FG000|Overall Study|Adverse Event|7|||
163962533|NCT01754857|592236591|FG000|Overall Study|Disease progression|3|||
163962534|NCT01754857|592236591|FG000|Overall Study|Physician Decision|2|||
163962535|NCT01754857|592236591|FG000|Overall Study|Withdrawal by Subject|3|||
163962536|NCT01754857|592236591|FG000|Overall Study|other complicating disease|1|||
163962537|NCT01754857|592236591|FG000|Overall Study|ineligible to continue onto maintenance|1|||
163962538|NCT01754857|592236591|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
163962539|NCT01754857|592236591|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
163962540|NCT04964960|592236592|FG000|Overall Study|Withdrawal by Subject|1|||
163962541|NCT04964960|592236592|FG000|Overall Study|Did not complete cycles|1|||
163962542|NCT02076113|592236593|FG000|Overall Study|Lost to Follow-up|4|||
163962543|NCT02076113|592236594|FG001|Overall Study|Lost to Follow-up|1|||
163962544|NCT02076113|592236593|FG000|Overall Study|Withdrawal by Subject|2|||
163962545|NCT02076113|592236594|FG001|Overall Study|Withdrawal by Subject|3|||
163962546|NCT02076113|592236593|FG000|Overall Study|Death|1|||
163962547|NCT02076113|592236594|FG001|Overall Study|Death|3|||
163962548|NCT02960854|592236597|FG000|Overall Study|Not Disclosed|2|||
163962549|NCT02960854|592236598|FG001|Overall Study|Not Disclosed|2|||
163962550|NCT02960854|592236597|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
163962551|NCT02960854|592236598|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
163962552|NCT02960854|592236597|FG000|Overall Study|Subject Withdrew Consent|0|||
163962553|NCT02960854|592236598|FG001|Overall Study|Subject Withdrew Consent|1|||
163962554|NCT02960854|592236597|FG000|Overall Study|Death|4|||
163962555|NCT02960854|592236598|FG001|Overall Study|Death|6|||
163962556|NCT00221195|592236599|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
163962557|NCT00221195|592236600|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
163962558|NCT00221195|592236599|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
163962559|NCT00221195|592236600|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
163962560|NCT00221195|592236599|FG000|Washout Period (Months 7-9)|Death|0|||
163962561|NCT00221195|592236600|FG001|Washout Period (Months 7-9)|Death|1|||
163962562|NCT00221195|592236599|FG000|Therapy 2 (Months 10-15)|Death|1|||
163962563|NCT00221195|592236600|FG001|Therapy 2 (Months 10-15)|Death|0|||
163962564|NCT00221195|592236599|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
163962565|NCT00221195|592236600|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
163962566|NCT03942406|592236604|FG000|Overall Study|Lost to Follow-up|4|||
163962567|NCT03942406|592236605|FG001|Overall Study|Lost to Follow-up|5|||
163962568|NCT03942406|592236606|FG002|Overall Study|Lost to Follow-up|3|||
163962569|NCT03942406|592236607|FG003|Overall Study|Lost to Follow-up|7|||
163962570|NCT03942406|592236608|FG004|Overall Study|Lost to Follow-up|1|||
163962571|NCT03942406|592236609|FG005|Overall Study|Lost to Follow-up|0|||
163962572|NCT03942406|592236610|FG006|Overall Study|Lost to Follow-up|0|||
163962573|NCT03942406|592236604|FG000|Overall Study|Withdrawal by Subject|3|||
163962574|NCT03942406|592236605|FG001|Overall Study|Withdrawal by Subject|1|||
163962575|NCT03942406|592236606|FG002|Overall Study|Withdrawal by Subject|1|||
163962576|NCT03942406|592236607|FG003|Overall Study|Withdrawal by Subject|3|||
163962577|NCT03942406|592236608|FG004|Overall Study|Withdrawal by Subject|0|||
163962578|NCT03942406|592236609|FG005|Overall Study|Withdrawal by Subject|0|||
163962579|NCT03942406|592236610|FG006|Overall Study|Withdrawal by Subject|0|||
163962580|NCT03942406|592236604|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
163962581|NCT03942406|592236605|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
163962582|NCT03942406|592236606|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
163962583|NCT03942406|592236607|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
163962584|NCT03942406|592236608|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
163962585|NCT03942406|592236609|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
163962586|NCT03942406|592236610|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
163962587|NCT03049735|592236631|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
163962588|NCT03049735|592236632|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
163962589|NCT03049735|592236633|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
163962590|NCT03049735|592236631|FG000|Overall Study|Other|5|||
163962591|NCT03049735|592236632|FG001|Overall Study|Other|3|||
163962592|NCT03049735|592236633|FG002|Overall Study|Other|1|||
163962593|NCT03049735|592236631|FG000|Overall Study|Lack of Efficacy|4|||
163962594|NCT03049735|592236632|FG001|Overall Study|Lack of Efficacy|0|||
163962595|NCT03049735|592236633|FG002|Overall Study|Lack of Efficacy|3|||
163962596|NCT03049735|592236631|FG000|Overall Study|Protocol deviation|1|||
163962597|NCT03049735|592236632|FG001|Overall Study|Protocol deviation|0|||
163962598|NCT03049735|592236633|FG002|Overall Study|Protocol deviation|0|||
163962599|NCT03049735|592236631|FG000|Overall Study|Pregnancy|0|||
163962600|NCT03049735|592236632|FG001|Overall Study|Pregnancy|0|||
163962601|NCT03049735|592236633|FG002|Overall Study|Pregnancy|1|||
163962602|NCT03049735|592236631|FG000|Overall Study|Adverse Event|7|||
163849975|NCT01323660|591822410|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163849976|NCT01323660|591822411|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163849977|NCT01323660|591822412|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163849978|NCT01323660|591822413|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
163849979|NCT01323660|591822414|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
163849980|NCT01323660|591822409|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163849981|NCT01323660|591822410|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163849982|NCT01323660|591822411|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163849983|NCT01323660|591822412|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163849984|NCT01323660|591822413|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
163849985|NCT01323660|591822414|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
163849986|NCT01323660|591822409|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
163849987|NCT01323660|591822410|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163849988|NCT01323660|591822411|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163849989|NCT01323660|591822412|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
163849990|NCT01323660|591822413|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
163849991|NCT01323660|591822414|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163849992|NCT01323660|591822409|FG000|Washout Period (14 Days)|Adverse Event|0|||
163849993|NCT01323660|591822410|FG001|Washout Period (14 Days)|Adverse Event|0|||
163849994|NCT01323660|591822411|FG002|Washout Period (14 Days)|Adverse Event|0|||
163849995|NCT01323660|591822412|FG003|Washout Period (14 Days)|Adverse Event|0|||
163849996|NCT01323660|591822413|FG004|Washout Period (14 Days)|Adverse Event|1|||
163962603|NCT03049735|592236632|FG001|Overall Study|Adverse Event|18|||
163962604|NCT03049735|592236633|FG002|Overall Study|Adverse Event|5|||
163962605|NCT03049735|592236631|FG000|Overall Study|Withdrawal by Subject|10|||
163962606|NCT03049735|592236632|FG001|Overall Study|Withdrawal by Subject|3|||
163962607|NCT03049735|592236633|FG002|Overall Study|Withdrawal by Subject|7|||
163962608|NCT03049735|592236631|FG000|Overall Study|Lost to Follow-up|1|||
163962609|NCT03049735|592236632|FG001|Overall Study|Lost to Follow-up|5|||
163962610|NCT03049735|592236633|FG002|Overall Study|Lost to Follow-up|5|||
163962611|NCT03254485|592236634|FG000|Overall Study|Adverse Event|3|||
163962612|NCT03254485|592236635|FG001|Overall Study|Adverse Event|0|||
163962613|NCT03254485|592236636|FG002|Overall Study|Adverse Event|0|||
163962614|NCT03254485|592236637|FG003|Overall Study|Adverse Event|6|||
163962615|NCT03254485|592236634|FG000|Overall Study|Protocol Violation|6|||
163962616|NCT03254485|592236635|FG001|Overall Study|Protocol Violation|0|||
163962617|NCT03254485|592236636|FG002|Overall Study|Protocol Violation|0|||
163962618|NCT03254485|592236637|FG003|Overall Study|Protocol Violation|2|||
163962619|NCT03254485|592236634|FG000|Overall Study|Withdrawal by Subject|1|||
163962620|NCT03254485|592236635|FG001|Overall Study|Withdrawal by Subject|0|||
163962621|NCT03254485|592236636|FG002|Overall Study|Withdrawal by Subject|0|||
163962622|NCT03254485|592236637|FG003|Overall Study|Withdrawal by Subject|4|||
163962623|NCT03254485|592236634|FG000|Overall Study|Death|0|||
163962624|NCT03254485|592236635|FG001|Overall Study|Death|0|||
163962625|NCT03254485|592236636|FG002|Overall Study|Death|0|||
163962626|NCT03254485|592236637|FG003|Overall Study|Death|1|||
163962627|NCT03254485|592236634|FG000|Overall Study|Lost to Follow-up|1|||
163962628|NCT03254485|592236635|FG001|Overall Study|Lost to Follow-up|0|||
163962629|NCT03254485|592236636|FG002|Overall Study|Lost to Follow-up|0|||
163962630|NCT03254485|592236637|FG003|Overall Study|Lost to Follow-up|0|||
163962631|NCT03254485|592236634|FG000|Overall Study|Other|1|||
163962632|NCT03254485|592236635|FG001|Overall Study|Other|0|||
163962633|NCT03254485|592236636|FG002|Overall Study|Other|0|||
163962634|NCT03254485|592236637|FG003|Overall Study|Other|2|||
163962635|NCT02146326|592236638|FG000|Overall Study|Lost to Follow-up|3|||
163962636|NCT02146326|592236639|FG001|Overall Study|Lost to Follow-up|3|||
163962637|NCT02146326|592236640|FG002|Overall Study|Lost to Follow-up|11|||
163962638|NCT02146326|592236641|FG003|Overall Study|Lost to Follow-up|19|||
163962639|NCT02146326|592236638|FG000|Overall Study|Withdrawal by Subject|2|||
163962640|NCT02146326|592236639|FG001|Overall Study|Withdrawal by Subject|1|||
163962641|NCT02146326|592236640|FG002|Overall Study|Withdrawal by Subject|15|||
163962642|NCT02146326|592236641|FG003|Overall Study|Withdrawal by Subject|11|||
163962643|NCT02146326|592236638|FG000|Overall Study|Separated from mental health center|23|||
163962644|NCT02146326|592236639|FG001|Overall Study|Separated from mental health center|33|||
163962645|NCT02146326|592236640|FG002|Overall Study|Separated from mental health center|0|||
163962646|NCT02146326|592236641|FG003|Overall Study|Separated from mental health center|0|||
163962647|NCT02146326|592236638|FG000|Overall Study|Incarcerated|0|||
163962648|NCT02146326|592236639|FG001|Overall Study|Incarcerated|0|||
163962649|NCT02146326|592236640|FG002|Overall Study|Incarcerated|3|||
163962650|NCT02146326|592236641|FG003|Overall Study|Incarcerated|8|||
163962651|NCT02146326|592236638|FG000|Overall Study|Death|0|||
163962652|NCT02146326|592236639|FG001|Overall Study|Death|0|||
163962653|NCT02146326|592236640|FG002|Overall Study|Death|4|||
163962654|NCT02146326|592236641|FG003|Overall Study|Death|4|||
163962655|NCT02146326|592236638|FG000|Overall Study|Unable to complete interview|0|||
163962656|NCT02146326|592236639|FG001|Overall Study|Unable to complete interview|0|||
163962657|NCT02146326|592236640|FG002|Overall Study|Unable to complete interview|10|||
163849997|NCT01323660|591822414|FG005|Washout Period (14 Days)|Adverse Event|0|||
163849998|NCT01323660|591822409|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
163849999|NCT01323660|591822410|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
163850000|NCT01323660|591822411|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
163850001|NCT01323660|591822412|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
163850002|NCT01323660|591822413|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
163850003|NCT01323660|591822414|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
163850004|NCT01323660|591822409|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163850005|NCT01323660|591822410|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163850006|NCT01323660|591822411|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
163850007|NCT01323660|591822412|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163850008|NCT01323660|591822413|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
163850009|NCT01323660|591822414|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
163850010|NCT01323660|591822409|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
163850011|NCT01323660|591822410|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
163850012|NCT01323660|591822411|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
163850013|NCT01323660|591822412|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
163850014|NCT01323660|591822413|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
163850015|NCT01323660|591822414|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
163850016|NCT01323660|591822409|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163962658|NCT02146326|592236641|FG003|Overall Study|Unable to complete interview|6|||
163962659|NCT03153111|592236642|FG000|Overall Study|Death|2|||
163962660|NCT03153111|592236643|FG001|Overall Study|Death|5|||
163962661|NCT03153111|592236642|FG000|Overall Study|Lost to Follow-up|1|||
163962662|NCT03153111|592236643|FG001|Overall Study|Lost to Follow-up|0|||
163962663|NCT03153111|592236642|FG000|Overall Study|Physician Decision|5|||
163962664|NCT03153111|592236643|FG001|Overall Study|Physician Decision|1|||
163962665|NCT03153111|592236642|FG000|Overall Study|Withdrawal by Subject|3|||
163962666|NCT03153111|592236643|FG001|Overall Study|Withdrawal by Subject|3|||
163962667|NCT02958267|592236645|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
163962668|NCT02958267|592236646|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
163962669|NCT02958267|592236645|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
163962670|NCT02958267|592236646|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
163850017|NCT01323660|591822410|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163962671|NCT02958267|592236645|FG000|Follow-up Visits|Additional treatment pursued|2|||
163962672|NCT02958267|592236646|FG001|Follow-up Visits|Additional treatment pursued|1|||
163962673|NCT00777946|592236649|FG000|Overall Study|Adverse Event|11|||
163962674|NCT00777946|592236650|FG001|Overall Study|Adverse Event|1|||
163962675|NCT00777946|592236651|FG002|Overall Study|Adverse Event|3|||
163962676|NCT00777946|592236649|FG000|Overall Study|Lack of Efficacy|0|||
163962677|NCT00777946|592236650|FG001|Overall Study|Lack of Efficacy|0|||
163962678|NCT00777946|592236651|FG002|Overall Study|Lack of Efficacy|9|||
163962679|NCT00777946|592236649|FG000|Overall Study|Condition no longer required study drug|1|||
163962680|NCT00777946|592236650|FG001|Overall Study|Condition no longer required study drug|0|||
163962681|NCT00777946|592236651|FG002|Overall Study|Condition no longer required study drug|0|||
163962682|NCT00777946|592236649|FG000|Overall Study|Patient withdrew consent|3|||
163962683|NCT00777946|592236650|FG001|Overall Study|Patient withdrew consent|2|||
163962684|NCT00777946|592236651|FG002|Overall Study|Patient withdrew consent|3|||
163962685|NCT00777946|592236649|FG000|Overall Study|Lost to Follow-up|3|||
163962686|NCT00777946|592236650|FG001|Overall Study|Lost to Follow-up|1|||
163962687|NCT00777946|592236651|FG002|Overall Study|Lost to Follow-up|0|||
163962688|NCT00777946|592236649|FG000|Overall Study|Protocol deviation|2|||
163962689|NCT00777946|592236650|FG001|Overall Study|Protocol deviation|1|||
163962690|NCT00777946|592236651|FG002|Overall Study|Protocol deviation|1|||
163962691|NCT00777946|592236649|FG000|Overall Study|Randomized in error|1|||
163962692|NCT00777946|592236650|FG001|Overall Study|Randomized in error|1|||
163962693|NCT00777946|592236651|FG002|Overall Study|Randomized in error|0|||
163962694|NCT02684357|592236652|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
163962695|NCT02684357|592236653|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
163962696|NCT02684357|592236654|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
163962697|NCT02684357|592236655|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
163962698|NCT02684357|592236656|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
163962699|NCT02684357|592236657|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
163962700|NCT02684357|592236652|FG000|Part A|Lost to Follow-up|0|||
163962701|NCT02684357|592236653|FG001|Part A|Lost to Follow-up|2|||
163962702|NCT02684357|592236654|FG002|Part A|Lost to Follow-up|2|||
163962703|NCT02684357|592236655|FG003|Part A|Lost to Follow-up|0|||
163962704|NCT02684357|592236656|FG004|Part A|Lost to Follow-up|0|||
163962705|NCT02684357|592236657|FG005|Part A|Lost to Follow-up|0|||
163962706|NCT02684357|592236652|FG000|Part A|Withdrawal by Subject|3|||
163962707|NCT02684357|592236653|FG001|Part A|Withdrawal by Subject|0|||
163962708|NCT02684357|592236654|FG002|Part A|Withdrawal by Subject|0|||
163962709|NCT02684357|592236655|FG003|Part A|Withdrawal by Subject|0|||
163962710|NCT02684357|592236656|FG004|Part A|Withdrawal by Subject|0|||
163962711|NCT02684357|592236657|FG005|Part A|Withdrawal by Subject|0|||
163962712|NCT02684357|592236652|FG000|Part A|Other|0|||
163962713|NCT02684357|592236653|FG001|Part A|Other|1|||
163962714|NCT02684357|592236654|FG002|Part A|Other|0|||
163962715|NCT02684357|592236655|FG003|Part A|Other|0|||
163850018|NCT01323660|591822411|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163850019|NCT01323660|591822412|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163850020|NCT01323660|591822413|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
163850021|NCT01323660|591822414|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
163962716|NCT02684357|592236656|FG004|Part A|Other|0|||
163962717|NCT02684357|592236657|FG005|Part A|Other|0|||
163962718|NCT02684357|592236652|FG000|Part B|Adverse Event (Other)|0|||
163962719|NCT02684357|592236653|FG001|Part B|Adverse Event (Other)|0|||
163962720|NCT02684357|592236654|FG002|Part B|Adverse Event (Other)|0|||
163962721|NCT02684357|592236655|FG003|Part B|Adverse Event (Other)|1|||
163962722|NCT02684357|592236656|FG004|Part B|Adverse Event (Other)|1|||
163962723|NCT02684357|592236657|FG005|Part B|Adverse Event (Other)|1|||
163850022|NCT01323660|591822409|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163850023|NCT01323660|591822410|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163962724|NCT02684357|592236652|FG000|Part B|Lost to Follow-up|0|||
163962725|NCT02684357|592236653|FG001|Part B|Lost to Follow-up|0|||
163962726|NCT02684357|592236654|FG002|Part B|Lost to Follow-up|0|||
163962727|NCT02684357|592236655|FG003|Part B|Lost to Follow-up|1|||
163962728|NCT02684357|592236656|FG004|Part B|Lost to Follow-up|1|||
163962729|NCT02684357|592236657|FG005|Part B|Lost to Follow-up|7|||
163962730|NCT02684357|592236652|FG000|Part B|Withdrawal by Subject|0|||
163962731|NCT02684357|592236653|FG001|Part B|Withdrawal by Subject|0|||
163962732|NCT02684357|592236654|FG002|Part B|Withdrawal by Subject|0|||
163962733|NCT02684357|592236655|FG003|Part B|Withdrawal by Subject|0|||
163962734|NCT02684357|592236656|FG004|Part B|Withdrawal by Subject|2|||
163962735|NCT02684357|592236657|FG005|Part B|Withdrawal by Subject|4|||
163962736|NCT02684357|592236652|FG000|Part B|Other|0|||
163962737|NCT02684357|592236653|FG001|Part B|Other|0|||
163962738|NCT02684357|592236654|FG002|Part B|Other|0|||
163962739|NCT02684357|592236655|FG003|Part B|Other|1|||
163962740|NCT02684357|592236656|FG004|Part B|Other|0|||
163962741|NCT02684357|592236657|FG005|Part B|Other|1|||
163962742|NCT01853982|592236658|FG000|Overall Study|Withdrawal by Subject|1|||
163962743|NCT01853982|592236659|FG001|Overall Study|Withdrawal by Subject|0|||
163962744|NCT01853982|592236658|FG000|Overall Study|Death|1|||
163962745|NCT01853982|592236659|FG001|Overall Study|Death|0|||
163962746|NCT01853982|592236658|FG000|Overall Study|Lost to Follow-up|0|||
163962747|NCT01853982|592236659|FG001|Overall Study|Lost to Follow-up|1|||
163962748|NCT00390910|592236660|FG000|Overall Study|Adverse Event|1|||
163962749|NCT00390910|592236661|FG001|Overall Study|Adverse Event|0|||
163962750|NCT00390910|592236662|FG002|Overall Study|Adverse Event|0|||
163962751|NCT00390910|592236660|FG000|Overall Study|Lost to Follow-up|0|||
163962752|NCT00390910|592236661|FG001|Overall Study|Lost to Follow-up|1|||
163962753|NCT00390910|592236662|FG002|Overall Study|Lost to Follow-up|5|||
163962754|NCT00390910|592236660|FG000|Overall Study|Withdrawal by Subject|1|||
163962755|NCT00390910|592236661|FG001|Overall Study|Withdrawal by Subject|3|||
163962756|NCT00390910|592236662|FG002|Overall Study|Withdrawal by Subject|2|||
163962757|NCT00390910|592236660|FG000|Overall Study|Migrated/moved from study area|0|||
163962758|NCT00390910|592236661|FG001|Overall Study|Migrated/moved from study area|0|||
163962759|NCT00390910|592236662|FG002|Overall Study|Migrated/moved from study area|3|||
163962760|NCT05066724|592236664|FG000|Overall Study|Adverse Event|1|||
163962761|NCT05066724|592236664|FG000|Overall Study|Non-Compliance With Study Drug|5|||
163962762|NCT05066724|592236664|FG000|Overall Study|Withdrawal by Subject|6|||
163962763|NCT05066724|592236664|FG000|Overall Study|Physician Decision|2|||
163962764|NCT01422850|592236676|FG000|Overall Study|Physician Decision|3|||
163962765|NCT04484831|592236677|FG000|Overall Study|Withdrawal by Subject|1|||
163962766|NCT04484831|592236678|FG001|Overall Study|Withdrawal by Subject|0|||
163962767|NCT02244996|592236680|FG000|Overall Study|Lack of Efficacy|2|||
163962768|NCT02244996|592236681|FG001|Overall Study|Lack of Efficacy|6|||
163962769|NCT00174265|592236682|FG000|Overall Study|Adverse Event|7|||
163962770|NCT00174265|592236683|FG001|Overall Study|Adverse Event|4|||
163962771|NCT00174265|592236682|FG000|Overall Study|Lack of Efficacy|2|||
163962772|NCT00174265|592236683|FG001|Overall Study|Lack of Efficacy|2|||
163962773|NCT00174265|592236682|FG000|Overall Study|Withdrawal by Subject|3|||
163962774|NCT00174265|592236683|FG001|Overall Study|Withdrawal by Subject|5|||
163962775|NCT00174265|592236682|FG000|Overall Study|Lost to Follow-up|1|||
163962776|NCT00174265|592236683|FG001|Overall Study|Lost to Follow-up|0|||
163962777|NCT00174265|592236682|FG000|Overall Study|Other (Not specified)|16|||
163962778|NCT00174265|592236683|FG001|Overall Study|Other (Not specified)|10|||
163962779|NCT03231943|592236685|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962780|NCT03231943|592236686|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
163962781|NCT03231943|592236687|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
163962782|NCT03231943|592236688|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962783|NCT03231943|592236689|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962784|NCT03231943|592236690|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962785|NCT03231943|592236691|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962786|NCT03231943|592236692|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962787|NCT03231943|592236693|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962788|NCT03231943|592236694|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962789|NCT03231943|592236695|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962790|NCT03231943|592236696|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962791|NCT03231943|592236697|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
163962792|NCT03231943|592236685|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962793|NCT03231943|592236686|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
163962794|NCT03231943|592236687|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962795|NCT03231943|592236688|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962796|NCT03231943|592236689|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962797|NCT03231943|592236690|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962798|NCT03231943|592236691|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962799|NCT03231943|592236692|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962800|NCT03231943|592236693|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962801|NCT03231943|592236694|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962802|NCT03231943|592236695|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962803|NCT03231943|592236696|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962804|NCT03231943|592236697|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
163962805|NCT03231943|592236685|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
163962806|NCT03231943|592236686|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962807|NCT03231943|592236687|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962808|NCT03231943|592236688|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962809|NCT03231943|592236689|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962810|NCT03231943|592236690|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962811|NCT03231943|592236691|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962812|NCT03231943|592236692|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962813|NCT03231943|592236693|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962814|NCT03231943|592236694|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962815|NCT03231943|592236695|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962816|NCT03231943|592236696|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962817|NCT03231943|592236697|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
163962818|NCT03231943|592236685|FG000|Part 2|Adverse Event|0|||
163962819|NCT03231943|592236686|FG001|Part 2|Adverse Event|0|||
163962820|NCT03231943|592236687|FG002|Part 2|Adverse Event|0|||
163962821|NCT03231943|592236688|FG003|Part 2|Adverse Event|0|||
163962822|NCT03231943|592236689|FG004|Part 2|Adverse Event|0|||
163962823|NCT03231943|592236690|FG005|Part 2|Adverse Event|0|||
163962824|NCT03231943|592236691|FG006|Part 2|Adverse Event|0|||
163962825|NCT03231943|592236692|FG007|Part 2|Adverse Event|0|||
163962826|NCT03231943|592236693|FG008|Part 2|Adverse Event|0|||
163962827|NCT03231943|592236694|FG009|Part 2|Adverse Event|0|||
163962828|NCT03231943|592236695|FG010|Part 2|Adverse Event|1|||
163962829|NCT03231943|592236696|FG011|Part 2|Adverse Event|0|||
163962830|NCT03231943|592236697|FG012|Part 2|Adverse Event|0|||
163962831|NCT03231943|592236685|FG000|Part 2|Withdrawal by Subject|0|||
163962832|NCT03231943|592236686|FG001|Part 2|Withdrawal by Subject|0|||
163962833|NCT03231943|592236687|FG002|Part 2|Withdrawal by Subject|0|||
163962834|NCT03231943|592236688|FG003|Part 2|Withdrawal by Subject|0|||
163962835|NCT03231943|592236689|FG004|Part 2|Withdrawal by Subject|0|||
163962836|NCT03231943|592236690|FG005|Part 2|Withdrawal by Subject|0|||
163962837|NCT03231943|592236691|FG006|Part 2|Withdrawal by Subject|0|||
163962838|NCT03231943|592236692|FG007|Part 2|Withdrawal by Subject|0|||
163962839|NCT03231943|592236693|FG008|Part 2|Withdrawal by Subject|0|||
163962840|NCT03231943|592236694|FG009|Part 2|Withdrawal by Subject|0|||
163962841|NCT03231943|592236695|FG010|Part 2|Withdrawal by Subject|0|||
163962842|NCT03231943|592236696|FG011|Part 2|Withdrawal by Subject|1|||
163962843|NCT03231943|592236697|FG012|Part 2|Withdrawal by Subject|0|||
163962844|NCT03471871|592236698|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163962845|NCT03471871|592236699|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163962846|NCT03471871|592236700|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
163962847|NCT03471871|592236701|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163962848|NCT03471871|592236702|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
163962849|NCT03471871|592236698|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
163962850|NCT03471871|592236699|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
163962851|NCT03471871|592236700|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
163962852|NCT03471871|592236701|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
163962853|NCT03471871|592236702|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
163962854|NCT03471871|592236698|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163962855|NCT03471871|592236699|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163962856|NCT03471871|592236700|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163962857|NCT03471871|592236701|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
163962858|NCT03471871|592236702|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
163962859|NCT03471871|592236698|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163962860|NCT03471871|592236699|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163962861|NCT03471871|592236700|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163962862|NCT03471871|592236701|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
163962863|NCT03471871|592236702|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
163962864|NCT03471871|592236698|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163962865|NCT03471871|592236699|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163962866|NCT03471871|592236700|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163962867|NCT03471871|592236701|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
163962868|NCT03471871|592236702|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
163962869|NCT00047320|592236703|FG000|Overall Study|Lack of Efficacy|8|||
163962870|NCT00047320|592236703|FG000|Overall Study|Lost to Follow-up|1|||
163962871|NCT00047320|592236703|FG000|Overall Study|Physician Decision|8|||
163962872|NCT00047320|592236703|FG000|Overall Study|Withdrawal by Subject|9|||
163962873|NCT00047320|592236703|FG000|Overall Study|Ineligible|2|||
163962874|NCT03040622|592236704|FG000|Overall Study|unable to implant device|3|||
163962875|NCT02818920|592236705|FG000|Overall Study|Unresectable|4|||
163962876|NCT02818920|592236705|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
163962877|NCT02818920|592236705|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
163962878|NCT02818920|592236705|FG000|Overall Study|Adverse Event|3|||
163962879|NCT02818920|592236705|FG000|Overall Study|Developed Other Disease|1|||
163850024|NCT01323660|591822411|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163850025|NCT01323660|591822412|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163850026|NCT01323660|591822413|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163850027|NCT01323660|591822414|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
163850028|NCT01323660|591822409|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163850029|NCT01323660|591822410|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163850030|NCT01323660|591822411|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163850031|NCT01323660|591822412|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163850032|NCT01323660|591822413|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
163850033|NCT01323660|591822414|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163850034|NCT04227340|591822420|FG000|Overall Study|Withdrawal by Subject|3|||
163850035|NCT02015663|591822422|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
163850036|NCT02015663|591822423|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
163850037|NCT02015663|591822422|FG000|Overall Study|Withdrawal by Subject|1|||
163850038|NCT02015663|591822423|FG001|Overall Study|Withdrawal by Subject|0|||
163850039|NCT02015663|591822422|FG000|Overall Study|Protocol Violation|0|||
163850040|NCT02015663|591822423|FG001|Overall Study|Protocol Violation|1|||
163850041|NCT02015663|591822422|FG000|Overall Study|Adverse Event|3|||
163850042|NCT02015663|591822423|FG001|Overall Study|Adverse Event|0|||
163850043|NCT02015663|591822422|FG000|Overall Study|Administrative problems|10|||
163850044|NCT02015663|591822423|FG001|Overall Study|Administrative problems|11|||
163850045|NCT02059161|591822424|FG000|Overall Study|Pregnancy|0|||
163850046|NCT02059161|591822425|FG001|Overall Study|Pregnancy|2|||
163850047|NCT02059161|591822424|FG000|Overall Study|Adverse Event|2|||
163850048|NCT02059161|591822425|FG001|Overall Study|Adverse Event|6|||
163850049|NCT02059161|591822424|FG000|Overall Study|Lost to Follow-up|20|||
163850050|NCT02059161|591822425|FG001|Overall Study|Lost to Follow-up|12|||
163850051|NCT02059161|591822424|FG000|Overall Study|Physician Decision|4|||
163850052|NCT02059161|591822425|FG001|Overall Study|Physician Decision|4|||
163850053|NCT02059161|591822424|FG000|Overall Study|Protocol Violation|1|||
163850054|NCT02059161|591822425|FG001|Overall Study|Protocol Violation|1|||
163850055|NCT02059161|591822424|FG000|Overall Study|Withdrawal by Subject|16|||
163850056|NCT02059161|591822425|FG001|Overall Study|Withdrawal by Subject|13|||
163850057|NCT02059161|591822424|FG000|Overall Study|Randomized in error, no study drug|0|||
163850058|NCT02059161|591822425|FG001|Overall Study|Randomized in error, no study drug|1|||
163850059|NCT02059161|591822424|FG000|Overall Study|Non-compliance with study drug|6|||
163850060|NCT02059161|591822425|FG001|Overall Study|Non-compliance with study drug|2|||
163850061|NCT00958009|591822426|FG000|Overall Study|Adverse Event|1|||
163850062|NCT00958009|591822426|FG000|Overall Study|Subject found device difficult to use|1|||
163850063|NCT00087490|591822438|FG000|Overall Study|Death|6|||
163850064|NCT00087490|591822439|FG001|Overall Study|Death|4|||
163850065|NCT00087490|591822438|FG000|Overall Study|Adverse Event|3|||
163850066|NCT00087490|591822439|FG001|Overall Study|Adverse Event|8|||
163850067|NCT00087490|591822438|FG000|Overall Study|Lack of Efficacy|0|||
163850068|NCT00087490|591822439|FG001|Overall Study|Lack of Efficacy|2|||
163850069|NCT00087490|591822438|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
163850070|NCT00087490|591822439|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
163850071|NCT00087490|591822438|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
163850072|NCT00087490|591822439|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
163850073|NCT00087490|591822438|FG000|Overall Study|Randomized but not treated|7|||
163850074|NCT00087490|591822439|FG001|Overall Study|Randomized but not treated|18|||
163850075|NCT02839681|591822442|FG000|Overall Study|Death|2|||
163850076|NCT02300311|591822443|FG000|Overall Study|Other than the reason specified|1|||
163850077|NCT02300311|591822444|FG001|Overall Study|Other than the reason specified|0|||
163850078|NCT02300311|591822443|FG000|Overall Study|Refused to continue taking medication|18|||
163850079|NCT02300311|591822444|FG001|Overall Study|Refused to continue taking medication|0|||
163850080|NCT00848211|591822445|FG000|Overall Study|Protocol Violation|0|||
163962880|NCT02818920|592236705|FG000|Overall Study|Refused Further Treatment|1|||
163962881|NCT00445068|592236706|FG000|Overall Study|Disease progression|26|||
163850081|NCT00848211|591822446|FG001|Overall Study|Protocol Violation|1|||
163962882|NCT00445068|592236706|FG000|Overall Study|Adverse Event|5|||
163850082|NCT00848211|591822447|FG002|Overall Study|Protocol Violation|1|||
163850083|NCT00848211|591822448|FG003|Overall Study|Protocol Violation|0|||
163850084|NCT00848211|591822445|FG000|Overall Study|Adverse Event|0|||
163850085|NCT00848211|591822446|FG001|Overall Study|Adverse Event|0|||
163962883|NCT00445068|592236706|FG000|Overall Study|Abnormal laboratory value|2|||
163962884|NCT00445068|592236706|FG000|Overall Study|Withdrawal by Subject|2|||
163962885|NCT00445068|592236706|FG000|Overall Study|Death|1|||
163850086|NCT00848211|591822447|FG002|Overall Study|Adverse Event|0|||
163850087|NCT00848211|591822448|FG003|Overall Study|Adverse Event|0|||
163850088|NCT00772928|591822449|FG000|Overall Study|Lost to Follow-up|9|||
163850089|NCT00772928|591822450|FG001|Overall Study|Lost to Follow-up|6|||
163850090|NCT00772928|591822449|FG000|Overall Study|Protocol Violation|10|||
163850091|NCT00772928|591822450|FG001|Overall Study|Protocol Violation|12|||
163962886|NCT02673619|592236707|FG000|Overall Study|Lost to Follow-up|1|||
163962887|NCT02673619|592236708|FG001|Overall Study|Lost to Follow-up|0|||
163962888|NCT02673619|592236709|FG002|Overall Study|Lost to Follow-up|0|||
163962889|NCT02673619|592236710|FG003|Overall Study|Lost to Follow-up|0|||
163962890|NCT02673619|592236707|FG000|Overall Study|Withdrawal by Subject|1|||
163962891|NCT02673619|592236708|FG001|Overall Study|Withdrawal by Subject|1|||
163962892|NCT02673619|592236709|FG002|Overall Study|Withdrawal by Subject|1|||
163962893|NCT02673619|592236710|FG003|Overall Study|Withdrawal by Subject|0|||
163962894|NCT02673619|592236707|FG000|Overall Study|Adverse Event|0|||
163962895|NCT02673619|592236708|FG001|Overall Study|Adverse Event|0|||
163962896|NCT02673619|592236709|FG002|Overall Study|Adverse Event|1|||
163962897|NCT02673619|592236710|FG003|Overall Study|Adverse Event|0|||
163962898|NCT02673619|592236707|FG000|Overall Study|Lack of Efficacy|0|||
163962899|NCT02673619|592236708|FG001|Overall Study|Lack of Efficacy|0|||
163962900|NCT02673619|592236709|FG002|Overall Study|Lack of Efficacy|1|||
163962901|NCT02673619|592236710|FG003|Overall Study|Lack of Efficacy|0|||
163962902|NCT03444324|592236711|FG000|Overall Study|Withdrawal by Subject|0|||
163962903|NCT03444324|592236712|FG001|Overall Study|Withdrawal by Subject|1|||
163962904|NCT03444324|592236711|FG000|Overall Study|Lost to Follow-up|4|||
163962905|NCT03444324|592236712|FG001|Overall Study|Lost to Follow-up|2|||
163962906|NCT03444324|592236711|FG000|Overall Study|Protocol Violation|0|||
163962907|NCT03444324|592236712|FG001|Overall Study|Protocol Violation|1|||
163962908|NCT03444324|592236711|FG000|Overall Study|Lack of Trial Compliance|1|||
163962909|NCT03444324|592236712|FG001|Overall Study|Lack of Trial Compliance|1|||
163962910|NCT03444324|592236711|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
163962911|NCT03444324|592236712|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
163962912|NCT00658684|592236714|FG000|Overall Study|Adverse Event|10|||
163962913|NCT00658684|592236715|FG001|Overall Study|Adverse Event|8|||
163962914|NCT00658684|592236716|FG002|Overall Study|Adverse Event|2|||
163962915|NCT00658684|592236717|FG003|Overall Study|Adverse Event|0|||
163962916|NCT00658684|592236714|FG000|Overall Study|Withdrawal by Subject|6|||
163962917|NCT00658684|592236715|FG001|Overall Study|Withdrawal by Subject|4|||
163962918|NCT00658684|592236716|FG002|Overall Study|Withdrawal by Subject|1|||
163962919|NCT00658684|592236717|FG003|Overall Study|Withdrawal by Subject|1|||
163962920|NCT00658684|592236714|FG000|Overall Study|Lack of Efficacy|1|||
163962921|NCT00658684|592236715|FG001|Overall Study|Lack of Efficacy|1|||
163962922|NCT00658684|592236716|FG002|Overall Study|Lack of Efficacy|0|||
163962923|NCT00658684|592236717|FG003|Overall Study|Lack of Efficacy|0|||
163962924|NCT00658684|592236714|FG000|Overall Study|Protocol Violation|1|||
163962925|NCT00658684|592236715|FG001|Overall Study|Protocol Violation|1|||
163962926|NCT00658684|592236716|FG002|Overall Study|Protocol Violation|0|||
163962927|NCT00658684|592236717|FG003|Overall Study|Protocol Violation|0|||
163962928|NCT00658684|592236714|FG000|Overall Study|Pregnancy|1|||
163962929|NCT00658684|592236715|FG001|Overall Study|Pregnancy|1|||
163962930|NCT00658684|592236716|FG002|Overall Study|Pregnancy|0|||
163962931|NCT00658684|592236717|FG003|Overall Study|Pregnancy|0|||
163962932|NCT00688103|592236718|FG000|Overall Study|Adverse Event|4|||
163962933|NCT00688103|592236719|FG001|Overall Study|Adverse Event|1|||
163962934|NCT00688103|592236718|FG000|Overall Study|Lack of Efficacy|11|||
163962935|NCT00688103|592236719|FG001|Overall Study|Lack of Efficacy|1|||
163962936|NCT00688103|592236718|FG000|Overall Study|Withdrawal by Subject|4|||
163962937|NCT00688103|592236719|FG001|Overall Study|Withdrawal by Subject|2|||
163962938|NCT00688103|592236718|FG000|Overall Study|complex reasons|11|||
163962939|NCT00688103|592236719|FG001|Overall Study|complex reasons|9|||
163962940|NCT06071754|592236720|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
163962941|NCT03226275|592236721|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
163962942|NCT03226275|592236722|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
163962943|NCT03226275|592236723|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
163962944|NCT03226275|592236724|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
163962945|NCT03226275|592236721|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
163962946|NCT03226275|592236722|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
163962947|NCT03226275|592236723|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
163962948|NCT03226275|592236724|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
163962949|NCT05959629|592236727|FG000|Overall Study|partially necrotic/technical issues|2|||
163962950|NCT05959629|592236728|FG001|Overall Study|partially necrotic/technical issues|2|||
163962951|NCT01436071|592238223|FG000|Overall Study|Adverse Event|1|||
163962952|NCT01436071|592238224|FG001|Overall Study|Adverse Event|0|||
163962953|NCT01436071|592238223|FG000|Overall Study|Lack of Efficacy|16|||
163962954|NCT01436071|592238224|FG001|Overall Study|Lack of Efficacy|7|||
163962955|NCT01436071|592238223|FG000|Overall Study|Protocol Violation|0|||
163962956|NCT01436071|592238224|FG001|Overall Study|Protocol Violation|1|||
163962957|NCT01436071|592238223|FG000|Overall Study|Lost to Follow-up|3|||
163962958|NCT01436071|592238224|FG001|Overall Study|Lost to Follow-up|1|||
163962959|NCT01436071|592238223|FG000|Overall Study|Physician Decision|1|||
163962960|NCT01436071|592238224|FG001|Overall Study|Physician Decision|0|||
163962961|NCT01436071|592238223|FG000|Overall Study|Withdrawal by Subject|2|||
163962962|NCT01436071|592238224|FG001|Overall Study|Withdrawal by Subject|2|||
163962963|NCT01436071|592238223|FG000|Overall Study|Did Not Receive Trial Medication|3|||
163962964|NCT01436071|592238224|FG001|Overall Study|Did Not Receive Trial Medication|3|||
163962965|NCT03808688|592238227|FG000|Overall Study|Adverse Event|13|||
163962966|NCT03808688|592238228|FG001|Overall Study|Adverse Event|17|||
163962967|NCT03808688|592238227|FG000|Overall Study|Lack of Efficacy|2|||
163962968|NCT03808688|592238228|FG001|Overall Study|Lack of Efficacy|0|||
163962969|NCT03808688|592238227|FG000|Overall Study|Lost to Follow-up|0|||
163962970|NCT03808688|592238228|FG001|Overall Study|Lost to Follow-up|2|||
163962971|NCT03808688|592238227|FG000|Overall Study|Withdrawal by Subject|1|||
163962972|NCT03808688|592238228|FG001|Overall Study|Withdrawal by Subject|0|||
163962973|NCT03808688|592238227|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
163962974|NCT03808688|592238228|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
163962975|NCT03808688|592238227|FG000|Overall Study|IOP Too High|1|||
163962976|NCT03808688|592238228|FG001|Overall Study|IOP Too High|1|||
163962977|NCT03808688|592238227|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
163962978|NCT03808688|592238228|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
163962979|NCT03808688|592238227|FG000|Overall Study|Visit Out of Window|0|||
163962980|NCT03808688|592238228|FG001|Overall Study|Visit Out of Window|1|||
163962981|NCT03808688|592238227|FG000|Overall Study|Medication Non-Compliance|0|||
163962982|NCT03808688|592238228|FG001|Overall Study|Medication Non-Compliance|1|||
163962983|NCT03335163|592238232|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
163962984|NCT03335163|592238232|FG000|Overall Study|Withdrawal by Subject|18|||
163962985|NCT01215175|592238234|FG000|Overall Study|Lost to Follow-up|0|||
163962986|NCT01215175|592238235|FG001|Overall Study|Lost to Follow-up|1|||
163962987|NCT01215175|592238236|FG002|Overall Study|Lost to Follow-up|0|||
163962988|NCT01215175|592238237|FG003|Overall Study|Lost to Follow-up|1|||
163962989|NCT01215175|592238238|FG004|Overall Study|Lost to Follow-up|0|||
163962990|NCT01016964|592238239|FG000|Overall Study|Lost to Follow-up|3|||
163962991|NCT01016964|592238240|FG001|Overall Study|Lost to Follow-up|3|||
163962992|NCT03872453|592238241|FG000|Overall Study|Adverse Event|1|||
163962993|NCT03872453|592238242|FG001|Overall Study|Adverse Event|1|||
163962994|NCT03872453|592238243|FG002|Overall Study|Adverse Event|0|||
163962995|NCT03872453|592238244|FG003|Overall Study|Adverse Event|0|||
163962996|NCT03872453|592238241|FG000|Overall Study|Lost to Follow-up|8|||
163962997|NCT03872453|592238242|FG001|Overall Study|Lost to Follow-up|7|||
163962998|NCT03872453|592238243|FG002|Overall Study|Lost to Follow-up|4|||
163962999|NCT03872453|592238244|FG003|Overall Study|Lost to Follow-up|4|||
163963000|NCT03872453|592238241|FG000|Overall Study|Never Treated Migraine|19|||
163963001|NCT03872453|592238242|FG001|Overall Study|Never Treated Migraine|17|||
163963002|NCT03872453|592238243|FG002|Overall Study|Never Treated Migraine|13|||
163963003|NCT03872453|592238244|FG003|Overall Study|Never Treated Migraine|12|||
163963004|NCT03872453|592238241|FG000|Overall Study|Pregnancy|1|||
163963005|NCT03872453|592238242|FG001|Overall Study|Pregnancy|0|||
163963006|NCT03872453|592238243|FG002|Overall Study|Pregnancy|0|||
163963007|NCT03872453|592238244|FG003|Overall Study|Pregnancy|0|||
163963008|NCT03872453|592238241|FG000|Overall Study|Protocol Deviation|2|||
163963009|NCT03872453|592238242|FG001|Overall Study|Protocol Deviation|0|||
163963010|NCT03872453|592238243|FG002|Overall Study|Protocol Deviation|0|||
163963011|NCT03872453|592238244|FG003|Overall Study|Protocol Deviation|2|||
163963012|NCT03872453|592238241|FG000|Overall Study|Withdrawal by Subject|0|||
163963013|NCT03872453|592238242|FG001|Overall Study|Withdrawal by Subject|1|||
163963014|NCT03872453|592238243|FG002|Overall Study|Withdrawal by Subject|2|||
163963015|NCT03872453|592238244|FG003|Overall Study|Withdrawal by Subject|0|||
163963016|NCT03872453|592238241|FG000|Overall Study|Other Than Specified|1|||
163963017|NCT03872453|592238242|FG001|Overall Study|Other Than Specified|0|||
163963018|NCT03872453|592238243|FG002|Overall Study|Other Than Specified|0|||
163963019|NCT03872453|592238244|FG003|Overall Study|Other Than Specified|0|||
163963020|NCT00352885|592238245|FG000|Overall Study|Withdrawal by Subject|0|||
163963021|NCT00352885|592238246|FG001|Overall Study|Withdrawal by Subject|3|||
163963022|NCT00352885|592238245|FG000|Overall Study|Development of major depression|0|||
163963023|NCT00352885|592238246|FG001|Overall Study|Development of major depression|1|||
163963024|NCT00352885|592238245|FG000|Overall Study|Progression of metastatic melanoma|5|||
163963025|NCT00352885|592238246|FG001|Overall Study|Progression of metastatic melanoma|3|||
163963026|NCT00352885|592238245|FG000|Overall Study|Side effects of IL-2 administration|1|||
163963027|NCT00352885|592238246|FG001|Overall Study|Side effects of IL-2 administration|0|||
163963028|NCT01678209|592238247|FG000|Overall Study|could not scan twice|1|||
163963029|NCT01678209|592238248|FG001|Overall Study|could not scan twice|1|||
163963030|NCT01678209|592238249|FG002|Overall Study|could not scan twice|1|||
163963031|NCT01678209|592238247|FG000|Overall Study|scheduling conflicts|0|||
163963032|NCT01678209|592238248|FG001|Overall Study|scheduling conflicts|0|||
163963033|NCT01678209|592238249|FG002|Overall Study|scheduling conflicts|1|||
163963034|NCT01678209|592238247|FG000|Overall Study|screen fail|16|||
163963035|NCT01678209|592238248|FG001|Overall Study|screen fail|17|||
163963036|NCT01678209|592238249|FG002|Overall Study|screen fail|16|||
163963037|NCT03756350|592238254|FG000|Overall Study|Lost to Follow-up|1|||
163963038|NCT00440700|592238257|FG000|Overall Study|Withdrawal by Subject|8|||
163963039|NCT00440700|592238258|FG001|Overall Study|Withdrawal by Subject|8|||
163963040|NCT00440700|592238259|FG002|Overall Study|Withdrawal by Subject|4|||
163963041|NCT01096342|592238260|FG000|Overall Study|Protocol Violation|1|||
163963042|NCT00385203|592238261|FG000|Overall Study|Adverse Event|5|||
163963043|NCT00385203|592238262|FG001|Overall Study|Adverse Event|4|||
163963044|NCT00385203|592238261|FG000|Overall Study|Death|1|||
163963045|NCT00385203|592238262|FG001|Overall Study|Death|0|||
163963046|NCT00385203|592238261|FG000|Overall Study|Condition under investigation worsened|18|||
163963047|NCT00385203|592238262|FG001|Overall Study|Condition under investigation worsened|3|||
163963048|NCT00385203|592238261|FG000|Overall Study|Incorrect enrollment|2|||
163963049|NCT00385203|592238262|FG001|Overall Study|Incorrect enrollment|0|||
163963050|NCT03422172|592238263|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
163963051|NCT03422172|592238263|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
163963052|NCT03422172|592238263|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
163963053|NCT00293722|592238272|FG000|Overall Study|Other|427|||
163963054|NCT01008696|592238273|FG000|Overall Study|Participant's evasion of hospital visit|5|||
163963055|NCT01008696|592238274|FG001|Overall Study|Participant's evasion of hospital visit|4|||
163963056|NCT01008696|592238273|FG000|Overall Study|Withdrawal by Subject|2|||
163963057|NCT01008696|592238274|FG001|Overall Study|Withdrawal by Subject|4|||
163963058|NCT01008696|592238273|FG000|Overall Study|Physician Decision|5|||
163963059|NCT01008696|592238274|FG001|Overall Study|Physician Decision|1|||
163963060|NCT01008696|592238273|FG000|Overall Study|Adverse Event|1|||
163963061|NCT01008696|592238274|FG001|Overall Study|Adverse Event|0|||
163963062|NCT01008696|592238273|FG000|Overall Study|Participants' non-cooperation|2|||
163963063|NCT01008696|592238274|FG001|Overall Study|Participants' non-cooperation|3|||
163963064|NCT01008696|592238273|FG000|Overall Study|Other|2|||
163963065|NCT01008696|592238274|FG001|Overall Study|Other|3|||
163963066|NCT01008696|592238273|FG000|Overall Study|Other|0|||
163963067|NCT01008696|592238274|FG001|Overall Study|Other|2|||
163963068|NCT01383161|592238275|FG000|Overall Study|Adverse Event|5|||
163963069|NCT01383161|592238276|FG001|Overall Study|Adverse Event|1|||
163963070|NCT01383161|592238275|FG000|Overall Study|Withdrawal by Subject|0|||
163963071|NCT01383161|592238276|FG001|Overall Study|Withdrawal by Subject|2|||
163963072|NCT01383161|592238275|FG000|Overall Study|Lack of Efficacy|0|||
163963073|NCT01383161|592238276|FG001|Overall Study|Lack of Efficacy|1|||
163963074|NCT00833911|592238277|FG000|Titration|Adverse Event|18|||
163963075|NCT00833911|592238277|FG000|Titration|Withdrawal by Subject|3|||
163963076|NCT00833911|592238277|FG000|Maintenance Phase I|Adverse Event|73|||
163963077|NCT00833911|592238277|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
163850092|NCT00772928|591822449|FG000|Overall Study|Withdrawal by Subject|25|||
163850093|NCT00772928|591822450|FG001|Overall Study|Withdrawal by Subject|22|||
163850094|NCT00772928|591822449|FG000|Overall Study|Did not receive vaccine|0|||
163850095|NCT00772928|591822450|FG001|Overall Study|Did not receive vaccine|1|||
163850096|NCT01347645|591822455|FG000|Overall Study|Death|1|||
163850097|NCT01347645|591822456|FG001|Overall Study|Death|5|||
163850098|NCT01347645|591822457|FG002|Overall Study|Death|2|||
163850099|NCT01347645|591822458|FG003|Overall Study|Death|7|||
163850100|NCT01347645|591822459|FG004|Overall Study|Death|7|||
163850101|NCT01347645|591822455|FG000|Overall Study|Lost to Follow-up|1|||
163850102|NCT01347645|591822456|FG001|Overall Study|Lost to Follow-up|1|||
163850103|NCT01347645|591822457|FG002|Overall Study|Lost to Follow-up|0|||
163850104|NCT01347645|591822458|FG003|Overall Study|Lost to Follow-up|1|||
163850105|NCT01347645|591822459|FG004|Overall Study|Lost to Follow-up|1|||
163850106|NCT01347645|591822455|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
163850107|NCT01347645|591822456|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
163850108|NCT01347645|591822457|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
163850109|NCT01347645|591822458|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
163850110|NCT01347645|591822459|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
163850111|NCT01347645|591822455|FG000|Overall Study|Other|1|||
163850112|NCT01347645|591822456|FG001|Overall Study|Other|0|||
163850113|NCT01347645|591822457|FG002|Overall Study|Other|0|||
163850114|NCT01347645|591822458|FG003|Overall Study|Other|0|||
163850115|NCT01347645|591822459|FG004|Overall Study|Other|1|||
163963078|NCT00833911|592238277|FG000|Maintenance Phase I|Physician Decision|10|||
163963079|NCT00833911|592238277|FG000|Maintenance Phase I|Lack of Efficacy|4|||
163963080|NCT00833911|592238277|FG000|Maintenance Phase II|Adverse Event|6|||
163963081|NCT00833911|592238277|FG000|Maintenance Phase II|Physician Decision|2|||
163963082|NCT00833911|592238277|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
163963083|NCT00833911|592238277|FG000|Maintenance Phase II|Lack of Efficacy|1|||
163963084|NCT01423812|592238284|FG000|Overall Study|Lost to Follow-up|2|||
163850116|NCT01347645|591822455|FG000|Overall Study|Withdrawal by Subject|0|||
163963085|NCT01423812|592238285|FG001|Overall Study|Lost to Follow-up|2|||
163963086|NCT01423812|592238284|FG000|Overall Study|Withdrawal by Subject|1|||
163963087|NCT01423812|592238285|FG001|Overall Study|Withdrawal by Subject|2|||
163963088|NCT02616614|592238286|FG000|Overall Study|Withdrawal by Subject|10|||
163963089|NCT02616614|592238287|FG001|Overall Study|Withdrawal by Subject|5|||
163963090|NCT02616614|592238288|FG002|Overall Study|Withdrawal by Subject|6|||
163963091|NCT02616614|592238286|FG000|Overall Study|Physician Decision|2|||
163963092|NCT02616614|592238287|FG001|Overall Study|Physician Decision|1|||
163963093|NCT02616614|592238288|FG002|Overall Study|Physician Decision|0|||
163963094|NCT02616614|592238286|FG000|Overall Study|Adverse Event|1|||
163963095|NCT02616614|592238287|FG001|Overall Study|Adverse Event|4|||
163963096|NCT02616614|592238288|FG002|Overall Study|Adverse Event|1|||
163963097|NCT02616614|592238286|FG000|Overall Study|Protocol Violation|0|||
163963098|NCT02616614|592238287|FG001|Overall Study|Protocol Violation|3|||
163963099|NCT02616614|592238288|FG002|Overall Study|Protocol Violation|1|||
163963100|NCT02616614|592238286|FG000|Overall Study|Prohibited Medication|12|||
163963101|NCT02616614|592238287|FG001|Overall Study|Prohibited Medication|9|||
163963102|NCT02616614|592238288|FG002|Overall Study|Prohibited Medication|5|||
163963103|NCT02616614|592238286|FG000|Overall Study|More than 3 applications missed|6|||
163963104|NCT02616614|592238287|FG001|Overall Study|More than 3 applications missed|8|||
163963105|NCT02616614|592238288|FG002|Overall Study|More than 3 applications missed|1|||
163963106|NCT02616614|592238286|FG000|Overall Study|Lost to Follow-up|31|||
163963107|NCT02616614|592238287|FG001|Overall Study|Lost to Follow-up|28|||
163963108|NCT02616614|592238288|FG002|Overall Study|Lost to Follow-up|13|||
163963109|NCT02616614|592238286|FG000|Overall Study|Pregnancy|2|||
163963110|NCT02616614|592238287|FG001|Overall Study|Pregnancy|0|||
163963111|NCT02616614|592238288|FG002|Overall Study|Pregnancy|1|||
163963112|NCT02616614|592238286|FG000|Overall Study|Other|1|||
163963113|NCT02616614|592238287|FG001|Overall Study|Other|2|||
163963114|NCT02616614|592238288|FG002|Overall Study|Other|1|||
163963115|NCT02748018|592238289|FG000|Study Period|Adverse Event|1|||
163963116|NCT02748018|592238290|FG001|Study Period|Adverse Event|3|||
163963117|NCT02748018|592238291|FG002|Study Period|Adverse Event|4|||
163963118|NCT02748018|592238292|FG003|Study Period|Adverse Event|0|||
163963119|NCT02748018|592238293|FG004|Study Period|Adverse Event|3|||
163963120|NCT02748018|592238294|FG005|Study Period|Adverse Event|3|||
163963121|NCT02748018|592238289|FG000|Study Period|Withdrawal by Subject|7|||
163963122|NCT02748018|592238290|FG001|Study Period|Withdrawal by Subject|4|||
163963123|NCT02748018|592238291|FG002|Study Period|Withdrawal by Subject|4|||
163963124|NCT02748018|592238292|FG003|Study Period|Withdrawal by Subject|11|||
163963125|NCT02748018|592238293|FG004|Study Period|Withdrawal by Subject|12|||
163963126|NCT02748018|592238294|FG005|Study Period|Withdrawal by Subject|10|||
163963127|NCT02748018|592238289|FG000|Study Period|Pregnancy|0|||
163963128|NCT02748018|592238290|FG001|Study Period|Pregnancy|1|||
163963129|NCT02748018|592238291|FG002|Study Period|Pregnancy|0|||
163963130|NCT02748018|592238292|FG003|Study Period|Pregnancy|0|||
163963131|NCT02748018|592238293|FG004|Study Period|Pregnancy|1|||
163963132|NCT02748018|592238294|FG005|Study Period|Pregnancy|0|||
163963133|NCT02748018|592238289|FG000|Study Period|Physician Decision|2|||
163963134|NCT02748018|592238290|FG001|Study Period|Physician Decision|2|||
163963135|NCT02748018|592238291|FG002|Study Period|Physician Decision|1|||
163963136|NCT02748018|592238292|FG003|Study Period|Physician Decision|0|||
163963137|NCT02748018|592238293|FG004|Study Period|Physician Decision|2|||
163963138|NCT02748018|592238294|FG005|Study Period|Physician Decision|0|||
163963139|NCT02748018|592238289|FG000|Study Period|Lost to Follow-up|0|||
163963140|NCT02748018|592238290|FG001|Study Period|Lost to Follow-up|0|||
163963141|NCT02748018|592238291|FG002|Study Period|Lost to Follow-up|0|||
163963142|NCT02748018|592238292|FG003|Study Period|Lost to Follow-up|2|||
163963143|NCT02748018|592238293|FG004|Study Period|Lost to Follow-up|0|||
163850117|NCT01347645|591822456|FG001|Overall Study|Withdrawal by Subject|0|||
163850118|NCT01347645|591822457|FG002|Overall Study|Withdrawal by Subject|0|||
163850119|NCT01347645|591822458|FG003|Overall Study|Withdrawal by Subject|3|||
163850120|NCT01347645|591822459|FG004|Overall Study|Withdrawal by Subject|3|||
163850121|NCT01347645|591822455|FG000|Overall Study|Physician Decision|0|||
163850122|NCT01347645|591822456|FG001|Overall Study|Physician Decision|0|||
163850123|NCT01347645|591822457|FG002|Overall Study|Physician Decision|0|||
163850124|NCT01347645|591822458|FG003|Overall Study|Physician Decision|0|||
163850125|NCT01347645|591822459|FG004|Overall Study|Physician Decision|1|||
163850126|NCT01347645|591822455|FG000|Overall Study|Adverse Event|0|||
163850127|NCT01347645|591822456|FG001|Overall Study|Adverse Event|0|||
163850128|NCT01347645|591822457|FG002|Overall Study|Adverse Event|0|||
163850129|NCT01347645|591822458|FG003|Overall Study|Adverse Event|1|||
163850130|NCT01347645|591822459|FG004|Overall Study|Adverse Event|1|||
163850131|NCT00388362|591822460|FG000|Enrolled|Ineligible|1|||
163850132|NCT00388362|591822460|FG000|Enrolled|Adverse Event|9|||
163850133|NCT00388362|591822460|FG000|Enrolled|Death|1|||
163850134|NCT00388362|591822460|FG000|Enrolled|Loss insurance|1|||
163850135|NCT00388362|591822460|FG000|Enrolled|Withdrawal by Subject|1|||
163850136|NCT00388362|591822460|FG000|Remained on Study Median of 514 Days|Death|2|||
163850137|NCT01141660|591822461|FG000|Overall Study|Physician Decision|0|||
163850138|NCT01141660|591822462|FG001|Overall Study|Physician Decision|12|||
163850139|NCT00209027|591822464|FG000|Overall Study|study terminated|10|||
163850140|NCT00209027|591822465|FG001|Overall Study|study terminated|0|||
163850141|NCT02335268|591822466|FG000|Overall Study|Physician Decision|5|||
163963144|NCT02748018|592238294|FG005|Study Period|Lost to Follow-up|1|||
163963145|NCT02748018|592238289|FG000|Continuation Period|Adverse Event|2|||
163963146|NCT02748018|592238290|FG001|Continuation Period|Adverse Event|0|||
163963147|NCT02748018|592238291|FG002|Continuation Period|Adverse Event|1|||
163963148|NCT02748018|592238292|FG003|Continuation Period|Adverse Event|1|||
163963149|NCT02748018|592238293|FG004|Continuation Period|Adverse Event|1|||
163963150|NCT02748018|592238294|FG005|Continuation Period|Adverse Event|4|||
163963151|NCT02748018|592238289|FG000|Continuation Period|Withdrawal by Subject|3|||
163963152|NCT02748018|592238290|FG001|Continuation Period|Withdrawal by Subject|5|||
163963153|NCT02748018|592238291|FG002|Continuation Period|Withdrawal by Subject|3|||
163963154|NCT02748018|592238292|FG003|Continuation Period|Withdrawal by Subject|9|||
163963155|NCT02748018|592238293|FG004|Continuation Period|Withdrawal by Subject|11|||
163963156|NCT02748018|592238294|FG005|Continuation Period|Withdrawal by Subject|1|||
163963157|NCT02748018|592238289|FG000|Continuation Period|Lost to Follow-up|0|||
163963158|NCT02748018|592238290|FG001|Continuation Period|Lost to Follow-up|2|||
163963159|NCT02748018|592238291|FG002|Continuation Period|Lost to Follow-up|1|||
163963160|NCT02748018|592238292|FG003|Continuation Period|Lost to Follow-up|0|||
163963161|NCT02748018|592238293|FG004|Continuation Period|Lost to Follow-up|1|||
163963162|NCT02748018|592238294|FG005|Continuation Period|Lost to Follow-up|0|||
163963163|NCT02748018|592238289|FG000|Continuation Period|Pregnancy|1|||
163963164|NCT02748018|592238290|FG001|Continuation Period|Pregnancy|2|||
163963165|NCT02748018|592238291|FG002|Continuation Period|Pregnancy|0|||
163963166|NCT02748018|592238292|FG003|Continuation Period|Pregnancy|0|||
163963167|NCT02748018|592238293|FG004|Continuation Period|Pregnancy|0|||
163963168|NCT02748018|592238294|FG005|Continuation Period|Pregnancy|0|||
163963169|NCT02748018|592238289|FG000|Continuation Period|Physician Decision|0|||
163963170|NCT02748018|592238290|FG001|Continuation Period|Physician Decision|1|||
163963171|NCT02748018|592238291|FG002|Continuation Period|Physician Decision|2|||
163963172|NCT02748018|592238292|FG003|Continuation Period|Physician Decision|0|||
163963173|NCT02748018|592238293|FG004|Continuation Period|Physician Decision|2|||
163963174|NCT02748018|592238294|FG005|Continuation Period|Physician Decision|1|||
163963175|NCT02748018|592238289|FG000|Continuation Period|Protocol Violation|0|||
163963176|NCT02748018|592238290|FG001|Continuation Period|Protocol Violation|1|||
163963177|NCT02748018|592238291|FG002|Continuation Period|Protocol Violation|0|||
163963178|NCT02748018|592238292|FG003|Continuation Period|Protocol Violation|0|||
163963179|NCT02748018|592238293|FG004|Continuation Period|Protocol Violation|0|||
163963180|NCT02748018|592238294|FG005|Continuation Period|Protocol Violation|0|||
163963181|NCT06069778|592238295|FG000|Overall Study|Withdrawal by Subject|1|||
163963182|NCT04704336|592238299|FG000|Overall Study|Death|2|||
163963183|NCT04704336|592238300|FG001|Overall Study|Death|2|||
163963184|NCT04704336|592238299|FG000|Overall Study|Lost to Follow-up|33|||
163963185|NCT04704336|592238300|FG001|Overall Study|Lost to Follow-up|40|||
163963186|NCT02119325|592238301|FG000|Washout Period 1|Adverse Event|0|||
163963187|NCT02119325|592238302|FG001|Washout Period 1|Adverse Event|1|||
163963188|NCT02249767|592238303|FG000|Overall Study|Did not use medication|8|||
163963189|NCT02249767|592238304|FG001|Overall Study|Did not use medication|9|||
163963190|NCT02249767|592238305|FG002|Overall Study|Did not use medication|8|||
163963191|NCT01372410|592238306|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
163963192|NCT01372410|592238307|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
163963193|NCT01372410|592238308|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163963194|NCT01372410|592238309|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163963195|NCT01372410|592238310|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
163963196|NCT01372410|592238311|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163963197|NCT01372410|592238312|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163963198|NCT01372410|592238313|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
163963199|NCT01372410|592238306|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
163963200|NCT01372410|592238307|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
163963201|NCT01372410|592238308|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
163963202|NCT01372410|592238309|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
163963203|NCT01372410|592238310|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
163963204|NCT01372410|592238311|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
163963205|NCT01372410|592238312|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
163963206|NCT01372410|592238313|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
163963207|NCT01372410|592238306|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963208|NCT01372410|592238307|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963209|NCT01372410|592238308|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963210|NCT01372410|592238309|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963211|NCT01372410|592238310|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
163963212|NCT01372410|592238311|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963213|NCT01372410|592238312|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963214|NCT01372410|592238313|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163963215|NCT01372410|592238306|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963216|NCT01372410|592238307|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963217|NCT01372410|592238308|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963218|NCT01372410|592238309|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963219|NCT01372410|592238310|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963220|NCT01372410|592238311|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963221|NCT01372410|592238312|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
163963222|NCT01372410|592238313|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
163963223|NCT01372410|592238306|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
163963224|NCT01372410|592238307|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163963225|NCT01372410|592238308|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163963226|NCT01372410|592238309|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163963227|NCT01372410|592238310|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163963228|NCT01372410|592238311|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163963229|NCT01372410|592238312|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
163963230|NCT01372410|592238313|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
163963231|NCT01372410|592238306|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963232|NCT01372410|592238307|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963233|NCT01372410|592238308|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963234|NCT01372410|592238309|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963235|NCT01372410|592238310|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
163963236|NCT01372410|592238311|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963237|NCT01372410|592238312|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963238|NCT01372410|592238313|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
163963239|NCT01372410|592238306|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163963240|NCT01372410|592238307|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163963241|NCT01372410|592238308|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163963242|NCT01372410|592238309|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163963243|NCT01372410|592238310|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
163963244|NCT01372410|592238311|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
163963245|NCT01372410|592238312|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
163963246|NCT01372410|592238313|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
163963247|NCT01372410|592238306|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963248|NCT01372410|592238307|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963249|NCT01372410|592238308|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963250|NCT01372410|592238309|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963251|NCT01372410|592238310|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963252|NCT01372410|592238311|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963253|NCT01372410|592238312|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
163963254|NCT01372410|592238313|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
163963255|NCT01372410|592238306|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963256|NCT01372410|592238307|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963257|NCT01372410|592238308|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
163963258|NCT01372410|592238309|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963259|NCT01372410|592238310|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963260|NCT01372410|592238311|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963261|NCT01372410|592238312|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963262|NCT01372410|592238313|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
163963263|NCT01372410|592238306|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963264|NCT01372410|592238307|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963265|NCT01372410|592238308|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963266|NCT01372410|592238309|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963267|NCT01372410|592238310|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963268|NCT01372410|592238311|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
163963269|NCT01372410|592238312|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963270|NCT01372410|592238313|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
163963271|NCT04585646|592238314|FG000|First Intervention|Physician Decision|1|||
163963272|NCT04585646|592238315|FG001|First Intervention|Physician Decision|0|||
163963273|NCT04585646|592238314|FG000|First Intervention|Lost to Follow-up|0|||
163963274|NCT04585646|592238315|FG001|First Intervention|Lost to Follow-up|3|||
163963275|NCT04585646|592238314|FG000|First Intervention|Withdrawal by Subject|0|||
163963276|NCT04585646|592238315|FG001|First Intervention|Withdrawal by Subject|1|||
163963277|NCT04614662|592238316|FG000|Overall Study|Withdrawal by Subject|0|||
163963278|NCT04614662|592238317|FG001|Overall Study|Withdrawal by Subject|1|||
163963279|NCT01862640|592238324|FG000|Overall Study|Adverse Event|4|||
163963280|NCT01862640|592238325|FG001|Overall Study|Adverse Event|10|||
163963281|NCT01862640|592238326|FG002|Overall Study|Adverse Event|6|||
163963282|NCT01862640|592238327|FG003|Overall Study|Adverse Event|8|||
163963283|NCT01862640|592238324|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
163963284|NCT01862640|592238325|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
163963285|NCT01862640|592238326|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
163963286|NCT01862640|592238327|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
163963287|NCT01862640|592238324|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
163963288|NCT01862640|592238325|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
163963289|NCT01862640|592238326|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
163963290|NCT01862640|592238327|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
163963291|NCT01862640|592238324|FG000|Overall Study|Withdrawal by Subject|2|||
163963292|NCT01862640|592238325|FG001|Overall Study|Withdrawal by Subject|4|||
163963293|NCT01862640|592238326|FG002|Overall Study|Withdrawal by Subject|8|||
163963294|NCT01862640|592238327|FG003|Overall Study|Withdrawal by Subject|5|||
163963295|NCT01862640|592238324|FG000|Overall Study|Protocol Deviation|0|||
163963296|NCT01862640|592238325|FG001|Overall Study|Protocol Deviation|0|||
163963297|NCT01862640|592238326|FG002|Overall Study|Protocol Deviation|1|||
163963298|NCT01862640|592238327|FG003|Overall Study|Protocol Deviation|0|||
163963299|NCT02178553|592238328|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
163963300|NCT02178553|592238329|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
163963301|NCT02178553|592238328|FG000|Overall Study|Physician Decision|0|||
163963302|NCT02178553|592238329|FG001|Overall Study|Physician Decision|4|||
163963303|NCT02178553|592238328|FG000|Overall Study|Technical problem with injection|1|||
163963304|NCT02178553|592238329|FG001|Overall Study|Technical problem with injection|3|||
163963305|NCT05085665|592238330|FG000|Overall Study|Physician Decision|2|||
163963306|NCT03294109|592238333|FG000|Overall Study|Withdrawal by Subject|6|||
163963307|NCT03294109|592238334|FG001|Overall Study|Withdrawal by Subject|5|||
163963308|NCT01717768|592238335|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963309|NCT01717768|592238336|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
163963310|NCT01717768|592238337|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963311|NCT01717768|592238338|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963312|NCT01717768|592238339|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963313|NCT01717768|592238340|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963314|NCT01717768|592238341|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963315|NCT01717768|592238342|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963316|NCT01717768|592238343|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963317|NCT01717768|592238344|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963318|NCT01717768|592238345|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963319|NCT01717768|592238346|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
163963320|NCT01717768|592238335|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963321|NCT01717768|592238336|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963322|NCT01717768|592238337|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963323|NCT01717768|592238338|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963324|NCT01717768|592238339|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963325|NCT01717768|592238340|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963326|NCT01717768|592238341|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963327|NCT01717768|592238342|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963328|NCT01717768|592238343|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963329|NCT01717768|592238344|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963330|NCT01717768|592238345|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
163963331|NCT01717768|592238346|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
163963332|NCT01717768|592238335|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963333|NCT01717768|592238336|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963334|NCT01717768|592238337|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963335|NCT01717768|592238338|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963336|NCT01717768|592238339|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963337|NCT01717768|592238340|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963338|NCT01717768|592238341|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963339|NCT01717768|592238342|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
163963340|NCT01717768|592238343|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963341|NCT01717768|592238344|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963342|NCT01717768|592238345|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963343|NCT01717768|592238346|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
163963344|NCT01717768|592238335|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963345|NCT01717768|592238336|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963346|NCT01717768|592238337|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963347|NCT01717768|592238338|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963348|NCT01717768|592238339|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963349|NCT01717768|592238340|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963350|NCT01717768|592238341|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963351|NCT01717768|592238342|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963352|NCT01717768|592238343|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963353|NCT01717768|592238344|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
164006474|NCT02158533|592390967|FG005|Stage 2|Physician Decision|0|||
163963354|NCT01717768|592238345|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963355|NCT01717768|592238346|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
163963356|NCT00448435|592238347|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
163963357|NCT00448435|592238348|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163963358|NCT02804178|592238349|FG000|Overall Study|Adverse Event|1|||
163963359|NCT00412971|592238354|FG000|Overall Study|Lost to Follow-up|17|||
163963360|NCT00412971|592238355|FG001|Overall Study|Lost to Follow-up|9|||
163963361|NCT00412971|592238354|FG000|Overall Study|Protocol Violation|13|||
163963362|NCT00412971|592238355|FG001|Overall Study|Protocol Violation|1|||
163963363|NCT01387230|592238356|FG000|Overall Study|Adverse Event|0|||
163963364|NCT01387230|592238357|FG001|Overall Study|Adverse Event|1|||
163963365|NCT01387230|592238358|FG002|Overall Study|Adverse Event|3|||
163963366|NCT01387230|592238356|FG000|Overall Study|Lack of Efficacy|8|||
163963367|NCT01387230|592238357|FG001|Overall Study|Lack of Efficacy|5|||
163963368|NCT01387230|592238358|FG002|Overall Study|Lack of Efficacy|4|||
163963369|NCT01387230|592238356|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
163963370|NCT01387230|592238357|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
163963371|NCT01387230|592238358|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
163963372|NCT01387230|592238356|FG000|Overall Study|Lost to Follow-up|0|||
163963373|NCT01387230|592238357|FG001|Overall Study|Lost to Follow-up|0|||
163963374|NCT01387230|592238358|FG002|Overall Study|Lost to Follow-up|1|||
163963375|NCT01387230|592238356|FG000|Overall Study|Withdrawal by Subject|4|||
163963376|NCT01387230|592238357|FG001|Overall Study|Withdrawal by Subject|1|||
163963377|NCT01387230|592238358|FG002|Overall Study|Withdrawal by Subject|0|||
163963378|NCT01163721|592238359|FG000|Overall Study|Adverse Event|5|||
163963379|NCT01163721|592238360|FG001|Overall Study|Adverse Event|6|||
163963380|NCT01163721|592238359|FG000|Overall Study|Withdrawal by Subject|3|||
163963381|NCT01163721|592238360|FG001|Overall Study|Withdrawal by Subject|4|||
163963382|NCT01163721|592238359|FG000|Overall Study|Lost to Follow-up|0|||
163963383|NCT01163721|592238360|FG001|Overall Study|Lost to Follow-up|1|||
163963384|NCT01163721|592238359|FG000|Overall Study|Physician Decision|0|||
163963385|NCT01163721|592238360|FG001|Overall Study|Physician Decision|1|||
163963386|NCT00364156|592238366|FG000|Overall Study|Withdrawal by Subject|73|||
163963387|NCT00364156|592238367|FG001|Overall Study|Withdrawal by Subject|80|||
163850142|NCT02335268|591822467|FG001|Overall Study|Physician Decision|1|||
163850143|NCT02335268|591822466|FG000|Overall Study|Lack of Efficacy|2|||
163850144|NCT02335268|591822467|FG001|Overall Study|Lack of Efficacy|1|||
163850145|NCT02335268|591822466|FG000|Overall Study|Adverse Event|5|||
163850146|NCT02335268|591822467|FG001|Overall Study|Adverse Event|2|||
163850147|NCT02335268|591822466|FG000|Overall Study|increase blasts|2|||
163850148|NCT02335268|591822467|FG001|Overall Study|increase blasts|0|||
163850149|NCT02335268|591822466|FG000|Overall Study|Withdrawal by Subject|3|||
163850150|NCT02335268|591822467|FG001|Overall Study|Withdrawal by Subject|2|||
163850151|NCT05893797|591822470|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
163850152|NCT05893797|591822470|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
163850153|NCT05893797|591822470|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
163850154|NCT05893797|591822470|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
163850155|NCT04770220|591822471|FG000|Overall Study|Adverse Event|2|||
163850156|NCT04770220|591822472|FG001|Overall Study|Adverse Event|11|||
163850157|NCT04770220|591822471|FG000|Overall Study|Withdrawal by Subject|5|||
163850158|NCT04770220|591822472|FG001|Overall Study|Withdrawal by Subject|11|||
163850159|NCT04770220|591822471|FG000|Overall Study|Lost to Follow-up|4|||
163850160|NCT04770220|591822472|FG001|Overall Study|Lost to Follow-up|3|||
163850161|NCT04770220|591822471|FG000|Overall Study|not otherwise specified|2|||
163850162|NCT04770220|591822472|FG001|Overall Study|not otherwise specified|3|||
163850163|NCT04770220|591822471|FG000|Overall Study|Physician Decision|1|||
163850164|NCT04770220|591822472|FG001|Overall Study|Physician Decision|3|||
163850165|NCT04894903|591822474|FG000|Overall Study|Death|1|||
163850166|NCT04894903|591822475|FG001|Overall Study|Death|0|||
163850167|NCT04894903|591822474|FG000|Overall Study|Pregnancy|1|||
163850168|NCT04894903|591822475|FG001|Overall Study|Pregnancy|0|||
163850169|NCT04894903|591822474|FG000|Overall Study|Withdrawal by Subject|1|||
163850170|NCT04894903|591822475|FG001|Overall Study|Withdrawal by Subject|1|||
163850171|NCT04894903|591822474|FG000|Overall Study|moved or exited health system|1|||
163850172|NCT04894903|591822475|FG001|Overall Study|moved or exited health system|3|||
163850173|NCT01923428|591822476|FG000|Overall Study|Adverse Event|8|||
163850174|NCT01923428|591822477|FG001|Overall Study|Adverse Event|6|||
163850175|NCT01923428|591822478|FG002|Overall Study|Adverse Event|3|||
163850176|NCT01923428|591822479|FG003|Overall Study|Adverse Event|3|||
163850177|NCT01923428|591822476|FG000|Overall Study|Withdrawal by Subject|5|||
163850178|NCT01923428|591822477|FG001|Overall Study|Withdrawal by Subject|3|||
163850179|NCT01923428|591822478|FG002|Overall Study|Withdrawal by Subject|0|||
163850180|NCT01923428|591822479|FG003|Overall Study|Withdrawal by Subject|4|||
163850181|NCT01923428|591822476|FG000|Overall Study|Lost to Follow-up|2|||
163850182|NCT01923428|591822477|FG001|Overall Study|Lost to Follow-up|1|||
163850183|NCT01923428|591822478|FG002|Overall Study|Lost to Follow-up|5|||
163963388|NCT00364156|592238366|FG000|Overall Study|Protocol Violation|6|||
163963389|NCT00364156|592238367|FG001|Overall Study|Protocol Violation|1|||
163963390|NCT01050205|592238368|FG000|Overall Study|Lost to Follow-up|7|||
163963391|NCT01050205|592238369|FG001|Overall Study|Lost to Follow-up|1|||
163963392|NCT01050205|592238368|FG000|Overall Study|Withdrawal by Subject|1|||
163963393|NCT01050205|592238369|FG001|Overall Study|Withdrawal by Subject|1|||
163963394|NCT01050205|592238368|FG000|Overall Study|Relocated from area|1|||
163963395|NCT01050205|592238369|FG001|Overall Study|Relocated from area|2|||
163963396|NCT01050205|592238368|FG000|Overall Study|Discontinued Intervention|2|||
163963397|NCT01050205|592238369|FG001|Overall Study|Discontinued Intervention|0|||
163963398|NCT01472380|592238370|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
163963399|NCT01472380|592238370|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
163963400|NCT01295281|592238371|FG000|First Intervention (7 Days)|Death|0|||
163963401|NCT01295281|592238372|FG001|First Intervention (7 Days)|Death|1|||
163963402|NCT00292461|592238373|FG000|Overall Study|Adverse Event|4|||
163963403|NCT00292461|592238374|FG001|Overall Study|Adverse Event|2|||
163963404|NCT00292461|592238373|FG000|Overall Study|Lack of Efficacy|1|||
163963405|NCT00292461|592238374|FG001|Overall Study|Lack of Efficacy|0|||
163963406|NCT00292461|592238373|FG000|Overall Study|Withdrawal by Subject|0|||
163963407|NCT00292461|592238374|FG001|Overall Study|Withdrawal by Subject|1|||
163963408|NCT00292461|592238373|FG000|Overall Study|Protocol Violation|4|||
163963409|NCT00292461|592238374|FG001|Overall Study|Protocol Violation|3|||
163963410|NCT00292461|592238373|FG000|Overall Study|Lost to Follow-up|1|||
163963411|NCT00292461|592238374|FG001|Overall Study|Lost to Follow-up|0|||
163963412|NCT00633061|592238375|FG000|Overall Study|Study closed|86|||
163963413|NCT00633061|592238376|FG001|Overall Study|Study closed|0|||
163963414|NCT02708095|592238377|FG000|Overall Study|Adverse Event|4|||
163963415|NCT02708095|592238378|FG001|Overall Study|Adverse Event|10|||
163963416|NCT02708095|592238379|FG002|Overall Study|Adverse Event|11|||
163963417|NCT02708095|592238377|FG000|Overall Study|Lack of Efficacy|9|||
163963418|NCT02708095|592238378|FG001|Overall Study|Lack of Efficacy|3|||
163963419|NCT02708095|592238379|FG002|Overall Study|Lack of Efficacy|0|||
163963420|NCT02708095|592238377|FG000|Overall Study|Lost to Follow-up|2|||
163963421|NCT02708095|592238378|FG001|Overall Study|Lost to Follow-up|0|||
163963422|NCT02708095|592238379|FG002|Overall Study|Lost to Follow-up|0|||
163963423|NCT02708095|592238377|FG000|Overall Study|Physician Decision|2|||
163963424|NCT02708095|592238378|FG001|Overall Study|Physician Decision|3|||
163963425|NCT02708095|592238379|FG002|Overall Study|Physician Decision|2|||
163963426|NCT02708095|592238377|FG000|Overall Study|Protocol Violation|0|||
163963427|NCT02708095|592238378|FG001|Overall Study|Protocol Violation|0|||
163963428|NCT02708095|592238379|FG002|Overall Study|Protocol Violation|1|||
163963429|NCT02708095|592238377|FG000|Overall Study|Withdrawal by Subject|5|||
163963430|NCT02708095|592238378|FG001|Overall Study|Withdrawal by Subject|3|||
163963431|NCT02708095|592238379|FG002|Overall Study|Withdrawal by Subject|4|||
163963432|NCT06268288|592238384|FG000|Overall Study|Withdrawal by Subject|1|||
163963433|NCT06268288|592238385|FG001|Overall Study|Withdrawal by Subject|2|||
163963434|NCT04821869|592238386|FG000|Overall Study|Adverse Event|4|||
163963435|NCT04821869|592238386|FG000|Overall Study|Withdrawal by Subject|2|||
163963436|NCT04821869|592238386|FG000|Overall Study|Did not meet FEV1 criteria|1|||
163963437|NCT01313117|592238390|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
163963438|NCT01313117|592238390|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
163963439|NCT03602261|592238391|FG000|Overall Study|Adverse Event|5|||
163963440|NCT03602261|592238392|FG001|Overall Study|Adverse Event|1|||
163963441|NCT03602261|592238391|FG000|Overall Study|Physician Decision|1|||
163963442|NCT03602261|592238392|FG001|Overall Study|Physician Decision|0|||
163963443|NCT03602261|592238391|FG000|Overall Study|Withdrawal by Subject|1|||
163963444|NCT03602261|592238392|FG001|Overall Study|Withdrawal by Subject|1|||
163963445|NCT03602261|592238391|FG000|Overall Study|Lack of Efficacy|0|||
163963446|NCT03602261|592238392|FG001|Overall Study|Lack of Efficacy|1|||
163963447|NCT03602261|592238391|FG000|Overall Study|Subject moving out of state|1|||
163963448|NCT03602261|592238392|FG001|Overall Study|Subject moving out of state|0|||
163963449|NCT02310672|592240228|FG000|Overall Study|Death|1|||
163963450|NCT02310672|592240228|FG000|Overall Study|Lost to Follow-up|1|||
163963451|NCT02310672|592240228|FG000|Overall Study|Withdrawal by Subject|1|||
163963452|NCT02310672|592240228|FG000|Overall Study|Sponsor's decision|12|||
163963453|NCT01214187|592240232|FG000|Overall Study|Adverse Event|6|||
163963454|NCT01214187|592240233|FG001|Overall Study|Adverse Event|2|||
163963455|NCT01214187|592240232|FG000|Overall Study|Death|1|||
163963456|NCT01214187|592240233|FG001|Overall Study|Death|1|||
163963457|NCT01214187|592240232|FG000|Overall Study|Withdrawal by Subject|0|||
163963458|NCT01214187|592240233|FG001|Overall Study|Withdrawal by Subject|3|||
163963459|NCT02308007|592240242|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
163963460|NCT02308007|592240243|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
163963461|NCT02308007|592240244|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
163963462|NCT02308007|592240242|FG000|Overall Study|Positive for STD at Baseline|7|||
163963463|NCT02308007|592240243|FG001|Overall Study|Positive for STD at Baseline|11|||
163963464|NCT02308007|592240244|FG002|Overall Study|Positive for STD at Baseline|7|||
163963465|NCT02308007|592240242|FG000|Overall Study|Lost to Follow-up|3|||
163963466|NCT02308007|592240243|FG001|Overall Study|Lost to Follow-up|0|||
163963467|NCT02308007|592240244|FG002|Overall Study|Lost to Follow-up|1|||
163963468|NCT03118674|592240245|FG000|Overall Study|Lost to Follow-up|2|||
163963469|NCT03118674|592240245|FG000|Overall Study|Screen Faliure|8|||
163963470|NCT03118674|592240245|FG000|Overall Study|Withdrawal by Subject|5|||
163963471|NCT01233869|592240246|FG000|Initial Treatment Period (24 Months)|Death|1|||
163963472|NCT01233869|592240247|FG001|Initial Treatment Period (24 Months)|Death|0|||
163963473|NCT01233869|592240248|FG002|Initial Treatment Period (24 Months)|Death|0|||
163963474|NCT01233869|592240249|FG003|Initial Treatment Period (24 Months)|Death|0|||
163963475|NCT01233869|592240246|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
163963476|NCT01233869|592240247|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
163963477|NCT01233869|592240248|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
163963478|NCT01233869|592240249|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
163963479|NCT01233869|592240246|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
163963480|NCT01233869|592240247|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
163963481|NCT01233869|592240248|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
163963482|NCT01233869|592240249|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
163963483|NCT01233869|592240246|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163963484|NCT01233869|592240247|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163963485|NCT01233869|592240248|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
163963486|NCT01233869|592240249|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
163963487|NCT01233869|592240246|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
163963488|NCT01233869|592240247|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
163963489|NCT01233869|592240248|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
163963490|NCT01233869|592240249|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
163963491|NCT01233869|592240246|FG000|Extended Treatment Period (46 Months)|Other|3|||
163963492|NCT01233869|592240247|FG001|Extended Treatment Period (46 Months)|Other|0|||
163963493|NCT01233869|592240248|FG002|Extended Treatment Period (46 Months)|Other|0|||
163963494|NCT01233869|592240249|FG003|Extended Treatment Period (46 Months)|Other|3|||
163963495|NCT01233869|592240246|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
163963496|NCT01233869|592240247|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
163963497|NCT01233869|592240248|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
163963498|NCT01233869|592240249|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
163963499|NCT01324323|592240250|FG000|Overall Study|Withdrawal by Subject|1|||
163963500|NCT00537485|592240251|FG000|Overall Study|Adverse Event|10|||
163963501|NCT00537485|592240252|FG001|Overall Study|Adverse Event|5|||
163963502|NCT00537485|592240251|FG000|Overall Study|Withdrawal by Subject|3|||
163963503|NCT00537485|592240252|FG001|Overall Study|Withdrawal by Subject|2|||
163963504|NCT00537485|592240251|FG000|Overall Study|Withdrawal by Subject|1|||
163963505|NCT00537485|592240252|FG001|Overall Study|Withdrawal by Subject|3|||
163963506|NCT00537485|592240251|FG000|Overall Study|Physician Decision|1|||
163963507|NCT00537485|592240252|FG001|Overall Study|Physician Decision|0|||
163963508|NCT01601847|592240261|FG000|Overall Study|Death|1|||
163963509|NCT01601847|592240262|FG001|Overall Study|Death|0|||
163963510|NCT01601847|592240261|FG000|Overall Study|Withdrawal by Subject|11|||
163963511|NCT01601847|592240262|FG001|Overall Study|Withdrawal by Subject|7|||
163963512|NCT01601847|592240261|FG000|Overall Study|Lost to Follow-up|1|||
163963513|NCT01601847|592240262|FG001|Overall Study|Lost to Follow-up|3|||
163963514|NCT00631189|592240263|FG000|Initial Phase|Protocol Violation|347|||
163963515|NCT00631189|592240264|FG001|Initial Phase|Protocol Violation|0|||
163963516|NCT00631189|592240265|FG002|Initial Phase|Protocol Violation|0|||
163963517|NCT00631189|592240266|FG003|Initial Phase|Protocol Violation|0|||
163963518|NCT00631189|592240263|FG000|Initial Phase|Withdrawal by Subject|4|||
163963519|NCT00631189|592240264|FG001|Initial Phase|Withdrawal by Subject|0|||
163963520|NCT00631189|592240265|FG002|Initial Phase|Withdrawal by Subject|0|||
163963521|NCT00631189|592240266|FG003|Initial Phase|Withdrawal by Subject|0|||
163963522|NCT00631189|592240263|FG000|Treatment Phase|Withdrawal by Subject|0|||
163963523|NCT00631189|592240264|FG001|Treatment Phase|Withdrawal by Subject|2|||
163963524|NCT00631189|592240265|FG002|Treatment Phase|Withdrawal by Subject|1|||
163963525|NCT00631189|592240266|FG003|Treatment Phase|Withdrawal by Subject|1|||
163963526|NCT00631189|592240263|FG000|Treatment Phase|Protocol Violation|0|||
163963527|NCT00631189|592240264|FG001|Treatment Phase|Protocol Violation|1|||
163963528|NCT00631189|592240265|FG002|Treatment Phase|Protocol Violation|6|||
163963529|NCT00631189|592240266|FG003|Treatment Phase|Protocol Violation|2|||
163963530|NCT00631189|592240263|FG000|Treatment Phase|Adverse Event|0|||
163963531|NCT00631189|592240264|FG001|Treatment Phase|Adverse Event|3|||
163963532|NCT00631189|592240265|FG002|Treatment Phase|Adverse Event|2|||
163963533|NCT00631189|592240266|FG003|Treatment Phase|Adverse Event|4|||
163963534|NCT00631189|592240263|FG000|Treatment Phase|Lost to Follow-up|0|||
163963535|NCT00631189|592240264|FG001|Treatment Phase|Lost to Follow-up|1|||
163963536|NCT00631189|592240265|FG002|Treatment Phase|Lost to Follow-up|0|||
163963537|NCT00631189|592240266|FG003|Treatment Phase|Lost to Follow-up|0|||
163963538|NCT00631189|592240263|FG000|Treatment Phase|Pregnancy|0|||
163963539|NCT00631189|592240264|FG001|Treatment Phase|Pregnancy|0|||
163963540|NCT00631189|592240265|FG002|Treatment Phase|Pregnancy|1|||
163963541|NCT00631189|592240266|FG003|Treatment Phase|Pregnancy|0|||
163963542|NCT00631189|592240263|FG000|Treatment Phase|patient did not take pravastatin|0|||
163963543|NCT00631189|592240264|FG001|Treatment Phase|patient did not take pravastatin|0|||
163963544|NCT00631189|592240265|FG002|Treatment Phase|patient did not take pravastatin|1|||
163963545|NCT00631189|592240266|FG003|Treatment Phase|patient did not take pravastatin|0|||
163963546|NCT04464265|592240267|FG000|Overall Study|Physician Decision|2|||
163963547|NCT00954174|592240274|FG000|Overall Study|Adverse Event|28|||
163963548|NCT00954174|592240275|FG001|Overall Study|Adverse Event|23|||
163963549|NCT00954174|592240276|FG002|Overall Study|Adverse Event|4|||
163963550|NCT00954174|592240277|FG003|Overall Study|Adverse Event|9|||
163963551|NCT00954174|592240274|FG000|Overall Study|Death|4|||
163963552|NCT00954174|592240275|FG001|Overall Study|Death|2|||
163963553|NCT00954174|592240276|FG002|Overall Study|Death|0|||
163963554|NCT00954174|592240277|FG003|Overall Study|Death|0|||
163963555|NCT00954174|592240274|FG000|Overall Study|Lack of Efficacy|32|||
163963556|NCT00954174|592240275|FG001|Overall Study|Lack of Efficacy|22|||
163963557|NCT00954174|592240276|FG002|Overall Study|Lack of Efficacy|8|||
163963558|NCT00954174|592240277|FG003|Overall Study|Lack of Efficacy|6|||
163963559|NCT00954174|592240274|FG000|Overall Study|Withdrawal by Subject|14|||
163963560|NCT00954174|592240275|FG001|Overall Study|Withdrawal by Subject|10|||
163963561|NCT00954174|592240276|FG002|Overall Study|Withdrawal by Subject|4|||
163963562|NCT00954174|592240277|FG003|Overall Study|Withdrawal by Subject|3|||
163963563|NCT00954174|592240274|FG000|Overall Study|Medical Reason|4|||
163963564|NCT00954174|592240275|FG001|Overall Study|Medical Reason|2|||
163963565|NCT00954174|592240276|FG002|Overall Study|Medical Reason|1|||
163963566|NCT00954174|592240277|FG003|Overall Study|Medical Reason|0|||
163963567|NCT00954174|592240274|FG000|Overall Study|Ineligible|40|||
163963568|NCT00954174|592240275|FG001|Overall Study|Ineligible|47|||
163963569|NCT00954174|592240276|FG002|Overall Study|Ineligible|7|||
163963570|NCT00954174|592240277|FG003|Overall Study|Ineligible|4|||
163963571|NCT00954174|592240274|FG000|Overall Study|Never Treated|4|||
163963572|NCT00954174|592240275|FG001|Overall Study|Never Treated|17|||
163963573|NCT00954174|592240276|FG002|Overall Study|Never Treated|0|||
163963574|NCT00954174|592240277|FG003|Overall Study|Never Treated|3|||
163963575|NCT02234323|592240278|FG000|All Enrolled|Not Treated: Completed study in database|2|||
163963576|NCT02234323|592240278|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
163963577|NCT02234323|592240278|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
163963578|NCT02234323|592240278|FG000|All Treated|Death|1|||
163963579|NCT02234323|592240278|FG000|All Treated|Physician Decision|5|||
163963580|NCT02234323|592240278|FG000|All Treated|Lack of Efficacy|3|||
163963581|NCT02234323|592240278|FG000|All Treated|Exceeded lab value limit|2|||
163963582|NCT02234323|592240278|FG000|All Treated|Other|7|||
163963583|NCT02644941|592240279|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
163963584|NCT02644941|592240280|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
163963585|NCT00867113|592240281|FG000|Treatment Period|Adverse Event|15|||
163963586|NCT00867113|592240281|FG000|Treatment Period|Death|2|||
163963587|NCT00867113|592240281|FG000|Treatment Period|Withdrawal by Subject|19|||
163963588|NCT00867113|592240281|FG000|Treatment Period|Lost to Follow-up|3|||
163963589|NCT00867113|592240281|FG000|Treatment Period|Administrative problems|1|||
163963590|NCT00867113|592240281|FG000|Treatment Period|Disease progression/relapse|1|||
163963591|NCT00867113|592240281|FG000|Treatment Period|Protocol Violation|4|||
163963592|NCT00867113|592240281|FG000|Post Treatment After Survival Follow-up|Death|1|||
163963593|NCT00867113|592240281|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
163963594|NCT00867113|592240281|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
163963595|NCT00867113|592240281|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
163963596|NCT01145495|592240282|FG000|Overall Study|Adverse Event|6|||
163963597|NCT01145495|592240282|FG000|Overall Study|Withdrawal by Subject|6|||
163963598|NCT01145495|592240282|FG000|Overall Study|Disease progression after respone|2|||
163963599|NCT01886313|592240285|FG000|Overall Study|Adverse Event|1|||
163963600|NCT01886313|592240286|FG001|Overall Study|Adverse Event|1|||
163963601|NCT01603082|592240287|FG000|Overall Study|Adverse Event|0|||
163963602|NCT01603082|592240288|FG001|Overall Study|Adverse Event|1|||
163963603|NCT01603082|592240287|FG000|Overall Study|Withdrawal by Subject|1|||
163963604|NCT01603082|592240288|FG001|Overall Study|Withdrawal by Subject|0|||
163963605|NCT01603082|592240287|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
163963606|NCT01603082|592240288|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
163963607|NCT01641809|592240294|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
163963608|NCT01641809|592240295|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
163963609|NCT01641809|592240296|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
163963610|NCT01641809|592240297|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
163963611|NCT01641809|592240294|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
163963612|NCT01641809|592240295|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
163963613|NCT01641809|592240296|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
163963614|NCT01641809|592240297|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
163963615|NCT01641809|592240294|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
163963616|NCT01641809|592240295|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
163963617|NCT01641809|592240296|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
163963618|NCT01641809|592240297|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
163963619|NCT01641809|592240294|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
163963620|NCT01641809|592240295|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
163963621|NCT01641809|592240296|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
163963622|NCT01641809|592240297|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
163963623|NCT01641809|592240294|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
163963624|NCT01641809|592240295|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
163963625|NCT01641809|592240296|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
163963626|NCT01641809|592240297|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
163963627|NCT01641809|592240294|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
163963628|NCT01641809|592240295|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
163963629|NCT01641809|592240296|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
163963630|NCT01641809|592240297|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
163963631|NCT01641809|592240294|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
163963632|NCT01641809|592240295|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
163963633|NCT01641809|592240296|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
163963634|NCT01641809|592240297|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
163963635|NCT01641809|592240294|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
163963636|NCT01641809|592240295|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
163963637|NCT01641809|592240296|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
163963638|NCT01641809|592240297|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
163963639|NCT01641809|592240294|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
163963640|NCT01641809|592240295|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
163963641|NCT01641809|592240296|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
163963642|NCT01641809|592240297|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
163963643|NCT01641809|592240294|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
163963644|NCT01641809|592240295|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
163963645|NCT01641809|592240296|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
163963646|NCT01641809|592240297|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
163963647|NCT01641809|592240294|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
163963648|NCT01641809|592240295|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
163963649|NCT01641809|592240296|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
163963650|NCT01641809|592240297|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
163963651|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
163963652|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
163963653|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
163963654|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
163963655|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
163963656|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
163963657|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
163963658|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
163963659|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
163963660|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
163963661|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
163963662|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
163963663|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
163963664|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
163963665|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
163963666|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
163963667|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
163963668|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
163963669|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
163963670|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
163963671|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
163963672|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
163963673|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
163963674|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
164189894|NCT00572455|593063990|FG004|Stage II (28 Days)|Death|0|||
163963675|NCT01641809|592240294|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
163963676|NCT01641809|592240295|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
163963677|NCT01641809|592240296|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
163963678|NCT01641809|592240297|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
163963679|NCT04195581|592240298|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
164189895|NCT00572455|593063991|FG005|Stage II (28 Days)|Death|0|||
163963680|NCT04195581|592240298|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
163963681|NCT04195581|592240298|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
163963682|NCT04195581|592240298|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
163963683|NCT04195581|592240298|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
163963684|NCT04195581|592240298|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
163963685|NCT00821431|592240299|FG000|Overall Study|Adverse Event|6|||
163963686|NCT00821431|592240300|FG001|Overall Study|Adverse Event|3|||
163963687|NCT00821431|592240299|FG000|Overall Study|Withdrawal by Subject|5|||
163963688|NCT00821431|592240300|FG001|Overall Study|Withdrawal by Subject|0|||
163963689|NCT00821431|592240299|FG000|Overall Study|Lost to Follow-up|1|||
163963690|NCT00821431|592240300|FG001|Overall Study|Lost to Follow-up|0|||
163963691|NCT00821431|592240299|FG000|Overall Study|Protocol Violation|3|||
163963692|NCT00821431|592240300|FG001|Overall Study|Protocol Violation|1|||
163963693|NCT00821431|592240299|FG000|Overall Study|Physician Decision|0|||
163963694|NCT00821431|592240300|FG001|Overall Study|Physician Decision|1|||
163963695|NCT04233164|592240306|FG000|Overall Study|Unable to obtain specimen|0|||
163963696|NCT04233164|592240307|FG001|Overall Study|Unable to obtain specimen|1|||
163963697|NCT01699789|592240308|FG000|Overall Study|Withdrawal by Subject|18|||
163963698|NCT01699789|592240309|FG001|Overall Study|Withdrawal by Subject|23|||
163963699|NCT01699789|592240308|FG000|Overall Study|Death|1|||
163963700|NCT01699789|592240309|FG001|Overall Study|Death|2|||
163963701|NCT01699789|592240308|FG000|Overall Study|Lost to Follow-up|83|||
163963702|NCT01699789|592240309|FG001|Overall Study|Lost to Follow-up|101|||
163963703|NCT00639223|592240310|FG000|Overall Study|Lost to Follow-up|0|||
163963704|NCT00639223|592240311|FG001|Overall Study|Lost to Follow-up|2|||
163963705|NCT04201821|592240312|FG000|Overall Study|Withdrawal by Subject|2|||
163963706|NCT00651157|592240313|FG000|Overall Study|Death|1|||
163963707|NCT00651157|592240313|FG000|Overall Study|Protocol Violation|1|||
163963708|NCT02511678|592240315|FG000|Overall Study|Withdrawal by Subject|2|||
163963709|NCT02511678|592240315|FG000|Overall Study|Lost to Follow-up|4|||
163963710|NCT02511678|592240315|FG000|Overall Study|Death|19|||
163963711|NCT02511678|592240315|FG000|Overall Study|Adverse Event|1|||
163963712|NCT02511678|592240315|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
163963713|NCT02511678|592240315|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
163963714|NCT02511678|592240315|FG000|Overall Study|Required Radiofrequency Ablation|1|||
163963715|NCT02511678|592240315|FG000|Overall Study|Biopsy was Negative|1|||
163963716|NCT02511678|592240315|FG000|Overall Study|Protocol Violation|1|||
163963717|NCT02511678|592240315|FG000|Overall Study|Received Radiation Treatment|1|||
163963718|NCT02000427|592240325|FG000|Overall Study|Death|22|||
163963719|NCT05125679|592240328|FG000|Overall Study|Study Terminated by Sponsor|2|||
163963720|NCT05125679|592240329|FG001|Overall Study|Study Terminated by Sponsor|5|||
163963721|NCT03829319|592240330|FG000|Overall Study|Sponsor's Decision|4|||
163963722|NCT03829319|592240331|FG001|Overall Study|Sponsor's Decision|90|||
163963723|NCT03829319|592240332|FG002|Overall Study|Sponsor's Decision|102|||
163963724|NCT03829319|592240330|FG000|Overall Study|Withdrawal by Subject|1|||
163850184|NCT01923428|591822479|FG003|Overall Study|Lost to Follow-up|0|||
163850185|NCT01923428|591822476|FG000|Overall Study|Protocol Violation|3|||
163850186|NCT01923428|591822477|FG001|Overall Study|Protocol Violation|0|||
163850187|NCT01923428|591822478|FG002|Overall Study|Protocol Violation|2|||
163850188|NCT01923428|591822479|FG003|Overall Study|Protocol Violation|1|||
163850189|NCT01923428|591822476|FG000|Overall Study|Non Compliance to treatment|1|||
163850190|NCT01923428|591822477|FG001|Overall Study|Non Compliance to treatment|2|||
163850191|NCT01923428|591822478|FG002|Overall Study|Non Compliance to treatment|0|||
163850192|NCT01923428|591822479|FG003|Overall Study|Non Compliance to treatment|1|||
163850193|NCT01923428|591822476|FG000|Overall Study|Lack of Efficacy|0|||
163850194|NCT01923428|591822477|FG001|Overall Study|Lack of Efficacy|0|||
163850195|NCT01923428|591822478|FG002|Overall Study|Lack of Efficacy|1|||
163850196|NCT01923428|591822479|FG003|Overall Study|Lack of Efficacy|1|||
163850197|NCT01822353|591822480|FG000|Overall Study|Adverse Event|1|||
163850198|NCT01822353|591822481|FG001|Overall Study|Adverse Event|3|||
163850199|NCT01822353|591822482|FG002|Overall Study|Adverse Event|1|||
163850200|NCT01822353|591822480|FG000|Overall Study|Pregnancy|0|||
163850201|NCT01822353|591822481|FG001|Overall Study|Pregnancy|1|||
163963725|NCT03829319|592240331|FG001|Overall Study|Withdrawal by Subject|5|||
163850202|NCT01822353|591822482|FG002|Overall Study|Pregnancy|0|||
163850203|NCT01822353|591822480|FG000|Overall Study|Withdrawal by Subject|3|||
163850204|NCT01822353|591822481|FG001|Overall Study|Withdrawal by Subject|1|||
163963726|NCT03829319|592240332|FG002|Overall Study|Withdrawal by Subject|4|||
163963727|NCT03829319|592240330|FG000|Overall Study|Physician Decision|0|||
163963728|NCT03829319|592240331|FG001|Overall Study|Physician Decision|3|||
163963729|NCT03829319|592240332|FG002|Overall Study|Physician Decision|0|||
163963730|NCT03829319|592240330|FG000|Overall Study|Lost to Follow-up|0|||
163963731|NCT03829319|592240331|FG001|Overall Study|Lost to Follow-up|0|||
163850205|NCT01822353|591822482|FG002|Overall Study|Withdrawal by Subject|0|||
163963732|NCT03829319|592240332|FG002|Overall Study|Lost to Follow-up|1|||
163963733|NCT03829319|592240330|FG000|Overall Study|Death|8|||
163963734|NCT03829319|592240331|FG001|Overall Study|Death|277|||
163963735|NCT03829319|592240332|FG002|Overall Study|Death|266|||
164006475|NCT02158533|592390962|FG000|Stage 2|Pregnancy|0|||
163963736|NCT04484259|592240333|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163963737|NCT04484259|592240334|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163963738|NCT04484259|592240335|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163963739|NCT04484259|592240336|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
163963740|NCT04484259|592240337|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
163963741|NCT04484259|592240333|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163963742|NCT04484259|592240334|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163963743|NCT04484259|592240335|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163963744|NCT04484259|592240336|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
163963745|NCT04484259|592240337|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
163963746|NCT04484259|592240333|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163963747|NCT04484259|592240334|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163963748|NCT04484259|592240335|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163963749|NCT04484259|592240336|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
163963750|NCT04484259|592240337|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
163963751|NCT04484259|592240333|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163963752|NCT04484259|592240334|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163963753|NCT04484259|592240335|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163963754|NCT04484259|592240336|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
163963755|NCT04484259|592240337|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
163963756|NCT04484259|592240333|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163963757|NCT04484259|592240334|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163963758|NCT04484259|592240335|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163963759|NCT04484259|592240336|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
163963760|NCT04484259|592240337|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
163963761|NCT04484259|592240333|FG000|Randomized Treatment|Withdrawal by Subject|1|||
163963762|NCT04484259|592240334|FG001|Randomized Treatment|Withdrawal by Subject|0|||
163963763|NCT04484259|592240335|FG002|Randomized Treatment|Withdrawal by Subject|0|||
163963764|NCT04484259|592240336|FG003|Randomized Treatment|Withdrawal by Subject|0|||
163963765|NCT04484259|592240337|FG004|Randomized Treatment|Withdrawal by Subject|0|||
163963766|NCT04498832|592240338|FG000|Overall Study|Adverse Event|1|||
163963767|NCT04498832|592240339|FG001|Overall Study|Adverse Event|3|||
163963768|NCT04498832|592240338|FG000|Overall Study|Withdrawal by Subject|0|||
163963769|NCT04498832|592240339|FG001|Overall Study|Withdrawal by Subject|1|||
163963770|NCT01313650|592240341|FG000|Overall Study|Adverse Event|9|||
163963771|NCT01313650|592240342|FG001|Overall Study|Adverse Event|34|||
163963772|NCT01313650|592240343|FG002|Overall Study|Adverse Event|24|||
163963773|NCT01313650|592240344|FG003|Overall Study|Adverse Event|23|||
163963774|NCT01313650|592240341|FG000|Overall Study|Lack of Efficacy|37|||
163963775|NCT01313650|592240342|FG001|Overall Study|Lack of Efficacy|20|||
163963776|NCT01313650|592240343|FG002|Overall Study|Lack of Efficacy|32|||
163963777|NCT01313650|592240344|FG003|Overall Study|Lack of Efficacy|20|||
163963778|NCT01313650|592240341|FG000|Overall Study|Lost to Follow-up|1|||
163963779|NCT01313650|592240342|FG001|Overall Study|Lost to Follow-up|0|||
163963780|NCT01313650|592240343|FG002|Overall Study|Lost to Follow-up|3|||
163963781|NCT01313650|592240344|FG003|Overall Study|Lost to Follow-up|2|||
163963782|NCT01313650|592240341|FG000|Overall Study|Withdrawal by Subject|16|||
163963783|NCT01313650|592240342|FG001|Overall Study|Withdrawal by Subject|20|||
163963784|NCT01313650|592240343|FG002|Overall Study|Withdrawal by Subject|15|||
163963785|NCT01313650|592240344|FG003|Overall Study|Withdrawal by Subject|15|||
163963786|NCT01313650|592240341|FG000|Overall Study|Protocol Violation|4|||
163963787|NCT01313650|592240342|FG001|Overall Study|Protocol Violation|7|||
163963788|NCT01313650|592240343|FG002|Overall Study|Protocol Violation|5|||
163963789|NCT01313650|592240344|FG003|Overall Study|Protocol Violation|6|||
163963790|NCT01313650|592240341|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
163963791|NCT01313650|592240342|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
163963792|NCT01313650|592240343|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
163963793|NCT01313650|592240344|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
163963794|NCT04029480|592240345|FG000|Overall Study|Physician Decision|0|||
163963795|NCT04029480|592240346|FG001|Overall Study|Physician Decision|0|||
163963796|NCT04029480|592240347|FG002|Overall Study|Physician Decision|2|||
163963797|NCT04029480|592240348|FG003|Overall Study|Physician Decision|1|||
163963798|NCT04029480|592240345|FG000|Overall Study|Withdrawal by Subject|2|||
163963799|NCT04029480|592240346|FG001|Overall Study|Withdrawal by Subject|0|||
163963800|NCT04029480|592240347|FG002|Overall Study|Withdrawal by Subject|1|||
163963801|NCT04029480|592240348|FG003|Overall Study|Withdrawal by Subject|1|||
163963802|NCT02593786|592240351|FG000|Overall Study|Disease progression|12|||
163963803|NCT02593786|592240352|FG001|Overall Study|Disease progression|16|||
163963804|NCT02593786|592240353|FG002|Overall Study|Disease progression|10|||
163963805|NCT02593786|592240354|FG003|Overall Study|Disease progression|7|||
163963806|NCT02593786|592240351|FG000|Overall Study|Study drug toxicity|1|||
163850206|NCT02550873|591822483|FG000|Randomized Double Blind|Adverse Event|3|||
163850207|NCT02550873|591822484|FG001|Randomized Double Blind|Adverse Event|1|||
163850208|NCT02550873|591822485|FG002|Randomized Double Blind|Adverse Event|0|||
163850209|NCT02550873|591822483|FG000|Randomized Double Blind|Disease progression|1|||
163850210|NCT02550873|591822484|FG001|Randomized Double Blind|Disease progression|1|||
163850211|NCT02550873|591822485|FG002|Randomized Double Blind|Disease progression|0|||
163850212|NCT02550873|591822483|FG000|Open Label Extension|Study ongoing|0|||
163850213|NCT02550873|591822484|FG001|Open Label Extension|Study ongoing|0|||
163850214|NCT02550873|591822485|FG002|Open Label Extension|Study ongoing|111|||
163850215|NCT04320615|591822486|FG000|Overall Study|Withdrawal by Subject|4|||
163850216|NCT04320615|591822487|FG001|Overall Study|Withdrawal by Subject|10|||
163850217|NCT04320615|591822486|FG000|Overall Study|Physician Decision|2|||
163850218|NCT04320615|591822487|FG001|Overall Study|Physician Decision|0|||
163850219|NCT04320615|591822486|FG000|Overall Study|Other|2|||
163850220|NCT04320615|591822487|FG001|Overall Study|Other|0|||
163850221|NCT04320615|591822486|FG000|Overall Study|Lost to Follow-up|5|||
163850222|NCT04320615|591822487|FG001|Overall Study|Lost to Follow-up|23|||
163850223|NCT04320615|591822486|FG000|Overall Study|Death|35|||
163850224|NCT04320615|591822487|FG001|Overall Study|Death|71|||
163850225|NCT03873246|591822489|FG000|Overall Study|Adverse Event|1|||
163850226|NCT03873246|591822490|FG001|Overall Study|Adverse Event|3|||
163850227|NCT03873246|591822491|FG002|Overall Study|Adverse Event|3|||
163850228|NCT03873246|591822489|FG000|Overall Study|Lost to Follow-up|4|||
163850229|NCT03873246|591822490|FG001|Overall Study|Lost to Follow-up|4|||
163850230|NCT03873246|591822491|FG002|Overall Study|Lost to Follow-up|5|||
163850231|NCT03873246|591822489|FG000|Overall Study|Protocol Violation|0|||
163850232|NCT03873246|591822490|FG001|Overall Study|Protocol Violation|1|||
163850233|NCT03873246|591822491|FG002|Overall Study|Protocol Violation|0|||
163850234|NCT03873246|591822489|FG000|Overall Study|Withdrawal by Subject|0|||
163850235|NCT03873246|591822490|FG001|Overall Study|Withdrawal by Subject|4|||
163850236|NCT03873246|591822491|FG002|Overall Study|Withdrawal by Subject|1|||
163850237|NCT00885495|591822492|FG000|Overall Study|Adverse Event|1|||
163850238|NCT00885495|591822493|FG001|Overall Study|Adverse Event|2|||
163850239|NCT00885495|591822492|FG000|Overall Study|Protocol Violation|0|||
163850240|NCT00885495|591822493|FG001|Overall Study|Protocol Violation|1|||
163850241|NCT00885495|591822492|FG000|Overall Study|Withdrawal by Subject|1|||
163850242|NCT00885495|591822493|FG001|Overall Study|Withdrawal by Subject|0|||
163850243|NCT02107443|591822494|FG000|Overall Study|Death|42|||
163850244|NCT02107443|591822495|FG001|Overall Study|Death|30|||
163850245|NCT02107443|591822494|FG000|Overall Study|Study Protocol Violation|3|||
163850246|NCT02107443|591822495|FG001|Overall Study|Study Protocol Violation|1|||
163850247|NCT02107443|591822494|FG000|Overall Study|Registered but Not Eligible|0|||
163850248|NCT02107443|591822495|FG001|Overall Study|Registered but Not Eligible|1|||
163850249|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
163850250|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
163850251|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
163850252|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
163850253|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Changed Mind|2|||
163850254|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Changed Mind|0|||
163850255|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
163850256|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
163850257|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
163850258|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
163850259|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
163850260|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
163850261|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
163850262|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
163850263|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Other Medical|9|||
163850264|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Other Medical|5|||
163850265|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Disease Progression|4|||
163850266|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Disease Progression|2|||
163850267|NCT02107443|591822494|FG000|Overall Study|Withdrawal: Personal Issues|0|||
163850268|NCT02107443|591822495|FG001|Overall Study|Withdrawal: Personal Issues|3|||
163850269|NCT00946647|591822496|FG000|Phase 1 Part|Adverse Event|2|||
163963807|NCT02593786|592240352|FG001|Overall Study|Study drug toxicity|0|||
163850270|NCT00946647|591822497|FG001|Phase 1 Part|Adverse Event|5|||
163850271|NCT00946647|591822498|FG002|Phase 1 Part|Adverse Event|3|||
163850272|NCT00946647|591822499|FG003|Phase 1 Part|Adverse Event|0|||
163963808|NCT02593786|592240353|FG002|Overall Study|Study drug toxicity|0|||
163850273|NCT00946647|591822500|FG004|Phase 1 Part|Adverse Event|0|||
163850274|NCT00946647|591822496|FG000|Phase 1 Part|Disease progression|3|||
163850275|NCT00946647|591822497|FG001|Phase 1 Part|Disease progression|6|||
163963809|NCT02593786|592240354|FG003|Overall Study|Study drug toxicity|0|||
163850276|NCT00946647|591822498|FG002|Phase 1 Part|Disease progression|1|||
163850277|NCT00946647|591822499|FG003|Phase 1 Part|Disease progression|0|||
163850278|NCT00946647|591822500|FG004|Phase 1 Part|Disease progression|0|||
163850279|NCT00946647|591822496|FG000|Phase 1 Part|Withdrawal by Subject|1|||
163850280|NCT00946647|591822497|FG001|Phase 1 Part|Withdrawal by Subject|4|||
163850281|NCT00946647|591822498|FG002|Phase 1 Part|Withdrawal by Subject|3|||
163850282|NCT00946647|591822499|FG003|Phase 1 Part|Withdrawal by Subject|0|||
163850283|NCT00946647|591822500|FG004|Phase 1 Part|Withdrawal by Subject|0|||
163850284|NCT00946647|591822496|FG000|Phase 1 Part|Abnormal values|0|||
163850285|NCT00946647|591822497|FG001|Phase 1 Part|Abnormal values|2|||
163850286|NCT00946647|591822498|FG002|Phase 1 Part|Abnormal values|0|||
163850287|NCT00946647|591822499|FG003|Phase 1 Part|Abnormal values|0|||
163850288|NCT00946647|591822500|FG004|Phase 1 Part|Abnormal values|0|||
163850289|NCT00946647|591822496|FG000|Phase 1 Part|Reason missing|0|||
163850290|NCT00946647|591822497|FG001|Phase 1 Part|Reason missing|1|||
163850291|NCT00946647|591822498|FG002|Phase 1 Part|Reason missing|0|||
163850292|NCT00946647|591822499|FG003|Phase 1 Part|Reason missing|0|||
163850293|NCT00946647|591822500|FG004|Phase 1 Part|Reason missing|0|||
163850294|NCT00946647|591822496|FG000|Phase ll Part|Untreated|0|||
163850295|NCT00946647|591822497|FG001|Phase ll Part|Untreated|0|||
163850296|NCT00946647|591822498|FG002|Phase ll Part|Untreated|0|||
163850297|NCT00946647|591822499|FG003|Phase ll Part|Untreated|0|||
163850298|NCT00946647|591822500|FG004|Phase ll Part|Untreated|2|||
163850299|NCT00946647|591822496|FG000|Phase ll Part|Adverse Event|0|||
163850300|NCT00946647|591822497|FG001|Phase ll Part|Adverse Event|0|||
163850301|NCT00946647|591822498|FG002|Phase ll Part|Adverse Event|0|||
163850302|NCT00946647|591822499|FG003|Phase ll Part|Adverse Event|10|||
163850303|NCT00946647|591822500|FG004|Phase ll Part|Adverse Event|6|||
163850304|NCT00946647|591822496|FG000|Phase ll Part|Withdrawal by Subject|0|||
163850305|NCT00946647|591822497|FG001|Phase ll Part|Withdrawal by Subject|0|||
163850306|NCT00946647|591822498|FG002|Phase ll Part|Withdrawal by Subject|0|||
163850307|NCT00946647|591822499|FG003|Phase ll Part|Withdrawal by Subject|8|||
163850308|NCT00946647|591822500|FG004|Phase ll Part|Withdrawal by Subject|6|||
163850309|NCT00946647|591822496|FG000|Phase ll Part|Administrative problems|0|||
163850310|NCT00946647|591822497|FG001|Phase ll Part|Administrative problems|0|||
163850311|NCT00946647|591822498|FG002|Phase ll Part|Administrative problems|0|||
163850312|NCT00946647|591822499|FG003|Phase ll Part|Administrative problems|3|||
163850313|NCT00946647|591822500|FG004|Phase ll Part|Administrative problems|8|||
163850314|NCT00946647|591822496|FG000|Phase ll Part|Death|0|||
163850315|NCT00946647|591822497|FG001|Phase ll Part|Death|0|||
163850316|NCT00946647|591822498|FG002|Phase ll Part|Death|0|||
163850317|NCT00946647|591822499|FG003|Phase ll Part|Death|7|||
163850318|NCT00946647|591822500|FG004|Phase ll Part|Death|4|||
163850319|NCT00946647|591822496|FG000|Phase ll Part|Disease progression|0|||
163850320|NCT00946647|591822497|FG001|Phase ll Part|Disease progression|0|||
163850321|NCT00946647|591822498|FG002|Phase ll Part|Disease progression|0|||
163850322|NCT00946647|591822499|FG003|Phase ll Part|Disease progression|6|||
163850323|NCT00946647|591822500|FG004|Phase ll Part|Disease progression|14|||
163850324|NCT00946647|591822496|FG000|Phase ll Part|Protocol Violation|0|||
163850325|NCT00946647|591822497|FG001|Phase ll Part|Protocol Violation|0|||
163850326|NCT00946647|591822498|FG002|Phase ll Part|Protocol Violation|0|||
163850327|NCT00946647|591822499|FG003|Phase ll Part|Protocol Violation|4|||
163850328|NCT00946647|591822500|FG004|Phase ll Part|Protocol Violation|2|||
163850329|NCT00946647|591822496|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
163850330|NCT00946647|591822497|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
163850331|NCT00946647|591822498|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
163850332|NCT00946647|591822499|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
163850333|NCT00946647|591822500|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
163850334|NCT01368211|591822501|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
163850335|NCT01368211|591822502|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
163850336|NCT05708846|591822506|FG000|Overall Study|Death|5|||
163850337|NCT05708846|591822506|FG000|Overall Study|Withdrawal by Subject|20|||
163850338|NCT03621982|591822507|FG000|Overall Study|Withdrawal by Subject|1|||
163850339|NCT03621982|591822508|FG001|Overall Study|Withdrawal by Subject|0|||
163850340|NCT03621982|591822509|FG002|Overall Study|Withdrawal by Subject|0|||
163850341|NCT03621982|591822510|FG003|Overall Study|Withdrawal by Subject|1|||
163850342|NCT03621982|591822511|FG004|Overall Study|Withdrawal by Subject|0|||
163850343|NCT03621982|591822512|FG005|Overall Study|Withdrawal by Subject|1|||
163850344|NCT03621982|591822513|FG006|Overall Study|Withdrawal by Subject|1|||
163850345|NCT03621982|591822514|FG007|Overall Study|Withdrawal by Subject|0|||
163963810|NCT02593786|592240351|FG000|Overall Study|Adverse event unrelated to study drug|1|||
163850346|NCT03621982|591822515|FG008|Overall Study|Withdrawal by Subject|1|||
163850347|NCT03621982|591822516|FG009|Overall Study|Withdrawal by Subject|0|||
163963811|NCT02593786|592240352|FG001|Overall Study|Adverse event unrelated to study drug|1|||
163850348|NCT03621982|591822517|FG010|Overall Study|Withdrawal by Subject|2|||
163850349|NCT03621982|591822518|FG011|Overall Study|Withdrawal by Subject|1|||
163850350|NCT03621982|591822519|FG012|Overall Study|Withdrawal by Subject|2|||
163850351|NCT03621982|591822520|FG013|Overall Study|Withdrawal by Subject|2|||
163850352|NCT03621982|591822507|FG000|Overall Study|Investigator/Sponsor decision|0|||
163850353|NCT03621982|591822508|FG001|Overall Study|Investigator/Sponsor decision|0|||
163850354|NCT03621982|591822509|FG002|Overall Study|Investigator/Sponsor decision|0|||
163850355|NCT03621982|591822510|FG003|Overall Study|Investigator/Sponsor decision|0|||
163850356|NCT03621982|591822511|FG004|Overall Study|Investigator/Sponsor decision|0|||
163850357|NCT03621982|591822512|FG005|Overall Study|Investigator/Sponsor decision|0|||
163850358|NCT03621982|591822513|FG006|Overall Study|Investigator/Sponsor decision|0|||
163850359|NCT03621982|591822514|FG007|Overall Study|Investigator/Sponsor decision|0|||
163850360|NCT03621982|591822515|FG008|Overall Study|Investigator/Sponsor decision|0|||
163850361|NCT03621982|591822516|FG009|Overall Study|Investigator/Sponsor decision|0|||
163850362|NCT03621982|591822517|FG010|Overall Study|Investigator/Sponsor decision|0|||
163850363|NCT03621982|591822518|FG011|Overall Study|Investigator/Sponsor decision|4|||
163850364|NCT03621982|591822519|FG012|Overall Study|Investigator/Sponsor decision|0|||
163850365|NCT03621982|591822520|FG013|Overall Study|Investigator/Sponsor decision|2|||
163850366|NCT03621982|591822507|FG000|Overall Study|Death|2|||
163850367|NCT03621982|591822508|FG001|Overall Study|Death|4|||
163850368|NCT03621982|591822509|FG002|Overall Study|Death|4|||
163850369|NCT03621982|591822510|FG003|Overall Study|Death|3|||
163850370|NCT03621982|591822511|FG004|Overall Study|Death|8|||
163850371|NCT03621982|591822512|FG005|Overall Study|Death|4|||
163850372|NCT03621982|591822513|FG006|Overall Study|Death|6|||
163850373|NCT03621982|591822514|FG007|Overall Study|Death|3|||
163850374|NCT03621982|591822515|FG008|Overall Study|Death|0|||
163850375|NCT03621982|591822516|FG009|Overall Study|Death|3|||
163850376|NCT03621982|591822517|FG010|Overall Study|Death|8|||
163850377|NCT03621982|591822518|FG011|Overall Study|Death|4|||
163850378|NCT03621982|591822519|FG012|Overall Study|Death|2|||
163850379|NCT03621982|591822520|FG013|Overall Study|Death|2|||
163850380|NCT03621982|591822507|FG000|Overall Study|Lost to Follow-up|0|||
163850381|NCT03621982|591822508|FG001|Overall Study|Lost to Follow-up|0|||
163850382|NCT03621982|591822509|FG002|Overall Study|Lost to Follow-up|1|||
163850383|NCT03621982|591822510|FG003|Overall Study|Lost to Follow-up|0|||
163850384|NCT03621982|591822511|FG004|Overall Study|Lost to Follow-up|0|||
163850385|NCT03621982|591822512|FG005|Overall Study|Lost to Follow-up|0|||
163850386|NCT03621982|591822513|FG006|Overall Study|Lost to Follow-up|1|||
163850387|NCT03621982|591822514|FG007|Overall Study|Lost to Follow-up|0|||
163850388|NCT03621982|591822515|FG008|Overall Study|Lost to Follow-up|0|||
163850389|NCT03621982|591822516|FG009|Overall Study|Lost to Follow-up|1|||
163850390|NCT03621982|591822517|FG010|Overall Study|Lost to Follow-up|0|||
163850391|NCT03621982|591822518|FG011|Overall Study|Lost to Follow-up|0|||
163850392|NCT03621982|591822519|FG012|Overall Study|Lost to Follow-up|0|||
163850393|NCT03621982|591822520|FG013|Overall Study|Lost to Follow-up|0|||
163850394|NCT00238420|591822521|FG000|Overall Study|Protocol Violation|1|||
163850395|NCT00238420|591822522|FG001|Overall Study|Protocol Violation|1|||
163850396|NCT01254890|591822523|FG000|Overall Study|Ineligible|0|||
163850397|NCT01254890|591822524|FG001|Overall Study|Ineligible|3|||
163850398|NCT01254890|591822523|FG000|Overall Study|Withdrawal by Subject|1|||
163850399|NCT01254890|591822524|FG001|Overall Study|Withdrawal by Subject|2|||
163850400|NCT01254890|591822523|FG000|Overall Study|Disease Progression|0|||
163850401|NCT01254890|591822524|FG001|Overall Study|Disease Progression|5|||
163850402|NCT02419755|591822532|FG000|Overall Study|Death|1|||
163850403|NCT02419755|591822533|FG001|Overall Study|Death|3|||
163850404|NCT02419755|591822532|FG000|Overall Study|Relapse|0|||
163850405|NCT02419755|591822533|FG001|Overall Study|Relapse|1|||
163850406|NCT02419755|591822532|FG000|Overall Study|Ineligible|1|||
163850407|NCT02419755|591822533|FG001|Overall Study|Ineligible|0|||
163850408|NCT02419755|591822532|FG000|Overall Study|Withdrawal by Subject|1|||
163850409|NCT02419755|591822533|FG001|Overall Study|Withdrawal by Subject|0|||
163850410|NCT02325713|591822534|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850411|NCT02325713|591822535|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850412|NCT02325713|591822536|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850413|NCT02325713|591822537|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850414|NCT02325713|591822538|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850415|NCT02325713|591822539|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850416|NCT02325713|591822540|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163963812|NCT02593786|592240353|FG002|Overall Study|Adverse event unrelated to study drug|1|||
163850417|NCT02325713|591822541|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850418|NCT02325713|591822542|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850419|NCT02325713|591822543|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850420|NCT02325713|591822544|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
163850421|NCT02325713|591822545|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850422|NCT02325713|591822546|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850423|NCT02325713|591822547|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850424|NCT02325713|591822548|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850425|NCT02325713|591822549|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
163850426|NCT02325713|591822534|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
163850427|NCT02325713|591822535|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850428|NCT02325713|591822536|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850429|NCT02325713|591822537|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850430|NCT02325713|591822538|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850431|NCT02325713|591822539|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850432|NCT02325713|591822540|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850433|NCT02325713|591822541|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850434|NCT02325713|591822542|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850435|NCT02325713|591822543|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850436|NCT02325713|591822544|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850437|NCT02325713|591822545|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850438|NCT02325713|591822546|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850439|NCT02325713|591822547|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850440|NCT02325713|591822548|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850441|NCT02325713|591822549|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
163850442|NCT02325713|591822534|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850443|NCT02325713|591822535|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850444|NCT02325713|591822536|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850445|NCT02325713|591822537|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850446|NCT02325713|591822538|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850447|NCT02325713|591822539|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850448|NCT02325713|591822540|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850449|NCT02325713|591822541|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850450|NCT02325713|591822542|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850451|NCT02325713|591822543|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
163850452|NCT02325713|591822544|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850453|NCT02325713|591822545|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850454|NCT02325713|591822546|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850455|NCT02325713|591822547|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850456|NCT02325713|591822548|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850457|NCT02325713|591822549|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
163850458|NCT04988477|591822552|FG000|Overall Study|Death|1|||
163850459|NCT04988477|591822553|FG001|Overall Study|Death|0|||
163850460|NCT04988477|591822554|FG002|Overall Study|Death|0|||
163850461|NCT04988477|591822552|FG000|Overall Study|Lost to Follow-up|5|||
163850462|NCT04988477|591822553|FG001|Overall Study|Lost to Follow-up|2|||
163850463|NCT04988477|591822554|FG002|Overall Study|Lost to Follow-up|0|||
163850464|NCT04988477|591822552|FG000|Overall Study|Withdrawal by Subject|2|||
163850465|NCT04988477|591822553|FG001|Overall Study|Withdrawal by Subject|0|||
163850466|NCT04988477|591822554|FG002|Overall Study|Withdrawal by Subject|0|||
163850467|NCT04034238|591823783|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
163850468|NCT04034238|591823784|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163850469|NCT04034238|591823785|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163850470|NCT04034238|591823786|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
163850471|NCT04034238|591823783|FG000|Dose Escalation Phase|Screen failures|0|||
163850472|NCT04034238|591823784|FG001|Dose Escalation Phase|Screen failures|0|||
163850473|NCT04034238|591823785|FG002|Dose Escalation Phase|Screen failures|0|||
163850474|NCT04034238|591823786|FG003|Dose Escalation Phase|Screen failures|2|||
163850475|NCT04034238|591823783|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
163850476|NCT04034238|591823784|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
163850477|NCT04034238|591823785|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
163850478|NCT04034238|591823786|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
163963813|NCT02593786|592240354|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163963814|NCT02593786|592240351|FG000|Overall Study|Participant request to discontinue study therapy|0|||
163963815|NCT02593786|592240352|FG001|Overall Study|Participant request to discontinue study therapy|2|||
163963816|NCT02593786|592240353|FG002|Overall Study|Participant request to discontinue study therapy|0|||
163963817|NCT02593786|592240354|FG003|Overall Study|Participant request to discontinue study therapy|0|||
163963818|NCT02593786|592240351|FG000|Overall Study|Other reasons|1|||
163963819|NCT02593786|592240352|FG001|Overall Study|Other reasons|1|||
163963820|NCT02593786|592240353|FG002|Overall Study|Other reasons|0|||
163850479|NCT04034238|591823783|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
163850480|NCT04034238|591823784|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
163850481|NCT04034238|591823785|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
163850482|NCT04034238|591823786|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
163850483|NCT04822298|591823787|FG000|Overall Study|Death|3|||
163850484|NCT00465361|591823788|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
163850485|NCT01625338|591823789|FG000|Overall Study|Enrolled but not Treated|0|||
163850486|NCT01625338|591823790|FG001|Overall Study|Enrolled but not Treated|0|||
163963821|NCT02593786|592240354|FG003|Overall Study|Other reasons|5|||
163963822|NCT01839487|592240355|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
163963823|NCT01839487|592240356|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163850487|NCT01625338|591823791|FG002|Overall Study|Enrolled but not Treated|1|||
163850488|NCT01625338|591823789|FG000|Overall Study|Efficacy Failure|27|||
163850489|NCT01625338|591823790|FG001|Overall Study|Efficacy Failure|39|||
163850490|NCT01625338|591823791|FG002|Overall Study|Efficacy Failure|31|||
163850491|NCT01625338|591823789|FG000|Overall Study|Lost to Follow-up|3|||
163850492|NCT01625338|591823790|FG001|Overall Study|Lost to Follow-up|3|||
163850493|NCT01625338|591823791|FG002|Overall Study|Lost to Follow-up|2|||
163850494|NCT01625338|591823789|FG000|Overall Study|Investigator Decision|0|||
163850495|NCT01625338|591823790|FG001|Overall Study|Investigator Decision|2|||
163850496|NCT01625338|591823791|FG002|Overall Study|Investigator Decision|1|||
163850497|NCT01625338|591823789|FG000|Overall Study|Subject Withdrew Consent|1|||
163850498|NCT01625338|591823790|FG001|Overall Study|Subject Withdrew Consent|0|||
163850499|NCT01625338|591823791|FG002|Overall Study|Subject Withdrew Consent|2|||
163850500|NCT01625338|591823789|FG000|Overall Study|Adverse Event|1|||
163850501|NCT01625338|591823790|FG001|Overall Study|Adverse Event|0|||
163850502|NCT01625338|591823791|FG002|Overall Study|Adverse Event|1|||
163850503|NCT01625338|591823789|FG000|Overall Study|Study Discontinued by Sponsor|0|||
163850504|NCT01625338|591823790|FG001|Overall Study|Study Discontinued by Sponsor|0|||
163850505|NCT01625338|591823791|FG002|Overall Study|Study Discontinued by Sponsor|1|||
163850506|NCT01789203|591823792|FG000|Overall Study|Adverse Event|2|||
163850507|NCT01789203|591823793|FG001|Overall Study|Adverse Event|2|||
163850508|NCT01789203|591823792|FG000|Overall Study|Withdrawal by Subject|1|||
163850509|NCT01789203|591823793|FG001|Overall Study|Withdrawal by Subject|0|||
163850510|NCT01789203|591823792|FG000|Overall Study|Death|1|||
163850511|NCT01789203|591823793|FG001|Overall Study|Death|0|||
163850512|NCT01789203|591823792|FG000|Overall Study|Protocol Violation|2|||
163850513|NCT01789203|591823793|FG001|Overall Study|Protocol Violation|1|||
163850514|NCT01789203|591823792|FG000|Overall Study|Other|1|||
163850515|NCT01789203|591823793|FG001|Overall Study|Other|1|||
163850516|NCT01789203|591823792|FG000|Overall Study|patient non-adherent|2|||
163850517|NCT01789203|591823793|FG001|Overall Study|patient non-adherent|0|||
163850518|NCT00515086|591823800|FG000|Overall Study|Adverse Event|1|||
163850519|NCT00515086|591823801|FG001|Overall Study|Adverse Event|1|||
163850520|NCT00515086|591823802|FG002|Overall Study|Adverse Event|2|||
163850521|NCT00515086|591823803|FG003|Overall Study|Adverse Event|3|||
163850522|NCT00515086|591823800|FG000|Overall Study|Administrative|1|||
163850523|NCT00515086|591823801|FG001|Overall Study|Administrative|1|||
163850524|NCT00515086|591823802|FG002|Overall Study|Administrative|0|||
163850525|NCT00515086|591823803|FG003|Overall Study|Administrative|0|||
163850526|NCT00515086|591823800|FG000|Overall Study|Withdrawal by Subject|1|||
163850527|NCT00515086|591823801|FG001|Overall Study|Withdrawal by Subject|0|||
163850528|NCT00515086|591823802|FG002|Overall Study|Withdrawal by Subject|0|||
163850529|NCT00515086|591823803|FG003|Overall Study|Withdrawal by Subject|1|||
163850530|NCT00515086|591823800|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
163850531|NCT00515086|591823801|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163850532|NCT00515086|591823802|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
163850533|NCT00515086|591823803|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163850534|NCT00515086|591823800|FG000|Overall Study|Lost to Follow-up|1|||
163850535|NCT00515086|591823801|FG001|Overall Study|Lost to Follow-up|0|||
163850536|NCT00515086|591823802|FG002|Overall Study|Lost to Follow-up|0|||
163850537|NCT00515086|591823803|FG003|Overall Study|Lost to Follow-up|0|||
163850538|NCT00515086|591823800|FG000|Overall Study|Study drug no longer required|0|||
163850539|NCT00515086|591823801|FG001|Overall Study|Study drug no longer required|1|||
163850540|NCT00515086|591823802|FG002|Overall Study|Study drug no longer required|0|||
163850541|NCT00515086|591823803|FG003|Overall Study|Study drug no longer required|0|||
163850542|NCT00515086|591823800|FG000|Overall Study|Death|2|||
163850543|NCT00515086|591823801|FG001|Overall Study|Death|0|||
163850544|NCT00515086|591823802|FG002|Overall Study|Death|0|||
163850545|NCT00515086|591823803|FG003|Overall Study|Death|0|||
163850546|NCT03487666|591823808|FG000|Overall Study|Disease progression|4|||
163850547|NCT03487666|591823809|FG001|Overall Study|Disease progression|2|||
163850548|NCT03487666|591823810|FG002|Overall Study|Disease progression|0|||
163850549|NCT03487666|591823808|FG000|Overall Study|Adverse Event|0|||
163850550|NCT03487666|591823809|FG001|Overall Study|Adverse Event|0|||
163850551|NCT03487666|591823810|FG002|Overall Study|Adverse Event|1|||
163850552|NCT03201757|591823811|FG000|Overall Study|Withdrawal by Subject|133|||
163850553|NCT03201757|591823811|FG000|Overall Study|Adverse Event|44|||
163850554|NCT03201757|591823811|FG000|Overall Study|Lost to Follow-up|37|||
163850555|NCT03201757|591823811|FG000|Overall Study|Pregnancy|2|||
163850556|NCT03201757|591823811|FG000|Overall Study|Lack of Efficacy|1|||
163850557|NCT03201757|591823811|FG000|Overall Study|Protocol Violation|20|||
163850558|NCT03201757|591823811|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
163850559|NCT03201757|591823811|FG000|Overall Study|Not Yet Determined|5|||
163850560|NCT03201757|591823811|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
163850561|NCT03201757|591823811|FG000|Overall Study|Other|20|||
163850562|NCT03930186|591823815|FG000|Weeks 0 to 16|Adverse Event|6|||
163850563|NCT03930186|591823815|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
163850564|NCT03930186|591823815|FG000|Weeks 16 to 32|Adverse Event|1|||
163963824|NCT01839487|592240357|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163963825|NCT01839487|592240358|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163963826|NCT01839487|592240359|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163963827|NCT01839487|592240360|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
163963828|NCT01839487|592240355|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
163963829|NCT01839487|592240356|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
163963830|NCT01839487|592240357|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163963831|NCT01839487|592240358|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163963832|NCT01839487|592240359|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163963833|NCT01839487|592240360|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
163963834|NCT01839487|592240355|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163963835|NCT01839487|592240356|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
163963836|NCT01839487|592240357|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163963837|NCT01839487|592240358|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163963838|NCT01839487|592240359|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163963839|NCT01839487|592240360|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
163963840|NCT01839487|592240355|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
163963841|NCT01839487|592240356|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163963842|NCT01839487|592240357|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163963843|NCT01839487|592240358|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163963844|NCT01839487|592240359|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163963845|NCT01839487|592240360|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
163963846|NCT01839487|592240355|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
163963847|NCT01839487|592240356|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
163963848|NCT01839487|592240357|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
164075492|NCT01039584|592641893|FG000|Overall Study|Protocol Violation|10|||
164075493|NCT01039584|592641894|FG001|Overall Study|Protocol Violation|4|||
164075494|NCT01039584|592641895|FG002|Overall Study|Protocol Violation|6|||
164075495|NCT01039584|592641893|FG000|Overall Study|Lost to Follow-up|5|||
164075496|NCT01039584|592641894|FG001|Overall Study|Lost to Follow-up|3|||
164075497|NCT01039584|592641895|FG002|Overall Study|Lost to Follow-up|4|||
164075498|NCT01039584|592641893|FG000|Overall Study|Negative Baseline culture for Candida|59|||
164075499|NCT01039584|592641894|FG001|Overall Study|Negative Baseline culture for Candida|59|||
164075500|NCT01039584|592641895|FG002|Overall Study|Negative Baseline culture for Candida|24|||
164075501|NCT01039584|592641893|FG000|Overall Study|Lack of Efficacy|7|||
164075502|NCT01039584|592641894|FG001|Overall Study|Lack of Efficacy|6|||
164075503|NCT01039584|592641895|FG002|Overall Study|Lack of Efficacy|10|||
164075504|NCT01039584|592641893|FG000|Overall Study|other|1|||
164075505|NCT01039584|592641894|FG001|Overall Study|other|3|||
164075506|NCT01039584|592641895|FG002|Overall Study|other|1|||
164075507|NCT01039584|592641893|FG000|Overall Study|Pap smear with significant pathology|10|||
164075508|NCT01039584|592641894|FG001|Overall Study|Pap smear with significant pathology|10|||
164075509|NCT01039584|592641895|FG002|Overall Study|Pap smear with significant pathology|3|||
164075510|NCT01039584|592641893|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
164075511|NCT01039584|592641894|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
164075512|NCT01039584|592641895|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
164075513|NCT01174368|592641898|FG000|Overall Study|Withdrawal by Subject|1|||
164075514|NCT00479765|592641901|FG000|Overall Study|study terminated|4|||
164075515|NCT03550794|592641904|FG000|Overall Study|No longer met inclusion criteria|1|||
164075516|NCT03550794|592641905|FG001|Overall Study|No longer met inclusion criteria|2|||
164075517|NCT03550794|592641904|FG000|Overall Study|Goals of care changed|1|||
164075518|NCT03550794|592641905|FG001|Overall Study|Goals of care changed|0|||
164075519|NCT03550794|592641904|FG000|Overall Study|Withdrawal by Subject|2|||
164075520|NCT03550794|592641905|FG001|Overall Study|Withdrawal by Subject|0|||
164075521|NCT03550794|592641904|FG000|Overall Study|Death|0|||
164075522|NCT03550794|592641905|FG001|Overall Study|Death|1|||
164075523|NCT01864525|592641906|FG000|Overall Study|Adverse Event|1|||
164075524|NCT01864525|592641907|FG001|Overall Study|Adverse Event|0|||
163850565|NCT03930186|591823815|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
163850566|NCT03019458|591823818|FG000|Overall Study|Death|0|||
163850567|NCT03019458|591823819|FG001|Overall Study|Death|1|||
163850568|NCT00031447|591823820|FG000|Overall Study|Lost to Follow-up|0|||
163850569|NCT00031447|591823821|FG001|Overall Study|Lost to Follow-up|1|||
163850570|NCT00031447|591823820|FG000|Overall Study|Non-compliant|1|||
164075525|NCT01890785|592641908|FG000|Third Intervention|Withdrawal by Subject|0|||
164075526|NCT01890785|592641909|FG001|Third Intervention|Withdrawal by Subject|1|||
164075527|NCT01890785|592641910|FG002|Third Intervention|Withdrawal by Subject|0|||
164075528|NCT01890785|592641911|FG003|Third Intervention|Withdrawal by Subject|0|||
163850571|NCT00031447|591823821|FG001|Overall Study|Non-compliant|1|||
163850572|NCT00031447|591823820|FG000|Overall Study|Re-activation of Disease|2|||
163850573|NCT00031447|591823821|FG001|Overall Study|Re-activation of Disease|1|||
163963849|NCT01839487|592240358|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
163963850|NCT01839487|592240359|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
163963851|NCT01839487|592240360|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
163963852|NCT01839487|592240355|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
163963853|NCT01839487|592240356|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
163963854|NCT01839487|592240357|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
163963855|NCT01839487|592240358|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
163963856|NCT01839487|592240359|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
163963857|NCT01839487|592240360|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
163963858|NCT01839487|592240355|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163963859|NCT01839487|592240356|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163963860|NCT01839487|592240357|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
163963861|NCT01839487|592240358|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163963862|NCT01839487|592240359|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
163963863|NCT01839487|592240360|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
163963864|NCT01839487|592240355|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
163963865|NCT01839487|592240356|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
163963866|NCT01839487|592240357|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
163963867|NCT01839487|592240358|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
163963868|NCT01839487|592240359|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
163963869|NCT01839487|592240360|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
163963870|NCT01839487|592240355|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
163963871|NCT01839487|592240356|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
163963872|NCT01839487|592240357|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
163963873|NCT01839487|592240358|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
163963874|NCT01839487|592240359|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
163963875|NCT01839487|592240360|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
163963876|NCT01019980|592240365|FG000|Overall Study|Drug not available.|2|||
163963877|NCT01019980|592240366|FG001|Overall Study|Drug not available.|0|||
163963878|NCT02038920|592240376|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
163963879|NCT02038920|592240377|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
163963880|NCT02038920|592240378|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163963881|NCT02038920|592240379|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163963882|NCT02038920|592240380|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163963883|NCT02038920|592240381|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
163963884|NCT02038920|592240376|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
163963885|NCT02038920|592240377|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163963886|NCT02038920|592240378|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163963887|NCT02038920|592240379|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163963888|NCT02038920|592240380|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163963889|NCT02038920|592240381|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
163963890|NCT02038920|592240376|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
163963891|NCT02038920|592240377|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
163963892|NCT02038920|592240378|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163963893|NCT02038920|592240379|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163963894|NCT02038920|592240380|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163963895|NCT02038920|592240381|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
163963896|NCT02038920|592240376|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
163963897|NCT02038920|592240377|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
163963898|NCT02038920|592240378|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
163963899|NCT02038920|592240379|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
163963900|NCT02038920|592240380|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
163963901|NCT02038920|592240381|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
163963902|NCT02038920|592240376|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163963903|NCT02038920|592240377|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163963904|NCT02038920|592240378|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
163963905|NCT02038920|592240379|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163963906|NCT02038920|592240380|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163963907|NCT02038920|592240381|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
163963908|NCT02038920|592240376|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
163963909|NCT02038920|592240377|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
163963910|NCT02038920|592240378|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
163963911|NCT02038920|592240379|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
163850574|NCT00031447|591823820|FG000|Overall Study|Disruption of blinded study drug supply|7|||
163850575|NCT00031447|591823821|FG001|Overall Study|Disruption of blinded study drug supply|4|||
163850576|NCT02271594|591823825|FG000|Overall Study|Study closed; recruiting failure|19|||
163850577|NCT02271594|591823826|FG001|Overall Study|Study closed; recruiting failure|12|||
164006476|NCT02158533|592390963|FG001|Stage 2|Pregnancy|0|||
164006477|NCT02158533|592390964|FG002|Stage 2|Pregnancy|0|||
164006478|NCT02158533|592390965|FG003|Stage 2|Pregnancy|1|||
164006479|NCT02158533|592390966|FG004|Stage 2|Pregnancy|0|||
164006480|NCT02158533|592390967|FG005|Stage 2|Pregnancy|0|||
164006481|NCT02158533|592390962|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
164006482|NCT02158533|592390963|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
164006483|NCT02158533|592390964|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
164006484|NCT02158533|592390965|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
164006485|NCT02158533|592390966|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
164006486|NCT02158533|592390967|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
164006487|NCT02158533|592390962|FG000|Stage 2|Non-adherence with study visits|0|||
164006488|NCT02158533|592390963|FG001|Stage 2|Non-adherence with study visits|0|||
164006489|NCT02158533|592390964|FG002|Stage 2|Non-adherence with study visits|0|||
164006490|NCT02158533|592390965|FG003|Stage 2|Non-adherence with study visits|0|||
164006491|NCT02158533|592390966|FG004|Stage 2|Non-adherence with study visits|0|||
164006492|NCT02158533|592390967|FG005|Stage 2|Non-adherence with study visits|1|||
164006493|NCT01389128|592390976|FG000|Overall Study|Fetal distress|1|||
164006494|NCT01389128|592390977|FG001|Overall Study|Fetal distress|0|||
164006495|NCT01389128|592390976|FG000|Overall Study|Cervix dilation stop|1|||
164006496|NCT01389128|592390977|FG001|Overall Study|Cervix dilation stop|2|||
164006497|NCT01389128|592390976|FG000|Overall Study|Rapid labor evolution|3|||
164006498|NCT01389128|592390977|FG001|Overall Study|Rapid labor evolution|2|||
164006499|NCT01389128|592390976|FG000|Overall Study|Intolerance to procedure|0|||
164006500|NCT01389128|592390977|FG001|Overall Study|Intolerance to procedure|2|||
164006501|NCT00756002|592390978|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
164006502|NCT00756002|592390979|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
164006503|NCT00756002|592390978|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164006504|NCT00756002|592390979|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164006505|NCT00756002|592390978|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
164006506|NCT00756002|592390979|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
164006507|NCT00756002|592390978|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
164006508|NCT00756002|592390979|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
164006509|NCT00756002|592390978|FG000|Double-Blind Treatment Period|Other|2|||
164006510|NCT00756002|592390979|FG001|Double-Blind Treatment Period|Other|2|||
164006511|NCT01451515|592390980|FG000|Overall Study|Death|0|||
164006512|NCT01451515|592390981|FG001|Overall Study|Death|1|||
164006513|NCT01451515|592390982|FG002|Overall Study|Death|0|||
164006514|NCT01451515|592390980|FG000|Overall Study|Withdrawal by Subject|0|||
164006515|NCT01451515|592390981|FG001|Overall Study|Withdrawal by Subject|1|||
164006516|NCT01451515|592390982|FG002|Overall Study|Withdrawal by Subject|0|||
164006517|NCT01451515|592390980|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
164006518|NCT01451515|592390981|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
164006519|NCT01451515|592390982|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
164006520|NCT01451515|592390980|FG000|Overall Study|Relapse (except CNS)|1|||
164006521|NCT01451515|592390981|FG001|Overall Study|Relapse (except CNS)|1|||
164006522|NCT01451515|592390982|FG002|Overall Study|Relapse (except CNS)|0|||
164006523|NCT04329923|592390987|FG000|Overall Study|Withdrawal by Subject|1|||
164006524|NCT04329923|592390988|FG001|Overall Study|Withdrawal by Subject|4|||
164006525|NCT04329923|592390989|FG002|Overall Study|Withdrawal by Subject|1|||
164006526|NCT04329923|592390990|FG003|Overall Study|Withdrawal by Subject|1|||
164006527|NCT04329923|592390991|FG004|Overall Study|Withdrawal by Subject|1|||
164006528|NCT04329923|592390992|FG005|Overall Study|Withdrawal by Subject|1|||
164006529|NCT04329923|592390987|FG000|Overall Study|early termination of study|0|||
164006530|NCT04329923|592390988|FG001|Overall Study|early termination of study|0|||
164006531|NCT04329923|592390989|FG002|Overall Study|early termination of study|0|||
164006532|NCT04329923|592390990|FG003|Overall Study|early termination of study|0|||
164006533|NCT04329923|592390991|FG004|Overall Study|early termination of study|1|||
164006534|NCT04329923|592390992|FG005|Overall Study|early termination of study|2|||
164006535|NCT04329923|592390987|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164006536|NCT04329923|592390988|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164006537|NCT04329923|592390989|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164006538|NCT04329923|592390990|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164006539|NCT04329923|592390991|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
164006540|NCT04329923|592390992|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
164006541|NCT01272180|592390993|FG000|Overall Study|Adverse Event|0|||
164006542|NCT01272180|592390994|FG001|Overall Study|Adverse Event|0|||
164075529|NCT01890785|592641912|FG004|Third Intervention|Withdrawal by Subject|0|||
164075530|NCT01890785|592641913|FG005|Third Intervention|Withdrawal by Subject|0|||
164075531|NCT03296553|592641914|FG000|Overall Study|Withdrawal by Subject|1|||
164075532|NCT03296553|592641915|FG001|Overall Study|Withdrawal by Subject|1|||
164075533|NCT03296553|592641914|FG000|Overall Study|Death|1|||
164075534|NCT03296553|592641915|FG001|Overall Study|Death|0|||
164075535|NCT00558519|592641916|FG000|Overall Study|Ph+|20|||
164075536|NCT00558519|592641916|FG000|Overall Study|Ineligible|1|||
164075537|NCT00558519|592641916|FG000|Overall Study|Insufficient data|1|||
164075538|NCT00558519|592641916|FG000|Overall Study|Never received treatment|1|||
164075539|NCT03001011|592641917|FG000|Overall Study|Adverse Event|9|||
164075540|NCT03001011|592641918|FG001|Overall Study|Adverse Event|3|||
164075541|NCT03001011|592641917|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
164075542|NCT03001011|592641918|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
164075543|NCT03001011|592641917|FG000|Overall Study|Other than specified above|3|||
164075544|NCT03001011|592641918|FG001|Overall Study|Other than specified above|8|||
164075545|NCT03077828|592641920|FG000|Treatment Cycles|Death|1|||
164075546|NCT03077828|592641920|FG000|Treatment Cycles|Withdrawal by Subject|1|||
164075547|NCT03077828|592641920|FG000|Treatment Cycles|Screen Fail|2|||
164075548|NCT03077828|592641920|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
164075549|NCT03077828|592641920|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
164075550|NCT03077828|592641920|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
164075551|NCT03077828|592641920|FG000|Follow-up|Patients still in follow-up|15|||
164075552|NCT02392559|592641921|FG000|Overall Study|Withdrawal by Subject|0|||
164075553|NCT02392559|592641922|FG001|Overall Study|Withdrawal by Subject|1|||
164075554|NCT03125915|592641928|FG000|1 Month Follow up|Lost to Follow-up|3|||
164075555|NCT03125915|592641929|FG001|1 Month Follow up|Lost to Follow-up|3|||
164075556|NCT03125915|592641930|FG002|1 Month Follow up|Lost to Follow-up|2|||
164075557|NCT03125915|592641931|FG003|1 Month Follow up|Lost to Follow-up|3|||
164075558|NCT03125915|592641928|FG000|3 Month Follow-up|Lost to Follow-up|6|||
164075559|NCT03125915|592641929|FG001|3 Month Follow-up|Lost to Follow-up|4|||
164075560|NCT03125915|592641930|FG002|3 Month Follow-up|Lost to Follow-up|4|||
164075561|NCT03125915|592641931|FG003|3 Month Follow-up|Lost to Follow-up|2|||
164075562|NCT03125915|592641928|FG000|6 Month Follow-up|Lost to Follow-up|7|||
164075563|NCT03125915|592641929|FG001|6 Month Follow-up|Lost to Follow-up|3|||
164075564|NCT03125915|592641930|FG002|6 Month Follow-up|Lost to Follow-up|6|||
164075565|NCT03125915|592641931|FG003|6 Month Follow-up|Lost to Follow-up|3|||
164075566|NCT04816877|592641934|FG000|Overall Study|Withdrawal by Subject|1|||
164075567|NCT04816877|592641935|FG001|Overall Study|Withdrawal by Subject|0|||
164075568|NCT00295620|592641937|FG000|Overall Study|Lost to Follow-up|9|||
164075569|NCT00295620|592641938|FG001|Overall Study|Lost to Follow-up|5|||
164075570|NCT00295620|592641937|FG000|Overall Study|Withdrawal by Subject|37|||
164075571|NCT00295620|592641938|FG001|Overall Study|Withdrawal by Subject|50|||
164075572|NCT00295620|592641937|FG000|Overall Study|Death|206|||
164075573|NCT00295620|592641938|FG001|Overall Study|Death|207|||
164075574|NCT00295620|592641937|FG000|Overall Study|Other reasons|10|||
164075575|NCT00295620|592641938|FG001|Overall Study|Other reasons|9|||
164075576|NCT00295620|592641937|FG000|Overall Study|Discontinuation by sponsor|580|||
164075577|NCT00295620|592641938|FG001|Overall Study|Discontinuation by sponsor|593|||
164075578|NCT00295620|592641937|FG000|Overall Study|Protocol Violation|30|||
164075579|NCT00295620|592641938|FG001|Overall Study|Protocol Violation|32|||
164075580|NCT01309828|592641939|FG000|Overall Study|Adverse Event|10|||
164075581|NCT01309828|592641940|FG001|Overall Study|Adverse Event|11|||
164075582|NCT01309828|592641939|FG000|Overall Study|Voluntary Withdrawal|5|||
164075583|NCT01309828|592641940|FG001|Overall Study|Voluntary Withdrawal|4|||
164075584|NCT01309828|592641939|FG000|Overall Study|Major Protocol Deviation|0|||
164075585|NCT01309828|592641940|FG001|Overall Study|Major Protocol Deviation|1|||
164075586|NCT01309828|592641939|FG000|Overall Study|Other|1|||
164075587|NCT01309828|592641940|FG001|Overall Study|Other|0|||
164075588|NCT00217971|592641941|FG000|Overall Study|Adverse Event|1|||
164189896|NCT00572455|593063992|FG006|Stage II (28 Days)|Death|0|||
164189897|NCT00572455|593063993|FG007|Stage II (28 Days)|Death|0|||
164189898|NCT00572455|593063994|FG008|Stage II (28 Days)|Death|1|||
164189899|NCT00572455|593063995|FG009|Stage II (28 Days)|Death|0|||
164189900|NCT00572455|593063996|FG010|Stage II (28 Days)|Death|0|||
164189901|NCT00572455|593063997|FG011|Stage II (28 Days)|Death|0|||
164189902|NCT00572455|593063998|FG012|Stage II (28 Days)|Death|0|||
164189903|NCT00572455|593063999|FG013|Stage II (28 Days)|Death|0|||
164189904|NCT00572455|593063986|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
164189905|NCT00572455|593063987|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
164189906|NCT00572455|593063988|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
164189907|NCT00572455|593063989|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
164189908|NCT00572455|593063990|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
164075589|NCT00217971|592641942|FG001|Overall Study|Adverse Event|1|||
164075590|NCT00217971|592641941|FG000|Overall Study|Lost to Follow-up|15|||
164075591|NCT00217971|592641942|FG001|Overall Study|Lost to Follow-up|19|||
164075592|NCT00217971|592641941|FG000|Overall Study|Physician Decision|0|||
164075593|NCT00217971|592641942|FG001|Overall Study|Physician Decision|1|||
164006543|NCT01272180|592390995|FG002|Overall Study|Adverse Event|1|||
164006544|NCT01272180|592390996|FG003|Overall Study|Adverse Event|0|||
164006545|NCT01272180|592390993|FG000|Overall Study|Withdrawal by Subject|2|||
164006546|NCT01272180|592390994|FG001|Overall Study|Withdrawal by Subject|6|||
164006547|NCT01272180|592390995|FG002|Overall Study|Withdrawal by Subject|3|||
164006548|NCT01272180|592390996|FG003|Overall Study|Withdrawal by Subject|2|||
164006549|NCT01272180|592390993|FG000|Overall Study|Lost to Follow-up|15|||
164006550|NCT01272180|592390994|FG001|Overall Study|Lost to Follow-up|14|||
164006551|NCT01272180|592390995|FG002|Overall Study|Lost to Follow-up|8|||
164006552|NCT01272180|592390996|FG003|Overall Study|Lost to Follow-up|10|||
164006553|NCT01272180|592390993|FG000|Overall Study|Inappropriate enrollment|0|||
164006554|NCT01272180|592390994|FG001|Overall Study|Inappropriate enrollment|0|||
164006555|NCT01272180|592390995|FG002|Overall Study|Inappropriate enrollment|1|||
164006556|NCT01272180|592390996|FG003|Overall Study|Inappropriate enrollment|1|||
164006557|NCT01272180|592390993|FG000|Overall Study|Protocol Violation|0|||
164006558|NCT01272180|592390994|FG001|Overall Study|Protocol Violation|1|||
164006559|NCT01272180|592390995|FG002|Overall Study|Protocol Violation|0|||
164006560|NCT01272180|592390996|FG003|Overall Study|Protocol Violation|1|||
164006561|NCT01702805|592390999|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
164006562|NCT01702805|592391000|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
164006563|NCT01702805|592390999|FG000|Overall Study|Incomplete Follow-up|18|||
164006564|NCT01702805|592391000|FG001|Overall Study|Incomplete Follow-up|15|||
164006565|NCT01702805|592390999|FG000|Overall Study|Vital Status Assessment Only|40|||
164006566|NCT01702805|592391000|FG001|Overall Study|Vital Status Assessment Only|39|||
164006567|NCT01702805|592390999|FG000|Overall Study|Lost to Follow-up|5|||
164006568|NCT01702805|592391000|FG001|Overall Study|Lost to Follow-up|5|||
164006569|NCT03056287|592391001|FG000|Overall Study|Withdrawal by Subject|0|||
164006570|NCT03056287|592391002|FG001|Overall Study|Withdrawal by Subject|1|||
164006571|NCT03056287|592391003|FG002|Overall Study|Withdrawal by Subject|0|||
164006572|NCT03056287|592391004|FG003|Overall Study|Withdrawal by Subject|0|||
164006573|NCT03056287|592391001|FG000|Overall Study|move out of area|0|||
164006574|NCT03056287|592391002|FG001|Overall Study|move out of area|0|||
164006575|NCT03056287|592391003|FG002|Overall Study|move out of area|1|||
164006576|NCT03056287|592391004|FG003|Overall Study|move out of area|1|||
164006577|NCT01588197|592391012|FG000|Overall Study|Lack of Efficacy|0|||
164006578|NCT01588197|592391013|FG001|Overall Study|Lack of Efficacy|1|||
164006579|NCT01588197|592391012|FG000|Overall Study|No MRI|1|||
164006580|NCT01588197|592391013|FG001|Overall Study|No MRI|0|||
164006581|NCT01844076|592391020|FG000|Overall Study|Adverse Event|1|||
164006582|NCT01844076|592391021|FG001|Overall Study|Adverse Event|0|||
164006583|NCT01844076|592391022|FG002|Overall Study|Adverse Event|0|||
164006584|NCT01844076|592391023|FG003|Overall Study|Adverse Event|0|||
164006585|NCT01844076|592391020|FG000|Overall Study|Withdrawal by Subject|1|||
164006586|NCT01844076|592391021|FG001|Overall Study|Withdrawal by Subject|0|||
164006587|NCT01844076|592391022|FG002|Overall Study|Withdrawal by Subject|0|||
164006588|NCT01844076|592391023|FG003|Overall Study|Withdrawal by Subject|0|||
164006589|NCT01937312|592391028|FG000|Overall Study|Adverse Event|10|||
164006590|NCT01937312|592391029|FG001|Overall Study|Adverse Event|1|||
164006591|NCT01937312|592391028|FG000|Overall Study|Lack of Efficacy|0|||
164006592|NCT01937312|592391029|FG001|Overall Study|Lack of Efficacy|1|||
164006593|NCT01937312|592391028|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
164006594|NCT01937312|592391029|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
164006595|NCT01486238|592391030|FG000|Overall Study|Death|0|||
164006596|NCT01486238|592391031|FG001|Overall Study|Death|2|||
164006597|NCT01486238|592391030|FG000|Overall Study|Withdrawal by Subject|2|||
164006598|NCT01486238|592391031|FG001|Overall Study|Withdrawal by Subject|1|||
164006599|NCT01486238|592391030|FG000|Overall Study|Lost to Follow-up|0|||
164006600|NCT01486238|592391031|FG001|Overall Study|Lost to Follow-up|3|||
164006601|NCT03043365|592391032|FG000|Weeks 0 to Week 8|Adverse Event|1|||
164006602|NCT03043365|592391033|FG001|Weeks 0 to Week 8|Adverse Event|3|||
164006603|NCT03043365|592391032|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
164006604|NCT03043365|592391033|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
164006605|NCT03043365|592391032|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
164006606|NCT03043365|592391033|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
164006607|NCT02723630|592391034|FG000|Intervention Period 1|Adverse Event|1|||
164006608|NCT02723630|592391035|FG001|Intervention Period 1|Adverse Event|0|||
164006609|NCT02723630|592391036|FG002|Intervention Period 1|Adverse Event|0|||
164006610|NCT02723630|592391037|FG003|Intervention Period 1|Adverse Event|0|||
164006611|NCT02723630|592391038|FG004|Intervention Period 1|Adverse Event|0|||
164006612|NCT02723630|592391039|FG005|Intervention Period 1|Adverse Event|0|||
164006613|NCT02723630|592391034|FG000|Intervention Period 3|consumption of restricted item|0|||
164006614|NCT02723630|592391035|FG001|Intervention Period 3|consumption of restricted item|1|||
164006615|NCT02723630|592391036|FG002|Intervention Period 3|consumption of restricted item|0|||
164006616|NCT02723630|592391037|FG003|Intervention Period 3|consumption of restricted item|0|||
164075594|NCT00217971|592641941|FG000|Overall Study|Withdrawal by Subject|7|||
164075595|NCT00217971|592641942|FG001|Overall Study|Withdrawal by Subject|12|||
164075596|NCT00217971|592641941|FG000|Overall Study|non compliant|1|||
164075597|NCT00217971|592641942|FG001|Overall Study|non compliant|0|||
164075598|NCT00808015|592641943|FG000|Overall Study|Death|1|||
164075599|NCT00808015|592641943|FG000|Overall Study|Lack of Efficacy|58|||
164075600|NCT00808015|592641943|FG000|Overall Study|Lost to Follow-up|76|||
164075601|NCT00808015|592641943|FG000|Overall Study|Participants not willing to participate|158|||
164075602|NCT00808015|592641943|FG000|Overall Study|Adverse Event|22|||
164075603|NCT00808015|592641943|FG000|Overall Study|Other|25|||
164075604|NCT00808015|592641943|FG000|Overall Study|Enrolled but not treated|4|||
164075605|NCT00084617|592641946|FG000|Overall Study|Withdrawal by Subject|7|||
164075606|NCT00084617|592641946|FG000|Overall Study|Lack of Efficacy|1|||
164075607|NCT00084617|592641946|FG000|Overall Study|Protocol Violation|1|||
164075608|NCT01625286|592641947|FG000|Overall Study|Adverse Event|0|||
164075609|NCT01625286|592641948|FG001|Overall Study|Adverse Event|0|||
164075610|NCT01625286|592641949|FG002|Overall Study|Adverse Event|0|||
164075611|NCT01625286|592641950|FG003|Overall Study|Adverse Event|0|||
164075612|NCT01625286|592641951|FG004|Overall Study|Adverse Event|1|||
164075613|NCT01625286|592641952|FG005|Overall Study|Adverse Event|2|||
164075614|NCT01625286|592641953|FG006|Overall Study|Adverse Event|1|||
164075615|NCT01625286|592641947|FG000|Overall Study|Death|0|||
164075616|NCT01625286|592641948|FG001|Overall Study|Death|0|||
164075617|NCT01625286|592641949|FG002|Overall Study|Death|1|||
164075618|NCT01625286|592641950|FG003|Overall Study|Death|1|||
164075619|NCT01625286|592641951|FG004|Overall Study|Death|0|||
164075620|NCT01625286|592641952|FG005|Overall Study|Death|11|||
164075621|NCT01625286|592641953|FG006|Overall Study|Death|16|||
164075622|NCT01625286|592641947|FG000|Overall Study|Withdrawal by Subject|0|||
164075623|NCT01625286|592641948|FG001|Overall Study|Withdrawal by Subject|1|||
164075624|NCT01625286|592641949|FG002|Overall Study|Withdrawal by Subject|0|||
164075625|NCT01625286|592641950|FG003|Overall Study|Withdrawal by Subject|1|||
164075626|NCT01625286|592641951|FG004|Overall Study|Withdrawal by Subject|0|||
164075627|NCT01625286|592641952|FG005|Overall Study|Withdrawal by Subject|0|||
164075628|NCT01625286|592641953|FG006|Overall Study|Withdrawal by Subject|1|||
164075629|NCT01625286|592641947|FG000|Overall Study|Any reason not specifically recorded|0|||
164075630|NCT01625286|592641948|FG001|Overall Study|Any reason not specifically recorded|0|||
164075631|NCT01625286|592641949|FG002|Overall Study|Any reason not specifically recorded|0|||
164075632|NCT01625286|592641950|FG003|Overall Study|Any reason not specifically recorded|0|||
164075633|NCT01625286|592641951|FG004|Overall Study|Any reason not specifically recorded|0|||
164075634|NCT01625286|592641952|FG005|Overall Study|Any reason not specifically recorded|1|||
164075635|NCT01625286|592641953|FG006|Overall Study|Any reason not specifically recorded|0|||
164075636|NCT01625286|592641947|FG000|Overall Study|Progressive disease|6|||
164075637|NCT01625286|592641948|FG001|Overall Study|Progressive disease|3|||
164075638|NCT01625286|592641949|FG002|Overall Study|Progressive disease|4|||
164075639|NCT01625286|592641950|FG003|Overall Study|Progressive disease|5|||
164075640|NCT01625286|592641951|FG004|Overall Study|Progressive disease|5|||
164075641|NCT01625286|592641952|FG005|Overall Study|Progressive disease|0|||
164075642|NCT01625286|592641953|FG006|Overall Study|Progressive disease|0|||
164075643|NCT01625286|592641947|FG000|Overall Study|Lost to Follow-up|0|||
164075644|NCT01625286|592641948|FG001|Overall Study|Lost to Follow-up|0|||
164075645|NCT01625286|592641949|FG002|Overall Study|Lost to Follow-up|0|||
164075646|NCT01625286|592641950|FG003|Overall Study|Lost to Follow-up|0|||
164075647|NCT01625286|592641951|FG004|Overall Study|Lost to Follow-up|0|||
164075648|NCT01625286|592641952|FG005|Overall Study|Lost to Follow-up|0|||
164075649|NCT01625286|592641953|FG006|Overall Study|Lost to Follow-up|1|||
164075650|NCT03338673|592641954|FG000|Overall Study|Lost to Follow-up|1|||
164075651|NCT03338673|592641955|FG001|Overall Study|Lost to Follow-up|1|||
164075652|NCT01963676|592643542|FG000|Overall Study|Withdrawal by Subject|1|||
164075653|NCT01963676|592643543|FG001|Overall Study|Withdrawal by Subject|0|||
164075654|NCT03627195|592643544|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
164075655|NCT03627195|592643545|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164075656|NCT03627195|592643546|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164075657|NCT03627195|592643547|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164075658|NCT03627195|592643548|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164075659|NCT03627195|592643549|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
164075660|NCT00096382|592643552|FG000|Overall Study|Not treated|1|||
164075661|NCT00096382|592643553|FG001|Overall Study|Not treated|0|||
164075662|NCT00096382|592643552|FG000|Overall Study|Death during treatment|1|||
164075663|NCT00096382|592643553|FG001|Overall Study|Death during treatment|0|||
164075664|NCT01977352|592643564|FG000|Overall Study|Lost to Follow-up|1|||
164075665|NCT01977352|592643565|FG001|Overall Study|Lost to Follow-up|2|||
164075666|NCT00409188|592643569|FG000|Overall Study|Ongoing at data cut-off|383|||
164075667|NCT00409188|592643570|FG001|Overall Study|Ongoing at data cut-off|175|||
164075668|NCT01835132|592643571|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
164075669|NCT00856778|592643572|FG000|Overall Study|Adverse Event|7|||
164075670|NCT00856778|592643572|FG000|Overall Study|Withdrawal by Subject|10|||
164075671|NCT00856778|592643572|FG000|Overall Study|Study deviation|2|||
163850578|NCT03330119|591823829|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
163850579|NCT03330119|591823830|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
163850580|NCT01561079|591823831|FG000|Overall Study|Physician Decision|17|||
163850581|NCT01561079|591823831|FG000|Overall Study|Withdrawal by Subject|59|||
163850582|NCT01561079|591823831|FG000|Overall Study|Protocol Violation|2|||
163850583|NCT01403987|591823840|FG000|Overall Study|Residents forgot their secret PIN|18|||
163850584|NCT01403987|591823841|FG001|Overall Study|Residents forgot their secret PIN|17|||
163850585|NCT01403987|591823842|FG002|Overall Study|Residents forgot their secret PIN|18|||
164075672|NCT00856778|592643572|FG000|Overall Study|Lost to Follow-up|5|||
164075673|NCT01681771|592643573|FG000|Overall Study|Lost to Follow-up|4|||
164075674|NCT01681771|592643574|FG001|Overall Study|Lost to Follow-up|2|||
164075675|NCT00265083|592643575|FG000|Overall Study|Adverse Event|5|||
164075676|NCT00265083|592643576|FG001|Overall Study|Adverse Event|13|||
164075677|NCT00265083|592643577|FG002|Overall Study|Adverse Event|15|||
164075678|NCT00265083|592643575|FG000|Overall Study|Lost to Follow-up|3|||
164075679|NCT00265083|592643576|FG001|Overall Study|Lost to Follow-up|4|||
164075680|NCT00265083|592643577|FG002|Overall Study|Lost to Follow-up|4|||
163850586|NCT00751790|591823846|FG000|Overall Study|Lost to Follow-up|1|||
163850587|NCT00751790|591823846|FG000|Overall Study|Death|3|||
163850588|NCT00751790|591823846|FG000|Overall Study|Withdrawal by Subject|1|||
163850589|NCT00180674|591823848|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
164075681|NCT00265083|592643575|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
164075682|NCT00265083|592643576|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164075683|NCT00265083|592643577|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
163963912|NCT02038920|592240380|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
163963913|NCT02038920|592240381|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
163963914|NCT02038920|592240376|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163963915|NCT02038920|592240377|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163963916|NCT02038920|592240378|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163963917|NCT02038920|592240379|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163963918|NCT02038920|592240380|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
163963919|NCT02038920|592240381|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
163963920|NCT02038920|592240376|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163963921|NCT02038920|592240377|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163963922|NCT02038920|592240378|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163963923|NCT02038920|592240379|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163963924|NCT02038920|592240380|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
163963925|NCT02038920|592240381|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
163963926|NCT02038920|592240376|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163963927|NCT02038920|592240377|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163963928|NCT02038920|592240378|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163963929|NCT02038920|592240379|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163963930|NCT02038920|592240380|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
163963931|NCT02038920|592240381|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
163963932|NCT02038920|592240376|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163963933|NCT02038920|592240377|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163963934|NCT02038920|592240378|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163963935|NCT02038920|592240379|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163963936|NCT02038920|592240380|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
163963937|NCT02038920|592240381|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
163963938|NCT02038920|592240376|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163850590|NCT00180674|591823848|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
163850591|NCT03302910|591823849|FG000|Overall Study|Protocol Violation|1|||
163850592|NCT03302910|591823850|FG001|Overall Study|Protocol Violation|0|||
163850593|NCT01106976|591823851|FG000|Overall Study|Lost to Follow-up|8|||
163963939|NCT02038920|592240377|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163963940|NCT02038920|592240378|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163963941|NCT02038920|592240379|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163963942|NCT02038920|592240380|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
163963943|NCT02038920|592240381|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
163963944|NCT02038920|592240376|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163963945|NCT02038920|592240377|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163963946|NCT02038920|592240378|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163963947|NCT02038920|592240379|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
164075684|NCT00265083|592643575|FG000|Overall Study|Other|1|||
164075685|NCT00265083|592643576|FG001|Overall Study|Other|12|||
164075686|NCT00265083|592643577|FG002|Overall Study|Other|9|||
164302034|NCT03847896|593482508|FG004|Overall Study|Lack of Efficacy|2|||
163850594|NCT01477749|591823854|FG000|Overall Study|Physician Decision|4|||
163850595|NCT03566680|591823855|FG000|Overall Study|Pregnancy|1|||
163963948|NCT02038920|592240380|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
163963949|NCT02038920|592240381|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
163963950|NCT00866697|592240382|FG000|Overall Study|Study closed/terminated|156|||
163963951|NCT00866697|592240383|FG001|Overall Study|Study closed/terminated|138|||
163963952|NCT00866697|592240382|FG000|Overall Study|Lost to Follow-up|22|||
163963953|NCT00866697|592240383|FG001|Overall Study|Lost to Follow-up|28|||
163963954|NCT00866697|592240382|FG000|Overall Study|Physician Decision|3|||
163963955|NCT00866697|592240383|FG001|Overall Study|Physician Decision|5|||
163963956|NCT00866697|592240382|FG000|Overall Study|Withdrawal by Subject|33|||
163963957|NCT00866697|592240383|FG001|Overall Study|Withdrawal by Subject|57|||
163963958|NCT02906787|592240386|FG000|Overall Study|Withdrawal by Subject|12|||
163963959|NCT02906787|592240387|FG001|Overall Study|Withdrawal by Subject|10|||
163963960|NCT02906787|592240386|FG000|Overall Study|Missed|24|||
163963961|NCT02906787|592240387|FG001|Overall Study|Missed|22|||
163963962|NCT03901053|592240392|FG000|Overall Study|Lost to Follow-up|6|||
163963963|NCT03901053|592240393|FG001|Overall Study|Lost to Follow-up|2|||
163963964|NCT03901053|592240392|FG000|Overall Study|Withdrawal by Subject|4|||
163963965|NCT03901053|592240393|FG001|Overall Study|Withdrawal by Subject|3|||
163963966|NCT03901053|592240392|FG000|Overall Study|Unsatisfactory Device|1|||
163963967|NCT03901053|592240393|FG001|Overall Study|Unsatisfactory Device|2|||
163963968|NCT03901053|592240392|FG000|Overall Study|No longer meets study criteria|1|||
163963969|NCT03901053|592240393|FG001|Overall Study|No longer meets study criteria|3|||
163963970|NCT03901053|592240392|FG000|Overall Study|Subject's Medical Status|0|||
163963971|NCT03901053|592240393|FG001|Overall Study|Subject's Medical Status|1|||
163963972|NCT03901053|592240392|FG000|Overall Study|Screening Failure|1|||
163963973|NCT03901053|592240393|FG001|Overall Study|Screening Failure|0|||
163963974|NCT03442114|592240398|FG000|Overall Study|Lost to Follow-up|13|||
163963975|NCT03442114|592240399|FG001|Overall Study|Lost to Follow-up|13|||
163963976|NCT03442114|592240398|FG000|Overall Study|Physician Decision|2|||
163963977|NCT03442114|592240399|FG001|Overall Study|Physician Decision|2|||
163963978|NCT03442114|592240398|FG000|Overall Study|Protocol Violation|0|||
163963979|NCT03442114|592240399|FG001|Overall Study|Protocol Violation|2|||
163963980|NCT03442114|592240398|FG000|Overall Study|Withdrawal by Subject|1|||
163963981|NCT03442114|592240399|FG001|Overall Study|Withdrawal by Subject|3|||
163963982|NCT03442114|592240398|FG000|Overall Study|Guardianship Change|0|||
163963983|NCT03442114|592240399|FG001|Overall Study|Guardianship Change|1|||
163963984|NCT04890054|592241725|FG000|Overall Study|Lost to Follow-up|202|||
163963985|NCT04890054|592241726|FG001|Overall Study|Lost to Follow-up|219|||
163963986|NCT04313153|592241727|FG000|Overall Study|Adverse Event (includes Death)|14|||
163963987|NCT04313153|592241728|FG001|Overall Study|Adverse Event (includes Death)|19|||
163963988|NCT04313153|592241729|FG002|Overall Study|Adverse Event (includes Death)|10|||
163963989|NCT04313153|592241727|FG000|Overall Study|Physician Decision|4|||
163963990|NCT04313153|592241728|FG001|Overall Study|Physician Decision|2|||
163963991|NCT04313153|592241729|FG002|Overall Study|Physician Decision|1|||
163963992|NCT04313153|592241727|FG000|Overall Study|Withdrawal by Subject|7|||
163963993|NCT04313153|592241728|FG001|Overall Study|Withdrawal by Subject|6|||
163963994|NCT04313153|592241729|FG002|Overall Study|Withdrawal by Subject|2|||
163963995|NCT04313153|592241727|FG000|Overall Study|Lack of Efficacy|3|||
163963996|NCT04313153|592241728|FG001|Overall Study|Lack of Efficacy|3|||
163963997|NCT04313153|592241729|FG002|Overall Study|Lack of Efficacy|0|||
163963998|NCT04313153|592241727|FG000|Overall Study|Lost to Follow-up|1|||
163963999|NCT04313153|592241728|FG001|Overall Study|Lost to Follow-up|0|||
163964000|NCT04313153|592241729|FG002|Overall Study|Lost to Follow-up|2|||
163964001|NCT04313153|592241727|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
163964002|NCT04313153|592241728|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
163964003|NCT04313153|592241729|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
163964004|NCT04313153|592241727|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
163850596|NCT03566680|591823855|FG000|Overall Study|Lost to Follow-up|13|||
163850597|NCT03566680|591823855|FG000|Overall Study|Withdrawal by Subject|3|||
163964005|NCT04313153|592241728|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
163964006|NCT04313153|592241729|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
163964007|NCT04313153|592241727|FG000|Overall Study|Change in Dialysis Modality|0|||
163964008|NCT04313153|592241728|FG001|Overall Study|Change in Dialysis Modality|1|||
163964009|NCT04313153|592241729|FG002|Overall Study|Change in Dialysis Modality|2|||
163964010|NCT04313153|592241727|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
163850598|NCT01066156|591823856|FG000|Overall Study|ineligible|2|||
163964011|NCT04313153|592241728|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
163964012|NCT04313153|592241729|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
163964013|NCT04313153|592241727|FG000|Overall Study|Other|5|||
163964014|NCT04313153|592241728|FG001|Overall Study|Other|3|||
163964015|NCT04313153|592241729|FG002|Overall Study|Other|2|||
163964016|NCT05586269|592241730|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
164302035|NCT03847896|593482504|FG000|Overall Study|Other reasons|3|||
163850599|NCT01066156|591823856|FG000|Overall Study|Lost to Follow-up|7|||
163964017|NCT05586269|592241731|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
163964018|NCT05586269|592241732|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
163964019|NCT05586269|592241733|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
163964020|NCT05586269|592241730|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
163964021|NCT05586269|592241731|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
163964022|NCT05586269|592241732|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
163964023|NCT05586269|592241733|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
163964024|NCT03047551|592241734|FG000|Overall Study|Did not receive TAS|1|||
163964025|NCT03047551|592241735|FG001|Overall Study|Did not receive TAS|0|||
163964026|NCT03047551|592241734|FG000|Overall Study|Physician Decision|1|||
163964027|NCT03047551|592241735|FG001|Overall Study|Physician Decision|0|||
163964028|NCT03047551|592241734|FG000|Overall Study|Withdrawal by Subject|0|||
163964029|NCT03047551|592241735|FG001|Overall Study|Withdrawal by Subject|1|||
163964030|NCT03047551|592241734|FG000|Overall Study|Probe malfunction|0|||
163964031|NCT03047551|592241735|FG001|Overall Study|Probe malfunction|1|||
163964032|NCT03047551|592241734|FG000|Overall Study|Ineligible|0|||
163964033|NCT03047551|592241735|FG001|Overall Study|Ineligible|1|||
163964034|NCT00726622|592241736|FG000|Overall Study|Withdrawal by Subject|16|||
163964035|NCT00726622|592241737|FG001|Overall Study|Withdrawal by Subject|2|||
163964036|NCT00726622|592241736|FG000|Overall Study|Physician Decision|0|||
163964037|NCT00726622|592241737|FG001|Overall Study|Physician Decision|1|||
163964038|NCT00726622|592241736|FG000|Overall Study|Metastasis|2|||
163964039|NCT00726622|592241737|FG001|Overall Study|Metastasis|0|||
163964040|NCT02462928|592241739|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
163964041|NCT02462928|592241740|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
163964042|NCT02462928|592241741|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
163964043|NCT02462928|592241739|FG000|Overall Study|Adverse Event|47|||
163964044|NCT02462928|592241740|FG001|Overall Study|Adverse Event|51|||
163964045|NCT02462928|592241741|FG002|Overall Study|Adverse Event|25|||
163964046|NCT02462928|592241739|FG000|Overall Study|Lack of Efficacy|3|||
163964047|NCT02462928|592241740|FG001|Overall Study|Lack of Efficacy|8|||
163964048|NCT02462928|592241741|FG002|Overall Study|Lack of Efficacy|3|||
163964049|NCT02462928|592241739|FG000|Overall Study|Lost to Follow-up|4|||
163964050|NCT02462928|592241740|FG001|Overall Study|Lost to Follow-up|4|||
163964051|NCT02462928|592241741|FG002|Overall Study|Lost to Follow-up|1|||
163964052|NCT02462928|592241739|FG000|Overall Study|Withdrawal by Patient|31|||
163964053|NCT02462928|592241740|FG001|Overall Study|Withdrawal by Patient|21|||
163964054|NCT02462928|592241741|FG002|Overall Study|Withdrawal by Patient|21|||
163964055|NCT02462928|592241739|FG000|Overall Study|Protocol Violation|0|||
163964056|NCT02462928|592241740|FG001|Overall Study|Protocol Violation|1|||
163964057|NCT02462928|592241741|FG002|Overall Study|Protocol Violation|0|||
163964058|NCT02462928|592241739|FG000|Overall Study|Reason not Specified|4|||
163964059|NCT02462928|592241740|FG001|Overall Study|Reason not Specified|6|||
163964060|NCT02462928|592241741|FG002|Overall Study|Reason not Specified|5|||
163964061|NCT00395863|592241742|FG000|Overall Study|Patients did not complete both exams|2|||
163964062|NCT00395863|592241743|FG001|Overall Study|Patients did not complete both exams|3|||
163964063|NCT01940354|592241747|FG000|Overall Study|Withdrawal by Subject|4|||
163964064|NCT01940354|592241748|FG001|Overall Study|Withdrawal by Subject|2|||
163964065|NCT02020863|592241749|FG000|Overall Study|Discovery of Metastatic disease|4|||
163964066|NCT02020863|592241749|FG000|Overall Study|Team chose not to place an a line|1|||
163964067|NCT00702845|592241751|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
163964068|NCT00702845|592241752|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
163964069|NCT00702845|592241751|FG000|Overall Study|Too high ovarian response|5|||
163964070|NCT00702845|592241752|FG001|Overall Study|Too high ovarian response|1|||
164075687|NCT03208933|592643581|FG000|Overall Study|Death|3|||
164075688|NCT03208933|592643581|FG000|Overall Study|Withdrawal by Subject|3|||
164075689|NCT03208933|592643581|FG000|Overall Study|Adverse Event|1|||
164075690|NCT03208933|592643581|FG000|Overall Study|Lost to Follow-up|2|||
164075691|NCT03208933|592643581|FG000|Overall Study|Physician Decision|3|||
164075692|NCT03208933|592643581|FG000|Overall Study|Protocol Violation|1|||
163850600|NCT01066156|591823856|FG000|Overall Study|Withdrawal by Subject|1|||
163850601|NCT04003974|591823857|FG000|Overall Study|Missing|1|||
163850602|NCT04003974|591823858|FG001|Overall Study|Missing|0|||
164075693|NCT00854620|592643584|FG000|Overall Study|Adverse Event|1|||
164075694|NCT04242186|592643590|FG000|Overall Study|Death|5|||
164075695|NCT00550420|592643592|FG000|Overall Study|Adverse Event|28|||
164075696|NCT00550420|592643592|FG000|Overall Study|Lost to Follow-up|8|||
164075697|NCT00550420|592643592|FG000|Overall Study|Protocol Violation|11|||
164075698|NCT00550420|592643592|FG000|Overall Study|Withdrawal by Subject|30|||
164075699|NCT00550420|592643592|FG000|Overall Study|Still in study at termination|206|||
164075700|NCT00550420|592643592|FG000|Overall Study|Missing|2|||
164075701|NCT00550420|592643592|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
164075702|NCT00550420|592643592|FG000|Overall Study|Investigators opinion|1|||
163964071|NCT00702845|592241751|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
163964072|NCT00702845|592241752|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
163964073|NCT00702845|592241751|FG000|Overall Study|Insufficient ovarian response|1|||
163964074|NCT00702845|592241752|FG001|Overall Study|Insufficient ovarian response|0|||
163964075|NCT00702845|592241751|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
163964076|NCT00702845|592241752|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
163964077|NCT00702845|592241751|FG000|Overall Study|No or abnormal fertilization|4|||
163964078|NCT00702845|592241752|FG001|Overall Study|No or abnormal fertilization|2|||
163964079|NCT00702845|592241751|FG000|Overall Study|Patient's decision|2|||
164075703|NCT00550420|592643592|FG000|Overall Study|Lack of curative effect|1|||
164075704|NCT00550420|592643592|FG000|Overall Study|Unethical stop of enrollment|2|||
164075705|NCT00550420|592643592|FG000|Overall Study|Caregiver's decision to withdraw|1|||
164075706|NCT00550420|592643592|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
164075707|NCT00550420|592643592|FG000|Overall Study|Exclusion criteria|1|||
164075708|NCT00550420|592643592|FG000|Overall Study|Prohibited medicine|1|||
164075709|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
164075710|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
164075711|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
164075712|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
164075713|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
164075714|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
164075715|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
164075716|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
164075717|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
164075718|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
164075719|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
164075720|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
164075721|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
164075722|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
164075723|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
164075724|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
164075725|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
164075726|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
164075727|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
164075728|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
164075729|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
164075730|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
164075731|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
164075732|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
164075733|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
164075734|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
164075735|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
164075736|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
164075737|NCT01872689|592643598|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
164075738|NCT01872689|592643599|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
164075739|NCT01872689|592643600|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
164075740|NCT01872689|592643601|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
164075741|NCT01872689|592643598|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
164075742|NCT01872689|592643599|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
164075743|NCT01872689|592643600|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
164075744|NCT01872689|592643601|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
164075745|NCT01872689|592643598|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
164075746|NCT01872689|592643599|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
164075747|NCT01872689|592643600|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
164075748|NCT01872689|592643601|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
164075749|NCT01872689|592643598|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
164075750|NCT01872689|592643599|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
164075751|NCT01872689|592643600|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
164075752|NCT01872689|592643601|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
164075753|NCT01872689|592643598|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
163850603|NCT04003974|591823857|FG000|Overall Study|Withdrawal by Subject|0|||
163850604|NCT04003974|591823858|FG001|Overall Study|Withdrawal by Subject|2|||
163964080|NCT00702845|592241752|FG001|Overall Study|Patient's decision|1|||
163964081|NCT00702845|592241751|FG000|Overall Study|Not randomized|0|||
163964082|NCT00702845|592241752|FG001|Overall Study|Not randomized|1|||
163964083|NCT00928564|592241756|FG000|Overall Study|Lost to Follow-up|6|||
163964084|NCT00928564|592241757|FG001|Overall Study|Lost to Follow-up|0|||
163964085|NCT03434353|592241764|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
163964086|NCT03434353|592241765|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
163964087|NCT03434353|592241766|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
163850605|NCT02400307|591823859|FG000|Overall Study|Enrolled and Never Dosed|1|||
164075754|NCT01872689|592643599|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
164075755|NCT01872689|592643600|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
164075756|NCT01872689|592643601|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
164075757|NCT01872689|592643598|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
164075758|NCT01872689|592643599|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
164075759|NCT01872689|592643600|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
164075760|NCT01872689|592643601|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
164075761|NCT01872689|592643598|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
164075762|NCT01872689|592643599|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
164075763|NCT01872689|592643600|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
164075764|NCT01872689|592643601|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
164075765|NCT01456052|592643602|FG000|Overall Study|Adverse Event|1|||
164075766|NCT01456052|592643603|FG001|Overall Study|Adverse Event|1|||
164075767|NCT01456052|592643604|FG002|Overall Study|Adverse Event|2|||
164075768|NCT01456052|592643602|FG000|Overall Study|Consent withdrawn|0|||
164075769|NCT01456052|592643603|FG001|Overall Study|Consent withdrawn|2|||
164075770|NCT01456052|592643604|FG002|Overall Study|Consent withdrawn|1|||
164075771|NCT01456052|592643602|FG000|Overall Study|Protocol Violation|0|||
164075772|NCT01456052|592643603|FG001|Overall Study|Protocol Violation|1|||
164075773|NCT01456052|592643604|FG002|Overall Study|Protocol Violation|0|||
164075774|NCT01456052|592643602|FG000|Overall Study|Physician Decision|1|||
164075775|NCT01456052|592643603|FG001|Overall Study|Physician Decision|0|||
164075776|NCT01456052|592643604|FG002|Overall Study|Physician Decision|1|||
164075777|NCT01456052|592643602|FG000|Overall Study|Treatment Failure|0|||
164075778|NCT01456052|592643603|FG001|Overall Study|Treatment Failure|1|||
164075779|NCT01456052|592643604|FG002|Overall Study|Treatment Failure|1|||
164075780|NCT02762565|592643607|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
164075781|NCT01113710|592643608|FG000|Overall Study|Adverse Event|64|||
164075782|NCT01113710|592643608|FG000|Overall Study|Lack of Efficacy|41|||
164075783|NCT01113710|592643608|FG000|Overall Study|No Information Available|40|||
164075784|NCT01113710|592643608|FG000|Overall Study|Withdrawal by Subject|28|||
164075785|NCT01113710|592643608|FG000|Overall Study|Lost to Follow-up|20|||
164075786|NCT01113710|592643608|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
164075787|NCT01113710|592643608|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
164075788|NCT01113710|592643608|FG000|Overall Study|Lack of Patient's Compliance|8|||
164075789|NCT01113710|592643608|FG000|Overall Study|Other|7|||
164075790|NCT01113710|592643608|FG000|Overall Study|Adverse Event/Other|5|||
164075791|NCT01113710|592643608|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
164075792|NCT01113710|592643608|FG000|Overall Study|Lack of Efficacy/Other|4|||
164075793|NCT01113710|592643608|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
164075794|NCT01113710|592643608|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
164075795|NCT01113710|592643608|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
164075796|NCT01113710|592643608|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
164075797|NCT01113710|592643608|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
164075798|NCT01113710|592643608|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
164075799|NCT01113710|592643608|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
164075800|NCT01113710|592643608|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
164075801|NCT01113710|592643608|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
164075802|NCT01113710|592643608|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
164075803|NCT01113710|592643608|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
164075804|NCT01113710|592643608|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
164075805|NCT01113710|592643608|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
164075806|NCT02770716|592643610|FG000|Overall Study|Death|101|||
164075807|NCT02770716|592643611|FG001|Overall Study|Death|45|||
164075808|NCT02770716|592643610|FG000|Overall Study|Withdrawal by Subject|4|||
164075809|NCT02770716|592643611|FG001|Overall Study|Withdrawal by Subject|2|||
164075810|NCT02770716|592643610|FG000|Overall Study|Lost to Follow-up|1|||
164075811|NCT02770716|592643611|FG001|Overall Study|Lost to Follow-up|0|||
163850606|NCT02400307|591823860|FG001|Overall Study|Enrolled and Never Dosed|0|||
164075812|NCT02770716|592643610|FG000|Overall Study|Various reasons|6|||
164075813|NCT02770716|592643611|FG001|Overall Study|Various reasons|2|||
164075814|NCT01042977|592643612|FG000|Overall Study|Adverse Event|4|||
164075815|NCT01042977|592643613|FG001|Overall Study|Adverse Event|12|||
164075816|NCT01042977|592643612|FG000|Overall Study|Death|2|||
164075817|NCT01042977|592643613|FG001|Overall Study|Death|1|||
164075818|NCT01042977|592643612|FG000|Overall Study|Withdrawal by Subject|8|||
164075819|NCT01042977|592643613|FG001|Overall Study|Withdrawal by Subject|16|||
164075820|NCT01042977|592643612|FG000|Overall Study|Lost to Follow-up|0|||
164075821|NCT01042977|592643613|FG001|Overall Study|Lost to Follow-up|2|||
164075822|NCT01042977|592643612|FG000|Overall Study|Poor/non-compliance|3|||
164075823|NCT01042977|592643613|FG001|Overall Study|Poor/non-compliance|4|||
164075824|NCT01042977|592643612|FG000|Overall Study|Subject no longer meets study criteria|15|||
163850607|NCT03389893|591823864|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
164075825|NCT01042977|592643613|FG001|Overall Study|Subject no longer meets study criteria|13|||
164075826|NCT01042977|592643612|FG000|Overall Study|Incorrect enrollment|6|||
164075827|NCT01042977|592643613|FG001|Overall Study|Incorrect enrollment|4|||
164075828|NCT01042977|592643612|FG000|Overall Study|Safety|0|||
164075829|NCT01042977|592643613|FG001|Overall Study|Safety|2|||
164075830|NCT01042977|592643612|FG000|Overall Study|Administrative reason by sponsor|0|||
164075831|NCT01042977|592643613|FG001|Overall Study|Administrative reason by sponsor|1|||
164075832|NCT01042977|592643612|FG000|Overall Study|Various|3|||
164075833|NCT01042977|592643613|FG001|Overall Study|Various|0|||
164075834|NCT02499354|592643614|FG000|Overall Study|Withdrawal by Subject|1|||
164075835|NCT02499354|592643615|FG001|Overall Study|Withdrawal by Subject|0|||
164075836|NCT01677910|592643617|FG000|Double-Blind Treatment Period|Adverse Event|6|||
164075837|NCT01677910|592643618|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164075838|NCT01677910|592643619|FG002|Double-Blind Treatment Period|Adverse Event|3|||
164075839|NCT01677910|592643620|FG003|Double-Blind Treatment Period|Adverse Event|0|||
164075840|NCT01677910|592643617|FG000|Double-Blind Treatment Period|Physician Decision|0|||
164075841|NCT01677910|592643618|FG001|Double-Blind Treatment Period|Physician Decision|0|||
164075842|NCT01677910|592643619|FG002|Double-Blind Treatment Period|Physician Decision|1|||
164075843|NCT01677910|592643620|FG003|Double-Blind Treatment Period|Physician Decision|0|||
164075844|NCT01677910|592643617|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
164075845|NCT01677910|592643618|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
164075846|NCT01677910|592643619|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
164075847|NCT01677910|592643620|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
164075848|NCT01677910|592643617|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
164075849|NCT01677910|592643618|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
164075850|NCT01677910|592643619|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
164075851|NCT01677910|592643620|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
164075852|NCT01677910|592643617|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
164075853|NCT01677910|592643618|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
164075854|NCT01677910|592643619|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
164075855|NCT01677910|592643620|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
164075856|NCT01677910|592643617|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164075857|NCT01677910|592643618|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164075858|NCT01677910|592643619|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
164075859|NCT01677910|592643620|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
164075860|NCT01677910|592643617|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164075861|NCT01677910|592643618|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164075862|NCT01677910|592643619|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164075863|NCT01677910|592643620|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
164075864|NCT01677910|592643617|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164075865|NCT01677910|592643618|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164075866|NCT01677910|592643619|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
164075867|NCT01677910|592643620|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
164075868|NCT01677910|592643617|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
164075869|NCT01677910|592643618|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
164075870|NCT01677910|592643619|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
164075871|NCT01677910|592643620|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
164075872|NCT01677910|592643617|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
164075873|NCT01677910|592643618|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
164075874|NCT01677910|592643619|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
164075875|NCT01677910|592643620|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
164075876|NCT01703741|592643622|FG000|Overall Study|Withdrawal by Subject|6|||
164075877|NCT01703741|592643622|FG000|Overall Study|Adverse Event|2|||
164075878|NCT01703741|592643622|FG000|Overall Study|Physician Decision|2|||
164075879|NCT01703741|592643622|FG000|Overall Study|Protocol Violation|1|||
164075880|NCT01703741|592643622|FG000|Overall Study|Lost to Follow-up|3|||
164075881|NCT01703741|592643622|FG000|Overall Study|Subject did not want to continue|2|||
164075882|NCT01703741|592643622|FG000|Overall Study|Subject cannot comply with study visits|1|||
164075883|NCT01703741|592643622|FG000|Overall Study|Subject started testosterone injections|1|||
164075884|NCT04132232|592643623|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
164075885|NCT04132232|592643624|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
164075886|NCT04132232|592643623|FG000|Overall Study|Lost to Follow-up|6|||
164075887|NCT04132232|592643624|FG001|Overall Study|Lost to Follow-up|7|||
164075888|NCT00755937|592643625|FG000|Recruitment|Unknown if infliximab received|164|||
164075889|NCT00755937|592643625|FG000|Observational Follow-up|Lost to Follow-up|148|||
164075890|NCT03876873|592643626|FG000|Overall Study|Physician Decision|0|||
164075891|NCT03876873|592643627|FG001|Overall Study|Physician Decision|1|||
164075892|NCT03547531|592643628|FG000|Overall Study|not coming in data collection : sick|2|||
164075893|NCT03547531|592643629|FG001|Overall Study|not coming in data collection : sick|2|||
164189909|NCT00572455|593063991|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
164075894|NCT03547531|592643628|FG000|Overall Study|having family occasion|0|||
164075895|NCT03547531|592643629|FG001|Overall Study|having family occasion|2|||
164075896|NCT02117479|592643639|FG000|Overall Study|Death|13|||
164075897|NCT02117479|592643640|FG001|Overall Study|Death|8|||
164075898|NCT02117479|592643639|FG000|Overall Study|Adverse Event|8|||
164075899|NCT02117479|592643640|FG001|Overall Study|Adverse Event|16|||
164075900|NCT02117479|592643639|FG000|Overall Study|Subject decision|8|||
164075901|NCT02117479|592643640|FG001|Overall Study|Subject decision|9|||
164075902|NCT02117479|592643639|FG000|Overall Study|Disease progression|104|||
164075903|NCT02117479|592643640|FG001|Overall Study|Disease progression|108|||
164075904|NCT02117479|592643639|FG000|Overall Study|Noncompliance with study treatment|1|||
164075905|NCT02117479|592643640|FG001|Overall Study|Noncompliance with study treatment|0|||
164075906|NCT02117479|592643639|FG000|Overall Study|Study terminated by the sponsor|4|||
164075907|NCT02117479|592643640|FG001|Overall Study|Study terminated by the sponsor|6|||
164075908|NCT02117479|592643639|FG000|Overall Study|Physician Decision|7|||
164075909|NCT02117479|592643640|FG001|Overall Study|Physician Decision|2|||
164075910|NCT02117479|592643639|FG000|Overall Study|Other unspecified|11|||
164075911|NCT02117479|592643640|FG001|Overall Study|Other unspecified|7|||
164075912|NCT01223196|592643645|FG000|Overall Study|Lost to Follow-up|2|||
164075913|NCT01223196|592643646|FG001|Overall Study|Lost to Follow-up|0|||
164075914|NCT01223196|592643645|FG000|Overall Study|Physician Decision|1|||
164075915|NCT01223196|592643646|FG001|Overall Study|Physician Decision|0|||
164075916|NCT01223196|592643645|FG000|Overall Study|Withdrawal by Subject|1|||
164075917|NCT01223196|592643646|FG001|Overall Study|Withdrawal by Subject|0|||
164075918|NCT02629133|592643647|FG000|Overall Study|Lost to Follow-up|3|||
164075919|NCT02629133|592643648|FG001|Overall Study|Lost to Follow-up|1|||
164075920|NCT02629133|592643647|FG000|Overall Study|Withdrawal by Subject|1|||
164075921|NCT02629133|592643648|FG001|Overall Study|Withdrawal by Subject|1|||
164075922|NCT02598193|592643649|FG000|Overall Study|Adverse Event|13|||
164075923|NCT02598193|592643649|FG000|Overall Study|Withdrawal by Subject|1|||
164075924|NCT02598193|592643649|FG000|Overall Study|Listed in active lung transplant list|1|||
164075925|NCT02598193|592643649|FG000|Overall Study|Does not want to take Nintedanib|1|||
164075926|NCT00078819|592643651|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
164075927|NCT00078819|592643652|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
164075928|NCT00078819|592643653|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
164075929|NCT00078819|592643654|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
164075930|NCT00078819|592643651|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
164075931|NCT00078819|592643652|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
164075932|NCT00078819|592643653|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
164075933|NCT00078819|592643654|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
164075934|NCT00078819|592643651|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
164075935|NCT00078819|592643652|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
164075936|NCT00078819|592643653|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
164075937|NCT00078819|592643654|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
164075938|NCT00078819|592643651|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
164075939|NCT00078819|592643652|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
164075940|NCT00078819|592643653|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
164075941|NCT00078819|592643654|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
164075942|NCT00078819|592643651|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
164075943|NCT00078819|592643652|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
164075944|NCT00078819|592643653|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
164075945|NCT00078819|592643654|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
164075946|NCT00078819|592643651|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
164075947|NCT00078819|592643652|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
164075948|NCT00078819|592643653|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
164075949|NCT00078819|592643654|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
164075950|NCT00078819|592643651|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
164075951|NCT00078819|592643652|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
164075952|NCT00078819|592643653|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
164075953|NCT00078819|592643654|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
164075954|NCT00078819|592643651|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
164075955|NCT00078819|592643652|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
164075956|NCT00078819|592643653|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
164075957|NCT00078819|592643654|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
164075958|NCT03012815|592643655|FG000|Overall Study|Lost to Follow-up|1|||
164075959|NCT03012815|592643656|FG001|Overall Study|Lost to Follow-up|0|||
164075960|NCT03012815|592643655|FG000|Overall Study|Physician Decision|3|||
164075961|NCT03012815|592643656|FG001|Overall Study|Physician Decision|2|||
164075962|NCT03012815|592643655|FG000|Overall Study|Adverse Event|1|||
164075963|NCT03012815|592643656|FG001|Overall Study|Adverse Event|0|||
164075964|NCT01462695|592643657|FG000|Overall Study|Adverse Event|1|||
164075965|NCT01462695|592643658|FG001|Overall Study|Adverse Event|1|||
164075966|NCT01462695|592643657|FG000|Overall Study|Death|2|||
164075967|NCT01462695|592643658|FG001|Overall Study|Death|0|||
164075968|NCT01462695|592643657|FG000|Overall Study|Lack of Efficacy|6|||
164075969|NCT01462695|592643658|FG001|Overall Study|Lack of Efficacy|12|||
164075970|NCT01462695|592643657|FG000|Overall Study|Physician Decision|5|||
164075971|NCT01462695|592643658|FG001|Overall Study|Physician Decision|0|||
164075972|NCT01462695|592643657|FG000|Overall Study|Withdrawal by Subject|2|||
164075973|NCT01462695|592643658|FG001|Overall Study|Withdrawal by Subject|0|||
164075974|NCT01462695|592643657|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
164075975|NCT01462695|592643658|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
164075976|NCT00879970|592643659|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
164075977|NCT00879970|592643660|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
164075978|NCT00879970|592643661|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
164075979|NCT00879970|592643662|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
164075980|NCT00879970|592643663|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
164075981|NCT00879970|592643659|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
164075982|NCT00879970|592643660|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
164075983|NCT00879970|592643661|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
164075984|NCT00879970|592643662|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
164075985|NCT00879970|592643663|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
164075986|NCT00879970|592643659|FG000|Period 1 TZD Randomization|Death|2|||
164075987|NCT00879970|592643660|FG001|Period 1 TZD Randomization|Death|1|||
164075988|NCT00879970|592643661|FG002|Period 1 TZD Randomization|Death|0|||
164075989|NCT00879970|592643662|FG003|Period 1 TZD Randomization|Death|0|||
164075990|NCT00879970|592643663|FG004|Period 1 TZD Randomization|Death|0|||
164075991|NCT00879970|592643659|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
164075992|NCT00879970|592643660|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
164075993|NCT00879970|592643661|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
164075994|NCT00879970|592643662|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
164075995|NCT00879970|592643663|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
164075996|NCT00879970|592643659|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
164075997|NCT00879970|592643660|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
164075998|NCT00879970|592643661|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
164075999|NCT00879970|592643662|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
164076000|NCT00879970|592643663|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
164076001|NCT00879970|592643659|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164076002|NCT00879970|592643660|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164076003|NCT00879970|592643661|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164076004|NCT00879970|592643662|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
164076005|NCT00879970|592643663|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
164076006|NCT00879970|592643659|FG000|Period 2 Vitamin D Randomization|Death|0|||
164076007|NCT00879970|592643660|FG001|Period 2 Vitamin D Randomization|Death|0|||
164076008|NCT00879970|592643661|FG002|Period 2 Vitamin D Randomization|Death|0|||
164189910|NCT00572455|593063992|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
164189911|NCT00572455|593063993|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
164189912|NCT00572455|593063994|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
164189913|NCT00572455|593063995|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
164189914|NCT00572455|593063996|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
164189915|NCT00572455|593063997|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
164189916|NCT00572455|593063998|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
164189917|NCT00572455|593063999|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
164189918|NCT00572455|593063986|FG000|Stage II (28 Days)|Other|0|||
164189919|NCT00572455|593063987|FG001|Stage II (28 Days)|Other|0|||
164189920|NCT00572455|593063988|FG002|Stage II (28 Days)|Other|0|||
164189921|NCT00572455|593063989|FG003|Stage II (28 Days)|Other|0|||
163850608|NCT03389893|591823865|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
163850609|NCT03389893|591823866|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
163850610|NCT03389893|591823867|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
163850611|NCT03389893|591823864|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
163850612|NCT03389893|591823865|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
164189922|NCT00572455|593063990|FG004|Stage II (28 Days)|Other|0|||
164189923|NCT00572455|593063991|FG005|Stage II (28 Days)|Other|0|||
164189924|NCT00572455|593063992|FG006|Stage II (28 Days)|Other|0|||
164189925|NCT00572455|593063993|FG007|Stage II (28 Days)|Other|0|||
164189926|NCT00572455|593063994|FG008|Stage II (28 Days)|Other|1|||
164189927|NCT00572455|593063995|FG009|Stage II (28 Days)|Other|0|||
164189928|NCT00572455|593063996|FG010|Stage II (28 Days)|Other|0|||
164189929|NCT00572455|593063997|FG011|Stage II (28 Days)|Other|0|||
164189930|NCT00572455|593063998|FG012|Stage II (28 Days)|Other|0|||
164189931|NCT00572455|593063999|FG013|Stage II (28 Days)|Other|0|||
164302036|NCT03847896|593482505|FG001|Overall Study|Other reasons|3|||
163850613|NCT03389893|591823866|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
164189932|NCT00572455|593063986|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
164189933|NCT00572455|593063987|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
164189934|NCT00572455|593063988|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
164189935|NCT00572455|593063989|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
164189936|NCT00572455|593063990|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
164189937|NCT00572455|593063991|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
164189938|NCT00572455|593063992|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
164189939|NCT00572455|593063993|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
164189940|NCT00572455|593063994|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
164189941|NCT00572455|593063995|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
164189942|NCT00572455|593063996|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
164189943|NCT00572455|593063997|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
164189944|NCT00572455|593063998|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
164189945|NCT00572455|593063999|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
164189946|NCT02609386|593064000|FG000|Overall Study|Withdrawal by Subject|6|||
164189947|NCT02609386|593064001|FG001|Overall Study|Withdrawal by Subject|1|||
164189948|NCT02609386|593064000|FG000|Overall Study|Lost to Follow-up|3|||
164189949|NCT02609386|593064001|FG001|Overall Study|Lost to Follow-up|5|||
164189950|NCT02609386|593064000|FG000|Overall Study|Death|19|||
164189951|NCT02609386|593064001|FG001|Overall Study|Death|9|||
164189952|NCT02609386|593064000|FG000|Overall Study|Physician Decision|0|||
164189953|NCT02609386|593064001|FG001|Overall Study|Physician Decision|2|||
164189954|NCT00610168|593064002|FG000|Overall Study|Withdrawal by Subject|2|||
164189955|NCT00610168|593064003|FG001|Overall Study|Withdrawal by Subject|0|||
164189956|NCT00613821|593064009|FG000|Overall Study|Withdrawal by Subject|1|||
164189957|NCT00613821|593064010|FG001|Overall Study|Withdrawal by Subject|0|||
163850614|NCT03389893|591823867|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
163850615|NCT03389893|591823864|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
163850616|NCT03389893|591823865|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
163850617|NCT03389893|591823866|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
163850618|NCT03389893|591823867|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
163850619|NCT03389893|591823864|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
163850620|NCT03389893|591823865|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
163850621|NCT03389893|591823866|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
163850622|NCT03389893|591823867|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
163850623|NCT01719861|591823871|FG000|Cycle 1|Death|4|||
163850624|NCT01719861|591823871|FG000|Cycle 2|Death|1|||
163850625|NCT01925170|591823873|FG000|Overall Study|Unverified cancer status|53|||
163850626|NCT01077024|591823876|FG000|Overall Study|Lost to Follow-up|20|||
163850627|NCT01077024|591823877|FG001|Overall Study|Lost to Follow-up|14|||
163850628|NCT01077024|591823876|FG000|Overall Study|Withdrawal by Subject|0|||
163850629|NCT01077024|591823877|FG001|Overall Study|Withdrawal by Subject|2|||
163850630|NCT01077024|591823876|FG000|Overall Study|Incarcerated|7|||
163850631|NCT01077024|591823877|FG001|Overall Study|Incarcerated|8|||
163850632|NCT01077024|591823876|FG000|Overall Study|Other|4|||
163850633|NCT01077024|591823877|FG001|Overall Study|Other|4|||
163850634|NCT02034435|591823878|FG000|Overall Study|Withdrawal by Subject|1|||
163850635|NCT02034435|591823879|FG001|Overall Study|Withdrawal by Subject|0|||
163850636|NCT02034435|591823880|FG002|Overall Study|Withdrawal by Subject|0|||
163850637|NCT02034435|591823881|FG003|Overall Study|Withdrawal by Subject|0|||
163850638|NCT02034435|591823878|FG000|Overall Study|Illness|0|||
163850639|NCT02034435|591823879|FG001|Overall Study|Illness|2|||
163850640|NCT02034435|591823880|FG002|Overall Study|Illness|0|||
163850641|NCT02034435|591823881|FG003|Overall Study|Illness|0|||
163850642|NCT02034435|591823878|FG000|Overall Study|Inadequate IV access|1|||
163850643|NCT02034435|591823879|FG001|Overall Study|Inadequate IV access|0|||
163850644|NCT02034435|591823880|FG002|Overall Study|Inadequate IV access|0|||
163850645|NCT02034435|591823881|FG003|Overall Study|Inadequate IV access|1|||
163850646|NCT03100838|591823885|FG000|Overall Study|Adverse Event|1|||
163850647|NCT03100838|591823886|FG001|Overall Study|Adverse Event|0|||
163850648|NCT03100838|591823887|FG002|Overall Study|Adverse Event|0|||
163850649|NCT03100838|591823888|FG003|Overall Study|Adverse Event|0|||
163850650|NCT03100838|591823885|FG000|Overall Study|Physician Decision|1|||
163850651|NCT03100838|591823886|FG001|Overall Study|Physician Decision|1|||
163850652|NCT03100838|591823887|FG002|Overall Study|Physician Decision|1|||
163850653|NCT03100838|591823888|FG003|Overall Study|Physician Decision|1|||
164189958|NCT00613821|593064009|FG000|Overall Study|Physician Decision|1|||
163850654|NCT03100838|591823885|FG000|Overall Study|Pregnancy|0|||
163850655|NCT03100838|591823886|FG001|Overall Study|Pregnancy|1|||
163850656|NCT03100838|591823887|FG002|Overall Study|Pregnancy|0|||
164189959|NCT00613821|593064010|FG001|Overall Study|Physician Decision|1|||
164189960|NCT00141518|593064011|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
163850657|NCT03100838|591823888|FG003|Overall Study|Pregnancy|0|||
164189961|NCT00141518|593064012|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
164189962|NCT00141518|593064013|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
163850658|NCT03100838|591823885|FG000|Overall Study|Lost to Follow-up|0|||
164189963|NCT00141518|593064011|FG000|Overall Study|Adverse Event|7|||
164189964|NCT00141518|593064012|FG001|Overall Study|Adverse Event|5|||
164189965|NCT00141518|593064013|FG002|Overall Study|Adverse Event|2|||
164189966|NCT00141518|593064011|FG000|Overall Study|Withdrawal by Subject|2|||
164189967|NCT00141518|593064012|FG001|Overall Study|Withdrawal by Subject|0|||
164189968|NCT00141518|593064013|FG002|Overall Study|Withdrawal by Subject|2|||
164189969|NCT00141518|593064011|FG000|Overall Study|Protocol Violation|1|||
164189970|NCT00141518|593064012|FG001|Overall Study|Protocol Violation|1|||
164189971|NCT00141518|593064013|FG002|Overall Study|Protocol Violation|2|||
164189972|NCT00141518|593064011|FG000|Overall Study|Lack of Efficacy|5|||
164189973|NCT00141518|593064012|FG001|Overall Study|Lack of Efficacy|0|||
164189974|NCT00141518|593064013|FG002|Overall Study|Lack of Efficacy|0|||
164189975|NCT02896569|593064014|FG000|Overall Study|Lost to Follow-up|2|||
164189976|NCT02896569|593064015|FG001|Overall Study|Lost to Follow-up|1|||
164189977|NCT02896569|593064014|FG000|Overall Study|Physician Decision|1|||
164189978|NCT02896569|593064015|FG001|Overall Study|Physician Decision|3|||
164189979|NCT02896569|593064014|FG000|Overall Study|Adverse Event|0|||
164189980|NCT02896569|593064015|FG001|Overall Study|Adverse Event|1|||
164189981|NCT02896569|593064014|FG000|Overall Study|Withdrawal by Subject|1|||
164189982|NCT02896569|593064015|FG001|Overall Study|Withdrawal by Subject|0|||
164189983|NCT03060291|593064020|FG000|3-month Follow-up|Declined to respond|8|||
164189984|NCT03060291|593064021|FG001|3-month Follow-up|Declined to respond|10|||
164189985|NCT03060291|593064022|FG002|3-month Follow-up|Declined to respond|2|||
164189986|NCT03060291|593064020|FG000|6-month Follow-up|Declined to respond|7|||
164189987|NCT03060291|593064021|FG001|6-month Follow-up|Declined to respond|13|||
164189988|NCT03060291|593064022|FG002|6-month Follow-up|Declined to respond|4|||
164189989|NCT03060291|593064020|FG000|12-month Follow-up|Declined to respond|7|||
164189990|NCT03060291|593064021|FG001|12-month Follow-up|Declined to respond|16|||
164189991|NCT03060291|593064022|FG002|12-month Follow-up|Declined to respond|6|||
164189992|NCT01509664|593064025|FG000|Overall Study|Lost to Follow-up|15|||
164189993|NCT01509664|593064026|FG001|Overall Study|Lost to Follow-up|21|||
164189994|NCT01210222|593064029|FG000|Overall Study|Ineligible|2|||
164189995|NCT01210222|593064029|FG000|Overall Study|Never treated|1|||
164189996|NCT00941304|593064030|FG000|Overall Study|Lost to Follow-up|1|||
164189997|NCT00941304|593064031|FG001|Overall Study|Lost to Follow-up|0|||
164189998|NCT00941304|593064032|FG002|Overall Study|Lost to Follow-up|0|||
164189999|NCT00941304|593064033|FG003|Overall Study|Lost to Follow-up|0|||
164190000|NCT00941304|593064034|FG004|Overall Study|Lost to Follow-up|0|||
164190001|NCT00320788|593064038|FG000|Overall Study|Adverse Event|0|||
164190002|NCT00320788|593064039|FG001|Overall Study|Adverse Event|0|||
164190003|NCT00320788|593064040|FG002|Overall Study|Adverse Event|0|||
164190004|NCT00320788|593064041|FG003|Overall Study|Adverse Event|1|||
164190005|NCT00320788|593064042|FG004|Overall Study|Adverse Event|0|||
164190006|NCT00320788|593064038|FG000|Overall Study|Death|0|||
164190007|NCT00320788|593064039|FG001|Overall Study|Death|0|||
164190008|NCT00320788|593064040|FG002|Overall Study|Death|1|||
164190009|NCT00320788|593064041|FG003|Overall Study|Death|0|||
164190010|NCT00320788|593064042|FG004|Overall Study|Death|1|||
164190011|NCT00320788|593064038|FG000|Overall Study|Lost to Follow-up|0|||
164190012|NCT00320788|593064039|FG001|Overall Study|Lost to Follow-up|2|||
164190013|NCT00320788|593064040|FG002|Overall Study|Lost to Follow-up|1|||
164190014|NCT00320788|593064041|FG003|Overall Study|Lost to Follow-up|0|||
164190015|NCT00320788|593064042|FG004|Overall Study|Lost to Follow-up|0|||
164190016|NCT00320788|593064038|FG000|Overall Study|Decision by the Sponsor|1|||
164190017|NCT00320788|593064039|FG001|Overall Study|Decision by the Sponsor|1|||
164190018|NCT00320788|593064040|FG002|Overall Study|Decision by the Sponsor|0|||
164190019|NCT00320788|593064041|FG003|Overall Study|Decision by the Sponsor|0|||
164190020|NCT00320788|593064042|FG004|Overall Study|Decision by the Sponsor|1|||
163850659|NCT03100838|591823886|FG001|Overall Study|Lost to Follow-up|0|||
163850660|NCT03100838|591823887|FG002|Overall Study|Lost to Follow-up|1|||
163850661|NCT03100838|591823888|FG003|Overall Study|Lost to Follow-up|0|||
163850662|NCT00801242|591823889|FG000|Overall Study|Adverse Event|10|||
163850663|NCT00801242|591823889|FG000|Overall Study|Withdrawal by Subject|13|||
164190021|NCT00320788|593064038|FG000|Overall Study|Other|1|||
164190022|NCT00320788|593064039|FG001|Overall Study|Other|2|||
164190023|NCT00320788|593064040|FG002|Overall Study|Other|1|||
163850664|NCT00801242|591823889|FG000|Overall Study|Protocol Violation|5|||
163850665|NCT00801242|591823889|FG000|Overall Study|Physician Decision|3|||
163850666|NCT00801242|591823889|FG000|Overall Study|Lost to Follow-up|1|||
164190024|NCT00320788|593064041|FG003|Overall Study|Other|1|||
164190025|NCT00320788|593064042|FG004|Overall Study|Other|1|||
164190026|NCT00320788|593064038|FG000|Overall Study|Physician Decision|1|||
164190027|NCT00320788|593064039|FG001|Overall Study|Physician Decision|1|||
164190028|NCT00320788|593064040|FG002|Overall Study|Physician Decision|0|||
164190029|NCT00320788|593064041|FG003|Overall Study|Physician Decision|0|||
164190030|NCT00320788|593064042|FG004|Overall Study|Physician Decision|0|||
164190031|NCT00320788|593064038|FG000|Overall Study|Protocol Violation|0|||
164190032|NCT00320788|593064039|FG001|Overall Study|Protocol Violation|0|||
164190033|NCT00320788|593064040|FG002|Overall Study|Protocol Violation|0|||
164190034|NCT00320788|593064041|FG003|Overall Study|Protocol Violation|0|||
164190035|NCT00320788|593064042|FG004|Overall Study|Protocol Violation|1|||
164190036|NCT00320788|593064038|FG000|Overall Study|Withdrawal by Subject|3|||
164190037|NCT00320788|593064039|FG001|Overall Study|Withdrawal by Subject|0|||
164190038|NCT00320788|593064040|FG002|Overall Study|Withdrawal by Subject|0|||
164190039|NCT00320788|593064041|FG003|Overall Study|Withdrawal by Subject|3|||
164190040|NCT00320788|593064042|FG004|Overall Study|Withdrawal by Subject|1|||
164190041|NCT00184093|593064049|FG000|Overall Study|Adverse Event|3|||
164190042|NCT00184093|593064049|FG000|Overall Study|Lost to Follow-up|3|||
164190043|NCT00184093|593064049|FG000|Overall Study|Physician Decision|1|||
164190044|NCT00184093|593064049|FG000|Overall Study|Withdrawal by Subject|2|||
164190045|NCT00805129|593064054|FG000|Overall Study|Not treated|1|||
164190046|NCT00571662|593064055|FG000|Overall Study|Withdrawal by Subject|2|||
164190047|NCT00571662|593064055|FG000|Overall Study|psychiatric instability|1|||
164190048|NCT00571662|593064055|FG000|Overall Study|Adverse Event|5|||
164190049|NCT03681184|593064058|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
164190050|NCT03681184|593064059|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
164190051|NCT02710084|593064064|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
163964088|NCT03434353|592241767|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
164190052|NCT02710084|593064065|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
164190053|NCT00792116|593064070|FG000|Overall Study|Lost to Follow-up|0|||
164190054|NCT00792116|593064071|FG001|Overall Study|Lost to Follow-up|1|||
164190055|NCT00792116|593064070|FG000|Overall Study|Discontnued intervention|1|||
164190056|NCT00792116|593064071|FG001|Overall Study|Discontnued intervention|0|||
164190057|NCT02453256|593064072|FG000|Double Blind Period|Death|1|||
164190058|NCT02453256|593064073|FG001|Double Blind Period|Death|1|||
164190059|NCT02453256|593064072|FG000|Double Blind Period|Adverse Event|3|||
164190060|NCT02453256|593064073|FG001|Double Blind Period|Adverse Event|2|||
164190061|NCT02453256|593064072|FG000|Double Blind Period|Withdrawal by Subject|9|||
164190062|NCT02453256|593064073|FG001|Double Blind Period|Withdrawal by Subject|5|||
164190063|NCT02453256|593064072|FG000|Double Blind Period|Other|0|||
164190064|NCT02453256|593064073|FG001|Double Blind Period|Other|1|||
164190065|NCT02453256|593064072|FG000|Open Label Period|Adverse Event|1|||
164190066|NCT02453256|593064073|FG001|Open Label Period|Adverse Event|3|||
164190067|NCT02453256|593064072|FG000|Open Label Period|Death|0|||
164190068|NCT02453256|593064073|FG001|Open Label Period|Death|1|||
164190069|NCT02453256|593064072|FG000|Open Label Period|Lost to Follow-up|1|||
164190070|NCT02453256|593064073|FG001|Open Label Period|Lost to Follow-up|0|||
164190071|NCT02453256|593064072|FG000|Open Label Period|Other|0|||
164190072|NCT02453256|593064073|FG001|Open Label Period|Other|2|||
164190073|NCT02453256|593064072|FG000|Open Label Period|Withdrawal by Subject|5|||
164190074|NCT02453256|593064073|FG001|Open Label Period|Withdrawal by Subject|1|||
164190075|NCT03373461|593064076|FG000|Part 2|Adverse Event|0|||
164190076|NCT03373461|593064077|FG001|Part 2|Adverse Event|1|||
164190077|NCT03373461|593064078|FG002|Part 2|Adverse Event|0|||
164190078|NCT03373461|593064079|FG003|Part 2|Adverse Event|0|||
164190079|NCT03373461|593064080|FG004|Part 2|Adverse Event|1|||
164190080|NCT01366638|593064081|FG000|Overall Study|Withdrawal by Subject|0|||
164190081|NCT01366638|593064082|FG001|Overall Study|Withdrawal by Subject|0|||
164190082|NCT01366638|593064083|FG002|Overall Study|Withdrawal by Subject|6|||
164190083|NCT01366638|593064081|FG000|Overall Study|Other|1|||
164190084|NCT01366638|593064082|FG001|Overall Study|Other|0|||
164190085|NCT01366638|593064083|FG002|Overall Study|Other|0|||
164190086|NCT01243177|593064084|FG000|Overall Study|Lack of Efficacy|47|||
164190087|NCT01243177|593064085|FG001|Overall Study|Lack of Efficacy|31|||
164190088|NCT01243177|593064084|FG000|Overall Study|Protocol Violation|11|||
164190089|NCT01243177|593064085|FG001|Overall Study|Protocol Violation|10|||
164190090|NCT01243177|593064084|FG000|Overall Study|Lost to Follow-up|15|||
164190091|NCT01243177|593064085|FG001|Overall Study|Lost to Follow-up|18|||
164190092|NCT01243177|593064084|FG000|Overall Study|Withdrawal by Subject|46|||
164190093|NCT01243177|593064085|FG001|Overall Study|Withdrawal by Subject|38|||
164190094|NCT01243177|593064084|FG000|Overall Study|AE, serious fatal|0|||
164190095|NCT01243177|593064085|FG001|Overall Study|AE, serious fatal|1|||
164190096|NCT01243177|593064084|FG000|Overall Study|SAE, non-fatal|7|||
164190097|NCT01243177|593064085|FG001|Overall Study|SAE, non-fatal|9|||
164190098|NCT01243177|593064084|FG000|Overall Study|AE, non-serious non-fatal|40|||
164190099|NCT01243177|593064085|FG001|Overall Study|AE, non-serious non-fatal|58|||
163964089|NCT03434353|592241768|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
164190100|NCT01243177|593064084|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
164190101|NCT01243177|593064085|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
164190102|NCT01243177|593064084|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164190103|NCT01243177|593064085|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
164190104|NCT01243177|593064084|FG000|Overall Study|Other Reason|11|||
164190105|NCT01243177|593064085|FG001|Overall Study|Other Reason|12|||
164190106|NCT05259163|593066220|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
164190107|NCT05259163|593066221|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
163850667|NCT00801242|591823889|FG000|Overall Study|Miscellaneous reasons|20|||
163850668|NCT00184028|591823890|FG000|Overall Study|Death|1|||
163850669|NCT00184028|591823890|FG000|Overall Study|Lack of Efficacy|4|||
163850670|NCT00184028|591823890|FG000|Overall Study|Adverse Event|2|||
163850671|NCT00184028|591823890|FG000|Overall Study|Withdrawal by Subject|1|||
163850672|NCT00184028|591823890|FG000|Overall Study|Non-compliance|2|||
163850673|NCT00994279|591823891|FG000|Overall Study|Withdrawal by Subject|2|||
163850674|NCT00994279|591823892|FG001|Overall Study|Withdrawal by Subject|2|||
163850675|NCT00994279|591823891|FG000|Overall Study|Toxicity|1|||
163850676|NCT00994279|591823892|FG001|Overall Study|Toxicity|0|||
163850677|NCT00994279|591823891|FG000|Overall Study|Multiple reasons|1|||
163850678|NCT00994279|591823892|FG001|Overall Study|Multiple reasons|3|||
163850679|NCT01606189|591823893|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
163850680|NCT01606189|591823894|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
163850681|NCT01606189|591823895|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
163850682|NCT01606189|591823896|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
163850683|NCT01606189|591823897|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
163850684|NCT01606189|591823898|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
163850685|NCT01606189|591823893|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163850686|NCT01606189|591823894|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163850687|NCT01606189|591823895|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163850688|NCT01606189|591823896|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163850689|NCT01606189|591823897|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
163850690|NCT01606189|591823898|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
163850691|NCT01857323|591823899|FG000|Overall Study|Adverse Event|1|||
163964090|NCT03434353|592241764|FG000|Overall Study|Withdrew consent|1|||
163964091|NCT03434353|592241765|FG001|Overall Study|Withdrew consent|0|||
163964092|NCT03434353|592241766|FG002|Overall Study|Withdrew consent|3|||
163964093|NCT03434353|592241767|FG003|Overall Study|Withdrew consent|0|||
163964094|NCT03434353|592241768|FG004|Overall Study|Withdrew consent|0|||
163964095|NCT03434353|592241764|FG000|Overall Study|Adverse Event|1|||
163964096|NCT03434353|592241765|FG001|Overall Study|Adverse Event|0|||
163964097|NCT03434353|592241766|FG002|Overall Study|Adverse Event|0|||
163964098|NCT03434353|592241767|FG003|Overall Study|Adverse Event|0|||
163964099|NCT03434353|592241768|FG004|Overall Study|Adverse Event|1|||
163964100|NCT03434353|592241764|FG000|Overall Study|Lost to Follow-up|2|||
163964101|NCT03434353|592241765|FG001|Overall Study|Lost to Follow-up|0|||
163964102|NCT03434353|592241766|FG002|Overall Study|Lost to Follow-up|0|||
163964103|NCT03434353|592241767|FG003|Overall Study|Lost to Follow-up|0|||
163964104|NCT03434353|592241768|FG004|Overall Study|Lost to Follow-up|0|||
163964105|NCT03739762|592241769|FG000|Overall Study|Lost to Follow-up|1|||
163964106|NCT03739762|592241770|FG001|Overall Study|Lost to Follow-up|1|||
163964107|NCT03739762|592241769|FG000|Overall Study|Withdrawal by Subject|2|||
163964108|NCT03739762|592241770|FG001|Overall Study|Withdrawal by Subject|6|||
163964109|NCT00929656|592241771|FG000|Overall Study|Lost to Follow-up|0|||
163964110|NCT00929656|592241772|FG001|Overall Study|Lost to Follow-up|1|||
163964111|NCT00607880|592241773|FG000|Overall Study|Unable to place port due to occlusion|1|||
163964112|NCT00607880|592241774|FG001|Overall Study|Unable to place port due to occlusion|0|||
163964113|NCT01170039|592241775|FG000|Overall Study|Withdrawal by Subject|5|||
163964114|NCT01170039|592241776|FG001|Overall Study|Withdrawal by Subject|3|||
163964115|NCT01170039|592241775|FG000|Overall Study|Lack of funding, drug not available|3|||
163964116|NCT01170039|592241776|FG001|Overall Study|Lack of funding, drug not available|3|||
163964117|NCT01990534|592241777|FG000|Overall Study|Death|22|||
163964118|NCT01990534|592241777|FG000|Overall Study|Progressive disease|3|||
163964119|NCT01990534|592241777|FG000|Overall Study|Protocol Violation|1|||
163964120|NCT01990534|592241777|FG000|Overall Study|Withdrawal of Informed Consent|2|||
163964121|NCT01990534|592241777|FG000|Overall Study|Symptomatic Deterioration|1|||
163964122|NCT01990534|592241777|FG000|Overall Study|Withdrawal by Subject|3|||
163964123|NCT01990534|592241777|FG000|Overall Study|Reason not Specified|2|||
163964124|NCT01990534|592241777|FG000|Overall Study|Lost to Follow-up|1|||
163964125|NCT01831544|592241778|FG000|Overall Study|Death|1|||
163964126|NCT01831544|592241778|FG000|Overall Study|Still on original MVAD device|2|||
163964127|NCT01131351|592241781|FG000|Overall Study|Adverse Event|0|||
163964128|NCT01131351|592241782|FG001|Overall Study|Adverse Event|2|||
163964129|NCT01131351|592241781|FG000|Overall Study|Protocol Deviation|0|||
163964130|NCT01131351|592241782|FG001|Overall Study|Protocol Deviation|1|||
163850692|NCT01857323|591823899|FG000|Overall Study|Withdrawal by Subject|3|||
163850693|NCT01857323|591823899|FG000|Overall Study|Non-compliance|1|||
163850694|NCT01857323|591823899|FG000|Overall Study|Protocol Violation|6|||
163964131|NCT01205438|592241783|FG000|Overall Study|Adverse Event|19|||
163964132|NCT01205438|592241784|FG001|Overall Study|Adverse Event|17|||
163964133|NCT01205438|592241785|FG002|Overall Study|Adverse Event|24|||
163964134|NCT01205438|592241783|FG000|Overall Study|Death|1|||
163964135|NCT01205438|592241784|FG001|Overall Study|Death|1|||
163850695|NCT01857323|591823899|FG000|Overall Study|Lost to Follow-up|1|||
163850696|NCT01857323|591823899|FG000|Overall Study|Other|4|||
163964136|NCT01205438|592241785|FG002|Overall Study|Death|3|||
163850697|NCT01857323|591823899|FG000|Overall Study|Did not complete 180 doses|48|||
163850698|NCT01400893|591823900|FG000|Overall Study|Death|27|||
163850699|NCT01400893|591823901|FG001|Overall Study|Death|21|||
163850700|NCT01400893|591823900|FG000|Overall Study|Lost to Follow-up|0|||
163850701|NCT01400893|591823901|FG001|Overall Study|Lost to Follow-up|6|||
163850702|NCT00519636|591823902|FG000|Treatment Period 1|Adverse Event|1|||
163850703|NCT00519636|591823903|FG001|Treatment Period 1|Adverse Event|0|||
163964137|NCT01205438|592241783|FG000|Overall Study|Entry Criteria Not Met|16|||
163964138|NCT01205438|592241784|FG001|Overall Study|Entry Criteria Not Met|15|||
163964139|NCT01205438|592241785|FG002|Overall Study|Entry Criteria Not Met|13|||
163964140|NCT01205438|592241783|FG000|Overall Study|Lack of Efficacy|14|||
163964141|NCT01205438|592241784|FG001|Overall Study|Lack of Efficacy|11|||
163964142|NCT01205438|592241785|FG002|Overall Study|Lack of Efficacy|14|||
163964143|NCT01205438|592241783|FG000|Overall Study|Lost to Follow-up|6|||
163964144|NCT01205438|592241784|FG001|Overall Study|Lost to Follow-up|7|||
163964145|NCT01205438|592241785|FG002|Overall Study|Lost to Follow-up|8|||
163964146|NCT01205438|592241783|FG000|Overall Study|Withdrawal by Subject|19|||
163964147|NCT01205438|592241784|FG001|Overall Study|Withdrawal by Subject|25|||
163964148|NCT01205438|592241785|FG002|Overall Study|Withdrawal by Subject|19|||
163964149|NCT01205438|592241783|FG000|Overall Study|Physician Decision|0|||
163964150|NCT01205438|592241784|FG001|Overall Study|Physician Decision|3|||
163964151|NCT01205438|592241785|FG002|Overall Study|Physician Decision|2|||
163964152|NCT01205438|592241783|FG000|Overall Study|Protocol Violation|2|||
163964153|NCT01205438|592241784|FG001|Overall Study|Protocol Violation|7|||
163964154|NCT01205438|592241785|FG002|Overall Study|Protocol Violation|4|||
163964155|NCT01205438|592241783|FG000|Overall Study|Sponsor Decision|0|||
163964156|NCT01205438|592241784|FG001|Overall Study|Sponsor Decision|1|||
163964157|NCT01205438|592241785|FG002|Overall Study|Sponsor Decision|1|||
163964158|NCT04606771|592241790|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
163964159|NCT04606771|592241791|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
163964160|NCT04606771|592241790|FG000|Overall Study|Death|5|||
163964161|NCT04606771|592241791|FG001|Overall Study|Death|6|||
163964162|NCT04606771|592241790|FG000|Overall Study|Wrong randomisation|0|||
163964163|NCT04606771|592241791|FG001|Overall Study|Wrong randomisation|1|||
163964164|NCT01207596|592241795|FG000|Overall Study|Physician Decision|4|||
163964165|NCT01207596|592241795|FG000|Overall Study|Lack of Efficacy|1|||
163964166|NCT01207596|592241795|FG000|Overall Study|Adverse Event|3|||
163964167|NCT01207596|592241795|FG000|Overall Study|Withdrawal by Subject|1|||
163964168|NCT03083847|592241796|FG000|Main|Physician Decision|0|||
163964169|NCT03083847|592241797|FG001|Main|Physician Decision|0|||
163964170|NCT03083847|592241798|FG002|Main|Physician Decision|0|||
163964171|NCT03083847|592241799|FG003|Main|Physician Decision|0|||
163964172|NCT03083847|592241800|FG004|Main|Physician Decision|0|||
163964173|NCT03083847|592241801|FG005|Main|Physician Decision|1|||
163964174|NCT03083847|592241802|FG006|Main|Physician Decision|0|||
163964175|NCT03083847|592241803|FG007|Main|Physician Decision|0|||
163964176|NCT03083847|592241804|FG008|Main|Physician Decision|0|||
163964177|NCT03083847|592241805|FG009|Main|Physician Decision|0|||
163964178|NCT03083847|592241796|FG000|Main|Pregnancy|0|||
163964179|NCT03083847|592241797|FG001|Main|Pregnancy|0|||
163964180|NCT03083847|592241798|FG002|Main|Pregnancy|0|||
163964181|NCT03083847|592241799|FG003|Main|Pregnancy|0|||
163964182|NCT03083847|592241800|FG004|Main|Pregnancy|0|||
163964183|NCT03083847|592241801|FG005|Main|Pregnancy|0|||
163964184|NCT03083847|592241802|FG006|Main|Pregnancy|0|||
163964185|NCT03083847|592241803|FG007|Main|Pregnancy|1|||
163964186|NCT03083847|592241804|FG008|Main|Pregnancy|0|||
163964187|NCT03083847|592241805|FG009|Main|Pregnancy|0|||
163964188|NCT03083847|592241796|FG000|Main|Adverse Event|0|||
163964189|NCT03083847|592241797|FG001|Main|Adverse Event|0|||
163964190|NCT03083847|592241798|FG002|Main|Adverse Event|0|||
163964191|NCT03083847|592241799|FG003|Main|Adverse Event|0|||
163964192|NCT03083847|592241800|FG004|Main|Adverse Event|0|||
163964193|NCT03083847|592241801|FG005|Main|Adverse Event|0|||
163964194|NCT03083847|592241802|FG006|Main|Adverse Event|0|||
163964195|NCT03083847|592241803|FG007|Main|Adverse Event|2|||
163964196|NCT03083847|592241804|FG008|Main|Adverse Event|0|||
163964197|NCT03083847|592241805|FG009|Main|Adverse Event|0|||
163964198|NCT03083847|592241796|FG000|Main|Withdrawal by Subject|0|||
163964199|NCT03083847|592241797|FG001|Main|Withdrawal by Subject|0|||
163964200|NCT03083847|592241798|FG002|Main|Withdrawal by Subject|0|||
163964201|NCT03083847|592241799|FG003|Main|Withdrawal by Subject|0|||
163964202|NCT03083847|592241800|FG004|Main|Withdrawal by Subject|0|||
163964203|NCT03083847|592241801|FG005|Main|Withdrawal by Subject|0|||
163964204|NCT03083847|592241802|FG006|Main|Withdrawal by Subject|1|||
163964205|NCT03083847|592241803|FG007|Main|Withdrawal by Subject|1|||
163964206|NCT03083847|592241804|FG008|Main|Withdrawal by Subject|0|||
163850704|NCT00519636|591823904|FG002|Treatment Period 1|Adverse Event|1|||
163964207|NCT03083847|592241805|FG009|Main|Withdrawal by Subject|0|||
163964208|NCT00216203|592241806|FG000|Overall Study|Withdrawal by Subject|2|||
163964209|NCT00733304|592241809|FG000|Overall Study|Adverse Event|3|||
163964210|NCT00733304|592241810|FG001|Overall Study|Adverse Event|0|||
163964211|NCT00733304|592241811|FG002|Overall Study|Adverse Event|0|||
163964212|NCT00733304|592241809|FG000|Overall Study|Lack of Efficacy|0|||
164190108|NCT05251233|593066222|FG000|Overall Study|Disease progression - did not start treatment|0|||
164190109|NCT05251233|593066223|FG001|Overall Study|Disease progression - did not start treatment|0|||
164190110|NCT05251233|593066224|FG002|Overall Study|Disease progression - did not start treatment|5|||
164190111|NCT05251233|593066222|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
164190112|NCT05251233|593066223|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
164190113|NCT05251233|593066224|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
164190114|NCT05251233|593066222|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
164190115|NCT05251233|593066223|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
164190116|NCT05251233|593066224|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
164190117|NCT05251233|593066222|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
164190118|NCT05251233|593066223|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
164190119|NCT05251233|593066224|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
164190120|NCT05251233|593066222|FG000|Overall Study|Death - did not start treatment|3|||
164190121|NCT05251233|593066223|FG001|Overall Study|Death - did not start treatment|0|||
164190122|NCT05251233|593066224|FG002|Overall Study|Death - did not start treatment|0|||
164190123|NCT05251233|593066222|FG000|Overall Study|Withdrawal by Subject|2|||
164190124|NCT05251233|593066223|FG001|Overall Study|Withdrawal by Subject|2|||
164190125|NCT05251233|593066224|FG002|Overall Study|Withdrawal by Subject|0|||
164190126|NCT05251233|593066222|FG000|Overall Study|Other complicating disease|2|||
164190127|NCT05251233|593066223|FG001|Overall Study|Other complicating disease|1|||
164190128|NCT05251233|593066224|FG002|Overall Study|Other complicating disease|0|||
164190129|NCT05251233|593066222|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
164190130|NCT05251233|593066223|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
164190131|NCT05251233|593066224|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
164190132|NCT05251233|593066222|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
164190133|NCT05251233|593066223|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
164190134|NCT05251233|593066224|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
164190135|NCT01639144|593066227|FG000|Overall Study|Withdrawal by Subject|4|||
164190136|NCT01639144|593066228|FG001|Overall Study|Withdrawal by Subject|2|||
164190137|NCT01639144|593066227|FG000|Overall Study|Physician Decision|2|||
164190138|NCT01639144|593066228|FG001|Overall Study|Physician Decision|0|||
164190139|NCT01639144|593066227|FG000|Overall Study|Met postoperative exclusion criteria|4|||
164190140|NCT01639144|593066228|FG001|Overall Study|Met postoperative exclusion criteria|3|||
164190141|NCT01000974|593066229|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
164190142|NCT01000974|593066230|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
164190143|NCT01000974|593066231|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
164190144|NCT01000974|593066229|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
164190145|NCT01000974|593066230|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
164190146|NCT01000974|593066231|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
164190147|NCT01000974|593066229|FG000|Primary Vaccination Phase|Protocol Violation|40|||
164190148|NCT01000974|593066230|FG001|Primary Vaccination Phase|Protocol Violation|3|||
164190149|NCT01000974|593066231|FG002|Primary Vaccination Phase|Protocol Violation|2|||
164190150|NCT01000974|593066229|FG000|Primary Vaccination Phase|Adverse Event|14|||
164190151|NCT01000974|593066230|FG001|Primary Vaccination Phase|Adverse Event|2|||
163850705|NCT00519636|591823905|FG003|Treatment Period 1|Adverse Event|0|||
163850706|NCT00519636|591823902|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
163850707|NCT00519636|591823903|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
163850708|NCT00519636|591823904|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
163850709|NCT00519636|591823905|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
163850710|NCT00519636|591823902|FG000|Washout Period|Adverse Event|2|||
163850711|NCT00519636|591823903|FG001|Washout Period|Adverse Event|1|||
163850712|NCT00519636|591823904|FG002|Washout Period|Adverse Event|1|||
163850713|NCT00519636|591823905|FG003|Washout Period|Adverse Event|0|||
163850714|NCT00519636|591823902|FG000|Washout Period|Lost to Follow-up|1|||
163850715|NCT00519636|591823903|FG001|Washout Period|Lost to Follow-up|0|||
163850716|NCT00519636|591823904|FG002|Washout Period|Lost to Follow-up|0|||
163850717|NCT00519636|591823905|FG003|Washout Period|Lost to Follow-up|0|||
163850718|NCT00519636|591823902|FG000|Washout Period|Protocol Violation|0|||
164190152|NCT01000974|593066231|FG002|Primary Vaccination Phase|Adverse Event|2|||
164190153|NCT01000974|593066229|FG000|Primary Vaccination Phase|Other|4|||
164190154|NCT01000974|593066230|FG001|Primary Vaccination Phase|Other|9|||
163850719|NCT00519636|591823903|FG001|Washout Period|Protocol Violation|0|||
164190155|NCT01000974|593066231|FG002|Primary Vaccination Phase|Other|12|||
163850720|NCT00519636|591823904|FG002|Washout Period|Protocol Violation|1|||
163850721|NCT00519636|591823905|FG003|Washout Period|Protocol Violation|2|||
163850722|NCT00519636|591823902|FG000|Washout Period|Withdrawal by Subject|1|||
163850723|NCT00519636|591823903|FG001|Washout Period|Withdrawal by Subject|0|||
163850724|NCT00519636|591823904|FG002|Washout Period|Withdrawal by Subject|1|||
163850725|NCT00519636|591823905|FG003|Washout Period|Withdrawal by Subject|0|||
164190156|NCT01000974|593066229|FG000|Booster Vaccination Phase|Protocol Violation|0|||
164190157|NCT01000974|593066230|FG001|Booster Vaccination Phase|Protocol Violation|0|||
164190158|NCT01000974|593066231|FG002|Booster Vaccination Phase|Protocol Violation|2|||
164190159|NCT01000974|593066229|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
164190160|NCT01000974|593066230|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
164190161|NCT01000974|593066231|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
164190162|NCT01000974|593066229|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
164190163|NCT01000974|593066230|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
164190164|NCT01000974|593066231|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
164190165|NCT01000974|593066229|FG000|Booster Vaccination Phase|Other|24|||
164190166|NCT01000974|593066230|FG001|Booster Vaccination Phase|Other|6|||
164190167|NCT01000974|593066231|FG002|Booster Vaccination Phase|Other|4|||
164190168|NCT03365934|593066232|FG000|Overall Study|Adverse Event|1|||
164190169|NCT03365934|593066232|FG000|Overall Study|Withdrawal by Subject|1|||
164190170|NCT01307891|593066233|FG000|Overall Study|Progressive Disease|3|||
164190171|NCT01307891|593066234|FG001|Overall Study|Progressive Disease|1|||
164190172|NCT02937740|593066235|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
164190173|NCT02937740|593066236|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
164190174|NCT02937740|593066235|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
164190175|NCT02937740|593066236|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
164190176|NCT02937740|593066235|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
164190177|NCT02937740|593066236|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
164190178|NCT02937740|593066235|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
164190179|NCT02937740|593066236|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
164190180|NCT02937740|593066235|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
164190181|NCT02937740|593066236|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
164190182|NCT02937740|593066235|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
164190183|NCT02937740|593066236|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
164190184|NCT04194489|593066237|FG000|Overall Study|Withdrawal by Subject|5|||
164190185|NCT04194489|593066237|FG000|Overall Study|Lost to Follow-up|48|||
164190186|NCT02964338|593066240|FG000|Overall Study|Sponsor terminated study for futility|12|||
164190187|NCT02964338|593066241|FG001|Overall Study|Sponsor terminated study for futility|15|||
164190188|NCT02964338|593066242|FG002|Overall Study|Sponsor terminated study for futility|14|||
164190189|NCT02964338|593066240|FG000|Overall Study|Lack of Efficacy|0|||
164190190|NCT02964338|593066241|FG001|Overall Study|Lack of Efficacy|3|||
164190191|NCT02964338|593066242|FG002|Overall Study|Lack of Efficacy|0|||
164190192|NCT02964338|593066240|FG000|Overall Study|Lost to Follow-up|1|||
164190193|NCT02964338|593066241|FG001|Overall Study|Lost to Follow-up|0|||
164190194|NCT02964338|593066242|FG002|Overall Study|Lost to Follow-up|3|||
164190195|NCT02964338|593066240|FG000|Overall Study|Protocol Violation|0|||
164190196|NCT02964338|593066241|FG001|Overall Study|Protocol Violation|1|||
164190197|NCT02964338|593066242|FG002|Overall Study|Protocol Violation|0|||
164190198|NCT02964338|593066240|FG000|Overall Study|Withdrawal by Subject|1|||
164190199|NCT02964338|593066241|FG001|Overall Study|Withdrawal by Subject|3|||
164190200|NCT02964338|593066242|FG002|Overall Study|Withdrawal by Subject|1|||
164190201|NCT02964338|593066240|FG000|Overall Study|Adverse Event|2|||
164076009|NCT00879970|592643662|FG003|Period 2 Vitamin D Randomization|Death|2|||
164076010|NCT00879970|592643663|FG004|Period 2 Vitamin D Randomization|Death|0|||
164076011|NCT04380701|592643666|FG000|Overall Study|Pregnancy|0|||
164076012|NCT04380701|592643667|FG001|Overall Study|Pregnancy|0|||
164076013|NCT04380701|592643668|FG002|Overall Study|Pregnancy|0|||
164076014|NCT04380701|592643669|FG003|Overall Study|Pregnancy|0|||
164076015|NCT04380701|592643670|FG004|Overall Study|Pregnancy|0|||
164076016|NCT04380701|592643671|FG005|Overall Study|Pregnancy|0|||
164076017|NCT04380701|592643672|FG006|Overall Study|Pregnancy|0|||
164076018|NCT04380701|592643673|FG007|Overall Study|Pregnancy|0|||
164076019|NCT04380701|592643674|FG008|Overall Study|Pregnancy|0|||
164076020|NCT04380701|592643675|FG009|Overall Study|Pregnancy|0|||
164076021|NCT04380701|592643676|FG010|Overall Study|Pregnancy|0|||
164076022|NCT04380701|592643677|FG011|Overall Study|Pregnancy|0|||
164076023|NCT04380701|592643678|FG012|Overall Study|Pregnancy|0|||
164076024|NCT04380701|592643679|FG013|Overall Study|Pregnancy|0|||
164076025|NCT04380701|592643680|FG014|Overall Study|Pregnancy|0|||
164076026|NCT04380701|592643681|FG015|Overall Study|Pregnancy|0|||
164076027|NCT04380701|592643682|FG016|Overall Study|Pregnancy|0|||
164076028|NCT04380701|592643683|FG017|Overall Study|Pregnancy|0|||
164076029|NCT04380701|592643684|FG018|Overall Study|Pregnancy|0|||
164076030|NCT04380701|592643685|FG019|Overall Study|Pregnancy|0|||
164076031|NCT04380701|592643686|FG020|Overall Study|Pregnancy|0|||
164076032|NCT04380701|592643687|FG021|Overall Study|Pregnancy|0|||
164076033|NCT04380701|592643688|FG022|Overall Study|Pregnancy|0|||
164076034|NCT04380701|592643689|FG023|Overall Study|Pregnancy|0|||
164076035|NCT04380701|592643690|FG024|Overall Study|Pregnancy|0|||
164076036|NCT04380701|592643691|FG025|Overall Study|Pregnancy|0|||
164076037|NCT04380701|592643692|FG026|Overall Study|Pregnancy|0|||
164076038|NCT04380701|592643693|FG027|Overall Study|Pregnancy|0|||
164076039|NCT04380701|592643694|FG028|Overall Study|Pregnancy|0|||
163850726|NCT00519636|591823902|FG000|Washout Period|Failed to meet continuation criteria|14|||
163850727|NCT00519636|591823903|FG001|Washout Period|Failed to meet continuation criteria|11|||
163850728|NCT00519636|591823904|FG002|Washout Period|Failed to meet continuation criteria|9|||
163850729|NCT00519636|591823905|FG003|Washout Period|Failed to meet continuation criteria|3|||
163850730|NCT00519636|591823902|FG000|Washout Period|Out of pollen area > 48 hours|1|||
163850731|NCT00519636|591823903|FG001|Washout Period|Out of pollen area > 48 hours|0|||
163850732|NCT00519636|591823904|FG002|Washout Period|Out of pollen area > 48 hours|0|||
163850733|NCT00519636|591823905|FG003|Washout Period|Out of pollen area > 48 hours|0|||
163850734|NCT00519636|591823902|FG000|Washout Period|Participating in study at another site|1|||
163850735|NCT00519636|591823903|FG001|Washout Period|Participating in study at another site|0|||
163850736|NCT00519636|591823904|FG002|Washout Period|Participating in study at another site|0|||
163850737|NCT00519636|591823905|FG003|Washout Period|Participating in study at another site|0|||
163850738|NCT00519636|591823902|FG000|Washout Period|Non-compliant|0|||
163850739|NCT00519636|591823903|FG001|Washout Period|Non-compliant|1|||
163850740|NCT00519636|591823904|FG002|Washout Period|Non-compliant|0|||
163850741|NCT00519636|591823905|FG003|Washout Period|Non-compliant|0|||
163850742|NCT00519636|591823902|FG000|Washout Period|Per doctors request|0|||
163850743|NCT00519636|591823903|FG001|Washout Period|Per doctors request|1|||
163850744|NCT00519636|591823904|FG002|Washout Period|Per doctors request|0|||
163850745|NCT00519636|591823905|FG003|Washout Period|Per doctors request|0|||
163850746|NCT00519636|591823902|FG000|Washout Period|Subject randomized in error|0|||
163850747|NCT00519636|591823903|FG001|Washout Period|Subject randomized in error|0|||
163850748|NCT00519636|591823904|FG002|Washout Period|Subject randomized in error|1|||
163850749|NCT00519636|591823905|FG003|Washout Period|Subject randomized in error|0|||
163850750|NCT00519636|591823902|FG000|Washout Period|Prohibited medications|0|||
163850751|NCT00519636|591823903|FG001|Washout Period|Prohibited medications|0|||
163850752|NCT00519636|591823904|FG002|Washout Period|Prohibited medications|1|||
163850753|NCT00519636|591823905|FG003|Washout Period|Prohibited medications|0|||
163964213|NCT00733304|592241810|FG001|Overall Study|Lack of Efficacy|0|||
163964214|NCT00733304|592241811|FG002|Overall Study|Lack of Efficacy|2|||
163964215|NCT00733304|592241809|FG000|Overall Study|Lost to Follow-up|0|||
163964216|NCT00733304|592241810|FG001|Overall Study|Lost to Follow-up|1|||
163964217|NCT00733304|592241811|FG002|Overall Study|Lost to Follow-up|0|||
163964218|NCT00733304|592241809|FG000|Overall Study|Physician Decision|3|||
163964219|NCT00733304|592241810|FG001|Overall Study|Physician Decision|1|||
163964220|NCT00733304|592241811|FG002|Overall Study|Physician Decision|3|||
163964221|NCT00733304|592241809|FG000|Overall Study|Withdrawal by Subject|1|||
163964222|NCT00733304|592241810|FG001|Overall Study|Withdrawal by Subject|1|||
163964223|NCT00733304|592241811|FG002|Overall Study|Withdrawal by Subject|0|||
163964224|NCT02596620|592241812|FG000|Overall Study|Lost to Follow-up|1|||
163964225|NCT02596620|592241813|FG001|Overall Study|Lost to Follow-up|1|||
163964226|NCT03155373|592241823|FG000|Overall Study|No longer required surgery|1|||
163964227|NCT03155373|592241823|FG000|Overall Study|Protocol Violation|1|||
163964228|NCT03155373|592241823|FG000|Overall Study|Death|2|||
163964229|NCT03155373|592241823|FG000|Overall Study|Withdrawal by Subject|3|||
163964230|NCT01054144|592241824|FG000|Overall Study|Death|2|||
163964231|NCT02856893|592241825|FG000|Overall Study|Lack of Efficacy|27|||
163964232|NCT02856893|592241826|FG001|Overall Study|Lack of Efficacy|15|||
163964233|NCT02856893|592241827|FG002|Overall Study|Lack of Efficacy|19|||
163964234|NCT02856893|592241825|FG000|Overall Study|Death|1|||
163964235|NCT02856893|592241826|FG001|Overall Study|Death|0|||
163964236|NCT02856893|592241827|FG002|Overall Study|Death|0|||
163964237|NCT02856893|592241825|FG000|Overall Study|Adverse Event|2|||
163964238|NCT02856893|592241826|FG001|Overall Study|Adverse Event|0|||
163964239|NCT02856893|592241827|FG002|Overall Study|Adverse Event|0|||
163964240|NCT02856893|592241825|FG000|Overall Study|Physician Decision|0|||
163964241|NCT02856893|592241826|FG001|Overall Study|Physician Decision|2|||
163964242|NCT02856893|592241827|FG002|Overall Study|Physician Decision|3|||
163964243|NCT02856893|592241825|FG000|Overall Study|Withdrawal by Subject|1|||
163964244|NCT02856893|592241826|FG001|Overall Study|Withdrawal by Subject|1|||
163964245|NCT02856893|592241827|FG002|Overall Study|Withdrawal by Subject|0|||
163964246|NCT02856893|592241825|FG000|Overall Study|Other reasons|2|||
163964247|NCT02856893|592241826|FG001|Overall Study|Other reasons|1|||
163964248|NCT02856893|592241827|FG002|Overall Study|Other reasons|2|||
163964249|NCT00528567|592241828|FG000|Overall Study|Death|4|||
163964250|NCT00528567|592241829|FG001|Overall Study|Death|5|||
163964251|NCT00528567|592241828|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
163964252|NCT00528567|592241829|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
163964253|NCT00528567|592241828|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
163964254|NCT00528567|592241829|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
163964255|NCT00528567|592241828|FG000|Overall Study|Violation Criteria at Entry|3|||
163964256|NCT00528567|592241829|FG001|Overall Study|Violation Criteria at Entry|17|||
163964257|NCT00528567|592241828|FG000|Overall Study|Withdrew Consent|59|||
164076040|NCT04380701|592643695|FG029|Overall Study|Pregnancy|0|||
164076041|NCT04380701|592643696|FG030|Overall Study|Pregnancy|0|||
164076042|NCT04380701|592643697|FG031|Overall Study|Pregnancy|0|||
164076043|NCT04380701|592643698|FG032|Overall Study|Pregnancy|1|||
164076044|NCT04380701|592643699|FG033|Overall Study|Pregnancy|0|||
164076045|NCT04380701|592643666|FG000|Overall Study|Lost to Follow-up|0|||
164076046|NCT04380701|592643667|FG001|Overall Study|Lost to Follow-up|0|||
164076047|NCT04380701|592643668|FG002|Overall Study|Lost to Follow-up|0|||
164076048|NCT04380701|592643669|FG003|Overall Study|Lost to Follow-up|0|||
164076049|NCT04380701|592643670|FG004|Overall Study|Lost to Follow-up|0|||
164076050|NCT04380701|592643671|FG005|Overall Study|Lost to Follow-up|0|||
164076051|NCT04380701|592643672|FG006|Overall Study|Lost to Follow-up|0|||
164076052|NCT04380701|592643673|FG007|Overall Study|Lost to Follow-up|0|||
164076053|NCT04380701|592643674|FG008|Overall Study|Lost to Follow-up|0|||
164076054|NCT04380701|592643675|FG009|Overall Study|Lost to Follow-up|0|||
164076055|NCT04380701|592643676|FG010|Overall Study|Lost to Follow-up|0|||
164076056|NCT04380701|592643677|FG011|Overall Study|Lost to Follow-up|0|||
164076057|NCT04380701|592643678|FG012|Overall Study|Lost to Follow-up|0|||
164076058|NCT04380701|592643679|FG013|Overall Study|Lost to Follow-up|0|||
164076059|NCT04380701|592643680|FG014|Overall Study|Lost to Follow-up|0|||
164076060|NCT04380701|592643681|FG015|Overall Study|Lost to Follow-up|0|||
164076061|NCT04380701|592643682|FG016|Overall Study|Lost to Follow-up|0|||
164076062|NCT04380701|592643683|FG017|Overall Study|Lost to Follow-up|0|||
164076063|NCT04380701|592643684|FG018|Overall Study|Lost to Follow-up|0|||
164076064|NCT04380701|592643685|FG019|Overall Study|Lost to Follow-up|0|||
164076065|NCT04380701|592643686|FG020|Overall Study|Lost to Follow-up|1|||
164076066|NCT04380701|592643687|FG021|Overall Study|Lost to Follow-up|0|||
164076067|NCT04380701|592643688|FG022|Overall Study|Lost to Follow-up|0|||
164076068|NCT04380701|592643689|FG023|Overall Study|Lost to Follow-up|1|||
164076069|NCT04380701|592643690|FG024|Overall Study|Lost to Follow-up|0|||
164076070|NCT04380701|592643691|FG025|Overall Study|Lost to Follow-up|0|||
164076071|NCT04380701|592643692|FG026|Overall Study|Lost to Follow-up|0|||
164076072|NCT04380701|592643693|FG027|Overall Study|Lost to Follow-up|0|||
164076073|NCT04380701|592643694|FG028|Overall Study|Lost to Follow-up|0|||
164076074|NCT04380701|592643695|FG029|Overall Study|Lost to Follow-up|1|||
164076075|NCT04380701|592643696|FG030|Overall Study|Lost to Follow-up|0|||
164076076|NCT04380701|592643697|FG031|Overall Study|Lost to Follow-up|0|||
164076077|NCT04380701|592643698|FG032|Overall Study|Lost to Follow-up|0|||
164076078|NCT04380701|592643699|FG033|Overall Study|Lost to Follow-up|1|||
164076079|NCT04380701|592643666|FG000|Overall Study|Private reason(s)|0|||
164076080|NCT04380701|592643667|FG001|Overall Study|Private reason(s)|0|||
164076081|NCT04380701|592643668|FG002|Overall Study|Private reason(s)|0|||
164076082|NCT04380701|592643669|FG003|Overall Study|Private reason(s)|0|||
164076083|NCT04380701|592643670|FG004|Overall Study|Private reason(s)|0|||
164076084|NCT04380701|592643671|FG005|Overall Study|Private reason(s)|0|||
164076085|NCT04380701|592643672|FG006|Overall Study|Private reason(s)|1|||
164076086|NCT04380701|592643673|FG007|Overall Study|Private reason(s)|0|||
164076087|NCT04380701|592643674|FG008|Overall Study|Private reason(s)|1|||
164076088|NCT04380701|592643675|FG009|Overall Study|Private reason(s)|1|||
164076089|NCT04380701|592643676|FG010|Overall Study|Private reason(s)|0|||
164076090|NCT04380701|592643677|FG011|Overall Study|Private reason(s)|0|||
164076091|NCT04380701|592643678|FG012|Overall Study|Private reason(s)|0|||
164076092|NCT04380701|592643679|FG013|Overall Study|Private reason(s)|0|||
164076093|NCT04380701|592643680|FG014|Overall Study|Private reason(s)|0|||
164076094|NCT04380701|592643681|FG015|Overall Study|Private reason(s)|0|||
164076095|NCT04380701|592643682|FG016|Overall Study|Private reason(s)|0|||
164076096|NCT04380701|592643683|FG017|Overall Study|Private reason(s)|0|||
164076097|NCT04380701|592643684|FG018|Overall Study|Private reason(s)|0|||
164076098|NCT04380701|592643685|FG019|Overall Study|Private reason(s)|0|||
164076099|NCT04380701|592643686|FG020|Overall Study|Private reason(s)|0|||
164076100|NCT04380701|592643687|FG021|Overall Study|Private reason(s)|0|||
164076101|NCT04380701|592643688|FG022|Overall Study|Private reason(s)|0|||
164076102|NCT04380701|592643689|FG023|Overall Study|Private reason(s)|1|||
164076103|NCT04380701|592643690|FG024|Overall Study|Private reason(s)|0|||
164076104|NCT04380701|592643691|FG025|Overall Study|Private reason(s)|0|||
164076105|NCT04380701|592643692|FG026|Overall Study|Private reason(s)|0|||
164076106|NCT04380701|592643693|FG027|Overall Study|Private reason(s)|0|||
164076107|NCT04380701|592643694|FG028|Overall Study|Private reason(s)|0|||
164076108|NCT04380701|592643695|FG029|Overall Study|Private reason(s)|1|||
164076109|NCT04380701|592643696|FG030|Overall Study|Private reason(s)|0|||
164076110|NCT04380701|592643697|FG031|Overall Study|Private reason(s)|0|||
164076111|NCT04380701|592643698|FG032|Overall Study|Private reason(s)|0|||
164076112|NCT04380701|592643699|FG033|Overall Study|Private reason(s)|0|||
164076113|NCT04380701|592643666|FG000|Overall Study|Withdrawal by Subject|0|||
164076114|NCT04380701|592643667|FG001|Overall Study|Withdrawal by Subject|0|||
164076115|NCT04380701|592643668|FG002|Overall Study|Withdrawal by Subject|0|||
164076116|NCT04380701|592643669|FG003|Overall Study|Withdrawal by Subject|0|||
164076117|NCT04380701|592643670|FG004|Overall Study|Withdrawal by Subject|0|||
164076118|NCT04380701|592643671|FG005|Overall Study|Withdrawal by Subject|0|||
164076119|NCT04380701|592643672|FG006|Overall Study|Withdrawal by Subject|1|||
164076120|NCT04380701|592643673|FG007|Overall Study|Withdrawal by Subject|1|||
164076121|NCT04380701|592643674|FG008|Overall Study|Withdrawal by Subject|0|||
164076122|NCT04380701|592643675|FG009|Overall Study|Withdrawal by Subject|0|||
164076123|NCT04380701|592643676|FG010|Overall Study|Withdrawal by Subject|0|||
164076124|NCT04380701|592643677|FG011|Overall Study|Withdrawal by Subject|1|||
164076125|NCT04380701|592643678|FG012|Overall Study|Withdrawal by Subject|0|||
164076126|NCT04380701|592643679|FG013|Overall Study|Withdrawal by Subject|1|||
164076127|NCT04380701|592643680|FG014|Overall Study|Withdrawal by Subject|0|||
164076128|NCT04380701|592643681|FG015|Overall Study|Withdrawal by Subject|0|||
164076129|NCT04380701|592643682|FG016|Overall Study|Withdrawal by Subject|1|||
164076130|NCT04380701|592643683|FG017|Overall Study|Withdrawal by Subject|0|||
164076131|NCT04380701|592643684|FG018|Overall Study|Withdrawal by Subject|0|||
164076132|NCT04380701|592643685|FG019|Overall Study|Withdrawal by Subject|0|||
164076133|NCT04380701|592643686|FG020|Overall Study|Withdrawal by Subject|0|||
164076134|NCT04380701|592643687|FG021|Overall Study|Withdrawal by Subject|0|||
164076135|NCT04380701|592643688|FG022|Overall Study|Withdrawal by Subject|2|||
164076136|NCT04380701|592643689|FG023|Overall Study|Withdrawal by Subject|2|||
164076137|NCT04380701|592643690|FG024|Overall Study|Withdrawal by Subject|1|||
164076138|NCT04380701|592643691|FG025|Overall Study|Withdrawal by Subject|1|||
164076139|NCT04380701|592643692|FG026|Overall Study|Withdrawal by Subject|0|||
164076140|NCT04380701|592643693|FG027|Overall Study|Withdrawal by Subject|0|||
164076141|NCT04380701|592643694|FG028|Overall Study|Withdrawal by Subject|0|||
164076142|NCT04380701|592643695|FG029|Overall Study|Withdrawal by Subject|0|||
164076143|NCT04380701|592643696|FG030|Overall Study|Withdrawal by Subject|0|||
164076144|NCT04380701|592643697|FG031|Overall Study|Withdrawal by Subject|0|||
164076145|NCT04380701|592643698|FG032|Overall Study|Withdrawal by Subject|0|||
164076146|NCT04380701|592643699|FG033|Overall Study|Withdrawal by Subject|0|||
164076147|NCT04380701|592643666|FG000|Overall Study|Adverse Event|0|||
164076148|NCT04380701|592643667|FG001|Overall Study|Adverse Event|0|||
164076149|NCT04380701|592643668|FG002|Overall Study|Adverse Event|0|||
164076150|NCT04380701|592643669|FG003|Overall Study|Adverse Event|0|||
164076151|NCT04380701|592643670|FG004|Overall Study|Adverse Event|0|||
164076152|NCT04380701|592643671|FG005|Overall Study|Adverse Event|1|||
164076153|NCT04380701|592643672|FG006|Overall Study|Adverse Event|0|||
164076154|NCT04380701|592643673|FG007|Overall Study|Adverse Event|0|||
164076155|NCT04380701|592643674|FG008|Overall Study|Adverse Event|0|||
164076156|NCT04380701|592643675|FG009|Overall Study|Adverse Event|0|||
164076157|NCT04380701|592643676|FG010|Overall Study|Adverse Event|0|||
164076158|NCT04380701|592643677|FG011|Overall Study|Adverse Event|0|||
164076159|NCT04380701|592643678|FG012|Overall Study|Adverse Event|0|||
164076160|NCT04380701|592643679|FG013|Overall Study|Adverse Event|0|||
164076161|NCT04380701|592643680|FG014|Overall Study|Adverse Event|0|||
164076162|NCT04380701|592643681|FG015|Overall Study|Adverse Event|1|||
164076163|NCT04380701|592643682|FG016|Overall Study|Adverse Event|0|||
164076164|NCT04380701|592643683|FG017|Overall Study|Adverse Event|0|||
164076165|NCT04380701|592643684|FG018|Overall Study|Adverse Event|0|||
164076166|NCT04380701|592643685|FG019|Overall Study|Adverse Event|1|||
164076167|NCT04380701|592643686|FG020|Overall Study|Adverse Event|0|||
164076168|NCT04380701|592643687|FG021|Overall Study|Adverse Event|0|||
164076169|NCT04380701|592643688|FG022|Overall Study|Adverse Event|0|||
164076170|NCT04380701|592643689|FG023|Overall Study|Adverse Event|0|||
164076171|NCT04380701|592643690|FG024|Overall Study|Adverse Event|0|||
164076172|NCT04380701|592643691|FG025|Overall Study|Adverse Event|0|||
164076173|NCT04380701|592643692|FG026|Overall Study|Adverse Event|0|||
164076174|NCT04380701|592643693|FG027|Overall Study|Adverse Event|0|||
164076175|NCT04380701|592643694|FG028|Overall Study|Adverse Event|0|||
164076176|NCT04380701|592643695|FG029|Overall Study|Adverse Event|0|||
164076177|NCT04380701|592643696|FG030|Overall Study|Adverse Event|0|||
164076178|NCT04380701|592643697|FG031|Overall Study|Adverse Event|0|||
164076179|NCT04380701|592643698|FG032|Overall Study|Adverse Event|0|||
164076180|NCT04380701|592643699|FG033|Overall Study|Adverse Event|0|||
164076181|NCT04380701|592643666|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
164076182|NCT04380701|592643667|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
164076183|NCT04380701|592643668|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
164076184|NCT04380701|592643669|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
164076185|NCT04380701|592643670|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
164076186|NCT04380701|592643671|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
164076187|NCT04380701|592643672|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
164076188|NCT04380701|592643673|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
164076189|NCT04380701|592643674|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
164076190|NCT04380701|592643675|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
164076191|NCT04380701|592643676|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
164076192|NCT04380701|592643677|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
164076193|NCT04380701|592643678|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
164076194|NCT04380701|592643679|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
164076195|NCT04380701|592643680|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
164076196|NCT04380701|592643681|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
164133332|NCT02912650|592852735|FG000|Overall Study|Adverse Event|0|||
164076197|NCT04380701|592643682|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
164076198|NCT04380701|592643683|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
164076199|NCT04380701|592643684|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
164076200|NCT04380701|592643685|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
164076201|NCT04380701|592643686|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
164076202|NCT04380701|592643687|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
164076203|NCT04380701|592643688|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
164076204|NCT04380701|592643689|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
164076205|NCT04380701|592643690|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
164076206|NCT04380701|592643691|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
164076207|NCT04380701|592643692|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
164076208|NCT04380701|592643693|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
164076209|NCT04380701|592643694|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
164076210|NCT04380701|592643695|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
164076211|NCT04380701|592643696|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
164076212|NCT04380701|592643697|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
164076213|NCT04380701|592643698|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
164076214|NCT04380701|592643699|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
164076215|NCT04380701|592643666|FG000|Overall Study|Physician Decision|0|||
164076216|NCT04380701|592643667|FG001|Overall Study|Physician Decision|0|||
164076217|NCT04380701|592643668|FG002|Overall Study|Physician Decision|0|||
164076218|NCT04380701|592643669|FG003|Overall Study|Physician Decision|0|||
164076219|NCT04380701|592643670|FG004|Overall Study|Physician Decision|0|||
164076220|NCT04380701|592643671|FG005|Overall Study|Physician Decision|0|||
164076221|NCT04380701|592643672|FG006|Overall Study|Physician Decision|0|||
164076222|NCT04380701|592643673|FG007|Overall Study|Physician Decision|0|||
164076223|NCT04380701|592643674|FG008|Overall Study|Physician Decision|0|||
164076224|NCT04380701|592643675|FG009|Overall Study|Physician Decision|0|||
164076225|NCT04380701|592643676|FG010|Overall Study|Physician Decision|0|||
164076226|NCT04380701|592643677|FG011|Overall Study|Physician Decision|0|||
164076227|NCT04380701|592643678|FG012|Overall Study|Physician Decision|0|||
164076228|NCT04380701|592643679|FG013|Overall Study|Physician Decision|0|||
164076229|NCT04380701|592643680|FG014|Overall Study|Physician Decision|0|||
164076230|NCT04380701|592643681|FG015|Overall Study|Physician Decision|0|||
164076231|NCT04380701|592643682|FG016|Overall Study|Physician Decision|0|||
164076232|NCT04380701|592643683|FG017|Overall Study|Physician Decision|0|||
164076233|NCT04380701|592643684|FG018|Overall Study|Physician Decision|0|||
164076234|NCT04380701|592643685|FG019|Overall Study|Physician Decision|0|||
164076235|NCT04380701|592643686|FG020|Overall Study|Physician Decision|0|||
164076236|NCT04380701|592643687|FG021|Overall Study|Physician Decision|0|||
164076237|NCT04380701|592643688|FG022|Overall Study|Physician Decision|0|||
164076238|NCT04380701|592643689|FG023|Overall Study|Physician Decision|0|||
164076239|NCT04380701|592643690|FG024|Overall Study|Physician Decision|2|||
164076240|NCT04380701|592643691|FG025|Overall Study|Physician Decision|0|||
164076241|NCT04380701|592643692|FG026|Overall Study|Physician Decision|0|||
164076242|NCT04380701|592643693|FG027|Overall Study|Physician Decision|0|||
164076243|NCT04380701|592643694|FG028|Overall Study|Physician Decision|0|||
164076244|NCT04380701|592643695|FG029|Overall Study|Physician Decision|0|||
164076245|NCT04380701|592643696|FG030|Overall Study|Physician Decision|0|||
164076246|NCT04380701|592643697|FG031|Overall Study|Physician Decision|0|||
164076247|NCT04380701|592643698|FG032|Overall Study|Physician Decision|0|||
164076248|NCT04380701|592643699|FG033|Overall Study|Physician Decision|0|||
164076249|NCT04380701|592643666|FG000|Overall Study|Death|0|||
164076250|NCT04380701|592643667|FG001|Overall Study|Death|0|||
164076251|NCT04380701|592643668|FG002|Overall Study|Death|0|||
164076252|NCT04380701|592643669|FG003|Overall Study|Death|0|||
164076253|NCT04380701|592643670|FG004|Overall Study|Death|0|||
164076254|NCT04380701|592643671|FG005|Overall Study|Death|0|||
164076255|NCT04380701|592643672|FG006|Overall Study|Death|0|||
164076256|NCT04380701|592643673|FG007|Overall Study|Death|0|||
164076257|NCT04380701|592643674|FG008|Overall Study|Death|0|||
164076258|NCT04380701|592643675|FG009|Overall Study|Death|0|||
164076259|NCT04380701|592643676|FG010|Overall Study|Death|0|||
163850754|NCT00519636|591823902|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
164076260|NCT04380701|592643677|FG011|Overall Study|Death|0|||
164076261|NCT04380701|592643678|FG012|Overall Study|Death|0|||
164076262|NCT04380701|592643679|FG013|Overall Study|Death|0|||
163850755|NCT00519636|591823903|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
164076263|NCT04380701|592643680|FG014|Overall Study|Death|0|||
164076264|NCT04380701|592643681|FG015|Overall Study|Death|0|||
164076265|NCT04380701|592643682|FG016|Overall Study|Death|0|||
164076266|NCT04380701|592643683|FG017|Overall Study|Death|0|||
164076267|NCT04380701|592643684|FG018|Overall Study|Death|0|||
164076268|NCT04380701|592643685|FG019|Overall Study|Death|0|||
164076269|NCT04380701|592643686|FG020|Overall Study|Death|0|||
164076270|NCT04380701|592643687|FG021|Overall Study|Death|0|||
164076271|NCT04380701|592643688|FG022|Overall Study|Death|0|||
164076272|NCT04380701|592643689|FG023|Overall Study|Death|0|||
164076273|NCT04380701|592643690|FG024|Overall Study|Death|1|||
164076274|NCT04380701|592643691|FG025|Overall Study|Death|0|||
164076275|NCT04380701|592643692|FG026|Overall Study|Death|0|||
164076276|NCT04380701|592643693|FG027|Overall Study|Death|0|||
164076277|NCT04380701|592643694|FG028|Overall Study|Death|0|||
164076278|NCT04380701|592643695|FG029|Overall Study|Death|0|||
164076279|NCT04380701|592643696|FG030|Overall Study|Death|0|||
164076280|NCT04380701|592643697|FG031|Overall Study|Death|0|||
164076281|NCT04380701|592643698|FG032|Overall Study|Death|0|||
164076282|NCT04380701|592643699|FG033|Overall Study|Death|0|||
164076283|NCT04380701|592643666|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076284|NCT04380701|592643667|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076285|NCT04380701|592643668|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076286|NCT04380701|592643669|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076287|NCT04380701|592643670|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076288|NCT04380701|592643671|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076289|NCT04380701|592643672|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076290|NCT04380701|592643673|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076291|NCT04380701|592643674|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076292|NCT04380701|592643675|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076293|NCT04380701|592643676|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076294|NCT04380701|592643677|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076295|NCT04380701|592643678|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076296|NCT04380701|592643679|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076297|NCT04380701|592643680|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076298|NCT04380701|592643681|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076299|NCT04380701|592643682|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076300|NCT04380701|592643683|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076301|NCT04380701|592643684|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076302|NCT04380701|592643685|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076303|NCT04380701|592643686|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076304|NCT04380701|592643687|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
164076305|NCT04380701|592643688|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
164076306|NCT04380701|592643689|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
164076307|NCT04380701|592643690|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
164076308|NCT04380701|592643691|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076309|NCT04380701|592643692|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076310|NCT04380701|592643693|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076311|NCT04380701|592643694|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076312|NCT04380701|592643695|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076313|NCT04380701|592643696|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076314|NCT04380701|592643697|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076315|NCT04380701|592643698|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076316|NCT04380701|592643699|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
164076317|NCT00065065|592643700|FG000|Overall Study|Adverse Event|3|||
164076318|NCT00065065|592643701|FG001|Overall Study|Adverse Event|2|||
164076319|NCT00065065|592643700|FG000|Overall Study|Withdrawal by Subject|1|||
164076320|NCT00065065|592643701|FG001|Overall Study|Withdrawal by Subject|5|||
164076321|NCT00065065|592643700|FG000|Overall Study|Lack of Efficacy|4|||
164076322|NCT00065065|592643701|FG001|Overall Study|Lack of Efficacy|11|||
164076323|NCT00065065|592643700|FG000|Overall Study|Other|2|||
164076324|NCT00065065|592643701|FG001|Overall Study|Other|2|||
164076325|NCT01050673|592643702|FG000|Overall Study|Physician Decision|4|||
164076326|NCT01050673|592643703|FG001|Overall Study|Physician Decision|5|||
164076327|NCT04363736|592643704|FG000|Overall Study|Withdrawal by Subject|1|||
164076328|NCT04363736|592643705|FG001|Overall Study|Withdrawal by Subject|0|||
163964258|NCT00528567|592241829|FG001|Overall Study|Withdrew Consent|55|||
163964259|NCT00528567|592241828|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
163964260|NCT00528567|592241829|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
163964261|NCT00528567|592241828|FG000|Overall Study|Failure to Return|1|||
163964262|NCT00528567|592241829|FG001|Overall Study|Failure to Return|4|||
163964263|NCT00528567|592241828|FG000|Overall Study|Other Protocol Violation|5|||
163964264|NCT00528567|592241829|FG001|Overall Study|Other Protocol Violation|21|||
163964265|NCT00528567|592241828|FG000|Overall Study|Administrative/Other|22|||
163964266|NCT00528567|592241829|FG001|Overall Study|Administrative/Other|75|||
163964267|NCT01284062|592241832|FG000|Overall Study|Adverse Event|4|||
163964268|NCT01284062|592241833|FG001|Overall Study|Adverse Event|5|||
163964269|NCT01284062|592241834|FG002|Overall Study|Adverse Event|0|||
163964270|NCT01284062|592241835|FG003|Overall Study|Adverse Event|5|||
163964271|NCT01284062|592241832|FG000|Overall Study|Lack of Efficacy|3|||
163964272|NCT01284062|592241833|FG001|Overall Study|Lack of Efficacy|2|||
163850756|NCT00519636|591823904|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
163850757|NCT00519636|591823905|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
163850758|NCT00519636|591823902|FG000|Treatment Period 2|Subject randomized in error|0|||
163850759|NCT00519636|591823903|FG001|Treatment Period 2|Subject randomized in error|1|||
163850760|NCT00519636|591823904|FG002|Treatment Period 2|Subject randomized in error|0|||
163850761|NCT00519636|591823905|FG003|Treatment Period 2|Subject randomized in error|0|||
163850762|NCT00519636|591823902|FG000|Treatment Period 2|Per doctors request|0|||
163850763|NCT00519636|591823903|FG001|Treatment Period 2|Per doctors request|0|||
163850764|NCT00519636|591823904|FG002|Treatment Period 2|Per doctors request|1|||
163850765|NCT00519636|591823905|FG003|Treatment Period 2|Per doctors request|0|||
163850766|NCT00519636|591823902|FG000|Treatment Period 2|Subject misrandomized|0|||
163850767|NCT00519636|591823903|FG001|Treatment Period 2|Subject misrandomized|0|||
163850768|NCT00519636|591823904|FG002|Treatment Period 2|Subject misrandomized|0|||
163850769|NCT00519636|591823905|FG003|Treatment Period 2|Subject misrandomized|1|||
163850770|NCT00519636|591823902|FG000|Post Study Period|Subject randomized in error|0|||
163850771|NCT00519636|591823903|FG001|Post Study Period|Subject randomized in error|0|||
163850772|NCT00519636|591823904|FG002|Post Study Period|Subject randomized in error|0|||
163850773|NCT00519636|591823905|FG003|Post Study Period|Subject randomized in error|1|||
163850774|NCT04504916|591823906|FG000|Overall Study|Study terminated|7|||
163850775|NCT04504916|591823907|FG001|Overall Study|Study terminated|8|||
163850776|NCT04504916|591823906|FG000|Overall Study|Death|54|||
163850777|NCT04504916|591823907|FG001|Overall Study|Death|18|||
163850778|NCT04504916|591823906|FG000|Overall Study|Lost to Follow-up|1|||
163850779|NCT04504916|591823907|FG001|Overall Study|Lost to Follow-up|1|||
163850780|NCT04504916|591823906|FG000|Overall Study|Withdrawal by Subject|8|||
163850781|NCT04504916|591823907|FG001|Overall Study|Withdrawal by Subject|4|||
163850782|NCT04504916|591823906|FG000|Overall Study|Did not agree to follow-up|0|||
163850783|NCT04504916|591823907|FG001|Overall Study|Did not agree to follow-up|1|||
163850784|NCT03057834|591823908|FG000|Overall Study|Withdrawal by Subject|25|||
163850785|NCT03057834|591823909|FG001|Overall Study|Withdrawal by Subject|29|||
163850786|NCT00003509|591823911|FG000|Overall Study|Not evaluable|5|||
163850787|NCT03803774|591823912|FG000|Dose Escalation|Withdrawal by Subject|0|||
163964273|NCT01284062|592241834|FG002|Overall Study|Lack of Efficacy|2|||
163964274|NCT01284062|592241835|FG003|Overall Study|Lack of Efficacy|1|||
163964275|NCT01284062|592241832|FG000|Overall Study|Medication error without adverse event|0|||
163964276|NCT01284062|592241833|FG001|Overall Study|Medication error without adverse event|0|||
163964277|NCT01284062|592241834|FG002|Overall Study|Medication error without adverse event|1|||
163964278|NCT01284062|592241835|FG003|Overall Study|Medication error without adverse event|0|||
163964279|NCT01284062|592241832|FG000|Overall Study|Protocol Violation|1|||
163964280|NCT01284062|592241833|FG001|Overall Study|Protocol Violation|0|||
163964281|NCT01284062|592241834|FG002|Overall Study|Protocol Violation|0|||
163964282|NCT01284062|592241835|FG003|Overall Study|Protocol Violation|2|||
163964283|NCT01284062|592241832|FG000|Overall Study|Withdrawal by Subject|3|||
163964284|NCT01284062|592241833|FG001|Overall Study|Withdrawal by Subject|1|||
163964285|NCT01284062|592241834|FG002|Overall Study|Withdrawal by Subject|2|||
163964286|NCT01284062|592241835|FG003|Overall Study|Withdrawal by Subject|5|||
163964287|NCT01284062|592241832|FG000|Overall Study|Other|0|||
163964288|NCT01284062|592241833|FG001|Overall Study|Other|0|||
163964289|NCT01284062|592241834|FG002|Overall Study|Other|0|||
163964290|NCT01284062|592241835|FG003|Overall Study|Other|1|||
163964291|NCT01284062|592241832|FG000|Overall Study|Site Closed|0|||
163964292|NCT01284062|592241833|FG001|Overall Study|Site Closed|0|||
163964293|NCT01284062|592241834|FG002|Overall Study|Site Closed|1|||
163964294|NCT01284062|592241835|FG003|Overall Study|Site Closed|0|||
163964295|NCT03189862|592241836|FG000|Overall Study|Withdrawal by Subject|1|||
163964296|NCT03189862|592241837|FG001|Overall Study|Withdrawal by Subject|0|||
163964297|NCT03189862|592241836|FG000|Overall Study|Lost to Follow-up|54|||
163964298|NCT03189862|592241837|FG001|Overall Study|Lost to Follow-up|62|||
163964299|NCT00931944|592241841|FG000|Overall Study|Adverse Event|4|||
163964300|NCT00931944|592241841|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
163964301|NCT00931944|592241841|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
163964302|NCT00931944|592241841|FG000|Overall Study|Death|28|||
163964303|NCT00931944|592241841|FG000|Overall Study|Other|2|||
163964304|NCT00634010|592241850|FG000|Overall Study|Adverse Event|2|||
163964305|NCT00634010|592241851|FG001|Overall Study|Adverse Event|5|||
163964306|NCT00634010|592241850|FG000|Overall Study|Withdrawal by Subject|5|||
163964307|NCT00634010|592241851|FG001|Overall Study|Withdrawal by Subject|6|||
163964308|NCT00634010|592241850|FG000|Overall Study|Physician Decision|1|||
163964309|NCT00634010|592241851|FG001|Overall Study|Physician Decision|1|||
163964310|NCT00634010|592241850|FG000|Overall Study|Disease Progression|1|||
163964311|NCT00634010|592241851|FG001|Overall Study|Disease Progression|1|||
163850788|NCT03803774|591823913|FG001|Dose Escalation|Withdrawal by Subject|0|||
163850789|NCT03803774|591823914|FG002|Dose Escalation|Withdrawal by Subject|0|||
163850790|NCT03803774|591823915|FG003|Dose Escalation|Withdrawal by Subject|1|||
163964312|NCT00634010|592241850|FG000|Overall Study|Non-Compliant|1|||
163964313|NCT00634010|592241851|FG001|Overall Study|Non-Compliant|1|||
163964314|NCT02545322|592241852|FG000|Overall Study|Withdrawal by Subject|3|||
164076329|NCT04363736|592643704|FG000|Overall Study|Lost to Follow-up|10|||
164076330|NCT04363736|592643705|FG001|Overall Study|Lost to Follow-up|7|||
164076331|NCT04363736|592643704|FG000|Overall Study|Death|8|||
164076332|NCT04363736|592643705|FG001|Overall Study|Death|6|||
164076333|NCT03797222|592643706|FG000|Overall Study|Withdrawal by Subject|1|||
164076334|NCT02556632|592643711|FG000|Overall Study|Lost to Follow-up|1|||
164076335|NCT02556632|592643712|FG001|Overall Study|Lost to Follow-up|0|||
164076336|NCT02556632|592643713|FG002|Overall Study|Lost to Follow-up|0|||
164076337|NCT02556632|592643711|FG000|Overall Study|Disliked Intervention|1|||
164076338|NCT02556632|592643712|FG001|Overall Study|Disliked Intervention|1|||
164076339|NCT02556632|592643713|FG002|Overall Study|Disliked Intervention|1|||
164076340|NCT02556632|592643711|FG000|Overall Study|No Reason|1|||
164076341|NCT02556632|592643712|FG001|Overall Study|No Reason|0|||
164076342|NCT02556632|592643713|FG002|Overall Study|No Reason|1|||
164076343|NCT02556632|592643711|FG000|Overall Study|Personal Issues|0|||
164076344|NCT02556632|592643712|FG001|Overall Study|Personal Issues|1|||
164076345|NCT02556632|592643713|FG002|Overall Study|Personal Issues|1|||
164076346|NCT02556632|592643711|FG000|Overall Study|Changed Mind|0|||
164076347|NCT02556632|592643712|FG001|Overall Study|Changed Mind|1|||
164076348|NCT02556632|592643713|FG002|Overall Study|Changed Mind|0|||
164076349|NCT02556632|592643711|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
164076350|NCT02556632|592643712|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
164076351|NCT02556632|592643713|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
164190202|NCT02964338|593066241|FG001|Overall Study|Adverse Event|1|||
164190203|NCT02964338|593066242|FG002|Overall Study|Adverse Event|1|||
164190204|NCT02964338|593066240|FG000|Overall Study|Non-compliant with e-diary|0|||
164190205|NCT02964338|593066241|FG001|Overall Study|Non-compliant with e-diary|1|||
164190206|NCT02964338|593066242|FG002|Overall Study|Non-compliant with e-diary|0|||
164190207|NCT02964338|593066240|FG000|Overall Study|Did not meet criteria|1|||
164190208|NCT02964338|593066241|FG001|Overall Study|Did not meet criteria|0|||
164190209|NCT02964338|593066242|FG002|Overall Study|Did not meet criteria|0|||
164190210|NCT02239640|593066243|FG000|Overall Study|Withdrawal by Subject|3|||
164190211|NCT02239640|593066243|FG000|Overall Study|Lost to Follow-up|72|||
164190212|NCT02239640|593066243|FG000|Overall Study|Death|142|||
164190213|NCT02291029|593066245|FG000|Overall Study|Withdrawal by Subject|0|||
164190214|NCT02291029|593066246|FG001|Overall Study|Withdrawal by Subject|0|||
164190215|NCT02291029|593066247|FG002|Overall Study|Withdrawal by Subject|1|||
164190216|NCT02291029|593066248|FG003|Overall Study|Withdrawal by Subject|0|||
164190217|NCT02291029|593066249|FG004|Overall Study|Withdrawal by Subject|0|||
164190218|NCT02291029|593066250|FG005|Overall Study|Withdrawal by Subject|0|||
164190219|NCT02291029|593066245|FG000|Overall Study|Adverse Event|0|||
164190220|NCT02291029|593066246|FG001|Overall Study|Adverse Event|1|||
164190221|NCT02291029|593066247|FG002|Overall Study|Adverse Event|0|||
164190222|NCT02291029|593066248|FG003|Overall Study|Adverse Event|0|||
164190223|NCT02291029|593066249|FG004|Overall Study|Adverse Event|0|||
164190224|NCT02291029|593066250|FG005|Overall Study|Adverse Event|0|||
164190225|NCT03872843|593066251|FG000|Overall Study|Lost to Follow-up|5|||
164190226|NCT03872843|593066252|FG001|Overall Study|Lost to Follow-up|7|||
164190227|NCT00823264|593066253|FG000|Overall Study|Protocol Violation|2|||
164190228|NCT00823264|593066254|FG001|Overall Study|Protocol Violation|0|||
164190229|NCT00856999|593066255|FG000|Overall Study|Withdrawal by Subject|5|||
164190230|NCT02465437|593066256|FG000|Overall Study|Physician Decision|0|||
164190231|NCT02465437|593066257|FG001|Overall Study|Physician Decision|0|||
164190232|NCT02465437|593066258|FG002|Overall Study|Physician Decision|1|||
164190233|NCT02465437|593066259|FG003|Overall Study|Physician Decision|0|||
164190234|NCT02465437|593066256|FG000|Overall Study|Withdrawal by Subject|1|||
164190235|NCT02465437|593066257|FG001|Overall Study|Withdrawal by Subject|0|||
164190236|NCT02465437|593066258|FG002|Overall Study|Withdrawal by Subject|0|||
164190237|NCT02465437|593066259|FG003|Overall Study|Withdrawal by Subject|1|||
164190238|NCT02465437|593066256|FG000|Overall Study|Adverse Event|0|||
163850791|NCT03803774|591823916|FG004|Dose Escalation|Withdrawal by Subject|0|||
163850792|NCT03077620|591823921|FG000|Overall Study|Unable to place lumbar catheter|1|||
163850793|NCT03077620|591823922|FG001|Overall Study|Unable to place lumbar catheter|0|||
163850794|NCT03077620|591823923|FG002|Overall Study|Unable to place lumbar catheter|1|||
164190239|NCT02465437|593066257|FG001|Overall Study|Adverse Event|1|||
164190240|NCT02465437|593066258|FG002|Overall Study|Adverse Event|0|||
163850795|NCT03077620|591823924|FG003|Overall Study|Unable to place lumbar catheter|0|||
164190241|NCT02465437|593066259|FG003|Overall Study|Adverse Event|0|||
164190242|NCT00003483|593066260|FG000|Overall Study|Not evaluable|1|||
163850796|NCT03077620|591823921|FG000|Overall Study|Withdrawal by Subject|0|||
164190243|NCT01308463|593066261|FG000|Overall Study|Study Discontinued|23|||
164190244|NCT01308463|593066261|FG000|Overall Study|Death|4|||
164190245|NCT01308463|593066261|FG000|Overall Study|Revision|2|||
164190246|NCT00103662|593066264|FG000|Overall Study|Entered Rescue Procedure|0|||
163850797|NCT03077620|591823922|FG001|Overall Study|Withdrawal by Subject|1|||
164190247|NCT00103662|593066265|FG001|Overall Study|Entered Rescue Procedure|7|||
164190248|NCT00103662|593066264|FG000|Overall Study|Death|7|||
164190249|NCT00103662|593066265|FG001|Overall Study|Death|7|||
164190250|NCT00103662|593066264|FG000|Overall Study|Elective Withdrawal|5|||
163964315|NCT00882310|592241853|FG000|Overall Study|Screen Failure|10|||
163964316|NCT00882310|592241853|FG000|Overall Study|Never received treatment|1|||
163964317|NCT00882310|592241853|FG000|Overall Study|Death|6|||
163964318|NCT00882310|592241853|FG000|Overall Study|Progression of disease|4|||
163964319|NCT00882310|592241853|FG000|Overall Study|Adverse Event|1|||
163964320|NCT01395316|592241854|FG000|Overall Study|Lost to Follow-up|2|||
163964321|NCT01395316|592241854|FG000|Overall Study|poor MRI quality|1|||
163964322|NCT04786119|592241856|FG000|Overall Study|Withdrawal by Subject|4|||
163964323|NCT04786119|592241857|FG001|Overall Study|Withdrawal by Subject|5|||
163964324|NCT04786119|592241856|FG000|Overall Study|Lost to Follow-up|5|||
163964325|NCT04786119|592241857|FG001|Overall Study|Lost to Follow-up|5|||
163964326|NCT04786119|592241856|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
163964327|NCT04786119|592241857|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
163964328|NCT03610165|592241858|FG000|Overall Study|Device didn't work|0|||
163964329|NCT03610165|592241859|FG001|Overall Study|Device didn't work|1|||
163964330|NCT04752475|592243149|FG000|Overall Study|Withdrawal by Subject|1|||
163964331|NCT04752475|592243150|FG001|Overall Study|Withdrawal by Subject|1|||
163964332|NCT01310803|592243156|FG000|Overall Study|Subject terminated by Sponsor|1|||
163964333|NCT01310803|592243157|FG001|Overall Study|Subject terminated by Sponsor|0|||
163964334|NCT02113579|592243160|FG000|Overall Study|Adverse Event|1|||
163964335|NCT02113579|592243161|FG001|Overall Study|Adverse Event|0|||
163964336|NCT02113579|592243160|FG000|Overall Study|Withdrawal by Subject|3|||
163964337|NCT02113579|592243161|FG001|Overall Study|Withdrawal by Subject|2|||
163964338|NCT02113579|592243160|FG000|Overall Study|Lost to Follow-up|6|||
163964339|NCT02113579|592243161|FG001|Overall Study|Lost to Follow-up|2|||
163964340|NCT00594516|592243165|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
163964341|NCT00594516|592243166|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
163964342|NCT00594516|592243167|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
163964343|NCT00594516|592243165|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
163964344|NCT00594516|592243166|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
163964345|NCT00594516|592243167|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
163964346|NCT00594516|592243165|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
163964347|NCT00594516|592243166|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
163964348|NCT00594516|592243167|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
163964349|NCT00594516|592243165|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
163964350|NCT00594516|592243166|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
163964351|NCT00594516|592243167|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
163964352|NCT00594516|592243165|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
163964353|NCT00594516|592243166|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
163964354|NCT00594516|592243167|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
163964355|NCT00594516|592243165|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
163964356|NCT00594516|592243166|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
163964357|NCT00594516|592243167|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
163964358|NCT00594516|592243165|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
163964359|NCT00594516|592243166|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
163964360|NCT00594516|592243167|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
163964361|NCT00594516|592243165|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
163964362|NCT00594516|592243166|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
163964363|NCT00594516|592243167|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
163964364|NCT00594516|592243165|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
163964365|NCT00594516|592243166|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
163964366|NCT00594516|592243167|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
163964367|NCT03873493|592243168|FG000|Overall Study|Withdrawal by Subject|1|||
163964368|NCT03873493|592243168|FG000|Overall Study|Death|9|||
163964369|NCT03873493|592243168|FG000|Overall Study|Lost to Follow-up|1|||
163964370|NCT03873493|592243168|FG000|Overall Study|Study Terminated by Sponsor|1|||
163964371|NCT03873493|592243168|FG000|Overall Study|Other|2|||
163964372|NCT01448213|592243171|FG000|Overall Study|Lost to Follow-up|12|||
163964373|NCT01448213|592243172|FG001|Overall Study|Lost to Follow-up|10|||
163964374|NCT01448213|592243171|FG000|Overall Study|Adverse Event|4|||
163964375|NCT01448213|592243172|FG001|Overall Study|Adverse Event|10|||
163964376|NCT01448213|592243171|FG000|Overall Study|Protocol Violation|1|||
163964377|NCT01448213|592243172|FG001|Overall Study|Protocol Violation|2|||
163964378|NCT03503513|592243177|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
163964379|NCT03503513|592243177|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
163964380|NCT03503513|592243177|FG000|Overall Study|Physician Decision|3|||
163964381|NCT03503513|592243177|FG000|Overall Study|Withdrawal by Subject|2|||
163964382|NCT03503513|592243177|FG000|Overall Study|Lost to Follow-up|1|||
163964383|NCT03308942|592243178|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
163964384|NCT03308942|592243179|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
163964385|NCT03308942|592243180|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
164190251|NCT00103662|593066265|FG001|Overall Study|Elective Withdrawal|5|||
164190252|NCT00103662|593066264|FG000|Overall Study|Lost to Follow-up|0|||
164190253|NCT00103662|593066265|FG001|Overall Study|Lost to Follow-up|1|||
164190254|NCT00103662|593066264|FG000|Overall Study|Other|6|||
163850798|NCT03077620|591823923|FG002|Overall Study|Withdrawal by Subject|0|||
163850799|NCT03077620|591823924|FG003|Overall Study|Withdrawal by Subject|0|||
163850800|NCT03077620|591823921|FG000|Overall Study|Physician Decision|0|||
163850801|NCT03077620|591823922|FG001|Overall Study|Physician Decision|0|||
163850802|NCT03077620|591823923|FG002|Overall Study|Physician Decision|1|||
163850803|NCT03077620|591823924|FG003|Overall Study|Physician Decision|0|||
163850804|NCT00245011|591823926|FG000|Overall Study|Lack of Efficacy|1|||
163850805|NCT00550173|591823927|FG000|Overall Study|Death|45|||
163850806|NCT00550173|591823928|FG001|Overall Study|Death|38|||
163850807|NCT00550173|591823929|FG002|Overall Study|Death|50|||
163850808|NCT00550173|591823927|FG000|Overall Study|Physician Decision|1|||
163850809|NCT00550173|591823928|FG001|Overall Study|Physician Decision|2|||
164190255|NCT00103662|593066265|FG001|Overall Study|Other|9|||
164190256|NCT00103662|593066264|FG000|Overall Study|Failed mobilization|0|||
164190257|NCT00103662|593066265|FG001|Overall Study|Failed mobilization|4|||
164190258|NCT00103662|593066264|FG000|Overall Study|Intercurrent illness|1|||
164190259|NCT00103662|593066265|FG001|Overall Study|Intercurrent illness|0|||
164190260|NCT03280056|593066266|FG000|Overall Study|Withdrawal by Subject|12|||
164190261|NCT03280056|593066267|FG001|Overall Study|Withdrawal by Subject|14|||
164190262|NCT03280056|593066266|FG000|Overall Study|Death|9|||
164190263|NCT03280056|593066267|FG001|Overall Study|Death|2|||
164190264|NCT03280056|593066266|FG000|Overall Study|Adverse Event|1|||
164190265|NCT03280056|593066267|FG001|Overall Study|Adverse Event|3|||
164190266|NCT03280056|593066266|FG000|Overall Study|Lost to Follow-up|1|||
164190267|NCT03280056|593066267|FG001|Overall Study|Lost to Follow-up|1|||
164190268|NCT03280056|593066266|FG000|Overall Study|Physician Decision|0|||
164190269|NCT03280056|593066267|FG001|Overall Study|Physician Decision|1|||
164190270|NCT03280056|593066266|FG000|Overall Study|Early Discontinuation|1|||
164190271|NCT03280056|593066267|FG001|Overall Study|Early Discontinuation|0|||
164190272|NCT01135524|593066268|FG000|Overall Study|Withdrawal by Subject|14|||
164190273|NCT01135524|593066268|FG000|Overall Study|Adverse Event|20|||
164190274|NCT01135524|593066268|FG000|Overall Study|Lost to Follow-up|3|||
164190275|NCT01135524|593066268|FG000|Overall Study|Administrative|151|||
164190276|NCT01135524|593066268|FG000|Overall Study|Lack of Efficacy|8|||
164190277|NCT02907463|593066270|FG000|Overall Study|Lost to Follow-up|17|||
164190278|NCT02907463|593066270|FG000|Overall Study|Death|10|||
164190279|NCT02907463|593066270|FG000|Overall Study|Withdrawal by Subject|4|||
164190280|NCT02907463|593066270|FG000|Overall Study|MIS Approach was not used|2|||
164190281|NCT02907463|593066270|FG000|Overall Study|Not Implanted with Study Device|2|||
164190282|NCT02907463|593066270|FG000|Overall Study|Device Explanted|1|||
164190283|NCT02907463|593066270|FG000|Overall Study|Missing Exit Form|1|||
164190284|NCT01266824|593066271|FG000|Overall Study|Study terminated prior to completion|2|||
164190285|NCT01266824|593066272|FG001|Overall Study|Study terminated prior to completion|3|||
164190286|NCT02302846|593066273|FG000|Overall Study|Withdrawal by Subject|1|||
164190287|NCT00397189|593066274|FG000|3 Weeks Period|Lost to Follow-up|5|||
164190288|NCT00397189|593066275|FG001|3 Weeks Period|Lost to Follow-up|4|||
164190289|NCT00397189|593066274|FG000|3 Weeks Period|Adverse Event|3|||
164190290|NCT00397189|593066275|FG001|3 Weeks Period|Adverse Event|2|||
164190291|NCT00397189|593066274|FG000|3 Weeks Period|Withdrawal by Subject|13|||
164190292|NCT00397189|593066275|FG001|3 Weeks Period|Withdrawal by Subject|9|||
164190293|NCT00397189|593066274|FG000|3 Weeks Period|Physician Decision|0|||
163850810|NCT00550173|591823929|FG002|Overall Study|Physician Decision|2|||
163850811|NCT00550173|591823927|FG000|Overall Study|Withdrawal by Subject|9|||
163850812|NCT00550173|591823928|FG001|Overall Study|Withdrawal by Subject|12|||
163850813|NCT00550173|591823929|FG002|Overall Study|Withdrawal by Subject|17|||
163850814|NCT00550173|591823927|FG000|Overall Study|Sponsor Decision|13|||
163850815|NCT00550173|591823928|FG001|Overall Study|Sponsor Decision|7|||
164190294|NCT00397189|593066275|FG001|3 Weeks Period|Physician Decision|2|||
164190295|NCT00397189|593066274|FG000|3 Weeks Period|Protocol Violation|0|||
164190296|NCT00397189|593066275|FG001|3 Weeks Period|Protocol Violation|3|||
164190297|NCT00397189|593066274|FG000|3 Weeks Period|Other|0|||
164190298|NCT00397189|593066275|FG001|3 Weeks Period|Other|2|||
164190299|NCT01447407|593066278|FG000|Overall Study|Withdrawal by Subject|2|||
164190300|NCT01447407|593066279|FG001|Overall Study|Withdrawal by Subject|0|||
164190301|NCT01447407|593066280|FG002|Overall Study|Withdrawal by Subject|0|||
164190302|NCT01447407|593066281|FG003|Overall Study|Withdrawal by Subject|1|||
164190303|NCT01447407|593066278|FG000|Overall Study|Physician Decision|0|||
164190304|NCT01447407|593066279|FG001|Overall Study|Physician Decision|0|||
164190305|NCT01447407|593066280|FG002|Overall Study|Physician Decision|1|||
163850816|NCT00550173|591823929|FG002|Overall Study|Sponsor Decision|1|||
163850817|NCT00550173|591823927|FG000|Overall Study|Lost to Follow-up|4|||
163850818|NCT00550173|591823928|FG001|Overall Study|Lost to Follow-up|4|||
164190306|NCT01447407|593066281|FG003|Overall Study|Physician Decision|1|||
164190307|NCT00872521|593066284|FG000|Completed PAD Induction|Patient choice|0|||
164190308|NCT00872521|593066285|FG001|Completed PAD Induction|Patient choice|1|||
164302037|NCT03847896|593482506|FG002|Overall Study|Other reasons|1|||
163964386|NCT03308942|592243181|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
163964387|NCT03308942|592243182|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
163964388|NCT03308942|592243178|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
163964389|NCT03308942|592243179|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
163964390|NCT03308942|592243180|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
163964391|NCT03308942|592243181|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
163964392|NCT03308942|592243182|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
163964393|NCT03308942|592243178|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163964394|NCT03308942|592243179|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
163964395|NCT03308942|592243180|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163964396|NCT03308942|592243181|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163964397|NCT03308942|592243182|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
163964398|NCT03308942|592243178|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
163964399|NCT03308942|592243179|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
163964400|NCT03308942|592243180|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
163964401|NCT03308942|592243181|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
163964402|NCT03308942|592243182|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
163964403|NCT03308942|592243178|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163964404|NCT03308942|592243179|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163964405|NCT03308942|592243180|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163964406|NCT03308942|592243181|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
163964407|NCT03308942|592243182|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
163964408|NCT03308942|592243178|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163964409|NCT03308942|592243179|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163964410|NCT03308942|592243180|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163964411|NCT03308942|592243181|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
163964412|NCT03308942|592243182|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
163964413|NCT03308942|592243178|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163964414|NCT03308942|592243179|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163964415|NCT03308942|592243180|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163964416|NCT03308942|592243181|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
163964417|NCT03308942|592243182|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
163964418|NCT01524133|592243187|FG000|Treatment Phase|Withdrawal by Subject|13|||
163964419|NCT01524133|592243188|FG001|Treatment Phase|Withdrawal by Subject|28|||
163964420|NCT01524133|592243189|FG002|Treatment Phase|Withdrawal by Subject|31|||
163964421|NCT01524133|592243187|FG000|Treatment Phase|Physician Decision|6|||
163964422|NCT01524133|592243188|FG001|Treatment Phase|Physician Decision|3|||
163964423|NCT01524133|592243189|FG002|Treatment Phase|Physician Decision|3|||
163964424|NCT01524133|592243187|FG000|Treatment Phase|Lost to Follow-up|0|||
163964425|NCT01524133|592243188|FG001|Treatment Phase|Lost to Follow-up|1|||
163964426|NCT01524133|592243189|FG002|Treatment Phase|Lost to Follow-up|2|||
163964427|NCT01524133|592243187|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
163964428|NCT01524133|592243188|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
163964429|NCT01524133|592243189|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
163964430|NCT01524133|592243187|FG000|Overall Study 52 Weeks|Physician Decision|1|||
163964431|NCT01524133|592243188|FG001|Overall Study 52 Weeks|Physician Decision|0|||
163964432|NCT01524133|592243189|FG002|Overall Study 52 Weeks|Physician Decision|2|||
163964433|NCT01524133|592243187|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
163964434|NCT01524133|592243188|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
163964435|NCT01524133|592243189|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
163964436|NCT01087957|592243190|FG000|Overall Study|Death|2|||
163964437|NCT01087957|592243191|FG001|Overall Study|Death|2|||
163964438|NCT01087957|592243190|FG000|Overall Study|Lost to Follow-up|3|||
163964439|NCT01087957|592243191|FG001|Overall Study|Lost to Follow-up|4|||
163964440|NCT01087957|592243190|FG000|Overall Study|Protocol Violation|13|||
163964441|NCT01087957|592243191|FG001|Overall Study|Protocol Violation|25|||
163964442|NCT01087957|592243190|FG000|Overall Study|Withdrawal by Subject|18|||
163964443|NCT01087957|592243191|FG001|Overall Study|Withdrawal by Subject|15|||
163964444|NCT01087957|592243190|FG000|Overall Study|Physician Decision|5|||
163964445|NCT01087957|592243191|FG001|Overall Study|Physician Decision|9|||
163964446|NCT01122576|592243193|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
163964447|NCT01122576|592243194|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
163964448|NCT01122576|592243195|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
163964449|NCT01122576|592243193|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
163964450|NCT01122576|592243194|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
163964451|NCT01122576|592243195|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
163964452|NCT01122576|592243193|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
163964453|NCT01122576|592243194|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
163964454|NCT01122576|592243195|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
163964455|NCT05696236|592243196|FG000|Overall Study|Lost to Follow-up|1|||
163964456|NCT05696236|592243197|FG001|Overall Study|Lost to Follow-up|0|||
163850819|NCT00550173|591823929|FG002|Overall Study|Lost to Follow-up|3|||
163850820|NCT01345292|591825415|FG000|Overall Study|Withdrawal by Subject|2|||
163850821|NCT01345292|591825416|FG001|Overall Study|Withdrawal by Subject|0|||
163850822|NCT01345292|591825417|FG002|Overall Study|Withdrawal by Subject|1|||
163850823|NCT05406791|591825423|FG000|Overall Study|Lost to Follow-up|13|||
163850824|NCT05406791|591825424|FG001|Overall Study|Lost to Follow-up|10|||
163850825|NCT02403674|591825425|FG000|Base Study|Death|1|||
163850826|NCT02403674|591825426|FG001|Base Study|Death|4|||
163850827|NCT02403674|591825425|FG000|Base Study|Adverse Event|11|||
163850828|NCT02403674|591825426|FG001|Base Study|Adverse Event|26|||
163850829|NCT02403674|591825425|FG000|Base Study|Lack of Efficacy|31|||
163850830|NCT02403674|591825426|FG001|Base Study|Lack of Efficacy|23|||
163850831|NCT02403674|591825425|FG000|Base Study|Lost to Follow-up|6|||
163850832|NCT02403674|591825426|FG001|Base Study|Lost to Follow-up|8|||
163850833|NCT02403674|591825425|FG000|Base Study|Withdrawal by Subject|10|||
163850834|NCT02403674|591825426|FG001|Base Study|Withdrawal by Subject|17|||
163850835|NCT02403674|591825425|FG000|Base Study|Physician Decision|2|||
163850836|NCT02403674|591825426|FG001|Base Study|Physician Decision|2|||
163850837|NCT02403674|591825425|FG000|Base Study|Pregnancy|2|||
163850838|NCT02403674|591825426|FG001|Base Study|Pregnancy|2|||
163850839|NCT02403674|591825425|FG000|Base Study|Protocol Violation|8|||
163850840|NCT02403674|591825426|FG001|Base Study|Protocol Violation|4|||
163850841|NCT02403674|591825425|FG000|Base Study|Non-Compliance with study drug|1|||
163850842|NCT02403674|591825426|FG001|Base Study|Non-Compliance with study drug|4|||
163850843|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
163850844|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
163850845|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
163850846|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
163850847|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
163850848|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
163850849|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
163850850|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
163850851|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
163850852|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
163964457|NCT05696236|592243196|FG000|Overall Study|Later determined to not be eligible for participation|0|||
163964458|NCT05696236|592243197|FG001|Overall Study|Later determined to not be eligible for participation|1|||
163964459|NCT05696236|592243196|FG000|Overall Study|Withdrawal by Subject|2|||
163964460|NCT05696236|592243197|FG001|Overall Study|Withdrawal by Subject|2|||
163964461|NCT01829360|592243198|FG000|Overall Study|Protocol Violation|0|||
163964462|NCT01829360|592243199|FG001|Overall Study|Protocol Violation|0|||
163964463|NCT01829360|592243200|FG002|Overall Study|Protocol Violation|1|||
163964464|NCT01829360|592243201|FG003|Overall Study|Protocol Violation|0|||
163964465|NCT01026142|592243202|FG000|Overall Study|Death|136|||
163964466|NCT01026142|592243203|FG001|Overall Study|Death|134|||
163964467|NCT01026142|592243202|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
163964468|NCT01026142|592243203|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
163964469|NCT00041067|592243204|FG000|Overall Study|Adverse Event|20|||
163964470|NCT00041067|592243204|FG000|Overall Study|Progression|19|||
163964471|NCT00041067|592243204|FG000|Overall Study|Patient refusal|12|||
163964472|NCT00041067|592243204|FG000|Overall Study|Other reasons|23|||
163964473|NCT00041067|592243204|FG000|Overall Study|Ineligible|2|||
163964474|NCT00778622|592243205|FG000|Overall Study|Adverse Event|5|||
163964475|NCT00778622|592243206|FG001|Overall Study|Adverse Event|4|||
163964476|NCT00778622|592243207|FG002|Overall Study|Adverse Event|7|||
163964477|NCT00778622|592243205|FG000|Overall Study|Withdrawal by Subject|4|||
163964478|NCT00778622|592243206|FG001|Overall Study|Withdrawal by Subject|5|||
163964479|NCT00778622|592243207|FG002|Overall Study|Withdrawal by Subject|5|||
163964480|NCT00778622|592243205|FG000|Overall Study|Lost to Follow-up|3|||
163964481|NCT00778622|592243206|FG001|Overall Study|Lost to Follow-up|3|||
163964482|NCT00778622|592243207|FG002|Overall Study|Lost to Follow-up|2|||
163964483|NCT00778622|592243205|FG000|Overall Study|Protocol Violation|0|||
163964484|NCT00778622|592243206|FG001|Overall Study|Protocol Violation|3|||
163964485|NCT00778622|592243207|FG002|Overall Study|Protocol Violation|0|||
163964486|NCT00778622|592243205|FG000|Overall Study|Lack of Efficacy|2|||
163964487|NCT00778622|592243206|FG001|Overall Study|Lack of Efficacy|0|||
163964488|NCT00778622|592243207|FG002|Overall Study|Lack of Efficacy|0|||
163964489|NCT00778622|592243205|FG000|Overall Study|immigration|1|||
163964490|NCT00778622|592243206|FG001|Overall Study|immigration|0|||
163964491|NCT00778622|592243207|FG002|Overall Study|immigration|0|||
163964492|NCT00778622|592243205|FG000|Overall Study|Other|1|||
163850853|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
163850854|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
163964493|NCT00778622|592243206|FG001|Overall Study|Other|0|||
163964494|NCT00778622|592243207|FG002|Overall Study|Other|1|||
163964495|NCT01251120|592243209|FG000|Overall Study|Lack of Efficacy|0|||
163964496|NCT01251120|592243210|FG001|Overall Study|Lack of Efficacy|1|||
163964497|NCT01968070|592243211|FG000|Period 1|Withdrawal by Subject|0|||
163964498|NCT01968070|592243212|FG001|Period 1|Withdrawal by Subject|1|||
163964499|NCT01968070|592243213|FG002|Period 1|Withdrawal by Subject|0|||
163850855|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Death|1|||
163850856|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Death|0|||
163850857|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
163850858|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
163850859|NCT02403674|591825425|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
163850860|NCT02403674|591825426|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
163850861|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
163850862|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
163850863|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
163850864|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
163850865|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
163850866|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
163850867|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
163850868|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
163850869|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
163850870|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
163850871|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Death|2|||
163850872|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Death|2|||
163850873|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
163850874|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
163850875|NCT02403674|591825425|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
163850876|NCT02403674|591825426|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
163850877|NCT02403674|591825425|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
163850878|NCT02403674|591825426|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
163850879|NCT02403674|591825425|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
163850880|NCT02403674|591825426|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
163850881|NCT02403674|591825425|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
163850882|NCT02403674|591825426|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
163850883|NCT02403674|591825425|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
163964500|NCT01968070|592243214|FG003|Period 1|Withdrawal by Subject|0|||
164190309|NCT00872521|593066286|FG002|Completed PAD Induction|Patient choice|0|||
164190310|NCT00872521|593066284|FG000|Completed PAD Induction|Disease progression|0|||
164190311|NCT00872521|593066285|FG001|Completed PAD Induction|Disease progression|2|||
164190312|NCT00872521|593066286|FG002|Completed PAD Induction|Disease progression|0|||
164190313|NCT00872521|593066284|FG000|Completed PAD Induction|Adverse Event|4|||
164190314|NCT00872521|593066285|FG001|Completed PAD Induction|Adverse Event|0|||
164190315|NCT00872521|593066286|FG002|Completed PAD Induction|Adverse Event|0|||
164190316|NCT00872521|593066284|FG000|Completed PAD Induction|Death|1|||
164190317|NCT00872521|593066285|FG001|Completed PAD Induction|Death|1|||
164190318|NCT00872521|593066286|FG002|Completed PAD Induction|Death|0|||
164190319|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Other|1|||
164190320|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Other|2|||
164190321|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Other|0|||
164190322|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Patient choice|0|||
164190323|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Patient choice|1|||
164190324|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Patient choice|0|||
164190325|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
164190326|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
164190327|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
164190328|NCT00872521|593066284|FG000|Primary Endpoint Analysis|Patient response missing|0|||
164190329|NCT00872521|593066285|FG001|Primary Endpoint Analysis|Patient response missing|0|||
164190330|NCT00872521|593066286|FG002|Primary Endpoint Analysis|Patient response missing|1|||
164190331|NCT00872521|593066284|FG000|Completed 3-month Follow up|Other|0|||
164190332|NCT00872521|593066285|FG001|Completed 3-month Follow up|Other|2|||
164190333|NCT00872521|593066286|FG002|Completed 3-month Follow up|Other|0|||
164190334|NCT00872521|593066284|FG000|Completed 3-month Follow up|Physician Decision|0|||
164190335|NCT00872521|593066285|FG001|Completed 3-month Follow up|Physician Decision|1|||
164190336|NCT00872521|593066286|FG002|Completed 3-month Follow up|Physician Decision|0|||
164190337|NCT00872521|593066284|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
164190338|NCT00872521|593066285|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
164190339|NCT00872521|593066286|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
163850884|NCT02403674|591825426|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
163850885|NCT02403674|591825425|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
163850886|NCT02403674|591825426|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
163964501|NCT01968070|592243215|FG004|Period 1|Withdrawal by Subject|0|||
164190340|NCT01029262|593066292|FG000|Overall Study|Adverse Event|9|||
164190341|NCT01029262|593066293|FG001|Overall Study|Adverse Event|52|||
164190342|NCT01029262|593066292|FG000|Overall Study|Lack of therapeutic effect|57|||
164190343|NCT01029262|593066293|FG001|Overall Study|Lack of therapeutic effect|76|||
164190344|NCT01029262|593066292|FG000|Overall Study|Withdrawal by Subject|10|||
163964502|NCT01968070|592243216|FG005|Period 1|Withdrawal by Subject|0|||
164190345|NCT01029262|593066293|FG001|Overall Study|Withdrawal by Subject|17|||
164190346|NCT01029262|593066292|FG000|Overall Study|Protocol Violation|2|||
164190347|NCT01029262|593066293|FG001|Overall Study|Protocol Violation|3|||
164190348|NCT01029262|593066292|FG000|Overall Study|Miscellaneous|1|||
164190349|NCT01029262|593066293|FG001|Overall Study|Miscellaneous|9|||
164190350|NCT01029262|593066292|FG000|Overall Study|Death|0|||
164190351|NCT01029262|593066293|FG001|Overall Study|Death|3|||
164190352|NCT01001910|593066294|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
164190353|NCT01468454|593066295|FG000|Overall Study|Did not have surgery after PET|9|||
164190354|NCT03200548|593066296|FG000|Overall Study|Withdrawal by Subject|5|||
164190355|NCT03200548|593066297|FG001|Overall Study|Withdrawal by Subject|11|||
164190356|NCT03200548|593066298|FG002|Overall Study|Withdrawal by Subject|7|||
164190357|NCT03200548|593066299|FG003|Overall Study|Withdrawal by Subject|6|||
164190358|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
164190359|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190360|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
164190361|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
164190362|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190363|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190364|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190365|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190366|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190367|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190368|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190369|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190370|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190371|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190372|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190373|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190374|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190375|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190376|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
164190377|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
164190378|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
164190379|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
164190380|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
164190381|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190382|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190383|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190384|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190385|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190386|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190387|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190388|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190389|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190390|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190391|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190392|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190393|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190394|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190395|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
164190396|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190397|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
164190398|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
164190399|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190400|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190401|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190402|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190403|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190404|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190405|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190406|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190407|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190408|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190409|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190410|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190411|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190412|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190413|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190414|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
164190415|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
164190416|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190417|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190418|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190419|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190420|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190421|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190422|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163964503|NCT01968070|592243217|FG006|Period 1|Withdrawal by Subject|1|||
163964504|NCT01968070|592243218|FG007|Period 1|Withdrawal by Subject|0|||
163964505|NCT01968070|592243219|FG008|Period 1|Withdrawal by Subject|0|||
163964506|NCT01968070|592243220|FG009|Period 1|Withdrawal by Subject|0|||
163964507|NCT01968070|592243221|FG010|Period 1|Withdrawal by Subject|0|||
163964508|NCT01968070|592243222|FG011|Period 1|Withdrawal by Subject|0|||
163964509|NCT01968070|592243223|FG012|Period 1|Withdrawal by Subject|0|||
163964510|NCT01968070|592243224|FG013|Period 1|Withdrawal by Subject|0|||
163964511|NCT01968070|592243225|FG014|Period 1|Withdrawal by Subject|0|||
163964512|NCT01968070|592243226|FG015|Period 1|Withdrawal by Subject|1|||
163964513|NCT01968070|592243227|FG016|Period 1|Withdrawal by Subject|0|||
163964514|NCT01968070|592243228|FG017|Period 1|Withdrawal by Subject|0|||
163964515|NCT01968070|592243211|FG000|Period 1|Protocol Violation|0|||
163964516|NCT01968070|592243212|FG001|Period 1|Protocol Violation|0|||
163964517|NCT01968070|592243213|FG002|Period 1|Protocol Violation|0|||
163964518|NCT01968070|592243214|FG003|Period 1|Protocol Violation|1|||
163964519|NCT01968070|592243215|FG004|Period 1|Protocol Violation|1|||
163964520|NCT01968070|592243216|FG005|Period 1|Protocol Violation|0|||
163964521|NCT01968070|592243217|FG006|Period 1|Protocol Violation|0|||
163964522|NCT01968070|592243218|FG007|Period 1|Protocol Violation|0|||
163964523|NCT01968070|592243219|FG008|Period 1|Protocol Violation|0|||
163964524|NCT01968070|592243220|FG009|Period 1|Protocol Violation|0|||
163964525|NCT01968070|592243221|FG010|Period 1|Protocol Violation|0|||
163964526|NCT01968070|592243222|FG011|Period 1|Protocol Violation|0|||
163964527|NCT01968070|592243223|FG012|Period 1|Protocol Violation|0|||
163964528|NCT01968070|592243224|FG013|Period 1|Protocol Violation|0|||
163964529|NCT01968070|592243225|FG014|Period 1|Protocol Violation|0|||
163964530|NCT01968070|592243226|FG015|Period 1|Protocol Violation|0|||
163964531|NCT01968070|592243227|FG016|Period 1|Protocol Violation|0|||
163964532|NCT01968070|592243228|FG017|Period 1|Protocol Violation|0|||
163964533|NCT01968070|592243211|FG000|Period 1|Lost to Follow-up|0|||
163964534|NCT01968070|592243212|FG001|Period 1|Lost to Follow-up|0|||
163964535|NCT01968070|592243213|FG002|Period 1|Lost to Follow-up|0|||
163964536|NCT01968070|592243214|FG003|Period 1|Lost to Follow-up|1|||
163964537|NCT01968070|592243215|FG004|Period 1|Lost to Follow-up|0|||
163964538|NCT01968070|592243216|FG005|Period 1|Lost to Follow-up|0|||
163964539|NCT01968070|592243217|FG006|Period 1|Lost to Follow-up|0|||
163964540|NCT01968070|592243218|FG007|Period 1|Lost to Follow-up|0|||
163964541|NCT01968070|592243219|FG008|Period 1|Lost to Follow-up|0|||
163964542|NCT01968070|592243220|FG009|Period 1|Lost to Follow-up|0|||
163964543|NCT01968070|592243221|FG010|Period 1|Lost to Follow-up|0|||
163964544|NCT01968070|592243222|FG011|Period 1|Lost to Follow-up|0|||
163964545|NCT01968070|592243223|FG012|Period 1|Lost to Follow-up|0|||
163964546|NCT01968070|592243224|FG013|Period 1|Lost to Follow-up|0|||
163964547|NCT01968070|592243225|FG014|Period 1|Lost to Follow-up|0|||
163964548|NCT01968070|592243226|FG015|Period 1|Lost to Follow-up|0|||
163964549|NCT01968070|592243227|FG016|Period 1|Lost to Follow-up|0|||
163964550|NCT01968070|592243228|FG017|Period 1|Lost to Follow-up|0|||
163964551|NCT01968070|592243211|FG000|Period 1|Adverse Event|0|||
163964552|NCT01968070|592243212|FG001|Period 1|Adverse Event|0|||
163964553|NCT01968070|592243213|FG002|Period 1|Adverse Event|0|||
163964554|NCT01968070|592243214|FG003|Period 1|Adverse Event|0|||
164190423|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190424|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
163964555|NCT01968070|592243215|FG004|Period 1|Adverse Event|0|||
163964556|NCT01968070|592243216|FG005|Period 1|Adverse Event|0|||
163964557|NCT01968070|592243217|FG006|Period 1|Adverse Event|1|||
163964558|NCT01968070|592243218|FG007|Period 1|Adverse Event|0|||
163964559|NCT01968070|592243219|FG008|Period 1|Adverse Event|0|||
163964560|NCT01968070|592243220|FG009|Period 1|Adverse Event|0|||
163964561|NCT01968070|592243221|FG010|Period 1|Adverse Event|0|||
163964562|NCT01968070|592243222|FG011|Period 1|Adverse Event|0|||
163964563|NCT01968070|592243223|FG012|Period 1|Adverse Event|0|||
163964564|NCT01968070|592243224|FG013|Period 1|Adverse Event|0|||
163964565|NCT01968070|592243225|FG014|Period 1|Adverse Event|0|||
163964566|NCT01968070|592243226|FG015|Period 1|Adverse Event|0|||
164190425|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190426|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190427|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190428|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190429|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190430|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190431|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190432|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190433|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
164190434|NCT03428100|593066300|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190435|NCT03428100|593066301|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
164190436|NCT03428100|593066302|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190437|NCT03428100|593066303|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190438|NCT03428100|593066304|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190439|NCT03428100|593066305|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190440|NCT03428100|593066306|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190441|NCT03428100|593066307|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190442|NCT03428100|593066308|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190443|NCT03428100|593066309|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190444|NCT03428100|593066310|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190445|NCT03428100|593066311|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190446|NCT03428100|593066312|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190447|NCT03428100|593066313|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190448|NCT03428100|593066314|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190449|NCT03428100|593066315|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190450|NCT03428100|593066316|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190451|NCT03428100|593066317|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190452|NCT03428100|593066318|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
164190453|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190454|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190455|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190456|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190457|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190458|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
164190459|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190460|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
164190461|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190462|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190463|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190464|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190465|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
164190466|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190467|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190468|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
164190469|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
164190470|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190471|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
164190472|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
164190473|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
164190474|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
164190475|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
164190476|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
164190477|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
164190478|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
164190479|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
164190480|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
164190481|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
164190482|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
164190483|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
164190484|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
164190485|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
164190486|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
164190487|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
164190488|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
164190489|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
163850887|NCT01254305|591825427|FG000|Overall Study|Adverse Event|6|||
163850888|NCT01254305|591825428|FG001|Overall Study|Adverse Event|3|||
163850889|NCT01254305|591825429|FG002|Overall Study|Adverse Event|2|||
163850890|NCT01254305|591825427|FG000|Overall Study|Lack of Efficacy|1|||
163850891|NCT01254305|591825428|FG001|Overall Study|Lack of Efficacy|0|||
163850892|NCT01254305|591825429|FG002|Overall Study|Lack of Efficacy|1|||
163850893|NCT01254305|591825427|FG000|Overall Study|Protocol Violation|1|||
163850894|NCT01254305|591825428|FG001|Overall Study|Protocol Violation|7|||
163850895|NCT01254305|591825429|FG002|Overall Study|Protocol Violation|3|||
163850896|NCT01254305|591825427|FG000|Overall Study|Withdrawal by Subject|4|||
163850897|NCT01254305|591825428|FG001|Overall Study|Withdrawal by Subject|2|||
163850898|NCT01254305|591825429|FG002|Overall Study|Withdrawal by Subject|4|||
163850899|NCT01254305|591825427|FG000|Overall Study|Lost to Follow-up|10|||
163850900|NCT01254305|591825428|FG001|Overall Study|Lost to Follow-up|6|||
163850901|NCT01254305|591825429|FG002|Overall Study|Lost to Follow-up|5|||
163850902|NCT01254305|591825427|FG000|Overall Study|Other Reasons|0|||
163850903|NCT01254305|591825428|FG001|Overall Study|Other Reasons|0|||
163850904|NCT01254305|591825429|FG002|Overall Study|Other Reasons|2|||
163850905|NCT01636362|591825430|FG000|Overall Study|Physician Decision|6|||
163850906|NCT01636362|591825430|FG000|Overall Study|Subject healed, not returning|1|||
163850907|NCT01636362|591825430|FG000|Overall Study|Withdrawal by Subject|1|||
163850908|NCT00926393|591825431|FG000|Overall Study|Withdrawal by Subject|1|||
163850909|NCT00926393|591825432|FG001|Overall Study|Withdrawal by Subject|2|||
163850910|NCT00926393|591825431|FG000|Overall Study|Adverse Event|1|||
163850911|NCT00926393|591825432|FG001|Overall Study|Adverse Event|1|||
163850912|NCT01094743|591825442|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
163850913|NCT02851511|591825443|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
163850914|NCT02851511|591825444|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
163850915|NCT02851511|591825445|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
163850916|NCT02851511|591825446|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
163850917|NCT02851511|591825443|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
163850918|NCT02851511|591825444|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
163850919|NCT02851511|591825445|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
163850920|NCT02851511|591825446|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
163850921|NCT02851511|591825443|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
163850922|NCT02851511|591825444|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
163850923|NCT02851511|591825445|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
163850924|NCT02851511|591825446|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
163850925|NCT02851511|591825443|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
163850926|NCT02851511|591825444|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
163850927|NCT02851511|591825445|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
163850928|NCT02851511|591825446|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
163850929|NCT02851511|591825443|FG000|Phase I|Physician Decision|0|||
163850930|NCT02851511|591825444|FG001|Phase I|Physician Decision|0|||
163850931|NCT02851511|591825445|FG002|Phase I|Physician Decision|0|||
163850932|NCT02851511|591825446|FG003|Phase I|Physician Decision|1|||
163850933|NCT02851511|591825443|FG000|Phase I|Withdrawal by Subject|2|||
163850934|NCT02851511|591825444|FG001|Phase I|Withdrawal by Subject|1|||
163850935|NCT02851511|591825445|FG002|Phase I|Withdrawal by Subject|0|||
163850936|NCT02851511|591825446|FG003|Phase I|Withdrawal by Subject|3|||
163850937|NCT02851511|591825443|FG000|Phase II|Physician Decision|18|||
163850938|NCT02851511|591825444|FG001|Phase II|Physician Decision|16|||
163850939|NCT02851511|591825445|FG002|Phase II|Physician Decision|0|||
163850940|NCT02851511|591825446|FG003|Phase II|Physician Decision|0|||
163850941|NCT02851511|591825443|FG000|Phase II|Withdrawal by Subject|18|||
163850942|NCT02851511|591825444|FG001|Phase II|Withdrawal by Subject|16|||
163850943|NCT02851511|591825445|FG002|Phase II|Withdrawal by Subject|0|||
163850944|NCT02851511|591825446|FG003|Phase II|Withdrawal by Subject|0|||
163850945|NCT02851511|591825443|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
163850946|NCT02851511|591825444|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
163850947|NCT02851511|591825445|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
163850948|NCT02851511|591825446|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
163850949|NCT02851511|591825443|FG000|Phase II|Lost to Follow-up|0|||
163964567|NCT01968070|592243227|FG016|Period 1|Adverse Event|0|||
163964568|NCT01968070|592243228|FG017|Period 1|Adverse Event|0|||
163964569|NCT01968070|592243211|FG000|Period 1|Physician Decision|0|||
163964570|NCT01968070|592243212|FG001|Period 1|Physician Decision|0|||
163964571|NCT01968070|592243213|FG002|Period 1|Physician Decision|0|||
163850950|NCT02851511|591825444|FG001|Phase II|Lost to Follow-up|1|||
163850951|NCT02851511|591825445|FG002|Phase II|Lost to Follow-up|0|||
163850952|NCT02851511|591825446|FG003|Phase II|Lost to Follow-up|0|||
163850953|NCT04004208|591825449|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163850954|NCT04004208|591825450|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163850955|NCT04004208|591825449|FG000|Overall Study|Death|3|||
163850956|NCT04004208|591825450|FG001|Overall Study|Death|0|||
163964572|NCT01968070|592243214|FG003|Period 1|Physician Decision|0|||
163850957|NCT04004208|591825449|FG000|Overall Study|COVID-19 pandemic|1|||
163850958|NCT04004208|591825450|FG001|Overall Study|COVID-19 pandemic|0|||
163850959|NCT04004208|591825449|FG000|Overall Study|Physician Decision|1|||
163850960|NCT04004208|591825450|FG001|Overall Study|Physician Decision|0|||
163850961|NCT04004208|591825449|FG000|Overall Study|Adverse Event|1|||
163850962|NCT04004208|591825450|FG001|Overall Study|Adverse Event|1|||
163850963|NCT02118714|591825464|FG000|Overall Study|Lost to Follow-up|2|||
163850964|NCT02118714|591825464|FG000|Overall Study|Protocol Violation|1|||
163850965|NCT03023332|591825468|FG000|Overall Study|Withdrawal by Subject|10|||
163850966|NCT03023332|591825469|FG001|Overall Study|Withdrawal by Subject|5|||
163850967|NCT03023332|591825470|FG002|Overall Study|Withdrawal by Subject|4|||
163850968|NCT03023332|591825471|FG003|Overall Study|Withdrawal by Subject|7|||
163850969|NCT03023332|591825468|FG000|Overall Study|Lost to Follow-up|13|||
163850970|NCT03023332|591825469|FG001|Overall Study|Lost to Follow-up|16|||
163850971|NCT03023332|591825470|FG002|Overall Study|Lost to Follow-up|8|||
163850972|NCT03023332|591825471|FG003|Overall Study|Lost to Follow-up|13|||
163850973|NCT03023332|591825468|FG000|Overall Study|Death|1|||
163850974|NCT03023332|591825469|FG001|Overall Study|Death|0|||
163850975|NCT03023332|591825470|FG002|Overall Study|Death|0|||
163850976|NCT03023332|591825471|FG003|Overall Study|Death|0|||
163850977|NCT02412761|591825472|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163850978|NCT02412761|591825473|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163850979|NCT02412761|591825474|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163850980|NCT02412761|591825475|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163850981|NCT02412761|591825476|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163850982|NCT02412761|591825477|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163850983|NCT01818700|591825478|FG000|Overall Study|Adverse Event|67|||
163850984|NCT01818700|591825478|FG000|Overall Study|Lack of Efficacy|2|||
163850985|NCT01818700|591825478|FG000|Overall Study|Lost to Follow-up|5|||
163850986|NCT01818700|591825478|FG000|Overall Study|Withdrawal by Subject|27|||
163850987|NCT01818700|591825478|FG000|Overall Study|Protocol Violation|2|||
163850988|NCT01818700|591825478|FG000|Overall Study|Other|1|||
163850989|NCT01272011|591825479|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
163850990|NCT01272011|591825480|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
163850991|NCT01272011|591825481|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
163850992|NCT02013687|591825482|FG000|Overall Study|Lost to Follow-up|0|||
163850993|NCT02013687|591825483|FG001|Overall Study|Lost to Follow-up|0|||
163850994|NCT02013687|591825484|FG002|Overall Study|Lost to Follow-up|1|||
163850995|NCT02013687|591825485|FG003|Overall Study|Lost to Follow-up|0|||
163850996|NCT02013687|591825482|FG000|Overall Study|Protocol Violation|0|||
163850997|NCT02013687|591825483|FG001|Overall Study|Protocol Violation|0|||
163850998|NCT02013687|591825484|FG002|Overall Study|Protocol Violation|0|||
163850999|NCT02013687|591825485|FG003|Overall Study|Protocol Violation|1|||
163851000|NCT02013687|591825482|FG000|Overall Study|Withdrawal by Subject|0|||
163851001|NCT02013687|591825483|FG001|Overall Study|Withdrawal by Subject|0|||
163851002|NCT02013687|591825484|FG002|Overall Study|Withdrawal by Subject|0|||
163851003|NCT02013687|591825485|FG003|Overall Study|Withdrawal by Subject|1|||
163851004|NCT02013687|591825482|FG000|Overall Study|Missed visits due to patient travel|0|||
163851005|NCT02013687|591825483|FG001|Overall Study|Missed visits due to patient travel|0|||
163851006|NCT02013687|591825484|FG002|Overall Study|Missed visits due to patient travel|1|||
163851007|NCT02013687|591825485|FG003|Overall Study|Missed visits due to patient travel|0|||
163851008|NCT01627340|591825486|FG000|Overall Study|Adverse Event|1|||
163851009|NCT01627340|591825487|FG001|Overall Study|Adverse Event|0|||
163851010|NCT01627340|591825486|FG000|Overall Study|Lost to Follow-up|8|||
163851011|NCT01627340|591825487|FG001|Overall Study|Lost to Follow-up|4|||
163851012|NCT01627340|591825486|FG000|Overall Study|Pregnancy|1|||
163851013|NCT01627340|591825487|FG001|Overall Study|Pregnancy|0|||
163851014|NCT01627340|591825486|FG000|Overall Study|Withdrawal by Subject|2|||
164190490|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
164190491|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190492|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190493|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163851015|NCT01627340|591825487|FG001|Overall Study|Withdrawal by Subject|0|||
163851016|NCT02240680|591825490|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
163851017|NCT02240680|591825491|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
164190494|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190495|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
164190496|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
164190497|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
164190498|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
163851018|NCT02240680|591825492|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
163851019|NCT02240680|591825493|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
163851020|NCT02240680|591825490|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
163851021|NCT02240680|591825491|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
164190499|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
163851022|NCT02240680|591825492|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
163851023|NCT02240680|591825493|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
163851024|NCT02240680|591825490|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
164190500|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190501|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190502|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
164190503|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
164190504|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
164190505|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
164190506|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
164190507|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190508|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
164190509|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
164190510|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190511|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190512|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190513|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190514|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190515|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190516|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190517|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
164190518|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190519|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190520|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190521|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
164190522|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
164190523|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190524|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
164190525|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190526|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190527|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
164190528|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
164190529|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
164190530|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
164190531|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
164190532|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
163851025|NCT02240680|591825491|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
163851026|NCT02240680|591825492|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
163851027|NCT02240680|591825493|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
163851028|NCT02240680|591825490|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
163851029|NCT02240680|591825491|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
163851030|NCT02240680|591825492|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
163851031|NCT02240680|591825493|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
163851032|NCT02240680|591825490|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
163851033|NCT02240680|591825491|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
163851034|NCT02240680|591825492|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
163851035|NCT02240680|591825493|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
163851036|NCT02240680|591825490|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
163851037|NCT02240680|591825491|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
163851038|NCT02240680|591825492|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
163851039|NCT02240680|591825493|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
163851040|NCT02240680|591825490|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
163851041|NCT02240680|591825491|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
163851042|NCT02240680|591825492|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
163851043|NCT02240680|591825493|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
163851044|NCT02240680|591825490|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
163851045|NCT02240680|591825491|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
163851046|NCT02240680|591825492|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
163851047|NCT02240680|591825493|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
163851048|NCT01657032|591825494|FG000|Overall Study|Lost to Follow-up|0|||
163851049|NCT01657032|591825495|FG001|Overall Study|Lost to Follow-up|7|||
163851050|NCT01782326|591825496|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
163851051|NCT01782326|591825497|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
163851052|NCT01782326|591825496|FG000|Planned Treatment Epoch|Death|29|||
163851053|NCT01782326|591825497|FG001|Planned Treatment Epoch|Death|30|||
163851054|NCT01782326|591825496|FG000|Planned Treatment Epoch|Physician Decision|18|||
163851055|NCT01782326|591825497|FG001|Planned Treatment Epoch|Physician Decision|16|||
163851056|NCT01782326|591825496|FG000|Planned Treatment Epoch|Protocol deviation|2|||
163851057|NCT01782326|591825497|FG001|Planned Treatment Epoch|Protocol deviation|3|||
163851058|NCT01782326|591825496|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
163851059|NCT01782326|591825497|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
163851060|NCT01782326|591825496|FG000|Planned Treatment Epoch|Technical problems|0|||
163851061|NCT01782326|591825497|FG001|Planned Treatment Epoch|Technical problems|4|||
163851062|NCT01782326|591825496|FG000|Double-blind Treatment|Adverse Event|129|||
163851063|NCT01782326|591825497|FG001|Double-blind Treatment|Adverse Event|145|||
163851064|NCT01782326|591825496|FG000|Double-blind Treatment|Subject/guardian decision|111|||
163851065|NCT01782326|591825497|FG001|Double-blind Treatment|Subject/guardian decision|125|||
163851066|NCT01782326|591825496|FG000|Double-blind Treatment|Lack of Efficacy|17|||
163851067|NCT01782326|591825497|FG001|Double-blind Treatment|Lack of Efficacy|22|||
163851068|NCT01782326|591825496|FG000|Double-blind Treatment|Physician Decision|13|||
163851069|NCT01782326|591825497|FG001|Double-blind Treatment|Physician Decision|16|||
163851070|NCT01782326|591825496|FG000|Double-blind Treatment|Protocol deviation|8|||
163851071|NCT01782326|591825497|FG001|Double-blind Treatment|Protocol deviation|7|||
163851072|NCT01782326|591825496|FG000|Double-blind Treatment|Technical problems|0|||
163851073|NCT01782326|591825497|FG001|Double-blind Treatment|Technical problems|5|||
163851074|NCT05968482|591825498|FG000|First Crossover Period|Withdrawal by Subject|0|||
163851075|NCT05968482|591825499|FG001|First Crossover Period|Withdrawal by Subject|0|||
163851076|NCT05968482|591825500|FG002|First Crossover Period|Withdrawal by Subject|1|||
163851077|NCT05968482|591825501|FG003|First Crossover Period|Withdrawal by Subject|0|||
163851078|NCT05968482|591825502|FG004|First Crossover Period|Withdrawal by Subject|0|||
163851079|NCT05968482|591825503|FG005|First Crossover Period|Withdrawal by Subject|0|||
163851080|NCT05968482|591825498|FG000|First Crossover Period|Adverse Event|0|||
163851081|NCT05968482|591825499|FG001|First Crossover Period|Adverse Event|0|||
163851082|NCT05968482|591825500|FG002|First Crossover Period|Adverse Event|0|||
163851083|NCT05968482|591825501|FG003|First Crossover Period|Adverse Event|0|||
163851084|NCT05968482|591825502|FG004|First Crossover Period|Adverse Event|0|||
163851085|NCT05968482|591825503|FG005|First Crossover Period|Adverse Event|1|||
163851086|NCT05968482|591825498|FG000|Second Crossover Period|Withdrawal by Subject|0|||
163851087|NCT05968482|591825499|FG001|Second Crossover Period|Withdrawal by Subject|0|||
163851088|NCT05968482|591825500|FG002|Second Crossover Period|Withdrawal by Subject|0|||
163851089|NCT05968482|591825501|FG003|Second Crossover Period|Withdrawal by Subject|0|||
163851090|NCT05968482|591825502|FG004|Second Crossover Period|Withdrawal by Subject|1|||
163851091|NCT05968482|591825503|FG005|Second Crossover Period|Withdrawal by Subject|0|||
163851092|NCT05968482|591825498|FG000|Third Crossover Period|Adverse Event|0|||
163851093|NCT05968482|591825499|FG001|Third Crossover Period|Adverse Event|0|||
163851094|NCT05968482|591825500|FG002|Third Crossover Period|Adverse Event|0|||
163851095|NCT05968482|591825501|FG003|Third Crossover Period|Adverse Event|0|||
163851096|NCT05968482|591825502|FG004|Third Crossover Period|Adverse Event|1|||
163851097|NCT05968482|591825503|FG005|Third Crossover Period|Adverse Event|0|||
163851098|NCT05968482|591825498|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
163851099|NCT05968482|591825499|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
163851100|NCT05968482|591825500|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
163851101|NCT05968482|591825501|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
163851102|NCT05968482|591825502|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
163851103|NCT05968482|591825503|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
163851104|NCT02559817|591825510|FG000|Treatment Period|Adverse Event|1|||
163851105|NCT02559817|591825511|FG001|Treatment Period|Adverse Event|0|||
163851106|NCT02559817|591825512|FG002|Treatment Period|Adverse Event|1|||
163851107|NCT02559817|591825513|FG003|Treatment Period|Adverse Event|0|||
163851108|NCT02559817|591825514|FG004|Treatment Period|Adverse Event|0|||
163851109|NCT02559817|591825510|FG000|Treatment Period|Lack of Efficacy|0|||
163851110|NCT02559817|591825511|FG001|Treatment Period|Lack of Efficacy|1|||
163851111|NCT02559817|591825512|FG002|Treatment Period|Lack of Efficacy|0|||
163851112|NCT02559817|591825513|FG003|Treatment Period|Lack of Efficacy|0|||
163851113|NCT02559817|591825514|FG004|Treatment Period|Lack of Efficacy|0|||
163851114|NCT02559817|591825510|FG000|Treatment Period|Lost to Follow-up|0|||
163851115|NCT02559817|591825511|FG001|Treatment Period|Lost to Follow-up|1|||
163851116|NCT02559817|591825512|FG002|Treatment Period|Lost to Follow-up|0|||
163851117|NCT02559817|591825513|FG003|Treatment Period|Lost to Follow-up|1|||
163851118|NCT02559817|591825514|FG004|Treatment Period|Lost to Follow-up|0|||
163851119|NCT02559817|591825510|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
163851120|NCT02559817|591825511|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
163851121|NCT02559817|591825512|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
163851122|NCT02559817|591825513|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
163851123|NCT02559817|591825514|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
163851124|NCT02559817|591825510|FG000|Treatment Period|Protocol Violation|0|||
163851125|NCT02559817|591825511|FG001|Treatment Period|Protocol Violation|0|||
163851126|NCT02559817|591825512|FG002|Treatment Period|Protocol Violation|0|||
163851127|NCT02559817|591825513|FG003|Treatment Period|Protocol Violation|1|||
163851128|NCT02559817|591825514|FG004|Treatment Period|Protocol Violation|0|||
163851129|NCT03379233|591825515|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
163851130|NCT03379233|591825516|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
163851131|NCT00965484|591825517|FG000|Overall Study|Protocol Violation|1|||
163851132|NCT00965484|591825517|FG000|Overall Study|Withdrawal by Subject|1|||
163851133|NCT02687919|591825518|FG000|Overall Study|Withdrawal by Subject|6|||
163851134|NCT02687919|591825519|FG001|Overall Study|Withdrawal by Subject|6|||
163851135|NCT02687919|591825518|FG000|Overall Study|Protocol Violation|2|||
163851136|NCT02687919|591825519|FG001|Overall Study|Protocol Violation|0|||
163851137|NCT00419003|591825520|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
163851138|NCT00419003|591825521|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
163851139|NCT00419003|591825520|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
163851140|NCT00419003|591825521|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
163851141|NCT02531438|591825522|FG000|Overall Study|Adverse Event|7|||
163851142|NCT02531438|591825523|FG001|Overall Study|Adverse Event|9|||
163851143|NCT02531438|591825522|FG000|Overall Study|Lost to Follow-up|0|||
163851144|NCT02531438|591825523|FG001|Overall Study|Lost to Follow-up|3|||
163851145|NCT02531438|591825522|FG000|Overall Study|Withdrawal by Subject|7|||
163851146|NCT02531438|591825523|FG001|Overall Study|Withdrawal by Subject|8|||
163851147|NCT02531438|591825522|FG000|Overall Study|Physician Decision|0|||
163851148|NCT02531438|591825523|FG001|Overall Study|Physician Decision|1|||
163851149|NCT02531438|591825522|FG000|Overall Study|Death|6|||
163851150|NCT02531438|591825523|FG001|Overall Study|Death|3|||
163851151|NCT02531438|591825522|FG000|Overall Study|Randomized, but Not Treated|4|||
163851152|NCT02531438|591825523|FG001|Overall Study|Randomized, but Not Treated|0|||
163851153|NCT02531438|591825522|FG000|Overall Study|Missed EOT/PTE Visit|5|||
163851154|NCT02531438|591825523|FG001|Overall Study|Missed EOT/PTE Visit|2|||
163851155|NCT02531438|591825522|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
163851156|NCT02531438|591825523|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
163851157|NCT01653847|591825524|FG000|Overall Study|Withdrawal by Subject|1|||
163851158|NCT01653847|591825525|FG001|Overall Study|Withdrawal by Subject|0|||
163851159|NCT01653743|591825526|FG000|Overall Study|Withdrawal by Subject|1|||
163851160|NCT01653743|591825527|FG001|Overall Study|Withdrawal by Subject|0|||
163851161|NCT01653743|591825526|FG000|Overall Study|Investigator discretion|3|||
163851162|NCT01653743|591825527|FG001|Overall Study|Investigator discretion|0|||
163851163|NCT02015195|591825529|FG000|Overall Study|Adverse Event|0|||
163851164|NCT02015195|591825530|FG001|Overall Study|Adverse Event|0|||
163851165|NCT02015195|591825531|FG002|Overall Study|Adverse Event|0|||
163851166|NCT02015195|591825532|FG003|Overall Study|Adverse Event|1|||
163851167|NCT02015195|591825533|FG004|Overall Study|Adverse Event|0|||
163851168|NCT02015195|591825534|FG005|Overall Study|Adverse Event|0|||
163851169|NCT02015195|591825535|FG006|Overall Study|Adverse Event|0|||
163851170|NCT02554513|591825536|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
163851171|NCT02554513|591825537|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
163851172|NCT02303574|591825541|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851173|NCT02303574|591825542|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851174|NCT02303574|591825543|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
163851175|NCT02303574|591825544|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851176|NCT02303574|591825545|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851177|NCT02303574|591825546|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851178|NCT02303574|591825547|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851179|NCT02303574|591825548|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851180|NCT02303574|591825549|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851181|NCT02303574|591825550|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
163851182|NCT02303574|591825541|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851183|NCT02303574|591825542|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851184|NCT02303574|591825543|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851185|NCT02303574|591825544|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851186|NCT02303574|591825545|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851187|NCT02303574|591825546|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851188|NCT02303574|591825547|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163964573|NCT01968070|592243215|FG004|Period 1|Physician Decision|0|||
163851189|NCT02303574|591825548|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
163851190|NCT02303574|591825549|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851191|NCT02303574|591825550|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
163851192|NCT00859014|591825555|FG000|Overall Study|Death|4|||
163851193|NCT00859014|591825555|FG000|Overall Study|Lost to Follow-up|1|||
163851194|NCT00162942|591825556|FG000|Overall Study|Adverse Event|10|||
163851195|NCT00162942|591825557|FG001|Overall Study|Adverse Event|6|||
163851196|NCT00162942|591825556|FG000|Overall Study|Death|1|||
163851197|NCT00162942|591825557|FG001|Overall Study|Death|0|||
163851198|NCT00162942|591825556|FG000|Overall Study|Withdrawal by Subject|3|||
163851199|NCT00162942|591825557|FG001|Overall Study|Withdrawal by Subject|6|||
163964574|NCT01968070|592243216|FG005|Period 1|Physician Decision|0|||
163851200|NCT00162942|591825556|FG000|Overall Study|Physician Decision|1|||
163851201|NCT00162942|591825557|FG001|Overall Study|Physician Decision|0|||
163851202|NCT00162942|591825556|FG000|Overall Study|Enter Open-Label Study|76|||
163851203|NCT00162942|591825557|FG001|Overall Study|Enter Open-Label Study|35|||
163851204|NCT00162942|591825556|FG000|Overall Study|Alternate Therapy|6|||
163851205|NCT00162942|591825557|FG001|Overall Study|Alternate Therapy|2|||
163851206|NCT00162942|591825556|FG000|Overall Study|Lack of Efficacy|1|||
163851207|NCT00162942|591825557|FG001|Overall Study|Lack of Efficacy|0|||
163851208|NCT00162942|591825556|FG000|Overall Study|Flare During Active Treatment|7|||
163851209|NCT00162942|591825557|FG001|Overall Study|Flare During Active Treatment|3|||
163851210|NCT00162942|591825556|FG000|Overall Study|2 or more consecutive treatments missed|1|||
163851211|NCT00162942|591825557|FG001|Overall Study|2 or more consecutive treatments missed|0|||
163851212|NCT04796935|591825558|FG000|Overall Study|Withdrawal by Subject|0|||
163851213|NCT04796935|591825559|FG001|Overall Study|Withdrawal by Subject|1|||
163851214|NCT04796935|591825558|FG000|Overall Study|Physician Decision|0|||
163851215|NCT04796935|591825559|FG001|Overall Study|Physician Decision|1|||
163851216|NCT04796935|591825558|FG000|Overall Study|Device not available|1|||
163851217|NCT04796935|591825559|FG001|Overall Study|Device not available|0|||
163851218|NCT04796935|591825558|FG000|Overall Study|Trained provider not available|1|||
163851219|NCT04796935|591825559|FG001|Overall Study|Trained provider not available|0|||
163851220|NCT00783718|591825562|FG000|Induction Phase|Adverse Event|4|||
163851221|NCT00783718|591825563|FG001|Induction Phase|Adverse Event|0|||
163851222|NCT00783718|591825564|FG002|Induction Phase|Adverse Event|7|||
163851223|NCT00783718|591825565|FG003|Induction Phase|Adverse Event|0|||
163851224|NCT00783718|591825566|FG004|Induction Phase|Adverse Event|0|||
163851225|NCT00783718|591825567|FG005|Induction Phase|Adverse Event|0|||
163851226|NCT00783718|591825568|FG006|Induction Phase|Adverse Event|0|||
163851227|NCT00783718|591825562|FG000|Induction Phase|Protocol Violation|1|||
163851228|NCT00783718|591825563|FG001|Induction Phase|Protocol Violation|1|||
163851229|NCT00783718|591825564|FG002|Induction Phase|Protocol Violation|6|||
163851230|NCT00783718|591825565|FG003|Induction Phase|Protocol Violation|0|||
163851231|NCT00783718|591825566|FG004|Induction Phase|Protocol Violation|0|||
163851232|NCT00783718|591825567|FG005|Induction Phase|Protocol Violation|0|||
163851233|NCT00783718|591825568|FG006|Induction Phase|Protocol Violation|0|||
163851234|NCT00783718|591825562|FG000|Induction Phase|Lack of Efficacy|5|||
163851235|NCT00783718|591825563|FG001|Induction Phase|Lack of Efficacy|2|||
163851236|NCT00783718|591825564|FG002|Induction Phase|Lack of Efficacy|14|||
163851237|NCT00783718|591825565|FG003|Induction Phase|Lack of Efficacy|0|||
163851238|NCT00783718|591825566|FG004|Induction Phase|Lack of Efficacy|0|||
163851239|NCT00783718|591825567|FG005|Induction Phase|Lack of Efficacy|0|||
163851240|NCT00783718|591825568|FG006|Induction Phase|Lack of Efficacy|0|||
163851241|NCT00783718|591825562|FG000|Induction Phase|Withdrawal by Subject|3|||
163851242|NCT00783718|591825563|FG001|Induction Phase|Withdrawal by Subject|4|||
163851243|NCT00783718|591825564|FG002|Induction Phase|Withdrawal by Subject|8|||
163851244|NCT00783718|591825565|FG003|Induction Phase|Withdrawal by Subject|0|||
163851245|NCT00783718|591825566|FG004|Induction Phase|Withdrawal by Subject|0|||
163851246|NCT00783718|591825567|FG005|Induction Phase|Withdrawal by Subject|0|||
163851247|NCT00783718|591825568|FG006|Induction Phase|Withdrawal by Subject|0|||
163851248|NCT00783718|591825562|FG000|Induction Phase|Lost to Follow-up|1|||
163851249|NCT00783718|591825563|FG001|Induction Phase|Lost to Follow-up|0|||
163851250|NCT00783718|591825564|FG002|Induction Phase|Lost to Follow-up|1|||
163851251|NCT00783718|591825565|FG003|Induction Phase|Lost to Follow-up|0|||
163851252|NCT00783718|591825566|FG004|Induction Phase|Lost to Follow-up|0|||
163851253|NCT00783718|591825567|FG005|Induction Phase|Lost to Follow-up|0|||
163851254|NCT00783718|591825568|FG006|Induction Phase|Lost to Follow-up|0|||
163851255|NCT00783718|591825562|FG000|Maintenance Phase|Adverse Event|12|||
163851256|NCT00783718|591825563|FG001|Maintenance Phase|Adverse Event|0|||
163851257|NCT00783718|591825564|FG002|Maintenance Phase|Adverse Event|0|||
163851258|NCT00783718|591825565|FG003|Maintenance Phase|Adverse Event|15|||
163851259|NCT00783718|591825566|FG004|Maintenance Phase|Adverse Event|7|||
163851260|NCT00783718|591825567|FG005|Maintenance Phase|Adverse Event|6|||
163851261|NCT00783718|591825568|FG006|Maintenance Phase|Adverse Event|16|||
163851262|NCT00783718|591825562|FG000|Maintenance Phase|Protocol Violation|1|||
164190533|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
163851263|NCT00783718|591825563|FG001|Maintenance Phase|Protocol Violation|0|||
163851264|NCT00783718|591825564|FG002|Maintenance Phase|Protocol Violation|0|||
164190534|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
163851265|NCT00783718|591825565|FG003|Maintenance Phase|Protocol Violation|0|||
163851266|NCT00783718|591825566|FG004|Maintenance Phase|Protocol Violation|0|||
163851267|NCT00783718|591825567|FG005|Maintenance Phase|Protocol Violation|0|||
163851268|NCT00783718|591825568|FG006|Maintenance Phase|Protocol Violation|2|||
163851269|NCT00783718|591825562|FG000|Maintenance Phase|Lack of Efficacy|83|||
163851270|NCT00783718|591825563|FG001|Maintenance Phase|Lack of Efficacy|0|||
163851271|NCT00783718|591825564|FG002|Maintenance Phase|Lack of Efficacy|0|||
163851272|NCT00783718|591825565|FG003|Maintenance Phase|Lack of Efficacy|61|||
163851273|NCT00783718|591825566|FG004|Maintenance Phase|Lack of Efficacy|31|||
163851274|NCT00783718|591825567|FG005|Maintenance Phase|Lack of Efficacy|33|||
163851275|NCT00783718|591825568|FG006|Maintenance Phase|Lack of Efficacy|155|||
163851276|NCT00783718|591825562|FG000|Maintenance Phase|Withdrawal by Subject|6|||
163851277|NCT00783718|591825563|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163851278|NCT00783718|591825564|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163851279|NCT00783718|591825565|FG003|Maintenance Phase|Withdrawal by Subject|2|||
163851280|NCT00783718|591825566|FG004|Maintenance Phase|Withdrawal by Subject|5|||
163851281|NCT00783718|591825567|FG005|Maintenance Phase|Withdrawal by Subject|2|||
163851282|NCT00783718|591825568|FG006|Maintenance Phase|Withdrawal by Subject|20|||
163851283|NCT00783718|591825562|FG000|Maintenance Phase|Lost to Follow-up|3|||
163851284|NCT00783718|591825563|FG001|Maintenance Phase|Lost to Follow-up|0|||
163851285|NCT00783718|591825564|FG002|Maintenance Phase|Lost to Follow-up|0|||
163851286|NCT00783718|591825565|FG003|Maintenance Phase|Lost to Follow-up|0|||
163851287|NCT00783718|591825566|FG004|Maintenance Phase|Lost to Follow-up|2|||
163851288|NCT00783718|591825567|FG005|Maintenance Phase|Lost to Follow-up|0|||
163851289|NCT00783718|591825568|FG006|Maintenance Phase|Lost to Follow-up|2|||
163851290|NCT01192295|591825569|FG000|Overall Study|Adverse Event|3|||
163851291|NCT01192295|591825570|FG001|Overall Study|Adverse Event|7|||
163851292|NCT01192295|591825569|FG000|Overall Study|Withdrawal by Subject|3|||
163851293|NCT01192295|591825570|FG001|Overall Study|Withdrawal by Subject|4|||
163851294|NCT01192295|591825569|FG000|Overall Study|Lost to Follow-up|0|||
163851295|NCT01192295|591825570|FG001|Overall Study|Lost to Follow-up|1|||
163851296|NCT01192295|591825569|FG000|Overall Study|Lack of Efficacy|0|||
163851297|NCT01192295|591825570|FG001|Overall Study|Lack of Efficacy|5|||
163851298|NCT01192295|591825569|FG000|Overall Study|Administrative|4|||
163851299|NCT01192295|591825570|FG001|Overall Study|Administrative|6|||
163851300|NCT00630539|591825571|FG000|Overall Study|Adverse Event|1|||
163851301|NCT00630539|591825572|FG001|Overall Study|Adverse Event|3|||
163851302|NCT00630539|591825573|FG002|Overall Study|Adverse Event|1|||
163851303|NCT00630539|591825574|FG003|Overall Study|Adverse Event|2|||
163851304|NCT00630539|591825571|FG000|Overall Study|Withdrawal by Subject|0|||
163851305|NCT00630539|591825572|FG001|Overall Study|Withdrawal by Subject|1|||
163851306|NCT00630539|591825573|FG002|Overall Study|Withdrawal by Subject|0|||
163851307|NCT00630539|591825574|FG003|Overall Study|Withdrawal by Subject|1|||
163851308|NCT02929108|591825579|FG000|Overall Study|Hospice patient death|100|||
163851309|NCT02929108|591825580|FG001|Overall Study|Hospice patient death|64|||
163851310|NCT02929108|591825581|FG002|Overall Study|Hospice patient death|28|||
163851311|NCT02929108|591825582|FG003|Overall Study|Hospice patient death|46|||
163851312|NCT02929108|591825583|FG004|Overall Study|Hospice patient death|55|||
163851313|NCT02929108|591825584|FG005|Overall Study|Hospice patient death|28|||
163851314|NCT02929108|591825585|FG006|Overall Study|Hospice patient death|78|||
163851315|NCT01027871|591825586|FG000|Overall Study|Physician Decision|1|||
163851316|NCT01027871|591825587|FG001|Overall Study|Physician Decision|5|||
163851317|NCT01027871|591825588|FG002|Overall Study|Physician Decision|0|||
163851318|NCT01027871|591825586|FG000|Overall Study|Protocol Violation|0|||
163851319|NCT01027871|591825587|FG001|Overall Study|Protocol Violation|2|||
163851320|NCT01027871|591825588|FG002|Overall Study|Protocol Violation|2|||
163851321|NCT01027871|591825586|FG000|Overall Study|Withdrawal by Subject|1|||
163851322|NCT01027871|591825587|FG001|Overall Study|Withdrawal by Subject|2|||
163851323|NCT01027871|591825588|FG002|Overall Study|Withdrawal by Subject|2|||
163851324|NCT01027871|591825586|FG000|Overall Study|Adverse Event|0|||
163851325|NCT01027871|591825587|FG001|Overall Study|Adverse Event|2|||
163851326|NCT01027871|591825588|FG002|Overall Study|Adverse Event|2|||
163851327|NCT01027871|591825586|FG000|Overall Study|Sponsor Decision|0|||
163851328|NCT01027871|591825587|FG001|Overall Study|Sponsor Decision|2|||
163851329|NCT01027871|591825588|FG002|Overall Study|Sponsor Decision|0|||
163851330|NCT01027871|591825586|FG000|Overall Study|Discontinued Prior to Treatment|0|||
163851331|NCT01027871|591825587|FG001|Overall Study|Discontinued Prior to Treatment|0|||
163851332|NCT01027871|591825588|FG002|Overall Study|Discontinued Prior to Treatment|1|||
163851333|NCT00052962|591825589|FG000|Overall Study|Not evaluable|0|||
163851334|NCT00052962|591825590|FG001|Overall Study|Not evaluable|2|||
163851335|NCT00052962|591825589|FG000|Overall Study|Not randomized/not evaluable|1|||
163851336|NCT00052962|591825590|FG001|Overall Study|Not randomized/not evaluable|0|||
163851337|NCT01414166|591825591|FG000|Overall Study|Adverse Event|10|||
163851338|NCT01414166|591825592|FG001|Overall Study|Adverse Event|2|||
163851339|NCT01414166|591825591|FG000|Overall Study|Lost to Follow-up|4|||
163851340|NCT01414166|591825592|FG001|Overall Study|Lost to Follow-up|1|||
163851341|NCT01414166|591825591|FG000|Overall Study|Non-compliance with study drug|2|||
163851342|NCT01414166|591825592|FG001|Overall Study|Non-compliance with study drug|0|||
163851343|NCT01414166|591825591|FG000|Overall Study|Physician Decision|2|||
163851344|NCT01414166|591825592|FG001|Overall Study|Physician Decision|0|||
163851345|NCT01414166|591825591|FG000|Overall Study|Protocol Violation|2|||
163851346|NCT01414166|591825592|FG001|Overall Study|Protocol Violation|0|||
163851347|NCT01414166|591825591|FG000|Overall Study|Study terminated by Sponsor|68|||
163851348|NCT01414166|591825592|FG001|Overall Study|Study terminated by Sponsor|75|||
163851349|NCT01414166|591825591|FG000|Overall Study|Withdrawal by Subject|3|||
163851350|NCT01414166|591825592|FG001|Overall Study|Withdrawal by Subject|5|||
163851351|NCT03782727|591825593|FG000|Overall Study|Lost to Follow-up|32|||
163851352|NCT03658811|591825594|FG000|Overall Study|Lost to Follow-up|3|||
163851353|NCT04209790|591825595|FG000|Overall Study|Physician Decision|1|||
163851354|NCT04060680|591825596|FG000|Overall Study|Unsuccessful implant|17|||
163851355|NCT04060680|591825597|FG001|Overall Study|Unsuccessful implant|2|||
163851356|NCT04060680|591825596|FG000|Overall Study|Adverse Event|3|||
163851357|NCT04060680|591825597|FG001|Overall Study|Adverse Event|0|||
163851358|NCT04060680|591825596|FG000|Overall Study|Death|2|||
163851359|NCT04060680|591825597|FG001|Overall Study|Death|0|||
163851360|NCT04060680|591825596|FG000|Overall Study|Study product no longer in use|1|||
163851361|NCT04060680|591825597|FG001|Overall Study|Study product no longer in use|0|||
163851362|NCT04060680|591825596|FG000|Overall Study|Withdrawal by Subject|1|||
163851363|NCT04060680|591825597|FG001|Overall Study|Withdrawal by Subject|0|||
163851364|NCT00940017|591827960|FG000|Overall Study|did not meet entrance criteria|3|||
163851365|NCT00940017|591827960|FG000|Overall Study|Adverse Event|1|||
163851366|NCT05458102|591827961|FG000|Overall Study|Withdrew consent|2|||
163851367|NCT05458102|591827962|FG001|Overall Study|Withdrew consent|0|||
163851368|NCT05458102|591827961|FG000|Overall Study|Adverse Event|1|||
163851369|NCT05458102|591827962|FG001|Overall Study|Adverse Event|0|||
163851370|NCT05458102|591827961|FG000|Overall Study|Enrolled but never treated|1|||
163851371|NCT05458102|591827962|FG001|Overall Study|Enrolled but never treated|0|||
163851372|NCT05458102|591827961|FG000|Overall Study|Protocol Violation|1|||
163851373|NCT05458102|591827962|FG001|Overall Study|Protocol Violation|0|||
163851374|NCT00852475|591827965|FG000|Overall Study|Lost to Follow-up|3|||
163851375|NCT00852475|591827966|FG001|Overall Study|Lost to Follow-up|4|||
163851376|NCT02373813|591827967|FG000|Run-In Period|Other, Not Specified|5|||
163851377|NCT02373813|591827968|FG001|Run-In Period|Other, Not Specified|0|||
163851378|NCT02373813|591827969|FG002|Run-In Period|Other, Not Specified|0|||
163851379|NCT02373813|591827970|FG003|Run-In Period|Other, Not Specified|0|||
163851380|NCT02373813|591827967|FG000|Run-In Period|Withdrawal by Subject|16|||
163851381|NCT02373813|591827968|FG001|Run-In Period|Withdrawal by Subject|0|||
163851382|NCT02373813|591827969|FG002|Run-In Period|Withdrawal by Subject|0|||
163851383|NCT02373813|591827970|FG003|Run-In Period|Withdrawal by Subject|0|||
163851384|NCT02373813|591827967|FG000|Run-In Period|Decision by Sponsor|11|||
163851385|NCT02373813|591827968|FG001|Run-In Period|Decision by Sponsor|0|||
163851386|NCT02373813|591827969|FG002|Run-In Period|Decision by Sponsor|0|||
163851387|NCT02373813|591827970|FG003|Run-In Period|Decision by Sponsor|0|||
163851388|NCT02373813|591827967|FG000|Run-In Period|Protocol Violation|75|||
163851389|NCT02373813|591827968|FG001|Run-In Period|Protocol Violation|0|||
163851390|NCT02373813|591827969|FG002|Run-In Period|Protocol Violation|0|||
163851391|NCT02373813|591827970|FG003|Run-In Period|Protocol Violation|0|||
163851392|NCT02373813|591827967|FG000|Run-In Period|Lost to Follow-up|2|||
163851393|NCT02373813|591827968|FG001|Run-In Period|Lost to Follow-up|0|||
163851394|NCT02373813|591827969|FG002|Run-In Period|Lost to Follow-up|0|||
163851395|NCT02373813|591827970|FG003|Run-In Period|Lost to Follow-up|0|||
163851396|NCT02373813|591827967|FG000|Run-In Period|Adverse Event|3|||
163851397|NCT02373813|591827968|FG001|Run-In Period|Adverse Event|0|||
163851398|NCT02373813|591827969|FG002|Run-In Period|Adverse Event|0|||
163851399|NCT02373813|591827970|FG003|Run-In Period|Adverse Event|0|||
163851400|NCT02373813|591827967|FG000|Run-In Period|Noncompliance|1|||
163851401|NCT02373813|591827968|FG001|Run-In Period|Noncompliance|0|||
163851402|NCT02373813|591827969|FG002|Run-In Period|Noncompliance|0|||
163851403|NCT02373813|591827970|FG003|Run-In Period|Noncompliance|0|||
163851404|NCT02373813|591827967|FG000|Run-In Period|Ineligibility Determined|3|||
163851405|NCT02373813|591827968|FG001|Run-In Period|Ineligibility Determined|0|||
163851406|NCT02373813|591827969|FG002|Run-In Period|Ineligibility Determined|0|||
163851407|NCT02373813|591827970|FG003|Run-In Period|Ineligibility Determined|0|||
163851408|NCT02373813|591827967|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
163851409|NCT02373813|591827968|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
163851410|NCT02373813|591827969|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
163851411|NCT02373813|591827970|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
163851412|NCT02373813|591827967|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
163851413|NCT02373813|591827968|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
163851414|NCT02373813|591827969|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
163851415|NCT02373813|591827970|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
163851416|NCT02373813|591827967|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163851417|NCT02373813|591827968|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
163851418|NCT02373813|591827969|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
163851419|NCT02373813|591827970|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
163851420|NCT02373813|591827967|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
163851421|NCT02373813|591827968|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
163851422|NCT02373813|591827969|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
163851423|NCT02373813|591827970|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
163851424|NCT01511536|591827971|FG000|Phase 1|Other|0|||
163851425|NCT01511536|591827972|FG001|Phase 1|Other|1|||
163851426|NCT01511536|591827973|FG002|Phase 1|Other|0|||
163851427|NCT01511536|591827971|FG000|Phase 2|Other|0|||
163851428|NCT01511536|591827972|FG001|Phase 2|Other|0|||
163851429|NCT01511536|591827973|FG002|Phase 2|Other|9|||
163851430|NCT02703532|591827975|FG000|Overall Study|Withdrawal by Subject|0|||
163851431|NCT02703532|591827976|FG001|Overall Study|Withdrawal by Subject|1|||
163851432|NCT02703532|591827977|FG002|Overall Study|Withdrawal by Subject|0|||
163851433|NCT02703532|591827978|FG003|Overall Study|Withdrawal by Subject|1|||
163851434|NCT02703532|591827975|FG000|Overall Study|Lost to Follow-up|2|||
163851435|NCT02703532|591827976|FG001|Overall Study|Lost to Follow-up|0|||
163851436|NCT02703532|591827977|FG002|Overall Study|Lost to Follow-up|2|||
163851437|NCT02703532|591827978|FG003|Overall Study|Lost to Follow-up|0|||
163851438|NCT00495469|591827979|FG000|Overall Study|Adverse Event|0|||
163851439|NCT00495469|591827980|FG001|Overall Study|Adverse Event|1|||
163851440|NCT00495469|591827981|FG002|Overall Study|Adverse Event|3|||
163851441|NCT00495469|591827982|FG003|Overall Study|Adverse Event|0|||
163851442|NCT00495469|591827983|FG004|Overall Study|Adverse Event|1|||
163851443|NCT00495469|591827984|FG005|Overall Study|Adverse Event|1|||
163851444|NCT00495469|591827985|FG006|Overall Study|Adverse Event|1|||
163851445|NCT00495469|591827979|FG000|Overall Study|Lost to Follow-up|1|||
163851446|NCT00495469|591827980|FG001|Overall Study|Lost to Follow-up|1|||
163851447|NCT00495469|591827981|FG002|Overall Study|Lost to Follow-up|3|||
163851448|NCT00495469|591827982|FG003|Overall Study|Lost to Follow-up|1|||
163851449|NCT00495469|591827983|FG004|Overall Study|Lost to Follow-up|0|||
163851450|NCT00495469|591827984|FG005|Overall Study|Lost to Follow-up|0|||
163851451|NCT00495469|591827985|FG006|Overall Study|Lost to Follow-up|0|||
163851452|NCT00495469|591827979|FG000|Overall Study|Protocol Violation|0|||
163851453|NCT00495469|591827980|FG001|Overall Study|Protocol Violation|0|||
163851454|NCT00495469|591827981|FG002|Overall Study|Protocol Violation|0|||
163851455|NCT00495469|591827982|FG003|Overall Study|Protocol Violation|0|||
163851456|NCT00495469|591827983|FG004|Overall Study|Protocol Violation|1|||
163851457|NCT00495469|591827984|FG005|Overall Study|Protocol Violation|2|||
163851458|NCT00495469|591827985|FG006|Overall Study|Protocol Violation|0|||
163851459|NCT00495469|591827979|FG000|Overall Study|Withdrawal by Subject|5|||
163851460|NCT00495469|591827980|FG001|Overall Study|Withdrawal by Subject|3|||
163851461|NCT00495469|591827981|FG002|Overall Study|Withdrawal by Subject|1|||
163851462|NCT00495469|591827982|FG003|Overall Study|Withdrawal by Subject|3|||
163851463|NCT00495469|591827983|FG004|Overall Study|Withdrawal by Subject|3|||
163851464|NCT00495469|591827984|FG005|Overall Study|Withdrawal by Subject|2|||
163851465|NCT00495469|591827985|FG006|Overall Study|Withdrawal by Subject|3|||
163851466|NCT00495469|591827979|FG000|Overall Study|Lack of Efficacy|0|||
163851467|NCT00495469|591827980|FG001|Overall Study|Lack of Efficacy|0|||
163851468|NCT00495469|591827981|FG002|Overall Study|Lack of Efficacy|0|||
163851469|NCT00495469|591827982|FG003|Overall Study|Lack of Efficacy|0|||
163851470|NCT00495469|591827983|FG004|Overall Study|Lack of Efficacy|0|||
163851471|NCT00495469|591827984|FG005|Overall Study|Lack of Efficacy|0|||
163851472|NCT00495469|591827985|FG006|Overall Study|Lack of Efficacy|1|||
163851473|NCT00495469|591827979|FG000|Overall Study|Liver function test abnormality|0|||
163851474|NCT00495469|591827980|FG001|Overall Study|Liver function test abnormality|1|||
163851475|NCT00495469|591827981|FG002|Overall Study|Liver function test abnormality|0|||
163851476|NCT00495469|591827982|FG003|Overall Study|Liver function test abnormality|0|||
163851477|NCT00495469|591827983|FG004|Overall Study|Liver function test abnormality|0|||
163851478|NCT00495469|591827984|FG005|Overall Study|Liver function test abnormality|0|||
163851479|NCT00495469|591827985|FG006|Overall Study|Liver function test abnormality|0|||
163851480|NCT00495469|591827979|FG000|Overall Study|ST depression at randomisation in ECG|0|||
163851481|NCT00495469|591827980|FG001|Overall Study|ST depression at randomisation in ECG|1|||
163851482|NCT00495469|591827981|FG002|Overall Study|ST depression at randomisation in ECG|0|||
163851483|NCT00495469|591827982|FG003|Overall Study|ST depression at randomisation in ECG|0|||
163851484|NCT00495469|591827983|FG004|Overall Study|ST depression at randomisation in ECG|0|||
163851485|NCT00495469|591827984|FG005|Overall Study|ST depression at randomisation in ECG|0|||
163851486|NCT00495469|591827985|FG006|Overall Study|ST depression at randomisation in ECG|0|||
163851487|NCT00051311|591827986|FG000|Overall Study|Starting new study|0|||
163851488|NCT00051311|591827987|FG001|Overall Study|Starting new study|1|||
163851489|NCT00051311|591827986|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
163851490|NCT00051311|591827987|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
163851491|NCT00051311|591827986|FG000|Overall Study|Death of recipient|8|||
164190535|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
163851492|NCT00051311|591827987|FG001|Overall Study|Death of recipient|8|||
163851493|NCT00051311|591827986|FG000|Overall Study|Recipient taken off study|4|||
163851494|NCT00051311|591827987|FG001|Overall Study|Recipient taken off study|4|||
163851495|NCT04170023|591827988|FG000|LTE Period|Withdrawal by Subject|1|||
163851496|NCT04170023|591827989|FG001|LTE Period|Withdrawal by Subject|0|||
163851497|NCT04170023|591827990|FG002|LTE Period|Withdrawal by Subject|0|||
163851498|NCT04170023|591827988|FG000|LTE Period|Study Termination|11|||
163851499|NCT04170023|591827989|FG001|LTE Period|Study Termination|11|||
163851500|NCT04170023|591827990|FG002|LTE Period|Study Termination|5|||
163851501|NCT04990440|591827991|FG000|Overall Study|Sponsor's Decision|0|||
163851502|NCT04990440|591827992|FG001|Overall Study|Sponsor's Decision|0|||
163851503|NCT04990440|591827993|FG002|Overall Study|Sponsor's Decision|1|||
163851504|NCT03712098|591827994|FG000|Overall Study|Lost to Follow-up|3|||
163851505|NCT03712098|591827995|FG001|Overall Study|Lost to Follow-up|7|||
163851506|NCT03712098|591827994|FG000|Overall Study|Withdrawal by Subject|9|||
163851507|NCT03712098|591827995|FG001|Overall Study|Withdrawal by Subject|4|||
163851508|NCT03712098|591827994|FG000|Overall Study|Protocol Violation|2|||
163851509|NCT03712098|591827995|FG001|Overall Study|Protocol Violation|1|||
163851510|NCT02256969|591827996|FG000|Overall Study|Screenfailed or withdrew|2|||
163851511|NCT02256969|591827997|FG001|Overall Study|Screenfailed or withdrew|1|||
163851512|NCT02256969|591827998|FG002|Overall Study|Screenfailed or withdrew|1|||
163851513|NCT00372567|591827999|FG000|Phase 3 Study|Adverse Event|5|||
163851514|NCT00372567|591828000|FG001|Phase 3 Study|Adverse Event|1|||
163851515|NCT00372567|591828001|FG002|Phase 3 Study|Adverse Event|1|||
163851516|NCT00372567|591827999|FG000|Phase 3 Study|Death|1|||
163851517|NCT00372567|591828000|FG001|Phase 3 Study|Death|1|||
163851518|NCT00372567|591828001|FG002|Phase 3 Study|Death|0|||
163851519|NCT00372567|591827999|FG000|Phase 3 Study|Protocol Violation|0|||
163851520|NCT00372567|591828000|FG001|Phase 3 Study|Protocol Violation|0|||
163851521|NCT00372567|591828001|FG002|Phase 3 Study|Protocol Violation|1|||
163851522|NCT00372567|591827999|FG000|Phase 3 Study|Objective progression or relapse|10|||
163851523|NCT00372567|591828000|FG001|Phase 3 Study|Objective progression or relapse|13|||
163851524|NCT00372567|591828001|FG002|Phase 3 Study|Objective progression or relapse|4|||
163851525|NCT00372567|591827999|FG000|Phase 3 Study|Global deterioration of health status|0|||
163851526|NCT00372567|591828000|FG001|Phase 3 Study|Global deterioration of health status|1|||
163851527|NCT00372567|591828001|FG002|Phase 3 Study|Global deterioration of health status|0|||
163851528|NCT00372567|591827999|FG000|Phase 3 Study|Other|2|||
163851529|NCT00372567|591828000|FG001|Phase 3 Study|Other|2|||
163851530|NCT00372567|591828001|FG002|Phase 3 Study|Other|1|||
163851531|NCT00372567|591827999|FG000|Phase 3 Study|study terminated by sponsor|13|||
163851532|NCT00372567|591828000|FG001|Phase 3 Study|study terminated by sponsor|8|||
163851533|NCT00372567|591828001|FG002|Phase 3 Study|study terminated by sponsor|5|||
163851534|NCT00953160|591828002|FG000|Overall Study|Lost to Follow-up|23|||
163851535|NCT00953160|591828002|FG000|Overall Study|Withdrawal by Subject|4|||
163851536|NCT03836664|591828005|FG000|Overall Study|Didn't complete forms and lost drug|3|||
163851537|NCT03836664|591828006|FG001|Overall Study|Didn't complete forms and lost drug|3|||
163851538|NCT01427907|591828007|FG000|Overall Study|Withdrawal by Subject|3|||
163851539|NCT01427907|591828008|FG001|Overall Study|Withdrawal by Subject|4|||
163851540|NCT00425503|591828011|FG000|Overall Study|Adverse Event|2|||
163851541|NCT00425503|591828011|FG000|Overall Study|Protocol Violation|1|||
163851542|NCT03278028|591828013|FG000|Overall Study|Lost to Follow-up|1|||
163851543|NCT03278028|591828014|FG001|Overall Study|Lost to Follow-up|0|||
163851544|NCT03278028|591828013|FG000|Overall Study|Withdrawal by Subject|3|||
163851545|NCT03278028|591828014|FG001|Overall Study|Withdrawal by Subject|1|||
163851546|NCT03278028|591828013|FG000|Overall Study|Pregnancy|0|||
163851547|NCT03278028|591828014|FG001|Overall Study|Pregnancy|1|||
163851548|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
163851549|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
163851550|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
163851551|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
163851552|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
163964575|NCT01968070|592243217|FG006|Period 1|Physician Decision|0|||
163964576|NCT01968070|592243218|FG007|Period 1|Physician Decision|0|||
163964577|NCT01968070|592243219|FG008|Period 1|Physician Decision|0|||
163964578|NCT01968070|592243220|FG009|Period 1|Physician Decision|0|||
163964579|NCT01968070|592243221|FG010|Period 1|Physician Decision|0|||
163964580|NCT01968070|592243222|FG011|Period 1|Physician Decision|1|||
163964581|NCT01968070|592243223|FG012|Period 1|Physician Decision|0|||
163964582|NCT01968070|592243224|FG013|Period 1|Physician Decision|0|||
163964583|NCT01968070|592243225|FG014|Period 1|Physician Decision|0|||
163964584|NCT01968070|592243226|FG015|Period 1|Physician Decision|0|||
163964585|NCT01968070|592243227|FG016|Period 1|Physician Decision|0|||
163964586|NCT01968070|592243228|FG017|Period 1|Physician Decision|0|||
163964587|NCT01968070|592243211|FG000|Period 2|Withdrawal by Subject|0|||
163964588|NCT01968070|592243212|FG001|Period 2|Withdrawal by Subject|0|||
163964589|NCT01968070|592243213|FG002|Period 2|Withdrawal by Subject|0|||
163964590|NCT01968070|592243214|FG003|Period 2|Withdrawal by Subject|0|||
163964591|NCT01968070|592243215|FG004|Period 2|Withdrawal by Subject|1|||
163964592|NCT01968070|592243216|FG005|Period 2|Withdrawal by Subject|0|||
163964593|NCT01968070|592243217|FG006|Period 2|Withdrawal by Subject|0|||
163964594|NCT01968070|592243218|FG007|Period 2|Withdrawal by Subject|0|||
163851553|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
163851554|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
163851555|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
163851556|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
163851557|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
163964595|NCT01968070|592243219|FG008|Period 2|Withdrawal by Subject|0|||
163964596|NCT01968070|592243220|FG009|Period 2|Withdrawal by Subject|0|||
163964597|NCT01968070|592243221|FG010|Period 2|Withdrawal by Subject|0|||
163851558|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
163851559|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
163851560|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
163851561|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
163851562|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
163851563|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
163851564|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
163851565|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
163851566|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
163851567|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
163851568|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
163851569|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
163851570|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
163851571|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
163851572|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
163851573|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
163851574|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
163851575|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
163851576|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163851577|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
163851578|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163851579|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
163851580|NCT03890120|591828016|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163851581|NCT03890120|591828017|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
163851582|NCT03890120|591828018|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163851583|NCT03890120|591828019|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
163851584|NCT03890120|591828016|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
163851585|NCT03890120|591828017|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
163851586|NCT03890120|591828018|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
163851587|NCT03890120|591828019|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
163851588|NCT03890120|591828016|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
163851589|NCT03890120|591828017|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
163851590|NCT03890120|591828018|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
163851591|NCT03890120|591828019|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
163851592|NCT03890120|591828016|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
163851593|NCT03890120|591828017|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
163851594|NCT03890120|591828018|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
163851595|NCT03890120|591828019|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
163851596|NCT03890120|591828016|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
163851597|NCT03890120|591828017|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
163851598|NCT03890120|591828018|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
163851599|NCT03890120|591828019|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
163851600|NCT01052662|591828020|FG000|Overall Study|Lost to Follow-up|15|||
163851601|NCT01052662|591828021|FG001|Overall Study|Lost to Follow-up|13|||
163851602|NCT01052662|591828022|FG002|Overall Study|Lost to Follow-up|18|||
163851603|NCT01052662|591828020|FG000|Overall Study|Withdrawal by Subject|3|||
163851604|NCT01052662|591828021|FG001|Overall Study|Withdrawal by Subject|2|||
163851605|NCT01052662|591828022|FG002|Overall Study|Withdrawal by Subject|1|||
163851606|NCT01052662|591828020|FG000|Overall Study|Pharmacy issue|1|||
163851607|NCT01052662|591828021|FG001|Overall Study|Pharmacy issue|3|||
163851608|NCT01052662|591828022|FG002|Overall Study|Pharmacy issue|3|||
163851609|NCT01052662|591828020|FG000|Overall Study|Adverse Event|1|||
163851610|NCT01052662|591828021|FG001|Overall Study|Adverse Event|1|||
163851611|NCT01052662|591828022|FG002|Overall Study|Adverse Event|0|||
163851612|NCT01052662|591828020|FG000|Overall Study|Legal Problem|2|||
163851613|NCT01052662|591828021|FG001|Overall Study|Legal Problem|0|||
163851614|NCT01052662|591828022|FG002|Overall Study|Legal Problem|0|||
163851615|NCT01052662|591828020|FG000|Overall Study|Administrative|0|||
163851616|NCT01052662|591828021|FG001|Overall Study|Administrative|3|||
163851617|NCT01052662|591828022|FG002|Overall Study|Administrative|0|||
163851618|NCT00479674|591828023|FG000|Overall Study|Adverse Event|18|||
163851619|NCT00479674|591828023|FG000|Overall Study|Withdrawal by Subject|6|||
163851620|NCT00479674|591828023|FG000|Overall Study|Physician Decision|14|||
163851621|NCT00479674|591828023|FG000|Overall Study|none provided|3|||
163851622|NCT02478359|591828025|FG000|Overall Study|Disenrolled from health plan|106|||
163851623|NCT02478359|591828026|FG001|Overall Study|Disenrolled from health plan|65|||
163851624|NCT03293485|591828028|FG000|Overall Study|Death|1|||
163851625|NCT03293485|591828028|FG000|Overall Study|Screen Failure|2|||
164076352|NCT02556632|592643711|FG000|Overall Study|Unrelated Adverse Event|1|||
163851626|NCT03293485|591828028|FG000|Overall Study|Withdrawal by Subject|2|||
163851627|NCT03633903|591828031|FG000|Overall Study|Withdrawal by Subject|1|||
163851628|NCT03633903|591828032|FG001|Overall Study|Withdrawal by Subject|2|||
163851629|NCT03633903|591828031|FG000|Overall Study|Lost to Follow-up|5|||
163851630|NCT03633903|591828032|FG001|Overall Study|Lost to Follow-up|5|||
163851631|NCT01813422|591828033|FG000|Overall Study|Withdrawal by Subject|14|||
163851632|NCT01813422|591828034|FG001|Overall Study|Withdrawal by Subject|8|||
163851633|NCT01813422|591828033|FG000|Overall Study|Death|2|||
163851634|NCT01813422|591828034|FG001|Overall Study|Death|3|||
163851635|NCT01813422|591828033|FG000|Overall Study|Sponsor Decision|2|||
163851636|NCT01813422|591828034|FG001|Overall Study|Sponsor Decision|1|||
163851637|NCT01813422|591828033|FG000|Overall Study|Lost to Follow-up|2|||
163851638|NCT01813422|591828034|FG001|Overall Study|Lost to Follow-up|4|||
163851639|NCT00410384|591828040|FG000|Overall Study|Withdrawal by Subject|28|||
163851640|NCT00410384|591828041|FG001|Overall Study|Withdrawal by Subject|17|||
163851641|NCT00410384|591828042|FG002|Overall Study|Withdrawal by Subject|20|||
163851642|NCT00410384|591828040|FG000|Overall Study|Adverse Event|23|||
163851643|NCT00410384|591828041|FG001|Overall Study|Adverse Event|18|||
163851644|NCT00410384|591828042|FG002|Overall Study|Adverse Event|23|||
163851645|NCT00410384|591828040|FG000|Overall Study|Lack of Efficacy|20|||
163851646|NCT00410384|591828041|FG001|Overall Study|Lack of Efficacy|12|||
163851647|NCT00410384|591828042|FG002|Overall Study|Lack of Efficacy|17|||
163851648|NCT00410384|591828040|FG000|Overall Study|Lack of Compliance|2|||
163851649|NCT00410384|591828041|FG001|Overall Study|Lack of Compliance|2|||
163851650|NCT00410384|591828042|FG002|Overall Study|Lack of Compliance|2|||
163851651|NCT00410384|591828040|FG000|Overall Study|Lost to Follow-up|4|||
163851652|NCT00410384|591828041|FG001|Overall Study|Lost to Follow-up|6|||
163851653|NCT00410384|591828042|FG002|Overall Study|Lost to Follow-up|6|||
163851654|NCT00410384|591828040|FG000|Overall Study|Protocol Violation|6|||
163851655|NCT00410384|591828041|FG001|Overall Study|Protocol Violation|6|||
163851656|NCT00410384|591828042|FG002|Overall Study|Protocol Violation|6|||
163851657|NCT00410384|591828040|FG000|Overall Study|Physician Decision|3|||
163851658|NCT00410384|591828041|FG001|Overall Study|Physician Decision|3|||
163851659|NCT00410384|591828042|FG002|Overall Study|Physician Decision|4|||
163851660|NCT00410384|591828040|FG000|Overall Study|Other|3|||
163851661|NCT00410384|591828041|FG001|Overall Study|Other|8|||
163851662|NCT00410384|591828042|FG002|Overall Study|Other|4|||
163851663|NCT00577629|591828052|FG000|Treatment Period|Death|1|||
163851664|NCT00577629|591828052|FG000|Long Term Follow-Up|Death|15|||
163851665|NCT00577629|591828052|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
163851666|NCT00577629|591828052|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
163851667|NCT00577629|591828052|FG000|Long Term Follow-Up|Physician Decision|1|||
163851668|NCT05489224|591828053|FG000|Treatment Period I|Withdrawal by Subject|6|||
164190536|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
164190537|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
164190538|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
164190539|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
164190540|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
164190541|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
164190542|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
164190543|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
164190544|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
164190545|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
164190546|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
164190547|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
164190548|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190549|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190550|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190551|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190552|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190553|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190554|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
164190555|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164302038|NCT03847896|593482507|FG003|Overall Study|Other reasons|2|||
163851669|NCT05489224|591828054|FG001|Treatment Period I|Withdrawal by Subject|5|||
163851670|NCT05489224|591828055|FG002|Treatment Period I|Withdrawal by Subject|0|||
163851671|NCT05489224|591828053|FG000|Treatment Period I|Adverse Event|3|||
163851672|NCT05489224|591828054|FG001|Treatment Period I|Adverse Event|11|||
163851673|NCT05489224|591828055|FG002|Treatment Period I|Adverse Event|0|||
163851674|NCT05489224|591828053|FG000|Treatment Period I|Lost to Follow-up|0|||
163851675|NCT05489224|591828054|FG001|Treatment Period I|Lost to Follow-up|1|||
163851676|NCT05489224|591828055|FG002|Treatment Period I|Lost to Follow-up|0|||
163851677|NCT05489224|591828053|FG000|Treatment Period I|Physician Decision|0|||
163851678|NCT05489224|591828054|FG001|Treatment Period I|Physician Decision|1|||
163851679|NCT05489224|591828055|FG002|Treatment Period I|Physician Decision|0|||
163851680|NCT05489224|591828053|FG000|Treatment Period II up to Week 32|Ongoing|222|||
163851681|NCT05489224|591828054|FG001|Treatment Period II up to Week 32|Ongoing|107|||
163851682|NCT05489224|591828055|FG002|Treatment Period II up to Week 32|Ongoing|107|||
163851683|NCT05489224|591828053|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
163851684|NCT05489224|591828054|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
163851685|NCT05489224|591828055|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
163851686|NCT05489224|591828053|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
163851687|NCT05489224|591828054|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
163851688|NCT05489224|591828055|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
163851689|NCT04887285|591828056|FG000|Overall Study|Lost to Follow-up|0|||
163851690|NCT04887285|591828057|FG001|Overall Study|Lost to Follow-up|2|||
163851691|NCT04887285|591828058|FG002|Overall Study|Lost to Follow-up|3|||
163851692|NCT04640571|591828059|FG000|Overall Study|Withdrawal by Subject|0|||
163851693|NCT04640571|591828060|FG001|Overall Study|Withdrawal by Subject|0|||
163851694|NCT04640571|591828061|FG002|Overall Study|Withdrawal by Subject|0|||
163851695|NCT04640571|591828062|FG003|Overall Study|Withdrawal by Subject|0|||
163851696|NCT04640571|591828063|FG004|Overall Study|Withdrawal by Subject|0|||
163851697|NCT04640571|591828064|FG005|Overall Study|Withdrawal by Subject|2|||
163851698|NCT00832780|591828069|FG000|Overall Study|Death|16|||
163851699|NCT00832780|591828069|FG000|Overall Study|Lost to Follow-up|4|||
163851700|NCT00832780|591828069|FG000|Overall Study|no reason given|2|||
163851701|NCT00832780|591828069|FG000|Overall Study|other complicating condition|2|||
163851702|NCT00832780|591828069|FG000|Overall Study|Physician Decision|1|||
163851703|NCT05705167|591828070|FG000|Overall Study|Randomised but not Treated|0|||
163851704|NCT05705167|591828071|FG001|Overall Study|Randomised but not Treated|2|||
163851705|NCT05705167|591828072|FG002|Overall Study|Randomised but not Treated|0|||
163851706|NCT05705167|591828073|FG003|Overall Study|Randomised but not Treated|7|||
163851707|NCT05705167|591828074|FG004|Overall Study|Randomised but not Treated|0|||
163851708|NCT05705167|591828075|FG005|Overall Study|Randomised but not Treated|0|||
163851709|NCT05705167|591828076|FG006|Overall Study|Randomised but not Treated|0|||
163851710|NCT05705167|591828070|FG000|Overall Study|Death|0|||
163851711|NCT05705167|591828071|FG001|Overall Study|Death|0|||
163851712|NCT05705167|591828072|FG002|Overall Study|Death|3|||
163851713|NCT05705167|591828073|FG003|Overall Study|Death|0|||
163851714|NCT05705167|591828074|FG004|Overall Study|Death|1|||
163851715|NCT05705167|591828075|FG005|Overall Study|Death|1|||
163851716|NCT05705167|591828076|FG006|Overall Study|Death|1|||
163851717|NCT05705167|591828070|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163851718|NCT05705167|591828071|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163851719|NCT05705167|591828072|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
163851720|NCT05705167|591828073|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
163851721|NCT05705167|591828074|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163851722|NCT05705167|591828075|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
163851723|NCT05705167|591828076|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
163851724|NCT01670500|591828079|FG000|Overall Study|Withdrawal by Subject|1|||
163851725|NCT01670500|591828080|FG001|Overall Study|Withdrawal by Subject|0|||
163851726|NCT04955626|591828081|FG000|Blinded Period|Lost to Follow-up|28|||
163851727|NCT04955626|591828082|FG001|Blinded Period|Lost to Follow-up|28|||
163851728|NCT04955626|591828083|FG002|Blinded Period|Lost to Follow-up|7|||
163851729|NCT04955626|591828084|FG003|Blinded Period|Lost to Follow-up|14|||
163851730|NCT04955626|591828085|FG004|Blinded Period|Lost to Follow-up|3|||
163851731|NCT04955626|591828086|FG005|Blinded Period|Lost to Follow-up|2|||
163851732|NCT04955626|591828087|FG006|Blinded Period|Lost to Follow-up|6|||
163851733|NCT04955626|591828088|FG007|Blinded Period|Lost to Follow-up|4|||
163851734|NCT04955626|591828089|FG008|Blinded Period|Lost to Follow-up|5|||
163851735|NCT04955626|591828090|FG009|Blinded Period|Lost to Follow-up|8|||
163851736|NCT04955626|591828091|FG010|Blinded Period|Lost to Follow-up|10|||
163851737|NCT04955626|591828092|FG011|Blinded Period|Lost to Follow-up|32|||
163851738|NCT04955626|591828093|FG012|Blinded Period|Lost to Follow-up|0|||
163851739|NCT04955626|591828094|FG013|Blinded Period|Lost to Follow-up|0|||
163851740|NCT04955626|591828095|FG014|Blinded Period|Lost to Follow-up|0|||
163851741|NCT04955626|591828096|FG015|Blinded Period|Lost to Follow-up|12|||
163851742|NCT04955626|591828097|FG016|Blinded Period|Lost to Follow-up|2|||
163851743|NCT04955626|591828098|FG017|Blinded Period|Lost to Follow-up|5|||
164190556|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
163851744|NCT04955626|591828099|FG018|Blinded Period|Lost to Follow-up|0|||
163851745|NCT04955626|591828100|FG019|Blinded Period|Lost to Follow-up|0|||
163851746|NCT04955626|591828101|FG020|Blinded Period|Lost to Follow-up|0|||
163851747|NCT04955626|591828102|FG021|Blinded Period|Lost to Follow-up|0|||
163851748|NCT04955626|591828103|FG022|Blinded Period|Lost to Follow-up|0|||
163851749|NCT04955626|591828104|FG023|Blinded Period|Lost to Follow-up|0|||
163851750|NCT04955626|591828105|FG024|Blinded Period|Lost to Follow-up|3|||
163851751|NCT04955626|591828106|FG025|Blinded Period|Lost to Follow-up|1|||
163851752|NCT04955626|591828107|FG026|Blinded Period|Lost to Follow-up|2|||
163851753|NCT04955626|591828108|FG027|Blinded Period|Lost to Follow-up|2|||
163851754|NCT04955626|591828109|FG028|Blinded Period|Lost to Follow-up|2|||
163851755|NCT04955626|591828110|FG029|Blinded Period|Lost to Follow-up|0|||
163851756|NCT04955626|591828111|FG030|Blinded Period|Lost to Follow-up|0|||
163851757|NCT04955626|591828112|FG031|Blinded Period|Lost to Follow-up|0|||
163851758|NCT04955626|591828113|FG032|Blinded Period|Lost to Follow-up|0|||
163851759|NCT04955626|591828114|FG033|Blinded Period|Lost to Follow-up|0|||
163851760|NCT04955626|591828115|FG034|Blinded Period|Lost to Follow-up|0|||
163851761|NCT04955626|591828116|FG035|Blinded Period|Lost to Follow-up|0|||
163851762|NCT04955626|591828081|FG000|Blinded Period|Protocol Violation|5|||
163851763|NCT04955626|591828082|FG001|Blinded Period|Protocol Violation|14|||
163851764|NCT04955626|591828083|FG002|Blinded Period|Protocol Violation|0|||
163851765|NCT04955626|591828084|FG003|Blinded Period|Protocol Violation|1|||
163851766|NCT04955626|591828085|FG004|Blinded Period|Protocol Violation|2|||
163851767|NCT04955626|591828086|FG005|Blinded Period|Protocol Violation|2|||
163851768|NCT04955626|591828087|FG006|Blinded Period|Protocol Violation|0|||
163851769|NCT04955626|591828088|FG007|Blinded Period|Protocol Violation|0|||
163851770|NCT04955626|591828089|FG008|Blinded Period|Protocol Violation|0|||
163851771|NCT04955626|591828090|FG009|Blinded Period|Protocol Violation|4|||
163851772|NCT04955626|591828091|FG010|Blinded Period|Protocol Violation|6|||
163851773|NCT04955626|591828092|FG011|Blinded Period|Protocol Violation|1|||
163851774|NCT04955626|591828093|FG012|Blinded Period|Protocol Violation|0|||
163851775|NCT04955626|591828094|FG013|Blinded Period|Protocol Violation|0|||
163851776|NCT04955626|591828095|FG014|Blinded Period|Protocol Violation|2|||
163851777|NCT04955626|591828096|FG015|Blinded Period|Protocol Violation|6|||
163851778|NCT04955626|591828097|FG016|Blinded Period|Protocol Violation|4|||
163851779|NCT04955626|591828098|FG017|Blinded Period|Protocol Violation|6|||
163851780|NCT04955626|591828099|FG018|Blinded Period|Protocol Violation|0|||
163851781|NCT04955626|591828100|FG019|Blinded Period|Protocol Violation|1|||
163851782|NCT04955626|591828101|FG020|Blinded Period|Protocol Violation|0|||
163851783|NCT04955626|591828102|FG021|Blinded Period|Protocol Violation|1|||
163851784|NCT04955626|591828103|FG022|Blinded Period|Protocol Violation|0|||
163851785|NCT04955626|591828104|FG023|Blinded Period|Protocol Violation|0|||
163851786|NCT04955626|591828105|FG024|Blinded Period|Protocol Violation|4|||
163851787|NCT04955626|591828106|FG025|Blinded Period|Protocol Violation|6|||
163851788|NCT04955626|591828107|FG026|Blinded Period|Protocol Violation|5|||
163851789|NCT04955626|591828108|FG027|Blinded Period|Protocol Violation|3|||
163851790|NCT04955626|591828109|FG028|Blinded Period|Protocol Violation|4|||
163851791|NCT04955626|591828110|FG029|Blinded Period|Protocol Violation|3|||
163851792|NCT04955626|591828111|FG030|Blinded Period|Protocol Violation|0|||
163851793|NCT04955626|591828112|FG031|Blinded Period|Protocol Violation|0|||
163851794|NCT04955626|591828113|FG032|Blinded Period|Protocol Violation|0|||
163851795|NCT04955626|591828114|FG033|Blinded Period|Protocol Violation|0|||
163851796|NCT04955626|591828115|FG034|Blinded Period|Protocol Violation|0|||
163851797|NCT04955626|591828116|FG035|Blinded Period|Protocol Violation|0|||
163851798|NCT04955626|591828081|FG000|Blinded Period|Death|0|||
163851799|NCT04955626|591828082|FG001|Blinded Period|Death|2|||
163851800|NCT04955626|591828083|FG002|Blinded Period|Death|0|||
163851801|NCT04955626|591828084|FG003|Blinded Period|Death|0|||
163851802|NCT04955626|591828085|FG004|Blinded Period|Death|0|||
163851803|NCT04955626|591828086|FG005|Blinded Period|Death|0|||
163851804|NCT04955626|591828087|FG006|Blinded Period|Death|0|||
163851805|NCT04955626|591828088|FG007|Blinded Period|Death|2|||
163851806|NCT04955626|591828089|FG008|Blinded Period|Death|1|||
163851807|NCT04955626|591828090|FG009|Blinded Period|Death|1|||
163851808|NCT04955626|591828091|FG010|Blinded Period|Death|0|||
163851809|NCT04955626|591828092|FG011|Blinded Period|Death|2|||
163851810|NCT04955626|591828093|FG012|Blinded Period|Death|0|||
163851811|NCT04955626|591828094|FG013|Blinded Period|Death|0|||
163851812|NCT04955626|591828095|FG014|Blinded Period|Death|0|||
163851813|NCT04955626|591828096|FG015|Blinded Period|Death|0|||
163851814|NCT04955626|591828097|FG016|Blinded Period|Death|0|||
163851815|NCT04955626|591828098|FG017|Blinded Period|Death|0|||
163851816|NCT04955626|591828099|FG018|Blinded Period|Death|0|||
163851817|NCT04955626|591828100|FG019|Blinded Period|Death|0|||
163851818|NCT04955626|591828101|FG020|Blinded Period|Death|0|||
163851819|NCT04955626|591828102|FG021|Blinded Period|Death|0|||
163851820|NCT04955626|591828103|FG022|Blinded Period|Death|0|||
163851821|NCT04955626|591828104|FG023|Blinded Period|Death|1|||
163851822|NCT04955626|591828105|FG024|Blinded Period|Death|0|||
163851823|NCT04955626|591828106|FG025|Blinded Period|Death|0|||
163851824|NCT04955626|591828107|FG026|Blinded Period|Death|1|||
163851825|NCT04955626|591828108|FG027|Blinded Period|Death|1|||
163851826|NCT04955626|591828109|FG028|Blinded Period|Death|0|||
163851827|NCT04955626|591828110|FG029|Blinded Period|Death|1|||
163851828|NCT04955626|591828111|FG030|Blinded Period|Death|0|||
163851829|NCT04955626|591828112|FG031|Blinded Period|Death|0|||
163851830|NCT04955626|591828113|FG032|Blinded Period|Death|0|||
163851831|NCT04955626|591828114|FG033|Blinded Period|Death|0|||
163851832|NCT04955626|591828115|FG034|Blinded Period|Death|0|||
163851833|NCT04955626|591828116|FG035|Blinded Period|Death|0|||
163851834|NCT04955626|591828081|FG000|Blinded Period|Adverse Event|0|||
163851835|NCT04955626|591828082|FG001|Blinded Period|Adverse Event|1|||
163851836|NCT04955626|591828083|FG002|Blinded Period|Adverse Event|1|||
163851837|NCT04955626|591828084|FG003|Blinded Period|Adverse Event|1|||
163851838|NCT04955626|591828085|FG004|Blinded Period|Adverse Event|0|||
163851839|NCT04955626|591828086|FG005|Blinded Period|Adverse Event|0|||
163851840|NCT04955626|591828087|FG006|Blinded Period|Adverse Event|0|||
164190557|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190558|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190559|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190560|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190561|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190562|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190563|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190564|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190565|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
164190566|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
164190567|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190568|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190569|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190570|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
164190571|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
164190572|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
164190573|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
164190574|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
164190575|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
164190576|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
164190577|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
164190578|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
164190579|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
164190580|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
164190581|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
164190582|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
164190583|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
164190584|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
164190585|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
164190586|NCT03428100|593066300|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190587|NCT03428100|593066301|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190588|NCT03428100|593066302|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190589|NCT03428100|593066303|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190590|NCT03428100|593066304|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190591|NCT03428100|593066305|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190592|NCT03428100|593066306|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
164190593|NCT03428100|593066307|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190594|NCT03428100|593066308|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190595|NCT03428100|593066309|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
164190596|NCT03428100|593066310|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
164190597|NCT03428100|593066311|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
164190598|NCT03428100|593066312|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190599|NCT03428100|593066313|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
164190600|NCT03428100|593066314|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
164190601|NCT03428100|593066315|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190602|NCT03428100|593066316|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
164190603|NCT03428100|593066317|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
164190604|NCT03428100|593066318|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
164190605|NCT01048541|593066321|FG000|Overall Study|Withdrawal by Subject|1|||
164190606|NCT01048541|593066322|FG001|Overall Study|Withdrawal by Subject|0|||
164190607|NCT00922116|593066323|FG000|Overall Study|Adverse Event|4|||
164190608|NCT00922116|593066323|FG000|Overall Study|Death|1|||
164190609|NCT00922116|593066323|FG000|Overall Study|Lost to Follow-up|1|||
164190610|NCT00922116|593066323|FG000|Overall Study|Withdrawal by Subject|4|||
164190611|NCT00922116|593066323|FG000|Overall Study|Other|5|||
164190612|NCT02258659|593066325|FG000|Overall Study|Withdrawal by Subject|1|||
164190613|NCT03990051|593066326|FG000|Masked Period|Lost to Follow-up|1|||
164190614|NCT03990051|593066327|FG001|Masked Period|Lost to Follow-up|0|||
164190615|NCT03990051|593066326|FG000|Long Term Period|Death|1|||
164190616|NCT03990051|593066327|FG001|Long Term Period|Death|1|||
164190617|NCT03990051|593066326|FG000|Long Term Period|Lost to Follow-up|7|||
164190618|NCT03990051|593066327|FG001|Long Term Period|Lost to Follow-up|2|||
164190619|NCT01411852|593066328|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
164190620|NCT01411852|593066329|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
163851841|NCT04955626|591828088|FG007|Blinded Period|Adverse Event|0|||
163851842|NCT04955626|591828089|FG008|Blinded Period|Adverse Event|0|||
163851843|NCT04955626|591828090|FG009|Blinded Period|Adverse Event|1|||
163851844|NCT04955626|591828091|FG010|Blinded Period|Adverse Event|1|||
163851845|NCT04955626|591828092|FG011|Blinded Period|Adverse Event|0|||
163851846|NCT04955626|591828093|FG012|Blinded Period|Adverse Event|0|||
163851847|NCT04955626|591828094|FG013|Blinded Period|Adverse Event|0|||
163851848|NCT04955626|591828095|FG014|Blinded Period|Adverse Event|0|||
163851849|NCT04955626|591828096|FG015|Blinded Period|Adverse Event|0|||
163851850|NCT04955626|591828097|FG016|Blinded Period|Adverse Event|0|||
163851851|NCT04955626|591828098|FG017|Blinded Period|Adverse Event|0|||
163851852|NCT04955626|591828099|FG018|Blinded Period|Adverse Event|1|||
163851853|NCT04955626|591828100|FG019|Blinded Period|Adverse Event|0|||
163851854|NCT04955626|591828101|FG020|Blinded Period|Adverse Event|0|||
163851855|NCT04955626|591828102|FG021|Blinded Period|Adverse Event|0|||
163851856|NCT04955626|591828103|FG022|Blinded Period|Adverse Event|0|||
163851857|NCT04955626|591828104|FG023|Blinded Period|Adverse Event|0|||
163851858|NCT04955626|591828105|FG024|Blinded Period|Adverse Event|0|||
163851859|NCT04955626|591828106|FG025|Blinded Period|Adverse Event|0|||
163851860|NCT04955626|591828107|FG026|Blinded Period|Adverse Event|1|||
163851861|NCT04955626|591828108|FG027|Blinded Period|Adverse Event|0|||
163851862|NCT04955626|591828109|FG028|Blinded Period|Adverse Event|0|||
163851863|NCT04955626|591828110|FG029|Blinded Period|Adverse Event|0|||
163851864|NCT04955626|591828111|FG030|Blinded Period|Adverse Event|0|||
163851865|NCT04955626|591828112|FG031|Blinded Period|Adverse Event|0|||
163851866|NCT04955626|591828113|FG032|Blinded Period|Adverse Event|0|||
163851867|NCT04955626|591828114|FG033|Blinded Period|Adverse Event|0|||
163851868|NCT04955626|591828115|FG034|Blinded Period|Adverse Event|0|||
163851869|NCT04955626|591828116|FG035|Blinded Period|Adverse Event|0|||
163851870|NCT04955626|591828081|FG000|Blinded Period|No longer meets eligibility criteria|1|||
163851871|NCT04955626|591828082|FG001|Blinded Period|No longer meets eligibility criteria|2|||
163851872|NCT04955626|591828083|FG002|Blinded Period|No longer meets eligibility criteria|0|||
163851873|NCT04955626|591828084|FG003|Blinded Period|No longer meets eligibility criteria|1|||
163851874|NCT04955626|591828085|FG004|Blinded Period|No longer meets eligibility criteria|0|||
163851875|NCT04955626|591828086|FG005|Blinded Period|No longer meets eligibility criteria|0|||
163851876|NCT04955626|591828087|FG006|Blinded Period|No longer meets eligibility criteria|0|||
163851877|NCT04955626|591828088|FG007|Blinded Period|No longer meets eligibility criteria|0|||
163851878|NCT04955626|591828089|FG008|Blinded Period|No longer meets eligibility criteria|1|||
163851879|NCT04955626|591828090|FG009|Blinded Period|No longer meets eligibility criteria|0|||
163851880|NCT04955626|591828091|FG010|Blinded Period|No longer meets eligibility criteria|1|||
163851881|NCT04955626|591828092|FG011|Blinded Period|No longer meets eligibility criteria|1|||
163851882|NCT04955626|591828093|FG012|Blinded Period|No longer meets eligibility criteria|0|||
163851883|NCT04955626|591828094|FG013|Blinded Period|No longer meets eligibility criteria|0|||
163851884|NCT04955626|591828095|FG014|Blinded Period|No longer meets eligibility criteria|0|||
163851885|NCT04955626|591828096|FG015|Blinded Period|No longer meets eligibility criteria|3|||
163851886|NCT04955626|591828097|FG016|Blinded Period|No longer meets eligibility criteria|0|||
163851887|NCT04955626|591828098|FG017|Blinded Period|No longer meets eligibility criteria|2|||
163851888|NCT04955626|591828099|FG018|Blinded Period|No longer meets eligibility criteria|0|||
163851889|NCT04955626|591828100|FG019|Blinded Period|No longer meets eligibility criteria|0|||
163851890|NCT04955626|591828101|FG020|Blinded Period|No longer meets eligibility criteria|0|||
163851891|NCT04955626|591828102|FG021|Blinded Period|No longer meets eligibility criteria|0|||
163851892|NCT04955626|591828103|FG022|Blinded Period|No longer meets eligibility criteria|0|||
163851893|NCT04955626|591828104|FG023|Blinded Period|No longer meets eligibility criteria|0|||
163851894|NCT04955626|591828105|FG024|Blinded Period|No longer meets eligibility criteria|1|||
163851895|NCT04955626|591828106|FG025|Blinded Period|No longer meets eligibility criteria|0|||
163851896|NCT04955626|591828107|FG026|Blinded Period|No longer meets eligibility criteria|0|||
163851897|NCT04955626|591828108|FG027|Blinded Period|No longer meets eligibility criteria|1|||
163851898|NCT04955626|591828109|FG028|Blinded Period|No longer meets eligibility criteria|0|||
163851899|NCT04955626|591828110|FG029|Blinded Period|No longer meets eligibility criteria|0|||
163851900|NCT04955626|591828111|FG030|Blinded Period|No longer meets eligibility criteria|0|||
163851901|NCT04955626|591828112|FG031|Blinded Period|No longer meets eligibility criteria|0|||
163851902|NCT04955626|591828113|FG032|Blinded Period|No longer meets eligibility criteria|0|||
163851903|NCT04955626|591828114|FG033|Blinded Period|No longer meets eligibility criteria|0|||
163851904|NCT04955626|591828115|FG034|Blinded Period|No longer meets eligibility criteria|0|||
163964598|NCT01968070|592243222|FG011|Period 2|Withdrawal by Subject|0|||
163851905|NCT04955626|591828116|FG035|Blinded Period|No longer meets eligibility criteria|0|||
163851906|NCT04955626|591828081|FG000|Blinded Period|Other|54|||
163851907|NCT04955626|591828082|FG001|Blinded Period|Other|3|||
163851908|NCT04955626|591828083|FG002|Blinded Period|Other|4|||
163851909|NCT04955626|591828084|FG003|Blinded Period|Other|2|||
163851910|NCT04955626|591828085|FG004|Blinded Period|Other|0|||
163851911|NCT04955626|591828086|FG005|Blinded Period|Other|0|||
163851912|NCT04955626|591828087|FG006|Blinded Period|Other|2|||
163851913|NCT04955626|591828088|FG007|Blinded Period|Other|2|||
163851914|NCT04955626|591828089|FG008|Blinded Period|Other|1|||
163851915|NCT04955626|591828090|FG009|Blinded Period|Other|0|||
163851916|NCT04955626|591828091|FG010|Blinded Period|Other|1|||
163851917|NCT04955626|591828092|FG011|Blinded Period|Other|1|||
163851918|NCT04955626|591828093|FG012|Blinded Period|Other|0|||
163851919|NCT04955626|591828094|FG013|Blinded Period|Other|0|||
163851920|NCT04955626|591828095|FG014|Blinded Period|Other|0|||
163851921|NCT04955626|591828096|FG015|Blinded Period|Other|0|||
163851922|NCT04955626|591828097|FG016|Blinded Period|Other|0|||
163851923|NCT04955626|591828098|FG017|Blinded Period|Other|1|||
163851924|NCT04955626|591828099|FG018|Blinded Period|Other|0|||
163851925|NCT04955626|591828100|FG019|Blinded Period|Other|0|||
163851926|NCT04955626|591828101|FG020|Blinded Period|Other|0|||
163851927|NCT04955626|591828102|FG021|Blinded Period|Other|0|||
163851928|NCT04955626|591828103|FG022|Blinded Period|Other|0|||
163851929|NCT04955626|591828104|FG023|Blinded Period|Other|0|||
163851930|NCT04955626|591828105|FG024|Blinded Period|Other|0|||
163851931|NCT04955626|591828106|FG025|Blinded Period|Other|0|||
163851932|NCT04955626|591828107|FG026|Blinded Period|Other|2|||
163851933|NCT04955626|591828108|FG027|Blinded Period|Other|0|||
163851934|NCT04955626|591828109|FG028|Blinded Period|Other|0|||
163851935|NCT04955626|591828110|FG029|Blinded Period|Other|0|||
163851936|NCT04955626|591828111|FG030|Blinded Period|Other|0|||
163851937|NCT04955626|591828112|FG031|Blinded Period|Other|0|||
163851938|NCT04955626|591828113|FG032|Blinded Period|Other|0|||
163851939|NCT04955626|591828114|FG033|Blinded Period|Other|0|||
163851940|NCT04955626|591828115|FG034|Blinded Period|Other|0|||
163851941|NCT04955626|591828116|FG035|Blinded Period|Other|0|||
163851942|NCT04955626|591828081|FG000|Blinded Period|Physician Decision|1|||
163851943|NCT04955626|591828082|FG001|Blinded Period|Physician Decision|1|||
163851944|NCT04955626|591828083|FG002|Blinded Period|Physician Decision|0|||
163851945|NCT04955626|591828084|FG003|Blinded Period|Physician Decision|3|||
163851946|NCT04955626|591828085|FG004|Blinded Period|Physician Decision|0|||
163851947|NCT04955626|591828086|FG005|Blinded Period|Physician Decision|0|||
163851948|NCT04955626|591828087|FG006|Blinded Period|Physician Decision|1|||
163851949|NCT04955626|591828088|FG007|Blinded Period|Physician Decision|1|||
163851950|NCT04955626|591828089|FG008|Blinded Period|Physician Decision|0|||
163851951|NCT04955626|591828090|FG009|Blinded Period|Physician Decision|0|||
163851952|NCT04955626|591828091|FG010|Blinded Period|Physician Decision|0|||
163851953|NCT04955626|591828092|FG011|Blinded Period|Physician Decision|5|||
163851954|NCT04955626|591828093|FG012|Blinded Period|Physician Decision|0|||
163851955|NCT04955626|591828094|FG013|Blinded Period|Physician Decision|0|||
163851956|NCT04955626|591828095|FG014|Blinded Period|Physician Decision|0|||
163851957|NCT04955626|591828096|FG015|Blinded Period|Physician Decision|0|||
163851958|NCT04955626|591828097|FG016|Blinded Period|Physician Decision|0|||
163851959|NCT04955626|591828098|FG017|Blinded Period|Physician Decision|0|||
163851960|NCT04955626|591828099|FG018|Blinded Period|Physician Decision|0|||
163851961|NCT04955626|591828100|FG019|Blinded Period|Physician Decision|0|||
163851962|NCT04955626|591828101|FG020|Blinded Period|Physician Decision|0|||
163851963|NCT04955626|591828102|FG021|Blinded Period|Physician Decision|0|||
163851964|NCT04955626|591828103|FG022|Blinded Period|Physician Decision|0|||
163851965|NCT04955626|591828104|FG023|Blinded Period|Physician Decision|0|||
163851966|NCT04955626|591828105|FG024|Blinded Period|Physician Decision|0|||
163851967|NCT04955626|591828106|FG025|Blinded Period|Physician Decision|0|||
163851968|NCT04955626|591828107|FG026|Blinded Period|Physician Decision|0|||
163851969|NCT04955626|591828108|FG027|Blinded Period|Physician Decision|0|||
163851970|NCT04955626|591828109|FG028|Blinded Period|Physician Decision|0|||
163851971|NCT04955626|591828110|FG029|Blinded Period|Physician Decision|0|||
163851972|NCT04955626|591828111|FG030|Blinded Period|Physician Decision|0|||
163851973|NCT04955626|591828112|FG031|Blinded Period|Physician Decision|0|||
163851974|NCT04955626|591828113|FG032|Blinded Period|Physician Decision|0|||
163851975|NCT04955626|591828114|FG033|Blinded Period|Physician Decision|0|||
163851976|NCT04955626|591828115|FG034|Blinded Period|Physician Decision|0|||
163851977|NCT04955626|591828116|FG035|Blinded Period|Physician Decision|0|||
163851978|NCT04955626|591828081|FG000|Blinded Period|Withdrawal by Subject|26|||
163851979|NCT04955626|591828082|FG001|Blinded Period|Withdrawal by Subject|62|||
163851980|NCT04955626|591828083|FG002|Blinded Period|Withdrawal by Subject|14|||
163851981|NCT04955626|591828084|FG003|Blinded Period|Withdrawal by Subject|16|||
163851982|NCT04955626|591828085|FG004|Blinded Period|Withdrawal by Subject|1|||
163851983|NCT04955626|591828086|FG005|Blinded Period|Withdrawal by Subject|2|||
163851984|NCT04955626|591828087|FG006|Blinded Period|Withdrawal by Subject|9|||
163851985|NCT04955626|591828088|FG007|Blinded Period|Withdrawal by Subject|5|||
163851986|NCT04955626|591828089|FG008|Blinded Period|Withdrawal by Subject|3|||
163851987|NCT04955626|591828090|FG009|Blinded Period|Withdrawal by Subject|15|||
163851988|NCT04955626|591828091|FG010|Blinded Period|Withdrawal by Subject|11|||
163851989|NCT04955626|591828092|FG011|Blinded Period|Withdrawal by Subject|7|||
163851990|NCT04955626|591828093|FG012|Blinded Period|Withdrawal by Subject|2|||
163851991|NCT04955626|591828094|FG013|Blinded Period|Withdrawal by Subject|0|||
163851992|NCT04955626|591828095|FG014|Blinded Period|Withdrawal by Subject|1|||
163851993|NCT04955626|591828096|FG015|Blinded Period|Withdrawal by Subject|11|||
163851994|NCT04955626|591828097|FG016|Blinded Period|Withdrawal by Subject|2|||
163851995|NCT04955626|591828098|FG017|Blinded Period|Withdrawal by Subject|5|||
163851996|NCT04955626|591828099|FG018|Blinded Period|Withdrawal by Subject|0|||
163851997|NCT04955626|591828100|FG019|Blinded Period|Withdrawal by Subject|0|||
163851998|NCT04955626|591828101|FG020|Blinded Period|Withdrawal by Subject|1|||
163851999|NCT04955626|591828102|FG021|Blinded Period|Withdrawal by Subject|0|||
163852000|NCT04955626|591828103|FG022|Blinded Period|Withdrawal by Subject|0|||
163852001|NCT04955626|591828104|FG023|Blinded Period|Withdrawal by Subject|0|||
163852002|NCT04955626|591828105|FG024|Blinded Period|Withdrawal by Subject|5|||
163852003|NCT04955626|591828106|FG025|Blinded Period|Withdrawal by Subject|1|||
163852004|NCT04955626|591828107|FG026|Blinded Period|Withdrawal by Subject|5|||
163852005|NCT04955626|591828108|FG027|Blinded Period|Withdrawal by Subject|1|||
163852006|NCT04955626|591828109|FG028|Blinded Period|Withdrawal by Subject|4|||
163852007|NCT04955626|591828110|FG029|Blinded Period|Withdrawal by Subject|2|||
163852008|NCT04955626|591828111|FG030|Blinded Period|Withdrawal by Subject|0|||
163852009|NCT04955626|591828112|FG031|Blinded Period|Withdrawal by Subject|0|||
163852010|NCT04955626|591828113|FG032|Blinded Period|Withdrawal by Subject|0|||
163852011|NCT04955626|591828114|FG033|Blinded Period|Withdrawal by Subject|0|||
163852012|NCT04955626|591828115|FG034|Blinded Period|Withdrawal by Subject|0|||
163852013|NCT04955626|591828116|FG035|Blinded Period|Withdrawal by Subject|0|||
163852014|NCT04955626|591828081|FG000|Blinded Period|Refused further study procedures|0|||
163852015|NCT04955626|591828082|FG001|Blinded Period|Refused further study procedures|0|||
163852016|NCT04955626|591828083|FG002|Blinded Period|Refused further study procedures|0|||
163852017|NCT04955626|591828084|FG003|Blinded Period|Refused further study procedures|0|||
163852018|NCT04955626|591828085|FG004|Blinded Period|Refused further study procedures|0|||
163852019|NCT04955626|591828086|FG005|Blinded Period|Refused further study procedures|0|||
163852020|NCT04955626|591828087|FG006|Blinded Period|Refused further study procedures|1|||
163852021|NCT04955626|591828088|FG007|Blinded Period|Refused further study procedures|0|||
163852022|NCT04955626|591828089|FG008|Blinded Period|Refused further study procedures|0|||
163852023|NCT04955626|591828090|FG009|Blinded Period|Refused further study procedures|0|||
163852024|NCT04955626|591828091|FG010|Blinded Period|Refused further study procedures|0|||
163852025|NCT04955626|591828092|FG011|Blinded Period|Refused further study procedures|2|||
163852026|NCT04955626|591828093|FG012|Blinded Period|Refused further study procedures|0|||
163852027|NCT04955626|591828094|FG013|Blinded Period|Refused further study procedures|0|||
163852028|NCT04955626|591828095|FG014|Blinded Period|Refused further study procedures|0|||
163852029|NCT04955626|591828096|FG015|Blinded Period|Refused further study procedures|0|||
163852030|NCT04955626|591828097|FG016|Blinded Period|Refused further study procedures|0|||
163852031|NCT04955626|591828098|FG017|Blinded Period|Refused further study procedures|0|||
163852032|NCT04955626|591828099|FG018|Blinded Period|Refused further study procedures|0|||
163852033|NCT04955626|591828100|FG019|Blinded Period|Refused further study procedures|0|||
163852034|NCT04955626|591828101|FG020|Blinded Period|Refused further study procedures|0|||
163852035|NCT04955626|591828102|FG021|Blinded Period|Refused further study procedures|0|||
163852036|NCT04955626|591828103|FG022|Blinded Period|Refused further study procedures|0|||
163852037|NCT04955626|591828104|FG023|Blinded Period|Refused further study procedures|0|||
163852038|NCT04955626|591828105|FG024|Blinded Period|Refused further study procedures|0|||
163852039|NCT04955626|591828106|FG025|Blinded Period|Refused further study procedures|0|||
163852040|NCT04955626|591828107|FG026|Blinded Period|Refused further study procedures|0|||
163852041|NCT04955626|591828108|FG027|Blinded Period|Refused further study procedures|0|||
163852042|NCT04955626|591828109|FG028|Blinded Period|Refused further study procedures|0|||
163852043|NCT04955626|591828110|FG029|Blinded Period|Refused further study procedures|0|||
163852044|NCT04955626|591828111|FG030|Blinded Period|Refused further study procedures|0|||
163852045|NCT04955626|591828112|FG031|Blinded Period|Refused further study procedures|0|||
163852046|NCT04955626|591828113|FG032|Blinded Period|Refused further study procedures|0|||
164190621|NCT01411852|593066328|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
164190622|NCT01411852|593066329|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
164190623|NCT01411852|593066328|FG000|Prehospital Intervention Phase|Found to be under age|0|||
164190624|NCT01411852|593066329|FG001|Prehospital Intervention Phase|Found to be under age|1|||
164190625|NCT01411852|593066328|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
164190626|NCT01411852|593066329|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
164190627|NCT01411852|593066328|FG000|Hospital Intervention Phase|Severe head injury|5|||
164190628|NCT01411852|593066329|FG001|Hospital Intervention Phase|Severe head injury|4|||
164190629|NCT01411852|593066328|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
163852047|NCT04955626|591828114|FG033|Blinded Period|Refused further study procedures|0|||
163852048|NCT04955626|591828115|FG034|Blinded Period|Refused further study procedures|0|||
163852049|NCT04955626|591828116|FG035|Blinded Period|Refused further study procedures|0|||
163852050|NCT04955626|591828081|FG000|Blinded Period|Participants entered open label period|4544|||
163852051|NCT04955626|591828082|FG001|Blinded Period|Participants entered open label period|4906|||
163852052|NCT04955626|591828083|FG002|Blinded Period|Participants entered open label period|0|||
163852053|NCT04955626|591828084|FG003|Blinded Period|Participants entered open label period|0|||
163852054|NCT04955626|591828085|FG004|Blinded Period|Participants entered open label period|0|||
163852055|NCT04955626|591828086|FG005|Blinded Period|Participants entered open label period|0|||
163852056|NCT04955626|591828087|FG006|Blinded Period|Participants entered open label period|0|||
163852057|NCT04955626|591828088|FG007|Blinded Period|Participants entered open label period|0|||
163852058|NCT04955626|591828089|FG008|Blinded Period|Participants entered open label period|0|||
163852059|NCT04955626|591828090|FG009|Blinded Period|Participants entered open label period|0|||
163852060|NCT04955626|591828091|FG010|Blinded Period|Participants entered open label period|0|||
163852061|NCT04955626|591828092|FG011|Blinded Period|Participants entered open label period|0|||
163852062|NCT04955626|591828093|FG012|Blinded Period|Participants entered open label period|0|||
163852063|NCT04955626|591828094|FG013|Blinded Period|Participants entered open label period|0|||
163852064|NCT04955626|591828095|FG014|Blinded Period|Participants entered open label period|0|||
163852065|NCT04955626|591828096|FG015|Blinded Period|Participants entered open label period|0|||
163852066|NCT04955626|591828097|FG016|Blinded Period|Participants entered open label period|0|||
163852067|NCT04955626|591828098|FG017|Blinded Period|Participants entered open label period|0|||
163852068|NCT04955626|591828099|FG018|Blinded Period|Participants entered open label period|0|||
163852069|NCT04955626|591828100|FG019|Blinded Period|Participants entered open label period|0|||
163852070|NCT04955626|591828101|FG020|Blinded Period|Participants entered open label period|0|||
163852071|NCT04955626|591828102|FG021|Blinded Period|Participants entered open label period|0|||
163852072|NCT04955626|591828103|FG022|Blinded Period|Participants entered open label period|0|||
163852073|NCT04955626|591828104|FG023|Blinded Period|Participants entered open label period|0|||
163852074|NCT04955626|591828105|FG024|Blinded Period|Participants entered open label period|0|||
163852075|NCT04955626|591828106|FG025|Blinded Period|Participants entered open label period|0|||
163852076|NCT04955626|591828107|FG026|Blinded Period|Participants entered open label period|0|||
163852077|NCT04955626|591828108|FG027|Blinded Period|Participants entered open label period|0|||
163852078|NCT04955626|591828109|FG028|Blinded Period|Participants entered open label period|0|||
163852079|NCT04955626|591828110|FG029|Blinded Period|Participants entered open label period|0|||
163852080|NCT04955626|591828111|FG030|Blinded Period|Participants entered open label period|0|||
163852081|NCT04955626|591828112|FG031|Blinded Period|Participants entered open label period|0|||
163852082|NCT04955626|591828113|FG032|Blinded Period|Participants entered open label period|0|||
163852083|NCT04955626|591828114|FG033|Blinded Period|Participants entered open label period|0|||
163852084|NCT04955626|591828115|FG034|Blinded Period|Participants entered open label period|0|||
163852085|NCT04955626|591828116|FG035|Blinded Period|Participants entered open label period|0|||
163852086|NCT04955626|591828081|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
163852087|NCT04955626|591828082|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
163852088|NCT04955626|591828083|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
163852089|NCT04955626|591828084|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
163852090|NCT04955626|591828085|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
163852091|NCT04955626|591828086|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
163852092|NCT04955626|591828087|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
163852093|NCT04955626|591828088|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
163852094|NCT04955626|591828089|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
163852095|NCT04955626|591828090|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
163852096|NCT04955626|591828091|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
163852097|NCT04955626|591828092|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
163852098|NCT04955626|591828093|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
163852099|NCT04955626|591828094|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
163852100|NCT04955626|591828095|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
163852101|NCT04955626|591828096|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
163852102|NCT04955626|591828097|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
163852103|NCT04955626|591828098|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
163852104|NCT04955626|591828099|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
163852105|NCT04955626|591828100|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
163852106|NCT04955626|591828101|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
163852107|NCT04955626|591828102|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
163852108|NCT04955626|591828103|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
163852109|NCT04955626|591828104|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
163852110|NCT04955626|591828105|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
163852111|NCT04955626|591828106|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
163852112|NCT04955626|591828107|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
163852113|NCT04955626|591828108|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
163852114|NCT04955626|591828109|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
163852115|NCT04955626|591828110|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
163852116|NCT04955626|591828111|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
163852117|NCT04955626|591828112|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
163852118|NCT04955626|591828113|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
163852119|NCT04955626|591828114|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
163852120|NCT04955626|591828115|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
163852121|NCT04955626|591828116|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
163852122|NCT04955626|591828081|FG000|Blinded Period|Medication error|0|||
163852123|NCT04955626|591828082|FG001|Blinded Period|Medication error|0|||
163852124|NCT04955626|591828083|FG002|Blinded Period|Medication error|0|||
163852125|NCT04955626|591828084|FG003|Blinded Period|Medication error|0|||
163852126|NCT04955626|591828085|FG004|Blinded Period|Medication error|0|||
163852127|NCT04955626|591828086|FG005|Blinded Period|Medication error|0|||
163852128|NCT04955626|591828087|FG006|Blinded Period|Medication error|0|||
163852129|NCT04955626|591828088|FG007|Blinded Period|Medication error|0|||
163852130|NCT04955626|591828089|FG008|Blinded Period|Medication error|0|||
163852131|NCT04955626|591828090|FG009|Blinded Period|Medication error|0|||
163852132|NCT04955626|591828091|FG010|Blinded Period|Medication error|2|||
163852133|NCT04955626|591828092|FG011|Blinded Period|Medication error|0|||
163852134|NCT04955626|591828093|FG012|Blinded Period|Medication error|0|||
163852135|NCT04955626|591828094|FG013|Blinded Period|Medication error|0|||
163852136|NCT04955626|591828095|FG014|Blinded Period|Medication error|0|||
163852137|NCT04955626|591828096|FG015|Blinded Period|Medication error|0|||
163852138|NCT04955626|591828097|FG016|Blinded Period|Medication error|0|||
163852139|NCT04955626|591828098|FG017|Blinded Period|Medication error|0|||
163852140|NCT04955626|591828099|FG018|Blinded Period|Medication error|0|||
163852141|NCT04955626|591828100|FG019|Blinded Period|Medication error|0|||
163852142|NCT04955626|591828101|FG020|Blinded Period|Medication error|0|||
163852143|NCT04955626|591828102|FG021|Blinded Period|Medication error|0|||
163852144|NCT04955626|591828103|FG022|Blinded Period|Medication error|0|||
163852145|NCT04955626|591828104|FG023|Blinded Period|Medication error|0|||
163852146|NCT04955626|591828105|FG024|Blinded Period|Medication error|0|||
163852147|NCT04955626|591828106|FG025|Blinded Period|Medication error|0|||
163852148|NCT04955626|591828107|FG026|Blinded Period|Medication error|0|||
163852149|NCT04955626|591828108|FG027|Blinded Period|Medication error|0|||
163852150|NCT04955626|591828109|FG028|Blinded Period|Medication error|4|||
163852151|NCT04955626|591828110|FG029|Blinded Period|Medication error|0|||
163852152|NCT04955626|591828111|FG030|Blinded Period|Medication error|0|||
163852153|NCT04955626|591828112|FG031|Blinded Period|Medication error|0|||
163852154|NCT04955626|591828113|FG032|Blinded Period|Medication error|0|||
163852155|NCT04955626|591828114|FG033|Blinded Period|Medication error|0|||
163852156|NCT04955626|591828115|FG034|Blinded Period|Medication error|0|||
163852157|NCT04955626|591828116|FG035|Blinded Period|Medication error|0|||
163852158|NCT04955626|591828081|FG000|Open-Label Period|Lost to Follow-up|109|||
163852159|NCT04955626|591828082|FG001|Open-Label Period|Lost to Follow-up|41|||
163852160|NCT04955626|591828083|FG002|Open-Label Period|Lost to Follow-up|0|||
163852161|NCT04955626|591828084|FG003|Open-Label Period|Lost to Follow-up|0|||
163852162|NCT04955626|591828085|FG004|Open-Label Period|Lost to Follow-up|0|||
163852163|NCT04955626|591828086|FG005|Open-Label Period|Lost to Follow-up|0|||
163852164|NCT04955626|591828087|FG006|Open-Label Period|Lost to Follow-up|0|||
163852165|NCT04955626|591828088|FG007|Open-Label Period|Lost to Follow-up|0|||
163852166|NCT04955626|591828089|FG008|Open-Label Period|Lost to Follow-up|0|||
163852167|NCT04955626|591828090|FG009|Open-Label Period|Lost to Follow-up|0|||
163852168|NCT04955626|591828091|FG010|Open-Label Period|Lost to Follow-up|0|||
163852169|NCT04955626|591828092|FG011|Open-Label Period|Lost to Follow-up|0|||
163852170|NCT04955626|591828093|FG012|Open-Label Period|Lost to Follow-up|0|||
163852171|NCT04955626|591828094|FG013|Open-Label Period|Lost to Follow-up|0|||
163852172|NCT04955626|591828095|FG014|Open-Label Period|Lost to Follow-up|0|||
163852173|NCT04955626|591828096|FG015|Open-Label Period|Lost to Follow-up|0|||
163852174|NCT04955626|591828097|FG016|Open-Label Period|Lost to Follow-up|0|||
163852175|NCT04955626|591828098|FG017|Open-Label Period|Lost to Follow-up|0|||
163852176|NCT04955626|591828099|FG018|Open-Label Period|Lost to Follow-up|0|||
163852177|NCT04955626|591828100|FG019|Open-Label Period|Lost to Follow-up|0|||
163852178|NCT04955626|591828101|FG020|Open-Label Period|Lost to Follow-up|0|||
163852179|NCT04955626|591828102|FG021|Open-Label Period|Lost to Follow-up|0|||
163852180|NCT04955626|591828103|FG022|Open-Label Period|Lost to Follow-up|0|||
163852181|NCT04955626|591828104|FG023|Open-Label Period|Lost to Follow-up|0|||
163852182|NCT04955626|591828105|FG024|Open-Label Period|Lost to Follow-up|0|||
163852183|NCT04955626|591828106|FG025|Open-Label Period|Lost to Follow-up|0|||
163852184|NCT04955626|591828107|FG026|Open-Label Period|Lost to Follow-up|0|||
164190630|NCT01411852|593066329|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
164190631|NCT01411852|593066328|FG000|Hospital Intervention Phase|Miscommunication error|1|||
164190632|NCT01411852|593066329|FG001|Hospital Intervention Phase|Miscommunication error|2|||
163852185|NCT04955626|591828108|FG027|Open-Label Period|Lost to Follow-up|0|||
163852186|NCT04955626|591828109|FG028|Open-Label Period|Lost to Follow-up|0|||
163852187|NCT04955626|591828110|FG029|Open-Label Period|Lost to Follow-up|0|||
163852188|NCT04955626|591828111|FG030|Open-Label Period|Lost to Follow-up|0|||
163852189|NCT04955626|591828112|FG031|Open-Label Period|Lost to Follow-up|0|||
163852190|NCT04955626|591828113|FG032|Open-Label Period|Lost to Follow-up|0|||
163852191|NCT04955626|591828114|FG033|Open-Label Period|Lost to Follow-up|0|||
163852192|NCT04955626|591828115|FG034|Open-Label Period|Lost to Follow-up|0|||
163852193|NCT04955626|591828116|FG035|Open-Label Period|Lost to Follow-up|0|||
163852194|NCT04955626|591828081|FG000|Open-Label Period|Protocol Violation|377|||
163852195|NCT04955626|591828082|FG001|Open-Label Period|Protocol Violation|48|||
163852196|NCT04955626|591828083|FG002|Open-Label Period|Protocol Violation|0|||
163852197|NCT04955626|591828084|FG003|Open-Label Period|Protocol Violation|0|||
163852198|NCT04955626|591828085|FG004|Open-Label Period|Protocol Violation|0|||
163852199|NCT04955626|591828086|FG005|Open-Label Period|Protocol Violation|0|||
163852200|NCT04955626|591828087|FG006|Open-Label Period|Protocol Violation|0|||
163852201|NCT04955626|591828088|FG007|Open-Label Period|Protocol Violation|0|||
163852202|NCT04955626|591828089|FG008|Open-Label Period|Protocol Violation|0|||
163852203|NCT04955626|591828090|FG009|Open-Label Period|Protocol Violation|0|||
163852204|NCT04955626|591828091|FG010|Open-Label Period|Protocol Violation|0|||
163852205|NCT04955626|591828092|FG011|Open-Label Period|Protocol Violation|0|||
163852206|NCT04955626|591828093|FG012|Open-Label Period|Protocol Violation|0|||
163852207|NCT04955626|591828094|FG013|Open-Label Period|Protocol Violation|0|||
163852208|NCT04955626|591828095|FG014|Open-Label Period|Protocol Violation|0|||
163852209|NCT04955626|591828096|FG015|Open-Label Period|Protocol Violation|0|||
163852210|NCT04955626|591828097|FG016|Open-Label Period|Protocol Violation|0|||
163852211|NCT04955626|591828098|FG017|Open-Label Period|Protocol Violation|0|||
163852212|NCT04955626|591828099|FG018|Open-Label Period|Protocol Violation|0|||
163852213|NCT04955626|591828100|FG019|Open-Label Period|Protocol Violation|0|||
163852214|NCT04955626|591828101|FG020|Open-Label Period|Protocol Violation|0|||
163852215|NCT04955626|591828102|FG021|Open-Label Period|Protocol Violation|0|||
163852216|NCT04955626|591828103|FG022|Open-Label Period|Protocol Violation|0|||
163852217|NCT04955626|591828104|FG023|Open-Label Period|Protocol Violation|0|||
163852218|NCT04955626|591828105|FG024|Open-Label Period|Protocol Violation|0|||
163852219|NCT04955626|591828106|FG025|Open-Label Period|Protocol Violation|0|||
163852220|NCT04955626|591828107|FG026|Open-Label Period|Protocol Violation|0|||
163852221|NCT04955626|591828108|FG027|Open-Label Period|Protocol Violation|0|||
163852222|NCT04955626|591828109|FG028|Open-Label Period|Protocol Violation|0|||
163852223|NCT04955626|591828110|FG029|Open-Label Period|Protocol Violation|0|||
163852224|NCT04955626|591828111|FG030|Open-Label Period|Protocol Violation|0|||
163852225|NCT04955626|591828112|FG031|Open-Label Period|Protocol Violation|0|||
163852226|NCT04955626|591828113|FG032|Open-Label Period|Protocol Violation|0|||
163852227|NCT04955626|591828114|FG033|Open-Label Period|Protocol Violation|0|||
163852228|NCT04955626|591828115|FG034|Open-Label Period|Protocol Violation|0|||
163852229|NCT04955626|591828116|FG035|Open-Label Period|Protocol Violation|0|||
163852230|NCT04955626|591828081|FG000|Open-Label Period|Death|5|||
163852231|NCT04955626|591828082|FG001|Open-Label Period|Death|5|||
163852232|NCT04955626|591828083|FG002|Open-Label Period|Death|0|||
163852233|NCT04955626|591828084|FG003|Open-Label Period|Death|0|||
163852234|NCT04955626|591828085|FG004|Open-Label Period|Death|0|||
163852235|NCT04955626|591828086|FG005|Open-Label Period|Death|0|||
163852236|NCT04955626|591828087|FG006|Open-Label Period|Death|0|||
163852237|NCT04955626|591828088|FG007|Open-Label Period|Death|0|||
163852238|NCT04955626|591828089|FG008|Open-Label Period|Death|0|||
163852239|NCT04955626|591828090|FG009|Open-Label Period|Death|0|||
163852240|NCT04955626|591828091|FG010|Open-Label Period|Death|0|||
163852241|NCT04955626|591828092|FG011|Open-Label Period|Death|0|||
163852242|NCT04955626|591828093|FG012|Open-Label Period|Death|0|||
163852243|NCT04955626|591828094|FG013|Open-Label Period|Death|0|||
163852244|NCT04955626|591828095|FG014|Open-Label Period|Death|0|||
163852245|NCT04955626|591828096|FG015|Open-Label Period|Death|0|||
163852246|NCT04955626|591828097|FG016|Open-Label Period|Death|0|||
163852247|NCT04955626|591828098|FG017|Open-Label Period|Death|0|||
163852248|NCT04955626|591828099|FG018|Open-Label Period|Death|0|||
163852249|NCT04955626|591828100|FG019|Open-Label Period|Death|0|||
163852250|NCT04955626|591828101|FG020|Open-Label Period|Death|0|||
163852251|NCT04955626|591828102|FG021|Open-Label Period|Death|0|||
163852252|NCT04955626|591828103|FG022|Open-Label Period|Death|0|||
163852253|NCT04955626|591828104|FG023|Open-Label Period|Death|0|||
163852254|NCT04955626|591828105|FG024|Open-Label Period|Death|0|||
163852255|NCT04955626|591828106|FG025|Open-Label Period|Death|0|||
163964599|NCT01968070|592243223|FG012|Period 2|Withdrawal by Subject|0|||
163964600|NCT01968070|592243224|FG013|Period 2|Withdrawal by Subject|0|||
163964601|NCT01968070|592243225|FG014|Period 2|Withdrawal by Subject|0|||
163964602|NCT01968070|592243226|FG015|Period 2|Withdrawal by Subject|0|||
163852256|NCT04955626|591828107|FG026|Open-Label Period|Death|0|||
163852257|NCT04955626|591828108|FG027|Open-Label Period|Death|0|||
163852258|NCT04955626|591828109|FG028|Open-Label Period|Death|0|||
163852259|NCT04955626|591828110|FG029|Open-Label Period|Death|0|||
163852260|NCT04955626|591828111|FG030|Open-Label Period|Death|0|||
163852261|NCT04955626|591828112|FG031|Open-Label Period|Death|0|||
163852262|NCT04955626|591828113|FG032|Open-Label Period|Death|0|||
163852263|NCT04955626|591828114|FG033|Open-Label Period|Death|0|||
163852264|NCT04955626|591828115|FG034|Open-Label Period|Death|0|||
163852265|NCT04955626|591828116|FG035|Open-Label Period|Death|0|||
163852266|NCT04955626|591828081|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
163852267|NCT04955626|591828082|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
163852268|NCT04955626|591828083|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
163852269|NCT04955626|591828084|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
163852270|NCT04955626|591828085|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
163852271|NCT04955626|591828086|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
163852272|NCT04955626|591828087|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
163964603|NCT01968070|592243227|FG016|Period 2|Withdrawal by Subject|0|||
163852273|NCT04955626|591828088|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
163852274|NCT04955626|591828089|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
163852275|NCT04955626|591828090|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
163852276|NCT04955626|591828091|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
163852277|NCT04955626|591828092|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
163852278|NCT04955626|591828093|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
163852279|NCT04955626|591828094|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
163852280|NCT04955626|591828095|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
163852281|NCT04955626|591828096|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
163852282|NCT04955626|591828097|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
163852283|NCT04955626|591828098|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
163852284|NCT04955626|591828099|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
163852285|NCT04955626|591828100|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
163852286|NCT04955626|591828101|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
163852287|NCT04955626|591828102|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
163852288|NCT04955626|591828103|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
163852289|NCT04955626|591828104|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
163852290|NCT04955626|591828105|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
164190633|NCT01411852|593066328|FG000|Hospital Intervention Phase|CPR administered|3|||
164190634|NCT01411852|593066329|FG001|Hospital Intervention Phase|CPR administered|1|||
164190635|NCT01411852|593066328|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
163852291|NCT04955626|591828106|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
163852292|NCT04955626|591828107|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
163852293|NCT04955626|591828108|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
163852294|NCT04955626|591828109|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
163852295|NCT04955626|591828110|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
163852296|NCT04955626|591828111|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
163852297|NCT04955626|591828112|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
163852298|NCT04955626|591828113|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
163852299|NCT04955626|591828114|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
163852300|NCT04955626|591828115|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
163852301|NCT04955626|591828116|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
163852302|NCT04955626|591828081|FG000|Open-Label Period|Other|621|||
163852303|NCT04955626|591828082|FG001|Open-Label Period|Other|429|||
163852304|NCT04955626|591828083|FG002|Open-Label Period|Other|0|||
163852305|NCT04955626|591828084|FG003|Open-Label Period|Other|0|||
163852306|NCT04955626|591828085|FG004|Open-Label Period|Other|0|||
163852307|NCT04955626|591828086|FG005|Open-Label Period|Other|0|||
163852308|NCT04955626|591828087|FG006|Open-Label Period|Other|0|||
163852309|NCT04955626|591828088|FG007|Open-Label Period|Other|0|||
163852310|NCT04955626|591828089|FG008|Open-Label Period|Other|0|||
163852311|NCT04955626|591828090|FG009|Open-Label Period|Other|0|||
163852312|NCT04955626|591828091|FG010|Open-Label Period|Other|0|||
163852313|NCT04955626|591828092|FG011|Open-Label Period|Other|0|||
163852314|NCT04955626|591828093|FG012|Open-Label Period|Other|0|||
163852315|NCT04955626|591828094|FG013|Open-Label Period|Other|0|||
163852316|NCT04955626|591828095|FG014|Open-Label Period|Other|0|||
163852317|NCT04955626|591828096|FG015|Open-Label Period|Other|0|||
163852318|NCT04955626|591828097|FG016|Open-Label Period|Other|0|||
163852319|NCT04955626|591828098|FG017|Open-Label Period|Other|0|||
163852320|NCT04955626|591828099|FG018|Open-Label Period|Other|0|||
163852321|NCT04955626|591828100|FG019|Open-Label Period|Other|0|||
163852322|NCT04955626|591828101|FG020|Open-Label Period|Other|0|||
163852323|NCT04955626|591828102|FG021|Open-Label Period|Other|0|||
163964604|NCT01968070|592243228|FG017|Period 2|Withdrawal by Subject|0|||
164190636|NCT01411852|593066329|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
164190637|NCT01411852|593066328|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
164190638|NCT01411852|593066329|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
164190639|NCT01411852|593066328|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
164190640|NCT01411852|593066329|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
164190641|NCT01411852|593066328|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
164190642|NCT01411852|593066329|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
164190643|NCT01411852|593066328|FG000|Hospital Intervention Phase|Other ineligible|2|||
164190644|NCT01411852|593066329|FG001|Hospital Intervention Phase|Other ineligible|2|||
163852324|NCT04955626|591828103|FG022|Open-Label Period|Other|0|||
163964605|NCT01843218|592243235|FG000|Overall Study|Withdrawal by Subject|5|||
163964606|NCT00688181|592243238|FG000|Overall Study|Lost to Follow-up|17|||
163964607|NCT00688181|592243238|FG000|Overall Study|Unknown Reason|4|||
163852325|NCT04955626|591828104|FG023|Open-Label Period|Other|0|||
163852326|NCT04955626|591828105|FG024|Open-Label Period|Other|0|||
163852327|NCT04955626|591828106|FG025|Open-Label Period|Other|0|||
163852328|NCT04955626|591828107|FG026|Open-Label Period|Other|0|||
163852329|NCT04955626|591828108|FG027|Open-Label Period|Other|0|||
163852330|NCT04955626|591828109|FG028|Open-Label Period|Other|0|||
163852331|NCT04955626|591828110|FG029|Open-Label Period|Other|0|||
163852332|NCT04955626|591828111|FG030|Open-Label Period|Other|0|||
163852333|NCT04955626|591828112|FG031|Open-Label Period|Other|0|||
163852334|NCT04955626|591828113|FG032|Open-Label Period|Other|0|||
163852335|NCT04955626|591828114|FG033|Open-Label Period|Other|0|||
163852336|NCT04955626|591828115|FG034|Open-Label Period|Other|0|||
163852337|NCT04955626|591828116|FG035|Open-Label Period|Other|0|||
163852338|NCT04955626|591828081|FG000|Open-Label Period|Physician Decision|2|||
163852339|NCT04955626|591828082|FG001|Open-Label Period|Physician Decision|0|||
163852340|NCT04955626|591828083|FG002|Open-Label Period|Physician Decision|0|||
163852341|NCT04955626|591828084|FG003|Open-Label Period|Physician Decision|0|||
163852342|NCT04955626|591828085|FG004|Open-Label Period|Physician Decision|0|||
163852343|NCT04955626|591828086|FG005|Open-Label Period|Physician Decision|0|||
163852344|NCT04955626|591828087|FG006|Open-Label Period|Physician Decision|0|||
163852345|NCT04955626|591828088|FG007|Open-Label Period|Physician Decision|0|||
163852346|NCT04955626|591828089|FG008|Open-Label Period|Physician Decision|0|||
163852347|NCT04955626|591828090|FG009|Open-Label Period|Physician Decision|0|||
163852348|NCT04955626|591828091|FG010|Open-Label Period|Physician Decision|0|||
163852349|NCT04955626|591828092|FG011|Open-Label Period|Physician Decision|0|||
163852350|NCT04955626|591828093|FG012|Open-Label Period|Physician Decision|0|||
163852351|NCT04955626|591828094|FG013|Open-Label Period|Physician Decision|0|||
163852352|NCT04955626|591828095|FG014|Open-Label Period|Physician Decision|0|||
163852353|NCT04955626|591828096|FG015|Open-Label Period|Physician Decision|0|||
163852354|NCT04955626|591828097|FG016|Open-Label Period|Physician Decision|0|||
163852355|NCT04955626|591828098|FG017|Open-Label Period|Physician Decision|0|||
163852356|NCT04955626|591828099|FG018|Open-Label Period|Physician Decision|0|||
163852357|NCT04955626|591828100|FG019|Open-Label Period|Physician Decision|0|||
163852358|NCT04955626|591828101|FG020|Open-Label Period|Physician Decision|0|||
163852359|NCT04955626|591828102|FG021|Open-Label Period|Physician Decision|0|||
163852360|NCT04955626|591828103|FG022|Open-Label Period|Physician Decision|0|||
163852361|NCT04955626|591828104|FG023|Open-Label Period|Physician Decision|0|||
163852362|NCT04955626|591828105|FG024|Open-Label Period|Physician Decision|0|||
163852363|NCT04955626|591828106|FG025|Open-Label Period|Physician Decision|0|||
163852364|NCT04955626|591828107|FG026|Open-Label Period|Physician Decision|0|||
163852365|NCT04955626|591828108|FG027|Open-Label Period|Physician Decision|0|||
163852366|NCT04955626|591828109|FG028|Open-Label Period|Physician Decision|0|||
163852367|NCT04955626|591828110|FG029|Open-Label Period|Physician Decision|0|||
163852368|NCT04955626|591828111|FG030|Open-Label Period|Physician Decision|0|||
163852369|NCT04955626|591828112|FG031|Open-Label Period|Physician Decision|0|||
163852370|NCT04955626|591828113|FG032|Open-Label Period|Physician Decision|0|||
163852371|NCT04955626|591828114|FG033|Open-Label Period|Physician Decision|0|||
163852372|NCT04955626|591828115|FG034|Open-Label Period|Physician Decision|0|||
163852373|NCT04955626|591828116|FG035|Open-Label Period|Physician Decision|0|||
163852374|NCT04955626|591828081|FG000|Open-Label Period|Withdrawal by Subject|135|||
163852375|NCT04955626|591828082|FG001|Open-Label Period|Withdrawal by Subject|25|||
163852376|NCT04955626|591828083|FG002|Open-Label Period|Withdrawal by Subject|0|||
163852377|NCT04955626|591828084|FG003|Open-Label Period|Withdrawal by Subject|0|||
163852378|NCT04955626|591828085|FG004|Open-Label Period|Withdrawal by Subject|0|||
163852379|NCT04955626|591828086|FG005|Open-Label Period|Withdrawal by Subject|0|||
163852380|NCT04955626|591828087|FG006|Open-Label Period|Withdrawal by Subject|0|||
163964608|NCT00688181|592243238|FG000|Overall Study|Non-clinical Reason|2|||
163964609|NCT01891721|592243239|FG000|Overall Study|Lost to Follow-up|10|||
163964610|NCT01891721|592243240|FG001|Overall Study|Lost to Follow-up|5|||
163964611|NCT01891721|592243241|FG002|Overall Study|Lost to Follow-up|1|||
163964612|NCT02846532|592243242|FG000|Overall Study|Lost to Follow-up|0|||
163964613|NCT02846532|592243243|FG001|Overall Study|Lost to Follow-up|1|||
163964614|NCT02846532|592243244|FG002|Overall Study|Lost to Follow-up|1|||
163964615|NCT02846532|592243242|FG000|Overall Study|Withdrawal by Subject|1|||
163964616|NCT02846532|592243243|FG001|Overall Study|Withdrawal by Subject|2|||
163964617|NCT02846532|592243244|FG002|Overall Study|Withdrawal by Subject|0|||
163964618|NCT04908189|592243245|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
163964619|NCT04908189|592243246|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
163964620|NCT04908189|592243247|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
163964621|NCT04908189|592243245|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
163964622|NCT04908189|592243246|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
163964623|NCT04908189|592243247|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
163964624|NCT04908189|592243245|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
163964625|NCT04908189|592243246|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
163964626|NCT04908189|592243247|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
163964627|NCT04908189|592243245|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
163964628|NCT04908189|592243246|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
163964629|NCT04908189|592243247|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
164076353|NCT02556632|592643712|FG001|Overall Study|Unrelated Adverse Event|0|||
163852381|NCT04955626|591828088|FG007|Open-Label Period|Withdrawal by Subject|0|||
163852382|NCT04955626|591828089|FG008|Open-Label Period|Withdrawal by Subject|0|||
163852383|NCT04955626|591828090|FG009|Open-Label Period|Withdrawal by Subject|0|||
163852384|NCT04955626|591828091|FG010|Open-Label Period|Withdrawal by Subject|0|||
163852385|NCT04955626|591828092|FG011|Open-Label Period|Withdrawal by Subject|0|||
163852386|NCT04955626|591828093|FG012|Open-Label Period|Withdrawal by Subject|0|||
163852387|NCT04955626|591828094|FG013|Open-Label Period|Withdrawal by Subject|0|||
163852388|NCT04955626|591828095|FG014|Open-Label Period|Withdrawal by Subject|0|||
163852389|NCT04955626|591828096|FG015|Open-Label Period|Withdrawal by Subject|0|||
163852390|NCT04955626|591828097|FG016|Open-Label Period|Withdrawal by Subject|0|||
163852391|NCT04955626|591828098|FG017|Open-Label Period|Withdrawal by Subject|0|||
163852392|NCT04955626|591828099|FG018|Open-Label Period|Withdrawal by Subject|0|||
163852393|NCT04955626|591828100|FG019|Open-Label Period|Withdrawal by Subject|0|||
163852394|NCT04955626|591828101|FG020|Open-Label Period|Withdrawal by Subject|0|||
163852395|NCT04955626|591828102|FG021|Open-Label Period|Withdrawal by Subject|0|||
163852396|NCT04955626|591828103|FG022|Open-Label Period|Withdrawal by Subject|0|||
163852397|NCT04955626|591828104|FG023|Open-Label Period|Withdrawal by Subject|0|||
163852398|NCT04955626|591828105|FG024|Open-Label Period|Withdrawal by Subject|0|||
163852399|NCT04955626|591828106|FG025|Open-Label Period|Withdrawal by Subject|0|||
163852400|NCT04955626|591828107|FG026|Open-Label Period|Withdrawal by Subject|0|||
163852401|NCT04955626|591828108|FG027|Open-Label Period|Withdrawal by Subject|0|||
163852402|NCT04955626|591828109|FG028|Open-Label Period|Withdrawal by Subject|0|||
163852403|NCT04955626|591828110|FG029|Open-Label Period|Withdrawal by Subject|0|||
163852404|NCT04955626|591828111|FG030|Open-Label Period|Withdrawal by Subject|0|||
163852405|NCT04955626|591828112|FG031|Open-Label Period|Withdrawal by Subject|0|||
163852406|NCT04955626|591828113|FG032|Open-Label Period|Withdrawal by Subject|0|||
163852407|NCT04955626|591828114|FG033|Open-Label Period|Withdrawal by Subject|0|||
163852408|NCT04955626|591828115|FG034|Open-Label Period|Withdrawal by Subject|0|||
163852409|NCT04955626|591828116|FG035|Open-Label Period|Withdrawal by Subject|0|||
163852410|NCT04955626|591828081|FG000|Open-Label Period|Refused further study procedures|1|||
163852411|NCT04955626|591828082|FG001|Open-Label Period|Refused further study procedures|0|||
163852412|NCT04955626|591828083|FG002|Open-Label Period|Refused further study procedures|0|||
163852413|NCT04955626|591828084|FG003|Open-Label Period|Refused further study procedures|0|||
163852414|NCT04955626|591828085|FG004|Open-Label Period|Refused further study procedures|0|||
163852415|NCT04955626|591828086|FG005|Open-Label Period|Refused further study procedures|0|||
163852416|NCT04955626|591828087|FG006|Open-Label Period|Refused further study procedures|0|||
163852417|NCT04955626|591828088|FG007|Open-Label Period|Refused further study procedures|0|||
163852418|NCT04955626|591828089|FG008|Open-Label Period|Refused further study procedures|0|||
163852419|NCT04955626|591828090|FG009|Open-Label Period|Refused further study procedures|0|||
163852420|NCT04955626|591828091|FG010|Open-Label Period|Refused further study procedures|0|||
163852421|NCT04955626|591828092|FG011|Open-Label Period|Refused further study procedures|0|||
163852422|NCT04955626|591828093|FG012|Open-Label Period|Refused further study procedures|0|||
163852423|NCT04955626|591828094|FG013|Open-Label Period|Refused further study procedures|0|||
163852424|NCT04955626|591828095|FG014|Open-Label Period|Refused further study procedures|0|||
163852425|NCT04955626|591828096|FG015|Open-Label Period|Refused further study procedures|0|||
163852426|NCT04955626|591828097|FG016|Open-Label Period|Refused further study procedures|0|||
163852427|NCT04955626|591828098|FG017|Open-Label Period|Refused further study procedures|0|||
163852428|NCT04955626|591828099|FG018|Open-Label Period|Refused further study procedures|0|||
163852429|NCT04955626|591828100|FG019|Open-Label Period|Refused further study procedures|0|||
163852430|NCT04955626|591828101|FG020|Open-Label Period|Refused further study procedures|0|||
163852431|NCT04955626|591828102|FG021|Open-Label Period|Refused further study procedures|0|||
163852432|NCT04955626|591828103|FG022|Open-Label Period|Refused further study procedures|0|||
163852433|NCT04955626|591828104|FG023|Open-Label Period|Refused further study procedures|0|||
163852434|NCT04955626|591828105|FG024|Open-Label Period|Refused further study procedures|0|||
163852435|NCT04955626|591828106|FG025|Open-Label Period|Refused further study procedures|0|||
163852436|NCT04955626|591828107|FG026|Open-Label Period|Refused further study procedures|0|||
163852437|NCT04955626|591828108|FG027|Open-Label Period|Refused further study procedures|0|||
163852438|NCT04955626|591828109|FG028|Open-Label Period|Refused further study procedures|0|||
163852439|NCT04955626|591828110|FG029|Open-Label Period|Refused further study procedures|0|||
163852440|NCT04955626|591828111|FG030|Open-Label Period|Refused further study procedures|0|||
163852441|NCT04955626|591828112|FG031|Open-Label Period|Refused further study procedures|0|||
163852442|NCT04955626|591828113|FG032|Open-Label Period|Refused further study procedures|0|||
163852443|NCT04955626|591828114|FG033|Open-Label Period|Refused further study procedures|0|||
163852444|NCT04955626|591828115|FG034|Open-Label Period|Refused further study procedures|0|||
163852445|NCT04955626|591828116|FG035|Open-Label Period|Refused further study procedures|0|||
163852446|NCT04955626|591828081|FG000|Open-Label Period|Adverse Event|1|||
163852447|NCT04955626|591828082|FG001|Open-Label Period|Adverse Event|0|||
163852448|NCT04955626|591828083|FG002|Open-Label Period|Adverse Event|0|||
163852449|NCT04955626|591828084|FG003|Open-Label Period|Adverse Event|0|||
163852450|NCT04955626|591828085|FG004|Open-Label Period|Adverse Event|0|||
163852451|NCT04955626|591828086|FG005|Open-Label Period|Adverse Event|0|||
163852452|NCT04955626|591828087|FG006|Open-Label Period|Adverse Event|0|||
163852453|NCT04955626|591828088|FG007|Open-Label Period|Adverse Event|0|||
163852454|NCT04955626|591828089|FG008|Open-Label Period|Adverse Event|0|||
163852455|NCT04955626|591828090|FG009|Open-Label Period|Adverse Event|0|||
163852456|NCT04955626|591828091|FG010|Open-Label Period|Adverse Event|0|||
163852457|NCT04955626|591828092|FG011|Open-Label Period|Adverse Event|0|||
163852458|NCT04955626|591828093|FG012|Open-Label Period|Adverse Event|0|||
163852459|NCT04955626|591828094|FG013|Open-Label Period|Adverse Event|0|||
163852460|NCT04955626|591828095|FG014|Open-Label Period|Adverse Event|0|||
163852461|NCT04955626|591828096|FG015|Open-Label Period|Adverse Event|0|||
163852462|NCT04955626|591828097|FG016|Open-Label Period|Adverse Event|0|||
163852463|NCT04955626|591828098|FG017|Open-Label Period|Adverse Event|0|||
163852464|NCT04955626|591828099|FG018|Open-Label Period|Adverse Event|0|||
163852465|NCT04955626|591828100|FG019|Open-Label Period|Adverse Event|0|||
163852466|NCT04955626|591828101|FG020|Open-Label Period|Adverse Event|0|||
163852467|NCT04955626|591828102|FG021|Open-Label Period|Adverse Event|0|||
163852468|NCT04955626|591828103|FG022|Open-Label Period|Adverse Event|0|||
163852469|NCT04955626|591828104|FG023|Open-Label Period|Adverse Event|0|||
163852470|NCT04955626|591828105|FG024|Open-Label Period|Adverse Event|0|||
163852471|NCT04955626|591828106|FG025|Open-Label Period|Adverse Event|0|||
163852472|NCT04955626|591828107|FG026|Open-Label Period|Adverse Event|0|||
163852473|NCT04955626|591828108|FG027|Open-Label Period|Adverse Event|0|||
163852474|NCT04955626|591828109|FG028|Open-Label Period|Adverse Event|0|||
163852475|NCT04955626|591828110|FG029|Open-Label Period|Adverse Event|0|||
163852476|NCT04955626|591828111|FG030|Open-Label Period|Adverse Event|0|||
163852477|NCT04955626|591828112|FG031|Open-Label Period|Adverse Event|0|||
163852478|NCT04955626|591828113|FG032|Open-Label Period|Adverse Event|0|||
163852479|NCT04955626|591828114|FG033|Open-Label Period|Adverse Event|0|||
163852480|NCT04955626|591828115|FG034|Open-Label Period|Adverse Event|0|||
163852481|NCT04955626|591828116|FG035|Open-Label Period|Adverse Event|0|||
163852482|NCT04955626|591828081|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
163852483|NCT04955626|591828082|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
163852484|NCT04955626|591828083|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
163852485|NCT04955626|591828084|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
163852486|NCT04955626|591828085|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
163852487|NCT04955626|591828086|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
163852488|NCT04955626|591828087|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
163852489|NCT04955626|591828088|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
163852490|NCT04955626|591828089|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
163852491|NCT04955626|591828090|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
163852492|NCT04955626|591828091|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
163852493|NCT04955626|591828092|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
163852494|NCT04955626|591828093|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
163852495|NCT04955626|591828094|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
163852496|NCT04955626|591828095|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
163852497|NCT04955626|591828096|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
163852498|NCT04955626|591828097|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
163852499|NCT04955626|591828098|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
163852500|NCT04955626|591828099|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
163852501|NCT04955626|591828100|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
163852502|NCT04955626|591828101|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
163852503|NCT04955626|591828102|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
163852504|NCT04955626|591828103|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
163852505|NCT04955626|591828104|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
163852506|NCT04955626|591828105|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
163852507|NCT04955626|591828106|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
163852508|NCT04955626|591828107|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
163852509|NCT04955626|591828108|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
163852510|NCT04955626|591828109|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
163852511|NCT04955626|591828110|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
163852512|NCT04955626|591828111|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
163852513|NCT04955626|591828112|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
163852514|NCT04955626|591828113|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
163852515|NCT04955626|591828114|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
163852516|NCT04955626|591828115|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
163852517|NCT04955626|591828116|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
163852518|NCT04955626|591828081|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852519|NCT04955626|591828082|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
163852520|NCT04955626|591828083|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852521|NCT04955626|591828084|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852522|NCT04955626|591828085|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852523|NCT04955626|591828086|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
164133333|NCT02912650|592852736|FG001|Overall Study|Adverse Event|0|||
163852524|NCT04955626|591828087|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852525|NCT04955626|591828088|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852526|NCT04955626|591828089|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852527|NCT04955626|591828090|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852528|NCT04955626|591828091|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852529|NCT04955626|591828092|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852530|NCT04955626|591828093|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852531|NCT04955626|591828094|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852532|NCT04955626|591828095|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852533|NCT04955626|591828096|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852534|NCT04955626|591828097|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852535|NCT04955626|591828098|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852536|NCT04955626|591828099|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852537|NCT04955626|591828100|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852538|NCT04955626|591828101|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852539|NCT04955626|591828102|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852540|NCT04955626|591828103|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852541|NCT04955626|591828104|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852542|NCT04955626|591828105|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852543|NCT04955626|591828106|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852544|NCT04955626|591828107|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852545|NCT04955626|591828108|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852546|NCT04955626|591828109|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852547|NCT04955626|591828110|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852548|NCT04955626|591828111|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852549|NCT04955626|591828112|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852550|NCT04955626|591828113|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852551|NCT04955626|591828114|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852552|NCT04955626|591828115|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852553|NCT04955626|591828116|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
163852554|NCT03473756|591828117|FG000|Overall Study|Withdrawal by Subject|1|||
163852555|NCT03473756|591828118|FG001|Overall Study|Withdrawal by Subject|4|||
163852556|NCT03473756|591828117|FG000|Overall Study|Adverse Event|6|||
163852557|NCT03473756|591828118|FG001|Overall Study|Adverse Event|7|||
163852558|NCT03473756|591828117|FG000|Overall Study|Lack of Efficacy|3|||
163852559|NCT03473756|591828118|FG001|Overall Study|Lack of Efficacy|10|||
163852560|NCT03473756|591828117|FG000|Overall Study|Physician Decision|0|||
163852561|NCT03473756|591828118|FG001|Overall Study|Physician Decision|2|||
163852562|NCT03473756|591828117|FG000|Overall Study|End of study treatment|0|||
163852563|NCT03473756|591828118|FG001|Overall Study|End of study treatment|2|||
163852564|NCT03473756|591828117|FG000|Overall Study|Lost to Follow-up|0|||
163852565|NCT03473756|591828118|FG001|Overall Study|Lost to Follow-up|1|||
163852566|NCT03714022|591828119|FG000|Overall Study|Adverse Event|1|||
163852567|NCT03714022|591828120|FG001|Overall Study|Adverse Event|0|||
163852568|NCT03714022|591828119|FG000|Overall Study|Consent withdrawal|0|||
163852569|NCT03714022|591828120|FG001|Overall Study|Consent withdrawal|1|||
163852570|NCT03714022|591828119|FG000|Overall Study|Lost to Follow-up|3|||
163852571|NCT03714022|591828120|FG001|Overall Study|Lost to Follow-up|2|||
163852572|NCT02487446|591828126|FG000|Period 1|Physician Decision|0|||
163852573|NCT02487446|591828127|FG001|Period 1|Physician Decision|1|||
163852574|NCT02487446|591828126|FG000|Period 1|Lack of Efficacy|1|||
163852575|NCT02487446|591828127|FG001|Period 1|Lack of Efficacy|0|||
163852576|NCT02487446|591828126|FG000|Period 1|Protocol deviation|3|||
163852577|NCT02487446|591828127|FG001|Period 1|Protocol deviation|2|||
163852578|NCT02487446|591828126|FG000|Period 1|Lost to Follow-up|2|||
163852579|NCT02487446|591828127|FG001|Period 1|Lost to Follow-up|0|||
163852580|NCT02487446|591828126|FG000|Period 1|Withdrawal by Subject|2|||
163852581|NCT02487446|591828127|FG001|Period 1|Withdrawal by Subject|0|||
163852582|NCT02487446|591828126|FG000|Period 1|Adverse Event|5|||
163852583|NCT02487446|591828127|FG001|Period 1|Adverse Event|5|||
163852584|NCT02487446|591828126|FG000|Washout|Lost to Follow-up|0|||
163852585|NCT02487446|591828127|FG001|Washout|Lost to Follow-up|2|||
163852586|NCT02487446|591828126|FG000|Washout|Withdrawal by Subject|1|||
163852587|NCT02487446|591828127|FG001|Washout|Withdrawal by Subject|4|||
163852588|NCT02487446|591828126|FG000|Washout|Adverse Event|2|||
163852589|NCT02487446|591828127|FG001|Washout|Adverse Event|2|||
163852590|NCT02487446|591828126|FG000|Period 2|Protocol deviation|0|||
163852591|NCT02487446|591828127|FG001|Period 2|Protocol deviation|1|||
163852592|NCT02487446|591828126|FG000|Period 2|Lost to Follow-up|1|||
163852593|NCT02487446|591828127|FG001|Period 2|Lost to Follow-up|1|||
163852594|NCT02487446|591828126|FG000|Period 2|Withdrawal by Subject|1|||
164006617|NCT02723630|592391038|FG004|Intervention Period 3|consumption of restricted item|0|||
163852595|NCT02487446|591828127|FG001|Period 2|Withdrawal by Subject|1|||
163852596|NCT02487446|591828126|FG000|Period 2|Adverse Event|6|||
163852597|NCT02487446|591828127|FG001|Period 2|Adverse Event|2|||
163852598|NCT02234310|591828128|FG000|Overall Study|Physician Decision|1|||
163852599|NCT02234310|591828128|FG000|Overall Study|Adverse Event|1|||
163852600|NCT02234310|591828128|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
163852601|NCT02234310|591828128|FG000|Overall Study|Withdrawal by Subject|2|||
163852602|NCT03289455|591828129|FG000|Overall Study|Death|1|||
163852603|NCT03289455|591828130|FG001|Overall Study|Death|0|||
163852604|NCT03289455|591828131|FG002|Overall Study|Death|0|||
163852605|NCT03289455|591828129|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
163852606|NCT03289455|591828130|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
163852607|NCT03289455|591828131|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
163852608|NCT03289455|591828129|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
163852609|NCT03289455|591828130|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
163852610|NCT03289455|591828131|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
163852611|NCT03289455|591828129|FG000|Overall Study|Progressive disease|3|||
163852612|NCT03289455|591828130|FG001|Overall Study|Progressive disease|4|||
163852613|NCT03289455|591828131|FG002|Overall Study|Progressive disease|5|||
163852614|NCT04951479|591828132|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
163852615|NCT03706690|591828133|FG000|Overall Study|Withdrawal by Subject|8|||
163852616|NCT03706690|591828134|FG001|Overall Study|Withdrawal by Subject|8|||
163852617|NCT03706690|591828133|FG000|Overall Study|Death|143|||
163852618|NCT03706690|591828134|FG001|Overall Study|Death|75|||
163852619|NCT03706690|591828133|FG000|Overall Study|Ongoing at DCO|121|||
163852620|NCT03706690|591828134|FG001|Overall Study|Ongoing at DCO|52|||
163852621|NCT05617040|591828135|FG000|Overall Study|Adverse Event|0|||
163852622|NCT05617040|591828136|FG001|Overall Study|Adverse Event|1|||
163852623|NCT05617040|591828137|FG002|Overall Study|Adverse Event|0|||
163852624|NCT05617040|591828135|FG000|Overall Study|Death|0|||
163852625|NCT05617040|591828136|FG001|Overall Study|Death|0|||
163852626|NCT05617040|591828137|FG002|Overall Study|Death|1|||
163852627|NCT02711826|591828138|FG000|Overall Study|Physician Decision|0|||
163852628|NCT02711826|591828139|FG001|Overall Study|Physician Decision|0|||
163852629|NCT02711826|591828140|FG002|Overall Study|Physician Decision|0|||
163852630|NCT02711826|591828141|FG003|Overall Study|Physician Decision|1|||
163852631|NCT02711826|591828142|FG004|Overall Study|Physician Decision|0|||
163852632|NCT02711826|591828138|FG000|Overall Study|Withdrawal by Subject|0|||
163852633|NCT02711826|591828139|FG001|Overall Study|Withdrawal by Subject|1|||
163852634|NCT02711826|591828140|FG002|Overall Study|Withdrawal by Subject|0|||
163852635|NCT02711826|591828141|FG003|Overall Study|Withdrawal by Subject|4|||
163852636|NCT02711826|591828142|FG004|Overall Study|Withdrawal by Subject|0|||
163852637|NCT02711826|591828138|FG000|Overall Study|Failure to manufacture cellular product|0|||
163852638|NCT02711826|591828139|FG001|Overall Study|Failure to manufacture cellular product|0|||
163852639|NCT02711826|591828140|FG002|Overall Study|Failure to manufacture cellular product|5|||
163852640|NCT02711826|591828141|FG003|Overall Study|Failure to manufacture cellular product|0|||
163852641|NCT02711826|591828142|FG004|Overall Study|Failure to manufacture cellular product|0|||
163852642|NCT02711826|591828138|FG000|Overall Study|Infusion canceled for active infection|0|||
163852643|NCT02711826|591828139|FG001|Overall Study|Infusion canceled for active infection|1|||
163852644|NCT02711826|591828140|FG002|Overall Study|Infusion canceled for active infection|0|||
163852645|NCT02711826|591828141|FG003|Overall Study|Infusion canceled for active infection|0|||
163852646|NCT02711826|591828142|FG004|Overall Study|Infusion canceled for active infection|0|||
163852647|NCT02711826|591828138|FG000|Overall Study|Screen failures|0|||
163852648|NCT02711826|591828139|FG001|Overall Study|Screen failures|0|||
163852649|NCT02711826|591828140|FG002|Overall Study|Screen failures|0|||
163852650|NCT02711826|591828141|FG003|Overall Study|Screen failures|4|||
163852651|NCT02711826|591828142|FG004|Overall Study|Screen failures|0|||
163852652|NCT00729690|591828143|FG000|Overall Study|IT Catheter Malfunction|0|||
163852653|NCT00729690|591828144|FG001|Overall Study|IT Catheter Malfunction|2|||
163852654|NCT00729690|591828145|FG002|Overall Study|IT Catheter Malfunction|2|||
163852655|NCT02169219|591828146|FG000|Overall Study|Lack of Efficacy|6|||
163852656|NCT04482855|591828147|FG000|Overall Study|Lost to Follow-up|1|||
163852657|NCT04482855|591828148|FG001|Overall Study|Lost to Follow-up|0|||
163852658|NCT04482855|591828147|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
163852659|NCT04482855|591828148|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
163852660|NCT04482855|591828147|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
163852661|NCT04482855|591828148|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
163852662|NCT02507219|591828152|FG000|Overall Study|Physician Decision|1|||
163852663|NCT02507219|591828153|FG001|Overall Study|Physician Decision|0|||
163852664|NCT02507219|591828154|FG002|Overall Study|Physician Decision|0|||
163852665|NCT02507219|591828155|FG003|Overall Study|Physician Decision|0|||
163852666|NCT02507219|591828156|FG004|Overall Study|Physician Decision|0|||
163852667|NCT02507219|591828157|FG005|Overall Study|Physician Decision|0|||
163852668|NCT02507219|591828152|FG000|Overall Study|Withdrawal by Subject|0|||
163852669|NCT02507219|591828153|FG001|Overall Study|Withdrawal by Subject|0|||
163852670|NCT02507219|591828154|FG002|Overall Study|Withdrawal by Subject|0|||
163852671|NCT02507219|591828155|FG003|Overall Study|Withdrawal by Subject|0|||
163852672|NCT02507219|591828156|FG004|Overall Study|Withdrawal by Subject|1|||
163852673|NCT02507219|591828157|FG005|Overall Study|Withdrawal by Subject|0|||
163852674|NCT02886936|591828158|FG000|Overall Study|Lost to Follow-up|4|||
163852675|NCT02886936|591828159|FG001|Overall Study|Lost to Follow-up|3|||
163852676|NCT02886936|591828160|FG002|Overall Study|Lost to Follow-up|0|||
163852677|NCT04562779|591828161|FG000|Overall Study|Lost to Follow-up|7|||
163852678|NCT04562779|591828162|FG001|Overall Study|Lost to Follow-up|5|||
163852679|NCT04562779|591828163|FG002|Overall Study|Lost to Follow-up|10|||
163852680|NCT04562779|591828161|FG000|Overall Study|Protocol Violation|2|||
163852681|NCT04562779|591828162|FG001|Overall Study|Protocol Violation|2|||
163852682|NCT04562779|591828163|FG002|Overall Study|Protocol Violation|0|||
163852683|NCT02320721|591828164|FG000|Overall Study|Adverse Event|6|||
163852684|NCT02320721|591828165|FG001|Overall Study|Adverse Event|6|||
163852685|NCT02320721|591828164|FG000|Overall Study|Lack of Efficacy|2|||
163852686|NCT02320721|591828165|FG001|Overall Study|Lack of Efficacy|0|||
163852687|NCT02320721|591828164|FG000|Overall Study|Poor compliance to protocol|3|||
163852688|NCT02320721|591828165|FG001|Overall Study|Poor compliance to protocol|7|||
163852689|NCT02320721|591828164|FG000|Overall Study|Randomized but not treated|0|||
163852690|NCT02320721|591828165|FG001|Overall Study|Randomized but not treated|1|||
163852691|NCT02320721|591828164|FG000|Overall Study|Hypoglycemia|1|||
163852692|NCT02320721|591828165|FG001|Overall Study|Hypoglycemia|0|||
163852693|NCT02320721|591828164|FG000|Overall Study|Other than specified above|15|||
163852694|NCT02320721|591828165|FG001|Overall Study|Other than specified above|20|||
163852695|NCT03173248|591828166|FG000|Overall Study|Death|28|||
163852696|NCT03173248|591828167|FG001|Overall Study|Death|46|||
163852697|NCT03173248|591828166|FG000|Overall Study|Lost to Follow-up|0|||
163852698|NCT03173248|591828167|FG001|Overall Study|Lost to Follow-up|1|||
163852699|NCT03173248|591828166|FG000|Overall Study|Withdrawal by Subject|6|||
163852700|NCT03173248|591828167|FG001|Overall Study|Withdrawal by Subject|4|||
163852701|NCT03173248|591828166|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
163852702|NCT03173248|591828167|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
163852703|NCT01544582|591828168|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
163852704|NCT01544582|591828169|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
163852705|NCT01544582|591828170|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
163852706|NCT01544582|591828171|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
163852707|NCT01544582|591828168|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
163852708|NCT01544582|591828169|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
163852709|NCT01544582|591828170|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
163852710|NCT01544582|591828171|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
163852711|NCT01544582|591828168|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
163852712|NCT01544582|591828169|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
163852713|NCT01544582|591828170|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
163852714|NCT01544582|591828171|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
163852715|NCT01544582|591828168|FG000|Analysis Population|Physician Decision|0|||
163852716|NCT01544582|591828169|FG001|Analysis Population|Physician Decision|13|||
163852717|NCT01544582|591828170|FG002|Analysis Population|Physician Decision|10|||
163852718|NCT01544582|591828171|FG003|Analysis Population|Physician Decision|9|||
163852719|NCT01544582|591828168|FG000|Analysis Population|Safety Reason|0|||
163852720|NCT01544582|591828169|FG001|Analysis Population|Safety Reason|33|||
163852721|NCT01544582|591828170|FG002|Analysis Population|Safety Reason|31|||
163852722|NCT01544582|591828171|FG003|Analysis Population|Safety Reason|8|||
163852723|NCT01544582|591828168|FG000|Analysis Population|Effectiveness Reason|0|||
163852724|NCT01544582|591828169|FG001|Analysis Population|Effectiveness Reason|48|||
163852725|NCT01544582|591828170|FG002|Analysis Population|Effectiveness Reason|29|||
163852726|NCT01544582|591828171|FG003|Analysis Population|Effectiveness Reason|12|||
163852727|NCT01544582|591828168|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
163852728|NCT01544582|591828169|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
163852729|NCT01544582|591828170|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
163852730|NCT01544582|591828171|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
163852731|NCT01544582|591828168|FG000|Analysis Population|Lost to Follow-up|0|||
163852732|NCT01544582|591828169|FG001|Analysis Population|Lost to Follow-up|6|||
163852733|NCT01544582|591828170|FG002|Analysis Population|Lost to Follow-up|6|||
163852734|NCT01544582|591828171|FG003|Analysis Population|Lost to Follow-up|5|||
163852735|NCT01544582|591828168|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
163852736|NCT01544582|591828169|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
163852737|NCT01544582|591828170|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
163852738|NCT01544582|591828171|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
163852739|NCT01544582|591828168|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
163852740|NCT01544582|591828169|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
163852741|NCT01544582|591828170|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
163852742|NCT01544582|591828171|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
163852743|NCT01544582|591828168|FG000|Analysis Population|Intolerance|0|||
163852744|NCT01544582|591828169|FG001|Analysis Population|Intolerance|1|||
163852745|NCT01544582|591828170|FG002|Analysis Population|Intolerance|0|||
163852746|NCT01544582|591828171|FG003|Analysis Population|Intolerance|0|||
163852747|NCT01544582|591828168|FG000|Analysis Population|Liver Transplantation|0|||
163852748|NCT01544582|591828169|FG001|Analysis Population|Liver Transplantation|0|||
163852749|NCT01544582|591828170|FG002|Analysis Population|Liver Transplantation|1|||
163852750|NCT01544582|591828171|FG003|Analysis Population|Liver Transplantation|0|||
163852751|NCT01544582|591828168|FG000|Analysis Population|No Social Insurance|0|||
163852752|NCT01544582|591828169|FG001|Analysis Population|No Social Insurance|0|||
163852753|NCT01544582|591828170|FG002|Analysis Population|No Social Insurance|1|||
163852754|NCT01544582|591828171|FG003|Analysis Population|No Social Insurance|0|||
163852755|NCT01544582|591828168|FG000|Analysis Population|Poor Adherence|0|||
163852756|NCT01544582|591828169|FG001|Analysis Population|Poor Adherence|0|||
163852757|NCT01544582|591828170|FG002|Analysis Population|Poor Adherence|1|||
163852758|NCT01544582|591828171|FG003|Analysis Population|Poor Adherence|0|||
163852759|NCT01544582|591828168|FG000|Analysis Population|Poor Participant Compliance|0|||
163852760|NCT01544582|591828169|FG001|Analysis Population|Poor Participant Compliance|1|||
163852761|NCT01544582|591828170|FG002|Analysis Population|Poor Participant Compliance|0|||
163852762|NCT01544582|591828171|FG003|Analysis Population|Poor Participant Compliance|0|||
163852763|NCT01544582|591828168|FG000|Analysis Population|Programmed Surgery|0|||
163852764|NCT01544582|591828169|FG001|Analysis Population|Programmed Surgery|1|||
163852765|NCT01544582|591828170|FG002|Analysis Population|Programmed Surgery|0|||
163852766|NCT01544582|591828171|FG003|Analysis Population|Programmed Surgery|0|||
163852767|NCT01544582|591828168|FG000|Analysis Population|Participant in Jail|0|||
163852768|NCT01544582|591828169|FG001|Analysis Population|Participant in Jail|0|||
163852769|NCT01544582|591828170|FG002|Analysis Population|Participant in Jail|1|||
163852770|NCT01544582|591828171|FG003|Analysis Population|Participant in Jail|0|||
163852771|NCT03015740|591828174|FG000|Overall Study|Adverse Event|1|||
163852772|NCT03015740|591828175|FG001|Overall Study|Adverse Event|0|||
163852773|NCT03015740|591828176|FG002|Overall Study|Adverse Event|0|||
163852774|NCT03015740|591828174|FG000|Overall Study|Death|3|||
163852775|NCT03015740|591828175|FG001|Overall Study|Death|5|||
163852776|NCT03015740|591828176|FG002|Overall Study|Death|0|||
163852777|NCT03015740|591828174|FG000|Overall Study|Withdrawal by Subject|2|||
163852778|NCT03015740|591828175|FG001|Overall Study|Withdrawal by Subject|0|||
163852779|NCT03015740|591828176|FG002|Overall Study|Withdrawal by Subject|0|||
163852780|NCT05194735|591830117|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
163852781|NCT05194735|591830118|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
163852782|NCT05194735|591830119|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
163852783|NCT05194735|591830117|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
163852784|NCT05194735|591830118|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
163852785|NCT05194735|591830119|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
163852786|NCT05194735|591830117|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
163852787|NCT05194735|591830118|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
163852788|NCT05194735|591830119|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
163852789|NCT05194735|591830117|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
163852790|NCT05194735|591830118|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
163852791|NCT05194735|591830119|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
163852792|NCT00731042|591830120|FG000|Second Intervention|Did not meet inclusion criteria|0|||
163852793|NCT00731042|591830121|FG001|Second Intervention|Did not meet inclusion criteria|2|||
163852794|NCT02624778|591830122|FG000|Overall Study|Lost to Follow-up|0|||
163852795|NCT02624778|591830123|FG001|Overall Study|Lost to Follow-up|0|||
163852796|NCT02624778|591830124|FG002|Overall Study|Lost to Follow-up|1|||
163852797|NCT02624778|591830125|FG003|Overall Study|Lost to Follow-up|0|||
163852798|NCT02624778|591830126|FG004|Overall Study|Lost to Follow-up|0|||
163852799|NCT02624778|591830127|FG005|Overall Study|Lost to Follow-up|0|||
163852800|NCT02624778|591830128|FG006|Overall Study|Lost to Follow-up|0|||
163852801|NCT02624778|591830129|FG007|Overall Study|Lost to Follow-up|0|||
163852802|NCT02624778|591830130|FG008|Overall Study|Lost to Follow-up|0|||
163852803|NCT02624778|591830122|FG000|Overall Study|Withdrawal by Subject|0|||
163852804|NCT02624778|591830123|FG001|Overall Study|Withdrawal by Subject|1|||
163852805|NCT02624778|591830124|FG002|Overall Study|Withdrawal by Subject|0|||
163852806|NCT02624778|591830125|FG003|Overall Study|Withdrawal by Subject|0|||
163852807|NCT02624778|591830126|FG004|Overall Study|Withdrawal by Subject|0|||
163852808|NCT02624778|591830127|FG005|Overall Study|Withdrawal by Subject|1|||
163852809|NCT02624778|591830128|FG006|Overall Study|Withdrawal by Subject|1|||
163852810|NCT02624778|591830129|FG007|Overall Study|Withdrawal by Subject|1|||
163852811|NCT02624778|591830130|FG008|Overall Study|Withdrawal by Subject|1|||
163852812|NCT02624778|591830122|FG000|Overall Study|Adverse Event|0|||
163852813|NCT02624778|591830123|FG001|Overall Study|Adverse Event|0|||
163852814|NCT02624778|591830124|FG002|Overall Study|Adverse Event|0|||
163852815|NCT02624778|591830125|FG003|Overall Study|Adverse Event|0|||
163852816|NCT02624778|591830126|FG004|Overall Study|Adverse Event|0|||
163852817|NCT02624778|591830127|FG005|Overall Study|Adverse Event|0|||
163852818|NCT02624778|591830128|FG006|Overall Study|Adverse Event|0|||
163852819|NCT02624778|591830129|FG007|Overall Study|Adverse Event|0|||
163852820|NCT02624778|591830130|FG008|Overall Study|Adverse Event|2|||
163852821|NCT02624778|591830122|FG000|Overall Study|Death|0|||
163852822|NCT02624778|591830123|FG001|Overall Study|Death|0|||
163852823|NCT02624778|591830124|FG002|Overall Study|Death|0|||
163852824|NCT02624778|591830125|FG003|Overall Study|Death|0|||
163852825|NCT02624778|591830126|FG004|Overall Study|Death|0|||
163852826|NCT02624778|591830127|FG005|Overall Study|Death|0|||
163852827|NCT02624778|591830128|FG006|Overall Study|Death|1|||
163852828|NCT02624778|591830129|FG007|Overall Study|Death|0|||
163852829|NCT02624778|591830130|FG008|Overall Study|Death|0|||
163852830|NCT02624778|591830122|FG000|Overall Study|Physician Decision|0|||
163852831|NCT02624778|591830123|FG001|Overall Study|Physician Decision|0|||
163852832|NCT02624778|591830124|FG002|Overall Study|Physician Decision|0|||
163852833|NCT02624778|591830125|FG003|Overall Study|Physician Decision|0|||
163852834|NCT02624778|591830126|FG004|Overall Study|Physician Decision|0|||
163852835|NCT02624778|591830127|FG005|Overall Study|Physician Decision|0|||
163852836|NCT02624778|591830128|FG006|Overall Study|Physician Decision|0|||
163852837|NCT02624778|591830129|FG007|Overall Study|Physician Decision|3|||
163852838|NCT02624778|591830130|FG008|Overall Study|Physician Decision|3|||
163852839|NCT04091672|591830133|FG000|Overall Study|Death|6|||
163852840|NCT04091672|591830134|FG001|Overall Study|Death|6|||
163852841|NCT04091672|591830133|FG000|Overall Study|Lost to Follow-up|7|||
163852842|NCT04091672|591830134|FG001|Overall Study|Lost to Follow-up|7|||
163852843|NCT04091672|591830133|FG000|Overall Study|Withdrawal by Subject|3|||
163852844|NCT04091672|591830134|FG001|Overall Study|Withdrawal by Subject|3|||
163964630|NCT04908189|592243245|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
163964631|NCT04908189|592243246|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
163964632|NCT04908189|592243247|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
163964633|NCT04908189|592243245|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
163852845|NCT04091672|591830133|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
163852846|NCT04091672|591830134|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
163852847|NCT01256476|591830135|FG000|Overall Study|Adverse Event|2|||
163852848|NCT01256476|591830136|FG001|Overall Study|Adverse Event|1|||
163852849|NCT01256476|591830135|FG000|Overall Study|Withdrawal by Subject|2|||
163852850|NCT01256476|591830136|FG001|Overall Study|Withdrawal by Subject|1|||
163852851|NCT01256476|591830135|FG000|Overall Study|Lost to Follow-up|1|||
163852852|NCT01256476|591830136|FG001|Overall Study|Lost to Follow-up|2|||
163852853|NCT01256476|591830135|FG000|Overall Study|Persistent ALT or AST elevation|1|||
163852854|NCT01256476|591830136|FG001|Overall Study|Persistent ALT or AST elevation|0|||
163852855|NCT01256476|591830135|FG000|Overall Study|Physician Decision|0|||
163852856|NCT01256476|591830136|FG001|Overall Study|Physician Decision|1|||
163852857|NCT01256476|591830135|FG000|Overall Study|Subject non-compliance|0|||
163852858|NCT01256476|591830136|FG001|Overall Study|Subject non-compliance|1|||
163852859|NCT01256476|591830135|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
163852860|NCT01256476|591830136|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
163852861|NCT05296629|591830137|FG000|Overall Study|Withdrawal by Subject|3|||
163852862|NCT05296629|591830138|FG001|Overall Study|Withdrawal by Subject|10|||
163852863|NCT05296629|591830139|FG002|Overall Study|Withdrawal by Subject|4|||
163852864|NCT05296629|591830137|FG000|Overall Study|Lost to Follow-up|2|||
163852865|NCT05296629|591830138|FG001|Overall Study|Lost to Follow-up|7|||
163852866|NCT05296629|591830139|FG002|Overall Study|Lost to Follow-up|1|||
163852867|NCT05296629|591830137|FG000|Overall Study|Adverse Event|0|||
163852868|NCT05296629|591830138|FG001|Overall Study|Adverse Event|4|||
163852869|NCT05296629|591830139|FG002|Overall Study|Adverse Event|2|||
163852870|NCT05296629|591830137|FG000|Overall Study|Protocol Violation|0|||
163852871|NCT05296629|591830138|FG001|Overall Study|Protocol Violation|2|||
163852872|NCT05296629|591830139|FG002|Overall Study|Protocol Violation|0|||
163852873|NCT00231179|591830145|FG000|Overall Study|Lost to Follow-up|21|||
163852874|NCT00231179|591830146|FG001|Overall Study|Lost to Follow-up|21|||
164133334|NCT02912650|592852737|FG002|Overall Study|Adverse Event|1|||
163852875|NCT00231179|591830145|FG000|Overall Study|Withdrawal by Subject|3|||
163852876|NCT00231179|591830146|FG001|Overall Study|Withdrawal by Subject|3|||
163852877|NCT02491411|591830147|FG000|Overall Study|Physician Decision|4|||
163852878|NCT04610684|591830150|FG000|Study Treatment|Withdrawal by Subject|1|||
163852879|NCT04610684|591830150|FG000|Study Treatment|Disease Progression|2|||
163852880|NCT04610684|591830150|FG000|Follow up|Death|2|||
163852881|NCT04610684|591830150|FG000|Follow up|Withdrawal by Subject|1|||
163852882|NCT00359619|591830152|FG000|Overall Study|Adverse Event|0|||
163852883|NCT00359619|591830153|FG001|Overall Study|Adverse Event|0|||
163852884|NCT00359619|591830154|FG002|Overall Study|Adverse Event|1|||
163852885|NCT00359619|591830155|FG003|Overall Study|Adverse Event|0|||
163852886|NCT00359619|591830156|FG004|Overall Study|Adverse Event|0|||
163852887|NCT00359619|591830157|FG005|Overall Study|Adverse Event|0|||
163852888|NCT00359619|591830158|FG006|Overall Study|Adverse Event|1|||
163852889|NCT00359619|591830152|FG000|Overall Study|Withdrawal by Subject|3|||
163852890|NCT00359619|591830153|FG001|Overall Study|Withdrawal by Subject|1|||
163852891|NCT00359619|591830154|FG002|Overall Study|Withdrawal by Subject|4|||
163852892|NCT00359619|591830155|FG003|Overall Study|Withdrawal by Subject|2|||
163852893|NCT00359619|591830156|FG004|Overall Study|Withdrawal by Subject|2|||
163852894|NCT00359619|591830157|FG005|Overall Study|Withdrawal by Subject|0|||
163852895|NCT00359619|591830158|FG006|Overall Study|Withdrawal by Subject|3|||
163852896|NCT00359619|591830152|FG000|Overall Study|Other|1|||
163852897|NCT00359619|591830153|FG001|Overall Study|Other|0|||
163852898|NCT00359619|591830154|FG002|Overall Study|Other|0|||
163852899|NCT00359619|591830155|FG003|Overall Study|Other|0|||
163852900|NCT00359619|591830156|FG004|Overall Study|Other|0|||
163852901|NCT00359619|591830157|FG005|Overall Study|Other|0|||
163852902|NCT00359619|591830158|FG006|Overall Study|Other|0|||
163852903|NCT00359619|591830152|FG000|Overall Study|Lost to Follow-up|4|||
163852904|NCT00359619|591830153|FG001|Overall Study|Lost to Follow-up|4|||
163852905|NCT00359619|591830154|FG002|Overall Study|Lost to Follow-up|2|||
163852906|NCT00359619|591830155|FG003|Overall Study|Lost to Follow-up|1|||
163852907|NCT00359619|591830156|FG004|Overall Study|Lost to Follow-up|1|||
163852908|NCT00359619|591830157|FG005|Overall Study|Lost to Follow-up|5|||
163852909|NCT00359619|591830158|FG006|Overall Study|Lost to Follow-up|0|||
163852910|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
163852911|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
163852912|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
163852913|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
163852914|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
163852915|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
163852916|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
163852917|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
163852918|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
163852919|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
163852920|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
163852921|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
163852922|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
163852923|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
163852924|NCT04672460|591830159|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
163852925|NCT04672460|591830160|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
163852926|NCT04672460|591830159|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
163852927|NCT04672460|591830160|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
163852928|NCT04672460|591830159|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
163852929|NCT04672460|591830160|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
163852930|NCT04672460|591830159|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
163852931|NCT04672460|591830160|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
163852932|NCT04672460|591830159|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
163852933|NCT04672460|591830160|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
163852934|NCT04672460|591830159|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
163852935|NCT04672460|591830160|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
163852936|NCT04672460|591830159|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
163852937|NCT04672460|591830160|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
163852938|NCT04672460|591830159|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
163852939|NCT04672460|591830160|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
163852940|NCT04672460|591830159|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
163852941|NCT04672460|591830160|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
163852942|NCT04672460|591830159|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
163852943|NCT04672460|591830160|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
163852944|NCT00049517|591830163|FG000|Induction|Disease progression|0|||
163964634|NCT04908189|592243246|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
163964635|NCT04908189|592243247|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
163964636|NCT04908189|592243245|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
164133335|NCT02912650|592852738|FG003|Overall Study|Adverse Event|0|||
163852945|NCT00049517|591830164|FG001|Induction|Disease progression|0|||
163852946|NCT00049517|591830165|FG002|Induction|Disease progression|0|||
163852947|NCT00049517|591830166|FG003|Induction|Disease progression|0|||
163852948|NCT00049517|591830167|FG004|Induction|Disease progression|18|||
163852949|NCT00049517|591830168|FG005|Induction|Disease progression|11|||
163852950|NCT00049517|591830163|FG000|Induction|Adverse Event|0|||
163852951|NCT00049517|591830164|FG001|Induction|Adverse Event|0|||
163852952|NCT00049517|591830165|FG002|Induction|Adverse Event|0|||
163852953|NCT00049517|591830166|FG003|Induction|Adverse Event|0|||
163852954|NCT00049517|591830167|FG004|Induction|Adverse Event|5|||
163852955|NCT00049517|591830168|FG005|Induction|Adverse Event|7|||
163852956|NCT00049517|591830163|FG000|Induction|Death|0|||
163852957|NCT00049517|591830164|FG001|Induction|Death|0|||
163852958|NCT00049517|591830165|FG002|Induction|Death|0|||
163852959|NCT00049517|591830166|FG003|Induction|Death|0|||
163852960|NCT00049517|591830167|FG004|Induction|Death|9|||
163852961|NCT00049517|591830168|FG005|Induction|Death|6|||
163852962|NCT00049517|591830163|FG000|Induction|Withdrawal by Subject|0|||
163852963|NCT00049517|591830164|FG001|Induction|Withdrawal by Subject|0|||
163852964|NCT00049517|591830165|FG002|Induction|Withdrawal by Subject|0|||
163852965|NCT00049517|591830166|FG003|Induction|Withdrawal by Subject|0|||
163852966|NCT00049517|591830167|FG004|Induction|Withdrawal by Subject|1|||
163852967|NCT00049517|591830168|FG005|Induction|Withdrawal by Subject|3|||
163852968|NCT00049517|591830163|FG000|Induction|Alternative therapy|0|||
163852969|NCT00049517|591830164|FG001|Induction|Alternative therapy|0|||
163852970|NCT00049517|591830165|FG002|Induction|Alternative therapy|0|||
163852971|NCT00049517|591830166|FG003|Induction|Alternative therapy|0|||
163852972|NCT00049517|591830167|FG004|Induction|Alternative therapy|2|||
163852973|NCT00049517|591830168|FG005|Induction|Alternative therapy|2|||
163852974|NCT00049517|591830163|FG000|Induction|Other complicating disease|0|||
163852975|NCT00049517|591830164|FG001|Induction|Other complicating disease|0|||
163852976|NCT00049517|591830165|FG002|Induction|Other complicating disease|0|||
163852977|NCT00049517|591830166|FG003|Induction|Other complicating disease|0|||
163852978|NCT00049517|591830167|FG004|Induction|Other complicating disease|3|||
163852979|NCT00049517|591830168|FG005|Induction|Other complicating disease|0|||
163852980|NCT00049517|591830163|FG000|Induction|Reasons not reported|0|||
163852981|NCT00049517|591830164|FG001|Induction|Reasons not reported|0|||
163852982|NCT00049517|591830165|FG002|Induction|Reasons not reported|0|||
163852983|NCT00049517|591830166|FG003|Induction|Reasons not reported|0|||
163852984|NCT00049517|591830167|FG004|Induction|Reasons not reported|22|||
163852985|NCT00049517|591830168|FG005|Induction|Reasons not reported|25|||
163852986|NCT00049517|591830163|FG000|Conditioning/Transplant|Disease progression|14|||
163852987|NCT00049517|591830164|FG001|Conditioning/Transplant|Disease progression|6|||
163852988|NCT00049517|591830165|FG002|Conditioning/Transplant|Disease progression|10|||
163852989|NCT00049517|591830166|FG003|Conditioning/Transplant|Disease progression|6|||
163852990|NCT00049517|591830167|FG004|Conditioning/Transplant|Disease progression|0|||
163852991|NCT00049517|591830168|FG005|Conditioning/Transplant|Disease progression|0|||
163852992|NCT00049517|591830163|FG000|Conditioning/Transplant|Adverse Event|2|||
163852993|NCT00049517|591830164|FG001|Conditioning/Transplant|Adverse Event|1|||
163852994|NCT00049517|591830165|FG002|Conditioning/Transplant|Adverse Event|4|||
163852995|NCT00049517|591830166|FG003|Conditioning/Transplant|Adverse Event|8|||
163852996|NCT00049517|591830167|FG004|Conditioning/Transplant|Adverse Event|0|||
163852997|NCT00049517|591830168|FG005|Conditioning/Transplant|Adverse Event|0|||
163852998|NCT00049517|591830163|FG000|Conditioning/Transplant|Death|1|||
163852999|NCT00049517|591830164|FG001|Conditioning/Transplant|Death|0|||
163853000|NCT00049517|591830165|FG002|Conditioning/Transplant|Death|0|||
163853001|NCT00049517|591830166|FG003|Conditioning/Transplant|Death|2|||
163853002|NCT00049517|591830167|FG004|Conditioning/Transplant|Death|0|||
163853003|NCT00049517|591830168|FG005|Conditioning/Transplant|Death|0|||
163853004|NCT00049517|591830163|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
163853005|NCT00049517|591830164|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
163853006|NCT00049517|591830165|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
163853007|NCT00049517|591830166|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
163853008|NCT00049517|591830167|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
163853009|NCT00049517|591830168|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
163853010|NCT00049517|591830163|FG000|Conditioning/Transplant|Alternative therapy|4|||
163853011|NCT00049517|591830164|FG001|Conditioning/Transplant|Alternative therapy|4|||
163853012|NCT00049517|591830165|FG002|Conditioning/Transplant|Alternative therapy|2|||
163853013|NCT00049517|591830166|FG003|Conditioning/Transplant|Alternative therapy|1|||
163853014|NCT00049517|591830167|FG004|Conditioning/Transplant|Alternative therapy|1|||
163853015|NCT00049517|591830168|FG005|Conditioning/Transplant|Alternative therapy|0|||
163853016|NCT00049517|591830163|FG000|Conditioning/Transplant|Other complicating disease|2|||
163853017|NCT00049517|591830164|FG001|Conditioning/Transplant|Other complicating disease|0|||
163853018|NCT00049517|591830165|FG002|Conditioning/Transplant|Other complicating disease|0|||
163853019|NCT00049517|591830166|FG003|Conditioning/Transplant|Other complicating disease|4|||
163853020|NCT00049517|591830167|FG004|Conditioning/Transplant|Other complicating disease|0|||
163853021|NCT00049517|591830168|FG005|Conditioning/Transplant|Other complicating disease|1|||
163853022|NCT00049517|591830163|FG000|Conditioning/Transplant|Reasons not reported|25|||
163853023|NCT00049517|591830164|FG001|Conditioning/Transplant|Reasons not reported|31|||
163853024|NCT00049517|591830165|FG002|Conditioning/Transplant|Reasons not reported|18|||
163853025|NCT00049517|591830166|FG003|Conditioning/Transplant|Reasons not reported|15|||
163853026|NCT00049517|591830167|FG004|Conditioning/Transplant|Reasons not reported|5|||
163853027|NCT00049517|591830168|FG005|Conditioning/Transplant|Reasons not reported|5|||
163853028|NCT00569946|591830169|FG000|Overall Study|Adverse Event|16|||
163853029|NCT00569946|591830169|FG000|Overall Study|Objective Progression or Relapse|42|||
163853030|NCT00569946|591830169|FG000|Overall Study|Global Deterioration of Health Status|1|||
163853031|NCT02949271|591830172|FG000|Overall Study|Lack of Efficacy|5|||
163853032|NCT02949271|591830173|FG001|Overall Study|Lack of Efficacy|4|||
163853033|NCT02949271|591830172|FG000|Overall Study|Lost to Follow-up|3|||
163853034|NCT02949271|591830173|FG001|Overall Study|Lost to Follow-up|6|||
163853035|NCT02949271|591830172|FG000|Overall Study|Physician Decision|5|||
163853036|NCT02949271|591830173|FG001|Overall Study|Physician Decision|5|||
163853037|NCT02949271|591830172|FG000|Overall Study|Protocol Violation|6|||
163853038|NCT02949271|591830173|FG001|Overall Study|Protocol Violation|3|||
163853039|NCT02949271|591830172|FG000|Overall Study|Withdrawal by Subject|1|||
163853040|NCT02949271|591830173|FG001|Overall Study|Withdrawal by Subject|0|||
163853041|NCT02949271|591830172|FG000|Overall Study|Delivered prior to intervention|7|||
163853042|NCT02949271|591830173|FG001|Overall Study|Delivered prior to intervention|9|||
163853043|NCT02949271|591830172|FG000|Overall Study|Outside the window for cervical dilation|2|||
163853044|NCT02949271|591830173|FG001|Overall Study|Outside the window for cervical dilation|3|||
163853045|NCT01764386|591830180|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
163853046|NCT01764386|591830181|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
163853047|NCT01764386|591830180|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
163853048|NCT01764386|591830181|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
163853049|NCT01764386|591830180|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
163853050|NCT01764386|591830181|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
163853051|NCT01764386|591830180|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
163853052|NCT01764386|591830181|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
163853053|NCT01764386|591830180|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
163853054|NCT01764386|591830181|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
163853055|NCT01764386|591830180|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
163853056|NCT01764386|591830181|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
163853057|NCT01764386|591830180|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
163853058|NCT01764386|591830181|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
163853059|NCT01764386|591830180|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
163853060|NCT01764386|591830181|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
163853061|NCT03738241|591830182|FG000|Overall Study|Withdrawal by Subject|0|||
163853062|NCT03738241|591830183|FG001|Overall Study|Withdrawal by Subject|0|||
163853063|NCT03738241|591830184|FG002|Overall Study|Withdrawal by Subject|0|||
163853064|NCT03738241|591830185|FG003|Overall Study|Withdrawal by Subject|0|||
163853065|NCT03738241|591830186|FG004|Overall Study|Withdrawal by Subject|0|||
163853066|NCT03738241|591830187|FG005|Overall Study|Withdrawal by Subject|0|||
163853067|NCT03738241|591830188|FG006|Overall Study|Withdrawal by Subject|0|||
163853068|NCT03738241|591830189|FG007|Overall Study|Withdrawal by Subject|0|||
163853069|NCT03738241|591830190|FG008|Overall Study|Withdrawal by Subject|0|||
163853070|NCT03738241|591830191|FG009|Overall Study|Withdrawal by Subject|1|||
163853071|NCT03738241|591830182|FG000|Overall Study|Physician Decision|0|||
163853072|NCT03738241|591830183|FG001|Overall Study|Physician Decision|0|||
163853073|NCT03738241|591830184|FG002|Overall Study|Physician Decision|0|||
163853074|NCT03738241|591830185|FG003|Overall Study|Physician Decision|0|||
163853075|NCT03738241|591830186|FG004|Overall Study|Physician Decision|0|||
163853076|NCT03738241|591830187|FG005|Overall Study|Physician Decision|0|||
163853077|NCT03738241|591830188|FG006|Overall Study|Physician Decision|0|||
163853078|NCT03738241|591830189|FG007|Overall Study|Physician Decision|0|||
163853079|NCT03738241|591830190|FG008|Overall Study|Physician Decision|1|||
163853080|NCT03738241|591830191|FG009|Overall Study|Physician Decision|0|||
163853081|NCT03738241|591830182|FG000|Overall Study|Adverse Event|1|||
163853082|NCT03738241|591830183|FG001|Overall Study|Adverse Event|0|||
163853083|NCT03738241|591830184|FG002|Overall Study|Adverse Event|0|||
163853084|NCT03738241|591830185|FG003|Overall Study|Adverse Event|0|||
163853085|NCT03738241|591830186|FG004|Overall Study|Adverse Event|0|||
163853086|NCT03738241|591830187|FG005|Overall Study|Adverse Event|0|||
163853087|NCT03738241|591830188|FG006|Overall Study|Adverse Event|0|||
163853088|NCT03738241|591830189|FG007|Overall Study|Adverse Event|0|||
164190645|NCT01411852|593066328|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
164190646|NCT01411852|593066329|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
164190647|NCT01411852|593066328|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
164190648|NCT01411852|593066329|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
164190649|NCT01411852|593066328|FG000|Hospital Intervention Phase|Vascular access failed|1|||
164190650|NCT01411852|593066329|FG001|Hospital Intervention Phase|Vascular access failed|0|||
163853089|NCT03738241|591830190|FG008|Overall Study|Adverse Event|0|||
163853090|NCT03738241|591830191|FG009|Overall Study|Adverse Event|0|||
163853091|NCT03169361|591830192|FG000|Overall Study|Protocol Violation|32|||
163853092|NCT02263885|591830193|FG000|Overall Study|Withdrawal by Subject|7|||
164190651|NCT00272844|593066330|FG000|Overall Study|Withdrawal by Subject|5|||
164190652|NCT03193047|593066331|FG000|Overall Study|Physician Decision|1|||
163853093|NCT02263885|591830193|FG000|Overall Study|Alternative Treatment|3|||
163853094|NCT04531540|591830201|FG000|Overall Study|Adverse Event|1|||
163853095|NCT04531540|591830201|FG000|Overall Study|Protocol Violation|3|||
163853096|NCT04531540|591830201|FG000|Overall Study|Withdrawal by Subject|4|||
163853097|NCT04531540|591830201|FG000|Overall Study|Found to be Ineligible|1|||
163853098|NCT02688621|591830202|FG000|Overall Study|Pregnancy|1|||
163853099|NCT02688621|591830203|FG001|Overall Study|Pregnancy|3|||
163853100|NCT02688621|591830202|FG000|Overall Study|Lost to Follow-up|38|||
163853101|NCT02688621|591830203|FG001|Overall Study|Lost to Follow-up|15|||
163853102|NCT02688621|591830202|FG000|Overall Study|Withdrawal by Subject|1|||
163853103|NCT02688621|591830203|FG001|Overall Study|Withdrawal by Subject|0|||
163853104|NCT03239210|591830208|FG000|Overall Study|Lost to Follow-up|2|||
163853105|NCT03239210|591830209|FG001|Overall Study|Lost to Follow-up|2|||
163853106|NCT03239210|591830208|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
163853107|NCT03239210|591830209|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
163853108|NCT03239210|591830208|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
163853109|NCT03239210|591830209|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
163853110|NCT01575860|591830210|FG000|Overall Study|Withdrawal by Subject|1|||
163853111|NCT01575860|591830210|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
163853112|NCT05349864|591830215|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
163853113|NCT05349864|591830216|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
163853114|NCT00984282|591830218|FG000|Double Blind Treatment|Adverse Event|40|||
163853115|NCT00984282|591830219|FG001|Double Blind Treatment|Adverse Event|6|||
163853116|NCT00984282|591830218|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
163853117|NCT00984282|591830219|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
163853118|NCT00984282|591830218|FG000|Double Blind Treatment|Physician Decision|1|||
163853119|NCT00984282|591830219|FG001|Double Blind Treatment|Physician Decision|2|||
163853120|NCT00984282|591830218|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
163853121|NCT00984282|591830219|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
163853122|NCT00984282|591830218|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
163853123|NCT00984282|591830219|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
163853124|NCT00984282|591830218|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
163853125|NCT00984282|591830219|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
163853126|NCT00984282|591830218|FG000|Double Blind Treatment|Lost to Follow-up|3|||
163853127|NCT00984282|591830219|FG001|Double Blind Treatment|Lost to Follow-up|0|||
163853128|NCT00984282|591830218|FG000|Double Blind Treatment|Death|8|||
163853129|NCT00984282|591830219|FG001|Double Blind Treatment|Death|4|||
163853130|NCT00984282|591830218|FG000|Double Blind Treatment|Not treated|0|||
163853131|NCT00984282|591830219|FG001|Double Blind Treatment|Not treated|1|||
163853132|NCT00984282|591830218|FG000|Double Blind Treatment|Switched to commercial drug|6|||
163853133|NCT00984282|591830219|FG001|Double Blind Treatment|Switched to commercial drug|1|||
163853134|NCT00984282|591830218|FG000|Double Blind Treatment|protocol driven decision point|1|||
163853135|NCT00984282|591830219|FG001|Double Blind Treatment|protocol driven decision point|1|||
163853136|NCT00984282|591830218|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
163853137|NCT00984282|591830219|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
163853138|NCT00984282|591830218|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
163853139|NCT00984282|591830219|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
163853140|NCT00984282|591830218|FG000|Open-label Treatment|Adverse Event|20|||
163853141|NCT00984282|591830219|FG001|Open-label Treatment|Adverse Event|30|||
163853142|NCT00984282|591830218|FG000|Open-label Treatment|Withdrawal by Subject|6|||
163853143|NCT00984282|591830219|FG001|Open-label Treatment|Withdrawal by Subject|21|||
163853144|NCT00984282|591830218|FG000|Open-label Treatment|Death|7|||
163853145|NCT00984282|591830219|FG001|Open-label Treatment|Death|15|||
163853146|NCT00984282|591830218|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
163853147|NCT00984282|591830219|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
163853148|NCT00984282|591830218|FG000|Open-label Treatment|Lost to Follow-up|1|||
163853149|NCT00984282|591830219|FG001|Open-label Treatment|Lost to Follow-up|1|||
163853150|NCT00984282|591830218|FG000|Open-label Treatment|Patient convenience|1|||
163853151|NCT00984282|591830219|FG001|Open-label Treatment|Patient convenience|0|||
163853152|NCT00984282|591830218|FG000|Open-label Treatment|Non-compliant with study medication|1|||
163853153|NCT00984282|591830219|FG001|Open-label Treatment|Non-compliant with study medication|0|||
163853154|NCT00984282|591830218|FG000|Open-label Treatment|Target lesion removed|0|||
163853155|NCT00984282|591830219|FG001|Open-label Treatment|Target lesion removed|1|||
163853156|NCT00984282|591830218|FG000|Open-label Treatment|Protocol driven decision point|1|||
163853157|NCT00984282|591830219|FG001|Open-label Treatment|Protocol driven decision point|1|||
163853158|NCT00984282|591830218|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
163853159|NCT00984282|591830219|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
163964637|NCT04908189|592243246|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
163853160|NCT00984282|591830218|FG000|Open-label Treatment|Switched to commercial drug|6|||
163853161|NCT00984282|591830219|FG001|Open-label Treatment|Switched to commercial drug|7|||
163853162|NCT00984282|591830218|FG000|Open-label Treatment|Physician Decision|1|||
163853163|NCT00984282|591830219|FG001|Open-label Treatment|Physician Decision|0|||
163853164|NCT00984282|591830218|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
163853165|NCT00984282|591830219|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
163853166|NCT00984282|591830218|FG000|Long Term Follow-up|Death|27|||
163853167|NCT00984282|591830219|FG001|Long Term Follow-up|Death|68|||
163853168|NCT00984282|591830218|FG000|Long Term Follow-up|Lost to Follow-up|3|||
163853169|NCT00984282|591830219|FG001|Long Term Follow-up|Lost to Follow-up|6|||
163853170|NCT00984282|591830218|FG000|Long Term Follow-up|Protocol driven decision point|25|||
163853171|NCT00984282|591830219|FG001|Long Term Follow-up|Protocol driven decision point|26|||
163853172|NCT00984282|591830218|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
163853173|NCT00984282|591830219|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
163853174|NCT00984282|591830218|FG000|Long Term Follow-up|Switched to commercial drug|4|||
163853175|NCT00984282|591830219|FG001|Long Term Follow-up|Switched to commercial drug|2|||
163853176|NCT00984282|591830218|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
163853177|NCT00984282|591830219|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
163853178|NCT02223793|591830220|FG000|Overall Study|Lost to Follow-up|10|||
163853179|NCT02223793|591830221|FG001|Overall Study|Lost to Follow-up|1|||
163853180|NCT02223793|591830222|FG002|Overall Study|Lost to Follow-up|2|||
163853181|NCT02223793|591830220|FG000|Overall Study|Withdrawal by Subject|3|||
163853182|NCT02223793|591830221|FG001|Overall Study|Withdrawal by Subject|2|||
163853183|NCT02223793|591830222|FG002|Overall Study|Withdrawal by Subject|3|||
163853184|NCT02223793|591830220|FG000|Overall Study|Moved/studycenter unable to participate|4|||
163853185|NCT02223793|591830221|FG001|Overall Study|Moved/studycenter unable to participate|6|||
163853186|NCT02223793|591830222|FG002|Overall Study|Moved/studycenter unable to participate|8|||
163853187|NCT00278564|591830224|FG000|Overall Study|Lack of Efficacy|4|||
163853188|NCT03606460|591830226|FG000|Overall Study|Lost to Follow-up|1|||
163853189|NCT03606460|591830227|FG001|Overall Study|Lost to Follow-up|8|||
163853190|NCT00003377|591830228|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
163853191|NCT00003377|591830229|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
163853192|NCT00003377|591830230|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
163853193|NCT00003377|591830231|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
163853194|NCT00003377|591830232|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
163853195|NCT00003377|591830228|FG000|Period II|Ureteral stent complications|0|||
163853196|NCT00003377|591830229|FG001|Period II|Ureteral stent complications|0|||
163853197|NCT00003377|591830230|FG002|Period II|Ureteral stent complications|0|||
163853198|NCT00003377|591830231|FG003|Period II|Ureteral stent complications|0|||
163853199|NCT00003377|591830232|FG004|Period II|Ureteral stent complications|1|||
163853200|NCT00582790|591830237|FG000|Overall Study|Rapid progression of disease|1|||
163853201|NCT02680756|591830242|FG000|Overall Study|Adverse Event|10|||
163853202|NCT02680756|591830243|FG001|Overall Study|Adverse Event|2|||
163853203|NCT02680756|591830242|FG000|Overall Study|Lost to Follow-up|7|||
163853204|NCT02680756|591830243|FG001|Overall Study|Lost to Follow-up|6|||
163853205|NCT02680756|591830242|FG000|Overall Study|Withdrawal by Subject|5|||
163853206|NCT02680756|591830243|FG001|Overall Study|Withdrawal by Subject|5|||
163853207|NCT02680756|591830242|FG000|Overall Study|Physician Decision|4|||
163853208|NCT02680756|591830243|FG001|Overall Study|Physician Decision|1|||
163853209|NCT02680756|591830242|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
163853210|NCT02680756|591830243|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
163853211|NCT02680756|591830242|FG000|Overall Study|Blood transfusion for any reason|0|||
163853212|NCT02680756|591830243|FG001|Overall Study|Blood transfusion for any reason|1|||
163853213|NCT02680756|591830242|FG000|Overall Study|Death|1|||
163853214|NCT02680756|591830243|FG001|Overall Study|Death|0|||
163853215|NCT02680756|591830242|FG000|Overall Study|Protocol Violation|1|||
163853216|NCT02680756|591830243|FG001|Overall Study|Protocol Violation|0|||
163853217|NCT02680756|591830242|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
163853218|NCT02680756|591830243|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
163853219|NCT02680756|591830242|FG000|Overall Study|None of above or not recorded|3|||
163853220|NCT02680756|591830243|FG001|Overall Study|None of above or not recorded|2|||
163853221|NCT00480441|591830244|FG000|Screening|Not Eligible|37|||
163853222|NCT00480441|591830245|FG001|Screening|Not Eligible|0|||
163964638|NCT04908189|592243247|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
163853223|NCT00480441|591830246|FG002|Screening|Not Eligible|0|||
163853224|NCT00480441|591830244|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
163964639|NCT04908189|592243245|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
163853225|NCT00480441|591830245|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
163853226|NCT00480441|591830246|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
163853227|NCT00480441|591830244|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
163964640|NCT04908189|592243246|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
163853228|NCT00480441|591830245|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
163853229|NCT00480441|591830246|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
163853230|NCT00480441|591830244|FG000|Baseline Functional MRI|physical contraindication|4|||
163853231|NCT00480441|591830245|FG001|Baseline Functional MRI|physical contraindication|0|||
163853232|NCT00480441|591830246|FG002|Baseline Functional MRI|physical contraindication|0|||
163853233|NCT00480441|591830244|FG000|Randomization|Lost to Follow-up|0|||
163853234|NCT00480441|591830245|FG001|Randomization|Lost to Follow-up|7|||
163853235|NCT00480441|591830246|FG002|Randomization|Lost to Follow-up|2|||
163853236|NCT02374957|591830247|FG000|Overall Study|Patient did not complete forms correctly|1|||
163853237|NCT02374957|591830248|FG001|Overall Study|Patient did not complete forms correctly|0|||
163853238|NCT01417000|591830249|FG000|Overall Study|Death|59|||
163853239|NCT01417000|591830250|FG001|Overall Study|Death|28|||
163853240|NCT01417000|591830249|FG000|Overall Study|Lost to Follow-up|1|||
163853241|NCT01417000|591830250|FG001|Overall Study|Lost to Follow-up|0|||
163853242|NCT01417000|591830249|FG000|Overall Study|Study Terminated by Sponsor|1|||
163853243|NCT01417000|591830250|FG001|Overall Study|Study Terminated by Sponsor|1|||
163853244|NCT01657682|591830251|FG000|Overall Study|Lost to Follow-up|1|||
163853245|NCT01657682|591830252|FG001|Overall Study|Lost to Follow-up|0|||
163853246|NCT01657682|591830253|FG002|Overall Study|Lost to Follow-up|0|||
163853247|NCT01657682|591830251|FG000|Overall Study|Withdrawal by Subject|0|||
163853248|NCT01657682|591830252|FG001|Overall Study|Withdrawal by Subject|1|||
163853249|NCT01657682|591830253|FG002|Overall Study|Withdrawal by Subject|1|||
163853250|NCT01657682|591830251|FG000|Overall Study|Adverse Event|0|||
163853251|NCT01657682|591830252|FG001|Overall Study|Adverse Event|1|||
163853252|NCT01657682|591830253|FG002|Overall Study|Adverse Event|0|||
163853253|NCT01318811|591830262|FG000|Overall Study|Physician Decision|1|||
163853254|NCT01318811|591830263|FG001|Overall Study|Physician Decision|1|||
163853255|NCT01318811|591830262|FG000|Overall Study|CRRT stopped for head CT|0|||
163853256|NCT01318811|591830263|FG001|Overall Study|CRRT stopped for head CT|1|||
163853257|NCT01318811|591830262|FG000|Overall Study|Death|0|||
163853258|NCT01318811|591830263|FG001|Overall Study|Death|1|||
163853259|NCT01318811|591830262|FG000|Overall Study|CRRT stopped for head MRI|0|||
163853260|NCT01318811|591830263|FG001|Overall Study|CRRT stopped for head MRI|1|||
163853261|NCT00811187|591830264|FG000|Overall Study|Unable to place device / procedure abort|3|||
163853262|NCT00811187|591830265|FG001|Overall Study|Unable to place device / procedure abort|3|||
163853263|NCT02825043|591830266|FG000|Overall Study|Lost to Follow-up|4|||
163853264|NCT00131911|591830267|FG000|Overall Study|Withdrawal by Subject|1|||
163853265|NCT00131911|591830268|FG001|Overall Study|Withdrawal by Subject|0|||
163853266|NCT00329303|591830272|FG000|Overall Study|Lack of Efficacy|1|||
163853267|NCT00329303|591830273|FG001|Overall Study|Lack of Efficacy|0|||
163853268|NCT00329303|591830272|FG000|Overall Study|Decision of the sponsor|0|||
163853269|NCT00329303|591830273|FG001|Overall Study|Decision of the sponsor|1|||
163853270|NCT00329303|591830272|FG000|Overall Study|Patient no longer available|1|||
163853271|NCT00329303|591830273|FG001|Overall Study|Patient no longer available|0|||
163853272|NCT00329303|591830272|FG000|Overall Study|Patient relocated|0|||
163853273|NCT00329303|591830273|FG001|Overall Study|Patient relocated|1|||
163853274|NCT03582137|591830276|FG000|Overall Study|Adverse Event|1|||
163853275|NCT03582137|591830277|FG001|Overall Study|Adverse Event|0|||
163853276|NCT03704298|591830278|FG000|Overall Study|Death|3|||
163853277|NCT03704298|591830279|FG001|Overall Study|Death|1|||
163853278|NCT03704298|591830280|FG002|Overall Study|Death|1|||
163853279|NCT03704298|591830281|FG003|Overall Study|Death|0|||
163853280|NCT03704298|591830278|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
163853281|NCT03704298|591830279|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
163853282|NCT03704298|591830280|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
163853283|NCT03704298|591830281|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
163853284|NCT03704298|591830278|FG000|Overall Study|Withdrawal by Subject|1|||
163853285|NCT03704298|591830279|FG001|Overall Study|Withdrawal by Subject|0|||
163853286|NCT03704298|591830280|FG002|Overall Study|Withdrawal by Subject|0|||
163853287|NCT03704298|591830281|FG003|Overall Study|Withdrawal by Subject|0|||
163853288|NCT03704298|591830278|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
163853289|NCT03704298|591830279|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
163853290|NCT03704298|591830280|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
163853291|NCT03704298|591830281|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
163853292|NCT00558753|591830286|FG000|Overall Study|Lost to Follow-up|5|||
163853293|NCT00558753|591830287|FG001|Overall Study|Lost to Follow-up|7|||
163853294|NCT01167023|591830288|FG000|Overall Study|Lost to Follow-up|0|||
163853295|NCT01167023|591830289|FG001|Overall Study|Lost to Follow-up|1|||
163853296|NCT01167023|591830290|FG002|Overall Study|Lost to Follow-up|1|||
163853297|NCT01167023|591830288|FG000|Overall Study|Screen Failure|0|||
163853298|NCT01167023|591830289|FG001|Overall Study|Screen Failure|1|||
163853299|NCT01167023|591830290|FG002|Overall Study|Screen Failure|0|||
163853300|NCT01167023|591830288|FG000|Overall Study|Sponsor Decision|0|||
163853301|NCT01167023|591830289|FG001|Overall Study|Sponsor Decision|1|||
163853302|NCT01167023|591830290|FG002|Overall Study|Sponsor Decision|0|||
163853303|NCT01167023|591830288|FG000|Overall Study|Withdrawal by Subject|0|||
163853304|NCT01167023|591830289|FG001|Overall Study|Withdrawal by Subject|0|||
163853305|NCT01167023|591830290|FG002|Overall Study|Withdrawal by Subject|1|||
163853306|NCT02820051|591830295|FG000|Overall Study|Lost to Follow-up|7|||
163853307|NCT02820051|591830296|FG001|Overall Study|Lost to Follow-up|4|||
163853308|NCT00114959|591830299|FG000|Overall Study|Lack of Efficacy|6|||
163853309|NCT00114959|591830299|FG000|Overall Study|Physician Decision|1|||
163853310|NCT00114959|591830299|FG000|Overall Study|Death|1|||
163853311|NCT02788656|591831950|FG000|Overall Study|Withdrawal by Subject|1|||
163853312|NCT02788656|591831951|FG001|Overall Study|Withdrawal by Subject|0|||
163853313|NCT03929302|591831956|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
163853314|NCT03929302|591831957|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
163853315|NCT03929302|591831958|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
163853316|NCT03929302|591831956|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
163853317|NCT03929302|591831957|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
163853318|NCT03929302|591831958|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
163853319|NCT03929302|591831956|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
163853320|NCT03929302|591831957|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
163853321|NCT03929302|591831958|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
163853322|NCT04454567|591831959|FG000|Overall Study|Study Terminated by Sponsor|1|||
163853323|NCT04454567|591831960|FG001|Overall Study|Study Terminated by Sponsor|1|||
163853324|NCT02757885|591831965|FG000|Overall Study|Screen Failures|4|||
163853325|NCT00664521|591831966|FG000|Overall Study|Adverse Event|4|||
163853326|NCT00664521|591831967|FG001|Overall Study|Adverse Event|1|||
163853327|NCT00664521|591831966|FG000|Overall Study|Lost to Follow-up|1|||
163853328|NCT00664521|591831967|FG001|Overall Study|Lost to Follow-up|0|||
163853329|NCT00664521|591831966|FG000|Overall Study|Other|1|||
163853330|NCT00664521|591831967|FG001|Overall Study|Other|0|||
163853331|NCT02459964|591831968|FG000|Overall Study|Withdrawal by Subject|0|||
163853332|NCT02459964|591831969|FG001|Overall Study|Withdrawal by Subject|0|||
163853333|NCT02459964|591831970|FG002|Overall Study|Withdrawal by Subject|1|||
163853334|NCT02459964|591831968|FG000|Overall Study|Abnormal EKG changes|0|||
163853335|NCT02459964|591831969|FG001|Overall Study|Abnormal EKG changes|0|||
163853336|NCT02459964|591831970|FG002|Overall Study|Abnormal EKG changes|1|||
163853337|NCT01175707|591831971|FG000|Overall Study|Adverse Event|4|||
163853338|NCT01175707|591831972|FG001|Overall Study|Adverse Event|6|||
163853339|NCT01456780|591831973|FG000|Overall Study|Lost to Follow-up|3|||
163853340|NCT01456780|591831974|FG001|Overall Study|Lost to Follow-up|3|||
163853341|NCT01456780|591831975|FG002|Overall Study|Lost to Follow-up|0|||
163853342|NCT02321540|591831981|FG000|Overall Study|Death|0|||
163853343|NCT02321540|591831982|FG001|Overall Study|Death|1|||
163853344|NCT02321540|591831981|FG000|Overall Study|Progression|3|||
163853345|NCT02321540|591831982|FG001|Overall Study|Progression|9|||
163853346|NCT04541186|591831986|FG000|Main Study|Adverse Event|0|||
163853347|NCT04541186|591831987|FG001|Main Study|Adverse Event|0|||
163853348|NCT04541186|591831988|FG002|Main Study|Adverse Event|4|||
163853349|NCT04541186|591831989|FG003|Main Study|Adverse Event|0|||
163853350|NCT04541186|591831990|FG004|Main Study|Adverse Event|0|||
163853351|NCT04541186|591831986|FG000|Main Study|Investigator Decision|0|||
163853352|NCT04541186|591831987|FG001|Main Study|Investigator Decision|0|||
163853353|NCT04541186|591831988|FG002|Main Study|Investigator Decision|1|||
163853354|NCT04541186|591831989|FG003|Main Study|Investigator Decision|1|||
163853355|NCT04541186|591831990|FG004|Main Study|Investigator Decision|0|||
163853356|NCT04541186|591831986|FG000|Main Study|Withdrawal by Subject|1|||
163853357|NCT04541186|591831987|FG001|Main Study|Withdrawal by Subject|1|||
163853358|NCT04541186|591831988|FG002|Main Study|Withdrawal by Subject|0|||
163853359|NCT04541186|591831989|FG003|Main Study|Withdrawal by Subject|0|||
163853360|NCT04541186|591831990|FG004|Main Study|Withdrawal by Subject|0|||
163853361|NCT04541186|591831986|FG000|Main Study|COVID-19-related Dose Interruption|0|||
163853362|NCT04541186|591831987|FG001|Main Study|COVID-19-related Dose Interruption|0|||
163853363|NCT04541186|591831988|FG002|Main Study|COVID-19-related Dose Interruption|0|||
163853364|NCT04541186|591831989|FG003|Main Study|COVID-19-related Dose Interruption|0|||
163853365|NCT04541186|591831990|FG004|Main Study|COVID-19-related Dose Interruption|1|||
163853366|NCT04541186|591831986|FG000|Main Study|Randomized in Error Not Treated|0|||
163964641|NCT04908189|592243247|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
164190653|NCT03193047|593066332|FG001|Overall Study|Physician Decision|0|||
164190654|NCT03193047|593066331|FG000|Overall Study|Participant Left State|1|||
163853367|NCT04541186|591831987|FG001|Main Study|Randomized in Error Not Treated|0|||
163853368|NCT04541186|591831988|FG002|Main Study|Randomized in Error Not Treated|1|||
163853369|NCT04541186|591831989|FG003|Main Study|Randomized in Error Not Treated|0|||
163853370|NCT04541186|591831990|FG004|Main Study|Randomized in Error Not Treated|0|||
163964642|NCT04908189|592243245|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
163853371|NCT04541186|591831986|FG000|Fibrate Expansion Study|Other than Specified|0|||
163853372|NCT04541186|591831987|FG001|Fibrate Expansion Study|Other than Specified|0|||
163853373|NCT04541186|591831988|FG002|Fibrate Expansion Study|Other than Specified|0|||
163853374|NCT04541186|591831989|FG003|Fibrate Expansion Study|Other than Specified|0|||
163853375|NCT04541186|591831990|FG004|Fibrate Expansion Study|Other than Specified|1|||
163853376|NCT00303303|591831993|FG000|Overall Study|Withdrawal by Subject|0|||
163853377|NCT00303303|591831994|FG001|Overall Study|Withdrawal by Subject|0|||
163853378|NCT00303303|591831995|FG002|Overall Study|Withdrawal by Subject|1|||
163853379|NCT03085017|591831996|FG000|Overall Study|Death|0|||
163853380|NCT03085017|591831997|FG001|Overall Study|Death|3|||
163853381|NCT00058058|591831998|FG000|Overall Study|Withdrawal by Subject|4|||
163853382|NCT00058058|591831998|FG000|Overall Study|Ineligible|20|||
163853383|NCT00058058|591831998|FG000|Overall Study|Claustrophobic|5|||
163853384|NCT00058058|591831998|FG000|Overall Study|technical issues|6|||
163853385|NCT00058058|591831998|FG000|Overall Study|Poor positioning, illness,pain|3|||
163853386|NCT00748969|591831999|FG000|Overall Study|Withdrawal by Subject|1|||
163853387|NCT00748969|591832000|FG001|Overall Study|Withdrawal by Subject|0|||
163853388|NCT00748969|591831999|FG000|Overall Study|Withdrawal by Subject|0|||
163853389|NCT00748969|591832000|FG001|Overall Study|Withdrawal by Subject|1|||
163853390|NCT03532178|591832001|FG000|First Period|Withdrawal by Subject|1|||
163853391|NCT03532178|591832002|FG001|First Period|Withdrawal by Subject|3|||
163853392|NCT03532178|591832001|FG000|First Period|technical issues in data collection Technical issues|0|||
163853393|NCT03532178|591832002|FG001|First Period|technical issues in data collection Technical issues|1|||
163853394|NCT03532178|591832001|FG000|Second Period|Withdrawal by Subject|1|||
163853395|NCT03532178|591832002|FG001|Second Period|Withdrawal by Subject|1|||
163853396|NCT03532178|591832001|FG000|Second Period|Technical issues|0|||
163853397|NCT03532178|591832002|FG001|Second Period|Technical issues|1|||
163853398|NCT01113463|591832005|FG000|Overall Study|Physician Decision|5|||
163853399|NCT00372528|591832007|FG000|Overall Study|Lack of Efficacy|1|||
163853400|NCT00372528|591832007|FG000|Overall Study|Adverse Event|1|||
163853401|NCT00372528|591832007|FG000|Overall Study|Study Terminated by Sponsor|18|||
163853402|NCT00372528|591832007|FG000|Overall Study|Other|1|||
163853403|NCT00562965|591832008|FG000|Overall Study|Withdrawal by Subject|0|||
163853404|NCT00562965|591832009|FG001|Overall Study|Withdrawal by Subject|1|||
163853405|NCT00562965|591832008|FG000|Overall Study|Death|2|||
164190655|NCT03193047|593066332|FG001|Overall Study|Participant Left State|0|||
164190656|NCT00791700|593066335|FG000|Overall Study|Insufficient clinical response|1|||
164190657|NCT00791700|593066336|FG001|Overall Study|Insufficient clinical response|4|||
164190658|NCT00791700|593066337|FG002|Overall Study|Insufficient clinical response|1|||
164190659|NCT00791700|593066338|FG003|Overall Study|Insufficient clinical response|8|||
163853406|NCT00562965|591832009|FG001|Overall Study|Death|4|||
163853407|NCT00562965|591832008|FG000|Overall Study|Lost to Follow-up|1|||
163853408|NCT00562965|591832009|FG001|Overall Study|Lost to Follow-up|0|||
163853409|NCT00562965|591832008|FG000|Overall Study|Other|0|||
163853410|NCT00562965|591832009|FG001|Overall Study|Other|1|||
163853411|NCT00761774|591832010|FG000|Overall Study|Adverse Event|17|||
163853412|NCT00761774|591832010|FG000|Overall Study|Lack of Efficacy|37|||
163853413|NCT00761774|591832010|FG000|Overall Study|Lost to Follow-up|2|||
163853414|NCT00761774|591832010|FG000|Overall Study|Withdrawal by Subject|9|||
163853415|NCT00761774|591832010|FG000|Overall Study|Non-compliance|4|||
163853416|NCT00761774|591832010|FG000|Overall Study|End of study|2|||
163853417|NCT00761774|591832010|FG000|Overall Study|Reclassification of seizures|1|||
163853418|NCT00761774|591832010|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
163853419|NCT00761774|591832010|FG000|Overall Study|Sponsor decision|1|||
163853420|NCT00761774|591832010|FG000|Overall Study|Investigator clinical judgement|1|||
163853421|NCT00761774|591832010|FG000|Overall Study|Patient moved out of study area|1|||
163853422|NCT00761774|591832010|FG000|Overall Study|Coordinator leaving site|1|||
163853423|NCT00761774|591832010|FG000|Overall Study|Subject IP non-compliance|1|||
163853424|NCT00761774|591832010|FG000|Overall Study|IP stopped by hospital physician|1|||
163853425|NCT01648283|591832011|FG000|Overall Study|Withdrawal by Subject|14|||
163853426|NCT01124617|591832012|FG000|Overall Study|Adverse Event|5|||
163853427|NCT01124617|591832013|FG001|Overall Study|Adverse Event|2|||
163853428|NCT01124617|591832012|FG000|Overall Study|Lack of Efficacy|2|||
163853429|NCT01124617|591832013|FG001|Overall Study|Lack of Efficacy|1|||
163853430|NCT01124617|591832012|FG000|Overall Study|Protocol Violation|1|||
163853431|NCT01124617|591832013|FG001|Overall Study|Protocol Violation|1|||
163853432|NCT01124617|591832012|FG000|Overall Study|Withdrawal by Subject|9|||
163853433|NCT01124617|591832013|FG001|Overall Study|Withdrawal by Subject|1|||
163853434|NCT01124617|591832012|FG000|Overall Study|Other|2|||
163964643|NCT04908189|592243246|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
163853435|NCT01124617|591832013|FG001|Overall Study|Other|1|||
163853436|NCT01354938|591832017|FG000|Overall Study|Lost to Follow-up|1|||
163853437|NCT01253200|591832018|FG000|Overall Study|Death|1|||
163853438|NCT01253200|591832019|FG001|Overall Study|Death|0|||
163853439|NCT01253200|591832020|FG002|Overall Study|Death|0|||
163853440|NCT01253200|591832021|FG003|Overall Study|Death|0|||
163853441|NCT01253200|591832022|FG004|Overall Study|Death|0|||
163853442|NCT01253200|591832018|FG000|Overall Study|Lost to Follow-up|1|||
163853443|NCT01253200|591832019|FG001|Overall Study|Lost to Follow-up|1|||
163853444|NCT01253200|591832020|FG002|Overall Study|Lost to Follow-up|0|||
164302039|NCT03847896|593482508|FG004|Overall Study|Other reasons|1|||
163853445|NCT01253200|591832021|FG003|Overall Study|Lost to Follow-up|0|||
163853446|NCT01253200|591832022|FG004|Overall Study|Lost to Follow-up|0|||
163853447|NCT01253200|591832018|FG000|Overall Study|Withdrawal by Subject|2|||
163853448|NCT01253200|591832019|FG001|Overall Study|Withdrawal by Subject|0|||
163853449|NCT01253200|591832020|FG002|Overall Study|Withdrawal by Subject|0|||
163853450|NCT01253200|591832021|FG003|Overall Study|Withdrawal by Subject|0|||
163853451|NCT01253200|591832022|FG004|Overall Study|Withdrawal by Subject|0|||
163853452|NCT01253200|591832018|FG000|Overall Study|Protocol Violation|1|||
163853453|NCT01253200|591832019|FG001|Overall Study|Protocol Violation|4|||
163853454|NCT01253200|591832020|FG002|Overall Study|Protocol Violation|0|||
163853455|NCT01253200|591832021|FG003|Overall Study|Protocol Violation|0|||
163853456|NCT01253200|591832022|FG004|Overall Study|Protocol Violation|5|||
163853457|NCT01253200|591832018|FG000|Overall Study|intents|10|||
163853458|NCT01253200|591832019|FG001|Overall Study|intents|10|||
163853459|NCT01253200|591832020|FG002|Overall Study|intents|1|||
163853460|NCT01253200|591832021|FG003|Overall Study|intents|3|||
163853461|NCT01253200|591832022|FG004|Overall Study|intents|0|||
163853462|NCT01253200|591832018|FG000|Overall Study|Attempts|6|||
163853463|NCT01253200|591832019|FG001|Overall Study|Attempts|4|||
163853464|NCT01253200|591832020|FG002|Overall Study|Attempts|1|||
163853465|NCT01253200|591832021|FG003|Overall Study|Attempts|2|||
163853466|NCT01253200|591832022|FG004|Overall Study|Attempts|0|||
163853467|NCT02049437|591832023|FG000|Period 1|Adverse Event|1|||
163853468|NCT02049437|591832024|FG001|Period 1|Adverse Event|1|||
163853469|NCT02049437|591832023|FG000|Period 1|Adverse Event|1|||
163853470|NCT02049437|591832024|FG001|Period 1|Adverse Event|0|||
163853471|NCT01163149|591832030|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
163853472|NCT01163149|591832031|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163853473|NCT01163149|591832032|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
163853474|NCT01163149|591832030|FG000|Extension Treatment Period|Adverse Event|0|||
163853475|NCT01163149|591832031|FG001|Extension Treatment Period|Adverse Event|1|||
163853476|NCT01163149|591832032|FG002|Extension Treatment Period|Adverse Event|0|||
163853477|NCT01163149|591832030|FG000|Extension Treatment Period|Noncompliance|0|||
163853478|NCT01163149|591832031|FG001|Extension Treatment Period|Noncompliance|0|||
163853479|NCT01163149|591832032|FG002|Extension Treatment Period|Noncompliance|1|||
163853480|NCT01700530|591832033|FG000|Overall Study|Withdrawal by Subject|0|||
163853481|NCT01700530|591832034|FG001|Overall Study|Withdrawal by Subject|3|||
163853482|NCT01700530|591832035|FG002|Overall Study|Withdrawal by Subject|1|||
163853483|NCT00578227|591832037|FG000|Overall Study|Lost to Follow-up|0|||
163853484|NCT00578227|591832038|FG001|Overall Study|Lost to Follow-up|1|||
163853485|NCT00578227|591832039|FG002|Overall Study|Lost to Follow-up|1|||
163853486|NCT00578227|591832037|FG000|Overall Study|Withdrawal by Subject|5|||
163853487|NCT00578227|591832038|FG001|Overall Study|Withdrawal by Subject|1|||
163853488|NCT00578227|591832039|FG002|Overall Study|Withdrawal by Subject|3|||
163853489|NCT00916006|591832045|FG000|Overall Study|Adverse Event|1|||
163853490|NCT00916006|591832046|FG001|Overall Study|Adverse Event|1|||
163853491|NCT00916006|591832045|FG000|Overall Study|Withdrawal by Subject|2|||
163853492|NCT00916006|591832046|FG001|Overall Study|Withdrawal by Subject|5|||
163853493|NCT00916006|591832045|FG000|Overall Study|Protocol Violation|0|||
163853494|NCT00916006|591832046|FG001|Overall Study|Protocol Violation|1|||
163853495|NCT01605136|591832049|FG000|Study Period|Withdrawal by Subject|2|||
163853496|NCT01605136|591832050|FG001|Study Period|Withdrawal by Subject|0|||
163853497|NCT01605136|591832049|FG000|Study Period|Physician Decision|1|||
163853498|NCT01605136|591832050|FG001|Study Period|Physician Decision|1|||
163853499|NCT01605136|591832049|FG000|Study Period|Lost to Follow-up|0|||
163853500|NCT01605136|591832050|FG001|Study Period|Lost to Follow-up|2|||
163853501|NCT01605136|591832049|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
163853502|NCT01605136|591832050|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
163853503|NCT01072929|591832051|FG000|Overall Study|Adverse Event|8|||
163853504|NCT01072929|591832052|FG001|Overall Study|Adverse Event|11|||
163853505|NCT01072929|591832053|FG002|Overall Study|Adverse Event|2|||
163853506|NCT01072929|591832051|FG000|Overall Study|Lack of Efficacy|7|||
163853507|NCT01072929|591832052|FG001|Overall Study|Lack of Efficacy|4|||
163853508|NCT01072929|591832053|FG002|Overall Study|Lack of Efficacy|0|||
163853509|NCT01072929|591832051|FG000|Overall Study|Withdrawal by Subject|7|||
163853510|NCT01072929|591832052|FG001|Overall Study|Withdrawal by Subject|15|||
163964644|NCT04908189|592243247|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
163853511|NCT01072929|591832053|FG002|Overall Study|Withdrawal by Subject|3|||
163853512|NCT01072929|591832051|FG000|Overall Study|Protocol Violation|13|||
163853513|NCT01072929|591832052|FG001|Overall Study|Protocol Violation|11|||
163853514|NCT01072929|591832053|FG002|Overall Study|Protocol Violation|2|||
163853515|NCT01072929|591832051|FG000|Overall Study|Lost to Follow-up|8|||
163853516|NCT01072929|591832052|FG001|Overall Study|Lost to Follow-up|4|||
163853517|NCT01072929|591832053|FG002|Overall Study|Lost to Follow-up|1|||
163853518|NCT01072929|591832051|FG000|Overall Study|Noncompliance with study medication|0|||
163853519|NCT01072929|591832052|FG001|Overall Study|Noncompliance with study medication|3|||
163964645|NCT04908189|592243245|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
163964646|NCT04908189|592243246|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
163964647|NCT04908189|592243247|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
164133411|NCT00914459|592852756|FG000|Overall Study|Protocol Violation|0|||
164133412|NCT00914459|592852757|FG001|Overall Study|Protocol Violation|1|||
163853520|NCT01072929|591832053|FG002|Overall Study|Noncompliance with study medication|0|||
163853521|NCT01072929|591832051|FG000|Overall Study|Noncompliance with study procedures|1|||
163853522|NCT01072929|591832052|FG001|Overall Study|Noncompliance with study procedures|0|||
163853523|NCT01072929|591832053|FG002|Overall Study|Noncompliance with study procedures|1|||
163853524|NCT01072929|591832051|FG000|Overall Study|Other|0|||
163853525|NCT01072929|591832052|FG001|Overall Study|Other|3|||
163853526|NCT01072929|591832053|FG002|Overall Study|Other|0|||
163853527|NCT04833855|591832054|FG000|Overall Study|Decision by sponsor|0|||
163853528|NCT04833855|591832055|FG001|Overall Study|Decision by sponsor|1|||
163853529|NCT04833855|591832056|FG002|Overall Study|Decision by sponsor|0|||
163853530|NCT04833855|591832057|FG003|Overall Study|Decision by sponsor|0|||
163853531|NCT04833855|591832054|FG000|Overall Study|Withdrawal by Subject|4|||
163853532|NCT04833855|591832055|FG001|Overall Study|Withdrawal by Subject|1|||
163853533|NCT04833855|591832056|FG002|Overall Study|Withdrawal by Subject|3|||
163853534|NCT04833855|591832057|FG003|Overall Study|Withdrawal by Subject|1|||
163853535|NCT04833855|591832054|FG000|Overall Study|Lost to Follow-up|1|||
163853536|NCT04833855|591832055|FG001|Overall Study|Lost to Follow-up|0|||
163853537|NCT04833855|591832056|FG002|Overall Study|Lost to Follow-up|2|||
163853538|NCT04833855|591832057|FG003|Overall Study|Lost to Follow-up|2|||
163853539|NCT04833855|591832054|FG000|Overall Study|Protocol specified criteria|0|||
163853540|NCT04833855|591832055|FG001|Overall Study|Protocol specified criteria|0|||
163853541|NCT04833855|591832056|FG002|Overall Study|Protocol specified criteria|2|||
163853542|NCT04833855|591832057|FG003|Overall Study|Protocol specified criteria|1|||
163853543|NCT02806336|591832058|FG000|Overall Study|Physician Decision|1|||
163853544|NCT02806336|591832059|FG001|Overall Study|Physician Decision|0|||
163853545|NCT02806336|591832058|FG000|Overall Study|Withdrawal by Subject|2|||
163853546|NCT02806336|591832059|FG001|Overall Study|Withdrawal by Subject|4|||
163853547|NCT02806336|591832058|FG000|Overall Study|COVID-19 research shut down|3|||
163853548|NCT02806336|591832059|FG001|Overall Study|COVID-19 research shut down|4|||
163853549|NCT02806336|591832058|FG000|Overall Study|Lack of Efficacy|0|||
163853550|NCT02806336|591832059|FG001|Overall Study|Lack of Efficacy|1|||
163853551|NCT03682536|591832060|FG000|Randomization|Withdrawal by Subject|0|||
163853552|NCT03682536|591832061|FG001|Randomization|Withdrawal by Subject|2|||
163853553|NCT03682536|591832060|FG000|Treatment|Other Reasons|8|||
163853554|NCT03682536|591832061|FG001|Treatment|Other Reasons|7|||
163853555|NCT03682536|591832060|FG000|Treatment|Physician Decision|5|||
163853556|NCT03682536|591832061|FG001|Treatment|Physician Decision|5|||
163853557|NCT03682536|591832060|FG000|Treatment|Protocol Violation|1|||
163853558|NCT03682536|591832061|FG001|Treatment|Protocol Violation|0|||
163853559|NCT03682536|591832060|FG000|Treatment|Study Terminated by Sponsor|1|||
163853560|NCT03682536|591832061|FG001|Treatment|Study Terminated by Sponsor|2|||
163853561|NCT03682536|591832060|FG000|Treatment|Lost to Follow-up|0|||
163853562|NCT03682536|591832061|FG001|Treatment|Lost to Follow-up|1|||
163853563|NCT03682536|591832060|FG000|Treatment|Withdrawal by Subject|16|||
163853564|NCT03682536|591832061|FG001|Treatment|Withdrawal by Subject|18|||
163853565|NCT03682536|591832060|FG000|Treatment|Lack of Efficacy|41|||
163853566|NCT03682536|591832061|FG001|Treatment|Lack of Efficacy|68|||
163853567|NCT03682536|591832060|FG000|Treatment|Disease Progression|9|||
163853568|NCT03682536|591832061|FG001|Treatment|Disease Progression|7|||
163853569|NCT03682536|591832060|FG000|Treatment|Adverse Event|9|||
163853570|NCT03682536|591832061|FG001|Treatment|Adverse Event|5|||
163853571|NCT03682536|591832060|FG000|Treatment|Death|14|||
163853572|NCT03682536|591832061|FG001|Treatment|Death|13|||
163853573|NCT04824131|591832062|FG000|CAB LA Oral Phase|Adverse Event|1|||
163853574|NCT04824131|591832062|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
163853575|NCT04824131|591832062|FG000|Step 3|Withdrawal by Subject|2|||
163853576|NCT02338609|591832069|FG000|Overall Study|Physician Decision|1|||
163853577|NCT02338609|591832069|FG000|Overall Study|Death|1|||
163853578|NCT02084082|591832070|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
163853579|NCT02084082|591832071|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
163853580|NCT02084082|591832072|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
163853581|NCT02084082|591832073|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
163853582|NCT02084082|591832070|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163853583|NCT02084082|591832071|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163964648|NCT04908189|592243245|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
163853584|NCT02084082|591832072|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163853585|NCT02084082|591832073|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
163853586|NCT04736056|591832078|FG000|Overall Study|Death|0|||
163853587|NCT04736056|591832079|FG001|Overall Study|Death|0|||
163853588|NCT04736056|591832080|FG002|Overall Study|Death|0|||
163853589|NCT04736056|591832081|FG003|Overall Study|Death|1|||
163853590|NCT04736056|591832078|FG000|Overall Study|Lost to Follow-up|1|||
163853591|NCT04736056|591832079|FG001|Overall Study|Lost to Follow-up|0|||
163853592|NCT04736056|591832080|FG002|Overall Study|Lost to Follow-up|1|||
163853593|NCT04736056|591832081|FG003|Overall Study|Lost to Follow-up|1|||
163853594|NCT04736056|591832078|FG000|Overall Study|Withdrawal by Subject|2|||
163853595|NCT04736056|591832079|FG001|Overall Study|Withdrawal by Subject|0|||
163853596|NCT04736056|591832080|FG002|Overall Study|Withdrawal by Subject|0|||
163853597|NCT04736056|591832081|FG003|Overall Study|Withdrawal by Subject|0|||
163853598|NCT04736056|591832078|FG000|Overall Study|Physician Decision|1|||
163853599|NCT04736056|591832079|FG001|Overall Study|Physician Decision|0|||
163853600|NCT04736056|591832080|FG002|Overall Study|Physician Decision|1|||
163853601|NCT04736056|591832081|FG003|Overall Study|Physician Decision|0|||
163853602|NCT02223182|591832082|FG000|Double-Blind Period|Adverse Event|0|||
163853603|NCT02223182|591832083|FG001|Double-Blind Period|Adverse Event|2|||
163853604|NCT02223182|591832084|FG002|Double-Blind Period|Adverse Event|1|||
163853605|NCT02223182|591832085|FG003|Double-Blind Period|Adverse Event|0|||
163853606|NCT02223182|591832082|FG000|Double-Blind Period|Withdrawal by Subject|1|||
163853607|NCT02223182|591832083|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163853608|NCT02223182|591832084|FG002|Double-Blind Period|Withdrawal by Subject|1|||
163853609|NCT02223182|591832085|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163853610|NCT02223182|591832082|FG000|Double-Blind Period|Lost to Follow-up|0|||
163853611|NCT02223182|591832083|FG001|Double-Blind Period|Lost to Follow-up|1|||
163853612|NCT02223182|591832084|FG002|Double-Blind Period|Lost to Follow-up|0|||
163853613|NCT02223182|591832085|FG003|Double-Blind Period|Lost to Follow-up|0|||
163853614|NCT02223182|591832082|FG000|Double-Blind Period|Non Compliance|0|||
163853615|NCT02223182|591832083|FG001|Double-Blind Period|Non Compliance|0|||
163853616|NCT02223182|591832084|FG002|Double-Blind Period|Non Compliance|0|||
163853617|NCT02223182|591832085|FG003|Double-Blind Period|Non Compliance|1|||
163853618|NCT02223182|591832082|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
163853619|NCT02223182|591832083|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
163853620|NCT02223182|591832084|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
163853621|NCT02223182|591832085|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
163853622|NCT02223182|591832082|FG000|Open-Label 500 Period|Adverse Event|1|||
163853623|NCT02223182|591832083|FG001|Open-Label 500 Period|Adverse Event|0|||
163853624|NCT02223182|591832084|FG002|Open-Label 500 Period|Adverse Event|2|||
163853625|NCT02223182|591832085|FG003|Open-Label 500 Period|Adverse Event|1|||
163853626|NCT02223182|591832082|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
163853627|NCT02223182|591832083|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
163853628|NCT02223182|591832084|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
163853629|NCT02223182|591832085|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
163853630|NCT02223182|591832082|FG000|Open-Label 500 Period|Physician Decision|0|||
163853631|NCT02223182|591832083|FG001|Open-Label 500 Period|Physician Decision|0|||
163853632|NCT02223182|591832084|FG002|Open-Label 500 Period|Physician Decision|0|||
163853633|NCT02223182|591832085|FG003|Open-Label 500 Period|Physician Decision|1|||
163853634|NCT02223182|591832082|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
163853635|NCT02223182|591832083|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
163853636|NCT02223182|591832084|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
163853637|NCT02223182|591832085|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
163853638|NCT02223182|591832082|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
163853639|NCT02223182|591832083|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
163853640|NCT02223182|591832084|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
163853641|NCT02223182|591832085|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
163853642|NCT02223182|591832082|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
163853643|NCT02223182|591832083|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
163853644|NCT02223182|591832084|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
163853645|NCT02223182|591832085|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
163853646|NCT02223182|591832082|FG000|Open-Label 300 Period|Non Compliance|0|||
163853647|NCT02223182|591832083|FG001|Open-Label 300 Period|Non Compliance|2|||
163853648|NCT02223182|591832084|FG002|Open-Label 300 Period|Non Compliance|1|||
163853649|NCT02223182|591832085|FG003|Open-Label 300 Period|Non Compliance|0|||
163853650|NCT04956692|591832092|FG000|Overall Study|Death|115|||
163853651|NCT04956692|591832093|FG001|Overall Study|Death|47|||
163853652|NCT04956692|591832092|FG000|Overall Study|Lost to Follow-up|0|||
163853653|NCT04956692|591832093|FG001|Overall Study|Lost to Follow-up|1|||
163853654|NCT04956692|591832092|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163853655|NCT04956692|591832093|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163853656|NCT04956692|591832092|FG000|Overall Study|Withdrawal by Subject|5|||
163853657|NCT04956692|591832093|FG001|Overall Study|Withdrawal by Subject|2|||
163853658|NCT04956692|591832092|FG000|Overall Study|Ongoing in Study|236|||
163853659|NCT04956692|591832093|FG001|Overall Study|Ongoing in Study|123|||
163853660|NCT02099539|591832096|FG000|Overall Study|Progressive Disease|3|||
163853661|NCT02099539|591832097|FG001|Overall Study|Progressive Disease|2|||
163853662|NCT02099539|591832098|FG002|Overall Study|Progressive Disease|2|||
163853663|NCT02099539|591832099|FG003|Overall Study|Progressive Disease|1|||
163853664|NCT02099539|591832100|FG004|Overall Study|Progressive Disease|4|||
163853665|NCT02099539|591832101|FG005|Overall Study|Progressive Disease|2|||
163853666|NCT02099539|591832102|FG006|Overall Study|Progressive Disease|0|||
163853667|NCT02099539|591832096|FG000|Overall Study|Adverse Event|0|||
163853668|NCT02099539|591832097|FG001|Overall Study|Adverse Event|0|||
163853669|NCT02099539|591832098|FG002|Overall Study|Adverse Event|1|||
163853670|NCT02099539|591832099|FG003|Overall Study|Adverse Event|1|||
163853671|NCT02099539|591832100|FG004|Overall Study|Adverse Event|0|||
163853672|NCT02099539|591832101|FG005|Overall Study|Adverse Event|0|||
163853673|NCT02099539|591832102|FG006|Overall Study|Adverse Event|0|||
163853674|NCT02099539|591832096|FG000|Overall Study|Physician Decision|0|||
163853675|NCT02099539|591832097|FG001|Overall Study|Physician Decision|0|||
163853676|NCT02099539|591832098|FG002|Overall Study|Physician Decision|0|||
163853677|NCT02099539|591832099|FG003|Overall Study|Physician Decision|0|||
163853678|NCT02099539|591832100|FG004|Overall Study|Physician Decision|0|||
163853679|NCT02099539|591832101|FG005|Overall Study|Physician Decision|1|||
163853680|NCT02099539|591832102|FG006|Overall Study|Physician Decision|0|||
163853681|NCT01449721|591832104|FG000|Overall Study|Physician Decision|0|||
163853682|NCT01449721|591832105|FG001|Overall Study|Physician Decision|1|||
163853683|NCT01449721|591832104|FG000|Overall Study|Physician Decision|0|||
163853684|NCT01449721|591832105|FG001|Overall Study|Physician Decision|1|||
163853685|NCT02148718|591832106|FG000|Overall Study|Protocol Violation|26|||
163853686|NCT02148718|591832106|FG000|Overall Study|Discontinued Study Prematurely|5|||
163853687|NCT00333788|591832113|FG000|Overall Study|Adverse Event|44|||
163853688|NCT00333788|591832113|FG000|Overall Study|Lack of Efficacy|80|||
163853689|NCT00333788|591832113|FG000|Overall Study|Lost to Follow-up|2|||
163853690|NCT00333788|591832113|FG000|Overall Study|Withdrawal by Subject|24|||
163853691|NCT00333788|591832113|FG000|Overall Study|Other: Non-compliance|2|||
163853692|NCT00333788|591832113|FG000|Overall Study|Other: Moved|2|||
163853693|NCT00333788|591832113|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
163853694|NCT00333788|591832113|FG000|Overall Study|Other: Investigator decision|1|||
163853695|NCT00333788|591832113|FG000|Overall Study|Other: Quality of life concern|1|||
163853696|NCT00333788|591832113|FG000|Overall Study|Other: Sponsor decision|1|||
163853697|NCT00333788|591832113|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
163853698|NCT00333788|591832113|FG000|Overall Study|Other: Medical monitor decision|1|||
163853699|NCT00333788|591832113|FG000|Overall Study|Other: Physician decision|1|||
163853700|NCT00333788|591832113|FG000|Overall Study|Other: Signed consent for another study|1|||
163853701|NCT04739423|591832114|FG000|Overall Study|Protocol Violation|0|||
163853702|NCT04739423|591832115|FG001|Overall Study|Protocol Violation|1|||
163853703|NCT04739423|591832116|FG002|Overall Study|Protocol Violation|0|||
163853704|NCT04739423|591832117|FG003|Overall Study|Protocol Violation|0|||
163853705|NCT04739423|591832118|FG004|Overall Study|Protocol Violation|0|||
163853706|NCT04739423|591832119|FG005|Overall Study|Protocol Violation|0|||
163853707|NCT04739423|591832114|FG000|Overall Study|Adverse Event|0|||
163853708|NCT04739423|591832115|FG001|Overall Study|Adverse Event|0|||
163853709|NCT04739423|591832116|FG002|Overall Study|Adverse Event|1|||
163853710|NCT04739423|591832117|FG003|Overall Study|Adverse Event|0|||
163853711|NCT04739423|591832118|FG004|Overall Study|Adverse Event|1|||
163853712|NCT04739423|591832119|FG005|Overall Study|Adverse Event|0|||
163853713|NCT04739423|591832114|FG000|Overall Study|Withdrawal by Subject|0|||
163853714|NCT04739423|591832115|FG001|Overall Study|Withdrawal by Subject|0|||
163853715|NCT04739423|591832116|FG002|Overall Study|Withdrawal by Subject|0|||
163853716|NCT04739423|591832117|FG003|Overall Study|Withdrawal by Subject|0|||
163853717|NCT04739423|591832118|FG004|Overall Study|Withdrawal by Subject|0|||
163853718|NCT04739423|591832119|FG005|Overall Study|Withdrawal by Subject|1|||
163853719|NCT04978363|591834241|FG000|Overall Study|Other medical issues unrelated to the study|0|||
163853720|NCT04978363|591834242|FG001|Overall Study|Other medical issues unrelated to the study|0|||
163853721|NCT04978363|591834243|FG002|Overall Study|Other medical issues unrelated to the study|0|||
163853722|NCT04978363|591834244|FG003|Overall Study|Other medical issues unrelated to the study|0|||
163853723|NCT04978363|591834245|FG004|Overall Study|Other medical issues unrelated to the study|1|||
163853724|NCT04978363|591834246|FG005|Overall Study|Other medical issues unrelated to the study|0|||
163853725|NCT04978363|591834247|FG006|Overall Study|Other medical issues unrelated to the study|0|||
163853726|NCT04978363|591834248|FG007|Overall Study|Other medical issues unrelated to the study|0|||
163853727|NCT04978363|591834249|FG008|Overall Study|Other medical issues unrelated to the study|0|||
163853728|NCT04978363|591834250|FG009|Overall Study|Other medical issues unrelated to the study|0|||
163853729|NCT04978363|591834251|FG010|Overall Study|Other medical issues unrelated to the study|0|||
163853730|NCT04978363|591834241|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
163964649|NCT04908189|592243246|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
163964650|NCT04908189|592243247|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
163964651|NCT04908189|592243245|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163964652|NCT04908189|592243246|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163964653|NCT04908189|592243247|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
163964654|NCT05118204|592243248|FG000|Overall Study|Lost to Follow-up|3|||
163964655|NCT05118204|592243249|FG001|Overall Study|Lost to Follow-up|2|||
163964656|NCT05118204|592243248|FG000|Overall Study|Withdrawal by Subject|0|||
163964657|NCT05118204|592243249|FG001|Overall Study|Withdrawal by Subject|2|||
163964658|NCT00607022|592243250|FG000|Overall Study|Withdrawal by Subject|1|||
163964659|NCT00607022|592243251|FG001|Overall Study|Withdrawal by Subject|0|||
163964660|NCT00607022|592243252|FG002|Overall Study|Withdrawal by Subject|0|||
163964661|NCT05393037|592243253|FG000|Part A|Death|1|||
163964662|NCT05393037|592243254|FG001|Part A|Death|0|||
163964663|NCT05393037|592243253|FG000|Part A|Lost to Follow-up|1|||
163964664|NCT05393037|592243254|FG001|Part A|Lost to Follow-up|1|||
163964665|NCT05393037|592243253|FG000|Part A|Withdrawal by Subject|2|||
163853731|NCT04978363|591834242|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
163964666|NCT05393037|592243254|FG001|Part A|Withdrawal by Subject|4|||
163964667|NCT05393037|592243253|FG000|Part B|Lost to Follow-up|1|||
163853732|NCT04978363|591834243|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
163853733|NCT04978363|591834244|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
163853734|NCT04978363|591834245|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
163853735|NCT04978363|591834246|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
163853736|NCT04978363|591834247|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
163853737|NCT04978363|591834248|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
163853738|NCT04978363|591834249|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
163853739|NCT04978363|591834250|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
163853740|NCT04978363|591834251|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
163853741|NCT04978363|591834241|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853742|NCT04978363|591834242|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
163853743|NCT04978363|591834243|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853744|NCT04978363|591834244|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853745|NCT04978363|591834245|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853746|NCT04978363|591834246|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853747|NCT04978363|591834247|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853748|NCT04978363|591834248|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853749|NCT04978363|591834249|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853750|NCT04978363|591834250|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853751|NCT04978363|591834251|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
163853752|NCT01251614|591834252|FG000|Overall Study|Adverse Event|1|||
163853753|NCT01251614|591834253|FG001|Overall Study|Adverse Event|0|||
163853754|NCT01251614|591834254|FG002|Overall Study|Adverse Event|1|||
163853755|NCT01251614|591834252|FG000|Overall Study|Lack of Efficacy|1|||
163853756|NCT01251614|591834253|FG001|Overall Study|Lack of Efficacy|9|||
163853757|NCT01251614|591834254|FG002|Overall Study|Lack of Efficacy|4|||
163853758|NCT01251614|591834252|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
163853759|NCT01251614|591834253|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
163853760|NCT01251614|591834254|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
163853761|NCT01251614|591834252|FG000|Overall Study|Pregnancy|0|||
163853762|NCT01251614|591834253|FG001|Overall Study|Pregnancy|0|||
163853763|NCT01251614|591834254|FG002|Overall Study|Pregnancy|2|||
163853764|NCT01251614|591834252|FG000|Overall Study|Loss of Disease Control|0|||
163853765|NCT01251614|591834253|FG001|Overall Study|Loss of Disease Control|1|||
163853766|NCT01251614|591834254|FG002|Overall Study|Loss of Disease Control|0|||
163853767|NCT01251614|591834252|FG000|Overall Study|Withdrawal by Subject|0|||
163853768|NCT01251614|591834253|FG001|Overall Study|Withdrawal by Subject|2|||
163853769|NCT01251614|591834254|FG002|Overall Study|Withdrawal by Subject|1|||
163853770|NCT01251614|591834252|FG000|Overall Study|Lost to Follow-up|0|||
163853771|NCT01251614|591834253|FG001|Overall Study|Lost to Follow-up|1|||
163853772|NCT01251614|591834254|FG002|Overall Study|Lost to Follow-up|0|||
163853773|NCT01876043|591834256|FG000|Overall Study|Death|1|||
163853774|NCT01876043|591834256|FG000|Overall Study|Withdrawal by Subject|1|||
163853775|NCT01211665|591834257|FG000|Overall Study|Withdrawal by Subject|1|||
163853776|NCT01211665|591834258|FG001|Overall Study|Withdrawal by Subject|0|||
163853777|NCT01211665|591834257|FG000|Overall Study|Death|1|||
163853778|NCT01211665|591834258|FG001|Overall Study|Death|0|||
163853779|NCT00498186|591834261|FG000|Overall Study|Protocol Violation|10|||
163853780|NCT00498186|591834261|FG000|Overall Study|Lack of Efficacy|31|||
163853781|NCT00498186|591834261|FG000|Overall Study|Adverse Event|89|||
163853782|NCT00498186|591834261|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
163853783|NCT00498186|591834261|FG000|Overall Study|Withdrawal by Subject|18|||
163853784|NCT00498186|591834261|FG000|Overall Study|Lost to Follow-up|3|||
163853785|NCT00498186|591834261|FG000|Overall Study|Other|10|||
163853786|NCT03302156|591834264|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
163853787|NCT03302156|591834265|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
163853788|NCT03302156|591834266|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
163853789|NCT02390557|591834267|FG000|Wave 2|Survey non-respondent|72|||
163853790|NCT02390557|591834268|FG001|Wave 2|Survey non-respondent|41|||
163853791|NCT02390557|591834269|FG002|Wave 2|Survey non-respondent|23|||
163853792|NCT03635112|591834271|FG000|Overall Study|Adverse Event|5|||
163853793|NCT03635112|591834272|FG001|Overall Study|Adverse Event|9|||
163853794|NCT03635112|591834273|FG002|Overall Study|Adverse Event|14|||
163853795|NCT03635112|591834271|FG000|Overall Study|Lost to Follow-up|1|||
163853796|NCT03635112|591834272|FG001|Overall Study|Lost to Follow-up|0|||
163853797|NCT03635112|591834273|FG002|Overall Study|Lost to Follow-up|1|||
163853798|NCT03635112|591834271|FG000|Overall Study|Physician Decision|5|||
163964668|NCT05393037|592243254|FG001|Part B|Lost to Follow-up|0|||
163853799|NCT03635112|591834272|FG001|Overall Study|Physician Decision|7|||
163853800|NCT03635112|591834273|FG002|Overall Study|Physician Decision|5|||
163964669|NCT04409353|592243255|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
164190660|NCT00791700|593066335|FG000|Overall Study|No longer willing to participate|1|||
163853801|NCT03635112|591834271|FG000|Overall Study|Protocol Violation|0|||
163853802|NCT03635112|591834272|FG001|Overall Study|Protocol Violation|0|||
163853803|NCT03635112|591834273|FG002|Overall Study|Protocol Violation|1|||
163853804|NCT03635112|591834271|FG000|Overall Study|Study Terminated by Sponsor|11|||
163853805|NCT03635112|591834272|FG001|Overall Study|Study Terminated by Sponsor|17|||
163853806|NCT03635112|591834273|FG002|Overall Study|Study Terminated by Sponsor|21|||
163853807|NCT03635112|591834271|FG000|Overall Study|Withdrawal by Subject|4|||
163853808|NCT03635112|591834272|FG001|Overall Study|Withdrawal by Subject|9|||
163853809|NCT03635112|591834273|FG002|Overall Study|Withdrawal by Subject|7|||
163853810|NCT03635112|591834271|FG000|Overall Study|Miscellaneous|0|||
163853811|NCT03635112|591834272|FG001|Overall Study|Miscellaneous|0|||
163853812|NCT03635112|591834273|FG002|Overall Study|Miscellaneous|1|||
163853813|NCT03006341|591834276|FG000|Overall Study|Not linked in the EMR|25069|||
163853814|NCT03006341|591834277|FG001|Overall Study|Not linked in the EMR|67505|||
163853815|NCT03006341|591834278|FG002|Overall Study|Not linked in the EMR|30993|||
163853816|NCT03006341|591834279|FG003|Overall Study|Not linked in the EMR|10685|||
163853817|NCT02950545|591834281|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163853818|NCT02950545|591834282|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163853819|NCT02950545|591834283|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163853820|NCT02950545|591834284|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163853821|NCT02950545|591834285|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
163853822|NCT02950545|591834286|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
163853823|NCT02950545|591834281|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
163853824|NCT02950545|591834282|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
163853825|NCT02950545|591834283|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
163853826|NCT02950545|591834284|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
163853827|NCT02950545|591834285|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
163853828|NCT02950545|591834286|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
163853829|NCT02950545|591834281|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163853830|NCT02950545|591834282|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163853831|NCT02950545|591834283|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163853832|NCT02950545|591834284|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163853833|NCT02950545|591834285|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
163853834|NCT02950545|591834286|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
163853835|NCT02950545|591834281|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
163853836|NCT02950545|591834282|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163853837|NCT02950545|591834283|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163853838|NCT02950545|591834284|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163853839|NCT02950545|591834285|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163853840|NCT02950545|591834286|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
163853841|NCT02950545|591834281|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163853842|NCT02950545|591834282|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163853843|NCT02950545|591834283|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163853844|NCT02950545|591834284|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163853845|NCT02950545|591834285|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
163853846|NCT02950545|591834286|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
163853847|NCT03283553|591834290|FG000|Patient Participant Flow|Death|5|||
163853848|NCT03283553|591834291|FG001|Patient Participant Flow|Death|10|||
163853849|NCT03283553|591834290|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
163853850|NCT03283553|591834291|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
163853851|NCT03283553|591834290|FG000|Patient Participant Flow|Lost to Follow-up|1|||
163853852|NCT03283553|591834291|FG001|Patient Participant Flow|Lost to Follow-up|1|||
163853853|NCT03283553|591834290|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
163853854|NCT03283553|591834291|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
163853855|NCT03283553|591834290|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
163853856|NCT03283553|591834291|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
163853857|NCT03283553|591834290|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
163853858|NCT03283553|591834291|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
164190661|NCT00791700|593066336|FG001|Overall Study|No longer willing to participate|1|||
164190662|NCT00791700|593066337|FG002|Overall Study|No longer willing to participate|0|||
164190663|NCT00791700|593066338|FG003|Overall Study|No longer willing to participate|8|||
164190664|NCT00791700|593066335|FG000|Overall Study|Non-compliance with study treatment|0|||
164190665|NCT00791700|593066336|FG001|Overall Study|Non-compliance with study treatment|2|||
164190666|NCT00791700|593066337|FG002|Overall Study|Non-compliance with study treatment|0|||
164190667|NCT00791700|593066338|FG003|Overall Study|Non-compliance with study treatment|4|||
164190668|NCT00791700|593066335|FG000|Overall Study|Withdrawn due to pregnancy|0|||
164190669|NCT00791700|593066336|FG001|Overall Study|Withdrawn due to pregnancy|0|||
164190670|NCT00791700|593066337|FG002|Overall Study|Withdrawn due to pregnancy|0|||
163853859|NCT03686683|591834292|FG000|Overall Study|Withdrawal by Subject|52|||
163853860|NCT03686683|591834293|FG001|Overall Study|Withdrawal by Subject|32|||
163853861|NCT03686683|591834292|FG000|Overall Study|Lost to Follow-up|23|||
164190671|NCT00791700|593066338|FG003|Overall Study|Withdrawn due to pregnancy|1|||
163853862|NCT03686683|591834293|FG001|Overall Study|Lost to Follow-up|19|||
163853863|NCT03686683|591834292|FG000|Overall Study|Adverse Event|1|||
163853864|NCT03686683|591834293|FG001|Overall Study|Adverse Event|0|||
163853865|NCT03686683|591834292|FG000|Overall Study|Death|10|||
163853866|NCT03686683|591834293|FG001|Overall Study|Death|5|||
163853867|NCT03686683|591834292|FG000|Overall Study|Progressive Disease|1|||
163853868|NCT03686683|591834293|FG001|Overall Study|Progressive Disease|1|||
163853869|NCT03686683|591834292|FG000|Overall Study|Noncompliance|1|||
163853870|NCT03686683|591834293|FG001|Overall Study|Noncompliance|0|||
163853871|NCT03686683|591834292|FG000|Overall Study|Physician Decision|1|||
163853872|NCT03686683|591834293|FG001|Overall Study|Physician Decision|1|||
163853873|NCT03686683|591834292|FG000|Overall Study|Screen fail post-randomization|1|||
163853874|NCT03686683|591834293|FG001|Overall Study|Screen fail post-randomization|0|||
163853875|NCT03686683|591834292|FG000|Overall Study|Protocol Violation|3|||
163853876|NCT03686683|591834293|FG001|Overall Study|Protocol Violation|0|||
163853877|NCT03686683|591834292|FG000|Overall Study|No data available|1|||
163853878|NCT03686683|591834293|FG001|Overall Study|No data available|0|||
163853879|NCT01770860|591834294|FG000|Overall Study|Withdrawal by Subject|4|||
163853880|NCT01770860|591834294|FG000|Overall Study|Lost to Follow-up|1|||
163853881|NCT01770860|591834294|FG000|Overall Study|Administrative decision made by the PI|1|||
163853882|NCT01528709|591834295|FG000|Overall Study|Death|2|||
163853883|NCT01528709|591834296|FG001|Overall Study|Death|0|||
163853884|NCT01528709|591834295|FG000|Overall Study|Withdrawal by Subject|10|||
163853885|NCT01528709|591834296|FG001|Overall Study|Withdrawal by Subject|15|||
163853886|NCT01528709|591834295|FG000|Overall Study|allergy|1|||
163853887|NCT01528709|591834296|FG001|Overall Study|allergy|0|||
163853888|NCT05124899|591834297|FG000|Overall Study|Lost to Follow-up|3|||
163853889|NCT03432533|591834302|FG000|Overall Study|Lost to Follow-up|1|||
163853890|NCT03432533|591834303|FG001|Overall Study|Lost to Follow-up|2|||
163853891|NCT03432533|591834302|FG000|Overall Study|Withdrawal by Subject|14|||
163853892|NCT03432533|591834303|FG001|Overall Study|Withdrawal by Subject|9|||
163853893|NCT00945477|591834304|FG000|Overall Study|Adverse Event|3|||
163853894|NCT00945477|591834304|FG000|Overall Study|Lack of Efficacy|2|||
163853895|NCT00945477|591834304|FG000|Overall Study|Withdrawal by Subject|1|||
163853896|NCT00797225|591834309|FG000|Weeks 1 to 12|Adverse Event|0|||
163853897|NCT00797225|591834310|FG001|Weeks 1 to 12|Adverse Event|0|||
163853898|NCT00797225|591834311|FG002|Weeks 1 to 12|Adverse Event|1|||
163853899|NCT00797225|591834312|FG003|Weeks 1 to 12|Adverse Event|0|||
163853900|NCT00797225|591834313|FG004|Weeks 1 to 12|Adverse Event|0|||
163853901|NCT00797225|591834314|FG005|Weeks 1 to 12|Adverse Event|0|||
163853902|NCT00797225|591834315|FG006|Weeks 1 to 12|Adverse Event|0|||
163853903|NCT00797225|591834316|FG007|Weeks 1 to 12|Adverse Event|0|||
163853904|NCT00797225|591834309|FG000|Weeks 1 to 12|Non-compliance|0|||
163853905|NCT00797225|591834310|FG001|Weeks 1 to 12|Non-compliance|1|||
163853906|NCT00797225|591834311|FG002|Weeks 1 to 12|Non-compliance|0|||
163853907|NCT00797225|591834312|FG003|Weeks 1 to 12|Non-compliance|0|||
163853908|NCT00797225|591834313|FG004|Weeks 1 to 12|Non-compliance|0|||
163853909|NCT00797225|591834314|FG005|Weeks 1 to 12|Non-compliance|0|||
163853910|NCT00797225|591834315|FG006|Weeks 1 to 12|Non-compliance|0|||
163853911|NCT00797225|591834316|FG007|Weeks 1 to 12|Non-compliance|0|||
163853912|NCT00797225|591834309|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
163853913|NCT00797225|591834310|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
163853914|NCT00797225|591834311|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
163853915|NCT00797225|591834312|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
163853916|NCT00797225|591834313|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
163853917|NCT00797225|591834314|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
163853918|NCT00797225|591834315|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
163853919|NCT00797225|591834316|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
163853920|NCT00797225|591834309|FG000|Weeks 1 to 12|Sponsor Decision|1|||
163853921|NCT00797225|591834310|FG001|Weeks 1 to 12|Sponsor Decision|0|||
163853922|NCT00797225|591834311|FG002|Weeks 1 to 12|Sponsor Decision|0|||
163853923|NCT00797225|591834312|FG003|Weeks 1 to 12|Sponsor Decision|0|||
163853924|NCT00797225|591834313|FG004|Weeks 1 to 12|Sponsor Decision|0|||
163853925|NCT00797225|591834314|FG005|Weeks 1 to 12|Sponsor Decision|0|||
163853926|NCT00797225|591834315|FG006|Weeks 1 to 12|Sponsor Decision|0|||
163853927|NCT00797225|591834316|FG007|Weeks 1 to 12|Sponsor Decision|0|||
163853928|NCT00797225|591834309|FG000|Weeks 13 to 24|Non-compliance|0|||
163853929|NCT00797225|591834310|FG001|Weeks 13 to 24|Non-compliance|2|||
163853930|NCT00797225|591834311|FG002|Weeks 13 to 24|Non-compliance|0|||
163853931|NCT00797225|591834312|FG003|Weeks 13 to 24|Non-compliance|0|||
163853932|NCT00797225|591834313|FG004|Weeks 13 to 24|Non-compliance|0|||
163853933|NCT00797225|591834314|FG005|Weeks 13 to 24|Non-compliance|0|||
163853934|NCT00797225|591834315|FG006|Weeks 13 to 24|Non-compliance|0|||
163853935|NCT00797225|591834316|FG007|Weeks 13 to 24|Non-compliance|0|||
163853936|NCT00797225|591834309|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
163853937|NCT00797225|591834310|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
163853938|NCT00797225|591834311|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
163853939|NCT00797225|591834312|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
163853940|NCT00797225|591834313|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
163853941|NCT00797225|591834314|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
163853942|NCT00797225|591834315|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
163853943|NCT00797225|591834316|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
163853944|NCT00797225|591834309|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
163853945|NCT00797225|591834310|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
163853946|NCT00797225|591834311|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
163853947|NCT00797225|591834312|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
163853948|NCT00797225|591834313|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
163853949|NCT00797225|591834314|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
163853950|NCT00797225|591834315|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
163853951|NCT00797225|591834316|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
163853952|NCT00797225|591834309|FG000|Weeks 13 to 24|Adverse Event|0|||
163853953|NCT00797225|591834310|FG001|Weeks 13 to 24|Adverse Event|1|||
163853954|NCT00797225|591834311|FG002|Weeks 13 to 24|Adverse Event|0|||
163853955|NCT00797225|591834312|FG003|Weeks 13 to 24|Adverse Event|0|||
163853956|NCT00797225|591834313|FG004|Weeks 13 to 24|Adverse Event|0|||
163853957|NCT00797225|591834314|FG005|Weeks 13 to 24|Adverse Event|0|||
163853958|NCT00797225|591834315|FG006|Weeks 13 to 24|Adverse Event|1|||
163853959|NCT00797225|591834316|FG007|Weeks 13 to 24|Adverse Event|0|||
163853960|NCT00797225|591834309|FG000|Weeks 13 to 24|Sponsor Decision|0|||
163853961|NCT00797225|591834310|FG001|Weeks 13 to 24|Sponsor Decision|0|||
163853962|NCT00797225|591834311|FG002|Weeks 13 to 24|Sponsor Decision|0|||
163853963|NCT00797225|591834312|FG003|Weeks 13 to 24|Sponsor Decision|0|||
163853964|NCT00797225|591834313|FG004|Weeks 13 to 24|Sponsor Decision|0|||
163853965|NCT00797225|591834314|FG005|Weeks 13 to 24|Sponsor Decision|0|||
163853966|NCT00797225|591834315|FG006|Weeks 13 to 24|Sponsor Decision|1|||
163853967|NCT00797225|591834316|FG007|Weeks 13 to 24|Sponsor Decision|0|||
163853968|NCT01008748|591834320|FG000|Overall Study|Lost to Follow-up|80|||
163853969|NCT01008748|591834320|FG000|Overall Study|Other|1|||
163853970|NCT03008122|591834321|FG000|Overall Study|Physician Decision|3|||
163853971|NCT03008122|591834322|FG001|Overall Study|Physician Decision|2|||
163853972|NCT03008122|591834323|FG002|Overall Study|Physician Decision|0|||
163853973|NCT03008122|591834321|FG000|Overall Study|Withdrawal by Subject|1|||
163853974|NCT03008122|591834322|FG001|Overall Study|Withdrawal by Subject|3|||
163853975|NCT03008122|591834323|FG002|Overall Study|Withdrawal by Subject|0|||
163853976|NCT03008122|591834321|FG000|Overall Study|Lost to Follow-up|4|||
163853977|NCT03008122|591834322|FG001|Overall Study|Lost to Follow-up|8|||
163853978|NCT03008122|591834323|FG002|Overall Study|Lost to Follow-up|3|||
163853979|NCT03008122|591834321|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
163853980|NCT03008122|591834322|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
163853981|NCT03008122|591834323|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
163853982|NCT03008122|591834321|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
163853983|NCT03008122|591834322|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
163853984|NCT03008122|591834323|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
163853985|NCT03008122|591834321|FG000|Overall Study|Death|0|||
163853986|NCT03008122|591834322|FG001|Overall Study|Death|0|||
163853987|NCT03008122|591834323|FG002|Overall Study|Death|1|||
163853988|NCT04159896|591834324|FG000|Overall Study|Lack of Efficacy|7|||
163853989|NCT04159896|591834324|FG000|Overall Study|Withdrawal by Subject|1|||
163853990|NCT04159896|591834324|FG000|Overall Study|Adverse Event|1|||
163853991|NCT04159896|591834324|FG000|Overall Study|A transient ischaemic attack|1|||
163853992|NCT01222247|591834325|FG000|Overall Study|Lost to Follow-up|2|||
163853993|NCT01222247|591834326|FG001|Overall Study|Lost to Follow-up|2|||
163853994|NCT04529538|591834327|FG000|Overall Study|Lost to Follow-up|3|||
163853995|NCT04529538|591834328|FG001|Overall Study|Lost to Follow-up|2|||
163853996|NCT04529538|591834329|FG002|Overall Study|Lost to Follow-up|1|||
163853997|NCT04529538|591834330|FG003|Overall Study|Lost to Follow-up|0|||
163853998|NCT04529538|591834331|FG004|Overall Study|Lost to Follow-up|1|||
163853999|NCT04529538|591834332|FG005|Overall Study|Lost to Follow-up|1|||
163854000|NCT04529538|591834333|FG006|Overall Study|Lost to Follow-up|2|||
163854001|NCT04529538|591834334|FG007|Overall Study|Lost to Follow-up|0|||
163854002|NCT04529538|591834327|FG000|Overall Study|Not eligible at enrollment|0|||
163854003|NCT04529538|591834328|FG001|Overall Study|Not eligible at enrollment|1|||
163854004|NCT04529538|591834329|FG002|Overall Study|Not eligible at enrollment|2|||
163854005|NCT04529538|591834330|FG003|Overall Study|Not eligible at enrollment|1|||
163854006|NCT04529538|591834331|FG004|Overall Study|Not eligible at enrollment|0|||
163854007|NCT04529538|591834332|FG005|Overall Study|Not eligible at enrollment|0|||
163854008|NCT04529538|591834333|FG006|Overall Study|Not eligible at enrollment|0|||
163854009|NCT04529538|591834334|FG007|Overall Study|Not eligible at enrollment|1|||
163854010|NCT04529538|591834327|FG000|Overall Study|Withdrawal by Subject|0|||
163854011|NCT04529538|591834328|FG001|Overall Study|Withdrawal by Subject|1|||
163854012|NCT04529538|591834329|FG002|Overall Study|Withdrawal by Subject|1|||
163854013|NCT04529538|591834330|FG003|Overall Study|Withdrawal by Subject|2|||
163854014|NCT04529538|591834331|FG004|Overall Study|Withdrawal by Subject|0|||
163854015|NCT04529538|591834332|FG005|Overall Study|Withdrawal by Subject|2|||
163854016|NCT04529538|591834333|FG006|Overall Study|Withdrawal by Subject|3|||
163854017|NCT04529538|591834334|FG007|Overall Study|Withdrawal by Subject|0|||
163854018|NCT04529538|591834327|FG000|Overall Study|Other|0|||
163854019|NCT04529538|591834328|FG001|Overall Study|Other|1|||
163854020|NCT04529538|591834329|FG002|Overall Study|Other|0|||
163854021|NCT04529538|591834330|FG003|Overall Study|Other|0|||
163854022|NCT04529538|591834331|FG004|Overall Study|Other|0|||
163854023|NCT04529538|591834332|FG005|Overall Study|Other|0|||
163854024|NCT04529538|591834333|FG006|Overall Study|Other|0|||
163854025|NCT04529538|591834334|FG007|Overall Study|Other|0|||
163854026|NCT04529538|591834327|FG000|Overall Study|Adverse Event|0|||
163854027|NCT04529538|591834328|FG001|Overall Study|Adverse Event|0|||
163854028|NCT04529538|591834329|FG002|Overall Study|Adverse Event|0|||
163854029|NCT04529538|591834330|FG003|Overall Study|Adverse Event|1|||
163854030|NCT04529538|591834331|FG004|Overall Study|Adverse Event|0|||
163854031|NCT04529538|591834332|FG005|Overall Study|Adverse Event|0|||
163854032|NCT04529538|591834333|FG006|Overall Study|Adverse Event|0|||
163854033|NCT04529538|591834334|FG007|Overall Study|Adverse Event|0|||
163854034|NCT04529538|591834327|FG000|Overall Study|Protocol Deviation|0|||
163854035|NCT04529538|591834328|FG001|Overall Study|Protocol Deviation|0|||
163854036|NCT04529538|591834329|FG002|Overall Study|Protocol Deviation|0|||
163854037|NCT04529538|591834330|FG003|Overall Study|Protocol Deviation|1|||
163854038|NCT04529538|591834331|FG004|Overall Study|Protocol Deviation|0|||
163854039|NCT04529538|591834332|FG005|Overall Study|Protocol Deviation|0|||
163854040|NCT04529538|591834333|FG006|Overall Study|Protocol Deviation|0|||
163854041|NCT04529538|591834334|FG007|Overall Study|Protocol Deviation|0|||
163854042|NCT04529538|591834327|FG000|Overall Study|Physician Decision|0|||
163854043|NCT04529538|591834328|FG001|Overall Study|Physician Decision|0|||
163854044|NCT04529538|591834329|FG002|Overall Study|Physician Decision|0|||
163854045|NCT04529538|591834330|FG003|Overall Study|Physician Decision|0|||
163854046|NCT04529538|591834331|FG004|Overall Study|Physician Decision|0|||
163854047|NCT04529538|591834332|FG005|Overall Study|Physician Decision|1|||
163854048|NCT04529538|591834333|FG006|Overall Study|Physician Decision|0|||
163854049|NCT04529538|591834334|FG007|Overall Study|Physician Decision|1|||
163854050|NCT01822821|591834338|FG000|Overall Study|Eligible surgery cancelled|1|||
163854051|NCT01822821|591834339|FG001|Overall Study|Eligible surgery cancelled|1|||
163854052|NCT01822821|591834338|FG000|Overall Study|Other reasons|1|||
163854053|NCT01822821|591834339|FG001|Overall Study|Other reasons|0|||
163854054|NCT03251378|591834342|FG000|Overall Study|Death|3|||
163854055|NCT03251378|591834343|FG001|Overall Study|Death|2|||
163854056|NCT03251378|591834344|FG002|Overall Study|Death|3|||
163854057|NCT03251378|591834345|FG003|Overall Study|Death|30|||
163854058|NCT03251378|591834346|FG004|Overall Study|Death|24|||
163854059|NCT03251378|591834347|FG005|Overall Study|Death|12|||
163854060|NCT03251378|591834348|FG006|Overall Study|Death|12|||
163854061|NCT03251378|591834342|FG000|Overall Study|Lost to Follow-up|0|||
163854062|NCT03251378|591834343|FG001|Overall Study|Lost to Follow-up|0|||
163854063|NCT03251378|591834344|FG002|Overall Study|Lost to Follow-up|1|||
163854064|NCT03251378|591834345|FG003|Overall Study|Lost to Follow-up|3|||
163854065|NCT03251378|591834346|FG004|Overall Study|Lost to Follow-up|0|||
163854066|NCT03251378|591834347|FG005|Overall Study|Lost to Follow-up|0|||
163854067|NCT03251378|591834348|FG006|Overall Study|Lost to Follow-up|0|||
163854068|NCT03251378|591834342|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
163854069|NCT03251378|591834343|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
163854070|NCT03251378|591834344|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
163854071|NCT03251378|591834345|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
163854072|NCT03251378|591834346|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
163854073|NCT03251378|591834347|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
163854074|NCT03251378|591834348|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
163854075|NCT03251378|591834342|FG000|Overall Study|Progressive disease|2|||
163854076|NCT03251378|591834343|FG001|Overall Study|Progressive disease|0|||
163854077|NCT03251378|591834344|FG002|Overall Study|Progressive disease|0|||
163854078|NCT03251378|591834345|FG003|Overall Study|Progressive disease|1|||
163854079|NCT03251378|591834346|FG004|Overall Study|Progressive disease|0|||
163854080|NCT03251378|591834347|FG005|Overall Study|Progressive disease|0|||
163854081|NCT03251378|591834348|FG006|Overall Study|Progressive disease|0|||
163854082|NCT03251378|591834342|FG000|Overall Study|Physician Decision|0|||
163854083|NCT03251378|591834343|FG001|Overall Study|Physician Decision|2|||
163854084|NCT03251378|591834344|FG002|Overall Study|Physician Decision|0|||
163854085|NCT03251378|591834345|FG003|Overall Study|Physician Decision|0|||
163854086|NCT03251378|591834346|FG004|Overall Study|Physician Decision|0|||
163854087|NCT03251378|591834347|FG005|Overall Study|Physician Decision|0|||
163854088|NCT03251378|591834348|FG006|Overall Study|Physician Decision|0|||
163854089|NCT03251378|591834342|FG000|Overall Study|Other|2|||
163854090|NCT03251378|591834343|FG001|Overall Study|Other|3|||
163854091|NCT03251378|591834344|FG002|Overall Study|Other|2|||
163854092|NCT03251378|591834345|FG003|Overall Study|Other|0|||
163854093|NCT03251378|591834346|FG004|Overall Study|Other|1|||
163854094|NCT03251378|591834347|FG005|Overall Study|Other|1|||
163854095|NCT03251378|591834348|FG006|Overall Study|Other|1|||
163854096|NCT03251378|591834342|FG000|Overall Study|Other|0|||
163854097|NCT03251378|591834343|FG001|Overall Study|Other|0|||
163854098|NCT03251378|591834344|FG002|Overall Study|Other|0|||
164190672|NCT00791700|593066335|FG000|Overall Study|Other|0|||
164190673|NCT00791700|593066336|FG001|Overall Study|Other|1|||
164190674|NCT00791700|593066337|FG002|Overall Study|Other|0|||
164190675|NCT00791700|593066338|FG003|Overall Study|Other|1|||
164190676|NCT00791700|593066335|FG000|Overall Study|Death|0|||
164190677|NCT00791700|593066336|FG001|Overall Study|Death|0|||
164190678|NCT00791700|593066337|FG002|Overall Study|Death|0|||
164190679|NCT00791700|593066338|FG003|Overall Study|Death|1|||
164190680|NCT00791700|593066335|FG000|Overall Study|Lost to Follow-up|4|||
164190681|NCT00791700|593066336|FG001|Overall Study|Lost to Follow-up|3|||
163854099|NCT03251378|591834345|FG003|Overall Study|Other|4|||
164190682|NCT00791700|593066337|FG002|Overall Study|Lost to Follow-up|4|||
164190683|NCT00791700|593066338|FG003|Overall Study|Lost to Follow-up|6|||
164190684|NCT00791700|593066335|FG000|Overall Study|Adverse Event|0|||
164190685|NCT00791700|593066336|FG001|Overall Study|Adverse Event|0|||
164190686|NCT00791700|593066337|FG002|Overall Study|Adverse Event|1|||
164190687|NCT00791700|593066338|FG003|Overall Study|Adverse Event|1|||
164190688|NCT00996034|593066341|FG000|Overall Study|Lost to Follow-up|2|||
164190689|NCT00996034|593066341|FG000|Overall Study|withdrawn by PI|1|||
164190690|NCT01720524|593066342|FG000|Part A|Insufficient Clinical Response|2|||
164190691|NCT01720524|593066343|FG001|Part A|Insufficient Clinical Response|4|||
164190692|NCT01720524|593066342|FG000|Part A|Adverse Event|2|||
164190693|NCT01720524|593066343|FG001|Part A|Adverse Event|2|||
164190694|NCT01720524|593066342|FG000|Part A|Death|2|||
164190695|NCT01720524|593066343|FG001|Part A|Death|1|||
164190696|NCT01720524|593066342|FG000|Part A|Lost to Follow-up|0|||
164190697|NCT01720524|593066343|FG001|Part A|Lost to Follow-up|1|||
164190698|NCT01720524|593066342|FG000|Part A|Missed 28 day follow-up visit|1|||
164190699|NCT01720524|593066343|FG001|Part A|Missed 28 day follow-up visit|1|||
164190700|NCT01720524|593066342|FG000|Part A|Withdrawal by Subject|0|||
164190701|NCT01720524|593066343|FG001|Part A|Withdrawal by Subject|1|||
164190702|NCT01720524|593066342|FG000|Part A|Other|0|||
164190703|NCT01720524|593066343|FG001|Part A|Other|1|||
164190704|NCT01720524|593066342|FG000|Part A|Lost to Follow-up|0|||
164190705|NCT01720524|593066343|FG001|Part A|Lost to Follow-up|1|||
164190706|NCT01720524|593066342|FG000|Part B|No longer willing to participate in study|1|||
164190707|NCT01720524|593066343|FG001|Part B|No longer willing to participate in study|4|||
164190708|NCT01720524|593066342|FG000|Part B|Other|2|||
164190709|NCT01720524|593066343|FG001|Part B|Other|0|||
164190710|NCT01720524|593066342|FG000|Part B|Lost to Follow-up|2|||
164190711|NCT01720524|593066343|FG001|Part B|Lost to Follow-up|3|||
164190712|NCT01720524|593066342|FG000|Part B|Death|0|||
164190713|NCT01720524|593066343|FG001|Part B|Death|2|||
164190714|NCT00527826|593066347|FG000|Overall Study|Adverse Event|10|||
164190715|NCT00527826|593066348|FG001|Overall Study|Adverse Event|10|||
164190716|NCT00527826|593066347|FG000|Overall Study|Lost to Follow-up|3|||
164190717|NCT00527826|593066348|FG001|Overall Study|Lost to Follow-up|2|||
164190718|NCT00527826|593066347|FG000|Overall Study|Withdrawal by Subject|5|||
164190719|NCT00527826|593066348|FG001|Overall Study|Withdrawal by Subject|8|||
164190720|NCT00527826|593066347|FG000|Overall Study|Inclusion Criteria Not Met|3|||
164190721|NCT00527826|593066348|FG001|Overall Study|Inclusion Criteria Not Met|3|||
163854100|NCT03251378|591834346|FG004|Overall Study|Other|13|||
163854101|NCT03251378|591834347|FG005|Overall Study|Other|0|||
163854102|NCT03251378|591834348|FG006|Overall Study|Other|0|||
163854103|NCT02322775|591834353|FG000|Overall Study|Adverse Event|1|||
163854104|NCT02322775|591834354|FG001|Overall Study|Adverse Event|0|||
163854105|NCT02322775|591834353|FG000|Overall Study|Lost to Follow-up|0|||
163854106|NCT02322775|591834354|FG001|Overall Study|Lost to Follow-up|1|||
163854107|NCT02322775|591834353|FG000|Overall Study|Protocol Violation|1|||
163854108|NCT02322775|591834354|FG001|Overall Study|Protocol Violation|0|||
163854109|NCT02322775|591834353|FG000|Overall Study|Withdrawal by Subject|3|||
163854110|NCT02322775|591834354|FG001|Overall Study|Withdrawal by Subject|4|||
164190722|NCT00527826|593066347|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
164190723|NCT00527826|593066348|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
164190724|NCT00527826|593066347|FG000|Overall Study|Additional Intake of Viani forte|0|||
164190725|NCT00527826|593066348|FG001|Overall Study|Additional Intake of Viani forte|1|||
164190726|NCT00527826|593066347|FG000|Overall Study|Participant moved away|0|||
163854111|NCT02322775|591834353|FG000|Overall Study|Not willing to perform all FU visits|0|||
163854112|NCT02322775|591834354|FG001|Overall Study|Not willing to perform all FU visits|1|||
164190727|NCT00527826|593066348|FG001|Overall Study|Participant moved away|1|||
164190728|NCT00158262|593066349|FG000|Overall Study|Lost to Follow-up|1|||
164190729|NCT00158262|593066350|FG001|Overall Study|Lost to Follow-up|1|||
164190730|NCT03293394|593066358|FG000|Follow-up (6 Months)|Adverse Event|4|||
164190731|NCT03293394|593066359|FG001|Follow-up (6 Months)|Adverse Event|2|||
164190732|NCT02716584|593066360|FG000|Overall Study|Lost to Follow-up|8|||
164190733|NCT02716584|593066361|FG001|Overall Study|Lost to Follow-up|5|||
164190734|NCT00420628|593066362|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
163854113|NCT05780047|591834355|FG000|Overall Study|Did not submit baseline urine test kit|226|||
164190735|NCT00420628|593066363|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
164190736|NCT00420628|593066362|FG000|Overall Study|Lost to Follow-up|3|||
164190737|NCT00420628|593066363|FG001|Overall Study|Lost to Follow-up|2|||
163854114|NCT05780047|591834355|FG000|Overall Study|Lost to Follow-up|34|||
163854115|NCT05780047|591834355|FG000|Overall Study|Did not submit second urine test kit|124|||
163854116|NCT01007552|591834358|FG000|Overall Study|Withdrawal by Subject|1|||
163854117|NCT03212365|591834374|FG000|Overall Study|Discharged prior to Xa level|12|||
163854118|NCT03212365|591834375|FG001|Overall Study|Discharged prior to Xa level|8|||
163854119|NCT03212365|591834374|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
163854120|NCT03212365|591834375|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
163854121|NCT03212365|591834374|FG000|Overall Study|Refused study medication|3|||
163854122|NCT03212365|591834375|FG001|Overall Study|Refused study medication|0|||
163854123|NCT03212365|591834374|FG000|Overall Study|Initiated heparin infusion on floor|1|||
163854124|NCT03212365|591834375|FG001|Overall Study|Initiated heparin infusion on floor|1|||
163854125|NCT03212365|591834374|FG000|Overall Study|Unexpected return to OR|1|||
163854126|NCT03212365|591834375|FG001|Overall Study|Unexpected return to OR|1|||
163854127|NCT03212365|591834374|FG000|Overall Study|Medication distribution error|1|||
163854128|NCT03212365|591834375|FG001|Overall Study|Medication distribution error|0|||
163854129|NCT03212365|591834374|FG000|Overall Study|Required epidural placement|1|||
163854130|NCT03212365|591834375|FG001|Overall Study|Required epidural placement|0|||
163854131|NCT03212365|591834374|FG000|Overall Study|Withdrawal by Subject|0|||
163854132|NCT03212365|591834375|FG001|Overall Study|Withdrawal by Subject|1|||
163854133|NCT03212365|591834374|FG000|Overall Study|developed acute renal failure|0|||
163854134|NCT03212365|591834375|FG001|Overall Study|developed acute renal failure|1|||
163854135|NCT00333138|591834376|FG000|Core Study (6 Months)|Adverse Event|4|||
163854136|NCT00333138|591834377|FG001|Core Study (6 Months)|Adverse Event|5|||
163854137|NCT00333138|591834378|FG002|Core Study (6 Months)|Adverse Event|8|||
163854138|NCT00333138|591834376|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
163854139|NCT00333138|591834377|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
163854140|NCT00333138|591834378|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
163854141|NCT00333138|591834376|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
163854142|NCT00333138|591834377|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
163854143|NCT00333138|591834378|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
163854144|NCT00333138|591834376|FG000|Core Study (6 Months)|Protocol Violation|1|||
163854145|NCT00333138|591834377|FG001|Core Study (6 Months)|Protocol Violation|0|||
163854146|NCT00333138|591834378|FG002|Core Study (6 Months)|Protocol Violation|1|||
163854147|NCT00333138|591834376|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
163854148|NCT00333138|591834377|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
163854149|NCT00333138|591834378|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
163854150|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
163854151|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
163854152|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
163854153|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
163854154|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
163854155|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
163854156|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
163854157|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
163854158|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
163854159|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
163854160|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
163854161|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
163854162|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
163854163|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
163854164|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
163854165|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
163854166|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
163854167|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
163854168|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
163854169|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
163854170|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
163854171|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
163854172|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
163854173|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
163854174|NCT00333138|591834376|FG000|Extension Study (Month6 to End of Study)|Death|0|||
163854175|NCT00333138|591834377|FG001|Extension Study (Month6 to End of Study)|Death|1|||
163854176|NCT00333138|591834378|FG002|Extension Study (Month6 to End of Study)|Death|0|||
163854177|NCT03005288|591834379|FG000|Overall Study|Withdrawal by Subject|7|||
163854178|NCT03005288|591834380|FG001|Overall Study|Withdrawal by Subject|5|||
163854179|NCT03005288|591834379|FG000|Overall Study|Lost to Follow-up|0|||
163854180|NCT03005288|591834380|FG001|Overall Study|Lost to Follow-up|1|||
163854181|NCT03005288|591834379|FG000|Overall Study|Adverse Event|5|||
163854182|NCT03005288|591834380|FG001|Overall Study|Adverse Event|0|||
163854183|NCT03005288|591834379|FG000|Overall Study|Protocol deviation|0|||
163854184|NCT03005288|591834380|FG001|Overall Study|Protocol deviation|1|||
163854185|NCT03005288|591834379|FG000|Overall Study|Physician Decision|0|||
163854186|NCT03005288|591834380|FG001|Overall Study|Physician Decision|1|||
163854187|NCT04011033|591834381|FG000|Overall Study|Physician Decision|2|||
163854188|NCT04011033|591834382|FG001|Overall Study|Physician Decision|3|||
163854189|NCT04011033|591834381|FG000|Overall Study|Withdrawal by Subject|1|||
164190738|NCT00420628|593066362|FG000|Overall Study|Adverse Event|1|||
164190739|NCT00420628|593066363|FG001|Overall Study|Adverse Event|0|||
164190740|NCT01903993|593066364|FG000|Overall Study|Death|118|||
164190741|NCT01903993|593066365|FG001|Overall Study|Death|121|||
164190742|NCT01903993|593066364|FG000|Overall Study|Withdrawal by Subject|15|||
164190743|NCT01903993|593066365|FG001|Overall Study|Withdrawal by Subject|4|||
164190744|NCT01903993|593066364|FG000|Overall Study|Lost to Follow-up|2|||
164190745|NCT01903993|593066365|FG001|Overall Study|Lost to Follow-up|3|||
164190746|NCT01903993|593066364|FG000|Overall Study|Study Terminated by Sponsor|8|||
164190747|NCT01903993|593066365|FG001|Overall Study|Study Terminated by Sponsor|14|||
164190748|NCT01903993|593066364|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
164190749|NCT01903993|593066365|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
164190750|NCT03283930|593066366|FG000|Overall Study|Scheduling conflict|8|||
164190751|NCT03283930|593066367|FG001|Overall Study|Scheduling conflict|10|||
164190752|NCT03283930|593066366|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
164190753|NCT03283930|593066367|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
164190754|NCT03283930|593066366|FG000|Overall Study|Technical software issue|2|||
164190755|NCT03283930|593066367|FG001|Overall Study|Technical software issue|2|||
164190756|NCT02588664|593066368|FG000|Overall Study|Death|56|||
164190757|NCT02588664|593066369|FG001|Overall Study|Death|55|||
164190758|NCT02588664|593066368|FG000|Overall Study|Lost to Follow-up|1305|||
164190759|NCT02588664|593066369|FG001|Overall Study|Lost to Follow-up|990|||
164190760|NCT02500719|593066370|FG000|Overall Study|Lost to Follow-up|2|||
164190761|NCT02500719|593066371|FG001|Overall Study|Lost to Follow-up|3|||
164190762|NCT02500719|593066370|FG000|Overall Study|Trauma history|1|||
164190763|NCT02500719|593066371|FG001|Overall Study|Trauma history|0|||
164190764|NCT02500719|593066370|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
164190765|NCT02500719|593066371|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
164190766|NCT02500719|593066370|FG000|Overall Study|Did not meet criteria for PTSD|0|||
164190767|NCT02500719|593066371|FG001|Overall Study|Did not meet criteria for PTSD|1|||
164190768|NCT02500719|593066370|FG000|Overall Study|Claustrophobia|0|||
164190769|NCT02500719|593066371|FG001|Overall Study|Claustrophobia|1|||
164190770|NCT02500719|593066370|FG000|Overall Study|History of head trauma|0|||
164190771|NCT02500719|593066371|FG001|Overall Study|History of head trauma|1|||
164190772|NCT02787083|593066372|FG000|Overall Study|Adverse Event|1|||
164190773|NCT02787083|593066373|FG001|Overall Study|Adverse Event|0|||
164190774|NCT02787083|593066372|FG000|Overall Study|Withdrawal by Subject|2|||
164190775|NCT02787083|593066373|FG001|Overall Study|Withdrawal by Subject|2|||
164190776|NCT00154375|593066374|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
164190777|NCT00154375|593066375|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
164190778|NCT00154375|593066374|FG000|Overall Study|Adverse Event|18|||
164190779|NCT00154375|593066375|FG001|Overall Study|Adverse Event|20|||
164190780|NCT00154375|593066374|FG000|Overall Study|Withdrawal by Subject|14|||
163854190|NCT04011033|591834382|FG001|Overall Study|Withdrawal by Subject|0|||
163854191|NCT01823341|591834383|FG000|Overall Study|Failed run-in|7|||
163854192|NCT01823341|591834383|FG000|Overall Study|Withdrawal by Subject|7|||
163854193|NCT01823341|591834383|FG000|Overall Study|Adverse Event|1|||
163854194|NCT01342887|591834384|FG000|Overall Study|Death|2|||
163854195|NCT00663962|591834385|FG000|Overall Study|somnolence|1|||
164190781|NCT00154375|593066375|FG001|Overall Study|Withdrawal by Subject|10|||
164190782|NCT00154375|593066374|FG000|Overall Study|Death|5|||
164190783|NCT00154375|593066375|FG001|Overall Study|Death|13|||
164190784|NCT00154375|593066374|FG000|Overall Study|Study drug no longer required|5|||
164190785|NCT00154375|593066375|FG001|Overall Study|Study drug no longer required|3|||
164190786|NCT00154375|593066374|FG000|Overall Study|Lost to Follow-up|2|||
164190787|NCT00154375|593066375|FG001|Overall Study|Lost to Follow-up|1|||
164190788|NCT00154375|593066374|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164190789|NCT00154375|593066375|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164190790|NCT00154375|593066374|FG000|Overall Study|Protocol Violation|0|||
164190791|NCT00154375|593066375|FG001|Overall Study|Protocol Violation|1|||
164190792|NCT00154375|593066374|FG000|Overall Study|Suspected progression of disease|44|||
164190793|NCT00154375|593066375|FG001|Overall Study|Suspected progression of disease|30|||
164190794|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
163854196|NCT00663962|591834386|FG001|Overall Study|somnolence|0|||
163854197|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Adverse Event|5|||
163854198|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Adverse Event|13|||
164302040|NCT02395471|593482509|FG000|Overall Study|Lost to Follow-up|2|||
163854199|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Adverse Event|0|||
163854200|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
163854201|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
163854202|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
163854203|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
163854204|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
163854205|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
163854206|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
163854207|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
163854208|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
163854209|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
163854210|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
163854211|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
163854212|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
163854213|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
163854214|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
163854215|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Physician Decision|2|||
163854216|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Physician Decision|3|||
163854217|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Physician Decision|0|||
163854218|NCT01449929|591834402|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
163854219|NCT01449929|591834403|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
163854220|NCT01449929|591834404|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
163854221|NCT01449929|591834402|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
163854222|NCT01449929|591834403|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
163854223|NCT01449929|591834404|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
163854224|NCT01449929|591834402|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
163854225|NCT01449929|591834403|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
163854226|NCT01449929|591834404|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
163854227|NCT01449929|591834402|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
163854228|NCT01449929|591834403|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
163854229|NCT01449929|591834404|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
163854230|NCT03253653|591834405|FG000|Overall Study|Withdrawal by Subject|4|||
163854231|NCT03253653|591834406|FG001|Overall Study|Withdrawal by Subject|1|||
163854232|NCT03253653|591834405|FG000|Overall Study|Protocol Violation|0|||
163854233|NCT03253653|591834406|FG001|Overall Study|Protocol Violation|5|||
163854234|NCT00079937|591836328|FG000|Overall Study|Adverse Event|2|||
163854235|NCT00079937|591836329|FG001|Overall Study|Adverse Event|1|||
163854236|NCT00079937|591836328|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163854237|NCT00079937|591836329|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163854238|NCT00079937|591836328|FG000|Overall Study|Subject no longer requires study drug|3|||
163854239|NCT00079937|591836329|FG001|Overall Study|Subject no longer requires study drug|0|||
163854240|NCT00079937|591836328|FG000|Overall Study|Protocol Violation|8|||
163854241|NCT00079937|591836329|FG001|Overall Study|Protocol Violation|6|||
163854242|NCT00079937|591836328|FG000|Overall Study|Withdrawal by Subject|21|||
163854243|NCT00079937|591836329|FG001|Overall Study|Withdrawal by Subject|7|||
163854244|NCT00079937|591836328|FG000|Overall Study|Lost to Follow-up|12|||
163854245|NCT00079937|591836329|FG001|Overall Study|Lost to Follow-up|5|||
163854246|NCT00079937|591836328|FG000|Overall Study|Administrative problems|22|||
163854247|NCT00079937|591836329|FG001|Overall Study|Administrative problems|11|||
163854248|NCT02857283|591836330|FG000|First Exposure|Withdrawal by Subject|1|||
163854249|NCT02857283|591836331|FG001|First Exposure|Withdrawal by Subject|0|||
163854250|NCT00093795|591836332|FG000|Overall Study|No follow up data|20|||
163854251|NCT00093795|591836333|FG001|Overall Study|No follow up data|16|||
163854252|NCT00093795|591836334|FG002|Overall Study|No follow up data|17|||
163854253|NCT00613301|591836335|FG000|Overall Study|Adverse Event|49|||
163854254|NCT00613301|591836335|FG000|Overall Study|Lost to Follow-up|88|||
163854255|NCT00613301|591836335|FG000|Overall Study|Withdrawal by Subject|5|||
163854256|NCT00613301|591836335|FG000|Overall Study|Death|6|||
163854257|NCT00613301|591836335|FG000|Overall Study|Lack of Efficacy|13|||
163854258|NCT00613301|591836335|FG000|Overall Study|Physician Decision|2|||
163854259|NCT00613301|591836335|FG000|Overall Study|No data was collected|53|||
163854260|NCT00613301|591836335|FG000|Overall Study|Irregularly enrolled patients|12|||
163854261|NCT01684046|591836338|FG000|Period 1, First 30 Days|Adverse Event|0|||
163854262|NCT01684046|591836339|FG001|Period 1, First 30 Days|Adverse Event|2|||
163964670|NCT04409353|592243256|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
164190795|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
164190796|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
163854263|NCT00587288|591836340|FG000|Overall Study|Adverse Event|0|||
163854264|NCT00587288|591836341|FG001|Overall Study|Adverse Event|1|||
163854265|NCT00587288|591836340|FG000|Overall Study|Lack of Efficacy|2|||
163854266|NCT00587288|591836341|FG001|Overall Study|Lack of Efficacy|8|||
163854267|NCT00587288|591836340|FG000|Overall Study|Protocol Violation|1|||
163854268|NCT00587288|591836341|FG001|Overall Study|Protocol Violation|0|||
163964671|NCT04409353|592243257|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
163854269|NCT00762463|591836342|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
163854270|NCT00762463|591836343|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
163854271|NCT00762463|591836344|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
163854272|NCT00762463|591836345|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
163854273|NCT00762463|591836342|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
163854274|NCT00762463|591836343|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
163854275|NCT00762463|591836344|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
163854276|NCT00762463|591836345|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
163854277|NCT00762463|591836342|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
163854278|NCT00762463|591836343|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
163854279|NCT00762463|591836344|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
163854280|NCT00762463|591836345|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
163854281|NCT00762463|591836342|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
163854282|NCT00762463|591836343|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
163854283|NCT00762463|591836344|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
163854284|NCT00762463|591836345|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
163854285|NCT00762463|591836342|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
163854286|NCT00762463|591836343|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
163854287|NCT00762463|591836344|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
163854288|NCT00762463|591836345|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
163854289|NCT00762463|591836342|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
163854290|NCT00762463|591836343|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
163854291|NCT00762463|591836344|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
163854292|NCT00762463|591836345|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
163854293|NCT00762463|591836342|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
163854294|NCT00762463|591836343|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
163854295|NCT00762463|591836344|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
163854296|NCT00762463|591836345|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
163854297|NCT00762463|591836342|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
163854298|NCT00762463|591836343|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
163854299|NCT00762463|591836344|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
163854300|NCT00762463|591836345|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
163854301|NCT00797862|591836346|FG000|Overall Study|Adverse Event|86|||
163854302|NCT00797862|591836347|FG001|Overall Study|Adverse Event|44|||
163854303|NCT00797862|591836348|FG002|Overall Study|Adverse Event|58|||
163854304|NCT00797862|591836346|FG000|Overall Study|Abnormal Test Procedure Result|0|||
163854305|NCT00797862|591836347|FG001|Overall Study|Abnormal Test Procedure Result|1|||
163854306|NCT00797862|591836348|FG002|Overall Study|Abnormal Test Procedure Result|1|||
163854307|NCT00797862|591836346|FG000|Overall Study|Lack of Efficacy|1|||
163854308|NCT00797862|591836347|FG001|Overall Study|Lack of Efficacy|7|||
163854309|NCT00797862|591836348|FG002|Overall Study|Lack of Efficacy|6|||
163854310|NCT00797862|591836346|FG000|Overall Study|No longer required study medication|1|||
163854311|NCT00797862|591836347|FG001|Overall Study|No longer required study medication|0|||
163854312|NCT00797862|591836348|FG002|Overall Study|No longer required study medication|0|||
163854313|NCT00797862|591836346|FG000|Overall Study|Withdrawal by Subject|14|||
163854314|NCT00797862|591836347|FG001|Overall Study|Withdrawal by Subject|7|||
163854315|NCT00797862|591836348|FG002|Overall Study|Withdrawal by Subject|7|||
163854316|NCT00797862|591836346|FG000|Overall Study|Lost to Follow-up|11|||
163854317|NCT00797862|591836347|FG001|Overall Study|Lost to Follow-up|0|||
163854318|NCT00797862|591836348|FG002|Overall Study|Lost to Follow-up|5|||
163854319|NCT00797862|591836346|FG000|Overall Study|Administrative Problem|4|||
163854320|NCT00797862|591836347|FG001|Overall Study|Administrative Problem|0|||
163854321|NCT00797862|591836348|FG002|Overall Study|Administrative Problem|0|||
163854322|NCT00797862|591836346|FG000|Overall Study|Protocol Violation|4|||
163854323|NCT00797862|591836347|FG001|Overall Study|Protocol Violation|6|||
163854324|NCT00797862|591836348|FG002|Overall Study|Protocol Violation|8|||
163854325|NCT00797862|591836346|FG000|Overall Study|Mis-randomized|3|||
163854326|NCT00797862|591836347|FG001|Overall Study|Mis-randomized|3|||
163854327|NCT00797862|591836348|FG002|Overall Study|Mis-randomized|1|||
163854328|NCT00531479|591836349|FG000|Overall Study|Death|68|||
163854329|NCT00531479|591836350|FG001|Overall Study|Death|71|||
163854330|NCT00531479|591836349|FG000|Overall Study|Lost to Follow-up|0|||
163854331|NCT00531479|591836350|FG001|Overall Study|Lost to Follow-up|2|||
163854332|NCT00531479|591836349|FG000|Overall Study|Other|0|||
163854333|NCT00531479|591836350|FG001|Overall Study|Other|1|||
163854334|NCT00531479|591836349|FG000|Overall Study|Withdrawal by Subject|6|||
163854335|NCT00531479|591836350|FG001|Overall Study|Withdrawal by Subject|6|||
163854336|NCT00531479|591836349|FG000|Overall Study|Did not receive treatment|2|||
163854337|NCT00531479|591836350|FG001|Overall Study|Did not receive treatment|3|||
163854338|NCT05074498|591836355|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163854339|NCT05074498|591836356|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163854340|NCT05074498|591836357|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163854341|NCT05074498|591836358|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
163854342|NCT05074498|591836359|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163854343|NCT05074498|591836360|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
163854344|NCT05074498|591836355|FG000|Part 1 (Upto Day 104)|Other|1|||
163854345|NCT05074498|591836356|FG001|Part 1 (Upto Day 104)|Other|0|||
163854346|NCT05074498|591836357|FG002|Part 1 (Upto Day 104)|Other|0|||
163854347|NCT05074498|591836358|FG003|Part 1 (Upto Day 104)|Other|0|||
163854348|NCT05074498|591836359|FG004|Part 1 (Upto Day 104)|Other|0|||
163854349|NCT05074498|591836360|FG005|Part 1 (Upto Day 104)|Other|0|||
163854350|NCT05074498|591836355|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163854351|NCT05074498|591836356|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163854352|NCT05074498|591836357|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163854353|NCT05074498|591836358|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163854354|NCT05074498|591836359|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
163854355|NCT05074498|591836360|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
163854356|NCT05074498|591836355|FG000|Part 2 (Upto Day 104)|Death|0|||
163854357|NCT05074498|591836356|FG001|Part 2 (Upto Day 104)|Death|0|||
163854358|NCT05074498|591836357|FG002|Part 2 (Upto Day 104)|Death|0|||
163854359|NCT05074498|591836358|FG003|Part 2 (Upto Day 104)|Death|0|||
163854360|NCT05074498|591836359|FG004|Part 2 (Upto Day 104)|Death|1|||
163854361|NCT05074498|591836360|FG005|Part 2 (Upto Day 104)|Death|0|||
163854362|NCT05074498|591836355|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163854363|NCT05074498|591836356|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163854364|NCT05074498|591836357|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163854365|NCT05074498|591836358|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
163854366|NCT05074498|591836359|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
163854367|NCT05074498|591836360|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
163854368|NCT05074498|591836355|FG000|Part 2 (Upto Day 104)|Other|0|||
163854369|NCT05074498|591836356|FG001|Part 2 (Upto Day 104)|Other|0|||
163854370|NCT05074498|591836357|FG002|Part 2 (Upto Day 104)|Other|0|||
163854371|NCT05074498|591836358|FG003|Part 2 (Upto Day 104)|Other|0|||
163854372|NCT05074498|591836359|FG004|Part 2 (Upto Day 104)|Other|1|||
163854373|NCT05074498|591836360|FG005|Part 2 (Upto Day 104)|Other|0|||
163854374|NCT01306331|591836362|FG000|Overall Study|Adverse Event|28|||
163854375|NCT01306331|591836363|FG001|Overall Study|Adverse Event|25|||
163854376|NCT01306331|591836362|FG000|Overall Study|Lost to Follow-up|321|||
163854377|NCT01306331|591836363|FG001|Overall Study|Lost to Follow-up|323|||
163854378|NCT01306331|591836362|FG000|Overall Study|Physician Decision|26|||
163854379|NCT01306331|591836363|FG001|Overall Study|Physician Decision|22|||
163854380|NCT01306331|591836362|FG000|Overall Study|Pregnancy|136|||
163854381|NCT01306331|591836363|FG001|Overall Study|Pregnancy|151|||
163854382|NCT01306331|591836362|FG000|Overall Study|Protocol Violation|154|||
163854383|NCT01306331|591836363|FG001|Overall Study|Protocol Violation|124|||
163854384|NCT01306331|591836362|FG000|Overall Study|Withdrawal by Subject|163|||
163854385|NCT01306331|591836363|FG001|Overall Study|Withdrawal by Subject|152|||
163854386|NCT01306331|591836362|FG000|Overall Study|Not sexually active|29|||
163854387|NCT01306331|591836363|FG001|Overall Study|Not sexually active|28|||
163854388|NCT01306331|591836362|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
163854389|NCT01306331|591836363|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
163854390|NCT01306331|591836362|FG000|Overall Study|Other|34|||
163854391|NCT01306331|591836363|FG001|Overall Study|Other|32|||
163854392|NCT00172185|591836370|FG000|Overall Study|Adverse Event|0|||
163854393|NCT00172185|591836371|FG001|Overall Study|Adverse Event|1|||
163854394|NCT00172185|591836372|FG002|Overall Study|Adverse Event|3|||
163854395|NCT00172185|591836373|FG003|Overall Study|Adverse Event|4|||
163854396|NCT00172185|591836370|FG000|Overall Study|Physician Decision|0|||
163854397|NCT00172185|591836371|FG001|Overall Study|Physician Decision|0|||
163854398|NCT00172185|591836372|FG002|Overall Study|Physician Decision|1|||
163854399|NCT00172185|591836373|FG003|Overall Study|Physician Decision|0|||
163854400|NCT00172185|591836370|FG000|Overall Study|SPONSOR Decision|0|||
163854401|NCT00172185|591836371|FG001|Overall Study|SPONSOR Decision|1|||
163854402|NCT00172185|591836372|FG002|Overall Study|SPONSOR Decision|0|||
163854403|NCT00172185|591836373|FG003|Overall Study|SPONSOR Decision|0|||
163854404|NCT00172185|591836370|FG000|Overall Study|Withdrawal by Subject|0|||
163854405|NCT00172185|591836371|FG001|Overall Study|Withdrawal by Subject|0|||
163854406|NCT00172185|591836372|FG002|Overall Study|Withdrawal by Subject|1|||
163854407|NCT00172185|591836373|FG003|Overall Study|Withdrawal by Subject|0|||
163854408|NCT01677936|591836374|FG000|Overall Study|Lost to Follow-up|4|||
163854409|NCT01677936|591836375|FG001|Overall Study|Lost to Follow-up|1|||
163854410|NCT01677936|591836374|FG000|Overall Study|Protocol Violation|3|||
163854411|NCT01677936|591836375|FG001|Overall Study|Protocol Violation|0|||
163854412|NCT01677936|591836374|FG000|Overall Study|Adverse Event|1|||
163854413|NCT01677936|591836375|FG001|Overall Study|Adverse Event|0|||
163854414|NCT01677936|591836374|FG000|Overall Study|Lost to Follow-up|1|||
164133492|NCT05424042|592857146|FG000|Overall Study|Lost to Follow-up|0|||
163854415|NCT01677936|591836375|FG001|Overall Study|Lost to Follow-up|0|||
163854416|NCT01677936|591836374|FG000|Overall Study|Protocol Violation|0|||
163854417|NCT01677936|591836375|FG001|Overall Study|Protocol Violation|4|||
164190797|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
164190798|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
164190799|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
164190800|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
164190801|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
164190802|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
164190803|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
164190804|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
164190805|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
164190806|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
164190807|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
164190808|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
164190809|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
164190810|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
164190811|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
164190812|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
164190813|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
164190814|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
164190815|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
164190816|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
164190817|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
164190818|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
164190819|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
163854418|NCT02790606|591836378|FG000|Overall Study|Death|27|||
163854419|NCT02790606|591836378|FG000|Overall Study|Lost to Follow-up|4|||
163854420|NCT02790606|591836378|FG000|Overall Study|Physician Decision|3|||
164190820|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
164190821|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
164190822|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
164190823|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
164190824|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
164190825|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
164190826|NCT03538691|593066376|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
164190827|NCT03538691|593066377|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
164190828|NCT03538691|593066378|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
164190829|NCT03538691|593066379|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
164190830|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
164190831|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
164190832|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
164190833|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
164190834|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
164190835|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
164190836|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
164190837|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
164190838|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
164190839|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
164190840|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
164190841|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
164190842|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
164190843|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
164190844|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
164190845|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
164190846|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
164190847|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
164190848|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
164190849|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
164190850|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
164190851|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
164190852|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
163854421|NCT02790606|591836378|FG000|Overall Study|Withdrawal by Subject|1|||
163854422|NCT02735915|591836379|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
163964672|NCT04409353|592243255|FG000|Overall Study|Lost to Follow-up|6|||
163964673|NCT04409353|592243256|FG001|Overall Study|Lost to Follow-up|8|||
163964674|NCT04409353|592243257|FG002|Overall Study|Lost to Follow-up|7|||
163964675|NCT04409353|592243255|FG000|Overall Study|Major surgery during participation window|4|||
163964676|NCT04409353|592243256|FG001|Overall Study|Major surgery during participation window|3|||
163964677|NCT04409353|592243257|FG002|Overall Study|Major surgery during participation window|3|||
163964678|NCT04409353|592243255|FG000|Overall Study|Life event occurred during participation window|3|||
163964679|NCT04409353|592243256|FG001|Overall Study|Life event occurred during participation window|2|||
163964680|NCT04409353|592243257|FG002|Overall Study|Life event occurred during participation window|4|||
163964681|NCT04409353|592243255|FG000|Overall Study|Lack of Efficacy|4|||
163964682|NCT04409353|592243256|FG001|Overall Study|Lack of Efficacy|1|||
163964683|NCT04409353|592243257|FG002|Overall Study|Lack of Efficacy|3|||
163964684|NCT04409353|592243255|FG000|Overall Study|Adverse Event|2|||
163964685|NCT04409353|592243256|FG001|Overall Study|Adverse Event|1|||
163964686|NCT04409353|592243257|FG002|Overall Study|Adverse Event|1|||
163964687|NCT04409353|592243255|FG000|Overall Study|Disease burden - unable to participate|0|||
163964688|NCT04409353|592243256|FG001|Overall Study|Disease burden - unable to participate|1|||
163964689|NCT04409353|592243257|FG002|Overall Study|Disease burden - unable to participate|1|||
163964690|NCT04409353|592243255|FG000|Overall Study|Intervention too complicated|1|||
163964691|NCT04409353|592243256|FG001|Overall Study|Intervention too complicated|0|||
163964692|NCT04409353|592243257|FG002|Overall Study|Intervention too complicated|1|||
163964693|NCT01012739|592243258|FG000|Treatment Period 1|Adverse Event|0|||
163964694|NCT01012739|592243259|FG001|Treatment Period 1|Adverse Event|0|||
163964695|NCT01012739|592243260|FG002|Treatment Period 1|Adverse Event|0|||
163964696|NCT01012739|592243261|FG003|Treatment Period 1|Adverse Event|1|||
163964697|NCT01012739|592243258|FG000|Treatment Period 2|Abnormal test procedure results|0|||
163964698|NCT01012739|592243259|FG001|Treatment Period 2|Abnormal test procedure results|0|||
163964699|NCT01012739|592243260|FG002|Treatment Period 2|Abnormal test procedure results|0|||
163964700|NCT01012739|592243261|FG003|Treatment Period 2|Abnormal test procedure results|1|||
163964701|NCT04540133|592243262|FG000|Overall Study|Lost to Follow-up|1|||
163964702|NCT04540133|592243263|FG001|Overall Study|Lost to Follow-up|0|||
163964703|NCT04014361|592243264|FG000|Period 2|Physician Decision|0|||
163964704|NCT04014361|592243265|FG001|Period 2|Physician Decision|0|||
163964705|NCT04014361|592243266|FG002|Period 2|Physician Decision|0|||
163964706|NCT04014361|592243267|FG003|Period 2|Physician Decision|1|||
163964707|NCT04014361|592243268|FG004|Period 2|Physician Decision|0|||
163964708|NCT04014361|592243269|FG005|Period 2|Physician Decision|0|||
163964709|NCT04014361|592243270|FG006|Period 2|Physician Decision|0|||
163964710|NCT04014361|592243271|FG007|Period 2|Physician Decision|0|||
163964711|NCT06308666|592243272|FG000|Overall Study|Withdrawal by Subject|1|||
163964712|NCT06308666|592243272|FG000|Overall Study|Protocol Violation|2|||
163964713|NCT01130051|592243278|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
163964714|NCT01130051|592243279|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
163964715|NCT01130051|592243278|FG000|Washout Period of 14 Days|Protocol Violation|1|||
163964716|NCT01130051|592243279|FG001|Washout Period of 14 Days|Protocol Violation|1|||
163964717|NCT00835120|592243284|FG000|Overall Study|Lack of Efficacy|1|||
163964718|NCT00835120|592243284|FG000|Overall Study|Lost to Follow-up|3|||
163964719|NCT00835120|592243284|FG000|Overall Study|Adverse Event|2|||
163964720|NCT00835120|592243284|FG000|Overall Study|Withdrawal by Subject|2|||
163964721|NCT01658826|592243285|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
163964722|NCT01658826|592243286|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
163964723|NCT01658826|592243285|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
163964724|NCT01658826|592243286|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
163964725|NCT01658826|592243285|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
163964726|NCT01658826|592243286|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
163964727|NCT01658826|592243285|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
163964728|NCT01658826|592243286|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
163964729|NCT01658826|592243285|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
163964730|NCT01658826|592243286|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
163964731|NCT01658826|592243285|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
163964732|NCT01658826|592243286|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
163964733|NCT01658826|592243285|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
163964734|NCT01658826|592243286|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
163964735|NCT01658826|592243285|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
163964736|NCT01658826|592243286|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
163964737|NCT01658826|592243285|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
163964738|NCT01658826|592243286|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
163964739|NCT02383589|592243288|FG000|Treatment Period|Adverse Event|1|||
163964740|NCT02383589|592243289|FG001|Treatment Period|Adverse Event|3|||
163854423|NCT02735915|591836379|FG000|Overall Study|Withdrawal following SAE|2|||
163854424|NCT02735915|591836379|FG000|Overall Study|Withdrawal by Subject|1|||
163854425|NCT05328973|591836380|FG000|Overall Study|Withdrawal by Subject|0|||
163854426|NCT05328973|591836381|FG001|Overall Study|Withdrawal by Subject|1|||
163854427|NCT00409708|591836387|FG000|Treatment|Abnormal test procedure result(s)|1|||
163854428|NCT00409708|591836388|FG001|Treatment|Abnormal test procedure result(s)|0|||
163854429|NCT00409708|591836387|FG000|Treatment|Lack of Efficacy|0|||
163854430|NCT00409708|591836388|FG001|Treatment|Lack of Efficacy|1|||
163854431|NCT00409708|591836387|FG000|Treatment|Protocol Violation|6|||
163854432|NCT00409708|591836388|FG001|Treatment|Protocol Violation|2|||
163854433|NCT00409708|591836387|FG000|Treatment|Withdrawal by Subject|3|||
163854434|NCT00409708|591836388|FG001|Treatment|Withdrawal by Subject|8|||
163854435|NCT00409708|591836387|FG000|Treatment|Lost to Follow-up|0|||
163854436|NCT00409708|591836388|FG001|Treatment|Lost to Follow-up|6|||
163854437|NCT00409708|591836387|FG000|Treatment|Administrative problems|5|||
163854438|NCT00409708|591836388|FG001|Treatment|Administrative problems|0|||
163854439|NCT00409708|591836387|FG000|Washout|Lack of Efficacy|9|||
163854440|NCT00409708|591836388|FG001|Washout|Lack of Efficacy|1|||
163854441|NCT00409708|591836387|FG000|Washout|Protocol Violation|0|||
163854442|NCT00409708|591836388|FG001|Washout|Protocol Violation|1|||
163854443|NCT00409708|591836387|FG000|Washout|Withdrawal by Subject|11|||
163854444|NCT00409708|591836388|FG001|Washout|Withdrawal by Subject|5|||
163854445|NCT00409708|591836387|FG000|Washout|Lost to Follow-up|1|||
163854446|NCT00409708|591836388|FG001|Washout|Lost to Follow-up|3|||
163854447|NCT00946114|591836389|FG000|Overall Study|Death|5|||
164190853|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
164190854|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
164190855|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
164190856|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
164190857|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
164190858|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
164190859|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
164190860|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
164190861|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
164190862|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
164190863|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
164190864|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
164190865|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
164190866|NCT03538691|593066376|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190867|NCT03538691|593066377|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
164190868|NCT03538691|593066378|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190869|NCT03538691|593066379|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190870|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
164190871|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
164190872|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
164190873|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
164190874|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
164190875|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
164190876|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
164190877|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
164190878|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
164190879|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
164190880|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
164190881|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
164190882|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
164190883|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
164190884|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
164190885|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
164190886|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
164190887|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
164190888|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
164190889|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
163854448|NCT00946114|591836390|FG001|Overall Study|Death|2|||
163854449|NCT00946114|591836389|FG000|Overall Study|Other|1|||
164302041|NCT02395471|593482510|FG001|Overall Study|Lost to Follow-up|0|||
163854450|NCT00946114|591836390|FG001|Overall Study|Other|0|||
163854451|NCT00946114|591836389|FG000|Overall Study|Withdrawal by Subject|2|||
163854452|NCT00946114|591836390|FG001|Overall Study|Withdrawal by Subject|0|||
163854453|NCT00723294|591836391|FG000|Overall Study|Lobular histology|2|||
164190890|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
164190891|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
164190892|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
164190893|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
164190894|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
164190895|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
164190896|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
164190897|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
164190898|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
164190899|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
164190900|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
164190901|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
164190902|NCT03538691|593066376|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190903|NCT03538691|593066377|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
164190904|NCT03538691|593066378|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
164190905|NCT03538691|593066379|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
164190906|NCT00481767|593066381|FG000|Overall Study|Withdrawal by Subject|16|||
164190907|NCT00481767|593066382|FG001|Overall Study|Withdrawal by Subject|11|||
164190908|NCT00481767|593066381|FG000|Overall Study|Lost to Follow-up|16|||
164190909|NCT00481767|593066382|FG001|Overall Study|Lost to Follow-up|10|||
164190910|NCT00636636|593066383|FG000|Overall Study|Other reason|4|||
164190911|NCT00636636|593066384|FG001|Overall Study|Other reason|6|||
164190912|NCT00636636|593066383|FG000|Overall Study|Adverse Event|19|||
164190913|NCT00636636|593066384|FG001|Overall Study|Adverse Event|8|||
164190914|NCT00636636|593066383|FG000|Overall Study|Lack of Efficacy|7|||
164190915|NCT00636636|593066384|FG001|Overall Study|Lack of Efficacy|12|||
164190916|NCT00636636|593066383|FG000|Overall Study|Protocol Violation|2|||
164190917|NCT00636636|593066384|FG001|Overall Study|Protocol Violation|2|||
164190918|NCT00636636|593066383|FG000|Overall Study|Lost to Follow-up|0|||
164190919|NCT00636636|593066384|FG001|Overall Study|Lost to Follow-up|1|||
164190920|NCT00636636|593066383|FG000|Overall Study|Death|0|||
164190921|NCT00636636|593066384|FG001|Overall Study|Death|1|||
164190922|NCT00636636|593066383|FG000|Overall Study|Withdrawal by Subject|4|||
164190923|NCT00636636|593066384|FG001|Overall Study|Withdrawal by Subject|9|||
164190924|NCT00524173|593066385|FG000|Overall Study|Lost to Follow-up|0|||
164190925|NCT00524173|593066386|FG001|Overall Study|Lost to Follow-up|1|||
164190926|NCT00524173|593066385|FG000|Overall Study|Death|1|||
164190927|NCT00524173|593066386|FG001|Overall Study|Death|0|||
163854454|NCT00723294|591836391|FG000|Overall Study|>25% intraductal component|1|||
163854455|NCT00723294|591836391|FG000|Overall Study|No MRI tumor enhancement|1|||
163854456|NCT00723294|591836391|FG000|Overall Study|1.0-Tesla MRI|1|||
163854457|NCT00723294|591836391|FG000|Overall Study|No cryoabalation|2|||
163854458|NCT00723294|591836391|FG000|Overall Study|Did not undergo surgery|1|||
163854459|NCT00723294|591836391|FG000|Overall Study|Treated prior to registration|1|||
163854460|NCT00723294|591836391|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
163854461|NCT00723294|591836391|FG000|Overall Study|Benign lesion|1|||
163854462|NCT00723294|591836391|FG000|Overall Study|Withdrawal by Subject|1|||
163854463|NCT00723294|591836391|FG000|Overall Study|No treatment due to probe failure|1|||
163854464|NCT01257503|591836392|FG000|Overall Study|Lost to Follow-up|7|||
163854465|NCT01257503|591836393|FG001|Overall Study|Lost to Follow-up|10|||
163854466|NCT01257503|591836392|FG000|Overall Study|Over 5 years old at enrollment|0|||
163854467|NCT01257503|591836393|FG001|Overall Study|Over 5 years old at enrollment|1|||
163854468|NCT01257503|591836392|FG000|Overall Study|strep culture positive at enrollment|1|||
163854469|NCT01257503|591836393|FG001|Overall Study|strep culture positive at enrollment|0|||
163854470|NCT00088465|591836394|FG000|Overall Study|Withdrawal by Subject|290|||
163854471|NCT00088465|591836394|FG000|Overall Study|Adverse Event|77|||
163854472|NCT00088465|591836394|FG000|Overall Study|Lost to Follow-up|57|||
163854473|NCT00088465|591836394|FG000|Overall Study|Physician Decision|45|||
163854474|NCT00088465|591836394|FG000|Overall Study|Sponsor Decision|37|||
163854475|NCT00088465|591836394|FG000|Overall Study|Lack of Efficacy|27|||
164190928|NCT00524173|593066385|FG000|Overall Study|Had not reached endpoint at study close|4|||
164190929|NCT00524173|593066386|FG001|Overall Study|Had not reached endpoint at study close|1|||
164190930|NCT03300180|593066387|FG000|Baseline|Withdrawal by Subject|4|||
163854476|NCT00088465|591836394|FG000|Overall Study|Protocol Violation|17|||
163854477|NCT00088465|591836394|FG000|Overall Study|Death|11|||
163854478|NCT04565249|591836395|FG000|Overall Study|Death|0|||
163854479|NCT04565249|591836396|FG001|Overall Study|Death|0|||
163854480|NCT04565249|591836397|FG002|Overall Study|Death|0|||
163854481|NCT04565249|591836398|FG003|Overall Study|Death|1|||
163854482|NCT02333630|591836399|FG000|Overall Study|Lost to Follow-up|5|||
164190931|NCT03300180|593066388|FG001|Baseline|Withdrawal by Subject|6|||
164190932|NCT03300180|593066389|FG002|Baseline|Withdrawal by Subject|4|||
163854483|NCT02333630|591836400|FG001|Overall Study|Lost to Follow-up|2|||
164190933|NCT03300180|593066387|FG000|6 Month Outcome|Withdrawal by Subject|12|||
164190934|NCT03300180|593066388|FG001|6 Month Outcome|Withdrawal by Subject|12|||
164190935|NCT03300180|593066389|FG002|6 Month Outcome|Withdrawal by Subject|19|||
164190936|NCT03300180|593066387|FG000|6 Month Outcome|Death|2|||
164190937|NCT03300180|593066388|FG001|6 Month Outcome|Death|4|||
164190938|NCT03300180|593066389|FG002|6 Month Outcome|Death|3|||
164190939|NCT03300180|593066387|FG000|6 Month Outcome|Missed Assessment|43|||
164190940|NCT03300180|593066388|FG001|6 Month Outcome|Missed Assessment|52|||
164190941|NCT03300180|593066389|FG002|6 Month Outcome|Missed Assessment|46|||
164190942|NCT03300180|593066387|FG000|12 Month Outcome|Withdrawal by Subject|3|||
164190943|NCT03300180|593066388|FG001|12 Month Outcome|Withdrawal by Subject|6|||
164190944|NCT03300180|593066389|FG002|12 Month Outcome|Withdrawal by Subject|6|||
164190945|NCT03300180|593066387|FG000|12 Month Outcome|Death|9|||
164190946|NCT03300180|593066388|FG001|12 Month Outcome|Death|6|||
164190947|NCT03300180|593066389|FG002|12 Month Outcome|Death|6|||
164190948|NCT03300180|593066387|FG000|12 Month Outcome|Missed Assessment|62|||
164190949|NCT03300180|593066388|FG001|12 Month Outcome|Missed Assessment|59|||
164190950|NCT03300180|593066389|FG002|12 Month Outcome|Missed Assessment|58|||
164190951|NCT03300180|593066387|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
164190952|NCT03300180|593066388|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
164190953|NCT03300180|593066389|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
164190954|NCT03300180|593066387|FG000|18 Month Outcome Assessment|Death|8|||
164190955|NCT03300180|593066388|FG001|18 Month Outcome Assessment|Death|5|||
164190956|NCT03300180|593066389|FG002|18 Month Outcome Assessment|Death|5|||
164190957|NCT03300180|593066387|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
164190958|NCT03300180|593066388|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
164190959|NCT03300180|593066389|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
164190960|NCT03300180|593066387|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
164190961|NCT03300180|593066388|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
164190962|NCT03300180|593066389|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
164190963|NCT03300180|593066387|FG000|24 Month Outcome Assessment|Death|13|||
164190964|NCT03300180|593066388|FG001|24 Month Outcome Assessment|Death|13|||
164190965|NCT03300180|593066389|FG002|24 Month Outcome Assessment|Death|3|||
164190966|NCT03300180|593066387|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
164190967|NCT03300180|593066388|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
164190968|NCT03300180|593066389|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
164190969|NCT00103285|593067733|FG000|Induction|Adverse Event|14|||
164190970|NCT00103285|593067734|FG001|Induction|Adverse Event|0|||
164190971|NCT00103285|593067735|FG002|Induction|Adverse Event|0|||
164190972|NCT00103285|593067736|FG003|Induction|Adverse Event|0|||
164190973|NCT00103285|593067737|FG004|Induction|Adverse Event|0|||
164190974|NCT00103285|593067738|FG005|Induction|Adverse Event|0|||
164190975|NCT00103285|593067739|FG006|Induction|Adverse Event|0|||
164190976|NCT00103285|593067740|FG007|Induction|Adverse Event|0|||
164190977|NCT00103285|593067733|FG000|Induction|Death|24|||
164190978|NCT00103285|593067734|FG001|Induction|Death|0|||
164190979|NCT00103285|593067735|FG002|Induction|Death|0|||
164190980|NCT00103285|593067736|FG003|Induction|Death|0|||
164190981|NCT00103285|593067737|FG004|Induction|Death|0|||
164190982|NCT00103285|593067738|FG005|Induction|Death|0|||
164190983|NCT00103285|593067739|FG006|Induction|Death|0|||
164190984|NCT00103285|593067740|FG007|Induction|Death|0|||
164190985|NCT00103285|593067733|FG000|Induction|Physician Decision|103|||
164190986|NCT00103285|593067734|FG001|Induction|Physician Decision|0|||
164190987|NCT00103285|593067735|FG002|Induction|Physician Decision|0|||
164190988|NCT00103285|593067736|FG003|Induction|Physician Decision|0|||
164190989|NCT00103285|593067737|FG004|Induction|Physician Decision|0|||
164190990|NCT00103285|593067738|FG005|Induction|Physician Decision|0|||
164190991|NCT00103285|593067739|FG006|Induction|Physician Decision|0|||
164190992|NCT00103285|593067740|FG007|Induction|Physician Decision|0|||
164190993|NCT00103285|593067733|FG000|Induction|Withdrawal by Subject|1|||
164190994|NCT00103285|593067734|FG001|Induction|Withdrawal by Subject|0|||
164190995|NCT00103285|593067735|FG002|Induction|Withdrawal by Subject|0|||
164190996|NCT00103285|593067736|FG003|Induction|Withdrawal by Subject|0|||
164190997|NCT00103285|593067737|FG004|Induction|Withdrawal by Subject|0|||
164190998|NCT00103285|593067738|FG005|Induction|Withdrawal by Subject|0|||
164190999|NCT00103285|593067739|FG006|Induction|Withdrawal by Subject|0|||
164191000|NCT00103285|593067740|FG007|Induction|Withdrawal by Subject|0|||
164191001|NCT00103285|593067733|FG000|Induction|Ineligible|43|||
164191002|NCT00103285|593067734|FG001|Induction|Ineligible|0|||
164191003|NCT00103285|593067735|FG002|Induction|Ineligible|0|||
164191004|NCT00103285|593067736|FG003|Induction|Ineligible|0|||
164191005|NCT00103285|593067737|FG004|Induction|Ineligible|0|||
164191006|NCT00103285|593067738|FG005|Induction|Ineligible|0|||
164191007|NCT00103285|593067739|FG006|Induction|Ineligible|0|||
164191008|NCT00103285|593067740|FG007|Induction|Ineligible|0|||
164191009|NCT00103285|593067733|FG000|Induction|Refusal|906|||
164191010|NCT00103285|593067734|FG001|Induction|Refusal|0|||
164191011|NCT00103285|593067735|FG002|Induction|Refusal|0|||
164191012|NCT00103285|593067736|FG003|Induction|Refusal|0|||
164191013|NCT00103285|593067737|FG004|Induction|Refusal|0|||
164191014|NCT00103285|593067738|FG005|Induction|Refusal|0|||
164191015|NCT00103285|593067739|FG006|Induction|Refusal|0|||
164191016|NCT00103285|593067740|FG007|Induction|Refusal|0|||
164191017|NCT00103285|593067733|FG000|Induction|Other|258|||
164191018|NCT00103285|593067734|FG001|Induction|Other|0|||
164191019|NCT00103285|593067735|FG002|Induction|Other|0|||
164191020|NCT00103285|593067736|FG003|Induction|Other|0|||
164191021|NCT00103285|593067737|FG004|Induction|Other|0|||
164191022|NCT00103285|593067738|FG005|Induction|Other|0|||
164191023|NCT00103285|593067739|FG006|Induction|Other|0|||
164191024|NCT00103285|593067740|FG007|Induction|Other|0|||
164191025|NCT00103285|593067733|FG000|Response Assignment|Adverse Event|0|||
164191026|NCT00103285|593067734|FG001|Response Assignment|Adverse Event|8|||
164191027|NCT00103285|593067735|FG002|Response Assignment|Adverse Event|3|||
164191028|NCT00103285|593067736|FG003|Response Assignment|Adverse Event|2|||
164191029|NCT00103285|593067737|FG004|Response Assignment|Adverse Event|3|||
164191030|NCT00103285|593067738|FG005|Response Assignment|Adverse Event|1|||
164191031|NCT00103285|593067739|FG006|Response Assignment|Adverse Event|1|||
164191032|NCT00103285|593067740|FG007|Response Assignment|Adverse Event|2|||
164191033|NCT00103285|593067733|FG000|Response Assignment|Death|0|||
164191034|NCT00103285|593067734|FG001|Response Assignment|Death|5|||
164191035|NCT00103285|593067735|FG002|Response Assignment|Death|2|||
164191036|NCT00103285|593067736|FG003|Response Assignment|Death|2|||
164191037|NCT00103285|593067737|FG004|Response Assignment|Death|3|||
164191038|NCT00103285|593067738|FG005|Response Assignment|Death|1|||
164191039|NCT00103285|593067739|FG006|Response Assignment|Death|0|||
164191040|NCT00103285|593067740|FG007|Response Assignment|Death|8|||
164191041|NCT00103285|593067733|FG000|Response Assignment|Lost to Follow-up|0|||
164191042|NCT00103285|593067734|FG001|Response Assignment|Lost to Follow-up|9|||
164191043|NCT00103285|593067735|FG002|Response Assignment|Lost to Follow-up|5|||
164191044|NCT00103285|593067736|FG003|Response Assignment|Lost to Follow-up|5|||
164191045|NCT00103285|593067737|FG004|Response Assignment|Lost to Follow-up|1|||
164191046|NCT00103285|593067738|FG005|Response Assignment|Lost to Follow-up|2|||
164191047|NCT00103285|593067739|FG006|Response Assignment|Lost to Follow-up|2|||
164191048|NCT00103285|593067740|FG007|Response Assignment|Lost to Follow-up|5|||
164191049|NCT00103285|593067733|FG000|Response Assignment|Physician Decision|0|||
164191050|NCT00103285|593067734|FG001|Response Assignment|Physician Decision|13|||
164191051|NCT00103285|593067735|FG002|Response Assignment|Physician Decision|14|||
164191052|NCT00103285|593067736|FG003|Response Assignment|Physician Decision|9|||
163854484|NCT02359435|591836401|FG000|Overall Study|Lost to Follow-up|4|||
163854485|NCT02359435|591836402|FG001|Overall Study|Lost to Follow-up|4|||
163854486|NCT00315055|591836403|FG000|Overall Study|Protocol Violation|2|||
164191053|NCT00103285|593067737|FG004|Response Assignment|Physician Decision|13|||
164191054|NCT00103285|593067738|FG005|Response Assignment|Physician Decision|7|||
164191055|NCT00103285|593067739|FG006|Response Assignment|Physician Decision|4|||
164191056|NCT00103285|593067740|FG007|Response Assignment|Physician Decision|35|||
164191057|NCT00103285|593067733|FG000|Response Assignment|Protocol Violation|0|||
164191058|NCT00103285|593067734|FG001|Response Assignment|Protocol Violation|2|||
164191059|NCT00103285|593067735|FG002|Response Assignment|Protocol Violation|0|||
164191060|NCT00103285|593067736|FG003|Response Assignment|Protocol Violation|0|||
164191061|NCT00103285|593067737|FG004|Response Assignment|Protocol Violation|0|||
164191062|NCT00103285|593067738|FG005|Response Assignment|Protocol Violation|0|||
164191063|NCT00103285|593067739|FG006|Response Assignment|Protocol Violation|0|||
164191064|NCT00103285|593067740|FG007|Response Assignment|Protocol Violation|0|||
164191065|NCT00103285|593067733|FG000|Response Assignment|Withdrawal by Subject|0|||
164191066|NCT00103285|593067734|FG001|Response Assignment|Withdrawal by Subject|4|||
164191067|NCT00103285|593067735|FG002|Response Assignment|Withdrawal by Subject|1|||
164191068|NCT00103285|593067736|FG003|Response Assignment|Withdrawal by Subject|1|||
164191069|NCT00103285|593067737|FG004|Response Assignment|Withdrawal by Subject|2|||
164191070|NCT00103285|593067738|FG005|Response Assignment|Withdrawal by Subject|2|||
164191071|NCT00103285|593067739|FG006|Response Assignment|Withdrawal by Subject|0|||
164191072|NCT00103285|593067740|FG007|Response Assignment|Withdrawal by Subject|2|||
163854487|NCT00315055|591836404|FG001|Overall Study|Protocol Violation|4|||
163854488|NCT00315055|591836403|FG000|Overall Study|Lost to Follow-up|1|||
164191073|NCT00103285|593067733|FG000|Response Assignment|Ineligible|0|||
164191074|NCT00103285|593067734|FG001|Response Assignment|Ineligible|8|||
164191075|NCT00103285|593067735|FG002|Response Assignment|Ineligible|6|||
164191076|NCT00103285|593067736|FG003|Response Assignment|Ineligible|2|||
164191077|NCT00103285|593067737|FG004|Response Assignment|Ineligible|0|||
164191078|NCT00103285|593067738|FG005|Response Assignment|Ineligible|3|||
164191079|NCT00103285|593067739|FG006|Response Assignment|Ineligible|1|||
164191080|NCT00103285|593067740|FG007|Response Assignment|Ineligible|5|||
164191081|NCT00103285|593067733|FG000|Response Assignment|Refusal|0|||
164191082|NCT00103285|593067734|FG001|Response Assignment|Refusal|53|||
163854489|NCT00315055|591836404|FG001|Overall Study|Lost to Follow-up|1|||
164191083|NCT00103285|593067735|FG002|Response Assignment|Refusal|5|||
164191084|NCT00103285|593067736|FG003|Response Assignment|Refusal|3|||
164191085|NCT00103285|593067737|FG004|Response Assignment|Refusal|25|||
164191086|NCT00103285|593067738|FG005|Response Assignment|Refusal|15|||
164191087|NCT00103285|593067739|FG006|Response Assignment|Refusal|30|||
164191088|NCT00103285|593067740|FG007|Response Assignment|Refusal|10|||
164191089|NCT00103285|593067733|FG000|Response Assignment|Other|0|||
164191090|NCT00103285|593067734|FG001|Response Assignment|Other|30|||
164191091|NCT00103285|593067735|FG002|Response Assignment|Other|48|||
164191092|NCT00103285|593067736|FG003|Response Assignment|Other|38|||
164191093|NCT00103285|593067737|FG004|Response Assignment|Other|37|||
164191094|NCT00103285|593067738|FG005|Response Assignment|Other|17|||
164191095|NCT00103285|593067739|FG006|Response Assignment|Other|11|||
164191096|NCT00103285|593067740|FG007|Response Assignment|Other|53|||
164191097|NCT00452439|593067741|FG000|Overall Study|Lost to Follow-up|1|||
164191098|NCT00452439|593067742|FG001|Overall Study|Lost to Follow-up|1|||
164191099|NCT00452439|593067741|FG000|Overall Study|Refused Treatment|4|||
164191100|NCT00452439|593067742|FG001|Overall Study|Refused Treatment|3|||
164191101|NCT00452439|593067741|FG000|Overall Study|Death|3|||
164191102|NCT00452439|593067742|FG001|Overall Study|Death|1|||
164191103|NCT00452439|593067741|FG000|Overall Study|Bone Marrow Transplant|0|||
164191104|NCT00452439|593067742|FG001|Overall Study|Bone Marrow Transplant|1|||
164191105|NCT00452439|593067741|FG000|Overall Study|Too Ill to Continue|0|||
164191106|NCT00452439|593067742|FG001|Overall Study|Too Ill to Continue|1|||
164191107|NCT00452439|593067741|FG000|Overall Study|Failed to achieve complete response|2|||
164191108|NCT00452439|593067742|FG001|Overall Study|Failed to achieve complete response|0|||
164191109|NCT00452439|593067741|FG000|Overall Study|Relapse|3|||
164191110|NCT00452439|593067742|FG001|Overall Study|Relapse|0|||
164191111|NCT00452439|593067741|FG000|Overall Study|Fracture|1|||
164191112|NCT00452439|593067742|FG001|Overall Study|Fracture|0|||
164191113|NCT01381926|593067745|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
164191114|NCT01381926|593067746|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
164191115|NCT01381926|593067745|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
164191116|NCT01381926|593067746|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
164191117|NCT02624947|593067751|FG000|Maternal Participants|Adverse Event|5|||
164191118|NCT02624947|593067752|FG001|Maternal Participants|Adverse Event|0|||
164191119|NCT02624947|593067751|FG000|Maternal Participants|Investigator Decision|5|||
164191120|NCT02624947|593067752|FG001|Maternal Participants|Investigator Decision|3|||
164191121|NCT02624947|593067751|FG000|Maternal Participants|Lost to Follow-up|54|||
164191122|NCT02624947|593067752|FG001|Maternal Participants|Lost to Follow-up|24|||
164191123|NCT02624947|593067751|FG000|Maternal Participants|Non Compliance|8|||
164191124|NCT02624947|593067752|FG001|Maternal Participants|Non Compliance|5|||
164191125|NCT02624947|593067751|FG000|Maternal Participants|Sponsor Request|1|||
164191126|NCT02624947|593067752|FG001|Maternal Participants|Sponsor Request|1|||
164191127|NCT02624947|593067751|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
164191128|NCT02624947|593067752|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
164191129|NCT02624947|593067751|FG000|Maternal Participants|Miscellaneous|23|||
164191130|NCT02624947|593067752|FG001|Maternal Participants|Miscellaneous|15|||
164191131|NCT02624947|593067751|FG000|Infant Participants|Adverse Event|18|||
164191132|NCT02624947|593067752|FG001|Infant Participants|Adverse Event|11|||
164191133|NCT02624947|593067751|FG000|Infant Participants|Investigator Decision|5|||
164191134|NCT02624947|593067752|FG001|Infant Participants|Investigator Decision|4|||
164191135|NCT02624947|593067751|FG000|Infant Participants|Lost to Follow-up|93|||
164191136|NCT02624947|593067752|FG001|Infant Participants|Lost to Follow-up|58|||
163854490|NCT02347943|591836406|FG000|Overall Study|Study was cancelled|140|||
163854491|NCT02347943|591836407|FG001|Overall Study|Study was cancelled|67|||
163854492|NCT02347943|591836408|FG002|Overall Study|Study was cancelled|45|||
163854493|NCT03613129|591836413|FG000|Pre-treatment Assessment|Protocol Violation|2|||
163854494|NCT03613129|591836414|FG001|Pre-treatment Assessment|Protocol Violation|0|||
163854495|NCT03613129|591836415|FG002|Pre-treatment Assessment|Protocol Violation|0|||
163854496|NCT03613129|591836416|FG003|Pre-treatment Assessment|Protocol Violation|0|||
163854497|NCT03613129|591836417|FG004|Pre-treatment Assessment|Protocol Violation|0|||
163854498|NCT03613129|591836413|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
163854499|NCT03613129|591836414|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
163854500|NCT03613129|591836415|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
163854501|NCT03613129|591836416|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
164191137|NCT02624947|593067751|FG000|Infant Participants|Non Compliance|17|||
164191138|NCT02624947|593067752|FG001|Infant Participants|Non Compliance|7|||
164191139|NCT02624947|593067751|FG000|Infant Participants|Sponsor Request|0|||
164191140|NCT02624947|593067752|FG001|Infant Participants|Sponsor Request|1|||
164191141|NCT02624947|593067751|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
164191142|NCT02624947|593067752|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
164191143|NCT02624947|593067751|FG000|Infant Participants|Miscellaneous|50|||
163854502|NCT03613129|591836417|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
163854503|NCT02334306|591836418|FG000|Double-blind Period|Adverse Event|0|||
164191144|NCT02624947|593067752|FG001|Infant Participants|Miscellaneous|26|||
164191145|NCT03654729|593067761|FG000|Overall Study|Death|9|||
164191146|NCT03654729|593067762|FG001|Overall Study|Death|9|||
164191147|NCT03654729|593067763|FG002|Overall Study|Death|16|||
164191148|NCT03654729|593067761|FG000|Overall Study|Withdrawal by Subject|8|||
163854504|NCT02334306|591836419|FG001|Double-blind Period|Adverse Event|1|||
163854505|NCT02334306|591836418|FG000|Double-blind Period|Withdrawal by Subject|1|||
164191149|NCT03654729|593067762|FG001|Overall Study|Withdrawal by Subject|6|||
164191150|NCT03654729|593067763|FG002|Overall Study|Withdrawal by Subject|4|||
163854506|NCT02334306|591836419|FG001|Double-blind Period|Withdrawal by Subject|1|||
163854507|NCT01687270|591836420|FG000|Overall Study|Lack of Efficacy|11|||
163854508|NCT01687270|591836420|FG000|Overall Study|Lost to Follow-up|1|||
163854509|NCT00711646|591836421|FG000|Overall Study|Adverse Event|6|||
163854510|NCT00711646|591836422|FG001|Overall Study|Adverse Event|1|||
163854511|NCT00711646|591836421|FG000|Overall Study|Withdrawal by Subject|4|||
163854512|NCT00711646|591836422|FG001|Overall Study|Withdrawal by Subject|0|||
163854513|NCT00711646|591836421|FG000|Overall Study|Protocol Violation|0|||
163854514|NCT00711646|591836422|FG001|Overall Study|Protocol Violation|1|||
163854515|NCT00711646|591836421|FG000|Overall Study|Lost to Follow-up|1|||
163854516|NCT00711646|591836422|FG001|Overall Study|Lost to Follow-up|0|||
163854517|NCT00711646|591836421|FG000|Overall Study|administrative decision|0|||
163854518|NCT00711646|591836422|FG001|Overall Study|administrative decision|1|||
163854519|NCT00711646|591836421|FG000|Overall Study|patient non-compliance|1|||
163854520|NCT00711646|591836422|FG001|Overall Study|patient non-compliance|0|||
163854521|NCT03441360|591836423|FG000|Overall Study|Radiological disease progression|5|||
163854522|NCT03441360|591836424|FG001|Overall Study|Radiological disease progression|6|||
163854523|NCT03441360|591836425|FG002|Overall Study|Radiological disease progression|4|||
163854524|NCT03441360|591836423|FG000|Overall Study|Clinical disease progression|2|||
163854525|NCT03441360|591836424|FG001|Overall Study|Clinical disease progression|2|||
163854526|NCT03441360|591836425|FG002|Overall Study|Clinical disease progression|0|||
163854527|NCT03441360|591836423|FG000|Overall Study|Adverse Event|1|||
163854528|NCT03441360|591836424|FG001|Overall Study|Adverse Event|0|||
163854529|NCT03441360|591836425|FG002|Overall Study|Adverse Event|1|||
163854530|NCT01360840|591836428|FG000|Overall Study|Ongoing at data cut-off|10|||
163854531|NCT01360840|591836429|FG001|Overall Study|Ongoing at data cut-off|10|||
163854532|NCT01360840|591836430|FG002|Overall Study|Ongoing at data cut-off|9|||
163854533|NCT00920686|591836432|FG000|Overall Study|Lost to Follow-up|2|||
163854534|NCT00920686|591836433|FG001|Overall Study|Lost to Follow-up|3|||
163854535|NCT00920686|591836434|FG002|Overall Study|Lost to Follow-up|1|||
163854536|NCT00920686|591836432|FG000|Overall Study|Study drug dosing criteria not met|17|||
163854537|NCT00920686|591836433|FG001|Overall Study|Study drug dosing criteria not met|19|||
163854538|NCT00920686|591836434|FG002|Overall Study|Study drug dosing criteria not met|12|||
163854539|NCT04337489|591836435|FG000|Overall Study|Withdrawal by Subject|1|||
163854540|NCT00688688|591836436|FG000|Overall Study|Eligibility criterion not met|7|||
163854541|NCT00688688|591836437|FG001|Overall Study|Eligibility criterion not met|7|||
163854542|NCT00688688|591836438|FG002|Overall Study|Eligibility criterion not met|10|||
163854543|NCT00688688|591836436|FG000|Overall Study|Adverse Event|52|||
163854544|NCT00688688|591836437|FG001|Overall Study|Adverse Event|51|||
163854545|NCT00688688|591836438|FG002|Overall Study|Adverse Event|50|||
163854546|NCT00688688|591836436|FG000|Overall Study|Lack of Efficacy|34|||
163854547|NCT00688688|591836437|FG001|Overall Study|Lack of Efficacy|25|||
163854548|NCT00688688|591836438|FG002|Overall Study|Lack of Efficacy|45|||
163854549|NCT00688688|591836436|FG000|Overall Study|Withdrawal by Subject|66|||
163854550|NCT00688688|591836437|FG001|Overall Study|Withdrawal by Subject|75|||
163854551|NCT00688688|591836438|FG002|Overall Study|Withdrawal by Subject|65|||
163854552|NCT00688688|591836436|FG000|Overall Study|Lost to Follow-up|14|||
163854553|NCT00688688|591836437|FG001|Overall Study|Lost to Follow-up|7|||
163854554|NCT00688688|591836438|FG002|Overall Study|Lost to Follow-up|7|||
163854555|NCT00688688|591836436|FG000|Overall Study|Protocol Violation|6|||
163854556|NCT00688688|591836437|FG001|Overall Study|Protocol Violation|9|||
163854557|NCT00688688|591836438|FG002|Overall Study|Protocol Violation|11|||
163854558|NCT00688688|591836436|FG000|Overall Study|Randomized but never received study drug|1|||
163854559|NCT00688688|591836437|FG001|Overall Study|Randomized but never received study drug|0|||
163854560|NCT00688688|591836438|FG002|Overall Study|Randomized but never received study drug|0|||
163854561|NCT00688688|591836436|FG000|Overall Study|Non-compliance with study procedures|5|||
163854562|NCT00688688|591836437|FG001|Overall Study|Non-compliance with study procedures|3|||
163854563|NCT00688688|591836438|FG002|Overall Study|Non-compliance with study procedures|4|||
163854564|NCT00688688|591836436|FG000|Overall Study|Taking exclusionary medications|1|||
163854565|NCT00688688|591836437|FG001|Overall Study|Taking exclusionary medications|0|||
163854566|NCT00688688|591836438|FG002|Overall Study|Taking exclusionary medications|0|||
163854567|NCT00688688|591836436|FG000|Overall Study|Site closure|0|||
163854568|NCT00688688|591836437|FG001|Overall Study|Site closure|1|||
163854569|NCT00688688|591836438|FG002|Overall Study|Site closure|0|||
163854570|NCT00688688|591836436|FG000|Overall Study|Violation of exclusion criterion|0|||
163854571|NCT00688688|591836437|FG001|Overall Study|Violation of exclusion criterion|1|||
163854572|NCT00688688|591836438|FG002|Overall Study|Violation of exclusion criterion|0|||
163854573|NCT04296942|591836439|FG000|Overall Study|Study closure by sponsor|1|||
163854574|NCT04296942|591836440|FG001|Overall Study|Study closure by sponsor|0|||
163854575|NCT04296942|591836441|FG002|Overall Study|Study closure by sponsor|0|||
163854576|NCT03255941|591836442|FG000|Overall Study|Not eligible or refused injection|37|||
163854577|NCT03255941|591836443|FG001|Overall Study|Not eligible or refused injection|44|||
163854578|NCT03255941|591836444|FG002|Overall Study|Not eligible or refused injection|5|||
163854579|NCT03255941|591836445|FG003|Overall Study|Not eligible or refused injection|6|||
163854580|NCT03255941|591836442|FG000|Overall Study|Did not complete exit interview|1|||
163854581|NCT03255941|591836443|FG001|Overall Study|Did not complete exit interview|2|||
163854582|NCT03255941|591836444|FG002|Overall Study|Did not complete exit interview|0|||
163854583|NCT03255941|591836445|FG003|Overall Study|Did not complete exit interview|0|||
163854584|NCT00335153|591836457|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
163854585|NCT00335153|591836457|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
163854586|NCT00335153|591836457|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
163854587|NCT00335153|591836457|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
163854588|NCT00335153|591836457|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
163854589|NCT00335153|591836457|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
163854590|NCT00335153|591836457|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
163854591|NCT00335153|591836457|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
163854592|NCT00335153|591836457|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
163854593|NCT00335153|591836457|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
163854594|NCT01237678|591836460|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
163854595|NCT01237678|591836461|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
163854596|NCT01237678|591836462|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
163854597|NCT01237678|591836460|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
163854598|NCT01237678|591836461|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
163854599|NCT01237678|591836462|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
163854600|NCT01237678|591836460|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
163854601|NCT01237678|591836461|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
163854602|NCT01237678|591836462|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
163854603|NCT01237678|591836460|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
163854604|NCT01237678|591836461|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
163854605|NCT01237678|591836462|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
163854606|NCT01237678|591836460|FG000|Phase II|Adverse Event|0|||
163854607|NCT01237678|591836461|FG001|Phase II|Adverse Event|39|||
163854608|NCT01237678|591836462|FG002|Phase II|Adverse Event|9|||
163854609|NCT01237678|591836460|FG000|Phase II|Death|0|||
163854610|NCT01237678|591836461|FG001|Phase II|Death|0|||
163854611|NCT01237678|591836462|FG002|Phase II|Death|2|||
163854612|NCT01237678|591836460|FG000|Phase II|Lack of Efficacy|0|||
163854613|NCT01237678|591836461|FG001|Phase II|Lack of Efficacy|25|||
163854614|NCT01237678|591836462|FG002|Phase II|Lack of Efficacy|3|||
163854615|NCT01237678|591836460|FG000|Phase II|Withdrawal by Subject|0|||
163854616|NCT01237678|591836461|FG001|Phase II|Withdrawal by Subject|1|||
163854617|NCT01237678|591836462|FG002|Phase II|Withdrawal by Subject|5|||
163854618|NCT01237678|591836460|FG000|Phase II|Completed Cycles 4-6|0|||
163854619|NCT01237678|591836461|FG001|Phase II|Completed Cycles 4-6|11|||
163854620|NCT01237678|591836462|FG002|Phase II|Completed Cycles 4-6|21|||
163854621|NCT01237678|591836460|FG000|Phase II|Sponsor Decision/Study Closed|0|||
163854622|NCT01237678|591836461|FG001|Phase II|Sponsor Decision/Study Closed|18|||
163854623|NCT01237678|591836462|FG002|Phase II|Sponsor Decision/Study Closed|7|||
163854624|NCT01237678|591836460|FG000|Phase II|Randomized but were not treated|0|||
163854625|NCT01237678|591836461|FG001|Phase II|Randomized but were not treated|4|||
163854626|NCT01237678|591836462|FG002|Phase II|Randomized but were not treated|3|||
163854627|NCT02954055|591836463|FG000|Overall Study|Did not initiate therapy|6|||
163854628|NCT02954055|591836464|FG001|Overall Study|Did not initiate therapy|1|||
163854629|NCT00764868|591836468|FG000|Overall Study|Adverse Event|18|||
163854630|NCT00764868|591836468|FG000|Overall Study|Withdrawal by Subject|31|||
163854631|NCT00764868|591836468|FG000|Overall Study|Non-compliance|16|||
163854632|NCT00764868|591836468|FG000|Overall Study|Lost to Follow-up|25|||
163854633|NCT00764868|591836468|FG000|Overall Study|Lack of Efficacy|5|||
163854634|NCT00764868|591836468|FG000|Overall Study|Subject moved|7|||
163854635|NCT00764868|591836468|FG000|Overall Study|Pregnancy|3|||
163854636|NCT00764868|591836468|FG000|Overall Study|Prohibited medication|1|||
163854637|NCT00764868|591836468|FG000|Overall Study|Out of town|1|||
163854638|NCT00764868|591836468|FG000|Overall Study|Misuse and compliance of study drug|1|||
163854639|NCT00764868|591836468|FG000|Overall Study|Subject sent to boarding school|1|||
163964741|NCT02383589|592243288|FG000|Treatment Period|Lost to Follow-up|0|||
163854640|NCT00764868|591836468|FG000|Overall Study|Met an exclusion criteria|1|||
163854641|NCT00764868|591836468|FG000|Overall Study|Positive drug screen|2|||
163854642|NCT00764868|591836468|FG000|Overall Study|Sponsor requested withdrawal|1|||
163854643|NCT04438785|591836476|FG000|Overall Study|change of weight, give up intervention|2|||
163854644|NCT04438785|591836477|FG001|Overall Study|change of weight, give up intervention|10|||
163854645|NCT04831775|591836478|FG000|Overall Study|Lost to Follow-up|11|||
163854646|NCT04831775|591836479|FG001|Overall Study|Lost to Follow-up|13|||
163854647|NCT02027935|591836480|FG000|Overall Study|Death|1|||
163854648|NCT02027935|591836480|FG000|Overall Study|Lack of Efficacy|5|||
163854649|NCT02027935|591836480|FG000|Overall Study|Study Closure|1|||
163854650|NCT03115346|591836481|FG000|Overall Study|Did not have AAA surgery|28|||
163854651|NCT03115346|591836482|FG001|Overall Study|Did not have AAA surgery|15|||
163854652|NCT03115346|591836481|FG000|Overall Study|Death|3|||
163854653|NCT03115346|591836482|FG001|Overall Study|Death|1|||
163854654|NCT03115346|591836481|FG000|Overall Study|Withdrawal by Subject|0|||
163854655|NCT03115346|591836482|FG001|Overall Study|Withdrawal by Subject|3|||
163854656|NCT03115346|591836481|FG000|Overall Study|Lost to Follow-up|0|||
163854657|NCT03115346|591836482|FG001|Overall Study|Lost to Follow-up|3|||
163854658|NCT00689104|591836483|FG000|Overall Study|Eligibility criterion not met|5|||
163854659|NCT00689104|591836484|FG001|Overall Study|Eligibility criterion not met|8|||
163854660|NCT00689104|591836485|FG002|Overall Study|Eligibility criterion not met|0|||
163854661|NCT00689104|591836486|FG003|Overall Study|Eligibility criterion not met|4|||
163854662|NCT00689104|591836483|FG000|Overall Study|Adverse Event|13|||
163854663|NCT00689104|591836484|FG001|Overall Study|Adverse Event|25|||
163854664|NCT00689104|591836485|FG002|Overall Study|Adverse Event|16|||
163854665|NCT00689104|591836486|FG003|Overall Study|Adverse Event|24|||
163854666|NCT00689104|591836483|FG000|Overall Study|Lack of Efficacy|5|||
163854667|NCT00689104|591836484|FG001|Overall Study|Lack of Efficacy|6|||
163854668|NCT00689104|591836485|FG002|Overall Study|Lack of Efficacy|2|||
163854669|NCT00689104|591836486|FG003|Overall Study|Lack of Efficacy|3|||
163854670|NCT00689104|591836483|FG000|Overall Study|Withdrawal by Subject|12|||
163854671|NCT00689104|591836484|FG001|Overall Study|Withdrawal by Subject|11|||
163854672|NCT00689104|591836485|FG002|Overall Study|Withdrawal by Subject|18|||
163854673|NCT00689104|591836486|FG003|Overall Study|Withdrawal by Subject|11|||
163854674|NCT00689104|591836483|FG000|Overall Study|Lost to Follow-up|4|||
163854675|NCT00689104|591836484|FG001|Overall Study|Lost to Follow-up|3|||
163854676|NCT00689104|591836485|FG002|Overall Study|Lost to Follow-up|2|||
163854677|NCT00689104|591836486|FG003|Overall Study|Lost to Follow-up|5|||
163854678|NCT00689104|591836483|FG000|Overall Study|Protocol Violation|2|||
163854679|NCT00689104|591836484|FG001|Overall Study|Protocol Violation|3|||
163854680|NCT00689104|591836485|FG002|Overall Study|Protocol Violation|5|||
163854681|NCT00689104|591836486|FG003|Overall Study|Protocol Violation|3|||
163854682|NCT00689104|591836483|FG000|Overall Study|Randomized but never received study drug|2|||
163854683|NCT00689104|591836484|FG001|Overall Study|Randomized but never received study drug|1|||
163854684|NCT00689104|591836485|FG002|Overall Study|Randomized but never received study drug|1|||
163854685|NCT00689104|591836486|FG003|Overall Study|Randomized but never received study drug|0|||
163854686|NCT00689104|591836483|FG000|Overall Study|Physician Decision|1|||
163854687|NCT00689104|591836484|FG001|Overall Study|Physician Decision|0|||
163854688|NCT00689104|591836485|FG002|Overall Study|Physician Decision|0|||
163854689|NCT00689104|591836486|FG003|Overall Study|Physician Decision|0|||
163854690|NCT00689104|591836483|FG000|Overall Study|Non-compliance with study procedures|0|||
163854691|NCT00689104|591836484|FG001|Overall Study|Non-compliance with study procedures|0|||
163854692|NCT00689104|591836485|FG002|Overall Study|Non-compliance with study procedures|1|||
163854693|NCT00689104|591836486|FG003|Overall Study|Non-compliance with study procedures|0|||
163854694|NCT02698436|591836487|FG000|Overall Study|Adverse Event|1|||
163854695|NCT02698436|591836488|FG001|Overall Study|Adverse Event|0|||
163854696|NCT02698436|591836487|FG000|Overall Study|Withdrawal by Subject|3|||
163854697|NCT02698436|591836488|FG001|Overall Study|Withdrawal by Subject|3|||
163854698|NCT02698436|591836487|FG000|Overall Study|Lost to Follow-up|2|||
163854699|NCT02698436|591836488|FG001|Overall Study|Lost to Follow-up|4|||
163854700|NCT02698436|591836487|FG000|Overall Study|Non-compliance with study regimen|1|||
163854701|NCT02698436|591836488|FG001|Overall Study|Non-compliance with study regimen|0|||
163854702|NCT00665561|591836489|FG000|Overall Study|Death recorded on subject summary pages|75|||
163854703|NCT00665561|591836490|FG001|Overall Study|Death recorded on subject summary pages|75|||
164191151|NCT03654729|593067761|FG000|Overall Study|Study terminated by Sponsor|3|||
164191152|NCT03654729|593067762|FG001|Overall Study|Study terminated by Sponsor|5|||
164191153|NCT03654729|593067763|FG002|Overall Study|Study terminated by Sponsor|4|||
163854704|NCT00665561|591836489|FG000|Overall Study|Does not meet entrance criteria|19|||
163854705|NCT00665561|591836490|FG001|Overall Study|Does not meet entrance criteria|21|||
163854706|NCT00665561|591836489|FG000|Overall Study|Lost to Follow-up|203|||
163854707|NCT00665561|591836490|FG001|Overall Study|Lost to Follow-up|264|||
163854708|NCT00665561|591836489|FG000|Overall Study|Withdrawal by Subject|74|||
163854709|NCT00665561|591836490|FG001|Overall Study|Withdrawal by Subject|65|||
163854710|NCT00665561|591836489|FG000|Overall Study|Other|123|||
163854711|NCT00665561|591836490|FG001|Overall Study|Other|108|||
163854712|NCT00665561|591836489|FG000|Overall Study|Site closed|8|||
163854713|NCT00665561|591836490|FG001|Overall Study|Site closed|0|||
163854714|NCT00665561|591836489|FG000|Overall Study|Withdrawn due to pregnancy|0|||
163854715|NCT00665561|591836490|FG001|Overall Study|Withdrawn due to pregnancy|1|||
163854716|NCT04949399|591836491|FG000|Overall Study|Lost to Follow-up|11|||
163854717|NCT04949399|591836492|FG001|Overall Study|Lost to Follow-up|6|||
163854718|NCT04949399|591836491|FG000|Overall Study|Withdrawal by Subject|2|||
163854719|NCT04949399|591836492|FG001|Overall Study|Withdrawal by Subject|3|||
163854720|NCT01515319|591836493|FG000|Overall Study|Withdrawal by Subject|0|||
163854721|NCT01515319|591836494|FG001|Overall Study|Withdrawal by Subject|0|||
163854722|NCT01515319|591836495|FG002|Overall Study|Withdrawal by Subject|0|||
163854723|NCT01515319|591836496|FG003|Overall Study|Withdrawal by Subject|0|||
163854724|NCT01515319|591836497|FG004|Overall Study|Withdrawal by Subject|0|||
163854725|NCT01515319|591836498|FG005|Overall Study|Withdrawal by Subject|0|||
164191154|NCT03654729|593067761|FG000|Overall Study|Not reported|2|||
163854726|NCT01515319|591836499|FG006|Overall Study|Withdrawal by Subject|1|||
163854727|NCT01515319|591836500|FG007|Overall Study|Withdrawal by Subject|0|||
163854728|NCT01515319|591836501|FG008|Overall Study|Withdrawal by Subject|0|||
163854729|NCT01515319|591836502|FG009|Overall Study|Withdrawal by Subject|0|||
163854730|NCT01515319|591836493|FG000|Overall Study|Adverse Event|0|||
163854731|NCT01515319|591836494|FG001|Overall Study|Adverse Event|0|||
163854732|NCT01515319|591836495|FG002|Overall Study|Adverse Event|0|||
163854733|NCT01515319|591836496|FG003|Overall Study|Adverse Event|0|||
163854734|NCT01515319|591836497|FG004|Overall Study|Adverse Event|0|||
163854735|NCT01515319|591836498|FG005|Overall Study|Adverse Event|0|||
163854736|NCT01515319|591836499|FG006|Overall Study|Adverse Event|0|||
163854737|NCT01515319|591836500|FG007|Overall Study|Adverse Event|0|||
163854738|NCT01515319|591836501|FG008|Overall Study|Adverse Event|3|||
163854739|NCT01515319|591836502|FG009|Overall Study|Adverse Event|0|||
163854740|NCT01515319|591836493|FG000|Overall Study|Protocol Violation|0|||
163854741|NCT01515319|591836494|FG001|Overall Study|Protocol Violation|0|||
163854742|NCT01515319|591836495|FG002|Overall Study|Protocol Violation|0|||
163854743|NCT01515319|591836496|FG003|Overall Study|Protocol Violation|0|||
163854744|NCT01515319|591836497|FG004|Overall Study|Protocol Violation|0|||
163854745|NCT01515319|591836498|FG005|Overall Study|Protocol Violation|0|||
163854746|NCT01515319|591836499|FG006|Overall Study|Protocol Violation|0|||
163854747|NCT01515319|591836500|FG007|Overall Study|Protocol Violation|0|||
163854748|NCT01515319|591836501|FG008|Overall Study|Protocol Violation|2|||
163854749|NCT01515319|591836502|FG009|Overall Study|Protocol Violation|0|||
163854750|NCT01354106|591836503|FG000|Overall Study|Withdrawal by Subject|2|||
163854751|NCT01871285|591836504|FG000|First Intervention (1 Day)|Adverse Event|1|||
163854752|NCT01871285|591836505|FG001|First Intervention (1 Day)|Adverse Event|0|||
163854753|NCT01871285|591836506|FG002|First Intervention (1 Day)|Adverse Event|0|||
163854754|NCT01871285|591836507|FG003|First Intervention (1 Day)|Adverse Event|0|||
163854755|NCT01871285|591836504|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
163854756|NCT01871285|591836505|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
163854757|NCT01871285|591836506|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
163854758|NCT01871285|591836507|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
163854759|NCT05397470|591836508|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
163854760|NCT05397470|591836509|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
163854761|NCT05397470|591836510|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
163854762|NCT05397470|591836508|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
163854763|NCT05397470|591836509|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
163854764|NCT05397470|591836510|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
163854765|NCT05397470|591836508|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
163854766|NCT05397470|591836509|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
163854767|NCT05397470|591836510|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
163854768|NCT05397470|591836508|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
163854769|NCT05397470|591836509|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
163854770|NCT05397470|591836510|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
163854771|NCT05397470|591836508|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
163854772|NCT05397470|591836509|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
163854773|NCT05397470|591836510|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
163854774|NCT05397470|591836508|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
163854775|NCT05397470|591836509|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
163854776|NCT05397470|591836510|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
163854777|NCT05397470|591836508|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
163854778|NCT05397470|591836509|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
163854779|NCT05397470|591836510|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
163854780|NCT01919619|591836511|FG000|Overall Study|Physician Decision|1|||
163854781|NCT01919619|591836512|FG001|Overall Study|Physician Decision|1|||
163854782|NCT02738840|591838166|FG000|Overall Study|MRI Scan not Performed|5|||
163854783|NCT02738840|591838166|FG000|Overall Study|Lost to Follow-up|1|||
163964742|NCT02383589|592243289|FG001|Treatment Period|Lost to Follow-up|1|||
163964743|NCT02383589|592243288|FG000|Treatment Period|Withdrawal by Subject|0|||
163854784|NCT02738840|591838166|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
163854785|NCT02738840|591838166|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
163964744|NCT02383589|592243289|FG001|Treatment Period|Withdrawal by Subject|5|||
163964745|NCT02383589|592243288|FG000|Treatment Period|Non-compliance with study drug|0|||
163964746|NCT02383589|592243289|FG001|Treatment Period|Non-compliance with study drug|1|||
163964747|NCT02383589|592243288|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
163854786|NCT01311648|591838169|FG000|Main Study|Protocol Violation|0|||
163854787|NCT01311648|591838170|FG001|Main Study|Protocol Violation|1|||
163964748|NCT02383589|592243289|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
163854788|NCT01311648|591838169|FG000|Main Study|Adverse Event|0|||
163854789|NCT01311648|591838170|FG001|Main Study|Adverse Event|1|||
163854790|NCT01311648|591838169|FG000|Main Study|Inhibitor management|0|||
163964749|NCT02383589|592243288|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
163854791|NCT01311648|591838170|FG001|Main Study|Inhibitor management|17|||
163854792|NCT01311648|591838169|FG000|Main Study|Withdrawal by Subject|0|||
163854793|NCT01311648|591838170|FG001|Main Study|Withdrawal by Subject|2|||
163854794|NCT01311648|591838169|FG000|Extension Study|Physician Decision|0|||
163854795|NCT01311648|591838170|FG001|Extension Study|Physician Decision|1|||
163854796|NCT01311648|591838169|FG000|Extension Study|ITI therapy with marketed product|0|||
163854797|NCT01311648|591838170|FG001|Extension Study|ITI therapy with marketed product|1|||
163854798|NCT01311648|591838169|FG000|Extension Study|Incorrect visit planning|0|||
163854799|NCT01311648|591838170|FG001|Extension Study|Incorrect visit planning|1|||
163854800|NCT01311648|591838169|FG000|Extension Study|Family's decision|0|||
163854801|NCT01311648|591838170|FG001|Extension Study|Family's decision|1|||
163854802|NCT01311648|591838169|FG000|Extension Study|Failure of ITI therapy|0|||
163854803|NCT01311648|591838170|FG001|Extension Study|Failure of ITI therapy|3|||
163854804|NCT01311648|591838169|FG000|Extension Study|Long travel|0|||
163854805|NCT01311648|591838170|FG001|Extension Study|Long travel|1|||
163854806|NCT01311648|591838169|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
163854807|NCT01311648|591838170|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
163854808|NCT01311648|591838169|FG000|Extension Study|Withdrawal by Subject|0|||
163854809|NCT01311648|591838170|FG001|Extension Study|Withdrawal by Subject|1|||
163854810|NCT01311648|591838169|FG000|Extension Study|Inhibitor management|0|||
163854811|NCT01311648|591838170|FG001|Extension Study|Inhibitor management|2|||
163854812|NCT02268396|591838171|FG000|Overall Study|Adverse Event|3|||
163854813|NCT02268396|591838171|FG000|Overall Study|Administrative|2|||
163854814|NCT02268396|591838171|FG000|Overall Study|Withdrawal by Subject|1|||
163854815|NCT02268396|591838171|FG000|Overall Study|Lost to Follow-up|2|||
163854816|NCT02268396|591838171|FG000|Overall Study|Protocol-Specified Criteria|2|||
163854817|NCT02268396|591838171|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
163854818|NCT01645111|591838172|FG000|Overall Study|Did not require Clevidipine|15|||
164191155|NCT03654729|593067762|FG001|Overall Study|Not reported|4|||
164191156|NCT03654729|593067763|FG002|Overall Study|Not reported|5|||
164191157|NCT03654729|593067761|FG000|Overall Study|Progressive disease|3|||
164191158|NCT03654729|593067762|FG001|Overall Study|Progressive disease|0|||
164191159|NCT03654729|593067763|FG002|Overall Study|Progressive disease|0|||
164191160|NCT03654729|593067761|FG000|Overall Study|Lost to Follow-up|2|||
164191161|NCT03654729|593067762|FG001|Overall Study|Lost to Follow-up|0|||
164191162|NCT03654729|593067763|FG002|Overall Study|Lost to Follow-up|0|||
164191163|NCT03654729|593067761|FG000|Overall Study|Physician Decision|2|||
164191164|NCT03654729|593067762|FG001|Overall Study|Physician Decision|0|||
164191165|NCT03654729|593067763|FG002|Overall Study|Physician Decision|0|||
163854819|NCT01304706|591838178|FG000|Overall Study|Adverse Event|2|||
163854820|NCT01304706|591838178|FG000|Overall Study|Lack of Efficacy|1|||
163854821|NCT01304706|591838178|FG000|Overall Study|Death|3|||
163854822|NCT01304706|591838178|FG000|Overall Study|Withdrawal by Subject|3|||
163854823|NCT01304706|591838178|FG000|Overall Study|Lost to Follow-up|7|||
163854824|NCT01304706|591838178|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
163854825|NCT05526911|591838181|FG000|Overall Study|Adverse Event|2|||
163854826|NCT05025449|591838182|FG000|Overall Study|Withdrawal by Subject|1|||
163854827|NCT05025449|591838182|FG000|Overall Study|Patient emergently taken to operating room|1|||
163854828|NCT01982760|591838188|FG000|Overall Study|Physician Decision|1|||
163854829|NCT01982760|591838189|FG001|Overall Study|Physician Decision|0|||
163854830|NCT00530777|591838190|FG000|Overall Study|Lost to Follow-up|0|||
163854831|NCT00530777|591838191|FG001|Overall Study|Lost to Follow-up|1|||
163854832|NCT00530777|591838190|FG000|Overall Study|Death|1|||
163854833|NCT00530777|591838191|FG001|Overall Study|Death|2|||
163854834|NCT00530777|591838190|FG000|Overall Study|Physician Decision|1|||
163854835|NCT00530777|591838191|FG001|Overall Study|Physician Decision|0|||
163854836|NCT00530777|591838190|FG000|Overall Study|Withdrawal by Subject|0|||
163854837|NCT00530777|591838191|FG001|Overall Study|Withdrawal by Subject|1|||
163854838|NCT00530777|591838190|FG000|Overall Study|Unable to adhere to visit schedule|5|||
163854839|NCT00530777|591838191|FG001|Overall Study|Unable to adhere to visit schedule|1|||
163854840|NCT01763047|591838193|FG000|Period 1|Test Article Not Available|4|||
164191166|NCT03654729|593067761|FG000|Overall Study|Protocol Violation|1|||
164191167|NCT03654729|593067762|FG001|Overall Study|Protocol Violation|1|||
164191168|NCT03654729|593067763|FG002|Overall Study|Protocol Violation|0|||
163854841|NCT01763047|591838194|FG001|Period 1|Test Article Not Available|1|||
163854842|NCT01763047|591838193|FG000|Period 1|Protocol Violation|4|||
163854843|NCT01763047|591838194|FG001|Period 1|Protocol Violation|4|||
163854844|NCT01763047|591838193|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
163854845|NCT01763047|591838194|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
163854846|NCT01763047|591838193|FG000|Period 1|Adverse Event|0|||
163854847|NCT01763047|591838194|FG001|Period 1|Adverse Event|1|||
163854848|NCT01763047|591838193|FG000|Period 1|Unsatisfactory Visual Response|0|||
163854849|NCT01763047|591838194|FG001|Period 1|Unsatisfactory Visual Response|3|||
163854850|NCT01763047|591838193|FG000|Period 1|Lens Power Not Available|0|||
164191169|NCT03654729|593067761|FG000|Overall Study|Non-compliance with study drug|0|||
164191170|NCT03654729|593067762|FG001|Overall Study|Non-compliance with study drug|1|||
164191171|NCT03654729|593067763|FG002|Overall Study|Non-compliance with study drug|0|||
163854851|NCT01763047|591838194|FG001|Period 1|Lens Power Not Available|1|||
163854852|NCT01763047|591838193|FG000|Period 1|Study Site office Closed|0|||
163854853|NCT01763047|591838194|FG001|Period 1|Study Site office Closed|1|||
163854854|NCT01763047|591838193|FG000|Period 2|Lens Discomfort|1|||
163854855|NCT01763047|591838194|FG001|Period 2|Lens Discomfort|0|||
163854856|NCT01763047|591838193|FG000|Period 2|No longer meets Eligibility Criteria|1|||
163854857|NCT01763047|591838194|FG001|Period 2|No longer meets Eligibility Criteria|0|||
163854858|NCT01763047|591838193|FG000|Period 2|Study Site office Closed|1|||
163854859|NCT01763047|591838194|FG001|Period 2|Study Site office Closed|1|||
163854860|NCT01763047|591838193|FG000|Period 2|Unsatisfactory Visual Response|1|||
163854861|NCT01763047|591838194|FG001|Period 2|Unsatisfactory Visual Response|1|||
163854862|NCT01763047|591838193|FG000|Period 2|Protocol Violation|0|||
163854863|NCT01763047|591838194|FG001|Period 2|Protocol Violation|2|||
163854864|NCT01763047|591838193|FG000|Period 2|Unsatisfactory lens Fitting|0|||
163854865|NCT01763047|591838194|FG001|Period 2|Unsatisfactory lens Fitting|1|||
163854866|NCT01941316|591838200|FG000|Overall Study|Adverse Event|0|||
163854867|NCT01941316|591838201|FG001|Overall Study|Adverse Event|1|||
163854868|NCT01941316|591838202|FG002|Overall Study|Adverse Event|0|||
163854869|NCT01941316|591838203|FG003|Overall Study|Adverse Event|7|||
163854870|NCT01941316|591838200|FG000|Overall Study|Progressive Disease|3|||
163854871|NCT01941316|591838201|FG001|Overall Study|Progressive Disease|6|||
163854872|NCT01941316|591838202|FG002|Overall Study|Progressive Disease|2|||
163854873|NCT01941316|591838203|FG003|Overall Study|Progressive Disease|29|||
163854874|NCT01941316|591838200|FG000|Overall Study|Withdrawal by Subject|0|||
163854875|NCT01941316|591838201|FG001|Overall Study|Withdrawal by Subject|2|||
163854876|NCT01941316|591838202|FG002|Overall Study|Withdrawal by Subject|1|||
163854877|NCT01941316|591838203|FG003|Overall Study|Withdrawal by Subject|8|||
163854878|NCT01941316|591838200|FG000|Overall Study|Death|0|||
163854879|NCT01941316|591838201|FG001|Overall Study|Death|0|||
163854880|NCT01941316|591838202|FG002|Overall Study|Death|0|||
163854881|NCT01941316|591838203|FG003|Overall Study|Death|3|||
163854882|NCT01941316|591838200|FG000|Overall Study|Physician Decision|0|||
163854883|NCT01941316|591838201|FG001|Overall Study|Physician Decision|0|||
163854884|NCT01941316|591838202|FG002|Overall Study|Physician Decision|0|||
163854885|NCT01941316|591838203|FG003|Overall Study|Physician Decision|3|||
163854886|NCT01941316|591838200|FG000|Overall Study|Protocol Violation|0|||
163854887|NCT01941316|591838201|FG001|Overall Study|Protocol Violation|0|||
163854888|NCT01941316|591838202|FG002|Overall Study|Protocol Violation|0|||
163854889|NCT01941316|591838203|FG003|Overall Study|Protocol Violation|3|||
163854890|NCT01941316|591838200|FG000|Overall Study|Intercurrent illness|0|||
163854891|NCT01941316|591838201|FG001|Overall Study|Intercurrent illness|0|||
163854892|NCT01941316|591838202|FG002|Overall Study|Intercurrent illness|0|||
163854893|NCT01941316|591838203|FG003|Overall Study|Intercurrent illness|1|||
163854894|NCT01941316|591838200|FG000|Overall Study|Other, not specified|0|||
163854895|NCT01941316|591838201|FG001|Overall Study|Other, not specified|0|||
163854896|NCT01941316|591838202|FG002|Overall Study|Other, not specified|0|||
163854897|NCT01941316|591838203|FG003|Overall Study|Other, not specified|1|||
163854898|NCT02775435|591838204|FG000|Overall Study|Adverse Event|32|||
163854899|NCT02775435|591838205|FG001|Overall Study|Adverse Event|27|||
163854900|NCT02775435|591838204|FG000|Overall Study|Lost to Follow-up|2|||
163854901|NCT02775435|591838205|FG001|Overall Study|Lost to Follow-up|2|||
163854902|NCT02775435|591838204|FG000|Overall Study|Sponsor decision|44|||
163854903|NCT02775435|591838205|FG001|Overall Study|Sponsor decision|19|||
163854904|NCT02775435|591838204|FG000|Overall Study|Withdrawal by Subject|4|||
163854905|NCT02775435|591838205|FG001|Overall Study|Withdrawal by Subject|9|||
163854906|NCT02775435|591838204|FG000|Overall Study|Death|196|||
163854907|NCT02775435|591838205|FG001|Overall Study|Death|224|||
163854908|NCT00320489|591838206|FG000|Overall Study|Adverse Event|26|||
163854909|NCT00320489|591838207|FG001|Overall Study|Adverse Event|25|||
163854910|NCT00320489|591838206|FG000|Overall Study|Clinical Relapse|26|||
163854911|NCT00320489|591838207|FG001|Overall Study|Clinical Relapse|20|||
163854912|NCT00320489|591838206|FG000|Overall Study|Death|0|||
163854913|NCT00320489|591838207|FG001|Overall Study|Death|2|||
163854914|NCT00320489|591838206|FG000|Overall Study|Entry Criteria Exclusion|2|||
163854915|NCT00320489|591838207|FG001|Overall Study|Entry Criteria Exclusion|4|||
163854916|NCT00320489|591838206|FG000|Overall Study|Lack of Efficacy|16|||
163854917|NCT00320489|591838207|FG001|Overall Study|Lack of Efficacy|7|||
163854918|NCT00320489|591838206|FG000|Overall Study|Lost to Follow-up|21|||
163854919|NCT00320489|591838207|FG001|Overall Study|Lost to Follow-up|22|||
163854920|NCT00320489|591838206|FG000|Overall Study|Physician Decision|8|||
163854921|NCT00320489|591838207|FG001|Overall Study|Physician Decision|8|||
163854922|NCT00320489|591838206|FG000|Overall Study|Protocol Violation|4|||
163854923|NCT00320489|591838207|FG001|Overall Study|Protocol Violation|4|||
163854924|NCT00320489|591838206|FG000|Overall Study|Sponsor Decision|3|||
163854925|NCT00320489|591838207|FG001|Overall Study|Sponsor Decision|3|||
163854926|NCT00320489|591838206|FG000|Overall Study|Withdrawal by Subject|39|||
163964750|NCT02383589|592243289|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
164133493|NCT05424042|592857147|FG001|Overall Study|Lost to Follow-up|0|||
163854927|NCT00320489|591838207|FG001|Overall Study|Withdrawal by Subject|41|||
163854928|NCT02282527|591838208|FG000|Overall Study|Lost to Follow-up|0|||
163854929|NCT02282527|591838209|FG001|Overall Study|Lost to Follow-up|1|||
163854930|NCT02282527|591838208|FG000|Overall Study|Lack of home health aid|1|||
163854931|NCT02282527|591838209|FG001|Overall Study|Lack of home health aid|0|||
163854932|NCT00941031|591838210|FG000|Induction Period|Lack of Efficacy|2|||
163854933|NCT00941031|591838211|FG001|Induction Period|Lack of Efficacy|1|||
163854934|NCT00941031|591838212|FG002|Induction Period|Lack of Efficacy|0|||
163854935|NCT00941031|591838213|FG003|Induction Period|Lack of Efficacy|5|||
163854936|NCT00941031|591838214|FG004|Induction Period|Lack of Efficacy|0|||
163854937|NCT00941031|591838215|FG005|Induction Period|Lack of Efficacy|0|||
163854938|NCT00941031|591838216|FG006|Induction Period|Lack of Efficacy|0|||
163854939|NCT00941031|591838210|FG000|Induction Period|Withdrawal by Subject|1|||
163854940|NCT00941031|591838211|FG001|Induction Period|Withdrawal by Subject|2|||
163854941|NCT00941031|591838212|FG002|Induction Period|Withdrawal by Subject|2|||
163854942|NCT00941031|591838213|FG003|Induction Period|Withdrawal by Subject|2|||
163854943|NCT00941031|591838214|FG004|Induction Period|Withdrawal by Subject|0|||
163854944|NCT00941031|591838215|FG005|Induction Period|Withdrawal by Subject|0|||
163854945|NCT00941031|591838216|FG006|Induction Period|Withdrawal by Subject|0|||
163854946|NCT00941031|591838210|FG000|Induction Period|Adminstative Problems|1|||
163854947|NCT00941031|591838211|FG001|Induction Period|Adminstative Problems|1|||
163854948|NCT00941031|591838212|FG002|Induction Period|Adminstative Problems|1|||
163854949|NCT00941031|591838213|FG003|Induction Period|Adminstative Problems|0|||
163854950|NCT00941031|591838214|FG004|Induction Period|Adminstative Problems|0|||
163854951|NCT00941031|591838215|FG005|Induction Period|Adminstative Problems|0|||
163854952|NCT00941031|591838216|FG006|Induction Period|Adminstative Problems|0|||
163854953|NCT00941031|591838210|FG000|Induction Period|Adverse Event|1|||
163854954|NCT00941031|591838211|FG001|Induction Period|Adverse Event|0|||
163854955|NCT00941031|591838212|FG002|Induction Period|Adverse Event|3|||
163854956|NCT00941031|591838213|FG003|Induction Period|Adverse Event|2|||
163854957|NCT00941031|591838214|FG004|Induction Period|Adverse Event|0|||
163854958|NCT00941031|591838215|FG005|Induction Period|Adverse Event|0|||
163854959|NCT00941031|591838216|FG006|Induction Period|Adverse Event|0|||
163854960|NCT00941031|591838210|FG000|Maintenance Period|Withdrawal by Subject|0|||
163854961|NCT00941031|591838211|FG001|Maintenance Period|Withdrawal by Subject|0|||
163854962|NCT00941031|591838212|FG002|Maintenance Period|Withdrawal by Subject|0|||
163854963|NCT00941031|591838213|FG003|Maintenance Period|Withdrawal by Subject|0|||
163854964|NCT00941031|591838214|FG004|Maintenance Period|Withdrawal by Subject|6|||
163854965|NCT00941031|591838215|FG005|Maintenance Period|Withdrawal by Subject|2|||
163854966|NCT00941031|591838216|FG006|Maintenance Period|Withdrawal by Subject|13|||
163854967|NCT00941031|591838210|FG000|Maintenance Period|Administrative Problems|0|||
163854968|NCT00941031|591838211|FG001|Maintenance Period|Administrative Problems|0|||
163854969|NCT00941031|591838212|FG002|Maintenance Period|Administrative Problems|0|||
163854970|NCT00941031|591838213|FG003|Maintenance Period|Administrative Problems|0|||
163854971|NCT00941031|591838214|FG004|Maintenance Period|Administrative Problems|1|||
163854972|NCT00941031|591838215|FG005|Maintenance Period|Administrative Problems|0|||
163854973|NCT00941031|591838216|FG006|Maintenance Period|Administrative Problems|1|||
163854974|NCT00941031|591838210|FG000|Maintenance Period|Protocol Violation|0|||
163854975|NCT00941031|591838211|FG001|Maintenance Period|Protocol Violation|0|||
163854976|NCT00941031|591838212|FG002|Maintenance Period|Protocol Violation|0|||
163854977|NCT00941031|591838213|FG003|Maintenance Period|Protocol Violation|0|||
163854978|NCT00941031|591838214|FG004|Maintenance Period|Protocol Violation|0|||
163854979|NCT00941031|591838215|FG005|Maintenance Period|Protocol Violation|0|||
163854980|NCT00941031|591838216|FG006|Maintenance Period|Protocol Violation|1|||
163964751|NCT02383589|592243288|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
163964752|NCT02383589|592243289|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
163964753|NCT04600336|592243290|FG000|Initial Treatment|Withdrawal by Subject|1|||
164191172|NCT03654729|593067761|FG000|Overall Study|Site terminated by Sponsor|1|||
163964754|NCT04600336|592243291|FG001|Initial Treatment|Withdrawal by Subject|2|||
163964755|NCT04600336|592243292|FG002|Initial Treatment|Withdrawal by Subject|0|||
163964756|NCT04600336|592243293|FG003|Initial Treatment|Withdrawal by Subject|0|||
163964757|NCT04600336|592243290|FG000|Initial Treatment|Adverse Event|0|||
163964758|NCT04600336|592243291|FG001|Initial Treatment|Adverse Event|2|||
163964759|NCT04600336|592243292|FG002|Initial Treatment|Adverse Event|0|||
163964760|NCT04600336|592243293|FG003|Initial Treatment|Adverse Event|0|||
163964761|NCT04600336|592243290|FG000|Initial Treatment|Other complicating disease|0|||
163964762|NCT04600336|592243291|FG001|Initial Treatment|Other complicating disease|0|||
163964763|NCT04600336|592243292|FG002|Initial Treatment|Other complicating disease|1|||
163964764|NCT04600336|592243293|FG003|Initial Treatment|Other complicating disease|0|||
163964765|NCT04600336|592243290|FG000|Crossover Treatment|Withdrawal by Subject|0|||
163964766|NCT04600336|592243291|FG001|Crossover Treatment|Withdrawal by Subject|0|||
163964767|NCT04600336|592243292|FG002|Crossover Treatment|Withdrawal by Subject|2|||
163964768|NCT04600336|592243293|FG003|Crossover Treatment|Withdrawal by Subject|1|||
164191173|NCT03654729|593067762|FG001|Overall Study|Site terminated by Sponsor|0|||
164191174|NCT03654729|593067763|FG002|Overall Study|Site terminated by Sponsor|0|||
163854981|NCT00941031|591838210|FG000|Maintenance Period|Adverse Event|0|||
163854982|NCT00941031|591838211|FG001|Maintenance Period|Adverse Event|0|||
164302197|NCT01134055|593482561|FG005|Overall Study|Adverse Event|7|||
164191175|NCT00588146|593067764|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
164191176|NCT00588146|593067765|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
164191177|NCT02100839|593067766|FG000|Multiple Ascending Dose|Adverse Event|2|||
164191178|NCT02100839|593067767|FG001|Multiple Ascending Dose|Adverse Event|0|||
164191179|NCT02100839|593067766|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
164191180|NCT02100839|593067767|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
164191181|NCT03272347|593067769|FG000|Overall Study|Death|0|||
164191182|NCT03272347|593067770|FG001|Overall Study|Death|0|||
164191183|NCT03272347|593067771|FG002|Overall Study|Death|0|||
164191184|NCT03272347|593067772|FG003|Overall Study|Death|1|||
164191185|NCT03272347|593067769|FG000|Overall Study|Lost to Follow-up|1|||
164191186|NCT03272347|593067770|FG001|Overall Study|Lost to Follow-up|3|||
164191187|NCT03272347|593067771|FG002|Overall Study|Lost to Follow-up|5|||
164191188|NCT03272347|593067772|FG003|Overall Study|Lost to Follow-up|1|||
164191189|NCT03272347|593067769|FG000|Overall Study|Physician Decision|4|||
164191190|NCT03272347|593067770|FG001|Overall Study|Physician Decision|2|||
164191191|NCT03272347|593067771|FG002|Overall Study|Physician Decision|5|||
164191192|NCT03272347|593067772|FG003|Overall Study|Physician Decision|4|||
164191193|NCT03272347|593067769|FG000|Overall Study|Screen Failure|1|||
164191194|NCT03272347|593067770|FG001|Overall Study|Screen Failure|0|||
164191195|NCT03272347|593067771|FG002|Overall Study|Screen Failure|0|||
164191196|NCT03272347|593067772|FG003|Overall Study|Screen Failure|0|||
164191197|NCT03272347|593067769|FG000|Overall Study|Withdrawal by Subject|5|||
164191198|NCT03272347|593067770|FG001|Overall Study|Withdrawal by Subject|1|||
164191199|NCT03272347|593067771|FG002|Overall Study|Withdrawal by Subject|2|||
164191200|NCT03272347|593067772|FG003|Overall Study|Withdrawal by Subject|1|||
164191201|NCT01971567|593067773|FG000|Overall Study|Withdrawal by Subject|3|||
164191202|NCT01971567|593067774|FG001|Overall Study|Withdrawal by Subject|2|||
164191203|NCT01971567|593067773|FG000|Overall Study|Lost to Follow-up|1|||
164191204|NCT01971567|593067774|FG001|Overall Study|Lost to Follow-up|0|||
164191205|NCT00391872|593067775|FG000|Overall Study|Protocol Violation|7|||
164191206|NCT00391872|593067776|FG001|Overall Study|Protocol Violation|2|||
164191207|NCT00391872|593067775|FG000|Overall Study|Withdrawal by Subject|296|||
164191208|NCT00391872|593067776|FG001|Overall Study|Withdrawal by Subject|249|||
164191209|NCT00391872|593067775|FG000|Overall Study|Reason unknown|2|||
164191210|NCT00391872|593067776|FG001|Overall Study|Reason unknown|4|||
164191211|NCT00391872|593067775|FG000|Overall Study|Lost to Follow-up|2|||
164191212|NCT00391872|593067776|FG001|Overall Study|Lost to Follow-up|0|||
164191213|NCT04826484|593067777|FG000|Overall Study|Lost to Follow-up|2|||
164191214|NCT04826484|593067778|FG001|Overall Study|Lost to Follow-up|0|||
164191215|NCT02581488|593067779|FG000|Overall Study|Adverse Event|6|||
164191216|NCT02581488|593067780|FG001|Overall Study|Adverse Event|7|||
164191217|NCT02581488|593067779|FG000|Overall Study|Lost to Follow-up|1|||
164191218|NCT02581488|593067780|FG001|Overall Study|Lost to Follow-up|0|||
164191219|NCT02581488|593067779|FG000|Overall Study|Withdrawal by Subject|1|||
164191220|NCT02581488|593067780|FG001|Overall Study|Withdrawal by Subject|0|||
164191221|NCT02581488|593067779|FG000|Overall Study|Non-Compliance|1|||
164191222|NCT02581488|593067780|FG001|Overall Study|Non-Compliance|0|||
164191223|NCT02581488|593067779|FG000|Overall Study|Protocol Violation|0|||
164191224|NCT02581488|593067780|FG001|Overall Study|Protocol Violation|4|||
164191225|NCT03373760|593067795|FG000|Overall Study|Adverse Event|8|||
164191226|NCT03373760|593067795|FG000|Overall Study|Disease Progression|46|||
164191227|NCT03373760|593067795|FG000|Overall Study|Death|4|||
164191228|NCT00003537|593067798|FG000|Overall Study|Not evalauable|1|||
164191229|NCT01001520|593067799|FG000|Medication Period 1|Withdrawal by Subject|2|||
164191230|NCT01001520|593067800|FG001|Medication Period 1|Withdrawal by Subject|2|||
164191231|NCT01001520|593067799|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
164191232|NCT01001520|593067800|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
164191233|NCT01001520|593067799|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
164191234|NCT01001520|593067800|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
164191235|NCT01001520|593067799|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
164191236|NCT01001520|593067800|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
164191237|NCT01001520|593067799|FG000|Washout Period|Withdrawal by Subject|2|||
164191238|NCT01001520|593067800|FG001|Washout Period|Withdrawal by Subject|1|||
164191239|NCT01001520|593067799|FG000|Medication Period 2|Withdrawal by Subject|0|||
164191240|NCT01001520|593067800|FG001|Medication Period 2|Withdrawal by Subject|3|||
164191241|NCT01896193|593067809|FG000|Overall Study|Lack of Efficacy|20|||
164191242|NCT01896193|593067810|FG001|Overall Study|Lack of Efficacy|11|||
164191243|NCT01896193|593067809|FG000|Overall Study|Protocol Violation|0|||
164191244|NCT01896193|593067810|FG001|Overall Study|Protocol Violation|1|||
164191245|NCT01896193|593067809|FG000|Overall Study|Withdrew Consent|1|||
164191246|NCT01896193|593067810|FG001|Overall Study|Withdrew Consent|0|||
164191247|NCT01300247|593067811|FG000|Overall Study|Death|1|||
164191248|NCT01300247|593067812|FG001|Overall Study|Death|1|||
164191249|NCT01300247|593067811|FG000|Overall Study|Lost to Follow-up|2|||
164191250|NCT01300247|593067812|FG001|Overall Study|Lost to Follow-up|0|||
164191251|NCT01300247|593067811|FG000|Overall Study|Withdrawal by Subject|1|||
164191252|NCT01300247|593067812|FG001|Overall Study|Withdrawal by Subject|0|||
164191253|NCT01300247|593067811|FG000|Overall Study|Non-Compliance|0|||
164191254|NCT01300247|593067812|FG001|Overall Study|Non-Compliance|1|||
164191255|NCT03743025|593067814|FG000|Overall Study|Surgery was cancelled|2|||
164191256|NCT03743025|593067815|FG001|Overall Study|Surgery was cancelled|1|||
164191257|NCT04501952|593067816|FG000|Overall Study|Adverse Event|0|||
164191258|NCT04501952|593067817|FG001|Overall Study|Adverse Event|3|||
164191259|NCT04501952|593067816|FG000|Overall Study|Investigator's Discretion|0|||
164191260|NCT04501952|593067817|FG001|Overall Study|Investigator's Discretion|1|||
164191261|NCT04501952|593067816|FG000|Overall Study|Protocol Violation|1|||
164191262|NCT04501952|593067817|FG001|Overall Study|Protocol Violation|1|||
164191263|NCT04501952|593067816|FG000|Overall Study|Withdrew Consent|5|||
164191264|NCT04501952|593067817|FG001|Overall Study|Withdrew Consent|4|||
164191265|NCT04501952|593067816|FG000|Overall Study|Lost to Follow-up|7|||
163854983|NCT00941031|591838212|FG002|Maintenance Period|Adverse Event|0|||
163854984|NCT00941031|591838213|FG003|Maintenance Period|Adverse Event|0|||
163854985|NCT00941031|591838214|FG004|Maintenance Period|Adverse Event|0|||
163854986|NCT00941031|591838215|FG005|Maintenance Period|Adverse Event|2|||
163854987|NCT00941031|591838216|FG006|Maintenance Period|Adverse Event|8|||
163854988|NCT00941031|591838210|FG000|Maintenance Period|Lost to Follow-up|0|||
163854989|NCT00941031|591838211|FG001|Maintenance Period|Lost to Follow-up|0|||
163854990|NCT00941031|591838212|FG002|Maintenance Period|Lost to Follow-up|0|||
163854991|NCT00941031|591838213|FG003|Maintenance Period|Lost to Follow-up|0|||
163854992|NCT00941031|591838214|FG004|Maintenance Period|Lost to Follow-up|2|||
163854993|NCT00941031|591838215|FG005|Maintenance Period|Lost to Follow-up|2|||
163854994|NCT00941031|591838216|FG006|Maintenance Period|Lost to Follow-up|7|||
163854995|NCT00941031|591838210|FG000|Maintenance Period|Lack of Efficacy|0|||
163854996|NCT00941031|591838211|FG001|Maintenance Period|Lack of Efficacy|0|||
163854997|NCT00941031|591838212|FG002|Maintenance Period|Lack of Efficacy|0|||
163854998|NCT00941031|591838213|FG003|Maintenance Period|Lack of Efficacy|0|||
163854999|NCT00941031|591838214|FG004|Maintenance Period|Lack of Efficacy|0|||
163855000|NCT00941031|591838215|FG005|Maintenance Period|Lack of Efficacy|0|||
163855001|NCT00941031|591838216|FG006|Maintenance Period|Lack of Efficacy|13|||
163855002|NCT01872611|591838217|FG000|Overall Study|Adverse Event|3|||
163855003|NCT01872611|591838218|FG001|Overall Study|Adverse Event|1|||
163855004|NCT01872611|591838217|FG000|Overall Study|Adverse Event, prior to treatment|0|||
163855005|NCT01872611|591838218|FG001|Overall Study|Adverse Event, prior to treatment|1|||
163855006|NCT01872611|591838217|FG000|Overall Study|Death|0|||
163855007|NCT01872611|591838218|FG001|Overall Study|Death|1|||
163855008|NCT01872611|591838217|FG000|Overall Study|Death, prior to treatment|0|||
163855009|NCT01872611|591838218|FG001|Overall Study|Death, prior to treatment|1|||
163855010|NCT01872611|591838217|FG000|Overall Study|Lost to Follow-up|8|||
163855011|NCT01872611|591838218|FG001|Overall Study|Lost to Follow-up|1|||
163855012|NCT01872611|591838217|FG000|Overall Study|Physician Decision|1|||
163855013|NCT01872611|591838218|FG001|Overall Study|Physician Decision|0|||
163855014|NCT01872611|591838217|FG000|Overall Study|Withdrawal by Subject|6|||
163855015|NCT01872611|591838218|FG001|Overall Study|Withdrawal by Subject|1|||
163855016|NCT01872611|591838217|FG000|Overall Study|Reason not provided|6|||
163855017|NCT01872611|591838218|FG001|Overall Study|Reason not provided|6|||
163855018|NCT04555044|591838219|FG000|Overall Study|Adverse Event|0|||
163855019|NCT04555044|591838220|FG001|Overall Study|Adverse Event|1|||
163855020|NCT04088188|591838222|FG000|Overall Study|Withdrawal by Subject|2|||
163855021|NCT04088188|591838223|FG001|Overall Study|Withdrawal by Subject|0|||
163855022|NCT04088188|591838222|FG000|Overall Study|Adverse Event|2|||
163855023|NCT04088188|591838223|FG001|Overall Study|Adverse Event|0|||
163855024|NCT03686384|591838224|FG000|Overall Study|Lack of Efficacy|4|||
163855025|NCT03686384|591838225|FG001|Overall Study|Lack of Efficacy|13|||
163855026|NCT03686384|591838224|FG000|Overall Study|Lost to Follow-up|3|||
163855027|NCT03686384|591838225|FG001|Overall Study|Lost to Follow-up|0|||
163855028|NCT03686384|591838224|FG000|Overall Study|Physician Decision|0|||
163855029|NCT03686384|591838225|FG001|Overall Study|Physician Decision|1|||
163855030|NCT03686384|591838224|FG000|Overall Study|Took prohibited medication|0|||
163855031|NCT03686384|591838225|FG001|Overall Study|Took prohibited medication|1|||
163855032|NCT01767909|591838226|FG000|Overall Study|Withdrawal by Subject|4|||
163855033|NCT01767909|591838227|FG001|Overall Study|Withdrawal by Subject|7|||
163855034|NCT01767909|591838226|FG000|Overall Study|Adverse Event|3|||
164191266|NCT04501952|593067817|FG001|Overall Study|Lost to Follow-up|2|||
164191267|NCT04501952|593067816|FG000|Overall Study|Randomized and Never Treated|13|||
163855035|NCT01767909|591838227|FG001|Overall Study|Adverse Event|1|||
163855036|NCT01767909|591838226|FG000|Overall Study|Withdrawal by Study Partner|3|||
163855037|NCT01767909|591838227|FG001|Overall Study|Withdrawal by Study Partner|1|||
163855038|NCT01767909|591838226|FG000|Overall Study|Non-Compliance|2|||
164191268|NCT04501952|593067817|FG001|Overall Study|Randomized and Never Treated|9|||
163855039|NCT01767909|591838227|FG001|Overall Study|Non-Compliance|0|||
163855040|NCT01767909|591838226|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163855041|NCT01767909|591838227|FG001|Overall Study|Perceived Lack of Efficacy|0|||
164191269|NCT03382418|593067824|FG000|Overall Study|Withdrawal by Subject|1|||
163855042|NCT01767909|591838226|FG000|Overall Study|Investigator Recommendation|0|||
164191270|NCT03382418|593067825|FG001|Overall Study|Withdrawal by Subject|0|||
163964769|NCT04600336|592243290|FG000|Crossover Treatment|Adverse Event|0|||
163964770|NCT04600336|592243291|FG001|Crossover Treatment|Adverse Event|0|||
163964771|NCT04600336|592243292|FG002|Crossover Treatment|Adverse Event|1|||
163855043|NCT01767909|591838227|FG001|Overall Study|Investigator Recommendation|1|||
163855044|NCT01767909|591838226|FG000|Overall Study|Lost to Follow-up|0|||
163855045|NCT01767909|591838227|FG001|Overall Study|Lost to Follow-up|1|||
163855046|NCT01767909|591838226|FG000|Overall Study|LP uncessessful|0|||
163855047|NCT01767909|591838227|FG001|Overall Study|LP uncessessful|1|||
163855048|NCT01740557|591838230|FG000|Overall Study|Ineligible|1|||
163855049|NCT01740557|591838230|FG000|Overall Study|Screen failure|1|||
163855050|NCT02320253|591838231|FG000|Overall Study|Withdrawal by Subject|3|||
163855051|NCT02320253|591838232|FG001|Overall Study|Withdrawal by Subject|0|||
163855052|NCT02320253|591838233|FG002|Overall Study|Withdrawal by Subject|0|||
163855053|NCT02320253|591838231|FG000|Overall Study|Lost to Follow-up|2|||
163855054|NCT02320253|591838232|FG001|Overall Study|Lost to Follow-up|2|||
163855055|NCT02320253|591838233|FG002|Overall Study|Lost to Follow-up|1|||
163855056|NCT02320253|591838231|FG000|Overall Study|Death|1|||
163855057|NCT02320253|591838232|FG001|Overall Study|Death|0|||
163855058|NCT02320253|591838233|FG002|Overall Study|Death|1|||
163855059|NCT00783692|591838238|FG000|Induction Phase|Adverse Event|7|||
163855060|NCT00783692|591838239|FG001|Induction Phase|Adverse Event|9|||
163855061|NCT00783692|591838240|FG002|Induction Phase|Adverse Event|24|||
163855062|NCT00783692|591838241|FG003|Induction Phase|Adverse Event|0|||
163855063|NCT00783692|591838242|FG004|Induction Phase|Adverse Event|0|||
163855064|NCT00783692|591838243|FG005|Induction Phase|Adverse Event|0|||
163855065|NCT00783692|591838244|FG006|Induction Phase|Adverse Event|0|||
163855066|NCT00783692|591838238|FG000|Induction Phase|Protocol Violation|0|||
163855067|NCT00783692|591838239|FG001|Induction Phase|Protocol Violation|0|||
163855068|NCT00783692|591838240|FG002|Induction Phase|Protocol Violation|1|||
163855069|NCT00783692|591838241|FG003|Induction Phase|Protocol Violation|0|||
163855070|NCT00783692|591838242|FG004|Induction Phase|Protocol Violation|0|||
163855071|NCT00783692|591838243|FG005|Induction Phase|Protocol Violation|0|||
163855072|NCT00783692|591838244|FG006|Induction Phase|Protocol Violation|0|||
163855073|NCT00783692|591838238|FG000|Induction Phase|Lack of Efficacy|1|||
163855074|NCT00783692|591838239|FG001|Induction Phase|Lack of Efficacy|3|||
163855075|NCT00783692|591838240|FG002|Induction Phase|Lack of Efficacy|28|||
163855076|NCT00783692|591838241|FG003|Induction Phase|Lack of Efficacy|0|||
163855077|NCT00783692|591838242|FG004|Induction Phase|Lack of Efficacy|0|||
163855078|NCT00783692|591838243|FG005|Induction Phase|Lack of Efficacy|0|||
163855079|NCT00783692|591838244|FG006|Induction Phase|Lack of Efficacy|0|||
163855080|NCT00783692|591838238|FG000|Induction Phase|Withdrawal by Subject|3|||
163855081|NCT00783692|591838239|FG001|Induction Phase|Withdrawal by Subject|9|||
163855082|NCT00783692|591838240|FG002|Induction Phase|Withdrawal by Subject|16|||
163855083|NCT00783692|591838241|FG003|Induction Phase|Withdrawal by Subject|0|||
163855084|NCT00783692|591838242|FG004|Induction Phase|Withdrawal by Subject|0|||
163855085|NCT00783692|591838243|FG005|Induction Phase|Withdrawal by Subject|0|||
163855086|NCT00783692|591838244|FG006|Induction Phase|Withdrawal by Subject|0|||
163855087|NCT00783692|591838238|FG000|Induction Phase|Lost to Follow-up|0|||
163855088|NCT00783692|591838239|FG001|Induction Phase|Lost to Follow-up|0|||
163855089|NCT00783692|591838240|FG002|Induction Phase|Lost to Follow-up|3|||
163855090|NCT00783692|591838241|FG003|Induction Phase|Lost to Follow-up|0|||
163855091|NCT00783692|591838242|FG004|Induction Phase|Lost to Follow-up|0|||
163855092|NCT00783692|591838243|FG005|Induction Phase|Lost to Follow-up|0|||
163855093|NCT00783692|591838244|FG006|Induction Phase|Lost to Follow-up|0|||
163855094|NCT00783692|591838238|FG000|Induction Phase|Other|0|||
163855095|NCT00783692|591838239|FG001|Induction Phase|Other|0|||
163855096|NCT00783692|591838240|FG002|Induction Phase|Other|2|||
163855097|NCT00783692|591838241|FG003|Induction Phase|Other|0|||
163855098|NCT00783692|591838242|FG004|Induction Phase|Other|0|||
163855099|NCT00783692|591838243|FG005|Induction Phase|Other|0|||
163855100|NCT00783692|591838244|FG006|Induction Phase|Other|0|||
163855101|NCT00783692|591838238|FG000|Maintenance Phase|Adverse Event|7|||
163855102|NCT00783692|591838239|FG001|Maintenance Phase|Adverse Event|0|||
163855103|NCT00783692|591838240|FG002|Maintenance Phase|Adverse Event|0|||
163855104|NCT00783692|591838241|FG003|Maintenance Phase|Adverse Event|15|||
163855105|NCT00783692|591838242|FG004|Maintenance Phase|Adverse Event|12|||
163855106|NCT00783692|591838243|FG005|Maintenance Phase|Adverse Event|9|||
163855107|NCT00783692|591838244|FG006|Maintenance Phase|Adverse Event|38|||
163855108|NCT00783692|591838238|FG000|Maintenance Phase|Protocol Violation|0|||
163855109|NCT00783692|591838239|FG001|Maintenance Phase|Protocol Violation|0|||
163855110|NCT00783692|591838240|FG002|Maintenance Phase|Protocol Violation|0|||
163855111|NCT00783692|591838241|FG003|Maintenance Phase|Protocol Violation|1|||
163855112|NCT00783692|591838242|FG004|Maintenance Phase|Protocol Violation|2|||
163855113|NCT00783692|591838243|FG005|Maintenance Phase|Protocol Violation|3|||
163855114|NCT00783692|591838244|FG006|Maintenance Phase|Protocol Violation|4|||
163855115|NCT00783692|591838238|FG000|Maintenance Phase|Lack of Efficacy|79|||
163855116|NCT00783692|591838239|FG001|Maintenance Phase|Lack of Efficacy|0|||
163964772|NCT04600336|592243293|FG003|Crossover Treatment|Adverse Event|1|||
163964773|NCT04223791|592243294|FG000|Overall Study|Lost to Follow-up|0|||
163964774|NCT04223791|592243295|FG001|Overall Study|Lost to Follow-up|4|||
163964775|NCT04223791|592243294|FG000|Overall Study|Physician Decision|5|||
163964776|NCT04223791|592243295|FG001|Overall Study|Physician Decision|1|||
163964777|NCT04223791|592243294|FG000|Overall Study|Protocol Violation|1|||
163964778|NCT04223791|592243295|FG001|Overall Study|Protocol Violation|1|||
163964779|NCT04223791|592243294|FG000|Overall Study|Withdrawal by Subject|10|||
163964780|NCT04223791|592243295|FG001|Overall Study|Withdrawal by Subject|12|||
163964781|NCT04223791|592243294|FG000|Overall Study|Pregnancy|1|||
163964782|NCT04223791|592243295|FG001|Overall Study|Pregnancy|1|||
163964783|NCT04223791|592243294|FG000|Overall Study|Ongoing in Study|305|||
163964784|NCT04223791|592243295|FG001|Overall Study|Ongoing in Study|302|||
163964785|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
163964786|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
163964787|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
163964788|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
163964789|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
163964790|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
163964791|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
163964792|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
163964793|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
163964794|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
163964795|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
163964796|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
163964797|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
163964798|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
163964799|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
163964800|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
163964801|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
163964802|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
163964803|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Early termination|0|||
163964804|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Early termination|0|||
163964805|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Early termination|34|||
163964806|NCT01493557|592244732|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
163964807|NCT01493557|592244733|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
163964808|NCT01493557|592244734|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
163964809|NCT01493557|592244732|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
163964810|NCT01493557|592244733|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
164133494|NCT05424042|592857148|FG002|Overall Study|Lost to Follow-up|1|||
164133495|NCT05091307|592857149|FG000|Overall Study|Death|0|||
164133496|NCT05091307|592857150|FG001|Overall Study|Death|0|||
164133497|NCT05091307|592857151|FG002|Overall Study|Death|1|||
164133498|NCT05091307|592857152|FG003|Overall Study|Death|0|||
164133499|NCT05091307|592857149|FG000|Overall Study|Lost to Follow-up|33|||
164133500|NCT05091307|592857150|FG001|Overall Study|Lost to Follow-up|33|||
164133501|NCT05091307|592857151|FG002|Overall Study|Lost to Follow-up|2|||
164133502|NCT05091307|592857152|FG003|Overall Study|Lost to Follow-up|0|||
164133503|NCT05091307|592857149|FG000|Overall Study|Physician Decision|1|||
164133504|NCT05091307|592857150|FG001|Overall Study|Physician Decision|0|||
164133505|NCT05091307|592857151|FG002|Overall Study|Physician Decision|0|||
164133506|NCT05091307|592857152|FG003|Overall Study|Physician Decision|0|||
164133507|NCT05091307|592857149|FG000|Overall Study|Protocol Violation|1|||
164133508|NCT05091307|592857150|FG001|Overall Study|Protocol Violation|0|||
164133509|NCT05091307|592857151|FG002|Overall Study|Protocol Violation|0|||
164133510|NCT05091307|592857152|FG003|Overall Study|Protocol Violation|0|||
164133511|NCT05091307|592857149|FG000|Overall Study|Withdrawal by Subject|16|||
164133512|NCT05091307|592857150|FG001|Overall Study|Withdrawal by Subject|16|||
164133513|NCT05091307|592857151|FG002|Overall Study|Withdrawal by Subject|0|||
164133514|NCT05091307|592857152|FG003|Overall Study|Withdrawal by Subject|1|||
164133515|NCT05091307|592857149|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
164133516|NCT05091307|592857150|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
164133517|NCT05091307|592857151|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
164133518|NCT05091307|592857152|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
164133519|NCT05091307|592857149|FG000|Overall Study|Initiated Prohibited Medication|1|||
164133520|NCT05091307|592857150|FG001|Overall Study|Initiated Prohibited Medication|0|||
164133521|NCT05091307|592857151|FG002|Overall Study|Initiated Prohibited Medication|0|||
164133522|NCT05091307|592857152|FG003|Overall Study|Initiated Prohibited Medication|0|||
164133523|NCT05091307|592857149|FG000|Overall Study|Other|4|||
164133524|NCT05091307|592857150|FG001|Overall Study|Other|4|||
164191271|NCT03382418|593067826|FG002|Overall Study|Withdrawal by Subject|0|||
164191272|NCT03382418|593067824|FG000|Overall Study|Lost to Follow-up|2|||
164191273|NCT03382418|593067825|FG001|Overall Study|Lost to Follow-up|3|||
164191274|NCT03382418|593067826|FG002|Overall Study|Lost to Follow-up|0|||
164191275|NCT01189461|593067836|FG000|Overall Study|Lack of Efficacy|13|||
164191276|NCT01189461|593067836|FG000|Overall Study|Lost to Follow-up|1|||
164191277|NCT01189461|593067836|FG000|Overall Study|Withdrawal by Subject|6|||
164191278|NCT01189461|593067836|FG000|Overall Study|Protocol Violation|1|||
164191279|NCT01189461|593067836|FG000|Overall Study|Adverse Event|2|||
164191280|NCT01189461|593067836|FG000|Overall Study|Did not meet entrance criteria|3|||
164191281|NCT01189461|593067836|FG000|Overall Study|Other|8|||
164191282|NCT05095311|593067842|FG000|Overall Study|Lost to Follow-up|7|||
164191283|NCT05095311|593067843|FG001|Overall Study|Lost to Follow-up|0|||
164191284|NCT05095311|593067844|FG002|Overall Study|Lost to Follow-up|0|||
164191285|NCT02385110|593067847|FG000|Overall Study|Early Death|1|||
164191286|NCT02385110|593067848|FG001|Overall Study|Early Death|0|||
164191287|NCT00534638|593067849|FG000|Overall Study|Withdrawal by Subject|3|||
164191288|NCT00534638|593067850|FG001|Overall Study|Withdrawal by Subject|4|||
164191289|NCT00534638|593067849|FG000|Overall Study|Migrated/moved from study area|13|||
164191290|NCT00534638|593067850|FG001|Overall Study|Migrated/moved from study area|11|||
164191291|NCT00534638|593067849|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
164191292|NCT00534638|593067850|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
164191293|NCT00534638|593067849|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
164191294|NCT00534638|593067850|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
164191295|NCT00534638|593067849|FG000|Overall Study|Other|1685|||
164191296|NCT00534638|593067850|FG001|Overall Study|Other|902|||
164191297|NCT00282152|593067853|FG000|Overall Study|Withdrawal by Subject|1|||
164191298|NCT00282152|593067854|FG001|Overall Study|Withdrawal by Subject|0|||
164191299|NCT00585325|593067855|FG000|Overall Study|Withdrawal by Subject|1|||
164191300|NCT00585325|593067856|FG001|Overall Study|Withdrawal by Subject|1|||
164191301|NCT03301831|593067857|FG000|Overall Study|Lost to Follow-up|5|||
164191302|NCT03301831|593067858|FG001|Overall Study|Lost to Follow-up|3|||
164191303|NCT03301831|593067857|FG000|Overall Study|Protocol Violation|4|||
164191304|NCT03301831|593067858|FG001|Overall Study|Protocol Violation|0|||
164191305|NCT03301831|593067857|FG000|Overall Study|Withdrawal by Subject|11|||
164191306|NCT03301831|593067858|FG001|Overall Study|Withdrawal by Subject|0|||
164191307|NCT01919164|593069490|FG000|Overall Study|Adverse Event|6|||
164191308|NCT01919164|593069491|FG001|Overall Study|Adverse Event|4|||
164191309|NCT01919164|593069492|FG002|Overall Study|Adverse Event|9|||
164191310|NCT01919164|593069493|FG003|Overall Study|Adverse Event|3|||
164191311|NCT01919164|593069494|FG004|Overall Study|Adverse Event|2|||
164191312|NCT01919164|593069490|FG000|Overall Study|Lost to Follow-up|2|||
164191313|NCT01919164|593069491|FG001|Overall Study|Lost to Follow-up|2|||
164191314|NCT01919164|593069492|FG002|Overall Study|Lost to Follow-up|2|||
164191315|NCT01919164|593069493|FG003|Overall Study|Lost to Follow-up|0|||
164191316|NCT01919164|593069494|FG004|Overall Study|Lost to Follow-up|4|||
164191317|NCT01919164|593069490|FG000|Overall Study|Death|1|||
164191318|NCT01919164|593069491|FG001|Overall Study|Death|0|||
164191319|NCT01919164|593069492|FG002|Overall Study|Death|0|||
164191320|NCT01919164|593069493|FG003|Overall Study|Death|0|||
164191321|NCT01919164|593069494|FG004|Overall Study|Death|0|||
164191322|NCT01919164|593069490|FG000|Overall Study|Protocol Violation|6|||
164191323|NCT01919164|593069491|FG001|Overall Study|Protocol Violation|0|||
164191324|NCT01919164|593069492|FG002|Overall Study|Protocol Violation|3|||
164191325|NCT01919164|593069493|FG003|Overall Study|Protocol Violation|2|||
164191326|NCT01919164|593069494|FG004|Overall Study|Protocol Violation|2|||
164191327|NCT01919164|593069490|FG000|Overall Study|Disease progression|2|||
164191328|NCT01919164|593069491|FG001|Overall Study|Disease progression|2|||
164191329|NCT01919164|593069492|FG002|Overall Study|Disease progression|1|||
164191330|NCT01919164|593069493|FG003|Overall Study|Disease progression|2|||
164191331|NCT01919164|593069494|FG004|Overall Study|Disease progression|1|||
164191332|NCT01919164|593069490|FG000|Overall Study|Withdrew consent|13|||
164191333|NCT01919164|593069491|FG001|Overall Study|Withdrew consent|13|||
164191334|NCT01919164|593069492|FG002|Overall Study|Withdrew consent|14|||
164191335|NCT01919164|593069493|FG003|Overall Study|Withdrew consent|14|||
164191336|NCT01919164|593069494|FG004|Overall Study|Withdrew consent|9|||
164191337|NCT01919164|593069490|FG000|Overall Study|Other Un-specified|13|||
164191338|NCT01919164|593069491|FG001|Overall Study|Other Un-specified|9|||
164191339|NCT01919164|593069492|FG002|Overall Study|Other Un-specified|8|||
164191340|NCT01919164|593069493|FG003|Overall Study|Other Un-specified|7|||
164191341|NCT01919164|593069494|FG004|Overall Study|Other Un-specified|15|||
164191342|NCT01239394|593069495|FG000|Overall Study|Adverse Event|1|||
164191343|NCT00905632|593069497|FG000|Overall Study|Adverse Event|0|||
164191344|NCT00905632|593069498|FG001|Overall Study|Adverse Event|0|||
164191345|NCT00905632|593069499|FG002|Overall Study|Adverse Event|0|||
164191346|NCT00905632|593069500|FG003|Overall Study|Adverse Event|0|||
164191347|NCT00905632|593069501|FG004|Overall Study|Adverse Event|0|||
164191348|NCT00905632|593069502|FG005|Overall Study|Adverse Event|1|||
164191349|NCT00905632|593069503|FG006|Overall Study|Adverse Event|4|||
164191350|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
164191351|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
164191352|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
164191353|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
164191354|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
164191355|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
164191356|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
164191357|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
164191358|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
164191359|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
164191360|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
164191361|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
164191362|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
164191363|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
164191364|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
164191365|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
164191366|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
164191367|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
164191368|NCT03569098|593069504|FG000|Double-Blind Treatment Cycle 1|Other|1|||
164191369|NCT03569098|593069505|FG001|Double-Blind Treatment Cycle 1|Other|0|||
164191370|NCT03569098|593069506|FG002|Double-Blind Treatment Cycle 1|Other|1|||
164191371|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
164191372|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
164191373|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
164191374|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
164191375|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
164191376|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
163855117|NCT00783692|591838240|FG002|Maintenance Phase|Lack of Efficacy|0|||
163855118|NCT00783692|591838241|FG003|Maintenance Phase|Lack of Efficacy|64|||
163855119|NCT00783692|591838242|FG004|Maintenance Phase|Lack of Efficacy|58|||
163855120|NCT00783692|591838243|FG005|Maintenance Phase|Lack of Efficacy|48|||
164191377|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
164191378|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
164191379|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
164191380|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
164191381|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
164191382|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
164191383|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
164191384|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
164191385|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
164191386|NCT03569098|593069504|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
164191387|NCT03569098|593069505|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
164191388|NCT03569098|593069506|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
164191389|NCT02485483|593069511|FG000|Overall Study|Depression at baseline|15|||
164191390|NCT02485483|593069512|FG001|Overall Study|Depression at baseline|0|||
164191391|NCT02485483|593069511|FG000|Overall Study|Discontinued after baseline|39|||
164191392|NCT02485483|593069512|FG001|Overall Study|Discontinued after baseline|0|||
164191393|NCT00377637|593069513|FG000|Induction Phase|Adverse Event|12|||
164191394|NCT00377637|593069514|FG001|Induction Phase|Adverse Event|21|||
164191395|NCT00377637|593069515|FG002|Induction Phase|Adverse Event|0|||
164191396|NCT00377637|593069516|FG003|Induction Phase|Adverse Event|0|||
164191397|NCT00377637|593069513|FG000|Induction Phase|Deterioration/serum creatinine|2|||
164191398|NCT00377637|593069514|FG001|Induction Phase|Deterioration/serum creatinine|0|||
164191399|NCT00377637|593069515|FG002|Induction Phase|Deterioration/serum creatinine|0|||
164191400|NCT00377637|593069516|FG003|Induction Phase|Deterioration/serum creatinine|0|||
164191401|NCT00377637|593069513|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
164191402|NCT00377637|593069514|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
164191403|NCT00377637|593069515|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
164191404|NCT00377637|593069516|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
164191405|NCT00377637|593069513|FG000|Induction Phase|Lost to Follow-up|2|||
164191406|NCT00377637|593069514|FG001|Induction Phase|Lost to Follow-up|1|||
164191407|NCT00377637|593069515|FG002|Induction Phase|Lost to Follow-up|0|||
164191408|NCT00377637|593069516|FG003|Induction Phase|Lost to Follow-up|0|||
164191409|NCT00377637|593069513|FG000|Induction Phase|Death|1|||
164191410|NCT00377637|593069514|FG001|Induction Phase|Death|3|||
164191411|NCT00377637|593069515|FG002|Induction Phase|Death|0|||
164191412|NCT00377637|593069516|FG003|Induction Phase|Death|0|||
164191413|NCT00377637|593069513|FG000|Induction Phase|Withdrawal by Subject|5|||
164191414|NCT00377637|593069514|FG001|Induction Phase|Withdrawal by Subject|6|||
163855121|NCT00783692|591838244|FG006|Maintenance Phase|Lack of Efficacy|177|||
164191415|NCT00377637|593069515|FG002|Induction Phase|Withdrawal by Subject|0|||
164191416|NCT00377637|593069516|FG003|Induction Phase|Withdrawal by Subject|0|||
164191417|NCT00377637|593069513|FG000|Induction Phase|Physician Decision|3|||
164191418|NCT00377637|593069514|FG001|Induction Phase|Physician Decision|1|||
164191419|NCT00377637|593069515|FG002|Induction Phase|Physician Decision|0|||
164191420|NCT00377637|593069516|FG003|Induction Phase|Physician Decision|0|||
164191421|NCT00377637|593069513|FG000|Induction Phase|Sponsor decision|1|||
164191422|NCT00377637|593069514|FG001|Induction Phase|Sponsor decision|2|||
164191423|NCT00377637|593069515|FG002|Induction Phase|Sponsor decision|0|||
164191424|NCT00377637|593069516|FG003|Induction Phase|Sponsor decision|0|||
164191425|NCT00377637|593069513|FG000|Induction Phase|Non-Compliance|1|||
164191426|NCT00377637|593069514|FG001|Induction Phase|Non-Compliance|0|||
164191427|NCT00377637|593069515|FG002|Induction Phase|Non-Compliance|0|||
164191428|NCT00377637|593069516|FG003|Induction Phase|Non-Compliance|0|||
164191429|NCT00377637|593069513|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
164191430|NCT00377637|593069514|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
164191431|NCT00377637|593069515|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
164191432|NCT00377637|593069516|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
164191433|NCT00377637|593069513|FG000|Maintenance Phase|Adverse Event|0|||
164191434|NCT00377637|593069514|FG001|Maintenance Phase|Adverse Event|0|||
164191435|NCT00377637|593069515|FG002|Maintenance Phase|Adverse Event|29|||
164191436|NCT00377637|593069516|FG003|Maintenance Phase|Adverse Event|43|||
164191437|NCT00377637|593069513|FG000|Maintenance Phase|Physician Decision|0|||
164191438|NCT00377637|593069514|FG001|Maintenance Phase|Physician Decision|0|||
164191439|NCT00377637|593069515|FG002|Maintenance Phase|Physician Decision|5|||
164191440|NCT00377637|593069516|FG003|Maintenance Phase|Physician Decision|4|||
164191441|NCT00377637|593069513|FG000|Maintenance Phase|Lost to Follow-up|0|||
164191442|NCT00377637|593069514|FG001|Maintenance Phase|Lost to Follow-up|0|||
164191443|NCT00377637|593069515|FG002|Maintenance Phase|Lost to Follow-up|3|||
164191444|NCT00377637|593069516|FG003|Maintenance Phase|Lost to Follow-up|1|||
164191445|NCT00377637|593069513|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164191446|NCT00377637|593069514|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164191447|NCT00377637|593069515|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164191448|NCT00377637|593069516|FG003|Maintenance Phase|Withdrawal by Subject|3|||
164191449|NCT00377637|593069513|FG000|Maintenance Phase|Sponsor decision|0|||
164191450|NCT00377637|593069514|FG001|Maintenance Phase|Sponsor decision|0|||
164191451|NCT00377637|593069515|FG002|Maintenance Phase|Sponsor decision|2|||
164191452|NCT00377637|593069516|FG003|Maintenance Phase|Sponsor decision|3|||
164191453|NCT00377637|593069513|FG000|Maintenance Phase|Non-compliance|0|||
164191454|NCT00377637|593069514|FG001|Maintenance Phase|Non-compliance|0|||
164191455|NCT00377637|593069515|FG002|Maintenance Phase|Non-compliance|1|||
164191456|NCT00377637|593069516|FG003|Maintenance Phase|Non-compliance|1|||
164191457|NCT00377637|593069513|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
164191458|NCT00377637|593069514|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
164191459|NCT00377637|593069515|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
164191460|NCT00377637|593069516|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
164191461|NCT00377637|593069513|FG000|Maintenance Phase|Death|0|||
164191462|NCT00377637|593069514|FG001|Maintenance Phase|Death|0|||
164191463|NCT00377637|593069515|FG002|Maintenance Phase|Death|0|||
164191464|NCT00377637|593069516|FG003|Maintenance Phase|Death|1|||
164191465|NCT02922153|593069518|FG000|Overall Study|Death|8|||
164191466|NCT02922153|593069519|FG001|Overall Study|Death|1|||
164191467|NCT02922153|593069518|FG000|Overall Study|Lost to Follow-up|1|||
164191468|NCT02922153|593069519|FG001|Overall Study|Lost to Follow-up|0|||
164191469|NCT02922153|593069518|FG000|Overall Study|Physician Decision|1|||
164191470|NCT02922153|593069519|FG001|Overall Study|Physician Decision|1|||
164191471|NCT00522548|593069522|FG000|Overall Study|Adverse Event|2|||
164191472|NCT00522548|593069523|FG001|Overall Study|Adverse Event|2|||
164191473|NCT00522548|593069522|FG000|Overall Study|Withdrawal by Subject|0|||
164191474|NCT00522548|593069523|FG001|Overall Study|Withdrawal by Subject|2|||
164191475|NCT00956839|593069524|FG000|Overall Study|Lost to Follow-up|3|||
164191476|NCT00956839|593069525|FG001|Overall Study|Lost to Follow-up|0|||
164191477|NCT00956839|593069526|FG002|Overall Study|Lost to Follow-up|3|||
164191478|NCT03506438|593069527|FG000|Overall Study|Lost to Follow-up|8|||
164191479|NCT03506438|593069528|FG001|Overall Study|Lost to Follow-up|7|||
164191480|NCT03506438|593069529|FG002|Overall Study|Lost to Follow-up|8|||
164191481|NCT03506438|593069530|FG003|Overall Study|Lost to Follow-up|7|||
164191482|NCT03506438|593069531|FG004|Overall Study|Lost to Follow-up|0|||
164191483|NCT03506438|593069532|FG005|Overall Study|Lost to Follow-up|0|||
164191484|NCT01128296|593069533|FG000|Overall Study|Physician Decision|0|||
164191485|NCT01128296|593069534|FG001|Overall Study|Physician Decision|0|||
164191486|NCT01128296|593069535|FG002|Overall Study|Physician Decision|0|||
164191487|NCT01128296|593069536|FG003|Overall Study|Physician Decision|0|||
164191488|NCT01128296|593069537|FG004|Overall Study|Physician Decision|0|||
164191489|NCT01128296|593069538|FG005|Overall Study|Physician Decision|3|||
164191490|NCT01128296|593069533|FG000|Overall Study|Withdrawal by Subject|0|||
164191491|NCT01128296|593069534|FG001|Overall Study|Withdrawal by Subject|0|||
164191492|NCT01128296|593069535|FG002|Overall Study|Withdrawal by Subject|0|||
164191493|NCT01128296|593069536|FG003|Overall Study|Withdrawal by Subject|0|||
164191494|NCT01128296|593069537|FG004|Overall Study|Withdrawal by Subject|0|||
164133525|NCT05091307|592857151|FG002|Overall Study|Other|0|||
164133526|NCT05091307|592857152|FG003|Overall Study|Other|0|||
164133527|NCT05091307|592857149|FG000|Overall Study|Randomized but not vaccinated|0|||
164133528|NCT05091307|592857150|FG001|Overall Study|Randomized but not vaccinated|2|||
164133529|NCT05091307|592857151|FG002|Overall Study|Randomized but not vaccinated|0|||
164133530|NCT05091307|592857152|FG003|Overall Study|Randomized but not vaccinated|0|||
164133531|NCT00379340|592857155|FG000|Overall Study|Death|0|||
164133532|NCT00379340|592857156|FG001|Overall Study|Death|0|||
164133533|NCT00379340|592857157|FG002|Overall Study|Death|0|||
164133534|NCT00379340|592857158|FG003|Overall Study|Death|2|||
164133535|NCT00379340|592857159|FG004|Overall Study|Death|0|||
164133536|NCT00379340|592857155|FG000|Overall Study|Lack of Efficacy|6|||
164133537|NCT00379340|592857156|FG001|Overall Study|Lack of Efficacy|1|||
164133538|NCT00379340|592857157|FG002|Overall Study|Lack of Efficacy|0|||
164133539|NCT00379340|592857158|FG003|Overall Study|Lack of Efficacy|4|||
164133540|NCT00379340|592857159|FG004|Overall Study|Lack of Efficacy|3|||
164133541|NCT00379340|592857155|FG000|Overall Study|Physician Decision|6|||
164133542|NCT00379340|592857156|FG001|Overall Study|Physician Decision|2|||
164133543|NCT00379340|592857157|FG002|Overall Study|Physician Decision|1|||
164133544|NCT00379340|592857158|FG003|Overall Study|Physician Decision|2|||
164133545|NCT00379340|592857159|FG004|Overall Study|Physician Decision|3|||
164133546|NCT00379340|592857155|FG000|Overall Study|Withdrawal by Subject|0|||
164133547|NCT00379340|592857156|FG001|Overall Study|Withdrawal by Subject|0|||
164133548|NCT00379340|592857157|FG002|Overall Study|Withdrawal by Subject|0|||
164133549|NCT00379340|592857158|FG003|Overall Study|Withdrawal by Subject|1|||
164133550|NCT00379340|592857159|FG004|Overall Study|Withdrawal by Subject|0|||
164133551|NCT00379340|592857155|FG000|Overall Study|Refusal of further protocol therapy|1|||
164133552|NCT00379340|592857156|FG001|Overall Study|Refusal of further protocol therapy|0|||
164133553|NCT00379340|592857157|FG002|Overall Study|Refusal of further protocol therapy|1|||
164133554|NCT00379340|592857158|FG003|Overall Study|Refusal of further protocol therapy|1|||
164133555|NCT00379340|592857159|FG004|Overall Study|Refusal of further protocol therapy|7|||
164133556|NCT00379340|592857155|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
164133557|NCT00379340|592857156|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
164133558|NCT00379340|592857157|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
164133559|NCT00379340|592857158|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
164133560|NCT00379340|592857159|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
164133561|NCT00379340|592857155|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
164133562|NCT00379340|592857156|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
164133563|NCT00379340|592857157|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
164133564|NCT00379340|592857158|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
164133565|NCT00379340|592857159|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
164133566|NCT05327816|592857160|FG000|Overall Study|Lost to Follow-up|1|||
164133567|NCT05327816|592857161|FG001|Overall Study|Lost to Follow-up|0|||
164133568|NCT05327816|592857162|FG002|Overall Study|Lost to Follow-up|0|||
164133569|NCT05327816|592857163|FG003|Overall Study|Lost to Follow-up|0|||
164133570|NCT05327816|592857164|FG004|Overall Study|Lost to Follow-up|0|||
164133571|NCT05327816|592857165|FG005|Overall Study|Lost to Follow-up|0|||
164133572|NCT05327816|592857166|FG006|Overall Study|Lost to Follow-up|0|||
164133573|NCT05327816|592857167|FG007|Overall Study|Lost to Follow-up|0|||
164133574|NCT05327816|592857168|FG008|Overall Study|Lost to Follow-up|0|||
164133575|NCT05327816|592857169|FG009|Overall Study|Lost to Follow-up|1|||
164133576|NCT05327816|592857170|FG010|Overall Study|Lost to Follow-up|0|||
164133577|NCT05327816|592857160|FG000|Overall Study|Withdrawal by Subject|0|||
164133578|NCT05327816|592857161|FG001|Overall Study|Withdrawal by Subject|0|||
164133579|NCT05327816|592857162|FG002|Overall Study|Withdrawal by Subject|0|||
164133580|NCT05327816|592857163|FG003|Overall Study|Withdrawal by Subject|0|||
164133581|NCT05327816|592857164|FG004|Overall Study|Withdrawal by Subject|1|||
164133582|NCT05327816|592857165|FG005|Overall Study|Withdrawal by Subject|1|||
164133583|NCT05327816|592857166|FG006|Overall Study|Withdrawal by Subject|0|||
164133584|NCT05327816|592857167|FG007|Overall Study|Withdrawal by Subject|0|||
164133585|NCT05327816|592857168|FG008|Overall Study|Withdrawal by Subject|0|||
164133586|NCT05327816|592857169|FG009|Overall Study|Withdrawal by Subject|0|||
164133587|NCT05327816|592857170|FG010|Overall Study|Withdrawal by Subject|0|||
164133588|NCT05327816|592857160|FG000|Overall Study|Study Terminated by Sponsor|11|||
164133589|NCT05327816|592857161|FG001|Overall Study|Study Terminated by Sponsor|12|||
164133590|NCT05327816|592857162|FG002|Overall Study|Study Terminated by Sponsor|12|||
164133591|NCT05327816|592857163|FG003|Overall Study|Study Terminated by Sponsor|12|||
164133592|NCT05327816|592857164|FG004|Overall Study|Study Terminated by Sponsor|11|||
164133593|NCT05327816|592857165|FG005|Overall Study|Study Terminated by Sponsor|11|||
164133594|NCT05327816|592857166|FG006|Overall Study|Study Terminated by Sponsor|11|||
164133595|NCT05327816|592857167|FG007|Overall Study|Study Terminated by Sponsor|11|||
164133596|NCT05327816|592857168|FG008|Overall Study|Study Terminated by Sponsor|11|||
164133597|NCT05327816|592857169|FG009|Overall Study|Study Terminated by Sponsor|11|||
164191495|NCT01128296|593069538|FG005|Overall Study|Withdrawal by Subject|2|||
164191496|NCT04155463|593069539|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
164191497|NCT04155463|593069540|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
164191498|NCT00113295|593069541|FG000|Overall Study|Adverse Event|4|||
164191499|NCT00113295|593069542|FG001|Overall Study|Adverse Event|1|||
164191500|NCT00113295|593069541|FG000|Overall Study|Unrelated Medical Illness|1|||
164191501|NCT00113295|593069542|FG001|Overall Study|Unrelated Medical Illness|0|||
164191502|NCT01714544|593069543|FG000|Overall Study|Lost to Follow-up|1|||
164191503|NCT01714544|593069543|FG000|Overall Study|Physician Decision|1|||
164191504|NCT01714544|593069543|FG000|Overall Study|Withdrawal by Subject|1|||
164191505|NCT01053741|593069544|FG000|2nd Study Intervention|Physician Decision|0|||
164191506|NCT01053741|593069545|FG001|2nd Study Intervention|Physician Decision|1|||
164191507|NCT00666211|593069546|FG000|Overall Study|Withdrawal by Subject|10|||
164191508|NCT00666211|593069547|FG001|Overall Study|Withdrawal by Subject|13|||
164191509|NCT00666211|593069546|FG000|Overall Study|went off medication, no more pain|1|||
164191510|NCT00666211|593069547|FG001|Overall Study|went off medication, no more pain|0|||
164191511|NCT00666211|593069546|FG000|Overall Study|patient non-compliant|6|||
164191512|NCT00666211|593069547|FG001|Overall Study|patient non-compliant|6|||
164191513|NCT00666211|593069546|FG000|Overall Study|disease progression|1|||
164191514|NCT00666211|593069547|FG001|Overall Study|disease progression|8|||
164191515|NCT00666211|593069546|FG000|Overall Study|Lost to Follow-up|2|||
164191516|NCT00666211|593069547|FG001|Overall Study|Lost to Follow-up|0|||
164191517|NCT00666211|593069546|FG000|Overall Study|toxicity|0|||
164191518|NCT00666211|593069547|FG001|Overall Study|toxicity|2|||
164191519|NCT00666211|593069546|FG000|Overall Study|hospital admission|0|||
164191520|NCT00666211|593069547|FG001|Overall Study|hospital admission|5|||
164191521|NCT00666211|593069546|FG000|Overall Study|Death|0|||
164191522|NCT00666211|593069547|FG001|Overall Study|Death|2|||
164191523|NCT00666211|593069546|FG000|Overall Study|off tx for other complicating disease|0|||
164191524|NCT00666211|593069547|FG001|Overall Study|off tx for other complicating disease|1|||
164191525|NCT00666211|593069546|FG000|Overall Study|Physician Decision|0|||
164191526|NCT00666211|593069547|FG001|Overall Study|Physician Decision|1|||
164191527|NCT02824224|593069550|FG000|Overall Study|Discontinued, IUS expulsion|0|||
164191528|NCT02824224|593069551|FG001|Overall Study|Discontinued, IUS expulsion|1|||
164191529|NCT02824224|593069550|FG000|Overall Study|Did not show up for allocation visit|2|||
164191530|NCT02824224|593069551|FG001|Overall Study|Did not show up for allocation visit|0|||
164191531|NCT04668209|593069552|FG000|Overall Study|Withdrawal by Subject|2|||
164191532|NCT04668209|593069553|FG001|Overall Study|Withdrawal by Subject|2|||
164191533|NCT04668209|593069552|FG000|Overall Study|Lost to Follow-up|3|||
164191534|NCT04668209|593069553|FG001|Overall Study|Lost to Follow-up|4|||
164191535|NCT04668209|593069552|FG000|Overall Study|Subject Expired|2|||
164191536|NCT04668209|593069553|FG001|Overall Study|Subject Expired|0|||
164191537|NCT04668209|593069552|FG000|Overall Study|Withdrawn from study|0|||
164191538|NCT04668209|593069553|FG001|Overall Study|Withdrawn from study|1|||
164191539|NCT04668209|593069552|FG000|Overall Study|Adverse Event|0|||
164191540|NCT04668209|593069553|FG001|Overall Study|Adverse Event|1|||
164191541|NCT05225558|593069554|FG000|Overall Study|Withdrawal by Subject|4|||
164191542|NCT05225558|593069555|FG001|Overall Study|Withdrawal by Subject|3|||
164191543|NCT05225558|593069554|FG000|Overall Study|Adverse Event|1|||
164191544|NCT05225558|593069555|FG001|Overall Study|Adverse Event|0|||
164191545|NCT05225558|593069554|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
164191546|NCT05225558|593069555|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
164191547|NCT05225558|593069554|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
164191548|NCT05225558|593069555|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
164191549|NCT00875563|593069557|FG000|Overall Study|Death|4|||
164191550|NCT00875563|593069557|FG000|Overall Study|Withdrawal by Subject|7|||
164191551|NCT00875563|593069557|FG000|Overall Study|No long-term (3-5 year) consent|6|||
164191552|NCT00875563|593069557|FG000|Overall Study|Still be eligible for follow-up|7|||
164191553|NCT00313846|593069558|FG000|Overall Study|Withdrawal by Subject|2|||
164191554|NCT00313846|593069559|FG001|Overall Study|Withdrawal by Subject|0|||
164191555|NCT00313846|593069558|FG000|Overall Study|Adverse Event|1|||
164191556|NCT00313846|593069559|FG001|Overall Study|Adverse Event|8|||
164191557|NCT00313846|593069558|FG000|Overall Study|Administrative|2|||
164191558|NCT00313846|593069559|FG001|Overall Study|Administrative|3|||
164191559|NCT02592447|593069562|FG000|Overall Study|Lost to Follow-up|1|||
164191560|NCT02592447|593069563|FG001|Overall Study|Lost to Follow-up|0|||
164191561|NCT02592447|593069562|FG000|Overall Study|Ineligible after randomization|1|||
164191562|NCT02592447|593069563|FG001|Overall Study|Ineligible after randomization|0|||
164191563|NCT02592447|593069562|FG000|Overall Study|Withdrawal by Subject|0|||
164191564|NCT02592447|593069563|FG001|Overall Study|Withdrawal by Subject|1|||
164191565|NCT02028507|593069564|FG000|Overall Study|Progressive Disease|122|||
164191566|NCT02028507|593069565|FG001|Overall Study|Progressive Disease|90|||
164191567|NCT02028507|593069566|FG002|Overall Study|Progressive Disease|102|||
164191568|NCT02028507|593069567|FG003|Overall Study|Progressive Disease|89|||
164133750|NCT01175811|592857219|FG001|Overall Study|Adverse Event|1|||
164133751|NCT01175811|592857218|FG000|Overall Study|Entry criteria not met|3|||
164133752|NCT01175811|592857219|FG001|Overall Study|Entry criteria not met|1|||
164133753|NCT01175811|592857218|FG000|Overall Study|Lack of Efficacy|1|||
164133754|NCT01175811|592857219|FG001|Overall Study|Lack of Efficacy|0|||
164133755|NCT01175811|592857218|FG000|Overall Study|Lost to Follow-up|3|||
164133756|NCT01175811|592857219|FG001|Overall Study|Lost to Follow-up|2|||
164133757|NCT01175811|592857218|FG000|Overall Study|Physician Decision|1|||
164133758|NCT01175811|592857219|FG001|Overall Study|Physician Decision|1|||
164133759|NCT01175811|592857218|FG000|Overall Study|Protocol Violation|1|||
164133760|NCT01175811|592857219|FG001|Overall Study|Protocol Violation|2|||
164133761|NCT01175811|592857218|FG000|Overall Study|Withdrawal by Subject|6|||
164133762|NCT01175811|592857219|FG001|Overall Study|Withdrawal by Subject|7|||
164133763|NCT00114166|592857220|FG000|Overall Study|Wrong primary|0|||
164133764|NCT00114166|592857221|FG001|Overall Study|Wrong primary|1|||
164133765|NCT02628743|592857224|FG000|Overall Study|Other|3|||
164133766|NCT02628743|592857224|FG000|Overall Study|Withdrawal by Subject|50|||
164133767|NCT02628743|592857224|FG000|Overall Study|Study Terminated by Sponsor|76|||
164133768|NCT02628743|592857224|FG000|Overall Study|Physician Decision|2|||
164133769|NCT04715932|592857225|FG000|Overall Study|Lost to Follow-up|1|||
164133770|NCT04715932|592857226|FG001|Overall Study|Lost to Follow-up|0|||
164133771|NCT02740699|592857227|FG000|Overall Study|Lost to Follow-up|5|||
164133772|NCT02740699|592857227|FG000|Overall Study|Withdrawal by Subject|14|||
164133773|NCT02740699|592857227|FG000|Overall Study|Physician Decision|5|||
164133774|NCT02393248|592857228|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133775|NCT02393248|592857229|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
164133776|NCT02393248|592857230|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133777|NCT02393248|592857231|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133778|NCT02393248|592857232|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133779|NCT02393248|592857233|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
164133780|NCT02393248|592857234|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
164133781|NCT02393248|592857235|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133782|NCT02393248|592857236|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133783|NCT02393248|592857237|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133784|NCT02393248|592857238|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133785|NCT02393248|592857239|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133786|NCT02393248|592857240|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133787|NCT02393248|592857241|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133788|NCT02393248|592857242|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133789|NCT02393248|592857243|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133790|NCT02393248|592857244|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133791|NCT02393248|592857245|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133792|NCT02393248|592857246|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133793|NCT02393248|592857247|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133794|NCT02393248|592857248|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133795|NCT02393248|592857249|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133796|NCT02393248|592857250|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133797|NCT02393248|592857251|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133798|NCT02393248|592857252|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
164133799|NCT02393248|592857228|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133800|NCT02393248|592857229|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
164133801|NCT02393248|592857230|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133802|NCT02393248|592857231|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133803|NCT02393248|592857232|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133804|NCT02393248|592857233|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133805|NCT02393248|592857234|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133806|NCT02393248|592857235|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133807|NCT02393248|592857236|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133808|NCT02393248|592857237|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133809|NCT02393248|592857238|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133810|NCT02393248|592857239|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133811|NCT02393248|592857240|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133812|NCT02393248|592857241|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133813|NCT02393248|592857242|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133814|NCT02393248|592857243|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133815|NCT02393248|592857244|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133816|NCT02393248|592857245|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
163964811|NCT01493557|592244734|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
163964812|NCT01493557|592244732|FG000|Randomized to Management Strategies|Other adverse event|8|||
163964813|NCT01493557|592244733|FG001|Randomized to Management Strategies|Other adverse event|5|||
163964814|NCT01493557|592244734|FG002|Randomized to Management Strategies|Other adverse event|0|||
163964815|NCT01493557|592244732|FG000|Randomized to Management Strategies|Protocol Violation|3|||
163964816|NCT01493557|592244733|FG001|Randomized to Management Strategies|Protocol Violation|0|||
163964817|NCT01493557|592244734|FG002|Randomized to Management Strategies|Protocol Violation|0|||
163964818|NCT01493557|592244732|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
163964819|NCT01493557|592244733|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
163964820|NCT01493557|592244734|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
163964821|NCT01493557|592244732|FG000|Randomized to Management Strategies|Other than stated above|1|||
163964822|NCT01493557|592244733|FG001|Randomized to Management Strategies|Other than stated above|3|||
163964823|NCT01493557|592244734|FG002|Randomized to Management Strategies|Other than stated above|0|||
163855122|NCT00783692|591838238|FG000|Maintenance Phase|Withdrawal by Subject|7|||
163855123|NCT00783692|591838239|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163855124|NCT00783692|591838240|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163855125|NCT00783692|591838241|FG003|Maintenance Phase|Withdrawal by Subject|7|||
163855126|NCT00783692|591838242|FG004|Maintenance Phase|Withdrawal by Subject|6|||
163855127|NCT00783692|591838243|FG005|Maintenance Phase|Withdrawal by Subject|9|||
163855128|NCT00783692|591838244|FG006|Maintenance Phase|Withdrawal by Subject|24|||
163855129|NCT00783692|591838238|FG000|Maintenance Phase|Lost to Follow-up|2|||
163855130|NCT00783692|591838239|FG001|Maintenance Phase|Lost to Follow-up|0|||
163855131|NCT00783692|591838240|FG002|Maintenance Phase|Lost to Follow-up|0|||
163855132|NCT00783692|591838241|FG003|Maintenance Phase|Lost to Follow-up|1|||
163855133|NCT00783692|591838242|FG004|Maintenance Phase|Lost to Follow-up|3|||
163855134|NCT00783692|591838243|FG005|Maintenance Phase|Lost to Follow-up|2|||
163855135|NCT00783692|591838244|FG006|Maintenance Phase|Lost to Follow-up|5|||
163855136|NCT00783692|591838238|FG000|Maintenance Phase|Other|0|||
163855137|NCT00783692|591838239|FG001|Maintenance Phase|Other|0|||
163855138|NCT00783692|591838240|FG002|Maintenance Phase|Other|0|||
163855139|NCT00783692|591838241|FG003|Maintenance Phase|Other|1|||
163855140|NCT00783692|591838242|FG004|Maintenance Phase|Other|0|||
163855141|NCT00783692|591838243|FG005|Maintenance Phase|Other|1|||
163855142|NCT00783692|591838244|FG006|Maintenance Phase|Other|1|||
163855143|NCT05174065|591838245|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
163855144|NCT05174065|591838246|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
163855145|NCT05174065|591838247|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
163855146|NCT05174065|591838245|FG000|Placebo-controlled Period|Other|0|||
163855147|NCT05174065|591838246|FG001|Placebo-controlled Period|Other|1|||
163855148|NCT05174065|591838247|FG002|Placebo-controlled Period|Other|0|||
163855149|NCT05174065|591838245|FG000|Placebo-controlled Period|Adverse Event|1|||
163855150|NCT05174065|591838246|FG001|Placebo-controlled Period|Adverse Event|1|||
163855151|NCT05174065|591838247|FG002|Placebo-controlled Period|Adverse Event|0|||
163855152|NCT05174065|591838245|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
163855153|NCT05174065|591838246|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
163855154|NCT05174065|591838247|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
163855155|NCT05174065|591838245|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
163855156|NCT05174065|591838246|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
163855157|NCT05174065|591838247|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
163855158|NCT05174065|591838245|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
163855159|NCT05174065|591838246|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
163855160|NCT05174065|591838247|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
163855161|NCT01737268|591838248|FG000|Overall Study|Adverse Event|6|||
163855162|NCT01737268|591838248|FG000|Overall Study|Worsening of Target Disease|2|||
163855163|NCT01737268|591838248|FG000|Overall Study|In consideration of the patient's safety|1|||
163855164|NCT04873817|591838249|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
163855165|NCT04873817|591838249|FG000|Overall Study|Lost to Follow-up|4|||
163855166|NCT04873817|591838249|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
163855167|NCT04873817|591838249|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
163855168|NCT04873817|591838249|FG000|Overall Study|Other Reasons|3|||
163855169|NCT02696226|591838257|FG000|Overall Study|Study terminated - lack of enrollment|1|||
163855170|NCT02696226|591838258|FG001|Overall Study|Study terminated - lack of enrollment|0|||
163855171|NCT02696226|591838259|FG002|Overall Study|Study terminated - lack of enrollment|2|||
163855172|NCT02696226|591838260|FG003|Overall Study|Study terminated - lack of enrollment|0|||
163855173|NCT02909101|591838261|FG000|Overall Study|Lost to Follow-up|1|||
163855174|NCT02909101|591838262|FG001|Overall Study|Lost to Follow-up|1|||
163855175|NCT00097370|591838265|FG000|Stage 1|Adverse Event|3|||
163855176|NCT00097370|591838265|FG000|Stage 1|Withdrawal by Subject|1|||
163855177|NCT00097370|591838265|FG000|Stage 1|Lack of Efficacy|2|||
163855178|NCT00097370|591838265|FG000|Stage 2|Adverse Event|5|||
164191569|NCT02028507|593069564|FG000|Overall Study|Adverse Event|8|||
164191570|NCT02028507|593069565|FG001|Overall Study|Adverse Event|25|||
164191571|NCT02028507|593069566|FG002|Overall Study|Adverse Event|3|||
164191572|NCT02028507|593069567|FG003|Overall Study|Adverse Event|16|||
164191573|NCT02028507|593069564|FG000|Overall Study|Withdrawal by Subject|6|||
164191574|NCT02028507|593069565|FG001|Overall Study|Withdrawal by Subject|8|||
164191575|NCT02028507|593069566|FG002|Overall Study|Withdrawal by Subject|5|||
164191576|NCT02028507|593069567|FG003|Overall Study|Withdrawal by Subject|9|||
164191577|NCT02028507|593069564|FG000|Overall Study|Protocol Violation|2|||
164191578|NCT02028507|593069565|FG001|Overall Study|Protocol Violation|4|||
164191579|NCT02028507|593069566|FG002|Overall Study|Protocol Violation|1|||
164191580|NCT02028507|593069567|FG003|Overall Study|Protocol Violation|3|||
164191581|NCT02028507|593069564|FG000|Overall Study|Physician Decision|0|||
164191582|NCT02028507|593069565|FG001|Overall Study|Physician Decision|4|||
164191583|NCT02028507|593069566|FG002|Overall Study|Physician Decision|0|||
164191584|NCT02028507|593069567|FG003|Overall Study|Physician Decision|0|||
164191585|NCT02028507|593069564|FG000|Overall Study|Death|1|||
164191586|NCT02028507|593069565|FG001|Overall Study|Death|0|||
164191587|NCT02028507|593069566|FG002|Overall Study|Death|1|||
164191588|NCT02028507|593069567|FG003|Overall Study|Death|3|||
164191589|NCT02028507|593069564|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
164191590|NCT02028507|593069565|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
164191591|NCT02028507|593069566|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
164191592|NCT02028507|593069567|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
164191593|NCT02028507|593069564|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
164191594|NCT02028507|593069565|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
164191595|NCT02028507|593069566|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
164191596|NCT02028507|593069567|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
164191597|NCT02028507|593069564|FG000|Overall Study|Randomized But Not Treated|3|||
164191598|NCT02028507|593069565|FG001|Overall Study|Randomized But Not Treated|6|||
164191599|NCT02028507|593069566|FG002|Overall Study|Randomized But Not Treated|0|||
164191600|NCT02028507|593069567|FG003|Overall Study|Randomized But Not Treated|4|||
164191601|NCT02028507|593069564|FG000|Overall Study|Enzyme defect|0|||
164191602|NCT02028507|593069565|FG001|Overall Study|Enzyme defect|0|||
164191603|NCT02028507|593069566|FG002|Overall Study|Enzyme defect|0|||
164191604|NCT02028507|593069567|FG003|Overall Study|Enzyme defect|1|||
164191605|NCT02028507|593069564|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
164191606|NCT02028507|593069565|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
164191607|NCT02028507|593069566|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
164191608|NCT02028507|593069567|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
164191609|NCT02028507|593069564|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
164191610|NCT02028507|593069565|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
164191611|NCT02028507|593069566|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
164191612|NCT02028507|593069567|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
164191613|NCT00618826|593069568|FG000|Overall Study|Adverse Event|1|||
164191614|NCT01556932|593069569|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
164191615|NCT01556932|593069570|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
164191616|NCT02105285|593069577|FG000|Overall Study|Adverse Event|1|||
164191617|NCT02105285|593069578|FG001|Overall Study|Adverse Event|1|||
164191618|NCT02105285|593069579|FG002|Overall Study|Adverse Event|0|||
164191619|NCT02105285|593069577|FG000|Overall Study|Protocol Violation|0|||
164191620|NCT02105285|593069578|FG001|Overall Study|Protocol Violation|1|||
164191621|NCT02105285|593069579|FG002|Overall Study|Protocol Violation|0|||
164191622|NCT02105285|593069577|FG000|Overall Study|Withdrawal by Subject|1|||
164191623|NCT02105285|593069578|FG001|Overall Study|Withdrawal by Subject|0|||
164191624|NCT02105285|593069579|FG002|Overall Study|Withdrawal by Subject|0|||
164191625|NCT01421641|593069580|FG000|Overall Study|Protocol Violation|2|||
164191626|NCT01421641|593069581|FG001|Overall Study|Protocol Violation|2|||
164191627|NCT02420119|593069582|FG000|Overall Study|insufficient laboratory data|5|||
164191628|NCT03231306|593069583|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
164191629|NCT03231306|593069583|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
164191630|NCT03231306|593069583|FG000|Overall Study|Treatment delay > 21 days|2|||
164191631|NCT03231306|593069583|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
163855179|NCT00097370|591838265|FG000|Stage 2|Withdrawal by Subject|1|||
163855180|NCT00097370|591838265|FG000|Stage 2|Lack of Efficacy|3|||
163855181|NCT00097370|591838265|FG000|Stage 2|Pregnancy|1|||
164191632|NCT03231306|593069583|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
164191633|NCT03231306|593069583|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
164191634|NCT03231306|593069583|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
164191635|NCT03231306|593069583|FG000|Overall Study|More than 1 Reason|2|||
164191636|NCT01502033|593069584|FG000|Overall Study|1 participant had scalp discomfort|1|||
164191637|NCT01502033|593069584|FG000|Overall Study|1 participant had worsening depression|1|||
164191638|NCT01502033|593069584|FG000|Overall Study|1 participant went back to school|1|||
164191639|NCT02983045|593069585|FG000|Overall Study|Withdrawal by Subject|0|||
164191640|NCT02983045|593069586|FG001|Overall Study|Withdrawal by Subject|1|||
164191641|NCT02983045|593069587|FG002|Overall Study|Withdrawal by Subject|0|||
164191642|NCT02983045|593069588|FG003|Overall Study|Withdrawal by Subject|5|||
164191643|NCT02983045|593069589|FG004|Overall Study|Withdrawal by Subject|0|||
164191644|NCT02983045|593069590|FG005|Overall Study|Withdrawal by Subject|72|||
164191645|NCT02983045|593069591|FG006|Overall Study|Withdrawal by Subject|0|||
164191646|NCT02983045|593069592|FG007|Overall Study|Withdrawal by Subject|0|||
164191647|NCT02983045|593069593|FG008|Overall Study|Withdrawal by Subject|0|||
164191648|NCT02983045|593069594|FG009|Overall Study|Withdrawal by Subject|2|||
164191649|NCT02983045|593069585|FG000|Overall Study|Lost to Follow-up|0|||
164191650|NCT02983045|593069586|FG001|Overall Study|Lost to Follow-up|0|||
164191651|NCT02983045|593069587|FG002|Overall Study|Lost to Follow-up|0|||
164191652|NCT02983045|593069588|FG003|Overall Study|Lost to Follow-up|0|||
164191653|NCT02983045|593069589|FG004|Overall Study|Lost to Follow-up|0|||
164191654|NCT02983045|593069590|FG005|Overall Study|Lost to Follow-up|10|||
164191655|NCT02983045|593069591|FG006|Overall Study|Lost to Follow-up|0|||
164191656|NCT02983045|593069592|FG007|Overall Study|Lost to Follow-up|0|||
164191657|NCT02983045|593069593|FG008|Overall Study|Lost to Follow-up|0|||
164191658|NCT02983045|593069594|FG009|Overall Study|Lost to Follow-up|0|||
164191659|NCT01808261|593069595|FG000|Overall Study|Physician Decision|0|||
164191660|NCT01808261|593069596|FG001|Overall Study|Physician Decision|2|||
164191661|NCT01808261|593069595|FG000|Overall Study|Study Closed/Terminated|25|||
164191662|NCT01808261|593069596|FG001|Overall Study|Study Closed/Terminated|23|||
164191663|NCT01808261|593069595|FG000|Overall Study|Adverse event, non-fatal|2|||
164191664|NCT01808261|593069596|FG001|Overall Study|Adverse event, non-fatal|0|||
164191665|NCT01808261|593069595|FG000|Overall Study|Consent withdrawn by subject|6|||
164191666|NCT01808261|593069596|FG001|Overall Study|Consent withdrawn by subject|7|||
164191667|NCT01808261|593069595|FG000|Overall Study|Lost to Follow-up|3|||
164191668|NCT01808261|593069596|FG001|Overall Study|Lost to Follow-up|1|||
164191669|NCT02585713|593069597|FG000|Overall Study|Withdrew prior to treatment|2|||
164191670|NCT02585713|593069598|FG001|Overall Study|Withdrew prior to treatment|7|||
164191671|NCT02585713|593069597|FG000|Overall Study|Other|3|||
164191672|NCT02585713|593069598|FG001|Overall Study|Other|1|||
164191673|NCT02080364|593069601|FG000|Baseline Period|Protocol Violation|2|||
164191674|NCT02080364|593069602|FG001|Baseline Period|Protocol Violation|1|||
164191675|NCT02080364|593069603|FG002|Baseline Period|Protocol Violation|0|||
164191676|NCT02080364|593069604|FG003|Baseline Period|Protocol Violation|0|||
164191677|NCT02080364|593069601|FG000|Baseline Period|Other|0|||
164191678|NCT02080364|593069602|FG001|Baseline Period|Other|1|||
164191679|NCT02080364|593069603|FG002|Baseline Period|Other|1|||
164191680|NCT02080364|593069604|FG003|Baseline Period|Other|0|||
164191681|NCT02080364|593069601|FG000|Treatment Period|Adverse Event|10|||
164191682|NCT02080364|593069602|FG001|Treatment Period|Adverse Event|15|||
164191683|NCT02080364|593069603|FG002|Treatment Period|Adverse Event|11|||
164191684|NCT02080364|593069604|FG003|Treatment Period|Adverse Event|14|||
164191685|NCT02080364|593069601|FG000|Treatment Period|Lost to Follow-up|2|||
164191686|NCT02080364|593069602|FG001|Treatment Period|Lost to Follow-up|3|||
164191687|NCT02080364|593069603|FG002|Treatment Period|Lost to Follow-up|5|||
164191688|NCT02080364|593069604|FG003|Treatment Period|Lost to Follow-up|0|||
164191689|NCT02080364|593069601|FG000|Treatment Period|Protocol Violation|5|||
164191690|NCT02080364|593069602|FG001|Treatment Period|Protocol Violation|3|||
164191691|NCT02080364|593069603|FG002|Treatment Period|Protocol Violation|5|||
164191692|NCT02080364|593069604|FG003|Treatment Period|Protocol Violation|1|||
164191693|NCT02080364|593069601|FG000|Treatment Period|Withdrawal by Subject|16|||
164191694|NCT02080364|593069602|FG001|Treatment Period|Withdrawal by Subject|16|||
164191695|NCT02080364|593069603|FG002|Treatment Period|Withdrawal by Subject|15|||
164191696|NCT02080364|593069604|FG003|Treatment Period|Withdrawal by Subject|10|||
164191697|NCT02080364|593069601|FG000|Treatment Period|Study Terminated by Sponsor|0|||
164191698|NCT02080364|593069602|FG001|Treatment Period|Study Terminated by Sponsor|0|||
164191699|NCT02080364|593069603|FG002|Treatment Period|Study Terminated by Sponsor|180|||
164191700|NCT02080364|593069604|FG003|Treatment Period|Study Terminated by Sponsor|183|||
164191701|NCT02080364|593069601|FG000|Treatment Period|Other|14|||
164191702|NCT02080364|593069602|FG001|Treatment Period|Other|12|||
163855182|NCT00097370|591838265|FG000|Stage 2|Sponsor Terminated Study|2|||
164191703|NCT02080364|593069603|FG002|Treatment Period|Other|21|||
164191704|NCT02080364|593069604|FG003|Treatment Period|Other|16|||
164191705|NCT02609984|593069605|FG000|Overall Study|Death|29|||
164191706|NCT02609984|593069606|FG001|Overall Study|Death|26|||
164191707|NCT02609984|593069605|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
164191708|NCT02609984|593069606|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
164191709|NCT02609984|593069605|FG000|Overall Study|Lost to Follow-up|1|||
164191710|NCT02609984|593069606|FG001|Overall Study|Lost to Follow-up|2|||
164191711|NCT02609984|593069605|FG000|Overall Study|Withdrawal by Subject|0|||
164191712|NCT02609984|593069606|FG001|Overall Study|Withdrawal by Subject|1|||
164191713|NCT02609984|593069605|FG000|Overall Study|Disease Progression|2|||
164191714|NCT02609984|593069606|FG001|Overall Study|Disease Progression|0|||
164191715|NCT00991289|593069607|FG000|Overall Study|Adverse Event|1|||
164191716|NCT00991289|593069607|FG000|Overall Study|Physician Decision|2|||
164191717|NCT00991289|593069607|FG000|Overall Study|Withdrawal by Subject|3|||
164191718|NCT00991289|593069607|FG000|Overall Study|Lost to Follow-up|4|||
164191719|NCT00991289|593069607|FG000|Overall Study|Protocol Violation|2|||
164191720|NCT02256839|593069609|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
164191721|NCT02256839|593069610|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
164191722|NCT01843803|593069611|FG000|Overall Study|not a Veteran, did not see provider|1|||
164191723|NCT01843803|593069612|FG001|Overall Study|not a Veteran, did not see provider|3|||
164191724|NCT00436826|593069616|FG000|Double Blind Period (DBP)|Adverse Event|2|||
164191725|NCT00436826|593069617|FG001|Double Blind Period (DBP)|Adverse Event|0|||
164191726|NCT00436826|593069618|FG002|Double Blind Period (DBP)|Adverse Event|0|||
164191727|NCT00436826|593069619|FG003|Double Blind Period (DBP)|Adverse Event|0|||
164191728|NCT00436826|593069620|FG004|Double Blind Period (DBP)|Adverse Event|0|||
164191729|NCT00436826|593069621|FG005|Double Blind Period (DBP)|Adverse Event|0|||
164191730|NCT00436826|593069616|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
164191731|NCT00436826|593069617|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
164191732|NCT00436826|593069618|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
164191733|NCT00436826|593069619|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
164191734|NCT00436826|593069620|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
164191735|NCT00436826|593069621|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
164191736|NCT00436826|593069616|FG000|Double Blind Period (DBP)|Other|10|||
164191737|NCT00436826|593069617|FG001|Double Blind Period (DBP)|Other|11|||
164191738|NCT00436826|593069618|FG002|Double Blind Period (DBP)|Other|0|||
164191739|NCT00436826|593069619|FG003|Double Blind Period (DBP)|Other|0|||
164191740|NCT00436826|593069620|FG004|Double Blind Period (DBP)|Other|0|||
164191741|NCT00436826|593069621|FG005|Double Blind Period (DBP)|Other|0|||
164191742|NCT00436826|593069616|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191743|NCT00436826|593069617|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191744|NCT00436826|593069618|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191745|NCT00436826|593069619|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
164191746|NCT00436826|593069620|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191747|NCT00436826|593069621|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
164191748|NCT00436826|593069616|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191749|NCT00436826|593069617|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191750|NCT00436826|593069618|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
164191751|NCT00436826|593069619|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
164191752|NCT00436826|593069620|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191753|NCT00436826|593069621|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
164191754|NCT00436826|593069616|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191755|NCT00436826|593069617|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191756|NCT00436826|593069618|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191757|NCT00436826|593069619|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
164191758|NCT00436826|593069620|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
164191759|NCT00436826|593069621|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
164191760|NCT00784719|593069622|FG000|Overall Study|Adverse Event|0|||
164191761|NCT00784719|593069623|FG001|Overall Study|Adverse Event|2|||
164191762|NCT00784719|593069624|FG002|Overall Study|Adverse Event|0|||
164191763|NCT00784719|593069625|FG003|Overall Study|Adverse Event|0|||
164191764|NCT00784719|593069626|FG004|Overall Study|Adverse Event|1|||
164191765|NCT00784719|593069627|FG005|Overall Study|Adverse Event|1|||
164191766|NCT00784719|593069628|FG006|Overall Study|Adverse Event|1|||
164191767|NCT00784719|593069622|FG000|Overall Study|Lost to Follow-up|0|||
164191768|NCT00784719|593069623|FG001|Overall Study|Lost to Follow-up|0|||
164191769|NCT00784719|593069624|FG002|Overall Study|Lost to Follow-up|0|||
164191770|NCT00784719|593069625|FG003|Overall Study|Lost to Follow-up|0|||
164191771|NCT00784719|593069626|FG004|Overall Study|Lost to Follow-up|1|||
164191772|NCT00784719|593069627|FG005|Overall Study|Lost to Follow-up|1|||
164191773|NCT00784719|593069628|FG006|Overall Study|Lost to Follow-up|0|||
164191774|NCT00784719|593069622|FG000|Overall Study|Other|2|||
164191775|NCT00784719|593069623|FG001|Overall Study|Other|1|||
164191776|NCT00784719|593069624|FG002|Overall Study|Other|1|||
164191777|NCT00784719|593069625|FG003|Overall Study|Other|0|||
164191778|NCT00784719|593069626|FG004|Overall Study|Other|2|||
164191779|NCT00784719|593069627|FG005|Overall Study|Other|1|||
164191780|NCT00784719|593069628|FG006|Overall Study|Other|3|||
164191781|NCT00784719|593069622|FG000|Overall Study|Withdrawal by Subject|1|||
164191782|NCT00784719|593069623|FG001|Overall Study|Withdrawal by Subject|0|||
164191783|NCT00784719|593069624|FG002|Overall Study|Withdrawal by Subject|0|||
163855183|NCT00097370|591838265|FG000|Stage 2|Lost to Follow-up|1|||
163855184|NCT00097370|591838265|FG000|Stage 3|Adverse Event|2|||
164191784|NCT00784719|593069625|FG003|Overall Study|Withdrawal by Subject|0|||
164191785|NCT00784719|593069626|FG004|Overall Study|Withdrawal by Subject|2|||
164191786|NCT00784719|593069627|FG005|Overall Study|Withdrawal by Subject|0|||
164191787|NCT00784719|593069628|FG006|Overall Study|Withdrawal by Subject|1|||
164191788|NCT02401035|593069632|FG000|Overall Study|Withdrawal by Subject|1|||
164191789|NCT02401035|593069633|FG001|Overall Study|Withdrawal by Subject|0|||
164191790|NCT00869128|593069634|FG000|Overall Study|lack of Compliance|6|||
164191791|NCT00869128|593069635|FG001|Overall Study|lack of Compliance|6|||
164191792|NCT00985686|593069641|FG000|Overall Study|Lost to Follow-up|1|||
164191793|NCT00985686|593069642|FG001|Overall Study|Lost to Follow-up|1|||
164191794|NCT00985686|593069643|FG002|Overall Study|Lost to Follow-up|0|||
164191795|NCT00985686|593069644|FG003|Overall Study|Lost to Follow-up|2|||
164191796|NCT03046953|593069645|FG000|Overall Study|Relapse/progressive disease|21|||
164191797|NCT03046953|593069645|FG000|Overall Study|Death|2|||
164191798|NCT03046953|593069645|FG000|Overall Study|Withdrawal by Subject|3|||
164191799|NCT04039204|593069647|FG000|Overall Study|Withdrawal by Subject|0|||
164191800|NCT04039204|593069648|FG001|Overall Study|Withdrawal by Subject|2|||
164191801|NCT00396383|593069655|FG000|Overall Study|Death|2|||
164191802|NCT00396383|593069655|FG000|Overall Study|Lost to Follow-up|1|||
164191803|NCT01124292|593069656|FG000|Overall Study|Lost to Follow-up|2|||
164191804|NCT01124292|593069657|FG001|Overall Study|Lost to Follow-up|4|||
164191805|NCT01124292|593069658|FG002|Overall Study|Lost to Follow-up|3|||
164191806|NCT01124292|593069656|FG000|Overall Study|Physician Decision|0|||
164191807|NCT01124292|593069657|FG001|Overall Study|Physician Decision|3|||
164191808|NCT01124292|593069658|FG002|Overall Study|Physician Decision|2|||
164191809|NCT01124292|593069656|FG000|Overall Study|Withdrawal by Subject|0|||
164191810|NCT01124292|593069657|FG001|Overall Study|Withdrawal by Subject|6|||
164191811|NCT01124292|593069658|FG002|Overall Study|Withdrawal by Subject|2|||
164191812|NCT01124292|593069656|FG000|Overall Study|medical issue unrelated to the study|0|||
164191813|NCT01124292|593069657|FG001|Overall Study|medical issue unrelated to the study|0|||
164191814|NCT01124292|593069658|FG002|Overall Study|medical issue unrelated to the study|2|||
164191815|NCT01124292|593069656|FG000|Overall Study|piercing track closed|0|||
164191816|NCT01124292|593069657|FG001|Overall Study|piercing track closed|2|||
164191817|NCT01124292|593069658|FG002|Overall Study|piercing track closed|1|||
164191818|NCT01237327|593069659|FG000|Overall Study|Protocol Violation: Core Study|1|||
164191819|NCT01237327|593069660|FG001|Overall Study|Protocol Violation: Core Study|0|||
164191820|NCT01237327|593069659|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
164191821|NCT01237327|593069660|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
164191822|NCT01237327|593069659|FG000|Overall Study|Progression of Disease: Core Study|18|||
164191823|NCT01237327|593069660|FG001|Overall Study|Progression of Disease: Core Study|22|||
164191824|NCT01237327|593069659|FG000|Overall Study|Progression of Disease: Extension Study|15|||
164191825|NCT01237327|593069660|FG001|Overall Study|Progression of Disease: Extension Study|13|||
164191826|NCT01237327|593069659|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
164191827|NCT01237327|593069660|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
164191828|NCT01237327|593069659|FG000|Overall Study|Withdrawal by Subject|1|||
164302198|NCT01134055|593482562|FG006|Overall Study|Adverse Event|2|||
163964824|NCT01493557|592244732|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
163964825|NCT01493557|592244733|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
163964826|NCT01493557|592244734|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
163964827|NCT01493557|592244732|FG000|Adding the Second Strategy|Other adverse event|1|||
163964828|NCT01493557|592244733|FG001|Adding the Second Strategy|Other adverse event|2|||
163964829|NCT01493557|592244734|FG002|Adding the Second Strategy|Other adverse event|0|||
163964830|NCT01493557|592244732|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
164134283|NCT01739348|592857280|FG002|Part I (Base Study)|Death|2|||
164134284|NCT01739348|592857281|FG003|Part I (Base Study)|Death|8|||
164134285|NCT01739348|592857278|FG000|Part I (Base Study)|Lack of Efficacy|3|||
164134286|NCT01739348|592857279|FG001|Part I (Base Study)|Lack of Efficacy|8|||
164134287|NCT01739348|592857280|FG002|Part I (Base Study)|Lack of Efficacy|0|||
164134288|NCT01739348|592857281|FG003|Part I (Base Study)|Lack of Efficacy|7|||
164134289|NCT01739348|592857278|FG000|Part I (Base Study)|Lost to Follow-up|4|||
164134290|NCT01739348|592857279|FG001|Part I (Base Study)|Lost to Follow-up|2|||
164134291|NCT01739348|592857280|FG002|Part I (Base Study)|Lost to Follow-up|4|||
164134292|NCT01739348|592857281|FG003|Part I (Base Study)|Lost to Follow-up|4|||
164134293|NCT01739348|592857278|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
164134294|NCT01739348|592857279|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
164134295|NCT01739348|592857280|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
164134296|NCT01739348|592857281|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
164134297|NCT01739348|592857278|FG000|Part I (Base Study)|Physician Decision|10|||
164134298|NCT01739348|592857279|FG001|Part I (Base Study)|Physician Decision|7|||
164134299|NCT01739348|592857280|FG002|Part I (Base Study)|Physician Decision|1|||
164134300|NCT01739348|592857281|FG003|Part I (Base Study)|Physician Decision|4|||
164134301|NCT01739348|592857278|FG000|Part I (Base Study)|Protocol Violation|2|||
164134302|NCT01739348|592857279|FG001|Part I (Base Study)|Protocol Violation|0|||
164134303|NCT01739348|592857280|FG002|Part I (Base Study)|Protocol Violation|1|||
164134304|NCT01739348|592857281|FG003|Part I (Base Study)|Protocol Violation|2|||
164191829|NCT01237327|593069660|FG001|Overall Study|Withdrawal by Subject|3|||
164191830|NCT01237327|593069659|FG000|Overall Study|Lost to Follow-up|3|||
164191831|NCT01237327|593069660|FG001|Overall Study|Lost to Follow-up|0|||
164191832|NCT02557516|593069661|FG000|Overall Study|Adverse Event|1|||
164191833|NCT02557516|593069662|FG001|Overall Study|Adverse Event|0|||
164191834|NCT02557516|593069663|FG002|Overall Study|Adverse Event|2|||
164191835|NCT02557516|593069664|FG003|Overall Study|Adverse Event|1|||
164191836|NCT02557516|593069661|FG000|Overall Study|Disease progression|0|||
164191837|NCT02557516|593069662|FG001|Overall Study|Disease progression|2|||
164191838|NCT02557516|593069663|FG002|Overall Study|Disease progression|0|||
164191839|NCT02557516|593069664|FG003|Overall Study|Disease progression|0|||
164191840|NCT02557516|593069661|FG000|Overall Study|Physician Decision|0|||
164191841|NCT02557516|593069662|FG001|Overall Study|Physician Decision|2|||
164191842|NCT02557516|593069663|FG002|Overall Study|Physician Decision|0|||
164191843|NCT02557516|593069664|FG003|Overall Study|Physician Decision|0|||
164191844|NCT02557516|593069661|FG000|Overall Study|Sponsor decision|0|||
164191845|NCT02557516|593069662|FG001|Overall Study|Sponsor decision|1|||
164191846|NCT02557516|593069663|FG002|Overall Study|Sponsor decision|2|||
164191847|NCT02557516|593069664|FG003|Overall Study|Sponsor decision|8|||
164191848|NCT01972464|593069665|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
164191849|NCT01972464|593069666|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
164191850|NCT01972464|593069665|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
164191851|NCT01972464|593069666|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
164191852|NCT01972464|593069665|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
164191853|NCT01972464|593069666|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
164191854|NCT01972464|593069665|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
164191855|NCT01972464|593069666|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
164191856|NCT02358031|593071861|FG000|Overall Study|Death|253|||
164191857|NCT02358031|593071862|FG001|Overall Study|Death|237|||
164191858|NCT02358031|593071863|FG002|Overall Study|Death|266|||
164191859|NCT02358031|593071861|FG000|Overall Study|Lost to Follow-up|1|||
164191860|NCT02358031|593071862|FG001|Overall Study|Lost to Follow-up|1|||
164191861|NCT02358031|593071863|FG002|Overall Study|Lost to Follow-up|0|||
164191862|NCT02358031|593071861|FG000|Overall Study|Withdrawal by Subject|19|||
164191863|NCT02358031|593071862|FG001|Overall Study|Withdrawal by Subject|14|||
164191864|NCT02358031|593071863|FG002|Overall Study|Withdrawal by Subject|18|||
164191865|NCT02358031|593071861|FG000|Overall Study|Sponsor Decision|26|||
164191866|NCT02358031|593071862|FG001|Overall Study|Sponsor Decision|28|||
164191867|NCT02358031|593071863|FG002|Overall Study|Sponsor Decision|16|||
164191868|NCT04980014|593071872|FG000|Overall Study|Participants who are Duplicated|1|||
164191869|NCT04980014|593071872|FG000|Overall Study|Follow-up Failure|13|||
164191870|NCT04980014|593071872|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
164191871|NCT04980014|593071872|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
164191872|NCT04980014|593071872|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
164191873|NCT00940888|593071873|FG000|Overall Study|Unsuccessful Implant|4|||
164191874|NCT00940888|593071873|FG000|Overall Study|Death|461|||
164191875|NCT00940888|593071873|FG000|Overall Study|Withdrawn - Non-Death|364|||
164191876|NCT00940888|593071873|FG000|Overall Study|Lost to Follow-up|6|||
164191877|NCT01409915|593071877|FG000|Overall Study|Adverse Event|0|||
164191878|NCT01409915|593071878|FG001|Overall Study|Adverse Event|2|||
164191879|NCT01409915|593071877|FG000|Overall Study|Withdrawal by Subject|0|||
164191880|NCT01409915|593071878|FG001|Overall Study|Withdrawal by Subject|1|||
164191881|NCT01409915|593071877|FG000|Overall Study|Protocol Violation|1|||
164191882|NCT01409915|593071878|FG001|Overall Study|Protocol Violation|0|||
164191883|NCT02250300|593071882|FG000|Expansion Phase|Death|6|||
164191884|NCT02250300|593071883|FG001|Expansion Phase|Death|7|||
164191885|NCT02250300|593071884|FG002|Expansion Phase|Death|0|||
164191886|NCT02250300|593071885|FG003|Expansion Phase|Death|0|||
164191887|NCT00715559|593071887|FG000|Overall Study|medication not tolerated - nausea|1|||
164191888|NCT00758498|593071888|FG000|Overall Study|Adverse Event|2|||
164191889|NCT00758498|593071889|FG001|Overall Study|Adverse Event|2|||
164191890|NCT00758498|593071890|FG002|Overall Study|Adverse Event|3|||
163855185|NCT00097370|591838265|FG000|Stage 3|Withdrawal by Subject|3|||
164191891|NCT00758498|593071888|FG000|Overall Study|Subject legally detained out of state|1|||
164191892|NCT00758498|593071889|FG001|Overall Study|Subject legally detained out of state|0|||
164191893|NCT00758498|593071890|FG002|Overall Study|Subject legally detained out of state|0|||
164191894|NCT00758498|593071888|FG000|Overall Study|Withdrawal by Subject|0|||
164191895|NCT00758498|593071889|FG001|Overall Study|Withdrawal by Subject|0|||
164191896|NCT00758498|593071890|FG002|Overall Study|Withdrawal by Subject|1|||
164191897|NCT00758498|593071888|FG000|Overall Study|Noncompliance to study procedures|0|||
164191898|NCT00758498|593071889|FG001|Overall Study|Noncompliance to study procedures|0|||
164191899|NCT00758498|593071890|FG002|Overall Study|Noncompliance to study procedures|1|||
164191900|NCT01845597|593071891|FG000|Overall Study|Death|8|||
164191901|NCT01845597|593071891|FG000|Overall Study|Lost to Follow-up|22|||
164191902|NCT01516736|593071895|FG000|Overall Study|Withdrawal by Subject|10|||
164191903|NCT01516736|593071896|FG001|Overall Study|Withdrawal by Subject|4|||
164191904|NCT01516736|593071895|FG000|Overall Study|Adverse Event|4|||
164191905|NCT01516736|593071896|FG001|Overall Study|Adverse Event|5|||
164191906|NCT01516736|593071895|FG000|Overall Study|Death|3|||
164191907|NCT01516736|593071896|FG001|Overall Study|Death|1|||
164191908|NCT01516736|593071895|FG000|Overall Study|Physician Decision|2|||
164191909|NCT01516736|593071896|FG001|Overall Study|Physician Decision|1|||
164191910|NCT01516736|593071895|FG000|Overall Study|Lack of Efficacy|1|||
164191911|NCT01516736|593071896|FG001|Overall Study|Lack of Efficacy|0|||
164191912|NCT01516736|593071895|FG000|Overall Study|Protocol Violation|0|||
164191913|NCT01516736|593071896|FG001|Overall Study|Protocol Violation|1|||
164191914|NCT01516736|593071895|FG000|Overall Study|Other (not specified)|0|||
164191915|NCT01516736|593071896|FG001|Overall Study|Other (not specified)|1|||
164191916|NCT00524771|593071899|FG000|Overall Study|Protocol Violation|220|||
164191917|NCT00524771|593071900|FG001|Overall Study|Protocol Violation|585|||
164191918|NCT02781818|593071901|FG000|Overall Study|Lost to Follow-up|4|||
164191919|NCT02781818|593071902|FG001|Overall Study|Lost to Follow-up|2|||
164191920|NCT02781818|593071903|FG002|Overall Study|Lost to Follow-up|1|||
164191921|NCT01877668|593071904|FG000|Overall Study|Death|0|||
164191922|NCT01877668|593071905|FG001|Overall Study|Death|0|||
164191923|NCT01877668|593071906|FG002|Overall Study|Death|0|||
164191924|NCT01877668|593071907|FG003|Overall Study|Death|1|||
164191925|NCT01877668|593071908|FG004|Overall Study|Death|0|||
164191926|NCT01877668|593071904|FG000|Overall Study|No longer met study criteria|1|||
164191927|NCT01877668|593071905|FG001|Overall Study|No longer met study criteria|0|||
164191928|NCT01877668|593071906|FG002|Overall Study|No longer met study criteria|1|||
164191929|NCT01877668|593071907|FG003|Overall Study|No longer met study criteria|0|||
164191930|NCT01877668|593071908|FG004|Overall Study|No longer met study criteria|0|||
164191931|NCT01877668|593071904|FG000|Overall Study|Insufficient clinical response|0|||
164191932|NCT01877668|593071905|FG001|Overall Study|Insufficient clinical response|1|||
164191933|NCT01877668|593071906|FG002|Overall Study|Insufficient clinical response|2|||
164191934|NCT01877668|593071907|FG003|Overall Study|Insufficient clinical response|2|||
164191935|NCT01877668|593071908|FG004|Overall Study|Insufficient clinical response|0|||
164191936|NCT01877668|593071904|FG000|Overall Study|Lost to Follow-up|0|||
164191937|NCT01877668|593071905|FG001|Overall Study|Lost to Follow-up|2|||
164191938|NCT01877668|593071906|FG002|Overall Study|Lost to Follow-up|1|||
164191939|NCT01877668|593071907|FG003|Overall Study|Lost to Follow-up|0|||
164191940|NCT01877668|593071908|FG004|Overall Study|Lost to Follow-up|0|||
164191941|NCT01877668|593071904|FG000|Overall Study|Withdrawal by Subject|2|||
164191942|NCT01877668|593071905|FG001|Overall Study|Withdrawal by Subject|0|||
164191943|NCT01877668|593071906|FG002|Overall Study|Withdrawal by Subject|3|||
164191944|NCT01877668|593071907|FG003|Overall Study|Withdrawal by Subject|2|||
164191945|NCT01877668|593071908|FG004|Overall Study|Withdrawal by Subject|2|||
164191946|NCT01877668|593071904|FG000|Overall Study|Other|1|||
164191947|NCT01877668|593071905|FG001|Overall Study|Other|1|||
164191948|NCT01877668|593071906|FG002|Overall Study|Other|1|||
164191949|NCT01877668|593071907|FG003|Overall Study|Other|1|||
164191950|NCT01877668|593071908|FG004|Overall Study|Other|3|||
164191951|NCT01877668|593071904|FG000|Overall Study|Protocol Violation|1|||
164191952|NCT01877668|593071905|FG001|Overall Study|Protocol Violation|1|||
164191953|NCT01877668|593071906|FG002|Overall Study|Protocol Violation|0|||
164191954|NCT01877668|593071907|FG003|Overall Study|Protocol Violation|0|||
164191955|NCT01877668|593071908|FG004|Overall Study|Protocol Violation|3|||
164191956|NCT01877668|593071904|FG000|Overall Study|Adverse event related to study drug|2|||
164191957|NCT01877668|593071905|FG001|Overall Study|Adverse event related to study drug|2|||
164191958|NCT01877668|593071906|FG002|Overall Study|Adverse event related to study drug|2|||
164191959|NCT01877668|593071907|FG003|Overall Study|Adverse event related to study drug|2|||
164191960|NCT01877668|593071908|FG004|Overall Study|Adverse event related to study drug|1|||
164191961|NCT01877668|593071904|FG000|Overall Study|Adverse event unrelated to study drug|4|||
164191962|NCT01877668|593071905|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164191963|NCT01877668|593071906|FG002|Overall Study|Adverse event unrelated to study drug|2|||
164191964|NCT01877668|593071907|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164191965|NCT01877668|593071908|FG004|Overall Study|Adverse event unrelated to study drug|1|||
164191966|NCT02317991|593071909|FG000|Overall Study|Adverse Event|12|||
164191967|NCT02317991|593071909|FG000|Overall Study|Death|4|||
164191968|NCT02317991|593071909|FG000|Overall Study|Withdrawal by Subject|8|||
164191969|NCT02317991|593071909|FG000|Overall Study|Progressive Disease|41|||
164191970|NCT01223404|593071910|FG000|First Intervention (1 Day)|Adverse Event|0|||
164191971|NCT01223404|593071911|FG001|First Intervention (1 Day)|Adverse Event|0|||
164191972|NCT01223404|593071912|FG002|First Intervention (1 Day)|Adverse Event|0|||
164191973|NCT01223404|593071913|FG003|First Intervention (1 Day)|Adverse Event|1|||
164191974|NCT01223404|593071914|FG004|First Intervention (1 Day)|Adverse Event|0|||
164191975|NCT01223404|593071915|FG005|First Intervention (1 Day)|Adverse Event|0|||
164191976|NCT01223404|593071910|FG000|Second Intervention (1 Day)|Adverse Event|1|||
164191977|NCT01223404|593071911|FG001|Second Intervention (1 Day)|Adverse Event|0|||
164191978|NCT01223404|593071912|FG002|Second Intervention (1 Day)|Adverse Event|0|||
164191979|NCT01223404|593071913|FG003|Second Intervention (1 Day)|Adverse Event|0|||
164191980|NCT01223404|593071914|FG004|Second Intervention (1 Day)|Adverse Event|0|||
164191981|NCT01223404|593071915|FG005|Second Intervention (1 Day)|Adverse Event|0|||
164191982|NCT01223404|593071910|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191983|NCT01223404|593071911|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191984|NCT01223404|593071912|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191985|NCT01223404|593071913|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
164191986|NCT01223404|593071914|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191987|NCT01223404|593071915|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
164191988|NCT02492165|593071916|FG000|Overall Study|Withdrawal by Subject|0|||
164191989|NCT02492165|593071917|FG001|Overall Study|Withdrawal by Subject|1|||
164191990|NCT02492165|593071918|FG002|Overall Study|Withdrawal by Subject|0|||
164191991|NCT02492165|593071919|FG003|Overall Study|Withdrawal by Subject|0|||
164191992|NCT00707057|593071920|FG000|Overall Study|Withdrawal by Subject|8|||
164191993|NCT00707057|593071921|FG001|Overall Study|Withdrawal by Subject|3|||
164191994|NCT00707057|593071920|FG000|Overall Study|Dosed incorrectly|0|||
164191995|NCT00707057|593071921|FG001|Overall Study|Dosed incorrectly|1|||
164191996|NCT01697800|593071922|FG000|Overall Study|Death|0|||
164191997|NCT01697800|593071923|FG001|Overall Study|Death|1|||
164191998|NCT00954122|593071924|FG000|Overall Study|Withdrawal by Subject|5|||
164191999|NCT00954122|593071924|FG000|Overall Study|Adverse Event|1|||
164192000|NCT00954122|593071924|FG000|Overall Study|Safety Reason|1|||
164192001|NCT01957579|593071929|FG000|Overall Study|Withdrawal of concent|0|||
164192002|NCT01957579|593071930|FG001|Overall Study|Withdrawal of concent|1|||
164192003|NCT01957579|593071931|FG002|Overall Study|Withdrawal of concent|0|||
164192004|NCT01957579|593071932|FG003|Overall Study|Withdrawal of concent|0|||
164192005|NCT01957579|593071929|FG000|Overall Study|Death|0|||
164192006|NCT01957579|593071930|FG001|Overall Study|Death|0|||
164192007|NCT01957579|593071931|FG002|Overall Study|Death|2|||
164192008|NCT01957579|593071932|FG003|Overall Study|Death|0|||
164192009|NCT02019550|593071933|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164192010|NCT02019550|593071934|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
164192011|NCT02750332|593071936|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164192012|NCT02750332|593071937|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164192013|NCT00823134|593071943|FG000|Overall Study|Invalid measurement|1|||
164192014|NCT03316586|593071954|FG000|Overall Study|Adverse Event|2|||
164192015|NCT03316586|593071954|FG000|Overall Study|Physician Decision|3|||
164192016|NCT03316586|593071954|FG000|Overall Study|Lack of Efficacy|10|||
164192017|NCT03316586|593071954|FG000|Overall Study|still on treatment|1|||
164192018|NCT03316586|593071954|FG000|Overall Study|Patient needed radiation therapy|1|||
164192019|NCT03316586|593071954|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
164192020|NCT00994110|593071955|FG000|Overall Study|Withdrawal by Subject|9|||
164192021|NCT00994110|593071956|FG001|Overall Study|Withdrawal by Subject|9|||
164192022|NCT00994110|593071955|FG000|Overall Study|Not Treated|4|||
164192023|NCT00994110|593071956|FG001|Overall Study|Not Treated|8|||
164192024|NCT00994110|593071955|FG000|Overall Study|Adverse Event|1|||
164192025|NCT00994110|593071956|FG001|Overall Study|Adverse Event|0|||
164192026|NCT00994110|593071955|FG000|Overall Study|Patient not resected|41|||
164192027|NCT00994110|593071956|FG001|Overall Study|Patient not resected|52|||
164192028|NCT00994110|593071955|FG000|Overall Study|Pt not eligible|10|||
164192029|NCT00994110|593071956|FG001|Overall Study|Pt not eligible|5|||
164192030|NCT00619827|593071957|FG000|Overall Study|Adverse Event|1|||
164192031|NCT00619827|593071958|FG001|Overall Study|Adverse Event|2|||
164192032|NCT00619827|593071957|FG000|Overall Study|Withdrawal by Subject|2|||
164192033|NCT00619827|593071958|FG001|Overall Study|Withdrawal by Subject|2|||
164192034|NCT02806713|593071959|FG000|Overall Study|Urethral injury during procedure|1|||
164192035|NCT02806713|593071960|FG001|Overall Study|Urethral injury during procedure|0|||
164192036|NCT02806713|593071959|FG000|Overall Study|cancelled surgery|1|||
164192037|NCT02806713|593071960|FG001|Overall Study|cancelled surgery|2|||
164192038|NCT02163395|593071961|FG000|Overall Study|Withdrawal by Subject|1|||
164192039|NCT02163395|593071961|FG000|Overall Study|Lost to Follow-up|3|||
164192040|NCT02163395|593071961|FG000|Overall Study|Adverse Event|1|||
164192041|NCT04878055|593071962|FG000|Overall Study|Patient transferred in another department|0|||
164192042|NCT04878055|593071963|FG001|Overall Study|Patient transferred in another department|2|||
164192043|NCT04878055|593071962|FG000|Overall Study|Physician Decision|1|||
163855186|NCT00097370|591838265|FG000|Stage 3|Lack of Efficacy|1|||
163855187|NCT00097370|591838265|FG000|Stage 3|Sponsor Terminated Study|52|||
163855188|NCT00097370|591838265|FG000|Stage 3|Lost to Follow-up|1|||
164192044|NCT04878055|593071963|FG001|Overall Study|Physician Decision|1|||
164192045|NCT04878055|593071962|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
164192046|NCT04878055|593071963|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
164192047|NCT04878055|593071962|FG000|Overall Study|Adverse Event|12|||
163855189|NCT01394991|591838266|FG000|Overall Study|Adverse Event|0|||
164192048|NCT04878055|593071963|FG001|Overall Study|Adverse Event|7|||
164192049|NCT04878055|593071962|FG000|Overall Study|Other|5|||
164192050|NCT04878055|593071963|FG001|Overall Study|Other|0|||
164192051|NCT04878055|593071962|FG000|Overall Study|Withdrawal by Subject|7|||
164192052|NCT04878055|593071963|FG001|Overall Study|Withdrawal by Subject|3|||
164192053|NCT04878055|593071962|FG000|Overall Study|Lost to Follow-up|10|||
164192054|NCT04878055|593071963|FG001|Overall Study|Lost to Follow-up|1|||
164192055|NCT01968811|593071964|FG000|Overall Study|Protocol Violation|4|||
164192056|NCT01968811|593071964|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
164192057|NCT01178125|593071966|FG000|Overall Study|Lost to Follow-up|397|||
164192058|NCT01178125|593071966|FG000|Overall Study|Adverse Event|244|||
164192059|NCT01178125|593071966|FG000|Overall Study|Withdrawal by Subject|209|||
164192060|NCT01178125|593071966|FG000|Overall Study|Noncompliance|184|||
164192061|NCT01178125|593071966|FG000|Overall Study|Pregnancy|55|||
164192062|NCT01178125|593071966|FG000|Overall Study|Other Reason|39|||
164192063|NCT01178125|593071966|FG000|Overall Study|Sponsor Decision|28|||
164192064|NCT01178125|593071966|FG000|Overall Study|Protocol Violation|17|||
164192065|NCT01178125|593071966|FG000|Overall Study|Investigator Decision|5|||
164192066|NCT01004978|593071967|FG000|Overall Study|Disease progression|31|||
164192067|NCT01004978|593071968|FG001|Overall Study|Disease progression|48|||
164192068|NCT01004978|593071967|FG000|Overall Study|Adverse Event|42|||
164192069|NCT01004978|593071968|FG001|Overall Study|Adverse Event|22|||
164192070|NCT01004978|593071967|FG000|Overall Study|Death|3|||
164192071|NCT01004978|593071968|FG001|Overall Study|Death|2|||
164192072|NCT01004978|593071967|FG000|Overall Study|Withdrawal by Subject|16|||
164192073|NCT01004978|593071968|FG001|Overall Study|Withdrawal by Subject|16|||
164192074|NCT01004978|593071967|FG000|Overall Study|Alternative therapy|4|||
164192075|NCT01004978|593071968|FG001|Overall Study|Alternative therapy|8|||
164192076|NCT01004978|593071967|FG000|Overall Study|Physician Decision|6|||
164192077|NCT01004978|593071968|FG001|Overall Study|Physician Decision|3|||
164192078|NCT01004978|593071967|FG000|Overall Study|Other complicating disease|2|||
164192079|NCT01004978|593071968|FG001|Overall Study|Other complicating disease|2|||
164192080|NCT01004978|593071967|FG000|Overall Study|Protocol Violation|2|||
164192081|NCT01004978|593071968|FG001|Overall Study|Protocol Violation|3|||
164192082|NCT01004978|593071967|FG000|Overall Study|Non-compliance|3|||
164192083|NCT01004978|593071968|FG001|Overall Study|Non-compliance|2|||
164192084|NCT01004978|593071967|FG000|Overall Study|Ineligible|1|||
164192085|NCT01004978|593071968|FG001|Overall Study|Ineligible|0|||
164192086|NCT01004978|593071967|FG000|Overall Study|Unblinded|0|||
164192087|NCT01004978|593071968|FG001|Overall Study|Unblinded|1|||
164192088|NCT01004978|593071967|FG000|Overall Study|Performance status worsening|0|||
164192089|NCT01004978|593071968|FG001|Overall Study|Performance status worsening|1|||
164192090|NCT01004978|593071967|FG000|Overall Study|Never started treatment|8|||
164192091|NCT01004978|593071968|FG001|Overall Study|Never started treatment|9|||
164192092|NCT00369915|593071969|FG000|Overall Study|expected side effects|2|||
164192093|NCT00369915|593071970|FG001|Overall Study|expected side effects|1|||
164192094|NCT00369915|593071969|FG000|Overall Study|Withdrawal by Subject|4|||
164192095|NCT00369915|593071970|FG001|Overall Study|Withdrawal by Subject|1|||
164192096|NCT00369915|593071969|FG000|Overall Study|W/drawl by investigators|0|||
164192097|NCT00369915|593071970|FG001|Overall Study|W/drawl by investigators|1|||
164192098|NCT00268983|593071976|FG000|Overall Study|Death|3|||
164192099|NCT00268983|593071977|FG001|Overall Study|Death|0|||
164192100|NCT02532374|593071980|FG000|Overall Study|Withdrawal by Subject|1|||
164192101|NCT02532374|593071980|FG000|Overall Study|Physician Decision|1|||
164192102|NCT01089127|593071981|FG000|Overall Study|Adverse Event|5|||
164192103|NCT01089127|593071982|FG001|Overall Study|Adverse Event|1|||
164192104|NCT01089127|593071983|FG002|Overall Study|Adverse Event|1|||
164192105|NCT01089127|593071984|FG003|Overall Study|Adverse Event|0|||
164192106|NCT01089127|593071985|FG004|Overall Study|Adverse Event|0|||
164192107|NCT01089127|593071986|FG005|Overall Study|Adverse Event|1|||
164192108|NCT01089127|593071981|FG000|Overall Study|Subject withdrew consent|0|||
164192109|NCT01089127|593071982|FG001|Overall Study|Subject withdrew consent|1|||
164192110|NCT01089127|593071983|FG002|Overall Study|Subject withdrew consent|1|||
164192111|NCT01089127|593071984|FG003|Overall Study|Subject withdrew consent|1|||
164192112|NCT01089127|593071985|FG004|Overall Study|Subject withdrew consent|0|||
164192113|NCT01089127|593071986|FG005|Overall Study|Subject withdrew consent|2|||
164192114|NCT01089127|593071981|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164192115|NCT01089127|593071982|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164192116|NCT01089127|593071983|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164192117|NCT01089127|593071984|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164192118|NCT01089127|593071985|FG004|Overall Study|Abnormal test procedure result(s)|0|||
164192119|NCT01089127|593071986|FG005|Overall Study|Abnormal test procedure result(s)|0|||
164192120|NCT01089127|593071981|FG000|Overall Study|Lost to Follow-up|1|||
164192121|NCT01089127|593071982|FG001|Overall Study|Lost to Follow-up|1|||
164192122|NCT01089127|593071983|FG002|Overall Study|Lost to Follow-up|0|||
164192123|NCT01089127|593071984|FG003|Overall Study|Lost to Follow-up|0|||
164192124|NCT01089127|593071985|FG004|Overall Study|Lost to Follow-up|1|||
164192125|NCT01089127|593071986|FG005|Overall Study|Lost to Follow-up|0|||
164192126|NCT01089127|593071981|FG000|Overall Study|Protocol deviation|0|||
164192127|NCT01089127|593071982|FG001|Overall Study|Protocol deviation|1|||
164192128|NCT01089127|593071983|FG002|Overall Study|Protocol deviation|0|||
164192129|NCT01089127|593071984|FG003|Overall Study|Protocol deviation|0|||
164192130|NCT01089127|593071985|FG004|Overall Study|Protocol deviation|1|||
164192131|NCT01089127|593071986|FG005|Overall Study|Protocol deviation|0|||
164192132|NCT00511810|593071989|FG000|Overall Study|Lost to Follow-up|1|||
164192133|NCT00511810|593071990|FG001|Overall Study|Lost to Follow-up|2|||
164192134|NCT00511810|593071989|FG000|Overall Study|Lack of Efficacy|0|||
164192135|NCT00511810|593071990|FG001|Overall Study|Lack of Efficacy|2|||
164192136|NCT00511810|593071989|FG000|Overall Study|Refused second scn|0|||
164192137|NCT00511810|593071990|FG001|Overall Study|Refused second scn|1|||
164192138|NCT02659943|593071991|FG000|Overall Study|Switched to alternative treatment|1|||
164192139|NCT02659943|593071992|FG001|Overall Study|Switched to alternative treatment|1|||
164192140|NCT02659943|593071993|FG002|Overall Study|Switched to alternative treatment|0|||
164192141|NCT02659943|593071994|FG003|Overall Study|Switched to alternative treatment|2|||
164192142|NCT02659943|593071995|FG004|Overall Study|Switched to alternative treatment|1|||
164192143|NCT02659943|593071996|FG005|Overall Study|Switched to alternative treatment|0|||
164192144|NCT02659943|593071997|FG006|Overall Study|Switched to alternative treatment|1|||
164192145|NCT02659943|593071991|FG000|Overall Study|Disease progression on study|0|||
164192146|NCT02659943|593071992|FG001|Overall Study|Disease progression on study|1|||
164192147|NCT02659943|593071993|FG002|Overall Study|Disease progression on study|1|||
164192148|NCT02659943|593071994|FG003|Overall Study|Disease progression on study|1|||
164192149|NCT02659943|593071995|FG004|Overall Study|Disease progression on study|1|||
164192150|NCT02659943|593071996|FG005|Overall Study|Disease progression on study|4|||
164192151|NCT02659943|593071997|FG006|Overall Study|Disease progression on study|0|||
164192152|NCT02659943|593071991|FG000|Overall Study|Patient's condition per principal investigator|0|||
164192153|NCT02659943|593071992|FG001|Overall Study|Patient's condition per principal investigator|0|||
164192154|NCT02659943|593071993|FG002|Overall Study|Patient's condition per principal investigator|0|||
164192155|NCT02659943|593071994|FG003|Overall Study|Patient's condition per principal investigator|0|||
164192156|NCT02659943|593071995|FG004|Overall Study|Patient's condition per principal investigator|0|||
164192157|NCT02659943|593071996|FG005|Overall Study|Patient's condition per principal investigator|1|||
164192158|NCT02659943|593071997|FG006|Overall Study|Patient's condition per principal investigator|0|||
164192159|NCT02659943|593071991|FG000|Overall Study|Ineligible|0|||
164192160|NCT02659943|593071992|FG001|Overall Study|Ineligible|0|||
164192161|NCT02659943|593071993|FG002|Overall Study|Ineligible|0|||
164192162|NCT02659943|593071994|FG003|Overall Study|Ineligible|0|||
164192163|NCT02659943|593071995|FG004|Overall Study|Ineligible|0|||
164192164|NCT02659943|593071996|FG005|Overall Study|Ineligible|0|||
164192165|NCT02659943|593071997|FG006|Overall Study|Ineligible|1|||
164192166|NCT02659943|593071991|FG000|Overall Study|No longer meets eligibility|0|||
164192167|NCT02659943|593071992|FG001|Overall Study|No longer meets eligibility|0|||
164192168|NCT02659943|593071993|FG002|Overall Study|No longer meets eligibility|0|||
164192169|NCT02659943|593071994|FG003|Overall Study|No longer meets eligibility|0|||
164192170|NCT02659943|593071995|FG004|Overall Study|No longer meets eligibility|0|||
164192171|NCT02659943|593071996|FG005|Overall Study|No longer meets eligibility|0|||
164192172|NCT02659943|593071997|FG006|Overall Study|No longer meets eligibility|1|||
164192173|NCT02659943|593071991|FG000|Overall Study|No treatment, per protocol|0|||
164192174|NCT02659943|593071992|FG001|Overall Study|No treatment, per protocol|0|||
164192175|NCT02659943|593071993|FG002|Overall Study|No treatment, per protocol|0|||
164192176|NCT02659943|593071994|FG003|Overall Study|No treatment, per protocol|0|||
164192177|NCT02659943|593071995|FG004|Overall Study|No treatment, per protocol|0|||
164192178|NCT02659943|593071996|FG005|Overall Study|No treatment, per protocol|0|||
164192179|NCT02659943|593071997|FG006|Overall Study|No treatment, per protocol|3|||
164192180|NCT01096160|593072001|FG000|Overall Study|Adverse Event|0|||
164192181|NCT01096160|593072002|FG001|Overall Study|Adverse Event|0|||
164192182|NCT01096160|593072003|FG002|Overall Study|Adverse Event|1|||
164192183|NCT01096160|593072004|FG003|Overall Study|Adverse Event|0|||
164192184|NCT01096160|593072005|FG004|Overall Study|Adverse Event|0|||
164192185|NCT01096160|593072006|FG005|Overall Study|Adverse Event|0|||
164192186|NCT01096160|593072007|FG006|Overall Study|Adverse Event|0|||
164192187|NCT01096160|593072008|FG007|Overall Study|Adverse Event|0|||
164192188|NCT01096160|593072009|FG008|Overall Study|Adverse Event|0|||
164192189|NCT01096160|593072010|FG009|Overall Study|Adverse Event|1|||
164192190|NCT01096160|593072001|FG000|Overall Study|Met stopping criteria per protocol|0|||
164192191|NCT01096160|593072002|FG001|Overall Study|Met stopping criteria per protocol|0|||
164192192|NCT01096160|593072003|FG002|Overall Study|Met stopping criteria per protocol|0|||
164192193|NCT01096160|593072004|FG003|Overall Study|Met stopping criteria per protocol|0|||
164192194|NCT01096160|593072005|FG004|Overall Study|Met stopping criteria per protocol|1|||
164192195|NCT01096160|593072006|FG005|Overall Study|Met stopping criteria per protocol|0|||
164192196|NCT01096160|593072007|FG006|Overall Study|Met stopping criteria per protocol|2|||
164192197|NCT01096160|593072008|FG007|Overall Study|Met stopping criteria per protocol|0|||
164192198|NCT01096160|593072009|FG008|Overall Study|Met stopping criteria per protocol|2|||
164192199|NCT01096160|593072010|FG009|Overall Study|Met stopping criteria per protocol|0|||
164192200|NCT04767373|593072014|FG000|Overall Study|Death|6|||
164192201|NCT04767373|593072015|FG001|Overall Study|Death|3|||
164192202|NCT04767373|593072014|FG000|Overall Study|Lost to Follow-up|67|||
164192203|NCT04767373|593072015|FG001|Overall Study|Lost to Follow-up|35|||
164192204|NCT04767373|593072014|FG000|Overall Study|Physician Decision|15|||
164192205|NCT04767373|593072015|FG001|Overall Study|Physician Decision|4|||
164192206|NCT04767373|593072014|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164192207|NCT04767373|593072015|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164192208|NCT04767373|593072014|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
164192209|NCT04767373|593072015|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
164192210|NCT04767373|593072014|FG000|Overall Study|Other|1|||
164192211|NCT04767373|593072015|FG001|Overall Study|Other|2|||
164192212|NCT02472886|593072030|FG000|Overall Study|Lack of Efficacy|0|||
164192213|NCT02472886|593072031|FG001|Overall Study|Lack of Efficacy|2|||
164192214|NCT02472886|593072032|FG002|Overall Study|Lack of Efficacy|1|||
164192215|NCT04346199|593072033|FG000|Overall Study|Death|8|||
164192216|NCT04346199|593072034|FG001|Overall Study|Death|9|||
164192217|NCT04346199|593072033|FG000|Overall Study|Lost to Follow-up|0|||
164192218|NCT04346199|593072034|FG001|Overall Study|Lost to Follow-up|1|||
164192219|NCT04346199|593072033|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
164192220|NCT04346199|593072034|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
164192221|NCT04346199|593072033|FG000|Overall Study|Withdrawal by Subject|5|||
164192222|NCT04346199|593072034|FG001|Overall Study|Withdrawal by Subject|1|||
164192223|NCT04533438|593072035|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
164192224|NCT04533438|593072036|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
164192225|NCT05568797|593072037|FG000|Overall Study|Adverse Event|0|||
164192226|NCT05568797|593072038|FG001|Overall Study|Adverse Event|8|||
164192227|NCT05568797|593072037|FG000|Overall Study|Lost to Follow-up|2|||
164192228|NCT05568797|593072038|FG001|Overall Study|Lost to Follow-up|3|||
164192229|NCT05568797|593072037|FG000|Overall Study|Withdrawal by Subject|1|||
164192230|NCT05568797|593072038|FG001|Overall Study|Withdrawal by Subject|10|||
164192231|NCT05568797|593072037|FG000|Overall Study|Other|2|||
164192232|NCT05568797|593072038|FG001|Overall Study|Other|2|||
164192233|NCT00099632|593072039|FG000|Overall Study|Lost to Follow-up|1|||
164192234|NCT00099632|593072040|FG001|Overall Study|Lost to Follow-up|0|||
164192235|NCT00099632|593072041|FG002|Overall Study|Lost to Follow-up|3|||
164192236|NCT00099632|593072042|FG003|Overall Study|Lost to Follow-up|1|||
164192237|NCT00099632|593072043|FG004|Overall Study|Lost to Follow-up|1|||
164192238|NCT00099632|593072044|FG005|Overall Study|Lost to Follow-up|0|||
164192239|NCT00099632|593072039|FG000|Overall Study|Withdrawal by Subject|0|||
164192240|NCT00099632|593072040|FG001|Overall Study|Withdrawal by Subject|1|||
164192241|NCT00099632|593072041|FG002|Overall Study|Withdrawal by Subject|0|||
164192242|NCT00099632|593072042|FG003|Overall Study|Withdrawal by Subject|0|||
164192243|NCT00099632|593072043|FG004|Overall Study|Withdrawal by Subject|0|||
164192244|NCT00099632|593072044|FG005|Overall Study|Withdrawal by Subject|1|||
164192245|NCT00099632|593072039|FG000|Overall Study|Protocol Violation|0|||
164192246|NCT00099632|593072040|FG001|Overall Study|Protocol Violation|0|||
164192247|NCT00099632|593072041|FG002|Overall Study|Protocol Violation|0|||
164192248|NCT00099632|593072042|FG003|Overall Study|Protocol Violation|0|||
164192249|NCT00099632|593072043|FG004|Overall Study|Protocol Violation|0|||
164192250|NCT00099632|593072044|FG005|Overall Study|Protocol Violation|1|||
164192251|NCT03131687|593072045|FG000|Overall Study|Adverse Event|0|||
164192252|NCT03131687|593072046|FG001|Overall Study|Adverse Event|1|||
164192253|NCT03131687|593072047|FG002|Overall Study|Adverse Event|0|||
164192254|NCT03131687|593072048|FG003|Overall Study|Adverse Event|1|||
164192255|NCT03131687|593072049|FG004|Overall Study|Adverse Event|2|||
164192256|NCT03131687|593072050|FG005|Overall Study|Adverse Event|2|||
164192257|NCT03131687|593072045|FG000|Overall Study|Death|1|||
164192258|NCT03131687|593072046|FG001|Overall Study|Death|0|||
164192259|NCT03131687|593072047|FG002|Overall Study|Death|0|||
164192260|NCT03131687|593072048|FG003|Overall Study|Death|0|||
164192261|NCT03131687|593072049|FG004|Overall Study|Death|0|||
164192262|NCT03131687|593072050|FG005|Overall Study|Death|0|||
164192263|NCT03131687|593072045|FG000|Overall Study|Withdrawal by Subject|3|||
164192264|NCT03131687|593072046|FG001|Overall Study|Withdrawal by Subject|3|||
164192265|NCT03131687|593072047|FG002|Overall Study|Withdrawal by Subject|3|||
164192266|NCT03131687|593072048|FG003|Overall Study|Withdrawal by Subject|1|||
164192267|NCT03131687|593072049|FG004|Overall Study|Withdrawal by Subject|2|||
164192268|NCT03131687|593072050|FG005|Overall Study|Withdrawal by Subject|1|||
164192269|NCT03131687|593072045|FG000|Overall Study|Lost to Follow-up|1|||
164192270|NCT03131687|593072046|FG001|Overall Study|Lost to Follow-up|4|||
164192271|NCT03131687|593072047|FG002|Overall Study|Lost to Follow-up|0|||
164192272|NCT03131687|593072048|FG003|Overall Study|Lost to Follow-up|1|||
164192273|NCT03131687|593072049|FG004|Overall Study|Lost to Follow-up|4|||
164192274|NCT03131687|593072050|FG005|Overall Study|Lost to Follow-up|2|||
164192275|NCT03131687|593072045|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
164192276|NCT03131687|593072046|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
164192277|NCT03131687|593072047|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
164192278|NCT03131687|593072048|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
164192279|NCT03131687|593072049|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
164192280|NCT03131687|593072050|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
164192281|NCT03131687|593072045|FG000|Overall Study|Principle Investigator Decision|0|||
164192282|NCT03131687|593072046|FG001|Overall Study|Principle Investigator Decision|1|||
164192283|NCT03131687|593072047|FG002|Overall Study|Principle Investigator Decision|0|||
164192284|NCT03131687|593072048|FG003|Overall Study|Principle Investigator Decision|0|||
164192285|NCT03131687|593072049|FG004|Overall Study|Principle Investigator Decision|0|||
164192286|NCT03131687|593072050|FG005|Overall Study|Principle Investigator Decision|0|||
164192287|NCT03131687|593072045|FG000|Overall Study|Inadvertent Enrollment|0|||
164192288|NCT03131687|593072046|FG001|Overall Study|Inadvertent Enrollment|0|||
164192289|NCT03131687|593072047|FG002|Overall Study|Inadvertent Enrollment|0|||
164192290|NCT03131687|593072048|FG003|Overall Study|Inadvertent Enrollment|1|||
164192291|NCT03131687|593072049|FG004|Overall Study|Inadvertent Enrollment|0|||
164192292|NCT03131687|593072050|FG005|Overall Study|Inadvertent Enrollment|0|||
164192293|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
164192294|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
164192295|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
164192296|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
164192297|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
164192298|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
164192299|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
164192300|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
164192301|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
164192302|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
164192303|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
164192304|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
164192305|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
164192306|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
164192307|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
164192308|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
164192309|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
164192310|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
164192311|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
164192312|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
164192313|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
164192314|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192315|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192316|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192317|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
164192318|NCT02137226|593072051|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
164192319|NCT02137226|593072052|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
164192320|NCT02137226|593072053|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
164192321|NCT02137226|593072054|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
164192322|NCT02137226|593072055|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
164192323|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
164192324|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
164192325|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
164192326|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
164192327|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
164192328|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
164192329|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
164192330|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
164192331|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
164192332|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
164192333|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
164192334|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
164192335|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
164192336|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
164192337|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
164192338|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192339|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192340|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
164192341|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192342|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
164192343|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192344|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192345|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
164192346|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192347|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
164192348|NCT02137226|593072051|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
163855190|NCT01394991|591838267|FG001|Overall Study|Adverse Event|4|||
163855191|NCT01394991|591838266|FG000|Overall Study|Lack of Efficacy|5|||
164192349|NCT02137226|593072052|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
164192350|NCT02137226|593072053|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
164192351|NCT02137226|593072054|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
164192352|NCT02137226|593072055|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
164192353|NCT03472521|593072062|FG000|Overall Study|Lost to Follow-up|3|||
164192354|NCT03472521|593072063|FG001|Overall Study|Lost to Follow-up|2|||
164192355|NCT03472521|593072062|FG000|Overall Study|Discontinued intervention|3|||
164192356|NCT03472521|593072063|FG001|Overall Study|Discontinued intervention|1|||
164192357|NCT01603407|593072064|FG000|Overall Study|Adverse Event|1|||
164192358|NCT01603407|593072065|FG001|Overall Study|Adverse Event|1|||
164192359|NCT01603407|593072066|FG002|Overall Study|Adverse Event|1|||
164192360|NCT01603407|593072064|FG000|Overall Study|Protocol Violation|2|||
164192361|NCT01603407|593072065|FG001|Overall Study|Protocol Violation|2|||
164192362|NCT01603407|593072066|FG002|Overall Study|Protocol Violation|0|||
164192363|NCT01603407|593072064|FG000|Overall Study|Withdrawal by Subject|8|||
164192364|NCT01603407|593072065|FG001|Overall Study|Withdrawal by Subject|5|||
164192365|NCT01603407|593072066|FG002|Overall Study|Withdrawal by Subject|7|||
164192366|NCT01603407|593072064|FG000|Overall Study|Lost to Follow-up|0|||
164192367|NCT01603407|593072065|FG001|Overall Study|Lost to Follow-up|3|||
164192368|NCT01603407|593072066|FG002|Overall Study|Lost to Follow-up|2|||
164192369|NCT01325350|593073909|FG000|Overall Study|Adverse Event|3|||
164192370|NCT01325350|593073910|FG001|Overall Study|Adverse Event|3|||
164192371|NCT01325350|593073911|FG002|Overall Study|Adverse Event|3|||
164192372|NCT01325350|593073912|FG003|Overall Study|Adverse Event|1|||
164192373|NCT01325350|593073913|FG004|Overall Study|Adverse Event|2|||
164192374|NCT01325350|593073909|FG000|Overall Study|Pregnancy|0|||
164192375|NCT01325350|593073910|FG001|Overall Study|Pregnancy|0|||
164192376|NCT01325350|593073911|FG002|Overall Study|Pregnancy|1|||
164192377|NCT01325350|593073912|FG003|Overall Study|Pregnancy|0|||
164192378|NCT01325350|593073913|FG004|Overall Study|Pregnancy|1|||
164192379|NCT01325350|593073909|FG000|Overall Study|Lost to Follow-up|1|||
164192380|NCT01325350|593073910|FG001|Overall Study|Lost to Follow-up|0|||
164192381|NCT01325350|593073911|FG002|Overall Study|Lost to Follow-up|5|||
164192382|NCT01325350|593073912|FG003|Overall Study|Lost to Follow-up|1|||
164192383|NCT01325350|593073913|FG004|Overall Study|Lost to Follow-up|5|||
164192384|NCT01325350|593073909|FG000|Overall Study|Personal Reasons|2|||
164192385|NCT01325350|593073910|FG001|Overall Study|Personal Reasons|1|||
164192386|NCT01325350|593073911|FG002|Overall Study|Personal Reasons|6|||
164192387|NCT01325350|593073912|FG003|Overall Study|Personal Reasons|5|||
164192388|NCT01325350|593073913|FG004|Overall Study|Personal Reasons|3|||
164192389|NCT01325350|593073909|FG000|Overall Study|Protocol Violation|0|||
164192390|NCT01325350|593073910|FG001|Overall Study|Protocol Violation|0|||
164192391|NCT01325350|593073911|FG002|Overall Study|Protocol Violation|0|||
164192392|NCT01325350|593073912|FG003|Overall Study|Protocol Violation|1|||
164192393|NCT01325350|593073913|FG004|Overall Study|Protocol Violation|0|||
164192394|NCT01325350|593073909|FG000|Overall Study|Withdrawal by Subject|0|||
164192395|NCT01325350|593073910|FG001|Overall Study|Withdrawal by Subject|0|||
164192396|NCT01325350|593073911|FG002|Overall Study|Withdrawal by Subject|1|||
164192397|NCT01325350|593073912|FG003|Overall Study|Withdrawal by Subject|1|||
164192398|NCT01325350|593073913|FG004|Overall Study|Withdrawal by Subject|0|||
164192399|NCT01325350|593073909|FG000|Overall Study|Did Not Receive Treatment|0|||
164192400|NCT01325350|593073910|FG001|Overall Study|Did Not Receive Treatment|1|||
164192401|NCT01325350|593073911|FG002|Overall Study|Did Not Receive Treatment|1|||
164192402|NCT01325350|593073912|FG003|Overall Study|Did Not Receive Treatment|0|||
164192403|NCT01325350|593073913|FG004|Overall Study|Did Not Receive Treatment|1|||
164192404|NCT02692586|593073914|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
164192405|NCT02692586|593073914|FG000|Overall Study|Received adjunctive thrombolytics|2|||
164192406|NCT01396083|593073918|FG000|Overall Study|Adverse Event|2|||
164192407|NCT01396083|593073919|FG001|Overall Study|Adverse Event|28|||
164192408|NCT01396083|593073918|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164192409|NCT01396083|593073919|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164192410|NCT01396083|593073918|FG000|Overall Study|Consent withdrawn|4|||
164192411|NCT01396083|593073919|FG001|Overall Study|Consent withdrawn|5|||
164192412|NCT01396083|593073918|FG000|Overall Study|Protocol deviation(s)|0|||
164192413|NCT01396083|593073919|FG001|Overall Study|Protocol deviation(s)|1|||
164192414|NCT01396083|593073918|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164192415|NCT01396083|593073919|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164192416|NCT01396083|593073918|FG000|Overall Study|Administrative problems|1|||
163964831|NCT01493557|592244733|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
164192417|NCT01396083|593073919|FG001|Overall Study|Administrative problems|0|||
164192418|NCT01396083|593073918|FG000|Overall Study|Lost to Follow-up|1|||
164192419|NCT01396083|593073919|FG001|Overall Study|Lost to Follow-up|0|||
164192420|NCT01063855|593073920|FG000|Overall Study|Adverse Event|4|||
164192421|NCT01063855|593073921|FG001|Overall Study|Adverse Event|4|||
164192422|NCT01063855|593073920|FG000|Overall Study|Death|0|||
164192423|NCT01063855|593073921|FG001|Overall Study|Death|1|||
163964832|NCT01493557|592244734|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
164192424|NCT01063855|593073920|FG000|Overall Study|Lost to Follow-up|8|||
164192425|NCT01063855|593073921|FG001|Overall Study|Lost to Follow-up|4|||
164192426|NCT01063855|593073920|FG000|Overall Study|Pregnancy|1|||
164192427|NCT01063855|593073921|FG001|Overall Study|Pregnancy|0|||
164192428|NCT01063855|593073920|FG000|Overall Study|Lack of Efficacy|0|||
164192429|NCT01063855|593073921|FG001|Overall Study|Lack of Efficacy|1|||
164192430|NCT01063855|593073920|FG000|Overall Study|Withdrawal by Subject|11|||
164192431|NCT01063855|593073921|FG001|Overall Study|Withdrawal by Subject|8|||
164192432|NCT01063855|593073920|FG000|Overall Study|Reason not specified|13|||
164192433|NCT01063855|593073921|FG001|Overall Study|Reason not specified|11|||
164192434|NCT01165307|593073922|FG000|Overall Study|Lost to Follow-up|11|||
164192435|NCT01165307|593073923|FG001|Overall Study|Lost to Follow-up|3|||
164192436|NCT01165307|593073922|FG000|Overall Study|Withdrawal by Subject|2|||
164192437|NCT01165307|593073923|FG001|Overall Study|Withdrawal by Subject|0|||
164192438|NCT01165307|593073922|FG000|Overall Study|Subject not available for contact|1|||
164192439|NCT01165307|593073923|FG001|Overall Study|Subject not available for contact|0|||
164192440|NCT03234036|593073927|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
164192441|NCT03234036|593073928|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
164192442|NCT03234036|593073929|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
164192443|NCT03234036|593073930|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
164192444|NCT02999789|593073933|FG000|Overall Study|Withdrawal by Subject|0|||
164192445|NCT02999789|593073934|FG001|Overall Study|Withdrawal by Subject|1|||
164192446|NCT02999789|593073933|FG000|Overall Study|Became ineligible|1|||
164192447|NCT02999789|593073934|FG001|Overall Study|Became ineligible|2|||
164192448|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
164192449|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192450|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192451|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192452|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
164192453|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
164192454|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192455|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192456|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192457|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
164192458|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
164192459|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192460|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192461|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192462|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
164192463|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
164192464|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192465|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192466|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192467|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
164192468|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
164192469|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192470|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192471|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192472|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
164192473|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
164192474|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192475|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192476|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192477|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
164192478|NCT01111565|593073949|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
164192479|NCT01111565|593073950|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192480|NCT01111565|593073951|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192481|NCT01111565|593073952|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192482|NCT01111565|593073953|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
164192483|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192484|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192485|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192486|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
164192487|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164192488|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192489|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192490|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
164192491|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192492|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164192493|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
164192494|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
163964833|NCT02973425|592244736|FG000|Overall Study|Lost to Follow-up|49|||
164192495|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
164192496|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
164192497|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
164192498|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192499|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192500|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192501|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
164192502|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
164192503|NCT01111565|593073949|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192504|NCT01111565|593073950|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192505|NCT01111565|593073951|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192506|NCT01111565|593073952|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
164192507|NCT01111565|593073953|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
164192508|NCT02683239|593073957|FG000|Overall Study|Protocol Violation|35|||
164192509|NCT02683239|593073958|FG001|Overall Study|Protocol Violation|23|||
164192510|NCT02683239|593073959|FG002|Overall Study|Protocol Violation|26|||
164192511|NCT02683239|593073960|FG003|Overall Study|Protocol Violation|4|||
164192512|NCT02683239|593073961|FG004|Overall Study|Protocol Violation|35|||
164192513|NCT02683239|593073962|FG005|Overall Study|Protocol Violation|4|||
164192514|NCT02683239|593073963|FG006|Overall Study|Protocol Violation|5|||
164192515|NCT02683239|593073957|FG000|Overall Study|Adverse Event|64|||
164192516|NCT02683239|593073958|FG001|Overall Study|Adverse Event|39|||
164192517|NCT02683239|593073959|FG002|Overall Study|Adverse Event|42|||
164192518|NCT02683239|593073960|FG003|Overall Study|Adverse Event|16|||
164192519|NCT02683239|593073961|FG004|Overall Study|Adverse Event|189|||
164192520|NCT02683239|593073962|FG005|Overall Study|Adverse Event|9|||
164192521|NCT02683239|593073963|FG006|Overall Study|Adverse Event|9|||
164192522|NCT02683239|593073957|FG000|Overall Study|Physician Decision|38|||
164192523|NCT02683239|593073958|FG001|Overall Study|Physician Decision|19|||
164192524|NCT02683239|593073959|FG002|Overall Study|Physician Decision|14|||
164192525|NCT02683239|593073960|FG003|Overall Study|Physician Decision|73|||
164192526|NCT02683239|593073961|FG004|Overall Study|Physician Decision|143|||
164192527|NCT02683239|593073962|FG005|Overall Study|Physician Decision|14|||
164192528|NCT02683239|593073963|FG006|Overall Study|Physician Decision|15|||
164192529|NCT02683239|593073957|FG000|Overall Study|Withdrawal by Subject|187|||
164192530|NCT02683239|593073958|FG001|Overall Study|Withdrawal by Subject|99|||
164192531|NCT02683239|593073959|FG002|Overall Study|Withdrawal by Subject|91|||
164192532|NCT02683239|593073960|FG003|Overall Study|Withdrawal by Subject|18|||
164192533|NCT02683239|593073961|FG004|Overall Study|Withdrawal by Subject|248|||
164192534|NCT02683239|593073962|FG005|Overall Study|Withdrawal by Subject|22|||
164192535|NCT02683239|593073963|FG006|Overall Study|Withdrawal by Subject|28|||
164192536|NCT02683239|593073957|FG000|Overall Study|Lost to Follow-up|77|||
164192537|NCT02683239|593073958|FG001|Overall Study|Lost to Follow-up|24|||
164192538|NCT02683239|593073959|FG002|Overall Study|Lost to Follow-up|25|||
164192539|NCT02683239|593073960|FG003|Overall Study|Lost to Follow-up|7|||
164192540|NCT02683239|593073961|FG004|Overall Study|Lost to Follow-up|88|||
164192541|NCT02683239|593073962|FG005|Overall Study|Lost to Follow-up|8|||
164192542|NCT02683239|593073963|FG006|Overall Study|Lost to Follow-up|11|||
164192543|NCT02683239|593073957|FG000|Overall Study|Death|9|||
164192544|NCT02683239|593073958|FG001|Overall Study|Death|5|||
164192545|NCT02683239|593073959|FG002|Overall Study|Death|8|||
164192546|NCT02683239|593073960|FG003|Overall Study|Death|0|||
164192547|NCT02683239|593073961|FG004|Overall Study|Death|12|||
164192548|NCT02683239|593073962|FG005|Overall Study|Death|1|||
164192549|NCT02683239|593073963|FG006|Overall Study|Death|0|||
164192550|NCT02683239|593073957|FG000|Overall Study|Lack of Efficacy|50|||
164192551|NCT02683239|593073958|FG001|Overall Study|Lack of Efficacy|23|||
164192552|NCT02683239|593073959|FG002|Overall Study|Lack of Efficacy|12|||
164192553|NCT02683239|593073960|FG003|Overall Study|Lack of Efficacy|2|||
164192554|NCT02683239|593073961|FG004|Overall Study|Lack of Efficacy|29|||
164192555|NCT02683239|593073962|FG005|Overall Study|Lack of Efficacy|2|||
164192556|NCT02683239|593073963|FG006|Overall Study|Lack of Efficacy|3|||
164192557|NCT02683239|593073957|FG000|Overall Study|Missing data|0|||
164192558|NCT02683239|593073958|FG001|Overall Study|Missing data|1|||
164192559|NCT02683239|593073959|FG002|Overall Study|Missing data|1|||
164192560|NCT02683239|593073960|FG003|Overall Study|Missing data|0|||
164192561|NCT02683239|593073961|FG004|Overall Study|Missing data|1|||
164192562|NCT02683239|593073962|FG005|Overall Study|Missing data|0|||
164192563|NCT02683239|593073963|FG006|Overall Study|Missing data|0|||
164192564|NCT00521365|593073966|FG000|Overall Study|Adverse Event|3|||
164192565|NCT00521365|593073966|FG000|Overall Study|Lost to Follow-up|6|||
163855192|NCT01394991|591838267|FG001|Overall Study|Lack of Efficacy|7|||
163855193|NCT01394991|591838266|FG000|Overall Study|Lost to Follow-up|6|||
164192566|NCT00521365|593073966|FG000|Overall Study|Protocol deviation|2|||
164192567|NCT00521365|593073966|FG000|Overall Study|Drug compliance|3|||
164192568|NCT00521365|593073966|FG000|Overall Study|Usage of not allowed drugs|6|||
164192569|NCT00368108|593073967|FG000|Overall Study|Adverse Event|38|||
164192570|NCT00368108|593073968|FG001|Overall Study|Adverse Event|26|||
164192571|NCT00368108|593073969|FG002|Overall Study|Adverse Event|44|||
164192572|NCT00368108|593073967|FG000|Overall Study|Abnormal Laboratory Value|0|||
164192573|NCT00368108|593073968|FG001|Overall Study|Abnormal Laboratory Value|0|||
164192574|NCT00368108|593073969|FG002|Overall Study|Abnormal Laboratory Value|3|||
164192575|NCT00368108|593073967|FG000|Overall Study|Protocol Violation|5|||
164192576|NCT00368108|593073968|FG001|Overall Study|Protocol Violation|9|||
164192577|NCT00368108|593073969|FG002|Overall Study|Protocol Violation|9|||
164192578|NCT00368108|593073967|FG000|Overall Study|Withdrawal by Subject|9|||
164192579|NCT00368108|593073968|FG001|Overall Study|Withdrawal by Subject|3|||
164192580|NCT00368108|593073969|FG002|Overall Study|Withdrawal by Subject|5|||
164192581|NCT00368108|593073967|FG000|Overall Study|Lack of Efficacy|7|||
164192582|NCT00368108|593073968|FG001|Overall Study|Lack of Efficacy|8|||
164192583|NCT00368108|593073969|FG002|Overall Study|Lack of Efficacy|5|||
164192584|NCT00368108|593073967|FG000|Overall Study|Physician Decision|2|||
164192585|NCT00368108|593073968|FG001|Overall Study|Physician Decision|0|||
164192586|NCT00368108|593073969|FG002|Overall Study|Physician Decision|1|||
164192587|NCT00368108|593073967|FG000|Overall Study|Other|3|||
164192588|NCT00368108|593073968|FG001|Overall Study|Other|7|||
164192589|NCT00368108|593073969|FG002|Overall Study|Other|1|||
164192590|NCT03150082|593073970|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
164192591|NCT03150082|593073971|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
164192592|NCT01718483|593073972|FG000|Overall Study|Withdrawal by Subject|14|||
164192593|NCT01718483|593073973|FG001|Overall Study|Withdrawal by Subject|12|||
164192594|NCT01718483|593073972|FG000|Overall Study|Adverse Event|5|||
164192595|NCT01718483|593073973|FG001|Overall Study|Adverse Event|12|||
164192596|NCT01718483|593073972|FG000|Overall Study|Lost to Follow-up|8|||
164192597|NCT01718483|593073973|FG001|Overall Study|Lost to Follow-up|3|||
164192598|NCT01718483|593073972|FG000|Overall Study|Protocol Violation|4|||
164192599|NCT01718483|593073973|FG001|Overall Study|Protocol Violation|2|||
164192600|NCT01718483|593073972|FG000|Overall Study|Other|1|||
164192601|NCT01718483|593073973|FG001|Overall Study|Other|4|||
164192602|NCT01718483|593073972|FG000|Overall Study|Pregnancy|1|||
164192603|NCT01718483|593073973|FG001|Overall Study|Pregnancy|1|||
164192604|NCT01718483|593073972|FG000|Overall Study|Lack of Efficacy|1|||
164192605|NCT01718483|593073973|FG001|Overall Study|Lack of Efficacy|0|||
164192606|NCT04131712|593073978|FG000|Overall Study|COVID related|0|||
164192607|NCT04131712|593073979|FG001|Overall Study|COVID related|0|||
164192608|NCT04131712|593073980|FG002|Overall Study|COVID related|2|||
164192609|NCT04131712|593073981|FG003|Overall Study|COVID related|0|||
164192610|NCT04131712|593073978|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
164192611|NCT04131712|593073979|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
164192612|NCT04131712|593073980|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
164192613|NCT04131712|593073981|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
164192614|NCT02299388|593073984|FG000|Overall Study|Withdrawal by Subject|0|||
164192615|NCT02299388|593073985|FG001|Overall Study|Withdrawal by Subject|1|||
164192616|NCT03334188|593073986|FG000|Overall Study|Withdrawal by Subject|0|||
164192617|NCT03334188|593073987|FG001|Overall Study|Withdrawal by Subject|1|||
164192618|NCT03334188|593073986|FG000|Overall Study|Death|1|||
164192619|NCT03334188|593073987|FG001|Overall Study|Death|0|||
164192620|NCT03334188|593073986|FG000|Overall Study|Never had qualifying clinic visit|7|||
164192621|NCT03334188|593073987|FG001|Overall Study|Never had qualifying clinic visit|7|||
164192622|NCT01093586|593073992|FG000|Overall Study|Failed to engraft|3|||
164192623|NCT00357877|593073993|FG000|Overall Study|Death|2|||
164192624|NCT00357877|593073994|FG001|Overall Study|Death|1|||
164192625|NCT00357877|593073993|FG000|Overall Study|Lost to Follow-up|20|||
164192626|NCT00357877|593073994|FG001|Overall Study|Lost to Follow-up|23|||
164192627|NCT00357877|593073993|FG000|Overall Study|Withdrawal by Subject|3|||
164192628|NCT00357877|593073994|FG001|Overall Study|Withdrawal by Subject|3|||
164192629|NCT00357877|593073993|FG000|Overall Study|Administrative withdrawal|1|||
164192630|NCT00357877|593073994|FG001|Overall Study|Administrative withdrawal|1|||
164192631|NCT00357877|593073993|FG000|Overall Study|Other|0|||
164192632|NCT00357877|593073994|FG001|Overall Study|Other|2|||
164192633|NCT00613366|593074004|FG000|Overall Study|Withdrawal by Subject|3|||
164192634|NCT00613366|593074005|FG001|Overall Study|Withdrawal by Subject|2|||
164192635|NCT00943397|593074006|FG000|Overall Study|Adverse Event|0|||
164192636|NCT00943397|593074007|FG001|Overall Study|Adverse Event|6|||
163964834|NCT02973425|592244737|FG001|Overall Study|Lost to Follow-up|53|||
163964835|NCT00909792|592244738|FG000|Period 1|Did not meet inclusion criteria|0|||
163964836|NCT00909792|592244739|FG001|Period 1|Did not meet inclusion criteria|1|||
164192637|NCT00943397|593074006|FG000|Overall Study|Lost to Follow-up|0|||
164192638|NCT00943397|593074007|FG001|Overall Study|Lost to Follow-up|4|||
164192639|NCT00943397|593074006|FG000|Overall Study|Protocol Violation|2|||
164192640|NCT00943397|593074007|FG001|Overall Study|Protocol Violation|5|||
164192641|NCT00943397|593074006|FG000|Overall Study|Withdrawal by Subject|1|||
164192642|NCT00943397|593074007|FG001|Overall Study|Withdrawal by Subject|1|||
164192643|NCT00943397|593074006|FG000|Overall Study|Site terminated and other|12|||
164192644|NCT00943397|593074007|FG001|Overall Study|Site terminated and other|56|||
164192645|NCT02948829|593074008|FG000|Overall Study|Lost to Follow-up|2|||
164192646|NCT02948829|593074008|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
164192647|NCT02948829|593074008|FG000|Overall Study|Pregnancy|1|||
164192648|NCT02948829|593074008|FG000|Overall Study|Other: Reason not Specified|8|||
164192649|NCT01719380|593074026|FG000|Overall Study|Adverse Event|0|||
164192650|NCT01719380|593074027|FG001|Overall Study|Adverse Event|0|||
164192651|NCT01719380|593074028|FG002|Overall Study|Adverse Event|1|||
164192652|NCT01719380|593074029|FG003|Overall Study|Adverse Event|2|||
164192653|NCT01719380|593074030|FG004|Overall Study|Adverse Event|0|||
164192654|NCT01719380|593074031|FG005|Overall Study|Adverse Event|1|||
164192655|NCT01719380|593074032|FG006|Overall Study|Adverse Event|0|||
164192656|NCT01719380|593074033|FG007|Overall Study|Adverse Event|1|||
164192657|NCT01719380|593074034|FG008|Overall Study|Adverse Event|4|||
164192658|NCT01719380|593074035|FG009|Overall Study|Adverse Event|3|||
164192659|NCT01719380|593074026|FG000|Overall Study|Death|0|||
164192660|NCT01719380|593074027|FG001|Overall Study|Death|1|||
164192661|NCT01719380|593074028|FG002|Overall Study|Death|0|||
164192662|NCT01719380|593074029|FG003|Overall Study|Death|0|||
164192663|NCT01719380|593074030|FG004|Overall Study|Death|0|||
164192664|NCT01719380|593074031|FG005|Overall Study|Death|0|||
164192665|NCT01719380|593074032|FG006|Overall Study|Death|0|||
164192666|NCT01719380|593074033|FG007|Overall Study|Death|0|||
164192667|NCT01719380|593074034|FG008|Overall Study|Death|3|||
164192668|NCT01719380|593074035|FG009|Overall Study|Death|3|||
164192669|NCT01719380|593074026|FG000|Overall Study|Participant/Guardian Decision|0|||
164192670|NCT01719380|593074027|FG001|Overall Study|Participant/Guardian Decision|0|||
164192671|NCT01719380|593074028|FG002|Overall Study|Participant/Guardian Decision|1|||
164192672|NCT01719380|593074029|FG003|Overall Study|Participant/Guardian Decision|0|||
164192673|NCT01719380|593074030|FG004|Overall Study|Participant/Guardian Decision|0|||
164192674|NCT01719380|593074031|FG005|Overall Study|Participant/Guardian Decision|0|||
164192675|NCT01719380|593074032|FG006|Overall Study|Participant/Guardian Decision|0|||
164192676|NCT01719380|593074033|FG007|Overall Study|Participant/Guardian Decision|0|||
164192677|NCT01719380|593074034|FG008|Overall Study|Participant/Guardian Decision|2|||
164192678|NCT01719380|593074035|FG009|Overall Study|Participant/Guardian Decision|2|||
164192679|NCT01719380|593074026|FG000|Overall Study|Physician Decision|0|||
164192680|NCT01719380|593074027|FG001|Overall Study|Physician Decision|0|||
164192681|NCT01719380|593074028|FG002|Overall Study|Physician Decision|2|||
164192682|NCT01719380|593074029|FG003|Overall Study|Physician Decision|0|||
164192683|NCT01719380|593074030|FG004|Overall Study|Physician Decision|0|||
164192684|NCT01719380|593074031|FG005|Overall Study|Physician Decision|0|||
164192685|NCT01719380|593074032|FG006|Overall Study|Physician Decision|0|||
164192686|NCT01719380|593074033|FG007|Overall Study|Physician Decision|0|||
164192687|NCT01719380|593074034|FG008|Overall Study|Physician Decision|1|||
164192688|NCT01719380|593074035|FG009|Overall Study|Physician Decision|1|||
164192689|NCT01719380|593074026|FG000|Overall Study|Lack of Efficacy|2|||
164192690|NCT01719380|593074027|FG001|Overall Study|Lack of Efficacy|6|||
164192691|NCT01719380|593074028|FG002|Overall Study|Lack of Efficacy|5|||
164192692|NCT01719380|593074029|FG003|Overall Study|Lack of Efficacy|6|||
164192693|NCT01719380|593074030|FG004|Overall Study|Lack of Efficacy|3|||
163855194|NCT01394991|591838267|FG001|Overall Study|Lost to Follow-up|8|||
163855195|NCT01394991|591838266|FG000|Overall Study|Physician Decision|1|||
163855196|NCT01394991|591838267|FG001|Overall Study|Physician Decision|3|||
163855197|NCT01394991|591838266|FG000|Overall Study|Protocol Violation|1|||
163855198|NCT01394991|591838267|FG001|Overall Study|Protocol Violation|1|||
163855199|NCT01394991|591838266|FG000|Overall Study|Withdrawal by Subject|20|||
163855200|NCT01394991|591838267|FG001|Overall Study|Withdrawal by Subject|17|||
163855201|NCT01394991|591838266|FG000|Overall Study|Chemotherapy Termination|10|||
163855202|NCT01394991|591838267|FG001|Overall Study|Chemotherapy Termination|15|||
163855203|NCT01394991|591838266|FG000|Overall Study|Disease Progression|7|||
163855204|NCT01394991|591838267|FG001|Overall Study|Disease Progression|7|||
163855205|NCT01394991|591838266|FG000|Overall Study|Prematurely Termination of Trial|9|||
163855206|NCT01394991|591838267|FG001|Overall Study|Prematurely Termination of Trial|10|||
164192694|NCT01719380|593074031|FG005|Overall Study|Lack of Efficacy|7|||
164192695|NCT01719380|593074032|FG006|Overall Study|Lack of Efficacy|10|||
164192696|NCT01719380|593074033|FG007|Overall Study|Lack of Efficacy|6|||
164192697|NCT01719380|593074034|FG008|Overall Study|Lack of Efficacy|39|||
164192698|NCT01719380|593074035|FG009|Overall Study|Lack of Efficacy|42|||
164192699|NCT01719380|593074026|FG000|Overall Study|Progressive Disease|0|||
164192700|NCT01719380|593074027|FG001|Overall Study|Progressive Disease|0|||
164192701|NCT01719380|593074028|FG002|Overall Study|Progressive Disease|0|||
163855207|NCT02337361|591838269|FG000|3-month Follow-up|Lost to Follow-up|19|||
163855208|NCT02337361|591838270|FG001|3-month Follow-up|Lost to Follow-up|14|||
163855209|NCT02337361|591838269|FG000|6-month Follow-up|Lost to Follow-up|2|||
164192702|NCT01719380|593074029|FG003|Overall Study|Progressive Disease|0|||
164192703|NCT01719380|593074030|FG004|Overall Study|Progressive Disease|0|||
163855210|NCT02337361|591838270|FG001|6-month Follow-up|Lost to Follow-up|4|||
164192704|NCT01719380|593074031|FG005|Overall Study|Progressive Disease|0|||
164192705|NCT01719380|593074032|FG006|Overall Study|Progressive Disease|0|||
164192706|NCT01719380|593074033|FG007|Overall Study|Progressive Disease|0|||
164192707|NCT01719380|593074034|FG008|Overall Study|Progressive Disease|1|||
164192708|NCT01719380|593074035|FG009|Overall Study|Progressive Disease|0|||
164192709|NCT00249873|593074036|FG000|Overall Study|Not treated|7|||
164192710|NCT00249873|593074037|FG001|Overall Study|Not treated|8|||
164192711|NCT00249873|593074036|FG000|Overall Study|Significant thrombocytopenia|9|||
164192712|NCT00249873|593074037|FG001|Overall Study|Significant thrombocytopenia|8|||
164192713|NCT00249873|593074036|FG000|Overall Study|Severe allergic reaction|8|||
164192714|NCT00249873|593074037|FG001|Overall Study|Severe allergic reaction|1|||
164192715|NCT00249873|593074036|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
164192716|NCT00249873|593074037|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
164192717|NCT00249873|593074036|FG000|Overall Study|Other Serious Adverse Event|86|||
164192718|NCT00249873|593074037|FG001|Overall Study|Other Serious Adverse Event|97|||
164192719|NCT00249873|593074036|FG000|Overall Study|Qualifying condition not present|20|||
164192720|NCT00249873|593074037|FG001|Overall Study|Qualifying condition not present|23|||
164192721|NCT00249873|593074036|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
164192722|NCT00249873|593074037|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
164192723|NCT00249873|593074036|FG000|Overall Study|Withdrawal by Subject|504|||
164192724|NCT00249873|593074037|FG001|Overall Study|Withdrawal by Subject|466|||
164192725|NCT00249873|593074036|FG000|Overall Study|Lost to Follow-up|4|||
164192726|NCT00249873|593074037|FG001|Overall Study|Lost to Follow-up|7|||
164192727|NCT00249873|593074036|FG000|Overall Study|Minor bleeding|99|||
164192728|NCT00249873|593074037|FG001|Overall Study|Minor bleeding|37|||
164192729|NCT00249873|593074036|FG000|Overall Study|Non-compliance|41|||
164192730|NCT00249873|593074037|FG001|Overall Study|Non-compliance|46|||
164192731|NCT00249873|593074036|FG000|Overall Study|Other non serious Adverse Event|112|||
164192732|NCT00249873|593074037|FG001|Overall Study|Other non serious Adverse Event|108|||
164192733|NCT00249873|593074036|FG000|Overall Study|Other contraindicated medication|1|||
164192734|NCT00249873|593074037|FG001|Overall Study|Other contraindicated medication|0|||
164192735|NCT00249873|593074036|FG000|Overall Study|Patient not wish to continue after May08|3|||
164192736|NCT00249873|593074037|FG001|Overall Study|Patient not wish to continue after May08|4|||
164192737|NCT00249873|593074036|FG000|Overall Study|Physician withdrew consent|59|||
164192738|NCT00249873|593074037|FG001|Overall Study|Physician withdrew consent|60|||
164192739|NCT00249873|593074036|FG000|Overall Study|Open label clopidogrel required|31|||
164192740|NCT00249873|593074037|FG001|Overall Study|Open label clopidogrel required|42|||
164192741|NCT00249873|593074036|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
164192742|NCT00249873|593074037|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
164192743|NCT00249873|593074036|FG000|Overall Study|Oral anticoagulant required|159|||
164192744|NCT00249873|593074037|FG001|Overall Study|Oral anticoagulant required|157|||
164192745|NCT00249873|593074036|FG000|Overall Study|Study drug intolerance|5|||
164192746|NCT00249873|593074037|FG001|Overall Study|Study drug intolerance|0|||
164192747|NCT00249873|593074036|FG000|Overall Study|Surgery/ procedure|9|||
164192748|NCT00249873|593074037|FG001|Overall Study|Surgery/ procedure|9|||
164192749|NCT00249873|593074036|FG000|Overall Study|Event related to cardiac condition|12|||
164192750|NCT00249873|593074037|FG001|Overall Study|Event related to cardiac condition|21|||
164192751|NCT00249873|593074036|FG000|Overall Study|Thromboembolic/outcome event|82|||
164192752|NCT00249873|593074037|FG001|Overall Study|Thromboembolic/outcome event|122|||
164192753|NCT02762084|593074040|FG000|Overall Study|Withdrawal by Subject|1|||
164192754|NCT02762084|593074041|FG001|Overall Study|Withdrawal by Subject|0|||
164192755|NCT02762084|593074042|FG002|Overall Study|Withdrawal by Subject|0|||
164192756|NCT02762084|593074040|FG000|Overall Study|Adverse Event|0|||
164192757|NCT02762084|593074041|FG001|Overall Study|Adverse Event|0|||
164192758|NCT02762084|593074042|FG002|Overall Study|Adverse Event|1|||
164192759|NCT00928434|593074043|FG000|Overall Study|Adverse Event|14|||
164192760|NCT00928434|593074044|FG001|Overall Study|Adverse Event|5|||
164192761|NCT00928434|593074045|FG002|Overall Study|Adverse Event|18|||
164192762|NCT00928434|593074043|FG000|Overall Study|Protocol Violation|5|||
164192763|NCT00928434|593074044|FG001|Overall Study|Protocol Violation|0|||
164192764|NCT00928434|593074045|FG002|Overall Study|Protocol Violation|8|||
164192765|NCT00928434|593074043|FG000|Overall Study|Physician Decision|2|||
164192766|NCT00928434|593074044|FG001|Overall Study|Physician Decision|0|||
164192767|NCT00928434|593074045|FG002|Overall Study|Physician Decision|3|||
164192768|NCT00928434|593074043|FG000|Overall Study|Lost to Follow-up|1|||
164192769|NCT00928434|593074044|FG001|Overall Study|Lost to Follow-up|0|||
164192770|NCT00928434|593074045|FG002|Overall Study|Lost to Follow-up|3|||
164192771|NCT00928434|593074043|FG000|Overall Study|Withdrawal by Subject|5|||
164192772|NCT00928434|593074044|FG001|Overall Study|Withdrawal by Subject|3|||
164192773|NCT00928434|593074045|FG002|Overall Study|Withdrawal by Subject|2|||
164192774|NCT00928434|593074043|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
164192775|NCT00928434|593074044|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
164192776|NCT00928434|593074045|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
164192777|NCT00928434|593074043|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
164192778|NCT00928434|593074044|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
164192779|NCT00928434|593074045|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
164192780|NCT00928434|593074043|FG000|Overall Study|Other (not meeting above criteria)|5|||
164302199|NCT01134055|593482556|FG000|Overall Study|Lost to Follow-up|0|||
164192781|NCT00928434|593074044|FG001|Overall Study|Other (not meeting above criteria)|1|||
164192782|NCT00928434|593074045|FG002|Overall Study|Other (not meeting above criteria)|2|||
164192783|NCT00716456|593074046|FG000|Overall Study|Adverse Event|0|||
164192784|NCT00716456|593074047|FG001|Overall Study|Adverse Event|2|||
164192785|NCT00716456|593074048|FG002|Overall Study|Adverse Event|0|||
164192786|NCT00447772|593074049|FG000|Overall Study|Lack of Efficacy|3|||
164192787|NCT00447772|593074049|FG000|Overall Study|Insufficient compliance|6|||
164192788|NCT00447772|593074049|FG000|Overall Study|Discontinuation of drug therapy|1|||
164192789|NCT00447772|593074049|FG000|Overall Study|Lost to Follow-up|9|||
164192790|NCT00447772|593074049|FG000|Overall Study|Withdrawal by Subject|1|||
164192791|NCT00447772|593074049|FG000|Overall Study|Unable to attend all study visits|2|||
164192792|NCT00447772|593074049|FG000|Overall Study|Adverse Event|1|||
164192793|NCT00447772|593074049|FG000|Overall Study|Patient relocated|1|||
164192794|NCT00447772|593074049|FG000|Overall Study|Incomplete documentation at visit 1|1|||
164192795|NCT00447772|593074049|FG000|Overall Study|Chemotherapy for lung cancer|1|||
164192796|NCT00447772|593074049|FG000|Overall Study|Premature re-injection required|1|||
164192797|NCT01765296|593074050|FG000|Overall Study|Protocol Violation|0|||
164192798|NCT01765296|593074051|FG001|Overall Study|Protocol Violation|5|||
164192799|NCT01765296|593074052|FG002|Overall Study|Protocol Violation|4|||
164192800|NCT01765296|593074050|FG000|Overall Study|Withdrawal by Subject|4|||
164192801|NCT01765296|593074051|FG001|Overall Study|Withdrawal by Subject|2|||
164192802|NCT01765296|593074052|FG002|Overall Study|Withdrawal by Subject|2|||
164192803|NCT01765296|593074050|FG000|Overall Study|Adverse Event|1|||
164192804|NCT01765296|593074051|FG001|Overall Study|Adverse Event|13|||
164192805|NCT01765296|593074052|FG002|Overall Study|Adverse Event|5|||
164192806|NCT01765296|593074050|FG000|Overall Study|Lack of Efficacy|0|||
164192807|NCT01765296|593074051|FG001|Overall Study|Lack of Efficacy|0|||
164192808|NCT01765296|593074052|FG002|Overall Study|Lack of Efficacy|2|||
164192809|NCT03478371|593074054|FG000|Overall Study|non-compliance|1|||
164192810|NCT03478371|593074054|FG000|Overall Study|Lost to Follow-up|4|||
164192811|NCT00627497|593074055|FG000|Overall Study|Lost to Follow-up|1|||
164192812|NCT00627497|593074056|FG001|Overall Study|Lost to Follow-up|1|||
164192813|NCT00627497|593074057|FG002|Overall Study|Lost to Follow-up|0|||
164192814|NCT00627497|593074058|FG003|Overall Study|Lost to Follow-up|0|||
164192815|NCT00838097|593074059|FG000|Overall Study|Ineligibility determined|6|||
164192816|NCT00838097|593074059|FG000|Overall Study|Adverse Event|2|||
164192817|NCT00838097|593074059|FG000|Overall Study|Withdrawal by Subject|3|||
164192818|NCT00838097|593074059|FG000|Overall Study|Requirement for alternative therapy|2|||
164192819|NCT00838097|593074059|FG000|Overall Study|Physician Decision|4|||
164192820|NCT00838097|593074059|FG000|Overall Study|Lost to Follow-up|11|||
164192821|NCT00838097|593074059|FG000|Overall Study|Death|6|||
164192822|NCT00838097|593074059|FG000|Overall Study|Protocol-specified criteria|142|||
164192823|NCT03134911|593074066|FG000|Overall Study|Screen failure|31|||
164192824|NCT03134911|593074066|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
164192825|NCT01118663|593074067|FG000|Overall Study|Adverse Event|2|||
164192826|NCT01118663|593074068|FG001|Overall Study|Adverse Event|1|||
164192827|NCT01118663|593074067|FG000|Overall Study|Withdrawal by Subject|0|||
164192828|NCT01118663|593074068|FG001|Overall Study|Withdrawal by Subject|1|||
164192829|NCT00656175|593074069|FG000|Overall Study|Adverse Event|1|||
164192830|NCT00656175|593074070|FG001|Overall Study|Adverse Event|0|||
164192831|NCT00656175|593074069|FG000|Overall Study|Transportation issues|0|||
164192832|NCT00656175|593074070|FG001|Overall Study|Transportation issues|1|||
164192833|NCT00672633|593074074|FG000|Overall Study|Withdrawal by Subject|0|||
164192834|NCT00672633|593074075|FG001|Overall Study|Withdrawal by Subject|1|||
164192835|NCT02824627|593074076|FG000|Overall Study|Adverse Event|1|||
164192836|NCT02824627|593074077|FG001|Overall Study|Adverse Event|2|||
164192837|NCT02824627|593074076|FG000|Overall Study|Lost to Follow-up|2|||
164192838|NCT02824627|593074077|FG001|Overall Study|Lost to Follow-up|1|||
164192839|NCT01868165|593074078|FG000|Overall Study|Withdrawal by Subject|36|||
164192840|NCT01868165|593074078|FG000|Overall Study|Physician Decision|2|||
164192841|NCT01868165|593074078|FG000|Overall Study|Lost to Follow-up|3|||
164192842|NCT01868165|593074078|FG000|Overall Study|Death|4|||
164192843|NCT05664581|593075629|FG000|Overall Study|Withdrawal by Subject|2|||
164192844|NCT03101150|593075630|FG000|Overall Study|Lost to Follow-up|2|||
164192845|NCT03101150|593075631|FG001|Overall Study|Lost to Follow-up|4|||
164192846|NCT03101150|593075630|FG000|Overall Study|Miscarriage|3|||
164192847|NCT03101150|593075631|FG001|Overall Study|Miscarriage|6|||
164192848|NCT01317641|593075635|FG000|Overall Study|Not treated|0|||
164192849|NCT01317641|593075636|FG001|Overall Study|Not treated|0|||
164192850|NCT01317641|593075637|FG002|Overall Study|Not treated|0|||
164192851|NCT01317641|593075638|FG003|Overall Study|Not treated|0|||
164192852|NCT01317641|593075639|FG004|Overall Study|Not treated|0|||
164192853|NCT01317641|593075640|FG005|Overall Study|Not treated|0|||
164192854|NCT01317641|593075641|FG006|Overall Study|Not treated|0|||
164192855|NCT01317641|593075642|FG007|Overall Study|Not treated|1|||
164192856|NCT01317641|593075643|FG008|Overall Study|Not treated|1|||
164192857|NCT01317641|593075635|FG000|Overall Study|Adverse Event|0|||
164192858|NCT01317641|593075636|FG001|Overall Study|Adverse Event|1|||
164192859|NCT01317641|593075637|FG002|Overall Study|Adverse Event|0|||
164192860|NCT01317641|593075638|FG003|Overall Study|Adverse Event|1|||
164192861|NCT01317641|593075639|FG004|Overall Study|Adverse Event|0|||
164192862|NCT01317641|593075640|FG005|Overall Study|Adverse Event|0|||
164192863|NCT01317641|593075641|FG006|Overall Study|Adverse Event|2|||
164192864|NCT01317641|593075642|FG007|Overall Study|Adverse Event|1|||
164192865|NCT01317641|593075643|FG008|Overall Study|Adverse Event|0|||
164192866|NCT01317641|593075635|FG000|Overall Study|Protocol Violation|1|||
164192867|NCT01317641|593075636|FG001|Overall Study|Protocol Violation|0|||
164192868|NCT01317641|593075637|FG002|Overall Study|Protocol Violation|0|||
164192869|NCT01317641|593075638|FG003|Overall Study|Protocol Violation|0|||
164192870|NCT01317641|593075639|FG004|Overall Study|Protocol Violation|0|||
164192871|NCT01317641|593075640|FG005|Overall Study|Protocol Violation|0|||
164192872|NCT01317641|593075641|FG006|Overall Study|Protocol Violation|0|||
164192873|NCT01317641|593075642|FG007|Overall Study|Protocol Violation|0|||
164192874|NCT01317641|593075643|FG008|Overall Study|Protocol Violation|0|||
164192875|NCT01317641|593075635|FG000|Overall Study|Disease progression|0|||
164192876|NCT01317641|593075636|FG001|Overall Study|Disease progression|0|||
164192877|NCT01317641|593075637|FG002|Overall Study|Disease progression|0|||
164192878|NCT01317641|593075638|FG003|Overall Study|Disease progression|0|||
164192879|NCT01317641|593075639|FG004|Overall Study|Disease progression|0|||
164192880|NCT01317641|593075640|FG005|Overall Study|Disease progression|0|||
164192881|NCT01317641|593075641|FG006|Overall Study|Disease progression|0|||
164192882|NCT01317641|593075642|FG007|Overall Study|Disease progression|3|||
164192883|NCT01317641|593075643|FG008|Overall Study|Disease progression|4|||
164192884|NCT01317641|593075635|FG000|Overall Study|Withdrawal by Subject|0|||
164192885|NCT01317641|593075636|FG001|Overall Study|Withdrawal by Subject|0|||
164192886|NCT01317641|593075637|FG002|Overall Study|Withdrawal by Subject|0|||
164192887|NCT01317641|593075638|FG003|Overall Study|Withdrawal by Subject|0|||
164192888|NCT01317641|593075639|FG004|Overall Study|Withdrawal by Subject|0|||
164192889|NCT01317641|593075640|FG005|Overall Study|Withdrawal by Subject|0|||
164192890|NCT01317641|593075641|FG006|Overall Study|Withdrawal by Subject|1|||
164192891|NCT01317641|593075642|FG007|Overall Study|Withdrawal by Subject|0|||
164192892|NCT01317641|593075643|FG008|Overall Study|Withdrawal by Subject|0|||
164192893|NCT00329108|593075644|FG000|Overall Study|Adverse Event|2|||
164192894|NCT00329108|593075645|FG001|Overall Study|Adverse Event|2|||
164192895|NCT00329108|593075644|FG000|Overall Study|Lack of Efficacy|3|||
164192896|NCT00329108|593075645|FG001|Overall Study|Lack of Efficacy|3|||
164192897|NCT00329108|593075644|FG000|Overall Study|Withdrawal by Subject|0|||
164192898|NCT00329108|593075645|FG001|Overall Study|Withdrawal by Subject|2|||
164192899|NCT00329108|593075644|FG000|Overall Study|symptomatic deterioration|1|||
164192900|NCT00329108|593075645|FG001|Overall Study|symptomatic deterioration|1|||
164192901|NCT00329108|593075644|FG000|Overall Study|Subject no longer willing to participate|2|||
164192902|NCT00329108|593075645|FG001|Overall Study|Subject no longer willing to participate|2|||
164192903|NCT00329108|593075644|FG000|Overall Study|study terminated by sponsor|1|||
164192904|NCT00329108|593075645|FG001|Overall Study|study terminated by sponsor|0|||
164192905|NCT00329108|593075644|FG000|Overall Study|withdrew patient after SAE resolved|1|||
164192906|NCT00329108|593075645|FG001|Overall Study|withdrew patient after SAE resolved|0|||
164192907|NCT00329108|593075644|FG000|Overall Study|Protocol Violation|0|||
164192908|NCT00329108|593075645|FG001|Overall Study|Protocol Violation|2|||
164192909|NCT01302418|593075646|FG000|Overall Study|Protocol Violation|9|||
164192910|NCT01302418|593075646|FG000|Overall Study|Non-evaluable|9|||
164192911|NCT02498678|593075654|FG000|Overall Study|interference from the surgical team|0|||
164192912|NCT02498678|593075655|FG001|Overall Study|interference from the surgical team|2|||
164192913|NCT03257436|593075656|FG000|Overall Study|Withdrawal by Subject|76|||
164192914|NCT03257436|593075656|FG000|Overall Study|Death|19|||
164192915|NCT01619852|593075657|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
164192916|NCT01619852|593075658|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
164192917|NCT01619852|593075657|FG000|3 Month Follow up|Lost to Follow-up|31|||
164192918|NCT01619852|593075658|FG001|3 Month Follow up|Lost to Follow-up|34|||
164192919|NCT00970489|593075659|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
164192920|NCT00970489|593075660|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
164192921|NCT05417412|593075661|FG000|Overall Study|Lost to Follow-up|2|||
164192922|NCT01576575|593075662|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
164192923|NCT01576575|593075662|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
164192924|NCT01576575|593075662|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
164192925|NCT00891813|593075663|FG000|Overall Study|Adverse Event|3|||
164192926|NCT00891813|593075663|FG000|Overall Study|Withdrawal by Subject|1|||
164192927|NCT00891813|593075663|FG000|Overall Study|Patient Noncompliance|6|||
164192928|NCT00891813|593075663|FG000|Overall Study|Protocol Violation|2|||
164192929|NCT01723072|593075668|FG000|Overall Study|Withdrawal by Subject|7|||
164192930|NCT01723072|593075669|FG001|Overall Study|Withdrawal by Subject|13|||
164192931|NCT01723072|593075668|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
164192932|NCT01723072|593075669|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
164192933|NCT01723072|593075668|FG000|Overall Study|Other|4|||
163855211|NCT03073005|591838271|FG000|Overall Study|Death|6|||
163855212|NCT03073005|591838272|FG001|Overall Study|Death|0|||
164192934|NCT01723072|593075669|FG001|Overall Study|Other|3|||
164192935|NCT01610037|593075673|FG000|All Patients|Adverse Event|27|||
164192936|NCT01610037|593075674|FG001|All Patients|Adverse Event|22|||
164192937|NCT01610037|593075675|FG002|All Patients|Adverse Event|26|||
164192938|NCT01610037|593075673|FG000|All Patients|Withdrawal by Subject|12|||
164192939|NCT01610037|593075674|FG001|All Patients|Withdrawal by Subject|10|||
164192940|NCT01610037|593075675|FG002|All Patients|Withdrawal by Subject|20|||
164192941|NCT01610037|593075673|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
164192942|NCT01610037|593075674|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
164192943|NCT01610037|593075675|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
164192944|NCT01610037|593075673|FG000|All Patients|Death|4|||
164192945|NCT01610037|593075674|FG001|All Patients|Death|2|||
164192946|NCT01610037|593075675|FG002|All Patients|Death|1|||
164192947|NCT01610037|593075673|FG000|All Patients|Protocol deviation|4|||
164192948|NCT01610037|593075674|FG001|All Patients|Protocol deviation|3|||
164192949|NCT01610037|593075675|FG002|All Patients|Protocol deviation|3|||
164192950|NCT01610037|593075673|FG000|All Patients|Abnormal laboratory value|1|||
164192951|NCT01610037|593075674|FG001|All Patients|Abnormal laboratory value|1|||
164192952|NCT01610037|593075675|FG002|All Patients|Abnormal laboratory value|0|||
164192953|NCT01610037|593075673|FG000|All Patients|Administrative problems|1|||
164192954|NCT01610037|593075674|FG001|All Patients|Administrative problems|4|||
164192955|NCT01610037|593075675|FG002|All Patients|Administrative problems|4|||
164192956|NCT01610037|593075673|FG000|All Patients|Lost to Follow-up|1|||
164192957|NCT01610037|593075674|FG001|All Patients|Lost to Follow-up|0|||
164192958|NCT01610037|593075675|FG002|All Patients|Lost to Follow-up|0|||
164192959|NCT01610037|593075673|FG000|All Patients|Abnormal test procedure result(s)|0|||
164192960|NCT01610037|593075674|FG001|All Patients|Abnormal test procedure result(s)|1|||
164192961|NCT01610037|593075675|FG002|All Patients|Abnormal test procedure result(s)|3|||
164192962|NCT01610037|593075673|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
164192963|NCT01610037|593075674|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
164192964|NCT01610037|593075675|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
164192965|NCT01610037|593075673|FG000|Treatment and Follow up Period|Death|10|||
164192966|NCT01610037|593075674|FG001|Treatment and Follow up Period|Death|5|||
164192967|NCT01610037|593075675|FG002|Treatment and Follow up Period|Death|4|||
164192968|NCT01610037|593075673|FG000|Treatment and Follow up Period|Administrative problems|1|||
164192969|NCT01610037|593075674|FG001|Treatment and Follow up Period|Administrative problems|3|||
164192970|NCT01610037|593075675|FG002|Treatment and Follow up Period|Administrative problems|2|||
164192971|NCT01610037|593075673|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
164192972|NCT01610037|593075674|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
164192973|NCT01610037|593075675|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
164192974|NCT03489343|593075682|FG000|Overall Study|Documented progressive disease|1|||
164192975|NCT03489343|593075683|FG001|Overall Study|Documented progressive disease|0|||
164192976|NCT03489343|593075684|FG002|Overall Study|Documented progressive disease|3|||
164192977|NCT03489343|593075685|FG003|Overall Study|Documented progressive disease|1|||
164192978|NCT03489343|593075686|FG004|Overall Study|Documented progressive disease|3|||
164192979|NCT03489343|593075687|FG005|Overall Study|Documented progressive disease|5|||
164192980|NCT03489343|593075688|FG006|Overall Study|Documented progressive disease|4|||
164192981|NCT03489343|593075682|FG000|Overall Study|Adverse Event|0|||
164192982|NCT03489343|593075683|FG001|Overall Study|Adverse Event|1|||
164192983|NCT03489343|593075684|FG002|Overall Study|Adverse Event|0|||
164192984|NCT03489343|593075685|FG003|Overall Study|Adverse Event|0|||
164192985|NCT03489343|593075686|FG004|Overall Study|Adverse Event|0|||
164192986|NCT03489343|593075687|FG005|Overall Study|Adverse Event|1|||
164192987|NCT03489343|593075688|FG006|Overall Study|Adverse Event|0|||
164192988|NCT03489343|593075682|FG000|Overall Study|Withdrawal by Subject|0|||
164192989|NCT03489343|593075683|FG001|Overall Study|Withdrawal by Subject|0|||
164192990|NCT03489343|593075684|FG002|Overall Study|Withdrawal by Subject|0|||
164192991|NCT03489343|593075685|FG003|Overall Study|Withdrawal by Subject|1|||
164192992|NCT03489343|593075686|FG004|Overall Study|Withdrawal by Subject|0|||
164192993|NCT03489343|593075687|FG005|Overall Study|Withdrawal by Subject|1|||
164192994|NCT03489343|593075688|FG006|Overall Study|Withdrawal by Subject|1|||
164192995|NCT03489343|593075682|FG000|Overall Study|Clinical progression|0|||
164192996|NCT03489343|593075683|FG001|Overall Study|Clinical progression|0|||
164192997|NCT03489343|593075684|FG002|Overall Study|Clinical progression|0|||
164192998|NCT03489343|593075685|FG003|Overall Study|Clinical progression|1|||
164192999|NCT03489343|593075686|FG004|Overall Study|Clinical progression|0|||
164193000|NCT03489343|593075687|FG005|Overall Study|Clinical progression|0|||
164193001|NCT03489343|593075688|FG006|Overall Study|Clinical progression|1|||
164193002|NCT00327717|593075689|FG000|Overall Study|Adverse Event|6|||
164193003|NCT00327717|593075690|FG001|Overall Study|Adverse Event|6|||
164193004|NCT00327717|593075689|FG000|Overall Study|Lack of Efficacy|0|||
164193005|NCT00327717|593075690|FG001|Overall Study|Lack of Efficacy|1|||
164193006|NCT00327717|593075689|FG000|Overall Study|Withdrawal by Subject|3|||
164193007|NCT00327717|593075690|FG001|Overall Study|Withdrawal by Subject|7|||
164193008|NCT01630135|593075693|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
164193009|NCT01630135|593075694|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
164193010|NCT02658669|593075695|FG000|Overall Study|Lost to Follow-up|7|||
164193011|NCT02658669|593075696|FG001|Overall Study|Lost to Follow-up|5|||
164193012|NCT03311841|593075705|FG000|14-day Wash-out|Adverse Event|0|||
164193013|NCT03311841|593075706|FG001|14-day Wash-out|Adverse Event|1|||
164193014|NCT03311841|593075707|FG002|14-day Wash-out|Adverse Event|0|||
164193015|NCT03311841|593075708|FG003|14-day Wash-out|Adverse Event|0|||
164193016|NCT03311841|593075709|FG004|14-day Wash-out|Adverse Event|0|||
163855213|NCT03073005|591838273|FG002|Overall Study|Death|7|||
163855214|NCT03073005|591838274|FG003|Overall Study|Death|0|||
163855215|NCT03073005|591838271|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
163855216|NCT03073005|591838272|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
163855217|NCT03073005|591838273|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
163855218|NCT03073005|591838274|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
163855219|NCT03073005|591838271|FG000|Overall Study|Lost to Follow-up|2|||
163855220|NCT03073005|591838272|FG001|Overall Study|Lost to Follow-up|2|||
163855221|NCT03073005|591838273|FG002|Overall Study|Lost to Follow-up|1|||
163855222|NCT03073005|591838274|FG003|Overall Study|Lost to Follow-up|2|||
163855223|NCT03073005|591838271|FG000|Overall Study|Withdrawal by Subject|0|||
163855224|NCT03073005|591838272|FG001|Overall Study|Withdrawal by Subject|4|||
163855225|NCT03073005|591838273|FG002|Overall Study|Withdrawal by Subject|4|||
163855226|NCT03073005|591838274|FG003|Overall Study|Withdrawal by Subject|4|||
163855227|NCT02427646|591838282|FG000|Overall Study|Lack of Efficacy|2|||
163855228|NCT02427646|591838283|FG001|Overall Study|Lack of Efficacy|3|||
163855229|NCT02427646|591838282|FG000|Overall Study|Physician Decision|1|||
163855230|NCT02427646|591838283|FG001|Overall Study|Physician Decision|4|||
163855231|NCT02427646|591838282|FG000|Overall Study|Protocol Violation|3|||
163855232|NCT02427646|591838283|FG001|Overall Study|Protocol Violation|3|||
163855233|NCT02427646|591838282|FG000|Overall Study|Bothersome hand weakness|2|||
163855234|NCT02427646|591838283|FG001|Overall Study|Bothersome hand weakness|4|||
163855235|NCT01734811|591838284|FG000|Overall Study|Lost to Follow-up|2|||
163855236|NCT01734811|591838285|FG001|Overall Study|Lost to Follow-up|3|||
163855237|NCT01734811|591838284|FG000|Overall Study|Withdrawal by Subject|2|||
163855238|NCT01734811|591838285|FG001|Overall Study|Withdrawal by Subject|0|||
163855239|NCT00062868|591838286|FG000|Dose Level 1|Death|2|||
163855240|NCT00062868|591838287|FG001|Dose Level 1|Death|0|||
163855241|NCT00062868|591838288|FG002|Dose Level 1|Death|0|||
163855242|NCT00062868|591838289|FG003|Dose Level 1|Death|2|||
163855243|NCT00062868|591838290|FG004|Dose Level 1|Death|0|||
163855244|NCT00062868|591838291|FG005|Dose Level 1|Death|0|||
163855245|NCT00062868|591838292|FG006|Dose Level 1|Death|3|||
163855246|NCT00062868|591838293|FG007|Dose Level 1|Death|0|||
163855247|NCT00062868|591838294|FG008|Dose Level 1|Death|0|||
163855248|NCT00062868|591838295|FG009|Dose Level 1|Death|0|||
163855249|NCT00062868|591838296|FG010|Dose Level 1|Death|0|||
163855250|NCT00062868|591838297|FG011|Dose Level 1|Death|0|||
163855251|NCT00062868|591838298|FG012|Dose Level 1|Death|0|||
163855252|NCT00062868|591838299|FG013|Dose Level 1|Death|0|||
163855253|NCT00062868|591838300|FG014|Dose Level 1|Death|0|||
163855254|NCT00062868|591838301|FG015|Dose Level 1|Death|0|||
163855255|NCT00062868|591838302|FG016|Dose Level 1|Death|0|||
163855256|NCT00062868|591838303|FG017|Dose Level 1|Death|0|||
163855257|NCT00062868|591838304|FG018|Dose Level 1|Death|7|||
163855258|NCT00062868|591838305|FG019|Dose Level 1|Death|0|||
163855259|NCT00062868|591838306|FG020|Dose Level 1|Death|1|||
163855260|NCT00062868|591838286|FG000|Dose Level 1|Lost to Follow-up|0|||
163855261|NCT00062868|591838287|FG001|Dose Level 1|Lost to Follow-up|0|||
163855262|NCT00062868|591838288|FG002|Dose Level 1|Lost to Follow-up|0|||
163855263|NCT00062868|591838289|FG003|Dose Level 1|Lost to Follow-up|0|||
163855264|NCT00062868|591838290|FG004|Dose Level 1|Lost to Follow-up|0|||
163855265|NCT00062868|591838291|FG005|Dose Level 1|Lost to Follow-up|0|||
163855266|NCT00062868|591838292|FG006|Dose Level 1|Lost to Follow-up|0|||
163855267|NCT00062868|591838293|FG007|Dose Level 1|Lost to Follow-up|0|||
163964837|NCT00909792|592244738|FG000|Period 2|Biomicroscopy|1|||
163964838|NCT00909792|592244739|FG001|Period 2|Biomicroscopy|0|||
163964839|NCT00909792|592244738|FG000|Period 2|Lost to Follow-up|0|||
164193017|NCT03311841|593075705|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193018|NCT03311841|593075706|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193019|NCT03311841|593075707|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193020|NCT03311841|593075708|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
163855268|NCT00062868|591838294|FG008|Dose Level 1|Lost to Follow-up|0|||
163855269|NCT00062868|591838295|FG009|Dose Level 1|Lost to Follow-up|0|||
163855270|NCT00062868|591838296|FG010|Dose Level 1|Lost to Follow-up|0|||
163855271|NCT00062868|591838297|FG011|Dose Level 1|Lost to Follow-up|0|||
163855272|NCT00062868|591838298|FG012|Dose Level 1|Lost to Follow-up|1|||
163855273|NCT00062868|591838299|FG013|Dose Level 1|Lost to Follow-up|0|||
163855274|NCT00062868|591838300|FG014|Dose Level 1|Lost to Follow-up|0|||
163855275|NCT00062868|591838301|FG015|Dose Level 1|Lost to Follow-up|0|||
163855276|NCT00062868|591838302|FG016|Dose Level 1|Lost to Follow-up|0|||
163855277|NCT00062868|591838303|FG017|Dose Level 1|Lost to Follow-up|0|||
163855278|NCT00062868|591838304|FG018|Dose Level 1|Lost to Follow-up|2|||
163855279|NCT00062868|591838305|FG019|Dose Level 1|Lost to Follow-up|0|||
164193021|NCT03311841|593075709|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
164193022|NCT00977613|593075712|FG000|Overall Study|Lost to Follow-up|16|||
164193023|NCT05464420|593075713|FG000|Overall Study|Death|0|||
164193024|NCT05464420|593075714|FG001|Overall Study|Death|0|||
164193025|NCT05464420|593075715|FG002|Overall Study|Death|0|||
164193026|NCT05464420|593075716|FG003|Overall Study|Death|1|||
164193027|NCT05464420|593075713|FG000|Overall Study|Lost to Follow-up|16|||
164193028|NCT05464420|593075714|FG001|Overall Study|Lost to Follow-up|11|||
164193029|NCT05464420|593075715|FG002|Overall Study|Lost to Follow-up|11|||
164193030|NCT05464420|593075716|FG003|Overall Study|Lost to Follow-up|11|||
164193031|NCT05464420|593075713|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
164193032|NCT05464420|593075714|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
164193033|NCT05464420|593075715|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
164193034|NCT05464420|593075716|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
164193035|NCT05464420|593075713|FG000|Overall Study|Withdrawal by Subject|4|||
164193036|NCT05464420|593075714|FG001|Overall Study|Withdrawal by Subject|8|||
164193037|NCT05464420|593075715|FG002|Overall Study|Withdrawal by Subject|3|||
164193038|NCT05464420|593075716|FG003|Overall Study|Withdrawal by Subject|1|||
164193039|NCT05464420|593075713|FG000|Overall Study|Protocol Violation|0|||
164193040|NCT05464420|593075714|FG001|Overall Study|Protocol Violation|0|||
164193041|NCT05464420|593075715|FG002|Overall Study|Protocol Violation|1|||
164193042|NCT05464420|593075716|FG003|Overall Study|Protocol Violation|1|||
164193043|NCT05464420|593075713|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
164193044|NCT05464420|593075714|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
164193045|NCT05464420|593075715|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
164193046|NCT05464420|593075716|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
164193047|NCT01383018|593075719|FG000|Overall Study|Adverse Event|14|||
164193048|NCT01383018|593075719|FG000|Overall Study|Death|10|||
164193049|NCT01383018|593075719|FG000|Overall Study|Lost to Follow-up|5|||
164193050|NCT01383018|593075719|FG000|Overall Study|Physician Decision|5|||
164193051|NCT01383018|593075719|FG000|Overall Study|Withdrawal by Subject|9|||
164193052|NCT01383018|593075719|FG000|Overall Study|Subject not implanted|76|||
164193053|NCT01383018|593075719|FG000|Overall Study|Missed Visit|247|||
164193054|NCT01383018|593075719|FG000|Overall Study|Site closed early-not compliance related|7|||
164193055|NCT01383018|593075719|FG000|Overall Study|Patient moved away from site|1|||
164193056|NCT01383018|593075719|FG000|Overall Study|Subject Incarcerated|1|||
164193057|NCT01051817|593075720|FG000|Overall Study|Adverse Event|0|||
164193058|NCT01051817|593075721|FG001|Overall Study|Adverse Event|2|||
164193059|NCT01051817|593075720|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
164193060|NCT01051817|593075721|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
164193061|NCT01051817|593075720|FG000|Overall Study|Withdrawal by Subject|3|||
164193062|NCT01051817|593075721|FG001|Overall Study|Withdrawal by Subject|5|||
164193063|NCT01051817|593075720|FG000|Overall Study|Protocol Violation|0|||
164193064|NCT01051817|593075721|FG001|Overall Study|Protocol Violation|1|||
164193065|NCT01598610|593075724|FG000|Overall Study|Adverse Event|1|||
164193066|NCT00627926|593075725|FG000|Overall Study|Adverse Event|26|||
164193067|NCT00627926|593075726|FG001|Overall Study|Adverse Event|37|||
164193068|NCT00627926|593075727|FG002|Overall Study|Adverse Event|36|||
164193069|NCT00627926|593075725|FG000|Overall Study|Death|1|||
164193070|NCT00627926|593075726|FG001|Overall Study|Death|0|||
164193071|NCT00627926|593075727|FG002|Overall Study|Death|0|||
164193072|NCT00627926|593075725|FG000|Overall Study|Lost to Follow-up|4|||
164193073|NCT00627926|593075726|FG001|Overall Study|Lost to Follow-up|3|||
164193074|NCT00627926|593075727|FG002|Overall Study|Lost to Follow-up|4|||
164193075|NCT00627926|593075725|FG000|Overall Study|Withdrawal by Subject|2|||
164193076|NCT00627926|593075726|FG001|Overall Study|Withdrawal by Subject|1|||
164193077|NCT00627926|593075727|FG002|Overall Study|Withdrawal by Subject|0|||
164193078|NCT00627926|593075725|FG000|Overall Study|Lack of Efficacy|118|||
164193079|NCT00627926|593075726|FG001|Overall Study|Lack of Efficacy|40|||
164193080|NCT00627926|593075727|FG002|Overall Study|Lack of Efficacy|38|||
164193081|NCT00627926|593075725|FG000|Overall Study|Noncompliance/unspecified|8|||
164193082|NCT00627926|593075726|FG001|Overall Study|Noncompliance/unspecified|23|||
164193083|NCT00627926|593075727|FG002|Overall Study|Noncompliance/unspecified|17|||
164193084|NCT02989402|593075729|FG000|Overall Study|Adverse event, or serious adverse event|4|||
164193085|NCT02989402|593075729|FG000|Overall Study|Death|2|||
164193086|NCT02989402|593075729|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
164193087|NCT02989402|593075729|FG000|Overall Study|Lost to Follow-up|8|||
163964840|NCT00909792|592244739|FG001|Period 2|Lost to Follow-up|1|||
164193088|NCT02989402|593075729|FG000|Overall Study|Patient no longer on monotherapy|1|||
164193089|NCT02989402|593075729|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
164193090|NCT02989402|593075729|FG000|Overall Study|Withdrawal by Subject|7|||
164193091|NCT02989402|593075729|FG000|Overall Study|Other|2|||
164193092|NCT03066830|593075730|FG000|Overall Study|At the Participant's own Request|16|||
163964841|NCT03823404|592244740|FG000|Overall Study|Lost to Follow-up|1|||
163964842|NCT03823404|592244741|FG001|Overall Study|Lost to Follow-up|2|||
163964843|NCT03823404|592244742|FG002|Overall Study|Lost to Follow-up|3|||
164193093|NCT03066830|593075731|FG001|Overall Study|At the Participant's own Request|17|||
164193094|NCT03066830|593075730|FG000|Overall Study|Other|3|||
164193095|NCT03066830|593075731|FG001|Overall Study|Other|0|||
164193096|NCT03066830|593075730|FG000|Overall Study|Poor Compliance to Protocol|1|||
164193097|NCT03066830|593075731|FG001|Overall Study|Poor Compliance to Protocol|0|||
164193098|NCT03066830|593075730|FG000|Overall Study|Adverse Event|2|||
164193099|NCT03066830|593075731|FG001|Overall Study|Adverse Event|2|||
164193100|NCT03066830|593075730|FG000|Overall Study|Lost to Follow-up|11|||
164193101|NCT03066830|593075731|FG001|Overall Study|Lost to Follow-up|3|||
164193102|NCT03414229|593075732|FG000|Overall Study|Adverse Event|1|||
164193103|NCT03414229|593075733|FG001|Overall Study|Adverse Event|0|||
164193104|NCT03414229|593075734|FG002|Overall Study|Adverse Event|2|||
164193105|NCT03414229|593075735|FG003|Overall Study|Adverse Event|1|||
164193106|NCT03414229|593075732|FG000|Overall Study|Lack of Efficacy|7|||
164193107|NCT03414229|593075733|FG001|Overall Study|Lack of Efficacy|4|||
164193108|NCT03414229|593075734|FG002|Overall Study|Lack of Efficacy|1|||
164193109|NCT03414229|593075735|FG003|Overall Study|Lack of Efficacy|9|||
164193110|NCT03414229|593075732|FG000|Overall Study|Change in therapy|1|||
164193111|NCT03414229|593075733|FG001|Overall Study|Change in therapy|0|||
164193112|NCT03414229|593075734|FG002|Overall Study|Change in therapy|0|||
164193113|NCT03414229|593075735|FG003|Overall Study|Change in therapy|0|||
164193114|NCT03414229|593075732|FG000|Overall Study|Pregnancy|0|||
164193115|NCT03414229|593075733|FG001|Overall Study|Pregnancy|0|||
164193116|NCT03414229|593075734|FG002|Overall Study|Pregnancy|1|||
164193117|NCT03414229|593075735|FG003|Overall Study|Pregnancy|0|||
164193118|NCT03414229|593075732|FG000|Overall Study|Withdrawal by Subject|0|||
164193119|NCT03414229|593075733|FG001|Overall Study|Withdrawal by Subject|1|||
164193120|NCT03414229|593075734|FG002|Overall Study|Withdrawal by Subject|1|||
164193121|NCT03414229|593075735|FG003|Overall Study|Withdrawal by Subject|0|||
164193122|NCT02797678|593075759|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
164193123|NCT02797678|593075760|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
164193124|NCT02797678|593075761|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
164193125|NCT02797678|593075762|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
164193126|NCT02797678|593075759|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
164193127|NCT02797678|593075760|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
164193128|NCT02797678|593075761|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
164193129|NCT02797678|593075762|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
164193130|NCT02797678|593075759|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
164193131|NCT02797678|593075760|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
164193132|NCT02797678|593075761|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
164193133|NCT02797678|593075762|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
164193134|NCT02149264|593075771|FG000|Overall Study|Withdrawal by Subject|9|||
164193135|NCT02149264|593075771|FG000|Overall Study|Adverse Event|7|||
164193136|NCT02149264|593075771|FG000|Overall Study|Physician Decision|3|||
164193137|NCT02149264|593075771|FG000|Overall Study|Protocol Violation|1|||
164193138|NCT01938846|593075774|FG000|Overall Study|Progressive disease|26|||
164193139|NCT01938846|593075775|FG001|Overall Study|Progressive disease|18|||
164193140|NCT01938846|593075776|FG002|Overall Study|Progressive disease|16|||
164193141|NCT01938846|593075774|FG000|Overall Study|Adverse Event|8|||
164193142|NCT01938846|593075775|FG001|Overall Study|Adverse Event|4|||
164193143|NCT01938846|593075776|FG002|Overall Study|Adverse Event|3|||
164193144|NCT01938846|593075774|FG000|Overall Study|Withdrawal by Subject|2|||
164193145|NCT01938846|593075775|FG001|Overall Study|Withdrawal by Subject|2|||
164193146|NCT01938846|593075776|FG002|Overall Study|Withdrawal by Subject|1|||
164193147|NCT01938846|593075774|FG000|Overall Study|Other than listed|5|||
164193148|NCT01938846|593075775|FG001|Overall Study|Other than listed|1|||
164193149|NCT01938846|593075776|FG002|Overall Study|Other than listed|4|||
164193150|NCT02499120|593075780|FG000|Overall Study|Death|52|||
164193151|NCT02499120|593075781|FG001|Overall Study|Death|43|||
164193152|NCT02499120|593075780|FG000|Overall Study|Lost to Follow-up|1|||
164193153|NCT02499120|593075781|FG001|Overall Study|Lost to Follow-up|2|||
164193154|NCT02499120|593075780|FG000|Overall Study|Participant refused further follow-up|1|||
164193155|NCT02499120|593075781|FG001|Overall Study|Participant refused further follow-up|0|||
164193156|NCT02499120|593075780|FG000|Overall Study|Withdrawal by Subject|2|||
164193157|NCT02499120|593075781|FG001|Overall Study|Withdrawal by Subject|5|||
164193158|NCT02499120|593075780|FG000|Overall Study|Other|9|||
164193159|NCT02499120|593075781|FG001|Overall Study|Other|10|||
164193160|NCT02282163|593075782|FG000|Overall Study|Protocol Violation|1|||
164193161|NCT01839916|593075783|FG000|Overall Study|Death|9|||
164193162|NCT01839916|593075783|FG000|Overall Study|Physician Decision|17|||
164193163|NCT01839916|593075783|FG000|Overall Study|Relapse|12|||
164193164|NCT01839916|593075783|FG000|Overall Study|GVHD|2|||
163855280|NCT00062868|591838306|FG020|Dose Level 1|Lost to Follow-up|1|||
164193165|NCT01839916|593075783|FG000|Overall Study|Graft Failure|1|||
164193166|NCT01216332|593075785|FG000|Overall Study|Withdrawal by Subject|4|||
164193167|NCT01216332|593075786|FG001|Overall Study|Withdrawal by Subject|0|||
164193168|NCT03677869|593075787|FG000|Overall Study|Withdrawal by Subject|1|||
164193169|NCT05219968|593075788|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
164193170|NCT05219968|593075789|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193171|NCT05219968|593075790|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193172|NCT05219968|593075791|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193173|NCT05219968|593075792|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
164193174|NCT05219968|593075788|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
164193175|NCT05219968|593075789|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193176|NCT05219968|593075790|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193177|NCT05219968|593075791|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193178|NCT05219968|593075792|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
164193179|NCT05219968|593075788|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
164193180|NCT05219968|593075789|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
164193181|NCT05219968|593075790|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
164193182|NCT05219968|593075791|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
164193183|NCT05219968|593075792|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
164193184|NCT05219968|593075788|FG000|Week 24 Treatment Period|Adverse Event|3|||
164193185|NCT05219968|593075789|FG001|Week 24 Treatment Period|Adverse Event|0|||
164193186|NCT05219968|593075790|FG002|Week 24 Treatment Period|Adverse Event|0|||
164193187|NCT05219968|593075791|FG003|Week 24 Treatment Period|Adverse Event|0|||
164193188|NCT05219968|593075792|FG004|Week 24 Treatment Period|Adverse Event|0|||
164193189|NCT05219968|593075788|FG000|Week 24 Treatment Period|Physician Decision|0|||
164193190|NCT05219968|593075789|FG001|Week 24 Treatment Period|Physician Decision|1|||
164193191|NCT05219968|593075790|FG002|Week 24 Treatment Period|Physician Decision|0|||
164193192|NCT05219968|593075791|FG003|Week 24 Treatment Period|Physician Decision|0|||
164193193|NCT05219968|593075792|FG004|Week 24 Treatment Period|Physician Decision|0|||
164193194|NCT05219968|593075788|FG000|Week 24 Treatment Period|Other, not specified|3|||
164193195|NCT05219968|593075789|FG001|Week 24 Treatment Period|Other, not specified|0|||
164193196|NCT05219968|593075790|FG002|Week 24 Treatment Period|Other, not specified|0|||
164193197|NCT05219968|593075791|FG003|Week 24 Treatment Period|Other, not specified|0|||
164193198|NCT05219968|593075792|FG004|Week 24 Treatment Period|Other, not specified|0|||
164193199|NCT05219968|593075788|FG000|Safety Extension Period|Treatment administration failure|0|||
164193200|NCT05219968|593075789|FG001|Safety Extension Period|Treatment administration failure|0|||
164193201|NCT05219968|593075790|FG002|Safety Extension Period|Treatment administration failure|0|||
164193202|NCT05219968|593075791|FG003|Safety Extension Period|Treatment administration failure|1|||
164193203|NCT05219968|593075792|FG004|Safety Extension Period|Treatment administration failure|4|||
164193204|NCT05219968|593075788|FG000|Safety Extension Period|Bilateral dislodgement|0|||
164193205|NCT05219968|593075789|FG001|Safety Extension Period|Bilateral dislodgement|0|||
164193206|NCT05219968|593075790|FG002|Safety Extension Period|Bilateral dislodgement|4|||
164193207|NCT05219968|593075791|FG003|Safety Extension Period|Bilateral dislodgement|0|||
164193208|NCT05219968|593075792|FG004|Safety Extension Period|Bilateral dislodgement|1|||
164193209|NCT05219968|593075788|FG000|Safety Extension Period|Withdrawal by Subject|0|||
164193210|NCT05219968|593075789|FG001|Safety Extension Period|Withdrawal by Subject|0|||
164193211|NCT05219968|593075790|FG002|Safety Extension Period|Withdrawal by Subject|2|||
164193212|NCT05219968|593075791|FG003|Safety Extension Period|Withdrawal by Subject|0|||
164193213|NCT05219968|593075792|FG004|Safety Extension Period|Withdrawal by Subject|4|||
164193214|NCT05219968|593075788|FG000|Safety Extension Period|Adverse Event|0|||
164193215|NCT05219968|593075789|FG001|Safety Extension Period|Adverse Event|0|||
164193216|NCT05219968|593075790|FG002|Safety Extension Period|Adverse Event|2|||
164193217|NCT05219968|593075791|FG003|Safety Extension Period|Adverse Event|1|||
164193218|NCT05219968|593075792|FG004|Safety Extension Period|Adverse Event|1|||
164193219|NCT05219968|593075788|FG000|Safety Extension Period|Lost to Follow-up|0|||
164193220|NCT05219968|593075789|FG001|Safety Extension Period|Lost to Follow-up|0|||
164193221|NCT05219968|593075790|FG002|Safety Extension Period|Lost to Follow-up|0|||
164193222|NCT05219968|593075791|FG003|Safety Extension Period|Lost to Follow-up|1|||
164193223|NCT05219968|593075792|FG004|Safety Extension Period|Lost to Follow-up|0|||
164193224|NCT03877224|593075793|FG000|Overall Study|Death|3|||
164193225|NCT03877224|593075794|FG001|Overall Study|Death|2|||
164193226|NCT03877224|593075793|FG000|Overall Study|Withdrawal by Subject|1|||
164193227|NCT03877224|593075794|FG001|Overall Study|Withdrawal by Subject|6|||
164193228|NCT03877224|593075793|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
164193229|NCT03877224|593075794|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
164193230|NCT04587336|593075797|FG000|Overall Study|Lost to Follow-up|1|||
164193231|NCT04587336|593075798|FG001|Overall Study|Lost to Follow-up|0|||
164193232|NCT01212094|593077446|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
164193233|NCT01212094|593077447|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
164193234|NCT01212094|593077448|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
164193235|NCT01212094|593077446|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
164193236|NCT01212094|593077447|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
164193237|NCT01212094|593077448|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
164193238|NCT01212094|593077446|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
163855281|NCT00062868|591838286|FG000|Dose Level 2|Death|0|||
164193239|NCT01212094|593077447|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
164193240|NCT01212094|593077448|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
164193241|NCT01212094|593077446|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
164193242|NCT01212094|593077447|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
164193243|NCT01212094|593077448|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
164193244|NCT01212094|593077446|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
164193245|NCT01212094|593077447|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
164193246|NCT01212094|593077448|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
164193247|NCT01212094|593077446|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
164193248|NCT01212094|593077447|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
164193249|NCT01212094|593077448|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
164193250|NCT02787304|593077450|FG000|Overall Study|Adverse Event|9|||
164193251|NCT02787304|593077451|FG001|Overall Study|Adverse Event|3|||
164193252|NCT02787304|593077452|FG002|Overall Study|Adverse Event|8|||
164193253|NCT02787304|593077453|FG003|Overall Study|Adverse Event|1|||
164193254|NCT02787304|593077450|FG000|Overall Study|Withdrawal by Subject|1|||
164193255|NCT02787304|593077451|FG001|Overall Study|Withdrawal by Subject|4|||
164193256|NCT02787304|593077452|FG002|Overall Study|Withdrawal by Subject|0|||
164193257|NCT02787304|593077453|FG003|Overall Study|Withdrawal by Subject|0|||
164193258|NCT02787304|593077450|FG000|Overall Study|Lost to Follow-up|1|||
164193259|NCT02787304|593077451|FG001|Overall Study|Lost to Follow-up|0|||
164193260|NCT02787304|593077452|FG002|Overall Study|Lost to Follow-up|0|||
164193261|NCT02787304|593077453|FG003|Overall Study|Lost to Follow-up|1|||
164193262|NCT02787304|593077450|FG000|Overall Study|Noncompliance with study drug|0|||
164193263|NCT02787304|593077451|FG001|Overall Study|Noncompliance with study drug|0|||
164193264|NCT02787304|593077452|FG002|Overall Study|Noncompliance with study drug|1|||
164193265|NCT02787304|593077453|FG003|Overall Study|Noncompliance with study drug|0|||
164193266|NCT02787304|593077450|FG000|Overall Study|Physician Decision|0|||
164193267|NCT02787304|593077451|FG001|Overall Study|Physician Decision|0|||
164193268|NCT02787304|593077452|FG002|Overall Study|Physician Decision|1|||
164193269|NCT02787304|593077453|FG003|Overall Study|Physician Decision|0|||
164193270|NCT02787304|593077450|FG000|Overall Study|Study terminated by sponsor|25|||
164193271|NCT02787304|593077451|FG001|Overall Study|Study terminated by sponsor|31|||
164193272|NCT02787304|593077452|FG002|Overall Study|Study terminated by sponsor|31|||
164193273|NCT02787304|593077453|FG003|Overall Study|Study terminated by sponsor|32|||
164193274|NCT04771013|593077456|FG000|Overall Study|Withdrawal by Subject|2|||
164193275|NCT04771013|593077457|FG001|Overall Study|Withdrawal by Subject|0|||
164193276|NCT04771013|593077456|FG000|Overall Study|Death|0|||
164193277|NCT04771013|593077457|FG001|Overall Study|Death|5|||
164193278|NCT04771013|593077456|FG000|Overall Study|Referred to another hospital before day 20|0|||
164193279|NCT04771013|593077457|FG001|Overall Study|Referred to another hospital before day 20|1|||
164193280|NCT01051921|593077458|FG000|Overall Study|Physician Decision|9|||
164193281|NCT01051921|593077458|FG000|Overall Study|Adverse Event|8|||
164193282|NCT01051921|593077458|FG000|Overall Study|Withdrawal by Subject|7|||
164193283|NCT01051921|593077458|FG000|Overall Study|Lost to Follow-up|4|||
164193284|NCT01051921|593077458|FG000|Overall Study|virological failure|1|||
164193285|NCT01051921|593077458|FG000|Overall Study|patient moved|1|||
164193286|NCT00379834|593077459|FG000|Overall Study|Time constraints|2|||
164193287|NCT01519817|593077460|FG000|Overall Study|Withdrawal by Subject|1|||
164193288|NCT01519817|593077461|FG001|Overall Study|Withdrawal by Subject|0|||
164193289|NCT01519817|593077462|FG002|Overall Study|Withdrawal by Subject|0|||
164193290|NCT01519817|593077463|FG003|Overall Study|Withdrawal by Subject|0|||
164193291|NCT01519817|593077460|FG000|Overall Study|Off study due to infection|0|||
164193292|NCT01519817|593077461|FG001|Overall Study|Off study due to infection|0|||
164193293|NCT01519817|593077462|FG002|Overall Study|Off study due to infection|0|||
164193294|NCT01519817|593077463|FG003|Overall Study|Off study due to infection|1|||
164193295|NCT01716806|593077466|FG000|Overall Study|Patient withdrawal of consent|4|||
164193296|NCT01716806|593077467|FG001|Overall Study|Patient withdrawal of consent|2|||
164193297|NCT01716806|593077468|FG002|Overall Study|Patient withdrawal of consent|4|||
164193298|NCT01716806|593077469|FG003|Overall Study|Patient withdrawal of consent|3|||
164193299|NCT01716806|593077470|FG004|Overall Study|Patient withdrawal of consent|2|||
164193300|NCT01716806|593077471|FG005|Overall Study|Patient withdrawal of consent|0|||
164193301|NCT01716806|593077466|FG000|Overall Study|Lost to Follow-up|3|||
164193302|NCT01716806|593077467|FG001|Overall Study|Lost to Follow-up|3|||
164193303|NCT01716806|593077468|FG002|Overall Study|Lost to Follow-up|0|||
164193304|NCT01716806|593077469|FG003|Overall Study|Lost to Follow-up|2|||
164193305|NCT01716806|593077470|FG004|Overall Study|Lost to Follow-up|1|||
164193306|NCT01716806|593077471|FG005|Overall Study|Lost to Follow-up|0|||
164193307|NCT01716806|593077466|FG000|Overall Study|Death|13|||
164193308|NCT01716806|593077467|FG001|Overall Study|Death|9|||
164193309|NCT01716806|593077468|FG002|Overall Study|Death|12|||
164193310|NCT01716806|593077469|FG003|Overall Study|Death|4|||
164193311|NCT01716806|593077470|FG004|Overall Study|Death|10|||
164193312|NCT01716806|593077471|FG005|Overall Study|Death|5|||
164193313|NCT01716806|593077466|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
163964844|NCT03823404|592244740|FG000|Overall Study|Protocol Violation|2|||
163964845|NCT03823404|592244741|FG001|Overall Study|Protocol Violation|0|||
163964846|NCT03823404|592244742|FG002|Overall Study|Protocol Violation|2|||
163964847|NCT03823404|592244740|FG000|Overall Study|Adverse Event|35|||
163964848|NCT03823404|592244741|FG001|Overall Study|Adverse Event|38|||
163964849|NCT03823404|592244742|FG002|Overall Study|Adverse Event|8|||
163964850|NCT03823404|592244740|FG000|Overall Study|Withdrawal by Subject|38|||
163964851|NCT03823404|592244741|FG001|Overall Study|Withdrawal by Subject|40|||
163964852|NCT03823404|592244742|FG002|Overall Study|Withdrawal by Subject|35|||
163964853|NCT03823404|592244740|FG000|Overall Study|Death|4|||
163964854|NCT03823404|592244741|FG001|Overall Study|Death|0|||
163964855|NCT03823404|592244742|FG002|Overall Study|Death|0|||
163964856|NCT03823404|592244740|FG000|Overall Study|Other: Various reasons provided|5|||
163964857|NCT03823404|592244741|FG001|Overall Study|Other: Various reasons provided|5|||
163964858|NCT03823404|592244742|FG002|Overall Study|Other: Various reasons provided|6|||
163964859|NCT00059839|592244744|FG000|Overall Study|Death|1|||
163964860|NCT00059839|592244745|FG001|Overall Study|Death|1|||
163964861|NCT00059839|592244744|FG000|Overall Study|Lack of Efficacy|6|||
163964862|NCT00059839|592244745|FG001|Overall Study|Lack of Efficacy|5|||
163964863|NCT00059839|592244744|FG000|Overall Study|Lost to Follow-up|2|||
163964864|NCT00059839|592244745|FG001|Overall Study|Lost to Follow-up|0|||
163964865|NCT00059839|592244744|FG000|Overall Study|Physician Decision|1|||
163964866|NCT00059839|592244745|FG001|Overall Study|Physician Decision|2|||
163964867|NCT00059839|592244744|FG000|Overall Study|Withdrawal by Subject|1|||
163964868|NCT00059839|592244745|FG001|Overall Study|Withdrawal by Subject|6|||
163964869|NCT00059839|592244744|FG000|Overall Study|Ineligible|1|||
163964870|NCT00059839|592244745|FG001|Overall Study|Ineligible|3|||
163964871|NCT00698451|592244746|FG000|Overall Study|Adverse Event|22|||
163964872|NCT00698451|592244746|FG000|Overall Study|Physician Decision|2|||
163964873|NCT00698451|592244746|FG000|Overall Study|Protocol Violation|6|||
163964874|NCT00698451|592244746|FG000|Overall Study|Withdrawal by Subject|6|||
163964875|NCT00698451|592244746|FG000|Overall Study|Disease progression|3|||
163964876|NCT02224599|592244749|FG000|Overall Study|Physician Decision|1|||
163964877|NCT02224599|592244749|FG000|Overall Study|Progression of Disease|1|||
163964878|NCT02315898|592244752|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
163964879|NCT02315898|592244753|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
163964880|NCT02315898|592244754|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
163964881|NCT02315898|592244755|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
163964882|NCT01330914|592244756|FG000|Overall Study|Withdrawal by Subject|4|||
163964883|NCT01330914|592244756|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
163964884|NCT02445755|592244759|FG000|Overall Study|Withdrawal by Subject|2|||
163964885|NCT02445755|592244759|FG000|Overall Study|Protocol Violation|6|||
163964886|NCT02445755|592244759|FG000|Overall Study|Screen Failure|5|||
163964887|NCT03239483|592244760|FG000|Overall Study|Lost to Follow-up|1|||
163964888|NCT03239483|592244761|FG001|Overall Study|Lost to Follow-up|0|||
163964889|NCT03239483|592244760|FG000|Overall Study|Withdrawal by Subject|1|||
163964890|NCT03239483|592244761|FG001|Overall Study|Withdrawal by Subject|0|||
163964891|NCT05352048|592244764|FG000|Overall Study|Lost to Follow-up|1|||
163964892|NCT05352048|592244764|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
163964893|NCT03085758|592244767|FG000|Overall Study|Death|26|||
163964894|NCT03085758|592244768|FG001|Overall Study|Death|24|||
163964895|NCT03085758|592244769|FG002|Overall Study|Death|53|||
163964896|NCT03085758|592244767|FG000|Overall Study|Lost to Follow-up|1|||
163964897|NCT03085758|592244768|FG001|Overall Study|Lost to Follow-up|1|||
163964898|NCT03085758|592244769|FG002|Overall Study|Lost to Follow-up|1|||
163964899|NCT03085758|592244767|FG000|Overall Study|Withdrawal by Subject|2|||
163964900|NCT03085758|592244768|FG001|Overall Study|Withdrawal by Subject|2|||
163964901|NCT03085758|592244769|FG002|Overall Study|Withdrawal by Subject|1|||
163964902|NCT03085758|592244767|FG000|Overall Study|Refusal to recall it up to day 90|0|||
163964903|NCT03085758|592244768|FG001|Overall Study|Refusal to recall it up to day 90|0|||
163964904|NCT03085758|592244769|FG002|Overall Study|Refusal to recall it up to day 90|1|||
163964905|NCT03085758|592244767|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
163964906|NCT03085758|592244768|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
163964907|NCT03085758|592244769|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
163964908|NCT00056862|592244770|FG000|Overall Study|Protocol Violation|1|||
163964909|NCT00056862|592244771|FG001|Overall Study|Protocol Violation|0|||
163964910|NCT03974334|592244772|FG000|Overall Study|Lost to Follow-up|1|||
163964911|NCT01109173|592244773|FG000|Overall Study|Adverse Event|15|||
163964912|NCT01109173|592244774|FG001|Overall Study|Adverse Event|17|||
163964913|NCT01109173|592244775|FG002|Overall Study|Adverse Event|9|||
163964914|NCT01109173|592244776|FG003|Overall Study|Adverse Event|6|||
163964915|NCT01109173|592244773|FG000|Overall Study|Lost to Follow-up|0|||
163964916|NCT01109173|592244774|FG001|Overall Study|Lost to Follow-up|1|||
163964917|NCT01109173|592244775|FG002|Overall Study|Lost to Follow-up|0|||
163964918|NCT01109173|592244776|FG003|Overall Study|Lost to Follow-up|0|||
163964919|NCT01109173|592244773|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
164193314|NCT01716806|593077467|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164193315|NCT01716806|593077468|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164193316|NCT01716806|593077469|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
164193317|NCT01716806|593077470|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
164193318|NCT01716806|593077471|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
164193319|NCT01716806|593077466|FG000|Overall Study|PI decision|0|||
164193320|NCT01716806|593077467|FG001|Overall Study|PI decision|0|||
164193321|NCT01716806|593077468|FG002|Overall Study|PI decision|0|||
164193322|NCT01716806|593077469|FG003|Overall Study|PI decision|0|||
164193323|NCT01716806|593077470|FG004|Overall Study|PI decision|1|||
164193324|NCT01716806|593077471|FG005|Overall Study|PI decision|0|||
164193325|NCT01716806|593077466|FG000|Overall Study|Change in performance status|1|||
164193326|NCT01716806|593077467|FG001|Overall Study|Change in performance status|0|||
164193327|NCT01716806|593077468|FG002|Overall Study|Change in performance status|0|||
164193328|NCT01716806|593077469|FG003|Overall Study|Change in performance status|0|||
164193329|NCT01716806|593077470|FG004|Overall Study|Change in performance status|0|||
164193330|NCT01716806|593077471|FG005|Overall Study|Change in performance status|0|||
164193331|NCT01716806|593077466|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193332|NCT01716806|593077467|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193333|NCT01716806|593077468|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
164193334|NCT01716806|593077469|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193335|NCT01716806|593077470|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193336|NCT01716806|593077471|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
164193337|NCT01716806|593077466|FG000|Overall Study|Sponsor direction|7|||
164193338|NCT01716806|593077467|FG001|Overall Study|Sponsor direction|8|||
164193339|NCT01716806|593077468|FG002|Overall Study|Sponsor direction|5|||
164193340|NCT01716806|593077469|FG003|Overall Study|Sponsor direction|12|||
164193341|NCT01716806|593077470|FG004|Overall Study|Sponsor direction|16|||
164193342|NCT01716806|593077471|FG005|Overall Study|Sponsor direction|1|||
164193343|NCT00735709|593077474|FG000|Overall Study|Adverse Event|2|||
164193344|NCT00735709|593077475|FG001|Overall Study|Adverse Event|3|||
164193345|NCT00735709|593077476|FG002|Overall Study|Adverse Event|1|||
164193346|NCT00735709|593077477|FG003|Overall Study|Adverse Event|5|||
164193347|NCT00735709|593077474|FG000|Overall Study|Lack of Efficacy|8|||
164193348|NCT00735709|593077475|FG001|Overall Study|Lack of Efficacy|4|||
164193349|NCT00735709|593077476|FG002|Overall Study|Lack of Efficacy|2|||
164193350|NCT00735709|593077477|FG003|Overall Study|Lack of Efficacy|3|||
164193351|NCT00735709|593077474|FG000|Overall Study|Noncompliance|0|||
164193352|NCT00735709|593077475|FG001|Overall Study|Noncompliance|0|||
164193353|NCT00735709|593077476|FG002|Overall Study|Noncompliance|1|||
164193354|NCT00735709|593077477|FG003|Overall Study|Noncompliance|0|||
164193355|NCT00735709|593077474|FG000|Overall Study|Protocol deviations|1|||
164193356|NCT00735709|593077475|FG001|Overall Study|Protocol deviations|2|||
164193357|NCT00735709|593077476|FG002|Overall Study|Protocol deviations|1|||
164193358|NCT00735709|593077477|FG003|Overall Study|Protocol deviations|1|||
164193359|NCT00735709|593077474|FG000|Overall Study|Voluntary Withdrawal|1|||
164193360|NCT00735709|593077475|FG001|Overall Study|Voluntary Withdrawal|3|||
164193361|NCT00735709|593077476|FG002|Overall Study|Voluntary Withdrawal|5|||
164193362|NCT00735709|593077477|FG003|Overall Study|Voluntary Withdrawal|7|||
164193363|NCT00735709|593077474|FG000|Overall Study|Lost to Follow-up|0|||
164193364|NCT00735709|593077475|FG001|Overall Study|Lost to Follow-up|1|||
164193365|NCT00735709|593077476|FG002|Overall Study|Lost to Follow-up|1|||
164193366|NCT00735709|593077477|FG003|Overall Study|Lost to Follow-up|1|||
164193367|NCT00735709|593077474|FG000|Overall Study|Excluded medication|1|||
164193368|NCT00735709|593077475|FG001|Overall Study|Excluded medication|0|||
164193369|NCT00735709|593077476|FG002|Overall Study|Excluded medication|0|||
164193370|NCT00735709|593077477|FG003|Overall Study|Excluded medication|1|||
164193371|NCT01145482|593077478|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164193372|NCT01145482|593077479|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164193373|NCT04547140|593077480|FG000|Overall Study|Adverse Event|0|||
164193374|NCT04547140|593077481|FG001|Overall Study|Adverse Event|1|||
164193375|NCT04547140|593077480|FG000|Overall Study|Withdrawal by Subject|0|||
164193376|NCT04547140|593077481|FG001|Overall Study|Withdrawal by Subject|1|||
164193377|NCT04547140|593077480|FG000|Overall Study|Lost to Follow-up|3|||
164193378|NCT04547140|593077481|FG001|Overall Study|Lost to Follow-up|1|||
164193379|NCT04547140|593077480|FG000|Overall Study|Death|2|||
164193380|NCT04547140|593077481|FG001|Overall Study|Death|1|||
164193381|NCT04547140|593077480|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
164193382|NCT04547140|593077481|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
164193383|NCT04547140|593077480|FG000|Overall Study|Pregnancy|1|||
164193384|NCT04547140|593077481|FG001|Overall Study|Pregnancy|0|||
164193385|NCT04547140|593077480|FG000|Overall Study|Reason Not Specified|4|||
164193386|NCT04547140|593077481|FG001|Overall Study|Reason Not Specified|1|||
164193387|NCT02119299|593077482|FG000|Overall Study|Withdrawal by Subject|7|||
164193388|NCT02119299|593077482|FG000|Overall Study|Lack of Efficacy|1|||
164193389|NCT02119299|593077482|FG000|Overall Study|Pregnancy|1|||
164193390|NCT00873730|593077483|FG000|Overall Study|Protocol Deviation|5|||
164193391|NCT00873730|593077484|FG001|Overall Study|Protocol Deviation|2|||
164193392|NCT00873730|593077483|FG000|Overall Study|Adverse Event|0|||
164193393|NCT00873730|593077484|FG001|Overall Study|Adverse Event|2|||
164193394|NCT00873730|593077483|FG000|Overall Study|Withdrawal by Subject|0|||
164193395|NCT00873730|593077484|FG001|Overall Study|Withdrawal by Subject|1|||
164193396|NCT00873730|593077483|FG000|Overall Study|Sponsor decision|1|||
164193397|NCT00873730|593077484|FG001|Overall Study|Sponsor decision|0|||
164193398|NCT04613739|593077485|FG000|Overall Study|Lost to Follow-up|6|||
164193399|NCT04613739|593077486|FG001|Overall Study|Lost to Follow-up|9|||
164193400|NCT04613739|593077485|FG000|Overall Study|potentially duplicative/fraudulent|1|||
164193401|NCT04613739|593077486|FG001|Overall Study|potentially duplicative/fraudulent|3|||
164193402|NCT03442088|593077487|FG000|Overall Study|Adverse Event|1|||
164193403|NCT03442088|593077487|FG000|Overall Study|Lack of Efficacy|2|||
164193404|NCT03442088|593077487|FG000|Overall Study|Lost to Follow-up|2|||
164193405|NCT01051557|593077490|FG000|Overall Study|Physician Decision|1|||
164193406|NCT01051557|593077491|FG001|Overall Study|Physician Decision|0|||
164193407|NCT01051557|593077492|FG002|Overall Study|Physician Decision|0|||
164193408|NCT01051557|593077493|FG003|Overall Study|Physician Decision|0|||
164193409|NCT01051557|593077494|FG004|Overall Study|Physician Decision|0|||
164193410|NCT01051557|593077495|FG005|Overall Study|Physician Decision|0|||
164193411|NCT01051557|593077496|FG006|Overall Study|Physician Decision|0|||
164193412|NCT01051557|593077490|FG000|Overall Study|disease progression|3|||
164193413|NCT01051557|593077491|FG001|Overall Study|disease progression|3|||
164193414|NCT01051557|593077492|FG002|Overall Study|disease progression|5|||
164193415|NCT01051557|593077493|FG003|Overall Study|disease progression|2|||
164193416|NCT01051557|593077494|FG004|Overall Study|disease progression|4|||
164193417|NCT01051557|593077495|FG005|Overall Study|disease progression|3|||
164193418|NCT01051557|593077496|FG006|Overall Study|disease progression|1|||
164193419|NCT01051557|593077490|FG000|Overall Study|Withdrawal by Subject|0|||
164193420|NCT01051557|593077491|FG001|Overall Study|Withdrawal by Subject|0|||
164193421|NCT01051557|593077492|FG002|Overall Study|Withdrawal by Subject|1|||
164193422|NCT01051557|593077493|FG003|Overall Study|Withdrawal by Subject|0|||
164193423|NCT01051557|593077494|FG004|Overall Study|Withdrawal by Subject|2|||
164193424|NCT01051557|593077495|FG005|Overall Study|Withdrawal by Subject|0|||
164193425|NCT01051557|593077496|FG006|Overall Study|Withdrawal by Subject|1|||
164193426|NCT01051557|593077490|FG000|Overall Study|Adverse Event|0|||
164193427|NCT01051557|593077491|FG001|Overall Study|Adverse Event|0|||
164193428|NCT01051557|593077492|FG002|Overall Study|Adverse Event|0|||
164193429|NCT01051557|593077493|FG003|Overall Study|Adverse Event|1|||
164193430|NCT01051557|593077494|FG004|Overall Study|Adverse Event|1|||
164193431|NCT01051557|593077495|FG005|Overall Study|Adverse Event|3|||
164193432|NCT01051557|593077496|FG006|Overall Study|Adverse Event|4|||
164193433|NCT00130689|593077497|FG000|Overall Study|Progressive Disease|29|||
164193434|NCT00130689|593077497|FG000|Overall Study|Death|1|||
164193435|NCT00130689|593077497|FG000|Overall Study|Clinical Deterioration|4|||
164193436|NCT00130689|593077497|FG000|Overall Study|Withdrawal by Subject|3|||
164193437|NCT00130689|593077497|FG000|Overall Study|Ineligible|6|||
164193438|NCT00766597|593077498|FG000|Overall Study|Unexpected closure of study|4|||
164193439|NCT00766597|593077498|FG000|Overall Study|Without CCR5-tropic virus|5|||
164193440|NCT00048035|593077499|FG000|Core Period|Early Withdrawals|4|||
164193441|NCT00048035|593077500|FG001|Core Period|Early Withdrawals|2|||
164193442|NCT00048035|593077501|FG002|Core Period|Early Withdrawals|1|||
164193443|NCT00048035|593077502|FG003|Core Period|Early Withdrawals|1|||
164193444|NCT00048035|593077503|FG004|Core Period|Early Withdrawals|1|||
164193445|NCT00048035|593077504|FG005|Core Period|Early Withdrawals|1|||
164193446|NCT00048035|593077505|FG006|Core Period|Early Withdrawals|0|||
164193447|NCT00048035|593077506|FG007|Core Period|Early Withdrawals|0|||
164193448|NCT00048035|593077499|FG000|Extension Year 1|Early Withdrawals|0|||
164193449|NCT00048035|593077500|FG001|Extension Year 1|Early Withdrawals|0|||
164193450|NCT00048035|593077501|FG002|Extension Year 1|Early Withdrawals|0|||
164193451|NCT00048035|593077502|FG003|Extension Year 1|Early Withdrawals|0|||
164193452|NCT00048035|593077503|FG004|Extension Year 1|Early Withdrawals|0|||
164193453|NCT00048035|593077504|FG005|Extension Year 1|Early Withdrawals|0|||
164193454|NCT00048035|593077505|FG006|Extension Year 1|Early Withdrawals|11|||
164193455|NCT00048035|593077506|FG007|Extension Year 1|Early Withdrawals|11|||
164193456|NCT00048035|593077499|FG000|Extension Year 2|Early Withdrawals|0|||
164193457|NCT00048035|593077500|FG001|Extension Year 2|Early Withdrawals|0|||
164193458|NCT00048035|593077501|FG002|Extension Year 2|Early Withdrawals|0|||
164193459|NCT00048035|593077502|FG003|Extension Year 2|Early Withdrawals|0|||
164193460|NCT00048035|593077503|FG004|Extension Year 2|Early Withdrawals|0|||
164193461|NCT00048035|593077504|FG005|Extension Year 2|Early Withdrawals|0|||
164193462|NCT00048035|593077505|FG006|Extension Year 2|Early Withdrawals|3|||
164193463|NCT00048035|593077506|FG007|Extension Year 2|Early Withdrawals|3|||
164193464|NCT05137717|593077511|FG000|Overall Study|Death|2|||
164193465|NCT05137717|593077511|FG000|Overall Study|Withdrawal by Subject|6|||
164193466|NCT02619617|593077512|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
164193467|NCT02619617|593077513|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
164193468|NCT02619617|593077512|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
164193469|NCT02619617|593077513|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
164193470|NCT00509899|593077514|FG000|Overall Study|Progressive disease|1|||
164193471|NCT00509899|593077515|FG001|Overall Study|Progressive disease|3|||
164193472|NCT00509899|593077516|FG002|Overall Study|Progressive disease|5|||
164193473|NCT00509899|593077517|FG003|Overall Study|Progressive disease|1|||
164193474|NCT00509899|593077518|FG004|Overall Study|Progressive disease|0|||
164193475|NCT00509899|593077519|FG005|Overall Study|Progressive disease|1|||
164193476|NCT00509899|593077520|FG006|Overall Study|Progressive disease|0|||
164193477|NCT00509899|593077521|FG007|Overall Study|Progressive disease|0|||
164193478|NCT00509899|593077514|FG000|Overall Study|Unacceptable Toxicity|1|||
164193479|NCT00509899|593077515|FG001|Overall Study|Unacceptable Toxicity|0|||
164193480|NCT00509899|593077516|FG002|Overall Study|Unacceptable Toxicity|0|||
164193481|NCT00509899|593077517|FG003|Overall Study|Unacceptable Toxicity|2|||
164193482|NCT00509899|593077518|FG004|Overall Study|Unacceptable Toxicity|0|||
164193483|NCT00509899|593077519|FG005|Overall Study|Unacceptable Toxicity|0|||
164193484|NCT00509899|593077520|FG006|Overall Study|Unacceptable Toxicity|0|||
164193485|NCT00509899|593077521|FG007|Overall Study|Unacceptable Toxicity|0|||
164193486|NCT00509899|593077514|FG000|Overall Study|Withdrawal by Subject|6|||
164193487|NCT00509899|593077515|FG001|Overall Study|Withdrawal by Subject|2|||
164193488|NCT00509899|593077516|FG002|Overall Study|Withdrawal by Subject|3|||
164193489|NCT00509899|593077517|FG003|Overall Study|Withdrawal by Subject|0|||
164193490|NCT00509899|593077518|FG004|Overall Study|Withdrawal by Subject|3|||
164193491|NCT00509899|593077519|FG005|Overall Study|Withdrawal by Subject|2|||
164193492|NCT00509899|593077520|FG006|Overall Study|Withdrawal by Subject|0|||
164193493|NCT00509899|593077521|FG007|Overall Study|Withdrawal by Subject|0|||
164193494|NCT00509899|593077514|FG000|Overall Study|Physician Decision|4|||
164193495|NCT00509899|593077515|FG001|Overall Study|Physician Decision|2|||
164193496|NCT00509899|593077516|FG002|Overall Study|Physician Decision|7|||
164193497|NCT00509899|593077517|FG003|Overall Study|Physician Decision|0|||
164193498|NCT00509899|593077518|FG004|Overall Study|Physician Decision|1|||
164193499|NCT00509899|593077519|FG005|Overall Study|Physician Decision|4|||
164193500|NCT00509899|593077520|FG006|Overall Study|Physician Decision|0|||
164193501|NCT00509899|593077521|FG007|Overall Study|Physician Decision|0|||
164193502|NCT00509899|593077514|FG000|Overall Study|Intercurrent Illness|1|||
164193503|NCT00509899|593077515|FG001|Overall Study|Intercurrent Illness|0|||
164193504|NCT00509899|593077516|FG002|Overall Study|Intercurrent Illness|0|||
164193505|NCT00509899|593077517|FG003|Overall Study|Intercurrent Illness|1|||
164193506|NCT00509899|593077518|FG004|Overall Study|Intercurrent Illness|0|||
164193507|NCT00509899|593077519|FG005|Overall Study|Intercurrent Illness|1|||
164193508|NCT00509899|593077520|FG006|Overall Study|Intercurrent Illness|0|||
164193509|NCT00509899|593077521|FG007|Overall Study|Intercurrent Illness|0|||
164193510|NCT00509899|593077514|FG000|Overall Study|Death|2|||
164193511|NCT00509899|593077515|FG001|Overall Study|Death|2|||
164193512|NCT00509899|593077516|FG002|Overall Study|Death|3|||
164193513|NCT00509899|593077517|FG003|Overall Study|Death|0|||
164193514|NCT00509899|593077518|FG004|Overall Study|Death|1|||
164193515|NCT00509899|593077519|FG005|Overall Study|Death|1|||
164193516|NCT00509899|593077520|FG006|Overall Study|Death|1|||
164193517|NCT00509899|593077521|FG007|Overall Study|Death|1|||
164193518|NCT00509899|593077514|FG000|Overall Study|Lack of Efficacy|1|||
164193519|NCT00509899|593077515|FG001|Overall Study|Lack of Efficacy|0|||
164193520|NCT00509899|593077516|FG002|Overall Study|Lack of Efficacy|2|||
164193521|NCT00509899|593077517|FG003|Overall Study|Lack of Efficacy|0|||
164193522|NCT00509899|593077518|FG004|Overall Study|Lack of Efficacy|0|||
164193523|NCT00509899|593077519|FG005|Overall Study|Lack of Efficacy|1|||
164193524|NCT00509899|593077520|FG006|Overall Study|Lack of Efficacy|0|||
163855282|NCT00062868|591838287|FG001|Dose Level 2|Death|3|||
163855283|NCT00062868|591838288|FG002|Dose Level 2|Death|0|||
164193525|NCT00509899|593077521|FG007|Overall Study|Lack of Efficacy|0|||
164193526|NCT01254656|593077522|FG000|Overall Study|Discontinued due to termination of study|40|||
164193527|NCT01254656|593077523|FG001|Overall Study|Discontinued due to termination of study|39|||
164193528|NCT01254656|593077524|FG002|Overall Study|Discontinued due to termination of study|13|||
164193529|NCT01254656|593077522|FG000|Overall Study|Lack of Efficacy|3|||
164193530|NCT01254656|593077523|FG001|Overall Study|Lack of Efficacy|0|||
164193531|NCT01254656|593077524|FG002|Overall Study|Lack of Efficacy|0|||
164193532|NCT01254656|593077522|FG000|Overall Study|Lost to Follow-up|1|||
164193533|NCT01254656|593077523|FG001|Overall Study|Lost to Follow-up|0|||
164193534|NCT01254656|593077524|FG002|Overall Study|Lost to Follow-up|2|||
164193535|NCT01254656|593077522|FG000|Overall Study|Withdrawal by Subject|2|||
164193536|NCT01254656|593077523|FG001|Overall Study|Withdrawal by Subject|2|||
164193537|NCT01254656|593077524|FG002|Overall Study|Withdrawal by Subject|1|||
164193538|NCT01254656|593077522|FG000|Overall Study|Pregnancy|0|||
164193539|NCT01254656|593077523|FG001|Overall Study|Pregnancy|0|||
164193540|NCT01254656|593077524|FG002|Overall Study|Pregnancy|2|||
164193541|NCT01254656|593077522|FG000|Overall Study|Adverse Event|1|||
164193542|NCT01254656|593077523|FG001|Overall Study|Adverse Event|1|||
164193543|NCT01254656|593077524|FG002|Overall Study|Adverse Event|0|||
164193544|NCT01254656|593077522|FG000|Overall Study|Death|0|||
164193545|NCT01254656|593077523|FG001|Overall Study|Death|1|||
164193546|NCT01254656|593077524|FG002|Overall Study|Death|0|||
164193547|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193548|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
164193549|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
164193550|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193551|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193552|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193553|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193554|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193555|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193556|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193557|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193558|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193559|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193560|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193561|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164193562|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
164193563|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
164193564|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193565|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193566|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193567|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193568|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193569|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193570|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193571|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193572|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193573|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193574|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193575|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193576|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164193577|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
164193578|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
164193579|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
164193580|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193581|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193582|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193583|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193584|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193585|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193586|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193587|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193588|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193589|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193590|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193591|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164193592|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193593|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193594|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
164193595|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193596|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193597|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193598|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193599|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193600|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193601|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193602|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193603|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193604|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193605|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193606|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
164193607|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193608|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193609|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
164193610|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193611|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193612|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193613|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193614|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193615|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193616|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193617|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193618|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193619|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193620|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193621|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
164193622|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193623|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193624|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
164193625|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193626|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193627|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193628|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193629|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193630|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193631|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193632|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193633|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193634|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193635|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193636|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
164193637|NCT02326272|593077527|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193638|NCT02326272|593077528|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193639|NCT02326272|593077529|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
164193640|NCT02326272|593077530|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193641|NCT02326272|593077531|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193642|NCT02326272|593077532|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193643|NCT02326272|593077533|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193644|NCT02326272|593077534|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193645|NCT02326272|593077535|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193646|NCT02326272|593077536|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193647|NCT02326272|593077537|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193648|NCT02326272|593077538|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193649|NCT02326272|593077539|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193650|NCT02326272|593077540|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
164193651|NCT02326272|593077541|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
163855284|NCT00062868|591838289|FG003|Dose Level 2|Death|0|||
163855285|NCT00062868|591838290|FG004|Dose Level 2|Death|2|||
163855286|NCT00062868|591838291|FG005|Dose Level 2|Death|0|||
163855287|NCT00062868|591838292|FG006|Dose Level 2|Death|0|||
163855288|NCT00062868|591838293|FG007|Dose Level 2|Death|0|||
163855289|NCT00062868|591838294|FG008|Dose Level 2|Death|0|||
163855290|NCT00062868|591838295|FG009|Dose Level 2|Death|0|||
163855291|NCT00062868|591838296|FG010|Dose Level 2|Death|1|||
163855292|NCT00062868|591838297|FG011|Dose Level 2|Death|0|||
163855293|NCT00062868|591838298|FG012|Dose Level 2|Death|0|||
163855294|NCT00062868|591838299|FG013|Dose Level 2|Death|0|||
163855295|NCT00062868|591838300|FG014|Dose Level 2|Death|0|||
163855296|NCT00062868|591838301|FG015|Dose Level 2|Death|0|||
163855297|NCT00062868|591838302|FG016|Dose Level 2|Death|2|||
163855298|NCT00062868|591838303|FG017|Dose Level 2|Death|0|||
163855299|NCT00062868|591838304|FG018|Dose Level 2|Death|0|||
163855300|NCT00062868|591838305|FG019|Dose Level 2|Death|0|||
163855301|NCT00062868|591838306|FG020|Dose Level 2|Death|0|||
163855302|NCT00062868|591838286|FG000|Dose Level 2|Lost to Follow-up|0|||
163855303|NCT00062868|591838287|FG001|Dose Level 2|Lost to Follow-up|0|||
163855304|NCT00062868|591838288|FG002|Dose Level 2|Lost to Follow-up|0|||
163855305|NCT00062868|591838289|FG003|Dose Level 2|Lost to Follow-up|0|||
163855306|NCT00062868|591838290|FG004|Dose Level 2|Lost to Follow-up|0|||
164193652|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193653|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193654|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193655|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193656|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164193657|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
164193658|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
164193659|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164193660|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164193661|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193662|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193663|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193664|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193665|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193666|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164193667|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193668|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193669|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193670|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193671|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193672|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
164193673|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164193674|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193675|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164193676|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164193677|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193678|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193679|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193680|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193681|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164193682|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193683|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193684|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193685|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193686|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193687|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
164193688|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193689|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
164193690|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193691|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193692|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193693|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193694|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193695|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193696|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164193697|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193698|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193699|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193700|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193701|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193702|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
164193703|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193704|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193705|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193706|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164193707|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193708|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193709|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193710|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193711|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164193712|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193713|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193714|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193715|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193716|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193717|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193718|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193719|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
164193720|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193721|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193722|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193723|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193724|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193725|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193726|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
164193727|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193728|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193729|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193730|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193731|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193732|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193733|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
164193734|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193735|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193736|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193737|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193738|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193739|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193740|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193741|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164193742|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193743|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193744|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193745|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193746|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193747|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193748|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193749|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193750|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
164193751|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193752|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193753|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193754|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193755|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193756|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
164193757|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193758|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193759|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193760|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193761|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193762|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
164193763|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
164193764|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
164193765|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
164193766|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193767|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193768|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193769|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193770|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193771|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164193772|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193773|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193774|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193775|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193776|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
163855307|NCT00062868|591838291|FG005|Dose Level 2|Lost to Follow-up|0|||
163855308|NCT00062868|591838292|FG006|Dose Level 2|Lost to Follow-up|0|||
164193777|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
164193778|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193779|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193780|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193781|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193782|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193783|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193784|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193785|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193786|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
164193787|NCT02326272|593077527|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193788|NCT02326272|593077528|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193789|NCT02326272|593077529|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193790|NCT02326272|593077530|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193791|NCT02326272|593077531|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193792|NCT02326272|593077532|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193793|NCT02326272|593077533|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
164193794|NCT02326272|593077534|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193795|NCT02326272|593077535|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193796|NCT02326272|593077536|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193797|NCT02326272|593077537|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193798|NCT02326272|593077538|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193799|NCT02326272|593077539|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193800|NCT02326272|593077540|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193801|NCT02326272|593077541|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
164193802|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
164193803|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
164193804|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
164193805|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
164193806|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
164193807|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
164193808|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
164193809|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
164193810|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
164193811|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
164193812|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
164193813|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
164193814|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
164193815|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
164193816|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
164193817|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193818|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193819|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193820|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193821|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193822|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193823|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193824|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193825|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193826|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193827|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
164193828|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
164193829|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
164193830|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164193831|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
164193832|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193833|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193834|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193835|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193836|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193837|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193838|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
163855309|NCT00062868|591838293|FG007|Dose Level 2|Lost to Follow-up|0|||
164193839|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193840|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193841|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193842|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164193843|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193844|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164193845|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193846|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164193847|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193848|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193849|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193850|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193851|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193852|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193853|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193854|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193855|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193856|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193857|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193858|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
164193859|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193860|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193861|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164193862|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193863|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193864|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193865|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193866|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193867|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193868|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193869|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193870|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193871|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193872|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164193873|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193874|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
164193875|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164193876|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
164193877|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193878|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193879|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193880|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193881|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193882|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193883|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193884|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193885|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193886|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193887|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193888|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
164193889|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193890|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164193891|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
164193892|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193893|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193894|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193895|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193896|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193897|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164302200|NCT01134055|593482557|FG001|Overall Study|Lost to Follow-up|1|||
163855310|NCT00062868|591838294|FG008|Dose Level 2|Lost to Follow-up|0|||
163855311|NCT00062868|591838295|FG009|Dose Level 2|Lost to Follow-up|0|||
163855312|NCT00062868|591838296|FG010|Dose Level 2|Lost to Follow-up|0|||
163855313|NCT00062868|591838297|FG011|Dose Level 2|Lost to Follow-up|0|||
164193898|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193899|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193900|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193901|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193902|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193903|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
164193904|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
164193905|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164193906|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
164193907|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193908|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193909|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193910|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193911|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193912|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163855314|NCT00062868|591838298|FG012|Dose Level 2|Lost to Follow-up|0|||
163855315|NCT00062868|591838299|FG013|Dose Level 2|Lost to Follow-up|1|||
163855316|NCT00062868|591838300|FG014|Dose Level 2|Lost to Follow-up|0|||
163855317|NCT00062868|591838301|FG015|Dose Level 2|Lost to Follow-up|0|||
163855318|NCT00062868|591838302|FG016|Dose Level 2|Lost to Follow-up|1|||
163855319|NCT00062868|591838303|FG017|Dose Level 2|Lost to Follow-up|0|||
163855320|NCT00062868|591838304|FG018|Dose Level 2|Lost to Follow-up|0|||
163855321|NCT00062868|591838305|FG019|Dose Level 2|Lost to Follow-up|0|||
163855322|NCT00062868|591838306|FG020|Dose Level 2|Lost to Follow-up|0|||
163855323|NCT00062868|591838286|FG000|Dose Level 3|Death|0|||
163855324|NCT00062868|591838287|FG001|Dose Level 3|Death|0|||
164134612|NCT01121666|592857346|FG001|Overall Study|Protocol Violation|10|||
163855325|NCT00062868|591838288|FG002|Dose Level 3|Death|0|||
163855326|NCT00062868|591838289|FG003|Dose Level 3|Death|0|||
163855327|NCT00062868|591838290|FG004|Dose Level 3|Death|0|||
163855328|NCT00062868|591838291|FG005|Dose Level 3|Death|0|||
164134613|NCT02041091|592857349|FG000|Treatment|Adverse Event|3|||
164134614|NCT02041091|592857350|FG001|Treatment|Adverse Event|3|||
164134615|NCT02041091|592857349|FG000|Treatment|Withdrawal by Subject|2|||
164134616|NCT02041091|592857350|FG001|Treatment|Withdrawal by Subject|4|||
164134617|NCT02041091|592857349|FG000|Treatment|Physician Decision|1|||
164134618|NCT02041091|592857350|FG001|Treatment|Physician Decision|0|||
164134619|NCT02041091|592857349|FG000|Treatment|Sponsor Decision|15|||
164134620|NCT02041091|592857350|FG001|Treatment|Sponsor Decision|16|||
164134621|NCT02041091|592857349|FG000|Treatment|Lost to Follow-up|1|||
164134622|NCT02041091|592857350|FG001|Treatment|Lost to Follow-up|0|||
164134623|NCT02041091|592857349|FG000|Optional Safety Extension Period|Adverse Event|4|||
164134624|NCT02041091|592857350|FG001|Optional Safety Extension Period|Adverse Event|2|||
164134625|NCT02041091|592857349|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
164134626|NCT02041091|592857350|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
164134627|NCT02041091|592857349|FG000|Optional Safety Extension Period|Protocol Violation|2|||
164134628|NCT02041091|592857350|FG001|Optional Safety Extension Period|Protocol Violation|0|||
164134629|NCT02041091|592857349|FG000|Optional Safety Extension Period|Physician Decision|2|||
164134630|NCT02041091|592857350|FG001|Optional Safety Extension Period|Physician Decision|1|||
164134631|NCT02041091|592857349|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
164134632|NCT02041091|592857350|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
164134633|NCT02041091|592857349|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
164134634|NCT02041091|592857350|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
164134635|NCT01855074|592857351|FG000|Overall Study|Adverse Event|1|||
164134636|NCT01855074|592857351|FG000|Overall Study|Lost to Follow-up|4|||
164134637|NCT01855074|592857351|FG000|Overall Study|Withdrawal by Subject|8|||
164134638|NCT01855074|592857351|FG000|Overall Study|Started but not treated|1|||
164134639|NCT02991430|592857352|FG000|Treatment Period 1|Adverse Event|1|||
164134640|NCT02991430|592857353|FG001|Treatment Period 1|Adverse Event|0|||
164134641|NCT02991430|592857354|FG002|Treatment Period 1|Adverse Event|2|||
164134642|NCT02991430|592857352|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164134643|NCT02991430|592857353|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164134644|NCT02991430|592857354|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164134645|NCT02991430|592857352|FG000|Treatment Period 2|Study Termination|6|||
164134646|NCT02991430|592857353|FG001|Treatment Period 2|Study Termination|3|||
164134647|NCT02991430|592857354|FG002|Treatment Period 2|Study Termination|3|||
164134648|NCT02991430|592857352|FG000|Treatment Period 2|Lost to Follow-up|0|||
164134649|NCT02991430|592857353|FG001|Treatment Period 2|Lost to Follow-up|0|||
164134650|NCT02991430|592857354|FG002|Treatment Period 2|Lost to Follow-up|1|||
164134651|NCT02991430|592857352|FG000|Post-treatment Observation Period|Study Termination|3|||
164134652|NCT02991430|592857353|FG001|Post-treatment Observation Period|Study Termination|6|||
164134653|NCT02991430|592857354|FG002|Post-treatment Observation Period|Study Termination|5|||
163855329|NCT00062868|591838292|FG006|Dose Level 3|Death|0|||
163855330|NCT00062868|591838293|FG007|Dose Level 3|Death|0|||
163855331|NCT00062868|591838294|FG008|Dose Level 3|Death|0|||
163855332|NCT00062868|591838295|FG009|Dose Level 3|Death|0|||
163855333|NCT00062868|591838296|FG010|Dose Level 3|Death|0|||
163855334|NCT00062868|591838297|FG011|Dose Level 3|Death|1|||
163855335|NCT00062868|591838298|FG012|Dose Level 3|Death|0|||
163855336|NCT00062868|591838299|FG013|Dose Level 3|Death|0|||
163855337|NCT00062868|591838300|FG014|Dose Level 3|Death|0|||
163855338|NCT00062868|591838301|FG015|Dose Level 3|Death|0|||
163855339|NCT00062868|591838302|FG016|Dose Level 3|Death|0|||
163855340|NCT00062868|591838303|FG017|Dose Level 3|Death|1|||
163855341|NCT00062868|591838304|FG018|Dose Level 3|Death|0|||
163855342|NCT00062868|591838305|FG019|Dose Level 3|Death|0|||
163855343|NCT00062868|591838306|FG020|Dose Level 3|Death|0|||
163855344|NCT00062868|591838286|FG000|Dose Level 3|Lost to Follow-up|0|||
163855345|NCT00062868|591838287|FG001|Dose Level 3|Lost to Follow-up|0|||
163855346|NCT00062868|591838288|FG002|Dose Level 3|Lost to Follow-up|0|||
163855347|NCT00062868|591838289|FG003|Dose Level 3|Lost to Follow-up|0|||
163855348|NCT00062868|591838290|FG004|Dose Level 3|Lost to Follow-up|0|||
163855349|NCT00062868|591838291|FG005|Dose Level 3|Lost to Follow-up|0|||
163855350|NCT00062868|591838292|FG006|Dose Level 3|Lost to Follow-up|0|||
163855351|NCT00062868|591838293|FG007|Dose Level 3|Lost to Follow-up|0|||
163855352|NCT00062868|591838294|FG008|Dose Level 3|Lost to Follow-up|0|||
163855353|NCT00062868|591838295|FG009|Dose Level 3|Lost to Follow-up|0|||
163855354|NCT00062868|591838296|FG010|Dose Level 3|Lost to Follow-up|0|||
163855355|NCT00062868|591838297|FG011|Dose Level 3|Lost to Follow-up|0|||
163855356|NCT00062868|591838298|FG012|Dose Level 3|Lost to Follow-up|0|||
163855357|NCT00062868|591838299|FG013|Dose Level 3|Lost to Follow-up|0|||
163855358|NCT00062868|591838300|FG014|Dose Level 3|Lost to Follow-up|1|||
163855359|NCT00062868|591838301|FG015|Dose Level 3|Lost to Follow-up|0|||
163855360|NCT00062868|591838302|FG016|Dose Level 3|Lost to Follow-up|0|||
163855361|NCT00062868|591838303|FG017|Dose Level 3|Lost to Follow-up|0|||
163855362|NCT00062868|591838304|FG018|Dose Level 3|Lost to Follow-up|0|||
163855363|NCT00062868|591838305|FG019|Dose Level 3|Lost to Follow-up|0|||
164193913|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193914|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193915|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163855364|NCT00062868|591838306|FG020|Dose Level 3|Lost to Follow-up|0|||
163855365|NCT00062868|591838286|FG000|Dose Level 3|Withdrew|0|||
163855366|NCT00062868|591838287|FG001|Dose Level 3|Withdrew|0|||
163855367|NCT00062868|591838288|FG002|Dose Level 3|Withdrew|2|||
163855368|NCT00062868|591838289|FG003|Dose Level 3|Withdrew|0|||
163855369|NCT00062868|591838290|FG004|Dose Level 3|Withdrew|0|||
163855370|NCT00062868|591838291|FG005|Dose Level 3|Withdrew|0|||
163855371|NCT00062868|591838292|FG006|Dose Level 3|Withdrew|0|||
163855372|NCT00062868|591838293|FG007|Dose Level 3|Withdrew|0|||
163855373|NCT00062868|591838294|FG008|Dose Level 3|Withdrew|0|||
163855374|NCT00062868|591838295|FG009|Dose Level 3|Withdrew|0|||
163855375|NCT00062868|591838296|FG010|Dose Level 3|Withdrew|0|||
163855376|NCT00062868|591838297|FG011|Dose Level 3|Withdrew|0|||
163855377|NCT00062868|591838298|FG012|Dose Level 3|Withdrew|0|||
163855378|NCT00062868|591838299|FG013|Dose Level 3|Withdrew|0|||
163855379|NCT00062868|591838300|FG014|Dose Level 3|Withdrew|0|||
163855380|NCT00062868|591838301|FG015|Dose Level 3|Withdrew|0|||
163855381|NCT00062868|591838302|FG016|Dose Level 3|Withdrew|0|||
163855382|NCT00062868|591838303|FG017|Dose Level 3|Withdrew|0|||
163855383|NCT00062868|591838304|FG018|Dose Level 3|Withdrew|0|||
163855384|NCT00062868|591838305|FG019|Dose Level 3|Withdrew|0|||
163855385|NCT00062868|591838306|FG020|Dose Level 3|Withdrew|0|||
163855386|NCT03824236|591838307|FG000|Overall Study|Lost to Follow-up|0|||
163855387|NCT03824236|591838308|FG001|Overall Study|Lost to Follow-up|0|||
163964920|NCT01109173|592244774|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
163964921|NCT01109173|592244775|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
163964922|NCT01109173|592244776|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
163964923|NCT01109173|592244773|FG000|Overall Study|Noncompliance|0|||
163964924|NCT01109173|592244774|FG001|Overall Study|Noncompliance|1|||
163964925|NCT01109173|592244775|FG002|Overall Study|Noncompliance|0|||
164193916|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193917|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
163855388|NCT03824236|591838309|FG002|Overall Study|Lost to Follow-up|1|||
163855389|NCT01641861|591838310|FG000|Overall Study|Lost to Follow-up|21|||
163855390|NCT01641861|591838311|FG001|Overall Study|Lost to Follow-up|16|||
163855391|NCT01641861|591838310|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
163855392|NCT01641861|591838311|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
163855393|NCT01641861|591838310|FG000|Overall Study|Died due to drowning|0|||
163855394|NCT01641861|591838311|FG001|Overall Study|Died due to drowning|1|||
163855395|NCT01101542|591838314|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
163855396|NCT01101542|591838314|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
163855397|NCT01101542|591838314|FG000|Year 4 Surveillance Period|Other|287|||
163855398|NCT01101542|591838314|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
163855399|NCT01101542|591838314|FG000|Year 5 Surveillance Period|Pregnancy|1|||
163855400|NCT01101542|591838314|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
163855401|NCT01101542|591838314|FG000|Year 6 Surveillance Period|Pregnancy|1|||
163855402|NCT01101542|591838314|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
163855403|NCT00701311|591838315|FG000|Overall Study|Lack of Efficacy|3|||
164193918|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
164193919|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193920|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193921|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
164193922|NCT02326272|593077527|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193923|NCT02326272|593077528|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193924|NCT02326272|593077529|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193925|NCT02326272|593077530|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193926|NCT02326272|593077531|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193927|NCT02326272|593077532|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193928|NCT02326272|593077533|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193929|NCT02326272|593077534|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193930|NCT02326272|593077535|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193931|NCT02326272|593077536|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193932|NCT02326272|593077537|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193933|NCT02326272|593077538|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193934|NCT02326272|593077539|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
164193935|NCT02326272|593077540|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193936|NCT02326272|593077541|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
164193937|NCT01265394|593077546|FG000|Overall Study|Subjects withdrawn|37|||
164193938|NCT01348139|593077550|FG000|Period 1|Adverse Event|1|||
164193939|NCT01348139|593077551|FG001|Period 1|Adverse Event|0|||
164193940|NCT01348139|593077552|FG002|Period 1|Adverse Event|0|||
164193941|NCT01348139|593077553|FG003|Period 1|Adverse Event|0|||
164193942|NCT01348139|593077554|FG004|Period 1|Adverse Event|0|||
164193943|NCT01348139|593077555|FG005|Period 1|Adverse Event|0|||
164193944|NCT02254772|593077558|FG000|Overall Study|Ineligible|1|||
164193945|NCT02254772|593077558|FG000|Overall Study|Withdrawal by Subject|1|||
164193946|NCT00483652|593077559|FG000|Double-blind Treatment Period|Protocol Violation|2|||
164193947|NCT00483652|593077560|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163855404|NCT00701311|591838315|FG000|Overall Study|Adverse Event|3|||
163855405|NCT00701311|591838315|FG000|Overall Study|Withdrawal by Subject|2|||
164193948|NCT00483652|593077559|FG000|Double-blind Treatment Period|Adverse Event|3|||
164193949|NCT00483652|593077560|FG001|Double-blind Treatment Period|Adverse Event|4|||
164193950|NCT00483652|593077559|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
164193951|NCT00483652|593077560|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
164193952|NCT00483652|593077559|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
164193953|NCT00483652|593077560|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
164193954|NCT03006562|593077561|FG000|Overall Study|Lost to Follow-up|0|||
164193955|NCT03006562|593077562|FG001|Overall Study|Lost to Follow-up|1|||
164193956|NCT02427841|593077571|FG000|Overall Study|Lack of Efficacy|5|||
164193957|NCT02427841|593077571|FG000|Overall Study|Physician Decision|2|||
164193958|NCT02427841|593077571|FG000|Overall Study|Withdrawal by Subject|1|||
164193959|NCT01841970|593077572|FG000|Overall Study|Withdrawal by Subject|1|||
164193960|NCT01841970|593077572|FG000|Overall Study|Physician Decision|2|||
164193961|NCT01841970|593077572|FG000|Overall Study|Lost to Follow-up|8|||
164193962|NCT03075267|593077583|FG000|Overall Study|Protocol Violation|1|||
164193963|NCT03075267|593077584|FG001|Overall Study|Protocol Violation|0|||
164193964|NCT03075267|593077585|FG002|Overall Study|Protocol Violation|0|||
163855406|NCT04580407|591838316|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
163855407|NCT00814489|591838319|FG000|Overall Study|Other|2|||
163855408|NCT00814489|591838320|FG001|Overall Study|Other|0|||
163855409|NCT00814489|591838321|FG002|Overall Study|Other|1|||
163964926|NCT01109173|592244776|FG003|Overall Study|Noncompliance|0|||
164193965|NCT03874013|593077586|FG000|Overall Study|Adverse Event|0|||
164193966|NCT03874013|593077587|FG001|Overall Study|Adverse Event|1|||
164193967|NCT00274742|593077588|FG000|Overall Study|Adverse Event|0|||
164193968|NCT00274742|593077589|FG001|Overall Study|Adverse Event|4|||
163855410|NCT01712685|591838347|FG000|Overall Study|pt declined to participate before trmt|1|||
163855411|NCT04880161|591838348|FG000|Overall Study|Withdrawal by Subject|1|||
163855412|NCT04880161|591838349|FG001|Overall Study|Withdrawal by Subject|0|||
164193969|NCT00274742|593077590|FG002|Overall Study|Adverse Event|1|||
164193970|NCT00274742|593077591|FG003|Overall Study|Adverse Event|4|||
164193971|NCT00274742|593077592|FG004|Overall Study|Adverse Event|12|||
164193972|NCT00274742|593077593|FG005|Overall Study|Adverse Event|3|||
164193973|NCT00274742|593077588|FG000|Overall Study|Lost to Follow-up|0|||
164193974|NCT00274742|593077589|FG001|Overall Study|Lost to Follow-up|0|||
164193975|NCT00274742|593077590|FG002|Overall Study|Lost to Follow-up|0|||
163855413|NCT04880161|591838348|FG000|Overall Study|Lack of Compliance|1|||
163855414|NCT04880161|591838349|FG001|Overall Study|Lack of Compliance|1|||
163855415|NCT04880161|591838348|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
163855416|NCT04880161|591838349|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
163855417|NCT04880161|591838348|FG000|Overall Study|Screen Failure|0|||
163855418|NCT04880161|591838349|FG001|Overall Study|Screen Failure|1|||
163855419|NCT00901485|591838350|FG000|Overall Study|Lack of Efficacy|0|||
163855420|NCT00901485|591838351|FG001|Overall Study|Lack of Efficacy|2|||
163855421|NCT00901485|591838350|FG000|Overall Study|Withdrawal by Subject|1|||
163855422|NCT00901485|591838351|FG001|Overall Study|Withdrawal by Subject|2|||
163855423|NCT00256308|591839930|FG000|Overall Study|Death|2|||
163855424|NCT01419717|591839931|FG000|Overall Study|Protocol-specified Criteria|62|||
163855425|NCT01419717|591839931|FG000|Overall Study|Adverse Event|19|||
163855426|NCT01419717|591839931|FG000|Overall Study|Death|17|||
163855427|NCT01419717|591839931|FG000|Overall Study|Withdrawal by Subject|10|||
163855428|NCT01419717|591839931|FG000|Overall Study|Disease Progression|9|||
163855429|NCT01419717|591839931|FG000|Overall Study|Other|4|||
163855430|NCT01419717|591839931|FG000|Overall Study|Lost to Follow-up|2|||
163855431|NCT01419717|591839931|FG000|Overall Study|Administrative Decision|1|||
163855432|NCT01419717|591839931|FG000|Overall Study|Noncompliance|1|||
163855433|NCT01240356|591839933|FG000|Overall Study|Withdrawal by Subject|2|||
163855434|NCT01240356|591839934|FG001|Overall Study|Withdrawal by Subject|0|||
163855435|NCT01240356|591839933|FG000|Overall Study|MRI contraindication|1|||
163855436|NCT01240356|591839934|FG001|Overall Study|MRI contraindication|0|||
163855437|NCT04048135|591839937|FG000|Overall Study|Withdrawal by Subject|1|||
163855438|NCT04048135|591839938|FG001|Overall Study|Withdrawal by Subject|1|||
163855439|NCT04048135|591839939|FG002|Overall Study|Withdrawal by Subject|1|||
163855440|NCT04048135|591839940|FG003|Overall Study|Withdrawal by Subject|2|||
163855441|NCT04048135|591839941|FG004|Overall Study|Withdrawal by Subject|0|||
163855442|NCT04048135|591839942|FG005|Overall Study|Withdrawal by Subject|0|||
163855443|NCT04048135|591839943|FG006|Overall Study|Withdrawal by Subject|1|||
163855444|NCT04048135|591839944|FG007|Overall Study|Withdrawal by Subject|1|||
163855445|NCT04048135|591839937|FG000|Overall Study|Adverse Event|0|||
164193976|NCT00274742|593077591|FG003|Overall Study|Lost to Follow-up|0|||
164193977|NCT00274742|593077592|FG004|Overall Study|Lost to Follow-up|1|||
164193978|NCT00274742|593077593|FG005|Overall Study|Lost to Follow-up|0|||
164193979|NCT00274742|593077588|FG000|Overall Study|End of Study|0|||
164193980|NCT00274742|593077589|FG001|Overall Study|End of Study|0|||
164193981|NCT00274742|593077590|FG002|Overall Study|End of Study|0|||
164193982|NCT00274742|593077591|FG003|Overall Study|End of Study|1|||
164193983|NCT00274742|593077592|FG004|Overall Study|End of Study|0|||
164193984|NCT00274742|593077593|FG005|Overall Study|End of Study|0|||
164193985|NCT00274742|593077588|FG000|Overall Study|Disease Progression|0|||
164193986|NCT00274742|593077589|FG001|Overall Study|Disease Progression|1|||
164193987|NCT00274742|593077590|FG002|Overall Study|Disease Progression|1|||
164193988|NCT00274742|593077591|FG003|Overall Study|Disease Progression|0|||
164193989|NCT00274742|593077592|FG004|Overall Study|Disease Progression|1|||
164193990|NCT00274742|593077593|FG005|Overall Study|Disease Progression|0|||
164193991|NCT00274742|593077588|FG000|Overall Study|Other|0|||
164193992|NCT00274742|593077589|FG001|Overall Study|Other|3|||
164193993|NCT00274742|593077590|FG002|Overall Study|Other|0|||
164193994|NCT00274742|593077591|FG003|Overall Study|Other|0|||
164193995|NCT00274742|593077592|FG004|Overall Study|Other|2|||
164193996|NCT00274742|593077593|FG005|Overall Study|Other|0|||
164193997|NCT03421379|593077594|FG000|Period 1|Withdrawal by Subject|0|||
164193998|NCT03421379|593077595|FG001|Period 1|Withdrawal by Subject|1|||
164193999|NCT03421379|593077594|FG000|Period 1|Physician Decision|1|||
164194000|NCT03421379|593077595|FG001|Period 1|Physician Decision|1|||
164194001|NCT03421379|593077594|FG000|Period 1|Did not receive treatment|1|||
163855446|NCT04048135|591839938|FG001|Overall Study|Adverse Event|0|||
163855447|NCT04048135|591839939|FG002|Overall Study|Adverse Event|0|||
163855448|NCT04048135|591839940|FG003|Overall Study|Adverse Event|1|||
163855449|NCT04048135|591839941|FG004|Overall Study|Adverse Event|1|||
164194002|NCT03421379|593077595|FG001|Period 1|Did not receive treatment|2|||
164194003|NCT03771963|593077600|FG000|Overall Study|Lost to Follow-up|22|||
164194004|NCT03771963|593077600|FG000|Overall Study|Withdrawal of Consent|10|||
164194005|NCT00102596|593077601|FG000|Part A|Screen failures|6|||
163855450|NCT04048135|591839942|FG005|Overall Study|Adverse Event|0|||
163855451|NCT04048135|591839943|FG006|Overall Study|Adverse Event|0|||
163855452|NCT04048135|591839944|FG007|Overall Study|Adverse Event|0|||
163855453|NCT04048135|591839937|FG000|Overall Study|Protocol Violation|0|||
163855454|NCT04048135|591839938|FG001|Overall Study|Protocol Violation|0|||
163855455|NCT04048135|591839939|FG002|Overall Study|Protocol Violation|0|||
164194006|NCT00102596|593077602|FG001|Part A|Screen failures|0|||
164194007|NCT00102596|593077601|FG000|Part A|Adverse Event|1|||
163855456|NCT04048135|591839940|FG003|Overall Study|Protocol Violation|0|||
164194008|NCT00102596|593077602|FG001|Part A|Adverse Event|0|||
164194009|NCT02039778|593077607|FG000|Overall Study|Death|2|||
164194010|NCT02039778|593077607|FG000|Overall Study|Withdrawal by Subject|1|||
164194011|NCT02039778|593077607|FG000|Overall Study|Never started the protocol treatment|1|||
164194012|NCT01670045|593077609|FG000|Overall Study|Withdrawal by Subject|3|||
164194013|NCT01670045|593077609|FG000|Overall Study|Adverse Event|1|||
163855457|NCT04048135|591839941|FG004|Overall Study|Protocol Violation|0|||
163855458|NCT04048135|591839942|FG005|Overall Study|Protocol Violation|1|||
163855459|NCT04048135|591839943|FG006|Overall Study|Protocol Violation|0|||
163855460|NCT04048135|591839944|FG007|Overall Study|Protocol Violation|0|||
163855461|NCT02466516|591839945|FG000|Overall Study|Adverse Event|1|||
163855462|NCT02466516|591839946|FG001|Overall Study|Adverse Event|1|||
163855463|NCT02466516|591839947|FG002|Overall Study|Adverse Event|0|||
163855464|NCT02466516|591839948|FG003|Overall Study|Adverse Event|0|||
163855465|NCT02466516|591839949|FG004|Overall Study|Adverse Event|0|||
163855466|NCT02466516|591839945|FG000|Overall Study|Withdrew Consent|1|||
163855467|NCT02466516|591839946|FG001|Overall Study|Withdrew Consent|0|||
163855468|NCT02466516|591839947|FG002|Overall Study|Withdrew Consent|0|||
163855469|NCT02466516|591839948|FG003|Overall Study|Withdrew Consent|0|||
163855470|NCT02466516|591839949|FG004|Overall Study|Withdrew Consent|0|||
163855471|NCT02466516|591839945|FG000|Overall Study|Lost to Follow-up|2|||
163855472|NCT02466516|591839946|FG001|Overall Study|Lost to Follow-up|0|||
163855473|NCT02466516|591839947|FG002|Overall Study|Lost to Follow-up|1|||
163855474|NCT02466516|591839948|FG003|Overall Study|Lost to Follow-up|0|||
163855475|NCT02466516|591839949|FG004|Overall Study|Lost to Follow-up|0|||
164194014|NCT01670045|593077609|FG000|Overall Study|Death|1|||
164194015|NCT01670045|593077609|FG000|Overall Study|Lost to Follow-up|11|||
164194016|NCT01462110|593077610|FG000|Overall Study|Adverse Event|1|||
164194017|NCT01462110|593077611|FG001|Overall Study|Adverse Event|0|||
164194018|NCT05279131|593077612|FG000|Overall Study|Lost to Follow-up|1|||
164194019|NCT05279131|593077612|FG000|Overall Study|Death|1|||
164194020|NCT05279131|593077612|FG000|Overall Study|Physician Decision|1|||
164194021|NCT00964028|593077613|FG000|Overall Study|Withdrawal by Subject|0|||
164194022|NCT00964028|593077614|FG001|Overall Study|Withdrawal by Subject|1|||
164194023|NCT00069823|593077621|FG000|Overall Study|Did not have follow-up diary cards|6|||
164194024|NCT00069823|593077622|FG001|Overall Study|Did not have follow-up diary cards|3|||
164194025|NCT00419757|593079320|FG000|Overall Study|Adverse Event|1|||
164194026|NCT00419757|593079321|FG001|Overall Study|Adverse Event|4|||
164194027|NCT00419757|593079320|FG000|Overall Study|Lost to Follow-up|1|||
164194028|NCT00419757|593079321|FG001|Overall Study|Lost to Follow-up|4|||
164194029|NCT00419757|593079320|FG000|Overall Study|Withdrawal by Subject|7|||
164194030|NCT00419757|593079321|FG001|Overall Study|Withdrawal by Subject|1|||
164194031|NCT00419757|593079320|FG000|Overall Study|Protocol Violation|2|||
164194032|NCT00419757|593079321|FG001|Overall Study|Protocol Violation|3|||
164194033|NCT00419757|593079320|FG000|Overall Study|Study specific discontinuation criteria|4|||
164194034|NCT00419757|593079321|FG001|Overall Study|Study specific discontinuation criteria|8|||
164194035|NCT00419757|593079320|FG000|Overall Study|Multiple reasons|3|||
164194036|NCT00419757|593079321|FG001|Overall Study|Multiple reasons|1|||
164194037|NCT03934216|593079327|FG000|Overall Study|Other Reasons|5|||
164194038|NCT03934216|593079328|FG001|Overall Study|Other Reasons|5|||
164194039|NCT03934216|593079327|FG000|Overall Study|Adverse Event|22|||
164194040|NCT03934216|593079328|FG001|Overall Study|Adverse Event|11|||
164194041|NCT03934216|593079327|FG000|Overall Study|Lack of Efficacy|8|||
164194042|NCT03934216|593079328|FG001|Overall Study|Lack of Efficacy|7|||
164194043|NCT03934216|593079327|FG000|Overall Study|Lost to Follow-up|2|||
164194044|NCT03934216|593079328|FG001|Overall Study|Lost to Follow-up|0|||
164194045|NCT03934216|593079327|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164194046|NCT03934216|593079328|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164194047|NCT03934216|593079327|FG000|Overall Study|Pregnancy|1|||
164194048|NCT03934216|593079328|FG001|Overall Study|Pregnancy|0|||
164194049|NCT03934216|593079327|FG000|Overall Study|Withdrawal by Subject|18|||
164194050|NCT03934216|593079328|FG001|Overall Study|Withdrawal by Subject|6|||
164194051|NCT03934216|593079327|FG000|Overall Study|Randomized but not treated|1|||
164194052|NCT03934216|593079328|FG001|Overall Study|Randomized but not treated|1|||
164194053|NCT01711983|593079330|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
164194054|NCT01711983|593079330|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
164194055|NCT01711983|593079330|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
164194056|NCT01711983|593079330|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
164194057|NCT00735943|593079331|FG000|Overall Study|Lost to Follow-up|1|||
163855476|NCT04358549|591839950|FG000|Overall Study|Adverse Event|0|||
163855477|NCT04358549|591839951|FG001|Overall Study|Adverse Event|1|||
163855478|NCT04358549|591839950|FG000|Overall Study|Death|1|||
163855479|NCT04358549|591839951|FG001|Overall Study|Death|0|||
163855480|NCT04358549|591839950|FG000|Overall Study|Lost to Follow-up|2|||
163855481|NCT04358549|591839951|FG001|Overall Study|Lost to Follow-up|1|||
163855482|NCT04358549|591839950|FG000|Overall Study|Withdrawal by Subject|6|||
163855483|NCT04358549|591839951|FG001|Overall Study|Withdrawal by Subject|6|||
163855484|NCT04358549|591839950|FG000|Overall Study|Start remdesivir|1|||
164194058|NCT00735943|593079331|FG000|Overall Study|Adverse Event|1|||
164194059|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
164194060|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
164194061|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
164194062|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Death|0|||
164194063|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Death|1|||
163855485|NCT04358549|591839951|FG001|Overall Study|Start remdesivir|0|||
163855486|NCT03712930|591839952|FG000|Overall Study|Death|7|||
163855487|NCT03712930|591839952|FG000|Overall Study|Physician Decision|1|||
163855488|NCT03712930|591839952|FG000|Overall Study|Study Terminated by Sponsor|3|||
163855489|NCT03712930|591839952|FG000|Overall Study|Progressive Disease|2|||
163855490|NCT01062126|591839956|FG000|Overall Study|Death|209|||
163855491|NCT01062126|591839956|FG000|Overall Study|All Withdrawals|324|||
163855492|NCT03837028|591839957|FG000|Overall Study|Lost to Follow-up|4|||
163855493|NCT03837028|591839958|FG001|Overall Study|Lost to Follow-up|0|||
163855494|NCT03837028|591839959|FG002|Overall Study|Lost to Follow-up|2|||
163855495|NCT03837028|591839960|FG003|Overall Study|Lost to Follow-up|0|||
163855496|NCT03837028|591839957|FG000|Overall Study|Withdrawal by Subject|12|||
163855497|NCT03837028|591839958|FG001|Overall Study|Withdrawal by Subject|11|||
163855498|NCT03837028|591839959|FG002|Overall Study|Withdrawal by Subject|11|||
163855499|NCT03837028|591839960|FG003|Overall Study|Withdrawal by Subject|7|||
163855500|NCT00646451|591839961|FG000|Overall Study|Adverse Event|3|||
163855501|NCT00646451|591839962|FG001|Overall Study|Adverse Event|0|||
163855502|NCT00646451|591839961|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
163855503|NCT00646451|591839962|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
163855504|NCT03784963|591839963|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
163855505|NCT03784963|591839964|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
163855506|NCT03784963|591839965|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
163855507|NCT03784963|591839966|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
163855508|NCT00157014|591839967|FG000|Overall Study|Death|4|||
163855509|NCT00157014|591839968|FG001|Overall Study|Death|2|||
163855510|NCT00157014|591839969|FG002|Overall Study|Death|1|||
163855511|NCT00157014|591839970|FG003|Overall Study|Death|1|||
163855512|NCT00157014|591839967|FG000|Overall Study|Physician Decision|0|||
163855513|NCT00157014|591839968|FG001|Overall Study|Physician Decision|1|||
163855514|NCT00157014|591839969|FG002|Overall Study|Physician Decision|0|||
163855515|NCT00157014|591839970|FG003|Overall Study|Physician Decision|0|||
163855516|NCT00157014|591839967|FG000|Overall Study|Medications withdrawn on family request|0|||
163855517|NCT00157014|591839968|FG001|Overall Study|Medications withdrawn on family request|1|||
163855518|NCT00157014|591839969|FG002|Overall Study|Medications withdrawn on family request|0|||
163855519|NCT00157014|591839970|FG003|Overall Study|Medications withdrawn on family request|0|||
163855520|NCT00157014|591839967|FG000|Overall Study|Patient withdrawn by investigator|1|||
163855521|NCT00157014|591839968|FG001|Overall Study|Patient withdrawn by investigator|0|||
163855522|NCT00157014|591839969|FG002|Overall Study|Patient withdrawn by investigator|0|||
163855523|NCT00157014|591839970|FG003|Overall Study|Patient withdrawn by investigator|0|||
163855524|NCT00157014|591839967|FG000|Overall Study|Patient unable to return in nursing home|1|||
163855525|NCT00157014|591839968|FG001|Overall Study|Patient unable to return in nursing home|0|||
163855526|NCT00157014|591839969|FG002|Overall Study|Patient unable to return in nursing home|0|||
163855527|NCT00157014|591839970|FG003|Overall Study|Patient unable to return in nursing home|0|||
163855528|NCT00157014|591839967|FG000|Overall Study|Patient would not receive transplant|0|||
163855529|NCT00157014|591839968|FG001|Overall Study|Patient would not receive transplant|1|||
163855530|NCT00157014|591839969|FG002|Overall Study|Patient would not receive transplant|0|||
163855531|NCT00157014|591839970|FG003|Overall Study|Patient would not receive transplant|0|||
163855532|NCT00157014|591839967|FG000|Overall Study|Withdrawal by Subject|1|||
163855533|NCT00157014|591839968|FG001|Overall Study|Withdrawal by Subject|0|||
163855534|NCT00157014|591839969|FG002|Overall Study|Withdrawal by Subject|0|||
163855535|NCT00157014|591839970|FG003|Overall Study|Withdrawal by Subject|0|||
163855536|NCT01362491|591839971|FG000|Overall Study|Ineligible|1|||
163855537|NCT01362491|591839972|FG001|Overall Study|Ineligible|0|||
163855538|NCT01362491|591839973|FG002|Overall Study|Ineligible|0|||
163855539|NCT04867902|591839974|FG000|Overall Study|Lost to Follow-up|1|||
163855540|NCT04867902|591839974|FG000|Overall Study|Withdrawal by Subject|2|||
163855541|NCT04867902|591839974|FG000|Overall Study|Protocol Violation|1|||
163855542|NCT05355116|591839975|FG000|Overall Study|Withdrawal by Subject|2|||
163855543|NCT00448864|591839978|FG000|Overall Study|Death|1|||
163855544|NCT00448864|591839979|FG001|Overall Study|Death|0|||
163855545|NCT00448864|591839980|FG002|Overall Study|Death|0|||
163855546|NCT00448864|591839978|FG000|Overall Study|Lost to Follow-up|3|||
163855547|NCT00448864|591839979|FG001|Overall Study|Lost to Follow-up|1|||
163855548|NCT00448864|591839980|FG002|Overall Study|Lost to Follow-up|0|||
163855549|NCT00448864|591839978|FG000|Overall Study|Physician Decision|1|||
163855550|NCT00448864|591839979|FG001|Overall Study|Physician Decision|0|||
163855551|NCT00448864|591839980|FG002|Overall Study|Physician Decision|1|||
163855552|NCT00448864|591839978|FG000|Overall Study|Withdrawal by Subject|0|||
163855553|NCT00448864|591839979|FG001|Overall Study|Withdrawal by Subject|2|||
163855554|NCT00448864|591839980|FG002|Overall Study|Withdrawal by Subject|0|||
163855555|NCT00448864|591839978|FG000|Overall Study|Protocol Violation|0|||
163855556|NCT00448864|591839979|FG001|Overall Study|Protocol Violation|2|||
163855557|NCT00448864|591839980|FG002|Overall Study|Protocol Violation|0|||
163855558|NCT01390857|591839981|FG000|Overall Study|Protocol Violation|2|||
163855559|NCT01390857|591839981|FG000|Overall Study|Lost to Follow-up|1|||
163855560|NCT01390857|591839981|FG000|Overall Study|No Visit after the First Visit|7|||
163855561|NCT01474538|591839983|FG000|Treatment Period 1|Death|1|||
163855562|NCT01474538|591839984|FG001|Treatment Period 1|Death|0|||
163855563|NCT01474538|591839983|FG000|Treatment Period 1|Physician Decision|1|||
163855564|NCT01474538|591839984|FG001|Treatment Period 1|Physician Decision|0|||
163855565|NCT01474538|591839983|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163855566|NCT01474538|591839984|FG001|Treatment Period 1|Withdrawal by Subject|3|||
163855567|NCT01474538|591839983|FG000|Treatment Period 1|Protocol Violation|0|||
163855568|NCT01474538|591839984|FG001|Treatment Period 1|Protocol Violation|1|||
163855569|NCT01474538|591839983|FG000|Treatment Period 2|Death|1|||
163855570|NCT01474538|591839984|FG001|Treatment Period 2|Death|0|||
163855571|NCT01474538|591839983|FG000|Treatment Period 2|Adverse Event|1|||
163855572|NCT01474538|591839984|FG001|Treatment Period 2|Adverse Event|1|||
163855573|NCT01474538|591839983|FG000|Treatment Period 2|Withdrawal by Subject|2|||
163855574|NCT01474538|591839984|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163855575|NCT01474538|591839983|FG000|Treatment Period 2|Sponsor decision|1|||
163855576|NCT01474538|591839984|FG001|Treatment Period 2|Sponsor decision|0|||
163855577|NCT01474538|591839983|FG000|Treatment Period 2|Physician Decision|0|||
163855578|NCT01474538|591839984|FG001|Treatment Period 2|Physician Decision|1|||
163855579|NCT01474538|591839983|FG000|Treatment Period 2|Protocol Violation|1|||
163855580|NCT01474538|591839984|FG001|Treatment Period 2|Protocol Violation|0|||
163855581|NCT00367237|591839985|FG000|Overall Study|Adverse Event|7|||
163855582|NCT00367237|591839986|FG001|Overall Study|Adverse Event|2|||
163855583|NCT00367237|591839985|FG000|Overall Study|Lost to Follow-up|1|||
163855584|NCT00367237|591839986|FG001|Overall Study|Lost to Follow-up|0|||
163855585|NCT00367237|591839985|FG000|Overall Study|Withdrawal by Subject|0|||
163855586|NCT00367237|591839986|FG001|Overall Study|Withdrawal by Subject|4|||
163855587|NCT00367237|591839985|FG000|Overall Study|Protocol Violation|2|||
163855588|NCT00367237|591839986|FG001|Overall Study|Protocol Violation|5|||
163855589|NCT02501629|591839987|FG000|Overall Study|Death|0|||
163855590|NCT02501629|591839988|FG001|Overall Study|Death|1|||
163855591|NCT02501629|591839987|FG000|Overall Study|Withdrawn from study by sponsor|1|||
163855592|NCT02501629|591839988|FG001|Overall Study|Withdrawn from study by sponsor|0|||
163855593|NCT02501629|591839987|FG000|Overall Study|Early termination by sponsor|1|||
163855594|NCT02501629|591839988|FG001|Overall Study|Early termination by sponsor|0|||
163855595|NCT02501629|591839987|FG000|Overall Study|Withdrawal by Subject|3|||
163855596|NCT02501629|591839988|FG001|Overall Study|Withdrawal by Subject|5|||
163855597|NCT02501629|591839987|FG000|Overall Study|Subject did not return to site|0|||
163855598|NCT02501629|591839988|FG001|Overall Study|Subject did not return to site|1|||
163855599|NCT00868231|591839991|FG000|Treatment Period 1|Adverse Event|0|||
163855600|NCT00868231|591839992|FG001|Treatment Period 1|Adverse Event|0|||
163855601|NCT00868231|591839993|FG002|Treatment Period 1|Adverse Event|0|||
163855602|NCT00868231|591839994|FG003|Treatment Period 1|Adverse Event|0|||
163855603|NCT00868231|591839995|FG004|Treatment Period 1|Adverse Event|1|||
163855604|NCT00868231|591839996|FG005|Treatment Period 1|Adverse Event|0|||
163855605|NCT00868231|591839991|FG000|Treatment Period 2|Adverse Event|1|||
163855606|NCT00868231|591839992|FG001|Treatment Period 2|Adverse Event|0|||
163855607|NCT00868231|591839993|FG002|Treatment Period 2|Adverse Event|0|||
163855608|NCT00868231|591839994|FG003|Treatment Period 2|Adverse Event|0|||
163855609|NCT00868231|591839995|FG004|Treatment Period 2|Adverse Event|0|||
163855610|NCT00868231|591839996|FG005|Treatment Period 2|Adverse Event|0|||
163855611|NCT00868231|591839991|FG000|Treatment Period 3|Adverse Event|0|||
163855612|NCT00868231|591839992|FG001|Treatment Period 3|Adverse Event|0|||
163855613|NCT00868231|591839993|FG002|Treatment Period 3|Adverse Event|1|||
163855614|NCT00868231|591839994|FG003|Treatment Period 3|Adverse Event|0|||
163855615|NCT00868231|591839995|FG004|Treatment Period 3|Adverse Event|0|||
163855616|NCT00868231|591839996|FG005|Treatment Period 3|Adverse Event|0|||
163855617|NCT03120676|591839997|FG000|Overall Study|Not treated|1|||
163855618|NCT00886613|591840002|FG000|Overall Study|Protocol deviation (Part B)|1|||
163855619|NCT00886613|591840003|FG001|Overall Study|Protocol deviation (Part B)|0|||
163855620|NCT00886613|591840004|FG002|Overall Study|Protocol deviation (Part B)|0|||
163855621|NCT00886613|591840002|FG000|Overall Study|Lost to follow-up (Part B)|1|||
163964927|NCT01109173|592244773|FG000|Overall Study|Treatment Failure|25|||
163964928|NCT01109173|592244774|FG001|Overall Study|Treatment Failure|32|||
163855622|NCT00886613|591840003|FG001|Overall Study|Lost to follow-up (Part B)|0|||
163855623|NCT00886613|591840004|FG002|Overall Study|Lost to follow-up (Part B)|1|||
163855624|NCT00886613|591840002|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
163855625|NCT00886613|591840003|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
163855626|NCT00886613|591840004|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
163855627|NCT00672256|591840009|FG000|Overall Study|PI dropped, bad data|44|||
163855628|NCT03255018|591840012|FG000|Overall Study|Death on study|0|||
163855629|NCT03255018|591840013|FG001|Overall Study|Death on study|5|||
163855630|NCT03255018|591840012|FG000|Overall Study|Withdrawal by Subject|0|||
163855631|NCT03255018|591840013|FG001|Overall Study|Withdrawal by Subject|2|||
163855632|NCT01124162|591840014|FG000|First Intervention|Adverse Event|2|||
163855633|NCT01124162|591840015|FG001|First Intervention|Adverse Event|0|||
163964929|NCT01109173|592244775|FG002|Overall Study|Treatment Failure|69|||
163855634|NCT01124162|591840014|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163855635|NCT01124162|591840015|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163855636|NCT03681691|591840016|FG000|Overall Study|COVID|1|||
163855637|NCT03681691|591840017|FG001|Overall Study|COVID|0|||
163855638|NCT03681691|591840016|FG000|Overall Study|prolonged bleeding|1|||
163855639|NCT03681691|591840017|FG001|Overall Study|prolonged bleeding|0|||
163855640|NCT03681691|591840016|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
163855641|NCT03681691|591840017|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
163855642|NCT02534896|591840018|FG000|Overall Study|Adverse Event|2|||
163855643|NCT02534896|591840019|FG001|Overall Study|Adverse Event|1|||
163855644|NCT02534896|591840020|FG002|Overall Study|Adverse Event|1|||
163855645|NCT02534896|591840018|FG000|Overall Study|Insufficient therapeutic response|2|||
163855646|NCT02534896|591840019|FG001|Overall Study|Insufficient therapeutic response|0|||
163855647|NCT02534896|591840020|FG002|Overall Study|Insufficient therapeutic response|0|||
163855648|NCT00465985|591840021|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
163855649|NCT00465985|591840022|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
163855650|NCT00465985|591840021|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
163855651|NCT00465985|591840022|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
163855652|NCT00465985|591840021|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
163855653|NCT00465985|591840022|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
163855654|NCT00465985|591840021|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
163855655|NCT00465985|591840022|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
163855656|NCT00269399|591840023|FG000|Overall Study|Lack of Efficacy|27|||
163855657|NCT00269399|591840024|FG001|Overall Study|Lack of Efficacy|10|||
163855658|NCT00269399|591840023|FG000|Overall Study|Adverse Event|10|||
163855659|NCT00269399|591840024|FG001|Overall Study|Adverse Event|4|||
163855660|NCT00269399|591840023|FG000|Overall Study|Withdrawal by Subject|2|||
163855661|NCT00269399|591840024|FG001|Overall Study|Withdrawal by Subject|5|||
163855662|NCT00269399|591840023|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
163855663|NCT00269399|591840024|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
163855664|NCT00269399|591840023|FG000|Overall Study|Other|0|||
163855665|NCT00269399|591840024|FG001|Overall Study|Other|4|||
164194064|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Death|0|||
164194065|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
164194066|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
164194067|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
164194068|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
164194069|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
164194070|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
163855666|NCT00269399|591840023|FG000|Overall Study|Development of exclusion criteria|0|||
163855667|NCT00269399|591840024|FG001|Overall Study|Development of exclusion criteria|1|||
163855668|NCT03439124|591840025|FG000|Overall Study|Adverse Event|2|||
163855669|NCT03439124|591840026|FG001|Overall Study|Adverse Event|0|||
163855670|NCT03439124|591840025|FG000|Overall Study|Lost to Follow-up|1|||
163855671|NCT03439124|591840026|FG001|Overall Study|Lost to Follow-up|0|||
163855672|NCT03439124|591840025|FG000|Overall Study|Other reasons|1|||
163855673|NCT03439124|591840026|FG001|Overall Study|Other reasons|0|||
163855674|NCT04353037|591840027|FG000|Overall Study|Lost to Follow-up|0|||
163855675|NCT04353037|591840028|FG001|Overall Study|Lost to Follow-up|1|||
163855676|NCT04353037|591840029|FG002|Overall Study|Lost to Follow-up|2|||
163855677|NCT04353037|591840030|FG003|Overall Study|Lost to Follow-up|3|||
163855678|NCT04353037|591840027|FG000|Overall Study|Withdrawal by Subject|0|||
163855679|NCT04353037|591840028|FG001|Overall Study|Withdrawal by Subject|2|||
163855680|NCT04353037|591840029|FG002|Overall Study|Withdrawal by Subject|3|||
163855681|NCT04353037|591840030|FG003|Overall Study|Withdrawal by Subject|5|||
163855682|NCT04353037|591840027|FG000|Overall Study|Adverse Event|0|||
164194071|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
163855683|NCT04353037|591840028|FG001|Overall Study|Adverse Event|0|||
163855684|NCT04353037|591840029|FG002|Overall Study|Adverse Event|2|||
163855685|NCT04353037|591840030|FG003|Overall Study|Adverse Event|0|||
163855686|NCT04353037|591840027|FG000|Overall Study|Exposure Change|0|||
163855687|NCT04353037|591840028|FG001|Overall Study|Exposure Change|0|||
163855688|NCT04353037|591840029|FG002|Overall Study|Exposure Change|0|||
163855689|NCT04353037|591840030|FG003|Overall Study|Exposure Change|2|||
163855690|NCT00463151|591840032|FG000|Overall Study|Adverse Event|0|||
163855691|NCT00463151|591840033|FG001|Overall Study|Adverse Event|0|||
163855692|NCT00463151|591840034|FG002|Overall Study|Adverse Event|1|||
163855693|NCT00463151|591840035|FG003|Overall Study|Adverse Event|0|||
163855694|NCT00463151|591840032|FG000|Overall Study|Lack of Efficacy|2|||
163855695|NCT00463151|591840033|FG001|Overall Study|Lack of Efficacy|5|||
163964930|NCT01109173|592244776|FG003|Overall Study|Treatment Failure|64|||
163855696|NCT00463151|591840034|FG002|Overall Study|Lack of Efficacy|2|||
163855697|NCT00463151|591840035|FG003|Overall Study|Lack of Efficacy|5|||
163855698|NCT00463151|591840032|FG000|Overall Study|Protocol Violation|0|||
164194072|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164194073|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164194074|NCT01064414|593079332|FG000|Core Period: Baseline to Week 26|Other|4|||
164194075|NCT01064414|593079333|FG001|Core Period: Baseline to Week 26|Other|7|||
164194076|NCT01064414|593079334|FG002|Core Period: Baseline to Week 26|Other|2|||
164194077|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164194078|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164194079|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164194080|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Death|0|||
164194081|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Death|1|||
164194082|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Death|0|||
164194083|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
164194084|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164194085|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164194086|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
164194087|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164194088|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164194089|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164194090|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164194091|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164194092|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
164194093|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164194094|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
164194095|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164194096|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164194097|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164194098|NCT01064414|593079332|FG000|Extension Period: Week 26 to Week 52|Other|5|||
164194099|NCT01064414|593079333|FG001|Extension Period: Week 26 to Week 52|Other|2|||
164194100|NCT01064414|593079334|FG002|Extension Period: Week 26 to Week 52|Other|1|||
164194101|NCT00165503|593079337|FG000|Overall Study|Death|1|||
164194102|NCT00165503|593079337|FG000|Overall Study|Lost to Follow-up|12|||
164194103|NCT00165503|593079337|FG000|Overall Study|Unresectable|3|||
164194104|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Death|20|||
164194105|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Death|26|||
164194106|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
164194107|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
164194108|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
164194109|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
164194110|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
164194111|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
164194112|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
164194113|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
164194114|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
164194115|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
164194116|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
164194117|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
164194118|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
164194119|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
164194120|NCT00643201|593079338|FG000|Randomized, Completed 6 Months of Study|Other|107|||
164194121|NCT00643201|593079339|FG001|Randomized, Completed 6 Months of Study|Other|107|||
164194122|NCT00643201|593079338|FG000|Completed Study Follow Up|Death|28|||
164194123|NCT00643201|593079339|FG001|Completed Study Follow Up|Death|34|||
164194124|NCT00643201|593079338|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
164194125|NCT00643201|593079339|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
164194126|NCT00643201|593079338|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
164194127|NCT00643201|593079339|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
163855699|NCT00463151|591840033|FG001|Overall Study|Protocol Violation|0|||
163855700|NCT00463151|591840034|FG002|Overall Study|Protocol Violation|0|||
163855701|NCT00463151|591840035|FG003|Overall Study|Protocol Violation|1|||
164194128|NCT00643201|593079338|FG000|Completed Study Follow Up|non-specified|1|||
164194129|NCT00643201|593079339|FG001|Completed Study Follow Up|non-specified|0|||
164194130|NCT02976519|593079340|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194131|NCT02976519|593079341|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
164194132|NCT02976519|593079342|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163855702|NCT00463151|591840032|FG000|Overall Study|Withdrawal by Subject|0|||
163855703|NCT00463151|591840033|FG001|Overall Study|Withdrawal by Subject|0|||
163855704|NCT00463151|591840034|FG002|Overall Study|Withdrawal by Subject|0|||
163855705|NCT00463151|591840035|FG003|Overall Study|Withdrawal by Subject|1|||
163855706|NCT05349084|591840036|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
163855707|NCT01579578|591840037|FG000|Overall Study|Death|4|||
163855708|NCT01579578|591840038|FG001|Overall Study|Death|1|||
163855709|NCT01579578|591840037|FG000|Overall Study|Lost to Follow-up|1|||
163855710|NCT01579578|591840038|FG001|Overall Study|Lost to Follow-up|1|||
163855711|NCT01579578|591840037|FG000|Overall Study|Withdrawal by Subject|2|||
163855712|NCT01579578|591840038|FG001|Overall Study|Withdrawal by Subject|1|||
163855713|NCT01579578|591840037|FG000|Overall Study|Eligibility criteria|3|||
163855714|NCT01579578|591840038|FG001|Overall Study|Eligibility criteria|9|||
163855715|NCT01579578|591840037|FG000|Overall Study|Ongoing|3|||
163855716|NCT01579578|591840038|FG001|Overall Study|Ongoing|0|||
163855717|NCT01004263|591840041|FG000|Overall Study|Adverse Event|15|||
163855718|NCT01004263|591840041|FG000|Overall Study|Withdrawal by Subject|58|||
163855719|NCT01004263|591840041|FG000|Overall Study|Protocol Violation|10|||
163855720|NCT01004263|591840041|FG000|Overall Study|Lost to Follow-up|64|||
163855721|NCT01004263|591840041|FG000|Overall Study|Lack of Efficacy|13|||
163855722|NCT01004263|591840041|FG000|Overall Study|Pregnancy|2|||
163855723|NCT01004263|591840041|FG000|Overall Study|Physician Decision|15|||
163855724|NCT01004263|591840041|FG000|Overall Study|Lack of Qualifying Event|2|||
163855725|NCT03398356|591840045|FG000|Before Treatment|Lost to Follow-up|1|||
163855726|NCT03398356|591840046|FG001|Before Treatment|Lost to Follow-up|2|||
163855727|NCT03398356|591840047|FG002|Before Treatment|Lost to Follow-up|0|||
163855728|NCT03398356|591840045|FG000|Before Treatment|drug intolerance|2|||
163855729|NCT03398356|591840046|FG001|Before Treatment|drug intolerance|1|||
163855730|NCT03398356|591840047|FG002|Before Treatment|drug intolerance|0|||
163855731|NCT03398356|591840045|FG000|Before Treatment|Withdrawal by Subject|0|||
163855732|NCT03398356|591840046|FG001|Before Treatment|Withdrawal by Subject|5|||
163855733|NCT03398356|591840047|FG002|Before Treatment|Withdrawal by Subject|0|||
163855734|NCT03398356|591840045|FG000|Before Treatment|Physician Decision|0|||
163855735|NCT03398356|591840046|FG001|Before Treatment|Physician Decision|0|||
163855736|NCT03398356|591840047|FG002|Before Treatment|Physician Decision|11|||
163855737|NCT03398356|591840045|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
163855738|NCT03398356|591840046|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
163855739|NCT03398356|591840047|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
163855740|NCT00821236|591840050|FG000|Overall Study|Lost to Follow-up|3|||
163855741|NCT01582243|591840051|FG000|Overall Study|Withdrawal by Subject|1|||
163855742|NCT01582243|591840051|FG000|Overall Study|Adverse Event|1|||
163855743|NCT01582243|591840051|FG000|Overall Study|Lost to Follow-up|1|||
163855744|NCT02096003|591840053|FG000|Overall Study|Protocol Violation|0|||
163855745|NCT02096003|591840054|FG001|Overall Study|Protocol Violation|2|||
163855746|NCT02096003|591840053|FG000|Overall Study|additional surgery|2|||
163855747|NCT02096003|591840054|FG001|Overall Study|additional surgery|1|||
163855748|NCT00209274|591840065|FG000|Overall Study|Missed visit|3|||
163855749|NCT00209274|591840066|FG001|Overall Study|Missed visit|2|||
163855750|NCT00209274|591840065|FG000|Overall Study|Death|32|||
163855751|NCT00209274|591840066|FG001|Overall Study|Death|15|||
163855752|NCT00209274|591840065|FG000|Overall Study|Withdrawal by Subject|30|||
163855753|NCT00209274|591840066|FG001|Overall Study|Withdrawal by Subject|15|||
163964931|NCT01109173|592244773|FG000|Overall Study|Protocol Violation|4|||
163964932|NCT01109173|592244774|FG001|Overall Study|Protocol Violation|5|||
163964933|NCT01109173|592244775|FG002|Overall Study|Protocol Violation|1|||
163855754|NCT00209274|591840065|FG000|Overall Study|Randomized not treated (RNT)|6|||
163855755|NCT00209274|591840066|FG001|Overall Study|Randomized not treated (RNT)|15|||
163855756|NCT01190176|591840067|FG000|Overall Study|Withdrawal by Subject|1|||
163855757|NCT01190176|591840067|FG000|Overall Study|Lost to Follow-up|1|||
163855758|NCT01221181|591840068|FG000|Overall Study|Lost to Follow-up|1|||
163855759|NCT01168401|591842307|FG000|Overall Study|Lost to Follow-up|1|||
163855760|NCT01168401|591842308|FG001|Overall Study|Lost to Follow-up|1|||
163855761|NCT01168401|591842309|FG002|Overall Study|Lost to Follow-up|2|||
163855762|NCT01168401|591842310|FG003|Overall Study|Lost to Follow-up|1|||
163855763|NCT01168401|591842311|FG004|Overall Study|Lost to Follow-up|0|||
163855764|NCT01168401|591842312|FG005|Overall Study|Lost to Follow-up|0|||
163855765|NCT01168401|591842313|FG006|Overall Study|Lost to Follow-up|0|||
163855766|NCT01168401|591842314|FG007|Overall Study|Lost to Follow-up|0|||
163855767|NCT01168401|591842315|FG008|Overall Study|Lost to Follow-up|0|||
163855768|NCT01168401|591842316|FG009|Overall Study|Lost to Follow-up|0|||
163855769|NCT01168401|591842317|FG010|Overall Study|Lost to Follow-up|0|||
163855770|NCT01168401|591842307|FG000|Overall Study|Withdrawal by Subject|0|||
163855771|NCT01168401|591842308|FG001|Overall Study|Withdrawal by Subject|0|||
163855772|NCT01168401|591842309|FG002|Overall Study|Withdrawal by Subject|0|||
163964934|NCT01109173|592244776|FG003|Overall Study|Protocol Violation|2|||
163964935|NCT01109173|592244773|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
163855773|NCT01168401|591842310|FG003|Overall Study|Withdrawal by Subject|1|||
163855774|NCT01168401|591842311|FG004|Overall Study|Withdrawal by Subject|0|||
163855775|NCT01168401|591842312|FG005|Overall Study|Withdrawal by Subject|0|||
163855776|NCT01168401|591842313|FG006|Overall Study|Withdrawal by Subject|0|||
163855777|NCT01168401|591842314|FG007|Overall Study|Withdrawal by Subject|0|||
163855778|NCT01168401|591842315|FG008|Overall Study|Withdrawal by Subject|0|||
163855779|NCT01168401|591842316|FG009|Overall Study|Withdrawal by Subject|0|||
163855780|NCT01168401|591842317|FG010|Overall Study|Withdrawal by Subject|0|||
163855781|NCT01720043|591842323|FG000|Overall Study|Withdrawal by Subject|1|||
163855782|NCT01688973|591842324|FG000|Overall Study|Ineligible|2|||
163855783|NCT01688973|591842325|FG001|Overall Study|Ineligible|3|||
163855784|NCT03710564|591842334|FG000|Overall Study|Study Terminated by Sponsor|104|||
163855785|NCT03710564|591842335|FG001|Overall Study|Study Terminated by Sponsor|55|||
163855786|NCT03710564|591842334|FG000|Overall Study|Withdrawal by Subject|57|||
163855787|NCT03710564|591842335|FG001|Overall Study|Withdrawal by Subject|25|||
163855788|NCT03710564|591842334|FG000|Overall Study|Death|10|||
163855789|NCT03710564|591842335|FG001|Overall Study|Death|4|||
163855790|NCT03710564|591842334|FG000|Overall Study|Lost to Follow-up|5|||
163855791|NCT03710564|591842335|FG001|Overall Study|Lost to Follow-up|4|||
163855792|NCT03710564|591842334|FG000|Overall Study|Protocol Violation|3|||
163855793|NCT03710564|591842335|FG001|Overall Study|Protocol Violation|2|||
163855794|NCT03710564|591842334|FG000|Overall Study|Adverse Event|3|||
163855795|NCT03710564|591842335|FG001|Overall Study|Adverse Event|0|||
163855796|NCT03710564|591842334|FG000|Overall Study|Physician Decision|2|||
163855797|NCT03710564|591842335|FG001|Overall Study|Physician Decision|3|||
163855798|NCT00293462|591842336|FG000|Overall Study|Withdrawal by Subject|4|||
163855799|NCT00293462|591842337|FG001|Overall Study|Withdrawal by Subject|3|||
163855800|NCT00293462|591842338|FG002|Overall Study|Withdrawal by Subject|8|||
163855801|NCT00293462|591842336|FG000|Overall Study|Death|1|||
163855802|NCT00293462|591842337|FG001|Overall Study|Death|0|||
163855803|NCT00293462|591842338|FG002|Overall Study|Death|0|||
163855804|NCT00293462|591842336|FG000|Overall Study|Lost to Follow-up|0|||
163855805|NCT00293462|591842337|FG001|Overall Study|Lost to Follow-up|1|||
163855806|NCT00293462|591842338|FG002|Overall Study|Lost to Follow-up|0|||
163855807|NCT00293462|591842336|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
163855808|NCT00293462|591842337|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
163855809|NCT00293462|591842338|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
163855810|NCT00293462|591842336|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
163855811|NCT00293462|591842337|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
163855812|NCT00293462|591842338|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
163855813|NCT00293462|591842336|FG000|Overall Study|Refuse Radiation Treatment|1|||
163855814|NCT00293462|591842337|FG001|Overall Study|Refuse Radiation Treatment|0|||
163855815|NCT00293462|591842338|FG002|Overall Study|Refuse Radiation Treatment|0|||
163855816|NCT00293462|591842336|FG000|Overall Study|No Show|0|||
163855817|NCT00293462|591842337|FG001|Overall Study|No Show|0|||
163855818|NCT00293462|591842338|FG002|Overall Study|No Show|1|||
163855819|NCT00293462|591842336|FG000|Overall Study|Went back to his home country|0|||
163855820|NCT00293462|591842337|FG001|Overall Study|Went back to his home country|0|||
163855821|NCT00293462|591842338|FG002|Overall Study|Went back to his home country|1|||
163855822|NCT00293462|591842336|FG000|Overall Study|Blood clot after chemotherapy|0|||
163855823|NCT00293462|591842337|FG001|Overall Study|Blood clot after chemotherapy|0|||
163855824|NCT00293462|591842338|FG002|Overall Study|Blood clot after chemotherapy|1|||
163855825|NCT00293462|591842336|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
163855826|NCT00293462|591842337|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
163855827|NCT00293462|591842338|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
163855828|NCT00293462|591842336|FG000|Overall Study|Possible Tracheostomy leakage|0|||
163855829|NCT00293462|591842337|FG001|Overall Study|Possible Tracheostomy leakage|1|||
163855830|NCT00293462|591842338|FG002|Overall Study|Possible Tracheostomy leakage|0|||
163855831|NCT00293462|591842336|FG000|Overall Study|Low radiation dose in oral cavity|0|||
163855832|NCT00293462|591842337|FG001|Overall Study|Low radiation dose in oral cavity|1|||
163855833|NCT00293462|591842338|FG002|Overall Study|Low radiation dose in oral cavity|0|||
163855834|NCT00293462|591842336|FG000|Overall Study|Physician Decision|0|||
163855835|NCT00293462|591842337|FG001|Overall Study|Physician Decision|1|||
163855836|NCT00293462|591842338|FG002|Overall Study|Physician Decision|0|||
163855837|NCT00372060|591842339|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
163855838|NCT00372060|591842340|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
163855839|NCT00372060|591842339|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
163855840|NCT00372060|591842340|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
163855841|NCT00372060|591842339|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
163855842|NCT00372060|591842340|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
163855843|NCT00372060|591842339|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
163855844|NCT00372060|591842340|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
163855845|NCT00372060|591842339|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
163855846|NCT00372060|591842340|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
163855847|NCT00372060|591842339|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
163855848|NCT00372060|591842340|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
163855849|NCT00647348|591842341|FG000|Overall Study|Lost to Follow-up|3|||
163855850|NCT00647348|591842342|FG001|Overall Study|Lost to Follow-up|6|||
163855851|NCT03382821|591842346|FG000|Overall Study|Did not receive allocated intervention.|0|||
164134654|NCT03970837|592857355|FG000|Overall Study|Adverse Event|23|||
163855852|NCT03382821|591842347|FG001|Overall Study|Did not receive allocated intervention.|3|||
163855853|NCT00282438|591842348|FG000|Overall Study|Lack of Efficacy|1|||
163855854|NCT00282438|591842349|FG001|Overall Study|Lack of Efficacy|0|||
164194133|NCT02976519|593079343|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
163855855|NCT00282438|591842348|FG000|Overall Study|Death|0|||
163855856|NCT00282438|591842349|FG001|Overall Study|Death|1|||
163855857|NCT01119703|591842358|FG000|Overall Study|Adverse Event|0|||
163855858|NCT01119703|591842359|FG001|Overall Study|Adverse Event|1|||
163855859|NCT01511250|591842360|FG000|Overall Study|Withdrawal of Consent|1|||
163855860|NCT01511250|591842361|FG001|Overall Study|Withdrawal of Consent|0|||
163855861|NCT01511250|591842362|FG002|Overall Study|Withdrawal of Consent|0|||
163855862|NCT01511250|591842363|FG003|Overall Study|Withdrawal of Consent|0|||
163855863|NCT01511250|591842364|FG004|Overall Study|Withdrawal of Consent|0|||
164194134|NCT02976519|593079344|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194135|NCT02976519|593079345|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194136|NCT02976519|593079346|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
164194137|NCT02976519|593079340|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194138|NCT02976519|593079341|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194139|NCT02976519|593079342|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194140|NCT02976519|593079343|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
164194141|NCT02976519|593079344|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194142|NCT02976519|593079345|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194143|NCT02976519|593079346|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
164194144|NCT02976519|593079340|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194145|NCT02976519|593079341|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194146|NCT02976519|593079342|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194147|NCT02976519|593079343|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194148|NCT02976519|593079344|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194149|NCT02976519|593079345|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
164194150|NCT02976519|593079346|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
164194151|NCT02976519|593079340|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194152|NCT02976519|593079341|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194153|NCT02976519|593079342|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194154|NCT02976519|593079343|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
163855864|NCT01511250|591842365|FG005|Overall Study|Withdrawal of Consent|0|||
163855865|NCT01511250|591842366|FG006|Overall Study|Withdrawal of Consent|0|||
163855866|NCT01511250|591842367|FG007|Overall Study|Withdrawal of Consent|1|||
163855867|NCT01511250|591842368|FG008|Overall Study|Withdrawal of Consent|1|||
163855868|NCT01511250|591842369|FG009|Overall Study|Withdrawal of Consent|0|||
163855869|NCT01511250|591842360|FG000|Overall Study|Sponsor/Investigator Decision|1|||
163855870|NCT01511250|591842361|FG001|Overall Study|Sponsor/Investigator Decision|0|||
163855871|NCT01511250|591842362|FG002|Overall Study|Sponsor/Investigator Decision|0|||
163855872|NCT01511250|591842363|FG003|Overall Study|Sponsor/Investigator Decision|0|||
163855873|NCT01511250|591842364|FG004|Overall Study|Sponsor/Investigator Decision|0|||
163855874|NCT01511250|591842365|FG005|Overall Study|Sponsor/Investigator Decision|0|||
163855875|NCT01511250|591842366|FG006|Overall Study|Sponsor/Investigator Decision|0|||
163855876|NCT01511250|591842367|FG007|Overall Study|Sponsor/Investigator Decision|0|||
164194155|NCT02976519|593079344|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194156|NCT02976519|593079345|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
164194157|NCT02976519|593079346|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
164194158|NCT02976519|593079340|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194159|NCT02976519|593079341|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194160|NCT02976519|593079342|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194161|NCT02976519|593079343|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194162|NCT02976519|593079344|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194163|NCT02976519|593079345|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
164194164|NCT02976519|593079346|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
164194165|NCT02346708|593079347|FG000|Overall Study|Adverse Event|2|||
164194166|NCT02346708|593079348|FG001|Overall Study|Adverse Event|0|||
164194167|NCT02346708|593079347|FG000|Overall Study|Protocol Violation|0|||
164194168|NCT02346708|593079348|FG001|Overall Study|Protocol Violation|1|||
164194169|NCT01781962|593079351|FG000|Overall Study|Other Miscellaneous Reasons|5|||
163855877|NCT01511250|591842368|FG008|Overall Study|Sponsor/Investigator Decision|0|||
163855878|NCT01511250|591842369|FG009|Overall Study|Sponsor/Investigator Decision|0|||
163855879|NCT01511250|591842360|FG000|Overall Study|Lost to Follow-up|7|||
163855880|NCT01511250|591842361|FG001|Overall Study|Lost to Follow-up|3|||
163855881|NCT01511250|591842362|FG002|Overall Study|Lost to Follow-up|3|||
163855882|NCT01511250|591842363|FG003|Overall Study|Lost to Follow-up|3|||
163855883|NCT01511250|591842364|FG004|Overall Study|Lost to Follow-up|0|||
163855884|NCT01511250|591842365|FG005|Overall Study|Lost to Follow-up|0|||
163855885|NCT01511250|591842366|FG006|Overall Study|Lost to Follow-up|2|||
163855886|NCT01511250|591842367|FG007|Overall Study|Lost to Follow-up|3|||
163855887|NCT01511250|591842368|FG008|Overall Study|Lost to Follow-up|13|||
163855888|NCT01511250|591842369|FG009|Overall Study|Lost to Follow-up|5|||
163855889|NCT01511250|591842360|FG000|Overall Study|Protocol Violation|0|||
163855890|NCT01511250|591842361|FG001|Overall Study|Protocol Violation|2|||
163855891|NCT01511250|591842362|FG002|Overall Study|Protocol Violation|1|||
163855892|NCT01511250|591842363|FG003|Overall Study|Protocol Violation|0|||
163855893|NCT01511250|591842364|FG004|Overall Study|Protocol Violation|0|||
163855894|NCT01511250|591842365|FG005|Overall Study|Protocol Violation|0|||
163855895|NCT01511250|591842366|FG006|Overall Study|Protocol Violation|0|||
163855896|NCT01511250|591842367|FG007|Overall Study|Protocol Violation|0|||
163855897|NCT01511250|591842368|FG008|Overall Study|Protocol Violation|0|||
163855898|NCT01511250|591842369|FG009|Overall Study|Protocol Violation|0|||
163855899|NCT04668144|591842370|FG000|Overall Study|Protocol Violation|0|||
163855900|NCT04668144|591842371|FG001|Overall Study|Protocol Violation|1|||
163855901|NCT04668144|591842372|FG002|Overall Study|Protocol Violation|2|||
163855902|NCT02095158|591842373|FG000|Overall Study|Adverse Event|14|||
163855903|NCT02095158|591842373|FG000|Overall Study|Lack of Efficacy|3|||
163855904|NCT02095158|591842373|FG000|Overall Study|Pregnancy|1|||
163855905|NCT02095158|591842373|FG000|Overall Study|Lost to Follow-up|20|||
163855906|NCT02095158|591842373|FG000|Overall Study|Personal Reasons|35|||
163855907|NCT02095158|591842373|FG000|Overall Study|Protocol Violation|1|||
163855908|NCT02095158|591842373|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163855909|NCT03441984|591842374|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855910|NCT03441984|591842375|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855911|NCT03441984|591842376|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
163855912|NCT03441984|591842377|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855913|NCT03441984|591842378|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855914|NCT03441984|591842379|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855915|NCT03441984|591842380|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855916|NCT03441984|591842381|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855917|NCT03441984|591842382|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855918|NCT03441984|591842383|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855919|NCT03441984|591842384|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855920|NCT03441984|591842385|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
163855921|NCT00631917|591842386|FG000|Overall Study|Adverse Event|34|||
163855922|NCT00631917|591842387|FG001|Overall Study|Adverse Event|45|||
163855923|NCT00631917|591842386|FG000|Overall Study|Abnormal laboratory value(s)|2|||
163855924|NCT00631917|591842387|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163855925|NCT00631917|591842386|FG000|Overall Study|Abnormal test procedure result(s)|3|||
163855926|NCT00631917|591842387|FG001|Overall Study|Abnormal test procedure result(s)|2|||
163855927|NCT00631917|591842386|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
163855928|NCT00631917|591842387|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
163855929|NCT00631917|591842386|FG000|Overall Study|No longer required study drug|0|||
163855930|NCT00631917|591842387|FG001|Overall Study|No longer required study drug|1|||
163855931|NCT00631917|591842386|FG000|Overall Study|Protocol deviation|6|||
163855932|NCT00631917|591842387|FG001|Overall Study|Protocol deviation|5|||
163855933|NCT00631917|591842386|FG000|Overall Study|Subject withdrew consent|25|||
163855934|NCT00631917|591842387|FG001|Overall Study|Subject withdrew consent|33|||
163855935|NCT00631917|591842386|FG000|Overall Study|Lost to Follow-up|7|||
163855936|NCT00631917|591842387|FG001|Overall Study|Lost to Follow-up|7|||
163855937|NCT00631917|591842386|FG000|Overall Study|Administrative problems|2|||
163855938|NCT00631917|591842387|FG001|Overall Study|Administrative problems|0|||
163855939|NCT00631917|591842386|FG000|Overall Study|Death|1|||
163855940|NCT00631917|591842387|FG001|Overall Study|Death|0|||
163855941|NCT02696785|591842391|FG000|Blinded Treatment Period|Adverse Event|0|||
163855942|NCT02696785|591842392|FG001|Blinded Treatment Period|Adverse Event|1|||
163855943|NCT02696785|591842393|FG002|Blinded Treatment Period|Adverse Event|3|||
163855944|NCT02696785|591842394|FG003|Blinded Treatment Period|Adverse Event|0|||
163855945|NCT02696785|591842391|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
163855946|NCT02696785|591842392|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
163855947|NCT02696785|591842393|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
163855948|NCT02696785|591842394|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
163855949|NCT02696785|591842391|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
164194170|NCT01278342|593079354|FG000|Overall Study|Physician Decision|0|||
164194171|NCT01278342|593079355|FG001|Overall Study|Physician Decision|1|||
163855950|NCT02696785|591842392|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
163855951|NCT02696785|591842393|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
163855952|NCT02696785|591842394|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
164194172|NCT01278342|593079356|FG002|Overall Study|Physician Decision|0|||
163855953|NCT02696785|591842391|FG000|Blinded Treatment Period|Screen Failure|1|||
163964936|NCT01109173|592244774|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
164194173|NCT01278342|593079354|FG000|Overall Study|Lost to Follow-up|1|||
163855954|NCT02696785|591842392|FG001|Blinded Treatment Period|Screen Failure|0|||
163855955|NCT02696785|591842393|FG002|Blinded Treatment Period|Screen Failure|0|||
163855956|NCT02696785|591842394|FG003|Blinded Treatment Period|Screen Failure|0|||
163855957|NCT02696785|591842391|FG000|Washout Period|Withdrawal by Subject|0|||
163855958|NCT02696785|591842392|FG001|Washout Period|Withdrawal by Subject|1|||
163855959|NCT02696785|591842393|FG002|Washout Period|Withdrawal by Subject|0|||
163855960|NCT02696785|591842394|FG003|Washout Period|Withdrawal by Subject|0|||
163855961|NCT02696785|591842391|FG000|Washout Period|Lack of Efficacy|0|||
163855962|NCT02696785|591842392|FG001|Washout Period|Lack of Efficacy|1|||
163855963|NCT02696785|591842393|FG002|Washout Period|Lack of Efficacy|0|||
163855964|NCT02696785|591842394|FG003|Washout Period|Lack of Efficacy|0|||
163855965|NCT02696785|591842391|FG000|Extended Treatment Period|Adverse Event|2|||
163855966|NCT02696785|591842392|FG001|Extended Treatment Period|Adverse Event|3|||
163855967|NCT02696785|591842393|FG002|Extended Treatment Period|Adverse Event|2|||
163855968|NCT02696785|591842394|FG003|Extended Treatment Period|Adverse Event|1|||
163855969|NCT02696785|591842391|FG000|Extended Treatment Period|Lack of Efficacy|0|||
163855970|NCT02696785|591842392|FG001|Extended Treatment Period|Lack of Efficacy|1|||
163855971|NCT02696785|591842393|FG002|Extended Treatment Period|Lack of Efficacy|0|||
163855972|NCT02696785|591842394|FG003|Extended Treatment Period|Lack of Efficacy|0|||
163855973|NCT02696785|591842391|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
163855974|NCT02696785|591842392|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
163855975|NCT02696785|591842393|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
163855976|NCT02696785|591842394|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
163855977|NCT02696785|591842391|FG000|Follow-up Period|Adverse Event|0|||
163855978|NCT02696785|591842392|FG001|Follow-up Period|Adverse Event|0|||
163855979|NCT02696785|591842393|FG002|Follow-up Period|Adverse Event|8|||
163855980|NCT02696785|591842394|FG003|Follow-up Period|Adverse Event|2|||
163855981|NCT02696785|591842391|FG000|Follow-up Period|Lost to Follow-up|0|||
163855982|NCT02696785|591842392|FG001|Follow-up Period|Lost to Follow-up|0|||
163855983|NCT02696785|591842393|FG002|Follow-up Period|Lost to Follow-up|0|||
163855984|NCT02696785|591842394|FG003|Follow-up Period|Lost to Follow-up|1|||
163855985|NCT02696785|591842391|FG000|Follow-up Period|Lack of Efficacy|0|||
163855986|NCT02696785|591842392|FG001|Follow-up Period|Lack of Efficacy|0|||
163855987|NCT02696785|591842393|FG002|Follow-up Period|Lack of Efficacy|0|||
163855988|NCT02696785|591842394|FG003|Follow-up Period|Lack of Efficacy|1|||
163855989|NCT02696785|591842391|FG000|Follow-up Period|Withdrawal by Subject|1|||
163855990|NCT02696785|591842392|FG001|Follow-up Period|Withdrawal by Subject|0|||
163855991|NCT02696785|591842393|FG002|Follow-up Period|Withdrawal by Subject|5|||
163855992|NCT02696785|591842394|FG003|Follow-up Period|Withdrawal by Subject|4|||
163855993|NCT04863898|591842398|FG000|Overall Study|Away from study clinic during intervention training period|2|||
163855994|NCT04863898|591842398|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
163855995|NCT04863898|591842398|FG000|Overall Study|Lost to Follow-up|3|||
163855996|NCT04863898|591842398|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
163855997|NCT04863898|591842398|FG000|Overall Study|No longer employed at clinic|3|||
163855998|NCT00614744|591842399|FG000|Overall Study|Lost to Follow-up|5|||
163855999|NCT00614744|591842400|FG001|Overall Study|Lost to Follow-up|4|||
163856000|NCT00614744|591842399|FG000|Overall Study|Incomplete for Behavior Issues|0|||
163856001|NCT00614744|591842400|FG001|Overall Study|Incomplete for Behavior Issues|2|||
163856002|NCT03285711|591842401|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
163856003|NCT03285711|591842402|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
163856004|NCT03285711|591842403|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
163856005|NCT03285711|591842404|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
163856006|NCT03285711|591842401|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
163856007|NCT03285711|591842402|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
164194174|NCT01278342|593079355|FG001|Overall Study|Lost to Follow-up|0|||
164194175|NCT01278342|593079356|FG002|Overall Study|Lost to Follow-up|0|||
164194176|NCT01278342|593079354|FG000|Overall Study|Administrative problems|2|||
164194177|NCT01278342|593079355|FG001|Overall Study|Administrative problems|0|||
164194178|NCT01278342|593079356|FG002|Overall Study|Administrative problems|0|||
164194179|NCT01278342|593079354|FG000|Overall Study|Other|1|||
164194180|NCT01278342|593079355|FG001|Overall Study|Other|0|||
164194181|NCT01278342|593079356|FG002|Overall Study|Other|0|||
163856008|NCT03285711|591842403|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
163856009|NCT03285711|591842404|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
163856010|NCT03285711|591842401|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
163856011|NCT03285711|591842402|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
163856012|NCT03285711|591842403|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
163856013|NCT03285711|591842404|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
163856014|NCT03285711|591842401|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
163856015|NCT03285711|591842402|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
163856016|NCT03285711|591842403|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
163856017|NCT03285711|591842404|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
163856018|NCT00877851|591842405|FG000|Overall Study|Lost to Follow-up|5|||
163856019|NCT00877851|591842406|FG001|Overall Study|Lost to Follow-up|5|||
163856020|NCT00877851|591842405|FG000|Overall Study|computer problem|3|||
163856021|NCT00877851|591842406|FG001|Overall Study|computer problem|0|||
163856022|NCT00877851|591842405|FG000|Overall Study|no longer interested in participating|1|||
163856023|NCT00877851|591842406|FG001|Overall Study|no longer interested in participating|0|||
163856024|NCT02431533|591842407|FG000|Overall Study|Withdrawal by Subject|1|||
163856025|NCT02431533|591842408|FG001|Overall Study|Withdrawal by Subject|3|||
163856026|NCT02431533|591842407|FG000|Overall Study|Developed Exclusionary criteria|1|||
163856027|NCT02431533|591842408|FG001|Overall Study|Developed Exclusionary criteria|0|||
163856028|NCT00770211|591842411|FG000|Overall Study|Lost to Follow-up|1|||
163856029|NCT00770211|591842412|FG001|Overall Study|Lost to Follow-up|0|||
163856030|NCT00770211|591842411|FG000|Overall Study|Withdrawal by Subject|0|||
163856031|NCT00770211|591842412|FG001|Overall Study|Withdrawal by Subject|2|||
163856032|NCT01446003|591842414|FG000|Period 1|Protocol Violation|2|||
163856033|NCT01446003|591842415|FG001|Period 1|Protocol Violation|0|||
163856034|NCT01446003|591842414|FG000|Period 2|Adverse Event|1|||
163856035|NCT01446003|591842415|FG001|Period 2|Adverse Event|0|||
163856036|NCT00318656|591842416|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
163856037|NCT00318656|591842417|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
163856038|NCT00318656|591842416|FG000|Overall Study|Did not receive any treatment|0|||
163856039|NCT00318656|591842417|FG001|Overall Study|Did not receive any treatment|1|||
163856040|NCT00490555|591842418|FG000|Overall Study|noncompliant with drug administration|0|||
163856041|NCT00490555|591842419|FG001|Overall Study|noncompliant with drug administration|0|||
163856042|NCT00490555|591842420|FG002|Overall Study|noncompliant with drug administration|2|||
163856043|NCT00490555|591842421|FG003|Overall Study|noncompliant with drug administration|0|||
163856044|NCT01007149|591842422|FG000|Overall Study|Administrative problems|0|||
163856045|NCT01007149|591842423|FG001|Overall Study|Administrative problems|1|||
163856046|NCT01516892|591842425|FG000|Overall Study|Adverse Event|25|||
163856047|NCT01516892|591842425|FG000|Overall Study|Lack of Efficacy|35|||
163856048|NCT01516892|591842425|FG000|Overall Study|Pregnancy|5|||
163856049|NCT01516892|591842425|FG000|Overall Study|Lost to Follow-up|82|||
163856050|NCT01516892|591842425|FG000|Overall Study|Subject Withdrew Consent|92|||
163856051|NCT01516892|591842425|FG000|Overall Study|Protocol Violation|60|||
163856052|NCT01516892|591842425|FG000|Overall Study|Other Miscellaneous Reasons|43|||
163856053|NCT01516892|591842425|FG000|Overall Study|Missing|1|||
163856054|NCT02956967|591842426|FG000|Overall Study|Adverse Event|3|||
163856055|NCT02956967|591842426|FG000|Overall Study|Reason non-related to neutropenia|10|||
163856056|NCT02956967|591842426|FG000|Overall Study|Lost to Follow-up|5|||
163856057|NCT02956967|591842426|FG000|Overall Study|Missing|1|||
163856058|NCT02956967|591842426|FG000|Overall Study|Termination of Nivestim administration|29|||
163856059|NCT00819234|591842429|FG000|Overall Study|Withdrawal by Subject|8|||
163856060|NCT00819234|591842430|FG001|Overall Study|Withdrawal by Subject|13|||
163856061|NCT00819234|591842431|FG002|Overall Study|Withdrawal by Subject|6|||
163856062|NCT00819234|591842432|FG003|Overall Study|Withdrawal by Subject|3|||
163856063|NCT00819234|591842433|FG004|Overall Study|Withdrawal by Subject|0|||
163856064|NCT00819234|591842434|FG005|Overall Study|Withdrawal by Subject|4|||
163856065|NCT00819234|591842435|FG006|Overall Study|Withdrawal by Subject|4|||
163856066|NCT00819234|591842436|FG007|Overall Study|Withdrawal by Subject|8|||
163856067|NCT00819234|591842437|FG008|Overall Study|Withdrawal by Subject|5|||
163856068|NCT00819234|591842438|FG009|Overall Study|Withdrawal by Subject|3|||
163856069|NCT00819234|591842429|FG000|Overall Study|Adverse Event|0|||
163856070|NCT00819234|591842430|FG001|Overall Study|Adverse Event|0|||
163856071|NCT00819234|591842431|FG002|Overall Study|Adverse Event|1|||
163856072|NCT00819234|591842432|FG003|Overall Study|Adverse Event|0|||
163856073|NCT00819234|591842433|FG004|Overall Study|Adverse Event|0|||
163856074|NCT00819234|591842434|FG005|Overall Study|Adverse Event|2|||
163856075|NCT00819234|591842435|FG006|Overall Study|Adverse Event|0|||
163856076|NCT00819234|591842436|FG007|Overall Study|Adverse Event|0|||
163856077|NCT00819234|591842437|FG008|Overall Study|Adverse Event|0|||
163856078|NCT00819234|591842438|FG009|Overall Study|Adverse Event|0|||
163856079|NCT00819234|591842429|FG000|Overall Study|Physician Decision|0|||
163856080|NCT00819234|591842430|FG001|Overall Study|Physician Decision|0|||
163856081|NCT00819234|591842431|FG002|Overall Study|Physician Decision|0|||
163856082|NCT00819234|591842432|FG003|Overall Study|Physician Decision|1|||
163856083|NCT00819234|591842433|FG004|Overall Study|Physician Decision|0|||
163856084|NCT00819234|591842434|FG005|Overall Study|Physician Decision|0|||
163856085|NCT00819234|591842435|FG006|Overall Study|Physician Decision|0|||
163856086|NCT00819234|591842436|FG007|Overall Study|Physician Decision|0|||
163856087|NCT00819234|591842437|FG008|Overall Study|Physician Decision|0|||
163856088|NCT00819234|591842438|FG009|Overall Study|Physician Decision|2|||
163856089|NCT00819234|591842429|FG000|Overall Study|Protocol Violation|0|||
163856090|NCT00819234|591842430|FG001|Overall Study|Protocol Violation|0|||
163856091|NCT00819234|591842431|FG002|Overall Study|Protocol Violation|1|||
163856092|NCT00819234|591842432|FG003|Overall Study|Protocol Violation|0|||
163856093|NCT00819234|591842433|FG004|Overall Study|Protocol Violation|0|||
163856094|NCT00819234|591842434|FG005|Overall Study|Protocol Violation|0|||
163856095|NCT00819234|591842435|FG006|Overall Study|Protocol Violation|0|||
163856096|NCT00819234|591842436|FG007|Overall Study|Protocol Violation|0|||
163856097|NCT00819234|591842437|FG008|Overall Study|Protocol Violation|0|||
163856098|NCT00819234|591842438|FG009|Overall Study|Protocol Violation|0|||
163856099|NCT00819234|591842429|FG000|Overall Study|Lost to Follow-up|2|||
163856100|NCT00819234|591842430|FG001|Overall Study|Lost to Follow-up|2|||
163856101|NCT00819234|591842431|FG002|Overall Study|Lost to Follow-up|0|||
163856102|NCT00819234|591842432|FG003|Overall Study|Lost to Follow-up|2|||
163856103|NCT00819234|591842433|FG004|Overall Study|Lost to Follow-up|1|||
163856104|NCT00819234|591842434|FG005|Overall Study|Lost to Follow-up|1|||
163856105|NCT00819234|591842435|FG006|Overall Study|Lost to Follow-up|1|||
163856106|NCT00819234|591842436|FG007|Overall Study|Lost to Follow-up|1|||
163856107|NCT00819234|591842437|FG008|Overall Study|Lost to Follow-up|1|||
163856108|NCT00819234|591842438|FG009|Overall Study|Lost to Follow-up|2|||
163856109|NCT01096056|591842439|FG000|Overall Study|Lost to Follow-up|0|||
163856110|NCT01096056|591842440|FG001|Overall Study|Lost to Follow-up|1|||
163856111|NCT03568162|591842441|FG000|Overall Study|Adverse Event|0|||
163856112|NCT03568162|591842442|FG001|Overall Study|Adverse Event|1|||
163856113|NCT03568162|591842443|FG002|Overall Study|Adverse Event|2|||
163856114|NCT03568162|591842444|FG003|Overall Study|Adverse Event|0|||
163856115|NCT03568162|591842445|FG004|Overall Study|Adverse Event|0|||
163856116|NCT03568162|591842446|FG005|Overall Study|Adverse Event|1|||
163856117|NCT03568162|591842441|FG000|Overall Study|Death|0|||
163856118|NCT03568162|591842442|FG001|Overall Study|Death|0|||
163856119|NCT03568162|591842443|FG002|Overall Study|Death|0|||
163856120|NCT03568162|591842444|FG003|Overall Study|Death|0|||
163856121|NCT03568162|591842445|FG004|Overall Study|Death|1|||
163856122|NCT03568162|591842446|FG005|Overall Study|Death|0|||
163856123|NCT03568162|591842441|FG000|Overall Study|Lost to Follow-up|3|||
163856124|NCT03568162|591842442|FG001|Overall Study|Lost to Follow-up|2|||
163856125|NCT03568162|591842443|FG002|Overall Study|Lost to Follow-up|4|||
163856126|NCT03568162|591842444|FG003|Overall Study|Lost to Follow-up|2|||
163856127|NCT03568162|591842445|FG004|Overall Study|Lost to Follow-up|3|||
163856128|NCT03568162|591842446|FG005|Overall Study|Lost to Follow-up|2|||
163856129|NCT03568162|591842441|FG000|Overall Study|Physician Decision|0|||
163856130|NCT03568162|591842442|FG001|Overall Study|Physician Decision|1|||
163856131|NCT03568162|591842443|FG002|Overall Study|Physician Decision|1|||
163856132|NCT03568162|591842444|FG003|Overall Study|Physician Decision|0|||
163856133|NCT03568162|591842445|FG004|Overall Study|Physician Decision|1|||
163856134|NCT03568162|591842446|FG005|Overall Study|Physician Decision|0|||
163856135|NCT03568162|591842441|FG000|Overall Study|Pregnancy|0|||
163856136|NCT03568162|591842442|FG001|Overall Study|Pregnancy|0|||
163856137|NCT03568162|591842443|FG002|Overall Study|Pregnancy|0|||
163856138|NCT03568162|591842444|FG003|Overall Study|Pregnancy|1|||
163856139|NCT03568162|591842445|FG004|Overall Study|Pregnancy|0|||
163856140|NCT03568162|591842446|FG005|Overall Study|Pregnancy|0|||
163856141|NCT03568162|591842441|FG000|Overall Study|Protocol Violation|1|||
163856142|NCT03568162|591842442|FG001|Overall Study|Protocol Violation|0|||
163856143|NCT03568162|591842443|FG002|Overall Study|Protocol Violation|1|||
163856144|NCT03568162|591842444|FG003|Overall Study|Protocol Violation|1|||
163856145|NCT03568162|591842445|FG004|Overall Study|Protocol Violation|1|||
163856146|NCT03568162|591842446|FG005|Overall Study|Protocol Violation|1|||
163856147|NCT03568162|591842441|FG000|Overall Study|Withdrawal by Subject|15|||
163856148|NCT03568162|591842442|FG001|Overall Study|Withdrawal by Subject|15|||
163856149|NCT03568162|591842443|FG002|Overall Study|Withdrawal by Subject|26|||
163856150|NCT03568162|591842444|FG003|Overall Study|Withdrawal by Subject|22|||
163856151|NCT03568162|591842445|FG004|Overall Study|Withdrawal by Subject|6|||
163856152|NCT03568162|591842446|FG005|Overall Study|Withdrawal by Subject|9|||
163856153|NCT03568162|591842441|FG000|Overall Study|Others|3|||
163856154|NCT03568162|591842442|FG001|Overall Study|Others|4|||
163856155|NCT03568162|591842443|FG002|Overall Study|Others|1|||
163856156|NCT03568162|591842444|FG003|Overall Study|Others|4|||
164302201|NCT01134055|593482558|FG002|Overall Study|Lost to Follow-up|0|||
163856157|NCT03568162|591842445|FG004|Overall Study|Others|2|||
163856158|NCT03568162|591842446|FG005|Overall Study|Others|1|||
163856159|NCT00337818|591842447|FG000|Overall Study|Lost to Follow-up|289|||
163856160|NCT00337818|591842448|FG001|Overall Study|Lost to Follow-up|91|||
163856161|NCT00337818|591842449|FG002|Overall Study|Lost to Follow-up|107|||
163856162|NCT00938340|591842451|FG000|Overall Study|Withdrawal by Subject|3|||
163856163|NCT00938340|591842451|FG000|Overall Study|Protocol Violation|1|||
163856164|NCT00938340|591842451|FG000|Overall Study|Adverse Event|1|||
163856165|NCT00924560|591842454|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
163856166|NCT00924560|591842455|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
163856167|NCT00924560|591842456|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
163856168|NCT00924560|591842454|FG000|Overall Study|Non Compliance with the Protocol|20|||
163856169|NCT00924560|591842455|FG001|Overall Study|Non Compliance with the Protocol|15|||
163856170|NCT00924560|591842456|FG002|Overall Study|Non Compliance with the Protocol|4|||
163856171|NCT00924560|591842454|FG000|Overall Study|Physician Decision|2|||
163964937|NCT01109173|592244775|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
163856172|NCT00924560|591842455|FG001|Overall Study|Physician Decision|3|||
163856173|NCT00924560|591842456|FG002|Overall Study|Physician Decision|4|||
163856174|NCT00924560|591842454|FG000|Overall Study|Withdrawal by Subject|50|||
163856175|NCT00924560|591842455|FG001|Overall Study|Withdrawal by Subject|44|||
163856176|NCT00924560|591842456|FG002|Overall Study|Withdrawal by Subject|18|||
163856177|NCT00924560|591842454|FG000|Overall Study|Adverse Event|39|||
163856178|NCT00924560|591842455|FG001|Overall Study|Adverse Event|33|||
163856179|NCT00924560|591842456|FG002|Overall Study|Adverse Event|0|||
163856180|NCT00924560|591842454|FG000|Overall Study|Pregnancy|5|||
163856181|NCT00924560|591842455|FG001|Overall Study|Pregnancy|7|||
163856182|NCT00924560|591842456|FG002|Overall Study|Pregnancy|1|||
163856183|NCT00924560|591842454|FG000|Overall Study|Lost to Follow-up|78|||
163856184|NCT00924560|591842455|FG001|Overall Study|Lost to Follow-up|94|||
163856185|NCT00924560|591842456|FG002|Overall Study|Lost to Follow-up|45|||
163856186|NCT00924560|591842454|FG000|Overall Study|Miscellaneous Reasons|13|||
163856187|NCT00924560|591842455|FG001|Overall Study|Miscellaneous Reasons|10|||
163856188|NCT00924560|591842456|FG002|Overall Study|Miscellaneous Reasons|10|||
163856189|NCT02753530|591842460|FG000|Overall Study|Adverse Event|7|||
163856190|NCT02753530|591842461|FG001|Overall Study|Adverse Event|1|||
163856191|NCT02753530|591842460|FG000|Overall Study|Death|0|||
163856192|NCT02753530|591842461|FG001|Overall Study|Death|1|||
163856193|NCT02753530|591842460|FG000|Overall Study|Physician Decision|0|||
163856194|NCT02753530|591842461|FG001|Overall Study|Physician Decision|1|||
163856195|NCT02753530|591842460|FG000|Overall Study|Protocol Violation|1|||
163856196|NCT02753530|591842461|FG001|Overall Study|Protocol Violation|0|||
163856197|NCT02753530|591842460|FG000|Overall Study|Withdrawal by Subject|4|||
163856198|NCT02753530|591842461|FG001|Overall Study|Withdrawal by Subject|3|||
163856199|NCT03590743|591842462|FG000|Overall Study|Withdrawal by Subject|0|||
163856200|NCT03590743|591842463|FG001|Overall Study|Withdrawal by Subject|1|||
163856201|NCT00604786|591842464|FG000|Overall Study|Lost to Follow-up|2|||
163856202|NCT00604786|591842465|FG001|Overall Study|Lost to Follow-up|0|||
163856203|NCT03369951|591842466|FG000|Overall Study|Withdrawal by Subject|3|||
163856204|NCT03369951|591842466|FG000|Overall Study|Death|1|||
163856205|NCT03369951|591842466|FG000|Overall Study|Lost to Follow-up|1|||
163856206|NCT03369951|591842466|FG000|Overall Study|Protocol Violation|1|||
163856207|NCT03677375|591842467|FG000|Overall Study|Incomplete procedure|8|||
163856208|NCT03677375|591842467|FG000|Overall Study|Adverse Event|3|||
163856209|NCT03677375|591842467|FG000|Overall Study|Physician Decision|1|||
163856210|NCT00725010|591842473|FG000|Overall Study|Toxicity|9|||
163856211|NCT00725010|591842473|FG000|Overall Study|Tumor Progression|7|||
163856212|NCT00725010|591842473|FG000|Overall Study|Withdrawal by Subject|2|||
163856213|NCT00725010|591842473|FG000|Overall Study|Death|1|||
163856214|NCT00725010|591842473|FG000|Overall Study|Lost to Follow-up|1|||
163856215|NCT00725010|591842473|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
163856216|NCT00725010|591842473|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
163856217|NCT00725010|591842473|FG000|Overall Study|No further documentation|1|||
163856218|NCT00725010|591842473|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
163856219|NCT01290094|591842474|FG000|Overall Study|Withdrawal by Subject|1|||
163856220|NCT01290094|591842474|FG000|Overall Study|Lost to Follow-up|5|||
163856221|NCT01959880|591842475|FG000|Overall Study|Withdrawal by Subject|11|||
163856222|NCT01959880|591842476|FG001|Overall Study|Withdrawal by Subject|13|||
163856223|NCT01959880|591842477|FG002|Overall Study|Withdrawal by Subject|8|||
163856224|NCT01959880|591842478|FG003|Overall Study|Withdrawal by Subject|7|||
163856225|NCT01959880|591842475|FG000|Overall Study|Death|1|||
163856226|NCT01959880|591842476|FG001|Overall Study|Death|10|||
163856227|NCT01959880|591842477|FG002|Overall Study|Death|1|||
163856228|NCT01959880|591842478|FG003|Overall Study|Death|2|||
163856229|NCT01959880|591842475|FG000|Overall Study|Lost to Follow-up|95|||
163856230|NCT01959880|591842476|FG001|Overall Study|Lost to Follow-up|18|||
163856231|NCT01959880|591842477|FG002|Overall Study|Lost to Follow-up|15|||
163856232|NCT01959880|591842478|FG003|Overall Study|Lost to Follow-up|8|||
163856233|NCT01959880|591842475|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
163856234|NCT01959880|591842476|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
163856235|NCT01959880|591842477|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
163856236|NCT01959880|591842478|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
163856237|NCT01959880|591842475|FG000|Overall Study|Study completed early-FDA approved|1003|||
163856238|NCT01959880|591842476|FG001|Overall Study|Study completed early-FDA approved|311|||
163856239|NCT01959880|591842477|FG002|Overall Study|Study completed early-FDA approved|179|||
163856240|NCT01959880|591842478|FG003|Overall Study|Study completed early-FDA approved|152|||
163856241|NCT01537133|591844289|FG000|Overall Study|Withdrawal by Subject|2|||
163856242|NCT01537133|591844290|FG001|Overall Study|Withdrawal by Subject|0|||
163856243|NCT01537133|591844291|FG002|Overall Study|Withdrawal by Subject|0|||
163856244|NCT01537133|591844292|FG003|Overall Study|Withdrawal by Subject|0|||
163856245|NCT01537133|591844289|FG000|Overall Study|Lost to Follow-up|1|||
163856246|NCT01537133|591844290|FG001|Overall Study|Lost to Follow-up|0|||
163856247|NCT01537133|591844291|FG002|Overall Study|Lost to Follow-up|0|||
163856248|NCT01537133|591844292|FG003|Overall Study|Lost to Follow-up|0|||
163856249|NCT00349908|591844293|FG000|Overall Study|Withdrawal by Subject|0|||
163856250|NCT00349908|591844294|FG001|Overall Study|Withdrawal by Subject|4|||
163856251|NCT01289119|591844298|FG000|Overall Study|Adverse Event|2|||
163856252|NCT01289119|591844299|FG001|Overall Study|Adverse Event|1|||
163856253|NCT01289119|591844300|FG002|Overall Study|Adverse Event|0|||
163856254|NCT01289119|591844301|FG003|Overall Study|Adverse Event|2|||
163856255|NCT01289119|591844302|FG004|Overall Study|Adverse Event|1|||
163856256|NCT01289119|591844303|FG005|Overall Study|Adverse Event|0|||
163856257|NCT01289119|591844298|FG000|Overall Study|Major Protocol Deviation|2|||
163856258|NCT01289119|591844299|FG001|Overall Study|Major Protocol Deviation|1|||
163856259|NCT01289119|591844300|FG002|Overall Study|Major Protocol Deviation|3|||
163856260|NCT01289119|591844301|FG003|Overall Study|Major Protocol Deviation|0|||
163856261|NCT01289119|591844302|FG004|Overall Study|Major Protocol Deviation|2|||
163856262|NCT01289119|591844303|FG005|Overall Study|Major Protocol Deviation|1|||
163856263|NCT01289119|591844298|FG000|Overall Study|Lost to Follow-up|0|||
163856264|NCT01289119|591844299|FG001|Overall Study|Lost to Follow-up|3|||
163856265|NCT01289119|591844300|FG002|Overall Study|Lost to Follow-up|0|||
163856266|NCT01289119|591844301|FG003|Overall Study|Lost to Follow-up|0|||
163856267|NCT01289119|591844302|FG004|Overall Study|Lost to Follow-up|0|||
163856268|NCT01289119|591844303|FG005|Overall Study|Lost to Follow-up|1|||
163856269|NCT01289119|591844298|FG000|Overall Study|Withdrawal by Subject|4|||
163856270|NCT01289119|591844299|FG001|Overall Study|Withdrawal by Subject|2|||
163856271|NCT01289119|591844300|FG002|Overall Study|Withdrawal by Subject|4|||
163856272|NCT01289119|591844301|FG003|Overall Study|Withdrawal by Subject|3|||
163856273|NCT01289119|591844302|FG004|Overall Study|Withdrawal by Subject|1|||
163856274|NCT01289119|591844303|FG005|Overall Study|Withdrawal by Subject|1|||
163856275|NCT01289119|591844298|FG000|Overall Study|Pregnancy|0|||
163856276|NCT01289119|591844299|FG001|Overall Study|Pregnancy|1|||
163856277|NCT01289119|591844300|FG002|Overall Study|Pregnancy|0|||
163856278|NCT01289119|591844301|FG003|Overall Study|Pregnancy|0|||
163856279|NCT01289119|591844302|FG004|Overall Study|Pregnancy|0|||
163856280|NCT01289119|591844303|FG005|Overall Study|Pregnancy|0|||
163856281|NCT01289119|591844298|FG000|Overall Study|Lack of Efficacy|0|||
163856282|NCT01289119|591844299|FG001|Overall Study|Lack of Efficacy|1|||
163856283|NCT01289119|591844300|FG002|Overall Study|Lack of Efficacy|1|||
163856284|NCT01289119|591844301|FG003|Overall Study|Lack of Efficacy|1|||
163856285|NCT01289119|591844302|FG004|Overall Study|Lack of Efficacy|1|||
163856286|NCT01289119|591844303|FG005|Overall Study|Lack of Efficacy|1|||
163856287|NCT01289119|591844298|FG000|Overall Study|Other|1|||
163856288|NCT01289119|591844299|FG001|Overall Study|Other|0|||
163856289|NCT01289119|591844300|FG002|Overall Study|Other|1|||
163856290|NCT01289119|591844301|FG003|Overall Study|Other|0|||
163856291|NCT01289119|591844302|FG004|Overall Study|Other|0|||
163856292|NCT01289119|591844303|FG005|Overall Study|Other|0|||
163856293|NCT01704846|591844304|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163856294|NCT01704846|591844305|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163856295|NCT00530335|591844308|FG000|Overall Study|Adverse Event|3|||
163856296|NCT00530335|591844308|FG000|Overall Study|Protocol Violation|1|||
163856297|NCT00530335|591844308|FG000|Overall Study|Withdrawal by Subject|1|||
163856298|NCT00530335|591844308|FG000|Overall Study|Physician Decision|1|||
163856299|NCT01244984|591844310|FG000|Overall Study|Adverse Event|2|||
163856300|NCT01244984|591844311|FG001|Overall Study|Adverse Event|11|||
163856301|NCT01244984|591844312|FG002|Overall Study|Adverse Event|2|||
163856302|NCT01244984|591844310|FG000|Overall Study|Protocol Violation|1|||
163856303|NCT01244984|591844311|FG001|Overall Study|Protocol Violation|0|||
163856304|NCT01244984|591844312|FG002|Overall Study|Protocol Violation|0|||
163856305|NCT01244984|591844310|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
163856306|NCT01244984|591844311|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
163856307|NCT01244984|591844312|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
163856308|NCT01244984|591844310|FG000|Overall Study|Withdrawal by Subject|1|||
163856309|NCT01244984|591844311|FG001|Overall Study|Withdrawal by Subject|2|||
163856310|NCT01244984|591844312|FG002|Overall Study|Withdrawal by Subject|2|||
163856311|NCT04577183|591844313|FG000|Overall Study|Death|1|||
163856312|NCT04577183|591844313|FG000|Overall Study|Withdrawal by Subject|3|||
163856313|NCT04577183|591844313|FG000|Overall Study|Early termination|2|||
163856314|NCT01801930|591844315|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
163856315|NCT01801930|591844316|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
163856316|NCT01801930|591844317|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
163856317|NCT01801930|591844318|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
163856318|NCT01801930|591844315|FG000|Overall Study|DLT occurs|0|||
163856319|NCT01801930|591844316|FG001|Overall Study|DLT occurs|1|||
163856320|NCT01801930|591844317|FG002|Overall Study|DLT occurs|0|||
163856321|NCT01801930|591844318|FG003|Overall Study|DLT occurs|0|||
163856322|NCT02072226|591844325|FG000|Overall Study|Lost to Follow-up|11|||
163856323|NCT02072226|591844326|FG001|Overall Study|Lost to Follow-up|7|||
163856324|NCT02072226|591844325|FG000|Overall Study|Patient Non-compliance|2|||
163856325|NCT02072226|591844326|FG001|Overall Study|Patient Non-compliance|3|||
163856326|NCT02072226|591844325|FG000|Overall Study|Death|1|||
163856327|NCT02072226|591844326|FG001|Overall Study|Death|0|||
163856328|NCT02072226|591844325|FG000|Overall Study|Patient Withdrawal of Consent|1|||
163856329|NCT02072226|591844326|FG001|Overall Study|Patient Withdrawal of Consent|0|||
163856330|NCT00972543|591844329|FG000|Overall Study|Adverse Event|1|||
163856331|NCT00972543|591844330|FG001|Overall Study|Adverse Event|0|||
163856332|NCT00972543|591844329|FG000|Overall Study|Early study termination by sponsor|4|||
163856333|NCT00972543|591844330|FG001|Overall Study|Early study termination by sponsor|1|||
163856334|NCT01466881|591844331|FG000|Overall Study|Ineligible|5|||
163856335|NCT01466881|591844331|FG000|Overall Study|Adverse Event|6|||
163856336|NCT01466881|591844331|FG000|Overall Study|Progression/relapse|20|||
163856337|NCT01466881|591844331|FG000|Overall Study|Death|4|||
163856338|NCT01466881|591844331|FG000|Overall Study|Other reason not protocol specified|5|||
163856339|NCT03101592|591844332|FG000|Overall Study|participant files could not be located|111|||
163856340|NCT03101592|591844333|FG001|Overall Study|participant files could not be located|170|||
163856341|NCT03101592|591844334|FG002|Overall Study|participant files could not be located|118|||
163856342|NCT02397889|591844337|FG000|Overall Study|Physician Decision|1|||
163856343|NCT02397889|591844338|FG001|Overall Study|Physician Decision|0|||
163856344|NCT02219490|591844342|FG000|Overall Study|Adverse Event|24|||
163856345|NCT02219490|591844342|FG000|Overall Study|Withdrew consent|96|||
163856346|NCT02219490|591844342|FG000|Overall Study|Lost to Follow-up|126|||
163856347|NCT02219490|591844342|FG000|Overall Study|COVID-19 infection|2|||
163856348|NCT02219490|591844342|FG000|Overall Study|COVID-19 logistical restrictions|33|||
163856349|NCT02219490|591844342|FG000|Overall Study|Other, not specified|57|||
163856350|NCT01928940|591844346|FG000|Overall Study|Adverse Event|0|||
163856351|NCT01928940|591844347|FG001|Overall Study|Adverse Event|1|||
163856352|NCT01352507|591844350|FG000|Treatment Period 1|Adverse Event|3|||
163856353|NCT01352507|591844351|FG001|Treatment Period 1|Adverse Event|0|||
163856354|NCT01352507|591844350|FG000|Treatment Period 1|Lost to Follow-up|3|||
163856355|NCT01352507|591844351|FG001|Treatment Period 1|Lost to Follow-up|4|||
163856356|NCT01352507|591844350|FG000|Treatment Period 1|Withdrawal by Subject|7|||
163856357|NCT01352507|591844351|FG001|Treatment Period 1|Withdrawal by Subject|5|||
163856358|NCT01352507|591844350|FG000|Treatment Period 1|Physician Decision|1|||
163856359|NCT01352507|591844351|FG001|Treatment Period 1|Physician Decision|0|||
163856360|NCT01352507|591844350|FG000|Washout Period|Withdrawal by Subject|0|||
163856361|NCT01352507|591844351|FG001|Washout Period|Withdrawal by Subject|1|||
163856362|NCT01352507|591844350|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
163856363|NCT01352507|591844351|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
163856364|NCT01352507|591844350|FG000|Treatment Period 2|Withdrawal by Subject|4|||
163856365|NCT01352507|591844351|FG001|Treatment Period 2|Withdrawal by Subject|3|||
163856366|NCT01352507|591844350|FG000|Treatment Period 2|Lack of Efficacy|1|||
163856367|NCT01352507|591844351|FG001|Treatment Period 2|Lack of Efficacy|0|||
163856368|NCT03178201|591844352|FG000|Overall Study|Off study|5|||
163856369|NCT04639947|591844357|FG000|Overall Study|Screen fail|1|||
163856370|NCT01018511|591844358|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
163856371|NCT01018511|591844359|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
163856372|NCT01018511|591844360|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
163856373|NCT01018511|591844361|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
163856374|NCT01018511|591844358|FG000|Overall Study|Adverse Event|5|||
163856375|NCT01018511|591844359|FG001|Overall Study|Adverse Event|9|||
163856376|NCT01018511|591844360|FG002|Overall Study|Adverse Event|13|||
163856377|NCT01018511|591844361|FG003|Overall Study|Adverse Event|10|||
163856378|NCT01018511|591844358|FG000|Overall Study|Lack of Efficacy|4|||
163856379|NCT01018511|591844359|FG001|Overall Study|Lack of Efficacy|1|||
163856380|NCT01018511|591844360|FG002|Overall Study|Lack of Efficacy|1|||
163856381|NCT01018511|591844361|FG003|Overall Study|Lack of Efficacy|2|||
163856382|NCT01018511|591844358|FG000|Overall Study|Withdrawal by Subject|6|||
163856383|NCT01018511|591844359|FG001|Overall Study|Withdrawal by Subject|5|||
163856384|NCT01018511|591844360|FG002|Overall Study|Withdrawal by Subject|11|||
163856385|NCT01018511|591844361|FG003|Overall Study|Withdrawal by Subject|9|||
163856386|NCT01018511|591844358|FG000|Overall Study|Lost to Follow-up|0|||
163856387|NCT01018511|591844359|FG001|Overall Study|Lost to Follow-up|0|||
163856388|NCT01018511|591844360|FG002|Overall Study|Lost to Follow-up|1|||
163856389|NCT01018511|591844361|FG003|Overall Study|Lost to Follow-up|0|||
163856390|NCT01018511|591844358|FG000|Overall Study|Protocol Violation|5|||
163856391|NCT01018511|591844359|FG001|Overall Study|Protocol Violation|8|||
163856392|NCT01018511|591844360|FG002|Overall Study|Protocol Violation|7|||
163856393|NCT01018511|591844361|FG003|Overall Study|Protocol Violation|9|||
163856394|NCT01018511|591844358|FG000|Overall Study|Miscellaneous|0|||
164134655|NCT03970837|592857356|FG001|Overall Study|Adverse Event|20|||
163856395|NCT01018511|591844359|FG001|Overall Study|Miscellaneous|2|||
163856396|NCT01018511|591844360|FG002|Overall Study|Miscellaneous|0|||
163856397|NCT01018511|591844361|FG003|Overall Study|Miscellaneous|0|||
163856398|NCT03424239|591844362|FG000|Overall Study|Withdrawal by Subject|2|||
163856399|NCT03697460|591844370|FG000|Overall Study|Withdrawal by Subject|3|||
163856400|NCT02414828|591844371|FG000|Overall Study|Lost to Follow-up|0|||
163856401|NCT02414828|591844372|FG001|Overall Study|Lost to Follow-up|1|||
163856402|NCT02414828|591844373|FG002|Overall Study|Lost to Follow-up|1|||
163856403|NCT02414828|591844374|FG003|Overall Study|Lost to Follow-up|2|||
163856404|NCT00630864|591844376|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
163856405|NCT00630864|591844376|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
163856406|NCT00430677|591844377|FG000|Short-term Period|Death|1|||
163856407|NCT00430677|591844378|FG001|Short-term Period|Death|1|||
164134656|NCT03970837|592857357|FG002|Overall Study|Adverse Event|16|||
163856408|NCT00430677|591844379|FG002|Short-term Period|Death|5|||
163856409|NCT00430677|591844377|FG000|Short-term Period|Adverse Event|15|||
163856410|NCT00430677|591844378|FG001|Short-term Period|Adverse Event|13|||
163856411|NCT00430677|591844379|FG002|Short-term Period|Adverse Event|9|||
163856412|NCT00430677|591844377|FG000|Short-term Period|Lack of Efficacy|5|||
163856413|NCT00430677|591844378|FG001|Short-term Period|Lack of Efficacy|6|||
163856414|NCT00430677|591844379|FG002|Short-term Period|Lack of Efficacy|4|||
163856415|NCT00430677|591844377|FG000|Short-term Period|Withdrawal by Subject|1|||
163856416|NCT00430677|591844378|FG001|Short-term Period|Withdrawal by Subject|1|||
163856417|NCT00430677|591844379|FG002|Short-term Period|Withdrawal by Subject|2|||
163856418|NCT00430677|591844377|FG000|Short-term Period|Participant no longer met study criteria|1|||
163856419|NCT00430677|591844378|FG001|Short-term Period|Participant no longer met study criteria|1|||
163856420|NCT00430677|591844379|FG002|Short-term Period|Participant no longer met study criteria|2|||
163856421|NCT00430677|591844377|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
163856422|NCT00430677|591844378|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
163856423|NCT00430677|591844379|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
163856424|NCT00430677|591844377|FG000|Short-term Period|Pregnancy|0|||
163856425|NCT00430677|591844378|FG001|Short-term Period|Pregnancy|2|||
163856426|NCT00430677|591844379|FG002|Short-term Period|Pregnancy|0|||
163856427|NCT00430677|591844377|FG000|Long-term Extension Period|Death|1|||
163856428|NCT00430677|591844378|FG001|Long-term Extension Period|Death|0|||
163856429|NCT00430677|591844379|FG002|Long-term Extension Period|Death|0|||
163856430|NCT00430677|591844377|FG000|Long-term Extension Period|Adverse Event|3|||
163856431|NCT00430677|591844378|FG001|Long-term Extension Period|Adverse Event|2|||
163856432|NCT00430677|591844379|FG002|Long-term Extension Period|Adverse Event|5|||
163856433|NCT00430677|591844377|FG000|Long-term Extension Period|Lack of Efficacy|5|||
163856434|NCT00430677|591844378|FG001|Long-term Extension Period|Lack of Efficacy|3|||
163856435|NCT00430677|591844379|FG002|Long-term Extension Period|Lack of Efficacy|8|||
163856436|NCT00430677|591844377|FG000|Long-term Extension Period|Lost to Follow-up|1|||
163856437|NCT00430677|591844378|FG001|Long-term Extension Period|Lost to Follow-up|1|||
163856438|NCT00430677|591844379|FG002|Long-term Extension Period|Lost to Follow-up|1|||
163856439|NCT00430677|591844377|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
163856440|NCT00430677|591844378|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
163856441|NCT00430677|591844379|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
163856442|NCT00430677|591844377|FG000|Long-term Extension Period|Pregnancy|1|||
163856443|NCT00430677|591844378|FG001|Long-term Extension Period|Pregnancy|1|||
163856444|NCT00430677|591844379|FG002|Long-term Extension Period|Pregnancy|0|||
163856445|NCT00430677|591844377|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
163856446|NCT00430677|591844378|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
163856447|NCT00430677|591844379|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
163856448|NCT00430677|591844377|FG000|Long-term Extension Period|Other|2|||
163856449|NCT00430677|591844378|FG001|Long-term Extension Period|Other|1|||
163856450|NCT00430677|591844379|FG002|Long-term Extension Period|Other|1|||
163856451|NCT00430677|591844377|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
163856452|NCT00430677|591844378|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
163856453|NCT00430677|591844379|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
163856454|NCT01555762|591844382|FG000|Overall Study|No information on Bevacizumab intake|11|||
163856455|NCT01555762|591844382|FG000|Overall Study|Missing start date of infusion|8|||
163856456|NCT01555762|591844382|FG000|Overall Study|75 years old or more ticked No|1|||
163856457|NCT01555762|591844382|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
163856458|NCT01555762|591844382|FG000|Overall Study|Death linked to progression of disease|165|||
163856459|NCT01555762|591844382|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
163856460|NCT01555762|591844382|FG000|Overall Study|Investigator's decision|10|||
163856461|NCT01555762|591844382|FG000|Overall Study|Participant not wishing to continue|5|||
163856462|NCT01555762|591844382|FG000|Overall Study|Missing data|1|||
163856463|NCT01555762|591844382|FG000|Overall Study|Death linked to an adverse event|14|||
163856464|NCT00819910|591844383|FG000|Overall Study|Adverse Event|0|||
163856465|NCT00819910|591844384|FG001|Overall Study|Adverse Event|0|||
163856466|NCT00819910|591844385|FG002|Overall Study|Adverse Event|2|||
163856467|NCT00819910|591844386|FG003|Overall Study|Adverse Event|1|||
163856468|NCT00819910|591844383|FG000|Overall Study|Withdrawal by Subject|1|||
163856469|NCT00819910|591844384|FG001|Overall Study|Withdrawal by Subject|1|||
163856470|NCT00819910|591844385|FG002|Overall Study|Withdrawal by Subject|1|||
163856471|NCT00819910|591844386|FG003|Overall Study|Withdrawal by Subject|0|||
163856472|NCT00819910|591844383|FG000|Overall Study|Lost to Follow-up|1|||
163856473|NCT00819910|591844384|FG001|Overall Study|Lost to Follow-up|0|||
163856474|NCT00819910|591844385|FG002|Overall Study|Lost to Follow-up|0|||
163856475|NCT00819910|591844386|FG003|Overall Study|Lost to Follow-up|0|||
163856476|NCT00871429|591844389|FG000|Overall Study|Lost to Follow-up|6|||
163856477|NCT00871429|591844389|FG000|Overall Study|Withdrawal by Subject|17|||
163856478|NCT00871429|591844389|FG000|Overall Study|Questionnaire not completed|1|||
163856479|NCT01772719|591844391|FG000|Overall Study|Withdrawal by Subject|3|||
163856480|NCT01772719|591844391|FG000|Overall Study|Adverse Event|2|||
163856481|NCT01772719|591844391|FG000|Overall Study|Protocol Violation|1|||
163856482|NCT01772719|591844391|FG000|Overall Study|Lost to Follow-up|1|||
163856483|NCT00477412|591844396|FG000|Overall Study|Death|0|||
163856484|NCT00477412|591844397|FG001|Overall Study|Death|0|||
163856485|NCT00477412|591844398|FG002|Overall Study|Death|0|||
163856486|NCT00477412|591844399|FG003|Overall Study|Death|4|||
163856487|NCT00477412|591844396|FG000|Overall Study|Lost to Follow-up|0|||
163856488|NCT00477412|591844397|FG001|Overall Study|Lost to Follow-up|0|||
163856489|NCT00477412|591844398|FG002|Overall Study|Lost to Follow-up|0|||
163856490|NCT00477412|591844399|FG003|Overall Study|Lost to Follow-up|1|||
163856491|NCT00477412|591844396|FG000|Overall Study|Withdrawal by Subject|0|||
163856492|NCT00477412|591844397|FG001|Overall Study|Withdrawal by Subject|0|||
163856493|NCT00477412|591844398|FG002|Overall Study|Withdrawal by Subject|0|||
163856494|NCT00477412|591844399|FG003|Overall Study|Withdrawal by Subject|2|||
163856495|NCT00477412|591844396|FG000|Overall Study|Second Malignancy|0|||
163856496|NCT00477412|591844397|FG001|Overall Study|Second Malignancy|0|||
163856497|NCT00477412|591844398|FG002|Overall Study|Second Malignancy|0|||
163856498|NCT00477412|591844399|FG003|Overall Study|Second Malignancy|1|||
163856499|NCT00477412|591844396|FG000|Overall Study|Adverse Event|1|||
163856500|NCT00477412|591844397|FG001|Overall Study|Adverse Event|0|||
163856501|NCT00477412|591844398|FG002|Overall Study|Adverse Event|1|||
163856502|NCT00477412|591844399|FG003|Overall Study|Adverse Event|0|||
163856503|NCT00299702|591844402|FG000|Overall Study|Death|1|||
163856504|NCT00299702|591844403|FG001|Overall Study|Death|0|||
163856505|NCT00299702|591844402|FG000|Overall Study|Adverse Event|0|||
163856506|NCT00299702|591844403|FG001|Overall Study|Adverse Event|4|||
163856507|NCT00299702|591844402|FG000|Overall Study|Lost to Follow-up|18|||
163856508|NCT00299702|591844403|FG001|Overall Study|Lost to Follow-up|10|||
163856509|NCT00299702|591844402|FG000|Overall Study|Withdrawal by Subject|25|||
163856510|NCT00299702|591844403|FG001|Overall Study|Withdrawal by Subject|23|||
163856511|NCT00299702|591844402|FG000|Overall Study|Pregnancy|0|||
163856512|NCT00299702|591844403|FG001|Overall Study|Pregnancy|1|||
163856513|NCT00299702|591844402|FG000|Overall Study|Insufficient Response|4|||
163856514|NCT00299702|591844403|FG001|Overall Study|Insufficient Response|3|||
163856515|NCT00299702|591844402|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
163856516|NCT00299702|591844403|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
163856517|NCT01560949|591844404|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
163856518|NCT01560949|591844404|FG000|Surgery Phase|Physician Decision|3|||
163856519|NCT02931396|591844407|FG000|Overall Study|Lost to Follow-up|3|||
163856520|NCT02931396|591844408|FG001|Overall Study|Lost to Follow-up|0|||
163856521|NCT02931396|591844407|FG000|Overall Study|Withdrawal by Subject|2|||
163856522|NCT02931396|591844408|FG001|Overall Study|Withdrawal by Subject|0|||
163856523|NCT05460663|591844411|FG000|Overall Study|Withdrawal by Subject|2|||
163856524|NCT05460663|591844412|FG001|Overall Study|Withdrawal by Subject|5|||
163856525|NCT00670540|591844413|FG000|Overall Study|ineligible|17|||
163856526|NCT00670540|591844413|FG000|Overall Study|not living in France|348|||
163856527|NCT00670540|591844413|FG000|Overall Study|refused to participate|189|||
163856528|NCT00670540|591844413|FG000|Overall Study|controls randomised for no follow up|2770|||
163856529|NCT00670540|591844413|FG000|Overall Study|missing information inclusion criteria|1|||
163856530|NCT00681811|591844414|FG000|Overall Study|Adverse Event|1|||
163856531|NCT00681811|591844415|FG001|Overall Study|Adverse Event|1|||
163856532|NCT00681811|591844414|FG000|Overall Study|Withdrawal by Subject|2|||
164194182|NCT02154139|593079362|FG000|Overall Study|Injection not administered|2|||
164194183|NCT02154139|593079362|FG000|Overall Study|Other|2|||
164194184|NCT02154139|593079362|FG000|Overall Study|Investigator transferred|3|||
164194185|NCT00473655|593079365|FG000|Overall Study|Lost to Follow-up|9|||
164194186|NCT00473655|593079366|FG001|Overall Study|Lost to Follow-up|5|||
164194187|NCT00473655|593079367|FG002|Overall Study|Lost to Follow-up|8|||
164194188|NCT00807885|593079382|FG000|Overall Study|Lost to Follow-up|0|||
164194189|NCT00807885|593079383|FG001|Overall Study|Lost to Follow-up|0|||
164194190|NCT00807885|593079384|FG002|Overall Study|Lost to Follow-up|0|||
164194191|NCT00807885|593079385|FG003|Overall Study|Lost to Follow-up|0|||
164194192|NCT00807885|593079386|FG004|Overall Study|Lost to Follow-up|0|||
164194193|NCT00807885|593079387|FG005|Overall Study|Lost to Follow-up|1|||
163856533|NCT00681811|591844415|FG001|Overall Study|Withdrawal by Subject|2|||
163856534|NCT00681811|591844414|FG000|Overall Study|Non-compliance|0|||
163856535|NCT00681811|591844415|FG001|Overall Study|Non-compliance|1|||
163856536|NCT01866917|591844422|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
163856537|NCT01866917|591844423|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
163856538|NCT01140347|591844424|FG000|Overall Study|Lost to Follow-up|5|||
163856539|NCT01140347|591844425|FG001|Overall Study|Lost to Follow-up|6|||
163856540|NCT01140347|591844424|FG000|Overall Study|Withdrawal by Subject|13|||
163856541|NCT01140347|591844425|FG001|Overall Study|Withdrawal by Subject|8|||
163856542|NCT00828919|591844426|FG000|Overall Study|Death|0|||
163964938|NCT01109173|592244776|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
163964939|NCT01109173|592244773|FG000|Overall Study|Not Specifiied|5|||
163856543|NCT00828919|591844427|FG001|Overall Study|Death|1|||
163856544|NCT00828919|591844428|FG002|Overall Study|Death|2|||
163856545|NCT00828919|591844429|FG003|Overall Study|Death|0|||
164194194|NCT00807885|593079388|FG006|Overall Study|Lost to Follow-up|0|||
164194195|NCT00807885|593079389|FG007|Overall Study|Lost to Follow-up|0|||
164194196|NCT00807885|593079390|FG008|Overall Study|Lost to Follow-up|0|||
164194197|NCT02899065|593079391|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
164194198|NCT02899065|593079392|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
164194199|NCT02899065|593079391|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
164194200|NCT02899065|593079392|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
164194201|NCT02899065|593079391|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
164194202|NCT02899065|593079392|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
164194203|NCT00186485|593079394|FG000|Overall Study|Lost to Follow-up|3|||
164194204|NCT01166750|593079395|FG000|Overall Study|Lost to Follow-up|1|||
164194205|NCT01166750|593079396|FG001|Overall Study|Lost to Follow-up|0|||
164194206|NCT05225389|593079397|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
164194207|NCT02417753|593079398|FG000|Overall Study|Death|1|||
164194208|NCT04805671|593079399|FG000|Overall Study|Death|2|||
164194209|NCT04805671|593079400|FG001|Overall Study|Death|7|||
164194210|NCT04805671|593079399|FG000|Overall Study|Lost to Follow-up|1|||
164194211|NCT04805671|593079400|FG001|Overall Study|Lost to Follow-up|0|||
164194212|NCT04805671|593079399|FG000|Overall Study|Withdrawal by Subject|9|||
164194213|NCT04805671|593079400|FG001|Overall Study|Withdrawal by Subject|7|||
164194214|NCT04805671|593079399|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
164194215|NCT04805671|593079400|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
164194216|NCT03804268|593079401|FG000|Overall Study|Adverse Event|2|||
164194217|NCT03804268|593079402|FG001|Overall Study|Adverse Event|2|||
164194218|NCT03804268|593079401|FG000|Overall Study|Withdrawal by Subject|2|||
164194219|NCT03804268|593079402|FG001|Overall Study|Withdrawal by Subject|0|||
164194220|NCT03804268|593079401|FG000|Overall Study|Lost to Follow-up|1|||
164194221|NCT03804268|593079402|FG001|Overall Study|Lost to Follow-up|0|||
164194222|NCT03804268|593079401|FG000|Overall Study|Physician Decision|2|||
164194223|NCT03804268|593079402|FG001|Overall Study|Physician Decision|0|||
164194224|NCT02849587|593079403|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
164194225|NCT02849587|593079404|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
164194226|NCT02849587|593079405|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
164194227|NCT02849587|593079403|FG000|Overall Study|Withdrawal by Subject|0|||
164194228|NCT02849587|593079404|FG001|Overall Study|Withdrawal by Subject|1|||
164194229|NCT02849587|593079405|FG002|Overall Study|Withdrawal by Subject|0|||
164194230|NCT03380377|593079406|FG000|Overall Study|Physician Decision|1|||
164194231|NCT03380377|593079406|FG000|Overall Study|Withdrawal by Subject|1|||
164194232|NCT00385918|593079407|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
164194233|NCT00385918|593079408|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
164194234|NCT00385918|593079409|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
164194235|NCT00385918|593079407|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
164194236|NCT00385918|593079408|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
164194237|NCT00385918|593079409|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
164194238|NCT00385918|593079407|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
164194239|NCT00385918|593079408|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
164194240|NCT00385918|593079409|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
164194241|NCT00385918|593079407|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
164194242|NCT00385918|593079408|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
164194243|NCT00385918|593079409|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
164194244|NCT00385918|593079407|FG000|Intervention Phase After Randomization|Physician Decision|1|||
163856546|NCT00828919|591844430|FG004|Overall Study|Death|0|||
163856547|NCT00828919|591844426|FG000|Overall Study|Adverse Event|2|||
163856548|NCT00828919|591844427|FG001|Overall Study|Adverse Event|2|||
163856549|NCT00828919|591844428|FG002|Overall Study|Adverse Event|2|||
163856550|NCT00828919|591844429|FG003|Overall Study|Adverse Event|1|||
163856551|NCT00828919|591844430|FG004|Overall Study|Adverse Event|3|||
163856552|NCT00828919|591844426|FG000|Overall Study|Objective progression or relapse|4|||
163856553|NCT00828919|591844427|FG001|Overall Study|Objective progression or relapse|4|||
163856554|NCT00828919|591844428|FG002|Overall Study|Objective progression or relapse|11|||
163856555|NCT00828919|591844429|FG003|Overall Study|Objective progression or relapse|0|||
163856556|NCT00828919|591844430|FG004|Overall Study|Objective progression or relapse|5|||
163856557|NCT00828919|591844426|FG000|Overall Study|No longer willing to participate in study|0|||
163856558|NCT00828919|591844427|FG001|Overall Study|No longer willing to participate in study|0|||
164194245|NCT00385918|593079408|FG001|Intervention Phase After Randomization|Physician Decision|0|||
164194246|NCT00385918|593079409|FG002|Intervention Phase After Randomization|Physician Decision|0|||
163856559|NCT00828919|591844428|FG002|Overall Study|No longer willing to participate in study|2|||
163856560|NCT00828919|591844429|FG003|Overall Study|No longer willing to participate in study|0|||
163856561|NCT00828919|591844430|FG004|Overall Study|No longer willing to participate in study|0|||
163964940|NCT01109173|592244774|FG001|Overall Study|Not Specifiied|4|||
163856562|NCT00828919|591844426|FG000|Overall Study|Insufficient Clinical Response|0|||
163856563|NCT00828919|591844427|FG001|Overall Study|Insufficient Clinical Response|1|||
163856564|NCT00828919|591844428|FG002|Overall Study|Insufficient Clinical Response|2|||
163856565|NCT00828919|591844429|FG003|Overall Study|Insufficient Clinical Response|0|||
163856566|NCT00828919|591844430|FG004|Overall Study|Insufficient Clinical Response|0|||
163856567|NCT00828919|591844426|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163856568|NCT00828919|591844427|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163856569|NCT00828919|591844428|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163856570|NCT00828919|591844429|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
163856571|NCT00828919|591844430|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
163856572|NCT00828919|591844426|FG000|Overall Study|Other|1|||
163856573|NCT00828919|591844427|FG001|Overall Study|Other|0|||
163856574|NCT00828919|591844428|FG002|Overall Study|Other|1|||
163856575|NCT00828919|591844429|FG003|Overall Study|Other|1|||
163856576|NCT00828919|591844430|FG004|Overall Study|Other|0|||
163856577|NCT00828919|591844426|FG000|Overall Study|Lost to Follow-up|0|||
163856578|NCT00828919|591844427|FG001|Overall Study|Lost to Follow-up|1|||
163856579|NCT00828919|591844428|FG002|Overall Study|Lost to Follow-up|0|||
163856580|NCT00828919|591844429|FG003|Overall Study|Lost to Follow-up|0|||
163856581|NCT00828919|591844430|FG004|Overall Study|Lost to Follow-up|0|||
163856582|NCT01562743|591844435|FG000|Overall Study|Adverse Event|29|||
163856583|NCT01562743|591844435|FG000|Overall Study|Lack of Efficacy|3|||
163856584|NCT01562743|591844435|FG000|Overall Study|Withdrawal by Subject|13|||
163856585|NCT01562743|591844435|FG000|Overall Study|Protocol Violation|1|||
163856586|NCT01562743|591844435|FG000|Overall Study|Discontinuation criteria|2|||
163856587|NCT01562743|591844435|FG000|Overall Study|Lost to Follow-up|2|||
163856588|NCT01562743|591844435|FG000|Overall Study|Physician Decision|2|||
163856589|NCT05567159|591844436|FG000|Overall Study|Adverse Event|4|||
163856590|NCT05567159|591844436|FG000|Overall Study|Physician Decision|3|||
163856591|NCT05567159|591844436|FG000|Overall Study|Protocol deviation|1|||
163856592|NCT00662909|591844438|FG000|Overall Study|Adverse Event|17|||
163856593|NCT00662909|591844439|FG001|Overall Study|Adverse Event|18|||
163856594|NCT00662909|591844440|FG002|Overall Study|Adverse Event|19|||
163856595|NCT00662909|591844438|FG000|Overall Study|Lack of Efficacy|9|||
163856596|NCT00662909|591844439|FG001|Overall Study|Lack of Efficacy|1|||
163856597|NCT00662909|591844440|FG002|Overall Study|Lack of Efficacy|5|||
163856598|NCT00662909|591844438|FG000|Overall Study|Withdrawal by Subject|29|||
163856599|NCT00662909|591844439|FG001|Overall Study|Withdrawal by Subject|22|||
163856600|NCT00662909|591844440|FG002|Overall Study|Withdrawal by Subject|16|||
163856601|NCT00662909|591844438|FG000|Overall Study|Lost to Follow-up|2|||
163856602|NCT00662909|591844439|FG001|Overall Study|Lost to Follow-up|9|||
163856603|NCT00662909|591844440|FG002|Overall Study|Lost to Follow-up|3|||
163856604|NCT00662909|591844438|FG000|Overall Study|Protocol Violation|7|||
163856605|NCT00662909|591844439|FG001|Overall Study|Protocol Violation|4|||
163856606|NCT00662909|591844440|FG002|Overall Study|Protocol Violation|5|||
163856607|NCT00662909|591844438|FG000|Overall Study|Randomized- never received study drug|1|||
163856608|NCT00662909|591844439|FG001|Overall Study|Randomized- never received study drug|0|||
163856609|NCT00662909|591844440|FG002|Overall Study|Randomized- never received study drug|0|||
163856610|NCT00662909|591844438|FG000|Overall Study|Non-compliance with study procedures|3|||
163856611|NCT00662909|591844439|FG001|Overall Study|Non-compliance with study procedures|3|||
163856612|NCT00662909|591844440|FG002|Overall Study|Non-compliance with study procedures|2|||
163856613|NCT00662909|591844438|FG000|Overall Study|Physician Decision|1|||
163856614|NCT00662909|591844439|FG001|Overall Study|Physician Decision|1|||
163856615|NCT00662909|591844440|FG002|Overall Study|Physician Decision|2|||
163856616|NCT00662909|591844438|FG000|Overall Study|Eligibility criterion not met|0|||
163856617|NCT00662909|591844439|FG001|Overall Study|Eligibility criterion not met|1|||
163856618|NCT00662909|591844440|FG002|Overall Study|Eligibility criterion not met|1|||
163856619|NCT03396835|591846114|FG000|Overall Study|Withdrawn prior to completion|1|||
163856620|NCT03396835|591846114|FG000|Overall Study|Did not meet criteria for data analysis|1|||
163856621|NCT03467724|591846115|FG000|Overall Study|Lost to Follow-up|5|||
163856622|NCT03467724|591846115|FG000|Overall Study|Withdrawal by Subject|1|||
163856623|NCT03467724|591846115|FG000|Overall Study|Protocol Violation|1|||
163856624|NCT03467724|591846115|FG000|Overall Study|Adverse Event|1|||
163856625|NCT01451814|591846116|FG000|Overall Study|Withdrawal by Subject|1|||
163856626|NCT01451814|591846117|FG001|Overall Study|Withdrawal by Subject|1|||
163856627|NCT01451814|591846116|FG000|Overall Study|Lost to Follow-up|5|||
163856628|NCT01451814|591846117|FG001|Overall Study|Lost to Follow-up|4|||
163856629|NCT02049866|591846118|FG000|Overall Study|Withdrawal by Subject|1|||
163856630|NCT00918957|591846121|FG000|Overall Study|Adverse Event|2|||
163856631|NCT00918957|591846122|FG001|Overall Study|Adverse Event|0|||
163856632|NCT00918957|591846121|FG000|Overall Study|Withdrawal by Subject|1|||
163856633|NCT00918957|591846122|FG001|Overall Study|Withdrawal by Subject|0|||
163856634|NCT03107611|591846123|FG000|Overall Study|Adverse Event|1|||
163856635|NCT03107611|591846124|FG001|Overall Study|Adverse Event|0|||
163856636|NCT03107611|591846125|FG002|Overall Study|Adverse Event|2|||
163856637|NCT03107611|591846123|FG000|Overall Study|Lost to Follow-up|3|||
163856638|NCT03107611|591846124|FG001|Overall Study|Lost to Follow-up|3|||
163856639|NCT03107611|591846125|FG002|Overall Study|Lost to Follow-up|3|||
163856640|NCT03107611|591846123|FG000|Overall Study|Protocol Violation|0|||
163856641|NCT03107611|591846124|FG001|Overall Study|Protocol Violation|0|||
163856642|NCT03107611|591846125|FG002|Overall Study|Protocol Violation|1|||
163856643|NCT03107611|591846123|FG000|Overall Study|Withdrawal by Subject|1|||
163856644|NCT03107611|591846124|FG001|Overall Study|Withdrawal by Subject|0|||
163856645|NCT03107611|591846125|FG002|Overall Study|Withdrawal by Subject|1|||
163856646|NCT03107611|591846123|FG000|Overall Study|Worsening signs/symptoms|2|||
163856647|NCT03107611|591846124|FG001|Overall Study|Worsening signs/symptoms|1|||
163856648|NCT03107611|591846125|FG002|Overall Study|Worsening signs/symptoms|2|||
163856649|NCT01020838|591846128|FG000|Overall Study|Death|90|||
163856650|NCT01020838|591846128|FG000|Overall Study|Adverse Event|1|||
163856651|NCT01020838|591846128|FG000|Overall Study|Withdrawal by Subject|9|||
163856652|NCT01020838|591846128|FG000|Overall Study|Lost to Follow-up|6|||
163856653|NCT01020838|591846128|FG000|Overall Study|Most common: Study ended by sponsor|77|||
163856654|NCT04176458|591846129|FG000|Overall Study|Covid 19|4|||
163856655|NCT00891618|591846130|FG000|Overall Study|Withdrawal by Subject|1|||
163856656|NCT02145182|591846131|FG000|Overall Study|Adverse Event|4|||
163856657|NCT02145182|591846132|FG001|Overall Study|Adverse Event|1|||
163856658|NCT02145182|591846131|FG000|Overall Study|Death|7|||
163856659|NCT02145182|591846132|FG001|Overall Study|Death|7|||
163856660|NCT02145182|591846131|FG000|Overall Study|Lost to Follow-up|2|||
163856661|NCT02145182|591846132|FG001|Overall Study|Lost to Follow-up|2|||
163856662|NCT02145182|591846131|FG000|Overall Study|Pre-transplant Withdrawal|0|||
163856663|NCT02145182|591846132|FG001|Overall Study|Pre-transplant Withdrawal|2|||
163856664|NCT02145182|591846131|FG000|Overall Study|Withdrawal by Subject|5|||
163856665|NCT02145182|591846132|FG001|Overall Study|Withdrawal by Subject|4|||
163856666|NCT03586167|591846133|FG000|Overall Study|Other|1|||
163856667|NCT03586167|591846134|FG001|Overall Study|Other|0|||
163856668|NCT03537651|591846137|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
163856669|NCT03537651|591846137|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
163856670|NCT03537651|591846137|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
163856671|NCT03537651|591846137|FG000|Part A (Up to 96 Weeks)|Other|1|||
163856672|NCT03537651|591846137|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
163856673|NCT03537651|591846137|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
163856674|NCT03537651|591846137|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
163856675|NCT03537651|591846137|FG000|Part B (Up to 192 Weeks)|Other|1|||
163856676|NCT05487703|591846138|FG000|Overall Study|Other|19|||
163856677|NCT05487703|591846138|FG000|Overall Study|Participant not well|5|||
163856678|NCT05487703|591846138|FG000|Overall Study|Insurance Reasons|6|||
163856679|NCT05487703|591846138|FG000|Overall Study|Physician Decision|19|||
163856680|NCT05487703|591846138|FG000|Overall Study|Lack of Efficacy|60|||
163856681|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
163856682|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
163856683|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
163856684|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Death|3|||
163856685|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Death|0|||
163856686|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Death|0|||
163856687|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
163856688|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163856689|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
163856690|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
163856691|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
163856692|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
163856693|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
163856694|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
163856695|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
163856696|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
163856697|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
163856698|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
163856699|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
163856700|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
163856701|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
163856702|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Other|1|||
163856703|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Other|0|||
163856704|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Other|0|||
163856705|NCT02403323|591846139|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
163856706|NCT02403323|591846140|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
163856707|NCT02403323|591846141|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
163856708|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163856709|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
163856710|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
163856711|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
163856712|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
163856713|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
163856714|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
163856715|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
163856716|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
163856717|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163856718|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
163856719|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
163856720|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
163856721|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
163856722|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
163856723|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
163856724|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
163856725|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
163856726|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
163856727|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
163856728|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
163856729|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
163856730|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
163856731|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
163856732|NCT02403323|591846139|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
163856733|NCT02403323|591846140|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
163856734|NCT02403323|591846141|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
163856735|NCT00197236|591846144|FG000|Overall Study|Adverse Event|1|||
163856736|NCT00197236|591846145|FG001|Overall Study|Adverse Event|0|||
163856737|NCT00197236|591846146|FG002|Overall Study|Adverse Event|1|||
163856738|NCT00197236|591846144|FG000|Overall Study|Lost to Follow-up|5|||
163856739|NCT00197236|591846145|FG001|Overall Study|Lost to Follow-up|14|||
163856740|NCT00197236|591846146|FG002|Overall Study|Lost to Follow-up|6|||
163856741|NCT00197236|591846144|FG000|Overall Study|Protocol Violation|0|||
163856742|NCT00197236|591846145|FG001|Overall Study|Protocol Violation|0|||
163856743|NCT00197236|591846146|FG002|Overall Study|Protocol Violation|1|||
163856744|NCT00197236|591846144|FG000|Overall Study|Withdrawal by Subject|7|||
163856745|NCT00197236|591846145|FG001|Overall Study|Withdrawal by Subject|3|||
163856746|NCT00197236|591846146|FG002|Overall Study|Withdrawal by Subject|11|||
163856747|NCT00197236|591846144|FG000|Overall Study|Study drug/medication expiration|1|||
163856748|NCT00197236|591846145|FG001|Overall Study|Study drug/medication expiration|0|||
163856749|NCT00197236|591846146|FG002|Overall Study|Study drug/medication expiration|3|||
163856750|NCT00197236|591846144|FG000|Overall Study|Returned out of specified time window|0|||
163856751|NCT00197236|591846145|FG001|Overall Study|Returned out of specified time window|0|||
163856752|NCT00197236|591846146|FG002|Overall Study|Returned out of specified time window|1|||
163856753|NCT00746330|591846147|FG000|Period 1|Abnormal test procedure result|0|||
163856754|NCT00746330|591846148|FG001|Period 1|Abnormal test procedure result|0|||
163856755|NCT00746330|591846149|FG002|Period 1|Abnormal test procedure result|1|||
163856756|NCT00746330|591846150|FG003|Period 1|Abnormal test procedure result|0|||
163856757|NCT01076335|591846151|FG000|Overall Study|Withdrawal by Subject|3|||
163856758|NCT01076335|591846151|FG000|Overall Study|Withdrawal without treatment|1|||
163856759|NCT02524288|591846152|FG000|Overall Study|Adverse Event|115|||
163856760|NCT02524288|591846152|FG000|Overall Study|Lost to Follow-up|216|||
163856761|NCT02524288|591846152|FG000|Overall Study|Non-Compliance With Protocol|32|||
163856762|NCT02524288|591846152|FG000|Overall Study|Non-Compliance With Study Drug|14|||
164194247|NCT00385918|593079407|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
164194248|NCT00385918|593079408|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
164194249|NCT00385918|593079409|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
164194250|NCT00128661|593079410|FG000|Overall Study|Adverse Event|14|||
164194251|NCT00128661|593079411|FG001|Overall Study|Adverse Event|11|||
164194252|NCT00128661|593079410|FG000|Overall Study|Lost to Follow-up|10|||
164194253|NCT00128661|593079411|FG001|Overall Study|Lost to Follow-up|7|||
164194254|NCT00128661|593079410|FG000|Overall Study|Withdrawal by Subject|243|||
164194255|NCT00128661|593079411|FG001|Overall Study|Withdrawal by Subject|232|||
164194256|NCT00128661|593079410|FG000|Overall Study|Other|7|||
164194257|NCT00128661|593079411|FG001|Overall Study|Other|8|||
164194258|NCT01261390|593079412|FG000|Overall Study|Significant Concurrent Illness|1|||
164194259|NCT01261390|593079413|FG001|Overall Study|Significant Concurrent Illness|0|||
163856763|NCT02524288|591846152|FG000|Overall Study|Pregnancy Wish|6|||
164194260|NCT01261390|593079414|FG002|Overall Study|Significant Concurrent Illness|1|||
164194261|NCT01261390|593079415|FG003|Overall Study|Significant Concurrent Illness|0|||
164194262|NCT01261390|593079412|FG000|Overall Study|Dissatisfaction with Treatment|2|||
163856764|NCT02524288|591846152|FG000|Overall Study|Protocol Violation|6|||
163856765|NCT02524288|591846152|FG000|Overall Study|Screen Failure|2|||
163856766|NCT02524288|591846152|FG000|Overall Study|Site Discontinued Study Participation|1|||
163856767|NCT02524288|591846152|FG000|Overall Study|Study Terminated By Sponsor|1417|||
163856768|NCT02524288|591846152|FG000|Overall Study|Subject Moved|32|||
163856769|NCT02524288|591846152|FG000|Overall Study|Withdrawal by Subject|76|||
163856770|NCT02524288|591846152|FG000|Overall Study|Pregnancy|22|||
163856771|NCT02524288|591846152|FG000|Overall Study|Physician Decision|2|||
163856772|NCT01835899|591846154|FG000|Overall Study|Adverse Event|0|||
163856773|NCT01835899|591846155|FG001|Overall Study|Adverse Event|0|||
163856774|NCT01835899|591846156|FG002|Overall Study|Adverse Event|1|||
163856775|NCT01835899|591846154|FG000|Overall Study|Other than stated above|0|||
163856776|NCT01835899|591846155|FG001|Overall Study|Other than stated above|1|||
163856777|NCT01835899|591846156|FG002|Overall Study|Other than stated above|0|||
163856778|NCT02616263|591846157|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
163856779|NCT02616263|591846158|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
163856780|NCT02616263|591846157|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
163856781|NCT02616263|591846158|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
163856782|NCT02616263|591846157|FG000|6 Month to 1.5 Year|Death|1|||
163856783|NCT02616263|591846158|FG001|6 Month to 1.5 Year|Death|0|||
163856784|NCT02616263|591846157|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
163856785|NCT02616263|591846158|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
163856786|NCT02616263|591846157|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
163856787|NCT02616263|591846158|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
163856788|NCT02616263|591846157|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
163856789|NCT02616263|591846158|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
163856790|NCT02939183|591846164|FG000|Overall Study|Death|0|||
163856791|NCT02939183|591846165|FG001|Overall Study|Death|0|||
163856792|NCT02939183|591846166|FG002|Overall Study|Death|1|||
163856793|NCT02939183|591846167|FG003|Overall Study|Death|0|||
163856794|NCT02939183|591846168|FG004|Overall Study|Death|0|||
163856795|NCT02939183|591846169|FG005|Overall Study|Death|2|||
163856796|NCT02939183|591846170|FG006|Overall Study|Death|1|||
163856797|NCT02939183|591846171|FG007|Overall Study|Death|0|||
163856798|NCT02939183|591846172|FG008|Overall Study|Death|0|||
163856799|NCT02939183|591846164|FG000|Overall Study|Sponsor decision|0|||
163856800|NCT02939183|591846165|FG001|Overall Study|Sponsor decision|1|||
163856801|NCT02939183|591846166|FG002|Overall Study|Sponsor decision|0|||
163856802|NCT02939183|591846167|FG003|Overall Study|Sponsor decision|1|||
163856803|NCT02939183|591846168|FG004|Overall Study|Sponsor decision|2|||
163856804|NCT02939183|591846169|FG005|Overall Study|Sponsor decision|0|||
163856805|NCT02939183|591846170|FG006|Overall Study|Sponsor decision|3|||
163856806|NCT02939183|591846171|FG007|Overall Study|Sponsor decision|1|||
163856807|NCT02939183|591846172|FG008|Overall Study|Sponsor decision|4|||
163856808|NCT02939183|591846164|FG000|Overall Study|Withdrawal by Subject|0|||
163856809|NCT02939183|591846165|FG001|Overall Study|Withdrawal by Subject|2|||
163856810|NCT02939183|591846166|FG002|Overall Study|Withdrawal by Subject|0|||
163856811|NCT02939183|591846167|FG003|Overall Study|Withdrawal by Subject|1|||
163856812|NCT02939183|591846168|FG004|Overall Study|Withdrawal by Subject|0|||
163856813|NCT02939183|591846169|FG005|Overall Study|Withdrawal by Subject|0|||
163856814|NCT02939183|591846170|FG006|Overall Study|Withdrawal by Subject|2|||
163856815|NCT02939183|591846171|FG007|Overall Study|Withdrawal by Subject|2|||
163856816|NCT02939183|591846172|FG008|Overall Study|Withdrawal by Subject|2|||
163856817|NCT02939183|591846164|FG000|Overall Study|Not treated due to adverse event|0|||
163856818|NCT02939183|591846165|FG001|Overall Study|Not treated due to adverse event|0|||
163856819|NCT02939183|591846166|FG002|Overall Study|Not treated due to adverse event|0|||
163856820|NCT02939183|591846167|FG003|Overall Study|Not treated due to adverse event|1|||
163856821|NCT02939183|591846168|FG004|Overall Study|Not treated due to adverse event|0|||
163856822|NCT02939183|591846169|FG005|Overall Study|Not treated due to adverse event|0|||
163856823|NCT02939183|591846170|FG006|Overall Study|Not treated due to adverse event|1|||
163856824|NCT02939183|591846171|FG007|Overall Study|Not treated due to adverse event|0|||
163856825|NCT02939183|591846172|FG008|Overall Study|Not treated due to adverse event|0|||
163856826|NCT05015478|591846173|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
163856827|NCT05015478|591846174|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
163856828|NCT05015478|591846175|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
163856829|NCT05015478|591846176|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
164194263|NCT01261390|593079413|FG001|Overall Study|Dissatisfaction with Treatment|1|||
164194264|NCT01261390|593079414|FG002|Overall Study|Dissatisfaction with Treatment|1|||
163856830|NCT04939428|591846177|FG000|Overall Study|Death|0|||
163856831|NCT04939428|591846178|FG001|Overall Study|Death|1|||
163856832|NCT04939428|591846179|FG002|Overall Study|Death|0|||
163856833|NCT04939428|591846177|FG000|Overall Study|Lost to Follow-up|0|||
164194265|NCT01261390|593079415|FG003|Overall Study|Dissatisfaction with Treatment|2|||
164194266|NCT01261390|593079412|FG000|Overall Study|Relocation|0|||
163856834|NCT04939428|591846178|FG001|Overall Study|Lost to Follow-up|5|||
163856835|NCT04939428|591846179|FG002|Overall Study|Lost to Follow-up|0|||
163856836|NCT04939428|591846177|FG000|Overall Study|Physician Decision|1|||
163856837|NCT04939428|591846178|FG001|Overall Study|Physician Decision|0|||
163856838|NCT04939428|591846179|FG002|Overall Study|Physician Decision|0|||
163856839|NCT04939428|591846177|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163856840|NCT04939428|591846178|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163856841|NCT04939428|591846179|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163856842|NCT04939428|591846177|FG000|Overall Study|Withdrawal by Subject|10|||
163856843|NCT04939428|591846178|FG001|Overall Study|Withdrawal by Subject|11|||
163856844|NCT04939428|591846179|FG002|Overall Study|Withdrawal by Subject|0|||
163856845|NCT04939428|591846177|FG000|Overall Study|Unkown|6|||
163856846|NCT04939428|591846178|FG001|Overall Study|Unkown|3|||
163856847|NCT04939428|591846179|FG002|Overall Study|Unkown|0|||
163856848|NCT04939428|591846177|FG000|Overall Study|Discotinued per protocol|0|||
163856849|NCT04939428|591846178|FG001|Overall Study|Discotinued per protocol|0|||
163856850|NCT04939428|591846179|FG002|Overall Study|Discotinued per protocol|902|||
163856851|NCT04319094|591846182|FG000|Baseline|Lost to Follow-up|4|||
163856852|NCT04319094|591846183|FG001|Baseline|Lost to Follow-up|5|||
163856853|NCT04319094|591846182|FG000|Baseline|Protocol Violation|0|||
163856854|NCT04319094|591846183|FG001|Baseline|Protocol Violation|3|||
163856855|NCT04319094|591846182|FG000|Baseline|Withdrawal by Subject|2|||
163856856|NCT04319094|591846183|FG001|Baseline|Withdrawal by Subject|1|||
163856857|NCT04319094|591846182|FG000|Post-Intervention|Death|0|||
163856858|NCT04319094|591846183|FG001|Post-Intervention|Death|1|||
163856859|NCT04319094|591846182|FG000|Post-Intervention|Lost to Follow-up|4|||
163856860|NCT04319094|591846183|FG001|Post-Intervention|Lost to Follow-up|4|||
163856861|NCT04319094|591846182|FG000|Post-Intervention|Withdrawal by Subject|8|||
163856862|NCT04319094|591846183|FG001|Post-Intervention|Withdrawal by Subject|5|||
163856863|NCT04319094|591846182|FG000|Post-Intervention|Incomplete Data Collection|1|||
163856864|NCT04319094|591846183|FG001|Post-Intervention|Incomplete Data Collection|3|||
163856865|NCT04319094|591846182|FG000|3-month|Death|1|||
163856866|NCT04319094|591846183|FG001|3-month|Death|0|||
163856867|NCT04319094|591846182|FG000|3-month|Lost to Follow-up|2|||
163856868|NCT04319094|591846183|FG001|3-month|Lost to Follow-up|2|||
163856869|NCT04319094|591846182|FG000|3-month|Withdrawal by Subject|0|||
163856870|NCT04319094|591846183|FG001|3-month|Withdrawal by Subject|3|||
163856871|NCT04319094|591846182|FG000|3-month|Incomplete data collection|9|||
163856872|NCT04319094|591846183|FG001|3-month|Incomplete data collection|7|||
163856873|NCT04319094|591846182|FG000|6-month|Lost to Follow-up|1|||
163856874|NCT04319094|591846183|FG001|6-month|Lost to Follow-up|1|||
163856875|NCT04319094|591846182|FG000|6-month|Withdrawal by Subject|0|||
163856876|NCT04319094|591846183|FG001|6-month|Withdrawal by Subject|3|||
163856877|NCT04319094|591846182|FG000|6-month|Incomplete data collection|14|||
163856878|NCT04319094|591846183|FG001|6-month|Incomplete data collection|9|||
163856879|NCT04319094|591846182|FG000|9-month|Lost to Follow-up|8|||
163856880|NCT04319094|591846183|FG001|9-month|Lost to Follow-up|4|||
163856881|NCT04319094|591846182|FG000|9-month|Withdrawal by Subject|0|||
163856882|NCT04319094|591846183|FG001|9-month|Withdrawal by Subject|1|||
163856883|NCT04319094|591846182|FG000|9-month|Incomplete data collection|8|||
163856884|NCT04319094|591846183|FG001|9-month|Incomplete data collection|5|||
163856885|NCT04319094|591846182|FG000|12-month|Lost to Follow-up|11|||
163856886|NCT04319094|591846183|FG001|12-month|Lost to Follow-up|8|||
163856887|NCT00654238|591846187|FG000|Overall Study|Screen Failures|4|||
163856888|NCT03905135|591846189|FG000|Dose Escalation|Adverse Event|1|||
163856889|NCT03905135|591846190|FG001|Dose Escalation|Adverse Event|1|||
163856890|NCT03905135|591846189|FG000|Dose Escalation|Progressive disease|3|||
163856891|NCT03905135|591846190|FG001|Dose Escalation|Progressive disease|1|||
163856892|NCT03905135|591846189|FG000|Dose Escalation|Intercurrent illness|1|||
163856893|NCT03905135|591846190|FG001|Dose Escalation|Intercurrent illness|0|||
163856894|NCT04523181|591846191|FG000|Overall Study|Withdrawal by Subject|4|||
163856895|NCT04523181|591846192|FG001|Overall Study|Withdrawal by Subject|5|||
163856896|NCT04523181|591846191|FG000|Overall Study|Lost to Follow-up|2|||
163856897|NCT04523181|591846192|FG001|Overall Study|Lost to Follow-up|3|||
163856898|NCT04523181|591846191|FG000|Overall Study|Physician Decision|1|||
163856899|NCT04523181|591846192|FG001|Overall Study|Physician Decision|0|||
163856900|NCT04523181|591846191|FG000|Overall Study|Transferred to external facility.|1|||
163856901|NCT04523181|591846192|FG001|Overall Study|Transferred to external facility.|1|||
163856902|NCT02042443|591846195|FG000|Overall Study|Adverse Event|2|||
163856903|NCT02042443|591846196|FG001|Overall Study|Adverse Event|1|||
163856904|NCT02042443|591846195|FG000|Overall Study|Withdrawal by Subject|0|||
163856905|NCT02042443|591846196|FG001|Overall Study|Withdrawal by Subject|1|||
163856906|NCT02042443|591846195|FG000|Overall Study|Progression|21|||
163856907|NCT02042443|591846196|FG001|Overall Study|Progression|17|||
163964941|NCT01109173|592244775|FG002|Overall Study|Not Specifiied|9|||
163964942|NCT01109173|592244776|FG003|Overall Study|Not Specifiied|14|||
163856908|NCT02042443|591846195|FG000|Overall Study|not protocol specified|1|||
163856909|NCT02042443|591846196|FG001|Overall Study|not protocol specified|1|||
163856910|NCT02042443|591846195|FG000|Overall Study|Not eligible/not analyzable|3|||
163856911|NCT02042443|591846196|FG001|Overall Study|Not eligible/not analyzable|6|||
163856912|NCT01649427|591846197|FG000|Overall Study|Adverse Event|1|||
163856913|NCT01649427|591846198|FG001|Overall Study|Adverse Event|1|||
163856914|NCT01649427|591846197|FG000|Overall Study|Withdrawal by Subject|8|||
163856915|NCT01649427|591846198|FG001|Overall Study|Withdrawal by Subject|7|||
163856916|NCT01649427|591846197|FG000|Overall Study|Lost to Follow-up|0|||
163856917|NCT01649427|591846198|FG001|Overall Study|Lost to Follow-up|1|||
163856918|NCT01649427|591846197|FG000|Overall Study|Graft loss|0|||
163856919|NCT01649427|591846198|FG001|Overall Study|Graft loss|1|||
163856920|NCT01649427|591846197|FG000|Overall Study|Surgical problems during nephrectomy|2|||
163856921|NCT01649427|591846198|FG001|Overall Study|Surgical problems during nephrectomy|2|||
163856922|NCT02138916|591846201|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
163856923|NCT02138916|591846202|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
163856924|NCT02138916|591846203|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
163856925|NCT02138916|591846201|FG000|Overall Study|Death|14|||
163964943|NCT01132612|592244780|FG000|Overall Study|Death|0|||
164194267|NCT01261390|593079413|FG001|Overall Study|Relocation|1|||
164194268|NCT01261390|593079414|FG002|Overall Study|Relocation|0|||
164194269|NCT01261390|593079415|FG003|Overall Study|Relocation|0|||
164194270|NCT01261390|593079412|FG000|Overall Study|Loss of Interest in the Study|3|||
164194271|NCT01261390|593079413|FG001|Overall Study|Loss of Interest in the Study|1|||
164194272|NCT01261390|593079414|FG002|Overall Study|Loss of Interest in the Study|0|||
164194273|NCT01261390|593079415|FG003|Overall Study|Loss of Interest in the Study|0|||
164194274|NCT01261390|593079412|FG000|Overall Study|Lost to Follow-up|1|||
164194275|NCT01261390|593079413|FG001|Overall Study|Lost to Follow-up|6|||
164194276|NCT01261390|593079414|FG002|Overall Study|Lost to Follow-up|5|||
164194277|NCT01261390|593079415|FG003|Overall Study|Lost to Follow-up|6|||
164194278|NCT01951417|593079417|FG000|Overall Study|Withdrawal by Subject|1|||
164194279|NCT01951417|593079417|FG000|Overall Study|Protocol Violation|2|||
164194280|NCT01951417|593079417|FG000|Overall Study|Lost to Follow-up|6|||
164194281|NCT04010461|593079418|FG000|Overall Study|COVID based withdrawal|5|||
164194282|NCT04010461|593079418|FG000|Overall Study|Withdrawal by Subject|5|||
164194283|NCT04010461|593079418|FG000|Overall Study|Adverse Event|1|||
164194284|NCT04010461|593079418|FG000|Overall Study|No Motor Threshold obtainable|1|||
164194285|NCT04010461|593079418|FG000|Overall Study|Physician Decision|1|||
164194286|NCT01026948|593079419|FG000|Overall Study|Physician Decision|8|||
164194287|NCT03360019|593079423|FG000|Overall Study|Withdrawal by Subject|2|||
164194288|NCT03360019|593079424|FG001|Overall Study|Withdrawal by Subject|0|||
164194289|NCT03360019|593079425|FG002|Overall Study|Withdrawal by Subject|0|||
164194290|NCT03360019|593079423|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
164194291|NCT03360019|593079424|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
164194292|NCT03360019|593079425|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
164194293|NCT00753675|593079428|FG000|Overall Study|other reason|11|||
164194294|NCT00753675|593079429|FG001|Overall Study|other reason|12|||
164194295|NCT00753675|593079430|FG002|Overall Study|other reason|13|||
164194296|NCT00753675|593079428|FG000|Overall Study|Death|1|||
164194297|NCT00753675|593079429|FG001|Overall Study|Death|2|||
164194298|NCT00753675|593079430|FG002|Overall Study|Death|4|||
164194299|NCT00753675|593079428|FG000|Overall Study|Adverse Event|11|||
164194300|NCT00753675|593079429|FG001|Overall Study|Adverse Event|9|||
164194301|NCT00753675|593079430|FG002|Overall Study|Adverse Event|4|||
164194302|NCT00753675|593079428|FG000|Overall Study|Objective progression of disease|35|||
164194303|NCT00753675|593079429|FG001|Overall Study|Objective progression of disease|35|||
164194304|NCT00753675|593079430|FG002|Overall Study|Objective progression of disease|35|||
164194305|NCT00753675|593079428|FG000|Overall Study|Withdrawal by Subject|0|||
164194306|NCT00753675|593079429|FG001|Overall Study|Withdrawal by Subject|1|||
164194307|NCT00753675|593079430|FG002|Overall Study|Withdrawal by Subject|0|||
164194308|NCT00753675|593079428|FG000|Overall Study|Lost to Follow-up|1|||
164194309|NCT00753675|593079429|FG001|Overall Study|Lost to Follow-up|0|||
164194310|NCT00753675|593079430|FG002|Overall Study|Lost to Follow-up|0|||
164194311|NCT02106351|593079435|FG000|Treatment Cycle 1|Adverse Event|2|||
164194312|NCT02106351|593079436|FG001|Treatment Cycle 1|Adverse Event|0|||
163964944|NCT01132612|592244781|FG001|Overall Study|Death|0|||
164194313|NCT02106351|593079437|FG002|Treatment Cycle 1|Adverse Event|0|||
164194314|NCT02106351|593079435|FG000|Treatment Cycle 1|Consent withdrawn|1|||
164194315|NCT02106351|593079436|FG001|Treatment Cycle 1|Consent withdrawn|0|||
164194316|NCT02106351|593079437|FG002|Treatment Cycle 1|Consent withdrawn|2|||
164194317|NCT02106351|593079435|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
164194318|NCT02106351|593079436|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
164194319|NCT02106351|593079437|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
164194320|NCT02106351|593079435|FG000|Treatment Cycle 1|Other|0|||
164194321|NCT02106351|593079436|FG001|Treatment Cycle 1|Other|3|||
164194322|NCT02106351|593079437|FG002|Treatment Cycle 1|Other|1|||
164194323|NCT02106351|593079435|FG000|Treatment Cycle 1|Randomised but not treated|1|||
164194324|NCT02106351|593079436|FG001|Treatment Cycle 1|Randomised but not treated|0|||
164194325|NCT02106351|593079437|FG002|Treatment Cycle 1|Randomised but not treated|1|||
163856926|NCT02138916|591846202|FG001|Overall Study|Death|11|||
163856927|NCT02138916|591846203|FG002|Overall Study|Death|12|||
163856928|NCT02138916|591846201|FG000|Overall Study|Withdrawal by Subject|27|||
163964945|NCT01132612|592244782|FG002|Overall Study|Death|1|||
163856929|NCT02138916|591846202|FG001|Overall Study|Withdrawal by Subject|31|||
163856930|NCT02138916|591846203|FG002|Overall Study|Withdrawal by Subject|32|||
163856931|NCT02138916|591846201|FG000|Overall Study|Study specific withdrawal criteria|0|||
163856932|NCT02138916|591846202|FG001|Overall Study|Study specific withdrawal criteria|0|||
163856933|NCT02138916|591846203|FG002|Overall Study|Study specific withdrawal criteria|1|||
163856934|NCT02138916|591846201|FG000|Overall Study|incorrect enrolment|1|||
163856935|NCT02138916|591846202|FG001|Overall Study|incorrect enrolment|1|||
163856936|NCT02138916|591846203|FG002|Overall Study|incorrect enrolment|0|||
163856937|NCT02138916|591846201|FG000|Overall Study|Severe non-compliance|1|||
163856938|NCT02138916|591846202|FG001|Overall Study|Severe non-compliance|2|||
163856939|NCT02138916|591846203|FG002|Overall Study|Severe non-compliance|1|||
163856940|NCT02138916|591846201|FG000|Overall Study|Lost to Follow-up|4|||
163856941|NCT02138916|591846202|FG001|Overall Study|Lost to Follow-up|2|||
163856942|NCT02138916|591846203|FG002|Overall Study|Lost to Follow-up|3|||
163856943|NCT02138916|591846201|FG000|Overall Study|Adverse Event|4|||
163856944|NCT02138916|591846202|FG001|Overall Study|Adverse Event|4|||
163856945|NCT02138916|591846203|FG002|Overall Study|Adverse Event|3|||
163856946|NCT01913340|591846204|FG000|Overall Study|Death|2|||
163856947|NCT01913340|591846205|FG001|Overall Study|Death|5|||
163856948|NCT01913340|591846204|FG000|Overall Study|Lost to Follow-up|1|||
163856949|NCT01913340|591846205|FG001|Overall Study|Lost to Follow-up|1|||
163856950|NCT05750745|591846207|FG000|Overall Study|Adverse Event|1|||
163856951|NCT05750745|591846208|FG001|Overall Study|Adverse Event|0|||
163856952|NCT05750745|591846209|FG002|Overall Study|Adverse Event|0|||
163856953|NCT05750745|591846207|FG000|Overall Study|Protocol Violation|1|||
163856954|NCT05750745|591846208|FG001|Overall Study|Protocol Violation|0|||
163856955|NCT05750745|591846209|FG002|Overall Study|Protocol Violation|0|||
163856956|NCT05750745|591846207|FG000|Overall Study|Withdrawal by Subject|0|||
163856957|NCT05750745|591846208|FG001|Overall Study|Withdrawal by Subject|1|||
163856958|NCT05750745|591846209|FG002|Overall Study|Withdrawal by Subject|0|||
163856959|NCT05096884|591846211|FG000|Overall Study|Excluded based on negative tilt table test|4|||
163856960|NCT02482233|591846212|FG000|Overall Study|Lost to Follow-up|1|||
163856961|NCT02482233|591846213|FG001|Overall Study|Lost to Follow-up|1|||
163856962|NCT04888585|591846214|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
163856963|NCT04888585|591846215|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
163856964|NCT04888585|591846216|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
163856965|NCT04888585|591846217|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
163856966|NCT04888585|591846218|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
163856967|NCT04888585|591846219|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163856968|NCT04888585|591846220|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163856969|NCT04888585|591846221|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163856970|NCT04888585|591846222|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163856971|NCT04888585|591846223|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163856972|NCT04888585|591846224|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
163856973|NCT04888585|591846214|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856974|NCT04888585|591846215|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
163856975|NCT04888585|591846216|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
163856976|NCT04888585|591846217|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
163856977|NCT04888585|591846218|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
163856978|NCT04888585|591846219|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856979|NCT04888585|591846220|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856980|NCT04888585|591846221|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856981|NCT04888585|591846222|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856982|NCT04888585|591846223|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856983|NCT04888585|591846224|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
163856984|NCT04888585|591846214|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856985|NCT04888585|591846215|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856986|NCT04888585|591846216|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
163856987|NCT04888585|591846217|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856988|NCT04888585|591846218|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
163856989|NCT04888585|591846219|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856990|NCT04888585|591846220|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856991|NCT04888585|591846221|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856992|NCT04888585|591846222|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856993|NCT04888585|591846223|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856994|NCT04888585|591846224|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
163856995|NCT04888585|591846214|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
163856996|NCT04888585|591846215|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
163856997|NCT04888585|591846216|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
163856998|NCT04888585|591846217|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
163856999|NCT04888585|591846218|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
163857000|NCT04888585|591846219|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
163857001|NCT04888585|591846220|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
163857002|NCT04888585|591846221|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
163857003|NCT04888585|591846222|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
163857004|NCT04888585|591846223|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
163857005|NCT04888585|591846224|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
163857006|NCT04888585|591846214|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163857007|NCT04888585|591846215|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163857008|NCT04888585|591846216|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163857009|NCT04888585|591846217|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163857010|NCT04888585|591846218|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
163857011|NCT04888585|591846219|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
163857012|NCT04888585|591846220|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
163857013|NCT04888585|591846221|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
163857014|NCT04888585|591846222|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
163857015|NCT04888585|591846223|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
163857016|NCT04888585|591846224|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
163857017|NCT04888585|591846214|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163857018|NCT04888585|591846215|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163857019|NCT04888585|591846216|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163857020|NCT04888585|591846217|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163857021|NCT04888585|591846218|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
163857022|NCT04888585|591846219|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
163857023|NCT04888585|591846220|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
163857024|NCT04888585|591846221|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
163857025|NCT04888585|591846222|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
163857026|NCT04888585|591846223|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
163857027|NCT04888585|591846224|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
163857028|NCT04888585|591846214|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
163857029|NCT04888585|591846215|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
163857030|NCT04888585|591846216|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
163857031|NCT04888585|591846217|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
163857032|NCT04888585|591846218|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
163857033|NCT04888585|591846219|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
163857034|NCT04888585|591846220|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
163857035|NCT04888585|591846221|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
163857036|NCT04888585|591846222|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
163857037|NCT04888585|591846223|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
163857038|NCT04888585|591846224|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
163857039|NCT04888585|591846214|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857040|NCT04888585|591846215|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857041|NCT04888585|591846216|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857042|NCT04888585|591846217|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857043|NCT04888585|591846218|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857044|NCT04888585|591846219|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857045|NCT04888585|591846220|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
163857046|NCT04888585|591846221|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
163857047|NCT04888585|591846222|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
163857048|NCT04888585|591846223|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
163857049|NCT04888585|591846224|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
163857050|NCT04927975|591846225|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
163857051|NCT04927975|591846226|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
163857052|NCT04927975|591846227|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
163857053|NCT04927975|591846228|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
163857054|NCT04927975|591846229|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
163857055|NCT04927975|591846230|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
163857056|NCT04927975|591846225|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163857057|NCT04927975|591846226|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163857058|NCT04927975|591846227|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163857059|NCT04927975|591846228|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
163857060|NCT04927975|591846229|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
163857061|NCT04927975|591846230|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
163857062|NCT04927975|591846225|FG000|Period 1 (Baseline-Week 24)|Death|0|||
163857063|NCT04927975|591846226|FG001|Period 1 (Baseline-Week 24)|Death|0|||
163857064|NCT04927975|591846227|FG002|Period 1 (Baseline-Week 24)|Death|0|||
163857065|NCT04927975|591846228|FG003|Period 1 (Baseline-Week 24)|Death|0|||
163857066|NCT04927975|591846229|FG004|Period 1 (Baseline-Week 24)|Death|0|||
163857067|NCT04927975|591846230|FG005|Period 1 (Baseline-Week 24)|Death|1|||
163857068|NCT04927975|591846225|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
163857069|NCT04927975|591846226|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
163857070|NCT04927975|591846227|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
163857071|NCT04927975|591846228|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
163857072|NCT04927975|591846229|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
163857073|NCT04927975|591846230|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
163857074|NCT04927975|591846225|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
163857075|NCT04927975|591846226|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163857076|NCT04927975|591846227|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163857077|NCT04927975|591846228|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
163857078|NCT04927975|591846229|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163857079|NCT04927975|591846230|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
163857080|NCT03822351|591846231|FG000|Overall Study|Death|27|||
163857081|NCT03822351|591846232|FG001|Overall Study|Death|23|||
163857082|NCT03822351|591846233|FG002|Overall Study|Death|24|||
163857083|NCT03822351|591846231|FG000|Overall Study|Lost to Follow-up|6|||
163857084|NCT03822351|591846232|FG001|Overall Study|Lost to Follow-up|2|||
163857085|NCT03822351|591846233|FG002|Overall Study|Lost to Follow-up|1|||
163857086|NCT03822351|591846231|FG000|Overall Study|Withdrawal by Subject|10|||
163857087|NCT03822351|591846232|FG001|Overall Study|Withdrawal by Subject|4|||
163857088|NCT03822351|591846233|FG002|Overall Study|Withdrawal by Subject|6|||
163857089|NCT03822351|591846231|FG000|Overall Study|Progressive Disease|2|||
163857090|NCT03822351|591846232|FG001|Overall Study|Progressive Disease|1|||
163857091|NCT03822351|591846233|FG002|Overall Study|Progressive Disease|0|||
163857092|NCT03822351|591846231|FG000|Overall Study|Not Treated|1|||
163857093|NCT03822351|591846232|FG001|Overall Study|Not Treated|1|||
163857094|NCT03822351|591846233|FG002|Overall Study|Not Treated|1|||
163857095|NCT00768066|591846236|FG000|Overall Study|Did not receive study product injection.|3|||
163857096|NCT00768066|591846237|FG001|Overall Study|Did not receive study product injection.|3|||
163857097|NCT00768066|591846238|FG002|Overall Study|Did not receive study product injection.|0|||
163857098|NCT05550337|591846239|FG000|Overall Study|Lack of Efficacy|0|||
163857099|NCT05550337|591846240|FG001|Overall Study|Lack of Efficacy|0|||
163857100|NCT05550337|591846241|FG002|Overall Study|Lack of Efficacy|1|||
163857101|NCT05550337|591846239|FG000|Overall Study|Adverse Event|1|||
163857102|NCT05550337|591846240|FG001|Overall Study|Adverse Event|5|||
163857103|NCT05550337|591846241|FG002|Overall Study|Adverse Event|0|||
163857104|NCT05550337|591846239|FG000|Overall Study|Withdrawal by Subject|8|||
163857105|NCT05550337|591846240|FG001|Overall Study|Withdrawal by Subject|14|||
163857106|NCT05550337|591846241|FG002|Overall Study|Withdrawal by Subject|10|||
163857107|NCT05550337|591846239|FG000|Overall Study|Pregnancy|0|||
163857108|NCT05550337|591846240|FG001|Overall Study|Pregnancy|0|||
163857109|NCT05550337|591846241|FG002|Overall Study|Pregnancy|1|||
163857110|NCT05550337|591846239|FG000|Overall Study|Protocol Violation|1|||
163857111|NCT05550337|591846240|FG001|Overall Study|Protocol Violation|3|||
163857112|NCT05550337|591846241|FG002|Overall Study|Protocol Violation|4|||
163857113|NCT05550337|591846239|FG000|Overall Study|Physician Decision|2|||
163857114|NCT05550337|591846240|FG001|Overall Study|Physician Decision|1|||
163857115|NCT05550337|591846241|FG002|Overall Study|Physician Decision|1|||
163857116|NCT05550337|591846239|FG000|Overall Study|Lost to Follow-up|16|||
163857117|NCT05550337|591846240|FG001|Overall Study|Lost to Follow-up|11|||
163857118|NCT05550337|591846241|FG002|Overall Study|Lost to Follow-up|11|||
163857119|NCT02189863|591846242|FG000|First 2 Weeks|Motion Sickness|4|||
163857120|NCT02189863|591846243|FG001|First 2 Weeks|Motion Sickness|2|||
163857121|NCT00813488|591846249|FG000|Titration Period 1|Adverse Event|6|||
163857122|NCT00813488|591846250|FG001|Titration Period 1|Adverse Event|1|||
163857123|NCT00813488|591846249|FG000|Titration Period 1|Lack of Efficacy|9|||
163857124|NCT00813488|591846250|FG001|Titration Period 1|Lack of Efficacy|7|||
163857125|NCT00813488|591846249|FG000|Titration Period 1|Withdrawal by Subject|2|||
163857126|NCT00813488|591846250|FG001|Titration Period 1|Withdrawal by Subject|2|||
163857127|NCT00813488|591846249|FG000|Titration Period 1|Protocol Violation|4|||
163857128|NCT00813488|591846250|FG001|Titration Period 1|Protocol Violation|3|||
163857129|NCT00813488|591846249|FG000|Titration Period 1|Non-compliance to study medication|4|||
163857130|NCT00813488|591846250|FG001|Titration Period 1|Non-compliance to study medication|1|||
163857131|NCT00813488|591846249|FG000|Titration Period 1|Non-compliance to study procedures|2|||
163857132|NCT00813488|591846250|FG001|Titration Period 1|Non-compliance to study procedures|2|||
163857133|NCT00813488|591846249|FG000|Titration Period 1|Technical Difficulties|0|||
163857134|NCT00813488|591846250|FG001|Titration Period 1|Technical Difficulties|1|||
163857135|NCT00813488|591846249|FG000|Titration Period 2|Adverse Event|2|||
163857136|NCT00813488|591846250|FG001|Titration Period 2|Adverse Event|3|||
163857137|NCT00813488|591846249|FG000|Titration Period 2|Lack of Efficacy|8|||
163857138|NCT00813488|591846250|FG001|Titration Period 2|Lack of Efficacy|4|||
163857139|NCT00813488|591846249|FG000|Titration Period 2|Protocol Violation|3|||
163857140|NCT00813488|591846250|FG001|Titration Period 2|Protocol Violation|2|||
163857141|NCT00813488|591846249|FG000|Titration Period 2|Lost to Follow-up|1|||
163857142|NCT00813488|591846250|FG001|Titration Period 2|Lost to Follow-up|0|||
163857143|NCT00813488|591846249|FG000|Titration Period 2|Non-compliance with study procedures|2|||
163857144|NCT00813488|591846250|FG001|Titration Period 2|Non-compliance with study procedures|1|||
163857145|NCT00813488|591846249|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
163857146|NCT00813488|591846250|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
163857147|NCT00813488|591846249|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
163857148|NCT00813488|591846250|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
163857149|NCT00813488|591846249|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
163857150|NCT00813488|591846250|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
163857151|NCT00813488|591846249|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
163857152|NCT00813488|591846250|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
163857153|NCT00813488|591846249|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
163857154|NCT00813488|591846250|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
163857155|NCT00813488|591846249|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
163857156|NCT00813488|591846250|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
163857157|NCT00813488|591846249|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
163857158|NCT00813488|591846250|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
163857159|NCT00813488|591846249|FG000|Double-blind Treatment Period 2|Other|1|||
163857160|NCT00813488|591846250|FG001|Double-blind Treatment Period 2|Other|0|||
163857161|NCT00813488|591846249|FG000|Open-label Extension|Adverse Event|1|||
163857162|NCT00813488|591846250|FG001|Open-label Extension|Adverse Event|2|||
163857163|NCT00813488|591846249|FG000|Open-label Extension|Lack of Efficacy|3|||
163857164|NCT00813488|591846250|FG001|Open-label Extension|Lack of Efficacy|0|||
163857165|NCT00813488|591846249|FG000|Open-label Extension|Withdrawal by Subject|0|||
163857166|NCT00813488|591846250|FG001|Open-label Extension|Withdrawal by Subject|2|||
163857167|NCT00813488|591846249|FG000|Open-label Extension|Protocol Violation|1|||
163857168|NCT00813488|591846250|FG001|Open-label Extension|Protocol Violation|2|||
163857169|NCT00813488|591846249|FG000|Open-label Extension|Non-compliance study medication|4|||
163857170|NCT00813488|591846250|FG001|Open-label Extension|Non-compliance study medication|0|||
163857171|NCT00813488|591846249|FG000|Open-label Extension|Non-compliance study procedures|2|||
163857172|NCT00813488|591846250|FG001|Open-label Extension|Non-compliance study procedures|1|||
163857173|NCT00813488|591846249|FG000|Open-label Extension|Other|1|||
163857174|NCT00813488|591846250|FG001|Open-label Extension|Other|0|||
163857175|NCT02926937|591846252|FG000|Overall Study|Adverse Event|0|||
163857176|NCT02926937|591846253|FG001|Overall Study|Adverse Event|1|||
163857177|NCT02926937|591846254|FG002|Overall Study|Adverse Event|1|||
163857178|NCT02926937|591846252|FG000|Overall Study|Poor Compliance to Protocol|1|||
163857179|NCT02926937|591846253|FG001|Overall Study|Poor Compliance to Protocol|0|||
163857180|NCT02926937|591846254|FG002|Overall Study|Poor Compliance to Protocol|0|||
163857181|NCT02926937|591846252|FG000|Overall Study|Lost to Follow-up|4|||
163857182|NCT02926937|591846253|FG001|Overall Study|Lost to Follow-up|5|||
163857183|NCT02926937|591846254|FG002|Overall Study|Lost to Follow-up|0|||
163857184|NCT02926937|591846252|FG000|Overall Study|At the Participant's own Request|11|||
163857185|NCT02926937|591846253|FG001|Overall Study|At the Participant's own Request|5|||
163857186|NCT02926937|591846254|FG002|Overall Study|At the Participant's own Request|8|||
163857187|NCT02926937|591846252|FG000|Overall Study|Reason not Specified|3|||
163857188|NCT02926937|591846253|FG001|Overall Study|Reason not Specified|4|||
163857189|NCT02926937|591846254|FG002|Overall Study|Reason not Specified|2|||
163857190|NCT01559090|591846255|FG000|Stage I|Withdrawal by Subject|2|||
163857191|NCT01559090|591846256|FG001|Stage I|Withdrawal by Subject|2|||
163857192|NCT01559090|591846257|FG002|Stage I|Withdrawal by Subject|3|||
163857193|NCT01559090|591846255|FG000|Stage II|Withdrawal by Subject|1|||
163857194|NCT01559090|591846256|FG001|Stage II|Withdrawal by Subject|0|||
163857195|NCT01559090|591846257|FG002|Stage II|Withdrawal by Subject|0|||
163857196|NCT03499600|591846261|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
163857197|NCT03499600|591846262|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
163857198|NCT00561574|591846263|FG000|Overall Study|Adverse Event|21|||
163857199|NCT00561574|591846264|FG001|Overall Study|Adverse Event|24|||
163857200|NCT00561574|591846263|FG000|Overall Study|Lack of Efficacy|11|||
163857201|NCT00561574|591846264|FG001|Overall Study|Lack of Efficacy|21|||
163857202|NCT00561574|591846263|FG000|Overall Study|Withdrawal by Subject|4|||
163857203|NCT00561574|591846264|FG001|Overall Study|Withdrawal by Subject|4|||
163857204|NCT00561574|591846263|FG000|Overall Study|Reason Unrelated to Trial|6|||
163857205|NCT00561574|591846264|FG001|Overall Study|Reason Unrelated to Trial|2|||
163857206|NCT00561574|591846263|FG000|Overall Study|Lost to Follow-up|1|||
163857207|NCT00561574|591846264|FG001|Overall Study|Lost to Follow-up|0|||
163857208|NCT00561574|591846263|FG000|Overall Study|Other|5|||
163857209|NCT00561574|591846264|FG001|Overall Study|Other|7|||
163857210|NCT00445692|591846265|FG000|Overall Study|Adverse Event|11|||
163857211|NCT00445692|591846265|FG000|Overall Study|Lack of Efficacy|5|||
163857212|NCT03971357|591846266|FG000|Overall Study|Lack of Efficacy|0|||
163857213|NCT03971357|591846267|FG001|Overall Study|Lack of Efficacy|1|||
163857214|NCT01729871|591846268|FG000|Overall Study|Adverse Event|7|||
163857215|NCT01729871|591846269|FG001|Overall Study|Adverse Event|7|||
163857216|NCT01729871|591846268|FG000|Overall Study|Death|0|||
163857217|NCT01729871|591846269|FG001|Overall Study|Death|1|||
163857218|NCT01729871|591846268|FG000|Overall Study|Lack of Efficacy|0|||
163857219|NCT01729871|591846269|FG001|Overall Study|Lack of Efficacy|1|||
163857220|NCT01729871|591846268|FG000|Overall Study|Physician Decision|0|||
163857221|NCT01729871|591846269|FG001|Overall Study|Physician Decision|2|||
163857222|NCT01729871|591846268|FG000|Overall Study|Protocol Violation|1|||
163857223|NCT01729871|591846269|FG001|Overall Study|Protocol Violation|0|||
163857224|NCT01729871|591846268|FG000|Overall Study|Withdrawal by Subject|0|||
163857225|NCT01729871|591846269|FG001|Overall Study|Withdrawal by Subject|3|||
163857226|NCT01729871|591846268|FG000|Overall Study|Other|4|||
163857227|NCT01729871|591846269|FG001|Overall Study|Other|9|||
163857228|NCT01143077|591846271|FG000|Overall Study|Lack of Efficacy|0|||
163857229|NCT01143077|591846272|FG001|Overall Study|Lack of Efficacy|2|||
163857230|NCT01143077|591846273|FG002|Overall Study|Lack of Efficacy|1|||
163857231|NCT01143077|591846271|FG000|Overall Study|Adverse Event|5|||
163857232|NCT01143077|591846272|FG001|Overall Study|Adverse Event|6|||
163857233|NCT01143077|591846273|FG002|Overall Study|Adverse Event|5|||
163857234|NCT01143077|591846271|FG000|Overall Study|Lost to Follow-up|2|||
163857235|NCT01143077|591846272|FG001|Overall Study|Lost to Follow-up|3|||
163857236|NCT01143077|591846273|FG002|Overall Study|Lost to Follow-up|4|||
163857237|NCT01143077|591846271|FG000|Overall Study|Protocol Violation|2|||
163857238|NCT01143077|591846272|FG001|Overall Study|Protocol Violation|0|||
163857239|NCT01143077|591846273|FG002|Overall Study|Protocol Violation|0|||
163857240|NCT01143077|591846271|FG000|Overall Study|Withdrawal by Subject|4|||
163857241|NCT01143077|591846272|FG001|Overall Study|Withdrawal by Subject|3|||
163857242|NCT01143077|591846273|FG002|Overall Study|Withdrawal by Subject|3|||
163857243|NCT01143077|591846271|FG000|Overall Study|Non-compliance with study drug|0|||
163857244|NCT01143077|591846272|FG001|Overall Study|Non-compliance with study drug|1|||
163857245|NCT01143077|591846273|FG002|Overall Study|Non-compliance with study drug|1|||
163857246|NCT01143077|591846271|FG000|Overall Study|Administrative|1|||
163857247|NCT01143077|591846272|FG001|Overall Study|Administrative|0|||
163857248|NCT01143077|591846273|FG002|Overall Study|Administrative|0|||
163857249|NCT01143077|591846271|FG000|Overall Study|Principal Investigator Decision|2|||
163857250|NCT01143077|591846272|FG001|Overall Study|Principal Investigator Decision|0|||
163857251|NCT01143077|591846273|FG002|Overall Study|Principal Investigator Decision|1|||
163857252|NCT01333514|591846279|FG000|Overall Study|Withdrawal by Subject|1|||
163857253|NCT01333514|591846280|FG001|Overall Study|Withdrawal by Subject|0|||
163857254|NCT04155424|591846281|FG000|Overall Study|Other than specified|3|||
163857255|NCT04155424|591846281|FG000|Overall Study|Withdrawal by Subject|1|||
163857256|NCT04155424|591846281|FG000|Overall Study|Adverse Event|1|||
163857257|NCT01091454|591848417|FG000|Overall Study|Ineligible|1|||
163857258|NCT01510912|591848418|FG000|Overall Study|Adverse Event|99|||
163857259|NCT01510912|591848418|FG000|Overall Study|Lack of Efficacy|12|||
163857260|NCT01510912|591848418|FG000|Overall Study|Non-compliance with trial drug|23|||
163857261|NCT01510912|591848418|FG000|Overall Study|Withdrawal by Subject|49|||
163857262|NCT01510912|591848418|FG000|Overall Study|Physician Decision|1|||
163857263|NCT01510912|591848418|FG000|Overall Study|Protocol Violation|27|||
163857264|NCT01510912|591848418|FG000|Overall Study|Lost to Follow-up|26|||
163857265|NCT01510912|591848418|FG000|Overall Study|Other, including joint replacement|5|||
163857266|NCT02030028|591848419|FG000|Overall Study|Withdrawal by Subject|4|||
163857267|NCT02030028|591848419|FG000|Overall Study|lack of transportation|1|||
163857268|NCT00661778|591848420|FG000|Overall Study|Disease Progression|23|||
163857269|NCT00661778|591848420|FG000|Overall Study|Adverse Event|18|||
163857270|NCT00661778|591848420|FG000|Overall Study|Reason not Specified|6|||
163857271|NCT00661778|591848420|FG000|Overall Study|Protocol Violation|2|||
163857272|NCT00661778|591848420|FG000|Overall Study|Withdrawal of Consent|1|||
163857273|NCT02236559|591848422|FG000|Overall Study|Met Exclusion|3|||
163857274|NCT02236559|591848423|FG001|Overall Study|Met Exclusion|6|||
163857275|NCT02236559|591848422|FG000|Overall Study|Did not Meet Inclusion|3|||
163857276|NCT02236559|591848423|FG001|Overall Study|Did not Meet Inclusion|3|||
163964946|NCT01132612|592244780|FG000|Overall Study|Protocol deviation|0|||
163964947|NCT01132612|592244781|FG001|Overall Study|Protocol deviation|0|||
163857277|NCT02236559|591848422|FG000|Overall Study|Subject Did Not Consent|4|||
163857278|NCT02236559|591848423|FG001|Overall Study|Subject Did Not Consent|2|||
163857279|NCT02236559|591848422|FG000|Overall Study|Physician Decision|1|||
163857280|NCT02236559|591848423|FG001|Overall Study|Physician Decision|1|||
163857281|NCT02236559|591848422|FG000|Overall Study|Withdrawal by Subject|1|||
163964948|NCT01132612|592244782|FG002|Overall Study|Protocol deviation|3|||
163964949|NCT01132612|592244780|FG000|Overall Study|Lost to Follow-up|2|||
163857282|NCT02236559|591848423|FG001|Overall Study|Withdrawal by Subject|0|||
163964950|NCT01132612|592244781|FG001|Overall Study|Lost to Follow-up|2|||
163857283|NCT01149681|591848426|FG000|Overall Study|Withdrawal by Subject|7|||
163857284|NCT01149681|591848426|FG000|Overall Study|Progressive disease|1|||
163857285|NCT01149681|591848426|FG000|Overall Study|Physician Decision|2|||
163857286|NCT01149681|591848426|FG000|Overall Study|adverse events nonrelated study drug|2|||
163857287|NCT00817635|591848427|FG000|Overall Study|Adverse Event|1|||
164194326|NCT02106351|593079435|FG000|Treatment Cycle 2|Adverse Event|0|||
163857288|NCT00817635|591848428|FG001|Overall Study|Adverse Event|0|||
163857289|NCT00817635|591848429|FG002|Overall Study|Adverse Event|0|||
163857290|NCT00817635|591848430|FG003|Overall Study|Adverse Event|1|||
163857291|NCT00817635|591848431|FG004|Overall Study|Adverse Event|1|||
163857292|NCT00817635|591848427|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163857293|NCT00817635|591848428|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
163857294|NCT00817635|591848429|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163857295|NCT00817635|591848430|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
163857296|NCT00817635|591848431|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
163857297|NCT00817635|591848427|FG000|Overall Study|Withdrawal by Subject|2|||
163857298|NCT00817635|591848428|FG001|Overall Study|Withdrawal by Subject|1|||
163857299|NCT00817635|591848429|FG002|Overall Study|Withdrawal by Subject|0|||
163857300|NCT00817635|591848430|FG003|Overall Study|Withdrawal by Subject|1|||
163857301|NCT00817635|591848431|FG004|Overall Study|Withdrawal by Subject|2|||
163857302|NCT00817635|591848427|FG000|Overall Study|Lost to Follow-up|0|||
163857303|NCT00817635|591848428|FG001|Overall Study|Lost to Follow-up|1|||
163857304|NCT00817635|591848429|FG002|Overall Study|Lost to Follow-up|0|||
163857305|NCT00817635|591848430|FG003|Overall Study|Lost to Follow-up|1|||
163857306|NCT00817635|591848431|FG004|Overall Study|Lost to Follow-up|0|||
163857307|NCT00817635|591848427|FG000|Overall Study|Administrative Problems|0|||
163857308|NCT00817635|591848428|FG001|Overall Study|Administrative Problems|0|||
163857309|NCT00817635|591848429|FG002|Overall Study|Administrative Problems|0|||
163857310|NCT00817635|591848430|FG003|Overall Study|Administrative Problems|0|||
163857311|NCT00817635|591848431|FG004|Overall Study|Administrative Problems|1|||
163857312|NCT00817635|591848427|FG000|Overall Study|Protocol Violation|5|||
163857313|NCT00817635|591848428|FG001|Overall Study|Protocol Violation|1|||
163857314|NCT00817635|591848429|FG002|Overall Study|Protocol Violation|3|||
163857315|NCT00817635|591848430|FG003|Overall Study|Protocol Violation|2|||
163857316|NCT00817635|591848431|FG004|Overall Study|Protocol Violation|3|||
163857317|NCT01259102|591848432|FG000|Overall Study|Adverse Event|1|||
163857318|NCT01259102|591848433|FG001|Overall Study|Adverse Event|0|||
163857319|NCT01259102|591848434|FG002|Overall Study|Adverse Event|1|||
163857320|NCT01259102|591848435|FG003|Overall Study|Adverse Event|1|||
163857321|NCT01259102|591848436|FG004|Overall Study|Adverse Event|0|||
163857322|NCT01259102|591848432|FG000|Overall Study|Other|0|||
163857323|NCT01259102|591848433|FG001|Overall Study|Other|0|||
163857324|NCT01259102|591848434|FG002|Overall Study|Other|1|||
163857325|NCT01259102|591848435|FG003|Overall Study|Other|1|||
163857326|NCT01259102|591848436|FG004|Overall Study|Other|1|||
163857327|NCT01720446|591848437|FG000|Overall Study|Lost to Follow-up|12|||
163857328|NCT01720446|591848438|FG001|Overall Study|Lost to Follow-up|6|||
163857329|NCT01720446|591848439|FG002|Overall Study|Lost to Follow-up|16|||
163857330|NCT01720446|591848440|FG003|Overall Study|Lost to Follow-up|16|||
163857331|NCT01720446|591848437|FG000|Overall Study|Withdrawal by Subject|2|||
163857332|NCT01720446|591848438|FG001|Overall Study|Withdrawal by Subject|5|||
163857333|NCT01720446|591848439|FG002|Overall Study|Withdrawal by Subject|4|||
163857334|NCT01720446|591848440|FG003|Overall Study|Withdrawal by Subject|4|||
163857335|NCT01803646|591848441|FG000|Overall Study|Protocol Violation|1|||
163857336|NCT01803646|591848442|FG001|Overall Study|Protocol Violation|0|||
163857337|NCT01803646|591848441|FG000|Overall Study|Adverse Event|1|||
163857338|NCT01803646|591848442|FG001|Overall Study|Adverse Event|1|||
163857339|NCT01803646|591848441|FG000|Overall Study|Withdrawal by Subject|9|||
163857340|NCT01803646|591848442|FG001|Overall Study|Withdrawal by Subject|6|||
163857341|NCT01803646|591848441|FG000|Overall Study|Randomization error|1|||
163857342|NCT01803646|591848442|FG001|Overall Study|Randomization error|2|||
163857343|NCT01803646|591848441|FG000|Overall Study|Lost to Follow-up|5|||
163857344|NCT01803646|591848442|FG001|Overall Study|Lost to Follow-up|1|||
163857345|NCT02993471|591848443|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
163857346|NCT02993471|591848443|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
163857347|NCT03999554|591848445|FG000|Overall Study|Lost to Follow-up|4|||
163857348|NCT03999554|591848446|FG001|Overall Study|Lost to Follow-up|5|||
163857349|NCT03999554|591848447|FG002|Overall Study|Lost to Follow-up|4|||
163857350|NCT03999554|591848448|FG003|Overall Study|Lost to Follow-up|5|||
163857351|NCT03999554|591848449|FG004|Overall Study|Lost to Follow-up|8|||
163857352|NCT03999554|591848445|FG000|Overall Study|Protocol Violation|0|||
163857353|NCT03999554|591848446|FG001|Overall Study|Protocol Violation|0|||
163857354|NCT03999554|591848447|FG002|Overall Study|Protocol Violation|5|||
163857355|NCT03999554|591848448|FG003|Overall Study|Protocol Violation|0|||
163857356|NCT03999554|591848449|FG004|Overall Study|Protocol Violation|0|||
163857357|NCT03999554|591848445|FG000|Overall Study|Pregnancy|0|||
163857358|NCT03999554|591848446|FG001|Overall Study|Pregnancy|0|||
163857359|NCT03999554|591848447|FG002|Overall Study|Pregnancy|1|||
163857360|NCT03999554|591848448|FG003|Overall Study|Pregnancy|0|||
163857361|NCT03999554|591848449|FG004|Overall Study|Pregnancy|0|||
163857362|NCT03999554|591848445|FG000|Overall Study|Withdrawal by Subject|2|||
163857363|NCT03999554|591848446|FG001|Overall Study|Withdrawal by Subject|2|||
163857364|NCT03999554|591848447|FG002|Overall Study|Withdrawal by Subject|2|||
163857365|NCT03999554|591848448|FG003|Overall Study|Withdrawal by Subject|1|||
163857366|NCT03999554|591848449|FG004|Overall Study|Withdrawal by Subject|1|||
163857367|NCT03999554|591848445|FG000|Overall Study|failure to comply with protocol requirements|0|||
163857368|NCT03999554|591848446|FG001|Overall Study|failure to comply with protocol requirements|0|||
163857369|NCT03999554|591848447|FG002|Overall Study|failure to comply with protocol requirements|0|||
163857370|NCT03999554|591848448|FG003|Overall Study|failure to comply with protocol requirements|1|||
163857371|NCT03999554|591848449|FG004|Overall Study|failure to comply with protocol requirements|0|||
163857372|NCT02082158|591848450|FG000|Overall Study|Withdrawal by Subject|0|||
163857373|NCT02082158|591848451|FG001|Overall Study|Withdrawal by Subject|0|||
163857374|NCT02082158|591848452|FG002|Overall Study|Withdrawal by Subject|0|||
163857375|NCT02082158|591848453|FG003|Overall Study|Withdrawal by Subject|0|||
163857376|NCT02082158|591848454|FG004|Overall Study|Withdrawal by Subject|1|||
163857377|NCT02082158|591848455|FG005|Overall Study|Withdrawal by Subject|0|||
163857378|NCT02082158|591848450|FG000|Overall Study|Failed Fit-testing|8|||
163857379|NCT02082158|591848451|FG001|Overall Study|Failed Fit-testing|8|||
163857380|NCT02082158|591848452|FG002|Overall Study|Failed Fit-testing|14|||
163857381|NCT02082158|591848453|FG003|Overall Study|Failed Fit-testing|4|||
163857382|NCT02082158|591848454|FG004|Overall Study|Failed Fit-testing|3|||
163857383|NCT02082158|591848455|FG005|Overall Study|Failed Fit-testing|7|||
163857384|NCT00742274|591848458|FG000|Overall Study|Death|1|||
163857385|NCT00742274|591848459|FG001|Overall Study|Death|0|||
163857386|NCT00742274|591848458|FG000|Overall Study|Withdrawal by Subject|1|||
163857387|NCT00742274|591848459|FG001|Overall Study|Withdrawal by Subject|2|||
163857388|NCT00742274|591848458|FG000|Overall Study|Removed for medical reasons|1|||
163857389|NCT00742274|591848459|FG001|Overall Study|Removed for medical reasons|1|||
163857390|NCT01101165|591848460|FG000|Period 1|Adverse Event|1|||
163857391|NCT01101165|591848461|FG001|Period 1|Adverse Event|2|||
163857392|NCT01101165|591848460|FG000|Period 1|Withdrawal by Subject|0|||
163857393|NCT01101165|591848461|FG001|Period 1|Withdrawal by Subject|2|||
163857394|NCT01101165|591848460|FG000|Period 1|Positive Drug Screen|0|||
163857395|NCT01101165|591848461|FG001|Period 1|Positive Drug Screen|1|||
163857396|NCT01101165|591848460|FG000|Period 1|Lost to Follow-up|1|||
163857397|NCT01101165|591848461|FG001|Period 1|Lost to Follow-up|0|||
163857398|NCT01101165|591848460|FG000|Period 2|Withdrawal by Subject|3|||
163857399|NCT01101165|591848461|FG001|Period 2|Withdrawal by Subject|1|||
163857400|NCT01101165|591848460|FG000|Period 2|Adverse Event|1|||
163857401|NCT01101165|591848461|FG001|Period 2|Adverse Event|0|||
163857402|NCT00619151|591848463|FG000|Overall Study|Study terminated prior to followup|1|||
163857403|NCT00619151|591848464|FG001|Overall Study|Study terminated prior to followup|0|||
163857404|NCT03124108|591848477|FG000|Overall Study|Adverse Event|0|||
163857405|NCT03124108|591848478|FG001|Overall Study|Adverse Event|1|||
163857406|NCT03124108|591848479|FG002|Overall Study|Adverse Event|0|||
163857407|NCT01670019|591848489|FG000|Overall Study|Adverse Event|3|||
163857408|NCT01670019|591848490|FG001|Overall Study|Adverse Event|0|||
163857409|NCT01670019|591848489|FG000|Overall Study|Withdrawal by Subject|6|||
163857410|NCT01670019|591848490|FG001|Overall Study|Withdrawal by Subject|0|||
163857411|NCT03885596|591848498|FG000|Overall Study|Withdrawal by Subject|2|||
163857412|NCT03885596|591848499|FG001|Overall Study|Withdrawal by Subject|1|||
163857413|NCT03885596|591848500|FG002|Overall Study|Withdrawal by Subject|0|||
163857414|NCT03885596|591848501|FG003|Overall Study|Withdrawal by Subject|0|||
163857415|NCT00517933|591848503|FG000|Period 1|Death|2|||
163857416|NCT00517933|591848504|FG001|Period 1|Death|1|||
163857417|NCT00517933|591848503|FG000|Period 1|Adverse Event|4|||
163857418|NCT00517933|591848504|FG001|Period 1|Adverse Event|4|||
163857419|NCT00517933|591848503|FG000|Period 1|Lost to Follow-up|2|||
163857420|NCT00517933|591848504|FG001|Period 1|Lost to Follow-up|0|||
163857421|NCT00517933|591848503|FG000|Period 1|Underwent lung transplant|0|||
163857422|NCT00517933|591848504|FG001|Period 1|Underwent lung transplant|1|||
163857423|NCT00517933|591848503|FG000|Period 2|Death|2|||
163857424|NCT00517933|591848504|FG001|Period 2|Death|4|||
163857425|NCT00517933|591848503|FG000|Period 2|Adverse Event|2|||
163857426|NCT00517933|591848504|FG001|Period 2|Adverse Event|4|||
163857427|NCT00517933|591848503|FG000|Period 2|Physician Decision|1|||
163857428|NCT00517933|591848504|FG001|Period 2|Physician Decision|0|||
163857429|NCT00517933|591848503|FG000|Period 2|Withdrawal by Subject|1|||
163857430|NCT00517933|591848504|FG001|Period 2|Withdrawal by Subject|3|||
163857431|NCT00517933|591848503|FG000|Period 2|Underwent lung transplant|0|||
163857432|NCT00517933|591848504|FG001|Period 2|Underwent lung transplant|2|||
163857433|NCT00235495|591848512|FG000|Overall Study|Death|52|||
163857434|NCT00235495|591848513|FG001|Overall Study|Death|42|||
163857435|NCT00235495|591848512|FG000|Overall Study|Withdrawal by Subject|5|||
163857436|NCT00235495|591848513|FG001|Overall Study|Withdrawal by Subject|3|||
163857437|NCT00235495|591848512|FG000|Overall Study|Lost to Follow-up|11|||
163964951|NCT01132612|592244782|FG002|Overall Study|Lost to Follow-up|7|||
163964952|NCT01132612|592244780|FG000|Overall Study|Adverse Event|5|||
163857438|NCT00235495|591848513|FG001|Overall Study|Lost to Follow-up|13|||
163857439|NCT00235495|591848512|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
164194327|NCT02106351|593079436|FG001|Treatment Cycle 2|Adverse Event|2|||
163857440|NCT00235495|591848513|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
163857441|NCT01268566|591848520|FG000|Overall Study|Lost to Follow-up|1|||
163857442|NCT01268566|591848520|FG000|Overall Study|Withdrawal by Subject|12|||
163857443|NCT01268566|591848520|FG000|Overall Study|Death|30|||
163857444|NCT02784704|591848525|FG000|Overall Study|Adverse Event|4|||
163857445|NCT02784704|591848526|FG001|Overall Study|Adverse Event|2|||
163857446|NCT02784704|591848525|FG000|Overall Study|Lost to Follow-up|6|||
163857447|NCT02784704|591848526|FG001|Overall Study|Lost to Follow-up|4|||
163857448|NCT02784704|591848525|FG000|Overall Study|Withdrawal by Subject|1|||
163857449|NCT02784704|591848526|FG001|Overall Study|Withdrawal by Subject|3|||
163964953|NCT01132612|592244781|FG001|Overall Study|Adverse Event|2|||
163964954|NCT01132612|592244782|FG002|Overall Study|Adverse Event|15|||
163964955|NCT01132612|592244780|FG000|Overall Study|Withdrawal by Subject|5|||
163964956|NCT01132612|592244781|FG001|Overall Study|Withdrawal by Subject|8|||
163964957|NCT01132612|592244782|FG002|Overall Study|Withdrawal by Subject|19|||
163964958|NCT01132612|592244780|FG000|Overall Study|Administrative problems|5|||
163964959|NCT01132612|592244781|FG001|Overall Study|Administrative problems|1|||
163964960|NCT01132612|592244782|FG002|Overall Study|Administrative problems|52|||
163964961|NCT01132612|592244780|FG000|Overall Study|Lack of Efficacy|23|||
163964962|NCT01132612|592244781|FG001|Overall Study|Lack of Efficacy|22|||
163964963|NCT01132612|592244782|FG002|Overall Study|Lack of Efficacy|73|||
163964964|NCT02459769|592244785|FG000|Overall Study|Withdrawal by Subject|7|||
163964965|NCT02459769|592244786|FG001|Overall Study|Withdrawal by Subject|4|||
163964966|NCT02459769|592244787|FG002|Overall Study|Withdrawal by Subject|8|||
163964967|NCT02459769|592244788|FG003|Overall Study|Withdrawal by Subject|5|||
163964968|NCT02459769|592244785|FG000|Overall Study|Lost to Follow-up|1|||
163964969|NCT02459769|592244786|FG001|Overall Study|Lost to Follow-up|0|||
163964970|NCT02459769|592244787|FG002|Overall Study|Lost to Follow-up|1|||
163964971|NCT02459769|592244788|FG003|Overall Study|Lost to Follow-up|0|||
163964972|NCT00312221|592244793|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
163964973|NCT00312221|592244794|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
163964974|NCT00312221|592244795|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
163964975|NCT00312221|592244796|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
163964976|NCT00312221|592244793|FG000|Open-label Run-in Period|Adverse Event|74|||
163964977|NCT00312221|592244794|FG001|Open-label Run-in Period|Adverse Event|0|||
163964978|NCT00312221|592244795|FG002|Open-label Run-in Period|Adverse Event|0|||
163964979|NCT00312221|592244796|FG003|Open-label Run-in Period|Adverse Event|0|||
163964980|NCT00312221|592244793|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
163964981|NCT00312221|592244794|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
163964982|NCT00312221|592244795|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
163964983|NCT00312221|592244796|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
163964984|NCT00312221|592244793|FG000|Open-label Run-in Period|Administrative|42|||
163964985|NCT00312221|592244794|FG001|Open-label Run-in Period|Administrative|0|||
163964986|NCT00312221|592244795|FG002|Open-label Run-in Period|Administrative|0|||
163964987|NCT00312221|592244796|FG003|Open-label Run-in Period|Administrative|0|||
163964988|NCT00312221|592244793|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
163964989|NCT00312221|592244794|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
163964990|NCT00312221|592244795|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
163964991|NCT00312221|592244796|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
163964992|NCT00312221|592244793|FG000|Open-label Run-in Period|Did not qualify|5|||
163964993|NCT00312221|592244794|FG001|Open-label Run-in Period|Did not qualify|0|||
163964994|NCT00312221|592244795|FG002|Open-label Run-in Period|Did not qualify|0|||
163964995|NCT00312221|592244796|FG003|Open-label Run-in Period|Did not qualify|0|||
163964996|NCT00312221|592244793|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163964997|NCT00312221|592244794|FG001|Double-blind Phase|Withdrawal by Subject|6|||
163964998|NCT00312221|592244795|FG002|Double-blind Phase|Withdrawal by Subject|8|||
163964999|NCT00312221|592244796|FG003|Double-blind Phase|Withdrawal by Subject|7|||
163965000|NCT00312221|592244793|FG000|Double-blind Phase|Adverse Event|0|||
163965001|NCT00312221|592244794|FG001|Double-blind Phase|Adverse Event|10|||
163965002|NCT00312221|592244795|FG002|Double-blind Phase|Adverse Event|19|||
163965003|NCT00312221|592244796|FG003|Double-blind Phase|Adverse Event|18|||
163965004|NCT00312221|592244793|FG000|Double-blind Phase|Lost to Follow-up|0|||
163965005|NCT00312221|592244794|FG001|Double-blind Phase|Lost to Follow-up|0|||
163965006|NCT00312221|592244795|FG002|Double-blind Phase|Lost to Follow-up|2|||
163965007|NCT00312221|592244796|FG003|Double-blind Phase|Lost to Follow-up|2|||
163857450|NCT02784704|591848525|FG000|Overall Study|Subject Non Compliance|2|||
163857451|NCT02784704|591848526|FG001|Overall Study|Subject Non Compliance|0|||
163857452|NCT00603538|591848527|FG000|Overall Study|Adverse Event|0|||
163965008|NCT00312221|592244793|FG000|Double-blind Phase|Administrative|0|||
163965009|NCT00312221|592244794|FG001|Double-blind Phase|Administrative|26|||
163965010|NCT00312221|592244795|FG002|Double-blind Phase|Administrative|37|||
163965011|NCT00312221|592244796|FG003|Double-blind Phase|Administrative|33|||
163965012|NCT00312221|592244793|FG000|Double-blind Phase|Lack of Efficacy|0|||
163965013|NCT00312221|592244794|FG001|Double-blind Phase|Lack of Efficacy|17|||
163965014|NCT00312221|592244795|FG002|Double-blind Phase|Lack of Efficacy|6|||
163965015|NCT00312221|592244796|FG003|Double-blind Phase|Lack of Efficacy|10|||
163965016|NCT02060721|592244797|FG000|Overall Study|Lost to Follow-up|1|||
163965017|NCT02060721|592244797|FG000|Overall Study|Physician Decision|2|||
163965018|NCT02060721|592244797|FG000|Overall Study|Death|14|||
163857453|NCT00603538|591848528|FG001|Overall Study|Adverse Event|4|||
163857454|NCT00603538|591848529|FG002|Overall Study|Adverse Event|2|||
163857455|NCT00603538|591848527|FG000|Overall Study|Objective progression or relapse|3|||
163857456|NCT00603538|591848528|FG001|Overall Study|Objective progression or relapse|0|||
163857457|NCT00603538|591848529|FG002|Overall Study|Objective progression or relapse|0|||
163857458|NCT04794179|591848531|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
163857459|NCT04794179|591848532|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
163857460|NCT03781804|591848537|FG000|Overall Study|Adverse Event|2|||
163857461|NCT03781804|591848538|FG001|Overall Study|Adverse Event|2|||
163857462|NCT03781804|591848539|FG002|Overall Study|Adverse Event|3|||
163857463|NCT03781804|591848537|FG000|Overall Study|Lost to Follow-up|1|||
163857464|NCT03781804|591848538|FG001|Overall Study|Lost to Follow-up|1|||
163857465|NCT03781804|591848539|FG002|Overall Study|Lost to Follow-up|2|||
163857466|NCT03781804|591848537|FG000|Overall Study|Lack of Efficacy|4|||
163857467|NCT03781804|591848538|FG001|Overall Study|Lack of Efficacy|2|||
163857468|NCT03781804|591848539|FG002|Overall Study|Lack of Efficacy|9|||
163857469|NCT03781804|591848537|FG000|Overall Study|Protocol Violation|0|||
163857470|NCT03781804|591848538|FG001|Overall Study|Protocol Violation|0|||
163857471|NCT03781804|591848539|FG002|Overall Study|Protocol Violation|1|||
163857472|NCT03781804|591848537|FG000|Overall Study|Withdrawal by Subject|0|||
163857473|NCT03781804|591848538|FG001|Overall Study|Withdrawal by Subject|1|||
163857474|NCT03781804|591848539|FG002|Overall Study|Withdrawal by Subject|1|||
163857475|NCT03781804|591848537|FG000|Overall Study|Reason not provided|2|||
163857476|NCT03781804|591848538|FG001|Overall Study|Reason not provided|2|||
163857477|NCT03781804|591848539|FG002|Overall Study|Reason not provided|0|||
163857478|NCT04678830|591848540|FG000|Overall Study|Lack of Efficacy|2|||
163857479|NCT04678830|591848541|FG001|Overall Study|Lack of Efficacy|0|||
163857480|NCT04678830|591848540|FG000|Overall Study|Withdrawal by Subject|0|||
163857481|NCT04678830|591848541|FG001|Overall Study|Withdrawal by Subject|1|||
163857482|NCT01836458|591848544|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
163857483|NCT01836458|591848545|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163857484|NCT01836458|591848546|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
163857485|NCT01836458|591848547|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
163857486|NCT00429793|591848548|FG000|Overall Study|Improper pre-protocol treatment|3|||
163857487|NCT00429793|591848548|FG000|Overall Study|Required test not done|1|||
163857488|NCT00429793|591848548|FG000|Overall Study|Never treated|1|||
163857489|NCT00429793|591848548|FG000|Overall Study|Non-measurable|1|||
163857490|NCT00836810|591848549|FG000|Overall Study|New diagnosis|1|||
163857491|NCT00836810|591848550|FG001|Overall Study|New diagnosis|0|||
163857492|NCT02040844|591848553|FG000|Overall Study|Adverse Event|0|||
163857493|NCT02040844|591848554|FG001|Overall Study|Adverse Event|0|||
163857494|NCT02040844|591848555|FG002|Overall Study|Adverse Event|1|||
163857495|NCT02040844|591848553|FG000|Overall Study|Withdrawal by Subject|16|||
163857496|NCT02040844|591848554|FG001|Overall Study|Withdrawal by Subject|22|||
163857497|NCT02040844|591848555|FG002|Overall Study|Withdrawal by Subject|25|||
163857498|NCT02040844|591848553|FG000|Overall Study|Lost to Follow-up|12|||
163857499|NCT02040844|591848554|FG001|Overall Study|Lost to Follow-up|9|||
163857500|NCT02040844|591848555|FG002|Overall Study|Lost to Follow-up|13|||
163857501|NCT02040844|591848553|FG000|Overall Study|Missing|13|||
163857502|NCT02040844|591848554|FG001|Overall Study|Missing|3|||
163857503|NCT02040844|591848555|FG002|Overall Study|Missing|2|||
163857504|NCT02040844|591848553|FG000|Overall Study|Non-specified|8|||
163857505|NCT02040844|591848554|FG001|Overall Study|Non-specified|2|||
163857506|NCT02040844|591848555|FG002|Overall Study|Non-specified|5|||
163857507|NCT02040844|591848553|FG000|Overall Study|Concomitant medication|1|||
163857508|NCT02040844|591848554|FG001|Overall Study|Concomitant medication|3|||
163857509|NCT02040844|591848555|FG002|Overall Study|Concomitant medication|1|||
163857510|NCT02014558|591848556|FG000|Overall Study|Never Received Study Drug|0|||
163857511|NCT02014558|591848557|FG001|Overall Study|Never Received Study Drug|0|||
163857512|NCT02014558|591848558|FG002|Overall Study|Never Received Study Drug|0|||
163857513|NCT02014558|591848559|FG003|Overall Study|Never Received Study Drug|0|||
163857514|NCT02014558|591848560|FG004|Overall Study|Never Received Study Drug|1|||
163857515|NCT02014558|591848561|FG005|Overall Study|Never Received Study Drug|0|||
163857516|NCT02014558|591848562|FG006|Overall Study|Never Received Study Drug|1|||
163857517|NCT02014558|591848563|FG007|Overall Study|Never Received Study Drug|0|||
163857518|NCT02014558|591848564|FG008|Overall Study|Never Received Study Drug|2|||
163857519|NCT02014558|591848565|FG009|Overall Study|Never Received Study Drug|0|||
163857520|NCT02014558|591848566|FG010|Overall Study|Never Received Study Drug|2|||
163857521|NCT02014558|591848567|FG011|Overall Study|Never Received Study Drug|2|||
163857522|NCT02014558|591848568|FG012|Overall Study|Never Received Study Drug|0|||
163857523|NCT02014558|591848556|FG000|Overall Study|Adverse Event|0|||
163857524|NCT02014558|591848557|FG001|Overall Study|Adverse Event|0|||
163857525|NCT02014558|591848558|FG002|Overall Study|Adverse Event|0|||
163857526|NCT02014558|591848559|FG003|Overall Study|Adverse Event|0|||
163857527|NCT02014558|591848560|FG004|Overall Study|Adverse Event|1|||
163857528|NCT02014558|591848561|FG005|Overall Study|Adverse Event|0|||
163857529|NCT02014558|591848562|FG006|Overall Study|Adverse Event|0|||
163857530|NCT02014558|591848563|FG007|Overall Study|Adverse Event|0|||
163857531|NCT02014558|591848564|FG008|Overall Study|Adverse Event|2|||
163857532|NCT02014558|591848565|FG009|Overall Study|Adverse Event|2|||
163857533|NCT02014558|591848566|FG010|Overall Study|Adverse Event|5|||
163857534|NCT02014558|591848567|FG011|Overall Study|Adverse Event|21|||
163857535|NCT02014558|591848568|FG012|Overall Study|Adverse Event|3|||
163857536|NCT02014558|591848556|FG000|Overall Study|Death|1|||
163857537|NCT02014558|591848557|FG001|Overall Study|Death|0|||
163857538|NCT02014558|591848558|FG002|Overall Study|Death|0|||
163857539|NCT02014558|591848559|FG003|Overall Study|Death|0|||
163857540|NCT02014558|591848560|FG004|Overall Study|Death|0|||
163857541|NCT02014558|591848561|FG005|Overall Study|Death|0|||
163857542|NCT02014558|591848562|FG006|Overall Study|Death|1|||
163857543|NCT02014558|591848563|FG007|Overall Study|Death|1|||
163857544|NCT02014558|591848564|FG008|Overall Study|Death|2|||
163857545|NCT02014558|591848565|FG009|Overall Study|Death|5|||
163857546|NCT02014558|591848566|FG010|Overall Study|Death|5|||
163857547|NCT02014558|591848567|FG011|Overall Study|Death|19|||
163857548|NCT02014558|591848568|FG012|Overall Study|Death|2|||
163857549|NCT02014558|591848556|FG000|Overall Study|Lack of Efficacy|1|||
163857550|NCT02014558|591848557|FG001|Overall Study|Lack of Efficacy|2|||
163857551|NCT02014558|591848558|FG002|Overall Study|Lack of Efficacy|1|||
163857552|NCT02014558|591848559|FG003|Overall Study|Lack of Efficacy|1|||
163857553|NCT02014558|591848560|FG004|Overall Study|Lack of Efficacy|0|||
163857554|NCT02014558|591848561|FG005|Overall Study|Lack of Efficacy|0|||
163857555|NCT02014558|591848562|FG006|Overall Study|Lack of Efficacy|1|||
163857556|NCT02014558|591848563|FG007|Overall Study|Lack of Efficacy|3|||
163857557|NCT02014558|591848564|FG008|Overall Study|Lack of Efficacy|3|||
163857558|NCT02014558|591848565|FG009|Overall Study|Lack of Efficacy|3|||
163857559|NCT02014558|591848566|FG010|Overall Study|Lack of Efficacy|16|||
163857560|NCT02014558|591848567|FG011|Overall Study|Lack of Efficacy|8|||
163857561|NCT02014558|591848568|FG012|Overall Study|Lack of Efficacy|5|||
163857562|NCT02014558|591848556|FG000|Overall Study|Lost to Follow-up|0|||
163965019|NCT02060721|592244797|FG000|Overall Study|Withdrawal by Subject|2|||
163965020|NCT02060721|592244797|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
163965021|NCT01019317|592244798|FG000|Overall Study|Not Eligible|4|||
163965022|NCT00728481|592244799|FG000|Overall Study|Withdrawal by Subject|0|||
163965023|NCT00728481|592244800|FG001|Overall Study|Withdrawal by Subject|1|||
163965024|NCT00728481|592244799|FG000|Overall Study|Adverse Event|0|||
163965025|NCT00728481|592244800|FG001|Overall Study|Adverse Event|1|||
163965026|NCT00728481|592244799|FG000|Overall Study|Study medication non-compliance|0|||
163965027|NCT00728481|592244800|FG001|Overall Study|Study medication non-compliance|2|||
163965028|NCT00728481|592244799|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
163965029|NCT00728481|592244800|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
163965030|NCT03690141|592244801|FG000|Overall Study|Adverse Event|5|||
163965031|NCT03690141|592244801|FG000|Overall Study|Withdrawal by Subject|3|||
163965032|NCT03690141|592244801|FG000|Overall Study|Physician Decision|4|||
163965033|NCT03690141|592244801|FG000|Overall Study|Disease progression|4|||
163965034|NCT01505010|592244802|FG000|Overall Study|Protocol Violation|0|||
163965035|NCT01505010|592244803|FG001|Overall Study|Protocol Violation|1|||
163965036|NCT01505010|592244802|FG000|Overall Study|Lost to Follow-up|0|||
163965037|NCT01505010|592244803|FG001|Overall Study|Lost to Follow-up|1|||
163965038|NCT04744285|592244804|FG000|Overall Study|Withdrawal by Subject|1|||
163965039|NCT04744285|592244805|FG001|Overall Study|Withdrawal by Subject|1|||
163965040|NCT04744285|592244806|FG002|Overall Study|Withdrawal by Subject|2|||
163965041|NCT04744285|592244807|FG003|Overall Study|Withdrawal by Subject|1|||
163965042|NCT01822522|592244811|FG000|Overall Study|Adverse Event|1|||
163965043|NCT01822522|592244812|FG001|Overall Study|Adverse Event|1|||
163965044|NCT01822522|592244813|FG002|Overall Study|Adverse Event|1|||
163965045|NCT01822522|592244814|FG003|Overall Study|Adverse Event|0|||
163965046|NCT01822522|592244815|FG004|Overall Study|Adverse Event|0|||
163857563|NCT02014558|591848557|FG001|Overall Study|Lost to Follow-up|0|||
163857564|NCT02014558|591848558|FG002|Overall Study|Lost to Follow-up|0|||
163857565|NCT02014558|591848559|FG003|Overall Study|Lost to Follow-up|0|||
163857566|NCT02014558|591848560|FG004|Overall Study|Lost to Follow-up|0|||
163965047|NCT01822522|592244816|FG005|Overall Study|Adverse Event|1|||
163857567|NCT02014558|591848561|FG005|Overall Study|Lost to Follow-up|0|||
163857568|NCT02014558|591848562|FG006|Overall Study|Lost to Follow-up|0|||
163857569|NCT02014558|591848563|FG007|Overall Study|Lost to Follow-up|0|||
163857570|NCT02014558|591848564|FG008|Overall Study|Lost to Follow-up|0|||
163965048|NCT01822522|592244811|FG000|Overall Study|Death|3|||
163965049|NCT01822522|592244812|FG001|Overall Study|Death|0|||
163965050|NCT01822522|592244813|FG002|Overall Study|Death|2|||
163965051|NCT01822522|592244814|FG003|Overall Study|Death|0|||
163965052|NCT01822522|592244815|FG004|Overall Study|Death|0|||
163857571|NCT02014558|591848565|FG009|Overall Study|Lost to Follow-up|0|||
163857572|NCT02014558|591848566|FG010|Overall Study|Lost to Follow-up|1|||
163857573|NCT02014558|591848567|FG011|Overall Study|Lost to Follow-up|0|||
163857574|NCT02014558|591848568|FG012|Overall Study|Lost to Follow-up|0|||
163965053|NCT01822522|592244816|FG005|Overall Study|Death|0|||
163965054|NCT01822522|592244811|FG000|Overall Study|Lost to Follow-up|0|||
163857575|NCT02014558|591848556|FG000|Overall Study|Progressive Disease|1|||
163857576|NCT02014558|591848557|FG001|Overall Study|Progressive Disease|0|||
163857577|NCT02014558|591848558|FG002|Overall Study|Progressive Disease|1|||
163857578|NCT02014558|591848559|FG003|Overall Study|Progressive Disease|1|||
163857579|NCT02014558|591848560|FG004|Overall Study|Progressive Disease|1|||
163857580|NCT02014558|591848561|FG005|Overall Study|Progressive Disease|2|||
163857581|NCT02014558|591848562|FG006|Overall Study|Progressive Disease|1|||
163857582|NCT02014558|591848563|FG007|Overall Study|Progressive Disease|6|||
163857583|NCT02014558|591848564|FG008|Overall Study|Progressive Disease|5|||
163857584|NCT02014558|591848565|FG009|Overall Study|Progressive Disease|6|||
163857585|NCT02014558|591848566|FG010|Overall Study|Progressive Disease|22|||
163857586|NCT02014558|591848567|FG011|Overall Study|Progressive Disease|31|||
163857587|NCT02014558|591848568|FG012|Overall Study|Progressive Disease|6|||
163857588|NCT02014558|591848556|FG000|Overall Study|Withdrawal by Subject|0|||
163857589|NCT02014558|591848557|FG001|Overall Study|Withdrawal by Subject|0|||
163857590|NCT02014558|591848558|FG002|Overall Study|Withdrawal by Subject|0|||
163857591|NCT02014558|591848559|FG003|Overall Study|Withdrawal by Subject|0|||
163857592|NCT02014558|591848560|FG004|Overall Study|Withdrawal by Subject|1|||
163857593|NCT02014558|591848561|FG005|Overall Study|Withdrawal by Subject|0|||
163857594|NCT02014558|591848562|FG006|Overall Study|Withdrawal by Subject|0|||
163857595|NCT02014558|591848563|FG007|Overall Study|Withdrawal by Subject|0|||
163857596|NCT02014558|591848564|FG008|Overall Study|Withdrawal by Subject|0|||
163857597|NCT02014558|591848565|FG009|Overall Study|Withdrawal by Subject|2|||
163857598|NCT02014558|591848566|FG010|Overall Study|Withdrawal by Subject|6|||
163857599|NCT02014558|591848567|FG011|Overall Study|Withdrawal by Subject|10|||
163857600|NCT02014558|591848568|FG012|Overall Study|Withdrawal by Subject|0|||
163857601|NCT02014558|591848556|FG000|Overall Study|Miscellaneous|2|||
163857602|NCT02014558|591848557|FG001|Overall Study|Miscellaneous|1|||
163857603|NCT02014558|591848558|FG002|Overall Study|Miscellaneous|1|||
163857604|NCT02014558|591848559|FG003|Overall Study|Miscellaneous|1|||
163857605|NCT02014558|591848560|FG004|Overall Study|Miscellaneous|0|||
163857606|NCT02014558|591848561|FG005|Overall Study|Miscellaneous|1|||
163857607|NCT02014558|591848562|FG006|Overall Study|Miscellaneous|0|||
163857608|NCT02014558|591848563|FG007|Overall Study|Miscellaneous|1|||
163857609|NCT02014558|591848564|FG008|Overall Study|Miscellaneous|1|||
163857610|NCT02014558|591848565|FG009|Overall Study|Miscellaneous|3|||
163857611|NCT02014558|591848566|FG010|Overall Study|Miscellaneous|12|||
163857612|NCT02014558|591848567|FG011|Overall Study|Miscellaneous|11|||
163857613|NCT02014558|591848568|FG012|Overall Study|Miscellaneous|1|||
163857614|NCT05273801|591848569|FG000|Overall Study|Physician Decision|1|||
163857615|NCT04257058|591850040|FG000|Overall Study|Lost to Follow-up|31|||
163857616|NCT03227757|591850041|FG000|Overall Study|Death|25|||
163857617|NCT03227757|591850041|FG000|Overall Study|Withdrawal|10|||
163857618|NCT03227757|591850041|FG000|Overall Study|Missed visits|1|||
163857619|NCT03227757|591850041|FG000|Overall Study|Lost to Follow-up|2|||
163857620|NCT05570006|591850042|FG000|Overall Study|Lost to Follow-up|2|||
163857621|NCT05570006|591850042|FG000|Overall Study|Withdrawal by Subject|5|||
163857622|NCT05570006|591850042|FG000|Overall Study|Other than Specified|5|||
163857623|NCT01144468|591850043|FG000|Overall Study|Lost to Follow-up|4|||
163857624|NCT01144468|591850044|FG001|Overall Study|Lost to Follow-up|7|||
163857625|NCT01144468|591850043|FG000|Overall Study|Adverse Event|3|||
163857626|NCT01144468|591850044|FG001|Overall Study|Adverse Event|2|||
163857627|NCT01144468|591850043|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
163857628|NCT01144468|591850044|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
163857629|NCT02960659|591850045|FG000|Overall Study|Withdrawal by Subject|1|||
163857630|NCT02960659|591850046|FG001|Overall Study|Withdrawal by Subject|0|||
163857631|NCT02960659|591850045|FG000|Overall Study|Poor compliance|0|||
163857632|NCT02960659|591850046|FG001|Overall Study|Poor compliance|1|||
163857633|NCT04199728|591850052|FG000|Overall Study|Adverse Event|1|||
163857634|NCT04199728|591850053|FG001|Overall Study|Adverse Event|0|||
163857635|NCT04199728|591850052|FG000|Overall Study|Withdrawal by Subject|8|||
163857636|NCT04199728|591850053|FG001|Overall Study|Withdrawal by Subject|3|||
163857637|NCT04199728|591850052|FG000|Overall Study|Screen fail after consent|0|||
163857638|NCT04199728|591850053|FG001|Overall Study|Screen fail after consent|1|||
163857639|NCT04199728|591850052|FG000|Overall Study|Early withdraw criteria met|0|||
164194328|NCT02106351|593079437|FG002|Treatment Cycle 2|Adverse Event|0|||
163857640|NCT04199728|591850053|FG001|Overall Study|Early withdraw criteria met|1|||
163857641|NCT04199728|591850052|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
163857642|NCT04199728|591850053|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
163857643|NCT01875250|591850057|FG000|Overall Study|Adverse Event|2|||
163857644|NCT01875250|591850058|FG001|Overall Study|Adverse Event|0|||
163857645|NCT03068468|591850064|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
163857646|NCT03068468|591850065|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
163857647|NCT03068468|591850066|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
164194329|NCT02106351|593079435|FG000|Treatment Cycle 2|Consent withdrawn|0|||
163857648|NCT03068468|591850067|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
163857649|NCT03068468|591850064|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
163857650|NCT03068468|591850065|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
163857651|NCT03068468|591850066|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
163857652|NCT03068468|591850067|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
163857653|NCT03068468|591850064|FG000|Placebo-Controlled Period|Adverse Event|16|||
163857654|NCT03068468|591850065|FG001|Placebo-Controlled Period|Adverse Event|21|||
163857655|NCT03068468|591850066|FG002|Placebo-Controlled Period|Adverse Event|0|||
163857656|NCT03068468|591850067|FG003|Placebo-Controlled Period|Adverse Event|0|||
163857657|NCT03068468|591850064|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
163857658|NCT03068468|591850065|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
163857659|NCT03068468|591850066|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
163857660|NCT03068468|591850067|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
163857661|NCT03068468|591850064|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163857662|NCT03068468|591850065|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
163857663|NCT03068468|591850066|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163857664|NCT03068468|591850067|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163857665|NCT03068468|591850064|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
163857666|NCT03068468|591850065|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
163857667|NCT03068468|591850066|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
163857668|NCT03068468|591850067|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
163857669|NCT03068468|591850064|FG000|Placebo-Controlled Period|Death|0|||
163857670|NCT03068468|591850065|FG001|Placebo-Controlled Period|Death|1|||
163857671|NCT03068468|591850066|FG002|Placebo-Controlled Period|Death|0|||
163857672|NCT03068468|591850067|FG003|Placebo-Controlled Period|Death|0|||
163857673|NCT03068468|591850064|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
163857674|NCT03068468|591850065|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
163857675|NCT03068468|591850066|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
163857676|NCT03068468|591850067|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
163857677|NCT03068468|591850064|FG000|Open-Label Extension Period|Adverse Event|0|||
163857678|NCT03068468|591850065|FG001|Open-Label Extension Period|Adverse Event|0|||
163857679|NCT03068468|591850066|FG002|Open-Label Extension Period|Adverse Event|13|||
163857680|NCT03068468|591850067|FG003|Open-Label Extension Period|Adverse Event|17|||
163857681|NCT03068468|591850064|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
163857682|NCT03068468|591850065|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
163857683|NCT03068468|591850066|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
163857684|NCT03068468|591850067|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
163857685|NCT03068468|591850064|FG000|Open-Label Extension Period|Death|0|||
163857686|NCT03068468|591850065|FG001|Open-Label Extension Period|Death|0|||
163857687|NCT03068468|591850066|FG002|Open-Label Extension Period|Death|0|||
163857688|NCT03068468|591850067|FG003|Open-Label Extension Period|Death|1|||
163857689|NCT03068468|591850064|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
163857690|NCT03068468|591850065|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
163857691|NCT03068468|591850066|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
163857692|NCT03068468|591850067|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
163857693|NCT03068468|591850064|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
163857694|NCT03068468|591850065|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
163857695|NCT03068468|591850066|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
163857696|NCT03068468|591850067|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
163857697|NCT03068468|591850064|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
163857698|NCT03068468|591850065|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
163857699|NCT03068468|591850066|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
163857700|NCT03068468|591850067|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
163857701|NCT03068468|591850064|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
163857702|NCT03068468|591850065|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
163857703|NCT03068468|591850066|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
163857704|NCT03068468|591850067|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
163857705|NCT03068468|591850064|FG000|Open-Label Extension Period|Reason not Specified|0|||
163857706|NCT03068468|591850065|FG001|Open-Label Extension Period|Reason not Specified|0|||
163857707|NCT03068468|591850066|FG002|Open-Label Extension Period|Reason not Specified|1|||
163857708|NCT03068468|591850067|FG003|Open-Label Extension Period|Reason not Specified|4|||
163857709|NCT03895034|591850069|FG000|Overall Study|Lost to Follow-up|2|||
163857710|NCT01118377|591850074|FG000|Overall Study|Did Not Receive Study Medication|1|||
163857711|NCT01118377|591850074|FG000|Overall Study|Death|38|||
163857712|NCT01118377|591850074|FG000|Overall Study|Failure to Return|3|||
163857713|NCT03140176|591850078|FG000|Overall Study|Reason missing|23|||
163857714|NCT03140176|591850078|FG000|Overall Study|Death|33|||
163857715|NCT03140176|591850078|FG000|Overall Study|Disease progression|1|||
163857716|NCT03140176|591850078|FG000|Overall Study|Physician Decision|1|||
163857717|NCT03140176|591850078|FG000|Overall Study|Withdrawal by Subject|1|||
163857718|NCT03140176|591850078|FG000|Overall Study|Lost to Follow-up|15|||
163857719|NCT01331824|591850080|FG000|Overall Study|Adverse Event|2|||
163857720|NCT01331824|591850080|FG000|Overall Study|Death|1|||
163857721|NCT01331824|591850080|FG000|Overall Study|Disease Progression|9|||
163857722|NCT01331824|591850080|FG000|Overall Study|Withdrawal by Subject|1|||
163857723|NCT03179787|591850086|FG000|Overall Study|Lost to Follow-up|15|||
163857724|NCT03179787|591850086|FG000|Overall Study|Case report failures|2|||
163857725|NCT03179787|591850086|FG000|Overall Study|Treatment not administered|1|||
163857726|NCT03181958|591850087|FG000|Overall Study|Lost to Follow-up|17|||
163857727|NCT03181958|591850088|FG001|Overall Study|Lost to Follow-up|21|||
163857728|NCT03181958|591850089|FG002|Overall Study|Lost to Follow-up|15|||
163857729|NCT01063036|591850095|FG000|Participants Treated With Study Drug|Adverse Event|1|||
163857730|NCT01063036|591850095|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
163857731|NCT01063036|591850095|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
163857732|NCT01063036|591850095|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
163857733|NCT01063036|591850095|FG000|Participants Treated With Study Drug|Pregnancy|1|||
163857734|NCT01063036|591850095|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
163857735|NCT01063036|591850095|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
163857736|NCT01063036|591850095|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
163857737|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
163857738|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
163857739|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
163857740|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
163857741|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Adverse Event|198|||
163857742|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Adverse Event|0|||
163857743|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Adverse Event|0|||
163857744|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Adverse Event|0|||
163857745|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Death|62|||
163857746|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Death|0|||
163857747|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Death|0|||
163857748|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Death|0|||
163857749|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
163857750|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
163857751|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
163857752|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
163857753|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Complicating disease|13|||
163857754|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Complicating disease|0|||
163857755|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Complicating disease|0|||
163857756|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Complicating disease|0|||
163857757|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
163857758|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
163857759|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
163857760|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
163857761|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
163857762|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
163857763|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
163857764|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
163857765|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Non-compliance|4|||
163857766|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Non-compliance|0|||
163857767|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Non-compliance|0|||
163857768|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Non-compliance|0|||
163857769|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Pain|4|||
163857770|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Pain|0|||
163857771|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Pain|0|||
163857772|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Pain|0|||
163857773|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
163857774|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
163857775|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
163857776|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
163857777|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Hospice care|1|||
163857778|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Hospice care|0|||
163857779|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Hospice care|0|||
163857780|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Hospice care|0|||
163857781|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Physician Decision|1|||
163857782|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Physician Decision|0|||
163857783|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Physician Decision|0|||
163857784|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Physician Decision|0|||
163857785|NCT01107626|591850098|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
163857786|NCT01107626|591850099|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
163857787|NCT01107626|591850100|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
163857788|NCT01107626|591850101|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
163857789|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
163857790|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
163857791|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
163857792|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
163857793|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
163857794|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
163857795|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
163857796|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
163857797|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Death|0|||
163857798|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Death|8|||
163857799|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Death|2|||
163857800|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Death|13|||
163857801|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
163857802|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
163857803|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
163857804|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
163857805|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
163857806|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
163857807|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
163857808|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
163857809|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
163857810|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
163857811|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
163857812|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
163857813|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
163857814|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
163857815|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
163857816|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
163857817|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
163857818|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
163857819|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
163857820|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
163857821|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
163857822|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
163857823|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
163857824|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
163857825|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
163857826|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
163857827|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
163857828|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
163857829|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
163857830|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
163857831|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
163857832|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
163857833|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
163857834|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
163857835|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
163857836|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
163857837|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
163857838|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
163857839|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
163857840|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
163857841|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Pain|0|||
163857842|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Pain|0|||
163857843|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Pain|0|||
163857844|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Pain|1|||
163857845|NCT01107626|591850098|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
163857846|NCT01107626|591850099|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
163857847|NCT01107626|591850100|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
163857848|NCT01107626|591850101|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
163857849|NCT01977612|591850102|FG000|Overall Study|Lost to Follow-up|1|||
163857850|NCT01977612|591850103|FG001|Overall Study|Lost to Follow-up|1|||
163857851|NCT04381494|591850104|FG000|Overall Study|Early termination of trial|19|||
163857852|NCT04381494|591850104|FG000|Overall Study|Investigator's discretion|1|||
163857853|NCT04381494|591850104|FG000|Overall Study|Withdrawal by Subject|9|||
163857854|NCT04381494|591850104|FG000|Overall Study|NSCLC disease progression|4|||
163857855|NCT04381494|591850104|FG000|Overall Study|Device-Related Adverse Event|2|||
163857856|NCT02715258|591850106|FG000|Overall Study|Withdrawal by Subject|6|||
163857857|NCT02715258|591850107|FG001|Overall Study|Withdrawal by Subject|1|||
163857858|NCT02715258|591850106|FG000|Overall Study|Lost to Follow-up|7|||
163857859|NCT02715258|591850107|FG001|Overall Study|Lost to Follow-up|1|||
163857860|NCT02715258|591850106|FG000|Overall Study|Terminated by Sponsor|0|||
163857861|NCT02715258|591850107|FG001|Overall Study|Terminated by Sponsor|1|||
163857862|NCT02715258|591850106|FG000|Overall Study|Death|0|||
163857863|NCT02715258|591850107|FG001|Overall Study|Death|1|||
163857864|NCT02715258|591850106|FG000|Overall Study|Subject non-compliant|1|||
164194330|NCT02106351|593079436|FG001|Treatment Cycle 2|Consent withdrawn|1|||
164194331|NCT02106351|593079437|FG002|Treatment Cycle 2|Consent withdrawn|1|||
164194332|NCT02106351|593079435|FG000|Treatment Cycle 2|Other|0|||
164194333|NCT02106351|593079436|FG001|Treatment Cycle 2|Other|2|||
164194334|NCT02106351|593079437|FG002|Treatment Cycle 2|Other|2|||
164194335|NCT02106351|593079435|FG000|Treatment Cycle 3|Adverse Event|0|||
164194336|NCT02106351|593079436|FG001|Treatment Cycle 3|Adverse Event|1|||
164194337|NCT02106351|593079437|FG002|Treatment Cycle 3|Adverse Event|0|||
164194338|NCT02106351|593079435|FG000|Treatment Cycle 3|Consent withdrawn|0|||
164194339|NCT02106351|593079436|FG001|Treatment Cycle 3|Consent withdrawn|0|||
164194340|NCT02106351|593079437|FG002|Treatment Cycle 3|Consent withdrawn|2|||
164194341|NCT02106351|593079435|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
164194342|NCT02106351|593079436|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
164194343|NCT02106351|593079437|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
164194344|NCT02106351|593079435|FG000|Treatment Cycle 3|Other|0|||
164194345|NCT02106351|593079436|FG001|Treatment Cycle 3|Other|2|||
164194346|NCT02106351|593079437|FG002|Treatment Cycle 3|Other|3|||
164194347|NCT02106351|593079435|FG000|Treatment Cycle 4|Consent withdrawn|0|||
164194348|NCT02106351|593079436|FG001|Treatment Cycle 4|Consent withdrawn|0|||
164194349|NCT02106351|593079437|FG002|Treatment Cycle 4|Consent withdrawn|2|||
164194350|NCT02106351|593079435|FG000|Treatment Cycle 4|Other|0|||
164194351|NCT02106351|593079436|FG001|Treatment Cycle 4|Other|1|||
164194352|NCT02106351|593079437|FG002|Treatment Cycle 4|Other|0|||
164194353|NCT01801111|593079438|FG000|Overall Study|Adverse Event|12|||
164194354|NCT01801111|593079438|FG000|Overall Study|Death|8|||
164194355|NCT01801111|593079438|FG000|Overall Study|Physician Decision|5|||
164194356|NCT01801111|593079438|FG000|Overall Study|Other|1|||
164194357|NCT01801111|593079438|FG000|Overall Study|Withdrawal by Subject|4|||
164194358|NCT01801111|593079438|FG000|Overall Study|Study Terminated by Sponsor|27|||
164194359|NCT01801111|593079438|FG000|Overall Study|Progressive Disease|81|||
164194360|NCT01210482|593079439|FG000|Overall Study|Protocol Violation|1|||
164194361|NCT01210482|593079439|FG000|Overall Study|Case Report Forms were not collected|18|||
164194362|NCT01210482|593079439|FG000|Overall Study|Duplicated|2|||
164194363|NCT01210482|593079439|FG000|Overall Study|No Drug Administration|28|||
164194364|NCT01223937|593079440|FG000|Overall Study|Withdrawal by Subject|3|||
164194365|NCT01223937|593079441|FG001|Overall Study|Withdrawal by Subject|2|||
164194366|NCT01223937|593079440|FG000|Overall Study|Lost to Follow-up|1|||
164194367|NCT01223937|593079441|FG001|Overall Study|Lost to Follow-up|4|||
164194368|NCT01223937|593079440|FG000|Overall Study|Adverse Event|1|||
164194369|NCT01223937|593079441|FG001|Overall Study|Adverse Event|4|||
164194370|NCT01223937|593079440|FG000|Overall Study|Protocol Violation|8|||
164194371|NCT01223937|593079441|FG001|Overall Study|Protocol Violation|7|||
164194372|NCT01223937|593079440|FG000|Overall Study|Other|4|||
164194373|NCT01223937|593079441|FG001|Overall Study|Other|1|||
164194374|NCT05176717|593079442|FG000|Overall Study|Sponsor Decision|1|||
164194375|NCT05176717|593079443|FG001|Overall Study|Sponsor Decision|2|||
164194376|NCT05176717|593079444|FG002|Overall Study|Sponsor Decision|2|||
164194377|NCT03284853|593079445|FG000|Overall Study|Adverse Event|40|||
164194378|NCT03284853|593079446|FG001|Overall Study|Adverse Event|4|||
164194379|NCT03284853|593079445|FG000|Overall Study|Withdrawal by Subject|5|||
164194380|NCT03284853|593079446|FG001|Overall Study|Withdrawal by Subject|1|||
164194381|NCT03284853|593079445|FG000|Overall Study|Lost to Follow-up|1|||
164194382|NCT03284853|593079446|FG001|Overall Study|Lost to Follow-up|0|||
164194383|NCT03284853|593079445|FG000|Overall Study|Lack of Efficacy|1|||
164194384|NCT03284853|593079446|FG001|Overall Study|Lack of Efficacy|0|||
164194385|NCT03284853|593079445|FG000|Overall Study|Disallowed Concurrent Medication|1|||
164194386|NCT03284853|593079446|FG001|Overall Study|Disallowed Concurrent Medication|1|||
164194387|NCT03284853|593079445|FG000|Overall Study|Protocol Violation|3|||
164194388|NCT03284853|593079446|FG001|Overall Study|Protocol Violation|3|||
164194389|NCT03284853|593079445|FG000|Overall Study|Death|0|||
164194390|NCT03284853|593079446|FG001|Overall Study|Death|1|||
163857865|NCT02715258|591850107|FG001|Overall Study|Subject non-compliant|1|||
163857866|NCT02715258|591850106|FG000|Overall Study|GCP violation|2|||
163857867|NCT02715258|591850107|FG001|Overall Study|GCP violation|1|||
164194391|NCT03284853|593079445|FG000|Overall Study|Other - Reason not reported in CSR|4|||
164194392|NCT03284853|593079446|FG001|Overall Study|Other - Reason not reported in CSR|3|||
164194393|NCT00765817|593079448|FG000|Overall Study|Adverse Event|13|||
164194394|NCT00765817|593079449|FG001|Overall Study|Adverse Event|1|||
164194395|NCT00765817|593079448|FG000|Overall Study|Death|0|||
164194396|NCT00765817|593079449|FG001|Overall Study|Death|1|||
164194397|NCT00765817|593079448|FG000|Overall Study|Entry criteria not met|2|||
164194398|NCT00765817|593079449|FG001|Overall Study|Entry criteria not met|2|||
164194399|NCT00765817|593079448|FG000|Overall Study|Loss of glucose control|0|||
164194400|NCT00765817|593079449|FG001|Overall Study|Loss of glucose control|2|||
164194401|NCT00765817|593079448|FG000|Overall Study|Lost to Follow-up|1|||
164194402|NCT00765817|593079449|FG001|Overall Study|Lost to Follow-up|3|||
164194403|NCT00765817|593079448|FG000|Overall Study|Physician Decision|2|||
164194404|NCT00765817|593079449|FG001|Overall Study|Physician Decision|1|||
164194405|NCT00765817|593079448|FG000|Overall Study|Protocol Violation|1|||
163857868|NCT04310579|591850108|FG000|Overall Study|Adverse Event|0|||
163857869|NCT04310579|591850109|FG001|Overall Study|Adverse Event|0|||
163857870|NCT04310579|591850110|FG002|Overall Study|Adverse Event|0|||
163965055|NCT01822522|592244812|FG001|Overall Study|Lost to Follow-up|0|||
164194406|NCT00765817|593079449|FG001|Overall Study|Protocol Violation|1|||
163857871|NCT04310579|591850111|FG003|Overall Study|Adverse Event|0|||
163857872|NCT04310579|591850112|FG004|Overall Study|Adverse Event|0|||
163857873|NCT04310579|591850113|FG005|Overall Study|Adverse Event|0|||
163857874|NCT04310579|591850114|FG006|Overall Study|Adverse Event|2|||
164194407|NCT00765817|593079448|FG000|Overall Study|Subject decision|7|||
164194408|NCT00765817|593079449|FG001|Overall Study|Subject decision|11|||
164194409|NCT02058589|593079451|FG000|Overall Study|Serious Adverse Event|1|||
164194410|NCT02058589|593079452|FG001|Overall Study|Serious Adverse Event|1|||
163857875|NCT04310579|591850115|FG007|Overall Study|Adverse Event|0|||
163857876|NCT04310579|591850116|FG008|Overall Study|Adverse Event|1|||
164194411|NCT02058589|593079451|FG000|Overall Study|Non-Serious Adverse Event|1|||
164194412|NCT02058589|593079452|FG001|Overall Study|Non-Serious Adverse Event|0|||
164194413|NCT02058589|593079451|FG000|Overall Study|Withdrawal by Subject|0|||
164194414|NCT02058589|593079452|FG001|Overall Study|Withdrawal by Subject|1|||
164194415|NCT02143024|593079453|FG000|Overall Study|Lost to Follow-up|1|||
164194416|NCT02143024|593079454|FG001|Overall Study|Lost to Follow-up|1|||
164194417|NCT02143024|593079453|FG000|Overall Study|Withdrawal by Subject|1|||
164194418|NCT02143024|593079454|FG001|Overall Study|Withdrawal by Subject|0|||
164194419|NCT02308228|593079455|FG000|Overall Study|Adverse Event|3|||
164194420|NCT02308228|593079456|FG001|Overall Study|Adverse Event|4|||
164194421|NCT02308228|593079455|FG000|Overall Study|Withdrawal by Subject|5|||
164194422|NCT02308228|593079456|FG001|Overall Study|Withdrawal by Subject|3|||
164194423|NCT06597084|593079457|FG000|Overall Study|Withdrawal by Subject|4|||
164194424|NCT06597084|593079458|FG001|Overall Study|Withdrawal by Subject|9|||
164194425|NCT06597084|593079457|FG000|Overall Study|Consent was not given by the patient until V2|0|||
164194426|NCT06597084|593079458|FG001|Overall Study|Consent was not given by the patient until V2|3|||
164194427|NCT06597084|593079457|FG000|Overall Study|Physician Decision|1|||
164194428|NCT06597084|593079458|FG001|Overall Study|Physician Decision|0|||
164194429|NCT06597084|593079457|FG000|Overall Study|Adverse Event|3|||
164194430|NCT06597084|593079458|FG001|Overall Study|Adverse Event|2|||
164194431|NCT06597084|593079457|FG000|Overall Study|Death|4|||
164194432|NCT06597084|593079458|FG001|Overall Study|Death|0|||
164194433|NCT06597084|593079457|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
164194434|NCT06597084|593079458|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
164194435|NCT06597084|593079457|FG000|Overall Study|Lost to Follow-up|4|||
164194436|NCT06597084|593079458|FG001|Overall Study|Lost to Follow-up|2|||
164194437|NCT06597084|593079457|FG000|Overall Study|Other. Not specified|1|||
164194438|NCT06597084|593079458|FG001|Overall Study|Other. Not specified|0|||
164194439|NCT00490971|593079463|FG000|Acute/Continuation|Adverse Event|62|||
164194440|NCT00490971|593079464|FG001|Acute/Continuation|Adverse Event|13|||
164194441|NCT00490971|593079465|FG002|Acute/Continuation|Adverse Event|0|||
164194442|NCT00490971|593079466|FG003|Acute/Continuation|Adverse Event|0|||
164194443|NCT00490971|593079467|FG004|Acute/Continuation|Adverse Event|0|||
164194444|NCT00490971|593079463|FG000|Acute/Continuation|Death|2|||
164194445|NCT00490971|593079464|FG001|Acute/Continuation|Death|0|||
164194446|NCT00490971|593079465|FG002|Acute/Continuation|Death|0|||
164194447|NCT00490971|593079466|FG003|Acute/Continuation|Death|0|||
164194448|NCT00490971|593079467|FG004|Acute/Continuation|Death|0|||
164194449|NCT00490971|593079463|FG000|Acute/Continuation|Lack of Efficacy|106|||
164194450|NCT00490971|593079464|FG001|Acute/Continuation|Lack of Efficacy|12|||
164194451|NCT00490971|593079465|FG002|Acute/Continuation|Lack of Efficacy|0|||
164194452|NCT00490971|593079466|FG003|Acute/Continuation|Lack of Efficacy|0|||
164194453|NCT00490971|593079467|FG004|Acute/Continuation|Lack of Efficacy|0|||
164194454|NCT00490971|593079463|FG000|Acute/Continuation|Lost to Follow-up|23|||
164194455|NCT00490971|593079464|FG001|Acute/Continuation|Lost to Follow-up|7|||
163857877|NCT04310579|591850117|FG009|Overall Study|Adverse Event|1|||
163857878|NCT04310579|591850118|FG010|Overall Study|Adverse Event|0|||
163857879|NCT04310579|591850108|FG000|Overall Study|Withdrawal by Subject|0|||
163857880|NCT04310579|591850109|FG001|Overall Study|Withdrawal by Subject|0|||
163857881|NCT04310579|591850110|FG002|Overall Study|Withdrawal by Subject|0|||
163857882|NCT04310579|591850111|FG003|Overall Study|Withdrawal by Subject|0|||
163857883|NCT04310579|591850112|FG004|Overall Study|Withdrawal by Subject|0|||
164194456|NCT00490971|593079465|FG002|Acute/Continuation|Lost to Follow-up|0|||
163857884|NCT04310579|591850113|FG005|Overall Study|Withdrawal by Subject|1|||
163857885|NCT04310579|591850114|FG006|Overall Study|Withdrawal by Subject|0|||
163965056|NCT01822522|592244813|FG002|Overall Study|Lost to Follow-up|1|||
164194457|NCT00490971|593079466|FG003|Acute/Continuation|Lost to Follow-up|0|||
164194458|NCT00490971|593079467|FG004|Acute/Continuation|Lost to Follow-up|0|||
164194459|NCT00490971|593079463|FG000|Acute/Continuation|Protocol Violation|10|||
164194460|NCT00490971|593079464|FG001|Acute/Continuation|Protocol Violation|2|||
164194461|NCT00490971|593079465|FG002|Acute/Continuation|Protocol Violation|0|||
164194462|NCT00490971|593079466|FG003|Acute/Continuation|Protocol Violation|0|||
164194463|NCT00490971|593079467|FG004|Acute/Continuation|Protocol Violation|0|||
163857886|NCT04310579|591850115|FG007|Overall Study|Withdrawal by Subject|0|||
163857887|NCT04310579|591850116|FG008|Overall Study|Withdrawal by Subject|0|||
163857888|NCT04310579|591850117|FG009|Overall Study|Withdrawal by Subject|0|||
163857889|NCT04310579|591850118|FG010|Overall Study|Withdrawal by Subject|0|||
163857890|NCT04310579|591850108|FG000|Overall Study|Positive COVID-19 test|0|||
163857891|NCT04310579|591850109|FG001|Overall Study|Positive COVID-19 test|0|||
163857892|NCT04310579|591850110|FG002|Overall Study|Positive COVID-19 test|0|||
163857893|NCT04310579|591850111|FG003|Overall Study|Positive COVID-19 test|0|||
163857894|NCT04310579|591850112|FG004|Overall Study|Positive COVID-19 test|0|||
163857895|NCT04310579|591850113|FG005|Overall Study|Positive COVID-19 test|0|||
163857896|NCT04310579|591850114|FG006|Overall Study|Positive COVID-19 test|0|||
163857897|NCT04310579|591850115|FG007|Overall Study|Positive COVID-19 test|0|||
163857898|NCT04310579|591850116|FG008|Overall Study|Positive COVID-19 test|0|||
163857899|NCT04310579|591850117|FG009|Overall Study|Positive COVID-19 test|0|||
163857900|NCT04310579|591850118|FG010|Overall Study|Positive COVID-19 test|1|||
163857901|NCT01280591|591850128|FG000|Overall Study|Withdrawal by Subject|0|||
163857902|NCT01280591|591850129|FG001|Overall Study|Withdrawal by Subject|0|||
163857903|NCT01280591|591850130|FG002|Overall Study|Withdrawal by Subject|0|||
163857904|NCT01280591|591850131|FG003|Overall Study|Withdrawal by Subject|2|||
163857905|NCT01280591|591850128|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
163857906|NCT01280591|591850129|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
163857907|NCT01280591|591850130|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
163857908|NCT01280591|591850131|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
163857909|NCT02263508|591850132|FG000|Overall Study|Withdrawal by Subject|1|||
163857910|NCT02263508|591850133|FG001|Overall Study|Withdrawal by Subject|23|||
163857911|NCT02263508|591850134|FG002|Overall Study|Withdrawal by Subject|17|||
163857912|NCT02263508|591850132|FG000|Overall Study|Sponsor Decision|12|||
163857913|NCT02263508|591850133|FG001|Overall Study|Sponsor Decision|165|||
163857914|NCT02263508|591850134|FG002|Overall Study|Sponsor Decision|182|||
163857915|NCT02263508|591850132|FG000|Overall Study|Lost to Follow-up|2|||
163857916|NCT02263508|591850133|FG001|Overall Study|Lost to Follow-up|7|||
163857917|NCT02263508|591850134|FG002|Overall Study|Lost to Follow-up|7|||
163857918|NCT02263508|591850132|FG000|Overall Study|Death|6|||
163857919|NCT02263508|591850133|FG001|Overall Study|Death|151|||
163857920|NCT02263508|591850134|FG002|Overall Study|Death|140|||
163857921|NCT04148937|591850135|FG000|Overall Study|Withdrawal by Subject|0|||
163857922|NCT04148937|591850136|FG001|Overall Study|Withdrawal by Subject|0|||
163857923|NCT04148937|591850137|FG002|Overall Study|Withdrawal by Subject|0|||
163857924|NCT04148937|591850138|FG003|Overall Study|Withdrawal by Subject|1|||
163857925|NCT04148937|591850139|FG004|Overall Study|Withdrawal by Subject|0|||
163857926|NCT04148937|591850140|FG005|Overall Study|Withdrawal by Subject|1|||
163857927|NCT04148937|591850141|FG006|Overall Study|Withdrawal by Subject|1|||
163857928|NCT04148937|591850142|FG007|Overall Study|Withdrawal by Subject|0|||
163857929|NCT04148937|591850135|FG000|Overall Study|Lost to Follow-up|0|||
163857930|NCT04148937|591850136|FG001|Overall Study|Lost to Follow-up|0|||
163857931|NCT04148937|591850137|FG002|Overall Study|Lost to Follow-up|1|||
163857932|NCT04148937|591850138|FG003|Overall Study|Lost to Follow-up|0|||
163857933|NCT04148937|591850139|FG004|Overall Study|Lost to Follow-up|0|||
163857934|NCT04148937|591850140|FG005|Overall Study|Lost to Follow-up|2|||
163857935|NCT04148937|591850141|FG006|Overall Study|Lost to Follow-up|0|||
163857936|NCT04148937|591850142|FG007|Overall Study|Lost to Follow-up|0|||
164194464|NCT00490971|593079463|FG000|Acute/Continuation|Withdrawal by Subject|92|||
164194465|NCT00490971|593079464|FG001|Acute/Continuation|Withdrawal by Subject|24|||
163857937|NCT00686517|591850143|FG000|Treatment|Serious Adverse Event|1|||
163857938|NCT00686517|591850144|FG001|Treatment|Serious Adverse Event|2|||
163857939|NCT00686517|591850145|FG002|Treatment|Serious Adverse Event|1|||
163857940|NCT00686517|591850143|FG000|Treatment|Adverse Event|2|||
163857941|NCT00686517|591850144|FG001|Treatment|Adverse Event|0|||
163857942|NCT00686517|591850145|FG002|Treatment|Adverse Event|0|||
163965057|NCT01822522|592244814|FG003|Overall Study|Lost to Follow-up|1|||
164194466|NCT00490971|593079465|FG002|Acute/Continuation|Withdrawal by Subject|0|||
164194467|NCT00490971|593079466|FG003|Acute/Continuation|Withdrawal by Subject|0|||
163965058|NCT01822522|592244815|FG004|Overall Study|Lost to Follow-up|0|||
164194468|NCT00490971|593079467|FG004|Acute/Continuation|Withdrawal by Subject|0|||
164194469|NCT00490971|593079463|FG000|Acute/Continuation|Other|11|||
163965059|NCT01822522|592244816|FG005|Overall Study|Lost to Follow-up|1|||
164194470|NCT00490971|593079464|FG001|Acute/Continuation|Other|4|||
164194471|NCT00490971|593079465|FG002|Acute/Continuation|Other|0|||
163857943|NCT00686517|591850143|FG000|Treatment|Poor Protocol Compliance|1|||
163857944|NCT00686517|591850144|FG001|Treatment|Poor Protocol Compliance|0|||
163857945|NCT00686517|591850145|FG002|Treatment|Poor Protocol Compliance|0|||
163857946|NCT00686517|591850143|FG000|Treatment|Protocol Violation|2|||
163857947|NCT00686517|591850144|FG001|Treatment|Protocol Violation|1|||
163857948|NCT00686517|591850145|FG002|Treatment|Protocol Violation|0|||
163857949|NCT01167426|591850146|FG000|Overall Study|Lost to Follow-up|6|||
163857950|NCT01167426|591850146|FG000|Overall Study|Protocol Violation|1|||
163857951|NCT01167426|591850146|FG000|Overall Study|Withdrawal by Subject|2|||
163965060|NCT01822522|592244811|FG000|Overall Study|Withdrawal by Subject|0|||
164194472|NCT00490971|593079466|FG003|Acute/Continuation|Other|0|||
164194473|NCT00490971|593079467|FG004|Acute/Continuation|Other|0|||
164194474|NCT00490971|593079463|FG000|Maintenance|Adverse Event|0|||
164194475|NCT00490971|593079464|FG001|Maintenance|Adverse Event|0|||
164194476|NCT00490971|593079465|FG002|Maintenance|Adverse Event|4|||
164194477|NCT00490971|593079466|FG003|Maintenance|Adverse Event|5|||
164194478|NCT00490971|593079467|FG004|Maintenance|Adverse Event|7|||
164194479|NCT00490971|593079463|FG000|Maintenance|Death|0|||
164194480|NCT00490971|593079464|FG001|Maintenance|Death|0|||
164194481|NCT00490971|593079465|FG002|Maintenance|Death|0|||
164194482|NCT00490971|593079466|FG003|Maintenance|Death|2|||
164194483|NCT00490971|593079467|FG004|Maintenance|Death|0|||
164194484|NCT00490971|593079463|FG000|Maintenance|Lost to Follow-up|0|||
164194485|NCT00490971|593079464|FG001|Maintenance|Lost to Follow-up|0|||
164194486|NCT00490971|593079465|FG002|Maintenance|Lost to Follow-up|5|||
164194487|NCT00490971|593079466|FG003|Maintenance|Lost to Follow-up|8|||
164194488|NCT00490971|593079467|FG004|Maintenance|Lost to Follow-up|10|||
164194489|NCT00490971|593079463|FG000|Maintenance|Pregnancy|0|||
164194490|NCT00490971|593079464|FG001|Maintenance|Pregnancy|0|||
164194491|NCT00490971|593079465|FG002|Maintenance|Pregnancy|1|||
164194492|NCT00490971|593079466|FG003|Maintenance|Pregnancy|0|||
164194493|NCT00490971|593079467|FG004|Maintenance|Pregnancy|0|||
164194494|NCT00490971|593079463|FG000|Maintenance|Protocol Violation|0|||
164194495|NCT00490971|593079464|FG001|Maintenance|Protocol Violation|0|||
164194496|NCT00490971|593079465|FG002|Maintenance|Protocol Violation|4|||
164194497|NCT00490971|593079466|FG003|Maintenance|Protocol Violation|1|||
164194498|NCT00490971|593079467|FG004|Maintenance|Protocol Violation|1|||
164194499|NCT00490971|593079463|FG000|Maintenance|Withdrawal by Subject|0|||
164194500|NCT00490971|593079464|FG001|Maintenance|Withdrawal by Subject|0|||
164194501|NCT00490971|593079465|FG002|Maintenance|Withdrawal by Subject|26|||
164194502|NCT00490971|593079466|FG003|Maintenance|Withdrawal by Subject|28|||
164194503|NCT00490971|593079467|FG004|Maintenance|Withdrawal by Subject|18|||
164194504|NCT00490971|593079463|FG000|Maintenance|Other|0|||
164194505|NCT00490971|593079464|FG001|Maintenance|Other|0|||
164194506|NCT00490971|593079465|FG002|Maintenance|Other|11|||
164194507|NCT00490971|593079466|FG003|Maintenance|Other|9|||
164194508|NCT00490971|593079467|FG004|Maintenance|Other|3|||
164194509|NCT03999749|593079469|FG000|Overall Study|Toxicity|16|||
163857952|NCT01167426|591850146|FG000|Overall Study|Sponsor Decision|1|||
163857953|NCT04044664|591850148|FG000|Stage 1|Adverse Event|3|||
163857954|NCT04044664|591850149|FG001|Stage 1|Adverse Event|3|||
163857955|NCT04044664|591850150|FG002|Stage 1|Adverse Event|1|||
163857956|NCT04044664|591850148|FG000|Stage 1|Lost to Follow-up|3|||
163857957|NCT04044664|591850149|FG001|Stage 1|Lost to Follow-up|2|||
163857958|NCT04044664|591850150|FG002|Stage 1|Lost to Follow-up|2|||
163857959|NCT04044664|591850148|FG000|Stage 1|Withdrawal by Subject|9|||
163857960|NCT04044664|591850149|FG001|Stage 1|Withdrawal by Subject|1|||
163857961|NCT04044664|591850150|FG002|Stage 1|Withdrawal by Subject|0|||
163857962|NCT04044664|591850148|FG000|Stage 1|noncompliance, personal reason|2|||
163857963|NCT04044664|591850149|FG001|Stage 1|noncompliance, personal reason|0|||
163857964|NCT04044664|591850150|FG002|Stage 1|noncompliance, personal reason|0|||
163857965|NCT04044664|591850148|FG000|Stage 1|randomization error|0|||
163857966|NCT04044664|591850149|FG001|Stage 1|randomization error|1|||
163857967|NCT04044664|591850150|FG002|Stage 1|randomization error|0|||
163857968|NCT04044664|591850148|FG000|Stage 2|Adverse Event|2|||
163857969|NCT04044664|591850149|FG001|Stage 2|Adverse Event|0|||
163857970|NCT04044664|591850150|FG002|Stage 2|Adverse Event|0|||
163857971|NCT04044664|591850148|FG000|Stage 2|Lost to Follow-up|3|||
163857972|NCT04044664|591850149|FG001|Stage 2|Lost to Follow-up|2|||
164194510|NCT03999749|593079469|FG000|Overall Study|Withdrawal by Subject|3|||
164194511|NCT03999749|593079469|FG000|Overall Study|Disease progression|26|||
164194512|NCT03999749|593079469|FG000|Overall Study|Physician Decision|4|||
164194513|NCT03999749|593079469|FG000|Overall Study|Death|5|||
164194514|NCT03999749|593079469|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
164194515|NCT00255164|593079470|FG000|Overall Study|Adverse Event|10|||
164194516|NCT00255164|593079471|FG001|Overall Study|Adverse Event|6|||
164194517|NCT00255164|593079472|FG002|Overall Study|Adverse Event|9|||
164194518|NCT00255164|593079470|FG000|Overall Study|Lost to Follow-up|4|||
164194519|NCT00255164|593079471|FG001|Overall Study|Lost to Follow-up|3|||
164194520|NCT00255164|593079472|FG002|Overall Study|Lost to Follow-up|4|||
163857973|NCT04044664|591850150|FG002|Stage 2|Lost to Follow-up|1|||
163857974|NCT04044664|591850148|FG000|Stage 2|Withdrawal by Subject|3|||
163857975|NCT04044664|591850149|FG001|Stage 2|Withdrawal by Subject|0|||
163857976|NCT04044664|591850150|FG002|Stage 2|Withdrawal by Subject|0|||
163857977|NCT04044664|591850148|FG000|Stage 2|protocol deviation|1|||
164194521|NCT00255164|593079470|FG000|Overall Study|Withdrawal by Subject|18|||
164194522|NCT00255164|593079471|FG001|Overall Study|Withdrawal by Subject|17|||
164194523|NCT00255164|593079472|FG002|Overall Study|Withdrawal by Subject|8|||
163857978|NCT04044664|591850149|FG001|Stage 2|protocol deviation|0|||
164194524|NCT00255164|593079470|FG000|Overall Study|Noncompliance|0|||
164194525|NCT00255164|593079471|FG001|Overall Study|Noncompliance|1|||
164194526|NCT00255164|593079472|FG002|Overall Study|Noncompliance|2|||
164194527|NCT00255164|593079470|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
164194528|NCT00255164|593079471|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
163857979|NCT04044664|591850150|FG002|Stage 2|protocol deviation|0|||
163857980|NCT00001575|591850154|FG000|Overall Study|Screening failures-Ph I portion|22|||
163857981|NCT00001575|591850154|FG000|Overall Study|Withdrawn/deaths|23|||
163857982|NCT00831792|591850157|FG000|Overall Study|Not Eligible|3|||
163857983|NCT00831792|591850157|FG000|Overall Study|Adverse Event|1|||
163857984|NCT00831792|591850157|FG000|Overall Study|Death|1|||
163857985|NCT00831792|591850157|FG000|Overall Study|Lack of Efficacy|1|||
163857986|NCT03736785|591850158|FG000|Overall Study|Adverse Event|1|||
163857987|NCT03736785|591850159|FG001|Overall Study|Adverse Event|1|||
163857988|NCT03736785|591850160|FG002|Overall Study|Adverse Event|1|||
163965061|NCT01822522|592244812|FG001|Overall Study|Withdrawal by Subject|0|||
163965062|NCT01822522|592244813|FG002|Overall Study|Withdrawal by Subject|0|||
163965063|NCT01822522|592244814|FG003|Overall Study|Withdrawal by Subject|1|||
163965064|NCT01822522|592244815|FG004|Overall Study|Withdrawal by Subject|0|||
163857989|NCT03736785|591850158|FG000|Overall Study|Death|1|||
163857990|NCT03736785|591850159|FG001|Overall Study|Death|0|||
163857991|NCT03736785|591850160|FG002|Overall Study|Death|1|||
163857992|NCT03736785|591850158|FG000|Overall Study|Lost to Follow-up|0|||
163857993|NCT03736785|591850159|FG001|Overall Study|Lost to Follow-up|2|||
163857994|NCT03736785|591850160|FG002|Overall Study|Lost to Follow-up|3|||
163857995|NCT03736785|591850158|FG000|Overall Study|Non compliance with study drug|1|||
163857996|NCT03736785|591850159|FG001|Overall Study|Non compliance with study drug|1|||
163857997|NCT03736785|591850160|FG002|Overall Study|Non compliance with study drug|0|||
163857998|NCT03736785|591850158|FG000|Overall Study|Physician Decision|0|||
163857999|NCT03736785|591850159|FG001|Overall Study|Physician Decision|1|||
163858000|NCT03736785|591850160|FG002|Overall Study|Physician Decision|1|||
163858001|NCT03736785|591850158|FG000|Overall Study|Protocol Violation|1|||
163858002|NCT03736785|591850159|FG001|Overall Study|Protocol Violation|4|||
163858003|NCT03736785|591850160|FG002|Overall Study|Protocol Violation|3|||
163858004|NCT03736785|591850158|FG000|Overall Study|Sponsor Decision|1|||
163858005|NCT03736785|591850159|FG001|Overall Study|Sponsor Decision|0|||
163858006|NCT03736785|591850160|FG002|Overall Study|Sponsor Decision|0|||
163858007|NCT03736785|591850158|FG000|Overall Study|Unknown/Missing data|3|||
163858008|NCT03736785|591850159|FG001|Overall Study|Unknown/Missing data|2|||
163858009|NCT03736785|591850160|FG002|Overall Study|Unknown/Missing data|1|||
163858010|NCT03736785|591850158|FG000|Overall Study|Withdrawal by Subject|9|||
163858011|NCT03736785|591850159|FG001|Overall Study|Withdrawal by Subject|6|||
163858012|NCT03736785|591850160|FG002|Overall Study|Withdrawal by Subject|4|||
163858013|NCT02974010|591850163|FG000|Overall Study|Lost to Follow-up|3|||
163858014|NCT02974010|591850164|FG001|Overall Study|Lost to Follow-up|1|||
163858015|NCT02974010|591850165|FG002|Overall Study|Lost to Follow-up|0|||
163858016|NCT02974010|591850166|FG003|Overall Study|Lost to Follow-up|0|||
163858017|NCT02974010|591850163|FG000|Overall Study|Withdrawal by Subject|2|||
163858018|NCT02974010|591850164|FG001|Overall Study|Withdrawal by Subject|1|||
163858019|NCT02974010|591850165|FG002|Overall Study|Withdrawal by Subject|0|||
163858020|NCT02974010|591850166|FG003|Overall Study|Withdrawal by Subject|0|||
163858021|NCT02974010|591850163|FG000|Overall Study|Adverse Event|0|||
163858022|NCT02974010|591850164|FG001|Overall Study|Adverse Event|1|||
163858023|NCT02974010|591850165|FG002|Overall Study|Adverse Event|0|||
163858024|NCT02974010|591850166|FG003|Overall Study|Adverse Event|0|||
163858025|NCT02974010|591850163|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
163858026|NCT02974010|591850164|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
163858027|NCT02974010|591850165|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
163858028|NCT02974010|591850166|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
163858029|NCT02974010|591850163|FG000|Overall Study|Lack of Efficacy|0|||
163858030|NCT02974010|591850164|FG001|Overall Study|Lack of Efficacy|0|||
163858031|NCT02974010|591850165|FG002|Overall Study|Lack of Efficacy|1|||
163858032|NCT02974010|591850166|FG003|Overall Study|Lack of Efficacy|0|||
163858033|NCT03256344|591850167|FG000|Overall Study|Death|6|||
163858034|NCT03256344|591850168|FG001|Overall Study|Death|22|||
163858035|NCT03256344|591850167|FG000|Overall Study|Withdrawal by Subject|3|||
163858036|NCT03256344|591850168|FG001|Overall Study|Withdrawal by Subject|3|||
163858037|NCT03256344|591850167|FG000|Overall Study|Sponsor Decision|1|||
163965065|NCT01822522|592244816|FG005|Overall Study|Withdrawal by Subject|0|||
163965066|NCT01822522|592244811|FG000|Overall Study|Lack of Efficacy|0|||
163858038|NCT03256344|591850168|FG001|Overall Study|Sponsor Decision|0|||
163858039|NCT00880906|591850169|FG000|Overall Study|Lost to Follow-up|0|||
163858040|NCT00880906|591850170|FG001|Overall Study|Lost to Follow-up|1|||
163965067|NCT01822522|592244812|FG001|Overall Study|Lack of Efficacy|0|||
164194529|NCT00255164|593079472|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
163858041|NCT00880906|591850169|FG000|Overall Study|Did not meet criteria following patholog|12|||
163858042|NCT00880906|591850170|FG001|Overall Study|Did not meet criteria following patholog|6|||
163858043|NCT04163458|591850171|FG000|Overall Study|Protocol Deviation|7|||
163858044|NCT04163458|591850172|FG001|Overall Study|Protocol Deviation|13|||
163858045|NCT04163458|591850171|FG000|Overall Study|Adverse Event|5|||
163965068|NCT01822522|592244813|FG002|Overall Study|Lack of Efficacy|0|||
163858046|NCT04163458|591850172|FG001|Overall Study|Adverse Event|8|||
163965069|NCT01822522|592244814|FG003|Overall Study|Lack of Efficacy|0|||
163858047|NCT04163458|591850171|FG000|Overall Study|Due to COVID-19 pandemic|4|||
163858048|NCT04163458|591850172|FG001|Overall Study|Due to COVID-19 pandemic|2|||
163858049|NCT04163458|591850171|FG000|Overall Study|Participant withdrew consent|2|||
163858050|NCT04163458|591850172|FG001|Overall Study|Participant withdrew consent|3|||
163858051|NCT04163458|591850171|FG000|Overall Study|Randomization failure|2|||
163858052|NCT04163458|591850172|FG001|Overall Study|Randomization failure|2|||
163858053|NCT04163458|591850171|FG000|Overall Study|Other|4|||
163858054|NCT04163458|591850172|FG001|Overall Study|Other|2|||
163858055|NCT03852433|591850173|FG000|Overall Study|Withdrawal of consent|5|||
163858056|NCT03852433|591850174|FG001|Overall Study|Withdrawal of consent|8|||
163858057|NCT03852433|591850175|FG002|Overall Study|Withdrawal of consent|1|||
163858058|NCT03852433|591850176|FG003|Overall Study|Withdrawal of consent|1|||
163858059|NCT03852433|591850173|FG000|Overall Study|Adverse Event|1|||
163858060|NCT03852433|591850174|FG001|Overall Study|Adverse Event|1|||
163858061|NCT03852433|591850175|FG002|Overall Study|Adverse Event|1|||
163858062|NCT03852433|591850176|FG003|Overall Study|Adverse Event|1|||
163858063|NCT03852433|591850173|FG000|Overall Study|Lost to Follow-up|0|||
163858064|NCT03852433|591850174|FG001|Overall Study|Lost to Follow-up|1|||
163858065|NCT03852433|591850175|FG002|Overall Study|Lost to Follow-up|0|||
163858066|NCT03852433|591850176|FG003|Overall Study|Lost to Follow-up|1|||
163858067|NCT03852433|591850173|FG000|Overall Study|Pregnancy|0|||
163858068|NCT03852433|591850174|FG001|Overall Study|Pregnancy|1|||
163858069|NCT03852433|591850175|FG002|Overall Study|Pregnancy|1|||
163858070|NCT03852433|591850176|FG003|Overall Study|Pregnancy|0|||
163858071|NCT03852433|591850173|FG000|Overall Study|Protocol Violation|0|||
163858072|NCT03852433|591850174|FG001|Overall Study|Protocol Violation|0|||
163858073|NCT03852433|591850175|FG002|Overall Study|Protocol Violation|1|||
163858074|NCT03852433|591850176|FG003|Overall Study|Protocol Violation|1|||
163858075|NCT03852433|591850173|FG000|Overall Study|Death|0|||
163858076|NCT03852433|591850174|FG001|Overall Study|Death|0|||
163858077|NCT03852433|591850175|FG002|Overall Study|Death|1|||
163858078|NCT03852433|591850176|FG003|Overall Study|Death|0|||
163858079|NCT03852433|591850173|FG000|Overall Study|Lack of Efficacy|0|||
163858080|NCT03852433|591850174|FG001|Overall Study|Lack of Efficacy|1|||
163858081|NCT03852433|591850175|FG002|Overall Study|Lack of Efficacy|0|||
163858082|NCT03852433|591850176|FG003|Overall Study|Lack of Efficacy|0|||
163858083|NCT03852433|591850173|FG000|Overall Study|Non-compliance with study drug|0|||
163858084|NCT03852433|591850174|FG001|Overall Study|Non-compliance with study drug|0|||
163858085|NCT03852433|591850175|FG002|Overall Study|Non-compliance with study drug|0|||
163858086|NCT03852433|591850176|FG003|Overall Study|Non-compliance with study drug|1|||
163858087|NCT03852433|591850173|FG000|Overall Study|Physician Decision|1|||
163858088|NCT03852433|591850174|FG001|Overall Study|Physician Decision|0|||
163858089|NCT03852433|591850175|FG002|Overall Study|Physician Decision|0|||
163858090|NCT03852433|591850176|FG003|Overall Study|Physician Decision|0|||
163858091|NCT03852433|591850173|FG000|Overall Study|Randomized but never treated|1|||
163858092|NCT03852433|591850174|FG001|Overall Study|Randomized but never treated|0|||
163858093|NCT03852433|591850175|FG002|Overall Study|Randomized but never treated|0|||
163858094|NCT03852433|591850176|FG003|Overall Study|Randomized but never treated|0|||
163858095|NCT03717194|591850184|FG000|Overall Study|Withdrawal by Subject|2|||
163858096|NCT03717194|591850185|FG001|Overall Study|Withdrawal by Subject|4|||
163858097|NCT03717194|591850184|FG000|Overall Study|Adverse Event|1|||
163858098|NCT03717194|591850185|FG001|Overall Study|Adverse Event|1|||
163858099|NCT03102242|591850186|FG000|Overall Study|Adverse Event|2|||
163858100|NCT00389519|591850187|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
163858101|NCT00389519|591850188|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
163858102|NCT00389519|591850189|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
163858103|NCT00389519|591850190|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
163858104|NCT00389519|591850187|FG000|Placebo Run-In|Withdrawal by Subject|19|||
163858105|NCT00389519|591850188|FG001|Placebo Run-In|Withdrawal by Subject|0|||
163858106|NCT00389519|591850189|FG002|Placebo Run-In|Withdrawal by Subject|0|||
163858107|NCT00389519|591850190|FG003|Placebo Run-In|Withdrawal by Subject|0|||
163858108|NCT00389519|591850187|FG000|Placebo Run-In|Reason not specified|40|||
163858109|NCT00389519|591850188|FG001|Placebo Run-In|Reason not specified|0|||
163858110|NCT00389519|591850189|FG002|Placebo Run-In|Reason not specified|0|||
163858111|NCT00389519|591850190|FG003|Placebo Run-In|Reason not specified|0|||
163858112|NCT00389519|591850187|FG000|Randomized|Did not receive study drug|2|||
163858113|NCT00389519|591850188|FG001|Randomized|Did not receive study drug|0|||
163858114|NCT00389519|591850189|FG002|Randomized|Did not receive study drug|0|||
163858115|NCT00389519|591850190|FG003|Randomized|Did not receive study drug|0|||
163858116|NCT00389519|591850187|FG000|Treated|Adverse Event|1|||
163858117|NCT00389519|591850188|FG001|Treated|Adverse Event|0|||
163858118|NCT00389519|591850189|FG002|Treated|Adverse Event|0|||
163858119|NCT00389519|591850190|FG003|Treated|Adverse Event|2|||
163858120|NCT00389519|591850187|FG000|Treated|Reason not specified|1|||
163858121|NCT00389519|591850188|FG001|Treated|Reason not specified|1|||
163858122|NCT00389519|591850189|FG002|Treated|Reason not specified|0|||
163858123|NCT00389519|591850190|FG003|Treated|Reason not specified|2|||
163858124|NCT03425539|591850191|FG000|Overall Study|Randomized but not treated|0|||
163858125|NCT03425539|591850192|FG001|Overall Study|Randomized but not treated|1|||
163858126|NCT03425539|591850191|FG000|Overall Study|Adverse Event|2|||
163858127|NCT03425539|591850192|FG001|Overall Study|Adverse Event|2|||
163858128|NCT03425539|591850191|FG000|Overall Study|Withdrawal by Subject|3|||
163858129|NCT03425539|591850192|FG001|Overall Study|Withdrawal by Subject|0|||
163858130|NCT03425539|591850191|FG000|Overall Study|Lost to Follow-up|0|||
163858131|NCT03425539|591850192|FG001|Overall Study|Lost to Follow-up|1|||
163858132|NCT00946192|591850193|FG000|Overall Study|Lost to Follow-up|6|||
163858133|NCT00946192|591850194|FG001|Overall Study|Lost to Follow-up|11|||
163858134|NCT00946192|591850195|FG002|Overall Study|Lost to Follow-up|9|||
163858135|NCT00946192|591850193|FG000|Overall Study|Withdrawal by Subject|10|||
163858136|NCT00946192|591850194|FG001|Overall Study|Withdrawal by Subject|7|||
163858137|NCT00946192|591850195|FG002|Overall Study|Withdrawal by Subject|3|||
163858138|NCT00946192|591850193|FG000|Overall Study|Did not start medication|2|||
163858139|NCT00946192|591850194|FG001|Overall Study|Did not start medication|0|||
163858140|NCT00946192|591850195|FG002|Overall Study|Did not start medication|0|||
163858141|NCT01080131|591850196|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
163858142|NCT01080131|591850197|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
163858143|NCT01080131|591850196|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
163858144|NCT01080131|591850197|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
163858145|NCT01080131|591850196|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
163858146|NCT01080131|591850197|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
163858147|NCT01080131|591850196|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
163858148|NCT01080131|591850197|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
163858149|NCT01080131|591850196|FG000|Core Study (0- 12 Weeks)|Death|1|||
163858150|NCT01080131|591850197|FG001|Core Study (0- 12 Weeks)|Death|0|||
163858151|NCT01080131|591850196|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
163858152|NCT01080131|591850197|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
163858153|NCT01080131|591850196|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
163858154|NCT01080131|591850197|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
163858155|NCT01080131|591850196|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
163858156|NCT01080131|591850197|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
163858157|NCT01080131|591850196|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
163858158|NCT01080131|591850197|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
163858159|NCT01080131|591850196|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
163858160|NCT01080131|591850197|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
163858161|NCT01080131|591850196|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
163858162|NCT01080131|591850197|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
163858163|NCT01080131|591850196|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
163858164|NCT01080131|591850197|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
163858165|NCT01080131|591850196|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
163858166|NCT01080131|591850197|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
163858167|NCT04159506|591850198|FG000|Overall Study|Lost to Follow-up|2|||
163858168|NCT04159506|591850199|FG001|Overall Study|Lost to Follow-up|5|||
163858169|NCT02449044|591850200|FG000|Overall Study|Lost to Follow-up|2|||
163858170|NCT02449044|591850200|FG000|Overall Study|Withdrawal by Subject|13|||
163858171|NCT02449044|591850200|FG000|Overall Study|Adverse Event|30|||
163858172|NCT02449044|591850200|FG000|Overall Study|Met Withdrawal Criteria|7|||
163858173|NCT02449044|591850200|FG000|Overall Study|Physician Decision|9|||
163858174|NCT02449044|591850200|FG000|Overall Study|Sponsor Discontinued Trial|3|||
163858175|NCT04057196|591851772|FG000|Overall Study|Withdrawal by Subject|3|||
163858176|NCT04057196|591851772|FG000|Overall Study|Death|3|||
163858177|NCT00739102|591851773|FG000|Overall Study|Death|5|||
163858178|NCT00739102|591851773|FG000|Overall Study|Withdrawal by Subject|10|||
163858179|NCT00149630|591851778|FG000|Overall Study|Incarceration|2|||
163858180|NCT00149630|591851779|FG001|Overall Study|Incarceration|0|||
163858181|NCT00149630|591851778|FG000|Overall Study|Treatment Programs|4|||
163858182|NCT00149630|591851779|FG001|Overall Study|Treatment Programs|5|||
163858183|NCT00149630|591851778|FG000|Overall Study|Adverse Event|2|||
163858184|NCT00149630|591851779|FG001|Overall Study|Adverse Event|0|||
163858185|NCT05298111|591851783|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
163858186|NCT05298111|591851784|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
163858187|NCT00991276|591851792|FG000|First Intervention Period|Adverse Event|0|||
163858188|NCT00991276|591851793|FG001|First Intervention Period|Adverse Event|1|||
163858189|NCT00991276|591851794|FG002|First Intervention Period|Adverse Event|0|||
163858190|NCT00991276|591851795|FG003|First Intervention Period|Adverse Event|1|||
163858191|NCT00991276|591851796|FG004|First Intervention Period|Adverse Event|0|||
163858192|NCT00991276|591851797|FG005|First Intervention Period|Adverse Event|0|||
163858193|NCT00991276|591851792|FG000|First Intervention Period|Protocol Violation|0|||
163858194|NCT00991276|591851793|FG001|First Intervention Period|Protocol Violation|0|||
163858195|NCT00991276|591851794|FG002|First Intervention Period|Protocol Violation|0|||
163858196|NCT00991276|591851795|FG003|First Intervention Period|Protocol Violation|0|||
163858197|NCT00991276|591851796|FG004|First Intervention Period|Protocol Violation|2|||
163858198|NCT00991276|591851797|FG005|First Intervention Period|Protocol Violation|0|||
163858199|NCT00991276|591851792|FG000|First Intervention Period|Insufficient clinical response|0|||
163858200|NCT00991276|591851793|FG001|First Intervention Period|Insufficient clinical response|0|||
163858201|NCT00991276|591851794|FG002|First Intervention Period|Insufficient clinical response|0|||
163858202|NCT00991276|591851795|FG003|First Intervention Period|Insufficient clinical response|0|||
163858203|NCT00991276|591851796|FG004|First Intervention Period|Insufficient clinical response|1|||
163858204|NCT00991276|591851797|FG005|First Intervention Period|Insufficient clinical response|0|||
163858205|NCT00991276|591851792|FG000|First Intervention Period|Other|0|||
163858206|NCT00991276|591851793|FG001|First Intervention Period|Other|0|||
163858207|NCT00991276|591851794|FG002|First Intervention Period|Other|0|||
163858208|NCT00991276|591851795|FG003|First Intervention Period|Other|1|||
163858209|NCT00991276|591851796|FG004|First Intervention Period|Other|1|||
163858210|NCT00991276|591851797|FG005|First Intervention Period|Other|0|||
163858211|NCT00991276|591851792|FG000|First Intervention Period|Withdrawal by Subject|0|||
163858212|NCT00991276|591851793|FG001|First Intervention Period|Withdrawal by Subject|1|||
164194530|NCT00255164|593079470|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
163858213|NCT00991276|591851794|FG002|First Intervention Period|Withdrawal by Subject|0|||
163858214|NCT00991276|591851795|FG003|First Intervention Period|Withdrawal by Subject|1|||
163858215|NCT00991276|591851796|FG004|First Intervention Period|Withdrawal by Subject|0|||
163858216|NCT00991276|591851797|FG005|First Intervention Period|Withdrawal by Subject|1|||
163858217|NCT00991276|591851792|FG000|First Intervention Period|Lost to Follow-up|0|||
163858218|NCT00991276|591851793|FG001|First Intervention Period|Lost to Follow-up|1|||
163858219|NCT00991276|591851794|FG002|First Intervention Period|Lost to Follow-up|0|||
163858220|NCT00991276|591851795|FG003|First Intervention Period|Lost to Follow-up|1|||
163858221|NCT00991276|591851796|FG004|First Intervention Period|Lost to Follow-up|0|||
163858222|NCT00991276|591851797|FG005|First Intervention Period|Lost to Follow-up|0|||
163858223|NCT00991276|591851792|FG000|Second Intervention Period|Adverse Event|0|||
163858224|NCT00991276|591851793|FG001|Second Intervention Period|Adverse Event|2|||
163858225|NCT00991276|591851794|FG002|Second Intervention Period|Adverse Event|0|||
163858226|NCT00991276|591851795|FG003|Second Intervention Period|Adverse Event|1|||
163858227|NCT00991276|591851796|FG004|Second Intervention Period|Adverse Event|1|||
163858228|NCT00991276|591851797|FG005|Second Intervention Period|Adverse Event|0|||
163858229|NCT00991276|591851792|FG000|Second Intervention Period|Protocol Violation|1|||
163858230|NCT00991276|591851793|FG001|Second Intervention Period|Protocol Violation|0|||
163858231|NCT00991276|591851794|FG002|Second Intervention Period|Protocol Violation|0|||
163858232|NCT00991276|591851795|FG003|Second Intervention Period|Protocol Violation|0|||
163858233|NCT00991276|591851796|FG004|Second Intervention Period|Protocol Violation|0|||
163858234|NCT00991276|591851797|FG005|Second Intervention Period|Protocol Violation|0|||
163858235|NCT00991276|591851792|FG000|Second Intervention Period|Other|0|||
163858236|NCT00991276|591851793|FG001|Second Intervention Period|Other|0|||
163858237|NCT00991276|591851794|FG002|Second Intervention Period|Other|0|||
163858238|NCT00991276|591851795|FG003|Second Intervention Period|Other|1|||
163858239|NCT00991276|591851796|FG004|Second Intervention Period|Other|0|||
163858240|NCT00991276|591851797|FG005|Second Intervention Period|Other|1|||
163858241|NCT00991276|591851792|FG000|Third Intervention Period|Protocol Violation|1|||
163858242|NCT00991276|591851793|FG001|Third Intervention Period|Protocol Violation|0|||
163858243|NCT00991276|591851794|FG002|Third Intervention Period|Protocol Violation|0|||
163858244|NCT00991276|591851795|FG003|Third Intervention Period|Protocol Violation|0|||
163858245|NCT00991276|591851796|FG004|Third Intervention Period|Protocol Violation|0|||
163858246|NCT00991276|591851797|FG005|Third Intervention Period|Protocol Violation|0|||
163858247|NCT00991276|591851792|FG000|Third Intervention Period|Other|0|||
163858248|NCT00991276|591851793|FG001|Third Intervention Period|Other|0|||
163858249|NCT00991276|591851794|FG002|Third Intervention Period|Other|0|||
163858250|NCT00991276|591851795|FG003|Third Intervention Period|Other|0|||
163858251|NCT00991276|591851796|FG004|Third Intervention Period|Other|0|||
163858252|NCT00991276|591851797|FG005|Third Intervention Period|Other|1|||
163858253|NCT00991276|591851792|FG000|Third Intervention Period|Adverse Event|0|||
163858254|NCT00991276|591851793|FG001|Third Intervention Period|Adverse Event|0|||
163858255|NCT00991276|591851794|FG002|Third Intervention Period|Adverse Event|1|||
163858256|NCT00991276|591851795|FG003|Third Intervention Period|Adverse Event|0|||
163858257|NCT00991276|591851796|FG004|Third Intervention Period|Adverse Event|0|||
163858258|NCT00991276|591851797|FG005|Third Intervention Period|Adverse Event|0|||
163858259|NCT00991276|591851792|FG000|Third Intervention Period|Withdrawal by Subject|0|||
163858260|NCT00991276|591851793|FG001|Third Intervention Period|Withdrawal by Subject|0|||
163858261|NCT00991276|591851794|FG002|Third Intervention Period|Withdrawal by Subject|0|||
163858262|NCT00991276|591851795|FG003|Third Intervention Period|Withdrawal by Subject|1|||
163858263|NCT00991276|591851796|FG004|Third Intervention Period|Withdrawal by Subject|0|||
163858264|NCT00991276|591851797|FG005|Third Intervention Period|Withdrawal by Subject|0|||
163858265|NCT01268891|591851798|FG000|Overall Study|Adverse Event|3|||
163858266|NCT01268891|591851799|FG001|Overall Study|Adverse Event|7|||
163858267|NCT01268891|591851798|FG000|Overall Study|Lack of Efficacy|1|||
163858268|NCT01268891|591851799|FG001|Overall Study|Lack of Efficacy|0|||
163858269|NCT01268891|591851798|FG000|Overall Study|Withdrawal of Consent|3|||
163965070|NCT01822522|592244815|FG004|Overall Study|Lack of Efficacy|0|||
163965071|NCT01822522|592244816|FG005|Overall Study|Lack of Efficacy|2|||
163858270|NCT01268891|591851799|FG001|Overall Study|Withdrawal of Consent|1|||
163858271|NCT01268891|591851798|FG000|Overall Study|Administrative or other reason(s)|1|||
163858272|NCT01268891|591851799|FG001|Overall Study|Administrative or other reason(s)|0|||
163858273|NCT02001623|591851802|FG000|Overall Study|Disease Progression|2|||
163858274|NCT02001623|591851803|FG001|Overall Study|Disease Progression|2|||
163858275|NCT02001623|591851804|FG002|Overall Study|Disease Progression|3|||
163858276|NCT02001623|591851805|FG003|Overall Study|Disease Progression|2|||
163858277|NCT02001623|591851806|FG004|Overall Study|Disease Progression|3|||
163858278|NCT02001623|591851807|FG005|Overall Study|Disease Progression|2|||
163858279|NCT02001623|591851808|FG006|Overall Study|Disease Progression|3|||
163858280|NCT02001623|591851809|FG007|Overall Study|Disease Progression|3|||
163858281|NCT02001623|591851810|FG008|Overall Study|Disease Progression|7|||
163858282|NCT02001623|591851811|FG009|Overall Study|Disease Progression|40|||
163858283|NCT02001623|591851812|FG010|Overall Study|Disease Progression|5|||
163858284|NCT02001623|591851813|FG011|Overall Study|Disease Progression|9|||
163858285|NCT02001623|591851814|FG012|Overall Study|Disease Progression|9|||
163858286|NCT02001623|591851815|FG013|Overall Study|Disease Progression|20|||
163858287|NCT02001623|591851816|FG014|Overall Study|Disease Progression|9|||
163858288|NCT02001623|591851802|FG000|Overall Study|Physician Decision|0|||
163858289|NCT02001623|591851803|FG001|Overall Study|Physician Decision|0|||
163858290|NCT02001623|591851804|FG002|Overall Study|Physician Decision|0|||
163858291|NCT02001623|591851805|FG003|Overall Study|Physician Decision|0|||
163858292|NCT02001623|591851806|FG004|Overall Study|Physician Decision|0|||
163858293|NCT02001623|591851807|FG005|Overall Study|Physician Decision|0|||
163858294|NCT02001623|591851808|FG006|Overall Study|Physician Decision|0|||
163858295|NCT02001623|591851809|FG007|Overall Study|Physician Decision|0|||
163858296|NCT02001623|591851810|FG008|Overall Study|Physician Decision|3|||
163858297|NCT02001623|591851811|FG009|Overall Study|Physician Decision|2|||
163858298|NCT02001623|591851812|FG010|Overall Study|Physician Decision|3|||
163858299|NCT02001623|591851813|FG011|Overall Study|Physician Decision|3|||
163858300|NCT02001623|591851814|FG012|Overall Study|Physician Decision|1|||
163858301|NCT02001623|591851815|FG013|Overall Study|Physician Decision|2|||
163858302|NCT02001623|591851816|FG014|Overall Study|Physician Decision|1|||
163858303|NCT02001623|591851802|FG000|Overall Study|Death|0|||
163858304|NCT02001623|591851803|FG001|Overall Study|Death|1|||
163858305|NCT02001623|591851804|FG002|Overall Study|Death|0|||
163858306|NCT02001623|591851805|FG003|Overall Study|Death|0|||
163858307|NCT02001623|591851806|FG004|Overall Study|Death|0|||
163858308|NCT02001623|591851807|FG005|Overall Study|Death|0|||
163858309|NCT02001623|591851808|FG006|Overall Study|Death|0|||
163858310|NCT02001623|591851809|FG007|Overall Study|Death|0|||
163858311|NCT02001623|591851810|FG008|Overall Study|Death|0|||
163858312|NCT02001623|591851811|FG009|Overall Study|Death|0|||
163858313|NCT02001623|591851812|FG010|Overall Study|Death|0|||
163858314|NCT02001623|591851813|FG011|Overall Study|Death|0|||
163858315|NCT02001623|591851814|FG012|Overall Study|Death|0|||
163858316|NCT02001623|591851815|FG013|Overall Study|Death|0|||
163858317|NCT02001623|591851816|FG014|Overall Study|Death|0|||
163858318|NCT02001623|591851802|FG000|Overall Study|Adverse Event|0|||
163858319|NCT02001623|591851803|FG001|Overall Study|Adverse Event|0|||
163858320|NCT02001623|591851804|FG002|Overall Study|Adverse Event|0|||
163858321|NCT02001623|591851805|FG003|Overall Study|Adverse Event|0|||
163858322|NCT02001623|591851806|FG004|Overall Study|Adverse Event|0|||
163858323|NCT02001623|591851807|FG005|Overall Study|Adverse Event|1|||
163858324|NCT02001623|591851808|FG006|Overall Study|Adverse Event|0|||
163858325|NCT02001623|591851809|FG007|Overall Study|Adverse Event|3|||
163858326|NCT02001623|591851810|FG008|Overall Study|Adverse Event|4|||
163858327|NCT02001623|591851811|FG009|Overall Study|Adverse Event|6|||
163858328|NCT02001623|591851812|FG010|Overall Study|Adverse Event|4|||
163858329|NCT02001623|591851813|FG011|Overall Study|Adverse Event|0|||
163858330|NCT02001623|591851814|FG012|Overall Study|Adverse Event|3|||
163858331|NCT02001623|591851815|FG013|Overall Study|Adverse Event|5|||
163858332|NCT02001623|591851816|FG014|Overall Study|Adverse Event|6|||
163965072|NCT00890929|592244817|FG000|Overall Study|Death before treatment|2|||
163965073|NCT00890929|592244817|FG000|Overall Study|Withdrawal by Subject|3|||
163858333|NCT02001623|591851802|FG000|Overall Study|Other - Miscellaneous|0|||
163858334|NCT02001623|591851803|FG001|Overall Study|Other - Miscellaneous|0|||
163858335|NCT02001623|591851804|FG002|Overall Study|Other - Miscellaneous|0|||
163858336|NCT02001623|591851805|FG003|Overall Study|Other - Miscellaneous|0|||
163858337|NCT02001623|591851806|FG004|Overall Study|Other - Miscellaneous|0|||
163858338|NCT02001623|591851807|FG005|Overall Study|Other - Miscellaneous|0|||
163858339|NCT02001623|591851808|FG006|Overall Study|Other - Miscellaneous|0|||
163858340|NCT02001623|591851809|FG007|Overall Study|Other - Miscellaneous|0|||
163858341|NCT02001623|591851810|FG008|Overall Study|Other - Miscellaneous|0|||
163858342|NCT02001623|591851811|FG009|Overall Study|Other - Miscellaneous|1|||
163858343|NCT02001623|591851812|FG010|Overall Study|Other - Miscellaneous|0|||
163858344|NCT02001623|591851813|FG011|Overall Study|Other - Miscellaneous|0|||
163858345|NCT02001623|591851814|FG012|Overall Study|Other - Miscellaneous|0|||
163858346|NCT02001623|591851815|FG013|Overall Study|Other - Miscellaneous|1|||
163858347|NCT02001623|591851816|FG014|Overall Study|Other - Miscellaneous|0|||
163858348|NCT02001623|591851802|FG000|Overall Study|Withdrawal by Subject|1|||
163858349|NCT02001623|591851803|FG001|Overall Study|Withdrawal by Subject|0|||
163858350|NCT02001623|591851804|FG002|Overall Study|Withdrawal by Subject|0|||
163858351|NCT02001623|591851805|FG003|Overall Study|Withdrawal by Subject|0|||
163858352|NCT02001623|591851806|FG004|Overall Study|Withdrawal by Subject|0|||
163858353|NCT02001623|591851807|FG005|Overall Study|Withdrawal by Subject|0|||
163858354|NCT02001623|591851808|FG006|Overall Study|Withdrawal by Subject|0|||
163858355|NCT02001623|591851809|FG007|Overall Study|Withdrawal by Subject|0|||
163858356|NCT02001623|591851810|FG008|Overall Study|Withdrawal by Subject|1|||
163858357|NCT02001623|591851811|FG009|Overall Study|Withdrawal by Subject|3|||
163858358|NCT02001623|591851812|FG010|Overall Study|Withdrawal by Subject|2|||
163858359|NCT02001623|591851813|FG011|Overall Study|Withdrawal by Subject|2|||
163858360|NCT02001623|591851814|FG012|Overall Study|Withdrawal by Subject|1|||
163858361|NCT02001623|591851815|FG013|Overall Study|Withdrawal by Subject|5|||
163858362|NCT02001623|591851816|FG014|Overall Study|Withdrawal by Subject|2|||
163858363|NCT02001623|591851802|FG000|Overall Study|Lost to Follow-up|0|||
163858364|NCT02001623|591851803|FG001|Overall Study|Lost to Follow-up|0|||
163858365|NCT02001623|591851804|FG002|Overall Study|Lost to Follow-up|0|||
163858366|NCT02001623|591851805|FG003|Overall Study|Lost to Follow-up|0|||
163858367|NCT02001623|591851806|FG004|Overall Study|Lost to Follow-up|0|||
163858368|NCT02001623|591851807|FG005|Overall Study|Lost to Follow-up|0|||
163858369|NCT02001623|591851808|FG006|Overall Study|Lost to Follow-up|0|||
163858370|NCT02001623|591851809|FG007|Overall Study|Lost to Follow-up|0|||
163858371|NCT02001623|591851810|FG008|Overall Study|Lost to Follow-up|0|||
163858372|NCT02001623|591851811|FG009|Overall Study|Lost to Follow-up|1|||
163858373|NCT02001623|591851812|FG010|Overall Study|Lost to Follow-up|0|||
163858374|NCT02001623|591851813|FG011|Overall Study|Lost to Follow-up|0|||
163858375|NCT02001623|591851814|FG012|Overall Study|Lost to Follow-up|0|||
163858376|NCT02001623|591851815|FG013|Overall Study|Lost to Follow-up|0|||
163858377|NCT02001623|591851816|FG014|Overall Study|Lost to Follow-up|0|||
163858378|NCT02001623|591851802|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
163858379|NCT02001623|591851803|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
163858380|NCT02001623|591851804|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
163858381|NCT02001623|591851805|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
163858382|NCT02001623|591851806|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
163858383|NCT02001623|591851807|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
163858384|NCT02001623|591851808|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
163858385|NCT02001623|591851809|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
163858386|NCT02001623|591851810|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
163858387|NCT02001623|591851811|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
163858388|NCT02001623|591851812|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
163858389|NCT02001623|591851813|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
163858390|NCT02001623|591851814|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
163858391|NCT02001623|591851815|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
163858392|NCT02001623|591851816|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
163858393|NCT02001623|591851802|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
163858394|NCT02001623|591851803|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
163858395|NCT02001623|591851804|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
163858396|NCT02001623|591851805|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
163858397|NCT02001623|591851806|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
163858398|NCT02001623|591851807|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
163858399|NCT02001623|591851808|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
163858400|NCT02001623|591851809|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
163858401|NCT02001623|591851810|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
163858402|NCT02001623|591851811|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
163858403|NCT02001623|591851812|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
163858404|NCT02001623|591851813|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
163858405|NCT02001623|591851814|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
163858406|NCT02001623|591851815|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
163858407|NCT02001623|591851816|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
163858408|NCT00109967|591851823|FG000|Overall Study|Cancel Prior to Treatment|2|||
163858409|NCT00109967|591851824|FG001|Overall Study|Cancel Prior to Treatment|0|||
163858410|NCT00109967|591851823|FG000|Overall Study|Adverse Event|12|||
163858411|NCT00109967|591851824|FG001|Overall Study|Adverse Event|1|||
163858412|NCT00109967|591851823|FG000|Overall Study|Withdrawal by Subject|5|||
163858413|NCT00109967|591851824|FG001|Overall Study|Withdrawal by Subject|0|||
163858414|NCT00109967|591851823|FG000|Overall Study|Physician Decision|1|||
164194531|NCT00255164|593079471|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
163858415|NCT00109967|591851824|FG001|Overall Study|Physician Decision|3|||
163858416|NCT00109967|591851823|FG000|Overall Study|Death|0|||
163858417|NCT00109967|591851824|FG001|Overall Study|Death|2|||
163858418|NCT01117480|591851828|FG000|Overall Study|Protocol Violation|8|||
163858419|NCT01117480|591851828|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
163858420|NCT02955069|591851829|FG000|Overall Study|Adverse Event|7|||
163858421|NCT02955069|591851830|FG001|Overall Study|Adverse Event|2|||
163858422|NCT02955069|591851829|FG000|Overall Study|Death|7|||
163858423|NCT02955069|591851830|FG001|Overall Study|Death|3|||
163858424|NCT02955069|591851829|FG000|Overall Study|Physician Decision|10|||
163858425|NCT02955069|591851830|FG001|Overall Study|Physician Decision|2|||
163858426|NCT02955069|591851829|FG000|Overall Study|Progressive disease|64|||
163858427|NCT02955069|591851830|FG001|Overall Study|Progressive disease|13|||
163858428|NCT02955069|591851829|FG000|Overall Study|Study terminated by sponsor|4|||
163858429|NCT02955069|591851830|FG001|Overall Study|Study terminated by sponsor|0|||
163858430|NCT02955069|591851829|FG000|Overall Study|Subject/Guardian decision|3|||
163858431|NCT02955069|591851830|FG001|Overall Study|Subject/Guardian decision|1|||
163858432|NCT03721016|591851831|FG000|Overall Study|Adverse Event|0|||
163858433|NCT03721016|591851832|FG001|Overall Study|Adverse Event|1|||
163858434|NCT03721016|591851833|FG002|Overall Study|Adverse Event|1|||
163858435|NCT03721016|591851831|FG000|Overall Study|Withdrawal by Subject|8|||
163858436|NCT03721016|591851832|FG001|Overall Study|Withdrawal by Subject|16|||
163858437|NCT03721016|591851833|FG002|Overall Study|Withdrawal by Subject|13|||
163858438|NCT03721016|591851831|FG000|Overall Study|Lost to Follow-up|4|||
163858439|NCT03721016|591851832|FG001|Overall Study|Lost to Follow-up|6|||
163858440|NCT03721016|591851833|FG002|Overall Study|Lost to Follow-up|5|||
163858441|NCT03721016|591851831|FG000|Overall Study|Physician Decision|0|||
163858442|NCT03721016|591851832|FG001|Overall Study|Physician Decision|1|||
163858443|NCT03721016|591851833|FG002|Overall Study|Physician Decision|2|||
163858444|NCT03721016|591851831|FG000|Overall Study|Protocol Violation|0|||
163858445|NCT03721016|591851832|FG001|Overall Study|Protocol Violation|1|||
163858446|NCT03721016|591851833|FG002|Overall Study|Protocol Violation|0|||
163858447|NCT03721016|591851831|FG000|Overall Study|Site terminated by sponsor|3|||
163858448|NCT03721016|591851832|FG001|Overall Study|Site terminated by sponsor|7|||
163858449|NCT03721016|591851833|FG002|Overall Study|Site terminated by sponsor|6|||
163858450|NCT03721016|591851831|FG000|Overall Study|Subject exited early due to COVID-19|1|||
163858451|NCT03721016|591851832|FG001|Overall Study|Subject exited early due to COVID-19|0|||
163858452|NCT03721016|591851833|FG002|Overall Study|Subject exited early due to COVID-19|0|||
163858453|NCT04083976|591851834|FG000|Overall Study|Lost to Follow-up|3|||
163858454|NCT04083976|591851835|FG001|Overall Study|Lost to Follow-up|0|||
163858455|NCT04083976|591851836|FG002|Overall Study|Lost to Follow-up|0|||
163858456|NCT04083976|591851837|FG003|Overall Study|Lost to Follow-up|1|||
163858457|NCT04083976|591851834|FG000|Overall Study|Withdrawal by Subject|16|||
163858458|NCT04083976|591851835|FG001|Overall Study|Withdrawal by Subject|1|||
163858459|NCT04083976|591851836|FG002|Overall Study|Withdrawal by Subject|9|||
163858460|NCT04083976|591851837|FG003|Overall Study|Withdrawal by Subject|0|||
163858461|NCT04083976|591851834|FG000|Overall Study|Sponsor Decision|14|||
163858462|NCT04083976|591851835|FG001|Overall Study|Sponsor Decision|0|||
163858463|NCT04083976|591851836|FG002|Overall Study|Sponsor Decision|0|||
163858464|NCT04083976|591851837|FG003|Overall Study|Sponsor Decision|7|||
163858465|NCT04083976|591851834|FG000|Overall Study|Other|1|||
163858466|NCT04083976|591851835|FG001|Overall Study|Other|0|||
163858467|NCT04083976|591851836|FG002|Overall Study|Other|1|||
163858468|NCT04083976|591851837|FG003|Overall Study|Other|0|||
163858469|NCT03357341|591851838|FG000|Overall Study|Withdrawal by Subject|3|||
163858470|NCT03357341|591851839|FG001|Overall Study|Withdrawal by Subject|6|||
163858471|NCT03357341|591851838|FG000|Overall Study|Lost to Follow-up|4|||
163858472|NCT03357341|591851839|FG001|Overall Study|Lost to Follow-up|5|||
163858473|NCT03357341|591851838|FG000|Overall Study|Death|0|||
163858474|NCT03357341|591851839|FG001|Overall Study|Death|1|||
163858475|NCT01908634|591851843|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
163858476|NCT01908634|591851843|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
163858477|NCT01072357|591851844|FG000|Overall Study|Lost to Follow-up|0|||
163858478|NCT01072357|591851845|FG001|Overall Study|Lost to Follow-up|1|||
163858479|NCT01876511|591851846|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
163858480|NCT01876511|591851847|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
163858481|NCT01876511|591851848|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
163858482|NCT01876511|591851846|FG000|Overall Study|Death (unrelated)|3|||
163858483|NCT01876511|591851847|FG001|Overall Study|Death (unrelated)|0|||
164194532|NCT00255164|593079472|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
163858484|NCT01876511|591851848|FG002|Overall Study|Death (unrelated)|2|||
163858485|NCT01876511|591851846|FG000|Overall Study|Drug-related Toxicity|5|||
163858486|NCT01876511|591851847|FG001|Overall Study|Drug-related Toxicity|1|||
163858487|NCT01876511|591851848|FG002|Overall Study|Drug-related Toxicity|6|||
163858488|NCT01876511|591851846|FG000|Overall Study|Patient Decision|3|||
163858489|NCT01876511|591851847|FG001|Overall Study|Patient Decision|0|||
163858490|NCT01876511|591851848|FG002|Overall Study|Patient Decision|6|||
163858491|NCT01876511|591851846|FG000|Overall Study|Physician Decision|1|||
163858492|NCT01876511|591851847|FG001|Overall Study|Physician Decision|0|||
163858493|NCT01876511|591851848|FG002|Overall Study|Physician Decision|1|||
163858494|NCT02131324|591851849|FG000|Overall Study|Withdrawal by Subject|1|||
163858495|NCT02131324|591851850|FG001|Overall Study|Withdrawal by Subject|2|||
163858496|NCT02131324|591851849|FG000|Overall Study|Lost to Follow-up|1|||
163858497|NCT02131324|591851850|FG001|Overall Study|Lost to Follow-up|1|||
163858498|NCT05790408|591851851|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
163858499|NCT01048788|591851852|FG000|Overall Study|Adverse Event|5|||
163858500|NCT01048788|591851853|FG001|Overall Study|Adverse Event|1|||
163858501|NCT01048788|591851854|FG002|Overall Study|Adverse Event|1|||
163858502|NCT01048788|591851852|FG000|Overall Study|Lack of Efficacy|0|||
163858503|NCT01048788|591851853|FG001|Overall Study|Lack of Efficacy|0|||
163858504|NCT01048788|591851854|FG002|Overall Study|Lack of Efficacy|1|||
163858505|NCT01048788|591851852|FG000|Overall Study|Withdrawal by Subject|0|||
163858506|NCT01048788|591851853|FG001|Overall Study|Withdrawal by Subject|1|||
163858507|NCT01048788|591851854|FG002|Overall Study|Withdrawal by Subject|0|||
163858508|NCT01233050|591851855|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
163858509|NCT01233050|591851856|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
163858510|NCT01064817|591851860|FG000|Study Completion|Physician Decision|1|||
163858511|NCT01064817|591851861|FG001|Study Completion|Physician Decision|0|||
163858512|NCT01064817|591851860|FG000|Study Completion|Withdrawal by Subject|1|||
163858513|NCT01064817|591851861|FG001|Study Completion|Withdrawal by Subject|0|||
163858514|NCT03102710|591851864|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
163858515|NCT03102710|591851865|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
163858516|NCT03102710|591851866|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
163858517|NCT03102710|591851864|FG000|Overall Study|Technical issues during final MRI scan|0|||
163858518|NCT03102710|591851865|FG001|Overall Study|Technical issues during final MRI scan|1|||
163858519|NCT03102710|591851866|FG002|Overall Study|Technical issues during final MRI scan|0|||
163858520|NCT03102710|591851864|FG000|Overall Study|Nausea during MRI scan|0|||
163858521|NCT03102710|591851865|FG001|Overall Study|Nausea during MRI scan|1|||
163858522|NCT03102710|591851866|FG002|Overall Study|Nausea during MRI scan|0|||
163858523|NCT03102710|591851864|FG000|Overall Study|Subject unable to attend final session|0|||
163858524|NCT03102710|591851865|FG001|Overall Study|Subject unable to attend final session|1|||
163858525|NCT03102710|591851866|FG002|Overall Study|Subject unable to attend final session|0|||
163858526|NCT01368406|591851867|FG000|Overall Study|Lost to Follow-up|8|||
163858527|NCT01368406|591851868|FG001|Overall Study|Lost to Follow-up|4|||
163858528|NCT01368406|591851867|FG000|Overall Study|Withdrawal by Subject|8|||
163858529|NCT01368406|591851868|FG001|Overall Study|Withdrawal by Subject|4|||
163858530|NCT01368406|591851867|FG000|Overall Study|relapse of the disease|3|||
163858531|NCT01368406|591851868|FG001|Overall Study|relapse of the disease|2|||
163858532|NCT01368406|591851867|FG000|Overall Study|started working|2|||
163858533|NCT01368406|591851868|FG001|Overall Study|started working|3|||
163858534|NCT04582877|591851869|FG000|Overall Study|Did not use device measurement|5|||
163858535|NCT04582877|591851869|FG000|Overall Study|No fractional flow reserve test results|2|||
163858536|NCT04582877|591851869|FG000|Overall Study|Protocol Violation|1|||
163858537|NCT04304534|591851870|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
163858538|NCT04304534|591851871|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
163858539|NCT04304534|591851872|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
163858540|NCT04304534|591851873|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
163858541|NCT04304534|591851870|FG000|Overall Study|Non-Compliance with study drug|0|||
163858542|NCT04304534|591851871|FG001|Overall Study|Non-Compliance with study drug|1|||
163858543|NCT04304534|591851872|FG002|Overall Study|Non-Compliance with study drug|1|||
163858544|NCT04304534|591851873|FG003|Overall Study|Non-Compliance with study drug|1|||
163858545|NCT04304534|591851870|FG000|Overall Study|Lost to Follow-up|0|||
163858546|NCT04304534|591851871|FG001|Overall Study|Lost to Follow-up|1|||
163858547|NCT04304534|591851872|FG002|Overall Study|Lost to Follow-up|2|||
163858548|NCT04304534|591851873|FG003|Overall Study|Lost to Follow-up|3|||
163858549|NCT04304534|591851870|FG000|Overall Study|Unspecific|4|||
163858550|NCT04304534|591851871|FG001|Overall Study|Unspecific|2|||
163858551|NCT04304534|591851872|FG002|Overall Study|Unspecific|2|||
163858552|NCT04304534|591851873|FG003|Overall Study|Unspecific|2|||
163858553|NCT04304534|591851870|FG000|Overall Study|Technical Problems|2|||
163858554|NCT04304534|591851871|FG001|Overall Study|Technical Problems|2|||
163858555|NCT04304534|591851872|FG002|Overall Study|Technical Problems|3|||
163858556|NCT04304534|591851873|FG003|Overall Study|Technical Problems|4|||
163858557|NCT04304534|591851870|FG000|Overall Study|Death|7|||
163858558|NCT04304534|591851871|FG001|Overall Study|Death|2|||
163858559|NCT04304534|591851872|FG002|Overall Study|Death|4|||
163858560|NCT04304534|591851873|FG003|Overall Study|Death|3|||
163858561|NCT04304534|591851870|FG000|Overall Study|Withdrawal by Subject|7|||
163858562|NCT04304534|591851871|FG001|Overall Study|Withdrawal by Subject|2|||
163858563|NCT04304534|591851872|FG002|Overall Study|Withdrawal by Subject|7|||
163858564|NCT04304534|591851873|FG003|Overall Study|Withdrawal by Subject|4|||
163858565|NCT04304534|591851870|FG000|Overall Study|Physician Decision|4|||
163858566|NCT04304534|591851871|FG001|Overall Study|Physician Decision|9|||
163858567|NCT04304534|591851872|FG002|Overall Study|Physician Decision|9|||
163858568|NCT04304534|591851873|FG003|Overall Study|Physician Decision|5|||
163858569|NCT04304534|591851870|FG000|Overall Study|Subject Decision|34|||
163858570|NCT04304534|591851871|FG001|Overall Study|Subject Decision|25|||
163858571|NCT04304534|591851872|FG002|Overall Study|Subject Decision|25|||
163858572|NCT04304534|591851873|FG003|Overall Study|Subject Decision|26|||
163858573|NCT04304534|591851870|FG000|Overall Study|Adverse Event|35|||
163858574|NCT04304534|591851871|FG001|Overall Study|Adverse Event|40|||
163858575|NCT04304534|591851872|FG002|Overall Study|Adverse Event|39|||
163858576|NCT04304534|591851873|FG003|Overall Study|Adverse Event|44|||
163858577|NCT04012853|591851874|FG000|Overall Study|Withdrawal by Subject|1|||
163858578|NCT04012853|591851875|FG001|Overall Study|Withdrawal by Subject|1|||
163858579|NCT04012853|591851874|FG000|Overall Study|Protocol Violation|1|||
163858580|NCT04012853|591851875|FG001|Overall Study|Protocol Violation|0|||
163858581|NCT04012853|591851874|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
163858582|NCT04012853|591851875|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
163858583|NCT01313182|591851876|FG000|Overall Study|Protocol Violation|66|||
163858584|NCT01313182|591851877|FG001|Overall Study|Protocol Violation|92|||
163858585|NCT01695317|591851878|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
163858586|NCT01695317|591851879|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
163858587|NCT01695317|591851878|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
163858588|NCT01695317|591851879|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
163858589|NCT00464672|591851880|FG000|Overall Study|withdrawal of consent|0|||
163858590|NCT00464672|591851881|FG001|Overall Study|withdrawal of consent|0|||
163858591|NCT00464672|591851882|FG002|Overall Study|withdrawal of consent|0|||
163858592|NCT00464672|591851883|FG003|Overall Study|withdrawal of consent|1|||
163858593|NCT00464672|591851884|FG004|Overall Study|withdrawal of consent|9|||
163858594|NCT00464672|591851885|FG005|Overall Study|withdrawal of consent|4|||
163858595|NCT00464672|591851880|FG000|Overall Study|Lost to Follow-up|25|||
163858596|NCT00464672|591851881|FG001|Overall Study|Lost to Follow-up|10|||
163858597|NCT00464672|591851882|FG002|Overall Study|Lost to Follow-up|0|||
163858598|NCT00464672|591851883|FG003|Overall Study|Lost to Follow-up|0|||
163858599|NCT00464672|591851884|FG004|Overall Study|Lost to Follow-up|1|||
163858600|NCT00464672|591851885|FG005|Overall Study|Lost to Follow-up|0|||
163858601|NCT00003656|591851886|FG000|Overall Study|Adverse Event|0|||
163858602|NCT00003656|591851887|FG001|Overall Study|Adverse Event|1|||
163858603|NCT01664104|591851894|FG000|Overall Study|Adverse Event|6|||
163858604|NCT01664104|591851894|FG000|Overall Study|Lack of Efficacy|2|||
163858605|NCT01664104|591851894|FG000|Overall Study|Withdrawal by Subject|1|||
163858606|NCT01664104|591851894|FG000|Overall Study|Lost to Follow-up|4|||
163858607|NCT01664104|591851894|FG000|Overall Study|Other|1|||
163858608|NCT01664104|591851894|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
163858609|NCT00121199|591851897|FG000|Overall Study|Adverse Event|11|||
163858610|NCT00121199|591851897|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
163858611|NCT00121199|591851897|FG000|Overall Study|Progression/Relapse|1|||
163858612|NCT00121199|591851897|FG000|Overall Study|Death|3|||
163858613|NCT00121199|591851897|FG000|Overall Study|Other - Not Protocol Specified|3|||
163858614|NCT00121199|591851897|FG000|Overall Study|Ineligible|9|||
163858615|NCT03168438|591851898|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
163858616|NCT03168438|591851899|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
163858617|NCT01458275|591851901|FG000|Overall Study|Adverse Event|3|||
163858618|NCT01458275|591851902|FG001|Overall Study|Adverse Event|4|||
163858619|NCT01458275|591851903|FG002|Overall Study|Adverse Event|1|||
163858620|NCT01458275|591851901|FG000|Overall Study|Lost to Follow-up|3|||
163858621|NCT01458275|591851902|FG001|Overall Study|Lost to Follow-up|2|||
163858622|NCT01458275|591851903|FG002|Overall Study|Lost to Follow-up|5|||
163858623|NCT01458275|591851901|FG000|Overall Study|Protocol Violation|5|||
163858624|NCT01458275|591851902|FG001|Overall Study|Protocol Violation|5|||
163858625|NCT01458275|591851903|FG002|Overall Study|Protocol Violation|2|||
163858626|NCT01458275|591851901|FG000|Overall Study|Withdrawal by Subject|3|||
163858627|NCT01458275|591851902|FG001|Overall Study|Withdrawal by Subject|2|||
163858628|NCT01458275|591851903|FG002|Overall Study|Withdrawal by Subject|1|||
163858629|NCT00751036|591851904|FG000|Overall Study|Disease Progression|28|||
163858630|NCT00751036|591851905|FG001|Overall Study|Disease Progression|29|||
163858631|NCT00751036|591851904|FG000|Overall Study|Adverse Event|6|||
163858632|NCT00751036|591851905|FG001|Overall Study|Adverse Event|4|||
163858633|NCT00751036|591851904|FG000|Overall Study|Administrative Problems|3|||
163858634|NCT00751036|591851905|FG001|Overall Study|Administrative Problems|4|||
163858635|NCT00751036|591851904|FG000|Overall Study|Withdrawal by Subject|5|||
163858636|NCT00751036|591851905|FG001|Overall Study|Withdrawal by Subject|2|||
163858637|NCT00751036|591851904|FG000|Overall Study|Death|3|||
163858638|NCT00751036|591851905|FG001|Overall Study|Death|3|||
163858639|NCT00751036|591851904|FG000|Overall Study|Lost to Follow-up|0|||
163858640|NCT00751036|591851905|FG001|Overall Study|Lost to Follow-up|1|||
163858641|NCT00751036|591851904|FG000|Overall Study|Protocol Violation|1|||
163858642|NCT00751036|591851905|FG001|Overall Study|Protocol Violation|0|||
163858643|NCT00751036|591851904|FG000|Overall Study|Missing end of Treatment Page|2|||
163858644|NCT00751036|591851905|FG001|Overall Study|Missing end of Treatment Page|3|||
163858645|NCT03410992|591854257|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858646|NCT03410992|591854258|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
163858647|NCT03410992|591854259|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858648|NCT03410992|591854260|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858649|NCT03410992|591854261|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858650|NCT03410992|591854262|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858651|NCT03410992|591854263|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858652|NCT03410992|591854264|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858653|NCT03410992|591854265|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858654|NCT03410992|591854266|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858655|NCT03410992|591854267|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
163858656|NCT03410992|591854257|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
163858657|NCT03410992|591854258|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
163858658|NCT03410992|591854259|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858659|NCT03410992|591854260|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858660|NCT03410992|591854261|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858661|NCT03410992|591854262|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858662|NCT03410992|591854263|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858663|NCT03410992|591854264|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858664|NCT03410992|591854265|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858665|NCT03410992|591854266|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858666|NCT03410992|591854267|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
163858667|NCT03410992|591854257|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
163858668|NCT03410992|591854258|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
163858669|NCT03410992|591854259|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858670|NCT03410992|591854260|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858671|NCT03410992|591854261|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858672|NCT03410992|591854262|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858673|NCT03410992|591854263|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858674|NCT03410992|591854264|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858675|NCT03410992|591854265|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858676|NCT03410992|591854266|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858677|NCT03410992|591854267|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
163858678|NCT03410992|591854257|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
163858679|NCT03410992|591854258|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858680|NCT03410992|591854259|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858681|NCT03410992|591854260|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858682|NCT03410992|591854261|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858683|NCT03410992|591854262|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858684|NCT03410992|591854263|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858685|NCT03410992|591854264|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858686|NCT03410992|591854265|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858687|NCT03410992|591854266|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858688|NCT03410992|591854267|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
163858689|NCT03410992|591854257|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
163858690|NCT03410992|591854258|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
163858691|NCT03410992|591854259|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858692|NCT03410992|591854260|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858693|NCT03410992|591854261|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858694|NCT03410992|591854262|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858695|NCT03410992|591854263|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858696|NCT03410992|591854264|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858697|NCT03410992|591854265|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858698|NCT03410992|591854266|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858699|NCT03410992|591854267|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
163858700|NCT03410992|591854257|FG000|Week 16 Assessment|Incorrect escapers|0|||
163858701|NCT03410992|591854258|FG001|Week 16 Assessment|Incorrect escapers|6|||
163858702|NCT03410992|591854259|FG002|Week 16 Assessment|Incorrect escapers|0|||
163858703|NCT03410992|591854260|FG003|Week 16 Assessment|Incorrect escapers|0|||
163858704|NCT03410992|591854261|FG004|Week 16 Assessment|Incorrect escapers|0|||
163858705|NCT03410992|591854262|FG005|Week 16 Assessment|Incorrect escapers|0|||
163858706|NCT03410992|591854263|FG006|Week 16 Assessment|Incorrect escapers|0|||
163858707|NCT03410992|591854264|FG007|Week 16 Assessment|Incorrect escapers|0|||
163858708|NCT03410992|591854265|FG008|Week 16 Assessment|Incorrect escapers|0|||
163858709|NCT03410992|591854266|FG009|Week 16 Assessment|Incorrect escapers|0|||
163858710|NCT03410992|591854267|FG010|Week 16 Assessment|Incorrect escapers|0|||
163858711|NCT03410992|591854257|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858712|NCT03410992|591854258|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858713|NCT03410992|591854259|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858714|NCT03410992|591854260|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
163858715|NCT03410992|591854261|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
163858716|NCT03410992|591854262|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858717|NCT03410992|591854263|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858718|NCT03410992|591854264|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858719|NCT03410992|591854265|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858720|NCT03410992|591854266|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858721|NCT03410992|591854267|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
163858722|NCT03410992|591854257|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858723|NCT03410992|591854258|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858724|NCT03410992|591854259|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858725|NCT03410992|591854260|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
163858726|NCT03410992|591854261|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
163858727|NCT03410992|591854262|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
163858728|NCT03410992|591854263|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858729|NCT03410992|591854264|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858730|NCT03410992|591854265|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858731|NCT03410992|591854266|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858732|NCT03410992|591854267|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
163858733|NCT03410992|591854257|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858734|NCT03410992|591854258|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858735|NCT03410992|591854259|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858736|NCT03410992|591854260|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858737|NCT03410992|591854261|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858738|NCT03410992|591854262|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
163858739|NCT03410992|591854263|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858740|NCT03410992|591854264|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858741|NCT03410992|591854265|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858742|NCT03410992|591854266|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858743|NCT03410992|591854267|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
163858744|NCT03410992|591854257|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858745|NCT03410992|591854258|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858746|NCT03410992|591854259|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858747|NCT03410992|591854260|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
163858748|NCT03410992|591854261|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
163858749|NCT03410992|591854262|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
163858750|NCT03410992|591854263|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858751|NCT03410992|591854264|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858752|NCT03410992|591854265|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858753|NCT03410992|591854266|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858754|NCT03410992|591854267|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
163858755|NCT03410992|591854257|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858756|NCT03410992|591854258|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858757|NCT03410992|591854259|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858758|NCT03410992|591854260|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858759|NCT03410992|591854261|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858760|NCT03410992|591854262|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858761|NCT03410992|591854263|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858762|NCT03410992|591854264|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
163858763|NCT03410992|591854265|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858764|NCT03410992|591854266|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858765|NCT03410992|591854267|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
163858766|NCT03410992|591854257|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858767|NCT03410992|591854258|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858768|NCT03410992|591854259|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858769|NCT03410992|591854260|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858770|NCT03410992|591854261|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858771|NCT03410992|591854262|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858772|NCT03410992|591854263|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858773|NCT03410992|591854264|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858774|NCT03410992|591854265|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
163858775|NCT03410992|591854266|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858776|NCT03410992|591854267|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
163858777|NCT04988295|591854270|FG000|Overall Study|Withdrawal by Subject|9|||
163858778|NCT04988295|591854271|FG001|Overall Study|Withdrawal by Subject|29|||
163858779|NCT04988295|591854272|FG002|Overall Study|Withdrawal by Subject|6|||
163858780|NCT04988295|591854273|FG003|Overall Study|Withdrawal by Subject|0|||
163858781|NCT04988295|591854270|FG000|Overall Study|Lost to Follow-up|1|||
163858782|NCT04988295|591854271|FG001|Overall Study|Lost to Follow-up|0|||
163858783|NCT04988295|591854272|FG002|Overall Study|Lost to Follow-up|0|||
163858784|NCT04988295|591854273|FG003|Overall Study|Lost to Follow-up|0|||
163858785|NCT04988295|591854270|FG000|Overall Study|Study participation ongoing|186|||
163858786|NCT04988295|591854271|FG001|Overall Study|Study participation ongoing|169|||
163858787|NCT04988295|591854272|FG002|Overall Study|Study participation ongoing|99|||
163858788|NCT04988295|591854273|FG003|Overall Study|Study participation ongoing|119|||
163858789|NCT00943605|591854276|FG000|Overall Study|Study termination|30|||
163858790|NCT00943605|591854277|FG001|Overall Study|Study termination|30|||
163858791|NCT02232178|591854279|FG000|Overall Study|Lost to Follow-up|0|||
163858792|NCT02232178|591854280|FG001|Overall Study|Lost to Follow-up|1|||
163858793|NCT02232178|591854281|FG002|Overall Study|Lost to Follow-up|0|||
163858794|NCT02232178|591854279|FG000|Overall Study|ineligibility|0|||
163858795|NCT02232178|591854280|FG001|Overall Study|ineligibility|0|||
163858796|NCT02232178|591854281|FG002|Overall Study|ineligibility|1|||
163858797|NCT02232178|591854279|FG000|Overall Study|surgical complication|1|||
163858798|NCT02232178|591854280|FG001|Overall Study|surgical complication|0|||
163858799|NCT02232178|591854281|FG002|Overall Study|surgical complication|0|||
163858800|NCT01956669|591854284|FG000|Overall Study|Disease Progression|12|||
163858801|NCT01956669|591854285|FG001|Overall Study|Disease Progression|7|||
163858802|NCT01956669|591854286|FG002|Overall Study|Disease Progression|7|||
163858803|NCT01956669|591854287|FG003|Overall Study|Disease Progression|8|||
163858804|NCT01956669|591854288|FG004|Overall Study|Disease Progression|4|||
163858805|NCT01956669|591854289|FG005|Overall Study|Disease Progression|3|||
163858806|NCT01956669|591854290|FG006|Overall Study|Disease Progression|5|||
163858807|NCT01956669|591854284|FG000|Overall Study|Adverse Event|0|||
163858808|NCT01956669|591854285|FG001|Overall Study|Adverse Event|2|||
163858809|NCT01956669|591854286|FG002|Overall Study|Adverse Event|2|||
163858810|NCT01956669|591854287|FG003|Overall Study|Adverse Event|1|||
163858811|NCT01956669|591854288|FG004|Overall Study|Adverse Event|0|||
163858812|NCT01956669|591854289|FG005|Overall Study|Adverse Event|0|||
163858813|NCT01956669|591854290|FG006|Overall Study|Adverse Event|0|||
163858814|NCT01956669|591854284|FG000|Overall Study|Physician Decision|0|||
163858815|NCT01956669|591854285|FG001|Overall Study|Physician Decision|2|||
163858816|NCT01956669|591854286|FG002|Overall Study|Physician Decision|0|||
163858817|NCT01956669|591854287|FG003|Overall Study|Physician Decision|0|||
163858818|NCT01956669|591854288|FG004|Overall Study|Physician Decision|0|||
163965074|NCT00890929|592244817|FG000|Overall Study|Physician Decision|1|||
163965075|NCT00108069|592244818|FG000|Overall Study|Never rec'd study drug|0|||
163965076|NCT00108069|592244819|FG001|Overall Study|Never rec'd study drug|1|||
163965077|NCT00108069|592244818|FG000|Overall Study|Adverse Event|1|||
163965078|NCT00108069|592244819|FG001|Overall Study|Adverse Event|1|||
163965079|NCT00108069|592244818|FG000|Overall Study|Withdrawal by Subject|1|||
163965080|NCT00108069|592244819|FG001|Overall Study|Withdrawal by Subject|0|||
163965081|NCT00108069|592244818|FG000|Overall Study|Death|1|||
163965082|NCT00108069|592244819|FG001|Overall Study|Death|0|||
163965083|NCT00108069|592244818|FG000|Overall Study|Progessive disease|27|||
163965084|NCT00108069|592244819|FG001|Overall Study|Progessive disease|11|||
163965085|NCT02558231|592244820|FG000|Overall Study|Death|4|||
163965086|NCT02558231|592244821|FG001|Overall Study|Death|12|||
163965087|NCT02558231|592244820|FG000|Overall Study|Lost to Follow-up|7|||
163965088|NCT02558231|592244821|FG001|Overall Study|Lost to Follow-up|4|||
163965089|NCT02558231|592244820|FG000|Overall Study|Withdrawal by Subject|7|||
163965090|NCT02558231|592244821|FG001|Overall Study|Withdrawal by Subject|4|||
163965091|NCT02558231|592244820|FG000|Overall Study|Physician Decision|7|||
163965092|NCT02558231|592244821|FG001|Overall Study|Physician Decision|5|||
163965093|NCT02558231|592244820|FG000|Overall Study|Sponsor Decision|0|||
163965094|NCT02558231|592244821|FG001|Overall Study|Sponsor Decision|1|||
163965095|NCT02066051|592244824|FG000|Overall Study|Subject developed active GVHD|1|||
163965096|NCT03836807|592244829|FG000|Overall Study|Physician Decision|1|||
163965097|NCT03836807|592244830|FG001|Overall Study|Physician Decision|0|||
163965098|NCT00685685|592244831|FG000|Washout Period of 7 Days|Adverse Event|2|||
163965099|NCT00685685|592244832|FG001|Washout Period of 7 Days|Adverse Event|0|||
163858819|NCT01956669|591854289|FG005|Overall Study|Physician Decision|1|||
163858820|NCT01956669|591854290|FG006|Overall Study|Physician Decision|0|||
163858821|NCT01956669|591854284|FG000|Overall Study|Withdrawal by Subject|0|||
163858822|NCT01956669|591854285|FG001|Overall Study|Withdrawal by Subject|0|||
163965100|NCT00685685|592244831|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
163965101|NCT00685685|592244832|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
163858823|NCT01956669|591854286|FG002|Overall Study|Withdrawal by Subject|1|||
163858824|NCT01956669|591854287|FG003|Overall Study|Withdrawal by Subject|1|||
163965102|NCT04029116|592244833|FG000|Overall Study|Adverse Event|0|||
163965103|NCT04029116|592244834|FG001|Overall Study|Adverse Event|2|||
163965104|NCT04029116|592244833|FG000|Overall Study|Lost to Follow-up|3|||
163965105|NCT04029116|592244834|FG001|Overall Study|Lost to Follow-up|5|||
163858825|NCT01956669|591854288|FG004|Overall Study|Withdrawal by Subject|0|||
163858826|NCT01956669|591854289|FG005|Overall Study|Withdrawal by Subject|0|||
163965106|NCT04029116|592244833|FG000|Overall Study|Physician Decision|2|||
163965107|NCT04029116|592244834|FG001|Overall Study|Physician Decision|0|||
163858827|NCT01956669|591854290|FG006|Overall Study|Withdrawal by Subject|1|||
163858828|NCT01570751|591854291|FG000|Period A (16 Weeks)|Protocol Violation|1|||
163965108|NCT04029116|592244833|FG000|Overall Study|Pregnancy|1|||
163858829|NCT01570751|591854292|FG001|Period A (16 Weeks)|Protocol Violation|1|||
163858830|NCT01570751|591854291|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
163858831|NCT01570751|591854292|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
163858832|NCT01570751|591854291|FG000|Period A (16 Weeks)|Unclassified|2|||
163858833|NCT01570751|591854292|FG001|Period A (16 Weeks)|Unclassified|3|||
163858834|NCT01570751|591854291|FG000|Period B (16 Weeks)|Adverse Event|1|||
163858835|NCT01570751|591854292|FG001|Period B (16 Weeks)|Adverse Event|0|||
163858836|NCT01570751|591854291|FG000|Period B (16 Weeks)|Protocol Violation|0|||
163858837|NCT01570751|591854292|FG001|Period B (16 Weeks)|Protocol Violation|1|||
163858838|NCT00930813|591854293|FG000|Overall Study|Death|4|||
163858839|NCT00930813|591854294|FG001|Overall Study|Death|5|||
163858840|NCT00930813|591854293|FG000|Overall Study|Withdrawal by Subject|2|||
163858841|NCT00930813|591854294|FG001|Overall Study|Withdrawal by Subject|5|||
163858842|NCT00930813|591854293|FG000|Overall Study|Lost to Follow-up|2|||
163858843|NCT00930813|591854294|FG001|Overall Study|Lost to Follow-up|4|||
163858844|NCT01693614|591854299|FG000|Overall Study|Adverse Event|7|||
163858845|NCT01693614|591854300|FG001|Overall Study|Adverse Event|11|||
163858846|NCT01693614|591854301|FG002|Overall Study|Adverse Event|5|||
163858847|NCT01693614|591854299|FG000|Overall Study|Disease progression|11|||
163858848|NCT01693614|591854300|FG001|Overall Study|Disease progression|8|||
163858849|NCT01693614|591854301|FG002|Overall Study|Disease progression|7|||
163858850|NCT01693614|591854299|FG000|Overall Study|Protocol Violation|5|||
163858851|NCT01693614|591854300|FG001|Overall Study|Protocol Violation|2|||
163858852|NCT01693614|591854301|FG002|Overall Study|Protocol Violation|1|||
163858853|NCT01693614|591854299|FG000|Overall Study|Death|1|||
163858854|NCT01693614|591854300|FG001|Overall Study|Death|0|||
163858855|NCT01693614|591854301|FG002|Overall Study|Death|0|||
163858856|NCT01693614|591854299|FG000|Overall Study|Physician Decision|1|||
163858857|NCT01693614|591854300|FG001|Overall Study|Physician Decision|1|||
163858858|NCT01693614|591854301|FG002|Overall Study|Physician Decision|4|||
163858859|NCT01693614|591854299|FG000|Overall Study|Withdrawal by subject/guardian|0|||
163858860|NCT01693614|591854300|FG001|Overall Study|Withdrawal by subject/guardian|0|||
163858861|NCT01693614|591854301|FG002|Overall Study|Withdrawal by subject/guardian|2|||
163858862|NCT01693614|591854299|FG000|Overall Study|Withdrawal by Subject|1|||
163858863|NCT01693614|591854300|FG001|Overall Study|Withdrawal by Subject|0|||
163858864|NCT01693614|591854301|FG002|Overall Study|Withdrawal by Subject|5|||
163858865|NCT04618471|591854302|FG000|Overall Study|Screen Failure|62|||
163858866|NCT04618471|591854302|FG000|Overall Study|Withdrawal by Subject|6|||
163858867|NCT04618471|591854302|FG000|Overall Study|Physician Decision|2|||
163858868|NCT04618471|591854302|FG000|Overall Study|Lost to Follow-up|1|||
163858869|NCT04618471|591854302|FG000|Overall Study|Various other reasons|2|||
163858870|NCT04618471|591854302|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
163858871|NCT01131494|591854303|FG000|Overall Study|Withdrawal by Subject|2|||
163858872|NCT01196988|591854304|FG000|Overall Study|Adverse Event|1|||
163858873|NCT01196988|591854305|FG001|Overall Study|Adverse Event|2|||
163858874|NCT01196988|591854306|FG002|Overall Study|Adverse Event|0|||
163858875|NCT01196988|591854307|FG003|Overall Study|Adverse Event|0|||
163858876|NCT01196988|591854304|FG000|Overall Study|Withdrawal by Subject|5|||
163858877|NCT01196988|591854305|FG001|Overall Study|Withdrawal by Subject|1|||
163858878|NCT01196988|591854306|FG002|Overall Study|Withdrawal by Subject|4|||
163858879|NCT01196988|591854307|FG003|Overall Study|Withdrawal by Subject|0|||
163858880|NCT01196988|591854304|FG000|Overall Study|Lost to Follow-up|16|||
163858881|NCT01196988|591854305|FG001|Overall Study|Lost to Follow-up|29|||
163858882|NCT01196988|591854306|FG002|Overall Study|Lost to Follow-up|21|||
163858883|NCT01196988|591854307|FG003|Overall Study|Lost to Follow-up|1|||
163858884|NCT01196988|591854304|FG000|Overall Study|Other|2|||
163858885|NCT01196988|591854305|FG001|Overall Study|Other|0|||
163858886|NCT01196988|591854306|FG002|Overall Study|Other|0|||
163858887|NCT01196988|591854307|FG003|Overall Study|Other|0|||
163858888|NCT05419557|591854309|FG000|Overall Study|Lost to Follow-up|11|||
163858889|NCT05419557|591854310|FG001|Overall Study|Lost to Follow-up|4|||
163858890|NCT00588666|591854311|FG000|Overall Study|Adverse Event|4|||
163858891|NCT02281318|591854312|FG000|Overall Study|Adverse Event|2|||
163858892|NCT02281318|591854313|FG001|Overall Study|Adverse Event|2|||
163858893|NCT02281318|591854312|FG000|Overall Study|Lack of Efficacy|2|||
163858894|NCT02281318|591854313|FG001|Overall Study|Lack of Efficacy|0|||
163858895|NCT02281318|591854312|FG000|Overall Study|Lost to Follow-up|2|||
163858896|NCT02281318|591854313|FG001|Overall Study|Lost to Follow-up|1|||
163858897|NCT02281318|591854312|FG000|Overall Study|Physician Decision|2|||
163858898|NCT02281318|591854313|FG001|Overall Study|Physician Decision|0|||
163858899|NCT02281318|591854312|FG000|Overall Study|Withdrawal by Subject|6|||
163858900|NCT02281318|591854313|FG001|Overall Study|Withdrawal by Subject|2|||
163858901|NCT05257798|591854314|FG000|Follow-up Phase|Lost to Follow-up|1|||
163858902|NCT05257798|591854315|FG001|Follow-up Phase|Lost to Follow-up|0|||
163858903|NCT00703911|591854316|FG000|Overall Study|Death|1|||
163858904|NCT00703911|591854316|FG000|Overall Study|Physician Decision|6|||
163858905|NCT00703911|591854316|FG000|Overall Study|Lost to Follow-up|1|||
163858906|NCT00703911|591854316|FG000|Overall Study|Withdrawal by Subject|2|||
163858907|NCT03055767|591854317|FG000|Open-Label Period|Lost to Follow-up|0|||
163858908|NCT03055767|591854318|FG001|Open-Label Period|Lost to Follow-up|0|||
163858909|NCT03055767|591854319|FG002|Open-Label Period|Lost to Follow-up|2|||
163858910|NCT03055767|591854320|FG003|Open-Label Period|Lost to Follow-up|0|||
163858911|NCT03055767|591854317|FG000|Open-Label Period|Withdrawal by Subject|0|||
163858912|NCT03055767|591854318|FG001|Open-Label Period|Withdrawal by Subject|0|||
163858913|NCT03055767|591854319|FG002|Open-Label Period|Withdrawal by Subject|0|||
163858914|NCT03055767|591854320|FG003|Open-Label Period|Withdrawal by Subject|1|||
163858915|NCT02759731|591854323|FG000|Overall Study|Did not complete treatment.|8|||
163858916|NCT00957229|591854329|FG000|Study Start|Adverse Event|0|||
163858917|NCT00957229|591854330|FG001|Study Start|Adverse Event|3|||
163858918|NCT00957229|591854329|FG000|Study Start|Disease Progression|1|||
163858919|NCT00957229|591854330|FG001|Study Start|Disease Progression|0|||
163858920|NCT00957229|591854329|FG000|Reallocated to or Continued Vismodegib|Death|1|||
163858921|NCT00957229|591854330|FG001|Reallocated to or Continued Vismodegib|Death|1|||
163858922|NCT00957229|591854329|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
163858923|NCT00957229|591854330|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
163858924|NCT00763282|591854331|FG000|Overall Study|Withdrawal by Subject|6|||
163858925|NCT00763282|591854332|FG001|Overall Study|Withdrawal by Subject|5|||
163858926|NCT00763282|591854331|FG000|Overall Study|Death|4|||
163858927|NCT00763282|591854332|FG001|Overall Study|Death|3|||
163858928|NCT00763282|591854331|FG000|Overall Study|Lost to Follow-up|22|||
163858929|NCT00763282|591854332|FG001|Overall Study|Lost to Follow-up|26|||
163858930|NCT00606580|591854333|FG000|Overall Study|Lost to Follow-up|1|||
163858931|NCT00606580|591854334|FG001|Overall Study|Lost to Follow-up|1|||
163858932|NCT00606580|591854335|FG002|Overall Study|Lost to Follow-up|4|||
163858933|NCT00606580|591854333|FG000|Overall Study|Clinical failures|1|||
163858934|NCT00606580|591854334|FG001|Overall Study|Clinical failures|0|||
163858935|NCT00606580|591854335|FG002|Overall Study|Clinical failures|12|||
163858936|NCT00606580|591854333|FG000|Overall Study|Withdrawal by investigator|0|||
163858937|NCT00606580|591854334|FG001|Overall Study|Withdrawal by investigator|1|||
163858938|NCT00606580|591854335|FG002|Overall Study|Withdrawal by investigator|6|||
163858939|NCT00606580|591854333|FG000|Overall Study|Withdrawal by Subject|0|||
163858940|NCT00606580|591854334|FG001|Overall Study|Withdrawal by Subject|1|||
163858941|NCT00606580|591854335|FG002|Overall Study|Withdrawal by Subject|0|||
163858942|NCT04580303|591854336|FG000|Overall Study|Adverse Event|0|||
163858943|NCT04580303|591854337|FG001|Overall Study|Adverse Event|1|||
163858944|NCT04580303|591854338|FG002|Overall Study|Adverse Event|0|||
163858945|NCT04580303|591854339|FG003|Overall Study|Adverse Event|0|||
163858946|NCT04580303|591854336|FG000|Overall Study|Withdrawal by Subject|0|||
163858947|NCT04580303|591854337|FG001|Overall Study|Withdrawal by Subject|0|||
163858948|NCT04580303|591854338|FG002|Overall Study|Withdrawal by Subject|1|||
163858949|NCT04580303|591854339|FG003|Overall Study|Withdrawal by Subject|0|||
163858950|NCT01833065|591854341|FG000|Overall Study|Adverse Event|6|||
163858951|NCT01833065|591854342|FG001|Overall Study|Adverse Event|1|||
163858952|NCT01833065|591854343|FG002|Overall Study|Adverse Event|0|||
163858953|NCT01833065|591854344|FG003|Overall Study|Adverse Event|2|||
163858954|NCT01833065|591854345|FG004|Overall Study|Adverse Event|3|||
163858955|NCT01833065|591854341|FG000|Overall Study|Protocol Violation|1|||
163858956|NCT01833065|591854342|FG001|Overall Study|Protocol Violation|0|||
163858957|NCT01833065|591854343|FG002|Overall Study|Protocol Violation|0|||
163858958|NCT01833065|591854344|FG003|Overall Study|Protocol Violation|0|||
163858959|NCT01833065|591854345|FG004|Overall Study|Protocol Violation|2|||
163858960|NCT01833065|591854341|FG000|Overall Study|Lost to Follow-up|1|||
163858961|NCT01833065|591854342|FG001|Overall Study|Lost to Follow-up|0|||
163858962|NCT01833065|591854343|FG002|Overall Study|Lost to Follow-up|0|||
163858963|NCT01833065|591854344|FG003|Overall Study|Lost to Follow-up|0|||
163858964|NCT01833065|591854345|FG004|Overall Study|Lost to Follow-up|3|||
163858965|NCT01833065|591854341|FG000|Overall Study|Withdrawal by Subject|6|||
163858966|NCT01833065|591854342|FG001|Overall Study|Withdrawal by Subject|2|||
163858967|NCT01833065|591854343|FG002|Overall Study|Withdrawal by Subject|4|||
163858968|NCT01833065|591854344|FG003|Overall Study|Withdrawal by Subject|3|||
163858969|NCT01833065|591854345|FG004|Overall Study|Withdrawal by Subject|11|||
163858970|NCT01833065|591854341|FG000|Overall Study|Subject's substantial non-compliance|0|||
163858971|NCT01833065|591854342|FG001|Overall Study|Subject's substantial non-compliance|1|||
163858972|NCT01833065|591854343|FG002|Overall Study|Subject's substantial non-compliance|0|||
163858973|NCT01833065|591854344|FG003|Overall Study|Subject's substantial non-compliance|0|||
163858974|NCT01833065|591854345|FG004|Overall Study|Subject's substantial non-compliance|0|||
163858975|NCT01833065|591854341|FG000|Overall Study|Trial terminated by sponsor|8|||
163858976|NCT01833065|591854342|FG001|Overall Study|Trial terminated by sponsor|8|||
163858977|NCT01833065|591854343|FG002|Overall Study|Trial terminated by sponsor|7|||
163858978|NCT01833065|591854344|FG003|Overall Study|Trial terminated by sponsor|3|||
163858979|NCT01833065|591854345|FG004|Overall Study|Trial terminated by sponsor|13|||
163858980|NCT01833065|591854341|FG000|Overall Study|Others|2|||
163858981|NCT01833065|591854342|FG001|Overall Study|Others|1|||
163858982|NCT01833065|591854343|FG002|Overall Study|Others|1|||
163858983|NCT01833065|591854344|FG003|Overall Study|Others|1|||
163858984|NCT01833065|591854345|FG004|Overall Study|Others|4|||
163858985|NCT00828672|591854346|FG000|Study Treatment|Lost to Follow-up|1|||
163858986|NCT00828672|591854347|FG001|Study Treatment|Lost to Follow-up|0|||
163858987|NCT00828672|591854346|FG000|Study Treatment|Adverse Event|0|||
163858988|NCT00828672|591854347|FG001|Study Treatment|Adverse Event|1|||
163858989|NCT00828672|591854346|FG000|Study Treatment|Complete response, no surgery|1|||
163858990|NCT00828672|591854347|FG001|Study Treatment|Complete response, no surgery|1|||
163858991|NCT00828672|591854346|FG000|Post-surgery (<30 Days)|No central review materials|0|||
163858992|NCT00828672|591854347|FG001|Post-surgery (<30 Days)|No central review materials|1|||
163858993|NCT04889118|591854348|FG000|Overall Study|Death|49|||
163858994|NCT04889118|591854349|FG001|Overall Study|Death|47|||
163858995|NCT04889118|591854348|FG000|Overall Study|Sponsor Decision|15|||
163858996|NCT04889118|591854349|FG001|Overall Study|Sponsor Decision|20|||
163858997|NCT00601640|591854351|FG000|Overall Study|Withdrawal by Subject|3|||
163858998|NCT00601640|591854352|FG001|Overall Study|Withdrawal by Subject|0|||
163858999|NCT00601640|591854353|FG002|Overall Study|Withdrawal by Subject|7|||
163859000|NCT00601640|591854351|FG000|Overall Study|Death|1|||
163859001|NCT00601640|591854352|FG001|Overall Study|Death|0|||
163859002|NCT00601640|591854353|FG002|Overall Study|Death|0|||
163859003|NCT00601640|591854351|FG000|Overall Study|Adverse Event|0|||
163859004|NCT00601640|591854352|FG001|Overall Study|Adverse Event|4|||
163859005|NCT00601640|591854353|FG002|Overall Study|Adverse Event|2|||
163859006|NCT00601640|591854351|FG000|Overall Study|intercurrent illness|1|||
163859007|NCT00601640|591854352|FG001|Overall Study|intercurrent illness|0|||
163859008|NCT00601640|591854353|FG002|Overall Study|intercurrent illness|0|||
163859009|NCT00601640|591854351|FG000|Overall Study|change in eligibility status|0|||
163859010|NCT00601640|591854352|FG001|Overall Study|change in eligibility status|1|||
163859011|NCT00601640|591854353|FG002|Overall Study|change in eligibility status|1|||
163859012|NCT00543725|591854356|FG000|Overall Study|Adverse Event|18|||
163859013|NCT00543725|591854357|FG001|Overall Study|Adverse Event|27|||
163859014|NCT00543725|591854356|FG000|Overall Study|Sponsor's Decision|0|||
163859015|NCT00543725|591854357|FG001|Overall Study|Sponsor's Decision|1|||
163859016|NCT00543725|591854356|FG000|Overall Study|Subject Non-Compliant|4|||
163859017|NCT00543725|591854357|FG001|Overall Study|Subject Non-Compliant|4|||
163859018|NCT00543725|591854356|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
163859019|NCT00543725|591854357|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
163859020|NCT00543725|591854356|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
163859021|NCT00543725|591854357|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
163859022|NCT00543725|591854356|FG000|Overall Study|Protocol Violation|0|||
163859023|NCT00543725|591854357|FG001|Overall Study|Protocol Violation|1|||
163859024|NCT00543725|591854356|FG000|Overall Study|Withdrawal by Subject|4|||
163859025|NCT00543725|591854357|FG001|Overall Study|Withdrawal by Subject|13|||
163859026|NCT00543725|591854356|FG000|Overall Study|Lost to Follow-up|15|||
163859027|NCT00543725|591854357|FG001|Overall Study|Lost to Follow-up|11|||
163859028|NCT00543725|591854356|FG000|Overall Study|Other|3|||
163859029|NCT00543725|591854357|FG001|Overall Study|Other|3|||
163859030|NCT01250002|591854358|FG000|Overall Study|Change to open surgical procedure|4|||
163859031|NCT01250002|591854359|FG001|Overall Study|Change to open surgical procedure|3|||
163859032|NCT02317705|591854360|FG000|Overall Study|Withdrawal by Subject|3|||
164194533|NCT00255164|593079470|FG000|Overall Study|Possible Barrett's Esophagus|1|||
164194534|NCT00255164|593079471|FG001|Overall Study|Possible Barrett's Esophagus|3|||
163859033|NCT02317705|591854360|FG000|Overall Study|Physician Decision|1|||
163859034|NCT02317705|591854360|FG000|Overall Study|Drug not usable|1|||
163859035|NCT03095508|591854361|FG000|Overall Study|Adverse Event|0|||
163859036|NCT03095508|591854362|FG001|Overall Study|Adverse Event|1|||
163859037|NCT00335556|591854363|FG000|Overall Study|Death|0|||
163859038|NCT00335556|591854364|FG001|Overall Study|Death|5|||
163859039|NCT00335556|591854365|FG002|Overall Study|Death|0|||
163859040|NCT00335556|591854366|FG003|Overall Study|Death|0|||
163859041|NCT00335556|591854367|FG004|Overall Study|Death|1|||
163859042|NCT00335556|591854368|FG005|Overall Study|Death|0|||
163859043|NCT00335556|591854363|FG000|Overall Study|Lack of Efficacy|0|||
163859044|NCT00335556|591854364|FG001|Overall Study|Lack of Efficacy|19|||
163859045|NCT00335556|591854365|FG002|Overall Study|Lack of Efficacy|3|||
163859046|NCT00335556|591854366|FG003|Overall Study|Lack of Efficacy|3|||
164194535|NCT00255164|593079472|FG002|Overall Study|Possible Barrett's Esophagus|8|||
164194536|NCT00255164|593079470|FG000|Overall Study|Esophageal Stricture|0|||
164194537|NCT00255164|593079471|FG001|Overall Study|Esophageal Stricture|0|||
163859047|NCT00335556|591854367|FG004|Overall Study|Lack of Efficacy|0|||
163859048|NCT00335556|591854368|FG005|Overall Study|Lack of Efficacy|1|||
163859049|NCT00335556|591854363|FG000|Overall Study|Physician Decision|0|||
163859050|NCT00335556|591854364|FG001|Overall Study|Physician Decision|6|||
163965109|NCT04029116|592244834|FG001|Overall Study|Pregnancy|2|||
163859051|NCT00335556|591854365|FG002|Overall Study|Physician Decision|2|||
163859052|NCT00335556|591854366|FG003|Overall Study|Physician Decision|1|||
163859053|NCT00335556|591854367|FG004|Overall Study|Physician Decision|0|||
163859054|NCT00335556|591854368|FG005|Overall Study|Physician Decision|0|||
163859055|NCT00335556|591854363|FG000|Overall Study|Ineligible|2|||
163859056|NCT00335556|591854364|FG001|Overall Study|Ineligible|0|||
163859057|NCT00335556|591854365|FG002|Overall Study|Ineligible|0|||
163859058|NCT00335556|591854366|FG003|Overall Study|Ineligible|0|||
163859059|NCT00335556|591854367|FG004|Overall Study|Ineligible|0|||
163859060|NCT00335556|591854368|FG005|Overall Study|Ineligible|0|||
163859061|NCT00335556|591854363|FG000|Overall Study|Refusal of further protocol therapy|0|||
163859062|NCT00335556|591854364|FG001|Overall Study|Refusal of further protocol therapy|4|||
163859063|NCT00335556|591854365|FG002|Overall Study|Refusal of further protocol therapy|0|||
163859064|NCT00335556|591854366|FG003|Overall Study|Refusal of further protocol therapy|1|||
163859065|NCT00335556|591854367|FG004|Overall Study|Refusal of further protocol therapy|0|||
163859066|NCT00335556|591854368|FG005|Overall Study|Refusal of further protocol therapy|0|||
163859067|NCT01674569|591854369|FG000|Overall Study|Adverse Event|0|||
163859068|NCT01674569|591854370|FG001|Overall Study|Adverse Event|2|||
163859069|NCT01674569|591854371|FG002|Overall Study|Adverse Event|0|||
163859070|NCT01674569|591854372|FG003|Overall Study|Adverse Event|1|||
163859071|NCT01674569|591854373|FG004|Overall Study|Adverse Event|2|||
163859072|NCT01674569|591854374|FG005|Overall Study|Adverse Event|2|||
163859073|NCT01674569|591854369|FG000|Overall Study|Protocol Violation|0|||
163859074|NCT01674569|591854370|FG001|Overall Study|Protocol Violation|1|||
163859075|NCT01674569|591854371|FG002|Overall Study|Protocol Violation|1|||
163859076|NCT01674569|591854372|FG003|Overall Study|Protocol Violation|0|||
163859077|NCT01674569|591854373|FG004|Overall Study|Protocol Violation|0|||
163859078|NCT01674569|591854374|FG005|Overall Study|Protocol Violation|0|||
163859079|NCT01674569|591854369|FG000|Overall Study|Withdrawal by Subject|0|||
163859080|NCT01674569|591854370|FG001|Overall Study|Withdrawal by Subject|0|||
163859081|NCT01674569|591854371|FG002|Overall Study|Withdrawal by Subject|1|||
163859082|NCT01674569|591854372|FG003|Overall Study|Withdrawal by Subject|0|||
163859083|NCT01674569|591854373|FG004|Overall Study|Withdrawal by Subject|0|||
163859084|NCT01674569|591854374|FG005|Overall Study|Withdrawal by Subject|0|||
163859085|NCT01599325|591854382|FG000|Primary Parent Phase|Adverse Event|5|||
163859086|NCT01599325|591854382|FG000|Primary Parent Phase|Disease Progression|7|||
163859087|NCT01599325|591854382|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
163859088|NCT01599325|591854382|FG000|Primary Parent Phase|Death|13|||
163859089|NCT01599325|591854382|FG000|Primary Parent Phase|Protocol Violation|1|||
163859090|NCT01599325|591854382|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
163859091|NCT01599325|591854382|FG000|Primary Parent Phase|Other|2|||
163859092|NCT01599325|591854382|FG000|Extension Phase|Study Closure|1|||
163859093|NCT01599325|591854382|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
163859094|NCT01599325|591854382|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
163859095|NCT01599325|591854382|FG000|Extension Phase|Disease Progression|1|||
163859096|NCT01599325|591854382|FG000|Extension Phase|Withdrawal by Subject|8|||
163859097|NCT02365298|591854383|FG000|Period 2|incorrect Rx dispensed|1|||
163859098|NCT02365298|591854384|FG001|Period 2|incorrect Rx dispensed|0|||
163859099|NCT02365298|591854383|FG000|Period 2|Discontinued at request of Sponsor|1|||
163859100|NCT02365298|591854384|FG001|Period 2|Discontinued at request of Sponsor|0|||
163859101|NCT02365298|591854383|FG000|Period 2|Test Article longer available|0|||
163859102|NCT02365298|591854384|FG001|Period 2|Test Article longer available|1|||
163859103|NCT02365298|591854383|FG000|Period 2|Protocol Violation|0|||
163859104|NCT02365298|591854384|FG001|Period 2|Protocol Violation|1|||
163859105|NCT01878890|591854385|FG000|Overall Study|Protocol Violation|0|||
163859106|NCT01878890|591854386|FG001|Overall Study|Protocol Violation|1|||
163859107|NCT01878890|591854387|FG002|Overall Study|Protocol Violation|0|||
163859108|NCT01878890|591854388|FG003|Overall Study|Protocol Violation|0|||
163859109|NCT01710514|591854393|FG000|Overall Study|Adverse Event|6|||
163859110|NCT01710514|591854394|FG001|Overall Study|Adverse Event|7|||
163859111|NCT01710514|591854393|FG000|Overall Study|Withdrawal by Subject|1|||
163859112|NCT01710514|591854394|FG001|Overall Study|Withdrawal by Subject|0|||
163859113|NCT02846415|591854395|FG000|Overall Study|Lost to Follow-up|2|||
163859114|NCT02846415|591854396|FG001|Overall Study|Lost to Follow-up|0|||
163859115|NCT02846415|591854395|FG000|Overall Study|Withdrawal by Subject|1|||
163859116|NCT02846415|591854396|FG001|Overall Study|Withdrawal by Subject|1|||
163965110|NCT04029116|592244833|FG000|Overall Study|Withdrawal by Subject|4|||
163859117|NCT03404843|591854397|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
163859118|NCT03404843|591854398|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
163859119|NCT00567164|591854399|FG000|Overall Study|Withdrawal by Subject|171|||
163859120|NCT00567164|591854400|FG001|Overall Study|Withdrawal by Subject|21|||
163859121|NCT00567164|591854401|FG002|Overall Study|Withdrawal by Subject|17|||
163859122|NCT00567164|591854399|FG000|Overall Study|Protocol Violation|23|||
163859123|NCT00567164|591854400|FG001|Overall Study|Protocol Violation|4|||
163965111|NCT04029116|592244834|FG001|Overall Study|Withdrawal by Subject|6|||
163859124|NCT00567164|591854401|FG002|Overall Study|Protocol Violation|2|||
163859125|NCT00567164|591854399|FG000|Overall Study|Adverse Event|92|||
163859126|NCT00567164|591854400|FG001|Overall Study|Adverse Event|13|||
163859127|NCT00567164|591854401|FG002|Overall Study|Adverse Event|9|||
163859128|NCT00567164|591854399|FG000|Overall Study|Death|0|||
163859129|NCT00567164|591854400|FG001|Overall Study|Death|0|||
163859130|NCT00567164|591854401|FG002|Overall Study|Death|1|||
163859131|NCT00567164|591854399|FG000|Overall Study|Lost to Follow-up|202|||
163859132|NCT00567164|591854400|FG001|Overall Study|Lost to Follow-up|23|||
163859133|NCT00567164|591854401|FG002|Overall Study|Lost to Follow-up|21|||
163859134|NCT00567164|591854399|FG000|Overall Study|Pregnancy|20|||
163859135|NCT00567164|591854400|FG001|Overall Study|Pregnancy|4|||
163859136|NCT00567164|591854401|FG002|Overall Study|Pregnancy|6|||
163859137|NCT00567164|591854399|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
163859138|NCT00567164|591854400|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
163859139|NCT00567164|591854401|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
163859140|NCT00567164|591854399|FG000|Overall Study|Missing|1|||
163859141|NCT00567164|591854400|FG001|Overall Study|Missing|0|||
163859142|NCT00567164|591854401|FG002|Overall Study|Missing|0|||
163859143|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Other|4|||
163859144|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Other|0|||
163859145|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
163859146|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
163859147|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
163859148|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
163859149|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
163859150|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
163859151|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
163859152|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
163859153|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
163859154|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
163859155|NCT00853827|591854416|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
163859156|NCT00853827|591854417|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
163859157|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
163859158|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
163859159|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
163859160|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
163859161|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
163859162|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
163859163|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
163859164|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
163859165|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
163859166|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
163859167|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
163859168|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
163859169|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
163859170|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
163859171|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
163859172|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
163859173|NCT00853827|591854416|FG000|Double Blind Period (103 Weeks)|Death|1|||
163859174|NCT00853827|591854417|FG001|Double Blind Period (103 Weeks)|Death|6|||
163859175|NCT00580801|591854422|FG000|Overall Study|Physician Decision|1|||
163859176|NCT00580801|591854423|FG001|Overall Study|Physician Decision|0|||
163859177|NCT00580801|591854424|FG002|Overall Study|Physician Decision|0|||
163859178|NCT00580801|591854422|FG000|Overall Study|Adverse Event|2|||
163859179|NCT00580801|591854423|FG001|Overall Study|Adverse Event|0|||
163859180|NCT00580801|591854424|FG002|Overall Study|Adverse Event|0|||
163859181|NCT00580801|591854422|FG000|Overall Study|Lost to Follow-up|2|||
163859182|NCT00580801|591854423|FG001|Overall Study|Lost to Follow-up|0|||
163859183|NCT00580801|591854424|FG002|Overall Study|Lost to Follow-up|0|||
163859184|NCT00580801|591854422|FG000|Overall Study|Reached a virologic endpoint|0|||
163859185|NCT00580801|591854423|FG001|Overall Study|Reached a virologic endpoint|1|||
163859186|NCT00580801|591854424|FG002|Overall Study|Reached a virologic endpoint|2|||
163859187|NCT00580801|591854422|FG000|Overall Study|Participant non-compliant|0|||
163859188|NCT00580801|591854423|FG001|Overall Study|Participant non-compliant|0|||
163859189|NCT00580801|591854424|FG002|Overall Study|Participant non-compliant|1|||
163859190|NCT00580801|591854422|FG000|Overall Study|Travel|1|||
163859191|NCT00580801|591854423|FG001|Overall Study|Travel|0|||
163859192|NCT00580801|591854424|FG002|Overall Study|Travel|0|||
163859193|NCT02595398|591854425|FG000|Overall Study|Non-compliance|1|||
163859194|NCT02595398|591854426|FG001|Overall Study|Non-compliance|0|||
163859195|NCT02595398|591854425|FG000|Overall Study|Withdrawal by Subject|2|||
163859196|NCT02595398|591854426|FG001|Overall Study|Withdrawal by Subject|1|||
163859197|NCT02595398|591854425|FG000|Overall Study|Lost to Follow-up|1|||
163859198|NCT02595398|591854426|FG001|Overall Study|Lost to Follow-up|0|||
163859199|NCT00502593|591854427|FG000|Overall Study|Withdrawn unspecified reason|1|||
163859200|NCT00502593|591854428|FG001|Overall Study|Withdrawn unspecified reason|1|||
163859201|NCT00502593|591854429|FG002|Overall Study|Withdrawn unspecified reason|3|||
163859202|NCT00502593|591854430|FG003|Overall Study|Withdrawn unspecified reason|1|||
163859203|NCT00502593|591854431|FG004|Overall Study|Withdrawn unspecified reason|2|||
163859204|NCT00502593|591854432|FG005|Overall Study|Withdrawn unspecified reason|0|||
163859205|NCT00502593|591854433|FG006|Overall Study|Withdrawn unspecified reason|2|||
163859206|NCT00502593|591854434|FG007|Overall Study|Withdrawn unspecified reason|0|||
164194538|NCT00255164|593079472|FG002|Overall Study|Esophageal Stricture|1|||
164194539|NCT00255164|593079470|FG000|Overall Study|Therapeutic Failure|11|||
164194540|NCT00255164|593079471|FG001|Overall Study|Therapeutic Failure|2|||
164194541|NCT00255164|593079472|FG002|Overall Study|Therapeutic Failure|3|||
164194542|NCT04754542|593079475|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
164194543|NCT04754542|593079476|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
164194544|NCT03627832|593080911|FG000|Overall Study|Withdrawal by Subject|10|||
164194545|NCT03627832|593080912|FG001|Overall Study|Withdrawal by Subject|1|||
164194546|NCT04110314|593080918|FG000|Overall Study|Did not meet inclusion criteria|35255|||
164194547|NCT04110314|593080919|FG001|Overall Study|Did not meet inclusion criteria|35104|||
164194548|NCT04110314|593080920|FG002|Overall Study|Did not meet inclusion criteria|35636|||
164194549|NCT04110314|593080921|FG003|Overall Study|Did not meet inclusion criteria|35135|||
164194550|NCT04110314|593080922|FG004|Overall Study|Did not meet inclusion criteria|35247|||
164194551|NCT04110314|593080923|FG005|Overall Study|Did not meet inclusion criteria|35727|||
164194552|NCT00737100|593080927|FG000|Overall Study|Adverse Event|6|||
164194553|NCT00737100|593080928|FG001|Overall Study|Adverse Event|5|||
164194554|NCT00737100|593080929|FG002|Overall Study|Adverse Event|3|||
164194555|NCT00737100|593080927|FG000|Overall Study|Lost to Follow-up|0|||
164194556|NCT00737100|593080928|FG001|Overall Study|Lost to Follow-up|1|||
164194557|NCT00737100|593080929|FG002|Overall Study|Lost to Follow-up|0|||
164194558|NCT00737100|593080927|FG000|Overall Study|Withdrawal by Subject|0|||
164194559|NCT00737100|593080928|FG001|Overall Study|Withdrawal by Subject|0|||
164194560|NCT00737100|593080929|FG002|Overall Study|Withdrawal by Subject|3|||
164194561|NCT00737100|593080927|FG000|Overall Study|Reason discontinued not explained above|1|||
164194562|NCT00737100|593080928|FG001|Overall Study|Reason discontinued not explained above|1|||
164194563|NCT00737100|593080929|FG002|Overall Study|Reason discontinued not explained above|1|||
164194564|NCT01607593|593080934|FG000|Overall Study|Adverse Event|15|||
164194565|NCT01607593|593080934|FG000|Overall Study|Lack of Efficacy|16|||
164194566|NCT01607593|593080934|FG000|Overall Study|Lost to Follow-up|25|||
164194567|NCT01607593|593080934|FG000|Overall Study|Continuation|33|||
164194568|NCT01607593|593080934|FG000|Overall Study|Other|4|||
164194569|NCT00115778|593080935|FG000|Overall Study|Withdrawal by Subject|0|||
164194570|NCT00115778|593080936|FG001|Overall Study|Withdrawal by Subject|1|||
164194571|NCT03713684|593080941|FG000|Overall Study|Adverse Event|1|||
164194572|NCT03713684|593080942|FG001|Overall Study|Adverse Event|3|||
164194573|NCT03713684|593080943|FG002|Overall Study|Adverse Event|1|||
164194574|NCT03713684|593080944|FG003|Overall Study|Adverse Event|0|||
164194575|NCT03713684|593080941|FG000|Overall Study|Poor compliance to protocol|2|||
164194576|NCT03713684|593080942|FG001|Overall Study|Poor compliance to protocol|1|||
164194577|NCT03713684|593080943|FG002|Overall Study|Poor compliance to protocol|0|||
164194578|NCT03713684|593080944|FG003|Overall Study|Poor compliance to protocol|1|||
164194579|NCT03713684|593080941|FG000|Overall Study|Withdrawal by Subject|14|||
164194580|NCT03713684|593080942|FG001|Overall Study|Withdrawal by Subject|6|||
164194581|NCT03713684|593080943|FG002|Overall Study|Withdrawal by Subject|14|||
164194582|NCT03713684|593080944|FG003|Overall Study|Withdrawal by Subject|16|||
164194583|NCT03713684|593080941|FG000|Overall Study|Other than specified|69|||
164194584|NCT03713684|593080942|FG001|Overall Study|Other than specified|77|||
164194585|NCT03713684|593080943|FG002|Overall Study|Other than specified|73|||
164194586|NCT03713684|593080944|FG003|Overall Study|Other than specified|70|||
164194587|NCT00528424|593080945|FG000|Overall Study|Lost to Follow-up|13|||
164194588|NCT00528424|593080945|FG000|Overall Study|Withdrew consent|2|||
164194589|NCT00528424|593080945|FG000|Overall Study|Administrative reason|2|||
164194590|NCT00528424|593080945|FG000|Overall Study|Other|12|||
164194591|NCT02515630|593080946|FG000|Overall Study|Withdrawal by Subject|5|||
164194592|NCT02515630|593080946|FG000|Overall Study|Adverse Event|4|||
164194593|NCT02515630|593080946|FG000|Overall Study|Physician Decision|4|||
164194594|NCT02515630|593080946|FG000|Overall Study|Death|2|||
164194595|NCT02515630|593080946|FG000|Overall Study|Disease Progression|1|||
164194596|NCT02595502|593080949|FG000|Period 1|Adverse Event|0|||
164194597|NCT02595502|593080950|FG001|Period 1|Adverse Event|1|||
164194598|NCT02595502|593080949|FG000|Period 1|Withdrawal by Subject|1|||
164194599|NCT02595502|593080950|FG001|Period 1|Withdrawal by Subject|0|||
163859207|NCT00502593|591854435|FG008|Overall Study|Withdrawn unspecified reason|0|||
163859208|NCT00502593|591854436|FG009|Overall Study|Withdrawn unspecified reason|0|||
164194600|NCT02595502|593080949|FG000|Period 1|Lost to Follow-up|0|||
164194601|NCT02595502|593080950|FG001|Period 1|Lost to Follow-up|1|||
164194602|NCT02595502|593080949|FG000|Period 2|Adverse Event|1|||
164194603|NCT02595502|593080950|FG001|Period 2|Adverse Event|1|||
164194604|NCT02595502|593080949|FG000|Period 2|Received incorrect lens at Period 1|0|||
164194605|NCT02595502|593080950|FG001|Period 2|Received incorrect lens at Period 1|1|||
164194606|NCT02595502|593080949|FG000|Period 3|Protocol Violation|0|||
163859209|NCT00502593|591854437|FG010|Overall Study|Withdrawn unspecified reason|0|||
164194607|NCT02595502|593080950|FG001|Period 3|Protocol Violation|1|||
164194608|NCT02595502|593080949|FG000|Period 3|Lost to Follow-up|1|||
164194609|NCT02595502|593080950|FG001|Period 3|Lost to Follow-up|0|||
164194610|NCT02595502|593080949|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
163859210|NCT00502593|591854438|FG011|Overall Study|Withdrawn unspecified reason|0|||
163859211|NCT00502593|591854427|FG000|Overall Study|Withdrawal by Subject|0|||
163859212|NCT00502593|591854428|FG001|Overall Study|Withdrawal by Subject|0|||
163859213|NCT00502593|591854429|FG002|Overall Study|Withdrawal by Subject|6|||
163859214|NCT00502593|591854430|FG003|Overall Study|Withdrawal by Subject|2|||
163859215|NCT00502593|591854431|FG004|Overall Study|Withdrawal by Subject|2|||
163859216|NCT00502593|591854432|FG005|Overall Study|Withdrawal by Subject|0|||
163859217|NCT00502593|591854433|FG006|Overall Study|Withdrawal by Subject|3|||
163859218|NCT00502593|591854434|FG007|Overall Study|Withdrawal by Subject|0|||
163859219|NCT00502593|591854435|FG008|Overall Study|Withdrawal by Subject|3|||
163859220|NCT00502593|591854436|FG009|Overall Study|Withdrawal by Subject|0|||
163859221|NCT00502593|591854437|FG010|Overall Study|Withdrawal by Subject|1|||
163859222|NCT00502593|591854438|FG011|Overall Study|Withdrawal by Subject|0|||
163859223|NCT00502593|591854427|FG000|Overall Study|Lost to Follow-up|2|||
163859224|NCT00502593|591854428|FG001|Overall Study|Lost to Follow-up|1|||
163859225|NCT00502593|591854429|FG002|Overall Study|Lost to Follow-up|1|||
163859226|NCT00502593|591854430|FG003|Overall Study|Lost to Follow-up|1|||
163859227|NCT00502593|591854431|FG004|Overall Study|Lost to Follow-up|0|||
163859228|NCT00502593|591854432|FG005|Overall Study|Lost to Follow-up|0|||
163859229|NCT00502593|591854433|FG006|Overall Study|Lost to Follow-up|0|||
163859230|NCT00502593|591854434|FG007|Overall Study|Lost to Follow-up|0|||
163859231|NCT00502593|591854435|FG008|Overall Study|Lost to Follow-up|3|||
163859232|NCT00502593|591854436|FG009|Overall Study|Lost to Follow-up|0|||
163859233|NCT00502593|591854437|FG010|Overall Study|Lost to Follow-up|1|||
163859234|NCT00502593|591854438|FG011|Overall Study|Lost to Follow-up|0|||
164194611|NCT02595502|593080950|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
164194612|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
164194613|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
164194614|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Death|561|||
164194615|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Death|298|||
164194616|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
163859235|NCT05576051|591854439|FG000|Overall Study|Lack of Efficacy|543|||
163859236|NCT05576051|591854440|FG001|Overall Study|Lack of Efficacy|343|||
163859237|NCT05576051|591854441|FG002|Overall Study|Lack of Efficacy|108|||
163859238|NCT05576051|591854442|FG003|Overall Study|Lack of Efficacy|72|||
163859239|NCT05576051|591854443|FG004|Overall Study|Lack of Efficacy|28|||
164194617|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
164194618|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
164194619|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
164194620|NCT00974311|593080951|FG000|DB Phase (up to 24 Months)|Other|1|||
164194621|NCT00974311|593080952|FG001|DB Phase (up to 24 Months)|Other|0|||
164194622|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Death|14|||
164194623|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Death|21|||
164194624|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
164194625|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
164194626|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Other|15|||
164194627|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Other|2|||
164194628|NCT00974311|593080951|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
164194629|NCT00974311|593080952|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
164194630|NCT03286218|593080955|FG000|Qualification Phase Period 1|Adverse Event|1|||
164194631|NCT03286218|593080956|FG001|Qualification Phase Period 1|Adverse Event|0|||
164194632|NCT03286218|593080957|FG002|Qualification Phase Period 1|Adverse Event|0|||
163859240|NCT05576051|591854444|FG005|Overall Study|Lack of Efficacy|50|||
163859241|NCT05576051|591854439|FG000|Overall Study|Safety|78|||
163859242|NCT05576051|591854440|FG001|Overall Study|Safety|74|||
163859243|NCT05576051|591854441|FG002|Overall Study|Safety|16|||
163859244|NCT05576051|591854442|FG003|Overall Study|Safety|14|||
163859245|NCT05576051|591854443|FG004|Overall Study|Safety|4|||
163859246|NCT05576051|591854444|FG005|Overall Study|Safety|5|||
163859247|NCT05576051|591854439|FG000|Overall Study|Efficacy + Safety|10|||
163859248|NCT05576051|591854440|FG001|Overall Study|Efficacy + Safety|7|||
163859249|NCT05576051|591854441|FG002|Overall Study|Efficacy + Safety|3|||
163859250|NCT05576051|591854442|FG003|Overall Study|Efficacy + Safety|0|||
163859251|NCT05576051|591854443|FG004|Overall Study|Efficacy + Safety|0|||
163859252|NCT05576051|591854444|FG005|Overall Study|Efficacy + Safety|0|||
163859253|NCT05576051|591854439|FG000|Overall Study|Other|231|||
163859254|NCT05576051|591854440|FG001|Overall Study|Other|127|||
163859255|NCT05576051|591854441|FG002|Overall Study|Other|35|||
163859256|NCT05576051|591854442|FG003|Overall Study|Other|14|||
163859257|NCT05576051|591854443|FG004|Overall Study|Other|6|||
163859258|NCT05576051|591854444|FG005|Overall Study|Other|0|||
163859259|NCT00544440|591854445|FG000|Overall Study|Other|1|||
163859260|NCT00544440|591854445|FG000|Overall Study|Adverse Event|1|||
163859261|NCT00544440|591854445|FG000|Overall Study|Withdrawal by Subject|2|||
163859262|NCT00544440|591854445|FG000|Overall Study|Subject Non-compliance|1|||
163859263|NCT00544440|591854445|FG000|Overall Study|Progressive Disease|47|||
164194633|NCT03286218|593080958|FG003|Qualification Phase Period 1|Adverse Event|0|||
164194634|NCT03286218|593080959|FG004|Qualification Phase Period 1|Adverse Event|0|||
164194635|NCT03286218|593080960|FG005|Qualification Phase Period 1|Adverse Event|0|||
164194636|NCT03286218|593080961|FG006|Qualification Phase Period 1|Adverse Event|0|||
164194637|NCT03286218|593080962|FG007|Qualification Phase Period 1|Adverse Event|0|||
164194638|NCT03286218|593080963|FG008|Qualification Phase Period 1|Adverse Event|0|||
164194639|NCT03286218|593080964|FG009|Qualification Phase Period 1|Adverse Event|0|||
164194640|NCT03286218|593080965|FG010|Qualification Phase Period 1|Adverse Event|0|||
164194641|NCT03286218|593080966|FG011|Qualification Phase Period 1|Adverse Event|0|||
164194642|NCT03286218|593080955|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194643|NCT03286218|593080956|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
164194644|NCT03286218|593080957|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194645|NCT03286218|593080958|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194646|NCT03286218|593080959|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194647|NCT03286218|593080960|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194648|NCT03286218|593080961|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194649|NCT03286218|593080962|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194650|NCT03286218|593080963|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194651|NCT03286218|593080964|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194652|NCT03286218|593080965|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194653|NCT03286218|593080966|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
164194654|NCT03286218|593080955|FG000|Qualification Phase Period 2|Adverse Event|0|||
164194655|NCT03286218|593080956|FG001|Qualification Phase Period 2|Adverse Event|1|||
164194656|NCT03286218|593080957|FG002|Qualification Phase Period 2|Adverse Event|0|||
164194657|NCT03286218|593080958|FG003|Qualification Phase Period 2|Adverse Event|0|||
164194658|NCT03286218|593080959|FG004|Qualification Phase Period 2|Adverse Event|0|||
164194659|NCT03286218|593080960|FG005|Qualification Phase Period 2|Adverse Event|0|||
164194660|NCT03286218|593080961|FG006|Qualification Phase Period 2|Adverse Event|0|||
164194661|NCT03286218|593080962|FG007|Qualification Phase Period 2|Adverse Event|0|||
164194662|NCT03286218|593080963|FG008|Qualification Phase Period 2|Adverse Event|0|||
164194663|NCT03286218|593080964|FG009|Qualification Phase Period 2|Adverse Event|0|||
164194664|NCT03286218|593080965|FG010|Qualification Phase Period 2|Adverse Event|0|||
164194665|NCT03286218|593080966|FG011|Qualification Phase Period 2|Adverse Event|0|||
164194666|NCT03286218|593080955|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
164194667|NCT03286218|593080956|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
164194668|NCT03286218|593080957|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194669|NCT03286218|593080958|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194670|NCT03286218|593080959|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194671|NCT03286218|593080960|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194672|NCT03286218|593080961|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194673|NCT03286218|593080962|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194674|NCT03286218|593080963|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194675|NCT03286218|593080964|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194676|NCT03286218|593080965|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194677|NCT03286218|593080966|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
164194678|NCT03286218|593080955|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
164194679|NCT03286218|593080956|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
164194680|NCT03286218|593080957|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
164194681|NCT03286218|593080958|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
164194682|NCT03286218|593080959|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
164194683|NCT03286218|593080960|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
164194684|NCT03286218|593080961|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
164194685|NCT03286218|593080962|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
164194686|NCT03286218|593080963|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
164194687|NCT03286218|593080964|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
164194688|NCT03286218|593080965|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
164194689|NCT03286218|593080966|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
164194690|NCT03286218|593080955|FG000|Qualification Phase Period 2|Protocol Violation|2|||
164194691|NCT03286218|593080956|FG001|Qualification Phase Period 2|Protocol Violation|0|||
164194692|NCT03286218|593080957|FG002|Qualification Phase Period 2|Protocol Violation|0|||
164194693|NCT03286218|593080958|FG003|Qualification Phase Period 2|Protocol Violation|0|||
164194694|NCT03286218|593080959|FG004|Qualification Phase Period 2|Protocol Violation|0|||
164194695|NCT03286218|593080960|FG005|Qualification Phase Period 2|Protocol Violation|0|||
164194696|NCT03286218|593080961|FG006|Qualification Phase Period 2|Protocol Violation|0|||
164194697|NCT03286218|593080962|FG007|Qualification Phase Period 2|Protocol Violation|0|||
164194698|NCT03286218|593080963|FG008|Qualification Phase Period 2|Protocol Violation|0|||
164194699|NCT03286218|593080964|FG009|Qualification Phase Period 2|Protocol Violation|0|||
164194700|NCT03286218|593080965|FG010|Qualification Phase Period 2|Protocol Violation|0|||
164194701|NCT03286218|593080966|FG011|Qualification Phase Period 2|Protocol Violation|0|||
164194702|NCT03286218|593080955|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
164194703|NCT03286218|593080956|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
164194704|NCT03286218|593080957|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194705|NCT03286218|593080958|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194706|NCT03286218|593080959|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194707|NCT03286218|593080960|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194708|NCT03286218|593080961|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194709|NCT03286218|593080962|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194710|NCT03286218|593080963|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194711|NCT03286218|593080964|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194712|NCT03286218|593080965|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194713|NCT03286218|593080966|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
164194714|NCT03286218|593080955|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194715|NCT03286218|593080956|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194716|NCT03286218|593080957|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
164194717|NCT03286218|593080958|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
164194718|NCT03286218|593080959|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194719|NCT03286218|593080960|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
163859264|NCT00544440|591854445|FG000|Overall Study|Other|5|||
163859265|NCT03601507|591854446|FG000|Overall Study|Adverse Event|1|||
164194720|NCT03286218|593080961|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194721|NCT03286218|593080962|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194722|NCT03286218|593080963|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194723|NCT03286218|593080964|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194724|NCT03286218|593080965|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
164194725|NCT03286218|593080966|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
164194726|NCT03286218|593080955|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194727|NCT03286218|593080956|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194728|NCT03286218|593080957|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194729|NCT03286218|593080958|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194730|NCT03286218|593080959|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194731|NCT03286218|593080960|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194732|NCT03286218|593080961|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194733|NCT03286218|593080962|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194734|NCT03286218|593080963|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194735|NCT03286218|593080964|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194736|NCT03286218|593080965|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
164194737|NCT03286218|593080966|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
164194738|NCT00458003|593080967|FG000|Overall Study|Non protocol spinal anesthesia|1|||
164194739|NCT00458003|593080968|FG001|Overall Study|Non protocol spinal anesthesia|1|||
164194740|NCT04556760|593080969|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194741|NCT04556760|593080970|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
164194742|NCT04556760|593080971|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194743|NCT04556760|593080972|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194744|NCT04556760|593080973|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194745|NCT04556760|593080974|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
164194746|NCT04556760|593080969|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
163859266|NCT01460342|591854449|FG000|Overall Study|Adverse Event|5|||
164194747|NCT04556760|593080970|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194748|NCT04556760|593080971|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194749|NCT04556760|593080972|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
164194750|NCT04556760|593080973|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194751|NCT04556760|593080974|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
164194752|NCT02513550|593080975|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
164194753|NCT02513550|593080976|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
164194754|NCT02513550|593080977|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
164194755|NCT02513550|593080978|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
164194756|NCT02513550|593080979|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164194757|NCT02513550|593080980|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
163859267|NCT01460342|591854450|FG001|Overall Study|Adverse Event|4|||
163859268|NCT01460342|591854449|FG000|Overall Study|Lost to Follow-up|1|||
163859269|NCT01460342|591854450|FG001|Overall Study|Lost to Follow-up|2|||
163859270|NCT01460342|591854449|FG000|Overall Study|Protocol Violation|0|||
163859271|NCT01460342|591854450|FG001|Overall Study|Protocol Violation|1|||
164194758|NCT02513550|593080975|FG000|Double Blind Treatment Period|Adverse Event|5|||
164194759|NCT02513550|593080976|FG001|Double Blind Treatment Period|Adverse Event|13|||
163965112|NCT04029116|592244833|FG000|Overall Study|Other|2|||
164194760|NCT02513550|593080977|FG002|Double Blind Treatment Period|Adverse Event|17|||
164194761|NCT02513550|593080978|FG003|Double Blind Treatment Period|Adverse Event|0|||
164194762|NCT02513550|593080979|FG004|Double Blind Treatment Period|Adverse Event|1|||
164194763|NCT02513550|593080980|FG005|Double Blind Treatment Period|Adverse Event|0|||
164194764|NCT02513550|593080975|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
164194765|NCT02513550|593080976|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
164194766|NCT02513550|593080977|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
164194767|NCT02513550|593080978|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
164194768|NCT02513550|593080979|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
164194769|NCT02513550|593080980|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
164194770|NCT02513550|593080975|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
164194771|NCT02513550|593080976|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
164194772|NCT02513550|593080977|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
164194773|NCT02513550|593080978|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
164194774|NCT02513550|593080979|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
164194775|NCT02513550|593080980|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
164194776|NCT02513550|593080975|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164194777|NCT02513550|593080976|FG001|Double Blind Treatment Period|Protocol Violation|1|||
164194778|NCT02513550|593080977|FG002|Double Blind Treatment Period|Protocol Violation|4|||
164194779|NCT02513550|593080978|FG003|Double Blind Treatment Period|Protocol Violation|0|||
164194780|NCT02513550|593080979|FG004|Double Blind Treatment Period|Protocol Violation|0|||
164194781|NCT02513550|593080980|FG005|Double Blind Treatment Period|Protocol Violation|0|||
164194782|NCT02513550|593080975|FG000|Double Blind Treatment Period|Physician Decision|2|||
164194783|NCT02513550|593080976|FG001|Double Blind Treatment Period|Physician Decision|0|||
164194784|NCT02513550|593080977|FG002|Double Blind Treatment Period|Physician Decision|4|||
164194785|NCT02513550|593080978|FG003|Double Blind Treatment Period|Physician Decision|0|||
164194786|NCT02513550|593080979|FG004|Double Blind Treatment Period|Physician Decision|0|||
164194787|NCT02513550|593080980|FG005|Double Blind Treatment Period|Physician Decision|0|||
164194788|NCT02513550|593080975|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
164194789|NCT02513550|593080976|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
164194790|NCT02513550|593080977|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
164194791|NCT02513550|593080978|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
164194792|NCT02513550|593080979|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
164194793|NCT02513550|593080980|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
164194794|NCT02513550|593080975|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194795|NCT02513550|593080976|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194796|NCT02513550|593080977|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
163859272|NCT01460342|591854449|FG000|Overall Study|Withdrawal by Subject|3|||
163859273|NCT01460342|591854450|FG001|Overall Study|Withdrawal by Subject|4|||
163859274|NCT01460342|591854449|FG000|Overall Study|Physician Decision|1|||
163859275|NCT01460342|591854450|FG001|Overall Study|Physician Decision|3|||
163859276|NCT01460342|591854449|FG000|Overall Study|Lack of Efficacy|1|||
163859277|NCT01460342|591854450|FG001|Overall Study|Lack of Efficacy|0|||
163859278|NCT00559949|591854451|FG000|Overall Study|Progressive Disease during cycle 1|1|||
163859279|NCT00559949|591854451|FG000|Overall Study|Adverse Event|1|||
164194797|NCT02513550|593080978|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194798|NCT02513550|593080979|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194799|NCT02513550|593080980|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
164194800|NCT02513550|593080975|FG000|Double Blind Treatment Period|Due to personal business|2|||
164194801|NCT02513550|593080976|FG001|Double Blind Treatment Period|Due to personal business|0|||
164194802|NCT02513550|593080977|FG002|Double Blind Treatment Period|Due to personal business|1|||
164194803|NCT02513550|593080978|FG003|Double Blind Treatment Period|Due to personal business|0|||
164194804|NCT02513550|593080979|FG004|Double Blind Treatment Period|Due to personal business|0|||
164194805|NCT02513550|593080980|FG005|Double Blind Treatment Period|Due to personal business|0|||
164194806|NCT02513550|593080975|FG000|Double Blind Treatment Period|Death|1|||
164194807|NCT02513550|593080976|FG001|Double Blind Treatment Period|Death|0|||
164194808|NCT02513550|593080977|FG002|Double Blind Treatment Period|Death|2|||
164194809|NCT02513550|593080978|FG003|Double Blind Treatment Period|Death|0|||
164194810|NCT02513550|593080979|FG004|Double Blind Treatment Period|Death|0|||
164194811|NCT02513550|593080980|FG005|Double Blind Treatment Period|Death|0|||
164194812|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
164194813|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
164194814|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
163859280|NCT00559949|591854451|FG000|Overall Study|Withdrawal by Subject|4|||
163859281|NCT00559949|591854451|FG000|Overall Study|No disease evaluation per protocol|1|||
163859282|NCT01194258|591854452|FG000|Titration Period|Withdrawal by Subject|6|||
164194815|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164194816|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164194817|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
164194818|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
164194819|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
164194820|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
163859283|NCT01194258|591854453|FG001|Titration Period|Withdrawal by Subject|0|||
163859284|NCT01194258|591854454|FG002|Titration Period|Withdrawal by Subject|0|||
163859285|NCT01194258|591854455|FG003|Titration Period|Withdrawal by Subject|0|||
163859286|NCT01194258|591854456|FG004|Titration Period|Withdrawal by Subject|0|||
163859287|NCT01194258|591854452|FG000|Titration Period|Lost to Follow-up|2|||
163859288|NCT01194258|591854453|FG001|Titration Period|Lost to Follow-up|0|||
164194821|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
164194822|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
164194823|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
164194824|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
164194825|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
164194826|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
164194827|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164194828|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164194829|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
164194830|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
164194831|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
164194832|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
164194833|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
164194834|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
164194835|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
164194836|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
164194837|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
164194838|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
164194839|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
164194840|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
164194841|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
164194842|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Death|0|||
164194843|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Death|0|||
164194844|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Death|1|||
164194845|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Death|0|||
164194846|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Death|0|||
164194847|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Death|0|||
164194848|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194849|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194850|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
164194851|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
163859289|NCT01194258|591854454|FG002|Titration Period|Lost to Follow-up|0|||
163859290|NCT01194258|591854455|FG003|Titration Period|Lost to Follow-up|0|||
163859291|NCT01194258|591854456|FG004|Titration Period|Lost to Follow-up|0|||
163859292|NCT01194258|591854452|FG000|Titration Period|Titration failure|3|||
163859293|NCT01194258|591854453|FG001|Titration Period|Titration failure|0|||
163859294|NCT01194258|591854454|FG002|Titration Period|Titration failure|0|||
163859295|NCT01194258|591854455|FG003|Titration Period|Titration failure|0|||
163859296|NCT01194258|591854456|FG004|Titration Period|Titration failure|0|||
163859297|NCT01194258|591854452|FG000|Period 1 (12 Weeks)|Death|0|||
163859298|NCT01194258|591854453|FG001|Period 1 (12 Weeks)|Death|0|||
163859299|NCT01194258|591854454|FG002|Period 1 (12 Weeks)|Death|0|||
164194852|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194853|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
164194854|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194855|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194856|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
164194857|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194858|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194859|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
164194860|NCT02513550|593080975|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194861|NCT02513550|593080976|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
163859300|NCT01194258|591854455|FG003|Period 1 (12 Weeks)|Death|0|||
163859301|NCT01194258|591854456|FG004|Period 1 (12 Weeks)|Death|1|||
163859302|NCT01194258|591854452|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163859303|NCT01194258|591854453|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163859304|NCT01194258|591854454|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163859305|NCT01194258|591854455|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163965113|NCT04029116|592244834|FG001|Overall Study|Other|1|||
163859306|NCT01194258|591854456|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
163859307|NCT01194258|591854452|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
163859308|NCT01194258|591854453|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
163859309|NCT01194258|591854454|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
163859310|NCT01194258|591854455|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
163859311|NCT01194258|591854456|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
163859312|NCT01194258|591854452|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163859313|NCT01194258|591854453|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163859314|NCT01194258|591854454|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
163859315|NCT01194258|591854455|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163859316|NCT01194258|591854456|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163859317|NCT01467700|591854457|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
163859318|NCT01467700|591854458|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
163859319|NCT01467700|591854459|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
163859320|NCT01467700|591854460|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
163859321|NCT01467700|591854457|FG000|Overall Study|Major Protocol Deviation|3|||
163859322|NCT01467700|591854458|FG001|Overall Study|Major Protocol Deviation|3|||
163859323|NCT01467700|591854459|FG002|Overall Study|Major Protocol Deviation|2|||
163859324|NCT01467700|591854460|FG003|Overall Study|Major Protocol Deviation|3|||
163859325|NCT01467700|591854457|FG000|Overall Study|Lost to Follow-up|6|||
163859326|NCT01467700|591854458|FG001|Overall Study|Lost to Follow-up|5|||
163859327|NCT01467700|591854459|FG002|Overall Study|Lost to Follow-up|2|||
163965114|NCT01272947|592244835|FG000|Overall Study|Abnormal Laboratory Value|2|||
164194862|NCT02513550|593080977|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
164194863|NCT02513550|593080978|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194864|NCT02513550|593080979|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194865|NCT02513550|593080980|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
164194866|NCT02849743|593080981|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
164194867|NCT02849743|593080982|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
164194868|NCT02849743|593080981|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
164194869|NCT02849743|593080982|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164194870|NCT02168491|593080985|FG000|Overall Study|Withdrawal by Subject|1|||
164194871|NCT00809445|593080986|FG000|1 Month Follow-up|Lost contact|1|||
164194872|NCT00809445|593080987|FG001|1 Month Follow-up|Lost contact|2|||
164194873|NCT00809445|593080988|FG002|1 Month Follow-up|Lost contact|1|||
164194874|NCT00809445|593080986|FG000|1 Month Follow-up|Withdrew consent|1|||
164194875|NCT00809445|593080987|FG001|1 Month Follow-up|Withdrew consent|1|||
164194876|NCT00809445|593080988|FG002|1 Month Follow-up|Withdrew consent|1|||
164194877|NCT00809445|593080986|FG000|1 Month Follow-up|Death|0|||
164194878|NCT00809445|593080987|FG001|1 Month Follow-up|Death|1|||
164194879|NCT00809445|593080988|FG002|1 Month Follow-up|Death|1|||
164194880|NCT00809445|593080986|FG000|1 Month Follow-up|Incarcerated|0|||
164194881|NCT00809445|593080987|FG001|1 Month Follow-up|Incarcerated|0|||
164194882|NCT00809445|593080988|FG002|1 Month Follow-up|Incarcerated|1|||
164194883|NCT00809445|593080986|FG000|6 Month Follow-up|Lost contact|16|||
164194884|NCT00809445|593080987|FG001|6 Month Follow-up|Lost contact|14|||
164194885|NCT00809445|593080988|FG002|6 Month Follow-up|Lost contact|14|||
164194886|NCT00809445|593080986|FG000|6 Month Follow-up|Death|2|||
164194887|NCT00809445|593080987|FG001|6 Month Follow-up|Death|1|||
164194888|NCT00809445|593080988|FG002|6 Month Follow-up|Death|1|||
164194889|NCT00809445|593080986|FG000|6 Month Follow-up|Incarcerated|6|||
164194890|NCT00809445|593080987|FG001|6 Month Follow-up|Incarcerated|8|||
164194891|NCT00809445|593080988|FG002|6 Month Follow-up|Incarcerated|8|||
164194892|NCT00809445|593080986|FG000|6 Month Follow-up|Withdrew consent|0|||
164194893|NCT00809445|593080987|FG001|6 Month Follow-up|Withdrew consent|0|||
164194894|NCT00809445|593080988|FG002|6 Month Follow-up|Withdrew consent|1|||
164194895|NCT04919317|593080989|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
164194896|NCT04919317|593080990|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
164194897|NCT04919317|593080989|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
164194898|NCT04919317|593080990|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
163859328|NCT01467700|591854460|FG003|Overall Study|Lost to Follow-up|3|||
163859329|NCT01467700|591854457|FG000|Overall Study|Voluntary Withdrawal|5|||
163965115|NCT01272947|592244836|FG001|Overall Study|Abnormal Laboratory Value|2|||
163965116|NCT02019420|592244839|FG000|Overall Study|Did not receive study drug|2|||
163965117|NCT02019420|592244840|FG001|Overall Study|Did not receive study drug|2|||
163965118|NCT02019420|592244839|FG000|Overall Study|Withdrawal by Subject|1|||
163965119|NCT02019420|592244840|FG001|Overall Study|Withdrawal by Subject|3|||
163965120|NCT02019420|592244839|FG000|Overall Study|At request of sponsor or investigator|0|||
164194899|NCT01566604|593080991|FG000|Overall Study|Patient's inability to use the device|1|||
164194900|NCT01566604|593080992|FG001|Overall Study|Patient's inability to use the device|0|||
164194901|NCT01566604|593080991|FG000|Overall Study|Administrative problems|1|||
164194902|NCT01566604|593080992|FG001|Overall Study|Administrative problems|0|||
164194903|NCT01566604|593080991|FG000|Overall Study|Lack of Efficacy|1|||
164194904|NCT01566604|593080992|FG001|Overall Study|Lack of Efficacy|2|||
163859330|NCT01467700|591854458|FG001|Overall Study|Voluntary Withdrawal|7|||
164194905|NCT01566604|593080991|FG000|Overall Study|Protocol deviation|2|||
164194906|NCT01566604|593080992|FG001|Overall Study|Protocol deviation|0|||
164194907|NCT01566604|593080991|FG000|Overall Study|Abnormal laboratory value|2|||
164194908|NCT01566604|593080992|FG001|Overall Study|Abnormal laboratory value|0|||
164194909|NCT01566604|593080991|FG000|Overall Study|Death|4|||
164194910|NCT01566604|593080992|FG001|Overall Study|Death|1|||
164194911|NCT01566604|593080991|FG000|Overall Study|Adverse Event|4|||
164194912|NCT01566604|593080992|FG001|Overall Study|Adverse Event|2|||
163965121|NCT02019420|592244840|FG001|Overall Study|At request of sponsor or investigator|1|||
163965122|NCT02019420|592244839|FG000|Overall Study|Death|104|||
163965123|NCT02019420|592244840|FG001|Overall Study|Death|99|||
163965124|NCT02019420|592244839|FG000|Overall Study|Transferred to other care facility|1|||
163965125|NCT02019420|592244840|FG001|Overall Study|Transferred to other care facility|1|||
163965126|NCT02469896|592244841|FG000|Overall Study|Withdrawal by Subject|2|||
163965127|NCT02469896|592244842|FG001|Overall Study|Withdrawal by Subject|0|||
163965128|NCT02510560|592244843|FG000|Overall Study|Discontinued from Treatment|27|||
163965129|NCT02510560|592244844|FG001|Overall Study|Discontinued from Treatment|18|||
163965130|NCT02510560|592244845|FG002|Overall Study|Discontinued from Treatment|19|||
163965131|NCT02510560|592244843|FG000|Overall Study|Other|4|||
163965132|NCT02510560|592244844|FG001|Overall Study|Other|4|||
163965133|NCT02510560|592244845|FG002|Overall Study|Other|3|||
163965134|NCT01294150|592244846|FG000|Overall Study|Physician Decision|2|||
163965135|NCT01294150|592244847|FG001|Overall Study|Physician Decision|2|||
163965136|NCT02401412|592244848|FG000|Overall Study|Lost to Follow-up|1|||
163965137|NCT02401412|592244849|FG001|Overall Study|Lost to Follow-up|0|||
163965138|NCT02401412|592244848|FG000|Overall Study|Discontinued Intervention|15|||
163965139|NCT02401412|592244849|FG001|Overall Study|Discontinued Intervention|21|||
163965140|NCT02401412|592244848|FG000|Overall Study|Withdrawal by Subject|4|||
163965141|NCT02401412|592244849|FG001|Overall Study|Withdrawal by Subject|4|||
163965142|NCT02401412|592244848|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
163965143|NCT02401412|592244849|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
163965144|NCT02401412|592244848|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
163965145|NCT02401412|592244849|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
163965146|NCT03684642|592244856|FG000|Overall Study|Adverse Event|6|||
163965147|NCT03684642|592244857|FG001|Overall Study|Adverse Event|15|||
163965148|NCT03684642|592244858|FG002|Overall Study|Adverse Event|11|||
163965149|NCT03684642|592244856|FG000|Overall Study|Withdrawal by Subject|35|||
163965150|NCT03684642|592244857|FG001|Overall Study|Withdrawal by Subject|53|||
163965151|NCT03684642|592244858|FG002|Overall Study|Withdrawal by Subject|23|||
163965152|NCT03684642|592244856|FG000|Overall Study|Lack of Efficacy|0|||
163965153|NCT03684642|592244857|FG001|Overall Study|Lack of Efficacy|0|||
163965154|NCT03684642|592244858|FG002|Overall Study|Lack of Efficacy|1|||
163965155|NCT03684642|592244856|FG000|Overall Study|Poor compliance to protocol|0|||
163965156|NCT03684642|592244857|FG001|Overall Study|Poor compliance to protocol|4|||
163965157|NCT03684642|592244858|FG002|Overall Study|Poor compliance to protocol|1|||
163965158|NCT03684642|592244856|FG000|Overall Study|Other than specified|62|||
163965159|NCT03684642|592244857|FG001|Overall Study|Other than specified|60|||
163965160|NCT03684642|592244858|FG002|Overall Study|Other than specified|67|||
163965161|NCT03684642|592244856|FG000|Overall Study|Randomized and not treated|0|||
163965162|NCT03684642|592244857|FG001|Overall Study|Randomized and not treated|0|||
163965163|NCT03684642|592244858|FG002|Overall Study|Randomized and not treated|1|||
163965164|NCT03684642|592244856|FG000|Overall Study|Missing completion status but alive at last contact|0|||
163965165|NCT03684642|592244857|FG001|Overall Study|Missing completion status but alive at last contact|1|||
164134657|NCT03970837|592857358|FG003|Overall Study|Adverse Event|6|||
164134658|NCT03970837|592857359|FG004|Overall Study|Adverse Event|4|||
164134659|NCT03970837|592857360|FG005|Overall Study|Adverse Event|5|||
164134660|NCT03970837|592857361|FG006|Overall Study|Adverse Event|1|||
164134661|NCT03970837|592857362|FG007|Overall Study|Adverse Event|5|||
164134662|NCT03970837|592857363|FG008|Overall Study|Adverse Event|0|||
164134663|NCT03970837|592857364|FG009|Overall Study|Adverse Event|0|||
164134664|NCT03970837|592857365|FG010|Overall Study|Adverse Event|1|||
164134665|NCT03970837|592857366|FG011|Overall Study|Adverse Event|1|||
164134666|NCT03970837|592857355|FG000|Overall Study|Lack of Efficacy|14|||
164134667|NCT03970837|592857356|FG001|Overall Study|Lack of Efficacy|12|||
164134668|NCT03970837|592857357|FG002|Overall Study|Lack of Efficacy|1|||
164134669|NCT03970837|592857358|FG003|Overall Study|Lack of Efficacy|2|||
164134670|NCT03970837|592857359|FG004|Overall Study|Lack of Efficacy|3|||
164134671|NCT03970837|592857360|FG005|Overall Study|Lack of Efficacy|4|||
164134672|NCT03970837|592857361|FG006|Overall Study|Lack of Efficacy|6|||
164134673|NCT03970837|592857362|FG007|Overall Study|Lack of Efficacy|1|||
164134674|NCT03970837|592857363|FG008|Overall Study|Lack of Efficacy|1|||
164134675|NCT03970837|592857364|FG009|Overall Study|Lack of Efficacy|0|||
164134676|NCT03970837|592857365|FG010|Overall Study|Lack of Efficacy|0|||
164134677|NCT03970837|592857366|FG011|Overall Study|Lack of Efficacy|0|||
164134678|NCT03970837|592857355|FG000|Overall Study|Lost to Follow-up|6|||
164134679|NCT03970837|592857356|FG001|Overall Study|Lost to Follow-up|5|||
164134680|NCT03970837|592857357|FG002|Overall Study|Lost to Follow-up|5|||
164134681|NCT03970837|592857358|FG003|Overall Study|Lost to Follow-up|1|||
164134682|NCT03970837|592857359|FG004|Overall Study|Lost to Follow-up|0|||
164194913|NCT01566604|593080991|FG000|Overall Study|Withdrawal by Subject|9|||
164194914|NCT01566604|593080992|FG001|Overall Study|Withdrawal by Subject|6|||
164194915|NCT01443858|593080999|FG000|Overall Study|Withdrawal by Subject|9|||
164194916|NCT01443858|593081000|FG001|Overall Study|Withdrawal by Subject|8|||
164194917|NCT01443858|593081001|FG002|Overall Study|Withdrawal by Subject|5|||
164194918|NCT01443858|593080999|FG000|Overall Study|Lack of Efficacy|1|||
164194919|NCT01443858|593081000|FG001|Overall Study|Lack of Efficacy|0|||
164194920|NCT01443858|593081001|FG002|Overall Study|Lack of Efficacy|0|||
164194921|NCT01443858|593080999|FG000|Overall Study|Lost to Follow-up|5|||
164194922|NCT01443858|593081000|FG001|Overall Study|Lost to Follow-up|5|||
164194923|NCT01443858|593081001|FG002|Overall Study|Lost to Follow-up|2|||
164194924|NCT06060496|593081002|FG000|Overall Study|Withdrawal by Subject|2|||
164194925|NCT06060496|593081002|FG000|Overall Study|Lost to Follow-up|2|||
164194926|NCT00321906|593081005|FG000|Overall Study|Adverse Event|36|||
164194927|NCT00321906|593081006|FG001|Overall Study|Adverse Event|44|||
164194928|NCT00321906|593081005|FG000|Overall Study|Death|9|||
164194929|NCT00321906|593081006|FG001|Overall Study|Death|6|||
164194930|NCT00321906|593081005|FG000|Overall Study|Lost to Follow-up|1|||
164194931|NCT00321906|593081006|FG001|Overall Study|Lost to Follow-up|2|||
164194932|NCT00321906|593081005|FG000|Overall Study|Withdrawal by Subject|0|||
164194933|NCT00321906|593081006|FG001|Overall Study|Withdrawal by Subject|4|||
164194934|NCT02221648|593081007|FG000|Overall Study|Withdrawal by Subject|3|||
164194935|NCT02221648|593081008|FG001|Overall Study|Withdrawal by Subject|3|||
164194936|NCT00149396|593081011|FG000|Overall Study|Death|15|||
164194937|NCT00149396|593081011|FG000|Overall Study|Withdrawal by Subject|1|||
164194938|NCT00149396|593081011|FG000|Overall Study|Subject noncompliance|2|||
164194939|NCT00149396|593081011|FG000|Overall Study|other treatment|5|||
164194940|NCT00810069|593081012|FG000|Lead-in Period I|Adverse Event|43|||
164194941|NCT00810069|593081013|FG001|Lead-in Period I|Adverse Event|0|||
164194942|NCT00810069|593081014|FG002|Lead-in Period I|Adverse Event|0|||
164194943|NCT00810069|593081012|FG000|Lead-in Period I|Lack of Efficacy|1|||
164194944|NCT00810069|593081013|FG001|Lead-in Period I|Lack of Efficacy|0|||
164194945|NCT00810069|593081014|FG002|Lead-in Period I|Lack of Efficacy|0|||
164194946|NCT00810069|593081012|FG000|Lead-in Period I|Lost to Follow-up|19|||
164194947|NCT00810069|593081013|FG001|Lead-in Period I|Lost to Follow-up|0|||
164194948|NCT00810069|593081014|FG002|Lead-in Period I|Lost to Follow-up|0|||
164194949|NCT00810069|593081012|FG000|Lead-in Period I|Physician Decision|1|||
164194950|NCT00810069|593081013|FG001|Lead-in Period I|Physician Decision|0|||
164194951|NCT00810069|593081014|FG002|Lead-in Period I|Physician Decision|0|||
164194952|NCT00810069|593081012|FG000|Lead-in Period I|Protocol Violation|1|||
164194953|NCT00810069|593081013|FG001|Lead-in Period I|Protocol Violation|0|||
164194954|NCT00810069|593081014|FG002|Lead-in Period I|Protocol Violation|0|||
164194955|NCT00810069|593081012|FG000|Lead-in Period I|Withdrawal by Subject|46|||
164194956|NCT00810069|593081013|FG001|Lead-in Period I|Withdrawal by Subject|0|||
164194957|NCT00810069|593081014|FG002|Lead-in Period I|Withdrawal by Subject|0|||
164194958|NCT00810069|593081012|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
164194959|NCT00810069|593081013|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
164194960|NCT00810069|593081014|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
164194961|NCT00810069|593081012|FG000|Lead-in Period I|Randomization criteria not met|158|||
164194962|NCT00810069|593081013|FG001|Lead-in Period I|Randomization criteria not met|0|||
164194963|NCT00810069|593081014|FG002|Lead-in Period I|Randomization criteria not met|0|||
164194964|NCT00810069|593081012|FG000|Double-Blind Period II|Adverse Event|0|||
164194965|NCT00810069|593081013|FG001|Double-Blind Period II|Adverse Event|9|||
164194966|NCT00810069|593081014|FG002|Double-Blind Period II|Adverse Event|8|||
164194967|NCT00810069|593081012|FG000|Double-Blind Period II|Lack of Efficacy|0|||
164194968|NCT00810069|593081013|FG001|Double-Blind Period II|Lack of Efficacy|7|||
164194969|NCT00810069|593081014|FG002|Double-Blind Period II|Lack of Efficacy|12|||
164194970|NCT00810069|593081012|FG000|Double-Blind Period II|Lost to Follow-up|0|||
164194971|NCT00810069|593081013|FG001|Double-Blind Period II|Lost to Follow-up|9|||
164194972|NCT00810069|593081014|FG002|Double-Blind Period II|Lost to Follow-up|9|||
164194973|NCT00810069|593081012|FG000|Double-Blind Period II|Physician Decision|0|||
164194974|NCT00810069|593081013|FG001|Double-Blind Period II|Physician Decision|0|||
164194975|NCT00810069|593081014|FG002|Double-Blind Period II|Physician Decision|1|||
164194976|NCT00810069|593081012|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
164194977|NCT00810069|593081013|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
164194978|NCT00810069|593081014|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
164194979|NCT00810069|593081012|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
164194980|NCT00810069|593081013|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
164194981|NCT00810069|593081014|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
164194982|NCT00810069|593081012|FG000|Double-Blind Period II|Clinical relapse|0|||
164194983|NCT00810069|593081013|FG001|Double-Blind Period II|Clinical relapse|3|||
164194984|NCT00810069|593081014|FG002|Double-Blind Period II|Clinical relapse|0|||
164194985|NCT00810069|593081012|FG000|Double-Blind Period II|Protocol Violation|0|||
164194986|NCT00810069|593081013|FG001|Double-Blind Period II|Protocol Violation|7|||
164194987|NCT00810069|593081014|FG002|Double-Blind Period II|Protocol Violation|6|||
164194988|NCT00426764|593081017|FG000|Overall Study|Protocol Violation|1|||
164194989|NCT00426764|593081017|FG000|Overall Study|Withdrawal by Subject|4|||
164194990|NCT00426764|593081017|FG000|Overall Study|Physician Decision|6|||
164194991|NCT00426764|593081017|FG000|Overall Study|Compassionate Use|1|||
164194992|NCT00426764|593081017|FG000|Overall Study|Progressive Disease|83|||
164194993|NCT00426764|593081017|FG000|Overall Study|Adverse Event|24|||
164194994|NCT00426764|593081017|FG000|Overall Study|Other|1|||
164194995|NCT00426764|593081017|FG000|Overall Study|Death|1|||
164194996|NCT00426764|593081017|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
164194997|NCT01922258|593081018|FG000|Overall Study|Lost to Follow-up|1|||
164194998|NCT01922258|593081019|FG001|Overall Study|Lost to Follow-up|1|||
164194999|NCT01922258|593081018|FG000|Overall Study|Adverse Event|9|||
164195000|NCT01922258|593081019|FG001|Overall Study|Adverse Event|2|||
164195001|NCT01922258|593081018|FG000|Overall Study|Met Withdrawal Criteria|0|||
164195002|NCT01922258|593081019|FG001|Overall Study|Met Withdrawal Criteria|4|||
164195003|NCT01922258|593081018|FG000|Overall Study|Withdrawn by the Investigator|1|||
164195004|NCT01922258|593081019|FG001|Overall Study|Withdrawn by the Investigator|4|||
164195005|NCT01922258|593081018|FG000|Overall Study|Withdrawal by participant|5|||
164195006|NCT01922258|593081019|FG001|Overall Study|Withdrawal by participant|5|||
164195007|NCT03113968|593081020|FG000|Overall Study|Withdrawal by Subject|31|||
164195008|NCT03113968|593081021|FG001|Overall Study|Withdrawal by Subject|4|||
164195009|NCT00901342|593081022|FG000|Overall Study|Adverse Event|1|||
164195010|NCT00901342|593081022|FG000|Overall Study|Death|4|||
164195011|NCT00901342|593081022|FG000|Overall Study|Disease progression|1|||
164195012|NCT00901342|593081022|FG000|Overall Study|Withdrawal by Subject|9|||
164195013|NCT02782741|593081023|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
164195014|NCT02782741|593081024|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
164195015|NCT02782741|593081025|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
164195016|NCT02782741|593081023|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
164195017|NCT02782741|593081024|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
164195018|NCT02782741|593081025|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
164195019|NCT02782741|593081023|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
164195020|NCT02782741|593081024|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
164195021|NCT02782741|593081025|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
164195022|NCT02782741|593081023|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
164195023|NCT02782741|593081024|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
164195024|NCT02782741|593081025|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
164195025|NCT02782741|593081023|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
164195026|NCT02782741|593081024|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
164195027|NCT02782741|593081025|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
164195028|NCT05116202|593081026|FG000|Overall Study|Study Terminated by Sponsor|21|||
164195029|NCT05116202|593081027|FG001|Overall Study|Study Terminated by Sponsor|38|||
164195030|NCT05116202|593081028|FG002|Overall Study|Study Terminated by Sponsor|17|||
164195031|NCT05116202|593081029|FG003|Overall Study|Study Terminated by Sponsor|18|||
164195032|NCT05116202|593081030|FG004|Overall Study|Study Terminated by Sponsor|0|||
164195033|NCT05116202|593081026|FG000|Overall Study|Withdrawal by Subject|0|||
164195034|NCT05116202|593081027|FG001|Overall Study|Withdrawal by Subject|1|||
164195035|NCT05116202|593081028|FG002|Overall Study|Withdrawal by Subject|1|||
164195036|NCT05116202|593081029|FG003|Overall Study|Withdrawal by Subject|1|||
164195037|NCT05116202|593081030|FG004|Overall Study|Withdrawal by Subject|1|||
164195038|NCT05116202|593081026|FG000|Overall Study|Lost to Follow-up|0|||
164195039|NCT05116202|593081027|FG001|Overall Study|Lost to Follow-up|0|||
164195040|NCT05116202|593081028|FG002|Overall Study|Lost to Follow-up|0|||
164195041|NCT05116202|593081029|FG003|Overall Study|Lost to Follow-up|0|||
164195042|NCT05116202|593081030|FG004|Overall Study|Lost to Follow-up|2|||
164195043|NCT05116202|593081026|FG000|Overall Study|Death|1|||
164195044|NCT05116202|593081027|FG001|Overall Study|Death|1|||
164195045|NCT05116202|593081028|FG002|Overall Study|Death|2|||
164195046|NCT05116202|593081029|FG003|Overall Study|Death|1|||
164195047|NCT05116202|593081030|FG004|Overall Study|Death|5|||
164195048|NCT02686164|593081034|FG000|Overall Study|Adverse Event|1|||
164195049|NCT02686164|593081034|FG000|Overall Study|Withdrawal of consent|1|||
164195050|NCT02686164|593081034|FG000|Overall Study|Clinical progression|1|||
164195051|NCT01827592|593081037|FG000|Overall Study|Adverse Event|11|||
163859331|NCT01467700|591854459|FG002|Overall Study|Voluntary Withdrawal|6|||
163859332|NCT01467700|591854460|FG003|Overall Study|Voluntary Withdrawal|2|||
163859333|NCT01467700|591854457|FG000|Overall Study|Study Termination|6|||
164195052|NCT01827592|593081038|FG001|Overall Study|Adverse Event|9|||
164195053|NCT01827592|593081039|FG002|Overall Study|Adverse Event|2|||
164195054|NCT01827592|593081037|FG000|Overall Study|Physician Decision|0|||
164195055|NCT01827592|593081038|FG001|Overall Study|Physician Decision|2|||
164195056|NCT01827592|593081039|FG002|Overall Study|Physician Decision|1|||
164195057|NCT01827592|593081037|FG000|Overall Study|Protocol Violation|2|||
164195058|NCT01827592|593081038|FG001|Overall Study|Protocol Violation|1|||
164195059|NCT01827592|593081039|FG002|Overall Study|Protocol Violation|0|||
164195060|NCT01827592|593081037|FG000|Overall Study|Lost to Follow-up|1|||
164195061|NCT01827592|593081038|FG001|Overall Study|Lost to Follow-up|2|||
164195062|NCT01827592|593081039|FG002|Overall Study|Lost to Follow-up|2|||
164195063|NCT01827592|593081037|FG000|Overall Study|Withdrawal by Subject|12|||
164195064|NCT01827592|593081038|FG001|Overall Study|Withdrawal by Subject|11|||
164195065|NCT01827592|593081039|FG002|Overall Study|Withdrawal by Subject|11|||
164195066|NCT01827592|593081037|FG000|Overall Study|Patient's substantial non-compliance|1|||
164195067|NCT01827592|593081038|FG001|Overall Study|Patient's substantial non-compliance|1|||
164195068|NCT01827592|593081039|FG002|Overall Study|Patient's substantial non-compliance|6|||
164195069|NCT01827592|593081037|FG000|Overall Study|Trial terminated by Sponsor|47|||
164195070|NCT01827592|593081038|FG001|Overall Study|Trial terminated by Sponsor|53|||
164195071|NCT01827592|593081039|FG002|Overall Study|Trial terminated by Sponsor|51|||
164195072|NCT01827592|593081037|FG000|Overall Study|Others|0|||
164195073|NCT01827592|593081038|FG001|Overall Study|Others|1|||
164195074|NCT01827592|593081039|FG002|Overall Study|Others|3|||
164195075|NCT02324361|593081040|FG000|Overall Study|Lost to Follow-up|5|||
164195076|NCT02324361|593081041|FG001|Overall Study|Lost to Follow-up|2|||
164195077|NCT02329327|593081049|FG000|Overall Study|Death|78|||
164195078|NCT02329327|593081050|FG001|Overall Study|Death|0|||
164195079|NCT02329327|593081049|FG000|Overall Study|Withdrawal by Subject|3|||
164195080|NCT02329327|593081050|FG001|Overall Study|Withdrawal by Subject|0|||
164195081|NCT02329327|593081049|FG000|Overall Study|Lost to Follow-up|4|||
164195082|NCT02329327|593081050|FG001|Overall Study|Lost to Follow-up|0|||
164195083|NCT03560869|593081051|FG000|Overall Study|Withdrawal by Subject|3|||
164195084|NCT03560869|593081052|FG001|Overall Study|Withdrawal by Subject|4|||
164195085|NCT03560869|593081051|FG000|Overall Study|Screening failure|4|||
164195086|NCT03560869|593081052|FG001|Overall Study|Screening failure|4|||
164195087|NCT03560869|593081051|FG000|Overall Study|Withdrawal by PI|0|||
164195088|NCT03560869|593081052|FG001|Overall Study|Withdrawal by PI|1|||
164195089|NCT03718429|593081053|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
164195090|NCT03718429|593081054|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
164195091|NCT03718429|593081055|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
164195092|NCT03718429|593081056|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
164195093|NCT02346877|593081057|FG000|Overall Study|Adverse Event|1|||
164195094|NCT02346877|593081058|FG001|Overall Study|Adverse Event|0|||
164195095|NCT02346877|593081057|FG000|Overall Study|Administrative Decision|1|||
164195096|NCT02346877|593081058|FG001|Overall Study|Administrative Decision|0|||
164195097|NCT02346877|593081057|FG000|Overall Study|Sponsor Decision|12|||
164195098|NCT02346877|593081058|FG001|Overall Study|Sponsor Decision|0|||
164195099|NCT02346877|593081057|FG000|Overall Study|Missing|5|||
163859334|NCT01467700|591854458|FG001|Overall Study|Study Termination|5|||
163859335|NCT01467700|591854459|FG002|Overall Study|Study Termination|10|||
163859336|NCT01467700|591854460|FG003|Overall Study|Study Termination|7|||
163859337|NCT01467700|591854457|FG000|Overall Study|Pregnancy|0|||
163859338|NCT01467700|591854458|FG001|Overall Study|Pregnancy|1|||
163859339|NCT01467700|591854459|FG002|Overall Study|Pregnancy|1|||
163859340|NCT01467700|591854460|FG003|Overall Study|Pregnancy|0|||
163859341|NCT01467700|591854457|FG000|Overall Study|Lack of Efficacy|2|||
163859342|NCT01467700|591854458|FG001|Overall Study|Lack of Efficacy|0|||
163859343|NCT01467700|591854459|FG002|Overall Study|Lack of Efficacy|2|||
163859344|NCT01467700|591854460|FG003|Overall Study|Lack of Efficacy|1|||
163859345|NCT01467700|591854457|FG000|Overall Study|Reason not Specified|1|||
163859346|NCT01467700|591854458|FG001|Overall Study|Reason not Specified|3|||
163859347|NCT01467700|591854459|FG002|Overall Study|Reason not Specified|2|||
163859348|NCT01467700|591854460|FG003|Overall Study|Reason not Specified|8|||
163859349|NCT03381274|591854461|FG000|Overall Study|Death|2|||
163859350|NCT03381274|591854462|FG001|Overall Study|Death|9|||
163859351|NCT03381274|591854463|FG002|Overall Study|Death|3|||
163859352|NCT03381274|591854464|FG003|Overall Study|Death|2|||
163859353|NCT03381274|591854465|FG004|Overall Study|Death|3|||
163859354|NCT03381274|591854461|FG000|Overall Study|Lost to Follow-up|0|||
163859355|NCT03381274|591854462|FG001|Overall Study|Lost to Follow-up|0|||
163859356|NCT03381274|591854463|FG002|Overall Study|Lost to Follow-up|0|||
163859357|NCT03381274|591854464|FG003|Overall Study|Lost to Follow-up|1|||
163965166|NCT03684642|592244858|FG002|Overall Study|Missing completion status but alive at last contact|2|||
163965167|NCT01431534|592244859|FG000|Treatment Phase|Adverse Event|0|||
163965168|NCT01431534|592244860|FG001|Treatment Phase|Adverse Event|0|||
164195100|NCT02346877|593081058|FG001|Overall Study|Missing|0|||
164195101|NCT01386606|593083222|FG000|Overall Study|Adverse Event|0|||
164195102|NCT01386606|593083223|FG001|Overall Study|Adverse Event|1|||
164195103|NCT01386606|593083224|FG002|Overall Study|Adverse Event|0|||
164195104|NCT01386606|593083225|FG003|Overall Study|Adverse Event|0|||
163859358|NCT03381274|591854465|FG004|Overall Study|Lost to Follow-up|0|||
163859359|NCT03381274|591854461|FG000|Overall Study|Withdrawal by Subject|2|||
163859360|NCT03381274|591854462|FG001|Overall Study|Withdrawal by Subject|1|||
163859361|NCT03381274|591854463|FG002|Overall Study|Withdrawal by Subject|3|||
163859362|NCT03381274|591854464|FG003|Overall Study|Withdrawal by Subject|1|||
163859363|NCT03381274|591854465|FG004|Overall Study|Withdrawal by Subject|0|||
163859364|NCT03381274|591854461|FG000|Overall Study|Other|1|||
163965169|NCT01431534|592244861|FG002|Treatment Phase|Adverse Event|1|||
164195105|NCT01386606|593083222|FG000|Overall Study|Withdrawal by Subject|0|||
164195106|NCT01386606|593083223|FG001|Overall Study|Withdrawal by Subject|1|||
164195107|NCT01386606|593083224|FG002|Overall Study|Withdrawal by Subject|1|||
164195108|NCT01386606|593083225|FG003|Overall Study|Withdrawal by Subject|0|||
164195109|NCT01386606|593083222|FG000|Overall Study|Protocol Violation|1|||
164195110|NCT01386606|593083223|FG001|Overall Study|Protocol Violation|0|||
164195111|NCT01386606|593083224|FG002|Overall Study|Protocol Violation|1|||
164195112|NCT01386606|593083225|FG003|Overall Study|Protocol Violation|1|||
164195113|NCT01386606|593083222|FG000|Overall Study|Lost to Follow-up|2|||
164195114|NCT01386606|593083223|FG001|Overall Study|Lost to Follow-up|0|||
164195115|NCT01386606|593083224|FG002|Overall Study|Lost to Follow-up|0|||
164195116|NCT01386606|593083225|FG003|Overall Study|Lost to Follow-up|0|||
164195117|NCT01386606|593083222|FG000|Overall Study|Subject incarcerated|0|||
164195118|NCT01386606|593083223|FG001|Overall Study|Subject incarcerated|1|||
164195119|NCT01386606|593083224|FG002|Overall Study|Subject incarcerated|0|||
164195120|NCT01386606|593083225|FG003|Overall Study|Subject incarcerated|0|||
164195121|NCT01386606|593083222|FG000|Overall Study|Unable to draw PK|1|||
164195122|NCT01386606|593083223|FG001|Overall Study|Unable to draw PK|0|||
164195123|NCT01386606|593083224|FG002|Overall Study|Unable to draw PK|0|||
164195124|NCT01386606|593083225|FG003|Overall Study|Unable to draw PK|0|||
164195125|NCT01386606|593083222|FG000|Overall Study|T levels too high|0|||
164195126|NCT01386606|593083223|FG001|Overall Study|T levels too high|1|||
164195127|NCT01386606|593083224|FG002|Overall Study|T levels too high|1|||
164195128|NCT01386606|593083225|FG003|Overall Study|T levels too high|0|||
163859365|NCT03381274|591854462|FG001|Overall Study|Other|11|||
163859366|NCT03381274|591854463|FG002|Overall Study|Other|0|||
163859367|NCT03381274|591854464|FG003|Overall Study|Other|2|||
163859368|NCT03381274|591854465|FG004|Overall Study|Other|2|||
163859369|NCT04109118|591854468|FG000|Overall Study|Lost to Follow-up|3|||
163859370|NCT02824432|591854469|FG000|Overall Study|Major Protocol Deviation|1|||
163859371|NCT02824432|591854470|FG001|Overall Study|Major Protocol Deviation|0|||
163859372|NCT01348087|591854471|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
164195129|NCT00593814|593083227|FG000|Overall Study|Death|7|||
164195130|NCT00593814|593083228|FG001|Overall Study|Death|0|||
164195131|NCT00593814|593083227|FG000|Overall Study|Withdrawal by Subject|7|||
164195132|NCT00593814|593083228|FG001|Overall Study|Withdrawal by Subject|0|||
164195133|NCT00593814|593083227|FG000|Overall Study|Lost to Follow-up|7|||
164195134|NCT00593814|593083228|FG001|Overall Study|Lost to Follow-up|0|||
164195135|NCT00593814|593083227|FG000|Overall Study|Physician Decision|3|||
164195136|NCT00593814|593083228|FG001|Overall Study|Physician Decision|0|||
164195137|NCT02723188|593083231|FG000|Overall Study|Withdrawal by Subject|1|||
164195138|NCT02723188|593083232|FG001|Overall Study|Withdrawal by Subject|0|||
164195139|NCT02723188|593083233|FG002|Overall Study|Withdrawal by Subject|0|||
164195140|NCT03110354|593083237|FG000|Overall Study|Death|1|||
164195141|NCT03110354|593083238|FG001|Overall Study|Death|0|||
164195142|NCT03110354|593083239|FG002|Overall Study|Death|0|||
164195143|NCT03110354|593083240|FG003|Overall Study|Death|1|||
164195144|NCT03110354|593083241|FG004|Overall Study|Death|0|||
164195145|NCT03110354|593083237|FG000|Overall Study|Start of new therapy|0|||
164195146|NCT03110354|593083238|FG001|Overall Study|Start of new therapy|0|||
164195147|NCT03110354|593083239|FG002|Overall Study|Start of new therapy|0|||
164195148|NCT03110354|593083240|FG003|Overall Study|Start of new therapy|0|||
164195149|NCT03110354|593083241|FG004|Overall Study|Start of new therapy|1|||
164195150|NCT03110354|593083237|FG000|Overall Study|Failure to achieve response|2|||
164195151|NCT03110354|593083238|FG001|Overall Study|Failure to achieve response|3|||
164195152|NCT03110354|593083239|FG002|Overall Study|Failure to achieve response|0|||
164195153|NCT03110354|593083240|FG003|Overall Study|Failure to achieve response|2|||
164195154|NCT03110354|593083241|FG004|Overall Study|Failure to achieve response|1|||
164195155|NCT03110354|593083237|FG000|Overall Study|Progressive disease|1|||
164195156|NCT03110354|593083238|FG001|Overall Study|Progressive disease|1|||
164195157|NCT03110354|593083239|FG002|Overall Study|Progressive disease|3|||
164195158|NCT03110354|593083240|FG003|Overall Study|Progressive disease|4|||
164195159|NCT03110354|593083241|FG004|Overall Study|Progressive disease|2|||
164195160|NCT03110354|593083237|FG000|Overall Study|Adverse Event|0|||
164195161|NCT03110354|593083238|FG001|Overall Study|Adverse Event|0|||
164195162|NCT03110354|593083239|FG002|Overall Study|Adverse Event|0|||
164195163|NCT03110354|593083240|FG003|Overall Study|Adverse Event|2|||
164195164|NCT03110354|593083241|FG004|Overall Study|Adverse Event|2|||
164195165|NCT03110354|593083237|FG000|Overall Study|Other|0|||
164195166|NCT03110354|593083238|FG001|Overall Study|Other|0|||
164195167|NCT03110354|593083239|FG002|Overall Study|Other|0|||
164195168|NCT03110354|593083240|FG003|Overall Study|Other|1|||
164195169|NCT03110354|593083241|FG004|Overall Study|Other|1|||
164195170|NCT02026141|593083248|FG000|Overall Study|Protocol Violation|0|||
163859373|NCT01348087|591854471|FG000|Overall Study|Administrative problems|79|||
163859374|NCT01348087|591854471|FG000|Overall Study|protocol deviation|1|||
163859375|NCT01348087|591854471|FG000|Overall Study|Lost to Follow-up|1|||
164195171|NCT02026141|593083249|FG001|Overall Study|Protocol Violation|1|||
164195172|NCT02169505|593083250|FG000|Overall Study|Withdrawal by Subject|1|||
164195173|NCT02735980|593083251|FG000|Overall Study|Adverse Event|0|||
164195174|NCT02735980|593083252|FG001|Overall Study|Adverse Event|4|||
164195175|NCT02735980|593083253|FG002|Overall Study|Adverse Event|1|||
164195176|NCT02735980|593083251|FG000|Overall Study|Death|5|||
164195177|NCT02735980|593083252|FG001|Overall Study|Death|4|||
164195178|NCT02735980|593083253|FG002|Overall Study|Death|0|||
164195179|NCT02735980|593083251|FG000|Overall Study|Physician Decision|3|||
164195180|NCT02735980|593083252|FG001|Overall Study|Physician Decision|1|||
164195181|NCT02735980|593083253|FG002|Overall Study|Physician Decision|0|||
164195182|NCT02735980|593083251|FG000|Overall Study|Screen failure|1|||
164195183|NCT02735980|593083252|FG001|Overall Study|Screen failure|0|||
163965170|NCT01431534|592244859|FG000|Treatment Phase|Progressive Disease|4|||
163965171|NCT01431534|592244860|FG001|Treatment Phase|Progressive Disease|3|||
164195184|NCT02735980|593083253|FG002|Overall Study|Screen failure|0|||
164195185|NCT02735980|593083251|FG000|Overall Study|Withdrawal by Subject|1|||
164195186|NCT02735980|593083252|FG001|Overall Study|Withdrawal by Subject|2|||
164195187|NCT02735980|593083253|FG002|Overall Study|Withdrawal by Subject|0|||
164195188|NCT00917124|593083257|FG000|Overall Study|Protocol Violation|4|||
164195189|NCT00917124|593083258|FG001|Overall Study|Protocol Violation|6|||
164195190|NCT02185417|593083260|FG000|Overall Study|Death|448|||
164195191|NCT02185417|593083261|FG001|Overall Study|Death|446|||
164195192|NCT02185417|593083262|FG002|Overall Study|Death|0|||
164195193|NCT02185417|593083260|FG000|Overall Study|Withdrawal by Subject|7|||
164195194|NCT02185417|593083261|FG001|Overall Study|Withdrawal by Subject|12|||
164195195|NCT02185417|593083262|FG002|Overall Study|Withdrawal by Subject|0|||
164195196|NCT03131167|593083263|FG000|Overall Study|Other (Unspecified)|0|||
164195197|NCT03131167|593083264|FG001|Overall Study|Other (Unspecified)|0|||
164195198|NCT03131167|593083265|FG002|Overall Study|Other (Unspecified)|0|||
164195199|NCT03131167|593083266|FG003|Overall Study|Other (Unspecified)|0|||
164195200|NCT03131167|593083267|FG004|Overall Study|Other (Unspecified)|0|||
164195201|NCT03131167|593083268|FG005|Overall Study|Other (Unspecified)|1|||
164195202|NCT03131167|593083269|FG006|Overall Study|Other (Unspecified)|0|||
164195203|NCT03131167|593083270|FG007|Overall Study|Other (Unspecified)|0|||
164195204|NCT03131167|593083271|FG008|Overall Study|Other (Unspecified)|0|||
164195205|NCT03131167|593083272|FG009|Overall Study|Other (Unspecified)|0|||
164195206|NCT03131167|593083273|FG010|Overall Study|Other (Unspecified)|0|||
164195207|NCT03131167|593083274|FG011|Overall Study|Other (Unspecified)|0|||
164195208|NCT03131167|593083275|FG012|Overall Study|Other (Unspecified)|0|||
164195209|NCT00126594|593083280|FG000|Overall Study|Ineligible|2|||
164195210|NCT00126594|593083281|FG001|Overall Study|Ineligible|0|||
164195211|NCT00126594|593083280|FG000|Overall Study|Withdrawal by Subject|0|||
164195212|NCT00126594|593083281|FG001|Overall Study|Withdrawal by Subject|4|||
164195213|NCT00126594|593083280|FG000|Overall Study|Physician Decision|1|||
164195214|NCT00126594|593083281|FG001|Overall Study|Physician Decision|3|||
164195215|NCT00126594|593083280|FG000|Overall Study|Adverse Event|7|||
164195216|NCT00126594|593083281|FG001|Overall Study|Adverse Event|5|||
164195217|NCT00126594|593083280|FG000|Overall Study|Non-compliance|0|||
164195218|NCT00126594|593083281|FG001|Overall Study|Non-compliance|1|||
164195219|NCT00126594|593083280|FG000|Overall Study|Disease Progression|29|||
164195220|NCT00126594|593083281|FG001|Overall Study|Disease Progression|24|||
164195221|NCT00243919|593083288|FG000|Overall Study|Death|3|||
164195222|NCT00243919|593083289|FG001|Overall Study|Death|4|||
164195223|NCT00243919|593083290|FG002|Overall Study|Death|6|||
164195224|NCT00243919|593083288|FG000|Overall Study|Withdrawal by Subject|6|||
164195225|NCT00243919|593083289|FG001|Overall Study|Withdrawal by Subject|6|||
164195226|NCT00243919|593083290|FG002|Overall Study|Withdrawal by Subject|2|||
164195227|NCT00243919|593083288|FG000|Overall Study|Lost to Follow-up|6|||
164195228|NCT00243919|593083289|FG001|Overall Study|Lost to Follow-up|7|||
164195229|NCT00243919|593083290|FG002|Overall Study|Lost to Follow-up|3|||
164195230|NCT00243919|593083288|FG000|Overall Study|Administrative Error|1|||
164195231|NCT00243919|593083289|FG001|Overall Study|Administrative Error|0|||
164195232|NCT00243919|593083290|FG002|Overall Study|Administrative Error|0|||
164195233|NCT00243919|593083288|FG000|Overall Study|Physician Decision|1|||
164195234|NCT00243919|593083289|FG001|Overall Study|Physician Decision|1|||
164195235|NCT00243919|593083290|FG002|Overall Study|Physician Decision|0|||
163965172|NCT01431534|592244861|FG002|Treatment Phase|Progressive Disease|10|||
163965173|NCT04252287|592244866|FG000|Overall Study|Death|5|||
164195236|NCT02157519|593083291|FG000|Overall Study|Death|3|||
164195237|NCT02157519|593083292|FG001|Overall Study|Death|1|||
164195238|NCT02157519|593083291|FG000|Overall Study|Withdrawal by Subject|7|||
164195239|NCT02157519|593083292|FG001|Overall Study|Withdrawal by Subject|0|||
164195240|NCT02157519|593083291|FG000|Overall Study|Lost to Follow-up|1|||
164195241|NCT02157519|593083292|FG001|Overall Study|Lost to Follow-up|0|||
164195242|NCT01656395|593083293|FG000|Overall Study|Adverse Event|1|||
164195243|NCT01656395|593083294|FG001|Overall Study|Adverse Event|14|||
164195244|NCT01656395|593083295|FG002|Overall Study|Adverse Event|5|||
164195245|NCT01656395|593083296|FG003|Overall Study|Adverse Event|4|||
164195246|NCT01656395|593083297|FG004|Overall Study|Adverse Event|5|||
163965174|NCT04252287|592244867|FG001|Overall Study|Death|3|||
164195247|NCT01656395|593083298|FG005|Overall Study|Adverse Event|7|||
164195248|NCT01656395|593083299|FG006|Overall Study|Adverse Event|0|||
164195249|NCT01656395|593083300|FG007|Overall Study|Adverse Event|0|||
164195250|NCT01656395|593083293|FG000|Overall Study|Lack of Efficacy|1|||
164195251|NCT01656395|593083294|FG001|Overall Study|Lack of Efficacy|8|||
164195252|NCT01656395|593083295|FG002|Overall Study|Lack of Efficacy|6|||
164195253|NCT01656395|593083296|FG003|Overall Study|Lack of Efficacy|1|||
164195254|NCT01656395|593083297|FG004|Overall Study|Lack of Efficacy|1|||
164195255|NCT01656395|593083298|FG005|Overall Study|Lack of Efficacy|6|||
164195256|NCT01656395|593083299|FG006|Overall Study|Lack of Efficacy|0|||
164195257|NCT01656395|593083300|FG007|Overall Study|Lack of Efficacy|0|||
164195258|NCT01656395|593083293|FG000|Overall Study|Lost to Follow-up|1|||
164195259|NCT01656395|593083294|FG001|Overall Study|Lost to Follow-up|0|||
164195260|NCT01656395|593083295|FG002|Overall Study|Lost to Follow-up|0|||
164195261|NCT01656395|593083296|FG003|Overall Study|Lost to Follow-up|0|||
164195262|NCT01656395|593083297|FG004|Overall Study|Lost to Follow-up|0|||
164195263|NCT01656395|593083298|FG005|Overall Study|Lost to Follow-up|0|||
164195264|NCT01656395|593083299|FG006|Overall Study|Lost to Follow-up|0|||
164195265|NCT01656395|593083300|FG007|Overall Study|Lost to Follow-up|0|||
164195266|NCT01656395|593083293|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164195267|NCT01656395|593083294|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164195268|NCT01656395|593083295|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164195269|NCT01656395|593083296|FG003|Overall Study|Non-Compliance with Study Drug|0|||
164195270|NCT01656395|593083297|FG004|Overall Study|Non-Compliance with Study Drug|1|||
164195271|NCT01656395|593083298|FG005|Overall Study|Non-Compliance with Study Drug|1|||
164195272|NCT01656395|593083299|FG006|Overall Study|Non-Compliance with Study Drug|0|||
164195273|NCT01656395|593083300|FG007|Overall Study|Non-Compliance with Study Drug|0|||
164195274|NCT01656395|593083293|FG000|Overall Study|Other|0|||
164195275|NCT01656395|593083294|FG001|Overall Study|Other|0|||
164195276|NCT01656395|593083295|FG002|Overall Study|Other|1|||
164195277|NCT01656395|593083296|FG003|Overall Study|Other|0|||
164195278|NCT01656395|593083297|FG004|Overall Study|Other|0|||
164195279|NCT01656395|593083298|FG005|Overall Study|Other|1|||
164195280|NCT01656395|593083299|FG006|Overall Study|Other|0|||
164195281|NCT01656395|593083300|FG007|Overall Study|Other|0|||
164195282|NCT01656395|593083293|FG000|Overall Study|Physician Decision|2|||
164195283|NCT01656395|593083294|FG001|Overall Study|Physician Decision|3|||
164195284|NCT01656395|593083295|FG002|Overall Study|Physician Decision|3|||
164195285|NCT01656395|593083296|FG003|Overall Study|Physician Decision|2|||
164195286|NCT01656395|593083297|FG004|Overall Study|Physician Decision|3|||
164195287|NCT01656395|593083298|FG005|Overall Study|Physician Decision|3|||
164195288|NCT01656395|593083299|FG006|Overall Study|Physician Decision|0|||
164195289|NCT01656395|593083300|FG007|Overall Study|Physician Decision|0|||
164195290|NCT01656395|593083293|FG000|Overall Study|Pregnancy|0|||
164195291|NCT01656395|593083294|FG001|Overall Study|Pregnancy|0|||
164195292|NCT01656395|593083295|FG002|Overall Study|Pregnancy|1|||
164195293|NCT01656395|593083296|FG003|Overall Study|Pregnancy|0|||
164195294|NCT01656395|593083297|FG004|Overall Study|Pregnancy|0|||
164195295|NCT01656395|593083298|FG005|Overall Study|Pregnancy|0|||
164195296|NCT01656395|593083299|FG006|Overall Study|Pregnancy|0|||
164195297|NCT01656395|593083300|FG007|Overall Study|Pregnancy|0|||
164195298|NCT01656395|593083293|FG000|Overall Study|Progressive Disease|0|||
164195299|NCT01656395|593083294|FG001|Overall Study|Progressive Disease|0|||
164195300|NCT01656395|593083295|FG002|Overall Study|Progressive Disease|0|||
164195301|NCT01656395|593083296|FG003|Overall Study|Progressive Disease|0|||
164195302|NCT01656395|593083297|FG004|Overall Study|Progressive Disease|0|||
164195303|NCT01656395|593083298|FG005|Overall Study|Progressive Disease|1|||
164195304|NCT01656395|593083299|FG006|Overall Study|Progressive Disease|0|||
164195305|NCT01656395|593083300|FG007|Overall Study|Progressive Disease|0|||
164195306|NCT01656395|593083293|FG000|Overall Study|Protocol Violation|6|||
164195307|NCT01656395|593083294|FG001|Overall Study|Protocol Violation|6|||
164195308|NCT01656395|593083295|FG002|Overall Study|Protocol Violation|9|||
164195309|NCT01656395|593083296|FG003|Overall Study|Protocol Violation|2|||
164195310|NCT01656395|593083297|FG004|Overall Study|Protocol Violation|4|||
164195311|NCT01656395|593083298|FG005|Overall Study|Protocol Violation|10|||
164195312|NCT01656395|593083299|FG006|Overall Study|Protocol Violation|0|||
164195313|NCT01656395|593083300|FG007|Overall Study|Protocol Violation|0|||
163859376|NCT01348087|591854471|FG000|Overall Study|Subject withdrew consent|7|||
163859377|NCT01348087|591854471|FG000|Overall Study|Adverse Event|25|||
163859378|NCT02081391|591854474|FG000|12-hour Treatment|Withdrawal by Subject|3|||
163859379|NCT02081391|591854475|FG001|12-hour Treatment|Withdrawal by Subject|2|||
163859380|NCT02081391|591854476|FG002|12-hour Treatment|Withdrawal by Subject|0|||
163859381|NCT02081391|591854477|FG003|12-hour Treatment|Withdrawal by Subject|0|||
163859382|NCT02081391|591854474|FG000|12-hour Treatment|Physician Decision|4|||
164195314|NCT01656395|593083293|FG000|Overall Study|Screen Failure|2|||
164195315|NCT01656395|593083294|FG001|Overall Study|Screen Failure|1|||
164195316|NCT01656395|593083295|FG002|Overall Study|Screen Failure|7|||
164195317|NCT01656395|593083296|FG003|Overall Study|Screen Failure|1|||
164195318|NCT01656395|593083297|FG004|Overall Study|Screen Failure|0|||
164195319|NCT01656395|593083298|FG005|Overall Study|Screen Failure|8|||
164195320|NCT01656395|593083299|FG006|Overall Study|Screen Failure|0|||
164195321|NCT01656395|593083300|FG007|Overall Study|Screen Failure|0|||
164195322|NCT01656395|593083293|FG000|Overall Study|Withdrawal by Subject|3|||
164195323|NCT01656395|593083294|FG001|Overall Study|Withdrawal by Subject|1|||
164302202|NCT01134055|593482559|FG003|Overall Study|Lost to Follow-up|1|||
164195324|NCT01656395|593083295|FG002|Overall Study|Withdrawal by Subject|4|||
164195325|NCT01656395|593083296|FG003|Overall Study|Withdrawal by Subject|2|||
164195326|NCT01656395|593083297|FG004|Overall Study|Withdrawal by Subject|0|||
164195327|NCT01656395|593083298|FG005|Overall Study|Withdrawal by Subject|3|||
164195328|NCT01656395|593083299|FG006|Overall Study|Withdrawal by Subject|0|||
164195329|NCT01656395|593083300|FG007|Overall Study|Withdrawal by Subject|0|||
164195330|NCT03225170|593083302|FG000|Overall Study|Lost to Follow-up|4|||
164195331|NCT03225170|593083303|FG001|Overall Study|Lost to Follow-up|4|||
164195332|NCT03225170|593083304|FG002|Overall Study|Lost to Follow-up|0|||
164195333|NCT03225170|593083302|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
164195334|NCT03225170|593083303|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
164195335|NCT03225170|593083304|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
164195336|NCT01272908|593083307|FG000|Initial Treatment Period|Adverse Event|1|||
164195337|NCT01272908|593083307|FG000|Initial Treatment Period|Lack of Efficacy|5|||
164195338|NCT01272908|593083307|FG000|Initial Treatment Period|Protocol Violation|1|||
164195339|NCT01272908|593083307|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
164195340|NCT01272908|593083307|FG000|Re-Treatment Period|Adverse Event|2|||
164195341|NCT01272908|593083307|FG000|Re-Treatment Period|Lack of Efficacy|3|||
164195342|NCT01272908|593083307|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
164195343|NCT02716779|593083313|FG000|Monotherapy|Adverse Event|0|||
164195344|NCT02716779|593083314|FG001|Monotherapy|Adverse Event|1|||
164195345|NCT02716779|593083315|FG002|Monotherapy|Adverse Event|1|||
164195346|NCT02716779|593083313|FG000|Combination Therapy|Adverse Event|0|||
164195347|NCT02716779|593083314|FG001|Combination Therapy|Adverse Event|2|||
164195348|NCT02716779|593083315|FG002|Combination Therapy|Adverse Event|1|||
164195349|NCT02600923|593083316|FG000|Overall Study|Death|10|||
164195350|NCT02600923|593083316|FG000|Overall Study|Adverse Event|3|||
164195351|NCT02600923|593083316|FG000|Overall Study|Global deterioration of health status|2|||
164195352|NCT02600923|593083316|FG000|Overall Study|Insufficient clinical response|6|||
164195353|NCT02600923|593083316|FG000|Overall Study|Lost to Follow-up|1|||
164195354|NCT02600923|593083316|FG000|Overall Study|Withdrawal by Subject|5|||
164195355|NCT02600923|593083316|FG000|Overall Study|Objective progression or relapse|50|||
164195356|NCT02600923|593083316|FG000|Overall Study|Study terminated by Sponsor|53|||
164195357|NCT02600923|593083316|FG000|Overall Study|Not treated|1|||
164195358|NCT01497067|593083322|FG000|Overall Study|Lost to Follow-up|56|||
164195359|NCT01497067|593083322|FG000|Overall Study|Adverse Event|3|||
164195360|NCT01497067|593083322|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
164195361|NCT01497067|593083322|FG000|Overall Study|Other|13|||
164195362|NCT04058028|593083323|FG000|Overall Study|Withdrawal of Consent from Study|12|||
164195363|NCT04058028|593083324|FG001|Overall Study|Withdrawal of Consent from Study|8|||
163859383|NCT02081391|591854475|FG001|12-hour Treatment|Physician Decision|1|||
163859384|NCT02081391|591854476|FG002|12-hour Treatment|Physician Decision|0|||
164195364|NCT04058028|593083325|FG002|Overall Study|Withdrawal of Consent from Study|6|||
164195365|NCT04058028|593083326|FG003|Overall Study|Withdrawal of Consent from Study|7|||
164195366|NCT04058028|593083323|FG000|Overall Study|Decision by Sponsor|13|||
164195367|NCT04058028|593083324|FG001|Overall Study|Decision by Sponsor|4|||
164195368|NCT04058028|593083325|FG002|Overall Study|Decision by Sponsor|1|||
164195369|NCT04058028|593083326|FG003|Overall Study|Decision by Sponsor|35|||
164195370|NCT04058028|593083323|FG000|Overall Study|Lost to Follow-up|1|||
164195371|NCT04058028|593083324|FG001|Overall Study|Lost to Follow-up|1|||
164195372|NCT04058028|593083325|FG002|Overall Study|Lost to Follow-up|1|||
164195373|NCT04058028|593083326|FG003|Overall Study|Lost to Follow-up|0|||
164195374|NCT04058028|593083323|FG000|Overall Study|Death|0|||
164195375|NCT04058028|593083324|FG001|Overall Study|Death|1|||
164195376|NCT04058028|593083325|FG002|Overall Study|Death|0|||
164195377|NCT04058028|593083326|FG003|Overall Study|Death|0|||
164195378|NCT02227784|593083327|FG000|Double-Blind Phase|Adverse Event|3|||
164195379|NCT02227784|593083328|FG001|Double-Blind Phase|Adverse Event|2|||
164195380|NCT02227784|593083329|FG002|Double-Blind Phase|Adverse Event|1|||
164195381|NCT02227784|593083330|FG003|Double-Blind Phase|Adverse Event|3|||
164195382|NCT02227784|593083331|FG004|Double-Blind Phase|Adverse Event|0|||
164195383|NCT02227784|593083327|FG000|Double-Blind Phase|Physician Decision|1|||
164195384|NCT02227784|593083328|FG001|Double-Blind Phase|Physician Decision|0|||
164195385|NCT02227784|593083329|FG002|Double-Blind Phase|Physician Decision|0|||
164195386|NCT02227784|593083330|FG003|Double-Blind Phase|Physician Decision|1|||
164195387|NCT02227784|593083331|FG004|Double-Blind Phase|Physician Decision|0|||
164195388|NCT02227784|593083327|FG000|Double-Blind Phase|Protocol Violation|0|||
164195389|NCT02227784|593083328|FG001|Double-Blind Phase|Protocol Violation|0|||
164195390|NCT02227784|593083329|FG002|Double-Blind Phase|Protocol Violation|1|||
164195391|NCT02227784|593083330|FG003|Double-Blind Phase|Protocol Violation|1|||
164195392|NCT02227784|593083331|FG004|Double-Blind Phase|Protocol Violation|0|||
164195393|NCT02227784|593083327|FG000|Double-Blind Phase|Sponsor Decision|34|||
164195394|NCT02227784|593083328|FG001|Double-Blind Phase|Sponsor Decision|15|||
164195395|NCT02227784|593083329|FG002|Double-Blind Phase|Sponsor Decision|14|||
164195396|NCT02227784|593083330|FG003|Double-Blind Phase|Sponsor Decision|32|||
164195397|NCT02227784|593083331|FG004|Double-Blind Phase|Sponsor Decision|0|||
163859385|NCT02081391|591854477|FG003|12-hour Treatment|Physician Decision|0|||
164195398|NCT02227784|593083327|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164195399|NCT02227784|593083328|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
164195400|NCT02227784|593083329|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
164195401|NCT02227784|593083330|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
164195402|NCT02227784|593083331|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164195403|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195404|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195405|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195406|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
164195407|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
164195408|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Death|0|||
164195409|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Death|0|||
164195410|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Death|0|||
164195411|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Death|0|||
164195412|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Death|1|||
163859386|NCT02081391|591854474|FG000|12-hour Treatment|Lack of Efficacy|3|||
163859387|NCT02081391|591854475|FG001|12-hour Treatment|Lack of Efficacy|0|||
163859388|NCT02081391|591854476|FG002|12-hour Treatment|Lack of Efficacy|0|||
164195413|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195414|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195415|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195416|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164195417|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
164195418|NCT02227784|593083327|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
163859389|NCT02081391|591854477|FG003|12-hour Treatment|Lack of Efficacy|0|||
163859390|NCT02081391|591854474|FG000|12-hour Treatment|Adverse Event|4|||
163859391|NCT02081391|591854475|FG001|12-hour Treatment|Adverse Event|2|||
163859392|NCT02081391|591854476|FG002|12-hour Treatment|Adverse Event|0|||
163859393|NCT02081391|591854477|FG003|12-hour Treatment|Adverse Event|0|||
164195419|NCT02227784|593083328|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164195420|NCT02227784|593083329|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164195421|NCT02227784|593083330|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
164195422|NCT02227784|593083331|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
164195423|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
164195424|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
164195425|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Adverse Event|57|||
164195426|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Adverse Event|49|||
164195427|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
164195428|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
164195429|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Site closure|3|||
164195430|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Site closure|2|||
164195431|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
164195432|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
164195433|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Physician Decision|48|||
164195434|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Physician Decision|38|||
164195435|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
164195436|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
164195437|NCT01705977|593083332|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
164195438|NCT01705977|593083333|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
164195439|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
164195440|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
164195441|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
164195442|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
164195443|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
164195444|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
164195445|NCT01705977|593083332|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
164195446|NCT01705977|593083333|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
164195447|NCT01275144|593083334|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
164195448|NCT01275144|593083335|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
164195449|NCT00828113|593083336|FG000|Overall Study|Withdrawal by Subject|27|||
164195450|NCT00828113|593083337|FG001|Overall Study|Withdrawal by Subject|26|||
164195451|NCT00828113|593083336|FG000|Overall Study|Lost to Follow-up|3|||
164195452|NCT00828113|593083337|FG001|Overall Study|Lost to Follow-up|5|||
164195453|NCT02864407|593083348|FG000|Overall Study|Protocol Violation|3|||
164195454|NCT02864407|593083348|FG000|Overall Study|Lost to Follow-up|115|||
164195455|NCT02864407|593083348|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
164195456|NCT02864407|593083348|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
164195457|NCT02864407|593083348|FG000|Overall Study|Consent prior to the contract date|1|||
164195458|NCT00096538|593083349|FG000|Overall Study|Withdrawal by Subject|1|||
164195459|NCT00003471|593083369|FG000|Overall Study|Not evaluable|4|||
164195460|NCT00715403|593083374|FG000|Overall Study|Progressive disease|0|||
164195461|NCT00715403|593083375|FG001|Overall Study|Progressive disease|1|||
164195462|NCT00715403|593083376|FG002|Overall Study|Progressive disease|3|||
164195463|NCT00715403|593083377|FG003|Overall Study|Progressive disease|9|||
164195464|NCT00715403|593083378|FG004|Overall Study|Progressive disease|5|||
164195465|NCT00715403|593083379|FG005|Overall Study|Progressive disease|14|||
164195466|NCT00715403|593083380|FG006|Overall Study|Progressive disease|1|||
164195467|NCT00715403|593083374|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195468|NCT00715403|593083375|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195469|NCT00715403|593083376|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195470|NCT00715403|593083377|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195471|NCT00715403|593083378|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195472|NCT00715403|593083379|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
164195473|NCT00715403|593083380|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
164195474|NCT00715403|593083374|FG000|Overall Study|Other Adverse Event than DLT|1|||
164195475|NCT00715403|593083375|FG001|Overall Study|Other Adverse Event than DLT|0|||
164195476|NCT00715403|593083376|FG002|Overall Study|Other Adverse Event than DLT|0|||
164195477|NCT00715403|593083377|FG003|Overall Study|Other Adverse Event than DLT|0|||
164195478|NCT00715403|593083378|FG004|Overall Study|Other Adverse Event than DLT|0|||
164195479|NCT00715403|593083379|FG005|Overall Study|Other Adverse Event than DLT|2|||
164195480|NCT00715403|593083380|FG006|Overall Study|Other Adverse Event than DLT|0|||
164195481|NCT00715403|593083374|FG000|Overall Study|Protocol Violation|0|||
164195482|NCT00715403|593083375|FG001|Overall Study|Protocol Violation|0|||
164195483|NCT00715403|593083376|FG002|Overall Study|Protocol Violation|0|||
164195484|NCT00715403|593083377|FG003|Overall Study|Protocol Violation|0|||
164195485|NCT00715403|593083378|FG004|Overall Study|Protocol Violation|0|||
164195486|NCT00715403|593083379|FG005|Overall Study|Protocol Violation|1|||
164195487|NCT00715403|593083380|FG006|Overall Study|Protocol Violation|0|||
164195488|NCT00715403|593083374|FG000|Overall Study|Other reason not defined above|0|||
164195489|NCT00715403|593083375|FG001|Overall Study|Other reason not defined above|0|||
164195490|NCT00715403|593083376|FG002|Overall Study|Other reason not defined above|1|||
164195491|NCT00715403|593083377|FG003|Overall Study|Other reason not defined above|0|||
164195492|NCT00715403|593083378|FG004|Overall Study|Other reason not defined above|1|||
164195493|NCT00715403|593083379|FG005|Overall Study|Other reason not defined above|1|||
164195494|NCT00715403|593083380|FG006|Overall Study|Other reason not defined above|0|||
164195495|NCT00101868|593083381|FG000|Overall Study|Death|10|||
164195496|NCT00101868|593083382|FG001|Overall Study|Death|10|||
164195497|NCT00101868|593083381|FG000|Overall Study|Withdrawal by Subject|8|||
164195498|NCT00101868|593083382|FG001|Overall Study|Withdrawal by Subject|9|||
164195499|NCT00101868|593083381|FG000|Overall Study|Protocol Violation|3|||
164195500|NCT00101868|593083382|FG001|Overall Study|Protocol Violation|0|||
164195501|NCT00101868|593083381|FG000|Overall Study|Lost to Follow-up|8|||
164195502|NCT00101868|593083382|FG001|Overall Study|Lost to Follow-up|13|||
164195503|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
164195504|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
164195505|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
164195506|NCT04001803|593083383|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
164195507|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
164195508|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
164195509|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
164195510|NCT04001803|593083383|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
164195511|NCT04001803|593083383|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
164195512|NCT04001803|593083383|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
164195513|NCT01931397|593083386|FG000|Overall Study|Physician Decision|2|||
164195514|NCT01931397|593083386|FG000|Overall Study|Withdrawal by Subject|8|||
164195515|NCT01931397|593083386|FG000|Overall Study|moved out of state|1|||
164195516|NCT00520039|593083387|FG000|Overall Study|Exclusion criteria met at first visit|7|||
164195517|NCT00520039|593083388|FG001|Overall Study|Exclusion criteria met at first visit|5|||
164195518|NCT02493517|593083392|FG000|Overall Study|Protocol Violation|1|||
164195519|NCT02493517|593083393|FG001|Overall Study|Protocol Violation|2|||
164195520|NCT02493517|593083392|FG000|Overall Study|Withdrawal by Subject|1|||
164195521|NCT02493517|593083393|FG001|Overall Study|Withdrawal by Subject|2|||
164195522|NCT02493517|593083392|FG000|Overall Study|Adverse Event|0|||
164195523|NCT02493517|593083393|FG001|Overall Study|Adverse Event|2|||
164195524|NCT02493517|593083392|FG000|Overall Study|Missed study visit|0|||
164195525|NCT02493517|593083393|FG001|Overall Study|Missed study visit|1|||
164195526|NCT01367249|593083394|FG000|Overall Study|Withdrawal by Subject|6|||
164195527|NCT01367249|593083395|FG001|Overall Study|Withdrawal by Subject|6|||
164195528|NCT01367249|593083394|FG000|Overall Study|Other|3|||
164195529|NCT01367249|593083395|FG001|Overall Study|Other|10|||
164195530|NCT05404711|593083396|FG000|Completed Study Visit|Withdrawal by Subject|1|||
164195531|NCT05404711|593083396|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
164195532|NCT05404711|593083396|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
164195533|NCT05404711|593083396|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
164195534|NCT05404711|593083396|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
164195535|NCT05404711|593083396|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
164195536|NCT00325819|593083397|FG000|Overall Study|Study product lost in mail|2|||
164195537|NCT00325819|593083398|FG001|Overall Study|Study product lost in mail|1|||
163859394|NCT02081391|591854474|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
163859395|NCT02081391|591854475|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
163859396|NCT02081391|591854476|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
163859397|NCT02081391|591854477|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
163859398|NCT02081391|591854474|FG000|12-hour Treatment|Further reasons|2|||
163859399|NCT02081391|591854475|FG001|12-hour Treatment|Further reasons|1|||
163859400|NCT02081391|591854476|FG002|12-hour Treatment|Further reasons|0|||
164195538|NCT00325819|593083397|FG000|Overall Study|Did not take a dose of study product|4|||
164195539|NCT00325819|593083398|FG001|Overall Study|Did not take a dose of study product|9|||
164195540|NCT00325819|593083397|FG000|Overall Study|Lost to Follow-up|3|||
164195541|NCT00325819|593083398|FG001|Overall Study|Lost to Follow-up|3|||
164195542|NCT01683604|593083399|FG000|Overall Study|Adverse Event|2|||
164195543|NCT01683604|593083399|FG000|Overall Study|Lack of Efficacy|1|||
164195544|NCT01683604|593083399|FG000|Overall Study|Other|2|||
164195545|NCT01548599|593085425|FG000|Overall Study|Lost to Follow-up|0|||
164195546|NCT01548599|593085426|FG001|Overall Study|Lost to Follow-up|1|||
164195547|NCT01548599|593085425|FG000|Overall Study|Withdrawal by Subject|4|||
164195548|NCT01548599|593085426|FG001|Overall Study|Withdrawal by Subject|0|||
164195549|NCT01548599|593085425|FG000|Overall Study|Death|2|||
164195550|NCT01548599|593085426|FG001|Overall Study|Death|1|||
164195551|NCT02188160|593085427|FG000|Overall Study|Adverse Event|1|||
164195552|NCT02188160|593085428|FG001|Overall Study|Adverse Event|0|||
164195553|NCT02188160|593085427|FG000|Overall Study|Use of an excluded medication|0|||
164195554|NCT02188160|593085428|FG001|Overall Study|Use of an excluded medication|1|||
164195555|NCT00916578|593085429|FG000|Overall Study|Physician Decision|2|||
164195556|NCT00916578|593085429|FG000|Overall Study|Withdrawal by Subject|3|||
164195557|NCT00916578|593085429|FG000|Overall Study|Insurance Denial|2|||
164195558|NCT00945243|593085434|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
164195559|NCT02371616|593085435|FG000|Overall Study|Protocol Violation|2|||
164195560|NCT02371616|593085436|FG001|Overall Study|Protocol Violation|1|||
164195561|NCT02371616|593085435|FG000|Overall Study|Adverse Event|0|||
164195562|NCT02371616|593085436|FG001|Overall Study|Adverse Event|1|||
164195563|NCT02371616|593085435|FG000|Overall Study|Withdrawal of Consent|1|||
164195564|NCT02371616|593085436|FG001|Overall Study|Withdrawal of Consent|0|||
164195565|NCT02371616|593085435|FG000|Overall Study|Other (Not specified)|1|||
164195566|NCT02371616|593085436|FG001|Overall Study|Other (Not specified)|5|||
164195567|NCT00754741|593085439|FG000|Overall Study|Died or disenrolled|57|||
164195568|NCT00754741|593085440|FG001|Overall Study|Died or disenrolled|69|||
164195569|NCT00754741|593085441|FG002|Overall Study|Died or disenrolled|54|||
164195570|NCT04152200|593085442|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
164195571|NCT04152200|593085443|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
164195572|NCT04969289|593085444|FG000|Overall Study|Lost to Follow-up|13|||
164195573|NCT04969289|593085445|FG001|Overall Study|Lost to Follow-up|9|||
164195574|NCT02699996|593085446|FG000|Overall Study|Withdrawal by Subject|5|||
164195575|NCT02699996|593085447|FG001|Overall Study|Withdrawal by Subject|2|||
164195576|NCT04069715|593085448|FG000|Overall Study|Lost to Follow-up|1|||
164195577|NCT04069715|593085449|FG001|Overall Study|Lost to Follow-up|1|||
164195578|NCT04069715|593085448|FG000|Overall Study|Physician Decision|1|||
164195579|NCT04069715|593085449|FG001|Overall Study|Physician Decision|1|||
164195580|NCT04069715|593085448|FG000|Overall Study|Withdrawal by Subject|3|||
164195581|NCT04069715|593085449|FG001|Overall Study|Withdrawal by Subject|3|||
164195582|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
164195583|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
164195584|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
164195585|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
164195586|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
164195587|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
164195588|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
164195589|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
164195590|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
164195591|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
164195592|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
164195593|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
164195594|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
164195595|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
164195596|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
164195597|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
164195598|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
164195599|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
164195600|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
164195601|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
164195602|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
164195603|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
164195604|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
164195605|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
164195606|NCT01198002|593085450|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
164195607|NCT01198002|593085451|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
164195608|NCT01198002|593085452|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
164195609|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
164195610|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
164195611|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
164195612|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
164195613|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
164195614|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
164195615|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
164195616|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
164195617|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
164195618|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
164195619|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
164195620|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
164195621|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
164195622|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
164195623|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
164195624|NCT01198002|593085450|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
164195625|NCT01198002|593085451|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
164195626|NCT01198002|593085452|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
164195627|NCT02063672|593085453|FG000|Overall Study|Ongoing Follow-up|27|||
164195628|NCT02063672|593085454|FG001|Overall Study|Ongoing Follow-up|14|||
164195629|NCT02063672|593085453|FG000|Overall Study|Death|5|||
164195630|NCT02063672|593085454|FG001|Overall Study|Death|3|||
164195631|NCT02063672|593085453|FG000|Overall Study|Lost to Follow-up|1|||
164195632|NCT02063672|593085454|FG001|Overall Study|Lost to Follow-up|3|||
164195633|NCT02063672|593085453|FG000|Overall Study|Withdrawal by Subject|2|||
164195634|NCT02063672|593085454|FG001|Overall Study|Withdrawal by Subject|2|||
164195635|NCT01307787|593085456|FG000|Overall Study|Withdrawal by Subject|2|||
164195636|NCT01307787|593085457|FG001|Overall Study|Withdrawal by Subject|0|||
164195637|NCT03353792|593085461|FG000|Overall Study|Lost to Follow-up|1|||
164195638|NCT03353792|593085462|FG001|Overall Study|Lost to Follow-up|0|||
164195639|NCT03353792|593085461|FG000|Overall Study|Participant Unable to Manage Device|1|||
164195640|NCT03353792|593085462|FG001|Overall Study|Participant Unable to Manage Device|0|||
164195641|NCT01965327|593085463|FG000|Overall Study|Physician Decision|2|||
163965175|NCT04252287|592244866|FG000|Overall Study|Lost to Follow-up|4|||
163965176|NCT04252287|592244867|FG001|Overall Study|Lost to Follow-up|6|||
163965177|NCT04252287|592244866|FG000|Overall Study|Withdrawal by Subject|19|||
163965178|NCT04252287|592244867|FG001|Overall Study|Withdrawal by Subject|16|||
163965179|NCT04252287|592244866|FG000|Overall Study|Protocol Violation|3|||
163965180|NCT04252287|592244867|FG001|Overall Study|Protocol Violation|4|||
163965181|NCT00671554|592244875|FG000|Overall Study|Disease progression|3|||
163965182|NCT00447382|592244885|FG000|Overall Study|Adverse Event|1|||
164195642|NCT01294423|593085464|FG000|Overall Study|Adverse Event|1|||
164195643|NCT01294423|593085465|FG001|Overall Study|Adverse Event|2|||
164195644|NCT01294423|593085466|FG002|Overall Study|Adverse Event|3|||
164195645|NCT01294423|593085464|FG000|Overall Study|Withdrawal by Subject|1|||
164195646|NCT01294423|593085465|FG001|Overall Study|Withdrawal by Subject|2|||
164195647|NCT01294423|593085466|FG002|Overall Study|Withdrawal by Subject|2|||
164195648|NCT01294423|593085464|FG000|Overall Study|subject no longer meets study criteria|2|||
164195649|NCT01294423|593085465|FG001|Overall Study|subject no longer meets study criteria|5|||
164195650|NCT01294423|593085466|FG002|Overall Study|subject no longer meets study criteria|2|||
164195651|NCT01294423|593085464|FG000|Overall Study|poor/non-compliance|1|||
164195652|NCT01294423|593085465|FG001|Overall Study|poor/non-compliance|0|||
164195653|NCT01294423|593085466|FG002|Overall Study|poor/non-compliance|1|||
164195654|NCT01241279|593085467|FG000|Overall Study|Lost to Follow-up|0|||
164195655|NCT01241279|593085468|FG001|Overall Study|Lost to Follow-up|1|||
164195656|NCT01484951|593085470|FG000|Overall Study|Adverse Event|3|||
164195657|NCT01484951|593085470|FG000|Overall Study|Personal Reasons|1|||
164195658|NCT01484951|593085470|FG000|Overall Study|Non-Compliance|1|||
164195659|NCT02452047|593085471|FG000|Overall Study|Adverse Event|0|||
164195660|NCT02452047|593085472|FG001|Overall Study|Adverse Event|1|||
164195661|NCT02452047|593085473|FG002|Overall Study|Adverse Event|1|||
164195662|NCT02452047|593085471|FG000|Overall Study|Death|1|||
164195663|NCT02452047|593085472|FG001|Overall Study|Death|3|||
164195664|NCT02452047|593085473|FG002|Overall Study|Death|1|||
163965183|NCT00447382|592244886|FG001|Overall Study|Adverse Event|1|||
163965184|NCT00447382|592244885|FG000|Overall Study|Lack of Efficacy|1|||
164195665|NCT02452047|593085471|FG000|Overall Study|Physician Decision|1|||
164195666|NCT02452047|593085472|FG001|Overall Study|Physician Decision|0|||
164195667|NCT02452047|593085473|FG002|Overall Study|Physician Decision|0|||
164195668|NCT02452047|593085471|FG000|Overall Study|Lost to Follow-up|1|||
164195669|NCT02452047|593085472|FG001|Overall Study|Lost to Follow-up|1|||
164195670|NCT02452047|593085473|FG002|Overall Study|Lost to Follow-up|0|||
164195671|NCT02452047|593085471|FG000|Overall Study|Withdrawal by Subject|1|||
164195672|NCT02452047|593085472|FG001|Overall Study|Withdrawal by Subject|0|||
164195673|NCT02452047|593085473|FG002|Overall Study|Withdrawal by Subject|0|||
164195674|NCT01248455|593085475|FG000|Overall Study|switched to alternate treatment|1|||
164195675|NCT02631941|593085491|FG000|Overall Study|Physician Decision|0|||
164195676|NCT02631941|593085492|FG001|Overall Study|Physician Decision|1|||
164195677|NCT02631941|593085493|FG002|Overall Study|Physician Decision|0|||
164195678|NCT02631941|593085494|FG003|Overall Study|Physician Decision|0|||
164195679|NCT02631941|593085495|FG004|Overall Study|Physician Decision|0|||
164195680|NCT02631941|593085496|FG005|Overall Study|Physician Decision|0|||
164195681|NCT02631941|593085497|FG006|Overall Study|Physician Decision|0|||
164195682|NCT02631941|593085498|FG007|Overall Study|Physician Decision|0|||
164195683|NCT02631941|593085499|FG008|Overall Study|Physician Decision|0|||
164195684|NCT02631941|593085500|FG009|Overall Study|Physician Decision|0|||
164195685|NCT02631941|593085491|FG000|Overall Study|Adverse Event|0|||
164195686|NCT02631941|593085492|FG001|Overall Study|Adverse Event|1|||
164195687|NCT02631941|593085493|FG002|Overall Study|Adverse Event|0|||
164195688|NCT02631941|593085494|FG003|Overall Study|Adverse Event|0|||
164195689|NCT02631941|593085495|FG004|Overall Study|Adverse Event|0|||
164195690|NCT02631941|593085496|FG005|Overall Study|Adverse Event|0|||
164195691|NCT02631941|593085497|FG006|Overall Study|Adverse Event|0|||
164195692|NCT02631941|593085498|FG007|Overall Study|Adverse Event|0|||
164195693|NCT02631941|593085499|FG008|Overall Study|Adverse Event|0|||
164195694|NCT02631941|593085500|FG009|Overall Study|Adverse Event|0|||
164195695|NCT02631941|593085491|FG000|Overall Study|Withdrawal by Subject|0|||
164195696|NCT02631941|593085492|FG001|Overall Study|Withdrawal by Subject|0|||
164195697|NCT02631941|593085493|FG002|Overall Study|Withdrawal by Subject|0|||
164195698|NCT02631941|593085494|FG003|Overall Study|Withdrawal by Subject|0|||
164195699|NCT02631941|593085495|FG004|Overall Study|Withdrawal by Subject|1|||
164195700|NCT02631941|593085496|FG005|Overall Study|Withdrawal by Subject|0|||
164195701|NCT02631941|593085497|FG006|Overall Study|Withdrawal by Subject|0|||
164195702|NCT02631941|593085498|FG007|Overall Study|Withdrawal by Subject|1|||
164195703|NCT02631941|593085499|FG008|Overall Study|Withdrawal by Subject|0|||
164195704|NCT02631941|593085500|FG009|Overall Study|Withdrawal by Subject|0|||
164195705|NCT02631941|593085491|FG000|Overall Study|Lost to Follow-up|0|||
164195706|NCT02631941|593085492|FG001|Overall Study|Lost to Follow-up|0|||
164195707|NCT02631941|593085493|FG002|Overall Study|Lost to Follow-up|0|||
164195708|NCT02631941|593085494|FG003|Overall Study|Lost to Follow-up|0|||
164195709|NCT02631941|593085495|FG004|Overall Study|Lost to Follow-up|0|||
164195710|NCT02631941|593085496|FG005|Overall Study|Lost to Follow-up|0|||
164195711|NCT02631941|593085497|FG006|Overall Study|Lost to Follow-up|0|||
164195712|NCT02631941|593085498|FG007|Overall Study|Lost to Follow-up|0|||
164195713|NCT02631941|593085499|FG008|Overall Study|Lost to Follow-up|1|||
164195714|NCT02631941|593085500|FG009|Overall Study|Lost to Follow-up|0|||
164195715|NCT04176939|593085505|FG000|Overall Study|Withdrawal by Subject|5|||
164195716|NCT04176939|593085505|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
164195717|NCT04176939|593085505|FG000|Overall Study|Lost to Follow-up|2|||
164195718|NCT04176939|593085505|FG000|Overall Study|Unspecified reason|4|||
164195719|NCT04176939|593085505|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
164195720|NCT00230048|593085509|FG000|Overall Study|Lost to Follow-up|13|||
164195721|NCT00230048|593085510|FG001|Overall Study|Lost to Follow-up|18|||
164195722|NCT00676403|593085511|FG000|Overall Study|Adverse Event|1|||
164195723|NCT00676403|593085512|FG001|Overall Study|Adverse Event|2|||
164195724|NCT00676403|593085513|FG002|Overall Study|Adverse Event|0|||
164195725|NCT00676403|593085514|FG003|Overall Study|Adverse Event|5|||
164195726|NCT00676403|593085515|FG004|Overall Study|Adverse Event|1|||
164195727|NCT00676403|593085516|FG005|Overall Study|Adverse Event|2|||
164195728|NCT00676403|593085511|FG000|Overall Study|Lost to Follow-up|0|||
164195729|NCT00676403|593085512|FG001|Overall Study|Lost to Follow-up|0|||
164195730|NCT00676403|593085513|FG002|Overall Study|Lost to Follow-up|0|||
164195731|NCT00676403|593085514|FG003|Overall Study|Lost to Follow-up|0|||
164195732|NCT00676403|593085515|FG004|Overall Study|Lost to Follow-up|0|||
164195733|NCT00676403|593085516|FG005|Overall Study|Lost to Follow-up|1|||
164195734|NCT00676403|593085511|FG000|Overall Study|Reason Unspecified|1|||
164195735|NCT00676403|593085512|FG001|Overall Study|Reason Unspecified|0|||
164195736|NCT00676403|593085513|FG002|Overall Study|Reason Unspecified|1|||
164195737|NCT00676403|593085514|FG003|Overall Study|Reason Unspecified|0|||
164195738|NCT00676403|593085515|FG004|Overall Study|Reason Unspecified|0|||
164195739|NCT00676403|593085516|FG005|Overall Study|Reason Unspecified|1|||
164195740|NCT00676403|593085511|FG000|Overall Study|Withdrawal by Subject|0|||
164195741|NCT00676403|593085512|FG001|Overall Study|Withdrawal by Subject|0|||
164195742|NCT00676403|593085513|FG002|Overall Study|Withdrawal by Subject|0|||
164195743|NCT00676403|593085514|FG003|Overall Study|Withdrawal by Subject|0|||
164195744|NCT00676403|593085515|FG004|Overall Study|Withdrawal by Subject|0|||
164195745|NCT00676403|593085516|FG005|Overall Study|Withdrawal by Subject|1|||
164195746|NCT00661089|593085518|FG000|Overall Study|1 subject withdrawal|0|||
164195747|NCT00661089|593085519|FG001|Overall Study|1 subject withdrawal|1|||
164195748|NCT00661089|593085518|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
164195749|NCT00661089|593085519|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
164195750|NCT00983372|593085520|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
164195751|NCT00983372|593085520|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
164195752|NCT00983372|593085520|FG000|Diltiazem ER Alone|Adverse Event|1|||
164195753|NCT05635045|593085521|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
164195754|NCT05635045|593085522|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
164195755|NCT05635045|593085523|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
164195756|NCT05635045|593085524|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
164195757|NCT00971867|593085530|FG000|Overall Study|Adverse Event|4|||
164195758|NCT00971867|593085530|FG000|Overall Study|Participant Withdrew Consent|1|||
164195759|NCT00971867|593085530|FG000|Overall Study|Disease Progression|6|||
164195760|NCT03727841|593085533|FG000|Overall Study|Physician Decision|3|||
164195761|NCT03727841|593085534|FG001|Overall Study|Physician Decision|1|||
164195762|NCT00905424|593085543|FG000|Overall Study|Lost to Follow-up|3|||
164195763|NCT00905424|593085544|FG001|Overall Study|Lost to Follow-up|3|||
164195764|NCT00905424|593085543|FG000|Overall Study|Withdrawal by Subject|1|||
164195765|NCT00905424|593085544|FG001|Overall Study|Withdrawal by Subject|2|||
164195766|NCT00905424|593085543|FG000|Overall Study|Adverse Event|4|||
164195767|NCT00905424|593085544|FG001|Overall Study|Adverse Event|2|||
164195768|NCT00905424|593085543|FG000|Overall Study|Non-compliance with study medication|2|||
164195769|NCT00905424|593085544|FG001|Overall Study|Non-compliance with study medication|0|||
164195770|NCT00905424|593085543|FG000|Overall Study|Sponsor decision|1|||
164195771|NCT00905424|593085544|FG001|Overall Study|Sponsor decision|0|||
164195772|NCT00905424|593085543|FG000|Overall Study|Positive urine drug screen|0|||
164195773|NCT00905424|593085544|FG001|Overall Study|Positive urine drug screen|1|||
164195774|NCT00905424|593085543|FG000|Overall Study|Non-adherence to visit schedule|0|||
164195775|NCT00905424|593085544|FG001|Overall Study|Non-adherence to visit schedule|1|||
164195776|NCT00379899|593085546|FG000|Overall Study|Adverse Event|7|||
164195777|NCT00379899|593085547|FG001|Overall Study|Adverse Event|3|||
164195778|NCT00379899|593085546|FG000|Overall Study|Death|10|||
164195779|NCT00379899|593085547|FG001|Overall Study|Death|10|||
164195780|NCT00379899|593085546|FG000|Overall Study|Lost to Follow-up|2|||
164195781|NCT00379899|593085547|FG001|Overall Study|Lost to Follow-up|4|||
164195782|NCT00379899|593085546|FG000|Overall Study|Physician Decision|3|||
164195783|NCT00379899|593085547|FG001|Overall Study|Physician Decision|4|||
164195784|NCT00379899|593085546|FG000|Overall Study|Withdrawal by Subject|5|||
164195785|NCT00379899|593085547|FG001|Overall Study|Withdrawal by Subject|5|||
164195786|NCT00379899|593085546|FG000|Overall Study|Ineligibility determined|0|||
164195787|NCT00379899|593085547|FG001|Overall Study|Ineligibility determined|1|||
164195788|NCT00379899|593085546|FG000|Overall Study|Noncompliance|1|||
164195789|NCT00379899|593085547|FG001|Overall Study|Noncompliance|1|||
164195790|NCT00379899|593085546|FG000|Overall Study|Parathyroidectomy|0|||
164195791|NCT00379899|593085547|FG001|Overall Study|Parathyroidectomy|2|||
164195792|NCT00379899|593085546|FG000|Overall Study|Renal transplantation|5|||
164195793|NCT00379899|593085547|FG001|Overall Study|Renal transplantation|4|||
163859401|NCT02081391|591854477|FG003|12-hour Treatment|Further reasons|0|||
163859402|NCT02081391|591854474|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
163859403|NCT02081391|591854475|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
163859404|NCT02081391|591854476|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
163859405|NCT02081391|591854477|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
163859406|NCT02081391|591854474|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
163859407|NCT02081391|591854475|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
163859408|NCT02081391|591854476|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
163859409|NCT02081391|591854477|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
163859410|NCT02081391|591854474|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
163859411|NCT02081391|591854475|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
163859412|NCT02081391|591854476|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
163859413|NCT02081391|591854477|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
163859414|NCT02081391|591854474|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
163859415|NCT02081391|591854475|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
163859416|NCT02081391|591854476|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
163859417|NCT02081391|591854477|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
163859418|NCT02081391|591854474|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
163859419|NCT02081391|591854475|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
163859420|NCT02081391|591854476|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
163965185|NCT00447382|592244886|FG001|Overall Study|Lack of Efficacy|0|||
164195794|NCT00379899|593085546|FG000|Overall Study|Coronary artery bypass graft|1|||
164195795|NCT00379899|593085547|FG001|Overall Study|Coronary artery bypass graft|1|||
164195796|NCT00379899|593085546|FG000|Overall Study|Other protocol-specified criteria|3|||
163859421|NCT02081391|591854477|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
164195797|NCT00379899|593085547|FG001|Overall Study|Other protocol-specified criteria|4|||
164195798|NCT00379899|593085546|FG000|Overall Study|Other|3|||
164195799|NCT00379899|593085547|FG001|Overall Study|Other|1|||
164195800|NCT01585246|593085554|FG000|Overall Study|Lost to Follow-up|0|||
164195801|NCT01585246|593085555|FG001|Overall Study|Lost to Follow-up|0|||
164195802|NCT01585246|593085556|FG002|Overall Study|Lost to Follow-up|2|||
164195803|NCT01585246|593085557|FG003|Overall Study|Lost to Follow-up|1|||
164195804|NCT01585246|593085558|FG004|Overall Study|Lost to Follow-up|0|||
164195805|NCT01585246|593085554|FG000|Overall Study|Protocol Violation|0|||
164195806|NCT01585246|593085555|FG001|Overall Study|Protocol Violation|0|||
164195807|NCT01585246|593085556|FG002|Overall Study|Protocol Violation|0|||
164195808|NCT01585246|593085557|FG003|Overall Study|Protocol Violation|0|||
164195809|NCT01585246|593085558|FG004|Overall Study|Protocol Violation|1|||
164195810|NCT01585246|593085554|FG000|Overall Study|Withdrawal by Subject|0|||
164195811|NCT01585246|593085555|FG001|Overall Study|Withdrawal by Subject|0|||
164195812|NCT01585246|593085556|FG002|Overall Study|Withdrawal by Subject|1|||
164195813|NCT01585246|593085557|FG003|Overall Study|Withdrawal by Subject|2|||
164195814|NCT01585246|593085558|FG004|Overall Study|Withdrawal by Subject|1|||
164195815|NCT01585246|593085554|FG000|Overall Study|Other|0|||
164195816|NCT01585246|593085555|FG001|Overall Study|Other|1|||
164195817|NCT01585246|593085556|FG002|Overall Study|Other|1|||
164195818|NCT01585246|593085557|FG003|Overall Study|Other|1|||
164195819|NCT01585246|593085558|FG004|Overall Study|Other|0|||
164195820|NCT04396626|593085559|FG000|Overall Study|Premature termination of study|975|||
164195821|NCT02111174|593085560|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
164195822|NCT02111174|593085561|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
164195823|NCT02111174|593085560|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
164195824|NCT02111174|593085561|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
164195825|NCT02111174|593085560|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
164195826|NCT02111174|593085561|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
164195827|NCT02111174|593085560|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
164195828|NCT02111174|593085561|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
164195829|NCT04552132|593085562|FG000|Overall Study|Lost to Follow-up|4|||
164195830|NCT04552132|593085563|FG001|Overall Study|Lost to Follow-up|3|||
164195831|NCT04552132|593085562|FG000|Overall Study|Protocol Violation|1|||
164195832|NCT04552132|593085563|FG001|Overall Study|Protocol Violation|0|||
164195833|NCT01657162|593085564|FG000|Overall Study|Adverse Event|26|||
164195834|NCT01657162|593085565|FG001|Overall Study|Adverse Event|36|||
164195835|NCT01657162|593085564|FG000|Overall Study|Withdrawal by Subject|13|||
164195836|NCT01657162|593085565|FG001|Overall Study|Withdrawal by Subject|13|||
164195837|NCT01657162|593085564|FG000|Overall Study|Continuing Significant Deterioration|9|||
164195838|NCT01657162|593085565|FG001|Overall Study|Continuing Significant Deterioration|3|||
164195839|NCT01657162|593085564|FG000|Overall Study|Refusal of Treatment|4|||
164195840|NCT01657162|593085565|FG001|Overall Study|Refusal of Treatment|6|||
164195841|NCT01657162|593085564|FG000|Overall Study|Lost to Follow-up|3|||
164195842|NCT01657162|593085565|FG001|Overall Study|Lost to Follow-up|4|||
164195843|NCT01657162|593085564|FG000|Overall Study|Death|2|||
164195844|NCT01657162|593085565|FG001|Overall Study|Death|3|||
164195845|NCT01657162|593085564|FG000|Overall Study|Inability to Complete Study Procedures|1|||
164195846|NCT01657162|593085565|FG001|Overall Study|Inability to Complete Study Procedures|7|||
164195847|NCT01657162|593085564|FG000|Overall Study|Protocol Violation|1|||
164195848|NCT01657162|593085565|FG001|Overall Study|Protocol Violation|0|||
164195849|NCT01657162|593085564|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
164195850|NCT01657162|593085565|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
163859422|NCT02081391|591854474|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
163859423|NCT02081391|591854475|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
164195851|NCT01657162|593085564|FG000|Overall Study|Other than Specified|0|||
164195852|NCT01657162|593085565|FG001|Overall Study|Other than Specified|2|||
164195853|NCT02421419|593085569|FG000|Overall Study|Physician Decision|0|||
164195854|NCT02421419|593085570|FG001|Overall Study|Physician Decision|0|||
164195855|NCT02421419|593085571|FG002|Overall Study|Physician Decision|1|||
164195856|NCT01747499|593085573|FG000|Overall Study|Steroid refractory aGvHD|1|||
164195857|NCT01747499|593085574|FG001|Overall Study|Steroid refractory aGvHD|0|||
164195858|NCT01747499|593085575|FG002|Overall Study|Steroid refractory aGvHD|0|||
164195859|NCT01747499|593085576|FG003|Overall Study|Steroid refractory aGvHD|1|||
164195860|NCT01747499|593085577|FG004|Overall Study|Steroid refractory aGvHD|4|||
164195861|NCT01747499|593085573|FG000|Overall Study|Physician Decision|0|||
164195862|NCT01747499|593085574|FG001|Overall Study|Physician Decision|1|||
164195863|NCT01747499|593085575|FG002|Overall Study|Physician Decision|0|||
164195864|NCT01747499|593085576|FG003|Overall Study|Physician Decision|0|||
164195865|NCT01747499|593085577|FG004|Overall Study|Physician Decision|2|||
164195866|NCT01747499|593085573|FG000|Overall Study|Death|0|||
164195867|NCT01747499|593085574|FG001|Overall Study|Death|0|||
164195868|NCT01747499|593085575|FG002|Overall Study|Death|0|||
164195869|NCT01747499|593085576|FG003|Overall Study|Death|1|||
164195870|NCT01747499|593085577|FG004|Overall Study|Death|1|||
164195871|NCT01747499|593085573|FG000|Overall Study|Withdrawal by Subject|0|||
164195872|NCT01747499|593085574|FG001|Overall Study|Withdrawal by Subject|0|||
164195873|NCT01747499|593085575|FG002|Overall Study|Withdrawal by Subject|0|||
164195874|NCT01747499|593085576|FG003|Overall Study|Withdrawal by Subject|0|||
164195875|NCT01747499|593085577|FG004|Overall Study|Withdrawal by Subject|6|||
164195876|NCT01747499|593085573|FG000|Overall Study|Developed AML and death|0|||
164195877|NCT01747499|593085574|FG001|Overall Study|Developed AML and death|0|||
164195878|NCT01747499|593085575|FG002|Overall Study|Developed AML and death|0|||
164195879|NCT01747499|593085576|FG003|Overall Study|Developed AML and death|0|||
164195880|NCT01747499|593085577|FG004|Overall Study|Developed AML and death|1|||
164195881|NCT01747499|593085573|FG000|Overall Study|Determined not to be eligible|0|||
164195882|NCT01747499|593085574|FG001|Overall Study|Determined not to be eligible|0|||
164195883|NCT01747499|593085575|FG002|Overall Study|Determined not to be eligible|0|||
164195884|NCT01747499|593085576|FG003|Overall Study|Determined not to be eligible|0|||
164195885|NCT01747499|593085577|FG004|Overall Study|Determined not to be eligible|1|||
164195886|NCT01676701|593085578|FG000|Overall Study|Protocol Violation|1|||
164195887|NCT01676701|593085579|FG001|Overall Study|Protocol Violation|0|||
164195888|NCT01676701|593085578|FG000|Overall Study|Sponsor Decision|3|||
164195889|NCT01676701|593085579|FG001|Overall Study|Sponsor Decision|4|||
164195890|NCT00196105|593085580|FG000|Overall Study|Lost to Follow-up|4|||
164195891|NCT00196105|593085581|FG001|Overall Study|Lost to Follow-up|5|||
164195892|NCT00196105|593085582|FG002|Overall Study|Lost to Follow-up|7|||
164195893|NCT00248651|593085586|FG000|Overall Study|Withdrawal by Subject|28|||
164195894|NCT00248651|593085587|FG001|Overall Study|Withdrawal by Subject|40|||
164195895|NCT00248651|593085588|FG002|Overall Study|Withdrawal by Subject|32|||
164195896|NCT01365130|593085591|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
164195897|NCT05607576|593085593|FG000|Overall Study|immediate sensor error|2|||
164195898|NCT05607576|593085593|FG000|Overall Study|Physician Decision|2|||
164195899|NCT05616013|593085594|FG000|Overall Study|Adverse Event|6|||
164195900|NCT05616013|593085595|FG001|Overall Study|Adverse Event|12|||
164195901|NCT05616013|593085596|FG002|Overall Study|Adverse Event|8|||
164195902|NCT05616013|593085597|FG003|Overall Study|Adverse Event|4|||
164195903|NCT05616013|593085598|FG004|Overall Study|Adverse Event|6|||
164195904|NCT05616013|593085599|FG005|Overall Study|Adverse Event|8|||
164195905|NCT05616013|593085600|FG006|Overall Study|Adverse Event|3|||
164195906|NCT05616013|593085601|FG007|Overall Study|Adverse Event|6|||
164195907|NCT05616013|593085602|FG008|Overall Study|Adverse Event|1|||
164195908|NCT05616013|593085594|FG000|Overall Study|Lost to Follow-up|5|||
164195909|NCT05616013|593085595|FG001|Overall Study|Lost to Follow-up|4|||
164195910|NCT05616013|593085596|FG002|Overall Study|Lost to Follow-up|3|||
164195911|NCT05616013|593085597|FG003|Overall Study|Lost to Follow-up|2|||
164195912|NCT05616013|593085598|FG004|Overall Study|Lost to Follow-up|0|||
164195913|NCT05616013|593085599|FG005|Overall Study|Lost to Follow-up|5|||
164195914|NCT05616013|593085600|FG006|Overall Study|Lost to Follow-up|2|||
164195915|NCT05616013|593085601|FG007|Overall Study|Lost to Follow-up|1|||
164195916|NCT05616013|593085602|FG008|Overall Study|Lost to Follow-up|2|||
164195917|NCT05616013|593085594|FG000|Overall Study|Non-compliance with study requirements|2|||
164195918|NCT05616013|593085595|FG001|Overall Study|Non-compliance with study requirements|2|||
164195919|NCT05616013|593085596|FG002|Overall Study|Non-compliance with study requirements|2|||
164195920|NCT05616013|593085597|FG003|Overall Study|Non-compliance with study requirements|3|||
164195921|NCT05616013|593085598|FG004|Overall Study|Non-compliance with study requirements|0|||
164195922|NCT05616013|593085599|FG005|Overall Study|Non-compliance with study requirements|2|||
164195923|NCT05616013|593085600|FG006|Overall Study|Non-compliance with study requirements|1|||
164195924|NCT05616013|593085601|FG007|Overall Study|Non-compliance with study requirements|1|||
163965186|NCT00447382|592244885|FG000|Overall Study|Protocol Violation|2|||
163965187|NCT00447382|592244886|FG001|Overall Study|Protocol Violation|0|||
164195925|NCT05616013|593085602|FG008|Overall Study|Non-compliance with study requirements|4|||
163965188|NCT00447382|592244885|FG000|Overall Study|Unclassified|2|||
163965189|NCT00447382|592244886|FG001|Overall Study|Unclassified|5|||
163965190|NCT00977574|592244887|FG000|Overall Study|Never Treated|4|||
163965191|NCT00977574|592244888|FG001|Overall Study|Never Treated|2|||
164195926|NCT05616013|593085594|FG000|Overall Study|Withdrawal by Subject|11|||
163965192|NCT00977574|592244889|FG002|Overall Study|Never Treated|4|||
163965193|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
163965194|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
164195927|NCT05616013|593085595|FG001|Overall Study|Withdrawal by Subject|9|||
164195928|NCT05616013|593085596|FG002|Overall Study|Withdrawal by Subject|8|||
164195929|NCT05616013|593085597|FG003|Overall Study|Withdrawal by Subject|6|||
164195930|NCT05616013|593085598|FG004|Overall Study|Withdrawal by Subject|3|||
164195931|NCT05616013|593085599|FG005|Overall Study|Withdrawal by Subject|4|||
164195932|NCT05616013|593085600|FG006|Overall Study|Withdrawal by Subject|6|||
163965195|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
164195933|NCT05616013|593085601|FG007|Overall Study|Withdrawal by Subject|5|||
164195934|NCT05616013|593085602|FG008|Overall Study|Withdrawal by Subject|4|||
164195935|NCT05616013|593085594|FG000|Overall Study|Physician Decision|0|||
164195936|NCT05616013|593085595|FG001|Overall Study|Physician Decision|0|||
164195937|NCT05616013|593085596|FG002|Overall Study|Physician Decision|1|||
164195938|NCT05616013|593085597|FG003|Overall Study|Physician Decision|0|||
164195939|NCT05616013|593085598|FG004|Overall Study|Physician Decision|0|||
164195940|NCT05616013|593085599|FG005|Overall Study|Physician Decision|1|||
164195941|NCT05616013|593085600|FG006|Overall Study|Physician Decision|3|||
164195942|NCT05616013|593085601|FG007|Overall Study|Physician Decision|0|||
164195943|NCT05616013|593085602|FG008|Overall Study|Physician Decision|0|||
164195944|NCT05616013|593085594|FG000|Overall Study|Protocol Violation|0|||
164195945|NCT05616013|593085595|FG001|Overall Study|Protocol Violation|0|||
164195946|NCT05616013|593085596|FG002|Overall Study|Protocol Violation|0|||
164195947|NCT05616013|593085597|FG003|Overall Study|Protocol Violation|0|||
164195948|NCT05616013|593085598|FG004|Overall Study|Protocol Violation|0|||
164195949|NCT05616013|593085599|FG005|Overall Study|Protocol Violation|0|||
164195950|NCT05616013|593085600|FG006|Overall Study|Protocol Violation|1|||
164195951|NCT05616013|593085601|FG007|Overall Study|Protocol Violation|0|||
164195952|NCT05616013|593085602|FG008|Overall Study|Protocol Violation|2|||
164195953|NCT05616013|593085594|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
164195954|NCT05616013|593085595|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195955|NCT05616013|593085596|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195956|NCT05616013|593085597|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195957|NCT05616013|593085598|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195958|NCT05616013|593085599|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195959|NCT05616013|593085600|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195960|NCT05616013|593085601|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195961|NCT05616013|593085602|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
164195962|NCT05616013|593085594|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
164195963|NCT05616013|593085595|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195964|NCT05616013|593085596|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195965|NCT05616013|593085597|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195966|NCT05616013|593085598|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195967|NCT05616013|593085599|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195968|NCT05616013|593085600|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195969|NCT05616013|593085601|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195970|NCT05616013|593085602|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
164195971|NCT05616013|593085594|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
164195972|NCT05616013|593085595|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195973|NCT05616013|593085596|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195974|NCT05616013|593085597|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195975|NCT05616013|593085598|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195976|NCT05616013|593085599|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195977|NCT05616013|593085600|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195978|NCT05616013|593085601|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195979|NCT05616013|593085602|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
164195980|NCT05616013|593085594|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195981|NCT05616013|593085595|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
164195982|NCT05616013|593085596|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195983|NCT05616013|593085597|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195984|NCT05616013|593085598|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195985|NCT05616013|593085599|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195986|NCT05616013|593085600|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195987|NCT05616013|593085601|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195988|NCT05616013|593085602|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
164195989|NCT05616013|593085594|FG000|Overall Study|Participant Decision, Time Constraints|0|||
164195990|NCT05616013|593085595|FG001|Overall Study|Participant Decision, Time Constraints|1|||
164195991|NCT05616013|593085596|FG002|Overall Study|Participant Decision, Time Constraints|0|||
164195992|NCT05616013|593085597|FG003|Overall Study|Participant Decision, Time Constraints|0|||
164195993|NCT05616013|593085598|FG004|Overall Study|Participant Decision, Time Constraints|0|||
164195994|NCT05616013|593085599|FG005|Overall Study|Participant Decision, Time Constraints|0|||
164195995|NCT05616013|593085600|FG006|Overall Study|Participant Decision, Time Constraints|0|||
164195996|NCT05616013|593085601|FG007|Overall Study|Participant Decision, Time Constraints|0|||
164195997|NCT05616013|593085602|FG008|Overall Study|Participant Decision, Time Constraints|0|||
164195998|NCT05616013|593085594|FG000|Overall Study|Prohibited Concomitant Medication|0|||
164195999|NCT05616013|593085595|FG001|Overall Study|Prohibited Concomitant Medication|0|||
164196000|NCT05616013|593085596|FG002|Overall Study|Prohibited Concomitant Medication|1|||
164196001|NCT05616013|593085597|FG003|Overall Study|Prohibited Concomitant Medication|0|||
164196002|NCT05616013|593085598|FG004|Overall Study|Prohibited Concomitant Medication|0|||
164196003|NCT05616013|593085599|FG005|Overall Study|Prohibited Concomitant Medication|0|||
164196004|NCT05616013|593085600|FG006|Overall Study|Prohibited Concomitant Medication|0|||
164196005|NCT05616013|593085601|FG007|Overall Study|Prohibited Concomitant Medication|0|||
164196006|NCT05616013|593085602|FG008|Overall Study|Prohibited Concomitant Medication|0|||
163859424|NCT02081391|591854476|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
163859425|NCT02081391|591854477|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
163859426|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
163859427|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
163859428|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
163859429|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
163859430|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
163859431|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
163859432|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
163859433|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
163859434|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
163859435|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
163859436|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
163859437|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
163859438|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163859439|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163859440|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163859441|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
163859442|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163859443|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
163859444|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
163859445|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
163859446|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
163859447|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163859448|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163859449|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163859450|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163859451|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163859452|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
163859453|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
163859454|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
163859455|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
163859456|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163859457|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163859458|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163859459|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163859460|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163859461|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
163859462|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
163859463|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
163859464|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
163859465|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163859466|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163859467|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163859468|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
163859469|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163859470|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
163859471|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
163859472|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859473|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859474|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859475|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859476|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859477|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859478|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859479|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
163859480|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163965196|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
163965197|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
163965198|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
163965199|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163965200|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163965201|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163965202|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
163965203|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
163965204|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163965205|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163965206|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163965207|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
163965208|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
163965209|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163965210|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
164196007|NCT05616013|593085594|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196008|NCT05616013|593085595|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196009|NCT05616013|593085596|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
164196010|NCT05616013|593085597|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196011|NCT05616013|593085598|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196012|NCT05616013|593085599|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196013|NCT05616013|593085600|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196014|NCT05616013|593085601|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196015|NCT05616013|593085602|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
164196016|NCT05616013|593085594|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196017|NCT05616013|593085595|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196018|NCT05616013|593085596|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196019|NCT05616013|593085597|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
164196020|NCT05616013|593085598|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196021|NCT05616013|593085599|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196022|NCT05616013|593085600|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196023|NCT05616013|593085601|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196024|NCT05616013|593085602|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
164196025|NCT05616013|593085594|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196026|NCT05616013|593085595|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196027|NCT05616013|593085596|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196028|NCT05616013|593085597|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196029|NCT05616013|593085598|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196030|NCT05616013|593085599|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196031|NCT05616013|593085600|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
164196032|NCT05616013|593085601|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196033|NCT05616013|593085602|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
164196034|NCT05616013|593085594|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196035|NCT05616013|593085595|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196036|NCT05616013|593085596|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196037|NCT05616013|593085597|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196038|NCT05616013|593085598|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196039|NCT05616013|593085599|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196040|NCT05616013|593085600|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196041|NCT05616013|593085601|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
164196042|NCT05616013|593085602|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
164196043|NCT05616013|593085594|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196044|NCT05616013|593085595|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196045|NCT05616013|593085596|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196046|NCT05616013|593085597|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196047|NCT05616013|593085598|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196048|NCT05616013|593085599|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196049|NCT05616013|593085600|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
164196050|NCT05616013|593085601|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
164307249|NCT02023697|593499224|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
163965211|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163965212|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
163965213|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
163965214|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163965215|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163965216|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163965217|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
163965218|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
163965219|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163965220|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163965221|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163965222|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
163965223|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
163965224|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163965225|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163965226|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163965227|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
163965228|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
163965229|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163965230|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163965231|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163965232|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
163965233|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
163965234|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
163965235|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
163965236|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
164134683|NCT03970837|592857360|FG005|Overall Study|Lost to Follow-up|2|||
164134684|NCT03970837|592857361|FG006|Overall Study|Lost to Follow-up|0|||
164134685|NCT03970837|592857362|FG007|Overall Study|Lost to Follow-up|0|||
164134686|NCT03970837|592857363|FG008|Overall Study|Lost to Follow-up|0|||
164134687|NCT03970837|592857364|FG009|Overall Study|Lost to Follow-up|0|||
164134688|NCT03970837|592857365|FG010|Overall Study|Lost to Follow-up|0|||
164134689|NCT03970837|592857366|FG011|Overall Study|Lost to Follow-up|0|||
164134690|NCT03970837|592857355|FG000|Overall Study|Protocol Violation|1|||
164134691|NCT03970837|592857356|FG001|Overall Study|Protocol Violation|0|||
164134692|NCT03970837|592857357|FG002|Overall Study|Protocol Violation|0|||
164134693|NCT03970837|592857358|FG003|Overall Study|Protocol Violation|0|||
164134694|NCT03970837|592857359|FG004|Overall Study|Protocol Violation|0|||
164134695|NCT03970837|592857360|FG005|Overall Study|Protocol Violation|0|||
164134696|NCT03970837|592857361|FG006|Overall Study|Protocol Violation|0|||
164134697|NCT03970837|592857362|FG007|Overall Study|Protocol Violation|0|||
164134698|NCT03970837|592857363|FG008|Overall Study|Protocol Violation|0|||
164134699|NCT03970837|592857364|FG009|Overall Study|Protocol Violation|0|||
164134700|NCT03970837|592857365|FG010|Overall Study|Protocol Violation|0|||
164134701|NCT03970837|592857366|FG011|Overall Study|Protocol Violation|0|||
164134702|NCT03970837|592857355|FG000|Overall Study|Physician Decision|5|||
164134703|NCT03970837|592857356|FG001|Overall Study|Physician Decision|8|||
164134704|NCT03970837|592857357|FG002|Overall Study|Physician Decision|4|||
164134705|NCT03970837|592857358|FG003|Overall Study|Physician Decision|1|||
164134706|NCT03970837|592857359|FG004|Overall Study|Physician Decision|5|||
164134707|NCT03970837|592857360|FG005|Overall Study|Physician Decision|2|||
164134708|NCT03970837|592857361|FG006|Overall Study|Physician Decision|4|||
164134709|NCT03970837|592857362|FG007|Overall Study|Physician Decision|5|||
164134710|NCT03970837|592857363|FG008|Overall Study|Physician Decision|0|||
164134711|NCT03970837|592857364|FG009|Overall Study|Physician Decision|1|||
164134712|NCT03970837|592857365|FG010|Overall Study|Physician Decision|0|||
164134713|NCT03970837|592857366|FG011|Overall Study|Physician Decision|0|||
164134714|NCT03970837|592857355|FG000|Overall Study|Withdrawal by Subject|32|||
164134715|NCT03970837|592857356|FG001|Overall Study|Withdrawal by Subject|35|||
164134716|NCT03970837|592857357|FG002|Overall Study|Withdrawal by Subject|12|||
164134717|NCT03970837|592857358|FG003|Overall Study|Withdrawal by Subject|8|||
164134718|NCT03970837|592857359|FG004|Overall Study|Withdrawal by Subject|6|||
164134719|NCT03970837|592857360|FG005|Overall Study|Withdrawal by Subject|8|||
164134720|NCT03970837|592857361|FG006|Overall Study|Withdrawal by Subject|2|||
164134721|NCT03970837|592857362|FG007|Overall Study|Withdrawal by Subject|3|||
164134722|NCT03970837|592857363|FG008|Overall Study|Withdrawal by Subject|0|||
164134723|NCT03970837|592857364|FG009|Overall Study|Withdrawal by Subject|0|||
164196051|NCT05616013|593085602|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
164196052|NCT03430856|593085609|FG000|Overall Study|Adverse Event|0|||
164196053|NCT03430856|593085610|FG001|Overall Study|Adverse Event|1|||
164196054|NCT03430856|593085611|FG002|Overall Study|Adverse Event|0|||
164196055|NCT03430856|593085609|FG000|Overall Study|Rescue criteria|1|||
164196056|NCT03430856|593085610|FG001|Overall Study|Rescue criteria|1|||
164196057|NCT03430856|593085611|FG002|Overall Study|Rescue criteria|0|||
164196058|NCT03430856|593085609|FG000|Overall Study|Voluntary withdrawal of consent|1|||
164196059|NCT03430856|593085610|FG001|Overall Study|Voluntary withdrawal of consent|1|||
164196060|NCT03430856|593085611|FG002|Overall Study|Voluntary withdrawal of consent|1|||
164196061|NCT02481050|593087435|FG000|Overall Study|Adverse Event|1|||
164196062|NCT02481050|593087435|FG000|Overall Study|Disease Progression|47|||
164196063|NCT02481050|593087435|FG000|Overall Study|Withdrawal by Subject|7|||
164196064|NCT02481050|593087435|FG000|Overall Study|Other|3|||
164196065|NCT02357459|593087438|FG000|Overall Study|Adverse Event|0|||
164196066|NCT02357459|593087439|FG001|Overall Study|Adverse Event|1|||
164196067|NCT02357459|593087440|FG002|Overall Study|Adverse Event|1|||
164196068|NCT02357459|593087438|FG000|Overall Study|Withdrawal by Subject|5|||
164196069|NCT02357459|593087439|FG001|Overall Study|Withdrawal by Subject|3|||
163965237|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
164196070|NCT02357459|593087440|FG002|Overall Study|Withdrawal by Subject|3|||
164196071|NCT02357459|593087438|FG000|Overall Study|Physician Decision|0|||
164196072|NCT02357459|593087439|FG001|Overall Study|Physician Decision|2|||
164196073|NCT02357459|593087440|FG002|Overall Study|Physician Decision|0|||
164196074|NCT02357459|593087438|FG000|Overall Study|Protocol Violation|1|||
164196075|NCT02357459|593087439|FG001|Overall Study|Protocol Violation|1|||
164196076|NCT02357459|593087440|FG002|Overall Study|Protocol Violation|0|||
164196077|NCT02357459|593087438|FG000|Overall Study|Lost to Follow-up|1|||
164196078|NCT02357459|593087439|FG001|Overall Study|Lost to Follow-up|3|||
164196079|NCT02357459|593087440|FG002|Overall Study|Lost to Follow-up|0|||
164196080|NCT02357459|593087438|FG000|Overall Study|Lack of Efficacy|7|||
164196081|NCT02357459|593087439|FG001|Overall Study|Lack of Efficacy|4|||
164196082|NCT02357459|593087440|FG002|Overall Study|Lack of Efficacy|4|||
164196083|NCT02357459|593087438|FG000|Overall Study|Patient Relocated|2|||
164196084|NCT02357459|593087439|FG001|Overall Study|Patient Relocated|0|||
164196085|NCT02357459|593087440|FG002|Overall Study|Patient Relocated|0|||
164196086|NCT02357459|593087438|FG000|Overall Study|Instruction from PCP|1|||
164196087|NCT02357459|593087439|FG001|Overall Study|Instruction from PCP|0|||
164196088|NCT02357459|593087440|FG002|Overall Study|Instruction from PCP|0|||
164196089|NCT02357459|593087438|FG000|Overall Study|Incarceration|0|||
164196090|NCT02357459|593087439|FG001|Overall Study|Incarceration|0|||
164196091|NCT02357459|593087440|FG002|Overall Study|Incarceration|1|||
164196092|NCT02357459|593087438|FG000|Overall Study|Pre-planned Knee surgery|0|||
164196093|NCT02357459|593087439|FG001|Overall Study|Pre-planned Knee surgery|0|||
164196094|NCT02357459|593087440|FG002|Overall Study|Pre-planned Knee surgery|2|||
164196095|NCT02357459|593087438|FG000|Overall Study|Job Commitments|0|||
164196096|NCT02357459|593087439|FG001|Overall Study|Job Commitments|0|||
164196097|NCT02357459|593087440|FG002|Overall Study|Job Commitments|1|||
164196098|NCT01022203|593087441|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
164196099|NCT01022203|593087442|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
164196100|NCT01022203|593087441|FG000|Post Treatment Assessment|Physician Decision|2|||
164196101|NCT01022203|593087442|FG001|Post Treatment Assessment|Physician Decision|0|||
164196102|NCT01022203|593087441|FG000|Post Treatment Assessment|Adverse Event|0|||
164196103|NCT01022203|593087442|FG001|Post Treatment Assessment|Adverse Event|2|||
164196104|NCT01022203|593087441|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
164196105|NCT01022203|593087442|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
164196106|NCT03638128|593087445|FG000|Overall Study|Withdrawal by Subject|1|||
164196107|NCT03638128|593087446|FG001|Overall Study|Withdrawal by Subject|7|||
164196108|NCT03638128|593087447|FG002|Overall Study|Withdrawal by Subject|6|||
164196109|NCT03638128|593087445|FG000|Overall Study|Sponsor Decision|15|||
164196110|NCT03638128|593087446|FG001|Overall Study|Sponsor Decision|12|||
164196111|NCT03638128|593087447|FG002|Overall Study|Sponsor Decision|19|||
164196112|NCT03638128|593087445|FG000|Overall Study|Lost to Follow-up|0|||
164196113|NCT03638128|593087446|FG001|Overall Study|Lost to Follow-up|0|||
164196114|NCT03638128|593087447|FG002|Overall Study|Lost to Follow-up|1|||
164196115|NCT03163446|593087448|FG000|Overall Study|Unable to return for Day 180 visit|2|||
164196116|NCT03163446|593087449|FG001|Overall Study|Unable to return for Day 180 visit|0|||
164196117|NCT03163446|593087448|FG000|Overall Study|Withdrawal by Subject|2|||
164196118|NCT03163446|593087449|FG001|Overall Study|Withdrawal by Subject|6|||
164196119|NCT03163446|593087448|FG000|Overall Study|Death|16|||
164196120|NCT03163446|593087449|FG001|Overall Study|Death|5|||
164196121|NCT03163446|593087448|FG000|Overall Study|Lost to Follow-up|6|||
163965238|NCT03627767|592246884|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
164196122|NCT03163446|593087449|FG001|Overall Study|Lost to Follow-up|5|||
164196123|NCT03163446|593087448|FG000|Overall Study|Physician Decision|1|||
164196124|NCT03163446|593087449|FG001|Overall Study|Physician Decision|1|||
164196125|NCT03163446|593087448|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
163965239|NCT03627767|592246885|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163965240|NCT03627767|592246886|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163965241|NCT03627767|592246887|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163965242|NCT03627767|592246888|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
163965243|NCT03627767|592246884|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
163965244|NCT03627767|592246885|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
163965245|NCT03627767|592246886|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
163965246|NCT03627767|592246887|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
163965247|NCT03627767|592246888|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
163965248|NCT03627767|592246884|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163965249|NCT03627767|592246885|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163965250|NCT03627767|592246886|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
163965251|NCT03627767|592246887|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
163965252|NCT03627767|592246888|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163965253|NCT03627767|592246884|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
163965254|NCT03627767|592246885|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
163965255|NCT03627767|592246886|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
163965256|NCT03627767|592246887|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
163965257|NCT03627767|592246888|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
163965258|NCT03627767|592246884|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163965259|NCT03627767|592246885|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
163965260|NCT03627767|592246886|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
163965261|NCT03627767|592246887|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
163965262|NCT03627767|592246888|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163965263|NCT03627767|592246884|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163965264|NCT03627767|592246885|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163965265|NCT03627767|592246886|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
163965266|NCT03627767|592246887|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163965267|NCT03627767|592246888|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
163965268|NCT03627767|592246884|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
163965269|NCT03627767|592246885|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
163965270|NCT03627767|592246886|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
163965271|NCT03627767|592246887|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
163965272|NCT03627767|592246888|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
163965273|NCT03627767|592246884|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163965274|NCT03627767|592246885|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163965275|NCT03627767|592246886|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163965276|NCT03627767|592246887|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
163965277|NCT03627767|592246888|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
163965278|NCT03627767|592246884|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163965279|NCT03627767|592246885|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163965280|NCT03627767|592246886|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163965281|NCT03627767|592246887|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
163965282|NCT03627767|592246888|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
163965283|NCT03627767|592246884|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163965284|NCT03627767|592246885|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163965285|NCT03627767|592246886|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163965286|NCT03627767|592246887|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
163965287|NCT03627767|592246888|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
163965288|NCT03627767|592246884|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
163965289|NCT03627767|592246885|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
163965290|NCT03627767|592246886|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
163965291|NCT03627767|592246887|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
164196126|NCT03163446|593087449|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
163965292|NCT03627767|592246888|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
163965293|NCT00283049|592246889|FG000|Overall Study|Adverse Event|6|||
163965294|NCT00283049|592246890|FG001|Overall Study|Adverse Event|1|||
163965295|NCT00283049|592246891|FG002|Overall Study|Adverse Event|4|||
164196127|NCT00611806|593087450|FG000|Overall Study|Withdrawal by Subject|8|||
164196128|NCT00611806|593087451|FG001|Overall Study|Withdrawal by Subject|2|||
164196129|NCT00611806|593087450|FG000|Overall Study|Adverse Event|2|||
164196130|NCT00611806|593087451|FG001|Overall Study|Adverse Event|1|||
164196131|NCT00611806|593087450|FG000|Overall Study|Lost to Follow-up|6|||
164196132|NCT00611806|593087451|FG001|Overall Study|Lost to Follow-up|0|||
164196133|NCT00903201|593087453|FG000|Overall Study|Adverse Event|1|||
164307250|NCT02023697|593499225|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
163965296|NCT00283049|592246889|FG000|Overall Study|Protocol Violation|3|||
163965297|NCT00283049|592246890|FG001|Overall Study|Protocol Violation|0|||
163965298|NCT00283049|592246891|FG002|Overall Study|Protocol Violation|3|||
163965299|NCT00283049|592246889|FG000|Overall Study|Death|1|||
163965300|NCT00283049|592246890|FG001|Overall Study|Death|1|||
163965301|NCT00283049|592246891|FG002|Overall Study|Death|1|||
163965302|NCT00283049|592246889|FG000|Overall Study|Lack of Efficacy|0|||
163965303|NCT00283049|592246890|FG001|Overall Study|Lack of Efficacy|1|||
163965304|NCT00283049|592246891|FG002|Overall Study|Lack of Efficacy|1|||
163965305|NCT00283049|592246889|FG000|Overall Study|Lost to Follow-up|4|||
163965306|NCT00283049|592246890|FG001|Overall Study|Lost to Follow-up|2|||
163965307|NCT00283049|592246891|FG002|Overall Study|Lost to Follow-up|5|||
163965308|NCT00283049|592246889|FG000|Overall Study|Withdrawal by Subject|26|||
163965309|NCT00283049|592246890|FG001|Overall Study|Withdrawal by Subject|24|||
163965310|NCT00283049|592246891|FG002|Overall Study|Withdrawal by Subject|19|||
163965311|NCT00283049|592246889|FG000|Overall Study|Discontinuation of Study|18|||
163965312|NCT00283049|592246890|FG001|Overall Study|Discontinuation of Study|16|||
163965313|NCT00283049|592246891|FG002|Overall Study|Discontinuation of Study|20|||
163965314|NCT00283049|592246889|FG000|Overall Study|No longer requires study treatment|0|||
163965315|NCT00283049|592246890|FG001|Overall Study|No longer requires study treatment|0|||
163965316|NCT00283049|592246891|FG002|Overall Study|No longer requires study treatment|1|||
163965317|NCT02953639|592246892|FG000|Overall Study|Adverse Event|2|||
163965318|NCT02953639|592246893|FG001|Overall Study|Adverse Event|0|||
163965319|NCT02953639|592246894|FG002|Overall Study|Adverse Event|1|||
163965320|NCT02953639|592246892|FG000|Overall Study|Lost to Follow-up|8|||
163965321|NCT02953639|592246893|FG001|Overall Study|Lost to Follow-up|4|||
163965322|NCT02953639|592246894|FG002|Overall Study|Lost to Follow-up|3|||
163965323|NCT02953639|592246892|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163965324|NCT02953639|592246893|FG001|Overall Study|Non-Compliance With Study Drug|2|||
163965325|NCT02953639|592246894|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163965326|NCT02953639|592246892|FG000|Overall Study|Multiple Reasons|1|||
163965327|NCT02953639|592246893|FG001|Overall Study|Multiple Reasons|0|||
163965328|NCT02953639|592246894|FG002|Overall Study|Multiple Reasons|1|||
163965329|NCT02953639|592246892|FG000|Overall Study|Physician Decision|1|||
163965330|NCT02953639|592246893|FG001|Overall Study|Physician Decision|0|||
163965331|NCT02953639|592246894|FG002|Overall Study|Physician Decision|0|||
163965332|NCT02953639|592246892|FG000|Overall Study|Withdrawal by Subject|7|||
163965333|NCT02953639|592246893|FG001|Overall Study|Withdrawal by Subject|8|||
163965334|NCT02953639|592246894|FG002|Overall Study|Withdrawal by Subject|10|||
163965335|NCT02953639|592246892|FG000|Overall Study|Completed or Discontinued information is missing|1|||
163965336|NCT02953639|592246893|FG001|Overall Study|Completed or Discontinued information is missing|0|||
163965337|NCT02953639|592246894|FG002|Overall Study|Completed or Discontinued information is missing|0|||
163965338|NCT01667081|592246895|FG000|Overall Study|Death|43|||
163965339|NCT01667081|592246896|FG001|Overall Study|Death|3|||
163965340|NCT01667081|592246895|FG000|Overall Study|Lost to Follow-up|99|||
163965341|NCT01667081|592246896|FG001|Overall Study|Lost to Follow-up|48|||
163965342|NCT01667081|592246895|FG000|Overall Study|Physician Decision|16|||
164196134|NCT00903201|593087454|FG001|Overall Study|Adverse Event|4|||
163965343|NCT01667081|592246896|FG001|Overall Study|Physician Decision|2|||
163965344|NCT01667081|592246895|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
163965345|NCT01667081|592246896|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
163965346|NCT01667081|592246895|FG000|Overall Study|Withdrawal by Subject|90|||
163965347|NCT01667081|592246896|FG001|Overall Study|Withdrawal by Subject|35|||
163965348|NCT03034460|592246897|FG000|Overall Study|Adverse Event|0|||
163965349|NCT03034460|592246898|FG001|Overall Study|Adverse Event|1|||
163965350|NCT03034460|592246897|FG000|Overall Study|Withdrawal by Subject|2|||
163965351|NCT03034460|592246898|FG001|Overall Study|Withdrawal by Subject|2|||
163965352|NCT03034460|592246897|FG000|Overall Study|Personal Reasons|1|||
163965353|NCT03034460|592246898|FG001|Overall Study|Personal Reasons|0|||
163965354|NCT02294682|592246899|FG000|Overall Study|Could not swallow pills|1|||
164196135|NCT00903201|593087455|FG002|Overall Study|Adverse Event|0|||
164196136|NCT00903201|593087453|FG000|Overall Study|Protocol Violation|2|||
164196137|NCT00903201|593087454|FG001|Overall Study|Protocol Violation|1|||
164196138|NCT00903201|593087455|FG002|Overall Study|Protocol Violation|0|||
164196139|NCT00903201|593087453|FG000|Overall Study|Lost to Follow-up|0|||
164196140|NCT00903201|593087454|FG001|Overall Study|Lost to Follow-up|1|||
164196141|NCT00903201|593087455|FG002|Overall Study|Lost to Follow-up|0|||
164196142|NCT00903201|593087453|FG000|Overall Study|Physician Decision|1|||
164196143|NCT00903201|593087454|FG001|Overall Study|Physician Decision|0|||
164196144|NCT00903201|593087455|FG002|Overall Study|Physician Decision|1|||
164196145|NCT00903201|593087453|FG000|Overall Study|Withdrawal by Subject|1|||
163965355|NCT02294682|592246900|FG001|Overall Study|Could not swallow pills|0|||
163965356|NCT01516970|592246901|FG000|Overall Study|Lost to Follow-up|7|||
163965357|NCT01516970|592246902|FG001|Overall Study|Lost to Follow-up|8|||
163965358|NCT01516970|592246901|FG000|Overall Study|Adverse Event|1|||
163965359|NCT01516970|592246902|FG001|Overall Study|Adverse Event|5|||
163965360|NCT01516970|592246901|FG000|Overall Study|Withdrawal by Subject|1|||
163965361|NCT01516970|592246902|FG001|Overall Study|Withdrawal by Subject|1|||
163965362|NCT01516970|592246901|FG000|Overall Study|Other|9|||
163965363|NCT01516970|592246902|FG001|Overall Study|Other|7|||
163965364|NCT00434421|592246903|FG000|Overall Study|Withdrawal by Subject|1|||
163965365|NCT00434421|592246903|FG000|Overall Study|Non-compliance with study treatment|1|||
163965366|NCT02366728|592246904|FG000|Overall Study|Death|0|||
163965367|NCT02366728|592246905|FG001|Overall Study|Death|0|||
163965368|NCT02366728|592246906|FG002|Overall Study|Death|1|||
163965369|NCT02366728|592246904|FG000|Overall Study|Adverse Event|1|||
163965370|NCT02366728|592246905|FG001|Overall Study|Adverse Event|0|||
163965371|NCT02366728|592246906|FG002|Overall Study|Adverse Event|0|||
163965372|NCT02366728|592246904|FG000|Overall Study|Screen Failure|2|||
163965373|NCT02366728|592246905|FG001|Overall Study|Screen Failure|1|||
163965374|NCT02366728|592246906|FG002|Overall Study|Screen Failure|0|||
163965375|NCT02366728|592246904|FG000|Overall Study|Only yielded 2 vaccines|1|||
163965376|NCT02366728|592246905|FG001|Overall Study|Only yielded 2 vaccines|0|||
163965377|NCT02366728|592246906|FG002|Overall Study|Only yielded 2 vaccines|0|||
163965378|NCT01399190|592246909|FG000|Overall Study|Not Eligible for Final Analysis|5|||
163965379|NCT01399190|592246909|FG000|Overall Study|Adverse Event|8|||
163965380|NCT01399190|592246909|FG000|Overall Study|Participant's Request|5|||
163965381|NCT01399190|592246909|FG000|Overall Study|Physician Decision|2|||
163965382|NCT03829241|592246913|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
163965383|NCT03829241|592246914|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
163965384|NCT03829241|592246913|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
163965385|NCT03829241|592246914|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
163965386|NCT03829241|592246913|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
163965387|NCT03829241|592246914|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
163965388|NCT03829241|592246913|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
163965389|NCT03829241|592246914|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
163965390|NCT03829241|592246913|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
163965391|NCT03829241|592246914|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
163965392|NCT03829241|592246913|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
163965393|NCT03829241|592246914|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
163965394|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
163965395|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
163965396|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
163965397|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
163965398|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
163965399|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
163965400|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
163965401|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
163965402|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
163965403|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
163965404|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
163965405|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
163965406|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
163965407|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
163965408|NCT03829241|592246913|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
163965409|NCT03829241|592246914|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
163965410|NCT03678103|592246924|FG000|Overall Study|Withdrawn prior to completion|4|||
163965411|NCT01674712|592246926|FG000|Overall Study|Adverse Event|5|||
163965412|NCT01674712|592246927|FG001|Overall Study|Adverse Event|6|||
163965413|NCT01674712|592246928|FG002|Overall Study|Adverse Event|3|||
163965414|NCT01674712|592246929|FG003|Overall Study|Adverse Event|4|||
163965415|NCT01674712|592246930|FG004|Overall Study|Adverse Event|6|||
163965416|NCT01674712|592246926|FG000|Overall Study|Lost to Follow-up|1|||
163965417|NCT01674712|592246927|FG001|Overall Study|Lost to Follow-up|0|||
163965418|NCT01674712|592246928|FG002|Overall Study|Lost to Follow-up|0|||
163965419|NCT01674712|592246929|FG003|Overall Study|Lost to Follow-up|0|||
163965420|NCT01674712|592246930|FG004|Overall Study|Lost to Follow-up|0|||
163965421|NCT01674712|592246926|FG000|Overall Study|Protocol Violation|2|||
163965422|NCT01674712|592246927|FG001|Overall Study|Protocol Violation|0|||
163965423|NCT01674712|592246928|FG002|Overall Study|Protocol Violation|0|||
163965424|NCT01674712|592246929|FG003|Overall Study|Protocol Violation|0|||
163965425|NCT01674712|592246930|FG004|Overall Study|Protocol Violation|0|||
163965426|NCT01674712|592246926|FG000|Overall Study|Withdrawal by Subject|2|||
163965427|NCT01674712|592246927|FG001|Overall Study|Withdrawal by Subject|2|||
163965428|NCT01674712|592246928|FG002|Overall Study|Withdrawal by Subject|5|||
163965429|NCT01674712|592246929|FG003|Overall Study|Withdrawal by Subject|4|||
163965430|NCT01674712|592246930|FG004|Overall Study|Withdrawal by Subject|3|||
163965431|NCT01674712|592246926|FG000|Overall Study|Administrative|0|||
163965432|NCT01674712|592246927|FG001|Overall Study|Administrative|1|||
163965433|NCT01674712|592246928|FG002|Overall Study|Administrative|0|||
164196146|NCT00903201|593087454|FG001|Overall Study|Withdrawal by Subject|0|||
164196147|NCT00903201|593087455|FG002|Overall Study|Withdrawal by Subject|1|||
164196148|NCT01094288|593087456|FG000|Overall Study|Adverse Event|0|||
164196149|NCT01094288|593087457|FG001|Overall Study|Adverse Event|3|||
164196150|NCT01094288|593087458|FG002|Overall Study|Adverse Event|1|||
164196151|NCT01094288|593087459|FG003|Overall Study|Adverse Event|1|||
164196152|NCT01094288|593087460|FG004|Overall Study|Adverse Event|0|||
164196153|NCT01094288|593087461|FG005|Overall Study|Adverse Event|0|||
164196154|NCT01094288|593087462|FG006|Overall Study|Adverse Event|0|||
164196155|NCT01094288|593087463|FG007|Overall Study|Adverse Event|0|||
164196156|NCT01094288|593087456|FG000|Overall Study|Withdrawal by Subject|0|||
164196157|NCT01094288|593087457|FG001|Overall Study|Withdrawal by Subject|1|||
164196158|NCT01094288|593087458|FG002|Overall Study|Withdrawal by Subject|2|||
164196159|NCT01094288|593087459|FG003|Overall Study|Withdrawal by Subject|0|||
164196160|NCT01094288|593087460|FG004|Overall Study|Withdrawal by Subject|0|||
164196161|NCT01094288|593087461|FG005|Overall Study|Withdrawal by Subject|0|||
164196162|NCT01094288|593087462|FG006|Overall Study|Withdrawal by Subject|0|||
164196163|NCT01094288|593087463|FG007|Overall Study|Withdrawal by Subject|2|||
164196164|NCT01094288|593087456|FG000|Overall Study|Initiation of Alternative Therapy|0|||
164196165|NCT01094288|593087457|FG001|Overall Study|Initiation of Alternative Therapy|0|||
164196166|NCT01094288|593087458|FG002|Overall Study|Initiation of Alternative Therapy|1|||
164196167|NCT01094288|593087459|FG003|Overall Study|Initiation of Alternative Therapy|0|||
164196168|NCT01094288|593087460|FG004|Overall Study|Initiation of Alternative Therapy|0|||
164196169|NCT01094288|593087461|FG005|Overall Study|Initiation of Alternative Therapy|0|||
164196170|NCT01094288|593087462|FG006|Overall Study|Initiation of Alternative Therapy|0|||
164196171|NCT01094288|593087463|FG007|Overall Study|Initiation of Alternative Therapy|0|||
164196172|NCT01094288|593087456|FG000|Overall Study|Reason not Specified|2|||
164196173|NCT01094288|593087457|FG001|Overall Study|Reason not Specified|3|||
164196174|NCT01094288|593087458|FG002|Overall Study|Reason not Specified|0|||
164196175|NCT01094288|593087459|FG003|Overall Study|Reason not Specified|1|||
164196176|NCT01094288|593087460|FG004|Overall Study|Reason not Specified|0|||
164196177|NCT01094288|593087461|FG005|Overall Study|Reason not Specified|0|||
164196178|NCT01094288|593087462|FG006|Overall Study|Reason not Specified|0|||
164196179|NCT01094288|593087463|FG007|Overall Study|Reason not Specified|0|||
164196180|NCT01094288|593087456|FG000|Overall Study|Ongoing Participants|0|||
164196181|NCT01094288|593087457|FG001|Overall Study|Ongoing Participants|3|||
164196182|NCT01094288|593087458|FG002|Overall Study|Ongoing Participants|0|||
164196183|NCT01094288|593087459|FG003|Overall Study|Ongoing Participants|0|||
164196184|NCT01094288|593087460|FG004|Overall Study|Ongoing Participants|0|||
164196185|NCT01094288|593087461|FG005|Overall Study|Ongoing Participants|0|||
164196186|NCT01094288|593087462|FG006|Overall Study|Ongoing Participants|0|||
164196187|NCT01094288|593087463|FG007|Overall Study|Ongoing Participants|0|||
164196188|NCT02611882|593087466|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
164196189|NCT02611882|593087467|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
164196190|NCT02611882|593087468|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
164196191|NCT01228591|593087469|FG000|Baseline|Lack of Efficacy|1|||
164196192|NCT01228591|593087470|FG001|Baseline|Lack of Efficacy|2|||
164196193|NCT01389232|593087471|FG000|Overall Study|Had scaffold removed|15|||
164196194|NCT01389232|593087471|FG000|Overall Study|Personal reasons|2|||
164196195|NCT01389232|593087471|FG000|Overall Study|Adverse Event|1|||
164196196|NCT01389232|593087471|FG000|Overall Study|Death|1|||
164196197|NCT01317940|593087472|FG000|Overall Study|Death|1|||
164196198|NCT01317940|593087473|FG001|Overall Study|Death|0|||
164196199|NCT01317940|593087474|FG002|Overall Study|Death|1|||
164196200|NCT01317940|593087475|FG003|Overall Study|Death|0|||
164196201|NCT01317940|593087476|FG004|Overall Study|Death|0|||
164196202|NCT01317940|593087477|FG005|Overall Study|Death|0|||
164196203|NCT01317940|593087472|FG000|Overall Study|Lost to Follow-up|0|||
164196204|NCT01317940|593087473|FG001|Overall Study|Lost to Follow-up|0|||
164196205|NCT01317940|593087474|FG002|Overall Study|Lost to Follow-up|1|||
164196206|NCT01317940|593087475|FG003|Overall Study|Lost to Follow-up|1|||
164196207|NCT01317940|593087476|FG004|Overall Study|Lost to Follow-up|1|||
164196208|NCT01317940|593087477|FG005|Overall Study|Lost to Follow-up|0|||
164196209|NCT01317940|593087472|FG000|Overall Study|Change in therapy plan|0|||
164196210|NCT01317940|593087473|FG001|Overall Study|Change in therapy plan|0|||
164196211|NCT01317940|593087474|FG002|Overall Study|Change in therapy plan|3|||
164196212|NCT01317940|593087475|FG003|Overall Study|Change in therapy plan|0|||
164196213|NCT01317940|593087476|FG004|Overall Study|Change in therapy plan|0|||
164196214|NCT01317940|593087477|FG005|Overall Study|Change in therapy plan|0|||
164196215|NCT01921517|593087479|FG000|Overall Study|Lost to Follow-up|5|||
164196216|NCT01921517|593087480|FG001|Overall Study|Lost to Follow-up|0|||
164196217|NCT01921517|593087479|FG000|Overall Study|Newly diagnosed health concern|2|||
164196218|NCT01921517|593087480|FG001|Overall Study|Newly diagnosed health concern|0|||
164196219|NCT01921517|593087479|FG000|Overall Study|Physician Decision|0|||
164196220|NCT01921517|593087480|FG001|Overall Study|Physician Decision|2|||
164196221|NCT01921517|593087479|FG000|Overall Study|Withdrawal by Subject|7|||
163965434|NCT01674712|592246929|FG003|Overall Study|Administrative|0|||
163965435|NCT01674712|592246930|FG004|Overall Study|Administrative|1|||
163965436|NCT01674712|592246926|FG000|Overall Study|Lack of Efficacy|0|||
163965437|NCT01674712|592246927|FG001|Overall Study|Lack of Efficacy|0|||
163965438|NCT01674712|592246928|FG002|Overall Study|Lack of Efficacy|1|||
163965439|NCT01674712|592246929|FG003|Overall Study|Lack of Efficacy|0|||
163965440|NCT01674712|592246930|FG004|Overall Study|Lack of Efficacy|1|||
163965441|NCT00381563|592246937|FG000|Overall Study|Withdrawal by Subject|5|||
163965442|NCT00381563|592246938|FG001|Overall Study|Withdrawal by Subject|5|||
163965443|NCT00381563|592246937|FG000|Overall Study|Lost to Follow-up|2|||
163965444|NCT00381563|592246938|FG001|Overall Study|Lost to Follow-up|0|||
163965445|NCT00381563|592246937|FG000|Overall Study|Protocol Violation|0|||
163965446|NCT00381563|592246938|FG001|Overall Study|Protocol Violation|1|||
163965447|NCT00024167|592246939|FG000|Overall Study|Death|53|||
163965448|NCT00024167|592246940|FG001|Overall Study|Death|47|||
163965449|NCT02252536|592246941|FG000|Overall Study|Lost to Follow-up|5|||
163965450|NCT02252536|592246942|FG001|Overall Study|Lost to Follow-up|3|||
163965451|NCT01438151|592246943|FG000|Overall Study|study terminated|8|||
163965452|NCT00006392|592246952|FG000|Overall Study|Ineligible|11|||
163965453|NCT00006392|592246953|FG001|Overall Study|Ineligible|3|||
163965454|NCT00006392|592246954|FG002|Overall Study|Ineligible|5|||
163965455|NCT00006392|592246955|FG003|Overall Study|Ineligible|5|||
163965456|NCT00006392|592246952|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
163965457|NCT00006392|592246953|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
163965458|NCT00006392|592246954|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
163965459|NCT00006392|592246955|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
163965460|NCT01186796|592246956|FG000|Overall Study|Adverse Event|3|||
163965461|NCT01186796|592246957|FG001|Overall Study|Adverse Event|0|||
163965462|NCT01186796|592246956|FG000|Overall Study|Withdrawal by Subject|1|||
163965463|NCT01186796|592246957|FG001|Overall Study|Withdrawal by Subject|1|||
163965464|NCT01186796|592246956|FG000|Overall Study|Protocol Violation|0|||
163965465|NCT01186796|592246957|FG001|Overall Study|Protocol Violation|1|||
163965466|NCT03838198|592246958|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
163965467|NCT03838198|592246959|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
163965468|NCT03838198|592246960|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
163965469|NCT03838198|592246961|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
163965470|NCT03838198|592246958|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
163965471|NCT03838198|592246959|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
163965472|NCT03838198|592246960|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
163965473|NCT03838198|592246961|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
163965474|NCT02378220|592246962|FG000|Overall Study|Death|6|||
163965475|NCT02378220|592246963|FG001|Overall Study|Death|1|||
163965476|NCT00578786|592246964|FG000|Overall Study|Adverse Event|27|||
163965477|NCT00578786|592246965|FG001|Overall Study|Adverse Event|37|||
163965478|NCT00578786|592246966|FG002|Overall Study|Adverse Event|17|||
163965479|NCT00578786|592246964|FG000|Overall Study|Lack of Efficacy|2|||
163965480|NCT00578786|592246965|FG001|Overall Study|Lack of Efficacy|5|||
163965481|NCT00578786|592246966|FG002|Overall Study|Lack of Efficacy|2|||
163965482|NCT00578786|592246964|FG000|Overall Study|Early Escape from Prior Study|2|||
163965483|NCT00578786|592246965|FG001|Overall Study|Early Escape from Prior Study|1|||
163965484|NCT00578786|592246966|FG002|Overall Study|Early Escape from Prior Study|2|||
163965485|NCT00578786|592246964|FG000|Overall Study|Withdrawal by Subject|7|||
163965486|NCT00578786|592246965|FG001|Overall Study|Withdrawal by Subject|8|||
163965487|NCT00578786|592246966|FG002|Overall Study|Withdrawal by Subject|5|||
163965488|NCT00578786|592246964|FG000|Overall Study|Protocol Violation|0|||
163965489|NCT00578786|592246965|FG001|Overall Study|Protocol Violation|3|||
163965490|NCT00578786|592246966|FG002|Overall Study|Protocol Violation|1|||
163965491|NCT00578786|592246964|FG000|Overall Study|Physician Decision|1|||
163965492|NCT00578786|592246965|FG001|Overall Study|Physician Decision|0|||
163965493|NCT00578786|592246966|FG002|Overall Study|Physician Decision|1|||
163965494|NCT00578786|592246964|FG000|Overall Study|Sponsor Decision|0|||
163965495|NCT00578786|592246965|FG001|Overall Study|Sponsor Decision|0|||
163965496|NCT00578786|592246966|FG002|Overall Study|Sponsor Decision|1|||
163965497|NCT00578786|592246964|FG000|Overall Study|Lost to Follow-up|0|||
163965498|NCT00578786|592246965|FG001|Overall Study|Lost to Follow-up|4|||
163965499|NCT00578786|592246966|FG002|Overall Study|Lost to Follow-up|0|||
163965500|NCT00578786|592246964|FG000|Overall Study|Pregnancy|0|||
163965501|NCT00578786|592246965|FG001|Overall Study|Pregnancy|1|||
163965502|NCT00578786|592246966|FG002|Overall Study|Pregnancy|0|||
163965503|NCT00578786|592246964|FG000|Overall Study|Not Otherwise Specified|0|||
163965504|NCT00578786|592246965|FG001|Overall Study|Not Otherwise Specified|4|||
163965505|NCT00578786|592246966|FG002|Overall Study|Not Otherwise Specified|1|||
163965506|NCT00578786|592246964|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
163965507|NCT00578786|592246965|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
163965508|NCT00578786|592246966|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
164196222|NCT01921517|593087480|FG001|Overall Study|Withdrawal by Subject|3|||
163965509|NCT00117507|592246973|FG000|Overall Study|Adverse Event|4|||
163965510|NCT00117507|592246973|FG000|Overall Study|Abnormal laboratory values|3|||
163965511|NCT00117507|592246973|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163965512|NCT00117507|592246973|FG000|Overall Study|Patient withdrew consent|4|||
163965513|NCT00117507|592246973|FG000|Overall Study|Death|3|||
163965514|NCT00866723|592246974|FG000|Overall Study|Withdrawal by Subject|1|||
163965515|NCT00866723|592246974|FG000|Overall Study|Disease Progression|4|||
163965516|NCT05105789|592246975|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
163965517|NCT01003990|592246979|FG000|Overall Study|Adverse Event|8|||
163965518|NCT01003990|592246980|FG001|Overall Study|Adverse Event|5|||
163965519|NCT01003990|592246981|FG002|Overall Study|Adverse Event|11|||
163965520|NCT01003990|592246979|FG000|Overall Study|Death|0|||
163965521|NCT01003990|592246980|FG001|Overall Study|Death|8|||
163965522|NCT01003990|592246981|FG002|Overall Study|Death|1|||
163965523|NCT01003990|592246979|FG000|Overall Study|Lack of Efficacy|10|||
163965524|NCT01003990|592246980|FG001|Overall Study|Lack of Efficacy|2|||
163965525|NCT01003990|592246981|FG002|Overall Study|Lack of Efficacy|3|||
163965526|NCT01003990|592246979|FG000|Overall Study|Lost to Follow-up|30|||
163965527|NCT01003990|592246980|FG001|Overall Study|Lost to Follow-up|12|||
163965528|NCT01003990|592246981|FG002|Overall Study|Lost to Follow-up|7|||
163965529|NCT01003990|592246979|FG000|Overall Study|Reasons Not Identified|14|||
163965530|NCT01003990|592246980|FG001|Overall Study|Reasons Not Identified|13|||
163965531|NCT01003990|592246981|FG002|Overall Study|Reasons Not Identified|8|||
163965532|NCT01003990|592246979|FG000|Overall Study|Poor/Non-compliance|4|||
163965533|NCT01003990|592246980|FG001|Overall Study|Poor/Non-compliance|3|||
163965534|NCT01003990|592246981|FG002|Overall Study|Poor/Non-compliance|2|||
163965535|NCT01003990|592246979|FG000|Overall Study|Pregnancy|10|||
163965536|NCT01003990|592246980|FG001|Overall Study|Pregnancy|2|||
163965537|NCT01003990|592246981|FG002|Overall Study|Pregnancy|4|||
163965538|NCT01003990|592246979|FG000|Overall Study|No Longer Met Study Criteria|4|||
163965539|NCT01003990|592246980|FG001|Overall Study|No Longer Met Study Criteria|1|||
163965540|NCT01003990|592246981|FG002|Overall Study|No Longer Met Study Criteria|0|||
163965541|NCT01003990|592246979|FG000|Overall Study|Subject Withdrew Consent|12|||
163965542|NCT01003990|592246980|FG001|Overall Study|Subject Withdrew Consent|5|||
163965543|NCT01003990|592246981|FG002|Overall Study|Subject Withdrew Consent|7|||
163965544|NCT01271803|592246982|FG000|Overall Study|Progressive disease|0|||
163965545|NCT01271803|592246983|FG001|Overall Study|Progressive disease|0|||
163965546|NCT01271803|592246984|FG002|Overall Study|Progressive disease|2|||
163965547|NCT01271803|592246982|FG000|Overall Study|Death|53|||
163965548|NCT01271803|592246983|FG001|Overall Study|Death|34|||
163965549|NCT01271803|592246984|FG002|Overall Study|Death|0|||
163965550|NCT01271803|592246982|FG000|Overall Study|Withdrawal by Subject|1|||
163965551|NCT01271803|592246983|FG001|Overall Study|Withdrawal by Subject|5|||
163965552|NCT01271803|592246984|FG002|Overall Study|Withdrawal by Subject|0|||
163965553|NCT01271803|592246982|FG000|Overall Study|Lost to Follow-up|1|||
163965554|NCT01271803|592246983|FG001|Overall Study|Lost to Follow-up|0|||
163965555|NCT01271803|592246984|FG002|Overall Study|Lost to Follow-up|0|||
163965556|NCT05211739|592246985|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
163965557|NCT05211739|592246986|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
163965558|NCT05211739|592246985|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
163965559|NCT05211739|592246986|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
163965560|NCT05211739|592246985|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
164196223|NCT01921517|593087479|FG000|Overall Study|Subject missed final imaging|1|||
164196224|NCT01921517|593087480|FG001|Overall Study|Subject missed final imaging|4|||
164196225|NCT03205150|593087481|FG000|Overall Study|Protocol deviation|1|||
164196226|NCT03205150|593087482|FG001|Overall Study|Protocol deviation|3|||
164196227|NCT03205150|593087483|FG002|Overall Study|Protocol deviation|0|||
164196228|NCT03205150|593087481|FG000|Overall Study|Patient/guardian decision|0|||
164196229|NCT03205150|593087482|FG001|Overall Study|Patient/guardian decision|3|||
164196230|NCT03205150|593087483|FG002|Overall Study|Patient/guardian decision|0|||
164196231|NCT03205150|593087481|FG000|Overall Study|Adverse Event|1|||
163965561|NCT05211739|592246986|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
163965562|NCT05211739|592246985|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
163965563|NCT05211739|592246986|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
164196232|NCT03205150|593087482|FG001|Overall Study|Adverse Event|1|||
164196233|NCT03205150|593087483|FG002|Overall Study|Adverse Event|1|||
163965564|NCT04178967|592246987|FG000|Induction Period|Adverse Event|4|||
163965565|NCT04178967|592246988|FG001|Induction Period|Adverse Event|6|||
163965566|NCT04178967|592246989|FG002|Induction Period|Adverse Event|0|||
163965567|NCT04178967|592246990|FG003|Induction Period|Adverse Event|0|||
163965568|NCT04178967|592246991|FG004|Induction Period|Adverse Event|0|||
163965569|NCT04178967|592246992|FG005|Induction Period|Adverse Event|0|||
163965570|NCT04178967|592246993|FG006|Induction Period|Adverse Event|0|||
163965571|NCT04178967|592246994|FG007|Induction Period|Adverse Event|0|||
163965572|NCT04178967|592246995|FG008|Induction Period|Adverse Event|0|||
164196234|NCT03205150|593087481|FG000|Overall Study|Lost to Follow-up|0|||
163965573|NCT04178967|592246996|FG009|Induction Period|Adverse Event|0|||
163965574|NCT04178967|592246997|FG010|Induction Period|Adverse Event|0|||
163965575|NCT04178967|592246987|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
163965576|NCT04178967|592246988|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
164196235|NCT03205150|593087482|FG001|Overall Study|Lost to Follow-up|0|||
164196236|NCT03205150|593087483|FG002|Overall Study|Lost to Follow-up|1|||
164196237|NCT01095835|593087484|FG000|Overall Study|Adverse Event|8|||
163965577|NCT04178967|592246989|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
163965578|NCT04178967|592246990|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
163965579|NCT04178967|592246991|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
163965580|NCT04178967|592246992|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
163965581|NCT04178967|592246993|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
163965582|NCT04178967|592246994|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
163965583|NCT04178967|592246995|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
163965584|NCT04178967|592246996|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
163965585|NCT04178967|592246997|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
163965586|NCT04178967|592246987|FG000|Induction Period|Lack of Efficacy|4|||
163965587|NCT04178967|592246988|FG001|Induction Period|Lack of Efficacy|1|||
163965588|NCT04178967|592246989|FG002|Induction Period|Lack of Efficacy|0|||
163965589|NCT04178967|592246990|FG003|Induction Period|Lack of Efficacy|0|||
163965590|NCT04178967|592246991|FG004|Induction Period|Lack of Efficacy|0|||
163965591|NCT04178967|592246992|FG005|Induction Period|Lack of Efficacy|0|||
163965592|NCT04178967|592246993|FG006|Induction Period|Lack of Efficacy|0|||
163965593|NCT04178967|592246994|FG007|Induction Period|Lack of Efficacy|0|||
163965594|NCT04178967|592246995|FG008|Induction Period|Lack of Efficacy|0|||
163965595|NCT04178967|592246996|FG009|Induction Period|Lack of Efficacy|0|||
163965596|NCT04178967|592246997|FG010|Induction Period|Lack of Efficacy|0|||
163965597|NCT04178967|592246987|FG000|Induction Period|Protocol Violation|0|||
163965598|NCT04178967|592246988|FG001|Induction Period|Protocol Violation|6|||
163965599|NCT04178967|592246989|FG002|Induction Period|Protocol Violation|0|||
163965600|NCT04178967|592246990|FG003|Induction Period|Protocol Violation|0|||
163965601|NCT04178967|592246991|FG004|Induction Period|Protocol Violation|0|||
163965602|NCT04178967|592246992|FG005|Induction Period|Protocol Violation|0|||
163965603|NCT04178967|592246993|FG006|Induction Period|Protocol Violation|0|||
163965604|NCT04178967|592246994|FG007|Induction Period|Protocol Violation|0|||
163965605|NCT04178967|592246995|FG008|Induction Period|Protocol Violation|0|||
163965606|NCT04178967|592246996|FG009|Induction Period|Protocol Violation|0|||
163965607|NCT04178967|592246997|FG010|Induction Period|Protocol Violation|0|||
163965608|NCT04178967|592246987|FG000|Induction Period|Withdrawal by Subject|6|||
163965609|NCT04178967|592246988|FG001|Induction Period|Withdrawal by Subject|4|||
163965610|NCT04178967|592246989|FG002|Induction Period|Withdrawal by Subject|0|||
163965611|NCT04178967|592246990|FG003|Induction Period|Withdrawal by Subject|0|||
163965612|NCT04178967|592246991|FG004|Induction Period|Withdrawal by Subject|0|||
164196238|NCT01095835|593087485|FG001|Overall Study|Adverse Event|6|||
164196239|NCT01095835|593087486|FG002|Overall Study|Adverse Event|6|||
164196240|NCT01095835|593087484|FG000|Overall Study|Lack of Efficacy|0|||
164196241|NCT01095835|593087485|FG001|Overall Study|Lack of Efficacy|1|||
164196242|NCT01095835|593087486|FG002|Overall Study|Lack of Efficacy|0|||
164196243|NCT01095835|593087484|FG000|Overall Study|Physician Decision|0|||
164196244|NCT01095835|593087485|FG001|Overall Study|Physician Decision|0|||
164196245|NCT01095835|593087486|FG002|Overall Study|Physician Decision|1|||
164196246|NCT01095835|593087484|FG000|Overall Study|Withdrawal by Subject|1|||
164196247|NCT01095835|593087485|FG001|Overall Study|Withdrawal by Subject|3|||
164196248|NCT01095835|593087486|FG002|Overall Study|Withdrawal by Subject|0|||
164196249|NCT01095835|593087484|FG000|Overall Study|Non study compliance|0|||
164196250|NCT01095835|593087485|FG001|Overall Study|Non study compliance|0|||
164196251|NCT01095835|593087486|FG002|Overall Study|Non study compliance|1|||
164196252|NCT01095835|593087484|FG000|Overall Study|Protocol Violation|1|||
164196253|NCT01095835|593087485|FG001|Overall Study|Protocol Violation|2|||
164196254|NCT01095835|593087486|FG002|Overall Study|Protocol Violation|0|||
164196255|NCT02486692|593087489|FG000|Overall Study|did not login for randomization|4|||
164196256|NCT02486692|593087490|FG001|Overall Study|did not login for randomization|7|||
164196257|NCT03028142|593087491|FG000|Overall Study|Adverse Event|1|||
164196258|NCT03028142|593087492|FG001|Overall Study|Adverse Event|1|||
164196259|NCT03028142|593087493|FG002|Overall Study|Adverse Event|0|||
163965613|NCT04178967|592246992|FG005|Induction Period|Withdrawal by Subject|0|||
163965614|NCT04178967|592246993|FG006|Induction Period|Withdrawal by Subject|0|||
163965615|NCT04178967|592246994|FG007|Induction Period|Withdrawal by Subject|0|||
163965616|NCT04178967|592246995|FG008|Induction Period|Withdrawal by Subject|0|||
163965617|NCT04178967|592246996|FG009|Induction Period|Withdrawal by Subject|0|||
163965618|NCT04178967|592246997|FG010|Induction Period|Withdrawal by Subject|0|||
163965619|NCT04178967|592246987|FG000|Induction Period|Lost to Follow-up|2|||
163965620|NCT04178967|592246988|FG001|Induction Period|Lost to Follow-up|0|||
163965621|NCT04178967|592246989|FG002|Induction Period|Lost to Follow-up|0|||
163965622|NCT04178967|592246990|FG003|Induction Period|Lost to Follow-up|0|||
164196260|NCT03028142|593087494|FG003|Overall Study|Adverse Event|0|||
164196261|NCT03028142|593087495|FG004|Overall Study|Adverse Event|0|||
163965623|NCT04178967|592246991|FG004|Induction Period|Lost to Follow-up|0|||
163965624|NCT04178967|592246992|FG005|Induction Period|Lost to Follow-up|0|||
163965625|NCT04178967|592246993|FG006|Induction Period|Lost to Follow-up|0|||
163965626|NCT04178967|592246994|FG007|Induction Period|Lost to Follow-up|0|||
163965627|NCT04178967|592246995|FG008|Induction Period|Lost to Follow-up|0|||
163965628|NCT04178967|592246996|FG009|Induction Period|Lost to Follow-up|0|||
163965629|NCT04178967|592246997|FG010|Induction Period|Lost to Follow-up|0|||
163965630|NCT04178967|592246987|FG000|Induction Period|Participant Missed Study Visits|0|||
163965631|NCT04178967|592246988|FG001|Induction Period|Participant Missed Study Visits|1|||
163965632|NCT04178967|592246989|FG002|Induction Period|Participant Missed Study Visits|0|||
163965633|NCT04178967|592246990|FG003|Induction Period|Participant Missed Study Visits|0|||
163965634|NCT04178967|592246991|FG004|Induction Period|Participant Missed Study Visits|0|||
163965635|NCT04178967|592246992|FG005|Induction Period|Participant Missed Study Visits|0|||
163965636|NCT04178967|592246993|FG006|Induction Period|Participant Missed Study Visits|0|||
163965637|NCT04178967|592246994|FG007|Induction Period|Participant Missed Study Visits|0|||
163965638|NCT04178967|592246995|FG008|Induction Period|Participant Missed Study Visits|0|||
163965639|NCT04178967|592246996|FG009|Induction Period|Participant Missed Study Visits|0|||
163965640|NCT04178967|592246997|FG010|Induction Period|Participant Missed Study Visits|0|||
163965641|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
164196262|NCT03028142|593087496|FG005|Overall Study|Adverse Event|1|||
164196263|NCT03028142|593087491|FG000|Overall Study|Withdrawal by Subject|0|||
164196264|NCT03028142|593087492|FG001|Overall Study|Withdrawal by Subject|0|||
164196265|NCT03028142|593087493|FG002|Overall Study|Withdrawal by Subject|0|||
164196266|NCT03028142|593087494|FG003|Overall Study|Withdrawal by Subject|0|||
164196267|NCT03028142|593087495|FG004|Overall Study|Withdrawal by Subject|1|||
164196268|NCT03028142|593087496|FG005|Overall Study|Withdrawal by Subject|0|||
164196269|NCT00116688|593087501|FG000|Overall Study|Protocol deviation|1|||
164196270|NCT00116688|593087502|FG001|Overall Study|Protocol deviation|0|||
164196271|NCT00116688|593087501|FG000|Overall Study|Noncompliance|3|||
164196272|NCT00116688|593087502|FG001|Overall Study|Noncompliance|1|||
164196273|NCT00116688|593087501|FG000|Overall Study|Adverse Event|11|||
164196274|NCT00116688|593087502|FG001|Overall Study|Adverse Event|0|||
164196275|NCT00116688|593087501|FG000|Overall Study|Withdrawal by Subject|26|||
164196276|NCT00116688|593087502|FG001|Overall Study|Withdrawal by Subject|2|||
164196277|NCT00116688|593087501|FG000|Overall Study|Requirement for alternative therapy|11|||
164196278|NCT00116688|593087502|FG001|Overall Study|Requirement for alternative therapy|1|||
164196279|NCT00116688|593087501|FG000|Overall Study|Physician Decision|7|||
164196280|NCT00116688|593087502|FG001|Overall Study|Physician Decision|0|||
164196281|NCT00116688|593087501|FG000|Overall Study|Lost to Follow-up|3|||
164196282|NCT00116688|593087502|FG001|Overall Study|Lost to Follow-up|0|||
164196283|NCT00116688|593087501|FG000|Overall Study|Death|15|||
164196284|NCT00116688|593087502|FG001|Overall Study|Death|0|||
164196285|NCT00116688|593087501|FG000|Overall Study|Protocol-specified criteria|3|||
164196286|NCT00116688|593087502|FG001|Overall Study|Protocol-specified criteria|0|||
164196287|NCT00116688|593087501|FG000|Overall Study|Pregnancy|1|||
164196288|NCT00116688|593087502|FG001|Overall Study|Pregnancy|0|||
164196289|NCT00116688|593087501|FG000|Overall Study|Other|11|||
163965642|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965643|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965644|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965645|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965646|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
163965647|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
163965648|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
164196290|NCT00116688|593087502|FG001|Overall Study|Other|0|||
164196291|NCT01775670|593087507|FG000|Overall Study|Lost to Follow-up|1|||
164196292|NCT01775670|593087508|FG001|Overall Study|Lost to Follow-up|1|||
164196293|NCT01298700|593087509|FG000|Overall Study|Adverse Event|50|||
164196294|NCT01298700|593087510|FG001|Overall Study|Adverse Event|51|||
164196295|NCT01298700|593087509|FG000|Overall Study|Lack of Efficacy|9|||
164196296|NCT01298700|593087510|FG001|Overall Study|Lack of Efficacy|14|||
163965649|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965650|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965651|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
163965652|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164196297|NCT01298700|593087509|FG000|Overall Study|Lost to Follow-up|5|||
164196298|NCT01298700|593087510|FG001|Overall Study|Lost to Follow-up|2|||
164196299|NCT01298700|593087509|FG000|Overall Study|Withdrawal by Subject|12|||
164196300|NCT01298700|593087510|FG001|Overall Study|Withdrawal by Subject|9|||
164196301|NCT01298700|593087509|FG000|Overall Study|Protocol Violation|6|||
164196302|NCT01298700|593087510|FG001|Overall Study|Protocol Violation|4|||
164196303|NCT01298700|593087509|FG000|Overall Study|Other Miscellaneous Reasons|16|||
164196304|NCT01298700|593087510|FG001|Overall Study|Other Miscellaneous Reasons|15|||
164196305|NCT01298700|593087509|FG000|Overall Study|Did not Receive Study Drug|3|||
164196306|NCT01298700|593087510|FG001|Overall Study|Did not Receive Study Drug|5|||
163965653|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965654|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965655|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163859481|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
163859482|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859483|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859484|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859485|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859486|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859487|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859488|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859489|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859490|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859491|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
163859492|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859493|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859494|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859495|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859496|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859497|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
163859498|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
163859499|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859500|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859501|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859502|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859503|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859504|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859505|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859506|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
163859507|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
163859508|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859509|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859510|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859511|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859512|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859513|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859514|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859515|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
163859516|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
163859517|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859518|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859519|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859520|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859521|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859522|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859523|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859524|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
163859525|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859526|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
163859527|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
163859528|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859529|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859530|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859531|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859532|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859533|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
163859534|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
163859535|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
163859536|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163859537|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163859538|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
164196307|NCT04006145|593087513|FG000|Overall Study|Lost to Follow-up|0|||
164196308|NCT04006145|593087514|FG001|Overall Study|Lost to Follow-up|1|||
164196309|NCT04006145|593087513|FG000|Overall Study|Other|1|||
164196310|NCT04006145|593087514|FG001|Overall Study|Other|2|||
163965656|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965657|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
163965658|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965659|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965660|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965661|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965662|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
163965663|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965664|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965665|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965666|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
163965667|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965668|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965669|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965670|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965671|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965672|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965673|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
163965674|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965675|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965676|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965677|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965678|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965679|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965680|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
163965681|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965682|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965683|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965684|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
163965685|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965686|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965687|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965688|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965689|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
163965690|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
163965691|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965692|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
163965693|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965694|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965695|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
163965696|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163965697|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163965698|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163965699|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163965700|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163965701|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
163965702|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
163965703|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
163965704|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163965705|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163965706|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
163965707|NCT04178967|592246987|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965708|NCT04178967|592246988|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965709|NCT04178967|592246989|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965710|NCT04178967|592246990|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
163965711|NCT04178967|592246991|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965712|NCT04178967|592246992|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
163965713|NCT04178967|592246993|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
164196311|NCT01001429|593087517|FG000|Overall Study|surgery cancelled|0|||
164196312|NCT01001429|593087518|FG001|Overall Study|surgery cancelled|1|||
164196313|NCT00010257|593087519|FG000|Overall Study|Withdrawal by Subject|1|||
164196314|NCT00010257|593087520|FG001|Overall Study|Withdrawal by Subject|0|||
164196315|NCT02812186|593087521|FG000|Period 1|Post randomization screen failure|5|||
164196316|NCT02812186|593087522|FG001|Period 1|Post randomization screen failure|9|||
164196317|NCT02812186|593087521|FG000|Period 1|nonevaluable data sets|6|||
164196318|NCT02812186|593087522|FG001|Period 1|nonevaluable data sets|6|||
164196319|NCT00643760|593087525|FG000|Overall Study|Adverse Event|11|||
164196320|NCT00643760|593087526|FG001|Overall Study|Adverse Event|5|||
164196321|NCT00643760|593087527|FG002|Overall Study|Adverse Event|12|||
164196322|NCT00643760|593087528|FG003|Overall Study|Adverse Event|21|||
164196323|NCT00643760|593087529|FG004|Overall Study|Adverse Event|6|||
164196324|NCT00643760|593087525|FG000|Overall Study|Lack of Efficacy|3|||
164196325|NCT00643760|593087526|FG001|Overall Study|Lack of Efficacy|1|||
164196326|NCT00643760|593087527|FG002|Overall Study|Lack of Efficacy|0|||
164196327|NCT00643760|593087528|FG003|Overall Study|Lack of Efficacy|4|||
164196328|NCT00643760|593087529|FG004|Overall Study|Lack of Efficacy|3|||
164196329|NCT00643760|593087525|FG000|Overall Study|Protocol Violation|7|||
164196330|NCT00643760|593087526|FG001|Overall Study|Protocol Violation|6|||
164196331|NCT00643760|593087527|FG002|Overall Study|Protocol Violation|4|||
164196332|NCT00643760|593087528|FG003|Overall Study|Protocol Violation|4|||
164196333|NCT00643760|593087529|FG004|Overall Study|Protocol Violation|6|||
164196334|NCT00643760|593087525|FG000|Overall Study|Lost to Follow-up|6|||
164196335|NCT00643760|593087526|FG001|Overall Study|Lost to Follow-up|2|||
164196336|NCT00643760|593087527|FG002|Overall Study|Lost to Follow-up|1|||
164196337|NCT00643760|593087528|FG003|Overall Study|Lost to Follow-up|3|||
164196338|NCT00643760|593087529|FG004|Overall Study|Lost to Follow-up|3|||
164196339|NCT00643760|593087525|FG000|Overall Study|Investigator Discretion|0|||
164196340|NCT00643760|593087526|FG001|Overall Study|Investigator Discretion|0|||
164196341|NCT00643760|593087527|FG002|Overall Study|Investigator Discretion|0|||
164196342|NCT00643760|593087528|FG003|Overall Study|Investigator Discretion|2|||
164196343|NCT00643760|593087529|FG004|Overall Study|Investigator Discretion|0|||
164196344|NCT00643760|593087525|FG000|Overall Study|Withdrawal by Subject|3|||
164196345|NCT00643760|593087526|FG001|Overall Study|Withdrawal by Subject|1|||
164196346|NCT00643760|593087527|FG002|Overall Study|Withdrawal by Subject|2|||
164196347|NCT00643760|593087528|FG003|Overall Study|Withdrawal by Subject|4|||
164196348|NCT00643760|593087529|FG004|Overall Study|Withdrawal by Subject|1|||
164196349|NCT00789321|593087533|FG000|Overall Study|Adverse Event|0|||
164196350|NCT00789321|593087534|FG001|Overall Study|Adverse Event|1|||
164196351|NCT00104052|593087535|FG000|Overall Study|Adverse Event|1|||
164196352|NCT00104052|593087535|FG000|Overall Study|Lack of Efficacy|26|||
164196353|NCT00104052|593087535|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
164196354|NCT01162343|593087536|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
164196355|NCT01162343|593087536|FG000|Overall Study|Refused psychiatrist assessment|12|||
164196356|NCT03652818|593087537|FG000|Overall Study|Adverse Event|1|||
164196357|NCT03652818|593087538|FG001|Overall Study|Adverse Event|0|||
164196358|NCT03652818|593087539|FG002|Overall Study|Adverse Event|0|||
164196359|NCT03652818|593087540|FG003|Overall Study|Adverse Event|0|||
164196360|NCT03652818|593087541|FG004|Overall Study|Adverse Event|0|||
164196361|NCT03652818|593087537|FG000|Overall Study|Physician Decision|1|||
164196362|NCT03652818|593087538|FG001|Overall Study|Physician Decision|0|||
164196363|NCT03652818|593087539|FG002|Overall Study|Physician Decision|0|||
164196364|NCT03652818|593087540|FG003|Overall Study|Physician Decision|0|||
164196365|NCT03652818|593087541|FG004|Overall Study|Physician Decision|0|||
164196366|NCT03652818|593087537|FG000|Overall Study|Lost to Follow-up|0|||
164196367|NCT03652818|593087538|FG001|Overall Study|Lost to Follow-up|1|||
164196368|NCT03652818|593087539|FG002|Overall Study|Lost to Follow-up|2|||
164196369|NCT03652818|593087540|FG003|Overall Study|Lost to Follow-up|1|||
164196370|NCT03652818|593087541|FG004|Overall Study|Lost to Follow-up|1|||
164196371|NCT01783743|593087546|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
164196372|NCT01783743|593087547|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
164196373|NCT01783743|593087546|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
164196374|NCT01783743|593087547|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
164196375|NCT01783743|593087546|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
164196376|NCT01783743|593087547|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
164196377|NCT02771275|593087548|FG000|Overall Study|Reoperation|3|||
164196378|NCT02771275|593087548|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
163965714|NCT04178967|592246994|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
164196379|NCT03322293|593087549|FG000|Overall Study|Lost to Follow-up|0|||
164196380|NCT03322293|593087550|FG001|Overall Study|Lost to Follow-up|0|||
164196381|NCT03322293|593087551|FG002|Overall Study|Lost to Follow-up|1|||
164196382|NCT01239797|593087554|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
164196383|NCT01239797|593087555|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
164196384|NCT01239797|593087554|FG000|Randomized Participants|Participant withdrew consent|1|||
164196385|NCT01239797|593087555|FG001|Randomized Participants|Participant withdrew consent|7|||
164196386|NCT01239797|593087554|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
164196387|NCT01239797|593087555|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
164196388|NCT01239797|593087554|FG000|Treated Participants|Disease progression|185|||
163965715|NCT04178967|592246995|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965716|NCT04178967|592246996|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965717|NCT04178967|592246997|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
163965718|NCT04178967|592246987|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965719|NCT04178967|592246988|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965720|NCT04178967|592246989|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965721|NCT04178967|592246990|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965722|NCT04178967|592246991|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965723|NCT04178967|592246992|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965724|NCT04178967|592246993|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965725|NCT04178967|592246994|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965726|NCT04178967|592246995|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
163965727|NCT04178967|592246996|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
163965728|NCT04178967|592246997|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
163965729|NCT04178967|592246987|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965730|NCT04178967|592246988|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965731|NCT04178967|592246989|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965732|NCT04178967|592246990|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965733|NCT04178967|592246991|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965734|NCT04178967|592246992|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965735|NCT04178967|592246993|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965736|NCT04178967|592246994|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
163965737|NCT04178967|592246995|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
163965738|NCT04178967|592246996|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
163965739|NCT04178967|592246997|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
163965740|NCT04178967|592246987|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965741|NCT04178967|592246988|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965742|NCT04178967|592246989|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965743|NCT04178967|592246990|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965744|NCT04178967|592246991|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965745|NCT04178967|592246992|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965746|NCT04178967|592246993|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965747|NCT04178967|592246994|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965748|NCT04178967|592246995|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965749|NCT04178967|592246996|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
163965750|NCT04178967|592246997|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
163965751|NCT04178967|592246987|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965752|NCT04178967|592246988|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965753|NCT04178967|592246989|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965754|NCT04178967|592246990|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965755|NCT04178967|592246991|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965756|NCT04178967|592246992|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965757|NCT04178967|592246993|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965758|NCT04178967|592246994|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
163965759|NCT04178967|592246995|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
163965760|NCT04178967|592246996|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
163965761|NCT04178967|592246997|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
163965762|NCT04178967|592246987|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965763|NCT04178967|592246988|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965764|NCT04178967|592246989|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965765|NCT04178967|592246990|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965766|NCT04178967|592246991|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965767|NCT04178967|592246992|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965768|NCT04178967|592246993|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965769|NCT04178967|592246994|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965770|NCT04178967|592246995|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965771|NCT04178967|592246996|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
163965772|NCT04178967|592246997|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
163965773|NCT04178967|592246987|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965774|NCT04178967|592246988|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965775|NCT04178967|592246989|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965776|NCT04178967|592246990|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965777|NCT04178967|592246991|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965778|NCT04178967|592246992|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
164134882|NCT02132754|592857397|FG030|Overall Study|Excluded Medication|0|||
164134883|NCT02132754|592857398|FG031|Overall Study|Excluded Medication|0|||
164196389|NCT01239797|593087555|FG001|Treated Participants|Disease progression|185|||
163859539|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163859540|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163859541|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163859542|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
163859543|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
164196390|NCT01239797|593087554|FG000|Treated Participants|Study drug toxicity|39|||
164196391|NCT01239797|593087555|FG001|Treated Participants|Study drug toxicity|45|||
164196392|NCT01239797|593087554|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
164196393|NCT01239797|593087555|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
164196394|NCT01239797|593087554|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
164196395|NCT01239797|593087555|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
164196396|NCT01239797|593087554|FG000|Treated Participants|Administrative reason by sponsor|13|||
164196397|NCT01239797|593087555|FG001|Treated Participants|Administrative reason by sponsor|4|||
164196398|NCT01239797|593087554|FG000|Treated Participants|Other reasons|14|||
164196399|NCT01239797|593087555|FG001|Treated Participants|Other reasons|14|||
164196400|NCT01239797|593087554|FG000|Treated Participants|Participant withdrew consent|6|||
164196401|NCT01239797|593087555|FG001|Treated Participants|Participant withdrew consent|11|||
164196402|NCT01239797|593087554|FG000|Treated Participants|Death|1|||
164196403|NCT01239797|593087555|FG001|Treated Participants|Death|1|||
164196404|NCT01239797|593087554|FG000|Treated Participants|Participant no longer meets study criteria|1|||
164196405|NCT01239797|593087555|FG001|Treated Participants|Participant no longer meets study criteria|1|||
164196406|NCT01239797|593087554|FG000|Treated Participants|Poor/non-compliance|0|||
164196407|NCT01239797|593087555|FG001|Treated Participants|Poor/non-compliance|1|||
164196408|NCT00853762|593087556|FG000|Overall Study|Premature Termination|16|||
164196409|NCT00853762|593087557|FG001|Overall Study|Premature Termination|15|||
164196410|NCT00853762|593087558|FG002|Overall Study|Premature Termination|14|||
164196411|NCT00853762|593087559|FG003|Overall Study|Premature Termination|21|||
164196412|NCT00853762|593087556|FG000|Overall Study|Protocol Violation|0|||
164196413|NCT00853762|593087557|FG001|Overall Study|Protocol Violation|0|||
164196414|NCT00853762|593087558|FG002|Overall Study|Protocol Violation|0|||
164196415|NCT00853762|593087559|FG003|Overall Study|Protocol Violation|1|||
164196416|NCT00853762|593087556|FG000|Overall Study|Withdrawal by Subject|0|||
164196417|NCT00853762|593087557|FG001|Overall Study|Withdrawal by Subject|0|||
164196418|NCT00853762|593087558|FG002|Overall Study|Withdrawal by Subject|1|||
164196419|NCT00853762|593087559|FG003|Overall Study|Withdrawal by Subject|0|||
164196420|NCT00853762|593087556|FG000|Overall Study|Other|0|||
164196421|NCT00853762|593087557|FG001|Overall Study|Other|2|||
164196422|NCT00853762|593087558|FG002|Overall Study|Other|0|||
164196423|NCT00853762|593087559|FG003|Overall Study|Other|0|||
164196424|NCT00853762|593087556|FG000|Overall Study|Randomised but not Treated|0|||
164196425|NCT00853762|593087557|FG001|Overall Study|Randomised but not Treated|2|||
164196426|NCT00853762|593087558|FG002|Overall Study|Randomised but not Treated|2|||
164196427|NCT00853762|593087559|FG003|Overall Study|Randomised but not Treated|0|||
164196428|NCT01418339|593087562|FG000|Overall Study|Adverse Event|5|||
164196429|NCT01418339|593087563|FG001|Overall Study|Adverse Event|2|||
164196430|NCT01418339|593087562|FG000|Overall Study|Subject Withdrew Consent|1|||
164196431|NCT01418339|593087563|FG001|Overall Study|Subject Withdrew Consent|2|||
164196432|NCT01418339|593087562|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
164196433|NCT01418339|593087563|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
164196434|NCT02219685|593087564|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
164196435|NCT02219685|593087565|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
164196436|NCT02219685|593087564|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
164196437|NCT02219685|593087565|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
164196438|NCT02869789|593087566|FG000|Overall Study|Disease progression|184|||
164196439|NCT02869789|593087567|FG001|Overall Study|Disease progression|109|||
164196440|NCT02869789|593087568|FG002|Overall Study|Disease progression|260|||
164196441|NCT02869789|593087569|FG003|Overall Study|Disease progression|19|||
164196442|NCT02869789|593087566|FG000|Overall Study|Study drug toxicity|90|||
164196443|NCT02869789|593087567|FG001|Overall Study|Study drug toxicity|32|||
164196444|NCT02869789|593087568|FG002|Overall Study|Study drug toxicity|55|||
164196445|NCT02869789|593087569|FG003|Overall Study|Study drug toxicity|14|||
164196446|NCT02869789|593087566|FG000|Overall Study|Death|7|||
164196447|NCT02869789|593087567|FG001|Overall Study|Death|3|||
164196448|NCT02869789|593087568|FG002|Overall Study|Death|5|||
164196449|NCT02869789|593087569|FG003|Overall Study|Death|1|||
164196450|NCT02869789|593087566|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
164196451|NCT02869789|593087567|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
164196452|NCT02869789|593087568|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
164196453|NCT02869789|593087569|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
164196454|NCT02869789|593087566|FG000|Overall Study|Participant request to discontinue study treatment|10|||
164196455|NCT02869789|593087567|FG001|Overall Study|Participant request to discontinue study treatment|5|||
164196456|NCT02869789|593087568|FG002|Overall Study|Participant request to discontinue study treatment|5|||
164196457|NCT02869789|593087569|FG003|Overall Study|Participant request to discontinue study treatment|3|||
164196458|NCT02869789|593087566|FG000|Overall Study|Withdrawal by Subject|5|||
164196459|NCT02869789|593087567|FG001|Overall Study|Withdrawal by Subject|2|||
164196460|NCT02869789|593087568|FG002|Overall Study|Withdrawal by Subject|7|||
164196461|NCT02869789|593087569|FG003|Overall Study|Withdrawal by Subject|2|||
164196462|NCT02869789|593087566|FG000|Overall Study|Lost to Follow-up|0|||
164196463|NCT02869789|593087567|FG001|Overall Study|Lost to Follow-up|0|||
164196464|NCT02869789|593087568|FG002|Overall Study|Lost to Follow-up|2|||
164196465|NCT02869789|593087569|FG003|Overall Study|Lost to Follow-up|0|||
164196466|NCT02869789|593087566|FG000|Overall Study|Maximum clinical benefit|5|||
164196467|NCT02869789|593087567|FG001|Overall Study|Maximum clinical benefit|2|||
164196468|NCT02869789|593087568|FG002|Overall Study|Maximum clinical benefit|1|||
164196469|NCT02869789|593087569|FG003|Overall Study|Maximum clinical benefit|0|||
164196470|NCT02869789|593087566|FG000|Overall Study|Poor/Non-compliance|0|||
164196471|NCT02869789|593087567|FG001|Overall Study|Poor/Non-compliance|2|||
164196472|NCT02869789|593087568|FG002|Overall Study|Poor/Non-compliance|1|||
164196473|NCT02869789|593087569|FG003|Overall Study|Poor/Non-compliance|0|||
164196474|NCT02869789|593087566|FG000|Overall Study|Participant no longer meets study criteria|0|||
164196475|NCT02869789|593087567|FG001|Overall Study|Participant no longer meets study criteria|1|||
164196476|NCT02869789|593087568|FG002|Overall Study|Participant no longer meets study criteria|1|||
164196477|NCT02869789|593087569|FG003|Overall Study|Participant no longer meets study criteria|0|||
164196478|NCT02869789|593087566|FG000|Overall Study|Administrative reason by sponsor|0|||
164196479|NCT02869789|593087567|FG001|Overall Study|Administrative reason by sponsor|0|||
164196480|NCT02869789|593087568|FG002|Overall Study|Administrative reason by sponsor|1|||
163859544|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
163859545|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859546|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859547|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859548|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859549|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859550|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859551|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
163859552|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859553|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
163859554|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859555|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859556|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859557|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859558|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859559|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859560|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
163859561|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859562|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859563|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
163859564|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859565|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859566|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859567|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859568|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859569|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
163859570|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859571|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859572|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
163859573|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859574|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859575|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859576|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859577|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859578|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
163859579|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859580|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
164196481|NCT02869789|593087569|FG003|Overall Study|Administrative reason by sponsor|0|||
164196482|NCT02869789|593087566|FG000|Overall Study|Other reasons|4|||
164196483|NCT02869789|593087567|FG001|Overall Study|Other reasons|8|||
164196484|NCT02869789|593087568|FG002|Overall Study|Other reasons|6|||
163859581|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
163859582|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859583|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859584|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859585|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859586|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859587|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
163859588|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859589|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859590|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859591|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859592|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859593|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859594|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
163859595|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859596|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
163859597|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
163859598|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
163859599|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859600|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859601|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859602|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859603|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859604|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859605|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
163859606|NCT03598790|591855943|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859607|NCT03598790|591855944|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859608|NCT03598790|591855945|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
163859609|NCT03598790|591855946|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859610|NCT03598790|591855947|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859611|NCT03598790|591855948|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859612|NCT03598790|591855949|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859613|NCT03598790|591855950|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859614|NCT03598790|591855951|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
163859615|NCT03598790|591855943|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163859616|NCT03598790|591855944|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163859617|NCT03598790|591855945|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163859618|NCT03598790|591855946|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
163859619|NCT03598790|591855947|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
163859620|NCT03598790|591855948|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
163859621|NCT03598790|591855949|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163859622|NCT03598790|591855950|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163859623|NCT03598790|591855951|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163859624|NCT03598790|591855943|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859625|NCT03598790|591855944|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859626|NCT03598790|591855945|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859627|NCT03598790|591855946|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
163859628|NCT03598790|591855947|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859629|NCT03598790|591855948|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859630|NCT03598790|591855949|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859631|NCT03598790|591855950|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859632|NCT03598790|591855951|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
163859633|NCT03598790|591855943|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859634|NCT03598790|591855944|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859635|NCT03598790|591855945|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859636|NCT03598790|591855946|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
163859637|NCT03598790|591855947|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859638|NCT03598790|591855948|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859639|NCT03598790|591855949|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859640|NCT03598790|591855950|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859641|NCT03598790|591855951|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163859642|NCT03598790|591855943|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859643|NCT03598790|591855944|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859644|NCT03598790|591855945|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859645|NCT03598790|591855946|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
163859646|NCT03598790|591855947|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
163859647|NCT03598790|591855948|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859648|NCT03598790|591855949|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859649|NCT03598790|591855950|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859650|NCT03598790|591855951|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
163859651|NCT03598790|591855943|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163859652|NCT03598790|591855944|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163965779|NCT04178967|592246993|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163859653|NCT03598790|591855945|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163859654|NCT03598790|591855946|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
163859655|NCT03598790|591855947|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163859656|NCT03598790|591855948|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163965780|NCT04178967|592246994|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965781|NCT04178967|592246995|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163859657|NCT03598790|591855949|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163859658|NCT03598790|591855950|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163859659|NCT03598790|591855951|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
163965782|NCT04178967|592246996|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
163965783|NCT04178967|592246997|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
163965784|NCT01975428|592247001|FG000|Overall Study|Lost to Follow-up|17|||
163965785|NCT01975428|592247002|FG001|Overall Study|Lost to Follow-up|4|||
163965786|NCT01975428|592247001|FG000|Overall Study|Withdrawal by Subject|3|||
163965787|NCT01975428|592247002|FG001|Overall Study|Withdrawal by Subject|10|||
163965788|NCT02187809|592247003|FG000|Overall Study|The study was terminated|3|||
163965789|NCT00628251|592247004|FG000|Randomised Part|Withdrawal by Subject|0|||
163965790|NCT00628251|592247005|FG001|Randomised Part|Withdrawal by Subject|0|||
163965791|NCT00628251|592247006|FG002|Randomised Part|Withdrawal by Subject|1|||
163965792|NCT00628251|592247004|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
163965793|NCT00628251|592247005|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
163965794|NCT00628251|592247006|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
163965795|NCT00628251|592247004|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
163965796|NCT00628251|592247005|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
163965797|NCT00628251|592247006|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
163965798|NCT00628251|592247004|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
163965799|NCT00628251|592247005|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
163965800|NCT00628251|592247006|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
163965801|NCT00628251|592247004|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
163965802|NCT00628251|592247005|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
163965803|NCT00628251|592247006|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
163965804|NCT00628251|592247004|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
163965805|NCT00628251|592247005|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
163965806|NCT00628251|592247006|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
163965807|NCT01807923|592247010|FG000|Overall Study|Adverse Event|2|||
163965808|NCT01807923|592247011|FG001|Overall Study|Adverse Event|1|||
163965809|NCT01807923|592247012|FG002|Overall Study|Adverse Event|2|||
163965810|NCT01807923|592247010|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
163965811|NCT01807923|592247011|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
163965812|NCT01807923|592247012|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
163965813|NCT01807923|592247010|FG000|Overall Study|Physician Decision|0|||
163965814|NCT01807923|592247011|FG001|Overall Study|Physician Decision|0|||
163965815|NCT01807923|592247012|FG002|Overall Study|Physician Decision|1|||
163965816|NCT01807923|592247010|FG000|Overall Study|Not Eligible (Genotype)|0|||
163965817|NCT01807923|592247011|FG001|Overall Study|Not Eligible (Genotype)|0|||
163965818|NCT01807923|592247012|FG002|Overall Study|Not Eligible (Genotype)|1|||
163965819|NCT01807923|592247010|FG000|Overall Study|Randomized But Not Treated|3|||
163965820|NCT01807923|592247011|FG001|Overall Study|Randomized But Not Treated|2|||
163859660|NCT04018066|591855953|FG000|Overall Study|participants started taking medications during the study period|3|||
163859661|NCT04018066|591855953|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
163859662|NCT03568318|591855954|FG000|Overall Study|Adverse Event|3|||
163859663|NCT03568318|591855955|FG001|Overall Study|Adverse Event|1|||
163859664|NCT03568318|591855956|FG002|Overall Study|Adverse Event|1|||
163859665|NCT03568318|591855957|FG003|Overall Study|Adverse Event|0|||
163859666|NCT03568318|591855958|FG004|Overall Study|Adverse Event|1|||
163859667|NCT03568318|591855959|FG005|Overall Study|Adverse Event|0|||
163859668|NCT03568318|591855954|FG000|Overall Study|Withdrawal by Subject|6|||
163859669|NCT03568318|591855955|FG001|Overall Study|Withdrawal by Subject|5|||
163859670|NCT03568318|591855956|FG002|Overall Study|Withdrawal by Subject|2|||
163859671|NCT03568318|591855957|FG003|Overall Study|Withdrawal by Subject|1|||
163859672|NCT03568318|591855958|FG004|Overall Study|Withdrawal by Subject|0|||
163859673|NCT03568318|591855959|FG005|Overall Study|Withdrawal by Subject|0|||
163859674|NCT03568318|591855954|FG000|Overall Study|Lost to Follow-up|3|||
163859675|NCT03568318|591855955|FG001|Overall Study|Lost to Follow-up|2|||
163859676|NCT03568318|591855956|FG002|Overall Study|Lost to Follow-up|2|||
163859677|NCT03568318|591855957|FG003|Overall Study|Lost to Follow-up|2|||
163859678|NCT03568318|591855958|FG004|Overall Study|Lost to Follow-up|1|||
163859679|NCT03568318|591855959|FG005|Overall Study|Lost to Follow-up|0|||
163859680|NCT03568318|591855954|FG000|Overall Study|Other|3|||
163859681|NCT03568318|591855955|FG001|Overall Study|Other|1|||
163859682|NCT03568318|591855956|FG002|Overall Study|Other|3|||
163859683|NCT03568318|591855957|FG003|Overall Study|Other|0|||
163859684|NCT03568318|591855958|FG004|Overall Study|Other|0|||
163859685|NCT03568318|591855959|FG005|Overall Study|Other|0|||
163859686|NCT03568318|591855954|FG000|Overall Study|Ongoing at Time of Analysis|5|||
164196485|NCT02869789|593087569|FG003|Overall Study|Other reasons|0|||
163859687|NCT03568318|591855955|FG001|Overall Study|Ongoing at Time of Analysis|3|||
163859688|NCT03568318|591855956|FG002|Overall Study|Ongoing at Time of Analysis|2|||
163859689|NCT03568318|591855957|FG003|Overall Study|Ongoing at Time of Analysis|1|||
164196486|NCT00297648|593087571|FG000|Overall Study|Adverse Event|13|||
164196487|NCT00297648|593087571|FG000|Overall Study|Lack of Efficacy|18|||
164196488|NCT00297648|593087571|FG000|Overall Study|Lost to Follow-up|1|||
164196489|NCT00297648|593087571|FG000|Overall Study|Withdrawal by Subject|3|||
164196490|NCT00297648|593087571|FG000|Overall Study|Other: Incompliance|1|||
164196491|NCT01746862|593087572|FG000|Overall Study|Withdrawal by Subject|1|||
164196492|NCT01746862|593087573|FG001|Overall Study|Withdrawal by Subject|1|||
164196493|NCT01746862|593087572|FG000|Overall Study|Protocol Violation|1|||
164196494|NCT01746862|593087573|FG001|Overall Study|Protocol Violation|0|||
164196495|NCT01746862|593087572|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
164196496|NCT01746862|593087573|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
164196497|NCT01746862|593087572|FG000|Overall Study|Entered puberty during the study|1|||
164196498|NCT01746862|593087573|FG001|Overall Study|Entered puberty during the study|0|||
164196499|NCT04742673|593087574|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
164196500|NCT04742673|593087575|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
164196501|NCT03243305|593087576|FG000|Overall Study|Lost to Follow-up|250|||
164196502|NCT03243305|593087576|FG000|Overall Study|Withdrawal by Subject|170|||
164196503|NCT03243305|593087576|FG000|Overall Study|Pregnancy|104|||
164196504|NCT03243305|593087576|FG000|Overall Study|Non-Compliance with Study Drug|38|||
164196505|NCT03243305|593087576|FG000|Overall Study|Adverse Event|23|||
164196506|NCT03243305|593087576|FG000|Overall Study|No sexually active|26|||
164196507|NCT03243305|593087576|FG000|Overall Study|Physician Decision|22|||
164196508|NCT03243305|593087576|FG000|Overall Study|Protocol Violation|22|||
164196509|NCT03243305|593087576|FG000|Overall Study|Study method no longer primary method|12|||
164196510|NCT03243305|593087576|FG000|Overall Study|Study Terminated by Sponsor|1|||
164196511|NCT03243305|593087576|FG000|Overall Study|Early terminations|267|||
164196512|NCT02689804|593087577|FG000|Overall Study|Withdrawal by Subject|2|||
164196513|NCT02689804|593087578|FG001|Overall Study|Withdrawal by Subject|0|||
164196514|NCT00227539|593087579|FG000|Overall Study|Protocol Violation|1|||
164196515|NCT00673257|593087580|FG000|Overall Study|Withdrawal by Subject|4|||
164196516|NCT00673257|593087580|FG000|Overall Study|Unable to obtain specimen|1|||
164196517|NCT00570401|593087581|FG000|Overall Study|Adverse Event|2|||
164196518|NCT00792909|593087584|FG000|Overall Study|Withdrawal by Subject|0|||
164196519|NCT00792909|593087585|FG001|Overall Study|Withdrawal by Subject|1|||
164196520|NCT00792909|593087586|FG002|Overall Study|Withdrawal by Subject|0|||
164196521|NCT04157088|593087587|FG000|Overall Study|Study terminated by sponsor|23|||
164196522|NCT04157088|593087587|FG000|Overall Study|Withdrawal by Subject|4|||
164196523|NCT04157088|593087587|FG000|Overall Study|Lost to Follow-up|2|||
164196524|NCT04157088|593087587|FG000|Overall Study|Death|1|||
164196525|NCT00810199|593087588|FG000|Overall Study|Adverse Event|24|||
164196526|NCT00810199|593087589|FG001|Overall Study|Adverse Event|26|||
164196527|NCT00810199|593087588|FG000|Overall Study|Death|4|||
164196528|NCT00810199|593087589|FG001|Overall Study|Death|6|||
164196529|NCT00810199|593087588|FG000|Overall Study|Withdrew consent|9|||
164196530|NCT00810199|593087589|FG001|Overall Study|Withdrew consent|12|||
163859690|NCT03568318|591855958|FG004|Overall Study|Ongoing at Time of Analysis|0|||
163859691|NCT03568318|591855959|FG005|Overall Study|Ongoing at Time of Analysis|0|||
163859692|NCT03518112|591855963|FG000|Overall Study|Withdrawal by Subject|1|||
163859693|NCT05197049|591855968|FG000|Overall Study|Death|0|||
163859694|NCT05197049|591855969|FG001|Overall Study|Death|1|||
164196531|NCT00810199|593087588|FG000|Overall Study|Insufficient therapeutic response|5|||
163859695|NCT05197049|591855970|FG002|Overall Study|Death|0|||
163859696|NCT05197049|591855968|FG000|Overall Study|Lost to Follow-up|3|||
163859697|NCT05197049|591855969|FG001|Overall Study|Lost to Follow-up|1|||
163859698|NCT05197049|591855970|FG002|Overall Study|Lost to Follow-up|0|||
163859699|NCT05197049|591855968|FG000|Overall Study|Withdrawal by Subject|15|||
163859700|NCT05197049|591855969|FG001|Overall Study|Withdrawal by Subject|3|||
163859701|NCT05197049|591855970|FG002|Overall Study|Withdrawal by Subject|1|||
163859702|NCT05197049|591855968|FG000|Overall Study|GCP non-compliance|1|||
163859703|NCT05197049|591855969|FG001|Overall Study|GCP non-compliance|2|||
163859704|NCT05197049|591855970|FG002|Overall Study|GCP non-compliance|0|||
163859705|NCT00927823|591855973|FG000|Continuous Dosing Period|Death|0|||
163859706|NCT00927823|591855974|FG001|Continuous Dosing Period|Death|0|||
163859707|NCT00927823|591855975|FG002|Continuous Dosing Period|Death|6|||
163859708|NCT00927823|591855976|FG003|Continuous Dosing Period|Death|0|||
163859709|NCT00927823|591855973|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
163859710|NCT00927823|591855974|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
163859711|NCT00927823|591855975|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
163859712|NCT00927823|591855976|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
163859713|NCT00927823|591855973|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
163859714|NCT00927823|591855974|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
163859715|NCT00927823|591855975|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
163859716|NCT00927823|591855976|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
163859717|NCT00927823|591855973|FG000|Continuous Dosing Period|Other|1|||
163859718|NCT00927823|591855974|FG001|Continuous Dosing Period|Other|2|||
163859719|NCT00927823|591855975|FG002|Continuous Dosing Period|Other|9|||
163859720|NCT00927823|591855976|FG003|Continuous Dosing Period|Other|3|||
163859721|NCT02299635|591855977|FG000|Overall Study|Adverse Event|2|||
163859722|NCT02299635|591855977|FG000|Overall Study|Death|1|||
163859723|NCT02299635|591855977|FG000|Overall Study|Global deterioration of health status|1|||
163859724|NCT02299635|591855977|FG000|Overall Study|Objective progression or relapse|10|||
163859725|NCT02299635|591855977|FG000|Overall Study|Withdrawal by Subject|2|||
163859726|NCT02299635|591855977|FG000|Overall Study|Other|3|||
163859727|NCT00015457|591855978|FG000|First Intervention|Adverse Event|0|||
163859728|NCT00015457|591855979|FG001|First Intervention|Adverse Event|2|||
163859729|NCT00015457|591855978|FG000|First Intervention|Lack of Efficacy|0|||
163859730|NCT00015457|591855979|FG001|First Intervention|Lack of Efficacy|1|||
163859731|NCT00015457|591855978|FG000|Second Intervention|Withdrawal by Subject|1|||
163859732|NCT00015457|591855979|FG001|Second Intervention|Withdrawal by Subject|0|||
163859733|NCT01456936|591855980|FG000|Overall Study|Other reason|41|||
163859734|NCT01456936|591855981|FG001|Overall Study|Other reason|30|||
163859735|NCT01456936|591855982|FG002|Overall Study|Other reason|36|||
163859736|NCT01456936|591855983|FG003|Overall Study|Other reason|33|||
163859737|NCT01456936|591855980|FG000|Overall Study|No longer meets eligibility criteria|4|||
163859738|NCT01456936|591855981|FG001|Overall Study|No longer meets eligibility criteria|8|||
163859739|NCT01456936|591855982|FG002|Overall Study|No longer meets eligibility criteria|6|||
163859740|NCT01456936|591855983|FG003|Overall Study|No longer meets eligibility criteria|5|||
163859741|NCT01456936|591855980|FG000|Overall Study|Protocol Violation|4|||
163859742|NCT01456936|591855981|FG001|Overall Study|Protocol Violation|2|||
163859743|NCT01456936|591855982|FG002|Overall Study|Protocol Violation|5|||
163859744|NCT01456936|591855983|FG003|Overall Study|Protocol Violation|5|||
163859745|NCT01456936|591855980|FG000|Overall Study|Pregnancy|1|||
163859746|NCT01456936|591855981|FG001|Overall Study|Pregnancy|0|||
163859747|NCT01456936|591855982|FG002|Overall Study|Pregnancy|0|||
163859748|NCT01456936|591855983|FG003|Overall Study|Pregnancy|1|||
163859749|NCT01456936|591855980|FG000|Overall Study|Insufficient clinical response|4|||
163859750|NCT01456936|591855981|FG001|Overall Study|Insufficient clinical response|4|||
163859751|NCT01456936|591855982|FG002|Overall Study|Insufficient clinical response|14|||
163859752|NCT01456936|591855983|FG003|Overall Study|Insufficient clinical response|13|||
163859753|NCT01456936|591855980|FG000|Overall Study|No longer willing to participate|195|||
163859754|NCT01456936|591855981|FG001|Overall Study|No longer willing to participate|218|||
163859755|NCT01456936|591855982|FG002|Overall Study|No longer willing to participate|224|||
163859756|NCT01456936|591855983|FG003|Overall Study|No longer willing to participate|248|||
163859757|NCT01456936|591855980|FG000|Overall Study|Lost to Follow-up|135|||
163859758|NCT01456936|591855981|FG001|Overall Study|Lost to Follow-up|126|||
163859759|NCT01456936|591855982|FG002|Overall Study|Lost to Follow-up|144|||
163859760|NCT01456936|591855983|FG003|Overall Study|Lost to Follow-up|127|||
163859761|NCT01456936|591855980|FG000|Overall Study|Medication error|0|||
163859762|NCT01456936|591855981|FG001|Overall Study|Medication error|1|||
163859763|NCT01456936|591855982|FG002|Overall Study|Medication error|0|||
163859764|NCT01456936|591855983|FG003|Overall Study|Medication error|1|||
163859765|NCT01456936|591855980|FG000|Overall Study|Adverse event (study drug)|25|||
163859766|NCT01456936|591855981|FG001|Overall Study|Adverse event (study drug)|21|||
163859767|NCT01456936|591855982|FG002|Overall Study|Adverse event (study drug)|26|||
163859768|NCT01456936|591855983|FG003|Overall Study|Adverse event (study drug)|17|||
163859769|NCT01456936|591855980|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
163859770|NCT01456936|591855981|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
163859771|NCT01456936|591855982|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
163859772|NCT01456936|591855983|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
163859773|NCT01456936|591855980|FG000|Overall Study|Death|0|||
163859774|NCT01456936|591855981|FG001|Overall Study|Death|3|||
163859775|NCT01456936|591855982|FG002|Overall Study|Death|1|||
163859776|NCT01456936|591855983|FG003|Overall Study|Death|3|||
163859777|NCT01456936|591855980|FG000|Overall Study|Randomized but not treated|21|||
163859778|NCT01456936|591855981|FG001|Overall Study|Randomized but not treated|28|||
163859779|NCT01456936|591855982|FG002|Overall Study|Randomized but not treated|16|||
163859780|NCT01456936|591855983|FG003|Overall Study|Randomized but not treated|21|||
163859781|NCT00906698|591855984|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
163859782|NCT00906698|591855985|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
163859783|NCT00906698|591855986|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
163859784|NCT00906698|591855987|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
163859785|NCT00906698|591855988|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
163859786|NCT00906698|591855989|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
163859787|NCT00906698|591855984|FG000|Overall Study|Adverse Event|0|||
163859788|NCT00906698|591855985|FG001|Overall Study|Adverse Event|0|||
163859789|NCT00906698|591855986|FG002|Overall Study|Adverse Event|2|||
163859790|NCT00906698|591855987|FG003|Overall Study|Adverse Event|0|||
163859791|NCT00906698|591855988|FG004|Overall Study|Adverse Event|4|||
163859792|NCT00906698|591855989|FG005|Overall Study|Adverse Event|1|||
163859793|NCT00906698|591855984|FG000|Overall Study|Disease progression|3|||
163859794|NCT00906698|591855985|FG001|Overall Study|Disease progression|12|||
163859795|NCT00906698|591855986|FG002|Overall Study|Disease progression|4|||
163859796|NCT00906698|591855987|FG003|Overall Study|Disease progression|4|||
163859797|NCT00906698|591855988|FG004|Overall Study|Disease progression|12|||
163859798|NCT00906698|591855989|FG005|Overall Study|Disease progression|4|||
163859799|NCT00906698|591855984|FG000|Overall Study|Withdrawal by Subject|0|||
163859800|NCT00906698|591855985|FG001|Overall Study|Withdrawal by Subject|0|||
163859801|NCT00906698|591855986|FG002|Overall Study|Withdrawal by Subject|0|||
163859802|NCT00906698|591855987|FG003|Overall Study|Withdrawal by Subject|0|||
163859803|NCT00906698|591855988|FG004|Overall Study|Withdrawal by Subject|1|||
163859804|NCT00906698|591855989|FG005|Overall Study|Withdrawal by Subject|0|||
163859805|NCT00906698|591855984|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
163859806|NCT00906698|591855985|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
163859807|NCT00906698|591855986|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
163859808|NCT00906698|591855987|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
163859809|NCT00906698|591855988|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
163859810|NCT00906698|591855989|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
163859811|NCT01744691|591855992|FG000|Overall Study|Progressive Disease|18|||
163859812|NCT01744691|591855992|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
163859813|NCT01744691|591855992|FG000|Overall Study|Withdrawal of consent for treatment|3|||
163859814|NCT01744691|591855992|FG000|Overall Study|Physician Decision|4|||
163859815|NCT02701361|591855993|FG000|Overall Study|Lost to Follow-up|5|||
163859816|NCT02701361|591855994|FG001|Overall Study|Lost to Follow-up|2|||
163859817|NCT02701361|591855995|FG002|Overall Study|Lost to Follow-up|1|||
163859818|NCT02701361|591855993|FG000|Overall Study|Withdrawal by Subject|4|||
163859819|NCT02701361|591855994|FG001|Overall Study|Withdrawal by Subject|0|||
163859820|NCT02701361|591855995|FG002|Overall Study|Withdrawal by Subject|0|||
163859821|NCT02701361|591855993|FG000|Overall Study|timed out in rehab center|0|||
163859822|NCT02701361|591855994|FG001|Overall Study|timed out in rehab center|1|||
163859823|NCT02701361|591855995|FG002|Overall Study|timed out in rehab center|0|||
163859824|NCT02701361|591855993|FG000|Overall Study|incarceration|0|||
163859825|NCT02701361|591855994|FG001|Overall Study|incarceration|0|||
163965821|NCT01807923|592247012|FG002|Overall Study|Randomized But Not Treated|5|||
163965822|NCT00995007|592247014|FG000|Overall Study|Withdrew consent|1|||
163965823|NCT00995007|592247015|FG001|Overall Study|Withdrew consent|0|||
163965824|NCT00995007|592247014|FG000|Overall Study|Refused further treatment|8|||
163965825|NCT00995007|592247015|FG001|Overall Study|Refused further treatment|2|||
163965826|NCT00995007|592247014|FG000|Overall Study|Toxicity|8|||
163965827|NCT00995007|592247015|FG001|Overall Study|Toxicity|0|||
163965828|NCT03933397|592247016|FG000|Overall Study|No emergency department visit|65|||
163965829|NCT03933397|592247017|FG001|Overall Study|No emergency department visit|71|||
163965830|NCT03933397|592247016|FG000|Overall Study|Missed emergency department visit|25|||
163965831|NCT03933397|592247017|FG001|Overall Study|Missed emergency department visit|30|||
163965832|NCT03933397|592247016|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
163859826|NCT02701361|591855995|FG002|Overall Study|incarceration|1|||
163859827|NCT02322216|591855998|FG000|Overall Study|Adverse Event|1|||
163859828|NCT02322216|591855999|FG001|Overall Study|Adverse Event|0|||
163859829|NCT02322216|591855998|FG000|Overall Study|Withdrawal by Subject|1|||
163965833|NCT03933397|592247017|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
163859830|NCT02322216|591855999|FG001|Overall Study|Withdrawal by Subject|4|||
163859831|NCT00404079|591856002|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
163859832|NCT00404079|591856003|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
163965834|NCT03933397|592247016|FG000|Overall Study|Withdrawal by Subject|1|||
163965835|NCT03933397|592247017|FG001|Overall Study|Withdrawal by Subject|0|||
163965836|NCT03933397|592247016|FG000|Overall Study|Physician Decision|1|||
163859833|NCT04154943|591856005|FG000|Overall Study|Study Ongoing|68|||
163859834|NCT04154943|591856005|FG000|Overall Study|Lost to Follow-up|1|||
163859835|NCT04154943|591856005|FG000|Overall Study|Decision by the Investigator|1|||
163859836|NCT04154943|591856005|FG000|Overall Study|Death|5|||
163859837|NCT04154943|591856005|FG000|Overall Study|Withdrawal by Subject|4|||
163859838|NCT02107014|591856007|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
163859839|NCT00591838|591856008|FG000|Overall Study|Withdrawal by Subject|0|||
163859840|NCT00591838|591856009|FG001|Overall Study|Withdrawal by Subject|0|||
163859841|NCT00591838|591856010|FG002|Overall Study|Withdrawal by Subject|0|||
163859842|NCT00591838|591856011|FG003|Overall Study|Withdrawal by Subject|1|||
163859843|NCT00591838|591856012|FG004|Overall Study|Withdrawal by Subject|0|||
163859844|NCT03761784|591856013|FG000|Overall Study|Adverse Event|4|||
163859845|NCT03761784|591856014|FG001|Overall Study|Adverse Event|0|||
163859846|NCT03761784|591856013|FG000|Overall Study|Lost to Follow-up|10|||
163859847|NCT03761784|591856014|FG001|Overall Study|Lost to Follow-up|7|||
163859848|NCT03761784|591856013|FG000|Overall Study|Pregnancy|1|||
163859849|NCT03761784|591856014|FG001|Overall Study|Pregnancy|0|||
163859850|NCT03761784|591856013|FG000|Overall Study|Protocol Violation|2|||
163859851|NCT03761784|591856014|FG001|Overall Study|Protocol Violation|0|||
163859852|NCT03761784|591856013|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
163859853|NCT03761784|591856014|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
163859854|NCT03761784|591856013|FG000|Overall Study|Withdrawal by Subject|9|||
163859855|NCT03761784|591856014|FG001|Overall Study|Withdrawal by Subject|4|||
163859856|NCT03761784|591856013|FG000|Overall Study|Physician Decision|1|||
163859857|NCT03761784|591856014|FG001|Overall Study|Physician Decision|0|||
163859858|NCT03761784|591856013|FG000|Overall Study|Other Than Specified|1|||
163859859|NCT03761784|591856014|FG001|Overall Study|Other Than Specified|0|||
163859860|NCT01549652|591856015|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
163859861|NCT01549652|591856016|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
163859862|NCT01549652|591856017|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
163859863|NCT01549652|591856018|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
163859864|NCT01549652|591856015|FG000|Overall Study|Study Drug Titration Failure|5|||
163859865|NCT01549652|591856016|FG001|Overall Study|Study Drug Titration Failure|6|||
163859866|NCT01549652|591856017|FG002|Overall Study|Study Drug Titration Failure|0|||
163965837|NCT03933397|592247017|FG001|Overall Study|Physician Decision|1|||
163965838|NCT03933397|592247016|FG000|Overall Study|missing pain score|1|||
163965839|NCT03933397|592247017|FG001|Overall Study|missing pain score|1|||
163965840|NCT03933397|592247016|FG000|Overall Study|Confirmed COVID-19|1|||
163965841|NCT03933397|592247017|FG001|Overall Study|Confirmed COVID-19|2|||
163965842|NCT01237340|592247019|FG000|Overall Study|Adverse Event|3|||
163965843|NCT01237340|592247019|FG000|Overall Study|Withdrawal by Subject|1|||
163965844|NCT01237340|592247019|FG000|Overall Study|Early termination of the trial|36|||
163965845|NCT01610687|592247020|FG000|Overall Study|Lack of Efficacy|26|||
163965846|NCT01610687|592247020|FG000|Overall Study|Adverse Event|18|||
163965847|NCT01610687|592247020|FG000|Overall Study|Moved out of area|6|||
163965848|NCT01610687|592247020|FG000|Overall Study|Withdrawal by Subject|7|||
163965849|NCT01610687|592247020|FG000|Overall Study|Lost to Follow-up|4|||
163965850|NCT01610687|592247020|FG000|Overall Study|Symptom control without study medication|2|||
163965851|NCT01610687|592247020|FG000|Overall Study|Unable to make journey|1|||
163965852|NCT01610687|592247020|FG000|Overall Study|Death|1|||
163965853|NCT01610687|592247020|FG000|Overall Study|Cannabis affecting job|1|||
163965854|NCT01610687|592247020|FG000|Overall Study|Felt more alter without study medication|1|||
163965855|NCT03675776|592247023|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
163965856|NCT03675776|592247024|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
163965857|NCT03675776|592247025|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
163965858|NCT03675776|592247023|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
163965859|NCT03675776|592247024|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
163965860|NCT03675776|592247025|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
163965861|NCT01093625|592247026|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
163965862|NCT01093625|592247027|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
163965863|NCT01093625|592247026|FG000|2-Week Visit|Withdrawal by Subject|1|||
163859867|NCT01549652|591856018|FG003|Overall Study|Study Drug Titration Failure|0|||
163859868|NCT01549652|591856015|FG000|Overall Study|Withdrawal Effect|0|||
163859869|NCT01549652|591856016|FG001|Overall Study|Withdrawal Effect|2|||
163965864|NCT01093625|592247027|FG001|2-Week Visit|Withdrawal by Subject|0|||
163965865|NCT01093625|592247026|FG000|1-Month Visit|Lost to Follow-up|2|||
163859870|NCT01549652|591856017|FG002|Overall Study|Withdrawal Effect|0|||
163859871|NCT01549652|591856018|FG003|Overall Study|Withdrawal Effect|0|||
163965866|NCT01093625|592247027|FG001|1-Month Visit|Lost to Follow-up|0|||
163859872|NCT01549652|591856015|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
163859873|NCT01549652|591856016|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
163859874|NCT01549652|591856017|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
163965867|NCT01093625|592247026|FG000|3-Month Visit|Lost to Follow-up|2|||
163965868|NCT01093625|592247027|FG001|3-Month Visit|Lost to Follow-up|0|||
163965869|NCT01093625|592247026|FG000|6-Month Visit|Withdrawal by Subject|6|||
163965870|NCT01093625|592247027|FG001|6-Month Visit|Withdrawal by Subject|7|||
163965871|NCT01093625|592247026|FG000|6-Month Visit|Lost to Follow-up|2|||
163965872|NCT01093625|592247027|FG001|6-Month Visit|Lost to Follow-up|2|||
163965873|NCT01093625|592247026|FG000|1-Year Visit|Lost to Follow-up|5|||
163965874|NCT01093625|592247027|FG001|1-Year Visit|Lost to Follow-up|3|||
163965875|NCT00698932|592247028|FG000|Overall Study|Adverse Event|0|||
163965876|NCT00698932|592247029|FG001|Overall Study|Adverse Event|2|||
163965877|NCT00698932|592247028|FG000|Overall Study|Incorrect enrollment|0|||
163965878|NCT00698932|592247029|FG001|Overall Study|Incorrect enrollment|2|||
163965879|NCT00698932|592247028|FG000|Overall Study|Study specific discontinuation criteria|3|||
163965880|NCT00698932|592247029|FG001|Overall Study|Study specific discontinuation criteria|4|||
163965881|NCT00698932|592247028|FG000|Overall Study|Withdrawal by Subject|11|||
163965882|NCT00698932|592247029|FG001|Overall Study|Withdrawal by Subject|23|||
163965883|NCT00698932|592247028|FG000|Overall Study|Lost to Follow-up|6|||
163965884|NCT00698932|592247029|FG001|Overall Study|Lost to Follow-up|1|||
163965885|NCT00698932|592247028|FG000|Overall Study|Severe non-compliance to protocol|1|||
163965886|NCT00698932|592247029|FG001|Overall Study|Severe non-compliance to protocol|2|||
163965887|NCT00698932|592247028|FG000|Overall Study|Safety reasons|0|||
163965888|NCT00698932|592247029|FG001|Overall Study|Safety reasons|2|||
163965889|NCT00698932|592247028|FG000|Overall Study|Death|1|||
163965890|NCT00698932|592247029|FG001|Overall Study|Death|0|||
163965891|NCT02014740|592247030|FG000|Overall Study|Lost to Follow-up|4|||
163965892|NCT02014740|592247031|FG001|Overall Study|Lost to Follow-up|4|||
163965893|NCT02014740|592247030|FG000|Overall Study|Withdrawal by Subject|2|||
163965894|NCT02014740|592247031|FG001|Overall Study|Withdrawal by Subject|1|||
163965895|NCT02608879|592247032|FG000|Overall Study|Lost to Follow-up|1|||
163965896|NCT02608879|592247033|FG001|Overall Study|Lost to Follow-up|0|||
163965897|NCT02608879|592247034|FG002|Overall Study|Lost to Follow-up|0|||
163965898|NCT02608879|592247032|FG000|Overall Study|Did not meet continuation criteria|0|||
163965899|NCT02608879|592247033|FG001|Overall Study|Did not meet continuation criteria|0|||
163965900|NCT02608879|592247034|FG002|Overall Study|Did not meet continuation criteria|3|||
163965901|NCT01621542|592247035|FG000|Overall Study|Adverse Event|0|||
163965902|NCT01621542|592247036|FG001|Overall Study|Adverse Event|0|||
163965903|NCT01621542|592247037|FG002|Overall Study|Adverse Event|1|||
163965904|NCT01621542|592247038|FG003|Overall Study|Adverse Event|3|||
163965905|NCT01621542|592247039|FG004|Overall Study|Adverse Event|0|||
163965906|NCT01621542|592247040|FG005|Overall Study|Adverse Event|0|||
163965907|NCT01621542|592247035|FG000|Overall Study|Death|0|||
163965908|NCT01621542|592247036|FG001|Overall Study|Death|1|||
163965909|NCT01621542|592247037|FG002|Overall Study|Death|0|||
163965910|NCT01621542|592247038|FG003|Overall Study|Death|0|||
163965911|NCT01621542|592247039|FG004|Overall Study|Death|0|||
163965912|NCT01621542|592247040|FG005|Overall Study|Death|0|||
163965913|NCT01621542|592247035|FG000|Overall Study|Physician Decision|1|||
163965914|NCT01621542|592247036|FG001|Overall Study|Physician Decision|0|||
163965915|NCT01621542|592247037|FG002|Overall Study|Physician Decision|1|||
163965916|NCT01621542|592247038|FG003|Overall Study|Physician Decision|13|||
163965917|NCT01621542|592247039|FG004|Overall Study|Physician Decision|3|||
163965918|NCT01621542|592247040|FG005|Overall Study|Physician Decision|1|||
163965919|NCT01621542|592247035|FG000|Overall Study|Withdrawal by Subject|2|||
163965920|NCT01621542|592247036|FG001|Overall Study|Withdrawal by Subject|0|||
163965921|NCT01621542|592247037|FG002|Overall Study|Withdrawal by Subject|1|||
163965922|NCT01621542|592247038|FG003|Overall Study|Withdrawal by Subject|3|||
163965923|NCT01621542|592247039|FG004|Overall Study|Withdrawal by Subject|3|||
163965924|NCT01621542|592247040|FG005|Overall Study|Withdrawal by Subject|3|||
163965925|NCT01621542|592247035|FG000|Overall Study|progression/treatment failure|2|||
163965926|NCT01621542|592247036|FG001|Overall Study|progression/treatment failure|4|||
163965927|NCT01621542|592247037|FG002|Overall Study|progression/treatment failure|3|||
163965928|NCT01621542|592247038|FG003|Overall Study|progression/treatment failure|7|||
163965929|NCT01621542|592247039|FG004|Overall Study|progression/treatment failure|3|||
163965930|NCT01621542|592247040|FG005|Overall Study|progression/treatment failure|5|||
163965931|NCT01621542|592247035|FG000|Overall Study|Protocol Violation|0|||
163965932|NCT01621542|592247036|FG001|Overall Study|Protocol Violation|0|||
163965933|NCT01621542|592247037|FG002|Overall Study|Protocol Violation|0|||
163965934|NCT01621542|592247038|FG003|Overall Study|Protocol Violation|1|||
163965935|NCT01621542|592247039|FG004|Overall Study|Protocol Violation|0|||
163965936|NCT01621542|592247040|FG005|Overall Study|Protocol Violation|0|||
163965937|NCT01621542|592247035|FG000|Overall Study|study stopped by sponsor|0|||
163965938|NCT01621542|592247036|FG001|Overall Study|study stopped by sponsor|0|||
163965939|NCT01621542|592247037|FG002|Overall Study|study stopped by sponsor|0|||
163965940|NCT01621542|592247038|FG003|Overall Study|study stopped by sponsor|1|||
163965941|NCT01621542|592247039|FG004|Overall Study|study stopped by sponsor|0|||
163965942|NCT01621542|592247040|FG005|Overall Study|study stopped by sponsor|0|||
163965943|NCT02742766|592247041|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965944|NCT02742766|592247042|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965945|NCT02742766|592247043|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965946|NCT02742766|592247044|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965947|NCT02742766|592247045|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965948|NCT02742766|592247046|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965949|NCT02742766|592247047|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965950|NCT02742766|592247048|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965951|NCT02742766|592247049|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965952|NCT02742766|592247050|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965953|NCT02742766|592247051|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965954|NCT02742766|592247052|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965955|NCT02742766|592247053|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965956|NCT02742766|592247054|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
163965957|NCT02742766|592247055|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965958|NCT02742766|592247056|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965959|NCT02742766|592247057|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965960|NCT02742766|592247058|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965961|NCT02742766|592247059|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
163965962|NCT02742766|592247041|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965963|NCT02742766|592247042|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965964|NCT02742766|592247043|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965965|NCT02742766|592247044|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965966|NCT02742766|592247045|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965967|NCT02742766|592247046|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965968|NCT02742766|592247047|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965969|NCT02742766|592247048|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965970|NCT02742766|592247049|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965971|NCT02742766|592247050|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965972|NCT02742766|592247051|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965973|NCT02742766|592247052|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965974|NCT02742766|592247053|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
163965975|NCT02742766|592247054|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
163965976|NCT02742766|592247055|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965977|NCT02742766|592247056|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
163965978|NCT02742766|592247057|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965979|NCT02742766|592247058|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965980|NCT02742766|592247059|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
163965981|NCT03739437|592247060|FG000|Overall Study|Lost to Follow-up|2|||
163965982|NCT03739437|592247061|FG001|Overall Study|Lost to Follow-up|5|||
163965983|NCT01351623|592247062|FG000|Overall Study|Protocol Violation|2|||
163965984|NCT01351623|592247062|FG000|Overall Study|Adverse Event|4|||
163965985|NCT01351623|592247062|FG000|Overall Study|Withdrawal by Subject|1|||
163965986|NCT01351623|592247062|FG000|Overall Study|Death|2|||
163965987|NCT01130974|592247064|FG000|Overall Study|Protocol Violation|10|||
163965988|NCT01130974|592247065|FG001|Overall Study|Protocol Violation|10|||
163965989|NCT01130974|592247064|FG000|Overall Study|Withdrawal by Subject|0|||
163965990|NCT01130974|592247065|FG001|Overall Study|Withdrawal by Subject|1|||
163965991|NCT01130974|592247064|FG000|Overall Study|Ineligibility criteria|5|||
163965992|NCT01130974|592247065|FG001|Overall Study|Ineligibility criteria|2|||
163965993|NCT03359590|592247067|FG000|First Intervention|Withdrawal by Subject|1|||
164196532|NCT00810199|593087589|FG001|Overall Study|Insufficient therapeutic response|14|||
164196533|NCT00810199|593087588|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
164196534|NCT00810199|593087589|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
164196535|NCT00810199|593087588|FG000|Overall Study|Administrative/Other|5|||
164196536|NCT00810199|593087589|FG001|Overall Study|Administrative/Other|6|||
164196537|NCT00810199|593087588|FG000|Overall Study|Protocol Violation|2|||
164196538|NCT00810199|593087589|FG001|Overall Study|Protocol Violation|6|||
164196539|NCT00810199|593087588|FG000|Overall Study|Failure to return|1|||
164196540|NCT00810199|593087589|FG001|Overall Study|Failure to return|4|||
164196541|NCT00810199|593087588|FG000|Overall Study|Did not receive study drug|2|||
164196542|NCT00810199|593087589|FG001|Overall Study|Did not receive study drug|1|||
164196543|NCT00992017|593087590|FG000|Overall Study|Lost to Follow-up|2|||
164196544|NCT00992017|593087590|FG000|Overall Study|Withdrawal by Subject|2|||
164196545|NCT00992017|593087590|FG000|Overall Study|Unable to get to clinic|5|||
164196546|NCT00992017|593087590|FG000|Overall Study|Not adhere to study requirements|1|||
164196547|NCT01691378|593087591|FG000|Overall Study|Withdrawal by Subject|2|||
163965994|NCT03359590|592247068|FG001|First Intervention|Withdrawal by Subject|1|||
163965995|NCT03359590|592247067|FG000|First Intervention|Protocol Violation|0|||
163965996|NCT03359590|592247068|FG001|First Intervention|Protocol Violation|1|||
163965997|NCT02536755|592247069|FG000|Overall Study|Adverse Event|4|||
163965998|NCT02540538|592247070|FG000|Overall Study|Pregnancy|0|||
163965999|NCT02540538|592247071|FG001|Overall Study|Pregnancy|1|||
163966000|NCT02540538|592247072|FG002|Overall Study|Pregnancy|0|||
163966001|NCT04598477|592247074|FG000|Overall Study|Adverse Event|2|||
164307251|NCT02023697|593499223|FG000|Long-term Follow-up Period|Technical problems|0|||
163966002|NCT04598477|592247075|FG001|Overall Study|Adverse Event|0|||
163966003|NCT04598477|592247074|FG000|Overall Study|Death|0|||
163966004|NCT04598477|592247075|FG001|Overall Study|Death|1|||
163966005|NCT04598477|592247074|FG000|Overall Study|Lost to Follow-up|1|||
163966006|NCT04598477|592247075|FG001|Overall Study|Lost to Follow-up|0|||
163966007|NCT04598477|592247074|FG000|Overall Study|Physician Decision|7|||
163966008|NCT04598477|592247075|FG001|Overall Study|Physician Decision|2|||
163966009|NCT04598477|592247074|FG000|Overall Study|Pregnancy|0|||
163966010|NCT04598477|592247075|FG001|Overall Study|Pregnancy|1|||
163966011|NCT04598477|592247074|FG000|Overall Study|Requires Prohibited Medication|0|||
163966012|NCT04598477|592247075|FG001|Overall Study|Requires Prohibited Medication|1|||
163966013|NCT04598477|592247074|FG000|Overall Study|Study Terminated by Sponsor|18|||
163966014|NCT04598477|592247075|FG001|Overall Study|Study Terminated by Sponsor|12|||
163966015|NCT04598477|592247074|FG000|Overall Study|Withdrawal by Subject|16|||
163966016|NCT04598477|592247075|FG001|Overall Study|Withdrawal by Subject|12|||
163966017|NCT04598477|592247074|FG000|Overall Study|Other|15|||
163966018|NCT04598477|592247075|FG001|Overall Study|Other|8|||
163859875|NCT01549652|591856018|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
163859876|NCT01549652|591856015|FG000|Overall Study|Problem with Infusion|1|||
163859877|NCT01549652|591856016|FG001|Overall Study|Problem with Infusion|0|||
163859878|NCT01549652|591856017|FG002|Overall Study|Problem with Infusion|0|||
163859879|NCT01549652|591856018|FG003|Overall Study|Problem with Infusion|0|||
163859880|NCT01549652|591856015|FG000|Overall Study|Titration Non-Compliance|1|||
163859881|NCT01549652|591856016|FG001|Overall Study|Titration Non-Compliance|3|||
163859882|NCT01549652|591856017|FG002|Overall Study|Titration Non-Compliance|4|||
163859883|NCT01549652|591856018|FG003|Overall Study|Titration Non-Compliance|5|||
163859884|NCT01549652|591856015|FG000|Overall Study|Titration Side Effects|0|||
163859885|NCT01549652|591856016|FG001|Overall Study|Titration Side Effects|0|||
163859886|NCT01549652|591856017|FG002|Overall Study|Titration Side Effects|6|||
163859887|NCT01549652|591856018|FG003|Overall Study|Titration Side Effects|3|||
163859888|NCT01549652|591856015|FG000|Overall Study|Withdrawal by Subject|0|||
163859889|NCT01549652|591856016|FG001|Overall Study|Withdrawal by Subject|0|||
163859890|NCT01549652|591856017|FG002|Overall Study|Withdrawal by Subject|5|||
163859891|NCT01549652|591856018|FG003|Overall Study|Withdrawal by Subject|3|||
163859892|NCT00586339|591856019|FG000|Overall Study|Withdrawal by Subject|1|||
163859893|NCT00586339|591856020|FG001|Overall Study|Withdrawal by Subject|3|||
163859894|NCT00586339|591856021|FG002|Overall Study|Withdrawal by Subject|1|||
163859895|NCT00586339|591856019|FG000|Overall Study|Migrated/moved from study area|3|||
163859896|NCT00586339|591856020|FG001|Overall Study|Migrated/moved from study area|2|||
163859897|NCT00586339|591856021|FG002|Overall Study|Migrated/moved from study area|4|||
163859898|NCT00586339|591856019|FG000|Overall Study|Lost to Follow-up|3|||
163859899|NCT00586339|591856020|FG001|Overall Study|Lost to Follow-up|2|||
163859900|NCT00586339|591856021|FG002|Overall Study|Lost to Follow-up|1|||
163859901|NCT02512042|591856022|FG000|Overall Study|Adverse Event|0|||
163859902|NCT02512042|591856023|FG001|Overall Study|Adverse Event|4|||
163859903|NCT02512042|591856022|FG000|Overall Study|Withdrawal by Subject|6|||
163859904|NCT02512042|591856023|FG001|Overall Study|Withdrawal by Subject|6|||
163859905|NCT02512042|591856022|FG000|Overall Study|Non-compliance with study drug|1|||
163859906|NCT02512042|591856023|FG001|Overall Study|Non-compliance with study drug|2|||
163859907|NCT02512042|591856022|FG000|Overall Study|Lost to Follow-up|5|||
163859908|NCT02512042|591856023|FG001|Overall Study|Lost to Follow-up|2|||
163966019|NCT05579990|592247085|FG000|Overall Study|Lost to Follow-up|3|||
163966020|NCT00332839|592249138|FG000|Core (Months 0 - 12)|Administrative problems|1|||
163966021|NCT00332839|592249139|FG001|Core (Months 0 - 12)|Administrative problems|1|||
163966022|NCT00332839|592249138|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
163966023|NCT00332839|592249139|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
163966024|NCT00332839|592249138|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
163966025|NCT00332839|592249139|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
163966026|NCT00332839|592249138|FG000|Core (Months 0 - 12)|Adverse Event|5|||
164307252|NCT02023697|593499224|FG001|Long-term Follow-up Period|Technical problems|0|||
163859909|NCT02512042|591856022|FG000|Overall Study|Other|11|||
163859910|NCT02512042|591856023|FG001|Overall Study|Other|11|||
163859911|NCT02059980|591856033|FG000|Overall Study|Lost to Follow-up|2|||
163859912|NCT02059980|591856034|FG001|Overall Study|Lost to Follow-up|1|||
163859913|NCT01321606|591856035|FG000|Overall Study|Lost to Follow-up|0|||
163859914|NCT01321606|591856036|FG001|Overall Study|Lost to Follow-up|0|||
163859915|NCT01321606|591856037|FG002|Overall Study|Lost to Follow-up|0|||
163859916|NCT01321606|591856038|FG003|Overall Study|Lost to Follow-up|1|||
163859917|NCT03235349|591856041|FG000|Overall Study|Adverse Event|1|||
163859918|NCT03235349|591856041|FG000|Overall Study|Other|1|||
163859919|NCT03394027|591856042|FG000|Overall Study|Ineligible|3|||
163966027|NCT00332839|592249139|FG001|Core (Months 0 - 12)|Adverse Event|15|||
163859920|NCT03394027|591856043|FG001|Overall Study|Ineligible|1|||
163859921|NCT03394027|591856044|FG002|Overall Study|Ineligible|3|||
163859922|NCT03394027|591856042|FG000|Overall Study|Participant declined to participate before treatment started|0|||
163966028|NCT00332839|592249138|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
163966029|NCT00332839|592249139|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
163966030|NCT00332839|592249138|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
164196548|NCT01691378|593087592|FG001|Overall Study|Withdrawal by Subject|0|||
163859923|NCT03394027|591856043|FG001|Overall Study|Participant declined to participate before treatment started|0|||
163859924|NCT03394027|591856044|FG002|Overall Study|Participant declined to participate before treatment started|1|||
163859925|NCT00124982|591856049|FG000|Short-term Period|Death|1|||
163859926|NCT00124982|591856050|FG001|Short-term Period|Death|1|||
163859927|NCT00124982|591856051|FG002|Short-term Period|Death|0|||
163859928|NCT00124982|591856049|FG000|Short-term Period|Adverse Event|17|||
163859929|NCT00124982|591856050|FG001|Short-term Period|Adverse Event|22|||
163859930|NCT00124982|591856051|FG002|Short-term Period|Adverse Event|0|||
163859931|NCT00124982|591856049|FG000|Short-term Period|Lack of Efficacy|32|||
163859932|NCT00124982|591856050|FG001|Short-term Period|Lack of Efficacy|73|||
163859933|NCT00124982|591856051|FG002|Short-term Period|Lack of Efficacy|0|||
163859934|NCT00124982|591856049|FG000|Short-term Period|Lost to Follow-up|8|||
163859935|NCT00124982|591856050|FG001|Short-term Period|Lost to Follow-up|5|||
163859936|NCT00124982|591856051|FG002|Short-term Period|Lost to Follow-up|0|||
163859937|NCT00124982|591856049|FG000|Short-term Period|Withdrawal of Consent|7|||
163859938|NCT00124982|591856050|FG001|Short-term Period|Withdrawal of Consent|9|||
163859939|NCT00124982|591856051|FG002|Short-term Period|Withdrawal of Consent|0|||
163859940|NCT00124982|591856049|FG000|Short-term Period|Poor/Non-compliance|3|||
164196549|NCT01691378|593087591|FG000|Overall Study|Lost to Follow-up|5|||
164196550|NCT01691378|593087592|FG001|Overall Study|Lost to Follow-up|2|||
164196551|NCT01107925|593087597|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
164196552|NCT01107925|593087598|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196553|NCT01107925|593087599|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196554|NCT01107925|593087600|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196555|NCT01107925|593087601|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
164196556|NCT01107925|593087602|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
164196557|NCT01107925|593087597|FG000|Period 2|Withdrawal by Subject|0|||
164196558|NCT01107925|593087598|FG001|Period 2|Withdrawal by Subject|1|||
164196559|NCT01107925|593087599|FG002|Period 2|Withdrawal by Subject|0|||
164196560|NCT01107925|593087600|FG003|Period 2|Withdrawal by Subject|0|||
164196561|NCT01107925|593087601|FG004|Period 2|Withdrawal by Subject|0|||
164196562|NCT01107925|593087602|FG005|Period 2|Withdrawal by Subject|1|||
164196563|NCT04235504|593087603|FG000|Study Phase|Withdrawal by Subject|5|||
164196564|NCT04235504|593087604|FG001|Study Phase|Withdrawal by Subject|2|||
164196565|NCT04235504|593087605|FG002|Study Phase|Withdrawal by Subject|0|||
164196566|NCT04235504|593087606|FG003|Study Phase|Withdrawal by Subject|0|||
164196567|NCT04235504|593087603|FG000|Continuation Phase|Withdrawal by Subject|0|||
164196568|NCT04235504|593087604|FG001|Continuation Phase|Withdrawal by Subject|4|||
164196569|NCT04235504|593087605|FG002|Continuation Phase|Withdrawal by Subject|0|||
164196570|NCT04235504|593087606|FG003|Continuation Phase|Withdrawal by Subject|0|||
164196571|NCT04235504|593087603|FG000|Continuation Phase|Adverse Event|0|||
164196572|NCT04235504|593087604|FG001|Continuation Phase|Adverse Event|1|||
164196573|NCT04235504|593087605|FG002|Continuation Phase|Adverse Event|0|||
164196574|NCT04235504|593087606|FG003|Continuation Phase|Adverse Event|0|||
164196575|NCT04235504|593087603|FG000|Continuation Phase|Physician Decision|1|||
163859941|NCT00124982|591856050|FG001|Short-term Period|Poor/Non-compliance|1|||
163859942|NCT00124982|591856051|FG002|Short-term Period|Poor/Non-compliance|0|||
163859943|NCT00124982|591856049|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
163859944|NCT00124982|591856050|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
163859945|NCT00124982|591856051|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
163859946|NCT00124982|591856049|FG000|Short-term Period|Participant Decision|1|||
163859947|NCT00124982|591856050|FG001|Short-term Period|Participant Decision|0|||
163859948|NCT00124982|591856051|FG002|Short-term Period|Participant Decision|0|||
163859949|NCT00124982|591856049|FG000|Short-term Period|Participant Chose Own Doctor|0|||
163859950|NCT00124982|591856050|FG001|Short-term Period|Participant Chose Own Doctor|1|||
163859951|NCT00124982|591856051|FG002|Short-term Period|Participant Chose Own Doctor|0|||
163859952|NCT00124982|591856049|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
163859953|NCT00124982|591856050|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
163859954|NCT00124982|591856051|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
163859955|NCT00124982|591856049|FG000|Short-term Period|Participant Had Lymphopenia|1|||
163859956|NCT00124982|591856050|FG001|Short-term Period|Participant Had Lymphopenia|0|||
163859957|NCT00124982|591856051|FG002|Short-term Period|Participant Had Lymphopenia|0|||
163859958|NCT00124982|591856049|FG000|Long-term Period|Death|0|||
163859959|NCT00124982|591856050|FG001|Long-term Period|Death|0|||
163859960|NCT00124982|591856051|FG002|Long-term Period|Death|1|||
163966031|NCT00332839|592249139|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
164196576|NCT04235504|593087604|FG001|Continuation Phase|Physician Decision|2|||
164196577|NCT04235504|593087605|FG002|Continuation Phase|Physician Decision|1|||
164196578|NCT04235504|593087606|FG003|Continuation Phase|Physician Decision|0|||
164196579|NCT04877990|593087607|FG000|Treatment|Other reasons|3|||
164196580|NCT04877990|593087608|FG001|Treatment|Other reasons|1|||
163859961|NCT00124982|591856049|FG000|Long-term Period|Adverse Event|0|||
163859962|NCT00124982|591856050|FG001|Long-term Period|Adverse Event|0|||
163859963|NCT00124982|591856051|FG002|Long-term Period|Adverse Event|17|||
164196581|NCT04877990|593087607|FG000|Treatment|Administrative reasons by sponsor|17|||
164196582|NCT04877990|593087608|FG001|Treatment|Administrative reasons by sponsor|33|||
164196583|NCT04877990|593087607|FG000|Treatment|Withdrawal by Subject|2|||
164196584|NCT04877990|593087608|FG001|Treatment|Withdrawal by Subject|6|||
164196585|NCT04877990|593087607|FG000|Treatment|Adverse Event|2|||
164196586|NCT04877990|593087608|FG001|Treatment|Adverse Event|1|||
164196587|NCT01817075|593087610|FG000|Overall Study|Adverse Event|7|||
164196588|NCT01817075|593087611|FG001|Overall Study|Adverse Event|5|||
164196589|NCT01817075|593087610|FG000|Overall Study|Physician Decision|9|||
164196590|NCT01817075|593087611|FG001|Overall Study|Physician Decision|12|||
163859964|NCT00124982|591856049|FG000|Long-term Period|Lack of Efficacy|0|||
163859965|NCT00124982|591856050|FG001|Long-term Period|Lack of Efficacy|0|||
163859966|NCT00124982|591856051|FG002|Long-term Period|Lack of Efficacy|46|||
163859967|NCT00124982|591856049|FG000|Long-term Period|Lost to Follow-up|0|||
163859968|NCT00124982|591856050|FG001|Long-term Period|Lost to Follow-up|0|||
163859969|NCT00124982|591856051|FG002|Long-term Period|Lost to Follow-up|4|||
163859970|NCT00124982|591856049|FG000|Long-term Period|Withdrawal by Subject|0|||
163859971|NCT00124982|591856050|FG001|Long-term Period|Withdrawal by Subject|0|||
163859972|NCT00124982|591856051|FG002|Long-term Period|Withdrawal by Subject|16|||
163859973|NCT00124982|591856049|FG000|Long-term Period|Pregnancy|0|||
163859974|NCT00124982|591856050|FG001|Long-term Period|Pregnancy|0|||
163859975|NCT00124982|591856051|FG002|Long-term Period|Pregnancy|1|||
163859976|NCT00124982|591856049|FG000|Long-term Period|Poor/Non-compliance|0|||
163859977|NCT00124982|591856050|FG001|Long-term Period|Poor/Non-compliance|0|||
163859978|NCT00124982|591856051|FG002|Long-term Period|Poor/Non-compliance|2|||
163859979|NCT00124982|591856049|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
163859980|NCT00124982|591856050|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
163859981|NCT00124982|591856051|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
163859982|NCT00124982|591856049|FG000|Long-term Period|Neurologist Recommendation|0|||
163859983|NCT00124982|591856050|FG001|Long-term Period|Neurologist Recommendation|0|||
163859984|NCT00124982|591856051|FG002|Long-term Period|Neurologist Recommendation|1|||
163859985|NCT01311713|591856052|FG000|Overall Study|Death|0|||
163859986|NCT01311713|591856053|FG001|Overall Study|Death|0|||
163859987|NCT01311713|591856054|FG002|Overall Study|Death|1|||
163859988|NCT01311713|591856055|FG003|Overall Study|Death|1|||
163859989|NCT01311713|591856056|FG004|Overall Study|Death|0|||
163859990|NCT01311713|591856057|FG005|Overall Study|Death|1|||
163859991|NCT01311713|591856058|FG006|Overall Study|Death|0|||
163859992|NCT01311713|591856052|FG000|Overall Study|Adverse Event|0|||
163859993|NCT01311713|591856053|FG001|Overall Study|Adverse Event|1|||
163859994|NCT01311713|591856054|FG002|Overall Study|Adverse Event|0|||
163859995|NCT01311713|591856055|FG003|Overall Study|Adverse Event|2|||
163859996|NCT01311713|591856056|FG004|Overall Study|Adverse Event|0|||
163859997|NCT01311713|591856057|FG005|Overall Study|Adverse Event|0|||
163859998|NCT01311713|591856058|FG006|Overall Study|Adverse Event|2|||
163859999|NCT01311713|591856052|FG000|Overall Study|Withdrawal by Subject|0|||
163860000|NCT01311713|591856053|FG001|Overall Study|Withdrawal by Subject|1|||
163860001|NCT01311713|591856054|FG002|Overall Study|Withdrawal by Subject|1|||
163860002|NCT01311713|591856055|FG003|Overall Study|Withdrawal by Subject|0|||
163860003|NCT01311713|591856056|FG004|Overall Study|Withdrawal by Subject|0|||
163860004|NCT01311713|591856057|FG005|Overall Study|Withdrawal by Subject|1|||
163860005|NCT01311713|591856058|FG006|Overall Study|Withdrawal by Subject|2|||
163860006|NCT01311713|591856052|FG000|Overall Study|Disease progression|3|||
163860007|NCT01311713|591856053|FG001|Overall Study|Disease progression|4|||
163860008|NCT01311713|591856054|FG002|Overall Study|Disease progression|3|||
163860009|NCT01311713|591856055|FG003|Overall Study|Disease progression|2|||
163860010|NCT01311713|591856056|FG004|Overall Study|Disease progression|4|||
163860011|NCT01311713|591856057|FG005|Overall Study|Disease progression|4|||
163860012|NCT01311713|591856058|FG006|Overall Study|Disease progression|5|||
163860013|NCT01311713|591856052|FG000|Overall Study|Lost to Follow-up|0|||
163860014|NCT01311713|591856053|FG001|Overall Study|Lost to Follow-up|0|||
163860015|NCT01311713|591856054|FG002|Overall Study|Lost to Follow-up|1|||
163860016|NCT01311713|591856055|FG003|Overall Study|Lost to Follow-up|0|||
163860017|NCT01311713|591856056|FG004|Overall Study|Lost to Follow-up|0|||
163860018|NCT01311713|591856057|FG005|Overall Study|Lost to Follow-up|0|||
163860019|NCT01311713|591856058|FG006|Overall Study|Lost to Follow-up|0|||
163860020|NCT01311713|591856052|FG000|Overall Study|Stopped taking study medication|0|||
163860021|NCT01311713|591856053|FG001|Overall Study|Stopped taking study medication|0|||
164196591|NCT01817075|593087610|FG000|Overall Study|Withdrawal by Subject|31|||
163860022|NCT01311713|591856054|FG002|Overall Study|Stopped taking study medication|0|||
163860023|NCT01311713|591856055|FG003|Overall Study|Stopped taking study medication|1|||
163860024|NCT01311713|591856056|FG004|Overall Study|Stopped taking study medication|1|||
163860025|NCT01311713|591856057|FG005|Overall Study|Stopped taking study medication|0|||
163860026|NCT01311713|591856058|FG006|Overall Study|Stopped taking study medication|0|||
163860027|NCT01311713|591856052|FG000|Overall Study|Enrolled but not treated|0|||
163860028|NCT01311713|591856053|FG001|Overall Study|Enrolled but not treated|0|||
163860029|NCT01311713|591856054|FG002|Overall Study|Enrolled but not treated|1|||
163966032|NCT00332839|592249138|FG000|Follow-up (Months 12 - 60)|Death|1|||
163860030|NCT01311713|591856055|FG003|Overall Study|Enrolled but not treated|0|||
163860031|NCT01311713|591856056|FG004|Overall Study|Enrolled but not treated|0|||
163860032|NCT01311713|591856057|FG005|Overall Study|Enrolled but not treated|0|||
163860033|NCT01311713|591856058|FG006|Overall Study|Enrolled but not treated|0|||
163860034|NCT01311713|591856052|FG000|Overall Study|Other than specified|0|||
163860035|NCT01311713|591856053|FG001|Overall Study|Other than specified|1|||
163860036|NCT01311713|591856054|FG002|Overall Study|Other than specified|2|||
163860037|NCT01311713|591856055|FG003|Overall Study|Other than specified|0|||
163860038|NCT01311713|591856056|FG004|Overall Study|Other than specified|0|||
163860039|NCT01311713|591856057|FG005|Overall Study|Other than specified|0|||
163860040|NCT01311713|591856058|FG006|Overall Study|Other than specified|0|||
163860041|NCT00980538|591856059|FG000|Overall Study|Lost to Follow-up|20|||
163860042|NCT00980538|591856059|FG000|Overall Study|Sponsor's Decision|4|||
163860043|NCT00980538|591856059|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
163860044|NCT00980538|591856059|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
163860045|NCT00980538|591856059|FG000|Overall Study|Switch to Commercially Available Medication|25|||
163860046|NCT00980538|591856059|FG000|Overall Study|Participant Non-Compliant|9|||
163860047|NCT00980538|591856059|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
163860048|NCT00980538|591856059|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
163860049|NCT00980538|591856059|FG000|Overall Study|Other|60|||
163860050|NCT00980538|591856059|FG000|Overall Study|Other|1|||
163860051|NCT05663866|591856060|FG000|Overall Study|Adverse Event|0|||
163860052|NCT05663866|591856061|FG001|Overall Study|Adverse Event|0|||
163860053|NCT05663866|591856062|FG002|Overall Study|Adverse Event|1|||
163860054|NCT05663866|591856063|FG003|Overall Study|Adverse Event|0|||
163860055|NCT05663866|591856060|FG000|Overall Study|Physician Decision|0|||
163860056|NCT05663866|591856061|FG001|Overall Study|Physician Decision|0|||
163860057|NCT05663866|591856062|FG002|Overall Study|Physician Decision|0|||
163860058|NCT05663866|591856063|FG003|Overall Study|Physician Decision|1|||
163860059|NCT05663866|591856060|FG000|Overall Study|Withdrawal by Subject|0|||
163860060|NCT05663866|591856061|FG001|Overall Study|Withdrawal by Subject|2|||
163860061|NCT05663866|591856062|FG002|Overall Study|Withdrawal by Subject|1|||
163860062|NCT05663866|591856063|FG003|Overall Study|Withdrawal by Subject|2|||
163860063|NCT05663866|591856060|FG000|Overall Study|Progressive disease|4|||
163860064|NCT05663866|591856061|FG001|Overall Study|Progressive disease|8|||
163860065|NCT05663866|591856062|FG002|Overall Study|Progressive disease|5|||
163860066|NCT05663866|591856063|FG003|Overall Study|Progressive disease|2|||
163860067|NCT05663866|591856060|FG000|Overall Study|Other|1|||
163860068|NCT05663866|591856061|FG001|Overall Study|Other|0|||
163860069|NCT05663866|591856062|FG002|Overall Study|Other|0|||
163860070|NCT05663866|591856063|FG003|Overall Study|Other|0|||
163860071|NCT05663866|591856060|FG000|Overall Study|Ongoing|1|||
163860072|NCT05663866|591856061|FG001|Overall Study|Ongoing|27|||
163860073|NCT05663866|591856062|FG002|Overall Study|Ongoing|6|||
163860074|NCT05663866|591856063|FG003|Overall Study|Ongoing|1|||
163860075|NCT02501811|591856064|FG000|Overall Study|Death|1|||
164196592|NCT01817075|593087611|FG001|Overall Study|Withdrawal by Subject|15|||
164196593|NCT01817075|593087610|FG000|Overall Study|Received Sorafenib after enrollment|0|||
164196594|NCT01817075|593087611|FG001|Overall Study|Received Sorafenib after enrollment|1|||
164196595|NCT01817075|593087610|FG000|Overall Study|Ineligible|0|||
164196596|NCT01817075|593087611|FG001|Overall Study|Ineligible|2|||
164196597|NCT04888494|593087612|FG000|Overall Study|Lost to Follow-up|2|||
164196598|NCT04888494|593087613|FG001|Overall Study|Lost to Follow-up|3|||
164196599|NCT04888494|593087612|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
164196600|NCT04888494|593087613|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
164196601|NCT01699750|593089833|FG000|Overall Study|Withdrew Consent|0|||
164196602|NCT01699750|593089834|FG001|Overall Study|Withdrew Consent|1|||
164196603|NCT01699750|593089833|FG000|Overall Study|Other|0|||
164196604|NCT01699750|593089834|FG001|Overall Study|Other|2|||
164196605|NCT01868646|593089837|FG000|Overall Study|Do not meet inclusion criteria|3|||
164196606|NCT01868646|593089838|FG001|Overall Study|Do not meet inclusion criteria|5|||
164196607|NCT01831427|593089839|FG000|Overall Study|Adverse Event|0|||
164196608|NCT01831427|593089840|FG001|Overall Study|Adverse Event|1|||
164196609|NCT01831427|593089841|FG002|Overall Study|Adverse Event|0|||
163860076|NCT02501811|591856065|FG001|Overall Study|Death|3|||
163860077|NCT02501811|591856066|FG002|Overall Study|Death|2|||
163860078|NCT02501811|591856067|FG003|Overall Study|Death|3|||
163860079|NCT02501811|591856064|FG000|Overall Study|Withdrawal by Subject|3|||
163860080|NCT02501811|591856065|FG001|Overall Study|Withdrawal by Subject|3|||
163860081|NCT02501811|591856066|FG002|Overall Study|Withdrawal by Subject|2|||
164196610|NCT01831427|593089842|FG003|Overall Study|Adverse Event|0|||
164196611|NCT01831427|593089843|FG004|Overall Study|Adverse Event|0|||
164196612|NCT01831427|593089844|FG005|Overall Study|Adverse Event|1|||
163860082|NCT02501811|591856067|FG003|Overall Study|Withdrawal by Subject|3|||
163860083|NCT02501811|591856064|FG000|Overall Study|Lost to Follow-up|0|||
163860084|NCT02501811|591856065|FG001|Overall Study|Lost to Follow-up|0|||
163860085|NCT02501811|591856066|FG002|Overall Study|Lost to Follow-up|2|||
163966033|NCT00332839|592249139|FG001|Follow-up (Months 12 - 60)|Death|1|||
163966034|NCT01876251|592249140|FG000|Overall Study|Clinical progression|1|||
163966035|NCT01876251|592249141|FG001|Overall Study|Clinical progression|0|||
163966036|NCT01876251|592249142|FG002|Overall Study|Clinical progression|0|||
163966037|NCT01876251|592249140|FG000|Overall Study|Death|2|||
163966038|NCT01876251|592249141|FG001|Overall Study|Death|0|||
163966039|NCT01876251|592249142|FG002|Overall Study|Death|1|||
163966040|NCT01876251|592249140|FG000|Overall Study|Participant started new treatment|1|||
163966041|NCT01876251|592249141|FG001|Overall Study|Participant started new treatment|0|||
163966042|NCT01876251|592249142|FG002|Overall Study|Participant started new treatment|1|||
163966043|NCT01876251|592249140|FG000|Overall Study|Participant refused further follow-up|0|||
163966044|NCT01876251|592249141|FG001|Overall Study|Participant refused further follow-up|0|||
163966045|NCT01876251|592249142|FG002|Overall Study|Participant refused further follow-up|1|||
163966046|NCT01876251|592249140|FG000|Overall Study|Study terminated|1|||
163966047|NCT01876251|592249141|FG001|Overall Study|Study terminated|0|||
163966048|NCT01876251|592249142|FG002|Overall Study|Study terminated|0|||
163966049|NCT01876251|592249140|FG000|Overall Study|Objective progression or relapse|10|||
163966050|NCT01876251|592249141|FG001|Overall Study|Objective progression or relapse|3|||
163966051|NCT01876251|592249142|FG002|Overall Study|Objective progression or relapse|8|||
163966052|NCT03876171|592249151|FG000|Overall Study|Withdrawal by Subject|3|||
163966053|NCT03876171|592249152|FG001|Overall Study|Withdrawal by Subject|3|||
163966054|NCT03876171|592249151|FG000|Overall Study|Re-arrest|0|||
163966055|NCT03876171|592249152|FG001|Overall Study|Re-arrest|4|||
163966056|NCT02012296|592249153|FG000|Overall Study|Lack of Efficacy|0|||
163966057|NCT02012296|592249154|FG001|Overall Study|Lack of Efficacy|0|||
163966058|NCT02012296|592249155|FG002|Overall Study|Lack of Efficacy|15|||
163966059|NCT02012296|592249153|FG000|Overall Study|Adverse Event|0|||
163966060|NCT02012296|592249154|FG001|Overall Study|Adverse Event|0|||
163966061|NCT02012296|592249155|FG002|Overall Study|Adverse Event|2|||
163966062|NCT02012296|592249153|FG000|Overall Study|Early study closure|0|||
163966063|NCT02012296|592249154|FG001|Overall Study|Early study closure|0|||
163966064|NCT02012296|592249155|FG002|Overall Study|Early study closure|5|||
163966065|NCT02012296|592249153|FG000|Overall Study|Protocol Violation|0|||
163966066|NCT02012296|592249154|FG001|Overall Study|Protocol Violation|1|||
163966067|NCT02012296|592249155|FG002|Overall Study|Protocol Violation|0|||
163966068|NCT00727649|592249158|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
163966069|NCT00727649|592249159|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
163966070|NCT00727649|592249158|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
163966071|NCT00727649|592249159|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
163966072|NCT00727649|592249158|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
163966073|NCT00727649|592249159|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
163966074|NCT00727649|592249158|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
163966075|NCT00727649|592249159|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
163966076|NCT00727649|592249158|FG000|Second Intervention (4-weeks)|Death|1|||
163966077|NCT00727649|592249159|FG001|Second Intervention (4-weeks)|Death|0|||
163966078|NCT00727649|592249158|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
163966079|NCT00727649|592249159|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
163966080|NCT00727649|592249158|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
163966081|NCT00727649|592249159|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
163966082|NCT01650285|592249160|FG000|Overall Study|Adverse Event|1|||
163966083|NCT04163900|592249161|FG000|Overall Study|Radiological disease progression|112|||
163966084|NCT04163900|592249162|FG001|Overall Study|Radiological disease progression|127|||
163966085|NCT04163900|592249161|FG000|Overall Study|Study closure|98|||
163966086|NCT04163900|592249162|FG001|Overall Study|Study closure|133|||
163966087|NCT04163900|592249161|FG000|Overall Study|Adverse Event|78|||
163966088|NCT04163900|592249162|FG001|Overall Study|Adverse Event|32|||
163966089|NCT04163900|592249161|FG000|Overall Study|Withdrawal by Subject|37|||
163966090|NCT04163900|592249162|FG001|Overall Study|Withdrawal by Subject|34|||
163966091|NCT04163900|592249161|FG000|Overall Study|Death|29|||
163966092|NCT04163900|592249162|FG001|Overall Study|Death|16|||
163966093|NCT04163900|592249161|FG000|Overall Study|Physician Decision|17|||
163966094|NCT04163900|592249162|FG001|Overall Study|Physician Decision|25|||
163966095|NCT04163900|592249161|FG000|Overall Study|Clinical disease progression|14|||
163966096|NCT04163900|592249162|FG001|Overall Study|Clinical disease progression|13|||
163966097|NCT04163900|592249161|FG000|Overall Study|Protocol Violation|3|||
163966098|NCT04163900|592249162|FG001|Overall Study|Protocol Violation|4|||
164307253|NCT02023697|593499225|FG002|Long-term Follow-up Period|Technical problems|1|||
163966099|NCT04163900|592249161|FG000|Overall Study|Lost to Follow-up|0|||
163966100|NCT04163900|592249162|FG001|Overall Study|Lost to Follow-up|1|||
163966101|NCT01830855|592249163|FG000|Overall Study|Other|7|||
163966102|NCT01830855|592249164|FG001|Overall Study|Other|1|||
163966103|NCT01830855|592249165|FG002|Overall Study|Other|4|||
163966104|NCT01830855|592249166|FG003|Overall Study|Other|4|||
163966105|NCT01830855|592249163|FG000|Overall Study|Medication error without associated AE|1|||
163966106|NCT01830855|592249164|FG001|Overall Study|Medication error without associated AE|0|||
163966107|NCT01830855|592249165|FG002|Overall Study|Medication error without associated AE|0|||
163966108|NCT01830855|592249166|FG003|Overall Study|Medication error without associated AE|1|||
163966109|NCT01830855|592249163|FG000|Overall Study|Pregnancy|3|||
163966110|NCT01830855|592249164|FG001|Overall Study|Pregnancy|1|||
163966111|NCT01830855|592249165|FG002|Overall Study|Pregnancy|2|||
163966112|NCT01830855|592249166|FG003|Overall Study|Pregnancy|1|||
163966113|NCT01830855|592249163|FG000|Overall Study|No longer meets eligibility criteria|11|||
163966114|NCT01830855|592249164|FG001|Overall Study|No longer meets eligibility criteria|2|||
163966115|NCT01830855|592249165|FG002|Overall Study|No longer meets eligibility criteria|3|||
163966116|NCT01830855|592249166|FG003|Overall Study|No longer meets eligibility criteria|5|||
163966117|NCT01830855|592249163|FG000|Overall Study|Adverse Event|11|||
163966118|NCT01830855|592249164|FG001|Overall Study|Adverse Event|5|||
163966119|NCT01830855|592249165|FG002|Overall Study|Adverse Event|6|||
163966120|NCT01830855|592249166|FG003|Overall Study|Adverse Event|3|||
163966121|NCT01830855|592249163|FG000|Overall Study|Protocol deviation|10|||
163966122|NCT01830855|592249164|FG001|Overall Study|Protocol deviation|5|||
163966123|NCT01830855|592249165|FG002|Overall Study|Protocol deviation|6|||
163966124|NCT01830855|592249166|FG003|Overall Study|Protocol deviation|6|||
163966125|NCT01830855|592249163|FG000|Overall Study|Withdrawal by Subject|33|||
163966126|NCT01830855|592249164|FG001|Overall Study|Withdrawal by Subject|14|||
163966127|NCT01830855|592249165|FG002|Overall Study|Withdrawal by Subject|10|||
163966128|NCT01830855|592249166|FG003|Overall Study|Withdrawal by Subject|12|||
163966129|NCT01830855|592249163|FG000|Overall Study|No longer willing to participate|32|||
163966130|NCT01830855|592249164|FG001|Overall Study|No longer willing to participate|13|||
163966131|NCT01830855|592249165|FG002|Overall Study|No longer willing to participate|12|||
163966132|NCT01830855|592249166|FG003|Overall Study|No longer willing to participate|17|||
163966133|NCT01830855|592249163|FG000|Overall Study|Lost to Follow-up|47|||
163966134|NCT01830855|592249164|FG001|Overall Study|Lost to Follow-up|20|||
163966135|NCT01830855|592249165|FG002|Overall Study|Lost to Follow-up|23|||
163966136|NCT01830855|592249166|FG003|Overall Study|Lost to Follow-up|33|||
163966137|NCT01950247|592249170|FG000|Overall Study|Withdrawal by Subject|28|||
163860086|NCT02501811|591856067|FG003|Overall Study|Lost to Follow-up|1|||
163860087|NCT04804605|591857826|FG000|Overall Study|Withdrawal by Subject|46|||
163860088|NCT04804605|591857827|FG001|Overall Study|Withdrawal by Subject|26|||
163860089|NCT04804605|591857828|FG002|Overall Study|Withdrawal by Subject|37|||
163860090|NCT04804605|591857829|FG003|Overall Study|Withdrawal by Subject|21|||
163860091|NCT04804605|591857826|FG000|Overall Study|Lost to Follow-up|47|||
163860092|NCT04804605|591857827|FG001|Overall Study|Lost to Follow-up|21|||
163860093|NCT04804605|591857828|FG002|Overall Study|Lost to Follow-up|30|||
163860094|NCT04804605|591857829|FG003|Overall Study|Lost to Follow-up|17|||
163860095|NCT04804605|591857826|FG000|Overall Study|Lack of Efficacy|28|||
163860096|NCT04804605|591857827|FG001|Overall Study|Lack of Efficacy|11|||
163860097|NCT04804605|591857828|FG002|Overall Study|Lack of Efficacy|37|||
163860098|NCT04804605|591857829|FG003|Overall Study|Lack of Efficacy|8|||
163860099|NCT04804605|591857826|FG000|Overall Study|Adverse Event|10|||
163860100|NCT04804605|591857827|FG001|Overall Study|Adverse Event|10|||
163860101|NCT04804605|591857828|FG002|Overall Study|Adverse Event|10|||
163860102|NCT04804605|591857829|FG003|Overall Study|Adverse Event|7|||
163860103|NCT04804605|591857826|FG000|Overall Study|Non-compliance|8|||
163860104|NCT04804605|591857827|FG001|Overall Study|Non-compliance|3|||
163860105|NCT04804605|591857828|FG002|Overall Study|Non-compliance|5|||
163860106|NCT04804605|591857829|FG003|Overall Study|Non-compliance|1|||
163860107|NCT04804605|591857826|FG000|Overall Study|Physician Decision|3|||
163860108|NCT04804605|591857827|FG001|Overall Study|Physician Decision|0|||
163860109|NCT04804605|591857828|FG002|Overall Study|Physician Decision|5|||
163860110|NCT04804605|591857829|FG003|Overall Study|Physician Decision|0|||
163860111|NCT04804605|591857826|FG000|Overall Study|Protocol Violation|1|||
163860112|NCT04804605|591857827|FG001|Overall Study|Protocol Violation|0|||
163860113|NCT04804605|591857828|FG002|Overall Study|Protocol Violation|0|||
163860114|NCT04804605|591857829|FG003|Overall Study|Protocol Violation|1|||
163860115|NCT04804605|591857826|FG000|Overall Study|Miscellaneous|7|||
163860116|NCT04804605|591857827|FG001|Overall Study|Miscellaneous|3|||
163966138|NCT01950247|592249171|FG001|Overall Study|Withdrawal by Subject|13|||
163966139|NCT01950247|592249170|FG000|Overall Study|Lost to Follow-up|18|||
163966140|NCT01950247|592249171|FG001|Overall Study|Lost to Follow-up|16|||
163966141|NCT01950247|592249170|FG000|Overall Study|Physician Decision|3|||
163966142|NCT01950247|592249171|FG001|Overall Study|Physician Decision|4|||
163966143|NCT01950247|592249170|FG000|Overall Study|Adverse Event|3|||
163860117|NCT04804605|591857828|FG002|Overall Study|Miscellaneous|4|||
163860118|NCT04804605|591857829|FG003|Overall Study|Miscellaneous|2|||
163860119|NCT01249092|591857833|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
163966144|NCT01950247|592249171|FG001|Overall Study|Adverse Event|2|||
163966145|NCT01950247|592249170|FG000|Overall Study|Death|1|||
163966146|NCT01950247|592249171|FG001|Overall Study|Death|1|||
163966147|NCT01950247|592249170|FG000|Overall Study|Not Defined|4|||
163966148|NCT01950247|592249171|FG001|Overall Study|Not Defined|10|||
163966149|NCT01798992|592249174|FG000|Overall Study|Administrative withdrawal|0|||
163966150|NCT01798992|592249175|FG001|Overall Study|Administrative withdrawal|1|||
163860120|NCT01249092|591857833|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
164134884|NCT02132754|592857399|FG032|Overall Study|Excluded Medication|0|||
163860121|NCT04033432|591857837|FG000|Overall Study|Progressive Disease|8|||
163860122|NCT04033432|591857837|FG000|Overall Study|Adverse Event|4|||
163860123|NCT04033432|591857837|FG000|Overall Study|Death|1|||
163860124|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860125|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
163860126|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860127|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860128|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860129|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860130|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860131|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860132|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860133|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860134|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860135|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860136|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
163860137|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Death|0|||
163860138|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Death|0|||
163860139|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Death|0|||
163860140|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Death|1|||
163860141|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Death|0|||
163860142|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Death|0|||
163860143|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Death|0|||
163860144|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Death|0|||
163860145|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Death|0|||
163860146|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Death|0|||
163860147|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Death|0|||
163860148|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Death|0|||
163860149|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Death|0|||
163860150|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860151|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163860152|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163860153|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
163860154|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
163860155|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860156|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860157|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860158|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860159|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860160|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860161|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860162|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
163860163|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860164|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
163860165|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860166|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860167|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860168|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860169|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860170|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860171|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860172|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860173|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860174|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860175|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
163860176|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860177|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860178|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
163860179|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860180|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860181|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860182|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860183|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860184|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860185|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860186|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860187|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163966151|NCT01798992|592249176|FG002|Overall Study|Administrative withdrawal|0|||
163966152|NCT01798992|592249177|FG003|Overall Study|Administrative withdrawal|1|||
163966153|NCT01798992|592249174|FG000|Overall Study|Lost to Follow-up|0|||
163966154|NCT01798992|592249175|FG001|Overall Study|Lost to Follow-up|1|||
163966155|NCT01798992|592249176|FG002|Overall Study|Lost to Follow-up|1|||
163966156|NCT01798992|592249177|FG003|Overall Study|Lost to Follow-up|0|||
163966157|NCT01798992|592249174|FG000|Overall Study|Insufficient biopsy tissue|0|||
163966158|NCT01798992|592249175|FG001|Overall Study|Insufficient biopsy tissue|0|||
163966159|NCT01798992|592249176|FG002|Overall Study|Insufficient biopsy tissue|1|||
163966160|NCT01798992|592249177|FG003|Overall Study|Insufficient biopsy tissue|0|||
163966161|NCT03842163|592249178|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
163966162|NCT03842163|592249178|FG000|Overall Study|Scintigraphy was not performed|44|||
163966163|NCT01187550|592249180|FG000|Overall Study|Protocol Violation|3|||
163966164|NCT01187550|592249181|FG001|Overall Study|Protocol Violation|1|||
163966165|NCT01187550|592249180|FG000|Overall Study|Other|3|||
163966166|NCT01187550|592249181|FG001|Overall Study|Other|0|||
163966167|NCT01187550|592249180|FG000|Overall Study|Randomized but not treated|8|||
163966168|NCT01187550|592249181|FG001|Overall Study|Randomized but not treated|0|||
163966169|NCT00129623|592249182|FG000|Overall Study|Adverse Event|3|||
163966170|NCT00129623|592249183|FG001|Overall Study|Adverse Event|7|||
163966171|NCT00129623|592249182|FG000|Overall Study|Refused Treatment|5|||
163966172|NCT00129623|592249183|FG001|Overall Study|Refused Treatment|3|||
163966173|NCT00129623|592249182|FG000|Overall Study|Failure to Return|1|||
163966174|NCT00129623|592249183|FG001|Overall Study|Failure to Return|1|||
163966175|NCT00129623|592249182|FG000|Overall Study|Relocated job out of state|1|||
163966176|NCT00129623|592249183|FG001|Overall Study|Relocated job out of state|0|||
163966177|NCT00129623|592249182|FG000|Overall Study|Uncertainty to return|0|||
163966178|NCT00129623|592249183|FG001|Overall Study|Uncertainty to return|1|||
163966179|NCT00596934|592249184|FG000|Overall Study|Protocol Violation|1|||
163966180|NCT00596934|592249184|FG000|Overall Study|Withdrawal by Subject|1|||
163966181|NCT01296035|592249185|FG000|Overall Study|Withdrawal by Subject|1|||
163966182|NCT01245387|592249192|FG000|Overall Study|Lost to Follow-up|106|||
163966183|NCT01245387|592249192|FG000|Overall Study|Lack of Efficacy|195|||
163966184|NCT01245387|592249192|FG000|Overall Study|Adverse Event|9|||
163966185|NCT01245387|592249192|FG000|Overall Study|Death|3|||
163966186|NCT01245387|592249192|FG000|Overall Study|Other|131|||
163966187|NCT01245387|592249192|FG000|Overall Study|Missing discontinuation status|369|||
163860188|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
163860189|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
163860190|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
163860191|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
163860192|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
163860193|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
163860194|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860195|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860196|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860197|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860198|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860199|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860200|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860201|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
163860202|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860203|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860204|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860205|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860206|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
163860207|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860208|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860209|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860210|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860211|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163966188|NCT00601705|592249193|FG000|Overall Study|Withdrawal by Subject|1|||
163966189|NCT04513665|592249194|FG000|Overall Study|Adverse Event|2|||
163966190|NCT04513665|592249195|FG001|Overall Study|Adverse Event|0|||
163966191|NCT04513665|592249194|FG000|Overall Study|Lack of Efficacy|14|||
163966192|NCT04513665|592249195|FG001|Overall Study|Lack of Efficacy|0|||
163966193|NCT02146599|592249199|FG000|Overall Study|Failed to meet inclusion criteria|5|||
163966194|NCT02101021|592249200|FG000|Overall Study|Death|4|||
163966195|NCT02101021|592249201|FG001|Overall Study|Death|3|||
163966196|NCT02101021|592249202|FG002|Overall Study|Death|6|||
163966197|NCT02101021|592249203|FG003|Overall Study|Death|0|||
163860212|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860213|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860214|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
163860215|NCT04936035|591857838|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
163966198|NCT02101021|592249204|FG004|Overall Study|Death|3|||
163966199|NCT02101021|592249200|FG000|Overall Study|Withdrew Consent from study|1|||
163966200|NCT02101021|592249201|FG001|Overall Study|Withdrew Consent from study|1|||
164196613|NCT01831427|593089845|FG006|Overall Study|Adverse Event|0|||
164196614|NCT01831427|593089846|FG007|Overall Study|Adverse Event|1|||
164196615|NCT01831427|593089847|FG008|Overall Study|Adverse Event|0|||
163860216|NCT04936035|591857839|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860217|NCT04936035|591857840|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860218|NCT04936035|591857841|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860219|NCT04936035|591857842|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860220|NCT04936035|591857843|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860221|NCT04936035|591857844|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860222|NCT04936035|591857845|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860223|NCT04936035|591857846|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860224|NCT04936035|591857847|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860225|NCT04936035|591857848|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860226|NCT04936035|591857849|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860227|NCT04936035|591857850|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
163860228|NCT04936035|591857838|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860229|NCT04936035|591857839|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860230|NCT04936035|591857840|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860231|NCT04936035|591857841|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860232|NCT04936035|591857842|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860233|NCT04936035|591857843|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
163860234|NCT04936035|591857844|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
163860235|NCT04936035|591857845|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860236|NCT04936035|591857846|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
163860237|NCT04936035|591857847|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
163860238|NCT04936035|591857848|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
163860239|NCT04936035|591857849|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
163860240|NCT04936035|591857850|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
163860241|NCT04936035|591857838|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163860242|NCT04936035|591857839|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163966201|NCT02101021|592249202|FG002|Overall Study|Withdrew Consent from study|0|||
163966202|NCT02101021|592249203|FG003|Overall Study|Withdrew Consent from study|2|||
164196616|NCT01831427|593089848|FG009|Overall Study|Adverse Event|0|||
164196617|NCT01831427|593089849|FG010|Overall Study|Adverse Event|2|||
164196618|NCT01831427|593089839|FG000|Overall Study|Investigator's Discretion|0|||
164196619|NCT01831427|593089840|FG001|Overall Study|Investigator's Discretion|0|||
164196620|NCT01831427|593089841|FG002|Overall Study|Investigator's Discretion|0|||
164196621|NCT01831427|593089842|FG003|Overall Study|Investigator's Discretion|1|||
164196622|NCT01831427|593089843|FG004|Overall Study|Investigator's Discretion|0|||
164196623|NCT01831427|593089844|FG005|Overall Study|Investigator's Discretion|0|||
164196624|NCT01831427|593089845|FG006|Overall Study|Investigator's Discretion|0|||
164196625|NCT01831427|593089846|FG007|Overall Study|Investigator's Discretion|0|||
164196626|NCT01831427|593089847|FG008|Overall Study|Investigator's Discretion|0|||
164196627|NCT01831427|593089848|FG009|Overall Study|Investigator's Discretion|0|||
164196628|NCT01831427|593089849|FG010|Overall Study|Investigator's Discretion|0|||
164196629|NCT01831427|593089839|FG000|Overall Study|Withdrew Consent|0|||
164196630|NCT01831427|593089840|FG001|Overall Study|Withdrew Consent|0|||
164196631|NCT01831427|593089841|FG002|Overall Study|Withdrew Consent|0|||
164196632|NCT01831427|593089842|FG003|Overall Study|Withdrew Consent|0|||
164196633|NCT01831427|593089843|FG004|Overall Study|Withdrew Consent|0|||
164196634|NCT01831427|593089844|FG005|Overall Study|Withdrew Consent|0|||
164196635|NCT01831427|593089845|FG006|Overall Study|Withdrew Consent|2|||
164196636|NCT01831427|593089846|FG007|Overall Study|Withdrew Consent|0|||
164196637|NCT01831427|593089847|FG008|Overall Study|Withdrew Consent|0|||
164196638|NCT01831427|593089848|FG009|Overall Study|Withdrew Consent|1|||
164196639|NCT01831427|593089849|FG010|Overall Study|Withdrew Consent|1|||
164196640|NCT01249417|593089852|FG000|Randomised Population|Study treatment not received|0|||
164196641|NCT01249417|593089853|FG001|Randomised Population|Study treatment not received|0|||
164196642|NCT01249417|593089854|FG002|Randomised Population|Study treatment not received|2|||
164196643|NCT01249417|593089852|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
163860243|NCT04936035|591857840|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163860244|NCT04936035|591857841|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163860245|NCT04936035|591857842|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163860246|NCT04936035|591857843|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163860247|NCT04936035|591857844|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163860248|NCT04936035|591857845|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163860249|NCT04936035|591857846|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
163860250|NCT04936035|591857847|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
163860251|NCT04936035|591857848|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163860252|NCT04936035|591857849|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
163860253|NCT04936035|591857850|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
163860254|NCT04936035|591857838|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860255|NCT04936035|591857839|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860256|NCT04936035|591857840|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860257|NCT04936035|591857841|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860258|NCT04936035|591857842|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860259|NCT04936035|591857843|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860260|NCT04936035|591857844|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860261|NCT04936035|591857845|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860262|NCT04936035|591857846|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860263|NCT04936035|591857847|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
163860264|NCT04936035|591857848|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860265|NCT04936035|591857849|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
163860266|NCT04936035|591857850|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
163860267|NCT04936035|591857838|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860268|NCT04936035|591857839|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860269|NCT04936035|591857840|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860270|NCT04936035|591857841|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860271|NCT04936035|591857842|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860272|NCT04936035|591857843|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
163860273|NCT04936035|591857844|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860274|NCT04936035|591857845|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
163860275|NCT04936035|591857846|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860276|NCT04936035|591857847|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860277|NCT04936035|591857848|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860278|NCT04936035|591857849|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860279|NCT04936035|591857850|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
163860280|NCT04936035|591857838|FG000|Post-6-Month DB Period (30months)|Death|0|||
163860281|NCT04936035|591857839|FG001|Post-6-Month DB Period (30months)|Death|0|||
163860282|NCT04936035|591857840|FG002|Post-6-Month DB Period (30months)|Death|0|||
163860283|NCT04936035|591857841|FG003|Post-6-Month DB Period (30months)|Death|0|||
163860284|NCT04936035|591857842|FG004|Post-6-Month DB Period (30months)|Death|0|||
163860285|NCT04936035|591857843|FG005|Post-6-Month DB Period (30months)|Death|0|||
163860286|NCT04936035|591857844|FG006|Post-6-Month DB Period (30months)|Death|0|||
163860287|NCT04936035|591857845|FG007|Post-6-Month DB Period (30months)|Death|0|||
163860288|NCT04936035|591857846|FG008|Post-6-Month DB Period (30months)|Death|0|||
163860289|NCT04936035|591857847|FG009|Post-6-Month DB Period (30months)|Death|1|||
163860290|NCT04936035|591857848|FG010|Post-6-Month DB Period (30months)|Death|0|||
163860291|NCT04936035|591857849|FG011|Post-6-Month DB Period (30months)|Death|0|||
163860292|NCT04936035|591857850|FG012|Post-6-Month DB Period (30months)|Death|0|||
163860293|NCT04936035|591857838|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860294|NCT04936035|591857839|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860295|NCT04936035|591857840|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860296|NCT04936035|591857841|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860297|NCT04936035|591857842|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860298|NCT04936035|591857843|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
163860299|NCT04936035|591857844|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860300|NCT04936035|591857845|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860301|NCT04936035|591857846|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860302|NCT04936035|591857847|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
163860303|NCT04936035|591857848|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
163860304|NCT04936035|591857849|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860305|NCT04936035|591857850|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
163860306|NCT05827926|591857855|FG000|Overall Study|Lost to Follow-up|1|||
163860307|NCT05827926|591857856|FG001|Overall Study|Lost to Follow-up|0|||
163860308|NCT05827926|591857857|FG002|Overall Study|Lost to Follow-up|0|||
163860309|NCT05827926|591857858|FG003|Overall Study|Lost to Follow-up|0|||
163860310|NCT05827926|591857859|FG004|Overall Study|Lost to Follow-up|0|||
163860311|NCT05827926|591857860|FG005|Overall Study|Lost to Follow-up|1|||
164196644|NCT01249417|593089853|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
164196645|NCT01249417|593089854|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
164196646|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Other|0|||
164196647|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Other|0|||
164196648|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Other|1|||
164196649|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
164196650|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
164196651|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
164196652|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
164196653|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
164196654|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
164196655|NCT01249417|593089852|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
164196656|NCT01249417|593089853|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
164196657|NCT01249417|593089854|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
164196658|NCT01854697|593089855|FG000|Overall Study|Adverse Event|1|||
164196659|NCT01854697|593089856|FG001|Overall Study|Adverse Event|0|||
164196660|NCT01854697|593089857|FG002|Overall Study|Adverse Event|0|||
164196661|NCT01854697|593089858|FG003|Overall Study|Adverse Event|0|||
164196662|NCT01854697|593089859|FG004|Overall Study|Adverse Event|1|||
164196663|NCT01854697|593089855|FG000|Overall Study|Lost to Follow-up|4|||
164196664|NCT01854697|593089856|FG001|Overall Study|Lost to Follow-up|1|||
164196665|NCT01854697|593089857|FG002|Overall Study|Lost to Follow-up|1|||
164196666|NCT01854697|593089858|FG003|Overall Study|Lost to Follow-up|2|||
163860312|NCT05827926|591857861|FG006|Overall Study|Lost to Follow-up|0|||
163860313|NCT05827926|591857862|FG007|Overall Study|Lost to Follow-up|0|||
163860314|NCT05827926|591857863|FG008|Overall Study|Lost to Follow-up|0|||
164196667|NCT01854697|593089859|FG004|Overall Study|Lost to Follow-up|0|||
164196668|NCT01854697|593089855|FG000|Overall Study|To enter another AbbVie study|1|||
164196669|NCT01854697|593089856|FG001|Overall Study|To enter another AbbVie study|0|||
164196670|NCT01854697|593089857|FG002|Overall Study|To enter another AbbVie study|0|||
164196671|NCT01854697|593089858|FG003|Overall Study|To enter another AbbVie study|0|||
164196672|NCT01854697|593089859|FG004|Overall Study|To enter another AbbVie study|1|||
164196673|NCT01854697|593089855|FG000|Overall Study|Withdrew Consent|0|||
164196674|NCT01854697|593089856|FG001|Overall Study|Withdrew Consent|1|||
164196675|NCT01854697|593089857|FG002|Overall Study|Withdrew Consent|0|||
164196676|NCT01854697|593089858|FG003|Overall Study|Withdrew Consent|1|||
164196677|NCT01854697|593089859|FG004|Overall Study|Withdrew Consent|0|||
164196678|NCT01854697|593089855|FG000|Overall Study|Other|0|||
164196679|NCT01854697|593089856|FG001|Overall Study|Other|1|||
164196680|NCT01854697|593089857|FG002|Overall Study|Other|1|||
164196681|NCT01854697|593089858|FG003|Overall Study|Other|0|||
164196682|NCT01854697|593089859|FG004|Overall Study|Other|0|||
164196683|NCT05556148|593089864|FG000|Overall Study|Early Termination|29|||
163860315|NCT05827926|591857864|FG009|Overall Study|Lost to Follow-up|0|||
163860316|NCT05827926|591857865|FG010|Overall Study|Lost to Follow-up|0|||
163860317|NCT05827926|591857866|FG011|Overall Study|Lost to Follow-up|0|||
163860318|NCT05827926|591857867|FG012|Overall Study|Lost to Follow-up|1|||
163860319|NCT05827926|591857868|FG013|Overall Study|Lost to Follow-up|1|||
163860320|NCT05827926|591857869|FG014|Overall Study|Lost to Follow-up|0|||
163860321|NCT05827926|591857870|FG015|Overall Study|Lost to Follow-up|1|||
163860322|NCT05827926|591857871|FG016|Overall Study|Lost to Follow-up|2|||
163860323|NCT05827926|591857872|FG017|Overall Study|Lost to Follow-up|0|||
163860324|NCT05827926|591857873|FG018|Overall Study|Lost to Follow-up|0|||
163860325|NCT05827926|591857874|FG019|Overall Study|Lost to Follow-up|0|||
163860326|NCT05827926|591857875|FG020|Overall Study|Lost to Follow-up|1|||
163860327|NCT05827926|591857876|FG021|Overall Study|Lost to Follow-up|2|||
163860328|NCT05827926|591857877|FG022|Overall Study|Lost to Follow-up|1|||
163860329|NCT05827926|591857878|FG023|Overall Study|Lost to Follow-up|1|||
163860330|NCT05827926|591857879|FG024|Overall Study|Lost to Follow-up|2|||
163860331|NCT05827926|591857880|FG025|Overall Study|Lost to Follow-up|1|||
163860332|NCT05827926|591857881|FG026|Overall Study|Lost to Follow-up|4|||
163860333|NCT05827926|591857882|FG027|Overall Study|Lost to Follow-up|1|||
163860334|NCT05827926|591857883|FG028|Overall Study|Lost to Follow-up|2|||
164196684|NCT05556148|593089864|FG000|Overall Study|Baseline Tasks Expired|4|||
163860335|NCT05827926|591857884|FG029|Overall Study|Lost to Follow-up|1|||
163860336|NCT05827926|591857885|FG030|Overall Study|Lost to Follow-up|5|||
163860337|NCT05827926|591857886|FG031|Overall Study|Lost to Follow-up|0|||
163860338|NCT05827926|591857887|FG032|Overall Study|Lost to Follow-up|3|||
163860339|NCT05827926|591857888|FG033|Overall Study|Lost to Follow-up|2|||
164196685|NCT05556148|593089864|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
164196686|NCT05556148|593089864|FG000|Overall Study|No Longer Wished to Participate|1|||
164196687|NCT05556148|593089864|FG000|Overall Study|Bacterial Conjunctivitis|1|||
164196688|NCT01171898|593089865|FG000|Overall Study|Death|0|||
164196689|NCT01171898|593089866|FG001|Overall Study|Death|0|||
163860340|NCT05827926|591857889|FG034|Overall Study|Lost to Follow-up|1|||
163860341|NCT05827926|591857890|FG035|Overall Study|Lost to Follow-up|3|||
163860342|NCT05827926|591857891|FG036|Overall Study|Lost to Follow-up|4|||
163860343|NCT05827926|591857855|FG000|Overall Study|Withdrawal by Subject|1|||
163860344|NCT05827926|591857856|FG001|Overall Study|Withdrawal by Subject|0|||
163860345|NCT05827926|591857857|FG002|Overall Study|Withdrawal by Subject|1|||
163860346|NCT05827926|591857858|FG003|Overall Study|Withdrawal by Subject|1|||
163860347|NCT05827926|591857859|FG004|Overall Study|Withdrawal by Subject|0|||
163860348|NCT05827926|591857860|FG005|Overall Study|Withdrawal by Subject|0|||
163860349|NCT05827926|591857861|FG006|Overall Study|Withdrawal by Subject|0|||
163860350|NCT05827926|591857862|FG007|Overall Study|Withdrawal by Subject|0|||
163860351|NCT05827926|591857863|FG008|Overall Study|Withdrawal by Subject|0|||
163860352|NCT05827926|591857864|FG009|Overall Study|Withdrawal by Subject|0|||
163860353|NCT05827926|591857865|FG010|Overall Study|Withdrawal by Subject|0|||
163860354|NCT05827926|591857866|FG011|Overall Study|Withdrawal by Subject|0|||
163860355|NCT05827926|591857867|FG012|Overall Study|Withdrawal by Subject|1|||
163860356|NCT05827926|591857868|FG013|Overall Study|Withdrawal by Subject|1|||
163860357|NCT05827926|591857869|FG014|Overall Study|Withdrawal by Subject|1|||
163860358|NCT05827926|591857870|FG015|Overall Study|Withdrawal by Subject|2|||
163860359|NCT05827926|591857871|FG016|Overall Study|Withdrawal by Subject|1|||
163860360|NCT05827926|591857872|FG017|Overall Study|Withdrawal by Subject|1|||
163860361|NCT05827926|591857873|FG018|Overall Study|Withdrawal by Subject|0|||
163860362|NCT05827926|591857874|FG019|Overall Study|Withdrawal by Subject|0|||
163860363|NCT05827926|591857875|FG020|Overall Study|Withdrawal by Subject|1|||
163860364|NCT05827926|591857876|FG021|Overall Study|Withdrawal by Subject|0|||
163860365|NCT05827926|591857877|FG022|Overall Study|Withdrawal by Subject|0|||
163860366|NCT05827926|591857878|FG023|Overall Study|Withdrawal by Subject|2|||
163860367|NCT05827926|591857879|FG024|Overall Study|Withdrawal by Subject|1|||
163860368|NCT05827926|591857880|FG025|Overall Study|Withdrawal by Subject|0|||
163860369|NCT05827926|591857881|FG026|Overall Study|Withdrawal by Subject|0|||
163860370|NCT05827926|591857882|FG027|Overall Study|Withdrawal by Subject|1|||
163860371|NCT05827926|591857883|FG028|Overall Study|Withdrawal by Subject|0|||
163860372|NCT05827926|591857884|FG029|Overall Study|Withdrawal by Subject|0|||
163860373|NCT05827926|591857885|FG030|Overall Study|Withdrawal by Subject|0|||
163860374|NCT05827926|591857886|FG031|Overall Study|Withdrawal by Subject|2|||
163860375|NCT05827926|591857887|FG032|Overall Study|Withdrawal by Subject|0|||
163860376|NCT05827926|591857888|FG033|Overall Study|Withdrawal by Subject|0|||
163860377|NCT05827926|591857889|FG034|Overall Study|Withdrawal by Subject|0|||
163860378|NCT05827926|591857890|FG035|Overall Study|Withdrawal by Subject|0|||
163860379|NCT05827926|591857891|FG036|Overall Study|Withdrawal by Subject|1|||
163860380|NCT05827926|591857855|FG000|Overall Study|Other Than Specified|0|||
163860381|NCT05827926|591857856|FG001|Overall Study|Other Than Specified|0|||
163860382|NCT05827926|591857857|FG002|Overall Study|Other Than Specified|0|||
163860383|NCT05827926|591857858|FG003|Overall Study|Other Than Specified|1|||
163860384|NCT05827926|591857859|FG004|Overall Study|Other Than Specified|0|||
163860385|NCT05827926|591857860|FG005|Overall Study|Other Than Specified|0|||
163860386|NCT05827926|591857861|FG006|Overall Study|Other Than Specified|1|||
163860387|NCT05827926|591857862|FG007|Overall Study|Other Than Specified|0|||
163860388|NCT05827926|591857863|FG008|Overall Study|Other Than Specified|0|||
163860389|NCT05827926|591857864|FG009|Overall Study|Other Than Specified|0|||
163860390|NCT05827926|591857865|FG010|Overall Study|Other Than Specified|0|||
163860391|NCT05827926|591857866|FG011|Overall Study|Other Than Specified|0|||
163860392|NCT05827926|591857867|FG012|Overall Study|Other Than Specified|0|||
163860393|NCT05827926|591857868|FG013|Overall Study|Other Than Specified|1|||
163860394|NCT05827926|591857869|FG014|Overall Study|Other Than Specified|0|||
163860395|NCT05827926|591857870|FG015|Overall Study|Other Than Specified|1|||
163860396|NCT05827926|591857871|FG016|Overall Study|Other Than Specified|0|||
163860397|NCT05827926|591857872|FG017|Overall Study|Other Than Specified|0|||
163860398|NCT05827926|591857873|FG018|Overall Study|Other Than Specified|0|||
163860399|NCT05827926|591857874|FG019|Overall Study|Other Than Specified|0|||
163860400|NCT05827926|591857875|FG020|Overall Study|Other Than Specified|0|||
163860401|NCT05827926|591857876|FG021|Overall Study|Other Than Specified|1|||
163860402|NCT05827926|591857877|FG022|Overall Study|Other Than Specified|1|||
163860403|NCT05827926|591857878|FG023|Overall Study|Other Than Specified|0|||
163860404|NCT05827926|591857879|FG024|Overall Study|Other Than Specified|0|||
163860405|NCT05827926|591857880|FG025|Overall Study|Other Than Specified|1|||
163860406|NCT05827926|591857881|FG026|Overall Study|Other Than Specified|0|||
163860407|NCT05827926|591857882|FG027|Overall Study|Other Than Specified|0|||
163860408|NCT05827926|591857883|FG028|Overall Study|Other Than Specified|0|||
163860409|NCT05827926|591857884|FG029|Overall Study|Other Than Specified|0|||
163860410|NCT05827926|591857885|FG030|Overall Study|Other Than Specified|0|||
163860411|NCT05827926|591857886|FG031|Overall Study|Other Than Specified|1|||
163860412|NCT05827926|591857887|FG032|Overall Study|Other Than Specified|0|||
163860413|NCT05827926|591857888|FG033|Overall Study|Other Than Specified|0|||
163860414|NCT05827926|591857889|FG034|Overall Study|Other Than Specified|0|||
163860415|NCT05827926|591857890|FG035|Overall Study|Other Than Specified|0|||
163860416|NCT05827926|591857891|FG036|Overall Study|Other Than Specified|0|||
163860417|NCT05827926|591857855|FG000|Overall Study|Physician Decision|0|||
163860418|NCT05827926|591857856|FG001|Overall Study|Physician Decision|0|||
163860419|NCT05827926|591857857|FG002|Overall Study|Physician Decision|0|||
163860420|NCT05827926|591857858|FG003|Overall Study|Physician Decision|0|||
163860421|NCT05827926|591857859|FG004|Overall Study|Physician Decision|0|||
163860422|NCT05827926|591857860|FG005|Overall Study|Physician Decision|0|||
163860423|NCT05827926|591857861|FG006|Overall Study|Physician Decision|0|||
163860424|NCT05827926|591857862|FG007|Overall Study|Physician Decision|0|||
163860425|NCT05827926|591857863|FG008|Overall Study|Physician Decision|0|||
163860426|NCT05827926|591857864|FG009|Overall Study|Physician Decision|0|||
163860427|NCT05827926|591857865|FG010|Overall Study|Physician Decision|0|||
163860428|NCT05827926|591857866|FG011|Overall Study|Physician Decision|0|||
163860429|NCT05827926|591857867|FG012|Overall Study|Physician Decision|0|||
163860430|NCT05827926|591857868|FG013|Overall Study|Physician Decision|0|||
163860431|NCT05827926|591857869|FG014|Overall Study|Physician Decision|0|||
163860432|NCT05827926|591857870|FG015|Overall Study|Physician Decision|0|||
163860433|NCT05827926|591857871|FG016|Overall Study|Physician Decision|0|||
163860434|NCT05827926|591857872|FG017|Overall Study|Physician Decision|0|||
163860435|NCT05827926|591857873|FG018|Overall Study|Physician Decision|1|||
163860436|NCT05827926|591857874|FG019|Overall Study|Physician Decision|0|||
163860437|NCT05827926|591857875|FG020|Overall Study|Physician Decision|0|||
163860438|NCT05827926|591857876|FG021|Overall Study|Physician Decision|0|||
163860439|NCT05827926|591857877|FG022|Overall Study|Physician Decision|0|||
163860440|NCT05827926|591857878|FG023|Overall Study|Physician Decision|0|||
163860441|NCT05827926|591857879|FG024|Overall Study|Physician Decision|0|||
163860442|NCT05827926|591857880|FG025|Overall Study|Physician Decision|0|||
163860443|NCT05827926|591857881|FG026|Overall Study|Physician Decision|0|||
163860444|NCT05827926|591857882|FG027|Overall Study|Physician Decision|0|||
163860445|NCT05827926|591857883|FG028|Overall Study|Physician Decision|0|||
163860446|NCT05827926|591857884|FG029|Overall Study|Physician Decision|0|||
163860447|NCT05827926|591857885|FG030|Overall Study|Physician Decision|0|||
163860448|NCT05827926|591857886|FG031|Overall Study|Physician Decision|0|||
163860449|NCT05827926|591857887|FG032|Overall Study|Physician Decision|0|||
163860450|NCT05827926|591857888|FG033|Overall Study|Physician Decision|0|||
163860451|NCT05827926|591857889|FG034|Overall Study|Physician Decision|0|||
163860452|NCT05827926|591857890|FG035|Overall Study|Physician Decision|0|||
163860453|NCT05827926|591857891|FG036|Overall Study|Physician Decision|0|||
163860454|NCT01242085|591857899|FG000|Overall Study|Withdrawal by Subject|4|||
163860455|NCT01242085|591857900|FG001|Overall Study|Withdrawal by Subject|2|||
163860456|NCT01242085|591857901|FG002|Overall Study|Withdrawal by Subject|0|||
163860457|NCT01242085|591857899|FG000|Overall Study|medically unable to have surgery|4|||
163860458|NCT01242085|591857900|FG001|Overall Study|medically unable to have surgery|5|||
163860459|NCT01242085|591857901|FG002|Overall Study|medically unable to have surgery|0|||
163860460|NCT02430532|591857903|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
163860461|NCT02430532|591857904|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
163860462|NCT02430532|591857903|FG000|Overall Study|Consent Withdrawn|0|||
163860463|NCT02430532|591857904|FG001|Overall Study|Consent Withdrawn|2|||
163860464|NCT02430532|591857903|FG000|Overall Study|Adverse Event|0|||
163860465|NCT02430532|591857904|FG001|Overall Study|Adverse Event|1|||
163860466|NCT04511650|591857905|FG000|Overall Study|Lost to Follow-up|1|||
163860467|NCT04511650|591857906|FG001|Overall Study|Lost to Follow-up|0|||
163860468|NCT04511650|591857907|FG002|Overall Study|Lost to Follow-up|0|||
163860469|NCT04511650|591857905|FG000|Overall Study|Withdrawal by Subject|1|||
163860470|NCT04511650|591857906|FG001|Overall Study|Withdrawal by Subject|0|||
163860471|NCT04511650|591857907|FG002|Overall Study|Withdrawal by Subject|0|||
163860472|NCT04511650|591857905|FG000|Overall Study|reason not provided|0|||
163860473|NCT04511650|591857906|FG001|Overall Study|reason not provided|0|||
163860474|NCT04511650|591857907|FG002|Overall Study|reason not provided|1|||
163860475|NCT04511650|591857905|FG000|Overall Study|Death|1|||
163860476|NCT04511650|591857906|FG001|Overall Study|Death|1|||
163860477|NCT04511650|591857907|FG002|Overall Study|Death|1|||
163860478|NCT05650333|591857908|FG000|Treatment Period (7 Days)|Adverse Event|1|||
163860479|NCT02873754|591857909|FG000|Overall Study|Lost to Follow-up|5|||
163860480|NCT02873754|591857909|FG000|Overall Study|Couldn't complete study procedures|1|||
163860481|NCT01981850|591857910|FG000|Main Phase Stage 1|Death|2|||
164196690|NCT01171898|593089867|FG002|Overall Study|Death|2|||
164196691|NCT01171898|593089868|FG003|Overall Study|Death|0|||
164196692|NCT01171898|593089865|FG000|Overall Study|Lost to Follow-up|0|||
164196693|NCT01171898|593089866|FG001|Overall Study|Lost to Follow-up|1|||
164196694|NCT01171898|593089867|FG002|Overall Study|Lost to Follow-up|1|||
163860482|NCT01981850|591857911|FG001|Main Phase Stage 1|Death|0|||
163860483|NCT01981850|591857912|FG002|Main Phase Stage 1|Death|0|||
163860484|NCT01981850|591857913|FG003|Main Phase Stage 1|Death|0|||
163860485|NCT01981850|591857914|FG004|Main Phase Stage 1|Death|0|||
163860486|NCT01981850|591857915|FG005|Main Phase Stage 1|Death|0|||
163860487|NCT01981850|591857916|FG006|Main Phase Stage 1|Death|0|||
163860488|NCT01981850|591857917|FG007|Main Phase Stage 1|Death|0|||
164196695|NCT01171898|593089868|FG003|Overall Study|Lost to Follow-up|1|||
163860489|NCT01981850|591857918|FG008|Main Phase Stage 1|Death|0|||
163860490|NCT01981850|591857919|FG009|Main Phase Stage 1|Death|0|||
163860491|NCT01981850|591857910|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
164302203|NCT01134055|593482560|FG004|Overall Study|Lost to Follow-up|0|||
164196696|NCT01171898|593089865|FG000|Overall Study|Withdrawal by Subject|1|||
164196697|NCT01171898|593089866|FG001|Overall Study|Withdrawal by Subject|4|||
164196698|NCT01171898|593089867|FG002|Overall Study|Withdrawal by Subject|6|||
164196699|NCT01171898|593089868|FG003|Overall Study|Withdrawal by Subject|3|||
164196700|NCT01171898|593089865|FG000|Overall Study|Terminated by Sponsor|1|||
163860492|NCT01981850|591857911|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860493|NCT01981850|591857912|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860494|NCT01981850|591857913|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860495|NCT01981850|591857914|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860496|NCT01981850|591857915|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860497|NCT01981850|591857916|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860498|NCT01981850|591857917|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860499|NCT01981850|591857918|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860500|NCT01981850|591857919|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
163860501|NCT01981850|591857910|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
163860502|NCT01981850|591857911|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
163860503|NCT01981850|591857912|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
163860504|NCT01981850|591857913|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
163860505|NCT01981850|591857914|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
163860506|NCT01981850|591857915|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
163860507|NCT01981850|591857916|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
163860508|NCT01981850|591857917|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
163860509|NCT01981850|591857918|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
163860510|NCT01981850|591857919|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
163860511|NCT01981850|591857910|FG000|Main Phase Stage 1|Various reasons|0|||
163860512|NCT01981850|591857911|FG001|Main Phase Stage 1|Various reasons|0|||
163860513|NCT01981850|591857912|FG002|Main Phase Stage 1|Various reasons|2|||
163860514|NCT01981850|591857913|FG003|Main Phase Stage 1|Various reasons|0|||
163860515|NCT01981850|591857914|FG004|Main Phase Stage 1|Various reasons|0|||
163860516|NCT01981850|591857915|FG005|Main Phase Stage 1|Various reasons|0|||
163860517|NCT01981850|591857916|FG006|Main Phase Stage 1|Various reasons|0|||
163860518|NCT01981850|591857917|FG007|Main Phase Stage 1|Various reasons|0|||
163860519|NCT01981850|591857918|FG008|Main Phase Stage 1|Various reasons|0|||
163860520|NCT01981850|591857919|FG009|Main Phase Stage 1|Various reasons|0|||
163860521|NCT01981850|591857910|FG000|Main Phase Stage 2|Adverse Event|0|||
163860522|NCT01981850|591857911|FG001|Main Phase Stage 2|Adverse Event|0|||
163860523|NCT01981850|591857912|FG002|Main Phase Stage 2|Adverse Event|0|||
163860524|NCT01981850|591857913|FG003|Main Phase Stage 2|Adverse Event|0|||
163860525|NCT01981850|591857914|FG004|Main Phase Stage 2|Adverse Event|6|||
163860526|NCT01981850|591857915|FG005|Main Phase Stage 2|Adverse Event|5|||
163860527|NCT01981850|591857916|FG006|Main Phase Stage 2|Adverse Event|7|||
163860528|NCT01981850|591857917|FG007|Main Phase Stage 2|Adverse Event|0|||
163860529|NCT01981850|591857918|FG008|Main Phase Stage 2|Adverse Event|0|||
163860530|NCT01981850|591857919|FG009|Main Phase Stage 2|Adverse Event|0|||
163860531|NCT01981850|591857910|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860532|NCT01981850|591857911|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860533|NCT01981850|591857912|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860534|NCT01981850|591857913|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860535|NCT01981850|591857914|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
163860536|NCT01981850|591857915|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
163860537|NCT01981850|591857916|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
163860538|NCT01981850|591857917|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860539|NCT01981850|591857918|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860540|NCT01981850|591857919|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
163860541|NCT01981850|591857910|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
163860542|NCT01981850|591857911|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
163860543|NCT01981850|591857912|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
163860544|NCT01981850|591857913|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
163860545|NCT01981850|591857914|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
163860546|NCT01981850|591857915|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
163860547|NCT01981850|591857916|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
163860548|NCT01981850|591857917|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
163860549|NCT01981850|591857918|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
163860550|NCT01981850|591857919|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
163860551|NCT01981850|591857910|FG000|Main Phase Stage 2|Various reasons|0|||
163860552|NCT01981850|591857911|FG001|Main Phase Stage 2|Various reasons|0|||
163860553|NCT01981850|591857912|FG002|Main Phase Stage 2|Various reasons|0|||
163860554|NCT01981850|591857913|FG003|Main Phase Stage 2|Various reasons|0|||
163966203|NCT02101021|592249204|FG004|Overall Study|Withdrew Consent from study|0|||
163966204|NCT02101021|592249200|FG000|Overall Study|Lost to Follow-up|1|||
163860555|NCT01981850|591857914|FG004|Main Phase Stage 2|Various reasons|2|||
163860556|NCT01981850|591857915|FG005|Main Phase Stage 2|Various reasons|0|||
163966205|NCT02101021|592249201|FG001|Overall Study|Lost to Follow-up|0|||
163966206|NCT02101021|592249202|FG002|Overall Study|Lost to Follow-up|0|||
164196701|NCT01171898|593089866|FG001|Overall Study|Terminated by Sponsor|0|||
163966207|NCT02101021|592249203|FG003|Overall Study|Lost to Follow-up|0|||
163966208|NCT02101021|592249204|FG004|Overall Study|Lost to Follow-up|0|||
163966209|NCT02101021|592249200|FG000|Overall Study|Study Terminated by Sponsor|1|||
163966210|NCT02101021|592249201|FG001|Overall Study|Study Terminated by Sponsor|0|||
163966211|NCT02101021|592249202|FG002|Overall Study|Study Terminated by Sponsor|1|||
163966212|NCT02101021|592249203|FG003|Overall Study|Study Terminated by Sponsor|1|||
163966213|NCT02101021|592249204|FG004|Overall Study|Study Terminated by Sponsor|1|||
163966214|NCT01368042|592249205|FG000|Overall Study|Death|14|||
163966215|NCT01368042|592249205|FG000|Overall Study|Protocol Violation|11|||
163966216|NCT01368042|592249205|FG000|Overall Study|Lost to Follow-up|4|||
163966217|NCT01368042|592249205|FG000|Overall Study|Transplanted|1|||
163966218|NCT02632721|592249206|FG000|Overall Study|Adverse Event|0|||
163966219|NCT02632721|592249207|FG001|Overall Study|Adverse Event|0|||
163966220|NCT02632721|592249208|FG002|Overall Study|Adverse Event|2|||
163966221|NCT02632721|592249209|FG003|Overall Study|Adverse Event|5|||
163966222|NCT02632721|592249210|FG004|Overall Study|Adverse Event|3|||
163966223|NCT02632721|592249206|FG000|Overall Study|Dose limiting toxicity|0|||
163966224|NCT02632721|592249207|FG001|Overall Study|Dose limiting toxicity|0|||
163966225|NCT02632721|592249208|FG002|Overall Study|Dose limiting toxicity|0|||
163966226|NCT02632721|592249209|FG003|Overall Study|Dose limiting toxicity|1|||
163966227|NCT02632721|592249210|FG004|Overall Study|Dose limiting toxicity|0|||
163966228|NCT02632721|592249206|FG000|Overall Study|Progressive disease|3|||
163966229|NCT02632721|592249207|FG001|Overall Study|Progressive disease|0|||
163966230|NCT02632721|592249208|FG002|Overall Study|Progressive disease|4|||
163966231|NCT02632721|592249209|FG003|Overall Study|Progressive disease|6|||
163966232|NCT02632721|592249210|FG004|Overall Study|Progressive disease|5|||
163966233|NCT02632721|592249206|FG000|Overall Study|Refused to continue taking trial medication|0|||
163966234|NCT02632721|592249207|FG001|Overall Study|Refused to continue taking trial medication|1|||
163966235|NCT02632721|592249208|FG002|Overall Study|Refused to continue taking trial medication|1|||
163966236|NCT02632721|592249209|FG003|Overall Study|Refused to continue taking trial medication|1|||
163966237|NCT02632721|592249210|FG004|Overall Study|Refused to continue taking trial medication|2|||
163966238|NCT02632721|592249206|FG000|Overall Study|Inadequate clinical condition|0|||
163966239|NCT02632721|592249207|FG001|Overall Study|Inadequate clinical condition|0|||
163966240|NCT02632721|592249208|FG002|Overall Study|Inadequate clinical condition|0|||
163966241|NCT02632721|592249209|FG003|Overall Study|Inadequate clinical condition|0|||
163966242|NCT02632721|592249210|FG004|Overall Study|Inadequate clinical condition|1|||
163966243|NCT02632721|592249206|FG000|Overall Study|No meet eligibility|0|||
163966244|NCT02632721|592249207|FG001|Overall Study|No meet eligibility|0|||
163966245|NCT02632721|592249208|FG002|Overall Study|No meet eligibility|0|||
163966246|NCT02632721|592249209|FG003|Overall Study|No meet eligibility|0|||
163966247|NCT02632721|592249210|FG004|Overall Study|No meet eligibility|1|||
163966248|NCT02632721|592249206|FG000|Overall Study|Allergic reaction|0|||
163966249|NCT02632721|592249207|FG001|Overall Study|Allergic reaction|0|||
163966250|NCT02632721|592249208|FG002|Overall Study|Allergic reaction|0|||
163966251|NCT02632721|592249209|FG003|Overall Study|Allergic reaction|1|||
163966252|NCT02632721|592249210|FG004|Overall Study|Allergic reaction|0|||
163966253|NCT02632721|592249206|FG000|Overall Study|Receiving Decitabine locally|0|||
163966254|NCT02632721|592249207|FG001|Overall Study|Receiving Decitabine locally|0|||
163966255|NCT02632721|592249208|FG002|Overall Study|Receiving Decitabine locally|1|||
163966256|NCT02632721|592249209|FG003|Overall Study|Receiving Decitabine locally|0|||
163966257|NCT02632721|592249210|FG004|Overall Study|Receiving Decitabine locally|0|||
163966258|NCT02632721|592249206|FG000|Overall Study|No benefit from study treatment|1|||
163966259|NCT02632721|592249207|FG001|Overall Study|No benefit from study treatment|1|||
163966260|NCT02632721|592249208|FG002|Overall Study|No benefit from study treatment|0|||
163966261|NCT02632721|592249209|FG003|Overall Study|No benefit from study treatment|0|||
163966262|NCT02632721|592249210|FG004|Overall Study|No benefit from study treatment|1|||
163966263|NCT02632721|592249206|FG000|Overall Study|Patient wish for other treatment|0|||
163966264|NCT02632721|592249207|FG001|Overall Study|Patient wish for other treatment|1|||
163966265|NCT02632721|592249208|FG002|Overall Study|Patient wish for other treatment|0|||
163966266|NCT02632721|592249209|FG003|Overall Study|Patient wish for other treatment|0|||
163966267|NCT02632721|592249210|FG004|Overall Study|Patient wish for other treatment|0|||
163966268|NCT02632721|592249206|FG000|Overall Study|Relapsed Pneumonia|0|||
163966269|NCT02632721|592249207|FG001|Overall Study|Relapsed Pneumonia|0|||
163966270|NCT02632721|592249208|FG002|Overall Study|Relapsed Pneumonia|0|||
163966271|NCT02632721|592249209|FG003|Overall Study|Relapsed Pneumonia|0|||
163966272|NCT02632721|592249210|FG004|Overall Study|Relapsed Pneumonia|1|||
163966273|NCT02632721|592249206|FG000|Overall Study|Therapy refractory AML|0|||
163966274|NCT02632721|592249207|FG001|Overall Study|Therapy refractory AML|0|||
163966275|NCT02632721|592249208|FG002|Overall Study|Therapy refractory AML|0|||
163966276|NCT02632721|592249209|FG003|Overall Study|Therapy refractory AML|0|||
163966277|NCT02632721|592249210|FG004|Overall Study|Therapy refractory AML|1|||
163966278|NCT02632721|592249206|FG000|Overall Study|Increase of white blood cell count|0|||
163966279|NCT02632721|592249207|FG001|Overall Study|Increase of white blood cell count|0|||
163966280|NCT02632721|592249208|FG002|Overall Study|Increase of white blood cell count|0|||
164196702|NCT01171898|593089867|FG002|Overall Study|Terminated by Sponsor|0|||
163860557|NCT01981850|591857916|FG006|Main Phase Stage 2|Various reasons|1|||
163860558|NCT01981850|591857917|FG007|Main Phase Stage 2|Various reasons|0|||
163860559|NCT01981850|591857918|FG008|Main Phase Stage 2|Various reasons|0|||
163860560|NCT01981850|591857919|FG009|Main Phase Stage 2|Various reasons|0|||
163860561|NCT01981850|591857910|FG000|Main Phase Stage 2|Progressive Disease|0|||
163860562|NCT01981850|591857911|FG001|Main Phase Stage 2|Progressive Disease|0|||
163860563|NCT01981850|591857912|FG002|Main Phase Stage 2|Progressive Disease|0|||
163860564|NCT01981850|591857913|FG003|Main Phase Stage 2|Progressive Disease|0|||
163860565|NCT01981850|591857914|FG004|Main Phase Stage 2|Progressive Disease|0|||
163860566|NCT01981850|591857915|FG005|Main Phase Stage 2|Progressive Disease|6|||
163860567|NCT01981850|591857916|FG006|Main Phase Stage 2|Progressive Disease|6|||
163860568|NCT01981850|591857917|FG007|Main Phase Stage 2|Progressive Disease|0|||
163860569|NCT01981850|591857918|FG008|Main Phase Stage 2|Progressive Disease|0|||
163860570|NCT01981850|591857919|FG009|Main Phase Stage 2|Progressive Disease|0|||
163860571|NCT01981850|591857910|FG000|Open Label Extension (OLE)|Adverse Event|0|||
163860572|NCT01981850|591857911|FG001|Open Label Extension (OLE)|Adverse Event|0|||
163860573|NCT01981850|591857912|FG002|Open Label Extension (OLE)|Adverse Event|0|||
163860574|NCT01981850|591857913|FG003|Open Label Extension (OLE)|Adverse Event|0|||
163860575|NCT01981850|591857914|FG004|Open Label Extension (OLE)|Adverse Event|0|||
163860576|NCT01981850|591857915|FG005|Open Label Extension (OLE)|Adverse Event|0|||
163860577|NCT01981850|591857916|FG006|Open Label Extension (OLE)|Adverse Event|0|||
163860578|NCT01981850|591857917|FG007|Open Label Extension (OLE)|Adverse Event|2|||
163860579|NCT01981850|591857918|FG008|Open Label Extension (OLE)|Adverse Event|1|||
163860580|NCT01981850|591857919|FG009|Open Label Extension (OLE)|Adverse Event|8|||
163860581|NCT01981850|591857910|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860582|NCT01981850|591857911|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860583|NCT01981850|591857912|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860584|NCT01981850|591857913|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860585|NCT01981850|591857914|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860586|NCT01981850|591857915|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860587|NCT01981850|591857916|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
163860588|NCT01981850|591857917|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
163860589|NCT01981850|591857918|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
163860590|NCT01981850|591857919|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
163860591|NCT01981850|591857910|FG000|Open Label Extension (OLE)|Various reasons|0|||
163860592|NCT01981850|591857911|FG001|Open Label Extension (OLE)|Various reasons|0|||
163860593|NCT01981850|591857912|FG002|Open Label Extension (OLE)|Various reasons|0|||
163860594|NCT01981850|591857913|FG003|Open Label Extension (OLE)|Various reasons|0|||
163860595|NCT01981850|591857914|FG004|Open Label Extension (OLE)|Various reasons|0|||
163860596|NCT01981850|591857915|FG005|Open Label Extension (OLE)|Various reasons|0|||
163860597|NCT01981850|591857916|FG006|Open Label Extension (OLE)|Various reasons|0|||
163860598|NCT01981850|591857917|FG007|Open Label Extension (OLE)|Various reasons|3|||
163860599|NCT01981850|591857918|FG008|Open Label Extension (OLE)|Various reasons|1|||
163860600|NCT01981850|591857919|FG009|Open Label Extension (OLE)|Various reasons|3|||
163860601|NCT01981850|591857910|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
163860602|NCT01981850|591857911|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
163860603|NCT01981850|591857912|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
163860604|NCT01981850|591857913|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
163860605|NCT01981850|591857914|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
163860606|NCT01981850|591857915|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
163860607|NCT01981850|591857916|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
163860608|NCT01981850|591857917|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
163860609|NCT01981850|591857918|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
163860610|NCT01981850|591857919|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
163860611|NCT01981850|591857910|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860612|NCT01981850|591857911|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860613|NCT01981850|591857912|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860614|NCT01981850|591857913|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860615|NCT01981850|591857914|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860616|NCT01981850|591857915|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860617|NCT01981850|591857916|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860618|NCT01981850|591857917|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860619|NCT01981850|591857918|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
163860620|NCT01981850|591857919|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
163860621|NCT01981850|591857910|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860622|NCT01981850|591857911|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860623|NCT01981850|591857912|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860624|NCT01981850|591857913|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860625|NCT01981850|591857914|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860626|NCT01981850|591857915|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860627|NCT01981850|591857916|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
163966281|NCT02632721|592249209|FG003|Overall Study|Increase of white blood cell count|0|||
163966282|NCT02632721|592249210|FG004|Overall Study|Increase of white blood cell count|1|||
163966283|NCT02632721|592249206|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
163966284|NCT02632721|592249207|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
163966285|NCT02632721|592249208|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
163966286|NCT02632721|592249209|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
163966287|NCT02632721|592249210|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
163966288|NCT00544648|592249211|FG000|Overall Study|Withdrawal by Subject|1|||
163966289|NCT00544648|592249212|FG001|Overall Study|Withdrawal by Subject|0|||
163966290|NCT00544648|592249211|FG000|Overall Study|Adverse Event|1|||
163966291|NCT00544648|592249212|FG001|Overall Study|Adverse Event|1|||
163966292|NCT00544648|592249211|FG000|Overall Study|progression of disease|1|||
163966293|NCT00544648|592249212|FG001|Overall Study|progression of disease|0|||
163966294|NCT02322229|592249214|FG000|Overall Study|Physician Decision|2|||
163966295|NCT03065023|592249215|FG000|Overall Study|Progressive Disease|0|||
163966296|NCT03065023|592249216|FG001|Overall Study|Progressive Disease|1|||
163966297|NCT03065023|592249217|FG002|Overall Study|Progressive Disease|0|||
163966298|NCT03065023|592249218|FG003|Overall Study|Progressive Disease|0|||
163966299|NCT03065023|592249219|FG004|Overall Study|Progressive Disease|0|||
163966300|NCT03065023|592249215|FG000|Overall Study|Death|2|||
163966301|NCT03065023|592249216|FG001|Overall Study|Death|0|||
163966302|NCT03065023|592249217|FG002|Overall Study|Death|1|||
163966303|NCT03065023|592249218|FG003|Overall Study|Death|1|||
163966304|NCT03065023|592249219|FG004|Overall Study|Death|0|||
163966305|NCT03065023|592249215|FG000|Overall Study|Lost to Follow-up|0|||
163966306|NCT03065023|592249216|FG001|Overall Study|Lost to Follow-up|1|||
163966307|NCT03065023|592249217|FG002|Overall Study|Lost to Follow-up|0|||
163966308|NCT03065023|592249218|FG003|Overall Study|Lost to Follow-up|0|||
163966309|NCT03065023|592249219|FG004|Overall Study|Lost to Follow-up|0|||
163966310|NCT03065023|592249215|FG000|Overall Study|Participant Decision|0|||
163966311|NCT03065023|592249216|FG001|Overall Study|Participant Decision|0|||
163966312|NCT03065023|592249217|FG002|Overall Study|Participant Decision|0|||
163966313|NCT03065023|592249218|FG003|Overall Study|Participant Decision|1|||
163966314|NCT03065023|592249219|FG004|Overall Study|Participant Decision|0|||
163966315|NCT03065023|592249215|FG000|Overall Study|Withdrawal by Subject|0|||
163966316|NCT03065023|592249216|FG001|Overall Study|Withdrawal by Subject|0|||
163966317|NCT03065023|592249217|FG002|Overall Study|Withdrawal by Subject|0|||
163966318|NCT03065023|592249218|FG003|Overall Study|Withdrawal by Subject|1|||
163966319|NCT03065023|592249219|FG004|Overall Study|Withdrawal by Subject|0|||
163966320|NCT00705432|592249220|FG000|Treatment Period|Adverse Event|45|||
163966321|NCT00705432|592249221|FG001|Treatment Period|Adverse Event|37|||
163966322|NCT00705432|592249222|FG002|Treatment Period|Adverse Event|51|||
163966323|NCT00705432|592249223|FG003|Treatment Period|Adverse Event|12|||
163966324|NCT00705432|592249224|FG004|Treatment Period|Adverse Event|8|||
163966325|NCT00705432|592249225|FG005|Treatment Period|Adverse Event|9|||
163966326|NCT00705432|592249220|FG000|Treatment Period|Treatment failure|92|||
163860628|NCT01981850|591857917|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860629|NCT01981850|591857918|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
163860630|NCT01981850|591857919|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
163860631|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
163860632|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
163860633|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
163860634|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
163860635|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
163860636|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
163860637|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
163860638|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
163860639|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
163860640|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
163966327|NCT00705432|592249221|FG001|Treatment Period|Treatment failure|42|||
163966328|NCT00705432|592249222|FG002|Treatment Period|Treatment failure|33|||
163966329|NCT00705432|592249223|FG003|Treatment Period|Treatment failure|25|||
163966330|NCT00705432|592249224|FG004|Treatment Period|Treatment failure|13|||
163966331|NCT00705432|592249225|FG005|Treatment Period|Treatment failure|14|||
163966332|NCT00705432|592249220|FG000|Treatment Period|Non medical reason|26|||
163966333|NCT00705432|592249221|FG001|Treatment Period|Non medical reason|32|||
163966334|NCT00705432|592249222|FG002|Treatment Period|Non medical reason|37|||
163966335|NCT00705432|592249223|FG003|Treatment Period|Non medical reason|4|||
164196703|NCT01171898|593089868|FG003|Overall Study|Terminated by Sponsor|0|||
163966336|NCT00705432|592249224|FG004|Treatment Period|Non medical reason|7|||
163966337|NCT00705432|592249225|FG005|Treatment Period|Non medical reason|7|||
163966338|NCT00705432|592249220|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
164196704|NCT01171898|593089865|FG000|Overall Study|Ongoing|1|||
163860641|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
164196705|NCT01171898|593089866|FG001|Overall Study|Ongoing|9|||
163860642|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
163860643|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
163860644|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
163860645|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
163860646|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
163860647|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
163860648|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
163860649|NCT03412747|591857921|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
163860650|NCT03412747|591857922|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
163860651|NCT03412747|591857923|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
163860652|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
163860653|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
163860654|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
163860655|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
163860656|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
163860657|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
163860658|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
164196706|NCT01171898|593089867|FG002|Overall Study|Ongoing|3|||
164196707|NCT01171898|593089868|FG003|Overall Study|Ongoing|0|||
164196708|NCT01171898|593089865|FG000|Overall Study|Other|1|||
163860659|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
163860660|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
163860661|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
163860662|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
163860663|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
163966339|NCT00705432|592249221|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
163966340|NCT00705432|592249222|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
163966341|NCT00705432|592249223|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
163966342|NCT00705432|592249224|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
163966343|NCT00705432|592249225|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
163966344|NCT00705432|592249220|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
163966345|NCT00705432|592249221|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
163966346|NCT00705432|592249222|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
163966347|NCT00705432|592249223|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
163966348|NCT00705432|592249224|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
163966349|NCT00705432|592249225|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
163966350|NCT00521053|592249226|FG000|Observation Phase|Disease Progression|55|||
163966351|NCT00521053|592249226|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
163966352|NCT00521053|592249226|FG000|Observation Phase|Death|2|||
163966353|NCT00521053|592249226|FG000|Observation Phase|Adverse Event|1|||
163966354|NCT00521053|592249226|FG000|Observation Phase|Other non-study melanoma treatment|1|||
163966355|NCT00521053|592249226|FG000|Observation Phase|Physician Decision|1|||
163966356|NCT01667107|592249227|FG000|Overall Study|Adverse Event|4|||
163860664|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
163860665|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
163860666|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
163860667|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
163966357|NCT01667107|592249228|FG001|Overall Study|Adverse Event|3|||
163966358|NCT01667107|592249227|FG000|Overall Study|Tolerability issues|0|||
164196709|NCT01171898|593089866|FG001|Overall Study|Other|5|||
163966359|NCT01667107|592249228|FG001|Overall Study|Tolerability issues|2|||
163966360|NCT01667107|592249227|FG000|Overall Study|Protocol Violation|0|||
163966361|NCT01667107|592249228|FG001|Overall Study|Protocol Violation|1|||
163966362|NCT01667107|592249227|FG000|Overall Study|Lack of Efficacy|0|||
163966363|NCT01667107|592249228|FG001|Overall Study|Lack of Efficacy|1|||
163966364|NCT01557348|592249229|FG000|Overall Study|Adverse Event|6|||
164196710|NCT01171898|593089867|FG002|Overall Study|Other|0|||
164196711|NCT01171898|593089868|FG003|Overall Study|Other|2|||
164196712|NCT03191799|593089869|FG000|Overall Study|Withdrawal by Subject|4|||
164196713|NCT03191799|593089869|FG000|Overall Study|Physician Decision|2|||
164196714|NCT03191799|593089869|FG000|Overall Study|Lost to Follow-up|1|||
164196715|NCT03191799|593089869|FG000|Overall Study|Death|2|||
163860668|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
163966365|NCT01557348|592249230|FG001|Overall Study|Adverse Event|16|||
163966366|NCT01557348|592249229|FG000|Overall Study|Infusion reaction event|5|||
164196716|NCT00468585|593089870|FG000|Overall Study|Patient not treated|1|||
164196717|NCT00468585|593089871|FG001|Overall Study|Patient not treated|0|||
164196718|NCT00468585|593089872|FG002|Overall Study|Patient not treated|1|||
164196719|NCT00468585|593089873|FG003|Overall Study|Patient not treated|0|||
164196720|NCT00468585|593089870|FG000|Overall Study|Patient found to be ineligible|0|||
164196721|NCT00468585|593089871|FG001|Overall Study|Patient found to be ineligible|0|||
164302204|NCT01134055|593482561|FG005|Overall Study|Lost to Follow-up|0|||
163966367|NCT01557348|592249230|FG001|Overall Study|Infusion reaction event|5|||
163966368|NCT01557348|592249229|FG000|Overall Study|Death|7|||
163966369|NCT01557348|592249230|FG001|Overall Study|Death|4|||
163966370|NCT01557348|592249229|FG000|Overall Study|Insufficient Therapeutic Response|13|||
163966371|NCT01557348|592249230|FG001|Overall Study|Insufficient Therapeutic Response|28|||
163966372|NCT01557348|592249229|FG000|Overall Study|Withdrawal by Subject|5|||
163966373|NCT01557348|592249230|FG001|Overall Study|Withdrawal by Subject|4|||
163966374|NCT01557348|592249229|FG000|Overall Study|Lost to Follow-up|26|||
163966375|NCT01557348|592249230|FG001|Overall Study|Lost to Follow-up|22|||
163966376|NCT01557348|592249229|FG000|Overall Study|Administrative|18|||
163966377|NCT01557348|592249230|FG001|Overall Study|Administrative|11|||
163966378|NCT03427125|592249231|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
163966379|NCT03427125|592249232|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
163966380|NCT03427125|592249233|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
163966381|NCT02281357|592249234|FG000|Overall Study|Adverse Event|2|||
163966382|NCT02281357|592249235|FG001|Overall Study|Adverse Event|1|||
163966383|NCT02281357|592249234|FG000|Overall Study|Lost to Follow-up|1|||
163966384|NCT02281357|592249235|FG001|Overall Study|Lost to Follow-up|0|||
163966385|NCT02281357|592249234|FG000|Overall Study|Withdrawal by Subject|4|||
163966386|NCT02281357|592249235|FG001|Overall Study|Withdrawal by Subject|3|||
163966387|NCT01162239|592249236|FG000|Treatment Phase|Withdrawal by Subject|1|||
163966388|NCT01162239|592249237|FG001|Treatment Phase|Withdrawal by Subject|3|||
163966389|NCT01162239|592249238|FG002|Treatment Phase|Withdrawal by Subject|2|||
163966390|NCT01162239|592249239|FG003|Treatment Phase|Withdrawal by Subject|3|||
163966391|NCT01162239|592249236|FG000|Treatment Phase|Death|0|||
163966392|NCT01162239|592249237|FG001|Treatment Phase|Death|0|||
163966393|NCT01162239|592249238|FG002|Treatment Phase|Death|0|||
163966394|NCT01162239|592249239|FG003|Treatment Phase|Death|1|||
163966395|NCT01162239|592249236|FG000|Treatment Phase|Lost to Follow-up|5|||
163966396|NCT01162239|592249237|FG001|Treatment Phase|Lost to Follow-up|4|||
163966397|NCT01162239|592249238|FG002|Treatment Phase|Lost to Follow-up|2|||
163966398|NCT01162239|592249239|FG003|Treatment Phase|Lost to Follow-up|1|||
163966399|NCT01162239|592249236|FG000|Extended Follow-up|Lost to Follow-up|8|||
163966400|NCT01162239|592249237|FG001|Extended Follow-up|Lost to Follow-up|13|||
163966401|NCT01162239|592249238|FG002|Extended Follow-up|Lost to Follow-up|8|||
163966402|NCT01162239|592249239|FG003|Extended Follow-up|Lost to Follow-up|6|||
163966403|NCT06132425|592249240|FG000|Overall Study|Withdrawal by Subject|3|||
163966404|NCT06132425|592249241|FG001|Overall Study|Withdrawal by Subject|0|||
163966405|NCT06132425|592249240|FG000|Overall Study|Did not follow study instructions|0|||
163966406|NCT06132425|592249241|FG001|Overall Study|Did not follow study instructions|2|||
163966407|NCT06132425|592249240|FG000|Overall Study|Lost to Follow-up|3|||
163966408|NCT06132425|592249241|FG001|Overall Study|Lost to Follow-up|5|||
163966409|NCT04448756|592249244|FG000|Overall Study|Adverse Event|0|||
163966410|NCT04448756|592249245|FG001|Overall Study|Adverse Event|1|||
163966411|NCT04448756|592249246|FG002|Overall Study|Adverse Event|0|||
163966412|NCT04448756|592249244|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
163966413|NCT04448756|592249245|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
163966414|NCT04448756|592249246|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
163966415|NCT04448756|592249244|FG000|Overall Study|Withdrawal by Subject|0|||
163966416|NCT04448756|592249245|FG001|Overall Study|Withdrawal by Subject|3|||
163966417|NCT04448756|592249246|FG002|Overall Study|Withdrawal by Subject|1|||
163966418|NCT04448756|592249244|FG000|Overall Study|Death|2|||
163966419|NCT04448756|592249245|FG001|Overall Study|Death|1|||
163966420|NCT04448756|592249246|FG002|Overall Study|Death|0|||
163966421|NCT02733185|592249247|FG000|Overall Study|Withdrawal by Subject|12|||
163966422|NCT02733185|592249248|FG001|Overall Study|Withdrawal by Subject|10|||
163966423|NCT02733185|592249249|FG002|Overall Study|Withdrawal by Subject|17|||
163966424|NCT02733185|592249250|FG003|Overall Study|Withdrawal by Subject|21|||
163966425|NCT02733185|592249247|FG000|Overall Study|Death|46|||
163966426|NCT02733185|592249248|FG001|Overall Study|Death|34|||
163966427|NCT02733185|592249249|FG002|Overall Study|Death|35|||
163966428|NCT02733185|592249250|FG003|Overall Study|Death|43|||
164196722|NCT00468585|593089872|FG002|Overall Study|Patient found to be ineligible|1|||
164196723|NCT00468585|593089873|FG003|Overall Study|Patient found to be ineligible|0|||
164196724|NCT00468585|593089870|FG000|Overall Study|Adverse Event|0|||
163966429|NCT02733185|592249247|FG000|Overall Study|Lost to Follow-up|17|||
163966430|NCT02733185|592249248|FG001|Overall Study|Lost to Follow-up|18|||
164196725|NCT00468585|593089871|FG001|Overall Study|Adverse Event|0|||
163966431|NCT02733185|592249249|FG002|Overall Study|Lost to Follow-up|16|||
163966432|NCT02733185|592249250|FG003|Overall Study|Lost to Follow-up|11|||
163966433|NCT02499770|592249254|FG000|Overall Study|Death|17|||
163966434|NCT02499770|592249255|FG001|Overall Study|Death|56|||
163966435|NCT02499770|592249254|FG000|Overall Study|Study completion|1|||
163966436|NCT02499770|592249255|FG001|Overall Study|Study completion|10|||
163966437|NCT02499770|592249254|FG000|Overall Study|Withdrawal by Subject|0|||
163966438|NCT02499770|592249255|FG001|Overall Study|Withdrawal by Subject|7|||
163966439|NCT02499770|592249254|FG000|Overall Study|Lost to Follow-up|0|||
163860669|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
163860670|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
163860671|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
163860672|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
163860673|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
163860674|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
163860675|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
163860676|NCT03412747|591857921|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
163860677|NCT03412747|591857922|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
163860678|NCT03412747|591857923|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
163860679|NCT04075266|591857924|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
163860680|NCT04075266|591857925|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
163860681|NCT04075266|591857924|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
163860682|NCT04075266|591857925|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
163860683|NCT01582945|591857926|FG000|Overall Study|Intolerable side-effects|1|||
163860684|NCT01582945|591857926|FG000|Overall Study|Scheduling conflicts|1|||
163860685|NCT01726023|591857927|FG000|Overall Study|Death|1|||
163860686|NCT01726023|591857928|FG001|Overall Study|Death|1|||
163860687|NCT01726023|591857927|FG000|Overall Study|Lost to Follow-up|5|||
163860688|NCT01726023|591857928|FG001|Overall Study|Lost to Follow-up|10|||
163860689|NCT01726023|591857927|FG000|Overall Study|Other Eligibility criteria|7|||
163860690|NCT01726023|591857928|FG001|Overall Study|Other Eligibility criteria|7|||
163860691|NCT01726023|591857927|FG000|Overall Study|Withdrawal by Subject|16|||
163860692|NCT01726023|591857928|FG001|Overall Study|Withdrawal by Subject|8|||
163860693|NCT04982575|591857935|FG000|Overall Study|Withdrawal by Subject|2|||
163860694|NCT04982575|591857936|FG001|Overall Study|Withdrawal by Subject|0|||
163860695|NCT04982575|591857937|FG002|Overall Study|Withdrawal by Subject|2|||
163860696|NCT03038022|591857940|FG000|Overall Study|Withdrawal by Subject|2|||
163860697|NCT03038022|591857941|FG001|Overall Study|Withdrawal by Subject|0|||
163860698|NCT03038022|591857940|FG000|Overall Study|Adverse Event|4|||
163860699|NCT03038022|591857941|FG001|Overall Study|Adverse Event|2|||
163860700|NCT01467427|591857944|FG000|Overall Study|Withdrawal by Subject|1|||
163860701|NCT01467427|591857945|FG001|Overall Study|Withdrawal by Subject|0|||
163860702|NCT01467427|591857944|FG000|Overall Study|Not continuing in extension phase|0|||
163860703|NCT01467427|591857945|FG001|Overall Study|Not continuing in extension phase|2|||
163860704|NCT01467427|591857944|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
163860705|NCT01467427|591857945|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
163860706|NCT01467427|591857944|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
163860707|NCT01467427|591857945|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
163860708|NCT01467427|591857944|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
163860709|NCT01467427|591857945|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
163860710|NCT01467427|591857944|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
163860711|NCT01467427|591857945|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
163860712|NCT04925752|591857946|FG000|Overall Study|Still on Study|1826|||
163860713|NCT04925752|591857947|FG001|Overall Study|Still on Study|926|||
163860714|NCT04925752|591857946|FG000|Overall Study|Withdrew Consent|128|||
163860715|NCT04925752|591857947|FG001|Overall Study|Withdrew Consent|59|||
163860716|NCT04925752|591857946|FG000|Overall Study|Lost to Follow-up|73|||
163860717|NCT04925752|591857947|FG001|Overall Study|Lost to Follow-up|47|||
163860718|NCT04925752|591857946|FG000|Overall Study|Randomized but Never Treated|12|||
163860719|NCT04925752|591857947|FG001|Overall Study|Randomized but Never Treated|9|||
163860720|NCT04925752|591857946|FG000|Overall Study|Hiv-1 Infection|6|||
163860721|NCT04925752|591857947|FG001|Overall Study|Hiv-1 Infection|7|||
163860722|NCT04925752|591857946|FG000|Overall Study|Investigator's discretion|8|||
163860723|NCT04925752|591857947|FG001|Overall Study|Investigator's discretion|5|||
163860724|NCT04925752|591857946|FG000|Overall Study|Non-compliance with Study Drug|8|||
163860725|NCT04925752|591857947|FG001|Overall Study|Non-compliance with Study Drug|5|||
163860726|NCT04925752|591857946|FG000|Overall Study|Adverse Event|5|||
163860727|NCT04925752|591857947|FG001|Overall Study|Adverse Event|2|||
163860728|NCT04925752|591857946|FG000|Overall Study|Death|4|||
163860729|NCT04925752|591857947|FG001|Overall Study|Death|2|||
163860730|NCT04925752|591857946|FG000|Overall Study|Protocol Violation|1|||
163860731|NCT04925752|591857947|FG001|Overall Study|Protocol Violation|3|||
163860732|NCT04925752|591857946|FG000|Overall Study|Withdrew Assent|1|||
163860733|NCT04925752|591857947|FG001|Overall Study|Withdrew Assent|0|||
163860734|NCT04269200|591857948|FG000|Global Cohort|Death|72|||
163860735|NCT04269200|591857949|FG001|Global Cohort|Death|54|||
163860736|NCT04269200|591857950|FG002|Global Cohort|Death|49|||
163966440|NCT02499770|592249255|FG001|Overall Study|Lost to Follow-up|2|||
163860737|NCT04269200|591857948|FG000|Global Cohort|Lost to Follow-up|0|||
163860738|NCT04269200|591857949|FG001|Global Cohort|Lost to Follow-up|0|||
163860739|NCT04269200|591857950|FG002|Global Cohort|Lost to Follow-up|2|||
163860740|NCT04269200|591857948|FG000|Global Cohort|Withdrawal by Subject|22|||
163966441|NCT02499770|592249254|FG000|Overall Study|Subject declined further treatment|1|||
163966442|NCT02499770|592249255|FG001|Overall Study|Subject declined further treatment|0|||
163966443|NCT02499770|592249254|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
163966444|NCT02499770|592249255|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
163966445|NCT02499770|592249254|FG000|Overall Study|Randomized but not enrolled|0|||
163966446|NCT02499770|592249255|FG001|Overall Study|Randomized but not enrolled|1|||
163966447|NCT02129205|592249258|FG000|Overall Study|Withdrawal by Subject|0|||
163966448|NCT02129205|592249259|FG001|Overall Study|Withdrawal by Subject|0|||
163966449|NCT02129205|592249260|FG002|Overall Study|Withdrawal by Subject|0|||
163966450|NCT02129205|592249261|FG003|Overall Study|Withdrawal by Subject|0|||
163966451|NCT02129205|592249262|FG004|Overall Study|Withdrawal by Subject|1|||
163966452|NCT02129205|592249263|FG005|Overall Study|Withdrawal by Subject|1|||
163966453|NCT02129205|592249264|FG006|Overall Study|Withdrawal by Subject|1|||
163966454|NCT02129205|592249265|FG007|Overall Study|Withdrawal by Subject|0|||
163966455|NCT02129205|592249266|FG008|Overall Study|Withdrawal by Subject|1|||
163966456|NCT02129205|592249267|FG009|Overall Study|Withdrawal by Subject|0|||
163966457|NCT02129205|592249258|FG000|Overall Study|Other|1|||
163966458|NCT02129205|592249259|FG001|Overall Study|Other|0|||
163966459|NCT02129205|592249260|FG002|Overall Study|Other|0|||
163966460|NCT02129205|592249261|FG003|Overall Study|Other|0|||
163966461|NCT02129205|592249262|FG004|Overall Study|Other|2|||
163966462|NCT02129205|592249263|FG005|Overall Study|Other|3|||
163966463|NCT02129205|592249264|FG006|Overall Study|Other|3|||
163966464|NCT02129205|592249265|FG007|Overall Study|Other|2|||
163966465|NCT02129205|592249266|FG008|Overall Study|Other|1|||
163966466|NCT02129205|592249267|FG009|Overall Study|Other|0|||
163966467|NCT02877927|592249268|FG000|Overall Study|Adverse Event|1|||
163966468|NCT02877927|592249269|FG001|Overall Study|Adverse Event|0|||
163966469|NCT02877927|592249268|FG000|Overall Study|Lost to Follow-up|37|||
163966470|NCT02877927|592249269|FG001|Overall Study|Lost to Follow-up|38|||
163966471|NCT02877927|592249268|FG000|Overall Study|Withdrawal by Subject|11|||
163966472|NCT02877927|592249269|FG001|Overall Study|Withdrawal by Subject|12|||
163966473|NCT02877927|592249268|FG000|Overall Study|Physician Decision|0|||
163966474|NCT02877927|592249269|FG001|Overall Study|Physician Decision|1|||
163966475|NCT02877927|592249268|FG000|Overall Study|Missed EOT/PTE Visit|5|||
163966476|NCT02877927|592249269|FG001|Overall Study|Missed EOT/PTE Visit|6|||
163966477|NCT00708175|592249270|FG000|Overall Study|Adverse Event|4|||
163966478|NCT00708175|592249271|FG001|Overall Study|Adverse Event|5|||
163966479|NCT00708175|592249270|FG000|Overall Study|Protocol Violation|2|||
163966480|NCT00708175|592249271|FG001|Overall Study|Protocol Violation|3|||
163966481|NCT00708175|592249270|FG000|Overall Study|Lost to Follow-up|5|||
163966482|NCT00708175|592249271|FG001|Overall Study|Lost to Follow-up|3|||
163966483|NCT00708175|592249270|FG000|Overall Study|Withdrawal by Subject|5|||
163966484|NCT00708175|592249271|FG001|Overall Study|Withdrawal by Subject|7|||
163966485|NCT00708175|592249270|FG000|Overall Study|BMD loss >7%|2|||
163966486|NCT00708175|592249271|FG001|Overall Study|BMD loss >7%|3|||
163966487|NCT01093326|592249273|FG000|Overall Study|Death|0|||
163966488|NCT01093326|592249274|FG001|Overall Study|Death|1|||
163966489|NCT01093326|592249275|FG002|Overall Study|Death|0|||
163966490|NCT01093326|592249273|FG000|Overall Study|Lack of Efficacy|7|||
163966491|NCT01093326|592249274|FG001|Overall Study|Lack of Efficacy|6|||
163966492|NCT01093326|592249275|FG002|Overall Study|Lack of Efficacy|3|||
163966493|NCT01093326|592249273|FG000|Overall Study|Lost to Follow-up|2|||
163966494|NCT01093326|592249274|FG001|Overall Study|Lost to Follow-up|5|||
163966495|NCT01093326|592249275|FG002|Overall Study|Lost to Follow-up|4|||
163966496|NCT01093326|592249273|FG000|Overall Study|Physician Decision|3|||
163966497|NCT01093326|592249274|FG001|Overall Study|Physician Decision|1|||
163966498|NCT01093326|592249275|FG002|Overall Study|Physician Decision|3|||
163966499|NCT01093326|592249273|FG000|Overall Study|Withdrawal by Subject|30|||
163966500|NCT01093326|592249274|FG001|Overall Study|Withdrawal by Subject|27|||
163966501|NCT01093326|592249275|FG002|Overall Study|Withdrawal by Subject|26|||
163966502|NCT01093326|592249273|FG000|Overall Study|Adverse Event|2|||
164196726|NCT00468585|593089872|FG002|Overall Study|Adverse Event|1|||
164196727|NCT00468585|593089873|FG003|Overall Study|Adverse Event|0|||
164196728|NCT00468585|593089870|FG000|Overall Study|Withdrawal by Subject|0|||
163966503|NCT01093326|592249274|FG001|Overall Study|Adverse Event|1|||
163966504|NCT01093326|592249275|FG002|Overall Study|Adverse Event|4|||
163966505|NCT01093326|592249273|FG000|Overall Study|Other|0|||
163966506|NCT01093326|592249274|FG001|Overall Study|Other|0|||
163966507|NCT01093326|592249275|FG002|Overall Study|Other|1|||
163966508|NCT04435782|592249276|FG000|Overall Study|Study terminated by sponsor|4|||
163966509|NCT03672461|592249277|FG000|Overall Study|COVID Related|4|||
163966510|NCT03672461|592249278|FG001|Overall Study|COVID Related|2|||
163966511|NCT03672461|592249277|FG000|Overall Study|Adverse Event|2|||
163966512|NCT03672461|592249278|FG001|Overall Study|Adverse Event|0|||
163966513|NCT03672461|592249277|FG000|Overall Study|Serious Adverse Event|0|||
164196729|NCT00468585|593089871|FG001|Overall Study|Withdrawal by Subject|0|||
163966514|NCT03672461|592249278|FG001|Overall Study|Serious Adverse Event|1|||
163966515|NCT03672461|592249277|FG000|Overall Study|Too Busy|3|||
163966516|NCT03672461|592249278|FG001|Overall Study|Too Busy|1|||
163966517|NCT03672461|592249277|FG000|Overall Study|Lost to Follow-up|1|||
164196730|NCT00468585|593089872|FG002|Overall Study|Withdrawal by Subject|2|||
164196731|NCT00468585|593089873|FG003|Overall Study|Withdrawal by Subject|1|||
164196732|NCT03769649|593089874|FG000|Overall Study|Lost to Follow-up|4|||
164196733|NCT02000921|593089879|FG000|Overall Study|Withdrawal by Subject|3|||
164196734|NCT02000921|593089880|FG001|Overall Study|Withdrawal by Subject|10|||
164196735|NCT02000921|593089881|FG002|Overall Study|Withdrawal by Subject|5|||
164196736|NCT02000921|593089879|FG000|Overall Study|Lost to Follow-up|2|||
164196737|NCT02000921|593089880|FG001|Overall Study|Lost to Follow-up|4|||
164196738|NCT02000921|593089881|FG002|Overall Study|Lost to Follow-up|5|||
164196739|NCT02000921|593089879|FG000|Overall Study|Physician Decision|0|||
164196740|NCT02000921|593089880|FG001|Overall Study|Physician Decision|2|||
164196741|NCT02000921|593089881|FG002|Overall Study|Physician Decision|0|||
164196742|NCT03933449|593089884|FG000|Overall Study|Adverse Event|6|||
164196743|NCT03933449|593089885|FG001|Overall Study|Adverse Event|4|||
164196744|NCT03933449|593089884|FG000|Overall Study|Death|55|||
164196745|NCT03933449|593089885|FG001|Overall Study|Death|57|||
164196746|NCT03933449|593089884|FG000|Overall Study|Sponsor Decision|1|||
164196747|NCT03933449|593089885|FG001|Overall Study|Sponsor Decision|0|||
164196748|NCT02087774|593089888|FG000|Overall Study|Were absent day of data collection|8|||
164196749|NCT02087774|593089889|FG001|Overall Study|Were absent day of data collection|20|||
164196750|NCT00719901|593089890|FG000|Overall Study|Adverse Event|5|||
164196751|NCT00719901|593089890|FG000|Overall Study|Withdrawal by Subject|1|||
164196752|NCT00719901|593089890|FG000|Overall Study|Alternate Treatment|1|||
164196753|NCT00719901|593089890|FG000|Overall Study|Disease Progression|3|||
164196754|NCT00719901|593089890|FG000|Overall Study|Availability of Study Drug|1|||
164196755|NCT02858401|593089891|FG000|Overall Study|Withdrew Consent|0|||
164196756|NCT02858401|593089892|FG001|Overall Study|Withdrew Consent|0|||
164196757|NCT02858401|593089893|FG002|Overall Study|Withdrew Consent|0|||
164196758|NCT02858401|593089894|FG003|Overall Study|Withdrew Consent|0|||
164196759|NCT02858401|593089895|FG004|Overall Study|Withdrew Consent|0|||
164196760|NCT02858401|593089896|FG005|Overall Study|Withdrew Consent|1|||
164196761|NCT02858401|593089897|FG006|Overall Study|Withdrew Consent|0|||
164196762|NCT02858401|593089891|FG000|Overall Study|Lost to Follow-up|0|||
164196763|NCT02858401|593089892|FG001|Overall Study|Lost to Follow-up|1|||
164196764|NCT02858401|593089893|FG002|Overall Study|Lost to Follow-up|0|||
164196765|NCT02858401|593089894|FG003|Overall Study|Lost to Follow-up|0|||
164196766|NCT02858401|593089895|FG004|Overall Study|Lost to Follow-up|0|||
164196767|NCT02858401|593089896|FG005|Overall Study|Lost to Follow-up|0|||
164196768|NCT02858401|593089897|FG006|Overall Study|Lost to Follow-up|0|||
164196769|NCT02059239|593089898|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
164196770|NCT02059239|593089899|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
164196771|NCT02059239|593089898|FG000|Overall Study|Physician Decision|1|||
164196772|NCT02059239|593089899|FG001|Overall Study|Physician Decision|0|||
164196773|NCT01408706|593089901|FG000|Overall Study|Physician Decision|1|||
164196774|NCT01408706|593089902|FG001|Overall Study|Physician Decision|0|||
164196775|NCT01268267|593089903|FG000|Overall Study|Protocol Violation|1|||
164196776|NCT02204917|593089905|FG000|Overall Study|Protocol Violation|1|||
164196777|NCT01529606|593089907|FG000|Overall Study|Lost to Follow-up|21|||
164196778|NCT01529606|593089908|FG001|Overall Study|Lost to Follow-up|18|||
164196779|NCT00490035|593089910|FG000|Overall Study|AE, non-serious non-fatal|3|||
164196780|NCT00490035|593089911|FG001|Overall Study|AE, non-serious non-fatal|4|||
164196781|NCT00490035|593089912|FG002|Overall Study|AE, non-serious non-fatal|4|||
164196782|NCT00490035|593089913|FG003|Overall Study|AE, non-serious non-fatal|5|||
164196783|NCT00490035|593089910|FG000|Overall Study|Lost to Follow-up|2|||
164196784|NCT00490035|593089911|FG001|Overall Study|Lost to Follow-up|0|||
164196785|NCT00490035|593089912|FG002|Overall Study|Lost to Follow-up|1|||
164196786|NCT00490035|593089913|FG003|Overall Study|Lost to Follow-up|0|||
164196787|NCT00490035|593089910|FG000|Overall Study|Withdrawal by Subject|2|||
164196788|NCT00490035|593089911|FG001|Overall Study|Withdrawal by Subject|1|||
164196789|NCT00490035|593089912|FG002|Overall Study|Withdrawal by Subject|1|||
164196790|NCT00490035|593089913|FG003|Overall Study|Withdrawal by Subject|0|||
164196791|NCT00490035|593089910|FG000|Overall Study|Other reason|0|||
164196792|NCT00490035|593089911|FG001|Overall Study|Other reason|1|||
164196793|NCT00490035|593089912|FG002|Overall Study|Other reason|3|||
164196794|NCT00490035|593089913|FG003|Overall Study|Other reason|1|||
164196795|NCT00490035|593089910|FG000|Overall Study|AE, serious fatal|1|||
163966518|NCT03672461|592249278|FG001|Overall Study|Lost to Follow-up|2|||
163966519|NCT03672461|592249277|FG000|Overall Study|Family|2|||
164196796|NCT00490035|593089911|FG001|Overall Study|AE, serious fatal|0|||
164196797|NCT00490035|593089912|FG002|Overall Study|AE, serious fatal|0|||
164196798|NCT00490035|593089913|FG003|Overall Study|AE, serious fatal|0|||
164196799|NCT00490035|593089910|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
164196800|NCT00490035|593089911|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
163966520|NCT03672461|592249278|FG001|Overall Study|Family|2|||
164196801|NCT00490035|593089912|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
164196802|NCT00490035|593089913|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
164196803|NCT00490035|593089910|FG000|Overall Study|AE of unknown type|0|||
164196804|NCT00490035|593089911|FG001|Overall Study|AE of unknown type|0|||
164196805|NCT00490035|593089912|FG002|Overall Study|AE of unknown type|2|||
164196806|NCT00490035|593089913|FG003|Overall Study|AE of unknown type|0|||
164196807|NCT00731822|593089918|FG000|Overall Study|Adverse Event|2|||
164196808|NCT00731822|593089919|FG001|Overall Study|Adverse Event|1|||
164196809|NCT00731822|593089918|FG000|Overall Study|Protocol Violation|1|||
164196810|NCT00731822|593089919|FG001|Overall Study|Protocol Violation|0|||
164196811|NCT00731822|593089918|FG000|Overall Study|Lost to Follow-up|1|||
164196812|NCT00731822|593089919|FG001|Overall Study|Lost to Follow-up|0|||
164196813|NCT05209880|593089921|FG000|1-Month Follow-up|Spoke with Doctor|5|||
164196814|NCT05209880|593089922|FG001|1-Month Follow-up|Spoke with Doctor|5|||
164196815|NCT05209880|593089921|FG000|1-Month Follow-up|Lost to Follow-up|7|||
164196816|NCT05209880|593089922|FG001|1-Month Follow-up|Lost to Follow-up|9|||
164196817|NCT05209880|593089921|FG000|1-Month Follow-up|Discontinued|0|||
164196818|NCT05209880|593089922|FG001|1-Month Follow-up|Discontinued|1|||
164196819|NCT05209880|593089921|FG000|3-Month Follow-up|Spoke with Doctor|17|||
164196820|NCT05209880|593089922|FG001|3-Month Follow-up|Spoke with Doctor|7|||
164196821|NCT05209880|593089921|FG000|3-Month Follow-up|Lost to Follow-up|8|||
164196822|NCT05209880|593089922|FG001|3-Month Follow-up|Lost to Follow-up|10|||
164196823|NCT05209880|593089921|FG000|3-Month Follow-up|Discontinued|1|||
164196824|NCT05209880|593089922|FG001|3-Month Follow-up|Discontinued|3|||
164196825|NCT05209880|593089921|FG000|6-Month Follow-up|Spoke with Doctor|25|||
164196826|NCT05209880|593089922|FG001|6-Month Follow-up|Spoke with Doctor|14|||
164196827|NCT05209880|593089921|FG000|6-Month Follow-up|Lost to Follow-up|9|||
164196828|NCT05209880|593089922|FG001|6-Month Follow-up|Lost to Follow-up|14|||
164196829|NCT05209880|593089921|FG000|6-Month Follow-up|Discontinued|1|||
164196830|NCT05209880|593089922|FG001|6-Month Follow-up|Discontinued|3|||
164196831|NCT03834493|593089923|FG000|Overall Study|Participants Ongoing|311|||
164196832|NCT03834493|593089924|FG001|Overall Study|Participants Ongoing|324|||
164196833|NCT03834493|593089923|FG000|Overall Study|Withdrawal by Subject|20|||
164196834|NCT03834493|593089924|FG001|Overall Study|Withdrawal by Subject|17|||
164196835|NCT03834493|593089923|FG000|Overall Study|Physician Decision|1|||
164196836|NCT03834493|593089924|FG001|Overall Study|Physician Decision|0|||
164196837|NCT03834493|593089923|FG000|Overall Study|Death|289|||
164196838|NCT03834493|593089924|FG001|Overall Study|Death|282|||
164196839|NCT05276973|593089929|FG000|Overall Study|Treated and DLT unevaluable|1|||
164196840|NCT05276973|593089930|FG001|Overall Study|Treated and DLT unevaluable|1|||
164196841|NCT05276973|593089931|FG002|Overall Study|Treated and DLT unevaluable|0|||
164196842|NCT03180736|593089932|FG000|Overall Study|Adverse Event|3|||
164196843|NCT03180736|593089933|FG001|Overall Study|Adverse Event|4|||
164196844|NCT03180736|593089932|FG000|Overall Study|Death|10|||
164196845|NCT03180736|593089933|FG001|Overall Study|Death|7|||
164196846|NCT03180736|593089932|FG000|Overall Study|Withdrawal by Subject|5|||
164196847|NCT03180736|593089933|FG001|Overall Study|Withdrawal by Subject|12|||
164196848|NCT03180736|593089932|FG000|Overall Study|Lost to Follow-up|1|||
164196849|NCT03180736|593089933|FG001|Overall Study|Lost to Follow-up|0|||
164196850|NCT03180736|593089932|FG000|Overall Study|Lack of Efficacy|66|||
164196851|NCT03180736|593089933|FG001|Overall Study|Lack of Efficacy|87|||
164196852|NCT03180736|593089932|FG000|Overall Study|Physician Decision|4|||
164196853|NCT03180736|593089933|FG001|Overall Study|Physician Decision|7|||
164196854|NCT03180736|593089932|FG000|Overall Study|randomized but not treated|2|||
164196855|NCT03180736|593089933|FG001|Overall Study|randomized but not treated|3|||
164196856|NCT04073303|593089934|FG000|Overall Study|Adverse Event|0|||
164196857|NCT04073303|593089935|FG001|Overall Study|Adverse Event|2|||
164196858|NCT04073303|593089934|FG000|Overall Study|Withdrawal by Subject|16|||
164196859|NCT04073303|593089935|FG001|Overall Study|Withdrawal by Subject|36|||
164196860|NCT04073303|593089934|FG000|Overall Study|Lost to Follow-up|6|||
164196861|NCT04073303|593089935|FG001|Overall Study|Lost to Follow-up|1|||
164196862|NCT04073303|593089934|FG000|Overall Study|Protocol Deviation|0|||
164196863|NCT04073303|593089935|FG001|Overall Study|Protocol Deviation|4|||
164196864|NCT04073303|593089934|FG000|Overall Study|Other|1|||
164196865|NCT04073303|593089935|FG001|Overall Study|Other|1|||
164196866|NCT03258593|593089936|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
164196867|NCT03258593|593089937|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
164196868|NCT03258593|593089938|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
164196869|NCT03258593|593089939|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
164196870|NCT03258593|593089936|FG000|Run-In Maintenance Phase|Disease progression|3|||
164196871|NCT03258593|593089937|FG001|Run-In Maintenance Phase|Disease progression|0|||
164196872|NCT03258593|593089938|FG002|Run-In Maintenance Phase|Disease progression|0|||
164196873|NCT03258593|593089939|FG003|Run-In Maintenance Phase|Disease progression|0|||
164196874|NCT03258593|593089936|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
164196875|NCT03258593|593089937|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
164196876|NCT03258593|593089938|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
164196877|NCT03258593|593089939|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
164196878|NCT03258593|593089936|FG000|Expansion Maintenance Phase|Physician Decision|0|||
164196879|NCT03258593|593089937|FG001|Expansion Maintenance Phase|Physician Decision|1|||
164196880|NCT03258593|593089938|FG002|Expansion Maintenance Phase|Physician Decision|0|||
164196881|NCT03258593|593089939|FG003|Expansion Maintenance Phase|Physician Decision|0|||
164196882|NCT04144322|593089943|FG000|Overall Study|Lack of Efficacy|2|||
164196883|NCT04144322|593089944|FG001|Overall Study|Lack of Efficacy|2|||
164196884|NCT02277028|593089945|FG000|Overall Study|Lost to Follow-up|1|||
164196885|NCT02277028|593089946|FG001|Overall Study|Lost to Follow-up|0|||
164196886|NCT02277028|593089945|FG000|Overall Study|Withdrawal by Subject|0|||
164196887|NCT02277028|593089946|FG001|Overall Study|Withdrawal by Subject|1|||
164196888|NCT02718911|593089947|FG000|Overall Study|Adverse Event|0|||
164196889|NCT02718911|593089948|FG001|Overall Study|Adverse Event|0|||
164196890|NCT02718911|593089949|FG002|Overall Study|Adverse Event|0|||
164196891|NCT02718911|593089950|FG003|Overall Study|Adverse Event|0|||
164196892|NCT02718911|593089951|FG004|Overall Study|Adverse Event|0|||
164196893|NCT02718911|593089952|FG005|Overall Study|Adverse Event|0|||
164196894|NCT02718911|593089953|FG006|Overall Study|Adverse Event|0|||
164196895|NCT02718911|593089954|FG007|Overall Study|Adverse Event|0|||
164196896|NCT02718911|593089955|FG008|Overall Study|Adverse Event|0|||
164196897|NCT02718911|593089956|FG009|Overall Study|Adverse Event|2|||
164196898|NCT02718911|593089947|FG000|Overall Study|Death|2|||
164196899|NCT02718911|593089948|FG001|Overall Study|Death|3|||
164196900|NCT02718911|593089949|FG002|Overall Study|Death|1|||
164196901|NCT02718911|593089950|FG003|Overall Study|Death|0|||
164196902|NCT02718911|593089951|FG004|Overall Study|Death|1|||
164196903|NCT02718911|593089952|FG005|Overall Study|Death|3|||
164196904|NCT02718911|593089953|FG006|Overall Study|Death|1|||
164196905|NCT02718911|593089954|FG007|Overall Study|Death|1|||
164196906|NCT02718911|593089955|FG008|Overall Study|Death|4|||
164196907|NCT02718911|593089956|FG009|Overall Study|Death|3|||
164196908|NCT02718911|593089947|FG000|Overall Study|Lost to Follow-up|0|||
164196909|NCT02718911|593089948|FG001|Overall Study|Lost to Follow-up|0|||
164196910|NCT02718911|593089949|FG002|Overall Study|Lost to Follow-up|0|||
164196911|NCT02718911|593089950|FG003|Overall Study|Lost to Follow-up|0|||
164196912|NCT02718911|593089951|FG004|Overall Study|Lost to Follow-up|0|||
164196913|NCT02718911|593089952|FG005|Overall Study|Lost to Follow-up|0|||
164196914|NCT02718911|593089953|FG006|Overall Study|Lost to Follow-up|0|||
164196915|NCT02718911|593089954|FG007|Overall Study|Lost to Follow-up|0|||
164196916|NCT02718911|593089955|FG008|Overall Study|Lost to Follow-up|1|||
164196917|NCT02718911|593089956|FG009|Overall Study|Lost to Follow-up|0|||
164196918|NCT02718911|593089947|FG000|Overall Study|Physician Decision|2|||
164196919|NCT02718911|593089948|FG001|Overall Study|Physician Decision|0|||
164196920|NCT02718911|593089949|FG002|Overall Study|Physician Decision|1|||
164196921|NCT02718911|593089950|FG003|Overall Study|Physician Decision|1|||
164196922|NCT02718911|593089951|FG004|Overall Study|Physician Decision|0|||
164196923|NCT02718911|593089952|FG005|Overall Study|Physician Decision|0|||
164196924|NCT02718911|593089953|FG006|Overall Study|Physician Decision|0|||
164196925|NCT02718911|593089954|FG007|Overall Study|Physician Decision|1|||
164196926|NCT02718911|593089955|FG008|Overall Study|Physician Decision|2|||
164196927|NCT02718911|593089956|FG009|Overall Study|Physician Decision|1|||
164196928|NCT02718911|593089947|FG000|Overall Study|Withdrawal by Subject|0|||
164196929|NCT02718911|593089948|FG001|Overall Study|Withdrawal by Subject|0|||
164196930|NCT02718911|593089949|FG002|Overall Study|Withdrawal by Subject|0|||
164196931|NCT02718911|593089950|FG003|Overall Study|Withdrawal by Subject|0|||
164196932|NCT02718911|593089951|FG004|Overall Study|Withdrawal by Subject|1|||
164196933|NCT02718911|593089952|FG005|Overall Study|Withdrawal by Subject|0|||
164196934|NCT02718911|593089953|FG006|Overall Study|Withdrawal by Subject|0|||
164196935|NCT02718911|593089954|FG007|Overall Study|Withdrawal by Subject|0|||
164196936|NCT02718911|593089955|FG008|Overall Study|Withdrawal by Subject|1|||
164196937|NCT02718911|593089956|FG009|Overall Study|Withdrawal by Subject|4|||
164196938|NCT02718911|593089947|FG000|Overall Study|Reason Not Collected|0|||
164196939|NCT02718911|593089948|FG001|Overall Study|Reason Not Collected|0|||
164196940|NCT02718911|593089949|FG002|Overall Study|Reason Not Collected|1|||
164196941|NCT02718911|593089950|FG003|Overall Study|Reason Not Collected|0|||
164196942|NCT02718911|593089951|FG004|Overall Study|Reason Not Collected|0|||
164196943|NCT02718911|593089952|FG005|Overall Study|Reason Not Collected|0|||
164196944|NCT02718911|593089953|FG006|Overall Study|Reason Not Collected|2|||
164196945|NCT02718911|593089954|FG007|Overall Study|Reason Not Collected|1|||
164196946|NCT02718911|593089955|FG008|Overall Study|Reason Not Collected|4|||
164196947|NCT02718911|593089956|FG009|Overall Study|Reason Not Collected|9|||
164196948|NCT04817332|593089957|FG000|Overall Study|Lost to Follow-up|3|||
164196949|NCT04817332|593089958|FG001|Overall Study|Lost to Follow-up|3|||
164196950|NCT04817332|593089957|FG000|Overall Study|Protocol Violation|2|||
163966521|NCT03672461|592249277|FG000|Overall Study|No remote technology access|0|||
164196951|NCT04817332|593089958|FG001|Overall Study|Protocol Violation|0|||
164196952|NCT01867008|593089964|FG000|Overall Study|Withdrawal by Subject|1|||
164196953|NCT05457257|593089971|FG000|Overall Study|Withdrawal by Subject|0|||
164196954|NCT05457257|593089972|FG001|Overall Study|Withdrawal by Subject|2|||
164196955|NCT05457257|593089971|FG000|Overall Study|Death|10|||
164196956|NCT05457257|593089972|FG001|Overall Study|Death|3|||
164196957|NCT05457257|593089971|FG000|Overall Study|Ongoing|19|||
164196958|NCT05457257|593089972|FG001|Overall Study|Ongoing|9|||
164196959|NCT01158261|593089973|FG000|Overall Study|Lost to Follow-up|9|||
164196960|NCT01158261|593089973|FG000|Overall Study|Death|7|||
164196961|NCT01158261|593089973|FG000|Overall Study|Withdrawal by Subject|1|||
164196962|NCT03143101|593089974|FG000|Overall Study|Withdrawal by Subject|0|||
164196963|NCT03143101|593089975|FG001|Overall Study|Withdrawal by Subject|1|||
164196964|NCT03143101|593089976|FG002|Overall Study|Withdrawal by Subject|0|||
164196965|NCT03143101|593089974|FG000|Overall Study|Lost to Follow-up|2|||
164196966|NCT03143101|593089975|FG001|Overall Study|Lost to Follow-up|2|||
164196967|NCT03143101|593089976|FG002|Overall Study|Lost to Follow-up|0|||
164196968|NCT05227118|593089977|FG000|Overall Study|Adverse Event|0|||
164196969|NCT05227118|593089978|FG001|Overall Study|Adverse Event|0|||
164196970|NCT05227118|593089979|FG002|Overall Study|Adverse Event|1|||
164196971|NCT05227118|593089980|FG003|Overall Study|Adverse Event|0|||
164196972|NCT05227118|593089977|FG000|Overall Study|Withdrawal by Subject|0|||
164196973|NCT05227118|593089978|FG001|Overall Study|Withdrawal by Subject|0|||
164196974|NCT05227118|593089979|FG002|Overall Study|Withdrawal by Subject|2|||
164196975|NCT05227118|593089980|FG003|Overall Study|Withdrawal by Subject|0|||
164196976|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
164196977|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
164196978|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
164196979|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
164196980|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
164196981|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
164196982|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
164196983|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196984|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196985|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196986|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196987|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
164196988|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
164196989|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196990|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196991|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196992|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196993|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164196994|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
164196995|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196996|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196997|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196998|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164196999|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164197000|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
164197001|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197002|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197003|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197004|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197005|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197006|NCT01435759|593089981|FG000|Antidepressant Lead-in Phase|Other|119|||
164197007|NCT01435759|593089982|FG001|Antidepressant Lead-in Phase|Other|0|||
164197008|NCT01435759|593089983|FG002|Antidepressant Lead-in Phase|Other|0|||
164197009|NCT01435759|593089984|FG003|Antidepressant Lead-in Phase|Other|0|||
164197010|NCT01435759|593089985|FG004|Antidepressant Lead-in Phase|Other|0|||
164197011|NCT01435759|593089986|FG005|Antidepressant Lead-in Phase|Other|0|||
164197012|NCT01435759|593089981|FG000|Double-blind Phase|Adverse Event|7|||
164197013|NCT01435759|593089982|FG001|Double-blind Phase|Adverse Event|0|||
164197014|NCT01435759|593089983|FG002|Double-blind Phase|Adverse Event|1|||
164197015|NCT01435759|593089984|FG003|Double-blind Phase|Adverse Event|1|||
164197016|NCT01435759|593089985|FG004|Double-blind Phase|Adverse Event|1|||
164197017|NCT01435759|593089986|FG005|Double-blind Phase|Adverse Event|3|||
164197018|NCT01435759|593089981|FG000|Double-blind Phase|Protocol Violation|2|||
164197019|NCT01435759|593089982|FG001|Double-blind Phase|Protocol Violation|0|||
164197020|NCT01435759|593089983|FG002|Double-blind Phase|Protocol Violation|1|||
164197021|NCT01435759|593089984|FG003|Double-blind Phase|Protocol Violation|2|||
164197022|NCT01435759|593089985|FG004|Double-blind Phase|Protocol Violation|0|||
164197023|NCT01435759|593089986|FG005|Double-blind Phase|Protocol Violation|1|||
164197024|NCT01435759|593089981|FG000|Double-blind Phase|Withdrawal by Subject|17|||
164197025|NCT01435759|593089982|FG001|Double-blind Phase|Withdrawal by Subject|4|||
164197026|NCT01435759|593089983|FG002|Double-blind Phase|Withdrawal by Subject|3|||
164197027|NCT01435759|593089984|FG003|Double-blind Phase|Withdrawal by Subject|4|||
164197028|NCT01435759|593089985|FG004|Double-blind Phase|Withdrawal by Subject|2|||
164197029|NCT01435759|593089986|FG005|Double-blind Phase|Withdrawal by Subject|2|||
164197030|NCT01435759|593089981|FG000|Double-blind Phase|Lost to Follow-up|31|||
164197031|NCT01435759|593089982|FG001|Double-blind Phase|Lost to Follow-up|1|||
164197032|NCT01435759|593089983|FG002|Double-blind Phase|Lost to Follow-up|2|||
164197033|NCT01435759|593089984|FG003|Double-blind Phase|Lost to Follow-up|0|||
164197034|NCT01435759|593089985|FG004|Double-blind Phase|Lost to Follow-up|3|||
164197035|NCT01435759|593089986|FG005|Double-blind Phase|Lost to Follow-up|3|||
164197036|NCT01435759|593089981|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
164197037|NCT01435759|593089982|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197038|NCT01435759|593089983|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197039|NCT01435759|593089984|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197040|NCT01435759|593089985|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
164197041|NCT01435759|593089986|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
164197042|NCT01435759|593089981|FG000|Double-blind Phase|Other|8|||
164197043|NCT01435759|593089982|FG001|Double-blind Phase|Other|2|||
164197044|NCT01435759|593089983|FG002|Double-blind Phase|Other|0|||
164197045|NCT01435759|593089984|FG003|Double-blind Phase|Other|2|||
164197046|NCT01435759|593089985|FG004|Double-blind Phase|Other|0|||
164197047|NCT01435759|593089986|FG005|Double-blind Phase|Other|0|||
164197048|NCT01601496|593089987|FG000|Overall Study|Physician Decision|1|||
164197049|NCT01601496|593089987|FG000|Overall Study|Withdrawal by Subject|1|||
164197050|NCT01601496|593089987|FG000|Overall Study|Lost to Follow-up|6|||
164197051|NCT01601496|593089987|FG000|Overall Study|Death|4|||
164197052|NCT01601496|593089987|FG000|Overall Study|Other: patient refusal to continue|3|||
164197053|NCT03126786|593089988|FG000|Overall Study|Adverse Event|3|||
164197054|NCT03126786|593089989|FG001|Overall Study|Adverse Event|0|||
164197055|NCT03126786|593089988|FG000|Overall Study|Lost to Follow-up|0|||
164197056|NCT03126786|593089989|FG001|Overall Study|Lost to Follow-up|1|||
164197057|NCT03126786|593089988|FG000|Overall Study|Withdrawal by Subject|3|||
164197058|NCT03126786|593089989|FG001|Overall Study|Withdrawal by Subject|1|||
164197059|NCT01710020|593089992|FG000|Period 1|Protocol Violation|1|||
164197060|NCT00427908|593089993|FG000|Primary Phase|Lost to Follow-up|4|||
164197061|NCT00427908|593089994|FG001|Primary Phase|Lost to Follow-up|0|||
164197062|NCT00427908|593089995|FG002|Primary Phase|Lost to Follow-up|2|||
164197063|NCT00427908|593089996|FG003|Primary Phase|Lost to Follow-up|0|||
164197064|NCT00427908|593089993|FG000|Primary Phase|Withdrawal by Subject|1|||
164197065|NCT00427908|593089994|FG001|Primary Phase|Withdrawal by Subject|2|||
164197066|NCT00427908|593089995|FG002|Primary Phase|Withdrawal by Subject|1|||
164197067|NCT00427908|593089996|FG003|Primary Phase|Withdrawal by Subject|0|||
164197068|NCT00427908|593089993|FG000|Primary Phase|Adverse Event|0|||
164197069|NCT00427908|593089994|FG001|Primary Phase|Adverse Event|1|||
164197070|NCT00427908|593089995|FG002|Primary Phase|Adverse Event|0|||
164197071|NCT00427908|593089996|FG003|Primary Phase|Adverse Event|0|||
164197072|NCT05067972|593090001|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197073|NCT05067972|593090002|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
164197074|NCT05067972|593090003|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197075|NCT05067972|593090004|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
164197076|NCT05067972|593090005|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197077|NCT05067972|593090006|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
164197078|NCT05067972|593090007|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
164197079|NCT05067972|593090001|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
164197080|NCT05067972|593090002|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
164197081|NCT05067972|593090003|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
164197082|NCT05067972|593090004|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
164197083|NCT05067972|593090005|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
164197084|NCT05067972|593090006|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
164197085|NCT05067972|593090007|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
164197086|NCT05067972|593090001|FG000|Part 1: Treatment|Progressive Disease|3|||
164197087|NCT05067972|593090002|FG001|Part 1: Treatment|Progressive Disease|3|||
164197088|NCT05067972|593090003|FG002|Part 1: Treatment|Progressive Disease|4|||
164197089|NCT05067972|593090004|FG003|Part 1: Treatment|Progressive Disease|2|||
164197090|NCT05067972|593090005|FG004|Part 1: Treatment|Progressive Disease|3|||
164197091|NCT05067972|593090006|FG005|Part 1: Treatment|Progressive Disease|0|||
164197092|NCT05067972|593090007|FG006|Part 1: Treatment|Progressive Disease|2|||
164197093|NCT05067972|593090001|FG000|Part 1: Treatment|Physician Decision|0|||
164197094|NCT05067972|593090002|FG001|Part 1: Treatment|Physician Decision|0|||
164197095|NCT05067972|593090003|FG002|Part 1: Treatment|Physician Decision|0|||
164197096|NCT05067972|593090004|FG003|Part 1: Treatment|Physician Decision|1|||
164197097|NCT05067972|593090005|FG004|Part 1: Treatment|Physician Decision|0|||
164197098|NCT05067972|593090006|FG005|Part 1: Treatment|Physician Decision|0|||
164197099|NCT05067972|593090007|FG006|Part 1: Treatment|Physician Decision|0|||
164197100|NCT05067972|593090001|FG000|Part 1: Treatment|Death|0|||
164197101|NCT05067972|593090002|FG001|Part 1: Treatment|Death|0|||
164197102|NCT05067972|593090003|FG002|Part 1: Treatment|Death|0|||
164197103|NCT05067972|593090004|FG003|Part 1: Treatment|Death|2|||
164197104|NCT05067972|593090005|FG004|Part 1: Treatment|Death|0|||
164197105|NCT05067972|593090006|FG005|Part 1: Treatment|Death|0|||
164197106|NCT05067972|593090007|FG006|Part 1: Treatment|Death|0|||
164197107|NCT05067972|593090001|FG000|Part 1: Treatment|Adverse Event|0|||
164197108|NCT05067972|593090002|FG001|Part 1: Treatment|Adverse Event|0|||
164197109|NCT05067972|593090003|FG002|Part 1: Treatment|Adverse Event|0|||
164197110|NCT05067972|593090004|FG003|Part 1: Treatment|Adverse Event|0|||
163860741|NCT04269200|591857949|FG001|Global Cohort|Withdrawal by Subject|25|||
163860742|NCT04269200|591857950|FG002|Global Cohort|Withdrawal by Subject|18|||
163860743|NCT04269200|591857948|FG000|China Cohort|Death|12|||
163860744|NCT04269200|591857949|FG001|China Cohort|Death|11|||
163860745|NCT04269200|591857950|FG002|China Cohort|Death|13|||
163860746|NCT04269200|591857948|FG000|China Cohort|Lost to Follow-up|0|||
163860747|NCT04269200|591857949|FG001|China Cohort|Lost to Follow-up|1|||
163860748|NCT04269200|591857950|FG002|China Cohort|Lost to Follow-up|1|||
163860749|NCT04269200|591857948|FG000|China Cohort|Withdrawal by Subject|2|||
163860750|NCT04269200|591857949|FG001|China Cohort|Withdrawal by Subject|2|||
163860751|NCT04269200|591857950|FG002|China Cohort|Withdrawal by Subject|4|||
164134885|NCT02132754|592857400|FG033|Overall Study|Excluded Medication|1|||
163860752|NCT04181827|591857951|FG000|Overall Study|Ongoing|124|||
163860753|NCT04181827|591857952|FG001|Overall Study|Ongoing|157|||
163860754|NCT04181827|591857951|FG000|Overall Study|Death|82|||
164134886|NCT02132754|592857367|FG000|Overall Study|Physician Decision|0|||
164134887|NCT02132754|592857368|FG001|Overall Study|Physician Decision|0|||
164134888|NCT02132754|592857369|FG002|Overall Study|Physician Decision|0|||
164134889|NCT02132754|592857370|FG003|Overall Study|Physician Decision|0|||
164134890|NCT02132754|592857371|FG004|Overall Study|Physician Decision|0|||
164134891|NCT02132754|592857372|FG005|Overall Study|Physician Decision|0|||
164134892|NCT02132754|592857373|FG006|Overall Study|Physician Decision|0|||
164134893|NCT02132754|592857374|FG007|Overall Study|Physician Decision|0|||
164134894|NCT02132754|592857375|FG008|Overall Study|Physician Decision|0|||
164134895|NCT02132754|592857376|FG009|Overall Study|Physician Decision|1|||
164134896|NCT02132754|592857377|FG010|Overall Study|Physician Decision|0|||
164134897|NCT02132754|592857378|FG011|Overall Study|Physician Decision|1|||
164134898|NCT02132754|592857379|FG012|Overall Study|Physician Decision|1|||
164134899|NCT02132754|592857380|FG013|Overall Study|Physician Decision|0|||
164134900|NCT02132754|592857381|FG014|Overall Study|Physician Decision|0|||
164134901|NCT02132754|592857382|FG015|Overall Study|Physician Decision|1|||
164134902|NCT02132754|592857383|FG016|Overall Study|Physician Decision|0|||
164134903|NCT02132754|592857384|FG017|Overall Study|Physician Decision|0|||
164134904|NCT02132754|592857385|FG018|Overall Study|Physician Decision|0|||
164134905|NCT02132754|592857386|FG019|Overall Study|Physician Decision|0|||
164134906|NCT02132754|592857387|FG020|Overall Study|Physician Decision|0|||
164134907|NCT02132754|592857388|FG021|Overall Study|Physician Decision|0|||
164134908|NCT02132754|592857389|FG022|Overall Study|Physician Decision|0|||
164134909|NCT02132754|592857390|FG023|Overall Study|Physician Decision|0|||
164134910|NCT02132754|592857391|FG024|Overall Study|Physician Decision|1|||
164134911|NCT02132754|592857392|FG025|Overall Study|Physician Decision|0|||
164134912|NCT02132754|592857393|FG026|Overall Study|Physician Decision|0|||
164134913|NCT02132754|592857394|FG027|Overall Study|Physician Decision|0|||
164134914|NCT02132754|592857395|FG028|Overall Study|Physician Decision|0|||
164134915|NCT02132754|592857396|FG029|Overall Study|Physician Decision|0|||
164134916|NCT02132754|592857397|FG030|Overall Study|Physician Decision|0|||
164134917|NCT02132754|592857398|FG031|Overall Study|Physician Decision|1|||
164134918|NCT02132754|592857399|FG032|Overall Study|Physician Decision|0|||
164134919|NCT02132754|592857400|FG033|Overall Study|Physician Decision|3|||
164134920|NCT02132754|592857367|FG000|Overall Study|Progressive Disease|1|||
164134921|NCT02132754|592857368|FG001|Overall Study|Progressive Disease|1|||
164134922|NCT02132754|592857369|FG002|Overall Study|Progressive Disease|1|||
164134923|NCT02132754|592857370|FG003|Overall Study|Progressive Disease|1|||
164134924|NCT02132754|592857371|FG004|Overall Study|Progressive Disease|1|||
164134925|NCT02132754|592857372|FG005|Overall Study|Progressive Disease|1|||
164134926|NCT02132754|592857373|FG006|Overall Study|Progressive Disease|1|||
164134927|NCT02132754|592857374|FG007|Overall Study|Progressive Disease|1|||
164134928|NCT02132754|592857375|FG008|Overall Study|Progressive Disease|1|||
164134929|NCT02132754|592857376|FG009|Overall Study|Progressive Disease|3|||
164134930|NCT02132754|592857377|FG010|Overall Study|Progressive Disease|3|||
164134931|NCT02132754|592857378|FG011|Overall Study|Progressive Disease|2|||
164134932|NCT02132754|592857379|FG012|Overall Study|Progressive Disease|2|||
164134933|NCT02132754|592857380|FG013|Overall Study|Progressive Disease|3|||
164134934|NCT02132754|592857381|FG014|Overall Study|Progressive Disease|2|||
164134935|NCT02132754|592857382|FG015|Overall Study|Progressive Disease|1|||
164134936|NCT02132754|592857383|FG016|Overall Study|Progressive Disease|2|||
164134937|NCT02132754|592857384|FG017|Overall Study|Progressive Disease|1|||
164134938|NCT02132754|592857385|FG018|Overall Study|Progressive Disease|3|||
164134939|NCT02132754|592857386|FG019|Overall Study|Progressive Disease|1|||
164134940|NCT02132754|592857387|FG020|Overall Study|Progressive Disease|1|||
164134941|NCT02132754|592857388|FG021|Overall Study|Progressive Disease|3|||
164134942|NCT02132754|592857389|FG022|Overall Study|Progressive Disease|2|||
164134943|NCT02132754|592857390|FG023|Overall Study|Progressive Disease|3|||
164134944|NCT02132754|592857391|FG024|Overall Study|Progressive Disease|0|||
164134945|NCT02132754|592857392|FG025|Overall Study|Progressive Disease|1|||
164134946|NCT02132754|592857393|FG026|Overall Study|Progressive Disease|2|||
164134947|NCT02132754|592857394|FG027|Overall Study|Progressive Disease|1|||
164134948|NCT02132754|592857395|FG028|Overall Study|Progressive Disease|2|||
164134949|NCT02132754|592857396|FG029|Overall Study|Progressive Disease|3|||
164197111|NCT05067972|593090005|FG004|Part 1: Treatment|Adverse Event|0|||
164197112|NCT05067972|593090006|FG005|Part 1: Treatment|Adverse Event|2|||
164197113|NCT05067972|593090007|FG006|Part 1: Treatment|Adverse Event|1|||
164197114|NCT05067972|593090001|FG000|Part 1: Follow-up|Adverse Event|0|||
164197115|NCT05067972|593090002|FG001|Part 1: Follow-up|Adverse Event|0|||
164197116|NCT05067972|593090003|FG002|Part 1: Follow-up|Adverse Event|0|||
164197117|NCT05067972|593090004|FG003|Part 1: Follow-up|Adverse Event|0|||
164197118|NCT05067972|593090005|FG004|Part 1: Follow-up|Adverse Event|0|||
164197119|NCT05067972|593090006|FG005|Part 1: Follow-up|Adverse Event|1|||
164197120|NCT05067972|593090007|FG006|Part 1: Follow-up|Adverse Event|0|||
164197121|NCT05067972|593090001|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
164197122|NCT05067972|593090002|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
164197123|NCT05067972|593090003|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
164197124|NCT05067972|593090004|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
163966522|NCT03672461|592249278|FG001|Overall Study|No remote technology access|1|||
163966523|NCT03672461|592249277|FG000|Overall Study|Withdrawal by Subject|1|||
163966524|NCT03672461|592249278|FG001|Overall Study|Withdrawal by Subject|0|||
163966525|NCT03672461|592249277|FG000|Overall Study|Cannot tolerate intervention|1|||
163966526|NCT03672461|592249278|FG001|Overall Study|Cannot tolerate intervention|0|||
163966527|NCT03672461|592249277|FG000|Overall Study|Incomplete outcome data|6|||
163966528|NCT03672461|592249278|FG001|Overall Study|Incomplete outcome data|1|||
163966529|NCT04225806|592249279|FG000|Overall Study|Trial termination|15|||
163966530|NCT07052682|592249282|FG000|Overall Study|Withdrawal by Subject|4|||
163966531|NCT04667247|592249283|FG000|Overall Study|Withdrawal by Subject|0|||
163966532|NCT04667247|592249284|FG001|Overall Study|Withdrawal by Subject|1|||
163966533|NCT05460273|592249285|FG000|Overall Study|Death|43|||
163966534|NCT05460273|592249286|FG001|Overall Study|Death|9|||
163966535|NCT05460273|592249285|FG000|Overall Study|Lost to Follow-up|7|||
163966536|NCT05460273|592249286|FG001|Overall Study|Lost to Follow-up|0|||
163966537|NCT05460273|592249285|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
163966538|NCT05460273|592249286|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
163966539|NCT04124614|592249287|FG000|Placebo Run-in Period|Not Randomized|34|||
163966540|NCT04124614|592249288|FG001|Placebo Run-in Period|Not Randomized|0|||
163966541|NCT04124614|592249289|FG002|Placebo Run-in Period|Not Randomized|0|||
163966542|NCT04124614|592249287|FG000|Double Blind Treatment Period|Adverse Event|0|||
163966543|NCT04124614|592249288|FG001|Double Blind Treatment Period|Adverse Event|7|||
164197125|NCT05067972|593090005|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
164197126|NCT05067972|593090006|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
164197127|NCT05067972|593090007|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
164197128|NCT05067972|593090001|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197129|NCT05067972|593090002|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197130|NCT05067972|593090003|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197131|NCT05067972|593090004|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197132|NCT05067972|593090005|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197133|NCT05067972|593090006|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
164197134|NCT05067972|593090007|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
164197135|NCT05067972|593090001|FG000|Part 1: Follow-up|Physician Decision|0|||
164197136|NCT05067972|593090002|FG001|Part 1: Follow-up|Physician Decision|0|||
164197137|NCT05067972|593090003|FG002|Part 1: Follow-up|Physician Decision|0|||
164197138|NCT05067972|593090004|FG003|Part 1: Follow-up|Physician Decision|1|||
164197139|NCT05067972|593090005|FG004|Part 1: Follow-up|Physician Decision|0|||
164197140|NCT05067972|593090006|FG005|Part 1: Follow-up|Physician Decision|0|||
164197141|NCT05067972|593090007|FG006|Part 1: Follow-up|Physician Decision|0|||
164197142|NCT05067972|593090001|FG000|Part 1: Follow-up|Death|1|||
164197143|NCT05067972|593090002|FG001|Part 1: Follow-up|Death|2|||
164197144|NCT05067972|593090003|FG002|Part 1: Follow-up|Death|1|||
164197145|NCT05067972|593090004|FG003|Part 1: Follow-up|Death|0|||
164197146|NCT05067972|593090005|FG004|Part 1: Follow-up|Death|1|||
164197147|NCT05067972|593090006|FG005|Part 1: Follow-up|Death|0|||
164197148|NCT05067972|593090007|FG006|Part 1: Follow-up|Death|1|||
164197149|NCT04391842|593090009|FG000|Overall Study|Withdrawal by Subject|2|||
164197150|NCT00808067|593090010|FG000|Overall Study|Major/minor bleed|30|||
163966544|NCT04124614|592249289|FG002|Double Blind Treatment Period|Adverse Event|22|||
163966545|NCT04124614|592249287|FG000|Double Blind Treatment Period|Death|0|||
164197151|NCT00808067|593090011|FG001|Overall Study|Major/minor bleed|44|||
164197152|NCT00808067|593090010|FG000|Overall Study|Outcome event - other|33|||
164197153|NCT00808067|593090011|FG001|Overall Study|Outcome event - other|25|||
164197154|NCT00808067|593090010|FG000|Overall Study|Adverse Event|111|||
164197155|NCT00808067|593090011|FG001|Overall Study|Adverse Event|121|||
163966546|NCT04124614|592249288|FG001|Double Blind Treatment Period|Death|0|||
163966547|NCT04124614|592249289|FG002|Double Blind Treatment Period|Death|1|||
163966548|NCT04124614|592249287|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164197156|NCT00808067|593090010|FG000|Overall Study|Hospitalization (not including surgery)|18|||
164197157|NCT00808067|593090011|FG001|Overall Study|Hospitalization (not including surgery)|17|||
164197158|NCT00808067|593090010|FG000|Overall Study|Hospitalization due to surgery|37|||
164197159|NCT00808067|593090011|FG001|Overall Study|Hospitalization due to surgery|40|||
163966549|NCT04124614|592249288|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
163966550|NCT04124614|592249289|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
163966551|NCT04124614|592249287|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
163966552|NCT04124614|592249288|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
163966553|NCT04124614|592249289|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
163966554|NCT04124614|592249287|FG000|Double Blind Treatment Period|Physician Decision|0|||
163966555|NCT04124614|592249288|FG001|Double Blind Treatment Period|Physician Decision|0|||
164197160|NCT00808067|593090010|FG000|Overall Study|Reduced creatinine clearance|53|||
164197161|NCT00808067|593090011|FG001|Overall Study|Reduced creatinine clearance|55|||
164197162|NCT00808067|593090010|FG000|Overall Study|Elevated LFT results|7|||
164197163|NCT00808067|593090011|FG001|Overall Study|Elevated LFT results|3|||
164197164|NCT00808067|593090010|FG000|Overall Study|Patient refused to take study medication|65|||
164197165|NCT00808067|593090011|FG001|Overall Study|Patient refused to take study medication|76|||
164197166|NCT00808067|593090010|FG000|Overall Study|Missing|1|||
164197167|NCT00808067|593090011|FG001|Overall Study|Missing|0|||
164197168|NCT00808067|593090010|FG000|Overall Study|Death|1|||
164197169|NCT00808067|593090011|FG001|Overall Study|Death|1|||
164197170|NCT00808067|593090010|FG000|Overall Study|Procedure|6|||
164197171|NCT00808067|593090011|FG001|Overall Study|Procedure|7|||
164197172|NCT00808067|593090010|FG000|Overall Study|Withdrawal by Subject|21|||
164197173|NCT00808067|593090011|FG001|Overall Study|Withdrawal by Subject|25|||
164197174|NCT00808067|593090010|FG000|Overall Study|Site closed|4|||
164197175|NCT00808067|593090011|FG001|Overall Study|Site closed|3|||
164197176|NCT00808067|593090010|FG000|Overall Study|Physician Decision|47|||
164197177|NCT00808067|593090011|FG001|Overall Study|Physician Decision|38|||
164197178|NCT00808067|593090010|FG000|Overall Study|Protocol Violation|3|||
164197179|NCT00808067|593090011|FG001|Overall Study|Protocol Violation|11|||
164197180|NCT00808067|593090010|FG000|Overall Study|Patient elected|7|||
164197181|NCT00808067|593090011|FG001|Overall Study|Patient elected|9|||
164197182|NCT00808067|593090010|FG000|Overall Study|Site closed for cause|19|||
164197183|NCT00808067|593090011|FG001|Overall Study|Site closed for cause|19|||
164197184|NCT00808067|593090010|FG000|Overall Study|Other reason not defined above|5|||
164197185|NCT00808067|593090011|FG001|Overall Study|Other reason not defined above|5|||
164197186|NCT00808067|593090010|FG000|Overall Study|Excluded from analysis|13|||
164197187|NCT00808067|593090011|FG001|Overall Study|Excluded from analysis|19|||
164197188|NCT04157517|593090012|FG000|Overall Study|Death|1|||
164197189|NCT04157517|593090013|FG001|Overall Study|Death|2|||
164197190|NCT04157517|593090014|FG002|Overall Study|Death|2|||
164197191|NCT04157517|593090015|FG003|Overall Study|Death|3|||
164197192|NCT04157517|593090016|FG004|Overall Study|Death|3|||
164197193|NCT04157517|593090017|FG005|Overall Study|Death|4|||
164197194|NCT04157517|593090018|FG006|Overall Study|Death|1|||
164197195|NCT04157517|593090019|FG007|Overall Study|Death|2|||
164197196|NCT04157517|593090020|FG008|Overall Study|Death|4|||
164197197|NCT04157517|593090021|FG009|Overall Study|Death|0|||
164197198|NCT04157517|593090012|FG000|Overall Study|Withdrawal by Subject|1|||
164197199|NCT04157517|593090013|FG001|Overall Study|Withdrawal by Subject|1|||
164197200|NCT04157517|593090014|FG002|Overall Study|Withdrawal by Subject|1|||
164197201|NCT04157517|593090015|FG003|Overall Study|Withdrawal by Subject|0|||
164197202|NCT04157517|593090016|FG004|Overall Study|Withdrawal by Subject|0|||
164197203|NCT04157517|593090017|FG005|Overall Study|Withdrawal by Subject|1|||
164197204|NCT04157517|593090018|FG006|Overall Study|Withdrawal by Subject|0|||
164197205|NCT04157517|593090019|FG007|Overall Study|Withdrawal by Subject|0|||
164197206|NCT04157517|593090020|FG008|Overall Study|Withdrawal by Subject|1|||
164197207|NCT04157517|593090021|FG009|Overall Study|Withdrawal by Subject|0|||
164197208|NCT04157517|593090012|FG000|Overall Study|Other|1|||
164197209|NCT04157517|593090013|FG001|Overall Study|Other|0|||
164197210|NCT04157517|593090014|FG002|Overall Study|Other|0|||
164197211|NCT04157517|593090015|FG003|Overall Study|Other|0|||
164197212|NCT04157517|593090016|FG004|Overall Study|Other|0|||
164197213|NCT04157517|593090017|FG005|Overall Study|Other|1|||
163966556|NCT04124614|592249289|FG002|Double Blind Treatment Period|Physician Decision|3|||
163966557|NCT04124614|592249287|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
163966558|NCT04124614|592249288|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
164197214|NCT04157517|593090018|FG006|Overall Study|Other|2|||
164197215|NCT04157517|593090019|FG007|Overall Study|Other|7|||
164197216|NCT04157517|593090020|FG008|Overall Study|Other|7|||
164197217|NCT04157517|593090021|FG009|Overall Study|Other|0|||
164197218|NCT00565604|593090025|FG000|Overall Study|Failure to treat|2|||
164197219|NCT00565604|593090025|FG000|Overall Study|Lost to Follow-up|2|||
164197220|NCT04579380|593092221|FG000|Overall Study|Death|9|||
163966559|NCT04124614|592249289|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
164197221|NCT04579380|593092222|FG001|Overall Study|Death|22|||
164197222|NCT04579380|593092223|FG002|Overall Study|Death|22|||
164197223|NCT04579380|593092224|FG003|Overall Study|Death|17|||
164197224|NCT04579380|593092225|FG004|Overall Study|Death|6|||
164197225|NCT04579380|593092226|FG005|Overall Study|Death|21|||
164197226|NCT04579380|593092227|FG006|Overall Study|Death|10|||
164197227|NCT04579380|593092228|FG007|Overall Study|Death|11|||
164197228|NCT04579380|593092229|FG008|Overall Study|Death|25|||
164197229|NCT04579380|593092221|FG000|Overall Study|Withdrawal by Subject|0|||
164197230|NCT04579380|593092222|FG001|Overall Study|Withdrawal by Subject|3|||
164197231|NCT04579380|593092223|FG002|Overall Study|Withdrawal by Subject|4|||
164197232|NCT04579380|593092224|FG003|Overall Study|Withdrawal by Subject|0|||
163860755|NCT04181827|591857952|FG001|Overall Study|Death|50|||
163860756|NCT04181827|591857951|FG000|Overall Study|Lost to Follow-up|0|||
163860757|NCT04181827|591857952|FG001|Overall Study|Lost to Follow-up|1|||
163860758|NCT04181827|591857951|FG000|Overall Study|Withdrawal by Subject|5|||
163860759|NCT04181827|591857952|FG001|Overall Study|Withdrawal by Subject|0|||
163860760|NCT03887936|591857953|FG000|Overall Study|Relocation|2|||
163860761|NCT03887936|591857954|FG001|Overall Study|Relocation|2|||
163860762|NCT03887936|591857953|FG000|Overall Study|Physician Decision|0|||
163860763|NCT03887936|591857954|FG001|Overall Study|Physician Decision|1|||
163860764|NCT03887936|591857953|FG000|Overall Study|Withdrawal by Subject|0|||
163860765|NCT03887936|591857954|FG001|Overall Study|Withdrawal by Subject|1|||
163860766|NCT06269367|591857955|FG000|Phase I|Unable to perform study procedures|0|||
163860767|NCT06269367|591857956|FG001|Phase I|Unable to perform study procedures|1|||
163860768|NCT06269367|591857955|FG000|Phase I|Could not continue study for personal reasons.|1|||
163860769|NCT06269367|591857956|FG001|Phase I|Could not continue study for personal reasons.|0|||
163860770|NCT03331250|591857957|FG000|Overall Study|Withdrawal by Subject|1|||
163860771|NCT01155869|591857966|FG000|Overall Study|Lost to Follow-up|3|||
163860772|NCT01155869|591857967|FG001|Overall Study|Lost to Follow-up|1|||
163860773|NCT00117988|591857969|FG000|Overall Study|Death|3|||
163860774|NCT00117988|591857969|FG000|Overall Study|Adverse Event|1|||
163860775|NCT05824351|591857970|FG000|Overall Study|Adverse Event|6|||
163860776|NCT02137850|591857971|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
163860777|NCT02137850|591857972|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
163860778|NCT02137850|591857973|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
163860779|NCT02137850|591857971|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
163860780|NCT02137850|591857972|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
163860781|NCT02137850|591857973|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
163860782|NCT02137850|591857971|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
163860783|NCT02137850|591857972|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
163860784|NCT02137850|591857973|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
163860785|NCT02137850|591857971|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
163860786|NCT02137850|591857972|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
163860787|NCT02137850|591857973|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
163860788|NCT02137850|591857971|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
163860789|NCT02137850|591857972|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
163860790|NCT02137850|591857973|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
163860791|NCT02137850|591857971|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
163860792|NCT02137850|591857972|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
163860793|NCT02137850|591857973|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
163860794|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163860795|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
163860796|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163860797|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
163860798|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
163860799|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
163860800|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
163860801|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
163860802|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
163860803|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
163860804|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
163860805|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
163860806|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Other|0|||
163860807|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Other|1|||
163860808|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Other|0|||
163860809|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
163860810|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
163860811|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
163860812|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Early site closure|0|||
163860813|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Early site closure|2|||
163860814|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Early site closure|0|||
163860815|NCT02137850|591857971|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
163860816|NCT02137850|591857972|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
163860817|NCT02137850|591857973|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
163966560|NCT04124614|592249287|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163860818|NCT02137850|591857971|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
163860819|NCT02137850|591857972|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
163860820|NCT02137850|591857973|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
164197233|NCT04579380|593092225|FG004|Overall Study|Withdrawal by Subject|1|||
163966561|NCT04124614|592249288|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
163966562|NCT04124614|592249289|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
163966563|NCT04124614|592249287|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
163966564|NCT04124614|592249288|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
163966565|NCT04124614|592249289|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
163966566|NCT05749952|592249290|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
163966567|NCT00257166|592250437|FG000|Overall Study|Adverse Event|18|||
163966568|NCT00257166|592250438|FG001|Overall Study|Adverse Event|13|||
163966569|NCT00257166|592250437|FG000|Overall Study|Laboratory abnormality|1|||
163966570|NCT00257166|592250438|FG001|Overall Study|Laboratory abnormality|0|||
163966571|NCT00257166|592250437|FG000|Overall Study|Lost to Follow-up|8|||
163966572|NCT00257166|592250438|FG001|Overall Study|Lost to Follow-up|1|||
163966573|NCT00257166|592250437|FG000|Overall Study|Withdrawal by Subject|9|||
163966574|NCT00257166|592250438|FG001|Overall Study|Withdrawal by Subject|2|||
163966575|NCT00257166|592250437|FG000|Overall Study|Other|16|||
163966576|NCT00257166|592250438|FG001|Overall Study|Other|21|||
163966577|NCT00257166|592250437|FG000|Overall Study|Randomized, but not treated|1|||
163966578|NCT00257166|592250438|FG001|Overall Study|Randomized, but not treated|0|||
163966579|NCT02592551|592250439|FG000|Overall Study|Not evaluable|1|||
163966580|NCT02592551|592250440|FG001|Overall Study|Not evaluable|3|||
163966581|NCT02592551|592250441|FG002|Overall Study|Not evaluable|0|||
163966582|NCT00761306|592250442|FG000|Overall Study|Adverse Event|5|||
163966583|NCT00761306|592250442|FG000|Overall Study|Lack of Efficacy|4|||
163966584|NCT00761306|592250442|FG000|Overall Study|Protocol Violation|2|||
163966585|NCT00761306|592250442|FG000|Overall Study|Withdrawal of Consent|3|||
163966586|NCT00761306|592250442|FG000|Overall Study|Lost to Follow-up|1|||
163966587|NCT00761306|592250442|FG000|Overall Study|Administrative or Other Reasons|5|||
163966588|NCT05162027|592250443|FG000|Overall Study|Adverse Event|1|||
163966589|NCT05162027|592250444|FG001|Overall Study|Adverse Event|0|||
163966590|NCT00993954|592250446|FG000|Overall Study|Protocol Violation|21|||
163966591|NCT00993954|592250447|FG001|Overall Study|Protocol Violation|2|||
163966592|NCT00907257|592250453|FG000|Overall Study|Adverse Event|0|||
163966593|NCT00907257|592250454|FG001|Overall Study|Adverse Event|4|||
163966594|NCT00907257|592250453|FG000|Overall Study|Protocol Violation|1|||
163966595|NCT00907257|592250454|FG001|Overall Study|Protocol Violation|2|||
163966596|NCT00907257|592250453|FG000|Overall Study|Lost to Follow-up|3|||
163966597|NCT00907257|592250454|FG001|Overall Study|Lost to Follow-up|3|||
163966598|NCT00907257|592250453|FG000|Overall Study|Withdrawal by Subject|1|||
163966599|NCT00907257|592250454|FG001|Overall Study|Withdrawal by Subject|2|||
163966600|NCT00907257|592250453|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
163966601|NCT00907257|592250454|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
163966602|NCT00907257|592250453|FG000|Overall Study|Moved|1|||
163966603|NCT00907257|592250454|FG001|Overall Study|Moved|0|||
163966604|NCT00907257|592250453|FG000|Overall Study|Personal Reasons|6|||
163966605|NCT00907257|592250454|FG001|Overall Study|Personal Reasons|1|||
163966606|NCT01873417|592250456|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
163966607|NCT01873417|592250456|FG000|Overall Study|Adverse Event|24|||
163966608|NCT01873417|592250456|FG000|Overall Study|Lost to Follow-up|2|||
163966609|NCT01873417|592250456|FG000|Overall Study|Withdrawal by Subject|2|||
163966610|NCT01873417|592250456|FG000|Overall Study|Physician Decision|3|||
163966611|NCT00785044|592250457|FG000|Overall Study|Dosed at non-participating sites|152|||
163966612|NCT00785044|592250457|FG000|Overall Study|Death|77|||
163966613|NCT00785044|592250457|FG000|Overall Study|Lost to Follow-up|266|||
163966614|NCT00785044|592250457|FG000|Overall Study|Withdrawal by Subject|1|||
163966615|NCT01628107|592250458|FG000|Overall Study|Withdrawal by Subject|17|||
163966616|NCT01628107|592250458|FG000|Overall Study|Lost to Follow-up|4|||
163966617|NCT01628107|592250458|FG000|Overall Study|Adverse Event|33|||
163966618|NCT01628107|592250458|FG000|Overall Study|Physician Decision|2|||
163966619|NCT01628107|592250458|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
163966620|NCT01628107|592250458|FG000|Overall Study|Non-compliant with Study Procedures|10|||
163966621|NCT01628107|592250458|FG000|Overall Study|Not Treated|8|||
163966622|NCT01628107|592250458|FG000|Overall Study|Sponsor Decision|11|||
163966623|NCT01628107|592250458|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
163966624|NCT01628107|592250458|FG000|Overall Study|Relocated|8|||
163966625|NCT01628107|592250458|FG000|Overall Study|Kidney Transplant|9|||
163966626|NCT01628107|592250458|FG000|Overall Study|Use of Standard of Care|9|||
163966627|NCT01069120|592250459|FG000|Overall Study|Study prematurely terminated|27|||
163966628|NCT00763971|592250460|FG000|Overall Study|Adverse Event|5|||
163966629|NCT00763971|592250461|FG001|Overall Study|Adverse Event|2|||
163966630|NCT00763971|592250462|FG002|Overall Study|Adverse Event|4|||
163966631|NCT00763971|592250460|FG000|Overall Study|Protocol Violation|3|||
163966632|NCT00763971|592250461|FG001|Overall Study|Protocol Violation|3|||
163966633|NCT00763971|592250462|FG002|Overall Study|Protocol Violation|2|||
163966634|NCT00763971|592250460|FG000|Overall Study|Withdrawal by Subject|4|||
163966635|NCT00763971|592250461|FG001|Overall Study|Withdrawal by Subject|5|||
163966636|NCT00763971|592250462|FG002|Overall Study|Withdrawal by Subject|5|||
163966637|NCT00763971|592250460|FG000|Overall Study|Lost to Follow-up|0|||
163966638|NCT00763971|592250461|FG001|Overall Study|Lost to Follow-up|1|||
164197234|NCT04579380|593092226|FG005|Overall Study|Withdrawal by Subject|2|||
164197235|NCT04579380|593092227|FG006|Overall Study|Withdrawal by Subject|0|||
164197236|NCT04579380|593092228|FG007|Overall Study|Withdrawal by Subject|1|||
164197237|NCT04579380|593092229|FG008|Overall Study|Withdrawal by Subject|2|||
164197238|NCT04579380|593092221|FG000|Overall Study|Ongoing|2|||
164197239|NCT04579380|593092222|FG001|Overall Study|Ongoing|6|||
164197240|NCT04579380|593092223|FG002|Overall Study|Ongoing|4|||
164197241|NCT04579380|593092224|FG003|Overall Study|Ongoing|8|||
164197242|NCT04579380|593092225|FG004|Overall Study|Ongoing|5|||
164197243|NCT04579380|593092226|FG005|Overall Study|Ongoing|8|||
164197244|NCT04579380|593092227|FG006|Overall Study|Ongoing|3|||
164197245|NCT04579380|593092228|FG007|Overall Study|Ongoing|19|||
164197246|NCT04579380|593092229|FG008|Overall Study|Ongoing|6|||
164197247|NCT04113694|593092231|FG000|Overall Study|Adverse Event|2|||
164197248|NCT04113694|593092231|FG000|Overall Study|Lost to Follow-up|2|||
164197249|NCT04113694|593092231|FG000|Overall Study|Withdrawal by Subject|6|||
164197250|NCT04113694|593092231|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
164197251|NCT05630196|593092234|FG000|Overall Study|Adverse Event|2|||
164197252|NCT05630196|593092235|FG001|Overall Study|Adverse Event|1|||
164197253|NCT05630196|593092234|FG000|Overall Study|Lost to Follow-up|1|||
164197254|NCT05630196|593092235|FG001|Overall Study|Lost to Follow-up|1|||
164197255|NCT05630196|593092234|FG000|Overall Study|Protocol Violation|2|||
164197256|NCT05630196|593092235|FG001|Overall Study|Protocol Violation|3|||
164197257|NCT05630196|593092234|FG000|Overall Study|Physician Decision|1|||
164197258|NCT05630196|593092235|FG001|Overall Study|Physician Decision|0|||
164197259|NCT05630196|593092234|FG000|Overall Study|Withdrawal by Subject|3|||
164197260|NCT05630196|593092235|FG001|Overall Study|Withdrawal by Subject|4|||
164197261|NCT03973996|593092237|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164197262|NCT03973996|593092238|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164197263|NCT03973996|593092239|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164197264|NCT03973996|593092240|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
164197265|NCT04070989|593092241|FG000|Overall Study|Death|1|||
164197266|NCT04070989|593092242|FG001|Overall Study|Death|0|||
164197267|NCT04070989|593092243|FG002|Overall Study|Death|0|||
164197268|NCT04070989|593092241|FG000|Overall Study|Study Terminated by Sponsor|7|||
164197269|NCT04070989|593092242|FG001|Overall Study|Study Terminated by Sponsor|8|||
164197270|NCT04070989|593092243|FG002|Overall Study|Study Terminated by Sponsor|23|||
164197271|NCT04070989|593092241|FG000|Overall Study|Withdrawal by Subject|0|||
164197272|NCT04070989|593092242|FG001|Overall Study|Withdrawal by Subject|1|||
164197273|NCT04070989|593092243|FG002|Overall Study|Withdrawal by Subject|0|||
164197274|NCT04070989|593092241|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
164197275|NCT04070989|593092242|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
164197276|NCT04070989|593092243|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
164197277|NCT04070989|593092241|FG000|Overall Study|Other|1|||
164197278|NCT04070989|593092242|FG001|Overall Study|Other|1|||
164197279|NCT04070989|593092243|FG002|Overall Study|Other|0|||
164197280|NCT06088784|593092244|FG000|Overall Study|Adverse Event|0|||
164197281|NCT06088784|593092245|FG001|Overall Study|Adverse Event|0|||
164197282|NCT06088784|593092246|FG002|Overall Study|Adverse Event|0|||
164197283|NCT06088784|593092247|FG003|Overall Study|Adverse Event|0|||
164197284|NCT06088784|593092248|FG004|Overall Study|Adverse Event|0|||
164197285|NCT06088784|593092249|FG005|Overall Study|Adverse Event|0|||
164197286|NCT06088784|593092250|FG006|Overall Study|Adverse Event|3|||
164197287|NCT06088784|593092251|FG007|Overall Study|Adverse Event|0|||
164197288|NCT06088784|593092252|FG008|Overall Study|Adverse Event|0|||
164197289|NCT06088784|593092253|FG009|Overall Study|Adverse Event|0|||
163860821|NCT02137850|591857971|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
163860822|NCT02137850|591857972|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
163860823|NCT02137850|591857973|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
163860824|NCT02137850|591857971|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
163860825|NCT02137850|591857972|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
163860826|NCT02137850|591857973|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
163860827|NCT02137850|591857971|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
163860828|NCT02137850|591857972|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
163860829|NCT02137850|591857973|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
163860830|NCT02137850|591857971|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
164197290|NCT06088784|593092254|FG010|Overall Study|Adverse Event|0|||
164197291|NCT06088784|593092255|FG011|Overall Study|Adverse Event|0|||
164197292|NCT06088784|593092244|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197293|NCT06088784|593092245|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197294|NCT06088784|593092246|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197295|NCT06088784|593092247|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197296|NCT06088784|593092248|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197297|NCT06088784|593092249|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197298|NCT06088784|593092250|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
163860831|NCT02137850|591857972|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
164197299|NCT06088784|593092251|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197300|NCT06088784|593092252|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197301|NCT06088784|593092253|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197302|NCT06088784|593092254|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197303|NCT06088784|593092255|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
164197304|NCT00830219|593092258|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164197305|NCT00830219|593092259|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164197306|NCT01130272|593092260|FG000|Overall Study|Adverse Event|2|||
164197307|NCT01130272|593092261|FG001|Overall Study|Adverse Event|5|||
164197308|NCT01130272|593092262|FG002|Overall Study|Adverse Event|6|||
164197309|NCT01130272|593092263|FG003|Overall Study|Adverse Event|22|||
164197310|NCT01130272|593092264|FG004|Overall Study|Adverse Event|7|||
164197311|NCT01130272|593092260|FG000|Overall Study|IVRS-confirmed constipation|0|||
164197312|NCT01130272|593092261|FG001|Overall Study|IVRS-confirmed constipation|1|||
164197313|NCT01130272|593092262|FG002|Overall Study|IVRS-confirmed constipation|1|||
164197314|NCT01130272|593092263|FG003|Overall Study|IVRS-confirmed constipation|2|||
164197315|NCT01130272|593092264|FG004|Overall Study|IVRS-confirmed constipation|0|||
164197316|NCT01130272|593092260|FG000|Overall Study|Rescue medications due to diarrhea|3|||
164197317|NCT01130272|593092261|FG001|Overall Study|Rescue medications due to diarrhea|5|||
164197318|NCT01130272|593092262|FG002|Overall Study|Rescue medications due to diarrhea|8|||
164197319|NCT01130272|593092263|FG003|Overall Study|Rescue medications due to diarrhea|8|||
164197320|NCT01130272|593092264|FG004|Overall Study|Rescue medications due to diarrhea|6|||
164197321|NCT01130272|593092260|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
164197322|NCT01130272|593092261|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
164197323|NCT01130272|593092262|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
164197324|NCT01130272|593092263|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
164197325|NCT01130272|593092264|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
163860832|NCT02137850|591857973|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
163860833|NCT02137850|591857971|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163860834|NCT02137850|591857972|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
163860835|NCT02137850|591857973|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
163860836|NCT02137850|591857971|FG000|Extension Phase: Prophylaxis|Other|0|||
163860837|NCT02137850|591857972|FG001|Extension Phase: Prophylaxis|Other|1|||
163860838|NCT02137850|591857973|FG002|Extension Phase: Prophylaxis|Other|0|||
163860839|NCT02137850|591857971|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
163860840|NCT02137850|591857972|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
163860841|NCT02137850|591857973|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
163860842|NCT02912260|591857974|FG000|Main Study|Lost to Follow-up|5|||
163860843|NCT02912260|591857975|FG001|Main Study|Lost to Follow-up|4|||
163860844|NCT02912260|591857974|FG000|Main Study|Withdrawal by Subject|2|||
163860845|NCT02912260|591857975|FG001|Main Study|Withdrawal by Subject|2|||
163860846|NCT02912260|591857974|FG000|Main Study|Adverse Event|3|||
163860847|NCT02912260|591857975|FG001|Main Study|Adverse Event|0|||
163860848|NCT02912260|591857974|FG000|Main Study|Physician Decision|0|||
163860849|NCT02912260|591857975|FG001|Main Study|Physician Decision|1|||
163860850|NCT02912260|591857974|FG000|Extension Study|Withdrawal by Subject|1|||
163860851|NCT02912260|591857975|FG001|Extension Study|Withdrawal by Subject|1|||
163860852|NCT03878446|591857978|FG000|Overall Study|Withdrawn by parent or guardian|1|||
163860853|NCT03878446|591857979|FG001|Overall Study|Withdrawn by parent or guardian|0|||
163860854|NCT03878446|591857980|FG002|Overall Study|Withdrawn by parent or guardian|0|||
163860855|NCT03878446|591857981|FG003|Overall Study|Withdrawn by parent or guardian|0|||
163860856|NCT03878446|591857982|FG004|Overall Study|Withdrawn by parent or guardian|0|||
163860857|NCT05803720|591857983|FG000|Overall Study|Lost to Follow-up|3|||
163860858|NCT05803720|591857984|FG001|Overall Study|Lost to Follow-up|4|||
163860859|NCT05803720|591857983|FG000|Overall Study|Family leave/emergency|1|||
163860860|NCT05803720|591857984|FG001|Overall Study|Family leave/emergency|1|||
163860861|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
163860862|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
163860863|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
163860864|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
163860865|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
163860866|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
163860867|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Death|1|||
164197326|NCT01130272|593092260|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164197327|NCT01130272|593092261|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
163860868|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Death|1|||
163860869|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Death|1|||
163860870|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Death|0|||
163860871|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Death|0|||
163860872|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Death|0|||
163860873|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
163860874|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
163860875|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
164197328|NCT01130272|593092262|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164197329|NCT01130272|593092263|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
164197330|NCT01130272|593092264|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
164197331|NCT01130272|593092260|FG000|Overall Study|Protocol Violation|0|||
164197332|NCT01130272|593092261|FG001|Overall Study|Protocol Violation|0|||
164197333|NCT01130272|593092262|FG002|Overall Study|Protocol Violation|3|||
164197334|NCT01130272|593092263|FG003|Overall Study|Protocol Violation|5|||
164197335|NCT01130272|593092264|FG004|Overall Study|Protocol Violation|5|||
164197336|NCT01130272|593092260|FG000|Overall Study|Lost to Follow-up|4|||
164197337|NCT01130272|593092261|FG001|Overall Study|Lost to Follow-up|3|||
164197338|NCT01130272|593092262|FG002|Overall Study|Lost to Follow-up|4|||
164197339|NCT01130272|593092263|FG003|Overall Study|Lost to Follow-up|7|||
164197340|NCT01130272|593092264|FG004|Overall Study|Lost to Follow-up|6|||
164197341|NCT01130272|593092260|FG000|Overall Study|Withdrawal by Subject|4|||
164197342|NCT01130272|593092261|FG001|Overall Study|Withdrawal by Subject|11|||
164197343|NCT01130272|593092262|FG002|Overall Study|Withdrawal by Subject|10|||
164197344|NCT01130272|593092263|FG003|Overall Study|Withdrawal by Subject|9|||
164197345|NCT01130272|593092264|FG004|Overall Study|Withdrawal by Subject|8|||
164197346|NCT01130272|593092260|FG000|Overall Study|Physician Decision|1|||
164197347|NCT01130272|593092261|FG001|Overall Study|Physician Decision|1|||
164197348|NCT01130272|593092262|FG002|Overall Study|Physician Decision|0|||
164197349|NCT01130272|593092263|FG003|Overall Study|Physician Decision|1|||
164197350|NCT01130272|593092264|FG004|Overall Study|Physician Decision|2|||
164197351|NCT01130272|593092260|FG000|Overall Study|Sponsor decision|6|||
164197352|NCT01130272|593092261|FG001|Overall Study|Sponsor decision|15|||
164197353|NCT01130272|593092262|FG002|Overall Study|Sponsor decision|16|||
164197354|NCT01130272|593092263|FG003|Overall Study|Sponsor decision|13|||
164197355|NCT01130272|593092264|FG004|Overall Study|Sponsor decision|16|||
164197356|NCT01130272|593092260|FG000|Overall Study|Study arm discontinued|38|||
164197357|NCT01130272|593092261|FG001|Overall Study|Study arm discontinued|0|||
164197358|NCT01130272|593092262|FG002|Overall Study|Study arm discontinued|0|||
164197359|NCT01130272|593092263|FG003|Overall Study|Study arm discontinued|0|||
164197360|NCT01130272|593092264|FG004|Overall Study|Study arm discontinued|0|||
164197361|NCT00641056|593092265|FG000|Overall Study|Adverse Event|12|||
164197362|NCT00641056|593092266|FG001|Overall Study|Adverse Event|2|||
164197363|NCT00641056|593092265|FG000|Overall Study|Lost to Follow-up|2|||
164197364|NCT00641056|593092266|FG001|Overall Study|Lost to Follow-up|1|||
164197365|NCT00641056|593092265|FG000|Overall Study|Physician Decision|3|||
164197366|NCT00641056|593092266|FG001|Overall Study|Physician Decision|1|||
164197367|NCT00641056|593092265|FG000|Overall Study|Protocol Violation|2|||
164197368|NCT00641056|593092266|FG001|Overall Study|Protocol Violation|0|||
164197369|NCT00641056|593092265|FG000|Overall Study|Entry Criteria Not Met|3|||
164197370|NCT00641056|593092266|FG001|Overall Study|Entry Criteria Not Met|0|||
164197371|NCT00641056|593092265|FG000|Overall Study|Subject Decision|6|||
164197372|NCT00641056|593092266|FG001|Overall Study|Subject Decision|19|||
164197373|NCT00641056|593092265|FG000|Overall Study|Sponsor Decision|1|||
164197374|NCT00641056|593092266|FG001|Overall Study|Sponsor Decision|2|||
164197375|NCT00239720|593092268|FG000|Overall Study|Adverse Event|1|||
164197376|NCT00239720|593092269|FG001|Overall Study|Adverse Event|0|||
164197377|NCT00239720|593092268|FG000|Overall Study|Lost to Follow-up|0|||
164197378|NCT00239720|593092269|FG001|Overall Study|Lost to Follow-up|1|||
164197379|NCT01811732|593092270|FG000|Overall Study|Lost to Follow-up|24|||
164197380|NCT01811732|593092271|FG001|Overall Study|Lost to Follow-up|30|||
164197381|NCT01811732|593092270|FG000|Overall Study|Withdrawal by Subject|16|||
164197382|NCT01811732|593092271|FG001|Overall Study|Withdrawal by Subject|10|||
164197383|NCT01811732|593092270|FG000|Overall Study|Adverse Event|3|||
164197384|NCT01811732|593092271|FG001|Overall Study|Adverse Event|9|||
164197385|NCT01811732|593092270|FG000|Overall Study|Lack of Efficacy|3|||
164197386|NCT01811732|593092271|FG001|Overall Study|Lack of Efficacy|1|||
164197387|NCT01811732|593092270|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
164197388|NCT01811732|593092271|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
164197389|NCT01811732|593092270|FG000|Overall Study|Physician Decision|2|||
164197390|NCT01811732|593092271|FG001|Overall Study|Physician Decision|0|||
164197391|NCT01811732|593092270|FG000|Overall Study|Death|1|||
164197392|NCT01811732|593092271|FG001|Overall Study|Death|1|||
164197393|NCT01811732|593092270|FG000|Overall Study|Insufficient venous access|0|||
164197394|NCT01811732|593092271|FG001|Overall Study|Insufficient venous access|1|||
164197395|NCT01811732|593092270|FG000|Overall Study|Protocol Violation|0|||
164197396|NCT01811732|593092271|FG001|Overall Study|Protocol Violation|1|||
164197397|NCT01811732|593092270|FG000|Overall Study|Subject incarcerated|1|||
164197398|NCT01811732|593092271|FG001|Overall Study|Subject incarcerated|2|||
164197399|NCT01811732|593092270|FG000|Overall Study|Admitted to another facility|1|||
164197400|NCT01811732|593092271|FG001|Overall Study|Admitted to another facility|0|||
164197401|NCT01811732|593092270|FG000|Overall Study|Correct study drug not available on site|1|||
164197402|NCT01811732|593092271|FG001|Overall Study|Correct study drug not available on site|0|||
164197403|NCT01405560|593092272|FG000|Overall Study|Physician Decision|1|||
164197404|NCT00896493|593092275|FG000|Overall Study|Early disease relapse|3|||
164197405|NCT00536510|593092276|FG000|Overall Study|Adverse Event|27|||
164197406|NCT00536510|593092277|FG001|Overall Study|Adverse Event|4|||
164197407|NCT00536510|593092276|FG000|Overall Study|Lost to Follow-up|11|||
164197408|NCT00536510|593092277|FG001|Overall Study|Lost to Follow-up|8|||
164197409|NCT00536510|593092276|FG000|Overall Study|Protocol Violation|4|||
164197410|NCT00536510|593092277|FG001|Overall Study|Protocol Violation|5|||
164197411|NCT00536510|593092276|FG000|Overall Study|Withdrawal by Subject|16|||
164197412|NCT00536510|593092277|FG001|Overall Study|Withdrawal by Subject|9|||
164197413|NCT00536510|593092276|FG000|Overall Study|Flushing with Product|20|||
164197414|NCT00536510|593092277|FG001|Overall Study|Flushing with Product|0|||
164197415|NCT00536510|593092276|FG000|Overall Study|Laboratory Adverse Event|2|||
164197416|NCT00536510|593092277|FG001|Overall Study|Laboratory Adverse Event|1|||
164197417|NCT00536510|593092276|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
164197418|NCT00536510|593092277|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
164197419|NCT02035553|593092278|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
163860876|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163860877|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163860878|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
163860879|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163860880|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163860881|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
163860882|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163860883|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163860884|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
163860885|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163860886|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
163860887|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163860888|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163860889|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163860890|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
163860891|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
163860892|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
163860893|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
163860894|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
163860895|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
163860896|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
163860897|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
163860898|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
163860899|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
163860900|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
163860901|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
163860902|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
163860903|NCT03370133|591857985|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
163860904|NCT03370133|591857986|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
163860905|NCT03370133|591857987|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
163860906|NCT03370133|591857988|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
163860907|NCT03370133|591857989|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
163860908|NCT03370133|591857990|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
163860909|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
163860910|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
163860911|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
163860912|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
163860913|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
163860914|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
163860915|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163860916|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163860917|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163860918|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
163860919|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
163860920|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
163860921|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
164197420|NCT02035553|593092279|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
164197421|NCT02035553|593092278|FG000|Overall Study|Adverse Event|10|||
164197422|NCT02035553|593092279|FG001|Overall Study|Adverse Event|6|||
163966639|NCT00763971|592250462|FG002|Overall Study|Lost to Follow-up|0|||
163860922|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163860923|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163860924|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
163860925|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
163860926|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
163966640|NCT00763971|592250460|FG000|Overall Study|Lack of Efficacy|11|||
164197423|NCT02035553|593092278|FG000|Overall Study|Physician Decision|3|||
164197424|NCT02035553|593092279|FG001|Overall Study|Physician Decision|2|||
164197425|NCT02035553|593092278|FG000|Overall Study|Lack of Efficacy|1|||
164197426|NCT02035553|593092279|FG001|Overall Study|Lack of Efficacy|1|||
164197427|NCT02035553|593092278|FG000|Overall Study|Withdrawal by Subject|4|||
164197428|NCT02035553|593092279|FG001|Overall Study|Withdrawal by Subject|7|||
164197429|NCT02035553|593092278|FG000|Overall Study|Non-compliance with Study Drug|0|||
164197430|NCT02035553|593092279|FG001|Overall Study|Non-compliance with Study Drug|1|||
164197431|NCT02035553|593092278|FG000|Overall Study|Lost to Follow-up|0|||
164197432|NCT02035553|593092279|FG001|Overall Study|Lost to Follow-up|1|||
164197433|NCT02035553|593092278|FG000|Overall Study|Other Reason|0|||
164197434|NCT02035553|593092279|FG001|Overall Study|Other Reason|4|||
163860927|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163860928|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163860929|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163860930|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
163860931|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
163860932|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
163860933|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
163860934|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
163860935|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
163860936|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
163860937|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
163860938|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
163860939|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163860940|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163860941|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163860942|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163860943|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
163860944|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
163860945|NCT03370133|591857985|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163860946|NCT03370133|591857986|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163860947|NCT03370133|591857987|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163860948|NCT03370133|591857988|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163860949|NCT03370133|591857989|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
163860950|NCT03370133|591857990|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
163860951|NCT06688370|591857991|FG000|Overall Study|Discontinued the treatment|1|||
163860952|NCT06688370|591857991|FG000|Overall Study|Prohibited treatment taken|4|||
163860953|NCT00567879|591859385|FG000|Overall Study|Adverse Event|2|||
163860954|NCT00567879|591859386|FG001|Overall Study|Adverse Event|0|||
163860955|NCT00567879|591859387|FG002|Overall Study|Adverse Event|1|||
163860956|NCT00567879|591859388|FG003|Overall Study|Adverse Event|0|||
163860957|NCT00567879|591859389|FG004|Overall Study|Adverse Event|1|||
163860958|NCT00567879|591859390|FG005|Overall Study|Adverse Event|0|||
163860959|NCT00567879|591859385|FG000|Overall Study|Abnormal test procedure(s)|0|||
163860960|NCT00567879|591859386|FG001|Overall Study|Abnormal test procedure(s)|0|||
163860961|NCT00567879|591859387|FG002|Overall Study|Abnormal test procedure(s)|1|||
163860962|NCT00567879|591859388|FG003|Overall Study|Abnormal test procedure(s)|0|||
163860963|NCT00567879|591859389|FG004|Overall Study|Abnormal test procedure(s)|0|||
163860964|NCT00567879|591859390|FG005|Overall Study|Abnormal test procedure(s)|0|||
163860965|NCT00567879|591859385|FG000|Overall Study|Withdrawal by Subject|0|||
163860966|NCT00567879|591859386|FG001|Overall Study|Withdrawal by Subject|0|||
163860967|NCT00567879|591859387|FG002|Overall Study|Withdrawal by Subject|3|||
163860968|NCT00567879|591859388|FG003|Overall Study|Withdrawal by Subject|1|||
163860969|NCT00567879|591859389|FG004|Overall Study|Withdrawal by Subject|0|||
163860970|NCT00567879|591859390|FG005|Overall Study|Withdrawal by Subject|0|||
163966641|NCT00763971|592250461|FG001|Overall Study|Lack of Efficacy|22|||
164197435|NCT04539964|593092280|FG000|Overall Study|device malfunction|1|||
164197436|NCT04539964|593092281|FG001|Overall Study|device malfunction|0|||
164197437|NCT04539964|593092280|FG000|Overall Study|Withdrawal by Subject|1|||
163860971|NCT00567879|591859385|FG000|Overall Study|New cancer therapy|0|||
163860972|NCT00567879|591859386|FG001|Overall Study|New cancer therapy|0|||
163860973|NCT00567879|591859387|FG002|Overall Study|New cancer therapy|1|||
163860974|NCT00567879|591859388|FG003|Overall Study|New cancer therapy|0|||
163860975|NCT00567879|591859389|FG004|Overall Study|New cancer therapy|0|||
163860976|NCT00567879|591859390|FG005|Overall Study|New cancer therapy|0|||
163860977|NCT00567879|591859385|FG000|Overall Study|Disease progression|5|||
163860978|NCT00567879|591859386|FG001|Overall Study|Disease progression|7|||
163860979|NCT00567879|591859387|FG002|Overall Study|Disease progression|15|||
163966642|NCT00763971|592250462|FG002|Overall Study|Lack of Efficacy|54|||
164197438|NCT04539964|593092281|FG001|Overall Study|Withdrawal by Subject|2|||
164197439|NCT04539964|593092280|FG000|Overall Study|Adverse Event|0|||
163860980|NCT00567879|591859388|FG003|Overall Study|Disease progression|5|||
163860981|NCT00567879|591859389|FG004|Overall Study|Disease progression|11|||
163860982|NCT00567879|591859390|FG005|Overall Study|Disease progression|3|||
163860983|NCT00151996|591859391|FG000|Overall Study|Adverse Event|3|||
163860984|NCT00151996|591859392|FG001|Overall Study|Adverse Event|2|||
163860985|NCT00151996|591859391|FG000|Overall Study|Withdrawal by Subject|1|||
163860986|NCT00151996|591859392|FG001|Overall Study|Withdrawal by Subject|1|||
163860987|NCT00151996|591859391|FG000|Overall Study|Protocol Violation|1|||
163860988|NCT00151996|591859392|FG001|Overall Study|Protocol Violation|2|||
163860989|NCT00151996|591859391|FG000|Overall Study|Sponsor's decision|0|||
163860990|NCT00151996|591859392|FG001|Overall Study|Sponsor's decision|2|||
163966643|NCT00763971|592250460|FG000|Overall Study|Unable to swallow capsule|2|||
164197440|NCT04539964|593092281|FG001|Overall Study|Adverse Event|2|||
164197441|NCT01674725|593092282|FG000|Overall Study|Adverse Event|1|||
164197442|NCT01674725|593092283|FG001|Overall Study|Adverse Event|0|||
164197443|NCT01674725|593092282|FG000|Overall Study|Did not receive study drug|1|||
164197444|NCT01674725|593092283|FG001|Overall Study|Did not receive study drug|0|||
164197445|NCT01674725|593092282|FG000|Overall Study|Withdrawal by Subject|1|||
164197446|NCT01674725|593092283|FG001|Overall Study|Withdrawal by Subject|0|||
164197447|NCT01674725|593092282|FG000|Overall Study|Lost to Follow-up|0|||
164197448|NCT01674725|593092283|FG001|Overall Study|Lost to Follow-up|1|||
164197449|NCT03102762|593092284|FG000|Overall Study|Lost to Follow-up|1|||
164197450|NCT03102762|593092285|FG001|Overall Study|Lost to Follow-up|0|||
164197451|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
164197452|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197453|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197454|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197455|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
164197456|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
164197457|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197458|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197459|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197460|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
164197461|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
164197462|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197463|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197464|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197465|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
164197466|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
164197467|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197468|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197469|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197470|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
164197471|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
164197472|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197473|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197474|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197475|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
164197476|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
164197477|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197478|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197479|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197480|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
164197481|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
164197482|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197483|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197484|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197485|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
164197486|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
164197487|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164197488|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164197489|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
163860991|NCT01546155|591859393|FG000|Overall Study|could not tolerate long scan duration|3|||
163860992|NCT01649791|591859397|FG000|Overall Study|Disease Progression|2|||
163860993|NCT01649791|591859397|FG000|Overall Study|Adverse Event|1|||
163860994|NCT02987543|591859398|FG000|Overall Study|Ongoing study at data cut off|49|||
163966644|NCT00763971|592250461|FG001|Overall Study|Unable to swallow capsule|1|||
164197490|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
164197491|NCT02709746|593092286|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
164197492|NCT02709746|593092287|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197493|NCT02709746|593092288|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197494|NCT02709746|593092289|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197495|NCT02709746|593092290|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
164197496|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
164197497|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
164197498|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
164197499|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
164197500|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
164197501|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
164197502|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
164197503|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
164197504|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
164197505|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
164197506|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
164197507|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
164197508|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
164197509|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
164197510|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
164197511|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
164197512|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
164197513|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
164197514|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
164197515|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
164197516|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
164197517|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
164197518|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
164197519|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
164197520|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
164197521|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
164197522|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
164197523|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
164197524|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
164197525|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
164197526|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197527|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197528|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
164197529|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197530|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
164197531|NCT02709746|593092286|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
164197532|NCT02709746|593092287|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
164197533|NCT02709746|593092288|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
164197534|NCT02709746|593092289|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
164197535|NCT02709746|593092290|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
164197536|NCT03074695|593092291|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
164197537|NCT03074695|593092292|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
164197538|NCT03074695|593092291|FG000|Overall Study|Research staff not available|1|||
164197539|NCT03074695|593092292|FG001|Overall Study|Research staff not available|2|||
164197540|NCT03074695|593092291|FG000|Overall Study|Did not receive neuraxial block|2|||
164197541|NCT03074695|593092292|FG001|Overall Study|Did not receive neuraxial block|2|||
164197542|NCT00902577|593092293|FG000|Overall Study|Withdrawal by Subject|6|||
164197543|NCT00902577|593092293|FG000|Overall Study|FMISO production failure|2|||
164197544|NCT01232790|593092294|FG000|Randomization|Withdrawal by Subject|2|||
164197545|NCT01232790|593092295|FG001|Randomization|Withdrawal by Subject|0|||
164197546|NCT01232790|593092294|FG000|Randomization|Protocol Violation|0|||
164197547|NCT01232790|593092295|FG001|Randomization|Protocol Violation|1|||
164197548|NCT01232790|593092294|FG000|Randomization|Physician Decision|0|||
164197549|NCT01232790|593092295|FG001|Randomization|Physician Decision|1|||
164197550|NCT01232790|593092294|FG000|Initial Assessment|Withdrawal by Subject|0|||
164197551|NCT01232790|593092295|FG001|Initial Assessment|Withdrawal by Subject|1|||
164197552|NCT01232790|593092294|FG000|First Crossover|Withdrawal by Subject|1|||
164197553|NCT01232790|593092295|FG001|First Crossover|Withdrawal by Subject|0|||
164197554|NCT01232790|593092294|FG000|Second Crossover|Withdrawal by Subject|1|||
164197555|NCT01232790|593092295|FG001|Second Crossover|Withdrawal by Subject|2|||
164197556|NCT00083915|593092296|FG000|Overall Study|Death|6|||
164197557|NCT00083915|593092297|FG001|Overall Study|Death|3|||
164197558|NCT00083915|593092296|FG000|Overall Study|Physician Decision|11|||
164197559|NCT00083915|593092297|FG001|Overall Study|Physician Decision|6|||
164197560|NCT00083915|593092296|FG000|Overall Study|Withdrawal by Subject|8|||
164197561|NCT00083915|593092297|FG001|Overall Study|Withdrawal by Subject|3|||
164197562|NCT00083915|593092296|FG000|Overall Study|disease progression|18|||
164197563|NCT00083915|593092297|FG001|Overall Study|disease progression|23|||
164197564|NCT00083915|593092296|FG000|Overall Study|Failure to collect|3|||
164197565|NCT00083915|593092297|FG001|Overall Study|Failure to collect|0|||
164197566|NCT00083915|593092296|FG000|Overall Study|No response|3|||
164197567|NCT00083915|593092297|FG001|Overall Study|No response|1|||
164197568|NCT00083915|593092296|FG000|Overall Study|Insurance issues|1|||
164197569|NCT00083915|593092297|FG001|Overall Study|Insurance issues|1|||
164197570|NCT04456686|593092301|FG000|Overall Study|Adverse Event|2|||
164197571|NCT04456686|593092302|FG001|Overall Study|Adverse Event|1|||
164197572|NCT04456686|593092301|FG000|Overall Study|Lack of Efficacy|3|||
164197573|NCT04456686|593092302|FG001|Overall Study|Lack of Efficacy|1|||
164197574|NCT04456686|593092301|FG000|Overall Study|Withdrew consent|3|||
164197575|NCT04456686|593092302|FG001|Overall Study|Withdrew consent|1|||
164197576|NCT04456686|593092301|FG000|Overall Study|Physician Decision|2|||
164197577|NCT04456686|593092302|FG001|Overall Study|Physician Decision|2|||
164197578|NCT04456686|593092301|FG000|Overall Study|Withdrawal by Subject|5|||
164197579|NCT04456686|593092302|FG001|Overall Study|Withdrawal by Subject|1|||
164197580|NCT04456686|593092301|FG000|Overall Study|Protocol Violation|0|||
164197581|NCT04456686|593092302|FG001|Overall Study|Protocol Violation|1|||
164197582|NCT03722576|593092305|FG000|Overall Study|Withdrawal by Subject|3|||
164197583|NCT03722576|593092305|FG000|Overall Study|Adverse Event|2|||
164197584|NCT03722576|593092305|FG000|Overall Study|Physician Decision|1|||
164197585|NCT03722576|593092305|FG000|Overall Study|Lost to Follow-up|1|||
164197586|NCT02048722|593092311|FG000|2 Cycles of Treatment|Adverse Event|2|||
164197587|NCT02048722|593092311|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
164197588|NCT02048722|593092311|FG000|2 Cycles of Treatment|Progressive Disease|2|||
164197589|NCT02048722|593092311|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
164197590|NCT02048722|593092311|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
164197591|NCT02048722|593092311|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
164197592|NCT03575702|593092312|FG000|Overall Study|Withdrawal by Subject|1|||
164197593|NCT03575702|593092313|FG001|Overall Study|Withdrawal by Subject|1|||
164197594|NCT03575702|593092312|FG000|Overall Study|Lost to Follow-up|1|||
164197595|NCT03575702|593092313|FG001|Overall Study|Lost to Follow-up|2|||
164197596|NCT03575702|593092312|FG000|Overall Study|Protocol Violation|0|||
164197597|NCT03575702|593092313|FG001|Overall Study|Protocol Violation|1|||
164197598|NCT03575702|593092312|FG000|Overall Study|Patient non compliance|4|||
164197599|NCT03575702|593092313|FG001|Overall Study|Patient non compliance|0|||
164197600|NCT02127658|593092323|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
164197601|NCT02127658|593092324|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
164197602|NCT02127658|593092323|FG000|Overall Study|Withdrawal by Subject|0|||
164197603|NCT02127658|593092324|FG001|Overall Study|Withdrawal by Subject|2|||
164197604|NCT02127658|593092323|FG000|Overall Study|Physician Decision|0|||
164197605|NCT02127658|593092324|FG001|Overall Study|Physician Decision|1|||
164197606|NCT05559905|593092325|FG000|Overall Study|Withdrawal by Subject|1|||
163860995|NCT02987543|591859399|FG001|Overall Study|Ongoing study at data cut off|21|||
163860996|NCT02987543|591859400|FG002|Overall Study|Ongoing study at data cut off|19|||
163860997|NCT02987543|591859401|FG003|Overall Study|Ongoing study at data cut off|12|||
163860998|NCT02987543|591859398|FG000|Overall Study|Death|88|||
163860999|NCT02987543|591859399|FG001|Overall Study|Death|54|||
163861000|NCT02987543|591859400|FG002|Overall Study|Death|67|||
163861001|NCT02987543|591859401|FG003|Overall Study|Death|28|||
163861002|NCT02987543|591859398|FG000|Overall Study|Lost to Follow-up|3|||
163861003|NCT02987543|591859399|FG001|Overall Study|Lost to Follow-up|0|||
163861004|NCT02987543|591859400|FG002|Overall Study|Lost to Follow-up|1|||
163861005|NCT02987543|591859401|FG003|Overall Study|Lost to Follow-up|0|||
163861006|NCT02987543|591859398|FG000|Overall Study|Screen failure|0|||
163861007|NCT02987543|591859399|FG001|Overall Study|Screen failure|0|||
163861008|NCT02987543|591859400|FG002|Overall Study|Screen failure|0|||
163861009|NCT02987543|591859401|FG003|Overall Study|Screen failure|1|||
163861010|NCT02987543|591859398|FG000|Overall Study|Withdrawal by Subject|21|||
163861011|NCT02987543|591859399|FG001|Overall Study|Withdrawal by Subject|7|||
164197607|NCT05559905|593092326|FG001|Overall Study|Withdrawal by Subject|0|||
164197608|NCT05559905|593092327|FG002|Overall Study|Withdrawal by Subject|0|||
164197609|NCT05559905|593092325|FG000|Overall Study|Not Reported|1|||
164197610|NCT05559905|593092326|FG001|Overall Study|Not Reported|0|||
164197611|NCT05559905|593092327|FG002|Overall Study|Not Reported|0|||
164197612|NCT04003103|593092328|FG000|Overall Study|Death|1|||
164197613|NCT04003103|593092329|FG001|Overall Study|Death|0|||
164197614|NCT04003103|593092330|FG002|Overall Study|Death|0|||
164197615|NCT04003103|593092328|FG000|Overall Study|Lost to Follow-up|4|||
164197616|NCT04003103|593092329|FG001|Overall Study|Lost to Follow-up|3|||
163966645|NCT00763971|592250462|FG002|Overall Study|Unable to swallow capsule|1|||
164197617|NCT04003103|593092330|FG002|Overall Study|Lost to Follow-up|2|||
163966646|NCT00763971|592250460|FG000|Overall Study|Personal reason|3|||
163966647|NCT00763971|592250461|FG001|Overall Study|Personal reason|0|||
163966648|NCT00763971|592250462|FG002|Overall Study|Personal reason|0|||
163966649|NCT00763971|592250460|FG000|Overall Study|Exclusion criteria met|1|||
163966650|NCT00763971|592250461|FG001|Overall Study|Exclusion criteria met|0|||
163966651|NCT00763971|592250462|FG002|Overall Study|Exclusion criteria met|0|||
163966652|NCT00763971|592250460|FG000|Overall Study|Sponsor decision|1|||
163966653|NCT00763971|592250461|FG001|Overall Study|Sponsor decision|0|||
163966654|NCT00763971|592250462|FG002|Overall Study|Sponsor decision|0|||
163966655|NCT00763971|592250460|FG000|Overall Study|Due to holiday season|2|||
163966656|NCT00763971|592250461|FG001|Overall Study|Due to holiday season|0|||
163966657|NCT00763971|592250462|FG002|Overall Study|Due to holiday season|1|||
163966658|NCT00763971|592250460|FG000|Overall Study|Randomization error|0|||
163966659|NCT00763971|592250461|FG001|Overall Study|Randomization error|0|||
163966660|NCT00763971|592250462|FG002|Overall Study|Randomization error|1|||
163966661|NCT00763971|592250460|FG000|Overall Study|Medical monitor decision|0|||
163966662|NCT00763971|592250461|FG001|Overall Study|Medical monitor decision|0|||
163966663|NCT00763971|592250462|FG002|Overall Study|Medical monitor decision|1|||
163966664|NCT00763971|592250460|FG000|Overall Study|Moved to another country|0|||
163966665|NCT00763971|592250461|FG001|Overall Study|Moved to another country|1|||
163966666|NCT00763971|592250462|FG002|Overall Study|Moved to another country|0|||
163966667|NCT00763971|592250460|FG000|Overall Study|Subject wanted dose reduction|0|||
163966668|NCT00763971|592250461|FG001|Overall Study|Subject wanted dose reduction|1|||
163966669|NCT00763971|592250462|FG002|Overall Study|Subject wanted dose reduction|0|||
163966670|NCT00763971|592250460|FG000|Overall Study|Lack of availability|0|||
163966671|NCT00763971|592250461|FG001|Overall Study|Lack of availability|1|||
163966672|NCT00763971|592250462|FG002|Overall Study|Lack of availability|0|||
163966673|NCT00763971|592250460|FG000|Overall Study|Performed final visit on phone|0|||
163966674|NCT00763971|592250461|FG001|Overall Study|Performed final visit on phone|1|||
164197618|NCT04003103|593092328|FG000|Overall Study|Withdrawal by Subject|10|||
164197619|NCT04003103|593092329|FG001|Overall Study|Withdrawal by Subject|1|||
164197620|NCT04003103|593092330|FG002|Overall Study|Withdrawal by Subject|1|||
164197621|NCT04003103|593092328|FG000|Overall Study|Status not recorded|0|||
164197622|NCT04003103|593092329|FG001|Overall Study|Status not recorded|2|||
164197623|NCT04003103|593092330|FG002|Overall Study|Status not recorded|0|||
164197624|NCT01764841|593092331|FG000|Overall Study|Logistical Difficulties|0|||
164197625|NCT01764841|593092332|FG001|Overall Study|Logistical Difficulties|1|||
164197626|NCT01764841|593092333|FG002|Overall Study|Logistical Difficulties|0|||
164197627|NCT01764841|593092334|FG003|Overall Study|Logistical Difficulties|0|||
164197628|NCT01764841|593092331|FG000|Overall Study|Death|3|||
164197629|NCT01764841|593092332|FG001|Overall Study|Death|0|||
164197630|NCT01764841|593092333|FG002|Overall Study|Death|1|||
164197631|NCT01764841|593092334|FG003|Overall Study|Death|4|||
164197632|NCT01764841|593092331|FG000|Overall Study|No Follow Up|1|||
164197633|NCT01764841|593092332|FG001|Overall Study|No Follow Up|0|||
164197634|NCT01764841|593092333|FG002|Overall Study|No Follow Up|1|||
164197635|NCT01764841|593092334|FG003|Overall Study|No Follow Up|0|||
164197636|NCT01764841|593092331|FG000|Overall Study|Protocol Violation|0|||
164197637|NCT01764841|593092332|FG001|Overall Study|Protocol Violation|1|||
164197638|NCT01764841|593092333|FG002|Overall Study|Protocol Violation|0|||
164197639|NCT01764841|593092334|FG003|Overall Study|Protocol Violation|0|||
164197640|NCT01764841|593092331|FG000|Overall Study|Withdrawal by Subject|16|||
164197641|NCT01764841|593092332|FG001|Overall Study|Withdrawal by Subject|24|||
164197642|NCT01764841|593092333|FG002|Overall Study|Withdrawal by Subject|11|||
164197643|NCT01764841|593092334|FG003|Overall Study|Withdrawal by Subject|15|||
164197644|NCT01764841|593092331|FG000|Overall Study|Lost to Follow-up|3|||
164197645|NCT01764841|593092332|FG001|Overall Study|Lost to Follow-up|0|||
164197646|NCT01764841|593092333|FG002|Overall Study|Lost to Follow-up|1|||
163966675|NCT00763971|592250462|FG002|Overall Study|Performed final visit on phone|0|||
163966676|NCT00763971|592250460|FG000|Overall Study|Participation in 489-326 required|1|||
163966677|NCT00763971|592250461|FG001|Overall Study|Participation in 489-326 required|0|||
163966678|NCT00763971|592250462|FG002|Overall Study|Participation in 489-326 required|0|||
163966679|NCT02713542|592250463|FG000|Overall Study|Use of prohibited medication|14|||
163966680|NCT02713542|592250464|FG001|Overall Study|Use of prohibited medication|5|||
163966681|NCT02713542|592250463|FG000|Overall Study|Withdrawal by Subject|4|||
163966682|NCT02713542|592250464|FG001|Overall Study|Withdrawal by Subject|1|||
164197647|NCT01764841|593092334|FG003|Overall Study|Lost to Follow-up|0|||
164197648|NCT02115607|593092335|FG000|Overall Study|Withdrawal by Subject|1|||
164197649|NCT04863872|593092336|FG000|Overall Study|Withdrawal by Subject|4|||
164197650|NCT04863872|593092337|FG001|Overall Study|Withdrawal by Subject|15|||
164197651|NCT04863872|593092336|FG000|Overall Study|Death|5|||
164197652|NCT04863872|593092337|FG001|Overall Study|Death|2|||
164197653|NCT04863872|593092336|FG000|Overall Study|Lost to Follow-up|2|||
164197654|NCT04863872|593092337|FG001|Overall Study|Lost to Follow-up|1|||
164197655|NCT00549549|593092338|FG000|Overall Study|Adverse Event|5|||
163861012|NCT02987543|591859400|FG002|Overall Study|Withdrawal by Subject|7|||
163861013|NCT02987543|591859401|FG003|Overall Study|Withdrawal by Subject|6|||
163861014|NCT02987543|591859398|FG000|Overall Study|Study terminated by sponsor|1|||
163861015|NCT02987543|591859399|FG001|Overall Study|Study terminated by sponsor|0|||
163861016|NCT02987543|591859400|FG002|Overall Study|Study terminated by sponsor|0|||
163861017|NCT02987543|591859401|FG003|Overall Study|Study terminated by sponsor|0|||
163861018|NCT02987543|591859398|FG000|Overall Study|Investigator decision|0|||
163861019|NCT02987543|591859399|FG001|Overall Study|Investigator decision|1|||
163861020|NCT02987543|591859400|FG002|Overall Study|Investigator decision|0|||
163861021|NCT02987543|591859401|FG003|Overall Study|Investigator decision|0|||
163861022|NCT02987543|591859398|FG000|Overall Study|Disease progression|0|||
163861023|NCT02987543|591859399|FG001|Overall Study|Disease progression|0|||
163861024|NCT02987543|591859400|FG002|Overall Study|Disease progression|0|||
163861025|NCT02987543|591859401|FG003|Overall Study|Disease progression|1|||
163861026|NCT03646669|591859402|FG000|Overall Study|Withdrawal by Subject|5|||
163861027|NCT03646669|591859403|FG001|Overall Study|Withdrawal by Subject|0|||
163861028|NCT01227278|591859404|FG000|Overall Study|Withdrawal by Subject|4|||
163861029|NCT01227278|591859405|FG001|Overall Study|Withdrawal by Subject|4|||
163861030|NCT01227278|591859404|FG000|Overall Study|Death|0|||
163861031|NCT01227278|591859405|FG001|Overall Study|Death|2|||
163861032|NCT01227278|591859404|FG000|Overall Study|Other|1|||
163861033|NCT01227278|591859405|FG001|Overall Study|Other|2|||
163861034|NCT00420316|591859408|FG000|Overall Study|Withdrawal by Subject|0|||
163861035|NCT00420316|591859409|FG001|Overall Study|Withdrawal by Subject|1|||
163861036|NCT00420316|591859408|FG000|Overall Study|Lost to Follow-up|12|||
163861037|NCT00420316|591859409|FG001|Overall Study|Lost to Follow-up|8|||
163966683|NCT03631667|592250465|FG000|Overall Study|Withdrawal by Subject|3|||
164197656|NCT00549549|593092339|FG001|Overall Study|Adverse Event|3|||
164197657|NCT00549549|593092340|FG002|Overall Study|Adverse Event|1|||
164197658|NCT00549549|593092341|FG003|Overall Study|Adverse Event|9|||
164197659|NCT00549549|593092338|FG000|Overall Study|Lack of Efficacy|9|||
164197660|NCT00549549|593092339|FG001|Overall Study|Lack of Efficacy|6|||
164197661|NCT00549549|593092340|FG002|Overall Study|Lack of Efficacy|4|||
164197662|NCT00549549|593092341|FG003|Overall Study|Lack of Efficacy|2|||
164197663|NCT00549549|593092338|FG000|Overall Study|Lost to Follow-up|1|||
164197664|NCT00549549|593092339|FG001|Overall Study|Lost to Follow-up|0|||
164197665|NCT00549549|593092340|FG002|Overall Study|Lost to Follow-up|1|||
164197666|NCT00549549|593092341|FG003|Overall Study|Lost to Follow-up|2|||
164197667|NCT00549549|593092338|FG000|Overall Study|Withdrawal by Subject|0|||
164197668|NCT00549549|593092339|FG001|Overall Study|Withdrawal by Subject|4|||
164197669|NCT00549549|593092340|FG002|Overall Study|Withdrawal by Subject|1|||
164197670|NCT00549549|593092341|FG003|Overall Study|Withdrawal by Subject|0|||
164197671|NCT00549549|593092338|FG000|Overall Study|Other|9|||
164197672|NCT00549549|593092339|FG001|Overall Study|Other|9|||
164197673|NCT00549549|593092340|FG002|Overall Study|Other|9|||
164197674|NCT00549549|593092341|FG003|Overall Study|Other|11|||
164197675|NCT00549549|593092338|FG000|Overall Study|Randomized but not treated|0|||
164197676|NCT00549549|593092339|FG001|Overall Study|Randomized but not treated|0|||
164197677|NCT00549549|593092340|FG002|Overall Study|Randomized but not treated|1|||
164197678|NCT00549549|593092341|FG003|Overall Study|Randomized but not treated|1|||
164197679|NCT02155699|593092342|FG000|Overall Study|Withdrawal by Subject|0|||
164197680|NCT02155699|593092343|FG001|Overall Study|Withdrawal by Subject|3|||
164197681|NCT02155699|593092344|FG002|Overall Study|Withdrawal by Subject|6|||
164197682|NCT02155699|593092345|FG003|Overall Study|Withdrawal by Subject|1|||
164197683|NCT02155699|593092342|FG000|Overall Study|Lost to Follow-up|0|||
164197684|NCT02155699|593092343|FG001|Overall Study|Lost to Follow-up|0|||
164197685|NCT02155699|593092344|FG002|Overall Study|Lost to Follow-up|0|||
164197686|NCT02155699|593092345|FG003|Overall Study|Lost to Follow-up|3|||
164197687|NCT02155699|593092342|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
164197688|NCT02155699|593092343|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
164197689|NCT02155699|593092344|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
164197690|NCT02155699|593092345|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
164197691|NCT05547386|593092346|FG000|Overall Study|Withdrawal by Subject|7|||
164197692|NCT02573259|593092352|FG000|Overall Study|Death|1|||
163861038|NCT03546907|591859416|FG000|Overall Study|Lack of Efficacy|1|||
163861039|NCT03546907|591859417|FG001|Overall Study|Lack of Efficacy|1|||
163861040|NCT03546907|591859416|FG000|Overall Study|Withdrawal by Subject|8|||
163861041|NCT03546907|591859417|FG001|Overall Study|Withdrawal by Subject|9|||
163861042|NCT03546907|591859416|FG000|Overall Study|Adverse events (AEs)|7|||
163966684|NCT00884325|592250477|FG000|Overall Study|Lost to Follow-up|1|||
163861043|NCT03546907|591859417|FG001|Overall Study|Adverse events (AEs)|10|||
163861044|NCT03546907|591859416|FG000|Overall Study|Other-unspecified|1|||
163861045|NCT03546907|591859417|FG001|Overall Study|Other-unspecified|1|||
163861046|NCT03720210|591859418|FG000|Overall Study|Lost to Follow-up|1|||
163966685|NCT00884325|592250478|FG001|Overall Study|Lost to Follow-up|2|||
164197693|NCT02573259|593092353|FG001|Overall Study|Death|6|||
164197694|NCT02573259|593092354|FG002|Overall Study|Death|5|||
164197695|NCT02573259|593092355|FG003|Overall Study|Death|6|||
163861047|NCT02274493|591859424|FG000|Overall Study|Withdrawal by Subject|1|||
163861048|NCT04588480|591859430|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
163861049|NCT04588480|591859431|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
163861050|NCT04588480|591859432|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
163861051|NCT04588480|591859430|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
163861052|NCT04588480|591859431|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
163861053|NCT04588480|591859432|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
163861054|NCT01190150|591859433|FG000|First Treatment|Withdrawal by Subject|1|||
163861055|NCT01190150|591859434|FG001|First Treatment|Withdrawal by Subject|0|||
163861056|NCT01190150|591859433|FG000|Washout|Withdrawal by Subject|0|||
163861057|NCT01190150|591859434|FG001|Washout|Withdrawal by Subject|1|||
163861058|NCT01190150|591859433|FG000|Washout|Difficulty in adherence|0|||
163861059|NCT01190150|591859434|FG001|Washout|Difficulty in adherence|1|||
163861060|NCT02982213|591859435|FG000|Overall Study|Did not complete follow up questionnaire|5|||
163861061|NCT02982213|591859436|FG001|Overall Study|Did not complete follow up questionnaire|1|||
163861062|NCT03523962|591859438|FG000|Closed Fractures|Death|86|||
163861063|NCT03523962|591859439|FG001|Closed Fractures|Death|71|||
163861064|NCT03523962|591859440|FG002|Closed Fractures|Death|0|||
163861065|NCT03523962|591859441|FG003|Closed Fractures|Death|0|||
163861066|NCT03523962|591859438|FG000|Closed Fractures|Lost to Follow-up|62|||
163861067|NCT03523962|591859439|FG001|Closed Fractures|Lost to Follow-up|36|||
163861068|NCT03523962|591859440|FG002|Closed Fractures|Lost to Follow-up|0|||
163861069|NCT03523962|591859441|FG003|Closed Fractures|Lost to Follow-up|0|||
163861070|NCT03523962|591859438|FG000|Closed Fractures|Withdrawal by Subject|19|||
163861071|NCT03523962|591859439|FG001|Closed Fractures|Withdrawal by Subject|29|||
163861072|NCT03523962|591859440|FG002|Closed Fractures|Withdrawal by Subject|0|||
163861073|NCT03523962|591859441|FG003|Closed Fractures|Withdrawal by Subject|0|||
163861074|NCT03523962|591859438|FG000|Closed Fractures|Incarceration|1|||
163861075|NCT03523962|591859439|FG001|Closed Fractures|Incarceration|4|||
163861076|NCT03523962|591859440|FG002|Closed Fractures|Incarceration|0|||
163861077|NCT03523962|591859441|FG003|Closed Fractures|Incarceration|0|||
163861078|NCT03523962|591859438|FG000|Open Fractures|Death|0|||
163861079|NCT03523962|591859439|FG001|Open Fractures|Death|0|||
163861080|NCT03523962|591859440|FG002|Open Fractures|Death|11|||
163861081|NCT03523962|591859441|FG003|Open Fractures|Death|6|||
163861082|NCT03523962|591859438|FG000|Open Fractures|Lost to Follow-up|0|||
163861083|NCT03523962|591859439|FG001|Open Fractures|Lost to Follow-up|0|||
163861084|NCT03523962|591859440|FG002|Open Fractures|Lost to Follow-up|15|||
163861085|NCT03523962|591859441|FG003|Open Fractures|Lost to Follow-up|8|||
164197696|NCT02573259|593092356|FG004|Overall Study|Death|9|||
164197697|NCT02573259|593092357|FG005|Overall Study|Death|32|||
164197698|NCT02573259|593092358|FG006|Overall Study|Death|21|||
164197699|NCT02573259|593092352|FG000|Overall Study|Lost to Follow-up|0|||
164197700|NCT02573259|593092353|FG001|Overall Study|Lost to Follow-up|0|||
164197701|NCT02573259|593092354|FG002|Overall Study|Lost to Follow-up|0|||
164197702|NCT02573259|593092355|FG003|Overall Study|Lost to Follow-up|0|||
164197703|NCT02573259|593092356|FG004|Overall Study|Lost to Follow-up|0|||
164197704|NCT02573259|593092357|FG005|Overall Study|Lost to Follow-up|2|||
164197705|NCT02573259|593092358|FG006|Overall Study|Lost to Follow-up|1|||
164197706|NCT02573259|593092352|FG000|Overall Study|Participant refused further follow-up|0|||
164197707|NCT02573259|593092353|FG001|Overall Study|Participant refused further follow-up|2|||
164197708|NCT02573259|593092354|FG002|Overall Study|Participant refused further follow-up|1|||
164197709|NCT02573259|593092355|FG003|Overall Study|Participant refused further follow-up|0|||
164197710|NCT02573259|593092356|FG004|Overall Study|Participant refused further follow-up|3|||
164197711|NCT02573259|593092357|FG005|Overall Study|Participant refused further follow-up|20|||
164197712|NCT02573259|593092358|FG006|Overall Study|Participant refused further follow-up|7|||
164197713|NCT02573259|593092352|FG000|Overall Study|Other|0|||
164197714|NCT02573259|593092353|FG001|Overall Study|Other|0|||
164197715|NCT02573259|593092354|FG002|Overall Study|Other|0|||
164197716|NCT02573259|593092355|FG003|Overall Study|Other|0|||
164197717|NCT02573259|593092356|FG004|Overall Study|Other|1|||
164197718|NCT02573259|593092357|FG005|Overall Study|Other|4|||
163861086|NCT03523962|591859438|FG000|Open Fractures|Withdrawal by Subject|0|||
163861087|NCT03523962|591859439|FG001|Open Fractures|Withdrawal by Subject|0|||
163861088|NCT03523962|591859440|FG002|Open Fractures|Withdrawal by Subject|6|||
163861089|NCT03523962|591859441|FG003|Open Fractures|Withdrawal by Subject|2|||
163861090|NCT03523962|591859438|FG000|Open Fractures|Incarceration|0|||
163861091|NCT03523962|591859439|FG001|Open Fractures|Incarceration|0|||
163966686|NCT00884325|592250477|FG000|Overall Study|Lack of Efficacy|0|||
164197719|NCT02573259|593092358|FG006|Overall Study|Other|5|||
164197720|NCT00751140|593092362|FG000|Overall Study|benign angioma excluded from analysis|1|||
164197721|NCT02895295|593092365|FG000|Overall Study|Survey Non-response|71|||
163861092|NCT03523962|591859440|FG002|Open Fractures|Incarceration|1|||
163861093|NCT03523962|591859441|FG003|Open Fractures|Incarceration|0|||
163861094|NCT03247543|591859442|FG000|Overall Study|Adverse Event|3|||
163861095|NCT03247543|591859443|FG001|Overall Study|Adverse Event|6|||
163861096|NCT03247543|591859444|FG002|Overall Study|Adverse Event|4|||
164197722|NCT02895295|593092366|FG001|Overall Study|Survey Non-response|94|||
164197723|NCT02895295|593092367|FG002|Overall Study|Survey Non-response|92|||
164197724|NCT01945944|593092377|FG000|Overall Study|Adverse Event|0|||
164197725|NCT01945944|593092378|FG001|Overall Study|Adverse Event|2|||
164197726|NCT01945944|593092377|FG000|Overall Study|Physician Decision|1|||
164197727|NCT01945944|593092378|FG001|Overall Study|Physician Decision|0|||
164197728|NCT01945944|593092377|FG000|Overall Study|Withdrawal by Subject|0|||
164197729|NCT01945944|593092378|FG001|Overall Study|Withdrawal by Subject|1|||
163861097|NCT03247543|591859442|FG000|Overall Study|Lost to Follow-up|10|||
163861098|NCT03247543|591859443|FG001|Overall Study|Lost to Follow-up|7|||
163861099|NCT03247543|591859444|FG002|Overall Study|Lost to Follow-up|8|||
163861100|NCT03247543|591859442|FG000|Overall Study|Consent withdrawn by caregiver|2|||
163861101|NCT03247543|591859443|FG001|Overall Study|Consent withdrawn by caregiver|2|||
163861102|NCT03247543|591859444|FG002|Overall Study|Consent withdrawn by caregiver|9|||
163861103|NCT03247543|591859442|FG000|Overall Study|Withdrawal by Subject|0|||
163861104|NCT03247543|591859443|FG001|Overall Study|Withdrawal by Subject|0|||
163861105|NCT03247543|591859444|FG002|Overall Study|Withdrawal by Subject|1|||
163861106|NCT03247543|591859442|FG000|Overall Study|Failure to Follow study procedures|1|||
163861107|NCT03247543|591859443|FG001|Overall Study|Failure to Follow study procedures|3|||
163861108|NCT03247543|591859444|FG002|Overall Study|Failure to Follow study procedures|1|||
163861109|NCT03247543|591859442|FG000|Overall Study|Lack of Efficacy|1|||
163861110|NCT03247543|591859443|FG001|Overall Study|Lack of Efficacy|0|||
163861111|NCT03247543|591859444|FG002|Overall Study|Lack of Efficacy|0|||
163861112|NCT03247543|591859442|FG000|Overall Study|Non-compliance with study visits|0|||
163861113|NCT03247543|591859443|FG001|Overall Study|Non-compliance with study visits|1|||
163861114|NCT03247543|591859444|FG002|Overall Study|Non-compliance with study visits|0|||
163861115|NCT01081145|591859445|FG000|Open-Label Phase|Lack of Efficacy|56|||
163861116|NCT01081145|591859446|FG001|Open-Label Phase|Lack of Efficacy|0|||
163861117|NCT01081145|591859445|FG000|Open-Label Phase|Response criteria not met|46|||
163861118|NCT01081145|591859446|FG001|Open-Label Phase|Response criteria not met|0|||
163861119|NCT01081145|591859445|FG000|Open-Label Phase|Adverse Event|42|||
163861120|NCT01081145|591859446|FG001|Open-Label Phase|Adverse Event|0|||
163861121|NCT01081145|591859445|FG000|Open-Label Phase|Withdrawal by Subject|41|||
163861122|NCT01081145|591859446|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163861123|NCT01081145|591859445|FG000|Open-Label Phase|Other|12|||
163861124|NCT01081145|591859446|FG001|Open-Label Phase|Other|0|||
163861125|NCT01081145|591859445|FG000|Open-Label Phase|Lost to Follow-up|11|||
163861126|NCT01081145|591859446|FG001|Open-Label Phase|Lost to Follow-up|0|||
163861127|NCT01081145|591859445|FG000|Open-Label Phase|Protocol Violation|4|||
163861128|NCT01081145|591859446|FG001|Open-Label Phase|Protocol Violation|0|||
163861129|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
163861130|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
163861131|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
163861132|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
163861133|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
163861134|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
163861135|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
163861136|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
163861137|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
163861138|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
163861139|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
163861140|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
163861141|NCT01081145|591859445|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
163861142|NCT01081145|591859446|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
163861143|NCT01253226|591859447|FG000|Overall Study|Adverse Event|0|||
163861144|NCT01253226|591859448|FG001|Overall Study|Adverse Event|0|||
163861145|NCT01253226|591859449|FG002|Overall Study|Adverse Event|1|||
163861146|NCT01253226|591859450|FG003|Overall Study|Adverse Event|0|||
163861147|NCT01253226|591859451|FG004|Overall Study|Adverse Event|0|||
163861148|NCT01253226|591859447|FG000|Overall Study|Death|0|||
163861149|NCT01253226|591859448|FG001|Overall Study|Death|1|||
163861150|NCT01253226|591859449|FG002|Overall Study|Death|0|||
163861151|NCT01253226|591859450|FG003|Overall Study|Death|0|||
163861152|NCT01253226|591859451|FG004|Overall Study|Death|0|||
163861153|NCT01253226|591859447|FG000|Overall Study|Physician Decision|0|||
163861154|NCT01253226|591859448|FG001|Overall Study|Physician Decision|0|||
163861155|NCT01253226|591859449|FG002|Overall Study|Physician Decision|0|||
163861156|NCT01253226|591859450|FG003|Overall Study|Physician Decision|0|||
163861157|NCT01253226|591859451|FG004|Overall Study|Physician Decision|2|||
163861158|NCT01253226|591859447|FG000|Overall Study|Withdrawal by Subject|0|||
163861159|NCT01253226|591859448|FG001|Overall Study|Withdrawal by Subject|0|||
163861160|NCT01253226|591859449|FG002|Overall Study|Withdrawal by Subject|0|||
163861161|NCT01253226|591859450|FG003|Overall Study|Withdrawal by Subject|1|||
164197730|NCT04376515|593092381|FG000|Overall Study|Found to have been vaccinated before study start|6|||
164197731|NCT04376515|593092382|FG001|Overall Study|Found to have been vaccinated before study start|6|||
163966687|NCT00884325|592250478|FG001|Overall Study|Lack of Efficacy|1|||
163966688|NCT00884325|592250477|FG000|Overall Study|Withdrawal by Subject|1|||
163966689|NCT00884325|592250478|FG001|Overall Study|Withdrawal by Subject|1|||
163966690|NCT00884325|592250477|FG000|Overall Study|Not provided|1|||
163861162|NCT01253226|591859451|FG004|Overall Study|Withdrawal by Subject|0|||
163861163|NCT03593070|591859452|FG000|Overall Study|administrative withdrawal|1|||
163966691|NCT00884325|592250478|FG001|Overall Study|Not provided|0|||
163966692|NCT01446016|592250479|FG000|Overall Study|Lost to Follow-up|3|||
163966693|NCT01446016|592250479|FG000|Overall Study|Withdrawal by Subject|1|||
163966694|NCT01446016|592250479|FG000|Overall Study|Toxicity|3|||
163966695|NCT00436618|592250486|FG000|Overall Study|Withdrawal by Subject|5|||
163966696|NCT00436618|592250487|FG001|Overall Study|Withdrawal by Subject|8|||
163966697|NCT00436618|592250488|FG002|Overall Study|Withdrawal by Subject|11|||
163966698|NCT00436618|592250486|FG000|Overall Study|Adverse Event|8|||
163966699|NCT00436618|592250487|FG001|Overall Study|Adverse Event|8|||
163966700|NCT00436618|592250488|FG002|Overall Study|Adverse Event|9|||
163966701|NCT00436618|592250486|FG000|Overall Study|Alternate Treatment|3|||
163966702|NCT00436618|592250487|FG001|Overall Study|Alternate Treatment|4|||
163966703|NCT00436618|592250488|FG002|Overall Study|Alternate Treatment|12|||
163966704|NCT00436618|592250486|FG000|Overall Study|Other Medical Problems|3|||
163966705|NCT00436618|592250487|FG001|Overall Study|Other Medical Problems|1|||
163966706|NCT00436618|592250488|FG002|Overall Study|Other Medical Problems|7|||
163966707|NCT00436618|592250486|FG000|Overall Study|Death|4|||
163966708|NCT00436618|592250487|FG001|Overall Study|Death|2|||
163966709|NCT00436618|592250488|FG002|Overall Study|Death|3|||
163966710|NCT00436618|592250486|FG000|Overall Study|New Primary or Other Reasons|6|||
163966711|NCT00436618|592250487|FG001|Overall Study|New Primary or Other Reasons|2|||
163966712|NCT00436618|592250488|FG002|Overall Study|New Primary or Other Reasons|12|||
163966713|NCT00436618|592250486|FG000|Overall Study|Still on treatment|1|||
163966714|NCT00436618|592250487|FG001|Overall Study|Still on treatment|2|||
163966715|NCT00436618|592250488|FG002|Overall Study|Still on treatment|7|||
163966716|NCT00698204|592250489|FG000|Overall Study|Withdrawal by Subject|1|||
163966717|NCT00698204|592250490|FG001|Overall Study|Withdrawal by Subject|0|||
163966718|NCT01949155|592250491|FG000|Overall Study|Lost to Follow-up|1|||
163966719|NCT01949155|592250492|FG001|Overall Study|Lost to Follow-up|0|||
163966720|NCT01949155|592250491|FG000|Overall Study|Protocol Violation|1|||
163966721|NCT01949155|592250492|FG001|Overall Study|Protocol Violation|0|||
163966722|NCT00314249|592250493|FG000|Overall Study|Adverse Event|73|||
163966723|NCT00314249|592250494|FG001|Overall Study|Adverse Event|94|||
163966724|NCT00314249|592250493|FG000|Overall Study|Lack of Efficacy|33|||
163966725|NCT00314249|592250494|FG001|Overall Study|Lack of Efficacy|24|||
163966726|NCT00314249|592250493|FG000|Overall Study|Withdrawal by Subject|21|||
163966727|NCT00314249|592250494|FG001|Overall Study|Withdrawal by Subject|28|||
163966728|NCT00314249|592250493|FG000|Overall Study|Lost to Follow-up|15|||
163966729|NCT00314249|592250494|FG001|Overall Study|Lost to Follow-up|9|||
163966730|NCT00314249|592250493|FG000|Overall Study|Physician Decision|1|||
163966731|NCT00314249|592250494|FG001|Overall Study|Physician Decision|1|||
163966732|NCT00314249|592250493|FG000|Overall Study|Withdrawn for other reasons|4|||
163966733|NCT00314249|592250494|FG001|Overall Study|Withdrawn for other reasons|1|||
163966734|NCT00314249|592250493|FG000|Overall Study|Non-Compliant|5|||
163966735|NCT00314249|592250494|FG001|Overall Study|Non-Compliant|6|||
163966736|NCT02448225|592250495|FG000|Overall Study|Withdrawal by Subject|1|||
163966737|NCT02448225|592250495|FG000|Overall Study|Did not get FSPG scan|18|||
163966738|NCT02448225|592250495|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
163966739|NCT01287364|592250498|FG000|Overall Study|Adverse Event|0|||
163861164|NCT03593070|591859453|FG001|Overall Study|administrative withdrawal|1|||
163861165|NCT03643211|591859455|FG000|Overall Study|Contract violation/deficiency|12|||
163861166|NCT03643211|591859455|FG000|Overall Study|Invalid registration|3|||
163861167|NCT03643211|591859455|FG000|Overall Study|No treatment information|2|||
163861168|NCT03643211|591859455|FG000|Overall Study|No adverse event information - No revisit|4|||
163861169|NCT04858425|591859456|FG000|Overall Study|Adverse Event|2|||
163861170|NCT04858425|591859457|FG001|Overall Study|Adverse Event|2|||
163861171|NCT04858425|591859456|FG000|Overall Study|Withdrawal by Subject|3|||
163861172|NCT04858425|591859457|FG001|Overall Study|Withdrawal by Subject|1|||
163861173|NCT04858425|591859456|FG000|Overall Study|Lost to Follow-up|4|||
163966740|NCT01287364|592250499|FG001|Overall Study|Adverse Event|3|||
163966741|NCT01287364|592250498|FG000|Overall Study|Protocol Violation|5|||
163966742|NCT01287364|592250499|FG001|Overall Study|Protocol Violation|5|||
163966743|NCT01287364|592250498|FG000|Overall Study|Other Reason|4|||
163966744|NCT01287364|592250499|FG001|Overall Study|Other Reason|2|||
163966745|NCT05372653|592250504|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
163966746|NCT05372653|592250505|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
163966747|NCT05372653|592250504|FG000|Overall Study|Adverse Event|0|||
163966748|NCT05372653|592250505|FG001|Overall Study|Adverse Event|1|||
163966749|NCT00711529|592250506|FG000|Overall Study|Protocol Violation|2|||
163861174|NCT04858425|591859457|FG001|Overall Study|Lost to Follow-up|2|||
163861175|NCT04858425|591859456|FG000|Overall Study|Lost to Follow-up|1|||
163861176|NCT04858425|591859457|FG001|Overall Study|Lost to Follow-up|0|||
163966750|NCT00711529|592250507|FG001|Overall Study|Protocol Violation|0|||
163966751|NCT00711529|592250506|FG000|Overall Study|Withdrawal by Subject|2|||
163861177|NCT03473743|591859458|FG000|Overall Study|Withdrawal by Subject|0|||
163861178|NCT03473743|591859459|FG001|Overall Study|Withdrawal by Subject|0|||
163861179|NCT03473743|591859460|FG002|Overall Study|Withdrawal by Subject|0|||
163861180|NCT03473743|591859461|FG003|Overall Study|Withdrawal by Subject|0|||
163861181|NCT03473743|591859462|FG004|Overall Study|Withdrawal by Subject|0|||
163861182|NCT03473743|591859463|FG005|Overall Study|Withdrawal by Subject|0|||
163861183|NCT03473743|591859464|FG006|Overall Study|Withdrawal by Subject|0|||
163861184|NCT03473743|591859465|FG007|Overall Study|Withdrawal by Subject|3|||
163861185|NCT03473743|591859458|FG000|Overall Study|Other|0|||
163861186|NCT03473743|591859459|FG001|Overall Study|Other|0|||
163861187|NCT03473743|591859460|FG002|Overall Study|Other|0|||
163861188|NCT03473743|591859461|FG003|Overall Study|Other|1|||
163861189|NCT03473743|591859462|FG004|Overall Study|Other|0|||
163861190|NCT03473743|591859463|FG005|Overall Study|Other|0|||
163861191|NCT03473743|591859464|FG006|Overall Study|Other|0|||
163861192|NCT03473743|591859465|FG007|Overall Study|Other|0|||
163861193|NCT03473743|591859458|FG000|Overall Study|Ongoing|0|||
163861194|NCT03473743|591859459|FG001|Overall Study|Ongoing|0|||
163861195|NCT03473743|591859460|FG002|Overall Study|Ongoing|6|||
163861196|NCT03473743|591859461|FG003|Overall Study|Ongoing|8|||
163861197|NCT03473743|591859462|FG004|Overall Study|Ongoing|1|||
163861198|NCT03473743|591859463|FG005|Overall Study|Ongoing|1|||
163861199|NCT03473743|591859464|FG006|Overall Study|Ongoing|22|||
163861200|NCT03473743|591859465|FG007|Overall Study|Ongoing|24|||
163861201|NCT03473743|591859458|FG000|Overall Study|Randomized but not treated|0|||
163861202|NCT03473743|591859459|FG001|Overall Study|Randomized but not treated|0|||
163861203|NCT03473743|591859460|FG002|Overall Study|Randomized but not treated|0|||
163861204|NCT03473743|591859461|FG003|Overall Study|Randomized but not treated|0|||
163861205|NCT03473743|591859462|FG004|Overall Study|Randomized but not treated|0|||
163861206|NCT03473743|591859463|FG005|Overall Study|Randomized but not treated|0|||
163861207|NCT03473743|591859464|FG006|Overall Study|Randomized but not treated|1|||
163861208|NCT03473743|591859465|FG007|Overall Study|Randomized but not treated|1|||
163861209|NCT02864992|591859466|FG000|Overall Study|still on treatment|15|||
163861210|NCT02864992|591859467|FG001|Overall Study|still on treatment|1|||
163861211|NCT02864992|591859468|FG002|Overall Study|still on treatment|33|||
163861212|NCT04536077|591859470|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
163966752|NCT00711529|592250507|FG001|Overall Study|Withdrawal by Subject|6|||
163966753|NCT03740997|592250508|FG000|Overall Study|Withdrawal by Subject|1|||
164197732|NCT03811821|593092383|FG000|Overall Study|Adverse Event|1|||
164197733|NCT03811821|593092384|FG001|Overall Study|Adverse Event|1|||
164197734|NCT03811821|593092383|FG000|Overall Study|Withdrawal by Subject|5|||
164197735|NCT03811821|593092384|FG001|Overall Study|Withdrawal by Subject|4|||
164197736|NCT03811821|593092383|FG000|Overall Study|Lost to Follow-up|2|||
164197737|NCT03811821|593092384|FG001|Overall Study|Lost to Follow-up|2|||
164197738|NCT03811821|593092383|FG000|Overall Study|Contraindication for treatment|0|||
164197739|NCT03811821|593092384|FG001|Overall Study|Contraindication for treatment|1|||
164197740|NCT03811821|593092383|FG000|Overall Study|Tolerability|0|||
164197741|NCT03811821|593092384|FG001|Overall Study|Tolerability|3|||
164197742|NCT03811821|593092383|FG000|Overall Study|Comorbidities|0|||
164197743|NCT03811821|593092384|FG001|Overall Study|Comorbidities|2|||
164197744|NCT03433898|593092387|FG000|Overall Study|Progressive disease|6|||
164197745|NCT03433898|593092388|FG001|Overall Study|Progressive disease|3|||
164197746|NCT03433898|593092389|FG002|Overall Study|Progressive disease|3|||
164197747|NCT03433898|593092390|FG003|Overall Study|Progressive disease|2|||
164197748|NCT03433898|593092391|FG004|Overall Study|Progressive disease|30|||
164197749|NCT03433898|593092392|FG005|Overall Study|Progressive disease|29|||
164197750|NCT03433898|593092393|FG006|Overall Study|Progressive disease|17|||
164197751|NCT03433898|593092394|FG007|Overall Study|Progressive disease|30|||
164197752|NCT03433898|593092387|FG000|Overall Study|Not treated|1|||
164197753|NCT03433898|593092388|FG001|Overall Study|Not treated|0|||
163861213|NCT04536077|591859471|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
163861214|NCT04536077|591859470|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
163861215|NCT04536077|591859471|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
163861216|NCT04948333|591859472|FG000|Overall Study|Adverse Event|6|||
163861217|NCT04948333|591859473|FG001|Overall Study|Adverse Event|4|||
163861218|NCT04948333|591859474|FG002|Overall Study|Adverse Event|0|||
163861219|NCT04948333|591859475|FG003|Overall Study|Adverse Event|2|||
163861220|NCT04948333|591859472|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
163966754|NCT03740997|592250509|FG001|Overall Study|Withdrawal by Subject|0|||
163966755|NCT03740997|592250508|FG000|Overall Study|Participant was unable to complete study procedures|1|||
164197754|NCT03433898|593092389|FG002|Overall Study|Not treated|0|||
164197755|NCT03433898|593092390|FG003|Overall Study|Not treated|0|||
164197756|NCT03433898|593092391|FG004|Overall Study|Not treated|1|||
164307254|NCT02023697|593499223|FG000|Long-term Follow-up Period|Other unspecified|6|||
164197757|NCT03433898|593092392|FG005|Overall Study|Not treated|0|||
164197758|NCT03433898|593092393|FG006|Overall Study|Not treated|0|||
164197759|NCT03433898|593092394|FG007|Overall Study|Not treated|0|||
164197760|NCT03433898|593092387|FG000|Overall Study|Death|0|||
164197761|NCT03433898|593092388|FG001|Overall Study|Death|0|||
164197762|NCT03433898|593092389|FG002|Overall Study|Death|0|||
164197763|NCT03433898|593092390|FG003|Overall Study|Death|0|||
164197764|NCT03433898|593092391|FG004|Overall Study|Death|0|||
164197765|NCT03433898|593092392|FG005|Overall Study|Death|0|||
164197766|NCT03433898|593092393|FG006|Overall Study|Death|1|||
164197767|NCT03433898|593092394|FG007|Overall Study|Death|1|||
163861221|NCT04948333|591859473|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163861222|NCT04948333|591859474|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163861223|NCT04948333|591859475|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163861224|NCT04948333|591859472|FG000|Overall Study|Progressive Disease|1|||
163861225|NCT04948333|591859473|FG001|Overall Study|Progressive Disease|5|||
163861226|NCT04948333|591859474|FG002|Overall Study|Progressive Disease|0|||
163861227|NCT04948333|591859475|FG003|Overall Study|Progressive Disease|0|||
163861228|NCT04948333|591859472|FG000|Overall Study|Physician Decision|2|||
163861229|NCT04948333|591859473|FG001|Overall Study|Physician Decision|2|||
163861230|NCT04948333|591859474|FG002|Overall Study|Physician Decision|0|||
163861231|NCT04948333|591859475|FG003|Overall Study|Physician Decision|0|||
163861232|NCT04948333|591859472|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
163861233|NCT04948333|591859473|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
163861234|NCT04948333|591859474|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
163861235|NCT04948333|591859475|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
163861236|NCT04948333|591859472|FG000|Overall Study|Withdrawal by Subject|2|||
163861237|NCT04948333|591859473|FG001|Overall Study|Withdrawal by Subject|0|||
163861238|NCT04948333|591859474|FG002|Overall Study|Withdrawal by Subject|0|||
163861239|NCT04948333|591859475|FG003|Overall Study|Withdrawal by Subject|1|||
163861240|NCT04948333|591859472|FG000|Overall Study|Protocol Violation|0|||
163861241|NCT04948333|591859473|FG001|Overall Study|Protocol Violation|1|||
163861242|NCT04948333|591859474|FG002|Overall Study|Protocol Violation|0|||
163861243|NCT04948333|591859475|FG003|Overall Study|Protocol Violation|0|||
163861244|NCT04948333|591859472|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
163861245|NCT04948333|591859473|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
163861246|NCT04948333|591859474|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
163861247|NCT04948333|591859475|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
163861248|NCT03805295|591859477|FG000|Overall Study|Lost to Follow-up|17|||
163861249|NCT03805295|591859478|FG001|Overall Study|Lost to Follow-up|43|||
163861250|NCT00539591|591859479|FG000|Overall Study|Toxicity|3|||
163861251|NCT00539591|591859480|FG001|Overall Study|Toxicity|0|||
163861252|NCT00539591|591859481|FG002|Overall Study|Toxicity|0|||
163861253|NCT00539591|591859479|FG000|Overall Study|Disease progression|2|||
163861254|NCT00539591|591859480|FG001|Overall Study|Disease progression|2|||
163861255|NCT00539591|591859481|FG002|Overall Study|Disease progression|3|||
163861256|NCT04305912|591859482|FG000|First Intervention|COVID-19 Suspension|2|||
163861257|NCT04305912|591859483|FG001|First Intervention|COVID-19 Suspension|0|||
163861258|NCT04305912|591859482|FG000|First Intervention|Withdrawal by Subject|0|||
163861259|NCT04305912|591859483|FG001|First Intervention|Withdrawal by Subject|1|||
163861260|NCT04305912|591859482|FG000|Second Intervention|Adverse Event|0|||
163861261|NCT04305912|591859483|FG001|Second Intervention|Adverse Event|1|||
163861262|NCT04538664|591859488|FG000|Overall Study|Withdrawal by Subject|5|||
163861263|NCT04538664|591859489|FG001|Overall Study|Withdrawal by Subject|9|||
163861264|NCT04538664|591859488|FG000|Overall Study|Lost to Follow-up|2|||
163861265|NCT04538664|591859489|FG001|Overall Study|Lost to Follow-up|1|||
163861266|NCT04538664|591859488|FG000|Overall Study|Ongoing|106|||
163861267|NCT04538664|591859489|FG001|Overall Study|Ongoing|115|||
163861268|NCT03681678|591859492|FG000|Overall Study|Lost to Follow-up|20|||
163861269|NCT00828945|591859495|FG000|Overall Study|Death|4|||
163861270|NCT00828945|591859495|FG000|Overall Study|Participant was missing|1|||
163861271|NCT00828945|591859495|FG000|Overall Study|Other|36|||
164197768|NCT03433898|593092387|FG000|Overall Study|Withdrawal by Subject|0|||
164197769|NCT03433898|593092388|FG001|Overall Study|Withdrawal by Subject|0|||
163861272|NCT03431350|591859496|FG000|Overall Study|ONGOING|0|||
163861273|NCT03431350|591859497|FG001|Overall Study|ONGOING|0|||
163861274|NCT03431350|591859498|FG002|Overall Study|ONGOING|2|||
163861275|NCT03431350|591859499|FG003|Overall Study|ONGOING|0|||
163861276|NCT03431350|591859500|FG004|Overall Study|ONGOING|1|||
163861277|NCT03431350|591859501|FG005|Overall Study|ONGOING|3|||
163861278|NCT03431350|591859502|FG006|Overall Study|ONGOING|0|||
163861279|NCT03431350|591859503|FG007|Overall Study|ONGOING|1|||
163861280|NCT03431350|591859504|FG008|Overall Study|ONGOING|3|||
163861281|NCT03431350|591859505|FG009|Overall Study|ONGOING|4|||
163861282|NCT03431350|591859506|FG010|Overall Study|ONGOING|2|||
163861283|NCT03431350|591859507|FG011|Overall Study|ONGOING|1|||
163861284|NCT03431350|591859496|FG000|Overall Study|Death|6|||
163861285|NCT03431350|591859497|FG001|Overall Study|Death|5|||
163861286|NCT03431350|591859498|FG002|Overall Study|Death|18|||
163861287|NCT03431350|591859499|FG003|Overall Study|Death|7|||
164197770|NCT03433898|593092389|FG002|Overall Study|Withdrawal by Subject|0|||
163966756|NCT03740997|592250509|FG001|Overall Study|Participant was unable to complete study procedures|0|||
163966757|NCT04246801|592250511|FG000|Overall Study|Adverse Event|1|||
163966758|NCT04246801|592250512|FG001|Overall Study|Adverse Event|1|||
163966759|NCT04246801|592250511|FG000|Overall Study|Protocol Violation|1|||
163966760|NCT04246801|592250512|FG001|Overall Study|Protocol Violation|1|||
163966761|NCT04246801|592250511|FG000|Overall Study|Lack of Efficacy|0|||
163966762|NCT04246801|592250512|FG001|Overall Study|Lack of Efficacy|2|||
163966763|NCT04246801|592250511|FG000|Overall Study|Lost to Follow-up|1|||
163966764|NCT04246801|592250512|FG001|Overall Study|Lost to Follow-up|1|||
163966765|NCT04246801|592250511|FG000|Overall Study|Withdrawal by Subject|2|||
163966766|NCT04246801|592250512|FG001|Overall Study|Withdrawal by Subject|1|||
163966767|NCT02663271|592250520|FG000|Overall Study|Withdrawal by Subject|5|||
163966768|NCT02663271|592250520|FG000|Overall Study|Lack of Efficacy|1|||
163966769|NCT01572675|592250521|FG000|Overall Study|End of prescribed treatment|140|||
163966770|NCT01572675|592250522|FG001|Overall Study|End of prescribed treatment|118|||
163966771|NCT01572675|592250521|FG000|Overall Study|Recovery|16|||
163966772|NCT01572675|592250522|FG001|Overall Study|Recovery|23|||
163966773|NCT01572675|592250521|FG000|Overall Study|Lack of Efficacy|31|||
163966774|NCT01572675|592250522|FG001|Overall Study|Lack of Efficacy|31|||
163966775|NCT01572675|592250521|FG000|Overall Study|Intolerance|6|||
163966776|NCT01572675|592250522|FG001|Overall Study|Intolerance|5|||
163966777|NCT01572675|592250521|FG000|Overall Study|Improved symptoms|8|||
163966778|NCT01572675|592250522|FG001|Overall Study|Improved symptoms|2|||
163966779|NCT01572675|592250521|FG000|Overall Study|Surgical intervention|3|||
163966780|NCT01572675|592250522|FG001|Overall Study|Surgical intervention|6|||
163966781|NCT01572675|592250521|FG000|Overall Study|Withdrawal by Subject|5|||
163966782|NCT01572675|592250522|FG001|Overall Study|Withdrawal by Subject|1|||
163966783|NCT01572675|592250521|FG000|Overall Study|Physician Decision|2|||
163966784|NCT01572675|592250522|FG001|Overall Study|Physician Decision|2|||
164197771|NCT03433898|593092390|FG003|Overall Study|Withdrawal by Subject|0|||
164197772|NCT03433898|593092391|FG004|Overall Study|Withdrawal by Subject|2|||
164197773|NCT03433898|593092392|FG005|Overall Study|Withdrawal by Subject|0|||
164197774|NCT03433898|593092393|FG006|Overall Study|Withdrawal by Subject|0|||
164197775|NCT03433898|593092394|FG007|Overall Study|Withdrawal by Subject|0|||
164197776|NCT03433898|593092387|FG000|Overall Study|Adverse Event|0|||
164197777|NCT03433898|593092388|FG001|Overall Study|Adverse Event|0|||
164197778|NCT03433898|593092389|FG002|Overall Study|Adverse Event|0|||
164197779|NCT03433898|593092390|FG003|Overall Study|Adverse Event|0|||
164197780|NCT03433898|593092391|FG004|Overall Study|Adverse Event|0|||
164197781|NCT03433898|593092392|FG005|Overall Study|Adverse Event|5|||
164197782|NCT03433898|593092393|FG006|Overall Study|Adverse Event|2|||
164197783|NCT03433898|593092394|FG007|Overall Study|Adverse Event|2|||
164197784|NCT03433898|593092387|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197785|NCT03433898|593092388|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197786|NCT03433898|593092389|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197787|NCT03433898|593092390|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197788|NCT03433898|593092391|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
164197789|NCT03433898|593092392|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197790|NCT03433898|593092393|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197791|NCT03433898|593092394|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
164197792|NCT01395810|593092397|FG000|Overall Study|Adverse Event|0|||
164197793|NCT01395810|593092398|FG001|Overall Study|Adverse Event|1|||
164197794|NCT01395810|593092399|FG002|Overall Study|Adverse Event|0|||
164197795|NCT01395810|593092400|FG003|Overall Study|Adverse Event|0|||
164197796|NCT01395810|593092397|FG000|Overall Study|Lack of Efficacy|0|||
164197797|NCT01395810|593092398|FG001|Overall Study|Lack of Efficacy|1|||
164197798|NCT01395810|593092399|FG002|Overall Study|Lack of Efficacy|0|||
164197799|NCT01395810|593092400|FG003|Overall Study|Lack of Efficacy|0|||
164197800|NCT01395810|593092397|FG000|Overall Study|Withdrawal criteria|0|||
164197801|NCT01395810|593092398|FG001|Overall Study|Withdrawal criteria|2|||
163966785|NCT01572675|592250521|FG000|Overall Study|Death unrelated to coxibs|1|||
163966786|NCT01572675|592250522|FG001|Overall Study|Death unrelated to coxibs|1|||
163966787|NCT01572675|592250521|FG000|Overall Study|Other disease detected|1|||
163966788|NCT01572675|592250522|FG001|Overall Study|Other disease detected|1|||
164197802|NCT01395810|593092399|FG002|Overall Study|Withdrawal criteria|0|||
164197803|NCT01395810|593092400|FG003|Overall Study|Withdrawal criteria|0|||
164197804|NCT01395810|593092397|FG000|Overall Study|Unclassified|2|||
163966789|NCT01572675|592250521|FG000|Overall Study|Unknown reason|1|||
164197805|NCT01395810|593092398|FG001|Overall Study|Unclassified|0|||
163966790|NCT01572675|592250522|FG001|Overall Study|Unknown reason|1|||
164197806|NCT01395810|593092399|FG002|Overall Study|Unclassified|0|||
164197807|NCT01395810|593092400|FG003|Overall Study|Unclassified|0|||
164197808|NCT05069259|593092404|FG000|Overall Study|Withdrawal by Subject|1|||
164197809|NCT05069259|593092404|FG000|Overall Study|Sponsor decision|1|||
163966791|NCT01572675|592250521|FG000|Overall Study|Rheumatologist new evaluation|0|||
163966792|NCT01572675|592250522|FG001|Overall Study|Rheumatologist new evaluation|1|||
163966793|NCT01572675|592250521|FG000|Overall Study|Missing data|1|||
163966794|NCT01572675|592250522|FG001|Overall Study|Missing data|4|||
164197810|NCT01496976|593093676|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
164197811|NCT05556616|593093677|FG000|Overall Study|Withdrawal by Subject|1|||
164197812|NCT05556616|593093678|FG001|Overall Study|Withdrawal by Subject|0|||
164197813|NCT05556616|593093679|FG002|Overall Study|Withdrawal by Subject|0|||
164197814|NCT05556616|593093680|FG003|Overall Study|Withdrawal by Subject|0|||
164197815|NCT05556616|593093681|FG004|Overall Study|Withdrawal by Subject|0|||
164197816|NCT05556616|593093682|FG005|Overall Study|Withdrawal by Subject|0|||
164197817|NCT05556616|593093683|FG006|Overall Study|Withdrawal by Subject|0|||
164197818|NCT05556616|593093677|FG000|Overall Study|Death|0|||
164197819|NCT05556616|593093678|FG001|Overall Study|Death|0|||
164197820|NCT05556616|593093679|FG002|Overall Study|Death|2|||
164197821|NCT05556616|593093680|FG003|Overall Study|Death|1|||
164197822|NCT05556616|593093681|FG004|Overall Study|Death|0|||
164197823|NCT05556616|593093682|FG005|Overall Study|Death|0|||
164197824|NCT05556616|593093683|FG006|Overall Study|Death|0|||
164197825|NCT05556616|593093677|FG000|Overall Study|Study Terminated by Sponsor|0|||
164197826|NCT05556616|593093678|FG001|Overall Study|Study Terminated by Sponsor|3|||
164197827|NCT05556616|593093679|FG002|Overall Study|Study Terminated by Sponsor|0|||
164197828|NCT05556616|593093680|FG003|Overall Study|Study Terminated by Sponsor|0|||
164197829|NCT05556616|593093681|FG004|Overall Study|Study Terminated by Sponsor|0|||
164197830|NCT05556616|593093682|FG005|Overall Study|Study Terminated by Sponsor|0|||
164197831|NCT05556616|593093683|FG006|Overall Study|Study Terminated by Sponsor|0|||
164197832|NCT03256578|593093684|FG000|Overall Study|Excluded Post Randomization|66|||
164197833|NCT03256578|593093685|FG001|Overall Study|Excluded Post Randomization|56|||
164197834|NCT05428436|593093686|FG000|Period 1 - 2 washout|Adverse Event|1|||
164197835|NCT05428436|593093687|FG001|Period 1 - 2 washout|Adverse Event|0|||
164197836|NCT05428436|593093688|FG002|Period 1 - 2 washout|Adverse Event|0|||
164197837|NCT03964207|593093689|FG000|First Treatment|Withdrawal by Subject|1|||
164197838|NCT03964207|593093690|FG001|First Treatment|Withdrawal by Subject|2|||
164197839|NCT03964207|593093689|FG000|First Treatment|Protocol Violation|1|||
164197840|NCT03964207|593093690|FG001|First Treatment|Protocol Violation|0|||
164197841|NCT03964207|593093689|FG000|First Treatment|Lost to Follow-up|1|||
164197842|NCT03964207|593093690|FG001|First Treatment|Lost to Follow-up|0|||
164197843|NCT03964207|593093689|FG000|Second Treatment|Lost to Follow-up|0|||
164197844|NCT03964207|593093690|FG001|Second Treatment|Lost to Follow-up|1|||
164197845|NCT03964207|593093689|FG000|Second Treatment|Adverse Event|1|||
164197846|NCT03964207|593093690|FG001|Second Treatment|Adverse Event|2|||
164197847|NCT00001566|593093695|FG000|Overall Study|patients' choice to discontinue protocol|3|||
164197848|NCT00001566|593093695|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
164197849|NCT00001566|593093695|FG000|Overall Study|Death|13|||
164197850|NCT00001566|593093695|FG000|Overall Study|Lost to Follow-up|1|||
164197851|NCT00001566|593093695|FG000|Overall Study|unable to complete initial apheresis|1|||
164197852|NCT01290718|593093696|FG000|Overall Study|Early termination of the study|4|||
164197853|NCT01222104|593093698|FG000|Overall Study|Lost to Follow-up|37|||
164197854|NCT01222104|593093698|FG000|Overall Study|Death|10|||
164197855|NCT00888654|593093699|FG000|Overall Study|Problems swallowing oral meds.|1|||
164197856|NCT00888654|593093699|FG000|Overall Study|Not enough oral meds before surgery|3|||
164197857|NCT00888654|593093699|FG000|Overall Study|Surgery aborted|2|||
164197858|NCT00888654|593093699|FG000|Overall Study|Withdrawal by Subject|1|||
164197859|NCT00888654|593093699|FG000|Overall Study|Inelig. due to contraindication of med|1|||
164197860|NCT00888654|593093699|FG000|Overall Study|Change in surg date|1|||
164197861|NCT00888654|593093699|FG000|Overall Study|Stopped meds due to headaches|1|||
164197862|NCT03669549|593093702|FG000|Overall Study|Adverse Event|4|||
164197863|NCT03669549|593093702|FG000|Overall Study|Withdrawal by Subject|1|||
164197864|NCT03669549|593093702|FG000|Overall Study|Study terminated by the Sponsor|1|||
164197865|NCT00705757|593093704|FG000|Overall Study|Lack of Efficacy|5|||
164197866|NCT00705757|593093705|FG001|Overall Study|Lack of Efficacy|1|||
164197867|NCT00705757|593093706|FG002|Overall Study|Lack of Efficacy|3|||
164197868|NCT00705757|593093704|FG000|Overall Study|Lost to Follow-up|7|||
164197869|NCT00705757|593093705|FG001|Overall Study|Lost to Follow-up|6|||
164197870|NCT00705757|593093706|FG002|Overall Study|Lost to Follow-up|6|||
164197871|NCT00705757|593093704|FG000|Overall Study|Withdrawal by Subject|1|||
164197872|NCT00705757|593093705|FG001|Overall Study|Withdrawal by Subject|1|||
164197873|NCT00705757|593093706|FG002|Overall Study|Withdrawal by Subject|2|||
164197874|NCT05953363|593093713|FG000|Overall Study|Screen Failure|2|||
164197875|NCT05953363|593093713|FG000|Overall Study|Withdrawal by Subject|3|||
164197876|NCT05953363|593093713|FG000|Overall Study|Surgery cancelled|2|||
164197877|NCT05953363|593093713|FG000|Overall Study|Adverse Event|1|||
164197878|NCT01701674|593093714|FG000|Overall Study|Unable to safely complete treatment|1|||
164197879|NCT05696392|593093716|FG000|Overall Study|Lost to Follow-up|3|||
164197880|NCT05696392|593093716|FG000|Overall Study|Protocol Violation|1|||
164197881|NCT05696392|593093716|FG000|Overall Study|Withdrawal by Subject|1|||
164197882|NCT04464707|593093721|FG000|Overall Study|Adverse Event|1|||
164197883|NCT04464707|593093722|FG001|Overall Study|Adverse Event|0|||
164197884|NCT04464707|593093723|FG002|Overall Study|Adverse Event|0|||
164197885|NCT04464707|593093721|FG000|Overall Study|Withdrawal by Subject|0|||
163861288|NCT03431350|591859500|FG004|Overall Study|Death|4|||
163861289|NCT03431350|591859501|FG005|Overall Study|Death|3|||
163861290|NCT03431350|591859502|FG006|Overall Study|Death|2|||
163861291|NCT03431350|591859503|FG007|Overall Study|Death|0|||
163861292|NCT03431350|591859504|FG008|Overall Study|Death|0|||
163861293|NCT03431350|591859505|FG009|Overall Study|Death|0|||
163861294|NCT03431350|591859506|FG010|Overall Study|Death|4|||
163861295|NCT03431350|591859507|FG011|Overall Study|Death|0|||
163861296|NCT03431350|591859496|FG000|Overall Study|Lost to Follow-up|0|||
163861297|NCT03431350|591859497|FG001|Overall Study|Lost to Follow-up|1|||
163861298|NCT03431350|591859498|FG002|Overall Study|Lost to Follow-up|0|||
163861299|NCT03431350|591859499|FG003|Overall Study|Lost to Follow-up|0|||
163861300|NCT03431350|591859500|FG004|Overall Study|Lost to Follow-up|0|||
163861301|NCT03431350|591859501|FG005|Overall Study|Lost to Follow-up|0|||
163861302|NCT03431350|591859502|FG006|Overall Study|Lost to Follow-up|0|||
163861303|NCT03431350|591859503|FG007|Overall Study|Lost to Follow-up|0|||
163861304|NCT03431350|591859504|FG008|Overall Study|Lost to Follow-up|0|||
163861305|NCT03431350|591859505|FG009|Overall Study|Lost to Follow-up|0|||
163861306|NCT03431350|591859506|FG010|Overall Study|Lost to Follow-up|0|||
163861307|NCT03431350|591859507|FG011|Overall Study|Lost to Follow-up|0|||
163861308|NCT03431350|591859496|FG000|Overall Study|Withdrawal by Subject|0|||
163861309|NCT03431350|591859497|FG001|Overall Study|Withdrawal by Subject|0|||
163861310|NCT03431350|591859498|FG002|Overall Study|Withdrawal by Subject|0|||
163861311|NCT03431350|591859499|FG003|Overall Study|Withdrawal by Subject|1|||
163861312|NCT03431350|591859500|FG004|Overall Study|Withdrawal by Subject|1|||
163861313|NCT03431350|591859501|FG005|Overall Study|Withdrawal by Subject|1|||
163861314|NCT03431350|591859502|FG006|Overall Study|Withdrawal by Subject|0|||
163861315|NCT03431350|591859503|FG007|Overall Study|Withdrawal by Subject|0|||
163861316|NCT03431350|591859504|FG008|Overall Study|Withdrawal by Subject|0|||
163861317|NCT03431350|591859505|FG009|Overall Study|Withdrawal by Subject|2|||
163861318|NCT03431350|591859506|FG010|Overall Study|Withdrawal by Subject|0|||
163861319|NCT03431350|591859507|FG011|Overall Study|Withdrawal by Subject|1|||
163861320|NCT03431350|591859496|FG000|Overall Study|Other|0|||
163861321|NCT03431350|591859497|FG001|Overall Study|Other|0|||
163861322|NCT03431350|591859498|FG002|Overall Study|Other|1|||
163861323|NCT03431350|591859499|FG003|Overall Study|Other|3|||
163861324|NCT03431350|591859500|FG004|Overall Study|Other|2|||
163861325|NCT03431350|591859501|FG005|Overall Study|Other|2|||
163861326|NCT03431350|591859502|FG006|Overall Study|Other|4|||
163861327|NCT03431350|591859503|FG007|Overall Study|Other|0|||
163861328|NCT03431350|591859504|FG008|Overall Study|Other|14|||
163861329|NCT03431350|591859505|FG009|Overall Study|Other|11|||
163861330|NCT03431350|591859506|FG010|Overall Study|Other|11|||
163861331|NCT03431350|591859507|FG011|Overall Study|Other|15|||
163861332|NCT02141074|591859510|FG000|Pre-prophylaxis|Adverse Event|3|||
163861333|NCT02141074|591859511|FG001|Pre-prophylaxis|Adverse Event|0|||
163861334|NCT02141074|591859510|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
163861335|NCT02141074|591859511|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
163861336|NCT02141074|591859510|FG000|Prophylaxis|Adverse Event|0|||
163861337|NCT02141074|591859511|FG001|Prophylaxis|Adverse Event|4|||
163861338|NCT02141074|591859510|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
163861339|NCT02141074|591859511|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
163861340|NCT02141074|591859510|FG000|Prophylaxis|Withdrawal by Subject|0|||
163861341|NCT02141074|591859511|FG001|Prophylaxis|Withdrawal by Subject|1|||
164197886|NCT04464707|593093722|FG001|Overall Study|Withdrawal by Subject|0|||
164197887|NCT04464707|593093723|FG002|Overall Study|Withdrawal by Subject|2|||
164197888|NCT04464707|593093721|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164197889|NCT04464707|593093722|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164197890|NCT04464707|593093723|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164197891|NCT04464707|593093721|FG000|Overall Study|Protocol Deviation|1|||
164197892|NCT04464707|593093722|FG001|Overall Study|Protocol Deviation|0|||
164197893|NCT04464707|593093723|FG002|Overall Study|Protocol Deviation|0|||
164197894|NCT04464707|593093721|FG000|Overall Study|Lost to Follow-up|2|||
164197895|NCT04464707|593093722|FG001|Overall Study|Lost to Follow-up|0|||
163861342|NCT03563053|591859512|FG000|Overall Study|Withdrawal by Subject|17|||
163861343|NCT03563053|591859512|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
163861344|NCT03563053|591859512|FG000|Overall Study|Adverse Event|3|||
163861345|NCT03563053|591859512|FG000|Overall Study|Physician Decision|1|||
163861346|NCT03563053|591859512|FG000|Overall Study|study terminated by sponsor|71|||
163861347|NCT03536884|591859513|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
163861348|NCT03536884|591859514|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
163861349|NCT03536884|591859515|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861350|NCT03536884|591859516|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861351|NCT03536884|591859517|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
164197896|NCT04464707|593093723|FG002|Overall Study|Lost to Follow-up|1|||
164197897|NCT02131064|593093724|FG000|Overall Study|Death|5|||
163861352|NCT03536884|591859518|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861353|NCT03536884|591859519|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861354|NCT03536884|591859520|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163966795|NCT01572675|592250521|FG000|Overall Study|Lost to Follow-up|22|||
163966796|NCT01572675|592250522|FG001|Overall Study|Lost to Follow-up|27|||
164197898|NCT02131064|593093725|FG001|Overall Study|Death|6|||
164197899|NCT02131064|593093724|FG000|Overall Study|Lost to Follow-up|4|||
164197900|NCT02131064|593093725|FG001|Overall Study|Lost to Follow-up|8|||
163966797|NCT02966223|592250528|FG000|Overall Study|Physician Decision|3|||
163966798|NCT02966223|592250528|FG000|Overall Study|Withdrawal by Subject|11|||
164197901|NCT02131064|593093724|FG000|Overall Study|Withdrawal by Subject|14|||
164197902|NCT02131064|593093725|FG001|Overall Study|Withdrawal by Subject|18|||
164197903|NCT02131064|593093724|FG000|Overall Study|Other|2|||
164197904|NCT02131064|593093725|FG001|Overall Study|Other|2|||
164197905|NCT00593918|593093730|FG000|Overall Study|Withdrawal by Subject|5|||
164197906|NCT00593918|593093731|FG001|Overall Study|Withdrawal by Subject|24|||
164197907|NCT00871234|593093745|FG000|Overall Study|Adverse Event|2|||
164197908|NCT00871234|593093745|FG000|Overall Study|Lost to Follow-up|3|||
164197909|NCT04202497|593093747|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
164197910|NCT04202497|593093748|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
164197911|NCT04202497|593093749|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
164197912|NCT04202497|593093750|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
164197913|NCT04344301|593093751|FG000|Overall Study|Withdrawal by Subject|1|||
164197914|NCT04344301|593093752|FG001|Overall Study|Withdrawal by Subject|0|||
164197915|NCT04344301|593093751|FG000|Overall Study|Death|0|||
164197916|NCT04344301|593093752|FG001|Overall Study|Death|1|||
164197917|NCT00072410|593093753|FG000|Overall Study|Progressive disease|0|||
164197918|NCT00072410|593093754|FG001|Overall Study|Progressive disease|3|||
164197919|NCT05590377|593093757|FG000|Overall Study|Death|1|||
164197920|NCT05590377|593093758|FG001|Overall Study|Death|1|||
164197921|NCT05590377|593093759|FG002|Overall Study|Death|2|||
164197922|NCT05590377|593093760|FG003|Overall Study|Death|0|||
164197923|NCT05590377|593093761|FG004|Overall Study|Death|0|||
164197924|NCT05590377|593093757|FG000|Overall Study|Study Terminated by Sponsor|1|||
164197925|NCT05590377|593093758|FG001|Overall Study|Study Terminated by Sponsor|5|||
164197926|NCT05590377|593093759|FG002|Overall Study|Study Terminated by Sponsor|4|||
164197927|NCT05590377|593093760|FG003|Overall Study|Study Terminated by Sponsor|0|||
164197928|NCT05590377|593093761|FG004|Overall Study|Study Terminated by Sponsor|0|||
164197929|NCT05590377|593093757|FG000|Overall Study|Withdrawal by Subject|1|||
164197930|NCT05590377|593093758|FG001|Overall Study|Withdrawal by Subject|0|||
164197931|NCT05590377|593093759|FG002|Overall Study|Withdrawal by Subject|0|||
164197932|NCT05590377|593093760|FG003|Overall Study|Withdrawal by Subject|0|||
163966799|NCT02966223|592250528|FG000|Overall Study|Lost to Follow-up|1|||
163966800|NCT01326728|592250529|FG000|Overall Study|Death|13|||
163966801|NCT01326728|592250530|FG001|Overall Study|Death|0|||
163966802|NCT01326728|592250529|FG000|Overall Study|Early closure of study|34|||
164076354|NCT02556632|592643713|FG002|Overall Study|Unrelated Adverse Event|3|||
164076355|NCT02556632|592643711|FG000|Overall Study|Related Adverse Event|0|||
164076356|NCT02556632|592643712|FG001|Overall Study|Related Adverse Event|1|||
164076357|NCT02556632|592643713|FG002|Overall Study|Related Adverse Event|0|||
164076358|NCT02556632|592643711|FG000|Overall Study|Possibly Related Adverse Event|0|||
164076359|NCT02556632|592643712|FG001|Overall Study|Possibly Related Adverse Event|0|||
164076360|NCT02556632|592643713|FG002|Overall Study|Possibly Related Adverse Event|1|||
164076361|NCT02556632|592643711|FG000|Overall Study|Did Not Start RT|0|||
164076362|NCT02556632|592643712|FG001|Overall Study|Did Not Start RT|1|||
164076363|NCT02556632|592643713|FG002|Overall Study|Did Not Start RT|0|||
164076364|NCT02556632|592643711|FG000|Overall Study|Ineligible|0|||
164076365|NCT02556632|592643712|FG001|Overall Study|Ineligible|1|||
164076366|NCT02556632|592643713|FG002|Overall Study|Ineligible|0|||
164076367|NCT02556632|592643711|FG000|Overall Study|Disliked Study Procedures|0|||
164076368|NCT02556632|592643712|FG001|Overall Study|Disliked Study Procedures|0|||
164076369|NCT02556632|592643713|FG002|Overall Study|Disliked Study Procedures|1|||
164076370|NCT02556632|592643711|FG000|Overall Study|Treatment or Change Delay|0|||
164076371|NCT02556632|592643712|FG001|Overall Study|Treatment or Change Delay|0|||
164076372|NCT02556632|592643713|FG002|Overall Study|Treatment or Change Delay|1|||
164076373|NCT04355767|592643723|FG000|Overall Study|Withdrawal by Subject|2|||
164076374|NCT04355767|592643724|FG001|Overall Study|Withdrawal by Subject|2|||
164076375|NCT04355767|592643723|FG000|Overall Study|Death|5|||
164076376|NCT04355767|592643724|FG001|Overall Study|Death|1|||
164076377|NCT01999322|592643725|FG000|Overall Study|Adverse Event|1|||
164076378|NCT01999322|592643726|FG001|Overall Study|Adverse Event|0|||
164076379|NCT04523831|592643736|FG000|Overall Study|Lost to Follow-up|15|||
164076380|NCT04523831|592643737|FG001|Overall Study|Lost to Follow-up|17|||
164076381|NCT04523831|592643736|FG000|Overall Study|Death|0|||
164076382|NCT04523831|592643737|FG001|Overall Study|Death|3|||
164076383|NCT04523831|592643736|FG000|Overall Study|Adverse Event|2|||
164076384|NCT04523831|592643737|FG001|Overall Study|Adverse Event|0|||
164076385|NCT00995930|592643738|FG000|Overall Study|Protocol deviation|2|||
164197933|NCT05590377|593093761|FG004|Overall Study|Withdrawal by Subject|0|||
163966803|NCT01326728|592250530|FG001|Overall Study|Early closure of study|9|||
163966804|NCT01184053|592250531|FG000|Overall Study|progression while on treatment|3|||
164197934|NCT03389620|593093762|FG000|Overall Study|Lost to Follow-up|5|||
163966805|NCT04399122|592250534|FG000|Overall Study|Lost to Follow-up|2|||
163966806|NCT04399122|592250535|FG001|Overall Study|Lost to Follow-up|0|||
163966807|NCT04399122|592250534|FG000|Overall Study|Withdrawal by Subject|1|||
163966808|NCT04399122|592250535|FG001|Overall Study|Withdrawal by Subject|0|||
163966809|NCT01174238|592250539|FG000|Overall Study|Lost to Follow-up|2|||
163966810|NCT01102803|592250540|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
163966811|NCT01102803|592250541|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
163966812|NCT01102803|592250540|FG000|Post to Follow-Up|Lost to Follow-up|1|||
164197935|NCT03389620|593093763|FG001|Overall Study|Lost to Follow-up|1|||
164197936|NCT04782180|593093770|FG000|Overall Study|Withdrawal by Subject|2|||
164197937|NCT04782180|593093770|FG000|Overall Study|Lost to Follow-up|2|||
164197938|NCT05852353|593093771|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
164197939|NCT05852353|593093771|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
164197940|NCT05852353|593093771|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
164197941|NCT05852353|593093771|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
164197942|NCT01005745|593093772|FG000|Overall Study|No TIL growth|1|||
164197943|NCT01005745|593093772|FG000|Overall Study|Disease progressed during TIL growth|3|||
164197944|NCT01005745|593093772|FG000|Overall Study|Death prior to treatment|1|||
164197945|NCT01005745|593093772|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
164197946|NCT06077773|593093773|FG000|Overall Study|Withdrawal by Subject|1|||
164197947|NCT06077773|593093774|FG001|Overall Study|Withdrawal by Subject|0|||
164197948|NCT06077773|593093775|FG002|Overall Study|Withdrawal by Subject|1|||
164197949|NCT06077773|593093773|FG000|Overall Study|Lost to Follow-up|0|||
164197950|NCT06077773|593093774|FG001|Overall Study|Lost to Follow-up|1|||
164197951|NCT06077773|593093775|FG002|Overall Study|Lost to Follow-up|0|||
164197952|NCT06077773|593093773|FG000|Overall Study|Adverse Event|0|||
164197953|NCT06077773|593093774|FG001|Overall Study|Adverse Event|0|||
164197954|NCT06077773|593093775|FG002|Overall Study|Adverse Event|2|||
164197955|NCT03834506|593093776|FG000|Overall Study|Death|336|||
164197956|NCT03834506|593093777|FG001|Overall Study|Death|326|||
164197957|NCT03834506|593093776|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164197958|NCT03834506|593093777|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164197959|NCT03834506|593093776|FG000|Overall Study|Withdrawal by Subject|10|||
164197960|NCT03834506|593093777|FG001|Overall Study|Withdrawal by Subject|8|||
164197961|NCT03834506|593093776|FG000|Overall Study|Sponsor decision|165|||
164197962|NCT03834506|593093777|FG001|Overall Study|Sponsor decision|178|||
164197963|NCT03834506|593093776|FG000|Overall Study|Physician Decision|3|||
164197964|NCT03834506|593093777|FG001|Overall Study|Physician Decision|1|||
164197965|NCT03834506|593093776|FG000|Overall Study|Lost to Follow-up|0|||
164197966|NCT03834506|593093777|FG001|Overall Study|Lost to Follow-up|1|||
164197967|NCT02499146|593093778|FG000|Overall Study|Global deterioration of health status|1|||
164197968|NCT02499146|593093778|FG000|Overall Study|Objective progression or relapse|20|||
164197969|NCT02499146|593093778|FG000|Overall Study|Other|2|||
164197970|NCT02499146|593093778|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
164197971|NCT04325828|593093779|FG000|Overall Study|Ongoing|26|||
164197972|NCT05115630|593093780|FG000|Overall Study|Due to COVID19|1|||
164197973|NCT05115630|593093780|FG000|Overall Study|Due to Bacteremia|1|||
164197974|NCT05115630|593093780|FG000|Overall Study|Due to viral infection|1|||
164197975|NCT02287038|593093781|FG000|Overall Study|Stopped attending appointments|3|||
164197976|NCT02287038|593093782|FG001|Overall Study|Stopped attending appointments|2|||
164197977|NCT02287038|593093781|FG000|Overall Study|Anxiety after starting medication|0|||
164197978|NCT02287038|593093782|FG001|Overall Study|Anxiety after starting medication|1|||
164197979|NCT02287038|593093781|FG000|Overall Study|Nausea after starting medication|1|||
164197980|NCT02287038|593093782|FG001|Overall Study|Nausea after starting medication|0|||
164197981|NCT02287038|593093781|FG000|Overall Study|Abnormal ECG after starting medication|1|||
164197982|NCT02287038|593093782|FG001|Overall Study|Abnormal ECG after starting medication|0|||
164197983|NCT03160716|593093783|FG000|Overall Study|Lost to Follow-up|1|||
164197984|NCT01628848|593093784|FG000|Overall Study|Adverse Event|9|||
164197985|NCT01628848|593093785|FG001|Overall Study|Adverse Event|7|||
164197986|NCT01628848|593093784|FG000|Overall Study|Lack of Efficacy|0|||
164197987|NCT01628848|593093785|FG001|Overall Study|Lack of Efficacy|4|||
164197988|NCT01628848|593093784|FG000|Overall Study|Withdrawal by Subject|0|||
164197989|NCT01628848|593093785|FG001|Overall Study|Withdrawal by Subject|2|||
164197990|NCT01628848|593093784|FG000|Overall Study|Physician Decision|3|||
164197991|NCT01628848|593093785|FG001|Overall Study|Physician Decision|1|||
164197992|NCT00689338|593093787|FG000|Overall Study|Death|65|||
164197993|NCT00689338|593093787|FG000|Overall Study|Adverse Event|13|||
163966813|NCT01102803|592250541|FG001|Post to Follow-Up|Lost to Follow-up|3|||
164197994|NCT00689338|593093787|FG000|Overall Study|Insufficient Clinical Response|1|||
164197995|NCT00689338|593093787|FG000|Overall Study|Lack of Efficacy|6|||
164197996|NCT00689338|593093787|FG000|Overall Study|Other|8|||
164197997|NCT00689338|593093787|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
163966814|NCT05390580|592250542|FG000|Overall Study|Physician Decision|3|||
163966815|NCT05390580|592250543|FG001|Overall Study|Physician Decision|2|||
163861355|NCT03536884|591859521|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861356|NCT03536884|591859522|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861357|NCT03536884|591859523|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861358|NCT03536884|591859524|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
163861359|NCT03536884|591859513|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861360|NCT03536884|591859514|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
163861361|NCT03536884|591859515|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861362|NCT03536884|591859516|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861363|NCT03536884|591859517|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861364|NCT03536884|591859518|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861365|NCT03536884|591859519|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861366|NCT03536884|591859520|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861367|NCT03536884|591859521|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861368|NCT03536884|591859522|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861369|NCT03536884|591859523|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861370|NCT03536884|591859524|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
163861371|NCT03536884|591859513|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
163861372|NCT03536884|591859514|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
163861373|NCT03536884|591859515|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861374|NCT03536884|591859516|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861375|NCT03536884|591859517|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163966816|NCT04376060|592250545|FG000|Overall Study|Physician Decision|1|||
163966817|NCT04275297|592250546|FG000|Overall Study|Lost to Follow-up|1|||
164197998|NCT00689338|593093787|FG000|Overall Study|Lost to Follow-up|5|||
164197999|NCT00689338|593093787|FG000|Overall Study|Withdrawal by Subject|3|||
164198000|NCT00689338|593093787|FG000|Overall Study|Protocol Violation|15|||
164198001|NCT01939314|593093788|FG000|Overall Study|Withdrawal by Subject|3|||
164198002|NCT01939314|593093789|FG001|Overall Study|Withdrawal by Subject|1|||
164198003|NCT01939314|593093788|FG000|Overall Study|Protocol Violation|1|||
164198004|NCT01939314|593093789|FG001|Overall Study|Protocol Violation|0|||
164198005|NCT01939314|593093788|FG000|Overall Study|Pregnancy|0|||
164198006|NCT01939314|593093789|FG001|Overall Study|Pregnancy|1|||
164198007|NCT01939314|593093788|FG000|Overall Study|Lost to Follow-up|5|||
164198008|NCT01939314|593093789|FG001|Overall Study|Lost to Follow-up|6|||
164198009|NCT00735007|593093790|FG000|Overall Study|Adverse Event|4|||
164198010|NCT00735007|593093790|FG000|Overall Study|Protocol Violation|1|||
164198011|NCT00969228|593093793|FG000|Overall Study|Adverse Event|1|||
164198012|NCT00969228|593093794|FG001|Overall Study|Adverse Event|0|||
164198013|NCT00969228|593093793|FG000|Overall Study|Withdrawal by Subject|4|||
164198014|NCT00969228|593093794|FG001|Overall Study|Withdrawal by Subject|0|||
164198015|NCT00969228|593093793|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
164198016|NCT00969228|593093794|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
164198017|NCT03311945|593093797|FG000|Overall Study|Adverse Event|2|||
164198018|NCT03311945|593093797|FG000|Overall Study|Lack of Efficacy|1|||
164198019|NCT01619878|593093798|FG000|6 Week Follow-up Phase|Adverse Event|1|||
164198020|NCT01619878|593093798|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
164198021|NCT01619878|593093798|FG000|Follow-up at 12 Months of Age|Death|2|||
164198022|NCT03839394|593093799|FG000|Overall Study|Lost to Follow-up|6|||
164198023|NCT03839394|593093800|FG001|Overall Study|Lost to Follow-up|8|||
164198024|NCT03839394|593093799|FG000|Overall Study|Withdrawal by Subject|0|||
164198025|NCT03839394|593093800|FG001|Overall Study|Withdrawal by Subject|2|||
164198026|NCT00922636|593095539|FG000|Overall Study|Adverse Event|3|||
164198027|NCT00922636|593095540|FG001|Overall Study|Adverse Event|3|||
164198028|NCT00922636|593095541|FG002|Overall Study|Adverse Event|2|||
164198029|NCT00922636|593095542|FG003|Overall Study|Adverse Event|3|||
164198030|NCT00922636|593095543|FG004|Overall Study|Adverse Event|2|||
164198031|NCT00922636|593095539|FG000|Overall Study|Lack of Efficacy|1|||
164198032|NCT00922636|593095540|FG001|Overall Study|Lack of Efficacy|7|||
164198033|NCT00922636|593095541|FG002|Overall Study|Lack of Efficacy|3|||
164198034|NCT00922636|593095542|FG003|Overall Study|Lack of Efficacy|2|||
164198035|NCT00922636|593095543|FG004|Overall Study|Lack of Efficacy|4|||
164198036|NCT00922636|593095539|FG000|Overall Study|Sponsor Decision|0|||
164198037|NCT00922636|593095540|FG001|Overall Study|Sponsor Decision|0|||
164198038|NCT00922636|593095541|FG002|Overall Study|Sponsor Decision|2|||
164198039|NCT00922636|593095542|FG003|Overall Study|Sponsor Decision|0|||
164198040|NCT00922636|593095543|FG004|Overall Study|Sponsor Decision|0|||
164198041|NCT00922636|593095539|FG000|Overall Study|Withdrawal by Subject|0|||
164198042|NCT00922636|593095540|FG001|Overall Study|Withdrawal by Subject|0|||
164198043|NCT00922636|593095541|FG002|Overall Study|Withdrawal by Subject|5|||
164198044|NCT00922636|593095542|FG003|Overall Study|Withdrawal by Subject|2|||
164198045|NCT00922636|593095543|FG004|Overall Study|Withdrawal by Subject|4|||
164198046|NCT00922636|593095539|FG000|Overall Study|Protocol Violation|0|||
164198047|NCT00922636|593095540|FG001|Overall Study|Protocol Violation|0|||
164198048|NCT00922636|593095541|FG002|Overall Study|Protocol Violation|2|||
164198049|NCT00922636|593095542|FG003|Overall Study|Protocol Violation|2|||
164198050|NCT00922636|593095543|FG004|Overall Study|Protocol Violation|0|||
164198051|NCT00922636|593095539|FG000|Overall Study|Entry Criteria Not Met|0|||
164198052|NCT00922636|593095540|FG001|Overall Study|Entry Criteria Not Met|0|||
164198053|NCT00922636|593095541|FG002|Overall Study|Entry Criteria Not Met|1|||
164198054|NCT00922636|593095542|FG003|Overall Study|Entry Criteria Not Met|1|||
164198055|NCT00922636|593095543|FG004|Overall Study|Entry Criteria Not Met|0|||
164198056|NCT00922636|593095539|FG000|Overall Study|Parent/Caregiver Decision|2|||
164198057|NCT00922636|593095540|FG001|Overall Study|Parent/Caregiver Decision|4|||
164198058|NCT00922636|593095541|FG002|Overall Study|Parent/Caregiver Decision|3|||
164198059|NCT00922636|593095542|FG003|Overall Study|Parent/Caregiver Decision|5|||
164198060|NCT00922636|593095543|FG004|Overall Study|Parent/Caregiver Decision|2|||
164198061|NCT00922636|593095539|FG000|Overall Study|Lost to Follow-up|1|||
164198062|NCT00922636|593095540|FG001|Overall Study|Lost to Follow-up|2|||
164198063|NCT00922636|593095541|FG002|Overall Study|Lost to Follow-up|2|||
164198064|NCT00922636|593095542|FG003|Overall Study|Lost to Follow-up|2|||
164198065|NCT00922636|593095543|FG004|Overall Study|Lost to Follow-up|4|||
164198066|NCT00870727|593095544|FG000|Overall Study|Lost to Follow-up|0|||
164198067|NCT00870727|593095545|FG001|Overall Study|Lost to Follow-up|1|||
164198068|NCT00870727|593095544|FG000|Overall Study|Lack of Efficacy|1|||
164198069|NCT00870727|593095545|FG001|Overall Study|Lack of Efficacy|3|||
164198070|NCT00870727|593095544|FG000|Overall Study|Adverse Event|0|||
164198071|NCT00870727|593095545|FG001|Overall Study|Adverse Event|1|||
164198072|NCT00557466|593095546|FG000|Overall Study|Adverse Event|3|||
164198073|NCT00557466|593095547|FG001|Overall Study|Adverse Event|1|||
164198074|NCT00557466|593095548|FG002|Overall Study|Adverse Event|4|||
164198075|NCT00557466|593095549|FG003|Overall Study|Adverse Event|1|||
164198076|NCT00557466|593095550|FG004|Overall Study|Adverse Event|2|||
164198077|NCT00557466|593095551|FG005|Overall Study|Adverse Event|4|||
164198078|NCT00557466|593095546|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164198079|NCT00557466|593095547|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164198080|NCT00557466|593095548|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164198081|NCT00557466|593095549|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164198082|NCT00557466|593095550|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164198083|NCT00557466|593095551|FG005|Overall Study|Abnormal laboratory value(s)|0|||
164198084|NCT00557466|593095546|FG000|Overall Study|Protocol deviation|0|||
164198085|NCT00557466|593095547|FG001|Overall Study|Protocol deviation|1|||
164198086|NCT00557466|593095548|FG002|Overall Study|Protocol deviation|0|||
164198087|NCT00557466|593095549|FG003|Overall Study|Protocol deviation|2|||
164198088|NCT00557466|593095550|FG004|Overall Study|Protocol deviation|0|||
164198089|NCT00557466|593095551|FG005|Overall Study|Protocol deviation|0|||
164198090|NCT00557466|593095546|FG000|Overall Study|Subject withdrew consent|0|||
164198091|NCT00557466|593095547|FG001|Overall Study|Subject withdrew consent|0|||
164198092|NCT00557466|593095548|FG002|Overall Study|Subject withdrew consent|0|||
163861376|NCT03536884|591859518|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861377|NCT03536884|591859519|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861378|NCT03536884|591859520|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861379|NCT03536884|591859521|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861380|NCT03536884|591859522|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861381|NCT03536884|591859523|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861382|NCT03536884|591859524|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
163861383|NCT03536884|591859513|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861384|NCT03536884|591859514|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
163861385|NCT03536884|591859515|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861386|NCT03536884|591859516|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861387|NCT03536884|591859517|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861388|NCT03536884|591859518|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861389|NCT03536884|591859519|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861390|NCT03536884|591859520|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861391|NCT03536884|591859521|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861392|NCT03536884|591859522|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
163861393|NCT03536884|591859523|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164198093|NCT00557466|593095549|FG003|Overall Study|Subject withdrew consent|0|||
164198094|NCT00557466|593095550|FG004|Overall Study|Subject withdrew consent|1|||
164198095|NCT00557466|593095551|FG005|Overall Study|Subject withdrew consent|2|||
163861394|NCT03536884|591859524|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
164198096|NCT00557466|593095546|FG000|Overall Study|Administrative problems|0|||
164198097|NCT00557466|593095547|FG001|Overall Study|Administrative problems|1|||
164198098|NCT00557466|593095548|FG002|Overall Study|Administrative problems|1|||
164198099|NCT00557466|593095549|FG003|Overall Study|Administrative problems|0|||
164198100|NCT00557466|593095550|FG004|Overall Study|Administrative problems|0|||
164198101|NCT00557466|593095551|FG005|Overall Study|Administrative problems|0|||
164198102|NCT00557466|593095546|FG000|Overall Study|Abnormal test procedure results|0|||
164198103|NCT00557466|593095547|FG001|Overall Study|Abnormal test procedure results|0|||
164198104|NCT00557466|593095548|FG002|Overall Study|Abnormal test procedure results|1|||
163861395|NCT03536884|591859513|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861396|NCT03536884|591859514|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
163861397|NCT03536884|591859515|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861398|NCT03536884|591859516|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861399|NCT03536884|591859517|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861400|NCT03536884|591859518|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861401|NCT03536884|591859519|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861402|NCT03536884|591859520|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861403|NCT03536884|591859521|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861404|NCT03536884|591859522|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861405|NCT03536884|591859523|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163861406|NCT03536884|591859524|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
163966818|NCT04275297|592250547|FG001|Overall Study|Lost to Follow-up|1|||
164198105|NCT00557466|593095549|FG003|Overall Study|Abnormal test procedure results|0|||
164198106|NCT00557466|593095550|FG004|Overall Study|Abnormal test procedure results|0|||
164198107|NCT00557466|593095551|FG005|Overall Study|Abnormal test procedure results|0|||
164198108|NCT00557466|593095546|FG000|Overall Study|Lost to Follow-up|0|||
164198109|NCT00557466|593095547|FG001|Overall Study|Lost to Follow-up|0|||
164198110|NCT00557466|593095548|FG002|Overall Study|Lost to Follow-up|0|||
164198111|NCT00557466|593095549|FG003|Overall Study|Lost to Follow-up|1|||
164198112|NCT00557466|593095550|FG004|Overall Study|Lost to Follow-up|0|||
164198113|NCT00557466|593095551|FG005|Overall Study|Lost to Follow-up|0|||
164198114|NCT01712516|593095552|FG000|Overall Study|Technical problems|0|||
164198115|NCT01712516|593095553|FG001|Overall Study|Technical problems|0|||
164198116|NCT01712516|593095554|FG002|Overall Study|Technical problems|0|||
164198117|NCT01712516|593095555|FG003|Overall Study|Technical problems|2|||
164198118|NCT01712516|593095552|FG000|Overall Study|Lost to Follow-up|0|||
164198119|NCT01712516|593095553|FG001|Overall Study|Lost to Follow-up|0|||
164198120|NCT01712516|593095554|FG002|Overall Study|Lost to Follow-up|2|||
164198121|NCT01712516|593095555|FG003|Overall Study|Lost to Follow-up|1|||
164198122|NCT01712516|593095552|FG000|Overall Study|Death|0|||
164198123|NCT01712516|593095553|FG001|Overall Study|Death|1|||
164198124|NCT01712516|593095554|FG002|Overall Study|Death|0|||
164198125|NCT01712516|593095555|FG003|Overall Study|Death|0|||
164198126|NCT01712516|593095552|FG000|Overall Study|Protocol deviation|1|||
164198127|NCT01712516|593095553|FG001|Overall Study|Protocol deviation|0|||
164198128|NCT01712516|593095554|FG002|Overall Study|Protocol deviation|1|||
164198129|NCT01712516|593095555|FG003|Overall Study|Protocol deviation|0|||
164198130|NCT01712516|593095552|FG000|Overall Study|Physician Decision|2|||
164198131|NCT01712516|593095553|FG001|Overall Study|Physician Decision|0|||
164198132|NCT01712516|593095554|FG002|Overall Study|Physician Decision|0|||
164198133|NCT01712516|593095555|FG003|Overall Study|Physician Decision|1|||
164198134|NCT01712516|593095552|FG000|Overall Study|Withdrawal by Subject|3|||
164198135|NCT01712516|593095553|FG001|Overall Study|Withdrawal by Subject|9|||
164198136|NCT01712516|593095554|FG002|Overall Study|Withdrawal by Subject|3|||
164198137|NCT01712516|593095555|FG003|Overall Study|Withdrawal by Subject|9|||
164198138|NCT01251952|593095556|FG000|Overall Study|Adverse Event|1|||
164198139|NCT00496769|593095557|FG000|Double Blind|>=1 reason assigned per patient|558|||
164198140|NCT00496769|593095558|FG001|Double Blind|>=1 reason assigned per patient|649|||
164198141|NCT00496769|593095559|FG002|Double Blind|>=1 reason assigned per patient|0|||
164198142|NCT00496769|593095557|FG000|Open Label|>=1 reason assigned per patient|0|||
164198143|NCT00496769|593095558|FG001|Open Label|>=1 reason assigned per patient|0|||
164198144|NCT00496769|593095559|FG002|Open Label|>=1 reason assigned per patient|1011|||
164198145|NCT02308046|593095560|FG000|Overall Study|Negative yeast culture at Baseline|32|||
164198146|NCT02308046|593095561|FG001|Overall Study|Negative yeast culture at Baseline|33|||
164198147|NCT02308046|593095560|FG000|Overall Study|Positive for STD at Baseline|1|||
164198148|NCT02308046|593095561|FG001|Overall Study|Positive for STD at Baseline|2|||
164198149|NCT02308046|593095560|FG000|Overall Study|Lost to Follow-up|1|||
164198150|NCT02308046|593095561|FG001|Overall Study|Lost to Follow-up|3|||
164198151|NCT02224625|593095567|FG000|Irritation|Adverse Event|6|||
164198152|NCT02224625|593095567|FG000|Sensitization|Adverse Event|55|||
164198153|NCT01181167|593095568|FG000|Overall Study|Adverse Event|11|||
164198154|NCT01181167|593095569|FG001|Overall Study|Adverse Event|21|||
164198155|NCT01181167|593095568|FG000|Overall Study|Lost to Follow-up|1|||
164198156|NCT01181167|593095569|FG001|Overall Study|Lost to Follow-up|0|||
164198157|NCT01181167|593095568|FG000|Overall Study|Physician Decision|2|||
164198158|NCT01181167|593095569|FG001|Overall Study|Physician Decision|3|||
164198159|NCT01181167|593095568|FG000|Overall Study|Protocol Violation|3|||
164198160|NCT01181167|593095569|FG001|Overall Study|Protocol Violation|0|||
164198161|NCT01181167|593095568|FG000|Overall Study|Withdrawal by Subject|6|||
164198162|NCT01181167|593095569|FG001|Overall Study|Withdrawal by Subject|8|||
164198163|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
164198164|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
164198165|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
164198166|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
164198167|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
164198168|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
164198169|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
164198170|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
164198171|NCT01573000|593095573|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
164198172|NCT01573000|593095574|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
164198173|NCT01573000|593095573|FG000|Crossover Phase|Lack of Efficacy|0|||
164198174|NCT01573000|593095574|FG001|Crossover Phase|Lack of Efficacy|13|||
164198175|NCT01573000|593095573|FG000|Crossover Phase|Lost to Follow-up|0|||
164198176|NCT01573000|593095574|FG001|Crossover Phase|Lost to Follow-up|2|||
164198177|NCT01573000|593095573|FG000|Crossover Phase|Death|0|||
164198178|NCT01573000|593095574|FG001|Crossover Phase|Death|3|||
164198179|NCT01573000|593095573|FG000|Long-Term Follow-Up|Death|3|||
164198180|NCT01573000|593095574|FG001|Long-Term Follow-Up|Death|0|||
163861407|NCT03536884|591859513|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861408|NCT03536884|591859514|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
164198181|NCT01573000|593095573|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
164198182|NCT01573000|593095574|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
164198183|NCT03342001|593095577|FG000|Overall Study|Adverse Event|1|||
164198184|NCT03342001|593095577|FG000|Overall Study|Lost to Follow-up|1|||
163861409|NCT03536884|591859515|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861410|NCT03536884|591859516|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861411|NCT03536884|591859517|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861412|NCT03536884|591859518|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861413|NCT03536884|591859519|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861414|NCT03536884|591859520|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861415|NCT03536884|591859521|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861416|NCT03536884|591859522|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861417|NCT03536884|591859523|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861418|NCT03536884|591859524|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
163861419|NCT03536884|591859513|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861420|NCT03536884|591859514|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861421|NCT03536884|591859515|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
163861422|NCT03536884|591859516|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861423|NCT03536884|591859517|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
163861424|NCT03536884|591859518|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861425|NCT03536884|591859519|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861426|NCT03536884|591859520|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861427|NCT03536884|591859521|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861428|NCT03536884|591859522|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861429|NCT03536884|591859523|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861430|NCT03536884|591859524|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
163861431|NCT03536884|591859513|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861432|NCT03536884|591859514|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861433|NCT03536884|591859515|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
163861434|NCT03536884|591859516|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
163861435|NCT03536884|591859517|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
163861436|NCT03536884|591859518|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861437|NCT03536884|591859519|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861438|NCT03536884|591859520|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861439|NCT03536884|591859521|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861440|NCT03536884|591859522|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861441|NCT03536884|591859523|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861442|NCT03536884|591859524|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
163861443|NCT03536884|591859513|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861444|NCT03536884|591859514|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163966819|NCT01791803|592250548|FG000|Overall Study|Withdrawal by Subject|0|||
164198185|NCT01384877|593095581|FG000|Treatment 2|Lost to Follow-up|2|||
164198186|NCT01384877|593095582|FG001|Treatment 2|Lost to Follow-up|2|||
164198187|NCT01930539|593095593|FG000|Overall Study|Withdrawal by Subject|2|||
164198188|NCT01930539|593095594|FG001|Overall Study|Withdrawal by Subject|2|||
163861445|NCT03536884|591859515|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163966820|NCT01791803|592250549|FG001|Overall Study|Withdrawal by Subject|0|||
164198189|NCT01548404|593095595|FG000|Overall Study|Adverse Event|3|||
164198190|NCT01548404|593095596|FG001|Overall Study|Adverse Event|1|||
164198191|NCT01548404|593095595|FG000|Overall Study|Physician Decision|2|||
164198192|NCT01548404|593095596|FG001|Overall Study|Physician Decision|1|||
164198193|NCT01548404|593095595|FG000|Overall Study|Inadequate response to study treatment|23|||
164198194|NCT01548404|593095596|FG001|Overall Study|Inadequate response to study treatment|7|||
164198195|NCT01548404|593095595|FG000|Overall Study|Lost to Follow-up|2|||
164198196|NCT01548404|593095596|FG001|Overall Study|Lost to Follow-up|0|||
164198197|NCT01548404|593095595|FG000|Overall Study|Withdrawal by Subject|0|||
164198198|NCT01548404|593095596|FG001|Overall Study|Withdrawal by Subject|3|||
164198199|NCT01548404|593095595|FG000|Overall Study|Other than specified above|0|||
164198200|NCT01548404|593095596|FG001|Overall Study|Other than specified above|2|||
164198201|NCT04040439|593095599|FG000|Overall Study|Invalid registration|11|||
164198202|NCT04040439|593095599|FG000|Overall Study|No IC* on publication of study results|2|||
164198203|NCT00426270|593095600|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
164198204|NCT00426270|593095600|FG000|Overall Study|Adverse Event|5|||
164198205|NCT01117870|593095601|FG000|Overall Study|Inability to place needle|1|||
164198206|NCT01117870|593095602|FG001|Overall Study|Inability to place needle|0|||
164198207|NCT01450813|593095603|FG000|Overall Study|Physician Decision|1|||
164198208|NCT01450813|593095604|FG001|Overall Study|Physician Decision|1|||
164198209|NCT01450813|593095605|FG002|Overall Study|Physician Decision|0|||
164198210|NCT01450813|593095606|FG003|Overall Study|Physician Decision|3|||
164198211|NCT01309386|593095609|FG000|Overall Study|Other|2|||
164198212|NCT01309386|593095610|FG001|Overall Study|Other|0|||
164198213|NCT01309386|593095609|FG000|Overall Study|Withdrawal by Subject|2|||
164198214|NCT01309386|593095610|FG001|Overall Study|Withdrawal by Subject|0|||
164198215|NCT01309386|593095609|FG000|Overall Study|Progressive disease|9|||
164198216|NCT01309386|593095610|FG001|Overall Study|Progressive disease|11|||
164198217|NCT01309386|593095609|FG000|Overall Study|Physician Decision|1|||
164198218|NCT01309386|593095610|FG001|Overall Study|Physician Decision|1|||
164198219|NCT01309386|593095609|FG000|Overall Study|Lack of Efficacy|3|||
164198220|NCT01309386|593095610|FG001|Overall Study|Lack of Efficacy|1|||
164198221|NCT01309386|593095609|FG000|Overall Study|Adverse Event|5|||
164198222|NCT01309386|593095610|FG001|Overall Study|Adverse Event|8|||
164198223|NCT02062437|593095611|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
164198224|NCT02062437|593095611|FG000|Overall Study|Patient not available for the 2y visit|18|||
164198225|NCT02062437|593095611|FG000|Overall Study|Death|2|||
164198226|NCT02062437|593095611|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
164198227|NCT00752089|593095616|FG000|Overall Study|Adverse Event|1|||
164198228|NCT00752089|593095616|FG000|Overall Study|Protocol Deviation|2|||
164198229|NCT00752089|593095616|FG000|Overall Study|Could not attend visit 9|1|||
164198230|NCT00752089|593095616|FG000|Overall Study|Not capable of wearing partial denture|1|||
164198231|NCT00752089|593095616|FG000|Overall Study|Cannot continue the study|1|||
163861446|NCT03536884|591859516|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
163861447|NCT03536884|591859517|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
163861448|NCT03536884|591859518|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861449|NCT03536884|591859519|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861450|NCT03536884|591859520|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861451|NCT03536884|591859521|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861452|NCT03536884|591859522|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861453|NCT03536884|591859523|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861454|NCT03536884|591859524|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
163861455|NCT03536884|591859513|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861456|NCT03536884|591859514|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861457|NCT03536884|591859515|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
163861458|NCT03536884|591859516|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
163861459|NCT03536884|591859517|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
163861460|NCT03536884|591859518|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861461|NCT03536884|591859519|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861462|NCT03536884|591859520|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861463|NCT03536884|591859521|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861464|NCT03536884|591859522|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163966821|NCT01791803|592250550|FG002|Overall Study|Withdrawal by Subject|0|||
164198232|NCT01774981|593095617|FG000|Overall Study|Adverse Event|0|||
164198233|NCT01774981|593095618|FG001|Overall Study|Adverse Event|0|||
164198234|NCT01774981|593095619|FG002|Overall Study|Adverse Event|0|||
164198235|NCT01774981|593095620|FG003|Overall Study|Adverse Event|0|||
164198236|NCT01774981|593095621|FG004|Overall Study|Adverse Event|0|||
164198237|NCT01774981|593095622|FG005|Overall Study|Adverse Event|1|||
164198238|NCT01774981|593095623|FG006|Overall Study|Adverse Event|0|||
164198239|NCT01774981|593095624|FG007|Overall Study|Adverse Event|0|||
163861465|NCT03536884|591859523|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
164198240|NCT01774981|593095617|FG000|Overall Study|Withdrawal by Subject|0|||
164198241|NCT01774981|593095618|FG001|Overall Study|Withdrawal by Subject|0|||
164198242|NCT01774981|593095619|FG002|Overall Study|Withdrawal by Subject|0|||
164198243|NCT01774981|593095620|FG003|Overall Study|Withdrawal by Subject|0|||
164198244|NCT01774981|593095621|FG004|Overall Study|Withdrawal by Subject|0|||
164198245|NCT01774981|593095622|FG005|Overall Study|Withdrawal by Subject|0|||
164198246|NCT01774981|593095623|FG006|Overall Study|Withdrawal by Subject|0|||
164198247|NCT01774981|593095624|FG007|Overall Study|Withdrawal by Subject|1|||
164198248|NCT01774981|593095617|FG000|Overall Study|Death|0|||
164198249|NCT01774981|593095618|FG001|Overall Study|Death|0|||
164198250|NCT01774981|593095619|FG002|Overall Study|Death|0|||
164198251|NCT01774981|593095620|FG003|Overall Study|Death|0|||
164198252|NCT01774981|593095621|FG004|Overall Study|Death|1|||
164198253|NCT01774981|593095622|FG005|Overall Study|Death|0|||
164198254|NCT01774981|593095623|FG006|Overall Study|Death|0|||
164198255|NCT01774981|593095624|FG007|Overall Study|Death|0|||
164198256|NCT01324102|593095625|FG000|Overall Study|illness|1|||
164198257|NCT01324102|593095626|FG001|Overall Study|illness|6|||
164198258|NCT00728494|593095631|FG000|Overall Study|Adverse Event|7|||
164198259|NCT00728494|593095632|FG001|Overall Study|Adverse Event|0|||
164198260|NCT00728494|593095631|FG000|Overall Study|Withdrawal by Subject|0|||
164198261|NCT00728494|593095632|FG001|Overall Study|Withdrawal by Subject|2|||
164198262|NCT00728494|593095631|FG000|Overall Study|Lack of Efficacy|2|||
164198263|NCT00728494|593095632|FG001|Overall Study|Lack of Efficacy|4|||
164198264|NCT00728494|593095631|FG000|Overall Study|No data available|0|||
164198265|NCT00728494|593095632|FG001|Overall Study|No data available|1|||
164198266|NCT00975416|593095633|FG000|Overall Study|early discharge from tx|3|||
164198267|NCT00975416|593095634|FG001|Overall Study|early discharge from tx|5|||
164198268|NCT02915835|593095635|FG000|Overall Study|Physician Decision|1|||
164198269|NCT02915835|593095636|FG001|Overall Study|Physician Decision|0|||
164198270|NCT02915835|593095635|FG000|Overall Study|Withdrawal by Subject|0|||
164198271|NCT02915835|593095636|FG001|Overall Study|Withdrawal by Subject|1|||
164198272|NCT00433836|593095637|FG000|Overall Study|Adverse Event|7|||
164198273|NCT00433836|593095638|FG001|Overall Study|Adverse Event|0|||
164198274|NCT00433836|593095637|FG000|Overall Study|Lost to Follow-up|3|||
164198275|NCT00433836|593095638|FG001|Overall Study|Lost to Follow-up|0|||
164198276|NCT00433836|593095637|FG000|Overall Study|Withdrawal by Subject|2|||
164198277|NCT00433836|593095638|FG001|Overall Study|Withdrawal by Subject|1|||
164198278|NCT00433836|593095637|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164198279|NCT00433836|593095638|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164198280|NCT00433836|593095637|FG000|Overall Study|Protocol Violation|0|||
164198281|NCT00433836|593095638|FG001|Overall Study|Protocol Violation|2|||
164198282|NCT00433836|593095637|FG000|Overall Study|Condition no longer requires study drug|0|||
164198283|NCT00433836|593095638|FG001|Overall Study|Condition no longer requires study drug|1|||
164198284|NCT00433836|593095637|FG000|Overall Study|Abnormal laboratory values|0|||
164198285|NCT00433836|593095638|FG001|Overall Study|Abnormal laboratory values|1|||
164198286|NCT00748241|593095639|FG000|Overall Study|Implant failure|1|||
164198287|NCT00748241|593095639|FG000|Overall Study|Lost to Follow-up|5|||
164198288|NCT00748241|593095639|FG000|Overall Study|Death|2|||
164198289|NCT01240382|593095640|FG000|Overall Study|Adverse Event|2|||
163861466|NCT03536884|591859524|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
163861467|NCT03536884|591859513|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861468|NCT03536884|591859514|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861469|NCT03536884|591859515|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
163861470|NCT03536884|591859516|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
163861471|NCT03536884|591859517|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
163861472|NCT03536884|591859518|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861473|NCT03536884|591859519|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861474|NCT03536884|591859520|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861475|NCT03536884|591859521|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861476|NCT03536884|591859522|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861477|NCT03536884|591859523|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861478|NCT03536884|591859524|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
163861479|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
163861480|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
164198290|NCT01240382|593095641|FG001|Overall Study|Adverse Event|1|||
164198291|NCT01240382|593095640|FG000|Overall Study|Lack of Efficacy|0|||
164198292|NCT01240382|593095641|FG001|Overall Study|Lack of Efficacy|2|||
164198293|NCT01240382|593095640|FG000|Overall Study|Fear of adverse events|0|||
164198294|NCT01240382|593095641|FG001|Overall Study|Fear of adverse events|1|||
164198295|NCT02456727|593095642|FG000|Overall Study|Lost to Follow-up|63|||
164198296|NCT02456727|593095643|FG001|Overall Study|Lost to Follow-up|65|||
164198297|NCT02456727|593095642|FG000|Overall Study|Death|2|||
164198298|NCT02456727|593095643|FG001|Overall Study|Death|1|||
164198299|NCT02456727|593095642|FG000|Overall Study|Withdrawal by Subject|1|||
163861481|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
163861482|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
164198300|NCT02456727|593095643|FG001|Overall Study|Withdrawal by Subject|10|||
164198301|NCT02456727|593095642|FG000|Overall Study|Never Initiated Treatment|43|||
164198302|NCT02456727|593095643|FG001|Overall Study|Never Initiated Treatment|30|||
164198303|NCT02643693|593095644|FG000|Overall Study|Physician Decision|0|||
164198304|NCT02643693|593095645|FG001|Overall Study|Physician Decision|1|||
164198305|NCT02643693|593095646|FG002|Overall Study|Physician Decision|0|||
164198306|NCT02643693|593095647|FG003|Overall Study|Physician Decision|0|||
164198307|NCT02643693|593095648|FG004|Overall Study|Physician Decision|0|||
164198308|NCT02643693|593095649|FG005|Overall Study|Physician Decision|0|||
163966822|NCT01791803|592250551|FG003|Overall Study|Withdrawal by Subject|2|||
163966823|NCT01791803|592250548|FG000|Overall Study|Physician Decision|0|||
163966824|NCT01791803|592250549|FG001|Overall Study|Physician Decision|2|||
163966825|NCT01791803|592250550|FG002|Overall Study|Physician Decision|0|||
163966826|NCT01791803|592250551|FG003|Overall Study|Physician Decision|1|||
163966827|NCT01791803|592250548|FG000|Overall Study|Death|0|||
163966828|NCT01791803|592250549|FG001|Overall Study|Death|0|||
163966829|NCT01791803|592250550|FG002|Overall Study|Death|2|||
163966830|NCT01791803|592250551|FG003|Overall Study|Death|2|||
163966831|NCT04572854|592250552|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
163966832|NCT04572854|592250553|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
163966833|NCT04572854|592250554|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
163966834|NCT04572854|592250555|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
163966835|NCT04572854|592250552|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
163966836|NCT04572854|592250553|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
163966837|NCT04572854|592250554|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
163966838|NCT04572854|592250555|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
163966839|NCT00972777|592250558|FG000|Overall Study|Adverse Event|3|||
163966840|NCT00972777|592250559|FG001|Overall Study|Adverse Event|2|||
163966841|NCT00972777|592250558|FG000|Overall Study|Lost to Follow-up|0|||
163966842|NCT00972777|592250559|FG001|Overall Study|Lost to Follow-up|4|||
163966843|NCT00972777|592250558|FG000|Overall Study|Withdrawal by Subject|4|||
163966844|NCT00972777|592250559|FG001|Overall Study|Withdrawal by Subject|5|||
163966845|NCT00972777|592250558|FG000|Overall Study|Physician Decision|4|||
163966846|NCT00972777|592250559|FG001|Overall Study|Physician Decision|0|||
163966847|NCT00972777|592250558|FG000|Overall Study|Protocol Violation|0|||
163966848|NCT00972777|592250559|FG001|Overall Study|Protocol Violation|2|||
163966849|NCT00972777|592250558|FG000|Overall Study|Screening Failure|2|||
163966850|NCT00972777|592250559|FG001|Overall Study|Screening Failure|1|||
163966851|NCT00972777|592250558|FG000|Overall Study|Missed visit|1|||
163966852|NCT00972777|592250559|FG001|Overall Study|Missed visit|0|||
163966853|NCT02246582|592252481|FG000|Overall Study|Withdrawal by Subject|3|||
163966854|NCT02246582|592252482|FG001|Overall Study|Withdrawal by Subject|4|||
163966855|NCT02060383|592252484|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
163966856|NCT02060383|592252485|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
163966857|NCT02060383|592252486|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
163966858|NCT02060383|592252487|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
163966859|NCT02060383|592252488|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
163966860|NCT02060383|592252484|FG000|Core Phase|Adverse Event|2|||
163966861|NCT02060383|592252485|FG001|Core Phase|Adverse Event|0|||
163966862|NCT02060383|592252486|FG002|Core Phase|Adverse Event|0|||
164198309|NCT02643693|593095644|FG000|Overall Study|Withdrawal by Subject|0|||
164198310|NCT02643693|593095645|FG001|Overall Study|Withdrawal by Subject|1|||
164198311|NCT02643693|593095646|FG002|Overall Study|Withdrawal by Subject|0|||
164198312|NCT02643693|593095647|FG003|Overall Study|Withdrawal by Subject|0|||
163966863|NCT02060383|592252487|FG003|Core Phase|Adverse Event|2|||
164198313|NCT02643693|593095648|FG004|Overall Study|Withdrawal by Subject|0|||
164198314|NCT02643693|593095649|FG005|Overall Study|Withdrawal by Subject|0|||
164198315|NCT02643693|593095644|FG000|Overall Study|Protocol Adherence Issues|2|||
164198316|NCT02643693|593095645|FG001|Overall Study|Protocol Adherence Issues|0|||
164198317|NCT02643693|593095646|FG002|Overall Study|Protocol Adherence Issues|1|||
164198318|NCT02643693|593095647|FG003|Overall Study|Protocol Adherence Issues|0|||
164198319|NCT02643693|593095648|FG004|Overall Study|Protocol Adherence Issues|0|||
164198320|NCT02643693|593095649|FG005|Overall Study|Protocol Adherence Issues|1|||
164198321|NCT01319565|593095650|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
164198322|NCT01319565|593095651|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
164198323|NCT01319565|593095652|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
164198324|NCT00113607|593095653|FG000|Overall Study|Adverse Event|40|||
163966864|NCT02060383|592252488|FG004|Core Phase|Adverse Event|6|||
163966865|NCT02060383|592252484|FG000|Core Phase|Administrative problems|0|||
163966866|NCT02060383|592252485|FG001|Core Phase|Administrative problems|1|||
163966867|NCT02060383|592252486|FG002|Core Phase|Administrative problems|0|||
164198325|NCT00113607|593095654|FG001|Overall Study|Adverse Event|71|||
164198326|NCT00113607|593095653|FG000|Overall Study|Death|8|||
164198327|NCT00113607|593095654|FG001|Overall Study|Death|8|||
163966868|NCT02060383|592252487|FG003|Core Phase|Administrative problems|0|||
163966869|NCT02060383|592252488|FG004|Core Phase|Administrative problems|0|||
163966870|NCT02060383|592252484|FG000|Core Phase|Protocol Violation|0|||
163966871|NCT02060383|592252485|FG001|Core Phase|Protocol Violation|0|||
163861483|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
163861484|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
163861485|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
163861486|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
163861487|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
163861488|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
163861489|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
163861490|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
163861491|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861492|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861493|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861494|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861495|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861496|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
163861497|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
163861498|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
163861499|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
163861500|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861501|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861502|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
163861503|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861504|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861505|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861506|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861507|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
164198328|NCT00113607|593095653|FG000|Overall Study|Withdrawal by Subject|50|||
164198329|NCT00113607|593095654|FG001|Overall Study|Withdrawal by Subject|58|||
164198330|NCT00113607|593095653|FG000|Overall Study|Lost to Follow-up|0|||
164198331|NCT00113607|593095654|FG001|Overall Study|Lost to Follow-up|2|||
164198332|NCT00113607|593095653|FG000|Overall Study|Disease Progression|180|||
164198333|NCT00113607|593095654|FG001|Overall Study|Disease Progression|142|||
164198334|NCT00113607|593095653|FG000|Overall Study|Complete Response (Confirmed)|14|||
164198335|NCT00113607|593095654|FG001|Overall Study|Complete Response (Confirmed)|24|||
164198336|NCT00113607|593095653|FG000|Overall Study|Other|43|||
164198337|NCT00113607|593095654|FG001|Overall Study|Other|32|||
164198338|NCT00909844|593095657|FG000|Overall Study|Adverse Event|1|||
164198339|NCT00909844|593095657|FG000|Overall Study|Withdrawal by Subject|1|||
164198340|NCT00909844|593095657|FG000|Overall Study|Lost to Follow-up|2|||
164198341|NCT00698815|593095658|FG000|Overall Study|Death|1|||
164198342|NCT00698815|593095659|FG001|Overall Study|Death|2|||
164198343|NCT00698815|593095660|FG002|Overall Study|Death|4|||
164198344|NCT00698815|593095658|FG000|Overall Study|Withdrawal by Subject|6|||
164198345|NCT00698815|593095659|FG001|Overall Study|Withdrawal by Subject|3|||
164198346|NCT00698815|593095660|FG002|Overall Study|Withdrawal by Subject|2|||
164198347|NCT00698815|593095658|FG000|Overall Study|MD discretion|2|||
164198348|NCT00698815|593095659|FG001|Overall Study|MD discretion|7|||
164198349|NCT00698815|593095660|FG002|Overall Study|MD discretion|2|||
164198350|NCT00698815|593095658|FG000|Overall Study|Did not receive protocol treatment|1|||
164198351|NCT00698815|593095659|FG001|Overall Study|Did not receive protocol treatment|2|||
164198352|NCT00698815|593095660|FG002|Overall Study|Did not receive protocol treatment|2|||
164198353|NCT02974868|593095661|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
164198354|NCT02974868|593095662|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
164198355|NCT02974868|593095663|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
164198356|NCT02974868|593095664|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
164198357|NCT02974868|593095661|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
164198358|NCT02974868|593095662|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
164198359|NCT02974868|593095663|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
164198360|NCT02974868|593095664|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
164198361|NCT02974868|593095661|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
164198362|NCT02974868|593095662|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
164198363|NCT02974868|593095663|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
164198364|NCT02974868|593095664|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
164198365|NCT02974868|593095661|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
164198366|NCT02974868|593095662|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
164198367|NCT02974868|593095663|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
164198368|NCT02974868|593095664|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
164198369|NCT00706004|593095665|FG000|Overall Study|Did not meet eligibility criteria|2|||
164198370|NCT02674516|593095666|FG000|Overall Study|Lost to Follow-up|3|||
164198371|NCT02674516|593095667|FG001|Overall Study|Lost to Follow-up|0|||
164198372|NCT02674516|593095666|FG000|Overall Study|Protocol Violation|0|||
164198373|NCT02674516|593095667|FG001|Overall Study|Protocol Violation|4|||
164198374|NCT02674516|593095666|FG000|Overall Study|Knowledge of study hypothesis|1|||
164198375|NCT02674516|593095667|FG001|Overall Study|Knowledge of study hypothesis|0|||
163861508|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
163966872|NCT02060383|592252486|FG002|Core Phase|Protocol Violation|0|||
163966873|NCT02060383|592252487|FG003|Core Phase|Protocol Violation|1|||
163966874|NCT02060383|592252488|FG004|Core Phase|Protocol Violation|0|||
163966875|NCT02060383|592252484|FG000|Core Phase|Withdrawal by Subject|0|||
163966876|NCT02060383|592252485|FG001|Core Phase|Withdrawal by Subject|0|||
163966877|NCT02060383|592252486|FG002|Core Phase|Withdrawal by Subject|0|||
163966878|NCT02060383|592252487|FG003|Core Phase|Withdrawal by Subject|4|||
163966879|NCT02060383|592252488|FG004|Core Phase|Withdrawal by Subject|2|||
163966880|NCT02060383|592252484|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
163966881|NCT02060383|592252485|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
163966882|NCT02060383|592252486|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
163966883|NCT02060383|592252487|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
163966884|NCT02060383|592252488|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
163966885|NCT02060383|592252484|FG000|Extension Phase|Adverse Event|1|||
163966886|NCT02060383|592252485|FG001|Extension Phase|Adverse Event|1|||
163966887|NCT02060383|592252486|FG002|Extension Phase|Adverse Event|2|||
164076386|NCT00995930|592643739|FG001|Overall Study|Protocol deviation|5|||
164076387|NCT00995930|592643738|FG000|Overall Study|Death|0|||
164076388|NCT00995930|592643739|FG001|Overall Study|Death|1|||
164076389|NCT00995930|592643738|FG000|Overall Study|Administrative problems|4|||
164076390|NCT00995930|592643739|FG001|Overall Study|Administrative problems|2|||
164076391|NCT00995930|592643738|FG000|Overall Study|Lost to Follow-up|1|||
164076392|NCT00995930|592643739|FG001|Overall Study|Lost to Follow-up|2|||
164076393|NCT00995930|592643738|FG000|Overall Study|Withdrawal by Subject|3|||
164076394|NCT00995930|592643739|FG001|Overall Study|Withdrawal by Subject|4|||
164076395|NCT00995930|592643738|FG000|Overall Study|Adverse Event|11|||
164076396|NCT00995930|592643739|FG001|Overall Study|Adverse Event|14|||
164076397|NCT00766506|592645671|FG000|Overall Study|Use rescue medication after 3 hours|3|||
164076398|NCT00766506|592645672|FG001|Overall Study|Use rescue medication after 3 hours|0|||
164076399|NCT00766506|592645671|FG000|Overall Study|Other|2|||
164076400|NCT00766506|592645672|FG001|Overall Study|Other|2|||
164076401|NCT03053622|592645673|FG000|Overall Study|Lost to Follow-up|0|||
164076402|NCT03053622|592645674|FG001|Overall Study|Lost to Follow-up|0|||
164076403|NCT03053622|592645675|FG002|Overall Study|Lost to Follow-up|0|||
164076404|NCT03053622|592645676|FG003|Overall Study|Lost to Follow-up|1|||
164076405|NCT01246986|592645677|FG000|Overall Study|Lost to Follow-up|0|||
164076406|NCT01246986|592645678|FG001|Overall Study|Lost to Follow-up|1|||
164076407|NCT01246986|592645679|FG002|Overall Study|Lost to Follow-up|3|||
164076408|NCT01246986|592645680|FG003|Overall Study|Lost to Follow-up|0|||
164076409|NCT01246986|592645681|FG004|Overall Study|Lost to Follow-up|0|||
164076410|NCT01246986|592645682|FG005|Overall Study|Lost to Follow-up|1|||
164076411|NCT01246986|592645683|FG006|Overall Study|Lost to Follow-up|0|||
164076412|NCT01246986|592645677|FG000|Overall Study|Withdrawal by Subject|3|||
164076413|NCT01246986|592645678|FG001|Overall Study|Withdrawal by Subject|4|||
164076414|NCT01246986|592645679|FG002|Overall Study|Withdrawal by Subject|3|||
164076415|NCT01246986|592645680|FG003|Overall Study|Withdrawal by Subject|0|||
164076416|NCT01246986|592645681|FG004|Overall Study|Withdrawal by Subject|4|||
164076417|NCT01246986|592645682|FG005|Overall Study|Withdrawal by Subject|0|||
164076418|NCT01246986|592645683|FG006|Overall Study|Withdrawal by Subject|0|||
164076419|NCT01440647|592645688|FG000|Overall Study|Death|2|||
164076420|NCT01440647|592645689|FG001|Overall Study|Death|3|||
164076421|NCT01406873|592645703|FG000|Overall Study|Withdrawal by Subject|1|||
164076422|NCT01406873|592645704|FG001|Overall Study|Withdrawal by Subject|1|||
164076423|NCT03990389|592645705|FG000|Overall Study|Lost to Follow-up|3|||
164076424|NCT03990389|592645706|FG001|Overall Study|Lost to Follow-up|0|||
164076425|NCT00207714|592645707|FG000|Overall Study|Adverse Event|6|||
164076426|NCT00207714|592645708|FG001|Overall Study|Adverse Event|2|||
164076427|NCT00207714|592645709|FG002|Overall Study|Adverse Event|4|||
164076428|NCT00207714|592645710|FG003|Overall Study|Adverse Event|3|||
164076429|NCT00207714|592645711|FG004|Overall Study|Adverse Event|1|||
164076430|NCT00207714|592645707|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164076431|NCT00207714|592645708|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164076432|NCT00207714|592645709|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
164076433|NCT00207714|592645710|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
164076434|NCT00207714|592645711|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
164076435|NCT00207714|592645707|FG000|Overall Study|Other|3|||
164076436|NCT00207714|592645708|FG001|Overall Study|Other|2|||
164076437|NCT00207714|592645709|FG002|Overall Study|Other|5|||
164076438|NCT00207714|592645710|FG003|Overall Study|Other|1|||
164076439|NCT00207714|592645711|FG004|Overall Study|Other|0|||
164076440|NCT02595528|592645712|FG000|Overall Study|Withdrawal by Subject|1|||
164076441|NCT02595528|592645713|FG001|Overall Study|Withdrawal by Subject|2|||
164076442|NCT02595528|592645714|FG002|Overall Study|Withdrawal by Subject|1|||
164076443|NCT02595528|592645715|FG003|Overall Study|Withdrawal by Subject|3|||
164076444|NCT02595528|592645712|FG000|Overall Study|Lost to Follow-up|1|||
164076445|NCT02595528|592645713|FG001|Overall Study|Lost to Follow-up|1|||
164076446|NCT02595528|592645714|FG002|Overall Study|Lost to Follow-up|0|||
163966888|NCT02060383|592252487|FG003|Extension Phase|Adverse Event|0|||
163966889|NCT02060383|592252488|FG004|Extension Phase|Adverse Event|1|||
163966890|NCT02060383|592252484|FG000|Extension Phase|Withdrawal by Subject|0|||
163966891|NCT02060383|592252485|FG001|Extension Phase|Withdrawal by Subject|1|||
163966892|NCT02060383|592252486|FG002|Extension Phase|Withdrawal by Subject|0|||
163966893|NCT02060383|592252487|FG003|Extension Phase|Withdrawal by Subject|0|||
163966894|NCT02060383|592252488|FG004|Extension Phase|Withdrawal by Subject|2|||
163966895|NCT02060383|592252484|FG000|Extension Phase|Administrative problems|1|||
163966896|NCT02060383|592252485|FG001|Extension Phase|Administrative problems|0|||
163966897|NCT02060383|592252486|FG002|Extension Phase|Administrative problems|0|||
163966898|NCT02060383|592252487|FG003|Extension Phase|Administrative problems|0|||
163966899|NCT02060383|592252488|FG004|Extension Phase|Administrative problems|0|||
163966900|NCT02060383|592252484|FG000|Extension Phase|Death|0|||
163966901|NCT02060383|592252485|FG001|Extension Phase|Death|0|||
163966902|NCT02060383|592252486|FG002|Extension Phase|Death|1|||
163966903|NCT02060383|592252487|FG003|Extension Phase|Death|0|||
163966904|NCT02060383|592252488|FG004|Extension Phase|Death|1|||
163966905|NCT02060383|592252484|FG000|Extension Phase|Protocol Violation|0|||
163966906|NCT02060383|592252485|FG001|Extension Phase|Protocol Violation|0|||
163966907|NCT02060383|592252486|FG002|Extension Phase|Protocol Violation|0|||
163966908|NCT02060383|592252487|FG003|Extension Phase|Protocol Violation|0|||
163966909|NCT02060383|592252488|FG004|Extension Phase|Protocol Violation|1|||
163966910|NCT03426787|592252489|FG000|Overall Study|Withdrawal by Subject|6|||
163966911|NCT03426787|592252489|FG000|Overall Study|Lost to Follow-up|7|||
163966912|NCT03426787|592252489|FG000|Overall Study|Unrelated to intervention death|1|||
163966913|NCT02460497|592252494|FG000|Overall Study|Participant Requested Withdrawal|4|||
163966914|NCT02460497|592252494|FG000|Overall Study|Non-Compliance|1|||
163966915|NCT02460497|592252494|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
163966916|NCT02460497|592252494|FG000|Overall Study|Lost to Follow-up|2|||
163966917|NCT02460497|592252494|FG000|Overall Study|Investigator Decision|1|||
163861509|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861510|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
163861511|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861512|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861513|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861514|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
163861515|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861516|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861517|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861518|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861519|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861520|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
163861521|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861522|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
163861523|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
163861524|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861525|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861526|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
163861527|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861528|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861529|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861530|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861531|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861532|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
163861533|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
163861534|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
163861535|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
163861536|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861537|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861538|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
163861539|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861540|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861541|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861542|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861543|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861544|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
163966918|NCT00908583|592252495|FG000|Phase 1|Withdrawal by Subject|1|||
163966919|NCT00908583|592252495|FG000|Phase 1|Adverse Event|4|||
163966920|NCT00908583|592252495|FG000|Phase 2|Physician Decision|1|||
163966921|NCT00908583|592252495|FG000|Phase 2|Adverse Event|1|||
163966922|NCT00908583|592252495|FG000|Phase 3|Adverse Event|2|||
163966923|NCT00908583|592252495|FG000|Phase 4|Adverse Event|1|||
163966924|NCT00908583|592252495|FG000|Phase 4|Physician Decision|1|||
163966925|NCT00908583|592252495|FG000|Phase 5|Adverse Event|3|||
163966926|NCT00860951|592252498|FG000|Overall Study|Withdrawal by Subject|2|||
163966927|NCT00860951|592252498|FG000|Overall Study|Lost to Follow-up|5|||
163966928|NCT02982239|592252499|FG000|Overall Study|Lost to Follow-up|3|||
163966929|NCT02982239|592252500|FG001|Overall Study|Lost to Follow-up|2|||
163966930|NCT02230254|592252501|FG000|Overall Study|Lost to Follow-up|3|||
163966931|NCT00295633|592252502|FG000|Overall Study|Lack of Efficacy|19|||
163966932|NCT00295633|592252503|FG001|Overall Study|Lack of Efficacy|7|||
163861545|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861546|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861547|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861548|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861549|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861550|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
163861551|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861552|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861553|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861554|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861555|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861556|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861557|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
163861558|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861559|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861560|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861561|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861562|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
163861563|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861564|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861565|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861566|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861567|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861568|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861569|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
163861570|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861571|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861572|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861573|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861574|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
163861575|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861576|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861577|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861578|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861579|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861580|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
163861581|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861582|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861583|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861584|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861585|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861586|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
163861587|NCT03536884|591859513|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861588|NCT03536884|591859514|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861589|NCT03536884|591859515|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861590|NCT03536884|591859516|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861591|NCT03536884|591859517|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861592|NCT03536884|591859518|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861593|NCT03536884|591859519|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861594|NCT03536884|591859520|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861595|NCT03536884|591859521|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
163861596|NCT03536884|591859522|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861597|NCT03536884|591859523|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861598|NCT03536884|591859524|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
163861599|NCT03536884|591859513|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861600|NCT03536884|591859514|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861601|NCT03536884|591859515|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163966933|NCT00295633|592252504|FG002|Overall Study|Lack of Efficacy|16|||
163966934|NCT00295633|592252502|FG000|Overall Study|Withdrawal of consent by subject|16|||
163966935|NCT00295633|592252503|FG001|Overall Study|Withdrawal of consent by subject|16|||
163861602|NCT03536884|591859516|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861603|NCT03536884|591859517|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861604|NCT03536884|591859518|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861605|NCT03536884|591859519|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861606|NCT03536884|591859520|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861607|NCT03536884|591859521|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
163861608|NCT03536884|591859522|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
163861609|NCT03536884|591859523|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
163861610|NCT03536884|591859524|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
163861611|NCT03536884|591859513|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861612|NCT03536884|591859514|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861613|NCT03536884|591859515|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861614|NCT03536884|591859516|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861615|NCT03536884|591859517|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861616|NCT03536884|591859518|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861617|NCT03536884|591859519|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861618|NCT03536884|591859520|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861619|NCT03536884|591859521|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
163861620|NCT03536884|591859522|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
163861621|NCT03536884|591859523|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
163861622|NCT03536884|591859524|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
163861623|NCT03536884|591859513|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861624|NCT03536884|591859514|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861625|NCT03536884|591859515|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861626|NCT03536884|591859516|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861627|NCT03536884|591859517|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
164198376|NCT01064479|593095668|FG000|Overall Study|Death|10|||
164198377|NCT01064479|593095669|FG001|Overall Study|Death|11|||
164198378|NCT01064479|593095668|FG000|Overall Study|Withdrawal by Subject|2|||
164198379|NCT01064479|593095669|FG001|Overall Study|Withdrawal by Subject|2|||
164198380|NCT01064479|593095668|FG000|Overall Study|Disease progression|1|||
164198381|NCT01064479|593095669|FG001|Overall Study|Disease progression|1|||
164198382|NCT01064479|593095668|FG000|Overall Study|Toxicity|1|||
164198383|NCT01064479|593095669|FG001|Overall Study|Toxicity|1|||
164198384|NCT01064479|593095668|FG000|Overall Study|Other|1|||
164198385|NCT01064479|593095669|FG001|Overall Study|Other|2|||
164198386|NCT00749398|593095671|FG000|Overall Study|Lack of Efficacy|7|||
164198387|NCT00749398|593095671|FG000|Overall Study|Adverse Event|4|||
164198388|NCT00749398|593095671|FG000|Overall Study|Serious adverse event|11|||
164198389|NCT00749398|593095671|FG000|Overall Study|Withdrawal by Subject|17|||
164198390|NCT00749398|593095671|FG000|Overall Study|Lost to Follow-up|11|||
164198391|NCT00749398|593095671|FG000|Overall Study|Reason not specified|2|||
164198392|NCT00749398|593095671|FG000|Overall Study|Unknown reason|1|||
164198393|NCT01663402|593095677|FG000|Overall Study|Randomized but not treated|19|||
164198394|NCT01663402|593095678|FG001|Overall Study|Randomized but not treated|11|||
164198395|NCT01663402|593095677|FG000|Overall Study|Adverse Event|347|||
164198396|NCT01663402|593095678|FG001|Overall Study|Adverse Event|362|||
164198397|NCT01663402|593095677|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
164198398|NCT01663402|593095678|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
164198399|NCT01663402|593095677|FG000|Overall Study|Poor compliance to protocol|529|||
164198400|NCT01663402|593095678|FG001|Overall Study|Poor compliance to protocol|454|||
164198401|NCT01663402|593095677|FG000|Overall Study|Physician Decision|77|||
164198402|NCT01663402|593095678|FG001|Overall Study|Physician Decision|62|||
164198403|NCT01663402|593095677|FG000|Overall Study|Site terminated by sponsor|1|||
164198404|NCT01663402|593095678|FG001|Overall Study|Site terminated by sponsor|3|||
164198405|NCT01663402|593095677|FG000|Overall Study|Participant moved|139|||
164198406|NCT01663402|593095678|FG001|Overall Study|Participant moved|104|||
164198407|NCT01663402|593095677|FG000|Overall Study|Withdrawal by Subject|118|||
164198408|NCT01663402|593095678|FG001|Overall Study|Withdrawal by Subject|91|||
164198409|NCT01663402|593095677|FG000|Overall Study|Related to study drug administration|96|||
164198410|NCT01663402|593095678|FG001|Overall Study|Related to study drug administration|105|||
164198411|NCT01663402|593095677|FG000|Overall Study|Lost to Follow-up|17|||
164198412|NCT01663402|593095678|FG001|Overall Study|Lost to Follow-up|15|||
164198413|NCT01663402|593095677|FG000|Overall Study|Other than specified above|172|||
164198414|NCT01663402|593095678|FG001|Overall Study|Other than specified above|147|||
164198415|NCT01211145|593095679|FG000|Overall Study|Reason not specified|3|||
164198416|NCT01211145|593095680|FG001|Overall Study|Reason not specified|2|||
164198417|NCT01211145|593095681|FG002|Overall Study|Reason not specified|2|||
164198418|NCT01211145|593095682|FG003|Overall Study|Reason not specified|1|||
164198419|NCT01211145|593095679|FG000|Overall Study|Lost to Follow-up|3|||
164198420|NCT01211145|593095680|FG001|Overall Study|Lost to Follow-up|2|||
164198421|NCT01211145|593095681|FG002|Overall Study|Lost to Follow-up|1|||
163966936|NCT00295633|592252504|FG002|Overall Study|Withdrawal of consent by subject|26|||
163966937|NCT00295633|592252502|FG000|Overall Study|Adverse Event|9|||
163966938|NCT00295633|592252503|FG001|Overall Study|Adverse Event|17|||
163966939|NCT00295633|592252504|FG002|Overall Study|Adverse Event|9|||
163966940|NCT00295633|592252502|FG000|Overall Study|Lost to Follow-up|6|||
163966941|NCT00295633|592252503|FG001|Overall Study|Lost to Follow-up|11|||
163966942|NCT00295633|592252504|FG002|Overall Study|Lost to Follow-up|7|||
163966943|NCT00295633|592252502|FG000|Overall Study|Physician Decision|9|||
163966944|NCT00295633|592252503|FG001|Overall Study|Physician Decision|10|||
163966945|NCT00295633|592252504|FG002|Overall Study|Physician Decision|8|||
163966946|NCT00295633|592252502|FG000|Overall Study|Poor/Noncompliance|2|||
163966947|NCT00295633|592252503|FG001|Overall Study|Poor/Noncompliance|2|||
163966948|NCT00295633|592252504|FG002|Overall Study|Poor/Noncompliance|6|||
163966949|NCT00295633|592252502|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
163966950|NCT00295633|592252503|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
164198422|NCT01211145|593095682|FG003|Overall Study|Lost to Follow-up|2|||
164198423|NCT01211145|593095679|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164198424|NCT01211145|593095680|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164198425|NCT01211145|593095681|FG002|Overall Study|Study-specific withdrawal criteria|0|||
164198426|NCT01211145|593095682|FG003|Overall Study|Study-specific withdrawal criteria|0|||
164198427|NCT01211145|593095679|FG000|Overall Study|Severe noncompliance to protocol|1|||
164198428|NCT01211145|593095680|FG001|Overall Study|Severe noncompliance to protocol|0|||
164198429|NCT01211145|593095681|FG002|Overall Study|Severe noncompliance to protocol|0|||
164198430|NCT01211145|593095682|FG003|Overall Study|Severe noncompliance to protocol|0|||
164198431|NCT01211145|593095679|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
164198432|NCT01211145|593095680|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
164198433|NCT01211145|593095681|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
164198434|NCT01211145|593095682|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
164198435|NCT01211145|593095679|FG000|Overall Study|Patient decision|2|||
164198436|NCT01211145|593095680|FG001|Overall Study|Patient decision|1|||
164198437|NCT01211145|593095681|FG002|Overall Study|Patient decision|0|||
164198438|NCT01211145|593095682|FG003|Overall Study|Patient decision|2|||
164198439|NCT04577794|593095689|FG000|Overall Study|Adverse Event|1|||
164198440|NCT04577794|593095690|FG001|Overall Study|Adverse Event|1|||
164198441|NCT02667301|593095698|FG000|Overall Study|Adverse Event|1|||
164198442|NCT02667301|593095698|FG000|Overall Study|Lack of Efficacy|1|||
164198443|NCT00846586|593095700|FG000|Overall Study|Adverse Event|20|||
164198444|NCT00846586|593095701|FG001|Overall Study|Adverse Event|10|||
164198445|NCT00846586|593095700|FG000|Overall Study|Subject withdrew consent|8|||
164198446|NCT00846586|593095701|FG001|Overall Study|Subject withdrew consent|10|||
164198447|NCT00846586|593095700|FG000|Overall Study|Administrative problems|5|||
164198448|NCT00846586|593095701|FG001|Overall Study|Administrative problems|4|||
164198449|NCT00846586|593095700|FG000|Overall Study|Death|2|||
164198450|NCT00846586|593095701|FG001|Overall Study|Death|0|||
164198451|NCT00846586|593095700|FG000|Overall Study|Protocol deviation|2|||
164198452|NCT00846586|593095701|FG001|Overall Study|Protocol deviation|6|||
164198453|NCT00846586|593095700|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164198454|NCT00846586|593095701|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164198455|NCT00846586|593095700|FG000|Overall Study|Lost to Follow-up|1|||
164198456|NCT00846586|593095701|FG001|Overall Study|Lost to Follow-up|4|||
164198457|NCT00846586|593095700|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164198458|NCT00846586|593095701|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164198459|NCT02104895|593095702|FG000|Overall Study|Withdrawal by Subject|0|||
164198460|NCT02104895|593095703|FG001|Overall Study|Withdrawal by Subject|14|||
164198461|NCT01883895|593095705|FG000|Overall Study|Lost to Follow-up|2|||
164198462|NCT04414787|593095706|FG000|Overall Study|Patient Death|18|||
164198463|NCT04414787|593095707|FG001|Overall Study|Patient Death|18|||
164198464|NCT04414787|593095708|FG002|Overall Study|Patient Death|15|||
164198465|NCT04414787|593095709|FG003|Overall Study|Patient Death|15|||
164198466|NCT04414787|593095706|FG000|Overall Study|Patient Hospitalization|1|||
164198467|NCT04414787|593095707|FG001|Overall Study|Patient Hospitalization|1|||
164198468|NCT04414787|593095708|FG002|Overall Study|Patient Hospitalization|2|||
163966951|NCT00295633|592252504|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
164198469|NCT04414787|593095709|FG003|Overall Study|Patient Hospitalization|2|||
164198470|NCT04414787|593095706|FG000|Overall Study|Lost to Follow-up|7|||
164198471|NCT04414787|593095707|FG001|Overall Study|Lost to Follow-up|7|||
164198472|NCT04414787|593095708|FG002|Overall Study|Lost to Follow-up|5|||
164198473|NCT04414787|593095709|FG003|Overall Study|Lost to Follow-up|5|||
164198474|NCT04414787|593095706|FG000|Overall Study|Residence in post-acute care facility|3|||
164198475|NCT04414787|593095707|FG001|Overall Study|Residence in post-acute care facility|3|||
163966952|NCT00295633|592252502|FG000|Overall Study|Death|1|||
164198476|NCT04414787|593095708|FG002|Overall Study|Residence in post-acute care facility|5|||
163966953|NCT00295633|592252503|FG001|Overall Study|Death|1|||
163966954|NCT00295633|592252504|FG002|Overall Study|Death|0|||
163966955|NCT00295633|592252502|FG000|Overall Study|Administrative reason by sponsor|0|||
163966956|NCT00295633|592252503|FG001|Overall Study|Administrative reason by sponsor|0|||
163966957|NCT00295633|592252504|FG002|Overall Study|Administrative reason by sponsor|1|||
163966958|NCT01641237|592252511|FG000|Period II|Withdrawal by Subject|1|||
163966959|NCT01641237|592252512|FG001|Period II|Withdrawal by Subject|0|||
163966960|NCT01641237|592252513|FG002|Period II|Withdrawal by Subject|0|||
163966961|NCT01641237|592252514|FG003|Period II|Withdrawal by Subject|0|||
163966962|NCT01641237|592252511|FG000|Period III|Lost to Follow-up|1|||
163966963|NCT01641237|592252512|FG001|Period III|Lost to Follow-up|0|||
163966964|NCT01641237|592252513|FG002|Period III|Lost to Follow-up|0|||
163966965|NCT01641237|592252514|FG003|Period III|Lost to Follow-up|0|||
163966966|NCT04439071|592252515|FG000|Overall Study|Lost to Follow-up|0|||
163966967|NCT04439071|592252516|FG001|Overall Study|Lost to Follow-up|3|||
163966968|NCT04439071|592252515|FG000|Overall Study|Withdrawal by Subject|3|||
163966969|NCT04439071|592252516|FG001|Overall Study|Withdrawal by Subject|8|||
163966970|NCT04439071|592252515|FG000|Overall Study|Death|6|||
163966971|NCT04439071|592252516|FG001|Overall Study|Death|4|||
163966972|NCT04439071|592252515|FG000|Overall Study|Other than specified|3|||
163966973|NCT04439071|592252516|FG001|Overall Study|Other than specified|3|||
163966974|NCT04439071|592252515|FG000|Overall Study|Randomized but not treated|2|||
163966975|NCT04439071|592252516|FG001|Overall Study|Randomized but not treated|0|||
163861628|NCT03536884|591859518|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861629|NCT03536884|591859519|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861630|NCT03536884|591859520|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861631|NCT03536884|591859521|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861632|NCT03536884|591859522|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861633|NCT03536884|591859523|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
163861634|NCT03536884|591859524|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
163861635|NCT03536884|591859513|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861636|NCT03536884|591859514|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163966976|NCT00832117|592252517|FG000|Overall Study|Death|1|||
164198477|NCT04414787|593095709|FG003|Overall Study|Residence in post-acute care facility|5|||
164198478|NCT05093933|593095710|FG000|Overall Study|Death|372|||
164198479|NCT05093933|593095711|FG001|Overall Study|Death|434|||
164198480|NCT05093933|593095710|FG000|Overall Study|Lost to Follow-up|13|||
164198481|NCT05093933|593095711|FG001|Overall Study|Lost to Follow-up|16|||
164198482|NCT05093933|593095710|FG000|Overall Study|Physician Decision|0|||
164198483|NCT05093933|593095711|FG001|Overall Study|Physician Decision|2|||
164198484|NCT05093933|593095710|FG000|Overall Study|Sponsor Decision|1|||
164198485|NCT05093933|593095711|FG001|Overall Study|Sponsor Decision|3|||
164198486|NCT05093933|593095710|FG000|Overall Study|Withdrawal by Guardian|1|||
164198487|NCT05093933|593095711|FG001|Overall Study|Withdrawal by Guardian|1|||
164198488|NCT05093933|593095710|FG000|Overall Study|Withdrawal by Subject|18|||
164198489|NCT05093933|593095711|FG001|Overall Study|Withdrawal by Subject|25|||
164198490|NCT02532283|593095712|FG000|Overall Study|Adverse Event|0|||
164198491|NCT02532283|593095713|FG001|Overall Study|Adverse Event|1|||
164198492|NCT02532283|593095712|FG000|Overall Study|Death|1|||
164198493|NCT02532283|593095713|FG001|Overall Study|Death|0|||
164198494|NCT02532283|593095712|FG000|Overall Study|Lost to Follow-up|0|||
164198495|NCT02532283|593095713|FG001|Overall Study|Lost to Follow-up|1|||
164198496|NCT02532283|593095712|FG000|Overall Study|Withdrawal by Subject|8|||
164198497|NCT02532283|593095713|FG001|Overall Study|Withdrawal by Subject|3|||
164198498|NCT01249131|593097620|FG000|Washout Period of 10 Days|Adverse Event|0|||
163966977|NCT00832117|592252517|FG000|Overall Study|Disease Progression|11|||
163966978|NCT01301456|592252518|FG000|Stage 1|Withdrawal by Subject|0|||
163966979|NCT01301456|592252519|FG001|Stage 1|Withdrawal by Subject|0|||
163966980|NCT01301456|592252520|FG002|Stage 1|Withdrawal by Subject|1|||
163966981|NCT01301456|592252521|FG003|Stage 1|Withdrawal by Subject|0|||
163966982|NCT01301456|592252522|FG004|Stage 1|Withdrawal by Subject|1|||
163966983|NCT01301456|592252523|FG005|Stage 1|Withdrawal by Subject|0|||
163966984|NCT01301456|592252524|FG006|Stage 1|Withdrawal by Subject|0|||
164198499|NCT01249131|593097621|FG001|Washout Period of 10 Days|Adverse Event|0|||
164198500|NCT01249131|593097622|FG002|Washout Period of 10 Days|Adverse Event|0|||
164198501|NCT01249131|593097623|FG003|Washout Period of 10 Days|Adverse Event|0|||
164198502|NCT01249131|593097624|FG004|Washout Period of 10 Days|Adverse Event|1|||
164198503|NCT01249131|593097625|FG005|Washout Period of 10 Days|Adverse Event|0|||
164198504|NCT00473083|593097626|FG000|Overall Study|Adverse Event|1|||
164198505|NCT00473083|593097627|FG001|Overall Study|Adverse Event|0|||
164198506|NCT00473083|593097628|FG002|Overall Study|Adverse Event|0|||
164198507|NCT01184872|593097629|FG000|Overall Study|Adverse Event|3|||
164198508|NCT01184872|593097630|FG001|Overall Study|Adverse Event|4|||
164198509|NCT01184872|593097629|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164198510|NCT01184872|593097630|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163966985|NCT01301456|592252525|FG007|Stage 1|Withdrawal by Subject|0|||
164198511|NCT01184872|593097629|FG000|Overall Study|Withdrawal by Subject|2|||
164198512|NCT01184872|593097630|FG001|Overall Study|Withdrawal by Subject|0|||
164198513|NCT01184872|593097629|FG000|Overall Study|Lost to Follow-up|0|||
164198514|NCT01184872|593097630|FG001|Overall Study|Lost to Follow-up|1|||
164198515|NCT01184872|593097629|FG000|Overall Study|Administrative problems|1|||
164198516|NCT01184872|593097630|FG001|Overall Study|Administrative problems|1|||
164198517|NCT01184872|593097629|FG000|Overall Study|Protocol deviation|1|||
164198518|NCT01184872|593097630|FG001|Overall Study|Protocol deviation|0|||
164198519|NCT03426345|593097631|FG000|Overall Study|Adverse Event|4|||
164198520|NCT03426345|593097632|FG001|Overall Study|Adverse Event|4|||
164198521|NCT03426345|593097631|FG000|Overall Study|Lack of Efficacy|1|||
164198522|NCT03426345|593097632|FG001|Overall Study|Lack of Efficacy|0|||
164198523|NCT03426345|593097631|FG000|Overall Study|Withdrawal by Subject|5|||
164198524|NCT03426345|593097632|FG001|Overall Study|Withdrawal by Subject|6|||
164198525|NCT03426345|593097631|FG000|Overall Study|Lost to Follow-up|3|||
164198526|NCT03426345|593097632|FG001|Overall Study|Lost to Follow-up|1|||
164198527|NCT03426345|593097631|FG000|Overall Study|Protocol Deviation|3|||
164198528|NCT03426345|593097632|FG001|Overall Study|Protocol Deviation|4|||
164198529|NCT03426345|593097631|FG000|Overall Study|Reason Not Specified|1|||
164198530|NCT03426345|593097632|FG001|Overall Study|Reason Not Specified|2|||
164198531|NCT03426345|593097631|FG000|Overall Study|Missing Completion Status|1|||
164198532|NCT03426345|593097632|FG001|Overall Study|Missing Completion Status|0|||
164198533|NCT02446691|593097639|FG000|Overall Study|Withdrawal by Subject|2|||
164198534|NCT02446691|593097639|FG000|Overall Study|Lost to Follow-up|8|||
164198535|NCT02446691|593097639|FG000|Overall Study|Protocol Violation|1|||
164198536|NCT00192114|593097640|FG000|Overall Study|Objective Tumor Progression|19|||
164198537|NCT00192114|593097640|FG000|Overall Study|Adverse Event|2|||
164198538|NCT00192114|593097640|FG000|Overall Study|Clinical Progression|2|||
164198539|NCT00192114|593097640|FG000|Overall Study|Death|1|||
164198540|NCT00492297|593097641|FG000|Treatment|Death|2|||
164198541|NCT00492297|593097641|FG000|Treatment|Study terminated by sponsor|3|||
164198542|NCT00492297|593097641|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
164198543|NCT00492297|593097641|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
164198544|NCT00492297|593097641|FG000|Survival Only Follow-up|Death|46|||
164198545|NCT00492297|593097641|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
164198546|NCT00492297|593097641|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
164198547|NCT03885908|593097642|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
164198548|NCT03885908|593097643|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
164198549|NCT03885908|593097642|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
164198550|NCT03885908|593097643|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
164198551|NCT03885908|593097642|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
163861637|NCT03536884|591859515|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861638|NCT03536884|591859516|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861639|NCT03536884|591859517|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861640|NCT03536884|591859518|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861641|NCT03536884|591859519|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861642|NCT03536884|591859520|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861643|NCT03536884|591859521|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861644|NCT03536884|591859522|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861645|NCT03536884|591859523|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
163861646|NCT03536884|591859524|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
163861647|NCT03536884|591859513|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861648|NCT03536884|591859514|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861649|NCT03536884|591859515|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861650|NCT03536884|591859516|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861651|NCT03536884|591859517|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861652|NCT03536884|591859518|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861653|NCT03536884|591859519|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861654|NCT03536884|591859520|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861655|NCT03536884|591859521|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861656|NCT03536884|591859522|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861657|NCT03536884|591859523|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
163861658|NCT03536884|591859524|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
163861659|NCT03722446|591859525|FG000|Overall Study|Protocol Violation|15|||
163861660|NCT03722446|591859526|FG001|Overall Study|Protocol Violation|2|||
163861661|NCT01137292|591859531|FG000|Overall Study|Death|30|||
163861662|NCT01137292|591859531|FG000|Overall Study|Adverse Event|3|||
163861663|NCT01137292|591859531|FG000|Overall Study|Lack of Efficacy|13|||
163861664|NCT01137292|591859531|FG000|Overall Study|Lost to Follow-up|1|||
164198552|NCT03885908|593097643|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
164302205|NCT01134055|593482562|FG006|Overall Study|Lost to Follow-up|0|||
164198553|NCT03885908|593097642|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
164198554|NCT03885908|593097643|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
164198555|NCT03903172|593097655|FG000|Overall Study|screen fail|4|||
164198556|NCT03903172|593097656|FG001|Overall Study|screen fail|1|||
164198557|NCT01545388|593097657|FG000|Overall Study|Adverse Event|2|||
164198558|NCT01545388|593097658|FG001|Overall Study|Adverse Event|4|||
164198559|NCT01545388|593097659|FG002|Overall Study|Adverse Event|1|||
164198560|NCT01545388|593097657|FG000|Overall Study|Lack of Efficacy|3|||
164198561|NCT01545388|593097658|FG001|Overall Study|Lack of Efficacy|2|||
164198562|NCT01545388|593097659|FG002|Overall Study|Lack of Efficacy|5|||
164198563|NCT01545388|593097657|FG000|Overall Study|Participant moved or relocated|1|||
164198564|NCT01545388|593097658|FG001|Overall Study|Participant moved or relocated|0|||
164198565|NCT01545388|593097659|FG002|Overall Study|Participant moved or relocated|0|||
164198566|NCT01545388|593097657|FG000|Overall Study|Withdrawal by Subject|1|||
164198567|NCT01545388|593097658|FG001|Overall Study|Withdrawal by Subject|4|||
164198568|NCT01545388|593097659|FG002|Overall Study|Withdrawal by Subject|2|||
164198569|NCT01545388|593097657|FG000|Overall Study|Other|1|||
164198570|NCT01545388|593097658|FG001|Overall Study|Other|1|||
164198571|NCT01545388|593097659|FG002|Overall Study|Other|0|||
164198572|NCT01900444|593097660|FG000|Overall Study|Protocol Violation|2|||
164198573|NCT01900444|593097660|FG000|Overall Study|Lost to Follow-up|1|||
164198574|NCT00072384|593097661|FG000|Overall Study|Physician Decision|1|||
164198575|NCT00072384|593097661|FG000|Overall Study|Ineligible|8|||
164198576|NCT06058390|593097663|FG000|Overall Study|Lost to Follow-up|0|||
164198577|NCT06058390|593097664|FG001|Overall Study|Lost to Follow-up|0|||
164198578|NCT06058390|593097665|FG002|Overall Study|Lost to Follow-up|2|||
164198579|NCT06058390|593097666|FG003|Overall Study|Lost to Follow-up|1|||
164198580|NCT06058390|593097663|FG000|Overall Study|Physician Decision|0|||
164198581|NCT06058390|593097664|FG001|Overall Study|Physician Decision|0|||
164198582|NCT06058390|593097665|FG002|Overall Study|Physician Decision|0|||
164198583|NCT06058390|593097666|FG003|Overall Study|Physician Decision|1|||
164198584|NCT06058390|593097663|FG000|Overall Study|Participants did not receive any study intervention|0|||
164198585|NCT06058390|593097664|FG001|Overall Study|Participants did not receive any study intervention|0|||
164198586|NCT06058390|593097665|FG002|Overall Study|Participants did not receive any study intervention|0|||
164198587|NCT06058390|593097666|FG003|Overall Study|Participants did not receive any study intervention|1|||
164198588|NCT02495389|593097667|FG000|Overall Study|Withdrawal by Subject|40|||
164198589|NCT03585270|593097668|FG000|Overall Study|Withdrawal by Subject|2|||
164198590|NCT03585270|593097669|FG001|Overall Study|Withdrawal by Subject|6|||
164198591|NCT03585270|593097668|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
164198592|NCT03585270|593097669|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
164198593|NCT03585270|593097668|FG000|Overall Study|Adverse Event|5|||
164198594|NCT03585270|593097669|FG001|Overall Study|Adverse Event|2|||
164198595|NCT03585270|593097668|FG000|Overall Study|Lost to Follow-up|1|||
164198596|NCT03585270|593097669|FG001|Overall Study|Lost to Follow-up|4|||
164198597|NCT03585270|593097668|FG000|Overall Study|Death|5|||
164198598|NCT03585270|593097669|FG001|Overall Study|Death|3|||
164198599|NCT03585270|593097668|FG000|Overall Study|Other reasons|2|||
164198600|NCT03585270|593097669|FG001|Overall Study|Other reasons|2|||
164198601|NCT03292016|593097670|FG000|Second Washout|Adverse Event|0|||
164198602|NCT03292016|593097671|FG001|Second Washout|Adverse Event|1|||
164198603|NCT03292016|593097672|FG002|Second Washout|Adverse Event|0|||
164198604|NCT03292016|593097673|FG003|Second Washout|Adverse Event|0|||
164198605|NCT03292016|593097674|FG004|Second Washout|Adverse Event|0|||
164198606|NCT03292016|593097675|FG005|Second Washout|Adverse Event|0|||
164198607|NCT01802385|593097677|FG000|Overall Study|Death|106|||
164198608|NCT01802385|593097678|FG001|Overall Study|Death|120|||
164198609|NCT00323063|593097680|FG000|Overall Study|Adverse Event|1|||
164198610|NCT00323063|593097681|FG001|Overall Study|Adverse Event|0|||
164198611|NCT00323063|593097680|FG000|Overall Study|brain mets discovered prior to treatment|1|||
164198612|NCT00323063|593097681|FG001|Overall Study|brain mets discovered prior to treatment|0|||
164198613|NCT03904693|593097682|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198614|NCT03904693|593097683|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198615|NCT03904693|593097684|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
163861665|NCT01137292|591859531|FG000|Overall Study|Other|7|||
163861666|NCT04540835|591859533|FG000|Week 1|Lost to Follow-up|1|||
163861667|NCT04540835|591859533|FG000|Week 6|Pregnancy|1|||
163861668|NCT04540835|591859533|FG000|Week 6|Lack of Efficacy|1|||
163861669|NCT01838200|591859534|FG000|Overall Study|Adverse Event|0|||
163861670|NCT01838200|591859535|FG001|Overall Study|Adverse Event|2|||
163861671|NCT01838200|591859534|FG000|Overall Study|Progressive disease|3|||
163861672|NCT01838200|591859535|FG001|Overall Study|Progressive disease|0|||
163861673|NCT03105336|591859536|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
163861674|NCT03105336|591859537|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
163861675|NCT03105336|591859536|FG000|Overall Study|Death|40|||
164076447|NCT02595528|592645715|FG003|Overall Study|Lost to Follow-up|1|||
164198616|NCT03904693|593097685|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198617|NCT03904693|593097686|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
163861676|NCT03105336|591859537|FG001|Overall Study|Death|8|||
163861677|NCT03105336|591859536|FG000|Overall Study|Lost to Follow-up|13|||
163861678|NCT03105336|591859537|FG001|Overall Study|Lost to Follow-up|2|||
163861679|NCT03105336|591859536|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
163861680|NCT03105336|591859537|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
163861681|NCT03105336|591859536|FG000|Overall Study|Reason Not Specified|3|||
163861682|NCT03105336|591859537|FG001|Overall Study|Reason Not Specified|3|||
163861683|NCT03105336|591859536|FG000|Overall Study|Investigator Decision|3|||
163861684|NCT03105336|591859537|FG001|Overall Study|Investigator Decision|0|||
163861685|NCT03451851|591859538|FG000|PCP: Week 0 -16|Adverse Event|1|||
163861686|NCT03451851|591859539|FG001|PCP: Week 0 -16|Adverse Event|0|||
163861687|NCT03451851|591859540|FG002|PCP: Week 0 -16|Adverse Event|0|||
163966986|NCT01301456|592252526|FG008|Stage 1|Withdrawal by Subject|0|||
163966987|NCT01301456|592252527|FG009|Stage 1|Withdrawal by Subject|0|||
163966988|NCT01301456|592252528|FG010|Stage 1|Withdrawal by Subject|0|||
164198618|NCT03904693|593097687|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
164198619|NCT03904693|593097682|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198620|NCT03904693|593097683|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198621|NCT03904693|593097684|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
164198622|NCT03904693|593097685|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198623|NCT03904693|593097686|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198624|NCT03904693|593097687|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
164198625|NCT03904693|593097682|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198626|NCT03904693|593097683|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
164198627|NCT03904693|593097684|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
164198628|NCT03904693|593097685|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198629|NCT03904693|593097686|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198630|NCT03904693|593097687|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
164198631|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
164198632|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163966989|NCT01301456|592252529|FG011|Stage 1|Withdrawal by Subject|0|||
163966990|NCT01301456|592252518|FG000|Stage 1|Randomized but not treated|0|||
163966991|NCT01301456|592252519|FG001|Stage 1|Randomized but not treated|0|||
163966992|NCT01301456|592252520|FG002|Stage 1|Randomized but not treated|0|||
163966993|NCT01301456|592252521|FG003|Stage 1|Randomized but not treated|0|||
163966994|NCT01301456|592252522|FG004|Stage 1|Randomized but not treated|0|||
163966995|NCT01301456|592252523|FG005|Stage 1|Randomized but not treated|0|||
163966996|NCT01301456|592252524|FG006|Stage 1|Randomized but not treated|1|||
163966997|NCT01301456|592252525|FG007|Stage 1|Randomized but not treated|0|||
163966998|NCT01301456|592252526|FG008|Stage 1|Randomized but not treated|0|||
163966999|NCT01301456|592252527|FG009|Stage 1|Randomized but not treated|0|||
163967000|NCT01301456|592252528|FG010|Stage 1|Randomized but not treated|0|||
163967001|NCT01301456|592252529|FG011|Stage 1|Randomized but not treated|0|||
163967002|NCT01301456|592252518|FG000|Stage 2|Adverse Event|0|||
163967003|NCT01301456|592252519|FG001|Stage 2|Adverse Event|0|||
163967004|NCT01301456|592252520|FG002|Stage 2|Adverse Event|0|||
163967005|NCT01301456|592252521|FG003|Stage 2|Adverse Event|0|||
163967006|NCT01301456|592252522|FG004|Stage 2|Adverse Event|0|||
163967007|NCT01301456|592252523|FG005|Stage 2|Adverse Event|0|||
163967008|NCT01301456|592252524|FG006|Stage 2|Adverse Event|0|||
163967009|NCT01301456|592252525|FG007|Stage 2|Adverse Event|0|||
163967010|NCT01301456|592252526|FG008|Stage 2|Adverse Event|0|||
163967011|NCT01301456|592252527|FG009|Stage 2|Adverse Event|0|||
163967012|NCT01301456|592252528|FG010|Stage 2|Adverse Event|1|||
163967013|NCT01301456|592252529|FG011|Stage 2|Adverse Event|0|||
163967014|NCT00892177|592252530|FG000|Phase II|Ineligible|0|||
163967015|NCT00892177|592252531|FG001|Phase II|Ineligible|0|||
163967016|NCT00892177|592252532|FG002|Phase II|Ineligible|0|||
163967017|NCT00892177|592252533|FG003|Phase II|Ineligible|0|||
163967018|NCT00892177|592252534|FG004|Phase II|Ineligible|1|||
163967019|NCT00892177|592252535|FG005|Phase II|Ineligible|1|||
163967020|NCT00892177|592252530|FG000|Phase II|Withdrawal by Subject|0|||
163967021|NCT00892177|592252531|FG001|Phase II|Withdrawal by Subject|0|||
163967022|NCT00892177|592252532|FG002|Phase II|Withdrawal by Subject|0|||
163967023|NCT00892177|592252533|FG003|Phase II|Withdrawal by Subject|0|||
163967024|NCT00892177|592252534|FG004|Phase II|Withdrawal by Subject|4|||
164198633|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
163861688|NCT03451851|591859541|FG003|PCP: Week 0 -16|Adverse Event|0|||
163861689|NCT03451851|591859542|FG004|PCP: Week 0 -16|Adverse Event|0|||
163967025|NCT00892177|592252535|FG005|Phase II|Withdrawal by Subject|1|||
163967026|NCT03583450|592252536|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
163967027|NCT03583450|592252537|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
163967028|NCT00404066|592252538|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
163967029|NCT00404066|592252538|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
163967030|NCT01186939|592252539|FG000|Overall Study|Death|7|||
164198634|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
164198635|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
164198636|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
164198637|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198638|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198639|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198640|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198641|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
164198642|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
164198643|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198644|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198645|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198646|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
164198647|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198648|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
164198649|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198650|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198651|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198652|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
164198653|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198654|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
164198655|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198656|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198657|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198658|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198659|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
164198660|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
164198661|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198662|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198663|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198664|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198665|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
164198666|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
164198667|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198668|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198669|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198670|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198671|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
164198672|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
164198673|NCT03904693|593097682|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198674|NCT03904693|593097683|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198675|NCT03904693|593097684|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198676|NCT03904693|593097685|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198677|NCT03904693|593097686|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
164198678|NCT03904693|593097687|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
164198679|NCT01172873|593097689|FG000|Overall Study|Withdrawal by Subject|3|||
164198680|NCT01172873|593097690|FG001|Overall Study|Withdrawal by Subject|2|||
164198681|NCT05518539|593097691|FG000|Overall Study|Lost to Follow-up|6|||
164198682|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
164198683|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
164198684|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
164198685|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Adverse Event|2|||
164198686|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Adverse Event|0|||
164198687|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Adverse Event|1|||
164198688|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
164198689|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
164198690|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
164198691|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
164198692|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
164198693|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
164198694|NCT04613518|593097697|FG000|Double-Blind Treatment Period|Other Reasons|2|||
164198695|NCT04613518|593097698|FG001|Double-Blind Treatment Period|Other Reasons|0|||
164198696|NCT04613518|593097699|FG002|Double-Blind Treatment Period|Other Reasons|0|||
163861690|NCT03451851|591859543|FG005|PCP: Week 0 -16|Adverse Event|0|||
163967031|NCT01186939|592252539|FG000|Overall Study|Withdrawal by Subject|2|||
163967032|NCT01186939|592252539|FG000|Overall Study|No longer receiving clinical benefit|17|||
163967033|NCT01186939|592252539|FG000|Overall Study|Program closed|5|||
163967034|NCT01186939|592252539|FG000|Overall Study|Sponsor decision|4|||
163967035|NCT01186939|592252539|FG000|Overall Study|Started additional treatment|1|||
163967036|NCT01186939|592252539|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
163967037|NCT01186939|592252539|FG000|Overall Study|Myocardial infarction|1|||
163967038|NCT01186939|592252539|FG000|Overall Study|Bone marrow transplant|1|||
163967039|NCT01186939|592252539|FG000|Overall Study|Transformation to AML|1|||
163967040|NCT00791258|592252542|FG000|Overall Study|Adverse Event|87|||
163967041|NCT00791258|592252542|FG000|Overall Study|Lost to Follow-up|18|||
163967042|NCT00791258|592252542|FG000|Overall Study|Protocol Violation|109|||
163967043|NCT00791258|592252542|FG000|Overall Study|Withdrawal by Subject|40|||
163967044|NCT00791258|592252542|FG000|Overall Study|Did not take medication for >3 days|1|||
163967045|NCT00791258|592252542|FG000|Overall Study|subject left area|2|||
163967046|NCT00791258|592252542|FG000|Overall Study|non-compliance|3|||
163967047|NCT00791258|592252542|FG000|Overall Study|Subject incarcerated|1|||
163967048|NCT00791258|592252542|FG000|Overall Study|Subject required restricted medication|1|||
163967049|NCT00791258|592252542|FG000|Overall Study|Lack of Efficacy|1|||
163967050|NCT02066311|592252543|FG000|Overall Study|Adverse Event|4|||
163967051|NCT02066311|592252543|FG000|Overall Study|Withdrawal by Subject|1|||
163967052|NCT01372150|592252544|FG000|Overall Study|Lack of Efficacy|3|||
163967053|NCT01372150|592252545|FG001|Overall Study|Lack of Efficacy|0|||
163967054|NCT01372150|592252546|FG002|Overall Study|Lack of Efficacy|1|||
163967055|NCT01372150|592252544|FG000|Overall Study|Lost to Follow-up|4|||
163967056|NCT01372150|592252545|FG001|Overall Study|Lost to Follow-up|5|||
163967057|NCT01372150|592252546|FG002|Overall Study|Lost to Follow-up|6|||
163967058|NCT01372150|592252544|FG000|Overall Study|Protocol Violation|1|||
163967059|NCT01372150|592252545|FG001|Overall Study|Protocol Violation|0|||
163861691|NCT03451851|591859544|FG006|PCP: Week 0 -16|Adverse Event|1|||
163861692|NCT03451851|591859545|FG007|PCP: Week 0 -16|Adverse Event|0|||
163861693|NCT03451851|591859538|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861694|NCT03451851|591859539|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861695|NCT03451851|591859540|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
163861696|NCT03451851|591859541|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861697|NCT03451851|591859542|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861698|NCT03451851|591859543|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861699|NCT03451851|591859544|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861700|NCT03451851|591859545|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
163861701|NCT03451851|591859538|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861702|NCT03451851|591859539|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861703|NCT03451851|591859540|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
163861704|NCT03451851|591859541|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861705|NCT03451851|591859542|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861706|NCT03451851|591859543|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861707|NCT03451851|591859544|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861708|NCT03451851|591859545|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
163861709|NCT03451851|591859538|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163861710|NCT03451851|591859539|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163861711|NCT03451851|591859540|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163861712|NCT03451851|591859541|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163861713|NCT03451851|591859542|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
163861714|NCT03451851|591859543|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
163861715|NCT03451851|591859544|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163861716|NCT03451851|591859545|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
163861717|NCT03451851|591859538|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163861718|NCT03451851|591859539|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163861719|NCT03451851|591859540|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163861720|NCT03451851|591859541|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163861721|NCT03451851|591859542|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
163861722|NCT03451851|591859543|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163861723|NCT03451851|591859544|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163861724|NCT03451851|591859545|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
163967060|NCT01372150|592252546|FG002|Overall Study|Protocol Violation|3|||
163967061|NCT01372150|592252544|FG000|Overall Study|Withdrawal by Subject|2|||
163967062|NCT01372150|592252545|FG001|Overall Study|Withdrawal by Subject|7|||
163967063|NCT01372150|592252546|FG002|Overall Study|Withdrawal by Subject|2|||
163967064|NCT01372150|592252544|FG000|Overall Study|Other|1|||
163967065|NCT01372150|592252545|FG001|Overall Study|Other|0|||
163967066|NCT01372150|592252546|FG002|Overall Study|Other|2|||
163967067|NCT01372150|592252544|FG000|Overall Study|Adverse Event|2|||
163967068|NCT01372150|592252545|FG001|Overall Study|Adverse Event|1|||
163967069|NCT01372150|592252546|FG002|Overall Study|Adverse Event|2|||
163861725|NCT03451851|591859538|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861726|NCT03451851|591859539|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861727|NCT03451851|591859540|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861728|NCT03451851|591859541|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861729|NCT03451851|591859542|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
163861730|NCT03451851|591859543|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861731|NCT03451851|591859544|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861732|NCT03451851|591859545|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
163861733|NCT03944512|591859547|FG000|Overall Study|Death|0|||
163861734|NCT03944512|591859548|FG001|Overall Study|Death|0|||
163861735|NCT03944512|591859549|FG002|Overall Study|Death|1|||
163861736|NCT03944512|591859550|FG003|Overall Study|Death|2|||
163861737|NCT03944512|591859547|FG000|Overall Study|Lost to Follow-up|0|||
163861738|NCT03944512|591859548|FG001|Overall Study|Lost to Follow-up|0|||
163861739|NCT03944512|591859549|FG002|Overall Study|Lost to Follow-up|4|||
163861740|NCT03944512|591859550|FG003|Overall Study|Lost to Follow-up|4|||
164198697|NCT04613518|593097697|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
164198698|NCT04613518|593097698|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
164198699|NCT04613518|593097699|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164198700|NCT04613518|593097697|FG000|Open-Label Treatment Period|Adverse Event|1|||
164198701|NCT04613518|593097698|FG001|Open-Label Treatment Period|Adverse Event|0|||
164198702|NCT04613518|593097699|FG002|Open-Label Treatment Period|Adverse Event|3|||
164198703|NCT04613518|593097697|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
164198704|NCT04613518|593097698|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
164198705|NCT04613518|593097699|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
164198706|NCT04613518|593097697|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
164198707|NCT04613518|593097698|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
164198708|NCT04613518|593097699|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
164198709|NCT04613518|593097697|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
164198710|NCT04613518|593097698|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
164198711|NCT04613518|593097699|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
164198712|NCT04613518|593097697|FG000|Open-Label Treatment Period|Other reasons|1|||
164198713|NCT04613518|593097698|FG001|Open-Label Treatment Period|Other reasons|0|||
164198714|NCT04613518|593097699|FG002|Open-Label Treatment Period|Other reasons|0|||
164198715|NCT03589807|593097700|FG000|Overall Study|Lost to Follow-up|0|||
164198716|NCT03589807|593097701|FG001|Overall Study|Lost to Follow-up|2|||
164198717|NCT03589807|593097702|FG002|Overall Study|Lost to Follow-up|2|||
164198718|NCT03589807|593097703|FG003|Overall Study|Lost to Follow-up|3|||
164198719|NCT03589807|593097704|FG004|Overall Study|Lost to Follow-up|1|||
164198720|NCT03589807|593097705|FG005|Overall Study|Lost to Follow-up|1|||
164198721|NCT03589807|593097700|FG000|Overall Study|Withdrawal by Subject|0|||
164198722|NCT03589807|593097701|FG001|Overall Study|Withdrawal by Subject|5|||
164198723|NCT03589807|593097702|FG002|Overall Study|Withdrawal by Subject|0|||
164198724|NCT03589807|593097703|FG003|Overall Study|Withdrawal by Subject|0|||
164198725|NCT03589807|593097704|FG004|Overall Study|Withdrawal by Subject|0|||
164198726|NCT03589807|593097705|FG005|Overall Study|Withdrawal by Subject|0|||
164198727|NCT03589807|593097700|FG000|Overall Study|Protocol Violation|0|||
164198728|NCT03589807|593097701|FG001|Overall Study|Protocol Violation|0|||
164198729|NCT03589807|593097702|FG002|Overall Study|Protocol Violation|0|||
164198730|NCT03589807|593097703|FG003|Overall Study|Protocol Violation|1|||
164198731|NCT03589807|593097704|FG004|Overall Study|Protocol Violation|0|||
164198732|NCT03589807|593097705|FG005|Overall Study|Protocol Violation|0|||
164198733|NCT03589807|593097700|FG000|Overall Study|Enrolled but treatment not administered|0|||
164198734|NCT03589807|593097701|FG001|Overall Study|Enrolled but treatment not administered|0|||
164198735|NCT03589807|593097702|FG002|Overall Study|Enrolled but treatment not administered|0|||
164198736|NCT03589807|593097703|FG003|Overall Study|Enrolled but treatment not administered|0|||
164198737|NCT03589807|593097704|FG004|Overall Study|Enrolled but treatment not administered|1|||
164198738|NCT03589807|593097705|FG005|Overall Study|Enrolled but treatment not administered|0|||
164198739|NCT01076543|593097706|FG000|Overall Study|Withdrawal by Subject|2|||
164198740|NCT01076543|593097707|FG001|Overall Study|Withdrawal by Subject|0|||
164198741|NCT01076543|593097708|FG002|Overall Study|Withdrawal by Subject|0|||
164198742|NCT01076543|593097709|FG003|Overall Study|Withdrawal by Subject|0|||
164198743|NCT01076543|593097710|FG004|Overall Study|Withdrawal by Subject|0|||
164198744|NCT01076543|593097711|FG005|Overall Study|Withdrawal by Subject|0|||
164198745|NCT00338741|593097712|FG000|Overall Study|Lost to Follow-up|2|||
164198746|NCT00338741|593097713|FG001|Overall Study|Lost to Follow-up|0|||
164198747|NCT01534273|593097714|FG000|Period 1|Physician Decision|0|||
164198748|NCT01534273|593097715|FG001|Period 1|Physician Decision|0|||
163861741|NCT03944512|591859547|FG000|Overall Study|refused follow-up|0|||
163861742|NCT03944512|591859548|FG001|Overall Study|refused follow-up|0|||
163861743|NCT03944512|591859549|FG002|Overall Study|refused follow-up|2|||
164198749|NCT01534273|593097716|FG002|Period 1|Physician Decision|0|||
164198750|NCT01534273|593097717|FG003|Period 1|Physician Decision|1|||
164198751|NCT01534273|593097718|FG004|Period 1|Physician Decision|0|||
164198752|NCT01534273|593097719|FG005|Period 1|Physician Decision|0|||
164198753|NCT01534273|593097720|FG006|Period 1|Physician Decision|0|||
164198754|NCT01619865|593097721|FG000|Overall Study|Adverse Event|1|||
164198755|NCT01619865|593097721|FG000|Overall Study|Death|2|||
164198756|NCT01619865|593097721|FG000|Overall Study|subject not able to comply|1|||
164198757|NCT03586050|593097722|FG000|Overall Study|Death|3|||
164198758|NCT03586050|593097722|FG000|Overall Study|Withdrawal by Subject|2|||
164198759|NCT01494818|593097723|FG000|Overall Study|Relocation|1|||
164198760|NCT01494818|593097724|FG001|Overall Study|Relocation|2|||
164198761|NCT01494818|593097723|FG000|Overall Study|Lost to Follow-up|1|||
164198762|NCT01494818|593097724|FG001|Overall Study|Lost to Follow-up|0|||
164198763|NCT04831138|593097725|FG000|Overall Study|Lost to Follow-up|2|||
164198764|NCT04831138|593097726|FG001|Overall Study|Lost to Follow-up|0|||
164198765|NCT00791999|593097727|FG000|Overall Study|Protocol planed withdrawal|14|||
164198766|NCT00791999|593097728|FG001|Overall Study|Protocol planed withdrawal|11|||
164198767|NCT00791999|593097729|FG002|Overall Study|Protocol planed withdrawal|11|||
164198768|NCT00791999|593097730|FG003|Overall Study|Protocol planed withdrawal|45|||
164198769|NCT00791999|593097727|FG000|Overall Study|Withdrawal by Subject|0|||
164307255|NCT02023697|593499224|FG001|Long-term Follow-up Period|Other unspecified|3|||
163861744|NCT03944512|591859550|FG003|Overall Study|refused follow-up|2|||
163861745|NCT01090024|591860614|FG000|Period 1|Met exclusion criteria|0|||
163861746|NCT01090024|591860615|FG001|Period 1|Met exclusion criteria|0|||
163861747|NCT01090024|591860616|FG002|Period 1|Met exclusion criteria|0|||
163861748|NCT01090024|591860617|FG003|Period 1|Met exclusion criteria|0|||
163861749|NCT01090024|591860618|FG004|Period 1|Met exclusion criteria|0|||
163861750|NCT01090024|591860619|FG005|Period 1|Met exclusion criteria|0|||
163861751|NCT01090024|591860620|FG006|Period 1|Met exclusion criteria|0|||
163861752|NCT01090024|591860621|FG007|Period 1|Met exclusion criteria|0|||
163861753|NCT01090024|591860622|FG008|Period 1|Met exclusion criteria|0|||
163861754|NCT01090024|591860623|FG009|Period 1|Met exclusion criteria|0|||
163861755|NCT01090024|591860624|FG010|Period 1|Met exclusion criteria|0|||
163861756|NCT01090024|591860625|FG011|Period 1|Met exclusion criteria|0|||
163861757|NCT01090024|591860626|FG012|Period 1|Met exclusion criteria|0|||
163861758|NCT01090024|591860627|FG013|Period 1|Met exclusion criteria|0|||
163861759|NCT01090024|591860628|FG014|Period 1|Met exclusion criteria|1|||
163861760|NCT01090024|591860629|FG015|Period 1|Met exclusion criteria|0|||
163861761|NCT01090024|591860630|FG016|Period 1|Met exclusion criteria|0|||
163861762|NCT01090024|591860631|FG017|Period 1|Met exclusion criteria|0|||
163861763|NCT01090024|591860614|FG000|Period 1|Adverse Event|0|||
163861764|NCT01090024|591860615|FG001|Period 1|Adverse Event|0|||
163861765|NCT01090024|591860616|FG002|Period 1|Adverse Event|0|||
163861766|NCT01090024|591860617|FG003|Period 1|Adverse Event|0|||
163861767|NCT01090024|591860618|FG004|Period 1|Adverse Event|0|||
163861768|NCT01090024|591860619|FG005|Period 1|Adverse Event|0|||
163861769|NCT01090024|591860620|FG006|Period 1|Adverse Event|0|||
163861770|NCT01090024|591860621|FG007|Period 1|Adverse Event|0|||
163861771|NCT01090024|591860622|FG008|Period 1|Adverse Event|0|||
163861772|NCT01090024|591860623|FG009|Period 1|Adverse Event|1|||
163861773|NCT01090024|591860624|FG010|Period 1|Adverse Event|0|||
163861774|NCT01090024|591860625|FG011|Period 1|Adverse Event|1|||
163861775|NCT01090024|591860626|FG012|Period 1|Adverse Event|0|||
163861776|NCT01090024|591860627|FG013|Period 1|Adverse Event|0|||
163861777|NCT01090024|591860628|FG014|Period 1|Adverse Event|0|||
163861778|NCT01090024|591860629|FG015|Period 1|Adverse Event|0|||
163861779|NCT01090024|591860630|FG016|Period 1|Adverse Event|0|||
163861780|NCT01090024|591860631|FG017|Period 1|Adverse Event|1|||
163861781|NCT01090024|591860614|FG000|Period 1|Withdrawal by Subject|0|||
163861782|NCT01090024|591860615|FG001|Period 1|Withdrawal by Subject|0|||
163861783|NCT01090024|591860616|FG002|Period 1|Withdrawal by Subject|0|||
163861784|NCT01090024|591860617|FG003|Period 1|Withdrawal by Subject|1|||
163861785|NCT01090024|591860618|FG004|Period 1|Withdrawal by Subject|0|||
163861786|NCT01090024|591860619|FG005|Period 1|Withdrawal by Subject|0|||
163861787|NCT01090024|591860620|FG006|Period 1|Withdrawal by Subject|0|||
163861788|NCT01090024|591860621|FG007|Period 1|Withdrawal by Subject|0|||
163861789|NCT01090024|591860622|FG008|Period 1|Withdrawal by Subject|0|||
163861790|NCT01090024|591860623|FG009|Period 1|Withdrawal by Subject|0|||
163861791|NCT01090024|591860624|FG010|Period 1|Withdrawal by Subject|0|||
163861792|NCT01090024|591860625|FG011|Period 1|Withdrawal by Subject|0|||
163861793|NCT01090024|591860626|FG012|Period 1|Withdrawal by Subject|0|||
163861794|NCT01090024|591860627|FG013|Period 1|Withdrawal by Subject|0|||
163861795|NCT01090024|591860628|FG014|Period 1|Withdrawal by Subject|0|||
163861796|NCT01090024|591860629|FG015|Period 1|Withdrawal by Subject|0|||
163861797|NCT01090024|591860630|FG016|Period 1|Withdrawal by Subject|0|||
163861798|NCT01090024|591860631|FG017|Period 1|Withdrawal by Subject|0|||
163861799|NCT01090024|591860614|FG000|Period 1|Lost to Follow-up|0|||
163861800|NCT01090024|591860615|FG001|Period 1|Lost to Follow-up|1|||
163861801|NCT01090024|591860616|FG002|Period 1|Lost to Follow-up|0|||
163861802|NCT01090024|591860617|FG003|Period 1|Lost to Follow-up|0|||
163861803|NCT01090024|591860618|FG004|Period 1|Lost to Follow-up|0|||
164198770|NCT00791999|593097728|FG001|Overall Study|Withdrawal by Subject|1|||
163967070|NCT01372150|592252544|FG000|Overall Study|Randomized but not treated|0|||
163967071|NCT01372150|592252545|FG001|Overall Study|Randomized but not treated|1|||
163967072|NCT01372150|592252546|FG002|Overall Study|Randomized but not treated|0|||
163967073|NCT02316340|592252547|FG000|First Progression|Clinical progression|2|||
163967074|NCT02316340|592252548|FG001|First Progression|Clinical progression|1|||
163967075|NCT02316340|592252547|FG000|First Progression|Withdrawal by Subject|1|||
163967076|NCT02316340|592252548|FG001|First Progression|Withdrawal by Subject|0|||
163967077|NCT01835015|592252549|FG000|Overall Study|Adverse Event|0|||
163967078|NCT01835015|592252550|FG001|Overall Study|Adverse Event|0|||
164307256|NCT02023697|593499225|FG002|Long-term Follow-up Period|Other unspecified|5|||
164307257|NCT00541385|593499226|FG000|Overall Study|Adverse Event|6|||
164307258|NCT00541385|593499227|FG001|Overall Study|Adverse Event|3|||
164307259|NCT00541385|593499226|FG000|Overall Study|Withdrawal by Subject|2|||
164307260|NCT00541385|593499227|FG001|Overall Study|Withdrawal by Subject|2|||
164307261|NCT00541385|593499226|FG000|Overall Study|Lost to Follow-up|6|||
164307262|NCT00541385|593499227|FG001|Overall Study|Lost to Follow-up|1|||
164307263|NCT00541385|593499226|FG000|Overall Study|Parasite reappearance/malaria|67|||
163967079|NCT01835015|592252551|FG002|Overall Study|Adverse Event|1|||
163967080|NCT01835015|592252552|FG003|Overall Study|Adverse Event|0|||
163967081|NCT01835015|592252553|FG004|Overall Study|Adverse Event|0|||
163967082|NCT00975715|592252557|FG000|Titration Period|Adverse Event|6|||
163967083|NCT00975715|592252558|FG001|Titration Period|Adverse Event|0|||
163967084|NCT00975715|592252557|FG000|Titration Period|Protocol Violation|1|||
163967085|NCT00975715|592252558|FG001|Titration Period|Protocol Violation|0|||
163967086|NCT00975715|592252557|FG000|Maintenance Period|Adverse Event|2|||
163967087|NCT00975715|592252558|FG001|Maintenance Period|Adverse Event|1|||
163967088|NCT01241552|592252562|FG000|Overall Study|Lack of Efficacy|1|||
163967089|NCT01241552|592252563|FG001|Overall Study|Lack of Efficacy|0|||
163967090|NCT01241552|592252564|FG002|Overall Study|Lack of Efficacy|0|||
163967091|NCT01241552|592252565|FG003|Overall Study|Lack of Efficacy|0|||
163967092|NCT01241552|592252562|FG000|Overall Study|Death|26|||
163967093|NCT01241552|592252563|FG001|Overall Study|Death|30|||
163967094|NCT01241552|592252564|FG002|Overall Study|Death|20|||
163967095|NCT01241552|592252565|FG003|Overall Study|Death|25|||
163967096|NCT01241552|592252562|FG000|Overall Study|Adverse Event|1|||
163967097|NCT01241552|592252563|FG001|Overall Study|Adverse Event|1|||
163967098|NCT01241552|592252564|FG002|Overall Study|Adverse Event|0|||
163967099|NCT01241552|592252565|FG003|Overall Study|Adverse Event|0|||
163967100|NCT01241552|592252562|FG000|Overall Study|Technical Problems|2|||
163967101|NCT01241552|592252563|FG001|Overall Study|Technical Problems|0|||
163967102|NCT01241552|592252564|FG002|Overall Study|Technical Problems|2|||
163967103|NCT01241552|592252565|FG003|Overall Study|Technical Problems|2|||
163967104|NCT01241552|592252562|FG000|Overall Study|Progressive Disease|0|||
163967105|NCT01241552|592252563|FG001|Overall Study|Progressive Disease|0|||
163967106|NCT01241552|592252564|FG002|Overall Study|Progressive Disease|1|||
163967107|NCT01241552|592252565|FG003|Overall Study|Progressive Disease|2|||
163967108|NCT01241552|592252562|FG000|Overall Study|Protocol Violation|0|||
163967109|NCT01241552|592252563|FG001|Overall Study|Protocol Violation|2|||
163967110|NCT01241552|592252564|FG002|Overall Study|Protocol Violation|6|||
163967111|NCT01241552|592252565|FG003|Overall Study|Protocol Violation|1|||
163967112|NCT01241552|592252562|FG000|Overall Study|Withdrawal by Subject|7|||
163967113|NCT01241552|592252563|FG001|Overall Study|Withdrawal by Subject|15|||
163967114|NCT01241552|592252564|FG002|Overall Study|Withdrawal by Subject|14|||
163967115|NCT01241552|592252565|FG003|Overall Study|Withdrawal by Subject|15|||
163967116|NCT01241552|592252562|FG000|Overall Study|Physician Decision|2|||
163967117|NCT01241552|592252563|FG001|Overall Study|Physician Decision|4|||
163967118|NCT01241552|592252564|FG002|Overall Study|Physician Decision|2|||
163967119|NCT01241552|592252565|FG003|Overall Study|Physician Decision|3|||
163967120|NCT01241552|592252562|FG000|Overall Study|Lost to Follow-up|2|||
163967121|NCT01241552|592252563|FG001|Overall Study|Lost to Follow-up|11|||
163967122|NCT01241552|592252564|FG002|Overall Study|Lost to Follow-up|15|||
163967123|NCT01241552|592252565|FG003|Overall Study|Lost to Follow-up|16|||
163967124|NCT04004429|592252566|FG000|Overall Study|Protocol Violation|1|||
163967125|NCT04004429|592252567|FG001|Overall Study|Protocol Violation|0|||
164307264|NCT00541385|593499227|FG001|Overall Study|Parasite reappearance/malaria|32|||
164307265|NCT01469377|593499228|FG000|Overall Study|Protocol Deviation|7|||
164307266|NCT01469377|593499229|FG001|Overall Study|Protocol Deviation|10|||
164307267|NCT01469377|593499230|FG002|Overall Study|Protocol Deviation|10|||
164307268|NCT01469377|593499228|FG000|Overall Study|Lost to Follow-up|3|||
164307269|NCT01469377|593499229|FG001|Overall Study|Lost to Follow-up|2|||
164307270|NCT01469377|593499230|FG002|Overall Study|Lost to Follow-up|5|||
164307271|NCT01469377|593499228|FG000|Overall Study|Withdrawal of Consent|12|||
164307272|NCT01469377|593499229|FG001|Overall Study|Withdrawal of Consent|14|||
164307273|NCT01469377|593499230|FG002|Overall Study|Withdrawal of Consent|15|||
164307274|NCT01469377|593499228|FG000|Overall Study|Adverse Event|8|||
164307275|NCT01469377|593499229|FG001|Overall Study|Adverse Event|18|||
163967126|NCT04004429|592252568|FG002|Overall Study|Protocol Violation|0|||
163967127|NCT04004429|592252566|FG000|Overall Study|Physician Decision|0|||
163967128|NCT04004429|592252567|FG001|Overall Study|Physician Decision|1|||
163967129|NCT04004429|592252568|FG002|Overall Study|Physician Decision|1|||
163967130|NCT04004429|592252566|FG000|Overall Study|Withdrawal by Subject|1|||
163967131|NCT04004429|592252567|FG001|Overall Study|Withdrawal by Subject|1|||
163967132|NCT04004429|592252568|FG002|Overall Study|Withdrawal by Subject|1|||
163967133|NCT02606461|592252569|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163967134|NCT02606461|592252570|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163967135|NCT02606461|592252571|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
163967136|NCT02606461|592252572|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163967137|NCT02606461|592252573|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163967138|NCT02606461|592252574|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
163967139|NCT05395104|592252575|FG000|Overall Study|Met Liver Stopping Criteria|1|||
163967140|NCT05395104|592252575|FG000|Overall Study|Withdrawal by Subject|1|||
163967141|NCT04422990|592252578|FG000|Overall Study|Withdrawal by Subject|0|||
163967142|NCT04422990|592252579|FG001|Overall Study|Withdrawal by Subject|1|||
163967143|NCT04422990|592252578|FG000|Overall Study|Travel|3|||
163967144|NCT04422990|592252579|FG001|Overall Study|Travel|0|||
163967145|NCT01849497|592252580|FG000|Overall Study|Withdrawal by Subject|1|||
164198771|NCT00791999|593097729|FG002|Overall Study|Withdrawal by Subject|0|||
164198772|NCT00791999|593097730|FG003|Overall Study|Withdrawal by Subject|2|||
164198773|NCT00791999|593097727|FG000|Overall Study|Protocol Violation|3|||
164198774|NCT00791999|593097728|FG001|Overall Study|Protocol Violation|0|||
164198775|NCT00791999|593097729|FG002|Overall Study|Protocol Violation|1|||
164198776|NCT00791999|593097730|FG003|Overall Study|Protocol Violation|0|||
164198777|NCT00791999|593097727|FG000|Overall Study|Adverse Event|3|||
164198778|NCT00791999|593097728|FG001|Overall Study|Adverse Event|3|||
164198779|NCT00791999|593097729|FG002|Overall Study|Adverse Event|7|||
164198780|NCT00791999|593097730|FG003|Overall Study|Adverse Event|3|||
164198781|NCT00791999|593097727|FG000|Overall Study|Lack of Efficacy|0|||
164198782|NCT00791999|593097728|FG001|Overall Study|Lack of Efficacy|1|||
164198783|NCT00791999|593097729|FG002|Overall Study|Lack of Efficacy|0|||
164198784|NCT00791999|593097730|FG003|Overall Study|Lack of Efficacy|2|||
164198785|NCT00791999|593097727|FG000|Overall Study|Reason other than those above|1|||
164198786|NCT00791999|593097728|FG001|Overall Study|Reason other than those above|0|||
164198787|NCT00791999|593097729|FG002|Overall Study|Reason other than those above|1|||
164198788|NCT00791999|593097730|FG003|Overall Study|Reason other than those above|0|||
164198789|NCT02688933|593097733|FG000|Overall Study|Adverse Event|3|||
164198790|NCT02688933|593097734|FG001|Overall Study|Adverse Event|1|||
164198791|NCT02688933|593097733|FG000|Overall Study|Lack of Efficacy|2|||
164198792|NCT02688933|593097734|FG001|Overall Study|Lack of Efficacy|2|||
164198793|NCT02688933|593097733|FG000|Overall Study|Poor compliance to protocol|7|||
164198794|NCT02688933|593097734|FG001|Overall Study|Poor compliance to protocol|4|||
164198795|NCT02688933|593097733|FG000|Overall Study|Hypoglycemia|2|||
164198796|NCT02688933|593097734|FG001|Overall Study|Hypoglycemia|0|||
164198797|NCT02688933|593097733|FG000|Overall Study|Other than Specified|14|||
164198798|NCT02688933|593097734|FG001|Overall Study|Other than Specified|25|||
164198799|NCT02688933|593097733|FG000|Overall Study|Lost to Follow-up|1|||
164198800|NCT02688933|593097734|FG001|Overall Study|Lost to Follow-up|5|||
164198801|NCT03509467|593097735|FG000|Overall Study|Withdrawal by Subject|5|||
164198802|NCT03509467|593097736|FG001|Overall Study|Withdrawal by Subject|1|||
164198803|NCT03509467|593097737|FG002|Overall Study|Withdrawal by Subject|6|||
164198804|NCT03509467|593097738|FG003|Overall Study|Withdrawal by Subject|7|||
164198805|NCT03509467|593097739|FG004|Overall Study|Withdrawal by Subject|10|||
164198806|NCT03509467|593097740|FG005|Overall Study|Withdrawal by Subject|10|||
164198807|NCT03509467|593097741|FG006|Overall Study|Withdrawal by Subject|10|||
164198808|NCT03509467|593097742|FG007|Overall Study|Withdrawal by Subject|10|||
164198809|NCT03509467|593097735|FG000|Overall Study|Death|0|||
164198810|NCT03509467|593097736|FG001|Overall Study|Death|0|||
164198811|NCT03509467|593097737|FG002|Overall Study|Death|2|||
164198812|NCT03509467|593097738|FG003|Overall Study|Death|2|||
164198813|NCT03509467|593097739|FG004|Overall Study|Death|1|||
164198814|NCT03509467|593097740|FG005|Overall Study|Death|0|||
164198815|NCT03509467|593097741|FG006|Overall Study|Death|1|||
164198816|NCT03509467|593097742|FG007|Overall Study|Death|0|||
164198817|NCT03509467|593097735|FG000|Overall Study|Proxy Withdrawal|0|||
164198818|NCT03509467|593097736|FG001|Overall Study|Proxy Withdrawal|0|||
164198819|NCT03509467|593097737|FG002|Overall Study|Proxy Withdrawal|0|||
163967146|NCT01849497|592252581|FG001|Overall Study|Withdrawal by Subject|2|||
164198820|NCT03509467|593097738|FG003|Overall Study|Proxy Withdrawal|0|||
164198821|NCT03509467|593097739|FG004|Overall Study|Proxy Withdrawal|0|||
164198822|NCT03509467|593097740|FG005|Overall Study|Proxy Withdrawal|0|||
164198823|NCT03509467|593097741|FG006|Overall Study|Proxy Withdrawal|0|||
164198824|NCT03509467|593097742|FG007|Overall Study|Proxy Withdrawal|1|||
164198825|NCT04275973|593097745|FG000|Overall Study|Withdrawal by Subject|2|||
164198826|NCT04275973|593097746|FG001|Overall Study|Withdrawal by Subject|1|||
164198827|NCT06110754|593097747|FG000|Overall Study|Withdrawal by Subject|0|||
164198828|NCT06110754|593097748|FG001|Overall Study|Withdrawal by Subject|0|||
164198829|NCT06110754|593097749|FG002|Overall Study|Withdrawal by Subject|1|||
164198830|NCT06110754|593097750|FG003|Overall Study|Withdrawal by Subject|0|||
164307276|NCT01469377|593499230|FG002|Overall Study|Adverse Event|36|||
164307277|NCT01469377|593499228|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164307278|NCT01469377|593499229|FG001|Overall Study|Insufficient Therapeutic Response|4|||
164307279|NCT01469377|593499230|FG002|Overall Study|Insufficient Therapeutic Response|0|||
164307280|NCT01469377|593499228|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164307281|NCT01469377|593499229|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164307282|NCT01469377|593499230|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164307283|NCT01733680|593499231|FG000|Overall Study|Withdrawal by Subject|0|||
164307284|NCT01733680|593499232|FG001|Overall Study|Withdrawal by Subject|1|||
164307285|NCT04139798|593499235|FG000|Overall Study|Withdrawal by Subject|6|||
164307286|NCT04139798|593499236|FG001|Overall Study|Withdrawal by Subject|5|||
164307287|NCT04139798|593499235|FG000|Overall Study|Lost to Follow-up|2|||
164307288|NCT04139798|593499236|FG001|Overall Study|Lost to Follow-up|5|||
164307289|NCT04139798|593499235|FG000|Overall Study|Discontinued|4|||
163967147|NCT01849497|592252580|FG000|Overall Study|Sponsor Decision|0|||
163967148|NCT01849497|592252581|FG001|Overall Study|Sponsor Decision|1|||
163967149|NCT01849497|592252580|FG000|Overall Study|Lost to Follow-up|0|||
163967150|NCT01849497|592252581|FG001|Overall Study|Lost to Follow-up|1|||
163967151|NCT01514136|592252582|FG000|Test Period 1; Test A|Protocol Violation|1|||
163967152|NCT01514136|592252583|FG001|Test Period 1; Test A|Protocol Violation|0|||
163967153|NCT01514136|592252584|FG002|Test Period 1; Test A|Protocol Violation|0|||
163967154|NCT01514136|592252585|FG003|Test Period 1; Test A|Protocol Violation|0|||
163967155|NCT01514136|592252586|FG004|Test Period 1; Test A|Protocol Violation|0|||
164307290|NCT04139798|593499236|FG001|Overall Study|Discontinued|2|||
164307291|NCT04139798|593499235|FG000|Overall Study|Adverse Event|1|||
164307292|NCT04139798|593499236|FG001|Overall Study|Adverse Event|3|||
164307293|NCT04139798|593499235|FG000|Overall Study|Protocol Violation|1|||
164307294|NCT04139798|593499236|FG001|Overall Study|Protocol Violation|0|||
164307295|NCT02839200|593499237|FG000|Overall Study|Withdrawal by Subject|2|||
164307296|NCT02839200|593499238|FG001|Overall Study|Withdrawal by Subject|0|||
164307297|NCT02839200|593499239|FG002|Overall Study|Withdrawal by Subject|1|||
164307298|NCT02839200|593499240|FG003|Overall Study|Withdrawal by Subject|0|||
163861804|NCT01090024|591860619|FG005|Period 1|Lost to Follow-up|0|||
163967156|NCT01514136|592252587|FG005|Test Period 1; Test A|Protocol Violation|0|||
163967157|NCT01514136|592252588|FG006|Test Period 1; Test A|Protocol Violation|0|||
163967158|NCT01514136|592252589|FG007|Test Period 1; Test A|Protocol Violation|0|||
163967159|NCT01514136|592252582|FG000|Test Period 1; Test A|Break from study holiday|2|||
163967160|NCT01514136|592252583|FG001|Test Period 1; Test A|Break from study holiday|0|||
163967161|NCT01514136|592252584|FG002|Test Period 1; Test A|Break from study holiday|0|||
163967162|NCT01514136|592252585|FG003|Test Period 1; Test A|Break from study holiday|0|||
163967163|NCT01514136|592252586|FG004|Test Period 1; Test A|Break from study holiday|0|||
163967164|NCT01514136|592252587|FG005|Test Period 1; Test A|Break from study holiday|0|||
163967165|NCT01514136|592252588|FG006|Test Period 1; Test A|Break from study holiday|0|||
163967166|NCT01514136|592252589|FG007|Test Period 1; Test A|Break from study holiday|0|||
163861805|NCT01090024|591860620|FG006|Period 1|Lost to Follow-up|0|||
163861806|NCT01090024|591860621|FG007|Period 1|Lost to Follow-up|0|||
163861807|NCT01090024|591860622|FG008|Period 1|Lost to Follow-up|0|||
163861808|NCT01090024|591860623|FG009|Period 1|Lost to Follow-up|0|||
163861809|NCT01090024|591860624|FG010|Period 1|Lost to Follow-up|0|||
163861810|NCT01090024|591860625|FG011|Period 1|Lost to Follow-up|0|||
163861811|NCT01090024|591860626|FG012|Period 1|Lost to Follow-up|0|||
163861812|NCT01090024|591860627|FG013|Period 1|Lost to Follow-up|0|||
163861813|NCT01090024|591860628|FG014|Period 1|Lost to Follow-up|0|||
163861814|NCT01090024|591860629|FG015|Period 1|Lost to Follow-up|0|||
163861815|NCT01090024|591860630|FG016|Period 1|Lost to Follow-up|0|||
163861816|NCT01090024|591860631|FG017|Period 1|Lost to Follow-up|0|||
163861817|NCT01090024|591860614|FG000|Period 2|Lost to Follow-up|0|||
163861818|NCT01090024|591860615|FG001|Period 2|Lost to Follow-up|0|||
163861819|NCT01090024|591860616|FG002|Period 2|Lost to Follow-up|0|||
163861820|NCT01090024|591860617|FG003|Period 2|Lost to Follow-up|1|||
163861821|NCT01090024|591860618|FG004|Period 2|Lost to Follow-up|0|||
163861822|NCT01090024|591860619|FG005|Period 2|Lost to Follow-up|0|||
163861823|NCT01090024|591860620|FG006|Period 2|Lost to Follow-up|0|||
163861824|NCT01090024|591860621|FG007|Period 2|Lost to Follow-up|0|||
163967167|NCT01514136|592252582|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
163967168|NCT01514136|592252583|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
163967169|NCT01514136|592252584|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
163967170|NCT01514136|592252585|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
163967171|NCT01514136|592252586|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
163967172|NCT01514136|592252587|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
163967173|NCT01514136|592252588|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
164307299|NCT02839200|593499241|FG004|Overall Study|Withdrawal by Subject|0|||
163861825|NCT01090024|591860622|FG008|Period 2|Lost to Follow-up|0|||
163861826|NCT01090024|591860623|FG009|Period 2|Lost to Follow-up|0|||
164307300|NCT02839200|593499242|FG005|Overall Study|Withdrawal by Subject|1|||
163861827|NCT01090024|591860624|FG010|Period 2|Lost to Follow-up|0|||
163861828|NCT01090024|591860625|FG011|Period 2|Lost to Follow-up|0|||
163967174|NCT01514136|592252589|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
163967175|NCT01514136|592252582|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967176|NCT01514136|592252583|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967177|NCT01514136|592252584|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967178|NCT01514136|592252585|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
163967179|NCT01514136|592252586|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967180|NCT01514136|592252587|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967181|NCT01514136|592252588|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967182|NCT01514136|592252589|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
163967183|NCT01514136|592252582|FG000|Test Period 2; Test A*|Adverse Event|0|||
163967184|NCT01514136|592252583|FG001|Test Period 2; Test A*|Adverse Event|0|||
163967185|NCT01514136|592252584|FG002|Test Period 2; Test A*|Adverse Event|0|||
163967186|NCT01514136|592252585|FG003|Test Period 2; Test A*|Adverse Event|0|||
163967187|NCT01514136|592252586|FG004|Test Period 2; Test A*|Adverse Event|1|||
163967188|NCT01514136|592252587|FG005|Test Period 2; Test A*|Adverse Event|0|||
163967189|NCT01514136|592252588|FG006|Test Period 2; Test A*|Adverse Event|0|||
163967190|NCT01514136|592252589|FG007|Test Period 2; Test A*|Adverse Event|0|||
163967191|NCT01514136|592252582|FG000|Test Period 2; Test A*|Holiday|0|||
163967192|NCT01514136|592252583|FG001|Test Period 2; Test A*|Holiday|0|||
163967193|NCT01514136|592252584|FG002|Test Period 2; Test A*|Holiday|0|||
163967194|NCT01514136|592252585|FG003|Test Period 2; Test A*|Holiday|0|||
163967195|NCT01514136|592252586|FG004|Test Period 2; Test A*|Holiday|1|||
163967196|NCT01514136|592252587|FG005|Test Period 2; Test A*|Holiday|0|||
163967197|NCT01514136|592252588|FG006|Test Period 2; Test A*|Holiday|0|||
163967198|NCT01514136|592252589|FG007|Test Period 2; Test A*|Holiday|0|||
163967199|NCT01514136|592252582|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
163967200|NCT01514136|592252583|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
163967201|NCT01514136|592252584|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
164307301|NCT02839200|593499237|FG000|Overall Study|Lost to Follow-up|2|||
164307302|NCT02839200|593499238|FG001|Overall Study|Lost to Follow-up|0|||
163967202|NCT01514136|592252585|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
163967203|NCT01514136|592252586|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
163967204|NCT01514136|592252587|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
163967205|NCT01514136|592252588|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
163967206|NCT01514136|592252589|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
163967207|NCT01514136|592252582|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967208|NCT01514136|592252583|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967209|NCT01514136|592252584|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967210|NCT01514136|592252585|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967211|NCT01514136|592252586|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967212|NCT01514136|592252587|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967213|NCT01514136|592252588|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
163967214|NCT01514136|592252589|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
163967215|NCT01514136|592252582|FG000|Test Period 2; Test C*|holiday|0|||
163967216|NCT01514136|592252583|FG001|Test Period 2; Test C*|holiday|0|||
163967217|NCT01514136|592252584|FG002|Test Period 2; Test C*|holiday|0|||
163967218|NCT01514136|592252585|FG003|Test Period 2; Test C*|holiday|0|||
163967219|NCT01514136|592252586|FG004|Test Period 2; Test C*|holiday|0|||
163967220|NCT01514136|592252587|FG005|Test Period 2; Test C*|holiday|0|||
163967221|NCT01514136|592252588|FG006|Test Period 2; Test C*|holiday|1|||
163967222|NCT01514136|592252589|FG007|Test Period 2; Test C*|holiday|0|||
163967223|NCT01514136|592252582|FG000|Test Period 2; Test C*|Protocol Violation|0|||
163967224|NCT01514136|592252583|FG001|Test Period 2; Test C*|Protocol Violation|0|||
163967225|NCT01514136|592252584|FG002|Test Period 2; Test C*|Protocol Violation|0|||
163967226|NCT01514136|592252585|FG003|Test Period 2; Test C*|Protocol Violation|0|||
163967227|NCT01514136|592252586|FG004|Test Period 2; Test C*|Protocol Violation|0|||
163967228|NCT01514136|592252587|FG005|Test Period 2; Test C*|Protocol Violation|0|||
163967229|NCT01514136|592252588|FG006|Test Period 2; Test C*|Protocol Violation|1|||
163967230|NCT01514136|592252589|FG007|Test Period 2; Test C*|Protocol Violation|0|||
163967231|NCT02729740|592252590|FG000|Overall Study|Early Termination|130|||
163967232|NCT02729740|592252590|FG000|Overall Study|Other|1|||
163967233|NCT03044249|592252591|FG000|Overall Study|Adverse Event|4|||
163967234|NCT03044249|592252592|FG001|Overall Study|Adverse Event|9|||
163967235|NCT03044249|592252591|FG000|Overall Study|Lost to Follow-up|1|||
163967236|NCT03044249|592252592|FG001|Overall Study|Lost to Follow-up|0|||
163967237|NCT03044249|592252591|FG000|Overall Study|Non-compliance with Study Drug|1|||
163967238|NCT03044249|592252592|FG001|Overall Study|Non-compliance with Study Drug|0|||
163967239|NCT03044249|592252591|FG000|Overall Study|Study Terminated by Sponsor|2|||
163967240|NCT03044249|592252592|FG001|Overall Study|Study Terminated by Sponsor|0|||
163967241|NCT03044249|592252591|FG000|Overall Study|Withdrawal by Subject|2|||
163967242|NCT03044249|592252592|FG001|Overall Study|Withdrawal by Subject|5|||
163967243|NCT00955279|592252593|FG000|Overall Study|Other|0|||
163967244|NCT00955279|592252594|FG001|Overall Study|Other|0|||
163967245|NCT00955279|592252595|FG002|Overall Study|Other|3|||
163967246|NCT00955279|592252593|FG000|Overall Study|Death|1|||
163861829|NCT01090024|591860626|FG012|Period 2|Lost to Follow-up|0|||
163861830|NCT01090024|591860627|FG013|Period 2|Lost to Follow-up|0|||
163861831|NCT01090024|591860628|FG014|Period 2|Lost to Follow-up|0|||
163861832|NCT01090024|591860629|FG015|Period 2|Lost to Follow-up|0|||
163861833|NCT01090024|591860630|FG016|Period 2|Lost to Follow-up|0|||
163861834|NCT01090024|591860631|FG017|Period 2|Lost to Follow-up|0|||
163861835|NCT01090024|591860614|FG000|Period 2|Adverse Event|1|||
163861836|NCT01090024|591860615|FG001|Period 2|Adverse Event|0|||
163861837|NCT01090024|591860616|FG002|Period 2|Adverse Event|0|||
163861838|NCT01090024|591860617|FG003|Period 2|Adverse Event|0|||
163861839|NCT01090024|591860618|FG004|Period 2|Adverse Event|0|||
163861840|NCT01090024|591860619|FG005|Period 2|Adverse Event|0|||
163861841|NCT01090024|591860620|FG006|Period 2|Adverse Event|0|||
163861842|NCT01090024|591860621|FG007|Period 2|Adverse Event|0|||
163861843|NCT01090024|591860622|FG008|Period 2|Adverse Event|0|||
163861844|NCT01090024|591860623|FG009|Period 2|Adverse Event|0|||
163861845|NCT01090024|591860624|FG010|Period 2|Adverse Event|0|||
163861846|NCT01090024|591860625|FG011|Period 2|Adverse Event|0|||
163861847|NCT01090024|591860626|FG012|Period 2|Adverse Event|0|||
163861848|NCT01090024|591860627|FG013|Period 2|Adverse Event|0|||
163861849|NCT01090024|591860628|FG014|Period 2|Adverse Event|0|||
163861850|NCT01090024|591860629|FG015|Period 2|Adverse Event|0|||
163861851|NCT01090024|591860630|FG016|Period 2|Adverse Event|0|||
163861852|NCT01090024|591860631|FG017|Period 2|Adverse Event|0|||
163861853|NCT01090024|591860614|FG000|Period 3|Withdrawal by Subject|0|||
163861854|NCT01090024|591860615|FG001|Period 3|Withdrawal by Subject|0|||
163861855|NCT01090024|591860616|FG002|Period 3|Withdrawal by Subject|0|||
163861856|NCT01090024|591860617|FG003|Period 3|Withdrawal by Subject|0|||
163861857|NCT01090024|591860618|FG004|Period 3|Withdrawal by Subject|0|||
163861858|NCT01090024|591860619|FG005|Period 3|Withdrawal by Subject|0|||
163861859|NCT01090024|591860620|FG006|Period 3|Withdrawal by Subject|0|||
163861860|NCT01090024|591860621|FG007|Period 3|Withdrawal by Subject|0|||
163861861|NCT01090024|591860622|FG008|Period 3|Withdrawal by Subject|0|||
163861862|NCT01090024|591860623|FG009|Period 3|Withdrawal by Subject|0|||
163861863|NCT01090024|591860624|FG010|Period 3|Withdrawal by Subject|0|||
163861864|NCT01090024|591860625|FG011|Period 3|Withdrawal by Subject|0|||
163861865|NCT01090024|591860626|FG012|Period 3|Withdrawal by Subject|0|||
163861866|NCT01090024|591860627|FG013|Period 3|Withdrawal by Subject|0|||
163861867|NCT01090024|591860628|FG014|Period 3|Withdrawal by Subject|0|||
163861868|NCT01090024|591860629|FG015|Period 3|Withdrawal by Subject|1|||
163861869|NCT01090024|591860630|FG016|Period 3|Withdrawal by Subject|0|||
163861870|NCT01090024|591860631|FG017|Period 3|Withdrawal by Subject|0|||
163861871|NCT01090024|591860614|FG000|Period 3|Protocol Violation|0|||
163861872|NCT01090024|591860615|FG001|Period 3|Protocol Violation|0|||
163861873|NCT01090024|591860616|FG002|Period 3|Protocol Violation|0|||
163861874|NCT01090024|591860617|FG003|Period 3|Protocol Violation|0|||
163861875|NCT01090024|591860618|FG004|Period 3|Protocol Violation|0|||
163861876|NCT01090024|591860619|FG005|Period 3|Protocol Violation|0|||
163861877|NCT01090024|591860620|FG006|Period 3|Protocol Violation|0|||
163861878|NCT01090024|591860621|FG007|Period 3|Protocol Violation|0|||
163861879|NCT01090024|591860622|FG008|Period 3|Protocol Violation|1|||
163861880|NCT01090024|591860623|FG009|Period 3|Protocol Violation|0|||
163861881|NCT01090024|591860624|FG010|Period 3|Protocol Violation|0|||
163861882|NCT01090024|591860625|FG011|Period 3|Protocol Violation|0|||
163861883|NCT01090024|591860626|FG012|Period 3|Protocol Violation|0|||
163861884|NCT01090024|591860627|FG013|Period 3|Protocol Violation|0|||
163861885|NCT01090024|591860628|FG014|Period 3|Protocol Violation|0|||
163861886|NCT01090024|591860629|FG015|Period 3|Protocol Violation|0|||
163861887|NCT01090024|591860630|FG016|Period 3|Protocol Violation|0|||
163861888|NCT01090024|591860631|FG017|Period 3|Protocol Violation|0|||
163861889|NCT01090024|591860614|FG000|Period 3|Adverse Event|0|||
163861890|NCT01090024|591860615|FG001|Period 3|Adverse Event|0|||
163861891|NCT01090024|591860616|FG002|Period 3|Adverse Event|0|||
163861892|NCT01090024|591860617|FG003|Period 3|Adverse Event|0|||
163861893|NCT01090024|591860618|FG004|Period 3|Adverse Event|0|||
163861894|NCT01090024|591860619|FG005|Period 3|Adverse Event|1|||
163861895|NCT01090024|591860620|FG006|Period 3|Adverse Event|0|||
163861896|NCT01090024|591860621|FG007|Period 3|Adverse Event|0|||
163967247|NCT00955279|592252594|FG001|Overall Study|Death|1|||
163967248|NCT00955279|592252595|FG002|Overall Study|Death|1|||
163967249|NCT00955279|592252593|FG000|Overall Study|Lost to Follow-up|0|||
163861897|NCT01090024|591860622|FG008|Period 3|Adverse Event|0|||
163861898|NCT01090024|591860623|FG009|Period 3|Adverse Event|0|||
163861899|NCT01090024|591860624|FG010|Period 3|Adverse Event|0|||
163861900|NCT01090024|591860625|FG011|Period 3|Adverse Event|0|||
163861901|NCT01090024|591860626|FG012|Period 3|Adverse Event|0|||
163861902|NCT01090024|591860627|FG013|Period 3|Adverse Event|0|||
163861903|NCT01090024|591860628|FG014|Period 3|Adverse Event|0|||
163861904|NCT01090024|591860629|FG015|Period 3|Adverse Event|0|||
163861905|NCT01090024|591860630|FG016|Period 3|Adverse Event|0|||
163861906|NCT01090024|591860631|FG017|Period 3|Adverse Event|0|||
163861907|NCT00470626|591860633|FG000|Overall Study|Lost to Follow-up|10|||
163861908|NCT00470626|591860633|FG000|Overall Study|Withdrawal by Subject|7|||
163861909|NCT00777556|591860634|FG000|Overall Study|Inappropriate self-selection|34|||
163967250|NCT00955279|592252594|FG001|Overall Study|Lost to Follow-up|3|||
163967251|NCT00955279|592252595|FG002|Overall Study|Lost to Follow-up|1|||
163967252|NCT00955279|592252593|FG000|Overall Study|Withdrawal by Subject|2|||
163967253|NCT00955279|592252594|FG001|Overall Study|Withdrawal by Subject|0|||
163967254|NCT00955279|592252595|FG002|Overall Study|Withdrawal by Subject|3|||
163967255|NCT00999713|592252598|FG000|Overall Study|Physician Decision|2|||
163967256|NCT00999713|592252599|FG001|Overall Study|Physician Decision|0|||
163967257|NCT03346057|592252600|FG000|Overall Study|Death|1|||
163967258|NCT03346057|592252601|FG001|Overall Study|Death|2|||
163967259|NCT03346057|592252602|FG002|Overall Study|Death|0|||
163967260|NCT03346057|592252603|FG003|Overall Study|Death|0|||
163967261|NCT03346057|592252600|FG000|Overall Study|Lost to Follow-up|0|||
163967262|NCT03346057|592252601|FG001|Overall Study|Lost to Follow-up|2|||
163967263|NCT03346057|592252602|FG002|Overall Study|Lost to Follow-up|1|||
163967264|NCT03346057|592252603|FG003|Overall Study|Lost to Follow-up|0|||
163967265|NCT03346057|592252600|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
163967266|NCT03346057|592252601|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
163967267|NCT03346057|592252602|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
163967268|NCT03346057|592252603|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
163967269|NCT03346057|592252600|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
163967270|NCT03346057|592252601|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
163967271|NCT03346057|592252602|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
163967272|NCT03346057|592252603|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
163967273|NCT03346057|592252600|FG000|Overall Study|Physician Decision|3|||
163967274|NCT03346057|592252601|FG001|Overall Study|Physician Decision|2|||
163967275|NCT03346057|592252602|FG002|Overall Study|Physician Decision|0|||
163967276|NCT03346057|592252603|FG003|Overall Study|Physician Decision|2|||
163967277|NCT03346057|592252600|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
163967278|NCT03346057|592252601|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
163967279|NCT03346057|592252602|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
163967280|NCT03346057|592252603|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
163967281|NCT03346057|592252600|FG000|Overall Study|Withdrawal by Subject|1|||
163967282|NCT03346057|592252601|FG001|Overall Study|Withdrawal by Subject|0|||
163967283|NCT03346057|592252602|FG002|Overall Study|Withdrawal by Subject|0|||
163967284|NCT03346057|592252603|FG003|Overall Study|Withdrawal by Subject|0|||
163967285|NCT02921269|592252604|FG000|Overall Study|Did not complete DLT period|1|||
163967286|NCT00387764|592252615|FG000|Overall Study|Adverse Event|12|||
163967287|NCT00387764|592252615|FG000|Overall Study|Withdrawal by Subject|8|||
163967288|NCT00387764|592252615|FG000|Overall Study|Sponsor Terminated Study|1|||
163967289|NCT00387764|592252615|FG000|Overall Study|Physician Decision|1|||
164307303|NCT02839200|593499239|FG002|Overall Study|Lost to Follow-up|0|||
164307304|NCT02839200|593499240|FG003|Overall Study|Lost to Follow-up|0|||
164307305|NCT02839200|593499241|FG004|Overall Study|Lost to Follow-up|1|||
164307306|NCT02839200|593499242|FG005|Overall Study|Lost to Follow-up|0|||
164307307|NCT02839200|593499237|FG000|Overall Study|Adverse Event|0|||
164307308|NCT02839200|593499238|FG001|Overall Study|Adverse Event|0|||
164307309|NCT02839200|593499239|FG002|Overall Study|Adverse Event|0|||
164307310|NCT02839200|593499240|FG003|Overall Study|Adverse Event|0|||
164307311|NCT02839200|593499241|FG004|Overall Study|Adverse Event|1|||
164307312|NCT02839200|593499242|FG005|Overall Study|Adverse Event|0|||
163967290|NCT00387764|592252615|FG000|Overall Study|Other|2|||
163967291|NCT00387764|592252615|FG000|Overall Study|Death|7|||
164307313|NCT02839200|593499237|FG000|Overall Study|Randomized in error|0|||
164307314|NCT02839200|593499238|FG001|Overall Study|Randomized in error|1|||
164307315|NCT02839200|593499239|FG002|Overall Study|Randomized in error|0|||
164307316|NCT02839200|593499240|FG003|Overall Study|Randomized in error|0|||
164307317|NCT02839200|593499241|FG004|Overall Study|Randomized in error|0|||
164307318|NCT02839200|593499242|FG005|Overall Study|Randomized in error|0|||
164307319|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
164307320|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
164307321|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
164307322|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
164307323|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
164307324|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
164307325|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
164307326|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
164307327|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
164307328|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
164307329|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
164307330|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
164307331|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
164307332|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
164307333|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
163967292|NCT02301936|592252616|FG000|Overall Study|Lost to Follow-up|1|||
163967293|NCT02301936|592252617|FG001|Overall Study|Lost to Follow-up|0|||
163967294|NCT05975840|592252622|FG000|Overall Study|Other|1|||
163967295|NCT05975840|592252623|FG001|Overall Study|Other|0|||
163967296|NCT05975840|592252624|FG002|Overall Study|Other|0|||
163967297|NCT05975840|592252625|FG003|Overall Study|Other|0|||
163967298|NCT05975840|592252626|FG004|Overall Study|Other|1|||
163967299|NCT05975840|592252627|FG005|Overall Study|Other|0|||
163967300|NCT05975840|592252628|FG006|Overall Study|Other|0|||
163967301|NCT05975840|592252629|FG007|Overall Study|Other|0|||
163967302|NCT05975840|592252622|FG000|Overall Study|Lost to Follow-up|3|||
163967303|NCT05975840|592252623|FG001|Overall Study|Lost to Follow-up|6|||
163967304|NCT05975840|592252624|FG002|Overall Study|Lost to Follow-up|3|||
163967305|NCT05975840|592252625|FG003|Overall Study|Lost to Follow-up|1|||
164307334|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
164307335|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
164307336|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
164307337|NCT02952820|593499243|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
164307338|NCT02952820|593499244|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
164307339|NCT02952820|593499245|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
164307340|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
164307341|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
164307342|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
164307343|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
164307344|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
164307345|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
164307346|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
164307347|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
164307348|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
163967306|NCT05975840|592252626|FG004|Overall Study|Lost to Follow-up|4|||
163967307|NCT05975840|592252627|FG005|Overall Study|Lost to Follow-up|1|||
163967308|NCT05975840|592252628|FG006|Overall Study|Lost to Follow-up|2|||
163967309|NCT05975840|592252629|FG007|Overall Study|Lost to Follow-up|4|||
163967310|NCT05975840|592252622|FG000|Overall Study|Migrated/moved from the study area|1|||
163967311|NCT05975840|592252623|FG001|Overall Study|Migrated/moved from the study area|0|||
163967312|NCT05975840|592252624|FG002|Overall Study|Migrated/moved from the study area|0|||
163967313|NCT05975840|592252625|FG003|Overall Study|Migrated/moved from the study area|0|||
163967314|NCT05975840|592252626|FG004|Overall Study|Migrated/moved from the study area|0|||
163967315|NCT05975840|592252627|FG005|Overall Study|Migrated/moved from the study area|0|||
163967316|NCT05975840|592252628|FG006|Overall Study|Migrated/moved from the study area|0|||
163967317|NCT05975840|592252629|FG007|Overall Study|Migrated/moved from the study area|0|||
163967318|NCT05975840|592252622|FG000|Overall Study|Withdrawal by Subject|0|||
163967319|NCT05975840|592252623|FG001|Overall Study|Withdrawal by Subject|5|||
163967320|NCT05975840|592252624|FG002|Overall Study|Withdrawal by Subject|2|||
163967321|NCT05975840|592252625|FG003|Overall Study|Withdrawal by Subject|2|||
163967322|NCT05975840|592252626|FG004|Overall Study|Withdrawal by Subject|0|||
163967323|NCT05975840|592252627|FG005|Overall Study|Withdrawal by Subject|2|||
163967324|NCT05975840|592252628|FG006|Overall Study|Withdrawal by Subject|2|||
163967325|NCT05975840|592252629|FG007|Overall Study|Withdrawal by Subject|1|||
163967326|NCT05975840|592252622|FG000|Overall Study|Protocol Violation|0|||
163967327|NCT05975840|592252623|FG001|Overall Study|Protocol Violation|1|||
163967328|NCT05975840|592252624|FG002|Overall Study|Protocol Violation|0|||
163967329|NCT05975840|592252625|FG003|Overall Study|Protocol Violation|0|||
163967330|NCT05975840|592252626|FG004|Overall Study|Protocol Violation|0|||
163967331|NCT05975840|592252627|FG005|Overall Study|Protocol Violation|0|||
163967332|NCT05975840|592252628|FG006|Overall Study|Protocol Violation|0|||
163967333|NCT05975840|592252629|FG007|Overall Study|Protocol Violation|0|||
163967334|NCT05975840|592252622|FG000|Overall Study|Adverse Event|0|||
163967335|NCT05975840|592252623|FG001|Overall Study|Adverse Event|0|||
163967336|NCT05975840|592252624|FG002|Overall Study|Adverse Event|0|||
163967337|NCT05975840|592252625|FG003|Overall Study|Adverse Event|1|||
163967338|NCT05975840|592252626|FG004|Overall Study|Adverse Event|0|||
163967339|NCT05975840|592252627|FG005|Overall Study|Adverse Event|0|||
163967340|NCT05975840|592252628|FG006|Overall Study|Adverse Event|0|||
163967341|NCT05975840|592252629|FG007|Overall Study|Adverse Event|0|||
163967342|NCT05975840|592252622|FG000|Overall Study|Death|0|||
163967343|NCT05975840|592252623|FG001|Overall Study|Death|1|||
163967344|NCT05975840|592252624|FG002|Overall Study|Death|0|||
163967345|NCT05975840|592252625|FG003|Overall Study|Death|0|||
163967346|NCT05975840|592252626|FG004|Overall Study|Death|0|||
163967347|NCT05975840|592252627|FG005|Overall Study|Death|0|||
163967348|NCT05975840|592252628|FG006|Overall Study|Death|0|||
163967349|NCT05975840|592252629|FG007|Overall Study|Death|1|||
163967350|NCT00232141|592252632|FG000|Overall Study|Adverse Event|9|||
163967351|NCT00232141|592252633|FG001|Overall Study|Adverse Event|4|||
163967352|NCT00232141|592252632|FG000|Overall Study|Lack of Efficacy|0|||
163967353|NCT00232141|592252633|FG001|Overall Study|Lack of Efficacy|3|||
163967354|NCT00232141|592252632|FG000|Overall Study|Lost to Follow-up|9|||
163967355|NCT00232141|592252633|FG001|Overall Study|Lost to Follow-up|6|||
163861910|NCT00777556|591860634|FG000|Overall Study|Dispensed but did not use product|12|||
163861911|NCT00777556|591860634|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
163861912|NCT02380742|591860635|FG000|Overall Study|Withdrawal by Subject|1|||
163861913|NCT02380742|591860636|FG001|Overall Study|Withdrawal by Subject|0|||
163861914|NCT02689349|591860637|FG000|Overall Study|Not implanted|4|||
163861915|NCT02689349|591860638|FG001|Overall Study|Not implanted|0|||
163861916|NCT02689349|591860637|FG000|Overall Study|Withdrawal by Subject|9|||
163861917|NCT02689349|591860638|FG001|Overall Study|Withdrawal by Subject|0|||
163861918|NCT02930343|591860639|FG000|Overall Study|Lost to Follow-up|9|||
163861919|NCT02930343|591860640|FG001|Overall Study|Lost to Follow-up|7|||
163861920|NCT01185522|591860641|FG000|Overall Study|Lack of Efficacy|28|||
163861921|NCT01185522|591860641|FG000|Overall Study|Lost to Follow-up|19|||
163861922|NCT01185522|591860641|FG000|Overall Study|Withdrawal by Subject|10|||
163861923|NCT01185522|591860641|FG000|Overall Study|Poor tolerance|39|||
163861924|NCT01185522|591860641|FG000|Overall Study|Other reasons|12|||
163861925|NCT01729819|591860642|FG000|Overall Study|Adverse Event|2|||
163861926|NCT01729819|591860643|FG001|Overall Study|Adverse Event|4|||
163861927|NCT01729819|591860642|FG000|Overall Study|Lack of Efficacy|1|||
163861928|NCT01729819|591860643|FG001|Overall Study|Lack of Efficacy|0|||
163861929|NCT01729819|591860642|FG000|Overall Study|Lost to Follow-up|2|||
163861930|NCT01729819|591860643|FG001|Overall Study|Lost to Follow-up|0|||
163861931|NCT01729819|591860642|FG000|Overall Study|Other reason|1|||
163861932|NCT01729819|591860643|FG001|Overall Study|Other reason|0|||
163861933|NCT01729819|591860642|FG000|Overall Study|Protocol Violation|0|||
163861934|NCT01729819|591860643|FG001|Overall Study|Protocol Violation|1|||
163861935|NCT01729819|591860642|FG000|Overall Study|Withdrawal by Subject|0|||
163861936|NCT01729819|591860643|FG001|Overall Study|Withdrawal by Subject|2|||
163861937|NCT01025843|591860644|FG000|Washout 4|Withdrawal by Subject|0|||
163861938|NCT01025843|591860645|FG001|Washout 4|Withdrawal by Subject|0|||
163861939|NCT01025843|591860646|FG002|Washout 4|Withdrawal by Subject|1|||
163861940|NCT01025843|591860647|FG003|Washout 4|Withdrawal by Subject|1|||
163861941|NCT01025843|591860648|FG004|Washout 4|Withdrawal by Subject|0|||
163861942|NCT01025843|591860649|FG005|Washout 4|Withdrawal by Subject|0|||
163861943|NCT01025843|591860650|FG006|Washout 4|Withdrawal by Subject|0|||
163861944|NCT01025843|591860651|FG007|Washout 4|Withdrawal by Subject|0|||
163861945|NCT01025843|591860652|FG008|Washout 4|Withdrawal by Subject|0|||
163861946|NCT01025843|591860653|FG009|Washout 4|Withdrawal by Subject|0|||
163861947|NCT01281813|591860660|FG000|Overall Study|Adverse Event|0|||
163861948|NCT01281813|591860661|FG001|Overall Study|Adverse Event|0|||
163861949|NCT01281813|591860662|FG002|Overall Study|Adverse Event|10|||
163861950|NCT01281813|591860660|FG000|Overall Study|Lost to Follow-up|0|||
163861951|NCT01281813|591860661|FG001|Overall Study|Lost to Follow-up|0|||
163861952|NCT01281813|591860662|FG002|Overall Study|Lost to Follow-up|31|||
163861953|NCT01281813|591860660|FG000|Overall Study|Withdrawal by Subject|0|||
163861954|NCT01281813|591860661|FG001|Overall Study|Withdrawal by Subject|0|||
163861955|NCT01281813|591860662|FG002|Overall Study|Withdrawal by Subject|13|||
163861956|NCT01281813|591860660|FG000|Overall Study|Subject Non-Compliant|0|||
163861957|NCT01281813|591860661|FG001|Overall Study|Subject Non-Compliant|0|||
163861958|NCT01281813|591860662|FG002|Overall Study|Subject Non-Compliant|6|||
163861959|NCT01281813|591860660|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
163861960|NCT01281813|591860661|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
163861961|NCT01281813|591860662|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
163861962|NCT01281813|591860660|FG000|Overall Study|Sponsor's Decision|4|||
163861963|NCT01281813|591860661|FG001|Overall Study|Sponsor's Decision|3|||
163861964|NCT01281813|591860662|FG002|Overall Study|Sponsor's Decision|7|||
163861965|NCT01281813|591860660|FG000|Overall Study|Switched to Commercially Available Medication|0|||
163861966|NCT01281813|591860661|FG001|Overall Study|Switched to Commercially Available Medication|0|||
163967356|NCT00232141|592252632|FG000|Overall Study|Other|8|||
163967357|NCT00232141|592252633|FG001|Overall Study|Other|10|||
163967358|NCT00232141|592252632|FG000|Overall Study|Withdrawal by Subject|5|||
163967359|NCT00232141|592252633|FG001|Overall Study|Withdrawal by Subject|3|||
163861967|NCT01281813|591860662|FG002|Overall Study|Switched to Commercially Available Medication|26|||
163861968|NCT01281813|591860660|FG000|Overall Study|Other|0|||
163861969|NCT01281813|591860661|FG001|Overall Study|Other|1|||
163861970|NCT01281813|591860662|FG002|Overall Study|Other|39|||
163861971|NCT00558363|591860663|FG000|Overall Study|Physician Decision|18|||
163861972|NCT00558363|591860664|FG001|Overall Study|Physician Decision|4|||
163861973|NCT00558363|591860663|FG000|Overall Study|Withdrawal by Subject|11|||
163861974|NCT00558363|591860664|FG001|Overall Study|Withdrawal by Subject|4|||
163861975|NCT00558363|591860663|FG000|Overall Study|Adverse Event|5|||
163861976|NCT00558363|591860664|FG001|Overall Study|Adverse Event|5|||
163861977|NCT00558363|591860663|FG000|Overall Study|Lack of Efficacy|2|||
163861978|NCT00558363|591860664|FG001|Overall Study|Lack of Efficacy|2|||
163861979|NCT00558363|591860663|FG000|Overall Study|Protocol Violation|2|||
163861980|NCT00558363|591860664|FG001|Overall Study|Protocol Violation|1|||
163861981|NCT00558363|591860663|FG000|Overall Study|Lost to Follow-up|0|||
163861982|NCT00558363|591860664|FG001|Overall Study|Lost to Follow-up|1|||
163861983|NCT00558363|591860663|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
164307349|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
164307350|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
164307351|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
164307352|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
164307353|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
164307354|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
164307355|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
164307356|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
164307357|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
164307358|NCT02952820|593499243|FG000|Active Treatment Period (6 Months)|Not treated|0|||
164307359|NCT02952820|593499244|FG001|Active Treatment Period (6 Months)|Not treated|0|||
164307360|NCT02952820|593499245|FG002|Active Treatment Period (6 Months)|Not treated|1|||
164307361|NCT03857867|593499247|FG000|Overall Study|Physician Decision|1|||
164307362|NCT03070964|593499248|FG000|Overall Study|Progressive disease|8|||
164307363|NCT03070964|593499248|FG000|Overall Study|Treatment-unrelated adverse event|2|||
164307364|NCT03070964|593499248|FG000|Overall Study|Never treated|1|||
164307365|NCT03070964|593499248|FG000|Overall Study|Physician Decision|1|||
164307366|NCT03070964|593499248|FG000|Overall Study|Withdrawal by Subject|1|||
164307367|NCT03070964|593499248|FG000|Overall Study|Adverse Event|1|||
164307368|NCT01286480|593499249|FG000|Overall Study|Withdrawal by Subject|5|||
164307369|NCT01286480|593499250|FG001|Overall Study|Withdrawal by Subject|3|||
164307370|NCT00834093|593499251|FG000|Overall Study|Progressive Disease|3|||
164307371|NCT00834093|593499251|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
164307372|NCT00885534|593499252|FG000|Overall Study|Patient deemed ineligible|1|||
164307373|NCT02453711|593499253|FG000|Overall Study|Withdrawal by Subject|5|||
164307374|NCT02453711|593499254|FG001|Overall Study|Withdrawal by Subject|4|||
164307375|NCT02453711|593499255|FG002|Overall Study|Withdrawal by Subject|6|||
164307376|NCT02453711|593499256|FG003|Overall Study|Withdrawal by Subject|4|||
164307377|NCT02453711|593499257|FG004|Overall Study|Withdrawal by Subject|1|||
164307378|NCT02453711|593499258|FG005|Overall Study|Withdrawal by Subject|1|||
164307379|NCT02453711|593499259|FG006|Overall Study|Withdrawal by Subject|0|||
164307380|NCT02453711|593499260|FG007|Overall Study|Withdrawal by Subject|1|||
164307381|NCT02453711|593499261|FG008|Overall Study|Withdrawal by Subject|7|||
164307382|NCT02453711|593499253|FG000|Overall Study|Lost to Follow-up|5|||
164307383|NCT02453711|593499254|FG001|Overall Study|Lost to Follow-up|3|||
164307384|NCT02453711|593499255|FG002|Overall Study|Lost to Follow-up|2|||
164307385|NCT02453711|593499256|FG003|Overall Study|Lost to Follow-up|3|||
164307386|NCT02453711|593499257|FG004|Overall Study|Lost to Follow-up|1|||
164307387|NCT02453711|593499258|FG005|Overall Study|Lost to Follow-up|5|||
164307388|NCT02453711|593499259|FG006|Overall Study|Lost to Follow-up|2|||
164307389|NCT02453711|593499260|FG007|Overall Study|Lost to Follow-up|6|||
164307390|NCT02453711|593499261|FG008|Overall Study|Lost to Follow-up|6|||
164307391|NCT02453711|593499253|FG000|Overall Study|Death|0|||
164307392|NCT02453711|593499254|FG001|Overall Study|Death|0|||
164307393|NCT02453711|593499255|FG002|Overall Study|Death|0|||
164307394|NCT02453711|593499256|FG003|Overall Study|Death|0|||
164307395|NCT02453711|593499257|FG004|Overall Study|Death|0|||
164307396|NCT02453711|593499258|FG005|Overall Study|Death|0|||
164307397|NCT02453711|593499259|FG006|Overall Study|Death|1|||
164307398|NCT02453711|593499260|FG007|Overall Study|Death|0|||
164307399|NCT02453711|593499261|FG008|Overall Study|Death|0|||
164307400|NCT02453711|593499253|FG000|Overall Study|Unclassified|1|||
164307401|NCT02453711|593499254|FG001|Overall Study|Unclassified|0|||
164307402|NCT02453711|593499255|FG002|Overall Study|Unclassified|1|||
164307403|NCT02453711|593499256|FG003|Overall Study|Unclassified|0|||
164307404|NCT02453711|593499257|FG004|Overall Study|Unclassified|0|||
164307405|NCT02453711|593499258|FG005|Overall Study|Unclassified|0|||
164307406|NCT02453711|593499259|FG006|Overall Study|Unclassified|0|||
164307407|NCT02453711|593499260|FG007|Overall Study|Unclassified|0|||
164307408|NCT02453711|593499261|FG008|Overall Study|Unclassified|0|||
164307409|NCT01587924|593499262|FG000|Overall Study|Adverse Event|0|||
164307410|NCT01587924|593499263|FG001|Overall Study|Adverse Event|2|||
164307411|NCT01587924|593499264|FG002|Overall Study|Adverse Event|0|||
164307412|NCT01587924|593499265|FG003|Overall Study|Adverse Event|0|||
164307413|NCT01587924|593499262|FG000|Overall Study|Protocol Violation|2|||
164307414|NCT01587924|593499263|FG001|Overall Study|Protocol Violation|1|||
164307415|NCT01587924|593499264|FG002|Overall Study|Protocol Violation|2|||
164307416|NCT01587924|593499265|FG003|Overall Study|Protocol Violation|1|||
164307417|NCT01587924|593499262|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
164307418|NCT01587924|593499263|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
164307419|NCT01587924|593499264|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
163967360|NCT00601250|592252637|FG000|Overall Study|Adverse Event|3|||
163967361|NCT00601250|592252638|FG001|Overall Study|Adverse Event|9|||
164307420|NCT01587924|593499265|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
164307421|NCT01587924|593499262|FG000|Overall Study|Withdrawal by Subject|0|||
164307422|NCT01587924|593499263|FG001|Overall Study|Withdrawal by Subject|1|||
164307423|NCT01587924|593499264|FG002|Overall Study|Withdrawal by Subject|1|||
163861984|NCT00558363|591860664|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
163861985|NCT00558363|591860663|FG000|Overall Study|Randomized in Error|1|||
163861986|NCT00558363|591860664|FG001|Overall Study|Randomized in Error|2|||
163861987|NCT00558363|591860663|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
163861988|NCT00558363|591860664|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
163861989|NCT00868192|591860665|FG000|Overall Study|Ineligible|4|||
163861990|NCT02174562|591860666|FG000|Overall Study|Withdrawal by Subject|7|||
163861991|NCT02174562|591860667|FG001|Overall Study|Withdrawal by Subject|2|||
163861992|NCT02174562|591860666|FG000|Overall Study|Death|2|||
163861993|NCT02174562|591860667|FG001|Overall Study|Death|0|||
163861994|NCT02174562|591860666|FG000|Overall Study|Lost to Follow-up|0|||
163861995|NCT02174562|591860667|FG001|Overall Study|Lost to Follow-up|3|||
163861996|NCT00798096|591860669|FG000|Overall Study|Ongoing|2|||
163861997|NCT01178762|591860670|FG000|Overall Study|Lost to Follow-up|15|||
163861998|NCT01651949|591860674|FG000|Overall Study|Unknown status|4|||
163861999|NCT01651949|591860675|FG001|Overall Study|Unknown status|4|||
163862000|NCT01651949|591860676|FG002|Overall Study|Unknown status|0|||
163862001|NCT01651949|591860674|FG000|Overall Study|Lost to Follow-up|30|||
163862002|NCT01651949|591860675|FG001|Overall Study|Lost to Follow-up|56|||
163862003|NCT01651949|591860676|FG002|Overall Study|Lost to Follow-up|20|||
163862004|NCT01651949|591860674|FG000|Overall Study|Protocol Violation|0|||
163862005|NCT01651949|591860675|FG001|Overall Study|Protocol Violation|2|||
163862006|NCT01651949|591860676|FG002|Overall Study|Protocol Violation|1|||
163862007|NCT01651949|591860674|FG000|Overall Study|Physician Decision|0|||
163862008|NCT01651949|591860675|FG001|Overall Study|Physician Decision|2|||
163862009|NCT01651949|591860676|FG002|Overall Study|Physician Decision|0|||
163862010|NCT01651949|591860674|FG000|Overall Study|Adverse Event|0|||
163862011|NCT01651949|591860675|FG001|Overall Study|Adverse Event|2|||
163862012|NCT01651949|591860676|FG002|Overall Study|Adverse Event|1|||
163862013|NCT01651949|591860674|FG000|Overall Study|Screen failure|2|||
163862014|NCT01651949|591860675|FG001|Overall Study|Screen failure|2|||
163862015|NCT01651949|591860676|FG002|Overall Study|Screen failure|0|||
163862016|NCT01651949|591860674|FG000|Overall Study|Withdrawal by Subject|17|||
163862017|NCT01651949|591860675|FG001|Overall Study|Withdrawal by Subject|18|||
163862018|NCT01651949|591860676|FG002|Overall Study|Withdrawal by Subject|9|||
163862019|NCT02155829|591860679|FG000|Overall Study|Adverse Event|1|||
163862020|NCT02155829|591860680|FG001|Overall Study|Adverse Event|0|||
163862021|NCT02155829|591860679|FG000|Overall Study|Withdrawal by Subject|3|||
163862022|NCT02155829|591860680|FG001|Overall Study|Withdrawal by Subject|3|||
163862023|NCT02155829|591860679|FG000|Overall Study|Protocol Violation|2|||
163862024|NCT02155829|591860680|FG001|Overall Study|Protocol Violation|0|||
163862025|NCT00678795|591860681|FG000|Overall Study|Adverse Event|7|||
163862026|NCT00678795|591860682|FG001|Overall Study|Adverse Event|3|||
163862027|NCT00678795|591860681|FG000|Overall Study|Withdrawal by Subject|3|||
163862028|NCT00678795|591860682|FG001|Overall Study|Withdrawal by Subject|0|||
163862029|NCT00678795|591860681|FG000|Overall Study|Protocol Violation|0|||
163862030|NCT00678795|591860682|FG001|Overall Study|Protocol Violation|1|||
164198831|NCT04037358|593097757|FG000|Overall Study|Patient withdrew before intervention|1|||
164198832|NCT04037358|593097758|FG001|Overall Study|Patient withdrew before intervention|0|||
164198833|NCT01949142|593097761|FG000|Overall Study|Withdrawal of consent|1|||
164198834|NCT01949142|593097762|FG001|Overall Study|Withdrawal of consent|0|||
164198835|NCT01949142|593097761|FG000|Overall Study|Lost to Follow-up|1|||
164198836|NCT01949142|593097762|FG001|Overall Study|Lost to Follow-up|1|||
164198837|NCT01949142|593097761|FG000|Overall Study|Parent changed their mind|1|||
164198838|NCT01949142|593097762|FG001|Overall Study|Parent changed their mind|0|||
164198839|NCT05027815|593097763|FG000|Overall Study|Death|2|||
164198840|NCT05027815|593097764|FG001|Overall Study|Death|1|||
164198841|NCT04802161|593097766|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
164198842|NCT04802161|593097767|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
164198843|NCT04802161|593097768|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
164198844|NCT04802161|593097769|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
164198845|NCT04802161|593097766|FG000|Overall Study|Clinical Instability|0|||
164198846|NCT04802161|593097767|FG001|Overall Study|Clinical Instability|0|||
164198847|NCT04802161|593097768|FG002|Overall Study|Clinical Instability|1|||
163862031|NCT00678795|591860681|FG000|Overall Study|Lost to Follow-up|0|||
163862032|NCT00678795|591860682|FG001|Overall Study|Lost to Follow-up|1|||
163862033|NCT00678795|591860681|FG000|Overall Study|Lack of Efficacy|1|||
163862034|NCT00678795|591860682|FG001|Overall Study|Lack of Efficacy|1|||
163862035|NCT01585038|591860683|FG000|Overall Study|Adverse Event|2|||
163862036|NCT01585038|591860684|FG001|Overall Study|Adverse Event|2|||
163862037|NCT02750709|591860685|FG000|Treatment Period 1|Adverse Event|0|||
163862038|NCT02750709|591860686|FG001|Treatment Period 1|Adverse Event|0|||
163862039|NCT02750709|591860687|FG002|Treatment Period 1|Adverse Event|0|||
163862040|NCT02750709|591860688|FG003|Treatment Period 1|Adverse Event|0|||
163862041|NCT02750709|591860689|FG004|Treatment Period 1|Adverse Event|0|||
163862042|NCT02750709|591860690|FG005|Treatment Period 1|Adverse Event|1|||
164198848|NCT04802161|593097769|FG003|Overall Study|Clinical Instability|0|||
164198849|NCT04802161|593097766|FG000|Overall Study|Adverse Event|0|||
163862043|NCT00771849|591860692|FG000|Overall Study|Lost to Follow-up|1|||
164307424|NCT01587924|593499265|FG003|Overall Study|Withdrawal by Subject|0|||
163967362|NCT00601250|592252637|FG000|Overall Study|Protocol Violation|3|||
163967363|NCT00601250|592252638|FG001|Overall Study|Protocol Violation|2|||
163967364|NCT00601250|592252637|FG000|Overall Study|Lost to Follow-up|2|||
163967365|NCT00601250|592252638|FG001|Overall Study|Lost to Follow-up|6|||
163967366|NCT00601250|592252637|FG000|Overall Study|Withdrawal by Subject|4|||
163967367|NCT00601250|592252638|FG001|Overall Study|Withdrawal by Subject|13|||
163967368|NCT00601250|592252637|FG000|Overall Study|Other incl. lack of efficacy|2|||
163967369|NCT00601250|592252638|FG001|Overall Study|Other incl. lack of efficacy|9|||
163967370|NCT01810016|592252639|FG000|Overall Study|Progressive disease|1|||
163967371|NCT01810016|592252640|FG001|Overall Study|Progressive disease|1|||
163967372|NCT01810016|592252641|FG002|Overall Study|Progressive disease|0|||
163967373|NCT01810016|592252639|FG000|Overall Study|Death|0|||
163967374|NCT01810016|592252640|FG001|Overall Study|Death|0|||
163967375|NCT01810016|592252641|FG002|Overall Study|Death|1|||
163967376|NCT04263896|592252644|FG000|Overall Study|Withdrawal by Subject|2|||
163967377|NCT04263896|592252645|FG001|Overall Study|Withdrawal by Subject|4|||
164307425|NCT01578486|593499266|FG000|Overall Study|Physician Decision|3|||
164307426|NCT01578486|593499266|FG000|Overall Study|Withdrawal by Subject|2|||
164307427|NCT03181529|593499267|FG000|Overall Study|Withdrawal by Subject|1|||
164307428|NCT03181529|593499268|FG001|Overall Study|Withdrawal by Subject|1|||
164307429|NCT03181529|593499267|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
164307430|NCT03181529|593499268|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
164307431|NCT00607373|593499269|FG000|Treatment Period|Adverse Event|0|||
164307432|NCT00607373|593499270|FG001|Treatment Period|Adverse Event|4|||
164307433|NCT00607373|593499269|FG000|Treatment Period|Physician Decision|0|||
164307434|NCT00607373|593499270|FG001|Treatment Period|Physician Decision|1|||
164307435|NCT00607373|593499269|FG000|Treatment Period|Withdrawal by Subject|0|||
164307436|NCT00607373|593499270|FG001|Treatment Period|Withdrawal by Subject|1|||
164307437|NCT00607373|593499269|FG000|Follow-up Period|Other|0|||
164307438|NCT00607373|593499270|FG001|Follow-up Period|Other|1|||
164307439|NCT00607373|593499269|FG000|Follow-up Period|Protocol Violation|0|||
164307440|NCT00607373|593499270|FG001|Follow-up Period|Protocol Violation|1|||
164307441|NCT00607373|593499269|FG000|Follow-up Period|Withdrawal by Subject|1|||
164307442|NCT00607373|593499270|FG001|Follow-up Period|Withdrawal by Subject|3|||
164307443|NCT01918306|593499271|FG000|Overall Study|progresive disease|4|||
164307444|NCT01918306|593499272|FG001|Overall Study|progresive disease|0|||
164307445|NCT01918306|593499273|FG002|Overall Study|progresive disease|1|||
164307446|NCT01918306|593499274|FG003|Overall Study|progresive disease|1|||
164307447|NCT01918306|593499271|FG000|Overall Study|Withdrawal by Subject|0|||
163967378|NCT04263896|592252644|FG000|Overall Study|converted to open procedure|0|||
163967379|NCT04263896|592252645|FG001|Overall Study|converted to open procedure|1|||
163967380|NCT04263896|592252644|FG000|Overall Study|Lost to Follow-up|9|||
163967381|NCT04263896|592252645|FG001|Overall Study|Lost to Follow-up|11|||
163967382|NCT04263896|592252644|FG000|Overall Study|surveys lost in mail|5|||
163967383|NCT04263896|592252645|FG001|Overall Study|surveys lost in mail|3|||
163967384|NCT04263896|592252644|FG000|Overall Study|excluded from analysis|1|||
163967385|NCT04263896|592252645|FG001|Overall Study|excluded from analysis|0|||
163967386|NCT06950879|592252646|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
163967387|NCT00525044|592254109|FG000|Overall Study|Lost to Follow-up|0|||
163967388|NCT00525044|592254110|FG001|Overall Study|Lost to Follow-up|1|||
163967389|NCT02553265|592254111|FG000|Enrollment|Death|0|||
163967390|NCT02553265|592254112|FG001|Enrollment|Death|0|||
163967391|NCT02553265|592254113|FG002|Enrollment|Death|1|||
163967392|NCT02553265|592254111|FG000|First Intervention (28 Days)|Adverse Event|1|||
163967393|NCT02553265|592254112|FG001|First Intervention (28 Days)|Adverse Event|0|||
163967394|NCT02553265|592254113|FG002|First Intervention (28 Days)|Adverse Event|0|||
163967395|NCT02553265|592254111|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
163967396|NCT02553265|592254112|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
163967397|NCT02553265|592254113|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
163967398|NCT02553265|592254111|FG000|Second Intervention (28 Days)|Adverse Event|1|||
163967399|NCT02553265|592254112|FG001|Second Intervention (28 Days)|Adverse Event|0|||
163967400|NCT02553265|592254113|FG002|Second Intervention (28 Days)|Adverse Event|0|||
163967401|NCT02553265|592254111|FG000|Third Intervention (28 Days)|Adverse Event|1|||
163967402|NCT02553265|592254112|FG001|Third Intervention (28 Days)|Adverse Event|0|||
163967403|NCT02553265|592254113|FG002|Third Intervention (28 Days)|Adverse Event|0|||
163967404|NCT02553265|592254111|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
163967405|NCT02553265|592254112|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
163967406|NCT02553265|592254113|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
163967407|NCT00659529|592254118|FG000|Overall Study|Withdrawal by Subject|4|||
163967408|NCT00659529|592254118|FG000|Overall Study|Protocol Violation|3|||
163967409|NCT00659529|592254118|FG000|Overall Study|Screen failure|9|||
163967410|NCT01086410|592254119|FG000|Overall Study|Adverse Event|1|||
163967411|NCT01086410|592254120|FG001|Overall Study|Adverse Event|0|||
163967412|NCT01086410|592254121|FG002|Overall Study|Adverse Event|0|||
163967413|NCT01086410|592254122|FG003|Overall Study|Adverse Event|2|||
163967414|NCT01086410|592254119|FG000|Overall Study|Lack of Efficacy|1|||
163967415|NCT01086410|592254120|FG001|Overall Study|Lack of Efficacy|1|||
163967416|NCT01086410|592254121|FG002|Overall Study|Lack of Efficacy|0|||
163967417|NCT01086410|592254122|FG003|Overall Study|Lack of Efficacy|0|||
163967418|NCT01086410|592254119|FG000|Overall Study|Protocol Violation|1|||
163967419|NCT01086410|592254120|FG001|Overall Study|Protocol Violation|1|||
163967420|NCT01086410|592254121|FG002|Overall Study|Protocol Violation|0|||
163967421|NCT01086410|592254122|FG003|Overall Study|Protocol Violation|0|||
163967422|NCT01086410|592254119|FG000|Overall Study|Lost to Follow-up|0|||
163967423|NCT01086410|592254120|FG001|Overall Study|Lost to Follow-up|0|||
163967424|NCT01086410|592254121|FG002|Overall Study|Lost to Follow-up|1|||
163967425|NCT01086410|592254122|FG003|Overall Study|Lost to Follow-up|0|||
163967426|NCT01022996|592254123|FG000|Overall Study|Adverse Event|14|||
163967427|NCT01022996|592254123|FG000|Overall Study|Withdrawal by Subject|3|||
163967428|NCT01022996|592254123|FG000|Overall Study|Lost to Follow-up|1|||
163967429|NCT01022996|592254123|FG000|Overall Study|Administrative problems|6|||
163967430|NCT01022996|592254123|FG000|Overall Study|Disease Progression|32|||
163967431|NCT01022996|592254123|FG000|Overall Study|Protocol Violation|1|||
163967432|NCT02767323|592254124|FG000|Overall Study|Withdrawal by Subject|17|||
163967433|NCT02767323|592254125|FG001|Overall Study|Withdrawal by Subject|5|||
163967434|NCT02767323|592254126|FG002|Overall Study|Withdrawal by Subject|13|||
163967435|NCT02767323|592254127|FG003|Overall Study|Withdrawal by Subject|0|||
163967436|NCT02767323|592254124|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
163967437|NCT02767323|592254125|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
163967438|NCT02767323|592254126|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
163967439|NCT02767323|592254127|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
163967440|NCT00930722|592254128|FG000|Overall Study|Lost to Follow-up|16|||
163967441|NCT00930722|592254128|FG000|Overall Study|No longer willing to participate|9|||
163967442|NCT00930722|592254128|FG000|Overall Study|Study terminated by sponsor|2|||
163967443|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Adverse Event|2|||
163967444|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Adverse Event|2|||
163967445|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Adverse Event|4|||
164307448|NCT01918306|593499272|FG001|Overall Study|Withdrawal by Subject|0|||
164307449|NCT01918306|593499273|FG002|Overall Study|Withdrawal by Subject|0|||
164307450|NCT01918306|593499274|FG003|Overall Study|Withdrawal by Subject|2|||
164307451|NCT01918306|593499271|FG000|Overall Study|neutropenia|1|||
164307452|NCT01918306|593499272|FG001|Overall Study|neutropenia|0|||
164307453|NCT01918306|593499273|FG002|Overall Study|neutropenia|0|||
164307454|NCT01918306|593499274|FG003|Overall Study|neutropenia|0|||
164307455|NCT01918306|593499271|FG000|Overall Study|Lack of Efficacy|1|||
164307456|NCT01918306|593499272|FG001|Overall Study|Lack of Efficacy|0|||
164307457|NCT01918306|593499273|FG002|Overall Study|Lack of Efficacy|0|||
164307458|NCT01918306|593499274|FG003|Overall Study|Lack of Efficacy|0|||
164307459|NCT01918306|593499271|FG000|Overall Study|progress disease, crossover|0|||
164307460|NCT01918306|593499272|FG001|Overall Study|progress disease, crossover|0|||
164307461|NCT01918306|593499273|FG002|Overall Study|progress disease, crossover|1|||
164307462|NCT01918306|593499274|FG003|Overall Study|progress disease, crossover|0|||
163967446|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Adverse Event|0|||
163967447|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Adverse Event|0|||
163967448|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Progressive disease|0|||
163967449|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Progressive disease|0|||
163967450|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Progressive disease|1|||
163967451|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Progressive disease|0|||
163967452|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Progressive disease|0|||
163967453|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
163967454|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
163967455|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
163967456|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
163967457|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
163967458|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
163967459|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163967460|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163967461|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163967462|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
163967463|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
163967464|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
163967465|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
163967466|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
164307463|NCT00314795|593499282|FG000|Overall Study|Adverse Event|8|||
163967467|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
163967468|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
163967469|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
163967470|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
164307464|NCT00314795|593499282|FG000|Overall Study|Death|4|||
164307465|NCT00314795|593499282|FG000|Overall Study|Reason not Specified|3|||
163967471|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
163967472|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
163967473|NCT03523728|592254129|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
163967474|NCT03523728|592254130|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
163967475|NCT03523728|592254131|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
163967476|NCT03523728|592254132|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
163967477|NCT03523728|592254133|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
163967478|NCT03523728|592254129|FG000|Stage 2 (24 Months)|Adverse Event|0|||
163967479|NCT03523728|592254130|FG001|Stage 2 (24 Months)|Adverse Event|0|||
163967480|NCT03523728|592254131|FG002|Stage 2 (24 Months)|Adverse Event|0|||
163967481|NCT03523728|592254132|FG003|Stage 2 (24 Months)|Adverse Event|1|||
163967482|NCT03523728|592254133|FG004|Stage 2 (24 Months)|Adverse Event|2|||
163967483|NCT03523728|592254129|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163967484|NCT03523728|592254130|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163967485|NCT03523728|592254131|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163967486|NCT03523728|592254132|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
163967487|NCT03523728|592254133|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
163967488|NCT03523728|592254129|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
163967489|NCT03523728|592254130|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
163967490|NCT03523728|592254131|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
163967491|NCT03523728|592254132|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
163967492|NCT03523728|592254133|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
163967493|NCT03523728|592254129|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
163967494|NCT03523728|592254130|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
163967495|NCT03523728|592254131|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
163967496|NCT03523728|592254132|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
163967497|NCT03523728|592254133|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
163967498|NCT03523728|592254129|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
163967499|NCT03523728|592254130|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
163967500|NCT03523728|592254131|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
163967501|NCT03523728|592254132|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
163967502|NCT03523728|592254133|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
163967503|NCT00621751|592254134|FG000|Overall Study|Adverse Event|0|||
163967504|NCT00621751|592254135|FG001|Overall Study|Adverse Event|1|||
163967505|NCT02023242|592254136|FG000|Overall Study|Lost to Follow-up|3|||
163862044|NCT00771849|591860693|FG001|Overall Study|Lost to Follow-up|2|||
163862045|NCT00771849|591860692|FG000|Overall Study|Withdrawal by Subject|1|||
163862046|NCT00771849|591860693|FG001|Overall Study|Withdrawal by Subject|1|||
163862047|NCT00771849|591860692|FG000|Overall Study|Not vaccinated|0|||
163862048|NCT00771849|591860693|FG001|Overall Study|Not vaccinated|1|||
163862049|NCT00290732|591860694|FG000|Overall Study|Inability to instill drug intraductally.|0|||
163862050|NCT00290732|591860695|FG001|Overall Study|Inability to instill drug intraductally.|1|||
163862051|NCT00290732|591860696|FG002|Overall Study|Inability to instill drug intraductally.|1|||
163862052|NCT00290732|591860697|FG003|Overall Study|Inability to instill drug intraductally.|0|||
163862053|NCT00290732|591860698|FG004|Overall Study|Inability to instill drug intraductally.|0|||
163862054|NCT02736799|591860702|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
163862055|NCT02736799|591860703|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
163862056|NCT02736799|591860704|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
163862057|NCT02736799|591860705|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
163862058|NCT00843193|591860706|FG000|Overall Study|Adverse Event|2|||
163862059|NCT00843193|591860707|FG001|Overall Study|Adverse Event|4|||
163862060|NCT00843193|591860706|FG000|Overall Study|Lack of Efficacy|1|||
163862061|NCT00843193|591860707|FG001|Overall Study|Lack of Efficacy|1|||
163862062|NCT00843193|591860706|FG000|Overall Study|Protocol Violation|1|||
163862063|NCT00843193|591860707|FG001|Overall Study|Protocol Violation|2|||
163862064|NCT00843193|591860706|FG000|Overall Study|Lost to Follow-up|1|||
163862065|NCT00843193|591860707|FG001|Overall Study|Lost to Follow-up|0|||
163862066|NCT00843193|591860706|FG000|Overall Study|Physician Decision|0|||
163862067|NCT00843193|591860707|FG001|Overall Study|Physician Decision|1|||
163862068|NCT00843193|591860706|FG000|Overall Study|Withdrawal by Subject|3|||
163862069|NCT00843193|591860707|FG001|Overall Study|Withdrawal by Subject|3|||
163862070|NCT00197015|591860708|FG000|Overall Study|Adverse Event|3|||
163862071|NCT00197015|591860709|FG001|Overall Study|Adverse Event|0|||
163862072|NCT00197015|591860710|FG002|Overall Study|Adverse Event|1|||
163862073|NCT00197015|591860708|FG000|Overall Study|Protocol Violation|0|||
163967506|NCT02023242|592254137|FG001|Overall Study|Lost to Follow-up|1|||
163862074|NCT00197015|591860709|FG001|Overall Study|Protocol Violation|3|||
163862075|NCT00197015|591860710|FG002|Overall Study|Protocol Violation|3|||
163862076|NCT00197015|591860708|FG000|Overall Study|Withdrawal by Subject|17|||
163862077|NCT00197015|591860709|FG001|Overall Study|Withdrawal by Subject|37|||
163967507|NCT02023242|592254136|FG000|Overall Study|Death|0|||
163967508|NCT02023242|592254137|FG001|Overall Study|Death|1|||
163967509|NCT03383289|592254148|FG000|Overall Study|Death|83|||
163967510|NCT03383289|592254149|FG001|Overall Study|Death|78|||
163967511|NCT03383289|592254148|FG000|Overall Study|discharge from facility|84|||
164198850|NCT04802161|593097767|FG001|Overall Study|Adverse Event|0|||
164198851|NCT04802161|593097768|FG002|Overall Study|Adverse Event|1|||
164198852|NCT04802161|593097769|FG003|Overall Study|Adverse Event|0|||
164198853|NCT04802161|593097766|FG000|Overall Study|Death|0|||
164198854|NCT04802161|593097767|FG001|Overall Study|Death|0|||
164198855|NCT04802161|593097768|FG002|Overall Study|Death|1|||
164198856|NCT04802161|593097769|FG003|Overall Study|Death|0|||
164198857|NCT00447902|593097775|FG000|Overall Study|Adverse Event|0|||
164198858|NCT00447902|593097776|FG001|Overall Study|Adverse Event|3|||
164198859|NCT00447902|593097775|FG000|Overall Study|Protocol Violation|1|||
164198860|NCT00447902|593097776|FG001|Overall Study|Protocol Violation|0|||
164198861|NCT00447902|593097775|FG000|Overall Study|Withdrawal by Subject|0|||
164198862|NCT00447902|593097776|FG001|Overall Study|Withdrawal by Subject|1|||
164198863|NCT00447902|593097775|FG000|Overall Study|included patients who discontinued|1|||
164198864|NCT00447902|593097776|FG001|Overall Study|included patients who discontinued|1|||
164198865|NCT00447902|593097775|FG000|Overall Study|Lack of Efficacy|2|||
164198866|NCT00447902|593097776|FG001|Overall Study|Lack of Efficacy|1|||
164198867|NCT02873689|593099583|FG000|Overall Study|Lack of Efficacy|1|||
164198868|NCT02873689|593099584|FG001|Overall Study|Lack of Efficacy|0|||
164198869|NCT02873689|593099583|FG000|Overall Study|Withdrawal by Subject|2|||
164198870|NCT02873689|593099584|FG001|Overall Study|Withdrawal by Subject|2|||
164198871|NCT02873689|593099583|FG000|Overall Study|Protocol Violation|1|||
164198872|NCT02873689|593099584|FG001|Overall Study|Protocol Violation|0|||
164198873|NCT02873689|593099583|FG000|Overall Study|Adverse Event|2|||
164198874|NCT02873689|593099584|FG001|Overall Study|Adverse Event|2|||
164198875|NCT02873689|593099583|FG000|Overall Study|Randomized but not Treated|1|||
164198876|NCT02873689|593099584|FG001|Overall Study|Randomized but not Treated|1|||
164198877|NCT00350545|593099585|FG000|Overall Study|Withdrawal by Subject|2|||
164198878|NCT00434252|593099589|FG000|Overall Study|Lack of Efficacy|50|||
164198879|NCT00434252|593099590|FG001|Overall Study|Lack of Efficacy|100|||
164198880|NCT00434252|593099589|FG000|Overall Study|Adverse Event|6|||
164198881|NCT00434252|593099590|FG001|Overall Study|Adverse Event|13|||
164198882|NCT00434252|593099589|FG000|Overall Study|Death|1|||
164198883|NCT00434252|593099590|FG001|Overall Study|Death|2|||
164198884|NCT00434252|593099589|FG000|Overall Study|Lost to Follow-up|0|||
164198885|NCT00434252|593099590|FG001|Overall Study|Lost to Follow-up|1|||
164198886|NCT00434252|593099589|FG000|Overall Study|Physician Decision|4|||
164198887|NCT00434252|593099590|FG001|Overall Study|Physician Decision|8|||
164198888|NCT00434252|593099589|FG000|Overall Study|Withdrawal by Subject|3|||
164198889|NCT00434252|593099590|FG001|Overall Study|Withdrawal by Subject|7|||
164198890|NCT00352118|593099593|FG000|Overall Study|Physician Decision|4|||
164198891|NCT02997163|593099594|FG000|Overall Study|Adverse Event|1|||
164198892|NCT02997163|593099595|FG001|Overall Study|Adverse Event|0|||
164198893|NCT02997163|593099596|FG002|Overall Study|Adverse Event|0|||
164198894|NCT02997163|593099597|FG003|Overall Study|Adverse Event|1|||
164198895|NCT02337764|593099598|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
164198896|NCT02337764|593099598|FG000|Overall Study|Voluntary Withdrawal|12|||
164198897|NCT02337764|593099598|FG000|Overall Study|Lack of Efficacy|2|||
164198898|NCT02990000|593099599|FG000|Overall Study|Failed to provide data beyond baseline|36|||
164198899|NCT02990000|593099600|FG001|Overall Study|Failed to provide data beyond baseline|34|||
164198900|NCT02810418|593099614|FG000|Arm A Dose Escalation|Adverse Event|2|||
164198901|NCT02810418|593099615|FG001|Arm A Dose Escalation|Adverse Event|1|||
164198902|NCT02810418|593099616|FG002|Arm A Dose Escalation|Adverse Event|0|||
164198903|NCT02810418|593099617|FG003|Arm A Dose Escalation|Adverse Event|0|||
164198904|NCT02810418|593099618|FG004|Arm A Dose Escalation|Adverse Event|0|||
164198905|NCT02810418|593099619|FG005|Arm A Dose Escalation|Adverse Event|0|||
164198906|NCT02810418|593099620|FG006|Arm A Dose Escalation|Adverse Event|0|||
164198907|NCT02810418|593099614|FG000|Dose Expansion|Adverse Event|0|||
164198908|NCT02810418|593099615|FG001|Dose Expansion|Adverse Event|1|||
164198909|NCT02810418|593099616|FG002|Dose Expansion|Adverse Event|1|||
164198910|NCT02810418|593099617|FG003|Dose Expansion|Adverse Event|0|||
164198911|NCT02810418|593099618|FG004|Dose Expansion|Adverse Event|0|||
164198912|NCT02810418|593099619|FG005|Dose Expansion|Adverse Event|0|||
164198913|NCT02810418|593099620|FG006|Dose Expansion|Adverse Event|0|||
164198914|NCT02810418|593099614|FG000|Dose Expansion|Physician Decision|0|||
164198915|NCT02810418|593099615|FG001|Dose Expansion|Physician Decision|0|||
164198916|NCT02810418|593099616|FG002|Dose Expansion|Physician Decision|2|||
164198917|NCT02810418|593099617|FG003|Dose Expansion|Physician Decision|0|||
164198918|NCT02810418|593099618|FG004|Dose Expansion|Physician Decision|0|||
164198919|NCT02810418|593099619|FG005|Dose Expansion|Physician Decision|0|||
164198920|NCT02810418|593099620|FG006|Dose Expansion|Physician Decision|0|||
164198921|NCT02810418|593099614|FG000|Arm B Dose Escalation|Adverse Event|0|||
164198922|NCT02810418|593099615|FG001|Arm B Dose Escalation|Adverse Event|0|||
164198923|NCT02810418|593099616|FG002|Arm B Dose Escalation|Adverse Event|0|||
164198924|NCT02810418|593099617|FG003|Arm B Dose Escalation|Adverse Event|0|||
164198925|NCT02810418|593099618|FG004|Arm B Dose Escalation|Adverse Event|1|||
164198926|NCT02810418|593099619|FG005|Arm B Dose Escalation|Adverse Event|2|||
164198927|NCT02810418|593099620|FG006|Arm B Dose Escalation|Adverse Event|0|||
164198928|NCT03103503|593099621|FG000|Overall Study|Death|64|||
164198929|NCT03103503|593099621|FG000|Overall Study|Physician Decision|57|||
164198930|NCT03103503|593099621|FG000|Overall Study|Withdrawal by Subject|10|||
164198931|NCT03103503|593099621|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
164198932|NCT03103503|593099621|FG000|Overall Study|Lost to Follow-up|3|||
164198933|NCT03103503|593099621|FG000|Overall Study|Study Closure|757|||
164198934|NCT01433159|593099624|FG000|Overall Study|Adverse Event|1|||
164198935|NCT01433159|593099625|FG001|Overall Study|Adverse Event|0|||
164198936|NCT01433159|593099624|FG000|Overall Study|Physician Decision|1|||
164198937|NCT01433159|593099625|FG001|Overall Study|Physician Decision|0|||
164198938|NCT01433159|593099624|FG000|Overall Study|Protocol Violation|0|||
164198939|NCT01433159|593099625|FG001|Overall Study|Protocol Violation|1|||
164198940|NCT01100853|593099626|FG000|Overall Study|Lost to Follow-up|11|||
164198941|NCT01100853|593099627|FG001|Overall Study|Lost to Follow-up|6|||
164198942|NCT01100853|593099626|FG000|Overall Study|Received <4 study injections|10|||
164198943|NCT01100853|593099627|FG001|Overall Study|Received <4 study injections|13|||
164198944|NCT01100853|593099626|FG000|Overall Study|Withdrawal by Subject|6|||
164198945|NCT01100853|593099627|FG001|Overall Study|Withdrawal by Subject|4|||
164198946|NCT04161391|593099628|FG000|Overall Study|Adverse Event|0|||
164198947|NCT04161391|593099629|FG001|Overall Study|Adverse Event|1|||
164198948|NCT04161391|593099630|FG002|Overall Study|Adverse Event|0|||
164198949|NCT04161391|593099631|FG003|Overall Study|Adverse Event|1|||
164198950|NCT04161391|593099632|FG004|Overall Study|Adverse Event|0|||
164198951|NCT04161391|593099633|FG005|Overall Study|Adverse Event|0|||
164198952|NCT04161391|593099634|FG006|Overall Study|Adverse Event|0|||
164198953|NCT04161391|593099635|FG007|Overall Study|Adverse Event|3|||
164198954|NCT04161391|593099636|FG008|Overall Study|Adverse Event|0|||
164198955|NCT04161391|593099628|FG000|Overall Study|Death|0|||
164198956|NCT04161391|593099629|FG001|Overall Study|Death|0|||
164198957|NCT04161391|593099630|FG002|Overall Study|Death|0|||
164198958|NCT04161391|593099631|FG003|Overall Study|Death|0|||
164198959|NCT04161391|593099632|FG004|Overall Study|Death|0|||
164198960|NCT04161391|593099633|FG005|Overall Study|Death|0|||
164198961|NCT04161391|593099634|FG006|Overall Study|Death|0|||
164198962|NCT04161391|593099635|FG007|Overall Study|Death|1|||
164198963|NCT04161391|593099636|FG008|Overall Study|Death|0|||
164198964|NCT04161391|593099628|FG000|Overall Study|Physician Decision|0|||
164198965|NCT04161391|593099629|FG001|Overall Study|Physician Decision|0|||
164198966|NCT04161391|593099630|FG002|Overall Study|Physician Decision|1|||
164198967|NCT04161391|593099631|FG003|Overall Study|Physician Decision|2|||
164198968|NCT04161391|593099632|FG004|Overall Study|Physician Decision|0|||
164198969|NCT04161391|593099633|FG005|Overall Study|Physician Decision|0|||
164198970|NCT04161391|593099634|FG006|Overall Study|Physician Decision|2|||
164198971|NCT04161391|593099635|FG007|Overall Study|Physician Decision|0|||
164198972|NCT04161391|593099636|FG008|Overall Study|Physician Decision|0|||
164198973|NCT04161391|593099628|FG000|Overall Study|Progressive Disease|4|||
164198974|NCT04161391|593099629|FG001|Overall Study|Progressive Disease|3|||
164198975|NCT04161391|593099630|FG002|Overall Study|Progressive Disease|3|||
164198976|NCT04161391|593099631|FG003|Overall Study|Progressive Disease|5|||
164198977|NCT04161391|593099632|FG004|Overall Study|Progressive Disease|3|||
164198978|NCT04161391|593099633|FG005|Overall Study|Progressive Disease|3|||
164198979|NCT04161391|593099634|FG006|Overall Study|Progressive Disease|5|||
164198980|NCT04161391|593099635|FG007|Overall Study|Progressive Disease|2|||
164198981|NCT04161391|593099636|FG008|Overall Study|Progressive Disease|2|||
164198982|NCT01863771|593099641|FG000|Induction Phase|Adverse Event|9|||
164198983|NCT01863771|593099642|FG001|Induction Phase|Adverse Event|0|||
164198984|NCT01863771|593099643|FG002|Induction Phase|Adverse Event|0|||
164198985|NCT01863771|593099644|FG003|Induction Phase|Adverse Event|0|||
164198986|NCT01863771|593099641|FG000|Induction Phase|Lack of Efficacy|10|||
164198987|NCT01863771|593099642|FG001|Induction Phase|Lack of Efficacy|0|||
164198988|NCT01863771|593099643|FG002|Induction Phase|Lack of Efficacy|0|||
164198989|NCT01863771|593099644|FG003|Induction Phase|Lack of Efficacy|0|||
164198990|NCT01863771|593099641|FG000|Induction Phase|Withdrawal by Subject|2|||
164198991|NCT01863771|593099642|FG001|Induction Phase|Withdrawal by Subject|0|||
164198992|NCT01863771|593099643|FG002|Induction Phase|Withdrawal by Subject|0|||
164198993|NCT01863771|593099644|FG003|Induction Phase|Withdrawal by Subject|0|||
164198994|NCT01863771|593099641|FG000|Maintenance Phase|Adverse Event|0|||
164198995|NCT01863771|593099642|FG001|Maintenance Phase|Adverse Event|0|||
164198996|NCT01863771|593099643|FG002|Maintenance Phase|Adverse Event|1|||
164198997|NCT01863771|593099644|FG003|Maintenance Phase|Adverse Event|1|||
164198998|NCT01863771|593099641|FG000|Maintenance Phase|Lack of Efficacy|0|||
164198999|NCT01863771|593099642|FG001|Maintenance Phase|Lack of Efficacy|3|||
164199000|NCT01863771|593099643|FG002|Maintenance Phase|Lack of Efficacy|7|||
164199001|NCT01863771|593099644|FG003|Maintenance Phase|Lack of Efficacy|38|||
164199002|NCT01863771|593099641|FG000|Maintenance Phase|Physician Decision|0|||
164199003|NCT01863771|593099642|FG001|Maintenance Phase|Physician Decision|0|||
164199004|NCT01863771|593099643|FG002|Maintenance Phase|Physician Decision|2|||
164199005|NCT01863771|593099644|FG003|Maintenance Phase|Physician Decision|1|||
164199006|NCT01863771|593099641|FG000|Maintenance Phase|Pregnancy|0|||
164199007|NCT01863771|593099642|FG001|Maintenance Phase|Pregnancy|1|||
164199008|NCT01863771|593099643|FG002|Maintenance Phase|Pregnancy|0|||
163967512|NCT03383289|592254149|FG001|Overall Study|discharge from facility|84|||
163967513|NCT03383289|592254148|FG000|Overall Study|Withdrawal by Subject|4|||
163967514|NCT03383289|592254149|FG001|Overall Study|Withdrawal by Subject|1|||
163967515|NCT05097716|592254150|FG000|Period 1|Adverse Event|1|||
164199009|NCT01863771|593099644|FG003|Maintenance Phase|Pregnancy|0|||
164199010|NCT01863771|593099641|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164199011|NCT01863771|593099642|FG001|Maintenance Phase|Withdrawal by Subject|1|||
164199012|NCT01863771|593099643|FG002|Maintenance Phase|Withdrawal by Subject|2|||
164199013|NCT01863771|593099644|FG003|Maintenance Phase|Withdrawal by Subject|3|||
164199014|NCT00386334|593099645|FG000|Double Blind Period|Adverse Event|9|||
164199015|NCT00386334|593099646|FG001|Double Blind Period|Adverse Event|14|||
164199016|NCT00386334|593099645|FG000|Double Blind Period|Protocol Violation|1|||
164199017|NCT00386334|593099646|FG001|Double Blind Period|Protocol Violation|1|||
164199018|NCT00386334|593099645|FG000|Double Blind Period|Withdrawal by Subject|9|||
164199019|NCT00386334|593099646|FG001|Double Blind Period|Withdrawal by Subject|13|||
164199020|NCT00386334|593099645|FG000|Double Blind Period|Lack of Efficacy|20|||
164199021|NCT00386334|593099646|FG001|Double Blind Period|Lack of Efficacy|11|||
164199022|NCT00386334|593099645|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
164199023|NCT00386334|593099646|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
164199024|NCT00386334|593099645|FG000|Double Blind Period|Other|3|||
164199025|NCT00386334|593099646|FG001|Double Blind Period|Other|3|||
164199026|NCT00386334|593099645|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
164199027|NCT00386334|593099646|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
164199028|NCT02089347|593099647|FG000|Overall Study|Protocol Violation|1|||
164199029|NCT02089347|593099648|FG001|Overall Study|Protocol Violation|0|||
164199030|NCT02914834|593099652|FG000|Overall Study|Study halted due to COVID|1|||
164199031|NCT02914834|593099653|FG001|Overall Study|Study halted due to COVID|1|||
164199032|NCT02914834|593099652|FG000|Overall Study|1 subject withdrew|0|||
164199033|NCT02914834|593099653|FG001|Overall Study|1 subject withdrew|1|||
164199034|NCT01225549|593099656|FG000|Period 4 - Washout|Disallowed medication|0|||
164199035|NCT01225549|593099657|FG001|Period 4 - Washout|Disallowed medication|1|||
164199036|NCT01225549|593099658|FG002|Period 4 - Washout|Disallowed medication|0|||
164199037|NCT01225549|593099659|FG003|Period 4 - Washout|Disallowed medication|0|||
164199038|NCT01225549|593099660|FG004|Period 4 - Washout|Disallowed medication|0|||
164199039|NCT01225549|593099661|FG005|Period 4 - Washout|Disallowed medication|0|||
164199040|NCT01225549|593099662|FG006|Period 4 - Washout|Disallowed medication|0|||
164199041|NCT01225549|593099663|FG007|Period 4 - Washout|Disallowed medication|0|||
164199042|NCT01225549|593099664|FG008|Period 4 - Washout|Disallowed medication|0|||
164199043|NCT01225549|593099665|FG009|Period 4 - Washout|Disallowed medication|0|||
164199044|NCT01225549|593099656|FG000|Period 6 - Washout|Disallowed medication|0|||
164199045|NCT01225549|593099657|FG001|Period 6 - Washout|Disallowed medication|0|||
164199046|NCT01225549|593099658|FG002|Period 6 - Washout|Disallowed medication|0|||
164199047|NCT01225549|593099659|FG003|Period 6 - Washout|Disallowed medication|1|||
164199048|NCT01225549|593099660|FG004|Period 6 - Washout|Disallowed medication|0|||
164199049|NCT01225549|593099661|FG005|Period 6 - Washout|Disallowed medication|0|||
164199050|NCT01225549|593099662|FG006|Period 6 - Washout|Disallowed medication|0|||
164199051|NCT01225549|593099663|FG007|Period 6 - Washout|Disallowed medication|0|||
164199052|NCT01225549|593099664|FG008|Period 6 - Washout|Disallowed medication|0|||
164199053|NCT01225549|593099665|FG009|Period 6 - Washout|Disallowed medication|0|||
164199054|NCT02666222|593099673|FG000|Overall Study|Death|2|||
164199055|NCT01825200|593099674|FG000|Overall Study|Lost to Follow-up|5|||
164199056|NCT01825200|593099675|FG001|Overall Study|Lost to Follow-up|6|||
164199057|NCT01825200|593099674|FG000|Overall Study|Withdrawal by Subject|0|||
164199058|NCT01825200|593099675|FG001|Overall Study|Withdrawal by Subject|1|||
164199059|NCT01474486|593099676|FG000|Overall Study|Death|2|||
164199060|NCT01474486|593099676|FG000|Overall Study|Withdrawal by Subject|4|||
164199061|NCT01474486|593099676|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
164199062|NCT01255163|593099677|FG000|Overall Study|Withdrawal by Subject|1|||
164199063|NCT01255163|593099678|FG001|Overall Study|Withdrawal by Subject|0|||
164199064|NCT01255163|593099677|FG000|Overall Study|Lost to Follow-up|2|||
164199065|NCT01255163|593099678|FG001|Overall Study|Lost to Follow-up|0|||
164199066|NCT01255163|593099677|FG000|Overall Study|Adverse Event|0|||
164199067|NCT01255163|593099678|FG001|Overall Study|Adverse Event|2|||
164199068|NCT01255163|593099677|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
164199069|NCT01255163|593099678|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
164199070|NCT04219189|593099682|FG000|Overall Study|Withdrawal by Subject|1|||
164199071|NCT04219189|593099683|FG001|Overall Study|Withdrawal by Subject|2|||
164199072|NCT04219189|593099682|FG000|Overall Study|Protocol Violation|0|||
164199073|NCT04219189|593099683|FG001|Overall Study|Protocol Violation|1|||
163967516|NCT05097716|592254150|FG000|Period 1|Close contact with highly-transmissible infection|1|||
163967517|NCT01011439|592254151|FG000|Overall Study|Death|37|||
164199074|NCT04219189|593099682|FG000|Overall Study|Lost to Follow-up|0|||
164199075|NCT04219189|593099683|FG001|Overall Study|Lost to Follow-up|1|||
163967518|NCT01011439|592254151|FG000|Overall Study|Lost to Follow-up|4|||
164199076|NCT04219189|593099682|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
163967519|NCT01011439|592254151|FG000|Overall Study|Withdrawal by Subject|1|||
163967520|NCT01011439|592254151|FG000|Overall Study|Sponsor's decision|15|||
163967521|NCT00058552|592254152|FG000|Overall Study|Died prior to receiving treatment|4|||
163967522|NCT00058552|592254153|FG001|Overall Study|Died prior to receiving treatment|2|||
163967523|NCT00058552|592254152|FG000|Overall Study|Disease progression|52|||
163967524|NCT00058552|592254153|FG001|Overall Study|Disease progression|44|||
163967525|NCT00058552|592254152|FG000|Overall Study|Adverse Event|4|||
163967526|NCT00058552|592254153|FG001|Overall Study|Adverse Event|2|||
163967527|NCT00058552|592254152|FG000|Overall Study|Withdrawal by Subject|3|||
163967528|NCT00058552|592254153|FG001|Overall Study|Withdrawal by Subject|5|||
163967529|NCT00058552|592254152|FG000|Overall Study|Physician Decision|2|||
163967530|NCT00058552|592254153|FG001|Overall Study|Physician Decision|5|||
163967531|NCT00058552|592254152|FG000|Overall Study|Clinical disease progression|0|||
163967532|NCT00058552|592254153|FG001|Overall Study|Clinical disease progression|4|||
163967533|NCT03781323|592254156|FG000|Overall Study|Withdrawal by Subject|1|||
163967534|NCT00239226|592254162|FG000|Overall Study|permAF during stabilization period|0|||
163967535|NCT00239226|592254163|FG001|Overall Study|permAF during stabilization period|0|||
164307466|NCT00314795|593499282|FG000|Overall Study|Renal Transplant|3|||
164307467|NCT00314795|593499282|FG000|Overall Study|Participants Withdrew Consent|2|||
164307468|NCT02908672|593499289|FG000|Run-in Period|Death|12|||
164307469|NCT02908672|593499290|FG001|Run-in Period|Death|10|||
164307470|NCT02908672|593499291|FG002|Run-in Period|Death|0|||
164307471|NCT02908672|593499292|FG003|Run-in Period|Death|0|||
164307472|NCT02908672|593499289|FG000|Run-in Period|Lost to Follow-up|1|||
164307473|NCT02908672|593499290|FG001|Run-in Period|Lost to Follow-up|1|||
164307474|NCT02908672|593499291|FG002|Run-in Period|Lost to Follow-up|0|||
164307475|NCT02908672|593499292|FG003|Run-in Period|Lost to Follow-up|0|||
164307476|NCT02908672|593499289|FG000|Run-in Period|Reason Not Specified|2|||
164307477|NCT02908672|593499290|FG001|Run-in Period|Reason Not Specified|0|||
164307478|NCT02908672|593499291|FG002|Run-in Period|Reason Not Specified|0|||
164307479|NCT02908672|593499292|FG003|Run-in Period|Reason Not Specified|0|||
164307480|NCT02908672|593499289|FG000|Run-in Period|Protocol Violation|1|||
164307481|NCT02908672|593499290|FG001|Run-in Period|Protocol Violation|1|||
164307482|NCT02908672|593499291|FG002|Run-in Period|Protocol Violation|0|||
163967536|NCT00239226|592254164|FG002|Overall Study|permAF during stabilization period|0|||
163967537|NCT00239226|592254165|FG003|Overall Study|permAF during stabilization period|3|||
163967538|NCT00239226|592254162|FG000|Overall Study|Lost to Follow-up|1|||
163967539|NCT00239226|592254163|FG001|Overall Study|Lost to Follow-up|0|||
164307483|NCT02908672|593499292|FG003|Run-in Period|Protocol Violation|0|||
164307484|NCT02908672|593499289|FG000|Run-in Period|Study Ended by Sponsor|5|||
164307485|NCT02908672|593499290|FG001|Run-in Period|Study Ended by Sponsor|1|||
164307486|NCT02908672|593499291|FG002|Run-in Period|Study Ended by Sponsor|0|||
164307487|NCT02908672|593499292|FG003|Run-in Period|Study Ended by Sponsor|0|||
164307488|NCT02908672|593499289|FG000|Run-in Period|Withdrawal by Subject|3|||
164307489|NCT02908672|593499290|FG001|Run-in Period|Withdrawal by Subject|9|||
164307490|NCT02908672|593499291|FG002|Run-in Period|Withdrawal by Subject|0|||
164307491|NCT02908672|593499292|FG003|Run-in Period|Withdrawal by Subject|0|||
164307492|NCT02908672|593499289|FG000|Triple Combination Period|Death|0|||
164307493|NCT02908672|593499290|FG001|Triple Combination Period|Death|0|||
164307494|NCT02908672|593499291|FG002|Triple Combination Period|Death|150|||
164307495|NCT02908672|593499292|FG003|Triple Combination Period|Death|127|||
164307496|NCT02908672|593499289|FG000|Triple Combination Period|Lost to Follow-up|0|||
164307497|NCT02908672|593499290|FG001|Triple Combination Period|Lost to Follow-up|0|||
164307498|NCT02908672|593499291|FG002|Triple Combination Period|Lost to Follow-up|6|||
164307499|NCT02908672|593499292|FG003|Triple Combination Period|Lost to Follow-up|8|||
164307500|NCT02908672|593499289|FG000|Triple Combination Period|Reason Not Specified|0|||
164307501|NCT02908672|593499290|FG001|Triple Combination Period|Reason Not Specified|0|||
164307502|NCT02908672|593499291|FG002|Triple Combination Period|Reason Not Specified|0|||
164307503|NCT02908672|593499292|FG003|Triple Combination Period|Reason Not Specified|1|||
164307504|NCT02908672|593499289|FG000|Triple Combination Period|Physician Decision|0|||
164307505|NCT02908672|593499290|FG001|Triple Combination Period|Physician Decision|0|||
164307506|NCT02908672|593499291|FG002|Triple Combination Period|Physician Decision|1|||
164307507|NCT02908672|593499292|FG003|Triple Combination Period|Physician Decision|1|||
164307508|NCT02908672|593499289|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
164307509|NCT02908672|593499290|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
164307510|NCT02908672|593499291|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
164307511|NCT02908672|593499292|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
164307512|NCT02908672|593499289|FG000|Triple Combination Period|Withdrawal by Subject|0|||
164307513|NCT02908672|593499290|FG001|Triple Combination Period|Withdrawal by Subject|0|||
164307514|NCT02908672|593499291|FG002|Triple Combination Period|Withdrawal by Subject|13|||
164307515|NCT02908672|593499292|FG003|Triple Combination Period|Withdrawal by Subject|16|||
164307516|NCT02876601|593499296|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
164307517|NCT02876601|593499297|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
164307518|NCT02876601|593499298|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
163967540|NCT00239226|592254164|FG002|Overall Study|Lost to Follow-up|1|||
164307519|NCT02876601|593499299|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
164307520|NCT00802945|593499301|FG000|Overall Study|Death|27|||
164307521|NCT00802945|593499302|FG001|Overall Study|Death|23|||
164307522|NCT00802945|593499301|FG000|Overall Study|Terminated by sponsor|8|||
164307523|NCT00802945|593499302|FG001|Overall Study|Terminated by sponsor|12|||
164307524|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
164307525|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
164307526|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
164307527|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
164307528|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
164307529|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
164307530|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
164307531|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
164307532|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
164307533|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
164307534|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
164199077|NCT04219189|593099683|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
164199078|NCT03863353|593099684|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
164199079|NCT03863353|593099685|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
164199080|NCT04079790|593099689|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
164199081|NCT04079790|593099690|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
164199082|NCT04079790|593099691|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
164199083|NCT04079790|593099692|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
164199084|NCT04079790|593099689|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
164199085|NCT04079790|593099690|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
164199086|NCT04079790|593099691|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
164199087|NCT04079790|593099692|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
164199088|NCT04079790|593099689|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
164199089|NCT04079790|593099690|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
164199090|NCT04079790|593099691|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
164199091|NCT04079790|593099692|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
164199092|NCT01924533|593099694|FG000|Overall Study|Death|181|||
164199093|NCT01924533|593099695|FG001|Overall Study|Death|200|||
164199094|NCT01924533|593099694|FG000|Overall Study|Lost to Follow-up|0|||
164199095|NCT01924533|593099695|FG001|Overall Study|Lost to Follow-up|1|||
164199096|NCT01924533|593099694|FG000|Overall Study|Withdrawal by Subject|7|||
164199097|NCT01924533|593099695|FG001|Overall Study|Withdrawal by Subject|3|||
164199098|NCT01924533|593099694|FG000|Overall Study|Other Eligibility criteria|1|||
164199099|NCT01924533|593099695|FG001|Overall Study|Other Eligibility criteria|1|||
164199100|NCT05817669|593099696|FG000|Overall Study|Prohibited medication used|1|||
164199101|NCT05817669|593099697|FG001|Overall Study|Prohibited medication used|2|||
164199102|NCT05817669|593099696|FG000|Overall Study|Adverse Event|1|||
164199103|NCT05817669|593099697|FG001|Overall Study|Adverse Event|0|||
164199104|NCT05817669|593099696|FG000|Overall Study|Withdrawal by Subject|1|||
164199105|NCT05817669|593099697|FG001|Overall Study|Withdrawal by Subject|2|||
164199106|NCT04233879|593099698|FG000|Overall Study|Death|2|||
164199107|NCT04233879|593099699|FG001|Overall Study|Death|0|||
164199108|NCT04233879|593099698|FG000|Overall Study|Lost to Follow-up|3|||
164199109|NCT04233879|593099699|FG001|Overall Study|Lost to Follow-up|8|||
164199110|NCT04233879|593099698|FG000|Overall Study|Physician Decision|4|||
164199111|NCT04233879|593099699|FG001|Overall Study|Physician Decision|4|||
164199112|NCT04233879|593099698|FG000|Overall Study|Withdrawal by Subject|7|||
164199113|NCT04233879|593099699|FG001|Overall Study|Withdrawal by Subject|10|||
164199114|NCT04233879|593099698|FG000|Overall Study|Other|281|||
164199115|NCT04233879|593099699|FG001|Overall Study|Other|279|||
164199116|NCT03055936|593099702|FG000|Overall Study|Adverse Event|0|||
164199117|NCT03055936|593099703|FG001|Overall Study|Adverse Event|1|||
164199118|NCT03055936|593099704|FG002|Overall Study|Adverse Event|1|||
164199119|NCT03055936|593099705|FG003|Overall Study|Adverse Event|1|||
164199120|NCT03055936|593099702|FG000|Overall Study|Personal reason|2|||
164199121|NCT03055936|593099703|FG001|Overall Study|Personal reason|0|||
164199122|NCT03055936|593099704|FG002|Overall Study|Personal reason|1|||
164199123|NCT03055936|593099705|FG003|Overall Study|Personal reason|0|||
164199124|NCT05002972|593099709|FG000|Overall Study|Withdrawal by Subject|2|||
164199125|NCT01664091|593099710|FG000|Overall Study|Death|1|||
164199126|NCT01664091|593099710|FG000|Overall Study|Disease Progression|2|||
164199127|NCT01664091|593099710|FG000|Overall Study|Lost to Follow-up|2|||
164199128|NCT01664091|593099710|FG000|Overall Study|Withdrawal by Subject|1|||
164199129|NCT00086190|593099714|FG000|Overall Study|Adverse Event|6|||
164199130|NCT00086190|593099715|FG001|Overall Study|Adverse Event|2|||
163967541|NCT00239226|592254165|FG003|Overall Study|Lost to Follow-up|0|||
164307535|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
164307536|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
164307537|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
164307538|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
164307539|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
164307540|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
164307541|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
164307542|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
164307543|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
164307544|NCT05307692|593499303|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
164307545|NCT05307692|593499304|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
164307546|NCT05307692|593499305|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
164307547|NCT05307692|593499306|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
164307548|NCT05307692|593499303|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
164307549|NCT05307692|593499304|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
164307550|NCT05307692|593499305|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
164307551|NCT05307692|593499306|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
164307552|NCT05307692|593499303|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
163862078|NCT00197015|591860710|FG002|Overall Study|Withdrawal by Subject|34|||
163862079|NCT00197015|591860708|FG000|Overall Study|Lost to Follow-up|28|||
163862080|NCT00197015|591860709|FG001|Overall Study|Lost to Follow-up|46|||
163862081|NCT00197015|591860710|FG002|Overall Study|Lost to Follow-up|37|||
163862082|NCT00197015|591860708|FG000|Overall Study|Other|2|||
163862083|NCT00197015|591860709|FG001|Overall Study|Other|3|||
163862084|NCT00197015|591860710|FG002|Overall Study|Other|2|||
163862085|NCT00608907|591860711|FG000|Overall Study|Adverse Event|6|||
164199131|NCT00086190|593099716|FG002|Overall Study|Adverse Event|2|||
164199132|NCT00086190|593099714|FG000|Overall Study|Withdrawal by Subject|0|||
164199133|NCT00086190|593099715|FG001|Overall Study|Withdrawal by Subject|2|||
164199134|NCT00086190|593099716|FG002|Overall Study|Withdrawal by Subject|2|||
164199135|NCT00086190|593099714|FG000|Overall Study|Protocol Violation|1|||
164199136|NCT00086190|593099715|FG001|Overall Study|Protocol Violation|0|||
164199137|NCT00086190|593099716|FG002|Overall Study|Protocol Violation|0|||
164199138|NCT00086190|593099714|FG000|Overall Study|Moved|1|||
164199139|NCT00086190|593099715|FG001|Overall Study|Moved|0|||
164199140|NCT00086190|593099716|FG002|Overall Study|Moved|0|||
164199141|NCT00086190|593099714|FG000|Overall Study|Worsening depression|0|||
164199142|NCT00086190|593099715|FG001|Overall Study|Worsening depression|0|||
164199143|NCT00086190|593099716|FG002|Overall Study|Worsening depression|2|||
164199144|NCT00249834|593099717|FG000|Overall Study|Ovarian stimulation failed|1|||
164199145|NCT00249834|593099718|FG001|Overall Study|Ovarian stimulation failed|0|||
164199146|NCT00249834|593099719|FG002|Overall Study|Ovarian stimulation failed|0|||
164199147|NCT00249834|593099720|FG003|Overall Study|Ovarian stimulation failed|0|||
164199148|NCT00249834|593099721|FG004|Overall Study|Ovarian stimulation failed|0|||
164199149|NCT00249834|593099722|FG005|Overall Study|Ovarian stimulation failed|0|||
164199150|NCT00249834|593099723|FG006|Overall Study|Ovarian stimulation failed|0|||
164199151|NCT00249834|593099724|FG007|Overall Study|Ovarian stimulation failed|0|||
164199152|NCT00249834|593099717|FG000|Overall Study|Failure of down-regulation|0|||
164199153|NCT00249834|593099718|FG001|Overall Study|Failure of down-regulation|0|||
164199154|NCT00249834|593099719|FG002|Overall Study|Failure of down-regulation|0|||
164199155|NCT00249834|593099720|FG003|Overall Study|Failure of down-regulation|0|||
164199156|NCT00249834|593099721|FG004|Overall Study|Failure of down-regulation|0|||
164199157|NCT00249834|593099722|FG005|Overall Study|Failure of down-regulation|0|||
164199158|NCT00249834|593099723|FG006|Overall Study|Failure of down-regulation|1|||
164199159|NCT00249834|593099724|FG007|Overall Study|Failure of down-regulation|0|||
164199160|NCT00249834|593099717|FG000|Overall Study|Protocol Violation|0|||
164199161|NCT00249834|593099718|FG001|Overall Study|Protocol Violation|19|||
164199162|NCT00249834|593099719|FG002|Overall Study|Protocol Violation|14|||
164199163|NCT00249834|593099720|FG003|Overall Study|Protocol Violation|8|||
164199164|NCT00249834|593099721|FG004|Overall Study|Protocol Violation|5|||
164199165|NCT00249834|593099722|FG005|Overall Study|Protocol Violation|2|||
164199166|NCT00249834|593099723|FG006|Overall Study|Protocol Violation|0|||
164199167|NCT00249834|593099724|FG007|Overall Study|Protocol Violation|0|||
164199168|NCT05502302|593099727|FG000|Overall Study|Lost to Follow-up|6|||
164199169|NCT05502302|593099727|FG000|Overall Study|Death|2|||
164199170|NCT02998151|593099728|FG000|Overall Study|Withdrawal by Subject|3|||
163862086|NCT00608907|591860712|FG001|Overall Study|Adverse Event|0|||
163862087|NCT00608907|591860713|FG002|Overall Study|Adverse Event|1|||
164199171|NCT02998151|593099728|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
164199172|NCT02998151|593099728|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
164199173|NCT01204671|593099734|FG000|Overall Study|Adverse Event|4|||
164199174|NCT01204671|593099735|FG001|Overall Study|Adverse Event|3|||
164199175|NCT01204671|593099736|FG002|Overall Study|Adverse Event|3|||
164199176|NCT01204671|593099737|FG003|Overall Study|Adverse Event|3|||
164307553|NCT05307692|593499304|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
164307554|NCT05307692|593499305|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
164307555|NCT05307692|593499306|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
164307556|NCT01648751|593499307|FG000|Overall Study|Withdrawal by Subject|2|||
164307557|NCT01648751|593499308|FG001|Overall Study|Withdrawal by Subject|3|||
164307558|NCT03467750|593499309|FG000|Overall Study|Surgery canceled|1|||
164307559|NCT03467750|593499310|FG001|Overall Study|Surgery canceled|0|||
164307560|NCT03467750|593499309|FG000|Overall Study|Protocol Violation|1|||
164307561|NCT03467750|593499310|FG001|Overall Study|Protocol Violation|1|||
164307562|NCT03467750|593499309|FG000|Overall Study|Withdrawal by Subject|0|||
164307563|NCT03467750|593499310|FG001|Overall Study|Withdrawal by Subject|1|||
164307564|NCT05673876|593499311|FG000|Overall Study|Death|3|||
164307565|NCT05673876|593499312|FG001|Overall Study|Death|1|||
164307566|NCT05673876|593499311|FG000|Overall Study|Study Terminated by Sponsor|0|||
164307567|NCT05673876|593499312|FG001|Overall Study|Study Terminated by Sponsor|1|||
164307568|NCT05673876|593499311|FG000|Overall Study|Physician Decision|0|||
164307569|NCT05673876|593499312|FG001|Overall Study|Physician Decision|1|||
164307570|NCT05006573|593499315|FG000|Double-blind Treatment Period|Physician Decision|2|||
164307571|NCT05006573|593499316|FG001|Double-blind Treatment Period|Physician Decision|0|||
164307572|NCT05006573|593499315|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
164307573|NCT05006573|593499316|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
164307574|NCT05006573|593499315|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
164307575|NCT05006573|593499316|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164307576|NCT05006573|593499315|FG000|Double-blind Treatment Period|Protocol Violation|2|||
164307577|NCT05006573|593499316|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164307578|NCT05006573|593499315|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
164307579|NCT05006573|593499316|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
164307580|NCT05006573|593499315|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
164307581|NCT05006573|593499316|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
164307582|NCT01077050|593500965|FG000|Overall Study|Subjects signed ICF could not be located|1|||
164307583|NCT01077050|593500965|FG000|Overall Study|Screen failure|8|||
164307584|NCT00684060|593500966|FG000|Overall Study|Lost to Follow-up|1|||
164307585|NCT00684060|593500967|FG001|Overall Study|Lost to Follow-up|0|||
164307586|NCT00684060|593500966|FG000|Overall Study|New stenosis identified|1|||
164307587|NCT00684060|593500967|FG001|Overall Study|New stenosis identified|0|||
164307588|NCT00684060|593500966|FG000|Overall Study|Unable to collect MRI|1|||
164307589|NCT00684060|593500967|FG001|Overall Study|Unable to collect MRI|2|||
164307590|NCT00684060|593500966|FG000|Overall Study|Death|0|||
164307591|NCT00684060|593500967|FG001|Overall Study|Death|1|||
164307592|NCT00702715|593500968|FG000|Overall Study|Lost to Follow-up|1|||
164307593|NCT00702715|593500969|FG001|Overall Study|Lost to Follow-up|0|||
164307594|NCT03126344|593500984|FG000|Overall Study|Lost to Follow-up|0|||
164307595|NCT03126344|593500985|FG001|Overall Study|Lost to Follow-up|0|||
164307596|NCT03126344|593500986|FG002|Overall Study|Lost to Follow-up|5|||
164307597|NCT01715857|593500987|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
164307598|NCT02563067|593500988|FG000|Overall Study|Subject/guardian decision|14|||
164307599|NCT02563067|593500989|FG001|Overall Study|Subject/guardian decision|20|||
164307600|NCT02563067|593500990|FG002|Overall Study|Subject/guardian decision|16|||
164307601|NCT02563067|593500988|FG000|Overall Study|Physician Decision|0|||
164307602|NCT02563067|593500989|FG001|Overall Study|Physician Decision|1|||
164307603|NCT02563067|593500990|FG002|Overall Study|Physician Decision|3|||
164307604|NCT02563067|593500988|FG000|Overall Study|Lost to Follow-up|1|||
164307605|NCT02563067|593500989|FG001|Overall Study|Lost to Follow-up|2|||
164307606|NCT02563067|593500990|FG002|Overall Study|Lost to Follow-up|0|||
164307607|NCT02563067|593500988|FG000|Overall Study|Technical problems|0|||
164307608|NCT02563067|593500989|FG001|Overall Study|Technical problems|1|||
164307609|NCT02563067|593500990|FG002|Overall Study|Technical problems|0|||
164307610|NCT02563067|593500988|FG000|Overall Study|Lack of Efficacy|1|||
164307611|NCT02563067|593500989|FG001|Overall Study|Lack of Efficacy|0|||
164307612|NCT02563067|593500990|FG002|Overall Study|Lack of Efficacy|0|||
164307613|NCT02563067|593500988|FG000|Overall Study|Death|0|||
164307614|NCT02563067|593500989|FG001|Overall Study|Death|1|||
164307615|NCT02563067|593500990|FG002|Overall Study|Death|1|||
164307616|NCT02563067|593500988|FG000|Overall Study|Adverse Event|2|||
164307617|NCT02563067|593500989|FG001|Overall Study|Adverse Event|1|||
164307618|NCT02563067|593500990|FG002|Overall Study|Adverse Event|0|||
164307619|NCT02563067|593500988|FG000|Overall Study|Death post Treatment/safety period|1|||
164307620|NCT02563067|593500989|FG001|Overall Study|Death post Treatment/safety period|0|||
164307621|NCT02563067|593500990|FG002|Overall Study|Death post Treatment/safety period|0|||
164307622|NCT03544333|593500991|FG000|Overall Study|Withdrawal by Subject|1|||
163967542|NCT04060563|592254167|FG000|Overall Study|Lost to Follow-up|1|||
164307623|NCT03544333|593500992|FG001|Overall Study|Withdrawal by Subject|0|||
164307624|NCT00475306|593501000|FG000|Overall Study|Protocol Violation|1|||
164307625|NCT00475306|593501001|FG001|Overall Study|Protocol Violation|1|||
164307626|NCT00475306|593501002|FG002|Overall Study|Protocol Violation|0|||
164307627|NCT00475306|593501003|FG003|Overall Study|Protocol Violation|1|||
164199177|NCT01204671|593099738|FG004|Overall Study|Adverse Event|1|||
164199178|NCT01204671|593099734|FG000|Overall Study|Withdrawal by Subject|2|||
164199179|NCT01204671|593099735|FG001|Overall Study|Withdrawal by Subject|3|||
164199180|NCT01204671|593099736|FG002|Overall Study|Withdrawal by Subject|4|||
164199181|NCT01204671|593099737|FG003|Overall Study|Withdrawal by Subject|5|||
164199182|NCT01204671|593099738|FG004|Overall Study|Withdrawal by Subject|3|||
164199183|NCT01204671|593099734|FG000|Overall Study|Lost to Follow-up|7|||
164199184|NCT01204671|593099735|FG001|Overall Study|Lost to Follow-up|8|||
164199185|NCT01204671|593099736|FG002|Overall Study|Lost to Follow-up|6|||
164199186|NCT01204671|593099737|FG003|Overall Study|Lost to Follow-up|4|||
164199187|NCT01204671|593099738|FG004|Overall Study|Lost to Follow-up|0|||
164199188|NCT01204671|593099734|FG000|Overall Study|Unknown Completion Status|1|||
164199189|NCT01204671|593099735|FG001|Overall Study|Unknown Completion Status|1|||
164199190|NCT01204671|593099736|FG002|Overall Study|Unknown Completion Status|0|||
164199191|NCT01204671|593099737|FG003|Overall Study|Unknown Completion Status|0|||
164199192|NCT01204671|593099738|FG004|Overall Study|Unknown Completion Status|0|||
164199193|NCT01204671|593099734|FG000|Overall Study|Physician Decision|0|||
164199194|NCT01204671|593099735|FG001|Overall Study|Physician Decision|0|||
164199195|NCT01204671|593099736|FG002|Overall Study|Physician Decision|0|||
164199196|NCT01204671|593099737|FG003|Overall Study|Physician Decision|1|||
164199197|NCT01204671|593099738|FG004|Overall Study|Physician Decision|0|||
164199198|NCT02700048|593099739|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
164199199|NCT02700048|593099740|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
164199200|NCT01121263|593099753|FG000|Overall Study|Death|3|||
164199201|NCT01121263|593099754|FG001|Overall Study|Death|2|||
164199202|NCT01121263|593099753|FG000|Overall Study|Lost to Follow-up|22|||
164199203|NCT01121263|593099754|FG001|Overall Study|Lost to Follow-up|12|||
164199204|NCT01121263|593099753|FG000|Overall Study|Withdrawal by Subject|0|||
164199205|NCT01121263|593099754|FG001|Overall Study|Withdrawal by Subject|1|||
164199206|NCT01655901|593101659|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199207|NCT01655901|593101660|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199208|NCT01655901|593101661|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199209|NCT01655901|593101662|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
164199210|NCT01655901|593101663|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
164199211|NCT01655901|593101664|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
164199212|NCT02579629|593101674|FG000|Overall Study|Withdrawal by Subject|0|||
164199213|NCT02579629|593101675|FG001|Overall Study|Withdrawal by Subject|1|||
164199214|NCT02579629|593101676|FG002|Overall Study|Withdrawal by Subject|0|||
164199215|NCT02579629|593101674|FG000|Overall Study|Screen Failure|2|||
164199216|NCT02579629|593101675|FG001|Overall Study|Screen Failure|0|||
164199217|NCT02579629|593101676|FG002|Overall Study|Screen Failure|2|||
164199218|NCT01190891|593101677|FG000|Overall Study|Protocol Violation|1|||
164199219|NCT01190891|593101678|FG001|Overall Study|Protocol Violation|0|||
164199220|NCT01190891|593101677|FG000|Overall Study|Withdrawal by Subject|5|||
164199221|NCT01190891|593101678|FG001|Overall Study|Withdrawal by Subject|0|||
164199222|NCT00737048|593101679|FG000|Overall Study|Physician Decision|0|||
164199223|NCT00737048|593101680|FG001|Overall Study|Physician Decision|0|||
164199224|NCT00737048|593101681|FG002|Overall Study|Physician Decision|1|||
164199225|NCT00737048|593101679|FG000|Overall Study|Adverse Event|0|||
164199226|NCT00737048|593101680|FG001|Overall Study|Adverse Event|1|||
164199227|NCT00737048|593101681|FG002|Overall Study|Adverse Event|0|||
164199228|NCT00737048|593101679|FG000|Overall Study|Worsening of the symptoms|3|||
164199229|NCT00737048|593101680|FG001|Overall Study|Worsening of the symptoms|5|||
164199230|NCT00737048|593101681|FG002|Overall Study|Worsening of the symptoms|3|||
164199231|NCT00301834|593101682|FG000|Overall Study|Death|1|||
164199232|NCT02737358|593101683|FG000|Overall Study|Withdrawal by Subject|7|||
164199233|NCT02737358|593101684|FG001|Overall Study|Withdrawal by Subject|12|||
164199234|NCT02737358|593101683|FG000|Overall Study|Lost to Follow-up|2|||
164199235|NCT02737358|593101684|FG001|Overall Study|Lost to Follow-up|3|||
164199236|NCT00744939|593101685|FG000|Overall Study|Withdrawal by Subject|9|||
164199237|NCT00744939|593101685|FG000|Overall Study|Protocol Violation|13|||
164199238|NCT00744939|593101685|FG000|Overall Study|Death|24|||
164199239|NCT00744939|593101685|FG000|Overall Study|distance|4|||
164199240|NCT00744939|593101685|FG000|Overall Study|Lost to Follow-up|12|||
164199241|NCT00744939|593101685|FG000|Overall Study|Medical history exclusionary|1|||
164199242|NCT00744939|593101685|FG000|Overall Study|Did not receive Magnevist|7|||
164199243|NCT00744939|593101685|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
164199244|NCT00744939|593101685|FG000|Overall Study|coma|1|||
164199245|NCT00744939|593101685|FG000|Overall Study|incorrect race|1|||
164199246|NCT01739335|593101686|FG000|Overall Study|Lost to Follow-up|7|||
164199247|NCT01739335|593101687|FG001|Overall Study|Lost to Follow-up|4|||
163862088|NCT00608907|591860711|FG000|Overall Study|Death|1|||
164199248|NCT01739335|593101686|FG000|Overall Study|Ineligible patient randomized|0|||
163862089|NCT00608907|591860712|FG001|Overall Study|Death|0|||
163862090|NCT00608907|591860713|FG002|Overall Study|Death|0|||
163862091|NCT00608907|591860711|FG000|Overall Study|Withdrawal by Subject|4|||
164199249|NCT01739335|593101687|FG001|Overall Study|Ineligible patient randomized|1|||
164307628|NCT01237899|593501004|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
164307629|NCT01237899|593501005|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
164307630|NCT01237899|593501006|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
164307631|NCT01237899|593501007|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
164307632|NCT01237899|593501008|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
164307633|NCT01237899|593501009|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
164307634|NCT01237899|593501010|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
164307635|NCT01237899|593501011|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
164307636|NCT01237899|593501012|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
164307637|NCT01237899|593501013|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
164307638|NCT01237899|593501014|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
164307639|NCT00790088|593501015|FG000|Overall Study|Protocol Violation|11|||
164307640|NCT00790088|593501015|FG000|Overall Study|Withdrawal by Subject|17|||
164307641|NCT00790088|593501015|FG000|Overall Study|Lost to Follow-up|7|||
164307642|NCT00790088|593501015|FG000|Overall Study|Physician Decision|4|||
164307643|NCT02910986|593501016|FG000|Overall Study|non-Latina|14|||
164307644|NCT02910986|593501017|FG001|Overall Study|non-Latina|13|||
164307645|NCT02910986|593501018|FG002|Overall Study|non-Latina|12|||
164307646|NCT02910986|593501016|FG000|Overall Study|Failure to return T! survey|72|||
164307647|NCT02910986|593501017|FG001|Overall Study|Failure to return T! survey|84|||
164307648|NCT02910986|593501018|FG002|Overall Study|Failure to return T! survey|72|||
164307649|NCT02910986|593501016|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
164307650|NCT02910986|593501017|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
164307651|NCT02910986|593501018|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
164307652|NCT02910986|593501016|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
164307653|NCT02910986|593501017|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
164307654|NCT02910986|593501018|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
164307655|NCT03682770|593501023|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307656|NCT03682770|593501024|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
164307657|NCT03682770|593501025|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307658|NCT03682770|593501026|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307659|NCT03682770|593501027|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307660|NCT03682770|593501028|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307661|NCT03682770|593501029|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
164307662|NCT03682770|593501023|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
164307663|NCT03682770|593501024|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
164307664|NCT03682770|593501025|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307665|NCT03682770|593501026|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307666|NCT03682770|593501027|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307667|NCT03682770|593501028|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307668|NCT03682770|593501029|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
164307669|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307670|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307671|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
164307672|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
163862092|NCT00608907|591860712|FG001|Overall Study|Withdrawal by Subject|0|||
163862093|NCT00608907|591860713|FG002|Overall Study|Withdrawal by Subject|0|||
163862094|NCT00608907|591860711|FG000|Overall Study|Progressive Disease|1|||
164199250|NCT00183430|593101689|FG000|Overall Study|Adverse Event|1|||
164199251|NCT00183430|593101690|FG001|Overall Study|Adverse Event|0|||
164199252|NCT00183430|593101689|FG000|Overall Study|Lost to Follow-up|3|||
164199253|NCT00183430|593101690|FG001|Overall Study|Lost to Follow-up|0|||
164199254|NCT00183430|593101689|FG000|Overall Study|did not meet inclusion criteria|1|||
164199255|NCT00183430|593101690|FG001|Overall Study|did not meet inclusion criteria|0|||
164199256|NCT00183430|593101689|FG000|Overall Study|Withdrawal by Subject|1|||
164199257|NCT00183430|593101690|FG001|Overall Study|Withdrawal by Subject|0|||
164199258|NCT00883181|593101695|FG000|Overall Study|Hematological Adverse Event|26|||
164199259|NCT00883181|593101695|FG000|Overall Study|Non-hematological Adverse Event|55|||
164199260|NCT00883181|593101695|FG000|Overall Study|Disease Progression|94|||
164199261|NCT00883181|593101695|FG000|Overall Study|Administrative Reason|24|||
164199262|NCT00883181|593101695|FG000|Overall Study|Withdrawal by Subject|4|||
164199263|NCT00883181|593101695|FG000|Overall Study|Death|31|||
164199264|NCT00883181|593101695|FG000|Overall Study|Other|38|||
164199265|NCT00883181|593101695|FG000|Overall Study|Protocol Deviation|3|||
164199266|NCT00883181|593101695|FG000|Overall Study|Noncompliance|3|||
164199267|NCT01218308|593101696|FG000|Overall Study|Adverse Event|1|||
164199268|NCT01218308|593101697|FG001|Overall Study|Adverse Event|2|||
164199269|NCT01218308|593101696|FG000|Overall Study|Protocol Violation|0|||
164307673|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307674|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164199270|NCT01218308|593101697|FG001|Overall Study|Protocol Violation|2|||
164307675|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
164307676|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307677|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307678|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307679|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
164307680|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307681|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307682|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
164307683|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307684|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307685|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
164307686|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
164307687|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307688|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307689|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
164307690|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307691|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307692|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
164307693|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307694|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164199271|NCT01218308|593101696|FG000|Overall Study|Withdrawal by Subject|61|||
164199272|NCT01218308|593101697|FG001|Overall Study|Withdrawal by Subject|64|||
164199273|NCT01218308|593101696|FG000|Overall Study|Lost to Follow-up|27|||
164199274|NCT01218308|593101697|FG001|Overall Study|Lost to Follow-up|31|||
164199275|NCT01218308|593101696|FG000|Overall Study|Other|14|||
164199276|NCT01218308|593101697|FG001|Overall Study|Other|21|||
164199277|NCT03238417|593101702|FG000|Overall|non-response|955|||
164199278|NCT03238417|593101703|FG001|Overall|non-response|1920|||
164199279|NCT03238417|593101702|FG000|Overall|partial completion|48|||
164199280|NCT03238417|593101703|FG001|Overall|partial completion|68|||
164199281|NCT03238417|593101702|FG000|Baseline|Partial completion|17|||
164199282|NCT03238417|593101703|FG001|Baseline|Partial completion|48|||
164199283|NCT03238417|593101702|FG000|Baseline|non-response|372|||
164199284|NCT03238417|593101703|FG001|Baseline|non-response|669|||
164199285|NCT03238417|593101702|FG000|12-month|non-response|296|||
164199286|NCT03238417|593101703|FG001|12-month|non-response|669|||
164199287|NCT03238417|593101702|FG000|12-month|partial completion|23|||
164199288|NCT03238417|593101703|FG001|12-month|partial completion|37|||
164199289|NCT03238417|593101702|FG000|24-month|non-response|287|||
164199290|NCT03238417|593101703|FG001|24-month|non-response|594|||
164199291|NCT03238417|593101702|FG000|24-month|partial completion|8|||
164199292|NCT03238417|593101703|FG001|24-month|partial completion|31|||
164199293|NCT00106002|593101708|FG000|Overall Study|Did not take any study drug|1|||
164199294|NCT00106002|593101708|FG000|Overall Study|Ineligible after Registration|1|||
164199295|NCT01122173|593101713|FG000|Overall Study|Lost to Follow-up|3|||
164199296|NCT01122173|593101713|FG000|Overall Study|Withdrawal by Subject|3|||
164199297|NCT01122173|593101713|FG000|Overall Study|Left study for other reasons|3|||
164199298|NCT04210986|593101715|FG000|Overall Study|Lost to Follow-up|5|||
164199299|NCT04210986|593101716|FG001|Overall Study|Lost to Follow-up|2|||
164199300|NCT04210986|593101715|FG000|Overall Study|Withdrawal by Subject|3|||
164199301|NCT04210986|593101716|FG001|Overall Study|Withdrawal by Subject|1|||
164199302|NCT04210986|593101715|FG000|Overall Study|Protocol Violation|1|||
164199303|NCT04210986|593101716|FG001|Overall Study|Protocol Violation|1|||
164199304|NCT04210986|593101715|FG000|Overall Study|Physician Decision|0|||
164199305|NCT04210986|593101716|FG001|Overall Study|Physician Decision|1|||
164199306|NCT01774591|593101717|FG000|Overall Study|Physician Decision|1|||
164199307|NCT01774591|593101718|FG001|Overall Study|Physician Decision|1|||
164199308|NCT01774591|593101717|FG000|Overall Study|Withdrawal by Subject|0|||
164199309|NCT01774591|593101718|FG001|Overall Study|Withdrawal by Subject|1|||
164199310|NCT01774591|593101717|FG000|Overall Study|Adverse Event|0|||
164199311|NCT01774591|593101718|FG001|Overall Study|Adverse Event|2|||
164199312|NCT03504917|593101719|FG000|Blinded Treatment Period|Protocol Violation|1|||
164199313|NCT03504917|593101720|FG001|Blinded Treatment Period|Protocol Violation|0|||
164199314|NCT03504917|593101719|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
164199315|NCT03504917|593101720|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
164199316|NCT03504917|593101719|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
164199317|NCT03504917|593101720|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
164199318|NCT03504917|593101719|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
164307695|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307696|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
164307697|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307698|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164199319|NCT03504917|593101720|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
164199320|NCT03504917|593101719|FG000|Blinded Treatment Period|Adverse Event|4|||
163862095|NCT00608907|591860712|FG001|Overall Study|Progressive Disease|0|||
163862096|NCT00608907|591860713|FG002|Overall Study|Progressive Disease|0|||
163862097|NCT02596035|591860719|FG000|Overall Study|Disease Progression|64|||
163862098|NCT02596035|591860720|FG001|Overall Study|Disease Progression|32|||
163862099|NCT02596035|591860721|FG002|Overall Study|Disease Progression|1|||
163862100|NCT02596035|591860719|FG000|Overall Study|study drug toxicity|12|||
163862101|NCT02596035|591860720|FG001|Overall Study|study drug toxicity|3|||
163862102|NCT02596035|591860721|FG002|Overall Study|study drug toxicity|0|||
163862103|NCT02596035|591860719|FG000|Overall Study|AE unrelated to study drug|5|||
163862104|NCT02596035|591860720|FG001|Overall Study|AE unrelated to study drug|2|||
163862105|NCT02596035|591860721|FG002|Overall Study|AE unrelated to study drug|0|||
163862106|NCT02596035|591860719|FG000|Overall Study|participant request to discontinue study treatment|2|||
163862107|NCT02596035|591860720|FG001|Overall Study|participant request to discontinue study treatment|0|||
163862108|NCT02596035|591860721|FG002|Overall Study|participant request to discontinue study treatment|0|||
163862109|NCT02596035|591860719|FG000|Overall Study|participant withdrew consent|2|||
163862110|NCT02596035|591860720|FG001|Overall Study|participant withdrew consent|2|||
163862111|NCT02596035|591860721|FG002|Overall Study|participant withdrew consent|0|||
163862112|NCT02596035|591860719|FG000|Overall Study|Poor/Non Comlpiance|0|||
163862113|NCT02596035|591860720|FG001|Overall Study|Poor/Non Comlpiance|1|||
163862114|NCT02596035|591860721|FG002|Overall Study|Poor/Non Comlpiance|0|||
163862115|NCT02596035|591860719|FG000|Overall Study|participant no longer meets study criteria|1|||
163862116|NCT02596035|591860720|FG001|Overall Study|participant no longer meets study criteria|0|||
163862117|NCT02596035|591860721|FG002|Overall Study|participant no longer meets study criteria|0|||
163862118|NCT02596035|591860719|FG000|Overall Study|other reasons|11|||
164199321|NCT03504917|593101720|FG001|Blinded Treatment Period|Adverse Event|4|||
164199322|NCT03504917|593101719|FG000|Blinded Treatment Period|Physician Decision|1|||
164199323|NCT03504917|593101720|FG001|Blinded Treatment Period|Physician Decision|0|||
164199324|NCT03504917|593101719|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
164199325|NCT03504917|593101720|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
164199326|NCT03504917|593101719|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
164199327|NCT03504917|593101720|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
164199328|NCT03504917|593101719|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
164199329|NCT03504917|593101720|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
164199330|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
164199331|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
164199332|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
164199333|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
164199334|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
164199335|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
164199336|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
164199337|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
164199338|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
164199339|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
164199340|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
164199341|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
164199342|NCT03504917|593101719|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
164199343|NCT03504917|593101720|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
164199344|NCT03810183|593101721|FG000|Overall Study|Study terminated by Sponsor|2|||
164199345|NCT03810183|593101722|FG001|Overall Study|Study terminated by Sponsor|1|||
164199346|NCT04275336|593101723|FG000|Overall Study|First venipuncture failed|4|||
164199347|NCT04275336|593101724|FG001|Overall Study|First venipuncture failed|6|||
164199348|NCT04275336|593101725|FG002|Overall Study|First venipuncture failed|5|||
164199349|NCT04275336|593101723|FG000|Overall Study|Unscheduled venipuncture|9|||
164199350|NCT04275336|593101724|FG001|Overall Study|Unscheduled venipuncture|13|||
164199351|NCT04275336|593101725|FG002|Overall Study|Unscheduled venipuncture|7|||
164199352|NCT04275336|593101723|FG000|Overall Study|Failed specimen of saliva|4|||
164199353|NCT04275336|593101724|FG001|Overall Study|Failed specimen of saliva|3|||
164199354|NCT04275336|593101725|FG002|Overall Study|Failed specimen of saliva|4|||
164199355|NCT02053493|593101729|FG000|Overall Study|Withdrawal by Subject|1|||
164199356|NCT02053493|593101730|FG001|Overall Study|Withdrawal by Subject|1|||
164199357|NCT01909804|593101731|FG000|Overall Study|Randomized but Never Treated|0|||
164199358|NCT01909804|593101732|FG001|Overall Study|Randomized but Never Treated|0|||
164199359|NCT01909804|593101733|FG002|Overall Study|Randomized but Never Treated|0|||
164199360|NCT01909804|593101734|FG003|Overall Study|Randomized but Never Treated|0|||
164199361|NCT01909804|593101735|FG004|Overall Study|Randomized but Never Treated|0|||
164199362|NCT01909804|593101736|FG005|Overall Study|Randomized but Never Treated|0|||
164199363|NCT01909804|593101737|FG006|Overall Study|Randomized but Never Treated|1|||
164199364|NCT01909804|593101738|FG007|Overall Study|Randomized but Never Treated|0|||
164199365|NCT01909804|593101739|FG008|Overall Study|Randomized but Never Treated|0|||
164199366|NCT01909804|593101740|FG009|Overall Study|Randomized but Never Treated|0|||
164199367|NCT01909804|593101741|FG010|Overall Study|Randomized but Never Treated|0|||
164199368|NCT01909804|593101742|FG011|Overall Study|Randomized but Never Treated|1|||
164199369|NCT01909804|593101731|FG000|Overall Study|Death|0|||
164199370|NCT01909804|593101732|FG001|Overall Study|Death|0|||
164199371|NCT01909804|593101733|FG002|Overall Study|Death|0|||
164199372|NCT01909804|593101734|FG003|Overall Study|Death|0|||
164199373|NCT01909804|593101735|FG004|Overall Study|Death|0|||
164199374|NCT01909804|593101736|FG005|Overall Study|Death|0|||
164199375|NCT01909804|593101737|FG006|Overall Study|Death|0|||
164199376|NCT01909804|593101738|FG007|Overall Study|Death|0|||
164199377|NCT01909804|593101739|FG008|Overall Study|Death|0|||
164199378|NCT01909804|593101740|FG009|Overall Study|Death|0|||
164199379|NCT01909804|593101741|FG010|Overall Study|Death|1|||
164199380|NCT01909804|593101742|FG011|Overall Study|Death|0|||
164199381|NCT01909804|593101731|FG000|Overall Study|Lack of Efficacy|4|||
164199382|NCT01909804|593101732|FG001|Overall Study|Lack of Efficacy|1|||
164199383|NCT01909804|593101733|FG002|Overall Study|Lack of Efficacy|0|||
164199384|NCT01909804|593101734|FG003|Overall Study|Lack of Efficacy|0|||
164199385|NCT01909804|593101735|FG004|Overall Study|Lack of Efficacy|7|||
163862119|NCT02596035|591860720|FG001|Overall Study|other reasons|4|||
163862120|NCT02596035|591860721|FG002|Overall Study|other reasons|0|||
163862121|NCT00835380|591860724|FG000|Overall Study|Withdrawal by Subject|2|||
163862122|NCT00881335|591860727|FG000|Overall Study|Lost to Follow-up|3|||
163862123|NCT00881335|591860728|FG001|Overall Study|Lost to Follow-up|2|||
163862124|NCT04487080|591860733|FG000|Overall Study|Withdrawal by Subject|19|||
163862125|NCT04487080|591860734|FG001|Overall Study|Withdrawal by Subject|18|||
163862126|NCT04487080|591860735|FG002|Overall Study|Withdrawal by Subject|13|||
163862127|NCT04487080|591860733|FG000|Overall Study|Lost to Follow-up|3|||
163862128|NCT04487080|591860734|FG001|Overall Study|Lost to Follow-up|1|||
163862129|NCT04487080|591860735|FG002|Overall Study|Lost to Follow-up|0|||
163862130|NCT04487080|591860733|FG000|Overall Study|Ongoing|313|||
163862131|NCT04487080|591860734|FG001|Overall Study|Ongoing|297|||
163862132|NCT04487080|591860735|FG002|Overall Study|Ongoing|149|||
163862133|NCT03354390|591860739|FG000|Level 1|Death|2|||
163862134|NCT03354390|591860740|FG001|Level 1|Death|0|||
163862135|NCT03354390|591860741|FG002|Level 1|Death|0|||
163862136|NCT03354390|591860742|FG003|Level 1|Death|0|||
163862137|NCT03354390|591860739|FG000|Level 1|Physician Decision|1|||
163862138|NCT03354390|591860740|FG001|Level 1|Physician Decision|0|||
163862139|NCT03354390|591860741|FG002|Level 1|Physician Decision|0|||
163862140|NCT03354390|591860742|FG003|Level 1|Physician Decision|0|||
163862141|NCT03354390|591860739|FG000|Level 2|Physician Decision|0|||
163862142|NCT03354390|591860740|FG001|Level 2|Physician Decision|2|||
163862143|NCT03354390|591860741|FG002|Level 2|Physician Decision|0|||
163862144|NCT03354390|591860742|FG003|Level 2|Physician Decision|0|||
163862145|NCT03354390|591860739|FG000|Level 2|Lack of Efficacy|0|||
163862146|NCT03354390|591860740|FG001|Level 2|Lack of Efficacy|1|||
163862147|NCT03354390|591860741|FG002|Level 2|Lack of Efficacy|0|||
163862148|NCT03354390|591860742|FG003|Level 2|Lack of Efficacy|0|||
163862149|NCT03354390|591860739|FG000|Level 2|Lost to Follow-up|0|||
163862150|NCT03354390|591860740|FG001|Level 2|Lost to Follow-up|1|||
163862151|NCT03354390|591860741|FG002|Level 2|Lost to Follow-up|0|||
163862152|NCT03354390|591860742|FG003|Level 2|Lost to Follow-up|0|||
163862153|NCT03354390|591860739|FG000|Level 3|Death|0|||
163862154|NCT03354390|591860740|FG001|Level 3|Death|0|||
163862155|NCT03354390|591860741|FG002|Level 3|Death|1|||
163862156|NCT03354390|591860742|FG003|Level 3|Death|0|||
163862157|NCT03354390|591860739|FG000|Level 3|Physician Decision|0|||
163862158|NCT03354390|591860740|FG001|Level 3|Physician Decision|0|||
164199386|NCT01909804|593101736|FG005|Overall Study|Lack of Efficacy|3|||
164199387|NCT01909804|593101737|FG006|Overall Study|Lack of Efficacy|1|||
164199388|NCT01909804|593101738|FG007|Overall Study|Lack of Efficacy|1|||
164199389|NCT01909804|593101739|FG008|Overall Study|Lack of Efficacy|0|||
164199390|NCT01909804|593101740|FG009|Overall Study|Lack of Efficacy|1|||
163862159|NCT03354390|591860741|FG002|Level 3|Physician Decision|2|||
164199391|NCT01909804|593101741|FG010|Overall Study|Lack of Efficacy|0|||
164199392|NCT01909804|593101742|FG011|Overall Study|Lack of Efficacy|1|||
163862160|NCT03354390|591860742|FG003|Level 3|Physician Decision|0|||
163862161|NCT03354390|591860739|FG000|Level 4|Death|0|||
163862162|NCT03354390|591860740|FG001|Level 4|Death|0|||
163862163|NCT03354390|591860741|FG002|Level 4|Death|0|||
163862164|NCT03354390|591860742|FG003|Level 4|Death|3|||
163862165|NCT00486759|591861969|FG000|Treatment|Adverse event/intercurrent illness|86|||
163862166|NCT00486759|591861970|FG001|Treatment|Adverse event/intercurrent illness|39|||
163862167|NCT00486759|591861969|FG000|Treatment|Insufficient therapeutic response|37|||
164199393|NCT01909804|593101731|FG000|Overall Study|Withdrew Consent|0|||
163862168|NCT00486759|591861970|FG001|Treatment|Insufficient therapeutic response|39|||
163862169|NCT00486759|591861969|FG000|Treatment|Death|17|||
164199394|NCT01909804|593101732|FG001|Overall Study|Withdrew Consent|0|||
163862170|NCT00486759|591861970|FG001|Treatment|Death|10|||
163862171|NCT00486759|591861969|FG000|Treatment|Withdrew consent|15|||
163862172|NCT00486759|591861970|FG001|Treatment|Withdrew consent|12|||
163862173|NCT00486759|591861969|FG000|Treatment|Administrative/reason not specified|17|||
164307699|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
164307700|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307701|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307702|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307703|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
164307704|NCT03682770|593501023|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307705|NCT03682770|593501024|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307706|NCT03682770|593501025|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307707|NCT03682770|593501026|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
164307708|NCT03682770|593501027|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307709|NCT03682770|593501028|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307710|NCT03682770|593501029|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
164307711|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307712|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307713|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307714|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
164307715|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
164307716|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
164307717|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
164307718|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307719|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307720|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307721|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307722|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
164307723|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307724|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
164307725|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307726|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307727|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307728|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307729|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307730|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
164307731|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
164307732|NCT03682770|593501023|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307733|NCT03682770|593501024|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307734|NCT03682770|593501025|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307735|NCT03682770|593501026|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307736|NCT03682770|593501027|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
164307737|NCT03682770|593501028|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
164307738|NCT03682770|593501029|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
164307739|NCT02304367|593501030|FG000|Overall Study|Lack of Response to Bruosumab|1|||
164307740|NCT02304367|593501030|FG000|Overall Study|Sponsor Decision|3|||
164307741|NCT02304367|593501030|FG000|Overall Study|Death|2|||
164307742|NCT02304367|593501030|FG000|Overall Study|Physician Decision|1|||
164307743|NCT02304367|593501030|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
164307744|NCT01262989|593501031|FG000|Period 1|Lost to Follow-up|1|||
164307745|NCT01262989|593501032|FG001|Period 1|Lost to Follow-up|1|||
164307746|NCT01262989|593501031|FG000|Period 1|Intercurrent disease|0|||
164307747|NCT01262989|593501032|FG001|Period 1|Intercurrent disease|1|||
164307748|NCT01262989|593501031|FG000|Period 1|Positive answer for exclusion criteria|0|||
164307749|NCT01262989|593501032|FG001|Period 1|Positive answer for exclusion criteria|1|||
164307750|NCT01262989|593501031|FG000|Period 2|Intercurrent disease|0|||
164307751|NCT01262989|593501032|FG001|Period 2|Intercurrent disease|1|||
164307752|NCT03599089|593501033|FG000|Overall Study|Lost to Follow-up|1|||
164307753|NCT03599089|593501034|FG001|Overall Study|Lost to Follow-up|0|||
164307754|NCT03599089|593501035|FG002|Overall Study|Lost to Follow-up|0|||
164307755|NCT03599089|593501036|FG003|Overall Study|Lost to Follow-up|0|||
164307756|NCT03599089|593501033|FG000|Overall Study|Withdrawal by Subject|2|||
164307757|NCT03599089|593501034|FG001|Overall Study|Withdrawal by Subject|1|||
164307758|NCT03599089|593501035|FG002|Overall Study|Withdrawal by Subject|0|||
164307759|NCT03599089|593501036|FG003|Overall Study|Withdrawal by Subject|0|||
164307760|NCT03599089|593501033|FG000|Overall Study|Lack of Efficacy|0|||
164307761|NCT03599089|593501034|FG001|Overall Study|Lack of Efficacy|0|||
164307762|NCT03599089|593501035|FG002|Overall Study|Lack of Efficacy|1|||
164307763|NCT03599089|593501036|FG003|Overall Study|Lack of Efficacy|2|||
164307764|NCT00459186|593501042|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
164307765|NCT00459186|593501042|FG000|PET Imaging and Assessment|Adverse Event|3|||
163967543|NCT04060563|592254168|FG001|Overall Study|Lost to Follow-up|1|||
164307766|NCT00573144|593501043|FG000|Overall Study|Withdrawal by Subject|2|||
164307767|NCT00573144|593501044|FG001|Overall Study|Withdrawal by Subject|3|||
164307768|NCT02500797|593501047|FG000|Overall Study|Cancel (rapid disease progression)|0|||
164307769|NCT02500797|593501048|FG001|Overall Study|Cancel (rapid disease progression)|0|||
164307770|NCT02500797|593501049|FG002|Overall Study|Cancel (rapid disease progression)|0|||
164307771|NCT02500797|593501050|FG003|Overall Study|Cancel (rapid disease progression)|0|||
164307772|NCT02500797|593501051|FG004|Overall Study|Cancel (rapid disease progression)|1|||
164307773|NCT02500797|593501052|FG005|Overall Study|Cancel (rapid disease progression)|1|||
164307774|NCT02500797|593501053|FG006|Overall Study|Cancel (rapid disease progression)|0|||
164307775|NCT02500797|593501054|FG007|Overall Study|Cancel (rapid disease progression)|0|||
164307776|NCT02500797|593501047|FG000|Overall Study|Withdrawal by Subject|1|||
164307777|NCT02500797|593501048|FG001|Overall Study|Withdrawal by Subject|0|||
164307778|NCT02500797|593501049|FG002|Overall Study|Withdrawal by Subject|0|||
164307779|NCT02500797|593501050|FG003|Overall Study|Withdrawal by Subject|0|||
164307780|NCT02500797|593501051|FG004|Overall Study|Withdrawal by Subject|0|||
164307781|NCT02500797|593501052|FG005|Overall Study|Withdrawal by Subject|0|||
164307782|NCT02500797|593501053|FG006|Overall Study|Withdrawal by Subject|0|||
164307783|NCT02500797|593501054|FG007|Overall Study|Withdrawal by Subject|0|||
164307784|NCT00357006|593501061|FG000|Overall Study|Lost to Follow-up|1|||
164307785|NCT00357006|593501062|FG001|Overall Study|Lost to Follow-up|2|||
164307786|NCT00357006|593501063|FG002|Overall Study|Lost to Follow-up|1|||
164307787|NCT00357006|593501061|FG000|Overall Study|Withdrawal by Subject|1|||
164307788|NCT00357006|593501062|FG001|Overall Study|Withdrawal by Subject|3|||
164307789|NCT00357006|593501063|FG002|Overall Study|Withdrawal by Subject|2|||
164307790|NCT03710161|593501064|FG000|Overall Study|Study halted due to COVID pandemic|3|||
164307791|NCT03710161|593501065|FG001|Overall Study|Study halted due to COVID pandemic|2|||
164307792|NCT02637037|593501066|FG000|Overall Study|Positive drug screen at admission|1|||
164307793|NCT02637037|593501067|FG001|Overall Study|Positive drug screen at admission|0|||
164307794|NCT02637037|593501066|FG000|Overall Study|Withdrawal by Subject|2|||
164307795|NCT02637037|593501067|FG001|Overall Study|Withdrawal by Subject|1|||
164307796|NCT02637037|593501066|FG000|Overall Study|Adverse Event|1|||
164307797|NCT02637037|593501067|FG001|Overall Study|Adverse Event|0|||
164307798|NCT00074490|593501068|FG000|Overall Study|Progressive malignancy|0|||
164307799|NCT00074490|593501069|FG001|Overall Study|Progressive malignancy|7|||
164307800|NCT00074490|593501070|FG002|Overall Study|Progressive malignancy|0|||
164307801|NCT00074490|593501071|FG003|Overall Study|Progressive malignancy|0|||
164307802|NCT00074490|593501072|FG004|Overall Study|Progressive malignancy|3|||
164307803|NCT00074490|593501073|FG005|Overall Study|Progressive malignancy|0|||
164307804|NCT01526733|593501074|FG000|Phase 1|Protocol Violation|1|||
164307805|NCT01526733|593501075|FG001|Phase 1|Protocol Violation|0|||
164307806|NCT01526733|593501074|FG000|Phase 1|Withdrawal by Subject|1|||
164307807|NCT01526733|593501075|FG001|Phase 1|Withdrawal by Subject|1|||
164307808|NCT01869764|593501081|FG000|Overall Study|Withdrawal by Subject|0|||
164307809|NCT01869764|593501082|FG001|Overall Study|Withdrawal by Subject|2|||
164307810|NCT02175030|593501083|FG000|Overall Study|Failed screen after consent|7|||
164307811|NCT02175030|593501084|FG001|Overall Study|Failed screen after consent|6|||
164307812|NCT02175030|593501083|FG000|Overall Study|Failed IUD Insertion|20|||
164307813|NCT02175030|593501084|FG001|Overall Study|Failed IUD Insertion|21|||
164307814|NCT02175030|593501083|FG000|Overall Study|Physician Decision|1|||
164307815|NCT02175030|593501084|FG001|Overall Study|Physician Decision|1|||
164307816|NCT02175030|593501083|FG000|Overall Study|Lost to Follow-up|6|||
164307817|NCT02175030|593501084|FG001|Overall Study|Lost to Follow-up|6|||
164307818|NCT02175030|593501083|FG000|Overall Study|Withdrawal by Subject|1|||
164307819|NCT02175030|593501084|FG001|Overall Study|Withdrawal by Subject|4|||
164307820|NCT00068419|593501090|FG000|Overall Study|Adverse Event|3|||
164307821|NCT00068419|593501090|FG000|Overall Study|Lack of Efficacy|24|||
164307822|NCT00068419|593501090|FG000|Overall Study|Lost to Follow-up|1|||
164307823|NCT00068419|593501090|FG000|Overall Study|Physician Decision|7|||
164307824|NCT00068419|593501090|FG000|Overall Study|Withdrawal by Subject|14|||
164307825|NCT00068419|593501090|FG000|Overall Study|Ineligible|11|||
164307826|NCT02506244|593501095|FG000|Overall Study|Did not undergo active monitoring|458|||
164307827|NCT02506244|593501096|FG001|Overall Study|Did not undergo active monitoring|459|||
164307828|NCT02506244|593501097|FG002|Overall Study|Did not undergo active monitoring|0|||
164307829|NCT02170077|593501102|FG000|Overall Study|Withdrawal by Subject|3|||
164307830|NCT02170077|593501103|FG001|Overall Study|Withdrawal by Subject|4|||
164307831|NCT02170077|593501104|FG002|Overall Study|Withdrawal by Subject|2|||
164307832|NCT02170077|593501102|FG000|Overall Study|Adverse Event|4|||
164307833|NCT02170077|593501103|FG001|Overall Study|Adverse Event|4|||
164307834|NCT02170077|593501104|FG002|Overall Study|Adverse Event|4|||
164307835|NCT02170077|593501102|FG000|Overall Study|Lost to Follow-up|0|||
164307836|NCT02170077|593501103|FG001|Overall Study|Lost to Follow-up|1|||
164307837|NCT02170077|593501104|FG002|Overall Study|Lost to Follow-up|0|||
164307838|NCT02170077|593501102|FG000|Overall Study|Exclusion criteria|2|||
164307839|NCT02170077|593501103|FG001|Overall Study|Exclusion criteria|2|||
164307840|NCT02170077|593501104|FG002|Overall Study|Exclusion criteria|5|||
164307841|NCT02170077|593501102|FG000|Overall Study|Exacerbation of seizures|0|||
164199395|NCT01909804|593101733|FG002|Overall Study|Withdrew Consent|0|||
164199396|NCT01909804|593101734|FG003|Overall Study|Withdrew Consent|0|||
164199397|NCT01909804|593101735|FG004|Overall Study|Withdrew Consent|1|||
164199398|NCT01909804|593101736|FG005|Overall Study|Withdrew Consent|1|||
164199399|NCT01909804|593101737|FG006|Overall Study|Withdrew Consent|0|||
164199400|NCT01909804|593101738|FG007|Overall Study|Withdrew Consent|0|||
164199401|NCT01909804|593101739|FG008|Overall Study|Withdrew Consent|0|||
164199402|NCT01909804|593101740|FG009|Overall Study|Withdrew Consent|0|||
164199403|NCT01909804|593101741|FG010|Overall Study|Withdrew Consent|0|||
164199404|NCT01909804|593101742|FG011|Overall Study|Withdrew Consent|0|||
164199405|NCT01909804|593101731|FG000|Overall Study|Protocol Violation|0|||
164199406|NCT01909804|593101732|FG001|Overall Study|Protocol Violation|0|||
164199407|NCT01909804|593101733|FG002|Overall Study|Protocol Violation|0|||
164199408|NCT01909804|593101734|FG003|Overall Study|Protocol Violation|0|||
164199409|NCT01909804|593101735|FG004|Overall Study|Protocol Violation|0|||
164199410|NCT01909804|593101736|FG005|Overall Study|Protocol Violation|0|||
164199411|NCT01909804|593101737|FG006|Overall Study|Protocol Violation|0|||
164199412|NCT01909804|593101738|FG007|Overall Study|Protocol Violation|0|||
164199413|NCT01909804|593101739|FG008|Overall Study|Protocol Violation|0|||
164199414|NCT01909804|593101740|FG009|Overall Study|Protocol Violation|0|||
164199415|NCT01909804|593101741|FG010|Overall Study|Protocol Violation|0|||
164199416|NCT01909804|593101742|FG011|Overall Study|Protocol Violation|1|||
164199417|NCT05222880|593101744|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164199418|NCT05222880|593101744|FG000|Overall Study|Withdrew Consent during Study|1|||
164199419|NCT05222880|593101744|FG000|Overall Study|COVID-19 Related|1|||
164199420|NCT05401565|593101745|FG000|Overall Study|Lost to Follow-up|1|||
164199421|NCT05401565|593101746|FG001|Overall Study|Lost to Follow-up|0|||
164199422|NCT05401565|593101745|FG000|Overall Study|Adverse Event|2|||
164199423|NCT05401565|593101746|FG001|Overall Study|Adverse Event|0|||
164199424|NCT00617357|593101749|FG000|Overall Study|Lost to Follow-up|7|||
164199425|NCT00617357|593101749|FG000|Overall Study|Death|5|||
164199426|NCT00617357|593101749|FG000|Overall Study|insurance concerns|2|||
164199427|NCT00617357|593101749|FG000|Overall Study|Withdrawal by Subject|1|||
164199428|NCT00617357|593101749|FG000|Overall Study|Physician Decision|1|||
164199429|NCT02153918|593101754|FG000|Overall Study|Refused further treatment|1|||
164199430|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199431|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199432|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199433|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199434|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199435|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
164199436|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Refused|0|||
164199437|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Refused|0|||
164199438|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Refused|0|||
164199439|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Refused|0|||
164199440|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Refused|1|||
164199441|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Refused|0|||
164199442|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199443|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
164199444|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199445|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199446|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199447|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
164199448|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|Death|0|||
164199449|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|Death|0|||
164199450|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|Death|0|||
164199451|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|Death|0|||
164199452|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|Death|1|||
164199453|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|Death|0|||
164199454|NCT03327324|593101755|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199455|NCT03327324|593101756|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199456|NCT03327324|593101757|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199457|NCT03327324|593101758|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199458|NCT03327324|593101759|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199459|NCT03327324|593101760|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
164199460|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199461|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164307842|NCT02170077|593501103|FG001|Overall Study|Exacerbation of seizures|2|||
164307843|NCT02170077|593501104|FG002|Overall Study|Exacerbation of seizures|1|||
164307844|NCT01780974|593501105|FG000|Overall Study|Death|1|||
164307845|NCT01780974|593501106|FG001|Overall Study|Death|0|||
164307846|NCT01780974|593501105|FG000|Overall Study|Adverse Event|1|||
164307847|NCT01780974|593501106|FG001|Overall Study|Adverse Event|3|||
164307848|NCT02447003|593501109|FG000|Overall Study|Other|0|||
164307849|NCT02447003|593501110|FG001|Overall Study|Other|4|||
164307850|NCT02447003|593501109|FG000|Overall Study|Site discontinued|0|||
164307851|NCT02447003|593501110|FG001|Overall Study|Site discontinued|2|||
164307852|NCT02447003|593501109|FG000|Overall Study|Physician Decision|0|||
164307853|NCT02447003|593501110|FG001|Overall Study|Physician Decision|1|||
164307854|NCT02447003|593501109|FG000|Overall Study|Withdrawal by Subject|4|||
164307855|NCT02447003|593501110|FG001|Overall Study|Withdrawal by Subject|3|||
164307856|NCT02447003|593501109|FG000|Overall Study|Sponsor Decision|6|||
164307857|NCT02447003|593501110|FG001|Overall Study|Sponsor Decision|11|||
164307858|NCT02447003|593501109|FG000|Overall Study|Progressive Disease|1|||
164307859|NCT02447003|593501110|FG001|Overall Study|Progressive Disease|0|||
164307860|NCT02447003|593501109|FG000|Overall Study|Lost to Follow-up|5|||
164307861|NCT02447003|593501110|FG001|Overall Study|Lost to Follow-up|0|||
164307862|NCT02447003|593501109|FG000|Overall Study|Death|154|||
164307863|NCT02447003|593501110|FG001|Overall Study|Death|63|||
164307864|NCT00750438|593501111|FG000|Overall Study|Protocol Violation|4|||
164307865|NCT00750438|593501112|FG001|Overall Study|Protocol Violation|1|||
164307866|NCT00750438|593501111|FG000|Overall Study|Physician Decision|2|||
164307867|NCT00750438|593501112|FG001|Overall Study|Physician Decision|2|||
164307868|NCT00750438|593501111|FG000|Overall Study|Withdrawal by Subject|1|||
164307869|NCT00750438|593501112|FG001|Overall Study|Withdrawal by Subject|1|||
164307870|NCT03848728|593501113|FG000|Overall Study|Death|16|||
164307871|NCT03848728|593501114|FG001|Overall Study|Death|13|||
164307872|NCT03848728|593501113|FG000|Overall Study|Outmigrated to non-study community|98|||
164307873|NCT03848728|593501114|FG001|Overall Study|Outmigrated to non-study community|106|||
164307874|NCT03848728|593501113|FG000|Overall Study|Transfered to non-study clinic|32|||
164307875|NCT03848728|593501114|FG001|Overall Study|Transfered to non-study clinic|48|||
164307876|NCT03848728|593501113|FG000|Overall Study|Withdrawal by Subject|1|||
164307877|NCT03848728|593501114|FG001|Overall Study|Withdrawal by Subject|0|||
164307878|NCT00670748|593501116|FG000|Overall Study|Death during treatment|1|||
164307879|NCT00670748|593501117|FG001|Overall Study|Death during treatment|1|||
164307880|NCT00670748|593501118|FG002|Overall Study|Death during treatment|1|||
164307881|NCT00670748|593501119|FG003|Overall Study|Death during treatment|0|||
164307882|NCT00670748|593501116|FG000|Overall Study|Not off study|2|||
164307883|NCT00670748|593501117|FG001|Overall Study|Not off study|1|||
164307884|NCT00670748|593501118|FG002|Overall Study|Not off study|1|||
164307885|NCT00670748|593501119|FG003|Overall Study|Not off study|1|||
164307886|NCT01185080|593501120|FG000|Overall Study|Adverse Event|1|||
164307887|NCT01185080|593501121|FG001|Overall Study|Adverse Event|1|||
164307888|NCT01185080|593501122|FG002|Overall Study|Adverse Event|0|||
164307889|NCT01185080|593501120|FG000|Overall Study|Personal reasons|0|||
164307890|NCT01185080|593501121|FG001|Overall Study|Personal reasons|0|||
164307891|NCT01185080|593501122|FG002|Overall Study|Personal reasons|1|||
164307892|NCT02736578|593501125|FG000|Overall Study|Adverse Event|1|||
164307893|NCT02736578|593501126|FG001|Overall Study|Adverse Event|0|||
164307894|NCT05615922|593501129|FG000|Overall Study|Lost to Follow-up|1|||
164307895|NCT06083506|593501130|FG000|Overall Study|Physician Decision|2|||
164307896|NCT06083506|593501130|FG000|Overall Study|Lack of Efficacy|1|||
164307897|NCT04500158|593501131|FG000|Overall Study|Physician Decision|17|||
164307898|NCT04500158|593501132|FG001|Overall Study|Physician Decision|11|||
164307899|NCT00905164|593501136|FG000|Period 1|Protocol Violation|0|||
164307900|NCT00905164|593501137|FG001|Period 1|Protocol Violation|1|||
164307901|NCT04730804|593501138|FG000|Overall Study|Physician Decision|0|||
164307902|NCT04730804|593501139|FG001|Overall Study|Physician Decision|0|||
164307903|NCT04730804|593501140|FG002|Overall Study|Physician Decision|0|||
164307904|NCT04730804|593501141|FG003|Overall Study|Physician Decision|0|||
164307905|NCT04730804|593501142|FG004|Overall Study|Physician Decision|0|||
164307906|NCT04730804|593501143|FG005|Overall Study|Physician Decision|1|||
164307907|NCT04730804|593501138|FG000|Overall Study|Withdrawal by Subject|0|||
164307908|NCT04730804|593501139|FG001|Overall Study|Withdrawal by Subject|0|||
164307909|NCT04730804|593501140|FG002|Overall Study|Withdrawal by Subject|0|||
164307910|NCT04730804|593501141|FG003|Overall Study|Withdrawal by Subject|0|||
164307911|NCT04730804|593501142|FG004|Overall Study|Withdrawal by Subject|1|||
164307912|NCT04730804|593501143|FG005|Overall Study|Withdrawal by Subject|2|||
164307913|NCT01193257|593502451|FG000|Overall Study|Death|202|||
164307914|NCT01193257|593502452|FG001|Overall Study|Death|391|||
164307915|NCT01193257|593502451|FG000|Overall Study|Study termination by sponsor|0|||
164307916|NCT01193257|593502452|FG001|Overall Study|Study termination by sponsor|3|||
164307917|NCT01193257|593502451|FG000|Overall Study|Withdrawal by Subject|26|||
164307918|NCT01193257|593502452|FG001|Overall Study|Withdrawal by Subject|86|||
164307919|NCT01193257|593502451|FG000|Overall Study|Lost to Follow-up|2|||
164307920|NCT01193257|593502452|FG001|Overall Study|Lost to Follow-up|3|||
164307921|NCT01193257|593502451|FG000|Overall Study|Unblinded due to futility|135|||
164307922|NCT01193257|593502452|FG001|Overall Study|Unblinded due to futility|251|||
164307923|NCT01330108|593502468|FG000|Overall Study|Withdrawal by Subject|4|||
164307924|NCT00423917|593502471|FG000|Overall Study|Cancel|2|||
164307925|NCT00423917|593502471|FG000|Overall Study|Ineligible|1|||
164307926|NCT00555061|593502472|FG000|Overall Study|Adverse Event|3|||
164307927|NCT00555061|593502472|FG000|Overall Study|Protocol Violation|1|||
164307928|NCT00555061|593502472|FG000|Overall Study|Lost to Follow-up|2|||
164307929|NCT00555061|593502472|FG000|Overall Study|Withdrawal by Subject|2|||
164307930|NCT00555061|593502472|FG000|Overall Study|Participant enrolled, but never treated|1|||
164307931|NCT01175083|593502473|FG000|Primary Epoch|Withdrawal by Subject|0|||
164307932|NCT01175083|593502474|FG001|Primary Epoch|Withdrawal by Subject|0|||
164307933|NCT01175083|593502475|FG002|Primary Epoch|Withdrawal by Subject|0|||
164307934|NCT01175083|593502476|FG003|Primary Epoch|Withdrawal by Subject|0|||
164307935|NCT01175083|593502477|FG004|Primary Epoch|Withdrawal by Subject|0|||
164307936|NCT01175083|593502478|FG005|Primary Epoch|Withdrawal by Subject|2|||
164307937|NCT01175083|593502473|FG000|Primary Epoch|Lost to Follow-up|0|||
164307938|NCT01175083|593502474|FG001|Primary Epoch|Lost to Follow-up|0|||
164307939|NCT01175083|593502475|FG002|Primary Epoch|Lost to Follow-up|0|||
164307940|NCT01175083|593502476|FG003|Primary Epoch|Lost to Follow-up|0|||
164307941|NCT01175083|593502477|FG004|Primary Epoch|Lost to Follow-up|0|||
164307942|NCT01175083|593502478|FG005|Primary Epoch|Lost to Follow-up|1|||
164307943|NCT01175083|593502473|FG000|Booster Epoch|Death|0|||
164307944|NCT01175083|593502474|FG001|Booster Epoch|Death|0|||
164307945|NCT01175083|593502475|FG002|Booster Epoch|Death|1|||
164307946|NCT01175083|593502476|FG003|Booster Epoch|Death|0|||
164307947|NCT01175083|593502477|FG004|Booster Epoch|Death|0|||
164307948|NCT01175083|593502478|FG005|Booster Epoch|Death|0|||
164307949|NCT01175083|593502473|FG000|Booster Epoch|Withdrawal by Subject|0|||
164307950|NCT01175083|593502474|FG001|Booster Epoch|Withdrawal by Subject|0|||
164307951|NCT01175083|593502475|FG002|Booster Epoch|Withdrawal by Subject|0|||
164307952|NCT01175083|593502476|FG003|Booster Epoch|Withdrawal by Subject|1|||
164307953|NCT01175083|593502477|FG004|Booster Epoch|Withdrawal by Subject|0|||
164307954|NCT01175083|593502478|FG005|Booster Epoch|Withdrawal by Subject|0|||
164307955|NCT02881567|593502479|FG000|Overall Study|Adverse Event|1|||
164307956|NCT02881567|593502479|FG000|Overall Study|Lost to Follow-up|3|||
164307957|NCT02881567|593502479|FG000|Overall Study|Consent withdrawn|1|||
164307958|NCT02881567|593502479|FG000|Overall Study|Investigator decision|1|||
164307959|NCT02881567|593502479|FG000|Overall Study|Study terminated by sponsor|9|||
164307960|NCT02881567|593502479|FG000|Overall Study|Reason not Specified|3|||
164307961|NCT00373113|593502481|FG000|Overall Study|Death|1|||
164307962|NCT00373113|593502482|FG001|Overall Study|Death|7|||
164307963|NCT00373113|593502481|FG000|Overall Study|Adverse Event|38|||
164307964|NCT00373113|593502482|FG001|Overall Study|Adverse Event|24|||
164307965|NCT00373113|593502481|FG000|Overall Study|Study terminated by sponsor|9|||
164307966|NCT00373113|593502482|FG001|Overall Study|Study terminated by sponsor|1|||
164307967|NCT00373113|593502481|FG000|Overall Study|Global deterioration of health status|10|||
164307968|NCT00373113|593502482|FG001|Overall Study|Global deterioration of health status|7|||
164307969|NCT00373113|593502481|FG000|Overall Study|Lost to Follow-up|1|||
164307970|NCT00373113|593502482|FG001|Overall Study|Lost to Follow-up|3|||
164307971|NCT00373113|593502481|FG000|Overall Study|Objective progression or relapse|150|||
164307972|NCT00373113|593502482|FG001|Overall Study|Objective progression or relapse|169|||
164307973|NCT00373113|593502481|FG000|Overall Study|Other|14|||
164307974|NCT00373113|593502482|FG001|Overall Study|Other|17|||
164307975|NCT00373113|593502481|FG000|Overall Study|Protocol Violation|5|||
164307976|NCT00373113|593502482|FG001|Overall Study|Protocol Violation|1|||
164307977|NCT00373113|593502481|FG000|Overall Study|Withdrawal by Subject|10|||
164307978|NCT00373113|593502482|FG001|Overall Study|Withdrawal by Subject|15|||
164307979|NCT03830892|593502484|FG000|Overall Study|Physician Decision|2|||
164307980|NCT03830892|593502485|FG001|Overall Study|Physician Decision|3|||
163967544|NCT04060563|592254167|FG000|Overall Study|Physician Decision|0|||
163967545|NCT04060563|592254168|FG001|Overall Study|Physician Decision|1|||
163967546|NCT00851682|592254169|FG000|Overall Study|screen failure|5|||
163967547|NCT00851682|592254170|FG001|Overall Study|screen failure|0|||
163967548|NCT01379573|592254176|FG000|Overall Study|Lost to Follow-up|1|||
164307981|NCT03830892|593502484|FG000|Overall Study|Study terminated due to COVID|4|||
164307982|NCT03830892|593502485|FG001|Overall Study|Study terminated due to COVID|0|||
164307983|NCT03830892|593502484|FG000|Overall Study|Protocol Violation|0|||
163967549|NCT01379573|592254176|FG000|Overall Study|Screen Failure|10|||
163967550|NCT00770770|592254179|FG000|Overall Study|Lost to Follow-up|1|||
164307984|NCT03830892|593502485|FG001|Overall Study|Protocol Violation|1|||
164307985|NCT03830892|593502484|FG000|Overall Study|Withdrawal by Subject|0|||
164307986|NCT03830892|593502485|FG001|Overall Study|Withdrawal by Subject|2|||
164307987|NCT01499277|593502486|FG000|Overall Study|Adverse Event|3|||
164307988|NCT01499277|593502487|FG001|Overall Study|Adverse Event|6|||
164307989|NCT01499277|593502486|FG000|Overall Study|Death|3|||
164307990|NCT01499277|593502487|FG001|Overall Study|Death|2|||
164307991|NCT01499277|593502486|FG000|Overall Study|Lost to Follow-up|15|||
164307992|NCT01499277|593502487|FG001|Overall Study|Lost to Follow-up|8|||
164307993|NCT01499277|593502486|FG000|Overall Study|Protocol Violation|2|||
164307994|NCT01499277|593502487|FG001|Overall Study|Protocol Violation|3|||
164307995|NCT01499277|593502486|FG000|Overall Study|Withdrawal by Subject|16|||
164307996|NCT01499277|593502487|FG001|Overall Study|Withdrawal by Subject|6|||
164307997|NCT01499277|593502486|FG000|Overall Study|Lack of therapeutic response and other|8|||
164307998|NCT01499277|593502487|FG001|Overall Study|Lack of therapeutic response and other|7|||
164307999|NCT00975689|593502488|FG000|Overall Study|Adverse Event|0|||
164308000|NCT00975689|593502489|FG001|Overall Study|Adverse Event|3|||
164308001|NCT00975689|593502488|FG000|Overall Study|Withdrawal by Subject|1|||
164308002|NCT00975689|593502489|FG001|Overall Study|Withdrawal by Subject|0|||
164308003|NCT00975689|593502488|FG000|Overall Study|Physician Decision|1|||
164308004|NCT00975689|593502489|FG001|Overall Study|Physician Decision|0|||
164308005|NCT00372593|593502492|FG000|Overall Study|Adverse Event|43|||
164308006|NCT00372593|593502493|FG001|Overall Study|Adverse Event|45|||
164308007|NCT00372593|593502494|FG002|Overall Study|Adverse Event|0|||
164308008|NCT00372593|593502492|FG000|Overall Study|Death|16|||
164308009|NCT00372593|593502493|FG001|Overall Study|Death|20|||
164308010|NCT00372593|593502494|FG002|Overall Study|Death|1|||
164308011|NCT00372593|593502492|FG000|Overall Study|Lack of Efficacy|82|||
164308012|NCT00372593|593502493|FG001|Overall Study|Lack of Efficacy|71|||
164308013|NCT00372593|593502494|FG002|Overall Study|Lack of Efficacy|2|||
164308014|NCT00372593|593502492|FG000|Overall Study|Lost to Follow-up|1|||
164308015|NCT00372593|593502493|FG001|Overall Study|Lost to Follow-up|0|||
164308016|NCT00372593|593502494|FG002|Overall Study|Lost to Follow-up|0|||
164308017|NCT00372593|593502492|FG000|Overall Study|Physician Decision|42|||
164308018|NCT00372593|593502493|FG001|Overall Study|Physician Decision|41|||
164308019|NCT00372593|593502494|FG002|Overall Study|Physician Decision|0|||
164308020|NCT00372593|593502492|FG000|Overall Study|Ineligible|20|||
164308021|NCT00372593|593502493|FG001|Overall Study|Ineligible|21|||
164308022|NCT00372593|593502494|FG002|Overall Study|Ineligible|1|||
164308023|NCT02974543|593502495|FG000|Overall Study|Withdrawal by Subject|1|||
164308024|NCT02974543|593502496|FG001|Overall Study|Withdrawal by Subject|0|||
164308025|NCT03534180|593502497|FG000|Overall Study|Withdrawal by Subject|1|||
164308026|NCT00220636|593502498|FG000|Overall Study|Withdrawal by Subject|4|||
164308027|NCT00330967|593502499|FG000|Overall Study|Withdrawal by Subject|0|||
164308028|NCT00330967|593502500|FG001|Overall Study|Withdrawal by Subject|5|||
164308029|NCT00330967|593502499|FG000|Overall Study|Physician Decision|0|||
164308030|NCT00330967|593502500|FG001|Overall Study|Physician Decision|9|||
164308031|NCT01662102|593502506|FG000|Overall Study|Sponsor's decision|1|||
164308032|NCT01662102|593502507|FG001|Overall Study|Sponsor's decision|0|||
164308033|NCT02586207|593502508|FG000|Overall Study|Physician Decision|1|||
164308034|NCT02586207|593502508|FG000|Overall Study|Withdrawal by Subject|1|||
164308035|NCT02362282|593502512|FG000|Overall Study|Withdrawal by Subject|1|||
164308036|NCT02362282|593502513|FG001|Overall Study|Withdrawal by Subject|0|||
164308037|NCT02004093|593502514|FG000|Overall Study|Death|2|||
164308038|NCT02004093|593502515|FG001|Overall Study|Death|1|||
164308039|NCT02004093|593502514|FG000|Overall Study|Lack of Efficacy|66|||
164308040|NCT02004093|593502515|FG001|Overall Study|Lack of Efficacy|62|||
164308041|NCT02004093|593502514|FG000|Overall Study|Protocol Violation|0|||
164308042|NCT02004093|593502515|FG001|Overall Study|Protocol Violation|1|||
164308043|NCT02004093|593502514|FG000|Overall Study|Lost to Follow-up|0|||
164308044|NCT02004093|593502515|FG001|Overall Study|Lost to Follow-up|1|||
164308045|NCT02004093|593502514|FG000|Overall Study|Withdrawal by Subject|3|||
164308046|NCT02004093|593502515|FG001|Overall Study|Withdrawal by Subject|7|||
164308047|NCT02004093|593502514|FG000|Overall Study|Other|3|||
164308048|NCT02004093|593502515|FG001|Overall Study|Other|1|||
164308049|NCT04085289|593502516|FG000|Overall Study|Withdrawal by Subject|0|||
164308050|NCT04085289|593502517|FG001|Overall Study|Withdrawal by Subject|0|||
164308051|NCT04085289|593502518|FG002|Overall Study|Withdrawal by Subject|1|||
164308052|NCT00774566|593502519|FG000|Overall Study|Protocol Violation|18|||
164308053|NCT00774566|593502520|FG001|Overall Study|Protocol Violation|15|||
164308054|NCT04896073|593502521|FG000|Overall Study|Screen failure|0|||
164308055|NCT04896073|593502522|FG001|Overall Study|Screen failure|2|||
164308056|NCT04896073|593502521|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
164308057|NCT04896073|593502522|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
164308058|NCT00439517|593502523|FG000|Overall Study|Subject on treatment|1|||
164308059|NCT00439517|593502524|FG001|Overall Study|Subject on treatment|0|||
164308060|NCT00439517|593502523|FG000|Overall Study|Subject in survival follow-up|1|||
164308061|NCT00439517|593502524|FG001|Overall Study|Subject in survival follow-up|0|||
164308062|NCT03527732|593502527|FG000|Overall Study|Lost to Follow-up|21|||
164308063|NCT03527732|593502528|FG001|Overall Study|Lost to Follow-up|23|||
164308064|NCT03527732|593502529|FG002|Overall Study|Lost to Follow-up|80|||
164308065|NCT03527732|593502530|FG003|Overall Study|Lost to Follow-up|62|||
164308066|NCT03527732|593502531|FG004|Overall Study|Lost to Follow-up|12|||
164308067|NCT03527732|593502532|FG005|Overall Study|Lost to Follow-up|20|||
164308068|NCT00470275|593502533|FG000|Overall Study|Death|1|||
164308069|NCT00470275|593502533|FG000|Overall Study|Lack of Efficacy|7|||
164308070|NCT00470275|593502533|FG000|Overall Study|Withdrawal by Subject|2|||
164308071|NCT02207088|593502534|FG000|Overall Study|Adverse Event|2|||
164308072|NCT04411667|593502544|FG000|Overall Study|Physician Decision|1|||
164308073|NCT04411667|593502545|FG001|Overall Study|Physician Decision|0|||
164308074|NCT03399552|593502547|FG000|Overall Study|No evidence of disease|1|||
164308075|NCT03399552|593502547|FG000|Overall Study|Unevaluable|1|||
164308076|NCT01147874|593502552|FG000|Overall Study|Adverse Event|5|||
164308077|NCT01147874|593502552|FG000|Overall Study|Investigator's Request|1|||
164308078|NCT01147874|593502552|FG000|Overall Study|Lost to Follow-up|25|||
164308079|NCT01147874|593502552|FG000|Overall Study|Other|5|||
164308080|NCT01147874|593502552|FG000|Overall Study|Protocol Violation|5|||
164308081|NCT01147874|593502552|FG000|Overall Study|Sponsor's Decision|2|||
164308082|NCT01147874|593502552|FG000|Overall Study|Withdrawal by Subject|24|||
164308083|NCT02991040|593502553|FG000|Overall Study|Withdrawal by Subject|2|||
164308084|NCT02991040|593502553|FG000|Overall Study|Lost to Follow-up|2|||
164308085|NCT04287517|593502554|FG000|Overall Study|Withdrawal by Subject|1|||
164308086|NCT04287517|593502555|FG001|Overall Study|Withdrawal by Subject|1|||
164308087|NCT02533453|593502559|FG000|Overall Study|Adverse Event|6|||
164308088|NCT02533453|593502559|FG000|Overall Study|Protocol Violation|1|||
164308089|NCT02533453|593502559|FG000|Overall Study|Withdrawal by Subject|2|||
164308090|NCT01273519|593502560|FG000|Overall Study|Adverse Event|3|||
164308091|NCT01273519|593502561|FG001|Overall Study|Adverse Event|0|||
164308092|NCT01273519|593502562|FG002|Overall Study|Adverse Event|0|||
164308093|NCT01273519|593502560|FG000|Overall Study|Lost to Follow-up|2|||
164308094|NCT01273519|593502561|FG001|Overall Study|Lost to Follow-up|1|||
164308095|NCT01273519|593502562|FG002|Overall Study|Lost to Follow-up|3|||
164308096|NCT01273519|593502560|FG000|Overall Study|Lack of Efficacy|8|||
164308097|NCT01273519|593502561|FG001|Overall Study|Lack of Efficacy|3|||
164308098|NCT01273519|593502562|FG002|Overall Study|Lack of Efficacy|4|||
164308099|NCT01273519|593502560|FG000|Overall Study|Other|6|||
164308100|NCT01273519|593502561|FG001|Overall Study|Other|1|||
164308101|NCT01273519|593502562|FG002|Overall Study|Other|1|||
164308102|NCT00396253|593502564|FG000|Overall Study|Protocol Violation|1|||
164308103|NCT00396253|593502564|FG000|Overall Study|Withdrawal by Subject|7|||
164308104|NCT00396253|593502564|FG000|Overall Study|Death|3|||
164308105|NCT00396253|593502564|FG000|Overall Study|Physician Decision|1|||
164308106|NCT00396253|593502564|FG000|Overall Study|Change in eligibility status|1|||
164308107|NCT00092443|593502565|FG000|Overall Study|Adverse Event|9|||
164308108|NCT00092443|593502566|FG001|Overall Study|Adverse Event|13|||
164308109|NCT00092443|593502565|FG000|Overall Study|Lost to Follow-up|7|||
164308110|NCT00092443|593502566|FG001|Overall Study|Lost to Follow-up|3|||
164308111|NCT00092443|593502565|FG000|Overall Study|Protocol Violation|11|||
164308112|NCT00092443|593502566|FG001|Overall Study|Protocol Violation|9|||
164308113|NCT00092443|593502565|FG000|Overall Study|Withdrawal by Subject|9|||
164308114|NCT00092443|593502566|FG001|Overall Study|Withdrawal by Subject|11|||
164308115|NCT00092443|593502565|FG000|Overall Study|Moved|5|||
164308116|NCT00092443|593502566|FG001|Overall Study|Moved|5|||
164308117|NCT00092443|593502565|FG000|Overall Study|Other|17|||
164308118|NCT00092443|593502566|FG001|Overall Study|Other|13|||
164308119|NCT04717336|593502567|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
164308120|NCT04717336|593502568|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
164308121|NCT04717336|593502567|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
164308122|NCT04717336|593502568|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
164308123|NCT01724346|593502572|FG000|Overall Study|Death|42|||
164308124|NCT01724346|593502573|FG001|Overall Study|Death|42|||
164308125|NCT01724346|593502572|FG000|Overall Study|Lost to Follow-up|5|||
164308126|NCT01724346|593502573|FG001|Overall Study|Lost to Follow-up|1|||
164308127|NCT01724346|593502572|FG000|Overall Study|Withdrawal by Subject|27|||
164308128|NCT01724346|593502573|FG001|Overall Study|Withdrawal by Subject|19|||
164308129|NCT01724346|593502572|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
164308130|NCT01724346|593502573|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
164308131|NCT00536744|593502576|FG000|Overall Study|Adverse Event|13|||
164308132|NCT00536744|593502577|FG001|Overall Study|Adverse Event|10|||
164308133|NCT00536744|593502576|FG000|Overall Study|Death|2|||
163967551|NCT00770770|592254180|FG001|Overall Study|Lost to Follow-up|0|||
163967552|NCT00770770|592254179|FG000|Overall Study|Withdrawal by Subject|1|||
164308134|NCT00536744|593502577|FG001|Overall Study|Death|1|||
164308135|NCT00536744|593502576|FG000|Overall Study|Physician Decision|3|||
164308136|NCT00536744|593502577|FG001|Overall Study|Physician Decision|1|||
164308137|NCT00536744|593502576|FG000|Overall Study|Lost to Follow-up|3|||
164308138|NCT00536744|593502577|FG001|Overall Study|Lost to Follow-up|5|||
164308139|NCT00536744|593502576|FG000|Overall Study|Withdrawal by Subject|7|||
164308140|NCT00536744|593502577|FG001|Overall Study|Withdrawal by Subject|8|||
164308141|NCT00536744|593502576|FG000|Overall Study|PI tried alternative treatment|1|||
164308142|NCT00536744|593502577|FG001|Overall Study|PI tried alternative treatment|3|||
164308143|NCT00787644|593502578|FG000|Overall Study|Lost to Follow-up|1|||
164308144|NCT00787644|593502579|FG001|Overall Study|Lost to Follow-up|1|||
164308145|NCT00787644|593502578|FG000|Overall Study|Withdrawal by Subject|1|||
164308146|NCT00787644|593502579|FG001|Overall Study|Withdrawal by Subject|1|||
164308147|NCT01642589|593502583|FG000|Overall Study|Withdrawal by Subject|1|||
164308148|NCT01642589|593502584|FG001|Overall Study|Withdrawal by Subject|1|||
164199462|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199463|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199464|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199465|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199466|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
164199467|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
164199468|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
164199469|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
164199470|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
164199471|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
164199472|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
164199473|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199474|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199475|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199476|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199477|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
164199478|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|Death|1|||
164199479|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|Death|0|||
164199480|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|Death|1|||
164199481|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|Death|1|||
164199482|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|Death|1|||
164199483|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|Death|0|||
164199484|NCT03327324|593101755|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199485|NCT03327324|593101756|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199486|NCT03327324|593101757|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199487|NCT03327324|593101758|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199488|NCT03327324|593101759|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199489|NCT03327324|593101760|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
164199490|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
164199491|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199492|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199493|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199494|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199495|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
164199496|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
164199497|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
164199498|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199499|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199500|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199501|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
164199502|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
164199503|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
164199504|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
164199505|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
164199506|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
164199507|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
164199508|NCT03327324|593101755|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199509|NCT03327324|593101756|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199510|NCT03327324|593101757|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199511|NCT03327324|593101758|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
164199512|NCT03327324|593101759|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
164199513|NCT03327324|593101760|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
164199514|NCT03327324|593101755|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
164199515|NCT03327324|593101756|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164308149|NCT01108185|593502589|FG000|Overall Study|Non-compliance|15|||
164308150|NCT01108185|593502589|FG000|Overall Study|Lost to Follow-up|12|||
164308151|NCT04774094|593502594|FG000|Overall Study|Other|2|||
164308152|NCT04774094|593502594|FG000|Overall Study|Withdrawal by Subject|9|||
164308153|NCT04774094|593502594|FG000|Overall Study|Lost to Follow-up|7|||
164308154|NCT04774094|593502594|FG000|Overall Study|Lack of Efficacy|5|||
164308155|NCT04774094|593502594|FG000|Overall Study|Death|17|||
164308156|NCT04774094|593502594|FG000|Overall Study|Adverse Event|4|||
164308157|NCT02374450|593502595|FG000|Overall Study|Protocol Violation|0|||
164308158|NCT02374450|593502596|FG001|Overall Study|Protocol Violation|1|||
164308159|NCT02374450|593502597|FG002|Overall Study|Protocol Violation|0|||
164308160|NCT02374450|593502595|FG000|Overall Study|Withdrawal by Subject|91|||
164308161|NCT02374450|593502596|FG001|Overall Study|Withdrawal by Subject|110|||
164308162|NCT02374450|593502597|FG002|Overall Study|Withdrawal by Subject|4|||
164308163|NCT02374450|593502595|FG000|Overall Study|Lost to Follow-up|168|||
164308164|NCT02374450|593502596|FG001|Overall Study|Lost to Follow-up|194|||
164308165|NCT02374450|593502597|FG002|Overall Study|Lost to Follow-up|138|||
164308166|NCT02374450|593502595|FG000|Overall Study|Death|173|||
164308167|NCT02374450|593502596|FG001|Overall Study|Death|185|||
164308168|NCT02374450|593502597|FG002|Overall Study|Death|81|||
164308169|NCT02374450|593502595|FG000|Overall Study|Migrated from the study area|538|||
164308170|NCT02374450|593502596|FG001|Overall Study|Migrated from the study area|648|||
164308171|NCT02374450|593502597|FG002|Overall Study|Migrated from the study area|181|||
164308172|NCT02374450|593502595|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
164308173|NCT02374450|593502596|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
164308174|NCT02374450|593502597|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
164308175|NCT02374450|593502595|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
164308176|NCT02374450|593502596|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
164308177|NCT02374450|593502597|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
164308178|NCT02374450|593502595|FG000|Overall Study|Other|0|||
164308179|NCT02374450|593502596|FG001|Overall Study|Other|21|||
164308180|NCT02374450|593502597|FG002|Overall Study|Other|79|||
164308181|NCT01006291|593504415|FG000|Overall Study|Adverse Event|2|||
164308182|NCT01006291|593504416|FG001|Overall Study|Adverse Event|1|||
164308183|NCT01006291|593504417|FG002|Overall Study|Adverse Event|2|||
164308184|NCT01006291|593504415|FG000|Overall Study|Lack of Efficacy|2|||
164308185|NCT01006291|593504416|FG001|Overall Study|Lack of Efficacy|2|||
164308186|NCT01006291|593504417|FG002|Overall Study|Lack of Efficacy|1|||
164308187|NCT01006291|593504415|FG000|Overall Study|Protocol Violation|3|||
164308188|NCT01006291|593504416|FG001|Overall Study|Protocol Violation|3|||
164308189|NCT01006291|593504417|FG002|Overall Study|Protocol Violation|3|||
164308190|NCT01006291|593504415|FG000|Overall Study|Withdrawal criteria|5|||
164308191|NCT01006291|593504416|FG001|Overall Study|Withdrawal criteria|4|||
164308192|NCT01006291|593504417|FG002|Overall Study|Withdrawal criteria|4|||
164308193|NCT01006291|593504415|FG000|Overall Study|Other|14|||
164308194|NCT01006291|593504416|FG001|Overall Study|Other|14|||
164308195|NCT01006291|593504417|FG002|Overall Study|Other|17|||
164308196|NCT01677377|593504418|FG000|Overall Study|Protocol Violation|1|||
164308197|NCT01677377|593504419|FG001|Overall Study|Protocol Violation|0|||
164308198|NCT01677377|593504420|FG002|Overall Study|Protocol Violation|0|||
164308199|NCT01677377|593504418|FG000|Overall Study|Lost to Follow-up|0|||
164308200|NCT01677377|593504419|FG001|Overall Study|Lost to Follow-up|1|||
164308201|NCT01677377|593504420|FG002|Overall Study|Lost to Follow-up|1|||
164308202|NCT01677377|593504418|FG000|Overall Study|Withdrawal by Subject|0|||
164308203|NCT01677377|593504419|FG001|Overall Study|Withdrawal by Subject|0|||
164308204|NCT01677377|593504420|FG002|Overall Study|Withdrawal by Subject|3|||
164308205|NCT01677377|593504418|FG000|Overall Study|Lack of Efficacy|0|||
164308206|NCT01677377|593504419|FG001|Overall Study|Lack of Efficacy|0|||
164308207|NCT01677377|593504420|FG002|Overall Study|Lack of Efficacy|1|||
164308208|NCT01677377|593504418|FG000|Overall Study|Pregnancy|0|||
164308209|NCT01677377|593504419|FG001|Overall Study|Pregnancy|0|||
163967553|NCT00770770|592254180|FG001|Overall Study|Withdrawal by Subject|0|||
163967554|NCT00770770|592254179|FG000|Overall Study|Death|0|||
163967555|NCT00770770|592254180|FG001|Overall Study|Death|1|||
164308210|NCT01677377|593504420|FG002|Overall Study|Pregnancy|1|||
164308211|NCT02260180|593504421|FG000|Overall Study|Adverse Event|2|||
164308212|NCT02260180|593504422|FG001|Overall Study|Adverse Event|0|||
164308213|NCT02260180|593504423|FG002|Overall Study|Adverse Event|1|||
164308214|NCT00943072|593504426|FG000|Overall Study|Adverse Event|0|||
164308215|NCT00943072|593504427|FG001|Overall Study|Adverse Event|3|||
164308216|NCT00943072|593504426|FG000|Overall Study|Death|0|||
164308217|NCT00943072|593504427|FG001|Overall Study|Death|2|||
164308218|NCT00943072|593504426|FG000|Overall Study|Withdrawal by Subject|3|||
164308219|NCT00943072|593504427|FG001|Overall Study|Withdrawal by Subject|1|||
164308220|NCT00943072|593504426|FG000|Overall Study|Protocol Violation|0|||
164308221|NCT00943072|593504427|FG001|Overall Study|Protocol Violation|1|||
164308222|NCT00943072|593504426|FG000|Overall Study|Lost to Follow-up|1|||
164308223|NCT00943072|593504427|FG001|Overall Study|Lost to Follow-up|2|||
164308224|NCT00943072|593504426|FG000|Overall Study|Lack of Efficacy|0|||
164308225|NCT00943072|593504427|FG001|Overall Study|Lack of Efficacy|4|||
164308226|NCT00943072|593504426|FG000|Overall Study|Other|1|||
164308227|NCT00943072|593504427|FG001|Overall Study|Other|1|||
164308228|NCT03275350|593504428|FG000|Overall Study|Lost to Follow-up|4|||
164308229|NCT03275350|593504429|FG001|Overall Study|Lost to Follow-up|6|||
164308230|NCT03275350|593504428|FG000|Overall Study|Death|2|||
164308231|NCT03275350|593504429|FG001|Overall Study|Death|1|||
164308232|NCT03275350|593504428|FG000|Overall Study|Physician Decision|1|||
164308233|NCT03275350|593504429|FG001|Overall Study|Physician Decision|0|||
164308234|NCT03275350|593504428|FG000|Overall Study|Incarcerated|1|||
164308235|NCT03275350|593504429|FG001|Overall Study|Incarcerated|1|||
164308236|NCT00905645|593504430|FG000|Overall Study|Death (not device related)|10|||
164308237|NCT00905645|593504431|FG001|Overall Study|Death (not device related)|4|||
164308238|NCT00905645|593504432|FG002|Overall Study|Death (not device related)|15|||
164308239|NCT00905645|593504433|FG003|Overall Study|Death (not device related)|8|||
164308240|NCT00905645|593504430|FG000|Overall Study|Explantation of study device(s)|78|||
164308241|NCT00905645|593504431|FG001|Overall Study|Explantation of study device(s)|47|||
164308242|NCT00905645|593504432|FG002|Overall Study|Explantation of study device(s)|28|||
164308243|NCT00905645|593504433|FG003|Overall Study|Explantation of study device(s)|21|||
164308244|NCT00905645|593504430|FG000|Overall Study|Subject Request|41|||
164308245|NCT00905645|593504431|FG001|Overall Study|Subject Request|17|||
164308246|NCT00905645|593504432|FG002|Overall Study|Subject Request|13|||
164308247|NCT00905645|593504433|FG003|Overall Study|Subject Request|11|||
164308248|NCT00905645|593504430|FG000|Overall Study|Lost to Follow-up|299|||
164308249|NCT00905645|593504431|FG001|Overall Study|Lost to Follow-up|103|||
164308250|NCT00905645|593504432|FG002|Overall Study|Lost to Follow-up|51|||
164308251|NCT00905645|593504433|FG003|Overall Study|Lost to Follow-up|12|||
164308252|NCT01386970|593504434|FG000|Overall Study|Withdrawal by Subject|0|||
164308253|NCT01386970|593504435|FG001|Overall Study|Withdrawal by Subject|1|||
164308254|NCT01386970|593504434|FG000|Overall Study|Adverse Event|4|||
164308255|NCT01386970|593504435|FG001|Overall Study|Adverse Event|1|||
164308256|NCT04439136|593504436|FG000|Overall Study|Ineligible|1|||
164308257|NCT04439136|593504436|FG000|Overall Study|Never Started Treatment|2|||
164308258|NCT04439136|593504436|FG000|Overall Study|Adverse Event|4|||
164308259|NCT04439136|593504436|FG000|Overall Study|Death|3|||
164308260|NCT04439136|593504436|FG000|Overall Study|Disease Progression|27|||
164308261|NCT04439136|593504436|FG000|Overall Study|Alternative Therapy|1|||
164308262|NCT04439136|593504436|FG000|Overall Study|Increased Tumor Burden|1|||
164308263|NCT04439136|593504436|FG000|Overall Study|Symptomatic Detrioration|1|||
164308264|NCT00578292|593504439|FG000|Overall Study|Death|1|||
164308265|NCT00578292|593504439|FG000|Overall Study|Graft failure|2|||
164308266|NCT04849559|593504440|FG000|Overall Study|Withdrawal by Subject|2|||
164308267|NCT04849559|593504441|FG001|Overall Study|Withdrawal by Subject|1|||
164308268|NCT03901469|593504442|FG000|Overall Study|Radiographic Progression|4|||
164308269|NCT03901469|593504443|FG001|Overall Study|Radiographic Progression|6|||
164308270|NCT03901469|593504444|FG002|Overall Study|Radiographic Progression|3|||
164308271|NCT03901469|593504445|FG003|Overall Study|Radiographic Progression|30|||
164308272|NCT03901469|593504446|FG004|Overall Study|Radiographic Progression|7|||
164308273|NCT03901469|593504447|FG005|Overall Study|Radiographic Progression|2|||
164308274|NCT03901469|593504448|FG006|Overall Study|Radiographic Progression|11|||
164308275|NCT03901469|593504442|FG000|Overall Study|Clinical Progression|0|||
164308276|NCT03901469|593504443|FG001|Overall Study|Clinical Progression|2|||
164308277|NCT03901469|593504444|FG002|Overall Study|Clinical Progression|0|||
164308278|NCT03901469|593504445|FG003|Overall Study|Clinical Progression|7|||
164308279|NCT03901469|593504446|FG004|Overall Study|Clinical Progression|6|||
164308280|NCT03901469|593504447|FG005|Overall Study|Clinical Progression|0|||
164308281|NCT03901469|593504448|FG006|Overall Study|Clinical Progression|2|||
164308282|NCT03901469|593504442|FG000|Overall Study|Adverse Event|1|||
164308283|NCT03901469|593504443|FG001|Overall Study|Adverse Event|0|||
164308284|NCT03901469|593504444|FG002|Overall Study|Adverse Event|0|||
164308285|NCT03901469|593504445|FG003|Overall Study|Adverse Event|0|||
164308286|NCT03901469|593504446|FG004|Overall Study|Adverse Event|0|||
164308287|NCT03901469|593504447|FG005|Overall Study|Adverse Event|0|||
164308288|NCT03901469|593504448|FG006|Overall Study|Adverse Event|9|||
164308289|NCT03901469|593504442|FG000|Overall Study|Physician Decision|0|||
164308290|NCT03901469|593504443|FG001|Overall Study|Physician Decision|0|||
164308291|NCT03901469|593504444|FG002|Overall Study|Physician Decision|0|||
164308292|NCT03901469|593504445|FG003|Overall Study|Physician Decision|1|||
164308293|NCT03901469|593504446|FG004|Overall Study|Physician Decision|0|||
164308294|NCT03901469|593504447|FG005|Overall Study|Physician Decision|0|||
164308295|NCT03901469|593504448|FG006|Overall Study|Physician Decision|0|||
164308296|NCT03901469|593504442|FG000|Overall Study|Withdrawal by Subject|0|||
164308297|NCT03901469|593504443|FG001|Overall Study|Withdrawal by Subject|0|||
164308298|NCT03901469|593504444|FG002|Overall Study|Withdrawal by Subject|0|||
164308299|NCT03901469|593504445|FG003|Overall Study|Withdrawal by Subject|0|||
164308300|NCT03901469|593504446|FG004|Overall Study|Withdrawal by Subject|2|||
164308301|NCT03901469|593504447|FG005|Overall Study|Withdrawal by Subject|0|||
164308302|NCT03901469|593504448|FG006|Overall Study|Withdrawal by Subject|8|||
164308303|NCT03901469|593504442|FG000|Overall Study|Death|0|||
164308304|NCT03901469|593504443|FG001|Overall Study|Death|0|||
164308305|NCT03901469|593504444|FG002|Overall Study|Death|0|||
164308306|NCT03901469|593504445|FG003|Overall Study|Death|3|||
164308307|NCT03901469|593504446|FG004|Overall Study|Death|5|||
164308308|NCT03901469|593504447|FG005|Overall Study|Death|0|||
164308309|NCT03901469|593504448|FG006|Overall Study|Death|1|||
164308310|NCT03901469|593504442|FG000|Overall Study|Termination of study by sponsor|0|||
164308311|NCT03901469|593504443|FG001|Overall Study|Termination of study by sponsor|0|||
164308312|NCT03901469|593504444|FG002|Overall Study|Termination of study by sponsor|0|||
164308313|NCT03901469|593504445|FG003|Overall Study|Termination of study by sponsor|0|||
164308314|NCT03901469|593504446|FG004|Overall Study|Termination of study by sponsor|1|||
164308315|NCT03901469|593504447|FG005|Overall Study|Termination of study by sponsor|1|||
164308316|NCT03901469|593504448|FG006|Overall Study|Termination of study by sponsor|0|||
164308317|NCT03901469|593504442|FG000|Overall Study|Not Reported|1|||
163862174|NCT00486759|591861970|FG001|Treatment|Administrative/reason not specified|21|||
163862175|NCT00486759|591861969|FG000|Treatment|Refused treatment|10|||
163862176|NCT00486759|591861970|FG001|Treatment|Refused treatment|7|||
164199516|NCT03327324|593101757|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199517|NCT03327324|593101758|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199518|NCT03327324|593101759|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199519|NCT03327324|593101760|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
164199520|NCT03327324|593101755|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
164199521|NCT03327324|593101756|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199522|NCT03327324|593101757|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199523|NCT03327324|593101758|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199524|NCT03327324|593101759|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199525|NCT03327324|593101760|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
164199526|NCT01791985|593101761|FG000|Overall Study|Adverse Event|7|||
164199527|NCT01791985|593101761|FG000|Overall Study|Withdrawal by Subject|1|||
164199528|NCT01103323|593101762|FG000|Without/Before Drug Switch|Adverse Event|50|||
164199529|NCT01103323|593101763|FG001|Without/Before Drug Switch|Adverse Event|7|||
164199530|NCT01103323|593101762|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
164199531|NCT01103323|593101763|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
164199532|NCT01103323|593101762|FG000|Without/Before Drug Switch|Protocol Violation|2|||
164199533|NCT01103323|593101763|FG001|Without/Before Drug Switch|Protocol Violation|0|||
164199534|NCT01103323|593101762|FG000|Without/Before Drug Switch|Physician Decision|2|||
164199535|NCT01103323|593101763|FG001|Without/Before Drug Switch|Physician Decision|0|||
164199536|NCT01103323|593101762|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
164199537|NCT01103323|593101763|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
164199538|NCT01103323|593101762|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
164199539|NCT01103323|593101763|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
164199540|NCT01103323|593101762|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
164199541|NCT01103323|593101763|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
164199542|NCT01946204|593101769|FG000|Overall Study|Death|38|||
164199543|NCT01946204|593101770|FG001|Overall Study|Death|59|||
164199544|NCT01946204|593101769|FG000|Overall Study|Withdrawal by Subject|37|||
164199545|NCT01946204|593101770|FG001|Overall Study|Withdrawal by Subject|50|||
164199546|NCT01946204|593101769|FG000|Overall Study|Lost to Follow-up|3|||
164199547|NCT01946204|593101770|FG001|Overall Study|Lost to Follow-up|7|||
164199548|NCT01946204|593101769|FG000|Overall Study|Ongoing|316|||
164199549|NCT01946204|593101770|FG001|Overall Study|Ongoing|687|||
164199550|NCT01946204|593101769|FG000|Overall Study|Other|7|||
164199551|NCT01946204|593101770|FG001|Overall Study|Other|3|||
164199552|NCT03797898|593101771|FG000|Overall Study|Lost to Follow-up|60|||
164199553|NCT03797898|593101772|FG001|Overall Study|Lost to Follow-up|69|||
164199554|NCT03797898|593101771|FG000|Overall Study|Withdrawal by Subject|9|||
164199555|NCT03797898|593101772|FG001|Overall Study|Withdrawal by Subject|7|||
164199556|NCT03797898|593101771|FG000|Overall Study|Became ineligible|5|||
164199557|NCT03797898|593101772|FG001|Overall Study|Became ineligible|2|||
164199558|NCT00485069|593101773|FG000|Overall Study|Adverse Event|10|||
164199559|NCT00485069|593101774|FG001|Overall Study|Adverse Event|4|||
164199560|NCT00485069|593101773|FG000|Overall Study|Lack of Efficacy|2|||
164199561|NCT00485069|593101774|FG001|Overall Study|Lack of Efficacy|1|||
164199562|NCT00485069|593101773|FG000|Overall Study|Protocol Violation|0|||
164199563|NCT00485069|593101774|FG001|Overall Study|Protocol Violation|1|||
164199564|NCT00485069|593101773|FG000|Overall Study|Withdrawal by Subject|6|||
164199565|NCT00485069|593101774|FG001|Overall Study|Withdrawal by Subject|6|||
164199566|NCT03217591|593101775|FG000|Overall Study|Adverse Event|1|||
164199567|NCT03217591|593101776|FG001|Overall Study|Adverse Event|2|||
164199568|NCT03217591|593101777|FG002|Overall Study|Adverse Event|6|||
164199569|NCT03217591|593101775|FG000|Overall Study|Withdrawal by Subject|0|||
164199570|NCT03217591|593101776|FG001|Overall Study|Withdrawal by Subject|1|||
164308318|NCT03901469|593504443|FG001|Overall Study|Not Reported|0|||
164308319|NCT03901469|593504444|FG002|Overall Study|Not Reported|0|||
164308320|NCT03901469|593504445|FG003|Overall Study|Not Reported|1|||
164308321|NCT03901469|593504446|FG004|Overall Study|Not Reported|0|||
164308322|NCT03901469|593504447|FG005|Overall Study|Not Reported|0|||
164308323|NCT03901469|593504448|FG006|Overall Study|Not Reported|1|||
164308324|NCT03306173|593504456|FG000|Overall Study|Lost to Follow-up|16|||
164308325|NCT03306173|593504457|FG001|Overall Study|Lost to Follow-up|23|||
164308326|NCT03306173|593504456|FG000|Overall Study|Withdrawal by Subject|4|||
164308327|NCT03306173|593504457|FG001|Overall Study|Withdrawal by Subject|3|||
164308328|NCT03306173|593504456|FG000|Overall Study|Discontinued|4|||
164308329|NCT03306173|593504457|FG001|Overall Study|Discontinued|4|||
164308330|NCT01077076|593504458|FG000|First Intervention|Withdrawal by Subject|1|||
164308331|NCT01077076|593504459|FG001|First Intervention|Withdrawal by Subject|0|||
164308332|NCT01077076|593504460|FG002|First Intervention|Withdrawal by Subject|0|||
164308333|NCT01077076|593504461|FG003|First Intervention|Withdrawal by Subject|0|||
164308334|NCT01077076|593504462|FG004|First Intervention|Withdrawal by Subject|0|||
163967556|NCT00770770|592254179|FG000|Overall Study|Study Terminated|8|||
163967557|NCT00770770|592254180|FG001|Overall Study|Study Terminated|0|||
163967558|NCT02486653|592254181|FG000|Overall Study|Withdrawal by Subject|1|||
163967559|NCT02486653|592254182|FG001|Overall Study|Withdrawal by Subject|3|||
163967560|NCT02486653|592254181|FG000|Overall Study|Protocol Violation|1|||
163967561|NCT02486653|592254182|FG001|Overall Study|Protocol Violation|0|||
164308335|NCT01077076|593504463|FG005|First Intervention|Withdrawal by Subject|0|||
164308336|NCT01077076|593504458|FG000|Third Intervention|Death in the participant's family|0|||
164308337|NCT01077076|593504459|FG001|Third Intervention|Death in the participant's family|0|||
164308338|NCT01077076|593504460|FG002|Third Intervention|Death in the participant's family|0|||
164308339|NCT01077076|593504461|FG003|Third Intervention|Death in the participant's family|0|||
164308340|NCT01077076|593504462|FG004|Third Intervention|Death in the participant's family|0|||
164308341|NCT01077076|593504463|FG005|Third Intervention|Death in the participant's family|1|||
164308342|NCT00060840|593504466|FG000|Overall Study|Change in surgical plan|2|||
164308343|NCT00060840|593504467|FG001|Overall Study|Change in surgical plan|6|||
164308344|NCT00060840|593504466|FG000|Overall Study|Death|0|||
164308345|NCT00060840|593504467|FG001|Overall Study|Death|1|||
164308346|NCT00060840|593504466|FG000|Overall Study|Withdrawal by Subject|0|||
164308347|NCT00060840|593504467|FG001|Overall Study|Withdrawal by Subject|1|||
164308348|NCT00060840|593504466|FG000|Overall Study|Subinvestigator unavailable|0|||
164308349|NCT00060840|593504467|FG001|Overall Study|Subinvestigator unavailable|1|||
164308350|NCT00060840|593504466|FG000|Overall Study|Physician Decision|1|||
164308351|NCT00060840|593504467|FG001|Overall Study|Physician Decision|0|||
164308352|NCT00060840|593504466|FG000|Overall Study|Other|1|||
164308353|NCT00060840|593504467|FG001|Overall Study|Other|0|||
164308354|NCT01388335|593504468|FG000|Period 1|Progressive Disease|1|||
164308355|NCT01388335|593504468|FG000|Period 2|Progressive Disease|2|||
164308356|NCT01388335|593504468|FG000|Period 2|Sponsor Decision|1|||
164308357|NCT01388335|593504468|FG000|Safety Extension|Progressive Disease|7|||
164308358|NCT01415882|593504469|FG000|Overall Study|Ineligible|1|||
164308359|NCT01415882|593504470|FG001|Overall Study|Ineligible|0|||
164308360|NCT01415882|593504471|FG002|Overall Study|Ineligible|0|||
164308361|NCT01415882|593504472|FG003|Overall Study|Ineligible|3|||
164308362|NCT01415882|593504473|FG004|Overall Study|Ineligible|0|||
164308363|NCT01415882|593504469|FG000|Overall Study|Withdrawal by Subject|0|||
164308364|NCT01415882|593504470|FG001|Overall Study|Withdrawal by Subject|1|||
164308365|NCT01415882|593504471|FG002|Overall Study|Withdrawal by Subject|0|||
164308366|NCT01415882|593504472|FG003|Overall Study|Withdrawal by Subject|1|||
164308367|NCT01415882|593504473|FG004|Overall Study|Withdrawal by Subject|0|||
164308368|NCT00976560|593504474|FG000|Overall Study|Adverse Event|5|||
164308369|NCT00976560|593504475|FG001|Overall Study|Adverse Event|5|||
164308370|NCT00976560|593504474|FG000|Overall Study|Lack of Efficacy|3|||
164308371|NCT00976560|593504475|FG001|Overall Study|Lack of Efficacy|5|||
164308372|NCT00976560|593504474|FG000|Overall Study|Protocol Violation|1|||
164308373|NCT00976560|593504475|FG001|Overall Study|Protocol Violation|0|||
164308374|NCT00976560|593504474|FG000|Overall Study|Lost to Follow-up|1|||
164308375|NCT00976560|593504475|FG001|Overall Study|Lost to Follow-up|0|||
164308376|NCT00976560|593504474|FG000|Overall Study|Physician Decision|2|||
164308377|NCT00976560|593504475|FG001|Overall Study|Physician Decision|0|||
163967562|NCT02486653|592254181|FG000|Overall Study|surgery cancelled|4|||
163967563|NCT02486653|592254182|FG001|Overall Study|surgery cancelled|1|||
163967564|NCT00800436|592254183|FG000|Overall Study|Withdrawal by Subject|0|||
163967565|NCT00800436|592254184|FG001|Overall Study|Withdrawal by Subject|0|||
164308378|NCT00976560|593504474|FG000|Overall Study|Withdrawal by Subject|2|||
164308379|NCT00976560|593504475|FG001|Overall Study|Withdrawal by Subject|3|||
164308380|NCT00125164|593504478|FG000|Overall Study|Adverse Event|0|||
164308381|NCT00125164|593504479|FG001|Overall Study|Adverse Event|0|||
164308382|NCT00125164|593504480|FG002|Overall Study|Adverse Event|2|||
164308383|NCT00125164|593504481|FG003|Overall Study|Adverse Event|4|||
164308384|NCT00125164|593504478|FG000|Overall Study|Lost to Follow-up|0|||
164308385|NCT00125164|593504479|FG001|Overall Study|Lost to Follow-up|0|||
164308386|NCT00125164|593504480|FG002|Overall Study|Lost to Follow-up|1|||
164308387|NCT00125164|593504481|FG003|Overall Study|Lost to Follow-up|1|||
164308388|NCT00125164|593504478|FG000|Overall Study|Withdrawal by Subject|2|||
164308389|NCT00125164|593504479|FG001|Overall Study|Withdrawal by Subject|0|||
164308390|NCT00125164|593504480|FG002|Overall Study|Withdrawal by Subject|1|||
164308391|NCT00125164|593504481|FG003|Overall Study|Withdrawal by Subject|1|||
164308392|NCT00670306|593504482|FG000|Overall Study|Adverse Event|8|||
164308393|NCT00670306|593504482|FG000|Overall Study|Lack of Efficacy|10|||
164199571|NCT03217591|593101777|FG002|Overall Study|Withdrawal by Subject|3|||
164199572|NCT03217591|593101775|FG000|Overall Study|Lost to Follow-up|1|||
164199573|NCT03217591|593101776|FG001|Overall Study|Lost to Follow-up|0|||
164199574|NCT03217591|593101777|FG002|Overall Study|Lost to Follow-up|0|||
164199575|NCT03217591|593101775|FG000|Overall Study|Protocol Violation|1|||
164199576|NCT03217591|593101776|FG001|Overall Study|Protocol Violation|0|||
164199577|NCT03217591|593101777|FG002|Overall Study|Protocol Violation|1|||
164199578|NCT00402727|593101783|FG000|Overall Study|Adverse Event|10|||
164308394|NCT00670306|593504482|FG000|Overall Study|Withdrawal by Subject|9|||
164308395|NCT00670306|593504482|FG000|Overall Study|Physician Decision|1|||
164308396|NCT00670306|593504482|FG000|Overall Study|Lost to Follow-up|8|||
164308397|NCT00670306|593504482|FG000|Overall Study|incl/excl criterias did not meet|19|||
164308398|NCT01339052|593504486|FG000|Overall Study|Disease progression|13|||
164308399|NCT01339052|593504487|FG001|Overall Study|Disease progression|46|||
164308400|NCT01339052|593504486|FG000|Overall Study|Adverse Event|1|||
164308401|NCT01339052|593504487|FG001|Overall Study|Adverse Event|1|||
164308402|NCT01339052|593504486|FG000|Overall Study|Withdrawal by Subject|0|||
164308403|NCT01339052|593504487|FG001|Overall Study|Withdrawal by Subject|3|||
164308404|NCT01339052|593504486|FG000|Overall Study|Physician Decision|1|||
164308405|NCT01339052|593504487|FG001|Overall Study|Physician Decision|0|||
164308406|NCT03339219|593504488|FG000|Overall Study|Death|12|||
164308407|NCT03339219|593504488|FG000|Overall Study|Site Terminated by Sponsor|22|||
164308408|NCT03339219|593504488|FG000|Overall Study|Withdrawal by Subject|1|||
164308409|NCT01301027|593504492|FG000|Overall Study|Physician Decision|2|||
164308410|NCT01301027|593504493|FG001|Overall Study|Physician Decision|0|||
164308411|NCT01301027|593504492|FG000|Overall Study|Withdrawal by Subject|2|||
164308412|NCT01301027|593504493|FG001|Overall Study|Withdrawal by Subject|3|||
164308413|NCT01301027|593504492|FG000|Overall Study|Adverse Event|0|||
164308414|NCT01301027|593504493|FG001|Overall Study|Adverse Event|2|||
164308415|NCT01301027|593504492|FG000|Overall Study|Fracture|1|||
164308416|NCT01301027|593504493|FG001|Overall Study|Fracture|3|||
164308417|NCT01301027|593504492|FG000|Overall Study|Transplant|0|||
164308418|NCT01301027|593504493|FG001|Overall Study|Transplant|2|||
164308419|NCT01301027|593504492|FG000|Overall Study|Volume Overload|3|||
164308420|NCT01301027|593504493|FG001|Overall Study|Volume Overload|0|||
164308421|NCT04939415|593504497|FG000|Overall Study|Withdrawal by Subject|1|||
164308422|NCT04939415|593504498|FG001|Overall Study|Withdrawal by Subject|3|||
164308423|NCT04939415|593504497|FG000|Overall Study|Lost to Follow-up|0|||
164308424|NCT04939415|593504498|FG001|Overall Study|Lost to Follow-up|2|||
164308425|NCT03155841|593504499|FG000|Overall Study|Protocol Violation|3|||
164308426|NCT03155841|593504500|FG001|Overall Study|Protocol Violation|4|||
164308427|NCT04308291|593504501|FG000|Run-In Phase|Withdrawal by Subject|4|||
164308428|NCT04308291|593504501|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
164308429|NCT04308291|593504501|FG000|Study Phase 6-M|Physician Decision|2|||
164308430|NCT04308291|593504501|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
164199579|NCT00402727|593101784|FG001|Overall Study|Adverse Event|6|||
164199580|NCT00402727|593101783|FG000|Overall Study|Death|1|||
164199581|NCT00402727|593101784|FG001|Overall Study|Death|0|||
164199582|NCT00402727|593101783|FG000|Overall Study|Lack of Efficacy|1|||
164308431|NCT04308291|593504501|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
164308432|NCT04308291|593504501|FG000|Study Phase 12-M|Physician Decision|2|||
164308433|NCT04308291|593504501|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
164308434|NCT00714870|593504507|FG000|Overall Study|Lost to Follow-up|22|||
164308435|NCT00714870|593504508|FG001|Overall Study|Lost to Follow-up|5|||
163862177|NCT00486759|591861969|FG000|Treatment|Violation of selection criteria at entry|3|||
163862178|NCT00486759|591861970|FG001|Treatment|Violation of selection criteria at entry|3|||
163862179|NCT00486759|591861969|FG000|Treatment|Other protocol violation|1|||
163862180|NCT00486759|591861970|FG001|Treatment|Other protocol violation|5|||
163862181|NCT00486759|591861969|FG000|Treatment|Failure to return|1|||
163862182|NCT00486759|591861970|FG001|Treatment|Failure to return|1|||
163862183|NCT00486759|591861969|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
163967566|NCT00800436|592254185|FG002|Overall Study|Withdrawal by Subject|1|||
163967567|NCT00800436|592254186|FG003|Overall Study|Withdrawal by Subject|1|||
163967568|NCT00800436|592254187|FG004|Overall Study|Withdrawal by Subject|0|||
163967569|NCT00800436|592254188|FG005|Overall Study|Withdrawal by Subject|0|||
163967570|NCT00800436|592254189|FG006|Overall Study|Withdrawal by Subject|0|||
163967571|NCT01829425|592254205|FG000|Overall Study|Withdrawal by Subject|4|||
163967572|NCT01829425|592254206|FG001|Overall Study|Withdrawal by Subject|3|||
163967573|NCT01829425|592254205|FG000|Overall Study|Lost to Follow-up|2|||
164199583|NCT00402727|593101784|FG001|Overall Study|Lack of Efficacy|3|||
164308436|NCT00714870|593504507|FG000|Overall Study|patient unable to come b/c back pain|1|||
164308437|NCT00714870|593504508|FG001|Overall Study|patient unable to come b/c back pain|0|||
164308438|NCT00714870|593504507|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
164308439|NCT00714870|593504508|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
164308440|NCT02357368|593504509|FG000|Overall Study|Lost to Follow-up|0|||
164308441|NCT02357368|593504510|FG001|Overall Study|Lost to Follow-up|0|||
164308442|NCT02357368|593504511|FG002|Overall Study|Lost to Follow-up|0|||
164308443|NCT02357368|593504512|FG003|Overall Study|Lost to Follow-up|1|||
164308444|NCT02357368|593504509|FG000|Overall Study|Pregnancy|3|||
164308445|NCT02357368|593504510|FG001|Overall Study|Pregnancy|2|||
164308446|NCT02357368|593504511|FG002|Overall Study|Pregnancy|0|||
164308447|NCT02357368|593504512|FG003|Overall Study|Pregnancy|0|||
164308448|NCT02357368|593504509|FG000|Overall Study|Withdrawal by Subject|3|||
164308449|NCT02357368|593504510|FG001|Overall Study|Withdrawal by Subject|1|||
164308450|NCT02357368|593504511|FG002|Overall Study|Withdrawal by Subject|1|||
164308451|NCT02357368|593504512|FG003|Overall Study|Withdrawal by Subject|2|||
164308452|NCT03895840|593504513|FG000|Overall Study|Withdrawal by Subject|21|||
164199584|NCT00402727|593101783|FG000|Overall Study|Lost to Follow-up|24|||
164199585|NCT00402727|593101784|FG001|Overall Study|Lost to Follow-up|11|||
164199586|NCT00402727|593101783|FG000|Overall Study|Physician Decision|1|||
164199587|NCT00402727|593101784|FG001|Overall Study|Physician Decision|1|||
164199588|NCT00402727|593101783|FG000|Overall Study|Protocol Violation|0|||
164199589|NCT00402727|593101784|FG001|Overall Study|Protocol Violation|4|||
164199590|NCT00402727|593101783|FG000|Overall Study|Withdrawal by Subject|3|||
164199591|NCT00402727|593101784|FG001|Overall Study|Withdrawal by Subject|7|||
164199592|NCT00402727|593101783|FG000|Overall Study|supply problems|2|||
164199593|NCT00402727|593101784|FG001|Overall Study|supply problems|1|||
164199594|NCT00402727|593101783|FG000|Overall Study|non-compliance|0|||
164199595|NCT00402727|593101784|FG001|Overall Study|non-compliance|1|||
164199596|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Early discharge|5|||
164199597|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Early discharge|5|||
164199598|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
164199599|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
164199600|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
164199601|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
164199602|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
164199603|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
164199604|NCT04460326|593101785|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
164199605|NCT04460326|593101786|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
164199606|NCT04460326|593101785|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
164199607|NCT04460326|593101786|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
164199608|NCT00577317|593101787|FG000|Overall Study|Study Terminated|0|||
164199609|NCT00577317|593101788|FG001|Overall Study|Study Terminated|2|||
164199610|NCT03372798|593101789|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
164199611|NCT03372798|593101790|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
164199612|NCT03372798|593101789|FG000|Overall Study|Failure of imaging probe|0|||
164199613|NCT03372798|593101790|FG001|Overall Study|Failure of imaging probe|1|||
164199614|NCT01687218|593101791|FG000|Overall Study|Withdrawal by Subject|2|||
164199615|NCT01687218|593101792|FG001|Overall Study|Withdrawal by Subject|3|||
164199616|NCT01687218|593101793|FG002|Overall Study|Withdrawal by Subject|0|||
164199617|NCT01687218|593101794|FG003|Overall Study|Withdrawal by Subject|1|||
164199618|NCT01687218|593101795|FG004|Overall Study|Withdrawal by Subject|1|||
164199619|NCT01687218|593101796|FG005|Overall Study|Withdrawal by Subject|0|||
164199620|NCT01687218|593101791|FG000|Overall Study|Relocated, no follow-up planned|1|||
164199621|NCT01687218|593101792|FG001|Overall Study|Relocated, no follow-up planned|0|||
164199622|NCT01687218|593101793|FG002|Overall Study|Relocated, no follow-up planned|1|||
164199623|NCT01687218|593101794|FG003|Overall Study|Relocated, no follow-up planned|1|||
164199624|NCT01687218|593101795|FG004|Overall Study|Relocated, no follow-up planned|0|||
164199625|NCT01687218|593101796|FG005|Overall Study|Relocated, no follow-up planned|0|||
164199626|NCT03528551|593101805|FG000|Overall Study|Lost to Follow-up|0|||
164199627|NCT03528551|593101806|FG001|Overall Study|Lost to Follow-up|1|||
164199628|NCT03528551|593101807|FG002|Overall Study|Lost to Follow-up|0|||
164199629|NCT03528551|593101805|FG000|Overall Study|Transferred to other arm/group|2|||
164199630|NCT03528551|593101806|FG001|Overall Study|Transferred to other arm/group|3|||
164199631|NCT03528551|593101807|FG002|Overall Study|Transferred to other arm/group|0|||
164199632|NCT03528551|593101805|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164199633|NCT03528551|593101806|FG001|Overall Study|Withdrawal by parent/guardian|5|||
164199634|NCT03528551|593101807|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164199635|NCT03528551|593101805|FG000|Overall Study|Protocol Violation|0|||
164308453|NCT01931566|593504514|FG000|Overall Study|Randomized But Not Treated|6|||
164308454|NCT01931566|593504515|FG001|Overall Study|Randomized But Not Treated|9|||
164199636|NCT03528551|593101806|FG001|Overall Study|Protocol Violation|3|||
164199637|NCT03528551|593101807|FG002|Overall Study|Protocol Violation|0|||
164199638|NCT03528551|593101805|FG000|Overall Study|Withdrawal by Subject|0|||
164199639|NCT03528551|593101806|FG001|Overall Study|Withdrawal by Subject|7|||
164308455|NCT01931566|593504516|FG002|Overall Study|Randomized But Not Treated|14|||
164308456|NCT01931566|593504514|FG000|Overall Study|Adverse Event|37|||
164308457|NCT01931566|593504515|FG001|Overall Study|Adverse Event|167|||
163862184|NCT00486759|591861970|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
163862185|NCT00486759|591861969|FG000|Safety Follow-up|Death|40|||
164199640|NCT03528551|593101807|FG002|Overall Study|Withdrawal by Subject|0|||
164199641|NCT00875810|593101815|FG000|Overall Study|Withdrawal by Subject|1|||
164199642|NCT00875810|593101815|FG000|Overall Study|Physician Decision|3|||
164199643|NCT00875810|593101815|FG000|Overall Study|Lost to Follow-up|39|||
164199644|NCT00875810|593101815|FG000|Overall Study|Patient enroled but not implanted|2|||
164199645|NCT00875810|593101815|FG000|Overall Study|Device explanted|1|||
164199646|NCT01789047|593101819|FG000|Overall Study|Adverse Event|3|||
164199647|NCT01789047|593101820|FG001|Overall Study|Adverse Event|2|||
164199648|NCT01789047|593101819|FG000|Overall Study|Withdrawal by Subject|1|||
164199649|NCT01789047|593101820|FG001|Overall Study|Withdrawal by Subject|2|||
164199650|NCT03644017|593101821|FG000|Overall Study|Access Abandonment|5|||
164199651|NCT03644017|593101821|FG000|Overall Study|Kidney Transplant|2|||
164199652|NCT02175225|593101822|FG000|Overall Study|Withdrawal by Subject|1|||
164199653|NCT02175225|593101823|FG001|Overall Study|Withdrawal by Subject|2|||
164199654|NCT02175225|593101822|FG000|Overall Study|Lost to Follow-up|6|||
164199655|NCT02175225|593101823|FG001|Overall Study|Lost to Follow-up|7|||
164199656|NCT02175225|593101822|FG000|Overall Study|Study drug not administered|1|||
164199657|NCT02175225|593101823|FG001|Overall Study|Study drug not administered|2|||
164199658|NCT02340000|593101824|FG000|Time Period 1|Withdrawal by Subject|6|||
164199659|NCT02340000|593101825|FG001|Time Period 1|Withdrawal by Subject|8|||
164199660|NCT02340000|593101824|FG000|Time Period 1|Lost to Follow-up|6|||
164199661|NCT02340000|593101825|FG001|Time Period 1|Lost to Follow-up|7|||
164199662|NCT02340000|593101824|FG000|Time Period 2|Withdrawal by Subject|9|||
164199663|NCT02340000|593101825|FG001|Time Period 2|Withdrawal by Subject|7|||
164199664|NCT02340000|593101824|FG000|Time Period 2|Lost to Follow-up|10|||
164199665|NCT02340000|593101825|FG001|Time Period 2|Lost to Follow-up|8|||
164199666|NCT03106077|593101826|FG000|Overall Study|Screen Failure|94|||
164199667|NCT03106077|593101827|FG001|Overall Study|Screen Failure|0|||
164199668|NCT02668640|593101828|FG000|Overall Study|Lost to Follow-up|13|||
164199669|NCT02668640|593101828|FG000|Overall Study|Other, not specified|1|||
164199670|NCT00919633|593101836|FG000|Overall Study|Adverse Event|1|||
164199671|NCT00919633|593101837|FG001|Overall Study|Adverse Event|9|||
164199672|NCT00919633|593101838|FG002|Overall Study|Adverse Event|12|||
164199673|NCT00919633|593101839|FG003|Overall Study|Adverse Event|10|||
164199674|NCT00919633|593101836|FG000|Overall Study|Death|0|||
164199675|NCT00919633|593101837|FG001|Overall Study|Death|0|||
164199676|NCT00919633|593101838|FG002|Overall Study|Death|2|||
164199677|NCT00919633|593101839|FG003|Overall Study|Death|0|||
164199678|NCT00919633|593101836|FG000|Overall Study|Lack of Efficacy|17|||
164199679|NCT00919633|593101837|FG001|Overall Study|Lack of Efficacy|3|||
164199680|NCT00919633|593101838|FG002|Overall Study|Lack of Efficacy|2|||
164199681|NCT00919633|593101839|FG003|Overall Study|Lack of Efficacy|3|||
164199682|NCT00919633|593101836|FG000|Overall Study|Withdrawal by Subject|1|||
164199683|NCT00919633|593101837|FG001|Overall Study|Withdrawal by Subject|2|||
164199684|NCT00919633|593101838|FG002|Overall Study|Withdrawal by Subject|4|||
164199685|NCT00919633|593101839|FG003|Overall Study|Withdrawal by Subject|3|||
164199686|NCT00919633|593101836|FG000|Overall Study|Lost to Follow-up|3|||
164199687|NCT00919633|593101837|FG001|Overall Study|Lost to Follow-up|1|||
164199688|NCT00919633|593101838|FG002|Overall Study|Lost to Follow-up|0|||
164199689|NCT00919633|593101839|FG003|Overall Study|Lost to Follow-up|2|||
164199690|NCT00919633|593101836|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
164199691|NCT00919633|593101837|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
164199692|NCT00919633|593101838|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
164199693|NCT00919633|593101839|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
164199694|NCT00919633|593101836|FG000|Overall Study|Protocol Violation|0|||
164199695|NCT00919633|593101837|FG001|Overall Study|Protocol Violation|0|||
164199696|NCT00919633|593101838|FG002|Overall Study|Protocol Violation|0|||
164199697|NCT00919633|593101839|FG003|Overall Study|Protocol Violation|1|||
164199698|NCT00919633|593101836|FG000|Overall Study|Physician Decision|0|||
164199699|NCT00919633|593101837|FG001|Overall Study|Physician Decision|0|||
164199700|NCT00919633|593101838|FG002|Overall Study|Physician Decision|0|||
164199701|NCT00919633|593101839|FG003|Overall Study|Physician Decision|1|||
164199702|NCT00919633|593101836|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
164199703|NCT00919633|593101837|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
164199704|NCT00919633|593101838|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
164199705|NCT00919633|593101839|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
164199706|NCT00919633|593101836|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
164199707|NCT00919633|593101837|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
164199708|NCT00919633|593101838|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
164199709|NCT00919633|593101839|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
164199710|NCT01526785|593101840|FG000|Overall Study|Study Terminated by Sponsor|8|||
164199711|NCT01526785|593101840|FG000|Overall Study|Death|2|||
164199712|NCT01526785|593101840|FG000|Overall Study|Physician Decision|1|||
164199713|NCT01526785|593101840|FG000|Overall Study|Withdrawal by Subject|2|||
163862186|NCT00486759|591861970|FG001|Safety Follow-up|Death|29|||
164308458|NCT01931566|593504516|FG002|Overall Study|Adverse Event|132|||
164308459|NCT01931566|593504514|FG000|Overall Study|Major Protocol Deviation|5|||
163967574|NCT01829425|592254206|FG001|Overall Study|Lost to Follow-up|1|||
163967575|NCT03681951|592254207|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
163967576|NCT03681951|592254208|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163967577|NCT03681951|592254209|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163967578|NCT03681951|592254210|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164199714|NCT03408899|593103470|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
164199715|NCT04745351|593103476|FG000|Overall Study|Death|51|||
164199716|NCT04745351|593103477|FG001|Overall Study|Death|25|||
164199717|NCT04745351|593103476|FG000|Overall Study|Lost to Follow-up|9|||
164199718|NCT04745351|593103477|FG001|Overall Study|Lost to Follow-up|3|||
164199719|NCT04745351|593103476|FG000|Overall Study|Randomized but Never Treated|3|||
164199720|NCT04745351|593103477|FG001|Overall Study|Randomized but Never Treated|3|||
164199721|NCT04745351|593103476|FG000|Overall Study|Adverse Event|4|||
164199722|NCT04745351|593103477|FG001|Overall Study|Adverse Event|0|||
164199723|NCT04745351|593103476|FG000|Overall Study|Withdrew Consent|1|||
164199724|NCT04745351|593103477|FG001|Overall Study|Withdrew Consent|2|||
164199725|NCT04745351|593103476|FG000|Overall Study|Investigator's Discretion|2|||
164199726|NCT04745351|593103477|FG001|Overall Study|Investigator's Discretion|0|||
164199727|NCT04745351|593103476|FG000|Overall Study|Protocol Violation|1|||
164199728|NCT04745351|593103477|FG001|Overall Study|Protocol Violation|0|||
164199729|NCT02014272|593103478|FG000|Intervention Period 1|Withdrawal by Subject|1|||
164199730|NCT02014272|593103479|FG001|Intervention Period 1|Withdrawal by Subject|0|||
164199731|NCT02014272|593103478|FG000|Intervention Period 1|Adverse Event|0|||
164199732|NCT02014272|593103479|FG001|Intervention Period 1|Adverse Event|1|||
164199733|NCT03636256|593103480|FG000|Overall Study|Lost to Follow-up|3|||
164199734|NCT03636256|593103481|FG001|Overall Study|Lost to Follow-up|0|||
164199735|NCT03636256|593103482|FG002|Overall Study|Lost to Follow-up|2|||
164199736|NCT03636256|593103483|FG003|Overall Study|Lost to Follow-up|1|||
164199737|NCT03636256|593103484|FG004|Overall Study|Lost to Follow-up|0|||
164199738|NCT03636256|593103485|FG005|Overall Study|Lost to Follow-up|4|||
164199739|NCT03636256|593103486|FG006|Overall Study|Lost to Follow-up|2|||
164199740|NCT03636256|593103487|FG007|Overall Study|Lost to Follow-up|0|||
164199741|NCT03636256|593103488|FG008|Overall Study|Lost to Follow-up|4|||
164199742|NCT03636256|593103480|FG000|Overall Study|Withdrawal by Subject|0|||
164199743|NCT03636256|593103481|FG001|Overall Study|Withdrawal by Subject|0|||
164199744|NCT03636256|593103482|FG002|Overall Study|Withdrawal by Subject|0|||
164199745|NCT03636256|593103483|FG003|Overall Study|Withdrawal by Subject|0|||
164199746|NCT03636256|593103484|FG004|Overall Study|Withdrawal by Subject|0|||
164199747|NCT03636256|593103485|FG005|Overall Study|Withdrawal by Subject|0|||
164199748|NCT03636256|593103486|FG006|Overall Study|Withdrawal by Subject|0|||
164199749|NCT03636256|593103487|FG007|Overall Study|Withdrawal by Subject|0|||
164199750|NCT03636256|593103488|FG008|Overall Study|Withdrawal by Subject|1|||
164199751|NCT00723229|593103491|FG000|First Intervention|Lost to Follow-up|7|||
164199752|NCT00723229|593103492|FG001|First Intervention|Lost to Follow-up|3|||
164199753|NCT02337491|593103493|FG000|Overall Study|Death|1|||
164199754|NCT02337491|593103494|FG001|Overall Study|Death|1|||
164199755|NCT02337491|593103493|FG000|Overall Study|Adverse Event|0|||
164199756|NCT02337491|593103494|FG001|Overall Study|Adverse Event|1|||
164199757|NCT02337491|593103493|FG000|Overall Study|Withdrawal by Subject|3|||
164199758|NCT02337491|593103494|FG001|Overall Study|Withdrawal by Subject|0|||
164199759|NCT02337491|593103493|FG000|Overall Study|Progressive Disease|44|||
164199760|NCT02337491|593103494|FG001|Overall Study|Progressive Disease|28|||
164199761|NCT02337491|593103493|FG000|Overall Study|On Treatment|2|||
164199762|NCT02337491|593103494|FG001|Overall Study|On Treatment|0|||
164199763|NCT01432951|593103495|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
164199764|NCT02900352|593103496|FG000|Overall Study|Lost to Follow-up|28|||
164199765|NCT02900352|593103497|FG001|Overall Study|Lost to Follow-up|17|||
164199766|NCT00960193|593103498|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
164199767|NCT00785356|593103500|FG000|Overall Study|Study prematurely terminated|8|||
164199768|NCT03712280|593103506|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
164199769|NCT03712280|593103507|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
164199770|NCT03712280|593103508|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
164199771|NCT03712280|593103509|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
164199772|NCT03712280|593103506|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
164199773|NCT03712280|593103507|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
164199774|NCT03712280|593103508|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
164199775|NCT03712280|593103509|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
164199776|NCT03712280|593103506|FG000|Overall Study|Adverse Event|0|||
164199777|NCT03712280|593103507|FG001|Overall Study|Adverse Event|0|||
164199778|NCT03712280|593103508|FG002|Overall Study|Adverse Event|1|||
164308460|NCT01931566|593504515|FG001|Overall Study|Major Protocol Deviation|14|||
164199779|NCT03712280|593103509|FG003|Overall Study|Adverse Event|0|||
164308461|NCT01931566|593504516|FG002|Overall Study|Major Protocol Deviation|21|||
164308462|NCT01931566|593504514|FG000|Overall Study|Lost to Follow-up|3|||
164199780|NCT01245101|593103510|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
164199781|NCT01245101|593103511|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
164199782|NCT01245101|593103510|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
164199783|NCT01245101|593103511|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
164199784|NCT01245101|593103510|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
164199785|NCT01245101|593103511|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
164199786|NCT03093181|593103512|FG000|Overall Study|Withdrawal by Subject|2|||
164199787|NCT03093181|593103513|FG001|Overall Study|Withdrawal by Subject|1|||
164199788|NCT03093181|593103514|FG002|Overall Study|Withdrawal by Subject|2|||
164199789|NCT03093181|593103512|FG000|Overall Study|Other (Not specified)|1|||
164199790|NCT03093181|593103513|FG001|Overall Study|Other (Not specified)|0|||
164199791|NCT03093181|593103514|FG002|Overall Study|Other (Not specified)|0|||
164199792|NCT03093181|593103512|FG000|Overall Study|Adverse Event|0|||
164199793|NCT03093181|593103513|FG001|Overall Study|Adverse Event|1|||
164199794|NCT03093181|593103514|FG002|Overall Study|Adverse Event|0|||
164199795|NCT03093181|593103512|FG000|Overall Study|Other (Protocol violation)|0|||
164199796|NCT03093181|593103513|FG001|Overall Study|Other (Protocol violation)|0|||
164199797|NCT03093181|593103514|FG002|Overall Study|Other (Protocol violation)|1|||
164199798|NCT04076917|593103515|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
164199799|NCT04076917|593103515|FG000|Overall Study|Study closure|13|||
164199800|NCT04076917|593103515|FG000|Overall Study|Physician Decision|3|||
164308463|NCT01931566|593504515|FG001|Overall Study|Lost to Follow-up|26|||
164308464|NCT01931566|593504516|FG002|Overall Study|Lost to Follow-up|23|||
164308465|NCT01931566|593504514|FG000|Overall Study|Voluntary Withdrawal|78|||
164308466|NCT01931566|593504515|FG001|Overall Study|Voluntary Withdrawal|245|||
164308467|NCT01931566|593504516|FG002|Overall Study|Voluntary Withdrawal|225|||
164308468|NCT01931566|593504514|FG000|Overall Study|Study Termination|289|||
164308469|NCT01931566|593504515|FG001|Overall Study|Study Termination|968|||
164308470|NCT01931566|593504516|FG002|Overall Study|Study Termination|1037|||
164308471|NCT01931566|593504514|FG000|Overall Study|Reason Not Specified|11|||
164308472|NCT01931566|593504515|FG001|Overall Study|Reason Not Specified|47|||
164308473|NCT01931566|593504516|FG002|Overall Study|Reason Not Specified|53|||
164308474|NCT01931566|593504514|FG000|Overall Study|Missing|0|||
164308475|NCT01931566|593504515|FG001|Overall Study|Missing|0|||
164308476|NCT01931566|593504516|FG002|Overall Study|Missing|1|||
164308477|NCT01599637|593504517|FG000|Overall Study|administrative problems|0|||
164308478|NCT01599637|593504518|FG001|Overall Study|administrative problems|2|||
164308479|NCT01599637|593504519|FG002|Overall Study|administrative problems|0|||
164308480|NCT01599637|593504517|FG000|Overall Study|Adverse Event|1|||
164308481|NCT01599637|593504518|FG001|Overall Study|Adverse Event|0|||
164308482|NCT01599637|593504519|FG002|Overall Study|Adverse Event|0|||
164308483|NCT00611026|593504520|FG000|Randomized to Double-blind Treatment|Not treated|2|||
164308484|NCT00611026|593504521|FG001|Randomized to Double-blind Treatment|Not treated|1|||
164308485|NCT00611026|593504522|FG002|Randomized to Double-blind Treatment|Not treated|3|||
164308486|NCT00611026|593504520|FG000|Double-blind Treatment Period|Death|1|||
164199801|NCT04076917|593103515|FG000|Overall Study|Death|1|||
164199802|NCT04076917|593103515|FG000|Overall Study|Lost to Follow-up|1|||
164199803|NCT04076917|593103515|FG000|Overall Study|Withdrawal by Subject|1|||
164199804|NCT04076917|593103515|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
164199805|NCT02378662|593103516|FG000|Overall Study|Early Discontinuation|2|||
164199806|NCT02378662|593103517|FG001|Overall Study|Early Discontinuation|0|||
164199807|NCT01159574|593103518|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
164199808|NCT01159574|593103518|FG000|Treatment Phase|Adverse Event|3|||
164199809|NCT01159574|593103518|FG000|Treatment Phase|Death|6|||
164199810|NCT01159574|593103518|FG000|Treatment Phase|Physician Decision|2|||
164199811|NCT01159574|593103518|FG000|Treatment Phase|Withdrawal by Subject|7|||
164199812|NCT01159574|593103518|FG000|Treatment Phase|still on treatment|2|||
164199813|NCT01159574|593103518|FG000|Follow Up Phase|Lost to Follow-up|2|||
164199814|NCT01159574|593103518|FG000|Follow Up Phase|still being followed for overall surviva|18|||
164199815|NCT05412134|593103519|FG000|Overall Study|Lost to Follow-up|2|||
164199816|NCT05412134|593103520|FG001|Overall Study|Lost to Follow-up|0|||
164199817|NCT03167242|593103524|FG000|Overall Study|Patient/Guardian Decision|0|||
164199818|NCT03167242|593103525|FG001|Overall Study|Patient/Guardian Decision|1|||
164199819|NCT03167242|593103526|FG002|Overall Study|Patient/Guardian Decision|2|||
164199820|NCT03167242|593103527|FG003|Overall Study|Patient/Guardian Decision|1|||
164199821|NCT03167242|593103528|FG004|Overall Study|Patient/Guardian Decision|1|||
164199822|NCT03167242|593103529|FG005|Overall Study|Patient/Guardian Decision|1|||
164199823|NCT03167242|593103530|FG006|Overall Study|Patient/Guardian Decision|0|||
164199824|NCT03167242|593103531|FG007|Overall Study|Patient/Guardian Decision|0|||
164199825|NCT03167242|593103532|FG008|Overall Study|Patient/Guardian Decision|0|||
164199826|NCT03167242|593103533|FG009|Overall Study|Patient/Guardian Decision|0|||
164308487|NCT00611026|593504521|FG001|Double-blind Treatment Period|Death|0|||
164308488|NCT00611026|593504522|FG002|Double-blind Treatment Period|Death|0|||
164308489|NCT00611026|593504520|FG000|Double-blind Treatment Period|Adverse Event|9|||
164308490|NCT00611026|593504521|FG001|Double-blind Treatment Period|Adverse Event|28|||
164308491|NCT00611026|593504522|FG002|Double-blind Treatment Period|Adverse Event|46|||
164308492|NCT00611026|593504520|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
164308493|NCT00611026|593504521|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
164308494|NCT00611026|593504522|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
164308495|NCT00611026|593504520|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
164308496|NCT00611026|593504521|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
164308497|NCT00611026|593504522|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
164308498|NCT00611026|593504520|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
164308499|NCT00611026|593504521|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
164308500|NCT00611026|593504522|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
164308501|NCT00611026|593504520|FG000|Double-blind Treatment Period|Other|13|||
164308502|NCT00611026|593504521|FG001|Double-blind Treatment Period|Other|20|||
164308503|NCT00611026|593504522|FG002|Double-blind Treatment Period|Other|18|||
164308504|NCT00760617|593504523|FG000|Overall Study|Adverse Event|5|||
164308505|NCT00760617|593504524|FG001|Overall Study|Adverse Event|2|||
164308506|NCT00760617|593504525|FG002|Overall Study|Adverse Event|0|||
164308507|NCT00760617|593504523|FG000|Overall Study|Lost to Follow-up|0|||
164308508|NCT00760617|593504524|FG001|Overall Study|Lost to Follow-up|0|||
164308509|NCT00760617|593504525|FG002|Overall Study|Lost to Follow-up|5|||
164308510|NCT04625101|593504526|FG000|Overall Study|Withdrawal by Subject|0|||
164308511|NCT04625101|593504527|FG001|Overall Study|Withdrawal by Subject|1|||
164308512|NCT04625101|593504526|FG000|Overall Study|Protocol Deviation|1|||
164308513|NCT04625101|593504527|FG001|Overall Study|Protocol Deviation|0|||
164308514|NCT01192191|593504529|FG000|Overall Study|Adverse Event|7|||
164308515|NCT01192191|593504530|FG001|Overall Study|Adverse Event|12|||
164308516|NCT01192191|593504529|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
164308517|NCT01192191|593504530|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
164308518|NCT01192191|593504529|FG000|Overall Study|Lost to Follow-up|0|||
164308519|NCT01192191|593504530|FG001|Overall Study|Lost to Follow-up|1|||
164308520|NCT01192191|593504529|FG000|Overall Study|Withdrawal by Subject|1|||
164308521|NCT01192191|593504530|FG001|Overall Study|Withdrawal by Subject|6|||
164308522|NCT00467753|593504531|FG000|Overall Study|Lost to Follow-up|1|||
164308523|NCT00467753|593504532|FG001|Overall Study|Lost to Follow-up|2|||
164308524|NCT00467753|593504531|FG000|Overall Study|Adverse Event|2|||
164308525|NCT00467753|593504532|FG001|Overall Study|Adverse Event|0|||
164308526|NCT01047553|593504533|FG000|Overall Study|Adverse Event|10|||
164308527|NCT01047553|593504534|FG001|Overall Study|Adverse Event|5|||
164308528|NCT01047553|593504533|FG000|Overall Study|Withdrawal by Subject|4|||
164308529|NCT01047553|593504534|FG001|Overall Study|Withdrawal by Subject|2|||
164308530|NCT01047553|593504533|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
164308531|NCT01047553|593504534|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
164308532|NCT01047553|593504533|FG000|Overall Study|Lost to Follow-up|1|||
164308533|NCT01047553|593504534|FG001|Overall Study|Lost to Follow-up|0|||
164308534|NCT01047553|593504533|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
164308535|NCT01047553|593504534|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
164308536|NCT01047553|593504533|FG000|Overall Study|PI's decision|0|||
164308537|NCT01047553|593504534|FG001|Overall Study|PI's decision|1|||
164308538|NCT02817464|593504536|FG000|Overall Study|Lost to Follow-up|1|||
164308539|NCT02817464|593504537|FG001|Overall Study|Lost to Follow-up|0|||
164308540|NCT02817464|593504536|FG000|Overall Study|Discontinued early due to personal decision|1|||
164308541|NCT02817464|593504537|FG001|Overall Study|Discontinued early due to personal decision|1|||
164308542|NCT04292899|593504539|FG000|Overall Study|Death|21|||
164308543|NCT04292899|593504540|FG001|Overall Study|Death|28|||
164308544|NCT04292899|593504541|FG002|Overall Study|Death|188|||
164308545|NCT04292899|593504542|FG003|Overall Study|Death|371|||
164308546|NCT04292899|593504539|FG000|Overall Study|Lost to Follow-up|8|||
164308547|NCT04292899|593504540|FG001|Overall Study|Lost to Follow-up|4|||
164308548|NCT04292899|593504541|FG002|Overall Study|Lost to Follow-up|22|||
164308549|NCT04292899|593504542|FG003|Overall Study|Lost to Follow-up|235|||
164308550|NCT04292899|593504539|FG000|Overall Study|Withdrew consent|1|||
164308551|NCT04292899|593504540|FG001|Overall Study|Withdrew consent|0|||
164308552|NCT04292899|593504541|FG002|Overall Study|Withdrew consent|11|||
164308553|NCT04292899|593504542|FG003|Overall Study|Withdrew consent|32|||
164308554|NCT04292899|593504539|FG000|Overall Study|Adverse Event|2|||
164308555|NCT04292899|593504540|FG001|Overall Study|Adverse Event|1|||
164308556|NCT04292899|593504541|FG002|Overall Study|Adverse Event|2|||
164308557|NCT04292899|593504542|FG003|Overall Study|Adverse Event|2|||
164308558|NCT04292899|593504539|FG000|Overall Study|Investigator's Discretion|0|||
164308559|NCT04292899|593504540|FG001|Overall Study|Investigator's Discretion|0|||
163862187|NCT00486759|591861969|FG000|Safety Follow-up|Withdrew consent|32|||
163862188|NCT00486759|591861970|FG001|Safety Follow-up|Withdrew consent|23|||
164308560|NCT04292899|593504541|FG002|Overall Study|Investigator's Discretion|0|||
164308561|NCT04292899|593504542|FG003|Overall Study|Investigator's Discretion|3|||
164308562|NCT04292899|593504539|FG000|Overall Study|Non-compliance With Study Drug|0|||
164308563|NCT04292899|593504540|FG001|Overall Study|Non-compliance With Study Drug|0|||
164308564|NCT04292899|593504541|FG002|Overall Study|Non-compliance With Study Drug|0|||
164199827|NCT03167242|593103534|FG010|Overall Study|Patient/Guardian Decision|1|||
164199828|NCT03167242|593103535|FG011|Overall Study|Patient/Guardian Decision|0|||
164199829|NCT03167242|593103524|FG000|Overall Study|Lost to Follow-up|0|||
164199830|NCT03167242|593103525|FG001|Overall Study|Lost to Follow-up|0|||
164199831|NCT03167242|593103526|FG002|Overall Study|Lost to Follow-up|1|||
164199832|NCT03167242|593103527|FG003|Overall Study|Lost to Follow-up|0|||
164199833|NCT03167242|593103528|FG004|Overall Study|Lost to Follow-up|0|||
164199834|NCT03167242|593103529|FG005|Overall Study|Lost to Follow-up|1|||
164199835|NCT03167242|593103530|FG006|Overall Study|Lost to Follow-up|2|||
164199836|NCT03167242|593103531|FG007|Overall Study|Lost to Follow-up|1|||
164199837|NCT03167242|593103532|FG008|Overall Study|Lost to Follow-up|0|||
164199838|NCT03167242|593103533|FG009|Overall Study|Lost to Follow-up|0|||
164199839|NCT03167242|593103534|FG010|Overall Study|Lost to Follow-up|1|||
164199840|NCT03167242|593103535|FG011|Overall Study|Lost to Follow-up|1|||
164199841|NCT03167242|593103524|FG000|Overall Study|Reason not provided|0|||
164199842|NCT03167242|593103525|FG001|Overall Study|Reason not provided|0|||
164199843|NCT03167242|593103526|FG002|Overall Study|Reason not provided|0|||
164199844|NCT03167242|593103527|FG003|Overall Study|Reason not provided|0|||
164199845|NCT03167242|593103528|FG004|Overall Study|Reason not provided|0|||
164199846|NCT03167242|593103529|FG005|Overall Study|Reason not provided|0|||
164199847|NCT03167242|593103530|FG006|Overall Study|Reason not provided|0|||
164199848|NCT03167242|593103531|FG007|Overall Study|Reason not provided|0|||
164199849|NCT03167242|593103532|FG008|Overall Study|Reason not provided|1|||
164199850|NCT03167242|593103533|FG009|Overall Study|Reason not provided|0|||
164199851|NCT03167242|593103534|FG010|Overall Study|Reason not provided|0|||
164199852|NCT03167242|593103535|FG011|Overall Study|Reason not provided|0|||
164199853|NCT03444584|593103536|FG000|Overall Study|Withdrawal by Subject|0|||
164199854|NCT03444584|593103537|FG001|Overall Study|Withdrawal by Subject|1|||
164199855|NCT03444584|593103536|FG000|Overall Study|Other|0|||
164199856|NCT03444584|593103537|FG001|Overall Study|Other|1|||
164199857|NCT01077323|593103540|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
164199858|NCT01077323|593103541|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
164199859|NCT01077323|593103542|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
164199860|NCT01077323|593103540|FG000|Overall Study|Dispensing of drug in baseline period|0|||
164199861|NCT01077323|593103541|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
164199862|NCT01077323|593103542|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
164199863|NCT01077323|593103540|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
164199864|NCT01077323|593103541|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
164199865|NCT01077323|593103542|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
164199866|NCT00372424|593103543|FG000|Overall Study|Adverse Event|2|||
164199867|NCT00372424|593103543|FG000|Overall Study|Withdrawal by Subject|1|||
164199868|NCT00372424|593103543|FG000|Overall Study|Death|1|||
164199869|NCT00372424|593103543|FG000|Overall Study|Objective Progression or Relapse|14|||
164199870|NCT00372424|593103543|FG000|Overall Study|Other|7|||
164199871|NCT00372424|593103543|FG000|Overall Study|Enrolled, Not Treated|1|||
164199872|NCT03118934|593103552|FG000|Overall Study|Adverse Event|0|||
164199873|NCT03118934|593103553|FG001|Overall Study|Adverse Event|0|||
164199874|NCT03118934|593103554|FG002|Overall Study|Adverse Event|0|||
164199875|NCT03118934|593103555|FG003|Overall Study|Adverse Event|0|||
164199876|NCT03118934|593103556|FG004|Overall Study|Adverse Event|0|||
164199877|NCT03118934|593103557|FG005|Overall Study|Adverse Event|1|||
164199878|NCT03118934|593103552|FG000|Overall Study|Physician Decision|0|||
164199879|NCT03118934|593103553|FG001|Overall Study|Physician Decision|0|||
164199880|NCT03118934|593103554|FG002|Overall Study|Physician Decision|0|||
164199881|NCT03118934|593103555|FG003|Overall Study|Physician Decision|0|||
164199882|NCT03118934|593103556|FG004|Overall Study|Physician Decision|0|||
164199883|NCT03118934|593103557|FG005|Overall Study|Physician Decision|1|||
164199884|NCT03118934|593103552|FG000|Overall Study|Discontinued prior to exposure|0|||
164199885|NCT03118934|593103553|FG001|Overall Study|Discontinued prior to exposure|1|||
164199886|NCT03118934|593103554|FG002|Overall Study|Discontinued prior to exposure|1|||
164199887|NCT03118934|593103555|FG003|Overall Study|Discontinued prior to exposure|1|||
164199888|NCT03118934|593103556|FG004|Overall Study|Discontinued prior to exposure|2|||
164199889|NCT03118934|593103557|FG005|Overall Study|Discontinued prior to exposure|0|||
164199890|NCT02849080|593103568|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
164199891|NCT02849080|593103569|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
164199892|NCT02849080|593103570|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
164199893|NCT02849080|593103571|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
164199894|NCT02849080|593103568|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
164199895|NCT02849080|593103569|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
164199896|NCT02849080|593103570|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
164199897|NCT02849080|593103571|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
164199898|NCT02849080|593103568|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
164199899|NCT02849080|593103569|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
164199900|NCT02849080|593103570|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
164199901|NCT02849080|593103571|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
164199902|NCT02849080|593103568|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
164308565|NCT04292899|593504542|FG003|Overall Study|Non-compliance With Study Drug|1|||
164308566|NCT04292899|593504539|FG000|Overall Study|Protocol Violation|0|||
164308567|NCT04292899|593504540|FG001|Overall Study|Protocol Violation|0|||
164308568|NCT04292899|593504541|FG002|Overall Study|Protocol Violation|0|||
164308569|NCT04292899|593504542|FG003|Overall Study|Protocol Violation|1|||
164308570|NCT00948441|593504543|FG000|Overall Study|no longer meet inclusion criteria|1|||
164308571|NCT00948441|593504544|FG001|Overall Study|no longer meet inclusion criteria|4|||
164308572|NCT03695367|593504545|FG000|Overall Study|Missed the Day 28 visit.|1|||
164308573|NCT03695367|593504546|FG001|Overall Study|Missed the Day 28 visit.|0|||
164308574|NCT03695367|593504545|FG000|Overall Study|Lost to Follow-up|0|||
164308575|NCT03695367|593504546|FG001|Overall Study|Lost to Follow-up|1|||
164308576|NCT03695367|593504545|FG000|Overall Study|Withdrawal by Subject|0|||
164308577|NCT03695367|593504546|FG001|Overall Study|Withdrawal by Subject|1|||
164308578|NCT03695367|593504545|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
164308579|NCT03695367|593504546|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
164308580|NCT02039843|593504548|FG000|Randomization and Observation Period|Adverse Event|2|||
164308581|NCT02039843|593504549|FG001|Randomization and Observation Period|Adverse Event|0|||
164308582|NCT02039843|593504548|FG000|Randomization and Observation Period|Death|1|||
164308583|NCT02039843|593504549|FG001|Randomization and Observation Period|Death|0|||
164308584|NCT02039843|593504548|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
164308585|NCT02039843|593504549|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
164308586|NCT02039843|593504548|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
164308587|NCT02039843|593504549|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
164308588|NCT02039843|593504548|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
164308589|NCT02039843|593504549|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
164308590|NCT02039843|593504548|FG000|Pairing With a Study Dog|Death|1|||
164308591|NCT02039843|593504549|FG001|Pairing With a Study Dog|Death|0|||
164308592|NCT02039843|593504548|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
164308593|NCT02039843|593504549|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
164308594|NCT02039843|593504548|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
164308595|NCT02039843|593504549|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
164308596|NCT02039843|593504548|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
164308597|NCT02039843|593504549|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
164308598|NCT01958164|593504550|FG000|Overall Study|Adverse Event|0|||
164308599|NCT01958164|593504551|FG001|Overall Study|Adverse Event|2|||
164308600|NCT01958164|593504550|FG000|Overall Study|Lost to Follow-up|2|||
164308601|NCT01958164|593504551|FG001|Overall Study|Lost to Follow-up|3|||
164308602|NCT00740857|593504552|FG000|Overall Study|Withdrawal by Subject|1|||
164308603|NCT00740857|593504553|FG001|Overall Study|Withdrawal by Subject|0|||
164308604|NCT00740857|593504554|FG002|Overall Study|Withdrawal by Subject|0|||
164308605|NCT02963506|593504555|FG000|Double-Blind Period|Adverse Event|0|||
164308606|NCT02963506|593504556|FG001|Double-Blind Period|Adverse Event|0|||
164308607|NCT02963506|593504557|FG002|Double-Blind Period|Adverse Event|1|||
164308608|NCT02963506|593504558|FG003|Double-Blind Period|Adverse Event|0|||
164308609|NCT02963506|593504559|FG004|Double-Blind Period|Adverse Event|0|||
164308610|NCT02963506|593504560|FG005|Double-Blind Period|Adverse Event|0|||
164308611|NCT02963506|593504561|FG006|Double-Blind Period|Adverse Event|0|||
164308612|NCT02963506|593504562|FG007|Double-Blind Period|Adverse Event|0|||
164308613|NCT02963506|593504563|FG008|Double-Blind Period|Adverse Event|0|||
164308614|NCT02963506|593504564|FG009|Double-Blind Period|Adverse Event|0|||
164308615|NCT02963506|593504565|FG010|Double-Blind Period|Adverse Event|0|||
164308616|NCT02963506|593504566|FG011|Double-Blind Period|Adverse Event|0|||
164308617|NCT02963506|593504567|FG012|Double-Blind Period|Adverse Event|0|||
164308618|NCT02963506|593504555|FG000|Double-Blind Period|Death|0|||
164308619|NCT02963506|593504556|FG001|Double-Blind Period|Death|0|||
164308620|NCT02963506|593504557|FG002|Double-Blind Period|Death|0|||
164308621|NCT02963506|593504558|FG003|Double-Blind Period|Death|1|||
164308622|NCT02963506|593504559|FG004|Double-Blind Period|Death|0|||
164308623|NCT02963506|593504560|FG005|Double-Blind Period|Death|0|||
164308624|NCT02963506|593504561|FG006|Double-Blind Period|Death|0|||
164308625|NCT02963506|593504562|FG007|Double-Blind Period|Death|0|||
164308626|NCT02963506|593504563|FG008|Double-Blind Period|Death|0|||
164308627|NCT02963506|593504564|FG009|Double-Blind Period|Death|0|||
164308628|NCT02963506|593504565|FG010|Double-Blind Period|Death|0|||
164308629|NCT02963506|593504566|FG011|Double-Blind Period|Death|0|||
164308630|NCT02963506|593504567|FG012|Double-Blind Period|Death|0|||
164308631|NCT02963506|593504555|FG000|Double-Blind Period|Lost to Follow-up|0|||
164308632|NCT02963506|593504556|FG001|Double-Blind Period|Lost to Follow-up|1|||
164308633|NCT02963506|593504557|FG002|Double-Blind Period|Lost to Follow-up|0|||
164308634|NCT02963506|593504558|FG003|Double-Blind Period|Lost to Follow-up|0|||
164308635|NCT02963506|593504559|FG004|Double-Blind Period|Lost to Follow-up|0|||
164308636|NCT02963506|593504560|FG005|Double-Blind Period|Lost to Follow-up|0|||
164308637|NCT02963506|593504561|FG006|Double-Blind Period|Lost to Follow-up|0|||
164308638|NCT02963506|593504562|FG007|Double-Blind Period|Lost to Follow-up|0|||
164308639|NCT02963506|593504563|FG008|Double-Blind Period|Lost to Follow-up|0|||
164308640|NCT02963506|593504564|FG009|Double-Blind Period|Lost to Follow-up|0|||
164308641|NCT02963506|593504565|FG010|Double-Blind Period|Lost to Follow-up|0|||
164308642|NCT02963506|593504566|FG011|Double-Blind Period|Lost to Follow-up|0|||
164308643|NCT02963506|593504567|FG012|Double-Blind Period|Lost to Follow-up|0|||
164308644|NCT02963506|593504555|FG000|Double-Blind Period|Withdrawal by Subject|0|||
164308645|NCT02963506|593504556|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164308646|NCT02963506|593504557|FG002|Double-Blind Period|Withdrawal by Subject|1|||
164308647|NCT02963506|593504558|FG003|Double-Blind Period|Withdrawal by Subject|1|||
164308648|NCT02963506|593504559|FG004|Double-Blind Period|Withdrawal by Subject|0|||
164308649|NCT02963506|593504560|FG005|Double-Blind Period|Withdrawal by Subject|0|||
164308650|NCT02963506|593504561|FG006|Double-Blind Period|Withdrawal by Subject|0|||
164308651|NCT02963506|593504562|FG007|Double-Blind Period|Withdrawal by Subject|0|||
164308652|NCT02963506|593504563|FG008|Double-Blind Period|Withdrawal by Subject|0|||
164308653|NCT02963506|593504564|FG009|Double-Blind Period|Withdrawal by Subject|0|||
164308654|NCT02963506|593504565|FG010|Double-Blind Period|Withdrawal by Subject|0|||
164308655|NCT02963506|593504566|FG011|Double-Blind Period|Withdrawal by Subject|0|||
164308656|NCT02963506|593504567|FG012|Double-Blind Period|Withdrawal by Subject|0|||
164308657|NCT02963506|593504555|FG000|Double-Blind Period|No compliance|0|||
164308658|NCT02963506|593504556|FG001|Double-Blind Period|No compliance|1|||
164308659|NCT02963506|593504557|FG002|Double-Blind Period|No compliance|0|||
164308660|NCT02963506|593504558|FG003|Double-Blind Period|No compliance|0|||
164308661|NCT02963506|593504559|FG004|Double-Blind Period|No compliance|0|||
164308662|NCT02963506|593504560|FG005|Double-Blind Period|No compliance|0|||
164308663|NCT02963506|593504561|FG006|Double-Blind Period|No compliance|0|||
164308664|NCT02963506|593504562|FG007|Double-Blind Period|No compliance|0|||
164308665|NCT02963506|593504563|FG008|Double-Blind Period|No compliance|0|||
164308666|NCT02963506|593504564|FG009|Double-Blind Period|No compliance|0|||
164308667|NCT02963506|593504565|FG010|Double-Blind Period|No compliance|0|||
164308668|NCT02963506|593504566|FG011|Double-Blind Period|No compliance|0|||
164308669|NCT02963506|593504567|FG012|Double-Blind Period|No compliance|0|||
164308670|NCT02963506|593504555|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308671|NCT02963506|593504556|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
164308672|NCT02963506|593504557|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308673|NCT02963506|593504558|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308674|NCT02963506|593504559|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308675|NCT02963506|593504560|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308676|NCT02963506|593504561|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308677|NCT02963506|593504562|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308678|NCT02963506|593504563|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308679|NCT02963506|593504564|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308680|NCT02963506|593504565|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308681|NCT02963506|593504566|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308682|NCT02963506|593504567|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
164308683|NCT02963506|593504555|FG000|Dose-Blind Period|Adverse Event|0|||
164308684|NCT02963506|593504556|FG001|Dose-Blind Period|Adverse Event|0|||
164308685|NCT02963506|593504557|FG002|Dose-Blind Period|Adverse Event|0|||
164308686|NCT02963506|593504558|FG003|Dose-Blind Period|Adverse Event|0|||
164308687|NCT02963506|593504559|FG004|Dose-Blind Period|Adverse Event|0|||
164308688|NCT02963506|593504560|FG005|Dose-Blind Period|Adverse Event|1|||
164308689|NCT02963506|593504561|FG006|Dose-Blind Period|Adverse Event|3|||
164308690|NCT02963506|593504562|FG007|Dose-Blind Period|Adverse Event|2|||
164308691|NCT02963506|593504563|FG008|Dose-Blind Period|Adverse Event|2|||
164308692|NCT02963506|593504564|FG009|Dose-Blind Period|Adverse Event|2|||
164308693|NCT02963506|593504565|FG010|Dose-Blind Period|Adverse Event|1|||
164308694|NCT02963506|593504566|FG011|Dose-Blind Period|Adverse Event|1|||
164308695|NCT02963506|593504567|FG012|Dose-Blind Period|Adverse Event|6|||
164308696|NCT02963506|593504555|FG000|Dose-Blind Period|Lack of Efficacy|0|||
164308697|NCT02963506|593504556|FG001|Dose-Blind Period|Lack of Efficacy|0|||
164308698|NCT02963506|593504557|FG002|Dose-Blind Period|Lack of Efficacy|0|||
164308699|NCT02963506|593504558|FG003|Dose-Blind Period|Lack of Efficacy|0|||
164308700|NCT02963506|593504559|FG004|Dose-Blind Period|Lack of Efficacy|0|||
164308701|NCT02963506|593504560|FG005|Dose-Blind Period|Lack of Efficacy|0|||
164308702|NCT02963506|593504561|FG006|Dose-Blind Period|Lack of Efficacy|0|||
164308703|NCT02963506|593504562|FG007|Dose-Blind Period|Lack of Efficacy|1|||
164308704|NCT02963506|593504563|FG008|Dose-Blind Period|Lack of Efficacy|0|||
164308705|NCT02963506|593504564|FG009|Dose-Blind Period|Lack of Efficacy|1|||
164308706|NCT02963506|593504565|FG010|Dose-Blind Period|Lack of Efficacy|0|||
164308707|NCT02963506|593504566|FG011|Dose-Blind Period|Lack of Efficacy|0|||
164308708|NCT02963506|593504567|FG012|Dose-Blind Period|Lack of Efficacy|0|||
164308709|NCT02963506|593504555|FG000|Dose-Blind Period|Lost to Follow-up|0|||
164308710|NCT02963506|593504556|FG001|Dose-Blind Period|Lost to Follow-up|0|||
164308711|NCT02963506|593504557|FG002|Dose-Blind Period|Lost to Follow-up|0|||
164308712|NCT02963506|593504558|FG003|Dose-Blind Period|Lost to Follow-up|0|||
164308713|NCT02963506|593504559|FG004|Dose-Blind Period|Lost to Follow-up|0|||
164308714|NCT02963506|593504560|FG005|Dose-Blind Period|Lost to Follow-up|1|||
164199903|NCT02849080|593103569|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
164199904|NCT02849080|593103570|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
164199905|NCT02849080|593103571|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
164199906|NCT02849080|593103568|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
164199907|NCT02849080|593103569|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
164199908|NCT02849080|593103570|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
164199909|NCT02849080|593103571|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
164199910|NCT02849080|593103568|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
164199911|NCT02849080|593103569|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
164199912|NCT02849080|593103570|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
164199913|NCT02849080|593103571|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
164199914|NCT02155985|593103574|FG000|Overall Study|Withdrawal by Subject|0|||
164199915|NCT02155985|593103575|FG001|Overall Study|Withdrawal by Subject|0|||
164199916|NCT02155985|593103576|FG002|Overall Study|Withdrawal by Subject|1|||
164199917|NCT02155985|593103574|FG000|Overall Study|Lost to Follow-up|1|||
164199918|NCT02155985|593103575|FG001|Overall Study|Lost to Follow-up|0|||
164199919|NCT02155985|593103576|FG002|Overall Study|Lost to Follow-up|0|||
164199920|NCT00732069|593103577|FG000|Washout After First Study Drug|Adverse Event|1|||
164199921|NCT00732069|593103578|FG001|Washout After First Study Drug|Adverse Event|0|||
164199922|NCT00732069|593103579|FG002|Washout After First Study Drug|Adverse Event|0|||
164199923|NCT00732069|593103580|FG003|Washout After First Study Drug|Adverse Event|0|||
164199924|NCT00732069|593103581|FG004|Washout After First Study Drug|Adverse Event|0|||
164199925|NCT00732069|593103582|FG005|Washout After First Study Drug|Adverse Event|0|||
164199926|NCT02283658|593103583|FG000|Overall Study|Withdrawal by Subject|1|||
164199927|NCT03608826|593103584|FG000|Overall Study|Death|3|||
164199928|NCT03608826|593103584|FG000|Overall Study|Heart Transplant|3|||
164199929|NCT03608826|593103584|FG000|Overall Study|Physician Decision|4|||
164199930|NCT03139552|593103589|FG000|Overall Study|unable to attend tasting due to schedule|3|||
164199931|NCT00780975|593103597|FG000|Overall Study|Progressive disease|3|||
164199932|NCT00780975|593103597|FG000|Overall Study|Toxicity|5|||
164199933|NCT00887484|593103598|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
164199934|NCT00887484|593103598|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
164199935|NCT00887484|593103598|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
164199936|NCT01061606|593103599|FG000|Overall Study|Adverse Event|1|||
164199937|NCT01061606|593103599|FG000|Overall Study|Death|1|||
164199938|NCT01061606|593103599|FG000|Overall Study|Disease Progression|4|||
164199939|NCT01061606|593103599|FG000|Overall Study|alternative therapy|2|||
164199940|NCT03122171|593103600|FG000|Overall Study|Withdrawal by Subject|1|||
164199941|NCT03044314|593103601|FG000|Overall Study|Physician Decision|2|||
164199942|NCT03044314|593103601|FG000|Overall Study|Withdrawal by Subject|1|||
164199943|NCT03044314|593103601|FG000|Overall Study|Connector tubing not available|1|||
164199944|NCT01316224|593103602|FG000|Overall Study|Protocol Violation|3|||
164199945|NCT01316224|593103602|FG000|Overall Study|Adverse Event|3|||
164199946|NCT01316224|593103602|FG000|Overall Study|Lack of Efficacy|1|||
164199947|NCT01316224|593103602|FG000|Overall Study|Withdrawal by Subject|1|||
164199948|NCT01316224|593103602|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
164199949|NCT01316224|593103602|FG000|Overall Study|Other|1|||
164199950|NCT00264147|593103603|FG000|Treatment I Period|Adverse Event|3|||
164199951|NCT00264147|593103604|FG001|Treatment I Period|Adverse Event|6|||
164199952|NCT00264147|593103605|FG002|Treatment I Period|Adverse Event|3|||
164199953|NCT00264147|593103606|FG003|Treatment I Period|Adverse Event|5|||
164199954|NCT00264147|593103607|FG004|Treatment I Period|Adverse Event|7|||
164199955|NCT00264147|593103608|FG005|Treatment I Period|Adverse Event|0|||
164199956|NCT00264147|593103603|FG000|Treatment I Period|Laboratory Adverse Event|0|||
164199957|NCT00264147|593103604|FG001|Treatment I Period|Laboratory Adverse Event|0|||
164199958|NCT00264147|593103605|FG002|Treatment I Period|Laboratory Adverse Event|0|||
164199959|NCT00264147|593103606|FG003|Treatment I Period|Laboratory Adverse Event|1|||
164199960|NCT00264147|593103607|FG004|Treatment I Period|Laboratory Adverse Event|0|||
164199961|NCT00264147|593103608|FG005|Treatment I Period|Laboratory Adverse Event|0|||
164199962|NCT00264147|593103603|FG000|Treatment I Period|Lack of Efficacy|6|||
164199963|NCT00264147|593103604|FG001|Treatment I Period|Lack of Efficacy|2|||
164199964|NCT00264147|593103605|FG002|Treatment I Period|Lack of Efficacy|8|||
164199965|NCT00264147|593103606|FG003|Treatment I Period|Lack of Efficacy|0|||
164199966|NCT00264147|593103607|FG004|Treatment I Period|Lack of Efficacy|1|||
164199967|NCT00264147|593103608|FG005|Treatment I Period|Lack of Efficacy|0|||
164199968|NCT00264147|593103603|FG000|Treatment I Period|Lost to Follow-up|1|||
164199969|NCT00264147|593103604|FG001|Treatment I Period|Lost to Follow-up|0|||
164199970|NCT00264147|593103605|FG002|Treatment I Period|Lost to Follow-up|0|||
164199971|NCT00264147|593103606|FG003|Treatment I Period|Lost to Follow-up|1|||
164199972|NCT00264147|593103607|FG004|Treatment I Period|Lost to Follow-up|1|||
164199973|NCT00264147|593103608|FG005|Treatment I Period|Lost to Follow-up|0|||
164199974|NCT00264147|593103603|FG000|Treatment I Period|Protocol Violation|2|||
164199975|NCT00264147|593103604|FG001|Treatment I Period|Protocol Violation|2|||
164199976|NCT00264147|593103605|FG002|Treatment I Period|Protocol Violation|0|||
164199977|NCT00264147|593103606|FG003|Treatment I Period|Protocol Violation|0|||
163862189|NCT00486759|591861969|FG000|Safety Follow-up|Failure to return|9|||
163862190|NCT00486759|591861970|FG001|Safety Follow-up|Failure to return|6|||
163862191|NCT00486759|591861969|FG000|Safety Follow-up|Administrative/not specified|8|||
163862192|NCT00486759|591861970|FG001|Safety Follow-up|Administrative/not specified|6|||
163862193|NCT00486759|591861969|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
163862194|NCT00486759|591861970|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
164199978|NCT00264147|593103607|FG004|Treatment I Period|Protocol Violation|0|||
164199979|NCT00264147|593103608|FG005|Treatment I Period|Protocol Violation|0|||
164199980|NCT00264147|593103603|FG000|Treatment I Period|Withdrawal by Subject|2|||
164199981|NCT00264147|593103604|FG001|Treatment I Period|Withdrawal by Subject|0|||
164199982|NCT00264147|593103605|FG002|Treatment I Period|Withdrawal by Subject|0|||
164199983|NCT00264147|593103606|FG003|Treatment I Period|Withdrawal by Subject|2|||
164199984|NCT00264147|593103607|FG004|Treatment I Period|Withdrawal by Subject|2|||
164199985|NCT00264147|593103608|FG005|Treatment I Period|Withdrawal by Subject|0|||
164199986|NCT00264147|593103603|FG000|Treatment I Period|Patient out of town for an extended time|0|||
164199987|NCT00264147|593103604|FG001|Treatment I Period|Patient out of town for an extended time|1|||
164199988|NCT00264147|593103605|FG002|Treatment I Period|Patient out of town for an extended time|0|||
164199989|NCT00264147|593103606|FG003|Treatment I Period|Patient out of town for an extended time|0|||
164199990|NCT00264147|593103607|FG004|Treatment I Period|Patient out of town for an extended time|0|||
164199991|NCT00264147|593103608|FG005|Treatment I Period|Patient out of town for an extended time|0|||
164199992|NCT00264147|593103603|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199993|NCT00264147|593103604|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199994|NCT00264147|593103605|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
164199995|NCT00264147|593103606|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199996|NCT00264147|593103607|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199997|NCT00264147|593103608|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
164199998|NCT00264147|593103603|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
164199999|NCT00264147|593103604|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
164200000|NCT00264147|593103605|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
164200001|NCT00264147|593103606|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
164200002|NCT00264147|593103607|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
164200003|NCT00264147|593103608|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
164200004|NCT00264147|593103603|FG000|Treatment II Period|Adverse Event|0|||
164200005|NCT00264147|593103604|FG001|Treatment II Period|Adverse Event|0|||
164200006|NCT00264147|593103605|FG002|Treatment II Period|Adverse Event|0|||
164200007|NCT00264147|593103606|FG003|Treatment II Period|Adverse Event|0|||
164200008|NCT00264147|593103607|FG004|Treatment II Period|Adverse Event|9|||
164200009|NCT00264147|593103608|FG005|Treatment II Period|Adverse Event|9|||
164200010|NCT00264147|593103603|FG000|Treatment II Period|Laboratory Adverse Event|0|||
164200011|NCT00264147|593103604|FG001|Treatment II Period|Laboratory Adverse Event|0|||
164200012|NCT00264147|593103605|FG002|Treatment II Period|Laboratory Adverse Event|0|||
164200013|NCT00264147|593103606|FG003|Treatment II Period|Laboratory Adverse Event|0|||
164200014|NCT00264147|593103607|FG004|Treatment II Period|Laboratory Adverse Event|0|||
164200015|NCT00264147|593103608|FG005|Treatment II Period|Laboratory Adverse Event|1|||
164200016|NCT00264147|593103603|FG000|Treatment II Period|Lack of Efficacy|0|||
164200017|NCT00264147|593103604|FG001|Treatment II Period|Lack of Efficacy|0|||
164200018|NCT00264147|593103605|FG002|Treatment II Period|Lack of Efficacy|0|||
164200019|NCT00264147|593103606|FG003|Treatment II Period|Lack of Efficacy|0|||
164200020|NCT00264147|593103607|FG004|Treatment II Period|Lack of Efficacy|20|||
164200021|NCT00264147|593103608|FG005|Treatment II Period|Lack of Efficacy|19|||
164200022|NCT00264147|593103603|FG000|Treatment II Period|Lost to Follow-up|0|||
164200023|NCT00264147|593103604|FG001|Treatment II Period|Lost to Follow-up|0|||
164200024|NCT00264147|593103605|FG002|Treatment II Period|Lost to Follow-up|0|||
164200025|NCT00264147|593103606|FG003|Treatment II Period|Lost to Follow-up|0|||
164200026|NCT00264147|593103607|FG004|Treatment II Period|Lost to Follow-up|1|||
164200027|NCT00264147|593103608|FG005|Treatment II Period|Lost to Follow-up|1|||
164200028|NCT00264147|593103603|FG000|Treatment II Period|Withdrawal by Subject|0|||
164200029|NCT00264147|593103604|FG001|Treatment II Period|Withdrawal by Subject|0|||
164200030|NCT00264147|593103605|FG002|Treatment II Period|Withdrawal by Subject|0|||
164200031|NCT00264147|593103606|FG003|Treatment II Period|Withdrawal by Subject|0|||
164200032|NCT00264147|593103607|FG004|Treatment II Period|Withdrawal by Subject|3|||
164200033|NCT00264147|593103608|FG005|Treatment II Period|Withdrawal by Subject|2|||
164200034|NCT00264147|593103603|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200035|NCT00264147|593103604|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200036|NCT00264147|593103605|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200037|NCT00264147|593103606|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200038|NCT00264147|593103607|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
164200039|NCT00264147|593103608|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
164200040|NCT03234465|593103609|FG000|Overall Study|Adverse Event|4|||
164200041|NCT03234465|593103610|FG001|Overall Study|Adverse Event|2|||
164200042|NCT03234465|593103609|FG000|Overall Study|Death|0|||
164308715|NCT02963506|593504561|FG006|Dose-Blind Period|Lost to Follow-up|0|||
164308716|NCT02963506|593504562|FG007|Dose-Blind Period|Lost to Follow-up|0|||
164308717|NCT02963506|593504563|FG008|Dose-Blind Period|Lost to Follow-up|1|||
164308718|NCT02963506|593504564|FG009|Dose-Blind Period|Lost to Follow-up|0|||
164308719|NCT02963506|593504565|FG010|Dose-Blind Period|Lost to Follow-up|0|||
164308720|NCT02963506|593504566|FG011|Dose-Blind Period|Lost to Follow-up|1|||
164308721|NCT02963506|593504567|FG012|Dose-Blind Period|Lost to Follow-up|0|||
164308722|NCT02963506|593504555|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
164308723|NCT02963506|593504556|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
164308724|NCT02963506|593504557|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
164308725|NCT02963506|593504558|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
164308726|NCT02963506|593504559|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
164308727|NCT02963506|593504560|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
164308728|NCT02963506|593504561|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
164308729|NCT02963506|593504562|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
164308730|NCT02963506|593504563|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
164308731|NCT02963506|593504564|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
164308732|NCT02963506|593504565|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
164308733|NCT02963506|593504566|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
164308734|NCT02963506|593504567|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
164308735|NCT02963506|593504555|FG000|Dose-Blind Period|Sponsor decision|0|||
164308736|NCT02963506|593504556|FG001|Dose-Blind Period|Sponsor decision|0|||
164308737|NCT02963506|593504557|FG002|Dose-Blind Period|Sponsor decision|0|||
164308738|NCT02963506|593504558|FG003|Dose-Blind Period|Sponsor decision|0|||
164308739|NCT02963506|593504559|FG004|Dose-Blind Period|Sponsor decision|0|||
164308740|NCT02963506|593504560|FG005|Dose-Blind Period|Sponsor decision|1|||
164308741|NCT02963506|593504561|FG006|Dose-Blind Period|Sponsor decision|0|||
164308742|NCT02963506|593504562|FG007|Dose-Blind Period|Sponsor decision|0|||
164308743|NCT02963506|593504563|FG008|Dose-Blind Period|Sponsor decision|0|||
164308744|NCT02963506|593504564|FG009|Dose-Blind Period|Sponsor decision|0|||
164308745|NCT02963506|593504565|FG010|Dose-Blind Period|Sponsor decision|0|||
164308746|NCT02963506|593504566|FG011|Dose-Blind Period|Sponsor decision|0|||
164308747|NCT02963506|593504567|FG012|Dose-Blind Period|Sponsor decision|0|||
164308748|NCT02963506|593504555|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308749|NCT02963506|593504556|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308750|NCT02963506|593504557|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308751|NCT02963506|593504558|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308752|NCT02963506|593504559|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308753|NCT02963506|593504560|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308754|NCT02963506|593504561|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308755|NCT02963506|593504562|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308756|NCT02963506|593504563|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308757|NCT02963506|593504564|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308758|NCT02963506|593504565|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308759|NCT02963506|593504566|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
164308760|NCT02963506|593504567|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
164308761|NCT02581410|593504568|FG000|Vaccination Phase|Adverse Event|2|||
164308762|NCT02581410|593504569|FG001|Vaccination Phase|Adverse Event|1|||
164308763|NCT02581410|593504568|FG000|Vaccination Phase|Withdrawal by Subject|0|||
164308764|NCT02581410|593504569|FG001|Vaccination Phase|Withdrawal by Subject|1|||
164308765|NCT02581410|593504568|FG000|Vaccination Phase|Migrated/moved from study area|0|||
164308766|NCT02581410|593504569|FG001|Vaccination Phase|Migrated/moved from study area|1|||
164308767|NCT02581410|593504568|FG000|End of Study Phase|Adverse Event|4|||
164308768|NCT02581410|593504569|FG001|End of Study Phase|Adverse Event|3|||
164308769|NCT02581410|593504568|FG000|End of Study Phase|Withdrawal by Subject|1|||
164308770|NCT02581410|593504569|FG001|End of Study Phase|Withdrawal by Subject|2|||
164308771|NCT02581410|593504568|FG000|End of Study Phase|Migrated/moved from study area|0|||
164308772|NCT02581410|593504569|FG001|End of Study Phase|Migrated/moved from study area|3|||
164308773|NCT02581410|593504568|FG000|End of Study Phase|Lost to Follow-up|0|||
164308774|NCT02581410|593504569|FG001|End of Study Phase|Lost to Follow-up|2|||
164308775|NCT02581410|593504568|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
164308776|NCT02581410|593504569|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
164308777|NCT02807402|593504571|FG000|Overall Study|Failure to Return|1|||
164308778|NCT02807402|593504571|FG000|Overall Study|Death|3|||
164308779|NCT02807402|593504571|FG000|Overall Study|Other|2|||
164308780|NCT01865552|593506489|FG000|Period 1|Adverse Event|1|||
164308781|NCT01865552|593506490|FG001|Period 1|Adverse Event|0|||
164308782|NCT01865552|593506491|FG002|Period 1|Adverse Event|0|||
164308783|NCT01865552|593506492|FG003|Period 1|Adverse Event|1|||
163862195|NCT00486759|591861969|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
164308784|NCT01865552|593506493|FG004|Period 1|Adverse Event|1|||
164308785|NCT01865552|593506494|FG005|Period 1|Adverse Event|1|||
164308786|NCT01865552|593506489|FG000|Period 1|Pathological lab|0|||
164308787|NCT01865552|593506490|FG001|Period 1|Pathological lab|0|||
163862196|NCT00486759|591861970|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
164308788|NCT01865552|593506491|FG002|Period 1|Pathological lab|0|||
164308789|NCT01865552|593506492|FG003|Period 1|Pathological lab|0|||
164308790|NCT01865552|593506493|FG004|Period 1|Pathological lab|1|||
164308791|NCT01865552|593506494|FG005|Period 1|Pathological lab|0|||
164308792|NCT01865552|593506489|FG000|Period 1|Other|0|||
164308793|NCT01865552|593506490|FG001|Period 1|Other|0|||
164308794|NCT01865552|593506491|FG002|Period 1|Other|0|||
164308795|NCT01865552|593506492|FG003|Period 1|Other|0|||
164308796|NCT01865552|593506493|FG004|Period 1|Other|1|||
164308797|NCT01865552|593506494|FG005|Period 1|Other|0|||
164308798|NCT03079102|593506497|FG000|Overall Study|Physician Decision|0|||
164308799|NCT03079102|593506498|FG001|Overall Study|Physician Decision|1|||
164308800|NCT02923921|593506499|FG000|Overall Study|Sponsor Decision|39|||
164308801|NCT02923921|593506500|FG001|Overall Study|Sponsor Decision|38|||
164308802|NCT02923921|593506499|FG000|Overall Study|Lost to Follow-up|1|||
164308803|NCT02923921|593506500|FG001|Overall Study|Lost to Follow-up|0|||
164308804|NCT02923921|593506499|FG000|Overall Study|Withdrawal by Subject|6|||
164308805|NCT02923921|593506500|FG001|Overall Study|Withdrawal by Subject|13|||
164308806|NCT02923921|593506499|FG000|Overall Study|Unknown, Not Collected|7|||
164308807|NCT02923921|593506500|FG001|Overall Study|Unknown, Not Collected|6|||
164308808|NCT03083873|593506501|FG000|Overall Study|Death|6|||
164308809|NCT03083873|593506502|FG001|Overall Study|Death|15|||
164308810|NCT03083873|593506503|FG002|Overall Study|Death|13|||
164308811|NCT03083873|593506504|FG003|Overall Study|Death|9|||
164308812|NCT03083873|593506505|FG004|Overall Study|Death|0|||
164308813|NCT03083873|593506501|FG000|Overall Study|Sponsor Terminated Study|0|||
164308814|NCT03083873|593506502|FG001|Overall Study|Sponsor Terminated Study|1|||
164308815|NCT03083873|593506503|FG002|Overall Study|Sponsor Terminated Study|2|||
164308816|NCT03083873|593506504|FG003|Overall Study|Sponsor Terminated Study|3|||
164308817|NCT03083873|593506505|FG004|Overall Study|Sponsor Terminated Study|0|||
164308818|NCT03083873|593506501|FG000|Overall Study|Lost to Follow-up|0|||
164308819|NCT03083873|593506502|FG001|Overall Study|Lost to Follow-up|1|||
164308820|NCT03083873|593506503|FG002|Overall Study|Lost to Follow-up|1|||
164308821|NCT03083873|593506504|FG003|Overall Study|Lost to Follow-up|0|||
164308822|NCT03083873|593506505|FG004|Overall Study|Lost to Follow-up|0|||
164308823|NCT03083873|593506501|FG000|Overall Study|Withdrawal by Subject|2|||
164308824|NCT03083873|593506502|FG001|Overall Study|Withdrawal by Subject|0|||
164308825|NCT03083873|593506503|FG002|Overall Study|Withdrawal by Subject|0|||
164308826|NCT03083873|593506504|FG003|Overall Study|Withdrawal by Subject|0|||
164308827|NCT03083873|593506505|FG004|Overall Study|Withdrawal by Subject|0|||
164308828|NCT03083873|593506501|FG000|Overall Study|Did Not Receive TIL|2|||
164308829|NCT03083873|593506502|FG001|Overall Study|Did Not Receive TIL|5|||
164308830|NCT03083873|593506503|FG002|Overall Study|Did Not Receive TIL|3|||
164308831|NCT03083873|593506504|FG003|Overall Study|Did Not Receive TIL|1|||
164308832|NCT03083873|593506505|FG004|Overall Study|Did Not Receive TIL|0|||
164308833|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
164308834|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
164308835|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
164308836|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
164308837|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
164308838|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
164308839|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
164308840|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
164308841|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
164308842|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
164308843|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
164308844|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
164308845|NCT00479687|593506506|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
164308846|NCT00479687|593506507|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
164308847|NCT00479687|593506508|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
164308848|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
164308849|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
164308850|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
164308851|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
164308852|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
164308853|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
164308854|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
164308855|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
164308856|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
164308857|NCT00479687|593506506|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
164308858|NCT00479687|593506507|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
164308859|NCT00479687|593506508|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
164308860|NCT00854113|593506512|FG000|Overall Study|Adverse Event|0|||
164308861|NCT00854113|593506513|FG001|Overall Study|Adverse Event|0|||
164308862|NCT00854113|593506514|FG002|Overall Study|Adverse Event|0|||
164200043|NCT03234465|593103610|FG001|Overall Study|Death|1|||
164200044|NCT03234465|593103609|FG000|Overall Study|Lost to Follow-up|1|||
164200045|NCT03234465|593103610|FG001|Overall Study|Lost to Follow-up|1|||
164200046|NCT03234465|593103609|FG000|Overall Study|Withdrawal by Subject|12|||
164200047|NCT03234465|593103610|FG001|Overall Study|Withdrawal by Subject|27|||
164200048|NCT03234465|593103609|FG000|Overall Study|Symptomatic deterioration|0|||
164200049|NCT03234465|593103610|FG001|Overall Study|Symptomatic deterioration|1|||
164200050|NCT03234465|593103609|FG000|Overall Study|Non-compliance|2|||
164200051|NCT03234465|593103610|FG001|Overall Study|Non-compliance|0|||
164200052|NCT03234465|593103609|FG000|Overall Study|Other|14|||
164200053|NCT03234465|593103610|FG001|Overall Study|Other|8|||
164200054|NCT01274533|593103615|FG000|Overall Study|Withdrawal by Subject|1|||
164200055|NCT01274533|593103615|FG000|Overall Study|Non-compliance|1|||
164200056|NCT01274533|593103615|FG000|Overall Study|Disease progression|2|||
164200057|NCT02563899|593103616|FG000|Overall Study|Protocol Violation|1|||
164200058|NCT02563899|593103617|FG001|Overall Study|Protocol Violation|0|||
164200059|NCT02563899|593103618|FG002|Overall Study|Protocol Violation|0|||
164200060|NCT02563899|593103619|FG003|Overall Study|Protocol Violation|0|||
164200061|NCT02563899|593103616|FG000|Overall Study|Withdrawal by Subject|0|||
164200062|NCT02563899|593103617|FG001|Overall Study|Withdrawal by Subject|0|||
164200063|NCT02563899|593103618|FG002|Overall Study|Withdrawal by Subject|1|||
164200064|NCT02563899|593103619|FG003|Overall Study|Withdrawal by Subject|0|||
164200065|NCT02008526|593103620|FG000|Overall Study|Death|0|||
164200066|NCT02008526|593103621|FG001|Overall Study|Death|2|||
164200067|NCT02008526|593103622|FG002|Overall Study|Death|1|||
164200068|NCT02008526|593103620|FG000|Overall Study|Withdrawal by Subject|3|||
164200069|NCT02008526|593103621|FG001|Overall Study|Withdrawal by Subject|3|||
164200070|NCT02008526|593103622|FG002|Overall Study|Withdrawal by Subject|2|||
164200071|NCT02008526|593103620|FG000|Overall Study|Lost to Follow-up|5|||
164200072|NCT02008526|593103621|FG001|Overall Study|Lost to Follow-up|9|||
164200073|NCT02008526|593103622|FG002|Overall Study|Lost to Follow-up|6|||
164200074|NCT01305564|593103625|FG000|Overall Study|Death|21|||
164200075|NCT01305564|593103625|FG000|Overall Study|Lost to Follow-up|12|||
164200076|NCT01305564|593103625|FG000|Overall Study|Withdrawal by Subject|1|||
164200077|NCT01305564|593103625|FG000|Overall Study|Physician Decision|3|||
164200078|NCT01190813|593103626|FG000|Overall Study|Lost to Follow-up|1|||
164200079|NCT01190813|593103627|FG001|Overall Study|Lost to Follow-up|2|||
164200080|NCT01190813|593103626|FG000|Overall Study|Withdrawal by Subject|2|||
164200081|NCT01190813|593103627|FG001|Overall Study|Withdrawal by Subject|1|||
164200082|NCT01190813|593103626|FG000|Overall Study|Refused study treatment after randomized|1|||
164200083|NCT01190813|593103627|FG001|Overall Study|Refused study treatment after randomized|0|||
164200084|NCT01190813|593103626|FG000|Overall Study|Adverse Event|0|||
164200085|NCT01190813|593103627|FG001|Overall Study|Adverse Event|1|||
164200086|NCT03810456|593103630|FG000|Treatment|Urgent Family Matters|3|||
164200087|NCT03810456|593103631|FG001|Treatment|Urgent Family Matters|0|||
164200088|NCT03810456|593103632|FG002|Treatment|Urgent Family Matters|0|||
164200089|NCT03810456|593103630|FG000|Treatment|Scheduling Conflicts|0|||
164200090|NCT03810456|593103631|FG001|Treatment|Scheduling Conflicts|11|||
164200091|NCT03810456|593103632|FG002|Treatment|Scheduling Conflicts|0|||
164200092|NCT03810456|593103630|FG000|Treatment|No Longer Interested|0|||
164200093|NCT03810456|593103631|FG001|Treatment|No Longer Interested|12|||
164200094|NCT03810456|593103632|FG002|Treatment|No Longer Interested|0|||
164200095|NCT03810456|593103630|FG000|Treatment|Transportation Issues|0|||
164200096|NCT03810456|593103631|FG001|Treatment|Transportation Issues|1|||
164200097|NCT03810456|593103632|FG002|Treatment|Transportation Issues|0|||
164200098|NCT03810456|593103630|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
164200099|NCT03810456|593103631|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
164200100|NCT03810456|593103632|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
164200101|NCT03810456|593103630|FG000|1 Month Follow-Up|Relocated to Different State|1|||
164200102|NCT03810456|593103631|FG001|1 Month Follow-Up|Relocated to Different State|0|||
164200103|NCT03810456|593103632|FG002|1 Month Follow-Up|Relocated to Different State|1|||
164200104|NCT03810456|593103630|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
164200105|NCT03810456|593103631|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
164200106|NCT03810456|593103632|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
164200107|NCT03810456|593103630|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
164200108|NCT03810456|593103631|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
164200109|NCT03810456|593103632|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
164200110|NCT03810456|593103630|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
164200111|NCT03810456|593103631|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
164200112|NCT03810456|593103632|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
164200113|NCT03810456|593103630|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
164200114|NCT03810456|593103631|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
164200115|NCT03810456|593103632|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
164200116|NCT03810456|593103630|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
164200117|NCT03810456|593103631|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
164200118|NCT03810456|593103632|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
164200119|NCT03499795|593105030|FG000|Overall Study|Adverse Event|1|||
164200120|NCT03499795|593105030|FG000|Overall Study|Lost to Follow-up|1|||
164308863|NCT00854113|593506515|FG003|Overall Study|Adverse Event|0|||
164308864|NCT00854113|593506516|FG004|Overall Study|Adverse Event|0|||
164308865|NCT00854113|593506517|FG005|Overall Study|Adverse Event|0|||
164308866|NCT00854113|593506518|FG006|Overall Study|Adverse Event|0|||
164308867|NCT00854113|593506519|FG007|Overall Study|Adverse Event|2|||
164308868|NCT00854113|593506520|FG008|Overall Study|Adverse Event|0|||
164308869|NCT00854113|593506521|FG009|Overall Study|Adverse Event|0|||
164308870|NCT00854113|593506522|FG010|Overall Study|Adverse Event|0|||
164308871|NCT00854113|593506512|FG000|Overall Study|Withdrawal by Subject|0|||
164308872|NCT00854113|593506513|FG001|Overall Study|Withdrawal by Subject|0|||
164308873|NCT00854113|593506514|FG002|Overall Study|Withdrawal by Subject|0|||
164308874|NCT00854113|593506515|FG003|Overall Study|Withdrawal by Subject|0|||
164308875|NCT00854113|593506516|FG004|Overall Study|Withdrawal by Subject|0|||
164308876|NCT00854113|593506517|FG005|Overall Study|Withdrawal by Subject|0|||
164308877|NCT00854113|593506518|FG006|Overall Study|Withdrawal by Subject|0|||
164308878|NCT00854113|593506519|FG007|Overall Study|Withdrawal by Subject|1|||
164308879|NCT00854113|593506520|FG008|Overall Study|Withdrawal by Subject|1|||
164308880|NCT00854113|593506521|FG009|Overall Study|Withdrawal by Subject|0|||
164308881|NCT00854113|593506522|FG010|Overall Study|Withdrawal by Subject|0|||
164308882|NCT00796419|593506523|FG000|Overall Study|Death|0|||
164308883|NCT00796419|593506524|FG001|Overall Study|Death|1|||
164308884|NCT00539864|593506527|FG000|Overall Study|Lost to Follow-up|0|||
164308885|NCT00539864|593506528|FG001|Overall Study|Lost to Follow-up|1|||
164308886|NCT00539864|593506527|FG000|Overall Study|Withdrawal by Subject|1|||
164308887|NCT00539864|593506528|FG001|Overall Study|Withdrawal by Subject|1|||
164308888|NCT01250145|593506529|FG000|Overall Study|Adverse Event|2|||
164308889|NCT01250145|593506530|FG001|Overall Study|Adverse Event|1|||
164308890|NCT01250145|593506529|FG000|Overall Study|Withdrawal by Subject|0|||
164308891|NCT01250145|593506530|FG001|Overall Study|Withdrawal by Subject|4|||
164308892|NCT02840799|593506533|FG000|Phase 1|Physician Decision|1|||
164308893|NCT02840799|593506534|FG001|Phase 1|Physician Decision|3|||
164308894|NCT02840799|593506533|FG000|Phase 1|Withdrawal by Subject|4|||
164308895|NCT02840799|593506534|FG001|Phase 1|Withdrawal by Subject|0|||
164308896|NCT02840799|593506533|FG000|Phase 2 (Crossover)|Adverse Event|0|||
164308897|NCT02840799|593506534|FG001|Phase 2 (Crossover)|Adverse Event|1|||
164308898|NCT02840799|593506533|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
164308899|NCT02840799|593506534|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
164308900|NCT02687191|593506541|FG000|Overall Study|Death|0|||
164308901|NCT02687191|593506542|FG001|Overall Study|Death|1|||
164308902|NCT02687191|593506543|FG002|Overall Study|Death|1|||
164308903|NCT02687191|593506544|FG003|Overall Study|Death|0|||
164308904|NCT02687191|593506545|FG004|Overall Study|Death|1|||
164308905|NCT02687191|593506546|FG005|Overall Study|Death|1|||
164308906|NCT02687191|593506541|FG000|Overall Study|Withdrawal by Subject|0|||
164308907|NCT02687191|593506542|FG001|Overall Study|Withdrawal by Subject|0|||
164308908|NCT02687191|593506543|FG002|Overall Study|Withdrawal by Subject|0|||
164308909|NCT02687191|593506544|FG003|Overall Study|Withdrawal by Subject|1|||
164308910|NCT02687191|593506545|FG004|Overall Study|Withdrawal by Subject|0|||
164308911|NCT02687191|593506546|FG005|Overall Study|Withdrawal by Subject|0|||
164308912|NCT01349049|593506547|FG000|Overall Study|Disease progression|3|||
164308913|NCT01349049|593506548|FG001|Overall Study|Disease progression|5|||
164308914|NCT01349049|593506549|FG002|Overall Study|Disease progression|3|||
164308915|NCT01349049|593506550|FG003|Overall Study|Disease progression|2|||
164308916|NCT01349049|593506551|FG004|Overall Study|Disease progression|2|||
164308917|NCT01349049|593506552|FG005|Overall Study|Disease progression|2|||
164308918|NCT01349049|593506553|FG006|Overall Study|Disease progression|3|||
164308919|NCT01349049|593506554|FG007|Overall Study|Disease progression|2|||
163967579|NCT03681951|592254211|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
164134950|NCT02132754|592857397|FG030|Overall Study|Progressive Disease|1|||
164308920|NCT01349049|593506555|FG008|Overall Study|Disease progression|33|||
164308921|NCT01349049|593506547|FG000|Overall Study|Adverse Event|0|||
164308922|NCT01349049|593506548|FG001|Overall Study|Adverse Event|1|||
164308923|NCT01349049|593506549|FG002|Overall Study|Adverse Event|0|||
164308924|NCT01349049|593506550|FG003|Overall Study|Adverse Event|0|||
164308925|NCT01349049|593506551|FG004|Overall Study|Adverse Event|0|||
164308926|NCT01349049|593506552|FG005|Overall Study|Adverse Event|3|||
164308927|NCT01349049|593506553|FG006|Overall Study|Adverse Event|1|||
164308928|NCT01349049|593506554|FG007|Overall Study|Adverse Event|0|||
164308929|NCT01349049|593506555|FG008|Overall Study|Adverse Event|4|||
164308930|NCT01349049|593506547|FG000|Overall Study|Physician Decision|0|||
164308931|NCT01349049|593506548|FG001|Overall Study|Physician Decision|1|||
164308932|NCT01349049|593506549|FG002|Overall Study|Physician Decision|0|||
164308933|NCT01349049|593506550|FG003|Overall Study|Physician Decision|0|||
164308934|NCT01349049|593506551|FG004|Overall Study|Physician Decision|0|||
164308935|NCT01349049|593506552|FG005|Overall Study|Physician Decision|0|||
164308936|NCT01349049|593506553|FG006|Overall Study|Physician Decision|0|||
164308937|NCT01349049|593506554|FG007|Overall Study|Physician Decision|0|||
164308938|NCT01349049|593506555|FG008|Overall Study|Physician Decision|2|||
164308939|NCT01349049|593506547|FG000|Overall Study|Protocol Violation|0|||
164308940|NCT01349049|593506548|FG001|Overall Study|Protocol Violation|0|||
164200121|NCT02265510|593105031|FG000|Overall Study|Withdrawal by Subject|1|||
164200122|NCT02265510|593105032|FG001|Overall Study|Withdrawal by Subject|1|||
164200123|NCT02265510|593105033|FG002|Overall Study|Withdrawal by Subject|2|||
164200124|NCT02265510|593105034|FG003|Overall Study|Withdrawal by Subject|1|||
164200125|NCT02265510|593105035|FG004|Overall Study|Withdrawal by Subject|0|||
164200126|NCT02265510|593105036|FG005|Overall Study|Withdrawal by Subject|2|||
164200127|NCT02265510|593105037|FG006|Overall Study|Withdrawal by Subject|0|||
164200128|NCT02265510|593105038|FG007|Overall Study|Withdrawal by Subject|2|||
164200129|NCT02265510|593105039|FG008|Overall Study|Withdrawal by Subject|0|||
164200130|NCT02265510|593105040|FG009|Overall Study|Withdrawal by Subject|0|||
164200131|NCT02265510|593105041|FG010|Overall Study|Withdrawal by Subject|0|||
164200132|NCT02265510|593105042|FG011|Overall Study|Withdrawal by Subject|0|||
164200133|NCT02265510|593105043|FG012|Overall Study|Withdrawal by Subject|1|||
164200134|NCT02265510|593105044|FG013|Overall Study|Withdrawal by Subject|0|||
164200135|NCT02265510|593105031|FG000|Overall Study|Disease Progression|0|||
164200136|NCT02265510|593105032|FG001|Overall Study|Disease Progression|1|||
164200137|NCT02265510|593105033|FG002|Overall Study|Disease Progression|2|||
164200138|NCT02265510|593105034|FG003|Overall Study|Disease Progression|1|||
164200139|NCT02265510|593105035|FG004|Overall Study|Disease Progression|1|||
164200140|NCT02265510|593105036|FG005|Overall Study|Disease Progression|0|||
164200141|NCT02265510|593105037|FG006|Overall Study|Disease Progression|0|||
164200142|NCT02265510|593105038|FG007|Overall Study|Disease Progression|0|||
164200143|NCT02265510|593105039|FG008|Overall Study|Disease Progression|0|||
164200144|NCT02265510|593105040|FG009|Overall Study|Disease Progression|0|||
164200145|NCT02265510|593105041|FG010|Overall Study|Disease Progression|0|||
164200146|NCT02265510|593105042|FG011|Overall Study|Disease Progression|0|||
164200147|NCT02265510|593105043|FG012|Overall Study|Disease Progression|0|||
164200148|NCT02265510|593105044|FG013|Overall Study|Disease Progression|0|||
164200149|NCT02265510|593105031|FG000|Overall Study|Death|2|||
164200150|NCT02265510|593105032|FG001|Overall Study|Death|0|||
164200151|NCT02265510|593105033|FG002|Overall Study|Death|2|||
164200152|NCT02265510|593105034|FG003|Overall Study|Death|2|||
164200153|NCT02265510|593105035|FG004|Overall Study|Death|1|||
164200154|NCT02265510|593105036|FG005|Overall Study|Death|3|||
164200155|NCT02265510|593105037|FG006|Overall Study|Death|2|||
164200156|NCT02265510|593105038|FG007|Overall Study|Death|1|||
164200157|NCT02265510|593105039|FG008|Overall Study|Death|3|||
164200158|NCT02265510|593105040|FG009|Overall Study|Death|3|||
164200159|NCT02265510|593105041|FG010|Overall Study|Death|4|||
164200160|NCT02265510|593105042|FG011|Overall Study|Death|12|||
164200161|NCT02265510|593105043|FG012|Overall Study|Death|7|||
164200162|NCT02265510|593105044|FG013|Overall Study|Death|6|||
164200163|NCT02265510|593105031|FG000|Overall Study|Lost to Follow-up|0|||
164200164|NCT02265510|593105032|FG001|Overall Study|Lost to Follow-up|0|||
164200165|NCT02265510|593105033|FG002|Overall Study|Lost to Follow-up|0|||
164200166|NCT02265510|593105034|FG003|Overall Study|Lost to Follow-up|0|||
164200167|NCT02265510|593105035|FG004|Overall Study|Lost to Follow-up|1|||
164200168|NCT02265510|593105036|FG005|Overall Study|Lost to Follow-up|0|||
164200169|NCT02265510|593105037|FG006|Overall Study|Lost to Follow-up|0|||
164200170|NCT02265510|593105038|FG007|Overall Study|Lost to Follow-up|0|||
164200171|NCT02265510|593105039|FG008|Overall Study|Lost to Follow-up|0|||
164200172|NCT02265510|593105040|FG009|Overall Study|Lost to Follow-up|2|||
164200173|NCT02265510|593105041|FG010|Overall Study|Lost to Follow-up|0|||
164200174|NCT02265510|593105042|FG011|Overall Study|Lost to Follow-up|0|||
164200175|NCT02265510|593105043|FG012|Overall Study|Lost to Follow-up|0|||
164200176|NCT02265510|593105044|FG013|Overall Study|Lost to Follow-up|2|||
164200177|NCT02265510|593105031|FG000|Overall Study|Other|0|||
164200178|NCT02265510|593105032|FG001|Overall Study|Other|1|||
164200179|NCT02265510|593105033|FG002|Overall Study|Other|0|||
164200180|NCT02265510|593105034|FG003|Overall Study|Other|0|||
164200181|NCT02265510|593105035|FG004|Overall Study|Other|0|||
164200182|NCT02265510|593105036|FG005|Overall Study|Other|0|||
164200183|NCT02265510|593105037|FG006|Overall Study|Other|0|||
164200184|NCT02265510|593105038|FG007|Overall Study|Other|0|||
163862197|NCT00377455|591861971|FG000|Overall Study|Withdrawal by Subject|1|||
164200185|NCT02265510|593105039|FG008|Overall Study|Other|0|||
164200186|NCT02265510|593105040|FG009|Overall Study|Other|0|||
164200187|NCT02265510|593105041|FG010|Overall Study|Other|0|||
164200188|NCT02265510|593105042|FG011|Overall Study|Other|0|||
163862198|NCT00309452|591861972|FG000|Overall Study|Withdrawal by Subject|3|||
164200189|NCT02265510|593105043|FG012|Overall Study|Other|0|||
164200190|NCT02265510|593105044|FG013|Overall Study|Other|0|||
164200191|NCT02265510|593105031|FG000|Overall Study|Study Terminated by Sponsor|0|||
164200192|NCT02265510|593105032|FG001|Overall Study|Study Terminated by Sponsor|0|||
164200193|NCT02265510|593105033|FG002|Overall Study|Study Terminated by Sponsor|0|||
164200194|NCT02265510|593105034|FG003|Overall Study|Study Terminated by Sponsor|0|||
164200195|NCT02265510|593105035|FG004|Overall Study|Study Terminated by Sponsor|0|||
164200196|NCT02265510|593105036|FG005|Overall Study|Study Terminated by Sponsor|1|||
164200197|NCT02265510|593105037|FG006|Overall Study|Study Terminated by Sponsor|1|||
164200198|NCT02265510|593105038|FG007|Overall Study|Study Terminated by Sponsor|1|||
164200199|NCT02265510|593105039|FG008|Overall Study|Study Terminated by Sponsor|1|||
164200200|NCT02265510|593105040|FG009|Overall Study|Study Terminated by Sponsor|2|||
164200201|NCT02265510|593105041|FG010|Overall Study|Study Terminated by Sponsor|1|||
164200202|NCT02265510|593105042|FG011|Overall Study|Study Terminated by Sponsor|4|||
164200203|NCT02265510|593105043|FG012|Overall Study|Study Terminated by Sponsor|1|||
164200204|NCT02265510|593105044|FG013|Overall Study|Study Terminated by Sponsor|2|||
164200205|NCT00630916|593105045|FG000|Overall Study|Death|110|||
164200206|NCT00630916|593105045|FG000|Overall Study|Explant|8|||
164200207|NCT00630916|593105045|FG000|Overall Study|Lost to Follow-up|5|||
164200208|NCT00630916|593105045|FG000|Overall Study|Withdrawal by Subject|30|||
164200209|NCT00630916|593105045|FG000|Overall Study|Protocol Violation|7|||
164200210|NCT00630916|593105045|FG000|Overall Study|Physician Decision|47|||
164200211|NCT00630916|593105045|FG000|Overall Study|Lack of Efficacy|3|||
164200212|NCT00324155|593105046|FG000|Enrolled and Randomized|No longer met study criteria|3|||
164200213|NCT00324155|593105047|FG001|Enrolled and Randomized|No longer met study criteria|0|||
164200214|NCT00324155|593105046|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
164200215|NCT00324155|593105047|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
164200216|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
164200217|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
164200218|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
164200219|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
164200220|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Death|8|||
164200221|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Death|15|||
164200222|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
164200223|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
164200224|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
164200225|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
164200226|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
164200227|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
164200228|NCT00324155|593105046|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
164200229|NCT00324155|593105047|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
164200230|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
164200231|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
164200232|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
164200233|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
164134951|NCT02132754|592857398|FG031|Overall Study|Progressive Disease|1|||
164134952|NCT02132754|592857399|FG032|Overall Study|Progressive Disease|3|||
164134953|NCT02132754|592857400|FG033|Overall Study|Progressive Disease|6|||
164134954|NCT02132754|592857367|FG000|Overall Study|Screen Failure|0|||
164134955|NCT02132754|592857368|FG001|Overall Study|Screen Failure|0|||
164134956|NCT02132754|592857369|FG002|Overall Study|Screen Failure|0|||
164134957|NCT02132754|592857370|FG003|Overall Study|Screen Failure|0|||
164134958|NCT02132754|592857371|FG004|Overall Study|Screen Failure|0|||
164134959|NCT02132754|592857372|FG005|Overall Study|Screen Failure|0|||
164134960|NCT02132754|592857373|FG006|Overall Study|Screen Failure|0|||
164134961|NCT02132754|592857374|FG007|Overall Study|Screen Failure|0|||
164134962|NCT02132754|592857375|FG008|Overall Study|Screen Failure|0|||
164134963|NCT02132754|592857376|FG009|Overall Study|Screen Failure|0|||
164134964|NCT02132754|592857377|FG010|Overall Study|Screen Failure|0|||
164134965|NCT02132754|592857378|FG011|Overall Study|Screen Failure|0|||
164134966|NCT02132754|592857379|FG012|Overall Study|Screen Failure|0|||
164134967|NCT02132754|592857380|FG013|Overall Study|Screen Failure|0|||
164134968|NCT02132754|592857381|FG014|Overall Study|Screen Failure|0|||
164134969|NCT02132754|592857382|FG015|Overall Study|Screen Failure|0|||
164134970|NCT02132754|592857383|FG016|Overall Study|Screen Failure|0|||
164134971|NCT02132754|592857384|FG017|Overall Study|Screen Failure|0|||
164134972|NCT02132754|592857385|FG018|Overall Study|Screen Failure|0|||
164134973|NCT02132754|592857386|FG019|Overall Study|Screen Failure|1|||
164134974|NCT02132754|592857387|FG020|Overall Study|Screen Failure|0|||
164134975|NCT02132754|592857388|FG021|Overall Study|Screen Failure|1|||
164134976|NCT02132754|592857389|FG022|Overall Study|Screen Failure|0|||
164134977|NCT02132754|592857390|FG023|Overall Study|Screen Failure|0|||
164134978|NCT02132754|592857391|FG024|Overall Study|Screen Failure|0|||
164134979|NCT02132754|592857392|FG025|Overall Study|Screen Failure|0|||
164134980|NCT02132754|592857393|FG026|Overall Study|Screen Failure|0|||
164134981|NCT02132754|592857394|FG027|Overall Study|Screen Failure|0|||
164134982|NCT02132754|592857395|FG028|Overall Study|Screen Failure|0|||
164134983|NCT02132754|592857396|FG029|Overall Study|Screen Failure|0|||
164134984|NCT02132754|592857397|FG030|Overall Study|Screen Failure|0|||
164134985|NCT02132754|592857398|FG031|Overall Study|Screen Failure|0|||
164134986|NCT02132754|592857399|FG032|Overall Study|Screen Failure|0|||
164134987|NCT02132754|592857400|FG033|Overall Study|Screen Failure|0|||
164134988|NCT02132754|592857367|FG000|Overall Study|Transferred to Extension Study|0|||
164134989|NCT02132754|592857368|FG001|Overall Study|Transferred to Extension Study|0|||
164200234|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
164200235|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
164200236|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
164200237|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
164200238|NCT00324155|593105046|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
164200239|NCT00324155|593105047|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
164200240|NCT00324155|593105046|FG000|Follow-up Phase|On-going participants still on drug|11|||
164200241|NCT00324155|593105047|FG001|Follow-up Phase|On-going participants still on drug|6|||
164200242|NCT00390689|593105048|FG000|Overall Study|Adverse Event|2|||
164200243|NCT00390689|593105049|FG001|Overall Study|Adverse Event|5|||
164200244|NCT00390689|593105050|FG002|Overall Study|Adverse Event|2|||
164200245|NCT00390689|593105048|FG000|Overall Study|Lack of Efficacy|0|||
164200246|NCT00390689|593105049|FG001|Overall Study|Lack of Efficacy|0|||
164200247|NCT00390689|593105050|FG002|Overall Study|Lack of Efficacy|1|||
164200248|NCT00390689|593105048|FG000|Overall Study|Protocol Violation|1|||
164200249|NCT00390689|593105049|FG001|Overall Study|Protocol Violation|0|||
164200250|NCT00390689|593105050|FG002|Overall Study|Protocol Violation|0|||
164200251|NCT00390689|593105048|FG000|Overall Study|Investigator's judgement|2|||
164200252|NCT00390689|593105049|FG001|Overall Study|Investigator's judgement|0|||
164200253|NCT00390689|593105050|FG002|Overall Study|Investigator's judgement|0|||
164200254|NCT01253161|593105051|FG000|Overall Study|Adverse Event|1|||
164200255|NCT03786380|593105053|FG000|Overall Study|Adverse Event|1|||
164200256|NCT03786380|593105054|FG001|Overall Study|Adverse Event|0|||
164200257|NCT03786380|593105055|FG002|Overall Study|Adverse Event|0|||
164200258|NCT03786380|593105056|FG003|Overall Study|Adverse Event|3|||
164200259|NCT03786380|593105057|FG004|Overall Study|Adverse Event|1|||
164200260|NCT03786380|593105053|FG000|Overall Study|Lack of Efficacy|0|||
164200261|NCT03786380|593105054|FG001|Overall Study|Lack of Efficacy|0|||
164200262|NCT03786380|593105055|FG002|Overall Study|Lack of Efficacy|0|||
164200263|NCT03786380|593105056|FG003|Overall Study|Lack of Efficacy|0|||
164200264|NCT03786380|593105057|FG004|Overall Study|Lack of Efficacy|1|||
164200265|NCT03786380|593105053|FG000|Overall Study|Withdrawal by Subject|1|||
164200266|NCT03786380|593105054|FG001|Overall Study|Withdrawal by Subject|2|||
164200267|NCT03786380|593105055|FG002|Overall Study|Withdrawal by Subject|2|||
164200268|NCT03786380|593105056|FG003|Overall Study|Withdrawal by Subject|1|||
164200269|NCT03786380|593105057|FG004|Overall Study|Withdrawal by Subject|2|||
164200270|NCT03786380|593105053|FG000|Overall Study|Lost to Follow-up|3|||
164200271|NCT03786380|593105054|FG001|Overall Study|Lost to Follow-up|0|||
164200272|NCT03786380|593105055|FG002|Overall Study|Lost to Follow-up|1|||
164200273|NCT03786380|593105056|FG003|Overall Study|Lost to Follow-up|2|||
164200274|NCT03786380|593105057|FG004|Overall Study|Lost to Follow-up|0|||
164200275|NCT03786380|593105053|FG000|Overall Study|Physician Decision|0|||
164200276|NCT03786380|593105054|FG001|Overall Study|Physician Decision|0|||
164200277|NCT03786380|593105055|FG002|Overall Study|Physician Decision|1|||
164200278|NCT03786380|593105056|FG003|Overall Study|Physician Decision|0|||
164200279|NCT03786380|593105057|FG004|Overall Study|Physician Decision|0|||
164200280|NCT03786380|593105053|FG000|Overall Study|Study Terminated by the Sponsor|30|||
164200281|NCT03786380|593105054|FG001|Overall Study|Study Terminated by the Sponsor|20|||
164200282|NCT03786380|593105055|FG002|Overall Study|Study Terminated by the Sponsor|50|||
164200283|NCT03786380|593105056|FG003|Overall Study|Study Terminated by the Sponsor|57|||
164200284|NCT03786380|593105057|FG004|Overall Study|Study Terminated by the Sponsor|23|||
164200285|NCT03786380|593105053|FG000|Overall Study|Reason Not Specified|0|||
164200286|NCT03786380|593105054|FG001|Overall Study|Reason Not Specified|0|||
164200287|NCT03786380|593105055|FG002|Overall Study|Reason Not Specified|0|||
164200288|NCT03786380|593105056|FG003|Overall Study|Reason Not Specified|0|||
164200289|NCT03786380|593105057|FG004|Overall Study|Reason Not Specified|1|||
164200290|NCT02984982|593105058|FG000|Overall Study|Adverse Event|2|||
164200291|NCT02984982|593105059|FG001|Overall Study|Adverse Event|5|||
164200292|NCT02984982|593105058|FG000|Overall Study|Poor Compliance to Protocol|4|||
164200293|NCT02984982|593105059|FG001|Overall Study|Poor Compliance to Protocol|4|||
164200294|NCT02984982|593105058|FG000|Overall Study|Withdrawal by Subject|2|||
164200295|NCT02984982|593105059|FG001|Overall Study|Withdrawal by Subject|0|||
164200296|NCT02984982|593105058|FG000|Overall Study|Randomized but not treated|0|||
164200297|NCT02984982|593105059|FG001|Overall Study|Randomized but not treated|1|||
164200298|NCT02144701|593105060|FG000|Overall Study|development of relapse, GVHD or death|9|||
164200299|NCT02144701|593105061|FG001|Overall Study|development of relapse, GVHD or death|3|||
164200300|NCT00467519|593105062|FG000|Overall Study|Protocol Violation|8|||
164200301|NCT00467519|593105063|FG001|Overall Study|Protocol Violation|4|||
164200302|NCT00467519|593105062|FG000|Overall Study|Lost to Follow-up|2|||
164200303|NCT00467519|593105063|FG001|Overall Study|Lost to Follow-up|9|||
164200304|NCT00467519|593105062|FG000|Overall Study|Withdrawal by Subject|4|||
164200305|NCT00467519|593105063|FG001|Overall Study|Withdrawal by Subject|10|||
164200306|NCT02314728|593105064|FG000|Overall Study|Protocol Violation|1|||
164200307|NCT02314728|593105065|FG001|Overall Study|Protocol Violation|0|||
164200308|NCT02314728|593105064|FG000|Overall Study|Lost to Follow-up|0|||
164200309|NCT02314728|593105065|FG001|Overall Study|Lost to Follow-up|1|||
163967580|NCT03681951|592254212|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163967581|NCT03681951|592254213|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163967582|NCT03681951|592254214|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
163967583|NCT03681951|592254207|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
163967584|NCT03681951|592254208|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967585|NCT03681951|592254209|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967586|NCT03681951|592254210|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967587|NCT03681951|592254211|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967588|NCT03681951|592254212|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967589|NCT03681951|592254213|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967590|NCT03681951|592254214|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
163967591|NCT03681951|592254207|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
163967592|NCT03681951|592254208|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967593|NCT03681951|592254209|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967594|NCT03681951|592254210|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967595|NCT03681951|592254211|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967596|NCT03681951|592254212|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967597|NCT03681951|592254213|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967598|NCT03681951|592254214|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
163967599|NCT01020448|592254215|FG000|Pre-assignment|Adverse Event|6|||
163967600|NCT01020448|592254215|FG000|Pre-assignment|Withdrawal by Subject|5|||
163967601|NCT01020448|592254215|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
163967602|NCT01020448|592254215|FG000|Treatment|Adverse Event|11|||
163967603|NCT01020448|592254215|FG000|Treatment|Consent Withdrawn|3|||
163967604|NCT01020448|592254215|FG000|Treatment|Disease Progression|2|||
163967605|NCT01020448|592254215|FG000|Treatment|Lack of Efficacy|8|||
163967606|NCT01020448|592254215|FG000|Treatment|Lost to Follow-up|2|||
163967607|NCT01230554|592254216|FG000|Overall Study|Lost to Follow-up|2|||
163967608|NCT01230554|592254216|FG000|Overall Study|Inability to maintain visit schedule|1|||
163967609|NCT01006265|592254227|FG000|Overall Study|Lost to Follow-up|1|||
163967610|NCT01006265|592254228|FG001|Overall Study|Lost to Follow-up|0|||
163967611|NCT01006265|592254229|FG002|Overall Study|Lost to Follow-up|1|||
163967612|NCT01006265|592254230|FG003|Overall Study|Lost to Follow-up|0|||
163967613|NCT01006265|592254227|FG000|Overall Study|Withdrawal by Subject|4|||
163967614|NCT01006265|592254228|FG001|Overall Study|Withdrawal by Subject|7|||
163967615|NCT01006265|592254229|FG002|Overall Study|Withdrawal by Subject|5|||
163967616|NCT01006265|592254230|FG003|Overall Study|Withdrawal by Subject|5|||
163967617|NCT01006265|592254227|FG000|Overall Study|Administrative reason|1|||
163967618|NCT01006265|592254228|FG001|Overall Study|Administrative reason|2|||
163967619|NCT01006265|592254229|FG002|Overall Study|Administrative reason|3|||
163967620|NCT01006265|592254230|FG003|Overall Study|Administrative reason|0|||
163967621|NCT01390272|592254231|FG000|Overall Study|Death|3|||
163967622|NCT01390272|592254232|FG001|Overall Study|Death|2|||
163967623|NCT01390272|592254231|FG000|Overall Study|Withdrawal by Subject|9|||
163967624|NCT01390272|592254232|FG001|Overall Study|Withdrawal by Subject|5|||
163967625|NCT01390272|592254231|FG000|Overall Study|Patient moved, no longer eligible|5|||
163967626|NCT01390272|592254232|FG001|Overall Study|Patient moved, no longer eligible|8|||
163967627|NCT01177384|592254233|FG000|Overall Study|Adverse Event|6|||
163967628|NCT01177384|592254234|FG001|Overall Study|Adverse Event|4|||
163967629|NCT01177384|592254233|FG000|Overall Study|Lack of Efficacy|0|||
163967630|NCT01177384|592254234|FG001|Overall Study|Lack of Efficacy|1|||
163967631|NCT01177384|592254233|FG000|Overall Study|Lost to Follow-up|3|||
163967632|NCT01177384|592254234|FG001|Overall Study|Lost to Follow-up|4|||
163967633|NCT01177384|592254233|FG000|Overall Study|Physician Decision|0|||
163967634|NCT01177384|592254234|FG001|Overall Study|Physician Decision|3|||
163967635|NCT01177384|592254233|FG000|Overall Study|Protocol Violation|0|||
163967636|NCT01177384|592254234|FG001|Overall Study|Protocol Violation|2|||
163967637|NCT01177384|592254233|FG000|Overall Study|Withdrawal by Subject|5|||
163967638|NCT01177384|592254234|FG001|Overall Study|Withdrawal by Subject|12|||
163967639|NCT00590044|592254235|FG000|Overall Study|Withdrawal by Subject|2|||
163967640|NCT00590044|592254236|FG001|Overall Study|Withdrawal by Subject|2|||
163967641|NCT00590044|592254235|FG000|Overall Study|wrong insulin arm assigned|1|||
163967642|NCT00590044|592254236|FG001|Overall Study|wrong insulin arm assigned|0|||
163967643|NCT00590044|592254235|FG000|Overall Study|Protocol Violation|1|||
163967644|NCT00590044|592254236|FG001|Overall Study|Protocol Violation|0|||
163967645|NCT00888381|592254237|FG000|Overall Study|Lost to Follow-up|0|||
163967646|NCT00888381|592254238|FG001|Overall Study|Lost to Follow-up|1|||
163967647|NCT00307333|592254239|FG000|Overall Study|Lost to Follow-up|11|||
163967648|NCT00307333|592254240|FG001|Overall Study|Lost to Follow-up|3|||
163967649|NCT00757003|592254244|FG000|Overall Study|Death|33|||
163967650|NCT00757003|592254244|FG000|Overall Study|Lost to Follow-up|9|||
163967651|NCT00757003|592254244|FG000|Overall Study|Withdrawal by Subject|4|||
163967652|NCT00757003|592254244|FG000|Overall Study|Surgically explanted|2|||
163967653|NCT00757003|592254244|FG000|Overall Study|Not implanted|1|||
164200310|NCT03902613|593105069|FG000|Overall Study|Physician Decision|1|||
164200311|NCT04622969|593105070|FG000|Overall Study|Withdrawal by Subject|2|||
164200312|NCT04622969|593105071|FG001|Overall Study|Withdrawal by Subject|3|||
164200313|NCT04467515|593105072|FG000|Overall Study|Lost to Follow-up|1|||
164200314|NCT04467515|593105073|FG001|Overall Study|Lost to Follow-up|0|||
164200315|NCT04467515|593105074|FG002|Overall Study|Lost to Follow-up|0|||
164200316|NCT04467515|593105072|FG000|Overall Study|Withdrawal by Subject|1|||
164200317|NCT04467515|593105073|FG001|Overall Study|Withdrawal by Subject|0|||
164200318|NCT04467515|593105074|FG002|Overall Study|Withdrawal by Subject|1|||
164200319|NCT04467515|593105072|FG000|Overall Study|Progressive Disease|0|||
164200320|NCT04467515|593105073|FG001|Overall Study|Progressive Disease|1|||
164200321|NCT04467515|593105074|FG002|Overall Study|Progressive Disease|3|||
164200322|NCT04467515|593105072|FG000|Overall Study|Death|0|||
164200323|NCT04467515|593105073|FG001|Overall Study|Death|1|||
164200324|NCT04467515|593105074|FG002|Overall Study|Death|0|||
164200325|NCT04249427|593105077|FG000|Overall Study|Adverse Event|3|||
164200326|NCT04249427|593105078|FG001|Overall Study|Adverse Event|1|||
164200327|NCT04249427|593105077|FG000|Overall Study|Lack of Efficacy|0|||
164200328|NCT04249427|593105078|FG001|Overall Study|Lack of Efficacy|1|||
164200329|NCT04249427|593105077|FG000|Overall Study|Withdrawal by Subject|1|||
164200330|NCT04249427|593105078|FG001|Overall Study|Withdrawal by Subject|2|||
164200331|NCT03886272|593105079|FG000|Period 1|Withdrawal by Subject|0|||
164200332|NCT03886272|593105080|FG001|Period 1|Withdrawal by Subject|0|||
164200333|NCT03886272|593105081|FG002|Period 1|Withdrawal by Subject|0|||
164200334|NCT03886272|593105082|FG003|Period 1|Withdrawal by Subject|0|||
164200335|NCT03886272|593105083|FG004|Period 1|Withdrawal by Subject|0|||
164200336|NCT03886272|593105084|FG005|Period 1|Withdrawal by Subject|1|||
164200337|NCT03886272|593105085|FG006|Period 1|Withdrawal by Subject|0|||
164200338|NCT01091246|593105086|FG000|Overall Study|Lost to Follow-up|23|||
164200339|NCT01091246|593105087|FG001|Overall Study|Lost to Follow-up|11|||
164200340|NCT01091246|593105088|FG002|Overall Study|Lost to Follow-up|7|||
164200341|NCT01091246|593105086|FG000|Overall Study|Adverse Event|1|||
164200342|NCT01091246|593105087|FG001|Overall Study|Adverse Event|0|||
164200343|NCT01091246|593105088|FG002|Overall Study|Adverse Event|1|||
164200344|NCT01091246|593105086|FG000|Overall Study|Withdrawal by Subject|9|||
164200345|NCT01091246|593105087|FG001|Overall Study|Withdrawal by Subject|5|||
164200346|NCT01091246|593105088|FG002|Overall Study|Withdrawal by Subject|4|||
164200347|NCT01091246|593105086|FG000|Overall Study|Subject not dosed|2|||
164200348|NCT01091246|593105087|FG001|Overall Study|Subject not dosed|0|||
164200349|NCT01091246|593105088|FG002|Overall Study|Subject not dosed|1|||
164200350|NCT01673178|593105092|FG000|Overall Study|Lost to Follow-up|0|||
164200351|NCT01673178|593105093|FG001|Overall Study|Lost to Follow-up|1|||
164200352|NCT01673178|593105094|FG002|Overall Study|Lost to Follow-up|0|||
164200353|NCT01673178|593105095|FG003|Overall Study|Lost to Follow-up|0|||
164200354|NCT01673178|593105096|FG004|Overall Study|Lost to Follow-up|0|||
164200355|NCT01673178|593105092|FG000|Overall Study|Withdrawal by Subject|0|||
164200356|NCT01673178|593105093|FG001|Overall Study|Withdrawal by Subject|0|||
164200357|NCT01673178|593105094|FG002|Overall Study|Withdrawal by Subject|1|||
164200358|NCT01673178|593105095|FG003|Overall Study|Withdrawal by Subject|4|||
164200359|NCT01673178|593105096|FG004|Overall Study|Withdrawal by Subject|2|||
164200360|NCT01673178|593105092|FG000|Overall Study|Protocol Violation|1|||
164200361|NCT01673178|593105093|FG001|Overall Study|Protocol Violation|1|||
164200362|NCT01673178|593105094|FG002|Overall Study|Protocol Violation|0|||
164308941|NCT01349049|593506549|FG002|Overall Study|Protocol Violation|0|||
163967654|NCT04166383|592254247|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
163967655|NCT04166383|592254247|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
163967656|NCT04166383|592254247|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
163967657|NCT03044886|592254248|FG000|Overall Study|Lost to Follow-up|15|||
163967658|NCT03044886|592254249|FG001|Overall Study|Lost to Follow-up|10|||
163967659|NCT03044886|592254250|FG002|Overall Study|Lost to Follow-up|12|||
163967660|NCT00375219|592254253|FG000|Overall Study|Failure to achieve a response|16|||
163967661|NCT00375219|592254254|FG001|Overall Study|Failure to achieve a response|2|||
164200363|NCT01673178|593105095|FG003|Overall Study|Protocol Violation|1|||
164200364|NCT01673178|593105096|FG004|Overall Study|Protocol Violation|0|||
164200365|NCT01673178|593105092|FG000|Overall Study|Adverse Event|1|||
164200366|NCT01673178|593105093|FG001|Overall Study|Adverse Event|0|||
164200367|NCT01673178|593105094|FG002|Overall Study|Adverse Event|0|||
164200368|NCT01673178|593105095|FG003|Overall Study|Adverse Event|2|||
164200369|NCT01673178|593105096|FG004|Overall Study|Adverse Event|0|||
164200370|NCT01673178|593105092|FG000|Overall Study|Other|1|||
164200371|NCT01673178|593105093|FG001|Overall Study|Other|0|||
164200372|NCT01673178|593105094|FG002|Overall Study|Other|2|||
164200373|NCT01673178|593105095|FG003|Overall Study|Other|1|||
164200374|NCT01673178|593105096|FG004|Overall Study|Other|0|||
164200375|NCT03177148|593105097|FG000|Overall Study|Lost to Follow-up|50|||
164200376|NCT03177148|593105098|FG001|Overall Study|Lost to Follow-up|1|||
164200377|NCT03177148|593105097|FG000|Overall Study|Death|1|||
164200378|NCT03177148|593105098|FG001|Overall Study|Death|0|||
164200379|NCT01676012|593105100|FG000|Overall Study|Adverse Event|2|||
164308942|NCT01349049|593506550|FG003|Overall Study|Protocol Violation|0|||
164308943|NCT01349049|593506551|FG004|Overall Study|Protocol Violation|0|||
164308944|NCT01349049|593506552|FG005|Overall Study|Protocol Violation|0|||
164308945|NCT01349049|593506553|FG006|Overall Study|Protocol Violation|0|||
164135063|NCT01193127|592857412|FG003|Treated|Withdrawal by Subject|1|||
164135064|NCT00761865|592857416|FG000|Overall Study|Lost to Follow-up|8|||
164135065|NCT00761865|592857417|FG001|Overall Study|Lost to Follow-up|7|||
164135066|NCT03190330|592859052|FG000|Overall Study|Adverse Event|2|||
164135067|NCT03190330|592859052|FG000|Overall Study|Death|10|||
164135068|NCT03190330|592859052|FG000|Overall Study|Lost to Follow-up|1|||
164135069|NCT03190330|592859052|FG000|Overall Study|Withdrawal by Subject|6|||
164135070|NCT03190330|592859052|FG000|Overall Study|Progressive Disease|1|||
164135071|NCT02081209|592859053|FG000|Overall Study|Withdrawal by Subject|1|||
164135072|NCT02370329|592859054|FG000|Overall Study|Alternate treatment|1|||
164135073|NCT02370329|592859054|FG000|Overall Study|Adverse Event|1|||
164135074|NCT02370329|592859054|FG000|Overall Study|Disease progression|3|||
164135075|NCT02370329|592859054|FG000|Overall Study|Physician Decision|2|||
164135076|NCT02370329|592859054|FG000|Overall Study|Study closure|4|||
164135077|NCT02022748|592859058|FG000|Overall Study|Adverse Event|1|||
164135078|NCT02022748|592859059|FG001|Overall Study|Adverse Event|1|||
164135079|NCT02022748|592859060|FG002|Overall Study|Adverse Event|0|||
164135080|NCT02022748|592859058|FG000|Overall Study|Withdrawal by Subject|0|||
164135081|NCT02022748|592859059|FG001|Overall Study|Withdrawal by Subject|1|||
164135082|NCT02022748|592859060|FG002|Overall Study|Withdrawal by Subject|0|||
164135083|NCT04347122|592859063|FG000|Overall Study|Physician Decision|0|||
164135084|NCT04347122|592859064|FG001|Overall Study|Physician Decision|3|||
164135085|NCT04347122|592859065|FG002|Overall Study|Physician Decision|3|||
164135086|NCT04347122|592859066|FG003|Overall Study|Physician Decision|6|||
164135087|NCT03510598|592859067|FG000|Overall Study|Withdrawal by Subject|1|||
164135088|NCT00112866|592859070|FG000|Overall Study|Protocol Violation|1|||
164135089|NCT00112866|592859071|FG001|Overall Study|Protocol Violation|0|||
164135090|NCT00112866|592859070|FG000|Overall Study|did not start treatment post-op|1|||
164135091|NCT00112866|592859071|FG001|Overall Study|did not start treatment post-op|2|||
164135092|NCT00658658|592859075|FG000|Overall Study|Withdrawal by Subject|0|||
164135093|NCT00658658|592859076|FG001|Overall Study|Withdrawal by Subject|1|||
164135094|NCT00658658|592859077|FG002|Overall Study|Withdrawal by Subject|0|||
164135095|NCT00658658|592859078|FG003|Overall Study|Withdrawal by Subject|0|||
164135096|NCT00658658|592859079|FG004|Overall Study|Withdrawal by Subject|0|||
164135097|NCT00658658|592859075|FG000|Overall Study|Death|4|||
164135098|NCT00658658|592859076|FG001|Overall Study|Death|0|||
164135099|NCT00658658|592859077|FG002|Overall Study|Death|0|||
164135100|NCT00658658|592859078|FG003|Overall Study|Death|1|||
164135101|NCT00658658|592859079|FG004|Overall Study|Death|1|||
164135102|NCT00658658|592859075|FG000|Overall Study|Disease Progression|0|||
164135103|NCT00658658|592859076|FG001|Overall Study|Disease Progression|1|||
164135104|NCT00658658|592859077|FG002|Overall Study|Disease Progression|0|||
164135105|NCT00658658|592859078|FG003|Overall Study|Disease Progression|1|||
164135106|NCT00658658|592859079|FG004|Overall Study|Disease Progression|3|||
164135107|NCT00658658|592859075|FG000|Overall Study|Protocol-specified Criteria|1|||
164135108|NCT00658658|592859076|FG001|Overall Study|Protocol-specified Criteria|0|||
164135109|NCT00658658|592859077|FG002|Overall Study|Protocol-specified Criteria|0|||
164135110|NCT00658658|592859078|FG003|Overall Study|Protocol-specified Criteria|0|||
164135111|NCT00658658|592859079|FG004|Overall Study|Protocol-specified Criteria|0|||
164135112|NCT00658658|592859075|FG000|Overall Study|Other|0|||
164135113|NCT00658658|592859076|FG001|Overall Study|Other|0|||
164135114|NCT00658658|592859077|FG002|Overall Study|Other|0|||
164135115|NCT00658658|592859078|FG003|Overall Study|Other|0|||
164135116|NCT00658658|592859079|FG004|Overall Study|Other|1|||
164135117|NCT01523457|592859080|FG000|Overall Study|Withdrawal by Subject|7|||
164135118|NCT01523457|592859081|FG001|Overall Study|Withdrawal by Subject|2|||
164135119|NCT02213510|592859082|FG000|Overall Study|Death|0|||
164135120|NCT02213510|592859083|FG001|Overall Study|Death|1|||
164135121|NCT02213510|592859082|FG000|Overall Study|Lost to Follow-up|1|||
164135122|NCT02213510|592859083|FG001|Overall Study|Lost to Follow-up|0|||
164135123|NCT03954834|592859084|FG000|Overall Study|Adverse Event|1|||
164135124|NCT03954834|592859085|FG001|Overall Study|Adverse Event|3|||
164135125|NCT03954834|592859086|FG002|Overall Study|Adverse Event|1|||
164135126|NCT03954834|592859087|FG003|Overall Study|Adverse Event|1|||
164135127|NCT03954834|592859084|FG000|Overall Study|Death|0|||
164135128|NCT03954834|592859085|FG001|Overall Study|Death|0|||
164135129|NCT03954834|592859086|FG002|Overall Study|Death|0|||
164135130|NCT03954834|592859087|FG003|Overall Study|Death|1|||
164135131|NCT03954834|592859084|FG000|Overall Study|Physician Decision|0|||
164135132|NCT03954834|592859085|FG001|Overall Study|Physician Decision|1|||
164135133|NCT03954834|592859086|FG002|Overall Study|Physician Decision|0|||
164135134|NCT03954834|592859087|FG003|Overall Study|Physician Decision|2|||
164135135|NCT03954834|592859084|FG000|Overall Study|Protocol Violation|1|||
164135136|NCT03954834|592859085|FG001|Overall Study|Protocol Violation|0|||
163862199|NCT00309452|591861973|FG001|Overall Study|Withdrawal by Subject|0|||
163862200|NCT02962674|591861975|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
163862201|NCT00771667|591861976|FG000|Induction Phase|Adverse Event|5|||
163862202|NCT00771667|591861977|FG001|Induction Phase|Adverse Event|2|||
164200380|NCT01676012|593105100|FG000|Overall Study|incomplete set of videos|1|||
164200381|NCT02848664|593105102|FG000|Overall Study|Withdrawal by Subject|2|||
164200382|NCT02848664|593105102|FG000|Overall Study|Adverse Event|1|||
164200383|NCT02848664|593105102|FG000|Overall Study|no assistance for device training|1|||
164200384|NCT01819727|593105108|FG000|Overall Study|Adverse Event|8|||
164200385|NCT01819727|593105109|FG001|Overall Study|Adverse Event|9|||
164200386|NCT01819727|593105108|FG000|Overall Study|Death|1|||
164200387|NCT01819727|593105109|FG001|Overall Study|Death|0|||
164200388|NCT01819727|593105108|FG000|Overall Study|Lost to Follow-up|1|||
164200389|NCT01819727|593105109|FG001|Overall Study|Lost to Follow-up|1|||
164200390|NCT01819727|593105108|FG000|Overall Study|Physician Decision|3|||
164200391|NCT01819727|593105109|FG001|Overall Study|Physician Decision|2|||
164200392|NCT01819727|593105108|FG000|Overall Study|Pregnancy|1|||
164200393|NCT01819727|593105109|FG001|Overall Study|Pregnancy|0|||
164200394|NCT01819727|593105108|FG000|Overall Study|Protocol Violation|0|||
164200395|NCT01819727|593105109|FG001|Overall Study|Protocol Violation|2|||
164200396|NCT01819727|593105108|FG000|Overall Study|Study Terminated by Sponsor|0|||
164200397|NCT01819727|593105109|FG001|Overall Study|Study Terminated by Sponsor|1|||
164200398|NCT01819727|593105108|FG000|Overall Study|Withdrawal by Subject|6|||
164200399|NCT01819727|593105109|FG001|Overall Study|Withdrawal by Subject|11|||
164200400|NCT01819727|593105108|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
164200401|NCT01819727|593105109|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
164200402|NCT01819727|593105108|FG000|Overall Study|Quit due to lack of health benifits|0|||
164200403|NCT01819727|593105109|FG001|Overall Study|Quit due to lack of health benifits|1|||
164200404|NCT04794751|593105115|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
164200405|NCT04794751|593105116|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
164200406|NCT04794751|593105115|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
164200407|NCT04794751|593105116|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
164200408|NCT04794751|593105115|FG000|Period 1|Protocol Violation|0|||
164200409|NCT04794751|593105116|FG001|Period 1|Protocol Violation|2|||
164200410|NCT04794751|593105115|FG000|Period 1|Withdrawal by Subject|0|||
164200411|NCT04794751|593105116|FG001|Period 1|Withdrawal by Subject|1|||
164200412|NCT04794751|593105115|FG000|Period 2|Withdrawal by Subject|0|||
164200413|NCT04794751|593105116|FG001|Period 2|Withdrawal by Subject|1|||
164200414|NCT04794751|593105115|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
164200415|NCT04794751|593105116|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
164200416|NCT04794751|593105115|FG000|Period 2|Protocol Violation|1|||
164200417|NCT04794751|593105116|FG001|Period 2|Protocol Violation|0|||
164200418|NCT01405898|593105119|FG000|Overall Study|Withdrawal by Subject|2|||
164200419|NCT01405898|593105120|FG001|Overall Study|Withdrawal by Subject|2|||
164200420|NCT00369343|593105136|FG000|Double-blind Phase|Adverse Event|19|||
164200421|NCT00369343|593105137|FG001|Double-blind Phase|Adverse Event|4|||
164200422|NCT00369343|593105136|FG000|Double-blind Phase|Failed to return|2|||
164200423|NCT00369343|593105137|FG001|Double-blind Phase|Failed to return|0|||
164200424|NCT00369343|593105136|FG000|Double-blind Phase|Lost to Follow-up|9|||
164200425|NCT00369343|593105137|FG001|Double-blind Phase|Lost to Follow-up|2|||
164200426|NCT00369343|593105136|FG000|Double-blind Phase|Protocol Violation|2|||
164200427|NCT00369343|593105137|FG001|Double-blind Phase|Protocol Violation|0|||
164200428|NCT00369343|593105136|FG000|Double-blind Phase|Withdrawal by Subject|8|||
164200429|NCT00369343|593105137|FG001|Double-blind Phase|Withdrawal by Subject|6|||
164200430|NCT00369343|593105136|FG000|Double-blind Phase|Lack of Efficacy|0|||
164200431|NCT00369343|593105137|FG001|Double-blind Phase|Lack of Efficacy|4|||
164200432|NCT00369343|593105136|FG000|Double-blind Phase|Protocol deviation|4|||
164200433|NCT00369343|593105137|FG001|Double-blind Phase|Protocol deviation|0|||
164200434|NCT00369343|593105136|FG000|Open-label Phase|Adverse Event|19|||
164200435|NCT00369343|593105137|FG001|Open-label Phase|Adverse Event|7|||
164200436|NCT00369343|593105136|FG000|Open-label Phase|Failed to return|4|||
164200437|NCT00369343|593105137|FG001|Open-label Phase|Failed to return|0|||
164200438|NCT00369343|593105136|FG000|Open-label Phase|Physician Decision|2|||
164200439|NCT00369343|593105137|FG001|Open-label Phase|Physician Decision|0|||
164200440|NCT00369343|593105136|FG000|Open-label Phase|Lost to Follow-up|5|||
164200441|NCT00369343|593105137|FG001|Open-label Phase|Lost to Follow-up|3|||
164200442|NCT00369343|593105136|FG000|Open-label Phase|inadvertently reported study completers|3|||
164200443|NCT00369343|593105137|FG001|Open-label Phase|inadvertently reported study completers|2|||
164200444|NCT00369343|593105136|FG000|Open-label Phase|Protocol Violation|1|||
164200445|NCT00369343|593105137|FG001|Open-label Phase|Protocol Violation|3|||
164200446|NCT00369343|593105136|FG000|Open-label Phase|Withdrawal by Subject|15|||
164200447|NCT00369343|593105137|FG001|Open-label Phase|Withdrawal by Subject|6|||
164200448|NCT00369343|593105136|FG000|Open-label Phase|Lack of Efficacy|4|||
164200449|NCT00369343|593105137|FG001|Open-label Phase|Lack of Efficacy|3|||
164200450|NCT00369343|593105136|FG000|Open-label Phase|Lack of continuance tolerability|3|||
164308946|NCT01349049|593506554|FG007|Overall Study|Protocol Violation|0|||
164308947|NCT01349049|593506555|FG008|Overall Study|Protocol Violation|1|||
164308948|NCT01349049|593506547|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
164308949|NCT01349049|593506548|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
164308950|NCT01349049|593506549|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
164308951|NCT01349049|593506550|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
164308952|NCT01349049|593506551|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
164308953|NCT01349049|593506552|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
164308954|NCT01349049|593506553|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
164308955|NCT01349049|593506554|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
164308956|NCT01349049|593506555|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
164308957|NCT01349049|593506547|FG000|Overall Study|Other|0|||
163967662|NCT00375219|592254255|FG002|Overall Study|Failure to achieve a response|0|||
164200451|NCT00369343|593105137|FG001|Open-label Phase|Lack of continuance tolerability|4|||
164200452|NCT00369343|593105136|FG000|Open-label Phase|did not take study drug|1|||
164200453|NCT00369343|593105137|FG001|Open-label Phase|did not take study drug|2|||
164200454|NCT01973218|593105138|FG000|Overall Study|Adverse Event|1|||
164200455|NCT01973218|593105139|FG001|Overall Study|Adverse Event|0|||
164200456|NCT01973218|593105138|FG000|Overall Study|Withdrawal by Subject|1|||
164200457|NCT01973218|593105139|FG001|Overall Study|Withdrawal by Subject|0|||
164200458|NCT02247466|593105140|FG000|Overall Study|Procedure changed to open surgery|0|||
164200459|NCT02247466|593105141|FG001|Overall Study|Procedure changed to open surgery|3|||
164200460|NCT02322749|593105146|FG000|Period 2|Adverse Event|0|||
164200461|NCT02322749|593105147|FG001|Period 2|Adverse Event|0|||
164200462|NCT02322749|593105148|FG002|Period 2|Adverse Event|0|||
164200463|NCT02322749|593105149|FG003|Period 2|Adverse Event|1|||
164200464|NCT02322749|593105150|FG004|Period 2|Adverse Event|0|||
164200465|NCT02322749|593105151|FG005|Period 2|Adverse Event|0|||
164200466|NCT02322749|593105146|FG000|Period 2|Withdrawal by Subject|0|||
164200467|NCT02322749|593105147|FG001|Period 2|Withdrawal by Subject|0|||
164200468|NCT02322749|593105148|FG002|Period 2|Withdrawal by Subject|0|||
164200469|NCT02322749|593105149|FG003|Period 2|Withdrawal by Subject|1|||
164200470|NCT02322749|593105150|FG004|Period 2|Withdrawal by Subject|0|||
164200471|NCT02322749|593105151|FG005|Period 2|Withdrawal by Subject|0|||
164200472|NCT02322749|593105146|FG000|Period 3|Withdrawal by Subject|0|||
164200473|NCT02322749|593105147|FG001|Period 3|Withdrawal by Subject|0|||
164200474|NCT02322749|593105148|FG002|Period 3|Withdrawal by Subject|1|||
164200475|NCT02322749|593105149|FG003|Period 3|Withdrawal by Subject|0|||
164200476|NCT02322749|593105150|FG004|Period 3|Withdrawal by Subject|0|||
164200477|NCT02322749|593105151|FG005|Period 3|Withdrawal by Subject|0|||
164200478|NCT00073918|593105152|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
164200479|NCT00073918|593105152|FG000|Overall Study|Rapid disease progression|2|||
164200480|NCT00073918|593105152|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
164200481|NCT02033759|593105155|FG000|Overall Study|Withdrawal by Subject|2|||
164200482|NCT02033759|593105156|FG001|Overall Study|Withdrawal by Subject|1|||
164200483|NCT02033759|593105155|FG000|Overall Study|Protocol Violation|1|||
164200484|NCT02033759|593105156|FG001|Overall Study|Protocol Violation|1|||
164200485|NCT02007720|593105163|FG000|Overall Study|Withdrawal by Subject|9|||
164200486|NCT02007720|593105164|FG001|Overall Study|Withdrawal by Subject|11|||
164200487|NCT02007720|593105163|FG000|Overall Study|study terminated by sponsor|58|||
164200488|NCT02007720|593105164|FG001|Overall Study|study terminated by sponsor|54|||
164200489|NCT02007720|593105163|FG000|Overall Study|technical problem|4|||
164200490|NCT02007720|593105164|FG001|Overall Study|technical problem|2|||
164200491|NCT02007720|593105163|FG000|Overall Study|patient followd less than 165 days|11|||
164200492|NCT02007720|593105164|FG001|Overall Study|patient followd less than 165 days|5|||
164200493|NCT00490919|593105166|FG000|Open-label Run-in Period|Adverse Event|239|||
164200494|NCT00490919|593105167|FG001|Open-label Run-in Period|Adverse Event|0|||
164200495|NCT00490919|593105168|FG002|Open-label Run-in Period|Adverse Event|0|||
164200496|NCT00490919|593105166|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
164200497|NCT00490919|593105167|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
164200498|NCT00490919|593105168|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
164200499|NCT00490919|593105166|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
164200500|NCT00490919|593105167|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
164200501|NCT00490919|593105168|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
164200502|NCT00490919|593105166|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
164200503|NCT00490919|593105167|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
164200504|NCT00490919|593105168|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
164200505|NCT00490919|593105166|FG000|Open-label Run-in Period|Administrative|40|||
164200506|NCT00490919|593105167|FG001|Open-label Run-in Period|Administrative|0|||
164200507|NCT00490919|593105168|FG002|Open-label Run-in Period|Administrative|0|||
164308958|NCT01349049|593506548|FG001|Overall Study|Other|0|||
163967663|NCT00375219|592254253|FG000|Overall Study|Adverse Event|8|||
163967664|NCT00375219|592254254|FG001|Overall Study|Adverse Event|2|||
164200508|NCT00490919|593105166|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
164200509|NCT00490919|593105167|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
164200510|NCT00490919|593105168|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
164308959|NCT01349049|593506549|FG002|Overall Study|Other|0|||
164308960|NCT01349049|593506550|FG003|Overall Study|Other|0|||
164308961|NCT01349049|593506551|FG004|Overall Study|Other|0|||
164308962|NCT01349049|593506552|FG005|Overall Study|Other|1|||
164308963|NCT01349049|593506553|FG006|Overall Study|Other|0|||
164308964|NCT01349049|593506554|FG007|Overall Study|Other|0|||
164308965|NCT01349049|593506555|FG008|Overall Study|Other|4|||
164308966|NCT01349049|593506547|FG000|Overall Study|Death|0|||
164308967|NCT01349049|593506548|FG001|Overall Study|Death|0|||
164308968|NCT01349049|593506549|FG002|Overall Study|Death|0|||
164308969|NCT01349049|593506550|FG003|Overall Study|Death|0|||
164308970|NCT01349049|593506551|FG004|Overall Study|Death|0|||
164308971|NCT01349049|593506552|FG005|Overall Study|Death|0|||
164308972|NCT01349049|593506553|FG006|Overall Study|Death|0|||
164308973|NCT01349049|593506554|FG007|Overall Study|Death|1|||
164308974|NCT01349049|593506555|FG008|Overall Study|Death|5|||
164308975|NCT01349049|593506547|FG000|Overall Study|Non-compliance|0|||
164308976|NCT01349049|593506548|FG001|Overall Study|Non-compliance|0|||
164308977|NCT01349049|593506549|FG002|Overall Study|Non-compliance|0|||
164308978|NCT01349049|593506550|FG003|Overall Study|Non-compliance|1|||
164308979|NCT01349049|593506551|FG004|Overall Study|Non-compliance|0|||
164308980|NCT01349049|593506552|FG005|Overall Study|Non-compliance|0|||
164308981|NCT01349049|593506553|FG006|Overall Study|Non-compliance|0|||
164308982|NCT01349049|593506554|FG007|Overall Study|Non-compliance|0|||
164308983|NCT01349049|593506555|FG008|Overall Study|Non-compliance|0|||
164308984|NCT01349049|593506547|FG000|Overall Study|Withdrawal by Subject|0|||
164308985|NCT01349049|593506548|FG001|Overall Study|Withdrawal by Subject|0|||
164308986|NCT01349049|593506549|FG002|Overall Study|Withdrawal by Subject|0|||
164308987|NCT01349049|593506550|FG003|Overall Study|Withdrawal by Subject|0|||
164308988|NCT01349049|593506551|FG004|Overall Study|Withdrawal by Subject|0|||
164308989|NCT01349049|593506552|FG005|Overall Study|Withdrawal by Subject|0|||
164308990|NCT01349049|593506553|FG006|Overall Study|Withdrawal by Subject|0|||
164308991|NCT01349049|593506554|FG007|Overall Study|Withdrawal by Subject|0|||
164308992|NCT01349049|593506555|FG008|Overall Study|Withdrawal by Subject|6|||
164308993|NCT03887702|593506556|FG000|Overall Study|Study terminated|0|||
164308994|NCT03887702|593506557|FG001|Overall Study|Study terminated|0|||
164308995|NCT03887702|593506558|FG002|Overall Study|Study terminated|2|||
164308996|NCT03887702|593506559|FG003|Overall Study|Study terminated|2|||
164308997|NCT01643772|593506560|FG000|Overall Study|Protocol Violation|0|||
164308998|NCT01643772|593506561|FG001|Overall Study|Protocol Violation|0|||
164308999|NCT01643772|593506562|FG002|Overall Study|Protocol Violation|0|||
164309000|NCT01643772|593506563|FG003|Overall Study|Protocol Violation|1|||
164309001|NCT01643772|593506560|FG000|Overall Study|Adverse Event|0|||
164309002|NCT01643772|593506561|FG001|Overall Study|Adverse Event|0|||
164309003|NCT01643772|593506562|FG002|Overall Study|Adverse Event|0|||
164309004|NCT01643772|593506563|FG003|Overall Study|Adverse Event|1|||
164309005|NCT03860818|593506564|FG000|Overall Study|Death|144|||
164309006|NCT03860818|593506565|FG001|Overall Study|Death|195|||
164309007|NCT03860818|593506564|FG000|Overall Study|Graft Loss|32|||
164309008|NCT03860818|593506565|FG001|Overall Study|Graft Loss|45|||
164309009|NCT00505778|593506566|FG000|Overall Study|Adverse Event|2|||
164309010|NCT00505778|593506567|FG001|Overall Study|Adverse Event|7|||
164309011|NCT00505778|593506566|FG000|Overall Study|Physician Decision|8|||
164309012|NCT00505778|593506567|FG001|Overall Study|Physician Decision|14|||
164309013|NCT00505778|593506566|FG000|Overall Study|Lost to Follow-up|17|||
164309014|NCT00505778|593506567|FG001|Overall Study|Lost to Follow-up|23|||
164309015|NCT00505778|593506566|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
164309016|NCT00505778|593506567|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
164309017|NCT00505778|593506566|FG000|Overall Study|Protocol Violation|7|||
164309018|NCT00505778|593506567|FG001|Overall Study|Protocol Violation|9|||
163967665|NCT00375219|592254255|FG002|Overall Study|Adverse Event|1|||
164309019|NCT00505778|593506566|FG000|Overall Study|Withdrawal by Subject|29|||
164309020|NCT00505778|593506567|FG001|Overall Study|Withdrawal by Subject|14|||
164309021|NCT00505778|593506566|FG000|Overall Study|Relapse|65|||
164309022|NCT00505778|593506567|FG001|Overall Study|Relapse|65|||
164309023|NCT00505778|593506566|FG000|Overall Study|Took No Study Drug|2|||
164309024|NCT00505778|593506567|FG001|Overall Study|Took No Study Drug|2|||
164309025|NCT03436082|593506568|FG000|Overall Study|Did not undergo procedure|1|||
164309026|NCT03436082|593506569|FG001|Overall Study|Did not undergo procedure|0|||
164309027|NCT01864603|593506572|FG000|Stage 2|DSMB design modification|86056|||
164309028|NCT01864603|593506573|FG001|Stage 2|DSMB design modification|92558|||
164309029|NCT04661579|593506576|FG000|Overall Study|Lost to Follow-up|19|||
164309030|NCT04661579|593506577|FG001|Overall Study|Lost to Follow-up|10|||
164309031|NCT04661579|593506578|FG002|Overall Study|Lost to Follow-up|2|||
164309032|NCT04661579|593506579|FG003|Overall Study|Lost to Follow-up|7|||
164309033|NCT04661579|593506580|FG004|Overall Study|Lost to Follow-up|11|||
164309034|NCT04661579|593506576|FG000|Overall Study|Physician Decision|2|||
164309035|NCT04661579|593506577|FG001|Overall Study|Physician Decision|0|||
164309036|NCT04661579|593506578|FG002|Overall Study|Physician Decision|0|||
164309037|NCT04661579|593506579|FG003|Overall Study|Physician Decision|1|||
164309038|NCT04661579|593506580|FG004|Overall Study|Physician Decision|0|||
164309039|NCT04661579|593506576|FG000|Overall Study|Withdrawal by Subject|1|||
164309040|NCT04661579|593506577|FG001|Overall Study|Withdrawal by Subject|4|||
164309041|NCT04661579|593506578|FG002|Overall Study|Withdrawal by Subject|0|||
164309042|NCT04661579|593506579|FG003|Overall Study|Withdrawal by Subject|2|||
164309043|NCT04661579|593506580|FG004|Overall Study|Withdrawal by Subject|0|||
164309044|NCT04661579|593506576|FG000|Overall Study|Death|1|||
164309045|NCT04661579|593506577|FG001|Overall Study|Death|0|||
164309046|NCT04661579|593506578|FG002|Overall Study|Death|0|||
164309047|NCT04661579|593506579|FG003|Overall Study|Death|0|||
164309048|NCT04661579|593506580|FG004|Overall Study|Death|0|||
164309049|NCT04661579|593506576|FG000|Overall Study|Other|1|||
164309050|NCT04661579|593506577|FG001|Overall Study|Other|2|||
164309051|NCT04661579|593506578|FG002|Overall Study|Other|1|||
164309052|NCT04661579|593506579|FG003|Overall Study|Other|1|||
164309053|NCT04661579|593506580|FG004|Overall Study|Other|1|||
164309054|NCT04661579|593506576|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
164309055|NCT04661579|593506577|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
164309056|NCT04661579|593506578|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
164309057|NCT04661579|593506579|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
164309058|NCT04661579|593506580|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
164309059|NCT03656562|593506581|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
164309060|NCT03656562|593506582|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
164309061|NCT03656562|593506583|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
164309062|NCT03656562|593506584|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
163862203|NCT00771667|591861978|FG002|Induction Phase|Adverse Event|4|||
163862204|NCT00771667|591861979|FG003|Induction Phase|Adverse Event|1|||
163862205|NCT00771667|591861980|FG004|Induction Phase|Adverse Event|0|||
163862206|NCT00771667|591861981|FG005|Induction Phase|Adverse Event|0|||
163862207|NCT00771667|591861982|FG006|Induction Phase|Adverse Event|0|||
163862208|NCT00771667|591861983|FG007|Induction Phase|Adverse Event|0|||
163862209|NCT00771667|591861984|FG008|Induction Phase|Adverse Event|0|||
163862210|NCT00771667|591861985|FG009|Induction Phase|Adverse Event|0|||
164200511|NCT00490919|593105166|FG000|Double-blind Phase|Adverse Event|0|||
164200512|NCT00490919|593105167|FG001|Double-blind Phase|Adverse Event|40|||
164200513|NCT00490919|593105168|FG002|Double-blind Phase|Adverse Event|20|||
164200514|NCT00490919|593105166|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164200515|NCT00490919|593105167|FG001|Double-blind Phase|Withdrawal by Subject|10|||
164200516|NCT00490919|593105168|FG002|Double-blind Phase|Withdrawal by Subject|11|||
164200517|NCT00490919|593105166|FG000|Double-blind Phase|Lost to Follow-up|0|||
164200518|NCT00490919|593105167|FG001|Double-blind Phase|Lost to Follow-up|8|||
164200519|NCT00490919|593105168|FG002|Double-blind Phase|Lost to Follow-up|11|||
164200520|NCT00490919|593105166|FG000|Double-blind Phase|Lack of Efficacy|0|||
164200521|NCT00490919|593105167|FG001|Double-blind Phase|Lack of Efficacy|22|||
164200522|NCT00490919|593105168|FG002|Double-blind Phase|Lack of Efficacy|36|||
164200523|NCT00490919|593105166|FG000|Double-blind Phase|Administrative|0|||
164200524|NCT00490919|593105167|FG001|Double-blind Phase|Administrative|6|||
164200525|NCT00490919|593105168|FG002|Double-blind Phase|Administrative|6|||
164200526|NCT04265261|593105175|FG000|Overall Study|Adverse Event|2|||
164200527|NCT04265261|593105176|FG001|Overall Study|Adverse Event|0|||
164200528|NCT04265261|593105177|FG002|Overall Study|Adverse Event|0|||
164200529|NCT04265261|593105175|FG000|Overall Study|Death|1|||
164200530|NCT04265261|593105176|FG001|Overall Study|Death|0|||
164200531|NCT04265261|593105177|FG002|Overall Study|Death|0|||
164200532|NCT04265261|593105175|FG000|Overall Study|Lost to Follow-up|4|||
164200533|NCT04265261|593105176|FG001|Overall Study|Lost to Follow-up|1|||
164200534|NCT04265261|593105177|FG002|Overall Study|Lost to Follow-up|3|||
164200535|NCT04265261|593105175|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164200536|NCT04265261|593105176|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164200537|NCT04265261|593105177|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164200538|NCT04265261|593105175|FG000|Overall Study|Physician Decision|0|||
164200539|NCT04265261|593105176|FG001|Overall Study|Physician Decision|0|||
163967666|NCT00375219|592254253|FG000|Overall Study|Protocol Violation|1|||
164200540|NCT04265261|593105177|FG002|Overall Study|Physician Decision|1|||
164200541|NCT04265261|593105175|FG000|Overall Study|Protocol Deviation|0|||
164200542|NCT04265261|593105176|FG001|Overall Study|Protocol Deviation|2|||
164200543|NCT04265261|593105177|FG002|Overall Study|Protocol Deviation|0|||
164309063|NCT03656562|593506581|FG000|Overall Study|Physician Decision|1|||
164309064|NCT03656562|593506582|FG001|Overall Study|Physician Decision|2|||
164309065|NCT03656562|593506583|FG002|Overall Study|Physician Decision|0|||
163862211|NCT00771667|591861976|FG000|Induction Phase|Lack of Efficacy|9|||
163862212|NCT00771667|591861977|FG001|Induction Phase|Lack of Efficacy|2|||
163967667|NCT00375219|592254254|FG001|Overall Study|Protocol Violation|0|||
164200544|NCT04265261|593105175|FG000|Overall Study|Withdrawal by Subject|2|||
164309066|NCT03656562|593506584|FG003|Overall Study|Physician Decision|0|||
164309067|NCT03656562|593506581|FG000|Overall Study|Subject Decision|3|||
164309068|NCT03656562|593506582|FG001|Overall Study|Subject Decision|5|||
164309069|NCT03656562|593506583|FG002|Overall Study|Subject Decision|0|||
164309070|NCT03656562|593506584|FG003|Overall Study|Subject Decision|2|||
164309071|NCT04335136|593506585|FG000|Overall Study|Death|8|||
164309072|NCT04335136|593506586|FG001|Overall Study|Death|4|||
164309073|NCT04335136|593506585|FG000|Overall Study|Lost to Follow-up|2|||
164309074|NCT04335136|593506586|FG001|Overall Study|Lost to Follow-up|0|||
164309075|NCT04335136|593506585|FG000|Overall Study|Protocol Violation|1|||
164309076|NCT04335136|593506586|FG001|Overall Study|Protocol Violation|0|||
164309077|NCT04335136|593506585|FG000|Overall Study|Withdrawal by Subject|1|||
164309078|NCT04335136|593506586|FG001|Overall Study|Withdrawal by Subject|1|||
164309079|NCT04335136|593506585|FG000|Overall Study|Health-threatening condition|0|||
164309080|NCT04335136|593506586|FG001|Overall Study|Health-threatening condition|1|||
164309081|NCT04335136|593506585|FG000|Overall Study|Adverse Event|0|||
164309082|NCT04335136|593506586|FG001|Overall Study|Adverse Event|1|||
164309083|NCT04335136|593506585|FG000|Overall Study|Erroneously randomized|2|||
164309084|NCT04335136|593506586|FG001|Overall Study|Erroneously randomized|0|||
164309085|NCT01396447|593506587|FG000|Overall Study|Did Not Receive Treatment|3|||
164309086|NCT01396447|593506588|FG001|Overall Study|Did Not Receive Treatment|2|||
164309087|NCT01396447|593506589|FG002|Overall Study|Did Not Receive Treatment|1|||
164309088|NCT01396447|593506590|FG003|Overall Study|Did Not Receive Treatment|0|||
164309089|NCT01396447|593506587|FG000|Overall Study|Adverse Event|15|||
164309090|NCT01396447|593506588|FG001|Overall Study|Adverse Event|12|||
164309091|NCT01396447|593506589|FG002|Overall Study|Adverse Event|12|||
164309092|NCT01396447|593506590|FG003|Overall Study|Adverse Event|17|||
164309093|NCT01396447|593506587|FG000|Overall Study|Insufficient Therapeutic Response|5|||
164309094|NCT01396447|593506588|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164309095|NCT01396447|593506589|FG002|Overall Study|Insufficient Therapeutic Response|2|||
164309096|NCT01396447|593506590|FG003|Overall Study|Insufficient Therapeutic Response|4|||
164309097|NCT01396447|593506587|FG000|Overall Study|Protocol Violation|5|||
164309098|NCT01396447|593506588|FG001|Overall Study|Protocol Violation|2|||
164309099|NCT01396447|593506589|FG002|Overall Study|Protocol Violation|3|||
164309100|NCT01396447|593506590|FG003|Overall Study|Protocol Violation|7|||
164309101|NCT01396447|593506587|FG000|Overall Study|Withdrawal of Consent|11|||
164309102|NCT01396447|593506588|FG001|Overall Study|Withdrawal of Consent|9|||
164309103|NCT01396447|593506589|FG002|Overall Study|Withdrawal of Consent|4|||
164309104|NCT01396447|593506590|FG003|Overall Study|Withdrawal of Consent|15|||
164309105|NCT01396447|593506587|FG000|Overall Study|Lost to Follow-up|4|||
164309106|NCT01396447|593506588|FG001|Overall Study|Lost to Follow-up|8|||
164309107|NCT01396447|593506589|FG002|Overall Study|Lost to Follow-up|7|||
164309108|NCT01396447|593506590|FG003|Overall Study|Lost to Follow-up|9|||
164309109|NCT01396447|593506587|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164309110|NCT01396447|593506588|FG001|Overall Study|Other Miscellaneous Reasons|2|||
164309111|NCT01396447|593506589|FG002|Overall Study|Other Miscellaneous Reasons|1|||
164309112|NCT01396447|593506590|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164309113|NCT01402102|593506591|FG000|Overall Study|Protocol Violation|1|||
164309114|NCT01402102|593506592|FG001|Overall Study|Protocol Violation|0|||
164309115|NCT01402102|593506591|FG000|Overall Study|Insufficiency of compliance|1|||
164309116|NCT01402102|593506592|FG001|Overall Study|Insufficiency of compliance|1|||
164309117|NCT01402102|593506591|FG000|Overall Study|Withdrawal by Subject|0|||
164309118|NCT01402102|593506592|FG001|Overall Study|Withdrawal by Subject|2|||
164309119|NCT02423902|593506593|FG000|Overall Study|Disease progression|1|||
164309120|NCT02423902|593506594|FG001|Overall Study|Disease progression|4|||
164309121|NCT02136069|593506595|FG000|Overall Study|UC flare-up|1|||
164309122|NCT02136069|593506596|FG001|Overall Study|UC flare-up|0|||
164309123|NCT02136069|593506595|FG000|Overall Study|Adverse Event|6|||
164309124|NCT02136069|593506596|FG001|Overall Study|Adverse Event|8|||
164309125|NCT02136069|593506595|FG000|Overall Study|Death|0|||
164309126|NCT02136069|593506596|FG001|Overall Study|Death|1|||
164309127|NCT02136069|593506595|FG000|Overall Study|Lack of Efficacy|10|||
164309128|NCT02136069|593506596|FG001|Overall Study|Lack of Efficacy|4|||
164309129|NCT02136069|593506595|FG000|Overall Study|Lost to Follow-up|1|||
164309130|NCT02136069|593506596|FG001|Overall Study|Lost to Follow-up|0|||
164309131|NCT02136069|593506595|FG000|Overall Study|Non-Compliance|1|||
164309132|NCT02136069|593506596|FG001|Overall Study|Non-Compliance|0|||
164309133|NCT02136069|593506595|FG000|Overall Study|Physician Decision|5|||
164309134|NCT02136069|593506596|FG001|Overall Study|Physician Decision|4|||
164309135|NCT02136069|593506595|FG000|Overall Study|Withdrawal by Subject|10|||
164309136|NCT02136069|593506596|FG001|Overall Study|Withdrawal by Subject|11|||
164309137|NCT04269265|593506597|FG000|Overall Study|Physician Decision|1|||
164309138|NCT04269265|593506597|FG000|Overall Study|Withdrawal by Subject|1|||
164309139|NCT04269265|593506597|FG000|Overall Study|Overenrolled (sample size reached)|4|||
164309140|NCT04693234|593506598|FG000|Overall Study|Death|79|||
164309141|NCT04693234|593506599|FG001|Overall Study|Death|19|||
164309142|NCT04693234|593506598|FG000|Overall Study|Sponsor Ended Study|47|||
164309143|NCT04693234|593506599|FG001|Overall Study|Sponsor Ended Study|18|||
164309144|NCT04693234|593506598|FG000|Overall Study|Withdrawal by Subject|10|||
164309145|NCT04693234|593506599|FG001|Overall Study|Withdrawal by Subject|2|||
164309146|NCT04693234|593506598|FG000|Overall Study|Lost to Follow-up|2|||
164309147|NCT04693234|593506599|FG001|Overall Study|Lost to Follow-up|1|||
164309148|NCT04838626|593506602|FG000|Overall Study|Adverse Event|2|||
164309149|NCT04838626|593506602|FG000|Overall Study|Physician Decision|6|||
164309150|NCT04838626|593506602|FG000|Overall Study|Protocol Violation|3|||
164309151|NCT04838626|593506602|FG000|Overall Study|Withdrawal by Subject|9|||
164309152|NCT04838626|593506602|FG000|Overall Study|Technical Problems|2|||
164309153|NCT02578706|593506603|FG000|Overall Study|Withdrawal by Subject|1|||
164309154|NCT02578706|593506604|FG001|Overall Study|Withdrawal by Subject|0|||
164309155|NCT02578706|593506605|FG002|Overall Study|Withdrawal by Subject|0|||
164309156|NCT02578706|593506603|FG000|Overall Study|Lost to Follow-up|0|||
164309157|NCT02578706|593506604|FG001|Overall Study|Lost to Follow-up|4|||
164309158|NCT02578706|593506605|FG002|Overall Study|Lost to Follow-up|0|||
164309159|NCT02578706|593506603|FG000|Overall Study|Physician Decision|0|||
164309160|NCT02578706|593506604|FG001|Overall Study|Physician Decision|1|||
164309161|NCT02578706|593506605|FG002|Overall Study|Physician Decision|0|||
164309162|NCT00811018|593506607|FG000|Overall Study|Additional Chronic Treatment|31|||
164309163|NCT00811018|593506607|FG000|Overall Study|Adverse Event|79|||
164309164|NCT00811018|593506607|FG000|Overall Study|Death|147|||
164309165|NCT00811018|593506607|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
164309166|NCT00811018|593506607|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
164309167|NCT00811018|593506607|FG000|Overall Study|Investigator Decision|57|||
164309168|NCT00811018|593506607|FG000|Overall Study|Lost to Follow-up|19|||
164309169|NCT00811018|593506607|FG000|Overall Study|Pregnancy|6|||
164309170|NCT00811018|593506607|FG000|Overall Study|Sponsor Decision|450|||
164309171|NCT00811018|593506607|FG000|Overall Study|Withdrawal by Subject|70|||
164309172|NCT00811018|593506607|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
164309173|NCT00811018|593506607|FG000|Overall Study|Other|26|||
164309174|NCT00392769|593506608|FG000|Overall Study|Clinical Deterioration|9|||
164309175|NCT00392769|593506608|FG000|Overall Study|Adverse Event|1|||
164309176|NCT04154189|593506609|FG000|Overall Study|Withdrawal by Subject|4|||
164309177|NCT04154189|593506610|FG001|Overall Study|Withdrawal by Subject|6|||
164309178|NCT04154189|593506609|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
164309179|NCT04154189|593506610|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
164309180|NCT04154189|593506609|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
164309181|NCT04154189|593506610|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
164309182|NCT04154189|593506609|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
164309183|NCT04154189|593506610|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
164309184|NCT04154189|593506609|FG000|Overall Study|Death|25|||
164309185|NCT04154189|593506610|FG001|Overall Study|Death|25|||
164309186|NCT00067002|593506613|FG000|Overall Study|Early Death|1|||
164309187|NCT00067002|593506614|FG001|Overall Study|Early Death|2|||
164309188|NCT00067002|593506613|FG000|Overall Study|Delayed|1|||
164309189|NCT00067002|593506614|FG001|Overall Study|Delayed|1|||
164309190|NCT00067002|593506613|FG000|Overall Study|Graft Failure|5|||
164309191|NCT00067002|593506614|FG001|Overall Study|Graft Failure|6|||
164309192|NCT03350672|593506615|FG000|Overall Study|Withdrawal by Subject|7|||
164309193|NCT03350672|593506616|FG001|Overall Study|Withdrawal by Subject|0|||
164309194|NCT03350672|593506617|FG002|Overall Study|Withdrawal by Subject|0|||
164309195|NCT00478023|593506618|FG000|Overall Study|Adverse Event|11|||
164309196|NCT00478023|593506619|FG001|Overall Study|Adverse Event|7|||
164309197|NCT00478023|593506620|FG002|Overall Study|Adverse Event|8|||
164309198|NCT00478023|593506621|FG003|Overall Study|Adverse Event|14|||
164309199|NCT00478023|593506622|FG004|Overall Study|Adverse Event|6|||
164309200|NCT00478023|593506618|FG000|Overall Study|Death|1|||
164309201|NCT00478023|593506619|FG001|Overall Study|Death|0|||
164309202|NCT00478023|593506620|FG002|Overall Study|Death|0|||
164309203|NCT00478023|593506621|FG003|Overall Study|Death|0|||
164309204|NCT00478023|593506622|FG004|Overall Study|Death|0|||
164309205|NCT00478023|593506618|FG000|Overall Study|Lack of Efficacy|11|||
164309206|NCT00478023|593506619|FG001|Overall Study|Lack of Efficacy|10|||
164309207|NCT00478023|593506620|FG002|Overall Study|Lack of Efficacy|4|||
163967668|NCT00375219|592254255|FG002|Overall Study|Protocol Violation|1|||
164309208|NCT00478023|593506621|FG003|Overall Study|Lack of Efficacy|5|||
164309209|NCT00478023|593506622|FG004|Overall Study|Lack of Efficacy|41|||
164309210|NCT00478023|593506618|FG000|Overall Study|Lost to Follow-up|3|||
164309211|NCT00478023|593506619|FG001|Overall Study|Lost to Follow-up|1|||
164309212|NCT00478023|593506620|FG002|Overall Study|Lost to Follow-up|1|||
164309213|NCT00478023|593506621|FG003|Overall Study|Lost to Follow-up|1|||
164309214|NCT00478023|593506622|FG004|Overall Study|Lost to Follow-up|0|||
164309215|NCT00478023|593506618|FG000|Overall Study|Withdrawal by Subject|2|||
164309216|NCT00478023|593506619|FG001|Overall Study|Withdrawal by Subject|3|||
164309217|NCT00478023|593506620|FG002|Overall Study|Withdrawal by Subject|2|||
164309218|NCT00478023|593506621|FG003|Overall Study|Withdrawal by Subject|4|||
164309219|NCT00478023|593506622|FG004|Overall Study|Withdrawal by Subject|5|||
164309220|NCT00478023|593506618|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
164309221|NCT00478023|593506619|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
164309222|NCT00478023|593506620|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
163862213|NCT00771667|591861978|FG002|Induction Phase|Lack of Efficacy|4|||
163862214|NCT00771667|591861979|FG003|Induction Phase|Lack of Efficacy|3|||
163862215|NCT00771667|591861980|FG004|Induction Phase|Lack of Efficacy|0|||
163862216|NCT00771667|591861981|FG005|Induction Phase|Lack of Efficacy|0|||
163862217|NCT00771667|591861982|FG006|Induction Phase|Lack of Efficacy|0|||
163862218|NCT00771667|591861983|FG007|Induction Phase|Lack of Efficacy|0|||
163862219|NCT00771667|591861984|FG008|Induction Phase|Lack of Efficacy|0|||
163862220|NCT00771667|591861985|FG009|Induction Phase|Lack of Efficacy|0|||
163862221|NCT00771667|591861976|FG000|Induction Phase|Lost to Follow-up|1|||
163862222|NCT00771667|591861977|FG001|Induction Phase|Lost to Follow-up|0|||
163862223|NCT00771667|591861978|FG002|Induction Phase|Lost to Follow-up|1|||
163862224|NCT00771667|591861979|FG003|Induction Phase|Lost to Follow-up|0|||
163862225|NCT00771667|591861980|FG004|Induction Phase|Lost to Follow-up|0|||
163862226|NCT00771667|591861981|FG005|Induction Phase|Lost to Follow-up|0|||
163862227|NCT00771667|591861982|FG006|Induction Phase|Lost to Follow-up|0|||
163862228|NCT00771667|591861983|FG007|Induction Phase|Lost to Follow-up|0|||
163862229|NCT00771667|591861984|FG008|Induction Phase|Lost to Follow-up|0|||
163862230|NCT00771667|591861985|FG009|Induction Phase|Lost to Follow-up|0|||
164200545|NCT04265261|593105176|FG001|Overall Study|Withdrawal by Subject|1|||
163862231|NCT00771667|591861976|FG000|Induction Phase|Other|4|||
163862232|NCT00771667|591861977|FG001|Induction Phase|Other|6|||
163862233|NCT00771667|591861978|FG002|Induction Phase|Other|3|||
163862234|NCT00771667|591861979|FG003|Induction Phase|Other|4|||
163862235|NCT00771667|591861980|FG004|Induction Phase|Other|0|||
163862236|NCT00771667|591861981|FG005|Induction Phase|Other|0|||
163862237|NCT00771667|591861982|FG006|Induction Phase|Other|0|||
163862238|NCT00771667|591861983|FG007|Induction Phase|Other|0|||
163862239|NCT00771667|591861984|FG008|Induction Phase|Other|0|||
163862240|NCT00771667|591861985|FG009|Induction Phase|Other|0|||
163862241|NCT00771667|591861976|FG000|Maintenance Phase|Adverse Event|0|||
163862242|NCT00771667|591861977|FG001|Maintenance Phase|Adverse Event|0|||
163862243|NCT00771667|591861978|FG002|Maintenance Phase|Adverse Event|0|||
164200546|NCT04265261|593105177|FG002|Overall Study|Withdrawal by Subject|4|||
164200547|NCT07116759|593105178|FG000|Overall Study|Incompatibility with the RHMC device|2|||
164200548|NCT01898078|593106799|FG000|Overall Study|Progressive Disease|1|||
164200549|NCT01898078|593106800|FG001|Overall Study|Progressive Disease|5|||
164200550|NCT01898078|593106799|FG000|Overall Study|Adverse Event|2|||
164200551|NCT01898078|593106800|FG001|Overall Study|Adverse Event|1|||
164200552|NCT01898078|593106799|FG000|Overall Study|Withdrawal by Subject|1|||
164200553|NCT01898078|593106800|FG001|Overall Study|Withdrawal by Subject|1|||
164200554|NCT01898078|593106799|FG000|Overall Study|Symptomatic Deterioration|2|||
164200555|NCT01898078|593106800|FG001|Overall Study|Symptomatic Deterioration|0|||
164200556|NCT01898078|593106799|FG000|Overall Study|Reason not Specified|0|||
164200557|NCT01898078|593106800|FG001|Overall Study|Reason not Specified|1|||
164200558|NCT04635839|593106807|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
164200559|NCT04635839|593106808|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
164200560|NCT02870868|593106809|FG000|Overall Study|Withdrawal by Subject|2|||
164200561|NCT02870868|593106810|FG001|Overall Study|Withdrawal by Subject|1|||
164200562|NCT00499122|593106812|FG000|Overall Study|Withdrawal by Subject|2|||
164200563|NCT00288912|593106813|FG000|Overall Study|Developed exclusion criterion|4|||
164200564|NCT00288912|593106814|FG001|Overall Study|Developed exclusion criterion|6|||
164200565|NCT00288912|593106815|FG002|Overall Study|Developed exclusion criterion|7|||
164200566|NCT00288912|593106813|FG000|Overall Study|Lost to Follow-up|9|||
164200567|NCT00288912|593106814|FG001|Overall Study|Lost to Follow-up|6|||
164200568|NCT00288912|593106815|FG002|Overall Study|Lost to Follow-up|9|||
164200569|NCT00288912|593106813|FG000|Overall Study|Withdrawal by Subject|4|||
164200570|NCT00288912|593106814|FG001|Overall Study|Withdrawal by Subject|5|||
164200571|NCT00288912|593106815|FG002|Overall Study|Withdrawal by Subject|12|||
164200572|NCT03312738|593106816|FG000|Overall Study|Progressive disease|58|||
164200573|NCT03312738|593106817|FG001|Overall Study|Progressive disease|67|||
164200574|NCT03312738|593106816|FG000|Overall Study|Patient/guardian decision|13|||
164200575|NCT03312738|593106817|FG001|Overall Study|Patient/guardian decision|5|||
164200576|NCT03312738|593106816|FG000|Overall Study|Adverse Event|5|||
164200577|NCT03312738|593106817|FG001|Overall Study|Adverse Event|3|||
164200578|NCT03312738|593106816|FG000|Overall Study|Protocol deviation|2|||
163862244|NCT00771667|591861979|FG003|Maintenance Phase|Adverse Event|0|||
163862245|NCT00771667|591861980|FG004|Maintenance Phase|Adverse Event|1|||
163862246|NCT00771667|591861981|FG005|Maintenance Phase|Adverse Event|3|||
163862247|NCT00771667|591861982|FG006|Maintenance Phase|Adverse Event|5|||
163862248|NCT00771667|591861983|FG007|Maintenance Phase|Adverse Event|1|||
163862249|NCT00771667|591861984|FG008|Maintenance Phase|Adverse Event|8|||
163862250|NCT00771667|591861985|FG009|Maintenance Phase|Adverse Event|7|||
163862251|NCT00771667|591861976|FG000|Maintenance Phase|Lack of Efficacy|0|||
163862252|NCT00771667|591861977|FG001|Maintenance Phase|Lack of Efficacy|0|||
163862253|NCT00771667|591861978|FG002|Maintenance Phase|Lack of Efficacy|0|||
164200579|NCT03312738|593106817|FG001|Overall Study|Protocol deviation|0|||
164200580|NCT03312738|593106816|FG000|Overall Study|Technical problems|0|||
164200581|NCT03312738|593106817|FG001|Overall Study|Technical problems|1|||
164200582|NCT03312738|593106816|FG000|Overall Study|Physician Decision|2|||
164309223|NCT00478023|593506621|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
164309224|NCT00478023|593506622|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
164309225|NCT01026324|593506626|FG000|Follow up/Survival|Withdrawal by Subject|1|||
164309226|NCT01026324|593506627|FG001|Follow up/Survival|Withdrawal by Subject|0|||
164309227|NCT01026324|593506628|FG002|Follow up/Survival|Withdrawal by Subject|0|||
164309228|NCT05340478|593506637|FG000|Overall Study|Scheduling Issues|10|||
164309229|NCT05340478|593506638|FG001|Overall Study|Scheduling Issues|4|||
164309230|NCT05340478|593506637|FG000|Overall Study|Neither member of dyad started treatment|2|||
164309231|NCT05340478|593506638|FG001|Overall Study|Neither member of dyad started treatment|2|||
164309232|NCT05340478|593506637|FG000|Overall Study|Withdrawn from study|2|||
164309233|NCT05340478|593506638|FG001|Overall Study|Withdrawn from study|2|||
164309234|NCT05340478|593506637|FG000|Overall Study|Lost to Follow-up|1|||
164309235|NCT05340478|593506638|FG001|Overall Study|Lost to Follow-up|4|||
164309236|NCT01032889|593506641|FG000|Overall Study|Adverse Event|2|||
164309237|NCT01032889|593506642|FG001|Overall Study|Adverse Event|2|||
164309238|NCT01032889|593506643|FG002|Overall Study|Adverse Event|0|||
164309239|NCT01032889|593506641|FG000|Overall Study|Withdrawal of Consent|1|||
164309240|NCT01032889|593506642|FG001|Overall Study|Withdrawal of Consent|2|||
164309241|NCT01032889|593506643|FG002|Overall Study|Withdrawal of Consent|1|||
164309242|NCT01032889|593506641|FG000|Overall Study|Patient Request|0|||
164309243|NCT01032889|593506642|FG001|Overall Study|Patient Request|1|||
164309244|NCT01032889|593506643|FG002|Overall Study|Patient Request|0|||
164309245|NCT01032889|593506641|FG000|Overall Study|Lost to Follow-up|1|||
164309246|NCT01032889|593506642|FG001|Overall Study|Lost to Follow-up|1|||
164309247|NCT01032889|593506643|FG002|Overall Study|Lost to Follow-up|0|||
164309248|NCT01032889|593506641|FG000|Overall Study|Lack of Submental Fat|2|||
164309249|NCT01032889|593506642|FG001|Overall Study|Lack of Submental Fat|8|||
164309250|NCT01032889|593506643|FG002|Overall Study|Lack of Submental Fat|1|||
164309251|NCT01032889|593506641|FG000|Overall Study|Miscellaneous Reasons|2|||
164309252|NCT01032889|593506642|FG001|Overall Study|Miscellaneous Reasons|1|||
164309253|NCT01032889|593506643|FG002|Overall Study|Miscellaneous Reasons|1|||
164309254|NCT01500720|593506644|FG000|Overall Study|Randomized But Not Treated|1|||
164309255|NCT01500720|593506645|FG001|Overall Study|Randomized But Not Treated|1|||
164309256|NCT01500720|593506644|FG000|Overall Study|Other|4|||
164309257|NCT01500720|593506645|FG001|Overall Study|Other|8|||
164309258|NCT02624986|593506646|FG000|Overall Study|Death|0|||
164309259|NCT02624986|593506647|FG001|Overall Study|Death|1|||
164309260|NCT02624986|593506648|FG002|Overall Study|Death|2|||
164309261|NCT02624986|593506649|FG003|Overall Study|Death|2|||
164309262|NCT02624986|593506650|FG004|Overall Study|Death|2|||
164309263|NCT02624986|593506651|FG005|Overall Study|Death|0|||
164309264|NCT02624986|593506652|FG006|Overall Study|Death|0|||
164309265|NCT02624986|593506653|FG007|Overall Study|Death|1|||
164309266|NCT02624986|593506646|FG000|Overall Study|Study Terminated by Sponsor|1|||
164309267|NCT02624986|593506647|FG001|Overall Study|Study Terminated by Sponsor|1|||
164309268|NCT02624986|593506648|FG002|Overall Study|Study Terminated by Sponsor|0|||
164309269|NCT02624986|593506649|FG003|Overall Study|Study Terminated by Sponsor|1|||
164309270|NCT02624986|593506650|FG004|Overall Study|Study Terminated by Sponsor|2|||
164309271|NCT02624986|593506651|FG005|Overall Study|Study Terminated by Sponsor|2|||
164309272|NCT02624986|593506652|FG006|Overall Study|Study Terminated by Sponsor|4|||
164309273|NCT02624986|593506653|FG007|Overall Study|Study Terminated by Sponsor|3|||
164309274|NCT02624986|593506646|FG000|Overall Study|Progressive Disease|0|||
164309275|NCT02624986|593506647|FG001|Overall Study|Progressive Disease|1|||
164309276|NCT02624986|593506648|FG002|Overall Study|Progressive Disease|0|||
164309277|NCT02624986|593506649|FG003|Overall Study|Progressive Disease|0|||
164309278|NCT02624986|593506650|FG004|Overall Study|Progressive Disease|0|||
164309279|NCT02624986|593506651|FG005|Overall Study|Progressive Disease|0|||
164309280|NCT02624986|593506652|FG006|Overall Study|Progressive Disease|0|||
164309281|NCT02624986|593506653|FG007|Overall Study|Progressive Disease|0|||
163967669|NCT00375219|592254253|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
164309282|NCT02624986|593506646|FG000|Overall Study|Protocol Violation|1|||
164309283|NCT02624986|593506647|FG001|Overall Study|Protocol Violation|0|||
164309284|NCT02624986|593506648|FG002|Overall Study|Protocol Violation|0|||
164309285|NCT02624986|593506649|FG003|Overall Study|Protocol Violation|0|||
164309286|NCT02624986|593506650|FG004|Overall Study|Protocol Violation|0|||
164309287|NCT02624986|593506651|FG005|Overall Study|Protocol Violation|0|||
164309288|NCT02624986|593506652|FG006|Overall Study|Protocol Violation|0|||
164309289|NCT02624986|593506653|FG007|Overall Study|Protocol Violation|0|||
164309290|NCT02624986|593506646|FG000|Overall Study|Withdrawal by Subject|0|||
164135137|NCT03954834|592859086|FG002|Overall Study|Protocol Violation|0|||
164309291|NCT02624986|593506647|FG001|Overall Study|Withdrawal by Subject|0|||
164309292|NCT02624986|593506648|FG002|Overall Study|Withdrawal by Subject|0|||
164309293|NCT02624986|593506649|FG003|Overall Study|Withdrawal by Subject|0|||
164309294|NCT02624986|593506650|FG004|Overall Study|Withdrawal by Subject|0|||
164309295|NCT02624986|593506651|FG005|Overall Study|Withdrawal by Subject|0|||
164309296|NCT02624986|593506652|FG006|Overall Study|Withdrawal by Subject|0|||
164309297|NCT02624986|593506653|FG007|Overall Study|Withdrawal by Subject|1|||
164309298|NCT03532451|593506655|FG000|Overall Study|Withdrawal by Subject|0|||
164309299|NCT03532451|593506656|FG001|Overall Study|Withdrawal by Subject|1|||
164309300|NCT03532451|593506655|FG000|Overall Study|Did not undergo surgery|1|||
164309301|NCT03532451|593506656|FG001|Overall Study|Did not undergo surgery|1|||
164309302|NCT02116205|593506657|FG000|Overall Study|Withdrawal by Subject|2|||
164309303|NCT02116205|593506658|FG001|Overall Study|Withdrawal by Subject|4|||
164309304|NCT02116205|593506659|FG002|Overall Study|Withdrawal by Subject|1|||
164309305|NCT02116205|593506660|FG003|Overall Study|Withdrawal by Subject|3|||
164309306|NCT02116205|593506657|FG000|Overall Study|Lost to Follow-up|0|||
164309307|NCT02116205|593506658|FG001|Overall Study|Lost to Follow-up|2|||
164309308|NCT02116205|593506659|FG002|Overall Study|Lost to Follow-up|1|||
164309309|NCT02116205|593506660|FG003|Overall Study|Lost to Follow-up|2|||
164309310|NCT02116205|593506657|FG000|Overall Study|Physician Decision|0|||
164309311|NCT02116205|593506658|FG001|Overall Study|Physician Decision|1|||
164309312|NCT02116205|593506659|FG002|Overall Study|Physician Decision|1|||
164309313|NCT02116205|593506660|FG003|Overall Study|Physician Decision|1|||
164309314|NCT02116205|593506657|FG000|Overall Study|Exclusion criteria|0|||
164309315|NCT02116205|593506658|FG001|Overall Study|Exclusion criteria|0|||
164309316|NCT02116205|593506659|FG002|Overall Study|Exclusion criteria|1|||
164309317|NCT02116205|593506660|FG003|Overall Study|Exclusion criteria|0|||
164309318|NCT00525161|593506663|FG000|Overall Study|Adverse Event|1|||
164309319|NCT01076361|593506664|FG000|Overall Study|22 leads were excluded from analysis|21|||
164309320|NCT00630838|593506674|FG000|Overall Study|Death|0|||
164309321|NCT00630838|593506675|FG001|Overall Study|Death|1|||
164309322|NCT00630838|593506674|FG000|Overall Study|Lost to Follow-up|0|||
164309323|NCT00630838|593506675|FG001|Overall Study|Lost to Follow-up|1|||
164309324|NCT00928408|593506676|FG000|Overall Study|Other|2|||
164309325|NCT00928408|593506676|FG000|Overall Study|Withdrawal by Subject|4|||
164309326|NCT00928408|593506676|FG000|Overall Study|Death|5|||
164309327|NCT00928408|593506676|FG000|Overall Study|Lost to Follow-up|12|||
164309328|NCT00256997|593506681|FG000|Overall Study|Protocol Violation|1|||
164309329|NCT00256997|593506682|FG001|Overall Study|Protocol Violation|4|||
164309330|NCT00256997|593506681|FG000|Overall Study|Lack of Efficacy|1|||
164309331|NCT00256997|593506682|FG001|Overall Study|Lack of Efficacy|4|||
164309332|NCT00256997|593506681|FG000|Overall Study|Death|2|||
164309333|NCT00256997|593506682|FG001|Overall Study|Death|0|||
164309334|NCT00256997|593506681|FG000|Overall Study|Adverse Event|4|||
164309335|NCT00256997|593506682|FG001|Overall Study|Adverse Event|0|||
164309336|NCT00256997|593506681|FG000|Overall Study|Lost to Follow-up|3|||
164309337|NCT00256997|593506682|FG001|Overall Study|Lost to Follow-up|5|||
164309338|NCT00256997|593506681|FG000|Overall Study|Withdrawal by Subject|13|||
164309339|NCT00256997|593506682|FG001|Overall Study|Withdrawal by Subject|3|||
164309340|NCT00256997|593506681|FG000|Overall Study|Started but not treated|2|||
164309341|NCT00256997|593506682|FG001|Overall Study|Started but not treated|0|||
163967670|NCT00375219|592254254|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
163967671|NCT00375219|592254255|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
163967672|NCT00375219|592254253|FG000|Overall Study|Lost to Follow-up|1|||
163967673|NCT00375219|592254254|FG001|Overall Study|Lost to Follow-up|1|||
163967674|NCT00375219|592254255|FG002|Overall Study|Lost to Follow-up|0|||
163967675|NCT00375219|592254253|FG000|Overall Study|Disease progression|18|||
163967676|NCT00375219|592254254|FG001|Overall Study|Disease progression|9|||
163967677|NCT00375219|592254255|FG002|Overall Study|Disease progression|12|||
163967678|NCT00375219|592254253|FG000|Overall Study|Death|4|||
163967679|NCT00375219|592254254|FG001|Overall Study|Death|3|||
163967680|NCT00375219|592254255|FG002|Overall Study|Death|7|||
163967681|NCT00375219|592254253|FG000|Overall Study|Hematologic resistance|1|||
163967682|NCT00375219|592254254|FG001|Overall Study|Hematologic resistance|0|||
163967683|NCT00375219|592254255|FG002|Overall Study|Hematologic resistance|0|||
163967684|NCT00375219|592254253|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
163967685|NCT00375219|592254254|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
163967686|NCT00375219|592254255|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
163967687|NCT00375219|592254253|FG000|Overall Study|Allograft|2|||
163967688|NCT00375219|592254254|FG001|Overall Study|Allograft|0|||
164309342|NCT00256997|593506681|FG000|Overall Study|Other|5|||
164309343|NCT00256997|593506682|FG001|Overall Study|Other|8|||
163967689|NCT00375219|592254255|FG002|Overall Study|Allograft|0|||
164309344|NCT00256997|593506681|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
164309345|NCT00256997|593506682|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
163967690|NCT00375219|592254253|FG000|Overall Study|Cord blood transplantation|1|||
163967691|NCT00375219|592254254|FG001|Overall Study|Cord blood transplantation|0|||
163967692|NCT00375219|592254255|FG002|Overall Study|Cord blood transplantation|0|||
164309346|NCT00256997|593506681|FG000|Overall Study|Participant Non-compliant|3|||
164309347|NCT00256997|593506682|FG001|Overall Study|Participant Non-compliant|6|||
164309348|NCT00256997|593506681|FG000|Overall Study|Investigator Withdrew Participant|2|||
164309349|NCT00256997|593506682|FG001|Overall Study|Investigator Withdrew Participant|1|||
164309350|NCT04672655|593506687|FG000|Overall Study|Lost to Follow-up|12|||
164309351|NCT04672655|593506688|FG001|Overall Study|Lost to Follow-up|17|||
164309352|NCT04672655|593506687|FG000|Overall Study|Withdrawal by Subject|1|||
164309353|NCT04672655|593506688|FG001|Overall Study|Withdrawal by Subject|0|||
164309354|NCT04672655|593506687|FG000|Overall Study|Withdrawal by Study|1|||
164309355|NCT04672655|593506688|FG001|Overall Study|Withdrawal by Study|0|||
164309356|NCT01326104|593506689|FG000|Overall Study|progressed prior to vaccine|0|||
164309357|NCT01326104|593506690|FG001|Overall Study|progressed prior to vaccine|2|||
164309358|NCT01326104|593506689|FG000|Overall Study|unable to make vaccine|0|||
164309359|NCT01326104|593506690|FG001|Overall Study|unable to make vaccine|2|||
164309360|NCT01287741|593506691|FG000|Overall Study|Withdrawal by Subject|35|||
164309361|NCT01287741|593506692|FG001|Overall Study|Withdrawal by Subject|38|||
164309362|NCT01287741|593506691|FG000|Overall Study|Protocol Violation|2|||
164309363|NCT01287741|593506692|FG001|Overall Study|Protocol Violation|0|||
164309364|NCT01287741|593506691|FG000|Overall Study|Physician Decision|15|||
164309365|NCT01287741|593506692|FG001|Overall Study|Physician Decision|23|||
164309366|NCT01287741|593506691|FG000|Overall Study|Non-compliance|8|||
164309367|NCT01287741|593506692|FG001|Overall Study|Non-compliance|6|||
164309368|NCT01287741|593506691|FG000|Overall Study|Lost to Follow-up|10|||
164309369|NCT01287741|593506692|FG001|Overall Study|Lost to Follow-up|8|||
164309370|NCT01287741|593506691|FG000|Overall Study|Death|32|||
164309371|NCT01287741|593506692|FG001|Overall Study|Death|44|||
164309372|NCT01287741|593506691|FG000|Overall Study|Adverse Event|4|||
164309373|NCT01287741|593506692|FG001|Overall Study|Adverse Event|6|||
164309374|NCT01287741|593506691|FG000|Overall Study|Study terminated by Sponsor|307|||
164309375|NCT01287741|593506692|FG001|Overall Study|Study terminated by Sponsor|315|||
164309376|NCT01287741|593506691|FG000|Overall Study|Progressive disease|190|||
164309377|NCT01287741|593506692|FG001|Overall Study|Progressive disease|166|||
164309378|NCT01287741|593506691|FG000|Overall Study|Reason not specified|23|||
164309379|NCT01287741|593506692|FG001|Overall Study|Reason not specified|9|||
164309380|NCT02930018|593506693|FG000|Overall Study|Lost to Follow-up|1|||
164309381|NCT02930018|593506694|FG001|Overall Study|Lost to Follow-up|1|||
164309382|NCT02930018|593506693|FG000|Overall Study|Withdrawal by Subject|5|||
164309383|NCT02930018|593506694|FG001|Overall Study|Withdrawal by Subject|2|||
164309384|NCT01256294|593508069|FG000|Overall Study|Adverse Event|1|||
164309385|NCT01256294|593508070|FG001|Overall Study|Adverse Event|0|||
164309386|NCT01256294|593508069|FG000|Overall Study|Withdrawal by Subject|1|||
164309387|NCT01256294|593508070|FG001|Overall Study|Withdrawal by Subject|1|||
164309388|NCT01256294|593508069|FG000|Overall Study|Protocol deviation|2|||
164309389|NCT01256294|593508070|FG001|Overall Study|Protocol deviation|1|||
164309390|NCT04681352|593508071|FG000|Overall Study|Lost to Follow-up|2|||
164309391|NCT04681352|593508071|FG000|Overall Study|Withdrawal by Subject|22|||
164309392|NCT01675544|593508074|FG000|Overall Study|Withdrawal by Subject|2|||
164309393|NCT02600819|593508075|FG000|GEN Phase|Adverse Event|2|||
164309394|NCT02600819|593508076|FG001|GEN Phase|Adverse Event|0|||
164309395|NCT02600819|593508075|FG000|GEN Phase|Death|2|||
164309396|NCT02600819|593508076|FG001|GEN Phase|Death|0|||
164309397|NCT02600819|593508075|FG000|GEN Phase|Investigator's Discretion|4|||
164309398|NCT02600819|593508076|FG001|GEN Phase|Investigator's Discretion|0|||
164309399|NCT02600819|593508075|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
164309400|NCT02600819|593508076|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
164309401|NCT02600819|593508075|FG000|GEN Phase|Withdrew Consent|5|||
164309402|NCT02600819|593508076|FG001|GEN Phase|Withdrew Consent|0|||
164309403|NCT02600819|593508075|FG000|GEN Phase|Lost to Follow-up|2|||
164309404|NCT02600819|593508076|FG001|GEN Phase|Lost to Follow-up|0|||
164309405|NCT01621802|593508078|FG000|Overall Study|Protocol Violation|0|||
164309406|NCT01621802|593508079|FG001|Overall Study|Protocol Violation|0|||
164309407|NCT01621802|593508080|FG002|Overall Study|Protocol Violation|0|||
164309408|NCT01621802|593508081|FG003|Overall Study|Protocol Violation|0|||
163862254|NCT00771667|591861979|FG003|Maintenance Phase|Lack of Efficacy|0|||
163862255|NCT00771667|591861980|FG004|Maintenance Phase|Lack of Efficacy|1|||
163862256|NCT00771667|591861981|FG005|Maintenance Phase|Lack of Efficacy|3|||
163862257|NCT00771667|591861982|FG006|Maintenance Phase|Lack of Efficacy|3|||
163862258|NCT00771667|591861983|FG007|Maintenance Phase|Lack of Efficacy|2|||
163862259|NCT00771667|591861984|FG008|Maintenance Phase|Lack of Efficacy|11|||
163862260|NCT00771667|591861985|FG009|Maintenance Phase|Lack of Efficacy|7|||
163862261|NCT00771667|591861976|FG000|Maintenance Phase|Other|0|||
163862262|NCT00771667|591861977|FG001|Maintenance Phase|Other|0|||
163862263|NCT00771667|591861978|FG002|Maintenance Phase|Other|0|||
163862264|NCT00771667|591861979|FG003|Maintenance Phase|Other|0|||
163862265|NCT00771667|591861980|FG004|Maintenance Phase|Other|0|||
163862266|NCT00771667|591861981|FG005|Maintenance Phase|Other|1|||
163862267|NCT00771667|591861982|FG006|Maintenance Phase|Other|2|||
164309409|NCT01621802|593508082|FG004|Overall Study|Protocol Violation|0|||
164309410|NCT01621802|593508083|FG005|Overall Study|Protocol Violation|1|||
164309411|NCT01621802|593508078|FG000|Overall Study|Withdrawal by Subject|8|||
164309412|NCT01621802|593508079|FG001|Overall Study|Withdrawal by Subject|4|||
164309413|NCT01621802|593508080|FG002|Overall Study|Withdrawal by Subject|4|||
164309414|NCT01621802|593508081|FG003|Overall Study|Withdrawal by Subject|2|||
164309415|NCT01621802|593508082|FG004|Overall Study|Withdrawal by Subject|2|||
164309416|NCT01621802|593508083|FG005|Overall Study|Withdrawal by Subject|0|||
164309417|NCT01621802|593508078|FG000|Overall Study|Migrated/moved from study area|0|||
164309418|NCT01621802|593508079|FG001|Overall Study|Migrated/moved from study area|0|||
164200583|NCT03312738|593106817|FG001|Overall Study|Physician Decision|3|||
164200584|NCT02466399|593106824|FG000|Overall Study|Adverse Event|1|||
164200585|NCT02466399|593106825|FG001|Overall Study|Adverse Event|0|||
164200586|NCT02466399|593106824|FG000|Overall Study|Early exit due to family emergency|1|||
164200587|NCT02466399|593106825|FG001|Overall Study|Early exit due to family emergency|0|||
164200588|NCT00607893|593106830|FG000|Overall Study|Lost to Follow-up|4|||
164200589|NCT00607893|593106831|FG001|Overall Study|Lost to Follow-up|0|||
164200590|NCT00607893|593106830|FG000|Overall Study|withdrew due to loss of interest|0|||
164200591|NCT00607893|593106831|FG001|Overall Study|withdrew due to loss of interest|1|||
164200592|NCT00607893|593106830|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
164200593|NCT00607893|593106831|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
164200594|NCT00607893|593106830|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
164200595|NCT00607893|593106831|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
164200596|NCT00607893|593106830|FG000|Overall Study|Declined to be treated|1|||
164200597|NCT00607893|593106831|FG001|Overall Study|Declined to be treated|0|||
164200598|NCT00607893|593106830|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
164200599|NCT00607893|593106831|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
164200600|NCT02669849|593106832|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164200601|NCT02669849|593106833|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164200602|NCT02669849|593106834|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
164200603|NCT02669849|593106832|FG000|Overall Study|Lost to Follow-up|1|||
164200604|NCT02669849|593106833|FG001|Overall Study|Lost to Follow-up|0|||
164200605|NCT02669849|593106834|FG002|Overall Study|Lost to Follow-up|3|||
164200606|NCT02669849|593106832|FG000|Overall Study|Death|1|||
164200607|NCT02669849|593106833|FG001|Overall Study|Death|1|||
164200608|NCT02669849|593106834|FG002|Overall Study|Death|2|||
164200609|NCT02669849|593106832|FG000|Overall Study|Study terminated by sponsor|16|||
164200610|NCT02669849|593106833|FG001|Overall Study|Study terminated by sponsor|1|||
164200611|NCT02669849|593106834|FG002|Overall Study|Study terminated by sponsor|14|||
164200612|NCT02669849|593106832|FG000|Overall Study|Other|0|||
163862268|NCT00771667|591861983|FG007|Maintenance Phase|Other|2|||
163862269|NCT00771667|591861984|FG008|Maintenance Phase|Other|3|||
163862270|NCT00771667|591861985|FG009|Maintenance Phase|Other|3|||
163862271|NCT01897233|591861986|FG000|Part B (24 Weeks)|Adverse Event|1|||
163862272|NCT01897233|591861986|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
163862273|NCT01897233|591861986|FG000|Part B (24 Weeks)|Physician Decision|1|||
163862274|NCT00628862|591861991|FG000|Overall Study|Adverse Event|6|||
163862275|NCT00628862|591861992|FG001|Overall Study|Adverse Event|8|||
163862276|NCT00628862|591861993|FG002|Overall Study|Adverse Event|10|||
163862277|NCT00628862|591861991|FG000|Overall Study|Withdrawal by Subject|4|||
163862278|NCT00628862|591861992|FG001|Overall Study|Withdrawal by Subject|6|||
163862279|NCT00628862|591861993|FG002|Overall Study|Withdrawal by Subject|11|||
163862280|NCT00628862|591861991|FG000|Overall Study|Lost to Follow-up|0|||
163862281|NCT00628862|591861992|FG001|Overall Study|Lost to Follow-up|2|||
163862282|NCT00628862|591861993|FG002|Overall Study|Lost to Follow-up|1|||
163862283|NCT00628862|591861991|FG000|Overall Study|Protocol Violation|1|||
163862284|NCT00628862|591861992|FG001|Overall Study|Protocol Violation|0|||
163862285|NCT00628862|591861993|FG002|Overall Study|Protocol Violation|0|||
163862286|NCT00628862|591861991|FG000|Overall Study|COPD Exacerbation|0|||
163862287|NCT00628862|591861992|FG001|Overall Study|COPD Exacerbation|1|||
163862288|NCT00628862|591861993|FG002|Overall Study|COPD Exacerbation|0|||
163862289|NCT02814643|591861994|FG000|Overall Study|Lost to Follow-up|0|||
163862290|NCT02814643|591861995|FG001|Overall Study|Lost to Follow-up|1|||
163862291|NCT02814643|591861994|FG000|Overall Study|Withdrawal by Subject|1|||
163862292|NCT02814643|591861995|FG001|Overall Study|Withdrawal by Subject|2|||
163862293|NCT01883492|591861999|FG000|Overall Study|Lost to Follow-up|3|||
163862294|NCT01883492|591862000|FG001|Overall Study|Lost to Follow-up|4|||
163862295|NCT01883492|591861999|FG000|Overall Study|Surgery on contra-lateral hip|0|||
163862296|NCT01883492|591862000|FG001|Overall Study|Surgery on contra-lateral hip|1|||
163862297|NCT01883492|591861999|FG000|Overall Study|Poor X-ray quality|7|||
163862298|NCT01883492|591862000|FG001|Overall Study|Poor X-ray quality|4|||
163862299|NCT01883492|591861999|FG000|Overall Study|Withdrawal by Subject|1|||
163862300|NCT01883492|591862000|FG001|Overall Study|Withdrawal by Subject|0|||
163967693|NCT00375219|592254253|FG000|Overall Study|Withdrawal by Subject|1|||
164200613|NCT02669849|593106833|FG001|Overall Study|Other|0|||
164200614|NCT02669849|593106834|FG002|Overall Study|Other|2|||
164200615|NCT00606008|593106835|FG000|Overall Study|Adverse Event|1|||
164200616|NCT00606008|593106835|FG000|Overall Study|Withdrawal by Subject|4|||
164200617|NCT03736967|593106836|FG000|Overall Study|Withdrawal by Subject|26|||
164309419|NCT01621802|593508080|FG002|Overall Study|Migrated/moved from study area|2|||
163862301|NCT01883492|591861999|FG000|Overall Study|inappropriate implant used|1|||
163862302|NCT01883492|591862000|FG001|Overall Study|inappropriate implant used|1|||
163862303|NCT01883492|591861999|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
163862304|NCT01883492|591862000|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
163862305|NCT02192606|591862011|FG000|Overall Study|surgery type was changed|1|||
163862306|NCT02192606|591862012|FG001|Overall Study|surgery type was changed|1|||
164309420|NCT01621802|593508081|FG003|Overall Study|Migrated/moved from study area|0|||
164309421|NCT01621802|593508082|FG004|Overall Study|Migrated/moved from study area|1|||
164309422|NCT01621802|593508083|FG005|Overall Study|Migrated/moved from study area|0|||
164309423|NCT01621802|593508078|FG000|Overall Study|Others|3|||
164309424|NCT01621802|593508079|FG001|Overall Study|Others|3|||
164309425|NCT01621802|593508080|FG002|Overall Study|Others|3|||
164309426|NCT01621802|593508081|FG003|Overall Study|Others|2|||
164309427|NCT01621802|593508082|FG004|Overall Study|Others|1|||
164309428|NCT01621802|593508083|FG005|Overall Study|Others|0|||
164309429|NCT01621802|593508078|FG000|Overall Study|Lost to Follow-up|36|||
164309430|NCT01621802|593508079|FG001|Overall Study|Lost to Follow-up|16|||
164309431|NCT01621802|593508080|FG002|Overall Study|Lost to Follow-up|24|||
164309432|NCT01621802|593508081|FG003|Overall Study|Lost to Follow-up|7|||
163862307|NCT02192606|591862011|FG000|Overall Study|Physician Decision|1|||
163862308|NCT02192606|591862012|FG001|Overall Study|Physician Decision|2|||
163862309|NCT02192606|591862011|FG000|Overall Study|3D equipment rep unable to join|0|||
163862310|NCT02192606|591862012|FG001|Overall Study|3D equipment rep unable to join|1|||
163862311|NCT00549848|591862013|FG000|Overall Study|Death|1|||
163862312|NCT00549848|591862014|FG001|Overall Study|Death|4|||
163862313|NCT00549848|591862015|FG002|Overall Study|Death|13|||
163862314|NCT00549848|591862013|FG000|Overall Study|Physician Decision|0|||
163862315|NCT00549848|591862014|FG001|Overall Study|Physician Decision|0|||
163862316|NCT00549848|591862015|FG002|Overall Study|Physician Decision|4|||
163862317|NCT00549848|591862013|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
163862318|NCT00549848|591862014|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
163862319|NCT00549848|591862015|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
163862320|NCT00549848|591862013|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
163862321|NCT00549848|591862014|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
163862322|NCT00549848|591862015|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
163862323|NCT00549848|591862013|FG000|Overall Study|Participant/Family Withdraw|2|||
163862324|NCT00549848|591862014|FG001|Overall Study|Participant/Family Withdraw|3|||
163862325|NCT00549848|591862015|FG002|Overall Study|Participant/Family Withdraw|5|||
163862326|NCT00549848|591862013|FG000|Overall Study|Second Malignancy|1|||
163862327|NCT00549848|591862014|FG001|Overall Study|Second Malignancy|0|||
163862328|NCT00549848|591862015|FG002|Overall Study|Second Malignancy|0|||
163862329|NCT00549848|591862013|FG000|Overall Study|Transplant|3|||
163862330|NCT00549848|591862014|FG001|Overall Study|Transplant|3|||
163862331|NCT00549848|591862015|FG002|Overall Study|Transplant|18|||
163862332|NCT00549848|591862013|FG000|Overall Study|Unacceptable Toxicity|1|||
163862333|NCT00549848|591862014|FG001|Overall Study|Unacceptable Toxicity|6|||
163862334|NCT00549848|591862015|FG002|Overall Study|Unacceptable Toxicity|6|||
163862335|NCT03673124|591862016|FG000|Overall Study|Eligible with no protocol therapy|2|||
163862336|NCT00957658|591862017|FG000|Overall Study|Death|1|||
163862337|NCT00957658|591862017|FG000|Overall Study|Lost to Follow-up|4|||
163862338|NCT00957658|591862017|FG000|Overall Study|Withdrawal by Subject|12|||
163862339|NCT00957658|591862017|FG000|Overall Study|Revision|1|||
163862340|NCT00957658|591862017|FG000|Overall Study|Incomplete 2 yr data|28|||
163862341|NCT00957658|591862017|FG000|Overall Study|Site termination|10|||
163862342|NCT00957658|591862017|FG000|Overall Study|unwilling/unable to return|2|||
163862343|NCT00957658|591862017|FG000|Overall Study|surgery cancelled|2|||
163862344|NCT00957658|591862017|FG000|Overall Study|Protocol Violation|5|||
163862345|NCT03383887|591862018|FG000|Overall Study|Lost to Follow-up|0|||
163862346|NCT03383887|591862019|FG001|Overall Study|Lost to Follow-up|1|||
163862347|NCT00975806|591862026|FG000|Overall Study|Adverse Event|2|||
163862348|NCT00975806|591862027|FG001|Overall Study|Adverse Event|1|||
163862349|NCT00975806|591862028|FG002|Overall Study|Adverse Event|2|||
163862350|NCT00975806|591862026|FG000|Overall Study|Disease Progression|1|||
163862351|NCT00975806|591862027|FG001|Overall Study|Disease Progression|5|||
163862352|NCT00975806|591862028|FG002|Overall Study|Disease Progression|1|||
163862353|NCT00975806|591862026|FG000|Overall Study|Withdrawal by Subject|1|||
164309433|NCT01621802|593508082|FG004|Overall Study|Lost to Follow-up|31|||
164309434|NCT01621802|593508083|FG005|Overall Study|Lost to Follow-up|11|||
164309435|NCT01149148|593508084|FG000|Overall Study|Lost to Follow-up|1|||
163862354|NCT00975806|591862027|FG001|Overall Study|Withdrawal by Subject|0|||
163862355|NCT00975806|591862028|FG002|Overall Study|Withdrawal by Subject|0|||
163967694|NCT00375219|592254254|FG001|Overall Study|Withdrawal by Subject|0|||
164309436|NCT01149148|593508085|FG001|Overall Study|Lost to Follow-up|2|||
164309437|NCT01149148|593508084|FG000|Overall Study|Death|1|||
164309438|NCT01149148|593508085|FG001|Overall Study|Death|0|||
164309439|NCT04605991|593508087|FG000|Overall Study|Adverse Event|5|||
163862356|NCT00975806|591862026|FG000|Overall Study|Death|0|||
163862357|NCT00975806|591862027|FG001|Overall Study|Death|1|||
163862358|NCT00975806|591862028|FG002|Overall Study|Death|0|||
163862359|NCT00975806|591862026|FG000|Overall Study|Physician decision and disease related|1|||
163862360|NCT00975806|591862027|FG001|Overall Study|Physician decision and disease related|0|||
163862361|NCT00975806|591862028|FG002|Overall Study|Physician decision and disease related|1|||
163862362|NCT01806714|591862031|FG000|Overall Study|No functioning phone number|200|||
163862363|NCT01806714|591862032|FG001|Overall Study|No functioning phone number|170|||
164135138|NCT03954834|592859087|FG003|Overall Study|Protocol Violation|1|||
164135139|NCT03954834|592859084|FG000|Overall Study|Withdrawal by Subject|2|||
164135140|NCT03954834|592859085|FG001|Overall Study|Withdrawal by Subject|3|||
164135141|NCT03954834|592859086|FG002|Overall Study|Withdrawal by Subject|13|||
164135142|NCT03954834|592859087|FG003|Overall Study|Withdrawal by Subject|6|||
164135143|NCT03954834|592859084|FG000|Overall Study|Participant left the country|0|||
164135144|NCT03954834|592859085|FG001|Overall Study|Participant left the country|0|||
164135145|NCT03954834|592859086|FG002|Overall Study|Participant left the country|1|||
164135146|NCT03954834|592859087|FG003|Overall Study|Participant left the country|0|||
164135147|NCT03954834|592859084|FG000|Overall Study|Lost to Follow-up|3|||
164135148|NCT03954834|592859085|FG001|Overall Study|Lost to Follow-up|2|||
164135149|NCT03954834|592859086|FG002|Overall Study|Lost to Follow-up|3|||
164135150|NCT03954834|592859087|FG003|Overall Study|Lost to Follow-up|5|||
164135151|NCT03469336|592859088|FG000|Overall Study|Adverse Event|1|||
164135152|NCT02603393|592859091|FG000|Overall Study|Patient/guardian decision|32|||
164135153|NCT02603393|592859092|FG001|Overall Study|Patient/guardian decision|18|||
164135154|NCT02603393|592859091|FG000|Overall Study|Adverse Event|17|||
164135155|NCT02603393|592859092|FG001|Overall Study|Adverse Event|15|||
164135156|NCT02603393|592859091|FG000|Overall Study|Technical problems|4|||
164135157|NCT02603393|592859092|FG001|Overall Study|Technical problems|7|||
164135158|NCT02603393|592859091|FG000|Overall Study|Lack of Efficacy|7|||
164135159|NCT02603393|592859092|FG001|Overall Study|Lack of Efficacy|2|||
164135160|NCT02603393|592859091|FG000|Overall Study|Death|3|||
164135161|NCT02603393|592859092|FG001|Overall Study|Death|4|||
164135162|NCT02603393|592859091|FG000|Overall Study|Physician Decision|3|||
164135163|NCT02603393|592859092|FG001|Overall Study|Physician Decision|3|||
164135164|NCT02603393|592859091|FG000|Overall Study|Protocol deviation|2|||
164135165|NCT02603393|592859092|FG001|Overall Study|Protocol deviation|3|||
164135166|NCT02603393|592859091|FG000|Overall Study|Lost to Follow-up|1|||
164135167|NCT02603393|592859092|FG001|Overall Study|Lost to Follow-up|2|||
164135168|NCT02603393|592859091|FG000|Overall Study|Non-compliance with study treatment|1|||
164135169|NCT02603393|592859092|FG001|Overall Study|Non-compliance with study treatment|0|||
164135170|NCT02603393|592859091|FG000|Overall Study|Sponsor decision|1|||
164135171|NCT02603393|592859092|FG001|Overall Study|Sponsor decision|0|||
164135172|NCT01359969|592859093|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
164143314|NCT05246670|592886588|FG002|Overall Study|Protocol Violation|0|||
164143315|NCT05246670|592886589|FG003|Overall Study|Protocol Violation|0|||
164143316|NCT00356525|592886595|FG000|Overall Study|Progressive Disease|8|||
164143317|NCT00356525|592886596|FG001|Overall Study|Progressive Disease|5|||
164143318|NCT00356525|592886597|FG002|Overall Study|Progressive Disease|4|||
164143319|NCT00356525|592886598|FG003|Overall Study|Progressive Disease|2|||
164143320|NCT00356525|592886595|FG000|Overall Study|Adverse Event|1|||
164143321|NCT00356525|592886596|FG001|Overall Study|Adverse Event|3|||
164143322|NCT00356525|592886597|FG002|Overall Study|Adverse Event|1|||
164143323|NCT00356525|592886598|FG003|Overall Study|Adverse Event|1|||
164143324|NCT00356525|592886595|FG000|Overall Study|Lost to Follow-up|1|||
164143325|NCT00356525|592886596|FG001|Overall Study|Lost to Follow-up|0|||
164143326|NCT00356525|592886597|FG002|Overall Study|Lost to Follow-up|0|||
164143327|NCT00356525|592886598|FG003|Overall Study|Lost to Follow-up|0|||
164143328|NCT00356525|592886595|FG000|Overall Study|Physician Decision|2|||
164143329|NCT00356525|592886596|FG001|Overall Study|Physician Decision|2|||
164143330|NCT00356525|592886597|FG002|Overall Study|Physician Decision|2|||
164143331|NCT00356525|592886598|FG003|Overall Study|Physician Decision|1|||
164143332|NCT00356525|592886595|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
164143333|NCT00356525|592886596|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
164143334|NCT00356525|592886597|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
164143335|NCT00356525|592886598|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
164143336|NCT00356525|592886595|FG000|Overall Study|Withdrawal by Subject|1|||
164143337|NCT00356525|592886596|FG001|Overall Study|Withdrawal by Subject|1|||
164143338|NCT00356525|592886597|FG002|Overall Study|Withdrawal by Subject|0|||
164143339|NCT00356525|592886598|FG003|Overall Study|Withdrawal by Subject|3|||
164143340|NCT00356525|592886595|FG000|Overall Study|Death|0|||
164143341|NCT00356525|592886596|FG001|Overall Study|Death|0|||
164143342|NCT00356525|592886597|FG002|Overall Study|Death|0|||
164143343|NCT00356525|592886598|FG003|Overall Study|Death|1|||
164143344|NCT00356525|592886595|FG000|Overall Study|Sponsor Decision|0|||
164143345|NCT00356525|592886596|FG001|Overall Study|Sponsor Decision|0|||
164143346|NCT00356525|592886597|FG002|Overall Study|Sponsor Decision|0|||
164143347|NCT00356525|592886598|FG003|Overall Study|Sponsor Decision|1|||
164143348|NCT00652340|592886599|FG000|Overall Study|Had not progressed.|4|||
164143349|NCT00652340|592886600|FG001|Overall Study|Had not progressed.|3|||
164143350|NCT04152291|592886601|FG000|Overall Study|Covid-19 restrictions|27|||
164143351|NCT04152291|592886601|FG000|Overall Study|Withdrawal by Subject|3|||
164143352|NCT03597295|592886602|FG000|Overall Study|Death|70|||
164309440|NCT04605991|593508087|FG000|Overall Study|Lack of Efficacy|1|||
164309441|NCT04605991|593508087|FG000|Overall Study|Lost to Follow-up|8|||
164309442|NCT04605991|593508087|FG000|Overall Study|Physician Decision|4|||
164309443|NCT04605991|593508087|FG000|Overall Study|Withdrawal by Subject|14|||
164309444|NCT04605991|593508087|FG000|Overall Study|Non-compliance with study|1|||
164309445|NCT01727024|593508089|FG000|Period 1|Lost to Follow-up|1|||
164309446|NCT01727024|593508090|FG001|Period 1|Lost to Follow-up|1|||
164309447|NCT01727024|593508089|FG000|Period 1|Withdrawal by Subject|2|||
164309448|NCT01727024|593508090|FG001|Period 1|Withdrawal by Subject|3|||
164309449|NCT02920242|593508091|FG000|Overall Study|Withdrawal by Subject|1|||
164309450|NCT02920242|593508092|FG001|Overall Study|Withdrawal by Subject|0|||
164309451|NCT02920242|593508093|FG002|Overall Study|Withdrawal by Subject|1|||
164309452|NCT02920242|593508091|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
164309453|NCT02920242|593508092|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
164309454|NCT02920242|593508093|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
164309455|NCT04995419|593508099|FG000|Overall Study|Withdrawal by Subject|3|||
164309456|NCT04995419|593508099|FG000|Overall Study|Progressive Disease|19|||
164309457|NCT04995419|593508099|FG000|Overall Study|Adverse Event|2|||
164309458|NCT04995419|593508099|FG000|Overall Study|Ongoing|16|||
164309459|NCT02948088|593508100|FG000|Overall Study|Lost to Follow-up|8|||
164309460|NCT02948088|593508100|FG000|Overall Study|Death|1|||
164309461|NCT02948088|593508100|FG000|Overall Study|Withdrawal by Subject|4|||
164309462|NCT02948088|593508100|FG000|Overall Study|Other|2|||
164309463|NCT00634101|593508101|FG000|Overall Study|Study Terminated|3|||
164309464|NCT00634101|593508102|FG001|Overall Study|Study Terminated|3|||
164309465|NCT00634101|593508101|FG000|Overall Study|Lost to Follow-up|2|||
164309466|NCT00634101|593508102|FG001|Overall Study|Lost to Follow-up|0|||
164309467|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
164309468|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
164309469|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
164309470|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
164309471|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
164309472|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
164309473|NCT00139477|593508103|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
164309474|NCT00139477|593508104|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
164309475|NCT00139477|593508103|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
164309476|NCT00139477|593508104|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
164309477|NCT00139477|593508103|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
164309478|NCT00139477|593508104|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
164309479|NCT00139477|593508103|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
164309480|NCT00139477|593508104|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
164309481|NCT00845897|593508105|FG000|Overall Study|Lost to Follow-up|1|||
164309482|NCT00845897|593508106|FG001|Overall Study|Lost to Follow-up|1|||
164309483|NCT00845897|593508107|FG002|Overall Study|Lost to Follow-up|0|||
164309484|NCT00845897|593508105|FG000|Overall Study|Withdrawal by Subject|0|||
164309485|NCT00845897|593508106|FG001|Overall Study|Withdrawal by Subject|3|||
164309486|NCT00845897|593508107|FG002|Overall Study|Withdrawal by Subject|2|||
164309487|NCT00845897|593508105|FG000|Overall Study|Ulcer did not heal|1|||
164309488|NCT00845897|593508106|FG001|Overall Study|Ulcer did not heal|0|||
164309489|NCT00845897|593508107|FG002|Overall Study|Ulcer did not heal|1|||
164309490|NCT00845897|593508105|FG000|Overall Study|Too ill to participate|0|||
164309491|NCT00845897|593508106|FG001|Overall Study|Too ill to participate|1|||
164309492|NCT00845897|593508107|FG002|Overall Study|Too ill to participate|0|||
164309493|NCT02722499|593508109|FG000|Overall Study|Lost to Follow-up|2|||
164309494|NCT02722499|593508110|FG001|Overall Study|Lost to Follow-up|0|||
164309495|NCT02722499|593508111|FG002|Overall Study|Lost to Follow-up|1|||
164309496|NCT04999852|593508112|FG000|Overall Study|Withdrawal by Subject|11|||
164309497|NCT04999852|593508113|FG001|Overall Study|Withdrawal by Subject|1|||
164309498|NCT04999852|593508112|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
163967695|NCT00375219|592254255|FG002|Overall Study|Withdrawal by Subject|0|||
163967696|NCT02684279|592254258|FG000|Overall Study|Adverse Event|87|||
164309499|NCT04999852|593508113|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
164309500|NCT05626322|593508114|FG000|Overall Study|Death|2|||
164309501|NCT05626322|593508115|FG001|Overall Study|Death|0|||
164309502|NCT05626322|593508116|FG002|Overall Study|Death|0|||
164309503|NCT05626322|593508114|FG000|Overall Study|Physician Decision|1|||
163967697|NCT02684279|592254258|FG000|Overall Study|Lack of Efficacy|4|||
164309504|NCT05626322|593508115|FG001|Overall Study|Physician Decision|0|||
164309505|NCT05626322|593508116|FG002|Overall Study|Physician Decision|0|||
164309506|NCT05626322|593508114|FG000|Overall Study|Progressive Disease|0|||
164309507|NCT05626322|593508115|FG001|Overall Study|Progressive Disease|1|||
164309508|NCT05626322|593508116|FG002|Overall Study|Progressive Disease|1|||
163967698|NCT02684279|592254258|FG000|Overall Study|Lost to Follow-up|61|||
163967699|NCT02684279|592254258|FG000|Overall Study|Protocol Violation|6|||
164309509|NCT05626322|593508114|FG000|Overall Study|Study terminated by sponsor|0|||
164309510|NCT05626322|593508115|FG001|Overall Study|Study terminated by sponsor|1|||
164309511|NCT05626322|593508116|FG002|Overall Study|Study terminated by sponsor|0|||
164309512|NCT03776812|593508117|FG000|Overall Study|Death|53|||
164309513|NCT03776812|593508118|FG001|Overall Study|Death|49|||
164309514|NCT03776812|593508119|FG002|Overall Study|Death|56|||
164309515|NCT03776812|593508117|FG000|Overall Study|Withdrawal by Subject|1|||
164309516|NCT03776812|593508118|FG001|Overall Study|Withdrawal by Subject|7|||
164309517|NCT03776812|593508119|FG002|Overall Study|Withdrawal by Subject|2|||
164309518|NCT03776812|593508117|FG000|Overall Study|Lost to Follow-up|1|||
164309519|NCT03776812|593508118|FG001|Overall Study|Lost to Follow-up|1|||
164309520|NCT03776812|593508119|FG002|Overall Study|Lost to Follow-up|0|||
164309521|NCT03776812|593508117|FG000|Overall Study|Did not enter long-term follow-up|3|||
164309522|NCT03776812|593508118|FG001|Overall Study|Did not enter long-term follow-up|3|||
164309523|NCT03776812|593508119|FG002|Overall Study|Did not enter long-term follow-up|2|||
164309524|NCT04758637|593508120|FG000|Overall Study|Lost to Follow-up|0|||
164309525|NCT04758637|593508121|FG001|Overall Study|Lost to Follow-up|1|||
164309526|NCT04758637|593508122|FG002|Overall Study|Lost to Follow-up|0|||
164309527|NCT04758637|593508123|FG003|Overall Study|Lost to Follow-up|0|||
164309528|NCT03610269|593508124|FG000|Overall Study|Physician Decision|10|||
164309529|NCT03610269|593508124|FG000|Overall Study|Protocol Violation|1|||
164309530|NCT03610269|593508124|FG000|Overall Study|Unable to draw blood|1|||
164309531|NCT03610269|593508124|FG000|Overall Study|Screen fail|4|||
164309532|NCT01354314|593508125|FG000|Overall Study|Lost to Follow-up|1|||
164309533|NCT01354314|593508126|FG001|Overall Study|Lost to Follow-up|0|||
164309534|NCT01354314|593508127|FG002|Overall Study|Lost to Follow-up|1|||
164309535|NCT01354314|593508128|FG003|Overall Study|Lost to Follow-up|1|||
164309536|NCT01354314|593508125|FG000|Overall Study|Withdrawal by Subject|0|||
164309537|NCT01354314|593508126|FG001|Overall Study|Withdrawal by Subject|0|||
164309538|NCT01354314|593508127|FG002|Overall Study|Withdrawal by Subject|1|||
164309539|NCT01354314|593508128|FG003|Overall Study|Withdrawal by Subject|0|||
164309540|NCT01354314|593508125|FG000|Overall Study|Adverse Event|0|||
164309541|NCT01354314|593508126|FG001|Overall Study|Adverse Event|0|||
164309542|NCT01354314|593508127|FG002|Overall Study|Adverse Event|0|||
164309543|NCT01354314|593508128|FG003|Overall Study|Adverse Event|1|||
164309544|NCT01354314|593508125|FG000|Overall Study|Protocol Violation|1|||
164309545|NCT01354314|593508126|FG001|Overall Study|Protocol Violation|1|||
164309546|NCT01354314|593508127|FG002|Overall Study|Protocol Violation|0|||
164309547|NCT01354314|593508128|FG003|Overall Study|Protocol Violation|0|||
164309548|NCT01354314|593508125|FG000|Overall Study|Less than 90% Adherence|4|||
164309549|NCT01354314|593508126|FG001|Overall Study|Less than 90% Adherence|2|||
164309550|NCT01354314|593508127|FG002|Overall Study|Less than 90% Adherence|6|||
164309551|NCT01354314|593508128|FG003|Overall Study|Less than 90% Adherence|4|||
164309552|NCT00369265|593508129|FG000|Overall Study|Study terminated|4|||
164309553|NCT00369265|593508130|FG001|Overall Study|Study terminated|7|||
164309554|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
164309555|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
164309556|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
164309557|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
164309558|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309559|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309560|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309561|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309562|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309563|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309564|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
164309565|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309566|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309567|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309568|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
164309569|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
164309570|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
164309571|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
163862364|NCT01120275|591862035|FG000|Overall Study|Adverse Event|3|||
163862365|NCT01120275|591862035|FG000|Overall Study|Progression|27|||
164309572|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309573|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309574|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309575|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
164309576|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164309577|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
163967700|NCT02684279|592254258|FG000|Overall Study|Pregnancy|8|||
163862366|NCT01120275|591862035|FG000|Overall Study|Ineligible|3|||
163967701|NCT02684279|592254258|FG000|Overall Study|Withdrawal by Subject|92|||
163967702|NCT02684279|592254258|FG000|Overall Study|non-compliance with study drug|9|||
163967703|NCT02684279|592254258|FG000|Overall Study|non compliance with study visits|2|||
163967704|NCT02684279|592254258|FG000|Overall Study|subject to have surgery|1|||
163967705|NCT02684279|592254258|FG000|Overall Study|family emergency|1|||
163967706|NCT02684279|592254258|FG000|Overall Study|Site closures|7|||
163967707|NCT02684279|592254258|FG000|Overall Study|Physician Decision|1|||
163967708|NCT00228566|592254259|FG000|Overall Study|Adverse Event|31|||
164200618|NCT03736967|593106837|FG001|Overall Study|Withdrawal by Subject|25|||
164200619|NCT03736967|593106838|FG002|Overall Study|Withdrawal by Subject|23|||
164200620|NCT03736967|593106839|FG003|Overall Study|Withdrawal by Subject|26|||
164200621|NCT03736967|593106836|FG000|Overall Study|Lost to Follow-up|3|||
164200622|NCT03736967|593106837|FG001|Overall Study|Lost to Follow-up|2|||
164200623|NCT03736967|593106838|FG002|Overall Study|Lost to Follow-up|1|||
164200624|NCT03736967|593106839|FG003|Overall Study|Lost to Follow-up|1|||
164200625|NCT03736967|593106836|FG000|Overall Study|Physician Decision|1|||
164200626|NCT03736967|593106837|FG001|Overall Study|Physician Decision|0|||
164200627|NCT03736967|593106838|FG002|Overall Study|Physician Decision|0|||
164200628|NCT03736967|593106839|FG003|Overall Study|Physician Decision|1|||
164200629|NCT03736967|593106836|FG000|Overall Study|Adverse Event|0|||
164200630|NCT03736967|593106837|FG001|Overall Study|Adverse Event|1|||
164200631|NCT03736967|593106838|FG002|Overall Study|Adverse Event|0|||
164200632|NCT03736967|593106839|FG003|Overall Study|Adverse Event|1|||
164200633|NCT03736967|593106836|FG000|Overall Study|Death|0|||
164200634|NCT03736967|593106837|FG001|Overall Study|Death|0|||
164200635|NCT03736967|593106838|FG002|Overall Study|Death|0|||
164200636|NCT03736967|593106839|FG003|Overall Study|Death|1|||
164200637|NCT03736967|593106836|FG000|Overall Study|Randomized but never treated|1|||
164200638|NCT03736967|593106837|FG001|Overall Study|Randomized but never treated|0|||
164200639|NCT03736967|593106838|FG002|Overall Study|Randomized but never treated|0|||
164200640|NCT03736967|593106839|FG003|Overall Study|Randomized but never treated|0|||
164200641|NCT02369653|593106840|FG000|Overall Study|Lost to Follow-up|0|||
164200642|NCT02369653|593106841|FG001|Overall Study|Lost to Follow-up|1|||
164200643|NCT02369653|593106840|FG000|Overall Study|Administrative reason by sponsor|0|||
164200644|NCT02369653|593106841|FG001|Overall Study|Administrative reason by sponsor|1|||
164200645|NCT02369653|593106840|FG000|Overall Study|Death|1|||
164200646|NCT02369653|593106841|FG001|Overall Study|Death|2|||
164200647|NCT02369653|593106840|FG000|Overall Study|Participant withdrew consent|13|||
164200648|NCT02369653|593106841|FG001|Overall Study|Participant withdrew consent|3|||
164200649|NCT01587885|593106842|FG000|Treatment Period 1|Failure to Return|0|||
164200650|NCT01587885|593106843|FG001|Treatment Period 1|Failure to Return|1|||
164200651|NCT01587885|593106842|FG000|Treatment Period 1|Protocol Violation|0|||
164200652|NCT01587885|593106843|FG001|Treatment Period 1|Protocol Violation|2|||
164200653|NCT01458587|593106844|FG000|Overall Study|Withdrawal by Subject|1|||
164200654|NCT01458587|593106845|FG001|Overall Study|Withdrawal by Subject|0|||
164200655|NCT01603602|593106846|FG000|Overall Study|Adverse Event|1|||
164200656|NCT01603602|593106847|FG001|Overall Study|Adverse Event|0|||
164200657|NCT01603602|593106848|FG002|Overall Study|Adverse Event|0|||
164200658|NCT01603602|593106846|FG000|Overall Study|Personal Reasons|1|||
164200659|NCT01603602|593106847|FG001|Overall Study|Personal Reasons|0|||
164200660|NCT01603602|593106848|FG002|Overall Study|Personal Reasons|1|||
164200661|NCT04748718|593106852|FG000|Overall Study|Lost to Follow-up|50|||
164200662|NCT00316004|593106853|FG000|Overall Study|Subject was not given study fluid.|14|||
164200663|NCT00316004|593106854|FG001|Overall Study|Subject was not given study fluid.|14|||
164200664|NCT00316004|593106855|FG002|Overall Study|Subject was not given study fluid.|21|||
164200665|NCT01118299|593106856|FG000|Overall Study|Death|7|||
164200666|NCT01118299|593106857|FG001|Overall Study|Death|5|||
164200667|NCT01118299|593106856|FG000|Overall Study|Withdrawal by Subject|8|||
164200668|NCT01118299|593106857|FG001|Overall Study|Withdrawal by Subject|8|||
164200669|NCT01118299|593106856|FG000|Overall Study|Lost to Follow-up|2|||
164200670|NCT01118299|593106857|FG001|Overall Study|Lost to Follow-up|1|||
164200671|NCT01118299|593106856|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
164200672|NCT01118299|593106857|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
164200673|NCT01935089|593106859|FG000|Overall Study|Adverse Event|2|||
164200674|NCT01935089|593106859|FG000|Overall Study|Withdrawal by Subject|1|||
164200675|NCT02932943|593106860|FG000|Overall Study|Lost to Follow-up|0|||
164200676|NCT02932943|593106861|FG001|Overall Study|Lost to Follow-up|2|||
164200677|NCT02932943|593106860|FG000|Overall Study|Adverse Event|2|||
164200678|NCT02932943|593106861|FG001|Overall Study|Adverse Event|2|||
164200679|NCT02932943|593106860|FG000|Overall Study|Withdrawal by Subject|3|||
164200680|NCT02932943|593106861|FG001|Overall Study|Withdrawal by Subject|3|||
164200681|NCT02665117|593106864|FG000|Overall Study|Physician Decision|1|||
164200682|NCT02665117|593106865|FG001|Overall Study|Physician Decision|0|||
163967709|NCT00228566|592254259|FG000|Overall Study|Lack of Efficacy|14|||
163967710|NCT00228566|592254259|FG000|Overall Study|Lost to Follow-up|16|||
164200683|NCT00977197|593106869|FG000|Overall Study|Withdrawal by Subject|3|||
164200684|NCT00977197|593106870|FG001|Overall Study|Withdrawal by Subject|4|||
164200685|NCT00977197|593106869|FG000|Overall Study|Adverse Event|3|||
163862367|NCT01120275|591862035|FG000|Overall Study|Withdrawal by Subject|1|||
163862368|NCT01120275|591862035|FG000|Overall Study|Refusal|1|||
163862369|NCT01120275|591862035|FG000|Overall Study|Not specific|1|||
163862370|NCT04379713|591862043|FG000|Overall Study|Adverse Event|2|||
163862371|NCT04379713|591862044|FG001|Overall Study|Adverse Event|0|||
163862372|NCT04379713|591862043|FG000|Overall Study|Physician Decision|2|||
163862373|NCT04379713|591862044|FG001|Overall Study|Physician Decision|1|||
163862374|NCT04379713|591862043|FG000|Overall Study|Protocol Violation|11|||
163862375|NCT04379713|591862044|FG001|Overall Study|Protocol Violation|6|||
163862376|NCT04379713|591862043|FG000|Overall Study|No longer met eligibility criteria|14|||
163862377|NCT04379713|591862044|FG001|Overall Study|No longer met eligibility criteria|11|||
163862378|NCT04379713|591862043|FG000|Overall Study|Withdrawal by parent/guardian|36|||
163862379|NCT04379713|591862044|FG001|Overall Study|Withdrawal by parent/guardian|15|||
163862380|NCT04379713|591862043|FG000|Overall Study|Lost to Follow-up|31|||
163862381|NCT04379713|591862044|FG001|Overall Study|Lost to Follow-up|21|||
163862382|NCT04567888|591862045|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
163862383|NCT04567888|591862046|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
163862384|NCT04567888|591862045|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
163862385|NCT04567888|591862046|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
163862386|NCT04567888|591862045|FG000|Overall Study|Reported Unusual Birth Year|2|||
163862387|NCT04567888|591862046|FG001|Overall Study|Reported Unusual Birth Year|3|||
163862388|NCT04567888|591862045|FG000|Overall Study|Duplicate Responses|0|||
163862389|NCT04567888|591862046|FG001|Overall Study|Duplicate Responses|1|||
163862390|NCT00554801|591862048|FG000|Overall Study|left area before completion|5|||
163862391|NCT00554801|591862049|FG001|Overall Study|left area before completion|0|||
163862392|NCT00554801|591862048|FG000|Overall Study|Withdrawal by Subject|14|||
164200686|NCT00977197|593106870|FG001|Overall Study|Adverse Event|1|||
164200687|NCT00977197|593106869|FG000|Overall Study|Lack of Efficacy|1|||
164200688|NCT00977197|593106870|FG001|Overall Study|Lack of Efficacy|0|||
164200689|NCT00977197|593106869|FG000|Overall Study|Lost to Follow-up|1|||
164200690|NCT00977197|593106870|FG001|Overall Study|Lost to Follow-up|3|||
164200691|NCT00977197|593106869|FG000|Overall Study|Nonadherence|1|||
164200692|NCT00977197|593106870|FG001|Overall Study|Nonadherence|1|||
164200693|NCT05379920|593106871|FG000|Overall Study|Lost to Follow-up|0|||
164200694|NCT05379920|593106872|FG001|Overall Study|Lost to Follow-up|5|||
164200695|NCT05379920|593106873|FG002|Overall Study|Lost to Follow-up|0|||
164200696|NCT05379920|593106874|FG003|Overall Study|Lost to Follow-up|0|||
164200697|NCT03530293|593106877|FG000|Pre-randomization|Adverse Event|12|||
164200698|NCT03530293|593106878|FG001|Pre-randomization|Adverse Event|0|||
164200699|NCT03530293|593106879|FG002|Pre-randomization|Adverse Event|0|||
164200700|NCT03530293|593106877|FG000|Pre-randomization|Protocol Violation|2|||
164200701|NCT03530293|593106878|FG001|Pre-randomization|Protocol Violation|0|||
164200702|NCT03530293|593106879|FG002|Pre-randomization|Protocol Violation|0|||
164200703|NCT03530293|593106877|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
164200704|NCT03530293|593106878|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
164200705|NCT03530293|593106879|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
164200706|NCT03530293|593106877|FG000|Pre-randomization|Withdrawal by Subject|5|||
164200707|NCT03530293|593106878|FG001|Pre-randomization|Withdrawal by Subject|0|||
164200708|NCT03530293|593106879|FG002|Pre-randomization|Withdrawal by Subject|0|||
164200709|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
164200710|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
164200711|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
164200712|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
164200713|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
164200714|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
164200715|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
164200716|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
164200717|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
164200718|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
164200719|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
164200720|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
164200721|NCT03530293|593106877|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
164200722|NCT03530293|593106878|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
164200723|NCT03530293|593106879|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
164200724|NCT02530385|593106881|FG000|Overall Study|Withdrawal by Subject|0|||
163862393|NCT00554801|591862049|FG001|Overall Study|Withdrawal by Subject|0|||
163862394|NCT04771273|591862052|FG000|Dose Escalation Period|Not treated with trial medication|0|||
163967711|NCT00228566|592254259|FG000|Overall Study|Physician Decision|5|||
163967712|NCT00228566|592254259|FG000|Overall Study|Withdrawal by Subject|4|||
163862395|NCT04771273|591862053|FG001|Dose Escalation Period|Not treated with trial medication|1|||
163967713|NCT00228566|592254259|FG000|Overall Study|Miscellaneous|1|||
163967714|NCT01479829|592254260|FG000|Overall Study|Withdrawal by Subject|8|||
164200725|NCT02530385|593106882|FG001|Overall Study|Withdrawal by Subject|1|||
163967715|NCT01479829|592254261|FG001|Overall Study|Withdrawal by Subject|10|||
163967716|NCT01444456|592254267|FG000|Overall Study|Withdrawal by Subject|21|||
163967717|NCT01444456|592254267|FG000|Overall Study|Physician Decision|9|||
164200726|NCT00116142|593106883|FG000|Overall Study|Adverse Event|8|||
164200727|NCT00116142|593106884|FG001|Overall Study|Adverse Event|7|||
164200728|NCT00116142|593106883|FG000|Overall Study|Protocol Violation|2|||
164200729|NCT00116142|593106884|FG001|Overall Study|Protocol Violation|1|||
164200730|NCT00116142|593106883|FG000|Overall Study|Withdrawal by Subject|5|||
164200731|NCT00116142|593106884|FG001|Overall Study|Withdrawal by Subject|5|||
164200732|NCT00116142|593106883|FG000|Overall Study|Physician Decision|3|||
164200733|NCT00116142|593106884|FG001|Overall Study|Physician Decision|1|||
164200734|NCT00116142|593106883|FG000|Overall Study|Delayed Radiation Therapy|1|||
164200735|NCT00116142|593106884|FG001|Overall Study|Delayed Radiation Therapy|0|||
164200736|NCT00116142|593106883|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
164200737|NCT00116142|593106884|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
164200738|NCT00116142|593106883|FG000|Overall Study|Patient stopped due to depression|0|||
164200739|NCT00116142|593106884|FG001|Overall Study|Patient stopped due to depression|1|||
164200740|NCT00116142|593106883|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
164200741|NCT00116142|593106884|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
164200742|NCT00116142|593106883|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
164200743|NCT00116142|593106884|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
164200744|NCT00116142|593106883|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
164200745|NCT00116142|593106884|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
164200746|NCT03482024|593106885|FG000|Overall Study|Physician Decision|1|||
164200747|NCT03482024|593106886|FG001|Overall Study|Physician Decision|0|||
164200748|NCT03482024|593106887|FG002|Overall Study|Physician Decision|0|||
164200749|NCT03482024|593106888|FG003|Overall Study|Physician Decision|0|||
164200750|NCT03482024|593106889|FG004|Overall Study|Physician Decision|0|||
164200751|NCT02295644|593106890|FG000|Overall Study|Did not meet inclusion criterion|0|||
164200752|NCT02295644|593106891|FG001|Overall Study|Did not meet inclusion criterion|0|||
164200753|NCT02295644|593106892|FG002|Overall Study|Did not meet inclusion criterion|1|||
164200754|NCT02295644|593106893|FG003|Overall Study|Did not meet inclusion criterion|2|||
164200755|NCT02147626|593106894|FG000|Overall Study|Lost to Follow-up|4|||
164200756|NCT02147626|593106895|FG001|Overall Study|Lost to Follow-up|4|||
164200757|NCT02147626|593106894|FG000|Overall Study|Pregnancy|1|||
164200758|NCT02147626|593106895|FG001|Overall Study|Pregnancy|2|||
164200759|NCT02147626|593106894|FG000|Overall Study|Withdrawal by Subject|0|||
164200760|NCT02147626|593106895|FG001|Overall Study|Withdrawal by Subject|1|||
164200761|NCT03101020|593106896|FG000|Overall Study|Lack of time to participate|1|||
164200762|NCT03101020|593106897|FG001|Overall Study|Lack of time to participate|0|||
164200763|NCT03101020|593106896|FG000|Overall Study|Ran over by a car|0|||
164200764|NCT03101020|593106897|FG001|Overall Study|Ran over by a car|1|||
164200765|NCT03101020|593106896|FG000|Overall Study|Withdrawal by Subject|0|||
164200766|NCT03101020|593106897|FG001|Overall Study|Withdrawal by Subject|2|||
164200767|NCT00423046|593106901|FG000|Overall Study|Other|340|||
164200768|NCT00423046|593106902|FG001|Overall Study|Other|345|||
164200769|NCT01038687|593106903|FG000|Overall Study|Adverse Event|0|||
164200770|NCT01038687|593106904|FG001|Overall Study|Adverse Event|2|||
164200771|NCT01038687|593106905|FG002|Overall Study|Adverse Event|1|||
164200772|NCT02783911|593106906|FG000|Overall Study|Lost to Follow-up|3|||
164200773|NCT02783911|593106907|FG001|Overall Study|Lost to Follow-up|32|||
164200774|NCT02616783|593106908|FG000|Overall Study|Randomized but Not Treated|1|||
164200775|NCT02616783|593106909|FG001|Overall Study|Randomized but Not Treated|0|||
164200776|NCT02616783|593106908|FG000|Overall Study|Adverse Event|1|||
164200777|NCT02616783|593106909|FG001|Overall Study|Adverse Event|0|||
164200778|NCT02616783|593106908|FG000|Overall Study|Death|1|||
164200779|NCT02616783|593106909|FG001|Overall Study|Death|0|||
164200780|NCT02616783|593106908|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164200781|NCT02616783|593106909|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164200782|NCT02616783|593106908|FG000|Overall Study|Protocol Violation|1|||
164200783|NCT02616783|593106909|FG001|Overall Study|Protocol Violation|1|||
164309578|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164200784|NCT02616783|593106908|FG000|Overall Study|Withdrew Consent|1|||
164200785|NCT02616783|593106909|FG001|Overall Study|Withdrew Consent|1|||
164200786|NCT03080935|593106913|FG000|Overall Study|Death|34|||
164200787|NCT03080935|593106914|FG001|Overall Study|Death|50|||
164309579|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
164309580|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163967718|NCT01444456|592254267|FG000|Overall Study|Lost to Follow-up|37|||
164200788|NCT03080935|593106913|FG000|Overall Study|Lost to Follow-up|5|||
164200789|NCT03080935|593106914|FG001|Overall Study|Lost to Follow-up|4|||
164200790|NCT03080935|593106913|FG000|Overall Study|Withdrawal by Subject|11|||
164200791|NCT03080935|593106914|FG001|Overall Study|Withdrawal by Subject|15|||
164200792|NCT01614470|593106915|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
164309581|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
163967719|NCT01444456|592254267|FG000|Overall Study|Death|73|||
163967720|NCT01444456|592254267|FG000|Overall Study|Ineligibility determined|23|||
163967721|NCT01444456|592254267|FG000|Overall Study|Other|18|||
163967722|NCT01444456|592254267|FG000|Overall Study|Not treated|104|||
163967723|NCT02229539|592255714|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
163967724|NCT02229539|592255715|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
163967725|NCT02229539|592255716|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
164200793|NCT01614470|593106916|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164200794|NCT01614470|593106917|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
164200795|NCT01614470|593106915|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
164200796|NCT01614470|593106916|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
164200797|NCT01614470|593106917|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
164200798|NCT00069264|593106920|FG000|Overall Study|Adverse Event|3|||
164200799|NCT00069264|593106920|FG000|Overall Study|Progressive Disease|23|||
164200800|NCT00069264|593106920|FG000|Overall Study|Withdrawal by Subject|3|||
164200801|NCT00069264|593106920|FG000|Overall Study|Discon Therapy|3|||
164200802|NCT03014206|593106921|FG000|Overall Study|Registration Violation|12|||
164200803|NCT02895347|593106924|FG000|Overall Study|Withdrawal by Subject|3|||
164200804|NCT02895347|593106925|FG001|Overall Study|Withdrawal by Subject|1|||
164200805|NCT00606307|593106930|FG000|Overall Study|Adverse Event|2|||
164200806|NCT00606307|593106930|FG000|Overall Study|Withdrawal by Subject|2|||
164200807|NCT00606307|593106930|FG000|Overall Study|Disease progression|6|||
164200808|NCT00606307|593106930|FG000|Overall Study|QTc prolongation|1|||
164200809|NCT03669588|593106940|FG000|Overall Study|Adverse Event|1|||
164200810|NCT03669588|593106941|FG001|Overall Study|Adverse Event|0|||
164200811|NCT03669588|593106940|FG000|Overall Study|Physician Decision|0|||
164200812|NCT03669588|593106941|FG001|Overall Study|Physician Decision|1|||
164200813|NCT03669588|593106940|FG000|Overall Study|Protocol Violation|1|||
164200814|NCT03669588|593106941|FG001|Overall Study|Protocol Violation|0|||
164200815|NCT03669588|593106940|FG000|Overall Study|Sponsor Decision|1|||
164200816|NCT03669588|593106941|FG001|Overall Study|Sponsor Decision|1|||
164200817|NCT03669588|593106940|FG000|Overall Study|Withdrawal by Subject|1|||
164200818|NCT03669588|593106941|FG001|Overall Study|Withdrawal by Subject|4|||
164200819|NCT03669588|593106940|FG000|Overall Study|Rescue Therapy Needed|0|||
164200820|NCT03669588|593106941|FG001|Overall Study|Rescue Therapy Needed|1|||
164200821|NCT00492726|593106946|FG000|Overall Study|Adverse Event|10|||
164200822|NCT00492726|593106947|FG001|Overall Study|Adverse Event|6|||
164200823|NCT00492726|593106946|FG000|Overall Study|Death|7|||
164200824|NCT00492726|593106947|FG001|Overall Study|Death|2|||
164200825|NCT00492726|593106946|FG000|Overall Study|Lack of Efficacy|0|||
164200826|NCT00492726|593106947|FG001|Overall Study|Lack of Efficacy|2|||
164200827|NCT00492726|593106946|FG000|Overall Study|Lost to Follow-up|27|||
164200828|NCT00492726|593106947|FG001|Overall Study|Lost to Follow-up|19|||
164200829|NCT00492726|593106946|FG000|Overall Study|Physician Decision|0|||
164200830|NCT00492726|593106947|FG001|Overall Study|Physician Decision|1|||
164200831|NCT00492726|593106946|FG000|Overall Study|Withdrawal by Subject|6|||
164200832|NCT00492726|593106947|FG001|Overall Study|Withdrawal by Subject|3|||
164200833|NCT00492726|593106946|FG000|Overall Study|Non compliant with study medication|0|||
164200834|NCT00492726|593106947|FG001|Overall Study|Non compliant with study medication|3|||
164200835|NCT04386902|593106948|FG000|Overall Study|Withdrawal by Subject|5|||
164200836|NCT04386902|593106948|FG000|Overall Study|Technical problems in the recording|5|||
164200837|NCT02557399|593106949|FG000|Overall Study|Adverse Event|6|||
163862396|NCT04771273|591862054|FG002|Dose Escalation Period|Not treated with trial medication|1|||
163862397|NCT04771273|591862055|FG003|Dose Escalation Period|Not treated with trial medication|0|||
163862398|NCT04771273|591862052|FG000|Dose Escalation Period|Other reasons than listed|2|||
163862399|NCT04771273|591862053|FG001|Dose Escalation Period|Other reasons than listed|0|||
163862400|NCT04771273|591862054|FG002|Dose Escalation Period|Other reasons than listed|2|||
163862401|NCT04771273|591862055|FG003|Dose Escalation Period|Other reasons than listed|1|||
163862402|NCT04771273|591862052|FG000|Dose Escalation Period|Protocol Violation|0|||
163862403|NCT04771273|591862053|FG001|Dose Escalation Period|Protocol Violation|0|||
163862404|NCT04771273|591862054|FG002|Dose Escalation Period|Protocol Violation|3|||
163862405|NCT04771273|591862055|FG003|Dose Escalation Period|Protocol Violation|1|||
163862406|NCT04771273|591862052|FG000|Dose Escalation Period|Burden of study procedures|1|||
163862407|NCT04771273|591862053|FG001|Dose Escalation Period|Burden of study procedures|0|||
163862408|NCT04771273|591862054|FG002|Dose Escalation Period|Burden of study procedures|0|||
163862409|NCT04771273|591862055|FG003|Dose Escalation Period|Burden of study procedures|0|||
163862410|NCT04771273|591862052|FG000|Dose Escalation Period|Change of residence|0|||
164200838|NCT02557399|593106950|FG001|Overall Study|Adverse Event|5|||
164200839|NCT02557399|593106949|FG000|Overall Study|Protocol Violation|0|||
163862411|NCT04771273|591862053|FG001|Dose Escalation Period|Change of residence|0|||
163967726|NCT02229539|592255714|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
164200840|NCT02557399|593106950|FG001|Overall Study|Protocol Violation|1|||
164200841|NCT02557399|593106949|FG000|Overall Study|Protocol-defined stopping criteria|0|||
163862412|NCT04771273|591862054|FG002|Dose Escalation Period|Change of residence|0|||
163862413|NCT04771273|591862055|FG003|Dose Escalation Period|Change of residence|1|||
164309582|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
164309583|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
164309584|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
164309585|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
164309586|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
164309587|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
164309588|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
164309589|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
164309590|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309591|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309592|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309593|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309594|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309595|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309596|NCT05019521|593508131|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309597|NCT05019521|593508132|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309598|NCT05019521|593508133|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309599|NCT05019521|593508134|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
164309600|NCT05019521|593508135|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309601|NCT05019521|593508136|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309602|NCT05019521|593508137|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309603|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
164309604|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
164309605|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
164309606|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309607|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309608|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
164309609|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
164309610|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
163862414|NCT04771273|591862052|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
163862415|NCT04771273|591862053|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
163862416|NCT04771273|591862054|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
163862417|NCT04771273|591862055|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
163862418|NCT04771273|591862052|FG000|Dose Escalation Period|Adverse Event|8|||
163862419|NCT04771273|591862053|FG001|Dose Escalation Period|Adverse Event|9|||
163862420|NCT04771273|591862054|FG002|Dose Escalation Period|Adverse Event|12|||
163862421|NCT04771273|591862055|FG003|Dose Escalation Period|Adverse Event|2|||
163862422|NCT04771273|591862052|FG000|Maintenance Period|Other than listed|4|||
163862423|NCT04771273|591862053|FG001|Maintenance Period|Other than listed|2|||
163862424|NCT04771273|591862054|FG002|Maintenance Period|Other than listed|0|||
163862425|NCT04771273|591862055|FG003|Maintenance Period|Other than listed|3|||
163862426|NCT04771273|591862052|FG000|Maintenance Period|Burden of study procedures|1|||
163862427|NCT04771273|591862053|FG001|Maintenance Period|Burden of study procedures|0|||
163862428|NCT04771273|591862054|FG002|Maintenance Period|Burden of study procedures|0|||
163862429|NCT04771273|591862055|FG003|Maintenance Period|Burden of study procedures|0|||
163862430|NCT04771273|591862052|FG000|Maintenance Period|Change of residence|0|||
163862431|NCT04771273|591862053|FG001|Maintenance Period|Change of residence|1|||
163862432|NCT04771273|591862054|FG002|Maintenance Period|Change of residence|3|||
163862433|NCT04771273|591862055|FG003|Maintenance Period|Change of residence|0|||
163862434|NCT04771273|591862052|FG000|Maintenance Period|Perceived lack of efficacy|0|||
163862435|NCT04771273|591862053|FG001|Maintenance Period|Perceived lack of efficacy|0|||
163862436|NCT04771273|591862054|FG002|Maintenance Period|Perceived lack of efficacy|0|||
163862437|NCT04771273|591862055|FG003|Maintenance Period|Perceived lack of efficacy|1|||
163862438|NCT04771273|591862052|FG000|Maintenance Period|Adverse Event|4|||
163862439|NCT04771273|591862053|FG001|Maintenance Period|Adverse Event|5|||
163862440|NCT04771273|591862054|FG002|Maintenance Period|Adverse Event|5|||
163862441|NCT04771273|591862055|FG003|Maintenance Period|Adverse Event|0|||
163862442|NCT05196737|591862056|FG000|Non-intervention Week|Lost to Follow-up|2|||
163862443|NCT05196737|591862056|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
163862444|NCT02357784|591862057|FG000|Overall Study|Withdrawal by Subject|1|||
163967727|NCT02229539|592255715|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
163862445|NCT00462943|591862058|FG000|Overall Study|Failure to achieve a response|5|||
163862446|NCT00462943|591862059|FG001|Overall Study|Failure to achieve a response|5|||
163862447|NCT00462943|591862060|FG002|Overall Study|Failure to achieve a response|1|||
163862448|NCT00462943|591862058|FG000|Overall Study|Adverse Event|6|||
163862449|NCT00462943|591862059|FG001|Overall Study|Adverse Event|4|||
163862450|NCT00462943|591862060|FG002|Overall Study|Adverse Event|1|||
163862451|NCT00462943|591862058|FG000|Overall Study|Protocol Violation|1|||
164309611|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
164309612|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309613|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309614|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309615|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
164309616|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
164309617|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
164309618|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309619|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309620|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
164309621|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
164309622|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
164309623|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
164309624|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309625|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
164309626|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
164309627|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309628|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309629|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309630|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
164309631|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309632|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
164309633|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
164309634|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309635|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
164309636|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309637|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
164309638|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309639|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309640|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309641|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309642|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309643|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
164309644|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
164309645|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309646|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
164309647|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
164309648|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309649|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309650|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
164309651|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
164309652|NCT05019521|593508131|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
164309653|NCT05019521|593508132|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
164309654|NCT05019521|593508133|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
164309655|NCT05019521|593508134|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
164309656|NCT05019521|593508135|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
164309657|NCT05019521|593508136|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
164309658|NCT05019521|593508137|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
164309659|NCT02721966|593508138|FG000|Overall Study|Protocol Violation|1|||
164309660|NCT02721966|593508139|FG001|Overall Study|Protocol Violation|0|||
164309661|NCT02721966|593508140|FG002|Overall Study|Protocol Violation|0|||
164309662|NCT02721966|593508141|FG003|Overall Study|Protocol Violation|0|||
164309663|NCT02721966|593508142|FG004|Overall Study|Protocol Violation|0|||
164309664|NCT02721966|593508138|FG000|Overall Study|Withdrawal by Subject|9|||
164309665|NCT02721966|593508139|FG001|Overall Study|Withdrawal by Subject|2|||
164309666|NCT02721966|593508140|FG002|Overall Study|Withdrawal by Subject|3|||
164309667|NCT02721966|593508141|FG003|Overall Study|Withdrawal by Subject|7|||
164309668|NCT02721966|593508142|FG004|Overall Study|Withdrawal by Subject|0|||
164309669|NCT02721966|593508138|FG000|Overall Study|Adverse Event|4|||
164309670|NCT02721966|593508139|FG001|Overall Study|Adverse Event|4|||
164309671|NCT02721966|593508140|FG002|Overall Study|Adverse Event|3|||
164309672|NCT02721966|593508141|FG003|Overall Study|Adverse Event|0|||
163967728|NCT02229539|592255716|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
163967729|NCT02229539|592255714|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
164309673|NCT02721966|593508142|FG004|Overall Study|Adverse Event|0|||
164309674|NCT02721966|593508138|FG000|Overall Study|Death|1|||
164309675|NCT02721966|593508139|FG001|Overall Study|Death|0|||
164309676|NCT02721966|593508140|FG002|Overall Study|Death|0|||
164309677|NCT02721966|593508141|FG003|Overall Study|Death|0|||
164309678|NCT02721966|593508142|FG004|Overall Study|Death|0|||
164309679|NCT02721966|593508138|FG000|Overall Study|Lack of Efficacy|7|||
164309680|NCT02721966|593508139|FG001|Overall Study|Lack of Efficacy|4|||
163862452|NCT00462943|591862059|FG001|Overall Study|Protocol Violation|0|||
163862453|NCT00462943|591862060|FG002|Overall Study|Protocol Violation|0|||
163862454|NCT00462943|591862058|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
163862455|NCT00462943|591862059|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
163862456|NCT00462943|591862060|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
163862457|NCT00462943|591862058|FG000|Overall Study|Disease Progression|15|||
163862458|NCT00462943|591862059|FG001|Overall Study|Disease Progression|15|||
163862459|NCT00462943|591862060|FG002|Overall Study|Disease Progression|9|||
163862460|NCT00462943|591862058|FG000|Overall Study|Death|5|||
163862461|NCT00462943|591862059|FG001|Overall Study|Death|2|||
163862462|NCT00462943|591862060|FG002|Overall Study|Death|7|||
163862463|NCT00462943|591862058|FG000|Overall Study|Stem Cell Transplant|1|||
163862464|NCT00462943|591862059|FG001|Overall Study|Stem Cell Transplant|1|||
163862465|NCT00462943|591862060|FG002|Overall Study|Stem Cell Transplant|0|||
163862466|NCT00462943|591862058|FG000|Overall Study|Bone Marrow Transplant|1|||
163862467|NCT00462943|591862059|FG001|Overall Study|Bone Marrow Transplant|0|||
163862468|NCT00462943|591862060|FG002|Overall Study|Bone Marrow Transplant|0|||
163862469|NCT00462943|591862058|FG000|Overall Study|Required Lymphocyte Infusion|1|||
163862470|NCT00462943|591862059|FG001|Overall Study|Required Lymphocyte Infusion|0|||
163862471|NCT00462943|591862060|FG002|Overall Study|Required Lymphocyte Infusion|0|||
163862472|NCT00462943|591862058|FG000|Overall Study|Transplant - not specified|1|||
163862473|NCT00462943|591862059|FG001|Overall Study|Transplant - not specified|0|||
163862474|NCT00462943|591862060|FG002|Overall Study|Transplant - not specified|1|||
163862475|NCT00462943|591862058|FG000|Overall Study|Physician Decision|1|||
163862476|NCT00462943|591862059|FG001|Overall Study|Physician Decision|0|||
163862477|NCT00462943|591862060|FG002|Overall Study|Physician Decision|0|||
163862478|NCT00462943|591862058|FG000|Overall Study|Withdrawal by Subject|0|||
163862479|NCT00462943|591862059|FG001|Overall Study|Withdrawal by Subject|1|||
163862480|NCT00462943|591862060|FG002|Overall Study|Withdrawal by Subject|0|||
163862481|NCT01144182|591862063|FG000|Overall Study|Death|5|||
163862482|NCT01144182|591862064|FG001|Overall Study|Death|6|||
163862483|NCT01144182|591862063|FG000|Overall Study|Withdrawal by Subject|3|||
163862484|NCT01144182|591862064|FG001|Overall Study|Withdrawal by Subject|6|||
163862485|NCT01144182|591862063|FG000|Overall Study|Lost to Follow-up|9|||
163862486|NCT01144182|591862064|FG001|Overall Study|Lost to Follow-up|9|||
163862487|NCT03395353|591862072|FG000|Overall Study|Adverse Event|20|||
163862488|NCT03395353|591862072|FG000|Overall Study|Protocol Violation|1|||
163862489|NCT03395353|591862072|FG000|Overall Study|Lack of Efficacy|3|||
163862490|NCT03395353|591862072|FG000|Overall Study|Withdrawal by Subject|24|||
163862491|NCT03395353|591862072|FG000|Overall Study|Discontinued visit|1|||
163862492|NCT03395353|591862072|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
163862493|NCT03395353|591862072|FG000|Overall Study|Physician Decision|4|||
163862494|NCT03395353|591862072|FG000|Overall Study|Early termination of overall study|33|||
163862495|NCT03301220|591862073|FG000|Overall Study|Death|26|||
163862496|NCT03301220|591862074|FG001|Overall Study|Death|15|||
163862497|NCT03301220|591862073|FG000|Overall Study|Withdrawal by Subject|23|||
163862498|NCT03301220|591862074|FG001|Overall Study|Withdrawal by Subject|12|||
163862499|NCT03301220|591862073|FG000|Overall Study|Lost to Follow-up|1|||
163862500|NCT03301220|591862074|FG001|Overall Study|Lost to Follow-up|1|||
163862501|NCT03301220|591862073|FG000|Overall Study|Randomized in error|1|||
163862502|NCT03301220|591862074|FG001|Overall Study|Randomized in error|1|||
163862503|NCT03301220|591862073|FG000|Overall Study|Randomized but not treated|0|||
163862504|NCT03301220|591862074|FG001|Overall Study|Randomized but not treated|1|||
163862505|NCT03301220|591862073|FG000|Overall Study|Ongoing followup|145|||
163862506|NCT03301220|591862074|FG001|Overall Study|Ongoing followup|163|||
163862507|NCT03301220|591862073|FG000|Overall Study|Principal Investigator and participant decision|0|||
163862508|NCT03301220|591862074|FG001|Overall Study|Principal Investigator and participant decision|1|||
163862509|NCT04845620|591862079|FG000|Overall Study|Withdrawal by Subject|11|||
163862510|NCT04845620|591862080|FG001|Overall Study|Withdrawal by Subject|10|||
163862511|NCT04845620|591862079|FG000|Overall Study|Adverse Event|5|||
163862512|NCT04845620|591862080|FG001|Overall Study|Adverse Event|4|||
163862513|NCT04845620|591862079|FG000|Overall Study|Lost to Follow-up|5|||
163862514|NCT04845620|591862080|FG001|Overall Study|Lost to Follow-up|4|||
163862515|NCT04845620|591862079|FG000|Overall Study|Lack of Efficacy|4|||
163862516|NCT04845620|591862080|FG001|Overall Study|Lack of Efficacy|4|||
163862517|NCT04845620|591862079|FG000|Overall Study|Physician Decision|2|||
163862518|NCT04845620|591862080|FG001|Overall Study|Physician Decision|1|||
163862519|NCT00708097|591862081|FG000|Period 1|Protocol Violation|0|||
164309681|NCT02721966|593508140|FG002|Overall Study|Lack of Efficacy|0|||
164309682|NCT02721966|593508141|FG003|Overall Study|Lack of Efficacy|0|||
163862520|NCT00708097|591862082|FG001|Period 1|Protocol Violation|1|||
163862521|NCT00708097|591862083|FG002|Period 1|Protocol Violation|0|||
163862522|NCT00708097|591862084|FG003|Period 1|Protocol Violation|2|||
163862523|NCT00708097|591862085|FG004|Period 1|Protocol Violation|0|||
164200842|NCT02557399|593106950|FG001|Overall Study|Protocol-defined stopping criteria|1|||
164200843|NCT02557399|593106949|FG000|Overall Study|Withdrawal by Subject|1|||
164200844|NCT02557399|593106950|FG001|Overall Study|Withdrawal by Subject|1|||
164200845|NCT00960804|593106951|FG000|Overall Study|Adverse Event|1|||
164200846|NCT00960804|593106952|FG001|Overall Study|Adverse Event|0|||
164200847|NCT00960804|593106953|FG002|Overall Study|Adverse Event|0|||
164200848|NCT00960804|593106951|FG000|Overall Study|Withdrawal by Subject|1|||
164200849|NCT00960804|593106952|FG001|Overall Study|Withdrawal by Subject|0|||
164200850|NCT00960804|593106953|FG002|Overall Study|Withdrawal by Subject|0|||
164200851|NCT00960804|593106951|FG000|Overall Study|Study terminated by the sponsor|5|||
164200852|NCT00960804|593106952|FG001|Overall Study|Study terminated by the sponsor|4|||
164200853|NCT00960804|593106953|FG002|Overall Study|Study terminated by the sponsor|10|||
164200854|NCT02100124|593106954|FG000|Overall Study|Lost to Follow-up|5|||
164200855|NCT02100124|593106955|FG001|Overall Study|Lost to Follow-up|11|||
164200856|NCT02100124|593106956|FG002|Overall Study|Lost to Follow-up|3|||
164200857|NCT02100124|593106954|FG000|Overall Study|Withdrawal by Subject|1|||
164200858|NCT02100124|593106955|FG001|Overall Study|Withdrawal by Subject|0|||
164200859|NCT02100124|593106956|FG002|Overall Study|Withdrawal by Subject|0|||
164200860|NCT04350827|593106957|FG000|Overall Study|Lost to Follow-up|1|||
164200861|NCT04350827|593106958|FG001|Overall Study|Lost to Follow-up|2|||
164200862|NCT02034006|593108347|FG000|Overall Study|Withdrawal by Subject|7|||
164200863|NCT02034006|593108347|FG000|Overall Study|Lost to Follow-up|5|||
164200864|NCT02034006|593108347|FG000|Overall Study|Death|1|||
164200865|NCT02034006|593108347|FG000|Overall Study|Pregnancy|1|||
164200866|NCT00750269|593108360|FG000|Overall Study|Protocol Violation|0|||
164200867|NCT00750269|593108361|FG001|Overall Study|Protocol Violation|1|||
164200868|NCT00750269|593108362|FG002|Overall Study|Protocol Violation|1|||
164200869|NCT00750269|593108363|FG003|Overall Study|Protocol Violation|2|||
164200870|NCT00750269|593108364|FG004|Overall Study|Protocol Violation|4|||
164200871|NCT00750269|593108360|FG000|Overall Study|Withdrawal by Subject|0|||
164200872|NCT00750269|593108361|FG001|Overall Study|Withdrawal by Subject|0|||
164200873|NCT00750269|593108362|FG002|Overall Study|Withdrawal by Subject|2|||
164200874|NCT00750269|593108363|FG003|Overall Study|Withdrawal by Subject|2|||
164200875|NCT00750269|593108364|FG004|Overall Study|Withdrawal by Subject|2|||
164200876|NCT00750269|593108360|FG000|Overall Study|Physician Decision|0|||
164200877|NCT00750269|593108361|FG001|Overall Study|Physician Decision|0|||
164200878|NCT00750269|593108362|FG002|Overall Study|Physician Decision|0|||
164200879|NCT00750269|593108363|FG003|Overall Study|Physician Decision|0|||
164200880|NCT00750269|593108364|FG004|Overall Study|Physician Decision|2|||
164200881|NCT00750269|593108360|FG000|Overall Study|Patient too large for positioning|0|||
164200882|NCT00750269|593108361|FG001|Overall Study|Patient too large for positioning|0|||
164200883|NCT00750269|593108362|FG002|Overall Study|Patient too large for positioning|1|||
164200884|NCT00750269|593108363|FG003|Overall Study|Patient too large for positioning|0|||
164200885|NCT00750269|593108364|FG004|Overall Study|Patient too large for positioning|0|||
164200886|NCT00750269|593108360|FG000|Overall Study|Site error|0|||
164200887|NCT00750269|593108361|FG001|Overall Study|Site error|0|||
164200888|NCT00750269|593108362|FG002|Overall Study|Site error|0|||
164200889|NCT00750269|593108363|FG003|Overall Study|Site error|1|||
164200890|NCT00750269|593108364|FG004|Overall Study|Site error|0|||
164200891|NCT00750269|593108360|FG000|Overall Study|SBRT plan could not be drawn|0|||
164200892|NCT00750269|593108361|FG001|Overall Study|SBRT plan could not be drawn|0|||
164200893|NCT00750269|593108362|FG002|Overall Study|SBRT plan could not be drawn|0|||
164200894|NCT00750269|593108363|FG003|Overall Study|SBRT plan could not be drawn|0|||
164200895|NCT00750269|593108364|FG004|Overall Study|SBRT plan could not be drawn|1|||
164200896|NCT00750269|593108360|FG000|Overall Study|Fiducials could not be placed|0|||
164200897|NCT00750269|593108361|FG001|Overall Study|Fiducials could not be placed|0|||
164200898|NCT00750269|593108362|FG002|Overall Study|Fiducials could not be placed|0|||
164200899|NCT00750269|593108363|FG003|Overall Study|Fiducials could not be placed|0|||
164200900|NCT00750269|593108364|FG004|Overall Study|Fiducials could not be placed|1|||
164200901|NCT00161213|593108365|FG000|Overall Study|Withdrawal by Subject|1|||
164200902|NCT00161213|593108365|FG000|Overall Study|Evaluable for toxicity but not response|1|||
164200903|NCT03630393|593108366|FG000|Overall Study|Death|1|||
164200904|NCT03630393|593108367|FG001|Overall Study|Death|0|||
164200905|NCT02351934|593108368|FG000|Allocation|POD weight<pre-op weight|3|||
164200906|NCT02351934|593108369|FG001|Allocation|POD weight<pre-op weight|0|||
164200907|NCT02351934|593108368|FG000|Allocation|Hypotension preventing administration|2|||
164200908|NCT02351934|593108369|FG001|Allocation|Hypotension preventing administration|0|||
164200909|NCT02351934|593108368|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
164200910|NCT02351934|593108369|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
164200911|NCT02351934|593108368|FG000|Follow-Up|POD weight<pre-op weight|3|||
164200912|NCT02351934|593108369|FG001|Follow-Up|POD weight<pre-op weight|0|||
164200913|NCT02351934|593108368|FG000|Follow-Up|Acute Kidney Injury|1|||
164309683|NCT02721966|593508142|FG004|Overall Study|Lack of Efficacy|0|||
164309684|NCT02721966|593508138|FG000|Overall Study|Lost to Follow-up|0|||
164309685|NCT02721966|593508139|FG001|Overall Study|Lost to Follow-up|0|||
164309686|NCT02721966|593508140|FG002|Overall Study|Lost to Follow-up|3|||
164309687|NCT02721966|593508141|FG003|Overall Study|Lost to Follow-up|0|||
164309688|NCT02721966|593508142|FG004|Overall Study|Lost to Follow-up|0|||
164309689|NCT02721966|593508138|FG000|Overall Study|Physician Decision|1|||
164309690|NCT02721966|593508139|FG001|Overall Study|Physician Decision|1|||
164309691|NCT02721966|593508140|FG002|Overall Study|Physician Decision|0|||
164309692|NCT02721966|593508141|FG003|Overall Study|Physician Decision|0|||
164309693|NCT02721966|593508142|FG004|Overall Study|Physician Decision|0|||
164309694|NCT02721966|593508138|FG000|Overall Study|Pregnancy|1|||
164309695|NCT02721966|593508139|FG001|Overall Study|Pregnancy|0|||
164309696|NCT02721966|593508140|FG002|Overall Study|Pregnancy|0|||
164309697|NCT02721966|593508141|FG003|Overall Study|Pregnancy|0|||
164309698|NCT02721966|593508142|FG004|Overall Study|Pregnancy|0|||
164309699|NCT02721966|593508138|FG000|Overall Study|Did not continue to period 2|5|||
164309700|NCT02721966|593508139|FG001|Overall Study|Did not continue to period 2|12|||
164309701|NCT02721966|593508140|FG002|Overall Study|Did not continue to period 2|0|||
164309702|NCT02721966|593508141|FG003|Overall Study|Did not continue to period 2|0|||
164309703|NCT02721966|593508142|FG004|Overall Study|Did not continue to period 2|5|||
164309704|NCT00828204|593508143|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
164309705|NCT00828204|593508144|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
164309706|NCT00828204|593508143|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
164309707|NCT00828204|593508144|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
164309708|NCT00828204|593508143|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
164309709|NCT00828204|593508144|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
164309710|NCT00828204|593508143|FG000|Main Study: After Study Restart|Adverse Event|0|||
164309711|NCT00828204|593508144|FG001|Main Study: After Study Restart|Adverse Event|2|||
164309712|NCT00828204|593508143|FG000|Main Study: After Study Restart|Noncompliance|0|||
164309713|NCT00828204|593508144|FG001|Main Study: After Study Restart|Noncompliance|1|||
164309714|NCT00828204|593508143|FG000|Extension Study|Lost to Follow-up|0|||
164309715|NCT00828204|593508144|FG001|Extension Study|Lost to Follow-up|1|||
164309716|NCT00828204|593508143|FG000|Extension Study|Physician Decision|0|||
164309717|NCT00828204|593508144|FG001|Extension Study|Physician Decision|2|||
164309718|NCT02840461|593508145|FG000|Overall Study|Adverse Event|1|||
164309719|NCT02840461|593508146|FG001|Overall Study|Adverse Event|5|||
164309720|NCT02840461|593508147|FG002|Overall Study|Adverse Event|3|||
164309721|NCT02840461|593508145|FG000|Overall Study|Lost to Follow-up|10|||
164309722|NCT02840461|593508146|FG001|Overall Study|Lost to Follow-up|7|||
164309723|NCT02840461|593508147|FG002|Overall Study|Lost to Follow-up|6|||
164309724|NCT02840461|593508145|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
164309725|NCT02840461|593508146|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
164309726|NCT02840461|593508147|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
164309727|NCT02840461|593508145|FG000|Overall Study|Protocol Violation|2|||
163862524|NCT00708097|591862081|FG000|Period 1|Other Reason|0|||
163862525|NCT00708097|591862082|FG001|Period 1|Other Reason|0|||
163862526|NCT00708097|591862083|FG002|Period 1|Other Reason|0|||
163862527|NCT00708097|591862084|FG003|Period 1|Other Reason|0|||
163862528|NCT00708097|591862085|FG004|Period 1|Other Reason|1|||
163862529|NCT00708097|591862081|FG000|Period 2|Protocol Violation|0|||
163862530|NCT00708097|591862082|FG001|Period 2|Protocol Violation|1|||
163862531|NCT00708097|591862083|FG002|Period 2|Protocol Violation|1|||
163862532|NCT00708097|591862084|FG003|Period 2|Protocol Violation|1|||
163862533|NCT00708097|591862085|FG004|Period 2|Protocol Violation|0|||
163862534|NCT03425643|591862086|FG000|Overall Study|Withdrawal by Subject|10|||
163862535|NCT03425643|591862087|FG001|Overall Study|Withdrawal by Subject|12|||
163862536|NCT03425643|591862086|FG000|Overall Study|Lost to Follow-up|2|||
163862537|NCT03425643|591862087|FG001|Overall Study|Lost to Follow-up|0|||
163862538|NCT03425643|591862086|FG000|Overall Study|Death|109|||
163862539|NCT03425643|591862087|FG001|Overall Study|Death|141|||
163862540|NCT03425643|591862086|FG000|Overall Study|Ongoing in study|276|||
163862541|NCT03425643|591862087|FG001|Overall Study|Ongoing in study|247|||
163862542|NCT04133363|591862088|FG000|Overall Study|Lost to Follow-up|2|||
163862543|NCT04133363|591862089|FG001|Overall Study|Lost to Follow-up|1|||
163862544|NCT04133363|591862090|FG002|Overall Study|Lost to Follow-up|4|||
163862545|NCT07214922|591862093|FG000|Overall Study|Adverse Event|0|||
163862546|NCT07214922|591862094|FG001|Overall Study|Adverse Event|0|||
163862547|NCT07214922|591862095|FG002|Overall Study|Adverse Event|1|||
163862548|NCT07214922|591862096|FG003|Overall Study|Adverse Event|0|||
163862549|NCT07214922|591862093|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163862550|NCT07214922|591862094|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
163862551|NCT07214922|591862095|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163862552|NCT07214922|591862096|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
163862553|NCT00726596|591863618|FG000|Overall Study|Adverse Event|2|||
163862554|NCT00726596|591863619|FG001|Overall Study|Adverse Event|1|||
163862555|NCT00726596|591863618|FG000|Overall Study|Withdrawal by Subject|3|||
163862556|NCT00726596|591863619|FG001|Overall Study|Withdrawal by Subject|3|||
163862557|NCT00482729|591863620|FG000|Overall Study|Adverse Event|29|||
163862558|NCT00482729|591863621|FG001|Overall Study|Adverse Event|33|||
163862559|NCT00482729|591863620|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
163862560|NCT00482729|591863621|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
163862561|NCT00482729|591863620|FG000|Overall Study|Hyperglycemia Criteria|7|||
163862562|NCT00482729|591863621|FG001|Overall Study|Hyperglycemia Criteria|5|||
163967730|NCT02229539|592255715|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
163967731|NCT02229539|592255716|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
163967732|NCT02229539|592255714|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
163967733|NCT02229539|592255715|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
164309728|NCT02840461|593508146|FG001|Overall Study|Protocol Violation|3|||
164309729|NCT02840461|593508147|FG002|Overall Study|Protocol Violation|1|||
164309730|NCT02840461|593508145|FG000|Overall Study|Withdrawal by Subject|10|||
164309731|NCT02840461|593508146|FG001|Overall Study|Withdrawal by Subject|6|||
164309732|NCT02840461|593508147|FG002|Overall Study|Withdrawal by Subject|2|||
164309733|NCT02840461|593508145|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
164309734|NCT02840461|593508146|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
164309735|NCT02840461|593508147|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
164309736|NCT03843541|593508148|FG000|Overall Study|Adverse Event|4|||
164309737|NCT03843541|593508149|FG001|Overall Study|Adverse Event|2|||
164309738|NCT03843541|593508150|FG002|Overall Study|Adverse Event|3|||
164309739|NCT03843541|593508148|FG000|Overall Study|Death|1|||
164309740|NCT03843541|593508149|FG001|Overall Study|Death|0|||
164309741|NCT03843541|593508150|FG002|Overall Study|Death|0|||
164309742|NCT03843541|593508148|FG000|Overall Study|Lack of adherence to study medication|0|||
164309743|NCT03843541|593508149|FG001|Overall Study|Lack of adherence to study medication|0|||
164309744|NCT03843541|593508150|FG002|Overall Study|Lack of adherence to study medication|1|||
164309745|NCT03843541|593508148|FG000|Overall Study|Physician Decision|1|||
164309746|NCT03843541|593508149|FG001|Overall Study|Physician Decision|2|||
164309747|NCT03843541|593508150|FG002|Overall Study|Physician Decision|2|||
164309748|NCT03843541|593508148|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
164309749|NCT03843541|593508149|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
164309750|NCT03843541|593508150|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
164309751|NCT03843541|593508148|FG000|Overall Study|Withdrawal by Subject|6|||
164309752|NCT03843541|593508149|FG001|Overall Study|Withdrawal by Subject|9|||
164309753|NCT03843541|593508150|FG002|Overall Study|Withdrawal by Subject|7|||
164309754|NCT03843541|593508148|FG000|Overall Study|Administration of rescue mucolytic|0|||
164309755|NCT03843541|593508149|FG001|Overall Study|Administration of rescue mucolytic|0|||
164309756|NCT03843541|593508150|FG002|Overall Study|Administration of rescue mucolytic|1|||
164309757|NCT03843541|593508148|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
164309758|NCT03843541|593508149|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
164309759|NCT03843541|593508150|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
164309760|NCT04163016|593508153|FG000|Enrollment|Adverse Event|1|||
164309761|NCT04163016|593508154|FG001|Enrollment|Adverse Event|0|||
164309762|NCT04163016|593508155|FG002|Enrollment|Adverse Event|0|||
164309763|NCT04163016|593508156|FG003|Enrollment|Adverse Event|0|||
164309764|NCT04163016|593508153|FG000|Treatment|Adverse Event|0|||
164309765|NCT04163016|593508154|FG001|Treatment|Adverse Event|1|||
164309766|NCT04163016|593508155|FG002|Treatment|Adverse Event|0|||
164309767|NCT04163016|593508156|FG003|Treatment|Adverse Event|0|||
164309768|NCT04163016|593508153|FG000|Treatment|Withdrawal by Subject|0|||
164309769|NCT04163016|593508154|FG001|Treatment|Withdrawal by Subject|2|||
163862563|NCT00482729|591863620|FG000|Overall Study|Lack of Efficacy|4|||
163862564|NCT00482729|591863621|FG001|Overall Study|Lack of Efficacy|16|||
163862565|NCT00482729|591863620|FG000|Overall Study|Lost to Follow-up|86|||
163862566|NCT00482729|591863621|FG001|Overall Study|Lost to Follow-up|66|||
163862567|NCT00482729|591863620|FG000|Overall Study|Physician Decision|10|||
163862568|NCT00482729|591863621|FG001|Overall Study|Physician Decision|7|||
163862569|NCT00482729|591863620|FG000|Overall Study|Pregnancy|4|||
163862570|NCT00482729|591863621|FG001|Overall Study|Pregnancy|2|||
163862571|NCT00482729|591863620|FG000|Overall Study|Protocol Violation|10|||
163862572|NCT00482729|591863621|FG001|Overall Study|Protocol Violation|18|||
163862573|NCT00482729|591863620|FG000|Overall Study|Withdrawal by Subject|67|||
163862574|NCT00482729|591863621|FG001|Overall Study|Withdrawal by Subject|69|||
163862575|NCT00954707|591863631|FG000|Overall Study|Death|34|||
163967734|NCT02229539|592255716|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
163967735|NCT02229539|592255714|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
163862576|NCT00954707|591863631|FG000|Overall Study|Withdrawal by Subject|100|||
163967736|NCT02229539|592255715|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
164309770|NCT04163016|593508155|FG002|Treatment|Withdrawal by Subject|0|||
164309771|NCT04163016|593508156|FG003|Treatment|Withdrawal by Subject|0|||
164309772|NCT04163016|593508153|FG000|Treatment|Indeterminate TB-test|0|||
164309773|NCT04163016|593508154|FG001|Treatment|Indeterminate TB-test|0|||
163862577|NCT00954707|591863631|FG000|Overall Study|Lost to Follow-up|33|||
163862578|NCT03265210|591863632|FG000|Overall Study|Withdrawal by Subject|7|||
163862579|NCT03265210|591863633|FG001|Overall Study|Withdrawal by Subject|9|||
163862580|NCT03265210|591863632|FG000|Overall Study|Lost to Follow-up|2|||
163862581|NCT03265210|591863633|FG001|Overall Study|Lost to Follow-up|0|||
163862582|NCT03265210|591863632|FG000|Overall Study|Physician Decision|2|||
163862583|NCT03265210|591863633|FG001|Overall Study|Physician Decision|0|||
163862584|NCT03265210|591863632|FG000|Overall Study|Adverse Event|1|||
163862585|NCT03265210|591863633|FG001|Overall Study|Adverse Event|0|||
163862586|NCT02488980|591863635|FG000|Overall Study|Protocol Violation|2|||
163862587|NCT02488980|591863636|FG001|Overall Study|Protocol Violation|2|||
163862588|NCT02488980|591863637|FG002|Overall Study|Protocol Violation|2|||
163862589|NCT02614560|591863641|FG000|Overall Study|Death|6|||
163862590|NCT02614560|591863642|FG001|Overall Study|Death|2|||
163862591|NCT00738699|591863643|FG000|Overall Study|Withdrawal by Subject|5|||
163862592|NCT00738699|591863644|FG001|Overall Study|Withdrawal by Subject|0|||
163862593|NCT00738699|591863643|FG000|Overall Study|Lost to Follow-up|1|||
163862594|NCT00738699|591863644|FG001|Overall Study|Lost to Follow-up|0|||
163862595|NCT00738699|591863643|FG000|Overall Study|Death|144|||
163862596|NCT00738699|591863644|FG001|Overall Study|Death|68|||
163862597|NCT00738699|591863643|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
163862598|NCT00738699|591863644|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
163862599|NCT00738699|591863643|FG000|Overall Study|Other|2|||
163862600|NCT00738699|591863644|FG001|Overall Study|Other|0|||
163862601|NCT05193318|591863645|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
163862602|NCT05193318|591863645|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
163862603|NCT03670602|591863646|FG000|Overall Study|Lost to Follow-up|1|||
163862604|NCT03670602|591863647|FG001|Overall Study|Lost to Follow-up|0|||
163862605|NCT03670602|591863646|FG000|Overall Study|Withdrawal by Subject|0|||
163862606|NCT03670602|591863647|FG001|Overall Study|Withdrawal by Subject|3|||
163862607|NCT03201809|591863648|FG000|Overall Study|Lost to Follow-up|2|||
163862608|NCT03201809|591863649|FG001|Overall Study|Lost to Follow-up|0|||
163862609|NCT00246012|591863650|FG000|Overall Study|Adverse Event|0|||
163862610|NCT00246012|591863651|FG001|Overall Study|Adverse Event|0|||
163862611|NCT00246012|591863652|FG002|Overall Study|Adverse Event|0|||
163862612|NCT00246012|591863653|FG003|Overall Study|Adverse Event|0|||
163862613|NCT00246012|591863654|FG004|Overall Study|Adverse Event|0|||
163862614|NCT00246012|591863655|FG005|Overall Study|Adverse Event|1|||
163862615|NCT00246012|591863656|FG006|Overall Study|Adverse Event|0|||
163862616|NCT00246012|591863657|FG007|Overall Study|Adverse Event|0|||
163862617|NCT00246012|591863658|FG008|Overall Study|Adverse Event|2|||
163862618|NCT00246012|591863650|FG000|Overall Study|Withdrawal by Subject|0|||
163862619|NCT00246012|591863651|FG001|Overall Study|Withdrawal by Subject|0|||
163862620|NCT00246012|591863652|FG002|Overall Study|Withdrawal by Subject|0|||
163862621|NCT00246012|591863653|FG003|Overall Study|Withdrawal by Subject|0|||
163862622|NCT00246012|591863654|FG004|Overall Study|Withdrawal by Subject|0|||
163862623|NCT00246012|591863655|FG005|Overall Study|Withdrawal by Subject|1|||
163862624|NCT00246012|591863656|FG006|Overall Study|Withdrawal by Subject|0|||
163862625|NCT00246012|591863657|FG007|Overall Study|Withdrawal by Subject|0|||
163862626|NCT00246012|591863658|FG008|Overall Study|Withdrawal by Subject|0|||
163862627|NCT00246012|591863650|FG000|Overall Study|Disease progression|3|||
163862628|NCT00246012|591863651|FG001|Overall Study|Disease progression|1|||
163862629|NCT00246012|591863652|FG002|Overall Study|Disease progression|2|||
163862630|NCT00246012|591863653|FG003|Overall Study|Disease progression|3|||
163862631|NCT00246012|591863654|FG004|Overall Study|Disease progression|3|||
163862632|NCT00246012|591863655|FG005|Overall Study|Disease progression|25|||
163862633|NCT00246012|591863656|FG006|Overall Study|Disease progression|30|||
163862634|NCT00246012|591863657|FG007|Overall Study|Disease progression|27|||
163967737|NCT02229539|592255716|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
163862635|NCT00246012|591863658|FG008|Overall Study|Disease progression|26|||
163862636|NCT00246012|591863650|FG000|Overall Study|Other|0|||
163862637|NCT00246012|591863651|FG001|Overall Study|Other|0|||
163862638|NCT00246012|591863652|FG002|Overall Study|Other|0|||
163862639|NCT00246012|591863653|FG003|Overall Study|Other|0|||
163862640|NCT00246012|591863654|FG004|Overall Study|Other|0|||
163862641|NCT00246012|591863655|FG005|Overall Study|Other|0|||
163862642|NCT00246012|591863656|FG006|Overall Study|Other|0|||
163862643|NCT00246012|591863657|FG007|Overall Study|Other|1|||
163862644|NCT00246012|591863658|FG008|Overall Study|Other|0|||
163862645|NCT00246012|591863650|FG000|Overall Study|Randomly assigned but not treated|0|||
163862646|NCT00246012|591863651|FG001|Overall Study|Randomly assigned but not treated|0|||
163862647|NCT00246012|591863652|FG002|Overall Study|Randomly assigned but not treated|0|||
163862648|NCT00246012|591863653|FG003|Overall Study|Randomly assigned but not treated|0|||
163862649|NCT00246012|591863654|FG004|Overall Study|Randomly assigned but not treated|0|||
163862650|NCT00246012|591863655|FG005|Overall Study|Randomly assigned but not treated|1|||
163862651|NCT00246012|591863656|FG006|Overall Study|Randomly assigned but not treated|1|||
163862652|NCT00246012|591863657|FG007|Overall Study|Randomly assigned but not treated|0|||
164135323|NCT00851318|592859132|FG003|Overall Study|Pregnancy|1|||
163862653|NCT00246012|591863658|FG008|Overall Study|Randomly assigned but not treated|0|||
164200914|NCT02351934|593108369|FG001|Follow-Up|Acute Kidney Injury|0|||
164200915|NCT02351934|593108368|FG000|Follow-Up|Early dismissal|3|||
164200916|NCT02351934|593108369|FG001|Follow-Up|Early dismissal|0|||
164200917|NCT02351934|593108368|FG000|Follow-Up|Hypotension|3|||
164200918|NCT02351934|593108369|FG001|Follow-Up|Hypotension|0|||
164200919|NCT02351934|593108368|FG000|Follow-Up|No documentation|2|||
164200920|NCT02351934|593108369|FG001|Follow-Up|No documentation|0|||
164200921|NCT02351934|593108368|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
164200922|NCT02351934|593108369|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
164200923|NCT02351934|593108368|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
164200924|NCT02351934|593108369|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
164200925|NCT02426684|593108372|FG000|Overall Study|Physician Decision|1|||
164200926|NCT00095979|593108379|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
164200927|NCT01483118|593108380|FG000|Overall Study|Lost to Follow-up|12|||
164200928|NCT01483118|593108381|FG001|Overall Study|Lost to Follow-up|16|||
164200929|NCT02783066|593108383|FG000|Overall Study|Withdrawal by Subject|13|||
164200930|NCT01004614|593108389|FG000|Washout|Withdrawal by Subject|0|||
164200931|NCT01004614|593108390|FG001|Washout|Withdrawal by Subject|1|||
164200932|NCT01004614|593108391|FG002|Washout|Withdrawal by Subject|0|||
164200933|NCT01004614|593108392|FG003|Washout|Withdrawal by Subject|0|||
164200934|NCT01569022|593108394|FG000|First Intervention|Lost to Follow-up|2|||
164200935|NCT01569022|593108395|FG001|First Intervention|Lost to Follow-up|1|||
164200936|NCT01569022|593108394|FG000|Second Intervention|Lost to Follow-up|2|||
164200937|NCT01569022|593108395|FG001|Second Intervention|Lost to Follow-up|2|||
164200938|NCT00644059|593108400|FG000|Overall Study|Lost to Follow-up|37|||
164200939|NCT00644059|593108401|FG001|Overall Study|Lost to Follow-up|34|||
164200940|NCT00644059|593108402|FG002|Overall Study|Lost to Follow-up|16|||
164200941|NCT00644059|593108400|FG000|Overall Study|Withdrawal by Subject|52|||
164200942|NCT00644059|593108401|FG001|Overall Study|Withdrawal by Subject|60|||
164200943|NCT00644059|593108402|FG002|Overall Study|Withdrawal by Subject|30|||
164200944|NCT00644059|593108400|FG000|Overall Study|Adverse Event|8|||
164200945|NCT00644059|593108401|FG001|Overall Study|Adverse Event|5|||
164200946|NCT00644059|593108402|FG002|Overall Study|Adverse Event|1|||
164200947|NCT00644059|593108400|FG000|Overall Study|Inappropriate Enrollment|1|||
164200948|NCT00644059|593108401|FG001|Overall Study|Inappropriate Enrollment|3|||
164200949|NCT00644059|593108402|FG002|Overall Study|Inappropriate Enrollment|0|||
164200950|NCT00644059|593108400|FG000|Overall Study|Protocol Deviation/violation|20|||
164200951|NCT00644059|593108401|FG001|Overall Study|Protocol Deviation/violation|19|||
164200952|NCT00644059|593108402|FG002|Overall Study|Protocol Deviation/violation|15|||
164200953|NCT00644059|593108400|FG000|Overall Study|Unable to classify|6|||
164200954|NCT00644059|593108401|FG001|Overall Study|Unable to classify|2|||
164200955|NCT00644059|593108402|FG002|Overall Study|Unable to classify|3|||
164200956|NCT02497469|593108403|FG000|Overall Study|Randomized but not Treated|0|||
164200957|NCT02497469|593108404|FG001|Overall Study|Randomized but not Treated|2|||
164200958|NCT02497469|593108403|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
164200959|NCT02497469|593108404|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
164200960|NCT02497469|593108403|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
164200961|NCT02497469|593108404|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
164200962|NCT02497469|593108403|FG000|Overall Study|Significant Protocol Deviation|4|||
164200963|NCT02497469|593108404|FG001|Overall Study|Significant Protocol Deviation|5|||
164200964|NCT02497469|593108403|FG000|Overall Study|Lost to Follow-up|14|||
164200965|NCT02497469|593108404|FG001|Overall Study|Lost to Follow-up|4|||
164200966|NCT02497469|593108403|FG000|Overall Study|Voluntary Withdrawal|39|||
164200967|NCT02497469|593108404|FG001|Overall Study|Voluntary Withdrawal|41|||
164200968|NCT02497469|593108403|FG000|Overall Study|Pregnancy|1|||
164200969|NCT02497469|593108404|FG001|Overall Study|Pregnancy|1|||
164200970|NCT02497469|593108403|FG000|Overall Study|Lack of Efficacy|86|||
164200971|NCT02497469|593108404|FG001|Overall Study|Lack of Efficacy|40|||
164200972|NCT02497469|593108403|FG000|Overall Study|Reason not Specified|6|||
164309774|NCT04163016|593508155|FG002|Treatment|Indeterminate TB-test|0|||
164309775|NCT04163016|593508156|FG003|Treatment|Indeterminate TB-test|1|||
164309776|NCT04163016|593508153|FG000|Treatment|Participant did not want to continue in study|0|||
164309777|NCT04163016|593508154|FG001|Treatment|Participant did not want to continue in study|0|||
164200973|NCT02497469|593108404|FG001|Overall Study|Reason not Specified|6|||
164200974|NCT03558516|593108405|FG000|Overall Study|Protocol Violation|2|||
164200975|NCT03558516|593108406|FG001|Overall Study|Protocol Violation|2|||
164200976|NCT01462942|593108410|FG000|Overall Study|Adverse Event|7|||
164200977|NCT01462942|593108411|FG001|Overall Study|Adverse Event|12|||
164200978|NCT01462942|593108412|FG002|Overall Study|Adverse Event|10|||
164200979|NCT01462942|593108413|FG003|Overall Study|Adverse Event|11|||
164200980|NCT01462942|593108414|FG004|Overall Study|Adverse Event|11|||
164200981|NCT01462942|593108410|FG000|Overall Study|Other, including COPD exacerbation|3|||
164200982|NCT01462942|593108411|FG001|Overall Study|Other, including COPD exacerbation|5|||
164200983|NCT01462942|593108412|FG002|Overall Study|Other, including COPD exacerbation|2|||
164200984|NCT01462942|593108413|FG003|Overall Study|Other, including COPD exacerbation|8|||
164200985|NCT01462942|593108414|FG004|Overall Study|Other, including COPD exacerbation|5|||
164200986|NCT01462942|593108410|FG000|Overall Study|Withdrawal by Subject|14|||
164309778|NCT04163016|593508155|FG002|Treatment|Participant did not want to continue in study|0|||
164309779|NCT04163016|593508156|FG003|Treatment|Participant did not want to continue in study|1|||
164309780|NCT01104311|593508158|FG000|Overall Study|Withdrawal by Subject|6|||
164309781|NCT01104311|593508159|FG001|Overall Study|Withdrawal by Subject|6|||
164309782|NCT01104311|593508158|FG000|Overall Study|Protocol Violation|0|||
164309783|NCT01104311|593508159|FG001|Overall Study|Protocol Violation|1|||
164309784|NCT01104311|593508158|FG000|Overall Study|Physician Decision|2|||
164309785|NCT01104311|593508159|FG001|Overall Study|Physician Decision|2|||
164309786|NCT01104311|593508158|FG000|Overall Study|low compliance|1|||
164309787|NCT01104311|593508159|FG001|Overall Study|low compliance|1|||
164309788|NCT01104311|593508158|FG000|Overall Study|Adverse Event|1|||
164309789|NCT01104311|593508159|FG001|Overall Study|Adverse Event|2|||
164309790|NCT04434937|593508161|FG000|Overall Study|Death|4|||
164309791|NCT04434937|593508161|FG000|Overall Study|Withdrawal by Subject|1|||
164309792|NCT04434937|593508161|FG000|Overall Study|Transitioned to Rollover Study|19|||
164309793|NCT04434937|593508161|FG000|Overall Study|Progressive Disease|18|||
164309794|NCT04193189|593508166|FG000|Overall Study|Lost to Follow-up|9|||
164309795|NCT04193189|593508167|FG001|Overall Study|Lost to Follow-up|7|||
164309796|NCT04193189|593508168|FG002|Overall Study|Lost to Follow-up|9|||
164309797|NCT04193189|593508169|FG003|Overall Study|Lost to Follow-up|0|||
164309798|NCT04193189|593508166|FG000|Overall Study|Withdrawal by Subject|1|||
164309799|NCT04193189|593508167|FG001|Overall Study|Withdrawal by Subject|2|||
164309800|NCT04193189|593508168|FG002|Overall Study|Withdrawal by Subject|2|||
164309801|NCT04193189|593508169|FG003|Overall Study|Withdrawal by Subject|0|||
164309802|NCT04193189|593508166|FG000|Overall Study|Death|1|||
164309803|NCT04193189|593508167|FG001|Overall Study|Death|1|||
164309804|NCT04193189|593508168|FG002|Overall Study|Death|0|||
164309805|NCT04193189|593508169|FG003|Overall Study|Death|0|||
164309806|NCT04193189|593508166|FG000|Overall Study|Protocol Violation|0|||
164309807|NCT04193189|593508167|FG001|Overall Study|Protocol Violation|0|||
164309808|NCT04193189|593508168|FG002|Overall Study|Protocol Violation|0|||
164309809|NCT04193189|593508169|FG003|Overall Study|Protocol Violation|1|||
164309810|NCT04549545|593509504|FG000|Initial Period|Withdrawal by Subject|4|||
164309811|NCT04549545|593509505|FG001|Initial Period|Withdrawal by Subject|0|||
164309812|NCT04549545|593509504|FG000|Initial Period|Additional ENT Procedure|3|||
164309813|NCT04549545|593509505|FG001|Initial Period|Additional ENT Procedure|0|||
164309814|NCT04549545|593509504|FG000|Initial Period|Lost to Follow-up|3|||
164309815|NCT04549545|593509505|FG001|Initial Period|Lost to Follow-up|1|||
164309816|NCT04549545|593509504|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
164309817|NCT04549545|593509505|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
164309818|NCT04549545|593509504|FG000|Crossover Period|Additional ENT Procedure|0|||
164309819|NCT04549545|593509505|FG001|Crossover Period|Additional ENT Procedure|6|||
164309820|NCT04549545|593509504|FG000|Crossover Period|Lost to Follow-up|0|||
164309821|NCT04549545|593509505|FG001|Crossover Period|Lost to Follow-up|1|||
164309822|NCT04549545|593509504|FG000|Crossover Period|Withdrawal by Subject|0|||
164309823|NCT04549545|593509505|FG001|Crossover Period|Withdrawal by Subject|4|||
164309824|NCT00295880|593509509|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
164309825|NCT00295880|593509509|FG000|Overall Study|Unit randomization did not occur|1|||
164309826|NCT01474239|593509510|FG000|Overall Study|Disease Progression|37|||
164309827|NCT01474239|593509511|FG001|Overall Study|Disease Progression|25|||
164309828|NCT01474239|593509510|FG000|Overall Study|Adverse Event|12|||
164309829|NCT01474239|593509511|FG001|Overall Study|Adverse Event|3|||
164309830|NCT01474239|593509510|FG000|Overall Study|Withdrawal by Subject|1|||
164309831|NCT01474239|593509511|FG001|Overall Study|Withdrawal by Subject|2|||
164309832|NCT01474239|593509510|FG000|Overall Study|Death|1|||
164309833|NCT01474239|593509511|FG001|Overall Study|Death|1|||
164309834|NCT01474239|593509510|FG000|Overall Study|Clinical Disease Progression|7|||
164309835|NCT01474239|593509511|FG001|Overall Study|Clinical Disease Progression|1|||
164309836|NCT01474239|593509510|FG000|Overall Study|Withdrawal for Economic Reason|1|||
164309837|NCT01474239|593509511|FG001|Overall Study|Withdrawal for Economic Reason|0|||
164309838|NCT01243242|593509512|FG000|Overall Study|Adverse Event|1|||
164309839|NCT01243242|593509513|FG001|Overall Study|Adverse Event|1|||
164309840|NCT01243242|593509512|FG000|Overall Study|Withdrawal by Subject|1|||
164309841|NCT01243242|593509513|FG001|Overall Study|Withdrawal by Subject|1|||
164309842|NCT01243242|593509512|FG000|Overall Study|Physician Decision|0|||
164309843|NCT01243242|593509513|FG001|Overall Study|Physician Decision|1|||
164309844|NCT01243242|593509512|FG000|Overall Study|sponsor decision|0|||
164309845|NCT01243242|593509513|FG001|Overall Study|sponsor decision|1|||
164309846|NCT01243242|593509512|FG000|Overall Study|non compliance|1|||
164309847|NCT01243242|593509513|FG001|Overall Study|non compliance|0|||
164309848|NCT03983317|593509514|FG000|Overall Study|Physician Decision|5|||
164309849|NCT00792571|593509515|FG000|Overall Study|Death|1|||
164309850|NCT00792571|593509515|FG000|Overall Study|Adverse Event|4|||
164309851|NCT00792571|593509515|FG000|Overall Study|Withdrawal by Subject|1|||
164309852|NCT00792571|593509515|FG000|Overall Study|Other|4|||
164309853|NCT03790696|593509517|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
164309854|NCT03790696|593509518|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
164309855|NCT04896086|593509519|FG000|Overall Study|Lost to Follow-up|0|||
164309856|NCT04896086|593509520|FG001|Overall Study|Lost to Follow-up|2|||
164309857|NCT04896086|593509521|FG002|Overall Study|Lost to Follow-up|1|||
164309858|NCT04896086|593509522|FG003|Overall Study|Lost to Follow-up|0|||
164309859|NCT04896086|593509523|FG004|Overall Study|Lost to Follow-up|0|||
164309860|NCT04896086|593509519|FG000|Overall Study|Physician Decision|0|||
164309861|NCT04896086|593509520|FG001|Overall Study|Physician Decision|1|||
164309862|NCT04896086|593509521|FG002|Overall Study|Physician Decision|0|||
164309863|NCT04896086|593509522|FG003|Overall Study|Physician Decision|0|||
164309864|NCT04896086|593509523|FG004|Overall Study|Physician Decision|0|||
164309865|NCT04896086|593509519|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309866|NCT04896086|593509520|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309867|NCT04896086|593509521|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309868|NCT04896086|593509522|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
164309869|NCT04896086|593509523|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
164309870|NCT04896086|593509519|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309871|NCT04896086|593509520|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309872|NCT04896086|593509521|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309873|NCT04896086|593509522|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
164309874|NCT04896086|593509523|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
164309875|NCT02249832|593509524|FG000|Overall Study|Withdrawal by Subject|3|||
164309876|NCT02249832|593509524|FG000|Overall Study|Lost to Follow-up|10|||
164309877|NCT00485134|593509530|FG000|Overall Study|Lost to Follow-up|1|||
164309878|NCT00485134|593509531|FG001|Overall Study|Lost to Follow-up|0|||
164309879|NCT00485134|593509532|FG002|Overall Study|Lost to Follow-up|0|||
164309880|NCT00485134|593509533|FG003|Overall Study|Lost to Follow-up|0|||
164309881|NCT00485134|593509534|FG004|Overall Study|Lost to Follow-up|0|||
164309882|NCT00485134|593509535|FG005|Overall Study|Lost to Follow-up|0|||
164309883|NCT00485134|593509536|FG006|Overall Study|Lost to Follow-up|0|||
164309884|NCT00485134|593509537|FG007|Overall Study|Lost to Follow-up|0|||
164309885|NCT00485134|593509530|FG000|Overall Study|Withdrawal by Subject|0|||
164309886|NCT00485134|593509531|FG001|Overall Study|Withdrawal by Subject|1|||
164309887|NCT00485134|593509532|FG002|Overall Study|Withdrawal by Subject|0|||
164309888|NCT00485134|593509533|FG003|Overall Study|Withdrawal by Subject|0|||
164309889|NCT00485134|593509534|FG004|Overall Study|Withdrawal by Subject|0|||
164309890|NCT00485134|593509535|FG005|Overall Study|Withdrawal by Subject|0|||
164309891|NCT00485134|593509536|FG006|Overall Study|Withdrawal by Subject|0|||
164309892|NCT00485134|593509537|FG007|Overall Study|Withdrawal by Subject|0|||
164309893|NCT00485134|593509530|FG000|Overall Study|Change in health status|0|||
164309894|NCT00485134|593509531|FG001|Overall Study|Change in health status|1|||
164309895|NCT00485134|593509532|FG002|Overall Study|Change in health status|2|||
164309896|NCT00485134|593509533|FG003|Overall Study|Change in health status|1|||
164309897|NCT00485134|593509534|FG004|Overall Study|Change in health status|0|||
164309898|NCT00485134|593509535|FG005|Overall Study|Change in health status|1|||
164309899|NCT00485134|593509536|FG006|Overall Study|Change in health status|0|||
164309900|NCT00485134|593509537|FG007|Overall Study|Change in health status|0|||
164309901|NCT00485134|593509530|FG000|Overall Study|Withdrew for adverse event|0|||
164309902|NCT00485134|593509531|FG001|Overall Study|Withdrew for adverse event|0|||
164309903|NCT00485134|593509532|FG002|Overall Study|Withdrew for adverse event|1|||
164309904|NCT00485134|593509533|FG003|Overall Study|Withdrew for adverse event|0|||
164309905|NCT00485134|593509534|FG004|Overall Study|Withdrew for adverse event|0|||
164309906|NCT00485134|593509535|FG005|Overall Study|Withdrew for adverse event|0|||
164309907|NCT00485134|593509536|FG006|Overall Study|Withdrew for adverse event|0|||
164309908|NCT00485134|593509537|FG007|Overall Study|Withdrew for adverse event|0|||
164309909|NCT00485134|593509530|FG000|Overall Study|Positive drug test|0|||
164309910|NCT00485134|593509531|FG001|Overall Study|Positive drug test|0|||
164309911|NCT00485134|593509532|FG002|Overall Study|Positive drug test|0|||
164309912|NCT00485134|593509533|FG003|Overall Study|Positive drug test|0|||
164309913|NCT00485134|593509534|FG004|Overall Study|Positive drug test|2|||
164309914|NCT00485134|593509535|FG005|Overall Study|Positive drug test|1|||
164309915|NCT00485134|593509536|FG006|Overall Study|Positive drug test|0|||
164309916|NCT00485134|593509537|FG007|Overall Study|Positive drug test|0|||
164309917|NCT00485134|593509530|FG000|Overall Study|Non-compliance|0|||
164309918|NCT00485134|593509531|FG001|Overall Study|Non-compliance|0|||
164309919|NCT00485134|593509532|FG002|Overall Study|Non-compliance|0|||
164309920|NCT00485134|593509533|FG003|Overall Study|Non-compliance|0|||
164309921|NCT00485134|593509534|FG004|Overall Study|Non-compliance|1|||
164309922|NCT00485134|593509535|FG005|Overall Study|Non-compliance|2|||
163862654|NCT02377362|591863659|FG000|Part A Second Treatment|Protocol Violation|0|||
163862655|NCT02377362|591863660|FG001|Part A Second Treatment|Protocol Violation|0|||
164309923|NCT00485134|593509536|FG006|Overall Study|Non-compliance|2|||
164309924|NCT00485134|593509537|FG007|Overall Study|Non-compliance|0|||
164309925|NCT00485134|593509530|FG000|Overall Study|Unable to comply with study schedule|0|||
163862656|NCT02377362|591863661|FG002|Part A Second Treatment|Protocol Violation|0|||
163967738|NCT02229539|592255714|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
163967739|NCT02229539|592255715|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
163967740|NCT02229539|592255716|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
163967741|NCT03441334|592255717|FG000|Overall Study|Withdrawal by Subject|1|||
163967742|NCT03441334|592255718|FG001|Overall Study|Withdrawal by Subject|0|||
163967743|NCT00088907|592255719|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
163967744|NCT00088907|592255720|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
163967745|NCT00088907|592255719|FG000|Randomized Study (Step 1)|Adverse Event|14|||
164200987|NCT01462942|593108411|FG001|Overall Study|Withdrawal by Subject|10|||
164200988|NCT01462942|593108412|FG002|Overall Study|Withdrawal by Subject|14|||
164200989|NCT01462942|593108413|FG003|Overall Study|Withdrawal by Subject|16|||
164200990|NCT01462942|593108414|FG004|Overall Study|Withdrawal by Subject|19|||
164200991|NCT01462942|593108410|FG000|Overall Study|Lack of Efficacy|6|||
164200992|NCT01462942|593108411|FG001|Overall Study|Lack of Efficacy|0|||
164200993|NCT01462942|593108412|FG002|Overall Study|Lack of Efficacy|4|||
164200994|NCT01462942|593108413|FG003|Overall Study|Lack of Efficacy|5|||
164200995|NCT01462942|593108414|FG004|Overall Study|Lack of Efficacy|3|||
164200996|NCT01462942|593108410|FG000|Overall Study|Lost to Follow-up|0|||
164200997|NCT01462942|593108411|FG001|Overall Study|Lost to Follow-up|1|||
164200998|NCT01462942|593108412|FG002|Overall Study|Lost to Follow-up|1|||
164200999|NCT01462942|593108413|FG003|Overall Study|Lost to Follow-up|1|||
164201000|NCT01462942|593108414|FG004|Overall Study|Lost to Follow-up|1|||
164201001|NCT01462942|593108410|FG000|Overall Study|Protocol Violation|4|||
164201002|NCT01462942|593108411|FG001|Overall Study|Protocol Violation|6|||
164201003|NCT01462942|593108412|FG002|Overall Study|Protocol Violation|9|||
164201004|NCT01462942|593108413|FG003|Overall Study|Protocol Violation|9|||
164201005|NCT01462942|593108414|FG004|Overall Study|Protocol Violation|6|||
164201006|NCT00572832|593108436|FG000|Overall Study|Lost to Follow-up|0|||
164201007|NCT00572832|593108437|FG001|Overall Study|Lost to Follow-up|11|||
164201008|NCT00572832|593108436|FG000|Overall Study|Pregnancy|0|||
164201009|NCT00572832|593108437|FG001|Overall Study|Pregnancy|1|||
164201010|NCT01604785|593108442|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
164201011|NCT01604785|593108443|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
164201012|NCT05214118|593108444|FG000|Overall Study|Lost to Follow-up|0|||
164201013|NCT05214118|593108445|FG001|Overall Study|Lost to Follow-up|2|||
164201014|NCT05214118|593108444|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
164201015|NCT05214118|593108445|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
164201016|NCT05214118|593108444|FG000|Overall Study|moved|1|||
164201017|NCT05214118|593108445|FG001|Overall Study|moved|0|||
164201018|NCT00931632|593108446|FG000|Overall Study|Withdrawal by Subject|2|||
164201019|NCT00931632|593108447|FG001|Overall Study|Withdrawal by Subject|3|||
164201020|NCT00931632|593108446|FG000|Overall Study|Adverse Event|19|||
164201021|NCT00931632|593108447|FG001|Overall Study|Adverse Event|15|||
164201022|NCT01419314|593108449|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
164201023|NCT01419314|593108450|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
164201024|NCT01419314|593108449|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
164201025|NCT01419314|593108450|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
164201026|NCT01419314|593108449|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
164201027|NCT01419314|593108450|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
164201028|NCT00449163|593108451|FG000|Overall Study|Physician Decision|3|||
164201029|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
164201030|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
164201031|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
164201032|NCT03368807|593108454|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
164201033|NCT01118052|593108455|FG000|Overall Study|Never treated|2|||
164201034|NCT00843492|593108457|FG000|Overall Study|Adverse Event|0|||
164201035|NCT00843492|593108458|FG001|Overall Study|Adverse Event|3|||
164201036|NCT00843492|593108457|FG000|Overall Study|Lost to Follow-up|4|||
164201037|NCT00843492|593108458|FG001|Overall Study|Lost to Follow-up|4|||
164201038|NCT00843492|593108457|FG000|Overall Study|Withdrawal by Subject|0|||
164201039|NCT00843492|593108458|FG001|Overall Study|Withdrawal by Subject|4|||
164201040|NCT00843492|593108457|FG000|Overall Study|Immobilization Stopped|1|||
164201041|NCT00843492|593108458|FG001|Overall Study|Immobilization Stopped|0|||
163967746|NCT00088907|592255720|FG001|Randomized Study (Step 1)|Adverse Event|19|||
163967747|NCT00088907|592255719|FG000|Randomized Study (Step 1)|Death|11|||
163967748|NCT00088907|592255720|FG001|Randomized Study (Step 1)|Death|12|||
164201042|NCT00843492|593108457|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
164201043|NCT00843492|593108458|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
164201044|NCT00843492|593108457|FG000|Overall Study|Orthopedic Surgery|0|||
164201045|NCT00843492|593108458|FG001|Overall Study|Orthopedic Surgery|2|||
164201046|NCT00843492|593108457|FG000|Overall Study|Visit Not Performed|1|||
164201047|NCT00843492|593108458|FG001|Overall Study|Visit Not Performed|0|||
164201048|NCT00843492|593108457|FG000|Overall Study|Deep-vein Thrombosis|1|||
164201049|NCT00843492|593108458|FG001|Overall Study|Deep-vein Thrombosis|0|||
164201050|NCT01677741|593108460|FG000|Overall Study|Death|0|||
164201051|NCT01677741|593108461|FG001|Overall Study|Death|0|||
163967749|NCT00088907|592255719|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
163967750|NCT00088907|592255720|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
163967751|NCT00088907|592255719|FG000|Randomized Study (Step 1)|complicating disease|3|||
163967752|NCT00088907|592255720|FG001|Randomized Study (Step 1)|complicating disease|1|||
163967753|NCT00088907|592255719|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
163967754|NCT00088907|592255720|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
163967755|NCT00088907|592255719|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
163967756|NCT00088907|592255720|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
163967757|NCT00088907|592255719|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
163967758|NCT00088907|592255720|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
163967759|NCT00088907|592255719|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
163967760|NCT00088907|592255720|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
163967761|NCT00088907|592255719|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
163967762|NCT00088907|592255720|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
163967763|NCT00088907|592255719|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
163967764|NCT00088907|592255720|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
163967765|NCT00682448|592255725|FG000|Overall Study|Adverse Event|1|||
163967766|NCT00682448|592255726|FG001|Overall Study|Adverse Event|2|||
163967767|NCT00682448|592255725|FG000|Overall Study|Lack of Efficacy|1|||
163862657|NCT02377362|591863662|FG003|Part A Second Treatment|Protocol Violation|0|||
163862658|NCT02377362|591863663|FG004|Part A Second Treatment|Protocol Violation|1|||
163967768|NCT00682448|592255726|FG001|Overall Study|Lack of Efficacy|0|||
163967769|NCT00682448|592255725|FG000|Overall Study|Lost to Follow-up|1|||
163967770|NCT00682448|592255726|FG001|Overall Study|Lost to Follow-up|3|||
163967771|NCT00682448|592255725|FG000|Overall Study|Pregnancy|0|||
163967772|NCT00682448|592255726|FG001|Overall Study|Pregnancy|1|||
163967773|NCT00682448|592255725|FG000|Overall Study|Withdrawal by Subject|2|||
163967774|NCT00682448|592255726|FG001|Overall Study|Withdrawal by Subject|0|||
163967775|NCT04050670|592255729|FG000|Period 3|Physician Decision|0|||
163967776|NCT04050670|592255730|FG001|Period 3|Physician Decision|1|||
163967777|NCT04050670|592255731|FG002|Period 3|Physician Decision|0|||
163967778|NCT00268437|592255732|FG000|Overall Study|Ineligible|1|||
163967779|NCT00388505|592255738|FG000|Overall Study|Adverse Event or Death|43|||
163967780|NCT00388505|592255739|FG001|Overall Study|Adverse Event or Death|17|||
163967781|NCT00388505|592255738|FG000|Overall Study|Withdrawal by Subject|24|||
163967782|NCT00388505|592255739|FG001|Overall Study|Withdrawal by Subject|9|||
163967783|NCT00388505|592255738|FG000|Overall Study|Lost to Follow-up|5|||
163967784|NCT00388505|592255739|FG001|Overall Study|Lost to Follow-up|3|||
163967785|NCT00388505|592255738|FG000|Overall Study|Inappropriate Enrollment|0|||
163967786|NCT00388505|592255739|FG001|Overall Study|Inappropriate Enrollment|1|||
163967787|NCT00388505|592255738|FG000|Overall Study|Administrative Reason|1|||
163967788|NCT00388505|592255739|FG001|Overall Study|Administrative Reason|0|||
163967789|NCT00388505|592255738|FG000|Overall Study|Protocol Violation|6|||
164201052|NCT01677741|593108462|FG002|Overall Study|Death|0|||
164201053|NCT01677741|593108463|FG003|Overall Study|Death|1|||
164201054|NCT01677741|593108464|FG004|Overall Study|Death|0|||
163862659|NCT02377362|591863664|FG005|Part A Second Treatment|Protocol Violation|0|||
163862660|NCT02377362|591863665|FG006|Part A Second Treatment|Protocol Violation|0|||
163862661|NCT02377362|591863666|FG007|Part A Second Treatment|Protocol Violation|0|||
163862662|NCT02377362|591863667|FG008|Part A Second Treatment|Protocol Violation|0|||
163862663|NCT02377362|591863668|FG009|Part A Second Treatment|Protocol Violation|0|||
163862664|NCT02377362|591863669|FG010|Part A Second Treatment|Protocol Violation|0|||
163862665|NCT02377362|591863670|FG011|Part A Second Treatment|Protocol Violation|0|||
163862666|NCT02377362|591863671|FG012|Part A Second Treatment|Protocol Violation|0|||
163862667|NCT02377362|591863659|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862668|NCT02377362|591863660|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862669|NCT02377362|591863661|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862670|NCT02377362|591863662|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
163862671|NCT02377362|591863663|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
163862672|NCT02377362|591863664|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
163862673|NCT02377362|591863665|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862674|NCT02377362|591863666|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862675|NCT02377362|591863667|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
163967790|NCT00388505|592255739|FG001|Overall Study|Protocol Violation|5|||
163967791|NCT00388505|592255738|FG000|Overall Study|Unable to classify|4|||
163967792|NCT00388505|592255739|FG001|Overall Study|Unable to classify|3|||
163967793|NCT00710879|592255742|FG000|Overall Study|Lost to Follow-up|2|||
163967794|NCT00710879|592255743|FG001|Overall Study|Lost to Follow-up|1|||
163967795|NCT00710879|592255742|FG000|Overall Study|Protocol Violation|0|||
163967796|NCT00710879|592255743|FG001|Overall Study|Protocol Violation|3|||
163967797|NCT01809132|592255744|FG000|Overall Study|Withdrawal by Subject|0|||
163967798|NCT01809132|592255745|FG001|Overall Study|Withdrawal by Subject|0|||
164201055|NCT01677741|593108465|FG005|Overall Study|Death|1|||
164201056|NCT01677741|593108466|FG006|Overall Study|Death|0|||
163967799|NCT01809132|592255746|FG002|Overall Study|Withdrawal by Subject|1|||
163967800|NCT04854434|592255747|FG000|Overall Study|Death|1|||
163967801|NCT04854434|592255748|FG001|Overall Study|Death|3|||
163967802|NCT04854434|592255749|FG002|Overall Study|Death|4|||
163967803|NCT04854434|592255747|FG000|Overall Study|Study Terminated by Sponsor|2|||
163967804|NCT04854434|592255748|FG001|Overall Study|Study Terminated by Sponsor|0|||
163967805|NCT04854434|592255749|FG002|Overall Study|Study Terminated by Sponsor|0|||
163967806|NCT04854434|592255747|FG000|Overall Study|Other|1|||
163967807|NCT04854434|592255748|FG001|Overall Study|Other|1|||
163967808|NCT04854434|592255749|FG002|Overall Study|Other|0|||
163967809|NCT03349775|592255750|FG000|Overall Study|Side Effects|1|||
163967810|NCT03349775|592255751|FG001|Overall Study|Side Effects|2|||
163967811|NCT03349775|592255750|FG000|Overall Study|Withdrawal by Subject|1|||
163967812|NCT03349775|592255751|FG001|Overall Study|Withdrawal by Subject|1|||
163967813|NCT03349775|592255750|FG000|Overall Study|No primary outcome measurements|0|||
163967814|NCT03349775|592255751|FG001|Overall Study|No primary outcome measurements|1|||
163967815|NCT02667275|592255752|FG000|Overall Study|Protocol Violation|11|||
163967816|NCT02667275|592255753|FG001|Overall Study|Protocol Violation|7|||
163967817|NCT02667275|592255752|FG000|Overall Study|Lost to Follow-up|0|||
163967818|NCT02667275|592255753|FG001|Overall Study|Lost to Follow-up|2|||
163967819|NCT02667275|592255752|FG000|Overall Study|Withdrawal by Subject|0|||
163967820|NCT02667275|592255753|FG001|Overall Study|Withdrawal by Subject|5|||
163967821|NCT02667275|592255752|FG000|Overall Study|Discontinued early without completing|0|||
163967822|NCT02667275|592255753|FG001|Overall Study|Discontinued early without completing|1|||
163967823|NCT01274715|592255754|FG000|Overall Study|Lost to Follow-up|1|||
163967824|NCT01274715|592255754|FG000|Overall Study|After consent, met exclusion criteria.|1|||
163967825|NCT01274715|592255754|FG000|Overall Study|After consent, met exclusion criteria.|1|||
163967826|NCT01274715|592255754|FG000|Overall Study|After consent, met exclusion criteria.|1|||
163967827|NCT04479436|592255755|FG000|Overall Study|Progressive disease|26|||
163967828|NCT04479436|592255756|FG001|Overall Study|Progressive disease|1|||
163967829|NCT04479436|592255755|FG000|Overall Study|Adverse Event|6|||
163967830|NCT04479436|592255756|FG001|Overall Study|Adverse Event|0|||
163967831|NCT04479436|592255755|FG000|Overall Study|Withdrawal by Subject|5|||
163967832|NCT04479436|592255756|FG001|Overall Study|Withdrawal by Subject|0|||
163967833|NCT04479436|592255755|FG000|Overall Study|Clinical progression|1|||
163967834|NCT04479436|592255756|FG001|Overall Study|Clinical progression|0|||
163967835|NCT04479436|592255755|FG000|Overall Study|Physician Decision|1|||
163967836|NCT04479436|592255756|FG001|Overall Study|Physician Decision|0|||
163967837|NCT00467779|592255764|FG000|Stage 1|Adverse Event|1|||
163967838|NCT00467779|592255765|FG001|Stage 1|Adverse Event|0|||
163967839|NCT00467779|592255766|FG002|Stage 1|Adverse Event|0|||
163967840|NCT00467779|592255767|FG003|Stage 1|Adverse Event|0|||
163967841|NCT00467779|592255768|FG004|Stage 1|Adverse Event|0|||
163967842|NCT00467779|592255769|FG005|Stage 1|Adverse Event|1|||
163967843|NCT00467779|592255770|FG006|Stage 1|Adverse Event|2|||
163967844|NCT00467779|592255771|FG007|Stage 1|Adverse Event|1|||
163967845|NCT00467779|592255772|FG008|Stage 1|Adverse Event|0|||
163967846|NCT00467779|592255773|FG009|Stage 1|Adverse Event|0|||
163967847|NCT00467779|592255774|FG010|Stage 1|Adverse Event|0|||
163967848|NCT00467779|592255775|FG011|Stage 1|Adverse Event|0|||
163967849|NCT00467779|592255776|FG012|Stage 1|Adverse Event|0|||
163967850|NCT00467779|592255777|FG013|Stage 1|Adverse Event|0|||
163967851|NCT00467779|592255778|FG014|Stage 1|Adverse Event|0|||
163967852|NCT00467779|592255764|FG000|Stage 1|Disease Progression|2|||
163967853|NCT00467779|592255765|FG001|Stage 1|Disease Progression|2|||
163967854|NCT00467779|592255766|FG002|Stage 1|Disease Progression|2|||
163967855|NCT00467779|592255767|FG003|Stage 1|Disease Progression|3|||
163967856|NCT00467779|592255768|FG004|Stage 1|Disease Progression|2|||
163967857|NCT00467779|592255769|FG005|Stage 1|Disease Progression|2|||
163967858|NCT00467779|592255770|FG006|Stage 1|Disease Progression|4|||
163967859|NCT00467779|592255771|FG007|Stage 1|Disease Progression|5|||
163967860|NCT00467779|592255772|FG008|Stage 1|Disease Progression|0|||
164309926|NCT00485134|593509531|FG001|Overall Study|Unable to comply with study schedule|0|||
163967861|NCT00467779|592255773|FG009|Stage 1|Disease Progression|0|||
163967862|NCT00467779|592255774|FG010|Stage 1|Disease Progression|0|||
163967863|NCT00467779|592255775|FG011|Stage 1|Disease Progression|0|||
163967864|NCT00467779|592255776|FG012|Stage 1|Disease Progression|0|||
163967865|NCT00467779|592255777|FG013|Stage 1|Disease Progression|0|||
163967866|NCT00467779|592255778|FG014|Stage 1|Disease Progression|0|||
163967867|NCT00467779|592255764|FG000|Stage 1|Unspecified Reason|1|||
163967868|NCT00467779|592255765|FG001|Stage 1|Unspecified Reason|0|||
163967869|NCT00467779|592255766|FG002|Stage 1|Unspecified Reason|1|||
163967870|NCT00467779|592255767|FG003|Stage 1|Unspecified Reason|0|||
163967871|NCT00467779|592255768|FG004|Stage 1|Unspecified Reason|1|||
163967872|NCT00467779|592255769|FG005|Stage 1|Unspecified Reason|2|||
163967873|NCT00467779|592255770|FG006|Stage 1|Unspecified Reason|0|||
163967874|NCT00467779|592255771|FG007|Stage 1|Unspecified Reason|0|||
163967875|NCT00467779|592255772|FG008|Stage 1|Unspecified Reason|0|||
163967876|NCT00467779|592255773|FG009|Stage 1|Unspecified Reason|0|||
163967877|NCT00467779|592255774|FG010|Stage 1|Unspecified Reason|0|||
163862676|NCT02377362|591863668|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862677|NCT02377362|591863669|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862678|NCT02377362|591863670|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862679|NCT02377362|591863671|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
163862680|NCT02377362|591863659|FG000|Part B Overall|Protocol Violation|0|||
163862681|NCT02377362|591863660|FG001|Part B Overall|Protocol Violation|0|||
163862682|NCT02377362|591863661|FG002|Part B Overall|Protocol Violation|0|||
163862683|NCT02377362|591863662|FG003|Part B Overall|Protocol Violation|0|||
163862684|NCT02377362|591863663|FG004|Part B Overall|Protocol Violation|0|||
163862685|NCT02377362|591863664|FG005|Part B Overall|Protocol Violation|0|||
163862686|NCT02377362|591863665|FG006|Part B Overall|Protocol Violation|0|||
163862687|NCT02377362|591863666|FG007|Part B Overall|Protocol Violation|0|||
163862688|NCT02377362|591863667|FG008|Part B Overall|Protocol Violation|0|||
163862689|NCT02377362|591863668|FG009|Part B Overall|Protocol Violation|1|||
163862690|NCT02377362|591863669|FG010|Part B Overall|Protocol Violation|0|||
163862691|NCT02377362|591863670|FG011|Part B Overall|Protocol Violation|0|||
163862692|NCT02377362|591863671|FG012|Part B Overall|Protocol Violation|0|||
163862693|NCT02377362|591863659|FG000|Part B Overall|Adverse Event|0|||
163862694|NCT02377362|591863660|FG001|Part B Overall|Adverse Event|0|||
163862695|NCT02377362|591863661|FG002|Part B Overall|Adverse Event|0|||
163862696|NCT02377362|591863662|FG003|Part B Overall|Adverse Event|0|||
163862697|NCT02377362|591863663|FG004|Part B Overall|Adverse Event|0|||
163862698|NCT02377362|591863664|FG005|Part B Overall|Adverse Event|0|||
163862699|NCT02377362|591863665|FG006|Part B Overall|Adverse Event|1|||
163862700|NCT02377362|591863666|FG007|Part B Overall|Adverse Event|1|||
163862701|NCT02377362|591863667|FG008|Part B Overall|Adverse Event|0|||
163862702|NCT02377362|591863668|FG009|Part B Overall|Adverse Event|0|||
163862703|NCT02377362|591863669|FG010|Part B Overall|Adverse Event|0|||
163862704|NCT02377362|591863670|FG011|Part B Overall|Adverse Event|0|||
163862705|NCT02377362|591863671|FG012|Part B Overall|Adverse Event|0|||
163862706|NCT02377362|591863659|FG000|Part B Overall|Withdrawal by Subject|0|||
163862707|NCT02377362|591863660|FG001|Part B Overall|Withdrawal by Subject|0|||
163862708|NCT02377362|591863661|FG002|Part B Overall|Withdrawal by Subject|0|||
163862709|NCT02377362|591863662|FG003|Part B Overall|Withdrawal by Subject|0|||
163862710|NCT02377362|591863663|FG004|Part B Overall|Withdrawal by Subject|0|||
163862711|NCT02377362|591863664|FG005|Part B Overall|Withdrawal by Subject|0|||
163862712|NCT02377362|591863665|FG006|Part B Overall|Withdrawal by Subject|1|||
163862713|NCT02377362|591863666|FG007|Part B Overall|Withdrawal by Subject|0|||
163862714|NCT02377362|591863667|FG008|Part B Overall|Withdrawal by Subject|0|||
163862715|NCT02377362|591863668|FG009|Part B Overall|Withdrawal by Subject|0|||
163862716|NCT02377362|591863669|FG010|Part B Overall|Withdrawal by Subject|0|||
163862717|NCT02377362|591863670|FG011|Part B Overall|Withdrawal by Subject|1|||
163862718|NCT02377362|591863671|FG012|Part B Overall|Withdrawal by Subject|0|||
163862719|NCT04889664|591863672|FG000|Screen|Lost to Follow-up|1|||
163862720|NCT04889664|591863672|FG000|Screen|Failed to meet screening criteria|1|||
163862721|NCT04889664|591863672|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
163862722|NCT02469064|591863678|FG000|Overall Study|Request not to receive intervention.|1|||
163862723|NCT02469064|591863679|FG001|Overall Study|Request not to receive intervention.|3|||
163862724|NCT04107805|591863680|FG000|Overall Study|Adverse Event|0|||
163862725|NCT04107805|591863681|FG001|Overall Study|Adverse Event|0|||
163862726|NCT04107805|591863682|FG002|Overall Study|Adverse Event|0|||
163862727|NCT04107805|591863683|FG003|Overall Study|Adverse Event|1|||
163862728|NCT04107805|591863684|FG004|Overall Study|Adverse Event|0|||
163862729|NCT04107805|591863685|FG005|Overall Study|Adverse Event|1|||
163862730|NCT04107805|591863686|FG006|Overall Study|Adverse Event|0|||
163862731|NCT04107805|591863687|FG007|Overall Study|Adverse Event|0|||
163862732|NCT04107805|591863688|FG008|Overall Study|Adverse Event|1|||
163862733|NCT01191086|591863691|FG000|Overall Study|Adverse Event|20|||
163862734|NCT01191086|591863691|FG000|Overall Study|Lack of Efficacy|10|||
163862735|NCT01191086|591863691|FG000|Overall Study|Lost to Follow-up|4|||
163862736|NCT01191086|591863691|FG000|Overall Study|Physician Decision|2|||
163862737|NCT01191086|591863691|FG000|Overall Study|Withdrawal by Subject|24|||
163862738|NCT01191086|591863691|FG000|Overall Study|Discontinuation criterion met|1|||
163862739|NCT01191086|591863691|FG000|Overall Study|Other|1|||
163862740|NCT00964366|591863692|FG000|Overall Study|Did not qualify at Day 1|1|||
163862741|NCT00964366|591863693|FG001|Overall Study|Did not qualify at Day 1|0|||
163862742|NCT00964366|591863692|FG000|Overall Study|Withdrawal by Subject|0|||
163862743|NCT00964366|591863693|FG001|Overall Study|Withdrawal by Subject|1|||
163862744|NCT02957539|591863694|FG000|Baseline to Week 16|Lost to Follow-up|8|||
163862745|NCT02957539|591863695|FG001|Baseline to Week 16|Lost to Follow-up|10|||
163862746|NCT02957539|591863696|FG002|Baseline to Week 16|Lost to Follow-up|16|||
163967878|NCT00467779|592255775|FG011|Stage 1|Unspecified Reason|0|||
163862747|NCT02957539|591863694|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
163862748|NCT02957539|591863695|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
163862749|NCT02957539|591863696|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
163862750|NCT02957539|591863694|FG000|Week 16 to 32|Withdrawal by Subject|3|||
163862751|NCT02957539|591863695|FG001|Week 16 to 32|Withdrawal by Subject|3|||
163967879|NCT00467779|592255776|FG012|Stage 1|Unspecified Reason|0|||
163967880|NCT00467779|592255777|FG013|Stage 1|Unspecified Reason|0|||
163967881|NCT00467779|592255778|FG014|Stage 1|Unspecified Reason|0|||
163967882|NCT00467779|592255764|FG000|Stage 1|Physician Decision|0|||
163967883|NCT00467779|592255765|FG001|Stage 1|Physician Decision|1|||
163967884|NCT00467779|592255766|FG002|Stage 1|Physician Decision|0|||
163967885|NCT00467779|592255767|FG003|Stage 1|Physician Decision|0|||
163967886|NCT00467779|592255768|FG004|Stage 1|Physician Decision|0|||
163967887|NCT00467779|592255769|FG005|Stage 1|Physician Decision|0|||
163967888|NCT00467779|592255770|FG006|Stage 1|Physician Decision|0|||
163967889|NCT00467779|592255771|FG007|Stage 1|Physician Decision|0|||
163967890|NCT00467779|592255772|FG008|Stage 1|Physician Decision|0|||
163967891|NCT00467779|592255773|FG009|Stage 1|Physician Decision|0|||
163967892|NCT00467779|592255774|FG010|Stage 1|Physician Decision|0|||
163967893|NCT00467779|592255775|FG011|Stage 1|Physician Decision|0|||
163967894|NCT00467779|592255776|FG012|Stage 1|Physician Decision|0|||
163967895|NCT00467779|592255777|FG013|Stage 1|Physician Decision|0|||
163967896|NCT00467779|592255778|FG014|Stage 1|Physician Decision|0|||
163967897|NCT00467779|592255764|FG000|Stage 1|Withdrawal by Subject|0|||
163967898|NCT00467779|592255765|FG001|Stage 1|Withdrawal by Subject|0|||
163967899|NCT00467779|592255766|FG002|Stage 1|Withdrawal by Subject|0|||
163967900|NCT00467779|592255767|FG003|Stage 1|Withdrawal by Subject|0|||
163967901|NCT00467779|592255768|FG004|Stage 1|Withdrawal by Subject|0|||
163967902|NCT00467779|592255769|FG005|Stage 1|Withdrawal by Subject|0|||
163967903|NCT00467779|592255770|FG006|Stage 1|Withdrawal by Subject|1|||
163967904|NCT00467779|592255771|FG007|Stage 1|Withdrawal by Subject|1|||
163967905|NCT00467779|592255772|FG008|Stage 1|Withdrawal by Subject|0|||
163967906|NCT00467779|592255773|FG009|Stage 1|Withdrawal by Subject|0|||
163967907|NCT00467779|592255774|FG010|Stage 1|Withdrawal by Subject|0|||
163967908|NCT00467779|592255775|FG011|Stage 1|Withdrawal by Subject|0|||
163967909|NCT00467779|592255776|FG012|Stage 1|Withdrawal by Subject|0|||
163967910|NCT00467779|592255777|FG013|Stage 1|Withdrawal by Subject|0|||
163967911|NCT00467779|592255778|FG014|Stage 1|Withdrawal by Subject|0|||
163967912|NCT00467779|592255764|FG000|Stage 1A|Adverse Event|0|||
163967913|NCT00467779|592255765|FG001|Stage 1A|Adverse Event|0|||
163967914|NCT00467779|592255766|FG002|Stage 1A|Adverse Event|0|||
163967915|NCT00467779|592255767|FG003|Stage 1A|Adverse Event|0|||
163967916|NCT00467779|592255768|FG004|Stage 1A|Adverse Event|0|||
163967917|NCT00467779|592255769|FG005|Stage 1A|Adverse Event|0|||
163967918|NCT00467779|592255770|FG006|Stage 1A|Adverse Event|0|||
163967919|NCT00467779|592255771|FG007|Stage 1A|Adverse Event|0|||
163967920|NCT00467779|592255772|FG008|Stage 1A|Adverse Event|0|||
163967921|NCT00467779|592255773|FG009|Stage 1A|Adverse Event|0|||
163967922|NCT00467779|592255774|FG010|Stage 1A|Adverse Event|0|||
163967923|NCT00467779|592255775|FG011|Stage 1A|Adverse Event|0|||
163967924|NCT00467779|592255776|FG012|Stage 1A|Adverse Event|1|||
163967925|NCT00467779|592255777|FG013|Stage 1A|Adverse Event|0|||
163967926|NCT00467779|592255778|FG014|Stage 1A|Adverse Event|0|||
163967927|NCT00467779|592255764|FG000|Stage 1A|Death|0|||
163967928|NCT00467779|592255765|FG001|Stage 1A|Death|0|||
163967929|NCT00467779|592255766|FG002|Stage 1A|Death|0|||
163967930|NCT00467779|592255767|FG003|Stage 1A|Death|0|||
163967931|NCT00467779|592255768|FG004|Stage 1A|Death|0|||
163967932|NCT00467779|592255769|FG005|Stage 1A|Death|0|||
163967933|NCT00467779|592255770|FG006|Stage 1A|Death|0|||
163967934|NCT00467779|592255771|FG007|Stage 1A|Death|0|||
164201057|NCT01677741|593108467|FG007|Overall Study|Death|0|||
163967935|NCT00467779|592255772|FG008|Stage 1A|Death|0|||
163967936|NCT00467779|592255773|FG009|Stage 1A|Death|0|||
164201058|NCT01677741|593108460|FG000|Overall Study|Withdrawal by Subject|2|||
164201059|NCT01677741|593108461|FG001|Overall Study|Withdrawal by Subject|7|||
163967937|NCT00467779|592255774|FG010|Stage 1A|Death|0|||
163967938|NCT00467779|592255775|FG011|Stage 1A|Death|1|||
163967939|NCT00467779|592255776|FG012|Stage 1A|Death|1|||
163967940|NCT00467779|592255777|FG013|Stage 1A|Death|0|||
163967941|NCT00467779|592255778|FG014|Stage 1A|Death|0|||
163967942|NCT00467779|592255764|FG000|Stage 1A|Disease Progression|0|||
163967943|NCT00467779|592255765|FG001|Stage 1A|Disease Progression|0|||
163967944|NCT00467779|592255766|FG002|Stage 1A|Disease Progression|0|||
163967945|NCT00467779|592255767|FG003|Stage 1A|Disease Progression|0|||
163967946|NCT00467779|592255768|FG004|Stage 1A|Disease Progression|0|||
163967947|NCT00467779|592255769|FG005|Stage 1A|Disease Progression|0|||
163967948|NCT00467779|592255770|FG006|Stage 1A|Disease Progression|0|||
163967949|NCT00467779|592255771|FG007|Stage 1A|Disease Progression|0|||
163967950|NCT00467779|592255772|FG008|Stage 1A|Disease Progression|0|||
163967951|NCT00467779|592255773|FG009|Stage 1A|Disease Progression|2|||
163967952|NCT00467779|592255774|FG010|Stage 1A|Disease Progression|2|||
163967953|NCT00467779|592255775|FG011|Stage 1A|Disease Progression|5|||
163967954|NCT00467779|592255776|FG012|Stage 1A|Disease Progression|2|||
163967955|NCT00467779|592255777|FG013|Stage 1A|Disease Progression|0|||
163967956|NCT00467779|592255778|FG014|Stage 1A|Disease Progression|0|||
163967957|NCT00467779|592255764|FG000|Stage 1A|Physician Decision|0|||
163967958|NCT00467779|592255765|FG001|Stage 1A|Physician Decision|0|||
163967959|NCT00467779|592255766|FG002|Stage 1A|Physician Decision|0|||
163967960|NCT00467779|592255767|FG003|Stage 1A|Physician Decision|0|||
163967961|NCT00467779|592255768|FG004|Stage 1A|Physician Decision|0|||
163967962|NCT00467779|592255769|FG005|Stage 1A|Physician Decision|0|||
163967963|NCT00467779|592255770|FG006|Stage 1A|Physician Decision|0|||
163967964|NCT00467779|592255771|FG007|Stage 1A|Physician Decision|0|||
163967965|NCT00467779|592255772|FG008|Stage 1A|Physician Decision|0|||
163967966|NCT00467779|592255773|FG009|Stage 1A|Physician Decision|1|||
163967967|NCT00467779|592255774|FG010|Stage 1A|Physician Decision|0|||
163967968|NCT00467779|592255775|FG011|Stage 1A|Physician Decision|0|||
163967969|NCT00467779|592255776|FG012|Stage 1A|Physician Decision|0|||
163967970|NCT00467779|592255777|FG013|Stage 1A|Physician Decision|0|||
163967971|NCT00467779|592255778|FG014|Stage 1A|Physician Decision|0|||
163967972|NCT00467779|592255764|FG000|Stage 1A|Withdrawal by Subject|0|||
163967973|NCT00467779|592255765|FG001|Stage 1A|Withdrawal by Subject|0|||
163967974|NCT00467779|592255766|FG002|Stage 1A|Withdrawal by Subject|0|||
163967975|NCT00467779|592255767|FG003|Stage 1A|Withdrawal by Subject|0|||
163967976|NCT00467779|592255768|FG004|Stage 1A|Withdrawal by Subject|0|||
163967977|NCT00467779|592255769|FG005|Stage 1A|Withdrawal by Subject|0|||
163967978|NCT00467779|592255770|FG006|Stage 1A|Withdrawal by Subject|0|||
163967979|NCT00467779|592255771|FG007|Stage 1A|Withdrawal by Subject|0|||
163967980|NCT00467779|592255772|FG008|Stage 1A|Withdrawal by Subject|0|||
163967981|NCT00467779|592255773|FG009|Stage 1A|Withdrawal by Subject|0|||
163967982|NCT00467779|592255774|FG010|Stage 1A|Withdrawal by Subject|1|||
163967983|NCT00467779|592255775|FG011|Stage 1A|Withdrawal by Subject|1|||
163967984|NCT00467779|592255776|FG012|Stage 1A|Withdrawal by Subject|1|||
163967985|NCT00467779|592255777|FG013|Stage 1A|Withdrawal by Subject|0|||
163967986|NCT00467779|592255778|FG014|Stage 1A|Withdrawal by Subject|0|||
163967987|NCT00467779|592255764|FG000|Stage 1A|Unspecified Reason|0|||
163967988|NCT00467779|592255765|FG001|Stage 1A|Unspecified Reason|0|||
163967989|NCT00467779|592255766|FG002|Stage 1A|Unspecified Reason|0|||
163967990|NCT00467779|592255767|FG003|Stage 1A|Unspecified Reason|0|||
163967991|NCT00467779|592255768|FG004|Stage 1A|Unspecified Reason|0|||
163967992|NCT00467779|592255769|FG005|Stage 1A|Unspecified Reason|0|||
163967993|NCT00467779|592255770|FG006|Stage 1A|Unspecified Reason|0|||
163967994|NCT00467779|592255771|FG007|Stage 1A|Unspecified Reason|0|||
163967995|NCT00467779|592255772|FG008|Stage 1A|Unspecified Reason|0|||
163967996|NCT00467779|592255773|FG009|Stage 1A|Unspecified Reason|0|||
163967997|NCT00467779|592255774|FG010|Stage 1A|Unspecified Reason|0|||
163967998|NCT00467779|592255775|FG011|Stage 1A|Unspecified Reason|1|||
163967999|NCT00467779|592255776|FG012|Stage 1A|Unspecified Reason|1|||
163968000|NCT00467779|592255777|FG013|Stage 1A|Unspecified Reason|0|||
163968001|NCT00467779|592255778|FG014|Stage 1A|Unspecified Reason|0|||
163968002|NCT00467779|592255764|FG000|Stage 2|Adverse Event|0|||
163968003|NCT00467779|592255765|FG001|Stage 2|Adverse Event|0|||
163968004|NCT00467779|592255766|FG002|Stage 2|Adverse Event|0|||
163968005|NCT00467779|592255767|FG003|Stage 2|Adverse Event|0|||
163968006|NCT00467779|592255768|FG004|Stage 2|Adverse Event|0|||
163968007|NCT00467779|592255769|FG005|Stage 2|Adverse Event|0|||
163968008|NCT00467779|592255770|FG006|Stage 2|Adverse Event|0|||
163968009|NCT00467779|592255771|FG007|Stage 2|Adverse Event|0|||
163968010|NCT00467779|592255772|FG008|Stage 2|Adverse Event|1|||
163968011|NCT00467779|592255773|FG009|Stage 2|Adverse Event|0|||
163968012|NCT00467779|592255774|FG010|Stage 2|Adverse Event|0|||
163968013|NCT00467779|592255775|FG011|Stage 2|Adverse Event|0|||
163968014|NCT00467779|592255776|FG012|Stage 2|Adverse Event|0|||
163968015|NCT00467779|592255777|FG013|Stage 2|Adverse Event|0|||
163968016|NCT00467779|592255778|FG014|Stage 2|Adverse Event|0|||
163968017|NCT00467779|592255764|FG000|Stage 2|Death|0|||
163968018|NCT00467779|592255765|FG001|Stage 2|Death|0|||
163968019|NCT00467779|592255766|FG002|Stage 2|Death|0|||
163968020|NCT00467779|592255767|FG003|Stage 2|Death|0|||
163968021|NCT00467779|592255768|FG004|Stage 2|Death|0|||
163968022|NCT00467779|592255769|FG005|Stage 2|Death|0|||
163968023|NCT00467779|592255770|FG006|Stage 2|Death|0|||
163968024|NCT00467779|592255771|FG007|Stage 2|Death|0|||
163968025|NCT00467779|592255772|FG008|Stage 2|Death|1|||
163968026|NCT00467779|592255773|FG009|Stage 2|Death|0|||
163968027|NCT00467779|592255774|FG010|Stage 2|Death|0|||
163968028|NCT00467779|592255775|FG011|Stage 2|Death|0|||
163968029|NCT00467779|592255776|FG012|Stage 2|Death|0|||
163968030|NCT00467779|592255777|FG013|Stage 2|Death|0|||
163968031|NCT00467779|592255778|FG014|Stage 2|Death|0|||
163968032|NCT00467779|592255764|FG000|Stage 2|Disease Progression|0|||
163968033|NCT00467779|592255765|FG001|Stage 2|Disease Progression|0|||
163968034|NCT00467779|592255766|FG002|Stage 2|Disease Progression|0|||
163968035|NCT00467779|592255767|FG003|Stage 2|Disease Progression|0|||
163968036|NCT00467779|592255768|FG004|Stage 2|Disease Progression|0|||
163968037|NCT00467779|592255769|FG005|Stage 2|Disease Progression|0|||
163968038|NCT00467779|592255770|FG006|Stage 2|Disease Progression|0|||
163968039|NCT00467779|592255771|FG007|Stage 2|Disease Progression|0|||
163968040|NCT00467779|592255772|FG008|Stage 2|Disease Progression|16|||
163968041|NCT00467779|592255773|FG009|Stage 2|Disease Progression|0|||
163968042|NCT00467779|592255774|FG010|Stage 2|Disease Progression|0|||
163968043|NCT00467779|592255775|FG011|Stage 2|Disease Progression|0|||
163968044|NCT00467779|592255776|FG012|Stage 2|Disease Progression|0|||
163968045|NCT00467779|592255777|FG013|Stage 2|Disease Progression|0|||
163968046|NCT00467779|592255778|FG014|Stage 2|Disease Progression|0|||
163968047|NCT00467779|592255764|FG000|Stage 2|Unspecified Reason|0|||
163968048|NCT00467779|592255765|FG001|Stage 2|Unspecified Reason|0|||
163968049|NCT00467779|592255766|FG002|Stage 2|Unspecified Reason|0|||
163968050|NCT00467779|592255767|FG003|Stage 2|Unspecified Reason|0|||
163968051|NCT00467779|592255768|FG004|Stage 2|Unspecified Reason|0|||
163968052|NCT00467779|592255769|FG005|Stage 2|Unspecified Reason|0|||
163968053|NCT00467779|592255770|FG006|Stage 2|Unspecified Reason|0|||
163968054|NCT00467779|592255771|FG007|Stage 2|Unspecified Reason|0|||
163862752|NCT02957539|591863696|FG002|Week 16 to 32|Withdrawal by Subject|1|||
163862753|NCT02957539|591863694|FG000|Week 16 to 32|Lost to Follow-up|8|||
163862754|NCT02957539|591863695|FG001|Week 16 to 32|Lost to Follow-up|7|||
163862755|NCT02957539|591863696|FG002|Week 16 to 32|Lost to Follow-up|5|||
163862756|NCT02957539|591863694|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
163862757|NCT02957539|591863695|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
163862758|NCT02957539|591863696|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
163862759|NCT02957539|591863694|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
163862760|NCT02957539|591863695|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
163862761|NCT02957539|591863696|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
163862762|NCT01833832|591863697|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
163862763|NCT01156116|591863698|FG000|Overall Study|Withdrawal by Subject|3|||
163862764|NCT01156116|591863699|FG001|Overall Study|Withdrawal by Subject|1|||
163862765|NCT01156116|591863698|FG000|Overall Study|CPAP intolerance|2|||
163862766|NCT01156116|591863699|FG001|Overall Study|CPAP intolerance|0|||
163862767|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
163862768|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
163862769|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
163862770|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
163862771|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
163862772|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
163862773|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
163862774|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
163862775|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
163862776|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
163862777|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
163862778|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
163862779|NCT02057718|591863700|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
163862780|NCT02057718|591863701|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
163862781|NCT02057718|591863700|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
163862782|NCT02057718|591863701|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
163862783|NCT02057718|591863700|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
163862784|NCT02057718|591863701|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
163862785|NCT02057718|591863700|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
163862786|NCT02057718|591863701|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
163862787|NCT02057718|591863700|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
163862788|NCT02057718|591863701|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
163862789|NCT00130637|591863708|FG000|Overall Study|Adverse Event|2|||
163862790|NCT00130637|591863708|FG000|Overall Study|Withdrawal by Subject|1|||
163862791|NCT00139737|591863709|FG000|Overall Study|Withdrawal by Subject|190|||
163862792|NCT00139737|591863709|FG000|Overall Study|Adverse Event|58|||
163862793|NCT00139737|591863709|FG000|Overall Study|Lack of Efficacy|40|||
163862794|NCT00139737|591863709|FG000|Overall Study|Lost to Follow-up|8|||
163862795|NCT00139737|591863709|FG000|Overall Study|Death|3|||
163862796|NCT00139737|591863709|FG000|Overall Study|Laboratory Abnormality|2|||
163862797|NCT00139737|591863709|FG000|Overall Study|Protocol Violation|18|||
163862798|NCT00139737|591863709|FG000|Overall Study|Withdrew During Screening Phase|8|||
163862799|NCT00139737|591863709|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
163862800|NCT00139737|591863709|FG000|Overall Study|Screened, Not Treated|13|||
163862801|NCT00217672|591863710|FG000|Allocation|Ineligible|2|||
163862802|NCT00217672|591863711|FG001|Allocation|Ineligible|0|||
163862803|NCT00217672|591863710|FG000|Treatment|disease progression|33|||
163862804|NCT00217672|591863711|FG001|Treatment|disease progression|4|||
163862805|NCT00217672|591863710|FG000|Treatment|Adverse Event|18|||
163862806|NCT00217672|591863711|FG001|Treatment|Adverse Event|2|||
163862807|NCT00217672|591863710|FG000|Treatment|reqd treatment not permitted by protocol|6|||
163862808|NCT00217672|591863711|FG001|Treatment|reqd treatment not permitted by protocol|0|||
163862809|NCT00217672|591863710|FG000|Treatment|Physician Decision|6|||
163862810|NCT00217672|591863711|FG001|Treatment|Physician Decision|0|||
163862811|NCT00217672|591863710|FG000|Treatment|insurance issues|1|||
163862812|NCT00217672|591863711|FG001|Treatment|insurance issues|1|||
163862813|NCT00217672|591863710|FG000|Treatment|Death|2|||
163968055|NCT00467779|592255772|FG008|Stage 2|Unspecified Reason|3|||
164309927|NCT00485134|593509532|FG002|Overall Study|Unable to comply with study schedule|0|||
164309928|NCT00485134|593509533|FG003|Overall Study|Unable to comply with study schedule|0|||
164309929|NCT00485134|593509534|FG004|Overall Study|Unable to comply with study schedule|0|||
164309930|NCT00485134|593509535|FG005|Overall Study|Unable to comply with study schedule|0|||
163862814|NCT00217672|591863711|FG001|Treatment|Death|0|||
163862815|NCT00217672|591863710|FG000|Treatment|secondary malignancy|1|||
163862816|NCT00217672|591863711|FG001|Treatment|secondary malignancy|0|||
163862817|NCT00217672|591863710|FG000|Follow-up|Withdrawal by Subject|4|||
163862818|NCT00217672|591863711|FG001|Follow-up|Withdrawal by Subject|0|||
163862819|NCT00217672|591863710|FG000|Follow-up|Lost to Follow-up|1|||
163862820|NCT00217672|591863711|FG001|Follow-up|Lost to Follow-up|0|||
163862821|NCT03781336|591863712|FG000|Overall Study|Withdrawal by Subject|2|||
163862822|NCT03781336|591863713|FG001|Overall Study|Withdrawal by Subject|2|||
163862823|NCT01972152|591863714|FG000|First Treatment Visit|Lost to Follow-up|0|||
163862824|NCT01972152|591863715|FG001|First Treatment Visit|Lost to Follow-up|1|||
163862825|NCT01972152|591863716|FG002|First Treatment Visit|Lost to Follow-up|0|||
163862826|NCT01972152|591863717|FG003|First Treatment Visit|Lost to Follow-up|0|||
163862827|NCT01972152|591863718|FG004|First Treatment Visit|Lost to Follow-up|0|||
163862828|NCT01972152|591863719|FG005|First Treatment Visit|Lost to Follow-up|0|||
163862829|NCT01972152|591863714|FG000|Second Treatment Visit|Protocol Violation|0|||
163862830|NCT01972152|591863715|FG001|Second Treatment Visit|Protocol Violation|1|||
163862831|NCT01972152|591863716|FG002|Second Treatment Visit|Protocol Violation|0|||
163862832|NCT01972152|591863717|FG003|Second Treatment Visit|Protocol Violation|0|||
163862833|NCT01972152|591863718|FG004|Second Treatment Visit|Protocol Violation|0|||
163862834|NCT01972152|591863719|FG005|Second Treatment Visit|Protocol Violation|0|||
163862835|NCT01157182|591863722|FG000|Washout of 28 Days|Adverse Event|2|||
163862836|NCT01157182|591863723|FG001|Washout of 28 Days|Adverse Event|0|||
163862837|NCT00878722|591863724|FG000|Overall Study|Progressive disease|3|||
163862838|NCT00878722|591863725|FG001|Overall Study|Progressive disease|3|||
163862839|NCT00878722|591863726|FG002|Overall Study|Progressive disease|3|||
163862840|NCT00878722|591863727|FG003|Overall Study|Progressive disease|7|||
163862841|NCT00878722|591863728|FG004|Overall Study|Progressive disease|7|||
163862842|NCT00878722|591863729|FG005|Overall Study|Progressive disease|1|||
163862843|NCT00878722|591863730|FG006|Overall Study|Progressive disease|4|||
163862844|NCT00878722|591863731|FG007|Overall Study|Progressive disease|3|||
163862845|NCT00878722|591863724|FG000|Overall Study|Death|0|||
163862846|NCT00878722|591863725|FG001|Overall Study|Death|0|||
163862847|NCT00878722|591863726|FG002|Overall Study|Death|0|||
163862848|NCT00878722|591863727|FG003|Overall Study|Death|1|||
163862849|NCT00878722|591863728|FG004|Overall Study|Death|0|||
163862850|NCT00878722|591863729|FG005|Overall Study|Death|1|||
163862851|NCT00878722|591863730|FG006|Overall Study|Death|0|||
163862852|NCT00878722|591863731|FG007|Overall Study|Death|2|||
163862853|NCT00878722|591863724|FG000|Overall Study|Adverse Event|0|||
163862854|NCT00878722|591863725|FG001|Overall Study|Adverse Event|0|||
163862855|NCT00878722|591863726|FG002|Overall Study|Adverse Event|0|||
163862856|NCT00878722|591863727|FG003|Overall Study|Adverse Event|0|||
163862857|NCT00878722|591863728|FG004|Overall Study|Adverse Event|0|||
163862858|NCT00878722|591863729|FG005|Overall Study|Adverse Event|0|||
163862859|NCT00878722|591863730|FG006|Overall Study|Adverse Event|2|||
163862860|NCT00878722|591863731|FG007|Overall Study|Adverse Event|0|||
163862861|NCT00878722|591863724|FG000|Overall Study|Withdrawal by Subject|0|||
163862862|NCT00878722|591863725|FG001|Overall Study|Withdrawal by Subject|0|||
163862863|NCT00878722|591863726|FG002|Overall Study|Withdrawal by Subject|0|||
163862864|NCT00878722|591863727|FG003|Overall Study|Withdrawal by Subject|0|||
163862865|NCT00878722|591863728|FG004|Overall Study|Withdrawal by Subject|0|||
163862866|NCT00878722|591863729|FG005|Overall Study|Withdrawal by Subject|0|||
163862867|NCT00878722|591863730|FG006|Overall Study|Withdrawal by Subject|0|||
163862868|NCT00878722|591863731|FG007|Overall Study|Withdrawal by Subject|2|||
163862869|NCT00878722|591863724|FG000|Overall Study|Relapse|0|||
163862870|NCT00878722|591863725|FG001|Overall Study|Relapse|0|||
164309931|NCT00485134|593509536|FG006|Overall Study|Unable to comply with study schedule|0|||
163862871|NCT00878722|591863726|FG002|Overall Study|Relapse|0|||
163862872|NCT00878722|591863727|FG003|Overall Study|Relapse|1|||
163862873|NCT00878722|591863728|FG004|Overall Study|Relapse|0|||
163862874|NCT00878722|591863729|FG005|Overall Study|Relapse|0|||
163862875|NCT00878722|591863730|FG006|Overall Study|Relapse|0|||
163862876|NCT00878722|591863731|FG007|Overall Study|Relapse|0|||
163862877|NCT00383188|591863732|FG000|Overall Study|Adverse Event|4|||
163862878|NCT00383188|591863733|FG001|Overall Study|Adverse Event|7|||
163862879|NCT00383188|591863734|FG002|Overall Study|Adverse Event|9|||
163862880|NCT00383188|591863735|FG003|Overall Study|Adverse Event|8|||
163862881|NCT00383188|591863736|FG004|Overall Study|Adverse Event|8|||
163862882|NCT00383188|591863732|FG000|Overall Study|Lack of Efficacy|9|||
163862883|NCT00383188|591863733|FG001|Overall Study|Lack of Efficacy|3|||
163862884|NCT00383188|591863734|FG002|Overall Study|Lack of Efficacy|3|||
163862885|NCT00383188|591863735|FG003|Overall Study|Lack of Efficacy|2|||
163862886|NCT00383188|591863736|FG004|Overall Study|Lack of Efficacy|6|||
163862887|NCT00383188|591863732|FG000|Overall Study|Other|3|||
163862888|NCT00383188|591863733|FG001|Overall Study|Other|1|||
163862889|NCT00383188|591863734|FG002|Overall Study|Other|0|||
163862890|NCT00383188|591863735|FG003|Overall Study|Other|2|||
163862891|NCT00383188|591863736|FG004|Overall Study|Other|6|||
163862892|NCT00383188|591863732|FG000|Overall Study|No longer willing to participate|1|||
163862893|NCT00383188|591863733|FG001|Overall Study|No longer willing to participate|0|||
163862894|NCT00383188|591863734|FG002|Overall Study|No longer willing to participate|1|||
163862895|NCT00383188|591863735|FG003|Overall Study|No longer willing to participate|0|||
163862896|NCT00383188|591863736|FG004|Overall Study|No longer willing to participate|2|||
163862897|NCT00383188|591863732|FG000|Overall Study|Lost to Follow-up|0|||
163862898|NCT00383188|591863733|FG001|Overall Study|Lost to Follow-up|0|||
163862899|NCT00383188|591863734|FG002|Overall Study|Lost to Follow-up|0|||
163862900|NCT00383188|591863735|FG003|Overall Study|Lost to Follow-up|0|||
163862901|NCT00383188|591863736|FG004|Overall Study|Lost to Follow-up|1|||
163862902|NCT00972504|591863737|FG000|Overall Study|Adverse Event|2|||
163862903|NCT00972504|591863737|FG000|Overall Study|Investigator discretion|1|||
163862904|NCT00319436|591863738|FG000|Overall Study|Withdrawal by Subject|6|||
163862905|NCT00319436|591863739|FG001|Overall Study|Withdrawal by Subject|7|||
163862906|NCT00639002|591863742|FG000|Overall Study|Death|1|||
163862907|NCT00639002|591863742|FG000|Overall Study|Adverse Event|1|||
163862908|NCT00639002|591863742|FG000|Overall Study|Protocol Violation|1|||
163862909|NCT00639002|591863742|FG000|Overall Study|Disease progression|3|||
163862910|NCT00639002|591863742|FG000|Overall Study|Physician Decision|6|||
163862911|NCT00639002|591863742|FG000|Overall Study|Lack of Efficacy|1|||
163862912|NCT01839877|591863746|FG000|Overall Study|Protocol Violation|1|||
163862913|NCT00597519|591863753|FG000|Overall Study|Death|1|||
163862914|NCT02104765|591863759|FG000|Overall Study|Lost to Follow-up|0|||
163862915|NCT02104765|591863760|FG001|Overall Study|Lost to Follow-up|0|||
163862916|NCT02104765|591863761|FG002|Overall Study|Lost to Follow-up|1|||
163862917|NCT02104765|591863762|FG003|Overall Study|Lost to Follow-up|0|||
163862918|NCT02104765|591863763|FG004|Overall Study|Lost to Follow-up|0|||
163862919|NCT02104765|591863764|FG005|Overall Study|Lost to Follow-up|0|||
163862920|NCT02104765|591863765|FG006|Overall Study|Lost to Follow-up|0|||
163862921|NCT02104765|591863759|FG000|Overall Study|Withdrawal by Subject|0|||
163862922|NCT02104765|591863760|FG001|Overall Study|Withdrawal by Subject|0|||
163862923|NCT02104765|591863761|FG002|Overall Study|Withdrawal by Subject|0|||
163862924|NCT02104765|591863762|FG003|Overall Study|Withdrawal by Subject|1|||
163862925|NCT02104765|591863763|FG004|Overall Study|Withdrawal by Subject|1|||
163862926|NCT02104765|591863764|FG005|Overall Study|Withdrawal by Subject|0|||
163862927|NCT02104765|591863765|FG006|Overall Study|Withdrawal by Subject|1|||
163862928|NCT02698241|591863766|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
163862929|NCT02698241|591863766|FG000|Overall Study|Screening not met|7|||
163862930|NCT02698241|591863766|FG000|Overall Study|Withdrawal by Subject|7|||
163862931|NCT02698241|591863766|FG000|Overall Study|Physician Decision|2|||
163862932|NCT02698241|591863766|FG000|Overall Study|Subject underwent system modification|2|||
163862933|NCT02698241|591863766|FG000|Overall Study|Lost to Follow-up|3|||
163862934|NCT02698241|591863766|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
163862935|NCT02698241|591863766|FG000|Overall Study|geographic and licensing issue|1|||
163862936|NCT02698241|591863766|FG000|Overall Study|Death|2|||
163862937|NCT01751724|591863767|FG000|Overall Study|extubated bef.start assigned treatment|1|||
163862938|NCT01751724|591863768|FG001|Overall Study|extubated bef.start assigned treatment|0|||
163862939|NCT01751724|591863767|FG000|Overall Study|withdrawn by parent|0|||
163862940|NCT01751724|591863768|FG001|Overall Study|withdrawn by parent|2|||
163862941|NCT02685033|591863771|FG000|Overall Study|Withdrawal of Consent|0|||
163862942|NCT02685033|591863772|FG001|Overall Study|Withdrawal of Consent|1|||
163862943|NCT02685033|591863771|FG000|Overall Study|Lost to Follow-up|2|||
163862944|NCT02685033|591863772|FG001|Overall Study|Lost to Follow-up|1|||
163862945|NCT02685033|591863771|FG000|Overall Study|Adverse Event|1|||
163862946|NCT02685033|591863772|FG001|Overall Study|Adverse Event|0|||
163862947|NCT00603447|591863773|FG000|Overall Study|Adverse Event|0|||
163862948|NCT00603447|591863774|FG001|Overall Study|Adverse Event|1|||
163862949|NCT00603447|591863775|FG002|Overall Study|Adverse Event|1|||
163862950|NCT00603447|591863776|FG003|Overall Study|Adverse Event|2|||
163862951|NCT00603447|591863777|FG004|Overall Study|Adverse Event|1|||
163862952|NCT00603447|591863778|FG005|Overall Study|Adverse Event|2|||
163862953|NCT00603447|591863779|FG006|Overall Study|Adverse Event|10|||
163862954|NCT00603447|591863773|FG000|Overall Study|Other|0|||
163862955|NCT00603447|591863774|FG001|Overall Study|Other|0|||
163862956|NCT00603447|591863775|FG002|Overall Study|Other|1|||
163862957|NCT00603447|591863776|FG003|Overall Study|Other|0|||
163862958|NCT00603447|591863777|FG004|Overall Study|Other|3|||
163862959|NCT00603447|591863778|FG005|Overall Study|Other|0|||
163862960|NCT00603447|591863779|FG006|Overall Study|Other|13|||
163862961|NCT00603447|591863773|FG000|Overall Study|Withdrew Consent|0|||
163862962|NCT00603447|591863774|FG001|Overall Study|Withdrew Consent|2|||
163862963|NCT00603447|591863775|FG002|Overall Study|Withdrew Consent|0|||
163862964|NCT00603447|591863776|FG003|Overall Study|Withdrew Consent|0|||
163862965|NCT00603447|591863777|FG004|Overall Study|Withdrew Consent|1|||
163862966|NCT00603447|591863778|FG005|Overall Study|Withdrew Consent|0|||
163862967|NCT00603447|591863779|FG006|Overall Study|Withdrew Consent|1|||
163862968|NCT00798265|591863780|FG000|Overall Study|Lost to Follow-up|1|||
163862969|NCT00798265|591863781|FG001|Overall Study|Lost to Follow-up|10|||
163862970|NCT00798265|591863780|FG000|Overall Study|Study closing|7|||
163862971|NCT00798265|591863781|FG001|Overall Study|Study closing|6|||
163862972|NCT00798265|591863780|FG000|Overall Study|Withdrawal by Subject|0|||
163862973|NCT00798265|591863781|FG001|Overall Study|Withdrawal by Subject|1|||
163862974|NCT00798265|591863780|FG000|Overall Study|Screen failure|0|||
163862975|NCT00798265|591863781|FG001|Overall Study|Screen failure|1|||
163862976|NCT00589667|591865228|FG000|Overall Study|Adverse Event|2|||
163862977|NCT00589667|591865228|FG000|Overall Study|Withdrawal by Subject|1|||
163862978|NCT03538041|591865231|FG000|12-Week Treatment Period|Adverse Event|1|||
163862979|NCT03538041|591865232|FG001|12-Week Treatment Period|Adverse Event|1|||
163862980|NCT03538041|591865231|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
163862981|NCT03538041|591865232|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
163862982|NCT03538041|591865231|FG000|Treatment Extension Period|Adverse Event|4|||
163862983|NCT03538041|591865232|FG001|Treatment Extension Period|Adverse Event|1|||
163862984|NCT03538041|591865231|FG000|Treatment Extension Period|Physician Decision|1|||
163862985|NCT03538041|591865232|FG001|Treatment Extension Period|Physician Decision|1|||
163862986|NCT03538041|591865231|FG000|Treatment Extension Period|Lack of Efficacy|1|||
163862987|NCT03538041|591865232|FG001|Treatment Extension Period|Lack of Efficacy|4|||
163862988|NCT03538041|591865231|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
163862989|NCT03538041|591865232|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
163862990|NCT03538041|591865231|FG000|Treatment Extension Period|Death|0|||
163862991|NCT03538041|591865232|FG001|Treatment Extension Period|Death|1|||
163862992|NCT00094809|591865233|FG000|Overall Study|Protocol deviation|2|||
163862993|NCT00094809|591865234|FG001|Overall Study|Protocol deviation|2|||
163862994|NCT00094809|591865233|FG000|Overall Study|Noncompliance|1|||
163862995|NCT00094809|591865234|FG001|Overall Study|Noncompliance|0|||
163862996|NCT00094809|591865233|FG000|Overall Study|Adverse Event|3|||
163862997|NCT00094809|591865234|FG001|Overall Study|Adverse Event|1|||
163862998|NCT00094809|591865233|FG000|Overall Study|Withdrawal by Subject|8|||
163862999|NCT00094809|591865234|FG001|Overall Study|Withdrawal by Subject|9|||
163863000|NCT00094809|591865233|FG000|Overall Study|Disease progression|3|||
163863001|NCT00094809|591865234|FG001|Overall Study|Disease progression|3|||
163863002|NCT00094809|591865233|FG000|Overall Study|Physician Decision|3|||
163863003|NCT00094809|591865234|FG001|Overall Study|Physician Decision|5|||
163863004|NCT00094809|591865233|FG000|Overall Study|Lost to Follow-up|6|||
163863005|NCT00094809|591865234|FG001|Overall Study|Lost to Follow-up|6|||
163863006|NCT00094809|591865233|FG000|Overall Study|Death|19|||
163863007|NCT00094809|591865234|FG001|Overall Study|Death|25|||
163863008|NCT00094809|591865233|FG000|Overall Study|Protocol-specified criteria|1|||
163863009|NCT00094809|591865234|FG001|Overall Study|Protocol-specified criteria|1|||
163863010|NCT00094809|591865233|FG000|Overall Study|Other|2|||
163863011|NCT00094809|591865234|FG001|Overall Study|Other|4|||
163863012|NCT00094809|591865233|FG000|Overall Study|Informed consent signed after treatment|1|||
163863013|NCT00094809|591865234|FG001|Overall Study|Informed consent signed after treatment|0|||
163863014|NCT00094809|591865233|FG000|Overall Study|Study drug not received|2|||
163863015|NCT00094809|591865234|FG001|Overall Study|Study drug not received|8|||
163863016|NCT00094809|591865233|FG000|Overall Study|Other|1|||
163863017|NCT00094809|591865234|FG001|Overall Study|Other|1|||
163863018|NCT02046616|591865248|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
163863019|NCT02046616|591865248|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
163863020|NCT02046616|591865248|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
163863021|NCT02046616|591865248|FG000|24-Week Treatment Period|Physician Decision|3|||
163863022|NCT02046616|591865248|FG000|24-Week Treatment Period|Other|1|||
163863023|NCT02046616|591865248|FG000|8-Week FU Period|Lost to Follow-up|1|||
163863024|NCT01563354|591865253|FG000|Core Phase|Adverse Event|5|||
163863025|NCT01563354|591865254|FG001|Core Phase|Adverse Event|15|||
163863026|NCT01563354|591865255|FG002|Core Phase|Adverse Event|13|||
163863027|NCT01563354|591865253|FG000|Core Phase|Withdrawal by Subject|1|||
163863028|NCT01563354|591865254|FG001|Core Phase|Withdrawal by Subject|0|||
163863029|NCT01563354|591865255|FG002|Core Phase|Withdrawal by Subject|3|||
163863030|NCT01563354|591865253|FG000|Core Phase|Lost to Follow-up|1|||
163863031|NCT01563354|591865254|FG001|Core Phase|Lost to Follow-up|0|||
163863032|NCT01563354|591865255|FG002|Core Phase|Lost to Follow-up|0|||
163863033|NCT01563354|591865253|FG000|Core Phase|Death|1|||
163863034|NCT01563354|591865254|FG001|Core Phase|Death|5|||
163863035|NCT01563354|591865255|FG002|Core Phase|Death|2|||
163863036|NCT01563354|591865253|FG000|Core Phase|Diseasse progression|18|||
163863037|NCT01563354|591865254|FG001|Core Phase|Diseasse progression|7|||
163863038|NCT01563354|591865255|FG002|Core Phase|Diseasse progression|8|||
163863039|NCT01563354|591865253|FG000|Core Phase|Protocol deviation|2|||
163863040|NCT01563354|591865254|FG001|Core Phase|Protocol deviation|0|||
163863041|NCT01563354|591865255|FG002|Core Phase|Protocol deviation|0|||
163863042|NCT01563354|591865253|FG000|Core Phase|PI decision - did not enter extension|0|||
163863043|NCT01563354|591865254|FG001|Core Phase|PI decision - did not enter extension|1|||
163863044|NCT01563354|591865255|FG002|Core Phase|PI decision - did not enter extension|0|||
163968056|NCT00467779|592255773|FG009|Stage 2|Unspecified Reason|0|||
163968057|NCT00467779|592255774|FG010|Stage 2|Unspecified Reason|0|||
163863045|NCT01563354|591865253|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
163863046|NCT01563354|591865254|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
163863047|NCT01563354|591865255|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
163863048|NCT01563354|591865253|FG000|Extension Phase|Adverse Event|0|||
163863049|NCT01563354|591865254|FG001|Extension Phase|Adverse Event|3|||
163863050|NCT01563354|591865255|FG002|Extension Phase|Adverse Event|2|||
163863051|NCT01563354|591865253|FG000|Extension Phase|Withdrawal by Subject|0|||
163863052|NCT01563354|591865254|FG001|Extension Phase|Withdrawal by Subject|1|||
163863053|NCT01563354|591865255|FG002|Extension Phase|Withdrawal by Subject|0|||
163863054|NCT01563354|591865253|FG000|Extension Phase|Administration problems|3|||
163863055|NCT01563354|591865254|FG001|Extension Phase|Administration problems|2|||
163863056|NCT01563354|591865255|FG002|Extension Phase|Administration problems|3|||
163863057|NCT01563354|591865253|FG000|Extension Phase|Disease progression|9|||
163863058|NCT01563354|591865254|FG001|Extension Phase|Disease progression|8|||
163863059|NCT01563354|591865255|FG002|Extension Phase|Disease progression|10|||
163863060|NCT00906035|591865262|FG000|Overall Study|Withdrawal by Subject|2|||
163863061|NCT00906035|591865263|FG001|Overall Study|Withdrawal by Subject|3|||
163863062|NCT00906035|591865264|FG002|Overall Study|Withdrawal by Subject|0|||
163863063|NCT01988233|591865270|FG000|Overall Study|Lost to Follow-up|64|||
163863064|NCT01988233|591865271|FG001|Overall Study|Lost to Follow-up|51|||
163863065|NCT01689519|591865272|FG000|Intent to Treat|Death|157|||
163863066|NCT01689519|591865273|FG001|Intent to Treat|Death|167|||
163863067|NCT01689519|591865272|FG000|Intent to Treat|Lost to Follow-up|4|||
163863068|NCT01689519|591865273|FG001|Intent to Treat|Lost to Follow-up|8|||
163863069|NCT01689519|591865272|FG000|Intent to Treat|Other|2|||
163863070|NCT01689519|591865273|FG001|Intent to Treat|Other|4|||
163863071|NCT01689519|591865272|FG000|Intent to Treat|Physician Decision|4|||
163863072|NCT01689519|591865273|FG001|Intent to Treat|Physician Decision|1|||
163863073|NCT01689519|591865272|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
163863074|NCT01689519|591865273|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
163863075|NCT01689519|591865272|FG000|Intent to Treat|Withdrawal by Subject|21|||
163863076|NCT01689519|591865273|FG001|Intent to Treat|Withdrawal by Subject|20|||
163863077|NCT01689519|591865272|FG000|Safety Population|Death|158|||
163863078|NCT01689519|591865273|FG001|Safety Population|Death|165|||
163863079|NCT01689519|591865272|FG000|Safety Population|Lost to Follow-up|4|||
163863080|NCT01689519|591865273|FG001|Safety Population|Lost to Follow-up|8|||
163863081|NCT01689519|591865272|FG000|Safety Population|Other|2|||
163863082|NCT01689519|591865273|FG001|Safety Population|Other|4|||
163863083|NCT01689519|591865272|FG000|Safety Population|Physician Decision|4|||
163863084|NCT01689519|591865273|FG001|Safety Population|Physician Decision|1|||
163863085|NCT01689519|591865272|FG000|Safety Population|Study Terminated By Sponsor|60|||
163863086|NCT01689519|591865273|FG001|Safety Population|Study Terminated By Sponsor|47|||
163863087|NCT01689519|591865272|FG000|Safety Population|Withdrawal by Subject|20|||
163863088|NCT01689519|591865273|FG001|Safety Population|Withdrawal by Subject|20|||
163863089|NCT01050569|591865275|FG000|Overall Study|Lost to Follow-up|20|||
163863090|NCT01050569|591865276|FG001|Overall Study|Lost to Follow-up|14|||
163863091|NCT01050569|591865277|FG002|Overall Study|Lost to Follow-up|16|||
163863092|NCT01050569|591865275|FG000|Overall Study|Withdrawal by Subject|9|||
163863093|NCT01050569|591865276|FG001|Overall Study|Withdrawal by Subject|3|||
163863094|NCT01050569|591865277|FG002|Overall Study|Withdrawal by Subject|11|||
163863095|NCT01050569|591865275|FG000|Overall Study|Lack of Efficacy|5|||
163863096|NCT01050569|591865276|FG001|Overall Study|Lack of Efficacy|4|||
163863097|NCT01050569|591865277|FG002|Overall Study|Lack of Efficacy|3|||
163863098|NCT01050569|591865275|FG000|Overall Study|Adverse Event|1|||
163863099|NCT01050569|591865276|FG001|Overall Study|Adverse Event|0|||
163863100|NCT01050569|591865277|FG002|Overall Study|Adverse Event|0|||
163968058|NCT00467779|592255775|FG011|Stage 2|Unspecified Reason|0|||
163968059|NCT00467779|592255776|FG012|Stage 2|Unspecified Reason|0|||
163968060|NCT00467779|592255777|FG013|Stage 2|Unspecified Reason|0|||
163968061|NCT00467779|592255778|FG014|Stage 2|Unspecified Reason|0|||
163968062|NCT00467779|592255764|FG000|Stage 2A|Adverse Event|0|||
163968063|NCT00467779|592255765|FG001|Stage 2A|Adverse Event|0|||
163968064|NCT00467779|592255766|FG002|Stage 2A|Adverse Event|0|||
163863101|NCT01050569|591865275|FG000|Overall Study|Physician Decision|3|||
163863102|NCT01050569|591865276|FG001|Overall Study|Physician Decision|3|||
163863103|NCT01050569|591865277|FG002|Overall Study|Physician Decision|3|||
163968065|NCT00467779|592255767|FG003|Stage 2A|Adverse Event|0|||
163968066|NCT00467779|592255768|FG004|Stage 2A|Adverse Event|0|||
163863104|NCT03525119|591865278|FG000|Overall Study|Adverse Event|0|||
163863105|NCT03525119|591865279|FG001|Overall Study|Adverse Event|1|||
163863106|NCT03525119|591865280|FG002|Overall Study|Adverse Event|0|||
163863107|NCT03525119|591865278|FG000|Overall Study|Lost to Follow-up|32|||
163863108|NCT03525119|591865279|FG001|Overall Study|Lost to Follow-up|33|||
163863109|NCT03525119|591865280|FG002|Overall Study|Lost to Follow-up|37|||
163863110|NCT03525119|591865278|FG000|Overall Study|Withdrawal by Subject|5|||
163863111|NCT03525119|591865279|FG001|Overall Study|Withdrawal by Subject|4|||
163863112|NCT03525119|591865280|FG002|Overall Study|Withdrawal by Subject|2|||
163863113|NCT03525119|591865278|FG000|Overall Study|Reason not Specified|2|||
163863114|NCT03525119|591865279|FG001|Overall Study|Reason not Specified|1|||
163863115|NCT03525119|591865280|FG002|Overall Study|Reason not Specified|2|||
163863116|NCT03525119|591865278|FG000|Overall Study|Randomized but not Vaccinated|1|||
163863117|NCT03525119|591865279|FG001|Overall Study|Randomized but not Vaccinated|0|||
163863118|NCT03525119|591865280|FG002|Overall Study|Randomized but not Vaccinated|2|||
163863119|NCT05046132|591865281|FG000|Overall Study|Adverse Event|4|||
163863120|NCT05046132|591865282|FG001|Overall Study|Adverse Event|0|||
163863121|NCT05046132|591865283|FG002|Overall Study|Adverse Event|0|||
163863122|NCT05046132|591865281|FG000|Overall Study|Withdrawal by Subject|3|||
163863123|NCT05046132|591865282|FG001|Overall Study|Withdrawal by Subject|0|||
163863124|NCT05046132|591865283|FG002|Overall Study|Withdrawal by Subject|0|||
163863125|NCT05046132|591865281|FG000|Overall Study|Positive Covid19 Result.|0|||
163863126|NCT05046132|591865282|FG001|Overall Study|Positive Covid19 Result.|1|||
163863127|NCT05046132|591865283|FG002|Overall Study|Positive Covid19 Result.|0|||
163863128|NCT01959412|591865284|FG000|Overall Study|Protocol deviation|1|||
163863129|NCT01959412|591865285|FG001|Overall Study|Protocol deviation|1|||
163863130|NCT01959412|591865286|FG002|Overall Study|Protocol deviation|0|||
163863131|NCT01959412|591865287|FG003|Overall Study|Protocol deviation|1|||
163863132|NCT01959412|591865288|FG004|Overall Study|Protocol deviation|3|||
163863133|NCT01959412|591865289|FG005|Overall Study|Protocol deviation|0|||
163863134|NCT01959412|591865284|FG000|Overall Study|Adverse Event|0|||
163863135|NCT01959412|591865285|FG001|Overall Study|Adverse Event|0|||
163863136|NCT01959412|591865286|FG002|Overall Study|Adverse Event|0|||
163863137|NCT01959412|591865287|FG003|Overall Study|Adverse Event|1|||
163863138|NCT01959412|591865288|FG004|Overall Study|Adverse Event|0|||
163863139|NCT01959412|591865289|FG005|Overall Study|Adverse Event|0|||
163863140|NCT01186848|591865290|FG000|Overall Study|Lost to Follow-up|4|||
163863141|NCT01186848|591865290|FG000|Overall Study|Withdrawal by Subject|2|||
163863142|NCT01186848|591865290|FG000|Overall Study|Adverse Event|2|||
163863143|NCT00158054|591865301|FG000|Overall Study|Refused to continue|3|||
163863144|NCT00158054|591865302|FG001|Overall Study|Refused to continue|0|||
163863145|NCT00158054|591865301|FG000|Overall Study|Unavailable for follow up|7|||
163863146|NCT00158054|591865302|FG001|Overall Study|Unavailable for follow up|3|||
163863147|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
163863148|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
163863149|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
163863150|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
163863151|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
163863152|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
163863153|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
163863154|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
163863155|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
163863156|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
163863157|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
163863158|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
163863159|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Death|7|||
163863160|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Death|4|||
163863161|NCT00410124|591865303|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
163863162|NCT00410124|591865304|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
163863163|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
163863164|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
163863165|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
163863166|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
163863167|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
163863168|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
163863169|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
163863170|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
163863171|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
163863172|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
163863173|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
163863174|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
163863175|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
163863176|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
163863177|NCT00410124|591865303|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
163863178|NCT00410124|591865304|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
163863179|NCT00880048|591865309|FG000|Overall Study|Adverse Event|2|||
163863180|NCT00880048|591865310|FG001|Overall Study|Adverse Event|3|||
163863181|NCT00880048|591865311|FG002|Overall Study|Adverse Event|5|||
163863182|NCT00880048|591865309|FG000|Overall Study|Lack of Efficacy|1|||
164309932|NCT00485134|593509537|FG007|Overall Study|Unable to comply with study schedule|1|||
164309933|NCT00485134|593509530|FG000|Overall Study|Pregnancy|0|||
164309934|NCT00485134|593509531|FG001|Overall Study|Pregnancy|0|||
164309935|NCT00485134|593509532|FG002|Overall Study|Pregnancy|0|||
164309936|NCT00485134|593509533|FG003|Overall Study|Pregnancy|0|||
164309937|NCT00485134|593509534|FG004|Overall Study|Pregnancy|0|||
164309938|NCT00485134|593509535|FG005|Overall Study|Pregnancy|0|||
164309939|NCT00485134|593509536|FG006|Overall Study|Pregnancy|1|||
164309940|NCT00485134|593509537|FG007|Overall Study|Pregnancy|0|||
164309941|NCT00970684|593509538|FG000|Overall Study|Lack of Efficacy|5|||
164309942|NCT00970684|593509538|FG000|Overall Study|Adverse Event|4|||
163863183|NCT00880048|591865310|FG001|Overall Study|Lack of Efficacy|2|||
163863184|NCT00880048|591865311|FG002|Overall Study|Lack of Efficacy|2|||
163863185|NCT00880048|591865309|FG000|Overall Study|Protocol Violation|4|||
163863186|NCT00880048|591865310|FG001|Overall Study|Protocol Violation|6|||
163863187|NCT00880048|591865311|FG002|Overall Study|Protocol Violation|5|||
163863188|NCT00880048|591865309|FG000|Overall Study|Lost to Follow-up|6|||
163863189|NCT00880048|591865310|FG001|Overall Study|Lost to Follow-up|6|||
163863190|NCT00880048|591865311|FG002|Overall Study|Lost to Follow-up|5|||
163863191|NCT00880048|591865309|FG000|Overall Study|Physician Decision|1|||
163863192|NCT00880048|591865310|FG001|Overall Study|Physician Decision|1|||
163863193|NCT00880048|591865311|FG002|Overall Study|Physician Decision|7|||
163863194|NCT00880048|591865309|FG000|Overall Study|Withdrawal by Subject|5|||
163863195|NCT00880048|591865310|FG001|Overall Study|Withdrawal by Subject|8|||
163863196|NCT00880048|591865311|FG002|Overall Study|Withdrawal by Subject|5|||
163863197|NCT00880048|591865309|FG000|Overall Study|Study closed/terminated|9|||
163863198|NCT00880048|591865310|FG001|Overall Study|Study closed/terminated|7|||
163863199|NCT00880048|591865311|FG002|Overall Study|Study closed/terminated|6|||
163863200|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
163863201|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
163863202|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
163863203|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
163863204|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
163863205|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
163863206|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
163863207|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
163863208|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
163863209|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
163863210|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
163863211|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
163863212|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
163863213|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
163863214|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
163863215|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
163863216|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
163863217|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
163863218|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
163863219|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
163863220|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
163863221|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
163863222|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
163863223|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
163863224|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
163863225|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
163863226|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
163863227|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
163863228|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
163863229|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
163863230|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
163863231|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
163863232|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
163863233|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863234|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
163863235|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
163863236|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
163863237|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863238|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863239|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863240|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863241|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163968067|NCT00467779|592255769|FG005|Stage 2A|Adverse Event|0|||
164309943|NCT00970684|593509538|FG000|Overall Study|Withdrawal by Subject|1|||
164309944|NCT00481091|593509539|FG000|Overall Study|Withdrawal by Subject|0|||
164309945|NCT00481091|593509540|FG001|Overall Study|Withdrawal by Subject|1|||
163863242|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863243|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
163863244|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863245|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863246|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863247|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863248|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
163863249|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863250|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863251|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863252|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863253|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863254|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
163863255|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
163863256|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863257|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863258|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863259|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863260|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863261|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863262|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863263|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863264|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863265|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
163863266|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
163863267|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
163863268|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
163863269|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
163863270|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
163863271|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
163863272|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
163863273|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
163863274|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
163863275|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
163863276|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
163863277|NCT02914522|591865312|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863278|NCT02914522|591865313|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163863279|NCT02914522|591865314|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863280|NCT02914522|591865315|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863281|NCT02914522|591865316|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163863282|NCT02914522|591865317|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
163863283|NCT02914522|591865318|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863284|NCT02914522|591865319|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863285|NCT02914522|591865320|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863286|NCT02914522|591865321|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863287|NCT02914522|591865322|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
163863288|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163863289|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163863290|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163863291|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163863292|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163863293|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
163863294|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
163863295|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
163863296|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
163863297|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
163863298|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
163863299|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163863300|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163863301|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163863302|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164201060|NCT01677741|593108462|FG002|Overall Study|Withdrawal by Subject|5|||
163863303|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
164201061|NCT01677741|593108463|FG003|Overall Study|Withdrawal by Subject|4|||
164302359|NCT00001959|593482599|FG000|Overall Study|non-compliance|1|||
164309946|NCT00481091|593509541|FG002|Overall Study|Withdrawal by Subject|1|||
164309947|NCT00481091|593509542|FG003|Overall Study|Withdrawal by Subject|0|||
164309948|NCT00481091|593509543|FG004|Overall Study|Withdrawal by Subject|0|||
164309949|NCT00481091|593509544|FG005|Overall Study|Withdrawal by Subject|0|||
164309950|NCT00481091|593509545|FG006|Overall Study|Withdrawal by Subject|0|||
164309951|NCT00481091|593509546|FG007|Overall Study|Withdrawal by Subject|0|||
164309952|NCT00481091|593509547|FG008|Overall Study|Withdrawal by Subject|1|||
164309953|NCT00481091|593509548|FG009|Overall Study|Withdrawal by Subject|6|||
164309954|NCT00481091|593509539|FG000|Overall Study|Other, Not Specified|0|||
164309955|NCT00481091|593509540|FG001|Overall Study|Other, Not Specified|1|||
164309956|NCT00481091|593509541|FG002|Overall Study|Other, Not Specified|1|||
164309957|NCT00481091|593509542|FG003|Overall Study|Other, Not Specified|0|||
163863304|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
163863305|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
163863306|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
163863307|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
163863308|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
163863309|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
163863310|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863311|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863312|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863313|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863314|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863315|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863316|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
163863317|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
163863318|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
163863319|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
163863320|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
163863321|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163863322|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163863323|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163863324|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163863325|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163863326|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
163863327|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
163863328|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
163863329|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
163863330|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
163863331|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
163863332|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
163863333|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
163863334|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
163863335|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
163863336|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
163863337|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
163863338|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
163863339|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
163863340|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
163863341|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
163863342|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
163863343|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863344|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863345|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863346|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863347|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863348|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863349|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863350|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
164309958|NCT00481091|593509543|FG004|Overall Study|Other, Not Specified|0|||
164309959|NCT00481091|593509544|FG005|Overall Study|Other, Not Specified|1|||
164309960|NCT00481091|593509545|FG006|Overall Study|Other, Not Specified|0|||
164309961|NCT00481091|593509546|FG007|Overall Study|Other, Not Specified|0|||
163863351|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
163863352|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
163863353|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
164309962|NCT00481091|593509547|FG008|Overall Study|Other, Not Specified|0|||
164309963|NCT00481091|593509548|FG009|Overall Study|Other, Not Specified|4|||
163968068|NCT00467779|592255770|FG006|Stage 2A|Adverse Event|0|||
163968069|NCT00467779|592255771|FG007|Stage 2A|Adverse Event|0|||
163968070|NCT00467779|592255772|FG008|Stage 2A|Adverse Event|0|||
163968071|NCT00467779|592255773|FG009|Stage 2A|Adverse Event|0|||
163968072|NCT00467779|592255774|FG010|Stage 2A|Adverse Event|0|||
163968073|NCT00467779|592255775|FG011|Stage 2A|Adverse Event|0|||
163968074|NCT00467779|592255776|FG012|Stage 2A|Adverse Event|0|||
163968075|NCT00467779|592255777|FG013|Stage 2A|Adverse Event|2|||
163968076|NCT00467779|592255778|FG014|Stage 2A|Adverse Event|0|||
163968077|NCT00467779|592255764|FG000|Stage 2A|Death|0|||
163968078|NCT00467779|592255765|FG001|Stage 2A|Death|0|||
163968079|NCT00467779|592255766|FG002|Stage 2A|Death|0|||
163968080|NCT00467779|592255767|FG003|Stage 2A|Death|0|||
163968081|NCT00467779|592255768|FG004|Stage 2A|Death|0|||
163968082|NCT00467779|592255769|FG005|Stage 2A|Death|0|||
163968083|NCT00467779|592255770|FG006|Stage 2A|Death|0|||
163968084|NCT00467779|592255771|FG007|Stage 2A|Death|0|||
163968085|NCT00467779|592255772|FG008|Stage 2A|Death|0|||
163968086|NCT00467779|592255773|FG009|Stage 2A|Death|0|||
163968087|NCT00467779|592255774|FG010|Stage 2A|Death|0|||
163968088|NCT00467779|592255775|FG011|Stage 2A|Death|0|||
163968089|NCT00467779|592255776|FG012|Stage 2A|Death|0|||
163968090|NCT00467779|592255777|FG013|Stage 2A|Death|1|||
163968091|NCT00467779|592255778|FG014|Stage 2A|Death|0|||
163968092|NCT00467779|592255764|FG000|Stage 2A|Disease Progression|0|||
163968093|NCT00467779|592255765|FG001|Stage 2A|Disease Progression|0|||
163968094|NCT00467779|592255766|FG002|Stage 2A|Disease Progression|0|||
163968095|NCT00467779|592255767|FG003|Stage 2A|Disease Progression|0|||
163968096|NCT00467779|592255768|FG004|Stage 2A|Disease Progression|0|||
163968097|NCT00467779|592255769|FG005|Stage 2A|Disease Progression|0|||
163968098|NCT00467779|592255770|FG006|Stage 2A|Disease Progression|0|||
163968099|NCT00467779|592255771|FG007|Stage 2A|Disease Progression|0|||
163968100|NCT00467779|592255772|FG008|Stage 2A|Disease Progression|0|||
163968101|NCT00467779|592255773|FG009|Stage 2A|Disease Progression|0|||
163968102|NCT00467779|592255774|FG010|Stage 2A|Disease Progression|0|||
163968103|NCT00467779|592255775|FG011|Stage 2A|Disease Progression|0|||
163968104|NCT00467779|592255776|FG012|Stage 2A|Disease Progression|0|||
163968105|NCT00467779|592255777|FG013|Stage 2A|Disease Progression|10|||
163968106|NCT00467779|592255778|FG014|Stage 2A|Disease Progression|0|||
163968107|NCT00467779|592255764|FG000|Stage 2A|Unspecified Reason|0|||
163968108|NCT00467779|592255765|FG001|Stage 2A|Unspecified Reason|0|||
163968109|NCT00467779|592255766|FG002|Stage 2A|Unspecified Reason|0|||
163968110|NCT00467779|592255767|FG003|Stage 2A|Unspecified Reason|0|||
163968111|NCT00467779|592255768|FG004|Stage 2A|Unspecified Reason|0|||
163968112|NCT00467779|592255769|FG005|Stage 2A|Unspecified Reason|0|||
163968113|NCT00467779|592255770|FG006|Stage 2A|Unspecified Reason|0|||
163968114|NCT00467779|592255771|FG007|Stage 2A|Unspecified Reason|0|||
163968115|NCT00467779|592255772|FG008|Stage 2A|Unspecified Reason|0|||
163968116|NCT00467779|592255773|FG009|Stage 2A|Unspecified Reason|0|||
163968117|NCT00467779|592255774|FG010|Stage 2A|Unspecified Reason|0|||
163968118|NCT00467779|592255775|FG011|Stage 2A|Unspecified Reason|0|||
163968119|NCT00467779|592255776|FG012|Stage 2A|Unspecified Reason|0|||
163968120|NCT00467779|592255777|FG013|Stage 2A|Unspecified Reason|7|||
163968121|NCT00467779|592255778|FG014|Stage 2A|Unspecified Reason|0|||
163968122|NCT00467779|592255764|FG000|Stage 2A|Withdrawal by Subject|0|||
163968123|NCT00467779|592255765|FG001|Stage 2A|Withdrawal by Subject|0|||
163968124|NCT00467779|592255766|FG002|Stage 2A|Withdrawal by Subject|0|||
163968125|NCT00467779|592255767|FG003|Stage 2A|Withdrawal by Subject|0|||
163968126|NCT00467779|592255768|FG004|Stage 2A|Withdrawal by Subject|0|||
163968127|NCT00467779|592255769|FG005|Stage 2A|Withdrawal by Subject|0|||
163968128|NCT00467779|592255770|FG006|Stage 2A|Withdrawal by Subject|0|||
163968129|NCT00467779|592255771|FG007|Stage 2A|Withdrawal by Subject|0|||
163968130|NCT00467779|592255772|FG008|Stage 2A|Withdrawal by Subject|0|||
163968131|NCT00467779|592255773|FG009|Stage 2A|Withdrawal by Subject|0|||
163968132|NCT00467779|592255774|FG010|Stage 2A|Withdrawal by Subject|0|||
163968133|NCT00467779|592255775|FG011|Stage 2A|Withdrawal by Subject|0|||
163968134|NCT00467779|592255776|FG012|Stage 2A|Withdrawal by Subject|0|||
163968135|NCT00467779|592255777|FG013|Stage 2A|Withdrawal by Subject|1|||
163968136|NCT00467779|592255778|FG014|Stage 2A|Withdrawal by Subject|0|||
163968137|NCT00467779|592255764|FG000|Stage 3|Adverse Event|0|||
163968138|NCT00467779|592255765|FG001|Stage 3|Adverse Event|0|||
163968139|NCT00467779|592255766|FG002|Stage 3|Adverse Event|0|||
163968140|NCT00467779|592255767|FG003|Stage 3|Adverse Event|0|||
163968141|NCT00467779|592255768|FG004|Stage 3|Adverse Event|0|||
163968142|NCT00467779|592255769|FG005|Stage 3|Adverse Event|0|||
163968143|NCT00467779|592255770|FG006|Stage 3|Adverse Event|0|||
163968144|NCT00467779|592255771|FG007|Stage 3|Adverse Event|0|||
163968145|NCT00467779|592255772|FG008|Stage 3|Adverse Event|0|||
163968146|NCT00467779|592255773|FG009|Stage 3|Adverse Event|0|||
163968147|NCT00467779|592255774|FG010|Stage 3|Adverse Event|0|||
163968148|NCT00467779|592255775|FG011|Stage 3|Adverse Event|0|||
163968149|NCT00467779|592255776|FG012|Stage 3|Adverse Event|0|||
163968150|NCT00467779|592255777|FG013|Stage 3|Adverse Event|0|||
163968151|NCT00467779|592255778|FG014|Stage 3|Adverse Event|2|||
163968152|NCT00467779|592255764|FG000|Stage 3|Death|0|||
163968153|NCT00467779|592255765|FG001|Stage 3|Death|0|||
163968154|NCT00467779|592255766|FG002|Stage 3|Death|0|||
163968155|NCT00467779|592255767|FG003|Stage 3|Death|0|||
163968156|NCT00467779|592255768|FG004|Stage 3|Death|0|||
163968157|NCT00467779|592255769|FG005|Stage 3|Death|0|||
163968158|NCT00467779|592255770|FG006|Stage 3|Death|0|||
163968159|NCT00467779|592255771|FG007|Stage 3|Death|0|||
163968160|NCT00467779|592255772|FG008|Stage 3|Death|0|||
163968161|NCT00467779|592255773|FG009|Stage 3|Death|0|||
163968162|NCT00467779|592255774|FG010|Stage 3|Death|0|||
163968163|NCT00467779|592255775|FG011|Stage 3|Death|0|||
163968164|NCT00467779|592255776|FG012|Stage 3|Death|0|||
163968165|NCT00467779|592255777|FG013|Stage 3|Death|0|||
163968166|NCT00467779|592255778|FG014|Stage 3|Death|1|||
163968167|NCT00467779|592255764|FG000|Stage 3|Disease Progression|0|||
163968168|NCT00467779|592255765|FG001|Stage 3|Disease Progression|0|||
163968169|NCT00467779|592255766|FG002|Stage 3|Disease Progression|0|||
163968170|NCT00467779|592255767|FG003|Stage 3|Disease Progression|0|||
163968171|NCT00467779|592255768|FG004|Stage 3|Disease Progression|0|||
163968172|NCT00467779|592255769|FG005|Stage 3|Disease Progression|0|||
163968173|NCT00467779|592255770|FG006|Stage 3|Disease Progression|0|||
163968174|NCT00467779|592255771|FG007|Stage 3|Disease Progression|0|||
163968175|NCT00467779|592255772|FG008|Stage 3|Disease Progression|0|||
163968176|NCT00467779|592255773|FG009|Stage 3|Disease Progression|0|||
163968177|NCT00467779|592255774|FG010|Stage 3|Disease Progression|0|||
163968178|NCT00467779|592255775|FG011|Stage 3|Disease Progression|0|||
163968179|NCT00467779|592255776|FG012|Stage 3|Disease Progression|0|||
163968180|NCT00467779|592255777|FG013|Stage 3|Disease Progression|0|||
163968181|NCT00467779|592255778|FG014|Stage 3|Disease Progression|9|||
163968182|NCT00467779|592255764|FG000|Stage 3|Unspecified Reason|0|||
163968183|NCT00467779|592255765|FG001|Stage 3|Unspecified Reason|0|||
163968184|NCT00467779|592255766|FG002|Stage 3|Unspecified Reason|0|||
164309964|NCT00481091|593509539|FG000|Overall Study|Adverse Event|1|||
164309965|NCT00481091|593509540|FG001|Overall Study|Adverse Event|2|||
163863354|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863355|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863356|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863357|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863358|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863359|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863360|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863361|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863362|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
163863363|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
163863364|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
163863365|NCT02914522|591865312|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863366|NCT02914522|591865313|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863367|NCT02914522|591865314|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863368|NCT02914522|591865315|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863369|NCT02914522|591865316|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863370|NCT02914522|591865317|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863371|NCT02914522|591865318|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863372|NCT02914522|591865319|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863373|NCT02914522|591865320|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863374|NCT02914522|591865321|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
163863375|NCT02914522|591865322|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
163863376|NCT03098030|591865323|FG000|Overall Study|Death|10|||
163863377|NCT03098030|591865324|FG001|Overall Study|Death|156|||
163863378|NCT03098030|591865325|FG002|Overall Study|Death|156|||
163863379|NCT03098030|591865326|FG003|Overall Study|Death|82|||
163863380|NCT03098030|591865323|FG000|Overall Study|Withdrawal by Subject|0|||
163863381|NCT03098030|591865324|FG001|Overall Study|Withdrawal by Subject|7|||
163863382|NCT03098030|591865325|FG002|Overall Study|Withdrawal by Subject|8|||
163863383|NCT03098030|591865326|FG003|Overall Study|Withdrawal by Subject|2|||
163863384|NCT03098030|591865323|FG000|Overall Study|Lost to Follow-up|0|||
163863385|NCT03098030|591865324|FG001|Overall Study|Lost to Follow-up|0|||
163863386|NCT03098030|591865325|FG002|Overall Study|Lost to Follow-up|2|||
163863387|NCT03098030|591865326|FG003|Overall Study|Lost to Follow-up|1|||
163968185|NCT00467779|592255767|FG003|Stage 3|Unspecified Reason|0|||
163968186|NCT00467779|592255768|FG004|Stage 3|Unspecified Reason|0|||
163968187|NCT00467779|592255769|FG005|Stage 3|Unspecified Reason|0|||
163968188|NCT00467779|592255770|FG006|Stage 3|Unspecified Reason|0|||
163968189|NCT00467779|592255771|FG007|Stage 3|Unspecified Reason|0|||
163968190|NCT00467779|592255772|FG008|Stage 3|Unspecified Reason|0|||
163968191|NCT00467779|592255773|FG009|Stage 3|Unspecified Reason|0|||
163968192|NCT00467779|592255774|FG010|Stage 3|Unspecified Reason|0|||
163968193|NCT00467779|592255775|FG011|Stage 3|Unspecified Reason|0|||
163968194|NCT00467779|592255776|FG012|Stage 3|Unspecified Reason|0|||
163863388|NCT03368001|591865328|FG000|Allocation|Lost to Pretest|16|||
163863389|NCT03368001|591865329|FG001|Allocation|Lost to Pretest|25|||
163863390|NCT03368001|591865328|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
163863391|NCT03368001|591865329|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
163863392|NCT03368001|591865328|FG000|Posttest|Lost to Posttest|7|||
163863393|NCT03368001|591865329|FG001|Posttest|Lost to Posttest|11|||
163863394|NCT03368001|591865328|FG000|Posttest|Discontinued Intervention|6|||
163863395|NCT03368001|591865329|FG001|Posttest|Discontinued Intervention|19|||
163863396|NCT03368001|591865328|FG000|Follow-up|Lost to Follow-up|6|||
163863397|NCT03368001|591865329|FG001|Follow-up|Lost to Follow-up|3|||
163863398|NCT03612804|591865330|FG000|Overall Study|Death|0|||
163863399|NCT03612804|591865331|FG001|Overall Study|Death|7|||
163863400|NCT03612804|591865332|FG002|Overall Study|Death|0|||
163863401|NCT03612804|591865333|FG003|Overall Study|Death|8|||
163863402|NCT03612804|591865330|FG000|Overall Study|Medication copay coverage issues|0|||
163863403|NCT03612804|591865331|FG001|Overall Study|Medication copay coverage issues|0|||
163863404|NCT03612804|591865332|FG002|Overall Study|Medication copay coverage issues|0|||
163863405|NCT03612804|591865333|FG003|Overall Study|Medication copay coverage issues|17|||
163863406|NCT03612804|591865330|FG000|Overall Study|Not current smoker at time of screening|0|||
163863407|NCT03612804|591865331|FG001|Overall Study|Not current smoker at time of screening|1|||
163863408|NCT03612804|591865332|FG002|Overall Study|Not current smoker at time of screening|0|||
163863409|NCT03612804|591865333|FG003|Overall Study|Not current smoker at time of screening|3|||
163863410|NCT03612804|591865330|FG000|Overall Study|Non-veteran status|0|||
163863411|NCT03612804|591865331|FG001|Overall Study|Non-veteran status|1|||
163863412|NCT03612804|591865332|FG002|Overall Study|Non-veteran status|0|||
163863413|NCT03612804|591865333|FG003|Overall Study|Non-veteran status|0|||
163863414|NCT03612804|591865330|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
163863415|NCT03612804|591865331|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
163863416|NCT03612804|591865332|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
163863417|NCT03612804|591865333|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
163863418|NCT03612804|591865330|FG000|Overall Study|Provider retired from VA|0|||
163863419|NCT03612804|591865331|FG001|Overall Study|Provider retired from VA|0|||
163863420|NCT03612804|591865332|FG002|Overall Study|Provider retired from VA|2|||
163863421|NCT03612804|591865333|FG003|Overall Study|Provider retired from VA|0|||
163863422|NCT03612804|591865330|FG000|Overall Study|Withdrawal by Subject|0|||
163863423|NCT03612804|591865331|FG001|Overall Study|Withdrawal by Subject|0|||
163863424|NCT03612804|591865332|FG002|Overall Study|Withdrawal by Subject|7|||
163863425|NCT03612804|591865333|FG003|Overall Study|Withdrawal by Subject|0|||
163863426|NCT03612804|591865330|FG000|Overall Study|Provider involved with study activities|1|||
163863427|NCT03612804|591865331|FG001|Overall Study|Provider involved with study activities|0|||
163863428|NCT03612804|591865332|FG002|Overall Study|Provider involved with study activities|0|||
163863429|NCT03612804|591865333|FG003|Overall Study|Provider involved with study activities|0|||
163863430|NCT05484726|591865334|FG000|Overall Study|Protocol Violation|3|||
163863431|NCT05484726|591865335|FG001|Overall Study|Protocol Violation|3|||
163863432|NCT05484726|591865334|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
163863433|NCT05484726|591865335|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
163863434|NCT05484726|591865334|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
163863435|NCT05484726|591865335|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
163863436|NCT05484726|591865334|FG000|Overall Study|continued need of mechanical ventilation|2|||
163863437|NCT05484726|591865335|FG001|Overall Study|continued need of mechanical ventilation|3|||
163863438|NCT05484726|591865334|FG000|Overall Study|Withdrawal by Subject|2|||
163863439|NCT05484726|591865335|FG001|Overall Study|Withdrawal by Subject|3|||
163863440|NCT05484726|591865334|FG000|Overall Study|IVH (G III & IV)|2|||
163863441|NCT05484726|591865335|FG001|Overall Study|IVH (G III & IV)|1|||
163863442|NCT05484726|591865334|FG000|Overall Study|NEC (stage II & III)|2|||
163863443|NCT05484726|591865335|FG001|Overall Study|NEC (stage II & III)|3|||
163863444|NCT04391309|591865336|FG000|Overall Study|Death|1|||
163863445|NCT04391309|591865337|FG001|Overall Study|Death|1|||
163863446|NCT04391309|591865336|FG000|Overall Study|Lost to Follow-up|3|||
163863447|NCT04391309|591865337|FG001|Overall Study|Lost to Follow-up|2|||
163863448|NCT04391309|591865336|FG000|Overall Study|Withdrawal by Subject|2|||
163863449|NCT04391309|591865337|FG001|Overall Study|Withdrawal by Subject|2|||
164201062|NCT01677741|593108464|FG004|Overall Study|Withdrawal by Subject|11|||
164201063|NCT01677741|593108465|FG005|Overall Study|Withdrawal by Subject|20|||
164201064|NCT01677741|593108466|FG006|Overall Study|Withdrawal by Subject|4|||
164201065|NCT01677741|593108467|FG007|Overall Study|Withdrawal by Subject|2|||
164201066|NCT01677741|593108460|FG000|Overall Study|Enrolled in a rollover study|0|||
163863450|NCT02781584|591865338|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
163863451|NCT02781584|591865339|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
163863452|NCT02781584|591865340|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
163863453|NCT02781584|591865341|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
164201067|NCT01677741|593108461|FG001|Overall Study|Enrolled in a rollover study|3|||
164201068|NCT01677741|593108462|FG002|Overall Study|Enrolled in a rollover study|2|||
163863454|NCT02781584|591865342|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
163863455|NCT02781584|591865343|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
163863456|NCT02781584|591865344|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
163863457|NCT02781584|591865345|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
163863458|NCT02781584|591865346|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
163863459|NCT02781584|591865347|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
163863460|NCT02781584|591865348|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
163863461|NCT02781584|591865349|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
163863462|NCT02781584|591865350|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
163863463|NCT02781584|591865338|FG000|Pre-treatment Phase|Adverse Event|0|||
163863464|NCT02781584|591865339|FG001|Pre-treatment Phase|Adverse Event|0|||
163863465|NCT02781584|591865340|FG002|Pre-treatment Phase|Adverse Event|0|||
163863466|NCT02781584|591865341|FG003|Pre-treatment Phase|Adverse Event|0|||
163863467|NCT02781584|591865342|FG004|Pre-treatment Phase|Adverse Event|0|||
163863468|NCT02781584|591865343|FG005|Pre-treatment Phase|Adverse Event|0|||
163863469|NCT02781584|591865344|FG006|Pre-treatment Phase|Adverse Event|0|||
163863470|NCT02781584|591865345|FG007|Pre-treatment Phase|Adverse Event|0|||
163863471|NCT02781584|591865346|FG008|Pre-treatment Phase|Adverse Event|0|||
163863472|NCT02781584|591865347|FG009|Pre-treatment Phase|Adverse Event|0|||
163863473|NCT02781584|591865348|FG010|Pre-treatment Phase|Adverse Event|0|||
163863474|NCT02781584|591865349|FG011|Pre-treatment Phase|Adverse Event|1|||
163863475|NCT02781584|591865350|FG012|Pre-treatment Phase|Adverse Event|0|||
163863476|NCT02781584|591865338|FG000|Treatment Phase|Withdrew Consent|0|||
163863477|NCT02781584|591865339|FG001|Treatment Phase|Withdrew Consent|0|||
163863478|NCT02781584|591865340|FG002|Treatment Phase|Withdrew Consent|0|||
163863479|NCT02781584|591865341|FG003|Treatment Phase|Withdrew Consent|0|||
163863480|NCT02781584|591865342|FG004|Treatment Phase|Withdrew Consent|0|||
163863481|NCT02781584|591865343|FG005|Treatment Phase|Withdrew Consent|1|||
163863482|NCT02781584|591865344|FG006|Treatment Phase|Withdrew Consent|0|||
163863483|NCT02781584|591865345|FG007|Treatment Phase|Withdrew Consent|0|||
163863484|NCT02781584|591865346|FG008|Treatment Phase|Withdrew Consent|0|||
163863485|NCT02781584|591865347|FG009|Treatment Phase|Withdrew Consent|0|||
163863486|NCT02781584|591865348|FG010|Treatment Phase|Withdrew Consent|1|||
163863487|NCT02781584|591865349|FG011|Treatment Phase|Withdrew Consent|2|||
163863488|NCT02781584|591865350|FG012|Treatment Phase|Withdrew Consent|0|||
163863489|NCT02781584|591865338|FG000|Treatment Phase|Adverse Event|0|||
163863490|NCT02781584|591865339|FG001|Treatment Phase|Adverse Event|0|||
163863491|NCT02781584|591865340|FG002|Treatment Phase|Adverse Event|0|||
163863492|NCT02781584|591865341|FG003|Treatment Phase|Adverse Event|0|||
163863493|NCT02781584|591865342|FG004|Treatment Phase|Adverse Event|0|||
164201069|NCT01677741|593108463|FG003|Overall Study|Enrolled in a rollover study|1|||
164201070|NCT01677741|593108464|FG004|Overall Study|Enrolled in a rollover study|6|||
164201071|NCT01677741|593108465|FG005|Overall Study|Enrolled in a rollover study|6|||
164201072|NCT01677741|593108466|FG006|Overall Study|Enrolled in a rollover study|7|||
164201073|NCT01677741|593108467|FG007|Overall Study|Enrolled in a rollover study|0|||
163863494|NCT02781584|591865343|FG005|Treatment Phase|Adverse Event|0|||
163863495|NCT02781584|591865344|FG006|Treatment Phase|Adverse Event|0|||
163863496|NCT02781584|591865345|FG007|Treatment Phase|Adverse Event|1|||
163863497|NCT02781584|591865346|FG008|Treatment Phase|Adverse Event|0|||
163863498|NCT02781584|591865347|FG009|Treatment Phase|Adverse Event|0|||
163863499|NCT02781584|591865348|FG010|Treatment Phase|Adverse Event|0|||
163863500|NCT02781584|591865349|FG011|Treatment Phase|Adverse Event|0|||
163863501|NCT02781584|591865350|FG012|Treatment Phase|Adverse Event|0|||
163863502|NCT00768651|591865355|FG000|Overall Study|Withdrawal by Subject|1|||
164201074|NCT01677741|593108460|FG000|Overall Study|Progressive disease|1|||
164201075|NCT01677741|593108461|FG001|Overall Study|Progressive disease|0|||
164201076|NCT01677741|593108462|FG002|Overall Study|Progressive disease|1|||
164201077|NCT01677741|593108463|FG003|Overall Study|Progressive disease|0|||
164201078|NCT01677741|593108464|FG004|Overall Study|Progressive disease|0|||
164201079|NCT01677741|593108465|FG005|Overall Study|Progressive disease|1|||
164201080|NCT01677741|593108466|FG006|Overall Study|Progressive disease|0|||
164201081|NCT01677741|593108467|FG007|Overall Study|Progressive disease|0|||
164201082|NCT00794664|593108468|FG000|Treatment Period|Withdrawal by Subject|0|||
164201083|NCT00794664|593108469|FG001|Treatment Period|Withdrawal by Subject|2|||
164201084|NCT00794664|593108468|FG000|Treatment Period|Protocol non-compliance|0|||
164309966|NCT00481091|593509541|FG002|Overall Study|Adverse Event|0|||
163863503|NCT00995709|591865356|FG000|Overall Study|Adverse Event|4|||
163863504|NCT00995709|591865357|FG001|Overall Study|Adverse Event|2|||
163863505|NCT00995709|591865358|FG002|Overall Study|Adverse Event|0|||
163863506|NCT00995709|591865356|FG000|Overall Study|Lack of Efficacy|0|||
163863507|NCT00995709|591865357|FG001|Overall Study|Lack of Efficacy|1|||
163863508|NCT00995709|591865358|FG002|Overall Study|Lack of Efficacy|4|||
163863509|NCT00995709|591865356|FG000|Overall Study|Withdrawal by Subject|0|||
163863510|NCT00995709|591865357|FG001|Overall Study|Withdrawal by Subject|4|||
163863511|NCT00995709|591865358|FG002|Overall Study|Withdrawal by Subject|1|||
163863512|NCT00995709|591865356|FG000|Overall Study|Lost to Follow-up|1|||
164201085|NCT00794664|593108469|FG001|Treatment Period|Protocol non-compliance|1|||
164201086|NCT00794664|593108468|FG000|Treatment Period|Other|0|||
164309967|NCT00481091|593509542|FG003|Overall Study|Adverse Event|1|||
164309968|NCT00481091|593509543|FG004|Overall Study|Adverse Event|1|||
164309969|NCT00481091|593509544|FG005|Overall Study|Adverse Event|1|||
164309970|NCT00481091|593509545|FG006|Overall Study|Adverse Event|2|||
164309971|NCT00481091|593509546|FG007|Overall Study|Adverse Event|1|||
164309972|NCT00481091|593509547|FG008|Overall Study|Adverse Event|1|||
164309973|NCT00481091|593509548|FG009|Overall Study|Adverse Event|6|||
164309974|NCT00481091|593509539|FG000|Overall Study|Progressive disease clinical|0|||
164309975|NCT00481091|593509540|FG001|Overall Study|Progressive disease clinical|0|||
164309976|NCT00481091|593509541|FG002|Overall Study|Progressive disease clinical|0|||
164309977|NCT00481091|593509542|FG003|Overall Study|Progressive disease clinical|0|||
164309978|NCT00481091|593509543|FG004|Overall Study|Progressive disease clinical|0|||
164309979|NCT00481091|593509544|FG005|Overall Study|Progressive disease clinical|0|||
164309980|NCT00481091|593509545|FG006|Overall Study|Progressive disease clinical|0|||
164309981|NCT00481091|593509546|FG007|Overall Study|Progressive disease clinical|0|||
164309982|NCT00481091|593509547|FG008|Overall Study|Progressive disease clinical|1|||
164309983|NCT00481091|593509548|FG009|Overall Study|Progressive disease clinical|7|||
164309984|NCT00481091|593509539|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
164309985|NCT00481091|593509540|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
164309986|NCT00481091|593509541|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309987|NCT00481091|593509542|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309988|NCT00481091|593509543|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309989|NCT00481091|593509544|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
164309990|NCT00481091|593509545|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309991|NCT00481091|593509546|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309992|NCT00481091|593509547|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309993|NCT00481091|593509548|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
164309994|NCT00481091|593509539|FG000|Overall Study|Progressive disease other|1|||
164309995|NCT00481091|593509540|FG001|Overall Study|Progressive disease other|1|||
164309996|NCT00481091|593509541|FG002|Overall Study|Progressive disease other|0|||
164309997|NCT00481091|593509542|FG003|Overall Study|Progressive disease other|1|||
164309998|NCT00481091|593509543|FG004|Overall Study|Progressive disease other|1|||
164309999|NCT00481091|593509544|FG005|Overall Study|Progressive disease other|1|||
164310000|NCT00481091|593509545|FG006|Overall Study|Progressive disease other|0|||
164310001|NCT00481091|593509546|FG007|Overall Study|Progressive disease other|2|||
164310002|NCT00481091|593509547|FG008|Overall Study|Progressive disease other|0|||
164310003|NCT00481091|593509548|FG009|Overall Study|Progressive disease other|0|||
164310004|NCT00481091|593509539|FG000|Overall Study|No reason given|0|||
164310005|NCT00481091|593509540|FG001|Overall Study|No reason given|0|||
164310006|NCT00481091|593509541|FG002|Overall Study|No reason given|1|||
164310007|NCT00481091|593509542|FG003|Overall Study|No reason given|1|||
164310008|NCT00481091|593509543|FG004|Overall Study|No reason given|1|||
164310009|NCT00481091|593509544|FG005|Overall Study|No reason given|0|||
164310010|NCT00481091|593509545|FG006|Overall Study|No reason given|1|||
164310011|NCT00481091|593509546|FG007|Overall Study|No reason given|1|||
164310012|NCT00481091|593509547|FG008|Overall Study|No reason given|1|||
164310013|NCT00481091|593509548|FG009|Overall Study|No reason given|4|||
164310014|NCT04294680|593509549|FG000|Overall Study|Withdrawal by Subject|2|||
164310015|NCT04294680|593509550|FG001|Overall Study|Withdrawal by Subject|1|||
164310016|NCT04294680|593509549|FG000|Overall Study|Follow-up visits completed outside of window|1|||
164310017|NCT04294680|593509550|FG001|Overall Study|Follow-up visits completed outside of window|0|||
164310018|NCT02078960|593509553|FG000|Treatment Period|Other|0|||
164310019|NCT02078960|593509554|FG001|Treatment Period|Other|0|||
164310020|NCT02078960|593509555|FG002|Treatment Period|Other|1|||
164310021|NCT02078960|593509553|FG000|Treatment Period|Lack of Efficacy|0|||
164310022|NCT02078960|593509554|FG001|Treatment Period|Lack of Efficacy|1|||
164310023|NCT02078960|593509555|FG002|Treatment Period|Lack of Efficacy|0|||
164310024|NCT02078960|593509553|FG000|Treatment Period|Disease progression - accelerated phase|0|||
164310025|NCT02078960|593509554|FG001|Treatment Period|Disease progression - accelerated phase|1|||
163863513|NCT00995709|591865357|FG001|Overall Study|Lost to Follow-up|0|||
163863514|NCT00995709|591865358|FG002|Overall Study|Lost to Follow-up|0|||
163863515|NCT00995709|591865356|FG000|Overall Study|Death|0|||
163863516|NCT00995709|591865357|FG001|Overall Study|Death|1|||
164310026|NCT02078960|593509555|FG002|Treatment Period|Disease progression - accelerated phase|0|||
164310027|NCT02078960|593509553|FG000|Treatment Period|Disease progression - blast phase|1|||
164310028|NCT02078960|593509554|FG001|Treatment Period|Disease progression - blast phase|0|||
164310029|NCT02078960|593509555|FG002|Treatment Period|Disease progression - blast phase|0|||
164310030|NCT02078960|593509553|FG000|Treatment Period|Withdrawal by Subject|0|||
163863517|NCT00995709|591865358|FG002|Overall Study|Death|0|||
164310031|NCT02078960|593509554|FG001|Treatment Period|Withdrawal by Subject|1|||
163863518|NCT00995709|591865356|FG000|Overall Study|Protocol Violation|2|||
164310032|NCT02078960|593509555|FG002|Treatment Period|Withdrawal by Subject|1|||
163968195|NCT00467779|592255777|FG013|Stage 3|Unspecified Reason|0|||
163968196|NCT00467779|592255778|FG014|Stage 3|Unspecified Reason|5|||
163968197|NCT01195090|592255779|FG000|Overall Study|Adverse Event|1|||
163968198|NCT01195090|592255780|FG001|Overall Study|Adverse Event|2|||
163968199|NCT01195090|592255779|FG000|Overall Study|Lost to Follow-up|2|||
163968200|NCT01195090|592255780|FG001|Overall Study|Lost to Follow-up|2|||
163968201|NCT01195090|592255779|FG000|Overall Study|Protocol Violation|3|||
163968202|NCT01195090|592255780|FG001|Overall Study|Protocol Violation|4|||
163968203|NCT05111041|592255781|FG000|Overall Study|Lost to Follow-up|6|||
163968204|NCT05111041|592255782|FG001|Overall Study|Lost to Follow-up|7|||
163968205|NCT05111041|592255781|FG000|Overall Study|Withdrawal by Subject|1|||
163968206|NCT05111041|592255782|FG001|Overall Study|Withdrawal by Subject|0|||
163968207|NCT04912245|592255783|FG000|Overall Study|Withdrawal by Subject|21|||
163968208|NCT04912245|592255784|FG001|Overall Study|Withdrawal by Subject|4|||
163968209|NCT04912245|592255783|FG000|Overall Study|Lost to Follow-up|5|||
163968210|NCT04912245|592255784|FG001|Overall Study|Lost to Follow-up|11|||
163968211|NCT01205230|592255785|FG000|Overall Study|Adverse Event|4|||
163863519|NCT00995709|591865357|FG001|Overall Study|Protocol Violation|1|||
163863520|NCT00995709|591865358|FG002|Overall Study|Protocol Violation|0|||
163863521|NCT01543685|591865362|FG000|Overall Study|Lack of Efficacy|1|||
163863522|NCT01543685|591865363|FG001|Overall Study|Lack of Efficacy|2|||
163863523|NCT01543685|591865364|FG002|Overall Study|Lack of Efficacy|2|||
163863524|NCT01543685|591865365|FG003|Overall Study|Lack of Efficacy|0|||
163863525|NCT01543685|591865366|FG004|Overall Study|Lack of Efficacy|2|||
163863526|NCT01543685|591865362|FG000|Overall Study|Adverse Event|2|||
163863527|NCT01543685|591865363|FG001|Overall Study|Adverse Event|1|||
163863528|NCT01543685|591865364|FG002|Overall Study|Adverse Event|0|||
163863529|NCT01543685|591865365|FG003|Overall Study|Adverse Event|0|||
163863530|NCT01543685|591865366|FG004|Overall Study|Adverse Event|2|||
163863531|NCT00604721|591865367|FG000|Overall Study|Physician Decision|1|||
163863532|NCT00604721|591865367|FG000|Overall Study|Withdrawal by Subject|1|||
163863533|NCT04776213|591865368|FG000|Overall Study|Other|1|||
163863534|NCT04776213|591865368|FG000|Overall Study|Withdrawal by Subject|7|||
163863535|NCT04776213|591865368|FG000|Overall Study|Protocol Violation|1|||
163863536|NCT04776213|591865368|FG000|Overall Study|Lost to Follow-up|2|||
163863537|NCT01838551|591865372|FG000|Overall Study|Adverse Event|16|||
163863538|NCT01838551|591865372|FG000|Overall Study|Death|1|||
163863539|NCT01838551|591865372|FG000|Overall Study|Lack of Efficacy|10|||
163863540|NCT01838551|591865372|FG000|Overall Study|Physician Decision|4|||
163863541|NCT01838551|591865372|FG000|Overall Study|Withdrawal by Subject|10|||
163863542|NCT01838551|591865372|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
163863543|NCT00906282|591865373|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
163863544|NCT00906282|591865373|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
163863545|NCT00906282|591865373|FG000|Preoperative Chemotherapy|Progressive disease|6|||
163863546|NCT00906282|591865373|FG000|Preoperative Chemotherapy|Toxicity|1|||
163863547|NCT00038103|591865374|FG000|Overall Study|Adverse Event|5|||
163863548|NCT00038103|591865375|FG001|Overall Study|Adverse Event|6|||
163863549|NCT00038103|591865374|FG000|Overall Study|Lack of Efficacy|48|||
163863550|NCT00038103|591865375|FG001|Overall Study|Lack of Efficacy|41|||
163863551|NCT00038103|591865374|FG000|Overall Study|Withdrawal by Subject|0|||
163863552|NCT00038103|591865375|FG001|Overall Study|Withdrawal by Subject|3|||
163863553|NCT00038103|591865374|FG000|Overall Study|Lost to Follow-up|0|||
163863554|NCT00038103|591865375|FG001|Overall Study|Lost to Follow-up|3|||
163863555|NCT00038103|591865374|FG000|Overall Study|Protocol Violation|0|||
163863556|NCT00038103|591865375|FG001|Overall Study|Protocol Violation|2|||
163863557|NCT00038103|591865374|FG000|Overall Study|Sponsor Decision|0|||
163863558|NCT00038103|591865375|FG001|Overall Study|Sponsor Decision|1|||
163863559|NCT00038103|591865374|FG000|Overall Study|Randomized/never treated|2|||
163863560|NCT00038103|591865375|FG001|Overall Study|Randomized/never treated|0|||
163863561|NCT02163915|591865380|FG000|Overall Study|Withdrawal by Subject|2|||
163863562|NCT02163915|591865381|FG001|Overall Study|Withdrawal by Subject|0|||
163863563|NCT02163915|591865382|FG002|Overall Study|Withdrawal by Subject|2|||
163863564|NCT02163915|591865383|FG003|Overall Study|Withdrawal by Subject|2|||
163863565|NCT02163915|591865384|FG004|Overall Study|Withdrawal by Subject|2|||
163863566|NCT02163915|591865380|FG000|Overall Study|Study termination|1|||
163863567|NCT02163915|591865381|FG001|Overall Study|Study termination|0|||
163968212|NCT01205230|592255786|FG001|Overall Study|Adverse Event|0|||
163968213|NCT01205230|592255785|FG000|Overall Study|Physician Decision|1|||
163968214|NCT01205230|592255786|FG001|Overall Study|Physician Decision|0|||
163968215|NCT00041080|592255787|FG000|Overall Study|Adverse Event|21|||
163968216|NCT00041080|592255788|FG001|Overall Study|Adverse Event|1|||
163968217|NCT00041080|592255787|FG000|Overall Study|Withdrawal by Subject|6|||
163863568|NCT02163915|591865382|FG002|Overall Study|Study termination|0|||
163863569|NCT02163915|591865383|FG003|Overall Study|Study termination|0|||
163863570|NCT02163915|591865384|FG004|Overall Study|Study termination|2|||
163968218|NCT00041080|592255788|FG001|Overall Study|Withdrawal by Subject|6|||
163968219|NCT00041080|592255787|FG000|Overall Study|Concommitant Illness/Other|1|||
163968220|NCT00041080|592255788|FG001|Overall Study|Concommitant Illness/Other|2|||
164310033|NCT02078960|593509553|FG000|Treatment Period|Adverse Event|1|||
164310034|NCT02078960|593509554|FG001|Treatment Period|Adverse Event|0|||
163863571|NCT02163915|591865380|FG000|Overall Study|Physician Decision|0|||
163863572|NCT02163915|591865381|FG001|Overall Study|Physician Decision|0|||
163863573|NCT02163915|591865382|FG002|Overall Study|Physician Decision|0|||
163863574|NCT02163915|591865383|FG003|Overall Study|Physician Decision|1|||
163863575|NCT02163915|591865384|FG004|Overall Study|Physician Decision|0|||
163863576|NCT02299336|591865389|FG000|Overall Study|Withdrawal by Subject|11|||
163863577|NCT02299336|591865389|FG000|Overall Study|Adverse Event|1|||
163863578|NCT02299336|591865389|FG000|Overall Study|Death|1|||
163863579|NCT02299336|591865389|FG000|Overall Study|Lost to Follow-up|1|||
163863580|NCT02013037|591865391|FG000|Overall Study|Death|6|||
163863581|NCT02013037|591865391|FG000|Overall Study|Withdrawal by Subject|1|||
163863582|NCT02013037|591865391|FG000|Overall Study|Awaiting Transplantation|7|||
163863583|NCT02013037|591865391|FG000|Overall Study|Transplanted without DSA|2|||
163863584|NCT02465359|591865392|FG000|Overall Study|Lack of Efficacy|1|||
163863585|NCT02465359|591865392|FG000|Overall Study|Withdrawal by Subject|1|||
163863586|NCT02465359|591865392|FG000|Overall Study|Adverse Event|1|||
163863587|NCT01304147|591865393|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
163863588|NCT01304147|591865394|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
163863589|NCT03141788|591865395|FG000|Overall Study|Lost to Follow-up|1|||
163863590|NCT03141788|591865395|FG000|Overall Study|Protocol Violation|3|||
163863591|NCT03141788|591865395|FG000|Overall Study|Withdrawal by Subject|4|||
163863592|NCT02812966|591865398|FG000|Overall Study|Death|1|||
163863593|NCT02812966|591865399|FG001|Overall Study|Death|0|||
163863594|NCT01066923|591865400|FG000|Overall Study|Withdrawal by Subject|3|||
163863595|NCT01066923|591865401|FG001|Overall Study|Withdrawal by Subject|3|||
163863596|NCT01066923|591865402|FG002|Overall Study|Withdrawal by Subject|8|||
163863597|NCT01066923|591865403|FG003|Overall Study|Withdrawal by Subject|8|||
163863598|NCT01070888|591867522|FG000|First Intervention (14 Days)|Adverse Event|0|||
163863599|NCT01070888|591867523|FG001|First Intervention (14 Days)|Adverse Event|1|||
163863600|NCT01070888|591867522|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
163863601|NCT01070888|591867523|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
163863602|NCT01070888|591867522|FG000|Washout (14 Days)|Physician Decision|1|||
163863603|NCT01070888|591867523|FG001|Washout (14 Days)|Physician Decision|0|||
163863604|NCT02577523|591867526|FG000|Overall Study|Adverse Event|1|||
163863605|NCT02577523|591867527|FG001|Overall Study|Adverse Event|1|||
163863606|NCT02577523|591867526|FG000|Overall Study|Lack of Efficacy|1|||
163863607|NCT02577523|591867527|FG001|Overall Study|Lack of Efficacy|1|||
163863608|NCT02577523|591867526|FG000|Overall Study|Withdrawal by Subject|1|||
163863609|NCT02577523|591867527|FG001|Overall Study|Withdrawal by Subject|0|||
163863610|NCT02525796|591867529|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
163863611|NCT02525796|591867530|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
163863612|NCT02525796|591867531|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
163863613|NCT02525796|591867529|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
163863614|NCT02525796|591867530|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
163863615|NCT02525796|591867531|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
163863616|NCT02525796|591867529|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
163863617|NCT02525796|591867530|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
164201087|NCT00794664|593108469|FG001|Treatment Period|Other|1|||
164201088|NCT00794664|593108468|FG000|Treatment Period|Adverse Event|1|||
164201089|NCT00794664|593108469|FG001|Treatment Period|Adverse Event|8|||
164201090|NCT00794664|593108468|FG000|Follow-up Period|Other|1|||
164201091|NCT00794664|593108469|FG001|Follow-up Period|Other|2|||
164201092|NCT00794664|593108468|FG000|Follow-up Period|Withdrawal by Subject|0|||
164201093|NCT00794664|593108469|FG001|Follow-up Period|Withdrawal by Subject|2|||
164201094|NCT00794664|593108468|FG000|Follow-up Period|Protocol non-compliance|0|||
164201095|NCT00794664|593108469|FG001|Follow-up Period|Protocol non-compliance|1|||
164201096|NCT02949947|593108470|FG000|Overall Study|Non Compliance|0|||
164201097|NCT02949947|593108471|FG001|Overall Study|Non Compliance|1|||
164310035|NCT02078960|593509555|FG002|Treatment Period|Adverse Event|0|||
164310036|NCT02078960|593509553|FG000|Treatment Period|Death|0|||
163863618|NCT02525796|591867531|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
163863619|NCT02525796|591867529|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
163863620|NCT02525796|591867530|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
163863621|NCT02525796|591867531|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
163863622|NCT02525796|591867529|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
163863623|NCT02525796|591867530|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
163863624|NCT02525796|591867531|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
163863625|NCT01198275|591867532|FG000|Overall Study|Adverse Event|2|||
163863626|NCT01198275|591867533|FG001|Overall Study|Adverse Event|3|||
163863627|NCT01198275|591867532|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
163863628|NCT01198275|591867533|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
164201098|NCT02949947|593108470|FG000|Overall Study|Insurance change|1|||
164201099|NCT02949947|593108471|FG001|Overall Study|Insurance change|0|||
164310037|NCT02078960|593509554|FG001|Treatment Period|Death|0|||
164310038|NCT02078960|593509555|FG002|Treatment Period|Death|1|||
164310039|NCT02078960|593509553|FG000|Follow-up Period|Death|2|||
164310040|NCT02078960|593509554|FG001|Follow-up Period|Death|0|||
164310041|NCT02078960|593509555|FG002|Follow-up Period|Death|0|||
164310042|NCT02078960|593509553|FG000|Follow-up Period|Lost to Follow-up|0|||
164310043|NCT02078960|593509554|FG001|Follow-up Period|Lost to Follow-up|1|||
164310044|NCT02078960|593509555|FG002|Follow-up Period|Lost to Follow-up|0|||
164310045|NCT04881942|593509557|FG000|Overall Study|Adverse Event|0|||
164310046|NCT04881942|593509558|FG001|Overall Study|Adverse Event|0|||
164310047|NCT04881942|593509559|FG002|Overall Study|Adverse Event|0|||
164310048|NCT04881942|593509560|FG003|Overall Study|Adverse Event|0|||
164310049|NCT04881942|593509561|FG004|Overall Study|Adverse Event|1|||
163863629|NCT00391846|591867534|FG000|Overall Study|Adverse Event|4|||
163863630|NCT00391846|591867535|FG001|Overall Study|Adverse Event|1|||
163863631|NCT00391846|591867534|FG000|Overall Study|Did not meet the required elig. crit|2|||
163863632|NCT00391846|591867535|FG001|Overall Study|Did not meet the required elig. crit|2|||
163863633|NCT00391846|591867534|FG000|Overall Study|Withdrawal by Subject|2|||
163863634|NCT00391846|591867535|FG001|Overall Study|Withdrawal by Subject|3|||
163863635|NCT00391846|591867534|FG000|Overall Study|Developed study specific DC criteria|0|||
163863636|NCT00391846|591867535|FG001|Overall Study|Developed study specific DC criteria|1|||
163863637|NCT02477670|591867536|FG000|Stage 1|Adverse Event|2|||
163863638|NCT02477670|591867537|FG001|Stage 1|Adverse Event|7|||
163863639|NCT02477670|591867538|FG002|Stage 1|Adverse Event|0|||
163863640|NCT02477670|591867539|FG003|Stage 1|Adverse Event|0|||
163863641|NCT02477670|591867540|FG004|Stage 1|Adverse Event|0|||
163863642|NCT02477670|591867541|FG005|Stage 1|Adverse Event|0|||
163863643|NCT02477670|591867542|FG006|Stage 1|Adverse Event|0|||
163863644|NCT02477670|591867536|FG000|Stage 1|Lost to Follow-up|0|||
163863645|NCT02477670|591867537|FG001|Stage 1|Lost to Follow-up|2|||
163863646|NCT02477670|591867538|FG002|Stage 1|Lost to Follow-up|0|||
163863647|NCT02477670|591867539|FG003|Stage 1|Lost to Follow-up|0|||
163863648|NCT02477670|591867540|FG004|Stage 1|Lost to Follow-up|0|||
163863649|NCT02477670|591867541|FG005|Stage 1|Lost to Follow-up|0|||
163863650|NCT02477670|591867542|FG006|Stage 1|Lost to Follow-up|0|||
163863651|NCT02477670|591867536|FG000|Stage 1|Withdrawal by Subject|1|||
163863652|NCT02477670|591867537|FG001|Stage 1|Withdrawal by Subject|2|||
163863653|NCT02477670|591867538|FG002|Stage 1|Withdrawal by Subject|0|||
163863654|NCT02477670|591867539|FG003|Stage 1|Withdrawal by Subject|0|||
163863655|NCT02477670|591867540|FG004|Stage 1|Withdrawal by Subject|0|||
163863656|NCT02477670|591867541|FG005|Stage 1|Withdrawal by Subject|0|||
163863657|NCT02477670|591867542|FG006|Stage 1|Withdrawal by Subject|0|||
163863658|NCT02477670|591867536|FG000|Stage 1|Non-compliance with Study Drug|1|||
163863659|NCT02477670|591867537|FG001|Stage 1|Non-compliance with Study Drug|2|||
163863660|NCT02477670|591867538|FG002|Stage 1|Non-compliance with Study Drug|0|||
163863661|NCT02477670|591867539|FG003|Stage 1|Non-compliance with Study Drug|0|||
163863662|NCT02477670|591867540|FG004|Stage 1|Non-compliance with Study Drug|0|||
163863663|NCT02477670|591867541|FG005|Stage 1|Non-compliance with Study Drug|0|||
163863664|NCT02477670|591867542|FG006|Stage 1|Non-compliance with Study Drug|0|||
163863665|NCT02477670|591867536|FG000|Stage 2|Adverse Event|0|||
163863666|NCT02477670|591867537|FG001|Stage 2|Adverse Event|0|||
163863667|NCT02477670|591867538|FG002|Stage 2|Adverse Event|1|||
163863668|NCT02477670|591867539|FG003|Stage 2|Adverse Event|0|||
163863669|NCT02477670|591867540|FG004|Stage 2|Adverse Event|0|||
163863670|NCT02477670|591867541|FG005|Stage 2|Adverse Event|0|||
163863671|NCT02477670|591867542|FG006|Stage 2|Adverse Event|0|||
163863672|NCT02477670|591867536|FG000|Stage 2|Antipsychotic Medication Changed|0|||
163863673|NCT02477670|591867537|FG001|Stage 2|Antipsychotic Medication Changed|0|||
163863674|NCT02477670|591867538|FG002|Stage 2|Antipsychotic Medication Changed|1|||
163863675|NCT02477670|591867539|FG003|Stage 2|Antipsychotic Medication Changed|0|||
163863676|NCT02477670|591867540|FG004|Stage 2|Antipsychotic Medication Changed|0|||
163863677|NCT02477670|591867541|FG005|Stage 2|Antipsychotic Medication Changed|0|||
163863678|NCT02477670|591867542|FG006|Stage 2|Antipsychotic Medication Changed|0|||
163863679|NCT02477670|591867536|FG000|Stage 2|Withdrawal by Subject|0|||
163863680|NCT02477670|591867537|FG001|Stage 2|Withdrawal by Subject|0|||
163863681|NCT02477670|591867538|FG002|Stage 2|Withdrawal by Subject|0|||
163863682|NCT02477670|591867539|FG003|Stage 2|Withdrawal by Subject|1|||
163863683|NCT02477670|591867540|FG004|Stage 2|Withdrawal by Subject|0|||
163863684|NCT02477670|591867541|FG005|Stage 2|Withdrawal by Subject|0|||
163863685|NCT02477670|591867542|FG006|Stage 2|Withdrawal by Subject|0|||
163863686|NCT00970307|591867543|FG000|Overall Study|Serious Adverse Event|1|||
163863687|NCT00970307|591867544|FG001|Overall Study|Serious Adverse Event|0|||
163863688|NCT00970307|591867545|FG002|Overall Study|Serious Adverse Event|0|||
164310050|NCT04881942|593509557|FG000|Overall Study|Alternates|0|||
164310051|NCT04881942|593509558|FG001|Overall Study|Alternates|0|||
163863689|NCT00970307|591867543|FG000|Overall Study|Withdrawal by Subject|2|||
164310052|NCT04881942|593509559|FG002|Overall Study|Alternates|0|||
163863690|NCT00970307|591867544|FG001|Overall Study|Withdrawal by Subject|3|||
163863691|NCT00970307|591867545|FG002|Overall Study|Withdrawal by Subject|2|||
163863692|NCT02810080|591867546|FG000|Overall Study|Adverse Event|3|||
164310053|NCT04881942|593509560|FG003|Overall Study|Alternates|0|||
164310054|NCT04881942|593509561|FG004|Overall Study|Alternates|2|||
164310055|NCT00859638|593509562|FG000|Overall Study|Lost to Follow-up|6|||
164310056|NCT00859638|593509563|FG001|Overall Study|Lost to Follow-up|1|||
164310057|NCT00859638|593509562|FG000|Overall Study|Withdrawal by Subject|3|||
164310058|NCT00859638|593509563|FG001|Overall Study|Withdrawal by Subject|2|||
164310059|NCT00859638|593509562|FG000|Overall Study|Ill health|1|||
164310060|NCT00859638|593509563|FG001|Overall Study|Ill health|1|||
164310061|NCT00771953|593509567|FG000|Overall Study|Adverse Event|5|||
163863693|NCT02810080|591867547|FG001|Overall Study|Adverse Event|0|||
163863694|NCT02810080|591867546|FG000|Overall Study|Death|0|||
163863695|NCT02810080|591867547|FG001|Overall Study|Death|2|||
163863696|NCT02810080|591867546|FG000|Overall Study|Physician Decision|4|||
163863697|NCT02810080|591867547|FG001|Overall Study|Physician Decision|0|||
163863698|NCT02810080|591867546|FG000|Overall Study|Withdrawal by Subject|0|||
163863699|NCT02810080|591867547|FG001|Overall Study|Withdrawal by Subject|2|||
163863700|NCT00753012|591867559|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
163863701|NCT00753012|591867560|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
163863702|NCT00753012|591867559|FG000|Overall Study|Adverse Event|2|||
163863703|NCT00753012|591867560|FG001|Overall Study|Adverse Event|0|||
163863704|NCT00753012|591867559|FG000|Overall Study|Withdrawal by Subject|0|||
163863705|NCT00753012|591867560|FG001|Overall Study|Withdrawal by Subject|1|||
163863706|NCT00753012|591867559|FG000|Overall Study|Lost to Follow-up|4|||
163863707|NCT00753012|591867560|FG001|Overall Study|Lost to Follow-up|0|||
163863708|NCT00753012|591867559|FG000|Overall Study|Confounded endpoint data|1|||
163863709|NCT00753012|591867560|FG001|Overall Study|Confounded endpoint data|0|||
163863710|NCT01930045|591867561|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163863711|NCT01930045|591867562|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163863712|NCT01930045|591867563|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163863713|NCT01930045|591867564|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163863714|NCT01930045|591867565|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
163863715|NCT01930045|591867566|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
163863716|NCT01930045|591867561|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
163863717|NCT01930045|591867562|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
163863718|NCT01930045|591867563|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
163863719|NCT01930045|591867564|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
163863720|NCT01930045|591867565|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
163863721|NCT01930045|591867566|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
163863722|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
163863723|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
163863724|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
163863725|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
163863726|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
163863727|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
163863728|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
163863729|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
163863730|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
163863731|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
163863732|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
163863733|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
163863734|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
163863735|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
163863736|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
163863737|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
163863738|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
163863739|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
163863740|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
163863741|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
163863742|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
163863743|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
163863744|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
163863745|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
163863746|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
163863747|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
163863748|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
163863749|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
163863750|NCT00241644|591867567|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
163863751|NCT00241644|591867568|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
163863752|NCT00241644|591867569|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
163863753|NCT00241644|591867570|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
163863754|NCT00241644|591867567|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
164135324|NCT00851318|592859129|FG000|Overall Study|Lack of Efficacy|8|||
164310062|NCT00771953|593509568|FG001|Overall Study|Adverse Event|3|||
163968221|NCT00041080|592255787|FG000|Overall Study|Did not start therapy|1|||
163968222|NCT00041080|592255788|FG001|Overall Study|Did not start therapy|1|||
163968223|NCT00041080|592255787|FG000|Overall Study|Ineligible|1|||
163968224|NCT00041080|592255788|FG001|Overall Study|Ineligible|0|||
163968225|NCT02428855|592255789|FG000|Overall Study|Withdrawal by Subject|2|||
163968226|NCT00210184|592255790|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
163968227|NCT03198520|592255791|FG000|Overall Study|Physician Decision|2|||
163968228|NCT03198520|592255791|FG000|Overall Study|Protocol Violation|2|||
163968229|NCT03198520|592255791|FG000|Overall Study|Withdrawal by Subject|1|||
163968230|NCT03198520|592255791|FG000|Overall Study|Study Ended|1|||
163968231|NCT00823823|592255792|FG000|Overall Study|Lost to Follow-up|3|||
163968232|NCT00823823|592255793|FG001|Overall Study|Lost to Follow-up|1|||
163968233|NCT00823823|592255792|FG000|Overall Study|Protocol Violation|5|||
163968234|NCT00823823|592255793|FG001|Overall Study|Protocol Violation|5|||
163968235|NCT01338415|592255794|FG000|Core + Extension|Adverse Event|8|||
163968236|NCT01338415|592255795|FG001|Core + Extension|Adverse Event|6|||
163968237|NCT01338415|592255796|FG002|Core + Extension|Adverse Event|0|||
163968238|NCT01338415|592255794|FG000|Core + Extension|Withdrawal by Subject|1|||
163968239|NCT01338415|592255795|FG001|Core + Extension|Withdrawal by Subject|1|||
163968240|NCT01338415|592255796|FG002|Core + Extension|Withdrawal by Subject|0|||
163968241|NCT01338415|592255794|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
163968242|NCT01338415|592255795|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
163968243|NCT01338415|592255796|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
163968244|NCT01338415|592255794|FG000|Core + Extension|Other (administrative reason)|1|||
163968245|NCT01338415|592255795|FG001|Core + Extension|Other (administrative reason)|0|||
163968246|NCT01338415|592255796|FG002|Core + Extension|Other (administrative reason)|0|||
163968247|NCT01338415|592255794|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
163968248|NCT01338415|592255795|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
163968249|NCT01338415|592255796|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
163968250|NCT01338415|592255794|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
163968251|NCT01338415|592255795|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
163968252|NCT01338415|592255796|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
163968253|NCT01338415|592255794|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
163968254|NCT01338415|592255795|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
163968255|NCT01338415|592255796|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
163968256|NCT01338415|592255794|FG000|Exceptional Use Treatment Period|Death|0|||
163968257|NCT01338415|592255795|FG001|Exceptional Use Treatment Period|Death|0|||
163968258|NCT01338415|592255796|FG002|Exceptional Use Treatment Period|Death|1|||
163968259|NCT01118325|592255797|FG000|Overall Study|Adverse Event|1|||
163968260|NCT01118325|592255798|FG001|Overall Study|Adverse Event|0|||
163968261|NCT01118325|592255799|FG002|Overall Study|Adverse Event|1|||
163968262|NCT00536809|592255800|FG000|Phase II|Adverse Event|1|||
163968263|NCT00536809|592255800|FG000|Phase II|Referred for surgical resection|1|||
163968264|NCT03334409|592255801|FG000|Overall Study|Did not meet inclusion criteria|1|||
163968265|NCT03334409|592255802|FG001|Overall Study|Did not meet inclusion criteria|0|||
163968266|NCT00233363|592255810|FG000|Overall Study|Adverse Event|1|||
163968267|NCT00233363|592255811|FG001|Overall Study|Adverse Event|2|||
163968268|NCT00233363|592255810|FG000|Overall Study|Lack of Efficacy|0|||
163968269|NCT00233363|592255811|FG001|Overall Study|Lack of Efficacy|2|||
163968270|NCT00233363|592255810|FG000|Overall Study|Withdrawal by Subject|1|||
163968271|NCT00233363|592255811|FG001|Overall Study|Withdrawal by Subject|1|||
163968272|NCT00233363|592255810|FG000|Overall Study|Aggravation of complication|1|||
163968273|NCT00233363|592255811|FG001|Overall Study|Aggravation of complication|0|||
163968274|NCT01526551|592255814|FG000|Overall Study|Lack of returned parental consent form|424|||
163968275|NCT00874770|592255815|FG000|Overall Study|Lack of Efficacy|2|||
163968276|NCT00874770|592255816|FG001|Overall Study|Lack of Efficacy|0|||
163968277|NCT00874770|592255817|FG002|Overall Study|Lack of Efficacy|0|||
163968278|NCT00874770|592255818|FG003|Overall Study|Lack of Efficacy|2|||
163968279|NCT00874770|592255815|FG000|Overall Study|Adverse Event|1|||
163968280|NCT00874770|592255816|FG001|Overall Study|Adverse Event|1|||
163968281|NCT00874770|592255817|FG002|Overall Study|Adverse Event|4|||
163968282|NCT00874770|592255818|FG003|Overall Study|Adverse Event|2|||
163968283|NCT00874770|592255815|FG000|Overall Study|Lost to Follow-up|1|||
163968284|NCT00874770|592255816|FG001|Overall Study|Lost to Follow-up|0|||
163968285|NCT00874770|592255817|FG002|Overall Study|Lost to Follow-up|0|||
163968286|NCT00874770|592255818|FG003|Overall Study|Lost to Follow-up|1|||
163968287|NCT00874770|592255815|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
163968288|NCT00874770|592255816|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
163968289|NCT00874770|592255817|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
163968290|NCT00874770|592255818|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
163968291|NCT00718549|592255819|FG000|Induction Phase|Disease Progression|1|||
163968292|NCT00718549|592255820|FG001|Induction Phase|Disease Progression|0|||
163968293|NCT00718549|592255821|FG002|Induction Phase|Disease Progression|0|||
163968294|NCT00718549|592255819|FG000|Induction Phase|Eligibility Criteria Violation|2|||
164201100|NCT00720499|593108474|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
164201101|NCT00720499|593108475|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
164201102|NCT00720499|593108474|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
164201103|NCT00720499|593108475|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
164201104|NCT00720499|593108474|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
164201105|NCT00720499|593108475|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
164201106|NCT01100502|593108476|FG000|Overall Study|Withdrawal by Subject|18|||
164201107|NCT01100502|593108477|FG001|Overall Study|Withdrawal by Subject|25|||
164201108|NCT01100502|593108476|FG000|Overall Study|Lost to Follow-up|13|||
164201109|NCT01100502|593108477|FG001|Overall Study|Lost to Follow-up|28|||
164201110|NCT01100502|593108476|FG000|Overall Study|Site request to end participation in study|0|||
164201111|NCT01100502|593108477|FG001|Overall Study|Site request to end participation in study|1|||
164201112|NCT01100502|593108476|FG000|Overall Study|Death|45|||
164201113|NCT01100502|593108477|FG001|Overall Study|Death|40|||
164201114|NCT00721799|593108485|FG000|Overall Study|Withdrawal by Subject|7|||
164201115|NCT00721799|593108485|FG000|Overall Study|withdraw by subject after scan 1|1|||
164201116|NCT01441973|593108487|FG000|Overall Study|Disease progression|8|||
164201117|NCT01441973|593108488|FG001|Overall Study|Disease progression|6|||
164201118|NCT01441973|593108487|FG000|Overall Study|Adverse event unrelated to study drug|3|||
164201119|NCT01441973|593108488|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164201120|NCT01441973|593108487|FG000|Overall Study|Participant request to discontinue|1|||
164201121|NCT01441973|593108488|FG001|Overall Study|Participant request to discontinue|1|||
164201122|NCT01441973|593108487|FG000|Overall Study|Poor compliance/noncompliance|0|||
164201123|NCT01441973|593108488|FG001|Overall Study|Poor compliance/noncompliance|1|||
164201124|NCT01441973|593108487|FG000|Overall Study|Administrative reason by sponsor|3|||
164201125|NCT01441973|593108488|FG001|Overall Study|Administrative reason by sponsor|5|||
164201126|NCT01441973|593108487|FG000|Overall Study|Participant withdrew consent|0|||
164201127|NCT01441973|593108488|FG001|Overall Study|Participant withdrew consent|1|||
163863755|NCT00241644|591867568|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
163863756|NCT00241644|591867569|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
163863757|NCT00241644|591867570|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
163863758|NCT00241644|591867567|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
163863759|NCT00241644|591867568|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
163863760|NCT00241644|591867569|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
163863761|NCT00241644|591867570|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
163863762|NCT00241644|591867567|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
163863763|NCT00241644|591867568|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
163863764|NCT00241644|591867569|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
163863765|NCT00241644|591867570|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
163863766|NCT00241644|591867567|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
163863767|NCT00241644|591867568|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
163863768|NCT00241644|591867569|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
163863769|NCT00241644|591867570|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
163863770|NCT00241644|591867567|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
163863771|NCT00241644|591867568|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
163863772|NCT00241644|591867569|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
163863773|NCT00241644|591867570|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
163863774|NCT00864682|591867572|FG000|Overall Study|Protocol Violation|2|||
163863775|NCT00864682|591867573|FG001|Overall Study|Protocol Violation|1|||
163863776|NCT00864682|591867574|FG002|Overall Study|Protocol Violation|2|||
163863777|NCT02506257|591867580|FG000|Overall Study|Adverse Event|0|||
163863778|NCT02506257|591867581|FG001|Overall Study|Adverse Event|2|||
163863779|NCT02506257|591867582|FG002|Overall Study|Adverse Event|3|||
163863780|NCT02506257|591867583|FG003|Overall Study|Adverse Event|0|||
163863781|NCT02506257|591867580|FG000|Overall Study|Protocol Violation|0|||
163863782|NCT02506257|591867581|FG001|Overall Study|Protocol Violation|0|||
163863783|NCT02506257|591867582|FG002|Overall Study|Protocol Violation|1|||
163863784|NCT02506257|591867583|FG003|Overall Study|Protocol Violation|0|||
163863785|NCT04842604|591867587|FG000|Overall Study|Death|1|||
163863786|NCT04842604|591867588|FG001|Overall Study|Death|0|||
163863787|NCT04842604|591867587|FG000|Overall Study|Other|4|||
163863788|NCT04842604|591867588|FG001|Overall Study|Other|4|||
163863789|NCT04842604|591867587|FG000|Overall Study|Randomized but not treated|1|||
163863790|NCT04842604|591867588|FG001|Overall Study|Randomized but not treated|0|||
163863791|NCT00344019|591867590|FG000|Overall Study|did not meet final inclusion criteria|0|||
163863792|NCT00344019|591867591|FG001|Overall Study|did not meet final inclusion criteria|0|||
163863793|NCT00344019|591867592|FG002|Overall Study|did not meet final inclusion criteria|74|||
163863794|NCT01193153|591867593|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
164201128|NCT04356937|593108489|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
164201129|NCT04356937|593108490|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
164201130|NCT00807365|593108491|FG000|Overall Study|Study Terminated|5|||
164201131|NCT04821830|593108492|FG000|Overall Study|Withdrawal by Subject|1|||
163863795|NCT01193153|591867594|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
163863796|NCT01193153|591867593|FG000|Open-label Lead in Period|Pregnancy|1|||
163863797|NCT01193153|591867594|FG001|Open-label Lead in Period|Pregnancy|0|||
163863798|NCT01193153|591867593|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
163863799|NCT01193153|591867594|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
163863800|NCT01193153|591867593|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
163863801|NCT01193153|591867594|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
163863802|NCT01193153|591867593|FG000|Open-label Lead in Period|Other|14|||
163863803|NCT01193153|591867594|FG001|Open-label Lead in Period|Other|0|||
164201132|NCT04821830|593108493|FG001|Overall Study|Withdrawal by Subject|0|||
164201133|NCT02934178|593110639|FG000|Received Vaccination 2|Death|0|||
164201134|NCT02934178|593110640|FG001|Received Vaccination 2|Death|1|||
164201135|NCT02934178|593110639|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
164201136|NCT02934178|593110640|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
164201137|NCT03944616|593110645|FG000|Overall Study|Lost to Follow-up|0|||
164201138|NCT03944616|593110646|FG001|Overall Study|Lost to Follow-up|2|||
164201139|NCT01926028|593110647|FG000|Overall Study|Lost to Follow-up|7|||
164201140|NCT01926028|593110648|FG001|Overall Study|Lost to Follow-up|6|||
164201141|NCT01926028|593110649|FG002|Overall Study|Lost to Follow-up|0|||
164201142|NCT01926028|593110647|FG000|Overall Study|Physician Decision|1|||
164201143|NCT01926028|593110648|FG001|Overall Study|Physician Decision|5|||
164201144|NCT01926028|593110649|FG002|Overall Study|Physician Decision|0|||
164201145|NCT01926028|593110647|FG000|Overall Study|Withdrawal by Subject|9|||
164201146|NCT01926028|593110648|FG001|Overall Study|Withdrawal by Subject|9|||
164201147|NCT01926028|593110649|FG002|Overall Study|Withdrawal by Subject|2|||
164201148|NCT01926028|593110647|FG000|Overall Study|Non compliance or other reasons|4|||
164201149|NCT01926028|593110648|FG001|Overall Study|Non compliance or other reasons|2|||
164201150|NCT01926028|593110649|FG002|Overall Study|Non compliance or other reasons|0|||
164201151|NCT04539275|593110650|FG000|Overall Study|Death|2|||
164201152|NCT04539275|593110651|FG001|Overall Study|Death|4|||
164201153|NCT04539275|593110650|FG000|Overall Study|Lost to Follow-up|1|||
164201154|NCT04539275|593110651|FG001|Overall Study|Lost to Follow-up|1|||
164201155|NCT04539275|593110650|FG000|Overall Study|Withdrawal by Subject|3|||
164201156|NCT04539275|593110651|FG001|Overall Study|Withdrawal by Subject|0|||
164201157|NCT01799941|593110652|FG000|Overall Study|Adverse Event|34|||
164201158|NCT01799941|593110652|FG000|Overall Study|Withdrawal by Subject|21|||
164201159|NCT01799941|593110652|FG000|Overall Study|Death|2|||
164201160|NCT01799941|593110652|FG000|Overall Study|Investigator Decision|4|||
164201161|NCT01799941|593110652|FG000|Overall Study|Lack of Efficacy|3|||
164201162|NCT01799941|593110652|FG000|Overall Study|Lost to Follow-up|17|||
164201163|NCT01799941|593110652|FG000|Overall Study|Other|15|||
164201164|NCT00547339|593110653|FG000|Overall Study|Physician Decision|0|||
164201165|NCT00547339|593110654|FG001|Overall Study|Physician Decision|0|||
164201166|NCT00547339|593110655|FG002|Overall Study|Physician Decision|1|||
164201167|NCT00547339|593110656|FG003|Overall Study|Physician Decision|0|||
164201168|NCT03587636|593110657|FG000|Overall Study|Lost to Follow-up|2|||
164201169|NCT03587636|593110658|FG001|Overall Study|Lost to Follow-up|5|||
164201170|NCT01079780|593110661|FG000|Overall Study|Disease progression|43|||
164201171|NCT01079780|593110662|FG001|Overall Study|Disease progression|7|||
164201172|NCT01079780|593110663|FG002|Overall Study|Disease progression|31|||
164201173|NCT01079780|593110661|FG000|Overall Study|Adverse Event|13|||
164201174|NCT01079780|593110662|FG001|Overall Study|Adverse Event|5|||
164201175|NCT01079780|593110663|FG002|Overall Study|Adverse Event|7|||
164201176|NCT01079780|593110661|FG000|Overall Study|Death|2|||
164201177|NCT01079780|593110662|FG001|Overall Study|Death|0|||
164201178|NCT01079780|593110663|FG002|Overall Study|Death|2|||
164201179|NCT01079780|593110661|FG000|Overall Study|Withdrawal by Subject|6|||
164201180|NCT01079780|593110662|FG001|Overall Study|Withdrawal by Subject|4|||
164201181|NCT01079780|593110663|FG002|Overall Study|Withdrawal by Subject|4|||
164201182|NCT01079780|593110661|FG000|Overall Study|Alternative therapy|2|||
164201183|NCT01079780|593110662|FG001|Overall Study|Alternative therapy|0|||
164201184|NCT01079780|593110663|FG002|Overall Study|Alternative therapy|2|||
164201185|NCT01079780|593110661|FG000|Overall Study|Physician Decision|1|||
164201186|NCT01079780|593110662|FG001|Overall Study|Physician Decision|0|||
164201187|NCT01079780|593110663|FG002|Overall Study|Physician Decision|1|||
164201188|NCT01079780|593110661|FG000|Overall Study|Error made in lesion measurement|1|||
164201189|NCT01079780|593110662|FG001|Overall Study|Error made in lesion measurement|0|||
164201190|NCT01079780|593110663|FG002|Overall Study|Error made in lesion measurement|0|||
164201191|NCT01079780|593110661|FG000|Overall Study|Patient had surgery|1|||
164201192|NCT01079780|593110662|FG001|Overall Study|Patient had surgery|0|||
164201193|NCT01079780|593110663|FG002|Overall Study|Patient had surgery|0|||
164201194|NCT01079780|593110661|FG000|Overall Study|Treatment cycle delay|0|||
163863804|NCT01193153|591867593|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
163863805|NCT01193153|591867594|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
164201195|NCT01079780|593110662|FG001|Overall Study|Treatment cycle delay|0|||
164201196|NCT01079780|593110663|FG002|Overall Study|Treatment cycle delay|1|||
164201197|NCT01079780|593110661|FG000|Overall Study|Never started treatment|1|||
164302360|NCT03755934|593482602|FG000|Overall Study|Adverse Event|4|||
163968295|NCT00718549|592255820|FG001|Induction Phase|Eligibility Criteria Violation|0|||
163968296|NCT00718549|592255821|FG002|Induction Phase|Eligibility Criteria Violation|0|||
163968297|NCT00718549|592255819|FG000|Induction Phase|Early Termination - No Additional Info|59|||
163968298|NCT00718549|592255820|FG001|Induction Phase|Early Termination - No Additional Info|0|||
163968299|NCT00718549|592255821|FG002|Induction Phase|Early Termination - No Additional Info|0|||
163968300|NCT00718549|592255819|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
163968301|NCT00718549|592255820|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
163968302|NCT00718549|592255821|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
163968303|NCT00718549|592255819|FG000|Maintenance/ Observation Phase|Death|0|||
163968304|NCT00718549|592255820|FG001|Maintenance/ Observation Phase|Death|1|||
163968305|NCT00718549|592255821|FG002|Maintenance/ Observation Phase|Death|2|||
163968306|NCT00718549|592255819|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
163968307|NCT00718549|592255820|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
163968308|NCT00718549|592255821|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
163968309|NCT00718549|592255819|FG000|Maintenance/ Observation Phase|Progression|0|||
163968310|NCT00718549|592255820|FG001|Maintenance/ Observation Phase|Progression|5|||
163968311|NCT00718549|592255821|FG002|Maintenance/ Observation Phase|Progression|14|||
163968312|NCT00718549|592255819|FG000|Maintenance/ Observation Phase|Relapse|0|||
163968313|NCT00718549|592255820|FG001|Maintenance/ Observation Phase|Relapse|3|||
163968314|NCT00718549|592255821|FG002|Maintenance/ Observation Phase|Relapse|2|||
163968315|NCT01303965|592255822|FG000|Overall Study|Adverse Event|1|||
163968316|NCT01303965|592255823|FG001|Overall Study|Adverse Event|1|||
163968317|NCT01303965|592255822|FG000|Overall Study|Death|0|||
163968318|NCT01303965|592255823|FG001|Overall Study|Death|3|||
163968319|NCT01303965|592255822|FG000|Overall Study|Withdrawal by Subject|1|||
163968320|NCT01303965|592255823|FG001|Overall Study|Withdrawal by Subject|0|||
163968321|NCT01303965|592255822|FG000|Overall Study|Disease Progression|1|||
163968322|NCT01303965|592255823|FG001|Overall Study|Disease Progression|6|||
163968323|NCT04534491|592255825|FG000|Overall Study|Not completed end-of-study interview|24|||
163968324|NCT04534491|592255825|FG000|Overall Study|Non-users|70|||
163968325|NCT04534491|592255825|FG000|Overall Study|Non-verifiable users|58|||
163968326|NCT02871778|592255828|FG000|Part A: Treatment Period 1|Adverse Event|1|||
163968327|NCT02871778|592255829|FG001|Part A: Treatment Period 1|Adverse Event|1|||
163968328|NCT02871778|592255830|FG002|Part A: Treatment Period 1|Adverse Event|1|||
164201198|NCT01079780|593110662|FG001|Overall Study|Never started treatment|0|||
164201199|NCT01079780|593110663|FG002|Overall Study|Never started treatment|2|||
164201200|NCT01178294|593110664|FG000|Overall Study|Adverse Event|4|||
164201201|NCT01178294|593110664|FG000|Overall Study|Lost to Follow-up|2|||
164201202|NCT01178294|593110664|FG000|Overall Study|Lack of Efficacy|1|||
164201203|NCT01178294|593110664|FG000|Overall Study|Death|1|||
164201204|NCT01178294|593110664|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
164201205|NCT01178294|593110664|FG000|Overall Study|Subject status is terminal|1|||
164201206|NCT01178294|593110664|FG000|Overall Study|Completion status could not be verified|1|||
164201207|NCT00551369|593110665|FG000|Overall Study|Protocol Violation|5|||
164201208|NCT00551369|593110665|FG000|Overall Study|Withdrawal by Subject|1|||
164201209|NCT00551369|593110665|FG000|Overall Study|Not treated per protocol and re|1|||
164201210|NCT02051296|593110670|FG000|Overall Study|Lost to Follow-up|1|||
164201211|NCT02051296|593110671|FG001|Overall Study|Lost to Follow-up|2|||
164201212|NCT02051296|593110670|FG000|Overall Study|withdraw prior to treatment|7|||
164201213|NCT02051296|593110671|FG001|Overall Study|withdraw prior to treatment|7|||
164201214|NCT01663623|593110672|FG000|Overall Study|Adverse Event|3|||
164201215|NCT01663623|593110673|FG001|Overall Study|Adverse Event|7|||
164201216|NCT01663623|593110672|FG000|Overall Study|Lack of Efficacy|5|||
164201217|NCT01663623|593110673|FG001|Overall Study|Lack of Efficacy|6|||
164201218|NCT01663623|593110672|FG000|Overall Study|Protocol Violation|0|||
164201219|NCT01663623|593110673|FG001|Overall Study|Protocol Violation|1|||
164201220|NCT01663623|593110672|FG000|Overall Study|Other-Study closed/terminated|1|||
164201221|NCT01663623|593110673|FG001|Overall Study|Other-Study closed/terminated|1|||
164201222|NCT01663623|593110672|FG000|Overall Study|Physician Decision|1|||
163968329|NCT02871778|592255831|FG003|Part A: Treatment Period 1|Adverse Event|0|||
163968330|NCT02871778|592255832|FG004|Part A: Treatment Period 1|Adverse Event|0|||
163968331|NCT02871778|592255833|FG005|Part A: Treatment Period 1|Adverse Event|0|||
163968332|NCT02871778|592255834|FG006|Part A: Treatment Period 1|Adverse Event|0|||
163968333|NCT02871778|592255835|FG007|Part A: Treatment Period 1|Adverse Event|0|||
163968334|NCT02871778|592255828|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
163968335|NCT02871778|592255829|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
164201223|NCT01663623|593110673|FG001|Overall Study|Physician Decision|4|||
164201224|NCT01663623|593110672|FG000|Overall Study|Withdrawal by Subject|2|||
164201225|NCT01663623|593110673|FG001|Overall Study|Withdrawal by Subject|1|||
164201226|NCT02251275|593110674|FG000|Overall Study|Adverse Event|23|||
164201227|NCT02251275|593110675|FG001|Overall Study|Adverse Event|60|||
164201228|NCT02251275|593110676|FG002|Overall Study|Adverse Event|28|||
164201229|NCT02251275|593110677|FG003|Overall Study|Adverse Event|0|||
164201230|NCT02251275|593110678|FG004|Overall Study|Adverse Event|0|||
163863806|NCT01193153|591867593|FG000|Open-label Lead in Period|Adverse Event|41|||
163863807|NCT01193153|591867594|FG001|Open-label Lead in Period|Adverse Event|0|||
163863808|NCT01193153|591867593|FG000|Open-label Lead in Period|Death|1|||
163863809|NCT01193153|591867594|FG001|Open-label Lead in Period|Death|0|||
163863810|NCT01193153|591867593|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
163863811|NCT01193153|591867594|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
163863812|NCT01193153|591867593|FG000|Open-label Stabilization Period|Adverse Event|9|||
163863813|NCT01193153|591867594|FG001|Open-label Stabilization Period|Adverse Event|0|||
163863814|NCT01193153|591867593|FG000|Open-label Stabilization Period|Death|2|||
163863815|NCT01193153|591867594|FG001|Open-label Stabilization Period|Death|0|||
163863816|NCT01193153|591867593|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
163863817|NCT01193153|591867594|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
163863818|NCT01193153|591867593|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
163863819|NCT01193153|591867594|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
163863820|NCT01193153|591867593|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
163863821|NCT01193153|591867594|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
163863822|NCT01193153|591867593|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
163863823|NCT01193153|591867594|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
163863824|NCT01193153|591867593|FG000|Open-label Stabilization Period|Other|8|||
163863825|NCT01193153|591867594|FG001|Open-label Stabilization Period|Other|0|||
163863826|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Other|2|||
163863827|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Other|3|||
163863828|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
163863829|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
163863830|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Death|2|||
163863831|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Death|0|||
163863832|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
163863833|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
163863834|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
163863835|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
163863836|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
163863837|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
163863838|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
163863839|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
163863840|NCT01193153|591867593|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
163863841|NCT01193153|591867594|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
163863842|NCT02503202|591867595|FG000|Base Study: Up to Month 6|Death|1|||
163863843|NCT02503202|591867596|FG001|Base Study: Up to Month 6|Death|1|||
163863844|NCT02503202|591867597|FG002|Base Study: Up to Month 6|Death|0|||
163863845|NCT02503202|591867598|FG003|Base Study: Up to Month 6|Death|0|||
163863846|NCT02503202|591867599|FG004|Base Study: Up to Month 6|Death|0|||
163863847|NCT02503202|591867595|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
163863848|NCT02503202|591867596|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
163863849|NCT02503202|591867597|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
163863850|NCT02503202|591867598|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
163863851|NCT02503202|591867599|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
163863852|NCT02503202|591867595|FG000|Base Study: Up to Month 6|Physician Decision|0|||
163863853|NCT02503202|591867596|FG001|Base Study: Up to Month 6|Physician Decision|0|||
163863854|NCT02503202|591867597|FG002|Base Study: Up to Month 6|Physician Decision|0|||
163863855|NCT02503202|591867598|FG003|Base Study: Up to Month 6|Physician Decision|0|||
163863856|NCT02503202|591867599|FG004|Base Study: Up to Month 6|Physician Decision|1|||
163863857|NCT02503202|591867595|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
163863858|NCT02503202|591867596|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
163863859|NCT02503202|591867597|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
163863860|NCT02503202|591867598|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
163863861|NCT02503202|591867599|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
163863862|NCT02503202|591867595|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
163863863|NCT02503202|591867596|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
163863864|NCT02503202|591867597|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
163863865|NCT02503202|591867598|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
163863866|NCT02503202|591867599|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
163863867|NCT02503202|591867595|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
163863868|NCT02503202|591867596|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
163863869|NCT02503202|591867597|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
163863870|NCT02503202|591867598|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
163863871|NCT02503202|591867599|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
163863872|NCT02503202|591867595|FG000|Extension: Month 6 to 24|Death|1|||
163863873|NCT02503202|591867596|FG001|Extension: Month 6 to 24|Death|0|||
163863874|NCT02503202|591867597|FG002|Extension: Month 6 to 24|Death|0|||
163863875|NCT02503202|591867598|FG003|Extension: Month 6 to 24|Death|0|||
163863876|NCT02503202|591867599|FG004|Extension: Month 6 to 24|Death|0|||
163863877|NCT02503202|591867595|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
163863878|NCT02503202|591867596|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
163863879|NCT02503202|591867597|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
163863880|NCT02503202|591867598|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
163863881|NCT02503202|591867599|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
163863882|NCT02503202|591867595|FG000|Extension: Month 6 to 24|Physician Decision|1|||
163863883|NCT02503202|591867596|FG001|Extension: Month 6 to 24|Physician Decision|0|||
163863884|NCT02503202|591867597|FG002|Extension: Month 6 to 24|Physician Decision|1|||
163863885|NCT02503202|591867598|FG003|Extension: Month 6 to 24|Physician Decision|3|||
163863886|NCT02503202|591867599|FG004|Extension: Month 6 to 24|Physician Decision|0|||
163863887|NCT02503202|591867595|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
163863888|NCT02503202|591867596|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
163863889|NCT02503202|591867597|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
163863890|NCT02503202|591867598|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
163863891|NCT02503202|591867599|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
163863892|NCT01119950|591867600|FG000|Overall Study|Adverse Event|25|||
163863893|NCT01119950|591867600|FG000|Overall Study|Withdrawal by Subject|9|||
163863894|NCT01119950|591867600|FG000|Overall Study|Protocol Violation|5|||
163863895|NCT01119950|591867600|FG000|Overall Study|Lost to Follow-up|4|||
163863896|NCT01119950|591867600|FG000|Overall Study|Administrative|2|||
163863897|NCT01119950|591867600|FG000|Overall Study|Abnormal lab value|1|||
163863898|NCT01119950|591867600|FG000|Overall Study|Death|1|||
163863899|NCT03058991|591867606|FG000|Overall Study|Lost to Follow-up|17|||
163863900|NCT03058991|591867607|FG001|Overall Study|Lost to Follow-up|12|||
163863901|NCT03058991|591867608|FG002|Overall Study|Lost to Follow-up|12|||
163863902|NCT03058991|591867606|FG000|Overall Study|Withdrawal by Subject|1|||
163863903|NCT03058991|591867607|FG001|Overall Study|Withdrawal by Subject|0|||
163863904|NCT03058991|591867608|FG002|Overall Study|Withdrawal by Subject|0|||
163863905|NCT01591616|591867611|FG000|Overall Study|Withdrawal by Subject|1|||
163863906|NCT00758602|591867612|FG000|Overall Study|Adverse Event|11|||
163863907|NCT00758602|591867613|FG001|Overall Study|Adverse Event|10|||
163863908|NCT00758602|591867612|FG000|Overall Study|Lost to Follow-up|4|||
163863909|NCT00758602|591867613|FG001|Overall Study|Lost to Follow-up|3|||
163863910|NCT00758602|591867612|FG000|Overall Study|Withdrawal by Subject|1|||
163863911|NCT00758602|591867613|FG001|Overall Study|Withdrawal by Subject|3|||
163863912|NCT00758602|591867612|FG000|Overall Study|Protocol Violation|0|||
163863913|NCT00758602|591867613|FG001|Overall Study|Protocol Violation|2|||
163863914|NCT00758602|591867612|FG000|Overall Study|Death|0|||
163863915|NCT00758602|591867613|FG001|Overall Study|Death|1|||
163863916|NCT00758602|591867612|FG000|Overall Study|Reason not specified|3|||
163863917|NCT00758602|591867613|FG001|Overall Study|Reason not specified|3|||
163863918|NCT00770965|591867618|FG000|Safety Set|Withdrawal by Subject|0|||
163863919|NCT00770965|591867619|FG001|Safety Set|Withdrawal by Subject|0|||
163863920|NCT00770965|591867620|FG002|Safety Set|Withdrawal by Subject|0|||
163863921|NCT00770965|591867621|FG003|Safety Set|Withdrawal by Subject|1|||
163863922|NCT00770965|591867618|FG000|Safety Set|Protocol deviation|0|||
163863923|NCT00770965|591867619|FG001|Safety Set|Protocol deviation|0|||
163863924|NCT00770965|591867620|FG002|Safety Set|Protocol deviation|1|||
163863925|NCT00770965|591867621|FG003|Safety Set|Protocol deviation|0|||
163863926|NCT00770965|591867618|FG000|Excluded Set|Administrative problems|14|||
163863927|NCT00770965|591867619|FG001|Excluded Set|Administrative problems|12|||
163863928|NCT00770965|591867620|FG002|Excluded Set|Administrative problems|12|||
163863929|NCT00770965|591867621|FG003|Excluded Set|Administrative problems|10|||
164201231|NCT02251275|593110674|FG000|Overall Study|Lost to Follow-up|5|||
164201232|NCT02251275|593110675|FG001|Overall Study|Lost to Follow-up|6|||
164201233|NCT02251275|593110676|FG002|Overall Study|Lost to Follow-up|4|||
164201234|NCT02251275|593110677|FG003|Overall Study|Lost to Follow-up|0|||
164201235|NCT02251275|593110678|FG004|Overall Study|Lost to Follow-up|0|||
164201236|NCT02251275|593110674|FG000|Overall Study|Physician Decision|19|||
163863930|NCT00770965|591867618|FG000|Excluded Set|Withdrawal by Subject|1|||
163863931|NCT00770965|591867619|FG001|Excluded Set|Withdrawal by Subject|1|||
163863932|NCT00770965|591867620|FG002|Excluded Set|Withdrawal by Subject|2|||
163863933|NCT00770965|591867621|FG003|Excluded Set|Withdrawal by Subject|3|||
163863934|NCT00509769|591867622|FG000|Overall Study|Progressive disease|77|||
163863935|NCT00509769|591867622|FG000|Overall Study|Adverse Event|4|||
163863936|NCT00509769|591867622|FG000|Overall Study|Patient's decision|1|||
163863937|NCT00509769|591867622|FG000|Overall Study|Physician Decision|8|||
163863938|NCT00509769|591867622|FG000|Overall Study|Use of prohibited therapies during study|1|||
163863939|NCT02371746|591867623|FG000|Overall Study|Consent withdrawn|0|||
163863940|NCT02371746|591867624|FG001|Overall Study|Consent withdrawn|0|||
163863941|NCT02371746|591867625|FG002|Overall Study|Consent withdrawn|0|||
163863942|NCT02371746|591867626|FG003|Overall Study|Consent withdrawn|0|||
164201237|NCT02251275|593110675|FG001|Overall Study|Physician Decision|30|||
163863943|NCT02371746|591867627|FG004|Overall Study|Consent withdrawn|0|||
163863944|NCT02371746|591867628|FG005|Overall Study|Consent withdrawn|0|||
163863945|NCT02371746|591867629|FG006|Overall Study|Consent withdrawn|1|||
163968336|NCT02871778|592255830|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163968337|NCT02871778|592255831|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
163968338|NCT02871778|592255832|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163968339|NCT02871778|592255833|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163968340|NCT02871778|592255834|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163968341|NCT02871778|592255835|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
163968342|NCT02871778|592255828|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968343|NCT02871778|592255829|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968344|NCT02871778|592255830|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
163968345|NCT02871778|592255831|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968346|NCT02871778|592255832|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968347|NCT02871778|592255833|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968348|NCT02871778|592255834|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968349|NCT02871778|592255835|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
163968350|NCT02871778|592255828|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163968351|NCT02871778|592255829|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163968352|NCT02871778|592255830|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
164310063|NCT00771953|593509567|FG000|Overall Study|Death|2|||
164310064|NCT00771953|593509568|FG001|Overall Study|Death|2|||
164310065|NCT00771953|593509567|FG000|Overall Study|Progression before active Tx|1|||
164310066|NCT00771953|593509568|FG001|Overall Study|Progression before active Tx|2|||
164310067|NCT00771953|593509567|FG000|Overall Study|Sponsor decision|1|||
164310068|NCT00771953|593509568|FG001|Overall Study|Sponsor decision|0|||
164310069|NCT00771953|593509567|FG000|Overall Study|Other complicating disease|1|||
164310070|NCT00771953|593509568|FG001|Overall Study|Other complicating disease|0|||
164310071|NCT00771953|593509567|FG000|Overall Study|Withdrawal by Subject|0|||
164310072|NCT00771953|593509568|FG001|Overall Study|Withdrawal by Subject|3|||
164310073|NCT00947193|593509571|FG000|Overall Study|Lost to Follow-up|1|||
164310074|NCT00947193|593509572|FG001|Overall Study|Lost to Follow-up|0|||
164310075|NCT00947193|593509571|FG000|Overall Study|Withdrawal by Subject|1|||
164310076|NCT00947193|593509572|FG001|Overall Study|Withdrawal by Subject|0|||
164310077|NCT00947193|593509571|FG000|Overall Study|Factor VIII >1%|1|||
164310078|NCT00947193|593509572|FG001|Overall Study|Factor VIII >1%|0|||
164310079|NCT04364984|593509573|FG000|Overall Study|Death|2|||
164310080|NCT04364984|593509574|FG001|Overall Study|Death|2|||
164310081|NCT04364984|593509575|FG002|Overall Study|Death|0|||
164310082|NCT01349959|593509576|FG000|Overall Study|Adverse Event|7|||
164310083|NCT02675634|593509577|FG000|Test Period 1|Adverse Event|0|||
164310084|NCT02675634|593509578|FG001|Test Period 1|Adverse Event|1|||
164310085|NCT02675634|593509579|FG002|Test Period 1|Adverse Event|0|||
164310086|NCT02675634|593509580|FG003|Test Period 1|Adverse Event|1|||
163968353|NCT02871778|592255831|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163968354|NCT02871778|592255832|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163968355|NCT02871778|592255833|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
164201238|NCT02251275|593110676|FG002|Overall Study|Physician Decision|26|||
164201239|NCT02251275|593110677|FG003|Overall Study|Physician Decision|0|||
164201240|NCT02251275|593110678|FG004|Overall Study|Physician Decision|1|||
164201241|NCT02251275|593110674|FG000|Overall Study|Protocol Deviation|0|||
164201242|NCT02251275|593110675|FG001|Overall Study|Protocol Deviation|0|||
164201243|NCT02251275|593110676|FG002|Overall Study|Protocol Deviation|1|||
164201244|NCT02251275|593110677|FG003|Overall Study|Protocol Deviation|0|||
164201245|NCT02251275|593110678|FG004|Overall Study|Protocol Deviation|0|||
164201246|NCT02251275|593110674|FG000|Overall Study|Withdrawal by Subject|25|||
164201247|NCT02251275|593110675|FG001|Overall Study|Withdrawal by Subject|51|||
164201248|NCT02251275|593110676|FG002|Overall Study|Withdrawal by Subject|35|||
164201249|NCT02251275|593110677|FG003|Overall Study|Withdrawal by Subject|1|||
164201250|NCT02251275|593110678|FG004|Overall Study|Withdrawal by Subject|0|||
164201251|NCT02133508|593110680|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
164201252|NCT02133508|593110680|FG000|Overall Study|Death|12|||
164201253|NCT02133508|593110680|FG000|Overall Study|Lost to Follow-up|2|||
164201254|NCT01302899|593110685|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
164201255|NCT01302899|593110686|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
164201256|NCT01302899|593110685|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
164201257|NCT01302899|593110686|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
164201258|NCT03451071|593110687|FG000|First Vaccine|Withdrawal by Subject|1|||
164310087|NCT02675634|593509581|FG004|Test Period 1|Adverse Event|0|||
164201259|NCT03451071|593110687|FG000|Second Vaccine|Lost to Follow-up|19|||
164310088|NCT02675634|593509582|FG005|Test Period 1|Adverse Event|0|||
164310089|NCT02675634|593509577|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
164310090|NCT02675634|593509578|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
164310091|NCT02675634|593509579|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
164310092|NCT02675634|593509580|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
163863946|NCT00414648|591867630|FG000|Overall Study|Adverse Event|5|||
163863947|NCT00414648|591867631|FG001|Overall Study|Adverse Event|5|||
163863948|NCT00414648|591867630|FG000|Overall Study|Death|0|||
163863949|NCT00414648|591867631|FG001|Overall Study|Death|1|||
163863950|NCT00414648|591867630|FG000|Overall Study|Lack of Efficacy|0|||
163863951|NCT00414648|591867631|FG001|Overall Study|Lack of Efficacy|2|||
163863952|NCT00414648|591867630|FG000|Overall Study|Withdrawal by Subject|0|||
163863953|NCT00414648|591867631|FG001|Overall Study|Withdrawal by Subject|1|||
163863954|NCT00754936|591867632|FG000|Overall Study|Lost to Follow-up|3|||
163863955|NCT00754936|591867632|FG000|Overall Study|Physician Decision|1|||
163863956|NCT00754936|591867632|FG000|Overall Study|Withdrawal by Subject|2|||
163863957|NCT00754936|591867632|FG000|Overall Study|Side Effects|3|||
163863958|NCT00754936|591867632|FG000|Overall Study|Inter-current medical events|3|||
163863959|NCT00436644|591867633|FG000|Overall Study|Adverse Event|2|||
163863960|NCT00436644|591867633|FG000|Overall Study|Death|1|||
163863961|NCT00619645|591867634|FG000|Overall Study|Adverse Event|1|||
163863962|NCT04364269|591867639|FG000|Overall Study|Adverse Event|1|||
163863963|NCT04364269|591867640|FG001|Overall Study|Adverse Event|0|||
163863964|NCT04364269|591867641|FG002|Overall Study|Adverse Event|0|||
163863965|NCT04364269|591867639|FG000|Overall Study|Withdrawal by Subject|0|||
163863966|NCT04364269|591867640|FG001|Overall Study|Withdrawal by Subject|1|||
163863967|NCT04364269|591867641|FG002|Overall Study|Withdrawal by Subject|0|||
163863968|NCT04173572|591867642|FG000|Overall Study|Withdrawal by Subject|1|||
163863969|NCT04173572|591867643|FG001|Overall Study|Withdrawal by Subject|5|||
163863970|NCT04173572|591867642|FG000|Overall Study|Lost to Follow-up|3|||
163863971|NCT04173572|591867643|FG001|Overall Study|Lost to Follow-up|1|||
163863972|NCT01490580|591867644|FG000|Overall Study|Parents withdrew consent|0|||
163863973|NCT01490580|591867645|FG001|Overall Study|Parents withdrew consent|2|||
163863974|NCT02026258|591867648|FG000|Randomized|Did not start treatment|2|||
163863975|NCT02026258|591867649|FG001|Randomized|Did not start treatment|1|||
163863976|NCT02026258|591867648|FG000|Randomized|Change in treatment plan|1|||
163863977|NCT02026258|591867649|FG001|Randomized|Change in treatment plan|0|||
163863978|NCT02026258|591867648|FG000|Randomized|Presence of periodontal disease|1|||
163863979|NCT02026258|591867649|FG001|Randomized|Presence of periodontal disease|1|||
163863980|NCT02026258|591867648|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
163863981|NCT02026258|591867649|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
163863982|NCT02026258|591867648|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
163863983|NCT02026258|591867649|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
163863984|NCT03478696|591867653|FG000|Overall Study|Adverse Event|1|||
163863985|NCT03478696|591867654|FG001|Overall Study|Adverse Event|5|||
163863986|NCT03478696|591867653|FG000|Overall Study|Lost to Follow-up|1|||
163863987|NCT03478696|591867654|FG001|Overall Study|Lost to Follow-up|0|||
163863988|NCT03478696|591867653|FG000|Overall Study|Physician Decision|6|||
163863989|NCT03478696|591867654|FG001|Overall Study|Physician Decision|3|||
163863990|NCT03478696|591867653|FG000|Overall Study|Withdrawal by Subject|9|||
163863991|NCT03478696|591867654|FG001|Overall Study|Withdrawal by Subject|4|||
163863992|NCT01104415|591867658|FG000|Core Phase|Consent withdrawn by subjects|1|||
163863993|NCT01104415|591867659|FG001|Core Phase|Consent withdrawn by subjects|0|||
163863994|NCT01104415|591867658|FG000|Extension Period|Progressive disease|0|||
163863995|NCT01104415|591867659|FG001|Extension Period|Progressive disease|4|||
163863996|NCT01104415|591867658|FG000|Extension Period|Death|0|||
163863997|NCT01104415|591867659|FG001|Extension Period|Death|1|||
163863998|NCT01104415|591867658|FG000|Extension Period|Physician Decision|0|||
163863999|NCT01104415|591867659|FG001|Extension Period|Physician Decision|1|||
163864000|NCT01104415|591867658|FG000|Extension Period|Transition to Study LX1606.302|0|||
163864001|NCT01104415|591867659|FG001|Extension Period|Transition to Study LX1606.302|4|||
163864002|NCT01104415|591867658|FG000|Extension Period|Heart surgery/feeling miserable|0|||
163864003|NCT01104415|591867659|FG001|Extension Period|Heart surgery/feeling miserable|1|||
163864004|NCT04550039|591867671|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
163864005|NCT04550039|591867672|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
163864006|NCT04550039|591867671|FG000|Overall Study|patient self-withdrew from study|0|||
163864007|NCT04550039|591867672|FG001|Overall Study|patient self-withdrew from study|1|||
163864008|NCT05826431|591867673|FG000|Overall Study|Withdrawal by Subject|1|||
163968356|NCT02871778|592255834|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163864009|NCT01697319|591867676|FG000|Primary Phase|Withdrawal by Subject|1|||
163864010|NCT01697319|591867676|FG000|Extension Phase|Terminated by Sponsor|15|||
163968357|NCT02871778|592255835|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
163864011|NCT04222959|591867679|FG000|Overall Study|Lost to Follow-up|76|||
163864012|NCT04222959|591867680|FG001|Overall Study|Lost to Follow-up|28|||
163864013|NCT03254394|591867685|FG000|Overall Study|Withdrawal by Subject|0|||
163864014|NCT03254394|591867686|FG001|Overall Study|Withdrawal by Subject|2|||
163864015|NCT04248829|591867688|FG000|Overall Study|Disease progression|44|||
163864016|NCT04248829|591867689|FG001|Overall Study|Disease progression|109|||
163864017|NCT04248829|591867688|FG000|Overall Study|Adverse Event|19|||
163864018|NCT04248829|591867689|FG001|Overall Study|Adverse Event|18|||
163864019|NCT04248829|591867688|FG000|Overall Study|Withdrawal by Subject|11|||
163968358|NCT02871778|592255828|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968359|NCT02871778|592255829|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
163968360|NCT02871778|592255830|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968361|NCT02871778|592255831|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968362|NCT02871778|592255832|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968363|NCT02871778|592255833|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968364|NCT02871778|592255834|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968365|NCT02871778|592255835|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
163968366|NCT02871778|592255828|FG000|Part A: Treatment Period 2|Adverse Event|2|||
163968367|NCT02871778|592255829|FG001|Part A: Treatment Period 2|Adverse Event|2|||
163968368|NCT02871778|592255830|FG002|Part A: Treatment Period 2|Adverse Event|0|||
163968369|NCT02871778|592255831|FG003|Part A: Treatment Period 2|Adverse Event|0|||
163968370|NCT02871778|592255832|FG004|Part A: Treatment Period 2|Adverse Event|0|||
163968371|NCT02871778|592255833|FG005|Part A: Treatment Period 2|Adverse Event|0|||
163968372|NCT02871778|592255834|FG006|Part A: Treatment Period 2|Adverse Event|0|||
163968373|NCT02871778|592255835|FG007|Part A: Treatment Period 2|Adverse Event|0|||
163968374|NCT02871778|592255828|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968375|NCT02871778|592255829|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968376|NCT02871778|592255830|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968377|NCT02871778|592255831|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
163968378|NCT02871778|592255832|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968379|NCT02871778|592255833|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968380|NCT02871778|592255834|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968381|NCT02871778|592255835|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
163968382|NCT02871778|592255828|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
163968383|NCT02871778|592255829|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163968384|NCT02871778|592255830|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
163968385|NCT02871778|592255831|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163968386|NCT02871778|592255832|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163968387|NCT02871778|592255833|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163968388|NCT02871778|592255834|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163968389|NCT02871778|592255835|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
163968390|NCT02871778|592255828|FG000|Part B: Treatment Period 3|Adverse Event|0|||
163968391|NCT02871778|592255829|FG001|Part B: Treatment Period 3|Adverse Event|0|||
163968392|NCT02871778|592255830|FG002|Part B: Treatment Period 3|Adverse Event|0|||
163968393|NCT02871778|592255831|FG003|Part B: Treatment Period 3|Adverse Event|0|||
163968394|NCT02871778|592255832|FG004|Part B: Treatment Period 3|Adverse Event|1|||
163968395|NCT02871778|592255833|FG005|Part B: Treatment Period 3|Adverse Event|1|||
163968396|NCT02871778|592255834|FG006|Part B: Treatment Period 3|Adverse Event|1|||
163968397|NCT02871778|592255835|FG007|Part B: Treatment Period 3|Adverse Event|0|||
163968398|NCT02653300|592255837|FG000|Overall Study|Withdrawal by Subject|2|||
163968399|NCT00369785|592255838|FG000|Overall Study|Physician Decision|3|||
163968400|NCT00369785|592255839|FG001|Overall Study|Physician Decision|2|||
163968401|NCT00369785|592255838|FG000|Overall Study|Death|1|||
163968402|NCT00369785|592255839|FG001|Overall Study|Death|2|||
163968403|NCT00369785|592255838|FG000|Overall Study|Withdrawal by Subject|7|||
163968404|NCT00369785|592255839|FG001|Overall Study|Withdrawal by Subject|6|||
163968405|NCT00369785|592255838|FG000|Overall Study|Toxicity|6|||
163968406|NCT00369785|592255839|FG001|Overall Study|Toxicity|4|||
163968407|NCT00369785|592255838|FG000|Overall Study|Never started|0|||
163968408|NCT00369785|592255839|FG001|Overall Study|Never started|2|||
163968409|NCT00369785|592255838|FG000|Overall Study|Progression|4|||
163968410|NCT00369785|592255839|FG001|Overall Study|Progression|4|||
163968411|NCT00369785|592255838|FG000|Overall Study|Multiple reasons|6|||
163968412|NCT00369785|592255839|FG001|Overall Study|Multiple reasons|5|||
163968413|NCT00800683|592255840|FG000|Overall Study|Adverse Event|11|||
164201260|NCT03451071|593110687|FG000|Third Vaccine|Lost to Follow-up|22|||
164201261|NCT03451071|593110687|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
164201262|NCT02834975|593110688|FG000|Overall Study|Physician Decision|2|||
164201263|NCT02834975|593110688|FG000|Overall Study|Adverse Event|1|||
163968414|NCT00800683|592255841|FG001|Overall Study|Adverse Event|8|||
163968415|NCT00800683|592255840|FG000|Overall Study|Lost to Follow-up|3|||
163968416|NCT00800683|592255841|FG001|Overall Study|Lost to Follow-up|1|||
163968417|NCT00800683|592255840|FG000|Overall Study|Withdrawal by Subject|1|||
163968418|NCT00800683|592255841|FG001|Overall Study|Withdrawal by Subject|7|||
163968419|NCT00800683|592255840|FG000|Overall Study|Lack of Efficacy|1|||
163968420|NCT00800683|592255841|FG001|Overall Study|Lack of Efficacy|1|||
163968421|NCT00800683|592255840|FG000|Overall Study|Other|1|||
163968422|NCT00800683|592255841|FG001|Overall Study|Other|2|||
163968423|NCT02247960|592255842|FG000|Patient Consent and Randomization|Physician Decision|2|||
163968424|NCT02247960|592255843|FG001|Patient Consent and Randomization|Physician Decision|2|||
163968425|NCT02247960|592255842|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
163968426|NCT02247960|592255843|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
164201264|NCT02834975|593110688|FG000|Overall Study|Withdrawal by Subject|1|||
163968427|NCT02247960|592255842|FG000|Catheter Removed|Lost to Follow-up|7|||
163968428|NCT02247960|592255843|FG001|Catheter Removed|Lost to Follow-up|10|||
163968429|NCT01848353|592255844|FG000|Phase 1|Withdrawal by Subject|3|||
163968430|NCT01848353|592255845|FG001|Phase 1|Withdrawal by Subject|1|||
163968431|NCT01848353|592255846|FG002|Phase 1|Withdrawal by Subject|0|||
163968432|NCT01848353|592255847|FG003|Phase 1|Withdrawal by Subject|0|||
163968433|NCT01848353|592255844|FG000|Phase 2|Withdrawal by Subject|3|||
163968434|NCT01848353|592255845|FG001|Phase 2|Withdrawal by Subject|2|||
163968435|NCT01848353|592255846|FG002|Phase 2|Withdrawal by Subject|0|||
163968436|NCT01848353|592255847|FG003|Phase 2|Withdrawal by Subject|0|||
163968437|NCT01848353|592255844|FG000|Phase 3|Withdrawal by Subject|1|||
163968438|NCT01848353|592255845|FG001|Phase 3|Withdrawal by Subject|1|||
163968439|NCT01848353|592255846|FG002|Phase 3|Withdrawal by Subject|0|||
163968440|NCT01848353|592255847|FG003|Phase 3|Withdrawal by Subject|0|||
163968441|NCT03606980|592255852|FG000|Overall Study|Lost to Follow-up|3|||
163968442|NCT03606980|592255853|FG001|Overall Study|Lost to Follow-up|2|||
163968443|NCT03606980|592255854|FG002|Overall Study|Lost to Follow-up|3|||
163864020|NCT04248829|591867689|FG001|Overall Study|Withdrawal by Subject|2|||
163864021|NCT04248829|591867688|FG000|Overall Study|Lost to Follow-up|0|||
163864022|NCT04248829|591867689|FG001|Overall Study|Lost to Follow-up|1|||
163864023|NCT04248829|591867688|FG000|Overall Study|Death|12|||
163864024|NCT04248829|591867689|FG001|Overall Study|Death|14|||
163864025|NCT04248829|591867688|FG000|Overall Study|Physician Decision|2|||
163864026|NCT04248829|591867689|FG001|Overall Study|Physician Decision|4|||
163864027|NCT04248829|591867688|FG000|Overall Study|Any reason not specifically recorded|0|||
163864028|NCT04248829|591867689|FG001|Overall Study|Any reason not specifically recorded|2|||
163864029|NCT01867580|591867692|FG000|Overall Study|Withdrawal by Subject|2|||
163864030|NCT01867580|591867693|FG001|Overall Study|Withdrawal by Subject|3|||
163864031|NCT01867580|591867692|FG000|Overall Study|Physician Decision|17|||
163864032|NCT01867580|591867693|FG001|Overall Study|Physician Decision|12|||
163864033|NCT01867580|591867692|FG000|Overall Study|Lost to Follow-up|3|||
163864034|NCT01867580|591867693|FG001|Overall Study|Lost to Follow-up|5|||
163864035|NCT01867580|591867692|FG000|Overall Study|Sponsor terminated study|1|||
163864036|NCT01867580|591867693|FG001|Overall Study|Sponsor terminated study|0|||
163864037|NCT01867580|591867692|FG000|Overall Study|Missed follow-up assessment|2|||
163864038|NCT01867580|591867693|FG001|Overall Study|Missed follow-up assessment|1|||
163864039|NCT01867580|591867692|FG000|Overall Study|Interruption to therapy|3|||
163864040|NCT01867580|591867693|FG001|Overall Study|Interruption to therapy|0|||
163864041|NCT01867580|591867692|FG000|Overall Study|Osteomyelitis|0|||
163864042|NCT01867580|591867693|FG001|Overall Study|Osteomyelitis|1|||
163968444|NCT03606980|592255852|FG000|Overall Study|Withdrawal by Subject|1|||
163968445|NCT03606980|592255853|FG001|Overall Study|Withdrawal by Subject|0|||
163968446|NCT03606980|592255854|FG002|Overall Study|Withdrawal by Subject|4|||
164201265|NCT02834975|593110688|FG000|Overall Study|Lack of Efficacy|1|||
164201266|NCT02714153|593110694|FG000|Overall Study|Death|1|||
164201267|NCT00686972|593110695|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
164201268|NCT01901185|593110696|FG000|Overall Study|Withdrawal by Subject|2|||
164201269|NCT02065557|593110697|FG000|Induction Period|Withdrawal by Subject|2|||
164201270|NCT02065557|593110698|FG001|Induction Period|Withdrawal by Subject|1|||
164201271|NCT02065557|593110699|FG002|Induction Period|Withdrawal by Subject|0|||
164201272|NCT02065557|593110700|FG003|Induction Period|Withdrawal by Subject|0|||
164201273|NCT02065557|593110701|FG004|Induction Period|Withdrawal by Subject|0|||
164201274|NCT02065557|593110702|FG005|Induction Period|Withdrawal by Subject|0|||
164201275|NCT02065557|593110697|FG000|Induction Period|Lack of Efficacy|2|||
164201276|NCT02065557|593110698|FG001|Induction Period|Lack of Efficacy|1|||
164201277|NCT02065557|593110699|FG002|Induction Period|Lack of Efficacy|1|||
164201278|NCT02065557|593110700|FG003|Induction Period|Lack of Efficacy|0|||
164201279|NCT02065557|593110701|FG004|Induction Period|Lack of Efficacy|0|||
164201280|NCT02065557|593110702|FG005|Induction Period|Lack of Efficacy|0|||
164201281|NCT02065557|593110697|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
164201282|NCT02065557|593110698|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
164201283|NCT02065557|593110699|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
164201284|NCT02065557|593110700|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
164201285|NCT02065557|593110701|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
164201286|NCT02065557|593110702|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
163968447|NCT00911625|592255859|FG000|Overall Study|Lost to Follow-up|7|||
163968448|NCT00911625|592255860|FG001|Overall Study|Lost to Follow-up|0|||
163968449|NCT03785678|592255863|FG000|Overall Study|Death|44|||
164201287|NCT02065557|593110697|FG000|Induction Period|Non-Responder at Week 8|4|||
164201288|NCT02065557|593110698|FG001|Induction Period|Non-Responder at Week 8|4|||
164201289|NCT02065557|593110699|FG002|Induction Period|Non-Responder at Week 8|0|||
164310093|NCT02675634|593509581|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
163968450|NCT03785678|592255864|FG001|Overall Study|Death|42|||
163968451|NCT03785678|592255863|FG000|Overall Study|Lost to Follow-up|4|||
163968452|NCT03785678|592255864|FG001|Overall Study|Lost to Follow-up|2|||
164201290|NCT02065557|593110700|FG003|Induction Period|Non-Responder at Week 8|0|||
163864043|NCT01867580|591867692|FG000|Overall Study|Continuation of therapy|0|||
163968453|NCT03785678|592255863|FG000|Overall Study|Physician Decision|0|||
163968454|NCT03785678|592255864|FG001|Overall Study|Physician Decision|2|||
163968455|NCT03785678|592255863|FG000|Overall Study|Withdrawal by Subject|5|||
163968456|NCT03785678|592255864|FG001|Overall Study|Withdrawal by Subject|3|||
163968457|NCT01159912|592255865|FG000|Overall Study|Adverse Event|2|||
163968458|NCT01159912|592255866|FG001|Overall Study|Adverse Event|2|||
163968459|NCT01159912|592255867|FG002|Overall Study|Adverse Event|3|||
163968460|NCT01159912|592255865|FG000|Overall Study|Lack of Efficacy|23|||
163968461|NCT01159912|592255866|FG001|Overall Study|Lack of Efficacy|15|||
163968462|NCT01159912|592255867|FG002|Overall Study|Lack of Efficacy|14|||
163968463|NCT01159912|592255865|FG000|Overall Study|Protocol Violation|1|||
163968464|NCT01159912|592255866|FG001|Overall Study|Protocol Violation|2|||
163968465|NCT01159912|592255867|FG002|Overall Study|Protocol Violation|3|||
163968466|NCT01159912|592255865|FG000|Overall Study|Lost to Follow-up|4|||
163968467|NCT01159912|592255866|FG001|Overall Study|Lost to Follow-up|0|||
163968468|NCT01159912|592255867|FG002|Overall Study|Lost to Follow-up|0|||
163968469|NCT01159912|592255865|FG000|Overall Study|Physician Decision|0|||
163968470|NCT01159912|592255866|FG001|Overall Study|Physician Decision|0|||
163968471|NCT01159912|592255867|FG002|Overall Study|Physician Decision|3|||
163968472|NCT01159912|592255865|FG000|Overall Study|Withdrawal by Subject|10|||
163968473|NCT01159912|592255866|FG001|Overall Study|Withdrawal by Subject|3|||
163968474|NCT01159912|592255867|FG002|Overall Study|Withdrawal by Subject|3|||
163968475|NCT02142738|592257320|FG000|Overall Study|Adverse Event|13|||
163968476|NCT02142738|592257321|FG001|Overall Study|Adverse Event|9|||
163968477|NCT02142738|592257320|FG000|Overall Study|Death|92|||
163968478|NCT02142738|592257321|FG001|Overall Study|Death|112|||
163968479|NCT02142738|592257320|FG000|Overall Study|Lost to Follow-up|0|||
163968480|NCT02142738|592257321|FG001|Overall Study|Lost to Follow-up|3|||
163968481|NCT02142738|592257320|FG000|Overall Study|Withdrawal by Subject|6|||
163968482|NCT02142738|592257321|FG001|Overall Study|Withdrawal by Subject|7|||
163968483|NCT02142738|592257320|FG000|Overall Study|Follow up ended by sponsor|43|||
163968484|NCT02142738|592257321|FG001|Overall Study|Follow up ended by sponsor|20|||
163968485|NCT03713034|592257322|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
163968486|NCT03713034|592257323|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
163968487|NCT02615470|592257324|FG000|Overall Study|Lost to Follow-up|21|||
163968488|NCT02615470|592257325|FG001|Overall Study|Lost to Follow-up|32|||
163968489|NCT00880555|592257330|FG000|Overall Study|Physician Decision|0|||
163968490|NCT00880555|592257331|FG001|Overall Study|Physician Decision|8|||
163968491|NCT00880555|592257332|FG002|Overall Study|Physician Decision|0|||
163968492|NCT00880555|592257333|FG003|Overall Study|Physician Decision|2|||
163968493|NCT00880555|592257334|FG004|Overall Study|Physician Decision|1|||
163968494|NCT00880555|592257335|FG005|Overall Study|Physician Decision|0|||
163968495|NCT00880555|592257330|FG000|Overall Study|Withdrawal by Subject|1|||
163968496|NCT00880555|592257331|FG001|Overall Study|Withdrawal by Subject|1|||
163968497|NCT00880555|592257332|FG002|Overall Study|Withdrawal by Subject|0|||
163968498|NCT00880555|592257333|FG003|Overall Study|Withdrawal by Subject|0|||
163968499|NCT00880555|592257334|FG004|Overall Study|Withdrawal by Subject|0|||
163968500|NCT00880555|592257335|FG005|Overall Study|Withdrawal by Subject|0|||
163968501|NCT00880555|592257330|FG000|Overall Study|Lack of resources (hired rater)|9|||
163968502|NCT00880555|592257331|FG001|Overall Study|Lack of resources (hired rater)|7|||
163968503|NCT00880555|592257332|FG002|Overall Study|Lack of resources (hired rater)|5|||
163968504|NCT00880555|592257333|FG003|Overall Study|Lack of resources (hired rater)|0|||
163968505|NCT00880555|592257334|FG004|Overall Study|Lack of resources (hired rater)|0|||
163968506|NCT00880555|592257335|FG005|Overall Study|Lack of resources (hired rater)|0|||
163968507|NCT00880555|592257330|FG000|Overall Study|Death|0|||
163968508|NCT00880555|592257331|FG001|Overall Study|Death|0|||
163968509|NCT00880555|592257332|FG002|Overall Study|Death|0|||
163968510|NCT00880555|592257333|FG003|Overall Study|Death|0|||
164201291|NCT02065557|593110701|FG004|Induction Period|Non-Responder at Week 8|0|||
164201292|NCT02065557|593110702|FG005|Induction Period|Non-Responder at Week 8|0|||
164201293|NCT02065557|593110697|FG000|Induction Period|Adverse Event|1|||
164201294|NCT02065557|593110698|FG001|Induction Period|Adverse Event|1|||
164201295|NCT02065557|593110699|FG002|Induction Period|Adverse Event|0|||
164201296|NCT02065557|593110700|FG003|Induction Period|Adverse Event|0|||
164201297|NCT02065557|593110701|FG004|Induction Period|Adverse Event|0|||
164201298|NCT02065557|593110702|FG005|Induction Period|Adverse Event|0|||
164201299|NCT02065557|593110697|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164310094|NCT02675634|593509582|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
163968511|NCT00880555|592257334|FG004|Overall Study|Death|0|||
163968512|NCT00880555|592257335|FG005|Overall Study|Death|1|||
163968513|NCT00880555|592257330|FG000|Overall Study|Lost to Follow-up|0|||
163968514|NCT00880555|592257331|FG001|Overall Study|Lost to Follow-up|1|||
163968515|NCT00880555|592257332|FG002|Overall Study|Lost to Follow-up|0|||
163968516|NCT00880555|592257333|FG003|Overall Study|Lost to Follow-up|0|||
163968517|NCT00880555|592257334|FG004|Overall Study|Lost to Follow-up|0|||
163968518|NCT00880555|592257335|FG005|Overall Study|Lost to Follow-up|0|||
163968519|NCT02982590|592257336|FG000|Overall Study|Lost to Follow-up|0|||
164310095|NCT02675634|593509577|FG000|Test Period 2|Lack of Efficacy|1|||
163968520|NCT02982590|592257337|FG001|Overall Study|Lost to Follow-up|1|||
163968521|NCT02982590|592257336|FG000|Overall Study|Death|4|||
163968522|NCT02982590|592257337|FG001|Overall Study|Death|0|||
163968523|NCT04196803|592257338|FG000|Overall Study|Withdrawal by Subject|1|||
163968524|NCT04196803|592257339|FG001|Overall Study|Withdrawal by Subject|3|||
163968525|NCT04196803|592257338|FG000|Overall Study|Adverse Event|4|||
163968526|NCT04196803|592257339|FG001|Overall Study|Adverse Event|2|||
163968527|NCT04196803|592257338|FG000|Overall Study|Lost to Follow-up|0|||
163968528|NCT04196803|592257339|FG001|Overall Study|Lost to Follow-up|1|||
163968529|NCT01168973|592257340|FG000|Overall Study|Progressive Disease|341|||
163968530|NCT01168973|592257341|FG001|Overall Study|Progressive Disease|429|||
163968531|NCT01168973|592257340|FG000|Overall Study|Adverse Event|94|||
163968532|NCT01168973|592257341|FG001|Overall Study|Adverse Event|55|||
163968533|NCT01168973|592257340|FG000|Overall Study|Withdrawal by Subject|90|||
163968534|NCT01168973|592257341|FG001|Overall Study|Withdrawal by Subject|53|||
163968535|NCT01168973|592257340|FG000|Overall Study|Death|42|||
163968536|NCT01168973|592257341|FG001|Overall Study|Death|45|||
163968537|NCT01168973|592257340|FG000|Overall Study|Physician Decision|37|||
163968538|NCT01168973|592257341|FG001|Overall Study|Physician Decision|19|||
163968539|NCT01168973|592257340|FG000|Overall Study|Sponsor Decision|2|||
163968540|NCT01168973|592257341|FG001|Overall Study|Sponsor Decision|1|||
163968541|NCT01168973|592257340|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
163968542|NCT01168973|592257341|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
163968543|NCT00419120|592257342|FG000|Long Term Follow up Period|study ongoing|10|||
163968544|NCT01756040|592257343|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
163968545|NCT01756040|592257343|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
163968546|NCT01756040|592257343|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
163968547|NCT01848288|592257344|FG000|Overall Study|Death|1|||
163968548|NCT01848288|592257344|FG000|Overall Study|Protocol Violation|1|||
163968549|NCT01848288|592257344|FG000|Overall Study|Withdrawal by Subject|1|||
163968550|NCT01007032|592257345|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
163968551|NCT01007032|592257346|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
163968552|NCT01007032|592257347|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
163968553|NCT01007032|592257348|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
163968554|NCT01007032|592257345|FG000|Overall Study|Withdrawal by Subject|0|||
163968555|NCT01007032|592257346|FG001|Overall Study|Withdrawal by Subject|0|||
163968556|NCT01007032|592257347|FG002|Overall Study|Withdrawal by Subject|0|||
163968557|NCT01007032|592257348|FG003|Overall Study|Withdrawal by Subject|1|||
163968558|NCT02716675|592257356|FG000|Overall Study|Death|2|||
163968559|NCT02716675|592257357|FG001|Overall Study|Death|3|||
163968560|NCT02716675|592257358|FG002|Overall Study|Death|0|||
163968561|NCT02716675|592257356|FG000|Overall Study|Physician Decision|2|||
163968562|NCT02716675|592257357|FG001|Overall Study|Physician Decision|1|||
163968563|NCT02716675|592257358|FG002|Overall Study|Physician Decision|1|||
163968564|NCT02716675|592257356|FG000|Overall Study|Lost to Follow-up|100|||
163968565|NCT02716675|592257357|FG001|Overall Study|Lost to Follow-up|87|||
163968566|NCT02716675|592257358|FG002|Overall Study|Lost to Follow-up|99|||
163968567|NCT02716675|592257356|FG000|Overall Study|Withdrawal by Subject|22|||
163968568|NCT02716675|592257357|FG001|Overall Study|Withdrawal by Subject|25|||
163968569|NCT02716675|592257358|FG002|Overall Study|Withdrawal by Subject|20|||
163968570|NCT02716675|592257356|FG000|Overall Study|Protocol Violation|0|||
163968571|NCT02716675|592257357|FG001|Overall Study|Protocol Violation|3|||
163968572|NCT02716675|592257358|FG002|Overall Study|Protocol Violation|1|||
163968573|NCT02716675|592257356|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
163968574|NCT02716675|592257357|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
163968575|NCT02716675|592257358|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
163968576|NCT02716675|592257356|FG000|Overall Study|Other|38|||
163968577|NCT02716675|592257357|FG001|Overall Study|Other|47|||
163968578|NCT02716675|592257358|FG002|Overall Study|Other|48|||
163968579|NCT00290290|592257361|FG000|Overall Study|Death|3|||
163968580|NCT00290290|592257362|FG001|Overall Study|Death|4|||
163968581|NCT00290290|592257361|FG000|Overall Study|Withdrawal by Subject|2|||
164201300|NCT02065557|593110698|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164201301|NCT02065557|593110699|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164201302|NCT02065557|593110700|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
163968582|NCT00290290|592257362|FG001|Overall Study|Withdrawal by Subject|2|||
163968583|NCT00290290|592257361|FG000|Overall Study|Underwent clean surgical procedure|13|||
163968584|NCT00290290|592257362|FG001|Overall Study|Underwent clean surgical procedure|12|||
163968585|NCT00003895|592257365|FG000|Overall Study|Adverse Event|4|||
163968586|NCT00003895|592257366|FG001|Overall Study|Adverse Event|0|||
163968587|NCT00003895|592257365|FG000|Overall Study|Lack of Efficacy|1|||
163968588|NCT00003895|592257366|FG001|Overall Study|Lack of Efficacy|1|||
163968589|NCT00003895|592257365|FG000|Overall Study|Patient Vacation|2|||
163968590|NCT00003895|592257366|FG001|Overall Study|Patient Vacation|0|||
163968591|NCT00003895|592257365|FG000|Overall Study|Withdrawal by Subject|0|||
163968592|NCT00003895|592257366|FG001|Overall Study|Withdrawal by Subject|3|||
163968593|NCT01380730|592257367|FG000|Overall Study|Death|0|||
164310096|NCT02675634|593509578|FG001|Test Period 2|Lack of Efficacy|0|||
164310097|NCT02675634|593509579|FG002|Test Period 2|Lack of Efficacy|0|||
164310098|NCT02675634|593509580|FG003|Test Period 2|Lack of Efficacy|0|||
164310099|NCT02675634|593509581|FG004|Test Period 2|Lack of Efficacy|0|||
164310100|NCT02675634|593509582|FG005|Test Period 2|Lack of Efficacy|0|||
164310101|NCT02675634|593509577|FG000|Test Period 2|Adverse Event|0|||
164310102|NCT02675634|593509578|FG001|Test Period 2|Adverse Event|0|||
164310103|NCT02675634|593509579|FG002|Test Period 2|Adverse Event|0|||
164310104|NCT02675634|593509580|FG003|Test Period 2|Adverse Event|0|||
163968594|NCT01380730|592257368|FG001|Overall Study|Death|0|||
163968595|NCT01380730|592257369|FG002|Overall Study|Death|0|||
163968596|NCT01380730|592257370|FG003|Overall Study|Death|0|||
163968597|NCT01380730|592257371|FG004|Overall Study|Death|1|||
163968598|NCT01380730|592257372|FG005|Overall Study|Death|0|||
163968599|NCT01380730|592257373|FG006|Overall Study|Death|0|||
163968600|NCT01380730|592257374|FG007|Overall Study|Death|0|||
163968601|NCT01509079|592257380|FG000|Overall Study|Lack of Efficacy|0|||
163968602|NCT01509079|592257381|FG001|Overall Study|Lack of Efficacy|2|||
163968603|NCT01509079|592257380|FG000|Overall Study|started an excluded medication|0|||
163968604|NCT01509079|592257381|FG001|Overall Study|started an excluded medication|1|||
163968605|NCT03945591|592257382|FG000|Overall Study|Participant not transplanted|1|||
163968606|NCT03945591|592257382|FG000|Overall Study|Change in treatment plan|3|||
163968607|NCT03945591|592257382|FG000|Overall Study|Adverse Event|1|||
164310105|NCT02675634|593509581|FG004|Test Period 2|Adverse Event|0|||
163864044|NCT01867580|591867693|FG001|Overall Study|Continuation of therapy|1|||
163864045|NCT01867580|591867692|FG000|Overall Study|Wound recurrence|0|||
163864046|NCT01867580|591867693|FG001|Overall Study|Wound recurrence|1|||
163864047|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
163864048|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
163864049|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
163864050|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163864051|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163864052|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163864053|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163864054|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163864055|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163864056|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
163864057|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
163864058|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
163864059|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163864060|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163864061|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163864062|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163864063|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163864064|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163864065|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
163864066|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
163864067|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
163864068|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163864069|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163864070|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163864071|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163864072|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163864073|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163864074|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
163864075|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163864076|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
163864077|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163864078|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163864079|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163864080|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163968608|NCT00359021|592257383|FG000|Overall Study|Adverse Event|26|||
163968609|NCT00359021|592257384|FG001|Overall Study|Adverse Event|8|||
164310106|NCT02675634|593509582|FG005|Test Period 2|Adverse Event|1|||
163968610|NCT00359021|592257383|FG000|Overall Study|Subject Non-Compliant|1|||
163968611|NCT00359021|592257384|FG001|Overall Study|Subject Non-Compliant|2|||
163968612|NCT00359021|592257383|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
163968613|NCT00359021|592257384|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
164310107|NCT01652534|593509583|FG000|Overall Study|Lack of Efficacy|1|||
164310108|NCT01652534|593509584|FG001|Overall Study|Lack of Efficacy|0|||
164310109|NCT02722304|593509585|FG000|Overall Study|Study Terminated by Sponsor|1|||
163968614|NCT00359021|592257383|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
163968615|NCT00359021|592257384|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
163968616|NCT00359021|592257383|FG000|Overall Study|Withdrawal by Subject|2|||
163968617|NCT00359021|592257384|FG001|Overall Study|Withdrawal by Subject|9|||
163968618|NCT00359021|592257383|FG000|Overall Study|Lost to Follow-up|1|||
163968619|NCT00359021|592257384|FG001|Overall Study|Lost to Follow-up|0|||
163968620|NCT00359021|592257383|FG000|Overall Study|Other|4|||
163968621|NCT00359021|592257384|FG001|Overall Study|Other|1|||
163968622|NCT00359021|592257383|FG000|Overall Study|Pregnancy|1|||
163968623|NCT00359021|592257384|FG001|Overall Study|Pregnancy|0|||
163968624|NCT03861936|592257385|FG000|Overall Study|Withdrawal by Subject|4|||
163968625|NCT03861936|592257386|FG001|Overall Study|Withdrawal by Subject|1|||
163968626|NCT03861936|592257387|FG002|Overall Study|Withdrawal by Subject|3|||
163968627|NCT03861936|592257385|FG000|Overall Study|Lost to Follow-up|5|||
163968628|NCT03861936|592257386|FG001|Overall Study|Lost to Follow-up|3|||
163968629|NCT03861936|592257387|FG002|Overall Study|Lost to Follow-up|3|||
163968630|NCT03861936|592257385|FG000|Overall Study|Physician Decision|0|||
163968631|NCT03861936|592257386|FG001|Overall Study|Physician Decision|1|||
163968632|NCT03861936|592257387|FG002|Overall Study|Physician Decision|0|||
163968633|NCT03861936|592257385|FG000|Overall Study|Protocol Deviation|0|||
163968634|NCT03861936|592257386|FG001|Overall Study|Protocol Deviation|0|||
163968635|NCT03861936|592257387|FG002|Overall Study|Protocol Deviation|1|||
163968636|NCT03861936|592257385|FG000|Overall Study|Reason not Specified|5|||
163968637|NCT03861936|592257386|FG001|Overall Study|Reason not Specified|5|||
163968638|NCT03861936|592257387|FG002|Overall Study|Reason not Specified|3|||
163968639|NCT01670539|592257392|FG000|Overall Study|Death|3|||
163968640|NCT01670539|592257393|FG001|Overall Study|Death|5|||
163968641|NCT01670539|592257392|FG000|Overall Study|Withdrawal by Subject|3|||
163968642|NCT01670539|592257393|FG001|Overall Study|Withdrawal by Subject|0|||
163968643|NCT04353596|592257394|FG000|Overall Study|Protocol Violation|4|||
163968644|NCT04353596|592257395|FG001|Overall Study|Protocol Violation|4|||
163968645|NCT04353596|592257394|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
163968646|NCT04353596|592257395|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
163968647|NCT01236573|592257396|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968648|NCT01236573|592257397|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968649|NCT01236573|592257398|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968650|NCT01236573|592257399|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968651|NCT01236573|592257400|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968652|NCT01236573|592257401|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968653|NCT01236573|592257402|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163968654|NCT01236573|592257403|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968655|NCT01236573|592257404|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163968656|NCT01236573|592257405|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
163968657|NCT01236573|592257406|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
163968658|NCT01236573|592257396|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968659|NCT01236573|592257397|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968660|NCT01236573|592257398|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968661|NCT01236573|592257399|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968662|NCT01236573|592257400|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968663|NCT01236573|592257401|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968664|NCT01236573|592257402|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968665|NCT01236573|592257403|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968666|NCT01236573|592257404|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
163968667|NCT01236573|592257405|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968668|NCT01236573|592257406|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
163968669|NCT01236573|592257396|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164201303|NCT02065557|593110701|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
164201304|NCT02065557|593110702|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
164201305|NCT02065557|593110697|FG000|Maintenance Period|Withdrawal by Subject|0|||
164201306|NCT02065557|593110698|FG001|Maintenance Period|Withdrawal by Subject|0|||
164201307|NCT02065557|593110699|FG002|Maintenance Period|Withdrawal by Subject|0|||
163968670|NCT01236573|592257397|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968671|NCT01236573|592257398|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968672|NCT01236573|592257399|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968673|NCT01236573|592257400|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968674|NCT01236573|592257401|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968675|NCT01236573|592257402|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968676|NCT01236573|592257403|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
164201308|NCT02065557|593110700|FG003|Maintenance Period|Withdrawal by Subject|0|||
164201309|NCT02065557|593110701|FG004|Maintenance Period|Withdrawal by Subject|2|||
164201310|NCT02065557|593110702|FG005|Maintenance Period|Withdrawal by Subject|1|||
163968677|NCT01236573|592257404|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968678|NCT01236573|592257405|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
163968679|NCT01236573|592257406|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
163968680|NCT05418673|592257409|FG000|Overall Study|Study Terminated by Sponsor|2|||
163968681|NCT05418673|592257410|FG001|Overall Study|Study Terminated by Sponsor|4|||
163968682|NCT05418673|592257409|FG000|Overall Study|Lost to Follow-up|1|||
163968683|NCT05418673|592257410|FG001|Overall Study|Lost to Follow-up|0|||
163968684|NCT02665052|592257411|FG000|Overall Study|Lost to Follow-up|1|||
163968685|NCT02665052|592257412|FG001|Overall Study|Lost to Follow-up|0|||
163968686|NCT02665052|592257413|FG002|Overall Study|Lost to Follow-up|0|||
163968687|NCT02665052|592257414|FG003|Overall Study|Lost to Follow-up|0|||
163968688|NCT02665052|592257411|FG000|Overall Study|Withdrawal by Subject|1|||
163968689|NCT02665052|592257412|FG001|Overall Study|Withdrawal by Subject|1|||
163968690|NCT02665052|592257413|FG002|Overall Study|Withdrawal by Subject|0|||
163968691|NCT02665052|592257414|FG003|Overall Study|Withdrawal by Subject|5|||
163968692|NCT02665052|592257411|FG000|Overall Study|Adverse Event|1|||
163968693|NCT02665052|592257412|FG001|Overall Study|Adverse Event|1|||
163968694|NCT02665052|592257413|FG002|Overall Study|Adverse Event|0|||
163968695|NCT02665052|592257414|FG003|Overall Study|Adverse Event|0|||
163968696|NCT02234284|592257415|FG000|Overall Study|Death|4|||
163968697|NCT02234284|592257416|FG001|Overall Study|Death|2|||
163968698|NCT02234284|592257415|FG000|Overall Study|Withdrawal by Subject|1|||
163968699|NCT02234284|592257416|FG001|Overall Study|Withdrawal by Subject|0|||
163968700|NCT02234284|592257415|FG000|Overall Study|Lost to Follow-up|20|||
163968701|NCT02234284|592257416|FG001|Overall Study|Lost to Follow-up|7|||
163968702|NCT01986920|592257419|FG000|A- 101 25%|Withdrawal by Subject|1|||
163968703|NCT01986920|592257420|FG001|A- 101 25%|Withdrawal by Subject|0|||
163968704|NCT01986920|592257421|FG002|A- 101 25%|Withdrawal by Subject|0|||
163968705|NCT01986920|592257422|FG003|A- 101 25%|Withdrawal by Subject|0|||
163968706|NCT01986920|592257419|FG000|A-101 32.5%|Withdrawal by Subject|0|||
163968707|NCT01986920|592257420|FG001|A-101 32.5%|Withdrawal by Subject|1|||
163968708|NCT01986920|592257421|FG002|A-101 32.5%|Withdrawal by Subject|0|||
163968709|NCT01986920|592257422|FG003|A-101 32.5%|Withdrawal by Subject|0|||
163968710|NCT01986920|592257419|FG000|A-101 40%|Withdrawal by Subject|0|||
163968711|NCT01986920|592257420|FG001|A-101 40%|Withdrawal by Subject|0|||
163968712|NCT01986920|592257421|FG002|A-101 40%|Withdrawal by Subject|1|||
163968713|NCT01986920|592257422|FG003|A-101 40%|Withdrawal by Subject|0|||
163968714|NCT01986920|592257419|FG000|Placebo|Withdrawal by Subject|0|||
163968715|NCT01986920|592257420|FG001|Placebo|Withdrawal by Subject|0|||
163968716|NCT01986920|592257421|FG002|Placebo|Withdrawal by Subject|0|||
163968717|NCT01986920|592257422|FG003|Placebo|Withdrawal by Subject|1|||
163968718|NCT03023059|592257425|FG000|Overall Study|Withdrawal by Subject|5|||
163968719|NCT05215262|592257426|FG000|Overall Study|Lost to Follow-up|12|||
163968720|NCT05215262|592257427|FG001|Overall Study|Lost to Follow-up|0|||
163968721|NCT04880447|592257429|FG000|Overall Study|No vaccination information|1|||
163968722|NCT04880447|592257429|FG000|Overall Study|No adverse event information (missing information)|1|||
163968723|NCT04880447|592257429|FG000|Overall Study|Disease not covered in this study|35|||
163968724|NCT01353508|592257430|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
163968725|NCT01353508|592257431|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
163968726|NCT01353508|592257432|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
163864081|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163864082|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163864083|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163864084|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163864085|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
163864086|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163864087|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163864088|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163864089|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163864090|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163864091|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163968727|NCT01353508|592257433|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
163968728|NCT01353508|592257430|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
163968729|NCT01353508|592257431|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
164302361|NCT03755934|593482603|FG001|Overall Study|Adverse Event|1|||
163968730|NCT01353508|592257432|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
163968731|NCT01353508|592257433|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
163864092|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864093|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163968732|NCT02092350|592257438|FG000|Overall Study|Adverse Event|0|||
163968733|NCT02092350|592257439|FG001|Overall Study|Adverse Event|3|||
163968734|NCT02092350|592257438|FG000|Overall Study|Death|2|||
163968735|NCT02092350|592257439|FG001|Overall Study|Death|5|||
163968736|NCT02092350|592257438|FG000|Overall Study|Lost to Follow-up|3|||
163968737|NCT02092350|592257439|FG001|Overall Study|Lost to Follow-up|1|||
163968738|NCT02092350|592257438|FG000|Overall Study|Protocol Violation|1|||
163968739|NCT02092350|592257439|FG001|Overall Study|Protocol Violation|0|||
163968740|NCT02092350|592257438|FG000|Overall Study|Physician Decision|1|||
163968741|NCT02092350|592257439|FG001|Overall Study|Physician Decision|1|||
163968742|NCT02092350|592257438|FG000|Overall Study|Screen Failure|1|||
163968743|NCT02092350|592257439|FG001|Overall Study|Screen Failure|0|||
163968744|NCT02092350|592257438|FG000|Overall Study|Withdrawal by Subject|2|||
163968745|NCT02092350|592257439|FG001|Overall Study|Withdrawal by Subject|2|||
163968746|NCT00646906|592257441|FG000|Crossover Period 1|Withdrawal by Subject|1|||
163968747|NCT00646906|592257442|FG001|Crossover Period 1|Withdrawal by Subject|0|||
163968748|NCT00646906|592257443|FG002|Crossover Period 1|Withdrawal by Subject|0|||
163968749|NCT00646906|592257444|FG003|Crossover Period 1|Withdrawal by Subject|0|||
163968750|NCT00646906|592257445|FG004|Crossover Period 1|Withdrawal by Subject|0|||
163968751|NCT00646906|592257446|FG005|Crossover Period 1|Withdrawal by Subject|1|||
163968752|NCT00646906|592257447|FG006|Crossover Period 1|Withdrawal by Subject|0|||
163968753|NCT00646906|592257441|FG000|Crossover Period 2|Withdrawal by Subject|0|||
163968754|NCT00646906|592257442|FG001|Crossover Period 2|Withdrawal by Subject|1|||
163968755|NCT00646906|592257443|FG002|Crossover Period 2|Withdrawal by Subject|2|||
163968756|NCT00646906|592257444|FG003|Crossover Period 2|Withdrawal by Subject|1|||
163968757|NCT00646906|592257445|FG004|Crossover Period 2|Withdrawal by Subject|0|||
163968758|NCT00646906|592257446|FG005|Crossover Period 2|Withdrawal by Subject|0|||
163968759|NCT00646906|592257447|FG006|Crossover Period 2|Withdrawal by Subject|0|||
163968760|NCT00646906|592257441|FG000|Crossover Period 2|Physician Decision|0|||
163968761|NCT00646906|592257442|FG001|Crossover Period 2|Physician Decision|0|||
163968762|NCT00646906|592257443|FG002|Crossover Period 2|Physician Decision|0|||
163968763|NCT00646906|592257444|FG003|Crossover Period 2|Physician Decision|0|||
163968764|NCT00646906|592257445|FG004|Crossover Period 2|Physician Decision|0|||
163968765|NCT00646906|592257446|FG005|Crossover Period 2|Physician Decision|0|||
163968766|NCT00646906|592257447|FG006|Crossover Period 2|Physician Decision|1|||
163968767|NCT00433914|592257453|FG000|Overall Study|Withdrawal by Subject|0|||
163968768|NCT00433914|592257454|FG001|Overall Study|Withdrawal by Subject|2|||
163968769|NCT00433914|592257453|FG000|Overall Study|Lost to Follow-up|0|||
163968770|NCT00433914|592257454|FG001|Overall Study|Lost to Follow-up|1|||
163968771|NCT02844920|592257455|FG000|Overall Study|Lost to Follow-up|2|||
163968772|NCT02678416|592257460|FG000|Part 1|Withdrawal by Subject|1|||
163968773|NCT02678416|592257460|FG000|Part 2|Adverse Event|2|||
163968774|NCT02678416|592257460|FG000|Part 2|Withdrawal by Subject|1|||
163968775|NCT01910116|592257466|FG000|Overall Study|Adverse Event|0|||
163968776|NCT01910116|592257467|FG001|Overall Study|Adverse Event|3|||
163968777|NCT01910116|592257466|FG000|Overall Study|Lack of Efficacy|3|||
163968778|NCT01910116|592257467|FG001|Overall Study|Lack of Efficacy|4|||
163968779|NCT01910116|592257466|FG000|Overall Study|Lost to Follow-up|1|||
163968780|NCT01910116|592257467|FG001|Overall Study|Lost to Follow-up|0|||
163968781|NCT01910116|592257466|FG000|Overall Study|Protocol Violation|1|||
163968782|NCT01910116|592257467|FG001|Overall Study|Protocol Violation|2|||
163968783|NCT01910116|592257466|FG000|Overall Study|Withdrawal by Subject|8|||
163968784|NCT01910116|592257467|FG001|Overall Study|Withdrawal by Subject|3|||
163968785|NCT01910116|592257466|FG000|Overall Study|uncertain allocation|1|||
163968786|NCT01910116|592257467|FG001|Overall Study|uncertain allocation|3|||
163968787|NCT01910116|592257466|FG000|Overall Study|incomplete data|0|||
163968788|NCT01910116|592257467|FG001|Overall Study|incomplete data|1|||
163968789|NCT02289352|592257470|FG000|Overall Study|Withdrawal by Subject|1|||
163968790|NCT02289352|592257471|FG001|Overall Study|Withdrawal by Subject|1|||
163968791|NCT02289352|592257472|FG002|Overall Study|Withdrawal by Subject|0|||
163968792|NCT03123250|592257473|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
163968793|NCT02361944|592257474|FG000|Overall Study|surgery cancellation|0|||
163968794|NCT02361944|592257475|FG001|Overall Study|surgery cancellation|1|||
163968795|NCT02054325|592257482|FG000|Overall Study|Lost to Follow-up|8|||
163968796|NCT02054325|592257483|FG001|Overall Study|Lost to Follow-up|5|||
163968797|NCT02374021|592257484|FG000|Overall Study|Adverse Event|1|||
163968798|NCT02374021|592257485|FG001|Overall Study|Adverse Event|0|||
163968799|NCT02374021|592257484|FG000|Overall Study|Lost to Follow-up|3|||
163968800|NCT02374021|592257485|FG001|Overall Study|Lost to Follow-up|2|||
163968801|NCT02374021|592257484|FG000|Overall Study|Physician Decision|0|||
163968802|NCT02374021|592257485|FG001|Overall Study|Physician Decision|3|||
163968803|NCT02374021|592257484|FG000|Overall Study|Withdrawal by Subject|6|||
164201311|NCT02065557|593110697|FG000|Maintenance Period|Lack of Efficacy|0|||
164201312|NCT02065557|593110698|FG001|Maintenance Period|Lack of Efficacy|0|||
163968804|NCT02374021|592257485|FG001|Overall Study|Withdrawal by Subject|5|||
163968805|NCT02374021|592257484|FG000|Overall Study|Poor Adherence|0|||
163968806|NCT02374021|592257485|FG001|Overall Study|Poor Adherence|1|||
163968807|NCT02374021|592257484|FG000|Overall Study|Scan protocol not followed|0|||
163968808|NCT02374021|592257485|FG001|Overall Study|Scan protocol not followed|1|||
163968809|NCT02374021|592257484|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
163968810|NCT02374021|592257485|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
163968811|NCT00732251|592257486|FG000|Overall Study|Lost to Follow-up|3|||
163864094|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163864095|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864096|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864097|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864098|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864099|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864100|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163864101|NCT01212757|591867694|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
163864102|NCT01212757|591867695|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
163864103|NCT01212757|591867696|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864104|NCT01212757|591867697|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864105|NCT01212757|591867698|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864106|NCT01212757|591867699|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864107|NCT01212757|591867700|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864108|NCT01212757|591867701|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864109|NCT01212757|591867702|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163864110|NCT01212757|591867694|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163864111|NCT01212757|591867695|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
163864112|NCT01212757|591867696|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
163864113|NCT01212757|591867697|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
163864114|NCT01212757|591867698|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163864115|NCT01212757|591867699|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
163864116|NCT01212757|591867700|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163864117|NCT01212757|591867701|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163864118|NCT01212757|591867702|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
163864119|NCT01212757|591867694|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163864120|NCT01212757|591867695|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
163864121|NCT01212757|591867696|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
163864122|NCT01212757|591867697|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
163864123|NCT01212757|591867698|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163864124|NCT01212757|591867699|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
163864125|NCT01212757|591867700|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163864126|NCT01212757|591867701|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163864127|NCT01212757|591867702|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
163864128|NCT01212757|591867694|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864129|NCT01212757|591867695|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864130|NCT01212757|591867696|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
163864131|NCT01212757|591867697|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864132|NCT01212757|591867698|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864133|NCT01212757|591867699|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864134|NCT01212757|591867700|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864135|NCT01212757|591867701|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864136|NCT01212757|591867702|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
163864137|NCT01212757|591867694|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163864138|NCT01212757|591867695|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
163864139|NCT01212757|591867696|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
163864140|NCT01212757|591867697|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
163864141|NCT01212757|591867698|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
163864142|NCT01212757|591867699|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
163864143|NCT01212757|591867700|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163864144|NCT01212757|591867701|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163864145|NCT01212757|591867702|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
163864146|NCT01212757|591867694|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163864147|NCT01212757|591867695|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
163864148|NCT01212757|591867696|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163864149|NCT01212757|591867697|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163864150|NCT01212757|591867698|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
163864151|NCT01212757|591867699|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163864152|NCT01212757|591867700|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163864153|NCT01212757|591867701|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163968812|NCT00732251|592257486|FG000|Overall Study|Withdrawal by Subject|3|||
163968813|NCT00732251|592257486|FG000|Overall Study|Early Term due to Site Closure|1|||
163968814|NCT00382720|592259671|FG000|Overall Study|Adverse Event|21|||
163968815|NCT00382720|592259672|FG001|Overall Study|Adverse Event|23|||
163864154|NCT01212757|591867702|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
163864155|NCT01212757|591867694|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864156|NCT01212757|591867695|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
163864157|NCT01212757|591867696|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
163864158|NCT01212757|591867697|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864159|NCT01212757|591867698|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864160|NCT01212757|591867699|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864161|NCT01212757|591867700|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864162|NCT01212757|591867701|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864163|NCT01212757|591867702|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
163864164|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864165|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864166|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864167|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864168|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864169|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864170|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864171|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
163864172|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
163864173|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163864174|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
163864175|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
163864176|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163864177|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163864178|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163864179|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
163864180|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
163864181|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
163864182|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163864183|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
163864184|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
163864185|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163864186|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163864187|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163864188|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163864189|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
163864190|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
163864191|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163864192|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
163864193|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
163864194|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163864195|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163864196|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163864197|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163864198|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
163864199|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
163864200|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864201|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864202|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
163864203|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864204|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864205|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864206|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864207|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864208|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
163864209|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163864210|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
163864211|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
163864212|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163864213|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163864214|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163864215|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163864216|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
163864217|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
163864218|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163864219|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
163864220|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
163864221|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163968816|NCT00382720|592259673|FG002|Overall Study|Adverse Event|15|||
163864222|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163864223|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163864224|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
163864225|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
163864226|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
163864227|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864228|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864229|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
163864230|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864231|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864232|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864233|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864234|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864235|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
163864236|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163864237|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
163864238|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163864239|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163864240|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163864241|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163864242|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163864243|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163864244|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163864245|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864246|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864247|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864248|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864249|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864250|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864251|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864252|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
163864253|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
163864254|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864255|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
163864256|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864257|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864258|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864259|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864260|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864261|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864262|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
163864263|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864264|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864265|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
163864266|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864267|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864268|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864269|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864270|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
163864271|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
163864272|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864273|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
163864274|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864275|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864276|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864277|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864278|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864279|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
163864280|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
163864281|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163864282|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163864283|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
163864284|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163864285|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163864286|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163864287|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
163968817|NCT00382720|592259671|FG000|Overall Study|Protocol Violation|2|||
163968818|NCT00382720|592259672|FG001|Overall Study|Protocol Violation|5|||
163968819|NCT00382720|592259673|FG002|Overall Study|Protocol Violation|1|||
163968820|NCT00382720|592259671|FG000|Overall Study|Death|0|||
163968821|NCT00382720|592259672|FG001|Overall Study|Death|1|||
163968822|NCT00382720|592259673|FG002|Overall Study|Death|2|||
163968823|NCT00382720|592259671|FG000|Overall Study|Progressive disease|37|||
163968824|NCT00382720|592259672|FG001|Overall Study|Progressive disease|28|||
163968825|NCT00382720|592259673|FG002|Overall Study|Progressive disease|38|||
163968826|NCT00382720|592259671|FG000|Overall Study|Withdrew consent|1|||
163968827|NCT00382720|592259672|FG001|Overall Study|Withdrew consent|1|||
163968828|NCT00382720|592259673|FG002|Overall Study|Withdrew consent|2|||
163968829|NCT00382720|592259671|FG000|Overall Study|Withdrawal by Subject|11|||
163968830|NCT00382720|592259672|FG001|Overall Study|Withdrawal by Subject|20|||
163968831|NCT00382720|592259673|FG002|Overall Study|Withdrawal by Subject|12|||
163968832|NCT00382720|592259671|FG000|Overall Study|Surgery|1|||
163968833|NCT00382720|592259672|FG001|Overall Study|Surgery|1|||
163968834|NCT00382720|592259673|FG002|Overall Study|Surgery|4|||
163968835|NCT00382720|592259671|FG000|Overall Study|Patient did not receive study medication|1|||
163968836|NCT00382720|592259672|FG001|Overall Study|Patient did not receive study medication|1|||
163968837|NCT00382720|592259673|FG002|Overall Study|Patient did not receive study medication|4|||
163968838|NCT00382720|592259671|FG000|Overall Study|Clinically progressive disease|0|||
163968839|NCT00382720|592259672|FG001|Overall Study|Clinically progressive disease|1|||
163968840|NCT00382720|592259673|FG002|Overall Study|Clinically progressive disease|0|||
163968841|NCT00382720|592259671|FG000|Overall Study|Good prognosis|0|||
163968842|NCT00382720|592259672|FG001|Overall Study|Good prognosis|1|||
163968843|NCT00382720|592259673|FG002|Overall Study|Good prognosis|0|||
163968844|NCT00382720|592259671|FG000|Overall Study|Investigator/Clinical decision|5|||
163968845|NCT00382720|592259672|FG001|Overall Study|Investigator/Clinical decision|6|||
163968846|NCT00382720|592259673|FG002|Overall Study|Investigator/Clinical decision|6|||
163968847|NCT00382720|592259671|FG000|Overall Study|Discontinued at end of study|0|||
163968848|NCT00382720|592259672|FG001|Overall Study|Discontinued at end of study|1|||
163968849|NCT00382720|592259673|FG002|Overall Study|Discontinued at end of study|2|||
163968850|NCT02737852|592259676|FG000|Overall Study|Withdrawal by Subject|2|||
163968851|NCT01704287|592259677|FG000|Initial Treatment Period|Death|139|||
163968852|NCT01704287|592259678|FG001|Initial Treatment Period|Death|129|||
163968853|NCT01704287|592259679|FG002|Initial Treatment Period|Death|71|||
163968854|NCT01704287|592259680|FG003|Initial Treatment Period|Death|0|||
163968855|NCT01704287|592259681|FG004|Initial Treatment Period|Death|0|||
163968856|NCT01704287|592259677|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
163968857|NCT01704287|592259678|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
163968858|NCT01704287|592259679|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
163968859|NCT01704287|592259680|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
163968860|NCT01704287|592259681|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
163968861|NCT01704287|592259677|FG000|Initial Treatment Period|Lost to Follow-up|5|||
163968862|NCT01704287|592259678|FG001|Initial Treatment Period|Lost to Follow-up|3|||
163968863|NCT01704287|592259679|FG002|Initial Treatment Period|Lost to Follow-up|0|||
163968864|NCT01704287|592259680|FG003|Initial Treatment Period|Lost to Follow-up|0|||
163968865|NCT01704287|592259681|FG004|Initial Treatment Period|Lost to Follow-up|0|||
163968866|NCT01704287|592259677|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
163968867|NCT01704287|592259678|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
163968868|NCT01704287|592259679|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
163968869|NCT01704287|592259680|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
163968870|NCT01704287|592259681|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
163968871|NCT01704287|592259677|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
163968872|NCT01704287|592259678|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
163968873|NCT01704287|592259679|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
163968874|NCT01704287|592259680|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
163968875|NCT01704287|592259681|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
163968876|NCT01704287|592259677|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
163968877|NCT01704287|592259678|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
163968878|NCT01704287|592259679|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
163968879|NCT01704287|592259680|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
163968880|NCT01704287|592259681|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
163968881|NCT01704287|592259677|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163968882|NCT01704287|592259678|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163968883|NCT01704287|592259679|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163968884|NCT01704287|592259680|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
163968885|NCT01704287|592259681|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
163968886|NCT01717287|592259682|FG000|Overall Study|Lost to Follow-up|0|||
163968887|NCT01717287|592259683|FG001|Overall Study|Lost to Follow-up|2|||
163968888|NCT01717287|592259682|FG000|Overall Study|Protocol Violation|0|||
163968889|NCT01717287|592259683|FG001|Overall Study|Protocol Violation|1|||
164310110|NCT02722304|593509586|FG001|Overall Study|Study Terminated by Sponsor|0|||
163968890|NCT04490395|592259687|FG000|Overall Study|Lost to Follow-up|0|||
163864288|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163864289|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
163864290|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163864291|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
163864292|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
163864293|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163864294|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163864295|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163864296|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
163864297|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
163864298|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
163864299|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163864300|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
163864301|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
163864302|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163864303|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163864304|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163864305|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163864306|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
163864307|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
163864308|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
163864309|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
163864310|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
163864311|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
163864312|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
163864313|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
163864314|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
163864315|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
163864316|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
163864317|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864318|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864319|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864320|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864321|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864322|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864323|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864324|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
163864325|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
163864326|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163864327|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
163864328|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
164201313|NCT02065557|593110699|FG002|Maintenance Period|Lack of Efficacy|0|||
164201314|NCT02065557|593110700|FG003|Maintenance Period|Lack of Efficacy|0|||
164201315|NCT02065557|593110701|FG004|Maintenance Period|Lack of Efficacy|5|||
164201316|NCT02065557|593110702|FG005|Maintenance Period|Lack of Efficacy|2|||
164201317|NCT02065557|593110697|FG000|Maintenance Period|Subject Non-Compliance|0|||
164201318|NCT02065557|593110698|FG001|Maintenance Period|Subject Non-Compliance|0|||
164201319|NCT02065557|593110699|FG002|Maintenance Period|Subject Non-Compliance|0|||
164201320|NCT02065557|593110700|FG003|Maintenance Period|Subject Non-Compliance|0|||
164201321|NCT02065557|593110701|FG004|Maintenance Period|Subject Non-Compliance|0|||
164201322|NCT02065557|593110702|FG005|Maintenance Period|Subject Non-Compliance|1|||
164201323|NCT00250588|593110703|FG000|Overall Study|Withdrawal by Subject|3|||
164201324|NCT00250588|593110704|FG001|Overall Study|Withdrawal by Subject|6|||
164201325|NCT00250588|593110705|FG002|Overall Study|Withdrawal by Subject|0|||
164201326|NCT00250588|593110703|FG000|Overall Study|Lost to Follow-up|6|||
164201327|NCT00250588|593110704|FG001|Overall Study|Lost to Follow-up|13|||
164201328|NCT00250588|593110705|FG002|Overall Study|Lost to Follow-up|13|||
164201329|NCT02737722|593110706|FG000|Overall Study|Physician Decision|0|||
164201330|NCT02737722|593110707|FG001|Overall Study|Physician Decision|0|||
164201331|NCT02737722|593110708|FG002|Overall Study|Physician Decision|1|||
164201332|NCT02737722|593110709|FG003|Overall Study|Physician Decision|0|||
164201333|NCT01026493|593110712|FG000|Overall Study|Protocol Violation|0|||
164201334|NCT01026493|593110713|FG001|Overall Study|Protocol Violation|1|||
164201335|NCT01026493|593110714|FG002|Overall Study|Protocol Violation|0|||
163864329|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163864330|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163864331|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163968891|NCT04490395|592259688|FG001|Overall Study|Lost to Follow-up|1|||
163968892|NCT02285920|592259696|FG000|Overall Study|Kidney transplantation|2|||
164201336|NCT01026493|593110715|FG003|Overall Study|Protocol Violation|0|||
164201337|NCT01026493|593110716|FG004|Overall Study|Protocol Violation|2|||
164201338|NCT01026493|593110717|FG005|Overall Study|Protocol Violation|3|||
163968893|NCT02285920|592259697|FG001|Overall Study|Kidney transplantation|2|||
163968894|NCT02285920|592259698|FG002|Overall Study|Kidney transplantation|2|||
163968895|NCT02285920|592259699|FG003|Overall Study|Kidney transplantation|0|||
163968896|NCT02285920|592259696|FG000|Overall Study|Change to peritoneal dialysis|0|||
163968897|NCT02285920|592259697|FG001|Overall Study|Change to peritoneal dialysis|0|||
163968898|NCT02285920|592259698|FG002|Overall Study|Change to peritoneal dialysis|1|||
163968899|NCT02285920|592259699|FG003|Overall Study|Change to peritoneal dialysis|0|||
163968900|NCT02285920|592259696|FG000|Overall Study|Transfer to non-participating unit|0|||
163968901|NCT02285920|592259697|FG001|Overall Study|Transfer to non-participating unit|1|||
163968902|NCT02285920|592259698|FG002|Overall Study|Transfer to non-participating unit|0|||
163968903|NCT02285920|592259699|FG003|Overall Study|Transfer to non-participating unit|0|||
163968904|NCT02285920|592259696|FG000|Overall Study|Dialysis discontinuation|0|||
163968905|NCT02285920|592259697|FG001|Overall Study|Dialysis discontinuation|1|||
163968906|NCT02285920|592259698|FG002|Overall Study|Dialysis discontinuation|0|||
163968907|NCT02285920|592259699|FG003|Overall Study|Dialysis discontinuation|0|||
163968908|NCT02285920|592259696|FG000|Overall Study|Death|2|||
163968909|NCT02285920|592259697|FG001|Overall Study|Death|0|||
163968910|NCT02285920|592259698|FG002|Overall Study|Death|2|||
163968911|NCT02285920|592259699|FG003|Overall Study|Death|1|||
163968912|NCT02357134|592259701|FG000|Overall Study|Lost to Follow-up|1|||
163968913|NCT02357134|592259702|FG001|Overall Study|Lost to Follow-up|0|||
163968914|NCT02357134|592259703|FG002|Overall Study|Lost to Follow-up|0|||
163968915|NCT02357134|592259704|FG003|Overall Study|Lost to Follow-up|0|||
163968916|NCT01179672|592259711|FG000|Overall Study|Adverse Event|17|||
163968917|NCT01179672|592259712|FG001|Overall Study|Adverse Event|8|||
163968918|NCT01179672|592259711|FG000|Overall Study|Withdrawal by Subject|10|||
163968919|NCT01179672|592259712|FG001|Overall Study|Withdrawal by Subject|12|||
163968920|NCT01179672|592259711|FG000|Overall Study|Entry Criteria Not Met|0|||
163968921|NCT01179672|592259712|FG001|Overall Study|Entry Criteria Not Met|2|||
163968922|NCT01179672|592259711|FG000|Overall Study|Lost to Follow-up|0|||
163968923|NCT01179672|592259712|FG001|Overall Study|Lost to Follow-up|1|||
163968924|NCT01179672|592259711|FG000|Overall Study|Protocol Violation|2|||
163968925|NCT01179672|592259712|FG001|Overall Study|Protocol Violation|2|||
163968926|NCT01179672|592259711|FG000|Overall Study|Physician Decision|1|||
163968927|NCT01179672|592259712|FG001|Overall Study|Physician Decision|1|||
163968928|NCT01994382|592259713|FG000|Overall Study|Informed consent withdrawn|0|||
163968929|NCT01994382|592259714|FG001|Overall Study|Informed consent withdrawn|0|||
163968930|NCT01994382|592259715|FG002|Overall Study|Informed consent withdrawn|0|||
163968931|NCT01994382|592259716|FG003|Overall Study|Informed consent withdrawn|0|||
163968932|NCT01994382|592259717|FG004|Overall Study|Informed consent withdrawn|0|||
163968933|NCT01994382|592259718|FG005|Overall Study|Informed consent withdrawn|0|||
163968934|NCT01994382|592259719|FG006|Overall Study|Informed consent withdrawn|1|||
163968935|NCT01994382|592259720|FG007|Overall Study|Informed consent withdrawn|0|||
163968936|NCT01994382|592259721|FG008|Overall Study|Informed consent withdrawn|0|||
163968937|NCT01994382|592259722|FG009|Overall Study|Informed consent withdrawn|0|||
163968938|NCT01994382|592259723|FG010|Overall Study|Informed consent withdrawn|0|||
163968939|NCT01994382|592259724|FG011|Overall Study|Informed consent withdrawn|0|||
163968940|NCT01994382|592259725|FG012|Overall Study|Informed consent withdrawn|0|||
163968941|NCT01994382|592259726|FG013|Overall Study|Informed consent withdrawn|0|||
163968942|NCT01994382|592259727|FG014|Overall Study|Informed consent withdrawn|0|||
163968943|NCT01994382|592259728|FG015|Overall Study|Informed consent withdrawn|0|||
163968944|NCT01994382|592259729|FG016|Overall Study|Informed consent withdrawn|0|||
163968945|NCT01994382|592259713|FG000|Overall Study|Progressive disease|3|||
163968946|NCT01994382|592259714|FG001|Overall Study|Progressive disease|4|||
163968947|NCT01994382|592259715|FG002|Overall Study|Progressive disease|4|||
163968948|NCT01994382|592259716|FG003|Overall Study|Progressive disease|3|||
163968949|NCT01994382|592259717|FG004|Overall Study|Progressive disease|2|||
163968950|NCT01994382|592259718|FG005|Overall Study|Progressive disease|3|||
163968951|NCT01994382|592259719|FG006|Overall Study|Progressive disease|3|||
163968952|NCT01994382|592259720|FG007|Overall Study|Progressive disease|6|||
163968953|NCT01994382|592259721|FG008|Overall Study|Progressive disease|2|||
163968954|NCT01994382|592259722|FG009|Overall Study|Progressive disease|2|||
163968955|NCT01994382|592259723|FG010|Overall Study|Progressive disease|13|||
163968956|NCT01994382|592259724|FG011|Overall Study|Progressive disease|8|||
163968957|NCT01994382|592259725|FG012|Overall Study|Progressive disease|7|||
163968958|NCT01994382|592259726|FG013|Overall Study|Progressive disease|3|||
164310111|NCT02722304|593509587|FG002|Overall Study|Study Terminated by Sponsor|2|||
163968959|NCT01994382|592259727|FG014|Overall Study|Progressive disease|6|||
163968960|NCT01994382|592259728|FG015|Overall Study|Progressive disease|44|||
163968961|NCT01994382|592259729|FG016|Overall Study|Progressive disease|28|||
163968962|NCT01994382|592259713|FG000|Overall Study|Physician Decision|0|||
163968963|NCT01994382|592259714|FG001|Overall Study|Physician Decision|1|||
163968964|NCT01994382|592259715|FG002|Overall Study|Physician Decision|0|||
163968965|NCT01994382|592259716|FG003|Overall Study|Physician Decision|0|||
163968966|NCT01994382|592259717|FG004|Overall Study|Physician Decision|0|||
163968967|NCT01994382|592259718|FG005|Overall Study|Physician Decision|0|||
163968968|NCT01994382|592259719|FG006|Overall Study|Physician Decision|0|||
163968969|NCT01994382|592259720|FG007|Overall Study|Physician Decision|0|||
163968970|NCT01994382|592259721|FG008|Overall Study|Physician Decision|0|||
163968971|NCT01994382|592259722|FG009|Overall Study|Physician Decision|0|||
163968972|NCT01994382|592259723|FG010|Overall Study|Physician Decision|3|||
163968973|NCT01994382|592259724|FG011|Overall Study|Physician Decision|1|||
163968974|NCT01994382|592259725|FG012|Overall Study|Physician Decision|1|||
163968975|NCT01994382|592259726|FG013|Overall Study|Physician Decision|0|||
163968976|NCT01994382|592259727|FG014|Overall Study|Physician Decision|1|||
163968977|NCT01994382|592259728|FG015|Overall Study|Physician Decision|4|||
163968978|NCT01994382|592259729|FG016|Overall Study|Physician Decision|2|||
163968979|NCT01994382|592259713|FG000|Overall Study|Death|0|||
163968980|NCT01994382|592259714|FG001|Overall Study|Death|0|||
163968981|NCT01994382|592259715|FG002|Overall Study|Death|0|||
163968982|NCT01994382|592259716|FG003|Overall Study|Death|0|||
163968983|NCT01994382|592259717|FG004|Overall Study|Death|1|||
163968984|NCT01994382|592259718|FG005|Overall Study|Death|0|||
163968985|NCT01994382|592259719|FG006|Overall Study|Death|0|||
163968986|NCT01994382|592259720|FG007|Overall Study|Death|0|||
163968987|NCT01994382|592259721|FG008|Overall Study|Death|1|||
163968988|NCT01994382|592259722|FG009|Overall Study|Death|1|||
163968989|NCT01994382|592259723|FG010|Overall Study|Death|0|||
163968990|NCT01994382|592259724|FG011|Overall Study|Death|0|||
163968991|NCT01994382|592259725|FG012|Overall Study|Death|0|||
163968992|NCT01994382|592259726|FG013|Overall Study|Death|0|||
163968993|NCT01994382|592259727|FG014|Overall Study|Death|0|||
163968994|NCT01994382|592259728|FG015|Overall Study|Death|1|||
163968995|NCT01994382|592259729|FG016|Overall Study|Death|0|||
163968996|NCT01994382|592259713|FG000|Overall Study|Adverse Event|0|||
163968997|NCT01994382|592259714|FG001|Overall Study|Adverse Event|1|||
163968998|NCT01994382|592259715|FG002|Overall Study|Adverse Event|2|||
163968999|NCT01994382|592259716|FG003|Overall Study|Adverse Event|0|||
163969000|NCT01994382|592259717|FG004|Overall Study|Adverse Event|0|||
163969001|NCT01994382|592259718|FG005|Overall Study|Adverse Event|0|||
163969002|NCT01994382|592259719|FG006|Overall Study|Adverse Event|0|||
163969003|NCT01994382|592259720|FG007|Overall Study|Adverse Event|0|||
163969004|NCT01994382|592259721|FG008|Overall Study|Adverse Event|0|||
163969005|NCT01994382|592259722|FG009|Overall Study|Adverse Event|0|||
163969006|NCT01994382|592259723|FG010|Overall Study|Adverse Event|15|||
163969007|NCT01994382|592259724|FG011|Overall Study|Adverse Event|2|||
163969008|NCT01994382|592259725|FG012|Overall Study|Adverse Event|7|||
163969009|NCT01994382|592259726|FG013|Overall Study|Adverse Event|3|||
163969010|NCT01994382|592259727|FG014|Overall Study|Adverse Event|17|||
163969011|NCT01994382|592259728|FG015|Overall Study|Adverse Event|6|||
163969012|NCT01994382|592259729|FG016|Overall Study|Adverse Event|3|||
163969013|NCT01994382|592259713|FG000|Overall Study|Other than specified|0|||
163969014|NCT01994382|592259714|FG001|Overall Study|Other than specified|0|||
163969015|NCT01994382|592259715|FG002|Overall Study|Other than specified|0|||
163969016|NCT01994382|592259716|FG003|Overall Study|Other than specified|0|||
163969017|NCT01994382|592259717|FG004|Overall Study|Other than specified|0|||
163969018|NCT01994382|592259718|FG005|Overall Study|Other than specified|0|||
163969019|NCT01994382|592259719|FG006|Overall Study|Other than specified|0|||
163969020|NCT01994382|592259720|FG007|Overall Study|Other than specified|0|||
163969021|NCT01994382|592259721|FG008|Overall Study|Other than specified|0|||
163969022|NCT01994382|592259722|FG009|Overall Study|Other than specified|0|||
163969023|NCT01994382|592259723|FG010|Overall Study|Other than specified|2|||
163969024|NCT01994382|592259724|FG011|Overall Study|Other than specified|0|||
163969025|NCT01994382|592259725|FG012|Overall Study|Other than specified|2|||
163969026|NCT01994382|592259726|FG013|Overall Study|Other than specified|0|||
163969027|NCT01994382|592259727|FG014|Overall Study|Other than specified|0|||
163969028|NCT01994382|592259728|FG015|Overall Study|Other than specified|4|||
163969029|NCT01994382|592259729|FG016|Overall Study|Other than specified|4|||
163969030|NCT01994382|592259713|FG000|Overall Study|Withdrawal by Subject|0|||
163969031|NCT01994382|592259714|FG001|Overall Study|Withdrawal by Subject|0|||
163969032|NCT01994382|592259715|FG002|Overall Study|Withdrawal by Subject|0|||
163969033|NCT01994382|592259716|FG003|Overall Study|Withdrawal by Subject|0|||
163969034|NCT01994382|592259717|FG004|Overall Study|Withdrawal by Subject|0|||
163969035|NCT01994382|592259718|FG005|Overall Study|Withdrawal by Subject|0|||
163969036|NCT01994382|592259719|FG006|Overall Study|Withdrawal by Subject|0|||
163969037|NCT01994382|592259720|FG007|Overall Study|Withdrawal by Subject|0|||
163969038|NCT01994382|592259721|FG008|Overall Study|Withdrawal by Subject|0|||
163969039|NCT01994382|592259722|FG009|Overall Study|Withdrawal by Subject|0|||
163969040|NCT01994382|592259723|FG010|Overall Study|Withdrawal by Subject|6|||
163969041|NCT01994382|592259724|FG011|Overall Study|Withdrawal by Subject|0|||
163969042|NCT01994382|592259725|FG012|Overall Study|Withdrawal by Subject|2|||
163969043|NCT01994382|592259726|FG013|Overall Study|Withdrawal by Subject|0|||
163969044|NCT01994382|592259727|FG014|Overall Study|Withdrawal by Subject|4|||
163969045|NCT01994382|592259728|FG015|Overall Study|Withdrawal by Subject|3|||
163969046|NCT01994382|592259729|FG016|Overall Study|Withdrawal by Subject|0|||
163969047|NCT01994382|592259713|FG000|Overall Study|Lost to Follow-up|0|||
163969048|NCT01994382|592259714|FG001|Overall Study|Lost to Follow-up|0|||
163969049|NCT01994382|592259715|FG002|Overall Study|Lost to Follow-up|0|||
163969050|NCT01994382|592259716|FG003|Overall Study|Lost to Follow-up|0|||
163969051|NCT01994382|592259717|FG004|Overall Study|Lost to Follow-up|0|||
163969052|NCT01994382|592259718|FG005|Overall Study|Lost to Follow-up|0|||
163969053|NCT01994382|592259719|FG006|Overall Study|Lost to Follow-up|0|||
163969054|NCT01994382|592259720|FG007|Overall Study|Lost to Follow-up|0|||
163969055|NCT01994382|592259721|FG008|Overall Study|Lost to Follow-up|0|||
163969056|NCT01994382|592259722|FG009|Overall Study|Lost to Follow-up|0|||
163969057|NCT01994382|592259723|FG010|Overall Study|Lost to Follow-up|1|||
163969058|NCT01994382|592259724|FG011|Overall Study|Lost to Follow-up|0|||
163969059|NCT01994382|592259725|FG012|Overall Study|Lost to Follow-up|0|||
163969060|NCT01994382|592259726|FG013|Overall Study|Lost to Follow-up|0|||
163969061|NCT01994382|592259727|FG014|Overall Study|Lost to Follow-up|0|||
163969062|NCT01994382|592259728|FG015|Overall Study|Lost to Follow-up|0|||
163969063|NCT01994382|592259729|FG016|Overall Study|Lost to Follow-up|0|||
163969064|NCT01994382|592259713|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969065|NCT01994382|592259714|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969066|NCT01994382|592259715|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969067|NCT01994382|592259716|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969068|NCT01994382|592259717|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969069|NCT01994382|592259718|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969070|NCT01994382|592259719|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969071|NCT01994382|592259720|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969072|NCT01994382|592259721|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969073|NCT01994382|592259722|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969074|NCT01994382|592259723|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
163969075|NCT01994382|592259724|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969076|NCT01994382|592259725|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
163969077|NCT01994382|592259726|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969078|NCT01994382|592259727|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
163969079|NCT01994382|592259728|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
163969080|NCT01994382|592259729|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
163969081|NCT01994382|592259713|FG000|Overall Study|Protocol violation/noncompliance|0|||
164201339|NCT01026493|593110718|FG006|Overall Study|Protocol Violation|4|||
164201340|NCT01026493|593110719|FG007|Overall Study|Protocol Violation|1|||
164201341|NCT02662569|593110721|FG000|Overall Study|Withdrawal by Subject|6|||
163864332|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163864333|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163864334|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163864335|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163864336|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
163864337|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
163864338|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163864339|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163864340|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163864341|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163864342|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
163864343|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
163864344|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163864345|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
163864346|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
163864347|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163864348|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163864349|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163864350|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
163864351|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
163864352|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
163864353|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864354|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
163864355|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864356|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864357|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864358|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864359|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864360|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864361|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
163864362|NCT01212757|591867694|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864363|NCT01212757|591867695|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
163864364|NCT01212757|591867696|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
163864365|NCT01212757|591867697|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864366|NCT01212757|591867698|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864367|NCT01212757|591867699|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864368|NCT01212757|591867700|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864369|NCT01212757|591867701|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864370|NCT01212757|591867702|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
163864371|NCT03284957|591870237|FG000|Overall Study|Adverse Event|0|||
163864372|NCT03284957|591870238|FG001|Overall Study|Adverse Event|0|||
163864373|NCT03284957|591870239|FG002|Overall Study|Adverse Event|0|||
163864374|NCT03284957|591870240|FG003|Overall Study|Adverse Event|0|||
163864375|NCT03284957|591870241|FG004|Overall Study|Adverse Event|0|||
163864376|NCT03284957|591870242|FG005|Overall Study|Adverse Event|1|||
163864377|NCT03284957|591870243|FG006|Overall Study|Adverse Event|1|||
163864378|NCT03284957|591870244|FG007|Overall Study|Adverse Event|1|||
163864379|NCT03284957|591870245|FG008|Overall Study|Adverse Event|0|||
163864380|NCT03284957|591870246|FG009|Overall Study|Adverse Event|4|||
163864381|NCT03284957|591870247|FG010|Overall Study|Adverse Event|1|||
163864382|NCT03284957|591870248|FG011|Overall Study|Adverse Event|1|||
163864383|NCT03284957|591870249|FG012|Overall Study|Adverse Event|0|||
163864384|NCT03284957|591870250|FG013|Overall Study|Adverse Event|0|||
163864385|NCT03284957|591870251|FG014|Overall Study|Adverse Event|0|||
163864386|NCT03284957|591870252|FG015|Overall Study|Adverse Event|0|||
163864387|NCT03284957|591870237|FG000|Overall Study|Progressive Disease|3|||
163864388|NCT03284957|591870238|FG001|Overall Study|Progressive Disease|3|||
163864389|NCT03284957|591870239|FG002|Overall Study|Progressive Disease|4|||
163864390|NCT03284957|591870240|FG003|Overall Study|Progressive Disease|3|||
163864391|NCT03284957|591870241|FG004|Overall Study|Progressive Disease|3|||
163864392|NCT03284957|591870242|FG005|Overall Study|Progressive Disease|5|||
163864393|NCT03284957|591870243|FG006|Overall Study|Progressive Disease|45|||
163864394|NCT03284957|591870244|FG007|Overall Study|Progressive Disease|8|||
163864395|NCT03284957|591870245|FG008|Overall Study|Progressive Disease|5|||
163864396|NCT03284957|591870246|FG009|Overall Study|Progressive Disease|18|||
163864397|NCT03284957|591870247|FG010|Overall Study|Progressive Disease|7|||
163864398|NCT03284957|591870248|FG011|Overall Study|Progressive Disease|2|||
163864399|NCT03284957|591870249|FG012|Overall Study|Progressive Disease|3|||
163864400|NCT03284957|591870250|FG013|Overall Study|Progressive Disease|1|||
163864401|NCT03284957|591870251|FG014|Overall Study|Progressive Disease|1|||
163864402|NCT03284957|591870252|FG015|Overall Study|Progressive Disease|2|||
163864403|NCT03284957|591870237|FG000|Overall Study|Withdrawal by Subject|0|||
163864404|NCT03284957|591870238|FG001|Overall Study|Withdrawal by Subject|0|||
163864405|NCT03284957|591870239|FG002|Overall Study|Withdrawal by Subject|0|||
163864406|NCT03284957|591870240|FG003|Overall Study|Withdrawal by Subject|0|||
163864407|NCT03284957|591870241|FG004|Overall Study|Withdrawal by Subject|0|||
163864408|NCT03284957|591870242|FG005|Overall Study|Withdrawal by Subject|0|||
163864409|NCT03284957|591870243|FG006|Overall Study|Withdrawal by Subject|0|||
163864410|NCT03284957|591870244|FG007|Overall Study|Withdrawal by Subject|0|||
163864411|NCT03284957|591870245|FG008|Overall Study|Withdrawal by Subject|0|||
163864412|NCT03284957|591870246|FG009|Overall Study|Withdrawal by Subject|2|||
163864413|NCT03284957|591870247|FG010|Overall Study|Withdrawal by Subject|0|||
163864414|NCT03284957|591870248|FG011|Overall Study|Withdrawal by Subject|0|||
163864415|NCT03284957|591870249|FG012|Overall Study|Withdrawal by Subject|0|||
163864416|NCT03284957|591870250|FG013|Overall Study|Withdrawal by Subject|0|||
163864417|NCT03284957|591870251|FG014|Overall Study|Withdrawal by Subject|0|||
163864418|NCT03284957|591870252|FG015|Overall Study|Withdrawal by Subject|0|||
163864419|NCT03284957|591870237|FG000|Overall Study|Other|0|||
163864420|NCT03284957|591870238|FG001|Overall Study|Other|0|||
163864421|NCT03284957|591870239|FG002|Overall Study|Other|0|||
163864422|NCT03284957|591870240|FG003|Overall Study|Other|0|||
163864423|NCT03284957|591870241|FG004|Overall Study|Other|0|||
163864424|NCT03284957|591870242|FG005|Overall Study|Other|0|||
163864425|NCT03284957|591870243|FG006|Overall Study|Other|3|||
163864426|NCT03284957|591870244|FG007|Overall Study|Other|0|||
163864427|NCT03284957|591870245|FG008|Overall Study|Other|1|||
163864428|NCT03284957|591870246|FG009|Overall Study|Other|6|||
163864429|NCT03284957|591870247|FG010|Overall Study|Other|0|||
163864430|NCT03284957|591870248|FG011|Overall Study|Other|0|||
163864431|NCT03284957|591870249|FG012|Overall Study|Other|0|||
163864432|NCT03284957|591870250|FG013|Overall Study|Other|0|||
163864433|NCT03284957|591870251|FG014|Overall Study|Other|2|||
163864434|NCT03284957|591870252|FG015|Overall Study|Other|0|||
163864435|NCT01049503|591870255|FG000|Overall Study|Lost to Follow-up|11|||
163864436|NCT01049503|591870256|FG001|Overall Study|Lost to Follow-up|12|||
163864437|NCT01049503|591870257|FG002|Overall Study|Lost to Follow-up|24|||
163864438|NCT01049503|591870258|FG003|Overall Study|Lost to Follow-up|26|||
163864439|NCT01049503|591870259|FG004|Overall Study|Lost to Follow-up|27|||
163864440|NCT01049503|591870260|FG005|Overall Study|Lost to Follow-up|8|||
163864441|NCT00487578|591870266|FG000|Overall Study|Adverse Event|1|||
163864442|NCT00487578|591870267|FG001|Overall Study|Adverse Event|2|||
163969082|NCT01994382|592259714|FG001|Overall Study|Protocol violation/noncompliance|0|||
163969083|NCT01994382|592259715|FG002|Overall Study|Protocol violation/noncompliance|0|||
163969084|NCT01994382|592259716|FG003|Overall Study|Protocol violation/noncompliance|0|||
163969085|NCT01994382|592259717|FG004|Overall Study|Protocol violation/noncompliance|0|||
163969086|NCT01994382|592259718|FG005|Overall Study|Protocol violation/noncompliance|0|||
163969087|NCT01994382|592259719|FG006|Overall Study|Protocol violation/noncompliance|0|||
163969088|NCT01994382|592259720|FG007|Overall Study|Protocol violation/noncompliance|0|||
163969089|NCT01994382|592259721|FG008|Overall Study|Protocol violation/noncompliance|0|||
163969090|NCT01994382|592259722|FG009|Overall Study|Protocol violation/noncompliance|0|||
163969091|NCT01994382|592259723|FG010|Overall Study|Protocol violation/noncompliance|0|||
163969092|NCT01994382|592259724|FG011|Overall Study|Protocol violation/noncompliance|1|||
163969093|NCT01994382|592259725|FG012|Overall Study|Protocol violation/noncompliance|0|||
163969094|NCT01994382|592259726|FG013|Overall Study|Protocol violation/noncompliance|0|||
163969095|NCT01994382|592259727|FG014|Overall Study|Protocol violation/noncompliance|0|||
163969096|NCT01994382|592259728|FG015|Overall Study|Protocol violation/noncompliance|0|||
163969097|NCT01994382|592259729|FG016|Overall Study|Protocol violation/noncompliance|2|||
163969098|NCT01994382|592259713|FG000|Overall Study|Rolled over to Phase 2a|0|||
163969099|NCT01994382|592259714|FG001|Overall Study|Rolled over to Phase 2a|0|||
163969100|NCT01994382|592259715|FG002|Overall Study|Rolled over to Phase 2a|1|||
163969101|NCT01994382|592259716|FG003|Overall Study|Rolled over to Phase 2a|0|||
163969102|NCT01994382|592259717|FG004|Overall Study|Rolled over to Phase 2a|0|||
163969103|NCT01994382|592259718|FG005|Overall Study|Rolled over to Phase 2a|0|||
163969104|NCT01994382|592259719|FG006|Overall Study|Rolled over to Phase 2a|0|||
163969105|NCT01994382|592259720|FG007|Overall Study|Rolled over to Phase 2a|0|||
163864443|NCT00487578|591870266|FG000|Overall Study|Lack of Efficacy|0|||
163864444|NCT00487578|591870267|FG001|Overall Study|Lack of Efficacy|1|||
163864445|NCT00487578|591870266|FG000|Overall Study|Lost to Follow-up|0|||
163864446|NCT00487578|591870267|FG001|Overall Study|Lost to Follow-up|1|||
163864447|NCT00726999|591870270|FG000|Overall Study|Physician Decision|0|||
163864448|NCT00726999|591870271|FG001|Overall Study|Physician Decision|1|||
163864449|NCT00726999|591870270|FG000|Overall Study|Withdrawal by Subject|2|||
163864450|NCT00726999|591870271|FG001|Overall Study|Withdrawal by Subject|0|||
163864451|NCT00726999|591870270|FG000|Overall Study|Protocol Violation|1|||
163864452|NCT00726999|591870271|FG001|Overall Study|Protocol Violation|0|||
163864453|NCT00955825|591870272|FG000|Overall Study|Adverse Event|15|||
163864454|NCT00955825|591870273|FG001|Overall Study|Adverse Event|2|||
163864455|NCT00955825|591870272|FG000|Overall Study|Withdrawal by Subject|4|||
163864456|NCT00955825|591870273|FG001|Overall Study|Withdrawal by Subject|6|||
163864457|NCT00955825|591870272|FG000|Overall Study|Any other reason not above-mentioned|7|||
163864458|NCT00955825|591870273|FG001|Overall Study|Any other reason not above-mentioned|9|||
163864459|NCT00708032|591870274|FG000|Overall Study|Adverse Event|0|||
163864460|NCT00708032|591870275|FG001|Overall Study|Adverse Event|2|||
163864461|NCT00708032|591870274|FG000|Overall Study|Lost to Follow-up|1|||
163864462|NCT00708032|591870275|FG001|Overall Study|Lost to Follow-up|2|||
163864463|NCT00708032|591870274|FG000|Overall Study|Pregnancy|0|||
163864464|NCT00708032|591870275|FG001|Overall Study|Pregnancy|1|||
163864465|NCT00708032|591870274|FG000|Overall Study|Poor vision|0|||
163864466|NCT00708032|591870275|FG001|Overall Study|Poor vision|6|||
163864467|NCT00708032|591870274|FG000|Overall Study|Visit out of range at month 12|4|||
163864468|NCT00708032|591870275|FG001|Overall Study|Visit out of range at month 12|1|||
163864469|NCT00708032|591870274|FG000|Overall Study|Did not meet protocol criteria|1|||
163864470|NCT00708032|591870275|FG001|Overall Study|Did not meet protocol criteria|2|||
163864471|NCT00708032|591870274|FG000|Overall Study|Protocol Violation|4|||
163864472|NCT00708032|591870275|FG001|Overall Study|Protocol Violation|1|||
163864473|NCT00708032|591870274|FG000|Overall Study|Withdrawal by Subject|0|||
163864474|NCT00708032|591870275|FG001|Overall Study|Withdrawal by Subject|1|||
163864475|NCT00150176|591870276|FG000|Overall Study|Adverse Event|16|||
163864476|NCT00150176|591870277|FG001|Overall Study|Adverse Event|53|||
163864477|NCT00150176|591870276|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
163864478|NCT00150176|591870277|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
163864479|NCT00150176|591870276|FG000|Overall Study|Withdrawal by Subject|19|||
163864480|NCT00150176|591870277|FG001|Overall Study|Withdrawal by Subject|12|||
163864481|NCT00150176|591870276|FG000|Overall Study|Lost to Follow-up|3|||
163969106|NCT01994382|592259721|FG008|Overall Study|Rolled over to Phase 2a|0|||
163969107|NCT01994382|592259722|FG009|Overall Study|Rolled over to Phase 2a|2|||
163969108|NCT01994382|592259723|FG010|Overall Study|Rolled over to Phase 2a|0|||
163969109|NCT01994382|592259724|FG011|Overall Study|Rolled over to Phase 2a|0|||
164310112|NCT02722304|593509588|FG003|Overall Study|Study Terminated by Sponsor|1|||
164310113|NCT02722304|593509589|FG004|Overall Study|Study Terminated by Sponsor|1|||
163864482|NCT00150176|591870277|FG001|Overall Study|Lost to Follow-up|3|||
163864483|NCT00150176|591870276|FG000|Overall Study|OTHER|11|||
163864484|NCT00150176|591870277|FG001|Overall Study|OTHER|13|||
163864485|NCT02937831|591870285|FG000|Overall Study|Protocol Violation|4|||
163864486|NCT01759264|591870286|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
163864487|NCT01759264|591870286|FG000|Overall Study|Adverse Event|1|||
163864488|NCT01759264|591870286|FG000|Overall Study|Other|2|||
163969110|NCT01994382|592259725|FG012|Overall Study|Rolled over to Phase 2a|0|||
163969111|NCT01994382|592259726|FG013|Overall Study|Rolled over to Phase 2a|0|||
163969112|NCT01994382|592259727|FG014|Overall Study|Rolled over to Phase 2a|0|||
163969113|NCT01994382|592259728|FG015|Overall Study|Rolled over to Phase 2a|0|||
163969114|NCT01994382|592259729|FG016|Overall Study|Rolled over to Phase 2a|0|||
163969115|NCT04667377|592259730|FG000|Dose Escalation Period|Other not specified below|3|||
163969116|NCT04667377|592259731|FG001|Dose Escalation Period|Other not specified below|3|||
163969117|NCT04667377|592259732|FG002|Dose Escalation Period|Other not specified below|2|||
163969118|NCT04667377|592259733|FG003|Dose Escalation Period|Other not specified below|1|||
163969119|NCT04667377|592259734|FG004|Dose Escalation Period|Other not specified below|3|||
163969120|NCT04667377|592259730|FG000|Dose Escalation Period|Protocol Violation|2|||
163969121|NCT04667377|592259731|FG001|Dose Escalation Period|Protocol Violation|2|||
163969122|NCT04667377|592259732|FG002|Dose Escalation Period|Protocol Violation|0|||
163969123|NCT04667377|592259733|FG003|Dose Escalation Period|Protocol Violation|2|||
163969124|NCT04667377|592259734|FG004|Dose Escalation Period|Protocol Violation|1|||
163969125|NCT04667377|592259730|FG000|Dose Escalation Period|Burden of study procedures|2|||
163969126|NCT04667377|592259731|FG001|Dose Escalation Period|Burden of study procedures|1|||
163969127|NCT04667377|592259732|FG002|Dose Escalation Period|Burden of study procedures|1|||
163969128|NCT04667377|592259733|FG003|Dose Escalation Period|Burden of study procedures|1|||
163969129|NCT04667377|592259734|FG004|Dose Escalation Period|Burden of study procedures|5|||
163969130|NCT04667377|592259730|FG000|Dose Escalation Period|Change of residence|0|||
163969131|NCT04667377|592259731|FG001|Dose Escalation Period|Change of residence|0|||
163969132|NCT04667377|592259732|FG002|Dose Escalation Period|Change of residence|1|||
163969133|NCT04667377|592259733|FG003|Dose Escalation Period|Change of residence|0|||
163969134|NCT04667377|592259734|FG004|Dose Escalation Period|Change of residence|0|||
163969135|NCT04667377|592259730|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
163969136|NCT04667377|592259731|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
163969137|NCT04667377|592259732|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
163969138|NCT04667377|592259733|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
163969139|NCT04667377|592259734|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
163969140|NCT04667377|592259730|FG000|Dose Escalation Period|Adverse Event|9|||
163969141|NCT04667377|592259731|FG001|Dose Escalation Period|Adverse Event|10|||
164201342|NCT02662569|593110722|FG001|Overall Study|Withdrawal by Subject|1|||
164201343|NCT02662569|593110723|FG002|Overall Study|Withdrawal by Subject|6|||
164201344|NCT02662569|593110724|FG003|Overall Study|Withdrawal by Subject|4|||
164201345|NCT02662569|593110721|FG000|Overall Study|Lost to Follow-up|1|||
164201346|NCT02662569|593110722|FG001|Overall Study|Lost to Follow-up|0|||
164201347|NCT02662569|593110723|FG002|Overall Study|Lost to Follow-up|0|||
164201348|NCT02662569|593110724|FG003|Overall Study|Lost to Follow-up|0|||
164201349|NCT03154086|593110727|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163969142|NCT04667377|592259732|FG002|Dose Escalation Period|Adverse Event|12|||
163969143|NCT04667377|592259733|FG003|Dose Escalation Period|Adverse Event|17|||
163969144|NCT04667377|592259734|FG004|Dose Escalation Period|Adverse Event|3|||
163969145|NCT04667377|592259730|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
163969146|NCT04667377|592259731|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
163969147|NCT04667377|592259732|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
163969148|NCT04667377|592259733|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
163969149|NCT04667377|592259734|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
163969150|NCT04667377|592259730|FG000|Dose Escalation Period|Not treated|1|||
163969151|NCT04667377|592259731|FG001|Dose Escalation Period|Not treated|0|||
163969152|NCT04667377|592259732|FG002|Dose Escalation Period|Not treated|0|||
163969153|NCT04667377|592259733|FG003|Dose Escalation Period|Not treated|0|||
163969154|NCT04667377|592259734|FG004|Dose Escalation Period|Not treated|0|||
164201350|NCT03154086|593110728|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201351|NCT03154086|593110729|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201352|NCT03154086|593110730|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
163969155|NCT04667377|592259730|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
163969156|NCT04667377|592259731|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
163969157|NCT04667377|592259732|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
163969158|NCT04667377|592259733|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
163969159|NCT04667377|592259734|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
163969160|NCT04667377|592259730|FG000|Dose Escalation Period|Lost to Follow-up|0|||
163969161|NCT04667377|592259731|FG001|Dose Escalation Period|Lost to Follow-up|1|||
164201353|NCT03154086|593110731|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201354|NCT03154086|593110732|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163969162|NCT04667377|592259732|FG002|Dose Escalation Period|Lost to Follow-up|0|||
163969163|NCT04667377|592259733|FG003|Dose Escalation Period|Lost to Follow-up|0|||
163969164|NCT04667377|592259734|FG004|Dose Escalation Period|Lost to Follow-up|0|||
163969165|NCT04667377|592259730|FG000|Maintenance Period|Perceived lack of efficacy|0|||
163969166|NCT04667377|592259731|FG001|Maintenance Period|Perceived lack of efficacy|2|||
164201355|NCT03154086|593110733|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
163969167|NCT04667377|592259732|FG002|Maintenance Period|Perceived lack of efficacy|1|||
163969168|NCT04667377|592259733|FG003|Maintenance Period|Perceived lack of efficacy|0|||
163969169|NCT04667377|592259734|FG004|Maintenance Period|Perceived lack of efficacy|1|||
163969170|NCT04667377|592259730|FG000|Maintenance Period|Adverse Event|2|||
163969171|NCT04667377|592259731|FG001|Maintenance Period|Adverse Event|8|||
163969172|NCT04667377|592259732|FG002|Maintenance Period|Adverse Event|5|||
163969173|NCT04667377|592259733|FG003|Maintenance Period|Adverse Event|4|||
163969174|NCT04667377|592259734|FG004|Maintenance Period|Adverse Event|1|||
163969175|NCT04667377|592259730|FG000|Maintenance Period|Adverse event: COVID infection|0|||
163969176|NCT04667377|592259731|FG001|Maintenance Period|Adverse event: COVID infection|1|||
163969177|NCT04667377|592259732|FG002|Maintenance Period|Adverse event: COVID infection|0|||
163969178|NCT04667377|592259733|FG003|Maintenance Period|Adverse event: COVID infection|0|||
163969179|NCT04667377|592259734|FG004|Maintenance Period|Adverse event: COVID infection|0|||
163969180|NCT04667377|592259730|FG000|Maintenance Period|COVID-related|0|||
163969181|NCT04667377|592259731|FG001|Maintenance Period|COVID-related|0|||
163969182|NCT04667377|592259732|FG002|Maintenance Period|COVID-related|1|||
163969183|NCT04667377|592259733|FG003|Maintenance Period|COVID-related|1|||
163969184|NCT04667377|592259734|FG004|Maintenance Period|COVID-related|0|||
163969185|NCT04667377|592259730|FG000|Maintenance Period|Protocol Violation|1|||
163969186|NCT04667377|592259731|FG001|Maintenance Period|Protocol Violation|0|||
163969187|NCT04667377|592259732|FG002|Maintenance Period|Protocol Violation|0|||
163969188|NCT04667377|592259733|FG003|Maintenance Period|Protocol Violation|0|||
163969189|NCT04667377|592259734|FG004|Maintenance Period|Protocol Violation|1|||
163969190|NCT04667377|592259730|FG000|Maintenance Period|Burden of study procedures|1|||
163969191|NCT04667377|592259731|FG001|Maintenance Period|Burden of study procedures|2|||
163969192|NCT04667377|592259732|FG002|Maintenance Period|Burden of study procedures|0|||
163969193|NCT04667377|592259733|FG003|Maintenance Period|Burden of study procedures|1|||
163969194|NCT04667377|592259734|FG004|Maintenance Period|Burden of study procedures|0|||
163969195|NCT04667377|592259730|FG000|Maintenance Period|Change of residence|0|||
163969196|NCT04667377|592259731|FG001|Maintenance Period|Change of residence|1|||
163969197|NCT04667377|592259732|FG002|Maintenance Period|Change of residence|0|||
163969198|NCT04667377|592259733|FG003|Maintenance Period|Change of residence|0|||
163969199|NCT04667377|592259734|FG004|Maintenance Period|Change of residence|1|||
163969200|NCT04667377|592259730|FG000|Maintenance Period|Missing|1|||
163969201|NCT04667377|592259731|FG001|Maintenance Period|Missing|0|||
163969202|NCT04667377|592259732|FG002|Maintenance Period|Missing|0|||
163969203|NCT04667377|592259733|FG003|Maintenance Period|Missing|0|||
164201356|NCT03154086|593110734|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201357|NCT03154086|593110735|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201358|NCT03154086|593110736|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201359|NCT03154086|593110737|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201360|NCT03154086|593110738|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201361|NCT03154086|593110739|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201362|NCT03154086|593110740|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201363|NCT03154086|593110741|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
164201364|NCT03154086|593110727|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201365|NCT03154086|593110728|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
164201366|NCT03154086|593110729|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201367|NCT03154086|593110730|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201368|NCT03154086|593110731|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201369|NCT03154086|593110732|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201370|NCT03154086|593110733|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201371|NCT03154086|593110734|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201372|NCT03154086|593110735|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201373|NCT03154086|593110736|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164302362|NCT03755934|593482604|FG002|Overall Study|Adverse Event|1|||
163969204|NCT04667377|592259734|FG004|Maintenance Period|Missing|0|||
163969205|NCT04667377|592259730|FG000|Maintenance Period|Other than listed above|2|||
163969206|NCT04667377|592259731|FG001|Maintenance Period|Other than listed above|0|||
163969207|NCT04667377|592259732|FG002|Maintenance Period|Other than listed above|3|||
163969208|NCT04667377|592259733|FG003|Maintenance Period|Other than listed above|2|||
163969209|NCT04667377|592259734|FG004|Maintenance Period|Other than listed above|6|||
163969210|NCT04667377|592259730|FG000|Maintenance Period|Withdrawal by Subject|0|||
163969211|NCT04667377|592259731|FG001|Maintenance Period|Withdrawal by Subject|1|||
163969212|NCT04667377|592259732|FG002|Maintenance Period|Withdrawal by Subject|0|||
163969213|NCT04667377|592259733|FG003|Maintenance Period|Withdrawal by Subject|0|||
163969214|NCT04667377|592259734|FG004|Maintenance Period|Withdrawal by Subject|0|||
163969215|NCT04667377|592259730|FG000|Maintenance Period|Lost to Follow-up|1|||
163969216|NCT04667377|592259731|FG001|Maintenance Period|Lost to Follow-up|0|||
163969217|NCT04667377|592259732|FG002|Maintenance Period|Lost to Follow-up|1|||
163969218|NCT04667377|592259733|FG003|Maintenance Period|Lost to Follow-up|0|||
163969219|NCT04667377|592259734|FG004|Maintenance Period|Lost to Follow-up|1|||
163969220|NCT02319668|592259735|FG000|Overall Study|Other (Not specified)|0|||
163969221|NCT02319668|592259736|FG001|Overall Study|Other (Not specified)|2|||
163969222|NCT01161043|592259737|FG000|Overall Study|Withdrawal by Subject|3|||
163969223|NCT02164929|592259738|FG000|Overall Study|Converted to open procedure|1|||
163969224|NCT02164929|592259739|FG001|Overall Study|Converted to open procedure|0|||
163969225|NCT02164929|592259740|FG002|Overall Study|Converted to open procedure|0|||
163969226|NCT02164929|592259741|FG003|Overall Study|Converted to open procedure|2|||
163969227|NCT02164929|592259738|FG000|Overall Study|Failed regional block|0|||
163969228|NCT02164929|592259739|FG001|Overall Study|Failed regional block|0|||
163969229|NCT02164929|592259740|FG002|Overall Study|Failed regional block|1|||
163969230|NCT02164929|592259741|FG003|Overall Study|Failed regional block|0|||
163969231|NCT00365456|592259745|FG000|Trial Period I (12 Months)|Adverse Event|84|||
163969232|NCT00365456|592259746|FG001|Trial Period I (12 Months)|Adverse Event|0|||
163969233|NCT00365456|592259745|FG000|Trial Period I (12 Months)|Non-compliance|3|||
163969234|NCT00365456|592259746|FG001|Trial Period I (12 Months)|Non-compliance|0|||
163969235|NCT00365456|592259745|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
163969236|NCT00365456|592259746|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
163969237|NCT00365456|592259745|FG000|Trial Period I (12 Months)|Other|11|||
163969238|NCT00365456|592259746|FG001|Trial Period I (12 Months)|Other|0|||
163969239|NCT00365456|592259745|FG000|Trial Period II (12 Months)|Adverse Event|0|||
163969240|NCT00365456|592259746|FG001|Trial Period II (12 Months)|Adverse Event|6|||
163969241|NCT00365456|592259745|FG000|Trial Period II (12 Months)|Non-compliance|0|||
163969242|NCT00365456|592259746|FG001|Trial Period II (12 Months)|Non-compliance|2|||
163969243|NCT00365456|592259745|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
163969244|NCT00365456|592259746|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
163969245|NCT00365456|592259745|FG000|Trial Period II (12 Months)|Other|0|||
163969246|NCT00365456|592259746|FG001|Trial Period II (12 Months)|Other|1|||
163969247|NCT00365456|592259745|FG000|Trial Period III (12 Months)|Adverse Event|13|||
163969248|NCT00365456|592259746|FG001|Trial Period III (12 Months)|Adverse Event|3|||
163969249|NCT00365456|592259745|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
163969250|NCT00365456|592259746|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
163969251|NCT00365456|592259745|FG000|Trial Period III (12 Months)|Other|1|||
163969252|NCT00365456|592259746|FG001|Trial Period III (12 Months)|Other|1|||
163969253|NCT04754802|592259748|FG000|Overall Study|Lost to Follow-up|0|||
163969254|NCT04754802|592259749|FG001|Overall Study|Lost to Follow-up|2|||
163969255|NCT04754802|592259748|FG000|Overall Study|Withdrawal by Subject|2|||
163969256|NCT04754802|592259749|FG001|Overall Study|Withdrawal by Subject|0|||
163969257|NCT00701090|592259752|FG000|Overall Study|Adverse Event|11|||
163969258|NCT00701090|592259753|FG001|Overall Study|Adverse Event|2|||
163969259|NCT00701090|592259752|FG000|Overall Study|Death|0|||
163969260|NCT00701090|592259753|FG001|Overall Study|Death|1|||
163969261|NCT00701090|592259752|FG000|Overall Study|Lack of Efficacy|5|||
163969262|NCT00701090|592259753|FG001|Overall Study|Lack of Efficacy|4|||
163969263|NCT00701090|592259752|FG000|Overall Study|Lost to Follow-up|9|||
163969264|NCT00701090|592259753|FG001|Overall Study|Lost to Follow-up|9|||
163969265|NCT00701090|592259752|FG000|Overall Study|Physician Decision|3|||
163969266|NCT00701090|592259753|FG001|Overall Study|Physician Decision|4|||
163969267|NCT00701090|592259752|FG000|Overall Study|Protocol Violation|2|||
163969268|NCT00701090|592259753|FG001|Overall Study|Protocol Violation|3|||
163969269|NCT00701090|592259752|FG000|Overall Study|Withdrawal by Subject|11|||
163969270|NCT00701090|592259753|FG001|Overall Study|Withdrawal by Subject|16|||
163969271|NCT00701090|592259752|FG000|Overall Study|Other|7|||
163864489|NCT01759264|591870286|FG000|Overall Study|Lost to Follow-up|2|||
163864490|NCT01759264|591870286|FG000|Overall Study|Withdrawal by Subject|3|||
163864491|NCT01759264|591870286|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
163864492|NCT01811706|591870291|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
163864493|NCT01811706|591870292|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
163864494|NCT05174013|591870293|FG000|Overall Study|Lost to Follow-up|0|||
163864495|NCT05174013|591870294|FG001|Overall Study|Lost to Follow-up|0|||
163864496|NCT05174013|591870295|FG002|Overall Study|Lost to Follow-up|0|||
163864497|NCT05174013|591870296|FG003|Overall Study|Lost to Follow-up|1|||
163864498|NCT05174013|591870297|FG004|Overall Study|Lost to Follow-up|0|||
163969272|NCT00701090|592259753|FG001|Overall Study|Other|12|||
163969273|NCT00873366|592259754|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
163969274|NCT00873366|592259754|FG000|Overall Study|Off tamoxifen due to side effects|2|||
163969275|NCT00873366|592259754|FG000|Overall Study|Refused to continue DM-BT testing|3|||
163969276|NCT01576172|592259755|FG000|Overall Study|Ineligible|2|||
163969277|NCT01576172|592259756|FG001|Overall Study|Ineligible|1|||
163969278|NCT01576172|592259755|FG000|Overall Study|Withdrawal by Subject|2|||
163969279|NCT01576172|592259756|FG001|Overall Study|Withdrawal by Subject|0|||
163864499|NCT05174013|591870298|FG005|Overall Study|Lost to Follow-up|0|||
163969280|NCT01576172|592259755|FG000|Overall Study|Insurance issue|1|||
163969281|NCT01576172|592259756|FG001|Overall Study|Insurance issue|0|||
163969282|NCT00962390|592259765|FG000|Overall Study|Adverse Event|0|||
163969283|NCT00962390|592259766|FG001|Overall Study|Adverse Event|0|||
163969284|NCT00962390|592259767|FG002|Overall Study|Adverse Event|3|||
163864500|NCT05174013|591870293|FG000|Overall Study|Withdrawal by Subject|0|||
163969285|NCT00962390|592259768|FG003|Overall Study|Adverse Event|1|||
163969286|NCT00962390|592259765|FG000|Overall Study|Lost to Follow-up|2|||
163969287|NCT00962390|592259766|FG001|Overall Study|Lost to Follow-up|2|||
163969288|NCT00962390|592259767|FG002|Overall Study|Lost to Follow-up|0|||
163969289|NCT00962390|592259768|FG003|Overall Study|Lost to Follow-up|0|||
163969290|NCT00962390|592259765|FG000|Overall Study|Protocol Violation|1|||
163969291|NCT00962390|592259766|FG001|Overall Study|Protocol Violation|0|||
163969292|NCT00962390|592259767|FG002|Overall Study|Protocol Violation|0|||
163969293|NCT00962390|592259768|FG003|Overall Study|Protocol Violation|0|||
163969294|NCT00962390|592259765|FG000|Overall Study|Withdrawal by Subject|1|||
163969295|NCT00962390|592259766|FG001|Overall Study|Withdrawal by Subject|1|||
163969296|NCT00962390|592259767|FG002|Overall Study|Withdrawal by Subject|1|||
163969297|NCT00962390|592259768|FG003|Overall Study|Withdrawal by Subject|0|||
163969298|NCT02613884|592259769|FG000|Overall Study|Death|1|||
163969299|NCT02613884|592259769|FG000|Overall Study|Lost to Follow-up|1|||
163969300|NCT01299376|592259775|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
163969301|NCT01299376|592259776|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
163969302|NCT01299376|592259775|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
163969303|NCT01299376|592259776|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
163969304|NCT01299376|592259775|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
163969305|NCT01299376|592259776|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
163969306|NCT01299376|592259775|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
163969307|NCT01299376|592259776|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
163969308|NCT01299376|592259775|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
164310114|NCT02722304|593509585|FG000|Overall Study|Other|0|||
164310115|NCT02722304|593509586|FG001|Overall Study|Other|0|||
164310116|NCT02722304|593509587|FG002|Overall Study|Other|0|||
164310117|NCT02722304|593509588|FG003|Overall Study|Other|1|||
164310118|NCT02722304|593509589|FG004|Overall Study|Other|1|||
164310119|NCT00393861|593509592|FG000|Overall Study|Adverse Event|2|||
164310120|NCT00393861|593509592|FG000|Overall Study|Disease Progression|24|||
164310121|NCT05300763|593509593|FG000|Overall Study|Adverse Event|0|||
164310122|NCT05300763|593509594|FG001|Overall Study|Adverse Event|1|||
164310123|NCT05300763|593509593|FG000|Overall Study|Major Protocol Deviation|1|||
164310124|NCT05300763|593509594|FG001|Overall Study|Major Protocol Deviation|0|||
164310125|NCT05300763|593509593|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
163969309|NCT01299376|592259776|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
163969310|NCT01299376|592259775|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
163969311|NCT01299376|592259776|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
163969312|NCT01299376|592259775|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
163969313|NCT01299376|592259776|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
163969314|NCT01299376|592259775|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
164310126|NCT05300763|593509594|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164310127|NCT01485172|593509595|FG000|Overall Study|Adverse Event|2|||
164310128|NCT01485172|593509596|FG001|Overall Study|Adverse Event|1|||
163864501|NCT05174013|591870294|FG001|Overall Study|Withdrawal by Subject|0|||
163864502|NCT05174013|591870295|FG002|Overall Study|Withdrawal by Subject|1|||
163864503|NCT05174013|591870296|FG003|Overall Study|Withdrawal by Subject|0|||
163864504|NCT05174013|591870297|FG004|Overall Study|Withdrawal by Subject|0|||
163864505|NCT05174013|591870298|FG005|Overall Study|Withdrawal by Subject|0|||
163864506|NCT02034916|591870299|FG000|Overall Study|Death|39|||
163864507|NCT02034916|591870300|FG001|Overall Study|Death|28|||
163864508|NCT02034916|591870299|FG000|Overall Study|Withdrawal by Subject|2|||
163864509|NCT02034916|591870300|FG001|Overall Study|Withdrawal by Subject|1|||
163864510|NCT02034916|591870299|FG000|Overall Study|Lost to Follow-up|4|||
163864511|NCT02034916|591870300|FG001|Overall Study|Lost to Follow-up|1|||
163864512|NCT02034916|591870299|FG000|Overall Study|Study terminated by sponsor|4|||
163864513|NCT02034916|591870300|FG001|Overall Study|Study terminated by sponsor|5|||
163864514|NCT01370694|591870301|FG000|Overall Study|Switched to rituximab|4|||
163864515|NCT01370694|591870301|FG000|Overall Study|Progressive disease|2|||
163864516|NCT02148133|591870310|FG000|Overall Study|Investigator discretion|1|||
163864517|NCT02148133|591870310|FG000|Overall Study|Lack of Efficacy|1|||
163864518|NCT02148133|591870310|FG000|Overall Study|Protocol deviation|1|||
163864519|NCT02148133|591870310|FG000|Overall Study|Protocol-defined stopping criteria|2|||
163969315|NCT01299376|592259776|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
164310129|NCT01485172|593509597|FG002|Overall Study|Adverse Event|2|||
164310130|NCT01485172|593509598|FG003|Overall Study|Adverse Event|2|||
163969316|NCT01299376|592259775|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
163969317|NCT01299376|592259776|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
164310131|NCT01485172|593509599|FG004|Overall Study|Adverse Event|1|||
164310132|NCT01485172|593509600|FG005|Overall Study|Adverse Event|2|||
163864520|NCT03808883|591870311|FG000|Overall Study|Withdrawal by Subject|2|||
163864521|NCT03808883|591870312|FG001|Overall Study|Withdrawal by Subject|0|||
163864522|NCT03808883|591870311|FG000|Overall Study|Did not complete pre test or post test survey|4|||
164310133|NCT01485172|593509595|FG000|Overall Study|Lack of Efficacy|2|||
163969318|NCT01299376|592259775|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
163969319|NCT01299376|592259776|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
163969320|NCT01299376|592259775|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
163969321|NCT01299376|592259776|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
163969322|NCT00766090|592259777|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969323|NCT00766090|592259778|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969324|NCT00766090|592259779|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
164310134|NCT01485172|593509596|FG001|Overall Study|Lack of Efficacy|0|||
163969325|NCT00766090|592259780|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969326|NCT00766090|592259781|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969327|NCT00766090|592259782|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969328|NCT00766090|592259783|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969329|NCT00766090|592259784|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969330|NCT00766090|592259785|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
163969331|NCT00766090|592259786|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969332|NCT00766090|592259787|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969333|NCT00766090|592259788|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163969334|NCT00766090|592259777|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
163969335|NCT00766090|592259778|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969336|NCT00766090|592259779|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969337|NCT00766090|592259780|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969338|NCT00766090|592259781|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969339|NCT00766090|592259782|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969340|NCT00766090|592259783|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969341|NCT00766090|592259784|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969342|NCT00766090|592259785|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969343|NCT00766090|592259786|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969344|NCT00766090|592259787|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969345|NCT00766090|592259788|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
163969346|NCT00766090|592259777|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163969347|NCT00766090|592259778|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969348|NCT00766090|592259779|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969349|NCT00766090|592259780|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163969350|NCT00766090|592259781|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969351|NCT00766090|592259782|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969352|NCT00766090|592259783|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969353|NCT00766090|592259784|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969354|NCT00766090|592259785|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969355|NCT00766090|592259786|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969356|NCT00766090|592259787|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969357|NCT00766090|592259788|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163969358|NCT00766090|592259777|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969359|NCT00766090|592259778|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969360|NCT00766090|592259779|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
163969361|NCT00766090|592259780|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969362|NCT00766090|592259781|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969363|NCT00766090|592259782|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969364|NCT00766090|592259783|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969365|NCT00766090|592259784|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969366|NCT00766090|592259785|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
164310135|NCT01485172|593509597|FG002|Overall Study|Lack of Efficacy|0|||
164310136|NCT01485172|593509598|FG003|Overall Study|Lack of Efficacy|0|||
164310137|NCT01485172|593509599|FG004|Overall Study|Lack of Efficacy|0|||
164310138|NCT01485172|593509600|FG005|Overall Study|Lack of Efficacy|0|||
164310139|NCT01485172|593509595|FG000|Overall Study|Protocol Violation|0|||
164310140|NCT01485172|593509596|FG001|Overall Study|Protocol Violation|0|||
164310141|NCT01485172|593509597|FG002|Overall Study|Protocol Violation|4|||
164310142|NCT01485172|593509598|FG003|Overall Study|Protocol Violation|5|||
164310143|NCT01485172|593509599|FG004|Overall Study|Protocol Violation|1|||
164310144|NCT01485172|593509600|FG005|Overall Study|Protocol Violation|0|||
164310145|NCT01485172|593509595|FG000|Overall Study|Protocol defined stopping criteria|1|||
163969367|NCT00766090|592259786|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969368|NCT00766090|592259787|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
163969369|NCT00766090|592259788|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
164310146|NCT01485172|593509596|FG001|Overall Study|Protocol defined stopping criteria|0|||
164310147|NCT01485172|593509597|FG002|Overall Study|Protocol defined stopping criteria|0|||
164310148|NCT01485172|593509598|FG003|Overall Study|Protocol defined stopping criteria|0|||
163969370|NCT00766090|592259777|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969371|NCT00766090|592259778|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164310149|NCT01485172|593509599|FG004|Overall Study|Protocol defined stopping criteria|1|||
163969372|NCT00766090|592259779|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969373|NCT00766090|592259780|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969374|NCT00766090|592259781|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
163969375|NCT00766090|592259782|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969376|NCT00766090|592259783|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969377|NCT00766090|592259784|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969378|NCT00766090|592259785|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969379|NCT00766090|592259786|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969380|NCT00766090|592259787|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969381|NCT00766090|592259788|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163969382|NCT00766090|592259777|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969383|NCT00766090|592259778|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969384|NCT00766090|592259779|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
163969385|NCT00766090|592259780|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969386|NCT00766090|592259781|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969387|NCT00766090|592259782|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969388|NCT00766090|592259783|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969389|NCT00766090|592259784|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969390|NCT00766090|592259785|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969391|NCT00766090|592259786|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969392|NCT00766090|592259787|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969393|NCT00766090|592259788|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
163969394|NCT00766090|592259777|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
163969395|NCT00766090|592259778|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
163969396|NCT00766090|592259779|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
163969397|NCT00766090|592259780|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
163969398|NCT00766090|592259781|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
163969399|NCT00766090|592259782|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
163969400|NCT00766090|592259783|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
163969401|NCT00766090|592259784|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
163969402|NCT00766090|592259785|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
163969403|NCT00766090|592259786|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
163969404|NCT00766090|592259787|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
163969405|NCT00766090|592259788|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
163969406|NCT00766090|592259777|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969407|NCT00766090|592259778|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969408|NCT00766090|592259779|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969409|NCT00766090|592259780|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969410|NCT00766090|592259781|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969411|NCT00766090|592259782|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
163969412|NCT00766090|592259783|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969413|NCT00766090|592259784|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969414|NCT00766090|592259785|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969415|NCT00766090|592259786|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969416|NCT00766090|592259787|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969417|NCT00766090|592259788|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
163969418|NCT00766090|592259777|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969419|NCT00766090|592259778|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
163969420|NCT00766090|592259779|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969421|NCT00766090|592259780|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
163969422|NCT00766090|592259781|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969423|NCT00766090|592259782|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969424|NCT00766090|592259783|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969425|NCT00766090|592259784|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969426|NCT00766090|592259785|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969427|NCT00766090|592259786|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969428|NCT00766090|592259787|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
163969429|NCT00766090|592259788|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
163969430|NCT00766090|592259777|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969431|NCT00766090|592259778|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969432|NCT00766090|592259779|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969433|NCT00766090|592259780|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969434|NCT00766090|592259781|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
163969435|NCT00766090|592259782|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969436|NCT00766090|592259783|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969437|NCT00766090|592259784|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969438|NCT00766090|592259785|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969439|NCT00766090|592259786|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969440|NCT00766090|592259787|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969441|NCT00766090|592259788|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
163969442|NCT03024970|592259791|FG000|First Intervention|Adverse Event|1|||
163969443|NCT03024970|592259792|FG001|First Intervention|Adverse Event|0|||
163969444|NCT03024970|592259791|FG000|Second Intervention|Lost to Follow-up|1|||
163969445|NCT03024970|592259792|FG001|Second Intervention|Lost to Follow-up|0|||
163969446|NCT00131469|592259793|FG000|Overall Study|Withdrawal by Subject|3|||
163969447|NCT00131469|592259794|FG001|Overall Study|Withdrawal by Subject|4|||
163969448|NCT00131469|592259793|FG000|Overall Study|Protocol Violation|3|||
163969449|NCT00131469|592259794|FG001|Overall Study|Protocol Violation|1|||
163969450|NCT00131469|592259793|FG000|Overall Study|Death|0|||
163969451|NCT00131469|592259794|FG001|Overall Study|Death|1|||
163969452|NCT00131469|592259793|FG000|Overall Study|Lost to Follow-up|0|||
163969453|NCT00131469|592259794|FG001|Overall Study|Lost to Follow-up|1|||
163969454|NCT00131469|592259793|FG000|Overall Study|scan not analyzable|3|||
163969455|NCT00131469|592259794|FG001|Overall Study|scan not analyzable|6|||
163969456|NCT00574288|592259795|FG000|Overall Study|Adverse Event|2|||
163969457|NCT00574288|592259796|FG001|Overall Study|Adverse Event|0|||
163969458|NCT00574288|592259797|FG002|Overall Study|Adverse Event|0|||
163969459|NCT00574288|592259798|FG003|Overall Study|Adverse Event|0|||
163969460|NCT00574288|592259799|FG004|Overall Study|Adverse Event|1|||
163969461|NCT00574288|592259800|FG005|Overall Study|Adverse Event|0|||
163969462|NCT00574288|592259801|FG006|Overall Study|Adverse Event|0|||
163969463|NCT00574288|592259795|FG000|Overall Study|Death|0|||
163969464|NCT00574288|592259796|FG001|Overall Study|Death|0|||
163969465|NCT00574288|592259797|FG002|Overall Study|Death|0|||
163969466|NCT00574288|592259798|FG003|Overall Study|Death|0|||
163969467|NCT00574288|592259799|FG004|Overall Study|Death|0|||
163969468|NCT00574288|592259800|FG005|Overall Study|Death|25|||
163969469|NCT00574288|592259801|FG006|Overall Study|Death|21|||
163969470|NCT00574288|592259795|FG000|Overall Study|Lost to Follow-up|0|||
163969471|NCT00574288|592259796|FG001|Overall Study|Lost to Follow-up|0|||
163969472|NCT00574288|592259797|FG002|Overall Study|Lost to Follow-up|0|||
163969473|NCT00574288|592259798|FG003|Overall Study|Lost to Follow-up|0|||
163969474|NCT00574288|592259799|FG004|Overall Study|Lost to Follow-up|0|||
163969475|NCT00574288|592259800|FG005|Overall Study|Lost to Follow-up|1|||
163969476|NCT00574288|592259801|FG006|Overall Study|Lost to Follow-up|2|||
163969477|NCT00574288|592259795|FG000|Overall Study|Study Terminated By Sponsor|0|||
163969478|NCT00574288|592259796|FG001|Overall Study|Study Terminated By Sponsor|0|||
163969479|NCT00574288|592259797|FG002|Overall Study|Study Terminated By Sponsor|0|||
163969480|NCT00574288|592259798|FG003|Overall Study|Study Terminated By Sponsor|0|||
163969481|NCT00574288|592259799|FG004|Overall Study|Study Terminated By Sponsor|0|||
163969482|NCT00574288|592259800|FG005|Overall Study|Study Terminated By Sponsor|0|||
163969483|NCT00574288|592259801|FG006|Overall Study|Study Terminated By Sponsor|5|||
163969484|NCT00574288|592259795|FG000|Overall Study|Progressive Disease|17|||
163969485|NCT00574288|592259796|FG001|Overall Study|Progressive Disease|2|||
163969486|NCT00574288|592259797|FG002|Overall Study|Progressive Disease|3|||
163969487|NCT00574288|592259798|FG003|Overall Study|Progressive Disease|2|||
163969488|NCT00574288|592259799|FG004|Overall Study|Progressive Disease|1|||
163969489|NCT00574288|592259800|FG005|Overall Study|Progressive Disease|0|||
163969490|NCT00574288|592259801|FG006|Overall Study|Progressive Disease|0|||
163969491|NCT00574288|592259795|FG000|Overall Study|Other|1|||
163969492|NCT00574288|592259796|FG001|Overall Study|Other|1|||
163969493|NCT00574288|592259797|FG002|Overall Study|Other|0|||
163969494|NCT00574288|592259798|FG003|Overall Study|Other|0|||
163969495|NCT00574288|592259799|FG004|Overall Study|Other|0|||
163969496|NCT00574288|592259800|FG005|Overall Study|Other|0|||
163969497|NCT00574288|592259801|FG006|Overall Study|Other|0|||
163969498|NCT01106027|592259802|FG000|Overall Study|Lost graft early, discontinued|1|||
163969499|NCT00356889|592259803|FG000|Overall Study|Protocol Violation|2|||
163969500|NCT00356889|592259803|FG000|Overall Study|Adverse Event|1|||
163969501|NCT00736034|592259804|FG000|Overall Study|Adverse Event|2|||
163969502|NCT00773136|592259834|FG000|Overall Study|Physician Decision|2|||
163969503|NCT02463071|592259838|FG000|Overall Study|Adverse Event|3|||
163969504|NCT02463071|592259839|FG001|Overall Study|Adverse Event|5|||
163969505|NCT02463071|592259840|FG002|Overall Study|Adverse Event|1|||
163969506|NCT02463071|592259838|FG000|Overall Study|Death|1|||
163969507|NCT02463071|592259839|FG001|Overall Study|Death|0|||
163969508|NCT02463071|592259840|FG002|Overall Study|Death|0|||
163969509|NCT02463071|592259838|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
163969510|NCT02463071|592259839|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163969511|NCT02463071|592259840|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
163969512|NCT02463071|592259838|FG000|Overall Study|Reason not specified|7|||
163969513|NCT02463071|592259839|FG001|Overall Study|Reason not specified|9|||
163969514|NCT02463071|592259840|FG002|Overall Study|Reason not specified|4|||
163969515|NCT02463071|592259838|FG000|Overall Study|Protocol Violation|0|||
163969516|NCT02463071|592259839|FG001|Overall Study|Protocol Violation|2|||
163969517|NCT02463071|592259840|FG002|Overall Study|Protocol Violation|0|||
163969518|NCT02463071|592259838|FG000|Overall Study|Lost to Follow-up|0|||
163969519|NCT02463071|592259839|FG001|Overall Study|Lost to Follow-up|0|||
163969520|NCT02463071|592259840|FG002|Overall Study|Lost to Follow-up|1|||
163969521|NCT00175877|592259856|FG000|Overall Study|Adverse Event|136|||
163969522|NCT00175877|592259856|FG000|Overall Study|Withdrawal by Subject|141|||
163969523|NCT00175877|592259856|FG000|Overall Study|Lost to Follow-up|9|||
163969524|NCT00175877|592259856|FG000|Overall Study|Lack of Efficacy|26|||
163969525|NCT00175877|592259856|FG000|Overall Study|Protocol Violation|15|||
163969526|NCT00175877|592259856|FG000|Overall Study|Other Reason|20|||
163969527|NCT00175877|592259856|FG000|Overall Study|AE & Other|1|||
163969528|NCT00175877|592259856|FG000|Overall Study|Withdrawal by subject & Other|1|||
163969529|NCT02003014|592259858|FG000|Overall Study|Case report forms uncollected|9|||
163969530|NCT02003014|592259858|FG000|Overall Study|Treatment started after contract period|1|||
163969531|NCT02003014|592259858|FG000|Overall Study|Patient did not visit the study site|5|||
163969532|NCT02003014|592259858|FG000|Overall Study|Investigator's transfer|4|||
163969533|NCT00617604|592259859|FG000|Overall Study|Death|2|||
163969534|NCT00617604|592259860|FG001|Overall Study|Death|1|||
163969535|NCT00617604|592259859|FG000|Overall Study|Lost to Follow-up|1|||
163969536|NCT00617604|592259860|FG001|Overall Study|Lost to Follow-up|0|||
163969537|NCT00617604|592259859|FG000|Overall Study|Miscellaneous Reasons|8|||
163969538|NCT00617604|592259860|FG001|Overall Study|Miscellaneous Reasons|10|||
163969539|NCT00617604|592259859|FG000|Overall Study|Withdrawal by Subject|4|||
163969540|NCT00617604|592259860|FG001|Overall Study|Withdrawal by Subject|6|||
163969541|NCT00617604|592259859|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
163969542|NCT00617604|592259860|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
163969543|NCT04029961|592259861|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
163969544|NCT04029961|592259862|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
163969545|NCT04029961|592259861|FG000|Overall Study|Change in Treatment Course|0|||
163969546|NCT04029961|592259862|FG001|Overall Study|Change in Treatment Course|1|||
163969547|NCT00688155|592259865|FG000|Overall Study|Withdrawal by Subject|2|||
163969548|NCT00688155|592259866|FG001|Overall Study|Withdrawal by Subject|2|||
163969549|NCT00688155|592259867|FG002|Overall Study|Withdrawal by Subject|1|||
163969550|NCT00688155|592259868|FG003|Overall Study|Withdrawal by Subject|1|||
163969551|NCT00445224|592259871|FG000|Specific Exercises|Withdrawal by Subject|3|||
163969552|NCT00445224|592259872|FG001|Specific Exercises|Withdrawal by Subject|3|||
163969553|NCT00445224|592259871|FG000|Specific Exercises|Withdrawal by Subject|1|||
163969554|NCT00445224|592259872|FG001|Specific Exercises|Withdrawal by Subject|0|||
163969555|NCT03184077|592259873|FG000|Overall Study|Lost to Follow-up|21|||
163969556|NCT03184077|592259874|FG001|Overall Study|Lost to Follow-up|21|||
163969557|NCT04136184|592259875|FG000|Overall Study|Lost to Follow-up|0|||
163969558|NCT04136184|592259876|FG001|Overall Study|Lost to Follow-up|3|||
163969559|NCT04136184|592259875|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
163969560|NCT04136184|592259876|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
163969561|NCT03318978|592259877|FG000|Overall Study|Withdrawal by Subject|1|||
163969562|NCT03007979|592259880|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
163969563|NCT03734016|592259881|FG000|Overall Study|Sponsor Ended Study|225|||
163969564|NCT03734016|592259882|FG001|Overall Study|Sponsor Ended Study|200|||
163969565|NCT03734016|592259881|FG000|Overall Study|Death|69|||
163969566|NCT03734016|592259882|FG001|Overall Study|Death|83|||
163969567|NCT03734016|592259881|FG000|Overall Study|Withdrawal by Subject|21|||
163969568|NCT03734016|592259882|FG001|Overall Study|Withdrawal by Subject|27|||
163969569|NCT03734016|592259881|FG000|Overall Study|Physician Decision|1|||
163969570|NCT03734016|592259882|FG001|Overall Study|Physician Decision|12|||
163969571|NCT03734016|592259881|FG000|Overall Study|Lost to Follow-up|6|||
163969572|NCT03734016|592259882|FG001|Overall Study|Lost to Follow-up|2|||
163969573|NCT03734016|592259881|FG000|Overall Study|Miscellaneous|5|||
163969574|NCT03734016|592259882|FG001|Overall Study|Miscellaneous|1|||
163969575|NCT01624259|592259885|FG000|Overall Study|Adverse Event|18|||
163969576|NCT01624259|592259886|FG001|Overall Study|Adverse Event|18|||
163969577|NCT01624259|592259885|FG000|Overall Study|Protocol Violation|1|||
163969578|NCT01624259|592259886|FG001|Overall Study|Protocol Violation|2|||
164201374|NCT03154086|593110737|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201375|NCT03154086|593110738|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201376|NCT03154086|593110739|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201377|NCT03154086|593110740|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201378|NCT03154086|593110741|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
164201379|NCT03154086|593110727|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201380|NCT03154086|593110728|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164310150|NCT01485172|593509600|FG005|Overall Study|Protocol defined stopping criteria|0|||
164310151|NCT01485172|593509595|FG000|Overall Study|Lost to Follow-up|0|||
163969579|NCT01624259|592259885|FG000|Overall Study|Withdrawal by Subject|5|||
163969580|NCT01624259|592259886|FG001|Overall Study|Withdrawal by Subject|7|||
163969581|NCT01624259|592259885|FG000|Overall Study|Physician Decision|1|||
163969582|NCT01624259|592259886|FG001|Overall Study|Physician Decision|1|||
163969583|NCT01624259|592259885|FG000|Overall Study|Lost to Follow-up|2|||
163969584|NCT01624259|592259886|FG001|Overall Study|Lost to Follow-up|3|||
163969585|NCT01624259|592259885|FG000|Overall Study|Abnormal laboratory measure|3|||
163969586|NCT01624259|592259886|FG001|Overall Study|Abnormal laboratory measure|0|||
163969587|NCT01298518|592259887|FG000|Overall Study|Withdrawal by Subject|0|||
164201381|NCT03154086|593110729|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
164201382|NCT03154086|593110730|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201383|NCT03154086|593110731|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201384|NCT03154086|593110732|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163969588|NCT01298518|592259888|FG001|Overall Study|Withdrawal by Subject|0|||
163969589|NCT01298518|592259889|FG002|Overall Study|Withdrawal by Subject|1|||
163969590|NCT02273726|592259890|FG000|Overall Study|Death|70|||
163969591|NCT02273726|592259891|FG001|Overall Study|Death|62|||
163969592|NCT02273726|592259890|FG000|Overall Study|Withdrawal by Subject|41|||
163969593|NCT02273726|592259891|FG001|Overall Study|Withdrawal by Subject|29|||
163969594|NCT02273726|592259890|FG000|Overall Study|Kidney transplant|31|||
163969595|NCT02273726|592259891|FG001|Overall Study|Kidney transplant|39|||
163969596|NCT02273726|592259890|FG000|Overall Study|Physician Decision|30|||
163969597|NCT02273726|592259891|FG001|Overall Study|Physician Decision|15|||
163969598|NCT02273726|592259890|FG000|Overall Study|Adverse Event|27|||
163969599|NCT02273726|592259891|FG001|Overall Study|Adverse Event|9|||
163969600|NCT02273726|592259890|FG000|Overall Study|Lost to Follow-up|6|||
163969601|NCT02273726|592259891|FG001|Overall Study|Lost to Follow-up|3|||
163969602|NCT02273726|592259890|FG000|Overall Study|Lack of Efficacy|6|||
163969603|NCT02273726|592259891|FG001|Overall Study|Lack of Efficacy|1|||
163969604|NCT02273726|592259890|FG000|Overall Study|Protocol Violation|4|||
163969605|NCT02273726|592259891|FG001|Overall Study|Protocol Violation|0|||
163969606|NCT02273726|592259890|FG000|Overall Study|Other than specified|28|||
163969607|NCT02273726|592259891|FG001|Overall Study|Other than specified|30|||
163969608|NCT01979835|592259892|FG000|Primary Outcome SA Measurment|failed insertion|18|||
163969609|NCT01979835|592259892|FG000|Follow-up|Lost to Follow-up|32|||
163969610|NCT03697720|592261201|FG000|Overall Study|Lost to Follow-up|7|||
163969611|NCT03688880|592261206|FG000|Overall Study|Withdrawal by Subject|0|||
163969612|NCT03688880|592261207|FG001|Overall Study|Withdrawal by Subject|2|||
163969613|NCT03688880|592261206|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
163969614|NCT03688880|592261207|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
163969615|NCT03688880|592261206|FG000|Overall Study|Lost to Follow-up|4|||
163969616|NCT03688880|592261207|FG001|Overall Study|Lost to Follow-up|7|||
163969617|NCT03688880|592261206|FG000|Overall Study|Adverse Event|0|||
163969618|NCT03688880|592261207|FG001|Overall Study|Adverse Event|2|||
163969619|NCT03688880|592261206|FG000|Overall Study|Device deficiencies|0|||
163969620|NCT03688880|592261207|FG001|Overall Study|Device deficiencies|2|||
163969621|NCT03688880|592261206|FG000|Overall Study|Other|10|||
163969622|NCT03688880|592261207|FG001|Overall Study|Other|16|||
163969623|NCT01183143|592261208|FG000|Overall Study|Protocol Violation|115|||
163969624|NCT01183143|592261208|FG000|Overall Study|Withdrawal by Subject|19|||
163969625|NCT01183143|592261208|FG000|Overall Study|Subject Questionnaires not returned|5|||
163969626|NCT01183143|592261208|FG000|Overall Study|Subjects enrolled, but not treated|11|||
163969627|NCT04042740|592261210|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
163969628|NCT04042740|592261210|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
163969629|NCT04024228|592261211|FG000|Overall Study|Adverse Event|1|||
163969630|NCT04024228|592261212|FG001|Overall Study|Adverse Event|0|||
163969631|NCT04024228|592261211|FG000|Overall Study|Protocol Deviation|0|||
163969632|NCT04024228|592261212|FG001|Overall Study|Protocol Deviation|2|||
163969633|NCT04024228|592261211|FG000|Overall Study|Withdrawal by Subject|3|||
163969634|NCT04024228|592261212|FG001|Overall Study|Withdrawal by Subject|4|||
163969635|NCT00938717|592261213|FG000|Overall Study|Adverse Event|10|||
163969636|NCT00938717|592261214|FG001|Overall Study|Adverse Event|41|||
163969637|NCT00938717|592261213|FG000|Overall Study|Protocol Violation|11|||
163969638|NCT00938717|592261214|FG001|Overall Study|Protocol Violation|8|||
163969639|NCT00938717|592261213|FG000|Overall Study|Withdrawal by Subject|26|||
163969640|NCT00938717|592261214|FG001|Overall Study|Withdrawal by Subject|24|||
163969641|NCT00938717|592261213|FG000|Overall Study|Lost to Follow-up|13|||
163969642|NCT00938717|592261214|FG001|Overall Study|Lost to Follow-up|18|||
163969643|NCT00938717|592261213|FG000|Overall Study|Lack of Efficacy|33|||
163969644|NCT00938717|592261214|FG001|Overall Study|Lack of Efficacy|15|||
163969645|NCT00938717|592261213|FG000|Overall Study|Other reason|5|||
163969646|NCT00938717|592261214|FG001|Overall Study|Other reason|2|||
163969647|NCT01942148|592261220|FG000|Overall Study|Adverse Event|4|||
163969648|NCT01942148|592261220|FG000|Overall Study|Lack of Efficacy|2|||
164302363|NCT03755934|593482605|FG003|Overall Study|Adverse Event|3|||
163969649|NCT01942148|592261220|FG000|Overall Study|Physician Decision|11|||
163969650|NCT01942148|592261220|FG000|Overall Study|Protocol Violation|1|||
163969651|NCT01942148|592261220|FG000|Overall Study|Withdrawal by Subject|8|||
163969652|NCT01942148|592261220|FG000|Overall Study|Use of the prohibition medicine|1|||
163969653|NCT02248259|592261221|FG000|Treatment Period 1|Adverse Event|0|||
163969654|NCT02248259|592261222|FG001|Treatment Period 1|Adverse Event|0|||
163969655|NCT02248259|592261223|FG002|Treatment Period 1|Adverse Event|1|||
163969656|NCT02248259|592261224|FG003|Treatment Period 1|Adverse Event|0|||
163969657|NCT02807480|592261227|FG000|Overall Study|Withdrawal by Subject|14|||
163969658|NCT02807480|592261228|FG001|Overall Study|Withdrawal by Subject|10|||
163969659|NCT02163187|592261231|FG000|Overall Study|Device removed|1|||
163969660|NCT02163187|592261232|FG001|Overall Study|Device removed|0|||
163969661|NCT02163187|592261231|FG000|Overall Study|Progressive disease|1|||
163969662|NCT02163187|592261232|FG001|Overall Study|Progressive disease|0|||
163969663|NCT02369848|592261233|FG000|Overall Study|Death|1|||
163969664|NCT02369848|592261233|FG000|Overall Study|Withdrawal by Subject|2|||
163969665|NCT02369848|592261233|FG000|Overall Study|Lost to Follow-up|1|||
163969666|NCT00257725|592261234|FG000|Overall Study|Adverse Event|3|||
163969667|NCT02573870|592261235|FG000|Overall Study|Adverse Event|0|||
163969668|NCT02573870|592261236|FG001|Overall Study|Adverse Event|2|||
163969669|NCT02573870|592261235|FG000|Overall Study|Lack of Efficacy|0|||
164310152|NCT01485172|593509596|FG001|Overall Study|Lost to Follow-up|0|||
164310153|NCT01485172|593509597|FG002|Overall Study|Lost to Follow-up|1|||
164310154|NCT01485172|593509598|FG003|Overall Study|Lost to Follow-up|0|||
164310155|NCT01485172|593509599|FG004|Overall Study|Lost to Follow-up|0|||
164310156|NCT01485172|593509600|FG005|Overall Study|Lost to Follow-up|1|||
164310157|NCT01485172|593509595|FG000|Overall Study|Physician Decision|0|||
164310158|NCT01485172|593509596|FG001|Overall Study|Physician Decision|0|||
164310159|NCT01485172|593509597|FG002|Overall Study|Physician Decision|0|||
164310160|NCT01485172|593509598|FG003|Overall Study|Physician Decision|0|||
164310161|NCT01485172|593509599|FG004|Overall Study|Physician Decision|1|||
164310162|NCT01485172|593509600|FG005|Overall Study|Physician Decision|0|||
164310163|NCT01485172|593509595|FG000|Overall Study|Withdrawal by Subject|2|||
164310164|NCT01485172|593509596|FG001|Overall Study|Withdrawal by Subject|0|||
164310165|NCT01485172|593509597|FG002|Overall Study|Withdrawal by Subject|0|||
164310166|NCT01485172|593509598|FG003|Overall Study|Withdrawal by Subject|1|||
164310167|NCT01485172|593509599|FG004|Overall Study|Withdrawal by Subject|1|||
164310168|NCT01485172|593509600|FG005|Overall Study|Withdrawal by Subject|1|||
164310169|NCT01587014|593509601|FG000|Overall Study|Death|2|||
164310170|NCT01409811|593509602|FG000|Overall Study|Insurance denial|1|||
164310171|NCT00441064|593509603|FG000|Overall Study|Adverse Event|1|||
164310172|NCT00441064|593509604|FG001|Overall Study|Adverse Event|0|||
164310173|NCT00441064|593509603|FG000|Overall Study|Abnormal laboratory values|0|||
164310174|NCT00441064|593509604|FG001|Overall Study|Abnormal laboratory values|2|||
164310175|NCT00441064|593509603|FG000|Overall Study|Abnormal test procedure results|0|||
164310176|NCT00441064|593509604|FG001|Overall Study|Abnormal test procedure results|1|||
164310177|NCT00441064|593509603|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164310178|NCT00441064|593509604|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164310179|NCT00441064|593509603|FG000|Overall Study|Protocol Deviation|3|||
164310180|NCT00441064|593509604|FG001|Overall Study|Protocol Deviation|2|||
164310181|NCT00441064|593509603|FG000|Overall Study|Patient withdrew consent|5|||
164310182|NCT00441064|593509604|FG001|Overall Study|Patient withdrew consent|2|||
164310183|NCT03051178|593509605|FG000|Overall Study|Withdrawal by Subject|5|||
164310184|NCT00953056|593509606|FG000|Overall Study|Withdrew Consent|0|||
164310185|NCT00953056|593509607|FG001|Overall Study|Withdrew Consent|0|||
164310186|NCT00953056|593509608|FG002|Overall Study|Withdrew Consent|0|||
164310187|NCT00953056|593509609|FG003|Overall Study|Withdrew Consent|0|||
164310188|NCT00953056|593509610|FG004|Overall Study|Withdrew Consent|2|||
164310189|NCT00953056|593509611|FG005|Overall Study|Withdrew Consent|3|||
164310190|NCT00953056|593509606|FG000|Overall Study|Serious Adverse Event|0|||
164310191|NCT00953056|593509607|FG001|Overall Study|Serious Adverse Event|0|||
164310192|NCT00953056|593509608|FG002|Overall Study|Serious Adverse Event|0|||
164310193|NCT00953056|593509609|FG003|Overall Study|Serious Adverse Event|0|||
164310194|NCT00953056|593509610|FG004|Overall Study|Serious Adverse Event|0|||
164310195|NCT00953056|593509611|FG005|Overall Study|Serious Adverse Event|1|||
164310196|NCT02442804|593509615|FG000|Overall Study|Withdrawal by Subject|0|||
164310197|NCT02442804|593509616|FG001|Overall Study|Withdrawal by Subject|1|||
164310198|NCT02442804|593509615|FG000|Overall Study|Adverse Event|1|||
164310199|NCT02442804|593509616|FG001|Overall Study|Adverse Event|0|||
164310200|NCT02527421|593509623|FG000|Overall Study|Withdrawal by Subject|1|||
164310201|NCT02527421|593509624|FG001|Overall Study|Withdrawal by Subject|0|||
164310202|NCT04200352|593509625|FG000|Overall Study|Death|1|||
163969670|NCT02573870|592261236|FG001|Overall Study|Lack of Efficacy|1|||
163969671|NCT02573870|592261235|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
163969672|NCT02573870|592261236|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
164310203|NCT04200352|593509625|FG000|Overall Study|Adverse Event|6|||
164310204|NCT04200352|593509625|FG000|Overall Study|Withdrawal by parent/guardian|6|||
164310205|NCT04200352|593509625|FG000|Overall Study|Lack of Efficacy|1|||
164310206|NCT04200352|593509625|FG000|Overall Study|Other than specified|6|||
164310207|NCT02541604|593509626|FG000|Overall Study|Death|6|||
164310208|NCT02541604|593509627|FG001|Overall Study|Death|5|||
164310209|NCT02541604|593509628|FG002|Overall Study|Death|7|||
164310210|NCT02541604|593509629|FG003|Overall Study|Death|2|||
164310211|NCT02541604|593509630|FG004|Overall Study|Death|9|||
164310212|NCT02541604|593509631|FG005|Overall Study|Death|8|||
164310213|NCT02541604|593509632|FG006|Overall Study|Death|9|||
164310214|NCT02541604|593509633|FG007|Overall Study|Death|9|||
164310215|NCT02541604|593509634|FG008|Overall Study|Death|3|||
164310216|NCT02541604|593509635|FG009|Overall Study|Death|4|||
164310217|NCT02541604|593509636|FG010|Overall Study|Death|2|||
164310218|NCT02541604|593509637|FG011|Overall Study|Death|3|||
164310219|NCT02541604|593509626|FG000|Overall Study|Lost to Follow-up|2|||
164310220|NCT02541604|593509627|FG001|Overall Study|Lost to Follow-up|0|||
164310221|NCT02541604|593509628|FG002|Overall Study|Lost to Follow-up|1|||
164310222|NCT02541604|593509629|FG003|Overall Study|Lost to Follow-up|0|||
164310223|NCT02541604|593509630|FG004|Overall Study|Lost to Follow-up|0|||
164310224|NCT02541604|593509631|FG005|Overall Study|Lost to Follow-up|1|||
164310225|NCT02541604|593509632|FG006|Overall Study|Lost to Follow-up|1|||
164310226|NCT02541604|593509633|FG007|Overall Study|Lost to Follow-up|0|||
163864523|NCT03808883|591870312|FG001|Overall Study|Did not complete pre test or post test survey|3|||
163864524|NCT00855465|591870314|FG000|Treatment Period|Adverse Event|4|||
163864525|NCT00855465|591870315|FG001|Treatment Period|Adverse Event|2|||
163864526|NCT00855465|591870314|FG000|Treatment Period|Death|2|||
163864527|NCT00855465|591870315|FG001|Treatment Period|Death|2|||
163864528|NCT00855465|591870314|FG000|Treatment Period|Lack of Efficacy|2|||
163864529|NCT00855465|591870315|FG001|Treatment Period|Lack of Efficacy|1|||
163864530|NCT00855465|591870314|FG000|Treatment Period|Non-compliance|1|||
163864531|NCT00855465|591870315|FG001|Treatment Period|Non-compliance|0|||
163864532|NCT00855465|591870314|FG000|Treatment Period|Protocol Violation|2|||
163864533|NCT00855465|591870315|FG001|Treatment Period|Protocol Violation|0|||
163864534|NCT00855465|591870314|FG000|Treatment Period|Withdrawal by Subject|2|||
163864535|NCT00855465|591870315|FG001|Treatment Period|Withdrawal by Subject|0|||
163864536|NCT00855465|591870314|FG000|Treatment Period|Not treated|1|||
163864537|NCT00855465|591870315|FG001|Treatment Period|Not treated|0|||
163864538|NCT00855465|591870314|FG000|Follow-up Period (FUP)|Adverse Event|0|||
163864539|NCT00855465|591870315|FG001|Follow-up Period (FUP)|Adverse Event|1|||
163864540|NCT00855465|591870314|FG000|Follow-up Period (FUP)|Death|0|||
163864541|NCT00855465|591870315|FG001|Follow-up Period (FUP)|Death|1|||
163864542|NCT00855465|591870314|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
163864543|NCT00855465|591870315|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
163864544|NCT00855465|591870314|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
163864545|NCT00855465|591870315|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
163864546|NCT00855465|591870314|FG000|Follow-up Period (FUP)|Missing|1|||
163864547|NCT00855465|591870315|FG001|Follow-up Period (FUP)|Missing|0|||
163864548|NCT00612586|591870326|FG000|Overall Study|Adverse Event|6|||
163864549|NCT00612586|591870327|FG001|Overall Study|Adverse Event|2|||
163864550|NCT00612586|591870326|FG000|Overall Study|Death|1|||
163864551|NCT00612586|591870327|FG001|Overall Study|Death|0|||
163864552|NCT00612586|591870326|FG000|Overall Study|Entry Criteria Not Met|0|||
163864553|NCT00612586|591870327|FG001|Overall Study|Entry Criteria Not Met|2|||
163864554|NCT00612586|591870326|FG000|Overall Study|Withdrawal by Subject|7|||
163864555|NCT00612586|591870327|FG001|Overall Study|Withdrawal by Subject|9|||
163864556|NCT00612586|591870326|FG000|Overall Study|Physician Decision|1|||
163864557|NCT00612586|591870327|FG001|Overall Study|Physician Decision|2|||
163864558|NCT00612586|591870326|FG000|Overall Study|Sponsor Decision|1|||
163864559|NCT00612586|591870327|FG001|Overall Study|Sponsor Decision|1|||
163864560|NCT00612586|591870326|FG000|Overall Study|Progressive Disease|26|||
163864561|NCT00612586|591870327|FG001|Overall Study|Progressive Disease|24|||
163864562|NCT00612586|591870326|FG000|Overall Study|Randomized and Not Treated|1|||
163864563|NCT00612586|591870327|FG001|Overall Study|Randomized and Not Treated|1|||
163864564|NCT02613364|591870328|FG000|Overall Study|Other|19|||
163864565|NCT02613364|591870329|FG001|Overall Study|Other|29|||
163864566|NCT02613364|591870330|FG002|Overall Study|Other|17|||
163864567|NCT02613364|591870328|FG000|Overall Study|Too time consuming|21|||
163864568|NCT02613364|591870329|FG001|Overall Study|Too time consuming|26|||
163864569|NCT02613364|591870330|FG002|Overall Study|Too time consuming|26|||
163864570|NCT02613364|591870328|FG000|Overall Study|Withdrawal by Subject|13|||
163864571|NCT02613364|591870329|FG001|Overall Study|Withdrawal by Subject|18|||
163864572|NCT02613364|591870330|FG002|Overall Study|Withdrawal by Subject|17|||
163864573|NCT02613364|591870328|FG000|Overall Study|Medical|12|||
163864574|NCT02613364|591870329|FG001|Overall Study|Medical|13|||
163864575|NCT02613364|591870330|FG002|Overall Study|Medical|9|||
163864576|NCT02613364|591870328|FG000|Overall Study|Disliked Study Procedure|1|||
163864577|NCT02613364|591870329|FG001|Overall Study|Disliked Study Procedure|1|||
163864578|NCT02613364|591870330|FG002|Overall Study|Disliked Study Procedure|4|||
163864579|NCT02613364|591870328|FG000|Overall Study|Disliked Intervention|0|||
163864580|NCT02613364|591870329|FG001|Overall Study|Disliked Intervention|3|||
163864581|NCT02613364|591870330|FG002|Overall Study|Disliked Intervention|3|||
163864582|NCT01909336|591870331|FG000|Overall Study|Lost to Follow-up|4|||
163864583|NCT01909336|591870332|FG001|Overall Study|Lost to Follow-up|2|||
163864584|NCT01909336|591870333|FG002|Overall Study|Lost to Follow-up|2|||
163969673|NCT02573870|592261235|FG000|Overall Study|Lost to Follow-up|0|||
164310227|NCT02541604|593509634|FG008|Overall Study|Lost to Follow-up|0|||
163864585|NCT01909336|591870331|FG000|Overall Study|Physician Decision|0|||
163864586|NCT01909336|591870332|FG001|Overall Study|Physician Decision|1|||
163864587|NCT01909336|591870333|FG002|Overall Study|Physician Decision|1|||
163864588|NCT01235949|591870334|FG000|Primary Phase|Migrated/moved from study area|1|||
163864589|NCT01235949|591870335|FG001|Primary Phase|Migrated/moved from study area|1|||
163864590|NCT01235949|591870336|FG002|Primary Phase|Migrated/moved from study area|0|||
163969674|NCT02573870|592261236|FG001|Overall Study|Lost to Follow-up|1|||
163864591|NCT01235949|591870337|FG003|Primary Phase|Migrated/moved from study area|0|||
163864592|NCT01235949|591870338|FG004|Primary Phase|Migrated/moved from study area|1|||
163864593|NCT01235949|591870339|FG005|Primary Phase|Migrated/moved from study area|2|||
163864594|NCT01235949|591870340|FG006|Primary Phase|Migrated/moved from study area|0|||
163864595|NCT01235949|591870341|FG007|Primary Phase|Migrated/moved from study area|0|||
163864596|NCT01235949|591870342|FG008|Primary Phase|Migrated/moved from study area|0|||
163864597|NCT01235949|591870343|FG009|Primary Phase|Migrated/moved from study area|0|||
163864598|NCT01235949|591870344|FG010|Primary Phase|Migrated/moved from study area|0|||
163864599|NCT01235949|591870345|FG011|Primary Phase|Migrated/moved from study area|0|||
163864600|NCT01235949|591870346|FG012|Primary Phase|Migrated/moved from study area|0|||
163864601|NCT01235949|591870347|FG013|Primary Phase|Migrated/moved from study area|0|||
163864602|NCT01235949|591870348|FG014|Primary Phase|Migrated/moved from study area|0|||
163864603|NCT01235949|591870349|FG015|Primary Phase|Migrated/moved from study area|0|||
163864604|NCT01235949|591870350|FG016|Primary Phase|Migrated/moved from study area|0|||
163864605|NCT01235949|591870351|FG017|Primary Phase|Migrated/moved from study area|0|||
163864606|NCT01235949|591870334|FG000|Primary Phase|Adverse Event|0|||
163864607|NCT01235949|591870335|FG001|Primary Phase|Adverse Event|0|||
163864608|NCT01235949|591870336|FG002|Primary Phase|Adverse Event|0|||
163864609|NCT01235949|591870337|FG003|Primary Phase|Adverse Event|1|||
163864610|NCT01235949|591870338|FG004|Primary Phase|Adverse Event|0|||
163864611|NCT01235949|591870339|FG005|Primary Phase|Adverse Event|0|||
163864612|NCT01235949|591870340|FG006|Primary Phase|Adverse Event|0|||
163864613|NCT01235949|591870341|FG007|Primary Phase|Adverse Event|0|||
163864614|NCT01235949|591870342|FG008|Primary Phase|Adverse Event|0|||
163864615|NCT01235949|591870343|FG009|Primary Phase|Adverse Event|0|||
163864616|NCT01235949|591870344|FG010|Primary Phase|Adverse Event|0|||
163864617|NCT01235949|591870345|FG011|Primary Phase|Adverse Event|0|||
163864618|NCT01235949|591870346|FG012|Primary Phase|Adverse Event|0|||
163864619|NCT01235949|591870347|FG013|Primary Phase|Adverse Event|0|||
163864620|NCT01235949|591870348|FG014|Primary Phase|Adverse Event|0|||
163864621|NCT01235949|591870349|FG015|Primary Phase|Adverse Event|0|||
163864622|NCT01235949|591870350|FG016|Primary Phase|Adverse Event|0|||
163864623|NCT01235949|591870351|FG017|Primary Phase|Adverse Event|0|||
163864624|NCT01235949|591870334|FG000|Primary Phase|Withdrawal by Subject|3|||
163864625|NCT01235949|591870335|FG001|Primary Phase|Withdrawal by Subject|2|||
163864626|NCT01235949|591870336|FG002|Primary Phase|Withdrawal by Subject|2|||
163864627|NCT01235949|591870337|FG003|Primary Phase|Withdrawal by Subject|0|||
163864628|NCT01235949|591870338|FG004|Primary Phase|Withdrawal by Subject|0|||
163864629|NCT01235949|591870339|FG005|Primary Phase|Withdrawal by Subject|3|||
163864630|NCT01235949|591870340|FG006|Primary Phase|Withdrawal by Subject|0|||
163864631|NCT01235949|591870341|FG007|Primary Phase|Withdrawal by Subject|0|||
163864632|NCT01235949|591870342|FG008|Primary Phase|Withdrawal by Subject|0|||
163864633|NCT01235949|591870343|FG009|Primary Phase|Withdrawal by Subject|0|||
163864634|NCT01235949|591870344|FG010|Primary Phase|Withdrawal by Subject|0|||
163864635|NCT01235949|591870345|FG011|Primary Phase|Withdrawal by Subject|0|||
163864636|NCT01235949|591870346|FG012|Primary Phase|Withdrawal by Subject|0|||
163864637|NCT01235949|591870347|FG013|Primary Phase|Withdrawal by Subject|0|||
163864638|NCT01235949|591870348|FG014|Primary Phase|Withdrawal by Subject|0|||
163864639|NCT01235949|591870349|FG015|Primary Phase|Withdrawal by Subject|0|||
163864640|NCT01235949|591870350|FG016|Primary Phase|Withdrawal by Subject|0|||
163864641|NCT01235949|591870351|FG017|Primary Phase|Withdrawal by Subject|0|||
163864642|NCT01235949|591870334|FG000|Primary Phase|Lost to Follow-up|0|||
163864643|NCT01235949|591870335|FG001|Primary Phase|Lost to Follow-up|0|||
163864644|NCT01235949|591870336|FG002|Primary Phase|Lost to Follow-up|1|||
163864645|NCT01235949|591870337|FG003|Primary Phase|Lost to Follow-up|1|||
163864646|NCT01235949|591870338|FG004|Primary Phase|Lost to Follow-up|0|||
163864647|NCT01235949|591870339|FG005|Primary Phase|Lost to Follow-up|2|||
163864648|NCT01235949|591870340|FG006|Primary Phase|Lost to Follow-up|0|||
163864649|NCT01235949|591870341|FG007|Primary Phase|Lost to Follow-up|0|||
163864650|NCT01235949|591870342|FG008|Primary Phase|Lost to Follow-up|0|||
163864651|NCT01235949|591870343|FG009|Primary Phase|Lost to Follow-up|0|||
164201385|NCT03154086|593110733|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163864652|NCT01235949|591870344|FG010|Primary Phase|Lost to Follow-up|0|||
163864653|NCT01235949|591870345|FG011|Primary Phase|Lost to Follow-up|0|||
163864654|NCT01235949|591870346|FG012|Primary Phase|Lost to Follow-up|0|||
164201386|NCT03154086|593110734|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201387|NCT03154086|593110735|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201388|NCT03154086|593110736|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201389|NCT03154086|593110737|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
163864655|NCT01235949|591870347|FG013|Primary Phase|Lost to Follow-up|0|||
163864656|NCT01235949|591870348|FG014|Primary Phase|Lost to Follow-up|0|||
163864657|NCT01235949|591870349|FG015|Primary Phase|Lost to Follow-up|0|||
163864658|NCT01235949|591870350|FG016|Primary Phase|Lost to Follow-up|0|||
163864659|NCT01235949|591870351|FG017|Primary Phase|Lost to Follow-up|0|||
163864660|NCT01235949|591870334|FG000|Booster Phase|Migrated/moved from study area|0|||
163969675|NCT02573870|592261235|FG000|Overall Study|Other: Fail to Meet Visit|0|||
163969676|NCT02573870|592261236|FG001|Overall Study|Other: Fail to Meet Visit|2|||
163969677|NCT01858532|592261237|FG000|Overall Study|Adverse Event|58|||
163969678|NCT01858532|592261238|FG001|Overall Study|Adverse Event|50|||
163969679|NCT01858532|592261239|FG002|Overall Study|Adverse Event|23|||
163969680|NCT01858532|592261240|FG003|Overall Study|Adverse Event|28|||
163969681|NCT01858532|592261237|FG000|Overall Study|Withdrew consent|71|||
163969682|NCT01858532|592261238|FG001|Overall Study|Withdrew consent|93|||
163969683|NCT01858532|592261239|FG002|Overall Study|Withdrew consent|46|||
163969684|NCT01858532|592261240|FG003|Overall Study|Withdrew consent|27|||
163969685|NCT01858532|592261237|FG000|Overall Study|Lost to Follow-up|17|||
163969686|NCT01858532|592261238|FG001|Overall Study|Lost to Follow-up|26|||
163969687|NCT01858532|592261239|FG002|Overall Study|Lost to Follow-up|11|||
163969688|NCT01858532|592261240|FG003|Overall Study|Lost to Follow-up|14|||
163969689|NCT01858532|592261237|FG000|Overall Study|Deterioration of medical status|3|||
163969690|NCT01858532|592261238|FG001|Overall Study|Deterioration of medical status|4|||
163969691|NCT01858532|592261239|FG002|Overall Study|Deterioration of medical status|3|||
163969692|NCT01858532|592261240|FG003|Overall Study|Deterioration of medical status|7|||
163969693|NCT01858532|592261237|FG000|Overall Study|Investigator request|3|||
163969694|NCT01858532|592261238|FG001|Overall Study|Investigator request|4|||
163969695|NCT01858532|592261239|FG002|Overall Study|Investigator request|2|||
163969696|NCT01858532|592261240|FG003|Overall Study|Investigator request|6|||
163969697|NCT01858532|592261237|FG000|Overall Study|Other, not specified|29|||
163969698|NCT01858532|592261238|FG001|Overall Study|Other, not specified|15|||
163969699|NCT01858532|592261239|FG002|Overall Study|Other, not specified|13|||
163969700|NCT01858532|592261240|FG003|Overall Study|Other, not specified|11|||
163969701|NCT00514514|592261241|FG000|Pre-phase|Death|10|||
163969702|NCT00514514|592261242|FG001|Pre-phase|Death|0|||
163969703|NCT00514514|592261243|FG002|Pre-phase|Death|0|||
163969704|NCT00514514|592261241|FG000|Pre-phase|administrative problems|2|||
163969705|NCT00514514|592261242|FG001|Pre-phase|administrative problems|0|||
163969706|NCT00514514|592261243|FG002|Pre-phase|administrative problems|0|||
163969707|NCT00514514|592261241|FG000|Pre-phase|Protocol Violation|6|||
163969708|NCT00514514|592261242|FG001|Pre-phase|Protocol Violation|0|||
163969709|NCT00514514|592261243|FG002|Pre-phase|Protocol Violation|0|||
163969710|NCT00514514|592261241|FG000|Pre-phase|condition no longer requires study drug|7|||
163969711|NCT00514514|592261242|FG001|Pre-phase|condition no longer requires study drug|0|||
163969712|NCT00514514|592261243|FG002|Pre-phase|condition no longer requires study drug|0|||
163969713|NCT00514514|592261241|FG000|Pre-phase|abnormal test procedure results|15|||
163969714|NCT00514514|592261242|FG001|Pre-phase|abnormal test procedure results|0|||
163969715|NCT00514514|592261243|FG002|Pre-phase|abnormal test procedure results|0|||
163969716|NCT00514514|592261241|FG000|Pre-phase|Lost to Follow-up|2|||
163969717|NCT00514514|592261242|FG001|Pre-phase|Lost to Follow-up|0|||
163969718|NCT00514514|592261243|FG002|Pre-phase|Lost to Follow-up|0|||
163969719|NCT00514514|592261241|FG000|Pre-phase|abnormal lab values|23|||
163969720|NCT00514514|592261242|FG001|Pre-phase|abnormal lab values|0|||
163969721|NCT00514514|592261243|FG002|Pre-phase|abnormal lab values|0|||
163969722|NCT00514514|592261241|FG000|Pre-phase|Lack of Efficacy|35|||
163969723|NCT00514514|592261242|FG001|Pre-phase|Lack of Efficacy|0|||
163969724|NCT00514514|592261243|FG002|Pre-phase|Lack of Efficacy|0|||
163969725|NCT00514514|592261241|FG000|Pre-phase|Adverse Event|137|||
163969726|NCT00514514|592261242|FG001|Pre-phase|Adverse Event|0|||
163969727|NCT00514514|592261243|FG002|Pre-phase|Adverse Event|0|||
163969728|NCT00514514|592261241|FG000|Pre-phase|Withdrawal by Subject|66|||
163969729|NCT00514514|592261242|FG001|Pre-phase|Withdrawal by Subject|0|||
163969730|NCT00514514|592261243|FG002|Pre-phase|Withdrawal by Subject|0|||
163969731|NCT00514514|592261241|FG000|Randomized - 9 Month|Death|3|||
163969732|NCT00514514|592261242|FG001|Randomized - 9 Month|Death|2|||
163969733|NCT00514514|592261243|FG002|Randomized - 9 Month|Death|2|||
163969734|NCT00514514|592261241|FG000|Randomized - 9 Month|Administrative problems|1|||
163969735|NCT00514514|592261242|FG001|Randomized - 9 Month|Administrative problems|1|||
163969736|NCT00514514|592261243|FG002|Randomized - 9 Month|Administrative problems|2|||
163969737|NCT00514514|592261241|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
163969738|NCT00514514|592261242|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
163969739|NCT00514514|592261243|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
163969740|NCT00514514|592261241|FG000|Randomized - 9 Month|Protocol Violation|1|||
163969741|NCT00514514|592261242|FG001|Randomized - 9 Month|Protocol Violation|1|||
163969742|NCT00514514|592261243|FG002|Randomized - 9 Month|Protocol Violation|0|||
164310228|NCT02541604|593509635|FG009|Overall Study|Lost to Follow-up|0|||
163969743|NCT00514514|592261241|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
163969744|NCT00514514|592261242|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
163969745|NCT00514514|592261243|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
163969746|NCT00514514|592261241|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
163969747|NCT00514514|592261242|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
163969748|NCT00514514|592261243|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
164310229|NCT02541604|593509636|FG010|Overall Study|Lost to Follow-up|0|||
163969749|NCT00514514|592261241|FG000|Randomized - 9 Month|Adverse Event|25|||
163969750|NCT00514514|592261242|FG001|Randomized - 9 Month|Adverse Event|44|||
164201390|NCT03154086|593110738|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201391|NCT03154086|593110739|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201392|NCT03154086|593110740|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201393|NCT03154086|593110741|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
164201394|NCT03154086|593110727|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
164201395|NCT03154086|593110728|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201396|NCT03154086|593110729|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201397|NCT03154086|593110730|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201398|NCT03154086|593110731|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201399|NCT03154086|593110732|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201400|NCT03154086|593110733|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201401|NCT03154086|593110734|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201402|NCT03154086|593110735|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201403|NCT03154086|593110736|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201404|NCT03154086|593110737|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201405|NCT03154086|593110738|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201406|NCT03154086|593110739|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201407|NCT03154086|593110740|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201408|NCT03154086|593110741|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
164201409|NCT03154086|593110727|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201410|NCT03154086|593110728|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201411|NCT03154086|593110729|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201412|NCT03154086|593110730|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201413|NCT03154086|593110731|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201414|NCT03154086|593110732|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201415|NCT03154086|593110733|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201416|NCT03154086|593110734|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201417|NCT03154086|593110735|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
164201418|NCT03154086|593110736|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201419|NCT03154086|593110737|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201420|NCT03154086|593110738|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201421|NCT03154086|593110739|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201422|NCT03154086|593110740|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201423|NCT03154086|593110741|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
164201424|NCT03154086|593110727|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201425|NCT03154086|593110728|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201426|NCT03154086|593110729|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201427|NCT03154086|593110730|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201428|NCT03154086|593110731|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201429|NCT03154086|593110732|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201430|NCT03154086|593110733|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201431|NCT03154086|593110734|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
164201432|NCT03154086|593110735|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
163864661|NCT01235949|591870335|FG001|Booster Phase|Migrated/moved from study area|0|||
163864662|NCT01235949|591870336|FG002|Booster Phase|Migrated/moved from study area|0|||
163864663|NCT01235949|591870337|FG003|Booster Phase|Migrated/moved from study area|0|||
163864664|NCT01235949|591870338|FG004|Booster Phase|Migrated/moved from study area|0|||
163864665|NCT01235949|591870339|FG005|Booster Phase|Migrated/moved from study area|0|||
163864666|NCT01235949|591870340|FG006|Booster Phase|Migrated/moved from study area|0|||
163864667|NCT01235949|591870341|FG007|Booster Phase|Migrated/moved from study area|0|||
163864668|NCT01235949|591870342|FG008|Booster Phase|Migrated/moved from study area|0|||
163864669|NCT01235949|591870343|FG009|Booster Phase|Migrated/moved from study area|0|||
163864670|NCT01235949|591870344|FG010|Booster Phase|Migrated/moved from study area|0|||
163864671|NCT01235949|591870345|FG011|Booster Phase|Migrated/moved from study area|1|||
163864672|NCT01235949|591870346|FG012|Booster Phase|Migrated/moved from study area|1|||
163864673|NCT01235949|591870347|FG013|Booster Phase|Migrated/moved from study area|0|||
163864674|NCT01235949|591870348|FG014|Booster Phase|Migrated/moved from study area|0|||
163864675|NCT01235949|591870349|FG015|Booster Phase|Migrated/moved from study area|0|||
163864676|NCT01235949|591870350|FG016|Booster Phase|Migrated/moved from study area|0|||
163864677|NCT01235949|591870351|FG017|Booster Phase|Migrated/moved from study area|1|||
163864678|NCT01235949|591870334|FG000|Booster Phase|Adverse Event|0|||
163864679|NCT01235949|591870335|FG001|Booster Phase|Adverse Event|0|||
163864680|NCT01235949|591870336|FG002|Booster Phase|Adverse Event|0|||
163864681|NCT01235949|591870337|FG003|Booster Phase|Adverse Event|0|||
163864682|NCT01235949|591870338|FG004|Booster Phase|Adverse Event|0|||
163864683|NCT01235949|591870339|FG005|Booster Phase|Adverse Event|0|||
163864684|NCT01235949|591870340|FG006|Booster Phase|Adverse Event|0|||
164201433|NCT03154086|593110736|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201434|NCT03154086|593110737|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201435|NCT03154086|593110738|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201436|NCT03154086|593110739|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201437|NCT03154086|593110740|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201438|NCT03154086|593110741|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
164201439|NCT03154086|593110727|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
164201440|NCT03154086|593110728|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
164201441|NCT03154086|593110729|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
164201442|NCT03154086|593110730|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
164201443|NCT03154086|593110731|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
164201444|NCT03154086|593110732|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
164201445|NCT03154086|593110733|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
164201446|NCT03154086|593110734|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
164201447|NCT03154086|593110735|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
164201448|NCT03154086|593110736|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
164201449|NCT03154086|593110737|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
164201450|NCT03154086|593110738|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
164201451|NCT03154086|593110739|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
164201452|NCT03154086|593110740|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
164201453|NCT03154086|593110741|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
164201454|NCT01603277|593110742|FG000|Overall Study|Adverse Event|1|||
164201455|NCT01603277|593110743|FG001|Overall Study|Adverse Event|2|||
164201456|NCT01603277|593110742|FG000|Overall Study|Physician Decision|0|||
163864685|NCT01235949|591870341|FG007|Booster Phase|Adverse Event|0|||
163864686|NCT01235949|591870342|FG008|Booster Phase|Adverse Event|0|||
163864687|NCT01235949|591870343|FG009|Booster Phase|Adverse Event|0|||
163864688|NCT01235949|591870344|FG010|Booster Phase|Adverse Event|0|||
163864689|NCT01235949|591870345|FG011|Booster Phase|Adverse Event|0|||
163864690|NCT01235949|591870346|FG012|Booster Phase|Adverse Event|0|||
163864691|NCT01235949|591870347|FG013|Booster Phase|Adverse Event|0|||
163864692|NCT01235949|591870348|FG014|Booster Phase|Adverse Event|0|||
163864693|NCT01235949|591870349|FG015|Booster Phase|Adverse Event|1|||
163864694|NCT01235949|591870350|FG016|Booster Phase|Adverse Event|0|||
163864695|NCT01235949|591870351|FG017|Booster Phase|Adverse Event|0|||
163864696|NCT01235949|591870334|FG000|Booster Phase|Withdrawal by Subject|0|||
163864697|NCT01235949|591870335|FG001|Booster Phase|Withdrawal by Subject|0|||
163864698|NCT01235949|591870336|FG002|Booster Phase|Withdrawal by Subject|0|||
163864699|NCT01235949|591870337|FG003|Booster Phase|Withdrawal by Subject|0|||
163864700|NCT01235949|591870338|FG004|Booster Phase|Withdrawal by Subject|0|||
163864701|NCT01235949|591870339|FG005|Booster Phase|Withdrawal by Subject|0|||
163864702|NCT01235949|591870340|FG006|Booster Phase|Withdrawal by Subject|0|||
163864703|NCT01235949|591870341|FG007|Booster Phase|Withdrawal by Subject|1|||
163864704|NCT01235949|591870342|FG008|Booster Phase|Withdrawal by Subject|1|||
163864705|NCT01235949|591870343|FG009|Booster Phase|Withdrawal by Subject|0|||
163864706|NCT01235949|591870344|FG010|Booster Phase|Withdrawal by Subject|1|||
163864707|NCT01235949|591870345|FG011|Booster Phase|Withdrawal by Subject|1|||
163864708|NCT01235949|591870346|FG012|Booster Phase|Withdrawal by Subject|2|||
163864709|NCT01235949|591870347|FG013|Booster Phase|Withdrawal by Subject|0|||
163864710|NCT01235949|591870348|FG014|Booster Phase|Withdrawal by Subject|2|||
163864711|NCT01235949|591870349|FG015|Booster Phase|Withdrawal by Subject|0|||
163864712|NCT01235949|591870350|FG016|Booster Phase|Withdrawal by Subject|0|||
163864713|NCT01235949|591870351|FG017|Booster Phase|Withdrawal by Subject|0|||
163864714|NCT01235949|591870334|FG000|Booster Phase|Lost to Follow-up|0|||
163864715|NCT01235949|591870335|FG001|Booster Phase|Lost to Follow-up|0|||
163864716|NCT01235949|591870336|FG002|Booster Phase|Lost to Follow-up|0|||
163864717|NCT01235949|591870337|FG003|Booster Phase|Lost to Follow-up|0|||
163864718|NCT01235949|591870338|FG004|Booster Phase|Lost to Follow-up|0|||
163864719|NCT01235949|591870339|FG005|Booster Phase|Lost to Follow-up|0|||
163864720|NCT01235949|591870340|FG006|Booster Phase|Lost to Follow-up|0|||
163864721|NCT01235949|591870341|FG007|Booster Phase|Lost to Follow-up|0|||
163864722|NCT01235949|591870342|FG008|Booster Phase|Lost to Follow-up|1|||
163864723|NCT01235949|591870343|FG009|Booster Phase|Lost to Follow-up|1|||
163864724|NCT01235949|591870344|FG010|Booster Phase|Lost to Follow-up|1|||
163864725|NCT01235949|591870345|FG011|Booster Phase|Lost to Follow-up|1|||
163864726|NCT01235949|591870346|FG012|Booster Phase|Lost to Follow-up|0|||
163864727|NCT01235949|591870347|FG013|Booster Phase|Lost to Follow-up|0|||
163864728|NCT01235949|591870348|FG014|Booster Phase|Lost to Follow-up|0|||
163864729|NCT01235949|591870349|FG015|Booster Phase|Lost to Follow-up|0|||
163864730|NCT01235949|591870350|FG016|Booster Phase|Lost to Follow-up|0|||
163864731|NCT01235949|591870351|FG017|Booster Phase|Lost to Follow-up|1|||
163864732|NCT03743246|591870352|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
163864733|NCT03743246|591870353|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
163864734|NCT03743246|591870354|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
163864735|NCT03743246|591870355|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
163864736|NCT03743246|591870352|FG000|Pre-Treatment Period|Death|0|||
163969751|NCT00514514|592261243|FG002|Randomized - 9 Month|Adverse Event|27|||
163969752|NCT00514514|592261241|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
163969753|NCT00514514|592261242|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
163969754|NCT00514514|592261243|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
163969755|NCT00514514|592261241|FG000|Extension - 4 Years|Lost to Follow-up|12|||
163969756|NCT00514514|592261242|FG001|Extension - 4 Years|Lost to Follow-up|10|||
163969757|NCT00514514|592261243|FG002|Extension - 4 Years|Lost to Follow-up|9|||
163969758|NCT00514514|592261241|FG000|Extension - 4 Years|Administrative problems|3|||
163969759|NCT00514514|592261242|FG001|Extension - 4 Years|Administrative problems|1|||
163969760|NCT00514514|592261243|FG002|Extension - 4 Years|Administrative problems|1|||
163969761|NCT00514514|592261241|FG000|Extension - 4 Years|Death|8|||
163969762|NCT00514514|592261242|FG001|Extension - 4 Years|Death|3|||
163969763|NCT00514514|592261243|FG002|Extension - 4 Years|Death|6|||
163969764|NCT00514514|592261241|FG000|Extension - 4 Years|Adverse Event|9|||
163969765|NCT00514514|592261242|FG001|Extension - 4 Years|Adverse Event|6|||
163969766|NCT00514514|592261243|FG002|Extension - 4 Years|Adverse Event|3|||
163969767|NCT02081534|592261245|FG000|Overall Study|Adverse Event|5|||
163969768|NCT02081534|592261246|FG001|Overall Study|Adverse Event|4|||
163969769|NCT02081534|592261247|FG002|Overall Study|Adverse Event|3|||
163969770|NCT02081534|592261248|FG003|Overall Study|Adverse Event|10|||
163969771|NCT02081534|592261249|FG004|Overall Study|Adverse Event|2|||
163969772|NCT02081534|592261250|FG005|Overall Study|Adverse Event|8|||
163969773|NCT02081534|592261251|FG006|Overall Study|Adverse Event|2|||
163969774|NCT02081534|592261245|FG000|Overall Study|Withdrawal by Subject|0|||
163969775|NCT02081534|592261246|FG001|Overall Study|Withdrawal by Subject|1|||
163969776|NCT02081534|592261247|FG002|Overall Study|Withdrawal by Subject|1|||
163969777|NCT02081534|592261248|FG003|Overall Study|Withdrawal by Subject|1|||
163969778|NCT02081534|592261249|FG004|Overall Study|Withdrawal by Subject|1|||
163969779|NCT02081534|592261250|FG005|Overall Study|Withdrawal by Subject|0|||
163969780|NCT02081534|592261251|FG006|Overall Study|Withdrawal by Subject|1|||
163969781|NCT02081534|592261245|FG000|Overall Study|Protocol Violation|0|||
163969782|NCT02081534|592261246|FG001|Overall Study|Protocol Violation|3|||
163969783|NCT02081534|592261247|FG002|Overall Study|Protocol Violation|0|||
163969784|NCT02081534|592261248|FG003|Overall Study|Protocol Violation|0|||
163969785|NCT02081534|592261249|FG004|Overall Study|Protocol Violation|0|||
163969786|NCT02081534|592261250|FG005|Overall Study|Protocol Violation|0|||
163969787|NCT02081534|592261251|FG006|Overall Study|Protocol Violation|1|||
163969788|NCT02081534|592261245|FG000|Overall Study|Lost to Follow-up|0|||
163969789|NCT02081534|592261246|FG001|Overall Study|Lost to Follow-up|0|||
163969790|NCT02081534|592261247|FG002|Overall Study|Lost to Follow-up|0|||
163969791|NCT02081534|592261248|FG003|Overall Study|Lost to Follow-up|2|||
163969792|NCT02081534|592261249|FG004|Overall Study|Lost to Follow-up|1|||
163969793|NCT02081534|592261250|FG005|Overall Study|Lost to Follow-up|1|||
163969794|NCT02081534|592261251|FG006|Overall Study|Lost to Follow-up|0|||
163969795|NCT01841749|592261257|FG000|Overall Study|Protocol Violation|1|||
163969796|NCT00677820|592261258|FG000|Overall Study|Lost to Follow-up|1|||
163969797|NCT00677820|592261259|FG001|Overall Study|Lost to Follow-up|0|||
163969798|NCT01480284|592261260|FG000|Overall Study|Withdrawal by Subject|2|||
163969799|NCT01480284|592261261|FG001|Overall Study|Withdrawal by Subject|0|||
163969800|NCT01480284|592261260|FG000|Overall Study|Adverse Event|1|||
163969801|NCT01480284|592261261|FG001|Overall Study|Adverse Event|0|||
163969802|NCT01480284|592261260|FG000|Overall Study|Study closed/terminated|3|||
163969803|NCT01480284|592261261|FG001|Overall Study|Study closed/terminated|0|||
163969804|NCT01480284|592261260|FG000|Overall Study|Lost to Follow-up|1|||
163969805|NCT01480284|592261261|FG001|Overall Study|Lost to Follow-up|0|||
163969806|NCT01480284|592261260|FG000|Overall Study|Physician Decision|1|||
163969807|NCT01480284|592261261|FG001|Overall Study|Physician Decision|0|||
163969808|NCT00066742|592261264|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
163969809|NCT00066742|592261264|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
163969810|NCT00066742|592261264|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
163969811|NCT00066742|592261264|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
163969812|NCT00066742|592261264|FG000|Induction Chemoradiotherapy|Ineligible|3|||
163969813|NCT00066742|592261264|FG000|Consolidation Chemotherapy|not protocol specified|1|||
163969814|NCT00066742|592261264|FG000|Consolidation Chemotherapy|Ineligible|2|||
163969815|NCT03374995|592261265|FG000|Overall Study|Withdrawal by Subject|0|||
163969816|NCT03374995|592261266|FG001|Overall Study|Withdrawal by Subject|1|||
163969817|NCT01383096|592261269|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
163969818|NCT01383096|592261270|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
163969819|NCT01383096|592261271|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
163969820|NCT01383096|592261269|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
163969821|NCT01383096|592261270|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
163969822|NCT01383096|592261271|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
163969823|NCT01383096|592261269|FG000|Third Intervention (8 Days)|Elevated AST|0|||
163969824|NCT01383096|592261270|FG001|Third Intervention (8 Days)|Elevated AST|1|||
163969825|NCT01383096|592261271|FG002|Third Intervention (8 Days)|Elevated AST|0|||
163969826|NCT01383096|592261269|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
163864737|NCT03743246|591870353|FG001|Pre-Treatment Period|Death|1|||
163864738|NCT03743246|591870354|FG002|Pre-Treatment Period|Death|0|||
163864739|NCT03743246|591870355|FG003|Pre-Treatment Period|Death|1|||
163864740|NCT03743246|591870352|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
163864741|NCT03743246|591870353|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163864742|NCT03743246|591870354|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163864743|NCT03743246|591870355|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
163864744|NCT03743246|591870352|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
163864745|NCT03743246|591870353|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163864746|NCT03743246|591870354|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163864747|NCT03743246|591870355|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
163864748|NCT03743246|591870352|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
163864749|NCT03743246|591870353|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
163864750|NCT03743246|591870354|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
163864751|NCT03743246|591870355|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
163864752|NCT03743246|591870352|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163864753|NCT03743246|591870353|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
163864754|NCT03743246|591870354|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163864755|NCT03743246|591870355|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
163864756|NCT03743246|591870352|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
163864757|NCT03743246|591870353|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
163864758|NCT03743246|591870354|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
163864759|NCT03743246|591870355|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
163864760|NCT03743246|591870352|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
163864761|NCT03743246|591870353|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
163864762|NCT03743246|591870354|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
163864763|NCT03743246|591870355|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
163864764|NCT03743246|591870352|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
163864765|NCT03743246|591870353|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
163864766|NCT03743246|591870354|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
163864767|NCT03743246|591870355|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
163864768|NCT00395018|591870356|FG000|On-Treatment|Death|4|||
163864769|NCT00395018|591870356|FG000|On-Treatment|Other Reason|2|||
163864770|NCT00395018|591870356|FG000|On-Treatment|Poor/non-compliance|2|||
163864771|NCT00395018|591870356|FG000|On-Treatment|Subject no longer meets study criteria|2|||
163864772|NCT00395018|591870356|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
163864773|NCT00395018|591870356|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
163864774|NCT00395018|591870356|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
163864775|NCT02534350|591870358|FG000|Overall Study|Randomized But Not Treated|1|||
163864776|NCT02534350|591870359|FG001|Overall Study|Randomized But Not Treated|0|||
163864777|NCT02534350|591870358|FG000|Overall Study|Protocol Violation|1|||
163864778|NCT02534350|591870359|FG001|Overall Study|Protocol Violation|0|||
163864779|NCT02534350|591870358|FG000|Overall Study|Withdrew Consent|2|||
163864780|NCT02534350|591870359|FG001|Overall Study|Withdrew Consent|0|||
163864781|NCT00716144|591870372|FG000|Overall Study|Withdrawal by Subject|4|||
163864782|NCT00716144|591870373|FG001|Overall Study|Withdrawal by Subject|2|||
163864783|NCT00716144|591870374|FG002|Overall Study|Withdrawal by Subject|6|||
163864784|NCT00716144|591870375|FG003|Overall Study|Withdrawal by Subject|6|||
163864785|NCT00716144|591870372|FG000|Overall Study|Lost to Follow-up|2|||
163864786|NCT00716144|591870373|FG001|Overall Study|Lost to Follow-up|2|||
163864787|NCT00716144|591870374|FG002|Overall Study|Lost to Follow-up|1|||
163864788|NCT00716144|591870375|FG003|Overall Study|Lost to Follow-up|2|||
163864789|NCT00716144|591870372|FG000|Overall Study|Adverse Event|0|||
163864790|NCT00716144|591870373|FG001|Overall Study|Adverse Event|0|||
163864791|NCT00716144|591870374|FG002|Overall Study|Adverse Event|0|||
163864792|NCT00716144|591870375|FG003|Overall Study|Adverse Event|2|||
164201457|NCT01603277|593110743|FG001|Overall Study|Physician Decision|1|||
164201458|NCT01603277|593110742|FG000|Overall Study|Protocol Violation|6|||
164201459|NCT01603277|593110743|FG001|Overall Study|Protocol Violation|10|||
164201460|NCT01603277|593110742|FG000|Overall Study|Withdrawal by Subject|5|||
164201461|NCT01603277|593110743|FG001|Overall Study|Withdrawal by Subject|4|||
164201462|NCT01603277|593110742|FG000|Overall Study|Non-Compliance|2|||
164201463|NCT01603277|593110743|FG001|Overall Study|Non-Compliance|1|||
164201464|NCT01701245|593110748|FG000|Overall Study|Protocol Violation|1|||
164201465|NCT01701245|593110749|FG001|Overall Study|Protocol Violation|3|||
163864793|NCT00716144|591870372|FG000|Overall Study|Non-compliance|1|||
163864794|NCT00716144|591870373|FG001|Overall Study|Non-compliance|0|||
163864795|NCT00716144|591870374|FG002|Overall Study|Non-compliance|0|||
163864796|NCT00716144|591870375|FG003|Overall Study|Non-compliance|0|||
163969827|NCT01383096|592261270|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
163969828|NCT01383096|592261271|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
163864797|NCT00716144|591870372|FG000|Overall Study|Protocol Violation|2|||
164201466|NCT01701245|593110748|FG000|Overall Study|Did not complete the open label period|11|||
164310230|NCT02541604|593509637|FG011|Overall Study|Lost to Follow-up|0|||
164310231|NCT02541604|593509626|FG000|Overall Study|Withdrawal by Subject|2|||
164310232|NCT02541604|593509627|FG001|Overall Study|Withdrawal by Subject|0|||
164310233|NCT02541604|593509628|FG002|Overall Study|Withdrawal by Subject|1|||
164310234|NCT02541604|593509629|FG003|Overall Study|Withdrawal by Subject|0|||
164310235|NCT02541604|593509630|FG004|Overall Study|Withdrawal by Subject|1|||
164310236|NCT02541604|593509631|FG005|Overall Study|Withdrawal by Subject|1|||
163864798|NCT00716144|591870373|FG001|Overall Study|Protocol Violation|0|||
163864799|NCT00716144|591870374|FG002|Overall Study|Protocol Violation|1|||
163864800|NCT00716144|591870375|FG003|Overall Study|Protocol Violation|0|||
163864801|NCT00716144|591870372|FG000|Overall Study|Physician Decision|0|||
163864802|NCT00716144|591870373|FG001|Overall Study|Physician Decision|1|||
163864803|NCT00716144|591870374|FG002|Overall Study|Physician Decision|2|||
163864804|NCT00716144|591870375|FG003|Overall Study|Physician Decision|2|||
163864805|NCT00716144|591870372|FG000|Overall Study|Intercurrent illness|0|||
163864806|NCT00716144|591870373|FG001|Overall Study|Intercurrent illness|0|||
163864807|NCT00716144|591870374|FG002|Overall Study|Intercurrent illness|1|||
163864808|NCT00716144|591870375|FG003|Overall Study|Intercurrent illness|0|||
163864809|NCT00716144|591870372|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
163864810|NCT00716144|591870373|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
163864811|NCT00716144|591870374|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
163864812|NCT00716144|591870375|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
163864813|NCT00716144|591870372|FG000|Overall Study|Adverse event: left foot pain|0|||
163864814|NCT00716144|591870373|FG001|Overall Study|Adverse event: left foot pain|1|||
163864815|NCT00716144|591870374|FG002|Overall Study|Adverse event: left foot pain|0|||
163864816|NCT00716144|591870375|FG003|Overall Study|Adverse event: left foot pain|0|||
163864817|NCT00716144|591870372|FG000|Overall Study|Clinical Depression|0|||
163864818|NCT00716144|591870373|FG001|Overall Study|Clinical Depression|1|||
163864819|NCT00716144|591870374|FG002|Overall Study|Clinical Depression|0|||
163864820|NCT00716144|591870375|FG003|Overall Study|Clinical Depression|0|||
163864821|NCT02341625|591870381|FG000|Overall Study|Disease Progression|2|||
163864822|NCT02341625|591870382|FG001|Overall Study|Disease Progression|2|||
163864823|NCT02341625|591870383|FG002|Overall Study|Disease Progression|3|||
163864824|NCT02341625|591870384|FG003|Overall Study|Disease Progression|6|||
163864825|NCT02341625|591870385|FG004|Overall Study|Disease Progression|7|||
163864826|NCT02341625|591870386|FG005|Overall Study|Disease Progression|7|||
163864827|NCT02341625|591870387|FG006|Overall Study|Disease Progression|28|||
163864828|NCT02341625|591870388|FG007|Overall Study|Disease Progression|5|||
163864829|NCT02341625|591870389|FG008|Overall Study|Disease Progression|4|||
163864830|NCT02341625|591870390|FG009|Overall Study|Disease Progression|19|||
163864831|NCT02341625|591870381|FG000|Overall Study|Study Drug Toxicity|0|||
163864832|NCT02341625|591870382|FG001|Overall Study|Study Drug Toxicity|0|||
163864833|NCT02341625|591870383|FG002|Overall Study|Study Drug Toxicity|0|||
163864834|NCT02341625|591870384|FG003|Overall Study|Study Drug Toxicity|1|||
163864835|NCT02341625|591870385|FG004|Overall Study|Study Drug Toxicity|0|||
163864836|NCT02341625|591870386|FG005|Overall Study|Study Drug Toxicity|3|||
163864837|NCT02341625|591870387|FG006|Overall Study|Study Drug Toxicity|10|||
163864838|NCT02341625|591870388|FG007|Overall Study|Study Drug Toxicity|0|||
163864839|NCT02341625|591870389|FG008|Overall Study|Study Drug Toxicity|0|||
163969829|NCT01383096|592261269|FG000|Third Intervention (8 Days)|Adverse Event|1|||
163969830|NCT01383096|592261270|FG001|Third Intervention (8 Days)|Adverse Event|0|||
163969831|NCT01383096|592261271|FG002|Third Intervention (8 Days)|Adverse Event|0|||
164310237|NCT02541604|593509632|FG006|Overall Study|Withdrawal by Subject|0|||
164310238|NCT02541604|593509633|FG007|Overall Study|Withdrawal by Subject|0|||
164310239|NCT02541604|593509634|FG008|Overall Study|Withdrawal by Subject|1|||
164310240|NCT02541604|593509635|FG009|Overall Study|Withdrawal by Subject|0|||
164310241|NCT02541604|593509636|FG010|Overall Study|Withdrawal by Subject|0|||
164310242|NCT02541604|593509637|FG011|Overall Study|Withdrawal by Subject|0|||
164310243|NCT02541604|593509626|FG000|Overall Study|Study Terminated by Sponsor|1|||
164310244|NCT02541604|593509627|FG001|Overall Study|Study Terminated by Sponsor|4|||
164310245|NCT02541604|593509628|FG002|Overall Study|Study Terminated by Sponsor|2|||
164310246|NCT02541604|593509629|FG003|Overall Study|Study Terminated by Sponsor|1|||
164310247|NCT02541604|593509630|FG004|Overall Study|Study Terminated by Sponsor|0|||
164310248|NCT02541604|593509631|FG005|Overall Study|Study Terminated by Sponsor|0|||
164310249|NCT02541604|593509632|FG006|Overall Study|Study Terminated by Sponsor|0|||
163864840|NCT02341625|591870390|FG009|Overall Study|Study Drug Toxicity|3|||
163864841|NCT02341625|591870381|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163864842|NCT02341625|591870382|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163864843|NCT02341625|591870383|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163864844|NCT02341625|591870384|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163864845|NCT02341625|591870385|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163864846|NCT02341625|591870386|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164310250|NCT02541604|593509633|FG007|Overall Study|Study Terminated by Sponsor|0|||
164310251|NCT02541604|593509634|FG008|Overall Study|Study Terminated by Sponsor|0|||
164310252|NCT02541604|593509635|FG009|Overall Study|Study Terminated by Sponsor|0|||
163969832|NCT01383096|592261269|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
163864847|NCT02341625|591870387|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163864848|NCT02341625|591870388|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
163864849|NCT02341625|591870389|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163864850|NCT02341625|591870390|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163864851|NCT02341625|591870381|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864852|NCT02341625|591870382|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864853|NCT02341625|591870383|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864854|NCT02341625|591870384|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864855|NCT02341625|591870385|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864856|NCT02341625|591870386|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864857|NCT02341625|591870387|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
163864858|NCT02341625|591870388|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
163864859|NCT02341625|591870389|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864860|NCT02341625|591870390|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
163864861|NCT02341625|591870381|FG000|Overall Study|Participant Withdrew Consent|0|||
163864862|NCT02341625|591870382|FG001|Overall Study|Participant Withdrew Consent|0|||
163864863|NCT02341625|591870383|FG002|Overall Study|Participant Withdrew Consent|0|||
163864864|NCT02341625|591870384|FG003|Overall Study|Participant Withdrew Consent|1|||
163864865|NCT02341625|591870385|FG004|Overall Study|Participant Withdrew Consent|0|||
163864866|NCT02341625|591870386|FG005|Overall Study|Participant Withdrew Consent|0|||
163864867|NCT02341625|591870387|FG006|Overall Study|Participant Withdrew Consent|0|||
163864868|NCT02341625|591870388|FG007|Overall Study|Participant Withdrew Consent|0|||
163864869|NCT02341625|591870389|FG008|Overall Study|Participant Withdrew Consent|0|||
163864870|NCT02341625|591870390|FG009|Overall Study|Participant Withdrew Consent|0|||
163864871|NCT02341625|591870381|FG000|Overall Study|Completed Treatment as per Protocol|0|||
163864872|NCT02341625|591870382|FG001|Overall Study|Completed Treatment as per Protocol|0|||
163864873|NCT02341625|591870383|FG002|Overall Study|Completed Treatment as per Protocol|0|||
163864874|NCT02341625|591870384|FG003|Overall Study|Completed Treatment as per Protocol|0|||
163864875|NCT02341625|591870385|FG004|Overall Study|Completed Treatment as per Protocol|0|||
163864876|NCT02341625|591870386|FG005|Overall Study|Completed Treatment as per Protocol|0|||
163864877|NCT02341625|591870387|FG006|Overall Study|Completed Treatment as per Protocol|0|||
163864878|NCT02341625|591870388|FG007|Overall Study|Completed Treatment as per Protocol|0|||
163864879|NCT02341625|591870389|FG008|Overall Study|Completed Treatment as per Protocol|0|||
163864880|NCT02341625|591870390|FG009|Overall Study|Completed Treatment as per Protocol|1|||
163864881|NCT02341625|591870381|FG000|Overall Study|Other Reasons|0|||
163864882|NCT02341625|591870382|FG001|Overall Study|Other Reasons|0|||
163864883|NCT02341625|591870383|FG002|Overall Study|Other Reasons|0|||
163864884|NCT02341625|591870384|FG003|Overall Study|Other Reasons|0|||
163864885|NCT02341625|591870385|FG004|Overall Study|Other Reasons|1|||
163864886|NCT02341625|591870386|FG005|Overall Study|Other Reasons|0|||
163864887|NCT02341625|591870387|FG006|Overall Study|Other Reasons|5|||
163864888|NCT02341625|591870388|FG007|Overall Study|Other Reasons|0|||
163864889|NCT02341625|591870389|FG008|Overall Study|Other Reasons|0|||
163864890|NCT02341625|591870390|FG009|Overall Study|Other Reasons|2|||
163864891|NCT02341625|591870381|FG000|Overall Study|Not Reported|0|||
163864892|NCT02341625|591870382|FG001|Overall Study|Not Reported|0|||
163864893|NCT02341625|591870383|FG002|Overall Study|Not Reported|0|||
163864894|NCT02341625|591870384|FG003|Overall Study|Not Reported|0|||
163864895|NCT02341625|591870385|FG004|Overall Study|Not Reported|0|||
163864896|NCT02341625|591870386|FG005|Overall Study|Not Reported|0|||
163864897|NCT02341625|591870387|FG006|Overall Study|Not Reported|0|||
163864898|NCT02341625|591870388|FG007|Overall Study|Not Reported|0|||
163864899|NCT02341625|591870389|FG008|Overall Study|Not Reported|0|||
163864900|NCT02341625|591870390|FG009|Overall Study|Not Reported|3|||
163864901|NCT01161498|591870391|FG000|Overall Study|Disease Progression|0|||
163864902|NCT01161498|591870392|FG001|Overall Study|Disease Progression|1|||
163864903|NCT03310983|591870396|FG000|Overall Study|Lost to Follow-up|15|||
163864904|NCT03310983|591870397|FG001|Overall Study|Lost to Follow-up|17|||
163864905|NCT01656304|591870398|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
163864906|NCT00823979|591870399|FG000|Overall Study|Lack of Efficacy|13|||
163864907|NCT00823979|591870400|FG001|Overall Study|Lack of Efficacy|16|||
163864908|NCT00823979|591870401|FG002|Overall Study|Lack of Efficacy|9|||
163864909|NCT00823979|591870399|FG000|Overall Study|Lost to Follow-up|2|||
163864910|NCT00823979|591870400|FG001|Overall Study|Lost to Follow-up|1|||
163864911|NCT00823979|591870401|FG002|Overall Study|Lost to Follow-up|0|||
163864912|NCT00823979|591870399|FG000|Overall Study|Withdrawal by Subject|2|||
163864913|NCT00823979|591870400|FG001|Overall Study|Withdrawal by Subject|3|||
163864914|NCT00823979|591870401|FG002|Overall Study|Withdrawal by Subject|2|||
163864915|NCT00823979|591870399|FG000|Overall Study|Protocol Violation|1|||
163864916|NCT00823979|591870400|FG001|Overall Study|Protocol Violation|1|||
163864917|NCT00823979|591870401|FG002|Overall Study|Protocol Violation|0|||
163864918|NCT00823979|591870399|FG000|Overall Study|Pregnancy|0|||
163864919|NCT00823979|591870400|FG001|Overall Study|Pregnancy|1|||
163864920|NCT00823979|591870401|FG002|Overall Study|Pregnancy|0|||
163864921|NCT00823979|591870399|FG000|Overall Study|Adverse Event|0|||
163864922|NCT00823979|591870400|FG001|Overall Study|Adverse Event|2|||
163864923|NCT00823979|591870401|FG002|Overall Study|Adverse Event|4|||
163864924|NCT00823979|591870399|FG000|Overall Study|Other|2|||
163864925|NCT00823979|591870400|FG001|Overall Study|Other|0|||
163864926|NCT00823979|591870401|FG002|Overall Study|Other|1|||
163864927|NCT00823979|591870399|FG000|Overall Study|Randomized but not Treated|4|||
163969833|NCT01383096|592261270|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
163969834|NCT01383096|592261271|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
163969835|NCT01383096|592261269|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
163969836|NCT01383096|592261270|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163969837|NCT01383096|592261271|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163969838|NCT01383096|592261269|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
163969839|NCT01383096|592261270|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
163969840|NCT01383096|592261271|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
163969841|NCT01383096|592261269|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
163969842|NCT01383096|592261270|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163969843|NCT01383096|592261271|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
163969844|NCT01383096|592261269|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
163969845|NCT01383096|592261270|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
163969846|NCT01383096|592261271|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
163969847|NCT01383096|592261269|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
163969848|NCT01383096|592261270|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
163969849|NCT01383096|592261271|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
164201467|NCT01701245|593110749|FG001|Overall Study|Did not complete the open label period|12|||
164201468|NCT03555149|593110756|FG000|Overall Study|Death|18|||
164201469|NCT03555149|593110757|FG001|Overall Study|Death|15|||
164201470|NCT03555149|593110758|FG002|Overall Study|Death|15|||
164201471|NCT03555149|593110759|FG003|Overall Study|Death|4|||
164201472|NCT03555149|593110760|FG004|Overall Study|Death|4|||
164201473|NCT03555149|593110761|FG005|Overall Study|Death|11|||
164201474|NCT03555149|593110762|FG006|Overall Study|Death|12|||
164201475|NCT03555149|593110763|FG007|Overall Study|Death|1|||
164201476|NCT03555149|593110756|FG000|Overall Study|Lost to Follow-up|1|||
164201477|NCT03555149|593110757|FG001|Overall Study|Lost to Follow-up|0|||
164201478|NCT03555149|593110758|FG002|Overall Study|Lost to Follow-up|0|||
164201479|NCT03555149|593110759|FG003|Overall Study|Lost to Follow-up|0|||
164201480|NCT03555149|593110760|FG004|Overall Study|Lost to Follow-up|0|||
164201481|NCT03555149|593110761|FG005|Overall Study|Lost to Follow-up|1|||
164201482|NCT03555149|593110762|FG006|Overall Study|Lost to Follow-up|0|||
164201483|NCT03555149|593110763|FG007|Overall Study|Lost to Follow-up|0|||
164201484|NCT03555149|593110756|FG000|Overall Study|Physician Decision|1|||
164201485|NCT03555149|593110757|FG001|Overall Study|Physician Decision|0|||
164201486|NCT03555149|593110758|FG002|Overall Study|Physician Decision|0|||
164201487|NCT03555149|593110759|FG003|Overall Study|Physician Decision|0|||
164201488|NCT03555149|593110760|FG004|Overall Study|Physician Decision|0|||
164201489|NCT03555149|593110761|FG005|Overall Study|Physician Decision|0|||
164201490|NCT03555149|593110762|FG006|Overall Study|Physician Decision|0|||
164201491|NCT03555149|593110763|FG007|Overall Study|Physician Decision|0|||
164201492|NCT03555149|593110756|FG000|Overall Study|Study Terminated By Sponsor|1|||
164201493|NCT03555149|593110757|FG001|Overall Study|Study Terminated By Sponsor|0|||
164201494|NCT03555149|593110758|FG002|Overall Study|Study Terminated By Sponsor|0|||
164201495|NCT03555149|593110759|FG003|Overall Study|Study Terminated By Sponsor|0|||
164201496|NCT03555149|593110760|FG004|Overall Study|Study Terminated By Sponsor|0|||
164201497|NCT03555149|593110761|FG005|Overall Study|Study Terminated By Sponsor|2|||
164201498|NCT03555149|593110762|FG006|Overall Study|Study Terminated By Sponsor|3|||
164201499|NCT03555149|593110763|FG007|Overall Study|Study Terminated By Sponsor|1|||
164201500|NCT03555149|593110756|FG000|Overall Study|Withdrawal by Subject|3|||
164201501|NCT03555149|593110757|FG001|Overall Study|Withdrawal by Subject|0|||
164201502|NCT03555149|593110758|FG002|Overall Study|Withdrawal by Subject|0|||
164201503|NCT03555149|593110759|FG003|Overall Study|Withdrawal by Subject|2|||
164201504|NCT03555149|593110760|FG004|Overall Study|Withdrawal by Subject|0|||
164201505|NCT03555149|593110761|FG005|Overall Study|Withdrawal by Subject|1|||
164201506|NCT03555149|593110762|FG006|Overall Study|Withdrawal by Subject|0|||
164201507|NCT03555149|593110763|FG007|Overall Study|Withdrawal by Subject|0|||
164201508|NCT02785939|593110765|FG000|Overall Study|Progression|25|||
164201509|NCT02785939|593110766|FG001|Overall Study|Progression|8|||
164201510|NCT02785939|593110765|FG000|Overall Study|Adverse Event|3|||
163864928|NCT00823979|591870400|FG001|Overall Study|Randomized but not Treated|3|||
163864929|NCT00823979|591870401|FG002|Overall Study|Randomized but not Treated|1|||
163864930|NCT00823979|591870399|FG000|Overall Study|Study Terminated by Sponsor|5|||
163864931|NCT00823979|591870400|FG001|Overall Study|Study Terminated by Sponsor|5|||
164201511|NCT02785939|593110766|FG001|Overall Study|Adverse Event|1|||
164201512|NCT02785939|593110765|FG000|Overall Study|Death|1|||
163864932|NCT00823979|591870401|FG002|Overall Study|Study Terminated by Sponsor|7|||
163864933|NCT03396913|591870402|FG000|Overall Study|Lost to Follow-up|0|||
163864934|NCT03396913|591870403|FG001|Overall Study|Lost to Follow-up|6|||
163864935|NCT03523091|591870404|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
163864936|NCT03523091|591870405|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
163864937|NCT03523091|591870404|FG000|Overall Study|Withdrawal by Subject|0|||
163864938|NCT03523091|591870405|FG001|Overall Study|Withdrawal by Subject|3|||
163864939|NCT03523091|591870404|FG000|Overall Study|Increase Botox dose|0|||
163864940|NCT03523091|591870405|FG001|Overall Study|Increase Botox dose|1|||
163864941|NCT01093534|591870406|FG000|Overall Study|Adverse Event|2|||
163864942|NCT01093534|591870407|FG001|Overall Study|Adverse Event|5|||
163864943|NCT01093534|591870408|FG002|Overall Study|Adverse Event|2|||
163864944|NCT01093534|591870406|FG000|Overall Study|Lack of Efficacy|2|||
163864945|NCT01093534|591870407|FG001|Overall Study|Lack of Efficacy|1|||
163864946|NCT01093534|591870408|FG002|Overall Study|Lack of Efficacy|1|||
163864947|NCT01093534|591870406|FG000|Overall Study|Withdrawal by Subject|5|||
163864948|NCT01093534|591870407|FG001|Overall Study|Withdrawal by Subject|7|||
163864949|NCT01093534|591870408|FG002|Overall Study|Withdrawal by Subject|2|||
163864950|NCT01093534|591870406|FG000|Overall Study|Other|1|||
163864951|NCT01093534|591870407|FG001|Overall Study|Other|3|||
163864952|NCT01093534|591870408|FG002|Overall Study|Other|4|||
163864953|NCT00741988|591870409|FG000|Overall Study|Adverse Event|2|||
163864954|NCT00741988|591870410|FG001|Overall Study|Adverse Event|4|||
163864955|NCT00741988|591870409|FG000|Overall Study|Lack of Efficacy|2|||
163864956|NCT00741988|591870410|FG001|Overall Study|Lack of Efficacy|0|||
163864957|NCT03863834|591870420|FG000|Overall Study|Lost to Follow-up|3|||
163864958|NCT03386929|591870426|FG000|Overall Study|Death|0|||
163864959|NCT03386929|591870427|FG001|Overall Study|Death|0|||
163864960|NCT03386929|591870428|FG002|Overall Study|Death|1|||
163864961|NCT03386929|591870426|FG000|Overall Study|Withdrawal by Subject|0|||
163864962|NCT03386929|591870427|FG001|Overall Study|Withdrawal by Subject|1|||
163864963|NCT03386929|591870428|FG002|Overall Study|Withdrawal by Subject|0|||
163864964|NCT03386929|591870426|FG000|Overall Study|Physician Decision|0|||
163864965|NCT03386929|591870427|FG001|Overall Study|Physician Decision|0|||
163864966|NCT03386929|591870428|FG002|Overall Study|Physician Decision|1|||
163864967|NCT03386929|591870426|FG000|Overall Study|Progression|4|||
163864968|NCT03386929|591870427|FG001|Overall Study|Progression|4|||
163864969|NCT03386929|591870428|FG002|Overall Study|Progression|0|||
163864970|NCT03386929|591870426|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
163864971|NCT03386929|591870427|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
163864972|NCT03386929|591870428|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
163864973|NCT03386929|591870426|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
163864974|NCT03386929|591870427|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
163864975|NCT03386929|591870428|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
163864976|NCT03538054|591870429|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
163864977|NCT03538054|591870429|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
163864978|NCT03538054|591870429|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
163864979|NCT01981356|591870430|FG000|Overall Study|Lost to Follow-up|4|||
163864980|NCT01981356|591870431|FG001|Overall Study|Lost to Follow-up|1|||
163864981|NCT01981356|591870430|FG000|Overall Study|Withdrawal by Subject|1|||
163864982|NCT01981356|591870431|FG001|Overall Study|Withdrawal by Subject|1|||
163864983|NCT01981356|591870430|FG000|Overall Study|Protocol Violation|2|||
163864984|NCT01981356|591870431|FG001|Overall Study|Protocol Violation|0|||
163864985|NCT01278862|591870432|FG000|Overall Study|Lost to Follow-up|1|||
163864986|NCT01278862|591870433|FG001|Overall Study|Lost to Follow-up|1|||
163864987|NCT02952261|591870435|FG000|Overall Study|Withdrawal by Subject|4|||
163864988|NCT02952261|591870436|FG001|Overall Study|Withdrawal by Subject|5|||
163864989|NCT02952261|591870435|FG000|Overall Study|Protocol Violation|1|||
163864990|NCT02952261|591870436|FG001|Overall Study|Protocol Violation|0|||
163864991|NCT05233085|591870437|FG000|Overall Study|Adverse Event|1|||
163864992|NCT05233085|591870438|FG001|Overall Study|Adverse Event|0|||
163864993|NCT05233085|591870439|FG002|Overall Study|Adverse Event|0|||
163864994|NCT05233085|591870440|FG003|Overall Study|Adverse Event|0|||
163864995|NCT05147233|591872391|FG000|Overall Study|Adverse Event|0|||
163864996|NCT05147233|591872392|FG001|Overall Study|Adverse Event|1|||
163864997|NCT05147233|591872391|FG000|Overall Study|Lost to Follow-up|1|||
163864998|NCT05147233|591872392|FG001|Overall Study|Lost to Follow-up|1|||
163864999|NCT05147233|591872391|FG000|Overall Study|Protocol Violation|0|||
163969850|NCT01211535|592261272|FG000|Overall Study|Adverse Event|0|||
163969851|NCT01211535|592261273|FG001|Overall Study|Adverse Event|1|||
163865000|NCT05147233|591872392|FG001|Overall Study|Protocol Violation|1|||
163865001|NCT05147233|591872391|FG000|Overall Study|Withdrawal by Subject|2|||
163865002|NCT05147233|591872392|FG001|Overall Study|Withdrawal by Subject|1|||
163865003|NCT04513522|591872393|FG000|Overall Study|Other reasons|1|||
163865004|NCT04513522|591872393|FG000|Overall Study|Adverse event unrelated to study drug|9|||
163865005|NCT04513522|591872393|FG000|Overall Study|Study drug toxicity|14|||
163865006|NCT04513522|591872393|FG000|Overall Study|Disease progression|39|||
163969852|NCT03593850|592261279|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
163969853|NCT03593850|592261280|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
163969854|NCT02490475|592261281|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
163969855|NCT02490475|592261282|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
163969856|NCT02490475|592261283|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
163969857|NCT02490475|592261284|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
163969858|NCT02490475|592261281|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
163969859|NCT02490475|592261282|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
163969860|NCT02490475|592261283|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
163969861|NCT02490475|592261284|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
163969862|NCT02490475|592261281|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
163969863|NCT02490475|592261282|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
163969864|NCT02490475|592261283|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
163969865|NCT02490475|592261284|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
163969866|NCT02490475|592261281|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
163969867|NCT02490475|592261282|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
163969868|NCT02490475|592261283|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
163969869|NCT02490475|592261284|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
163969870|NCT02490475|592261281|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
163969871|NCT02490475|592261282|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
163969872|NCT02490475|592261283|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
163969873|NCT02490475|592261284|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
163969874|NCT02490475|592261281|FG000|Period 2: Extension Phase|Refused Treatment|0|||
163969875|NCT02490475|592261282|FG001|Period 2: Extension Phase|Refused Treatment|0|||
163969876|NCT02490475|592261283|FG002|Period 2: Extension Phase|Refused Treatment|0|||
163969877|NCT02490475|592261284|FG003|Period 2: Extension Phase|Refused Treatment|1|||
163969878|NCT02490475|592261281|FG000|Period 2: Extension Phase|Adverse Event|0|||
163969879|NCT02490475|592261282|FG001|Period 2: Extension Phase|Adverse Event|0|||
163969880|NCT02490475|592261283|FG002|Period 2: Extension Phase|Adverse Event|1|||
163969881|NCT02490475|592261284|FG003|Period 2: Extension Phase|Adverse Event|0|||
163969882|NCT00616434|592261286|FG000|Overall Study|Adverse Event|5|||
163969883|NCT00616434|592261287|FG001|Overall Study|Adverse Event|2|||
163969884|NCT00616434|592261286|FG000|Overall Study|Physician Decision|0|||
163969885|NCT00616434|592261287|FG001|Overall Study|Physician Decision|4|||
163969886|NCT00616434|592261286|FG000|Overall Study|Withdrawal by Subject|1|||
163969887|NCT00616434|592261287|FG001|Overall Study|Withdrawal by Subject|1|||
163969888|NCT00616434|592261286|FG000|Overall Study|Protocol deviation|0|||
163969889|NCT00616434|592261287|FG001|Overall Study|Protocol deviation|1|||
163969890|NCT00914927|592261291|FG000|Overall Study|Adverse Event|0|||
163969891|NCT00914927|592261292|FG001|Overall Study|Adverse Event|0|||
163969892|NCT00914927|592261293|FG002|Overall Study|Adverse Event|0|||
163969893|NCT00914927|592261294|FG003|Overall Study|Adverse Event|0|||
163969894|NCT00914927|592261295|FG004|Overall Study|Adverse Event|1|||
163969895|NCT00914927|592261296|FG005|Overall Study|Adverse Event|0|||
163969896|NCT00914927|592261297|FG006|Overall Study|Adverse Event|0|||
163969897|NCT00914927|592261291|FG000|Overall Study|Withdrawal by Subject|0|||
163969898|NCT00914927|592261292|FG001|Overall Study|Withdrawal by Subject|1|||
163969899|NCT00914927|592261293|FG002|Overall Study|Withdrawal by Subject|0|||
163969900|NCT00914927|592261294|FG003|Overall Study|Withdrawal by Subject|1|||
163969901|NCT00914927|592261295|FG004|Overall Study|Withdrawal by Subject|0|||
163969902|NCT00914927|592261296|FG005|Overall Study|Withdrawal by Subject|0|||
163969903|NCT00914927|592261297|FG006|Overall Study|Withdrawal by Subject|0|||
163969904|NCT00914927|592261291|FG000|Overall Study|Lost to Follow-up|0|||
163969905|NCT00914927|592261292|FG001|Overall Study|Lost to Follow-up|0|||
163969906|NCT00914927|592261293|FG002|Overall Study|Lost to Follow-up|0|||
163969907|NCT00914927|592261294|FG003|Overall Study|Lost to Follow-up|1|||
163969908|NCT00914927|592261295|FG004|Overall Study|Lost to Follow-up|0|||
163969909|NCT00914927|592261296|FG005|Overall Study|Lost to Follow-up|0|||
163969910|NCT00914927|592261297|FG006|Overall Study|Lost to Follow-up|0|||
163969911|NCT00914927|592261291|FG000|Overall Study|Administrative/Other|2|||
163969912|NCT00914927|592261292|FG001|Overall Study|Administrative/Other|1|||
163969913|NCT00914927|592261293|FG002|Overall Study|Administrative/Other|0|||
163969914|NCT00914927|592261294|FG003|Overall Study|Administrative/Other|0|||
163969915|NCT00914927|592261295|FG004|Overall Study|Administrative/Other|1|||
163969916|NCT00914927|592261296|FG005|Overall Study|Administrative/Other|0|||
163969917|NCT00914927|592261297|FG006|Overall Study|Administrative/Other|0|||
163969918|NCT04784897|592261298|FG000|Overall Study|Death|4|||
163969919|NCT04784897|592261299|FG001|Overall Study|Death|2|||
163969920|NCT04784897|592261300|FG002|Overall Study|Death|1|||
163969921|NCT04784897|592261298|FG000|Overall Study|Withdrawal by Subject|0|||
163969922|NCT04784897|592261299|FG001|Overall Study|Withdrawal by Subject|0|||
163969923|NCT04784897|592261300|FG002|Overall Study|Withdrawal by Subject|1|||
163969924|NCT02170779|592261304|FG000|Overall Study|Withdrawal by Subject|1|||
164310253|NCT02541604|593509636|FG010|Overall Study|Study Terminated by Sponsor|0|||
164310254|NCT02541604|593509637|FG011|Overall Study|Study Terminated by Sponsor|0|||
164310255|NCT02541604|593509626|FG000|Overall Study|Medical condition may jeopardize safety|0|||
164310256|NCT02541604|593509627|FG001|Overall Study|Medical condition may jeopardize safety|0|||
164310257|NCT02541604|593509628|FG002|Overall Study|Medical condition may jeopardize safety|0|||
164310258|NCT02541604|593509629|FG003|Overall Study|Medical condition may jeopardize safety|0|||
164310259|NCT02541604|593509630|FG004|Overall Study|Medical condition may jeopardize safety|0|||
164310260|NCT02541604|593509631|FG005|Overall Study|Medical condition may jeopardize safety|0|||
164310261|NCT02541604|593509632|FG006|Overall Study|Medical condition may jeopardize safety|0|||
164310262|NCT02541604|593509633|FG007|Overall Study|Medical condition may jeopardize safety|1|||
164310263|NCT02541604|593509634|FG008|Overall Study|Medical condition may jeopardize safety|0|||
164310264|NCT02541604|593509635|FG009|Overall Study|Medical condition may jeopardize safety|0|||
164310265|NCT02541604|593509636|FG010|Overall Study|Medical condition may jeopardize safety|0|||
164310266|NCT02541604|593509637|FG011|Overall Study|Medical condition may jeopardize safety|0|||
164310267|NCT00993148|593509638|FG000|Overall Study|Lost to Follow-up|2|||
164310268|NCT00993148|593509638|FG000|Overall Study|never initiated treatment|1|||
164310269|NCT00806819|593509639|FG000|Overall Study|progressive disease (modified RECIST )|217|||
164310270|NCT00806819|593509640|FG001|Overall Study|progressive disease (modified RECIST )|216|||
163865007|NCT04513522|591872393|FG000|Overall Study|Participants withdrew consent|2|||
163865008|NCT04517864|591872394|FG000|Placebo-Controlled Phase|Adverse Event|1|||
163865009|NCT04517864|591872395|FG001|Placebo-Controlled Phase|Adverse Event|0|||
163865010|NCT04517864|591872396|FG002|Placebo-Controlled Phase|Adverse Event|0|||
163865011|NCT04517864|591872394|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
163865012|NCT04517864|591872395|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
163865013|NCT04517864|591872396|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
163865014|NCT04517864|591872394|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
163865015|NCT04517864|591872395|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
163865016|NCT04517864|591872396|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
163865017|NCT04517864|591872394|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
163865018|NCT04517864|591872395|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
163865019|NCT04517864|591872396|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
163865020|NCT04517864|591872394|FG000|Active Therapy Extension Phase|Adverse Event|1|||
163865021|NCT04517864|591872395|FG001|Active Therapy Extension Phase|Adverse Event|0|||
163865022|NCT04517864|591872396|FG002|Active Therapy Extension Phase|Adverse Event|0|||
163865023|NCT04517864|591872394|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
163865024|NCT04517864|591872395|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
163865025|NCT04517864|591872396|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
163865026|NCT04517864|591872394|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
163865027|NCT04517864|591872395|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
163865028|NCT04517864|591872396|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
163865029|NCT04517864|591872394|FG000|Active Therapy Extension Phase|Physician Decision|1|||
163865030|NCT04517864|591872395|FG001|Active Therapy Extension Phase|Physician Decision|0|||
163865031|NCT04517864|591872396|FG002|Active Therapy Extension Phase|Physician Decision|0|||
163865032|NCT04517864|591872394|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
163865033|NCT04517864|591872395|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
163865034|NCT04517864|591872396|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
163865035|NCT04517864|591872394|FG000|Extension Phase|Adverse Event|0|||
163865036|NCT04517864|591872395|FG001|Extension Phase|Adverse Event|0|||
163865037|NCT04517864|591872396|FG002|Extension Phase|Adverse Event|1|||
163865038|NCT04517864|591872394|FG000|Extension Phase|Lack of Efficacy|0|||
163865039|NCT04517864|591872395|FG001|Extension Phase|Lack of Efficacy|0|||
163865040|NCT04517864|591872396|FG002|Extension Phase|Lack of Efficacy|2|||
163865041|NCT04517864|591872394|FG000|Extension Phase|Study Terminated By Sponsor|0|||
163865042|NCT04517864|591872395|FG001|Extension Phase|Study Terminated By Sponsor|0|||
163865043|NCT04517864|591872396|FG002|Extension Phase|Study Terminated By Sponsor|32|||
163865044|NCT04517864|591872394|FG000|Extension Phase|Withdrawal by Subject|0|||
163865045|NCT04517864|591872395|FG001|Extension Phase|Withdrawal by Subject|0|||
163865046|NCT04517864|591872396|FG002|Extension Phase|Withdrawal by Subject|3|||
163865047|NCT04517864|591872394|FG000|Extension Phase|Approved Drug Available for Indication|0|||
163865048|NCT04517864|591872395|FG001|Extension Phase|Approved Drug Available for Indication|0|||
163865049|NCT04517864|591872396|FG002|Extension Phase|Approved Drug Available for Indication|7|||
163865050|NCT04722003|591872399|FG000|Overall Study|Lost to Follow-up|2|||
163865051|NCT04722003|591872400|FG001|Overall Study|Lost to Follow-up|0|||
163865052|NCT04722003|591872399|FG000|Overall Study|Physician Decision|1|||
163865053|NCT04722003|591872400|FG001|Overall Study|Physician Decision|0|||
163865054|NCT03351075|591872401|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
163865055|NCT03351075|591872402|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
163865056|NCT03351075|591872401|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
163865057|NCT03351075|591872402|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
163969925|NCT02170779|592261305|FG001|Overall Study|Withdrawal by Subject|0|||
164310271|NCT00806819|593509639|FG000|Overall Study|Worsening or AE of underlying disease|18|||
163865058|NCT03351075|591872401|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
163865059|NCT03351075|591872402|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
163865060|NCT03351075|591872401|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
163865061|NCT03351075|591872402|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
163865062|NCT05219253|591872408|FG000|Overall Study|Withdrawal by Subject|1|||
163865063|NCT05219253|591872409|FG001|Overall Study|Withdrawal by Subject|2|||
163865064|NCT03086369|591872410|FG000|Overall Study|Lost to Follow-up|1|||
163865065|NCT03086369|591872411|FG001|Overall Study|Lost to Follow-up|0|||
163865066|NCT03086369|591872412|FG002|Overall Study|Lost to Follow-up|0|||
163865067|NCT03086369|591872413|FG003|Overall Study|Lost to Follow-up|2|||
163865068|NCT03086369|591872414|FG004|Overall Study|Lost to Follow-up|1|||
163865069|NCT03086369|591872410|FG000|Overall Study|Physician Decision|0|||
163865070|NCT03086369|591872411|FG001|Overall Study|Physician Decision|0|||
163865071|NCT03086369|591872412|FG002|Overall Study|Physician Decision|0|||
163865072|NCT03086369|591872413|FG003|Overall Study|Physician Decision|1|||
163865073|NCT03086369|591872414|FG004|Overall Study|Physician Decision|2|||
163865074|NCT03086369|591872410|FG000|Overall Study|Withdrawal by Subject|0|||
163865075|NCT03086369|591872411|FG001|Overall Study|Withdrawal by Subject|0|||
164201513|NCT02785939|593110766|FG001|Overall Study|Death|0|||
164201514|NCT02785939|593110765|FG000|Overall Study|Refusal|1|||
164201515|NCT02785939|593110766|FG001|Overall Study|Refusal|0|||
164201516|NCT02785939|593110765|FG000|Overall Study|Deteriorating health|1|||
164201517|NCT02785939|593110766|FG001|Overall Study|Deteriorating health|0|||
164201518|NCT02785939|593110765|FG000|Overall Study|Not protocol specified|0|||
164201519|NCT02785939|593110766|FG001|Overall Study|Not protocol specified|1|||
164201520|NCT04465422|593110767|FG000|Overall Study|Lost to Follow-up|0|||
164201521|NCT04465422|593110768|FG001|Overall Study|Lost to Follow-up|2|||
164201522|NCT01787552|593110771|FG000|Overall Study|Withdrawal by Subject|2|||
164201523|NCT01787552|593110772|FG001|Overall Study|Withdrawal by Subject|0|||
164201524|NCT01787552|593110773|FG002|Overall Study|Withdrawal by Subject|0|||
164201525|NCT01787552|593110774|FG003|Overall Study|Withdrawal by Subject|4|||
164201526|NCT01787552|593110771|FG000|Overall Study|Physician Decision|2|||
164201527|NCT01787552|593110772|FG001|Overall Study|Physician Decision|2|||
164201528|NCT01787552|593110773|FG002|Overall Study|Physician Decision|1|||
164201529|NCT01787552|593110774|FG003|Overall Study|Physician Decision|2|||
164201530|NCT01787552|593110771|FG000|Overall Study|Death|0|||
164201531|NCT01787552|593110772|FG001|Overall Study|Death|0|||
164201532|NCT01787552|593110773|FG002|Overall Study|Death|0|||
164201533|NCT01787552|593110774|FG003|Overall Study|Death|1|||
164201534|NCT01787552|593110771|FG000|Overall Study|Adverse Event|2|||
164201535|NCT01787552|593110772|FG001|Overall Study|Adverse Event|5|||
164201536|NCT01787552|593110773|FG002|Overall Study|Adverse Event|2|||
164201537|NCT01787552|593110774|FG003|Overall Study|Adverse Event|16|||
164201538|NCT01787552|593110771|FG000|Overall Study|Study terminated by Sponsor|0|||
164201539|NCT01787552|593110772|FG001|Overall Study|Study terminated by Sponsor|0|||
164201540|NCT01787552|593110773|FG002|Overall Study|Study terminated by Sponsor|1|||
164201541|NCT01787552|593110774|FG003|Overall Study|Study terminated by Sponsor|3|||
164201542|NCT01787552|593110771|FG000|Overall Study|Progressive Disease|2|||
164201543|NCT01787552|593110772|FG001|Overall Study|Progressive Disease|2|||
164201544|NCT01787552|593110773|FG002|Overall Study|Progressive Disease|1|||
164201545|NCT01787552|593110774|FG003|Overall Study|Progressive Disease|1|||
164201546|NCT01299584|593110779|FG000|Overall Study|Protocol Violation|9|||
164201547|NCT02175121|593110787|FG000|Overall Study|Lack of Efficacy|1|||
164201548|NCT02175121|593110788|FG001|Overall Study|Lack of Efficacy|0|||
164201549|NCT02175121|593110789|FG002|Overall Study|Lack of Efficacy|0|||
164201550|NCT02175121|593110790|FG003|Overall Study|Lack of Efficacy|0|||
164201551|NCT02175121|593110791|FG004|Overall Study|Lack of Efficacy|0|||
164201552|NCT02175121|593110787|FG000|Overall Study|Lost to Follow-up|0|||
164201553|NCT02175121|593110788|FG001|Overall Study|Lost to Follow-up|1|||
164201554|NCT02175121|593110789|FG002|Overall Study|Lost to Follow-up|0|||
164201555|NCT02175121|593110790|FG003|Overall Study|Lost to Follow-up|1|||
164201556|NCT02175121|593110791|FG004|Overall Study|Lost to Follow-up|0|||
164201557|NCT02175121|593110787|FG000|Overall Study|Personal emergency|0|||
164201558|NCT02175121|593110788|FG001|Overall Study|Personal emergency|0|||
164201559|NCT02175121|593110789|FG002|Overall Study|Personal emergency|0|||
164201560|NCT02175121|593110790|FG003|Overall Study|Personal emergency|0|||
164201561|NCT02175121|593110791|FG004|Overall Study|Personal emergency|1|||
163865076|NCT03086369|591872412|FG002|Overall Study|Withdrawal by Subject|0|||
163865077|NCT03086369|591872413|FG003|Overall Study|Withdrawal by Subject|5|||
163865078|NCT03086369|591872414|FG004|Overall Study|Withdrawal by Subject|3|||
163865079|NCT03086369|591872410|FG000|Overall Study|Progressive Disease|0|||
163865080|NCT03086369|591872411|FG001|Overall Study|Progressive Disease|0|||
164201562|NCT02175121|593110787|FG000|Overall Study|Schedule conflict|0|||
164201563|NCT02175121|593110788|FG001|Overall Study|Schedule conflict|0|||
163865081|NCT03086369|591872412|FG002|Overall Study|Progressive Disease|0|||
164201564|NCT02175121|593110789|FG002|Overall Study|Schedule conflict|1|||
164201565|NCT02175121|593110790|FG003|Overall Study|Schedule conflict|0|||
164201566|NCT02175121|593110791|FG004|Overall Study|Schedule conflict|0|||
164201567|NCT02175121|593110787|FG000|Overall Study|Time issues|0|||
163969926|NCT02170779|592261304|FG000|Overall Study|Lost to Follow-up|0|||
163969927|NCT02170779|592261305|FG001|Overall Study|Lost to Follow-up|1|||
163969928|NCT00199836|592261310|FG000|Overall Study|Progressive Disease|5|||
163969929|NCT00199836|592261310|FG000|Overall Study|Death|1|||
163969930|NCT00805025|592261318|FG000|Overall Study|Screened but not enrolled/treated|42|||
163969931|NCT00805025|592261318|FG000|Overall Study|Adverse Event|4|||
163969932|NCT00805025|592261318|FG000|Overall Study|Withdrawal by Subject|2|||
163969933|NCT00805025|592261318|FG000|Overall Study|Physician Decision|1|||
163969934|NCT00932425|592261324|FG000|Overall Study|Lost to Follow-up|0|||
163969935|NCT00932425|592261325|FG001|Overall Study|Lost to Follow-up|1|||
163969936|NCT00932425|592261324|FG000|Overall Study|Withdrawal by Subject|0|||
163969937|NCT00932425|592261325|FG001|Overall Study|Withdrawal by Subject|1|||
163969938|NCT01252810|592261326|FG000|Overall Study|Withdrawal by Subject|4|||
163969939|NCT01252810|592261327|FG001|Overall Study|Withdrawal by Subject|1|||
163969940|NCT01252810|592261326|FG000|Overall Study|Lost to Follow-up|0|||
163969941|NCT01252810|592261327|FG001|Overall Study|Lost to Follow-up|1|||
163969942|NCT01252810|592261326|FG000|Overall Study|Physician Decision|2|||
163969943|NCT01252810|592261327|FG001|Overall Study|Physician Decision|1|||
163969944|NCT01252810|592261326|FG000|Overall Study|Various reasons|8|||
163969945|NCT01252810|592261327|FG001|Overall Study|Various reasons|0|||
163969946|NCT02811549|592261329|FG000|Overall Study|Lost to Follow-up|1|||
163969947|NCT02811549|592261329|FG000|Overall Study|Withdrawal by Subject|3|||
163969948|NCT02811549|592261329|FG000|Overall Study|Subject screen failed|4|||
163969949|NCT02811549|592261329|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
163969950|NCT05293743|592261330|FG000|Overall Study|Withdrawal by Subject|1|||
163969951|NCT05293743|592261331|FG001|Overall Study|Withdrawal by Subject|0|||
163969952|NCT01200238|592261334|FG000|Overall Study|Adverse Event|2|||
163969953|NCT01200238|592261335|FG001|Overall Study|Adverse Event|1|||
163969954|NCT01200238|592261334|FG000|Overall Study|Progressive Disease|5|||
163969955|NCT01200238|592261335|FG001|Overall Study|Progressive Disease|8|||
163969956|NCT01200238|592261334|FG000|Overall Study|Withdrawal by Subject|0|||
163969957|NCT01200238|592261335|FG001|Overall Study|Withdrawal by Subject|1|||
163969958|NCT02322125|592262936|FG000|Overall Study|Withdrawal by Subject|2|||
163969959|NCT04096274|592262945|FG000|Phase I|Lost to Follow-up|5|||
163969960|NCT04096274|592262946|FG001|Phase I|Lost to Follow-up|5|||
163969961|NCT04096274|592262945|FG000|Phase II|Lost to Follow-up|11|||
163969962|NCT04096274|592262946|FG001|Phase II|Lost to Follow-up|11|||
163969963|NCT01462435|592262948|FG000|Overall Study|Lack of Efficacy|1|||
163969964|NCT01462435|592262949|FG001|Overall Study|Lack of Efficacy|0|||
163969965|NCT01462435|592262950|FG002|Overall Study|Lack of Efficacy|0|||
163969966|NCT01462435|592262951|FG003|Overall Study|Lack of Efficacy|3|||
163969967|NCT01462435|592262948|FG000|Overall Study|Physician Decision|0|||
163969968|NCT01462435|592262949|FG001|Overall Study|Physician Decision|0|||
163969969|NCT01462435|592262950|FG002|Overall Study|Physician Decision|1|||
163969970|NCT01462435|592262951|FG003|Overall Study|Physician Decision|0|||
163969971|NCT01462435|592262948|FG000|Overall Study|Withdrawal by Subject|0|||
163969972|NCT01462435|592262949|FG001|Overall Study|Withdrawal by Subject|0|||
163969973|NCT01462435|592262950|FG002|Overall Study|Withdrawal by Subject|0|||
163969974|NCT01462435|592262951|FG003|Overall Study|Withdrawal by Subject|1|||
163969975|NCT01462435|592262948|FG000|Overall Study|Lost to Follow-up|0|||
163969976|NCT01462435|592262949|FG001|Overall Study|Lost to Follow-up|0|||
163969977|NCT01462435|592262950|FG002|Overall Study|Lost to Follow-up|0|||
163969978|NCT01462435|592262951|FG003|Overall Study|Lost to Follow-up|1|||
163969979|NCT05092919|592262952|FG000|Overall Study|Lost to Follow-up|7|||
163969980|NCT05092919|592262952|FG000|Overall Study|Withdrawal by Subject|2|||
163969981|NCT03281668|592262956|FG000|Overall Study|Physician Decision|1|||
163969982|NCT03281668|592262956|FG000|Overall Study|scheduling conflict, family circumstance|2|||
164201568|NCT02175121|593110788|FG001|Overall Study|Time issues|0|||
164201569|NCT02175121|593110789|FG002|Overall Study|Time issues|1|||
164201570|NCT02175121|593110790|FG003|Overall Study|Time issues|0|||
164201571|NCT02175121|593110791|FG004|Overall Study|Time issues|0|||
164201572|NCT04798027|593110796|FG000|Overall Study|Protocol Violation|0|||
164201573|NCT04798027|593110797|FG001|Overall Study|Protocol Violation|0|||
164201574|NCT04798027|593110798|FG002|Overall Study|Protocol Violation|0|||
163969983|NCT03281668|592262956|FG000|Overall Study|Withdrawal by Subject|4|||
163969984|NCT03281668|592262956|FG000|Overall Study|Lost to Follow-up|1|||
163969985|NCT01543152|592262957|FG000|Overall Study|Withdrawal by Subject|0|||
163969986|NCT01543152|592262958|FG001|Overall Study|Withdrawal by Subject|2|||
163969987|NCT01543152|592262959|FG002|Overall Study|Withdrawal by Subject|0|||
163969988|NCT01543152|592262960|FG003|Overall Study|Withdrawal by Subject|0|||
163969989|NCT01543152|592262961|FG004|Overall Study|Withdrawal by Subject|0|||
163969990|NCT01838616|592262964|FG000|Titration Period|Adverse Event|18|||
163969991|NCT01838616|592262965|FG001|Titration Period|Adverse Event|48|||
163969992|NCT01838616|592262964|FG000|Titration Period|Lack of Efficacy|5|||
163969993|NCT01838616|592262965|FG001|Titration Period|Lack of Efficacy|12|||
163969994|NCT01838616|592262964|FG000|Titration Period|Withdrawal by Subject|5|||
164201575|NCT04798027|593110799|FG003|Overall Study|Protocol Violation|0|||
164201576|NCT04798027|593110800|FG004|Overall Study|Protocol Violation|1|||
164201577|NCT04798027|593110801|FG005|Overall Study|Protocol Violation|0|||
164310272|NCT00806819|593509640|FG001|Overall Study|Worsening or AE of underlying disease|25|||
164310273|NCT00806819|593509639|FG000|Overall Study|Other AE|38|||
164310274|NCT00806819|593509640|FG001|Overall Study|Other AE|40|||
164310275|NCT00806819|593509639|FG000|Overall Study|Protocol Violation|9|||
164310276|NCT00806819|593509640|FG001|Overall Study|Protocol Violation|4|||
164310277|NCT00806819|593509639|FG000|Overall Study|Lost to Follow-up|1|||
164310278|NCT00806819|593509640|FG001|Overall Study|Lost to Follow-up|0|||
164310279|NCT00806819|593509639|FG000|Overall Study|Withdrawal by Subject|32|||
164310280|NCT00806819|593509640|FG001|Overall Study|Withdrawal by Subject|29|||
164310281|NCT00806819|593509639|FG000|Overall Study|Not treated|6|||
164310282|NCT00806819|593509640|FG001|Overall Study|Not treated|3|||
164310283|NCT00806819|593509639|FG000|Overall Study|Reasons other than stated above|25|||
164310284|NCT00806819|593509640|FG001|Overall Study|Reasons other than stated above|41|||
164310285|NCT00912197|593509643|FG000|Overall Study|Withdrawal by Subject|3|||
164310286|NCT00912197|593509644|FG001|Overall Study|Withdrawal by Subject|3|||
164310287|NCT03304249|593509649|FG000|Overall Study|Lost to Follow-up|8|||
163865082|NCT03086369|591872413|FG003|Overall Study|Progressive Disease|1|||
163865083|NCT03086369|591872414|FG004|Overall Study|Progressive Disease|1|||
163865084|NCT03544515|591872415|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
163865085|NCT03544515|591872416|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
163865086|NCT03544515|591872415|FG000|Overall Study|Lost to Follow-up|2|||
163865087|NCT03544515|591872416|FG001|Overall Study|Lost to Follow-up|0|||
163865088|NCT03169244|591872417|FG000|Overall Study|Lost to Follow-up|1|||
163865089|NCT03169244|591872418|FG001|Overall Study|Lost to Follow-up|2|||
163865090|NCT03169244|591872417|FG000|Overall Study|Adverse Event|1|||
163865091|NCT03169244|591872418|FG001|Overall Study|Adverse Event|0|||
163865092|NCT03169244|591872417|FG000|Overall Study|Withdrawal by Subject|2|||
163865093|NCT03169244|591872418|FG001|Overall Study|Withdrawal by Subject|2|||
163865094|NCT03169244|591872417|FG000|Overall Study|Physician Decision|1|||
163865095|NCT03169244|591872418|FG001|Overall Study|Physician Decision|0|||
163865096|NCT00178399|591872419|FG000|Overall Study|Physician Decision|4|||
163865097|NCT00178399|591872419|FG000|Overall Study|Withdrawal by Subject|8|||
163865098|NCT00178399|591872419|FG000|Overall Study|Lost to Follow-up|1|||
163865099|NCT02631148|591872420|FG000|Overall Study|8 were ineligible|8|||
163865100|NCT02631148|591872421|FG001|Overall Study|8 were ineligible|0|||
163865101|NCT02631148|591872420|FG000|Overall Study|Withdrawal by Subject|1|||
163865102|NCT02631148|591872421|FG001|Overall Study|Withdrawal by Subject|0|||
163865103|NCT02631148|591872420|FG000|Overall Study|PAH not available to study participant|1|||
163865104|NCT02631148|591872421|FG001|Overall Study|PAH not available to study participant|0|||
163865105|NCT00357396|591872424|FG000|Overall Study|Adverse Event|1|||
163865106|NCT00357396|591872425|FG001|Overall Study|Adverse Event|0|||
163865107|NCT04035668|591872426|FG000|Overall Study|Adverse Event|3|||
163865108|NCT04035668|591872427|FG001|Overall Study|Adverse Event|4|||
163865109|NCT04035668|591872428|FG002|Overall Study|Adverse Event|2|||
163865110|NCT04035668|591872426|FG000|Overall Study|Lost to Follow-up|0|||
163865111|NCT04035668|591872427|FG001|Overall Study|Lost to Follow-up|1|||
163865112|NCT04035668|591872428|FG002|Overall Study|Lost to Follow-up|0|||
163865113|NCT04035668|591872426|FG000|Overall Study|Physician Decision|2|||
163865114|NCT04035668|591872427|FG001|Overall Study|Physician Decision|1|||
163865115|NCT04035668|591872428|FG002|Overall Study|Physician Decision|1|||
163865116|NCT04035668|591872426|FG000|Overall Study|Subject Decision|2|||
163865117|NCT04035668|591872427|FG001|Overall Study|Subject Decision|2|||
163865118|NCT04035668|591872428|FG002|Overall Study|Subject Decision|0|||
163865119|NCT02385669|591872429|FG000|Overall Study|Adverse Event|2|||
163865120|NCT00004124|591872430|FG000|Overall Study|Received no protocol therapy|12|||
163865121|NCT00004124|591872431|FG001|Overall Study|Received no protocol therapy|20|||
163865122|NCT04218110|591872436|FG000|Overall Study|Withdrawal by Subject|0|||
163865123|NCT04218110|591872437|FG001|Overall Study|Withdrawal by Subject|0|||
163865124|NCT04218110|591872438|FG002|Overall Study|Withdrawal by Subject|0|||
163865125|NCT04218110|591872439|FG003|Overall Study|Withdrawal by Subject|1|||
163865126|NCT00114244|591872440|FG000|Overall Study|Adverse Event|2|||
163865127|NCT00114244|591872441|FG001|Overall Study|Adverse Event|5|||
163865128|NCT00114244|591872440|FG000|Overall Study|Withdrawal by Subject|0|||
164310288|NCT03304249|593509650|FG001|Overall Study|Lost to Follow-up|10|||
163865129|NCT00114244|591872441|FG001|Overall Study|Withdrawal by Subject|2|||
163865130|NCT01376089|591872448|FG000|Overall Study|Patient received no contrast media|3|||
164310289|NCT03304249|593509649|FG000|Overall Study|Withdrawal by Subject|12|||
163865131|NCT01376089|591872449|FG001|Overall Study|Patient received no contrast media|4|||
163865132|NCT03262935|591872450|FG000|Overall Study|Withdrawal by Subject|6|||
164310290|NCT03304249|593509650|FG001|Overall Study|Withdrawal by Subject|2|||
163865133|NCT03262935|591872451|FG001|Overall Study|Withdrawal by Subject|7|||
163865134|NCT03262935|591872450|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
163865135|NCT03262935|591872451|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
164135325|NCT00851318|592859130|FG001|Overall Study|Lack of Efficacy|2|||
164310291|NCT03304249|593509649|FG000|Overall Study|Moved Out of District|4|||
164310292|NCT03304249|593509650|FG001|Overall Study|Moved Out of District|2|||
164310293|NCT00552188|593510799|FG000|Overall Study|Adverse Event|0|||
163969995|NCT01838616|592262965|FG001|Titration Period|Withdrawal by Subject|5|||
163969996|NCT01838616|592262964|FG000|Titration Period|Technical problems|1|||
163969997|NCT01838616|592262965|FG001|Titration Period|Technical problems|0|||
163969998|NCT01838616|592262964|FG000|Titration Period|Other|1|||
163969999|NCT01838616|592262965|FG001|Titration Period|Other|0|||
163970000|NCT01838616|592262964|FG000|Titration Period|Protocol Violation|0|||
163970001|NCT01838616|592262965|FG001|Titration Period|Protocol Violation|1|||
163970002|NCT01838616|592262964|FG000|Continuation Period|Lack of Efficacy|3|||
163970003|NCT01838616|592262965|FG001|Continuation Period|Lack of Efficacy|5|||
163970004|NCT01838616|592262964|FG000|Continuation Period|Adverse Event|8|||
163970005|NCT01838616|592262965|FG001|Continuation Period|Adverse Event|4|||
163970006|NCT01838616|592262964|FG000|Continuation Period|Protocol Violation|2|||
163970007|NCT01838616|592262965|FG001|Continuation Period|Protocol Violation|0|||
163970008|NCT01838616|592262964|FG000|Continuation Period|Lost to Follow-up|1|||
163970009|NCT01838616|592262965|FG001|Continuation Period|Lost to Follow-up|0|||
163970010|NCT01838616|592262964|FG000|Continuation Period|Withdrawal by Subject|0|||
163970011|NCT01838616|592262965|FG001|Continuation Period|Withdrawal by Subject|4|||
163970012|NCT01838616|592262964|FG000|Continuation Period|Technical problems|0|||
163970013|NCT01838616|592262965|FG001|Continuation Period|Technical problems|1|||
163970014|NCT01838616|592262964|FG000|Pick-up Arm|Lack of Efficacy|4|||
163970015|NCT01838616|592262965|FG001|Pick-up Arm|Lack of Efficacy|0|||
163970016|NCT01838616|592262964|FG000|Pick-up Arm|Adverse Event|9|||
163970017|NCT01838616|592262965|FG001|Pick-up Arm|Adverse Event|0|||
163970018|NCT01838616|592262964|FG000|Pick-up Arm|Withdrawal by Subject|1|||
163970019|NCT01838616|592262965|FG001|Pick-up Arm|Withdrawal by Subject|0|||
163970020|NCT01838616|592262964|FG000|Pick-up Arm|Technical problems|1|||
163970021|NCT01838616|592262965|FG001|Pick-up Arm|Technical problems|0|||
163970022|NCT01227187|592262967|FG000|Overall Study|Physician Decision|0|||
163970023|NCT01227187|592262968|FG001|Overall Study|Physician Decision|0|||
163970024|NCT01227187|592262969|FG002|Overall Study|Physician Decision|0|||
163970025|NCT01227187|592262970|FG003|Overall Study|Physician Decision|1|||
163970026|NCT01566773|592262972|FG000|Overall Study|Protocol specified criteria|4|||
163970027|NCT01566773|592262972|FG000|Overall Study|Protocol Violation|4|||
163970028|NCT01566773|592262972|FG000|Overall Study|Withdrawal by Subject|9|||
163970029|NCT01566773|592262972|FG000|Overall Study|Administrative reason|1|||
163970030|NCT01566773|592262972|FG000|Overall Study|Adverse Event|10|||
163970031|NCT01566773|592262972|FG000|Overall Study|Physician Decision|2|||
163970032|NCT00833053|592262973|FG000|Overall Study|Adverse Event|4|||
163970033|NCT00833053|592262974|FG001|Overall Study|Adverse Event|0|||
163970034|NCT00833053|592262973|FG000|Overall Study|Treatment Failure|3|||
164201578|NCT04798027|593110802|FG006|Overall Study|Protocol Violation|0|||
164201579|NCT04798027|593110803|FG007|Overall Study|Protocol Violation|1|||
164201580|NCT04798027|593110804|FG008|Overall Study|Protocol Violation|0|||
164201581|NCT04798027|593110796|FG000|Overall Study|Withdrawal by Subject|1|||
164201582|NCT04798027|593110797|FG001|Overall Study|Withdrawal by Subject|0|||
164201583|NCT04798027|593110798|FG002|Overall Study|Withdrawal by Subject|1|||
164201584|NCT04798027|593110799|FG003|Overall Study|Withdrawal by Subject|1|||
164201585|NCT04798027|593110800|FG004|Overall Study|Withdrawal by Subject|1|||
164201586|NCT04798027|593110801|FG005|Overall Study|Withdrawal by Subject|1|||
164201587|NCT04798027|593110802|FG006|Overall Study|Withdrawal by Subject|3|||
164201588|NCT04798027|593110803|FG007|Overall Study|Withdrawal by Subject|2|||
164201589|NCT04798027|593110804|FG008|Overall Study|Withdrawal by Subject|2|||
164201590|NCT04798027|593110796|FG000|Overall Study|Lost to Follow-up|1|||
164201591|NCT04798027|593110797|FG001|Overall Study|Lost to Follow-up|3|||
164201592|NCT04798027|593110798|FG002|Overall Study|Lost to Follow-up|0|||
164201593|NCT04798027|593110799|FG003|Overall Study|Lost to Follow-up|0|||
164201594|NCT04798027|593110800|FG004|Overall Study|Lost to Follow-up|0|||
164201595|NCT04798027|593110801|FG005|Overall Study|Lost to Follow-up|1|||
164201596|NCT04798027|593110802|FG006|Overall Study|Lost to Follow-up|0|||
164201597|NCT04798027|593110803|FG007|Overall Study|Lost to Follow-up|0|||
164201598|NCT04798027|593110804|FG008|Overall Study|Lost to Follow-up|1|||
164201599|NCT04798027|593110796|FG000|Overall Study|Withdrawal by Sponsor|8|||
164201600|NCT04798027|593110797|FG001|Overall Study|Withdrawal by Sponsor|22|||
164201601|NCT04798027|593110798|FG002|Overall Study|Withdrawal by Sponsor|9|||
164201602|NCT04798027|593110799|FG003|Overall Study|Withdrawal by Sponsor|26|||
164201603|NCT04798027|593110800|FG004|Overall Study|Withdrawal by Sponsor|24|||
164201604|NCT04798027|593110801|FG005|Overall Study|Withdrawal by Sponsor|11|||
164201605|NCT04798027|593110802|FG006|Overall Study|Withdrawal by Sponsor|25|||
164201606|NCT04798027|593110803|FG007|Overall Study|Withdrawal by Sponsor|26|||
164201607|NCT04798027|593110804|FG008|Overall Study|Withdrawal by Sponsor|11|||
164201608|NCT01814007|593110810|FG000|Overall Study|Withdrawal by Subject|1|||
163970035|NCT00833053|592262974|FG001|Overall Study|Treatment Failure|1|||
163970036|NCT00833053|592262973|FG000|Overall Study|Withdrawal by Subject|0|||
163970037|NCT00833053|592262974|FG001|Overall Study|Withdrawal by Subject|1|||
164201609|NCT01274351|593110811|FG000|Overall Study|Lost to Follow-up|1|||
164201610|NCT01274351|593110811|FG000|Overall Study|patient not compliant with the protocol|1|||
164201611|NCT01274351|593110811|FG000|Overall Study|Pregnancy|1|||
164201612|NCT01274351|593110811|FG000|Overall Study|Death|2|||
164201613|NCT01274351|593110811|FG000|Overall Study|Withdrawal by Subject|3|||
164201614|NCT01274351|593110811|FG000|Overall Study|Adverse Event|8|||
164201615|NCT01274351|593110811|FG000|Overall Study|progression of disease|3|||
164201616|NCT01274351|593110811|FG000|Overall Study|hospitalization|1|||
164201617|NCT03861039|593112528|FG000|Overall Study|Adverse Event|2|||
164201618|NCT03861039|593112529|FG001|Overall Study|Adverse Event|5|||
164201619|NCT03861039|593112530|FG002|Overall Study|Adverse Event|11|||
164201620|NCT03861039|593112528|FG000|Overall Study|Withdrawal by Subject|1|||
164201621|NCT03861039|593112529|FG001|Overall Study|Withdrawal by Subject|3|||
164201622|NCT03861039|593112530|FG002|Overall Study|Withdrawal by Subject|4|||
164201623|NCT01113749|593112531|FG000|Overall Study|Lost to Follow-up|1|||
164201624|NCT01113749|593112532|FG001|Overall Study|Lost to Follow-up|2|||
164201625|NCT03427892|593112533|FG000|Overall Study|Lost to Follow-up|2|||
164201626|NCT00997334|593112535|FG000|Overall Study|still on therapy|12|||
164201627|NCT00997334|593112535|FG000|Overall Study|Adverse Event|3|||
164201628|NCT00997334|593112535|FG000|Overall Study|Patient non-compliance|1|||
164201629|NCT00997334|593112535|FG000|Overall Study|Withdrawal by Subject|3|||
164201630|NCT00997334|593112535|FG000|Overall Study|Death|2|||
164201631|NCT00997334|593112535|FG000|Overall Study|Urgent Palliative Care|2|||
164201632|NCT00997334|593112535|FG000|Overall Study|No lesion amenable|1|||
163865136|NCT03262935|591872450|FG000|Overall Study|Death|181|||
163865137|NCT03262935|591872451|FG001|Overall Study|Death|94|||
163865138|NCT03262935|591872450|FG000|Overall Study|Lost to Follow-up|9|||
163865139|NCT03262935|591872451|FG001|Overall Study|Lost to Follow-up|4|||
163865140|NCT03262935|591872450|FG000|Overall Study|Other reason|5|||
163865141|NCT03262935|591872451|FG001|Overall Study|Other reason|0|||
163865142|NCT03557008|591872452|FG000|Overall Study|Withdrawal by Subject|2|||
163865143|NCT03557008|591872453|FG001|Overall Study|Withdrawal by Subject|2|||
163865144|NCT03557008|591872452|FG000|Overall Study|Early termination from study|3|||
163865145|NCT03557008|591872453|FG001|Overall Study|Early termination from study|1|||
163865146|NCT02224924|591872454|FG000|Overall Study|Withdrawal by Subject|7|||
163865147|NCT02224924|591872455|FG001|Overall Study|Withdrawal by Subject|6|||
163865148|NCT02224924|591872454|FG000|Overall Study|Biopsy cancelled|20|||
163865149|NCT02224924|591872455|FG001|Overall Study|Biopsy cancelled|14|||
163865150|NCT02224924|591872454|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
163865151|NCT02224924|591872455|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
163865152|NCT02224924|591872454|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
163865153|NCT02224924|591872455|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
163865154|NCT01458210|591872458|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
163865155|NCT01458210|591872458|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
163865156|NCT01458210|591872458|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
163865157|NCT01458210|591872458|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
163865158|NCT03020745|591872459|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865159|NCT03020745|591872460|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865160|NCT03020745|591872461|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865161|NCT03020745|591872462|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865162|NCT03020745|591872463|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865163|NCT03020745|591872464|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865164|NCT03020745|591872465|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865165|NCT03020745|591872466|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865166|NCT03020745|591872467|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
163865167|NCT03020745|591872468|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
163865168|NCT03020745|591872459|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865169|NCT03020745|591872460|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865170|NCT03020745|591872461|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865171|NCT03020745|591872462|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865172|NCT03020745|591872463|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865173|NCT03020745|591872464|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865174|NCT03020745|591872465|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865175|NCT03020745|591872466|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
163865176|NCT03020745|591872467|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865177|NCT03020745|591872468|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
163865178|NCT03020745|591872459|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163865179|NCT03020745|591872460|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163865180|NCT03020745|591872461|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
164201633|NCT00997334|593112535|FG000|Overall Study|Ineligible|1|||
163865181|NCT03020745|591872462|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163865182|NCT03020745|591872463|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163865183|NCT03020745|591872464|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
163865184|NCT03020745|591872465|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163865185|NCT03020745|591872466|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163865186|NCT03020745|591872467|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
163865187|NCT03020745|591872468|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
163970038|NCT00833053|592262973|FG000|Overall Study|Protocol Violation|2|||
163970039|NCT00833053|592262974|FG001|Overall Study|Protocol Violation|1|||
163970040|NCT00762892|592262978|FG000|Overall Study|Lost to Follow-up|2|||
163970041|NCT00762892|592262979|FG001|Overall Study|Lost to Follow-up|5|||
163970042|NCT00762892|592262978|FG000|Overall Study|Withdrawal by Subject|0|||
163970043|NCT00762892|592262979|FG001|Overall Study|Withdrawal by Subject|1|||
163970044|NCT00762892|592262978|FG000|Overall Study|Death|1|||
163970045|NCT00762892|592262979|FG001|Overall Study|Death|0|||
163970046|NCT00762892|592262978|FG000|Overall Study|Pregnancy|1|||
163970047|NCT00762892|592262979|FG001|Overall Study|Pregnancy|0|||
163970048|NCT00762892|592262978|FG000|Overall Study|Incarceration|1|||
163970049|NCT00762892|592262979|FG001|Overall Study|Incarceration|0|||
163970050|NCT02234479|592262980|FG000|Overall Study|Withdrawal by Subject|1|||
163970051|NCT02234479|592262981|FG001|Overall Study|Withdrawal by Subject|3|||
163970052|NCT01671111|592262984|FG000|Overall Study|Adverse Event|2|||
163970053|NCT01671111|592262984|FG000|Overall Study|Lack of Efficacy|1|||
163970054|NCT01671111|592262984|FG000|Overall Study|Withdrawal by Subject|2|||
163970055|NCT01671111|592262984|FG000|Overall Study|Physician Decision|1|||
163970056|NCT01671111|592262984|FG000|Overall Study|Other|24|||
163970057|NCT01490814|592262989|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
163970058|NCT01490814|592262990|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
163970059|NCT01490814|592262989|FG000|Overall Study|Physician Decision|1|||
163970060|NCT01490814|592262990|FG001|Overall Study|Physician Decision|0|||
163970061|NCT01490814|592262989|FG000|Overall Study|Withdrawal by Subject|0|||
163970062|NCT01490814|592262990|FG001|Overall Study|Withdrawal by Subject|5|||
163970063|NCT01537198|592262991|FG000|Overall Study|RSV infection|2|||
163970064|NCT01537198|592262991|FG000|Overall Study|Adverse Event|4|||
163970065|NCT01537198|592262991|FG000|Overall Study|No Further Visits to the Clinic|37|||
163970066|NCT01537198|592262991|FG000|Overall Study|Other|111|||
163970067|NCT00496730|592262998|FG000|Overall Study|Lost to Follow-up|4|||
163970068|NCT00496730|592262999|FG001|Overall Study|Lost to Follow-up|3|||
163970069|NCT00496730|592262998|FG000|Overall Study|Withdrawal by Subject|2|||
163970070|NCT00496730|592262999|FG001|Overall Study|Withdrawal by Subject|2|||
163970071|NCT00113074|592263003|FG000|Overall Study|Lost to Follow-up|10|||
163970072|NCT00113074|592263004|FG001|Overall Study|Lost to Follow-up|10|||
163970073|NCT00113074|592263005|FG002|Overall Study|Lost to Follow-up|14|||
163970074|NCT03680911|592263006|FG000|At Home Treatment|Study Termination|3|||
163970075|NCT03680911|592263007|FG001|At Home Treatment|Study Termination|0|||
163970076|NCT03680911|592263006|FG000|At Home Treatment|Lost to Follow-up|0|||
163970077|NCT03680911|592263007|FG001|At Home Treatment|Lost to Follow-up|1|||
164201634|NCT01586195|593112536|FG000|Overall Study|Death|11|||
164201635|NCT01586195|593112536|FG000|Overall Study|Withdrawal of Consent|5|||
164201636|NCT01586195|593112536|FG000|Overall Study|Started new anti-melanoma therapy|1|||
164201637|NCT01586195|593112536|FG000|Overall Study|Reason not specified|9|||
164201638|NCT01287936|593112541|FG000|Overall Study|Lost to Follow-up|0|||
164201639|NCT01287936|593112542|FG001|Overall Study|Lost to Follow-up|1|||
164201640|NCT01287936|593112543|FG002|Overall Study|Lost to Follow-up|1|||
164201641|NCT01855958|593112544|FG000|Overall Study|Withdrawal by Subject|1|||
164201642|NCT01855958|593112545|FG001|Overall Study|Withdrawal by Subject|0|||
164201643|NCT00296244|593112546|FG000|Overall Study|Underwent retransplant|0|||
164201644|NCT00296244|593112547|FG001|Overall Study|Underwent retransplant|1|||
164201645|NCT00266708|593112552|FG000|Overall Study|No renal function|1|||
164201646|NCT00266708|593112553|FG001|Overall Study|No renal function|1|||
164201647|NCT00266708|593112552|FG000|Overall Study|Refused biopsy|3|||
164201648|NCT00266708|593112553|FG001|Overall Study|Refused biopsy|6|||
164201649|NCT00266708|593112552|FG000|Overall Study|Asthma|0|||
164201650|NCT00266708|593112553|FG001|Overall Study|Asthma|2|||
164201651|NCT00703534|593112554|FG000|Overall Study|Adverse Event|14|||
164201652|NCT00703534|593112555|FG001|Overall Study|Adverse Event|3|||
164201653|NCT00703534|593112554|FG000|Overall Study|Withdrawal by Subject|8|||
164201654|NCT00703534|593112555|FG001|Overall Study|Withdrawal by Subject|7|||
164201655|NCT00703534|593112554|FG000|Overall Study|Incorrect Enrollment|6|||
163970078|NCT03680911|592263006|FG000|At Home Treatment|Withdrawal by Subject|0|||
163970079|NCT03680911|592263007|FG001|At Home Treatment|Withdrawal by Subject|2|||
163970080|NCT03680911|592263006|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
163970081|NCT03680911|592263007|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
163970082|NCT03962738|592263014|FG000|Overall Study|Protocol Deviation|3|||
163970083|NCT03962738|592263015|FG001|Overall Study|Protocol Deviation|0|||
163970084|NCT03962738|592263016|FG002|Overall Study|Protocol Deviation|1|||
163970085|NCT03962738|592263017|FG003|Overall Study|Protocol Deviation|1|||
163970086|NCT03962738|592263014|FG000|Overall Study|Withdrawal by Subject|4|||
163970087|NCT03962738|592263015|FG001|Overall Study|Withdrawal by Subject|0|||
163970088|NCT03962738|592263016|FG002|Overall Study|Withdrawal by Subject|0|||
163970089|NCT03962738|592263017|FG003|Overall Study|Withdrawal by Subject|0|||
163970090|NCT03962738|592263014|FG000|Overall Study|Lost to Follow-up|0|||
163970091|NCT03962738|592263015|FG001|Overall Study|Lost to Follow-up|0|||
164201656|NCT00703534|593112555|FG001|Overall Study|Incorrect Enrollment|6|||
164201657|NCT00703534|593112554|FG000|Overall Study|Lost to Follow-up|1|||
164201658|NCT00703534|593112555|FG001|Overall Study|Lost to Follow-up|4|||
163865188|NCT03020745|591872459|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865189|NCT03020745|591872460|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865190|NCT03020745|591872461|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865191|NCT03020745|591872462|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865192|NCT03020745|591872463|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865193|NCT03020745|591872464|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865194|NCT03020745|591872465|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865195|NCT03020745|591872466|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865196|NCT03020745|591872467|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
163865197|NCT03020745|591872468|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
163865198|NCT01867216|591872469|FG000|Overall Study|Withdrawal by Subject|2|||
163865199|NCT01867216|591872470|FG001|Overall Study|Withdrawal by Subject|0|||
163865200|NCT01867216|591872471|FG002|Overall Study|Withdrawal by Subject|0|||
163865201|NCT01867216|591872472|FG003|Overall Study|Withdrawal by Subject|0|||
163865202|NCT01867216|591872473|FG004|Overall Study|Withdrawal by Subject|1|||
163865203|NCT01867216|591872474|FG005|Overall Study|Withdrawal by Subject|0|||
163865204|NCT01867216|591872475|FG006|Overall Study|Withdrawal by Subject|1|||
163865205|NCT01867216|591872469|FG000|Overall Study|Physician Decision|1|||
163865206|NCT01867216|591872470|FG001|Overall Study|Physician Decision|0|||
163865207|NCT01867216|591872471|FG002|Overall Study|Physician Decision|0|||
163865208|NCT01867216|591872472|FG003|Overall Study|Physician Decision|0|||
163865209|NCT01867216|591872473|FG004|Overall Study|Physician Decision|0|||
163865210|NCT01867216|591872474|FG005|Overall Study|Physician Decision|0|||
163865211|NCT01867216|591872475|FG006|Overall Study|Physician Decision|0|||
163865212|NCT01867216|591872469|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
163865213|NCT01867216|591872470|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163865214|NCT01867216|591872471|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163865215|NCT01867216|591872472|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163865216|NCT01867216|591872473|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163865217|NCT01867216|591872474|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163865218|NCT01867216|591872475|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
163865219|NCT00186186|591872476|FG000|Overall Study|Lack of Efficacy|3|||
163865220|NCT00186186|591872476|FG000|Overall Study|Withdrawal by Subject|3|||
163865221|NCT00186186|591872476|FG000|Overall Study|Not reported as to reason|2|||
163865222|NCT03622580|591872479|FG000|Overall Study|Death|16|||
163865223|NCT03622580|591872480|FG001|Overall Study|Death|21|||
163865224|NCT03622580|591872481|FG002|Overall Study|Death|13|||
163865225|NCT03622580|591872479|FG000|Overall Study|Adverse Event|6|||
163865226|NCT03622580|591872480|FG001|Overall Study|Adverse Event|6|||
163865227|NCT03622580|591872481|FG002|Overall Study|Adverse Event|5|||
163865228|NCT03622580|591872479|FG000|Overall Study|Withdrawal by Subject|12|||
163865229|NCT03622580|591872480|FG001|Overall Study|Withdrawal by Subject|7|||
163865230|NCT03622580|591872481|FG002|Overall Study|Withdrawal by Subject|19|||
163865231|NCT03622580|591872479|FG000|Overall Study|Lost to Follow-up|12|||
163865232|NCT03622580|591872480|FG001|Overall Study|Lost to Follow-up|9|||
163865233|NCT03622580|591872481|FG002|Overall Study|Lost to Follow-up|9|||
163865234|NCT03622580|591872479|FG000|Overall Study|Protocol Violation|1|||
163865235|NCT03622580|591872480|FG001|Overall Study|Protocol Violation|0|||
163865236|NCT03622580|591872481|FG002|Overall Study|Protocol Violation|1|||
164201659|NCT00703534|593112554|FG000|Overall Study|Severe Non Compliance|1|||
164201660|NCT00703534|593112555|FG001|Overall Study|Severe Non Compliance|5|||
164201661|NCT00427934|593112556|FG000|Overall Study|Adverse Event|1|||
164201662|NCT00427934|593112557|FG001|Overall Study|Adverse Event|0|||
164201663|NCT00427934|593112558|FG002|Overall Study|Adverse Event|5|||
164201664|NCT00427934|593112559|FG003|Overall Study|Adverse Event|4|||
164201665|NCT00427934|593112556|FG000|Overall Study|Lack of Efficacy|0|||
164201666|NCT00427934|593112557|FG001|Overall Study|Lack of Efficacy|0|||
164201667|NCT00427934|593112558|FG002|Overall Study|Lack of Efficacy|5|||
164201668|NCT00427934|593112559|FG003|Overall Study|Lack of Efficacy|2|||
164201669|NCT00427934|593112556|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
164201670|NCT00427934|593112557|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
164201671|NCT00427934|593112558|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
164201672|NCT00427934|593112559|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
163865237|NCT03622580|591872479|FG000|Overall Study|Physician Decision|3|||
163865238|NCT03622580|591872480|FG001|Overall Study|Physician Decision|0|||
163865239|NCT03622580|591872481|FG002|Overall Study|Physician Decision|1|||
163865240|NCT03622580|591872479|FG000|Overall Study|Pregnancy|0|||
163865241|NCT03622580|591872480|FG001|Overall Study|Pregnancy|1|||
163865242|NCT03622580|591872481|FG002|Overall Study|Pregnancy|0|||
163865243|NCT03622580|591872479|FG000|Overall Study|Lack of Efficacy|0|||
164201673|NCT00427934|593112556|FG000|Overall Study|Other|0|||
164201674|NCT00427934|593112557|FG001|Overall Study|Other|0|||
164201675|NCT00427934|593112558|FG002|Overall Study|Other|11|||
164201676|NCT00427934|593112559|FG003|Overall Study|Other|5|||
164201677|NCT00427934|593112556|FG000|Overall Study|Withdrawal by Subject|0|||
163970092|NCT03962738|592263016|FG002|Overall Study|Lost to Follow-up|1|||
163970093|NCT03962738|592263017|FG003|Overall Study|Lost to Follow-up|0|||
163970094|NCT04556136|592263021|FG000|Overall Study|Lost to Follow-up|6|||
163970095|NCT04556136|592263022|FG001|Overall Study|Lost to Follow-up|6|||
163970096|NCT04556136|592263021|FG000|Overall Study|Physician Decision|2|||
163970097|NCT04556136|592263022|FG001|Overall Study|Physician Decision|1|||
163970098|NCT04556136|592263021|FG000|Overall Study|Withdrawal by Subject|2|||
163970099|NCT04556136|592263022|FG001|Overall Study|Withdrawal by Subject|1|||
163970100|NCT00935272|592263025|FG000|Overall Study|Lost to Follow-up|10|||
163970101|NCT00935272|592263026|FG001|Overall Study|Lost to Follow-up|3|||
163970102|NCT00935272|592263025|FG000|Overall Study|Withdrawal by Subject|8|||
163970103|NCT00935272|592263026|FG001|Overall Study|Withdrawal by Subject|2|||
163970104|NCT00935272|592263025|FG000|Overall Study|Physician Decision|1|||
163970105|NCT00935272|592263026|FG001|Overall Study|Physician Decision|0|||
163970106|NCT00935272|592263025|FG000|Overall Study|Protocol Violation|0|||
163970107|NCT00935272|592263026|FG001|Overall Study|Protocol Violation|1|||
163970108|NCT03492554|592263027|FG000|Overall Study|Protocol Violation|0|||
163970109|NCT03492554|592263028|FG001|Overall Study|Protocol Violation|14|||
163970110|NCT01478360|592263029|FG000|Overall Study|Lost to Follow-up|1|||
163970111|NCT01478360|592263030|FG001|Overall Study|Lost to Follow-up|0|||
163970112|NCT01478360|592263029|FG000|Overall Study|Adverse Event|0|||
163970113|NCT01478360|592263030|FG001|Overall Study|Adverse Event|1|||
163970114|NCT01478360|592263029|FG000|Overall Study|Administrative problems|1|||
163970115|NCT01478360|592263030|FG001|Overall Study|Administrative problems|2|||
163970116|NCT04340557|592263034|FG000|Overall Study|Transferred to ICU and/or death|1|||
163970117|NCT04340557|592263035|FG001|Overall Study|Transferred to ICU and/or death|2|||
163970118|NCT01221727|592263036|FG000|Overall Study|Physician Decision|2|||
163970119|NCT01221727|592263037|FG001|Overall Study|Physician Decision|0|||
163970120|NCT01221727|592263036|FG000|Overall Study|Withdrawal by Subject|1|||
163970121|NCT01221727|592263037|FG001|Overall Study|Withdrawal by Subject|1|||
163970122|NCT01010633|592263038|FG000|Overall Study|Adverse Event|1|||
163970123|NCT01010633|592263039|FG001|Overall Study|Adverse Event|1|||
163970124|NCT01010633|592263038|FG000|Overall Study|Protocol Violation|1|||
163970125|NCT01010633|592263039|FG001|Overall Study|Protocol Violation|2|||
163970126|NCT01010633|592263038|FG000|Overall Study|Withdrawal by Subject|2|||
163970127|NCT01010633|592263039|FG001|Overall Study|Withdrawal by Subject|1|||
163970128|NCT01010633|592263038|FG000|Overall Study|Investigator decision|0|||
163970129|NCT01010633|592263039|FG001|Overall Study|Investigator decision|1|||
163970130|NCT02941926|592263040|FG000|Core Phase|Progressive disease|1109|||
163970131|NCT02941926|592263040|FG000|Core Phase|Adverse Event|504|||
163970132|NCT02941926|592263040|FG000|Core Phase|Subject/guardian decision|127|||
163970133|NCT02941926|592263040|FG000|Core Phase|Physician Decision|112|||
163970134|NCT02941926|592263040|FG000|Core Phase|Death|46|||
163970135|NCT02941926|592263040|FG000|Core Phase|Protocol deviation|34|||
163970136|NCT02941926|592263040|FG000|Core Phase|Lost to Follow-up|8|||
163970137|NCT02941926|592263040|FG000|Core Phase|Technical problems|5|||
163970138|NCT02941926|592263040|FG000|Extension Phase|Physician Decision|155|||
163970139|NCT02941926|592263040|FG000|Extension Phase|Progressive disease|115|||
163970140|NCT02941926|592263040|FG000|Extension Phase|Adverse Event|13|||
163970141|NCT02941926|592263040|FG000|Extension Phase|Subject/Guardian decision|12|||
163970142|NCT02941926|592263040|FG000|Extension Phase|Death|6|||
163970143|NCT00097773|592263041|FG000|Overall Study|Lost to Follow-up|2|||
163970144|NCT00097773|592263042|FG001|Overall Study|Lost to Follow-up|2|||
163970145|NCT00097773|592263043|FG002|Overall Study|Lost to Follow-up|0|||
163970146|NCT00097773|592263044|FG003|Overall Study|Lost to Follow-up|1|||
163970147|NCT00097773|592263041|FG000|Overall Study|Physician Decision|2|||
163970148|NCT00097773|592263042|FG001|Overall Study|Physician Decision|2|||
163970149|NCT00097773|592263043|FG002|Overall Study|Physician Decision|3|||
163970150|NCT00097773|592263044|FG003|Overall Study|Physician Decision|1|||
163970151|NCT00097773|592263041|FG000|Overall Study|Withdrawal by Subject|3|||
163970152|NCT00097773|592263042|FG001|Overall Study|Withdrawal by Subject|3|||
163970153|NCT00097773|592263043|FG002|Overall Study|Withdrawal by Subject|3|||
163970154|NCT00097773|592263044|FG003|Overall Study|Withdrawal by Subject|1|||
163970155|NCT00097773|592263041|FG000|Overall Study|Adverse Event|0|||
163970156|NCT00097773|592263042|FG001|Overall Study|Adverse Event|1|||
163970157|NCT00097773|592263043|FG002|Overall Study|Adverse Event|0|||
163970158|NCT00097773|592263044|FG003|Overall Study|Adverse Event|0|||
163970159|NCT00097773|592263041|FG000|Overall Study|Other|1|||
163970160|NCT00097773|592263042|FG001|Overall Study|Other|0|||
163970161|NCT00097773|592263043|FG002|Overall Study|Other|2|||
163970162|NCT00097773|592263044|FG003|Overall Study|Other|0|||
163970163|NCT01494350|592263045|FG000|Overall Study|Worsening of lesion|1|||
163970164|NCT00474708|592263046|FG000|Overall Study|Lack of Efficacy|11|||
163970165|NCT00474708|592263047|FG001|Overall Study|Lack of Efficacy|5|||
163970166|NCT00474708|592263046|FG000|Overall Study|Suicide ideation/behavior|0|||
163970167|NCT00474708|592263047|FG001|Overall Study|Suicide ideation/behavior|1|||
163970168|NCT00474708|592263046|FG000|Overall Study|Withdrawal by Subject|7|||
163970169|NCT00474708|592263047|FG001|Overall Study|Withdrawal by Subject|0|||
163970170|NCT00474708|592263046|FG000|Overall Study|Lack of compliance|12|||
163970171|NCT00474708|592263047|FG001|Overall Study|Lack of compliance|4|||
163970172|NCT00474708|592263046|FG000|Overall Study|Lost to Follow-up|18|||
163970173|NCT00474708|592263047|FG001|Overall Study|Lost to Follow-up|9|||
163970174|NCT00474708|592263046|FG000|Overall Study|Physician Decision|9|||
163970175|NCT00474708|592263047|FG001|Overall Study|Physician Decision|6|||
163970176|NCT03700320|592263048|FG000|Overall Study|Adverse Event|5|||
163970177|NCT03700320|592263049|FG001|Overall Study|Adverse Event|31|||
163970178|NCT03700320|592263048|FG000|Overall Study|Lack of Efficacy|2|||
163970179|NCT03700320|592263049|FG001|Overall Study|Lack of Efficacy|5|||
163970180|NCT03700320|592263048|FG000|Overall Study|Withdrawal by Subject|29|||
163970181|NCT03700320|592263049|FG001|Overall Study|Withdrawal by Subject|75|||
163970182|NCT03700320|592263048|FG000|Overall Study|Lost to Follow-up|16|||
163970183|NCT03700320|592263049|FG001|Overall Study|Lost to Follow-up|23|||
163970184|NCT03700320|592263048|FG000|Overall Study|Pregnancy|2|||
163970185|NCT03700320|592263049|FG001|Overall Study|Pregnancy|4|||
163970186|NCT03700320|592263048|FG000|Overall Study|Protocol Deviation|7|||
163970187|NCT03700320|592263049|FG001|Overall Study|Protocol Deviation|31|||
163970188|NCT03700320|592263048|FG000|Overall Study|Non-compliance with Study Drug|1|||
163970189|NCT03700320|592263049|FG001|Overall Study|Non-compliance with Study Drug|3|||
163970190|NCT03700320|592263048|FG000|Overall Study|Reason not Specified|0|||
163970191|NCT03700320|592263049|FG001|Overall Study|Reason not Specified|1|||
163970192|NCT04305275|592263050|FG000|Overall Study|Adverse Event|4|||
163970193|NCT04305275|592263051|FG001|Overall Study|Adverse Event|0|||
163970194|NCT04305275|592263050|FG000|Overall Study|Lost to Follow-up|1|||
163970195|NCT04305275|592263051|FG001|Overall Study|Lost to Follow-up|1|||
163970196|NCT04305275|592263050|FG000|Overall Study|Withdrawal by Participant|8|||
163970197|NCT04305275|592263051|FG001|Overall Study|Withdrawal by Participant|1|||
163970198|NCT03061175|592263052|FG000|Baseline|Participant was deemed ineligible|1|||
163970199|NCT03061175|592263053|FG001|Baseline|Participant was deemed ineligible|0|||
163970200|NCT03061175|592263052|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
163970201|NCT03061175|592263053|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
163970202|NCT03061175|592263052|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
163970203|NCT03061175|592263053|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
163970204|NCT03061175|592263052|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
163970205|NCT03061175|592263053|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
163970206|NCT00760669|592263054|FG000|Overall Study|Not assessed for overall improvement|18|||
163970207|NCT00760669|592263054|FG000|Overall Study|Participants missing efficacy assessment|6|||
163970208|NCT00760669|592263054|FG000|Overall Study|Participants with overlapping cases|1|||
163970209|NCT00760669|592263054|FG000|Overall Study|Took drug before entering in contract|5|||
163970210|NCT02456662|592263055|FG000|Overall Study|Lost to Follow-up|2|||
163970211|NCT02456662|592263056|FG001|Overall Study|Lost to Follow-up|1|||
163970212|NCT00504153|592263057|FG000|Overall Study|Withdrawal by Subject|1|||
163970213|NCT00504153|592263057|FG000|Overall Study|Adverse Event|4|||
163970214|NCT00504153|592263057|FG000|Overall Study|Death|1|||
163970215|NCT01889238|592263062|FG000|Overall Study|Death|1|||
163970216|NCT01889238|592263062|FG000|Overall Study|Withdrawal by Subject|1|||
163970217|NCT01889238|592263062|FG000|Overall Study|Adverse Event|6|||
163970218|NCT01889238|592263062|FG000|Overall Study|Disease Progression|104|||
163970219|NCT01889238|592263062|FG000|Overall Study|Other|6|||
163970220|NCT02717754|592263066|FG000|Overall Study|Incorrect Infusion Duration|0|||
163970221|NCT02717754|592263067|FG001|Overall Study|Incorrect Infusion Duration|0|||
163970222|NCT02717754|592263068|FG002|Overall Study|Incorrect Infusion Duration|0|||
163970223|NCT02717754|592263069|FG003|Overall Study|Incorrect Infusion Duration|10|||
163970224|NCT02717754|592263070|FG004|Overall Study|Incorrect Infusion Duration|20|||
163970225|NCT02717754|592263071|FG005|Overall Study|Incorrect Infusion Duration|20|||
163970226|NCT00482703|592263072|FG000|Overall Study|Poor compliance|1|||
163970227|NCT00482703|592263073|FG001|Overall Study|Poor compliance|0|||
163970228|NCT00667823|592263075|FG000|Overall Study|Lost to Follow-up|5|||
163970229|NCT00667823|592263075|FG000|Overall Study|Adverse Event|7|||
163970230|NCT00667823|592263075|FG000|Overall Study|Death|182|||
163970231|NCT00667823|592263075|FG000|Overall Study|Withdrawal by Subject|12|||
163970232|NCT00667823|592263075|FG000|Overall Study|Other|8|||
164201678|NCT00427934|593112557|FG001|Overall Study|Withdrawal by Subject|0|||
164201679|NCT00427934|593112558|FG002|Overall Study|Withdrawal by Subject|1|||
164201680|NCT00427934|593112559|FG003|Overall Study|Withdrawal by Subject|3|||
163970233|NCT00667823|592263075|FG000|Overall Study|Missing (completion page missing)|2|||
163970234|NCT04360551|592264636|FG000|Overall Study|Withdrawal by Subject|1|||
163970235|NCT04360551|592264637|FG001|Overall Study|Withdrawal by Subject|0|||
163970236|NCT03496012|592264641|FG000|Overall Study|Withdrawal by Subject|2|||
163970237|NCT03496012|592264642|FG001|Overall Study|Withdrawal by Subject|0|||
163970238|NCT03496012|592264643|FG002|Overall Study|Withdrawal by Subject|2|||
163970239|NCT03496012|592264641|FG000|Overall Study|Adverse Event|0|||
163970240|NCT03496012|592264642|FG001|Overall Study|Adverse Event|0|||
163970241|NCT03496012|592264643|FG002|Overall Study|Adverse Event|1|||
163970242|NCT03496012|592264641|FG000|Overall Study|Reason Not Specified|2|||
163970243|NCT03496012|592264642|FG001|Overall Study|Reason Not Specified|0|||
163970244|NCT03496012|592264643|FG002|Overall Study|Reason Not Specified|1|||
164201681|NCT02791269|593112560|FG000|Overall Study|Lost to Follow-up|0|||
164310294|NCT00552188|593510800|FG001|Overall Study|Adverse Event|2|||
164310295|NCT00552188|593510799|FG000|Overall Study|Lost to Follow-up|2|||
164310296|NCT00552188|593510800|FG001|Overall Study|Lost to Follow-up|1|||
164310297|NCT00552188|593510799|FG000|Overall Study|Withdrawal of consent|0|||
164310298|NCT00552188|593510800|FG001|Overall Study|Withdrawal of consent|1|||
164310299|NCT00552188|593510799|FG000|Overall Study|Subject returned to home country|0|||
164310300|NCT00552188|593510800|FG001|Overall Study|Subject returned to home country|1|||
164310301|NCT01368562|593510803|FG000|Overall Study|Adverse Event|1|||
164310302|NCT01368562|593510803|FG000|Overall Study|Disease progression|1|||
164310303|NCT01368562|593510803|FG000|Overall Study|Lost to Follow-up|1|||
164310304|NCT01368562|593510803|FG000|Overall Study|Death|6|||
164310305|NCT01368562|593510803|FG000|Overall Study|Unresponsive to treatment|5|||
164310306|NCT01368562|593510803|FG000|Overall Study|Other|3|||
164310307|NCT01368562|593510803|FG000|Overall Study|Other than specified|2|||
164310308|NCT00727441|593510805|FG000|Overall Study|Disease Progression|11|||
164310309|NCT00727441|593510806|FG001|Overall Study|Disease Progression|14|||
164310310|NCT00727441|593510807|FG002|Overall Study|Disease Progression|17|||
164310311|NCT00727441|593510805|FG000|Overall Study|Eligibility|7|||
164310312|NCT00727441|593510806|FG001|Overall Study|Eligibility|5|||
164310313|NCT00727441|593510807|FG002|Overall Study|Eligibility|7|||
164310314|NCT00727441|593510805|FG000|Overall Study|Death|0|||
164310315|NCT00727441|593510806|FG001|Overall Study|Death|1|||
164310316|NCT00727441|593510807|FG002|Overall Study|Death|1|||
164310317|NCT00727441|593510805|FG000|Overall Study|Physician Decision|0|||
164310318|NCT00727441|593510806|FG001|Overall Study|Physician Decision|1|||
164310319|NCT00727441|593510807|FG002|Overall Study|Physician Decision|0|||
164310320|NCT00727441|593510805|FG000|Overall Study|Withdrawal by Subject|0|||
164310321|NCT00727441|593510806|FG001|Overall Study|Withdrawal by Subject|1|||
164310322|NCT00727441|593510807|FG002|Overall Study|Withdrawal by Subject|0|||
164310323|NCT00243269|593510812|FG000|Overall Study|Protocol Violation|2|||
164310324|NCT00243269|593510813|FG001|Overall Study|Protocol Violation|1|||
164310325|NCT00243269|593510814|FG002|Overall Study|Protocol Violation|0|||
164310326|NCT00243269|593510815|FG003|Overall Study|Protocol Violation|1|||
164310327|NCT00243269|593510812|FG000|Overall Study|Lost to Follow-up|1|||
164310328|NCT00243269|593510813|FG001|Overall Study|Lost to Follow-up|0|||
164310329|NCT00243269|593510814|FG002|Overall Study|Lost to Follow-up|1|||
163865244|NCT03622580|591872480|FG001|Overall Study|Lack of Efficacy|0|||
163865245|NCT03622580|591872481|FG002|Overall Study|Lack of Efficacy|1|||
163865246|NCT03622580|591872479|FG000|Overall Study|Other|2|||
163865247|NCT03622580|591872480|FG001|Overall Study|Other|0|||
163865248|NCT03622580|591872481|FG002|Overall Study|Other|3|||
163865249|NCT00943735|591872486|FG000|Overall Study|Adverse Event|12|||
163865250|NCT00943735|591872486|FG000|Overall Study|Withdrawal by Subject|8|||
163865251|NCT00943735|591872486|FG000|Overall Study|Death|1|||
163865252|NCT00943735|591872486|FG000|Overall Study|Other|8|||
163865253|NCT00943735|591872486|FG000|Overall Study|Other|3|||
163865254|NCT03959241|591872487|FG000|Overall Study|Withdrawal by Subject|7|||
163865255|NCT03959241|591872488|FG001|Overall Study|Withdrawal by Subject|8|||
163865256|NCT03959241|591872487|FG000|Overall Study|Lost to Follow-up|1|||
163865257|NCT03959241|591872488|FG001|Overall Study|Lost to Follow-up|0|||
163865258|NCT03959241|591872487|FG000|Overall Study|Move to Hospice Care|1|||
163865259|NCT03959241|591872488|FG001|Overall Study|Move to Hospice Care|0|||
163865260|NCT03959241|591872487|FG000|Overall Study|Screen Failure|1|||
163865261|NCT03959241|591872488|FG001|Overall Study|Screen Failure|0|||
163865262|NCT03959241|591872487|FG000|Overall Study|Disease Relapse|0|||
163865263|NCT03959241|591872488|FG001|Overall Study|Disease Relapse|1|||
163865264|NCT03959241|591872487|FG000|Overall Study|Off Study|1|||
163865265|NCT03959241|591872488|FG001|Overall Study|Off Study|0|||
163865266|NCT00545844|591872489|FG000|Overall Study|Lost to Follow-up|9|||
163865267|NCT00545844|591872489|FG000|Overall Study|Protocol Violation|1|||
163865268|NCT00545844|591872489|FG000|Overall Study|Withdrawal by Subject|2|||
164310330|NCT00243269|593510815|FG003|Overall Study|Lost to Follow-up|3|||
164310331|NCT01296672|593510820|FG000|Overall Study|Lost to Follow-up|73|||
164310332|NCT01296672|593510821|FG001|Overall Study|Lost to Follow-up|18|||
163865269|NCT01329328|591872490|FG000|Overall Study|Withdrawal by Subject|2|||
163865270|NCT01329328|591872491|FG001|Overall Study|Withdrawal by Subject|4|||
163865271|NCT01329328|591872492|FG002|Overall Study|Withdrawal by Subject|3|||
163865272|NCT04439799|591872494|FG000|Overall Study|Lost to Follow-up|6|||
164310333|NCT01311024|593510822|FG000|Overall Study|Protocol Violation|35|||
163865273|NCT04439799|591872495|FG001|Overall Study|Lost to Follow-up|6|||
163865274|NCT04439799|591872494|FG000|Overall Study|Withdrawal by Subject|2|||
163865275|NCT04439799|591872495|FG001|Overall Study|Withdrawal by Subject|6|||
163865276|NCT04439799|591872494|FG000|Overall Study|Adverse Event|2|||
163865277|NCT04439799|591872495|FG001|Overall Study|Adverse Event|5|||
163865278|NCT00371566|591872496|FG000|Treatment Phase|Withdrawal by Subject|0|||
164310334|NCT01311024|593510823|FG001|Overall Study|Protocol Violation|22|||
164310335|NCT00856518|593510824|FG000|Overall Study|Lost to Follow-up|4|||
164310336|NCT00856518|593510825|FG001|Overall Study|Lost to Follow-up|2|||
164310337|NCT02867384|593510826|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
164310338|NCT02867384|593510827|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
163970245|NCT01524198|592264644|FG000|Overall Study|Protocol Violation|8|||
163970246|NCT01524198|592264645|FG001|Overall Study|Protocol Violation|6|||
163970247|NCT01524198|592264644|FG000|Overall Study|Withdrawal by Subject|15|||
163970248|NCT01524198|592264645|FG001|Overall Study|Withdrawal by Subject|10|||
163970249|NCT02232802|592264646|FG000|Period 1|Sponsor request|1|||
163970250|NCT02232802|592264647|FG001|Period 1|Sponsor request|0|||
163970251|NCT02232802|592264646|FG000|Period 1|Adverse Event|1|||
163970252|NCT02232802|592264647|FG001|Period 1|Adverse Event|1|||
163970253|NCT00885703|592264653|FG000|Overall Study|Death|9|||
163970254|NCT00885703|592264654|FG001|Overall Study|Death|7|||
163970255|NCT00885703|592264655|FG002|Overall Study|Death|8|||
163970256|NCT00885703|592264656|FG003|Overall Study|Death|7|||
163970257|NCT00885703|592264657|FG004|Overall Study|Death|7|||
163970258|NCT00885703|592264658|FG005|Overall Study|Death|8|||
163970259|NCT00885703|592264659|FG006|Overall Study|Death|4|||
163970260|NCT00885703|592264653|FG000|Overall Study|Lost to Follow-up|0|||
163970261|NCT00885703|592264654|FG001|Overall Study|Lost to Follow-up|0|||
163970262|NCT00885703|592264655|FG002|Overall Study|Lost to Follow-up|1|||
163970263|NCT00885703|592264656|FG003|Overall Study|Lost to Follow-up|0|||
163970264|NCT00885703|592264657|FG004|Overall Study|Lost to Follow-up|0|||
163970265|NCT00885703|592264658|FG005|Overall Study|Lost to Follow-up|1|||
163970266|NCT00885703|592264659|FG006|Overall Study|Lost to Follow-up|0|||
163970267|NCT00885703|592264653|FG000|Overall Study|Withdrawal by Subject|0|||
163970268|NCT00885703|592264654|FG001|Overall Study|Withdrawal by Subject|0|||
163970269|NCT00885703|592264655|FG002|Overall Study|Withdrawal by Subject|0|||
163970270|NCT00885703|592264656|FG003|Overall Study|Withdrawal by Subject|1|||
163970271|NCT00885703|592264657|FG004|Overall Study|Withdrawal by Subject|3|||
163970272|NCT00885703|592264658|FG005|Overall Study|Withdrawal by Subject|1|||
163970273|NCT00885703|592264659|FG006|Overall Study|Withdrawal by Subject|1|||
163970274|NCT00885703|592264653|FG000|Overall Study|Ineligible (no CM)|1|||
163970275|NCT00885703|592264654|FG001|Overall Study|Ineligible (no CM)|3|||
163970276|NCT00885703|592264655|FG002|Overall Study|Ineligible (no CM)|2|||
163970277|NCT00885703|592264656|FG003|Overall Study|Ineligible (no CM)|1|||
163970278|NCT00885703|592264657|FG004|Overall Study|Ineligible (no CM)|2|||
163970279|NCT00885703|592264658|FG005|Overall Study|Ineligible (no CM)|3|||
163970280|NCT00885703|592264659|FG006|Overall Study|Ineligible (no CM)|1|||
163970281|NCT00346073|592264660|FG000|Overall Study|Serious Adverse Event|2|||
163970282|NCT00346073|592264661|FG001|Overall Study|Serious Adverse Event|0|||
163970283|NCT00346073|592264660|FG000|Overall Study|Lost to Follow-up|39|||
163970284|NCT00346073|592264661|FG001|Overall Study|Lost to Follow-up|24|||
163970285|NCT02053168|592264669|FG000|Overall Study|Withdrawal by Subject|1|||
163970286|NCT02053168|592264669|FG000|Overall Study|Physician Decision|1|||
163970287|NCT02053168|592264669|FG000|Overall Study|Lost to Follow-up|1|||
163970288|NCT02687542|592264670|FG000|Overall Study|Medication error without associated AEs|0|||
163970289|NCT02687542|592264671|FG001|Overall Study|Medication error without associated AEs|0|||
163970290|NCT02687542|592264672|FG002|Overall Study|Medication error without associated AEs|0|||
163970291|NCT02687542|592264673|FG003|Overall Study|Medication error without associated AEs|0|||
163970292|NCT02687542|592264674|FG004|Overall Study|Medication error without associated AEs|1|||
163970293|NCT02687542|592264670|FG000|Overall Study|Lost to Follow-up|0|||
163970294|NCT02687542|592264671|FG001|Overall Study|Lost to Follow-up|0|||
163970295|NCT02687542|592264672|FG002|Overall Study|Lost to Follow-up|0|||
163970296|NCT02687542|592264673|FG003|Overall Study|Lost to Follow-up|0|||
163970297|NCT02687542|592264674|FG004|Overall Study|Lost to Follow-up|1|||
163970298|NCT02687542|592264670|FG000|Overall Study|Protocol Violation|0|||
163970299|NCT02687542|592264671|FG001|Overall Study|Protocol Violation|1|||
163970300|NCT02687542|592264672|FG002|Overall Study|Protocol Violation|0|||
163970301|NCT02687542|592264673|FG003|Overall Study|Protocol Violation|0|||
163970302|NCT02687542|592264674|FG004|Overall Study|Protocol Violation|0|||
163970303|NCT02687542|592264670|FG000|Overall Study|Other|5|||
163970304|NCT02687542|592264671|FG001|Overall Study|Other|9|||
163970305|NCT02687542|592264672|FG002|Overall Study|Other|10|||
163970306|NCT02687542|592264673|FG003|Overall Study|Other|6|||
164201682|NCT02791269|593112561|FG001|Overall Study|Lost to Follow-up|1|||
164201683|NCT02683109|593112562|FG000|Overall Study|Adverse Event|1|||
164201684|NCT02683109|593112563|FG001|Overall Study|Adverse Event|0|||
163970307|NCT02687542|592264674|FG004|Overall Study|Other|5|||
163970308|NCT02687542|592264670|FG000|Overall Study|Adverse Event|3|||
163970309|NCT02687542|592264671|FG001|Overall Study|Adverse Event|1|||
163970310|NCT02687542|592264672|FG002|Overall Study|Adverse Event|3|||
163970311|NCT02687542|592264673|FG003|Overall Study|Adverse Event|2|||
163970312|NCT02687542|592264674|FG004|Overall Study|Adverse Event|9|||
163970313|NCT02687542|592264670|FG000|Overall Study|Withdrawal by Subject|0|||
163970314|NCT02687542|592264671|FG001|Overall Study|Withdrawal by Subject|1|||
163970315|NCT02687542|592264672|FG002|Overall Study|Withdrawal by Subject|1|||
163970316|NCT02687542|592264673|FG003|Overall Study|Withdrawal by Subject|2|||
163970317|NCT02687542|592264674|FG004|Overall Study|Withdrawal by Subject|4|||
163970318|NCT00636675|592264675|FG000|Overall Study|Lost to Follow-up|121|||
163970319|NCT00636675|592264676|FG001|Overall Study|Lost to Follow-up|31|||
163970320|NCT00636675|592264675|FG000|Overall Study|Withdrawal by Subject|19|||
164201685|NCT00368251|593112564|FG000|Overall Study|SAE, non-fatal|1|||
164310339|NCT02867384|593510828|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
164310340|NCT02867384|593510826|FG000|Overall Study|Progression/ Relapse|15|||
164310341|NCT02867384|593510827|FG001|Overall Study|Progression/ Relapse|19|||
164310342|NCT02867384|593510828|FG002|Overall Study|Progression/ Relapse|0|||
164310343|NCT02867384|593510826|FG000|Overall Study|Adverse Event|13|||
164310344|NCT02867384|593510827|FG001|Overall Study|Adverse Event|1|||
164310345|NCT02867384|593510828|FG002|Overall Study|Adverse Event|0|||
164310346|NCT02867384|593510826|FG000|Overall Study|Withdrawal by Subject|6|||
164310347|NCT02867384|593510827|FG001|Overall Study|Withdrawal by Subject|5|||
164310348|NCT02867384|593510828|FG002|Overall Study|Withdrawal by Subject|0|||
164310349|NCT02867384|593510826|FG000|Overall Study|Physician Decision|1|||
164310350|NCT02867384|593510827|FG001|Overall Study|Physician Decision|2|||
164310351|NCT02867384|593510828|FG002|Overall Study|Physician Decision|0|||
164310352|NCT02867384|593510826|FG000|Overall Study|Patient compliance|1|||
164310353|NCT02867384|593510827|FG001|Overall Study|Patient compliance|0|||
164310354|NCT02867384|593510828|FG002|Overall Study|Patient compliance|0|||
164310355|NCT02867384|593510826|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
164310356|NCT02867384|593510827|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
164310357|NCT02867384|593510828|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
164310358|NCT02867384|593510826|FG000|Overall Study|Never start treatment|3|||
164310359|NCT02867384|593510827|FG001|Overall Study|Never start treatment|0|||
164310360|NCT02867384|593510828|FG002|Overall Study|Never start treatment|0|||
164310361|NCT01941186|593510829|FG000|Follow-up|Lost to Follow-up|1|||
164310362|NCT01941186|593510830|FG001|Follow-up|Lost to Follow-up|0|||
164310363|NCT02105961|593510831|FG000|Overall Study|Adverse Event|18|||
164310364|NCT02105961|593510832|FG001|Overall Study|Adverse Event|7|||
164310365|NCT02105961|593510833|FG002|Overall Study|Adverse Event|13|||
164310366|NCT02105961|593510831|FG000|Overall Study|Lack of Efficacy|3|||
164310367|NCT02105961|593510832|FG001|Overall Study|Lack of Efficacy|0|||
164310368|NCT02105961|593510833|FG002|Overall Study|Lack of Efficacy|3|||
163865279|NCT00371566|591872497|FG001|Treatment Phase|Withdrawal by Subject|1|||
163865280|NCT00371566|591872496|FG000|Treatment Phase|Adverse Event|0|||
163865281|NCT00371566|591872497|FG001|Treatment Phase|Adverse Event|1|||
163865282|NCT00371566|591872496|FG000|Treatment Phase|Protocol Violation|0|||
163865283|NCT00371566|591872497|FG001|Treatment Phase|Protocol Violation|1|||
163865284|NCT00371566|591872496|FG000|Chemoradiation Phase|Physician Decision|2|||
163865285|NCT00371566|591872497|FG001|Chemoradiation Phase|Physician Decision|0|||
163865286|NCT00371566|591872496|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
163865287|NCT00371566|591872497|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
163865288|NCT00371566|591872496|FG000|Chemoradiation Phase|Non compliant|0|||
163865289|NCT00371566|591872497|FG001|Chemoradiation Phase|Non compliant|1|||
163865290|NCT00371566|591872496|FG000|Chemoradiation Phase|Progressive Disease|1|||
163865291|NCT00371566|591872497|FG001|Chemoradiation Phase|Progressive Disease|1|||
163865292|NCT00371566|591872496|FG000|Chemoradiation Phase|Death|2|||
163865293|NCT00371566|591872497|FG001|Chemoradiation Phase|Death|0|||
163865294|NCT00371566|591872496|FG000|Follow Up Phase|Death|0|||
163865295|NCT00371566|591872497|FG001|Follow Up Phase|Death|5|||
163865296|NCT00371566|591872496|FG000|Follow Up Phase|Disease progression|1|||
163865297|NCT00371566|591872497|FG001|Follow Up Phase|Disease progression|0|||
163865298|NCT00371566|591872496|FG000|Follow Up Phase|Withdrawal by Subject|0|||
163865299|NCT00371566|591872497|FG001|Follow Up Phase|Withdrawal by Subject|1|||
163865300|NCT00371566|591872496|FG000|Follow Up Phase|Physician Decision|1|||
163865301|NCT00371566|591872497|FG001|Follow Up Phase|Physician Decision|1|||
163865302|NCT00371566|591872496|FG000|Follow Up Phase|Lost to Follow-up|1|||
163865303|NCT00371566|591872497|FG001|Follow Up Phase|Lost to Follow-up|0|||
163865304|NCT00530842|591872501|FG000|Overall Study|Adverse Event|10|||
163865305|NCT00530842|591872502|FG001|Overall Study|Adverse Event|6|||
163865306|NCT00530842|591872501|FG000|Overall Study|Lack of Efficacy|2|||
163865307|NCT00530842|591872502|FG001|Overall Study|Lack of Efficacy|1|||
163865308|NCT00530842|591872501|FG000|Overall Study|Lost to Follow-up|0|||
163865309|NCT00530842|591872502|FG001|Overall Study|Lost to Follow-up|4|||
163865310|NCT00530842|591872501|FG000|Overall Study|Protocol Violation|3|||
163865311|NCT00530842|591872502|FG001|Overall Study|Protocol Violation|2|||
163865312|NCT00530842|591872501|FG000|Overall Study|Withdrawal by Subject|4|||
163865313|NCT00530842|591872502|FG001|Overall Study|Withdrawal by Subject|5|||
163865314|NCT00530842|591872501|FG000|Overall Study|Individual different reasons|4|||
163865315|NCT00530842|591872502|FG001|Overall Study|Individual different reasons|3|||
163865316|NCT00530842|591872501|FG000|Period 1|Adverse Event|7|||
163970321|NCT00636675|592264676|FG001|Overall Study|Withdrawal by Subject|10|||
163865317|NCT00530842|591872502|FG001|Period 1|Adverse Event|3|||
163970322|NCT00096785|592264678|FG000|Overall Study|Lost to Follow-up|1|||
164310369|NCT02105961|593510831|FG000|Overall Study|Lost to Follow-up|2|||
164310370|NCT02105961|593510832|FG001|Overall Study|Lost to Follow-up|0|||
164310371|NCT02105961|593510833|FG002|Overall Study|Lost to Follow-up|1|||
164310372|NCT02105961|593510831|FG000|Overall Study|Physician Decision|3|||
163865318|NCT00530842|591872501|FG000|Period 1|Lack of Efficacy|1|||
163865319|NCT00530842|591872502|FG001|Period 1|Lack of Efficacy|1|||
164310373|NCT02105961|593510832|FG001|Overall Study|Physician Decision|3|||
164310374|NCT02105961|593510833|FG002|Overall Study|Physician Decision|2|||
164310375|NCT02105961|593510831|FG000|Overall Study|Withdrawal by Subject|15|||
164310376|NCT02105961|593510832|FG001|Overall Study|Withdrawal by Subject|7|||
164310377|NCT02105961|593510833|FG002|Overall Study|Withdrawal by Subject|11|||
164310378|NCT00934362|593510837|FG000|Overall Study|Adverse Event|1|||
164310379|NCT00934362|593510838|FG001|Overall Study|Adverse Event|0|||
164310380|NCT01092117|593510841|FG000|Index Procedure to 1 Month|Death|1|||
164310381|NCT01092117|593510841|FG000|1 Month|Death|1|||
164310382|NCT01092117|593510841|FG000|1 Month|Withdrawal by Subject|1|||
164310383|NCT01092117|593510841|FG000|1 Month|Lost to Follow-up|1|||
164310384|NCT01092117|593510841|FG000|6 Months|Death|2|||
164310385|NCT01092117|593510841|FG000|6 Months|Withdrawal by Subject|3|||
164310386|NCT01092117|593510841|FG000|12 Month|Death|11|||
164310387|NCT01092117|593510841|FG000|12 Month|Withdrawal by Subject|2|||
164310388|NCT01092117|593510841|FG000|12 Month|Lost to Follow-up|1|||
164310389|NCT01092117|593510841|FG000|Year 2|Death|5|||
164310390|NCT01092117|593510841|FG000|Year 2|Withdrawal by Subject|4|||
164310391|NCT01092117|593510841|FG000|Year 2|Lost to Follow-up|1|||
164310392|NCT01092117|593510841|FG000|Year 3|Death|7|||
164310393|NCT01092117|593510841|FG000|Year 3|Withdrawal by Subject|9|||
164310394|NCT01092117|593510841|FG000|Year 3|Lost to Follow-up|3|||
164310395|NCT01092117|593510841|FG000|Year 4|Death|8|||
164310396|NCT01092117|593510841|FG000|Year 4|Withdrawal by Subject|4|||
164310397|NCT01092117|593510841|FG000|Year 4|Lost to Follow-up|4|||
164310398|NCT04380519|593510842|FG000|Overall Study|Withdrawal by Subject|4|||
164310399|NCT04380519|593510843|FG001|Overall Study|Withdrawal by Subject|0|||
164310400|NCT04380519|593510844|FG002|Overall Study|Withdrawal by Subject|1|||
164310401|NCT04380519|593510842|FG000|Overall Study|Death|14|||
164310402|NCT04380519|593510843|FG001|Overall Study|Death|9|||
164310403|NCT04380519|593510844|FG002|Overall Study|Death|6|||
164310404|NCT04380519|593510842|FG000|Overall Study|Adverse Event|0|||
164310405|NCT04380519|593510843|FG001|Overall Study|Adverse Event|1|||
164310406|NCT04380519|593510844|FG002|Overall Study|Adverse Event|0|||
164310407|NCT04380519|593510842|FG000|Overall Study|relatives' decision|0|||
164310408|NCT04380519|593510843|FG001|Overall Study|relatives' decision|1|||
164201686|NCT00368251|593112565|FG001|Overall Study|SAE, non-fatal|0|||
164310409|NCT04380519|593510844|FG002|Overall Study|relatives' decision|0|||
164310410|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
164310411|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
164310412|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
164310413|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
164310414|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
164310415|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
164310416|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
164310417|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
164310418|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
164310419|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
164310420|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
164310421|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
164310422|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
164310423|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
164310424|NCT04173494|593510845|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
164310425|NCT04173494|593510846|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
164310426|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
164310427|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
164310428|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
164310429|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
164310430|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
164310431|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
164310432|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
164310433|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
164310434|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
164310435|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
164201687|NCT00368251|593112566|FG002|Overall Study|SAE, non-fatal|0|||
164201688|NCT00368251|593112564|FG000|Overall Study|AE, non-serious non-fatal|0|||
164201689|NCT00368251|593112565|FG001|Overall Study|AE, non-serious non-fatal|0|||
164201690|NCT00368251|593112566|FG002|Overall Study|AE, non-serious non-fatal|1|||
164201691|NCT01125930|593112574|FG000|Overall Study|Adverse Event|0|||
164201692|NCT01125930|593112575|FG001|Overall Study|Adverse Event|1|||
164201693|NCT01125930|593112574|FG000|Overall Study|Withdrawal by Subject|1|||
164201694|NCT01125930|593112575|FG001|Overall Study|Withdrawal by Subject|6|||
164201695|NCT01125930|593112574|FG000|Overall Study|Protocol Violation|0|||
164201696|NCT01125930|593112575|FG001|Overall Study|Protocol Violation|1|||
164201697|NCT01125930|593112574|FG000|Overall Study|Lost to Follow-up|0|||
164201698|NCT01125930|593112575|FG001|Overall Study|Lost to Follow-up|2|||
163970323|NCT00096785|592264679|FG001|Overall Study|Lost to Follow-up|0|||
163970324|NCT00096785|592264678|FG000|Overall Study|Withdrawal by Subject|0|||
163970325|NCT00096785|592264679|FG001|Overall Study|Withdrawal by Subject|1|||
163970326|NCT00096785|592264678|FG000|Overall Study|Relocated|1|||
163970327|NCT00096785|592264679|FG001|Overall Study|Relocated|0|||
163970328|NCT00176605|592264680|FG000|Overall Study|Withdrawal by Subject|2|||
163970329|NCT03785925|592264681|FG000|Overall Study|Withdrawal by Subject|15|||
163970330|NCT03785925|592264681|FG000|Overall Study|Lost to Follow-up|1|||
163970331|NCT02187471|592264682|FG000|Overall Study|Protocol Violation|4|||
163970332|NCT02187471|592264683|FG001|Overall Study|Protocol Violation|5|||
163970333|NCT02187471|592264684|FG002|Overall Study|Protocol Violation|4|||
163970334|NCT02187471|592264685|FG003|Overall Study|Protocol Violation|4|||
163970335|NCT02187471|592264682|FG000|Overall Study|Missing|0|||
163970336|NCT02187471|592264683|FG001|Overall Study|Missing|0|||
163970337|NCT02187471|592264684|FG002|Overall Study|Missing|0|||
163970338|NCT02187471|592264685|FG003|Overall Study|Missing|1|||
163970339|NCT02187471|592264682|FG000|Overall Study|Lack of Efficacy|18|||
163970340|NCT02187471|592264683|FG001|Overall Study|Lack of Efficacy|9|||
163970341|NCT02187471|592264684|FG002|Overall Study|Lack of Efficacy|13|||
163970342|NCT02187471|592264685|FG003|Overall Study|Lack of Efficacy|11|||
163970343|NCT02187471|592264682|FG000|Overall Study|Adverse Event|24|||
163970344|NCT02187471|592264683|FG001|Overall Study|Adverse Event|34|||
163970345|NCT02187471|592264684|FG002|Overall Study|Adverse Event|44|||
163970346|NCT02187471|592264685|FG003|Overall Study|Adverse Event|36|||
163970347|NCT02187471|592264682|FG000|Overall Study|Withdrawal by Subject|23|||
163970348|NCT02187471|592264683|FG001|Overall Study|Withdrawal by Subject|29|||
163970349|NCT02187471|592264684|FG002|Overall Study|Withdrawal by Subject|22|||
163970350|NCT02187471|592264685|FG003|Overall Study|Withdrawal by Subject|24|||
163970351|NCT02187471|592264682|FG000|Overall Study|Other|7|||
163970352|NCT02187471|592264683|FG001|Overall Study|Other|5|||
164310436|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
164310437|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
164310438|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
164310439|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
164310440|NCT04173494|593510845|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
164310441|NCT04173494|593510846|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
164310442|NCT01623050|593510847|FG000|Overall Study|Lost to Follow-up|9|||
164310443|NCT02147561|593510850|FG000|Overall Study|Lost to Follow-up|3|||
164310444|NCT02147561|593510850|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
164310445|NCT00526071|593510851|FG000|Overall Study|Adverse Event|1|||
164310446|NCT00526071|593510851|FG000|Overall Study|Withdrawal by Subject|1|||
164310447|NCT00526071|593510851|FG000|Overall Study|Lack of Response to Study Drug|4|||
164310448|NCT01191762|593510852|FG000|Overall Study|Adverse Event|1|||
164310449|NCT01191762|593510853|FG001|Overall Study|Adverse Event|0|||
164310450|NCT00048074|593510863|FG000|Overall Study|Adverse Event|46|||
164310451|NCT00048074|593510864|FG001|Overall Study|Adverse Event|41|||
164310452|NCT00048074|593510865|FG002|Overall Study|Adverse Event|53|||
164310453|NCT00048074|593510863|FG000|Overall Study|Death|3|||
164310454|NCT00048074|593510864|FG001|Overall Study|Death|3|||
164310455|NCT00048074|593510865|FG002|Overall Study|Death|2|||
164310456|NCT00048074|593510863|FG000|Overall Study|Lost to Follow-up|2|||
164310457|NCT00048074|593510864|FG001|Overall Study|Lost to Follow-up|6|||
164310458|NCT00048074|593510865|FG002|Overall Study|Lost to Follow-up|6|||
164310459|NCT00048074|593510863|FG000|Overall Study|Withdrawal by Subject|28|||
164310460|NCT00048074|593510864|FG001|Overall Study|Withdrawal by Subject|30|||
164310461|NCT00048074|593510865|FG002|Overall Study|Withdrawal by Subject|35|||
164310462|NCT00048074|593510863|FG000|Overall Study|Protocol Violation|1|||
164310463|NCT00048074|593510864|FG001|Overall Study|Protocol Violation|3|||
164310464|NCT00048074|593510865|FG002|Overall Study|Protocol Violation|0|||
164310465|NCT00048074|593510863|FG000|Overall Study|Study participation was terminated|0|||
164310466|NCT00048074|593510864|FG001|Overall Study|Study participation was terminated|1|||
164310467|NCT00048074|593510865|FG002|Overall Study|Study participation was terminated|0|||
164310468|NCT00048074|593510863|FG000|Overall Study|Husband ill|0|||
164310469|NCT00048074|593510864|FG001|Overall Study|Husband ill|1|||
164310470|NCT00048074|593510865|FG002|Overall Study|Husband ill|0|||
164310471|NCT00048074|593510863|FG000|Overall Study|Poor compliance|0|||
163970353|NCT02187471|592264684|FG002|Overall Study|Other|3|||
163970354|NCT02187471|592264685|FG003|Overall Study|Other|4|||
163970355|NCT00957528|592264686|FG000|Overall Study|Protocol Violation|0|||
163970356|NCT00957528|592264687|FG001|Overall Study|Protocol Violation|1|||
163970357|NCT00957528|592264688|FG002|Overall Study|Protocol Violation|0|||
163970358|NCT00957528|592264686|FG000|Overall Study|Withdrawal by Subject|0|||
163970359|NCT00957528|592264687|FG001|Overall Study|Withdrawal by Subject|0|||
163970360|NCT00957528|592264688|FG002|Overall Study|Withdrawal by Subject|1|||
163970361|NCT02318667|592264689|FG000|Overall Study|Adverse Event|1|||
163970362|NCT02318667|592264689|FG000|Overall Study|Lack of Efficacy|6|||
163970363|NCT02318667|592264689|FG000|Overall Study|Protocol Violation|2|||
163970364|NCT01735279|592264693|FG000|Overall Study|Lost to Follow-up|11|||
163865320|NCT00530842|591872501|FG000|Period 1|Protocol Violation|2|||
163865321|NCT00530842|591872502|FG001|Period 1|Protocol Violation|1|||
163865322|NCT00530842|591872501|FG000|Period 1|Withdrawal by Subject|2|||
163865323|NCT00530842|591872502|FG001|Period 1|Withdrawal by Subject|3|||
163865324|NCT00530842|591872501|FG000|Period 1|Individual different reasons|2|||
163865325|NCT00530842|591872502|FG001|Period 1|Individual different reasons|3|||
163865326|NCT00530842|591872501|FG000|Period 2|Adverse Event|3|||
163865327|NCT00530842|591872502|FG001|Period 2|Adverse Event|3|||
163865328|NCT00530842|591872501|FG000|Period 2|Lack of Efficacy|1|||
163865329|NCT00530842|591872502|FG001|Period 2|Lack of Efficacy|0|||
163865330|NCT00530842|591872501|FG000|Period 2|Lost to Follow-up|0|||
163865331|NCT00530842|591872502|FG001|Period 2|Lost to Follow-up|4|||
163865332|NCT00530842|591872501|FG000|Period 2|Protocol Violation|1|||
163865333|NCT00530842|591872502|FG001|Period 2|Protocol Violation|0|||
163865334|NCT00530842|591872501|FG000|Period 2|Withdrawal by Subject|1|||
163865335|NCT00530842|591872502|FG001|Period 2|Withdrawal by Subject|2|||
163865336|NCT00530842|591872501|FG000|Period 2|Individual different reasons|2|||
163865337|NCT00530842|591872502|FG001|Period 2|Individual different reasons|0|||
163865338|NCT00082810|591872503|FG000|Overall Study|Adverse Event|3|||
163865339|NCT00082810|591872503|FG000|Overall Study|Progressive disease|24|||
163865340|NCT00082810|591872503|FG000|Overall Study|Withdrawal by Subject|4|||
163865341|NCT00177216|591872504|FG000|Overall Study|Withdrawal by Subject|6|||
163865342|NCT00177216|591872505|FG001|Overall Study|Withdrawal by Subject|3|||
163865343|NCT00177216|591872506|FG002|Overall Study|Withdrawal by Subject|1|||
163865344|NCT02685488|591872513|FG000|Overall Study|Withdrawal by Subject|0|||
163865345|NCT02685488|591872514|FG001|Overall Study|Withdrawal by Subject|1|||
163865346|NCT04436120|591872515|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163865347|NCT04436120|591872516|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163865348|NCT04436120|591872517|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163865349|NCT04436120|591872518|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
163865350|NCT04436120|591872519|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163865351|NCT04436120|591872520|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
163865352|NCT04436120|591872521|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
163865353|NCT01769391|591872522|FG000|Overall Study|Death|10|||
163865354|NCT01769391|591872523|FG001|Overall Study|Death|1|||
163865355|NCT01769391|591872522|FG000|Overall Study|Adverse Event|0|||
163865356|NCT01769391|591872523|FG001|Overall Study|Adverse Event|3|||
163865357|NCT01769391|591872522|FG000|Overall Study|Progressive Disease|1|||
163865358|NCT01769391|591872523|FG001|Overall Study|Progressive Disease|2|||
163865359|NCT01769391|591872522|FG000|Overall Study|Withdrawal by Subject|4|||
163865360|NCT01769391|591872523|FG001|Overall Study|Withdrawal by Subject|3|||
163865361|NCT01769391|591872522|FG000|Overall Study|Investigator Decision|2|||
163865362|NCT01769391|591872523|FG001|Overall Study|Investigator Decision|0|||
163865363|NCT02351180|591872526|FG000|Overall Study|Withdrawal by Subject|1|||
163865364|NCT02351180|591872527|FG001|Overall Study|Withdrawal by Subject|0|||
163865365|NCT00208767|591872528|FG000|Overall Study|Adverse Event|9|||
163865366|NCT00208767|591872529|FG001|Overall Study|Adverse Event|1|||
163865367|NCT00208767|591872528|FG000|Overall Study|Withdrawal by Subject|14|||
163865368|NCT00208767|591872529|FG001|Overall Study|Withdrawal by Subject|3|||
163865369|NCT00208767|591872528|FG000|Overall Study|Death|1|||
163865370|NCT00208767|591872529|FG001|Overall Study|Death|0|||
163865371|NCT00208767|591872528|FG000|Overall Study|Lost to Follow-up|3|||
163865372|NCT00208767|591872529|FG001|Overall Study|Lost to Follow-up|3|||
163865373|NCT02317016|591872530|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
163865374|NCT02317016|591872530|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
163865375|NCT02317016|591872530|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
163865376|NCT02317016|591872530|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
163865377|NCT02317016|591872530|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
163865378|NCT02317016|591872530|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
163865379|NCT02317016|591872530|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
163865380|NCT03545984|591872531|FG000|Overall Study|CSF cases not present during rotation|11|||
163865381|NCT03545984|591872532|FG001|Overall Study|CSF cases not present during rotation|9|||
163865382|NCT03418324|591872533|FG000|Overall Study|Death|0|||
163865383|NCT03418324|591872534|FG001|Overall Study|Death|1|||
163865384|NCT03418324|591872533|FG000|Overall Study|Physician Decision|1|||
163970365|NCT01735279|592264694|FG001|Overall Study|Lost to Follow-up|8|||
163970366|NCT00294060|592264695|FG000|Overall Study|Death|225|||
163970367|NCT00294060|592264695|FG000|Overall Study|Other|59|||
163970368|NCT00294060|592264695|FG000|Overall Study|Lost to Follow-up|55|||
163865385|NCT03418324|591872534|FG001|Overall Study|Physician Decision|1|||
163970369|NCT00294060|592264695|FG000|Overall Study|Withdrawal by Subject|11|||
163970370|NCT00294060|592264695|FG000|Overall Study|Physician Decision|797|||
163970371|NCT00294060|592264695|FG000|Overall Study|Medical condition|3|||
163865386|NCT01768676|591872535|FG000|Overall Study|Adverse Event|3|||
163865387|NCT01768676|591872536|FG001|Overall Study|Adverse Event|3|||
163970372|NCT00294060|592264695|FG000|Overall Study|Device explanted/not replaced|23|||
164201699|NCT00900562|593112578|FG000|Overall Study|Progressive disease|9|||
164201700|NCT00900562|593112579|FG001|Overall Study|Progressive disease|5|||
164201701|NCT00900562|593112578|FG000|Overall Study|Toxicity|1|||
164201702|NCT00900562|593112579|FG001|Overall Study|Toxicity|0|||
164201703|NCT00900562|593112578|FG000|Overall Study|Death|1|||
164201704|NCT00900562|593112579|FG001|Overall Study|Death|1|||
164201705|NCT00900562|593112578|FG000|Overall Study|Withdrawal by Subject|0|||
164201706|NCT00900562|593112579|FG001|Overall Study|Withdrawal by Subject|1|||
164201707|NCT00900562|593112578|FG000|Overall Study|Unrelated adverse event|1|||
164201708|NCT00900562|593112579|FG001|Overall Study|Unrelated adverse event|0|||
164201709|NCT02300610|593112580|FG000|Overall Study|Withdrawal by Subject|1|||
164201710|NCT02300610|593112581|FG001|Overall Study|Withdrawal by Subject|0|||
164201711|NCT02300610|593112582|FG002|Overall Study|Withdrawal by Subject|1|||
164201712|NCT02152007|593112583|FG000|Overall Study|Withdrawal by Subject|1|||
164201713|NCT03363906|593112590|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
164201714|NCT03363906|593112591|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
164201715|NCT03363906|593112590|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
164201716|NCT03363906|593112591|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
164201717|NCT03363906|593112590|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
164201718|NCT03363906|593112591|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
164201719|NCT03363906|593112590|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
164201720|NCT03363906|593112591|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
164201721|NCT00676143|593112592|FG000|Overall Study|Adverse Event|34|||
164201722|NCT00676143|593112593|FG001|Overall Study|Adverse Event|60|||
164201723|NCT00676143|593112592|FG000|Overall Study|Death|4|||
164201724|NCT00676143|593112593|FG001|Overall Study|Death|4|||
164201725|NCT00676143|593112592|FG000|Overall Study|Lack of Efficacy|0|||
164201726|NCT00676143|593112593|FG001|Overall Study|Lack of Efficacy|6|||
164201727|NCT00676143|593112592|FG000|Overall Study|Lost to Follow-up|0|||
164201728|NCT00676143|593112593|FG001|Overall Study|Lost to Follow-up|13|||
164201729|NCT00676143|593112592|FG000|Overall Study|Physician Decision|5|||
164201730|NCT00676143|593112593|FG001|Overall Study|Physician Decision|8|||
164201731|NCT00676143|593112592|FG000|Overall Study|Protocol Violation|4|||
164201732|NCT00676143|593112593|FG001|Overall Study|Protocol Violation|8|||
164201733|NCT00676143|593112592|FG000|Overall Study|Withdrawal by Subject|24|||
164201734|NCT00676143|593112593|FG001|Overall Study|Withdrawal by Subject|42|||
164201735|NCT00676143|593112592|FG000|Overall Study|Discontinuation of study by sponsor|65|||
164201736|NCT00676143|593112593|FG001|Overall Study|Discontinuation of study by sponsor|88|||
164201737|NCT00676143|593112592|FG000|Overall Study|Failed to return|2|||
164201738|NCT00676143|593112593|FG001|Overall Study|Failed to return|1|||
164201739|NCT00676143|593112592|FG000|Overall Study|Loss of caregiver|5|||
164201740|NCT00676143|593112593|FG001|Overall Study|Loss of caregiver|3|||
164201741|NCT00676143|593112592|FG000|Overall Study|Other|11|||
164201742|NCT00676143|593112593|FG001|Overall Study|Other|20|||
164201743|NCT00676143|593112592|FG000|Overall Study|Participant participation unknown|1|||
163865388|NCT01768676|591872535|FG000|Overall Study|Lost to Follow-up|13|||
163865389|NCT01768676|591872536|FG001|Overall Study|Lost to Follow-up|16|||
163865390|NCT01768676|591872535|FG000|Overall Study|Protocol Violation|1|||
163865391|NCT01768676|591872536|FG001|Overall Study|Protocol Violation|1|||
163865392|NCT01768676|591872535|FG000|Overall Study|Physician Decision|4|||
163865393|NCT01768676|591872536|FG001|Overall Study|Physician Decision|1|||
163865394|NCT01768676|591872535|FG000|Overall Study|Withdrawal by Subject|3|||
163865395|NCT01768676|591872536|FG001|Overall Study|Withdrawal by Subject|10|||
163865396|NCT00605033|591872537|FG000|Overall Study|Adverse Event|2|||
163865397|NCT00605033|591872538|FG001|Overall Study|Adverse Event|2|||
163865398|NCT00605033|591872537|FG000|Overall Study|Lost to Follow-up|1|||
163865399|NCT00605033|591872538|FG001|Overall Study|Lost to Follow-up|1|||
163865400|NCT00605033|591872537|FG000|Overall Study|Withdrawal by Subject|3|||
163865401|NCT00605033|591872538|FG001|Overall Study|Withdrawal by Subject|4|||
163865402|NCT00605033|591872537|FG000|Overall Study|Protocol Violation|1|||
163865403|NCT00605033|591872538|FG001|Overall Study|Protocol Violation|1|||
163865404|NCT03121950|591872539|FG000|Overall Study|Withdrawal by Subject|11|||
163865405|NCT03121950|591872540|FG001|Overall Study|Withdrawal by Subject|2|||
163865406|NCT03175172|591874261|FG000|Overall Study|Death|3|||
163865407|NCT03175172|591874261|FG000|Overall Study|Withdrawal by Subject|3|||
163865408|NCT03175172|591874261|FG000|Overall Study|Lost to Follow-up|1|||
163865409|NCT03175172|591874261|FG000|Overall Study|Study Terminated by Sponsor|3|||
163865410|NCT00028769|591874264|FG000|Overall Study|Adverse Event|2|||
163865411|NCT00028769|591874264|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
163865412|NCT00028769|591874264|FG000|Overall Study|Progression or Death|31|||
163865413|NCT00028769|591874264|FG000|Overall Study|Other - Not Protocol Specified|1|||
163865414|NCT00028769|591874264|FG000|Overall Study|Ineligible|5|||
163865415|NCT00028769|591874264|FG000|Overall Study|Not Analyzable|1|||
163865416|NCT02496702|591874267|FG000|Overall Study|Lost to Follow-up|8|||
163865417|NCT02496702|591874268|FG001|Overall Study|Lost to Follow-up|6|||
163865418|NCT02496702|591874267|FG000|Overall Study|Only partially tested|0|||
163865419|NCT02496702|591874268|FG001|Overall Study|Only partially tested|2|||
164310472|NCT00048074|593510864|FG001|Overall Study|Poor compliance|1|||
164310473|NCT00048074|593510865|FG002|Overall Study|Poor compliance|0|||
164310474|NCT00048074|593510863|FG000|Overall Study|Out of station|0|||
164310475|NCT00048074|593510864|FG001|Overall Study|Out of station|1|||
164310476|NCT00048074|593510865|FG002|Overall Study|Out of station|1|||
164310477|NCT00048074|593510863|FG000|Overall Study|Social reasons|1|||
164310478|NCT00048074|593510864|FG001|Overall Study|Social reasons|0|||
164310479|NCT00048074|593510865|FG002|Overall Study|Social reasons|0|||
164310480|NCT04476797|593510866|FG000|Overall Study|Withdrawal by Subject|1|||
164310481|NCT04476797|593510867|FG001|Overall Study|Withdrawal by Subject|0|||
164310482|NCT04476797|593510868|FG002|Overall Study|Withdrawal by Subject|0|||
164310483|NCT04476797|593510866|FG000|Overall Study|Death|0|||
164310484|NCT04476797|593510867|FG001|Overall Study|Death|1|||
164310485|NCT04476797|593510868|FG002|Overall Study|Death|2|||
164310486|NCT04476797|593510866|FG000|Overall Study|Sponsor Terminated Study|0|||
164310487|NCT04476797|593510867|FG001|Overall Study|Sponsor Terminated Study|18|||
164310488|NCT04476797|593510868|FG002|Overall Study|Sponsor Terminated Study|17|||
163865420|NCT02698891|591874271|FG000|Overall Study|Withdrawal by Subject|2|||
163865421|NCT02698891|591874271|FG000|Overall Study|deemed ineligible|1|||
163865422|NCT02698891|591874271|FG000|Overall Study|Adverse Event|9|||
163865423|NCT00516386|591874272|FG000|Overall Study|not interested in the study|4|||
163865424|NCT00516386|591874272|FG000|Overall Study|Lost to Follow-up|2|||
163865425|NCT00002842|591874273|FG000|Overall Study|ineligible for surgical resection|27|||
163865426|NCT00393848|591874274|FG000|Overall Study|Surgical schedule|0|||
163865427|NCT00393848|591874275|FG001|Overall Study|Surgical schedule|0|||
163865428|NCT00393848|591874276|FG002|Overall Study|Surgical schedule|0|||
163865429|NCT00393848|591874277|FG003|Overall Study|Surgical schedule|1|||
163865430|NCT00393848|591874274|FG000|Overall Study|Personal reasons|0|||
163865431|NCT00393848|591874275|FG001|Overall Study|Personal reasons|0|||
163865432|NCT00393848|591874276|FG002|Overall Study|Personal reasons|2|||
163865433|NCT00393848|591874277|FG003|Overall Study|Personal reasons|0|||
163865434|NCT02694978|591874280|FG000|Overall Study|Adverse Event|10|||
163865435|NCT02694978|591874281|FG001|Overall Study|Adverse Event|9|||
163865436|NCT02694978|591874280|FG000|Overall Study|Withdrawal by Subject|22|||
163865437|NCT02694978|591874281|FG001|Overall Study|Withdrawal by Subject|19|||
163865438|NCT02694978|591874280|FG000|Overall Study|Lost to Follow-up|14|||
163865439|NCT02694978|591874281|FG001|Overall Study|Lost to Follow-up|17|||
163865440|NCT02694978|591874280|FG000|Overall Study|Death|4|||
163865441|NCT02694978|591874281|FG001|Overall Study|Death|1|||
163865442|NCT02694978|591874280|FG000|Overall Study|Other-Decision of Participant|6|||
163865443|NCT02694978|591874281|FG001|Overall Study|Other-Decision of Participant|1|||
163865444|NCT02694978|591874280|FG000|Overall Study|Other-Investigator's decision|1|||
163865445|NCT02694978|591874281|FG001|Overall Study|Other-Investigator's decision|0|||
163865446|NCT02694978|591874280|FG000|Overall Study|Other-Unable to be reached|0|||
163865447|NCT02694978|591874281|FG001|Overall Study|Other-Unable to be reached|1|||
163865448|NCT02694978|591874280|FG000|Overall Study|Other-Protocol noncompliant|2|||
163865449|NCT02694978|591874281|FG001|Overall Study|Other-Protocol noncompliant|1|||
163865450|NCT02694978|591874280|FG000|Overall Study|Other-Personal reasons|3|||
163865451|NCT02694978|591874281|FG001|Overall Study|Other-Personal reasons|3|||
163865452|NCT02694978|591874280|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
163865453|NCT02694978|591874281|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
163865454|NCT00807144|591874286|FG000|Overall Study|Lost to Follow-up|0|||
163865455|NCT00807144|591874287|FG001|Overall Study|Lost to Follow-up|1|||
163865456|NCT01713530|591874289|FG000|Overall Study|Adverse Event|0|||
163865457|NCT01713530|591874290|FG001|Overall Study|Adverse Event|5|||
163865458|NCT01713530|591874289|FG000|Overall Study|Withdrawal criteria|21|||
163865459|NCT01713530|591874290|FG001|Overall Study|Withdrawal criteria|12|||
163865460|NCT01713530|591874289|FG000|Overall Study|Unclassified|4|||
163865461|NCT01713530|591874290|FG001|Overall Study|Unclassified|2|||
163865462|NCT03939819|591874291|FG000|Overall Study|Death|2|||
163865463|NCT03939819|591874292|FG001|Overall Study|Death|0|||
163865464|NCT03987451|591874293|FG000|Overall Study|Lost to Follow-up|1|||
163865465|NCT03987451|591874294|FG001|Overall Study|Lost to Follow-up|0|||
163865466|NCT03987451|591874293|FG000|Overall Study|Withdrawal by Subject|1|||
163865467|NCT03987451|591874294|FG001|Overall Study|Withdrawal by Subject|1|||
163865468|NCT00949975|591874295|FG000|Overall Study|Voluntary discontinuation|6|||
163865469|NCT00949975|591874296|FG001|Overall Study|Voluntary discontinuation|5|||
163865470|NCT00949975|591874297|FG002|Overall Study|Voluntary discontinuation|3|||
163865471|NCT00949975|591874298|FG003|Overall Study|Voluntary discontinuation|6|||
163865472|NCT00949975|591874295|FG000|Overall Study|Adverse Event|11|||
163865473|NCT00949975|591874296|FG001|Overall Study|Adverse Event|11|||
163865474|NCT00949975|591874297|FG002|Overall Study|Adverse Event|10|||
163865475|NCT00949975|591874298|FG003|Overall Study|Adverse Event|10|||
163865476|NCT00949975|591874295|FG000|Overall Study|Safety reason|0|||
163865477|NCT00949975|591874296|FG001|Overall Study|Safety reason|1|||
163865478|NCT00949975|591874297|FG002|Overall Study|Safety reason|0|||
163865479|NCT00949975|591874298|FG003|Overall Study|Safety reason|0|||
164310489|NCT02395081|593510869|FG000|Overall Study|Withdrawal by Subject|1|||
164310490|NCT02395081|593510870|FG001|Overall Study|Withdrawal by Subject|1|||
163970373|NCT00806195|592264696|FG000|Overall Study|Death|6|||
163970374|NCT00806195|592264697|FG001|Overall Study|Death|0|||
163970375|NCT00806195|592264698|FG002|Overall Study|Death|1|||
163970376|NCT00806195|592264699|FG003|Overall Study|Death|0|||
163970377|NCT00806195|592264696|FG000|Overall Study|Adverse Event|25|||
163970378|NCT00806195|592264697|FG001|Overall Study|Adverse Event|5|||
163970379|NCT00806195|592264698|FG002|Overall Study|Adverse Event|11|||
163970380|NCT00806195|592264699|FG003|Overall Study|Adverse Event|2|||
163970381|NCT00806195|592264696|FG000|Overall Study|Withdrawal by Subject|119|||
163970382|NCT00806195|592264697|FG001|Overall Study|Withdrawal by Subject|31|||
163970383|NCT00806195|592264698|FG002|Overall Study|Withdrawal by Subject|76|||
163970384|NCT00806195|592264699|FG003|Overall Study|Withdrawal by Subject|35|||
163970385|NCT00806195|592264696|FG000|Overall Study|Lost to Follow-up|217|||
163970386|NCT00806195|592264697|FG001|Overall Study|Lost to Follow-up|66|||
163970387|NCT00806195|592264698|FG002|Overall Study|Lost to Follow-up|90|||
163970388|NCT00806195|592264699|FG003|Overall Study|Lost to Follow-up|34|||
163970389|NCT00806195|592264696|FG000|Overall Study|Inappropriate Enrollment|0|||
163970390|NCT00806195|592264697|FG001|Overall Study|Inappropriate Enrollment|1|||
163970391|NCT00806195|592264698|FG002|Overall Study|Inappropriate Enrollment|0|||
163970392|NCT00806195|592264699|FG003|Overall Study|Inappropriate Enrollment|0|||
163970393|NCT00806195|592264696|FG000|Overall Study|Administrative Reason|113|||
163970394|NCT00806195|592264697|FG001|Overall Study|Administrative Reason|35|||
163970395|NCT00806195|592264698|FG002|Overall Study|Administrative Reason|66|||
163970396|NCT00806195|592264699|FG003|Overall Study|Administrative Reason|26|||
163970397|NCT00806195|592264696|FG000|Overall Study|Protocol Violation|34|||
163970398|NCT00806195|592264697|FG001|Overall Study|Protocol Violation|24|||
163970399|NCT00806195|592264698|FG002|Overall Study|Protocol Violation|26|||
163970400|NCT00806195|592264699|FG003|Overall Study|Protocol Violation|9|||
163970401|NCT01519934|592264705|FG000|Overall Study|Lost to Follow-up|3|||
163970402|NCT00326209|592264710|FG000|Overall Study|Adverse Event|28|||
163970403|NCT00326209|592264710|FG000|Overall Study|Withdrawal by Subject|22|||
164201744|NCT00676143|593112593|FG001|Overall Study|Participant participation unknown|4|||
164201745|NCT00676143|593112592|FG000|Overall Study|Vasogenic edema recurrence|1|||
164201746|NCT00676143|593112593|FG001|Overall Study|Vasogenic edema recurrence|3|||
164201747|NCT00929669|593112594|FG000|Overall Study|elevated glucose levels|1|||
164201748|NCT00472420|593112595|FG000|Induction Treatment Period|Physician Decision|9|||
164201749|NCT00472420|593112595|FG000|Induction Treatment Period|Adverse Event|3|||
164201750|NCT00472420|593112595|FG000|Induction Treatment Period|Non-compliance|1|||
164201751|NCT00472420|593112595|FG000|Induction Treatment Period|Death|3|||
164201752|NCT00472420|593112595|FG000|Follow-up Period|Death|5|||
164201753|NCT00472420|593112595|FG000|Follow-up Period|Physician Decision|9|||
164201754|NCT00472420|593112595|FG000|Follow-up Period|Lost to Follow-up|2|||
164201755|NCT00472420|593112595|FG000|Follow-up Period|Protocol Violation|1|||
164201756|NCT04656652|593112597|FG000|Overall Study|Lost to Follow-up|2|||
164201757|NCT04656652|593112598|FG001|Overall Study|Lost to Follow-up|2|||
164201758|NCT04656652|593112597|FG000|Overall Study|Death|213|||
164201759|NCT04656652|593112598|FG001|Overall Study|Death|212|||
164201760|NCT04656652|593112597|FG000|Overall Study|Other|1|||
164201761|NCT04656652|593112598|FG001|Overall Study|Other|0|||
164201762|NCT04656652|593112597|FG000|Overall Study|Withdrawal by Subject|15|||
164201763|NCT04656652|593112598|FG001|Overall Study|Withdrawal by Subject|29|||
164201764|NCT02722967|593112599|FG000|Overall Study|Adverse Event|1|||
164201765|NCT02722967|593112600|FG001|Overall Study|Adverse Event|0|||
164201766|NCT02722967|593112601|FG002|Overall Study|Adverse Event|0|||
164201767|NCT02722967|593112599|FG000|Overall Study|Lost to Follow-up|0|||
164201768|NCT02722967|593112600|FG001|Overall Study|Lost to Follow-up|1|||
164201769|NCT02722967|593112601|FG002|Overall Study|Lost to Follow-up|0|||
164201770|NCT02722967|593112599|FG000|Overall Study|Non-compliance with patch wearing|2|||
164201771|NCT02722967|593112600|FG001|Overall Study|Non-compliance with patch wearing|1|||
164201772|NCT02722967|593112601|FG002|Overall Study|Non-compliance with patch wearing|1|||
164201773|NCT02722967|593112599|FG000|Overall Study|Withdrawal by Subject|1|||
164201774|NCT02722967|593112600|FG001|Overall Study|Withdrawal by Subject|0|||
164201775|NCT02722967|593112601|FG002|Overall Study|Withdrawal by Subject|1|||
163970404|NCT00326209|592264710|FG000|Overall Study|Lack of Efficacy|31|||
163970405|NCT00326209|592264710|FG000|Overall Study|Lost to Follow-up|18|||
163970406|NCT00326209|592264710|FG000|Overall Study|Participant non-compliant|6|||
163970407|NCT00326209|592264710|FG000|Overall Study|Sponsor closed study|173|||
163970408|NCT00326209|592264710|FG000|Overall Study|Prohibited medication use|1|||
163970409|NCT00326209|592264710|FG000|Overall Study|Violation of entry criteria|1|||
163970410|NCT00326209|592264710|FG000|Overall Study|Withdrawn in error|1|||
163970411|NCT00326209|592264710|FG000|Overall Study|Pregnancy|1|||
163970412|NCT02138617|592264711|FG000|Overall Study|Death|1|||
164201776|NCT02722967|593112599|FG000|Overall Study|Physician Decision|1|||
164201777|NCT02722967|593112600|FG001|Overall Study|Physician Decision|0|||
164201778|NCT02722967|593112601|FG002|Overall Study|Physician Decision|0|||
164201779|NCT02722967|593112599|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
164201780|NCT02722967|593112600|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
164201781|NCT02722967|593112601|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
164310491|NCT02395081|593510871|FG002|Overall Study|Withdrawal by Subject|0|||
164310492|NCT02395081|593510869|FG000|Overall Study|Moved where blood couldn't be collected|4|||
164310493|NCT02395081|593510870|FG001|Overall Study|Moved where blood couldn't be collected|1|||
164310494|NCT02395081|593510871|FG002|Overall Study|Moved where blood couldn't be collected|3|||
164310495|NCT02395081|593510869|FG000|Overall Study|Fetal Loss|2|||
164310496|NCT02395081|593510870|FG001|Overall Study|Fetal Loss|3|||
164310497|NCT02395081|593510871|FG002|Overall Study|Fetal Loss|1|||
164310498|NCT01583296|593510872|FG000|Overall Study|Withdrawal by Subject|11|||
164310499|NCT01583296|593510873|FG001|Overall Study|Withdrawal by Subject|10|||
164310500|NCT01063283|593510874|FG000|Cycle 1|Adverse Event|2|||
164310501|NCT01063283|593510875|FG001|Cycle 1|Adverse Event|0|||
164310502|NCT01063283|593510876|FG002|Cycle 1|Adverse Event|0|||
164310503|NCT01063283|593510874|FG000|Cycle 1|Technical failure in data collection|1|||
164310504|NCT01063283|593510875|FG001|Cycle 1|Technical failure in data collection|0|||
164310505|NCT01063283|593510876|FG002|Cycle 1|Technical failure in data collection|0|||
164310506|NCT02504216|593510879|FG000|Overall Study|Lost to Follow-up|3|||
164310507|NCT02504216|593510880|FG001|Overall Study|Lost to Follow-up|3|||
164310508|NCT02504216|593510879|FG000|Overall Study|Withdrawal by Subject|8|||
164310509|NCT02504216|593510880|FG001|Overall Study|Withdrawal by Subject|12|||
164310510|NCT00223080|593510881|FG000|Overall Study|Withdrawal by Subject|253|||
164310511|NCT00223080|593510882|FG001|Overall Study|Withdrawal by Subject|232|||
164310512|NCT00223080|593510881|FG000|Overall Study|Required contraindicated med|0|||
164310513|NCT00223080|593510882|FG001|Overall Study|Required contraindicated med|1|||
164310514|NCT00223080|593510881|FG000|Overall Study|Non-compliant|7|||
164310515|NCT00223080|593510882|FG001|Overall Study|Non-compliant|7|||
164310516|NCT00223080|593510881|FG000|Overall Study|Moved from study area|37|||
164310517|NCT00223080|593510882|FG001|Overall Study|Moved from study area|47|||
164310518|NCT00223080|593510881|FG000|Overall Study|Lost to Follow-up|259|||
164310519|NCT00223080|593510882|FG001|Overall Study|Lost to Follow-up|284|||
164310520|NCT00223080|593510881|FG000|Overall Study|Death|85|||
164310521|NCT00223080|593510882|FG001|Overall Study|Death|74|||
164310522|NCT00223080|593510881|FG000|Overall Study|Other|14|||
164310523|NCT00223080|593510882|FG001|Overall Study|Other|11|||
164310524|NCT00223080|593510881|FG000|Overall Study|Reason not provided|141|||
164310525|NCT00223080|593510882|FG001|Overall Study|Reason not provided|140|||
164310526|NCT00223080|593510881|FG000|Overall Study|Adverse Event|0|||
164310527|NCT00223080|593510882|FG001|Overall Study|Adverse Event|1|||
164310528|NCT02598583|593510883|FG000|Extension Period|Withdrawal by Subject|1|||
163865480|NCT00949975|591874295|FG000|Overall Study|Study-specific criteria|0|||
163865481|NCT00949975|591874296|FG001|Overall Study|Study-specific criteria|1|||
163865482|NCT00949975|591874297|FG002|Overall Study|Study-specific criteria|1|||
163865483|NCT00949975|591874298|FG003|Overall Study|Study-specific criteria|0|||
163865484|NCT00949975|591874295|FG000|Overall Study|Incorrect enrolment|5|||
163865485|NCT00949975|591874296|FG001|Overall Study|Incorrect enrolment|10|||
163865486|NCT00949975|591874297|FG002|Overall Study|Incorrect enrolment|4|||
163865487|NCT00949975|591874298|FG003|Overall Study|Incorrect enrolment|7|||
163865488|NCT00949975|591874295|FG000|Overall Study|Severe non-compliance|3|||
163865489|NCT00949975|591874296|FG001|Overall Study|Severe non-compliance|1|||
163865490|NCT00949975|591874297|FG002|Overall Study|Severe non-compliance|0|||
163865491|NCT00949975|591874298|FG003|Overall Study|Severe non-compliance|2|||
163865492|NCT00949975|591874295|FG000|Overall Study|Lost to Follow-up|1|||
163865493|NCT00949975|591874296|FG001|Overall Study|Lost to Follow-up|0|||
163865494|NCT00949975|591874297|FG002|Overall Study|Lost to Follow-up|1|||
163865495|NCT00949975|591874298|FG003|Overall Study|Lost to Follow-up|3|||
163865496|NCT00949975|591874295|FG000|Overall Study|Other|1|||
163865497|NCT00949975|591874296|FG001|Overall Study|Other|0|||
163865498|NCT00949975|591874297|FG002|Overall Study|Other|0|||
163865499|NCT00949975|591874298|FG003|Overall Study|Other|0|||
164310529|NCT02598583|593510884|FG001|Extension Period|Withdrawal by Subject|0|||
164310530|NCT03237286|593510885|FG000|Overall Study|Withdrawal by Subject|1|||
164310531|NCT03237286|593510886|FG001|Overall Study|Withdrawal by Subject|0|||
164310532|NCT03237286|593510887|FG002|Overall Study|Withdrawal by Subject|2|||
164310533|NCT03237286|593510885|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
164310534|NCT03237286|593510886|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
164310535|NCT03237286|593510887|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
164310536|NCT02792829|593510895|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310537|NCT02792829|593510896|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
163865500|NCT04347954|591874299|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
163865501|NCT04347954|591874300|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
163865502|NCT04347954|591874301|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
163865503|NCT04347954|591874299|FG000|Overall Study|Lost to Follow-up|0|||
164310538|NCT02792829|593510897|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310539|NCT02792829|593510898|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310540|NCT02792829|593510899|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310541|NCT02792829|593510900|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310542|NCT02792829|593510901|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310543|NCT02792829|593510902|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
164310544|NCT02792829|593510895|FG000|Treatment Period 2|Adverse Event|0|||
164310545|NCT02792829|593510896|FG001|Treatment Period 2|Adverse Event|0|||
164310546|NCT02792829|593510897|FG002|Treatment Period 2|Adverse Event|0|||
164310547|NCT02792829|593510898|FG003|Treatment Period 2|Adverse Event|0|||
164310548|NCT02792829|593510899|FG004|Treatment Period 2|Adverse Event|1|||
164310549|NCT02792829|593510900|FG005|Treatment Period 2|Adverse Event|0|||
164310550|NCT02792829|593510901|FG006|Treatment Period 2|Adverse Event|1|||
164310551|NCT02792829|593510902|FG007|Treatment Period 2|Adverse Event|1|||
164310552|NCT02792829|593510895|FG000|Treatment Period 2|Use of proscribed medications|0|||
164310553|NCT02792829|593510896|FG001|Treatment Period 2|Use of proscribed medications|0|||
164310554|NCT02792829|593510897|FG002|Treatment Period 2|Use of proscribed medications|0|||
164310555|NCT02792829|593510898|FG003|Treatment Period 2|Use of proscribed medications|0|||
164310556|NCT02792829|593510899|FG004|Treatment Period 2|Use of proscribed medications|0|||
164310557|NCT02792829|593510900|FG005|Treatment Period 2|Use of proscribed medications|0|||
164310558|NCT02792829|593510901|FG006|Treatment Period 2|Use of proscribed medications|0|||
164310559|NCT02792829|593510902|FG007|Treatment Period 2|Use of proscribed medications|1|||
164310560|NCT01262820|593510903|FG000|Overall Study|Adverse Event|5|||
164310561|NCT01262820|593510903|FG000|Overall Study|Lack of Efficacy|9|||
164310562|NCT01262820|593510903|FG000|Overall Study|Drug held for 21+ days|1|||
164310563|NCT01737502|593510907|FG000|Phase I|Disease progression|2|||
164310564|NCT01737502|593510908|FG001|Phase I|Disease progression|3|||
164310565|NCT01737502|593510907|FG000|Phase I|Complicating disease|1|||
164310566|NCT01737502|593510908|FG001|Phase I|Complicating disease|0|||
164310567|NCT01737502|593510907|FG000|Phase II|Adverse Event|0|||
164310568|NCT01737502|593510908|FG001|Phase II|Adverse Event|3|||
164310569|NCT01737502|593510907|FG000|Phase II|Disease progression|0|||
164310570|NCT01737502|593510908|FG001|Phase II|Disease progression|18|||
164310571|NCT01737502|593510907|FG000|Phase II|Death|0|||
164310572|NCT01737502|593510908|FG001|Phase II|Death|1|||
164310573|NCT01737502|593510907|FG000|Phase II|Transition to hospice care|0|||
164310574|NCT01737502|593510908|FG001|Phase II|Transition to hospice care|1|||
164310575|NCT04421027|593510912|FG000|Treatment Period|Adverse Event|5|||
164310576|NCT04421027|593510913|FG001|Treatment Period|Adverse Event|3|||
164310577|NCT04421027|593510914|FG002|Treatment Period|Adverse Event|0|||
164310578|NCT04421027|593510915|FG003|Treatment Period|Adverse Event|0|||
164310579|NCT04421027|593510912|FG000|Treatment Period|Death|98|||
164310580|NCT04421027|593510913|FG001|Treatment Period|Death|61|||
164310581|NCT04421027|593510914|FG002|Treatment Period|Death|0|||
164310582|NCT04421027|593510915|FG003|Treatment Period|Death|0|||
164310583|NCT04421027|593510912|FG000|Treatment Period|Lost to Follow-up|22|||
164310584|NCT04421027|593510913|FG001|Treatment Period|Lost to Follow-up|20|||
164310585|NCT04421027|593510914|FG002|Treatment Period|Lost to Follow-up|0|||
164310586|NCT04421027|593510915|FG003|Treatment Period|Lost to Follow-up|0|||
164310587|NCT04421027|593510912|FG000|Treatment Period|Other-Unknown|15|||
164310588|NCT04421027|593510913|FG001|Treatment Period|Other-Unknown|9|||
164310589|NCT04421027|593510914|FG002|Treatment Period|Other-Unknown|0|||
164310590|NCT04421027|593510915|FG003|Treatment Period|Other-Unknown|0|||
164310591|NCT04421027|593510912|FG000|Treatment Period|Physician Decision|1|||
164310592|NCT04421027|593510913|FG001|Treatment Period|Physician Decision|1|||
163865504|NCT04347954|591874300|FG001|Overall Study|Lost to Follow-up|1|||
163865505|NCT04347954|591874301|FG002|Overall Study|Lost to Follow-up|0|||
163865506|NCT03257813|591874302|FG000|Overall Study|Protocol Violation|6|||
163865507|NCT03257813|591874303|FG001|Overall Study|Protocol Violation|3|||
163865508|NCT04246762|591874304|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
163865509|NCT02878330|591874305|FG000|Overall Study|Death|3|||
163865510|NCT02878330|591874306|FG001|Overall Study|Death|2|||
163865511|NCT02878330|591874305|FG000|Overall Study|Lost to Follow-up|11|||
163865512|NCT02878330|591874306|FG001|Overall Study|Lost to Follow-up|26|||
163865513|NCT02878330|591874305|FG000|Overall Study|Withdrawal by Subject|11|||
163865514|NCT02878330|591874306|FG001|Overall Study|Withdrawal by Subject|21|||
163865515|NCT02878330|591874305|FG000|Overall Study|Other|4|||
163865516|NCT02878330|591874306|FG001|Overall Study|Other|7|||
163970413|NCT02138617|592264712|FG001|Overall Study|Death|2|||
164310593|NCT04421027|593510914|FG002|Treatment Period|Physician Decision|0|||
164310594|NCT04421027|593510915|FG003|Treatment Period|Physician Decision|0|||
164310595|NCT04421027|593510912|FG000|Treatment Period|Withdrawal by Subject|7|||
164310596|NCT04421027|593510913|FG001|Treatment Period|Withdrawal by Subject|12|||
164310597|NCT04421027|593510914|FG002|Treatment Period|Withdrawal by Subject|0|||
164310598|NCT04421027|593510915|FG003|Treatment Period|Withdrawal by Subject|0|||
163865517|NCT03615924|591874307|FG000|Overall Study|Withdrawal by Subject|2|||
163865518|NCT03615924|591874308|FG001|Overall Study|Withdrawal by Subject|5|||
163865519|NCT03615924|591874307|FG000|Overall Study|Death|3|||
163970414|NCT02138617|592264713|FG002|Overall Study|Death|2|||
164310599|NCT04421027|593510912|FG000|Treatment Period|Randomized Not Dosed|9|||
164310600|NCT04421027|593510913|FG001|Treatment Period|Randomized Not Dosed|14|||
164310601|NCT04421027|593510914|FG002|Treatment Period|Randomized Not Dosed|0|||
163865520|NCT03615924|591874308|FG001|Overall Study|Death|1|||
163865521|NCT03615924|591874307|FG000|Overall Study|Lost to Follow-up|1|||
163865522|NCT03615924|591874308|FG001|Overall Study|Lost to Follow-up|0|||
163865523|NCT03615924|591874307|FG000|Overall Study|Randomized in error|1|||
163865524|NCT03615924|591874308|FG001|Overall Study|Randomized in error|0|||
163865525|NCT03615924|591874307|FG000|Overall Study|Study termination by Sponsor|94|||
163865526|NCT03615924|591874308|FG001|Overall Study|Study termination by Sponsor|86|||
163865527|NCT02954848|591874311|FG000|Overall Study|Randomized but Not Treated|0|||
163865528|NCT02954848|591874312|FG001|Overall Study|Randomized but Not Treated|1|||
163865529|NCT02954848|591874311|FG000|Overall Study|Adverse Event|2|||
163865530|NCT02954848|591874312|FG001|Overall Study|Adverse Event|3|||
163865531|NCT02954848|591874311|FG000|Overall Study|Withdrawal by Participant|0|||
163865532|NCT02954848|591874312|FG001|Overall Study|Withdrawal by Participant|1|||
163865533|NCT01069341|591874313|FG000|Overall Study|Lost to Follow-up|1|||
163865534|NCT01802632|591874314|FG000|Overall Study|Death|28|||
163865535|NCT01802632|591874315|FG001|Overall Study|Death|1|||
163865536|NCT01802632|591874316|FG002|Overall Study|Death|38|||
163865537|NCT01802632|591874317|FG003|Overall Study|Death|0|||
163865538|NCT01802632|591874318|FG004|Overall Study|Death|2|||
163865539|NCT01802632|591874319|FG005|Overall Study|Death|0|||
163865540|NCT01802632|591874314|FG000|Overall Study|Withdrawal by Subject|4|||
163865541|NCT01802632|591874315|FG001|Overall Study|Withdrawal by Subject|2|||
163865542|NCT01802632|591874316|FG002|Overall Study|Withdrawal by Subject|7|||
163865543|NCT01802632|591874317|FG003|Overall Study|Withdrawal by Subject|3|||
163865544|NCT01802632|591874318|FG004|Overall Study|Withdrawal by Subject|0|||
163865545|NCT01802632|591874319|FG005|Overall Study|Withdrawal by Subject|1|||
163865546|NCT01802632|591874314|FG000|Overall Study|Objective Disease Progression|1|||
163865547|NCT01802632|591874315|FG001|Overall Study|Objective Disease Progression|12|||
163865548|NCT01802632|591874316|FG002|Overall Study|Objective Disease Progression|104|||
163865549|NCT01802632|591874317|FG003|Overall Study|Objective Disease Progression|6|||
163865550|NCT01802632|591874318|FG004|Overall Study|Objective Disease Progression|4|||
163865551|NCT01802632|591874319|FG005|Overall Study|Objective Disease Progression|4|||
163865552|NCT01802632|591874314|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
163865553|NCT01802632|591874315|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
163865554|NCT01802632|591874316|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
163865555|NCT01802632|591874317|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
163865556|NCT01802632|591874318|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
163865557|NCT01802632|591874319|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
163865558|NCT01802632|591874314|FG000|Overall Study|Other (not specified)|0|||
163865559|NCT01802632|591874315|FG001|Overall Study|Other (not specified)|0|||
163865560|NCT01802632|591874316|FG002|Overall Study|Other (not specified)|7|||
163865561|NCT01802632|591874317|FG003|Overall Study|Other (not specified)|1|||
163865562|NCT01802632|591874318|FG004|Overall Study|Other (not specified)|0|||
163865563|NCT01802632|591874319|FG005|Overall Study|Other (not specified)|1|||
163865564|NCT03299816|591874320|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
163865565|NCT03299816|591874321|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
163865566|NCT03299816|591874320|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
163865567|NCT03299816|591874321|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
163865568|NCT03299816|591874320|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
163865569|NCT03299816|591874321|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
163865570|NCT01184508|591874323|FG000|Overall Study|Adverse Event|4|||
163865571|NCT01184508|591874324|FG001|Overall Study|Adverse Event|6|||
163865572|NCT01184508|591874323|FG000|Overall Study|Lack of Efficacy|1|||
163865573|NCT01184508|591874324|FG001|Overall Study|Lack of Efficacy|1|||
163865574|NCT01184508|591874323|FG000|Overall Study|Lost to Follow-up|1|||
163865575|NCT01184508|591874324|FG001|Overall Study|Lost to Follow-up|1|||
163865576|NCT01184508|591874323|FG000|Overall Study|Physician Decision|1|||
163865577|NCT01184508|591874324|FG001|Overall Study|Physician Decision|0|||
163865578|NCT01184508|591874323|FG000|Overall Study|Protocol Violation|3|||
163865579|NCT01184508|591874324|FG001|Overall Study|Protocol Violation|1|||
163865580|NCT01184508|591874323|FG000|Overall Study|Sponsor Decision|5|||
163865581|NCT01184508|591874324|FG001|Overall Study|Sponsor Decision|2|||
163865582|NCT01184508|591874323|FG000|Overall Study|Withdrawal by Subject|1|||
163865583|NCT01184508|591874324|FG001|Overall Study|Withdrawal by Subject|3|||
163865584|NCT01184508|591874323|FG000|Overall Study|Randomized, Not Treated|0|||
163865585|NCT01184508|591874324|FG001|Overall Study|Randomized, Not Treated|1|||
163865586|NCT00790790|591874325|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
163865587|NCT00790790|591874326|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
163865588|NCT00790790|591874327|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
163865589|NCT00790790|591874325|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
163865590|NCT00790790|591874326|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
163865591|NCT00790790|591874327|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
163865592|NCT00790790|591874325|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
163865593|NCT00790790|591874326|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
163865594|NCT00790790|591874327|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
163970415|NCT02138617|592264711|FG000|Overall Study|Adverse Event|8|||
163970416|NCT02138617|592264712|FG001|Overall Study|Adverse Event|5|||
163970417|NCT02138617|592264713|FG002|Overall Study|Adverse Event|2|||
163970418|NCT02138617|592264711|FG000|Overall Study|Disease Progression|20|||
163970419|NCT02138617|592264712|FG001|Overall Study|Disease Progression|13|||
163970420|NCT02138617|592264713|FG002|Overall Study|Disease Progression|4|||
163970421|NCT02138617|592264711|FG000|Overall Study|Withdrawal by Subject|7|||
163970422|NCT02138617|592264712|FG001|Overall Study|Withdrawal by Subject|10|||
163970423|NCT02138617|592264713|FG002|Overall Study|Withdrawal by Subject|2|||
163970424|NCT02138617|592264711|FG000|Overall Study|other complicating disease|0|||
163970425|NCT02138617|592264712|FG001|Overall Study|other complicating disease|2|||
163970426|NCT02138617|592264713|FG002|Overall Study|other complicating disease|0|||
163970427|NCT02138617|592264711|FG000|Overall Study|Protocol Violation|1|||
163970428|NCT02138617|592264712|FG001|Overall Study|Protocol Violation|0|||
163970429|NCT02138617|592264713|FG002|Overall Study|Protocol Violation|0|||
163970430|NCT02138617|592264711|FG000|Overall Study|Physician Decision|7|||
163970431|NCT02138617|592264712|FG001|Overall Study|Physician Decision|6|||
163970432|NCT02138617|592264713|FG002|Overall Study|Physician Decision|0|||
163970433|NCT02138617|592264711|FG000|Overall Study|financial reason|0|||
163970434|NCT02138617|592264712|FG001|Overall Study|financial reason|1|||
163970435|NCT02138617|592264713|FG002|Overall Study|financial reason|0|||
163970436|NCT02138617|592264711|FG000|Overall Study|other therapy|3|||
163970437|NCT02138617|592264712|FG001|Overall Study|other therapy|4|||
163970438|NCT02138617|592264713|FG002|Overall Study|other therapy|0|||
163970439|NCT00529451|592264714|FG000|Overall Study|Subject withdrew consent|16|||
163970440|NCT00529451|592264715|FG001|Overall Study|Subject withdrew consent|21|||
164310602|NCT04421027|593510915|FG003|Treatment Period|Randomized Not Dosed|0|||
164310603|NCT04421027|593510912|FG000|Follow-Up Period|Adverse Event|0|||
164310604|NCT04421027|593510913|FG001|Follow-Up Period|Adverse Event|0|||
164310605|NCT04421027|593510914|FG002|Follow-Up Period|Adverse Event|0|||
164310606|NCT04421027|593510915|FG003|Follow-Up Period|Adverse Event|3|||
163865595|NCT00790790|591874325|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
163865596|NCT00790790|591874326|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
163865597|NCT00790790|591874327|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
163865598|NCT00790790|591874325|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
163865599|NCT00790790|591874326|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
163865600|NCT00790790|591874327|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
163865601|NCT02969863|591874328|FG000|Overall Study|Physician Decision|1|||
163865602|NCT02969863|591874329|FG001|Overall Study|Physician Decision|0|||
163865603|NCT02969863|591874330|FG002|Overall Study|Physician Decision|0|||
163865604|NCT02969863|591874331|FG003|Overall Study|Physician Decision|0|||
163865605|NCT02969863|591874332|FG004|Overall Study|Physician Decision|0|||
163865606|NCT02969863|591874333|FG005|Overall Study|Physician Decision|0|||
163865607|NCT02194933|591874335|FG000|Overall Study|Lost to Follow-up|1|||
163865608|NCT02194933|591874336|FG001|Overall Study|Lost to Follow-up|2|||
163865609|NCT02194933|591874335|FG000|Overall Study|Participant met withdrawal criteria|1|||
163865610|NCT02194933|591874336|FG001|Overall Study|Participant met withdrawal criteria|3|||
163865611|NCT02194933|591874335|FG000|Overall Study|Withdrawal by Subject|0|||
163865612|NCT02194933|591874336|FG001|Overall Study|Withdrawal by Subject|2|||
163865613|NCT02194933|591874335|FG000|Overall Study|Lack of Efficacy|1|||
163865614|NCT02194933|591874336|FG001|Overall Study|Lack of Efficacy|2|||
163865615|NCT00756730|591874339|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
163865616|NCT00756730|591874340|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
163865617|NCT00756730|591874339|FG000|Overall Study|persistent low-level viremmia|0|||
163865618|NCT00756730|591874340|FG001|Overall Study|persistent low-level viremmia|1|||
163865619|NCT05382104|591874343|FG000|Period 2 (2 Days)|Adverse Event|0|||
163865620|NCT05382104|591874344|FG001|Period 2 (2 Days)|Adverse Event|1|||
163865621|NCT05382104|591874345|FG002|Period 2 (2 Days)|Adverse Event|0|||
163865622|NCT05382104|591874346|FG003|Period 2 (2 Days)|Adverse Event|0|||
163865623|NCT05382104|591874347|FG004|Period 2 (2 Days)|Adverse Event|0|||
163865624|NCT05382104|591874348|FG005|Period 2 (2 Days)|Adverse Event|0|||
163865625|NCT00988637|591874349|FG000|Overall Study|Lost to Follow-up|2|||
163865626|NCT00988637|591874350|FG001|Overall Study|Lost to Follow-up|1|||
163865627|NCT00988637|591874349|FG000|Overall Study|Withdrawal by Subject|1|||
163865628|NCT00988637|591874350|FG001|Overall Study|Withdrawal by Subject|1|||
163865629|NCT00988637|591874349|FG000|Overall Study|non-compliance with study drug|0|||
164310607|NCT04421027|593510912|FG000|Follow-Up Period|Death|0|||
164310608|NCT04421027|593510913|FG001|Follow-Up Period|Death|0|||
163865630|NCT00988637|591874350|FG001|Overall Study|non-compliance with study drug|1|||
163865631|NCT02807493|591874352|FG000|Overall Study|Adverse Event|5|||
163865632|NCT02807493|591874353|FG001|Overall Study|Adverse Event|2|||
163970441|NCT00529451|592264716|FG002|Overall Study|Subject withdrew consent|13|||
163970442|NCT00529451|592264717|FG003|Overall Study|Subject withdrew consent|12|||
163970443|NCT00529451|592264714|FG000|Overall Study|Adverse Event|9|||
163970444|NCT00529451|592264715|FG001|Overall Study|Adverse Event|16|||
163865633|NCT02807493|591874352|FG000|Overall Study|Lost to Follow-up|6|||
163865634|NCT02807493|591874353|FG001|Overall Study|Lost to Follow-up|0|||
163865635|NCT02807493|591874352|FG000|Overall Study|Physician Decision|4|||
163970445|NCT00529451|592264716|FG002|Overall Study|Adverse Event|14|||
163865636|NCT02807493|591874353|FG001|Overall Study|Physician Decision|1|||
163865637|NCT02807493|591874352|FG000|Overall Study|Protocol Violation|7|||
163865638|NCT02807493|591874353|FG001|Overall Study|Protocol Violation|0|||
163865639|NCT02807493|591874352|FG000|Overall Study|Withdrawal by Subject|17|||
163865640|NCT02807493|591874353|FG001|Overall Study|Withdrawal by Subject|10|||
163865641|NCT02807493|591874352|FG000|Overall Study|Other withdrawal|17|||
163865642|NCT02807493|591874353|FG001|Overall Study|Other withdrawal|0|||
163865643|NCT02807493|591874352|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
163865644|NCT02807493|591874353|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
163865645|NCT01493778|591874354|FG000|Overall Study|Withdrawal by Subject|8|||
163865646|NCT05190419|591874355|FG000|Overall Study|Lack of Efficacy|8|||
163865647|NCT05190419|591874356|FG001|Overall Study|Lack of Efficacy|0|||
163865648|NCT05190419|591874357|FG002|Overall Study|Lack of Efficacy|1|||
163865649|NCT05190419|591874358|FG003|Overall Study|Lack of Efficacy|0|||
163865650|NCT05190419|591874355|FG000|Overall Study|Withdrawal by Subject|7|||
163865651|NCT05190419|591874356|FG001|Overall Study|Withdrawal by Subject|1|||
163865652|NCT05190419|591874357|FG002|Overall Study|Withdrawal by Subject|2|||
163865653|NCT05190419|591874358|FG003|Overall Study|Withdrawal by Subject|2|||
163865654|NCT05190419|591874355|FG000|Overall Study|Adverse Event|2|||
163865655|NCT05190419|591874356|FG001|Overall Study|Adverse Event|10|||
163865656|NCT05190419|591874357|FG002|Overall Study|Adverse Event|11|||
163865657|NCT05190419|591874358|FG003|Overall Study|Adverse Event|21|||
163865658|NCT05190419|591874355|FG000|Overall Study|Lost to Follow-up|1|||
163865659|NCT05190419|591874356|FG001|Overall Study|Lost to Follow-up|2|||
163865660|NCT05190419|591874357|FG002|Overall Study|Lost to Follow-up|3|||
163865661|NCT05190419|591874358|FG003|Overall Study|Lost to Follow-up|1|||
163865662|NCT05190419|591874355|FG000|Overall Study|Other|1|||
163865663|NCT05190419|591874356|FG001|Overall Study|Other|1|||
163865664|NCT05190419|591874357|FG002|Overall Study|Other|0|||
163865665|NCT05190419|591874358|FG003|Overall Study|Other|3|||
163865666|NCT02020616|591874359|FG000|Overall Study|Adverse Event|0|||
163865667|NCT02020616|591874360|FG001|Overall Study|Adverse Event|0|||
163865668|NCT02020616|591874361|FG002|Overall Study|Adverse Event|0|||
163865669|NCT02020616|591874362|FG003|Overall Study|Adverse Event|0|||
163865670|NCT02020616|591874363|FG004|Overall Study|Adverse Event|0|||
163865671|NCT02020616|591874364|FG005|Overall Study|Adverse Event|1|||
163865672|NCT02020616|591874365|FG006|Overall Study|Adverse Event|1|||
163865673|NCT02020616|591874359|FG000|Overall Study|Physician Decision|0|||
163865674|NCT02020616|591874360|FG001|Overall Study|Physician Decision|0|||
163865675|NCT02020616|591874361|FG002|Overall Study|Physician Decision|0|||
163865676|NCT02020616|591874362|FG003|Overall Study|Physician Decision|0|||
163865677|NCT02020616|591874363|FG004|Overall Study|Physician Decision|0|||
163865678|NCT02020616|591874364|FG005|Overall Study|Physician Decision|1|||
163865679|NCT02020616|591874365|FG006|Overall Study|Physician Decision|2|||
163865680|NCT02020616|591874359|FG000|Overall Study|Withdrawal by Subject|0|||
163865681|NCT02020616|591874360|FG001|Overall Study|Withdrawal by Subject|0|||
163865682|NCT02020616|591874361|FG002|Overall Study|Withdrawal by Subject|1|||
163865683|NCT02020616|591874362|FG003|Overall Study|Withdrawal by Subject|0|||
163865684|NCT02020616|591874363|FG004|Overall Study|Withdrawal by Subject|0|||
164201782|NCT04142242|593112602|FG000|Stage I|Non-compliance with the protocol|1|||
164201783|NCT04142242|593112603|FG001|Stage I|Non-compliance with the protocol|0|||
164201784|NCT04142242|593112604|FG002|Stage I|Non-compliance with the protocol|0|||
164201785|NCT04142242|593112605|FG003|Stage I|Non-compliance with the protocol|0|||
164201786|NCT04142242|593112606|FG004|Stage I|Non-compliance with the protocol|0|||
164201787|NCT04142242|593112607|FG005|Stage I|Non-compliance with the protocol|1|||
164201788|NCT04142242|593112602|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201789|NCT04142242|593112603|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
164201790|NCT04142242|593112604|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201791|NCT04142242|593112605|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201792|NCT04142242|593112606|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201793|NCT04142242|593112607|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
164201794|NCT04142242|593112602|FG000|Stage II|Non-compliance with the protocol|0|||
164201795|NCT04142242|593112603|FG001|Stage II|Non-compliance with the protocol|0|||
164310609|NCT04421027|593510914|FG002|Follow-Up Period|Death|16|||
163865685|NCT02020616|591874364|FG005|Overall Study|Withdrawal by Subject|1|||
163865686|NCT02020616|591874365|FG006|Overall Study|Withdrawal by Subject|1|||
163865687|NCT02020616|591874359|FG000|Overall Study|Lost to Follow-up|0|||
163865688|NCT02020616|591874360|FG001|Overall Study|Lost to Follow-up|1|||
163865689|NCT02020616|591874361|FG002|Overall Study|Lost to Follow-up|0|||
163865690|NCT02020616|591874362|FG003|Overall Study|Lost to Follow-up|1|||
163865691|NCT02020616|591874363|FG004|Overall Study|Lost to Follow-up|1|||
163865692|NCT02020616|591874364|FG005|Overall Study|Lost to Follow-up|1|||
163865693|NCT02020616|591874365|FG006|Overall Study|Lost to Follow-up|0|||
163865694|NCT02020616|591874359|FG000|Overall Study|Early Termination Criteria Met|0|||
163865695|NCT02020616|591874360|FG001|Overall Study|Early Termination Criteria Met|0|||
163865696|NCT02020616|591874361|FG002|Overall Study|Early Termination Criteria Met|1|||
164201796|NCT04142242|593112604|FG002|Stage II|Non-compliance with the protocol|0|||
163970446|NCT00529451|592264717|FG003|Overall Study|Adverse Event|8|||
163970447|NCT00529451|592264714|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
163970448|NCT00529451|592264715|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
163970449|NCT00529451|592264716|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
163970450|NCT00529451|592264717|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
163970451|NCT00529451|592264714|FG000|Overall Study|Lost to Follow-up|4|||
163970452|NCT00529451|592264715|FG001|Overall Study|Lost to Follow-up|7|||
163970453|NCT00529451|592264716|FG002|Overall Study|Lost to Follow-up|4|||
163970454|NCT00529451|592264717|FG003|Overall Study|Lost to Follow-up|4|||
163970455|NCT00529451|592264714|FG000|Overall Study|Protocol deviation|1|||
163970456|NCT00529451|592264715|FG001|Overall Study|Protocol deviation|1|||
163970457|NCT00529451|592264716|FG002|Overall Study|Protocol deviation|4|||
163970458|NCT00529451|592264717|FG003|Overall Study|Protocol deviation|1|||
163970459|NCT00529451|592264714|FG000|Overall Study|Administrative problems|1|||
163970460|NCT00529451|592264715|FG001|Overall Study|Administrative problems|1|||
163970461|NCT00529451|592264716|FG002|Overall Study|Administrative problems|0|||
163970462|NCT00529451|592264717|FG003|Overall Study|Administrative problems|2|||
163970463|NCT02566577|592264718|FG000|Overall Study|Withdrawal by Subject|1|||
163970464|NCT02566577|592264719|FG001|Overall Study|Withdrawal by Subject|1|||
163970465|NCT02566577|592264718|FG000|Overall Study|Equipment failure|1|||
163970466|NCT02566577|592264719|FG001|Overall Study|Equipment failure|1|||
163970467|NCT02566577|592264718|FG000|Overall Study|Physical limitation|1|||
163970468|NCT02566577|592264719|FG001|Overall Study|Physical limitation|0|||
163970469|NCT01009034|592264720|FG000|Overall Study|Lost to Follow-up|2|||
163970470|NCT01009034|592264720|FG000|Overall Study|Withdrawal by Subject|2|||
163970471|NCT02243865|592264723|FG000|Overall Study|Protocol Violation|1|||
163970472|NCT02243865|592264724|FG001|Overall Study|Protocol Violation|3|||
163970473|NCT02243865|592264723|FG000|Overall Study|Lost to Follow-up|1|||
163970474|NCT02243865|592264724|FG001|Overall Study|Lost to Follow-up|1|||
163970475|NCT02243865|592264723|FG000|Overall Study|Withdrawal by Subject|1|||
163970476|NCT02243865|592264724|FG001|Overall Study|Withdrawal by Subject|0|||
163970477|NCT02243865|592264723|FG000|Overall Study|Adverse Event|1|||
163970478|NCT02243865|592264724|FG001|Overall Study|Adverse Event|1|||
163970479|NCT03654976|592264725|FG000|Overall Study|Withdrawal by Subject|12|||
163970480|NCT03654976|592264726|FG001|Overall Study|Withdrawal by Subject|11|||
163970481|NCT03654976|592264725|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
163970482|NCT03654976|592264726|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
163970483|NCT03654976|592264725|FG000|Overall Study|Adverse Event|5|||
163970484|NCT03654976|592264726|FG001|Overall Study|Adverse Event|0|||
163970485|NCT03654976|592264725|FG000|Overall Study|Lost to Follow-up|2|||
163970486|NCT03654976|592264726|FG001|Overall Study|Lost to Follow-up|0|||
163970487|NCT03654976|592264725|FG000|Overall Study|Lack of Efficacy|0|||
163970488|NCT03654976|592264726|FG001|Overall Study|Lack of Efficacy|1|||
163970489|NCT00117598|592264727|FG000|Prior to Treatment Cross Over|Death|40|||
163970490|NCT00117598|592264728|FG001|Prior to Treatment Cross Over|Death|41|||
163970491|NCT00117598|592264729|FG002|Prior to Treatment Cross Over|Death|37|||
163970492|NCT00117598|592264730|FG003|Prior to Treatment Cross Over|Death|0|||
163970493|NCT00117598|592264731|FG004|Prior to Treatment Cross Over|Death|0|||
163970494|NCT00117598|592264727|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
163970495|NCT00117598|592264728|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
163970496|NCT00117598|592264729|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
163970497|NCT00117598|592264730|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
163970498|NCT00117598|592264731|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
163970499|NCT00117598|592264727|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
163970500|NCT00117598|592264728|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
163970501|NCT00117598|592264729|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
163970502|NCT00117598|592264730|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
163970503|NCT00117598|592264731|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
163970504|NCT00117598|592264727|FG000|Prior to Treatment Cross Over|Other|15|||
163970505|NCT00117598|592264728|FG001|Prior to Treatment Cross Over|Other|9|||
163970506|NCT00117598|592264729|FG002|Prior to Treatment Cross Over|Other|9|||
163970507|NCT00117598|592264730|FG003|Prior to Treatment Cross Over|Other|0|||
163970508|NCT00117598|592264731|FG004|Prior to Treatment Cross Over|Other|0|||
163970509|NCT00117598|592264727|FG000|After Treament Cross Over|Death|0|||
163970510|NCT00117598|592264728|FG001|After Treament Cross Over|Death|0|||
163970511|NCT00117598|592264729|FG002|After Treament Cross Over|Death|0|||
164201797|NCT04142242|593112605|FG003|Stage II|Non-compliance with the protocol|2|||
164201798|NCT04142242|593112606|FG004|Stage II|Non-compliance with the protocol|0|||
164201799|NCT04142242|593112607|FG005|Stage II|Non-compliance with the protocol|0|||
164201800|NCT04142242|593112602|FG000|Stage II|Lost to Follow-up|0|||
164201801|NCT04142242|593112603|FG001|Stage II|Lost to Follow-up|0|||
164201802|NCT04142242|593112604|FG002|Stage II|Lost to Follow-up|1|||
164201803|NCT04142242|593112605|FG003|Stage II|Lost to Follow-up|2|||
163970512|NCT00117598|592264730|FG003|After Treament Cross Over|Death|1|||
163970513|NCT00117598|592264731|FG004|After Treament Cross Over|Death|2|||
164201804|NCT04142242|593112606|FG004|Stage II|Lost to Follow-up|0|||
164310610|NCT04421027|593510915|FG003|Follow-Up Period|Death|17|||
164310611|NCT04421027|593510912|FG000|Follow-Up Period|Lost to Follow-up|0|||
164310612|NCT04421027|593510913|FG001|Follow-Up Period|Lost to Follow-up|0|||
164310613|NCT04421027|593510914|FG002|Follow-Up Period|Lost to Follow-up|7|||
164310614|NCT04421027|593510915|FG003|Follow-Up Period|Lost to Follow-up|7|||
164310615|NCT04421027|593510912|FG000|Follow-Up Period|Protocol Deviation|0|||
163865697|NCT02020616|591874362|FG003|Overall Study|Early Termination Criteria Met|0|||
163865698|NCT02020616|591874363|FG004|Overall Study|Early Termination Criteria Met|0|||
163865699|NCT02020616|591874364|FG005|Overall Study|Early Termination Criteria Met|1|||
163865700|NCT02020616|591874365|FG006|Overall Study|Early Termination Criteria Met|0|||
163865701|NCT02020616|591874359|FG000|Overall Study|Randomized in Error|0|||
163865702|NCT02020616|591874360|FG001|Overall Study|Randomized in Error|0|||
163865703|NCT02020616|591874361|FG002|Overall Study|Randomized in Error|0|||
163865704|NCT02020616|591874362|FG003|Overall Study|Randomized in Error|1|||
163865705|NCT02020616|591874363|FG004|Overall Study|Randomized in Error|0|||
163865706|NCT02020616|591874364|FG005|Overall Study|Randomized in Error|0|||
163865707|NCT02020616|591874365|FG006|Overall Study|Randomized in Error|0|||
163865708|NCT02020616|591874359|FG000|Overall Study|Lack of Efficacy|0|||
163865709|NCT02020616|591874360|FG001|Overall Study|Lack of Efficacy|0|||
163865710|NCT02020616|591874361|FG002|Overall Study|Lack of Efficacy|0|||
163865711|NCT02020616|591874362|FG003|Overall Study|Lack of Efficacy|0|||
163865712|NCT02020616|591874363|FG004|Overall Study|Lack of Efficacy|1|||
163865713|NCT02020616|591874364|FG005|Overall Study|Lack of Efficacy|0|||
163865714|NCT02020616|591874365|FG006|Overall Study|Lack of Efficacy|0|||
163865715|NCT05019729|591874368|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163865716|NCT05019729|591874369|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163865717|NCT05019729|591874370|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163865718|NCT05019729|591874371|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163865719|NCT05019729|591874372|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
163865720|NCT05019729|591874373|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
163865721|NCT03008915|591874378|FG000|Treatment 1|Withdrawal by Subject|0|||
163865722|NCT03008915|591874379|FG001|Treatment 1|Withdrawal by Subject|1|||
163865723|NCT00712166|591874382|FG000|Overall Study|Noncompliance|0|||
163865724|NCT00712166|591874383|FG001|Overall Study|Noncompliance|1|||
163865725|NCT01773122|591874384|FG000|Overall Study|Due to amended age eligibility criteria|3|||
163865726|NCT01773122|591874385|FG001|Overall Study|Due to amended age eligibility criteria|1|||
163865727|NCT01773122|591874386|FG002|Overall Study|Due to amended age eligibility criteria|0|||
163865728|NCT01773122|591874387|FG003|Overall Study|Due to amended age eligibility criteria|1|||
163865729|NCT02289560|591874390|FG000|Overall Study|Lost to Follow-up|6|||
163865730|NCT02289560|591874390|FG000|Overall Study|Alternative Treatment|4|||
163865731|NCT02289560|591874390|FG000|Overall Study|Inadequate Treatment|2|||
163865732|NCT02289560|591874390|FG000|Overall Study|Withdrawal by Subject|23|||
163865733|NCT02540213|591874391|FG000|Overall Study|Death/adverse event|18|||
163865734|NCT02540213|591874391|FG000|Overall Study|Administrative reasons|3|||
163865735|NCT02540213|591874391|FG000|Overall Study|Kidney transplant|3|||
163865736|NCT02540213|591874391|FG000|Overall Study|Lack of Efficacy|6|||
163865737|NCT02540213|591874391|FG000|Overall Study|Consent withdrawn|7|||
163865738|NCT02540213|591874391|FG000|Overall Study|Enrolled but not treated|2|||
163865739|NCT01264718|591874392|FG000|Overall Study|Lost to Follow-up|3|||
163865740|NCT01264718|591874393|FG001|Overall Study|Lost to Follow-up|2|||
163865741|NCT01264718|591874392|FG000|Overall Study|Withdrawal by Subject|9|||
163865742|NCT01264718|591874393|FG001|Overall Study|Withdrawal by Subject|15|||
163865743|NCT01264718|591874392|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
163865744|NCT01264718|591874393|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
163865745|NCT02908464|591874394|FG000|Overall Study|Withdrawal by Subject|2|||
163865746|NCT02908464|591874395|FG001|Overall Study|Withdrawal by Subject|1|||
163865747|NCT02908464|591874394|FG000|Overall Study|Found ineligible after randomization|0|||
163865748|NCT02908464|591874395|FG001|Overall Study|Found ineligible after randomization|2|||
163865749|NCT00536380|591874400|FG000|Overall Study|Adverse Event|0|||
163865750|NCT00536380|591874401|FG001|Overall Study|Adverse Event|2|||
163865751|NCT00536380|591874402|FG002|Overall Study|Adverse Event|2|||
163970514|NCT00117598|592264727|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
164310616|NCT04421027|593510913|FG001|Follow-Up Period|Protocol Deviation|0|||
164310617|NCT04421027|593510914|FG002|Follow-Up Period|Protocol Deviation|1|||
164310618|NCT04421027|593510915|FG003|Follow-Up Period|Protocol Deviation|0|||
163865752|NCT00536380|591874400|FG000|Overall Study|Lost to Follow-up|0|||
163865753|NCT00536380|591874401|FG001|Overall Study|Lost to Follow-up|0|||
163865754|NCT00536380|591874402|FG002|Overall Study|Lost to Follow-up|1|||
163865755|NCT00536380|591874400|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
163865756|NCT00536380|591874401|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
163865757|NCT00536380|591874402|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
163865758|NCT00536380|591874400|FG000|Overall Study|Withdrawal related to study drug|7|||
163970515|NCT00117598|592264728|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
163970516|NCT00117598|592264729|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
163970517|NCT00117598|592264730|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
163970518|NCT00117598|592264731|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
163970519|NCT00117598|592264727|FG000|After Treament Cross Over|Other|0|||
163970520|NCT00117598|592264728|FG001|After Treament Cross Over|Other|0|||
163970521|NCT00117598|592264729|FG002|After Treament Cross Over|Other|0|||
163970522|NCT00117598|592264730|FG003|After Treament Cross Over|Other|1|||
163970523|NCT00117598|592264731|FG004|After Treament Cross Over|Other|2|||
163970524|NCT01235793|592264732|FG000|Overall Study|Death|6|||
163970525|NCT00545064|592264738|FG000|Overall Study|Lost to Follow-up|3|||
163970526|NCT00545064|592264738|FG000|Overall Study|Withdrawal by Subject|2|||
163970527|NCT00545064|592264738|FG000|Overall Study|did not complete course of treatment|1|||
163970528|NCT00545064|592264738|FG000|Overall Study|cancel all appointments, no rebooking|1|||
163970529|NCT00545064|592264738|FG000|Overall Study|inclement weather|1|||
163970530|NCT05093322|592264741|FG000|Overall Study|Death|6|||
163970531|NCT05093322|592264742|FG001|Overall Study|Death|2|||
163970532|NCT05093322|592264741|FG000|Overall Study|Other|4|||
163970533|NCT05093322|592264742|FG001|Overall Study|Other|1|||
163970534|NCT00898443|592264743|FG000|Overall Study|Withdrawal by Subject|1|||
163970535|NCT00898443|592264744|FG001|Overall Study|Withdrawal by Subject|0|||
163970536|NCT00074581|592264748|FG000|Overall Study|Death|15|||
163970537|NCT00074581|592264749|FG001|Overall Study|Death|16|||
163970538|NCT00074581|592264748|FG000|Overall Study|Withdrawal by Subject|50|||
163970539|NCT00074581|592264749|FG001|Overall Study|Withdrawal by Subject|49|||
163970540|NCT00074581|592264748|FG000|Overall Study|Unable to adhere to visit schedule|13|||
163970541|NCT00074581|592264749|FG001|Overall Study|Unable to adhere to visit schedule|14|||
163970542|NCT00074581|592264748|FG000|Overall Study|Relocated|14|||
163970543|NCT00074581|592264749|FG001|Overall Study|Relocated|9|||
163970544|NCT00074581|592264748|FG000|Overall Study|Were withdrawn by investigator|5|||
163970545|NCT00074581|592264749|FG001|Overall Study|Were withdrawn by investigator|2|||
163970546|NCT00074581|592264748|FG000|Overall Study|Lost to Follow-up|16|||
163970547|NCT00074581|592264749|FG001|Overall Study|Lost to Follow-up|11|||
163970548|NCT00074581|592264748|FG000|Overall Study|Ended relationship w. index participant|117|||
163970549|NCT00074581|592264749|FG001|Overall Study|Ended relationship w. index participant|106|||
163970550|NCT00074581|592264748|FG000|Overall Study|Other|14|||
163970551|NCT00074581|592264749|FG001|Overall Study|Other|19|||
163970552|NCT01770912|592264750|FG000|Overall Study|Lost to Follow-up|2|||
163970553|NCT01770912|592264751|FG001|Overall Study|Lost to Follow-up|0|||
163970554|NCT03250832|592264753|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
163970555|NCT03250832|592264754|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
163970556|NCT03250832|592264755|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
163970557|NCT03250832|592264756|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
163970558|NCT03250832|592264757|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
163970559|NCT03250832|592264758|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
163970560|NCT03250832|592264759|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
163970561|NCT03250832|592264760|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
163970562|NCT03250832|592264761|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
163970563|NCT03250832|592264762|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
163970564|NCT03250832|592264763|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
163970565|NCT03250832|592264764|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
163970566|NCT03250832|592264753|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
163970567|NCT03250832|592264754|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
163970568|NCT03250832|592264755|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
163970569|NCT03250832|592264756|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
163970570|NCT03250832|592264757|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
163970571|NCT03250832|592264758|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
163970572|NCT03250832|592264759|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
163970573|NCT03250832|592264760|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163970574|NCT03250832|592264761|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163970575|NCT03250832|592264762|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163970576|NCT03250832|592264763|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163970577|NCT03250832|592264764|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
163970578|NCT03250832|592264753|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970579|NCT03250832|592264754|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970580|NCT03250832|592264755|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
163970581|NCT03250832|592264756|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970582|NCT03250832|592264757|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970583|NCT03250832|592264758|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970584|NCT03250832|592264759|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970585|NCT03250832|592264760|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970586|NCT03250832|592264761|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
164310619|NCT04421027|593510912|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
164310620|NCT04421027|593510913|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
164310621|NCT04421027|593510914|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
164310622|NCT04421027|593510915|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
163970587|NCT03250832|592264762|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970588|NCT03250832|592264763|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970589|NCT03250832|592264764|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
163970590|NCT03250832|592264753|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970591|NCT03250832|592264754|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970592|NCT03250832|592264755|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970593|NCT03250832|592264756|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970594|NCT03250832|592264757|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970595|NCT03250832|592264758|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970596|NCT03250832|592264759|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970597|NCT03250832|592264760|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
163970598|NCT03250832|592264761|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970599|NCT03250832|592264762|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970600|NCT03250832|592264763|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970601|NCT03250832|592264764|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
163970602|NCT03250832|592264753|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970603|NCT03250832|592264754|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970604|NCT03250832|592264755|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970605|NCT03250832|592264756|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970606|NCT03250832|592264757|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970607|NCT03250832|592264758|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970608|NCT03250832|592264759|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970609|NCT03250832|592264760|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
163970610|NCT03250832|592264761|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970611|NCT03250832|592264762|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970612|NCT03250832|592264763|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970613|NCT03250832|592264764|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
163970614|NCT03250832|592264753|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970615|NCT03250832|592264754|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970616|NCT03250832|592264755|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970617|NCT03250832|592264756|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970618|NCT03250832|592264757|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970619|NCT03250832|592264758|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970620|NCT03250832|592264759|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970621|NCT03250832|592264760|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
163970622|NCT03250832|592264761|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970623|NCT03250832|592264762|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970624|NCT03250832|592264763|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970625|NCT03250832|592264764|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
163970626|NCT03250832|592264753|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970627|NCT03250832|592264754|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970628|NCT03250832|592264755|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970629|NCT03250832|592264756|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970630|NCT03250832|592264757|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970631|NCT03250832|592264758|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970632|NCT03250832|592264759|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970633|NCT03250832|592264760|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
163970634|NCT03250832|592264761|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970635|NCT03250832|592264762|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970636|NCT03250832|592264763|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970637|NCT03250832|592264764|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
163970638|NCT03250832|592264753|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970639|NCT03250832|592264754|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970640|NCT03250832|592264755|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
164310623|NCT04421027|593510912|FG000|Follow-Up Period|Left message, participant did not call back|0|||
164310624|NCT04421027|593510913|FG001|Follow-Up Period|Left message, participant did not call back|0|||
164310625|NCT04421027|593510914|FG002|Follow-Up Period|Left message, participant did not call back|0|||
164310626|NCT04421027|593510915|FG003|Follow-Up Period|Left message, participant did not call back|1|||
164310627|NCT04421027|593510912|FG000|Follow-Up Period|Participant died|0|||
164310628|NCT04421027|593510913|FG001|Follow-Up Period|Participant died|0|||
164310629|NCT04421027|593510914|FG002|Follow-Up Period|Participant died|0|||
164310630|NCT04421027|593510915|FG003|Follow-Up Period|Participant died|1|||
163970641|NCT03250832|592264756|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970642|NCT03250832|592264757|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970643|NCT03250832|592264758|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970644|NCT03250832|592264759|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970645|NCT03250832|592264760|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
163970646|NCT03250832|592264761|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970647|NCT03250832|592264762|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970648|NCT03250832|592264763|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970649|NCT03250832|592264764|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
163970650|NCT03250832|592264753|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970651|NCT03250832|592264754|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970652|NCT03250832|592264755|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970653|NCT03250832|592264756|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970654|NCT03250832|592264757|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970655|NCT03250832|592264758|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970656|NCT03250832|592264759|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970657|NCT03250832|592264760|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970658|NCT03250832|592264761|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
163970659|NCT03250832|592264762|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
163970660|NCT03250832|592264763|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970661|NCT03250832|592264764|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
163970662|NCT03250832|592264753|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970663|NCT03250832|592264754|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970664|NCT03250832|592264755|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970665|NCT03250832|592264756|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970666|NCT03250832|592264757|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970667|NCT03250832|592264758|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970668|NCT03250832|592264759|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970669|NCT03250832|592264760|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970670|NCT03250832|592264761|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
163970671|NCT03250832|592264762|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
163970672|NCT03250832|592264763|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970673|NCT03250832|592264764|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
163970674|NCT03250832|592264753|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970675|NCT03250832|592264754|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970676|NCT03250832|592264755|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970677|NCT03250832|592264756|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970678|NCT03250832|592264757|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970679|NCT03250832|592264758|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970680|NCT03250832|592264759|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970681|NCT03250832|592264760|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970682|NCT03250832|592264761|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
163970683|NCT03250832|592264762|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
163970684|NCT03250832|592264763|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970685|NCT03250832|592264764|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
163970686|NCT03250832|592264753|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970687|NCT03250832|592264754|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970688|NCT03250832|592264755|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970689|NCT03250832|592264756|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970690|NCT03250832|592264757|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970691|NCT03250832|592264758|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970692|NCT03250832|592264759|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970693|NCT03250832|592264760|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970694|NCT03250832|592264761|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970695|NCT03250832|592264762|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970696|NCT03250832|592264763|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
163970697|NCT03250832|592264764|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
163970698|NCT01708291|592264765|FG000|Overall Study|fighting|2|||
163970699|NCT01708291|592264766|FG001|Overall Study|fighting|1|||
163970700|NCT02303704|592264767|FG000|Overall Study|Protocol Violation|5|||
163970701|NCT02303704|592264768|FG001|Overall Study|Protocol Violation|9|||
163970702|NCT04411628|592264770|FG000|Overall Study|Withdrawal by Subject|1|||
163970703|NCT04411628|592264771|FG001|Overall Study|Withdrawal by Subject|1|||
163970704|NCT04411628|592264772|FG002|Overall Study|Withdrawal by Subject|2|||
163970705|NCT04411628|592264773|FG003|Overall Study|Withdrawal by Subject|0|||
163970706|NCT04411628|592264770|FG000|Overall Study|Lost to Follow-up|0|||
163970707|NCT04411628|592264771|FG001|Overall Study|Lost to Follow-up|1|||
164310631|NCT04421027|593510912|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
164310632|NCT04421027|593510913|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
163865759|NCT00536380|591874401|FG001|Overall Study|Withdrawal related to study drug|5|||
163865760|NCT00536380|591874402|FG002|Overall Study|Withdrawal related to study drug|2|||
163865761|NCT00536380|591874400|FG000|Overall Study|Noncompliance with protocol|3|||
163865762|NCT00536380|591874401|FG001|Overall Study|Noncompliance with protocol|2|||
163865763|NCT00536380|591874402|FG002|Overall Study|Noncompliance with protocol|2|||
163865764|NCT00536380|591874400|FG000|Overall Study|Did not meet protocol eligibility|0|||
163865765|NCT00536380|591874401|FG001|Overall Study|Did not meet protocol eligibility|0|||
163865766|NCT00536380|591874402|FG002|Overall Study|Did not meet protocol eligibility|1|||
163865767|NCT00536380|591874400|FG000|Overall Study|Administrative|0|||
163865768|NCT00536380|591874401|FG001|Overall Study|Administrative|0|||
163865769|NCT00536380|591874402|FG002|Overall Study|Administrative|1|||
163865770|NCT00387465|591874403|FG000|Overall Study|Withdrawal by Subject|0|||
163865771|NCT00387465|591874404|FG001|Overall Study|Withdrawal by Subject|1|||
163865772|NCT00387465|591874405|FG002|Overall Study|Withdrawal by Subject|0|||
163865773|NCT02754479|591874408|FG000|Overall Study|Lost to Follow-up|1|||
163865774|NCT03183518|591874409|FG000|Overall Study|Other (Not specified)|2|||
163865775|NCT03183518|591874409|FG000|Overall Study|Other (Withdrawal of consent)|1|||
163865776|NCT02132702|591874410|FG000|Overall Study|Protocol Violation|2|||
163865777|NCT02132702|591874410|FG000|Overall Study|Adverse Event|3|||
163865778|NCT02132702|591874410|FG000|Overall Study|Withdrawal by Subject|3|||
163865779|NCT01244828|591874413|FG000|Overall Study|Adverse Event|37|||
163865780|NCT01244828|591874413|FG000|Overall Study|Withdrawal by Subject|31|||
163865781|NCT01244828|591874413|FG000|Overall Study|Lack of Efficacy|7|||
163865782|NCT01244828|591874413|FG000|Overall Study|Lost to Follow-up|2|||
163865783|NCT01244828|591874413|FG000|Overall Study|Other reason (not specified)|1|||
163865784|NCT00573833|591874414|FG000|Overall Study|Not Treated|2|||
163865785|NCT05052983|591874415|FG000|Overall Study|Lack of Efficacy|3|||
163865786|NCT05052983|591874416|FG001|Overall Study|Lack of Efficacy|12|||
163865787|NCT05052983|591874415|FG000|Overall Study|Adverse Event|1|||
163865788|NCT05052983|591874416|FG001|Overall Study|Adverse Event|0|||
163865789|NCT04493242|591874417|FG000|Overall Study|Death|10|||
163865790|NCT04493242|591874418|FG001|Overall Study|Death|14|||
163865791|NCT04493242|591874419|FG002|Overall Study|Death|16|||
163865792|NCT04493242|591874417|FG000|Overall Study|Lost to Follow-up|1|||
163865793|NCT04493242|591874418|FG001|Overall Study|Lost to Follow-up|1|||
163865794|NCT04493242|591874419|FG002|Overall Study|Lost to Follow-up|0|||
163865795|NCT04493242|591874417|FG000|Overall Study|Withdrawal by Subject|1|||
163865796|NCT04493242|591874418|FG001|Overall Study|Withdrawal by Subject|0|||
163865797|NCT04493242|591874419|FG002|Overall Study|Withdrawal by Subject|0|||
163865798|NCT04493242|591874417|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
163865799|NCT04493242|591874418|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
163865800|NCT04493242|591874419|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
163865801|NCT04493242|591874417|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
163865802|NCT04493242|591874418|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
163865803|NCT04493242|591874419|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
163865804|NCT00849147|591874420|FG000|Overall Study|Withdrawal by Subject|1|||
163865805|NCT00849147|591874420|FG000|Overall Study|Protocol Violation|2|||
163865806|NCT00849147|591874420|FG000|Overall Study|Disease Relapse/Progression|2|||
163865807|NCT03215927|591875922|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
163865808|NCT03215927|591875923|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
163865809|NCT03215927|591875922|FG000|Open Label Extension|Adverse Event|1|||
163865810|NCT03215927|591875923|FG001|Open Label Extension|Adverse Event|0|||
163865811|NCT03215927|591875922|FG000|Open Label Extension|Lack of Efficacy|1|||
163865812|NCT03215927|591875923|FG001|Open Label Extension|Lack of Efficacy|0|||
163865813|NCT03215927|591875922|FG000|Open Label Extension|Death|0|||
163865814|NCT03215927|591875923|FG001|Open Label Extension|Death|1|||
163865815|NCT03779048|591875924|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
163865816|NCT03779048|591875925|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
163970708|NCT04411628|592264772|FG002|Overall Study|Lost to Follow-up|0|||
163865817|NCT03779048|591875926|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
163865818|NCT03779048|591875924|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
163865819|NCT03779048|591875925|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
163865820|NCT03779048|591875926|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
163865821|NCT03779048|591875924|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
163865822|NCT03779048|591875925|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
163865823|NCT03779048|591875926|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
163970709|NCT04411628|592264773|FG003|Overall Study|Lost to Follow-up|0|||
163865824|NCT00446550|591875929|FG000|Overall Study|Adverse Event|1|||
163865825|NCT00446550|591875930|FG001|Overall Study|Adverse Event|0|||
163865826|NCT02983617|591875931|FG000|Overall Study|Adverse Event|0|||
163865827|NCT02983617|591875932|FG001|Overall Study|Adverse Event|7|||
163970710|NCT01034540|592264774|FG000|Overall Study|Adverse Event|0|||
163970711|NCT01034540|592264775|FG001|Overall Study|Adverse Event|1|||
163970712|NCT01721876|592264778|FG000|Overall Study|Not treated|1|||
163970713|NCT01721876|592264779|FG001|Overall Study|Not treated|4|||
163970714|NCT01721876|592264778|FG000|Overall Study|Disease progression / relapse|123|||
163970715|NCT01721876|592264779|FG001|Overall Study|Disease progression / relapse|156|||
163970716|NCT01721876|592264778|FG000|Overall Study|Death|6|||
163970717|NCT01721876|592264779|FG001|Overall Study|Death|13|||
163970718|NCT01721876|592264778|FG000|Overall Study|Adverse Event|41|||
163970719|NCT01721876|592264779|FG001|Overall Study|Adverse Event|165|||
163970720|NCT01721876|592264778|FG000|Overall Study|Protocol Violation|2|||
163970721|NCT01721876|592264779|FG001|Overall Study|Protocol Violation|1|||
163970722|NCT01721876|592264778|FG000|Overall Study|Withdrawal by Subject|15|||
163970723|NCT01721876|592264779|FG001|Overall Study|Withdrawal by Subject|38|||
163970724|NCT01721876|592264778|FG000|Overall Study|Reason not listed|34|||
163970725|NCT01721876|592264779|FG001|Overall Study|Reason not listed|63|||
163970726|NCT01721876|592264778|FG000|Overall Study|Sponsor terminated trial|0|||
163970727|NCT01721876|592264779|FG001|Overall Study|Sponsor terminated trial|4|||
163970728|NCT03805750|592264780|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
163970729|NCT03805750|592264781|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
163970730|NCT00493220|592264782|FG000|Third Intervention|Withdrawal by Subject|1|||
163970731|NCT00493220|592264783|FG001|Third Intervention|Withdrawal by Subject|0|||
163970732|NCT00493220|592264784|FG002|Third Intervention|Withdrawal by Subject|0|||
163970733|NCT00493220|592264785|FG003|Third Intervention|Withdrawal by Subject|0|||
163970734|NCT00493220|592264786|FG004|Third Intervention|Withdrawal by Subject|0|||
163970735|NCT00493220|592264787|FG005|Third Intervention|Withdrawal by Subject|0|||
163970736|NCT00310804|592264788|FG000|Overall Study|Lost to Follow-up|2|||
163970737|NCT00310804|592264789|FG001|Overall Study|Lost to Follow-up|0|||
163970738|NCT00310804|592264788|FG000|Overall Study|Withdrawal by Subject|3|||
163970739|NCT00310804|592264789|FG001|Overall Study|Withdrawal by Subject|0|||
163970740|NCT02844816|592264791|FG000|Overall Study|No protocol treatment received|5|||
163970741|NCT02844816|592264792|FG001|Overall Study|No protocol treatment received|1|||
163970742|NCT02844816|592264791|FG000|Overall Study|Ineligible|22|||
163970743|NCT02844816|592264792|FG001|Overall Study|Ineligible|15|||
163970744|NCT02844816|592264791|FG000|Overall Study|Participant refusal|5|||
163970745|NCT02844816|592264792|FG001|Overall Study|Participant refusal|5|||
163970746|NCT02844816|592264791|FG000|Overall Study|Adverse Event|5|||
163970747|NCT02844816|592264792|FG001|Overall Study|Adverse Event|4|||
163970748|NCT02844816|592264791|FG000|Overall Study|Death|0|||
163970749|NCT02844816|592264792|FG001|Overall Study|Death|1|||
163970750|NCT02844816|592264791|FG000|Overall Study|Disease progression/recurrence|50|||
163970751|NCT02844816|592264792|FG001|Overall Study|Disease progression/recurrence|24|||
163970752|NCT02844816|592264791|FG000|Overall Study|Physician Decision|1|||
163970753|NCT02844816|592264792|FG001|Overall Study|Physician Decision|1|||
163970754|NCT01428661|592264795|FG000|Double-Masked Phase|Protocol Violation|9|||
163970755|NCT01428661|592264796|FG001|Double-Masked Phase|Protocol Violation|4|||
163970756|NCT01428661|592264797|FG002|Double-Masked Phase|Protocol Violation|0|||
163970757|NCT01428661|592264795|FG000|Double-Masked Phase|Adverse Event|13|||
163970758|NCT01428661|592264796|FG001|Double-Masked Phase|Adverse Event|4|||
163970759|NCT01428661|592264797|FG002|Double-Masked Phase|Adverse Event|0|||
163970760|NCT01428661|592264795|FG000|Double-Masked Phase|Lost to Follow-up|14|||
163970761|NCT01428661|592264796|FG001|Double-Masked Phase|Lost to Follow-up|14|||
163970762|NCT01428661|592264797|FG002|Double-Masked Phase|Lost to Follow-up|0|||
163970763|NCT01428661|592264795|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
163970764|NCT01428661|592264796|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
163970765|NCT01428661|592264797|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
163865828|NCT02983617|591875931|FG000|Overall Study|Death|0|||
163865829|NCT02983617|591875932|FG001|Overall Study|Death|1|||
163865830|NCT02983617|591875931|FG000|Overall Study|Investigator's Discretion|0|||
163865831|NCT02983617|591875932|FG001|Overall Study|Investigator's Discretion|1|||
163865832|NCT02027558|591875933|FG000|Overall Study|Death|0|||
163865833|NCT02027558|591875934|FG001|Overall Study|Death|1|||
163865834|NCT02027558|591875933|FG000|Overall Study|Withdrawal by Subject|2|||
163865835|NCT02027558|591875934|FG001|Overall Study|Withdrawal by Subject|0|||
163865836|NCT02027558|591875933|FG000|Overall Study|Lost to Follow-up|4|||
163865837|NCT02027558|591875934|FG001|Overall Study|Lost to Follow-up|1|||
163865838|NCT02027558|591875933|FG000|Overall Study|Refused assessment|3|||
163865839|NCT02027558|591875934|FG001|Overall Study|Refused assessment|0|||
163865840|NCT02567656|591875935|FG000|Overall Study|Premature discontinuation due to PD|1|||
163865841|NCT02567656|591875936|FG001|Overall Study|Premature discontinuation due to PD|1|||
163865842|NCT02567656|591875937|FG002|Overall Study|Premature discontinuation due to PD|2|||
163970766|NCT01428661|592264795|FG000|Double-Masked Phase|Lack of Efficacy|2|||
163970767|NCT01428661|592264796|FG001|Double-Masked Phase|Lack of Efficacy|1|||
163970768|NCT01428661|592264797|FG002|Double-Masked Phase|Lack of Efficacy|0|||
163970769|NCT01428661|592264795|FG000|Double-Masked Phase|*Various|1|||
163865843|NCT02567656|591875938|FG003|Overall Study|Premature discontinuation due to PD|0|||
163970770|NCT01428661|592264796|FG001|Double-Masked Phase|*Various|6|||
163970771|NCT01428661|592264797|FG002|Double-Masked Phase|*Various|0|||
164310633|NCT04421027|593510914|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
164310634|NCT04421027|593510915|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
164310635|NCT00560352|593510920|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164310636|NCT00560352|593510921|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164310637|NCT00560352|593510922|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164310638|NCT00560352|593510920|FG000|Overall Study|Study drug toxicity|3|||
164310639|NCT00560352|593510921|FG001|Overall Study|Study drug toxicity|0|||
164310640|NCT00560352|593510922|FG002|Overall Study|Study drug toxicity|1|||
164310641|NCT00560352|593510920|FG000|Overall Study|Disease progression|0|||
164310642|NCT00560352|593510921|FG001|Overall Study|Disease progression|1|||
164310643|NCT00560352|593510922|FG002|Overall Study|Disease progression|1|||
164310644|NCT00560352|593510920|FG000|Overall Study|Withdrawal by Subject|1|||
164310645|NCT00560352|593510921|FG001|Overall Study|Withdrawal by Subject|1|||
164310646|NCT00560352|593510922|FG002|Overall Study|Withdrawal by Subject|1|||
164310647|NCT00560352|593510920|FG000|Overall Study|Maximum clinical benefit|1|||
164310648|NCT00560352|593510921|FG001|Overall Study|Maximum clinical benefit|0|||
164310649|NCT00560352|593510922|FG002|Overall Study|Maximum clinical benefit|0|||
164310650|NCT03568461|593510926|FG000|Overall Study|Death|7|||
164310651|NCT03568461|593510926|FG000|Overall Study|Physician Decision|5|||
164310652|NCT03568461|593510926|FG000|Overall Study|Subject decision|5|||
164310653|NCT03568461|593510926|FG000|Overall Study|Lost to Follow-up|1|||
164310654|NCT03387085|593510927|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
164310655|NCT01395524|593512901|FG000|Overall Study|Non-compliance with study schedule|1|||
164310656|NCT01395524|593512902|FG001|Overall Study|Non-compliance with study schedule|0|||
164310657|NCT01395524|593512903|FG002|Overall Study|Non-compliance with study schedule|1|||
164310658|NCT01395524|593512901|FG000|Overall Study|Lost to Follow-up|3|||
164310659|NCT01395524|593512902|FG001|Overall Study|Lost to Follow-up|1|||
164310660|NCT01395524|593512903|FG002|Overall Study|Lost to Follow-up|1|||
164310661|NCT01395524|593512901|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
164310662|NCT01395524|593512902|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
164310663|NCT01395524|593512903|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
164310664|NCT01395524|593512901|FG000|Overall Study|Severe noncompliance with protocol|1|||
164310665|NCT01395524|593512902|FG001|Overall Study|Severe noncompliance with protocol|0|||
164310666|NCT01395524|593512903|FG002|Overall Study|Severe noncompliance with protocol|0|||
164310667|NCT01395524|593512901|FG000|Overall Study|Adverse Event|4|||
164310668|NCT01395524|593512902|FG001|Overall Study|Adverse Event|4|||
164310669|NCT01395524|593512903|FG002|Overall Study|Adverse Event|3|||
164310670|NCT01395524|593512901|FG000|Overall Study|Death|1|||
163865844|NCT02567656|591875939|FG004|Overall Study|Premature discontinuation due to PD|0|||
163865845|NCT02567656|591875940|FG005|Overall Study|Premature discontinuation due to PD|0|||
163865846|NCT01616654|591875942|FG000|Overall Study|Lack of Efficacy|1|||
163865847|NCT01616654|591875943|FG001|Overall Study|Lack of Efficacy|0|||
163865848|NCT01616654|591875944|FG002|Overall Study|Lack of Efficacy|0|||
163865849|NCT01616654|591875945|FG003|Overall Study|Lack of Efficacy|0|||
163865850|NCT01616654|591875946|FG004|Overall Study|Lack of Efficacy|1|||
163865851|NCT01616654|591875942|FG000|Overall Study|Adverse Event|0|||
163865852|NCT01616654|591875943|FG001|Overall Study|Adverse Event|1|||
163865853|NCT01616654|591875944|FG002|Overall Study|Adverse Event|2|||
163865854|NCT01616654|591875945|FG003|Overall Study|Adverse Event|1|||
163865855|NCT01616654|591875946|FG004|Overall Study|Adverse Event|0|||
163865856|NCT01616654|591875942|FG000|Overall Study|Withdrawal by Subject|2|||
163865857|NCT01616654|591875943|FG001|Overall Study|Withdrawal by Subject|2|||
163865858|NCT01616654|591875944|FG002|Overall Study|Withdrawal by Subject|3|||
163865859|NCT01616654|591875945|FG003|Overall Study|Withdrawal by Subject|1|||
163865860|NCT01616654|591875946|FG004|Overall Study|Withdrawal by Subject|5|||
163865861|NCT01616654|591875942|FG000|Overall Study|Protocol Violation|0|||
163865862|NCT01616654|591875943|FG001|Overall Study|Protocol Violation|5|||
163865863|NCT01616654|591875944|FG002|Overall Study|Protocol Violation|2|||
163865864|NCT01616654|591875945|FG003|Overall Study|Protocol Violation|4|||
163865865|NCT01616654|591875946|FG004|Overall Study|Protocol Violation|4|||
163865866|NCT01616654|591875942|FG000|Overall Study|Lost to Follow-up|1|||
163865867|NCT01616654|591875943|FG001|Overall Study|Lost to Follow-up|0|||
163865868|NCT01616654|591875944|FG002|Overall Study|Lost to Follow-up|3|||
163865869|NCT01616654|591875945|FG003|Overall Study|Lost to Follow-up|2|||
163865870|NCT01616654|591875946|FG004|Overall Study|Lost to Follow-up|1|||
163865871|NCT01616654|591875942|FG000|Overall Study|Pregnancy|1|||
163865872|NCT01616654|591875943|FG001|Overall Study|Pregnancy|0|||
163865873|NCT01616654|591875944|FG002|Overall Study|Pregnancy|0|||
163865874|NCT01616654|591875945|FG003|Overall Study|Pregnancy|0|||
163865875|NCT01616654|591875946|FG004|Overall Study|Pregnancy|1|||
163865876|NCT02057692|591875947|FG000|Overall Study|Adverse Event|1|||
163865877|NCT02057692|591875948|FG001|Overall Study|Adverse Event|0|||
163865878|NCT02057692|591875949|FG002|Overall Study|Adverse Event|0|||
163865879|NCT02057692|591875950|FG003|Overall Study|Adverse Event|0|||
163865880|NCT02057692|591875947|FG000|Overall Study|Lost to Follow-up|0|||
163865881|NCT02057692|591875948|FG001|Overall Study|Lost to Follow-up|0|||
163865882|NCT02057692|591875949|FG002|Overall Study|Lost to Follow-up|0|||
163865883|NCT02057692|591875950|FG003|Overall Study|Lost to Follow-up|1|||
163865884|NCT03923491|591875951|FG000|Overall Study|Lost to Follow-up|5|||
163865885|NCT03923491|591875952|FG001|Overall Study|Lost to Follow-up|8|||
163865886|NCT03923491|591875951|FG000|Overall Study|Withdrawal by Subject|4|||
163865887|NCT03923491|591875952|FG001|Overall Study|Withdrawal by Subject|6|||
163865888|NCT03823300|591875957|FG000|Overall Study|Withdrawal by Subject|16|||
163865889|NCT03823300|591875958|FG001|Overall Study|Withdrawal by Subject|22|||
163865890|NCT03823300|591875957|FG000|Overall Study|Death|10|||
163865891|NCT03823300|591875958|FG001|Overall Study|Death|14|||
163865892|NCT03823300|591875957|FG000|Overall Study|Adverse Event|3|||
163865893|NCT03823300|591875958|FG001|Overall Study|Adverse Event|5|||
163865894|NCT03823300|591875957|FG000|Overall Study|Physician Decision|1|||
163865895|NCT03823300|591875958|FG001|Overall Study|Physician Decision|7|||
163865896|NCT03823300|591875957|FG000|Overall Study|Lost to Follow-up|1|||
163865897|NCT03823300|591875958|FG001|Overall Study|Lost to Follow-up|3|||
163865898|NCT03823300|591875957|FG000|Overall Study|Protocol Violation|1|||
163865899|NCT03823300|591875958|FG001|Overall Study|Protocol Violation|1|||
163865900|NCT03823300|591875957|FG000|Overall Study|Lack of Efficacy|1|||
163865901|NCT03823300|591875958|FG001|Overall Study|Lack of Efficacy|1|||
163865902|NCT03823300|591875957|FG000|Overall Study|Not Eligible|0|||
163865903|NCT03823300|591875958|FG001|Overall Study|Not Eligible|1|||
163865904|NCT03823300|591875957|FG000|Overall Study|Other|1|||
163865905|NCT03823300|591875958|FG001|Overall Study|Other|0|||
163865906|NCT00831415|591875959|FG000|Overall Study|Adverse Event|14|||
163865907|NCT00831415|591875959|FG000|Overall Study|Failed to return|3|||
164201805|NCT04142242|593112607|FG005|Stage II|Lost to Follow-up|0|||
164201806|NCT04142242|593112602|FG000|Stage II|Withdrawal by Subject|0|||
164201807|NCT04142242|593112603|FG001|Stage II|Withdrawal by Subject|0|||
164201808|NCT04142242|593112604|FG002|Stage II|Withdrawal by Subject|5|||
164201809|NCT04142242|593112605|FG003|Stage II|Withdrawal by Subject|9|||
164201810|NCT04142242|593112606|FG004|Stage II|Withdrawal by Subject|0|||
164201811|NCT04142242|593112607|FG005|Stage II|Withdrawal by Subject|0|||
164201812|NCT00846053|593112610|FG000|Overall Study|Physician Decision|3|||
164201813|NCT00846053|593112611|FG001|Overall Study|Physician Decision|0|||
164201814|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
164201815|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201816|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201817|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201818|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201819|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201820|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
164201821|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
164201822|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201823|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201824|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201825|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201826|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201827|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
164201828|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201829|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
164201830|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201831|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201832|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201833|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201834|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
164201835|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201836|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201837|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
164201838|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164310671|NCT01395524|593512902|FG001|Overall Study|Death|0|||
164310672|NCT01395524|593512903|FG002|Overall Study|Death|0|||
164310673|NCT01395524|593512901|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
163865908|NCT00831415|591875959|FG000|Overall Study|Physician Decision|6|||
164310674|NCT01395524|593512902|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163865909|NCT00831415|591875959|FG000|Overall Study|Lost to Follow-up|9|||
163865910|NCT00831415|591875959|FG000|Overall Study|Protocol Violation|3|||
163865911|NCT00831415|591875959|FG000|Overall Study|Withdrawal by Subject|35|||
163865912|NCT00831415|591875959|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
163865913|NCT00831415|591875959|FG000|Overall Study|Death|1|||
163865914|NCT00486330|591875960|FG000|Overall Study|Adverse Event|2|||
163865915|NCT01290224|591875961|FG000|Overall Study|Adverse Event|1|||
163865916|NCT01290224|591875961|FG000|Overall Study|Refused Further Treatment|4|||
164201839|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201840|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
163970772|NCT01428661|592264795|FG000|Open Label Extension|Protocol Violation|0|||
163970773|NCT01428661|592264796|FG001|Open Label Extension|Protocol Violation|0|||
163970774|NCT01428661|592264797|FG002|Open Label Extension|Protocol Violation|9|||
163970775|NCT01428661|592264795|FG000|Open Label Extension|Adverse Event|0|||
163970776|NCT01428661|592264796|FG001|Open Label Extension|Adverse Event|0|||
163970777|NCT01428661|592264797|FG002|Open Label Extension|Adverse Event|15|||
163970778|NCT01428661|592264795|FG000|Open Label Extension|Lost to Follow-up|0|||
163970779|NCT01428661|592264796|FG001|Open Label Extension|Lost to Follow-up|0|||
163970780|NCT01428661|592264797|FG002|Open Label Extension|Lost to Follow-up|38|||
163970781|NCT01428661|592264795|FG000|Open Label Extension|Withdrawal by Subject|0|||
163970782|NCT01428661|592264796|FG001|Open Label Extension|Withdrawal by Subject|0|||
163970783|NCT01428661|592264797|FG002|Open Label Extension|Withdrawal by Subject|49|||
163970784|NCT01428661|592264795|FG000|Open Label Extension|Lack of Efficacy|0|||
163970785|NCT01428661|592264796|FG001|Open Label Extension|Lack of Efficacy|0|||
163970786|NCT01428661|592264797|FG002|Open Label Extension|Lack of Efficacy|24|||
163970787|NCT01428661|592264795|FG000|Open Label Extension|**Various|0|||
163970788|NCT01428661|592264796|FG001|Open Label Extension|**Various|0|||
163970789|NCT01428661|592264797|FG002|Open Label Extension|**Various|185|||
163970790|NCT04376827|592264799|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
163970791|NCT04376827|592264800|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
163970792|NCT04376827|592264799|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
163970793|NCT04376827|592264800|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
163970794|NCT04376827|592264799|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
163970795|NCT04376827|592264800|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
163970796|NCT04376827|592264799|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
163970797|NCT04376827|592264800|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
163970798|NCT04376827|592264799|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
163970799|NCT04376827|592264800|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
163970800|NCT01490450|592266156|FG000|Period 1|Lack of Efficacy|2|||
163970801|NCT01490450|592266157|FG001|Period 1|Lack of Efficacy|0|||
163970802|NCT01490450|592266158|FG002|Period 1|Lack of Efficacy|3|||
163970803|NCT01490450|592266159|FG003|Period 1|Lack of Efficacy|0|||
163970804|NCT01490450|592266156|FG000|Period 1|Adverse Event|0|||
163970805|NCT01490450|592266157|FG001|Period 1|Adverse Event|0|||
163970806|NCT01490450|592266158|FG002|Period 1|Adverse Event|0|||
163970807|NCT01490450|592266159|FG003|Period 1|Adverse Event|5|||
163970808|NCT01490450|592266156|FG000|Period 1|Request to discontinue treatment|1|||
163970809|NCT01490450|592266157|FG001|Period 1|Request to discontinue treatment|0|||
163970810|NCT01490450|592266158|FG002|Period 1|Request to discontinue treatment|0|||
163970811|NCT01490450|592266159|FG003|Period 1|Request to discontinue treatment|0|||
163970812|NCT01490450|592266156|FG000|Period 1|Withdrawal by Subject|0|||
163970813|NCT01490450|592266157|FG001|Period 1|Withdrawal by Subject|0|||
163970814|NCT01490450|592266158|FG002|Period 1|Withdrawal by Subject|0|||
163970815|NCT01490450|592266159|FG003|Period 1|Withdrawal by Subject|3|||
163970816|NCT01490450|592266156|FG000|Period 1|No longer met study criteria|0|||
163970817|NCT01490450|592266157|FG001|Period 1|No longer met study criteria|1|||
163970818|NCT01490450|592266158|FG002|Period 1|No longer met study criteria|1|||
163970819|NCT01490450|592266159|FG003|Period 1|No longer met study criteria|0|||
163970820|NCT01490450|592266156|FG000|Period 2|Lack of Efficacy|0|||
163970821|NCT01490450|592266157|FG001|Period 2|Lack of Efficacy|0|||
163970822|NCT01490450|592266158|FG002|Period 2|Lack of Efficacy|0|||
163970823|NCT01490450|592266159|FG003|Period 2|Lack of Efficacy|1|||
163970824|NCT01490450|592266156|FG000|Period 2|Adverse Event|1|||
163970825|NCT01490450|592266157|FG001|Period 2|Adverse Event|1|||
163970826|NCT01490450|592266158|FG002|Period 2|Adverse Event|0|||
163970827|NCT01490450|592266159|FG003|Period 2|Adverse Event|1|||
163970828|NCT01490450|592266156|FG000|Period 2|Withdrawal by Subject|1|||
163970829|NCT01490450|592266157|FG001|Period 2|Withdrawal by Subject|0|||
163970830|NCT01490450|592266158|FG002|Period 2|Withdrawal by Subject|0|||
163970831|NCT01490450|592266159|FG003|Period 2|Withdrawal by Subject|0|||
163970832|NCT01490450|592266156|FG000|Period 2|Lost to Follow-up|0|||
163970833|NCT01490450|592266157|FG001|Period 2|Lost to Follow-up|0|||
163970834|NCT01490450|592266158|FG002|Period 2|Lost to Follow-up|0|||
163970835|NCT01490450|592266159|FG003|Period 2|Lost to Follow-up|2|||
163970836|NCT00404820|592266160|FG000|Overall Study|Adverse Event|4|||
163970837|NCT00404820|592266161|FG001|Overall Study|Adverse Event|16|||
163970838|NCT00404820|592266160|FG000|Overall Study|Withdrawal by Subject|5|||
163970839|NCT00404820|592266161|FG001|Overall Study|Withdrawal by Subject|3|||
163970840|NCT00404820|592266160|FG000|Overall Study|Lost to Follow-up|7|||
163970841|NCT00404820|592266161|FG001|Overall Study|Lost to Follow-up|3|||
163970842|NCT00404820|592266160|FG000|Overall Study|Administrative problems|2|||
163970843|NCT00404820|592266161|FG001|Overall Study|Administrative problems|0|||
163970844|NCT00404820|592266160|FG000|Overall Study|Death|1|||
163970845|NCT00404820|592266161|FG001|Overall Study|Death|0|||
163970846|NCT00404820|592266160|FG000|Overall Study|Other|0|||
163970847|NCT00404820|592266161|FG001|Overall Study|Other|2|||
163970848|NCT01101438|592266162|FG000|Overall Study|Withdrawal by Subject|8|||
163970849|NCT01101438|592266163|FG001|Overall Study|Withdrawal by Subject|9|||
163970850|NCT02289742|592266172|FG000|First Wear Period|Adverse event prior to treatment|0|||
163970851|NCT02289742|592266173|FG001|First Wear Period|Adverse event prior to treatment|1|||
163970852|NCT02289742|592266174|FG002|First Wear Period|Adverse event prior to treatment|0|||
163970853|NCT02289742|592266175|FG003|First Wear Period|Adverse event prior to treatment|0|||
163970854|NCT02289742|592266172|FG000|First Wear Period|Adverse Event|0|||
163970855|NCT02289742|592266173|FG001|First Wear Period|Adverse Event|0|||
163970856|NCT02289742|592266174|FG002|First Wear Period|Adverse Event|1|||
163970857|NCT02289742|592266175|FG003|First Wear Period|Adverse Event|0|||
163970858|NCT02289742|592266172|FG000|First Wear Period|Other prior to treatment|0|||
163970859|NCT02289742|592266173|FG001|First Wear Period|Other prior to treatment|0|||
163970860|NCT02289742|592266174|FG002|First Wear Period|Other prior to treatment|0|||
163970861|NCT02289742|592266175|FG003|First Wear Period|Other prior to treatment|1|||
163970862|NCT02289742|592266172|FG000|Third Wear Period|Adverse Event|0|||
163970863|NCT02289742|592266173|FG001|Third Wear Period|Adverse Event|1|||
163970864|NCT02289742|592266174|FG002|Third Wear Period|Adverse Event|0|||
163970865|NCT02289742|592266175|FG003|Third Wear Period|Adverse Event|0|||
163970866|NCT02289742|592266172|FG000|Third Wear Period|Reason not given|0|||
163970867|NCT02289742|592266173|FG001|Third Wear Period|Reason not given|0|||
163970868|NCT02289742|592266174|FG002|Third Wear Period|Reason not given|0|||
163970869|NCT02289742|592266175|FG003|Third Wear Period|Reason not given|1|||
163970870|NCT00709111|592266176|FG000|Overall Study|Withdrawal by Subject|1|||
163970871|NCT00709111|592266176|FG000|Overall Study|Unable to attend clinic visits|1|||
163970872|NCT02865018|592266177|FG000|Overall Study|Withdrawal by Subject|1|||
163970873|NCT00139776|592266180|FG000|Period I|Did not enter Period II|575|||
163970874|NCT00139776|592266181|FG001|Period I|Did not enter Period II|0|||
163970875|NCT00139776|592266182|FG002|Period I|Did not enter Period II|0|||
163970876|NCT00139776|592266183|FG003|Period I|Did not enter Period II|0|||
163970877|NCT00139776|592266180|FG000|Period II|Not Randomized into Period III|0|||
163970878|NCT00139776|592266181|FG001|Period II|Not Randomized into Period III|322|||
163970879|NCT00139776|592266182|FG002|Period II|Not Randomized into Period III|0|||
164310675|NCT01395524|593512903|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164310676|NCT01395524|593512901|FG000|Overall Study|Withdrawal by Subject|4|||
164310677|NCT01395524|593512902|FG001|Overall Study|Withdrawal by Subject|8|||
164310678|NCT01395524|593512903|FG002|Overall Study|Withdrawal by Subject|8|||
164310679|NCT01395524|593512901|FG000|Overall Study|Did not receive treatment|1|||
164310680|NCT01395524|593512902|FG001|Overall Study|Did not receive treatment|1|||
164310681|NCT01395524|593512903|FG002|Overall Study|Did not receive treatment|3|||
164310682|NCT01395524|593512901|FG000|Overall Study|Subject had spinal surgery|0|||
164310683|NCT01395524|593512902|FG001|Overall Study|Subject had spinal surgery|0|||
164310684|NCT01395524|593512903|FG002|Overall Study|Subject had spinal surgery|1|||
164310685|NCT02175199|593512910|FG000|Overall Study|Withdrawal by Subject|1|||
164310686|NCT02175199|593512911|FG001|Overall Study|Withdrawal by Subject|5|||
164310687|NCT02175199|593512910|FG000|Overall Study|Randomized in Error|1|||
164310688|NCT02175199|593512911|FG001|Overall Study|Randomized in Error|0|||
164310689|NCT02175199|593512910|FG000|Overall Study|Sponsor Decision|1|||
164310690|NCT02175199|593512911|FG001|Overall Study|Sponsor Decision|0|||
164310691|NCT00122980|593512912|FG000|Overall Study|Death|0|||
164310692|NCT00122980|593512913|FG001|Overall Study|Death|1|||
164310693|NCT00122980|593512912|FG000|Overall Study|Physician Decision|2|||
164310694|NCT00122980|593512913|FG001|Overall Study|Physician Decision|0|||
164310695|NCT00122980|593512912|FG000|Overall Study|Protocol Violation|5|||
164310696|NCT00122980|593512913|FG001|Overall Study|Protocol Violation|1|||
164310697|NCT00122980|593512912|FG000|Overall Study|Withdrawal by Subject|2|||
164310698|NCT00122980|593512913|FG001|Overall Study|Withdrawal by Subject|3|||
164310699|NCT00122980|593512912|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
164310700|NCT00122980|593512913|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
164310701|NCT00122980|593512912|FG000|Overall Study|Study termination|27|||
163970880|NCT00139776|592266183|FG003|Period II|Not Randomized into Period III|0|||
163970881|NCT00139776|592266180|FG000|Period III|Adverse Event|0|||
164310702|NCT00122980|593512913|FG001|Overall Study|Study termination|35|||
164310703|NCT01124864|593512914|FG000|Overall Study|Follow up phase competed as per protocol|18|||
164310704|NCT01124864|593512915|FG001|Overall Study|Follow up phase competed as per protocol|22|||
164310705|NCT01124864|593512916|FG002|Overall Study|Follow up phase competed as per protocol|24|||
164310706|NCT01124864|593512917|FG003|Overall Study|Follow up phase competed as per protocol|18|||
164310707|NCT01124864|593512918|FG004|Overall Study|Follow up phase competed as per protocol|26|||
164310708|NCT01124864|593512919|FG005|Overall Study|Follow up phase competed as per protocol|2|||
164310709|NCT01124864|593512914|FG000|Overall Study|Death|6|||
164310710|NCT01124864|593512915|FG001|Overall Study|Death|9|||
164310711|NCT01124864|593512916|FG002|Overall Study|Death|6|||
164310712|NCT01124864|593512917|FG003|Overall Study|Death|2|||
164310713|NCT01124864|593512918|FG004|Overall Study|Death|1|||
163970882|NCT00139776|592266181|FG001|Period III|Adverse Event|0|||
163970883|NCT00139776|592266182|FG002|Period III|Adverse Event|22|||
163970884|NCT00139776|592266183|FG003|Period III|Adverse Event|23|||
163865917|NCT01027286|591875962|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
163865918|NCT01027286|591875963|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
163865919|NCT01027286|591875962|FG000|Overall Study|Lost to Follow-up|0|||
163865920|NCT01027286|591875963|FG001|Overall Study|Lost to Follow-up|1|||
163865921|NCT05694065|591875964|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
163865922|NCT05694065|591875964|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
163865923|NCT05694065|591875964|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
163865924|NCT00813904|591875965|FG000|Overall Study|Death|1|||
163865925|NCT01087762|591875966|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
163865926|NCT01087762|591875967|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
163865927|NCT01087762|591875968|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
163865928|NCT01087762|591875969|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
163865929|NCT01087762|591875970|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
163865930|NCT01087762|591875966|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
163865931|NCT01087762|591875967|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
163865932|NCT01087762|591875968|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
163865933|NCT01087762|591875969|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
163865934|NCT01087762|591875970|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
163865935|NCT01087762|591875966|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
163865936|NCT01087762|591875967|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
163865937|NCT01087762|591875968|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
163865938|NCT01087762|591875969|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
163865939|NCT01087762|591875970|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
163865940|NCT01087762|591875966|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
163865941|NCT01087762|591875967|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
163865942|NCT01087762|591875968|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
163865943|NCT01087762|591875969|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
163865944|NCT01087762|591875970|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
163865945|NCT01087762|591875966|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
163865946|NCT01087762|591875967|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
163865947|NCT01087762|591875968|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
163865948|NCT01087762|591875969|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
163865949|NCT01087762|591875970|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
163865950|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
163865951|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
163865952|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
163865953|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
163865954|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
163865955|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
163865956|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
163865957|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
163865958|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
163865959|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
163865960|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
163865961|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
163865962|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
163865963|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
163865964|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
163865965|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
163865966|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
163865967|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
163865968|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
163865969|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
164201841|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
164201842|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201843|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201844|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
164201845|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201846|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201847|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201848|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
164201849|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201850|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201851|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
163865970|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
163865971|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
164310714|NCT01124864|593512919|FG005|Overall Study|Death|0|||
164310715|NCT01124864|593512914|FG000|Overall Study|Withdrawal by Subject|2|||
164310716|NCT01124864|593512915|FG001|Overall Study|Withdrawal by Subject|3|||
164310717|NCT01124864|593512916|FG002|Overall Study|Withdrawal by Subject|4|||
164310718|NCT01124864|593512917|FG003|Overall Study|Withdrawal by Subject|0|||
164310719|NCT01124864|593512918|FG004|Overall Study|Withdrawal by Subject|2|||
164310720|NCT01124864|593512919|FG005|Overall Study|Withdrawal by Subject|1|||
164310721|NCT01124864|593512914|FG000|Overall Study|Lost to Follow-up|1|||
164310722|NCT01124864|593512915|FG001|Overall Study|Lost to Follow-up|1|||
164310723|NCT01124864|593512916|FG002|Overall Study|Lost to Follow-up|0|||
164310724|NCT01124864|593512917|FG003|Overall Study|Lost to Follow-up|1|||
164310725|NCT01124864|593512918|FG004|Overall Study|Lost to Follow-up|0|||
164310726|NCT01124864|593512919|FG005|Overall Study|Lost to Follow-up|0|||
164310727|NCT01124864|593512914|FG000|Overall Study|Protocol Violation|1|||
164310728|NCT01124864|593512915|FG001|Overall Study|Protocol Violation|0|||
164310729|NCT01124864|593512916|FG002|Overall Study|Protocol Violation|0|||
164310730|NCT01124864|593512917|FG003|Overall Study|Protocol Violation|0|||
164310731|NCT01124864|593512918|FG004|Overall Study|Protocol Violation|1|||
164310732|NCT01124864|593512919|FG005|Overall Study|Protocol Violation|0|||
164310733|NCT00798759|593512922|FG000|Overall Study|Adverse Event|3|||
164310734|NCT00798759|593512923|FG001|Overall Study|Adverse Event|3|||
164310735|NCT00798759|593512922|FG000|Overall Study|Lost to Follow-up|1|||
164310736|NCT00798759|593512923|FG001|Overall Study|Lost to Follow-up|1|||
164310737|NCT00798759|593512922|FG000|Overall Study|Protocol Violation|4|||
164310738|NCT00798759|593512923|FG001|Overall Study|Protocol Violation|8|||
164310739|NCT00798759|593512922|FG000|Overall Study|Other|0|||
164310740|NCT00798759|593512923|FG001|Overall Study|Other|1|||
164310741|NCT00724711|593512924|FG000|Overall Study|Adverse Event|7|||
164310742|NCT00724711|593512925|FG001|Overall Study|Adverse Event|3|||
164310743|NCT00724711|593512924|FG000|Overall Study|Pregnancy|0|||
164310744|NCT00724711|593512925|FG001|Overall Study|Pregnancy|1|||
164310745|NCT00724711|593512924|FG000|Overall Study|Lack of Efficacy|0|||
164310746|NCT00724711|593512925|FG001|Overall Study|Lack of Efficacy|1|||
164310747|NCT00724711|593512924|FG000|Overall Study|Physician Decision|0|||
164310748|NCT00724711|593512925|FG001|Overall Study|Physician Decision|3|||
163865972|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
163865973|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
163865974|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
163865975|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
163865976|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
163865977|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
163865978|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
163865979|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
163865980|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
163865981|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
163865982|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
163865983|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
163865984|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
163865985|NCT01087762|591875966|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
163865986|NCT01087762|591875967|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
163865987|NCT01087762|591875968|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
163865988|NCT01087762|591875969|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
163865989|NCT01087762|591875970|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
163865990|NCT01405924|591875973|FG000|Overall Study|Protocol Violation|8|||
163865991|NCT01405924|591875973|FG000|Overall Study|Missing/Incomplete Data|2|||
163865992|NCT02393716|591875974|FG000|Overall Study|Death|29|||
163865993|NCT02393716|591875974|FG000|Overall Study|Withdrawal by Subject|8|||
163865994|NCT02393716|591875974|FG000|Overall Study|Device Explanted|8|||
163865995|NCT02393716|591875974|FG000|Overall Study|Missed visit|16|||
163865996|NCT01924767|591875975|FG000|Overall Study|Adverse Event|1|||
163865997|NCT01924767|591875976|FG001|Overall Study|Adverse Event|0|||
163865998|NCT01924767|591875977|FG002|Overall Study|Adverse Event|1|||
163865999|NCT01924767|591875978|FG003|Overall Study|Adverse Event|0|||
163866000|NCT01924767|591875979|FG004|Overall Study|Adverse Event|0|||
163866001|NCT01648140|591875980|FG000|Overall Study|Physician Decision|1|||
163866002|NCT01648140|591875981|FG001|Overall Study|Physician Decision|0|||
163866003|NCT01648140|591875982|FG002|Overall Study|Physician Decision|0|||
163866004|NCT01648140|591875983|FG003|Overall Study|Physician Decision|0|||
163866005|NCT01648140|591875980|FG000|Overall Study|Lack of Efficacy|4|||
164310749|NCT00724711|593512924|FG000|Overall Study|Withdrawal by Subject|5|||
164310750|NCT00724711|593512925|FG001|Overall Study|Withdrawal by Subject|4|||
164310751|NCT00724711|593512924|FG000|Overall Study|Lost to Follow-up|4|||
164310752|NCT00724711|593512925|FG001|Overall Study|Lost to Follow-up|5|||
163866006|NCT01648140|591875981|FG001|Overall Study|Lack of Efficacy|7|||
164310753|NCT00724711|593512924|FG000|Overall Study|Protocol Violation|1|||
164310754|NCT00724711|593512925|FG001|Overall Study|Protocol Violation|0|||
163970885|NCT00139776|592266180|FG000|Period III|Other|0|||
163970886|NCT00139776|592266181|FG001|Period III|Other|0|||
163970887|NCT00139776|592266182|FG002|Period III|Other|23|||
163970888|NCT00139776|592266183|FG003|Period III|Other|34|||
163970889|NCT00139776|592266180|FG000|Period III|Lack of Efficacy|0|||
163970890|NCT00139776|592266181|FG001|Period III|Lack of Efficacy|0|||
163970891|NCT00139776|592266182|FG002|Period III|Lack of Efficacy|10|||
163970892|NCT00139776|592266183|FG003|Period III|Lack of Efficacy|24|||
163970893|NCT00139776|592266180|FG000|Period III|Lost to Follow-up|0|||
163970894|NCT00139776|592266181|FG001|Period III|Lost to Follow-up|0|||
163970895|NCT00139776|592266182|FG002|Period III|Lost to Follow-up|5|||
163970896|NCT00139776|592266183|FG003|Period III|Lost to Follow-up|4|||
163970897|NCT00139776|592266180|FG000|Period III|Withdrawal by Subject|0|||
163970898|NCT00139776|592266181|FG001|Period III|Withdrawal by Subject|0|||
163970899|NCT00139776|592266182|FG002|Period III|Withdrawal by Subject|16|||
163970900|NCT00139776|592266183|FG003|Period III|Withdrawal by Subject|21|||
163970901|NCT00187096|592266184|FG000|Overall Study|unacceptable toxicity|0|||
163970902|NCT00187096|592266185|FG001|Overall Study|unacceptable toxicity|0|||
163970903|NCT00187096|592266186|FG002|Overall Study|unacceptable toxicity|1|||
163970904|NCT01911442|592266191|FG000|Overall Study|Adverse Event|2|||
163970905|NCT01911442|592266192|FG001|Overall Study|Adverse Event|2|||
163970906|NCT01911442|592266193|FG002|Overall Study|Adverse Event|4|||
163970907|NCT01911442|592266191|FG000|Overall Study|Lack of Efficacy|1|||
163970908|NCT01911442|592266192|FG001|Overall Study|Lack of Efficacy|1|||
163970909|NCT01911442|592266193|FG002|Overall Study|Lack of Efficacy|1|||
163970910|NCT01911442|592266191|FG000|Overall Study|Lost to Follow-up|2|||
163970911|NCT01911442|592266192|FG001|Overall Study|Lost to Follow-up|0|||
163970912|NCT01911442|592266193|FG002|Overall Study|Lost to Follow-up|1|||
163970913|NCT01911442|592266191|FG000|Overall Study|Withdrawal by Subject|1|||
163970914|NCT01911442|592266192|FG001|Overall Study|Withdrawal by Subject|0|||
163970915|NCT01911442|592266193|FG002|Overall Study|Withdrawal by Subject|6|||
163970916|NCT01911442|592266191|FG000|Overall Study|Mother's Work Schedule|0|||
163970917|NCT01911442|592266192|FG001|Overall Study|Mother's Work Schedule|1|||
163970918|NCT01911442|592266193|FG002|Overall Study|Mother's Work Schedule|0|||
163970919|NCT00922480|592266201|FG000|Main Study|Protocol Violation|3|||
163970920|NCT00922480|592266202|FG001|Main Study|Protocol Violation|6|||
163970921|NCT00922480|592266201|FG000|Main Study|Adverse Event|6|||
163970922|NCT00922480|592266202|FG001|Main Study|Adverse Event|7|||
163970923|NCT00922480|592266201|FG000|Main Study|Lack of Efficacy|3|||
163970924|NCT00922480|592266202|FG001|Main Study|Lack of Efficacy|0|||
163970925|NCT00922480|592266201|FG000|Main Study|Withdrawal by Subject|20|||
163970926|NCT00922480|592266202|FG001|Main Study|Withdrawal by Subject|15|||
163970927|NCT00922480|592266201|FG000|Main Study|Lost to Follow-up|5|||
163970928|NCT00922480|592266202|FG001|Main Study|Lost to Follow-up|0|||
163970929|NCT00922480|592266201|FG000|Main Study|Physician Decision|0|||
163970930|NCT00922480|592266202|FG001|Main Study|Physician Decision|1|||
163970931|NCT00922480|592266201|FG000|Extension Study|Protocol Violation|3|||
163970932|NCT00922480|592266202|FG001|Extension Study|Protocol Violation|0|||
163970933|NCT00922480|592266201|FG000|Extension Study|Adverse Event|1|||
163970934|NCT00922480|592266202|FG001|Extension Study|Adverse Event|1|||
163970935|NCT00922480|592266201|FG000|Extension Study|Withdrawal by Subject|1|||
163970936|NCT00922480|592266202|FG001|Extension Study|Withdrawal by Subject|1|||
163970937|NCT00922480|592266201|FG000|Extension Study|Others|0|||
163970938|NCT00922480|592266202|FG001|Extension Study|Others|1|||
163970939|NCT00971178|592266209|FG000|Overall Study|Lost to Follow-up|2|||
163970940|NCT00971178|592266210|FG001|Overall Study|Lost to Follow-up|2|||
163970941|NCT00971178|592266211|FG002|Overall Study|Lost to Follow-up|2|||
163970942|NCT02161575|592266212|FG000|Overall Study|Protocol Violation|8|||
163970943|NCT02161575|592266212|FG000|Overall Study|Lack of Efficacy|1|||
163970944|NCT02161575|592266212|FG000|Overall Study|Adverse Event|2|||
163970945|NCT00714285|592266213|FG000|Overall Study|Lost to Follow-up|0|||
163970946|NCT00714285|592266214|FG001|Overall Study|Lost to Follow-up|2|||
163970947|NCT00714285|592266215|FG002|Overall Study|Lost to Follow-up|0|||
163970948|NCT00714285|592266216|FG003|Overall Study|Lost to Follow-up|1|||
163970949|NCT00714285|592266213|FG000|Overall Study|Migrated/moved from study area|0|||
163970950|NCT00714285|592266214|FG001|Overall Study|Migrated/moved from study area|1|||
163970951|NCT00714285|592266215|FG002|Overall Study|Migrated/moved from study area|0|||
163970952|NCT00714285|592266216|FG003|Overall Study|Migrated/moved from study area|0|||
163970953|NCT01970488|592266217|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
163970954|NCT01970488|592266218|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
163970955|NCT01970488|592266219|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163970956|NCT01970488|592266220|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163970957|NCT01970488|592266221|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
163970958|NCT01970488|592266217|FG000|Part 1: Through Week 16|Protocol Violation|1|||
163970959|NCT01970488|592266218|FG001|Part 1: Through Week 16|Protocol Violation|2|||
163970960|NCT01970488|592266219|FG002|Part 1: Through Week 16|Protocol Violation|0|||
163970961|NCT01970488|592266220|FG003|Part 1: Through Week 16|Protocol Violation|0|||
163970962|NCT01970488|592266221|FG004|Part 1: Through Week 16|Protocol Violation|0|||
163970963|NCT01970488|592266217|FG000|Part 1: Through Week 16|Adverse Event|6|||
163970964|NCT01970488|592266218|FG001|Part 1: Through Week 16|Adverse Event|5|||
163970965|NCT01970488|592266219|FG002|Part 1: Through Week 16|Adverse Event|0|||
163970966|NCT01970488|592266220|FG003|Part 1: Through Week 16|Adverse Event|0|||
163970967|NCT01970488|592266221|FG004|Part 1: Through Week 16|Adverse Event|0|||
163970968|NCT01970488|592266217|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
163970969|NCT01970488|592266218|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
163970970|NCT01970488|592266219|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
163970971|NCT01970488|592266220|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
163970972|NCT01970488|592266221|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
163970973|NCT01970488|592266217|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
163970974|NCT01970488|592266218|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
163970975|NCT01970488|592266219|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
163970976|NCT01970488|592266220|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
163970977|NCT01970488|592266221|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
163970978|NCT01970488|592266217|FG000|Part 2: Post Week 16|Physician Decision|0|||
163970979|NCT01970488|592266218|FG001|Part 2: Post Week 16|Physician Decision|0|||
163970980|NCT01970488|592266219|FG002|Part 2: Post Week 16|Physician Decision|0|||
163970981|NCT01970488|592266220|FG003|Part 2: Post Week 16|Physician Decision|0|||
163970982|NCT01970488|592266221|FG004|Part 2: Post Week 16|Physician Decision|1|||
163970983|NCT01970488|592266217|FG000|Part 2: Post Week 16|Non-compliance|0|||
163970984|NCT01970488|592266218|FG001|Part 2: Post Week 16|Non-compliance|0|||
163970985|NCT01970488|592266219|FG002|Part 2: Post Week 16|Non-compliance|1|||
163970986|NCT01970488|592266220|FG003|Part 2: Post Week 16|Non-compliance|0|||
163970987|NCT01970488|592266221|FG004|Part 2: Post Week 16|Non-compliance|0|||
163970988|NCT01970488|592266217|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
163970989|NCT01970488|592266218|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
163970990|NCT01970488|592266219|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
163970991|NCT01970488|592266220|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
163970992|NCT01970488|592266221|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
163970993|NCT01970488|592266217|FG000|Part 2: Post Week 16|Adverse Event|0|||
163970994|NCT01970488|592266218|FG001|Part 2: Post Week 16|Adverse Event|0|||
163970995|NCT01970488|592266219|FG002|Part 2: Post Week 16|Adverse Event|5|||
163970996|NCT01970488|592266220|FG003|Part 2: Post Week 16|Adverse Event|1|||
163970997|NCT01970488|592266221|FG004|Part 2: Post Week 16|Adverse Event|1|||
163970998|NCT01970488|592266217|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
163970999|NCT01970488|592266218|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
163971000|NCT01970488|592266219|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
163971001|NCT01970488|592266220|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
163971002|NCT01970488|592266221|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
163971003|NCT01970488|592266217|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
163971004|NCT01970488|592266218|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
163971005|NCT01970488|592266219|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
164201852|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201853|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201854|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201855|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
164201856|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201857|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201858|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201859|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
164201860|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201861|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201862|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
164201863|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201864|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201865|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201866|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
164201867|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201868|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201869|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
164201870|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163971006|NCT01970488|592266220|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
163971007|NCT01970488|592266221|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
163971008|NCT05525689|592266222|FG000|Overall Study|Lost to Follow-up|1|||
163971009|NCT05525689|592266223|FG001|Overall Study|Lost to Follow-up|0|||
163971010|NCT01231659|592266224|FG000|Overall Study|Adverse Event|9|||
163971011|NCT01231659|592266224|FG000|Overall Study|Disease Progression|48|||
163971012|NCT01231659|592266224|FG000|Overall Study|Death|2|||
163971013|NCT01231659|592266224|FG000|Overall Study|Patient refused to complete study visit|1|||
163971014|NCT01231659|592266224|FG000|Overall Study|Other protocol defined criteria|12|||
164310755|NCT03387111|593512926|FG000|Overall Study|Progressive Disease|3|||
164310756|NCT03387111|593512926|FG000|Overall Study|Other|1|||
164310757|NCT01239992|593512927|FG000|Overall Study|Withdrawal by Subject|2|||
164310758|NCT00535288|593512928|FG000|Overall Study|Adverse Event|20|||
164310759|NCT00535288|593512929|FG001|Overall Study|Adverse Event|19|||
164310760|NCT00535288|593512930|FG002|Overall Study|Adverse Event|25|||
163866007|NCT01648140|591875982|FG002|Overall Study|Lack of Efficacy|1|||
163866008|NCT01648140|591875983|FG003|Overall Study|Lack of Efficacy|0|||
163866009|NCT01648140|591875980|FG000|Overall Study|Adverse Event|3|||
163866010|NCT01648140|591875981|FG001|Overall Study|Adverse Event|1|||
163866011|NCT01648140|591875982|FG002|Overall Study|Adverse Event|2|||
163866012|NCT01648140|591875983|FG003|Overall Study|Adverse Event|0|||
163866013|NCT01648140|591875980|FG000|Overall Study|Withdrawal by Subject|2|||
163866014|NCT01648140|591875981|FG001|Overall Study|Withdrawal by Subject|3|||
163866015|NCT01648140|591875982|FG002|Overall Study|Withdrawal by Subject|3|||
163866016|NCT01648140|591875983|FG003|Overall Study|Withdrawal by Subject|2|||
163866017|NCT01648140|591875980|FG000|Overall Study|Lost to Follow-up|2|||
163866018|NCT01648140|591875981|FG001|Overall Study|Lost to Follow-up|1|||
163866019|NCT01648140|591875982|FG002|Overall Study|Lost to Follow-up|2|||
163866020|NCT01648140|591875983|FG003|Overall Study|Lost to Follow-up|0|||
163866021|NCT01565928|591875984|FG000|Overall Study|Adverse Event|3|||
163866022|NCT01565928|591875984|FG000|Overall Study|Other|3|||
163866023|NCT01565928|591875984|FG000|Overall Study|Progressive Disease|13|||
163866024|NCT01565928|591875984|FG000|Overall Study|Withdrawal by Subject|1|||
163866025|NCT01565928|591875984|FG000|Overall Study|Death|2|||
163866026|NCT03621761|591875987|FG000|Overall Study|Lost to Follow-up|1|||
163866027|NCT03621761|591875988|FG001|Overall Study|Lost to Follow-up|1|||
163866028|NCT03621761|591875989|FG002|Overall Study|Lost to Follow-up|2|||
163866029|NCT03621761|591875987|FG000|Overall Study|Withdrawal by Subject|2|||
163866030|NCT03621761|591875988|FG001|Overall Study|Withdrawal by Subject|1|||
163866031|NCT03621761|591875989|FG002|Overall Study|Withdrawal by Subject|1|||
163866032|NCT03621761|591875987|FG000|Overall Study|Became Ineligible|0|||
163866033|NCT03621761|591875988|FG001|Overall Study|Became Ineligible|2|||
163866034|NCT03621761|591875989|FG002|Overall Study|Became Ineligible|0|||
163866035|NCT01191788|591875994|FG000|Overall Study|Lost to Follow-up|21|||
163866036|NCT01191788|591875995|FG001|Overall Study|Lost to Follow-up|22|||
163866037|NCT02441036|591876000|FG000|Overall Study|No tissue resected|0|||
163866038|NCT02441036|591876001|FG001|Overall Study|No tissue resected|1|||
163866039|NCT02441036|591876002|FG002|Overall Study|No tissue resected|0|||
163866040|NCT02441036|591876003|FG003|Overall Study|No tissue resected|1|||
163866041|NCT02441036|591876004|FG004|Overall Study|No tissue resected|0|||
163866042|NCT01183780|591876005|FG000|Overall Study|Withdrawal by Subject|25|||
163866043|NCT01183780|591876006|FG001|Overall Study|Withdrawal by Subject|14|||
163866044|NCT01183780|591876005|FG000|Overall Study|Lost to Follow-up|6|||
163866045|NCT01183780|591876006|FG001|Overall Study|Lost to Follow-up|11|||
163866046|NCT00079183|591876009|FG000|Overall Study|Withdrawal by Subject|4|||
163866047|NCT00079183|591876009|FG000|Overall Study|Study medication non-compliance|2|||
163866048|NCT00079183|591876009|FG000|Overall Study|Specimen collection non-compliance|1|||
163866049|NCT00762606|591876010|FG000|Overall Study|Lost to Follow-up|18|||
163866050|NCT00762606|591876011|FG001|Overall Study|Lost to Follow-up|13|||
163866051|NCT01505881|591876012|FG000|Overall Study|Adverse Event|0|||
163866052|NCT01505881|591876013|FG001|Overall Study|Adverse Event|1|||
163866053|NCT01505881|591876012|FG000|Overall Study|Lost to Follow-up|2|||
163866054|NCT01505881|591876013|FG001|Overall Study|Lost to Follow-up|0|||
163866055|NCT01505881|591876012|FG000|Overall Study|Withdrawal by Subject|2|||
163866056|NCT01505881|591876013|FG001|Overall Study|Withdrawal by Subject|0|||
163866057|NCT01147341|591876014|FG000|Double Blind Period|Lack of Efficacy|1|||
163866058|NCT01147341|591876015|FG001|Double Blind Period|Lack of Efficacy|1|||
163866059|NCT01147341|591876014|FG000|Double Blind Period|Withdrawal by Subject|0|||
163866060|NCT01147341|591876015|FG001|Double Blind Period|Withdrawal by Subject|1|||
163866061|NCT01147341|591876014|FG000|Open Label Period|Lack of Efficacy|3|||
163866062|NCT01147341|591876015|FG001|Open Label Period|Lack of Efficacy|0|||
163866063|NCT01147341|591876014|FG000|Open Label Period|Subject moved|1|||
163866064|NCT01147341|591876015|FG001|Open Label Period|Subject moved|0|||
163866065|NCT01596504|591876016|FG000|Overall Study|Participant's Private Reason|0|||
163866066|NCT01596504|591876017|FG001|Overall Study|Participant's Private Reason|1|||
163866067|NCT01596504|591876018|FG002|Overall Study|Participant's Private Reason|0|||
163866068|NCT01596504|591876016|FG000|Overall Study|Adverse Event|1|||
163866069|NCT01596504|591876017|FG001|Overall Study|Adverse Event|2|||
163866070|NCT01596504|591876018|FG002|Overall Study|Adverse Event|1|||
163866071|NCT01596504|591876016|FG000|Overall Study|Withdrawal by Subject|1|||
163866072|NCT01596504|591876017|FG001|Overall Study|Withdrawal by Subject|0|||
164310761|NCT00535288|593512931|FG003|Overall Study|Adverse Event|20|||
164310762|NCT00535288|593512932|FG004|Overall Study|Adverse Event|30|||
163866073|NCT01596504|591876018|FG002|Overall Study|Withdrawal by Subject|0|||
164310763|NCT00535288|593512928|FG000|Overall Study|Lost to Follow-up|0|||
163866074|NCT02314117|591876019|FG000|Overall Study|Lost to Follow-up|9|||
163866075|NCT02314117|591876020|FG001|Overall Study|Lost to Follow-up|14|||
164310764|NCT00535288|593512929|FG001|Overall Study|Lost to Follow-up|3|||
163866076|NCT02314117|591876019|FG000|Overall Study|Withdrawal by Subject|3|||
163866077|NCT02314117|591876020|FG001|Overall Study|Withdrawal by Subject|2|||
163866078|NCT00909363|591876024|FG000|Overall Study|Withdrawal by Subject|1|||
163866079|NCT00909363|591876025|FG001|Overall Study|Withdrawal by Subject|0|||
163866080|NCT00909363|591876026|FG002|Overall Study|Withdrawal by Subject|0|||
163866081|NCT00909363|591876024|FG000|Overall Study|Lack of Efficacy|1|||
163866082|NCT00909363|591876025|FG001|Overall Study|Lack of Efficacy|0|||
163866083|NCT00909363|591876026|FG002|Overall Study|Lack of Efficacy|0|||
163866084|NCT05641311|591876027|FG000|Dosing Period 1|Adverse Event|1|||
163866085|NCT05641311|591876028|FG001|Dosing Period 1|Adverse Event|0|||
163866086|NCT00922207|591876031|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
163866087|NCT00922207|591876032|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
163866088|NCT00922207|591876033|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
163866089|NCT00922207|591876031|FG000|Overall Study|Insufficient Therapeutic Response|0|||
163866090|NCT00922207|591876032|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163866091|NCT00922207|591876033|FG002|Overall Study|Insufficient Therapeutic Response|1|||
163866092|NCT00922207|591876031|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
163866093|NCT00922207|591876032|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
163866094|NCT00922207|591876033|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
163866095|NCT00922207|591876031|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
163866096|NCT00922207|591876032|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
163866097|NCT00922207|591876033|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
163866098|NCT00922207|591876031|FG000|Overall Study|Withdrew Consent|2|||
163866099|NCT00922207|591876032|FG001|Overall Study|Withdrew Consent|5|||
163866100|NCT00922207|591876033|FG002|Overall Study|Withdrew Consent|2|||
163866101|NCT00922207|591876031|FG000|Overall Study|Abnormality of Laboratory Test|0|||
163866102|NCT00922207|591876032|FG001|Overall Study|Abnormality of Laboratory Test|1|||
163866103|NCT00922207|591876033|FG002|Overall Study|Abnormality of Laboratory Test|1|||
163866104|NCT00367991|591876038|FG000|Overall Study|Withdrawal by Subject|1|||
163866105|NCT00367991|591876039|FG001|Overall Study|Withdrawal by Subject|1|||
163866106|NCT00367991|591876038|FG000|Overall Study|Adverse Event|1|||
163866107|NCT00367991|591876039|FG001|Overall Study|Adverse Event|1|||
163866108|NCT02705586|591876044|FG000|Overall Study|Health Issues|2|||
163866109|NCT02705586|591876044|FG000|Overall Study|Transportation Difficulties|5|||
163866110|NCT02705586|591876044|FG000|Overall Study|Vacation/Planned Absence|1|||
163866111|NCT02808338|591876045|FG000|Screening|Screen Failure|10|||
163866112|NCT02808338|591876045|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
163866113|NCT02808338|591876045|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
163866114|NCT01227707|591876047|FG000|Overall Study|Adverse Event|10|||
163866115|NCT01227707|591876047|FG000|Overall Study|Progression of disease|3|||
163866116|NCT01227707|591876047|FG000|Overall Study|Withdrawal by Subject|1|||
163866117|NCT01227707|591876047|FG000|Overall Study|Patient non-compliance|3|||
163866118|NCT01227707|591876047|FG000|Overall Study|Medical decision|6|||
163866119|NCT01227707|591876047|FG000|Overall Study|Death|1|||
163866120|NCT03210402|591876048|FG000|Overall Study|Withdrawal by Subject|0|||
163866121|NCT03210402|591876049|FG001|Overall Study|Withdrawal by Subject|1|||
163866122|NCT00811057|591876050|FG000|Overall Study|Protocol Violation|5|||
163866123|NCT00811057|591876051|FG001|Overall Study|Protocol Violation|10|||
163866124|NCT00811057|591876052|FG002|Overall Study|Protocol Violation|10|||
163866125|NCT00430300|591876054|FG000|Overall Study|Adverse Event|0|||
163866126|NCT00430300|591876055|FG001|Overall Study|Adverse Event|2|||
163866127|NCT00430300|591876056|FG002|Overall Study|Adverse Event|1|||
163866128|NCT00430300|591876057|FG003|Overall Study|Adverse Event|1|||
163866129|NCT00430300|591876054|FG000|Overall Study|Withdrawal by Subject|1|||
163866130|NCT00430300|591876055|FG001|Overall Study|Withdrawal by Subject|0|||
163866131|NCT00430300|591876056|FG002|Overall Study|Withdrawal by Subject|5|||
163866132|NCT00430300|591876057|FG003|Overall Study|Withdrawal by Subject|0|||
163866133|NCT00430300|591876054|FG000|Overall Study|Laboratory abnormality|1|||
163866134|NCT00430300|591876055|FG001|Overall Study|Laboratory abnormality|0|||
163866135|NCT00430300|591876056|FG002|Overall Study|Laboratory abnormality|0|||
163866136|NCT00430300|591876057|FG003|Overall Study|Laboratory abnormality|0|||
163866137|NCT00430300|591876054|FG000|Overall Study|Other|0|||
163866138|NCT00430300|591876055|FG001|Overall Study|Other|0|||
163866139|NCT00430300|591876056|FG002|Overall Study|Other|0|||
163866140|NCT00430300|591876057|FG003|Overall Study|Other|1|||
163866141|NCT02041104|591876060|FG000|Overall Study|Lost to Follow-up|1|||
163866142|NCT02041104|591876061|FG001|Overall Study|Lost to Follow-up|4|||
163866143|NCT02041104|591876060|FG000|Overall Study|discomfort during OGTT|0|||
163866144|NCT02041104|591876061|FG001|Overall Study|discomfort during OGTT|3|||
163866145|NCT05328297|591878022|FG000|Overall Study|Adverse Event|5|||
163866146|NCT05328297|591878023|FG001|Overall Study|Adverse Event|7|||
163866147|NCT05328297|591878022|FG000|Overall Study|Withdrawal by Subject|4|||
163866148|NCT05328297|591878023|FG001|Overall Study|Withdrawal by Subject|3|||
163866149|NCT05328297|591878022|FG000|Overall Study|Lack of Efficacy|1|||
163866150|NCT05328297|591878023|FG001|Overall Study|Lack of Efficacy|0|||
163866151|NCT05328297|591878022|FG000|Overall Study|Lost to Follow-up|1|||
163971015|NCT01075412|592266225|FG000|Overall Study|Withdrawal by Subject|0|||
163971016|NCT01075412|592266226|FG001|Overall Study|Withdrawal by Subject|1|||
163971017|NCT00509067|592266227|FG000|Overall Study|Lost to Follow-up|1|||
163971018|NCT00509067|592266228|FG001|Overall Study|Lost to Follow-up|1|||
163971019|NCT00509067|592266227|FG000|Overall Study|Adverse Event|3|||
163971020|NCT00509067|592266228|FG001|Overall Study|Adverse Event|1|||
163971021|NCT00509067|592266227|FG000|Overall Study|Protocol Violation|0|||
163971022|NCT00509067|592266228|FG001|Overall Study|Protocol Violation|3|||
163971023|NCT03716050|592266229|FG000|Overall Study|Lost to Follow-up|0|||
163971024|NCT03716050|592266230|FG001|Overall Study|Lost to Follow-up|0|||
163971025|NCT03716050|592266231|FG002|Overall Study|Lost to Follow-up|1|||
163971026|NCT03716050|592266232|FG003|Overall Study|Lost to Follow-up|0|||
163971027|NCT03716050|592266233|FG004|Overall Study|Lost to Follow-up|0|||
163971028|NCT03716050|592266234|FG005|Overall Study|Lost to Follow-up|0|||
163971029|NCT03716050|592266235|FG006|Overall Study|Lost to Follow-up|0|||
163971030|NCT03716050|592266236|FG007|Overall Study|Lost to Follow-up|0|||
163971031|NCT03716050|592266229|FG000|Overall Study|Physician Decision|0|||
163971032|NCT03716050|592266230|FG001|Overall Study|Physician Decision|0|||
163971033|NCT03716050|592266231|FG002|Overall Study|Physician Decision|0|||
163971034|NCT03716050|592266232|FG003|Overall Study|Physician Decision|1|||
163971035|NCT03716050|592266233|FG004|Overall Study|Physician Decision|0|||
163971036|NCT03716050|592266234|FG005|Overall Study|Physician Decision|0|||
163971037|NCT03716050|592266235|FG006|Overall Study|Physician Decision|0|||
163971038|NCT03716050|592266236|FG007|Overall Study|Physician Decision|0|||
163971039|NCT03716050|592266229|FG000|Overall Study|Protocol Violation|0|||
163971040|NCT03716050|592266230|FG001|Overall Study|Protocol Violation|0|||
163971041|NCT03716050|592266231|FG002|Overall Study|Protocol Violation|0|||
163971042|NCT03716050|592266232|FG003|Overall Study|Protocol Violation|1|||
163971043|NCT03716050|592266233|FG004|Overall Study|Protocol Violation|0|||
163971044|NCT03716050|592266234|FG005|Overall Study|Protocol Violation|0|||
163971045|NCT03716050|592266235|FG006|Overall Study|Protocol Violation|0|||
163971046|NCT03716050|592266236|FG007|Overall Study|Protocol Violation|2|||
163971047|NCT01092143|592266239|FG000|Overall Study|Adverse Event|10|||
163971048|NCT01092143|592266240|FG001|Overall Study|Adverse Event|5|||
163971049|NCT01092143|592266241|FG002|Overall Study|Adverse Event|1|||
163971050|NCT01092143|592266242|FG003|Overall Study|Adverse Event|4|||
163971051|NCT01092143|592266243|FG004|Overall Study|Adverse Event|3|||
163971052|NCT01092143|592266239|FG000|Overall Study|Lost to Follow-up|1|||
163971053|NCT01092143|592266240|FG001|Overall Study|Lost to Follow-up|0|||
163971054|NCT01092143|592266241|FG002|Overall Study|Lost to Follow-up|1|||
163971055|NCT01092143|592266242|FG003|Overall Study|Lost to Follow-up|0|||
163971056|NCT01092143|592266243|FG004|Overall Study|Lost to Follow-up|0|||
163971057|NCT01092143|592266239|FG000|Overall Study|Consent withdrawn|2|||
164310765|NCT00535288|593512930|FG002|Overall Study|Lost to Follow-up|0|||
164310766|NCT00535288|593512931|FG003|Overall Study|Lost to Follow-up|0|||
164310767|NCT00535288|593512932|FG004|Overall Study|Lost to Follow-up|0|||
164310768|NCT00535288|593512928|FG000|Overall Study|Lack of Efficacy|26|||
164310769|NCT00535288|593512929|FG001|Overall Study|Lack of Efficacy|3|||
164310770|NCT00535288|593512930|FG002|Overall Study|Lack of Efficacy|4|||
164310771|NCT00535288|593512931|FG003|Overall Study|Lack of Efficacy|4|||
164310772|NCT00535288|593512932|FG004|Overall Study|Lack of Efficacy|7|||
164310773|NCT00535288|593512928|FG000|Overall Study|Unwilling to cooperate|6|||
164310774|NCT00535288|593512929|FG001|Overall Study|Unwilling to cooperate|6|||
164310775|NCT00535288|593512930|FG002|Overall Study|Unwilling to cooperate|3|||
164310776|NCT00535288|593512931|FG003|Overall Study|Unwilling to cooperate|3|||
164310777|NCT00535288|593512932|FG004|Overall Study|Unwilling to cooperate|4|||
164310778|NCT00535288|593512928|FG000|Overall Study|Other|2|||
164310779|NCT00535288|593512929|FG001|Overall Study|Other|1|||
164310780|NCT00535288|593512930|FG002|Overall Study|Other|1|||
164310781|NCT00535288|593512931|FG003|Overall Study|Other|2|||
164310782|NCT00535288|593512932|FG004|Overall Study|Other|1|||
164310783|NCT02810444|593512933|FG000|Overall Study|Screen Failures|14|||
164310784|NCT02810444|593512933|FG000|Overall Study|Withdrawal by Subject|4|||
164310785|NCT02810444|593512933|FG000|Overall Study|Adverse Event|3|||
164310786|NCT03390101|593512934|FG000|Weeks 0-12|Withdrawal by Subject|0|||
164310787|NCT03390101|593512935|FG001|Weeks 0-12|Withdrawal by Subject|1|||
163971058|NCT01092143|592266240|FG001|Overall Study|Consent withdrawn|1|||
163971059|NCT01092143|592266241|FG002|Overall Study|Consent withdrawn|0|||
163971060|NCT01092143|592266242|FG003|Overall Study|Consent withdrawn|1|||
163971061|NCT01092143|592266243|FG004|Overall Study|Consent withdrawn|3|||
163971062|NCT01092143|592266239|FG000|Overall Study|Not treated|0|||
163971063|NCT01092143|592266240|FG001|Overall Study|Not treated|0|||
163971064|NCT01092143|592266241|FG002|Overall Study|Not treated|1|||
164310788|NCT03390101|593512936|FG002|Weeks 0-12|Withdrawal by Subject|1|||
164310789|NCT03390101|593512934|FG000|Weeks 0-12|Lost to Follow-up|0|||
164310790|NCT03390101|593512935|FG001|Weeks 0-12|Lost to Follow-up|1|||
163971065|NCT01092143|592266242|FG003|Overall Study|Not treated|0|||
164310791|NCT03390101|593512936|FG002|Weeks 0-12|Lost to Follow-up|0|||
164310792|NCT03390101|593512934|FG000|Weeks 12-54|Withdrawal by Subject|0|||
163971066|NCT01092143|592266243|FG004|Overall Study|Not treated|0|||
164135326|NCT00851318|592859131|FG002|Overall Study|Lack of Efficacy|4|||
164310793|NCT03390101|593512935|FG001|Weeks 12-54|Withdrawal by Subject|3|||
164310794|NCT03390101|593512936|FG002|Weeks 12-54|Withdrawal by Subject|1|||
164310795|NCT03390101|593512934|FG000|Weeks 12-54|Pregnancy|1|||
164310796|NCT03390101|593512935|FG001|Weeks 12-54|Pregnancy|0|||
164310797|NCT03390101|593512936|FG002|Weeks 12-54|Pregnancy|0|||
163971067|NCT01092143|592266239|FG000|Overall Study|did not reversibility criteria|0|||
163866152|NCT05328297|591878023|FG001|Overall Study|Lost to Follow-up|0|||
163866153|NCT05328297|591878022|FG000|Overall Study|Protocol Violation|1|||
163866154|NCT05328297|591878023|FG001|Overall Study|Protocol Violation|0|||
163866155|NCT05328297|591878022|FG000|Overall Study|Randomized but not treated|1|||
163866156|NCT05328297|591878023|FG001|Overall Study|Randomized but not treated|1|||
163866157|NCT01286272|591878024|FG000|Overall Study|Ineligible after beginning treatment|1|||
163866158|NCT01286272|591878025|FG001|Overall Study|Ineligible after beginning treatment|3|||
163866159|NCT03979365|591878028|FG000|Overall Study|Death|1|||
163866160|NCT03979365|591878029|FG001|Overall Study|Death|3|||
163866161|NCT03979365|591878028|FG000|Overall Study|Withdrawal by Subject|0|||
163866162|NCT03979365|591878029|FG001|Overall Study|Withdrawal by Subject|1|||
163866163|NCT03979365|591878028|FG000|Overall Study|Drug Conversion|0|||
163866164|NCT03979365|591878029|FG001|Overall Study|Drug Conversion|3|||
163866165|NCT04496960|591878030|FG000|Overall Study|Physician Decision|0|||
163866166|NCT04496960|591878031|FG001|Overall Study|Physician Decision|1|||
163866167|NCT04668339|591878034|FG000|Overall Study|Physician Decision|1|||
163866168|NCT04668339|591878035|FG001|Overall Study|Physician Decision|0|||
163866169|NCT04668339|591878036|FG002|Overall Study|Physician Decision|1|||
163866170|NCT04668339|591878037|FG003|Overall Study|Physician Decision|1|||
163866171|NCT04668339|591878034|FG000|Overall Study|Lost to Follow-up|14|||
163866172|NCT04668339|591878035|FG001|Overall Study|Lost to Follow-up|12|||
163866173|NCT04668339|591878036|FG002|Overall Study|Lost to Follow-up|8|||
163866174|NCT04668339|591878037|FG003|Overall Study|Lost to Follow-up|5|||
163866175|NCT04668339|591878034|FG000|Overall Study|Adverse Event|0|||
163866176|NCT04668339|591878035|FG001|Overall Study|Adverse Event|0|||
163866177|NCT04668339|591878036|FG002|Overall Study|Adverse Event|1|||
163866178|NCT04668339|591878037|FG003|Overall Study|Adverse Event|0|||
163866179|NCT04668339|591878034|FG000|Overall Study|Other than specified|3|||
163866180|NCT04668339|591878035|FG001|Overall Study|Other than specified|0|||
163866181|NCT04668339|591878036|FG002|Overall Study|Other than specified|1|||
163866182|NCT04668339|591878037|FG003|Overall Study|Other than specified|0|||
163866183|NCT04668339|591878034|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
163866184|NCT04668339|591878035|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
163866185|NCT04668339|591878036|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
163866186|NCT04668339|591878037|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
163866187|NCT04668339|591878034|FG000|Overall Study|Vaccine not Administered|0|||
163866188|NCT04668339|591878035|FG001|Overall Study|Vaccine not Administered|0|||
163866189|NCT04668339|591878036|FG002|Overall Study|Vaccine not Administered|1|||
163866190|NCT04668339|591878037|FG003|Overall Study|Vaccine not Administered|0|||
163866191|NCT04668339|591878034|FG000|Overall Study|Protocol Violation|18|||
163866192|NCT04668339|591878035|FG001|Overall Study|Protocol Violation|23|||
163866193|NCT04668339|591878036|FG002|Overall Study|Protocol Violation|12|||
163866194|NCT04668339|591878037|FG003|Overall Study|Protocol Violation|20|||
163866195|NCT04668339|591878034|FG000|Overall Study|Withdrawal by Subject|45|||
163866196|NCT04668339|591878035|FG001|Overall Study|Withdrawal by Subject|46|||
163866197|NCT04668339|591878036|FG002|Overall Study|Withdrawal by Subject|46|||
163866198|NCT04668339|591878037|FG003|Overall Study|Withdrawal by Subject|27|||
163866199|NCT04668339|591878034|FG000|Overall Study|Study Terminated by Sponsor|59|||
163866200|NCT04668339|591878035|FG001|Overall Study|Study Terminated by Sponsor|59|||
163866201|NCT04668339|591878036|FG002|Overall Study|Study Terminated by Sponsor|71|||
163866202|NCT04668339|591878037|FG003|Overall Study|Study Terminated by Sponsor|1|||
163866203|NCT03253848|591878041|FG000|Overall Study|Adverse Event|7|||
163866204|NCT03253848|591878041|FG000|Overall Study|Death|5|||
163866205|NCT03253848|591878041|FG000|Overall Study|initiation of other treatments|3|||
163866206|NCT03253848|591878041|FG000|Overall Study|Other complicating disease|1|||
163866207|NCT03253848|591878041|FG000|Overall Study|Withdrawal by Subject|1|||
163866208|NCT03253848|591878041|FG000|Overall Study|Declining health|1|||
163866209|NCT05758415|591878043|FG000|Overall Study|Subject Decision|2|||
163866210|NCT05758415|591878044|FG001|Overall Study|Subject Decision|5|||
163866211|NCT05758415|591878043|FG000|Overall Study|Lost to Follow-up|0|||
163866212|NCT05758415|591878044|FG001|Overall Study|Lost to Follow-up|1|||
163866213|NCT03622593|591878045|FG000|Overall Study|Withdrawal by Subject|11|||
163866214|NCT03622593|591878046|FG001|Overall Study|Withdrawal by Subject|9|||
163866215|NCT03622593|591878047|FG002|Overall Study|Withdrawal by Subject|13|||
163866216|NCT03622593|591878045|FG000|Overall Study|Death|12|||
163866217|NCT03622593|591878046|FG001|Overall Study|Death|9|||
163866218|NCT03622593|591878047|FG002|Overall Study|Death|10|||
163866219|NCT03622593|591878045|FG000|Overall Study|Lost to Follow-up|11|||
163866220|NCT03622593|591878046|FG001|Overall Study|Lost to Follow-up|5|||
163866221|NCT03622593|591878047|FG002|Overall Study|Lost to Follow-up|8|||
163866222|NCT03622593|591878045|FG000|Overall Study|Adverse Event|4|||
164310798|NCT03390101|593512934|FG000|Weeks 12-54|Adverse Event|2|||
163866223|NCT03622593|591878046|FG001|Overall Study|Adverse Event|5|||
163866224|NCT03622593|591878047|FG002|Overall Study|Adverse Event|6|||
163866225|NCT03622593|591878045|FG000|Overall Study|Physician Decision|2|||
163866226|NCT03622593|591878046|FG001|Overall Study|Physician Decision|1|||
163866227|NCT03622593|591878047|FG002|Overall Study|Physician Decision|6|||
163866228|NCT03622593|591878045|FG000|Overall Study|Other|2|||
163866229|NCT03622593|591878046|FG001|Overall Study|Other|2|||
163866230|NCT03622593|591878047|FG002|Overall Study|Other|3|||
163866231|NCT03622593|591878045|FG000|Overall Study|Protocol Violation|0|||
163866232|NCT03622593|591878046|FG001|Overall Study|Protocol Violation|0|||
163866233|NCT03622593|591878047|FG002|Overall Study|Protocol Violation|1|||
163866234|NCT03622593|591878045|FG000|Overall Study|Pregnancy|0|||
163866235|NCT03622593|591878046|FG001|Overall Study|Pregnancy|0|||
163866236|NCT03622593|591878047|FG002|Overall Study|Pregnancy|1|||
163866237|NCT01393119|591878050|FG000|Overall Study|Adverse Event|1|||
163866238|NCT01393119|591878051|FG001|Overall Study|Adverse Event|1|||
163866239|NCT01393119|591878052|FG002|Overall Study|Adverse Event|0|||
163866240|NCT01393119|591878053|FG003|Overall Study|Adverse Event|1|||
163866241|NCT01393119|591878050|FG000|Overall Study|Withdrawal by Subject|0|||
163866242|NCT01393119|591878051|FG001|Overall Study|Withdrawal by Subject|1|||
163866243|NCT01393119|591878052|FG002|Overall Study|Withdrawal by Subject|1|||
163866244|NCT01393119|591878053|FG003|Overall Study|Withdrawal by Subject|0|||
163866245|NCT01393119|591878050|FG000|Overall Study|Lack of Efficacy|1|||
163866246|NCT01393119|591878051|FG001|Overall Study|Lack of Efficacy|0|||
163866247|NCT01393119|591878052|FG002|Overall Study|Lack of Efficacy|2|||
163866248|NCT01393119|591878053|FG003|Overall Study|Lack of Efficacy|1|||
163866249|NCT01393119|591878050|FG000|Overall Study|Protocol Violation|0|||
163866250|NCT01393119|591878051|FG001|Overall Study|Protocol Violation|0|||
163866251|NCT01393119|591878052|FG002|Overall Study|Protocol Violation|1|||
163866252|NCT01393119|591878053|FG003|Overall Study|Protocol Violation|0|||
163866253|NCT01393119|591878050|FG000|Overall Study|Death|0|||
163866254|NCT01393119|591878051|FG001|Overall Study|Death|0|||
163866255|NCT01393119|591878052|FG002|Overall Study|Death|0|||
163866256|NCT01393119|591878053|FG003|Overall Study|Death|1|||
163866257|NCT01393119|591878050|FG000|Overall Study|Randomized but Not treated|1|||
163866258|NCT01393119|591878051|FG001|Overall Study|Randomized but Not treated|0|||
163866259|NCT01393119|591878052|FG002|Overall Study|Randomized but Not treated|1|||
163866260|NCT01393119|591878053|FG003|Overall Study|Randomized but Not treated|1|||
163866261|NCT01393119|591878050|FG000|Overall Study|Sponsor Termination of Study|11|||
163866262|NCT01393119|591878051|FG001|Overall Study|Sponsor Termination of Study|12|||
163866263|NCT01393119|591878052|FG002|Overall Study|Sponsor Termination of Study|9|||
163866264|NCT01393119|591878053|FG003|Overall Study|Sponsor Termination of Study|12|||
163866265|NCT04860258|591878054|FG000|Overall Study|Withdrawal by Subject|0|||
163866266|NCT04860258|591878055|FG001|Overall Study|Withdrawal by Subject|0|||
163866267|NCT04860258|591878056|FG002|Overall Study|Withdrawal by Subject|4|||
163866268|NCT04860258|591878057|FG003|Overall Study|Withdrawal by Subject|1|||
163866269|NCT04860258|591878058|FG004|Overall Study|Withdrawal by Subject|4|||
163866270|NCT04860258|591878059|FG005|Overall Study|Withdrawal by Subject|1|||
163866271|NCT04860258|591878060|FG006|Overall Study|Withdrawal by Subject|0|||
163866272|NCT01266265|591878061|FG000|Overall Study|Death|95|||
163866273|NCT01266265|591878062|FG001|Overall Study|Death|73|||
163866274|NCT01266265|591878061|FG000|Overall Study|Lost to Follow-up|23|||
163866275|NCT01266265|591878062|FG001|Overall Study|Lost to Follow-up|28|||
163866276|NCT01266265|591878061|FG000|Overall Study|Withdrawal by Subject|13|||
163866277|NCT01266265|591878062|FG001|Overall Study|Withdrawal by Subject|11|||
163866278|NCT01266265|591878061|FG000|Overall Study|Respiratory-related adverse event|2|||
163866279|NCT01266265|591878062|FG001|Overall Study|Respiratory-related adverse event|1|||
163866280|NCT01266265|591878061|FG000|Overall Study|Transferred care to another provider|22|||
163866281|NCT01266265|591878062|FG001|Overall Study|Transferred care to another provider|28|||
163866282|NCT01266265|591878061|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
163866283|NCT01266265|591878062|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
163866284|NCT01266265|591878061|FG000|Overall Study|Enrolled in another clinical study|15|||
164201871|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
163866285|NCT01266265|591878062|FG001|Overall Study|Enrolled in another clinical study|26|||
163866286|NCT01266265|591878061|FG000|Overall Study|Non-compliance|8|||
163866287|NCT01266265|591878062|FG001|Overall Study|Non-compliance|5|||
163866288|NCT01266265|591878061|FG000|Overall Study|Lung transplant|6|||
163866289|NCT01266265|591878062|FG001|Overall Study|Lung transplant|5|||
163866290|NCT01266265|591878061|FG000|Overall Study|Site closed early|4|||
163866291|NCT01266265|591878062|FG001|Overall Study|Site closed early|3|||
163866292|NCT01266265|591878061|FG000|Overall Study|Clinical worsening|1|||
163866293|NCT01266265|591878062|FG001|Overall Study|Clinical worsening|1|||
163866294|NCT01580293|591878063|FG000|Part A_Main Trial|Adverse Event|0|||
163866295|NCT01580293|591878064|FG001|Part A_Main Trial|Adverse Event|2|||
163971068|NCT01092143|592266240|FG001|Overall Study|did not reversibility criteria|0|||
163866296|NCT01580293|591878065|FG002|Part A_Main Trial|Adverse Event|0|||
163866297|NCT01580293|591878063|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
163866298|NCT01580293|591878064|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
164310799|NCT03390101|593512935|FG001|Weeks 12-54|Adverse Event|1|||
164310800|NCT03390101|593512936|FG002|Weeks 12-54|Adverse Event|1|||
164310801|NCT00545272|593512938|FG000|Overall Study|Protocol deviation|0|||
164310802|NCT00545272|593512939|FG001|Overall Study|Protocol deviation|1|||
164310803|NCT00545272|593512940|FG002|Overall Study|Protocol deviation|0|||
164310804|NCT00545272|593512941|FG003|Overall Study|Protocol deviation|1|||
164310805|NCT00545272|593512942|FG004|Overall Study|Protocol deviation|0|||
163866299|NCT01580293|591878065|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
163866300|NCT01580293|591878063|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
163866301|NCT01580293|591878064|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
163866302|NCT01580293|591878065|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
163866303|NCT01580293|591878063|FG000|Part A_Extension|Adverse Event|0|||
163866304|NCT01580293|591878064|FG001|Part A_Extension|Adverse Event|2|||
163866305|NCT01580293|591878065|FG002|Part A_Extension|Adverse Event|0|||
163866306|NCT01580293|591878063|FG000|Part A_Extension|Withdrawal by Subject|0|||
163866307|NCT01580293|591878064|FG001|Part A_Extension|Withdrawal by Subject|3|||
163866308|NCT01580293|591878065|FG002|Part A_Extension|Withdrawal by Subject|0|||
163866309|NCT01580293|591878063|FG000|Part A_Extension|Lost to Follow-up|0|||
163866310|NCT01580293|591878064|FG001|Part A_Extension|Lost to Follow-up|1|||
163866311|NCT01580293|591878065|FG002|Part A_Extension|Lost to Follow-up|0|||
163866312|NCT01580293|591878063|FG000|Part A_Extension|Other Reason|0|||
163866313|NCT01580293|591878064|FG001|Part A_Extension|Other Reason|1|||
163866314|NCT01580293|591878065|FG002|Part A_Extension|Other Reason|0|||
163866315|NCT01580293|591878063|FG000|Part A_Extension|Completed Japan only|0|||
163866316|NCT01580293|591878064|FG001|Part A_Extension|Completed Japan only|5|||
163866317|NCT01580293|591878065|FG002|Part A_Extension|Completed Japan only|0|||
163866318|NCT01580293|591878063|FG000|Part B|Withdrawal by Subject|0|||
163866319|NCT01580293|591878064|FG001|Part B|Withdrawal by Subject|0|||
163866320|NCT01580293|591878065|FG002|Part B|Withdrawal by Subject|1|||
163866321|NCT01580293|591878063|FG000|Part B|Other reason|0|||
163866322|NCT01580293|591878064|FG001|Part B|Other reason|0|||
163866323|NCT01580293|591878065|FG002|Part B|Other reason|1|||
163866324|NCT01134562|591878066|FG000|Overall Study|Adverse Event|0|||
163866325|NCT01134562|591878067|FG001|Overall Study|Adverse Event|1|||
163866326|NCT01134562|591878068|FG002|Overall Study|Adverse Event|0|||
163866327|NCT01134562|591878069|FG003|Overall Study|Adverse Event|0|||
163866328|NCT01134562|591878070|FG004|Overall Study|Adverse Event|0|||
163866329|NCT01499134|591878073|FG000|Overall Study|Withdrawal by Subject|0|||
163866330|NCT01499134|591878074|FG001|Overall Study|Withdrawal by Subject|1|||
163866331|NCT00941655|591878075|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
163866332|NCT00941655|591878076|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
163866333|NCT00941655|591878075|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
163866334|NCT00941655|591878076|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
163866335|NCT00941655|591878075|FG000|Overall Study|progressed while on chemo|0|||
163866336|NCT00941655|591878076|FG001|Overall Study|progressed while on chemo|2|||
163866337|NCT00941655|591878075|FG000|Overall Study|refused further treatment|0|||
163866338|NCT00941655|591878076|FG001|Overall Study|refused further treatment|1|||
163866339|NCT00941655|591878075|FG000|Overall Study|withdrew consent|0|||
163866340|NCT00941655|591878076|FG001|Overall Study|withdrew consent|1|||
163866341|NCT00941655|591878075|FG000|Overall Study|non-compliant|0|||
163866342|NCT00941655|591878076|FG001|Overall Study|non-compliant|1|||
163866343|NCT05855655|591878081|FG000|Overall Study|Withdrawal by Subject|0|||
163866344|NCT05855655|591878082|FG001|Overall Study|Withdrawal by Subject|1|||
163866345|NCT05855655|591878081|FG000|Overall Study|Lost to Follow-up|4|||
163866346|NCT05855655|591878082|FG001|Overall Study|Lost to Follow-up|0|||
163866347|NCT01613716|591878083|FG000|Overall Study|screen failures|3|||
163866348|NCT01613716|591878083|FG000|Overall Study|Lost to Follow-up|4|||
163866349|NCT01426269|591878084|FG000|Period 1: 12 Weeks|Adverse Event|5|||
163866350|NCT01426269|591878085|FG001|Period 1: 12 Weeks|Adverse Event|0|||
163866351|NCT01426269|591878086|FG002|Period 1: 12 Weeks|Adverse Event|0|||
163866352|NCT01426269|591878084|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
163866353|NCT01426269|591878085|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
163866354|NCT01426269|591878086|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
163866355|NCT01426269|591878084|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
163866356|NCT01426269|591878085|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
163866357|NCT01426269|591878086|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
163866358|NCT01426269|591878084|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
163866359|NCT01426269|591878085|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
163866360|NCT01426269|591878086|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
163866361|NCT01426269|591878084|FG000|Period 1: 12 Weeks|Pregnancy|1|||
163866362|NCT01426269|591878085|FG001|Period 1: 12 Weeks|Pregnancy|0|||
163866363|NCT01426269|591878086|FG002|Period 1: 12 Weeks|Pregnancy|0|||
163866364|NCT01426269|591878084|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
163866365|NCT01426269|591878085|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
163866366|NCT01426269|591878086|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
164135327|NCT00851318|592859132|FG003|Overall Study|Lack of Efficacy|2|||
164310806|NCT00545272|593512943|FG005|Overall Study|Protocol deviation|1|||
163971069|NCT01092143|592266241|FG002|Overall Study|did not reversibility criteria|1|||
163971070|NCT01092143|592266242|FG003|Overall Study|did not reversibility criteria|0|||
163971071|NCT01092143|592266243|FG004|Overall Study|did not reversibility criteria|0|||
163971072|NCT01092143|592266239|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
163971073|NCT01092143|592266240|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
163971074|NCT01092143|592266241|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
163971075|NCT01092143|592266242|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
163971076|NCT01092143|592266243|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
163971077|NCT01092143|592266239|FG000|Overall Study|Ineligible patient|1|||
163971078|NCT01092143|592266240|FG001|Overall Study|Ineligible patient|0|||
163971079|NCT01092143|592266241|FG002|Overall Study|Ineligible patient|0|||
163971080|NCT01092143|592266242|FG003|Overall Study|Ineligible patient|0|||
163971081|NCT01092143|592266243|FG004|Overall Study|Ineligible patient|0|||
163866367|NCT01426269|591878084|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
163866368|NCT01426269|591878085|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
163866369|NCT01426269|591878086|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
163866370|NCT01426269|591878084|FG000|Period 2: 40 Weeks|Adverse Event|0|||
163866371|NCT01426269|591878085|FG001|Period 2: 40 Weeks|Adverse Event|1|||
163866372|NCT01426269|591878086|FG002|Period 2: 40 Weeks|Adverse Event|2|||
163866373|NCT01426269|591878084|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
163866374|NCT01426269|591878085|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
163866375|NCT01426269|591878086|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
163866376|NCT01426269|591878084|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
163866377|NCT01426269|591878085|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
163866378|NCT01426269|591878086|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
163866379|NCT01426269|591878084|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
163866380|NCT01426269|591878085|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
163866381|NCT01426269|591878086|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
163866382|NCT01426269|591878084|FG000|Period 2: 40 Weeks|Site closed|0|||
163866383|NCT01426269|591878085|FG001|Period 2: 40 Weeks|Site closed|6|||
163866384|NCT01426269|591878086|FG002|Period 2: 40 Weeks|Site closed|5|||
163866385|NCT01426269|591878084|FG000|Period 2: 40 Weeks|Relapsed|0|||
163866386|NCT01426269|591878085|FG001|Period 2: 40 Weeks|Relapsed|9|||
163866387|NCT01426269|591878086|FG002|Period 2: 40 Weeks|Relapsed|18|||
163866388|NCT00419094|591878090|FG000|Overall Study|Adverse Event|3|||
163866389|NCT00419094|591878091|FG001|Overall Study|Adverse Event|7|||
163866390|NCT00419094|591878090|FG000|Overall Study|Lack of Efficacy|1|||
163866391|NCT00419094|591878091|FG001|Overall Study|Lack of Efficacy|0|||
163866392|NCT00419094|591878090|FG000|Overall Study|Lost to Follow-up|0|||
163866393|NCT00419094|591878091|FG001|Overall Study|Lost to Follow-up|2|||
163866394|NCT00419094|591878090|FG000|Overall Study|Protocol Violation|1|||
163866395|NCT00419094|591878091|FG001|Overall Study|Protocol Violation|14|||
163866396|NCT00419094|591878090|FG000|Overall Study|Withdrawal of consent|1|||
163866397|NCT00419094|591878091|FG001|Overall Study|Withdrawal of consent|5|||
163866398|NCT00419094|591878090|FG000|Overall Study|Other: Error determining exit criteria|1|||
163866399|NCT00419094|591878091|FG001|Overall Study|Other: Error determining exit criteria|0|||
163866400|NCT00419094|591878090|FG000|Overall Study|Other: Patient non-compliant|0|||
163866401|NCT00419094|591878091|FG001|Overall Study|Other: Patient non-compliant|1|||
163866402|NCT00419094|591878090|FG000|Overall Study|Other: No contact for extended period|0|||
163866403|NCT00419094|591878091|FG001|Overall Study|Other: No contact for extended period|1|||
163866404|NCT02296424|591878092|FG000|Part 1|New therapy for study indication|0|||
163866405|NCT02296424|591878093|FG001|Part 1|New therapy for study indication|1|||
163866406|NCT02296424|591878094|FG002|Part 1|New therapy for study indication|0|||
163866407|NCT02296424|591878095|FG003|Part 1|New therapy for study indication|0|||
163866408|NCT02296424|591878092|FG000|Part 1|Protocol Violation|0|||
163866409|NCT02296424|591878093|FG001|Part 1|Protocol Violation|1|||
163866410|NCT02296424|591878094|FG002|Part 1|Protocol Violation|0|||
163866411|NCT02296424|591878095|FG003|Part 1|Protocol Violation|0|||
163866412|NCT02296424|591878092|FG000|Part 1|Withdrawal by Subject|0|||
163866413|NCT02296424|591878093|FG001|Part 1|Withdrawal by Subject|2|||
163866414|NCT02296424|591878094|FG002|Part 1|Withdrawal by Subject|0|||
163866415|NCT02296424|591878095|FG003|Part 1|Withdrawal by Subject|0|||
163866416|NCT02296424|591878092|FG000|Part 1|Study terminated by sponsor|0|||
163866417|NCT02296424|591878093|FG001|Part 1|Study terminated by sponsor|1|||
163866418|NCT02296424|591878094|FG002|Part 1|Study terminated by sponsor|0|||
163866419|NCT02296424|591878095|FG003|Part 1|Study terminated by sponsor|0|||
163866420|NCT02296424|591878092|FG000|Part 1|Adverse Event|2|||
163866421|NCT02296424|591878093|FG001|Part 1|Adverse Event|11|||
163866422|NCT02296424|591878094|FG002|Part 1|Adverse Event|0|||
163866423|NCT02296424|591878095|FG003|Part 1|Adverse Event|0|||
163866424|NCT02296424|591878092|FG000|Part 1|Lack of Efficacy|5|||
163971082|NCT01092143|592266239|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
163971083|NCT01092143|592266240|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
163971084|NCT01092143|592266241|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
163866425|NCT02296424|591878093|FG001|Part 1|Lack of Efficacy|17|||
163866426|NCT02296424|591878094|FG002|Part 1|Lack of Efficacy|0|||
163866427|NCT02296424|591878095|FG003|Part 1|Lack of Efficacy|0|||
164310807|NCT00545272|593512938|FG000|Overall Study|Adverse Event|0|||
164310808|NCT00545272|593512939|FG001|Overall Study|Adverse Event|0|||
164310809|NCT00545272|593512940|FG002|Overall Study|Adverse Event|1|||
164310810|NCT00545272|593512941|FG003|Overall Study|Adverse Event|0|||
163866428|NCT02296424|591878092|FG000|Part 1|16 directly started part II|16|||
163866429|NCT02296424|591878093|FG001|Part 1|16 directly started part II|0|||
163866430|NCT02296424|591878094|FG002|Part 1|16 directly started part II|0|||
163866431|NCT02296424|591878095|FG003|Part 1|16 directly started part II|0|||
163866432|NCT02296424|591878092|FG000|Part 2|Lack of Efficacy|0|||
163866433|NCT02296424|591878093|FG001|Part 2|Lack of Efficacy|0|||
163866434|NCT02296424|591878094|FG002|Part 2|Lack of Efficacy|1|||
163866435|NCT02296424|591878095|FG003|Part 2|Lack of Efficacy|0|||
163866436|NCT02296424|591878092|FG000|Part 2|Adverse Event|0|||
163866437|NCT02296424|591878093|FG001|Part 2|Adverse Event|0|||
163866438|NCT02296424|591878094|FG002|Part 2|Adverse Event|1|||
163866439|NCT02296424|591878095|FG003|Part 2|Adverse Event|0|||
163866440|NCT02296424|591878092|FG000|Part 2|Lost to Follow-up|0|||
163866441|NCT02296424|591878093|FG001|Part 2|Lost to Follow-up|0|||
163866442|NCT02296424|591878094|FG002|Part 2|Lost to Follow-up|1|||
163866443|NCT02296424|591878095|FG003|Part 2|Lost to Follow-up|0|||
163866444|NCT00743444|591878096|FG000|First Intervention|Catheter placement problems|0|||
163866445|NCT00743444|591878097|FG001|First Intervention|Catheter placement problems|1|||
163866446|NCT00743444|591878096|FG000|Washout Period|Adverse Event|0|||
163866447|NCT00743444|591878097|FG001|Washout Period|Adverse Event|1|||
163866448|NCT01337635|591878106|FG000|Overall Study|Lost to Follow-up|0|||
163866449|NCT01337635|591878107|FG001|Overall Study|Lost to Follow-up|1|||
163866450|NCT03287622|591878110|FG000|Overall Study|Withdrawal by Subject|1|||
163866451|NCT03287622|591878111|FG001|Overall Study|Withdrawal by Subject|0|||
163866452|NCT03287622|591878110|FG000|Overall Study|Lost to Follow-up|27|||
163866453|NCT03287622|591878111|FG001|Overall Study|Lost to Follow-up|15|||
163866454|NCT03287622|591878110|FG000|Overall Study|No prescripion after surgery|28|||
163866455|NCT03287622|591878111|FG001|Overall Study|No prescripion after surgery|31|||
163866456|NCT03287622|591878110|FG000|Overall Study|prolonged Length of stay|2|||
163866457|NCT03287622|591878111|FG001|Overall Study|prolonged Length of stay|0|||
163866458|NCT03287622|591878110|FG000|Overall Study|surgery related|0|||
163866459|NCT03287622|591878111|FG001|Overall Study|surgery related|2|||
163866460|NCT03804918|591878120|FG000|Overall Study|Participant did not use the app|1|||
163866461|NCT03192046|591878123|FG000|Overall Study|Withdrawal by Subject|1|||
163866462|NCT03192046|591878124|FG001|Overall Study|Withdrawal by Subject|1|||
163866463|NCT01194154|591878127|FG000|Overall Study|Adverse Event|12|||
163866464|NCT01194154|591878128|FG001|Overall Study|Adverse Event|7|||
163866465|NCT01194154|591878127|FG000|Overall Study|Lost to Follow-up|2|||
163866466|NCT01194154|591878128|FG001|Overall Study|Lost to Follow-up|3|||
163866467|NCT01194154|591878127|FG000|Overall Study|Protocol Violation|0|||
163866468|NCT01194154|591878128|FG001|Overall Study|Protocol Violation|1|||
163866469|NCT01194154|591878127|FG000|Overall Study|Withdrawal by Subject|5|||
163866470|NCT01194154|591878128|FG001|Overall Study|Withdrawal by Subject|6|||
163866471|NCT01194154|591878127|FG000|Overall Study|Blood pressure increase|5|||
163866472|NCT01194154|591878128|FG001|Overall Study|Blood pressure increase|3|||
163866473|NCT01194154|591878127|FG000|Overall Study|Hemoglobin decrease|0|||
163866474|NCT01194154|591878128|FG001|Overall Study|Hemoglobin decrease|1|||
163866475|NCT01194154|591878127|FG000|Overall Study|Hemoglobin increase|12|||
163866476|NCT01194154|591878128|FG001|Overall Study|Hemoglobin increase|3|||
163866477|NCT01194154|591878127|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
163866478|NCT01194154|591878128|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
163866479|NCT01194154|591878127|FG000|Overall Study|Treatment with prohibited medication|4|||
163866480|NCT01194154|591878128|FG001|Overall Study|Treatment with prohibited medication|5|||
163866481|NCT01194154|591878127|FG000|Overall Study|Other|4|||
163866482|NCT01194154|591878128|FG001|Overall Study|Other|0|||
163866483|NCT01194154|591878127|FG000|Overall Study|Did not receive study medication|2|||
163866484|NCT01194154|591878128|FG001|Overall Study|Did not receive study medication|4|||
163866485|NCT00842257|591878129|FG000|Overall Study|Adverse Event|1|||
163866486|NCT01901276|591878130|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
163866487|NCT01901276|591878131|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
163866488|NCT03515304|591878136|FG000|Overall Study|Lost to Follow-up|0|||
163866489|NCT03515304|591878137|FG001|Overall Study|Lost to Follow-up|3|||
163866490|NCT02045836|591878145|FG000|Overall Study|Adverse Event|4|||
163866491|NCT02045836|591878146|FG001|Overall Study|Adverse Event|4|||
164310811|NCT00545272|593512942|FG004|Overall Study|Adverse Event|0|||
163866492|NCT02045836|591878145|FG000|Overall Study|Withdrawal by Subject|1|||
163866493|NCT02045836|591878146|FG001|Overall Study|Withdrawal by Subject|1|||
163866494|NCT02045836|591878145|FG000|Overall Study|Lost to Follow-up|4|||
163866495|NCT02045836|591878146|FG001|Overall Study|Lost to Follow-up|7|||
163866496|NCT02045836|591878145|FG000|Overall Study|Migrated from study area|0|||
163866497|NCT02045836|591878146|FG001|Overall Study|Migrated from study area|2|||
163866498|NCT00057837|591878147|FG000|Overall Study|Progression/relapse|12|||
163866499|NCT00057837|591878148|FG001|Overall Study|Progression/relapse|14|||
163866500|NCT00057837|591878147|FG000|Overall Study|Adverse Event|2|||
164310812|NCT00545272|593512943|FG005|Overall Study|Adverse Event|1|||
164310813|NCT00545272|593512938|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164310814|NCT00545272|593512939|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164310815|NCT00545272|593512940|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164310816|NCT00545272|593512941|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164310817|NCT00545272|593512942|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164310818|NCT00545272|593512943|FG005|Overall Study|Abnormal laboratory value(s)|1|||
164310819|NCT00545272|593512938|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164310820|NCT00545272|593512939|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164310821|NCT00545272|593512940|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164310822|NCT00545272|593512941|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164310823|NCT00545272|593512942|FG004|Overall Study|Abnormal test procedure result(s)|1|||
164310824|NCT00545272|593512943|FG005|Overall Study|Abnormal test procedure result(s)|0|||
164310825|NCT00545272|593512938|FG000|Overall Study|Lost to Follow-up|0|||
164310826|NCT00545272|593512939|FG001|Overall Study|Lost to Follow-up|0|||
164310827|NCT00545272|593512940|FG002|Overall Study|Lost to Follow-up|0|||
164310828|NCT00545272|593512941|FG003|Overall Study|Lost to Follow-up|0|||
164310829|NCT00545272|593512942|FG004|Overall Study|Lost to Follow-up|1|||
164310830|NCT00545272|593512943|FG005|Overall Study|Lost to Follow-up|0|||
163866501|NCT00057837|591878148|FG001|Overall Study|Adverse Event|12|||
163866502|NCT00057837|591878147|FG000|Overall Study|Death|5|||
163866503|NCT00057837|591878148|FG001|Overall Study|Death|4|||
163866504|NCT00057837|591878147|FG000|Overall Study|Withdrawal by Subject|5|||
163866505|NCT00057837|591878148|FG001|Overall Study|Withdrawal by Subject|3|||
163866506|NCT00057837|591878147|FG000|Overall Study|Alternative therapy|0|||
163866507|NCT00057837|591878148|FG001|Overall Study|Alternative therapy|1|||
163866508|NCT00057837|591878147|FG000|Overall Study|Other complicating disease|2|||
163866509|NCT00057837|591878148|FG001|Overall Study|Other complicating disease|1|||
163866510|NCT00057837|591878147|FG000|Overall Study|Physician Decision|1|||
163866511|NCT00057837|591878148|FG001|Overall Study|Physician Decision|0|||
163866512|NCT00057837|591878147|FG000|Overall Study|Ineligible|3|||
163866513|NCT00057837|591878148|FG001|Overall Study|Ineligible|3|||
163866514|NCT00057837|591878147|FG000|Overall Study|Never started treatment|1|||
163866515|NCT00057837|591878148|FG001|Overall Study|Never started treatment|1|||
163866516|NCT02000817|591878149|FG000|Overall Study|Withdrawal by Subject|2|||
163866517|NCT02000817|591878150|FG001|Overall Study|Withdrawal by Subject|0|||
163866518|NCT02000817|591878151|FG002|Overall Study|Withdrawal by Subject|0|||
163866519|NCT02000817|591878152|FG003|Overall Study|Withdrawal by Subject|0|||
163866520|NCT02000817|591878149|FG000|Overall Study|Adverse Event|0|||
163866521|NCT02000817|591878150|FG001|Overall Study|Adverse Event|1|||
163866522|NCT02000817|591878151|FG002|Overall Study|Adverse Event|0|||
163866523|NCT02000817|591878152|FG003|Overall Study|Adverse Event|0|||
163866524|NCT02000817|591878149|FG000|Overall Study|Lost to Follow-up|0|||
163866525|NCT02000817|591878150|FG001|Overall Study|Lost to Follow-up|0|||
163866526|NCT02000817|591878151|FG002|Overall Study|Lost to Follow-up|1|||
163866527|NCT02000817|591878152|FG003|Overall Study|Lost to Follow-up|0|||
163866528|NCT03383146|591878153|FG000|Overall Study|Screen Failure|1|||
163866529|NCT03383146|591878154|FG001|Overall Study|Screen Failure|0|||
163866530|NCT03383146|591878153|FG000|Overall Study|Adverse Event|6|||
163866531|NCT03383146|591878154|FG001|Overall Study|Adverse Event|18|||
163866532|NCT03383146|591878153|FG000|Overall Study|Lack of Efficacy|0|||
163866533|NCT03383146|591878154|FG001|Overall Study|Lack of Efficacy|3|||
163866534|NCT03383146|591878153|FG000|Overall Study|Withdrawal by Subject|20|||
163866535|NCT03383146|591878154|FG001|Overall Study|Withdrawal by Subject|36|||
163866536|NCT03383146|591878153|FG000|Overall Study|Lost to Follow-up|5|||
163866537|NCT03383146|591878154|FG001|Overall Study|Lost to Follow-up|15|||
163866538|NCT03383146|591878153|FG000|Overall Study|Death|0|||
163866539|NCT03383146|591878154|FG001|Overall Study|Death|2|||
163866540|NCT03383146|591878153|FG000|Overall Study|Physician Decision|0|||
163866541|NCT03383146|591878154|FG001|Overall Study|Physician Decision|1|||
163866542|NCT03383146|591878153|FG000|Overall Study|Protocol Deviation|1|||
163866543|NCT03383146|591878154|FG001|Overall Study|Protocol Deviation|8|||
163866544|NCT03383146|591878153|FG000|Overall Study|Study Terminated by the Sponsor|48|||
163866545|NCT03383146|591878154|FG001|Overall Study|Study Terminated by the Sponsor|95|||
163866546|NCT03383146|591878153|FG000|Overall Study|Reason not Specified|4|||
163866547|NCT03383146|591878154|FG001|Overall Study|Reason not Specified|6|||
164310831|NCT02934503|593512944|FG000|Overall Study|progression of disease|3|||
164310832|NCT02934503|593512944|FG000|Overall Study|Withdrawal by Subject|1|||
163866548|NCT01317420|591878155|FG000|Overall Study|Progressive disease according to RECIST|2|||
163866549|NCT01317420|591878156|FG001|Overall Study|Progressive disease according to RECIST|3|||
163866550|NCT01317420|591878157|FG002|Overall Study|Progressive disease according to RECIST|3|||
163866551|NCT01317420|591878158|FG003|Overall Study|Progressive disease according to RECIST|3|||
163866552|NCT01317420|591878159|FG004|Overall Study|Progressive disease according to RECIST|3|||
163866553|NCT01317420|591878160|FG005|Overall Study|Progressive disease according to RECIST|3|||
163866554|NCT01317420|591878161|FG006|Overall Study|Progressive disease according to RECIST|3|||
163866555|NCT01317420|591878162|FG007|Overall Study|Progressive disease according to RECIST|3|||
163866556|NCT01317420|591878163|FG008|Overall Study|Progressive disease according to RECIST|3|||
163866557|NCT01317420|591878164|FG009|Overall Study|Progressive disease according to RECIST|2|||
163866558|NCT01317420|591878165|FG010|Overall Study|Progressive disease according to RECIST|3|||
163866559|NCT01317420|591878166|FG011|Overall Study|Progressive disease according to RECIST|11|||
163866560|NCT01317420|591878167|FG012|Overall Study|Progressive disease according to RECIST|16|||
163866561|NCT01317420|591878155|FG000|Overall Study|Other adverse event|1|||
163866562|NCT01317420|591878156|FG001|Overall Study|Other adverse event|0|||
163866563|NCT01317420|591878157|FG002|Overall Study|Other adverse event|0|||
163866564|NCT01317420|591878158|FG003|Overall Study|Other adverse event|0|||
163866565|NCT01317420|591878159|FG004|Overall Study|Other adverse event|0|||
163866566|NCT01317420|591878160|FG005|Overall Study|Other adverse event|0|||
163866567|NCT01317420|591878161|FG006|Overall Study|Other adverse event|0|||
163866568|NCT01317420|591878162|FG007|Overall Study|Other adverse event|0|||
163866569|NCT01317420|591878163|FG008|Overall Study|Other adverse event|0|||
163866570|NCT01317420|591878164|FG009|Overall Study|Other adverse event|0|||
163866571|NCT01317420|591878165|FG010|Overall Study|Other adverse event|0|||
163866572|NCT01317420|591878166|FG011|Overall Study|Other adverse event|0|||
163866573|NCT01317420|591878167|FG012|Overall Study|Other adverse event|2|||
163866574|NCT01317420|591878155|FG000|Overall Study|Non-compliant with protocol|0|||
163866575|NCT01317420|591878156|FG001|Overall Study|Non-compliant with protocol|0|||
163866576|NCT01317420|591878157|FG002|Overall Study|Non-compliant with protocol|0|||
163866577|NCT01317420|591878158|FG003|Overall Study|Non-compliant with protocol|0|||
163866578|NCT01317420|591878159|FG004|Overall Study|Non-compliant with protocol|0|||
163866579|NCT01317420|591878160|FG005|Overall Study|Non-compliant with protocol|0|||
163866580|NCT01317420|591878161|FG006|Overall Study|Non-compliant with protocol|0|||
163866581|NCT01317420|591878162|FG007|Overall Study|Non-compliant with protocol|0|||
163866582|NCT01317420|591878163|FG008|Overall Study|Non-compliant with protocol|0|||
163866583|NCT01317420|591878164|FG009|Overall Study|Non-compliant with protocol|0|||
163866584|NCT01317420|591878165|FG010|Overall Study|Non-compliant with protocol|0|||
163866585|NCT01317420|591878166|FG011|Overall Study|Non-compliant with protocol|0|||
163866586|NCT01317420|591878167|FG012|Overall Study|Non-compliant with protocol|1|||
163866587|NCT01317420|591878155|FG000|Overall Study|Refused to cont. taking trial medication|0|||
163866588|NCT01317420|591878156|FG001|Overall Study|Refused to cont. taking trial medication|0|||
163866589|NCT01317420|591878157|FG002|Overall Study|Refused to cont. taking trial medication|0|||
163866590|NCT01317420|591878158|FG003|Overall Study|Refused to cont. taking trial medication|0|||
163866591|NCT01317420|591878159|FG004|Overall Study|Refused to cont. taking trial medication|0|||
163866592|NCT01317420|591878160|FG005|Overall Study|Refused to cont. taking trial medication|0|||
163866593|NCT01317420|591878161|FG006|Overall Study|Refused to cont. taking trial medication|0|||
163866594|NCT01317420|591878162|FG007|Overall Study|Refused to cont. taking trial medication|0|||
163866595|NCT01317420|591878163|FG008|Overall Study|Refused to cont. taking trial medication|0|||
163866596|NCT01317420|591878164|FG009|Overall Study|Refused to cont. taking trial medication|0|||
163866597|NCT01317420|591878165|FG010|Overall Study|Refused to cont. taking trial medication|0|||
163866598|NCT01317420|591878166|FG011|Overall Study|Refused to cont. taking trial medication|0|||
163866599|NCT01317420|591878167|FG012|Overall Study|Refused to cont. taking trial medication|1|||
163866600|NCT01317420|591878155|FG000|Overall Study|Reason other than those specified|0|||
163866601|NCT01317420|591878156|FG001|Overall Study|Reason other than those specified|0|||
163866602|NCT01317420|591878157|FG002|Overall Study|Reason other than those specified|0|||
163866603|NCT01317420|591878158|FG003|Overall Study|Reason other than those specified|0|||
163866604|NCT01317420|591878159|FG004|Overall Study|Reason other than those specified|0|||
163866605|NCT01317420|591878160|FG005|Overall Study|Reason other than those specified|0|||
163866606|NCT01317420|591878161|FG006|Overall Study|Reason other than those specified|0|||
163866607|NCT01317420|591878162|FG007|Overall Study|Reason other than those specified|0|||
163866608|NCT01317420|591878163|FG008|Overall Study|Reason other than those specified|0|||
163866609|NCT01317420|591878164|FG009|Overall Study|Reason other than those specified|1|||
163866610|NCT01317420|591878165|FG010|Overall Study|Reason other than those specified|0|||
163866611|NCT01317420|591878166|FG011|Overall Study|Reason other than those specified|0|||
163866612|NCT01317420|591878167|FG012|Overall Study|Reason other than those specified|0|||
163866613|NCT05686421|591878168|FG000|Overall Study|Screen failure|22|||
163866614|NCT05686421|591878169|FG001|Overall Study|Screen failure|0|||
163866615|NCT05686421|591878170|FG002|Overall Study|Screen failure|0|||
163866616|NCT05686421|591878171|FG003|Overall Study|Screen failure|0|||
163866617|NCT04210180|591878172|FG000|Overall Study|Withdrawal by Subject|2|||
163866618|NCT00367055|591878173|FG000|Overall Study|Adverse Event|6|||
163866619|NCT00367055|591878174|FG001|Overall Study|Adverse Event|3|||
163866620|NCT00367055|591878173|FG000|Overall Study|Patient's Willing|3|||
163866621|NCT00367055|591878174|FG001|Overall Study|Patient's Willing|2|||
163866622|NCT00367055|591878173|FG000|Overall Study|Lack of Efficacy|1|||
163866623|NCT00367055|591878174|FG001|Overall Study|Lack of Efficacy|2|||
163971085|NCT01092143|592266242|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
163866624|NCT00367055|591878173|FG000|Overall Study|Lost to Follow-up|1|||
163866625|NCT00367055|591878174|FG001|Overall Study|Lost to Follow-up|1|||
163866626|NCT00367055|591878173|FG000|Overall Study|Protocol Violation|0|||
163971086|NCT01092143|592266243|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
163971087|NCT01092143|592266239|FG000|Overall Study|Patient travel|0|||
164310833|NCT00724867|593512945|FG000|Overall Study|Adverse Event|25|||
164310834|NCT00724867|593512945|FG000|Overall Study|Lack of Efficacy|14|||
164310835|NCT00724867|593512945|FG000|Overall Study|Lost to Follow-up|12|||
164310836|NCT00724867|593512945|FG000|Overall Study|Non-compliance with study drug|6|||
164310837|NCT00724867|593512945|FG000|Overall Study|Physician Decision|17|||
164310838|NCT00724867|593512945|FG000|Overall Study|Protocol Violation|1|||
164310839|NCT00724867|593512945|FG000|Overall Study|Withdrawal by Subject|31|||
164310840|NCT00724867|593512945|FG000|Overall Study|Sponsor decision to end study|14|||
164310841|NCT00724867|593512945|FG000|Overall Study|Subject incarcerated|1|||
164310842|NCT00724867|593512945|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
164310843|NCT00724867|593512945|FG000|Overall Study|Subject moved out of state|1|||
164310844|NCT00724867|593512945|FG000|Overall Study|Elected to exit due to site closure|2|||
164310845|NCT00436345|593512946|FG000|Overall Study|ICU resident beyond follow-up period|3|||
164310846|NCT00436345|593512947|FG001|Overall Study|ICU resident beyond follow-up period|0|||
164310847|NCT04027608|593512948|FG000|Overall Study|Withdrawal by Subject|13|||
164310848|NCT04027608|593512949|FG001|Overall Study|Withdrawal by Subject|2|||
164310849|NCT04027608|593512948|FG000|Overall Study|Protocol Violation|2|||
164310850|NCT04027608|593512949|FG001|Overall Study|Protocol Violation|1|||
164310851|NCT04027608|593512948|FG000|Overall Study|Physician Decision|1|||
164310852|NCT04027608|593512949|FG001|Overall Study|Physician Decision|0|||
164310853|NCT04027608|593512948|FG000|Overall Study|Lost to Follow-up|20|||
164310854|NCT04027608|593512949|FG001|Overall Study|Lost to Follow-up|4|||
164310855|NCT04248491|593512953|FG000|Overall Study|Lost to Follow-up|1|||
164310856|NCT04248491|593512954|FG001|Overall Study|Lost to Follow-up|0|||
164310857|NCT04643158|593512964|FG000|Overall Study|Study terminated by sponsor|0|||
164310858|NCT04643158|593512965|FG001|Overall Study|Study terminated by sponsor|0|||
164310859|NCT04643158|593512966|FG002|Overall Study|Study terminated by sponsor|1|||
164310860|NCT04643158|593512967|FG003|Overall Study|Study terminated by sponsor|0|||
164310861|NCT04643158|593512968|FG004|Overall Study|Study terminated by sponsor|0|||
164310862|NCT04643158|593512969|FG005|Overall Study|Study terminated by sponsor|1|||
164310863|NCT04643158|593512970|FG006|Overall Study|Study terminated by sponsor|0|||
164310864|NCT04643158|593512964|FG000|Overall Study|Global/country situation|0|||
164310865|NCT04643158|593512965|FG001|Overall Study|Global/country situation|0|||
164310866|NCT04643158|593512966|FG002|Overall Study|Global/country situation|1|||
164310867|NCT04643158|593512967|FG003|Overall Study|Global/country situation|0|||
164310868|NCT04643158|593512968|FG004|Overall Study|Global/country situation|0|||
164310869|NCT04643158|593512969|FG005|Overall Study|Global/country situation|0|||
164310870|NCT04643158|593512970|FG006|Overall Study|Global/country situation|0|||
164310871|NCT04643158|593512964|FG000|Overall Study|Withdrawal by Subject|0|||
164310872|NCT04643158|593512965|FG001|Overall Study|Withdrawal by Subject|0|||
163866627|NCT00367055|591878174|FG001|Overall Study|Protocol Violation|1|||
163866628|NCT00367055|591878173|FG000|Overall Study|Stopping Criterion Met|0|||
163866629|NCT00367055|591878174|FG001|Overall Study|Stopping Criterion Met|1|||
163866630|NCT00367055|591878173|FG000|Overall Study|Participant Living too Far from Hospital|0|||
163866631|NCT00367055|591878174|FG001|Overall Study|Participant Living too Far from Hospital|1|||
163866632|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
163866633|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
163866634|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
163866635|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
163866636|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
163866637|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
163866638|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
163866639|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
163866640|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
163866641|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163866642|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163866643|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163866644|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
163866645|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
163971088|NCT01092143|592266240|FG001|Overall Study|Patient travel|0|||
164310873|NCT04643158|593512966|FG002|Overall Study|Withdrawal by Subject|0|||
164310874|NCT04643158|593512967|FG003|Overall Study|Withdrawal by Subject|0|||
163866646|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
164310875|NCT04643158|593512968|FG004|Overall Study|Withdrawal by Subject|0|||
164310876|NCT04643158|593512969|FG005|Overall Study|Withdrawal by Subject|1|||
164310877|NCT04643158|593512970|FG006|Overall Study|Withdrawal by Subject|0|||
164310878|NCT04329806|593512971|FG000|Overall Study|Physician Decision|3|||
164310879|NCT04329806|593512972|FG001|Overall Study|Physician Decision|4|||
164310880|NCT00622440|593512985|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
164310881|NCT00622440|593512986|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
164310882|NCT00622440|593512985|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
164310883|NCT00622440|593512986|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
164310884|NCT00622440|593512985|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
163866647|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866648|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866649|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
163866650|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866651|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866652|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866653|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866654|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866655|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866656|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866657|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
163866658|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
163866659|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
163866660|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
163866661|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
163866662|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
163866663|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
163866664|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
163866665|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
163866666|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
163866667|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163866668|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163866669|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163866670|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
163866671|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866672|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
163866673|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
163866674|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866675|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
163866676|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866677|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866678|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866679|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866680|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866681|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866682|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866683|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
163866684|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163866685|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
163866686|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163866687|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163866688|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
163866689|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163866690|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163866691|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163866692|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
163866693|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163866694|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163866695|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
164201872|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201873|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201874|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
164201875|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201876|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
164201877|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201878|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201879|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201880|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201881|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
164201882|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201883|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
164201884|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163866696|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
163866697|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
163866698|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
164201885|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163971089|NCT01092143|592266241|FG002|Overall Study|Patient travel|0|||
163971090|NCT01092143|592266242|FG003|Overall Study|Patient travel|0|||
163971091|NCT01092143|592266243|FG004|Overall Study|Patient travel|1|||
163971092|NCT01092143|592266239|FG000|Overall Study|Non compliance with study medication|0|||
163971093|NCT01092143|592266240|FG001|Overall Study|Non compliance with study medication|0|||
163971094|NCT01092143|592266241|FG002|Overall Study|Non compliance with study medication|0|||
163971095|NCT01092143|592266242|FG003|Overall Study|Non compliance with study medication|0|||
163971096|NCT01092143|592266243|FG004|Overall Study|Non compliance with study medication|1|||
163971097|NCT01092143|592266239|FG000|Overall Study|Randomized by mistake|0|||
163971098|NCT01092143|592266240|FG001|Overall Study|Randomized by mistake|0|||
163971099|NCT01092143|592266241|FG002|Overall Study|Randomized by mistake|0|||
163971100|NCT01092143|592266242|FG003|Overall Study|Randomized by mistake|1|||
163971101|NCT01092143|592266243|FG004|Overall Study|Randomized by mistake|0|||
163971102|NCT01092143|592266239|FG000|Overall Study|Pregnancy|0|||
163971103|NCT01092143|592266240|FG001|Overall Study|Pregnancy|0|||
163971104|NCT01092143|592266241|FG002|Overall Study|Pregnancy|0|||
163971105|NCT01092143|592266242|FG003|Overall Study|Pregnancy|1|||
163971106|NCT01092143|592266243|FG004|Overall Study|Pregnancy|0|||
163971107|NCT03098836|592266247|FG000|Overall Study|Adverse Event|1|||
163971108|NCT03098836|592266248|FG001|Overall Study|Adverse Event|3|||
163971109|NCT03098836|592266247|FG000|Overall Study|Lack of Efficacy|30|||
163971110|NCT03098836|592266248|FG001|Overall Study|Lack of Efficacy|15|||
163971111|NCT03098836|592266247|FG000|Overall Study|Physician Decision|2|||
163971112|NCT03098836|592266248|FG001|Overall Study|Physician Decision|1|||
163971113|NCT03098836|592266247|FG000|Overall Study|Withdrawal by Subject|3|||
163971114|NCT03098836|592266248|FG001|Overall Study|Withdrawal by Subject|2|||
163971115|NCT03986866|592266249|FG000|Overall Study|Withdrawal by Subject|0|||
163971116|NCT03986866|592266250|FG001|Overall Study|Withdrawal by Subject|3|||
163971117|NCT03986866|592266249|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
163971118|NCT03986866|592266250|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
163971119|NCT01660451|592266253|FG000|Overall Study|Protocol Violation|0|||
163971120|NCT01660451|592266254|FG001|Overall Study|Protocol Violation|1|||
163971121|NCT01660451|592266255|FG002|Overall Study|Protocol Violation|1|||
163971122|NCT01660451|592266253|FG000|Overall Study|AE not associated with clinical disease progression|13|||
163971123|NCT01660451|592266254|FG001|Overall Study|AE not associated with clinical disease progression|10|||
163971124|NCT01660451|592266255|FG002|Overall Study|AE not associated with clinical disease progression|40|||
163971125|NCT01660451|592266253|FG000|Overall Study|AE associated with clinical disease progression|1|||
163971126|NCT01660451|592266254|FG001|Overall Study|AE associated with clinical disease progression|3|||
163971127|NCT01660451|592266255|FG002|Overall Study|AE associated with clinical disease progression|11|||
163971128|NCT01660451|592266253|FG000|Overall Study|Sponsor Decision|0|||
163971129|NCT01660451|592266254|FG001|Overall Study|Sponsor Decision|0|||
163971130|NCT01660451|592266255|FG002|Overall Study|Sponsor Decision|1|||
163971131|NCT01660451|592266253|FG000|Overall Study|Protocol Deviation|0|||
163971132|NCT01660451|592266254|FG001|Overall Study|Protocol Deviation|0|||
163971133|NCT01660451|592266255|FG002|Overall Study|Protocol Deviation|1|||
163971134|NCT01660451|592266253|FG000|Overall Study|Physician Decision|1|||
163971135|NCT01660451|592266254|FG001|Overall Study|Physician Decision|2|||
163971136|NCT01660451|592266255|FG002|Overall Study|Physician Decision|5|||
163971137|NCT01660451|592266253|FG000|Overall Study|Withdrawal by Subject|1|||
163971138|NCT01660451|592266254|FG001|Overall Study|Withdrawal by Subject|1|||
163971139|NCT01660451|592266255|FG002|Overall Study|Withdrawal by Subject|20|||
163971140|NCT01660451|592266253|FG000|Overall Study|Trial closure.|0|||
163971141|NCT01660451|592266254|FG001|Overall Study|Trial closure.|0|||
163971142|NCT01660451|592266255|FG002|Overall Study|Trial closure.|1|||
163971143|NCT01660451|592266253|FG000|Overall Study|Switching to other therapy|0|||
163971144|NCT01660451|592266254|FG001|Overall Study|Switching to other therapy|1|||
164310885|NCT00622440|593512986|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
164310886|NCT00622440|593512985|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
164310887|NCT00622440|593512986|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
164310888|NCT02474069|593512992|FG000|Selection Phase (SP)|Adverse Event|8|||
164310889|NCT02474069|593512993|FG001|Selection Phase (SP)|Adverse Event|0|||
163971145|NCT01660451|592266255|FG002|Overall Study|Switching to other therapy|1|||
163971146|NCT01660451|592266253|FG000|Overall Study|Progressive disease - clinical progression|4|||
163971147|NCT01660451|592266254|FG001|Overall Study|Progressive disease - clinical progression|10|||
163971148|NCT01660451|592266255|FG002|Overall Study|Progressive disease - clinical progression|9|||
163971149|NCT01660451|592266253|FG000|Overall Study|Progressive disease - radiological progression|12|||
163971150|NCT01660451|592266254|FG001|Overall Study|Progressive disease - radiological progression|23|||
163971151|NCT01660451|592266255|FG002|Overall Study|Progressive disease - radiological progression|50|||
163971152|NCT01660451|592266253|FG000|Overall Study|Death|1|||
163971153|NCT01660451|592266254|FG001|Overall Study|Death|0|||
163971154|NCT01660451|592266255|FG002|Overall Study|Death|1|||
163971155|NCT01660451|592266253|FG000|Overall Study|Other|0|||
163971156|NCT01660451|592266254|FG001|Overall Study|Other|0|||
163971157|NCT01660451|592266255|FG002|Overall Study|Other|1|||
163971158|NCT04688775|592266256|FG000|Placebo-controlled Period|Randomized, not treated|1|||
163971159|NCT04688775|592266257|FG001|Placebo-controlled Period|Randomized, not treated|1|||
164201886|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164201887|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
163866699|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866700|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866701|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866702|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
163866703|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
163866704|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
163866705|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866706|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866707|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866708|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866709|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
163866710|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
163866711|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
163866712|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
163866713|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
163866714|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
163866715|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
163866716|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
163866717|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
163866718|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
163866719|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163866720|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163866721|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163866722|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
163866723|NCT04707313|591878175|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866724|NCT04707313|591878176|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866725|NCT04707313|591878177|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
163866726|NCT04707313|591878178|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866727|NCT04707313|591878179|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866728|NCT04707313|591878180|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866729|NCT04707313|591878181|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866730|NCT04707313|591878182|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
163866731|NCT04707313|591878183|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866732|NCT04707313|591878184|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866733|NCT04707313|591878185|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866734|NCT04707313|591878186|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866735|NCT04707313|591878187|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
163866736|NCT04707313|591878175|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866737|NCT04707313|591878176|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866738|NCT04707313|591878177|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866739|NCT04707313|591878178|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866740|NCT04707313|591878179|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866741|NCT04707313|591878180|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866742|NCT04707313|591878181|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866743|NCT04707313|591878182|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866744|NCT04707313|591878183|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866745|NCT04707313|591878184|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
163866746|NCT04707313|591878185|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
163866747|NCT04707313|591878186|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
163866748|NCT04707313|591878187|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
163866749|NCT04707313|591878175|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866750|NCT04707313|591878176|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866751|NCT04707313|591878177|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866752|NCT04707313|591878178|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866753|NCT04707313|591878179|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866754|NCT04707313|591878180|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866755|NCT04707313|591878181|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866756|NCT04707313|591878182|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866757|NCT04707313|591878183|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866758|NCT04707313|591878184|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
163866759|NCT04707313|591878185|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
163971160|NCT04688775|592266258|FG002|Placebo-controlled Period|Randomized, not treated|0|||
164302364|NCT03755934|593482602|FG000|Overall Study|Physician Decision|2|||
164310890|NCT02474069|593512994|FG002|Selection Phase (SP)|Adverse Event|0|||
164310891|NCT02474069|593512992|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
164310892|NCT02474069|593512993|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
164310893|NCT02474069|593512994|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
164310894|NCT02474069|593512992|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
164310895|NCT02474069|593512993|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
164310896|NCT02474069|593512994|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
164310897|NCT02474069|593512992|FG000|Selection Phase (SP)|Physician Decision|1|||
164310898|NCT02474069|593512993|FG001|Selection Phase (SP)|Physician Decision|0|||
164310899|NCT02474069|593512994|FG002|Selection Phase (SP)|Physician Decision|0|||
164310900|NCT02474069|593512992|FG000|Selection Phase (SP)|Protocol Violation|1|||
164310901|NCT02474069|593512993|FG001|Selection Phase (SP)|Protocol Violation|0|||
164310902|NCT02474069|593512994|FG002|Selection Phase (SP)|Protocol Violation|0|||
164310903|NCT02474069|593512992|FG000|Selection Phase (SP)|No longer requires treatment|1|||
164310904|NCT02474069|593512993|FG001|Selection Phase (SP)|No longer requires treatment|0|||
164310905|NCT02474069|593512994|FG002|Selection Phase (SP)|No longer requires treatment|0|||
164310906|NCT02474069|593512992|FG000|Selection Phase (SP)|Technical Problem|1|||
164310907|NCT02474069|593512993|FG001|Selection Phase (SP)|Technical Problem|0|||
164310908|NCT02474069|593512994|FG002|Selection Phase (SP)|Technical Problem|0|||
164310909|NCT02474069|593512992|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
164310910|NCT02474069|593512993|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
163866760|NCT04707313|591878186|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
163866761|NCT04707313|591878187|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
163866762|NCT04707313|591878175|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866763|NCT04707313|591878176|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866764|NCT04707313|591878177|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866765|NCT04707313|591878178|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866766|NCT04707313|591878179|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866767|NCT04707313|591878180|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866768|NCT04707313|591878181|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866769|NCT04707313|591878182|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866770|NCT04707313|591878183|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
163866771|NCT04707313|591878184|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
163866772|NCT04707313|591878185|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
163866773|NCT04707313|591878186|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
163866774|NCT04707313|591878187|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
163866775|NCT04707313|591878175|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866776|NCT04707313|591878176|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866777|NCT04707313|591878177|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866778|NCT04707313|591878178|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866779|NCT04707313|591878179|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866780|NCT04707313|591878180|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866781|NCT04707313|591878181|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866782|NCT04707313|591878182|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866783|NCT04707313|591878183|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866784|NCT04707313|591878184|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866785|NCT04707313|591878185|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
163866786|NCT04707313|591878186|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
163866787|NCT04707313|591878187|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
163866788|NCT04707313|591878175|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866789|NCT04707313|591878176|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866790|NCT04707313|591878177|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866791|NCT04707313|591878178|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866792|NCT04707313|591878179|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866793|NCT04707313|591878180|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866794|NCT04707313|591878181|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866795|NCT04707313|591878182|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866796|NCT04707313|591878183|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866797|NCT04707313|591878184|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
163866798|NCT04707313|591878185|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
163866799|NCT04707313|591878186|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866800|NCT04707313|591878187|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
163866801|NCT04707313|591878175|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866802|NCT04707313|591878176|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866803|NCT04707313|591878177|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866804|NCT04707313|591878178|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
164310911|NCT02474069|593512994|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
164310912|NCT02474069|593512992|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
164310913|NCT02474069|593512993|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
164310914|NCT02474069|593512994|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
164310915|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
163866805|NCT04707313|591878179|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866806|NCT04707313|591878180|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866807|NCT04707313|591878181|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866808|NCT04707313|591878182|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866809|NCT04707313|591878183|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
163866810|NCT04707313|591878184|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
163866811|NCT04707313|591878185|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
163866812|NCT04707313|591878186|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
163866813|NCT04707313|591878187|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
163866814|NCT02459899|591878188|FG000|Overall Study|Adverse Event|1|||
163866815|NCT02459899|591878189|FG001|Overall Study|Adverse Event|1|||
163866816|NCT02459899|591878190|FG002|Overall Study|Adverse Event|0|||
163866817|NCT02459899|591878191|FG003|Overall Study|Adverse Event|0|||
163866818|NCT02459899|591878188|FG000|Overall Study|Lost to Follow-up|1|||
163866819|NCT02459899|591878189|FG001|Overall Study|Lost to Follow-up|2|||
163866820|NCT02459899|591878190|FG002|Overall Study|Lost to Follow-up|0|||
163866821|NCT02459899|591878191|FG003|Overall Study|Lost to Follow-up|1|||
163866822|NCT02459899|591878188|FG000|Overall Study|Non-compliance with the treatment|0|||
163866823|NCT02459899|591878189|FG001|Overall Study|Non-compliance with the treatment|0|||
163866824|NCT02459899|591878190|FG002|Overall Study|Non-compliance with the treatment|0|||
163866825|NCT02459899|591878191|FG003|Overall Study|Non-compliance with the treatment|1|||
163866826|NCT02459899|591878188|FG000|Overall Study|Withdrawal by Subject|1|||
163866827|NCT02459899|591878189|FG001|Overall Study|Withdrawal by Subject|3|||
163866828|NCT02459899|591878190|FG002|Overall Study|Withdrawal by Subject|0|||
163866829|NCT02459899|591878191|FG003|Overall Study|Withdrawal by Subject|0|||
163866830|NCT00940992|591878192|FG000|Overall Study|Adverse Event|2|||
163866831|NCT00940992|591878193|FG001|Overall Study|Adverse Event|0|||
163866832|NCT00940992|591878194|FG002|Overall Study|Adverse Event|1|||
163866833|NCT00940992|591878192|FG000|Overall Study|subject request|2|||
163866834|NCT00940992|591878193|FG001|Overall Study|subject request|1|||
163866835|NCT00940992|591878194|FG002|Overall Study|subject request|0|||
163866836|NCT00940992|591878192|FG000|Overall Study|Lost to Follow-up|0|||
163866837|NCT00940992|591878193|FG001|Overall Study|Lost to Follow-up|1|||
163866838|NCT00940992|591878194|FG002|Overall Study|Lost to Follow-up|1|||
163866839|NCT03586544|591878207|FG000|First Intervention|Adverse Event|0|||
163866840|NCT03586544|591878208|FG001|First Intervention|Adverse Event|1|||
163866841|NCT03586544|591878207|FG000|Second Intervention|Withdrawal by Subject|0|||
163866842|NCT03586544|591878208|FG001|Second Intervention|Withdrawal by Subject|1|||
163866843|NCT00539292|591878209|FG000|Overall Study|Physician Decision|1|||
163866844|NCT00539292|591878210|FG001|Overall Study|Physician Decision|0|||
163866845|NCT01063517|591878214|FG000|Overall Study|Consent withdrawal|1|||
163866846|NCT01063517|591878215|FG001|Overall Study|Consent withdrawal|0|||
163866847|NCT01063517|591878214|FG000|Overall Study|Study reached data cut-off|19|||
163866848|NCT01063517|591878215|FG001|Overall Study|Study reached data cut-off|7|||
163866849|NCT01063517|591878214|FG000|Overall Study|Lost to Follow-up|4|||
163866850|NCT01063517|591878215|FG001|Overall Study|Lost to Follow-up|3|||
163866851|NCT01063517|591878214|FG000|Overall Study|Withdrawal by Subject|1|||
163866852|NCT01063517|591878215|FG001|Overall Study|Withdrawal by Subject|2|||
163866853|NCT01063517|591878214|FG000|Overall Study|Death|33|||
163866854|NCT01063517|591878215|FG001|Overall Study|Death|48|||
163866855|NCT06269640|591880160|FG000|Overall Study|Death|1|||
163866856|NCT02974634|591880161|FG000|Overall Study|Advanced disease|12|||
163866857|NCT02974634|591880162|FG001|Overall Study|Advanced disease|3|||
163866858|NCT02974634|591880161|FG000|Overall Study|Noncompliance|3|||
163866859|NCT02974634|591880162|FG001|Overall Study|Noncompliance|7|||
163866860|NCT02974634|591880161|FG000|Overall Study|intervention technology related issues|5|||
163866861|NCT02974634|591880162|FG001|Overall Study|intervention technology related issues|0|||
163866862|NCT02974634|591880161|FG000|Overall Study|Death|8|||
163866863|NCT02974634|591880162|FG001|Overall Study|Death|11|||
163866864|NCT05011396|591880163|FG000|Overall Study|Lost to Follow-up|3|||
163866865|NCT05011396|591880164|FG001|Overall Study|Lost to Follow-up|1|||
163866866|NCT05011396|591880163|FG000|Overall Study|Withdrawal by Subject|0|||
163866867|NCT05011396|591880164|FG001|Overall Study|Withdrawal by Subject|1|||
163866868|NCT05011396|591880163|FG000|Overall Study|Positive Drug Screen|0|||
163866869|NCT05011396|591880164|FG001|Overall Study|Positive Drug Screen|1|||
164135405|NCT01157897|592859158|FG001|Overall Study|Relocated|2|||
163866870|NCT01400776|591880165|FG000|Overall Study|Adverse Event|7|||
163866871|NCT01400776|591880166|FG001|Overall Study|Adverse Event|2|||
163866872|NCT01400776|591880167|FG002|Overall Study|Adverse Event|9|||
163866873|NCT01400776|591880168|FG003|Overall Study|Adverse Event|2|||
163866874|NCT01400776|591880165|FG000|Overall Study|Lost to Follow-up|1|||
163866875|NCT01400776|591880166|FG001|Overall Study|Lost to Follow-up|0|||
163866876|NCT01400776|591880167|FG002|Overall Study|Lost to Follow-up|4|||
163866877|NCT01400776|591880168|FG003|Overall Study|Lost to Follow-up|1|||
163866878|NCT01400776|591880165|FG000|Overall Study|Withdrew Consent|4|||
164135406|NCT01157897|592859159|FG002|Overall Study|Relocated|0|||
164135407|NCT01157897|592859160|FG003|Overall Study|Relocated|0|||
163971161|NCT04688775|592266259|FG003|Placebo-controlled Period|Randomized, not treated|0|||
163971162|NCT04688775|592266256|FG000|Placebo-controlled Period|Adverse Event|2|||
163971163|NCT04688775|592266257|FG001|Placebo-controlled Period|Adverse Event|0|||
163971164|NCT04688775|592266258|FG002|Placebo-controlled Period|Adverse Event|0|||
163971165|NCT04688775|592266259|FG003|Placebo-controlled Period|Adverse Event|0|||
163971166|NCT04688775|592266256|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
163971167|NCT04688775|592266257|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
163971168|NCT04688775|592266258|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
163971169|NCT04688775|592266259|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
163971170|NCT04688775|592266256|FG000|Placebo-controlled Period|Protocol Violation|0|||
163971171|NCT04688775|592266257|FG001|Placebo-controlled Period|Protocol Violation|1|||
163971172|NCT04688775|592266258|FG002|Placebo-controlled Period|Protocol Violation|0|||
163971173|NCT04688775|592266259|FG003|Placebo-controlled Period|Protocol Violation|0|||
163971174|NCT04688775|592266256|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
163971175|NCT04688775|592266257|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
163971176|NCT04688775|592266258|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
163971177|NCT04688775|592266259|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
163971178|NCT04688775|592266256|FG000|Placebo-controlled Period|Other reasons|0|||
163971179|NCT04688775|592266257|FG001|Placebo-controlled Period|Other reasons|1|||
163971180|NCT04688775|592266258|FG002|Placebo-controlled Period|Other reasons|0|||
163971181|NCT04688775|592266259|FG003|Placebo-controlled Period|Other reasons|0|||
163971182|NCT04688775|592266256|FG000|Delayed Start Period|Adverse Event|0|||
163971183|NCT04688775|592266257|FG001|Delayed Start Period|Adverse Event|0|||
163971184|NCT04688775|592266258|FG002|Delayed Start Period|Adverse Event|1|||
163971185|NCT04688775|592266259|FG003|Delayed Start Period|Adverse Event|0|||
163971186|NCT04688775|592266256|FG000|Delayed Start Period|Lack of Efficacy|0|||
163971187|NCT04688775|592266257|FG001|Delayed Start Period|Lack of Efficacy|0|||
163971188|NCT04688775|592266258|FG002|Delayed Start Period|Lack of Efficacy|0|||
163971189|NCT04688775|592266259|FG003|Delayed Start Period|Lack of Efficacy|3|||
163971190|NCT04688775|592266256|FG000|Delayed Start Period|Withdrawal by Subject|0|||
163971191|NCT04688775|592266257|FG001|Delayed Start Period|Withdrawal by Subject|0|||
163971192|NCT04688775|592266258|FG002|Delayed Start Period|Withdrawal by Subject|2|||
163971193|NCT04688775|592266259|FG003|Delayed Start Period|Withdrawal by Subject|4|||
163971194|NCT04688775|592266256|FG000|Delayed Start Period|Lost to Follow-up|0|||
163971195|NCT04688775|592266257|FG001|Delayed Start Period|Lost to Follow-up|0|||
163971196|NCT04688775|592266258|FG002|Delayed Start Period|Lost to Follow-up|2|||
163971197|NCT04688775|592266259|FG003|Delayed Start Period|Lost to Follow-up|1|||
163971198|NCT04688775|592266256|FG000|Delayed Start Period|other reasons|0|||
163971199|NCT04688775|592266257|FG001|Delayed Start Period|other reasons|0|||
163971200|NCT04688775|592266258|FG002|Delayed Start Period|other reasons|1|||
163971201|NCT04688775|592266259|FG003|Delayed Start Period|other reasons|0|||
163971202|NCT01536951|592266263|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971203|NCT01536951|592266264|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971204|NCT01536951|592266265|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
163971205|NCT01536951|592266266|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971206|NCT01536951|592266267|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971207|NCT01536951|592266268|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971208|NCT01536951|592266269|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971209|NCT01536951|592266270|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971210|NCT01536951|592266271|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
163971211|NCT01536951|592266263|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
163971212|NCT01536951|592266264|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
163971213|NCT01536951|592266265|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
163971214|NCT01536951|592266266|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
163971215|NCT01536951|592266267|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
163971216|NCT01536951|592266268|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
163971217|NCT01536951|592266269|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
163971218|NCT01536951|592266270|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
163971219|NCT01536951|592266271|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
163971220|NCT01843972|592266274|FG000|Overall Study|Withdrawal by Subject|0|||
163971221|NCT01843972|592266275|FG001|Overall Study|Withdrawal by Subject|0|||
163971222|NCT01843972|592266276|FG002|Overall Study|Withdrawal by Subject|0|||
163971223|NCT01843972|592266277|FG003|Overall Study|Withdrawal by Subject|0|||
163971224|NCT01843972|592266278|FG004|Overall Study|Withdrawal by Subject|1|||
163971225|NCT01843972|592266279|FG005|Overall Study|Withdrawal by Subject|0|||
163971226|NCT01843972|592266280|FG006|Overall Study|Withdrawal by Subject|0|||
163971227|NCT01843972|592266281|FG007|Overall Study|Withdrawal by Subject|0|||
163971228|NCT01843972|592266282|FG008|Overall Study|Withdrawal by Subject|0|||
163971229|NCT01843972|592266283|FG009|Overall Study|Withdrawal by Subject|0|||
163971230|NCT00545402|592266289|FG000|Overall Study|Discontinuation of treatment|17|||
164135635|NCT02799095|592861963|FG008|Part A|Adverse Event|0|||
163866879|NCT01400776|591880166|FG001|Overall Study|Withdrew Consent|2|||
163866880|NCT01400776|591880167|FG002|Overall Study|Withdrew Consent|6|||
163866881|NCT01400776|591880168|FG003|Overall Study|Withdrew Consent|1|||
163866882|NCT01400776|591880165|FG000|Overall Study|Protocol Deviation|6|||
163866883|NCT01400776|591880166|FG001|Overall Study|Protocol Deviation|1|||
163866884|NCT01400776|591880167|FG002|Overall Study|Protocol Deviation|5|||
163866885|NCT01400776|591880168|FG003|Overall Study|Protocol Deviation|2|||
163866886|NCT01400776|591880165|FG000|Overall Study|Reason not Specified|3|||
163866887|NCT01400776|591880166|FG001|Overall Study|Reason not Specified|0|||
163866888|NCT01400776|591880167|FG002|Overall Study|Reason not Specified|4|||
163866889|NCT01400776|591880168|FG003|Overall Study|Reason not Specified|3|||
163866890|NCT00711958|591880170|FG000|Overall Study|Withdrawal by Subject|6|||
163866891|NCT00711958|591880171|FG001|Overall Study|Withdrawal by Subject|8|||
163866892|NCT00711958|591880170|FG000|Overall Study|Lack of Efficacy|3|||
163866893|NCT00711958|591880171|FG001|Overall Study|Lack of Efficacy|1|||
163971231|NCT00545402|592266290|FG001|Overall Study|Discontinuation of treatment|9|||
163971232|NCT00545402|592266289|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
163971233|NCT00545402|592266290|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
164201888|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
164201889|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164201890|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
164201891|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201892|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201893|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201894|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201895|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
164201896|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201897|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
164201898|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201899|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201900|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201901|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201902|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164201903|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
163866894|NCT00711958|591880170|FG000|Overall Study|Clinical deterioration|1|||
163866895|NCT00711958|591880171|FG001|Overall Study|Clinical deterioration|0|||
163866896|NCT00711958|591880170|FG000|Overall Study|Adverse Event|9|||
163866897|NCT00711958|591880171|FG001|Overall Study|Adverse Event|7|||
163866898|NCT00711958|591880170|FG000|Overall Study|Protocol Violation|1|||
163971234|NCT00545402|592266289|FG000|Overall Study|Death|5|||
163971235|NCT00545402|592266290|FG001|Overall Study|Death|7|||
163971236|NCT00545402|592266289|FG000|Overall Study|Graft loss|2|||
163971237|NCT00545402|592266290|FG001|Overall Study|Graft loss|4|||
164201904|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
164302365|NCT03755934|593482603|FG001|Overall Study|Physician Decision|0|||
164302366|NCT03755934|593482604|FG002|Overall Study|Physician Decision|0|||
164302367|NCT03755934|593482605|FG003|Overall Study|Physician Decision|1|||
164302368|NCT03755934|593482602|FG000|Overall Study|Withdrawal by Subject|5|||
164302369|NCT03755934|593482603|FG001|Overall Study|Withdrawal by Subject|0|||
164302370|NCT03755934|593482604|FG002|Overall Study|Withdrawal by Subject|0|||
164302371|NCT03755934|593482605|FG003|Overall Study|Withdrawal by Subject|1|||
164302372|NCT03755934|593482602|FG000|Overall Study|Other|3|||
164302373|NCT03755934|593482603|FG001|Overall Study|Other|1|||
164302374|NCT03755934|593482604|FG002|Overall Study|Other|3|||
164302375|NCT03755934|593482605|FG003|Overall Study|Other|1|||
164302376|NCT00904982|593482607|FG000|Overall Study|Withdrawal by Subject|2|||
164302377|NCT00904982|593482608|FG001|Overall Study|Withdrawal by Subject|0|||
164302378|NCT00904982|593482609|FG002|Overall Study|Withdrawal by Subject|0|||
164302379|NCT00904982|593482610|FG003|Overall Study|Withdrawal by Subject|0|||
164302380|NCT02594124|593482613|FG000|Overall Study|Adverse Event|0|||
164302381|NCT02594124|593482614|FG001|Overall Study|Adverse Event|5|||
164302382|NCT02594124|593482615|FG002|Overall Study|Adverse Event|8|||
164302383|NCT02594124|593482616|FG003|Overall Study|Adverse Event|1|||
164302384|NCT02594124|593482617|FG004|Overall Study|Adverse Event|0|||
164302385|NCT02594124|593482618|FG005|Overall Study|Adverse Event|0|||
164302386|NCT02594124|593482619|FG006|Overall Study|Adverse Event|2|||
164302387|NCT02594124|593482620|FG007|Overall Study|Adverse Event|2|||
164302388|NCT02594124|593482621|FG008|Overall Study|Adverse Event|0|||
164302389|NCT02594124|593482613|FG000|Overall Study|Withdrawal by Subject|2|||
164302390|NCT02594124|593482614|FG001|Overall Study|Withdrawal by Subject|3|||
164302391|NCT02594124|593482615|FG002|Overall Study|Withdrawal by Subject|5|||
164302392|NCT02594124|593482616|FG003|Overall Study|Withdrawal by Subject|1|||
164302393|NCT02594124|593482617|FG004|Overall Study|Withdrawal by Subject|8|||
164302394|NCT02594124|593482618|FG005|Overall Study|Withdrawal by Subject|4|||
164201905|NCT01791595|593112614|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
163866899|NCT00711958|591880171|FG001|Overall Study|Protocol Violation|0|||
163866900|NCT00711958|591880170|FG000|Overall Study|Lost to Follow-up|2|||
163866901|NCT00711958|591880171|FG001|Overall Study|Lost to Follow-up|2|||
163866902|NCT00711958|591880170|FG000|Overall Study|Death|10|||
163866903|NCT00711958|591880171|FG001|Overall Study|Death|5|||
163866904|NCT00711958|591880170|FG000|Overall Study|Progression of disease|1|||
163866905|NCT00711958|591880171|FG001|Overall Study|Progression of disease|0|||
163866906|NCT01111526|591880172|FG000|Overall Study|GVHD Disease Progression|0|||
163866907|NCT01111526|591880173|FG001|Overall Study|GVHD Disease Progression|1|||
163866908|NCT01111526|591880174|FG002|Overall Study|GVHD Disease Progression|2|||
163866909|NCT04424641|591880175|FG000|Overall Study|Death|1|||
163866910|NCT04424641|591880176|FG001|Overall Study|Death|2|||
163866911|NCT04424641|591880177|FG002|Overall Study|Death|3|||
163866912|NCT04424641|591880178|FG003|Overall Study|Death|0|||
163866913|NCT04424641|591880179|FG004|Overall Study|Death|3|||
163866914|NCT04424641|591880180|FG005|Overall Study|Death|0|||
163866915|NCT04424641|591880181|FG006|Overall Study|Death|1|||
163866916|NCT04424641|591880182|FG007|Overall Study|Death|2|||
163866917|NCT04424641|591880175|FG000|Overall Study|Sponsor decision|0|||
163866918|NCT04424641|591880176|FG001|Overall Study|Sponsor decision|2|||
163866919|NCT04424641|591880177|FG002|Overall Study|Sponsor decision|3|||
163866920|NCT04424641|591880178|FG003|Overall Study|Sponsor decision|7|||
163866921|NCT04424641|591880179|FG004|Overall Study|Sponsor decision|2|||
163866922|NCT04424641|591880180|FG005|Overall Study|Sponsor decision|2|||
163866923|NCT04424641|591880181|FG006|Overall Study|Sponsor decision|3|||
163866924|NCT04424641|591880182|FG007|Overall Study|Sponsor decision|4|||
163866925|NCT04424641|591880175|FG000|Overall Study|Withdrawal by Subject|0|||
163866926|NCT04424641|591880176|FG001|Overall Study|Withdrawal by Subject|0|||
163866927|NCT04424641|591880177|FG002|Overall Study|Withdrawal by Subject|0|||
163866928|NCT04424641|591880178|FG003|Overall Study|Withdrawal by Subject|0|||
163866929|NCT04424641|591880179|FG004|Overall Study|Withdrawal by Subject|1|||
163866930|NCT04424641|591880180|FG005|Overall Study|Withdrawal by Subject|0|||
163866931|NCT04424641|591880181|FG006|Overall Study|Withdrawal by Subject|0|||
163866932|NCT04424641|591880182|FG007|Overall Study|Withdrawal by Subject|0|||
163866933|NCT04424641|591880175|FG000|Overall Study|Other|0|||
164201906|NCT01791595|593112615|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201907|NCT01791595|593112616|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201908|NCT01791595|593112617|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201909|NCT01791595|593112618|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201910|NCT01791595|593112619|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
164201911|NCT01791595|593112620|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
164201912|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201913|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201914|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201915|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201916|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201917|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
164201918|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
164201919|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201920|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201921|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201922|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201923|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201924|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
164201925|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
164201926|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201927|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201928|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201929|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201930|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
164201931|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
163866934|NCT04424641|591880176|FG001|Overall Study|Other|0|||
164201932|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
164201933|NCT01791595|593112614|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201934|NCT01791595|593112615|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164302984|NCT02760498|593484678|FG005|Overall Study|Not treated|2|||
163866935|NCT04424641|591880177|FG002|Overall Study|Other|1|||
163866936|NCT04424641|591880178|FG003|Overall Study|Other|0|||
163866937|NCT04424641|591880179|FG004|Overall Study|Other|0|||
163866938|NCT04424641|591880180|FG005|Overall Study|Other|0|||
163866939|NCT04424641|591880181|FG006|Overall Study|Other|0|||
163866940|NCT04424641|591880182|FG007|Overall Study|Other|0|||
163866941|NCT02015546|591880183|FG000|Overall Study|Withdrawal by Subject|1|||
163866942|NCT02015546|591880184|FG001|Overall Study|Withdrawal by Subject|1|||
163866943|NCT02015546|591880185|FG002|Overall Study|Withdrawal by Subject|1|||
163866944|NCT02015546|591880183|FG000|Overall Study|Screem Failure|2|||
163866945|NCT02015546|591880184|FG001|Overall Study|Screem Failure|1|||
163866946|NCT02015546|591880185|FG002|Overall Study|Screem Failure|3|||
163866947|NCT01171625|591880186|FG000|Overall Study|On-Protocol|67|||
163866948|NCT01171625|591880186|FG000|Overall Study|Death|38|||
163866949|NCT01171625|591880186|FG000|Overall Study|Withdrawal by Subject|31|||
163866950|NCT01171625|591880186|FG000|Overall Study|Explanted|10|||
163866951|NCT01171625|591880186|FG000|Overall Study|Lost to Follow-up|5|||
163866952|NCT01171625|591880186|FG000|Overall Study|Patient received valve-in-valve|3|||
163866953|NCT01171625|591880186|FG000|Overall Study|Other|1|||
163866954|NCT01171625|591880186|FG000|Overall Study|Consented but did not receive device|25|||
163866955|NCT00799396|591880189|FG000|Clopidogrel Treatment|Adverse Event|6|||
163866956|NCT00799396|591880189|FG000|Clopidogrel Treatment|Physician Decision|5|||
163866957|NCT00799396|591880189|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
163866958|NCT00799396|591880189|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
163866959|NCT00799396|591880189|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
163866960|NCT01113931|591880190|FG000|Overall Study|Adverse Event|2|||
163866961|NCT01113931|591880191|FG001|Overall Study|Adverse Event|2|||
163866962|NCT01113931|591880190|FG000|Overall Study|Physician Decision|0|||
163866963|NCT01113931|591880191|FG001|Overall Study|Physician Decision|2|||
163866964|NCT01113931|591880190|FG000|Overall Study|Lost to Follow-up|12|||
163866965|NCT01113931|591880191|FG001|Overall Study|Lost to Follow-up|9|||
163866966|NCT01113931|591880190|FG000|Overall Study|Various|2|||
163866967|NCT01113931|591880191|FG001|Overall Study|Various|4|||
163866968|NCT01113931|591880190|FG000|Overall Study|Withdrawal by Subject|3|||
163866969|NCT01113931|591880191|FG001|Overall Study|Withdrawal by Subject|0|||
163866970|NCT01307267|591880192|FG000|Overall Study|Death|4|||
163866971|NCT01307267|591880193|FG001|Overall Study|Death|3|||
163866972|NCT01307267|591880194|FG002|Overall Study|Death|5|||
163866973|NCT01307267|591880195|FG003|Overall Study|Death|3|||
163866974|NCT01307267|591880196|FG004|Overall Study|Death|1|||
163866975|NCT01307267|591880197|FG005|Overall Study|Death|26|||
163866976|NCT01307267|591880198|FG006|Overall Study|Death|2|||
163866977|NCT01307267|591880199|FG007|Overall Study|Death|2|||
163866978|NCT01307267|591880200|FG008|Overall Study|Death|21|||
163866979|NCT01307267|591880201|FG009|Overall Study|Death|2|||
163866980|NCT01307267|591880202|FG010|Overall Study|Death|3|||
163866981|NCT01307267|591880203|FG011|Overall Study|Death|9|||
163866982|NCT01307267|591880204|FG012|Overall Study|Death|0|||
163866983|NCT01307267|591880205|FG013|Overall Study|Death|0|||
163866984|NCT01307267|591880206|FG014|Overall Study|Death|0|||
163866985|NCT01307267|591880207|FG015|Overall Study|Death|0|||
163866986|NCT01307267|591880208|FG016|Overall Study|Death|1|||
163866987|NCT01307267|591880209|FG017|Overall Study|Death|1|||
163866988|NCT01307267|591880210|FG018|Overall Study|Death|2|||
163866989|NCT01307267|591880211|FG019|Overall Study|Death|8|||
163866990|NCT01307267|591880212|FG020|Overall Study|Death|1|||
163866991|NCT01307267|591880213|FG021|Overall Study|Death|2|||
163866992|NCT01307267|591880214|FG022|Overall Study|Death|2|||
163866993|NCT01307267|591880192|FG000|Overall Study|Lost to Follow-up|0|||
163866994|NCT01307267|591880193|FG001|Overall Study|Lost to Follow-up|0|||
163866995|NCT01307267|591880194|FG002|Overall Study|Lost to Follow-up|0|||
163866996|NCT01307267|591880195|FG003|Overall Study|Lost to Follow-up|0|||
163866997|NCT01307267|591880196|FG004|Overall Study|Lost to Follow-up|0|||
163866998|NCT01307267|591880197|FG005|Overall Study|Lost to Follow-up|7|||
163866999|NCT01307267|591880198|FG006|Overall Study|Lost to Follow-up|0|||
163867000|NCT01307267|591880199|FG007|Overall Study|Lost to Follow-up|0|||
163867001|NCT01307267|591880200|FG008|Overall Study|Lost to Follow-up|1|||
163867002|NCT01307267|591880201|FG009|Overall Study|Lost to Follow-up|2|||
163867003|NCT01307267|591880202|FG010|Overall Study|Lost to Follow-up|1|||
163867004|NCT01307267|591880203|FG011|Overall Study|Lost to Follow-up|0|||
163867005|NCT01307267|591880204|FG012|Overall Study|Lost to Follow-up|0|||
163867006|NCT01307267|591880205|FG013|Overall Study|Lost to Follow-up|0|||
163867007|NCT01307267|591880206|FG014|Overall Study|Lost to Follow-up|0|||
163867008|NCT01307267|591880207|FG015|Overall Study|Lost to Follow-up|0|||
163867009|NCT01307267|591880208|FG016|Overall Study|Lost to Follow-up|0|||
163867010|NCT01307267|591880209|FG017|Overall Study|Lost to Follow-up|0|||
163867011|NCT01307267|591880210|FG018|Overall Study|Lost to Follow-up|0|||
163867012|NCT01307267|591880211|FG019|Overall Study|Lost to Follow-up|2|||
163867013|NCT01307267|591880212|FG020|Overall Study|Lost to Follow-up|0|||
163867014|NCT01307267|591880213|FG021|Overall Study|Lost to Follow-up|0|||
163867015|NCT01307267|591880214|FG022|Overall Study|Lost to Follow-up|0|||
163867016|NCT01307267|591880192|FG000|Overall Study|Withdrawal by Subject|0|||
163867017|NCT01307267|591880193|FG001|Overall Study|Withdrawal by Subject|0|||
163867018|NCT01307267|591880194|FG002|Overall Study|Withdrawal by Subject|0|||
163867019|NCT01307267|591880195|FG003|Overall Study|Withdrawal by Subject|0|||
163867020|NCT01307267|591880196|FG004|Overall Study|Withdrawal by Subject|0|||
163867021|NCT01307267|591880197|FG005|Overall Study|Withdrawal by Subject|1|||
163867022|NCT01307267|591880198|FG006|Overall Study|Withdrawal by Subject|0|||
164310916|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
164310917|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
164310918|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
164310919|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
164310920|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
164310921|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
164310922|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
163867023|NCT01307267|591880199|FG007|Overall Study|Withdrawal by Subject|1|||
163867024|NCT01307267|591880200|FG008|Overall Study|Withdrawal by Subject|5|||
163867025|NCT01307267|591880201|FG009|Overall Study|Withdrawal by Subject|1|||
163867026|NCT01307267|591880202|FG010|Overall Study|Withdrawal by Subject|1|||
163867027|NCT01307267|591880203|FG011|Overall Study|Withdrawal by Subject|1|||
163867028|NCT01307267|591880204|FG012|Overall Study|Withdrawal by Subject|0|||
163867029|NCT01307267|591880205|FG013|Overall Study|Withdrawal by Subject|0|||
163867030|NCT01307267|591880206|FG014|Overall Study|Withdrawal by Subject|0|||
163867031|NCT01307267|591880207|FG015|Overall Study|Withdrawal by Subject|0|||
163867032|NCT01307267|591880208|FG016|Overall Study|Withdrawal by Subject|0|||
163867033|NCT01307267|591880209|FG017|Overall Study|Withdrawal by Subject|0|||
163867034|NCT01307267|591880210|FG018|Overall Study|Withdrawal by Subject|0|||
163867035|NCT01307267|591880211|FG019|Overall Study|Withdrawal by Subject|3|||
163867036|NCT01307267|591880212|FG020|Overall Study|Withdrawal by Subject|0|||
163867037|NCT01307267|591880213|FG021|Overall Study|Withdrawal by Subject|0|||
163867038|NCT01307267|591880214|FG022|Overall Study|Withdrawal by Subject|0|||
163867039|NCT01307267|591880192|FG000|Overall Study|Other|0|||
163867040|NCT01307267|591880193|FG001|Overall Study|Other|0|||
163867041|NCT01307267|591880194|FG002|Overall Study|Other|0|||
163867042|NCT01307267|591880195|FG003|Overall Study|Other|0|||
163867043|NCT01307267|591880196|FG004|Overall Study|Other|0|||
163867044|NCT01307267|591880197|FG005|Overall Study|Other|7|||
163867045|NCT01307267|591880198|FG006|Overall Study|Other|0|||
163867046|NCT01307267|591880199|FG007|Overall Study|Other|1|||
163867047|NCT01307267|591880200|FG008|Overall Study|Other|3|||
163867048|NCT01307267|591880201|FG009|Overall Study|Other|0|||
163867049|NCT01307267|591880202|FG010|Overall Study|Other|1|||
163867050|NCT01307267|591880203|FG011|Overall Study|Other|1|||
163867051|NCT01307267|591880204|FG012|Overall Study|Other|1|||
163867052|NCT01307267|591880205|FG013|Overall Study|Other|0|||
163867053|NCT01307267|591880206|FG014|Overall Study|Other|2|||
163867054|NCT01307267|591880207|FG015|Overall Study|Other|1|||
163867055|NCT01307267|591880208|FG016|Overall Study|Other|0|||
163867056|NCT01307267|591880209|FG017|Overall Study|Other|0|||
163867057|NCT01307267|591880210|FG018|Overall Study|Other|0|||
163867058|NCT01307267|591880211|FG019|Overall Study|Other|19|||
163867059|NCT01307267|591880212|FG020|Overall Study|Other|2|||
163867060|NCT01307267|591880213|FG021|Overall Study|Other|3|||
163867061|NCT01307267|591880214|FG022|Overall Study|Other|2|||
163867062|NCT04956575|591880217|FG000|Overall Study|Death|1|||
163867063|NCT04956575|591880218|FG001|Overall Study|Death|0|||
163867064|NCT04956575|591880219|FG002|Overall Study|Death|0|||
163867065|NCT04956575|591880220|FG003|Overall Study|Death|0|||
163867066|NCT04956575|591880221|FG004|Overall Study|Death|0|||
163867067|NCT04956575|591880222|FG005|Overall Study|Death|0|||
163867068|NCT04956575|591880223|FG006|Overall Study|Death|0|||
163867069|NCT04956575|591880224|FG007|Overall Study|Death|1|||
163867070|NCT04956575|591880225|FG008|Overall Study|Death|0|||
163867071|NCT04956575|591880226|FG009|Overall Study|Death|1|||
163867072|NCT04956575|591880227|FG010|Overall Study|Death|0|||
163867073|NCT04956575|591880228|FG011|Overall Study|Death|0|||
163867074|NCT04956575|591880217|FG000|Overall Study|Lost to Follow-up|3|||
164310923|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
164310924|NCT02474069|593512992|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
164310925|NCT02474069|593512993|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
164310926|NCT02474069|593512994|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
163867075|NCT04956575|591880218|FG001|Overall Study|Lost to Follow-up|4|||
163867076|NCT04956575|591880219|FG002|Overall Study|Lost to Follow-up|2|||
163867077|NCT04956575|591880220|FG003|Overall Study|Lost to Follow-up|3|||
163867078|NCT04956575|591880221|FG004|Overall Study|Lost to Follow-up|1|||
163867079|NCT04956575|591880222|FG005|Overall Study|Lost to Follow-up|10|||
163867080|NCT04956575|591880223|FG006|Overall Study|Lost to Follow-up|11|||
163867081|NCT04956575|591880224|FG007|Overall Study|Lost to Follow-up|7|||
163867082|NCT04956575|591880225|FG008|Overall Study|Lost to Follow-up|4|||
163867083|NCT04956575|591880226|FG009|Overall Study|Lost to Follow-up|2|||
163867084|NCT04956575|591880227|FG010|Overall Study|Lost to Follow-up|3|||
163867085|NCT04956575|591880228|FG011|Overall Study|Lost to Follow-up|8|||
163867086|NCT04956575|591880217|FG000|Overall Study|Withdrawal by Subject|1|||
163867087|NCT04956575|591880218|FG001|Overall Study|Withdrawal by Subject|2|||
163867088|NCT04956575|591880219|FG002|Overall Study|Withdrawal by Subject|1|||
163867089|NCT04956575|591880220|FG003|Overall Study|Withdrawal by Subject|4|||
163867090|NCT04956575|591880221|FG004|Overall Study|Withdrawal by Subject|2|||
163867091|NCT04956575|591880222|FG005|Overall Study|Withdrawal by Subject|8|||
163867092|NCT04956575|591880223|FG006|Overall Study|Withdrawal by Subject|5|||
163867093|NCT04956575|591880224|FG007|Overall Study|Withdrawal by Subject|1|||
164201935|NCT01791595|593112616|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
163867094|NCT04956575|591880225|FG008|Overall Study|Withdrawal by Subject|1|||
163867095|NCT04956575|591880226|FG009|Overall Study|Withdrawal by Subject|0|||
163867096|NCT04956575|591880227|FG010|Overall Study|Withdrawal by Subject|3|||
163867097|NCT04956575|591880228|FG011|Overall Study|Withdrawal by Subject|1|||
163867098|NCT00854906|591880231|FG000|Overall Study|One person had no ocular history|1|||
163867099|NCT05526248|591880232|FG000|Overall Study|Lost to Follow-up|1|||
163867100|NCT05526248|591880232|FG000|Overall Study|Adverse Event|2|||
163867101|NCT05526248|591880232|FG000|Overall Study|Withdrawal by Subject|1|||
163867102|NCT02425111|591880235|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
163867103|NCT02425111|591880235|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
163867104|NCT02425111|591880235|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
163867105|NCT02425111|591880235|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
163867106|NCT02425111|591880235|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
163867107|NCT02425111|591880235|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
163867108|NCT00585533|591880236|FG000|Overall Study|objective or symptomatic progression|9|||
163867109|NCT03482011|591880240|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
163867110|NCT03482011|591880241|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
163867111|NCT03482011|591880242|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
163867112|NCT03482011|591880243|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
163867113|NCT03482011|591880244|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
163867114|NCT03482011|591880245|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
163867115|NCT03482011|591880246|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
163971238|NCT00545402|592266289|FG000|Overall Study|Withdrawal by Subject|0|||
163971239|NCT00545402|592266290|FG001|Overall Study|Withdrawal by Subject|1|||
164201936|NCT01791595|593112617|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201937|NCT01791595|593112618|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201938|NCT01791595|593112619|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
164201939|NCT01791595|593112620|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
164201940|NCT01776554|593112621|FG000|Overall Study|Adverse Event|1|||
164201941|NCT01776554|593112622|FG001|Overall Study|Adverse Event|0|||
164201942|NCT01776554|593112621|FG000|Overall Study|Withdrawal by Subject|3|||
164201943|NCT01776554|593112622|FG001|Overall Study|Withdrawal by Subject|8|||
164201944|NCT01776554|593112621|FG000|Overall Study|Lost to Follow-up|6|||
164201945|NCT01776554|593112622|FG001|Overall Study|Lost to Follow-up|9|||
164201946|NCT01776554|593112621|FG000|Overall Study|Administrative Reason|2|||
164201947|NCT01776554|593112622|FG001|Overall Study|Administrative Reason|5|||
164201948|NCT01776554|593112621|FG000|Overall Study|Protocol Violation|1|||
164201949|NCT01776554|593112622|FG001|Overall Study|Protocol Violation|0|||
164201950|NCT01776554|593112621|FG000|Overall Study|Unclassified|4|||
164201951|NCT01776554|593112622|FG001|Overall Study|Unclassified|1|||
164201952|NCT01041859|593112623|FG000|Open-Label Titration|Adverse Event|69|||
164201953|NCT01041859|593112624|FG001|Open-Label Titration|Adverse Event|0|||
164201954|NCT01041859|593112625|FG002|Open-Label Titration|Adverse Event|0|||
164201955|NCT01041859|593112623|FG000|Open-Label Titration|Lack of Efficacy|3|||
164201956|NCT01041859|593112624|FG001|Open-Label Titration|Lack of Efficacy|0|||
164201957|NCT01041859|593112625|FG002|Open-Label Titration|Lack of Efficacy|0|||
164201958|NCT01041859|593112623|FG000|Open-Label Titration|Lost to Follow-up|1|||
164201959|NCT01041859|593112624|FG001|Open-Label Titration|Lost to Follow-up|0|||
164201960|NCT01041859|593112625|FG002|Open-Label Titration|Lost to Follow-up|0|||
164201961|NCT01041859|593112623|FG000|Open-Label Titration|Physician Decision|1|||
164201962|NCT01041859|593112624|FG001|Open-Label Titration|Physician Decision|0|||
164201963|NCT01041859|593112625|FG002|Open-Label Titration|Physician Decision|0|||
164201964|NCT01041859|593112623|FG000|Open-Label Titration|Protocol Violation|1|||
164201965|NCT01041859|593112624|FG001|Open-Label Titration|Protocol Violation|0|||
164201966|NCT01041859|593112625|FG002|Open-Label Titration|Protocol Violation|0|||
164201967|NCT01041859|593112623|FG000|Open-Label Titration|Other|7|||
164201968|NCT01041859|593112624|FG001|Open-Label Titration|Other|0|||
164201969|NCT01041859|593112625|FG002|Open-Label Titration|Other|0|||
164201970|NCT01041859|593112623|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
164201971|NCT01041859|593112624|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
164310927|NCT03023813|593512997|FG000|Overall Study|Lost to Follow-up|1|||
163867116|NCT03482011|591880247|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
163867117|NCT03482011|591880240|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
164201972|NCT01041859|593112625|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
164201973|NCT01041859|593112623|FG000|Open-Label Titration|Withdrawal by Subject|11|||
164201974|NCT01041859|593112624|FG001|Open-Label Titration|Withdrawal by Subject|0|||
164201975|NCT01041859|593112625|FG002|Open-Label Titration|Withdrawal by Subject|0|||
164201976|NCT01041859|593112623|FG000|Double-Blind Maintenance|Adverse Event|0|||
164201977|NCT01041859|593112624|FG001|Double-Blind Maintenance|Adverse Event|23|||
164201978|NCT01041859|593112625|FG002|Double-Blind Maintenance|Adverse Event|13|||
164201979|NCT01041859|593112623|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
163971240|NCT00545402|592266289|FG000|Overall Study|Protocol Violation|1|||
163971241|NCT00545402|592266290|FG001|Overall Study|Protocol Violation|0|||
163971242|NCT00545402|592266289|FG000|Overall Study|Reason not specified|1|||
163971243|NCT00545402|592266290|FG001|Overall Study|Reason not specified|1|||
163971244|NCT01817751|592266291|FG000|Overall Study|Physician Decision|1|||
163971245|NCT00555477|592266292|FG000|Overall Study|Adverse Event|0|||
163971246|NCT00555477|592266293|FG001|Overall Study|Adverse Event|9|||
163971247|NCT00555477|592266292|FG000|Overall Study|Withdrawal by Subject|1|||
163971248|NCT00555477|592266293|FG001|Overall Study|Withdrawal by Subject|2|||
163971249|NCT00555477|592266292|FG000|Overall Study|Physician Decision|1|||
163971250|NCT00555477|592266293|FG001|Overall Study|Physician Decision|2|||
163971251|NCT00382018|592266294|FG000|Overall Study|Progression|0|||
163971252|NCT00382018|592266295|FG001|Overall Study|Progression|136|||
163971253|NCT00382018|592266296|FG002|Overall Study|Progression|51|||
163971254|NCT00382018|592266297|FG003|Overall Study|Progression|43|||
163971255|NCT00382018|592266294|FG000|Overall Study|Death|0|||
163971256|NCT00382018|592266295|FG001|Overall Study|Death|9|||
163971257|NCT00382018|592266296|FG002|Overall Study|Death|7|||
163971258|NCT00382018|592266297|FG003|Overall Study|Death|11|||
163971259|NCT00382018|592266294|FG000|Overall Study|Withdrawal by Subject|0|||
163971260|NCT00382018|592266295|FG001|Overall Study|Withdrawal by Subject|4|||
163971261|NCT00382018|592266296|FG002|Overall Study|Withdrawal by Subject|3|||
163971262|NCT00382018|592266297|FG003|Overall Study|Withdrawal by Subject|4|||
163971263|NCT00382018|592266294|FG000|Overall Study|Other, not protocol specified|0|||
163971264|NCT00382018|592266295|FG001|Overall Study|Other, not protocol specified|16|||
163971265|NCT00382018|592266296|FG002|Overall Study|Other, not protocol specified|3|||
163971266|NCT00382018|592266297|FG003|Overall Study|Other, not protocol specified|1|||
163971267|NCT01984164|592266298|FG000|Overall Study|Withdrawal by Subject|4|||
163971268|NCT01984164|592266299|FG001|Overall Study|Withdrawal by Subject|3|||
163971269|NCT01984164|592266298|FG000|Overall Study|Adverse Event|5|||
163971270|NCT01984164|592266299|FG001|Overall Study|Adverse Event|19|||
163971271|NCT01984164|592266298|FG000|Overall Study|Lost to Follow-up|1|||
163971272|NCT01984164|592266299|FG001|Overall Study|Lost to Follow-up|3|||
163971273|NCT00427349|592266303|FG000|Overall Study|Lack of Efficacy|23|||
163971274|NCT00427349|592266303|FG000|Overall Study|Adverse Event|14|||
163971275|NCT00427349|592266303|FG000|Overall Study|Death|1|||
163971276|NCT00427349|592266303|FG000|Overall Study|Withdrawal by Subject|3|||
163971277|NCT00427349|592266303|FG000|Overall Study|Alternative therapy|1|||
163971278|NCT00427349|592266303|FG000|Overall Study|Other|2|||
163971279|NCT00427349|592266303|FG000|Overall Study|Ineligible|1|||
163971280|NCT00427349|592266303|FG000|Overall Study|Never started therapy|1|||
163971281|NCT00282295|592266307|FG000|Overall Study|Adverse Event|0|||
163971282|NCT00282295|592266308|FG001|Overall Study|Adverse Event|1|||
163971283|NCT00282295|592266309|FG002|Overall Study|Adverse Event|0|||
163971284|NCT00282295|592266307|FG000|Overall Study|Serious Adverse Events|0|||
163971285|NCT00282295|592266308|FG001|Overall Study|Serious Adverse Events|0|||
163971286|NCT00282295|592266309|FG002|Overall Study|Serious Adverse Events|1|||
163971287|NCT00282295|592266307|FG000|Overall Study|Protocol Violation|0|||
163971288|NCT00282295|592266308|FG001|Overall Study|Protocol Violation|2|||
163971289|NCT00282295|592266309|FG002|Overall Study|Protocol Violation|1|||
163971290|NCT00282295|592266307|FG000|Overall Study|Withdrawal by Subject|2|||
163971291|NCT00282295|592266308|FG001|Overall Study|Withdrawal by Subject|6|||
163971292|NCT00282295|592266309|FG002|Overall Study|Withdrawal by Subject|4|||
163971293|NCT00282295|592266307|FG000|Overall Study|Lost to Follow-up|1|||
163971294|NCT00282295|592266308|FG001|Overall Study|Lost to Follow-up|7|||
163971295|NCT00282295|592266309|FG002|Overall Study|Lost to Follow-up|2|||
163971296|NCT00282295|592266307|FG000|Overall Study|Other|0|||
163971297|NCT00282295|592266308|FG001|Overall Study|Other|1|||
163971298|NCT00282295|592266309|FG002|Overall Study|Other|0|||
163971299|NCT03337542|592266312|FG000|Overall Study|Withdrew Consent|17|||
163971300|NCT03337542|592266312|FG000|Overall Study|Allergic Adverse Event|1|||
163971301|NCT03337542|592266312|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
163971302|NCT03337542|592266312|FG000|Overall Study|Lost to Follow-up|1|||
163971303|NCT03337542|592266312|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
164201980|NCT01041859|593112624|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
164201981|NCT01041859|593112625|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
164201982|NCT01041859|593112623|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
164201983|NCT01041859|593112624|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
164201984|NCT01041859|593112625|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
163971304|NCT06156215|592266313|FG000|Overall Study|Withdrawal by Subject|2|||
163971305|NCT06156215|592266314|FG001|Overall Study|Withdrawal by Subject|4|||
163971306|NCT06156215|592266315|FG002|Overall Study|Withdrawal by Subject|4|||
163971307|NCT06156215|592266316|FG003|Overall Study|Withdrawal by Subject|0|||
163971308|NCT06156215|592266317|FG004|Overall Study|Withdrawal by Subject|2|||
163971309|NCT06156215|592266318|FG005|Overall Study|Withdrawal by Subject|2|||
163971310|NCT06156215|592266313|FG000|Overall Study|Left ED without completing study|9|||
163971311|NCT06156215|592266314|FG001|Overall Study|Left ED without completing study|3|||
164201985|NCT01041859|593112623|FG000|Double-Blind Maintenance|Physician Decision|0|||
164310928|NCT03023813|593512998|FG001|Overall Study|Lost to Follow-up|2|||
164310929|NCT03023813|593512999|FG002|Overall Study|Lost to Follow-up|0|||
164310930|NCT03710083|593513000|FG000|Overall Study|Withdrawal by Subject|2|||
164310931|NCT03710083|593513000|FG000|Overall Study|Unsuccessful Procedure|1|||
164310932|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
164310933|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
164310934|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
164310935|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
164310936|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
164310937|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
164310938|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
164310939|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
164310940|NCT02283762|593513001|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
164310941|NCT02283762|593513002|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
164310942|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
164310943|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
164310944|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
164310945|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
164310946|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
164310947|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
164310948|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
164310949|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
164310950|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
164310951|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
164310952|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
164310953|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
164310954|NCT02283762|593513001|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
164310955|NCT02283762|593513002|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
164310956|NCT00202878|593513006|FG000|Overall Study|Death|964|||
164310957|NCT00202878|593513007|FG001|Overall Study|Death|968|||
164310958|NCT00202878|593513006|FG000|Overall Study|Only Vital Status Known|357|||
164310959|NCT00202878|593513007|FG001|Overall Study|Only Vital Status Known|356|||
164310960|NCT00202878|593513006|FG000|Overall Study|Lost to Follow-up|44|||
164310961|NCT00202878|593513007|FG001|Overall Study|Lost to Follow-up|49|||
164310962|NCT00202878|593513006|FG000|Overall Study|Site Closure|39|||
164310963|NCT00202878|593513007|FG001|Overall Study|Site Closure|36|||
164310964|NCT00202878|593513006|FG000|Overall Study|Withdrawal by Subject|795|||
164310965|NCT00202878|593513007|FG001|Overall Study|Withdrawal by Subject|808|||
164310966|NCT00975780|593513016|FG000|Follow Up|Death|88|||
164310967|NCT00975780|593513017|FG001|Follow Up|Death|122|||
164310968|NCT00975780|593513016|FG000|Follow Up|Facility Withdrawal|7|||
164310969|NCT00975780|593513017|FG001|Follow Up|Facility Withdrawal|23|||
164310970|NCT00975780|593513016|FG000|Follow Up|Discharged from Facility|7|||
164310971|NCT00975780|593513017|FG001|Follow Up|Discharged from Facility|12|||
164310972|NCT02813577|593513018|FG000|Overall Study|Study terminated|4|||
164310973|NCT00035932|593513019|FG000|Overall Study|Adverse Event|10|||
164310974|NCT00035932|593513020|FG001|Overall Study|Adverse Event|9|||
164310975|NCT00035932|593513021|FG002|Overall Study|Adverse Event|9|||
164310976|NCT00035932|593513019|FG000|Overall Study|Death|0|||
164310977|NCT00035932|593513020|FG001|Overall Study|Death|0|||
164310978|NCT00035932|593513021|FG002|Overall Study|Death|1|||
164310979|NCT00035932|593513019|FG000|Overall Study|Disease Progression / Relapse|1|||
164310980|NCT00035932|593513020|FG001|Overall Study|Disease Progression / Relapse|1|||
163867118|NCT03482011|591880241|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
163867119|NCT03482011|591880242|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163867120|NCT03482011|591880243|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163867121|NCT03482011|591880244|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163867122|NCT03482011|591880245|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163867123|NCT03482011|591880246|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163867124|NCT03482011|591880247|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163971312|NCT06156215|592266315|FG002|Overall Study|Left ED without completing study|9|||
163971313|NCT06156215|592266316|FG003|Overall Study|Left ED without completing study|0|||
163971314|NCT06156215|592266317|FG004|Overall Study|Left ED without completing study|8|||
163971315|NCT06156215|592266318|FG005|Overall Study|Left ED without completing study|16|||
164310981|NCT00035932|593513021|FG002|Overall Study|Disease Progression / Relapse|0|||
164310982|NCT00035932|593513019|FG000|Overall Study|Lost to Follow-up|4|||
164310983|NCT00035932|593513020|FG001|Overall Study|Lost to Follow-up|4|||
164310984|NCT00035932|593513021|FG002|Overall Study|Lost to Follow-up|3|||
164310985|NCT00035932|593513019|FG000|Overall Study|Noncompliance|6|||
164310986|NCT00035932|593513020|FG001|Overall Study|Noncompliance|7|||
164310987|NCT00035932|593513021|FG002|Overall Study|Noncompliance|6|||
164310988|NCT00035932|593513019|FG000|Overall Study|Protocol Violation While on Study|0|||
164310989|NCT00035932|593513020|FG001|Overall Study|Protocol Violation While on Study|1|||
163867125|NCT03482011|591880240|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163971316|NCT06156215|592266313|FG000|Overall Study|Physician Decision|1|||
163971317|NCT06156215|592266314|FG001|Overall Study|Physician Decision|0|||
163971318|NCT06156215|592266315|FG002|Overall Study|Physician Decision|0|||
163971319|NCT06156215|592266316|FG003|Overall Study|Physician Decision|0|||
163971320|NCT06156215|592266317|FG004|Overall Study|Physician Decision|0|||
163971321|NCT06156215|592266318|FG005|Overall Study|Physician Decision|0|||
163971322|NCT06156215|592266313|FG000|Overall Study|Became or found ineligible|2|||
163971323|NCT06156215|592266314|FG001|Overall Study|Became or found ineligible|0|||
164310990|NCT00035932|593513021|FG002|Overall Study|Protocol Violation While on Study|2|||
164310991|NCT00035932|593513019|FG000|Overall Study|Withdrawal by Subject|1|||
164310992|NCT00035932|593513020|FG001|Overall Study|Withdrawal by Subject|5|||
163971324|NCT06156215|592266315|FG002|Overall Study|Became or found ineligible|2|||
163971325|NCT06156215|592266316|FG003|Overall Study|Became or found ineligible|0|||
163971326|NCT06156215|592266317|FG004|Overall Study|Became or found ineligible|1|||
163971327|NCT06156215|592266318|FG005|Overall Study|Became or found ineligible|2|||
163971328|NCT04198623|592267901|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
163971329|NCT00736255|592267909|FG000|Overall Study|Adverse Event|1|||
163971330|NCT00736255|592267910|FG001|Overall Study|Adverse Event|0|||
163971331|NCT00736255|592267909|FG000|Overall Study|Physician Decision|1|||
163971332|NCT00736255|592267910|FG001|Overall Study|Physician Decision|0|||
163971333|NCT00736255|592267909|FG000|Overall Study|Non-compliance|1|||
163971334|NCT00736255|592267910|FG001|Overall Study|Non-compliance|1|||
163971335|NCT00457015|592267916|FG000|Overall Study|Left study site against medical advice|0|||
163971336|NCT00457015|592267917|FG001|Overall Study|Left study site against medical advice|1|||
163971337|NCT03670953|592267918|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
164310993|NCT00035932|593513021|FG002|Overall Study|Withdrawal by Subject|0|||
164310994|NCT00035932|593513019|FG000|Overall Study|Study Termination by Sponsor|1|||
164310995|NCT00035932|593513020|FG001|Overall Study|Study Termination by Sponsor|0|||
164310996|NCT00035932|593513021|FG002|Overall Study|Study Termination by Sponsor|0|||
164310997|NCT00035932|593513019|FG000|Overall Study|Lack of Efficacy|33|||
164310998|NCT00035932|593513020|FG001|Overall Study|Lack of Efficacy|33|||
164310999|NCT00035932|593513021|FG002|Overall Study|Lack of Efficacy|28|||
164311000|NCT01976741|593513022|FG000|Overall Study|Withdrawal by Subject|1|||
164311001|NCT01976741|593513023|FG001|Overall Study|Withdrawal by Subject|0|||
164311002|NCT01976741|593513024|FG002|Overall Study|Withdrawal by Subject|1|||
164311003|NCT01976741|593513025|FG003|Overall Study|Withdrawal by Subject|1|||
164311004|NCT01976741|593513026|FG004|Overall Study|Withdrawal by Subject|0|||
164311005|NCT01976741|593513027|FG005|Overall Study|Withdrawal by Subject|0|||
164311006|NCT01976741|593513028|FG006|Overall Study|Withdrawal by Subject|1|||
164311007|NCT01976741|593513029|FG007|Overall Study|Withdrawal by Subject|4|||
164311008|NCT01976741|593513030|FG008|Overall Study|Withdrawal by Subject|0|||
164311009|NCT01976741|593513031|FG009|Overall Study|Withdrawal by Subject|0|||
164311010|NCT01976741|593513022|FG000|Overall Study|Adverse Event|0|||
164311011|NCT01976741|593513023|FG001|Overall Study|Adverse Event|0|||
164311012|NCT01976741|593513024|FG002|Overall Study|Adverse Event|2|||
164311013|NCT01976741|593513025|FG003|Overall Study|Adverse Event|0|||
164311014|NCT01976741|593513026|FG004|Overall Study|Adverse Event|0|||
164311015|NCT01976741|593513027|FG005|Overall Study|Adverse Event|0|||
164311016|NCT01976741|593513028|FG006|Overall Study|Adverse Event|3|||
164311017|NCT01976741|593513029|FG007|Overall Study|Adverse Event|8|||
164311018|NCT01976741|593513030|FG008|Overall Study|Adverse Event|1|||
164311019|NCT01976741|593513031|FG009|Overall Study|Adverse Event|4|||
164311020|NCT00889720|593513032|FG000|Overall Study|Withdrawal by Subject|4|||
164311021|NCT00889720|593513032|FG000|Overall Study|Other|4|||
164311022|NCT03865381|593513040|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
164311023|NCT03865381|593513040|FG000|Overall Study|Withdrawal by Subject|2|||
164311024|NCT02873377|593513041|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
164311025|NCT02873377|593513042|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
164311026|NCT02873377|593513041|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
164311027|NCT02873377|593513042|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
164311028|NCT00104520|593513043|FG000|Overall Study|Unrelated adverse event|34|||
164311029|NCT00104520|593513044|FG001|Overall Study|Unrelated adverse event|47|||
164311030|NCT00104520|593513043|FG000|Overall Study|Study drug intolerance|0|||
163971338|NCT03670953|592267919|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
163971339|NCT03670953|592267920|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
163971340|NCT03670953|592267921|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
163971341|NCT03670953|592267918|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
163971342|NCT03670953|592267919|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
164311031|NCT00104520|593513044|FG001|Overall Study|Study drug intolerance|1|||
164311032|NCT00104520|593513043|FG000|Overall Study|Related adverse event|13|||
164311033|NCT00104520|593513044|FG001|Overall Study|Related adverse event|15|||
164311034|NCT00104520|593513043|FG000|Overall Study|Lost to Follow-up|1|||
164311035|NCT00104520|593513044|FG001|Overall Study|Lost to Follow-up|0|||
164311036|NCT00104520|593513043|FG000|Overall Study|Noncompliance|0|||
164311037|NCT00104520|593513044|FG001|Overall Study|Noncompliance|2|||
164311038|NCT00104520|593513043|FG000|Overall Study|Personal/administrative|1|||
164311039|NCT00104520|593513044|FG001|Overall Study|Personal/administrative|1|||
164311040|NCT00104520|593513043|FG000|Overall Study|Other|1|||
164311041|NCT00104520|593513044|FG001|Overall Study|Other|5|||
164311042|NCT00452361|593513045|FG000|Overall Study|Adverse Event|8|||
164311043|NCT00452361|593513046|FG001|Overall Study|Adverse Event|0|||
164311044|NCT00452361|593513045|FG000|Overall Study|Withdrawal by Subject|0|||
164311045|NCT00452361|593513046|FG001|Overall Study|Withdrawal by Subject|1|||
164311046|NCT00452361|593513045|FG000|Overall Study|Premature termination|13|||
164311047|NCT00452361|593513046|FG001|Overall Study|Premature termination|9|||
164311048|NCT00233064|593513049|FG000|Overall Study|Lost to Follow-up|7|||
164311049|NCT00233064|593513050|FG001|Overall Study|Lost to Follow-up|7|||
164311050|NCT00233064|593513049|FG000|Overall Study|Withdrawal by Subject|5|||
164311051|NCT00233064|593513050|FG001|Overall Study|Withdrawal by Subject|3|||
164311052|NCT00233064|593513049|FG000|Overall Study|Death|0|||
164311053|NCT00233064|593513050|FG001|Overall Study|Death|1|||
164311054|NCT00233064|593513049|FG000|Overall Study|Relocation|0|||
164311055|NCT00233064|593513050|FG001|Overall Study|Relocation|1|||
164311056|NCT00233064|593513049|FG000|Overall Study|Protocol Violation|1|||
164311057|NCT00233064|593513050|FG001|Overall Study|Protocol Violation|0|||
164311058|NCT00233064|593513049|FG000|Overall Study|Moved to Dom. Republic|1|||
164311059|NCT00233064|593513050|FG001|Overall Study|Moved to Dom. Republic|0|||
164311060|NCT02302339|593513051|FG000|Overall Study|Lost to Follow-up|1|||
164311061|NCT02302339|593513052|FG001|Overall Study|Lost to Follow-up|0|||
164311062|NCT02302339|593513053|FG002|Overall Study|Lost to Follow-up|0|||
164311063|NCT02302339|593513054|FG003|Overall Study|Lost to Follow-up|0|||
164311064|NCT02302339|593513051|FG000|Overall Study|Withdrawal by Subject|0|||
164311065|NCT02302339|593513052|FG001|Overall Study|Withdrawal by Subject|2|||
164311066|NCT02302339|593513053|FG002|Overall Study|Withdrawal by Subject|1|||
164311067|NCT02302339|593513054|FG003|Overall Study|Withdrawal by Subject|0|||
164311068|NCT00494676|593513058|FG000|Allocation|Withdrawal by Subject|2|||
164311069|NCT00494676|593513059|FG001|Allocation|Withdrawal by Subject|4|||
164311070|NCT00494676|593513058|FG000|First Intervention|Withdrawal by Subject|1|||
164311071|NCT00494676|593513059|FG001|First Intervention|Withdrawal by Subject|3|||
164311072|NCT00494676|593513058|FG000|Second Intervention|Withdrawal by Subject|1|||
164311073|NCT00494676|593513059|FG001|Second Intervention|Withdrawal by Subject|1|||
164311074|NCT04073225|593513060|FG000|Overall Study|Lost to Follow-up|4|||
164311075|NCT04073225|593513061|FG001|Overall Study|Lost to Follow-up|3|||
164311076|NCT04238819|593513063|FG000|Overall Study|Ongoing Treatment|0|||
164311077|NCT04238819|593513064|FG001|Overall Study|Ongoing Treatment|0|||
164311078|NCT04238819|593513065|FG002|Overall Study|Ongoing Treatment|0|||
164311079|NCT04238819|593513066|FG003|Overall Study|Ongoing Treatment|0|||
164311080|NCT04238819|593513067|FG004|Overall Study|Ongoing Treatment|1|||
164311081|NCT04238819|593513068|FG005|Overall Study|Ongoing Treatment|4|||
164311082|NCT04238819|593513069|FG006|Overall Study|Ongoing Treatment|0|||
164311083|NCT04238819|593513063|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
164311084|NCT04238819|593513064|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
164311085|NCT04238819|593513065|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
164311086|NCT04238819|593513066|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
164311087|NCT04238819|593513067|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
164311088|NCT04238819|593513068|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
164311089|NCT04238819|593513069|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
164311090|NCT03892967|593513070|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
164311091|NCT03892967|593513071|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
164311092|NCT03892967|593513072|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
164311093|NCT03892967|593513073|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
163971343|NCT03670953|592267920|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
163971344|NCT03670953|592267921|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
163971345|NCT03670953|592267918|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
163971346|NCT03670953|592267919|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
163971347|NCT03670953|592267920|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
163971348|NCT03670953|592267921|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
163971349|NCT03670953|592267918|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
163971350|NCT03670953|592267919|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
163971351|NCT03670953|592267920|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
164311094|NCT03892967|593513074|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
164311095|NCT03892967|593513070|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
164311096|NCT03892967|593513071|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
164311097|NCT03892967|593513072|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
163971352|NCT03670953|592267921|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
163971353|NCT03670953|592267918|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
163971354|NCT03670953|592267919|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
163971355|NCT03670953|592267920|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
163971356|NCT03670953|592267921|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
163971357|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
163971358|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
163971359|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
163971360|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
163971361|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
163971362|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
163971363|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
163971364|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
163971365|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
163971366|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
163971367|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
163971368|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
163971369|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
163971370|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
163971371|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
163971372|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
163971373|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
163971374|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
163971375|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
163971376|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
163971377|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
163971378|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
163971379|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
163971380|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
163971381|NCT03670953|592267918|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
163971382|NCT03670953|592267919|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
163971383|NCT03670953|592267920|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
163971384|NCT03670953|592267921|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
163971385|NCT03670953|592267918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
163971386|NCT03670953|592267919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
163971387|NCT03670953|592267920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
163971388|NCT03670953|592267921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
163971389|NCT03670953|592267918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
163971390|NCT03670953|592267919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
163971391|NCT03670953|592267920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
163971392|NCT03670953|592267921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
163971393|NCT03670953|592267918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
163971394|NCT03670953|592267919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
163971395|NCT03670953|592267920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
163971396|NCT03670953|592267921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
163971397|NCT03670953|592267918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
163971398|NCT03670953|592267919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
163971399|NCT03670953|592267920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
163971400|NCT03670953|592267921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
163971401|NCT03670953|592267918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
163971402|NCT03670953|592267919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
163971403|NCT03670953|592267920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
163971404|NCT03670953|592267921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
163971405|NCT03670953|592267918|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
163971406|NCT03670953|592267919|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
163971407|NCT03670953|592267920|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
163971408|NCT03670953|592267921|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
163971409|NCT04179734|592267922|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
163971410|NCT04179734|592267923|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
163971411|NCT04179734|592267922|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
163971412|NCT04179734|592267923|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
163971413|NCT00937937|592267924|FG000|Overall Study|Adverse Event|6|||
163971414|NCT00937937|592267924|FG000|Overall Study|Withdrawal by Subject|2|||
163971415|NCT00937937|592267924|FG000|Overall Study|Progression/relapse|61|||
163971416|NCT00937937|592267924|FG000|Overall Study|Death|1|||
163971417|NCT00937937|592267924|FG000|Overall Study|Other|2|||
164201986|NCT01041859|593112624|FG001|Double-Blind Maintenance|Physician Decision|2|||
164201987|NCT01041859|593112625|FG002|Double-Blind Maintenance|Physician Decision|1|||
164302985|NCT02205736|593484679|FG000|Overall Study|Lost to Follow-up|106|||
164311098|NCT03892967|593513073|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
164311099|NCT03892967|593513074|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
164311100|NCT03892967|593513070|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
163971418|NCT00054704|592267925|FG000|Overall Study|Lack of Efficacy|2|||
163971419|NCT00054704|592267926|FG001|Overall Study|Lack of Efficacy|3|||
163971420|NCT00054704|592267925|FG000|Overall Study|Adverse Event|3|||
163971421|NCT00054704|592267926|FG001|Overall Study|Adverse Event|1|||
163971422|NCT00054704|592267925|FG000|Overall Study|Lost to Follow-up|0|||
163971423|NCT00054704|592267926|FG001|Overall Study|Lost to Follow-up|1|||
163971424|NCT00362414|592267929|FG000|Overall Study|Death|2|||
163971425|NCT00362414|592267929|FG000|Overall Study|Adverse Event|1|||
163971426|NCT01785160|592267935|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
163971427|NCT01785160|592267935|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
163971428|NCT00915772|592267937|FG000|Overall Study|Adverse Event|12|||
163971429|NCT00915772|592267938|FG001|Overall Study|Adverse Event|13|||
163971430|NCT00915772|592267939|FG002|Overall Study|Adverse Event|11|||
163971431|NCT00915772|592267937|FG000|Overall Study|Protocol Violation|4|||
163971432|NCT00915772|592267938|FG001|Overall Study|Protocol Violation|1|||
163971433|NCT00915772|592267939|FG002|Overall Study|Protocol Violation|2|||
163971434|NCT00915772|592267937|FG000|Overall Study|Lost to Follow-up|1|||
163971435|NCT00915772|592267938|FG001|Overall Study|Lost to Follow-up|2|||
163971436|NCT00915772|592267939|FG002|Overall Study|Lost to Follow-up|2|||
163971437|NCT00915772|592267937|FG000|Overall Study|Lack of Efficacy|9|||
163971438|NCT00915772|592267938|FG001|Overall Study|Lack of Efficacy|15|||
163971439|NCT00915772|592267939|FG002|Overall Study|Lack of Efficacy|3|||
163971440|NCT00915772|592267937|FG000|Overall Study|Refused to continue trial medication|6|||
163971441|NCT00915772|592267938|FG001|Overall Study|Refused to continue trial medication|8|||
163971442|NCT00915772|592267939|FG002|Overall Study|Refused to continue trial medication|4|||
163971443|NCT00915772|592267937|FG000|Overall Study|Any other reason|4|||
163971444|NCT00915772|592267938|FG001|Overall Study|Any other reason|7|||
163971445|NCT00915772|592267939|FG002|Overall Study|Any other reason|7|||
163971446|NCT01365039|592267942|FG000|Overall Study|Study related symptoms and complaints|1|||
163971447|NCT01365039|592267943|FG001|Overall Study|Study related symptoms and complaints|0|||
163971448|NCT00549939|592267952|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
163971449|NCT00549939|592267953|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
163971450|NCT00549939|592267954|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
163971451|NCT00549939|592267952|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
163971452|NCT00549939|592267953|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
163971453|NCT00549939|592267954|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
163971454|NCT00549939|592267952|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
163971455|NCT00549939|592267953|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
163971456|NCT00549939|592267954|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
163971457|NCT00549939|592267952|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
163971458|NCT00549939|592267953|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
163971459|NCT00549939|592267954|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
163971460|NCT00549939|592267952|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
163971461|NCT00549939|592267953|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
163971462|NCT00549939|592267954|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
163971463|NCT00549939|592267952|FG000|40-week Open Label Treatment Period|Other|0|||
163971464|NCT00549939|592267953|FG001|40-week Open Label Treatment Period|Other|1|||
163971465|NCT00549939|592267954|FG002|40-week Open Label Treatment Period|Other|4|||
163971466|NCT03677596|592267955|FG000|Overall Study|Adverse Event|0|||
163971467|NCT03677596|592267956|FG001|Overall Study|Adverse Event|1|||
163971468|NCT03677596|592267955|FG000|Overall Study|Death|10|||
163971469|NCT03677596|592267956|FG001|Overall Study|Death|6|||
163971470|NCT03677596|592267955|FG000|Overall Study|Lost to Follow-up|0|||
163971471|NCT03677596|592267956|FG001|Overall Study|Lost to Follow-up|1|||
163971472|NCT03677596|592267955|FG000|Overall Study|Progressive Disease|8|||
163971473|NCT03677596|592267956|FG001|Overall Study|Progressive Disease|8|||
163971474|NCT03677596|592267955|FG000|Overall Study|Withdrawal by Subject|3|||
163971475|NCT03677596|592267956|FG001|Overall Study|Withdrawal by Subject|0|||
163971476|NCT03677596|592267955|FG000|Overall Study|Disease Relapse|2|||
163971477|NCT03677596|592267956|FG001|Overall Study|Disease Relapse|2|||
163971478|NCT03677596|592267955|FG000|Overall Study|Other|0|||
163971479|NCT03677596|592267956|FG001|Overall Study|Other|1|||
163971480|NCT01360554|592267957|FG000|Overall Study|Death|359|||
163971481|NCT01360554|592267958|FG001|Overall Study|Death|371|||
163971482|NCT01360554|592267957|FG000|Overall Study|Lost to Follow-up|4|||
163971483|NCT01360554|592267958|FG001|Overall Study|Lost to Follow-up|4|||
163971484|NCT01360554|592267957|FG000|Overall Study|Withdrawal by Subject|23|||
163971485|NCT01360554|592267958|FG001|Overall Study|Withdrawal by Subject|24|||
163971486|NCT01360554|592267957|FG000|Overall Study|Study terminated by sponsor|49|||
163971487|NCT01360554|592267958|FG001|Overall Study|Study terminated by sponsor|37|||
163971488|NCT01360554|592267957|FG000|Overall Study|Other, not specified|1|||
163971489|NCT01360554|592267958|FG001|Overall Study|Other, not specified|0|||
163971490|NCT01360554|592267957|FG000|Overall Study|Randomized but not treated.|3|||
163971491|NCT01360554|592267958|FG001|Overall Study|Randomized but not treated.|3|||
163971492|NCT01131676|592267965|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
163971493|NCT01131676|592267966|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
163971494|NCT01131676|592267967|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
163971495|NCT01131676|592267965|FG000|Discontinuation From Treatment|Not treated|4|||
163971496|NCT01131676|592267966|FG001|Discontinuation From Treatment|Not treated|2|||
163971497|NCT01131676|592267967|FG002|Discontinuation From Treatment|Not treated|2|||
163971498|NCT01131676|592267965|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
163971499|NCT01131676|592267966|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
163971500|NCT01131676|592267967|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
163971501|NCT01131676|592267965|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
163971502|NCT01131676|592267966|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
163971503|NCT01131676|592267967|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
163971504|NCT01131676|592267965|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
163971505|NCT01131676|592267966|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
163971506|NCT01131676|592267967|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
163971507|NCT01131676|592267965|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
163971508|NCT01131676|592267966|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
163971509|NCT01131676|592267967|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
163971510|NCT01131676|592267965|FG000|Discontinuation From Treatment|Other than those specified|162|||
163971511|NCT01131676|592267966|FG001|Discontinuation From Treatment|Other than those specified|142|||
163971512|NCT01131676|592267967|FG002|Discontinuation From Treatment|Other than those specified|125|||
163971513|NCT01131676|592267965|FG000|Discontinuation From Treatment|Adverse Event|303|||
163971514|NCT01131676|592267966|FG001|Discontinuation From Treatment|Adverse Event|267|||
163971515|NCT01131676|592267967|FG002|Discontinuation From Treatment|Adverse Event|273|||
163971516|NCT01131676|592267965|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
163971517|NCT01131676|592267966|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
163971518|NCT01131676|592267967|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
163971519|NCT01131676|592267965|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
163971520|NCT01131676|592267966|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
163971521|NCT01131676|592267967|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
163971522|NCT01131676|592267965|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
163971523|NCT01131676|592267966|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
163971524|NCT01131676|592267967|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
163971525|NCT01131676|592267965|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
163971526|NCT01131676|592267966|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
163971527|NCT01131676|592267967|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
163971528|NCT01131676|592267965|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
163971529|NCT01131676|592267966|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
163971530|NCT01131676|592267967|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
163971531|NCT01131676|592267965|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
163971532|NCT01131676|592267966|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
163971533|NCT01131676|592267967|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
163971534|NCT01816061|592267969|FG000|Overall Study|Lost to Follow-up|13|||
163971535|NCT01816061|592267970|FG001|Overall Study|Lost to Follow-up|24|||
163971536|NCT00702325|592267983|FG000|Overall Study|Adverse Event|1|||
163971537|NCT00702325|592267984|FG001|Overall Study|Adverse Event|0|||
163971538|NCT00702325|592267983|FG000|Overall Study|Withdrawal by Subject|7|||
163971539|NCT00702325|592267984|FG001|Overall Study|Withdrawal by Subject|7|||
163971540|NCT00702325|592267983|FG000|Overall Study|Lost to Follow-up|3|||
163971541|NCT00702325|592267984|FG001|Overall Study|Lost to Follow-up|4|||
163971542|NCT00702325|592267983|FG000|Overall Study|Incorrect enrollment|5|||
163971543|NCT00702325|592267984|FG001|Overall Study|Incorrect enrollment|7|||
163971544|NCT00702325|592267983|FG000|Overall Study|Developed study discontinuation criteria|18|||
163971545|NCT00702325|592267984|FG001|Overall Study|Developed study discontinuation criteria|28|||
163971546|NCT00702325|592267983|FG000|Overall Study|Severe noncompliance to protocol|3|||
164311101|NCT03892967|593513071|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
164311102|NCT03892967|593513072|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
164311103|NCT03892967|593513073|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
164355613|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
164311104|NCT03892967|593513074|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
164311105|NCT03892967|593513070|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
164311106|NCT03892967|593513071|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
164311107|NCT03892967|593513072|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
164311108|NCT03892967|593513073|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
164311109|NCT03892967|593513074|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
164311110|NCT03892967|593513070|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
164311111|NCT03892967|593513071|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
164311112|NCT03892967|593513072|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
164311113|NCT03892967|593513073|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
164311114|NCT03892967|593513074|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
164311115|NCT03892967|593513070|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
164311116|NCT03892967|593513071|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
164311117|NCT03892967|593513072|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
164311118|NCT03892967|593513073|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
164311119|NCT03892967|593513074|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
164311120|NCT05767749|593513078|FG000|Overall Study|Withdrawal by Subject|0|||
164311121|NCT05767749|593513079|FG001|Overall Study|Withdrawal by Subject|0|||
164311122|NCT05767749|593513080|FG002|Overall Study|Withdrawal by Subject|2|||
164311123|NCT05767749|593513081|FG003|Overall Study|Withdrawal by Subject|2|||
164311124|NCT05767749|593513082|FG004|Overall Study|Withdrawal by Subject|2|||
164311125|NCT05767749|593513083|FG005|Overall Study|Withdrawal by Subject|2|||
164311126|NCT04236141|593515206|FG000|Overall Study|Death|18|||
164311127|NCT04236141|593515207|FG001|Overall Study|Death|10|||
164311128|NCT04236141|593515206|FG000|Overall Study|Withdrawal by Participant|1|||
164311129|NCT04236141|593515207|FG001|Overall Study|Withdrawal by Participant|0|||
164311130|NCT04236141|593515206|FG000|Overall Study|Reason not Specified|1|||
164311131|NCT04236141|593515207|FG001|Overall Study|Reason not Specified|0|||
164311132|NCT04236141|593515206|FG000|Overall Study|Study terminated by Sponsor|8|||
164311133|NCT04236141|593515207|FG001|Overall Study|Study terminated by Sponsor|4|||
164311134|NCT01657461|593515208|FG000|Overall Study|Death|9|||
164311135|NCT01657461|593515209|FG001|Overall Study|Death|12|||
164311136|NCT01657461|593515208|FG000|Overall Study|Lost to Follow-up|0|||
164311137|NCT01657461|593515209|FG001|Overall Study|Lost to Follow-up|3|||
164311138|NCT01657461|593515208|FG000|Overall Study|Physician Decision|0|||
164311139|NCT01657461|593515209|FG001|Overall Study|Physician Decision|2|||
164311140|NCT01657461|593515208|FG000|Overall Study|Withdrawal by Subject|1|||
164311141|NCT01657461|593515209|FG001|Overall Study|Withdrawal by Subject|3|||
164311142|NCT01754727|593515214|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
164311143|NCT02848729|593515217|FG000|Overall Study|Withdrawal by Subject|1|||
163971547|NCT00702325|592267984|FG001|Overall Study|Severe noncompliance to protocol|3|||
163971548|NCT00702325|592267983|FG000|Overall Study|Termination due to lab results|1|||
163971549|NCT00702325|592267984|FG001|Overall Study|Termination due to lab results|0|||
163971550|NCT00702325|592267983|FG000|Overall Study|Didn't follow study medication dosage|0|||
163971551|NCT00702325|592267984|FG001|Overall Study|Didn't follow study medication dosage|2|||
163971552|NCT00702325|592267983|FG000|Overall Study|Withdrew consent|0|||
163971553|NCT00702325|592267984|FG001|Overall Study|Withdrew consent|1|||
163971554|NCT00702325|592267983|FG000|Overall Study|Incorrectly Discontinued|0|||
163971555|NCT00702325|592267984|FG001|Overall Study|Incorrectly Discontinued|1|||
163971556|NCT01022502|592267987|FG000|Overall Study|Adverse Event|1|||
163971557|NCT01022502|592267987|FG000|Overall Study|employment related reasons|1|||
163971558|NCT01022502|592267987|FG000|Overall Study|Withdrawal by Subject|1|||
163971559|NCT01289821|592267991|FG000|Treatment Period|Withdrawal by Subject|1|||
163971560|NCT01289821|592267991|FG000|Treatment Period|Physician Decision|3|||
163971561|NCT01289821|592267991|FG000|Treatment Period|Adverse Event|4|||
163971562|NCT01289821|592267991|FG000|Treatment Period|Radiological Progression|43|||
163971563|NCT01289821|592267991|FG000|Treatment Period|Clinical Progression|2|||
163971564|NCT01289821|592267991|FG000|Treatment Period|Therapeutic procedure required|1|||
163971565|NCT01289821|592267991|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
163971566|NCT01289821|592267991|FG000|Safety Follow-up Period|Protocol Violation|3|||
163971567|NCT01289821|592267991|FG000|Safety Follow-up Period|Unspecified reason|1|||
163971568|NCT01289821|592267991|FG000|Survival Follow-up Period|Protocol Violation|1|||
163971569|NCT01289821|592267991|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
164311144|NCT02848729|593515218|FG001|Overall Study|Withdrawal by Subject|0|||
164311145|NCT02848729|593515217|FG000|Overall Study|Emesis|15|||
164311146|NCT02848729|593515218|FG001|Overall Study|Emesis|11|||
164311147|NCT04838977|593515219|FG000|Overall Study|Lost to Follow-up|2|||
164311148|NCT04838977|593515220|FG001|Overall Study|Lost to Follow-up|3|||
164311149|NCT04838977|593515219|FG000|Overall Study|Withdrawal by Subject|1|||
164311150|NCT04838977|593515220|FG001|Overall Study|Withdrawal by Subject|1|||
164311151|NCT05367492|593515221|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
164311152|NCT05367492|593515222|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
164311153|NCT05367492|593515223|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
164311154|NCT05367492|593515221|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
164311155|NCT05367492|593515222|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
164311156|NCT05367492|593515223|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
164311157|NCT05367492|593515221|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
164311158|NCT05367492|593515222|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
164311159|NCT05367492|593515223|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
164311160|NCT05367492|593515221|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
164311161|NCT05367492|593515222|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
164311162|NCT05367492|593515223|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
164311163|NCT00950859|593515227|FG000|Overall Study|Adverse Event|3|||
164311164|NCT00950859|593515228|FG001|Overall Study|Adverse Event|3|||
164311165|NCT00950859|593515227|FG000|Overall Study|Insufficient Viral Load Response|12|||
164311166|NCT00950859|593515228|FG001|Overall Study|Insufficient Viral Load Response|3|||
164311167|NCT00950859|593515227|FG000|Overall Study|Protocol Violation|1|||
164311168|NCT00950859|593515228|FG001|Overall Study|Protocol Violation|1|||
164311169|NCT00950859|593515227|FG000|Overall Study|Lost to Follow-up|0|||
164311170|NCT00950859|593515228|FG001|Overall Study|Lost to Follow-up|3|||
164311171|NCT00265148|593515229|FG000|Overall Study|Adverse Event|2|||
164311172|NCT00265148|593515230|FG001|Overall Study|Adverse Event|2|||
163867126|NCT03482011|591880241|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
163867127|NCT03482011|591880242|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163867128|NCT03482011|591880243|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163867129|NCT03482011|591880244|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163867130|NCT03482011|591880245|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163867131|NCT03482011|591880246|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163867132|NCT03482011|591880247|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
163867133|NCT03482011|591880240|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
163867134|NCT03482011|591880241|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
163867135|NCT03482011|591880242|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
163867136|NCT03482011|591880243|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
163867137|NCT03482011|591880244|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
163867138|NCT03482011|591880245|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
163867139|NCT03482011|591880246|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
163867140|NCT03482011|591880247|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
163867141|NCT03482011|591880240|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
163867142|NCT03482011|591880241|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
163867143|NCT03482011|591880242|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163867144|NCT03482011|591880243|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163867145|NCT03482011|591880244|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163867146|NCT03482011|591880245|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163867147|NCT03482011|591880246|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163867148|NCT03482011|591880247|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
163867149|NCT03482011|591880240|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
163867150|NCT03482011|591880241|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
163867151|NCT03482011|591880242|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
163867152|NCT03482011|591880243|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
163867153|NCT03482011|591880244|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
163867154|NCT03482011|591880245|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
163867155|NCT03482011|591880246|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
163867156|NCT03482011|591880247|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
163867157|NCT03482011|591880240|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163867158|NCT03482011|591880241|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
163867159|NCT03482011|591880242|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
163867160|NCT03482011|591880243|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
163867161|NCT03482011|591880244|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
163867162|NCT03482011|591880245|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
163867163|NCT03482011|591880246|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164311173|NCT00265148|593515229|FG000|Overall Study|Lack of Efficacy|0|||
164311174|NCT00265148|593515230|FG001|Overall Study|Lack of Efficacy|2|||
164311175|NCT00265148|593515229|FG000|Overall Study|Protocol Violation|3|||
164311176|NCT00265148|593515230|FG001|Overall Study|Protocol Violation|2|||
164311177|NCT00265148|593515229|FG000|Overall Study|Lost to Follow-up|0|||
164311178|NCT00265148|593515230|FG001|Overall Study|Lost to Follow-up|1|||
164311179|NCT00265148|593515229|FG000|Overall Study|Withdrawal by Subject|2|||
163971570|NCT01289821|592267991|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
163971571|NCT03086057|592267998|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
163971572|NCT03086057|592267999|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
163971573|NCT03086057|592268000|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
164311180|NCT00265148|593515230|FG001|Overall Study|Withdrawal by Subject|1|||
164311181|NCT00265148|593515229|FG000|Overall Study|Physician Decision|1|||
164311182|NCT00265148|593515230|FG001|Overall Study|Physician Decision|0|||
164311183|NCT00265148|593515229|FG000|Overall Study|Increasing frailty|0|||
164311184|NCT00265148|593515230|FG001|Overall Study|Increasing frailty|1|||
164311185|NCT00265148|593515229|FG000|Overall Study|Subject chose to change of the dose|1|||
164311186|NCT00265148|593515230|FG001|Overall Study|Subject chose to change of the dose|0|||
164311187|NCT01463007|593515231|FG000|Overall Study|Physician Decision|1|||
164311188|NCT03583385|593515232|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164311189|NCT03583385|593515233|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164311190|NCT03583385|593515232|FG000|Treatment Period 2|Adverse Event|1|||
164311191|NCT03583385|593515233|FG001|Treatment Period 2|Adverse Event|0|||
164311192|NCT03539549|593515236|FG000|Overall Study|Adverse Event|12|||
164311193|NCT03539549|593515236|FG000|Overall Study|Lost to Follow-up|1|||
164311194|NCT03539549|593515236|FG000|Overall Study|Death|2|||
164311195|NCT03539549|593515236|FG000|Overall Study|Progressive Disease|1|||
164311196|NCT03539549|593515236|FG000|Overall Study|Reason not Specified|1|||
164311197|NCT01652469|593515240|FG000|Overall Study|Withdrawal by Subject|1|||
164311198|NCT01652469|593515241|FG001|Overall Study|Withdrawal by Subject|4|||
164311199|NCT01652469|593515240|FG000|Overall Study|Lost to Follow-up|0|||
164311200|NCT01652469|593515241|FG001|Overall Study|Lost to Follow-up|2|||
164311201|NCT02123472|593515242|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
164311202|NCT02123472|593515243|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
164311203|NCT00918736|593515244|FG000|Overall Study|Withdrawal by Subject|4|||
164311204|NCT01474018|593515245|FG000|Overall Study|Lost to Follow-up|0|||
164311205|NCT01474018|593515246|FG001|Overall Study|Lost to Follow-up|1|||
163971574|NCT03086057|592268001|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
163971575|NCT03086057|592267998|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
163971576|NCT03086057|592267999|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
163971577|NCT03086057|592268000|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
163971578|NCT03086057|592268001|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
163971579|NCT03086057|592267998|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
163971580|NCT03086057|592267999|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
163971581|NCT03086057|592268000|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
163971582|NCT03086057|592268001|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
163971583|NCT03086057|592267998|FG000|Stage 1: PrEP Uptake|Death|1|||
163971584|NCT03086057|592267999|FG001|Stage 1: PrEP Uptake|Death|0|||
163971585|NCT03086057|592268000|FG002|Stage 1: PrEP Uptake|Death|0|||
163971586|NCT03086057|592268001|FG003|Stage 1: PrEP Uptake|Death|0|||
163971587|NCT03086057|592267998|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
163971588|NCT03086057|592267999|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
163971589|NCT03086057|592268000|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
163971590|NCT03086057|592268001|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
163971591|NCT03086057|592267998|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
163971592|NCT03086057|592267999|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
163971593|NCT03086057|592268000|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
163971594|NCT03086057|592268001|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
163971595|NCT03086057|592267998|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
163971596|NCT03086057|592267999|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
163971597|NCT03086057|592268000|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
163971598|NCT03086057|592268001|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
164311206|NCT01474018|593515245|FG000|Overall Study|Withdrawal by Subject|0|||
164311207|NCT01474018|593515246|FG001|Overall Study|Withdrawal by Subject|2|||
164311208|NCT03801031|593515247|FG000|Overall Study|Lost to Follow-up|1|||
164311209|NCT03801031|593515248|FG001|Overall Study|Lost to Follow-up|0|||
164311210|NCT03801031|593515247|FG000|Overall Study|Unable to comply|1|||
164311211|NCT03801031|593515248|FG001|Overall Study|Unable to comply|0|||
164311212|NCT03801031|593515247|FG000|Overall Study|Withdrawal by Subject|0|||
164311213|NCT03801031|593515248|FG001|Overall Study|Withdrawal by Subject|1|||
163971599|NCT02790138|592268004|FG000|Overall Study|Adverse Event|5|||
163971600|NCT02790138|592268005|FG001|Overall Study|Adverse Event|2|||
163971601|NCT02790138|592268004|FG000|Overall Study|Significant Protocol Deviation|0|||
163971602|NCT02790138|592268005|FG001|Overall Study|Significant Protocol Deviation|1|||
163971603|NCT02790138|592268004|FG000|Overall Study|Lost to Follow-up|1|||
163971604|NCT02790138|592268005|FG001|Overall Study|Lost to Follow-up|0|||
163971605|NCT02790138|592268004|FG000|Overall Study|Voluntary Withdrawal|8|||
164311214|NCT01942733|593515249|FG000|Overall Study|Lost to Follow-up|1|||
164311215|NCT01942733|593515249|FG000|Overall Study|Non-compliance with IMP|1|||
164311216|NCT01942733|593515249|FG000|Overall Study|Administrative|1|||
164311217|NCT00838513|593515250|FG000|Screening Period|Screen Failure|3|||
164311218|NCT00838513|593515250|FG000|Extension Treatment Period|Death|1|||
164311219|NCT00838513|593515250|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
163971606|NCT02790138|592268005|FG001|Overall Study|Voluntary Withdrawal|9|||
163971607|NCT02790138|592268004|FG000|Overall Study|Lack of Efficacy|6|||
163971608|NCT02790138|592268005|FG001|Overall Study|Lack of Efficacy|7|||
163971609|NCT02790138|592268004|FG000|Overall Study|Reason not Specified|1|||
163971610|NCT02790138|592268005|FG001|Overall Study|Reason not Specified|0|||
163971611|NCT03199040|592268006|FG000|Overall Study|Lack of Efficacy|2|||
163971612|NCT03199040|592268007|FG001|Overall Study|Lack of Efficacy|0|||
163971613|NCT03199040|592268006|FG000|Overall Study|Withdrawal by Subject|2|||
163971614|NCT03199040|592268007|FG001|Overall Study|Withdrawal by Subject|0|||
163971615|NCT03199040|592268006|FG000|Overall Study|Adverse Event|0|||
163971616|NCT03199040|592268007|FG001|Overall Study|Adverse Event|1|||
164311220|NCT00126490|593515251|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
164311221|NCT03462511|593515253|FG000|Overall Study|Withdrawal by Subject|2|||
164311222|NCT03462511|593515254|FG001|Overall Study|Withdrawal by Subject|3|||
164311223|NCT02925416|593515255|FG000|Overall Study|Adverse Event|2|||
164311224|NCT02925416|593515256|FG001|Overall Study|Adverse Event|0|||
164311225|NCT02625909|593515257|FG000|Overall Study|Death|2|||
164311226|NCT02625909|593515258|FG001|Overall Study|Death|0|||
164311227|NCT02625909|593515257|FG000|Overall Study|Lost to Follow-up|3|||
164311228|NCT02625909|593515258|FG001|Overall Study|Lost to Follow-up|5|||
164311229|NCT02625909|593515257|FG000|Overall Study|Lack of Efficacy|9|||
164311230|NCT02625909|593515258|FG001|Overall Study|Lack of Efficacy|2|||
164311231|NCT02625909|593515257|FG000|Overall Study|Reinfection|3|||
164311232|NCT02625909|593515258|FG001|Overall Study|Reinfection|2|||
164311233|NCT01598506|593515259|FG000|Overall Study|Withdrawal by Subject|2|||
164311234|NCT03962504|593515260|FG000|Overall Study|Other|11|||
164311235|NCT03962504|593515261|FG001|Overall Study|Other|32|||
164311236|NCT02367833|593515262|FG000|Overall Study|Withdrawal by Subject|1|||
164311237|NCT02367833|593515263|FG001|Overall Study|Withdrawal by Subject|1|||
164311238|NCT02367833|593515264|FG002|Overall Study|Withdrawal by Subject|0|||
163971617|NCT03199040|592268006|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
163971618|NCT03199040|592268007|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
163971619|NCT01786603|592268008|FG000|Overall Study|Death|5|||
163971620|NCT01786603|592268009|FG001|Overall Study|Death|1|||
163971621|NCT01786603|592268008|FG000|Overall Study|Adverse Event|6|||
163971622|NCT01786603|592268009|FG001|Overall Study|Adverse Event|2|||
163971623|NCT01786603|592268008|FG000|Overall Study|Physician decision to withdraw|6|||
163971624|NCT01786603|592268009|FG001|Overall Study|Physician decision to withdraw|7|||
163971625|NCT01786603|592268008|FG000|Overall Study|Lost to Follow-up|1|||
163971626|NCT01786603|592268009|FG001|Overall Study|Lost to Follow-up|2|||
163971627|NCT01226459|592268010|FG000|Overall Study|Adverse Event|2|||
163971628|NCT01226459|592268011|FG001|Overall Study|Adverse Event|8|||
163971629|NCT01226459|592268010|FG000|Overall Study|Protocol Violation|4|||
163971630|NCT01226459|592268011|FG001|Overall Study|Protocol Violation|3|||
163971631|NCT01226459|592268010|FG000|Overall Study|Withdrawal by Subject|10|||
163971632|NCT01226459|592268011|FG001|Overall Study|Withdrawal by Subject|13|||
163971633|NCT01226459|592268010|FG000|Overall Study|Lost to Follow-up|4|||
163971634|NCT01226459|592268011|FG001|Overall Study|Lost to Follow-up|8|||
163971635|NCT01226459|592268010|FG000|Overall Study|Pregnancy|1|||
163971636|NCT01226459|592268011|FG001|Overall Study|Pregnancy|0|||
163971637|NCT01854645|592268015|FG000|Overall Study|Protocol-Specified Criteria|13|||
163971638|NCT01854645|592268016|FG001|Overall Study|Protocol-Specified Criteria|10|||
163971639|NCT01854645|592268017|FG002|Overall Study|Protocol-Specified Criteria|8|||
163971640|NCT01854645|592268018|FG003|Overall Study|Protocol-Specified Criteria|5|||
163971641|NCT01854645|592268019|FG004|Overall Study|Protocol-Specified Criteria|7|||
163971642|NCT01854645|592268015|FG000|Overall Study|Administrative Reasons / Missing|0|||
163971643|NCT01854645|592268016|FG001|Overall Study|Administrative Reasons / Missing|0|||
163971644|NCT01854645|592268017|FG002|Overall Study|Administrative Reasons / Missing|0|||
163971645|NCT01854645|592268018|FG003|Overall Study|Administrative Reasons / Missing|1|||
164311239|NCT02167139|593515267|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
164311240|NCT02167139|593515268|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
164311241|NCT02167139|593515269|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
164311242|NCT02167139|593515270|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
164311243|NCT02167139|593515267|FG000|Randomised, Double-blind|Adverse Event|2|||
164311244|NCT02167139|593515268|FG001|Randomised, Double-blind|Adverse Event|9|||
163971646|NCT01854645|592268019|FG004|Overall Study|Administrative Reasons / Missing|1|||
163971647|NCT01854645|592268015|FG000|Overall Study|Protocol Violation|3|||
163971648|NCT01854645|592268016|FG001|Overall Study|Protocol Violation|0|||
164311245|NCT02167139|593515269|FG002|Randomised, Double-blind|Adverse Event|0|||
164311246|NCT02167139|593515270|FG003|Randomised, Double-blind|Adverse Event|0|||
164311247|NCT02167139|593515267|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
163971649|NCT01854645|592268017|FG002|Overall Study|Protocol Violation|5|||
163971650|NCT01854645|592268018|FG003|Overall Study|Protocol Violation|4|||
163971651|NCT01854645|592268019|FG004|Overall Study|Protocol Violation|1|||
163971652|NCT01854645|592268015|FG000|Overall Study|Lost to Follow-up|10|||
163971653|NCT01854645|592268016|FG001|Overall Study|Lost to Follow-up|7|||
163971654|NCT01854645|592268017|FG002|Overall Study|Lost to Follow-up|8|||
163971655|NCT01854645|592268018|FG003|Overall Study|Lost to Follow-up|5|||
164311248|NCT02167139|593515268|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
164311249|NCT02167139|593515269|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
164311250|NCT02167139|593515270|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
164311251|NCT02167139|593515267|FG000|Randomised, Double-blind|Other|3|||
164311252|NCT02167139|593515268|FG001|Randomised, Double-blind|Other|0|||
164311253|NCT02167139|593515269|FG002|Randomised, Double-blind|Other|0|||
163971656|NCT01854645|592268019|FG004|Overall Study|Lost to Follow-up|0|||
163971657|NCT01854645|592268015|FG000|Overall Study|Physician Decision|1|||
164311254|NCT02167139|593515270|FG003|Randomised, Double-blind|Other|0|||
164311255|NCT02167139|593515267|FG000|Transition-extension|Adverse Event|2|||
164311256|NCT02167139|593515268|FG001|Transition-extension|Adverse Event|0|||
164311257|NCT02167139|593515269|FG002|Transition-extension|Adverse Event|2|||
164311258|NCT02167139|593515270|FG003|Transition-extension|Adverse Event|3|||
163971658|NCT01854645|592268016|FG001|Overall Study|Physician Decision|5|||
163971659|NCT01854645|592268017|FG002|Overall Study|Physician Decision|3|||
163971660|NCT01854645|592268018|FG003|Overall Study|Physician Decision|3|||
163971661|NCT01854645|592268019|FG004|Overall Study|Physician Decision|7|||
163971662|NCT01854645|592268015|FG000|Overall Study|Withdrawal by Subject|31|||
163971663|NCT01854645|592268016|FG001|Overall Study|Withdrawal by Subject|41|||
163971664|NCT01854645|592268017|FG002|Overall Study|Withdrawal by Subject|30|||
163971665|NCT01854645|592268018|FG003|Overall Study|Withdrawal by Subject|21|||
163971666|NCT01854645|592268019|FG004|Overall Study|Withdrawal by Subject|24|||
163971667|NCT01854645|592268015|FG000|Overall Study|Lack of Efficacy|7|||
163971668|NCT01854645|592268016|FG001|Overall Study|Lack of Efficacy|12|||
163971669|NCT01854645|592268017|FG002|Overall Study|Lack of Efficacy|9|||
163971670|NCT01854645|592268018|FG003|Overall Study|Lack of Efficacy|3|||
163971671|NCT01854645|592268019|FG004|Overall Study|Lack of Efficacy|9|||
163971672|NCT01854645|592268015|FG000|Overall Study|Adverse Event|33|||
163971673|NCT01854645|592268016|FG001|Overall Study|Adverse Event|31|||
163971674|NCT01854645|592268017|FG002|Overall Study|Adverse Event|19|||
163971675|NCT01854645|592268018|FG003|Overall Study|Adverse Event|20|||
163971676|NCT01854645|592268019|FG004|Overall Study|Adverse Event|11|||
163971677|NCT01977820|592268022|FG000|Overall Study|Sponsor terminated the study|1|||
163971678|NCT01977820|592268023|FG001|Overall Study|Sponsor terminated the study|1|||
163971679|NCT00698997|592268024|FG000|Overall Study|Lost to Follow-up|3|||
163971680|NCT00698997|592268025|FG001|Overall Study|Lost to Follow-up|0|||
163971681|NCT00698997|592268024|FG000|Overall Study|Withdrawal by Subject|7|||
163971682|NCT00698997|592268025|FG001|Overall Study|Withdrawal by Subject|27|||
163971683|NCT00475722|592268026|FG000|Overall Study|Withdrawal by Subject|12|||
163971684|NCT00475722|592268027|FG001|Overall Study|Withdrawal by Subject|12|||
163971685|NCT00475722|592268026|FG000|Overall Study|Protocol Violation|3|||
163971686|NCT00475722|592268027|FG001|Overall Study|Protocol Violation|0|||
163971687|NCT05082376|592268030|FG000|Overall Study|Lost to Follow-up|2|||
163971688|NCT02568475|592268031|FG000|Overall Study|Lost to Follow-up|40|||
163971689|NCT02568475|592268032|FG001|Overall Study|Lost to Follow-up|39|||
163971690|NCT02568475|592268031|FG000|Overall Study|Withdrawal by Subject|2|||
164311259|NCT02167139|593515267|FG000|Transition-extension|Withdrawal by Subject|2|||
164311260|NCT02167139|593515268|FG001|Transition-extension|Withdrawal by Subject|0|||
164311261|NCT02167139|593515269|FG002|Transition-extension|Withdrawal by Subject|4|||
164311262|NCT02167139|593515270|FG003|Transition-extension|Withdrawal by Subject|1|||
164311263|NCT02167139|593515267|FG000|Transition-extension|Lack of Efficacy|0|||
164311264|NCT02167139|593515268|FG001|Transition-extension|Lack of Efficacy|0|||
164311265|NCT02167139|593515269|FG002|Transition-extension|Lack of Efficacy|1|||
164311266|NCT02167139|593515270|FG003|Transition-extension|Lack of Efficacy|1|||
164311267|NCT02167139|593515267|FG000|Transition-extension|Other|1|||
164311268|NCT02167139|593515268|FG001|Transition-extension|Other|0|||
164311269|NCT02167139|593515269|FG002|Transition-extension|Other|1|||
164311270|NCT02167139|593515270|FG003|Transition-extension|Other|0|||
163971691|NCT02568475|592268032|FG001|Overall Study|Withdrawal by Subject|0|||
163971692|NCT02568475|592268031|FG000|Overall Study|Discharged home|4|||
163971693|NCT02568475|592268032|FG001|Overall Study|Discharged home|4|||
163971694|NCT02568475|592268031|FG000|Overall Study|Short-term: Discharge location unknown|4|||
163971695|NCT02568475|592268032|FG001|Overall Study|Short-term: Discharge location unknown|0|||
164311271|NCT02167139|593515267|FG000|Transition-extension|Lost to Follow-up|1|||
164311272|NCT02167139|593515268|FG001|Transition-extension|Lost to Follow-up|0|||
164311273|NCT02167139|593515269|FG002|Transition-extension|Lost to Follow-up|0|||
164311274|NCT02167139|593515270|FG003|Transition-extension|Lost to Follow-up|0|||
164311275|NCT02067676|593515271|FG000|Overall Study|Withdrawal by Subject|1|||
163971696|NCT02568475|592268031|FG000|Overall Study|Transferred to another facility|1|||
163971697|NCT02568475|592268032|FG001|Overall Study|Transferred to another facility|0|||
163971698|NCT02625233|592268033|FG000|Overall Study|Adverse Event|2|||
163971699|NCT02625233|592268034|FG001|Overall Study|Adverse Event|0|||
163971700|NCT00916279|592268037|FG000|Overall Study|Death|2|||
163971701|NCT00916279|592268037|FG000|Overall Study|Lost to Follow-up|2|||
163971702|NCT00290186|592268047|FG000|Overall Study|Adverse Event|1|||
163971703|NCT00290186|592268048|FG001|Overall Study|Adverse Event|1|||
163971704|NCT00290186|592268047|FG000|Overall Study|Lost to Follow-up|3|||
163867164|NCT03482011|591880247|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
163867165|NCT03482011|591880240|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163867166|NCT03482011|591880241|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163867167|NCT03482011|591880242|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163867168|NCT03482011|591880243|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163867169|NCT03482011|591880244|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
163867170|NCT03482011|591880245|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163867171|NCT03482011|591880246|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
163867172|NCT03482011|591880247|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
163867173|NCT03482011|591880240|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
163867174|NCT03482011|591880241|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
163867175|NCT03482011|591880242|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
163867176|NCT03482011|591880243|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
163867177|NCT03482011|591880244|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
163867178|NCT03482011|591880245|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
163867179|NCT03482011|591880246|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
163867180|NCT03482011|591880247|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
163867181|NCT03482011|591880240|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163867182|NCT03482011|591880241|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163867183|NCT03482011|591880242|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
163867184|NCT03482011|591880243|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
163867185|NCT03482011|591880244|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163867186|NCT03482011|591880245|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
163867187|NCT03482011|591880246|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163867188|NCT03482011|591880247|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
163867189|NCT03482011|591880240|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163867190|NCT03482011|591880241|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163867191|NCT03482011|591880242|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163867192|NCT03482011|591880243|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
163867193|NCT03482011|591880244|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
163867194|NCT03482011|591880245|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
163867195|NCT03482011|591880246|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
163867196|NCT03482011|591880247|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
163867197|NCT03482011|591880240|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
163867198|NCT03482011|591880241|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
163867199|NCT03482011|591880242|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
163867200|NCT03482011|591880243|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
163867201|NCT03482011|591880244|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
163867202|NCT03482011|591880245|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
163867203|NCT03482011|591880246|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
163867204|NCT03482011|591880247|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
163867205|NCT03482011|591880240|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163867206|NCT03482011|591880241|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163867207|NCT03482011|591880242|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
163867208|NCT03482011|591880243|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
163867209|NCT03482011|591880244|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163867210|NCT03482011|591880245|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163867211|NCT03482011|591880246|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
163867212|NCT03482011|591880247|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
163867213|NCT03482011|591880240|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867214|NCT03482011|591880241|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867215|NCT03482011|591880242|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867216|NCT03482011|591880243|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867217|NCT03482011|591880244|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867218|NCT03482011|591880245|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867219|NCT03482011|591880246|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
163867220|NCT03482011|591880247|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
163867221|NCT03482011|591880240|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867222|NCT03482011|591880241|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867223|NCT03482011|591880242|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867224|NCT03482011|591880243|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867225|NCT03482011|591880244|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867226|NCT03482011|591880245|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867227|NCT03482011|591880246|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163867228|NCT03482011|591880247|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
163971705|NCT00290186|592268048|FG001|Overall Study|Lost to Follow-up|2|||
163867229|NCT00468052|591880248|FG000|Overall Study|Protocol Violation|7|||
163971706|NCT00290186|592268047|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
163867230|NCT00468052|591880249|FG001|Overall Study|Protocol Violation|8|||
163867231|NCT04446117|591880251|FG000|Overall Study|No Study Treatment Given|4|||
164311276|NCT02067676|593515272|FG001|Overall Study|Withdrawal by Subject|0|||
164311277|NCT02067676|593515273|FG002|Overall Study|Withdrawal by Subject|0|||
164311278|NCT02067676|593515274|FG003|Overall Study|Withdrawal by Subject|0|||
163867232|NCT04446117|591880252|FG001|Overall Study|No Study Treatment Given|3|||
163867233|NCT04446117|591880251|FG000|Overall Study|Radiographic Disease Progression|132|||
163867234|NCT04446117|591880252|FG001|Overall Study|Radiographic Disease Progression|158|||
163867235|NCT04446117|591880251|FG000|Overall Study|Adverse Event|79|||
163867236|NCT04446117|591880252|FG001|Overall Study|Adverse Event|43|||
163867237|NCT04446117|591880251|FG000|Overall Study|Lack of Clinical Benefit|1|||
163867238|NCT04446117|591880252|FG001|Overall Study|Lack of Clinical Benefit|1|||
163867239|NCT04446117|591880251|FG000|Overall Study|Withdrawal by Subject|24|||
163867240|NCT04446117|591880252|FG001|Overall Study|Withdrawal by Subject|22|||
163867241|NCT04446117|591880251|FG000|Overall Study|Lost to Follow-up|0|||
163867242|NCT04446117|591880252|FG001|Overall Study|Lost to Follow-up|3|||
163867243|NCT04446117|591880251|FG000|Overall Study|Miscellaneous|26|||
163867244|NCT04446117|591880252|FG001|Overall Study|Miscellaneous|36|||
163867245|NCT04446117|591880251|FG000|Overall Study|Missing Data/Data not yet Received|1|||
163867246|NCT04446117|591880252|FG001|Overall Study|Missing Data/Data not yet Received|0|||
163867247|NCT00324038|591880264|FG000|Overall Study|Adverse Event|38|||
163867248|NCT00324038|591880265|FG001|Overall Study|Adverse Event|23|||
163867249|NCT00324038|591880264|FG000|Overall Study|Lack of Efficacy|5|||
163867250|NCT00324038|591880265|FG001|Overall Study|Lack of Efficacy|13|||
163867251|NCT00324038|591880264|FG000|Overall Study|Lost to Follow-up|0|||
163867252|NCT00324038|591880265|FG001|Overall Study|Lost to Follow-up|2|||
163867253|NCT00324038|591880264|FG000|Overall Study|Other|6|||
163867254|NCT00324038|591880265|FG001|Overall Study|Other|13|||
163867255|NCT00361283|591880269|FG000|Overall Study|Lost to Follow-up|27|||
163867256|NCT01837641|591880270|FG000|Overall Study|Sponsor decision|1|||
163867257|NCT01837641|591880271|FG001|Overall Study|Sponsor decision|0|||
163867258|NCT01837641|591880272|FG002|Overall Study|Sponsor decision|0|||
163867259|NCT01837641|591880273|FG003|Overall Study|Sponsor decision|0|||
163867260|NCT01837641|591880274|FG004|Overall Study|Sponsor decision|0|||
163867261|NCT01837641|591880275|FG005|Overall Study|Sponsor decision|1|||
163867262|NCT01837641|591880276|FG006|Overall Study|Sponsor decision|0|||
163867263|NCT01837641|591880277|FG007|Overall Study|Sponsor decision|0|||
163867264|NCT01837641|591880270|FG000|Overall Study|Adverse Event|0|||
163867265|NCT01837641|591880271|FG001|Overall Study|Adverse Event|0|||
163867266|NCT01837641|591880272|FG002|Overall Study|Adverse Event|0|||
163867267|NCT01837641|591880273|FG003|Overall Study|Adverse Event|0|||
163867268|NCT01837641|591880274|FG004|Overall Study|Adverse Event|0|||
163867269|NCT01837641|591880275|FG005|Overall Study|Adverse Event|1|||
163867270|NCT01837641|591880276|FG006|Overall Study|Adverse Event|0|||
163867271|NCT01837641|591880277|FG007|Overall Study|Adverse Event|0|||
163867272|NCT01837641|591880270|FG000|Overall Study|Withdrawal by Subject|0|||
163867273|NCT01837641|591880271|FG001|Overall Study|Withdrawal by Subject|0|||
163867274|NCT01837641|591880272|FG002|Overall Study|Withdrawal by Subject|0|||
163867275|NCT01837641|591880273|FG003|Overall Study|Withdrawal by Subject|0|||
163867276|NCT01837641|591880274|FG004|Overall Study|Withdrawal by Subject|1|||
163867277|NCT01837641|591880275|FG005|Overall Study|Withdrawal by Subject|0|||
163867278|NCT01837641|591880276|FG006|Overall Study|Withdrawal by Subject|1|||
163867279|NCT01837641|591880277|FG007|Overall Study|Withdrawal by Subject|0|||
163867280|NCT01123083|591880284|FG000|Overall Study|Investigator recommendation|1|||
163867281|NCT01123083|591880285|FG001|Overall Study|Investigator recommendation|1|||
163867282|NCT01123083|591880284|FG000|Overall Study|Administrative reasons|0|||
163867283|NCT01123083|591880285|FG001|Overall Study|Administrative reasons|4|||
163867284|NCT01123083|591880284|FG000|Overall Study|Lost to Follow-up|2|||
163867285|NCT01123083|591880285|FG001|Overall Study|Lost to Follow-up|6|||
163867286|NCT01123083|591880284|FG000|Overall Study|Adverse Event|1|||
163867287|NCT01123083|591880285|FG001|Overall Study|Adverse Event|0|||
163867288|NCT01123083|591880284|FG000|Overall Study|Withdrew for another reason not covered|0|||
164311279|NCT02067676|593515275|FG004|Overall Study|Withdrawal by Subject|0|||
164311280|NCT02067676|593515276|FG005|Overall Study|Withdrawal by Subject|0|||
163867289|NCT01123083|591880285|FG001|Overall Study|Withdrew for another reason not covered|1|||
163867290|NCT01123083|591880284|FG000|Overall Study|Participant/legal representative request|7|||
163867291|NCT01123083|591880285|FG001|Overall Study|Participant/legal representative request|3|||
163867292|NCT00961636|591880286|FG000|Overall Study|Adverse Event|35|||
163867293|NCT00961636|591880287|FG001|Overall Study|Adverse Event|54|||
163867294|NCT00961636|591880288|FG002|Overall Study|Adverse Event|13|||
163867295|NCT00961636|591880286|FG000|Overall Study|Flushing Symptoms|29|||
164311281|NCT00996333|593515277|FG000|Overall Study|Screen failure|1|||
163867296|NCT00961636|591880287|FG001|Overall Study|Flushing Symptoms|46|||
163971707|NCT00290186|592268048|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
163867297|NCT00961636|591880288|FG002|Overall Study|Flushing Symptoms|3|||
163867298|NCT00961636|591880286|FG000|Overall Study|Lost to Follow-up|2|||
163867299|NCT00961636|591880287|FG001|Overall Study|Lost to Follow-up|3|||
163867300|NCT00961636|591880288|FG002|Overall Study|Lost to Follow-up|1|||
163867301|NCT00961636|591880286|FG000|Overall Study|Physician Decision|3|||
164311282|NCT00996333|593515277|FG000|Overall Study|Withdrawal by Subject|1|||
164311283|NCT00996333|593515277|FG000|Overall Study|Death|4|||
164311284|NCT00996333|593515277|FG000|Overall Study|Adverse Event|1|||
163867302|NCT00961636|591880287|FG001|Overall Study|Physician Decision|1|||
163867303|NCT00961636|591880288|FG002|Overall Study|Physician Decision|1|||
163867304|NCT00961636|591880286|FG000|Overall Study|Protocol Violation|9|||
163867305|NCT00961636|591880287|FG001|Overall Study|Protocol Violation|5|||
163867306|NCT00961636|591880288|FG002|Overall Study|Protocol Violation|1|||
163867307|NCT00961636|591880286|FG000|Overall Study|Withdrawal by Subject|29|||
163867308|NCT00961636|591880287|FG001|Overall Study|Withdrawal by Subject|22|||
163867309|NCT00961636|591880288|FG002|Overall Study|Withdrawal by Subject|13|||
163867310|NCT00290706|591880291|FG000|Overall Study|Withdrawal by Subject|2|||
163867311|NCT00290706|591880292|FG001|Overall Study|Withdrawal by Subject|0|||
163867312|NCT00290706|591880293|FG002|Overall Study|Withdrawal by Subject|0|||
163867313|NCT00290706|591880294|FG003|Overall Study|Withdrawal by Subject|0|||
163867314|NCT00290706|591880291|FG000|Overall Study|Progressive Disease|3|||
163867315|NCT00290706|591880292|FG001|Overall Study|Progressive Disease|5|||
163867316|NCT00290706|591880293|FG002|Overall Study|Progressive Disease|4|||
163867317|NCT00290706|591880294|FG003|Overall Study|Progressive Disease|10|||
163867318|NCT00290706|591880291|FG000|Overall Study|Adverse Event|0|||
163867319|NCT00290706|591880292|FG001|Overall Study|Adverse Event|1|||
163867320|NCT00290706|591880293|FG002|Overall Study|Adverse Event|2|||
163867321|NCT00290706|591880294|FG003|Overall Study|Adverse Event|0|||
163867322|NCT00290706|591880291|FG000|Overall Study|Receive auto transplant or radiation|0|||
163867323|NCT00290706|591880292|FG001|Overall Study|Receive auto transplant or radiation|0|||
163867324|NCT00290706|591880293|FG002|Overall Study|Receive auto transplant or radiation|0|||
163867325|NCT00290706|591880294|FG003|Overall Study|Receive auto transplant or radiation|1|||
163867326|NCT00290706|591880291|FG000|Overall Study|Physician Decision|0|||
163867327|NCT00290706|591880292|FG001|Overall Study|Physician Decision|0|||
163867328|NCT00290706|591880293|FG002|Overall Study|Physician Decision|0|||
163867329|NCT00290706|591880294|FG003|Overall Study|Physician Decision|1|||
163867330|NCT01196429|591880296|FG000|Overall Study|Ineligible - inadequate pathology|1|||
163867331|NCT01196429|591880297|FG001|Overall Study|Ineligible - inadequate pathology|0|||
163867332|NCT01196429|591880296|FG000|Overall Study|Ineligible - wrong cell type|1|||
163867333|NCT01196429|591880297|FG001|Overall Study|Ineligible - wrong cell type|0|||
163867334|NCT01196429|591880296|FG000|Overall Study|Refused - Never Treated|1|||
163867335|NCT01196429|591880297|FG001|Overall Study|Refused - Never Treated|0|||
163867336|NCT00688519|591880298|FG000|Overall Study|Adverse Event|2|||
163867337|NCT00688519|591880299|FG001|Overall Study|Adverse Event|3|||
163867338|NCT00688519|591880298|FG000|Overall Study|Lost to Follow-up|3|||
163867339|NCT00688519|591880299|FG001|Overall Study|Lost to Follow-up|3|||
163867340|NCT00688519|591880298|FG000|Overall Study|Lack of Efficacy|3|||
163867341|NCT00688519|591880299|FG001|Overall Study|Lack of Efficacy|1|||
163867342|NCT00688519|591880298|FG000|Overall Study|Withdrawal by Subject|7|||
163867343|NCT00688519|591880299|FG001|Overall Study|Withdrawal by Subject|6|||
163867344|NCT00688519|591880298|FG000|Overall Study|Prohibited medication|1|||
163867345|NCT00688519|591880299|FG001|Overall Study|Prohibited medication|0|||
163867346|NCT00688519|591880298|FG000|Overall Study|Non-compliance|0|||
163867347|NCT00688519|591880299|FG001|Overall Study|Non-compliance|1|||
163867348|NCT00688519|591880298|FG000|Overall Study|Subject moved out of state|1|||
163867349|NCT00688519|591880299|FG001|Overall Study|Subject moved out of state|0|||
163867350|NCT00688519|591880298|FG000|Overall Study|Investigator decision|1|||
163867351|NCT00688519|591880299|FG001|Overall Study|Investigator decision|0|||
163867352|NCT00688519|591880298|FG000|Overall Study|Subject moved out of area|1|||
163867353|NCT00688519|591880299|FG001|Overall Study|Subject moved out of area|0|||
163867354|NCT00688519|591880298|FG000|Overall Study|Pregnancy|0|||
163867355|NCT00688519|591880299|FG001|Overall Study|Pregnancy|1|||
163867356|NCT03768206|591880300|FG000|Overall Study|Lost to Follow-up|2|||
163867357|NCT03768206|591880301|FG001|Overall Study|Lost to Follow-up|1|||
163867358|NCT03768206|591880300|FG000|Overall Study|Withdrawal by Subject|0|||
163867359|NCT03768206|591880301|FG001|Overall Study|Withdrawal by Subject|1|||
163867360|NCT02551055|591880304|FG000|Overall Study|Death|2|||
163867361|NCT02551055|591880305|FG001|Overall Study|Death|4|||
163867362|NCT02551055|591880306|FG002|Overall Study|Death|2|||
163867363|NCT02551055|591880307|FG003|Overall Study|Death|2|||
163867364|NCT02551055|591880308|FG004|Overall Study|Death|2|||
163867365|NCT02551055|591880309|FG005|Overall Study|Death|1|||
163867366|NCT02551055|591880310|FG006|Overall Study|Death|2|||
163867367|NCT02551055|591880311|FG007|Overall Study|Death|0|||
163867368|NCT02551055|591880304|FG000|Overall Study|Study Terminated by Sponsor|1|||
163867369|NCT02551055|591880305|FG001|Overall Study|Study Terminated by Sponsor|1|||
163867370|NCT02551055|591880306|FG002|Overall Study|Study Terminated by Sponsor|0|||
163867371|NCT02551055|591880307|FG003|Overall Study|Study Terminated by Sponsor|2|||
163867372|NCT02551055|591880308|FG004|Overall Study|Study Terminated by Sponsor|2|||
163867373|NCT02551055|591880309|FG005|Overall Study|Study Terminated by Sponsor|0|||
163867374|NCT02551055|591880310|FG006|Overall Study|Study Terminated by Sponsor|0|||
163867375|NCT02551055|591880311|FG007|Overall Study|Study Terminated by Sponsor|0|||
163867376|NCT02551055|591880304|FG000|Overall Study|Withdrawal by Subject|1|||
164135636|NCT02799095|592861964|FG009|Part A|Adverse Event|0|||
164311285|NCT00996333|593515277|FG000|Overall Study|Physician Decision|1|||
164311286|NCT00996333|593515277|FG000|Overall Study|Other|5|||
164311287|NCT00476229|593515278|FG000|Overall Study|Progressive shortness of breath|1|||
164311288|NCT02100696|593515281|FG000|Induction Phase|Adverse Event|0|||
164311289|NCT02100696|593515282|FG001|Induction Phase|Adverse Event|0|||
164311290|NCT02100696|593515283|FG002|Induction Phase|Adverse Event|1|||
163971708|NCT00290186|592268047|FG000|Overall Study|Withdrawal by Subject|0|||
163971709|NCT00290186|592268048|FG001|Overall Study|Withdrawal by Subject|1|||
163971710|NCT00262522|592268051|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
163971711|NCT00262522|592268052|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
163971712|NCT00262522|592268053|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
163971713|NCT00262522|592268054|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
163971714|NCT00262522|592268051|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
163971715|NCT00262522|592268052|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
163971716|NCT00262522|592268053|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
163971717|NCT00262522|592268054|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
163971718|NCT00262522|592268051|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
163971719|NCT00262522|592268052|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
163971720|NCT00262522|592268053|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
163971721|NCT00262522|592268054|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
163971722|NCT00262522|592268051|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
163971723|NCT00262522|592268052|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
163971724|NCT00262522|592268053|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
163971725|NCT00262522|592268054|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
163971726|NCT00262522|592268051|FG000|Study Start Through 8 Weeks|Death|1|||
163971727|NCT00262522|592268052|FG001|Study Start Through 8 Weeks|Death|0|||
163971728|NCT00262522|592268053|FG002|Study Start Through 8 Weeks|Death|0|||
163971729|NCT00262522|592268054|FG003|Study Start Through 8 Weeks|Death|0|||
163971730|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
163971731|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
163971732|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
163971733|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
163971734|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
163971735|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
163971736|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
163971737|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
163971738|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
163971739|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
163971740|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
163971741|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
163971742|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
163971743|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
163971744|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
163971745|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
163971746|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Death|2|||
163971747|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Death|0|||
163971748|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Death|1|||
163971749|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Death|0|||
163971750|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
163971751|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
163971752|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
163971753|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
163971754|NCT00262522|592268051|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
163971755|NCT00262522|592268052|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
163971756|NCT00262522|592268053|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
163971757|NCT00262522|592268054|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
163971758|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
163971759|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
163971760|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
163971761|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
163971762|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
163971763|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
163971764|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
164311291|NCT02100696|593515284|FG003|Induction Phase|Adverse Event|0|||
163971765|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
163971766|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
163971767|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
163971768|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
163971769|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
163971770|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
163971771|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
164311292|NCT02100696|593515285|FG004|Induction Phase|Adverse Event|0|||
164311293|NCT02100696|593515286|FG005|Induction Phase|Adverse Event|0|||
164311294|NCT02100696|593515281|FG000|Induction Phase|Lost to Follow-up|1|||
164311295|NCT02100696|593515282|FG001|Induction Phase|Lost to Follow-up|0|||
164311296|NCT02100696|593515283|FG002|Induction Phase|Lost to Follow-up|1|||
164311297|NCT02100696|593515284|FG003|Induction Phase|Lost to Follow-up|0|||
164311298|NCT02100696|593515285|FG004|Induction Phase|Lost to Follow-up|0|||
164311299|NCT02100696|593515286|FG005|Induction Phase|Lost to Follow-up|0|||
164311300|NCT02100696|593515281|FG000|Induction Phase|Protocol Violation|0|||
164311301|NCT02100696|593515282|FG001|Induction Phase|Protocol Violation|1|||
164311302|NCT02100696|593515283|FG002|Induction Phase|Protocol Violation|1|||
164311303|NCT02100696|593515284|FG003|Induction Phase|Protocol Violation|0|||
164311304|NCT02100696|593515285|FG004|Induction Phase|Protocol Violation|0|||
164311305|NCT02100696|593515286|FG005|Induction Phase|Protocol Violation|0|||
164311306|NCT02100696|593515281|FG000|Induction Phase|Withdrawal by Subject|8|||
164311307|NCT02100696|593515282|FG001|Induction Phase|Withdrawal by Subject|2|||
164311308|NCT02100696|593515283|FG002|Induction Phase|Withdrawal by Subject|13|||
164311309|NCT02100696|593515284|FG003|Induction Phase|Withdrawal by Subject|0|||
164311310|NCT02100696|593515285|FG004|Induction Phase|Withdrawal by Subject|0|||
164311311|NCT02100696|593515286|FG005|Induction Phase|Withdrawal by Subject|0|||
164311312|NCT02100696|593515281|FG000|Induction Phase|Physician Decision|1|||
164311313|NCT02100696|593515282|FG001|Induction Phase|Physician Decision|0|||
164311314|NCT02100696|593515283|FG002|Induction Phase|Physician Decision|2|||
164311315|NCT02100696|593515284|FG003|Induction Phase|Physician Decision|0|||
164311316|NCT02100696|593515285|FG004|Induction Phase|Physician Decision|0|||
164311317|NCT02100696|593515286|FG005|Induction Phase|Physician Decision|0|||
164311318|NCT02100696|593515281|FG000|Induction Phase|Multiple Reasons|5|||
164311319|NCT02100696|593515282|FG001|Induction Phase|Multiple Reasons|2|||
164311320|NCT02100696|593515283|FG002|Induction Phase|Multiple Reasons|8|||
164311321|NCT02100696|593515284|FG003|Induction Phase|Multiple Reasons|0|||
164311322|NCT02100696|593515285|FG004|Induction Phase|Multiple Reasons|0|||
164311323|NCT02100696|593515286|FG005|Induction Phase|Multiple Reasons|0|||
164311324|NCT02100696|593515281|FG000|Maintenance Phase|Adverse Event|0|||
164311325|NCT02100696|593515282|FG001|Maintenance Phase|Adverse Event|0|||
164311326|NCT02100696|593515283|FG002|Maintenance Phase|Adverse Event|0|||
164311327|NCT02100696|593515284|FG003|Maintenance Phase|Adverse Event|0|||
164311328|NCT02100696|593515285|FG004|Maintenance Phase|Adverse Event|0|||
164311329|NCT02100696|593515286|FG005|Maintenance Phase|Adverse Event|2|||
164311330|NCT02100696|593515281|FG000|Maintenance Phase|Lost to Follow-up|0|||
164311331|NCT02100696|593515282|FG001|Maintenance Phase|Lost to Follow-up|0|||
164311332|NCT02100696|593515283|FG002|Maintenance Phase|Lost to Follow-up|0|||
164311333|NCT02100696|593515284|FG003|Maintenance Phase|Lost to Follow-up|0|||
164311334|NCT02100696|593515285|FG004|Maintenance Phase|Lost to Follow-up|1|||
164311335|NCT02100696|593515286|FG005|Maintenance Phase|Lost to Follow-up|0|||
164311336|NCT02100696|593515281|FG000|Maintenance Phase|Protocol Violation|0|||
164311337|NCT02100696|593515282|FG001|Maintenance Phase|Protocol Violation|0|||
164311338|NCT02100696|593515283|FG002|Maintenance Phase|Protocol Violation|0|||
164311339|NCT02100696|593515284|FG003|Maintenance Phase|Protocol Violation|0|||
164311340|NCT02100696|593515285|FG004|Maintenance Phase|Protocol Violation|1|||
164311341|NCT02100696|593515286|FG005|Maintenance Phase|Protocol Violation|0|||
164311342|NCT02100696|593515281|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164311343|NCT02100696|593515282|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164311344|NCT02100696|593515283|FG002|Maintenance Phase|Withdrawal by Subject|0|||
163867377|NCT02551055|591880305|FG001|Overall Study|Withdrawal by Subject|1|||
163867378|NCT02551055|591880306|FG002|Overall Study|Withdrawal by Subject|0|||
163867379|NCT02551055|591880307|FG003|Overall Study|Withdrawal by Subject|1|||
163867380|NCT02551055|591880308|FG004|Overall Study|Withdrawal by Subject|2|||
163867381|NCT02551055|591880309|FG005|Overall Study|Withdrawal by Subject|0|||
163867382|NCT02551055|591880310|FG006|Overall Study|Withdrawal by Subject|0|||
163867383|NCT02551055|591880311|FG007|Overall Study|Withdrawal by Subject|0|||
163867384|NCT02551055|591880304|FG000|Overall Study|Reason not specified|0|||
163867385|NCT02551055|591880305|FG001|Overall Study|Reason not specified|0|||
163867386|NCT02551055|591880306|FG002|Overall Study|Reason not specified|0|||
163867387|NCT02551055|591880307|FG003|Overall Study|Reason not specified|0|||
163867388|NCT02551055|591880308|FG004|Overall Study|Reason not specified|1|||
163867389|NCT02551055|591880309|FG005|Overall Study|Reason not specified|0|||
163867390|NCT02551055|591880310|FG006|Overall Study|Reason not specified|1|||
163867391|NCT02551055|591880311|FG007|Overall Study|Reason not specified|0|||
163867392|NCT02106442|591880315|FG000|Overall Study|Case Report Forms Uncollected|7|||
163867393|NCT02106442|591880315|FG000|Overall Study|Protocol Deviation|30|||
163867394|NCT00423098|591881592|FG000|Overall Study|Adverse Event|1|||
164311345|NCT02100696|593515284|FG003|Maintenance Phase|Withdrawal by Subject|1|||
164311346|NCT02100696|593515285|FG004|Maintenance Phase|Withdrawal by Subject|4|||
164311347|NCT02100696|593515286|FG005|Maintenance Phase|Withdrawal by Subject|2|||
164311348|NCT02100696|593515281|FG000|Maintenance Phase|Physician Decision|0|||
163867395|NCT00423098|591881593|FG001|Overall Study|Adverse Event|2|||
163867396|NCT00423098|591881592|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163971772|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
163971773|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
163971774|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Death|2|||
163971775|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Death|0|||
163971776|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Death|2|||
163971777|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Death|0|||
163971778|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
163971779|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
163971780|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
163971781|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
163971782|NCT00262522|592268051|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
163971783|NCT00262522|592268052|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
163971784|NCT00262522|592268053|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
163971785|NCT00262522|592268054|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
163971786|NCT01877915|592268055|FG000|Overall Study|Lost to Follow-up|10|||
163971787|NCT01877915|592268056|FG001|Overall Study|Lost to Follow-up|9|||
163971788|NCT01877915|592268055|FG000|Overall Study|Withdrawal by Subject|42|||
163971789|NCT01877915|592268056|FG001|Overall Study|Withdrawal by Subject|55|||
163971790|NCT01877915|592268055|FG000|Overall Study|Other|2|||
163971791|NCT01877915|592268056|FG001|Overall Study|Other|4|||
163971792|NCT02592018|592268057|FG000|Overall Study|Adverse Event|1|||
163971793|NCT02592018|592268057|FG000|Overall Study|Lost to Follow-up|1|||
163971794|NCT00798135|592268060|FG000|Overall Study|Disease progression, relapse|11|||
163971795|NCT00798135|592268060|FG000|Overall Study|Disease progression, refractory|1|||
163971796|NCT00798135|592268060|FG000|Overall Study|Physician Decision|1|||
163971797|NCT02228720|592268061|FG000|Open Label - Day 30|Lost to Follow-up|1|||
163971798|NCT01401842|592268062|FG000|Overall Study|Withdrawal by Subject|3|||
163971799|NCT01401842|592268063|FG001|Overall Study|Withdrawal by Subject|2|||
163971800|NCT01401842|592268062|FG000|Overall Study|academic reason|4|||
163971801|NCT01401842|592268063|FG001|Overall Study|academic reason|1|||
163971802|NCT01401842|592268062|FG000|Overall Study|changed companies|20|||
163971803|NCT01401842|592268063|FG001|Overall Study|changed companies|34|||
163971804|NCT01401842|592268062|FG000|Overall Study|discharged from US Army|3|||
163971805|NCT01401842|592268063|FG001|Overall Study|discharged from US Army|4|||
163971806|NCT01401842|592268062|FG000|Overall Study|invalid follow-up strength data|1|||
163971807|NCT01401842|592268063|FG001|Overall Study|invalid follow-up strength data|4|||
163971808|NCT01401842|592268062|FG000|Overall Study|on profile|9|||
163971809|NCT01401842|592268063|FG001|Overall Study|on profile|5|||
163971810|NCT01401842|592268062|FG000|Overall Study|other/unknown|28|||
163971811|NCT01401842|592268063|FG001|Overall Study|other/unknown|17|||
163971812|NCT03828292|592268066|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163971813|NCT03828292|592268067|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
163971814|NCT03828292|592268068|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163971815|NCT03828292|592268069|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163971816|NCT03828292|592268070|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163971817|NCT03828292|592268071|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
163971818|NCT03828292|592268066|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163971819|NCT03828292|592268067|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163971820|NCT03828292|592268068|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
163971821|NCT03828292|592268069|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163971822|NCT03828292|592268070|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163971823|NCT03828292|592268071|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
163971824|NCT03828292|592268066|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163971825|NCT03828292|592268067|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163971826|NCT03828292|592268068|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163971827|NCT03828292|592268069|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
163971828|NCT03828292|592268070|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163971829|NCT03828292|592268071|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
163971830|NCT03828292|592268066|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163971831|NCT03828292|592268067|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163971832|NCT03828292|592268068|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163971833|NCT03828292|592268069|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
163971834|NCT03828292|592268070|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163971835|NCT03828292|592268071|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
163971836|NCT03828292|592268066|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163971837|NCT03828292|592268067|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163971838|NCT03828292|592268068|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
163971839|NCT03828292|592268069|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
163971840|NCT03828292|592268070|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
163971841|NCT03828292|592268071|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
164311349|NCT02100696|593515282|FG001|Maintenance Phase|Physician Decision|0|||
164311350|NCT02100696|593515283|FG002|Maintenance Phase|Physician Decision|0|||
164311351|NCT02100696|593515284|FG003|Maintenance Phase|Physician Decision|0|||
164311352|NCT02100696|593515285|FG004|Maintenance Phase|Physician Decision|1|||
164311353|NCT02100696|593515286|FG005|Maintenance Phase|Physician Decision|0|||
164311354|NCT02100696|593515281|FG000|Maintenance Phase|Multiple Reasons|0|||
164311355|NCT02100696|593515282|FG001|Maintenance Phase|Multiple Reasons|0|||
164311356|NCT02100696|593515283|FG002|Maintenance Phase|Multiple Reasons|0|||
164311357|NCT02100696|593515284|FG003|Maintenance Phase|Multiple Reasons|0|||
164311358|NCT02100696|593515285|FG004|Maintenance Phase|Multiple Reasons|2|||
164311359|NCT02100696|593515286|FG005|Maintenance Phase|Multiple Reasons|1|||
164311360|NCT03566485|593515290|FG000|Overall Study|Disease progression|5|||
164311361|NCT03566485|593515291|FG001|Overall Study|Disease progression|4|||
164311362|NCT03566485|593515290|FG000|Overall Study|Clinical progression|0|||
164311363|NCT03566485|593515291|FG001|Overall Study|Clinical progression|1|||
164311364|NCT03566485|593515290|FG000|Overall Study|Toxicity|0|||
164311365|NCT03566485|593515291|FG001|Overall Study|Toxicity|2|||
164311366|NCT01387542|593515303|FG000|Overall Study|Adverse Event|3|||
164311367|NCT01387542|593515303|FG000|Overall Study|Withdrawal by Subject|1|||
164311368|NCT01387542|593515303|FG000|Overall Study|Changed diagnosis|1|||
164311369|NCT01387542|593515303|FG000|Overall Study|Insufficient response|1|||
164311370|NCT01387542|593515303|FG000|Overall Study|Non-compliant|1|||
164311371|NCT01387542|593515303|FG000|Overall Study|Lost to Follow-up|1|||
164311372|NCT01010867|593515304|FG000|Overall Study|< 50% adherence to probiotic|1|||
164311373|NCT01668589|593515307|FG000|Overall Study|Lost to Follow-up|29|||
164311374|NCT01668589|593515308|FG001|Overall Study|Lost to Follow-up|37|||
164311375|NCT01668589|593515309|FG002|Overall Study|Lost to Follow-up|15|||
164311376|NCT01668589|593515310|FG003|Overall Study|Lost to Follow-up|5|||
164311377|NCT01668589|593515307|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
164311378|NCT01668589|593515308|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
164311379|NCT01668589|593515309|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
164311380|NCT01668589|593515310|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
164311381|NCT01668589|593515307|FG000|Overall Study|Death|12|||
164311382|NCT01668589|593515308|FG001|Overall Study|Death|3|||
164311383|NCT01668589|593515309|FG002|Overall Study|Death|2|||
164311384|NCT01668589|593515310|FG003|Overall Study|Death|11|||
164311385|NCT01668589|593515307|FG000|Overall Study|Other|44|||
164311386|NCT01668589|593515308|FG001|Overall Study|Other|10|||
164311387|NCT01668589|593515309|FG002|Overall Study|Other|7|||
164311388|NCT01668589|593515310|FG003|Overall Study|Other|15|||
164311389|NCT02954172|593515311|FG000|Overall Study|Protocol Violation|3|||
164311390|NCT02954172|593515312|FG001|Overall Study|Protocol Violation|0|||
164311391|NCT02954172|593515311|FG000|Overall Study|allergic reaction|2|||
164311392|NCT02954172|593515312|FG001|Overall Study|allergic reaction|1|||
164311393|NCT02954172|593515311|FG000|Overall Study|non-measurable lesions at baseline|1|||
164311394|NCT02954172|593515312|FG001|Overall Study|non-measurable lesions at baseline|2|||
164311395|NCT01827956|593515314|FG000|Overall Study|Protocol Violation|3|||
164311396|NCT04393454|593515315|FG000|Overall Study|Death|1|||
164311397|NCT04393454|593515315|FG000|Overall Study|Lost to Follow-up|1|||
164311398|NCT02752165|593515316|FG000|Overall Study|Withdrawal by Subject|6|||
164311399|NCT02752165|593515317|FG001|Overall Study|Withdrawal by Subject|6|||
164311400|NCT02752165|593515316|FG000|Overall Study|Protocol Violation|6|||
164311401|NCT02752165|593515317|FG001|Overall Study|Protocol Violation|5|||
164311402|NCT02752165|593515316|FG000|Overall Study|Lost to Follow-up|33|||
164311403|NCT02752165|593515317|FG001|Overall Study|Lost to Follow-up|38|||
164311404|NCT01120964|593515318|FG000|Overall Study|Did not receive full treatment|1|||
164311405|NCT01120964|593515319|FG001|Overall Study|Did not receive full treatment|0|||
164311406|NCT01704599|593515321|FG000|Overall Study|Adverse Event|1|||
164311407|NCT05064358|593515322|FG000|Overall Study|Death|23|||
164311408|NCT05064358|593515323|FG001|Overall Study|Death|23|||
164311409|NCT05064358|593515324|FG002|Overall Study|Death|25|||
164311410|NCT05064358|593515325|FG003|Overall Study|Death|21|||
164311411|NCT05064358|593515326|FG004|Overall Study|Death|5|||
164311412|NCT05064358|593515322|FG000|Overall Study|Lost to Follow-up|1|||
164311413|NCT05064358|593515323|FG001|Overall Study|Lost to Follow-up|2|||
164311414|NCT05064358|593515324|FG002|Overall Study|Lost to Follow-up|0|||
164311415|NCT05064358|593515325|FG003|Overall Study|Lost to Follow-up|2|||
164311416|NCT05064358|593515326|FG004|Overall Study|Lost to Follow-up|0|||
164311417|NCT05064358|593515322|FG000|Overall Study|Physician Decision|1|||
164311418|NCT05064358|593515323|FG001|Overall Study|Physician Decision|1|||
164311419|NCT05064358|593515324|FG002|Overall Study|Physician Decision|2|||
164311420|NCT05064358|593515325|FG003|Overall Study|Physician Decision|0|||
164311421|NCT05064358|593515326|FG004|Overall Study|Physician Decision|0|||
164311422|NCT05064358|593515322|FG000|Overall Study|Withdrawal by Subject|4|||
164311423|NCT05064358|593515323|FG001|Overall Study|Withdrawal by Subject|5|||
164311424|NCT05064358|593515324|FG002|Overall Study|Withdrawal by Subject|3|||
164311425|NCT05064358|593515325|FG003|Overall Study|Withdrawal by Subject|6|||
164311426|NCT05064358|593515326|FG004|Overall Study|Withdrawal by Subject|3|||
164311427|NCT05064358|593515322|FG000|Overall Study|Ongoing at the time of analysis|1|||
164311428|NCT05064358|593515323|FG001|Overall Study|Ongoing at the time of analysis|2|||
164311429|NCT05064358|593515324|FG002|Overall Study|Ongoing at the time of analysis|2|||
164311430|NCT05064358|593515325|FG003|Overall Study|Ongoing at the time of analysis|2|||
164311431|NCT05064358|593515326|FG004|Overall Study|Ongoing at the time of analysis|2|||
164311432|NCT04976192|593515329|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311433|NCT04976192|593515330|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
164311434|NCT04976192|593515331|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311435|NCT04976192|593515332|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311436|NCT04976192|593515333|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311437|NCT04976192|593515334|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311438|NCT04976192|593515335|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311439|NCT04976192|593515336|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311440|NCT04976192|593515337|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311441|NCT04976192|593515338|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
164311442|NCT04976192|593515329|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
164311443|NCT04976192|593515330|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
164311444|NCT04976192|593515331|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
164311445|NCT04976192|593515332|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164311446|NCT04976192|593515333|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311447|NCT04976192|593515334|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311448|NCT04976192|593515335|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311449|NCT04976192|593515336|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311450|NCT04976192|593515337|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311451|NCT04976192|593515338|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311452|NCT04976192|593515329|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
164311453|NCT04976192|593515330|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311454|NCT04976192|593515331|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
164311455|NCT04976192|593515332|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311456|NCT04976192|593515333|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311457|NCT04976192|593515334|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311458|NCT04976192|593515335|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311459|NCT04976192|593515336|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311460|NCT04976192|593515337|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311461|NCT04976192|593515338|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
164311462|NCT04976192|593515329|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311463|NCT04976192|593515330|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311464|NCT04976192|593515331|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311465|NCT04976192|593515332|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164311466|NCT04976192|593515333|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
164311467|NCT04976192|593515334|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
164311468|NCT04976192|593515335|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164311469|NCT04976192|593515336|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
164311470|NCT04976192|593515337|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
164311471|NCT04976192|593515338|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
164311472|NCT04976192|593515329|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311473|NCT04976192|593515330|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311474|NCT04976192|593515331|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311475|NCT04976192|593515332|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311476|NCT04976192|593515333|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
164311477|NCT04976192|593515334|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311478|NCT04976192|593515335|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311479|NCT04976192|593515336|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163867397|NCT00423098|591881593|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163867398|NCT00423098|591881592|FG000|Overall Study|Administrative problems|0|||
163867399|NCT00423098|591881593|FG001|Overall Study|Administrative problems|1|||
163867400|NCT00423098|591881592|FG000|Overall Study|Death|2|||
163867401|NCT00423098|591881593|FG001|Overall Study|Death|0|||
163867402|NCT02383472|591881605|FG000|Overall Study|Withdrawal by Subject|1|||
163867403|NCT02383472|591881606|FG001|Overall Study|Withdrawal by Subject|1|||
163867404|NCT02013830|591881607|FG000|Overall Study|Adverse Event|3|||
163867405|NCT02013830|591881607|FG000|Overall Study|Death|1|||
163867406|NCT02013830|591881607|FG000|Overall Study|Insufficient therapeutic response|25|||
164311480|NCT04976192|593515337|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
163867407|NCT02013830|591881607|FG000|Overall Study|Refused treatment|1|||
164311481|NCT04976192|593515338|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
164311482|NCT04976192|593515329|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163867408|NCT06119113|591881608|FG000|Overall Study|Lost to Follow-up|15|||
164311483|NCT04976192|593515330|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311484|NCT04976192|593515331|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311485|NCT04976192|593515332|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311486|NCT04976192|593515333|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311487|NCT04976192|593515334|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164311488|NCT04976192|593515335|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311489|NCT04976192|593515336|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311490|NCT04976192|593515337|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311491|NCT04976192|593515338|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164311492|NCT02621151|593515339|FG000|Overall Study|Not eligible for trial|6|||
164311493|NCT00924027|593515345|FG000|Overall Study|Lost to Further Follow-Up|4|||
164311494|NCT00924027|593515346|FG001|Overall Study|Lost to Further Follow-Up|0|||
164311495|NCT00924027|593515347|FG002|Overall Study|Lost to Further Follow-Up|0|||
164311496|NCT00924027|593515348|FG003|Overall Study|Lost to Further Follow-Up|0|||
164311497|NCT00924027|593515345|FG000|Overall Study|Physician Decision|1|||
164311498|NCT00924027|593515346|FG001|Overall Study|Physician Decision|0|||
164311499|NCT00924027|593515347|FG002|Overall Study|Physician Decision|0|||
164311500|NCT00924027|593515348|FG003|Overall Study|Physician Decision|1|||
164311501|NCT00924027|593515345|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
164311502|NCT00924027|593515346|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
164311503|NCT00924027|593515347|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
164311504|NCT00924027|593515348|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
164311505|NCT00924027|593515345|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
164311506|NCT00924027|593515346|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
164311507|NCT00924027|593515347|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
164311508|NCT00924027|593515348|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
164311509|NCT00924027|593515345|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
164311510|NCT00924027|593515346|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
164311511|NCT00924027|593515347|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
164311512|NCT00924027|593515348|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
164311513|NCT01761162|593516609|FG000|Overall Study|Withdrawal by Subject|3|||
164311514|NCT02160899|593516614|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164311515|NCT02160899|593516615|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164311516|NCT02160899|593516616|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
164311517|NCT02160899|593516617|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
164311518|NCT02160899|593516618|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
164311519|NCT02160899|593516619|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
164311520|NCT04129151|593516620|FG000|Overall Study|Adverse Event|1|||
164311521|NCT04129151|593516620|FG000|Overall Study|Disease Progression|7|||
164311522|NCT04129151|593516620|FG000|Overall Study|Study closure|1|||
164311523|NCT04473235|593516621|FG000|Overall Study|Lost to Follow-up|6|||
164311524|NCT04473235|593516622|FG001|Overall Study|Lost to Follow-up|5|||
164311525|NCT04473235|593516621|FG000|Overall Study|Declined continuation|2|||
164311526|NCT04473235|593516622|FG001|Overall Study|Declined continuation|0|||
164311527|NCT04473235|593516621|FG000|Overall Study|Physician Decision|1|||
164311528|NCT04473235|593516622|FG001|Overall Study|Physician Decision|1|||
164311529|NCT04473235|593516621|FG000|Overall Study|Protocol Violation|10|||
164311530|NCT04473235|593516622|FG001|Overall Study|Protocol Violation|6|||
164311531|NCT01945710|593516625|FG000|Overall Study|Progressive Disease|5|||
164311532|NCT01945710|593516626|FG001|Overall Study|Progressive Disease|4|||
164311533|NCT01945710|593516627|FG002|Overall Study|Progressive Disease|3|||
164311534|NCT01945710|593516628|FG003|Overall Study|Progressive Disease|2|||
164311535|NCT01945710|593516629|FG004|Overall Study|Progressive Disease|7|||
164311536|NCT01945710|593516630|FG005|Overall Study|Progressive Disease|3|||
164311537|NCT01945710|593516631|FG006|Overall Study|Progressive Disease|19|||
164311538|NCT01945710|593516625|FG000|Overall Study|Adverse Event|0|||
164311539|NCT01945710|593516626|FG001|Overall Study|Adverse Event|1|||
164311540|NCT01945710|593516627|FG002|Overall Study|Adverse Event|0|||
164311541|NCT01945710|593516628|FG003|Overall Study|Adverse Event|0|||
164311542|NCT01945710|593516629|FG004|Overall Study|Adverse Event|0|||
164311543|NCT01945710|593516630|FG005|Overall Study|Adverse Event|0|||
163867409|NCT06119113|591881609|FG001|Overall Study|Lost to Follow-up|13|||
164311544|NCT01945710|593516631|FG006|Overall Study|Adverse Event|0|||
164311545|NCT01945710|593516625|FG000|Overall Study|Other|2|||
164311546|NCT01945710|593516626|FG001|Overall Study|Other|0|||
163867410|NCT06119113|591881610|FG002|Overall Study|Lost to Follow-up|21|||
163867411|NCT01786564|591881615|FG000|Overall Study|Lost to Follow-up|47|||
164311547|NCT01945710|593516627|FG002|Overall Study|Other|3|||
164311548|NCT01945710|593516628|FG003|Overall Study|Other|1|||
164311549|NCT01945710|593516629|FG004|Overall Study|Other|1|||
164311550|NCT01945710|593516630|FG005|Overall Study|Other|0|||
164311551|NCT01945710|593516631|FG006|Overall Study|Other|4|||
164311552|NCT01945710|593516625|FG000|Overall Study|Withdrawal by Subject|0|||
164311553|NCT01945710|593516626|FG001|Overall Study|Withdrawal by Subject|1|||
164311554|NCT01945710|593516627|FG002|Overall Study|Withdrawal by Subject|1|||
164311555|NCT01945710|593516628|FG003|Overall Study|Withdrawal by Subject|0|||
164311556|NCT01945710|593516629|FG004|Overall Study|Withdrawal by Subject|1|||
164311557|NCT01945710|593516630|FG005|Overall Study|Withdrawal by Subject|0|||
164311558|NCT01945710|593516631|FG006|Overall Study|Withdrawal by Subject|0|||
164311559|NCT02730195|593516632|FG000|Overall Study|Withdrawal by Subject|1|||
164311560|NCT00745849|593516633|FG000|First Intervention|Withdrawal by Subject|0|||
164311561|NCT00745849|593516634|FG001|First Intervention|Withdrawal by Subject|1|||
164311562|NCT00745849|593516633|FG000|First Intervention|Lost to Follow-up|1|||
164311563|NCT00745849|593516634|FG001|First Intervention|Lost to Follow-up|1|||
164311564|NCT00745849|593516633|FG000|Second Intervention|Lost to Follow-up|2|||
164311565|NCT00745849|593516634|FG001|Second Intervention|Lost to Follow-up|1|||
164311566|NCT01139008|593516635|FG000|Overall Study|Withdrawal by Subject|5|||
164311567|NCT01139008|593516635|FG000|Overall Study|Non-compliant, lost product|1|||
164311568|NCT02785770|593516636|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
164311569|NCT02785770|593516637|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
164311570|NCT02785770|593516638|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
164311571|NCT02785770|593516639|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
164311572|NCT02785770|593516636|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
164311573|NCT02785770|593516637|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
164311574|NCT02785770|593516638|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
164311575|NCT02785770|593516639|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
164311576|NCT02785770|593516636|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
164311577|NCT02785770|593516637|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
164311578|NCT02785770|593516638|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
164311579|NCT02785770|593516639|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
164311580|NCT00813943|593516645|FG000|Overall Study|Ongoing at cut-off date|5|||
164311581|NCT00813943|593516646|FG001|Overall Study|Ongoing at cut-off date|5|||
164311582|NCT00813943|593516647|FG002|Overall Study|Ongoing at cut-off date|3|||
164311583|NCT01088048|593516648|FG000|Overall Study|Adverse Event|7|||
164311584|NCT01088048|593516649|FG001|Overall Study|Adverse Event|9|||
164311585|NCT01088048|593516650|FG002|Overall Study|Adverse Event|7|||
164311586|NCT01088048|593516651|FG003|Overall Study|Adverse Event|5|||
164311587|NCT01088048|593516652|FG004|Overall Study|Adverse Event|6|||
164311588|NCT01088048|593516653|FG005|Overall Study|Adverse Event|3|||
164311589|NCT01088048|593516654|FG006|Overall Study|Adverse Event|3|||
164311590|NCT01088048|593516655|FG007|Overall Study|Adverse Event|0|||
164311591|NCT01088048|593516656|FG008|Overall Study|Adverse Event|2|||
164311592|NCT01088048|593516657|FG009|Overall Study|Adverse Event|2|||
164311593|NCT01088048|593516648|FG000|Overall Study|Withdrew Consent|1|||
164311594|NCT01088048|593516649|FG001|Overall Study|Withdrew Consent|1|||
164311595|NCT01088048|593516650|FG002|Overall Study|Withdrew Consent|1|||
164311596|NCT01088048|593516651|FG003|Overall Study|Withdrew Consent|1|||
164311597|NCT01088048|593516652|FG004|Overall Study|Withdrew Consent|2|||
164311598|NCT01088048|593516653|FG005|Overall Study|Withdrew Consent|1|||
164311599|NCT01088048|593516654|FG006|Overall Study|Withdrew Consent|0|||
164311600|NCT01088048|593516655|FG007|Overall Study|Withdrew Consent|2|||
164311601|NCT01088048|593516656|FG008|Overall Study|Withdrew Consent|2|||
164311602|NCT01088048|593516657|FG009|Overall Study|Withdrew Consent|1|||
164311603|NCT01088048|593516648|FG000|Overall Study|Concomitant Medication Prohibited|1|||
164311604|NCT01088048|593516649|FG001|Overall Study|Concomitant Medication Prohibited|0|||
164311605|NCT01088048|593516650|FG002|Overall Study|Concomitant Medication Prohibited|0|||
164311606|NCT01088048|593516651|FG003|Overall Study|Concomitant Medication Prohibited|0|||
164311607|NCT01088048|593516652|FG004|Overall Study|Concomitant Medication Prohibited|0|||
164311608|NCT01088048|593516653|FG005|Overall Study|Concomitant Medication Prohibited|0|||
164311609|NCT01088048|593516654|FG006|Overall Study|Concomitant Medication Prohibited|0|||
164311610|NCT01088048|593516655|FG007|Overall Study|Concomitant Medication Prohibited|0|||
164311611|NCT01088048|593516656|FG008|Overall Study|Concomitant Medication Prohibited|0|||
164311612|NCT01088048|593516657|FG009|Overall Study|Concomitant Medication Prohibited|0|||
164311613|NCT01088048|593516648|FG000|Overall Study|Investigator Request|2|||
164311614|NCT01088048|593516649|FG001|Overall Study|Investigator Request|2|||
164311615|NCT01088048|593516650|FG002|Overall Study|Investigator Request|0|||
164311616|NCT01088048|593516651|FG003|Overall Study|Investigator Request|0|||
164311617|NCT01088048|593516652|FG004|Overall Study|Investigator Request|3|||
164311618|NCT01088048|593516653|FG005|Overall Study|Investigator Request|1|||
164311619|NCT01088048|593516654|FG006|Overall Study|Investigator Request|1|||
164311620|NCT01088048|593516655|FG007|Overall Study|Investigator Request|0|||
164311621|NCT01088048|593516656|FG008|Overall Study|Investigator Request|0|||
164311622|NCT01088048|593516657|FG009|Overall Study|Investigator Request|0|||
164311623|NCT01088048|593516648|FG000|Overall Study|Patient Non-compliance|0|||
164311624|NCT01088048|593516649|FG001|Overall Study|Patient Non-compliance|1|||
164311625|NCT01088048|593516650|FG002|Overall Study|Patient Non-compliance|0|||
164311626|NCT01088048|593516651|FG003|Overall Study|Patient Non-compliance|0|||
164311627|NCT01088048|593516652|FG004|Overall Study|Patient Non-compliance|0|||
164311628|NCT01088048|593516653|FG005|Overall Study|Patient Non-compliance|0|||
164311629|NCT01088048|593516654|FG006|Overall Study|Patient Non-compliance|0|||
164311630|NCT01088048|593516655|FG007|Overall Study|Patient Non-compliance|0|||
164311631|NCT01088048|593516656|FG008|Overall Study|Patient Non-compliance|0|||
164311632|NCT01088048|593516657|FG009|Overall Study|Patient Non-compliance|0|||
164311633|NCT01088048|593516648|FG000|Overall Study|Disease Progression|7|||
164311634|NCT01088048|593516649|FG001|Overall Study|Disease Progression|4|||
164311635|NCT01088048|593516650|FG002|Overall Study|Disease Progression|3|||
164311636|NCT01088048|593516651|FG003|Overall Study|Disease Progression|5|||
164311637|NCT01088048|593516652|FG004|Overall Study|Disease Progression|3|||
164311638|NCT01088048|593516653|FG005|Overall Study|Disease Progression|3|||
164311639|NCT01088048|593516654|FG006|Overall Study|Disease Progression|2|||
164311640|NCT01088048|593516655|FG007|Overall Study|Disease Progression|1|||
164311641|NCT01088048|593516656|FG008|Overall Study|Disease Progression|0|||
164311642|NCT01088048|593516657|FG009|Overall Study|Disease Progression|0|||
164311643|NCT01088048|593516648|FG000|Overall Study|Death|1|||
164311644|NCT01088048|593516649|FG001|Overall Study|Death|5|||
164311645|NCT01088048|593516650|FG002|Overall Study|Death|3|||
164311646|NCT01088048|593516651|FG003|Overall Study|Death|3|||
164311647|NCT01088048|593516652|FG004|Overall Study|Death|1|||
164311648|NCT01088048|593516653|FG005|Overall Study|Death|3|||
164311649|NCT01088048|593516654|FG006|Overall Study|Death|0|||
164311650|NCT01088048|593516655|FG007|Overall Study|Death|0|||
164311651|NCT01088048|593516656|FG008|Overall Study|Death|3|||
164311652|NCT01088048|593516657|FG009|Overall Study|Death|1|||
164311653|NCT01088048|593516648|FG000|Overall Study|Other|3|||
164311654|NCT01088048|593516649|FG001|Overall Study|Other|5|||
164311655|NCT01088048|593516650|FG002|Overall Study|Other|0|||
164311656|NCT01088048|593516651|FG003|Overall Study|Other|0|||
164311657|NCT01088048|593516652|FG004|Overall Study|Other|2|||
164311658|NCT01088048|593516653|FG005|Overall Study|Other|0|||
164311659|NCT01088048|593516654|FG006|Overall Study|Other|0|||
164311660|NCT01088048|593516655|FG007|Overall Study|Other|2|||
164311661|NCT01088048|593516656|FG008|Overall Study|Other|0|||
164311662|NCT01088048|593516657|FG009|Overall Study|Other|0|||
164311663|NCT01049009|593516664|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
164311664|NCT01049009|593516665|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
164311665|NCT01049009|593516664|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164311666|NCT01049009|593516665|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164311667|NCT01049009|593516664|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
164311668|NCT01049009|593516665|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
164311669|NCT01049009|593516664|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
164311670|NCT01049009|593516665|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
164311671|NCT03760731|593516666|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
164311672|NCT03760731|593516667|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
164311673|NCT03760731|593516666|FG000|Treatment|Attended less than 70% of sessions|10|||
164311674|NCT03760731|593516667|FG001|Treatment|Attended less than 70% of sessions|15|||
164311675|NCT01092546|593516668|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
164311676|NCT01970358|593516669|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
164311677|NCT01970358|593516669|FG000|Overall Study|Ineligible at time of second consent|4|||
164311678|NCT02644109|593516670|FG000|Overall Study|Adverse Event|0|||
164311679|NCT02644109|593516671|FG001|Overall Study|Adverse Event|4|||
164311680|NCT01519869|593516674|FG000|Overall Study|Lost to Follow-up|1|||
164311681|NCT04075734|593516677|FG000|Overall Study|Lost to Follow-up|1|||
164311682|NCT04075734|593516678|FG001|Overall Study|Lost to Follow-up|1|||
164311683|NCT04075734|593516679|FG002|Overall Study|Lost to Follow-up|0|||
164311684|NCT04075734|593516677|FG000|Overall Study|Withdrawal by Subject|3|||
164311685|NCT04075734|593516678|FG001|Overall Study|Withdrawal by Subject|0|||
164311686|NCT04075734|593516679|FG002|Overall Study|Withdrawal by Subject|0|||
164311687|NCT02433080|593516681|FG000|Overall Study|Lost to Follow-up|1|||
164311688|NCT02433080|593516682|FG001|Overall Study|Lost to Follow-up|2|||
164311689|NCT02433080|593516681|FG000|Overall Study|Withdrawal by Subject|0|||
164311690|NCT02433080|593516682|FG001|Overall Study|Withdrawal by Subject|2|||
164311691|NCT04080167|593516688|FG000|Overall Study|Lost to Follow-up-Patients|7|||
164311692|NCT04080167|593516689|FG001|Overall Study|Lost to Follow-up-Patients|14|||
164311693|NCT04080167|593516690|FG002|Overall Study|Lost to Follow-up-Patients|0|||
164311694|NCT04080167|593516688|FG000|Overall Study|Lost to Follow-up-Providers|2|||
164311695|NCT04080167|593516689|FG001|Overall Study|Lost to Follow-up-Providers|2|||
164311696|NCT04080167|593516690|FG002|Overall Study|Lost to Follow-up-Providers|0|||
164311697|NCT04080167|593516688|FG000|Overall Study|Withdrawal by Subject|1|||
164311698|NCT04080167|593516689|FG001|Overall Study|Withdrawal by Subject|2|||
164311699|NCT04080167|593516690|FG002|Overall Study|Withdrawal by Subject|0|||
164311700|NCT04080167|593516688|FG000|Overall Study|Withdrawal by Provider|0|||
164311701|NCT04080167|593516689|FG001|Overall Study|Withdrawal by Provider|0|||
164311702|NCT04080167|593516690|FG002|Overall Study|Withdrawal by Provider|4|||
164311703|NCT04080167|593516688|FG000|Overall Study|Death-Patient|2|||
164311704|NCT04080167|593516689|FG001|Overall Study|Death-Patient|1|||
164311705|NCT04080167|593516690|FG002|Overall Study|Death-Patient|0|||
164311706|NCT04080167|593516688|FG000|Overall Study|Hydroxyurea New Starts|0|||
163867412|NCT01786564|591881615|FG000|Overall Study|Ineligible|17|||
163867413|NCT03034915|591881616|FG000|Overall Study|Adverse Event|29|||
163867414|NCT03034915|591881617|FG001|Overall Study|Adverse Event|32|||
163867415|NCT03034915|591881618|FG002|Overall Study|Adverse Event|22|||
163867416|NCT03034915|591881616|FG000|Overall Study|Lost to Follow-up|5|||
163867417|NCT03034915|591881617|FG001|Overall Study|Lost to Follow-up|13|||
163867418|NCT03034915|591881618|FG002|Overall Study|Lost to Follow-up|3|||
163867419|NCT03034915|591881616|FG000|Overall Study|Withdrawal by Subject|29|||
163867420|NCT03034915|591881617|FG001|Overall Study|Withdrawal by Subject|46|||
163971842|NCT05050318|592269729|FG000|Overall Study|Protocol Deviation|1|||
164201988|NCT01041859|593112623|FG000|Double-Blind Maintenance|Protocol Violation|0|||
164201989|NCT01041859|593112624|FG001|Double-Blind Maintenance|Protocol Violation|1|||
164201990|NCT01041859|593112625|FG002|Double-Blind Maintenance|Protocol Violation|3|||
164201991|NCT01041859|593112623|FG000|Double-Blind Maintenance|Other|0|||
164201992|NCT01041859|593112624|FG001|Double-Blind Maintenance|Other|6|||
164201993|NCT01041859|593112625|FG002|Double-Blind Maintenance|Other|2|||
164201994|NCT01041859|593112623|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
164201995|NCT01041859|593112624|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
164201996|NCT01041859|593112625|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
164201997|NCT01041859|593112623|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
164201998|NCT01041859|593112624|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
164201999|NCT01041859|593112625|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
164202000|NCT02027025|593112626|FG000|Overall Study|Adverse Event|0|||
164202001|NCT02027025|593112627|FG001|Overall Study|Adverse Event|1|||
164202002|NCT02027025|593112628|FG002|Overall Study|Adverse Event|1|||
164202003|NCT02027025|593112626|FG000|Overall Study|Protocol Violation|1|||
164202004|NCT02027025|593112627|FG001|Overall Study|Protocol Violation|0|||
164202005|NCT02027025|593112628|FG002|Overall Study|Protocol Violation|0|||
164202006|NCT02027025|593112626|FG000|Overall Study|Lost to Follow-up|0|||
164202007|NCT02027025|593112627|FG001|Overall Study|Lost to Follow-up|2|||
164202008|NCT02027025|593112628|FG002|Overall Study|Lost to Follow-up|0|||
164202009|NCT02027025|593112626|FG000|Overall Study|Withdrawal by Subject|0|||
164202010|NCT02027025|593112627|FG001|Overall Study|Withdrawal by Subject|1|||
164202011|NCT02027025|593112628|FG002|Overall Study|Withdrawal by Subject|0|||
164202012|NCT02027025|593112626|FG000|Overall Study|Sponsor's decision|0|||
164202013|NCT02027025|593112627|FG001|Overall Study|Sponsor's decision|1|||
164202014|NCT02027025|593112628|FG002|Overall Study|Sponsor's decision|0|||
164202015|NCT03210714|593112629|FG000|Overall Study|Adverse Event|6|||
164202016|NCT03210714|593112629|FG000|Overall Study|Physician Decision|1|||
164202017|NCT03210714|593112629|FG000|Overall Study|Progressive disease|11|||
164202018|NCT03210714|593112629|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
164202019|NCT04609514|593112630|FG000|Overall Study|Lost to Follow-up|5|||
164202020|NCT04609514|593112631|FG001|Overall Study|Lost to Follow-up|4|||
164202021|NCT04609514|593112630|FG000|Overall Study|Withdrawal by PI|0|||
164202022|NCT04609514|593112631|FG001|Overall Study|Withdrawal by PI|2|||
164202023|NCT00828711|593112634|FG000|Overall Study|Lost to Follow-up|1|||
164202024|NCT00828711|593112635|FG001|Overall Study|Lost to Follow-up|0|||
164202025|NCT00828711|593112636|FG002|Overall Study|Lost to Follow-up|0|||
164202026|NCT03883386|593112637|FG000|First Assignment|Lost to Follow-up|1|||
164202027|NCT03883386|593112638|FG001|First Assignment|Lost to Follow-up|0|||
164202028|NCT03883386|593112637|FG000|First Assignment|Withdrawal by Subject|1|||
164202029|NCT03883386|593112638|FG001|First Assignment|Withdrawal by Subject|1|||
164202030|NCT01618968|593112639|FG000|Overall Study|Adverse Event|1|||
164202031|NCT01618968|593112640|FG001|Overall Study|Adverse Event|0|||
164202032|NCT01618968|593112641|FG002|Overall Study|Adverse Event|0|||
164202033|NCT01618968|593112642|FG003|Overall Study|Adverse Event|0|||
164202034|NCT01618968|593112639|FG000|Overall Study|Death|0|||
164202035|NCT01618968|593112640|FG001|Overall Study|Death|0|||
164202036|NCT01618968|593112641|FG002|Overall Study|Death|0|||
164202037|NCT01618968|593112642|FG003|Overall Study|Death|1|||
164202038|NCT01326871|593112643|FG000|Overall Study|Major surgery|0|||
164202039|NCT01326871|593112644|FG001|Overall Study|Major surgery|1|||
164202040|NCT01326871|593112645|FG002|Overall Study|Major surgery|0|||
164202041|NCT01326871|593112643|FG000|Overall Study|SAE and death|0|||
164202042|NCT01326871|593112644|FG001|Overall Study|SAE and death|2|||
164202043|NCT01326871|593112645|FG002|Overall Study|SAE and death|0|||
164202044|NCT01326871|593112643|FG000|Overall Study|Physician decision and decreased performance status|0|||
164202045|NCT01326871|593112644|FG001|Overall Study|Physician decision and decreased performance status|1|||
163867421|NCT03034915|591881618|FG002|Overall Study|Withdrawal by Subject|41|||
163971843|NCT05050318|592269730|FG001|Overall Study|Protocol Deviation|0|||
164202046|NCT01326871|593112645|FG002|Overall Study|Physician decision and decreased performance status|0|||
164202047|NCT01326871|593112643|FG000|Overall Study|Disease progression|0|||
164202048|NCT01326871|593112644|FG001|Overall Study|Disease progression|11|||
164202049|NCT01326871|593112645|FG002|Overall Study|Disease progression|5|||
164202050|NCT01326871|593112643|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
164202051|NCT01326871|593112644|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
164202052|NCT01326871|593112645|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
163971844|NCT05050318|592269731|FG002|Overall Study|Protocol Deviation|0|||
163971845|NCT00574145|592269734|FG000|Overall Study|Withdrawal by Subject|2|||
163971846|NCT00574145|592269735|FG001|Overall Study|Withdrawal by Subject|1|||
163971847|NCT03227471|592269736|FG000|Overall Study|Withdrawal by Subject|0|||
163971848|NCT03227471|592269737|FG001|Overall Study|Withdrawal by Subject|0|||
163971849|NCT03227471|592269738|FG002|Overall Study|Withdrawal by Subject|0|||
163971850|NCT03227471|592269739|FG003|Overall Study|Withdrawal by Subject|0|||
163971851|NCT03227471|592269740|FG004|Overall Study|Withdrawal by Subject|1|||
163971852|NCT03227471|592269741|FG005|Overall Study|Withdrawal by Subject|0|||
163971853|NCT03227471|592269742|FG006|Overall Study|Withdrawal by Subject|0|||
163971854|NCT03227471|592269743|FG007|Overall Study|Withdrawal by Subject|0|||
163971855|NCT03227471|592269744|FG008|Overall Study|Withdrawal by Subject|0|||
163971856|NCT03227471|592269745|FG009|Overall Study|Withdrawal by Subject|0|||
163971857|NCT03227471|592269746|FG010|Overall Study|Withdrawal by Subject|0|||
163971858|NCT03227471|592269747|FG011|Overall Study|Withdrawal by Subject|0|||
164202053|NCT01326871|593112643|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
164202054|NCT01326871|593112644|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
164202055|NCT01326871|593112645|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
164202056|NCT01326871|593112643|FG000|Overall Study|Withdrawal by Subject|0|||
164202057|NCT01326871|593112644|FG001|Overall Study|Withdrawal by Subject|1|||
164202058|NCT01326871|593112645|FG002|Overall Study|Withdrawal by Subject|0|||
164202059|NCT01326871|593112643|FG000|Overall Study|DLT|0|||
164202060|NCT01326871|593112644|FG001|Overall Study|DLT|2|||
164202061|NCT01326871|593112645|FG002|Overall Study|DLT|0|||
164202062|NCT01326871|593112643|FG000|Overall Study|SAE, disease progression and subject decision|0|||
164202063|NCT01326871|593112644|FG001|Overall Study|SAE, disease progression and subject decision|1|||
164202064|NCT01326871|593112645|FG002|Overall Study|SAE, disease progression and subject decision|0|||
164202065|NCT01326871|593112643|FG000|Overall Study|Death|0|||
164202066|NCT01326871|593112644|FG001|Overall Study|Death|1|||
164202067|NCT01326871|593112645|FG002|Overall Study|Death|0|||
164202068|NCT01326871|593112643|FG000|Overall Study|Other|0|||
164202069|NCT01326871|593112644|FG001|Overall Study|Other|3|||
164202070|NCT01326871|593112645|FG002|Overall Study|Other|0|||
164202071|NCT01326871|593112643|FG000|Overall Study|SAE and disease progression|0|||
164202072|NCT01326871|593112644|FG001|Overall Study|SAE and disease progression|0|||
164202073|NCT01326871|593112645|FG002|Overall Study|SAE and disease progression|1|||
164202074|NCT01326871|593112643|FG000|Overall Study|SAE and physician decision|0|||
164202075|NCT01326871|593112644|FG001|Overall Study|SAE and physician decision|0|||
164202076|NCT01326871|593112645|FG002|Overall Study|SAE and physician decision|1|||
164202077|NCT01326871|593112643|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
164202078|NCT01326871|593112644|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
164202079|NCT01326871|593112645|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
164202080|NCT01326871|593112643|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
164202081|NCT01326871|593112644|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
164202082|NCT01326871|593112645|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
164202083|NCT01326871|593112643|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
164202084|NCT01326871|593112644|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
164202085|NCT01326871|593112645|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
164202086|NCT01326871|593112643|FG000|Overall Study|Physician Decision|0|||
164202087|NCT01326871|593112644|FG001|Overall Study|Physician Decision|0|||
164202088|NCT01326871|593112645|FG002|Overall Study|Physician Decision|1|||
164202089|NCT01326871|593112643|FG000|Overall Study|SAE|0|||
164202090|NCT01326871|593112644|FG001|Overall Study|SAE|0|||
164202091|NCT01326871|593112645|FG002|Overall Study|SAE|1|||
164202092|NCT01326871|593112643|FG000|Overall Study|Disease progression and death|0|||
164202093|NCT01326871|593112644|FG001|Overall Study|Disease progression and death|0|||
164202094|NCT01326871|593112645|FG002|Overall Study|Disease progression and death|1|||
164202095|NCT01326871|593112643|FG000|Overall Study|Subject decision|0|||
164202096|NCT01326871|593112644|FG001|Overall Study|Subject decision|0|||
164202097|NCT01326871|593112645|FG002|Overall Study|Subject decision|1|||
164202098|NCT00251758|593112647|FG000|Overall Study|Adverse Event|7|||
164202099|NCT00251758|593112648|FG001|Overall Study|Adverse Event|9|||
164202100|NCT00251758|593112649|FG002|Overall Study|Adverse Event|11|||
164202101|NCT00251758|593112647|FG000|Overall Study|Lost to Follow-up|4|||
164202102|NCT00251758|593112648|FG001|Overall Study|Lost to Follow-up|2|||
164202103|NCT00251758|593112649|FG002|Overall Study|Lost to Follow-up|5|||
164202104|NCT00251758|593112647|FG000|Overall Study|Withdrawal by Subject|13|||
164202105|NCT00251758|593112648|FG001|Overall Study|Withdrawal by Subject|7|||
164202106|NCT00251758|593112649|FG002|Overall Study|Withdrawal by Subject|3|||
164202107|NCT00251758|593112647|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164202108|NCT00251758|593112648|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
164202109|NCT00251758|593112649|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
164311707|NCT04080167|593516689|FG001|Overall Study|Hydroxyurea New Starts|0|||
164311708|NCT04080167|593516690|FG002|Overall Study|Hydroxyurea New Starts|1|||
164311709|NCT04080167|593516688|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
164311710|NCT04080167|593516689|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
164311711|NCT04080167|593516690|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
164311712|NCT04927364|593516691|FG000|Overall Study|Withdrawal by Subject|3|||
164311713|NCT04927364|593516691|FG000|Overall Study|Unable to complete preassessment MRI|1|||
164311714|NCT05188053|593516695|FG000|Overall Study|Lost to Follow-up|23|||
164311715|NCT05188053|593516696|FG001|Overall Study|Lost to Follow-up|30|||
164311716|NCT05188053|593516695|FG000|Overall Study|Protocol Violation|16|||
164311717|NCT05188053|593516696|FG001|Overall Study|Protocol Violation|16|||
164311718|NCT05188053|593516695|FG000|Overall Study|Physician Decision|3|||
164311719|NCT05188053|593516696|FG001|Overall Study|Physician Decision|0|||
164311720|NCT05188053|593516695|FG000|Overall Study|Withdrawal by Subject|0|||
164311721|NCT05188053|593516696|FG001|Overall Study|Withdrawal by Subject|1|||
164311722|NCT01761240|593516700|FG000|Overall Study|Progressive disease:radiology assessment|3|||
164311723|NCT01761240|593516701|FG001|Overall Study|Progressive disease:radiology assessment|3|||
164311724|NCT01761240|593516702|FG002|Overall Study|Progressive disease:radiology assessment|0|||
164311725|NCT01761240|593516703|FG003|Overall Study|Progressive disease:radiology assessment|0|||
164311726|NCT01761240|593516704|FG004|Overall Study|Progressive disease:radiology assessment|0|||
164311727|NCT01761240|593516700|FG000|Overall Study|Progressive disease:clinical assessment|0|||
164311728|NCT01761240|593516701|FG001|Overall Study|Progressive disease:clinical assessment|0|||
164311729|NCT01761240|593516702|FG002|Overall Study|Progressive disease:clinical assessment|3|||
164311730|NCT01761240|593516703|FG003|Overall Study|Progressive disease:clinical assessment|1|||
164311731|NCT01761240|593516704|FG004|Overall Study|Progressive disease:clinical assessment|0|||
164311732|NCT01761240|593516700|FG000|Overall Study|Withdrawal by Subject|0|||
164311733|NCT01761240|593516701|FG001|Overall Study|Withdrawal by Subject|0|||
164311734|NCT01761240|593516702|FG002|Overall Study|Withdrawal by Subject|0|||
164311735|NCT01761240|593516703|FG003|Overall Study|Withdrawal by Subject|3|||
164311736|NCT01761240|593516704|FG004|Overall Study|Withdrawal by Subject|1|||
164311737|NCT01761240|593516700|FG000|Overall Study|Adverse Event|0|||
164311738|NCT01761240|593516701|FG001|Overall Study|Adverse Event|0|||
164311739|NCT01761240|593516702|FG002|Overall Study|Adverse Event|0|||
164311740|NCT01761240|593516703|FG003|Overall Study|Adverse Event|1|||
164311741|NCT01761240|593516704|FG004|Overall Study|Adverse Event|6|||
164311742|NCT01761240|593516700|FG000|Overall Study|Death|0|||
164311743|NCT01761240|593516701|FG001|Overall Study|Death|1|||
164311744|NCT01761240|593516702|FG002|Overall Study|Death|1|||
164311745|NCT01761240|593516703|FG003|Overall Study|Death|2|||
164311746|NCT01761240|593516704|FG004|Overall Study|Death|1|||
164311747|NCT01761240|593516700|FG000|Overall Study|Non-compliance|0|||
164311748|NCT01761240|593516701|FG001|Overall Study|Non-compliance|0|||
164311749|NCT01761240|593516702|FG002|Overall Study|Non-compliance|1|||
164311750|NCT01761240|593516703|FG003|Overall Study|Non-compliance|0|||
164311751|NCT01761240|593516704|FG004|Overall Study|Non-compliance|0|||
163867422|NCT03034915|591881616|FG000|Overall Study|Protocol Deviation|2|||
163867423|NCT03034915|591881617|FG001|Overall Study|Protocol Deviation|14|||
163867424|NCT03034915|591881618|FG002|Overall Study|Protocol Deviation|7|||
163867425|NCT03034915|591881616|FG000|Overall Study|Lack of Efficacy|8|||
163867426|NCT03034915|591881617|FG001|Overall Study|Lack of Efficacy|16|||
163867427|NCT03034915|591881618|FG002|Overall Study|Lack of Efficacy|18|||
163867428|NCT03034915|591881616|FG000|Overall Study|Site closed|2|||
163867429|NCT03034915|591881617|FG001|Overall Study|Site closed|2|||
163867430|NCT03034915|591881618|FG002|Overall Study|Site closed|4|||
163867431|NCT03034915|591881616|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
163867432|NCT03034915|591881617|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
163867433|NCT03034915|591881618|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
163867434|NCT03034915|591881616|FG000|Overall Study|Physician Decision|1|||
163867435|NCT03034915|591881617|FG001|Overall Study|Physician Decision|5|||
163867436|NCT03034915|591881618|FG002|Overall Study|Physician Decision|2|||
163867437|NCT00424762|591881626|FG000|Overall Study|Withdrawal by Subject|18|||
163867438|NCT00424762|591881627|FG001|Overall Study|Withdrawal by Subject|19|||
163867439|NCT00424762|591881626|FG000|Overall Study|Lost to Follow-up|2|||
164311752|NCT05422638|593516705|FG000|Overall Study|Withdrawal by Subject|8|||
163867440|NCT00424762|591881627|FG001|Overall Study|Lost to Follow-up|3|||
164311753|NCT05422638|593516706|FG001|Overall Study|Withdrawal by Subject|2|||
164311754|NCT02529553|593516708|FG000|Overall Study|Progressive Disease|1|||
164311755|NCT02529553|593516709|FG001|Overall Study|Progressive Disease|0|||
164311756|NCT02529553|593516710|FG002|Overall Study|Progressive Disease|1|||
164311757|NCT02529553|593516711|FG003|Overall Study|Progressive Disease|3|||
164311758|NCT02529553|593516712|FG004|Overall Study|Progressive Disease|2|||
164311759|NCT02529553|593516713|FG005|Overall Study|Progressive Disease|3|||
163867441|NCT01135511|591881635|FG000|Overall Study|Adverse Event|0|||
163867442|NCT01135511|591881636|FG001|Overall Study|Adverse Event|1|||
163867443|NCT01135511|591881637|FG002|Overall Study|Adverse Event|2|||
163867444|NCT01135511|591881638|FG003|Overall Study|Adverse Event|0|||
163971859|NCT03227471|592269748|FG012|Overall Study|Withdrawal by Subject|1|||
163971860|NCT03227471|592269749|FG013|Overall Study|Withdrawal by Subject|0|||
163971861|NCT03227471|592269750|FG014|Overall Study|Withdrawal by Subject|0|||
163971862|NCT03227471|592269736|FG000|Overall Study|Randomized, Never Dosed|0|||
163971863|NCT03227471|592269737|FG001|Overall Study|Randomized, Never Dosed|0|||
163971864|NCT03227471|592269738|FG002|Overall Study|Randomized, Never Dosed|0|||
163971865|NCT03227471|592269739|FG003|Overall Study|Randomized, Never Dosed|0|||
163971866|NCT03227471|592269740|FG004|Overall Study|Randomized, Never Dosed|0|||
163971867|NCT03227471|592269741|FG005|Overall Study|Randomized, Never Dosed|0|||
163971868|NCT03227471|592269742|FG006|Overall Study|Randomized, Never Dosed|0|||
163971869|NCT03227471|592269743|FG007|Overall Study|Randomized, Never Dosed|0|||
163971870|NCT03227471|592269744|FG008|Overall Study|Randomized, Never Dosed|0|||
163971871|NCT03227471|592269745|FG009|Overall Study|Randomized, Never Dosed|0|||
164311760|NCT02529553|593516714|FG006|Overall Study|Progressive Disease|3|||
164311761|NCT02529553|593516715|FG007|Overall Study|Progressive Disease|5|||
164311762|NCT02529553|593516716|FG008|Overall Study|Progressive Disease|3|||
164311763|NCT02529553|593516708|FG000|Overall Study|Physician Decision|0|||
164311764|NCT02529553|593516709|FG001|Overall Study|Physician Decision|1|||
164311765|NCT02529553|593516710|FG002|Overall Study|Physician Decision|0|||
164311766|NCT02529553|593516711|FG003|Overall Study|Physician Decision|0|||
164311767|NCT02529553|593516712|FG004|Overall Study|Physician Decision|1|||
164311768|NCT02529553|593516713|FG005|Overall Study|Physician Decision|0|||
164311769|NCT02529553|593516714|FG006|Overall Study|Physician Decision|0|||
164311770|NCT02529553|593516715|FG007|Overall Study|Physician Decision|0|||
164311771|NCT02529553|593516716|FG008|Overall Study|Physician Decision|0|||
164311772|NCT02529553|593516708|FG000|Overall Study|Withdrawal by Subject|0|||
164311773|NCT02529553|593516709|FG001|Overall Study|Withdrawal by Subject|0|||
164311774|NCT02529553|593516710|FG002|Overall Study|Withdrawal by Subject|0|||
164311775|NCT02529553|593516711|FG003|Overall Study|Withdrawal by Subject|0|||
164311776|NCT02529553|593516712|FG004|Overall Study|Withdrawal by Subject|0|||
164311777|NCT02529553|593516713|FG005|Overall Study|Withdrawal by Subject|1|||
164311778|NCT02529553|593516714|FG006|Overall Study|Withdrawal by Subject|0|||
164311779|NCT02529553|593516715|FG007|Overall Study|Withdrawal by Subject|1|||
164311780|NCT02529553|593516716|FG008|Overall Study|Withdrawal by Subject|0|||
164311781|NCT00114517|593516723|FG000|Overall Study|Adverse Event|6|||
164311782|NCT00114517|593516724|FG001|Overall Study|Adverse Event|1|||
164311783|NCT00114517|593516725|FG002|Overall Study|Adverse Event|6|||
164311784|NCT00114517|593516726|FG003|Overall Study|Adverse Event|3|||
164311785|NCT00114517|593516723|FG000|Overall Study|Lost to Follow-up|2|||
164311786|NCT00114517|593516724|FG001|Overall Study|Lost to Follow-up|2|||
164311787|NCT00114517|593516725|FG002|Overall Study|Lost to Follow-up|2|||
164311788|NCT00114517|593516726|FG003|Overall Study|Lost to Follow-up|1|||
164311789|NCT00114517|593516723|FG000|Overall Study|Too busy|3|||
164311790|NCT00114517|593516724|FG001|Overall Study|Too busy|1|||
164311791|NCT00114517|593516725|FG002|Overall Study|Too busy|1|||
164311792|NCT00114517|593516726|FG003|Overall Study|Too busy|2|||
164311793|NCT00114517|593516723|FG000|Overall Study|Moved from area|0|||
164311794|NCT00114517|593516724|FG001|Overall Study|Moved from area|3|||
164311795|NCT00114517|593516725|FG002|Overall Study|Moved from area|2|||
164311796|NCT00114517|593516726|FG003|Overall Study|Moved from area|1|||
164311797|NCT00114517|593516723|FG000|Overall Study|Did not want estradiol|1|||
164311798|NCT00114517|593516724|FG001|Overall Study|Did not want estradiol|1|||
164311799|NCT00114517|593516725|FG002|Overall Study|Did not want estradiol|0|||
164311800|NCT00114517|593516726|FG003|Overall Study|Did not want estradiol|0|||
164311801|NCT00114517|593516723|FG000|Overall Study|Armed-services duty|0|||
164311802|NCT00114517|593516724|FG001|Overall Study|Armed-services duty|1|||
164311803|NCT00114517|593516725|FG002|Overall Study|Armed-services duty|0|||
164311804|NCT00114517|593516726|FG003|Overall Study|Armed-services duty|1|||
163971872|NCT03227471|592269746|FG010|Overall Study|Randomized, Never Dosed|0|||
163971873|NCT03227471|592269747|FG011|Overall Study|Randomized, Never Dosed|0|||
164311805|NCT00114517|593516723|FG000|Overall Study|Competing family issue|0|||
164311806|NCT00114517|593516724|FG001|Overall Study|Competing family issue|1|||
163971874|NCT03227471|592269748|FG012|Overall Study|Randomized, Never Dosed|0|||
163971875|NCT03227471|592269749|FG013|Overall Study|Randomized, Never Dosed|0|||
164311807|NCT00114517|593516725|FG002|Overall Study|Competing family issue|0|||
164311808|NCT00114517|593516726|FG003|Overall Study|Competing family issue|1|||
164311809|NCT00114517|593516723|FG000|Overall Study|Physician Decision|0|||
164311810|NCT00114517|593516724|FG001|Overall Study|Physician Decision|1|||
164311811|NCT00114517|593516725|FG002|Overall Study|Physician Decision|0|||
164311812|NCT00114517|593516726|FG003|Overall Study|Physician Decision|0|||
164311813|NCT00114517|593516723|FG000|Overall Study|Lost interest|0|||
164311814|NCT00114517|593516724|FG001|Overall Study|Lost interest|0|||
164311815|NCT00114517|593516725|FG002|Overall Study|Lost interest|1|||
164311816|NCT00114517|593516726|FG003|Overall Study|Lost interest|0|||
163971876|NCT03227471|592269750|FG014|Overall Study|Randomized, Never Dosed|1|||
164311817|NCT00114517|593516723|FG000|Overall Study|Weight increase|0|||
164311818|NCT00114517|593516724|FG001|Overall Study|Weight increase|0|||
164311819|NCT00114517|593516725|FG002|Overall Study|Weight increase|1|||
164311820|NCT00114517|593516726|FG003|Overall Study|Weight increase|0|||
164311821|NCT00114517|593516723|FG000|Overall Study|Concern about blood clots|0|||
164311822|NCT00114517|593516724|FG001|Overall Study|Concern about blood clots|0|||
164311823|NCT00114517|593516725|FG002|Overall Study|Concern about blood clots|1|||
164311824|NCT00114517|593516726|FG003|Overall Study|Concern about blood clots|0|||
164311825|NCT00114517|593516723|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
164311826|NCT00114517|593516724|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
164311827|NCT00114517|593516725|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
164311828|NCT00114517|593516726|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
164311829|NCT04695977|593516727|FG000|Overall Study|Sponsor Decision|9|||
164311830|NCT04695977|593516728|FG001|Overall Study|Sponsor Decision|4|||
164311831|NCT04695977|593516727|FG000|Overall Study|Death|2|||
164311832|NCT04695977|593516728|FG001|Overall Study|Death|5|||
164311833|NCT01868542|593518034|FG000|Overall Study|Protocol Violation|0|||
164311834|NCT01868542|593518035|FG001|Overall Study|Protocol Violation|1|||
164311835|NCT01868542|593518034|FG000|Overall Study|Unclassified|0|||
164311836|NCT01868542|593518035|FG001|Overall Study|Unclassified|1|||
164311837|NCT00130247|593518036|FG000|Overall Study|Pregnancy|1|||
164311838|NCT00130247|593518037|FG001|Overall Study|Pregnancy|0|||
164311839|NCT00130247|593518036|FG000|Overall Study|Post-randomization exclusion|1|||
164311840|NCT00130247|593518037|FG001|Overall Study|Post-randomization exclusion|2|||
164311841|NCT00130247|593518036|FG000|Overall Study|Not compliant with DOT|0|||
164311842|NCT00130247|593518037|FG001|Overall Study|Not compliant with DOT|2|||
164311843|NCT03844945|593518038|FG000|Overall Study|Adverse Event|1|||
164311844|NCT03844945|593518039|FG001|Overall Study|Adverse Event|1|||
164311845|NCT03844945|593518040|FG002|Overall Study|Adverse Event|4|||
164311846|NCT03844945|593518041|FG003|Overall Study|Adverse Event|0|||
164311847|NCT03844945|593518038|FG000|Overall Study|Withdrawal by Subject|0|||
164311848|NCT03844945|593518039|FG001|Overall Study|Withdrawal by Subject|0|||
164311849|NCT03844945|593518040|FG002|Overall Study|Withdrawal by Subject|1|||
164311850|NCT03844945|593518041|FG003|Overall Study|Withdrawal by Subject|0|||
164311851|NCT03844945|593518038|FG000|Overall Study|Lack of Efficacy|0|||
164311852|NCT03844945|593518039|FG001|Overall Study|Lack of Efficacy|0|||
164311853|NCT03844945|593518040|FG002|Overall Study|Lack of Efficacy|0|||
164311854|NCT03844945|593518041|FG003|Overall Study|Lack of Efficacy|1|||
164311855|NCT00220779|593518044|FG000|Overall Study|Adverse Event|1|||
164311856|NCT00220779|593518045|FG001|Overall Study|Adverse Event|0|||
164311857|NCT00220779|593518046|FG002|Overall Study|Adverse Event|0|||
164311858|NCT00220779|593518044|FG000|Overall Study|Withdrawal by Subject|1|||
164311859|NCT00220779|593518045|FG001|Overall Study|Withdrawal by Subject|4|||
164311860|NCT00220779|593518046|FG002|Overall Study|Withdrawal by Subject|1|||
164311861|NCT00220779|593518044|FG000|Overall Study|Non-compliance|1|||
164311862|NCT00220779|593518045|FG001|Overall Study|Non-compliance|0|||
164311863|NCT00220779|593518046|FG002|Overall Study|Non-compliance|0|||
164311864|NCT00220779|593518044|FG000|Overall Study|Too time consuming|1|||
164311865|NCT00220779|593518045|FG001|Overall Study|Too time consuming|0|||
164311866|NCT00220779|593518046|FG002|Overall Study|Too time consuming|0|||
164311867|NCT00220779|593518044|FG000|Overall Study|Pregnancy|0|||
164311868|NCT00220779|593518045|FG001|Overall Study|Pregnancy|0|||
164311869|NCT00220779|593518046|FG002|Overall Study|Pregnancy|2|||
164311870|NCT00220779|593518044|FG000|Overall Study|Lack of Efficacy|3|||
163971877|NCT04183790|592269751|FG000|Overall Study|Participants did not rollover to Part B|12|||
163971878|NCT04183790|592269752|FG001|Overall Study|Participants did not rollover to Part B|0|||
163971879|NCT04183790|592269751|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
163971880|NCT04183790|592269752|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163971881|NCT04183790|592269751|FG000|Overall Study|Commercial drug is available for participant|6|||
163971882|NCT04183790|592269752|FG001|Overall Study|Commercial drug is available for participant|0|||
163971883|NCT04183790|592269751|FG000|Overall Study|Adverse Event|1|||
163971884|NCT04183790|592269752|FG001|Overall Study|Adverse Event|0|||
163971885|NCT04183790|592269751|FG000|Overall Study|Not enrolled in 107 study|0|||
163971886|NCT04183790|592269752|FG001|Overall Study|Not enrolled in 107 study|2|||
164311871|NCT00220779|593518045|FG001|Overall Study|Lack of Efficacy|0|||
164311872|NCT00220779|593518046|FG002|Overall Study|Lack of Efficacy|1|||
164311873|NCT04518995|593518047|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
164311874|NCT04518995|593518048|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
164311875|NCT04518995|593518049|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
164311876|NCT04518995|593518047|FG000|Overall Study|Lack of Efficacy|2|||
164311877|NCT04518995|593518048|FG001|Overall Study|Lack of Efficacy|1|||
164311878|NCT04518995|593518049|FG002|Overall Study|Lack of Efficacy|0|||
164311879|NCT04518995|593518047|FG000|Overall Study|Non-compliance With Study Drug|0|||
164311880|NCT04518995|593518048|FG001|Overall Study|Non-compliance With Study Drug|3|||
164311881|NCT04518995|593518049|FG002|Overall Study|Non-compliance With Study Drug|2|||
164311882|NCT04518995|593518047|FG000|Overall Study|Pregnancy|0|||
164311883|NCT04518995|593518048|FG001|Overall Study|Pregnancy|0|||
164311884|NCT04518995|593518049|FG002|Overall Study|Pregnancy|1|||
164311885|NCT04518995|593518047|FG000|Overall Study|Protocol Violation|2|||
164311886|NCT04518995|593518048|FG001|Overall Study|Protocol Violation|0|||
164311887|NCT04518995|593518049|FG002|Overall Study|Protocol Violation|1|||
164311888|NCT04518995|593518047|FG000|Overall Study|Reason not Specified|4|||
164311889|NCT04518995|593518048|FG001|Overall Study|Reason not Specified|11|||
164311890|NCT04518995|593518049|FG002|Overall Study|Reason not Specified|2|||
164311891|NCT04518995|593518047|FG000|Overall Study|Lost to Follow-up|1|||
164311892|NCT04518995|593518048|FG001|Overall Study|Lost to Follow-up|10|||
164311893|NCT04518995|593518049|FG002|Overall Study|Lost to Follow-up|6|||
163867445|NCT01135511|591881639|FG004|Overall Study|Adverse Event|0|||
163867446|NCT01135511|591881640|FG005|Overall Study|Adverse Event|1|||
163867447|NCT01135511|591881641|FG006|Overall Study|Adverse Event|0|||
163867448|NCT01135511|591881642|FG007|Overall Study|Adverse Event|1|||
163867449|NCT01135511|591881643|FG008|Overall Study|Adverse Event|0|||
163867450|NCT01135511|591881635|FG000|Overall Study|Lack of Efficacy|0|||
163867451|NCT01135511|591881636|FG001|Overall Study|Lack of Efficacy|1|||
163867452|NCT01135511|591881637|FG002|Overall Study|Lack of Efficacy|1|||
163867453|NCT01135511|591881638|FG003|Overall Study|Lack of Efficacy|2|||
163867454|NCT01135511|591881639|FG004|Overall Study|Lack of Efficacy|0|||
163867455|NCT01135511|591881640|FG005|Overall Study|Lack of Efficacy|0|||
163867456|NCT01135511|591881641|FG006|Overall Study|Lack of Efficacy|0|||
163867457|NCT01135511|591881642|FG007|Overall Study|Lack of Efficacy|0|||
163867458|NCT01135511|591881643|FG008|Overall Study|Lack of Efficacy|0|||
163867459|NCT01135511|591881635|FG000|Overall Study|Protocol Violation|0|||
163867460|NCT01135511|591881636|FG001|Overall Study|Protocol Violation|0|||
163867461|NCT01135511|591881637|FG002|Overall Study|Protocol Violation|3|||
163867462|NCT01135511|591881638|FG003|Overall Study|Protocol Violation|0|||
163867463|NCT01135511|591881639|FG004|Overall Study|Protocol Violation|0|||
163867464|NCT01135511|591881640|FG005|Overall Study|Protocol Violation|0|||
163867465|NCT01135511|591881641|FG006|Overall Study|Protocol Violation|0|||
163867466|NCT01135511|591881642|FG007|Overall Study|Protocol Violation|0|||
163867467|NCT01135511|591881643|FG008|Overall Study|Protocol Violation|0|||
163867468|NCT01135511|591881635|FG000|Overall Study|Pregnancy|0|||
163867469|NCT01135511|591881636|FG001|Overall Study|Pregnancy|0|||
163867470|NCT01135511|591881637|FG002|Overall Study|Pregnancy|0|||
163867471|NCT01135511|591881638|FG003|Overall Study|Pregnancy|1|||
163867472|NCT01135511|591881639|FG004|Overall Study|Pregnancy|0|||
163867473|NCT01135511|591881640|FG005|Overall Study|Pregnancy|0|||
163867474|NCT01135511|591881641|FG006|Overall Study|Pregnancy|0|||
163867475|NCT01135511|591881642|FG007|Overall Study|Pregnancy|0|||
163867476|NCT01135511|591881643|FG008|Overall Study|Pregnancy|0|||
163867477|NCT01135511|591881635|FG000|Overall Study|could not visit the clinic|0|||
163867478|NCT01135511|591881636|FG001|Overall Study|could not visit the clinic|1|||
163867479|NCT01135511|591881637|FG002|Overall Study|could not visit the clinic|2|||
163867480|NCT01135511|591881638|FG003|Overall Study|could not visit the clinic|0|||
163867481|NCT01135511|591881639|FG004|Overall Study|could not visit the clinic|0|||
163867482|NCT01135511|591881640|FG005|Overall Study|could not visit the clinic|0|||
163867483|NCT01135511|591881641|FG006|Overall Study|could not visit the clinic|0|||
163867484|NCT01135511|591881642|FG007|Overall Study|could not visit the clinic|0|||
163867485|NCT01135511|591881643|FG008|Overall Study|could not visit the clinic|0|||
163867486|NCT01135511|591881635|FG000|Overall Study|noncompliance with study drug taken|0|||
163867487|NCT01135511|591881636|FG001|Overall Study|noncompliance with study drug taken|0|||
163867488|NCT01135511|591881637|FG002|Overall Study|noncompliance with study drug taken|0|||
163867489|NCT01135511|591881638|FG003|Overall Study|noncompliance with study drug taken|0|||
163867490|NCT01135511|591881639|FG004|Overall Study|noncompliance with study drug taken|1|||
163867491|NCT01135511|591881640|FG005|Overall Study|noncompliance with study drug taken|0|||
163867492|NCT01135511|591881641|FG006|Overall Study|noncompliance with study drug taken|0|||
163867493|NCT01135511|591881642|FG007|Overall Study|noncompliance with study drug taken|0|||
163867494|NCT01135511|591881643|FG008|Overall Study|noncompliance with study drug taken|0|||
163867495|NCT01135511|591881635|FG000|Overall Study|Withdrawal by Subject|0|||
163867496|NCT01135511|591881636|FG001|Overall Study|Withdrawal by Subject|0|||
163971887|NCT01251653|592269753|FG000|Overall Study|Progressive Disease|1|||
163867497|NCT01135511|591881637|FG002|Overall Study|Withdrawal by Subject|0|||
163867498|NCT01135511|591881638|FG003|Overall Study|Withdrawal by Subject|0|||
163867499|NCT01135511|591881639|FG004|Overall Study|Withdrawal by Subject|0|||
163867500|NCT01135511|591881640|FG005|Overall Study|Withdrawal by Subject|0|||
163971888|NCT01251653|592269754|FG001|Overall Study|Progressive Disease|7|||
163971889|NCT01251653|592269755|FG002|Overall Study|Progressive Disease|16|||
163971890|NCT01251653|592269756|FG003|Overall Study|Progressive Disease|4|||
164311894|NCT04590248|593518050|FG000|Overall Study|Lost to Follow-up|1|||
164311895|NCT04590248|593518050|FG000|Overall Study|Withdrawal by Subject|16|||
163867501|NCT01135511|591881641|FG006|Overall Study|Withdrawal by Subject|1|||
163867502|NCT01135511|591881642|FG007|Overall Study|Withdrawal by Subject|0|||
163867503|NCT01135511|591881643|FG008|Overall Study|Withdrawal by Subject|1|||
163867504|NCT03920215|591881647|FG000|Overall Study|Lost to Follow-up|1|||
163867505|NCT03920215|591881648|FG001|Overall Study|Lost to Follow-up|2|||
163867506|NCT03920215|591881649|FG002|Overall Study|Lost to Follow-up|0|||
163867507|NCT03920215|591881650|FG003|Overall Study|Lost to Follow-up|0|||
163867508|NCT03920215|591881647|FG000|Overall Study|Death|0|||
163867509|NCT03920215|591881648|FG001|Overall Study|Death|0|||
164311896|NCT04590248|593518050|FG000|Overall Study|Other|2|||
164311897|NCT02052414|593518051|FG000|Overall Study|Adverse Event|12|||
164311898|NCT02052414|593518051|FG000|Overall Study|Lack of Efficacy|2|||
164311899|NCT02052414|593518051|FG000|Overall Study|Withdrawal by Subject|3|||
164311900|NCT01343693|593518056|FG000|Overall Study|Lost to Follow-up|9|||
164311901|NCT01235598|593518057|FG000|Overall Study|Adverse Event|0|||
164311902|NCT01235598|593518058|FG001|Overall Study|Adverse Event|3|||
164311903|NCT01235598|593518057|FG000|Overall Study|Lack of Efficacy|0|||
164311904|NCT01235598|593518058|FG001|Overall Study|Lack of Efficacy|1|||
164311905|NCT01235598|593518057|FG000|Overall Study|Withdrawal by Subject|1|||
164311906|NCT01235598|593518058|FG001|Overall Study|Withdrawal by Subject|0|||
164311907|NCT00395343|593518059|FG000|Overall Study|Adverse Event|13|||
164311908|NCT00395343|593518060|FG001|Overall Study|Adverse Event|5|||
164311909|NCT00395343|593518059|FG000|Overall Study|Lack of Efficacy|0|||
164311910|NCT00395343|593518060|FG001|Overall Study|Lack of Efficacy|1|||
164311911|NCT00395343|593518059|FG000|Overall Study|Lost to Follow-up|4|||
164311912|NCT00395343|593518060|FG001|Overall Study|Lost to Follow-up|4|||
164311913|NCT00395343|593518059|FG000|Overall Study|Physician Decision|2|||
164311914|NCT00395343|593518060|FG001|Overall Study|Physician Decision|4|||
164311915|NCT00395343|593518059|FG000|Overall Study|Protocol Violation|6|||
164311916|NCT00395343|593518060|FG001|Overall Study|Protocol Violation|8|||
164311917|NCT00395343|593518059|FG000|Overall Study|Withdrawal by Subject|11|||
164311918|NCT00395343|593518060|FG001|Overall Study|Withdrawal by Subject|12|||
164311919|NCT00395343|593518059|FG000|Overall Study|Other|5|||
164311920|NCT00395343|593518060|FG001|Overall Study|Other|2|||
164311921|NCT01536067|593518061|FG000|Overall Study|Disease Progression|1|||
164311922|NCT00606905|593518062|FG000|Overall Study|No Pregnancy|9|||
164311923|NCT00606905|593518063|FG001|Overall Study|No Pregnancy|6|||
164311924|NCT00606905|593518062|FG000|Overall Study|Non-Index Pregnancy|1|||
164311925|NCT00606905|593518063|FG001|Overall Study|Non-Index Pregnancy|4|||
164311926|NCT00606905|593518062|FG000|Overall Study|Withdrew|5|||
164311927|NCT00606905|593518063|FG001|Overall Study|Withdrew|5|||
164311928|NCT04657666|593518064|FG000|Period 1|Withdrawal of participant consent|2|||
164311929|NCT04657666|593518065|FG001|Period 1|Withdrawal of participant consent|1|||
164311930|NCT04657666|593518064|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
164311931|NCT04657666|593518065|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
164311932|NCT04657666|593518064|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
164311933|NCT04657666|593518065|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
164311934|NCT04657666|593518064|FG000|Period 2|Other|2|||
164311935|NCT04657666|593518065|FG001|Period 2|Other|0|||
164311936|NCT04657666|593518064|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
164311937|NCT04657666|593518065|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
164311938|NCT02386189|593518067|FG000|Overall Study|Lost to Follow-up|2|||
164311939|NCT02386189|593518068|FG001|Overall Study|Lost to Follow-up|3|||
164311940|NCT02386189|593518067|FG000|Overall Study|Withdrawal by Subject|1|||
164311941|NCT02386189|593518068|FG001|Overall Study|Withdrawal by Subject|0|||
164311942|NCT02386189|593518067|FG000|Overall Study|Death|1|||
164311943|NCT02386189|593518068|FG001|Overall Study|Death|0|||
164311944|NCT03120351|593518069|FG000|Overall Study|Physician Decision|1|||
164311945|NCT03120351|593518070|FG001|Overall Study|Physician Decision|1|||
164311946|NCT04931888|593518072|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
164311947|NCT04931888|593518073|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
164311948|NCT04931888|593518074|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
164311949|NCT04931888|593518075|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
164311950|NCT02969408|593518077|FG000|Overall Study|Adverse Event|2|||
164311951|NCT02969408|593518077|FG000|Overall Study|Withdrawal by Subject|8|||
164311952|NCT02969408|593518077|FG000|Overall Study|Lost to Follow-up|4|||
164311953|NCT02969408|593518077|FG000|Overall Study|Protocol Violation|1|||
164311954|NCT02969408|593518077|FG000|Overall Study|Other than specified|1|||
164311955|NCT02350478|593518078|FG000|Overall Study|Lost to Follow-up|5|||
164311956|NCT02350478|593518079|FG001|Overall Study|Lost to Follow-up|1|||
163867510|NCT03920215|591881649|FG002|Overall Study|Death|0|||
164311957|NCT01667419|593518080|FG000|Overall Study|Reason Not Specified|1|||
164311958|NCT01667419|593518081|FG001|Overall Study|Reason Not Specified|0|||
164311959|NCT01667419|593518082|FG002|Overall Study|Reason Not Specified|0|||
164311960|NCT01667419|593518083|FG003|Overall Study|Reason Not Specified|0|||
164311961|NCT01667419|593518080|FG000|Overall Study|Withdrawal by Subject|16|||
164311962|NCT01667419|593518081|FG001|Overall Study|Withdrawal by Subject|8|||
164311963|NCT01667419|593518082|FG002|Overall Study|Withdrawal by Subject|9|||
164311964|NCT01667419|593518083|FG003|Overall Study|Withdrawal by Subject|8|||
164311965|NCT01667419|593518080|FG000|Overall Study|Non-compliance|0|||
163867511|NCT03920215|591881650|FG003|Overall Study|Death|1|||
164311966|NCT01667419|593518081|FG001|Overall Study|Non-compliance|0|||
164311967|NCT01667419|593518082|FG002|Overall Study|Non-compliance|0|||
164311968|NCT01667419|593518083|FG003|Overall Study|Non-compliance|1|||
164311969|NCT01667419|593518080|FG000|Overall Study|Protocol Violation|1|||
164311970|NCT01667419|593518081|FG001|Overall Study|Protocol Violation|0|||
163867512|NCT02547922|591881660|FG000|Overall Study|Withdrawal by Subject|9|||
164311971|NCT01667419|593518082|FG002|Overall Study|Protocol Violation|0|||
164311972|NCT01667419|593518083|FG003|Overall Study|Protocol Violation|0|||
164311973|NCT01667419|593518080|FG000|Overall Study|Lost to Follow-up|7|||
164311974|NCT01667419|593518081|FG001|Overall Study|Lost to Follow-up|6|||
164311975|NCT01667419|593518082|FG002|Overall Study|Lost to Follow-up|2|||
164311976|NCT01667419|593518083|FG003|Overall Study|Lost to Follow-up|4|||
164311977|NCT01667419|593518080|FG000|Overall Study|Death|18|||
164311978|NCT01667419|593518081|FG001|Overall Study|Death|33|||
164311979|NCT01667419|593518082|FG002|Overall Study|Death|25|||
164311980|NCT01667419|593518083|FG003|Overall Study|Death|26|||
164311981|NCT03330002|593518084|FG000|Overall Study|Lost to Follow-up|15|||
164311982|NCT03330002|593518084|FG000|Overall Study|Death|7|||
164311983|NCT03869216|593518085|FG000|Overall Study|prostate removed during the study|1|||
164311984|NCT03869216|593518086|FG001|Overall Study|prostate removed during the study|1|||
164311985|NCT03869216|593518085|FG000|Overall Study|Withdrawal by Subject|0|||
164311986|NCT03869216|593518086|FG001|Overall Study|Withdrawal by Subject|1|||
164311987|NCT03869216|593518085|FG000|Overall Study|Lost to Follow-up|3|||
164311988|NCT03869216|593518086|FG001|Overall Study|Lost to Follow-up|12|||
164311989|NCT03869216|593518085|FG000|Overall Study|Changed clinical site or moved out of city|5|||
164311990|NCT03869216|593518086|FG001|Overall Study|Changed clinical site or moved out of city|9|||
164311991|NCT03869216|593518085|FG000|Overall Study|No primary care appointment scheduled|10|||
164311992|NCT03869216|593518086|FG001|Overall Study|No primary care appointment scheduled|4|||
164311993|NCT03869216|593518085|FG000|Overall Study|Death|1|||
164311994|NCT03869216|593518086|FG001|Overall Study|Death|1|||
164311995|NCT03860259|593518093|FG000|Overall Study|Lost to Follow-up|5|||
164311996|NCT03860259|593518094|FG001|Overall Study|Lost to Follow-up|5|||
164311997|NCT03860259|593518093|FG000|Overall Study|Protocol Violation|1|||
164311998|NCT03860259|593518094|FG001|Overall Study|Protocol Violation|0|||
164311999|NCT01068600|593518095|FG000|Overall Study|Withdrawal by Subject|5|||
164312000|NCT01068600|593518096|FG001|Overall Study|Withdrawal by Subject|6|||
164312001|NCT01068600|593518095|FG000|Overall Study|Adverse Event|3|||
164312002|NCT01068600|593518096|FG001|Overall Study|Adverse Event|3|||
164312003|NCT01068600|593518095|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164312004|NCT01068600|593518096|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164312005|NCT01068600|593518095|FG000|Overall Study|Lost to Follow-up|1|||
164312006|NCT01068600|593518096|FG001|Overall Study|Lost to Follow-up|2|||
164202110|NCT00251758|593112647|FG000|Overall Study|Lack of Efficacy|3|||
164202111|NCT00251758|593112648|FG001|Overall Study|Lack of Efficacy|0|||
164202112|NCT00251758|593112649|FG002|Overall Study|Lack of Efficacy|0|||
164202113|NCT00251758|593112647|FG000|Overall Study|Noncompliant|0|||
164202114|NCT00251758|593112648|FG001|Overall Study|Noncompliant|2|||
164202115|NCT00251758|593112649|FG002|Overall Study|Noncompliant|2|||
164202116|NCT00251758|593112647|FG000|Overall Study|Pregnancy|0|||
164202117|NCT00251758|593112648|FG001|Overall Study|Pregnancy|1|||
164202118|NCT00251758|593112649|FG002|Overall Study|Pregnancy|0|||
164202119|NCT00251758|593112647|FG000|Overall Study|Per Subject Request|0|||
163971891|NCT01251653|592269757|FG004|Overall Study|Progressive Disease|0|||
163971892|NCT01251653|592269758|FG005|Overall Study|Progressive Disease|17|||
163971893|NCT01251653|592269759|FG006|Overall Study|Progressive Disease|14|||
163971894|NCT01251653|592269760|FG007|Overall Study|Progressive Disease|7|||
163971895|NCT01251653|592269761|FG008|Overall Study|Progressive Disease|5|||
163971896|NCT01251653|592269753|FG000|Overall Study|Dose-limiting toxicity|0|||
163971897|NCT01251653|592269754|FG001|Overall Study|Dose-limiting toxicity|1|||
163971898|NCT01251653|592269755|FG002|Overall Study|Dose-limiting toxicity|1|||
163971899|NCT01251653|592269756|FG003|Overall Study|Dose-limiting toxicity|1|||
163971900|NCT01251653|592269757|FG004|Overall Study|Dose-limiting toxicity|0|||
163971901|NCT01251653|592269758|FG005|Overall Study|Dose-limiting toxicity|0|||
163971902|NCT01251653|592269759|FG006|Overall Study|Dose-limiting toxicity|2|||
164312007|NCT01068600|593518095|FG000|Overall Study|Protocol deviation|1|||
164312008|NCT01068600|593518096|FG001|Overall Study|Protocol deviation|1|||
163971903|NCT01251653|592269760|FG007|Overall Study|Dose-limiting toxicity|0|||
163971904|NCT01251653|592269761|FG008|Overall Study|Dose-limiting toxicity|0|||
163971905|NCT01251653|592269753|FG000|Overall Study|Adverse Event|1|||
163971906|NCT01251653|592269754|FG001|Overall Study|Adverse Event|0|||
163971907|NCT01251653|592269755|FG002|Overall Study|Adverse Event|2|||
163971908|NCT01251653|592269756|FG003|Overall Study|Adverse Event|1|||
163971909|NCT01251653|592269757|FG004|Overall Study|Adverse Event|1|||
164202120|NCT00251758|593112648|FG001|Overall Study|Per Subject Request|0|||
164202121|NCT00251758|593112649|FG002|Overall Study|Per Subject Request|1|||
164312009|NCT01068600|593518095|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163971910|NCT01251653|592269758|FG005|Overall Study|Adverse Event|0|||
163971911|NCT01251653|592269759|FG006|Overall Study|Adverse Event|2|||
163971912|NCT01251653|592269760|FG007|Overall Study|Adverse Event|2|||
163971913|NCT01251653|592269761|FG008|Overall Study|Adverse Event|1|||
164202122|NCT00251758|593112647|FG000|Overall Study|Per Investigator Request|1|||
164312010|NCT01068600|593518096|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164312011|NCT01068600|593518095|FG000|Overall Study|Administrative problems|0|||
164312012|NCT01068600|593518096|FG001|Overall Study|Administrative problems|1|||
164312013|NCT00486291|593518103|FG000|Overall Study|Adverse Event|3|||
164202123|NCT00251758|593112648|FG001|Overall Study|Per Investigator Request|0|||
164202124|NCT00251758|593112649|FG002|Overall Study|Per Investigator Request|0|||
164202125|NCT01387269|593112653|FG000|Overall Study|Death|38|||
164202126|NCT01387269|593112654|FG001|Overall Study|Death|20|||
164202127|NCT01387269|593112653|FG000|Overall Study|Other|8|||
164202128|NCT01387269|593112654|FG001|Overall Study|Other|7|||
164202129|NCT01387269|593112653|FG000|Overall Study|Unrelated AE|12|||
164202130|NCT01387269|593112654|FG001|Overall Study|Unrelated AE|3|||
164202131|NCT01387269|593112653|FG000|Overall Study|Withdrawal by patient|32|||
164202132|NCT01387269|593112654|FG001|Overall Study|Withdrawal by patient|10|||
164202133|NCT01387269|593112653|FG000|Overall Study|Study drug-related AE|1|||
164202134|NCT01387269|593112654|FG001|Overall Study|Study drug-related AE|0|||
164202135|NCT01387269|593112653|FG000|Overall Study|Lost to Follow-up|1|||
164202136|NCT01387269|593112654|FG001|Overall Study|Lost to Follow-up|0|||
164202137|NCT01200329|593112655|FG000|Overall Study|Lack of financial coverage|2|||
164202138|NCT01200329|593112655|FG000|Overall Study|Progressive disease|1|||
164202139|NCT02230891|593112658|FG000|Baseline|Did not meet inclusion|0|||
164202140|NCT02230891|593112659|FG001|Baseline|Did not meet inclusion|1|||
164202141|NCT02230891|593112660|FG002|Baseline|Did not meet inclusion|1|||
164202142|NCT02230891|593112658|FG000|2 Week|Withdrawal by Subject|2|||
164202143|NCT02230891|593112659|FG001|2 Week|Withdrawal by Subject|2|||
164202144|NCT02230891|593112660|FG002|2 Week|Withdrawal by Subject|0|||
164202145|NCT02230891|593112658|FG000|2 Week|Consent withdrawn|1|||
164202146|NCT02230891|593112659|FG001|2 Week|Consent withdrawn|0|||
164202147|NCT02230891|593112660|FG002|2 Week|Consent withdrawn|0|||
164202148|NCT02230891|593112658|FG000|6 Month|Withdrawal by Subject|1|||
164202149|NCT02230891|593112659|FG001|6 Month|Withdrawal by Subject|1|||
164202150|NCT02230891|593112660|FG002|6 Month|Withdrawal by Subject|1|||
164202151|NCT02230891|593112658|FG000|6 Month|Physician Decision|0|||
164202152|NCT02230891|593112659|FG001|6 Month|Physician Decision|2|||
164202153|NCT02230891|593112660|FG002|6 Month|Physician Decision|0|||
164202154|NCT02230891|593112658|FG000|12 Month|Death|1|||
164202155|NCT02230891|593112659|FG001|12 Month|Death|0|||
164202156|NCT02230891|593112660|FG002|12 Month|Death|0|||
164202157|NCT02230891|593112658|FG000|12 Month|Lost to Follow-up|0|||
164202158|NCT02230891|593112659|FG001|12 Month|Lost to Follow-up|1|||
164202159|NCT02230891|593112660|FG002|12 Month|Lost to Follow-up|0|||
164202160|NCT02230891|593112658|FG000|12 Month|Withdrawal by Subject|0|||
164202161|NCT02230891|593112659|FG001|12 Month|Withdrawal by Subject|2|||
164202162|NCT02230891|593112660|FG002|12 Month|Withdrawal by Subject|0|||
164202163|NCT02230891|593112658|FG000|18 Month End of Study|Death|0|||
164202164|NCT02230891|593112659|FG001|18 Month End of Study|Death|0|||
164202165|NCT02230891|593112660|FG002|18 Month End of Study|Death|1|||
164202166|NCT02230891|593112658|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
164202167|NCT02230891|593112659|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
164202168|NCT02230891|593112660|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
164202169|NCT03642990|593112663|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
163867513|NCT02547922|591881661|FG001|Overall Study|Withdrawal by Subject|6|||
163867514|NCT02547922|591881662|FG002|Overall Study|Withdrawal by Subject|10|||
163867515|NCT02547922|591881660|FG000|Overall Study|Adverse Event|3|||
163867516|NCT02547922|591881661|FG001|Overall Study|Adverse Event|1|||
163867517|NCT02547922|591881662|FG002|Overall Study|Adverse Event|2|||
163867518|NCT02547922|591881660|FG000|Overall Study|Lost to Follow-up|1|||
163867519|NCT02547922|591881661|FG001|Overall Study|Lost to Follow-up|0|||
163867520|NCT02547922|591881662|FG002|Overall Study|Lost to Follow-up|0|||
163867521|NCT02547922|591881660|FG000|Overall Study|Lack of Efficacy|5|||
163867522|NCT02547922|591881661|FG001|Overall Study|Lack of Efficacy|7|||
163867523|NCT02547922|591881662|FG002|Overall Study|Lack of Efficacy|4|||
163867524|NCT02547922|591881660|FG000|Overall Study|Death|1|||
163867525|NCT02547922|591881661|FG001|Overall Study|Death|0|||
163867526|NCT02547922|591881662|FG002|Overall Study|Death|0|||
163867527|NCT02547922|591881660|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
163867528|NCT02547922|591881661|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
163867529|NCT02547922|591881662|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
163867530|NCT02547922|591881660|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
163867531|NCT02547922|591881661|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
163867532|NCT02547922|591881662|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
163867533|NCT02547922|591881660|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
163867534|NCT02547922|591881661|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
164202170|NCT03642990|593112663|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
164202171|NCT03087058|593112664|FG000|Overall Study|Withdrawal by Subject|2|||
164202172|NCT03087058|593112665|FG001|Overall Study|Withdrawal by Subject|0|||
164202173|NCT03087058|593112666|FG002|Overall Study|Withdrawal by Subject|0|||
164202174|NCT05158140|593112669|FG000|Overall Study|Death|0|||
164202175|NCT05158140|593112670|FG001|Overall Study|Death|0|||
163867535|NCT02547922|591881662|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
163867536|NCT02547922|591881660|FG000|Overall Study|Physician Decision|2|||
164202176|NCT05158140|593112671|FG002|Overall Study|Death|0|||
164312014|NCT00486291|593518104|FG001|Overall Study|Adverse Event|4|||
164312015|NCT00486291|593518103|FG000|Overall Study|Lost to Follow-up|3|||
164312016|NCT00486291|593518104|FG001|Overall Study|Lost to Follow-up|7|||
164312017|NCT00486291|593518103|FG000|Overall Study|protocol non-compliance|10|||
164312018|NCT00486291|593518104|FG001|Overall Study|protocol non-compliance|15|||
164312019|NCT00486291|593518103|FG000|Overall Study|requirement for restricted medication|0|||
164312020|NCT00486291|593518104|FG001|Overall Study|requirement for restricted medication|3|||
164312021|NCT01015638|593518109|FG000|Overall Study|Withdrawal by Subject|1|||
164312022|NCT01015638|593518110|FG001|Overall Study|Withdrawal by Subject|0|||
164312023|NCT00984620|593518111|FG000|Overall Study|Adverse Event|5|||
164312024|NCT00984620|593518112|FG001|Overall Study|Adverse Event|5|||
164312025|NCT00984620|593518111|FG000|Overall Study|Lost to Follow-up|1|||
164312026|NCT00984620|593518112|FG001|Overall Study|Lost to Follow-up|1|||
164312027|NCT00984620|593518111|FG000|Overall Study|Withdrawal by Subject|0|||
164312028|NCT00984620|593518112|FG001|Overall Study|Withdrawal by Subject|2|||
164312029|NCT00984620|593518111|FG000|Overall Study|reason other than listed above|0|||
164312030|NCT00984620|593518112|FG001|Overall Study|reason other than listed above|4|||
164312031|NCT02164461|593518113|FG000|Overall Study|Adverse Event|0|||
164312032|NCT02164461|593518114|FG001|Overall Study|Adverse Event|0|||
164312033|NCT02164461|593518115|FG002|Overall Study|Adverse Event|1|||
164312034|NCT02164461|593518113|FG000|Overall Study|Disease Progression|1|||
164312035|NCT02164461|593518114|FG001|Overall Study|Disease Progression|3|||
164312036|NCT02164461|593518115|FG002|Overall Study|Disease Progression|4|||
164312037|NCT02164461|593518113|FG000|Overall Study|Withdrawal by Subject|0|||
164312038|NCT02164461|593518114|FG001|Overall Study|Withdrawal by Subject|3|||
164312039|NCT02164461|593518115|FG002|Overall Study|Withdrawal by Subject|0|||
163867537|NCT02547922|591881661|FG001|Overall Study|Physician Decision|1|||
163867538|NCT02547922|591881662|FG002|Overall Study|Physician Decision|2|||
163867539|NCT02547922|591881660|FG000|Overall Study|Patients did not receive IP|1|||
163867540|NCT02547922|591881661|FG001|Overall Study|Patients did not receive IP|1|||
163867541|NCT02547922|591881662|FG002|Overall Study|Patients did not receive IP|0|||
163867542|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
163867543|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163867544|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163867545|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163867546|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
163867547|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
163867548|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163867549|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163867550|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163867551|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
163867552|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
163867553|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163867554|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163867555|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163867556|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
163867557|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
163867558|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163867559|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163867560|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163867561|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
163867562|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
163867563|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163867564|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163867565|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163867566|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
163867567|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
163867568|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163971914|NCT01251653|592269753|FG000|Overall Study|Withdrawal by Subject|1|||
163971915|NCT01251653|592269754|FG001|Overall Study|Withdrawal by Subject|0|||
163971916|NCT01251653|592269755|FG002|Overall Study|Withdrawal by Subject|1|||
163971917|NCT01251653|592269756|FG003|Overall Study|Withdrawal by Subject|0|||
163971918|NCT01251653|592269757|FG004|Overall Study|Withdrawal by Subject|1|||
163971919|NCT01251653|592269758|FG005|Overall Study|Withdrawal by Subject|1|||
164312040|NCT00324961|593518117|FG000|Overall Study|Adverse Event|5|||
164312041|NCT00324961|593518117|FG000|Overall Study|Consent Withdrawn|11|||
164312042|NCT00324961|593518117|FG000|Overall Study|Lost to Follow-up|22|||
164312043|NCT00324961|593518117|FG000|Overall Study|Protocol Violation|3|||
164312044|NCT00324961|593518117|FG000|Overall Study|Other|2|||
164312045|NCT00344487|593518118|FG000|Overall Study|immunologic failure|1|||
164312046|NCT02355184|593518122|FG000|Overall Study|Lost to Follow-up|2|||
164312047|NCT02355184|593518122|FG000|Overall Study|Study Terminated|10|||
164312048|NCT06173063|593518123|FG000|Overall Study|Withdrawal by Subject|2|||
164312049|NCT01925131|593520209|FG000|Overall Study|Death|0|||
163971920|NCT01251653|592269759|FG006|Overall Study|Withdrawal by Subject|0|||
164312050|NCT01925131|593520210|FG001|Overall Study|Death|0|||
164312051|NCT01925131|593520211|FG002|Overall Study|Death|1|||
164312052|NCT01925131|593520212|FG003|Overall Study|Death|0|||
164312053|NCT01925131|593520213|FG004|Overall Study|Death|0|||
164312054|NCT01925131|593520214|FG005|Overall Study|Death|0|||
164312055|NCT01925131|593520209|FG000|Overall Study|Progression/Relapse|1|||
164312056|NCT01925131|593520210|FG001|Overall Study|Progression/Relapse|1|||
164312057|NCT01925131|593520211|FG002|Overall Study|Progression/Relapse|4|||
164312058|NCT01925131|593520212|FG003|Overall Study|Progression/Relapse|0|||
164312059|NCT01925131|593520213|FG004|Overall Study|Progression/Relapse|0|||
164312060|NCT01925131|593520214|FG005|Overall Study|Progression/Relapse|1|||
164312061|NCT01925131|593520209|FG000|Overall Study|Patient Refusal|1|||
164312062|NCT01925131|593520210|FG001|Overall Study|Patient Refusal|0|||
164312063|NCT01925131|593520211|FG002|Overall Study|Patient Refusal|0|||
164312064|NCT01925131|593520212|FG003|Overall Study|Patient Refusal|0|||
164312065|NCT01925131|593520213|FG004|Overall Study|Patient Refusal|0|||
164312066|NCT01925131|593520214|FG005|Overall Study|Patient Refusal|0|||
164312067|NCT01925131|593520209|FG000|Overall Study|Adverse Event|0|||
164312068|NCT01925131|593520210|FG001|Overall Study|Adverse Event|0|||
164312069|NCT01925131|593520211|FG002|Overall Study|Adverse Event|2|||
164312070|NCT01925131|593520212|FG003|Overall Study|Adverse Event|0|||
164312071|NCT01925131|593520213|FG004|Overall Study|Adverse Event|1|||
164312072|NCT01925131|593520214|FG005|Overall Study|Adverse Event|3|||
164312073|NCT01925131|593520209|FG000|Overall Study|Other - Not Protocol Specified|3|||
164312074|NCT01925131|593520210|FG001|Overall Study|Other - Not Protocol Specified|1|||
164312075|NCT01925131|593520211|FG002|Overall Study|Other - Not Protocol Specified|2|||
164312076|NCT01925131|593520212|FG003|Overall Study|Other - Not Protocol Specified|5|||
164312077|NCT01925131|593520213|FG004|Overall Study|Other - Not Protocol Specified|10|||
164312078|NCT01925131|593520214|FG005|Overall Study|Other - Not Protocol Specified|6|||
164312079|NCT03320824|593520215|FG000|Overall Study|Withdrawal by Subject|8|||
164312080|NCT03320824|593520216|FG001|Overall Study|Withdrawal by Subject|1|||
164312081|NCT03320824|593520215|FG000|Overall Study|Lost to Follow-up|10|||
164312082|NCT03320824|593520216|FG001|Overall Study|Lost to Follow-up|1|||
164312083|NCT03320824|593520215|FG000|Overall Study|moved out of state|0|||
164312084|NCT03320824|593520216|FG001|Overall Study|moved out of state|1|||
164312085|NCT03320824|593520215|FG000|Overall Study|could not complete final visit|0|||
164312086|NCT03320824|593520216|FG001|Overall Study|could not complete final visit|1|||
164312087|NCT00109590|593520217|FG000|Overall Study|Lost to Follow-up|1|||
164312088|NCT00109590|593520218|FG001|Overall Study|Lost to Follow-up|0|||
164312089|NCT00109590|593520219|FG002|Overall Study|Lost to Follow-up|1|||
164312090|NCT00109590|593520217|FG000|Overall Study|Never Started Treatment|1|||
164312091|NCT00109590|593520218|FG001|Overall Study|Never Started Treatment|2|||
164312092|NCT00109590|593520219|FG002|Overall Study|Never Started Treatment|3|||
164312093|NCT00588861|593520220|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
164312094|NCT00588861|593520221|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
164312095|NCT00588861|593520220|FG000|6 Months|Patients did not return for follow-up|98|||
163971921|NCT01251653|592269760|FG007|Overall Study|Withdrawal by Subject|1|||
163971922|NCT01251653|592269761|FG008|Overall Study|Withdrawal by Subject|0|||
163971923|NCT01251653|592269753|FG000|Overall Study|Other reason not mentioned above|0|||
163971924|NCT01251653|592269754|FG001|Overall Study|Other reason not mentioned above|0|||
163971925|NCT01251653|592269755|FG002|Overall Study|Other reason not mentioned above|0|||
163971926|NCT01251653|592269756|FG003|Overall Study|Other reason not mentioned above|0|||
163971927|NCT01251653|592269757|FG004|Overall Study|Other reason not mentioned above|0|||
163971928|NCT01251653|592269758|FG005|Overall Study|Other reason not mentioned above|0|||
163971929|NCT01251653|592269759|FG006|Overall Study|Other reason not mentioned above|0|||
163971930|NCT01251653|592269760|FG007|Overall Study|Other reason not mentioned above|2|||
163971931|NCT01251653|592269761|FG008|Overall Study|Other reason not mentioned above|0|||
163971932|NCT00847145|592269762|FG000|Overall Study|AE or Death|0|||
164312096|NCT00588861|593520221|FG001|6 Months|Patients did not return for follow-up|73|||
164312097|NCT00588861|593520220|FG000|1 Year|Patients did not return for follow-up|89|||
163971933|NCT00847145|592269763|FG001|Overall Study|AE or Death|1|||
163971934|NCT00847145|592269764|FG002|Overall Study|AE or Death|1|||
163971935|NCT00847145|592269765|FG003|Overall Study|AE or Death|0|||
163971936|NCT00847145|592269766|FG004|Overall Study|AE or Death|0|||
163971937|NCT00847145|592269767|FG005|Overall Study|AE or Death|0|||
164312098|NCT00588861|593520221|FG001|1 Year|Patients did not return for follow-up|82|||
164312099|NCT00588861|593520220|FG000|2 Years|Patients did not return for follow-up|92|||
163971938|NCT00847145|592269768|FG006|Overall Study|AE or Death|0|||
164312100|NCT00588861|593520221|FG001|2 Years|Patients did not return for follow-up|87|||
164312101|NCT00588861|593520220|FG000|4 Years|Patients did not return for follow-up|91|||
164312102|NCT00588861|593520221|FG001|4 Years|Patients did not return for follow-up|103|||
164312103|NCT00588861|593520220|FG000|6 Years|Patients did not return for follow-up|104|||
164312104|NCT00588861|593520221|FG001|6 Years|Patients did not return for follow-up|109|||
164312105|NCT00588861|593520220|FG000|8 Years|Patients did not return for follow-up|105|||
164312106|NCT00588861|593520221|FG001|8 Years|Patients did not return for follow-up|114|||
164202177|NCT05158140|593112672|FG003|Overall Study|Death|1|||
164202178|NCT05158140|593112669|FG000|Overall Study|Lost to Follow-up|3|||
164202179|NCT05158140|593112670|FG001|Overall Study|Lost to Follow-up|6|||
164202180|NCT05158140|593112671|FG002|Overall Study|Lost to Follow-up|4|||
164202181|NCT05158140|593112672|FG003|Overall Study|Lost to Follow-up|3|||
164202182|NCT05158140|593112669|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164202183|NCT05158140|593112670|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164202184|NCT05158140|593112671|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
164202185|NCT05158140|593112672|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164202186|NCT05158140|593112669|FG000|Overall Study|Withdrawal by Subject|3|||
164202187|NCT05158140|593112670|FG001|Overall Study|Withdrawal by Subject|7|||
164202188|NCT05158140|593112671|FG002|Overall Study|Withdrawal by Subject|3|||
164202189|NCT05158140|593112672|FG003|Overall Study|Withdrawal by Subject|7|||
164202190|NCT01265498|593112675|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
164202191|NCT01265498|593112676|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
164202192|NCT00617279|593112678|FG000|Overall Study|Study terminated by Sponsor|10|||
164202193|NCT00617279|593112679|FG001|Overall Study|Study terminated by Sponsor|15|||
164202194|NCT00617279|593112678|FG000|Overall Study|Graft abandonment|2|||
164202195|NCT00617279|593112679|FG001|Overall Study|Graft abandonment|0|||
164202196|NCT00617279|593112678|FG000|Overall Study|Lost to Follow-up|1|||
164202197|NCT00617279|593112679|FG001|Overall Study|Lost to Follow-up|0|||
164202198|NCT00617279|593112678|FG000|Overall Study|Death|1|||
164202199|NCT00617279|593112679|FG001|Overall Study|Death|2|||
164202200|NCT04158219|593112685|FG000|Overall Study|Lost to Follow-up|1|||
164202201|NCT01324947|593112691|FG000|Overall Study|Adverse Event|7|||
164202202|NCT01324947|593112691|FG000|Overall Study|Death|10|||
164202203|NCT01324947|593112691|FG000|Overall Study|Other|3|||
164202204|NCT01324947|593112691|FG000|Overall Study|Progressive Disease|50|||
164202205|NCT01324947|593112691|FG000|Overall Study|Withdrawal by Subject|3|||
164202206|NCT01324947|593112691|FG000|Overall Study|1 discontinued before starting drug|1|||
164202207|NCT01296412|593112692|FG000|Overall Study|Adverse Event|8|||
164202208|NCT01296412|593112693|FG001|Overall Study|Adverse Event|29|||
164202209|NCT01296412|593112692|FG000|Overall Study|Lack of Efficacy|1|||
164202210|NCT01296412|593112693|FG001|Overall Study|Lack of Efficacy|0|||
164202211|NCT01296412|593112692|FG000|Overall Study|Lost to Follow-up|10|||
164202212|NCT01296412|593112693|FG001|Overall Study|Lost to Follow-up|7|||
164202213|NCT01296412|593112692|FG000|Overall Study|Non-compliance with study drug|1|||
164202214|NCT01296412|593112693|FG001|Overall Study|Non-compliance with study drug|2|||
164202215|NCT01296412|593112692|FG000|Overall Study|Other reason not specified|20|||
164202216|NCT01296412|593112693|FG001|Overall Study|Other reason not specified|15|||
164202217|NCT01296412|593112692|FG000|Overall Study|Physician Decision|1|||
164202218|NCT01296412|593112693|FG001|Overall Study|Physician Decision|3|||
164202219|NCT01296412|593112692|FG000|Overall Study|Pregnancy|0|||
164202220|NCT01296412|593112693|FG001|Overall Study|Pregnancy|1|||
164202221|NCT01296412|593112692|FG000|Overall Study|Withdrawal by Subject|10|||
164202222|NCT01296412|593112693|FG001|Overall Study|Withdrawal by Subject|13|||
164202223|NCT02160626|593112694|FG000|Overall Study|Adverse Event|1|||
164202224|NCT02160626|593112695|FG001|Overall Study|Adverse Event|0|||
164202225|NCT02160626|593112696|FG002|Overall Study|Adverse Event|0|||
164202226|NCT02160626|593112694|FG000|Overall Study|Schedule not conducive to study visits|0|||
164202227|NCT02160626|593112695|FG001|Overall Study|Schedule not conducive to study visits|0|||
164202228|NCT02160626|593112696|FG002|Overall Study|Schedule not conducive to study visits|1|||
164202229|NCT02160626|593112694|FG000|Overall Study|Withdrawal by Subject|0|||
164202230|NCT02160626|593112695|FG001|Overall Study|Withdrawal by Subject|1|||
164202231|NCT02160626|593112696|FG002|Overall Study|Withdrawal by Subject|0|||
164202232|NCT04239924|593112699|FG000|Overall Study|Lost to Follow-up|2|||
164202233|NCT05399680|593115049|FG000|Overall Study|Lost to Follow-up|1|||
164202234|NCT05399680|593115050|FG001|Overall Study|Lost to Follow-up|0|||
164202235|NCT05399680|593115049|FG000|Overall Study|Death|0|||
164202236|NCT05399680|593115050|FG001|Overall Study|Death|1|||
164202237|NCT03737994|593115052|FG000|Overall Study|Withdrawal by Subject|0|||
164202238|NCT03737994|593115053|FG001|Overall Study|Withdrawal by Subject|0|||
164202239|NCT03737994|593115054|FG002|Overall Study|Withdrawal by Subject|0|||
164202240|NCT03737994|593115055|FG003|Overall Study|Withdrawal by Subject|0|||
163971939|NCT00847145|592269769|FG007|Overall Study|AE or Death|0|||
164202241|NCT03737994|593115056|FG004|Overall Study|Withdrawal by Subject|0|||
164202242|NCT03737994|593115057|FG005|Overall Study|Withdrawal by Subject|0|||
164202243|NCT03737994|593115058|FG006|Overall Study|Withdrawal by Subject|1|||
164202244|NCT03255187|593115059|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
164202245|NCT03255187|593115060|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
164202246|NCT03255187|593115059|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
164202247|NCT03255187|593115060|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
164202248|NCT00720278|593115061|FG000|Overall Study|Adverse Event|5|||
164202249|NCT00720278|593115062|FG001|Overall Study|Adverse Event|3|||
164202250|NCT00720278|593115063|FG002|Overall Study|Adverse Event|4|||
164202251|NCT00720278|593115061|FG000|Overall Study|Withdrawal by Subject|0|||
164312107|NCT00588861|593520220|FG000|10 Years|Incomplete due to study termination|107|||
164312108|NCT00588861|593520221|FG001|10 Years|Incomplete due to study termination|114|||
164312109|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
164312110|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
164312111|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
164312112|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
164312113|NCT00490529|593520227|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
164312114|NCT00490529|593520227|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
164312115|NCT03254459|593520228|FG000|Overall Study|Adverse Event|7|||
164312116|NCT03254459|593520229|FG001|Overall Study|Adverse Event|20|||
164312117|NCT03254459|593520228|FG000|Overall Study|Withdrawal by Subject Consent|3|||
164312118|NCT03254459|593520229|FG001|Overall Study|Withdrawal by Subject Consent|1|||
164312119|NCT03254459|593520228|FG000|Overall Study|Lost to Follow-up|0|||
164312120|NCT03254459|593520229|FG001|Overall Study|Lost to Follow-up|1|||
164312121|NCT03254459|593520228|FG000|Overall Study|Miscellaneous|0|||
164312122|NCT03254459|593520229|FG001|Overall Study|Miscellaneous|1|||
164312123|NCT01129583|593520230|FG000|Overall Study|Death|1|||
164312124|NCT01129583|593520231|FG001|Overall Study|Death|0|||
164312125|NCT01129583|593520230|FG000|Overall Study|Lost to Follow-up|1|||
164312126|NCT01129583|593520231|FG001|Overall Study|Lost to Follow-up|1|||
164312127|NCT01129583|593520230|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
164312128|NCT01129583|593520231|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
164312129|NCT01904773|593520241|FG000|Screen|Screen failure|3|||
164312130|NCT01904773|593520242|FG001|Screen|Screen failure|0|||
164312131|NCT01904773|593520243|FG002|Screen|Screen failure|0|||
164312132|NCT01904773|593520244|FG003|Screen|Screen failure|0|||
164312133|NCT01904773|593520245|FG004|Screen|Screen failure|0|||
164312134|NCT01904773|593520246|FG005|Screen|Screen failure|0|||
164312135|NCT01904773|593520247|FG006|Screen|Screen failure|0|||
164312136|NCT01904773|593520248|FG007|Screen|Screen failure|0|||
164312137|NCT01904773|593520249|FG008|Screen|Screen failure|0|||
164312138|NCT01904773|593520241|FG000|Screen|Withdrawal by Subject|1|||
164312139|NCT01904773|593520242|FG001|Screen|Withdrawal by Subject|0|||
164312140|NCT01904773|593520243|FG002|Screen|Withdrawal by Subject|0|||
164312141|NCT01904773|593520244|FG003|Screen|Withdrawal by Subject|0|||
164312142|NCT01904773|593520245|FG004|Screen|Withdrawal by Subject|0|||
164312143|NCT01904773|593520246|FG005|Screen|Withdrawal by Subject|0|||
164312144|NCT01904773|593520247|FG006|Screen|Withdrawal by Subject|0|||
164312145|NCT01904773|593520248|FG007|Screen|Withdrawal by Subject|0|||
164312146|NCT01904773|593520249|FG008|Screen|Withdrawal by Subject|0|||
164312147|NCT01904773|593520241|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
164312148|NCT01904773|593520242|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312149|NCT01904773|593520243|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312150|NCT01904773|593520244|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312151|NCT01904773|593520245|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312152|NCT01904773|593520246|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312153|NCT01904773|593520247|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312154|NCT01904773|593520248|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312155|NCT01904773|593520249|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
164312156|NCT01904773|593520241|FG000|First Intervention|Adverse Event|0|||
164312157|NCT01904773|593520242|FG001|First Intervention|Adverse Event|0|||
164312158|NCT01904773|593520243|FG002|First Intervention|Adverse Event|0|||
164312159|NCT01904773|593520244|FG003|First Intervention|Adverse Event|0|||
164312160|NCT01904773|593520245|FG004|First Intervention|Adverse Event|0|||
164312161|NCT01904773|593520246|FG005|First Intervention|Adverse Event|0|||
164312162|NCT01904773|593520247|FG006|First Intervention|Adverse Event|1|||
164312163|NCT01904773|593520248|FG007|First Intervention|Adverse Event|0|||
164312164|NCT01904773|593520249|FG008|First Intervention|Adverse Event|0|||
164312165|NCT01904773|593520241|FG000|Placebo Washout First Intervention|Condition worsened|0|||
163867569|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163867570|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163867571|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
163867572|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
164312166|NCT01904773|593520242|FG001|Placebo Washout First Intervention|Condition worsened|1|||
164312167|NCT01904773|593520243|FG002|Placebo Washout First Intervention|Condition worsened|0|||
164312168|NCT01904773|593520244|FG003|Placebo Washout First Intervention|Condition worsened|0|||
164312169|NCT01904773|593520245|FG004|Placebo Washout First Intervention|Condition worsened|0|||
164312170|NCT01904773|593520246|FG005|Placebo Washout First Intervention|Condition worsened|0|||
164312171|NCT01904773|593520247|FG006|Placebo Washout First Intervention|Condition worsened|0|||
164312172|NCT01904773|593520248|FG007|Placebo Washout First Intervention|Condition worsened|0|||
164312173|NCT01904773|593520249|FG008|Placebo Washout First Intervention|Condition worsened|0|||
164312174|NCT01904773|593520241|FG000|Fifth Intervention|Adverse Event|0|||
163867573|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163971940|NCT00847145|592269762|FG000|Overall Study|Withdrawal by Subject|3|||
163971941|NCT00847145|592269763|FG001|Overall Study|Withdrawal by Subject|4|||
163971942|NCT00847145|592269764|FG002|Overall Study|Withdrawal by Subject|6|||
163971943|NCT00847145|592269765|FG003|Overall Study|Withdrawal by Subject|1|||
163971944|NCT00847145|592269766|FG004|Overall Study|Withdrawal by Subject|0|||
163971945|NCT00847145|592269767|FG005|Overall Study|Withdrawal by Subject|0|||
163971946|NCT00847145|592269768|FG006|Overall Study|Withdrawal by Subject|1|||
163971947|NCT00847145|592269769|FG007|Overall Study|Withdrawal by Subject|1|||
163971948|NCT00847145|592269762|FG000|Overall Study|Lost to Follow-up|3|||
163971949|NCT00847145|592269763|FG001|Overall Study|Lost to Follow-up|1|||
163971950|NCT00847145|592269764|FG002|Overall Study|Lost to Follow-up|1|||
163971951|NCT00847145|592269765|FG003|Overall Study|Lost to Follow-up|0|||
163971952|NCT00847145|592269766|FG004|Overall Study|Lost to Follow-up|4|||
163971953|NCT00847145|592269767|FG005|Overall Study|Lost to Follow-up|4|||
163971954|NCT00847145|592269768|FG006|Overall Study|Lost to Follow-up|8|||
163971955|NCT00847145|592269769|FG007|Overall Study|Lost to Follow-up|2|||
163971956|NCT00847145|592269762|FG000|Overall Study|Inappropriate enrollment|0|||
163971957|NCT00847145|592269763|FG001|Overall Study|Inappropriate enrollment|0|||
163971958|NCT00847145|592269764|FG002|Overall Study|Inappropriate enrollment|0|||
163971959|NCT00847145|592269765|FG003|Overall Study|Inappropriate enrollment|0|||
163971960|NCT00847145|592269766|FG004|Overall Study|Inappropriate enrollment|1|||
163971961|NCT00847145|592269767|FG005|Overall Study|Inappropriate enrollment|0|||
163971962|NCT00847145|592269768|FG006|Overall Study|Inappropriate enrollment|0|||
163971963|NCT00847145|592269769|FG007|Overall Study|Inappropriate enrollment|0|||
163971964|NCT00847145|592269762|FG000|Overall Study|Protocol Violation|0|||
163971965|NCT00847145|592269763|FG001|Overall Study|Protocol Violation|0|||
163971966|NCT00847145|592269764|FG002|Overall Study|Protocol Violation|3|||
163971967|NCT00847145|592269765|FG003|Overall Study|Protocol Violation|0|||
163971968|NCT00847145|592269766|FG004|Overall Study|Protocol Violation|1|||
163971969|NCT00847145|592269767|FG005|Overall Study|Protocol Violation|0|||
164202252|NCT00720278|593115062|FG001|Overall Study|Withdrawal by Subject|1|||
164202253|NCT00720278|593115063|FG002|Overall Study|Withdrawal by Subject|0|||
164202254|NCT00720278|593115061|FG000|Overall Study|Lost to Follow-up|0|||
164202255|NCT00720278|593115062|FG001|Overall Study|Lost to Follow-up|0|||
164202256|NCT00720278|593115063|FG002|Overall Study|Lost to Follow-up|1|||
164202257|NCT00720278|593115061|FG000|Overall Study|Non-compliance|1|||
164202258|NCT00720278|593115062|FG001|Overall Study|Non-compliance|0|||
164202259|NCT00720278|593115063|FG002|Overall Study|Non-compliance|0|||
164202260|NCT00720278|593115061|FG000|Overall Study|eligibility criteria violation|1|||
164202261|NCT00720278|593115062|FG001|Overall Study|eligibility criteria violation|0|||
164202262|NCT00720278|593115063|FG002|Overall Study|eligibility criteria violation|1|||
164202263|NCT01075048|593115064|FG000|Overall Study|Death|4|||
164202264|NCT01075048|593115065|FG001|Overall Study|Death|17|||
164202265|NCT01075048|593115066|FG002|Overall Study|Death|12|||
164202266|NCT01075048|593115064|FG000|Overall Study|Start of other or new therapy|4|||
164202267|NCT01075048|593115065|FG001|Overall Study|Start of other or new therapy|36|||
164202268|NCT01075048|593115066|FG002|Overall Study|Start of other or new therapy|46|||
164202269|NCT01075048|593115064|FG000|Overall Study|Withdrawal by Subject|1|||
164202270|NCT01075048|593115065|FG001|Overall Study|Withdrawal by Subject|6|||
164202271|NCT01075048|593115066|FG002|Overall Study|Withdrawal by Subject|3|||
164202272|NCT01075048|593115064|FG000|Overall Study|Lost to Follow-up|0|||
164202273|NCT01075048|593115065|FG001|Overall Study|Lost to Follow-up|1|||
164202274|NCT01075048|593115066|FG002|Overall Study|Lost to Follow-up|1|||
164202275|NCT00408499|593115068|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202276|NCT00408499|593115069|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202277|NCT00408499|593115070|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
164202278|NCT00408499|593115071|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202279|NCT00408499|593115072|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
164202280|NCT00408499|593115068|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
164202281|NCT00408499|593115069|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
164202282|NCT00408499|593115070|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
164202283|NCT00408499|593115071|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
164202284|NCT00408499|593115072|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
164202285|NCT00408499|593115068|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
164202286|NCT00408499|593115069|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
164312175|NCT01904773|593520242|FG001|Fifth Intervention|Adverse Event|0|||
164312176|NCT01904773|593520243|FG002|Fifth Intervention|Adverse Event|0|||
163971970|NCT00847145|592269768|FG006|Overall Study|Protocol Violation|0|||
163971971|NCT00847145|592269769|FG007|Overall Study|Protocol Violation|1|||
163971972|NCT02833974|592269770|FG000|Overall Study|Lost to Follow-up|1|||
163971973|NCT02833974|592269771|FG001|Overall Study|Lost to Follow-up|0|||
164202287|NCT00408499|593115070|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
164202288|NCT00408499|593115071|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
164202289|NCT00408499|593115072|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
164202290|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Adverse Event|0|||
164202291|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Adverse Event|0|||
164202292|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Adverse Event|0|||
163867574|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163867575|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163867576|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
163867577|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
163867578|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163867579|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163867580|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163867581|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
163867582|NCT02709655|591881663|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
163867583|NCT02709655|591881664|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163867584|NCT02709655|591881665|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163867585|NCT02709655|591881666|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163867586|NCT02709655|591881667|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
163867587|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
163867588|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
163867589|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
163867590|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
163867591|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
163867592|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
163867593|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
163867594|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
163867595|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
163867596|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
163867597|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
163867598|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
163867599|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
163867600|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
163867601|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
163867602|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163867603|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
163867604|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163867605|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163867606|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
163867607|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
163867608|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
163867609|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
163867610|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
163867611|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
163867612|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
163867613|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
163867614|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
163867615|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
163867616|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
163867617|NCT02709655|591881663|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
163867618|NCT02709655|591881664|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
163867619|NCT02709655|591881665|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
163867620|NCT02709655|591881666|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
163867621|NCT02709655|591881667|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
163867622|NCT00102063|591881668|FG000|Overall Study|Lack of Efficacy|5|||
163867623|NCT00102063|591881669|FG001|Overall Study|Lack of Efficacy|1|||
163867624|NCT00102063|591881670|FG002|Overall Study|Lack of Efficacy|1|||
163867625|NCT00102063|591881668|FG000|Overall Study|Adverse Event|7|||
163867626|NCT00102063|591881669|FG001|Overall Study|Adverse Event|4|||
163867627|NCT00102063|591881670|FG002|Overall Study|Adverse Event|2|||
163971974|NCT02833974|592269770|FG000|Overall Study|Adverse Event|0|||
164202293|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Adverse Event|0|||
164202294|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Adverse Event|9|||
164202295|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Death|0|||
164202296|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Death|0|||
164202297|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Death|0|||
164202298|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Death|0|||
164202299|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Death|2|||
164202300|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Physician Decision|0|||
163867628|NCT00102063|591881668|FG000|Overall Study|Withdrawal by Subject|4|||
163867629|NCT00102063|591881669|FG001|Overall Study|Withdrawal by Subject|12|||
163867630|NCT00102063|591881670|FG002|Overall Study|Withdrawal by Subject|5|||
163867631|NCT00102063|591881668|FG000|Overall Study|Lost to Follow-up|0|||
163867632|NCT00102063|591881669|FG001|Overall Study|Lost to Follow-up|0|||
163971975|NCT02833974|592269771|FG001|Overall Study|Adverse Event|3|||
164202301|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Physician Decision|0|||
164312177|NCT01904773|593520244|FG003|Fifth Intervention|Adverse Event|0|||
164312178|NCT01904773|593520245|FG004|Fifth Intervention|Adverse Event|0|||
164312179|NCT01904773|593520246|FG005|Fifth Intervention|Adverse Event|0|||
164312180|NCT01904773|593520247|FG006|Fifth Intervention|Adverse Event|0|||
164312181|NCT01904773|593520248|FG007|Fifth Intervention|Adverse Event|1|||
164312182|NCT01904773|593520249|FG008|Fifth Intervention|Adverse Event|0|||
164312183|NCT01904773|593520241|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312184|NCT01904773|593520242|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
164312185|NCT01904773|593520243|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312186|NCT01904773|593520244|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312187|NCT01904773|593520245|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312188|NCT01904773|593520246|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312189|NCT01904773|593520247|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312190|NCT01904773|593520248|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312191|NCT01904773|593520249|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
164312192|NCT01511055|593520252|FG000|Overall Study|Withdrawal by Subject|6|||
164312193|NCT02891070|593520259|FG000|Overall Study|Adverse Event|1|||
164312194|NCT02891070|593520260|FG001|Overall Study|Adverse Event|0|||
164312195|NCT02891070|593520259|FG000|Overall Study|Physician Decision|0|||
164312196|NCT02891070|593520260|FG001|Overall Study|Physician Decision|1|||
164312197|NCT02891070|593520259|FG000|Overall Study|Lost to Follow-up|4|||
164312198|NCT02891070|593520260|FG001|Overall Study|Lost to Follow-up|4|||
164312199|NCT02891070|593520259|FG000|Overall Study|Other|1|||
164312200|NCT02891070|593520260|FG001|Overall Study|Other|0|||
164312201|NCT02891070|593520259|FG000|Overall Study|Protocol Violation|0|||
164312202|NCT02891070|593520260|FG001|Overall Study|Protocol Violation|1|||
164312203|NCT02891070|593520259|FG000|Overall Study|Withdrawal by Subject|1|||
164312204|NCT02891070|593520260|FG001|Overall Study|Withdrawal by Subject|2|||
164312205|NCT02891070|593520259|FG000|Overall Study|Death|3|||
164312206|NCT02891070|593520260|FG001|Overall Study|Death|0|||
164312207|NCT02704143|593520263|FG000|Overall Study|disease progression|10|||
164312208|NCT02551991|593520266|FG000|Overall Study|Death|5|||
164312209|NCT02551991|593520267|FG001|Overall Study|Death|7|||
164312210|NCT02551991|593520268|FG002|Overall Study|Death|8|||
164312211|NCT02551991|593520269|FG003|Overall Study|Death|7|||
164312212|NCT02551991|593520270|FG004|Overall Study|Death|17|||
164312213|NCT02551991|593520266|FG000|Overall Study|Withdrawal by Subject|1|||
164312214|NCT02551991|593520267|FG001|Overall Study|Withdrawal by Subject|0|||
164312215|NCT02551991|593520268|FG002|Overall Study|Withdrawal by Subject|0|||
164312216|NCT02551991|593520269|FG003|Overall Study|Withdrawal by Subject|0|||
164312217|NCT02551991|593520270|FG004|Overall Study|Withdrawal by Subject|2|||
164312218|NCT02551991|593520266|FG000|Overall Study|Lost to Follow-up|0|||
164312219|NCT02551991|593520267|FG001|Overall Study|Lost to Follow-up|0|||
164312220|NCT02551991|593520268|FG002|Overall Study|Lost to Follow-up|1|||
164312221|NCT02551991|593520269|FG003|Overall Study|Lost to Follow-up|0|||
164312222|NCT02551991|593520270|FG004|Overall Study|Lost to Follow-up|0|||
164312223|NCT02551991|593520266|FG000|Overall Study|Sponsor Decision|1|||
164312224|NCT02551991|593520267|FG001|Overall Study|Sponsor Decision|0|||
164312225|NCT02551991|593520268|FG002|Overall Study|Sponsor Decision|1|||
164312226|NCT02551991|593520269|FG003|Overall Study|Sponsor Decision|0|||
164312227|NCT02551991|593520270|FG004|Overall Study|Sponsor Decision|5|||
164312228|NCT02551991|593520266|FG000|Overall Study|Other|0|||
164312229|NCT02551991|593520267|FG001|Overall Study|Other|0|||
164312230|NCT02551991|593520268|FG002|Overall Study|Other|0|||
164312231|NCT02551991|593520269|FG003|Overall Study|Other|0|||
164312232|NCT02551991|593520270|FG004|Overall Study|Other|1|||
164312233|NCT00942994|593520274|FG000|Overall Study|Adverse Event|7|||
164312234|NCT00942994|593520275|FG001|Overall Study|Adverse Event|4|||
164312235|NCT00942994|593520274|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164312236|NCT00942994|593520275|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164312237|NCT00942994|593520274|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164312238|NCT00942994|593520275|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163867633|NCT00102063|591881670|FG002|Overall Study|Lost to Follow-up|1|||
163867634|NCT00102063|591881668|FG000|Overall Study|Protocol Violation|0|||
163867635|NCT00102063|591881669|FG001|Overall Study|Protocol Violation|1|||
163867636|NCT00102063|591881670|FG002|Overall Study|Protocol Violation|1|||
163867637|NCT00857649|591881671|FG000|Overall Study|Adverse Event|15|||
164312239|NCT00942994|593520274|FG000|Overall Study|Patient withdrew consent|5|||
164312240|NCT00942994|593520275|FG001|Overall Study|Patient withdrew consent|8|||
164312241|NCT00942994|593520274|FG000|Overall Study|Lost to Follow-up|1|||
164312242|NCT00942994|593520275|FG001|Overall Study|Lost to Follow-up|4|||
164312243|NCT00942994|593520274|FG000|Overall Study|Protocol deviation|1|||
164312244|NCT00942994|593520275|FG001|Overall Study|Protocol deviation|2|||
164312245|NCT00387790|593520276|FG000|Overall Study|Adverse Event|5|||
164312246|NCT00387790|593520276|FG000|Overall Study|Lack of Efficacy|2|||
164312247|NCT00387790|593520276|FG000|Overall Study|Physician Decision|2|||
164312248|NCT00387790|593520276|FG000|Overall Study|Withdrawal by Subject|3|||
164202302|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Physician Decision|0|||
164202303|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Physician Decision|0|||
164202304|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Physician Decision|1|||
164202305|NCT00408499|593115068|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202306|NCT00408499|593115069|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202307|NCT00408499|593115070|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202308|NCT00408499|593115071|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
164202309|NCT00408499|593115072|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
164202310|NCT00408499|593115068|FG000|Phase II- MTD Expansion|treatment delay|0|||
164202311|NCT00408499|593115069|FG001|Phase II- MTD Expansion|treatment delay|0|||
164202312|NCT00408499|593115070|FG002|Phase II- MTD Expansion|treatment delay|0|||
164202313|NCT00408499|593115071|FG003|Phase II- MTD Expansion|treatment delay|0|||
164202314|NCT00408499|593115072|FG004|Phase II- MTD Expansion|treatment delay|3|||
164202315|NCT03617588|593115076|FG000|Overall Study|Withdrawal by Subject|1|||
164202316|NCT03617588|593115077|FG001|Overall Study|Withdrawal by Subject|0|||
164202317|NCT01715831|593115080|FG000|Overall Study|Adverse Event|1|||
164202318|NCT03261401|593115081|FG000|Overall Study|Withdrawal by Subject|0|||
164202319|NCT03261401|593115082|FG001|Overall Study|Withdrawal by Subject|0|||
164202320|NCT03261401|593115083|FG002|Overall Study|Withdrawal by Subject|0|||
164202321|NCT03261401|593115084|FG003|Overall Study|Withdrawal by Subject|0|||
164202322|NCT03261401|593115085|FG004|Overall Study|Withdrawal by Subject|0|||
163867638|NCT00857649|591881672|FG001|Overall Study|Adverse Event|10|||
163867639|NCT00857649|591881671|FG000|Overall Study|Non-compliance|1|||
163867640|NCT00857649|591881672|FG001|Overall Study|Non-compliance|1|||
163867641|NCT00857649|591881671|FG000|Overall Study|Protocol Violation|2|||
163867642|NCT00857649|591881672|FG001|Overall Study|Protocol Violation|2|||
163867643|NCT00857649|591881671|FG000|Overall Study|Withdrawal of Consent|10|||
163867644|NCT00857649|591881672|FG001|Overall Study|Withdrawal of Consent|7|||
163867645|NCT00857649|591881671|FG000|Overall Study|Nursing Home Placement|2|||
163867646|NCT00857649|591881672|FG001|Overall Study|Nursing Home Placement|9|||
163867647|NCT00857649|591881671|FG000|Overall Study|Other Reasons|1|||
163867648|NCT00857649|591881672|FG001|Overall Study|Other Reasons|3|||
163867649|NCT02739035|591881674|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
163867650|NCT02739035|591881675|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
163867651|NCT02739035|591881674|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
163867652|NCT02739035|591881675|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
163867653|NCT02739035|591881674|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
163867654|NCT02739035|591881675|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
163867655|NCT02739035|591881674|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
163867656|NCT02739035|591881675|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
163867657|NCT02517307|591881683|FG000|Overall Study|Withdrawal by Subject|1|||
163867658|NCT02517307|591881684|FG001|Overall Study|Withdrawal by Subject|0|||
163867659|NCT02517307|591881685|FG002|Overall Study|Withdrawal by Subject|1|||
163867660|NCT02517307|591881686|FG003|Overall Study|Withdrawal by Subject|0|||
164202323|NCT03261401|593115086|FG005|Overall Study|Withdrawal by Subject|1|||
164202324|NCT03261401|593115087|FG006|Overall Study|Withdrawal by Subject|0|||
164202325|NCT03261401|593115088|FG007|Overall Study|Withdrawal by Subject|0|||
164202326|NCT03261401|593115089|FG008|Overall Study|Withdrawal by Subject|0|||
164202327|NCT03261401|593115090|FG009|Overall Study|Withdrawal by Subject|0|||
164202328|NCT03261401|593115091|FG010|Overall Study|Withdrawal by Subject|0|||
164202329|NCT03261401|593115092|FG011|Overall Study|Withdrawal by Subject|0|||
164202330|NCT03261401|593115093|FG012|Overall Study|Withdrawal by Subject|0|||
164202331|NCT03261401|593115081|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
164202332|NCT03261401|593115082|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
164202333|NCT03261401|593115083|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
164202334|NCT03261401|593115084|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
164202335|NCT03261401|593115085|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
164202336|NCT03261401|593115086|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
164202337|NCT03261401|593115087|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
164202338|NCT03261401|593115088|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
164202339|NCT03261401|593115089|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
164312249|NCT00387790|593520276|FG000|Overall Study|Ineligible for study|2|||
164312250|NCT01874340|593520277|FG000|Overall Study|Study terminated by Sponsor|6|||
163867661|NCT02517307|591881683|FG000|Overall Study|Protocol Violation|0|||
164202340|NCT03261401|593115090|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
164202341|NCT03261401|593115091|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
164202342|NCT03261401|593115092|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
164202343|NCT03261401|593115093|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
164202344|NCT01516216|593115096|FG000|Overall Study|Adverse Event|2|||
164202345|NCT01516216|593115097|FG001|Overall Study|Adverse Event|4|||
164202346|NCT01516216|593115096|FG000|Overall Study|Disease Progression|38|||
164202347|NCT01516216|593115097|FG001|Overall Study|Disease Progression|34|||
163867662|NCT02517307|591881684|FG001|Overall Study|Protocol Violation|0|||
163867663|NCT02517307|591881685|FG002|Overall Study|Protocol Violation|1|||
164312251|NCT01874340|593520278|FG001|Overall Study|Study terminated by Sponsor|8|||
164312252|NCT01874340|593520279|FG002|Overall Study|Study terminated by Sponsor|8|||
164312253|NCT01874340|593520280|FG003|Overall Study|Study terminated by Sponsor|4|||
164312254|NCT01874340|593520277|FG000|Overall Study|Withdrawal by Subject|0|||
164312255|NCT01874340|593520278|FG001|Overall Study|Withdrawal by Subject|0|||
164312256|NCT01874340|593520279|FG002|Overall Study|Withdrawal by Subject|0|||
163971976|NCT04419610|592269772|FG000|Overall Study|Withdrawal by Subject|3|||
163971977|NCT04419610|592269773|FG001|Overall Study|Withdrawal by Subject|1|||
163971978|NCT04419610|592269772|FG000|Overall Study|Adverse Event|1|||
163971979|NCT04419610|592269773|FG001|Overall Study|Adverse Event|0|||
163971980|NCT04419610|592269772|FG000|Overall Study|discharged early|1|||
163971981|NCT04419610|592269773|FG001|Overall Study|discharged early|1|||
163971982|NCT00980200|592269777|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
163971983|NCT00980200|592269778|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
163971984|NCT00980200|592269779|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
163971985|NCT00980200|592269780|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
163971986|NCT00980200|592269781|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
163971987|NCT00980200|592269777|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
163971988|NCT00980200|592269778|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
163971989|NCT00980200|592269779|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
163971990|NCT00980200|592269780|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
163971991|NCT00980200|592269781|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
163971992|NCT01617460|592269782|FG000|Overall Study|Adverse Event|10|||
163971993|NCT01617460|592269782|FG000|Overall Study|Physician Decision|16|||
163971994|NCT01617460|592269782|FG000|Overall Study|Protocol Violation|5|||
163971995|NCT01617460|592269782|FG000|Overall Study|Withdrawal by Subject|9|||
164312257|NCT01874340|593520280|FG003|Overall Study|Withdrawal by Subject|1|||
164312258|NCT01716052|593520284|FG000|Overall Study|Withdrawal of funding|1|||
164312259|NCT01716052|593520285|FG001|Overall Study|Withdrawal of funding|1|||
164312260|NCT02864862|593520288|FG000|Overall Study|Lost to Follow-up|1|||
164312261|NCT02864862|593520289|FG001|Overall Study|Lost to Follow-up|0|||
164312262|NCT02864862|593520290|FG002|Overall Study|Lost to Follow-up|1|||
164312263|NCT02864862|593520288|FG000|Overall Study|Protocol Violation|0|||
164312264|NCT02864862|593520289|FG001|Overall Study|Protocol Violation|0|||
164312265|NCT02864862|593520290|FG002|Overall Study|Protocol Violation|1|||
164312266|NCT01523275|593520294|FG000|Overall Study|Lost to Follow-up|1|||
164312267|NCT01523275|593520295|FG001|Overall Study|Lost to Follow-up|2|||
164312268|NCT01523275|593520294|FG000|Overall Study|Withdrawal by Subject|1|||
164312269|NCT01523275|593520295|FG001|Overall Study|Withdrawal by Subject|0|||
164312270|NCT03598114|593520296|FG000|Overall Study|Staff turnover/left the program|3|||
164312271|NCT03598114|593520297|FG001|Overall Study|Staff turnover/left the program|39|||
164312272|NCT02527200|593520298|FG000|Overall Study|Withdrawal by Subject|3|||
164312273|NCT02527200|593520299|FG001|Overall Study|Withdrawal by Subject|2|||
164312274|NCT02527200|593520300|FG002|Overall Study|Withdrawal by Subject|1|||
164312275|NCT02527200|593520301|FG003|Overall Study|Withdrawal by Subject|0|||
164312276|NCT02527200|593520298|FG000|Overall Study|Unclassified|0|||
164312277|NCT02527200|593520299|FG001|Overall Study|Unclassified|1|||
164312278|NCT02527200|593520300|FG002|Overall Study|Unclassified|0|||
164312279|NCT02527200|593520301|FG003|Overall Study|Unclassified|0|||
164312280|NCT02527200|593520298|FG000|Overall Study|Lost to Follow-up|0|||
164312281|NCT02527200|593520299|FG001|Overall Study|Lost to Follow-up|0|||
164312282|NCT02527200|593520300|FG002|Overall Study|Lost to Follow-up|1|||
164312283|NCT02527200|593520301|FG003|Overall Study|Lost to Follow-up|0|||
164312284|NCT00689117|593520302|FG000|Overall Study|Adverse Event|6|||
164312285|NCT00689117|593520303|FG001|Overall Study|Adverse Event|0|||
164312286|NCT00689117|593520304|FG002|Overall Study|Adverse Event|5|||
164312287|NCT00689117|593520305|FG003|Overall Study|Adverse Event|0|||
164312288|NCT00689117|593520302|FG000|Overall Study|Lost to Follow-up|26|||
164312289|NCT00689117|593520303|FG001|Overall Study|Lost to Follow-up|19|||
164312290|NCT00689117|593520304|FG002|Overall Study|Lost to Follow-up|17|||
164312291|NCT00689117|593520305|FG003|Overall Study|Lost to Follow-up|11|||
163971996|NCT03197493|592269784|FG000|Overall Study|Withdrawal by Subject|5|||
164312292|NCT00689117|593520302|FG000|Overall Study|Lack of Efficacy|1|||
164312293|NCT00689117|593520303|FG001|Overall Study|Lack of Efficacy|2|||
164312294|NCT00689117|593520304|FG002|Overall Study|Lack of Efficacy|2|||
164312295|NCT00689117|593520305|FG003|Overall Study|Lack of Efficacy|2|||
163971997|NCT01469182|592269785|FG000|Overall Study|Adverse Event|21|||
163971998|NCT01469182|592269786|FG001|Overall Study|Adverse Event|3|||
163971999|NCT01469182|592269785|FG000|Overall Study|Lost to Follow-up|3|||
163972000|NCT01469182|592269786|FG001|Overall Study|Lost to Follow-up|0|||
164312296|NCT00689117|593520302|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
164312297|NCT00689117|593520303|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
164312298|NCT00689117|593520304|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
163972001|NCT01469182|592269785|FG000|Overall Study|Withdrawal by Subject|4|||
163972002|NCT01469182|592269786|FG001|Overall Study|Withdrawal by Subject|1|||
163972003|NCT01469182|592269785|FG000|Overall Study|Protocol Violation|4|||
164312299|NCT00689117|593520305|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
163867664|NCT02517307|591881686|FG003|Overall Study|Protocol Violation|1|||
163867665|NCT00843882|591881687|FG000|Step 1|Lack of Efficacy|14|||
163867666|NCT00843882|591881688|FG001|Step 1|Lack of Efficacy|10|||
163867667|NCT00843882|591881689|FG002|Step 1|Lack of Efficacy|21|||
163867668|NCT00843882|591881687|FG000|Step 1|Adverse Event|8|||
164202348|NCT01516216|593115096|FG000|Overall Study|Withdrawal by Subject|9|||
164202349|NCT01516216|593115097|FG001|Overall Study|Withdrawal by Subject|11|||
164202350|NCT01516216|593115096|FG000|Overall Study|Potentially Curative Resection|6|||
164202351|NCT01516216|593115097|FG001|Overall Study|Potentially Curative Resection|12|||
164202352|NCT01516216|593115096|FG000|Overall Study|Nonadherence|2|||
164202353|NCT01516216|593115097|FG001|Overall Study|Nonadherence|3|||
164202354|NCT01516216|593115096|FG000|Overall Study|Physician Decision|6|||
164202355|NCT01516216|593115097|FG001|Overall Study|Physician Decision|3|||
164202356|NCT01516216|593115096|FG000|Overall Study|Prolonged Treatment Delay|5|||
164202357|NCT01516216|593115097|FG001|Overall Study|Prolonged Treatment Delay|1|||
164202358|NCT01516216|593115096|FG000|Overall Study|Intercurrent Illness|1|||
164202359|NCT01516216|593115097|FG001|Overall Study|Intercurrent Illness|0|||
164202360|NCT01516216|593115096|FG000|Overall Study|Death|1|||
164202361|NCT01516216|593115097|FG001|Overall Study|Death|1|||
164202362|NCT03098979|593115098|FG000|Overall Study|Adverse Event|1|||
164202363|NCT03098979|593115099|FG001|Overall Study|Adverse Event|0|||
164202364|NCT03098979|593115100|FG002|Overall Study|Adverse Event|1|||
164202365|NCT03098979|593115101|FG003|Overall Study|Adverse Event|4|||
164202366|NCT03098979|593115102|FG004|Overall Study|Adverse Event|6|||
164202367|NCT03098979|593115103|FG005|Overall Study|Adverse Event|1|||
164202368|NCT03098979|593115098|FG000|Overall Study|Withdrawal by Subject|2|||
164202369|NCT03098979|593115099|FG001|Overall Study|Withdrawal by Subject|1|||
164202370|NCT03098979|593115100|FG002|Overall Study|Withdrawal by Subject|1|||
164202371|NCT03098979|593115101|FG003|Overall Study|Withdrawal by Subject|1|||
164202372|NCT03098979|593115102|FG004|Overall Study|Withdrawal by Subject|2|||
164202373|NCT03098979|593115103|FG005|Overall Study|Withdrawal by Subject|1|||
164202374|NCT03098979|593115098|FG000|Overall Study|Death|1|||
164202375|NCT03098979|593115099|FG001|Overall Study|Death|0|||
164202376|NCT03098979|593115100|FG002|Overall Study|Death|2|||
164202377|NCT03098979|593115101|FG003|Overall Study|Death|0|||
164202378|NCT03098979|593115102|FG004|Overall Study|Death|1|||
164202379|NCT03098979|593115103|FG005|Overall Study|Death|0|||
164202380|NCT03098979|593115098|FG000|Overall Study|Physician Decision|2|||
164202381|NCT03098979|593115099|FG001|Overall Study|Physician Decision|1|||
164202382|NCT03098979|593115100|FG002|Overall Study|Physician Decision|0|||
164202383|NCT03098979|593115101|FG003|Overall Study|Physician Decision|0|||
164202384|NCT03098979|593115102|FG004|Overall Study|Physician Decision|0|||
164202385|NCT03098979|593115103|FG005|Overall Study|Physician Decision|0|||
164202386|NCT03098979|593115098|FG000|Overall Study|Non-compliance|0|||
164202387|NCT03098979|593115099|FG001|Overall Study|Non-compliance|0|||
164202388|NCT03098979|593115100|FG002|Overall Study|Non-compliance|0|||
164202389|NCT03098979|593115101|FG003|Overall Study|Non-compliance|0|||
164202390|NCT03098979|593115102|FG004|Overall Study|Non-compliance|0|||
164202391|NCT03098979|593115103|FG005|Overall Study|Non-compliance|1|||
164202392|NCT03098979|593115098|FG000|Overall Study|Protocol Violation|0|||
164202393|NCT03098979|593115099|FG001|Overall Study|Protocol Violation|0|||
164202394|NCT03098979|593115100|FG002|Overall Study|Protocol Violation|0|||
164202395|NCT03098979|593115101|FG003|Overall Study|Protocol Violation|0|||
164202396|NCT03098979|593115102|FG004|Overall Study|Protocol Violation|0|||
164202397|NCT03098979|593115103|FG005|Overall Study|Protocol Violation|1|||
164202398|NCT01715298|593115104|FG000|Overall Study|Lost to Follow-up|0|||
164202399|NCT01715298|593115105|FG001|Overall Study|Lost to Follow-up|2|||
164202400|NCT01715298|593115104|FG000|Overall Study|Patient/guardian decision|7|||
164202401|NCT01715298|593115105|FG001|Overall Study|Patient/guardian decision|9|||
164202402|NCT02419807|593115106|FG000|Overall Study|Withdrawal by Subject|4|||
164202403|NCT02419807|593115106|FG000|Overall Study|Physician Decision|1|||
163867669|NCT00843882|591881688|FG001|Step 1|Adverse Event|17|||
164202404|NCT02419807|593115106|FG000|Overall Study|Protocol Violation|5|||
164202405|NCT01006629|593115109|FG000|Overall Study|Adverse Event|1|||
164202406|NCT01006629|593115109|FG000|Overall Study|Parent refused to continue participation|1|||
164202407|NCT01006629|593115109|FG000|Overall Study|Parent unable to perform site visit|4|||
164202408|NCT01499511|593115110|FG000|Overall Study|Death|1|||
164202409|NCT01499511|593115111|FG001|Overall Study|Death|0|||
164202410|NCT00998946|593115113|FG000|Overall Study|Lost to Follow-up|1|||
164202411|NCT00998946|593115113|FG000|Overall Study|Withdrawal by Subject|1|||
164202412|NCT00998946|593115113|FG000|Overall Study|Death|2|||
164202413|NCT00998946|593115113|FG000|Overall Study|Reason Unspecified|3|||
164202414|NCT00998946|593115113|FG000|Overall Study|Enrolled but not Dosed|2|||
164202415|NCT01065818|593115115|FG000|Overall Study|Withdrawal by Subject|1|||
164202416|NCT01065818|593115115|FG000|Overall Study|Not a candidate for surgery|1|||
164202417|NCT04459338|593115118|FG000|Overall Study|Loss of IV during study|1|||
164202418|NCT04459338|593115119|FG001|Overall Study|Loss of IV during study|0|||
164202419|NCT00958074|593115120|FG000|Overall Study|Withdrawal by Subject|0|||
163867670|NCT00843882|591881689|FG002|Step 1|Adverse Event|20|||
163867671|NCT00843882|591881687|FG000|Step 1|Death|1|||
164312300|NCT00689117|593520302|FG000|Overall Study|Withdrawal by Subject|19|||
164312301|NCT00689117|593520303|FG001|Overall Study|Withdrawal by Subject|18|||
164312302|NCT00689117|593520304|FG002|Overall Study|Withdrawal by Subject|26|||
164312303|NCT00689117|593520305|FG003|Overall Study|Withdrawal by Subject|13|||
164312304|NCT00689117|593520302|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
164312305|NCT00689117|593520303|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
164312306|NCT00689117|593520304|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
164312307|NCT00689117|593520305|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
164312308|NCT00689117|593520302|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164312309|NCT00689117|593520303|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
164312310|NCT00689117|593520304|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164312311|NCT00689117|593520305|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164312312|NCT00689117|593520302|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
164312313|NCT00689117|593520303|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
164312314|NCT00689117|593520304|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
164312315|NCT00689117|593520305|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
164312316|NCT00689117|593520302|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
164312317|NCT00689117|593520303|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
164312318|NCT00689117|593520304|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
164312319|NCT00689117|593520305|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
164312320|NCT00689117|593520302|FG000|Overall Study|Use of Prohibitive Medication|2|||
164312321|NCT00689117|593520303|FG001|Overall Study|Use of Prohibitive Medication|1|||
164312322|NCT00689117|593520304|FG002|Overall Study|Use of Prohibitive Medication|3|||
164312323|NCT00689117|593520305|FG003|Overall Study|Use of Prohibitive Medication|0|||
164312324|NCT00689117|593520302|FG000|Overall Study|Pregnancy|0|||
164312325|NCT00689117|593520303|FG001|Overall Study|Pregnancy|2|||
164312326|NCT00689117|593520304|FG002|Overall Study|Pregnancy|0|||
164312327|NCT00689117|593520305|FG003|Overall Study|Pregnancy|2|||
164312328|NCT00689117|593520302|FG000|Overall Study|Incarceration|2|||
164312329|NCT00689117|593520303|FG001|Overall Study|Incarceration|0|||
164312330|NCT00689117|593520304|FG002|Overall Study|Incarceration|0|||
164312331|NCT00689117|593520305|FG003|Overall Study|Incarceration|0|||
164312332|NCT00689117|593520302|FG000|Overall Study|Fear of Birth Defects|0|||
164312333|NCT00689117|593520303|FG001|Overall Study|Fear of Birth Defects|0|||
164312334|NCT00689117|593520304|FG002|Overall Study|Fear of Birth Defects|1|||
164312335|NCT00689117|593520305|FG003|Overall Study|Fear of Birth Defects|0|||
164312336|NCT00689117|593520302|FG000|Overall Study|Transportation|1|||
164312337|NCT00689117|593520303|FG001|Overall Study|Transportation|0|||
164312338|NCT00689117|593520304|FG002|Overall Study|Transportation|0|||
164312339|NCT00689117|593520305|FG003|Overall Study|Transportation|0|||
164312340|NCT00689117|593520302|FG000|Overall Study|Patient Withdrew from Study|0|||
164312341|NCT00689117|593520303|FG001|Overall Study|Patient Withdrew from Study|0|||
164312342|NCT00689117|593520304|FG002|Overall Study|Patient Withdrew from Study|0|||
164312343|NCT00689117|593520305|FG003|Overall Study|Patient Withdrew from Study|1|||
164312344|NCT00689117|593520302|FG000|Overall Study|Personal Reason|0|||
164312345|NCT00689117|593520303|FG001|Overall Study|Personal Reason|1|||
164312346|NCT00689117|593520304|FG002|Overall Study|Personal Reason|0|||
164312347|NCT00689117|593520305|FG003|Overall Study|Personal Reason|0|||
164312348|NCT00689117|593520302|FG000|Overall Study|Dispensing Error|0|||
164312349|NCT00689117|593520303|FG001|Overall Study|Dispensing Error|1|||
164312350|NCT00689117|593520304|FG002|Overall Study|Dispensing Error|0|||
164312351|NCT00689117|593520305|FG003|Overall Study|Dispensing Error|0|||
164312352|NCT00444678|593520308|FG000|Overall Study|Toxicity|11|||
164312353|NCT00444678|593520308|FG000|Overall Study|Disease Progression|12|||
163867672|NCT00843882|591881688|FG001|Step 1|Death|2|||
163867673|NCT00843882|591881689|FG002|Step 1|Death|4|||
163867674|NCT00843882|591881687|FG000|Step 1|Withdrawal by Subject|6|||
163867675|NCT00843882|591881688|FG001|Step 1|Withdrawal by Subject|12|||
163867676|NCT00843882|591881689|FG002|Step 1|Withdrawal by Subject|9|||
163867677|NCT00843882|591881687|FG000|Step 1|Physician Decision|0|||
163867678|NCT00843882|591881688|FG001|Step 1|Physician Decision|5|||
163867679|NCT00843882|591881689|FG002|Step 1|Physician Decision|1|||
163867680|NCT00843882|591881687|FG000|Step 1|Patient and physician's decision|0|||
163867681|NCT00843882|591881688|FG001|Step 1|Patient and physician's decision|0|||
163867682|NCT00843882|591881689|FG002|Step 1|Patient and physician's decision|1|||
163867683|NCT00843882|591881687|FG000|Step 1|Other complicating disease|1|||
164312354|NCT00444678|593520308|FG000|Overall Study|Death|3|||
164312355|NCT00444678|593520308|FG000|Overall Study|Physician Decision|3|||
164312356|NCT00444678|593520308|FG000|Overall Study|Withdrawal by Subject|2|||
164312357|NCT01022398|593520309|FG000|Overall Study|Study terminated|2|||
163867684|NCT00843882|591881688|FG001|Step 1|Other complicating disease|3|||
163867685|NCT00843882|591881689|FG002|Step 1|Other complicating disease|4|||
163867686|NCT00843882|591881687|FG000|Step 1|Alternative therapy|0|||
164312358|NCT01022398|593520310|FG001|Overall Study|Study terminated|2|||
164312359|NCT01317550|593520311|FG000|Overall Study|Withdrawal by Subject|1|||
164312360|NCT01317550|593520312|FG001|Overall Study|Withdrawal by Subject|0|||
164312361|NCT01317550|593520313|FG002|Overall Study|Withdrawal by Subject|0|||
164312362|NCT01317550|593520314|FG003|Overall Study|Withdrawal by Subject|0|||
164312363|NCT01317550|593520311|FG000|Overall Study|Lack of compliance study med|1|||
164312364|NCT01317550|593520312|FG001|Overall Study|Lack of compliance study med|0|||
164312365|NCT01317550|593520313|FG002|Overall Study|Lack of compliance study med|0|||
164312366|NCT01317550|593520314|FG003|Overall Study|Lack of compliance study med|0|||
164312367|NCT02888119|593520315|FG000|Overall Study|Lost to Follow-up|5|||
164312368|NCT02888119|593520316|FG001|Overall Study|Lost to Follow-up|4|||
164312369|NCT02888119|593520317|FG002|Overall Study|Lost to Follow-up|0|||
164312370|NCT03646123|593520319|FG000|Overall Study|Withdrawal by Subject|2|||
164312371|NCT03646123|593520320|FG001|Overall Study|Withdrawal by Subject|2|||
164312372|NCT03646123|593520321|FG002|Overall Study|Withdrawal by Subject|3|||
164312373|NCT03646123|593520319|FG000|Overall Study|Study termination by sponsor|0|||
164312374|NCT03646123|593520320|FG001|Overall Study|Study termination by sponsor|45|||
164312375|NCT03646123|593520321|FG002|Overall Study|Study termination by sponsor|139|||
164312376|NCT03646123|593520319|FG000|Overall Study|Lost to Follow-up|4|||
164312377|NCT03646123|593520320|FG001|Overall Study|Lost to Follow-up|10|||
164312378|NCT03646123|593520321|FG002|Overall Study|Lost to Follow-up|10|||
164312379|NCT03646123|593520319|FG000|Overall Study|Death|2|||
164312380|NCT03646123|593520320|FG001|Overall Study|Death|1|||
164312381|NCT03646123|593520321|FG002|Overall Study|Death|1|||
164312382|NCT03646123|593520319|FG000|Overall Study|Other|2|||
164312383|NCT03646123|593520320|FG001|Overall Study|Other|0|||
164312384|NCT03646123|593520321|FG002|Overall Study|Other|2|||
164312385|NCT02280408|593520322|FG000|Overall Study|Lost to Follow-up|0|||
164312386|NCT02280408|593520323|FG001|Overall Study|Lost to Follow-up|2|||
164312387|NCT02280408|593520324|FG002|Overall Study|Lost to Follow-up|0|||
164312388|NCT02280408|593520325|FG003|Overall Study|Lost to Follow-up|0|||
164312389|NCT02745145|593520331|FG000|Overall Study|Adverse Event|1|||
164312390|NCT02745145|593520332|FG001|Overall Study|Adverse Event|0|||
163867687|NCT00843882|591881688|FG001|Step 1|Alternative therapy|1|||
163867688|NCT00843882|591881689|FG002|Step 1|Alternative therapy|1|||
163867689|NCT00843882|591881687|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
163867690|NCT00843882|591881688|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
163867691|NCT00843882|591881689|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
163867692|NCT00843882|591881687|FG000|Step 1|Off treatment reason unknown|0|||
163867693|NCT00843882|591881688|FG001|Step 1|Off treatment reason unknown|1|||
163867694|NCT00843882|591881689|FG002|Step 1|Off treatment reason unknown|4|||
163867695|NCT00843882|591881687|FG000|Step 1|Never started treatment|2|||
163867696|NCT00843882|591881688|FG001|Step 1|Never started treatment|0|||
163867697|NCT00843882|591881689|FG002|Step 1|Never started treatment|0|||
163867698|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
163867699|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
163867700|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
163867701|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
163867702|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
163867703|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
163867704|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
163867705|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
163867706|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
163867707|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
163867708|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
163867709|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
163867710|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
163867711|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
164312391|NCT02745145|593520333|FG002|Overall Study|Adverse Event|0|||
163867712|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
163867713|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
163867714|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
163867715|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
163867716|NCT00843882|591881687|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
163867717|NCT00843882|591881688|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
163867718|NCT00843882|591881689|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
163972004|NCT01469182|592269786|FG001|Overall Study|Protocol Violation|2|||
164312392|NCT02745145|593520331|FG000|Overall Study|Death|0|||
164312393|NCT02745145|593520332|FG001|Overall Study|Death|1|||
164312394|NCT02745145|593520333|FG002|Overall Study|Death|0|||
164312395|NCT02745145|593520331|FG000|Overall Study|Progressive disease|0|||
164312396|NCT02745145|593520332|FG001|Overall Study|Progressive disease|0|||
163867719|NCT02248480|591881690|FG000|Overall Study|Lack of Efficacy|4|||
163867720|NCT02248480|591881691|FG001|Overall Study|Lack of Efficacy|6|||
163867721|NCT02248480|591881690|FG000|Overall Study|Adverse Event|11|||
163972005|NCT01469182|592269785|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
163972006|NCT01469182|592269786|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
163972007|NCT02236520|592269787|FG000|Overall Study|Physician Decision|0|||
163972008|NCT02236520|592269788|FG001|Overall Study|Physician Decision|5|||
163972009|NCT02236520|592269789|FG002|Overall Study|Physician Decision|0|||
163972010|NCT02236520|592269790|FG003|Overall Study|Physician Decision|0|||
163972011|NCT02236520|592269787|FG000|Overall Study|Withdrawal by Subject|1|||
163972012|NCT02236520|592269788|FG001|Overall Study|Withdrawal by Subject|0|||
163972013|NCT02236520|592269789|FG002|Overall Study|Withdrawal by Subject|0|||
163972014|NCT02236520|592269790|FG003|Overall Study|Withdrawal by Subject|1|||
163972015|NCT02236520|592269787|FG000|Overall Study|Pregnancy|1|||
163972016|NCT02236520|592269788|FG001|Overall Study|Pregnancy|0|||
163972017|NCT02236520|592269789|FG002|Overall Study|Pregnancy|0|||
163972018|NCT02236520|592269790|FG003|Overall Study|Pregnancy|0|||
163972019|NCT01033734|592269791|FG000|Overall Study|Withdrawal by Subject|1|||
163972020|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
163972021|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
163972022|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
163972023|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
163972024|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
164312397|NCT02745145|593520333|FG002|Overall Study|Progressive disease|1|||
164312398|NCT02745145|593520331|FG000|Overall Study|Withdrew consent|1|||
164312399|NCT02745145|593520332|FG001|Overall Study|Withdrew consent|1|||
164312400|NCT02745145|593520333|FG002|Overall Study|Withdrew consent|1|||
164312401|NCT02745145|593520331|FG000|Overall Study|Study Termination|8|||
164312402|NCT02745145|593520332|FG001|Overall Study|Study Termination|3|||
164312403|NCT02745145|593520333|FG002|Overall Study|Study Termination|7|||
164312404|NCT01297491|593520339|FG000|Overall Study|Adverse Event|11|||
164312405|NCT01297491|593520340|FG001|Overall Study|Adverse Event|6|||
164312406|NCT01297491|593520339|FG000|Overall Study|Physician Decision|3|||
164312407|NCT01297491|593520340|FG001|Overall Study|Physician Decision|2|||
164312408|NCT01297491|593520339|FG000|Overall Study|Progressive disease|11|||
164312409|NCT01297491|593520340|FG001|Overall Study|Progressive disease|20|||
164312410|NCT01297491|593520339|FG000|Overall Study|Patient/Guardian decision|3|||
164312411|NCT01297491|593520340|FG001|Overall Study|Patient/Guardian decision|4|||
164312412|NCT01297491|593520339|FG000|Overall Study|Death|2|||
164312413|NCT01297491|593520340|FG001|Overall Study|Death|1|||
164312414|NCT04413617|593520343|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312415|NCT04413617|593520344|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312416|NCT04413617|593520345|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312417|NCT04413617|593520346|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
164312418|NCT04413617|593520347|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
164312419|NCT04413617|593520343|FG000|Overall Study|Protocol Violation|0|||
164312420|NCT04413617|593520344|FG001|Overall Study|Protocol Violation|1|||
164312421|NCT04413617|593520345|FG002|Overall Study|Protocol Violation|0|||
164312422|NCT04413617|593520346|FG003|Overall Study|Protocol Violation|0|||
164312423|NCT04413617|593520347|FG004|Overall Study|Protocol Violation|1|||
164312424|NCT04413617|593520343|FG000|Overall Study|Lack of Efficacy|2|||
164312425|NCT04413617|593520344|FG001|Overall Study|Lack of Efficacy|0|||
164312426|NCT04413617|593520345|FG002|Overall Study|Lack of Efficacy|2|||
164312427|NCT04413617|593520346|FG003|Overall Study|Lack of Efficacy|1|||
164312428|NCT04413617|593520347|FG004|Overall Study|Lack of Efficacy|0|||
164312429|NCT04413617|593520343|FG000|Overall Study|Withdrawal by Subject|3|||
164312430|NCT04413617|593520344|FG001|Overall Study|Withdrawal by Subject|4|||
164312431|NCT04413617|593520345|FG002|Overall Study|Withdrawal by Subject|2|||
164312432|NCT04413617|593520346|FG003|Overall Study|Withdrawal by Subject|5|||
164312433|NCT04413617|593520347|FG004|Overall Study|Withdrawal by Subject|3|||
164312434|NCT04413617|593520343|FG000|Overall Study|Death|1|||
164312435|NCT04413617|593520344|FG001|Overall Study|Death|0|||
164312436|NCT04413617|593520345|FG002|Overall Study|Death|0|||
164312437|NCT04413617|593520346|FG003|Overall Study|Death|0|||
163972025|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
163972026|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
164312438|NCT04413617|593520347|FG004|Overall Study|Death|0|||
163972027|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
163972028|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
163972029|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
164312439|NCT04413617|593520343|FG000|Overall Study|Adverse Event|1|||
164312440|NCT04413617|593520344|FG001|Overall Study|Adverse Event|0|||
163972030|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
163972031|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
164312441|NCT04413617|593520345|FG002|Overall Study|Adverse Event|0|||
164312442|NCT04413617|593520346|FG003|Overall Study|Adverse Event|1|||
164312443|NCT04413617|593520347|FG004|Overall Study|Adverse Event|1|||
164312444|NCT04413617|593520343|FG000|Overall Study|COVID-19|0|||
164312445|NCT04413617|593520344|FG001|Overall Study|COVID-19|1|||
164202420|NCT00958074|593115121|FG001|Overall Study|Withdrawal by Subject|1|||
164202421|NCT00784875|593115122|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
164202422|NCT00784875|593115123|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
164202423|NCT00784875|593115124|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
164202424|NCT00784875|593115125|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
164202425|NCT00784875|593115122|FG000|Period A - Baseline|Adverse Event|0|||
164202426|NCT00784875|593115123|FG001|Period A - Baseline|Adverse Event|0|||
164202427|NCT00784875|593115124|FG002|Period A - Baseline|Adverse Event|0|||
164202428|NCT00784875|593115125|FG003|Period A - Baseline|Adverse Event|8|||
163867722|NCT02248480|591881691|FG001|Overall Study|Adverse Event|2|||
163867723|NCT02248480|591881690|FG000|Overall Study|Withdrawal by Subject|2|||
163867724|NCT02248480|591881691|FG001|Overall Study|Withdrawal by Subject|4|||
163867725|NCT02248480|591881690|FG000|Overall Study|Entry Criteria Not Met|0|||
164202429|NCT00784875|593115122|FG000|Period A - Baseline|Protocol Violation|0|||
164202430|NCT00784875|593115123|FG001|Period A - Baseline|Protocol Violation|0|||
164202431|NCT00784875|593115124|FG002|Period A - Baseline|Protocol Violation|0|||
164202432|NCT00784875|593115125|FG003|Period A - Baseline|Protocol Violation|25|||
164202433|NCT00784875|593115122|FG000|Period A - Baseline|Withdrawal by Subject|0|||
164202434|NCT00784875|593115123|FG001|Period A - Baseline|Withdrawal by Subject|0|||
164202435|NCT00784875|593115124|FG002|Period A - Baseline|Withdrawal by Subject|0|||
164202436|NCT00784875|593115125|FG003|Period A - Baseline|Withdrawal by Subject|27|||
163867726|NCT02248480|591881691|FG001|Overall Study|Entry Criteria Not Met|1|||
163867727|NCT02248480|591881690|FG000|Overall Study|Other:Physician Decision|0|||
163867728|NCT02248480|591881691|FG001|Overall Study|Other:Physician Decision|1|||
163867729|NCT00630786|591881692|FG000|Overall Study|Physician Decision|0|||
163867730|NCT00630786|591881693|FG001|Overall Study|Physician Decision|0|||
163867731|NCT00630786|591881694|FG002|Overall Study|Physician Decision|1|||
163867732|NCT00630786|591881692|FG000|Overall Study|Withdrawal by Subject|0|||
163867733|NCT00630786|591881693|FG001|Overall Study|Withdrawal by Subject|1|||
163867734|NCT00630786|591881694|FG002|Overall Study|Withdrawal by Subject|1|||
164202437|NCT00784875|593115122|FG000|Period A - Baseline|Physician Decision|0|||
164202438|NCT00784875|593115123|FG001|Period A - Baseline|Physician Decision|0|||
164202439|NCT00784875|593115124|FG002|Period A - Baseline|Physician Decision|0|||
164202440|NCT00784875|593115125|FG003|Period A - Baseline|Physician Decision|2|||
164312446|NCT04413617|593520345|FG002|Overall Study|COVID-19|0|||
164312447|NCT04413617|593520346|FG003|Overall Study|COVID-19|0|||
164312448|NCT04413617|593520347|FG004|Overall Study|COVID-19|0|||
164312449|NCT00775593|593520348|FG000|Overall Study|Unmet eligibility criteria|6|||
164312450|NCT00775593|593520348|FG000|Overall Study|Death|1|||
164312451|NCT00312195|593520349|FG000|Overall Study|Adverse Event|4|||
164312452|NCT00312195|593520350|FG001|Overall Study|Adverse Event|6|||
164312453|NCT00312195|593520349|FG000|Overall Study|Lost to Follow-up|1|||
164312454|NCT00312195|593520350|FG001|Overall Study|Lost to Follow-up|0|||
164312455|NCT00312195|593520349|FG000|Overall Study|Protocol Violation|1|||
164312456|NCT00312195|593520350|FG001|Overall Study|Protocol Violation|0|||
164312457|NCT04145219|593520353|FG000|Overall Study|Adverse Event|18|||
164312458|NCT04145219|593520354|FG001|Overall Study|Adverse Event|6|||
164312459|NCT04145219|593520353|FG000|Overall Study|Lost to Follow-up|2|||
163867735|NCT00630786|591881692|FG000|Overall Study|Lost to Follow-up|0|||
163867736|NCT00630786|591881693|FG001|Overall Study|Lost to Follow-up|1|||
163867737|NCT00630786|591881694|FG002|Overall Study|Lost to Follow-up|0|||
163867738|NCT00630786|591881692|FG000|Overall Study|Other|1|||
163867739|NCT00630786|591881693|FG001|Overall Study|Other|0|||
163867740|NCT00630786|591881694|FG002|Overall Study|Other|0|||
163867741|NCT02770248|591881695|FG000|Overall Study|Adverse Event|0|||
163867742|NCT02770248|591881696|FG001|Overall Study|Adverse Event|1|||
163867743|NCT02770248|591881695|FG000|Overall Study|Randomized in error, prior to treatment|0|||
163867744|NCT02770248|591881696|FG001|Overall Study|Randomized in error, prior to treatment|1|||
163867745|NCT01579916|591881697|FG000|Overall Study|Lost to Follow-up|6|||
163867746|NCT01579916|591881698|FG001|Overall Study|Lost to Follow-up|1|||
163867747|NCT01579916|591881697|FG000|Overall Study|Withdrawal by Subject|1|||
163867748|NCT01579916|591881698|FG001|Overall Study|Withdrawal by Subject|1|||
164312460|NCT04145219|593520354|FG001|Overall Study|Lost to Follow-up|3|||
163867749|NCT01579916|591881697|FG000|Overall Study|Death|1|||
163867750|NCT01579916|591881698|FG001|Overall Study|Death|0|||
163867751|NCT03264456|591881699|FG000|Overall Study|Withdrawal by Subject|3|||
163867752|NCT03264456|591881699|FG000|Overall Study|Lost to Follow-up|1|||
163867753|NCT06001177|591882923|FG000|Treatment Phase|Adverse Event|1|||
163867754|NCT06001177|591882924|FG001|Treatment Phase|Adverse Event|0|||
164202441|NCT00784875|593115122|FG000|Period A - Baseline|Sponsor Decision|0|||
164202442|NCT00784875|593115123|FG001|Period A - Baseline|Sponsor Decision|0|||
164202443|NCT00784875|593115124|FG002|Period A - Baseline|Sponsor Decision|0|||
164202444|NCT00784875|593115125|FG003|Period A - Baseline|Sponsor Decision|113|||
164312461|NCT04145219|593520353|FG000|Overall Study|Physician Decision|0|||
163867755|NCT06001177|591882923|FG000|Treatment Phase|Withdrawal by Subject|1|||
163867756|NCT06001177|591882924|FG001|Treatment Phase|Withdrawal by Subject|0|||
163867757|NCT06001177|591882923|FG000|Observation Phase|Adverse Event|1|||
164312462|NCT04145219|593520354|FG001|Overall Study|Physician Decision|2|||
164312463|NCT04145219|593520353|FG000|Overall Study|Withdrawal by Subject|12|||
164312464|NCT04145219|593520354|FG001|Overall Study|Withdrawal by Subject|8|||
164312465|NCT04145219|593520353|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
164312466|NCT04145219|593520354|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
164312467|NCT01703754|593520360|FG000|Overall Study|Clinically significant disease progression|2|||
164312468|NCT01703754|593520361|FG001|Overall Study|Clinically significant disease progression|2|||
164312469|NCT01703754|593520362|FG002|Overall Study|Clinically significant disease progression|1|||
164312470|NCT01703754|593520360|FG000|Overall Study|Adverse Event|1|||
164312471|NCT01703754|593520361|FG001|Overall Study|Adverse Event|1|||
164312472|NCT01703754|593520362|FG002|Overall Study|Adverse Event|0|||
164312473|NCT01703754|593520360|FG000|Overall Study|Withdrawal by Subject|2|||
164312474|NCT01703754|593520361|FG001|Overall Study|Withdrawal by Subject|0|||
164312475|NCT01703754|593520362|FG002|Overall Study|Withdrawal by Subject|0|||
164312476|NCT00947882|593520365|FG000|Overall Study|Adverse Event|0|||
164312477|NCT00947882|593520366|FG001|Overall Study|Adverse Event|1|||
164312478|NCT00947882|593520367|FG002|Overall Study|Adverse Event|4|||
164312479|NCT00947882|593520368|FG003|Overall Study|Adverse Event|4|||
164312480|NCT00947882|593520365|FG000|Overall Study|Withdrawal by Subject|2|||
164312481|NCT00947882|593520366|FG001|Overall Study|Withdrawal by Subject|0|||
164312482|NCT00947882|593520367|FG002|Overall Study|Withdrawal by Subject|8|||
164312483|NCT00947882|593520368|FG003|Overall Study|Withdrawal by Subject|2|||
164312484|NCT00947882|593520365|FG000|Overall Study|Protocol Violation|0|||
164312485|NCT00947882|593520366|FG001|Overall Study|Protocol Violation|0|||
164312486|NCT00947882|593520367|FG002|Overall Study|Protocol Violation|1|||
164312487|NCT00947882|593520368|FG003|Overall Study|Protocol Violation|0|||
164312488|NCT00947882|593520365|FG000|Overall Study|Lost to Follow-up|0|||
164312489|NCT00947882|593520366|FG001|Overall Study|Lost to Follow-up|2|||
164312490|NCT00947882|593520367|FG002|Overall Study|Lost to Follow-up|1|||
164312491|NCT00947882|593520368|FG003|Overall Study|Lost to Follow-up|0|||
164312492|NCT00947882|593520365|FG000|Overall Study|Other/Unknown|10|||
164312493|NCT00947882|593520366|FG001|Overall Study|Other/Unknown|13|||
164312494|NCT00947882|593520367|FG002|Overall Study|Other/Unknown|3|||
164312495|NCT00947882|593520368|FG003|Overall Study|Other/Unknown|6|||
164312496|NCT00947882|593520365|FG000|Overall Study|Trial Terminated by Sponsor|62|||
164312497|NCT00947882|593520366|FG001|Overall Study|Trial Terminated by Sponsor|61|||
164312498|NCT00947882|593520367|FG002|Overall Study|Trial Terminated by Sponsor|62|||
164312499|NCT00947882|593520368|FG003|Overall Study|Trial Terminated by Sponsor|70|||
164312500|NCT02379637|593520369|FG000|Overall Study|Protocol Violation|0|||
164312501|NCT02379637|593520370|FG001|Overall Study|Protocol Violation|1|||
164312502|NCT02379637|593520369|FG000|Overall Study|Adverse Event|1|||
164312503|NCT02379637|593520370|FG001|Overall Study|Adverse Event|0|||
164312504|NCT02379637|593520369|FG000|Overall Study|Withdrawal by Subject|1|||
164312505|NCT02379637|593520370|FG001|Overall Study|Withdrawal by Subject|0|||
164312506|NCT02447302|593520371|FG000|Overall Study|Physician Decision|1|||
164312507|NCT02447302|593520372|FG001|Overall Study|Physician Decision|0|||
164312508|NCT02447302|593520373|FG002|Overall Study|Physician Decision|0|||
164312509|NCT02447302|593520371|FG000|Overall Study|Adverse Event|4|||
164312510|NCT02447302|593520372|FG001|Overall Study|Adverse Event|3|||
164312511|NCT02447302|593520373|FG002|Overall Study|Adverse Event|0|||
164312512|NCT02447302|593520371|FG000|Overall Study|Withdrawal by Subject|0|||
164312513|NCT02447302|593520372|FG001|Overall Study|Withdrawal by Subject|1|||
164312514|NCT02447302|593520373|FG002|Overall Study|Withdrawal by Subject|5|||
164312515|NCT02447302|593520371|FG000|Overall Study|Sponsor Decision|0|||
164312516|NCT02447302|593520372|FG001|Overall Study|Sponsor Decision|0|||
164312517|NCT02447302|593520373|FG002|Overall Study|Sponsor Decision|1|||
164312518|NCT01561313|593520381|FG000|Overall Study|Withdrawal by Subject|1|||
164312519|NCT01561313|593520382|FG001|Overall Study|Withdrawal by Subject|0|||
164312520|NCT01561313|593520381|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
164312521|NCT01561313|593520382|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
164312522|NCT01742286|593520385|FG000|Escalation Phase|Administrative problems|1|||
164312523|NCT01742286|593520386|FG001|Escalation Phase|Administrative problems|1|||
164312524|NCT01742286|593520387|FG002|Escalation Phase|Administrative problems|0|||
164312525|NCT01742286|593520388|FG003|Escalation Phase|Administrative problems|0|||
163972032|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
163972033|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
164312526|NCT01742286|593520389|FG004|Escalation Phase|Administrative problems|0|||
164312527|NCT01742286|593520390|FG005|Escalation Phase|Administrative problems|0|||
164312528|NCT01742286|593520391|FG006|Escalation Phase|Administrative problems|2|||
164312529|NCT01742286|593520385|FG000|Escalation Phase|Adverse Event|0|||
164312530|NCT01742286|593520386|FG001|Escalation Phase|Adverse Event|1|||
164312531|NCT01742286|593520387|FG002|Escalation Phase|Adverse Event|2|||
164312532|NCT01742286|593520388|FG003|Escalation Phase|Adverse Event|0|||
164312533|NCT01742286|593520389|FG004|Escalation Phase|Adverse Event|0|||
164312534|NCT01742286|593520390|FG005|Escalation Phase|Adverse Event|1|||
164312535|NCT01742286|593520391|FG006|Escalation Phase|Adverse Event|0|||
164312536|NCT01742286|593520385|FG000|Escalation Phase|Disease progression|3|||
164312537|NCT01742286|593520386|FG001|Escalation Phase|Disease progression|7|||
164312538|NCT01742286|593520387|FG002|Escalation Phase|Disease progression|4|||
164312539|NCT01742286|593520388|FG003|Escalation Phase|Disease progression|1|||
164312540|NCT01742286|593520389|FG004|Escalation Phase|Disease progression|4|||
164312541|NCT01742286|593520390|FG005|Escalation Phase|Disease progression|3|||
164312542|NCT01742286|593520391|FG006|Escalation Phase|Disease progression|2|||
164312543|NCT01742286|593520385|FG000|Escalation Phase|Death|0|||
164312544|NCT01742286|593520386|FG001|Escalation Phase|Death|0|||
164312545|NCT01742286|593520387|FG002|Escalation Phase|Death|0|||
164312546|NCT01742286|593520388|FG003|Escalation Phase|Death|0|||
164312547|NCT01742286|593520389|FG004|Escalation Phase|Death|0|||
164312548|NCT01742286|593520390|FG005|Escalation Phase|Death|1|||
164312549|NCT01742286|593520391|FG006|Escalation Phase|Death|0|||
164312550|NCT01742286|593520385|FG000|Escalation Phase|Physician Decision|0|||
164312551|NCT01742286|593520386|FG001|Escalation Phase|Physician Decision|3|||
164312552|NCT01742286|593520387|FG002|Escalation Phase|Physician Decision|0|||
164312553|NCT01742286|593520388|FG003|Escalation Phase|Physician Decision|1|||
164312554|NCT01742286|593520389|FG004|Escalation Phase|Physician Decision|0|||
164312555|NCT01742286|593520390|FG005|Escalation Phase|Physician Decision|0|||
164312556|NCT01742286|593520391|FG006|Escalation Phase|Physician Decision|2|||
164312557|NCT01742286|593520385|FG000|Escalation Phase|Subject/guardian decision|1|||
164312558|NCT01742286|593520386|FG001|Escalation Phase|Subject/guardian decision|0|||
164312559|NCT01742286|593520387|FG002|Escalation Phase|Subject/guardian decision|0|||
164312560|NCT01742286|593520388|FG003|Escalation Phase|Subject/guardian decision|0|||
164312561|NCT01742286|593520389|FG004|Escalation Phase|Subject/guardian decision|0|||
164312562|NCT01742286|593520390|FG005|Escalation Phase|Subject/guardian decision|0|||
164312563|NCT01742286|593520391|FG006|Escalation Phase|Subject/guardian decision|0|||
164312564|NCT01742286|593520385|FG000|Expansion Phase|Administrative problems|0|||
164312565|NCT01742286|593520386|FG001|Expansion Phase|Administrative problems|0|||
164312566|NCT01742286|593520387|FG002|Expansion Phase|Administrative problems|0|||
164312567|NCT01742286|593520388|FG003|Expansion Phase|Administrative problems|0|||
164312568|NCT01742286|593520389|FG004|Expansion Phase|Administrative problems|0|||
164312569|NCT01742286|593520390|FG005|Expansion Phase|Administrative problems|0|||
164312570|NCT01742286|593520391|FG006|Expansion Phase|Administrative problems|5|||
164312571|NCT01742286|593520385|FG000|Expansion Phase|Physician Decision|0|||
164312572|NCT01742286|593520386|FG001|Expansion Phase|Physician Decision|0|||
164312573|NCT01742286|593520387|FG002|Expansion Phase|Physician Decision|4|||
164312574|NCT01742286|593520388|FG003|Expansion Phase|Physician Decision|0|||
164312575|NCT01742286|593520389|FG004|Expansion Phase|Physician Decision|0|||
164312576|NCT01742286|593520390|FG005|Expansion Phase|Physician Decision|0|||
164312577|NCT01742286|593520391|FG006|Expansion Phase|Physician Decision|9|||
164312578|NCT01742286|593520385|FG000|Expansion Phase|Adverse Event|0|||
164312579|NCT01742286|593520386|FG001|Expansion Phase|Adverse Event|0|||
164312580|NCT01742286|593520387|FG002|Expansion Phase|Adverse Event|0|||
164312581|NCT01742286|593520388|FG003|Expansion Phase|Adverse Event|0|||
164312582|NCT01742286|593520389|FG004|Expansion Phase|Adverse Event|0|||
164312583|NCT01742286|593520390|FG005|Expansion Phase|Adverse Event|0|||
164312584|NCT01742286|593520391|FG006|Expansion Phase|Adverse Event|6|||
164312585|NCT01742286|593520385|FG000|Expansion Phase|Disease progression|0|||
164312586|NCT01742286|593520386|FG001|Expansion Phase|Disease progression|0|||
164312587|NCT01742286|593520387|FG002|Expansion Phase|Disease progression|3|||
164312588|NCT01742286|593520388|FG003|Expansion Phase|Disease progression|0|||
164312589|NCT01742286|593520389|FG004|Expansion Phase|Disease progression|0|||
164312590|NCT01742286|593520390|FG005|Expansion Phase|Disease progression|0|||
164312591|NCT01742286|593520391|FG006|Expansion Phase|Disease progression|15|||
164312592|NCT01742286|593520385|FG000|Expansion Phase|Withdrawal by Subject|0|||
164312593|NCT01742286|593520386|FG001|Expansion Phase|Withdrawal by Subject|0|||
164312594|NCT01742286|593520387|FG002|Expansion Phase|Withdrawal by Subject|0|||
164312595|NCT01742286|593520388|FG003|Expansion Phase|Withdrawal by Subject|0|||
164312596|NCT01742286|593520389|FG004|Expansion Phase|Withdrawal by Subject|0|||
164312597|NCT01742286|593520390|FG005|Expansion Phase|Withdrawal by Subject|0|||
164312598|NCT01742286|593520391|FG006|Expansion Phase|Withdrawal by Subject|1|||
164312599|NCT01233232|593520392|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
164312600|NCT01233232|593520393|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
164312601|NCT01233232|593520394|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
164312602|NCT04198714|593520395|FG000|Overall Study|Physician Decision|0|||
164312603|NCT04198714|593520396|FG001|Overall Study|Physician Decision|1|||
164135637|NCT02799095|592861965|FG010|Part A|Adverse Event|0|||
164312604|NCT01031836|593522573|FG000|Stage I|Adverse Event|1|||
164312605|NCT01031836|593522574|FG001|Stage I|Adverse Event|1|||
164312606|NCT01031836|593522575|FG002|Stage I|Adverse Event|0|||
164312607|NCT01031836|593522576|FG003|Stage I|Adverse Event|0|||
164312608|NCT01031836|593522577|FG004|Stage I|Adverse Event|0|||
164312609|NCT01031836|593522578|FG005|Stage I|Adverse Event|0|||
164312610|NCT01031836|593522573|FG000|Stage I|Other|0|||
164312611|NCT01031836|593522574|FG001|Stage I|Other|1|||
164312612|NCT01031836|593522575|FG002|Stage I|Other|0|||
164312613|NCT01031836|593522576|FG003|Stage I|Other|0|||
164312614|NCT01031836|593522577|FG004|Stage I|Other|0|||
164312615|NCT01031836|593522578|FG005|Stage I|Other|1|||
164312616|NCT01031836|593522573|FG000|Stage II|Adverse Event|0|||
164312617|NCT01031836|593522574|FG001|Stage II|Adverse Event|0|||
164312618|NCT01031836|593522575|FG002|Stage II|Adverse Event|2|||
164312619|NCT01031836|593522576|FG003|Stage II|Adverse Event|2|||
164312620|NCT01031836|593522577|FG004|Stage II|Adverse Event|1|||
164312621|NCT01031836|593522578|FG005|Stage II|Adverse Event|1|||
164312622|NCT01031836|593522573|FG000|Stage II|Other|2|||
164312623|NCT01031836|593522574|FG001|Stage II|Other|0|||
164312624|NCT01031836|593522575|FG002|Stage II|Other|0|||
164312625|NCT01031836|593522576|FG003|Stage II|Other|1|||
164312626|NCT01031836|593522577|FG004|Stage II|Other|1|||
164312627|NCT01031836|593522578|FG005|Stage II|Other|0|||
164312628|NCT05091567|593522579|FG000|Enrollment Phase|Death|37|||
164312629|NCT05091567|593522580|FG001|Enrollment Phase|Death|0|||
164312630|NCT05091567|593522581|FG002|Enrollment Phase|Death|0|||
164312631|NCT05091567|593522579|FG000|Enrollment Phase|Adverse Event|21|||
164312632|NCT05091567|593522580|FG001|Enrollment Phase|Adverse Event|0|||
164312633|NCT05091567|593522581|FG002|Enrollment Phase|Adverse Event|0|||
164312634|NCT05091567|593522579|FG000|Enrollment Phase|Progressive Disease|10|||
164312635|NCT05091567|593522580|FG001|Enrollment Phase|Progressive Disease|0|||
164312636|NCT05091567|593522581|FG002|Enrollment Phase|Progressive Disease|0|||
164312637|NCT05091567|593522579|FG000|Enrollment Phase|Withdrawal by Subject|8|||
164312638|NCT05091567|593522580|FG001|Enrollment Phase|Withdrawal by Subject|0|||
164312639|NCT05091567|593522581|FG002|Enrollment Phase|Withdrawal by Subject|0|||
164312640|NCT05091567|593522579|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
164312641|NCT05091567|593522580|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
164312642|NCT05091567|593522581|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
164312643|NCT05091567|593522579|FG000|Enrollment Phase|Physician Decision|3|||
164312644|NCT05091567|593522580|FG001|Enrollment Phase|Physician Decision|0|||
164312645|NCT05091567|593522581|FG002|Enrollment Phase|Physician Decision|0|||
164312646|NCT05091567|593522579|FG000|Enrollment Phase|Protocol Violation|2|||
164312647|NCT05091567|593522580|FG001|Enrollment Phase|Protocol Violation|0|||
164312648|NCT05091567|593522581|FG002|Enrollment Phase|Protocol Violation|0|||
164312649|NCT05091567|593522579|FG000|Enrollment Phase|Reason not Specified|1|||
164312650|NCT05091567|593522580|FG001|Enrollment Phase|Reason not Specified|0|||
164312651|NCT05091567|593522581|FG002|Enrollment Phase|Reason not Specified|0|||
164312652|NCT05091567|593522579|FG000|Randomized Phase|Death|0|||
164312653|NCT05091567|593522580|FG001|Randomized Phase|Death|135|||
164312654|NCT05091567|593522581|FG002|Randomized Phase|Death|112|||
164312655|NCT05091567|593522579|FG000|Randomized Phase|Progressive Disease|0|||
164312656|NCT05091567|593522580|FG001|Randomized Phase|Progressive Disease|2|||
164312657|NCT05091567|593522581|FG002|Randomized Phase|Progressive Disease|0|||
164312658|NCT05091567|593522579|FG000|Randomized Phase|Withdrawal by Subject|0|||
164312659|NCT05091567|593522580|FG001|Randomized Phase|Withdrawal by Subject|1|||
164312660|NCT05091567|593522581|FG002|Randomized Phase|Withdrawal by Subject|3|||
164312661|NCT05091567|593522579|FG000|Randomized Phase|Lost to Follow-up|0|||
164312662|NCT05091567|593522580|FG001|Randomized Phase|Lost to Follow-up|1|||
164312663|NCT05091567|593522581|FG002|Randomized Phase|Lost to Follow-up|1|||
164312664|NCT05091567|593522579|FG000|Randomized Phase|Ongoing in Study|0|||
164312665|NCT05091567|593522580|FG001|Randomized Phase|Ongoing in Study|102|||
163867758|NCT06001177|591882924|FG001|Observation Phase|Adverse Event|1|||
163867759|NCT06001177|591882923|FG000|Observation Phase|Withdrawal by Subject|0|||
163867760|NCT06001177|591882924|FG001|Observation Phase|Withdrawal by Subject|1|||
163867761|NCT03593876|591882925|FG000|Overall Study|Withdrawal by Subject|1|||
163867762|NCT03593876|591882925|FG000|Overall Study|Discharged home before intervention completion|2|||
163867763|NCT05309668|591882926|FG000|Overall Study|Ongoing at data cut-off|14|||
163867764|NCT05309668|591882927|FG001|Overall Study|Ongoing at data cut-off|17|||
163867765|NCT05309668|591882928|FG002|Overall Study|Ongoing at data cut-off|4|||
163867766|NCT02696707|591882929|FG000|Per Protocol Population|Physician Decision|2|||
163972034|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
164312666|NCT05091567|593522581|FG002|Randomized Phase|Ongoing in Study|126|||
164312667|NCT01217307|593522582|FG000|Overall Study|Withdrawal by Subject|0|||
164312668|NCT01217307|593522583|FG001|Overall Study|Withdrawal by Subject|1|||
164312669|NCT00843284|593522586|FG000|Overall Study|Adverse Event|39|||
164135638|NCT02799095|592861966|FG011|Part A|Adverse Event|0|||
164312670|NCT00843284|593522586|FG000|Overall Study|Lack of Efficacy|5|||
164312671|NCT00843284|593522586|FG000|Overall Study|Lost to Follow-up|11|||
164312672|NCT00843284|593522586|FG000|Overall Study|Other|10|||
163867767|NCT02696707|591882930|FG001|Per Protocol Population|Physician Decision|1|||
163867768|NCT02696707|591882929|FG000|Per Protocol Population|Participant Decision|0|||
163867769|NCT02696707|591882930|FG001|Per Protocol Population|Participant Decision|2|||
164312673|NCT00843284|593522586|FG000|Overall Study|Withdrawal by Subject|4|||
164312674|NCT00843284|593522586|FG000|Overall Study|Death|3|||
164312675|NCT01696929|593522587|FG000|Overall Study|Physician Decision|1|||
164312676|NCT01794338|593522589|FG000|Overall Study|Death|2|||
164312677|NCT01794338|593522590|FG001|Overall Study|Death|0|||
164312678|NCT01794338|593522589|FG000|Overall Study|Lost to Follow-up|6|||
164312679|NCT01794338|593522590|FG001|Overall Study|Lost to Follow-up|9|||
163867770|NCT02696707|591882929|FG000|Completed Study as Planned|Reason = LVEF|2|||
163867771|NCT02696707|591882930|FG001|Completed Study as Planned|Reason = LVEF|2|||
163867772|NCT02696707|591882929|FG000|Completed Study as Planned|Protocol Violation|2|||
163867773|NCT02696707|591882930|FG001|Completed Study as Planned|Protocol Violation|6|||
163867774|NCT02696707|591882929|FG000|Completed Study as Planned|Metastatic disease|3|||
163867775|NCT02696707|591882930|FG001|Completed Study as Planned|Metastatic disease|0|||
163867776|NCT02696707|591882929|FG000|Completed Study as Planned|Location|1|||
163867777|NCT02696707|591882930|FG001|Completed Study as Planned|Location|1|||
163867778|NCT00071799|591882931|FG000|Overall Study|Adverse Event|19|||
163867779|NCT00071799|591882932|FG001|Overall Study|Adverse Event|10|||
163867780|NCT00071799|591882931|FG000|Overall Study|Protocol Violation|1|||
163867781|NCT00071799|591882932|FG001|Overall Study|Protocol Violation|7|||
163867782|NCT00071799|591882931|FG000|Overall Study|Lost to Follow-up|1|||
163867783|NCT00071799|591882932|FG001|Overall Study|Lost to Follow-up|1|||
163867784|NCT00071799|591882931|FG000|Overall Study|Withdrawal by Subject|15|||
163867785|NCT00071799|591882932|FG001|Overall Study|Withdrawal by Subject|37|||
163867786|NCT00071799|591882931|FG000|Overall Study|Physician Decision|0|||
163867787|NCT00071799|591882932|FG001|Overall Study|Physician Decision|2|||
163867788|NCT00071799|591882931|FG000|Overall Study|Lack of Efficacy|11|||
163867789|NCT00071799|591882932|FG001|Overall Study|Lack of Efficacy|18|||
163867790|NCT00071799|591882931|FG000|Overall Study|Disease Progression|23|||
163867791|NCT00071799|591882932|FG001|Overall Study|Disease Progression|20|||
163867792|NCT00071799|591882931|FG000|Overall Study|Different Central+Local Pathology Review|0|||
163867793|NCT00071799|591882932|FG001|Overall Study|Different Central+Local Pathology Review|1|||
163867794|NCT00071799|591882931|FG000|Overall Study|Not Documented|0|||
163867795|NCT00071799|591882932|FG001|Overall Study|Not Documented|2|||
163867796|NCT00814346|591882933|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
163867797|NCT00814346|591882934|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
163867798|NCT00814346|591882933|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
163867799|NCT00814346|591882934|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
164202445|NCT00784875|593115122|FG000|Period A - Baseline|Lost to Follow-up|0|||
164202446|NCT00784875|593115123|FG001|Period A - Baseline|Lost to Follow-up|0|||
164202447|NCT00784875|593115124|FG002|Period A - Baseline|Lost to Follow-up|0|||
164202448|NCT00784875|593115125|FG003|Period A - Baseline|Lost to Follow-up|2|||
164202449|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
164202450|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
164202451|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
164202452|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
164202453|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
164202454|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
164202455|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
164202456|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
164202457|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
164202458|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
164202459|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
164202460|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
164202461|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
164202462|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
164202463|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
164202464|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
164202465|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
164202466|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
164202467|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
164202468|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
164202469|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
164202470|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
164202471|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
164202472|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
164202473|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
164202474|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
164202475|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
164202476|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
164202477|NCT00784875|593115122|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
164202478|NCT00784875|593115123|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
164202479|NCT00784875|593115124|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
164202480|NCT00784875|593115125|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
164202481|NCT00784875|593115122|FG000|Period C|Adverse Event|1|||
164202482|NCT00784875|593115123|FG001|Period C|Adverse Event|0|||
164202483|NCT00784875|593115124|FG002|Period C|Adverse Event|4|||
164202484|NCT00784875|593115125|FG003|Period C|Adverse Event|2|||
164202485|NCT00784875|593115122|FG000|Period C|Protocol Violation|0|||
164202486|NCT00784875|593115123|FG001|Period C|Protocol Violation|0|||
164202487|NCT00784875|593115124|FG002|Period C|Protocol Violation|1|||
164312680|NCT01282463|593522591|FG000|Overall Study|Lost to Follow-up|1|||
164312681|NCT01282463|593522592|FG001|Overall Study|Lost to Follow-up|0|||
164312682|NCT01282463|593522593|FG002|Overall Study|Lost to Follow-up|0|||
164312683|NCT01282463|593522591|FG000|Overall Study|Withdrawal by Subject|6|||
164312684|NCT01282463|593522592|FG001|Overall Study|Withdrawal by Subject|2|||
164312685|NCT01282463|593522593|FG002|Overall Study|Withdrawal by Subject|3|||
164312686|NCT01282463|593522591|FG000|Overall Study|"Never Treated Death"|0|||
164312687|NCT01282463|593522592|FG001|Overall Study|"Never Treated Death"|1|||
164312688|NCT01282463|593522593|FG002|Overall Study|"Never Treated Death"|0|||
164312689|NCT01282463|593522591|FG000|Overall Study|"Never Treated PD"|0|||
164312690|NCT01282463|593522592|FG001|Overall Study|"Never Treated PD"|1|||
164312691|NCT01282463|593522593|FG002|Overall Study|"Never Treated PD"|0|||
164312692|NCT01282463|593522591|FG000|Overall Study|Protocol Violation|0|||
164312693|NCT01282463|593522592|FG001|Overall Study|Protocol Violation|0|||
164312694|NCT01282463|593522593|FG002|Overall Study|Protocol Violation|1|||
164312695|NCT01282463|593522591|FG000|Overall Study|Physician Decision|1|||
164312696|NCT01282463|593522592|FG001|Overall Study|Physician Decision|0|||
164312697|NCT01282463|593522593|FG002|Overall Study|Physician Decision|0|||
164312698|NCT02051933|593522594|FG000|Overall Study|Physician Decision|0|||
164312699|NCT02051933|593522595|FG001|Overall Study|Physician Decision|1|||
164312700|NCT01954927|593522596|FG000|Overall Study|Withdrawal by Subject|3|||
164312701|NCT01954927|593522597|FG001|Overall Study|Withdrawal by Subject|1|||
164312702|NCT02156271|593522598|FG000|Overall Study|Physician Decision|4|||
164312703|NCT02156271|593522599|FG001|Overall Study|Physician Decision|3|||
164312704|NCT02617485|593522600|FG000|Treatment and Observation Period|Adverse Event|9|||
164312705|NCT02617485|593522601|FG001|Treatment and Observation Period|Adverse Event|1|||
164312706|NCT02617485|593522600|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
164312707|NCT02617485|593522601|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
163867800|NCT00814346|591882933|FG000|Open Phase (17 Months)|Adverse Event|5|||
163867801|NCT00814346|591882934|FG001|Open Phase (17 Months)|Adverse Event|0|||
163867802|NCT00814346|591882933|FG000|Open Phase (17 Months)|Consent|2|||
163867803|NCT00814346|591882934|FG001|Open Phase (17 Months)|Consent|0|||
163867804|NCT00814346|591882933|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
163867805|NCT00814346|591882934|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
163867806|NCT00814346|591882933|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
163867807|NCT00814346|591882934|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
163867808|NCT05136443|591882935|FG000|Overall Study|Lost to Follow-up|2|||
163867809|NCT05136443|591882935|FG000|Overall Study|Adverse Event|2|||
163867810|NCT05764161|591882936|FG000|12-week DBVC Period|Lack of Efficacy|2|||
163867811|NCT05764161|591882937|FG001|12-week DBVC Period|Lack of Efficacy|1|||
163867812|NCT05764161|591882936|FG000|12-week DBVC Period|Lost to Follow-up|0|||
163867813|NCT05764161|591882937|FG001|12-week DBVC Period|Lost to Follow-up|2|||
163867814|NCT05764161|591882936|FG000|12-week DBVC Period|Protocol Violation|2|||
163867815|NCT05764161|591882937|FG001|12-week DBVC Period|Protocol Violation|4|||
164202488|NCT00784875|593115125|FG003|Period C|Protocol Violation|2|||
164202489|NCT00784875|593115122|FG000|Period C|Lack of Efficacy|0|||
163867816|NCT05764161|591882936|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
163867817|NCT05764161|591882937|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
163867818|NCT05764161|591882936|FG000|40-week OLE Period|Lack of Efficacy|0|||
163867819|NCT05764161|591882937|FG001|40-week OLE Period|Lack of Efficacy|1|||
164202490|NCT00784875|593115123|FG001|Period C|Lack of Efficacy|0|||
164202491|NCT00784875|593115124|FG002|Period C|Lack of Efficacy|1|||
164202492|NCT00784875|593115125|FG003|Period C|Lack of Efficacy|0|||
164202493|NCT00784875|593115122|FG000|Period C|Withdrawal by Subject|1|||
164202494|NCT00784875|593115123|FG001|Period C|Withdrawal by Subject|1|||
164202495|NCT00784875|593115124|FG002|Period C|Withdrawal by Subject|2|||
164202496|NCT00784875|593115125|FG003|Period C|Withdrawal by Subject|0|||
164202497|NCT00784875|593115122|FG000|Period C|Physician Decision|0|||
164202498|NCT00784875|593115123|FG001|Period C|Physician Decision|0|||
164202499|NCT00784875|593115124|FG002|Period C|Physician Decision|1|||
164202500|NCT00784875|593115125|FG003|Period C|Physician Decision|1|||
164202501|NCT00784875|593115122|FG000|Period C|Sponsor Decision|5|||
164202502|NCT00784875|593115123|FG001|Period C|Sponsor Decision|5|||
164202503|NCT00784875|593115124|FG002|Period C|Sponsor Decision|4|||
164202504|NCT00784875|593115125|FG003|Period C|Sponsor Decision|2|||
164202505|NCT00784875|593115122|FG000|Period D|Adverse Event|0|||
164202506|NCT00784875|593115123|FG001|Period D|Adverse Event|2|||
164312708|NCT02617485|593522600|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
164202507|NCT00784875|593115124|FG002|Period D|Adverse Event|2|||
164202508|NCT00784875|593115125|FG003|Period D|Adverse Event|0|||
164202509|NCT00784875|593115122|FG000|Period D|Protocol Violation|1|||
164202510|NCT00784875|593115123|FG001|Period D|Protocol Violation|0|||
164202511|NCT00784875|593115124|FG002|Period D|Protocol Violation|0|||
164202512|NCT00784875|593115125|FG003|Period D|Protocol Violation|0|||
164202513|NCT00784875|593115122|FG000|Period D|Withdrawal by Subject|2|||
163867820|NCT05764161|591882936|FG000|40-week OLE Period|Lost to Follow-up|1|||
164202514|NCT00784875|593115123|FG001|Period D|Withdrawal by Subject|0|||
164202515|NCT00784875|593115124|FG002|Period D|Withdrawal by Subject|2|||
164202516|NCT00784875|593115125|FG003|Period D|Withdrawal by Subject|0|||
163867821|NCT05764161|591882937|FG001|40-week OLE Period|Lost to Follow-up|4|||
163867822|NCT05764161|591882936|FG000|40-week OLE Period|Withdrawal by Subject|2|||
164202517|NCT00784875|593115122|FG000|Period D|Physician Decision|0|||
164202518|NCT00784875|593115123|FG001|Period D|Physician Decision|1|||
164202519|NCT00784875|593115124|FG002|Period D|Physician Decision|0|||
164202520|NCT00784875|593115125|FG003|Period D|Physician Decision|0|||
164202521|NCT00784875|593115122|FG000|Period D|Sponsor Decision|1|||
164202522|NCT00784875|593115123|FG001|Period D|Sponsor Decision|1|||
164202523|NCT00784875|593115124|FG002|Period D|Sponsor Decision|1|||
164202524|NCT00784875|593115125|FG003|Period D|Sponsor Decision|0|||
164202525|NCT00784875|593115122|FG000|Period D|Lost to Follow-up|1|||
164202526|NCT00784875|593115123|FG001|Period D|Lost to Follow-up|0|||
164202527|NCT00784875|593115124|FG002|Period D|Lost to Follow-up|1|||
164202528|NCT00784875|593115125|FG003|Period D|Lost to Follow-up|1|||
163867823|NCT05764161|591882937|FG001|40-week OLE Period|Withdrawal by Subject|7|||
163867824|NCT05764161|591882936|FG000|40-week OLE Period|Extended Travel|0|||
163867825|NCT05764161|591882937|FG001|40-week OLE Period|Extended Travel|1|||
163867826|NCT05764161|591882936|FG000|40-week OLE Period|Ongoing|66|||
163867827|NCT05764161|591882937|FG001|40-week OLE Period|Ongoing|59|||
163867828|NCT00507689|591882946|FG000|Pre-Randomization Period|Adverse Event|1|||
163867829|NCT00507689|591882947|FG001|Pre-Randomization Period|Adverse Event|0|||
163867830|NCT00507689|591882946|FG000|Pre-Randomization Period|Physician Decision|1|||
163867831|NCT00507689|591882947|FG001|Pre-Randomization Period|Physician Decision|0|||
163867832|NCT00507689|591882946|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
163867833|NCT00507689|591882947|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
163867834|NCT00507689|591882946|FG000|Randomized Period|Adverse Event|1|||
164202529|NCT00915525|593115126|FG000|Overall Study|Protocol Violation|9|||
164202530|NCT00915525|593115127|FG001|Overall Study|Protocol Violation|4|||
164202531|NCT00915525|593115126|FG000|Overall Study|Withdrawal by Subject|59|||
164202532|NCT00915525|593115127|FG001|Overall Study|Withdrawal by Subject|21|||
164202533|NCT00915525|593115126|FG000|Overall Study|Lost to Follow-up|27|||
164202534|NCT00915525|593115127|FG001|Overall Study|Lost to Follow-up|16|||
164202535|NCT00915525|593115126|FG000|Overall Study|Pregnancy|2|||
164202536|NCT00915525|593115127|FG001|Overall Study|Pregnancy|0|||
164202537|NCT00915525|593115126|FG000|Overall Study|Lack of Efficacy|15|||
163867835|NCT00507689|591882947|FG001|Randomized Period|Adverse Event|1|||
163867836|NCT00507689|591882946|FG000|Randomized Period|Withdrawal by Subject|0|||
163867837|NCT00507689|591882947|FG001|Randomized Period|Withdrawal by Subject|1|||
163867838|NCT01241292|591882948|FG000|Overall Study|Administrative Reason by Sponsor|1|||
163867839|NCT01241292|591882949|FG001|Overall Study|Administrative Reason by Sponsor|0|||
163867840|NCT01241292|591882948|FG000|Overall Study|Disease Progression|2|||
163867841|NCT01241292|591882949|FG001|Overall Study|Disease Progression|0|||
163867842|NCT01241292|591882948|FG000|Overall Study|Study Drug Toxicity|0|||
163867843|NCT01241292|591882949|FG001|Overall Study|Study Drug Toxicity|1|||
163867844|NCT01241292|591882948|FG000|Overall Study|Participant Discontinued Treatment|0|||
163867845|NCT01241292|591882949|FG001|Overall Study|Participant Discontinued Treatment|2|||
163867846|NCT03861767|591882950|FG000|Overall Study|Withdrawal by Subject|2|||
163867847|NCT03861767|591882951|FG001|Overall Study|Withdrawal by Subject|1|||
163867848|NCT03861767|591882952|FG002|Overall Study|Withdrawal by Subject|0|||
163867849|NCT03861767|591882953|FG003|Overall Study|Withdrawal by Subject|5|||
163867850|NCT03861767|591882954|FG004|Overall Study|Withdrawal by Subject|2|||
163867851|NCT03861767|591882955|FG005|Overall Study|Withdrawal by Subject|1|||
163867852|NCT03861767|591882956|FG006|Overall Study|Withdrawal by Subject|3|||
163867853|NCT03861767|591882957|FG007|Overall Study|Withdrawal by Subject|1|||
163867854|NCT03861767|591882958|FG008|Overall Study|Withdrawal by Subject|0|||
164202538|NCT00915525|593115127|FG001|Overall Study|Lack of Efficacy|32|||
164202539|NCT00915525|593115126|FG000|Overall Study|Adverse Event|29|||
164202540|NCT00915525|593115127|FG001|Overall Study|Adverse Event|13|||
164202541|NCT00915525|593115126|FG000|Overall Study|Missing|12|||
163972035|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
164312709|NCT02617485|593522601|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
164312710|NCT02617485|593522600|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
164312711|NCT02617485|593522601|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
164202542|NCT00915525|593115127|FG001|Overall Study|Missing|1|||
164202543|NCT00915525|593115126|FG000|Overall Study|Other Reason|35|||
164202544|NCT00915525|593115127|FG001|Overall Study|Other Reason|12|||
164202545|NCT00915525|593115126|FG000|Overall Study|Site Closed|27|||
164202546|NCT00915525|593115127|FG001|Overall Study|Site Closed|9|||
164202547|NCT00915525|593115126|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
164202548|NCT00915525|593115127|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
164202549|NCT00915525|593115126|FG000|Overall Study|Study Burden|28|||
164202550|NCT00915525|593115127|FG001|Overall Study|Study Burden|12|||
164202551|NCT00915525|593115126|FG000|Overall Study|Non-Compliance|3|||
164202552|NCT00915525|593115127|FG001|Overall Study|Non-Compliance|1|||
164202553|NCT00915525|593115126|FG000|Overall Study|Patient Moved|15|||
164202554|NCT00915525|593115127|FG001|Overall Study|Patient Moved|9|||
164202555|NCT00941928|593115132|FG000|Overall Study|Withdrawal by Subject|1|||
164202556|NCT00941928|593115132|FG000|Overall Study|Disease Progression|1|||
164312712|NCT02617485|593522600|FG000|Treatment and Observation Period|Physician Decision|0|||
164312713|NCT02617485|593522601|FG001|Treatment and Observation Period|Physician Decision|1|||
164312714|NCT02617485|593522600|FG000|Follow-up Period|Adverse Event|1|||
164312715|NCT02617485|593522601|FG001|Follow-up Period|Adverse Event|0|||
164312716|NCT02617485|593522600|FG000|Follow-up Period|Withdrawal by Subject|1|||
164312717|NCT02617485|593522601|FG001|Follow-up Period|Withdrawal by Subject|0|||
164312718|NCT02617485|593522600|FG000|Follow-up Period|Disease progression|2|||
164312719|NCT02617485|593522601|FG001|Follow-up Period|Disease progression|1|||
164312720|NCT02617485|593522600|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
164312721|NCT02617485|593522601|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
164312722|NCT02617485|593522600|FG000|Follow-up Period|Patient needed radiotherapy|9|||
164312723|NCT02617485|593522601|FG001|Follow-up Period|Patient needed radiotherapy|5|||
164312724|NCT02617485|593522600|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
164312725|NCT02617485|593522601|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
164312726|NCT00791076|593522605|FG000|Overall Study|Study was terminated,PI left institution|8|||
164312727|NCT00669409|593522607|FG000|Part 2|Withdrawal by Subject|0|||
164312728|NCT00669409|593522608|FG001|Part 2|Withdrawal by Subject|0|||
164312729|NCT00669409|593522609|FG002|Part 2|Withdrawal by Subject|0|||
164312730|NCT00669409|593522610|FG003|Part 2|Withdrawal by Subject|0|||
164312731|NCT00669409|593522611|FG004|Part 2|Withdrawal by Subject|0|||
164312732|NCT00669409|593522612|FG005|Part 2|Withdrawal by Subject|0|||
164312733|NCT00669409|593522613|FG006|Part 2|Withdrawal by Subject|0|||
164312734|NCT00669409|593522614|FG007|Part 2|Withdrawal by Subject|0|||
164312735|NCT00669409|593522615|FG008|Part 2|Withdrawal by Subject|0|||
164312736|NCT00669409|593522616|FG009|Part 2|Withdrawal by Subject|1|||
164312737|NCT00669409|593522617|FG010|Part 2|Withdrawal by Subject|0|||
164312738|NCT00095940|593522620|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
164312739|NCT00095940|593522621|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
164312740|NCT00095940|593522622|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
164312741|NCT00095940|593522623|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
164312742|NCT00095940|593522624|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
164312743|NCT00095940|593522625|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
164312744|NCT00095940|593522626|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
164312745|NCT00095940|593522627|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
164312746|NCT00095940|593522628|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
164312747|NCT00095940|593522620|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312748|NCT00095940|593522621|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312749|NCT00095940|593522622|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312750|NCT00095940|593522623|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312751|NCT00095940|593522624|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312752|NCT00095940|593522625|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312753|NCT00095940|593522626|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312754|NCT00095940|593522627|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
164312755|NCT00095940|593522628|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
164312756|NCT00095940|593522620|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312757|NCT00095940|593522621|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312758|NCT00095940|593522622|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312759|NCT00095940|593522623|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312760|NCT00095940|593522624|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312761|NCT00095940|593522625|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312762|NCT00095940|593522626|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312763|NCT00095940|593522627|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
164312764|NCT00095940|593522628|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
164312765|NCT04491604|593522629|FG000|Overall Study|Withdrawal by Subject|3|||
164312766|NCT03263702|593522635|FG000|Overall Study|Lost to Follow-up|2|||
164312767|NCT03263702|593522636|FG001|Overall Study|Lost to Follow-up|2|||
163972036|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
163972037|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
163972038|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
164312768|NCT03263702|593522635|FG000|Overall Study|Withdrawal by Subject|1|||
164312769|NCT03263702|593522636|FG001|Overall Study|Withdrawal by Subject|2|||
164312770|NCT00966875|593522637|FG000|Part A|Adverse Event|2|||
164312771|NCT00966875|593522638|FG001|Part A|Adverse Event|1|||
164312772|NCT00966875|593522639|FG002|Part A|Adverse Event|0|||
164312773|NCT00966875|593522640|FG003|Part A|Adverse Event|1|||
164312774|NCT00966875|593522641|FG004|Part A|Adverse Event|0|||
164312775|NCT00966875|593522642|FG005|Part A|Adverse Event|1|||
164312776|NCT00966875|593522643|FG006|Part A|Adverse Event|0|||
163972039|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
164312777|NCT00966875|593522644|FG007|Part A|Adverse Event|3|||
164312778|NCT00966875|593522645|FG008|Part A|Adverse Event|3|||
163972040|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
164312779|NCT00966875|593522637|FG000|Part A|Entry Criteria|0|||
164202557|NCT02732639|593115144|FG000|Overall Study|Lost to Follow-up|1|||
164202558|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
164202559|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
164202560|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
164202561|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
164202562|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
164202563|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
164202564|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
164202565|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
164202566|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
164202567|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
164202568|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
164202569|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
164202570|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
164202571|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
164202572|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
164202573|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
164202574|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
164202575|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
164202576|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
164202577|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
164202578|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
164202579|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
164202580|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
164202581|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
164202582|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
164202583|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
164202584|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
164202585|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
164202586|NCT01668797|593115145|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
164202587|NCT01668797|593115146|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
164202588|NCT01668797|593115147|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
164202589|NCT01668797|593115148|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
164202590|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
164202591|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
164202592|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
164202593|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
164202594|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
164202595|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
164202596|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
164202597|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
164202598|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
164202599|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
164202600|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
164202601|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
164202602|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
164202603|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
164202604|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
164202605|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
164202606|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
164202607|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
164202608|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
164202609|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
164202610|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
164202611|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
164202612|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
164202613|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
164202614|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
164202615|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
164202616|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
164202617|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
164202618|NCT01668797|593115145|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
164202619|NCT01668797|593115146|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
164202620|NCT01668797|593115147|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
164202621|NCT01668797|593115148|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
164202622|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
164312780|NCT00966875|593522638|FG001|Part A|Entry Criteria|0|||
164312781|NCT00966875|593522639|FG002|Part A|Entry Criteria|0|||
164312782|NCT00966875|593522640|FG003|Part A|Entry Criteria|0|||
164312783|NCT00966875|593522641|FG004|Part A|Entry Criteria|0|||
164312784|NCT00966875|593522642|FG005|Part A|Entry Criteria|2|||
164312785|NCT00966875|593522643|FG006|Part A|Entry Criteria|0|||
164202623|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
164202624|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
164202625|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
164202626|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
164202627|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
164202628|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
164202629|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
164202630|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
164202631|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
164202632|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
164202633|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
164202634|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
164202635|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
164202636|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
164202637|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
164202638|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
164202639|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
164202640|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
164202641|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
164202642|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
164202643|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
164202644|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
164202645|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
164202646|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
164202647|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
164202648|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
164202649|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
164202650|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
164202651|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
164202652|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
164202653|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
164202654|NCT01668797|593115145|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
164202655|NCT01668797|593115146|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
164202656|NCT01668797|593115147|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
164202657|NCT01668797|593115148|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
164202658|NCT02515227|593115149|FG000|Overall Study|Adverse Event|0|||
164202659|NCT02515227|593115150|FG001|Overall Study|Adverse Event|2|||
164202660|NCT02515227|593115149|FG000|Overall Study|Progressive disease|2|||
164202661|NCT02515227|593115150|FG001|Overall Study|Progressive disease|9|||
164202662|NCT02111083|593115151|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
164202663|NCT02111083|593115152|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
164202664|NCT00827567|593115153|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
164202665|NCT01259245|593115161|FG000|Overall Study|Withdrawal by Subject|27|||
164202666|NCT01259245|593115162|FG001|Overall Study|Withdrawal by Subject|24|||
164202667|NCT01259245|593115161|FG000|Overall Study|Death|1|||
164202668|NCT01259245|593115162|FG001|Overall Study|Death|2|||
164202669|NCT03937778|593115163|FG000|Overall Study|Withdrawal by Subject|1|||
164202670|NCT03937778|593115163|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
164202671|NCT01200355|593115167|FG000|Overall Study|Death|7|||
164202672|NCT01200355|593115168|FG001|Overall Study|Death|2|||
164202673|NCT00706797|593115171|FG000|Overall Study|Lack of Efficacy|3|||
164312786|NCT00966875|593522644|FG007|Part A|Entry Criteria|0|||
164312787|NCT00966875|593522645|FG008|Part A|Entry Criteria|0|||
164312788|NCT00966875|593522637|FG000|Part A|Lack of Efficacy|0|||
164312789|NCT00966875|593522638|FG001|Part A|Lack of Efficacy|1|||
164312790|NCT00966875|593522639|FG002|Part A|Lack of Efficacy|0|||
164312791|NCT00966875|593522640|FG003|Part A|Lack of Efficacy|0|||
164312792|NCT00966875|593522641|FG004|Part A|Lack of Efficacy|0|||
164202674|NCT00706797|593115172|FG001|Overall Study|Lack of Efficacy|0|||
164202675|NCT00706797|593115171|FG000|Overall Study|Adverse Event|0|||
164312793|NCT00966875|593522642|FG005|Part A|Lack of Efficacy|0|||
164312794|NCT00966875|593522643|FG006|Part A|Lack of Efficacy|4|||
164312795|NCT00966875|593522644|FG007|Part A|Lack of Efficacy|0|||
164312796|NCT00966875|593522645|FG008|Part A|Lack of Efficacy|0|||
164312797|NCT00966875|593522637|FG000|Part A|Lost to Follow-up|2|||
164312798|NCT00966875|593522638|FG001|Part A|Lost to Follow-up|0|||
164312799|NCT00966875|593522639|FG002|Part A|Lost to Follow-up|0|||
164312800|NCT00966875|593522640|FG003|Part A|Lost to Follow-up|0|||
164312801|NCT00966875|593522641|FG004|Part A|Lost to Follow-up|0|||
164312802|NCT00966875|593522642|FG005|Part A|Lost to Follow-up|1|||
164312803|NCT00966875|593522643|FG006|Part A|Lost to Follow-up|0|||
164312804|NCT00966875|593522644|FG007|Part A|Lost to Follow-up|0|||
164312805|NCT00966875|593522645|FG008|Part A|Lost to Follow-up|0|||
164312806|NCT00966875|593522637|FG000|Part A|Parent/Caregiver Decision|0|||
164312807|NCT00966875|593522638|FG001|Part A|Parent/Caregiver Decision|0|||
164312808|NCT00966875|593522639|FG002|Part A|Parent/Caregiver Decision|0|||
164312809|NCT00966875|593522640|FG003|Part A|Parent/Caregiver Decision|1|||
164312810|NCT00966875|593522641|FG004|Part A|Parent/Caregiver Decision|0|||
164312811|NCT00966875|593522642|FG005|Part A|Parent/Caregiver Decision|0|||
164312812|NCT00966875|593522643|FG006|Part A|Parent/Caregiver Decision|0|||
164312813|NCT00966875|593522644|FG007|Part A|Parent/Caregiver Decision|0|||
164312814|NCT00966875|593522645|FG008|Part A|Parent/Caregiver Decision|0|||
164312815|NCT00966875|593522637|FG000|Part A|Physician Decision|0|||
164312816|NCT00966875|593522638|FG001|Part A|Physician Decision|0|||
164312817|NCT00966875|593522639|FG002|Part A|Physician Decision|0|||
164312818|NCT00966875|593522640|FG003|Part A|Physician Decision|0|||
164312819|NCT00966875|593522641|FG004|Part A|Physician Decision|1|||
164312820|NCT00966875|593522642|FG005|Part A|Physician Decision|0|||
164312821|NCT00966875|593522643|FG006|Part A|Physician Decision|1|||
164312822|NCT00966875|593522644|FG007|Part A|Physician Decision|0|||
164312823|NCT00966875|593522645|FG008|Part A|Physician Decision|2|||
164312824|NCT00966875|593522637|FG000|Part A|Sponsor Decision|0|||
164312825|NCT00966875|593522638|FG001|Part A|Sponsor Decision|0|||
164312826|NCT00966875|593522639|FG002|Part A|Sponsor Decision|1|||
164312827|NCT00966875|593522640|FG003|Part A|Sponsor Decision|0|||
164312828|NCT00966875|593522641|FG004|Part A|Sponsor Decision|1|||
164312829|NCT00966875|593522642|FG005|Part A|Sponsor Decision|0|||
164312830|NCT00966875|593522643|FG006|Part A|Sponsor Decision|0|||
164312831|NCT00966875|593522644|FG007|Part A|Sponsor Decision|2|||
164312832|NCT00966875|593522645|FG008|Part A|Sponsor Decision|1|||
164312833|NCT00966875|593522637|FG000|Part A|Withdrawal by Subject|2|||
164312834|NCT00966875|593522638|FG001|Part A|Withdrawal by Subject|2|||
164312835|NCT00966875|593522639|FG002|Part A|Withdrawal by Subject|1|||
164312836|NCT00966875|593522640|FG003|Part A|Withdrawal by Subject|1|||
164312837|NCT00966875|593522641|FG004|Part A|Withdrawal by Subject|3|||
164312838|NCT00966875|593522642|FG005|Part A|Withdrawal by Subject|0|||
164312839|NCT00966875|593522643|FG006|Part A|Withdrawal by Subject|5|||
164312840|NCT00966875|593522644|FG007|Part A|Withdrawal by Subject|1|||
164312841|NCT00966875|593522645|FG008|Part A|Withdrawal by Subject|1|||
164312842|NCT00966875|593522637|FG000|Part A|Protocol Violation|0|||
164312843|NCT00966875|593522638|FG001|Part A|Protocol Violation|0|||
164312844|NCT00966875|593522639|FG002|Part A|Protocol Violation|0|||
164312845|NCT00966875|593522640|FG003|Part A|Protocol Violation|0|||
164312846|NCT00966875|593522641|FG004|Part A|Protocol Violation|0|||
164312847|NCT00966875|593522642|FG005|Part A|Protocol Violation|0|||
164312848|NCT00966875|593522643|FG006|Part A|Protocol Violation|2|||
164312849|NCT00966875|593522644|FG007|Part A|Protocol Violation|1|||
164312850|NCT00966875|593522645|FG008|Part A|Protocol Violation|1|||
164312851|NCT00966875|593522637|FG000|Part B|Adverse Event|0|||
164312852|NCT00966875|593522638|FG001|Part B|Adverse Event|1|||
164312853|NCT00966875|593522639|FG002|Part B|Adverse Event|1|||
164312854|NCT00966875|593522640|FG003|Part B|Adverse Event|0|||
164312855|NCT00966875|593522641|FG004|Part B|Adverse Event|1|||
164135639|NCT02799095|592861967|FG012|Part A|Adverse Event|0|||
164312856|NCT00966875|593522642|FG005|Part B|Adverse Event|0|||
164312857|NCT00966875|593522643|FG006|Part B|Adverse Event|5|||
164312858|NCT00966875|593522644|FG007|Part B|Adverse Event|2|||
164312859|NCT00966875|593522645|FG008|Part B|Adverse Event|2|||
164312860|NCT00966875|593522637|FG000|Part B|Death|0|||
164312861|NCT00966875|593522638|FG001|Part B|Death|0|||
164312862|NCT00966875|593522639|FG002|Part B|Death|1|||
164312863|NCT00966875|593522640|FG003|Part B|Death|0|||
164312864|NCT00966875|593522641|FG004|Part B|Death|0|||
164312865|NCT00966875|593522642|FG005|Part B|Death|0|||
164312866|NCT00966875|593522643|FG006|Part B|Death|0|||
164312867|NCT00966875|593522644|FG007|Part B|Death|1|||
164312868|NCT00966875|593522645|FG008|Part B|Death|0|||
164312869|NCT00966875|593522637|FG000|Part B|Lack of Efficacy|2|||
164312870|NCT00966875|593522638|FG001|Part B|Lack of Efficacy|1|||
164312871|NCT00966875|593522639|FG002|Part B|Lack of Efficacy|1|||
164312872|NCT00966875|593522640|FG003|Part B|Lack of Efficacy|1|||
164312873|NCT00966875|593522641|FG004|Part B|Lack of Efficacy|2|||
164312874|NCT00966875|593522642|FG005|Part B|Lack of Efficacy|3|||
164312875|NCT00966875|593522643|FG006|Part B|Lack of Efficacy|12|||
164312876|NCT00966875|593522644|FG007|Part B|Lack of Efficacy|9|||
164312877|NCT00966875|593522645|FG008|Part B|Lack of Efficacy|6|||
164312878|NCT00966875|593522637|FG000|Part B|Lost to Follow-up|0|||
164312879|NCT00966875|593522638|FG001|Part B|Lost to Follow-up|0|||
164312880|NCT00966875|593522639|FG002|Part B|Lost to Follow-up|0|||
164312881|NCT00966875|593522640|FG003|Part B|Lost to Follow-up|1|||
164312882|NCT00966875|593522641|FG004|Part B|Lost to Follow-up|0|||
164312883|NCT00966875|593522642|FG005|Part B|Lost to Follow-up|0|||
164312884|NCT00966875|593522643|FG006|Part B|Lost to Follow-up|0|||
164312885|NCT00966875|593522644|FG007|Part B|Lost to Follow-up|0|||
164312886|NCT00966875|593522645|FG008|Part B|Lost to Follow-up|1|||
164312887|NCT00966875|593522637|FG000|Part B|Physician Decision|0|||
164312888|NCT00966875|593522638|FG001|Part B|Physician Decision|0|||
163972041|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
163972042|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
163972043|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
163972044|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
163972045|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163972046|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163972047|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
163972048|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163972049|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
163972050|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972051|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163972052|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163972053|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163972054|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972055|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163972056|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
163972057|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
163972058|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
163972059|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
163972060|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
163972061|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
163972062|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
163972063|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
163972064|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163972065|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163972066|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163972067|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
163972068|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
163972069|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163972070|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163972071|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163972072|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163972073|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
163972074|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163972075|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
163972076|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
164312889|NCT00966875|593522639|FG002|Part B|Physician Decision|1|||
163972077|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163972078|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163972079|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
163972080|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163972081|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
163972082|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163972083|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163972084|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163972085|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
163972086|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163972087|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
163972088|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163972089|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163972090|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
163972091|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
164312890|NCT00966875|593522640|FG003|Part B|Physician Decision|0|||
164312891|NCT00966875|593522641|FG004|Part B|Physician Decision|2|||
164312892|NCT00966875|593522642|FG005|Part B|Physician Decision|1|||
164312893|NCT00966875|593522643|FG006|Part B|Physician Decision|0|||
164312894|NCT00966875|593522644|FG007|Part B|Physician Decision|0|||
164312895|NCT00966875|593522645|FG008|Part B|Physician Decision|2|||
164312896|NCT00966875|593522637|FG000|Part B|Sponsor Decision|1|||
164312897|NCT00966875|593522638|FG001|Part B|Sponsor Decision|0|||
163972092|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164312898|NCT00966875|593522639|FG002|Part B|Sponsor Decision|0|||
164312899|NCT00966875|593522640|FG003|Part B|Sponsor Decision|0|||
164312900|NCT00966875|593522641|FG004|Part B|Sponsor Decision|0|||
164312901|NCT00966875|593522642|FG005|Part B|Sponsor Decision|1|||
164312902|NCT00966875|593522643|FG006|Part B|Sponsor Decision|0|||
164312903|NCT00966875|593522644|FG007|Part B|Sponsor Decision|2|||
164312904|NCT00966875|593522645|FG008|Part B|Sponsor Decision|1|||
164312905|NCT00966875|593522637|FG000|Part B|Withdrawal by Subject|2|||
164312906|NCT00966875|593522638|FG001|Part B|Withdrawal by Subject|1|||
164312907|NCT00966875|593522639|FG002|Part B|Withdrawal by Subject|2|||
164312908|NCT00966875|593522640|FG003|Part B|Withdrawal by Subject|1|||
164312909|NCT00966875|593522641|FG004|Part B|Withdrawal by Subject|2|||
164312910|NCT00966875|593522642|FG005|Part B|Withdrawal by Subject|1|||
164312911|NCT00966875|593522643|FG006|Part B|Withdrawal by Subject|4|||
164312912|NCT00966875|593522644|FG007|Part B|Withdrawal by Subject|5|||
164312913|NCT00966875|593522645|FG008|Part B|Withdrawal by Subject|5|||
164312914|NCT00966875|593522637|FG000|Part B|Entry Criteria|0|||
164312915|NCT00966875|593522638|FG001|Part B|Entry Criteria|0|||
164312916|NCT00966875|593522639|FG002|Part B|Entry Criteria|0|||
164312917|NCT00966875|593522640|FG003|Part B|Entry Criteria|0|||
164312918|NCT00966875|593522641|FG004|Part B|Entry Criteria|0|||
164312919|NCT00966875|593522642|FG005|Part B|Entry Criteria|0|||
164312920|NCT00966875|593522643|FG006|Part B|Entry Criteria|1|||
164312921|NCT00966875|593522644|FG007|Part B|Entry Criteria|0|||
164312922|NCT00966875|593522645|FG008|Part B|Entry Criteria|1|||
164312923|NCT02597478|593522647|FG000|Overall Study|Withdrawal by Subject|2|||
164312924|NCT02597478|593522648|FG001|Overall Study|Withdrawal by Subject|0|||
164312925|NCT02597478|593522647|FG000|Overall Study|Change of opioid dose|1|||
164312926|NCT02597478|593522648|FG001|Overall Study|Change of opioid dose|0|||
164312927|NCT02597478|593522647|FG000|Overall Study|Insufficient exertional dyspnea|0|||
164312928|NCT02597478|593522648|FG001|Overall Study|Insufficient exertional dyspnea|1|||
164312929|NCT01305577|593522651|FG000|Overall Study|Adverse Event|2|||
164312930|NCT01305577|593522652|FG001|Overall Study|Adverse Event|2|||
164312931|NCT01305577|593522653|FG002|Overall Study|Adverse Event|1|||
164312932|NCT01305577|593522651|FG000|Overall Study|Withdrawal by Subject|7|||
164312933|NCT01305577|593522652|FG001|Overall Study|Withdrawal by Subject|5|||
164312934|NCT01305577|593522653|FG002|Overall Study|Withdrawal by Subject|6|||
164312935|NCT01305577|593522651|FG000|Overall Study|Lost to Follow-up|4|||
164312936|NCT01305577|593522652|FG001|Overall Study|Lost to Follow-up|3|||
164312937|NCT01305577|593522653|FG002|Overall Study|Lost to Follow-up|2|||
164312938|NCT01305577|593522651|FG000|Overall Study|Protocol Deviation|0|||
164312939|NCT01305577|593522652|FG001|Overall Study|Protocol Deviation|1|||
164312940|NCT01305577|593522653|FG002|Overall Study|Protocol Deviation|1|||
164312941|NCT00796978|593522654|FG000|Overall Study|Cardiac adverse event|5|||
164312942|NCT00796978|593522654|FG000|Overall Study|Adverse Event|4|||
164312943|NCT00796978|593522654|FG000|Overall Study|Withdrawal by Subject|3|||
164312944|NCT01256190|593522655|FG000|Overall Study|Lost to Follow-up|2|||
164312945|NCT01256190|593522656|FG001|Overall Study|Lost to Follow-up|0|||
164312946|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
164312947|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
164202676|NCT00706797|593115172|FG001|Overall Study|Adverse Event|3|||
164202677|NCT00706797|593115171|FG000|Overall Study|Withdrawal by Subject|8|||
164202678|NCT00706797|593115172|FG001|Overall Study|Withdrawal by Subject|1|||
164202679|NCT00706797|593115171|FG000|Overall Study|Death|1|||
164202680|NCT00706797|593115172|FG001|Overall Study|Death|0|||
164202681|NCT00706797|593115171|FG000|Overall Study|Discontinuation of study by sponsor|52|||
163972093|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
163972094|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163972095|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164006618|NCT02723630|592391039|FG005|Intervention Period 3|consumption of restricted item|0|||
164202682|NCT00706797|593115172|FG001|Overall Study|Discontinuation of study by sponsor|63|||
164312948|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
164312949|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
164312950|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
164312951|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
164312952|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
164312953|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
164312954|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
164312955|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
164312956|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
164312957|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
164312958|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
164312959|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
164202683|NCT00706797|593115171|FG000|Overall Study|Protocol Violation|3|||
164312960|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
164312961|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
164312962|NCT02834793|593522657|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
164312963|NCT02834793|593522658|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
164312964|NCT02834793|593522659|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
164312965|NCT02834793|593522660|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
164312966|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
164312967|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
164312968|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
164312969|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
164312970|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
164312971|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
164312972|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
164312973|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
164312974|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
164312975|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
164312976|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
164312977|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
164312978|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
164312979|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
164312980|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
164312981|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
164312982|NCT02834793|593522657|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
164312983|NCT02834793|593522658|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
164312984|NCT02834793|593522659|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
164312985|NCT02834793|593522660|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
164312986|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
164312987|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
164312988|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
164312989|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
164312990|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
164312991|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
164312992|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
164312993|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
164312994|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
164312995|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
164312996|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
164312997|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
164312998|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
164312999|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
164313000|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
164313001|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
164313002|NCT02834793|593522657|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
164313003|NCT02834793|593522658|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
164313004|NCT02834793|593522659|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
164313005|NCT02834793|593522660|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
164313006|NCT02364336|593522661|FG000|Overall Study|Adverse Event|0|||
164313007|NCT02364336|593522662|FG001|Overall Study|Adverse Event|1|||
164313008|NCT01731938|593522663|FG000|Preliminary Part I|Withdrawal by Subject|2|||
164313009|NCT01731938|593522664|FG001|Preliminary Part I|Withdrawal by Subject|2|||
164313010|NCT01731938|593522663|FG000|Preliminary Part I|Physician Decision|1|||
164313011|NCT01731938|593522664|FG001|Preliminary Part I|Physician Decision|0|||
164313012|NCT01731938|593522663|FG000|Preliminary Part I|Lost to Follow-up|0|||
164313013|NCT01731938|593522664|FG001|Preliminary Part I|Lost to Follow-up|3|||
164313014|NCT01731938|593522663|FG000|Preliminary Part I|Missed Week 6 visit|0|||
164313015|NCT01731938|593522664|FG001|Preliminary Part I|Missed Week 6 visit|3|||
164313016|NCT01731938|593522663|FG000|Primary Part II|Withdrawal by Subject|5|||
164313017|NCT01731938|593522664|FG001|Primary Part II|Withdrawal by Subject|4|||
164313018|NCT01731938|593522663|FG000|Primary Part II|Lost to Follow-up|4|||
164313019|NCT01731938|593522664|FG001|Primary Part II|Lost to Follow-up|5|||
164313020|NCT01731938|593522663|FG000|Primary Part II|Death|2|||
164313021|NCT01731938|593522664|FG001|Primary Part II|Death|1|||
164313022|NCT01731938|593522663|FG000|Primary Part II|Missed Week 6 visit|2|||
164313023|NCT01731938|593522664|FG001|Primary Part II|Missed Week 6 visit|3|||
164313024|NCT03319745|593522665|FG000|Overall Study|Death|1|||
164313025|NCT03319745|593522665|FG000|Overall Study|Toxicity Precluding Surgery|1|||
163972096|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
164313026|NCT00870103|593522666|FG000|Overall Study|Physician Decision|2|||
164313027|NCT00870103|593522666|FG000|Overall Study|Lost to Follow-up|2|||
164313028|NCT03179202|593522667|FG000|Overall Study|Screen Failure|67|||
164313029|NCT03179202|593522667|FG000|Overall Study|Subject Lost to Follow Up|12|||
164313030|NCT03179202|593522667|FG000|Overall Study|Withdrawal by Subject|7|||
164313031|NCT03179202|593522667|FG000|Overall Study|Adverse Event|3|||
163867855|NCT03861767|591882959|FG009|Overall Study|Withdrawal by Subject|5|||
163867856|NCT01145885|591882960|FG000|Overall Study|Progressive Disease|7|||
163867857|NCT05299606|591882961|FG000|Overall Study|Death|1|||
163867858|NCT03460756|591882963|FG000|Overall Study|Adverse Event|0|||
163867859|NCT03460756|591882964|FG001|Overall Study|Adverse Event|0|||
163867860|NCT03460756|591882965|FG002|Overall Study|Adverse Event|0|||
163867861|NCT03460756|591882966|FG003|Overall Study|Adverse Event|1|||
163867862|NCT03460756|591882963|FG000|Overall Study|Lack of Efficacy|0|||
163867863|NCT03460756|591882964|FG001|Overall Study|Lack of Efficacy|0|||
163867864|NCT03460756|591882965|FG002|Overall Study|Lack of Efficacy|0|||
163867865|NCT03460756|591882966|FG003|Overall Study|Lack of Efficacy|2|||
163867866|NCT03460756|591882963|FG000|Overall Study|Lost to Follow-up|0|||
163867867|NCT03460756|591882964|FG001|Overall Study|Lost to Follow-up|1|||
163867868|NCT03460756|591882965|FG002|Overall Study|Lost to Follow-up|2|||
163867869|NCT03460756|591882966|FG003|Overall Study|Lost to Follow-up|1|||
163867870|NCT03460756|591882963|FG000|Overall Study|Pregnancy|0|||
163867871|NCT03460756|591882964|FG001|Overall Study|Pregnancy|0|||
163867872|NCT03460756|591882965|FG002|Overall Study|Pregnancy|0|||
163867873|NCT03460756|591882966|FG003|Overall Study|Pregnancy|1|||
163867874|NCT03460756|591882963|FG000|Overall Study|Protocol Violation|0|||
163867875|NCT03460756|591882964|FG001|Overall Study|Protocol Violation|0|||
163867876|NCT03460756|591882965|FG002|Overall Study|Protocol Violation|0|||
163867877|NCT03460756|591882966|FG003|Overall Study|Protocol Violation|1|||
163867878|NCT03460756|591882963|FG000|Overall Study|Withdrawal by Subject|0|||
163867879|NCT03460756|591882964|FG001|Overall Study|Withdrawal by Subject|4|||
163867880|NCT03460756|591882965|FG002|Overall Study|Withdrawal by Subject|7|||
163867881|NCT03460756|591882966|FG003|Overall Study|Withdrawal by Subject|3|||
163867882|NCT00723450|591882968|FG000|Open-Label Phase|Adverse Event|26|||
163867883|NCT00723450|591882969|FG001|Open-Label Phase|Adverse Event|0|||
163867884|NCT00723450|591882970|FG002|Open-Label Phase|Adverse Event|0|||
163867885|NCT00723450|591882968|FG000|Open-Label Phase|Lack of Efficacy|18|||
163867886|NCT00723450|591882969|FG001|Open-Label Phase|Lack of Efficacy|0|||
163867887|NCT00723450|591882970|FG002|Open-Label Phase|Lack of Efficacy|0|||
163867888|NCT00723450|591882968|FG000|Open-Label Phase|Protocol Violation|35|||
163867889|NCT00723450|591882969|FG001|Open-Label Phase|Protocol Violation|0|||
163867890|NCT00723450|591882970|FG002|Open-Label Phase|Protocol Violation|0|||
163867891|NCT00723450|591882968|FG000|Open-Label Phase|Lost to Follow-up|7|||
163867892|NCT00723450|591882969|FG001|Open-Label Phase|Lost to Follow-up|0|||
163867893|NCT00723450|591882970|FG002|Open-Label Phase|Lost to Follow-up|0|||
163867894|NCT00723450|591882968|FG000|Open-Label Phase|Physician Decision|2|||
163867895|NCT00723450|591882969|FG001|Open-Label Phase|Physician Decision|0|||
163867896|NCT00723450|591882970|FG002|Open-Label Phase|Physician Decision|0|||
163867897|NCT00723450|591882968|FG000|Open-Label Phase|Withdrawal by Subject|37|||
163867898|NCT00723450|591882969|FG001|Open-Label Phase|Withdrawal by Subject|0|||
163867899|NCT00723450|591882970|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163867900|NCT00723450|591882968|FG000|Randomized Phase|Adverse Event|0|||
163867901|NCT00723450|591882969|FG001|Randomized Phase|Adverse Event|26|||
163867902|NCT00723450|591882970|FG002|Randomized Phase|Adverse Event|17|||
163867903|NCT00723450|591882968|FG000|Randomized Phase|Lack of Efficacy|0|||
163867904|NCT00723450|591882969|FG001|Randomized Phase|Lack of Efficacy|11|||
163867905|NCT00723450|591882970|FG002|Randomized Phase|Lack of Efficacy|11|||
163867906|NCT00723450|591882968|FG000|Randomized Phase|Protocol Violation|0|||
163972097|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
163972098|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163972099|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163972100|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
164135640|NCT02799095|592861968|FG013|Part A|Adverse Event|0|||
163867907|NCT00723450|591882969|FG001|Randomized Phase|Protocol Violation|9|||
163867908|NCT00723450|591882970|FG002|Randomized Phase|Protocol Violation|13|||
163867909|NCT00723450|591882968|FG000|Randomized Phase|Lost to Follow-up|0|||
163867910|NCT00723450|591882969|FG001|Randomized Phase|Lost to Follow-up|2|||
163867911|NCT00723450|591882970|FG002|Randomized Phase|Lost to Follow-up|3|||
163867912|NCT00723450|591882968|FG000|Randomized Phase|Physician Decision|0|||
163867913|NCT00723450|591882969|FG001|Randomized Phase|Physician Decision|3|||
163867914|NCT00723450|591882970|FG002|Randomized Phase|Physician Decision|1|||
163867915|NCT00723450|591882968|FG000|Randomized Phase|Withdrawal by Subject|0|||
164135641|NCT02799095|592861969|FG014|Part A|Adverse Event|0|||
164135642|NCT02799095|592861970|FG015|Part A|Adverse Event|0|||
164135643|NCT02799095|592861971|FG016|Part A|Adverse Event|0|||
164135644|NCT02799095|592861955|FG000|Part A|Death|0|||
164135645|NCT02799095|592861956|FG001|Part A|Death|0|||
164135646|NCT02799095|592861957|FG002|Part A|Death|0|||
164135647|NCT02799095|592861958|FG003|Part A|Death|0|||
164135648|NCT02799095|592861959|FG004|Part A|Death|0|||
164135649|NCT02799095|592861960|FG005|Part A|Death|0|||
164135650|NCT02799095|592861961|FG006|Part A|Death|3|||
164135651|NCT02799095|592861962|FG007|Part A|Death|0|||
164135652|NCT02799095|592861963|FG008|Part A|Death|0|||
164135653|NCT02799095|592861964|FG009|Part A|Death|0|||
164135654|NCT02799095|592861965|FG010|Part A|Death|0|||
164313032|NCT03179202|593522667|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
164313033|NCT03179202|593522667|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
164313034|NCT03255629|593522668|FG000|Overall Study|Adverse Event|1|||
164313035|NCT03255629|593522669|FG001|Overall Study|Adverse Event|0|||
164313036|NCT03255629|593522668|FG000|Overall Study|did not experience hypoglycemia|2|||
164313037|NCT03255629|593522669|FG001|Overall Study|did not experience hypoglycemia|1|||
164313038|NCT04540198|593522670|FG000|Overall Study|Lost to Follow-up|25|||
164313039|NCT04540198|593522671|FG001|Overall Study|Lost to Follow-up|23|||
164313040|NCT04540198|593522670|FG000|Overall Study|Withdrawal by Subject|15|||
164313041|NCT04540198|593522671|FG001|Overall Study|Withdrawal by Subject|9|||
164313042|NCT04540198|593522670|FG000|Overall Study|Discontinued|1|||
164313043|NCT04540198|593522671|FG001|Overall Study|Discontinued|0|||
164313044|NCT02779556|593522672|FG000|Baseline|Partial baseline interview completed|1|||
164313045|NCT02779556|593522673|FG001|Baseline|Partial baseline interview completed|0|||
164313046|NCT02779556|593522672|FG000|3 Months|Lost to Follow-up|40|||
164313047|NCT02779556|593522673|FG001|3 Months|Lost to Follow-up|29|||
164313048|NCT02779556|593522672|FG000|3 Months|Missed 3 month clinic visit|27|||
164313049|NCT02779556|593522673|FG001|3 Months|Missed 3 month clinic visit|19|||
164313050|NCT02779556|593522672|FG000|6 Month|Lost to Follow-up|33|||
164313051|NCT02779556|593522673|FG001|6 Month|Lost to Follow-up|39|||
164313052|NCT02779556|593522672|FG000|6 Month HbA1c|No value collected during window|69|||
164313053|NCT02779556|593522673|FG001|6 Month HbA1c|No value collected during window|50|||
164313054|NCT02779556|593522672|FG000|12 Month HbA1c|No value collected during window|138|||
164313055|NCT02779556|593522673|FG001|12 Month HbA1c|No value collected during window|102|||
164313056|NCT03110770|593522675|FG000|Overall Study|Death|1|||
164313057|NCT03110770|593522676|FG001|Overall Study|Death|0|||
164313058|NCT03110770|593522677|FG002|Overall Study|Death|0|||
164313059|NCT03110770|593522678|FG003|Overall Study|Death|1|||
164313060|NCT03110770|593522679|FG004|Overall Study|Death|0|||
164313061|NCT03110770|593522675|FG000|Overall Study|Enrolled but did not receive product|0|||
164313062|NCT03110770|593522676|FG001|Overall Study|Enrolled but did not receive product|0|||
164313063|NCT03110770|593522677|FG002|Overall Study|Enrolled but did not receive product|0|||
164313064|NCT03110770|593522678|FG003|Overall Study|Enrolled but did not receive product|8|||
164313065|NCT03110770|593522679|FG004|Overall Study|Enrolled but did not receive product|7|||
164313066|NCT03110770|593522675|FG000|Overall Study|Lost to Follow-up|0|||
164313067|NCT03110770|593522676|FG001|Overall Study|Lost to Follow-up|0|||
164313068|NCT03110770|593522677|FG002|Overall Study|Lost to Follow-up|0|||
164313069|NCT03110770|593522678|FG003|Overall Study|Lost to Follow-up|53|||
164313070|NCT03110770|593522679|FG004|Overall Study|Lost to Follow-up|45|||
164313071|NCT03110770|593522675|FG000|Overall Study|Investigator Decision|0|||
164313072|NCT03110770|593522676|FG001|Overall Study|Investigator Decision|0|||
164313073|NCT03110770|593522677|FG002|Overall Study|Investigator Decision|0|||
164313074|NCT03110770|593522678|FG003|Overall Study|Investigator Decision|5|||
164313075|NCT03110770|593522679|FG004|Overall Study|Investigator Decision|3|||
164313076|NCT03110770|593522675|FG000|Overall Study|Withdrawal by Subject|0|||
164313077|NCT03110770|593522676|FG001|Overall Study|Withdrawal by Subject|0|||
164313078|NCT03110770|593522677|FG002|Overall Study|Withdrawal by Subject|0|||
164313079|NCT03110770|593522678|FG003|Overall Study|Withdrawal by Subject|24|||
164313080|NCT03110770|593522679|FG004|Overall Study|Withdrawal by Subject|24|||
164313081|NCT03110770|593522675|FG000|Overall Study|Moved from area|5|||
164313082|NCT03110770|593522676|FG001|Overall Study|Moved from area|0|||
164313083|NCT03110770|593522677|FG002|Overall Study|Moved from area|2|||
164313084|NCT03110770|593522678|FG003|Overall Study|Moved from area|42|||
164313085|NCT03110770|593522679|FG004|Overall Study|Moved from area|43|||
164313086|NCT03110770|593522675|FG000|Overall Study|Illness/Injury unrelated to product|0|||
164313087|NCT03110770|593522676|FG001|Overall Study|Illness/Injury unrelated to product|0|||
164313088|NCT03110770|593522677|FG002|Overall Study|Illness/Injury unrelated to product|0|||
164313089|NCT03110770|593522678|FG003|Overall Study|Illness/Injury unrelated to product|0|||
164313090|NCT03110770|593522679|FG004|Overall Study|Illness/Injury unrelated to product|1|||
164313091|NCT01086358|593522682|FG000|First Intervention|Lost to Follow-up|9|||
164313092|NCT01086358|593522683|FG001|First Intervention|Lost to Follow-up|4|||
164313093|NCT01086358|593522682|FG000|First Intervention|Withdrawal by Subject|0|||
164313094|NCT01086358|593522683|FG001|First Intervention|Withdrawal by Subject|1|||
164313095|NCT01086358|593522682|FG000|Second Intervention|Lost to Follow-up|4|||
163867916|NCT00723450|591882969|FG001|Randomized Phase|Withdrawal by Subject|14|||
163867917|NCT00723450|591882970|FG002|Randomized Phase|Withdrawal by Subject|22|||
163867918|NCT00117286|591882971|FG000|Overall Study|Adverse Event|12|||
163867919|NCT00117286|591882972|FG001|Overall Study|Adverse Event|6|||
164313096|NCT01086358|593522683|FG001|Second Intervention|Lost to Follow-up|4|||
164313097|NCT03206788|593522689|FG000|Overall Study|Withdrawal by Subject|0|||
164313098|NCT03206788|593522690|FG001|Overall Study|Withdrawal by Subject|1|||
164313099|NCT03206788|593522689|FG000|Overall Study|Adverse Event|0|||
164313100|NCT03206788|593522690|FG001|Overall Study|Adverse Event|1|||
164313101|NCT03206788|593522689|FG000|Overall Study|Physician Decision|0|||
164313102|NCT03206788|593522690|FG001|Overall Study|Physician Decision|1|||
164313103|NCT02082340|593522691|FG000|Overall Study|Lost to Follow-up|1|||
163972101|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
163972102|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163972103|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
163972104|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163972105|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163972106|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163972107|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
163972108|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163972109|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
163972110|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163972111|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163972112|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
164202684|NCT00706797|593115172|FG001|Overall Study|Protocol Violation|2|||
164202685|NCT00706797|593115171|FG000|Overall Study|Lost to Follow-up|1|||
164202686|NCT00706797|593115172|FG001|Overall Study|Lost to Follow-up|2|||
164202687|NCT00706797|593115171|FG000|Overall Study|Other|1|||
163867920|NCT00117286|591882971|FG000|Overall Study|Lost to Follow-up|2|||
163867921|NCT00117286|591882972|FG001|Overall Study|Lost to Follow-up|0|||
163867922|NCT00117286|591882971|FG000|Overall Study|Protocol Violation|3|||
163867923|NCT00117286|591882972|FG001|Overall Study|Protocol Violation|3|||
163867924|NCT00117286|591882971|FG000|Overall Study|Withdrawal by Subject|6|||
163867925|NCT00117286|591882972|FG001|Overall Study|Withdrawal by Subject|2|||
163867926|NCT00117286|591882971|FG000|Overall Study|Physician Decision|3|||
163867927|NCT00117286|591882972|FG001|Overall Study|Physician Decision|7|||
163867928|NCT00117286|591882971|FG000|Overall Study|Lack of Efficacy|2|||
163867929|NCT00117286|591882972|FG001|Overall Study|Lack of Efficacy|1|||
163867930|NCT00117286|591882971|FG000|Overall Study|Research site closing|0|||
163867931|NCT00117286|591882972|FG001|Overall Study|Research site closing|2|||
163867932|NCT00189202|591882973|FG000|Overall Study|Physician Decision|5|||
163867933|NCT02950558|591882977|FG000|Overall Study|Lost to Follow-up|2|||
163867934|NCT02950558|591882978|FG001|Overall Study|Lost to Follow-up|0|||
163867935|NCT02537522|591882986|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
163867936|NCT02537522|591882987|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
163867937|NCT02537522|591882988|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
163867938|NCT02537522|591882989|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
163867939|NCT02537522|591882986|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
163867940|NCT02537522|591882987|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
163867941|NCT02537522|591882988|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
163867942|NCT02537522|591882989|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
163867943|NCT02537522|591882986|FG000|Phase I - Contralateral|incorrect randomization|0|||
163867944|NCT02537522|591882987|FG001|Phase I - Contralateral|incorrect randomization|1|||
163867945|NCT02537522|591882988|FG002|Phase I - Contralateral|incorrect randomization|0|||
163867946|NCT02537522|591882989|FG003|Phase I - Contralateral|incorrect randomization|0|||
163867947|NCT02537522|591882986|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
163867948|NCT02537522|591882987|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
163867949|NCT02537522|591882988|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
163867950|NCT02537522|591882989|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
163867951|NCT02537522|591882986|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
163867952|NCT02537522|591882987|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
163867953|NCT02537522|591882988|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
163867954|NCT02537522|591882989|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
163867955|NCT03024606|591882991|FG000|Overall Study|Withdrawal by Subject|9|||
163867956|NCT03024606|591882992|FG001|Overall Study|Withdrawal by Subject|10|||
163867957|NCT01595061|591882993|FG000|Overall Study|Never Treated|3|||
163867958|NCT01595061|591882993|FG000|Overall Study|Inadequate Pathology|1|||
163867959|NCT00356265|591882994|FG000|Overall Study|Withdrawal by Subject|0|||
163867960|NCT00356265|591882995|FG001|Overall Study|Withdrawal by Subject|0|||
163867961|NCT00356265|591882996|FG002|Overall Study|Withdrawal by Subject|1|||
163867962|NCT01582269|591882999|FG000|Overall Study|Withdrawal by Subject|1|||
163867963|NCT01582269|591883000|FG001|Overall Study|Withdrawal by Subject|0|||
164202688|NCT00706797|593115172|FG001|Overall Study|Other|0|||
164202689|NCT03502798|593115173|FG000|Overall Study|equipment failure|0|||
164202690|NCT03502798|593115174|FG001|Overall Study|equipment failure|7|||
164202691|NCT01027845|593115178|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
163867964|NCT01582269|591883001|FG002|Overall Study|Withdrawal by Subject|0|||
163867965|NCT02486588|591883004|FG000|Overall Study|Randomized in error- ineligible|738|||
163867966|NCT02486588|591883005|FG001|Overall Study|Randomized in error- ineligible|750|||
163867967|NCT02486588|591883006|FG002|Overall Study|Randomized in error- ineligible|755|||
163867968|NCT02486588|591883007|FG003|Overall Study|Randomized in error- ineligible|738|||
163867969|NCT02486588|591883008|FG004|Overall Study|Randomized in error- ineligible|746|||
163867970|NCT02486588|591883009|FG005|Overall Study|Randomized in error- ineligible|746|||
163972113|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163972114|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
163972115|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
163972116|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163972117|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163972118|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163972119|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163972120|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
163972121|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
163972122|NCT00111800|592269792|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
164202692|NCT01027845|593115179|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
164202693|NCT01027845|593115180|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
164202694|NCT01027845|593115181|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
164202695|NCT01027845|593115178|FG000|Primary Vaccination Phase|Adverse Event|1|||
164202696|NCT01027845|593115179|FG001|Primary Vaccination Phase|Adverse Event|0|||
164202697|NCT01027845|593115180|FG002|Primary Vaccination Phase|Adverse Event|0|||
164202698|NCT01027845|593115181|FG003|Primary Vaccination Phase|Adverse Event|0|||
164202699|NCT01027845|593115178|FG000|Primary Vaccination Phase|Protocol Violation|1|||
164202700|NCT01027845|593115179|FG001|Primary Vaccination Phase|Protocol Violation|0|||
164202701|NCT01027845|593115180|FG002|Primary Vaccination Phase|Protocol Violation|0|||
164202702|NCT01027845|593115181|FG003|Primary Vaccination Phase|Protocol Violation|0|||
164202703|NCT01027845|593115178|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
164202704|NCT01027845|593115179|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
164202705|NCT01027845|593115180|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
163867971|NCT00546871|591883010|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
163867972|NCT00546871|591883011|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
163972123|NCT00111800|592269793|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163972124|NCT00111800|592269794|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163972125|NCT00111800|592269795|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163972126|NCT00111800|592269796|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
163972127|NCT00111800|592269797|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
163972128|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
163972129|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
163972130|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
163972131|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
163972132|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
163972133|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
163972134|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163972135|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
163972136|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
163972137|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163972138|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163972139|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
163972140|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
163972141|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
163972142|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
163972143|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
163972144|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
163972145|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
163972146|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
164202706|NCT01027845|593115181|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
164202707|NCT01027845|593115178|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
164202708|NCT01027845|593115179|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164202709|NCT01027845|593115180|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
163867973|NCT00546871|591883010|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
163867974|NCT00546871|591883011|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
163867975|NCT00546871|591883010|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
163867976|NCT00546871|591883011|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
163867977|NCT00546871|591883010|FG000|Study Extension Period|Protocol Violation|1|||
163867978|NCT00546871|591883011|FG001|Study Extension Period|Protocol Violation|0|||
163867979|NCT00546871|591883010|FG000|Study Extension Period|Withdrawal by Subject|0|||
163867980|NCT00546871|591883011|FG001|Study Extension Period|Withdrawal by Subject|1|||
163867981|NCT01713946|591883012|FG000|Overall Study|Death|0|||
164202710|NCT01027845|593115181|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
163867982|NCT01713946|591883013|FG001|Overall Study|Death|2|||
163867983|NCT01713946|591883014|FG002|Overall Study|Death|2|||
164313104|NCT02082340|593522692|FG001|Overall Study|Lost to Follow-up|1|||
164313105|NCT00833417|593522693|FG000|Overall Study|Adverse Event|5|||
164313106|NCT00833417|593522694|FG001|Overall Study|Adverse Event|16|||
164313107|NCT00833417|593522693|FG000|Overall Study|Death|1|||
164313108|NCT00833417|593522694|FG001|Overall Study|Death|3|||
164313109|NCT00833417|593522693|FG000|Overall Study|Lost to Follow-up|1|||
164313110|NCT00833417|593522694|FG001|Overall Study|Lost to Follow-up|2|||
163867984|NCT01713946|591883012|FG000|Overall Study|Adverse Event|19|||
163867985|NCT01713946|591883013|FG001|Overall Study|Adverse Event|14|||
163867986|NCT01713946|591883014|FG002|Overall Study|Adverse Event|13|||
163867987|NCT01713946|591883012|FG000|Overall Study|Withdrawal by Subject|12|||
163867988|NCT01713946|591883013|FG001|Overall Study|Withdrawal by Subject|12|||
163867989|NCT01713946|591883014|FG002|Overall Study|Withdrawal by Subject|8|||
163867990|NCT01713946|591883012|FG000|Overall Study|Lack of Efficacy|8|||
163867991|NCT01713946|591883013|FG001|Overall Study|Lack of Efficacy|8|||
163867992|NCT01713946|591883014|FG002|Overall Study|Lack of Efficacy|14|||
163867993|NCT01713946|591883012|FG000|Overall Study|Protocol Violation|2|||
163867994|NCT01713946|591883013|FG001|Overall Study|Protocol Violation|4|||
163867995|NCT01713946|591883014|FG002|Overall Study|Protocol Violation|1|||
163867996|NCT01713946|591883012|FG000|Overall Study|Lost to Follow-up|0|||
163867997|NCT01713946|591883013|FG001|Overall Study|Lost to Follow-up|0|||
163867998|NCT01713946|591883014|FG002|Overall Study|Lost to Follow-up|1|||
163867999|NCT01713946|591883012|FG000|Overall Study|Administrative problems|1|||
163868000|NCT01713946|591883013|FG001|Overall Study|Administrative problems|0|||
163868001|NCT01713946|591883014|FG002|Overall Study|Administrative problems|0|||
163868002|NCT01713946|591883012|FG000|Overall Study|Did not continue in Ext|0|||
163868003|NCT01713946|591883013|FG001|Overall Study|Did not continue in Ext|3|||
163868004|NCT01713946|591883014|FG002|Overall Study|Did not continue in Ext|0|||
163868005|NCT01713946|591883012|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
163868006|NCT01713946|591883013|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
163868007|NCT01713946|591883014|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
163868008|NCT01713946|591883012|FG000|Overall Study|Patients never switched to everolimus|0|||
163868009|NCT01713946|591883013|FG001|Overall Study|Patients never switched to everolimus|0|||
163868010|NCT01713946|591883014|FG002|Overall Study|Patients never switched to everolimus|5|||
163868011|NCT05644444|591883790|FG000|Tolerance Phase|Adverse Event|0|||
163868012|NCT05644444|591883791|FG001|Tolerance Phase|Adverse Event|2|||
163868013|NCT05644444|591883790|FG000|Treatment Phase|Adverse Event|0|||
163868014|NCT05644444|591883791|FG001|Treatment Phase|Adverse Event|2|||
163868015|NCT00346333|591883796|FG000|Overall Study|Death|1|||
163868016|NCT00346333|591883797|FG001|Overall Study|Death|0|||
163868017|NCT00346333|591883796|FG000|Overall Study|unwilling or unable to continue|4|||
163868018|NCT00346333|591883797|FG001|Overall Study|unwilling or unable to continue|8|||
163868019|NCT02798835|591883800|FG000|Overall Study|Protocol Violation|0|||
163868020|NCT02798835|591883801|FG001|Overall Study|Protocol Violation|0|||
163868021|NCT02798835|591883802|FG002|Overall Study|Protocol Violation|3|||
163868022|NCT03194958|591883810|FG000|Overall Study|Death|0|||
163868023|NCT03194958|591883811|FG001|Overall Study|Death|1|||
163868024|NCT03194958|591883812|FG002|Overall Study|Death|1|||
163868025|NCT03194958|591883813|FG003|Overall Study|Death|1|||
163868026|NCT03194958|591883810|FG000|Overall Study|Withdrawal by Subject|24|||
163868027|NCT03194958|591883811|FG001|Overall Study|Withdrawal by Subject|27|||
163868028|NCT03194958|591883812|FG002|Overall Study|Withdrawal by Subject|7|||
163868029|NCT03194958|591883813|FG003|Overall Study|Withdrawal by Subject|22|||
163868030|NCT03194958|591883810|FG000|Overall Study|Lost to Follow-up|168|||
163868031|NCT03194958|591883811|FG001|Overall Study|Lost to Follow-up|196|||
163868032|NCT03194958|591883812|FG002|Overall Study|Lost to Follow-up|174|||
163868033|NCT03194958|591883813|FG003|Overall Study|Lost to Follow-up|186|||
163868034|NCT00588770|591883819|FG000|Overall Study|Disease progression|85|||
163868035|NCT00588770|591883820|FG001|Overall Study|Disease progression|68|||
163868036|NCT00588770|591883819|FG000|Overall Study|Adverse Event|29|||
163868037|NCT00588770|591883820|FG001|Overall Study|Adverse Event|58|||
163868038|NCT00588770|591883819|FG000|Overall Study|Death|13|||
163868039|NCT00588770|591883820|FG001|Overall Study|Death|22|||
164313111|NCT00833417|593522693|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
163868040|NCT00588770|591883819|FG000|Overall Study|Withdrawal by Subject|15|||
163868041|NCT00588770|591883820|FG001|Overall Study|Withdrawal by Subject|25|||
163868042|NCT00588770|591883819|FG000|Overall Study|Alternative therapy|2|||
163868043|NCT00588770|591883820|FG001|Overall Study|Alternative therapy|4|||
163868044|NCT00588770|591883819|FG000|Overall Study|Other complicating disease|3|||
163868045|NCT00588770|591883820|FG001|Overall Study|Other complicating disease|2|||
163868046|NCT00588770|591883819|FG000|Overall Study|Not start protocol therapy|0|||
163868047|NCT00588770|591883820|FG001|Overall Study|Not start protocol therapy|9|||
163868048|NCT00588770|591883819|FG000|Overall Study|Lack of Efficacy|8|||
163868049|NCT00588770|591883820|FG001|Overall Study|Lack of Efficacy|10|||
163868050|NCT00588770|591883819|FG000|Overall Study|Physician discretion|2|||
163868051|NCT00588770|591883820|FG001|Overall Study|Physician discretion|0|||
163868052|NCT00588770|591883819|FG000|Overall Study|Patient non-compliance|2|||
164313112|NCT00833417|593522694|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
164313113|NCT00833417|593522693|FG000|Overall Study|Patient Decision to Withdraw|4|||
164313114|NCT00833417|593522694|FG001|Overall Study|Patient Decision to Withdraw|23|||
164313115|NCT00833417|593522693|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
164202711|NCT01027845|593115178|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
164313116|NCT00833417|593522694|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
164313117|NCT00833417|593522693|FG000|Overall Study|Disease Progression|18|||
163868053|NCT00588770|591883820|FG001|Overall Study|Patient non-compliance|2|||
164202712|NCT01027845|593115179|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
164202713|NCT01027845|593115180|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
164202714|NCT01027845|593115181|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
164202715|NCT01281306|593115182|FG000|Overall Study|Lack of Efficacy|0|||
164202716|NCT01281306|593115183|FG001|Overall Study|Lack of Efficacy|1|||
164202717|NCT01281306|593115184|FG002|Overall Study|Lack of Efficacy|3|||
164202718|NCT01281306|593115185|FG003|Overall Study|Lack of Efficacy|0|||
164202719|NCT01281306|593115186|FG004|Overall Study|Lack of Efficacy|2|||
164202720|NCT01281306|593115187|FG005|Overall Study|Lack of Efficacy|0|||
164202721|NCT01281306|593115188|FG006|Overall Study|Lack of Efficacy|1|||
164202722|NCT01281306|593115182|FG000|Overall Study|Withdrawal by Subject|1|||
164202723|NCT01281306|593115183|FG001|Overall Study|Withdrawal by Subject|0|||
164202724|NCT01281306|593115184|FG002|Overall Study|Withdrawal by Subject|2|||
164202725|NCT01281306|593115185|FG003|Overall Study|Withdrawal by Subject|4|||
164202726|NCT01281306|593115186|FG004|Overall Study|Withdrawal by Subject|1|||
164202727|NCT01281306|593115187|FG005|Overall Study|Withdrawal by Subject|3|||
164202728|NCT01281306|593115188|FG006|Overall Study|Withdrawal by Subject|1|||
164202729|NCT01281306|593115182|FG000|Overall Study|Protocol deviation|0|||
164202730|NCT01281306|593115183|FG001|Overall Study|Protocol deviation|1|||
164202731|NCT01281306|593115184|FG002|Overall Study|Protocol deviation|1|||
164202732|NCT01281306|593115185|FG003|Overall Study|Protocol deviation|1|||
164202733|NCT01281306|593115186|FG004|Overall Study|Protocol deviation|1|||
164202734|NCT01281306|593115187|FG005|Overall Study|Protocol deviation|0|||
164202735|NCT01281306|593115188|FG006|Overall Study|Protocol deviation|0|||
164202736|NCT01281306|593115182|FG000|Overall Study|Condition no longer requires study drug|1|||
164202737|NCT01281306|593115183|FG001|Overall Study|Condition no longer requires study drug|0|||
164202738|NCT01281306|593115184|FG002|Overall Study|Condition no longer requires study drug|0|||
164202739|NCT01281306|593115185|FG003|Overall Study|Condition no longer requires study drug|0|||
164202740|NCT01281306|593115186|FG004|Overall Study|Condition no longer requires study drug|0|||
164202741|NCT01281306|593115187|FG005|Overall Study|Condition no longer requires study drug|1|||
164202742|NCT01281306|593115188|FG006|Overall Study|Condition no longer requires study drug|1|||
164202743|NCT01281306|593115182|FG000|Overall Study|Lost to Follow-up|1|||
164202744|NCT01281306|593115183|FG001|Overall Study|Lost to Follow-up|0|||
164202745|NCT01281306|593115184|FG002|Overall Study|Lost to Follow-up|0|||
164202746|NCT01281306|593115185|FG003|Overall Study|Lost to Follow-up|2|||
164202747|NCT01281306|593115186|FG004|Overall Study|Lost to Follow-up|0|||
164202748|NCT01281306|593115187|FG005|Overall Study|Lost to Follow-up|0|||
164202749|NCT01281306|593115188|FG006|Overall Study|Lost to Follow-up|1|||
164202750|NCT01281306|593115182|FG000|Overall Study|Death|1|||
164202751|NCT01281306|593115183|FG001|Overall Study|Death|0|||
164202752|NCT01281306|593115184|FG002|Overall Study|Death|0|||
164202753|NCT01281306|593115185|FG003|Overall Study|Death|0|||
164202754|NCT01281306|593115186|FG004|Overall Study|Death|0|||
164202755|NCT01281306|593115187|FG005|Overall Study|Death|0|||
164202756|NCT01281306|593115188|FG006|Overall Study|Death|0|||
164202757|NCT01281306|593115182|FG000|Overall Study|Adverse Event|3|||
164202758|NCT01281306|593115183|FG001|Overall Study|Adverse Event|2|||
164202759|NCT01281306|593115184|FG002|Overall Study|Adverse Event|2|||
164202760|NCT01281306|593115185|FG003|Overall Study|Adverse Event|3|||
164202761|NCT01281306|593115186|FG004|Overall Study|Adverse Event|5|||
164202762|NCT01281306|593115187|FG005|Overall Study|Adverse Event|3|||
163868054|NCT04697628|591883821|FG000|Overall Study|Withdrawal by Subject|17|||
163868055|NCT04697628|591883822|FG001|Overall Study|Withdrawal by Subject|23|||
163868056|NCT04697628|591883821|FG000|Overall Study|Lost to Follow-up|0|||
163868057|NCT04697628|591883822|FG001|Overall Study|Lost to Follow-up|4|||
163868058|NCT04697628|591883821|FG000|Overall Study|On-going in study|122|||
163868059|NCT04697628|591883822|FG001|Overall Study|On-going in study|91|||
164202763|NCT01281306|593115188|FG006|Overall Study|Adverse Event|3|||
164202764|NCT01281306|593115182|FG000|Overall Study|Randomized in error|1|||
164202765|NCT01281306|593115183|FG001|Overall Study|Randomized in error|0|||
164202766|NCT01281306|593115184|FG002|Overall Study|Randomized in error|0|||
163868060|NCT03388632|591883823|FG000|Triplet C|Clinical progression|0|||
163868061|NCT03388632|591883824|FG001|Triplet C|Clinical progression|0|||
164202767|NCT01281306|593115185|FG003|Overall Study|Randomized in error|1|||
164202768|NCT01281306|593115186|FG004|Overall Study|Randomized in error|0|||
164202769|NCT01281306|593115187|FG005|Overall Study|Randomized in error|0|||
164202770|NCT01281306|593115188|FG006|Overall Study|Randomized in error|0|||
164202771|NCT00368550|593115189|FG000|Overall Study|Adverse Event|7|||
164202772|NCT00368550|593115190|FG001|Overall Study|Adverse Event|4|||
164313118|NCT00833417|593522694|FG001|Overall Study|Disease Progression|17|||
164313119|NCT00833417|593522693|FG000|Overall Study|Reason Not Specified|0|||
164313120|NCT00833417|593522694|FG001|Overall Study|Reason Not Specified|1|||
164313121|NCT01625260|593522695|FG000|Overall Study|Adverse Event|3|||
164313122|NCT01625260|593522696|FG001|Overall Study|Adverse Event|0|||
164313123|NCT01625260|593522695|FG000|Overall Study|Study Terminated by Investigator|2|||
164313124|NCT01625260|593522696|FG001|Overall Study|Study Terminated by Investigator|0|||
164313125|NCT01625260|593522695|FG000|Overall Study|Disease Progression|2|||
164313126|NCT01625260|593522696|FG001|Overall Study|Disease Progression|0|||
164313127|NCT01625260|593522695|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
164313128|NCT01625260|593522696|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
164313129|NCT05573386|593522697|FG000|Overall Study|Withdrawal by Subject|3|||
164313130|NCT05573386|593522698|FG001|Overall Study|Withdrawal by Subject|2|||
164313131|NCT03899805|593522699|FG000|Overall Study|Physician Decision|3|||
164313132|NCT03899805|593522700|FG001|Overall Study|Physician Decision|0|||
164313133|NCT03899805|593522701|FG002|Overall Study|Physician Decision|2|||
164313134|NCT03899805|593522699|FG000|Overall Study|Withdrawal by Subject|1|||
164313135|NCT03899805|593522700|FG001|Overall Study|Withdrawal by Subject|0|||
164313136|NCT03899805|593522701|FG002|Overall Study|Withdrawal by Subject|2|||
164313137|NCT03899805|593522699|FG000|Overall Study|Progressive Disease|10|||
164313138|NCT03899805|593522700|FG001|Overall Study|Progressive Disease|18|||
164313139|NCT03899805|593522701|FG002|Overall Study|Progressive Disease|12|||
164313140|NCT03899805|593522699|FG000|Overall Study|Adverse Event|3|||
164313141|NCT03899805|593522700|FG001|Overall Study|Adverse Event|1|||
164313142|NCT03899805|593522701|FG002|Overall Study|Adverse Event|0|||
164313143|NCT03899805|593522699|FG000|Overall Study|Death|2|||
163868062|NCT03388632|591883825|FG002|Triplet C|Clinical progression|0|||
163868063|NCT03388632|591883826|FG003|Triplet C|Clinical progression|0|||
163868064|NCT03388632|591883827|FG004|Triplet C|Clinical progression|1|||
163868065|NCT03388632|591883828|FG005|Triplet C|Clinical progression|0|||
163868066|NCT03388632|591883829|FG006|Triplet C|Clinical progression|0|||
163868067|NCT03388632|591883830|FG007|Triplet C|Clinical progression|0|||
163868068|NCT03388632|591883831|FG008|Triplet C|Clinical progression|0|||
163868069|NCT03388632|591883823|FG000|Triplet C|42-day lapse in tx|0|||
163868070|NCT03388632|591883824|FG001|Triplet C|42-day lapse in tx|0|||
163868071|NCT03388632|591883825|FG002|Triplet C|42-day lapse in tx|0|||
163868072|NCT03388632|591883826|FG003|Triplet C|42-day lapse in tx|0|||
163868073|NCT03388632|591883827|FG004|Triplet C|42-day lapse in tx|1|||
163868074|NCT03388632|591883828|FG005|Triplet C|42-day lapse in tx|0|||
163868075|NCT03388632|591883829|FG006|Triplet C|42-day lapse in tx|0|||
163868076|NCT03388632|591883830|FG007|Triplet C|42-day lapse in tx|0|||
163868077|NCT03388632|591883831|FG008|Triplet C|42-day lapse in tx|0|||
163868078|NCT03388632|591883823|FG000|Triplet C|Adverse Event|0|||
163868079|NCT03388632|591883824|FG001|Triplet C|Adverse Event|0|||
163868080|NCT03388632|591883825|FG002|Triplet C|Adverse Event|0|||
163868081|NCT03388632|591883826|FG003|Triplet C|Adverse Event|0|||
163868082|NCT03388632|591883827|FG004|Triplet C|Adverse Event|0|||
163868083|NCT03388632|591883828|FG005|Triplet C|Adverse Event|0|||
163868084|NCT03388632|591883829|FG006|Triplet C|Adverse Event|0|||
163868085|NCT03388632|591883830|FG007|Triplet C|Adverse Event|0|||
163868086|NCT03388632|591883831|FG008|Triplet C|Adverse Event|1|||
163868087|NCT03388632|591883823|FG000|Triplet C|Switched to alternative treatment|0|||
163868088|NCT03388632|591883824|FG001|Triplet C|Switched to alternative treatment|0|||
163868089|NCT03388632|591883825|FG002|Triplet C|Switched to alternative treatment|0|||
163868090|NCT03388632|591883826|FG003|Triplet C|Switched to alternative treatment|0|||
163868091|NCT03388632|591883827|FG004|Triplet C|Switched to alternative treatment|0|||
163868092|NCT03388632|591883828|FG005|Triplet C|Switched to alternative treatment|0|||
163868093|NCT03388632|591883829|FG006|Triplet C|Switched to alternative treatment|0|||
164313144|NCT03899805|593522700|FG001|Overall Study|Death|0|||
164313145|NCT03899805|593522701|FG002|Overall Study|Death|0|||
164313146|NCT03899805|593522699|FG000|Overall Study|Came off for surgery|0|||
164313147|NCT03899805|593522700|FG001|Overall Study|Came off for surgery|0|||
163868094|NCT03388632|591883830|FG007|Triplet C|Switched to alternative treatment|1|||
163868095|NCT03388632|591883831|FG008|Triplet C|Switched to alternative treatment|0|||
163868096|NCT03388632|591883823|FG000|Triplet C|Participant choice|0|||
163868097|NCT03388632|591883824|FG001|Triplet C|Participant choice|0|||
163868098|NCT03388632|591883825|FG002|Triplet C|Participant choice|0|||
163868099|NCT03388632|591883826|FG003|Triplet C|Participant choice|0|||
163868100|NCT03388632|591883827|FG004|Triplet C|Participant choice|0|||
163868101|NCT03388632|591883828|FG005|Triplet C|Participant choice|1|||
163868102|NCT03388632|591883829|FG006|Triplet C|Participant choice|0|||
163868103|NCT03388632|591883830|FG007|Triplet C|Participant choice|0|||
163868104|NCT03388632|591883831|FG008|Triplet C|Participant choice|0|||
163868105|NCT04177394|591883832|FG000|Overall Study|Death|16|||
163868106|NCT04177394|591883832|FG000|Overall Study|Withdrawal by Subject|19|||
163868107|NCT04177394|591883832|FG000|Overall Study|Missed visits|61|||
163868108|NCT04177394|591883832|FG000|Overall Study|Expected Visits|15|||
164313148|NCT03899805|593522701|FG002|Overall Study|Came off for surgery|1|||
164313149|NCT05246514|593522702|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
163972147|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
163972148|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163972149|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163972150|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
163972151|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
163972152|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972153|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972154|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
163972155|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972156|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972157|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
163972158|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163972159|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
163972160|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163972161|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163972162|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163972163|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
163972164|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163972165|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163972166|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
163972167|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163972168|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163972169|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
163972170|NCT00111800|592269792|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163972171|NCT00111800|592269793|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163972172|NCT00111800|592269794|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
163972173|NCT00111800|592269795|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163972174|NCT00111800|592269796|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163972175|NCT00111800|592269797|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
163972176|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
163972177|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
163972178|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
163972179|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
163972180|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
163972181|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
163972182|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
163972183|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
163972184|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
163972185|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
163972186|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
163972187|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
163972188|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
163972189|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
163972190|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
163972191|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
163972192|NCT00094770|592269798|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
163972193|NCT00094770|592269799|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
163972194|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
163972195|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
163972196|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
163972197|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
163972198|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
163972199|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
163972200|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
163972201|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
163972202|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
163972203|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
164313150|NCT05246514|593522702|FG000|Overall Study|Withdrawal by Subject|1|||
164313151|NCT05246514|593522702|FG000|Overall Study|Death|13|||
164313152|NCT04195893|593522703|FG000|Second Intervention|Withdrawal by Subject|1|||
164313153|NCT04195893|593522704|FG001|Second Intervention|Withdrawal by Subject|0|||
163972204|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
163972205|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
164313154|NCT01802073|593522705|FG000|Overall Study|Lost to Follow-up|0|||
164313155|NCT01802073|593522706|FG001|Overall Study|Lost to Follow-up|1|||
164313156|NCT01802073|593522705|FG000|Overall Study|Non-compliant|4|||
164313157|NCT01802073|593522706|FG001|Overall Study|Non-compliant|2|||
163972206|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
164313158|NCT01802073|593522705|FG000|Overall Study|Withdrawal by Subject|1|||
163972207|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
163972208|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
163972209|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
163972210|NCT00094770|592269798|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
163972211|NCT00094770|592269799|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
164313159|NCT01802073|593522706|FG001|Overall Study|Withdrawal by Subject|1|||
164313160|NCT01802073|593522705|FG000|Overall Study|Physician Decision|0|||
164313161|NCT01802073|593522706|FG001|Overall Study|Physician Decision|7|||
163972212|NCT02752035|592269800|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
163972213|NCT02752035|592269801|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
163972214|NCT02752035|592269802|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
163972215|NCT02752035|592269803|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
164313162|NCT01327482|593522712|FG000|Overall Study|Adverse Event|1|||
164313163|NCT01018810|593522713|FG000|Overall Study|Withdrawal by Subject|0|||
164313164|NCT01018810|593522714|FG001|Overall Study|Withdrawal by Subject|1|||
164313165|NCT01018810|593522715|FG002|Overall Study|Withdrawal by Subject|0|||
164313166|NCT01018810|593522716|FG003|Overall Study|Withdrawal by Subject|0|||
164313167|NCT01018810|593522717|FG004|Overall Study|Withdrawal by Subject|0|||
164313168|NCT01018810|593522713|FG000|Overall Study|Sponsor Decision|2|||
164313169|NCT01018810|593522714|FG001|Overall Study|Sponsor Decision|0|||
164313170|NCT01018810|593522715|FG002|Overall Study|Sponsor Decision|1|||
164313171|NCT01018810|593522716|FG003|Overall Study|Sponsor Decision|1|||
164313172|NCT01018810|593522717|FG004|Overall Study|Sponsor Decision|1|||
164313173|NCT03672097|593522718|FG000|Period 1|Withdrawal by Subject|2|||
164313174|NCT03672097|593522718|FG000|Period 1|Adverse Event|1|||
164313175|NCT03672097|593522718|FG000|Period 1|Did not receive treatment|1|||
164313176|NCT03672097|593522718|FG000|Period 2|Withdrawal by Subject|3|||
164313177|NCT03672097|593522718|FG000|Period 2|Other|1|||
164313178|NCT00080899|593522719|FG000|Overall Study|Adverse Event|1|||
164313179|NCT02872935|593522720|FG000|Overall Study|Other|0|||
164313180|NCT02872935|593522721|FG001|Overall Study|Other|1|||
164313181|NCT03530124|593522722|FG000|Overall Study|Withdrawal by Subject|0|||
164313182|NCT03530124|593522723|FG001|Overall Study|Withdrawal by Subject|1|||
164313183|NCT03530124|593522722|FG000|Overall Study|Protocol Violation|1|||
164313184|NCT03530124|593522723|FG001|Overall Study|Protocol Violation|0|||
164313185|NCT03530124|593522722|FG000|Overall Study|Discharged prior to study completion|1|||
164313186|NCT03530124|593522723|FG001|Overall Study|Discharged prior to study completion|0|||
164313187|NCT05343624|593522724|FG000|Overall Study|Chart review not completed|1|||
164313188|NCT00530816|593522725|FG000|Overall Study|Progressive Disease|16|||
164313189|NCT00530816|593522726|FG001|Overall Study|Progressive Disease|24|||
164313190|NCT00530816|593522727|FG002|Overall Study|Progressive Disease|24|||
164313191|NCT00530816|593522725|FG000|Overall Study|Adverse Event|6|||
163972216|NCT02752035|592269800|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
163972217|NCT02752035|592269801|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
163972218|NCT02752035|592269802|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
163972219|NCT02752035|592269803|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
163972220|NCT02752035|592269800|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
163972221|NCT02752035|592269801|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
163972222|NCT02752035|592269802|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
163972223|NCT02752035|592269803|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
164313192|NCT00530816|593522726|FG001|Overall Study|Adverse Event|13|||
164313193|NCT00530816|593522727|FG002|Overall Study|Adverse Event|7|||
164313194|NCT00530816|593522725|FG000|Overall Study|Other|3|||
164313195|NCT00530816|593522726|FG001|Overall Study|Other|3|||
164313196|NCT00530816|593522727|FG002|Overall Study|Other|4|||
164313197|NCT00530816|593522725|FG000|Overall Study|Withdrawal by Subject|1|||
164313198|NCT00530816|593522726|FG001|Overall Study|Withdrawal by Subject|2|||
164313199|NCT00530816|593522727|FG002|Overall Study|Withdrawal by Subject|6|||
164313200|NCT02445794|593522728|FG000|Overall Study|Adverse Event|0|||
164313201|NCT02445794|593522729|FG001|Overall Study|Adverse Event|0|||
164313202|NCT02445794|593522730|FG002|Overall Study|Adverse Event|2|||
164313203|NCT02445794|593522731|FG003|Overall Study|Adverse Event|0|||
164313204|NCT01388985|593522732|FG000|Overall Study|Death|0|||
164313205|NCT01388985|593522733|FG001|Overall Study|Death|1|||
164313206|NCT01388985|593522732|FG000|Overall Study|Lost to Follow-up|30|||
164313207|NCT01388985|593522733|FG001|Overall Study|Lost to Follow-up|30|||
164313208|NCT01388985|593522732|FG000|Overall Study|Withdrawal by Subject|13|||
164313209|NCT01388985|593522733|FG001|Overall Study|Withdrawal by Subject|4|||
164313210|NCT01388985|593522732|FG000|Overall Study|Subject unavailable|1|||
164313211|NCT01388985|593522733|FG001|Overall Study|Subject unavailable|1|||
164313212|NCT01388985|593522732|FG000|Overall Study|Other (no reason)|0|||
164313213|NCT01388985|593522733|FG001|Overall Study|Other (no reason)|1|||
164313214|NCT01388985|593522732|FG000|Overall Study|Error of nurse|5|||
164313215|NCT01388985|593522733|FG001|Overall Study|Error of nurse|1|||
164313216|NCT01057589|593522734|FG000|Overall Study|Disease Progression|35|||
164313217|NCT01057589|593522734|FG000|Overall Study|Adverse Event|10|||
164313218|NCT01057589|593522734|FG000|Overall Study|Physician Decision|8|||
164313219|NCT01057589|593522734|FG000|Overall Study|Withdrawal by Subject|3|||
164313220|NCT01057589|593522734|FG000|Overall Study|Sponsor Decision|1|||
164313221|NCT01057589|593522734|FG000|Overall Study|Death|8|||
164313222|NCT01057589|593522734|FG000|Overall Study|Lost to Follow-up|1|||
164313223|NCT01519167|593522737|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
164313224|NCT01519167|593522738|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
164313225|NCT01519167|593522737|FG000|Overall Study|Adverse Event|0|||
164313226|NCT01519167|593522738|FG001|Overall Study|Adverse Event|1|||
164313227|NCT01519167|593522737|FG000|Overall Study|Lack of Efficacy|0|||
164313228|NCT01519167|593522738|FG001|Overall Study|Lack of Efficacy|1|||
164313229|NCT01519167|593522737|FG000|Overall Study|Medical condition changes&deep sedation|0|||
164313230|NCT01519167|593522738|FG001|Overall Study|Medical condition changes&deep sedation|2|||
164313231|NCT01519167|593522737|FG000|Overall Study|Physician Decision|0|||
164313232|NCT01519167|593522738|FG001|Overall Study|Physician Decision|1|||
164313233|NCT00870584|593522744|FG000|Overall Study|Adverse Event|3|||
164313234|NCT00870584|593522745|FG001|Overall Study|Adverse Event|3|||
164313235|NCT00870584|593522744|FG000|Overall Study|Withdrawal by Subject|6|||
164313236|NCT00870584|593522745|FG001|Overall Study|Withdrawal by Subject|7|||
164313237|NCT00870584|593522744|FG000|Overall Study|Lost to Follow-up|5|||
164313238|NCT00870584|593522745|FG001|Overall Study|Lost to Follow-up|1|||
164313239|NCT00870584|593522744|FG000|Overall Study|Protocol Deviation|2|||
164313240|NCT00870584|593522745|FG001|Overall Study|Protocol Deviation|2|||
164313241|NCT02560025|593522746|FG000|Overall Study|Ineligible after consent/ registration|3|||
164313242|NCT01497366|593522747|FG000|Overall Study|Virologic failure|2|||
164313243|NCT01497366|593522748|FG001|Overall Study|Virologic failure|50|||
164313244|NCT01497366|593522747|FG000|Overall Study|Lost to Follow-up|11|||
164313245|NCT01497366|593522748|FG001|Overall Study|Lost to Follow-up|10|||
164313246|NCT01497366|593522747|FG000|Overall Study|Withdrawal by Subject|6|||
164313247|NCT01497366|593522748|FG001|Overall Study|Withdrawal by Subject|6|||
164313248|NCT01497366|593522747|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
164313249|NCT01497366|593522748|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
164313250|NCT01497366|593522747|FG000|Overall Study|Other|5|||
164313251|NCT01497366|593522748|FG001|Overall Study|Other|0|||
164313252|NCT01497366|593522747|FG000|Overall Study|Death|1|||
164313253|NCT01497366|593522748|FG001|Overall Study|Death|1|||
164313254|NCT01497366|593522747|FG000|Overall Study|Randomized but not treated|7|||
164313255|NCT01497366|593522748|FG001|Overall Study|Randomized but not treated|21|||
164313256|NCT02745080|593522758|FG000|Overall Study|Adverse Event|13|||
164313257|NCT02745080|593522759|FG001|Overall Study|Adverse Event|21|||
164313258|NCT02745080|593522758|FG000|Overall Study|Lack of Efficacy|11|||
164313259|NCT02745080|593522759|FG001|Overall Study|Lack of Efficacy|23|||
164313260|NCT02745080|593522758|FG000|Overall Study|Lost to Follow-up|3|||
164313261|NCT02745080|593522759|FG001|Overall Study|Lost to Follow-up|3|||
164313262|NCT02745080|593522758|FG000|Overall Study|Physician Decision|3|||
164313263|NCT02745080|593522759|FG001|Overall Study|Physician Decision|0|||
164313264|NCT02745080|593522758|FG000|Overall Study|Protocol Violation|3|||
164313265|NCT02745080|593522759|FG001|Overall Study|Protocol Violation|1|||
164313266|NCT02745080|593522758|FG000|Overall Study|Withdrawal by Subject|22|||
164313267|NCT02745080|593522759|FG001|Overall Study|Withdrawal by Subject|41|||
164313268|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
164313269|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
164313270|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Physician Decision|1|||
164313271|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Physician Decision|1|||
164313272|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
164313273|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
164313274|NCT01888432|593524479|FG000|12-month Analysis (FAS)|Death|4|||
164313275|NCT01888432|593524480|FG001|12-month Analysis (FAS)|Death|3|||
164313276|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Graft loss|0|||
164313277|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Graft loss|1|||
164313278|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
163868109|NCT02115282|591883833|FG000|Overall Study|Disease progression during treatment|216|||
163868110|NCT02115282|591883834|FG001|Overall Study|Disease progression during treatment|229|||
164313279|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
164313280|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Physician Decision|2|||
164313281|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Physician Decision|4|||
164313282|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
164313283|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
164313284|NCT01888432|593524479|FG000|24-month Analysis (FAS)|Death|8|||
164313285|NCT01888432|593524480|FG001|24-month Analysis (FAS)|Death|4|||
163868111|NCT02115282|591883833|FG000|Overall Study|Adverse Event|49|||
164313286|NCT01888432|593524479|FG000|36-month Analysis (Extension)|Death|1|||
164313287|NCT01888432|593524480|FG001|36-month Analysis (Extension)|Death|0|||
163868112|NCT02115282|591883834|FG001|Overall Study|Adverse Event|23|||
164202773|NCT00368550|593115189|FG000|Overall Study|Lack of Efficacy|4|||
164202774|NCT00368550|593115190|FG001|Overall Study|Lack of Efficacy|9|||
164202775|NCT00368550|593115189|FG000|Overall Study|Withdrawal by Subject|17|||
164202776|NCT00368550|593115190|FG001|Overall Study|Withdrawal by Subject|10|||
164202777|NCT01401322|593115191|FG000|Overall Study|Withdrawal by Subject|1|||
164202778|NCT01401322|593115191|FG000|Overall Study|Physician Decision|1|||
164202779|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202780|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
164202781|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202782|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202783|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
164202784|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
164202785|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
164202786|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
164202787|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
164202788|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
164202789|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
164202790|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
164202791|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
164202792|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
164202793|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
164202794|NCT03466346|593115194|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
164202795|NCT03466346|593115195|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
164202796|NCT03466346|593115196|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
164202797|NCT03466346|593115197|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
164202798|NCT03466346|593115198|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
164202799|NCT03466346|593115194|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
163868113|NCT02115282|591883833|FG000|Overall Study|Death|1|||
163868114|NCT02115282|591883834|FG001|Overall Study|Death|3|||
163868115|NCT02115282|591883833|FG000|Overall Study|Alternative therapy|1|||
163868116|NCT02115282|591883834|FG001|Overall Study|Alternative therapy|1|||
163868117|NCT02115282|591883833|FG000|Overall Study|Complicating disease|0|||
163868118|NCT02115282|591883834|FG001|Overall Study|Complicating disease|3|||
163868119|NCT02115282|591883833|FG000|Overall Study|Withdrawal by Subject|12|||
163868120|NCT02115282|591883834|FG001|Overall Study|Withdrawal by Subject|10|||
163868121|NCT02115282|591883833|FG000|Overall Study|Symptomatic progression/deterioration|7|||
163868122|NCT02115282|591883834|FG001|Overall Study|Symptomatic progression/deterioration|18|||
163868123|NCT02115282|591883833|FG000|Overall Study|Non-compliance|5|||
163868124|NCT02115282|591883834|FG001|Overall Study|Non-compliance|1|||
163868125|NCT02115282|591883833|FG000|Overall Study|Protocol Violation|2|||
163868126|NCT02115282|591883834|FG001|Overall Study|Protocol Violation|2|||
163868127|NCT02115282|591883833|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
163868128|NCT02115282|591883834|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
163868129|NCT02115282|591883833|FG000|Overall Study|Not start protocol therapy|9|||
163868130|NCT02115282|591883834|FG001|Overall Study|Not start protocol therapy|10|||
163868131|NCT00256243|591883835|FG000|Overall Study|Lost to Follow-up|2|||
163868132|NCT00256243|591883835|FG000|Overall Study|Death|7|||
163868133|NCT00256243|591883835|FG000|Overall Study|Not treated|1|||
163868134|NCT06218251|591883838|FG000|Overall Study|Lost to Follow-up|4|||
163868135|NCT00997386|591883841|FG000|Overall Study|Death|7|||
163868136|NCT03492177|591883847|FG000|Overall Study|Adverse Event|1|||
163868137|NCT03492177|591883848|FG001|Overall Study|Adverse Event|0|||
163868138|NCT03492177|591883849|FG002|Overall Study|Adverse Event|0|||
163868139|NCT03492177|591883847|FG000|Overall Study|Death|3|||
163868140|NCT03492177|591883848|FG001|Overall Study|Death|0|||
163868141|NCT03492177|591883849|FG002|Overall Study|Death|3|||
163868142|NCT03492177|591883847|FG000|Overall Study|Lack of Efficacy|1|||
163868143|NCT03492177|591883848|FG001|Overall Study|Lack of Efficacy|2|||
163868144|NCT03492177|591883849|FG002|Overall Study|Lack of Efficacy|0|||
163868145|NCT03492177|591883847|FG000|Overall Study|Other|1|||
163868146|NCT03492177|591883848|FG001|Overall Study|Other|0|||
163868147|NCT03492177|591883849|FG002|Overall Study|Other|0|||
164202800|NCT03466346|593115195|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
163868148|NCT03492177|591883847|FG000|Overall Study|Ongoing|16|||
163868149|NCT03492177|591883848|FG001|Overall Study|Ongoing|19|||
163868150|NCT03492177|591883849|FG002|Overall Study|Ongoing|17|||
163868151|NCT00617201|591883850|FG000|Overall Study|Lost to Follow-up|9|||
163868152|NCT00617201|591883851|FG001|Overall Study|Lost to Follow-up|13|||
163868153|NCT03723616|591884721|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
163868154|NCT03723616|591884722|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
163868155|NCT03723616|591884723|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
163868156|NCT03723616|591884724|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
164313288|NCT01754402|593524486|FG000|Overall Study|Death|0|||
164313289|NCT01754402|593524487|FG001|Overall Study|Death|0|||
164313290|NCT01754402|593524488|FG002|Overall Study|Death|1|||
164313291|NCT01754402|593524486|FG000|Overall Study|Adverse Event|2|||
164313292|NCT01754402|593524487|FG001|Overall Study|Adverse Event|2|||
164313293|NCT01754402|593524488|FG002|Overall Study|Adverse Event|1|||
164313294|NCT01754402|593524486|FG000|Overall Study|Withdrawal by Subject|0|||
164313295|NCT01754402|593524487|FG001|Overall Study|Withdrawal by Subject|0|||
164313296|NCT01754402|593524488|FG002|Overall Study|Withdrawal by Subject|1|||
164313297|NCT01754402|593524486|FG000|Overall Study|Lack of Efficacy|0|||
164313298|NCT01754402|593524487|FG001|Overall Study|Lack of Efficacy|0|||
164313299|NCT01754402|593524488|FG002|Overall Study|Lack of Efficacy|1|||
164313300|NCT00955305|593524489|FG000|Overall Study|Disease progression|39|||
164313301|NCT00955305|593524490|FG001|Overall Study|Disease progression|41|||
164313302|NCT00955305|593524489|FG000|Overall Study|Adverse Event|22|||
164313303|NCT00955305|593524490|FG001|Overall Study|Adverse Event|22|||
164313304|NCT00955305|593524489|FG000|Overall Study|Death|2|||
164313305|NCT00955305|593524490|FG001|Overall Study|Death|1|||
164313306|NCT00955305|593524489|FG000|Overall Study|Withdrawal by Subject|5|||
164313307|NCT00955305|593524490|FG001|Overall Study|Withdrawal by Subject|4|||
164313308|NCT00955305|593524489|FG000|Overall Study|Alternative therapy|4|||
164313309|NCT00955305|593524490|FG001|Overall Study|Alternative therapy|0|||
164313310|NCT00955305|593524489|FG000|Overall Study|Other complicating disease|2|||
164313311|NCT00955305|593524490|FG001|Overall Study|Other complicating disease|4|||
164313312|NCT00955305|593524489|FG000|Overall Study|Physician Decision|1|||
164313313|NCT00955305|593524490|FG001|Overall Study|Physician Decision|0|||
164313314|NCT00955305|593524489|FG000|Overall Study|Continued presence of residual disease|0|||
164313315|NCT00955305|593524490|FG001|Overall Study|Continued presence of residual disease|1|||
164313316|NCT00955305|593524489|FG000|Overall Study|Functional decline|2|||
164313317|NCT00955305|593524490|FG001|Overall Study|Functional decline|0|||
164313318|NCT00955305|593524489|FG000|Overall Study|Maximum response achieved|0|||
164313319|NCT00955305|593524490|FG001|Overall Study|Maximum response achieved|1|||
164313320|NCT00955305|593524489|FG000|Overall Study|Lost to Follow-up|0|||
164313321|NCT00955305|593524490|FG001|Overall Study|Lost to Follow-up|1|||
164313322|NCT00955305|593524489|FG000|Overall Study|No off-treatment reason submitted|1|||
164313323|NCT00955305|593524490|FG001|Overall Study|No off-treatment reason submitted|0|||
164313324|NCT00955305|593524489|FG000|Overall Study|Never started protocol treatment|5|||
164313325|NCT00955305|593524490|FG001|Overall Study|Never started protocol treatment|5|||
164313326|NCT00955305|593524489|FG000|Overall Study|Ineligible|5|||
164313327|NCT00955305|593524490|FG001|Overall Study|Ineligible|7|||
164313328|NCT01221285|593524491|FG000|Overall Study|Withdrawal by Subject|1|||
164313329|NCT02123251|593524492|FG000|Overall Study|Death|1|||
164313330|NCT02123251|593524493|FG001|Overall Study|Death|1|||
164313331|NCT02123251|593524492|FG000|Overall Study|Withdrawal by Subject|0|||
164313332|NCT02123251|593524493|FG001|Overall Study|Withdrawal by Subject|3|||
164313333|NCT02123251|593524492|FG000|Overall Study|Lost Medicaid eligibility|29|||
164313334|NCT02123251|593524493|FG001|Overall Study|Lost Medicaid eligibility|22|||
164313335|NCT02123251|593524492|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
164313336|NCT02123251|593524493|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
164313337|NCT00375609|593524500|FG000|Overall Study|Did not receive treatment|1|||
164313338|NCT00375609|593524501|FG001|Overall Study|Did not receive treatment|0|||
164313339|NCT00375609|593524502|FG002|Overall Study|Did not receive treatment|0|||
164313340|NCT00375609|593524500|FG000|Overall Study|Adverse Event|0|||
163868157|NCT03723616|591884725|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
163868158|NCT03723616|591884726|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
163868159|NCT00493649|591884729|FG000|Overall Study|Adverse Event|44|||
163868160|NCT00493649|591884729|FG000|Overall Study|Patient Request|21|||
163868161|NCT00493649|591884729|FG000|Overall Study|Investigator Request|2|||
163868162|NCT00493649|591884729|FG000|Overall Study|Disease Progression|1|||
163868163|NCT00493649|591884729|FG000|Overall Study|Lost to Follow-up|1|||
163868164|NCT00493649|591884729|FG000|Overall Study|Other|13|||
163868165|NCT00925899|591884732|FG000|Part 1|Death|1|||
163868166|NCT00925899|591884733|FG001|Part 1|Death|2|||
164313341|NCT00375609|593524501|FG001|Overall Study|Adverse Event|3|||
164313342|NCT00375609|593524502|FG002|Overall Study|Adverse Event|0|||
164313343|NCT00375609|593524500|FG000|Overall Study|Lost to Follow-up|1|||
164313344|NCT00375609|593524501|FG001|Overall Study|Lost to Follow-up|0|||
164313345|NCT00375609|593524502|FG002|Overall Study|Lost to Follow-up|0|||
164313346|NCT00375609|593524500|FG000|Overall Study|Physician Decision|0|||
164313347|NCT00375609|593524501|FG001|Overall Study|Physician Decision|0|||
164313348|NCT00375609|593524502|FG002|Overall Study|Physician Decision|1|||
164313349|NCT00375609|593524500|FG000|Overall Study|Withdrawal by Subject|1|||
164313350|NCT00375609|593524501|FG001|Overall Study|Withdrawal by Subject|4|||
164313351|NCT00375609|593524502|FG002|Overall Study|Withdrawal by Subject|0|||
163868167|NCT00925899|591884732|FG000|Part 1|Withdrawal by Subject|10|||
163868168|NCT00925899|591884733|FG001|Part 1|Withdrawal by Subject|9|||
163868169|NCT00683696|591884734|FG000|Overall Study|Withdrawn due to study closure|337|||
164313352|NCT00375609|593524500|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
164313353|NCT00375609|593524501|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
164313354|NCT00375609|593524502|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
164313355|NCT02338882|593524503|FG000|Overall Study|Death|1|||
164313356|NCT02338882|593524504|FG001|Overall Study|Death|0|||
164313357|NCT02338882|593524503|FG000|Overall Study|Lost to Follow-up|6|||
164313358|NCT02338882|593524504|FG001|Overall Study|Lost to Follow-up|3|||
164313359|NCT02184455|593524505|FG000|Overall Study|Lost to Follow-up|1|||
164313360|NCT02248675|593524512|FG000|Overall Study|Lost to Follow-up|3|||
164313361|NCT02248675|593524513|FG001|Overall Study|Lost to Follow-up|1|||
164313362|NCT00617669|593524514|FG000|Overall Study|Withdrawal by Subject|71|||
164313363|NCT00617669|593524515|FG001|Overall Study|Withdrawal by Subject|77|||
164313364|NCT00617669|593524514|FG000|Overall Study|Lost to Follow-up|3|||
164313365|NCT00617669|593524515|FG001|Overall Study|Lost to Follow-up|2|||
164313366|NCT00617669|593524514|FG000|Overall Study|Adverse Event|87|||
164313367|NCT00617669|593524515|FG001|Overall Study|Adverse Event|76|||
164313368|NCT00617669|593524514|FG000|Overall Study|Protocol Violation|2|||
164313369|NCT00617669|593524515|FG001|Overall Study|Protocol Violation|3|||
164313370|NCT00617669|593524514|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
164313371|NCT00617669|593524515|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
164313372|NCT00617669|593524514|FG000|Overall Study|Patients randomized but not treated|2|||
164313373|NCT00617669|593524515|FG001|Overall Study|Patients randomized but not treated|3|||
164313374|NCT00926029|593524519|FG000|Overall Study|Lost to Follow-up|2|||
164313375|NCT00926029|593524520|FG001|Overall Study|Lost to Follow-up|1|||
164313376|NCT00926029|593524521|FG002|Overall Study|Lost to Follow-up|1|||
164313377|NCT01137604|593524527|FG000|Overall Study|Adverse Event|3|||
164313378|NCT01137604|593524528|FG001|Overall Study|Adverse Event|6|||
164313379|NCT01137604|593524529|FG002|Overall Study|Adverse Event|9|||
164313380|NCT01137604|593524530|FG003|Overall Study|Adverse Event|9|||
164313381|NCT01137604|593524527|FG000|Overall Study|Participant Choice|0|||
164313382|NCT01137604|593524528|FG001|Overall Study|Participant Choice|2|||
164313383|NCT01137604|593524529|FG002|Overall Study|Participant Choice|2|||
164313384|NCT01137604|593524530|FG003|Overall Study|Participant Choice|0|||
164313385|NCT01137604|593524527|FG000|Overall Study|Withdrawal of consent|0|||
164313386|NCT01137604|593524528|FG001|Overall Study|Withdrawal of consent|0|||
164313387|NCT01137604|593524529|FG002|Overall Study|Withdrawal of consent|0|||
164313388|NCT01137604|593524530|FG003|Overall Study|Withdrawal of consent|2|||
164313389|NCT01137604|593524527|FG000|Overall Study|Clinical progression/deterioration|1|||
164313390|NCT01137604|593524528|FG001|Overall Study|Clinical progression/deterioration|2|||
164313391|NCT01137604|593524529|FG002|Overall Study|Clinical progression/deterioration|2|||
164313392|NCT01137604|593524530|FG003|Overall Study|Clinical progression/deterioration|0|||
164313393|NCT00591318|593524531|FG000|Overall Study|Lack of Efficacy|2|||
164313394|NCT00591318|593524532|FG001|Overall Study|Lack of Efficacy|0|||
164313395|NCT00591318|593524531|FG000|Overall Study|Adverse Event|2|||
164313396|NCT00591318|593524532|FG001|Overall Study|Adverse Event|0|||
164313397|NCT01776307|593524533|FG000|Overall Study|Not dosed|0|||
164313398|NCT01776307|593524534|FG001|Overall Study|Not dosed|0|||
164313399|NCT01776307|593524535|FG002|Overall Study|Not dosed|1|||
164313400|NCT00567255|593524536|FG000|Overall Study|Adverse Event|241|||
164313401|NCT00567255|593524537|FG001|Overall Study|Adverse Event|68|||
164313402|NCT00567255|593524536|FG000|Overall Study|Lost to Follow-up|77|||
164313403|NCT00567255|593524537|FG001|Overall Study|Lost to Follow-up|48|||
164313404|NCT00567255|593524536|FG000|Overall Study|Withdrawal by Subject|75|||
164313405|NCT00567255|593524537|FG001|Overall Study|Withdrawal by Subject|56|||
164313406|NCT00567255|593524536|FG000|Overall Study|Lack of Efficacy|19|||
163868170|NCT00683696|591884735|FG001|Overall Study|Withdrawn due to study closure|338|||
163868171|NCT00683696|591884734|FG000|Overall Study|Withdrawn prior to study closure|13|||
163868172|NCT00683696|591884735|FG001|Overall Study|Withdrawn prior to study closure|28|||
163868173|NCT00683696|591884734|FG000|Overall Study|Lost to Follow-up|5|||
163868174|NCT00683696|591884735|FG001|Overall Study|Lost to Follow-up|6|||
163868175|NCT00683696|591884734|FG000|Overall Study|Vital status follow-up only|3|||
163868176|NCT00683696|591884735|FG001|Overall Study|Vital status follow-up only|3|||
163868177|NCT00683696|591884734|FG000|Overall Study|Death|46|||
163868178|NCT00683696|591884735|FG001|Overall Study|Death|30|||
163972224|NCT02752035|592269800|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
164313407|NCT00567255|593524537|FG001|Overall Study|Lack of Efficacy|33|||
164313408|NCT00567255|593524536|FG000|Overall Study|Protocol Violation|20|||
164313409|NCT00567255|593524537|FG001|Overall Study|Protocol Violation|8|||
164313410|NCT00567255|593524536|FG000|Overall Study|Pregnancy|6|||
164313411|NCT00567255|593524537|FG001|Overall Study|Pregnancy|0|||
164313412|NCT00567255|593524536|FG000|Overall Study|Drug noncompliance,moved,other|25|||
164313413|NCT00567255|593524537|FG001|Overall Study|Drug noncompliance,moved,other|15|||
164313414|NCT02657408|593524540|FG000|Overall Study|Adverse Event|3|||
164313415|NCT02657408|593524541|FG001|Overall Study|Adverse Event|7|||
163868179|NCT03648762|591884738|FG000|Overall Study|Lost to Follow-up|1|||
163868180|NCT03648762|591884739|FG001|Overall Study|Lost to Follow-up|2|||
163868181|NCT03648762|591884740|FG002|Overall Study|Lost to Follow-up|0|||
164313416|NCT01403948|593524542|FG000|Overall Study|Progressive disease|0|||
163868182|NCT03648762|591884738|FG000|Overall Study|Withdrawal by Subject|5|||
163868183|NCT03648762|591884739|FG001|Overall Study|Withdrawal by Subject|2|||
163868184|NCT03648762|591884740|FG002|Overall Study|Withdrawal by Subject|1|||
163868185|NCT01662336|591884750|FG000|Overall Study|Adverse Event|1|||
163868186|NCT01662336|591884750|FG000|Overall Study|No longer on LPV/r|30|||
163868187|NCT01662336|591884750|FG000|Overall Study|Other|29|||
164135655|NCT02799095|592861966|FG011|Part A|Death|0|||
163868188|NCT01662336|591884750|FG000|Overall Study|Withdrawal by Subject|6|||
163868189|NCT02189252|591884751|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
163868190|NCT02189252|591884752|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
164135656|NCT02799095|592861967|FG012|Part A|Death|0|||
164135657|NCT02799095|592861968|FG013|Part A|Death|0|||
164135658|NCT02799095|592861969|FG014|Part A|Death|0|||
164135659|NCT02799095|592861970|FG015|Part A|Death|0|||
164135660|NCT02799095|592861971|FG016|Part A|Death|0|||
164135661|NCT02799095|592861955|FG000|Part A|Lost to Follow-up|0|||
164135662|NCT02799095|592861956|FG001|Part A|Lost to Follow-up|1|||
164135663|NCT02799095|592861957|FG002|Part A|Lost to Follow-up|0|||
164135664|NCT02799095|592861958|FG003|Part A|Lost to Follow-up|0|||
164135665|NCT02799095|592861959|FG004|Part A|Lost to Follow-up|0|||
164135666|NCT02799095|592861960|FG005|Part A|Lost to Follow-up|0|||
164135667|NCT02799095|592861961|FG006|Part A|Lost to Follow-up|1|||
164135668|NCT02799095|592861962|FG007|Part A|Lost to Follow-up|0|||
164135669|NCT02799095|592861963|FG008|Part A|Lost to Follow-up|0|||
164135670|NCT02799095|592861964|FG009|Part A|Lost to Follow-up|0|||
164135671|NCT02799095|592861965|FG010|Part A|Lost to Follow-up|0|||
164135672|NCT02799095|592861966|FG011|Part A|Lost to Follow-up|0|||
164135673|NCT02799095|592861967|FG012|Part A|Lost to Follow-up|0|||
164135674|NCT02799095|592861968|FG013|Part A|Lost to Follow-up|0|||
164135675|NCT02799095|592861969|FG014|Part A|Lost to Follow-up|0|||
164135676|NCT02799095|592861970|FG015|Part A|Lost to Follow-up|0|||
164135677|NCT02799095|592861971|FG016|Part A|Lost to Follow-up|0|||
164135678|NCT02799095|592861955|FG000|Part A|Progressive Disease|3|||
164135679|NCT02799095|592861956|FG001|Part A|Progressive Disease|3|||
164135680|NCT02799095|592861957|FG002|Part A|Progressive Disease|3|||
164135681|NCT02799095|592861958|FG003|Part A|Progressive Disease|2|||
164135682|NCT02799095|592861959|FG004|Part A|Progressive Disease|2|||
164135683|NCT02799095|592861960|FG005|Part A|Progressive Disease|0|||
164135684|NCT02799095|592861961|FG006|Part A|Progressive Disease|0|||
164135685|NCT02799095|592861962|FG007|Part A|Progressive Disease|0|||
164135686|NCT02799095|592861963|FG008|Part A|Progressive Disease|0|||
164135687|NCT02799095|592861964|FG009|Part A|Progressive Disease|0|||
164135688|NCT02799095|592861965|FG010|Part A|Progressive Disease|0|||
164135689|NCT02799095|592861966|FG011|Part A|Progressive Disease|0|||
164135690|NCT02799095|592861967|FG012|Part A|Progressive Disease|0|||
164135691|NCT02799095|592861968|FG013|Part A|Progressive Disease|0|||
164135692|NCT02799095|592861969|FG014|Part A|Progressive Disease|0|||
164135693|NCT02799095|592861970|FG015|Part A|Progressive Disease|0|||
164135694|NCT02799095|592861971|FG016|Part A|Progressive Disease|0|||
164135695|NCT02799095|592861955|FG000|Part A|Clinical Progression|1|||
164135696|NCT02799095|592861956|FG001|Part A|Clinical Progression|0|||
164135697|NCT02799095|592861957|FG002|Part A|Clinical Progression|2|||
164135698|NCT02799095|592861958|FG003|Part A|Clinical Progression|1|||
164135699|NCT02799095|592861959|FG004|Part A|Clinical Progression|5|||
164135700|NCT02799095|592861960|FG005|Part A|Clinical Progression|0|||
164135701|NCT02799095|592861961|FG006|Part A|Clinical Progression|0|||
164135702|NCT02799095|592861962|FG007|Part A|Clinical Progression|0|||
164135703|NCT02799095|592861963|FG008|Part A|Clinical Progression|0|||
164135704|NCT02799095|592861964|FG009|Part A|Clinical Progression|0|||
164135705|NCT02799095|592861965|FG010|Part A|Clinical Progression|0|||
164135706|NCT02799095|592861966|FG011|Part A|Clinical Progression|0|||
164135707|NCT02799095|592861967|FG012|Part A|Clinical Progression|0|||
164135708|NCT02799095|592861968|FG013|Part A|Clinical Progression|0|||
164135709|NCT02799095|592861969|FG014|Part A|Clinical Progression|0|||
164135710|NCT02799095|592861970|FG015|Part A|Clinical Progression|0|||
164135711|NCT02799095|592861971|FG016|Part A|Clinical Progression|0|||
164135712|NCT02799095|592861955|FG000|Part A|Protocol Deviation|0|||
164135713|NCT02799095|592861956|FG001|Part A|Protocol Deviation|0|||
164135714|NCT02799095|592861957|FG002|Part A|Protocol Deviation|1|||
164135715|NCT02799095|592861958|FG003|Part A|Protocol Deviation|0|||
164135716|NCT02799095|592861959|FG004|Part A|Protocol Deviation|0|||
164135717|NCT02799095|592861960|FG005|Part A|Protocol Deviation|0|||
164135718|NCT02799095|592861961|FG006|Part A|Protocol Deviation|0|||
164135719|NCT02799095|592861962|FG007|Part A|Protocol Deviation|0|||
164135720|NCT02799095|592861963|FG008|Part A|Protocol Deviation|0|||
164135721|NCT02799095|592861964|FG009|Part A|Protocol Deviation|0|||
164135722|NCT02799095|592861965|FG010|Part A|Protocol Deviation|0|||
164135723|NCT02799095|592861966|FG011|Part A|Protocol Deviation|0|||
164135724|NCT02799095|592861967|FG012|Part A|Protocol Deviation|0|||
164135725|NCT02799095|592861968|FG013|Part A|Protocol Deviation|0|||
164135726|NCT02799095|592861969|FG014|Part A|Protocol Deviation|0|||
164135727|NCT02799095|592861970|FG015|Part A|Protocol Deviation|0|||
163972225|NCT02752035|592269801|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
163972226|NCT02752035|592269802|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
163972227|NCT02752035|592269803|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
163972228|NCT02752035|592269800|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
163972229|NCT02752035|592269801|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
163972230|NCT02752035|592269802|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
163972231|NCT02752035|592269803|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
163972232|NCT02752035|592269800|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
164313417|NCT01403948|593524543|FG001|Overall Study|Progressive disease|2|||
164313418|NCT01403948|593524544|FG002|Overall Study|Progressive disease|2|||
164313419|NCT01403948|593524545|FG003|Overall Study|Progressive disease|4|||
164313420|NCT01403948|593524546|FG004|Overall Study|Progressive disease|2|||
164313421|NCT01403948|593524547|FG005|Overall Study|Progressive disease|6|||
164313422|NCT01403948|593524548|FG006|Overall Study|Progressive disease|2|||
164313423|NCT01403948|593524549|FG007|Overall Study|Progressive disease|4|||
164313424|NCT01403948|593524550|FG008|Overall Study|Progressive disease|5|||
164313425|NCT01403948|593524551|FG009|Overall Study|Progressive disease|5|||
164313426|NCT01403948|593524542|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313427|NCT01403948|593524543|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313428|NCT01403948|593524544|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313429|NCT01403948|593524545|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313430|NCT01403948|593524546|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
164313431|NCT01403948|593524547|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313432|NCT01403948|593524548|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
164313433|NCT01403948|593524549|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313434|NCT01403948|593524550|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
164313435|NCT01403948|593524551|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
164313436|NCT01403948|593524542|FG000|Overall Study|Lost to Follow-up|0|||
164313437|NCT01403948|593524543|FG001|Overall Study|Lost to Follow-up|0|||
164313438|NCT01403948|593524544|FG002|Overall Study|Lost to Follow-up|0|||
164313439|NCT01403948|593524545|FG003|Overall Study|Lost to Follow-up|0|||
164313440|NCT01403948|593524546|FG004|Overall Study|Lost to Follow-up|0|||
164313441|NCT01403948|593524547|FG005|Overall Study|Lost to Follow-up|0|||
164313442|NCT01403948|593524548|FG006|Overall Study|Lost to Follow-up|0|||
164313443|NCT01403948|593524549|FG007|Overall Study|Lost to Follow-up|0|||
164313444|NCT01403948|593524550|FG008|Overall Study|Lost to Follow-up|0|||
164313445|NCT01403948|593524551|FG009|Overall Study|Lost to Follow-up|1|||
164313446|NCT01403948|593524542|FG000|Overall Study|Refused cont. medication|0|||
164313447|NCT01403948|593524543|FG001|Overall Study|Refused cont. medication|0|||
164313448|NCT01403948|593524544|FG002|Overall Study|Refused cont. medication|0|||
164313449|NCT01403948|593524545|FG003|Overall Study|Refused cont. medication|0|||
164313450|NCT01403948|593524546|FG004|Overall Study|Refused cont. medication|1|||
164313451|NCT01403948|593524547|FG005|Overall Study|Refused cont. medication|0|||
164313452|NCT01403948|593524548|FG006|Overall Study|Refused cont. medication|0|||
164313453|NCT01403948|593524549|FG007|Overall Study|Refused cont. medication|0|||
164313454|NCT01403948|593524550|FG008|Overall Study|Refused cont. medication|0|||
164313455|NCT01403948|593524551|FG009|Overall Study|Refused cont. medication|1|||
164313456|NCT01403948|593524542|FG000|Overall Study|other than above|1|||
164313457|NCT01403948|593524543|FG001|Overall Study|other than above|2|||
164313458|NCT01403948|593524544|FG002|Overall Study|other than above|1|||
164313459|NCT01403948|593524545|FG003|Overall Study|other than above|0|||
164313460|NCT01403948|593524546|FG004|Overall Study|other than above|1|||
164313461|NCT01403948|593524547|FG005|Overall Study|other than above|1|||
164313462|NCT01403948|593524548|FG006|Overall Study|other than above|2|||
164313463|NCT01403948|593524549|FG007|Overall Study|other than above|0|||
164313464|NCT01403948|593524550|FG008|Overall Study|other than above|0|||
164313465|NCT01403948|593524551|FG009|Overall Study|other than above|0|||
164313466|NCT02184572|593524552|FG000|Overall Study|Lost to Follow-up|29|||
164313467|NCT02184572|593524553|FG001|Overall Study|Lost to Follow-up|21|||
164313468|NCT02184572|593524552|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
164313469|NCT02184572|593524553|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
163972233|NCT02752035|592269801|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
163972234|NCT02752035|592269802|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
163972235|NCT02752035|592269803|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
163972236|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
164313470|NCT02184572|593524552|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
164313471|NCT02184572|593524553|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
164313472|NCT02184572|593524552|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
164313473|NCT02184572|593524553|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
164313474|NCT02184572|593524552|FG000|Overall Study|Traveling Outside The Country|1|||
164313475|NCT02184572|593524553|FG001|Overall Study|Traveling Outside The Country|0|||
164313476|NCT02184572|593524552|FG000|Overall Study|Withdrawal by Subject|14|||
164313477|NCT02184572|593524553|FG001|Overall Study|Withdrawal by Subject|9|||
164313478|NCT00763698|593524556|FG000|Overall Study|Unsuccessful Implant|5|||
164313479|NCT00763698|593524556|FG000|Overall Study|Death|4|||
164313480|NCT00763698|593524556|FG000|Overall Study|Withdrawal by Subject|1|||
164313481|NCT01459497|593524561|FG000|Overall Study|Inability to meet trial constraints.|1|||
164313482|NCT01459497|593524562|FG001|Overall Study|Inability to meet trial constraints.|0|||
164313483|NCT01459497|593524561|FG000|Overall Study|Physician Decision|1|||
164313484|NCT01459497|593524562|FG001|Overall Study|Physician Decision|1|||
164313485|NCT01459497|593524561|FG000|Overall Study|Hospitalization.|0|||
164313486|NCT01459497|593524562|FG001|Overall Study|Hospitalization.|3|||
164313487|NCT01459497|593524561|FG000|Overall Study|Disease progression.|0|||
164313488|NCT01459497|593524562|FG001|Overall Study|Disease progression.|1|||
164313489|NCT01120717|593524563|FG000|Overall Study|Withdrawal by Subject|11|||
164313490|NCT01120717|593524564|FG001|Overall Study|Withdrawal by Subject|6|||
164313491|NCT01120717|593524563|FG000|Overall Study|Adverse Event|10|||
164313492|NCT01120717|593524564|FG001|Overall Study|Adverse Event|6|||
164313493|NCT01120717|593524563|FG000|Overall Study|Protocol Deviation|2|||
164313494|NCT01120717|593524564|FG001|Overall Study|Protocol Deviation|5|||
164313495|NCT01120717|593524563|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164313496|NCT01120717|593524564|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164313497|NCT01120717|593524563|FG000|Overall Study|Lost to Follow-up|2|||
164313498|NCT01120717|593524564|FG001|Overall Study|Lost to Follow-up|3|||
164313499|NCT01120717|593524563|FG000|Overall Study|Death|3|||
164313500|NCT01120717|593524564|FG001|Overall Study|Death|1|||
164313501|NCT01120717|593524563|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164313502|NCT01120717|593524564|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164313503|NCT02640508|593524569|FG000|Overall Study|Death|19|||
164313504|NCT02640508|593524569|FG000|Overall Study|Withdrawal by Subject|8|||
164313505|NCT02640508|593524569|FG000|Overall Study|Physician Decision|1|||
164313506|NCT02640508|593524569|FG000|Overall Study|Lost to Follow-up|1|||
164313507|NCT00862082|593524570|FG000|Overall Study|Sponsor decision to terminate the study|5|||
164313508|NCT00862082|593524571|FG001|Overall Study|Sponsor decision to terminate the study|0|||
164313509|NCT00862082|593524570|FG000|Overall Study|Withdrawal by Subject|0|||
164313510|NCT00862082|593524571|FG001|Overall Study|Withdrawal by Subject|1|||
164313511|NCT02791763|593524576|FG000|Overall Study|Protocol Violation|0|||
164313512|NCT02791763|593524577|FG001|Overall Study|Protocol Violation|0|||
164313513|NCT02791763|593524578|FG002|Overall Study|Protocol Violation|1|||
164313514|NCT02791763|593524576|FG000|Overall Study|Withdrawal by Subject|5|||
164313515|NCT02791763|593524577|FG001|Overall Study|Withdrawal by Subject|1|||
164313516|NCT02791763|593524578|FG002|Overall Study|Withdrawal by Subject|0|||
164313517|NCT02791763|593524576|FG000|Overall Study|Physician Decision|0|||
164313518|NCT02791763|593524577|FG001|Overall Study|Physician Decision|1|||
164313519|NCT02791763|593524578|FG002|Overall Study|Physician Decision|0|||
164313520|NCT02791763|593524576|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
164313521|NCT02791763|593524577|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
164313522|NCT02791763|593524578|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
164313523|NCT02791763|593524576|FG000|Overall Study|Cancer event|1|||
164313524|NCT02791763|593524577|FG001|Overall Study|Cancer event|3|||
164313525|NCT02791763|593524578|FG002|Overall Study|Cancer event|0|||
164313526|NCT02791763|593524576|FG000|Overall Study|Participant had renal transplant|3|||
164313527|NCT02791763|593524577|FG001|Overall Study|Participant had renal transplant|0|||
164313528|NCT02791763|593524578|FG002|Overall Study|Participant had renal transplant|0|||
164313529|NCT02791763|593524576|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
164313530|NCT02791763|593524577|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
164313531|NCT02791763|593524578|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
164313532|NCT02791763|593524576|FG000|Overall Study|Adverse Event|12|||
164313533|NCT02791763|593524577|FG001|Overall Study|Adverse Event|13|||
163868191|NCT02189252|591884753|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
163868192|NCT02189252|591884754|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
163868193|NCT02189252|591884751|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
163868194|NCT02189252|591884752|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
163868195|NCT02189252|591884753|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
163868196|NCT02189252|591884754|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
163868197|NCT02139046|591884757|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
163868198|NCT02139046|591884758|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
164313534|NCT02791763|593524578|FG002|Overall Study|Adverse Event|7|||
164313535|NCT05334212|593524579|FG000|Overall Study|Study terminated prematurely|7|||
164313536|NCT04534686|593524580|FG000|Baseline Measurement|Lost to Follow-up|4|||
164313537|NCT04534686|593524581|FG001|Baseline Measurement|Lost to Follow-up|6|||
164313538|NCT04534686|593524580|FG000|Baseline Measurement|Withdrawal by Subject|3|||
164313539|NCT04534686|593524581|FG001|Baseline Measurement|Withdrawal by Subject|1|||
164313540|NCT04534686|593524580|FG000|Intervention|Withdrawal by Subject|2|||
164313541|NCT04534686|593524581|FG001|Intervention|Withdrawal by Subject|2|||
164313542|NCT03179605|593524582|FG000|Overall Study|Withdrawal by Subject|1|||
164313543|NCT00910299|593524583|FG000|Overall Study|Withdrawal by Subject|16|||
164313544|NCT00910299|593524584|FG001|Overall Study|Withdrawal by Subject|13|||
164313545|NCT00910299|593524583|FG000|Overall Study|Sponsor Decision|58|||
164313546|NCT00910299|593524584|FG001|Overall Study|Sponsor Decision|60|||
164313547|NCT00910299|593524583|FG000|Overall Study|Didn't receive any study drug|2|||
164313548|NCT00910299|593524584|FG001|Overall Study|Didn't receive any study drug|1|||
164313549|NCT01456897|593524585|FG000|Overall Study|Adverse Event|19|||
164313550|NCT01456897|593524586|FG001|Overall Study|Adverse Event|22|||
164313551|NCT01456897|593524585|FG000|Overall Study|Protocol Violation|3|||
164313552|NCT01456897|593524586|FG001|Overall Study|Protocol Violation|4|||
164313553|NCT01456897|593524585|FG000|Overall Study|Physician Decision|5|||
164313554|NCT01456897|593524586|FG001|Overall Study|Physician Decision|3|||
164313555|NCT01456897|593524585|FG000|Overall Study|Withdrawal by Subject|44|||
164313556|NCT01456897|593524586|FG001|Overall Study|Withdrawal by Subject|17|||
164313557|NCT01456897|593524585|FG000|Overall Study|Lack of Efficacy|4|||
164313558|NCT01456897|593524586|FG001|Overall Study|Lack of Efficacy|11|||
164313559|NCT01396070|593524588|FG000|Overall Study|Withdrawal by Subject|2|||
164313560|NCT01396070|593524588|FG000|Overall Study|Death|2|||
164313561|NCT01396070|593524588|FG000|Overall Study|Adverse Event|8|||
164313562|NCT01396070|593524588|FG000|Overall Study|Physician Decision|3|||
164313563|NCT01396070|593524588|FG000|Overall Study|Lack of Efficacy|4|||
164313564|NCT04535453|593524589|FG000|Overall Study|Death|0|||
164313565|NCT04535453|593524590|FG001|Overall Study|Death|1|||
164313566|NCT04535453|593524591|FG002|Overall Study|Death|0|||
164313567|NCT04535453|593524592|FG003|Overall Study|Death|0|||
164313568|NCT04535453|593524593|FG004|Overall Study|Death|0|||
164313569|NCT04535453|593524594|FG005|Overall Study|Death|0|||
164313570|NCT04535453|593524595|FG006|Overall Study|Death|0|||
164313571|NCT04535453|593524596|FG007|Overall Study|Death|0|||
164313572|NCT04535453|593524597|FG008|Overall Study|Death|0|||
164313573|NCT04535453|593524598|FG009|Overall Study|Death|0|||
164313574|NCT04535453|593524599|FG010|Overall Study|Death|0|||
164313575|NCT04535453|593524600|FG011|Overall Study|Death|0|||
164313576|NCT04535453|593524589|FG000|Overall Study|Lost to Follow-up|1|||
164313577|NCT04535453|593524590|FG001|Overall Study|Lost to Follow-up|1|||
164313578|NCT04535453|593524591|FG002|Overall Study|Lost to Follow-up|1|||
164313579|NCT04535453|593524592|FG003|Overall Study|Lost to Follow-up|0|||
164313580|NCT04535453|593524593|FG004|Overall Study|Lost to Follow-up|3|||
164313581|NCT04535453|593524594|FG005|Overall Study|Lost to Follow-up|1|||
164313582|NCT04535453|593524595|FG006|Overall Study|Lost to Follow-up|0|||
164313583|NCT04535453|593524596|FG007|Overall Study|Lost to Follow-up|0|||
164313584|NCT04535453|593524597|FG008|Overall Study|Lost to Follow-up|1|||
164313585|NCT04535453|593524598|FG009|Overall Study|Lost to Follow-up|1|||
164313586|NCT04535453|593524599|FG010|Overall Study|Lost to Follow-up|0|||
164313587|NCT04535453|593524600|FG011|Overall Study|Lost to Follow-up|0|||
164313588|NCT04535453|593524589|FG000|Overall Study|Physician Decision|0|||
164313589|NCT04535453|593524590|FG001|Overall Study|Physician Decision|0|||
164313590|NCT04535453|593524591|FG002|Overall Study|Physician Decision|0|||
164313591|NCT04535453|593524592|FG003|Overall Study|Physician Decision|1|||
164313592|NCT04535453|593524593|FG004|Overall Study|Physician Decision|0|||
164313593|NCT04535453|593524594|FG005|Overall Study|Physician Decision|0|||
164313594|NCT04535453|593524595|FG006|Overall Study|Physician Decision|0|||
164313595|NCT04535453|593524596|FG007|Overall Study|Physician Decision|0|||
164313596|NCT04535453|593524597|FG008|Overall Study|Physician Decision|0|||
164313597|NCT04535453|593524598|FG009|Overall Study|Physician Decision|0|||
164313598|NCT04535453|593524599|FG010|Overall Study|Physician Decision|0|||
164313599|NCT04535453|593524600|FG011|Overall Study|Physician Decision|0|||
164313600|NCT04535453|593524589|FG000|Overall Study|Withdrawal by Subject|3|||
164313601|NCT04535453|593524590|FG001|Overall Study|Withdrawal by Subject|6|||
164313602|NCT04535453|593524591|FG002|Overall Study|Withdrawal by Subject|3|||
164313603|NCT04535453|593524592|FG003|Overall Study|Withdrawal by Subject|3|||
164313604|NCT04535453|593524593|FG004|Overall Study|Withdrawal by Subject|2|||
164313605|NCT04535453|593524594|FG005|Overall Study|Withdrawal by Subject|1|||
164313606|NCT04535453|593524595|FG006|Overall Study|Withdrawal by Subject|1|||
164313607|NCT04535453|593524596|FG007|Overall Study|Withdrawal by Subject|1|||
164313608|NCT04535453|593524597|FG008|Overall Study|Withdrawal by Subject|1|||
164313609|NCT04535453|593524598|FG009|Overall Study|Withdrawal by Subject|1|||
164313610|NCT04535453|593524599|FG010|Overall Study|Withdrawal by Subject|0|||
164313611|NCT04535453|593524600|FG011|Overall Study|Withdrawal by Subject|1|||
164313612|NCT04535453|593524589|FG000|Overall Study|Other|0|||
164313613|NCT04535453|593524590|FG001|Overall Study|Other|0|||
163972237|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
164313614|NCT04535453|593524591|FG002|Overall Study|Other|1|||
164313615|NCT04535453|593524592|FG003|Overall Study|Other|0|||
164313616|NCT04535453|593524593|FG004|Overall Study|Other|1|||
164313617|NCT04535453|593524594|FG005|Overall Study|Other|0|||
164313618|NCT04535453|593524595|FG006|Overall Study|Other|1|||
164313619|NCT04535453|593524596|FG007|Overall Study|Other|1|||
164313620|NCT04535453|593524597|FG008|Overall Study|Other|1|||
164313621|NCT04535453|593524598|FG009|Overall Study|Other|0|||
164313622|NCT04535453|593524599|FG010|Overall Study|Other|0|||
164313623|NCT04535453|593524600|FG011|Overall Study|Other|0|||
164313624|NCT04530136|593524601|FG000|Overall Study|Lost to Follow-up|2|||
164313625|NCT04530136|593524602|FG001|Overall Study|Lost to Follow-up|3|||
164313626|NCT04530136|593524601|FG000|Overall Study|Withdrawal by Subject|1|||
164313627|NCT04530136|593524602|FG001|Overall Study|Withdrawal by Subject|0|||
164313628|NCT04530136|593524601|FG000|Overall Study|Death|0|||
164313629|NCT04530136|593524602|FG001|Overall Study|Death|1|||
164313630|NCT02878798|593524603|FG000|Overall Study|Withdrawal by Subject|5|||
164313631|NCT02878798|593524604|FG001|Overall Study|Withdrawal by Subject|4|||
164313632|NCT02878798|593524603|FG000|Overall Study|Lost to Follow-up|2|||
164313633|NCT02878798|593524604|FG001|Overall Study|Lost to Follow-up|2|||
164313634|NCT02878798|593524603|FG000|Overall Study|Protocol Violation|0|||
164313635|NCT02878798|593524604|FG001|Overall Study|Protocol Violation|1|||
164313636|NCT02762370|593524607|FG000|Overall Study|Protocol Violation|1|||
164313637|NCT02762370|593524608|FG001|Overall Study|Protocol Violation|0|||
164313638|NCT01708902|593524612|FG000|Overall Study|Adverse Event|3|||
164313639|NCT01708902|593524613|FG001|Overall Study|Adverse Event|4|||
164313640|NCT01708902|593524614|FG002|Overall Study|Adverse Event|9|||
164313641|NCT01708902|593524615|FG003|Overall Study|Adverse Event|2|||
164313642|NCT01708902|593524616|FG004|Overall Study|Adverse Event|7|||
164313643|NCT01708902|593524617|FG005|Overall Study|Adverse Event|3|||
164313644|NCT01708902|593524618|FG006|Overall Study|Adverse Event|5|||
164313645|NCT01708902|593524612|FG000|Overall Study|Lack of Efficacy|3|||
164313646|NCT01708902|593524613|FG001|Overall Study|Lack of Efficacy|1|||
164313647|NCT01708902|593524614|FG002|Overall Study|Lack of Efficacy|0|||
164313648|NCT01708902|593524615|FG003|Overall Study|Lack of Efficacy|0|||
164313649|NCT01708902|593524616|FG004|Overall Study|Lack of Efficacy|0|||
164313650|NCT01708902|593524617|FG005|Overall Study|Lack of Efficacy|1|||
164313651|NCT01708902|593524618|FG006|Overall Study|Lack of Efficacy|0|||
164313652|NCT01708902|593524612|FG000|Overall Study|Non compliance with protocol|0|||
164313653|NCT01708902|593524613|FG001|Overall Study|Non compliance with protocol|2|||
164313654|NCT01708902|593524614|FG002|Overall Study|Non compliance with protocol|1|||
164313655|NCT01708902|593524615|FG003|Overall Study|Non compliance with protocol|3|||
164313656|NCT01708902|593524616|FG004|Overall Study|Non compliance with protocol|0|||
164313657|NCT01708902|593524617|FG005|Overall Study|Non compliance with protocol|0|||
164313658|NCT01708902|593524618|FG006|Overall Study|Non compliance with protocol|0|||
164313659|NCT01708902|593524612|FG000|Overall Study|Lost to Follow-up|2|||
164313660|NCT01708902|593524613|FG001|Overall Study|Lost to Follow-up|1|||
164313661|NCT01708902|593524614|FG002|Overall Study|Lost to Follow-up|2|||
164313662|NCT01708902|593524615|FG003|Overall Study|Lost to Follow-up|2|||
164313663|NCT01708902|593524616|FG004|Overall Study|Lost to Follow-up|0|||
164313664|NCT01708902|593524617|FG005|Overall Study|Lost to Follow-up|0|||
164313665|NCT01708902|593524618|FG006|Overall Study|Lost to Follow-up|1|||
164313666|NCT01708902|593524612|FG000|Overall Study|Refused to continue trial medication|8|||
164313667|NCT01708902|593524613|FG001|Overall Study|Refused to continue trial medication|0|||
164313668|NCT01708902|593524614|FG002|Overall Study|Refused to continue trial medication|4|||
164313669|NCT01708902|593524615|FG003|Overall Study|Refused to continue trial medication|2|||
164313670|NCT01708902|593524616|FG004|Overall Study|Refused to continue trial medication|8|||
164313671|NCT01708902|593524617|FG005|Overall Study|Refused to continue trial medication|1|||
164313672|NCT01708902|593524618|FG006|Overall Study|Refused to continue trial medication|1|||
164313673|NCT01708902|593524612|FG000|Overall Study|Other Reason|1|||
164313674|NCT01708902|593524613|FG001|Overall Study|Other Reason|0|||
164313675|NCT01708902|593524614|FG002|Overall Study|Other Reason|1|||
163868199|NCT02139046|591884759|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
163868200|NCT02139046|591884760|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
163868201|NCT02139046|591884761|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
164202801|NCT03466346|593115196|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
164202802|NCT03466346|593115197|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
164202803|NCT03466346|593115198|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
164202804|NCT03466346|593115194|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
164202805|NCT03466346|593115195|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
164202806|NCT03466346|593115196|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
164313676|NCT01708902|593524615|FG003|Overall Study|Other Reason|1|||
164313677|NCT01708902|593524616|FG004|Overall Study|Other Reason|1|||
164313678|NCT01708902|593524617|FG005|Overall Study|Other Reason|2|||
164313679|NCT01708902|593524618|FG006|Overall Study|Other Reason|0|||
164313680|NCT01136785|593524622|FG000|Overall Study|Protocol Violation|2|||
164313681|NCT01136785|593524623|FG001|Overall Study|Protocol Violation|1|||
164313682|NCT02873429|593524624|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
164313683|NCT02873429|593524625|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
164313684|NCT02873429|593524624|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
164313685|NCT02873429|593524625|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
164313686|NCT02873429|593524624|FG000|16 Weeks|Lost to Follow-up|3|||
164313687|NCT02873429|593524625|FG001|16 Weeks|Lost to Follow-up|0|||
164313688|NCT00612807|593524626|FG000|Overall Study|Withdrawal by Subject|2|||
164313689|NCT00612807|593524627|FG001|Overall Study|Withdrawal by Subject|0|||
163868202|NCT02139046|591884757|FG000|Overall Study|Major Protocol Deviation|9|||
164313690|NCT01516034|593524628|FG000|Overall Study|Physician Decision|1|||
164313691|NCT01516034|593524628|FG000|Overall Study|Lack of Efficacy|7|||
164313692|NCT00472030|593524632|FG000|Overall Study|Physician Decision|1|||
164313693|NCT00472030|593524633|FG001|Overall Study|Physician Decision|0|||
164313694|NCT00829504|593524634|FG000|First Intervention|Adverse Event|1|||
164313695|NCT00829504|593524635|FG001|First Intervention|Adverse Event|0|||
164313696|NCT00829504|593524634|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164313697|NCT00829504|593524635|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164313698|NCT00829504|593524634|FG000|Second Intervention|Physician Decision|1|||
164313699|NCT00829504|593524635|FG001|Second Intervention|Physician Decision|0|||
164313700|NCT05564052|593524636|FG000|Overall Study|Withdrawal by Subject|0|||
164313701|NCT05564052|593524637|FG001|Overall Study|Withdrawal by Subject|0|||
164313702|NCT05564052|593524638|FG002|Overall Study|Withdrawal by Subject|0|||
164313703|NCT05564052|593524639|FG003|Overall Study|Withdrawal by Subject|1|||
164313704|NCT03745820|593525992|FG000|Overall Study|Adverse Event|0|||
164313705|NCT03745820|593525993|FG001|Overall Study|Adverse Event|3|||
164313706|NCT03745820|593525994|FG002|Overall Study|Adverse Event|2|||
164313707|NCT03745820|593525992|FG000|Overall Study|Non-Compliance with Study Drug|4|||
164313708|NCT03745820|593525993|FG001|Overall Study|Non-Compliance with Study Drug|3|||
164313709|NCT03745820|593525994|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164313710|NCT03745820|593525992|FG000|Overall Study|Withdrawal by Subject|4|||
164313711|NCT03745820|593525993|FG001|Overall Study|Withdrawal by Subject|4|||
164313712|NCT03745820|593525994|FG002|Overall Study|Withdrawal by Subject|4|||
164313713|NCT03745820|593525992|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
164313714|NCT03745820|593525993|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
164313715|NCT03745820|593525994|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
164313716|NCT03745820|593525992|FG000|Overall Study|Lost to Follow-up|2|||
164313717|NCT03745820|593525993|FG001|Overall Study|Lost to Follow-up|0|||
164313718|NCT03745820|593525994|FG002|Overall Study|Lost to Follow-up|3|||
164313719|NCT03745820|593525992|FG000|Overall Study|Reason not Specified|2|||
164313720|NCT03745820|593525993|FG001|Overall Study|Reason not Specified|4|||
164313721|NCT03745820|593525994|FG002|Overall Study|Reason not Specified|1|||
164313722|NCT02151773|593525995|FG000|Overall Study|Protocol Deviation|64|||
164313723|NCT03680742|593525996|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
164313724|NCT02894502|593525999|FG000|Baseline|Withdrawal by Subject|24|||
164313725|NCT02894502|593526000|FG001|Baseline|Withdrawal by Subject|31|||
164313726|NCT02894502|593526001|FG002|Baseline|Withdrawal by Subject|36|||
164313727|NCT02894502|593525999|FG000|Baseline|Death|3|||
164313728|NCT02894502|593526000|FG001|Baseline|Death|1|||
164313729|NCT02894502|593526001|FG002|Baseline|Death|9|||
164313730|NCT02894502|593525999|FG000|First Follow up|Withdrawal by Subject|32|||
164313731|NCT02894502|593526000|FG001|First Follow up|Withdrawal by Subject|29|||
164313732|NCT02894502|593526001|FG002|First Follow up|Withdrawal by Subject|37|||
164313733|NCT02894502|593525999|FG000|First Follow up|Death|2|||
164313734|NCT02894502|593526000|FG001|First Follow up|Death|2|||
164313735|NCT02894502|593526001|FG002|First Follow up|Death|3|||
164313736|NCT02894502|593525999|FG000|Second Follow up|Withdrawal by Subject|13|||
164313737|NCT02894502|593526000|FG001|Second Follow up|Withdrawal by Subject|15|||
164313738|NCT02894502|593526001|FG002|Second Follow up|Withdrawal by Subject|13|||
164313739|NCT02894502|593525999|FG000|Second Follow up|Death|2|||
164313740|NCT02894502|593526000|FG001|Second Follow up|Death|3|||
164313741|NCT02894502|593526001|FG002|Second Follow up|Death|1|||
164313742|NCT02894502|593525999|FG000|Third Follow up|Withdrawal by Subject|5|||
164313743|NCT02894502|593526000|FG001|Third Follow up|Withdrawal by Subject|6|||
164313744|NCT02894502|593526001|FG002|Third Follow up|Withdrawal by Subject|3|||
164313745|NCT02894502|593525999|FG000|Third Follow up|Death|1|||
164313746|NCT02894502|593526000|FG001|Third Follow up|Death|1|||
164313747|NCT02894502|593526001|FG002|Third Follow up|Death|0|||
164313748|NCT01410357|593526002|FG000|Overall Study|Death|2|||
164313749|NCT01410357|593526003|FG001|Overall Study|Death|1|||
164313750|NCT01410357|593526002|FG000|Overall Study|Withdrawal by Subject|1|||
164313751|NCT01410357|593526003|FG001|Overall Study|Withdrawal by Subject|2|||
164313752|NCT01410357|593526002|FG000|Overall Study|Lost to Follow-up|23|||
164313753|NCT01410357|593526003|FG001|Overall Study|Lost to Follow-up|21|||
164313754|NCT04250077|593526011|FG000|Overall Study|Withdrawal by Subject|0|||
163972238|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
163972239|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
164313755|NCT04250077|593526012|FG001|Overall Study|Withdrawal by Subject|1|||
164313756|NCT04250077|593526013|FG002|Overall Study|Withdrawal by Subject|0|||
164313757|NCT04250077|593526011|FG000|Overall Study|Lost to Follow-up|2|||
164313758|NCT04250077|593526012|FG001|Overall Study|Lost to Follow-up|3|||
163972240|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
164313759|NCT04250077|593526013|FG002|Overall Study|Lost to Follow-up|0|||
164313760|NCT03700684|593526014|FG000|Overall Study|COVID-19|0|||
164313761|NCT03700684|593526015|FG001|Overall Study|COVID-19|0|||
164313762|NCT03700684|593526016|FG002|Overall Study|COVID-19|2|||
164313763|NCT02471612|593526017|FG000|Overall Study|Lost to Follow-up|2|||
164313764|NCT01598129|593526020|FG000|Overall Study|Disease progression|6|||
163972241|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
163972242|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
163972243|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
163972244|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
163972245|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
163972246|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
163972247|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
163972248|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
163972249|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
163972250|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
163972251|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
163972252|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
163972253|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
163972254|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
163972255|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
163972256|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Death|0|||
163972257|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Death|25|||
163972258|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Death|13|||
163972259|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Death|4|||
163972260|NCT02752035|592269800|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
163972261|NCT02752035|592269801|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
163972262|NCT02752035|592269802|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
164202807|NCT03466346|593115197|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
164202808|NCT03466346|593115198|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
164202809|NCT03466346|593115194|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
164202810|NCT03466346|593115195|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
164202811|NCT03466346|593115196|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
164202812|NCT03466346|593115197|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
164202813|NCT03466346|593115198|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
164202814|NCT02410629|593115200|FG000|Overall Study|Family cannot commit to the study|2|||
164202815|NCT02410629|593115201|FG001|Overall Study|Family cannot commit to the study|1|||
164202816|NCT02410629|593115200|FG000|Overall Study|Subject returned to work|1|||
164202817|NCT02410629|593115201|FG001|Overall Study|Subject returned to work|0|||
164202818|NCT02410629|593115200|FG000|Overall Study|Subject moved back to home country|0|||
164202819|NCT02410629|593115201|FG001|Overall Study|Subject moved back to home country|1|||
164202820|NCT02410629|593115200|FG000|Overall Study|Subject underwent heart surgery|0|||
164202821|NCT02410629|593115201|FG001|Overall Study|Subject underwent heart surgery|1|||
164202822|NCT01670292|593115202|FG000|Overall Study|Lost to Follow-up|14|||
164202823|NCT00087178|593115203|FG000|Overall Study|No follow up data|5|||
164202824|NCT00087178|593115204|FG001|Overall Study|No follow up data|15|||
164202825|NCT00087178|593115203|FG000|Overall Study|No clinical assessment|1|||
164202826|NCT00087178|593115204|FG001|Overall Study|No clinical assessment|2|||
164202827|NCT00087178|593115203|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
164202828|NCT00087178|593115204|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
164202829|NCT01692119|593115209|FG000|Overall Study|Protocol Violation|3|||
164202830|NCT01692119|593115210|FG001|Overall Study|Protocol Violation|1|||
164202831|NCT01692119|593115209|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
164202832|NCT01692119|593115210|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
164202833|NCT03451045|593115211|FG000|Overall Study|Lack of Efficacy|3|||
164202834|NCT03451045|593115212|FG001|Overall Study|Lack of Efficacy|2|||
164202835|NCT03451045|593115213|FG002|Overall Study|Lack of Efficacy|2|||
164202836|NCT03451045|593115211|FG000|Overall Study|Physician Decision|1|||
164202837|NCT03451045|593115212|FG001|Overall Study|Physician Decision|1|||
164202838|NCT03451045|593115213|FG002|Overall Study|Physician Decision|1|||
164202839|NCT03451045|593115211|FG000|Overall Study|Withdrawal by Subject|4|||
164202840|NCT03451045|593115212|FG001|Overall Study|Withdrawal by Subject|0|||
164202841|NCT03451045|593115213|FG002|Overall Study|Withdrawal by Subject|5|||
164202842|NCT03451045|593115211|FG000|Overall Study|Pregnancy|0|||
164202843|NCT03451045|593115212|FG001|Overall Study|Pregnancy|0|||
164202844|NCT03451045|593115213|FG002|Overall Study|Pregnancy|2|||
164313765|NCT01598129|593526020|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
163972263|NCT02752035|592269803|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
164202845|NCT03451045|593115211|FG000|Overall Study|Adverse Event|7|||
164202846|NCT03451045|593115212|FG001|Overall Study|Adverse Event|1|||
164202847|NCT03451045|593115213|FG002|Overall Study|Adverse Event|3|||
164202848|NCT03451045|593115211|FG000|Overall Study|Non-compliance with study|2|||
164202849|NCT03451045|593115212|FG001|Overall Study|Non-compliance with study|0|||
164202850|NCT03451045|593115213|FG002|Overall Study|Non-compliance with study|1|||
164202851|NCT03451045|593115211|FG000|Overall Study|any other reason|10|||
164202852|NCT03451045|593115212|FG001|Overall Study|any other reason|2|||
164313766|NCT01598129|593526020|FG000|Overall Study|Withdrawal by Subject|1|||
164313767|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
164313768|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
164313769|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
164313770|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
164313771|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
164313772|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
164313773|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
164313774|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
164202853|NCT03451045|593115213|FG002|Overall Study|any other reason|13|||
164202854|NCT00863707|593115214|FG000|Overall Study|Randomized, but drug not received|4|||
164202855|NCT00863707|593115215|FG001|Overall Study|Randomized, but drug not received|3|||
164202856|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
163868203|NCT02139046|591884758|FG001|Overall Study|Major Protocol Deviation|10|||
163868204|NCT02139046|591884759|FG002|Overall Study|Major Protocol Deviation|16|||
163868205|NCT02139046|591884760|FG003|Overall Study|Major Protocol Deviation|12|||
163868206|NCT02139046|591884761|FG004|Overall Study|Major Protocol Deviation|6|||
163868207|NCT02139046|591884757|FG000|Overall Study|Lost to Follow-up|13|||
164202857|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
164202858|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
164202859|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
164202860|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
164202861|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
164202862|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
164202863|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
164202864|NCT03040726|593115222|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
164202865|NCT03040726|593115223|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
164202866|NCT00062166|593115224|FG000|Overall Study|Withdrawal by Subject|6|||
164202867|NCT05063448|593115225|FG000|Overall Study|Withdrawal by Subject|1|||
164202868|NCT06494761|593115229|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
164202869|NCT06494761|593115229|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
164202870|NCT04865289|593115230|FG000|Overall Study|Death|34|||
164202871|NCT04865289|593115231|FG001|Overall Study|Death|25|||
164202872|NCT04865289|593115230|FG000|Overall Study|Physician Decision|27|||
164202873|NCT04865289|593115231|FG001|Overall Study|Physician Decision|27|||
164202874|NCT04865289|593115230|FG000|Overall Study|Sponsor Decision|11|||
164202875|NCT04865289|593115231|FG001|Overall Study|Sponsor Decision|1|||
164202876|NCT04865289|593115230|FG000|Overall Study|Withdrawal by Subject|2|||
164202877|NCT04865289|593115231|FG001|Overall Study|Withdrawal by Subject|3|||
164202878|NCT03104374|593115232|FG000|Period 1|Adverse Event|7|||
164202879|NCT03104374|593115233|FG001|Period 1|Adverse Event|7|||
164202880|NCT03104374|593115234|FG002|Period 1|Adverse Event|12|||
164202881|NCT03104374|593115235|FG003|Period 1|Adverse Event|14|||
164202882|NCT03104374|593115232|FG000|Period 1|Withdrawal by Subject|18|||
164202883|NCT03104374|593115233|FG001|Period 1|Withdrawal by Subject|9|||
164202884|NCT03104374|593115234|FG002|Period 1|Withdrawal by Subject|10|||
164202885|NCT03104374|593115235|FG003|Period 1|Withdrawal by Subject|17|||
164202886|NCT03104374|593115232|FG000|Period 1|Lost to Follow-up|4|||
164202887|NCT03104374|593115233|FG001|Period 1|Lost to Follow-up|4|||
164202888|NCT03104374|593115234|FG002|Period 1|Lost to Follow-up|6|||
164202889|NCT03104374|593115235|FG003|Period 1|Lost to Follow-up|8|||
163868208|NCT02139046|591884758|FG001|Overall Study|Lost to Follow-up|16|||
163868209|NCT02139046|591884759|FG002|Overall Study|Lost to Follow-up|16|||
163868210|NCT02139046|591884760|FG003|Overall Study|Lost to Follow-up|18|||
163868211|NCT02139046|591884761|FG004|Overall Study|Lost to Follow-up|13|||
163868212|NCT02139046|591884757|FG000|Overall Study|Voluntary Withdrawal|20|||
163868213|NCT02139046|591884758|FG001|Overall Study|Voluntary Withdrawal|8|||
163868214|NCT02139046|591884759|FG002|Overall Study|Voluntary Withdrawal|10|||
163868215|NCT02139046|591884760|FG003|Overall Study|Voluntary Withdrawal|15|||
163868216|NCT02139046|591884761|FG004|Overall Study|Voluntary Withdrawal|16|||
163868217|NCT02139046|591884757|FG000|Overall Study|Lack of Efficacy|0|||
163868218|NCT02139046|591884758|FG001|Overall Study|Lack of Efficacy|1|||
163868219|NCT02139046|591884759|FG002|Overall Study|Lack of Efficacy|2|||
163972264|NCT02752035|592269800|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
163972265|NCT02752035|592269801|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
164202890|NCT03104374|593115232|FG000|Period 1|Lack of Efficacy|6|||
163868220|NCT02139046|591884760|FG003|Overall Study|Lack of Efficacy|1|||
163868221|NCT02139046|591884761|FG004|Overall Study|Lack of Efficacy|2|||
163868222|NCT02139046|591884757|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
164202891|NCT03104374|593115233|FG001|Period 1|Lack of Efficacy|7|||
164202892|NCT03104374|593115234|FG002|Period 1|Lack of Efficacy|12|||
164202893|NCT03104374|593115235|FG003|Period 1|Lack of Efficacy|6|||
163868223|NCT02139046|591884758|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
163868224|NCT02139046|591884759|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
163868225|NCT02139046|591884760|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
163868226|NCT02139046|591884761|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
163868227|NCT02139046|591884757|FG000|Overall Study|Other Miscellaneous Reasons|10|||
163868228|NCT02139046|591884758|FG001|Overall Study|Other Miscellaneous Reasons|9|||
163868229|NCT02139046|591884759|FG002|Overall Study|Other Miscellaneous Reasons|4|||
163868230|NCT02139046|591884760|FG003|Overall Study|Other Miscellaneous Reasons|9|||
163868231|NCT02139046|591884761|FG004|Overall Study|Other Miscellaneous Reasons|12|||
163868232|NCT00818454|591884762|FG000|Treatment Period 1|Adverse Event|0|||
163868233|NCT00818454|591884763|FG001|Treatment Period 1|Adverse Event|1|||
163972266|NCT02752035|592269802|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
164202894|NCT03104374|593115232|FG000|Period 1|Other|2|||
164202895|NCT03104374|593115233|FG001|Period 1|Other|2|||
164202896|NCT03104374|593115234|FG002|Period 1|Other|4|||
164202897|NCT03104374|593115235|FG003|Period 1|Other|7|||
164202898|NCT03104374|593115232|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
164202899|NCT03104374|593115233|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
164202900|NCT03104374|593115234|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
164202901|NCT03104374|593115235|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
164202902|NCT03104374|593115232|FG000|Period 2|Adverse Event|4|||
164202903|NCT03104374|593115233|FG001|Period 2|Adverse Event|7|||
164202904|NCT03104374|593115234|FG002|Period 2|Adverse Event|10|||
164202905|NCT03104374|593115235|FG003|Period 2|Adverse Event|10|||
164202906|NCT03104374|593115232|FG000|Period 2|Withdrawal by Subject|3|||
164202907|NCT03104374|593115233|FG001|Period 2|Withdrawal by Subject|7|||
164202908|NCT03104374|593115234|FG002|Period 2|Withdrawal by Subject|13|||
164202909|NCT03104374|593115235|FG003|Period 2|Withdrawal by Subject|16|||
164202910|NCT03104374|593115232|FG000|Period 2|Lost to Follow-up|2|||
164202911|NCT03104374|593115233|FG001|Period 2|Lost to Follow-up|2|||
164202912|NCT03104374|593115234|FG002|Period 2|Lost to Follow-up|3|||
164202913|NCT03104374|593115235|FG003|Period 2|Lost to Follow-up|5|||
164202914|NCT03104374|593115232|FG000|Period 2|Lack of Efficacy|2|||
164202915|NCT03104374|593115233|FG001|Period 2|Lack of Efficacy|4|||
164202916|NCT03104374|593115234|FG002|Period 2|Lack of Efficacy|7|||
164202917|NCT03104374|593115235|FG003|Period 2|Lack of Efficacy|4|||
164202918|NCT03104374|593115232|FG000|Period 2|COVID-19 Infection|0|||
164202919|NCT03104374|593115233|FG001|Period 2|COVID-19 Infection|0|||
164202920|NCT03104374|593115234|FG002|Period 2|COVID-19 Infection|1|||
164202921|NCT03104374|593115235|FG003|Period 2|COVID-19 Infection|0|||
164202922|NCT03104374|593115232|FG000|Period 2|Other|3|||
164202923|NCT03104374|593115233|FG001|Period 2|Other|2|||
164202924|NCT03104374|593115234|FG002|Period 2|Other|2|||
164202925|NCT03104374|593115235|FG003|Period 2|Other|4|||
164202926|NCT00803179|593115236|FG000|Overall Study|Lost to Follow-up|3|||
164202927|NCT00885118|593115237|FG000|Overall Study|Adverse Event|1|||
164202928|NCT00885118|593115238|FG001|Overall Study|Adverse Event|0|||
164202929|NCT00885118|593115239|FG002|Overall Study|Adverse Event|0|||
164202930|NCT00885118|593115240|FG003|Overall Study|Adverse Event|0|||
164202931|NCT00885118|593115241|FG004|Overall Study|Adverse Event|0|||
164202932|NCT00885118|593115237|FG000|Overall Study|Withdrawal by Subject|0|||
164202933|NCT00885118|593115238|FG001|Overall Study|Withdrawal by Subject|0|||
164202934|NCT00885118|593115239|FG002|Overall Study|Withdrawal by Subject|0|||
164202935|NCT00885118|593115240|FG003|Overall Study|Withdrawal by Subject|0|||
164202936|NCT00885118|593115241|FG004|Overall Study|Withdrawal by Subject|1|||
164202937|NCT00885118|593115237|FG000|Overall Study|Other reason not defined above|0|||
164202938|NCT00885118|593115238|FG001|Overall Study|Other reason not defined above|0|||
164202939|NCT00885118|593115239|FG002|Overall Study|Other reason not defined above|1|||
164202940|NCT00885118|593115240|FG003|Overall Study|Other reason not defined above|0|||
164202941|NCT00885118|593115241|FG004|Overall Study|Other reason not defined above|0|||
164202942|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
164202943|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
164202944|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
164202945|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
164202946|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
164202947|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
164202948|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
164202949|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164202950|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164202951|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
164202952|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
164202953|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
164202954|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
164202955|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
164202956|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
164202957|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
164202958|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
164202959|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164202960|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164202961|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
164202962|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
164202963|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
164202964|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164202965|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164202966|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
164202967|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
164202968|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
164202969|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
164202970|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
164202971|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
164202972|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
164202973|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
164202974|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
164202975|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
164202976|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
164202977|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
164202978|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
164202979|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
164202980|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
164202981|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
164202982|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
164202983|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202984|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202985|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202986|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
164202987|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
164202988|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
164202989|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
164202990|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
164202991|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
164202992|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
164202993|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
164202994|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
164202995|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
164202996|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
164202997|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
164202998|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164202999|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164203000|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164203001|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
164203002|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
164203003|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203004|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203005|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203006|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
164203007|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203008|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
164203009|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203010|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203011|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
164203012|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
164203013|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
164203014|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
164203015|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
164203016|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
164302986|NCT01198977|593484680|FG000|Overall Study|Lost to Follow-up|1|||
163868234|NCT00818454|591884764|FG002|Treatment Period 1|Adverse Event|0|||
163868235|NCT00818454|591884765|FG003|Treatment Period 1|Adverse Event|0|||
163868236|NCT00818454|591884762|FG000|Treatment Period 1|Other|3|||
163868237|NCT00818454|591884763|FG001|Treatment Period 1|Other|0|||
163868238|NCT00818454|591884764|FG002|Treatment Period 1|Other|0|||
163868239|NCT00818454|591884765|FG003|Treatment Period 1|Other|0|||
163868240|NCT00818454|591884762|FG000|Washout Period of 1 Week|Adverse Event|1|||
164203017|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203018|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
164203019|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203020|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203021|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
164203022|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
164203023|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203024|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203025|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203026|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
164203027|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203028|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
164203029|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203030|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203031|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
164203032|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
164203033|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
163868241|NCT00818454|591884763|FG001|Washout Period of 1 Week|Adverse Event|1|||
163868242|NCT00818454|591884764|FG002|Washout Period of 1 Week|Adverse Event|0|||
163868243|NCT00818454|591884765|FG003|Washout Period of 1 Week|Adverse Event|0|||
164203034|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164203035|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164203036|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
164203037|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164203038|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
164203039|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164203040|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
164203041|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
163868244|NCT00818454|591884762|FG000|Washout Period of 1 Week|Protocol Violation|2|||
163868245|NCT00818454|591884763|FG001|Washout Period of 1 Week|Protocol Violation|0|||
163868246|NCT00818454|591884764|FG002|Washout Period of 1 Week|Protocol Violation|0|||
163868247|NCT00818454|591884765|FG003|Washout Period of 1 Week|Protocol Violation|0|||
163868248|NCT00818454|591884762|FG000|Washout Period of 1 Week|Other|1|||
163868249|NCT00818454|591884763|FG001|Washout Period of 1 Week|Other|2|||
163868250|NCT00818454|591884764|FG002|Washout Period of 1 Week|Other|0|||
163868251|NCT00818454|591884765|FG003|Washout Period of 1 Week|Other|0|||
163868252|NCT00818454|591884762|FG000|Treatment Period 2|Other|2|||
163868253|NCT00818454|591884763|FG001|Treatment Period 2|Other|1|||
163868254|NCT00818454|591884764|FG002|Treatment Period 2|Other|0|||
163868255|NCT00818454|591884765|FG003|Treatment Period 2|Other|0|||
163868256|NCT00818454|591884762|FG000|Treatment Period 3|Adverse Event|0|||
163868257|NCT00818454|591884763|FG001|Treatment Period 3|Adverse Event|0|||
163868258|NCT00818454|591884764|FG002|Treatment Period 3|Adverse Event|0|||
163868259|NCT00818454|591884765|FG003|Treatment Period 3|Adverse Event|1|||
163868260|NCT03454529|591884770|FG000|Overall Study|Did not receive treatment|6|||
163868261|NCT03454529|591884770|FG000|Overall Study|Received < 80% doses|1|||
163868262|NCT01040689|591884775|FG000|Overall Study|Adverse Event|0|||
163868263|NCT01040689|591884776|FG001|Overall Study|Adverse Event|0|||
163868264|NCT01040689|591884777|FG002|Overall Study|Adverse Event|2|||
163868265|NCT01040689|591884778|FG003|Overall Study|Adverse Event|4|||
163868266|NCT01040689|591884775|FG000|Overall Study|Lack of Efficacy|0|||
164203042|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
164203043|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203044|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203045|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203046|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
164203047|NCT02717195|593115248|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
163868267|NCT01040689|591884776|FG001|Overall Study|Lack of Efficacy|0|||
163868268|NCT01040689|591884777|FG002|Overall Study|Lack of Efficacy|1|||
163868269|NCT01040689|591884778|FG003|Overall Study|Lack of Efficacy|0|||
164203048|NCT02717195|593115249|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164203049|NCT02717195|593115250|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
163972267|NCT02752035|592269803|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
163972268|NCT02752035|592269800|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
163972269|NCT02752035|592269801|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
163972270|NCT02752035|592269802|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
163972271|NCT02752035|592269803|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
163972272|NCT02752035|592269800|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
163972273|NCT02752035|592269801|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
163972274|NCT02752035|592269802|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
163972275|NCT02752035|592269803|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
163972276|NCT02752035|592269800|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
163972277|NCT02752035|592269801|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
163972278|NCT02752035|592269802|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
163972279|NCT02752035|592269803|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
163972280|NCT03668600|592269808|FG000|Overall Study|Study Terminated by the Sponsor|157|||
163972281|NCT03668600|592269808|FG000|Overall Study|Protocol Violation|1|||
163972282|NCT03668600|592269808|FG000|Overall Study|Pregnancy|1|||
163972283|NCT03668600|592269808|FG000|Overall Study|Lost to Follow-up|7|||
164313775|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
164313776|NCT00647270|593526021|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
164313777|NCT00647270|593526022|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
164313778|NCT00647270|593526023|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
164313779|NCT00647270|593526021|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
164313780|NCT00647270|593526022|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
164313781|NCT00647270|593526023|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
164313782|NCT00647270|593526021|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
164313783|NCT00647270|593526022|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
164313784|NCT00647270|593526023|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
164313785|NCT00647270|593526021|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
164313786|NCT00647270|593526022|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
164313787|NCT00647270|593526023|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
164313788|NCT03615040|593526024|FG000|Overall Study|Withdrawal by Subject|2|||
164313789|NCT03615040|593526025|FG001|Overall Study|Withdrawal by Subject|1|||
164313790|NCT03615040|593526024|FG000|Overall Study|Physician Decision|2|||
164313791|NCT03615040|593526025|FG001|Overall Study|Physician Decision|2|||
164313792|NCT03615040|593526024|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
164313793|NCT03615040|593526025|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
164313794|NCT03615040|593526024|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
164313795|NCT03615040|593526025|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
164313796|NCT03615040|593526024|FG000|Overall Study|Death|0|||
164313797|NCT03615040|593526025|FG001|Overall Study|Death|2|||
164313798|NCT01024309|593526028|FG000|Overall Study|Physician Decision|4|||
164313799|NCT01024309|593526029|FG001|Overall Study|Physician Decision|0|||
164313800|NCT01024309|593526028|FG000|Overall Study|Withdrawal by Subject|4|||
164313801|NCT01024309|593526029|FG001|Overall Study|Withdrawal by Subject|4|||
164313802|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
164313803|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
164313804|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
164313805|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
164313806|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
164313807|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
164313808|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
164313809|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
164313810|NCT00435045|593526032|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
164313811|NCT00435045|593526033|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
164313812|NCT00435045|593526032|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
164313813|NCT00435045|593526033|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
164313814|NCT00435045|593526032|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
164313815|NCT00435045|593526033|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
164313816|NCT00435045|593526032|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
164313817|NCT00435045|593526033|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
163972284|NCT03668600|592269808|FG000|Overall Study|Withdrawal by Subject|56|||
163972285|NCT03668600|592269808|FG000|Overall Study|Lack of Efficacy|7|||
164313818|NCT00435045|593526032|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
164313819|NCT00435045|593526033|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
163972286|NCT03668600|592269808|FG000|Overall Study|Adverse Event|1|||
163972287|NCT00424749|592269810|FG000|Overall Study|Withdrawal by Subject|1|||
163972288|NCT01263483|592269811|FG000|Overall Study|Adverse Event|4|||
163972289|NCT01263483|592269812|FG001|Overall Study|Adverse Event|0|||
163972290|NCT01263483|592269813|FG002|Overall Study|Adverse Event|3|||
164313820|NCT00435045|593526032|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
164313821|NCT00435045|593526033|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
164313822|NCT00435045|593526032|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
164313823|NCT00435045|593526033|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
164313824|NCT01743001|593526034|FG000|Overall Study|Physician Decision|1|||
164313825|NCT01743001|593526035|FG001|Overall Study|Physician Decision|0|||
164313826|NCT01743001|593526034|FG000|Overall Study|Pregnancy|1|||
164313827|NCT01743001|593526035|FG001|Overall Study|Pregnancy|0|||
164313828|NCT01743001|593526034|FG000|Overall Study|Death|1|||
164313829|NCT01743001|593526035|FG001|Overall Study|Death|0|||
164313830|NCT03052426|593526036|FG000|Overall Study|Withdrawal by Subject|0|||
164313831|NCT03052426|593526037|FG001|Overall Study|Withdrawal by Subject|1|||
164313832|NCT03052426|593526038|FG002|Overall Study|Withdrawal by Subject|0|||
164313833|NCT03052426|593526036|FG000|Overall Study|Lost to Follow-up|2|||
164313834|NCT03052426|593526037|FG001|Overall Study|Lost to Follow-up|0|||
164313835|NCT03052426|593526038|FG002|Overall Study|Lost to Follow-up|1|||
164313836|NCT01090323|593526041|FG000|Overall Study|Adverse Event|12|||
164313837|NCT01090323|593526042|FG001|Overall Study|Adverse Event|2|||
164313838|NCT01090323|593526041|FG000|Overall Study|Abnormal Lab Values|3|||
164313839|NCT01090323|593526042|FG001|Overall Study|Abnormal Lab Values|1|||
164313840|NCT01090323|593526041|FG000|Overall Study|Abnormal Test Procedure Results|2|||
164313841|NCT01090323|593526042|FG001|Overall Study|Abnormal Test Procedure Results|0|||
164313842|NCT01090323|593526041|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164313843|NCT01090323|593526042|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164313844|NCT01090323|593526041|FG000|Overall Study|Condition no longer requires drug|5|||
164313845|NCT01090323|593526042|FG001|Overall Study|Condition no longer requires drug|4|||
164313846|NCT01090323|593526041|FG000|Overall Study|Protocol Violation|2|||
164313847|NCT01090323|593526042|FG001|Overall Study|Protocol Violation|1|||
164313848|NCT01090323|593526041|FG000|Overall Study|Withdrew consent|33|||
164313849|NCT01090323|593526042|FG001|Overall Study|Withdrew consent|11|||
164313850|NCT01090323|593526041|FG000|Overall Study|Lost to Follow-up|11|||
164313851|NCT01090323|593526042|FG001|Overall Study|Lost to Follow-up|6|||
164313852|NCT01090323|593526041|FG000|Overall Study|Administrative problems|6|||
164313853|NCT01090323|593526042|FG001|Overall Study|Administrative problems|4|||
164313854|NCT01090323|593526041|FG000|Overall Study|Death|1|||
164313855|NCT01090323|593526042|FG001|Overall Study|Death|2|||
164313856|NCT01090323|593526041|FG000|Overall Study|Stopped end of core|7|||
164313857|NCT01090323|593526042|FG001|Overall Study|Stopped end of core|0|||
164313858|NCT01090323|593526041|FG000|Overall Study|Stopped end of extension 1#|3|||
164313859|NCT01090323|593526042|FG001|Overall Study|Stopped end of extension 1#|1|||
164313860|NCT05498701|593526043|FG000|Period 3|Adverse Event|1|||
164313861|NCT05498701|593526044|FG001|Period 3|Adverse Event|0|||
164313862|NCT01864005|593526045|FG000|Overall Study|Protocol Violation|0|||
164313863|NCT01864005|593526046|FG001|Overall Study|Protocol Violation|1|||
164313864|NCT01864005|593526045|FG000|Overall Study|Withdrawal by Subject|0|||
164313865|NCT01864005|593526046|FG001|Overall Study|Withdrawal by Subject|1|||
164313866|NCT01864005|593526045|FG000|Overall Study|Incorrect enrolment|1|||
164313867|NCT01864005|593526046|FG001|Overall Study|Incorrect enrolment|0|||
164313868|NCT01864005|593526045|FG000|Overall Study|Disease need|1|||
164313869|NCT01864005|593526046|FG001|Overall Study|Disease need|1|||
164313870|NCT01864005|593526045|FG000|Overall Study|Need GP IIb/IIIa|1|||
164313871|NCT01864005|593526046|FG001|Overall Study|Need GP IIb/IIIa|3|||
164313872|NCT02424578|593526047|FG000|Overall Study|Withdrawal by Subject|0|||
164313873|NCT02424578|593526048|FG001|Overall Study|Withdrawal by Subject|1|||
164313874|NCT03679754|593526049|FG000|Overall Study|Investigator request|1|||
164313875|NCT00964171|593526050|FG000|Overall Study|Death|5|||
164313876|NCT03179319|593526054|FG000|Overall Study|Lost to Follow-up|6|||
164313877|NCT03179319|593526055|FG001|Overall Study|Lost to Follow-up|0|||
164313878|NCT00635999|593526056|FG000|Overall Study|Withdrawal by Subject|4|||
164313879|NCT00635999|593526057|FG001|Overall Study|Withdrawal by Subject|2|||
164313880|NCT00635999|593526058|FG002|Overall Study|Withdrawal by Subject|1|||
164313881|NCT00711477|593526059|FG000|Overall Study|Adverse Event|3|||
164313882|NCT00711477|593526060|FG001|Overall Study|Adverse Event|1|||
163868270|NCT01040689|591884775|FG000|Overall Study|Lost to Follow-up|1|||
163868271|NCT01040689|591884776|FG001|Overall Study|Lost to Follow-up|0|||
164313883|NCT00711477|593526059|FG000|Overall Study|Lost to Follow-up|0|||
163868272|NCT01040689|591884777|FG002|Overall Study|Lost to Follow-up|0|||
164313884|NCT00711477|593526060|FG001|Overall Study|Lost to Follow-up|1|||
164313885|NCT00711477|593526059|FG000|Overall Study|Noncompliance|0|||
164313886|NCT00711477|593526060|FG001|Overall Study|Noncompliance|1|||
164313887|NCT02636361|593526061|FG000|Period 4|Physician Decision|0|||
164313888|NCT02636361|593526062|FG001|Period 4|Physician Decision|0|||
164313889|NCT02636361|593526063|FG002|Period 4|Physician Decision|0|||
164313890|NCT02636361|593526064|FG003|Period 4|Physician Decision|1|||
164313891|NCT02636361|593526065|FG004|Period 4|Physician Decision|0|||
164313892|NCT02695420|593526066|FG000|Overall Study|Death|0|||
164313893|NCT02695420|593526067|FG001|Overall Study|Death|1|||
164313894|NCT02695420|593526068|FG002|Overall Study|Death|0|||
164313895|NCT02695420|593526069|FG003|Overall Study|Death|0|||
164313896|NCT02929407|593526073|FG000|Overall Study|Adverse Event|1|||
164313897|NCT00916929|593526074|FG000|Overall Study|Lost to Follow-up|1|||
164313898|NCT00916929|593526075|FG001|Overall Study|Lost to Follow-up|3|||
164313899|NCT00916929|593526074|FG000|Overall Study|Death|5|||
164313900|NCT00916929|593526075|FG001|Overall Study|Death|10|||
164313901|NCT00916929|593526074|FG000|Overall Study|Withdrawal by Subject|1|||
164313902|NCT00916929|593526075|FG001|Overall Study|Withdrawal by Subject|5|||
164313903|NCT00916929|593526074|FG000|Overall Study|Left ventricular epicardial lead|1|||
164313904|NCT00916929|593526075|FG001|Overall Study|Left ventricular epicardial lead|2|||
164313905|NCT00916929|593526074|FG000|Overall Study|Transferred to hospice care|1|||
164313906|NCT00916929|593526075|FG001|Overall Study|Transferred to hospice care|1|||
164313907|NCT00916929|593526074|FG000|Overall Study|System explant|1|||
164313908|NCT00916929|593526075|FG001|Overall Study|System explant|0|||
164313909|NCT00916929|593526074|FG000|Overall Study|Moved to another state|0|||
164313910|NCT00916929|593526075|FG001|Overall Study|Moved to another state|1|||
164313911|NCT00916929|593526074|FG000|Overall Study|Device unable to process impedance data|0|||
164313912|NCT00916929|593526075|FG001|Overall Study|Device unable to process impedance data|7|||
164313913|NCT03037580|593526077|FG000|Overall Study|Withdrawal by Subject|3|||
164313914|NCT03037580|593526078|FG001|Overall Study|Withdrawal by Subject|0|||
164313915|NCT03037580|593526077|FG000|Overall Study|Adverse Event|1|||
164313916|NCT03037580|593526078|FG001|Overall Study|Adverse Event|0|||
164313917|NCT03037580|593526077|FG000|Overall Study|Study Terminated by Sponsor|12|||
164313918|NCT03037580|593526078|FG001|Overall Study|Study Terminated by Sponsor|15|||
164313919|NCT03037580|593526077|FG000|Overall Study|Death|0|||
164313920|NCT03037580|593526078|FG001|Overall Study|Death|1|||
164313921|NCT02036853|593526079|FG000|Overall Study|Adverse Event|0|||
164313922|NCT02036853|593526080|FG001|Overall Study|Adverse Event|2|||
164313923|NCT02036853|593526079|FG000|Overall Study|Lack of Efficacy|0|||
164313924|NCT02036853|593526080|FG001|Overall Study|Lack of Efficacy|2|||
164313925|NCT02036853|593526079|FG000|Overall Study|Physician Decision|0|||
164313926|NCT02036853|593526080|FG001|Overall Study|Physician Decision|1|||
164313927|NCT02036853|593526079|FG000|Overall Study|Withdrawal by Subject|0|||
164313928|NCT02036853|593526080|FG001|Overall Study|Withdrawal by Subject|1|||
164313929|NCT00228553|593526081|FG000|Overall Study|Adverse Event|112|||
164313930|NCT00228553|593526081|FG000|Overall Study|Lack of Efficacy|34|||
164313931|NCT00228553|593526081|FG000|Overall Study|Lost to Follow-up|67|||
164313932|NCT00228553|593526081|FG000|Overall Study|Physician Decision|48|||
164313933|NCT00228553|593526081|FG000|Overall Study|Protocol Violation|6|||
164313934|NCT00228553|593526081|FG000|Overall Study|Withdrawal by Subject|115|||
164313935|NCT00228553|593526081|FG000|Overall Study|Pregnancy|2|||
164313936|NCT00228553|593526081|FG000|Overall Study|Miscellaneous|46|||
164313937|NCT01309282|593526082|FG000|Overall Study|Lost to Follow-up|1|||
164313938|NCT02087423|593526083|FG000|Overall Study|Withdrawal by Subject|20|||
164313939|NCT02087423|593526084|FG001|Overall Study|Withdrawal by Subject|20|||
164313940|NCT02087423|593526085|FG002|Overall Study|Withdrawal by Subject|3|||
164313941|NCT02087423|593526083|FG000|Overall Study|Death|68|||
164313942|NCT02087423|593526084|FG001|Overall Study|Death|207|||
164313943|NCT02087423|593526085|FG002|Overall Study|Death|40|||
164313944|NCT02087423|593526083|FG000|Overall Study|Lost to Follow-up|0|||
164313945|NCT02087423|593526084|FG001|Overall Study|Lost to Follow-up|2|||
164313946|NCT02087423|593526085|FG002|Overall Study|Lost to Follow-up|0|||
164313947|NCT02087423|593526083|FG000|Overall Study|Terminated from study at final DCO|23|||
164313948|NCT02087423|593526084|FG001|Overall Study|Terminated from study at final DCO|36|||
164313949|NCT02087423|593526085|FG002|Overall Study|Terminated from study at final DCO|25|||
163972291|NCT01263483|592269811|FG000|Overall Study|Withdrawal by Subject|1|||
163972292|NCT01263483|592269812|FG001|Overall Study|Withdrawal by Subject|0|||
164313950|NCT00499590|593526088|FG000|Overall Study|Study Terminated|112|||
164313951|NCT00499590|593526089|FG001|Overall Study|Study Terminated|112|||
164313952|NCT00499590|593526090|FG002|Overall Study|Study Terminated|112|||
164313953|NCT00499590|593526088|FG000|Overall Study|Not treated|1|||
164313954|NCT00499590|593526089|FG001|Overall Study|Not treated|0|||
164313955|NCT00499590|593526090|FG002|Overall Study|Not treated|1|||
164313956|NCT02633020|593526094|FG000|Overall Study|Adverse Event|1|||
164313957|NCT02633020|593526095|FG001|Overall Study|Adverse Event|0|||
164313958|NCT00934440|593526096|FG000|Overall Study|Lost to Follow-up|1|||
164313959|NCT02152956|593526097|FG000|Overall Study|Adverse Event|0|||
164313960|NCT02152956|593526098|FG001|Overall Study|Adverse Event|0|||
164313961|NCT02152956|593526099|FG002|Overall Study|Adverse Event|0|||
164313962|NCT02152956|593526100|FG003|Overall Study|Adverse Event|0|||
164313963|NCT02152956|593526101|FG004|Overall Study|Adverse Event|0|||
164313964|NCT02152956|593526102|FG005|Overall Study|Adverse Event|0|||
164313965|NCT02152956|593526103|FG006|Overall Study|Adverse Event|0|||
164313966|NCT02152956|593526104|FG007|Overall Study|Adverse Event|0|||
164313967|NCT02152956|593526105|FG008|Overall Study|Adverse Event|0|||
164313968|NCT02152956|593526106|FG009|Overall Study|Adverse Event|0|||
164313969|NCT02152956|593526107|FG010|Overall Study|Adverse Event|0|||
164313970|NCT02152956|593526108|FG011|Overall Study|Adverse Event|4|||
164313971|NCT02152956|593526109|FG012|Overall Study|Adverse Event|0|||
164313972|NCT02152956|593526097|FG000|Overall Study|Death|0|||
164313973|NCT02152956|593526098|FG001|Overall Study|Death|3|||
164313974|NCT02152956|593526099|FG002|Overall Study|Death|3|||
164313975|NCT02152956|593526100|FG003|Overall Study|Death|4|||
164313976|NCT02152956|593526101|FG004|Overall Study|Death|1|||
164313977|NCT02152956|593526102|FG005|Overall Study|Death|2|||
164313978|NCT02152956|593526103|FG006|Overall Study|Death|6|||
164313979|NCT02152956|593526104|FG007|Overall Study|Death|6|||
164313980|NCT02152956|593526105|FG008|Overall Study|Death|4|||
164313981|NCT02152956|593526106|FG009|Overall Study|Death|5|||
164313982|NCT02152956|593526107|FG010|Overall Study|Death|3|||
164313983|NCT02152956|593526108|FG011|Overall Study|Death|143|||
164313984|NCT02152956|593526109|FG012|Overall Study|Death|12|||
164313985|NCT02152956|593526097|FG000|Overall Study|Lost to Follow-up|0|||
164313986|NCT02152956|593526098|FG001|Overall Study|Lost to Follow-up|1|||
164313987|NCT02152956|593526099|FG002|Overall Study|Lost to Follow-up|0|||
164313988|NCT02152956|593526100|FG003|Overall Study|Lost to Follow-up|0|||
164313989|NCT02152956|593526101|FG004|Overall Study|Lost to Follow-up|0|||
164313990|NCT02152956|593526102|FG005|Overall Study|Lost to Follow-up|0|||
164313991|NCT02152956|593526103|FG006|Overall Study|Lost to Follow-up|0|||
164313992|NCT02152956|593526104|FG007|Overall Study|Lost to Follow-up|0|||
164313993|NCT02152956|593526105|FG008|Overall Study|Lost to Follow-up|0|||
164313994|NCT02152956|593526106|FG009|Overall Study|Lost to Follow-up|0|||
164313995|NCT02152956|593526107|FG010|Overall Study|Lost to Follow-up|0|||
164313996|NCT02152956|593526108|FG011|Overall Study|Lost to Follow-up|3|||
164313997|NCT02152956|593526109|FG012|Overall Study|Lost to Follow-up|0|||
164313998|NCT02152956|593526097|FG000|Overall Study|Withdrawal by Subject|1|||
164313999|NCT02152956|593526098|FG001|Overall Study|Withdrawal by Subject|0|||
164314000|NCT02152956|593526099|FG002|Overall Study|Withdrawal by Subject|1|||
164314001|NCT02152956|593526100|FG003|Overall Study|Withdrawal by Subject|0|||
164314002|NCT02152956|593526101|FG004|Overall Study|Withdrawal by Subject|2|||
164314003|NCT02152956|593526102|FG005|Overall Study|Withdrawal by Subject|2|||
164314004|NCT02152956|593526103|FG006|Overall Study|Withdrawal by Subject|0|||
164314005|NCT02152956|593526104|FG007|Overall Study|Withdrawal by Subject|0|||
164314006|NCT02152956|593526105|FG008|Overall Study|Withdrawal by Subject|1|||
164314007|NCT02152956|593526106|FG009|Overall Study|Withdrawal by Subject|0|||
164314008|NCT02152956|593526107|FG010|Overall Study|Withdrawal by Subject|0|||
164314009|NCT02152956|593526108|FG011|Overall Study|Withdrawal by Subject|4|||
164314010|NCT02152956|593526109|FG012|Overall Study|Withdrawal by Subject|0|||
164314011|NCT02152956|593526097|FG000|Overall Study|Physician Decision|0|||
164314012|NCT02152956|593526098|FG001|Overall Study|Physician Decision|0|||
164314013|NCT02152956|593526099|FG002|Overall Study|Physician Decision|0|||
164314014|NCT02152956|593526100|FG003|Overall Study|Physician Decision|0|||
164314015|NCT02152956|593526101|FG004|Overall Study|Physician Decision|0|||
164314016|NCT02152956|593526102|FG005|Overall Study|Physician Decision|0|||
164314017|NCT02152956|593526103|FG006|Overall Study|Physician Decision|0|||
164314018|NCT02152956|593526104|FG007|Overall Study|Physician Decision|0|||
164314019|NCT02152956|593526105|FG008|Overall Study|Physician Decision|0|||
164314020|NCT02152956|593526106|FG009|Overall Study|Physician Decision|0|||
164314021|NCT02152956|593526107|FG010|Overall Study|Physician Decision|0|||
164314022|NCT02152956|593526108|FG011|Overall Study|Physician Decision|1|||
164314023|NCT02152956|593526109|FG012|Overall Study|Physician Decision|0|||
164314024|NCT02152956|593526097|FG000|Overall Study|Study terminated by sponsor|0|||
164314025|NCT02152956|593526098|FG001|Overall Study|Study terminated by sponsor|0|||
164314026|NCT02152956|593526099|FG002|Overall Study|Study terminated by sponsor|0|||
164314027|NCT02152956|593526100|FG003|Overall Study|Study terminated by sponsor|0|||
164314028|NCT02152956|593526101|FG004|Overall Study|Study terminated by sponsor|0|||
164314029|NCT02152956|593526102|FG005|Overall Study|Study terminated by sponsor|0|||
164314030|NCT02152956|593526103|FG006|Overall Study|Study terminated by sponsor|0|||
164314031|NCT02152956|593526104|FG007|Overall Study|Study terminated by sponsor|0|||
164314032|NCT02152956|593526105|FG008|Overall Study|Study terminated by sponsor|0|||
164314033|NCT02152956|593526106|FG009|Overall Study|Study terminated by sponsor|0|||
164314034|NCT02152956|593526107|FG010|Overall Study|Study terminated by sponsor|0|||
164314035|NCT02152956|593526108|FG011|Overall Study|Study terminated by sponsor|29|||
164314036|NCT02152956|593526109|FG012|Overall Study|Study terminated by sponsor|0|||
164314037|NCT02152956|593526097|FG000|Overall Study|progressive disease|0|||
164314038|NCT02152956|593526098|FG001|Overall Study|progressive disease|0|||
164314039|NCT02152956|593526099|FG002|Overall Study|progressive disease|0|||
164314040|NCT02152956|593526100|FG003|Overall Study|progressive disease|0|||
164314041|NCT02152956|593526101|FG004|Overall Study|progressive disease|0|||
164314042|NCT02152956|593526102|FG005|Overall Study|progressive disease|0|||
164314043|NCT02152956|593526103|FG006|Overall Study|progressive disease|0|||
164314044|NCT02152956|593526104|FG007|Overall Study|progressive disease|0|||
163972293|NCT01263483|592269813|FG002|Overall Study|Withdrawal by Subject|0|||
164314045|NCT02152956|593526105|FG008|Overall Study|progressive disease|1|||
163972294|NCT01263483|592269811|FG000|Overall Study|Lack of Efficacy|2|||
164314046|NCT02152956|593526106|FG009|Overall Study|progressive disease|0|||
164314047|NCT02152956|593526107|FG010|Overall Study|progressive disease|0|||
164314048|NCT02152956|593526108|FG011|Overall Study|progressive disease|1|||
164314049|NCT02152956|593526109|FG012|Overall Study|progressive disease|0|||
164314050|NCT05661851|593526110|FG000|Overall Study|Protocol Violation|1|||
164314051|NCT05661851|593526111|FG001|Overall Study|Protocol Violation|1|||
164314052|NCT05661851|593526110|FG000|Overall Study|Covid-19 Related|3|||
164314053|NCT05661851|593526111|FG001|Overall Study|Covid-19 Related|4|||
164314054|NCT05661851|593526110|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
164314055|NCT05661851|593526111|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
164314056|NCT05661851|593526110|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
164314057|NCT05661851|593526111|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
164314058|NCT01014910|593526112|FG000|Overall Study|Withdrawal by Subject|0|||
164314059|NCT01014910|593526113|FG001|Overall Study|Withdrawal by Subject|2|||
164314060|NCT00744042|593526116|FG000|Overall Study|Withdrawal by Subject|1|||
164314061|NCT00782834|593526117|FG000|Treatment Phase|fibrous tumor not GIST|1|||
164314062|NCT02252939|593526118|FG000|Overall Study|Lost to Follow-up|3|||
164314063|NCT01033448|593526119|FG000|Overall Study|Withdrawal by Subject|4|||
164314064|NCT01033448|593526119|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
164314065|NCT01033448|593526119|FG000|Overall Study|Lost to Follow-up|3|||
164314066|NCT01033448|593526119|FG000|Overall Study|Withdrew due to other reasons|3|||
164314067|NCT01033448|593526119|FG000|Overall Study|Unknown disposition|1|||
164314068|NCT04270370|593526120|FG000|Overall Study|Lost to Follow-up|1|||
164314069|NCT04270370|593526121|FG001|Overall Study|Lost to Follow-up|0|||
164314070|NCT04270370|593526122|FG002|Overall Study|Lost to Follow-up|0|||
164314071|NCT04270370|593526123|FG003|Overall Study|Lost to Follow-up|0|||
164314072|NCT04270370|593526124|FG004|Overall Study|Lost to Follow-up|0|||
164314073|NCT04270370|593526125|FG005|Overall Study|Lost to Follow-up|0|||
164314074|NCT04270370|593526126|FG006|Overall Study|Lost to Follow-up|0|||
163972295|NCT01263483|592269812|FG001|Overall Study|Lack of Efficacy|0|||
163972296|NCT01263483|592269813|FG002|Overall Study|Lack of Efficacy|0|||
163972297|NCT01263483|592269811|FG000|Overall Study|Protocol Violation|0|||
163972298|NCT01263483|592269812|FG001|Overall Study|Protocol Violation|1|||
163972299|NCT01263483|592269813|FG002|Overall Study|Protocol Violation|1|||
163972300|NCT01263483|592269811|FG000|Overall Study|Participant Unavailability|0|||
163972301|NCT01263483|592269812|FG001|Overall Study|Participant Unavailability|1|||
163972302|NCT01263483|592269813|FG002|Overall Study|Participant Unavailability|1|||
163972303|NCT04109222|592269814|FG000|Overall Study|Adverse Event|1|||
163972304|NCT04109222|592269815|FG001|Overall Study|Adverse Event|0|||
163972305|NCT04109222|592269816|FG002|Overall Study|Adverse Event|0|||
163972306|NCT02577406|592269817|FG000|Randomized Period|Death|1|||
163972307|NCT02577406|592269818|FG001|Randomized Period|Death|0|||
163972308|NCT02577406|592269817|FG000|Randomized Period|Other reasons|0|||
163972309|NCT02577406|592269818|FG001|Randomized Period|Other reasons|20|||
163972310|NCT02577406|592269817|FG000|Treatment Period|Death|38|||
163972311|NCT02577406|592269818|FG001|Treatment Period|Death|23|||
163972312|NCT02577406|592269817|FG000|Treatment Period|Adverse Event|17|||
163972313|NCT02577406|592269818|FG001|Treatment Period|Adverse Event|12|||
163972314|NCT02577406|592269817|FG000|Treatment Period|Progressive Disease|53|||
163972315|NCT02577406|592269818|FG001|Treatment Period|Progressive Disease|37|||
163972316|NCT02577406|592269817|FG000|Treatment Period|Withdrawal by Subject|10|||
163972317|NCT02577406|592269818|FG001|Treatment Period|Withdrawal by Subject|24|||
163972318|NCT02577406|592269817|FG000|Treatment Period|Lost to Follow-up|0|||
164314075|NCT04270370|593526127|FG007|Overall Study|Lost to Follow-up|0|||
164314076|NCT04270370|593526128|FG008|Overall Study|Lost to Follow-up|1|||
164314077|NCT04270370|593526129|FG009|Overall Study|Lost to Follow-up|0|||
164314078|NCT04270370|593526130|FG010|Overall Study|Lost to Follow-up|0|||
164314079|NCT04270370|593526131|FG011|Overall Study|Lost to Follow-up|0|||
164314080|NCT04189224|593526134|FG000|Period 2|Adverse Event|0|||
164314081|NCT04189224|593526135|FG001|Period 2|Adverse Event|1|||
164314082|NCT03338959|593527548|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
164314083|NCT03338959|593527548|FG000|Overall Study|Physician Decision|1|||
164314084|NCT00409331|593527550|FG000|Overall Study|Physician Decision|1|||
164314085|NCT00281658|593527551|FG000|Randomized Phase|Adverse Event|0|||
164314086|NCT00281658|593527552|FG001|Randomized Phase|Adverse Event|2|||
164314087|NCT00281658|593527553|FG002|Randomized Phase|Adverse Event|0|||
164314088|NCT00281658|593527554|FG003|Randomized Phase|Adverse Event|0|||
164314089|NCT00281658|593527551|FG000|Randomized Phase|Lost to Follow-up|34|||
164314090|NCT00281658|593527552|FG001|Randomized Phase|Lost to Follow-up|27|||
164314091|NCT00281658|593527553|FG002|Randomized Phase|Lost to Follow-up|0|||
164314092|NCT00281658|593527554|FG003|Randomized Phase|Lost to Follow-up|0|||
163972319|NCT02577406|592269818|FG001|Treatment Period|Lost to Follow-up|1|||
163972320|NCT02577406|592269817|FG000|Treatment Period|Transition to commercially available treatment|1|||
164314093|NCT00281658|593527551|FG000|Randomized Phase|Withdrawal by Subject|8|||
164314094|NCT00281658|593527552|FG001|Randomized Phase|Withdrawal by Subject|7|||
164314095|NCT00281658|593527553|FG002|Randomized Phase|Withdrawal by Subject|0|||
164314096|NCT00281658|593527554|FG003|Randomized Phase|Withdrawal by Subject|0|||
164314097|NCT00281658|593527551|FG000|Randomized Phase|Study closed/terminated|1|||
164314098|NCT00281658|593527552|FG001|Randomized Phase|Study closed/terminated|1|||
163972321|NCT02577406|592269818|FG001|Treatment Period|Transition to commercially available treatment|1|||
163972322|NCT02577406|592269817|FG000|Treatment Period|Physician Decision|1|||
163972323|NCT02577406|592269818|FG001|Treatment Period|Physician Decision|0|||
164314099|NCT00281658|593527553|FG002|Randomized Phase|Study closed/terminated|0|||
164314100|NCT00281658|593527554|FG003|Randomized Phase|Study closed/terminated|0|||
164314101|NCT00281658|593527551|FG000|Randomized Phase|Disease progression|36|||
164314102|NCT00281658|593527552|FG001|Randomized Phase|Disease progression|27|||
164314103|NCT00281658|593527553|FG002|Randomized Phase|Disease progression|0|||
164314104|NCT00281658|593527554|FG003|Randomized Phase|Disease progression|0|||
164314105|NCT00281658|593527551|FG000|Randomized Phase|Physician Decision|1|||
164314106|NCT00281658|593527552|FG001|Randomized Phase|Physician Decision|1|||
164314107|NCT00281658|593527553|FG002|Randomized Phase|Physician Decision|0|||
164314108|NCT00281658|593527554|FG003|Randomized Phase|Physician Decision|0|||
164314109|NCT00281658|593527551|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
164314110|NCT00281658|593527552|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
164314111|NCT00281658|593527553|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
164314112|NCT00281658|593527554|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
164314113|NCT00281658|593527551|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
164314114|NCT00281658|593527552|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
164314115|NCT00281658|593527553|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
164314116|NCT00281658|593527554|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
164314117|NCT00281658|593527551|FG000|Randomized Phase|Treatment ongoing|1|||
164314118|NCT00281658|593527552|FG001|Randomized Phase|Treatment ongoing|0|||
164314119|NCT00281658|593527553|FG002|Randomized Phase|Treatment ongoing|0|||
164314120|NCT00281658|593527554|FG003|Randomized Phase|Treatment ongoing|0|||
164314121|NCT00281658|593527551|FG000|Open Label Phase|Adverse Event|0|||
164314122|NCT00281658|593527552|FG001|Open Label Phase|Adverse Event|0|||
164314123|NCT00281658|593527553|FG002|Open Label Phase|Adverse Event|1|||
164314124|NCT00281658|593527554|FG003|Open Label Phase|Adverse Event|0|||
164314125|NCT00281658|593527551|FG000|Open Label Phase|Lost to Follow-up|0|||
164314126|NCT00281658|593527552|FG001|Open Label Phase|Lost to Follow-up|0|||
164314127|NCT00281658|593527553|FG002|Open Label Phase|Lost to Follow-up|16|||
164314128|NCT00281658|593527554|FG003|Open Label Phase|Lost to Follow-up|2|||
164314129|NCT00281658|593527551|FG000|Open Label Phase|Withdrawal by Subject|0|||
164314130|NCT00281658|593527552|FG001|Open Label Phase|Withdrawal by Subject|0|||
164314131|NCT00281658|593527553|FG002|Open Label Phase|Withdrawal by Subject|3|||
164314132|NCT00281658|593527554|FG003|Open Label Phase|Withdrawal by Subject|2|||
164314133|NCT00281658|593527551|FG000|Open Label Phase|Disease progression|0|||
164314134|NCT00281658|593527552|FG001|Open Label Phase|Disease progression|0|||
164314135|NCT00281658|593527553|FG002|Open Label Phase|Disease progression|18|||
164314136|NCT00281658|593527554|FG003|Open Label Phase|Disease progression|0|||
164314137|NCT00281658|593527551|FG000|Open Label Phase|Physician Decision|0|||
164314138|NCT00281658|593527552|FG001|Open Label Phase|Physician Decision|0|||
164314139|NCT00281658|593527553|FG002|Open Label Phase|Physician Decision|1|||
164314140|NCT00281658|593527554|FG003|Open Label Phase|Physician Decision|0|||
164314141|NCT00281658|593527551|FG000|Open Label Phase|Relocation of patient|0|||
164314142|NCT00281658|593527552|FG001|Open Label Phase|Relocation of patient|0|||
164314143|NCT00281658|593527553|FG002|Open Label Phase|Relocation of patient|1|||
163868273|NCT01040689|591884778|FG003|Overall Study|Lost to Follow-up|0|||
163868274|NCT01040689|591884775|FG000|Overall Study|Withdrawal by Subject|2|||
163868275|NCT01040689|591884776|FG001|Overall Study|Withdrawal by Subject|1|||
163868276|NCT01040689|591884777|FG002|Overall Study|Withdrawal by Subject|1|||
163868277|NCT01040689|591884778|FG003|Overall Study|Withdrawal by Subject|0|||
163868278|NCT01040689|591884775|FG000|Overall Study|Other reasons not listed above|0|||
163868279|NCT01040689|591884776|FG001|Overall Study|Other reasons not listed above|1|||
163868280|NCT01040689|591884777|FG002|Overall Study|Other reasons not listed above|0|||
163868281|NCT01040689|591884778|FG003|Overall Study|Other reasons not listed above|0|||
163868282|NCT06129045|591884781|FG000|Overall Study|Lost to Follow-up|1|||
163868283|NCT06129045|591884782|FG001|Overall Study|Lost to Follow-up|1|||
163868284|NCT06129045|591884783|FG002|Overall Study|Lost to Follow-up|4|||
163868285|NCT02031471|591884784|FG000|24 Week Treatment Period|Adverse Event|6|||
163868286|NCT02031471|591884784|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
163868287|NCT02031471|591884784|FG000|24 Week Treatment Period|Protocol Violation|1|||
163868288|NCT02031471|591884784|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
163972324|NCT02577406|592269817|FG000|Treatment Period|Disease Relapse|28|||
164314144|NCT00281658|593527554|FG003|Open Label Phase|Relocation of patient|0|||
164314145|NCT00281658|593527551|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
164314146|NCT00281658|593527552|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
164314147|NCT00281658|593527553|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
164314148|NCT00281658|593527554|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
163868289|NCT02031471|591884784|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
163868290|NCT02031471|591884784|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
163972325|NCT02577406|592269818|FG001|Treatment Period|Disease Relapse|1|||
164314149|NCT00730028|593527555|FG000|Overall Study|Adverse Event|23|||
164314150|NCT00730028|593527556|FG001|Overall Study|Adverse Event|26|||
164314151|NCT00730028|593527557|FG002|Overall Study|Adverse Event|16|||
163868291|NCT02031471|591884784|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
164203050|NCT02717195|593115251|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164203051|NCT02717195|593115252|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
164203052|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
164203053|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
164203054|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
164203055|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
164203056|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
164203057|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
164203058|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
164203059|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
164203060|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
164203061|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
164203062|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
164203063|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
164203064|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
164203065|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
164203066|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
164203067|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
164203068|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
164203069|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
164203070|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
164203071|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
164203072|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164203073|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164203074|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
164203075|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
164203076|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
164203077|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
164203078|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
164203079|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
164203080|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
164203081|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
164203082|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203083|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203084|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
164203085|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203086|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
164203087|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
164203088|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
164203089|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
164203090|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
164203091|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
164203092|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
164203093|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
164203094|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
164203095|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
164203096|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
164203097|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203098|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203099|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203100|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
164203101|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
164203102|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
164203103|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
164203104|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
164203105|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
164203106|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
164203107|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203108|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203109|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203110|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
164203111|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
164203112|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203113|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203114|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
164203115|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203116|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
164203117|NCT02717195|593115248|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
164203118|NCT02717195|593115249|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
164203119|NCT02717195|593115250|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
164203120|NCT02717195|593115251|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
164203121|NCT02717195|593115252|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
163868292|NCT05797155|591884791|FG000|Overall Study|Lost to Follow-up|33|||
163868293|NCT05797155|591884792|FG001|Overall Study|Lost to Follow-up|12|||
163868294|NCT01350804|591884793|FG000|Core Study|Withdrawal by Subject|11|||
163868295|NCT01350804|591884794|FG001|Core Study|Withdrawal by Subject|17|||
163868296|NCT01350804|591884795|FG002|Core Study|Withdrawal by Subject|16|||
163868297|NCT01350804|591884796|FG003|Core Study|Withdrawal by Subject|7|||
164203122|NCT04194814|593115253|FG000|Overall Study|Physician Decision|3|||
164203123|NCT04194814|593115254|FG001|Overall Study|Physician Decision|0|||
164203124|NCT04194814|593115253|FG000|Overall Study|Withdrawal by Subject|0|||
164203125|NCT04194814|593115254|FG001|Overall Study|Withdrawal by Subject|2|||
164203126|NCT02659865|593116456|FG000|Period 1|Withdrawal by Subject|1|||
164203127|NCT02659865|593116457|FG001|Period 1|Withdrawal by Subject|0|||
164203128|NCT02659865|593116458|FG002|Period 1|Withdrawal by Subject|0|||
164203129|NCT02659865|593116459|FG003|Period 1|Withdrawal by Subject|0|||
164203130|NCT02659865|593116460|FG004|Period 1|Withdrawal by Subject|0|||
164203131|NCT02659865|593116456|FG000|Period 1|Adverse Event|0|||
164203132|NCT02659865|593116457|FG001|Period 1|Adverse Event|0|||
164203133|NCT02659865|593116458|FG002|Period 1|Adverse Event|0|||
164203134|NCT02659865|593116459|FG003|Period 1|Adverse Event|0|||
164203135|NCT02659865|593116460|FG004|Period 1|Adverse Event|1|||
164203136|NCT02325414|593116461|FG000|Overall Study|Withdrawal by Subject|3|||
164203137|NCT02325414|593116462|FG001|Overall Study|Withdrawal by Subject|1|||
164203138|NCT02325414|593116461|FG000|Overall Study|Lost to Follow-up|5|||
164203139|NCT02325414|593116462|FG001|Overall Study|Lost to Follow-up|5|||
164203140|NCT00959751|593116465|FG000|Overall Study|Lost to Follow-up|2|||
164203141|NCT00959751|593116466|FG001|Overall Study|Lost to Follow-up|3|||
164203142|NCT00959751|593116465|FG000|Overall Study|Consent Withdrawn|0|||
164203143|NCT00959751|593116466|FG001|Overall Study|Consent Withdrawn|1|||
164203144|NCT00959751|593116465|FG000|Overall Study|Non-compliance to Study Procedures|0|||
164203145|NCT00959751|593116466|FG001|Overall Study|Non-compliance to Study Procedures|1|||
164203146|NCT00959751|593116465|FG000|Overall Study|No migraine headache without aura|7|||
164203147|NCT00959751|593116466|FG001|Overall Study|No migraine headache without aura|7|||
164203148|NCT00761319|593116467|FG000|Overall Study|Protocol Violation|21|||
164203149|NCT00761319|593116468|FG001|Overall Study|Protocol Violation|14|||
164203150|NCT00761319|593116467|FG000|Overall Study|Adverse Event|11|||
164203151|NCT00761319|593116468|FG001|Overall Study|Adverse Event|7|||
164203152|NCT00761319|593116467|FG000|Overall Study|Withdrawal by Subject|8|||
164203153|NCT00761319|593116468|FG001|Overall Study|Withdrawal by Subject|7|||
164203154|NCT00761319|593116467|FG000|Overall Study|Noncompliance|4|||
164203155|NCT00761319|593116468|FG001|Overall Study|Noncompliance|3|||
164203156|NCT00761319|593116467|FG000|Overall Study|Lost to Follow-up|1|||
164203157|NCT00761319|593116468|FG001|Overall Study|Lost to Follow-up|1|||
164203158|NCT00761319|593116467|FG000|Overall Study|Nonspecified|2|||
164203159|NCT00761319|593116468|FG001|Overall Study|Nonspecified|2|||
164203160|NCT00761319|593116467|FG000|Overall Study|Missing|1|||
164203161|NCT00761319|593116468|FG001|Overall Study|Missing|0|||
164203162|NCT03157089|593116471|FG000|Overall Study|Treated only with pembrolizumab|1|||
164203163|NCT03157089|593116472|FG001|Overall Study|Treated only with pembrolizumab|0|||
164203164|NCT03157089|593116471|FG000|Overall Study|Adverse Event|5|||
164203165|NCT03157089|593116472|FG001|Overall Study|Adverse Event|4|||
164203166|NCT03157089|593116471|FG000|Overall Study|Progressive disease|6|||
164203167|NCT03157089|593116472|FG001|Overall Study|Progressive disease|8|||
163868298|NCT01350804|591884793|FG000|Core Study|Study terminated by Sponsor|0|||
163868299|NCT01350804|591884794|FG001|Core Study|Study terminated by Sponsor|0|||
163868300|NCT01350804|591884795|FG002|Core Study|Study terminated by Sponsor|0|||
163868301|NCT01350804|591884796|FG003|Core Study|Study terminated by Sponsor|2|||
164203168|NCT00853385|593116473|FG000|Overall Study|Death|0|||
164203169|NCT00853385|593116474|FG001|Overall Study|Death|0|||
164203170|NCT00853385|593116475|FG002|Overall Study|Death|0|||
164203171|NCT00853385|593116476|FG003|Overall Study|Death|0|||
163868302|NCT01350804|591884793|FG000|Core Study|Protocol deviation|1|||
164203172|NCT00853385|593116477|FG004|Overall Study|Death|1|||
164203173|NCT00853385|593116473|FG000|Overall Study|Adverse Event|24|||
164203174|NCT00853385|593116474|FG001|Overall Study|Adverse Event|24|||
163868303|NCT01350804|591884794|FG001|Core Study|Protocol deviation|0|||
163868304|NCT01350804|591884795|FG002|Core Study|Protocol deviation|1|||
163972326|NCT02577406|592269817|FG000|Treatment Period|Protocol Violation|0|||
164314152|NCT00730028|593527558|FG003|Overall Study|Adverse Event|20|||
164314153|NCT00730028|593527559|FG004|Overall Study|Adverse Event|43|||
164314154|NCT00730028|593527555|FG000|Overall Study|Lost to Follow-up|13|||
164314155|NCT00730028|593527556|FG001|Overall Study|Lost to Follow-up|26|||
164314156|NCT00730028|593527557|FG002|Overall Study|Lost to Follow-up|22|||
164314157|NCT00730028|593527558|FG003|Overall Study|Lost to Follow-up|26|||
164314158|NCT00730028|593527559|FG004|Overall Study|Lost to Follow-up|25|||
164314159|NCT00730028|593527555|FG000|Overall Study|Protocol Violation|6|||
164314160|NCT00730028|593527556|FG001|Overall Study|Protocol Violation|1|||
164314161|NCT00730028|593527557|FG002|Overall Study|Protocol Violation|1|||
164314162|NCT00730028|593527558|FG003|Overall Study|Protocol Violation|2|||
164314163|NCT00730028|593527559|FG004|Overall Study|Protocol Violation|0|||
164314164|NCT00730028|593527555|FG000|Overall Study|Withdrawal by Subject|9|||
164314165|NCT00730028|593527556|FG001|Overall Study|Withdrawal by Subject|5|||
164314166|NCT00730028|593527557|FG002|Overall Study|Withdrawal by Subject|4|||
164314167|NCT00730028|593527558|FG003|Overall Study|Withdrawal by Subject|5|||
164314168|NCT00730028|593527559|FG004|Overall Study|Withdrawal by Subject|9|||
164314169|NCT00730028|593527555|FG000|Overall Study|Physician Decision|3|||
164314170|NCT00730028|593527556|FG001|Overall Study|Physician Decision|3|||
164314171|NCT00730028|593527557|FG002|Overall Study|Physician Decision|2|||
164314172|NCT00730028|593527558|FG003|Overall Study|Physician Decision|3|||
164314173|NCT00730028|593527559|FG004|Overall Study|Physician Decision|2|||
164314174|NCT00730028|593527555|FG000|Overall Study|Treatment Failure|5|||
164314175|NCT00730028|593527556|FG001|Overall Study|Treatment Failure|5|||
164314176|NCT00730028|593527557|FG002|Overall Study|Treatment Failure|0|||
164314177|NCT00730028|593527558|FG003|Overall Study|Treatment Failure|0|||
164314178|NCT00730028|593527559|FG004|Overall Study|Treatment Failure|1|||
164314179|NCT00730028|593527555|FG000|Overall Study|Randomization Error|1|||
164314180|NCT00730028|593527556|FG001|Overall Study|Randomization Error|0|||
164314181|NCT00730028|593527557|FG002|Overall Study|Randomization Error|0|||
164314182|NCT00730028|593527558|FG003|Overall Study|Randomization Error|0|||
164314183|NCT00730028|593527559|FG004|Overall Study|Randomization Error|2|||
164314184|NCT00615901|593527560|FG000|Overall Study|Withdrawal by Subject|2|||
164314185|NCT00615901|593527560|FG000|Overall Study|Adverse Event|7|||
164314186|NCT01206322|593527564|FG000|Overall Study|Adverse Event|0|||
164314187|NCT01206322|593527565|FG001|Overall Study|Adverse Event|0|||
164314188|NCT01206322|593527566|FG002|Overall Study|Adverse Event|0|||
164314189|NCT01206322|593527567|FG003|Overall Study|Adverse Event|1|||
164314190|NCT01250496|593527571|FG000|Overall Study|Study terminated|124|||
164314191|NCT01250496|593527572|FG001|Overall Study|Study terminated|124|||
164314192|NCT00003590|593527573|FG000|Overall Study|Ineligible Patient|1|||
164314193|NCT00003590|593527573|FG000|Overall Study|Adverse Event|7|||
164314194|NCT00003590|593527573|FG000|Overall Study|Withdrawal by Subject|1|||
164314195|NCT00003590|593527573|FG000|Overall Study|Lack of Efficacy|11|||
163868305|NCT01350804|591884796|FG003|Core Study|Protocol deviation|0|||
163868306|NCT01350804|591884793|FG000|Core Study|Physician Decision|1|||
163868307|NCT01350804|591884794|FG001|Core Study|Physician Decision|0|||
163868308|NCT01350804|591884795|FG002|Core Study|Physician Decision|1|||
163868309|NCT01350804|591884796|FG003|Core Study|Physician Decision|3|||
163868310|NCT01350804|591884793|FG000|Core Study|Lost to Follow-up|3|||
163868311|NCT01350804|591884794|FG001|Core Study|Lost to Follow-up|0|||
164314196|NCT00003590|593527573|FG000|Overall Study|Death|1|||
164314197|NCT00003590|593527573|FG000|Overall Study|Physician Decision|1|||
164314198|NCT01589653|593527576|FG000|Overall Study|Protocol Violation|3|||
164314199|NCT01589653|593527577|FG001|Overall Study|Protocol Violation|1|||
164314200|NCT01589653|593527576|FG000|Overall Study|Withdrawal criteria|4|||
164314201|NCT01589653|593527577|FG001|Overall Study|Withdrawal criteria|7|||
164314202|NCT01589653|593527576|FG000|Overall Study|Unclassified|0|||
164314203|NCT01589653|593527577|FG001|Overall Study|Unclassified|3|||
164314204|NCT01425463|593527583|FG000|Overall Study|Adverse Event|5|||
163972327|NCT02577406|592269818|FG001|Treatment Period|Protocol Violation|1|||
163972328|NCT02577406|592269817|FG000|Treatment Period|Other Reasons|3|||
163972329|NCT02577406|592269818|FG001|Treatment Period|Other Reasons|39|||
164314205|NCT01425463|593527584|FG001|Overall Study|Adverse Event|7|||
164314206|NCT01425463|593527583|FG000|Overall Study|Lack of Efficacy|1|||
163972330|NCT02577406|592269817|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
163868312|NCT01350804|591884795|FG002|Core Study|Lost to Follow-up|2|||
163868313|NCT01350804|591884796|FG003|Core Study|Lost to Follow-up|1|||
163868314|NCT01350804|591884793|FG000|Core Study|Lack of Efficacy|16|||
164135728|NCT02799095|592861971|FG016|Part A|Protocol Deviation|0|||
164135729|NCT02799095|592861955|FG000|Part A|Withdrawal by Subject|0|||
164135730|NCT02799095|592861956|FG001|Part A|Withdrawal by Subject|0|||
164135731|NCT02799095|592861957|FG002|Part A|Withdrawal by Subject|0|||
164135732|NCT02799095|592861958|FG003|Part A|Withdrawal by Subject|1|||
164135733|NCT02799095|592861959|FG004|Part A|Withdrawal by Subject|3|||
164135734|NCT02799095|592861960|FG005|Part A|Withdrawal by Subject|1|||
164135735|NCT02799095|592861961|FG006|Part A|Withdrawal by Subject|1|||
164135736|NCT02799095|592861962|FG007|Part A|Withdrawal by Subject|0|||
164135737|NCT02799095|592861963|FG008|Part A|Withdrawal by Subject|0|||
164314207|NCT01425463|593527584|FG001|Overall Study|Lack of Efficacy|1|||
164314208|NCT01425463|593527583|FG000|Overall Study|Protocol Violation|2|||
164314209|NCT01425463|593527584|FG001|Overall Study|Protocol Violation|2|||
164314210|NCT01425463|593527583|FG000|Overall Study|Lost to Follow-up|5|||
164314211|NCT01425463|593527584|FG001|Overall Study|Lost to Follow-up|2|||
164314212|NCT01425463|593527583|FG000|Overall Study|Withdrawal by Subject|7|||
164314213|NCT01425463|593527584|FG001|Overall Study|Withdrawal by Subject|5|||
164314214|NCT01425463|593527583|FG000|Overall Study|Unknown Reason|4|||
164314215|NCT01425463|593527584|FG001|Overall Study|Unknown Reason|7|||
164314216|NCT01332799|593527587|FG000|Overall Study|Insufficient funding|10|||
164314217|NCT01332799|593527588|FG001|Overall Study|Insufficient funding|10|||
164314218|NCT03467152|593527589|FG000|Overall Study|Adverse Event|4|||
164314219|NCT03467152|593527590|FG001|Overall Study|Adverse Event|5|||
164314220|NCT03467152|593527591|FG002|Overall Study|Adverse Event|0|||
164314221|NCT03467152|593527589|FG000|Overall Study|Subject Choice|1|||
164314222|NCT03467152|593527590|FG001|Overall Study|Subject Choice|3|||
164314223|NCT03467152|593527591|FG002|Overall Study|Subject Choice|0|||
164314224|NCT03467152|593527589|FG000|Overall Study|Lost to Follow-up|1|||
164314225|NCT03467152|593527590|FG001|Overall Study|Lost to Follow-up|0|||
164314226|NCT03467152|593527591|FG002|Overall Study|Lost to Follow-up|0|||
164314227|NCT03467152|593527589|FG000|Overall Study|Withdrawal by Subject|4|||
164314228|NCT03467152|593527590|FG001|Overall Study|Withdrawal by Subject|2|||
164314229|NCT03467152|593527591|FG002|Overall Study|Withdrawal by Subject|0|||
164314230|NCT03467152|593527589|FG000|Overall Study|Others|3|||
164314231|NCT03467152|593527590|FG001|Overall Study|Others|0|||
164314232|NCT03467152|593527591|FG002|Overall Study|Others|0|||
164314233|NCT03467152|593527589|FG000|Overall Study|Not treated|3|||
164314234|NCT03467152|593527590|FG001|Overall Study|Not treated|1|||
164314235|NCT03467152|593527591|FG002|Overall Study|Not treated|6|||
164314236|NCT00945906|593527592|FG000|Overall Study|Withdrawal by Subject|1|||
164314237|NCT00945906|593527592|FG000|Overall Study|Did not want to return for last visit|2|||
164314238|NCT00945906|593527592|FG000|Overall Study|Unable to return for last visit|2|||
164314239|NCT00945906|593527592|FG000|Overall Study|Moved to another country|2|||
164314240|NCT01236547|593527594|FG000|Overall Study|Protocol Violation|0|||
164314241|NCT01236547|593527595|FG001|Overall Study|Protocol Violation|1|||
164314242|NCT01236547|593527596|FG002|Overall Study|Protocol Violation|1|||
164314243|NCT01236547|593527597|FG003|Overall Study|Protocol Violation|6|||
164314244|NCT01236547|593527598|FG004|Overall Study|Protocol Violation|12|||
164314245|NCT01120782|593527599|FG000|Overall Study|Test article shipping error|11|||
164314246|NCT01767142|593527601|FG000|Overall Study|Lost to Follow-up|3|||
164314247|NCT03317405|593527602|FG000|Overall Study|Withdrawal by Subject|1|||
164314248|NCT03317405|593527603|FG001|Overall Study|Withdrawal by Subject|0|||
164314249|NCT03317405|593527604|FG002|Overall Study|Withdrawal by Subject|0|||
164314250|NCT03317405|593527602|FG000|Overall Study|Physician Decision|0|||
164314251|NCT03317405|593527603|FG001|Overall Study|Physician Decision|0|||
164314252|NCT03317405|593527604|FG002|Overall Study|Physician Decision|1|||
164314253|NCT03317405|593527602|FG000|Overall Study|Surgery Rescheduled|0|||
164314254|NCT03317405|593527603|FG001|Overall Study|Surgery Rescheduled|1|||
164314255|NCT03317405|593527604|FG002|Overall Study|Surgery Rescheduled|0|||
164314256|NCT00635219|593527605|FG000|Overall Study|Adverse Event|12|||
164314257|NCT00635219|593527606|FG001|Overall Study|Adverse Event|10|||
164314258|NCT00635219|593527607|FG002|Overall Study|Adverse Event|18|||
164314259|NCT00635219|593527608|FG003|Overall Study|Adverse Event|15|||
164314260|NCT00635219|593527609|FG004|Overall Study|Adverse Event|19|||
164314261|NCT00635219|593527605|FG000|Overall Study|Lack of Efficacy|5|||
164314262|NCT00635219|593527606|FG001|Overall Study|Lack of Efficacy|6|||
164314263|NCT00635219|593527607|FG002|Overall Study|Lack of Efficacy|3|||
164314264|NCT00635219|593527608|FG003|Overall Study|Lack of Efficacy|4|||
164314265|NCT00635219|593527609|FG004|Overall Study|Lack of Efficacy|6|||
164314266|NCT00635219|593527605|FG000|Overall Study|Non-compliance With Study Product|0|||
164314267|NCT00635219|593527606|FG001|Overall Study|Non-compliance With Study Product|0|||
164314268|NCT00635219|593527607|FG002|Overall Study|Non-compliance With Study Product|0|||
164314269|NCT00635219|593527608|FG003|Overall Study|Non-compliance With Study Product|2|||
163868315|NCT01350804|591884794|FG001|Core Study|Lack of Efficacy|19|||
163868316|NCT01350804|591884795|FG002|Core Study|Lack of Efficacy|18|||
163868317|NCT01350804|591884796|FG003|Core Study|Lack of Efficacy|5|||
163868318|NCT01350804|591884793|FG000|Core Study|Death|1|||
163868319|NCT01350804|591884794|FG001|Core Study|Death|1|||
163868320|NCT01350804|591884795|FG002|Core Study|Death|1|||
163868321|NCT01350804|591884796|FG003|Core Study|Death|0|||
163868322|NCT01350804|591884793|FG000|Core Study|Adverse Event|8|||
163868323|NCT01350804|591884794|FG001|Core Study|Adverse Event|10|||
163868324|NCT01350804|591884795|FG002|Core Study|Adverse Event|8|||
164314270|NCT00635219|593527609|FG004|Overall Study|Non-compliance With Study Product|1|||
164314271|NCT00635219|593527605|FG000|Overall Study|Protocol Violation|0|||
164314272|NCT00635219|593527606|FG001|Overall Study|Protocol Violation|2|||
164314273|NCT00635219|593527607|FG002|Overall Study|Protocol Violation|3|||
164314274|NCT00635219|593527608|FG003|Overall Study|Protocol Violation|2|||
164314275|NCT00635219|593527609|FG004|Overall Study|Protocol Violation|4|||
164314276|NCT00635219|593527605|FG000|Overall Study|Withdrawal of Consent|8|||
164314277|NCT00635219|593527606|FG001|Overall Study|Withdrawal of Consent|6|||
164314278|NCT00635219|593527607|FG002|Overall Study|Withdrawal of Consent|8|||
164314279|NCT00635219|593527608|FG003|Overall Study|Withdrawal of Consent|11|||
164314280|NCT00635219|593527609|FG004|Overall Study|Withdrawal of Consent|8|||
164314281|NCT00635219|593527605|FG000|Overall Study|Lost to Follow-up|0|||
164314282|NCT00635219|593527606|FG001|Overall Study|Lost to Follow-up|0|||
164314283|NCT00635219|593527607|FG002|Overall Study|Lost to Follow-up|2|||
164314284|NCT00635219|593527608|FG003|Overall Study|Lost to Follow-up|0|||
164314285|NCT00635219|593527609|FG004|Overall Study|Lost to Follow-up|3|||
164314286|NCT00635219|593527605|FG000|Overall Study|Administrative or Other Reasons|0|||
164314287|NCT00635219|593527606|FG001|Overall Study|Administrative or Other Reasons|1|||
164314288|NCT00635219|593527607|FG002|Overall Study|Administrative or Other Reasons|1|||
164314289|NCT00635219|593527608|FG003|Overall Study|Administrative or Other Reasons|0|||
164314290|NCT00635219|593527609|FG004|Overall Study|Administrative or Other Reasons|1|||
164314291|NCT04093024|593527610|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
164314292|NCT04093024|593527611|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
164314293|NCT04093024|593527610|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
164314294|NCT04093024|593527611|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
164314295|NCT04093024|593527610|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
164314296|NCT04093024|593527611|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
164314297|NCT04093024|593527610|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
164314298|NCT04093024|593527611|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
164314299|NCT01541397|593527616|FG000|Overall Study|Study ended prior to data collection|4|||
164314300|NCT01541397|593527617|FG001|Overall Study|Study ended prior to data collection|2|||
164314301|NCT01290796|593527622|FG000|Overall Study|Lost to Follow-up|21|||
164314302|NCT01290796|593527622|FG000|Overall Study|Withdrawal by Subject|4|||
164314303|NCT01290796|593527622|FG000|Overall Study|Physician Decision|2|||
164314304|NCT01290796|593527622|FG000|Overall Study|Secondary Surgical Intervention|2|||
164314305|NCT01290796|593527622|FG000|Overall Study|Withdrawal by Sponsor|1|||
164314306|NCT00329797|593527623|FG000|Overall Study|Protocol Violation|1|||
164314307|NCT00329797|593527624|FG001|Overall Study|Protocol Violation|0|||
164314308|NCT00329797|593527623|FG000|Overall Study|Withdrawal by Subject|6|||
164314309|NCT00329797|593527624|FG001|Overall Study|Withdrawal by Subject|6|||
164314310|NCT00776919|593527625|FG000|Overall Study|Withdrawal by Subject|16|||
164314311|NCT00776919|593527626|FG001|Overall Study|Withdrawal by Subject|14|||
164314312|NCT00776919|593527627|FG002|Overall Study|Withdrawal by Subject|15|||
164314313|NCT00776919|593527628|FG003|Overall Study|Withdrawal by Subject|26|||
164314314|NCT00776919|593527625|FG000|Overall Study|Lost to Follow-up|8|||
164314315|NCT00776919|593527626|FG001|Overall Study|Lost to Follow-up|12|||
164314316|NCT00776919|593527627|FG002|Overall Study|Lost to Follow-up|11|||
164314317|NCT00776919|593527628|FG003|Overall Study|Lost to Follow-up|8|||
164314318|NCT00776919|593527625|FG000|Overall Study|Adverse Event|1|||
164314319|NCT00776919|593527626|FG001|Overall Study|Adverse Event|0|||
164314320|NCT00776919|593527627|FG002|Overall Study|Adverse Event|2|||
164314321|NCT00776919|593527628|FG003|Overall Study|Adverse Event|2|||
164314322|NCT00776919|593527625|FG000|Overall Study|Protocol Violation|1|||
164314323|NCT00776919|593527626|FG001|Overall Study|Protocol Violation|2|||
164314324|NCT00776919|593527627|FG002|Overall Study|Protocol Violation|0|||
164314325|NCT00776919|593527628|FG003|Overall Study|Protocol Violation|1|||
164314326|NCT00776919|593527625|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
164314327|NCT00776919|593527626|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
164314328|NCT00776919|593527627|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
164314329|NCT00776919|593527628|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
163868325|NCT01350804|591884796|FG003|Core Study|Adverse Event|8|||
163868326|NCT01350804|591884793|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
163868327|NCT01350804|591884794|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
163868328|NCT01350804|591884795|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
163868329|NCT01350804|591884796|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
163868330|NCT01350804|591884793|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
163868331|NCT01350804|591884794|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
163868332|NCT01350804|591884795|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
163868333|NCT01350804|591884796|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
163868334|NCT01350804|591884793|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
163868335|NCT01350804|591884794|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
163868336|NCT01350804|591884795|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
163868337|NCT01350804|591884796|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
163868338|NCT01350804|591884793|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
163868339|NCT01350804|591884794|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
164314330|NCT03091348|593527644|FG000|Overall Study|Lost to Follow-up|2|||
164314331|NCT03091348|593527645|FG001|Overall Study|Lost to Follow-up|1|||
164203175|NCT00853385|593116475|FG002|Overall Study|Adverse Event|2|||
164203176|NCT00853385|593116476|FG003|Overall Study|Adverse Event|5|||
164203177|NCT00853385|593116477|FG004|Overall Study|Adverse Event|22|||
164203178|NCT00853385|593116473|FG000|Overall Study|Lack of Efficacy|6|||
164203179|NCT00853385|593116474|FG001|Overall Study|Lack of Efficacy|7|||
163868340|NCT01350804|591884795|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
163868341|NCT01350804|591884796|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
163868342|NCT01350804|591884793|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
163868343|NCT01350804|591884794|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
163868344|NCT01350804|591884795|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
163868345|NCT01350804|591884796|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
163868346|NCT01350804|591884793|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
163868347|NCT01350804|591884794|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
163868348|NCT01350804|591884795|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
163868349|NCT01350804|591884796|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
163868350|NCT00026312|591884797|FG000|Overall Study|Adverse Event|0|||
163868351|NCT00026312|591884798|FG001|Overall Study|Adverse Event|32|||
163868352|NCT00026312|591884797|FG000|Overall Study|Death|1|||
163868353|NCT00026312|591884798|FG001|Overall Study|Death|7|||
163868354|NCT00026312|591884797|FG000|Overall Study|Lack of Efficacy|19|||
163868355|NCT00026312|591884798|FG001|Overall Study|Lack of Efficacy|114|||
163868356|NCT00026312|591884797|FG000|Overall Study|Lost to Follow-up|0|||
163868357|NCT00026312|591884798|FG001|Overall Study|Lost to Follow-up|5|||
163868358|NCT00026312|591884797|FG000|Overall Study|Physician Decision|1|||
163868359|NCT00026312|591884798|FG001|Overall Study|Physician Decision|37|||
163868360|NCT00026312|591884797|FG000|Overall Study|Protocol Violation|0|||
163868361|NCT00026312|591884798|FG001|Overall Study|Protocol Violation|3|||
163868362|NCT00026312|591884797|FG000|Overall Study|Withdrawal by Subject|1|||
163868363|NCT00026312|591884798|FG001|Overall Study|Withdrawal by Subject|6|||
164203180|NCT00853385|593116475|FG002|Overall Study|Lack of Efficacy|3|||
164203181|NCT00853385|593116476|FG003|Overall Study|Lack of Efficacy|3|||
164203182|NCT00853385|593116477|FG004|Overall Study|Lack of Efficacy|6|||
164203183|NCT00853385|593116473|FG000|Overall Study|Lost to Follow-up|2|||
164203184|NCT00853385|593116474|FG001|Overall Study|Lost to Follow-up|1|||
164203185|NCT00853385|593116475|FG002|Overall Study|Lost to Follow-up|0|||
164203186|NCT00853385|593116476|FG003|Overall Study|Lost to Follow-up|0|||
164203187|NCT00853385|593116477|FG004|Overall Study|Lost to Follow-up|0|||
164203188|NCT00853385|593116473|FG000|Overall Study|Withdrawal by Subject|4|||
164203189|NCT00853385|593116474|FG001|Overall Study|Withdrawal by Subject|2|||
164203190|NCT00853385|593116475|FG002|Overall Study|Withdrawal by Subject|0|||
164203191|NCT00853385|593116476|FG003|Overall Study|Withdrawal by Subject|1|||
164203192|NCT00853385|593116477|FG004|Overall Study|Withdrawal by Subject|1|||
164203193|NCT00853385|593116473|FG000|Overall Study|Other|18|||
164203194|NCT00853385|593116474|FG001|Overall Study|Other|9|||
164203195|NCT00853385|593116475|FG002|Overall Study|Other|4|||
164203196|NCT00853385|593116476|FG003|Overall Study|Other|4|||
164203197|NCT00853385|593116477|FG004|Overall Study|Other|12|||
164203198|NCT00577408|593116478|FG000|Overall Study|Stopped attending study visits|9|||
164203199|NCT00577408|593116479|FG001|Overall Study|Stopped attending study visits|11|||
164203200|NCT00577408|593116478|FG000|Overall Study|Continued opioid use|3|||
164203201|NCT00577408|593116479|FG001|Overall Study|Continued opioid use|2|||
164203202|NCT00577408|593116478|FG000|Overall Study|Non-compliance with study meds|0|||
164203203|NCT00577408|593116479|FG001|Overall Study|Non-compliance with study meds|3|||
164203204|NCT00577408|593116478|FG000|Overall Study|Refused Oral Naltrexone|0|||
164203205|NCT00577408|593116479|FG001|Overall Study|Refused Oral Naltrexone|1|||
164203206|NCT00577408|593116478|FG000|Overall Study|Moved out of state|0|||
164203207|NCT00577408|593116479|FG001|Overall Study|Moved out of state|1|||
164203208|NCT00577408|593116478|FG000|Overall Study|Scheduling Issues|0|||
164203209|NCT00577408|593116479|FG001|Overall Study|Scheduling Issues|3|||
164203210|NCT00577408|593116478|FG000|Overall Study|Death|0|||
164203211|NCT00577408|593116479|FG001|Overall Study|Death|1|||
164203212|NCT00577408|593116478|FG000|Overall Study|Psychiatric hospitalization|0|||
164203213|NCT00577408|593116479|FG001|Overall Study|Psychiatric hospitalization|1|||
164203214|NCT01829347|593116480|FG000|VTI-210|Death|5|||
164203215|NCT01829347|593116481|FG001|VTI-210|Death|3|||
164203216|NCT01829347|593116480|FG000|VTI-210|Withdrawal by Subject|1|||
164203217|NCT01829347|593116481|FG001|VTI-210|Withdrawal by Subject|0|||
163868364|NCT00026312|591884797|FG000|Overall Study|Ineligible|4|||
164203218|NCT01829347|593116480|FG000|VTI-210E|Death|2|||
164203219|NCT01829347|593116481|FG001|VTI-210E|Death|1|||
164203220|NCT01829347|593116480|FG000|VTI-210E|Study terminated prematurely|1|||
164203221|NCT01829347|593116481|FG001|VTI-210E|Study terminated prematurely|5|||
164203222|NCT03055013|593116482|FG000|Overall Study|Adverse Event|78|||
164203223|NCT03055013|593116483|FG001|Overall Study|Adverse Event|0|||
164203224|NCT03055013|593116482|FG000|Overall Study|Death|6|||
164203225|NCT03055013|593116483|FG001|Overall Study|Death|0|||
164203226|NCT03055013|593116482|FG000|Overall Study|Disease relapse|33|||
164203227|NCT03055013|593116483|FG001|Overall Study|Disease relapse|0|||
164203228|NCT03055013|593116482|FG000|Overall Study|Withdrawal by Subject|28|||
163972331|NCT02577406|592269818|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
163972332|NCT01555151|592269821|FG000|Overall Study|Withdrawal by Subject|6|||
163972333|NCT01555151|592269822|FG001|Overall Study|Withdrawal by Subject|2|||
163972334|NCT01555151|592269823|FG002|Overall Study|Withdrawal by Subject|0|||
163972335|NCT01555151|592269824|FG003|Overall Study|Withdrawal by Subject|2|||
163972336|NCT01555151|592269821|FG000|Overall Study|Administrative|3|||
163972337|NCT01555151|592269822|FG001|Overall Study|Administrative|1|||
163972338|NCT01555151|592269823|FG002|Overall Study|Administrative|2|||
163972339|NCT01555151|592269824|FG003|Overall Study|Administrative|0|||
163972340|NCT01555151|592269821|FG000|Overall Study|Protocol Violation|3|||
163972341|NCT01555151|592269822|FG001|Overall Study|Protocol Violation|3|||
164203229|NCT03055013|593116483|FG001|Overall Study|Withdrawal by Subject|0|||
164203230|NCT03055013|593116482|FG000|Overall Study|Other complicating disease|5|||
164203231|NCT03055013|593116483|FG001|Overall Study|Other complicating disease|0|||
164203232|NCT03055013|593116482|FG000|Overall Study|Physician Decision|1|||
164203233|NCT03055013|593116483|FG001|Overall Study|Physician Decision|0|||
164203234|NCT03055013|593116482|FG000|Overall Study|Benign mass/non-RCC|4|||
164203235|NCT03055013|593116483|FG001|Overall Study|Benign mass/non-RCC|0|||
164203236|NCT03055013|593116482|FG000|Overall Study|Enrolled in another trial|1|||
164203237|NCT03055013|593116483|FG001|Overall Study|Enrolled in another trial|0|||
164203238|NCT03055013|593116482|FG000|Overall Study|Non-protocol therapy|1|||
164203239|NCT03055013|593116483|FG001|Overall Study|Non-protocol therapy|0|||
164203240|NCT03055013|593116482|FG000|Overall Study|Incompliance|1|||
164203241|NCT03055013|593116483|FG001|Overall Study|Incompliance|0|||
164203242|NCT03055013|593116482|FG000|Overall Study|Insurance issues|1|||
164203243|NCT03055013|593116483|FG001|Overall Study|Insurance issues|0|||
164203244|NCT03055013|593116482|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
164203245|NCT03055013|593116483|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
164203246|NCT03055013|593116482|FG000|Overall Study|Did not receive nivolumab|10|||
164203247|NCT03055013|593116483|FG001|Overall Study|Did not receive nivolumab|0|||
164203248|NCT03055013|593116482|FG000|Overall Study|Did not receive surgery|0|||
164203249|NCT03055013|593116483|FG001|Overall Study|Did not receive surgery|28|||
164203250|NCT03435055|593116484|FG000|Screening|Physician Decision|2|||
164203251|NCT03435055|593116484|FG000|Received Intervention|Did not complete nitrous administration|3|||
164203252|NCT03817528|593116487|FG000|Overall Study|Withdrawal by Subject|1|||
164203253|NCT03817528|593116487|FG000|Overall Study|Adverse Event|2|||
164203254|NCT00671749|593116488|FG000|Overall Study|Adverse Event|2|||
164203255|NCT00671749|593116488|FG000|Overall Study|Withdrawal by Subject|4|||
164203256|NCT00671749|593116488|FG000|Overall Study|Protocol Violation|1|||
164203257|NCT00671749|593116488|FG000|Overall Study|Lost to Follow-up|1|||
164203258|NCT00485303|593116489|FG000|Overall Study|Adverse Event|5|||
164203259|NCT00485303|593116489|FG000|Overall Study|Progressive Disease|44|||
164203260|NCT00485303|593116489|FG000|Overall Study|Other|3|||
164203261|NCT00485303|593116489|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
164203262|NCT00485303|593116489|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
164203263|NCT00296335|593116494|FG000|Overall Study|Recurrence|3|||
164203264|NCT00296335|593116495|FG001|Overall Study|Recurrence|51|||
164203265|NCT00296335|593116494|FG000|Overall Study|Adverse Event|17|||
164203266|NCT00296335|593116495|FG001|Overall Study|Adverse Event|27|||
164203267|NCT00296335|593116494|FG000|Overall Study|Lost to Follow-up|7|||
164203268|NCT00296335|593116495|FG001|Overall Study|Lost to Follow-up|33|||
164203269|NCT00296335|593116494|FG000|Overall Study|Physician Decision|3|||
164203270|NCT00296335|593116495|FG001|Overall Study|Physician Decision|11|||
164203271|NCT00830128|593116496|FG000|Overall Study|Adverse Event|5|||
164203272|NCT00830128|593116496|FG000|Overall Study|Lack of Efficacy|7|||
164203273|NCT00830128|593116496|FG000|Overall Study|Protocol Violation|1|||
164203274|NCT00830128|593116496|FG000|Overall Study|Withdrawal by Subject|2|||
164203275|NCT00830128|593116496|FG000|Overall Study|Family obligation|1|||
164203276|NCT00830128|593116496|FG000|Overall Study|Relocation|1|||
164203277|NCT00830128|593116496|FG000|Overall Study|Work obligation|1|||
164203278|NCT00830128|593116496|FG000|Overall Study|Operating a vehicle|1|||
164203279|NCT01123655|593116501|FG000|Overall Study|Medication for RA had to be changed|1|||
164203280|NCT01123655|593116502|FG001|Overall Study|Medication for RA had to be changed|0|||
164203281|NCT01123655|593116503|FG002|Overall Study|Medication for RA had to be changed|0|||
164203282|NCT01123655|593116501|FG000|Overall Study|new illness|0|||
164203283|NCT01123655|593116502|FG001|Overall Study|new illness|1|||
164203284|NCT01123655|593116503|FG002|Overall Study|new illness|0|||
164203285|NCT01123655|593116501|FG000|Overall Study|began prohibitive drug|0|||
164203286|NCT01123655|593116502|FG001|Overall Study|began prohibitive drug|0|||
164203287|NCT01123655|593116503|FG002|Overall Study|began prohibitive drug|1|||
164203288|NCT03329885|593116508|FG000|Overall Study|Sponsor discontinued the study early|0|||
164203289|NCT03329885|593116509|FG001|Overall Study|Sponsor discontinued the study early|0|||
164203290|NCT03329885|593116510|FG002|Overall Study|Sponsor discontinued the study early|0|||
164203291|NCT03329885|593116511|FG003|Overall Study|Sponsor discontinued the study early|0|||
164203292|NCT03329885|593116512|FG004|Overall Study|Sponsor discontinued the study early|0|||
164203293|NCT03329885|593116513|FG005|Overall Study|Sponsor discontinued the study early|0|||
164302987|NCT01198977|593484681|FG001|Overall Study|Lost to Follow-up|0|||
164203294|NCT03329885|593116514|FG006|Overall Study|Sponsor discontinued the study early|1|||
164203295|NCT03329885|593116515|FG007|Overall Study|Sponsor discontinued the study early|1|||
164203296|NCT03329885|593116516|FG008|Overall Study|Sponsor discontinued the study early|0|||
164203297|NCT04004000|593116517|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
164203298|NCT02121210|593116518|FG000|Overall Study|Adverse Event|5|||
164203299|NCT02121210|593116519|FG001|Overall Study|Adverse Event|7|||
164203300|NCT02121210|593116518|FG000|Overall Study|Lack of Efficacy|2|||
164203301|NCT02121210|593116519|FG001|Overall Study|Lack of Efficacy|0|||
164203302|NCT02121210|593116518|FG000|Overall Study|Other than specified above|0|||
164203303|NCT02121210|593116519|FG001|Overall Study|Other than specified above|2|||
164203304|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
164203305|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
164203306|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203307|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203308|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203309|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203310|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203311|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203312|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203313|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
164203314|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
164203315|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
164203316|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203317|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203318|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203319|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203320|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203321|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203322|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203323|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164203324|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
164203325|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203326|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203327|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203328|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203329|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203330|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203331|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203332|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203333|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
164203334|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
164203335|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
164203336|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203337|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203338|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203339|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203340|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203341|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203342|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203343|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164203344|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
164203345|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
164203346|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203347|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203348|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203349|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203350|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203351|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203352|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203353|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
164203354|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
164203355|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
164314332|NCT02969655|593527648|FG000|Overall Study|Withdrawal by Subject|3|||
163868365|NCT00026312|591884798|FG001|Overall Study|Ineligible|5|||
163868366|NCT00026312|591884797|FG000|Overall Study|Entry onto another COG study|0|||
163868367|NCT00026312|591884798|FG001|Overall Study|Entry onto another COG study|1|||
163868368|NCT00026312|591884797|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
163868369|NCT00026312|591884798|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
163868370|NCT02611037|591884799|FG000|Overall Study|Withdrawal prior to treatment|2|||
163868371|NCT02611037|591884800|FG001|Overall Study|Withdrawal prior to treatment|0|||
163868372|NCT05850520|591884803|FG000|Overall Study|Withdrawal by Subject|8|||
163868373|NCT05850520|591884804|FG001|Overall Study|Withdrawal by Subject|8|||
163972342|NCT01555151|592269823|FG002|Overall Study|Protocol Violation|3|||
163972343|NCT01555151|592269824|FG003|Overall Study|Protocol Violation|5|||
163972344|NCT01555151|592269821|FG000|Overall Study|Adverse Event|1|||
163972345|NCT01555151|592269822|FG001|Overall Study|Adverse Event|2|||
163972346|NCT01555151|592269823|FG002|Overall Study|Adverse Event|1|||
163972347|NCT01555151|592269824|FG003|Overall Study|Adverse Event|2|||
163972348|NCT01555151|592269821|FG000|Overall Study|Lost to Follow-up|0|||
164203356|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203357|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203358|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203359|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203360|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203361|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203362|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203363|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
164203364|NCT01232283|593116522|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
164203365|NCT01232283|593116523|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
164203366|NCT01232283|593116524|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203367|NCT01232283|593116525|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203368|NCT01232283|593116526|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203369|NCT01232283|593116527|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203370|NCT01232283|593116528|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203371|NCT01232283|593116529|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203372|NCT01232283|593116530|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203373|NCT01232283|593116531|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
164203374|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203375|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203376|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
164203377|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
164203378|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203379|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203380|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203381|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203382|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203383|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
164203384|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203385|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203386|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
164203387|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
164203388|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203389|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203390|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203391|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203392|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203393|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
164203394|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203395|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203396|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
164203397|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203398|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203399|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203400|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203401|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
163868374|NCT05850520|591884805|FG002|Overall Study|Withdrawal by Subject|16|||
163868375|NCT05850520|591884803|FG000|Overall Study|Lost to Follow-up|2|||
163868376|NCT05850520|591884804|FG001|Overall Study|Lost to Follow-up|2|||
163868377|NCT05850520|591884805|FG002|Overall Study|Lost to Follow-up|2|||
163868378|NCT05850520|591884803|FG000|Overall Study|Death|2|||
163972349|NCT01555151|592269822|FG001|Overall Study|Lost to Follow-up|0|||
163972350|NCT01555151|592269823|FG002|Overall Study|Lost to Follow-up|0|||
163972351|NCT01555151|592269824|FG003|Overall Study|Lost to Follow-up|1|||
163972352|NCT01961349|592269825|FG000|Overall Study|Withdrawal by Subject|1|||
164302988|NCT03205423|593484682|FG000|Overall Study|Personal|1|||
164314333|NCT02969655|593527649|FG001|Overall Study|Withdrawal by Subject|2|||
164314334|NCT02969655|593527648|FG000|Overall Study|Physician Decision|4|||
164314335|NCT02969655|593527649|FG001|Overall Study|Physician Decision|3|||
164314336|NCT02969655|593527648|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
164314337|NCT02969655|593527649|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
164314338|NCT02969655|593527648|FG000|Overall Study|Adverse Event|10|||
164314339|NCT02969655|593527649|FG001|Overall Study|Adverse Event|8|||
164314340|NCT03753789|593527650|FG000|Overall Study|Withdrawal by Subject|2|||
164314341|NCT00853567|593527653|FG000|Overall Study|Study prematurely terminated|71|||
164314342|NCT02055118|593527657|FG000|Overall Study|Withdrawal by Subject|0|||
164314343|NCT02055118|593527658|FG001|Overall Study|Withdrawal by Subject|2|||
164314344|NCT02055118|593527659|FG002|Overall Study|Withdrawal by Subject|0|||
164314345|NCT02281383|593527661|FG000|Overall Study|Progressive Disease|1|||
164314346|NCT02281383|593527661|FG000|Overall Study|Withdrawal by Subject|6|||
164314347|NCT02281383|593527661|FG000|Overall Study|Protocol Violation|2|||
164314348|NCT02281383|593527661|FG000|Overall Study|Death|1|||
164314349|NCT02281383|593527661|FG000|Overall Study|Adverse Event|2|||
164314350|NCT01324141|593527662|FG000|Overall Study|Declined to participate before treatment started|1|||
164314351|NCT01324141|593527662|FG000|Overall Study|Disease progression on study|1|||
164314352|NCT01001325|593527664|FG000|Overall Study|Lost to Follow-up|16|||
164314353|NCT01001325|593527665|FG001|Overall Study|Lost to Follow-up|10|||
164314354|NCT01001325|593527664|FG000|Overall Study|Protocol Violation|2|||
164314355|NCT01001325|593527665|FG001|Overall Study|Protocol Violation|0|||
164314356|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
163868379|NCT05850520|591884804|FG001|Overall Study|Death|2|||
163868380|NCT05850520|591884805|FG002|Overall Study|Death|3|||
163868381|NCT05850520|591884803|FG000|Overall Study|Adverse Event|2|||
163868382|NCT05850520|591884804|FG001|Overall Study|Adverse Event|0|||
163868383|NCT05850520|591884805|FG002|Overall Study|Adverse Event|1|||
163868384|NCT05850520|591884803|FG000|Overall Study|Physician Decision|0|||
163868385|NCT05850520|591884804|FG001|Overall Study|Physician Decision|1|||
163868386|NCT05850520|591884805|FG002|Overall Study|Physician Decision|0|||
163868387|NCT05850520|591884803|FG000|Overall Study|Protocol deviation|0|||
163868388|NCT05850520|591884804|FG001|Overall Study|Protocol deviation|0|||
163868389|NCT05850520|591884805|FG002|Overall Study|Protocol deviation|1|||
163868390|NCT05850520|591884803|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
163868391|NCT05850520|591884804|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
163868392|NCT05850520|591884805|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
163868393|NCT01170026|591885856|FG000|Overall Study|Lost to Follow-up|4|||
163868394|NCT01170026|591885857|FG001|Overall Study|Lost to Follow-up|2|||
163868395|NCT03785782|591885858|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
163868396|NCT03785782|591885859|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
163868397|NCT03785782|591885858|FG000|Overall Study|Withdrawal by Subject|1|||
163868398|NCT03785782|591885859|FG001|Overall Study|Withdrawal by Subject|1|||
163868399|NCT03785782|591885858|FG000|Overall Study|insufficient image quality.|3|||
163868400|NCT03785782|591885859|FG001|Overall Study|insufficient image quality.|0|||
163868401|NCT03889925|591885860|FG000|Overall Study|Lost to Follow-up|11|||
163868402|NCT03889925|591885861|FG001|Overall Study|Lost to Follow-up|10|||
163868403|NCT05777785|591885862|FG000|Overall Study|Withdrawal by Subject|5|||
163868404|NCT05777785|591885862|FG000|Overall Study|Lost to Follow-up|1|||
163868405|NCT04817670|591885863|FG000|Overall Study|Withdrawal by Subject|1|||
163868406|NCT04817670|591885864|FG001|Overall Study|Withdrawal by Subject|0|||
163868407|NCT04817670|591885865|FG002|Overall Study|Withdrawal by Subject|0|||
163868408|NCT04817670|591885866|FG003|Overall Study|Withdrawal by Subject|0|||
163868409|NCT04817670|591885867|FG004|Overall Study|Withdrawal by Subject|0|||
163868410|NCT04817670|591885863|FG000|Overall Study|Lost to Follow-up|0|||
163868411|NCT04817670|591885864|FG001|Overall Study|Lost to Follow-up|0|||
163868412|NCT04817670|591885865|FG002|Overall Study|Lost to Follow-up|1|||
163868413|NCT04817670|591885866|FG003|Overall Study|Lost to Follow-up|0|||
163972353|NCT01961349|592269826|FG001|Overall Study|Withdrawal by Subject|4|||
163972354|NCT01961349|592269827|FG002|Overall Study|Withdrawal by Subject|0|||
163972355|NCT01961349|592269825|FG000|Overall Study|Adverse Event|0|||
164314357|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314358|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314359|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314360|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
164314361|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
164314362|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
164314363|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
164314364|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
164314365|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
164314366|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
164314367|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314368|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
163868414|NCT04817670|591885867|FG004|Overall Study|Lost to Follow-up|0|||
164314369|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314370|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
164314371|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
164314372|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
164314373|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
164314374|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
164314375|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
164314376|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
164314377|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314378|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314379|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314380|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
164314381|NCT01584440|593527668|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314382|NCT01584440|593527669|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
164314383|NCT01584440|593527670|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314384|NCT01584440|593527671|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314385|NCT01584440|593527672|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
164314386|NCT01584440|593527668|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
164314387|NCT01584440|593527669|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
164314388|NCT01584440|593527670|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
164314389|NCT01584440|593527671|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
164314390|NCT01584440|593527672|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
164314391|NCT01584440|593527668|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
164314392|NCT01584440|593527669|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
164314393|NCT01584440|593527670|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
164314394|NCT01584440|593527671|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
163868415|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
163868416|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
163868417|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
163868418|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
163868419|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
163868420|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
163868421|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
163868422|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
163868423|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
163868424|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
163868425|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
163868426|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
163868427|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
163868428|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
163868429|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
163868430|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
163868431|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
163868432|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
163868433|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
163868434|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
163868435|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
163868436|NCT00304031|591885868|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
163868437|NCT00304031|591885869|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
163868438|NCT00304031|591885870|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
163868439|NCT00304031|591885868|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
163868440|NCT00304031|591885869|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
163868441|NCT00304031|591885870|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
163868442|NCT01188655|591885874|FG000|Overall Study|Lack of Efficacy|1|||
163868443|NCT01188655|591885874|FG000|Overall Study|Lost to Follow-up|1|||
163868444|NCT01188655|591885874|FG000|Overall Study|Other|11|||
163868445|NCT00089544|591885875|FG000|Overall Study|Ineligible|1|||
163868446|NCT00089544|591885876|FG001|Overall Study|Ineligible|0|||
163868447|NCT02396316|591885877|FG000|Overall Study|Physician Decision|1|||
164314395|NCT01584440|593527672|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
164314396|NCT01584440|593527668|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314397|NCT01584440|593527669|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314398|NCT01584440|593527670|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
164314399|NCT01584440|593527671|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314400|NCT01584440|593527672|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
164314401|NCT00599339|593527673|FG000|Overall Study|Adverse Event|79|||
164314402|NCT00599339|593527673|FG000|Overall Study|Withdrawal by Subject|137|||
164314403|NCT00599339|593527673|FG000|Overall Study|Other Reason|179|||
164314404|NCT00599339|593527673|FG000|Overall Study|Lost to Follow-up|221|||
164314405|NCT00599339|593527673|FG000|Overall Study|No valid data consent|36|||
164314406|NCT00599339|593527673|FG000|Overall Study|Study Termination Status Unknown|12|||
164314407|NCT00531427|593527674|FG000|Overall Study|Withdrawal by Subject|7|||
164314408|NCT00531427|593527675|FG001|Overall Study|Withdrawal by Subject|13|||
164314409|NCT00531427|593527674|FG000|Overall Study|Adverse Event|44|||
164314410|NCT00531427|593527675|FG001|Overall Study|Adverse Event|30|||
164314411|NCT00531427|593527674|FG000|Overall Study|Lost to Follow-up|4|||
164314412|NCT00531427|593527675|FG001|Overall Study|Lost to Follow-up|3|||
164314413|NCT00531427|593527674|FG000|Overall Study|Lack of Efficacy|14|||
164314414|NCT00531427|593527675|FG001|Overall Study|Lack of Efficacy|39|||
164314415|NCT00531427|593527674|FG000|Overall Study|Administrative|4|||
164314416|NCT00531427|593527675|FG001|Overall Study|Administrative|9|||
164314417|NCT05688670|593527676|FG000|Overall Study|Change in surgery plan|1|||
164314418|NCT05688670|593527677|FG001|Overall Study|Change in surgery plan|4|||
164314419|NCT05688670|593527676|FG000|Overall Study|Inability to extubate|1|||
164314420|NCT05688670|593527677|FG001|Overall Study|Inability to extubate|2|||
164314421|NCT05688670|593527676|FG000|Overall Study|Day of surgery cancellation|0|||
164314422|NCT05688670|593527677|FG001|Overall Study|Day of surgery cancellation|1|||
164314423|NCT05688670|593527676|FG000|Overall Study|Reintubated on PCICU arrival|0|||
164314424|NCT05688670|593527677|FG001|Overall Study|Reintubated on PCICU arrival|1|||
164314425|NCT00488683|593527678|FG000|Overall Study|Withdrawal by Subject|1|||
164314426|NCT00488683|593527679|FG001|Overall Study|Withdrawal by Subject|2|||
164314427|NCT00488683|593527680|FG002|Overall Study|Withdrawal by Subject|2|||
164314428|NCT00488683|593527678|FG000|Overall Study|Lost to Follow-up|5|||
164314429|NCT00488683|593527679|FG001|Overall Study|Lost to Follow-up|3|||
164314430|NCT00488683|593527680|FG002|Overall Study|Lost to Follow-up|0|||
164314431|NCT00488683|593527678|FG000|Overall Study|Protocol Violation|5|||
164314432|NCT00488683|593527679|FG001|Overall Study|Protocol Violation|1|||
164314433|NCT00488683|593527680|FG002|Overall Study|Protocol Violation|0|||
164314434|NCT00488683|593527678|FG000|Overall Study|Unable to Classify|1|||
164314435|NCT00488683|593527679|FG001|Overall Study|Unable to Classify|0|||
164314436|NCT00488683|593527680|FG002|Overall Study|Unable to Classify|0|||
164314437|NCT00336856|593529651|FG000|Overall Study|Withdrawal by Subject|3|||
164314438|NCT00336856|593529651|FG000|Overall Study|Found ineligible at time of analysis|1|||
164314439|NCT00843778|593529664|FG000|Overall Study|Adverse Event|15|||
164314440|NCT00843778|593529664|FG000|Overall Study|Lack of Efficacy|14|||
164314441|NCT00843778|593529664|FG000|Overall Study|Loss of efficacy|2|||
164314442|NCT00843778|593529664|FG000|Overall Study|Withdrawal by Subject|4|||
164314443|NCT00830869|593529667|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
164314444|NCT00830869|593529668|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
164314445|NCT00830869|593529669|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
164314446|NCT00830869|593529670|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
164314447|NCT00830869|593529671|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
164314448|NCT00830869|593529672|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
164314449|NCT00830869|593529673|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
164314450|NCT00830869|593529674|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
164314451|NCT00830869|593529675|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
164314452|NCT00830869|593529676|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
164314453|NCT00830869|593529677|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
164314454|NCT00830869|593529678|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
164314455|NCT00830869|593529667|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
164314456|NCT00830869|593529668|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
164314457|NCT00830869|593529669|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
164314458|NCT00830869|593529670|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
164314459|NCT00830869|593529671|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
164314460|NCT00830869|593529672|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
164314461|NCT00830869|593529673|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
164314462|NCT00830869|593529674|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
164314463|NCT00830869|593529675|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
164314464|NCT00830869|593529676|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
164314465|NCT00830869|593529677|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
164314466|NCT00830869|593529678|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
164314467|NCT00830869|593529667|FG000|Period 1: Part 1|Adverse Event|0|||
164314468|NCT00830869|593529668|FG001|Period 1: Part 1|Adverse Event|0|||
164314469|NCT00830869|593529669|FG002|Period 1: Part 1|Adverse Event|0|||
164314470|NCT00830869|593529670|FG003|Period 1: Part 1|Adverse Event|0|||
164314471|NCT00830869|593529671|FG004|Period 1: Part 1|Adverse Event|0|||
164314472|NCT00830869|593529672|FG005|Period 1: Part 1|Adverse Event|1|||
164314473|NCT00830869|593529673|FG006|Period 1: Part 1|Adverse Event|1|||
163868448|NCT02396316|591885878|FG001|Overall Study|Physician Decision|0|||
163868449|NCT02396316|591885877|FG000|Overall Study|Progressive disease|6|||
163868450|NCT02396316|591885878|FG001|Overall Study|Progressive disease|3|||
163868451|NCT02396316|591885877|FG000|Overall Study|Protocol Violation|0|||
164314474|NCT00830869|593529674|FG007|Period 1: Part 1|Adverse Event|0|||
164314475|NCT00830869|593529675|FG008|Period 1: Part 1|Adverse Event|0|||
164314476|NCT00830869|593529676|FG009|Period 1: Part 1|Adverse Event|0|||
164314477|NCT00830869|593529677|FG010|Period 1: Part 1|Adverse Event|0|||
164314478|NCT00830869|593529678|FG011|Period 1: Part 1|Adverse Event|0|||
163868452|NCT02396316|591885878|FG001|Overall Study|Protocol Violation|1|||
163868453|NCT02396316|591885877|FG000|Overall Study|Treatment unblinded|0|||
163868454|NCT02396316|591885878|FG001|Overall Study|Treatment unblinded|1|||
163868455|NCT01823536|591885879|FG000|Overall Study|Lost to Follow-up|1|||
164203402|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203403|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
164203404|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203405|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203406|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
164203407|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
164203408|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203409|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203410|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203411|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203412|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203413|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
164203414|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203415|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203416|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
164203417|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
164203418|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203419|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203420|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203421|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203422|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203423|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
164203424|NCT01232283|593116522|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
164203425|NCT01232283|593116523|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
164203426|NCT01232283|593116524|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
164203427|NCT01232283|593116525|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
164203428|NCT01232283|593116526|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
164203429|NCT01232283|593116527|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
164203430|NCT01232283|593116528|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
164203431|NCT01232283|593116529|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
164203432|NCT01232283|593116530|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
164203433|NCT01232283|593116531|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
164203434|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203435|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203436|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203437|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
163868456|NCT01823536|591885880|FG001|Overall Study|Lost to Follow-up|0|||
163868457|NCT01823536|591885881|FG002|Overall Study|Lost to Follow-up|0|||
163972356|NCT01961349|592269826|FG001|Overall Study|Adverse Event|0|||
163972357|NCT01961349|592269827|FG002|Overall Study|Adverse Event|1|||
163972358|NCT01961349|592269825|FG000|Overall Study|registration error, personal reason etc|2|||
163972359|NCT01961349|592269826|FG001|Overall Study|registration error, personal reason etc|2|||
163972360|NCT01961349|592269827|FG002|Overall Study|registration error, personal reason etc|1|||
163972361|NCT02343159|592269833|FG000|Overall Study|Early Study Termination|16|||
163972362|NCT02343159|592269834|FG001|Overall Study|Early Study Termination|19|||
163972363|NCT02343159|592269835|FG002|Overall Study|Early Study Termination|23|||
163972364|NCT02343159|592269833|FG000|Overall Study|Physician Decision|2|||
163972365|NCT02343159|592269834|FG001|Overall Study|Physician Decision|0|||
163972366|NCT02343159|592269835|FG002|Overall Study|Physician Decision|1|||
163972367|NCT02343159|592269833|FG000|Overall Study|Withdrawal by Subject|3|||
163972368|NCT02343159|592269834|FG001|Overall Study|Withdrawal by Subject|0|||
163972369|NCT02343159|592269835|FG002|Overall Study|Withdrawal by Subject|2|||
163972370|NCT02343159|592269833|FG000|Overall Study|Lost to Follow-up|0|||
163972371|NCT02343159|592269834|FG001|Overall Study|Lost to Follow-up|2|||
163972372|NCT02343159|592269835|FG002|Overall Study|Lost to Follow-up|2|||
163972373|NCT02343159|592269833|FG000|Overall Study|Adverse Event|4|||
163972374|NCT02343159|592269834|FG001|Overall Study|Adverse Event|4|||
163972375|NCT02343159|592269835|FG002|Overall Study|Adverse Event|2|||
163972376|NCT02343159|592269833|FG000|Overall Study|Sponsor Decision|0|||
163972377|NCT02343159|592269834|FG001|Overall Study|Sponsor Decision|1|||
163972378|NCT02343159|592269835|FG002|Overall Study|Sponsor Decision|0|||
163972379|NCT02343159|592269833|FG000|Overall Study|Enrollment Error|1|||
163972380|NCT02343159|592269834|FG001|Overall Study|Enrollment Error|0|||
163972381|NCT02343159|592269835|FG002|Overall Study|Enrollment Error|0|||
163972382|NCT02114268|592269838|FG000|Overall Study|Lost to Follow-up|4|||
163868458|NCT01823536|591885882|FG003|Overall Study|Lost to Follow-up|1|||
163868459|NCT01823536|591885883|FG004|Overall Study|Lost to Follow-up|1|||
163868460|NCT01823536|591885884|FG005|Overall Study|Lost to Follow-up|0|||
163868461|NCT01823536|591885879|FG000|Overall Study|Protocol Violation|0|||
164314479|NCT00830869|593529667|FG000|Period 1: Part 1|Progressive disease|1|||
164314480|NCT00830869|593529668|FG001|Period 1: Part 1|Progressive disease|0|||
164314481|NCT00830869|593529669|FG002|Period 1: Part 1|Progressive disease|1|||
164314482|NCT00830869|593529670|FG003|Period 1: Part 1|Progressive disease|6|||
164314483|NCT00830869|593529671|FG004|Period 1: Part 1|Progressive disease|4|||
164314484|NCT00830869|593529672|FG005|Period 1: Part 1|Progressive disease|4|||
164314485|NCT00830869|593529673|FG006|Period 1: Part 1|Progressive disease|1|||
164314486|NCT00830869|593529674|FG007|Period 1: Part 1|Progressive disease|0|||
164314487|NCT00830869|593529675|FG008|Period 1: Part 1|Progressive disease|0|||
164314488|NCT00830869|593529676|FG009|Period 1: Part 1|Progressive disease|0|||
164314489|NCT00830869|593529677|FG010|Period 1: Part 1|Progressive disease|0|||
164314490|NCT00830869|593529678|FG011|Period 1: Part 1|Progressive disease|0|||
164314491|NCT00830869|593529667|FG000|Period 2: Part 2|Protocol Violation|0|||
164314492|NCT00830869|593529668|FG001|Period 2: Part 2|Protocol Violation|0|||
164314493|NCT00830869|593529669|FG002|Period 2: Part 2|Protocol Violation|0|||
164314494|NCT00830869|593529670|FG003|Period 2: Part 2|Protocol Violation|0|||
164314495|NCT00830869|593529671|FG004|Period 2: Part 2|Protocol Violation|0|||
164314496|NCT00830869|593529672|FG005|Period 2: Part 2|Protocol Violation|0|||
164314497|NCT00830869|593529673|FG006|Period 2: Part 2|Protocol Violation|0|||
164314498|NCT00830869|593529674|FG007|Period 2: Part 2|Protocol Violation|1|||
164314499|NCT00830869|593529675|FG008|Period 2: Part 2|Protocol Violation|0|||
164314500|NCT00830869|593529676|FG009|Period 2: Part 2|Protocol Violation|1|||
164314501|NCT00830869|593529677|FG010|Period 2: Part 2|Protocol Violation|0|||
164314502|NCT00830869|593529678|FG011|Period 2: Part 2|Protocol Violation|0|||
164314503|NCT00830869|593529667|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
164314504|NCT00830869|593529668|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
164314505|NCT00830869|593529669|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
164314506|NCT00830869|593529670|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
164314507|NCT00830869|593529671|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
164314508|NCT00830869|593529672|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
164314509|NCT00830869|593529673|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
164314510|NCT00830869|593529674|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
164314511|NCT00830869|593529675|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
164314512|NCT00830869|593529676|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
164314513|NCT00830869|593529677|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
164314514|NCT00830869|593529678|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
164314515|NCT00830869|593529667|FG000|Period 2: Part 2|Adverse Event|0|||
164314516|NCT00830869|593529668|FG001|Period 2: Part 2|Adverse Event|0|||
164314517|NCT00830869|593529669|FG002|Period 2: Part 2|Adverse Event|0|||
164314518|NCT00830869|593529670|FG003|Period 2: Part 2|Adverse Event|0|||
164314519|NCT00830869|593529671|FG004|Period 2: Part 2|Adverse Event|0|||
164314520|NCT00830869|593529672|FG005|Period 2: Part 2|Adverse Event|0|||
164314521|NCT00830869|593529673|FG006|Period 2: Part 2|Adverse Event|0|||
164314522|NCT00830869|593529674|FG007|Period 2: Part 2|Adverse Event|4|||
164314523|NCT00830869|593529675|FG008|Period 2: Part 2|Adverse Event|3|||
164314524|NCT00830869|593529676|FG009|Period 2: Part 2|Adverse Event|2|||
164314525|NCT00830869|593529677|FG010|Period 2: Part 2|Adverse Event|2|||
164314526|NCT00830869|593529678|FG011|Period 2: Part 2|Adverse Event|0|||
164314527|NCT00830869|593529667|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
164314528|NCT00830869|593529668|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
164314529|NCT00830869|593529669|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
164314530|NCT00830869|593529670|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
164314531|NCT00830869|593529671|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
164314532|NCT00830869|593529672|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
164314533|NCT00830869|593529673|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
164314534|NCT00830869|593529674|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
164314535|NCT00830869|593529675|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
164314536|NCT00830869|593529676|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
164314537|NCT00830869|593529677|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
164314538|NCT00830869|593529678|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
163868462|NCT01823536|591885880|FG001|Overall Study|Protocol Violation|1|||
163868463|NCT01823536|591885881|FG002|Overall Study|Protocol Violation|0|||
163868464|NCT01823536|591885882|FG003|Overall Study|Protocol Violation|0|||
163868465|NCT01823536|591885883|FG004|Overall Study|Protocol Violation|0|||
163868466|NCT01823536|591885884|FG005|Overall Study|Protocol Violation|0|||
163868467|NCT01823536|591885879|FG000|Overall Study|Withdrawal by Subject|1|||
163868468|NCT01823536|591885880|FG001|Overall Study|Withdrawal by Subject|1|||
163868469|NCT01823536|591885881|FG002|Overall Study|Withdrawal by Subject|0|||
164314539|NCT00830869|593529667|FG000|Period 2: Part 2|Progressive disease|0|||
164314540|NCT00830869|593529668|FG001|Period 2: Part 2|Progressive disease|0|||
164314541|NCT00830869|593529669|FG002|Period 2: Part 2|Progressive disease|0|||
163868470|NCT01823536|591885882|FG003|Overall Study|Withdrawal by Subject|0|||
163868471|NCT01823536|591885883|FG004|Overall Study|Withdrawal by Subject|0|||
163868472|NCT01823536|591885884|FG005|Overall Study|Withdrawal by Subject|0|||
164314542|NCT00830869|593529670|FG003|Period 2: Part 2|Progressive disease|0|||
164314543|NCT00830869|593529671|FG004|Period 2: Part 2|Progressive disease|0|||
163868473|NCT01823536|591885879|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163868474|NCT01823536|591885880|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163868475|NCT01823536|591885881|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
163868476|NCT01823536|591885882|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163868477|NCT01823536|591885883|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
163868478|NCT01823536|591885884|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
164203438|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
164203439|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
164203440|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203441|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
164203442|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203443|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
164203444|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203445|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203446|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203447|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203448|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
164203449|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203450|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
164203451|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
164203452|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203453|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
164203454|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203455|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203456|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203457|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203458|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
164203459|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
164203460|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
164203461|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
164203462|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203463|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
164203464|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203465|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203466|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203467|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203468|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
164203469|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203470|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203471|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203472|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203473|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
164203474|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203475|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203476|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203477|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203478|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
164203479|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203480|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
164203481|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
164203482|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203483|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
164203484|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203485|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203486|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203487|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203488|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203489|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203490|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203491|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
164203492|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
163868479|NCT01823536|591885879|FG000|Overall Study|Met exclusion criterion No 6|0|||
163868480|NCT01823536|591885880|FG001|Overall Study|Met exclusion criterion No 6|0|||
163868481|NCT01823536|591885881|FG002|Overall Study|Met exclusion criterion No 6|0|||
164203493|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
164203494|NCT01232283|593116522|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203495|NCT01232283|593116523|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203496|NCT01232283|593116524|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203497|NCT01232283|593116525|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203498|NCT01232283|593116526|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203499|NCT01232283|593116527|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
164203500|NCT01232283|593116528|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203501|NCT01232283|593116529|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203502|NCT01232283|593116530|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203503|NCT01232283|593116531|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
164203504|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203505|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203506|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203507|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203508|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203509|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203510|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203511|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
164203512|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
164203513|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
164203514|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203515|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203516|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203517|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203518|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203519|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203520|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203521|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
164203522|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
164203523|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
164203524|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203525|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203526|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203527|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203528|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203529|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203530|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203531|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
164203532|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
164203533|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
164203534|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203535|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203536|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203537|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203538|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203539|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203540|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203541|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
164203542|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
164203543|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
164203544|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203545|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203546|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203547|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203548|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203549|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203550|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203551|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
164203552|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
164203553|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
164203554|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203555|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203556|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203557|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203558|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203559|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203560|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203561|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203562|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
164203563|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
164203564|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203565|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203566|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203567|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203568|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203569|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203570|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203571|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203572|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
164203573|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
164203574|NCT01232283|593116522|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203575|NCT01232283|593116523|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203576|NCT01232283|593116524|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203577|NCT01232283|593116525|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203578|NCT01232283|593116526|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203579|NCT01232283|593116527|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203580|NCT01232283|593116528|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203581|NCT01232283|593116529|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
164203582|NCT01232283|593116530|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
164203583|NCT01232283|593116531|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
164203584|NCT03641508|593116533|FG000|First Injection|Lost to Follow-up|2|||
164203585|NCT03641508|593116534|FG001|First Injection|Lost to Follow-up|0|||
164203586|NCT00094445|593116535|FG000|Overall Study|Withdrawal by Subject|3|||
164203587|NCT00094445|593116535|FG000|Overall Study|Lost to Follow-up|1|||
164203588|NCT00094445|593116535|FG000|Overall Study|Progressive Disease|2|||
164203589|NCT00855218|593116536|FG000|Overall Study|Adverse Event|43|||
164203590|NCT00855218|593116537|FG001|Overall Study|Adverse Event|27|||
164203591|NCT00855218|593116536|FG000|Overall Study|Withdrawal by Subject|10|||
164203592|NCT00855218|593116537|FG001|Overall Study|Withdrawal by Subject|6|||
164203593|NCT00855218|593116536|FG000|Overall Study|Physician Decision|18|||
164203594|NCT00855218|593116537|FG001|Overall Study|Physician Decision|11|||
164203595|NCT00855218|593116536|FG000|Overall Study|Lost to Follow-up|0|||
164203596|NCT00855218|593116537|FG001|Overall Study|Lost to Follow-up|1|||
164203597|NCT00855218|593116536|FG000|Overall Study|Protocol Violation|5|||
164203598|NCT00855218|593116537|FG001|Overall Study|Protocol Violation|9|||
164203599|NCT00855218|593116536|FG000|Overall Study|non-compliant with study drug|3|||
164203600|NCT00855218|593116537|FG001|Overall Study|non-compliant with study drug|1|||
164203601|NCT00855218|593116536|FG000|Overall Study|patient convenience|2|||
164203602|NCT00855218|593116537|FG001|Overall Study|patient convenience|0|||
164203603|NCT00855218|593116536|FG000|Overall Study|technical problems|2|||
164203604|NCT00855218|593116537|FG001|Overall Study|technical problems|1|||
164203605|NCT00855218|593116536|FG000|Overall Study|Still treated with study medication|0|||
164203606|NCT00855218|593116537|FG001|Overall Study|Still treated with study medication|1|||
164203607|NCT00855218|593116536|FG000|Overall Study|Untreatable disease progression|54|||
164203608|NCT00855218|593116537|FG001|Overall Study|Untreatable disease progression|67|||
164203609|NCT00855218|593116536|FG000|Overall Study|Second malignancy|0|||
164203610|NCT00855218|593116537|FG001|Overall Study|Second malignancy|1|||
164203611|NCT00855218|593116536|FG000|Overall Study|Progression measurement proven|7|||
164203612|NCT00855218|593116537|FG001|Overall Study|Progression measurement proven|15|||
164203613|NCT00855218|593116536|FG000|Overall Study|Clinical endpoint reached|10|||
164203614|NCT00855218|593116537|FG001|Overall Study|Clinical endpoint reached|13|||
164203615|NCT01773928|593116542|FG000|Overall Study|Adverse Event|0|||
164203616|NCT01773928|593116543|FG001|Overall Study|Adverse Event|0|||
164203617|NCT01773928|593116544|FG002|Overall Study|Adverse Event|0|||
164203618|NCT01773928|593116545|FG003|Overall Study|Adverse Event|0|||
164203619|NCT01773928|593116546|FG004|Overall Study|Adverse Event|0|||
164203620|NCT01773928|593116547|FG005|Overall Study|Adverse Event|0|||
164203621|NCT01773928|593116548|FG006|Overall Study|Adverse Event|0|||
164203622|NCT01773928|593116549|FG007|Overall Study|Adverse Event|1|||
164203623|NCT01773928|593116550|FG008|Overall Study|Adverse Event|0|||
164203624|NCT01773928|593116542|FG000|Overall Study|Physician Decision|0|||
164203625|NCT01773928|593116543|FG001|Overall Study|Physician Decision|0|||
164203626|NCT01773928|593116544|FG002|Overall Study|Physician Decision|0|||
164203627|NCT01773928|593116545|FG003|Overall Study|Physician Decision|1|||
164203628|NCT01773928|593116546|FG004|Overall Study|Physician Decision|0|||
164203629|NCT01773928|593116547|FG005|Overall Study|Physician Decision|0|||
164203630|NCT01773928|593116548|FG006|Overall Study|Physician Decision|0|||
164314544|NCT00830869|593529672|FG005|Period 2: Part 2|Progressive disease|0|||
164314545|NCT00830869|593529673|FG006|Period 2: Part 2|Progressive disease|0|||
164314546|NCT00830869|593529674|FG007|Period 2: Part 2|Progressive disease|14|||
164314547|NCT00830869|593529675|FG008|Period 2: Part 2|Progressive disease|11|||
164314548|NCT00830869|593529676|FG009|Period 2: Part 2|Progressive disease|12|||
164314549|NCT00830869|593529677|FG010|Period 2: Part 2|Progressive disease|8|||
164314550|NCT00830869|593529678|FG011|Period 2: Part 2|Progressive disease|15|||
164314551|NCT00830869|593529667|FG000|Period 2: Part 2|Other|0|||
164314552|NCT00830869|593529668|FG001|Period 2: Part 2|Other|0|||
164314553|NCT00830869|593529669|FG002|Period 2: Part 2|Other|0|||
164314554|NCT00830869|593529670|FG003|Period 2: Part 2|Other|0|||
164314555|NCT00830869|593529671|FG004|Period 2: Part 2|Other|0|||
164314556|NCT00830869|593529672|FG005|Period 2: Part 2|Other|0|||
164314557|NCT00830869|593529673|FG006|Period 2: Part 2|Other|0|||
164314558|NCT00830869|593529674|FG007|Period 2: Part 2|Other|0|||
164314559|NCT00830869|593529675|FG008|Period 2: Part 2|Other|0|||
164314560|NCT00830869|593529676|FG009|Period 2: Part 2|Other|1|||
164314561|NCT00830869|593529677|FG010|Period 2: Part 2|Other|0|||
164314562|NCT00830869|593529678|FG011|Period 2: Part 2|Other|0|||
164314563|NCT00507728|593529679|FG000|Randomization to Month 3|Lost to Follow-up|15|||
164314564|NCT00507728|593529680|FG001|Randomization to Month 3|Lost to Follow-up|14|||
164314565|NCT00507728|593529681|FG002|Randomization to Month 3|Lost to Follow-up|20|||
164314566|NCT00507728|593529679|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
164314567|NCT00507728|593529680|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
164314568|NCT00507728|593529681|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
164314569|NCT04140227|593529683|FG000|Overall Study|Withdrawal by Subject|26|||
164314570|NCT04140227|593529683|FG000|Overall Study|Lost to Follow-up|8|||
164314571|NCT04140227|593529683|FG000|Overall Study|Adverse Event|8|||
164314572|NCT04140227|593529683|FG000|Overall Study|Death|1|||
164314573|NCT04140227|593529683|FG000|Overall Study|Other|3|||
164314574|NCT04140227|593529683|FG000|Overall Study|Protocol Violation|2|||
164314575|NCT00538785|593529684|FG000|Overall Study|Death|9|||
164314576|NCT00538785|593529685|FG001|Overall Study|Death|10|||
164314577|NCT00538785|593529684|FG000|Overall Study|Withdrawal of consent|9|||
164314578|NCT00538785|593529685|FG001|Overall Study|Withdrawal of consent|7|||
164314579|NCT00538785|593529684|FG000|Overall Study|Lost to Follow-up|1|||
164314580|NCT00538785|593529685|FG001|Overall Study|Lost to Follow-up|0|||
164314581|NCT04022733|593529686|FG000|Overall Study|conversion to open surgery|3|||
164314582|NCT04022733|593529687|FG001|Overall Study|conversion to open surgery|2|||
164314583|NCT04022733|593529686|FG000|Overall Study|bradycardia|0|||
163972383|NCT02114268|592269839|FG001|Overall Study|Lost to Follow-up|1|||
163972384|NCT02114268|592269840|FG002|Overall Study|Lost to Follow-up|1|||
163972385|NCT02114268|592269841|FG003|Overall Study|Lost to Follow-up|0|||
163972386|NCT02114268|592269842|FG004|Overall Study|Lost to Follow-up|0|||
163972387|NCT02114268|592269843|FG005|Overall Study|Lost to Follow-up|2|||
163972388|NCT02114268|592269838|FG000|Overall Study|Withdrawal by Subject|1|||
163972389|NCT02114268|592269839|FG001|Overall Study|Withdrawal by Subject|0|||
163972390|NCT02114268|592269840|FG002|Overall Study|Withdrawal by Subject|0|||
163972391|NCT02114268|592269841|FG003|Overall Study|Withdrawal by Subject|0|||
163972392|NCT02114268|592269842|FG004|Overall Study|Withdrawal by Subject|0|||
163972393|NCT02114268|592269843|FG005|Overall Study|Withdrawal by Subject|1|||
163972394|NCT02114268|592269838|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
163972395|NCT02114268|592269839|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
163972396|NCT02114268|592269840|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
163972397|NCT02114268|592269841|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
163972398|NCT02114268|592269842|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
163972399|NCT02114268|592269843|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
163972400|NCT00397033|592269844|FG000|Overall Study|Adverse Event|7|||
163972401|NCT00397033|592269845|FG001|Overall Study|Adverse Event|10|||
163972402|NCT00397033|592269846|FG002|Overall Study|Adverse Event|4|||
163972403|NCT00397033|592269844|FG000|Overall Study|Lack of Efficacy|22|||
163972404|NCT00397033|592269845|FG001|Overall Study|Lack of Efficacy|12|||
163972405|NCT00397033|592269846|FG002|Overall Study|Lack of Efficacy|9|||
163972406|NCT00397033|592269844|FG000|Overall Study|Lost to Follow-up|3|||
164314584|NCT04022733|593529687|FG001|Overall Study|bradycardia|1|||
164314585|NCT05315908|593529691|FG000|Overall Study|Lost to Follow-up|4477|||
164314586|NCT05315908|593529692|FG001|Overall Study|Lost to Follow-up|4606|||
164314587|NCT01128621|593529701|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
163972407|NCT00397033|592269845|FG001|Overall Study|Lost to Follow-up|3|||
163972408|NCT00397033|592269846|FG002|Overall Study|Lost to Follow-up|3|||
163972409|NCT00397033|592269844|FG000|Overall Study|Withdrawal by Subject|12|||
164314588|NCT01128621|593529702|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
164314589|NCT00233454|593529705|FG000|Overall Study|Death|6|||
164314590|NCT04224688|593529706|FG000|Overall Study|Withdrawal by Subject|1|||
164314591|NCT04224688|593529707|FG001|Overall Study|Withdrawal by Subject|3|||
164314592|NCT04224688|593529706|FG000|Overall Study|Lack of Efficacy|1|||
164314593|NCT04224688|593529707|FG001|Overall Study|Lack of Efficacy|1|||
164314594|NCT04224688|593529706|FG000|Overall Study|Adverse event, not fatal|0|||
164203631|NCT01773928|593116549|FG007|Overall Study|Physician Decision|0|||
164203632|NCT01773928|593116550|FG008|Overall Study|Physician Decision|0|||
164203633|NCT01773928|593116542|FG000|Overall Study|Withdrawal by Subject|5|||
164203634|NCT01773928|593116543|FG001|Overall Study|Withdrawal by Subject|4|||
164203635|NCT01773928|593116544|FG002|Overall Study|Withdrawal by Subject|4|||
164203636|NCT01773928|593116545|FG003|Overall Study|Withdrawal by Subject|4|||
164203637|NCT01773928|593116546|FG004|Overall Study|Withdrawal by Subject|7|||
164203638|NCT01773928|593116547|FG005|Overall Study|Withdrawal by Subject|1|||
164203639|NCT01773928|593116548|FG006|Overall Study|Withdrawal by Subject|0|||
164203640|NCT01773928|593116549|FG007|Overall Study|Withdrawal by Subject|0|||
164203641|NCT01773928|593116550|FG008|Overall Study|Withdrawal by Subject|1|||
164203642|NCT01773928|593116542|FG000|Overall Study|Lost to Follow-up|0|||
164203643|NCT01773928|593116543|FG001|Overall Study|Lost to Follow-up|0|||
164203644|NCT01773928|593116544|FG002|Overall Study|Lost to Follow-up|0|||
164203645|NCT01773928|593116545|FG003|Overall Study|Lost to Follow-up|0|||
164203646|NCT01773928|593116546|FG004|Overall Study|Lost to Follow-up|0|||
164203647|NCT01773928|593116547|FG005|Overall Study|Lost to Follow-up|1|||
164203648|NCT01773928|593116548|FG006|Overall Study|Lost to Follow-up|0|||
164203649|NCT01773928|593116549|FG007|Overall Study|Lost to Follow-up|0|||
164203650|NCT01773928|593116550|FG008|Overall Study|Lost to Follow-up|0|||
164203651|NCT01773928|593116542|FG000|Overall Study|Subject misrepresented age|0|||
164203652|NCT01773928|593116543|FG001|Overall Study|Subject misrepresented age|1|||
164203653|NCT01773928|593116544|FG002|Overall Study|Subject misrepresented age|0|||
164203654|NCT01773928|593116545|FG003|Overall Study|Subject misrepresented age|0|||
164203655|NCT01773928|593116546|FG004|Overall Study|Subject misrepresented age|0|||
164203656|NCT01773928|593116547|FG005|Overall Study|Subject misrepresented age|0|||
164203657|NCT01773928|593116548|FG006|Overall Study|Subject misrepresented age|0|||
164203658|NCT01773928|593116549|FG007|Overall Study|Subject misrepresented age|0|||
164203659|NCT01773928|593116550|FG008|Overall Study|Subject misrepresented age|0|||
164203660|NCT01773928|593116542|FG000|Overall Study|Subject met exclusion criteria|0|||
164203661|NCT01773928|593116543|FG001|Overall Study|Subject met exclusion criteria|0|||
164203662|NCT01773928|593116544|FG002|Overall Study|Subject met exclusion criteria|0|||
164203663|NCT01773928|593116545|FG003|Overall Study|Subject met exclusion criteria|0|||
164203664|NCT01773928|593116546|FG004|Overall Study|Subject met exclusion criteria|0|||
164203665|NCT01773928|593116547|FG005|Overall Study|Subject met exclusion criteria|0|||
164203666|NCT01773928|593116548|FG006|Overall Study|Subject met exclusion criteria|0|||
164203667|NCT01773928|593116549|FG007|Overall Study|Subject met exclusion criteria|0|||
164203668|NCT01773928|593116550|FG008|Overall Study|Subject met exclusion criteria|1|||
164203669|NCT01773928|593116542|FG000|Overall Study|Randomized, had to leave, never returned|0|||
164203670|NCT01773928|593116543|FG001|Overall Study|Randomized, had to leave, never returned|0|||
164203671|NCT01773928|593116544|FG002|Overall Study|Randomized, had to leave, never returned|0|||
164203672|NCT01773928|593116545|FG003|Overall Study|Randomized, had to leave, never returned|1|||
164203673|NCT01773928|593116546|FG004|Overall Study|Randomized, had to leave, never returned|0|||
164203674|NCT01773928|593116547|FG005|Overall Study|Randomized, had to leave, never returned|0|||
164203675|NCT01773928|593116548|FG006|Overall Study|Randomized, had to leave, never returned|0|||
164203676|NCT01773928|593116549|FG007|Overall Study|Randomized, had to leave, never returned|0|||
164203677|NCT01773928|593116550|FG008|Overall Study|Randomized, had to leave, never returned|0|||
164203678|NCT01773928|593116542|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
164203679|NCT01773928|593116543|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
164203680|NCT01773928|593116544|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
164203681|NCT01773928|593116545|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
164203682|NCT01773928|593116546|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
164203683|NCT01773928|593116547|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
164203684|NCT01773928|593116548|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
164203685|NCT01773928|593116549|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
164203686|NCT01773928|593116550|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
164203687|NCT02370511|593116551|FG000|Overall Study|Death|10|||
164203688|NCT02370511|593116552|FG001|Overall Study|Death|7|||
164203689|NCT02370511|593116553|FG002|Overall Study|Death|1|||
164203690|NCT02370511|593116551|FG000|Overall Study|Withdrawal by Subject|2|||
164203691|NCT02370511|593116552|FG001|Overall Study|Withdrawal by Subject|0|||
164203692|NCT02370511|593116553|FG002|Overall Study|Withdrawal by Subject|0|||
164203693|NCT02370511|593116551|FG000|Overall Study|Lost to Follow-up|0|||
164203694|NCT02370511|593116552|FG001|Overall Study|Lost to Follow-up|4|||
164203695|NCT02370511|593116553|FG002|Overall Study|Lost to Follow-up|0|||
164203696|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
164203697|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
164203698|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
164203699|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
164203700|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
164203701|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
164203702|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
164203703|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
164203704|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
164203705|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164203706|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164203707|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164203708|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
164203709|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
164203710|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
164203711|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
164203712|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
164203713|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164203714|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164203715|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164203716|NCT01149655|593116554|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
164203717|NCT01149655|593116555|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
164203718|NCT01149655|593116556|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
164203719|NCT01149655|593116557|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
164203720|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
164203721|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
164203722|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
164203723|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
164203724|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
164203725|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
164203726|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
164203727|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
164203728|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
164203729|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
164203730|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
164203731|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
164203732|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
164203733|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
164203734|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
164203735|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
164203736|NCT01149655|593116554|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
164203737|NCT01149655|593116555|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
164203738|NCT01149655|593116556|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
164203739|NCT01149655|593116557|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
164203740|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
164203741|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
164203742|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
164203743|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
164203744|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
164203745|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
164203746|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
164203747|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
164203748|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
164203749|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
164203750|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
164203751|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
164203752|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
164203753|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
164203754|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
164203755|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
164203756|NCT01149655|593116554|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
164203757|NCT01149655|593116555|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
164203758|NCT01149655|593116556|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
164203759|NCT01149655|593116557|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
164203760|NCT03882918|593116558|FG000|Overall Study|Study terminated by sponsor|98|||
164203761|NCT03882918|593116558|FG000|Overall Study|Protocol Violation|1|||
164203762|NCT03882918|593116558|FG000|Overall Study|Other|9|||
164203763|NCT03882918|593116558|FG000|Overall Study|Lack of Efficacy|14|||
164203764|NCT03882918|593116558|FG000|Overall Study|Adverse Event|13|||
164203765|NCT03882918|593116558|FG000|Overall Study|Withdrawal by Subject|5|||
164203766|NCT02775851|593117784|FG000|Overall Study|Adverse Event|1|||
164203767|NCT02775851|593117785|FG001|Overall Study|Adverse Event|10|||
164203768|NCT02775851|593117784|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
164203769|NCT02775851|593117785|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
164203770|NCT02775851|593117784|FG000|Overall Study|Progression/Relapse|0|||
164203771|NCT02775851|593117785|FG001|Overall Study|Progression/Relapse|4|||
164203772|NCT02775851|593117784|FG000|Overall Study|Other - Not Protocol Specified|0|||
164203773|NCT02775851|593117785|FG001|Overall Study|Other - Not Protocol Specified|7|||
164203774|NCT02775851|593117784|FG000|Overall Study|Withdrawal by Subject|1|||
164203775|NCT02775851|593117785|FG001|Overall Study|Withdrawal by Subject|0|||
164203776|NCT06125964|593117786|FG000|Overall Study|Lost to Follow-up|0|||
164203777|NCT06125964|593117787|FG001|Overall Study|Lost to Follow-up|1|||
164203778|NCT06125964|593117788|FG002|Overall Study|Lost to Follow-up|0|||
164203779|NCT06125964|593117789|FG003|Overall Study|Lost to Follow-up|0|||
164203780|NCT03370172|593117790|FG000|Overall Study|Withdrawal by Subject|0|||
164203781|NCT03370172|593117791|FG001|Overall Study|Withdrawal by Subject|1|||
164203782|NCT02194465|593117792|FG000|Overall Study|Adverse Event|6|||
164203783|NCT02194465|593117793|FG001|Overall Study|Adverse Event|1|||
164203784|NCT02194465|593117794|FG002|Overall Study|Adverse Event|4|||
164203785|NCT02194465|593117795|FG003|Overall Study|Adverse Event|4|||
164203786|NCT02194465|593117796|FG004|Overall Study|Adverse Event|4|||
164203787|NCT02194465|593117797|FG005|Overall Study|Adverse Event|2|||
164203788|NCT02194465|593117798|FG006|Overall Study|Adverse Event|0|||
164203789|NCT02194465|593117792|FG000|Overall Study|Lost to Follow-up|0|||
164203790|NCT02194465|593117793|FG001|Overall Study|Lost to Follow-up|0|||
164203791|NCT02194465|593117794|FG002|Overall Study|Lost to Follow-up|0|||
164203792|NCT02194465|593117795|FG003|Overall Study|Lost to Follow-up|1|||
164203793|NCT02194465|593117796|FG004|Overall Study|Lost to Follow-up|0|||
164203794|NCT02194465|593117797|FG005|Overall Study|Lost to Follow-up|1|||
164203795|NCT02194465|593117798|FG006|Overall Study|Lost to Follow-up|0|||
164203796|NCT02194465|593117792|FG000|Overall Study|Physician Decision|1|||
164203797|NCT02194465|593117793|FG001|Overall Study|Physician Decision|0|||
164203798|NCT02194465|593117794|FG002|Overall Study|Physician Decision|0|||
164203799|NCT02194465|593117795|FG003|Overall Study|Physician Decision|0|||
164203800|NCT02194465|593117796|FG004|Overall Study|Physician Decision|0|||
164203801|NCT02194465|593117797|FG005|Overall Study|Physician Decision|0|||
164203802|NCT02194465|593117798|FG006|Overall Study|Physician Decision|0|||
164203803|NCT02194465|593117792|FG000|Overall Study|Protocol Violation|1|||
164203804|NCT02194465|593117793|FG001|Overall Study|Protocol Violation|1|||
164203805|NCT02194465|593117794|FG002|Overall Study|Protocol Violation|2|||
164203806|NCT02194465|593117795|FG003|Overall Study|Protocol Violation|1|||
164203807|NCT02194465|593117796|FG004|Overall Study|Protocol Violation|1|||
164203808|NCT02194465|593117797|FG005|Overall Study|Protocol Violation|0|||
164203809|NCT02194465|593117798|FG006|Overall Study|Protocol Violation|0|||
164203810|NCT02194465|593117792|FG000|Overall Study|Withdrawal by Subject|1|||
164203811|NCT02194465|593117793|FG001|Overall Study|Withdrawal by Subject|3|||
164203812|NCT02194465|593117794|FG002|Overall Study|Withdrawal by Subject|1|||
164203813|NCT02194465|593117795|FG003|Overall Study|Withdrawal by Subject|2|||
164203814|NCT02194465|593117796|FG004|Overall Study|Withdrawal by Subject|2|||
164203815|NCT02194465|593117797|FG005|Overall Study|Withdrawal by Subject|1|||
164203816|NCT02194465|593117798|FG006|Overall Study|Withdrawal by Subject|2|||
164203817|NCT02194465|593117792|FG000|Overall Study|Discontinued follow-up period|0|||
164203818|NCT02194465|593117793|FG001|Overall Study|Discontinued follow-up period|2|||
164203819|NCT02194465|593117794|FG002|Overall Study|Discontinued follow-up period|1|||
164203820|NCT02194465|593117795|FG003|Overall Study|Discontinued follow-up period|0|||
164203821|NCT02194465|593117796|FG004|Overall Study|Discontinued follow-up period|2|||
164203822|NCT02194465|593117797|FG005|Overall Study|Discontinued follow-up period|0|||
164203823|NCT02194465|593117798|FG006|Overall Study|Discontinued follow-up period|0|||
164203824|NCT01316614|593117799|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
164203825|NCT01316614|593117799|FG000|Overall Study|Cytology slides not available for review|4|||
164203826|NCT01316614|593117799|FG000|Overall Study|Cystic lesion|5|||
164203827|NCT01316614|593117799|FG000|Overall Study|Inadequate number of passes|2|||
164203828|NCT01316614|593117799|FG000|Overall Study|Medically unstable|1|||
164203829|NCT00076570|593117800|FG000|Overall Study|Drug intolerance|8|||
164203830|NCT00076570|593117801|FG001|Overall Study|Drug intolerance|8|||
164203831|NCT01373164|593117802|FG000|Overall Study|Lost to Follow-up|0|||
164203832|NCT01373164|593117803|FG001|Overall Study|Lost to Follow-up|0|||
164203833|NCT01373164|593117804|FG002|Overall Study|Lost to Follow-up|1|||
164203834|NCT01373164|593117805|FG003|Overall Study|Lost to Follow-up|2|||
164203835|NCT01373164|593117806|FG004|Overall Study|Lost to Follow-up|0|||
164203836|NCT01373164|593117802|FG000|Overall Study|Withdrawal by Subject|0|||
164203837|NCT01373164|593117803|FG001|Overall Study|Withdrawal by Subject|1|||
164203838|NCT01373164|593117804|FG002|Overall Study|Withdrawal by Subject|0|||
164203839|NCT01373164|593117805|FG003|Overall Study|Withdrawal by Subject|10|||
164203840|NCT01373164|593117806|FG004|Overall Study|Withdrawal by Subject|2|||
164203841|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
164203842|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
164203843|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
164203844|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
164203845|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
164203846|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
164302989|NCT03205423|593484683|FG001|Overall Study|Personal|1|||
164314595|NCT04224688|593529707|FG001|Overall Study|Adverse event, not fatal|2|||
164314596|NCT04224688|593529706|FG000|Overall Study|COVID-19|0|||
164314597|NCT04224688|593529707|FG001|Overall Study|COVID-19|1|||
164314598|NCT04074161|593529708|FG000|Overall Study|Withdrawal by Subject|2|||
164314599|NCT04074161|593529709|FG001|Overall Study|Withdrawal by Subject|4|||
164314600|NCT04074161|593529710|FG002|Overall Study|Withdrawal by Subject|1|||
164314601|NCT04074161|593529708|FG000|Overall Study|Lost to Follow-up|4|||
164314602|NCT04074161|593529709|FG001|Overall Study|Lost to Follow-up|5|||
164314603|NCT04074161|593529710|FG002|Overall Study|Lost to Follow-up|3|||
164314604|NCT03595228|593529713|FG000|Overall Study|Death|2|||
164314605|NCT03595228|593529713|FG000|Overall Study|Lack of Efficacy|13|||
164314606|NCT03595228|593529713|FG000|Overall Study|Withdrawal by Subject|3|||
164314607|NCT03595228|593529713|FG000|Overall Study|Withdrawal by Sponsor|1|||
164314608|NCT01639729|593529714|FG000|Overall Study|Withdrawal by Subject|1|||
164314609|NCT01639729|593529715|FG001|Overall Study|Withdrawal by Subject|0|||
164314610|NCT01639729|593529716|FG002|Overall Study|Withdrawal by Subject|1|||
164314611|NCT01639729|593529717|FG003|Overall Study|Withdrawal by Subject|1|||
164314612|NCT01639729|593529718|FG004|Overall Study|Withdrawal by Subject|0|||
164314613|NCT01639729|593529719|FG005|Overall Study|Withdrawal by Subject|0|||
164314614|NCT03083990|593529720|FG000|Overall Study|Adverse Event|1|||
164314615|NCT03083990|593529721|FG001|Overall Study|Adverse Event|0|||
164314616|NCT01853839|593529722|FG000|Overall Study|Violated inclusion criteria|2|||
164314617|NCT01853839|593529722|FG000|Overall Study|Not meet ITT population definition|58|||
164314618|NCT01853839|593529722|FG000|Overall Study|End of treatment visit too early|33|||
164314619|NCT01853839|593529722|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
164314620|NCT01640314|593529723|FG000|Overall Study|Protocol Violation|0|||
164314621|NCT01640314|593529724|FG001|Overall Study|Protocol Violation|1|||
164314622|NCT02709538|593529726|FG000|Overall Study|Adverse Event|13|||
164314623|NCT02709538|593529727|FG001|Overall Study|Adverse Event|2|||
164314624|NCT02709538|593529728|FG002|Overall Study|Adverse Event|3|||
164314625|NCT02709538|593529726|FG000|Overall Study|Lack of Efficacy|1|||
164314626|NCT02709538|593529727|FG001|Overall Study|Lack of Efficacy|0|||
164314627|NCT02709538|593529728|FG002|Overall Study|Lack of Efficacy|0|||
164314628|NCT02709538|593529726|FG000|Overall Study|Lost to Follow-up|24|||
164314629|NCT02709538|593529727|FG001|Overall Study|Lost to Follow-up|8|||
163868482|NCT01823536|591885882|FG003|Overall Study|Met exclusion criterion No 6|1|||
163868483|NCT01823536|591885883|FG004|Overall Study|Met exclusion criterion No 6|0|||
164314630|NCT02709538|593529728|FG002|Overall Study|Lost to Follow-up|4|||
163868484|NCT01823536|591885884|FG005|Overall Study|Met exclusion criterion No 6|0|||
163868485|NCT01823536|591885879|FG000|Overall Study|Subject moved out of the state|0|||
163868486|NCT01823536|591885880|FG001|Overall Study|Subject moved out of the state|0|||
163868487|NCT01823536|591885881|FG002|Overall Study|Subject moved out of the state|0|||
163868488|NCT01823536|591885882|FG003|Overall Study|Subject moved out of the state|0|||
163868489|NCT01823536|591885883|FG004|Overall Study|Subject moved out of the state|1|||
163868490|NCT01823536|591885884|FG005|Overall Study|Subject moved out of the state|0|||
163868491|NCT00566735|591885888|FG000|Overall Study|Withdrawal by Subject|0|||
163868492|NCT00566735|591885889|FG001|Overall Study|Withdrawal by Subject|1|||
163868493|NCT00566735|591885888|FG000|Overall Study|Refused neuropsychological testing|2|||
163868494|NCT00566735|591885889|FG001|Overall Study|Refused neuropsychological testing|5|||
163868495|NCT00566735|591885888|FG000|Overall Study|Switched into a manic episode|0|||
163868496|NCT00566735|591885889|FG001|Overall Study|Switched into a manic episode|1|||
163868497|NCT04603924|591885890|FG000|Overall Study|Not Dosed|2|||
163868498|NCT04603924|591885891|FG001|Overall Study|Not Dosed|1|||
163868499|NCT04603924|591885890|FG000|Overall Study|Withdrawal by Subject|6|||
163868500|NCT04603924|591885891|FG001|Overall Study|Withdrawal by Subject|6|||
164203847|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
164203848|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
164203849|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
164203850|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
164203851|NCT03979313|593117807|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
164203852|NCT03979313|593117808|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
164203853|NCT03979313|593117807|FG000|All Subjects|Any Other Reason|16|||
164203854|NCT03979313|593117808|FG001|All Subjects|Any Other Reason|23|||
164203855|NCT03979313|593117807|FG000|All Subjects|Covid-19|1|||
164203856|NCT03979313|593117808|FG001|All Subjects|Covid-19|3|||
164203857|NCT03979313|593117807|FG000|All Subjects|Withdrawal by Subject|35|||
164203858|NCT03979313|593117808|FG001|All Subjects|Withdrawal by Subject|44|||
164314631|NCT02709538|593529726|FG000|Overall Study|Physician Decision|1|||
164314632|NCT02709538|593529727|FG001|Overall Study|Physician Decision|0|||
164314633|NCT02709538|593529728|FG002|Overall Study|Physician Decision|0|||
164314634|NCT02709538|593529726|FG000|Overall Study|Withdrawal by Subject|40|||
164314635|NCT02709538|593529727|FG001|Overall Study|Withdrawal by Subject|7|||
164314636|NCT02709538|593529728|FG002|Overall Study|Withdrawal by Subject|4|||
163868501|NCT04603924|591885890|FG000|Overall Study|Adverse Event|2|||
163868502|NCT04603924|591885891|FG001|Overall Study|Adverse Event|2|||
163868503|NCT03762668|591885894|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
163868504|NCT03762668|591885895|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
163868505|NCT00768664|591885899|FG000|Overall Study|Death|57|||
163868506|NCT00768664|591885899|FG000|Overall Study|Lost to Follow-up|2|||
163868507|NCT00768664|591885899|FG000|Overall Study|Other|9|||
163868508|NCT00768664|591885899|FG000|Overall Study|Participant refused|1|||
163868509|NCT02544152|591885900|FG000|Overall Study|Adverse Event|0|||
163868510|NCT02544152|591885901|FG001|Overall Study|Adverse Event|4|||
163868511|NCT02544152|591885900|FG000|Overall Study|Withdrawal by Subject|0|||
163868512|NCT02544152|591885901|FG001|Overall Study|Withdrawal by Subject|3|||
163868513|NCT02544152|591885900|FG000|Overall Study|Other|1|||
163868514|NCT02544152|591885901|FG001|Overall Study|Other|0|||
163868515|NCT00686855|591885902|FG000|Overall Study|Lost to Follow-up|1|||
163868516|NCT00686855|591885903|FG001|Overall Study|Lost to Follow-up|0|||
163868517|NCT00686855|591885902|FG000|Overall Study|Progressive GVHD|0|||
163868518|NCT00686855|591885903|FG001|Overall Study|Progressive GVHD|1|||
163868519|NCT02731755|591885906|FG000|First Intervention|Withdrawal by Subject|0|||
163868520|NCT02731755|591885907|FG001|First Intervention|Withdrawal by Subject|2|||
163868521|NCT02320123|591885908|FG000|Overall Study|Lost to Follow-up|4|||
163868522|NCT02320123|591885909|FG001|Overall Study|Lost to Follow-up|6|||
163868523|NCT02320123|591885908|FG000|Overall Study|Death|6|||
163868524|NCT02320123|591885909|FG001|Overall Study|Death|5|||
163868525|NCT04480827|591885910|FG000|Overall Study|Adverse Event|0|||
163868526|NCT04480827|591885911|FG001|Overall Study|Adverse Event|0|||
163868527|NCT04480827|591885912|FG002|Overall Study|Adverse Event|0|||
163868528|NCT04480827|591885913|FG003|Overall Study|Adverse Event|0|||
163868529|NCT04480827|591885914|FG004|Overall Study|Adverse Event|0|||
163868530|NCT04480827|591885915|FG005|Overall Study|Adverse Event|1|||
163868531|NCT04480827|591885916|FG006|Overall Study|Adverse Event|0|||
163868532|NCT00465816|591885917|FG000|Overall Study|Lost to Follow-up|0|||
163868533|NCT00465816|591885918|FG001|Overall Study|Lost to Follow-up|0|||
163868534|NCT00465816|591885919|FG002|Overall Study|Lost to Follow-up|2|||
163868535|NCT01765543|591885924|FG000|Overall Study|Death|1|||
163868536|NCT01765543|591885924|FG000|Overall Study|Withdrawal by Subject|2|||
163868537|NCT01185561|591885925|FG000|Overall Study|Lost to Follow-up|0|||
163868538|NCT01185561|591885926|FG001|Overall Study|Lost to Follow-up|4|||
163868539|NCT01185561|591885925|FG000|Overall Study|Withdrawal by Subject|2|||
163868540|NCT01185561|591885926|FG001|Overall Study|Withdrawal by Subject|8|||
163868541|NCT05876949|591885929|FG000|Overall Study|Withdrawal by Subject|1|||
163868542|NCT05876949|591885930|FG001|Overall Study|Withdrawal by Subject|3|||
163868543|NCT05876949|591885929|FG000|Overall Study|Physician Decision|0|||
163868544|NCT05876949|591885930|FG001|Overall Study|Physician Decision|2|||
163868545|NCT05876949|591885929|FG000|Overall Study|Death|0|||
163868546|NCT05876949|591885930|FG001|Overall Study|Death|1|||
163868547|NCT02755805|591885931|FG000|Overall Study|Lost to Follow-up|1|||
163868548|NCT02755805|591885932|FG001|Overall Study|Lost to Follow-up|2|||
163868549|NCT02755805|591885931|FG000|Overall Study|Refused assessments|1|||
163868550|NCT02755805|591885932|FG001|Overall Study|Refused assessments|0|||
163868551|NCT02755805|591885931|FG000|Overall Study|Withdrawal by Subject|0|||
163868552|NCT02755805|591885932|FG001|Overall Study|Withdrawal by Subject|2|||
163868553|NCT03718767|591885942|FG000|Overall Study|Declined to participate (before treatment started)|0|||
163868554|NCT03718767|591885943|FG001|Overall Study|Declined to participate (before treatment started)|0|||
163868555|NCT03718767|591885944|FG002|Overall Study|Declined to participate (before treatment started)|7|||
163868556|NCT03718767|591885942|FG000|Overall Study|Ineligible|0|||
163868557|NCT03718767|591885943|FG001|Overall Study|Ineligible|0|||
163868558|NCT03718767|591885944|FG002|Overall Study|Ineligible|17|||
163868559|NCT00494442|591885945|FG000|Overall Study|Death|1|||
163868560|NCT00494442|591885946|FG001|Overall Study|Death|1|||
163868561|NCT00494442|591885945|FG000|Overall Study|Lack of Efficacy|16|||
163868562|NCT00494442|591885946|FG001|Overall Study|Lack of Efficacy|10|||
163868563|NCT00494442|591885945|FG000|Overall Study|Adverse Event|0|||
163868564|NCT00494442|591885946|FG001|Overall Study|Adverse Event|2|||
163868565|NCT00494442|591885945|FG000|Overall Study|Physician Decision|0|||
163868566|NCT00494442|591885946|FG001|Overall Study|Physician Decision|1|||
163868567|NCT00494442|591885945|FG000|Overall Study|Non-compliance|0|||
163868568|NCT00494442|591885946|FG001|Overall Study|Non-compliance|1|||
163868569|NCT00494442|591885945|FG000|Overall Study|Intercurrent illness|0|||
163868570|NCT00494442|591885946|FG001|Overall Study|Intercurrent illness|1|||
163868571|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
163868572|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
163868573|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
163868574|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
163868575|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
163868576|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
163868577|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
163868578|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
163868579|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
164135738|NCT02799095|592861964|FG009|Part A|Withdrawal by Subject|0|||
163972410|NCT00397033|592269845|FG001|Overall Study|Withdrawal by Subject|7|||
163972411|NCT00397033|592269846|FG002|Overall Study|Withdrawal by Subject|5|||
163972412|NCT00397033|592269844|FG000|Overall Study|Other|0|||
163972413|NCT00397033|592269845|FG001|Overall Study|Other|5|||
163972414|NCT00397033|592269846|FG002|Overall Study|Other|2|||
163972415|NCT03519867|592269847|FG000|Overall Study|Adverse Event|1|||
163972416|NCT03519867|592269848|FG001|Overall Study|Adverse Event|1|||
163972417|NCT03519867|592269849|FG002|Overall Study|Adverse Event|0|||
163972418|NCT03519867|592269850|FG003|Overall Study|Adverse Event|0|||
163972419|NCT03519867|592269851|FG004|Overall Study|Adverse Event|0|||
163972420|NCT03519867|592269852|FG005|Overall Study|Adverse Event|0|||
163972421|NCT03519867|592269853|FG006|Overall Study|Adverse Event|0|||
163972422|NCT03519867|592269854|FG007|Overall Study|Adverse Event|0|||
163972423|NCT03519867|592269855|FG008|Overall Study|Adverse Event|0|||
163972424|NCT03519867|592269856|FG009|Overall Study|Adverse Event|0|||
163972425|NCT03519867|592269847|FG000|Overall Study|Protocol Violation|0|||
163972426|NCT03519867|592269848|FG001|Overall Study|Protocol Violation|0|||
163972427|NCT03519867|592269849|FG002|Overall Study|Protocol Violation|0|||
163972428|NCT03519867|592269850|FG003|Overall Study|Protocol Violation|0|||
163972429|NCT03519867|592269851|FG004|Overall Study|Protocol Violation|0|||
163972430|NCT03519867|592269852|FG005|Overall Study|Protocol Violation|1|||
163972431|NCT03519867|592269853|FG006|Overall Study|Protocol Violation|0|||
163972432|NCT03519867|592269854|FG007|Overall Study|Protocol Violation|0|||
163972433|NCT03519867|592269855|FG008|Overall Study|Protocol Violation|0|||
163972434|NCT03519867|592269856|FG009|Overall Study|Protocol Violation|0|||
163972435|NCT03519867|592269847|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972436|NCT03519867|592269848|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972437|NCT03519867|592269849|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972438|NCT03519867|592269850|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163868580|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
163868581|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
163868582|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
163868583|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
163868584|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
163868585|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
163868586|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
163868587|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
163868588|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
163868589|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
163868590|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
163868591|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
163868592|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
163868593|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
163868594|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
163868595|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
163868596|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
163868597|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
163868598|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
163868599|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
163868600|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
163868601|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
163868602|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
163868603|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
163868604|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
163868605|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
163868606|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
163868607|NCT03593213|591885949|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
163868608|NCT03593213|591885950|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
163868609|NCT03593213|591885951|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
163972439|NCT03519867|592269851|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972440|NCT03519867|592269852|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972441|NCT03519867|592269853|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
163972442|NCT03519867|592269854|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972443|NCT03519867|592269855|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972444|NCT03519867|592269856|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
163972445|NCT03519867|592269847|FG000|Overall Study|Admin. of other reversal agent|1|||
163972446|NCT03519867|592269848|FG001|Overall Study|Admin. of other reversal agent|1|||
163972447|NCT03519867|592269849|FG002|Overall Study|Admin. of other reversal agent|0|||
163972448|NCT03519867|592269850|FG003|Overall Study|Admin. of other reversal agent|0|||
163868610|NCT03593213|591885952|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
163972449|NCT03519867|592269851|FG004|Overall Study|Admin. of other reversal agent|0|||
163972450|NCT03519867|592269852|FG005|Overall Study|Admin. of other reversal agent|1|||
163972451|NCT03519867|592269853|FG006|Overall Study|Admin. of other reversal agent|0|||
163972452|NCT03519867|592269854|FG007|Overall Study|Admin. of other reversal agent|0|||
163972453|NCT03519867|592269855|FG008|Overall Study|Admin. of other reversal agent|0|||
163972454|NCT03519867|592269856|FG009|Overall Study|Admin. of other reversal agent|0|||
163972455|NCT03519867|592269847|FG000|Overall Study|Reason not provided|1|||
163972456|NCT03519867|592269848|FG001|Overall Study|Reason not provided|1|||
163972457|NCT03519867|592269849|FG002|Overall Study|Reason not provided|1|||
163972458|NCT03519867|592269850|FG003|Overall Study|Reason not provided|1|||
163972459|NCT03519867|592269851|FG004|Overall Study|Reason not provided|0|||
163972460|NCT03519867|592269852|FG005|Overall Study|Reason not provided|1|||
163972461|NCT03519867|592269853|FG006|Overall Study|Reason not provided|0|||
163972462|NCT03519867|592269854|FG007|Overall Study|Reason not provided|1|||
163972463|NCT03519867|592269855|FG008|Overall Study|Reason not provided|1|||
163972464|NCT03519867|592269856|FG009|Overall Study|Reason not provided|0|||
163972465|NCT04702737|592269857|FG000|Overall Study|Decision by Sponsor|1|||
163972466|NCT04702737|592269857|FG000|Overall Study|Withdrawal of Consent from Study|3|||
163972467|NCT04702737|592269857|FG000|Overall Study|Lost to Follow-up|1|||
163972468|NCT04702737|592269857|FG000|Overall Study|Death|35|||
163972469|NCT02064920|592269858|FG000|Overall Study|Adverse Event|0|||
163972470|NCT02064920|592269859|FG001|Overall Study|Adverse Event|4|||
163972471|NCT02064920|592269858|FG000|Overall Study|Physician Decision|0|||
163972472|NCT02064920|592269859|FG001|Overall Study|Physician Decision|1|||
163972473|NCT02064920|592269858|FG000|Overall Study|Technical Problems|0|||
163972474|NCT02064920|592269859|FG001|Overall Study|Technical Problems|1|||
163972475|NCT02064920|592269858|FG000|Overall Study|Withdrawal by Subject|1|||
163972476|NCT02064920|592269859|FG001|Overall Study|Withdrawal by Subject|3|||
163972477|NCT02109562|592269860|FG000|Overall Study|Insufficient clinical response|2|||
163972478|NCT02109562|592269861|FG001|Overall Study|Insufficient clinical response|0|||
163972479|NCT02109562|592269862|FG002|Overall Study|Insufficient clinical response|4|||
163972480|NCT02109562|592269860|FG000|Overall Study|Adverse Event|0|||
163868611|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
163868612|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
163868613|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
163868614|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
163868615|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
163868616|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
163868617|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
163868618|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
163868619|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
163868620|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
163868621|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
163868622|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
163868623|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
163868624|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
163868625|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
163868626|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
163868627|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
163868628|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
163868629|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
163868630|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
163868631|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
163868632|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
163868633|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
163868634|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
163868635|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
163868636|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
163868637|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
163972481|NCT02109562|592269861|FG001|Overall Study|Adverse Event|2|||
163972482|NCT02109562|592269862|FG002|Overall Study|Adverse Event|3|||
163972483|NCT02109562|592269860|FG000|Overall Study|Lost to Follow-up|1|||
163972484|NCT02109562|592269861|FG001|Overall Study|Lost to Follow-up|0|||
163972485|NCT02109562|592269862|FG002|Overall Study|Lost to Follow-up|1|||
163972486|NCT02109562|592269860|FG000|Overall Study|Protocol Violation|0|||
163972487|NCT02109562|592269861|FG001|Overall Study|Protocol Violation|3|||
163972488|NCT02109562|592269862|FG002|Overall Study|Protocol Violation|1|||
163972489|NCT02109562|592269860|FG000|Overall Study|Withdrawal by Subject|20|||
163972490|NCT02109562|592269861|FG001|Overall Study|Withdrawal by Subject|25|||
163972491|NCT02109562|592269862|FG002|Overall Study|Withdrawal by Subject|21|||
163972492|NCT02109562|592269860|FG000|Overall Study|Physician Decision|3|||
163972493|NCT02109562|592269861|FG001|Overall Study|Physician Decision|4|||
163972494|NCT02109562|592269862|FG002|Overall Study|Physician Decision|5|||
163972495|NCT04814823|592269863|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
163972496|NCT04722042|592269864|FG000|Overall Study|Withdrawal by Subject|2|||
163972497|NCT04722042|592269865|FG001|Overall Study|Withdrawal by Subject|1|||
163972498|NCT04722042|592269866|FG002|Overall Study|Withdrawal by Subject|0|||
163972499|NCT05678257|592269878|FG000|Overall Study|Withdrawal by Subject|2|||
163972500|NCT05678257|592269879|FG001|Overall Study|Withdrawal by Subject|0|||
163972501|NCT05678257|592269880|FG002|Overall Study|Withdrawal by Subject|5|||
163972502|NCT05678257|592269878|FG000|Overall Study|Physician Decision|1|||
163972503|NCT05678257|592269879|FG001|Overall Study|Physician Decision|0|||
163972504|NCT05678257|592269880|FG002|Overall Study|Physician Decision|1|||
163972505|NCT05678257|592269878|FG000|Overall Study|Adverse Event|1|||
163972506|NCT05678257|592269879|FG001|Overall Study|Adverse Event|3|||
163972507|NCT05678257|592269880|FG002|Overall Study|Adverse Event|1|||
163972508|NCT05678257|592269878|FG000|Overall Study|Progressive disease|11|||
163972509|NCT05678257|592269879|FG001|Overall Study|Progressive disease|18|||
163972510|NCT05678257|592269880|FG002|Overall Study|Progressive disease|7|||
163972511|NCT05678257|592269878|FG000|Overall Study|No longer clinically benefitting|2|||
163972512|NCT05678257|592269879|FG001|Overall Study|No longer clinically benefitting|1|||
163972513|NCT05678257|592269880|FG002|Overall Study|No longer clinically benefitting|0|||
163972514|NCT05678257|592269878|FG000|Overall Study|Sponsor decision|5|||
163972515|NCT05678257|592269879|FG001|Overall Study|Sponsor decision|9|||
163972516|NCT05678257|592269880|FG002|Overall Study|Sponsor decision|8|||
163972517|NCT05678257|592269878|FG000|Overall Study|Protocol Violation|0|||
163972518|NCT05678257|592269879|FG001|Overall Study|Protocol Violation|0|||
163972519|NCT05678257|592269880|FG002|Overall Study|Protocol Violation|1|||
163972520|NCT05678257|592269878|FG000|Overall Study|Patient non-compliance|0|||
163972521|NCT05678257|592269879|FG001|Overall Study|Patient non-compliance|0|||
163972522|NCT05678257|592269880|FG002|Overall Study|Patient non-compliance|3|||
163972523|NCT01045798|592269881|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
163972524|NCT01045798|592269882|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
163972525|NCT01045798|592269881|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
163972526|NCT01045798|592269882|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
163972527|NCT01045798|592269881|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
163972528|NCT01045798|592269882|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
163972529|NCT01045798|592269881|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
163972530|NCT01045798|592269882|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
163972531|NCT01449461|592269883|FG000|Overall Study|Adverse Event|0|||
163972532|NCT01449461|592269884|FG001|Overall Study|Adverse Event|3|||
163972533|NCT01449461|592269885|FG002|Overall Study|Adverse Event|2|||
163972534|NCT01449461|592269886|FG003|Overall Study|Adverse Event|3|||
163972535|NCT01449461|592269887|FG004|Overall Study|Adverse Event|4|||
163972536|NCT01449461|592269888|FG005|Overall Study|Adverse Event|4|||
163972537|NCT01449461|592269883|FG000|Overall Study|Death|0|||
163972538|NCT01449461|592269884|FG001|Overall Study|Death|2|||
163972539|NCT01449461|592269885|FG002|Overall Study|Death|0|||
163972540|NCT01449461|592269886|FG003|Overall Study|Death|0|||
163972541|NCT01449461|592269887|FG004|Overall Study|Death|7|||
163972542|NCT01449461|592269888|FG005|Overall Study|Death|1|||
163972543|NCT01449461|592269883|FG000|Overall Study|Physician Decision|0|||
163972544|NCT01449461|592269884|FG001|Overall Study|Physician Decision|1|||
163972545|NCT01449461|592269885|FG002|Overall Study|Physician Decision|0|||
163972546|NCT01449461|592269886|FG003|Overall Study|Physician Decision|4|||
163972547|NCT01449461|592269887|FG004|Overall Study|Physician Decision|1|||
163972548|NCT01449461|592269888|FG005|Overall Study|Physician Decision|0|||
163972549|NCT01449461|592269883|FG000|Overall Study|Documented Progressive Disease|4|||
163972550|NCT01449461|592269884|FG001|Overall Study|Documented Progressive Disease|7|||
163972551|NCT01449461|592269885|FG002|Overall Study|Documented Progressive Disease|14|||
163972552|NCT01449461|592269886|FG003|Overall Study|Documented Progressive Disease|15|||
163972553|NCT01449461|592269887|FG004|Overall Study|Documented Progressive Disease|24|||
163972554|NCT01449461|592269888|FG005|Overall Study|Documented Progressive Disease|5|||
163972555|NCT01449461|592269883|FG000|Overall Study|Clinical Progressive Disease|2|||
163972556|NCT01449461|592269884|FG001|Overall Study|Clinical Progressive Disease|2|||
163972557|NCT01449461|592269885|FG002|Overall Study|Clinical Progressive Disease|0|||
163972558|NCT01449461|592269886|FG003|Overall Study|Clinical Progressive Disease|3|||
163972559|NCT01449461|592269887|FG004|Overall Study|Clinical Progressive Disease|4|||
163972560|NCT01449461|592269888|FG005|Overall Study|Clinical Progressive Disease|2|||
163972561|NCT01449461|592269883|FG000|Overall Study|Protocol Violation|0|||
163972562|NCT01449461|592269884|FG001|Overall Study|Protocol Violation|0|||
163972563|NCT01449461|592269885|FG002|Overall Study|Protocol Violation|0|||
163972564|NCT01449461|592269886|FG003|Overall Study|Protocol Violation|1|||
163972565|NCT01449461|592269887|FG004|Overall Study|Protocol Violation|0|||
164203859|NCT03979313|593117807|FG000|All Subjects|Death|0|||
164203860|NCT03979313|593117808|FG001|All Subjects|Death|5|||
164314637|NCT02709538|593529726|FG000|Overall Study|Non-compliance with study procedures|5|||
164314638|NCT02709538|593529727|FG001|Overall Study|Non-compliance with study procedures|0|||
164314639|NCT02709538|593529728|FG002|Overall Study|Non-compliance with study procedures|0|||
164314640|NCT02709538|593529726|FG000|Overall Study|Non-compliance with study drug|2|||
164314641|NCT02709538|593529727|FG001|Overall Study|Non-compliance with study drug|0|||
164314642|NCT02709538|593529728|FG002|Overall Study|Non-compliance with study drug|0|||
164314643|NCT02709538|593529726|FG000|Overall Study|Protocol deviation|10|||
164314644|NCT02709538|593529727|FG001|Overall Study|Protocol deviation|4|||
164314645|NCT02709538|593529728|FG002|Overall Study|Protocol deviation|4|||
164314646|NCT02709538|593529726|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
164314647|NCT02709538|593529727|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
164314648|NCT02709538|593529728|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
164314649|NCT02709538|593529726|FG000|Overall Study|Other|16|||
164314650|NCT02709538|593529727|FG001|Overall Study|Other|7|||
164314651|NCT02709538|593529728|FG002|Overall Study|Other|5|||
164314652|NCT00835211|593529730|FG000|First Intervention|Withdrawal by Subject|0|||
164314653|NCT00835211|593529731|FG001|First Intervention|Withdrawal by Subject|1|||
164314654|NCT00835211|593529730|FG000|Washout: 7 Days|Adverse Event|2|||
164314655|NCT00835211|593529731|FG001|Washout: 7 Days|Adverse Event|1|||
164314656|NCT00835211|593529730|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164314657|NCT00835211|593529731|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164314658|NCT03087617|593529732|FG000|Overall Study|Lost to Follow-up|32|||
164314659|NCT03087617|593529733|FG001|Overall Study|Lost to Follow-up|30|||
163868638|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
163868639|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
163868640|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
163868641|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
163868642|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
163868643|NCT03593213|591885949|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
163868644|NCT03593213|591885950|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
163868645|NCT03593213|591885951|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
163868646|NCT03593213|591885952|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
163868647|NCT03184558|591885955|FG000|Overall Study|Withdrawal by Subject|2|||
163868648|NCT03184558|591885955|FG000|Overall Study|Death|16|||
163868649|NCT03184558|591885955|FG000|Overall Study|Lost to Follow-up|2|||
163868650|NCT03184558|591885955|FG000|Overall Study|Other|9|||
163868651|NCT01254019|591885956|FG000|Overall Study|Adverse Event|0|||
163868652|NCT01254019|591885957|FG001|Overall Study|Adverse Event|2|||
163868653|NCT01254019|591885956|FG000|Overall Study|Protocol Violation|1|||
163868654|NCT01254019|591885957|FG001|Overall Study|Protocol Violation|0|||
163868655|NCT01254019|591885956|FG000|Overall Study|Withdrawal by Subject|0|||
163868656|NCT01254019|591885957|FG001|Overall Study|Withdrawal by Subject|2|||
163868657|NCT03061474|591885958|FG000|Overall Study|Adverse Event|2|||
163868658|NCT03061474|591885959|FG001|Overall Study|Adverse Event|0|||
163868659|NCT03061474|591885958|FG000|Overall Study|Safety Risk|0|||
163868660|NCT03061474|591885959|FG001|Overall Study|Safety Risk|1|||
163868661|NCT03061474|591885958|FG000|Overall Study|Participant unwilling or unable to participate|0|||
163868662|NCT03061474|591885959|FG001|Overall Study|Participant unwilling or unable to participate|2|||
163868663|NCT03061474|591885958|FG000|Overall Study|Lost to Follow-up|0|||
163868664|NCT03061474|591885959|FG001|Overall Study|Lost to Follow-up|1|||
163868665|NCT01391130|591885962|FG000|Overall Study|Withdrawal by Subject|3|||
163868666|NCT01391130|591885963|FG001|Overall Study|Withdrawal by Subject|2|||
163868667|NCT01391130|591885962|FG000|Overall Study|Physician Decision|2|||
163868668|NCT01391130|591885963|FG001|Overall Study|Physician Decision|3|||
163868669|NCT01391130|591885962|FG000|Overall Study|Did not Receive Drug|1|||
163868670|NCT01391130|591885963|FG001|Overall Study|Did not Receive Drug|1|||
163868671|NCT00566527|591885967|FG000|Overall Study|Reason not provided|3|||
163868672|NCT00566527|591885968|FG001|Overall Study|Reason not provided|11|||
163868673|NCT00566527|591885969|FG002|Overall Study|Reason not provided|10|||
163868674|NCT00566527|591885967|FG000|Overall Study|Adverse Event|2|||
163868675|NCT00566527|591885968|FG001|Overall Study|Adverse Event|0|||
163868676|NCT00566527|591885969|FG002|Overall Study|Adverse Event|1|||
163868677|NCT00566527|591885967|FG000|Overall Study|Physician Decision|3|||
163868678|NCT00566527|591885968|FG001|Overall Study|Physician Decision|8|||
163868679|NCT00566527|591885969|FG002|Overall Study|Physician Decision|20|||
163868680|NCT00566527|591885967|FG000|Overall Study|Lost to Follow-up|3|||
163868681|NCT00566527|591885968|FG001|Overall Study|Lost to Follow-up|4|||
163868682|NCT00566527|591885969|FG002|Overall Study|Lost to Follow-up|4|||
164314660|NCT03087617|593529734|FG002|Overall Study|Lost to Follow-up|30|||
163868683|NCT00566527|591885967|FG000|Overall Study|Withdrawal by Subject|6|||
163868684|NCT00566527|591885968|FG001|Overall Study|Withdrawal by Subject|43|||
163868685|NCT00566527|591885969|FG002|Overall Study|Withdrawal by Subject|43|||
164314661|NCT03087617|593529735|FG003|Overall Study|Lost to Follow-up|39|||
164314662|NCT02343549|593529736|FG000|Overall Study|Death|11|||
164314663|NCT02343549|593529736|FG000|Overall Study|Withdrawal by Subject|2|||
164314664|NCT02160041|593529738|FG000|Overall Study|Adverse Event|11|||
164314665|NCT02160041|593529738|FG000|Overall Study|Death|2|||
164314666|NCT02160041|593529738|FG000|Overall Study|disease progression|57|||
164314667|NCT02160041|593529738|FG000|Overall Study|Protocol Violation|1|||
164314668|NCT02160041|593529738|FG000|Overall Study|non-compliance with study|1|||
164314669|NCT02160041|593529738|FG000|Overall Study|Physician Decision|3|||
164314670|NCT02160041|593529738|FG000|Overall Study|Withdrawal by Subject|8|||
164314671|NCT02160041|593529738|FG000|Overall Study|study terminated by by sponsor|1|||
164314672|NCT04450381|593529739|FG000|Overall Study|Protocol Violation|4|||
164314673|NCT04450381|593529739|FG000|Overall Study|Wrong device setting|2|||
164314674|NCT00006409|593529742|FG000|Baseline|Protocol Violation|48|||
164314675|NCT00006409|593529743|FG001|Baseline|Protocol Violation|70|||
164314676|NCT00006409|593529744|FG002|Baseline|Protocol Violation|0|||
164314677|NCT00006409|593529745|FG003|Baseline|Protocol Violation|0|||
164314678|NCT00006409|593529746|FG004|Baseline|Protocol Violation|0|||
164314679|NCT00006409|593529747|FG005|Baseline|Protocol Violation|0|||
164314680|NCT00006409|593529742|FG000|Post-2 Year Intervention|Protocol Violation|0|||
164314681|NCT00006409|593529743|FG001|Post-2 Year Intervention|Protocol Violation|0|||
164314682|NCT00006409|593529744|FG002|Post-2 Year Intervention|Protocol Violation|251|||
164314683|NCT00006409|593529745|FG003|Post-2 Year Intervention|Protocol Violation|168|||
164314684|NCT00006409|593529746|FG004|Post-2 Year Intervention|Protocol Violation|0|||
164314685|NCT00006409|593529747|FG005|Post-2 Year Intervention|Protocol Violation|0|||
164314686|NCT00006409|593529742|FG000|Post-3 Year Intervention|Protocol Violation|0|||
164314687|NCT00006409|593529743|FG001|Post-3 Year Intervention|Protocol Violation|0|||
164314688|NCT00006409|593529744|FG002|Post-3 Year Intervention|Protocol Violation|0|||
164314689|NCT00006409|593529745|FG003|Post-3 Year Intervention|Protocol Violation|0|||
164314690|NCT00006409|593529746|FG004|Post-3 Year Intervention|Protocol Violation|62|||
164314691|NCT00006409|593529747|FG005|Post-3 Year Intervention|Protocol Violation|62|||
164314692|NCT04343235|593529750|FG000|Overall Study|Lost to Follow-up|3|||
164314693|NCT04343235|593529751|FG001|Overall Study|Lost to Follow-up|2|||
164314694|NCT00787267|593529752|FG000|Overall Study|Screen failure/Ineligible|10|||
164314695|NCT00787267|593529752|FG000|Overall Study|No Reason Provided|1|||
164314696|NCT00787267|593529752|FG000|Overall Study|Withdrawal by Subject|1|||
164314697|NCT01763996|593529753|FG000|Treatment Period 2|Adverse Event|0|||
164314698|NCT01763996|593529754|FG001|Treatment Period 2|Adverse Event|1|||
164314699|NCT00865280|593529755|FG000|Overall Study|Withdrawal by Subject|4|||
164314700|NCT00865280|593529756|FG001|Overall Study|Withdrawal by Subject|1|||
164314701|NCT00865280|593529755|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
164314702|NCT00865280|593529756|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
164314703|NCT00865280|593529755|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
164314704|NCT00865280|593529756|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
164314705|NCT00865280|593529755|FG000|Overall Study|Exclusion Condition|1|||
164314706|NCT00865280|593529756|FG001|Overall Study|Exclusion Condition|0|||
164314707|NCT00865280|593529755|FG000|Overall Study|Adverse Event|0|||
164314708|NCT00865280|593529756|FG001|Overall Study|Adverse Event|1|||
164314709|NCT01396057|593529757|FG000|Overall Study|Adverse Event|2|||
164314710|NCT01396057|593529758|FG001|Overall Study|Adverse Event|6|||
164314711|NCT01396057|593529757|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164314712|NCT01396057|593529758|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164314713|NCT01396057|593529757|FG000|Overall Study|Protocol deviation|4|||
164314714|NCT01396057|593529758|FG001|Overall Study|Protocol deviation|4|||
164314715|NCT01396057|593529757|FG000|Overall Study|Consent withdrawn|3|||
164314716|NCT01396057|593529758|FG001|Overall Study|Consent withdrawn|2|||
164314717|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
164314718|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
164314719|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
164314720|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
164314721|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Death|3|||
163868686|NCT01179334|591885974|FG000|Treatment Period|Adverse Event|1|||
163868687|NCT01179334|591885975|FG001|Treatment Period|Adverse Event|0|||
163868688|NCT01179334|591885974|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
163868689|NCT01179334|591885975|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
163868690|NCT01179334|591885974|FG000|Long-term Extension (LTE) Period|Death|3|||
163868691|NCT01179334|591885975|FG001|Long-term Extension (LTE) Period|Death|0|||
163868692|NCT01179334|591885974|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
163868693|NCT01179334|591885975|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
163868694|NCT01152190|591885977|FG000|Overall Study|Adverse Event|2|||
163868695|NCT01152190|591885978|FG001|Overall Study|Adverse Event|4|||
163868696|NCT01152190|591885977|FG000|Overall Study|Death|1|||
163868697|NCT01152190|591885978|FG001|Overall Study|Death|0|||
163972566|NCT01449461|592269888|FG005|Overall Study|Protocol Violation|0|||
164314722|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Death|0|||
164314723|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Death|0|||
164314724|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Death|0|||
164314725|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
164314726|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
164314727|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
164314728|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
163868698|NCT01152190|591885977|FG000|Overall Study|Protocol Violation|1|||
163868699|NCT01152190|591885978|FG001|Overall Study|Protocol Violation|1|||
163868700|NCT01152190|591885977|FG000|Overall Study|Withdrawal by Subject|1|||
163868701|NCT01152190|591885978|FG001|Overall Study|Withdrawal by Subject|3|||
163868702|NCT03070483|591885979|FG000|Overall Study|Lost to Follow-up|2|||
163868703|NCT00732381|591885982|FG000|Overall Study|Adverse Event|1|||
163868704|NCT00732381|591885983|FG001|Overall Study|Adverse Event|0|||
163868705|NCT00732381|591885982|FG000|Overall Study|Treatment Failure|1|||
163868706|NCT00732381|591885983|FG001|Overall Study|Treatment Failure|1|||
163868707|NCT01390402|591885984|FG000|Overall Study|Death|1|||
163868708|NCT01390402|591885984|FG000|Overall Study|Disease Progression|4|||
163868709|NCT00414544|591887181|FG000|Overall Study|Lost to Follow-up|14|||
163868710|NCT01599104|591887182|FG000|Overall Study|Withdrawal by Subject|1|||
163868711|NCT01599104|591887183|FG001|Overall Study|Withdrawal by Subject|1|||
163868712|NCT01599104|591887184|FG002|Overall Study|Withdrawal by Subject|2|||
163868713|NCT01599104|591887182|FG000|Overall Study|Technical Problems|1|||
163868714|NCT01599104|591887183|FG001|Overall Study|Technical Problems|0|||
163868715|NCT01599104|591887184|FG002|Overall Study|Technical Problems|0|||
163868716|NCT01599104|591887182|FG000|Overall Study|Physician Decision|3|||
163868717|NCT01599104|591887183|FG001|Overall Study|Physician Decision|2|||
163868718|NCT01599104|591887184|FG002|Overall Study|Physician Decision|2|||
163868719|NCT01599104|591887182|FG000|Overall Study|Non-compliance with study treatment|0|||
163868720|NCT01599104|591887183|FG001|Overall Study|Non-compliance with study treatment|1|||
163868721|NCT01599104|591887184|FG002|Overall Study|Non-compliance with study treatment|0|||
163868722|NCT01599104|591887182|FG000|Overall Study|Lack of Efficacy|4|||
163868723|NCT01599104|591887183|FG001|Overall Study|Lack of Efficacy|4|||
163868724|NCT01599104|591887184|FG002|Overall Study|Lack of Efficacy|10|||
163868725|NCT01599104|591887182|FG000|Overall Study|Adverse Event|7|||
163868726|NCT01599104|591887183|FG001|Overall Study|Adverse Event|6|||
163868727|NCT01599104|591887184|FG002|Overall Study|Adverse Event|12|||
163868728|NCT00714714|591887185|FG000|Overall Study|Adverse Event|1|||
163868729|NCT02616900|591887188|FG000|Overall Study|Lack of Efficacy|7|||
163868730|NCT02616900|591887188|FG000|Overall Study|Lost to Follow-up|2|||
163868731|NCT02616900|591887188|FG000|Overall Study|Protocol Violation|5|||
163868732|NCT02616900|591887188|FG000|Overall Study|Withdrawal by Subject|3|||
163868733|NCT02616900|591887188|FG000|Overall Study|Incomplete data|6|||
163868734|NCT04425863|591887189|FG000|Overall Study|Death|0|||
163868735|NCT04425863|591887190|FG001|Overall Study|Death|0|||
163868736|NCT04425863|591887191|FG002|Overall Study|Death|1|||
163868737|NCT03691428|591887192|FG000|Overall Study|Withdrawal by Subject|6|||
163868738|NCT03691428|591887193|FG001|Overall Study|Withdrawal by Subject|8|||
163868739|NCT01460290|591887194|FG000|Overall Study|Adverse Event|3|||
163868740|NCT01460290|591887194|FG000|Overall Study|Elevated liver function|1|||
163868741|NCT01831791|591887195|FG000|Overall Study|Withdrawal by Subject|10|||
163868742|NCT01190007|591887196|FG000|Overall Study|Withdrawal by Subject|4|||
163868743|NCT01190007|591887196|FG000|Overall Study|Adverse Event|8|||
163868744|NCT01190007|591887196|FG000|Overall Study|Difficulty of visit for complications|1|||
163868745|NCT01190007|591887196|FG000|Overall Study|Participant was arrested|1|||
163868746|NCT00845832|591887204|FG000|Treatment Period|Adverse Event|0|||
163868747|NCT00845832|591887205|FG001|Treatment Period|Adverse Event|2|||
163868748|NCT00845832|591887206|FG002|Treatment Period|Adverse Event|0|||
163868749|NCT00845832|591887204|FG000|Treatment Period|Protocol Violation|1|||
163868750|NCT00845832|591887205|FG001|Treatment Period|Protocol Violation|1|||
163868751|NCT00845832|591887206|FG002|Treatment Period|Protocol Violation|0|||
163868752|NCT00845832|591887204|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
163868753|NCT00845832|591887205|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
163868754|NCT00845832|591887206|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
163868755|NCT00845832|591887204|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
163868756|NCT00845832|591887205|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
163868757|NCT00845832|591887206|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
163868758|NCT03520413|591887211|FG000|Overall Study|Lost to Follow-up|1|||
163868759|NCT03520413|591887212|FG001|Overall Study|Lost to Follow-up|1|||
163868760|NCT03520413|591887211|FG000|Overall Study|Withdrawal by Subject|1|||
163868761|NCT03520413|591887212|FG001|Overall Study|Withdrawal by Subject|2|||
163868762|NCT03520413|591887211|FG000|Overall Study|Death|0|||
163868763|NCT03520413|591887212|FG001|Overall Study|Death|1|||
163868764|NCT03520413|591887211|FG000|Overall Study|Physician Decision|3|||
163868765|NCT03520413|591887212|FG001|Overall Study|Physician Decision|3|||
163868766|NCT03520413|591887211|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
163868767|NCT03520413|591887212|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
163868768|NCT00869323|591887213|FG000|Maintenance Therapy|concurrent illness|1|||
163868769|NCT02880241|591887214|FG000|Overall Study|Lack of Efficacy|1|||
163868770|NCT02880241|591887215|FG001|Overall Study|Lack of Efficacy|0|||
163868771|NCT02880241|591887216|FG002|Overall Study|Lack of Efficacy|0|||
163972567|NCT01449461|592269883|FG000|Overall Study|Site Terminated by Sponsor|0|||
163972568|NCT01449461|592269884|FG001|Overall Study|Site Terminated by Sponsor|1|||
163972569|NCT01449461|592269885|FG002|Overall Study|Site Terminated by Sponsor|2|||
163972570|NCT01449461|592269886|FG003|Overall Study|Site Terminated by Sponsor|3|||
163972571|NCT01449461|592269887|FG004|Overall Study|Site Terminated by Sponsor|4|||
163972572|NCT01449461|592269888|FG005|Overall Study|Site Terminated by Sponsor|1|||
163972573|NCT01449461|592269883|FG000|Overall Study|Withdrawal by Subject|0|||
163972574|NCT01449461|592269884|FG001|Overall Study|Withdrawal by Subject|1|||
163972575|NCT01449461|592269885|FG002|Overall Study|Withdrawal by Subject|0|||
163972576|NCT01449461|592269886|FG003|Overall Study|Withdrawal by Subject|0|||
163972577|NCT01449461|592269887|FG004|Overall Study|Withdrawal by Subject|2|||
163972578|NCT01449461|592269888|FG005|Overall Study|Withdrawal by Subject|1|||
163972579|NCT01449461|592269883|FG000|Overall Study|Reason not Specified|0|||
163972580|NCT01449461|592269884|FG001|Overall Study|Reason not Specified|1|||
163972581|NCT01449461|592269885|FG002|Overall Study|Reason not Specified|0|||
163972582|NCT01449461|592269886|FG003|Overall Study|Reason not Specified|3|||
163972583|NCT01449461|592269887|FG004|Overall Study|Reason not Specified|2|||
163972584|NCT01449461|592269888|FG005|Overall Study|Reason not Specified|1|||
163972585|NCT05314517|592269889|FG000|Double-blind Period|Adverse Event|4|||
163972586|NCT05314517|592269890|FG001|Double-blind Period|Adverse Event|0|||
163972587|NCT05314517|592269891|FG002|Double-blind Period|Adverse Event|0|||
163972588|NCT05314517|592269892|FG003|Double-blind Period|Adverse Event|0|||
163972589|NCT05314517|592269889|FG000|Double-blind Period|Noncompliance|0|||
163972590|NCT05314517|592269890|FG001|Double-blind Period|Noncompliance|1|||
163972591|NCT05314517|592269891|FG002|Double-blind Period|Noncompliance|0|||
163972592|NCT05314517|592269892|FG003|Double-blind Period|Noncompliance|0|||
163972593|NCT05314517|592269889|FG000|Double-blind Period|Randomized, not treated|1|||
163972594|NCT05314517|592269890|FG001|Double-blind Period|Randomized, not treated|0|||
163972595|NCT05314517|592269891|FG002|Double-blind Period|Randomized, not treated|0|||
163972596|NCT05314517|592269892|FG003|Double-blind Period|Randomized, not treated|0|||
163972597|NCT05314517|592269889|FG000|Open-label Extension|Adverse Event|0|||
163972598|NCT05314517|592269890|FG001|Open-label Extension|Adverse Event|0|||
163972599|NCT05314517|592269891|FG002|Open-label Extension|Adverse Event|1|||
163972600|NCT05314517|592269892|FG003|Open-label Extension|Adverse Event|2|||
163972601|NCT05314517|592269889|FG000|Open-label Extension|Investigator decision|0|||
163972602|NCT05314517|592269890|FG001|Open-label Extension|Investigator decision|0|||
163972603|NCT05314517|592269891|FG002|Open-label Extension|Investigator decision|1|||
163972604|NCT05314517|592269892|FG003|Open-label Extension|Investigator decision|0|||
163972605|NCT05314517|592269889|FG000|Open-label Extension|Lost to Follow-up|0|||
163972606|NCT05314517|592269890|FG001|Open-label Extension|Lost to Follow-up|0|||
163972607|NCT05314517|592269891|FG002|Open-label Extension|Lost to Follow-up|0|||
163972608|NCT05314517|592269892|FG003|Open-label Extension|Lost to Follow-up|1|||
163972609|NCT05314517|592269889|FG000|Open-label Extension|Withdrawal by Subject|0|||
163972610|NCT05314517|592269890|FG001|Open-label Extension|Withdrawal by Subject|0|||
163972611|NCT05314517|592269891|FG002|Open-label Extension|Withdrawal by Subject|1|||
163972612|NCT05314517|592269892|FG003|Open-label Extension|Withdrawal by Subject|2|||
163972613|NCT05314517|592269889|FG000|Open-label Extension|Use of prohibited medication|0|||
163972614|NCT05314517|592269890|FG001|Open-label Extension|Use of prohibited medication|0|||
163972615|NCT05314517|592269891|FG002|Open-label Extension|Use of prohibited medication|1|||
163972616|NCT05314517|592269892|FG003|Open-label Extension|Use of prohibited medication|0|||
163972617|NCT05314517|592269889|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
163972618|NCT05314517|592269890|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
163972619|NCT05314517|592269891|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
163972620|NCT05314517|592269892|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
163972621|NCT02710136|592269895|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
163972622|NCT02710136|592269896|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
163972623|NCT02269787|592269898|FG000|Overall Study|Lost to Follow-up|20|||
163972624|NCT02269787|592269899|FG001|Overall Study|Lost to Follow-up|6|||
163972625|NCT02269787|592269898|FG000|Overall Study|Death|2|||
163972626|NCT02269787|592269899|FG001|Overall Study|Death|3|||
163972627|NCT02269787|592269898|FG000|Overall Study|Incapacitated|0|||
163972628|NCT02269787|592269899|FG001|Overall Study|Incapacitated|1|||
163972629|NCT01439282|592271151|FG000|Overall Study|Adverse Event|5|||
163972630|NCT01439282|592271152|FG001|Overall Study|Adverse Event|0|||
163972631|NCT01439282|592271151|FG000|Overall Study|Withdrawal by Subject|2|||
163972632|NCT01439282|592271152|FG001|Overall Study|Withdrawal by Subject|0|||
163972633|NCT01439282|592271151|FG000|Overall Study|Other|1|||
163972634|NCT01439282|592271152|FG001|Overall Study|Other|1|||
163972635|NCT02966509|592271153|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
163972636|NCT02966509|592271154|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
163972637|NCT02966509|592271153|FG000|Baseline Satisfaction Survey|Death|0|||
163972638|NCT02966509|592271154|FG001|Baseline Satisfaction Survey|Death|1|||
163972639|NCT02966509|592271153|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
164203861|NCT03979313|593117807|FG000|All Subjects|Lost to Follow-up|28|||
164314729|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
164314730|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
164314731|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
164314732|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
164314733|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
164314734|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
164314735|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
164314736|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
164314737|NCT00884741|593529761|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
164314738|NCT00884741|593529762|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
164314739|NCT00884741|593529763|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
164314740|NCT00884741|593529764|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
164314741|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
164314742|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
164314743|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
164314744|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
164314745|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
164314746|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
164314747|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
163868772|NCT02880241|591887217|FG003|Overall Study|Lack of Efficacy|0|||
163868773|NCT02880241|591887218|FG004|Overall Study|Lack of Efficacy|0|||
163868774|NCT02880241|591887219|FG005|Overall Study|Lack of Efficacy|0|||
163868775|NCT00638963|591887220|FG000|Overall Study|Withdrawal by Subject|1|||
163868776|NCT00638963|591887221|FG001|Overall Study|Withdrawal by Subject|0|||
163868777|NCT05283395|591887223|FG000|Overall Study|Adverse Event|4|||
163868778|NCT05283395|591887224|FG001|Overall Study|Adverse Event|4|||
163868779|NCT05283395|591887225|FG002|Overall Study|Adverse Event|0|||
163868780|NCT05283395|591887223|FG000|Overall Study|Patient Lost to Follow-Up|0|||
163868781|NCT05283395|591887224|FG001|Overall Study|Patient Lost to Follow-Up|0|||
163868782|NCT05283395|591887225|FG002|Overall Study|Patient Lost to Follow-Up|1|||
163868783|NCT05283395|591887223|FG000|Overall Study|Patient Withdrawal|2|||
163868784|NCT05283395|591887224|FG001|Overall Study|Patient Withdrawal|4|||
163868785|NCT05283395|591887225|FG002|Overall Study|Patient Withdrawal|2|||
163868786|NCT05283395|591887223|FG000|Overall Study|Investigator Decision|1|||
163868787|NCT05283395|591887224|FG001|Overall Study|Investigator Decision|0|||
163868788|NCT05283395|591887225|FG002|Overall Study|Investigator Decision|1|||
163868789|NCT05283395|591887223|FG000|Overall Study|Enrolled in error|0|||
163868790|NCT05283395|591887224|FG001|Overall Study|Enrolled in error|0|||
163868791|NCT05283395|591887225|FG002|Overall Study|Enrolled in error|1|||
163868792|NCT00712335|591887226|FG000|Overall Study|Withdrawal by Subject|0|||
163868793|NCT00712335|591887227|FG001|Overall Study|Withdrawal by Subject|7|||
163868794|NCT00712335|591887228|FG002|Overall Study|Withdrawal by Subject|2|||
163868795|NCT00712335|591887229|FG003|Overall Study|Withdrawal by Subject|3|||
163868796|NCT00712335|591887230|FG004|Overall Study|Withdrawal by Subject|0|||
163868797|NCT00712335|591887226|FG000|Overall Study|Lost to Follow-up|2|||
163868798|NCT00712335|591887227|FG001|Overall Study|Lost to Follow-up|5|||
163868799|NCT00712335|591887228|FG002|Overall Study|Lost to Follow-up|0|||
163868800|NCT00712335|591887229|FG003|Overall Study|Lost to Follow-up|1|||
163868801|NCT00712335|591887230|FG004|Overall Study|Lost to Follow-up|0|||
163868802|NCT00712335|591887226|FG000|Overall Study|Protocol Violation|1|||
163868803|NCT00712335|591887227|FG001|Overall Study|Protocol Violation|2|||
163868804|NCT00712335|591887228|FG002|Overall Study|Protocol Violation|1|||
163868805|NCT00712335|591887229|FG003|Overall Study|Protocol Violation|0|||
163868806|NCT00712335|591887230|FG004|Overall Study|Protocol Violation|0|||
163868807|NCT00712335|591887226|FG000|Overall Study|Lack of Efficacy|0|||
163868808|NCT00712335|591887227|FG001|Overall Study|Lack of Efficacy|0|||
163868809|NCT00712335|591887228|FG002|Overall Study|Lack of Efficacy|1|||
163868810|NCT00712335|591887229|FG003|Overall Study|Lack of Efficacy|1|||
163868811|NCT00712335|591887230|FG004|Overall Study|Lack of Efficacy|0|||
163868812|NCT00712335|591887226|FG000|Overall Study|Other Reason|0|||
163868813|NCT00712335|591887227|FG001|Overall Study|Other Reason|3|||
163868814|NCT00712335|591887228|FG002|Overall Study|Other Reason|1|||
163868815|NCT00712335|591887229|FG003|Overall Study|Other Reason|0|||
163868816|NCT00712335|591887230|FG004|Overall Study|Other Reason|0|||
163868817|NCT03401112|591887231|FG000|Overall Study|Adverse Event|1|||
163868818|NCT03401112|591887232|FG001|Overall Study|Adverse Event|2|||
163868819|NCT03401112|591887233|FG002|Overall Study|Adverse Event|3|||
163868820|NCT03401112|591887234|FG003|Overall Study|Adverse Event|2|||
163868821|NCT03401112|591887235|FG004|Overall Study|Adverse Event|0|||
163868822|NCT03401112|591887231|FG000|Overall Study|Lost to Follow-up|1|||
163868823|NCT03401112|591887232|FG001|Overall Study|Lost to Follow-up|0|||
163868824|NCT03401112|591887233|FG002|Overall Study|Lost to Follow-up|0|||
163868825|NCT03401112|591887234|FG003|Overall Study|Lost to Follow-up|0|||
163868826|NCT03401112|591887235|FG004|Overall Study|Lost to Follow-up|0|||
163868827|NCT03401112|591887231|FG000|Overall Study|Noncompliance|1|||
163868828|NCT03401112|591887232|FG001|Overall Study|Noncompliance|2|||
163972640|NCT02966509|592271154|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
163972641|NCT02966509|592271153|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
163972642|NCT02966509|592271154|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
163972643|NCT02966509|592271153|FG000|6 Month Satisfaction Decision Survey|Death|22|||
163972644|NCT02966509|592271154|FG001|6 Month Satisfaction Decision Survey|Death|25|||
163972645|NCT02966509|592271153|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
163972646|NCT02966509|592271154|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
163972647|NCT02966509|592271153|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
164314748|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
163972648|NCT02966509|592271154|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
163972649|NCT02966509|592271153|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
164314749|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
163972650|NCT02966509|592271154|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
163972651|NCT02966509|592271153|FG000|6 Month Satisfaction Survey|Death|36|||
163972652|NCT02966509|592271154|FG001|6 Month Satisfaction Survey|Death|33|||
163972653|NCT02966509|592271153|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
163972654|NCT02966509|592271154|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
163972655|NCT02966509|592271153|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
163972656|NCT02966509|592271154|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
163972657|NCT02966509|592271153|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
163972658|NCT02966509|592271154|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
163972659|NCT02966509|592271153|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
163972660|NCT02966509|592271154|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
163972661|NCT02966509|592271153|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
163972662|NCT02966509|592271154|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
163972663|NCT02982954|592271155|FG000|Overall Study|Death|55|||
163972664|NCT02982954|592271156|FG001|Overall Study|Death|29|||
163972665|NCT02982954|592271157|FG002|Overall Study|Death|15|||
163972666|NCT02982954|592271158|FG003|Overall Study|Death|20|||
163972667|NCT02982954|592271155|FG000|Overall Study|Lost to Follow-up|2|||
163972668|NCT02982954|592271156|FG001|Overall Study|Lost to Follow-up|1|||
163972669|NCT02982954|592271157|FG002|Overall Study|Lost to Follow-up|0|||
163972670|NCT02982954|592271158|FG003|Overall Study|Lost to Follow-up|0|||
163972671|NCT02982954|592271155|FG000|Overall Study|Participant withdrew consent|7|||
163972672|NCT02982954|592271156|FG001|Overall Study|Participant withdrew consent|5|||
163972673|NCT02982954|592271157|FG002|Overall Study|Participant withdrew consent|1|||
163972674|NCT02982954|592271158|FG003|Overall Study|Participant withdrew consent|1|||
163972675|NCT02982954|592271155|FG000|Overall Study|Other reasons|42|||
163972676|NCT02982954|592271156|FG001|Overall Study|Other reasons|17|||
163972677|NCT02982954|592271157|FG002|Overall Study|Other reasons|12|||
163972678|NCT02982954|592271158|FG003|Overall Study|Other reasons|3|||
163972679|NCT02982954|592271155|FG000|Overall Study|Premature site closure|0|||
163972680|NCT02982954|592271156|FG001|Overall Study|Premature site closure|0|||
163972681|NCT02982954|592271157|FG002|Overall Study|Premature site closure|0|||
163972682|NCT02982954|592271158|FG003|Overall Study|Premature site closure|1|||
163972683|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
163972684|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
163972685|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
163972686|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
163972687|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
163972688|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
163972689|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Death|2|||
163972690|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Death|0|||
163972691|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
163972692|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
163972693|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
163972694|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
163972695|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
163972696|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
163972697|NCT02603120|592271159|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
163972698|NCT02603120|592271160|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
163972699|NCT02603120|592271159|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
163972700|NCT02603120|592271160|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
163972701|NCT02603120|592271159|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
163972702|NCT02603120|592271160|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
163972703|NCT02603120|592271159|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
163972704|NCT02603120|592271160|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
163972705|NCT02603120|592271159|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
163972706|NCT02603120|592271160|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
163972707|NCT02603120|592271159|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
163868829|NCT03401112|591887233|FG002|Overall Study|Noncompliance|3|||
163868830|NCT03401112|591887234|FG003|Overall Study|Noncompliance|0|||
163868831|NCT03401112|591887235|FG004|Overall Study|Noncompliance|0|||
163868832|NCT03401112|591887231|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
163868833|NCT03401112|591887232|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
163868834|NCT03401112|591887233|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
163868835|NCT03401112|591887234|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
163868836|NCT03401112|591887235|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
163868837|NCT03401112|591887231|FG000|Overall Study|Withdrawal by Subject|0|||
163868838|NCT03401112|591887232|FG001|Overall Study|Withdrawal by Subject|3|||
163868839|NCT03401112|591887233|FG002|Overall Study|Withdrawal by Subject|2|||
163868840|NCT03401112|591887234|FG003|Overall Study|Withdrawal by Subject|1|||
163868841|NCT03401112|591887235|FG004|Overall Study|Withdrawal by Subject|0|||
163868842|NCT03401112|591887231|FG000|Overall Study|Physician Decision|0|||
163868843|NCT03401112|591887232|FG001|Overall Study|Physician Decision|0|||
163868844|NCT03401112|591887233|FG002|Overall Study|Physician Decision|0|||
163868845|NCT03401112|591887234|FG003|Overall Study|Physician Decision|2|||
163868846|NCT03401112|591887235|FG004|Overall Study|Physician Decision|0|||
163868847|NCT03401112|591887231|FG000|Overall Study|Study was Terminated by Sponsor|0|||
163868848|NCT03401112|591887232|FG001|Overall Study|Study was Terminated by Sponsor|0|||
163868849|NCT03401112|591887233|FG002|Overall Study|Study was Terminated by Sponsor|0|||
163868850|NCT03401112|591887234|FG003|Overall Study|Study was Terminated by Sponsor|1|||
163868851|NCT03401112|591887235|FG004|Overall Study|Study was Terminated by Sponsor|0|||
163868852|NCT03401112|591887231|FG000|Overall Study|Day 1 Assessment not Done|1|||
163868853|NCT03401112|591887232|FG001|Overall Study|Day 1 Assessment not Done|0|||
163868854|NCT03401112|591887233|FG002|Overall Study|Day 1 Assessment not Done|0|||
163868855|NCT03401112|591887234|FG003|Overall Study|Day 1 Assessment not Done|0|||
163868856|NCT03401112|591887235|FG004|Overall Study|Day 1 Assessment not Done|0|||
163868857|NCT03401112|591887231|FG000|Overall Study|Not Dosed|0|||
163972708|NCT02603120|592271160|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
163972709|NCT02603120|592271159|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
163972710|NCT02603120|592271160|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
163972711|NCT00916357|592271162|FG000|Period 1|Withdrawal by Subject|1|||
163972712|NCT00916357|592271163|FG001|Period 1|Withdrawal by Subject|0|||
163972713|NCT00916357|592271164|FG002|Period 1|Withdrawal by Subject|0|||
163972714|NCT00916357|592271165|FG003|Period 1|Withdrawal by Subject|0|||
163972715|NCT00916357|592271166|FG004|Period 1|Withdrawal by Subject|0|||
163972716|NCT00916357|592271167|FG005|Period 1|Withdrawal by Subject|0|||
163972717|NCT00916357|592271162|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
163972718|NCT00916357|592271163|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
163972719|NCT00916357|592271164|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
163972720|NCT00916357|592271165|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
163972721|NCT00916357|592271166|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
163972722|NCT00916357|592271167|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
163972723|NCT03810781|592271171|FG000|Overall Study|COVID shut down|2|||
163972724|NCT03807349|592271174|FG000|Overall Study|Early Study Termination|9|||
163972725|NCT01111851|592271178|FG000|Overall Study|All planned PET scans were not obtained.|2|||
163972726|NCT01111851|592271179|FG001|Overall Study|All planned PET scans were not obtained.|0|||
163972727|NCT05500274|592271180|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
163972728|NCT05500274|592271181|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
163972729|NCT05500274|592271180|FG000|Overall Study|Lost to Follow-up|76|||
163972730|NCT05500274|592271181|FG001|Overall Study|Lost to Follow-up|51|||
163972731|NCT00596947|592271183|FG000|Overall Study|study halted due to low enrollment|5|||
163972732|NCT00596947|592271184|FG001|Overall Study|study halted due to low enrollment|3|||
163972733|NCT00596947|592271183|FG000|Overall Study|Lost to Follow-up|1|||
163972734|NCT00596947|592271184|FG001|Overall Study|Lost to Follow-up|0|||
163972735|NCT03000179|592271185|FG000|Overall Study|Lost to Follow-up|2|||
163972736|NCT00073528|592271190|FG000|Overall Study|Death|488|||
163972737|NCT00073528|592271191|FG001|Overall Study|Death|473|||
163972738|NCT00073528|592271190|FG000|Overall Study|Lost to Follow-up|52|||
163972739|NCT00073528|592271191|FG001|Overall Study|Lost to Follow-up|45|||
163972740|NCT00073528|592271190|FG000|Overall Study|Withdrawal by Subject|50|||
163972741|NCT00073528|592271191|FG001|Overall Study|Withdrawal by Subject|45|||
163972742|NCT00073528|592271190|FG000|Overall Study|Study terminated by Sponsor|10|||
163972743|NCT00073528|592271191|FG001|Overall Study|Study terminated by Sponsor|29|||
163972744|NCT00073528|592271190|FG000|Overall Study|Other|18|||
163972745|NCT00073528|592271191|FG001|Overall Study|Other|19|||
164203862|NCT03979313|593117808|FG001|All Subjects|Lost to Follow-up|61|||
164203863|NCT00089648|593117809|FG000|Overall Study|Adverse Event|7|||
163868858|NCT03401112|591887232|FG001|Overall Study|Not Dosed|0|||
163868859|NCT03401112|591887233|FG002|Overall Study|Not Dosed|1|||
163972746|NCT00073528|592271190|FG000|Overall Study|Other|9|||
163972747|NCT00073528|592271191|FG001|Overall Study|Other|12|||
163972748|NCT00073528|592271190|FG000|Overall Study|Protocol Violation|3|||
163972749|NCT00073528|592271191|FG001|Overall Study|Protocol Violation|5|||
163972750|NCT04037748|592271198|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164203864|NCT00089648|593117809|FG000|Overall Study|Withdrawal by Subject|1|||
164203865|NCT00089648|593117809|FG000|Overall Study|Lack of Efficacy|33|||
164203866|NCT00420745|593117810|FG000|Overall Study|Adverse Event|2|||
164203867|NCT00420745|593117811|FG001|Overall Study|Adverse Event|2|||
164203868|NCT00420745|593117810|FG000|Overall Study|Lost to Follow-up|10|||
164203869|NCT00420745|593117811|FG001|Overall Study|Lost to Follow-up|2|||
164203870|NCT00420745|593117810|FG000|Overall Study|Protocol Violation|1|||
164203871|NCT00420745|593117811|FG001|Overall Study|Protocol Violation|0|||
164203872|NCT00420745|593117810|FG000|Overall Study|Physician Decision|1|||
164203873|NCT00420745|593117811|FG001|Overall Study|Physician Decision|1|||
164203874|NCT00420745|593117810|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
164203875|NCT00420745|593117811|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
164203876|NCT00420745|593117810|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
164203877|NCT00420745|593117811|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
164203878|NCT00423605|593117812|FG000|Overall Study|Adverse Event|129|||
164203879|NCT00423605|593117812|FG000|Overall Study|Withdrawal by Subject|36|||
164203880|NCT00423605|593117812|FG000|Overall Study|Lost to Follow-up|15|||
164203881|NCT00423605|593117812|FG000|Overall Study|Lack of Efficacy|38|||
163868860|NCT03401112|591887234|FG003|Overall Study|Not Dosed|0|||
163868861|NCT03401112|591887235|FG004|Overall Study|Not Dosed|0|||
163868862|NCT03401112|591887231|FG000|Overall Study|Missed Clinical Visit|0|||
163868863|NCT03401112|591887232|FG001|Overall Study|Missed Clinical Visit|0|||
163868864|NCT03401112|591887233|FG002|Overall Study|Missed Clinical Visit|1|||
163868865|NCT03401112|591887234|FG003|Overall Study|Missed Clinical Visit|0|||
163868866|NCT03401112|591887235|FG004|Overall Study|Missed Clinical Visit|0|||
163868867|NCT03401112|591887231|FG000|Overall Study|Missed Doses|0|||
163868868|NCT03401112|591887232|FG001|Overall Study|Missed Doses|0|||
163868869|NCT03401112|591887233|FG002|Overall Study|Missed Doses|1|||
163868870|NCT03401112|591887234|FG003|Overall Study|Missed Doses|0|||
163868871|NCT03401112|591887235|FG004|Overall Study|Missed Doses|0|||
163868872|NCT01264679|591887236|FG000|Overall Study|Participation in Another Clinical Trial|1|||
163868873|NCT01264679|591887236|FG000|Overall Study|Physician Decision|1|||
163868874|NCT01264679|591887236|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
163868875|NCT01264679|591887236|FG000|Overall Study|Withdrawal by Subject|1|||
163868876|NCT03475316|591887237|FG000|6 Month Intervention|Adverse Event|2|||
163868877|NCT03475316|591887238|FG001|6 Month Intervention|Adverse Event|1|||
163868878|NCT03475316|591887237|FG000|6 Month Intervention|Withdrawal by Subject|2|||
163868879|NCT03475316|591887238|FG001|6 Month Intervention|Withdrawal by Subject|0|||
163868880|NCT03475316|591887237|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
163868881|NCT03475316|591887238|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
163868882|NCT03475316|591887237|FG000|9 Months|Study stopped due to COVID pandemic|3|||
163868883|NCT03475316|591887238|FG001|9 Months|Study stopped due to COVID pandemic|4|||
163868884|NCT01837966|591887245|FG000|Overall Study|Withdrawal by Subject|2|||
163868885|NCT01837966|591887246|FG001|Overall Study|Withdrawal by Subject|1|||
163868886|NCT04975308|591887250|FG000|Overall Study|Withdrawal by Subject|6|||
163868887|NCT04975308|591887251|FG001|Overall Study|Withdrawal by Subject|16|||
163868888|NCT04975308|591887252|FG002|Overall Study|Withdrawal by Subject|6|||
163868889|NCT04975308|591887250|FG000|Overall Study|Physician Decision|0|||
163868890|NCT04975308|591887251|FG001|Overall Study|Physician Decision|3|||
163868891|NCT04975308|591887252|FG002|Overall Study|Physician Decision|1|||
163868892|NCT04975308|591887250|FG000|Overall Study|Adverse Event|10|||
163868893|NCT04975308|591887251|FG001|Overall Study|Adverse Event|1|||
163868894|NCT04975308|591887252|FG002|Overall Study|Adverse Event|12|||
163868895|NCT04975308|591887250|FG000|Overall Study|On study treatment (Ongoing)|65|||
163868896|NCT04975308|591887251|FG001|Overall Study|On study treatment (Ongoing)|43|||
163868897|NCT04975308|591887252|FG002|Overall Study|On study treatment (Ongoing)|75|||
163868898|NCT04975308|591887250|FG000|Overall Study|Protocol Deviation|4|||
163868899|NCT04975308|591887251|FG001|Overall Study|Protocol Deviation|3|||
163868900|NCT04975308|591887252|FG002|Overall Study|Protocol Deviation|2|||
163868901|NCT00468910|591887253|FG000|Overall Study|Lost to Follow-up|2|||
163868902|NCT00468910|591887254|FG001|Overall Study|Lost to Follow-up|1|||
163868903|NCT00468910|591887253|FG000|Overall Study|Withdrawal by Subject|2|||
163868904|NCT00468910|591887254|FG001|Overall Study|Withdrawal by Subject|1|||
163868905|NCT00468910|591887253|FG000|Overall Study|Medical Contraindication|0|||
163868906|NCT00468910|591887254|FG001|Overall Study|Medical Contraindication|1|||
163868907|NCT01909778|591887255|FG000|Overall Study|failed screening|1|||
163868908|NCT01943916|591887256|FG000|Overall Study|Technically invalid images|10|||
163868909|NCT01943916|591887256|FG000|Overall Study|Enrollment Failure|23|||
163868910|NCT01943916|591887256|FG000|Overall Study|Pilot Phase exclusion|100|||
163868911|NCT01943916|591887256|FG000|Overall Study|Quality Assurance Reader Fail|130|||
164203882|NCT00423605|593117812|FG000|Overall Study|Sponsor Decision|3|||
164203883|NCT00423605|593117812|FG000|Overall Study|Physician Decision|8|||
164203884|NCT00423605|593117812|FG000|Overall Study|Protocol Violation|7|||
163868912|NCT01943916|591887256|FG000|Overall Study|Technical Failure|39|||
163868913|NCT01943916|591887256|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
163868914|NCT01943916|591887256|FG000|Overall Study|No Truth Panel Review|38|||
164302990|NCT03205423|593484682|FG000|Overall Study|Physician Decision|0|||
163868915|NCT01943916|591887256|FG000|Overall Study|Protocol Deviation|1|||
163868916|NCT00919763|591887257|FG000|Overall Study|Adverse Event|7|||
163868917|NCT00919763|591887258|FG001|Overall Study|Adverse Event|1|||
163868918|NCT00919763|591887257|FG000|Overall Study|Lost to Follow-up|1|||
163868919|NCT00919763|591887258|FG001|Overall Study|Lost to Follow-up|0|||
163868920|NCT00919763|591887257|FG000|Overall Study|Protocol Violation|1|||
163868921|NCT00919763|591887258|FG001|Overall Study|Protocol Violation|1|||
163868922|NCT00919763|591887257|FG000|Overall Study|Withdrawal by Subject|3|||
163868923|NCT00919763|591887258|FG001|Overall Study|Withdrawal by Subject|1|||
163868924|NCT00919763|591887257|FG000|Overall Study|Non-compliance|0|||
163868925|NCT00919763|591887258|FG001|Overall Study|Non-compliance|1|||
163868926|NCT03654768|591887259|FG000|Overall Study|Adverse Event|1|||
163868927|NCT03654768|591887260|FG001|Overall Study|Adverse Event|6|||
163868928|NCT03654768|591887259|FG000|Overall Study|Loss of response|2|||
163868929|NCT03654768|591887260|FG001|Overall Study|Loss of response|2|||
163868930|NCT03654768|591887259|FG000|Overall Study|Non-compliance|0|||
163868931|NCT03654768|591887260|FG001|Overall Study|Non-compliance|1|||
163868932|NCT03654768|591887259|FG000|Overall Study|Refusal not related to toxicity|1|||
163868933|NCT03654768|591887260|FG001|Overall Study|Refusal not related to toxicity|5|||
163868934|NCT03654768|591887259|FG000|Overall Study|Did not receive protocol therapy|1|||
163868935|NCT03654768|591887260|FG001|Overall Study|Did not receive protocol therapy|1|||
163868936|NCT05323734|591887261|FG000|Overall Study|Adverse Event|5|||
163868937|NCT05323734|591887262|FG001|Overall Study|Adverse Event|2|||
163868938|NCT05323734|591887261|FG000|Overall Study|Physician Decision|1|||
163868939|NCT05323734|591887262|FG001|Overall Study|Physician Decision|0|||
163868940|NCT05323734|591887261|FG000|Overall Study|Lack of Efficacy|1|||
163868941|NCT05323734|591887262|FG001|Overall Study|Lack of Efficacy|2|||
163868942|NCT05323734|591887261|FG000|Overall Study|Withdrawal by Subject|2|||
163868943|NCT05323734|591887262|FG001|Overall Study|Withdrawal by Subject|0|||
163868944|NCT05323734|591887261|FG000|Overall Study|Participant Withdrawn Due|0|||
163868945|NCT05323734|591887262|FG001|Overall Study|Participant Withdrawn Due|1|||
163868946|NCT00547118|591887263|FG000|Overall Study|Did not qualify prior to starting drug|1|||
163868947|NCT00547118|591887264|FG001|Overall Study|Did not qualify prior to starting drug|1|||
163868948|NCT00547118|591887263|FG000|Overall Study|Study suspended|7|||
163868949|NCT00547118|591887264|FG001|Overall Study|Study suspended|8|||
163868950|NCT01595321|591887267|FG000|Overall Study|Adverse Event|1|||
163868951|NCT01595321|591887268|FG001|Overall Study|Adverse Event|1|||
163868952|NCT01595321|591887269|FG002|Overall Study|Adverse Event|1|||
163868953|NCT01595321|591887267|FG000|Overall Study|Lack of Efficacy|0|||
163868954|NCT01595321|591887268|FG001|Overall Study|Lack of Efficacy|0|||
163868955|NCT01595321|591887269|FG002|Overall Study|Lack of Efficacy|4|||
163868956|NCT00834834|591887271|FG000|Overall Study|Withdrawal by Subject|4|||
163868957|NCT00834834|591887272|FG001|Overall Study|Withdrawal by Subject|3|||
163868958|NCT00373529|591887273|FG000|Overall Study|Physician Decision|19|||
163868959|NCT00373529|591887273|FG000|Overall Study|Withdrawal by Subject|7|||
163868960|NCT00373529|591887273|FG000|Overall Study|Adverse Event|7|||
164203885|NCT00423605|593117812|FG000|Overall Study|Not one of the pre-specified options|5|||
164203886|NCT03183908|593117813|FG000|Overall Study|Missing Symptom Diary Data|0|||
164203887|NCT03183908|593117814|FG001|Overall Study|Missing Symptom Diary Data|2|||
164203888|NCT02058095|593117818|FG000|Overall Study|Adverse Event|1|||
164203889|NCT02058095|593117819|FG001|Overall Study|Adverse Event|0|||
164203890|NCT00726453|593117820|FG000|Primary Enrollment Group|Death|18|||
164203891|NCT00726453|593117821|FG001|Primary Enrollment Group|Death|0|||
164203892|NCT00726453|593117820|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
164203893|NCT00726453|593117821|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
164203894|NCT00726453|593117820|FG000|38 mm Length Group|Death|0|||
164203895|NCT00726453|593117821|FG001|38 mm Length Group|Death|3|||
164203896|NCT01588509|593117825|FG000|Overall Study|Lost to Follow-up|1|||
163868961|NCT00373529|591887273|FG000|Overall Study|Treatment failure|36|||
163972751|NCT04037748|592271199|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163972752|NCT04037748|592271198|FG000|Treatment Period 1|Adverse Event|1|||
163972753|NCT04037748|592271199|FG001|Treatment Period 1|Adverse Event|1|||
163972754|NCT04037748|592271198|FG000|Treatment Period 1|Protocol Violation|4|||
163972755|NCT04037748|592271199|FG001|Treatment Period 1|Protocol Violation|5|||
163972756|NCT04037748|592271198|FG000|Treatment Period 2|Adverse Event|0|||
163972757|NCT04037748|592271199|FG001|Treatment Period 2|Adverse Event|1|||
163972758|NCT04037748|592271198|FG000|Treatment Period 2|Protocol Violation|2|||
163972759|NCT04037748|592271199|FG001|Treatment Period 2|Protocol Violation|0|||
163972760|NCT03073980|592271204|FG000|Overall Study|Lost to Follow-up|10|||
163972761|NCT03073980|592271205|FG001|Overall Study|Lost to Follow-up|2|||
163972762|NCT03073980|592271206|FG002|Overall Study|Lost to Follow-up|9|||
163868962|NCT00373529|591887273|FG000|Overall Study|Disease recurrence|10|||
163868963|NCT00373529|591887273|FG000|Overall Study|Death|16|||
163868964|NCT00373529|591887273|FG000|Overall Study|Need for treatment prohibited by study|1|||
163868965|NCT00373529|591887273|FG000|Overall Study|Other|8|||
163868966|NCT00373529|591887273|FG000|Overall Study|Failed independent confirmation of AML|3|||
163868967|NCT00373529|591887273|FG000|Overall Study|Consent violation|1|||
163972763|NCT03073980|592271204|FG000|Overall Study|No post-procedure data|0|||
163972764|NCT03073980|592271205|FG001|Overall Study|No post-procedure data|0|||
163972765|NCT03073980|592271206|FG002|Overall Study|No post-procedure data|2|||
163972766|NCT04810689|592271207|FG000|Overall Study|Withdrawal by Subject|0|||
163972767|NCT04810689|592271208|FG001|Overall Study|Withdrawal by Subject|1|||
163972768|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
163972769|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
163972770|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
163972771|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
163972772|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
163972773|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
163972774|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163972775|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
163972776|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
163972777|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
163972778|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
163972779|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
163972780|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
163972781|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
163972782|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
163972783|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
163972784|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
163972785|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
163972786|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
163972787|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
163972788|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
163972789|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
163972790|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
163972791|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
163972792|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Death|2|||
163972793|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Death|1|||
163972794|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Death|0|||
163972795|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Death|0|||
163972796|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
163972797|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
163972798|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163972799|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
163972800|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
163972801|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
163972802|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
163972803|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
163972804|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
163972805|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
163972806|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
163972807|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
163972808|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
163972809|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
163972810|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
163972811|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
163972812|NCT01940471|592271209|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
163972813|NCT01940471|592271210|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
163972814|NCT01940471|592271211|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
163972815|NCT01940471|592271212|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
163972816|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
163972817|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
163972818|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
163972819|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
163972820|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
163972821|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
163972822|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
163972823|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
163972824|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
163972825|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
163972826|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
163972827|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
163972828|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
163972829|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
164135739|NCT02799095|592861965|FG010|Part A|Withdrawal by Subject|0|||
164203897|NCT01588509|593117826|FG001|Overall Study|Lost to Follow-up|0|||
164203898|NCT01983930|593117827|FG000|Overall Study|Withdrawal by Subject|9|||
164203899|NCT01983930|593117828|FG001|Overall Study|Withdrawal by Subject|8|||
164203900|NCT01983930|593117827|FG000|Overall Study|Adverse Event|0|||
164203901|NCT01983930|593117828|FG001|Overall Study|Adverse Event|1|||
164203902|NCT01454284|593117829|FG000|Overall Study|Adverse Event|20|||
164203903|NCT01454284|593117830|FG001|Overall Study|Adverse Event|7|||
164203904|NCT01454284|593117829|FG000|Overall Study|Death|0|||
164203905|NCT01454284|593117830|FG001|Overall Study|Death|3|||
164203906|NCT01454284|593117829|FG000|Overall Study|Lost to Follow-up|13|||
164203907|NCT01454284|593117830|FG001|Overall Study|Lost to Follow-up|8|||
163868968|NCT04795752|591887274|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
163868969|NCT04795752|591887275|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
163868970|NCT04795752|591887274|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
163868971|NCT04795752|591887275|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
163868972|NCT04795752|591887274|FG000|Primary Endpoint Phase|Physician Decision|2|||
163868973|NCT04795752|591887275|FG001|Primary Endpoint Phase|Physician Decision|0|||
163868974|NCT04795752|591887274|FG000|Primary Endpoint Phase|Other|4|||
163868975|NCT04795752|591887275|FG001|Primary Endpoint Phase|Other|1|||
163868976|NCT04795752|591887274|FG000|Primary Endpoint Phase|Protocol Violation|1|||
163868977|NCT04795752|591887275|FG001|Primary Endpoint Phase|Protocol Violation|0|||
163868978|NCT04795752|591887274|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
163868979|NCT04795752|591887275|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
163868980|NCT04795752|591887274|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
163868981|NCT04795752|591887275|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
163868982|NCT04795752|591887274|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
163868983|NCT04795752|591887275|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
163868984|NCT04795752|591887274|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
163868985|NCT04795752|591887275|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
163868986|NCT04795752|591887274|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
163868987|NCT04795752|591887275|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
163868988|NCT00792948|591887276|FG000|Overall Study|Adverse Event|6|||
163868989|NCT00792948|591887276|FG000|Overall Study|Death|4|||
163868990|NCT00792948|591887276|FG000|Overall Study|Withdrawal by Subject|3|||
163868991|NCT00792948|591887276|FG000|Overall Study|Ineligible|2|||
163868992|NCT00792948|591887276|FG000|Overall Study|Insurance denial - not treated|1|||
163868993|NCT00792948|591887276|FG000|Overall Study|Physician Decision|11|||
163868994|NCT00792948|591887276|FG000|Overall Study|Protocol Violation|1|||
163868995|NCT01585558|591887287|FG000|Overall Study|Withdrawal by Subject|4|||
163868996|NCT01585558|591887288|FG001|Overall Study|Withdrawal by Subject|5|||
163868997|NCT01585558|591887289|FG002|Overall Study|Withdrawal by Subject|8|||
163868998|NCT01585558|591887287|FG000|Overall Study|Lost to Follow-up|2|||
163868999|NCT01585558|591887288|FG001|Overall Study|Lost to Follow-up|0|||
163869000|NCT01585558|591887289|FG002|Overall Study|Lost to Follow-up|3|||
163869001|NCT01585558|591887287|FG000|Overall Study|Adverse Event|3|||
163869002|NCT01585558|591887288|FG001|Overall Study|Adverse Event|4|||
163869003|NCT01585558|591887289|FG002|Overall Study|Adverse Event|1|||
163869004|NCT01585558|591887287|FG000|Overall Study|Protocol Violation|4|||
163869005|NCT01585558|591887288|FG001|Overall Study|Protocol Violation|3|||
163869006|NCT01585558|591887289|FG002|Overall Study|Protocol Violation|2|||
163869007|NCT01585558|591887287|FG000|Overall Study|Lack of Efficacy|0|||
163869008|NCT01585558|591887288|FG001|Overall Study|Lack of Efficacy|0|||
163869009|NCT01585558|591887289|FG002|Overall Study|Lack of Efficacy|1|||
163869010|NCT02994654|591887292|FG000|Overall Study|Lost to Follow-up|1|||
163869011|NCT00585052|591888597|FG000|Overall Study|Withdrawal by Subject|1|||
163869012|NCT02613871|591888599|FG000|Overall Study|Death|2|||
163869013|NCT02613871|591888599|FG000|Overall Study|Withdrew Consent|1|||
163869014|NCT02527148|591888600|FG000|Overall Study|Did not receive study intervention|1|||
163869015|NCT02527148|591888601|FG001|Overall Study|Did not receive study intervention|0|||
163869016|NCT02918279|591888602|FG000|Overall Study|Lost to Follow-up|3|||
163869017|NCT02918279|591888603|FG001|Overall Study|Lost to Follow-up|6|||
163869018|NCT02918279|591888602|FG000|Overall Study|Withdrawal by Subject|5|||
163869019|NCT02918279|591888603|FG001|Overall Study|Withdrawal by Subject|15|||
163869020|NCT02918279|591888602|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163869021|NCT02918279|591888603|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163869022|NCT02918279|591888602|FG000|Overall Study|Other|3|||
163869023|NCT02918279|591888603|FG001|Overall Study|Other|1|||
163869024|NCT00309907|591888604|FG000|Overall Study|Death|4|||
163869025|NCT00309907|591888604|FG000|Overall Study|Physician Decision|1|||
163869026|NCT00309907|591888604|FG000|Overall Study|Ineligible|11|||
163869027|NCT00309907|591888604|FG000|Overall Study|Major infectious event|4|||
163869028|NCT00494780|591888605|FG000|Overall Study|Adverse Event|1|||
163869029|NCT00494780|591888606|FG001|Overall Study|Adverse Event|0|||
163869030|NCT00494780|591888605|FG000|Overall Study|Withdrew before Dosed|0|||
163869031|NCT00494780|591888606|FG001|Overall Study|Withdrew before Dosed|1|||
163869032|NCT00494780|591888605|FG000|Overall Study|Progression of Study Disease|7|||
163972830|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
163972831|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
163972832|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
163972833|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
163972834|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
163972835|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
163972836|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
163972837|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
163972838|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
163972839|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
163972840|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
163972841|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
163972842|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
163972843|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
163972844|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
163972845|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
163972846|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
163972847|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
163972848|NCT01940471|592271209|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
163972849|NCT01940471|592271210|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
163972850|NCT01940471|592271211|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
163972851|NCT01940471|592271212|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
163972852|NCT01358760|592271213|FG000|Overall Study|Adverse Event|3|||
163972853|NCT01358760|592271214|FG001|Overall Study|Adverse Event|4|||
163972854|NCT01358760|592271215|FG002|Overall Study|Adverse Event|3|||
163972855|NCT01358760|592271213|FG000|Overall Study|Lost to Follow-up|1|||
163972856|NCT01358760|592271214|FG001|Overall Study|Lost to Follow-up|1|||
163972857|NCT01358760|592271215|FG002|Overall Study|Lost to Follow-up|3|||
163972858|NCT01358760|592271213|FG000|Overall Study|Withdrawal by Subject|5|||
164314750|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
164314751|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
164314752|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
164314753|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
163972859|NCT01358760|592271214|FG001|Overall Study|Withdrawal by Subject|3|||
163869033|NCT00494780|591888606|FG001|Overall Study|Progression of Study Disease|8|||
163972860|NCT01358760|592271215|FG002|Overall Study|Withdrawal by Subject|2|||
163972861|NCT01358760|592271213|FG000|Overall Study|Physician Decision|1|||
163972862|NCT01358760|592271214|FG001|Overall Study|Physician Decision|0|||
163972863|NCT01358760|592271215|FG002|Overall Study|Physician Decision|1|||
163972864|NCT01358760|592271213|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
163972865|NCT01358760|592271214|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
163972866|NCT01358760|592271215|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
163869034|NCT00494780|591888605|FG000|Overall Study|New Treatment|2|||
163869035|NCT00494780|591888606|FG001|Overall Study|New Treatment|2|||
163869036|NCT00494780|591888605|FG000|Overall Study|Non-compliance|1|||
163869037|NCT00494780|591888606|FG001|Overall Study|Non-compliance|0|||
163869038|NCT00494780|591888605|FG000|Overall Study|Residual Tumour Mass|0|||
163869039|NCT00494780|591888606|FG001|Overall Study|Residual Tumour Mass|1|||
163869040|NCT00494780|591888605|FG000|Overall Study|Insurance Issues|0|||
163869041|NCT00494780|591888606|FG001|Overall Study|Insurance Issues|1|||
163869042|NCT00869258|591888607|FG000|Overall Study|Physician Decision|1|||
163869043|NCT01641198|591888608|FG000|After 12 Months of Function|Lost to Follow-up|3|||
163869044|NCT01641198|591888609|FG001|After 12 Months of Function|Lost to Follow-up|2|||
163869045|NCT01641198|591888610|FG002|After 12 Months of Function|Lost to Follow-up|2|||
163869046|NCT01641198|591888608|FG000|After 12 Months of Function|Protocol Violation|1|||
163869047|NCT01641198|591888609|FG001|After 12 Months of Function|Protocol Violation|0|||
163869048|NCT01641198|591888610|FG002|After 12 Months of Function|Protocol Violation|0|||
163869049|NCT01641198|591888608|FG000|After 12 Months of Function|Adverse Event|0|||
163869050|NCT01641198|591888609|FG001|After 12 Months of Function|Adverse Event|1|||
163869051|NCT01641198|591888610|FG002|After 12 Months of Function|Adverse Event|0|||
163869052|NCT01641198|591888608|FG000|After 24 Months of Function|Lost to Follow-up|4|||
163869053|NCT01641198|591888609|FG001|After 24 Months of Function|Lost to Follow-up|9|||
163869054|NCT01641198|591888610|FG002|After 24 Months of Function|Lost to Follow-up|6|||
163869055|NCT01641198|591888608|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
163869056|NCT01641198|591888609|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
163869057|NCT01641198|591888610|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
163869058|NCT01641198|591888608|FG000|At 15-20 Years of Function|Death|1|||
163869059|NCT01641198|591888609|FG001|At 15-20 Years of Function|Death|0|||
163869060|NCT01641198|591888610|FG002|At 15-20 Years of Function|Death|1|||
163972867|NCT01506960|592271216|FG000|Overall Study|Did not meet angiographic criteria|47|||
163972868|NCT00450723|592271217|FG000|Overall Study|Physician Decision|5|||
163972869|NCT01846624|592271218|FG000|Overall Study|Died during induction, no midostaurin|1|||
163972870|NCT01721057|592271221|FG000|Treatment Period|Withdrawal by Subject|11|||
163972871|NCT01721057|592271222|FG001|Treatment Period|Withdrawal by Subject|5|||
163972872|NCT01721057|592271223|FG002|Treatment Period|Withdrawal by Subject|8|||
163972873|NCT01721057|592271224|FG003|Treatment Period|Withdrawal by Subject|0|||
163972874|NCT01721057|592271225|FG004|Treatment Period|Withdrawal by Subject|0|||
163972875|NCT01721057|592271226|FG005|Treatment Period|Withdrawal by Subject|0|||
163972876|NCT01721057|592271227|FG006|Treatment Period|Withdrawal by Subject|0|||
163972877|NCT01721057|592271221|FG000|Treatment Period|Adverse Event|7|||
163972878|NCT01721057|592271222|FG001|Treatment Period|Adverse Event|10|||
163972879|NCT01721057|592271223|FG002|Treatment Period|Adverse Event|12|||
163972880|NCT01721057|592271224|FG003|Treatment Period|Adverse Event|0|||
163972881|NCT01721057|592271225|FG004|Treatment Period|Adverse Event|0|||
163972882|NCT01721057|592271226|FG005|Treatment Period|Adverse Event|0|||
163972883|NCT01721057|592271227|FG006|Treatment Period|Adverse Event|0|||
163972884|NCT01721057|592271221|FG000|Treatment Period|Lack of Efficacy|7|||
163972885|NCT01721057|592271222|FG001|Treatment Period|Lack of Efficacy|3|||
163972886|NCT01721057|592271223|FG002|Treatment Period|Lack of Efficacy|0|||
163972887|NCT01721057|592271224|FG003|Treatment Period|Lack of Efficacy|0|||
163972888|NCT01721057|592271225|FG004|Treatment Period|Lack of Efficacy|0|||
163972889|NCT01721057|592271226|FG005|Treatment Period|Lack of Efficacy|0|||
163972890|NCT01721057|592271227|FG006|Treatment Period|Lack of Efficacy|0|||
163972891|NCT01721057|592271221|FG000|Treatment Period|Lost to Follow-up|1|||
163972892|NCT01721057|592271222|FG001|Treatment Period|Lost to Follow-up|0|||
163972893|NCT01721057|592271223|FG002|Treatment Period|Lost to Follow-up|0|||
163972894|NCT01721057|592271224|FG003|Treatment Period|Lost to Follow-up|0|||
163972895|NCT01721057|592271225|FG004|Treatment Period|Lost to Follow-up|0|||
163972896|NCT01721057|592271226|FG005|Treatment Period|Lost to Follow-up|0|||
163972897|NCT01721057|592271227|FG006|Treatment Period|Lost to Follow-up|0|||
163972898|NCT01721057|592271221|FG000|Treatment Period|Physician Decision|0|||
163972899|NCT01721057|592271222|FG001|Treatment Period|Physician Decision|1|||
163972900|NCT01721057|592271223|FG002|Treatment Period|Physician Decision|3|||
163972901|NCT01721057|592271224|FG003|Treatment Period|Physician Decision|0|||
163972902|NCT01721057|592271225|FG004|Treatment Period|Physician Decision|0|||
163972903|NCT01721057|592271226|FG005|Treatment Period|Physician Decision|0|||
163972904|NCT01721057|592271227|FG006|Treatment Period|Physician Decision|0|||
163972905|NCT01721057|592271221|FG000|Treatment Period|Death|2|||
163972906|NCT01721057|592271222|FG001|Treatment Period|Death|0|||
163972907|NCT01721057|592271223|FG002|Treatment Period|Death|0|||
163972908|NCT01721057|592271224|FG003|Treatment Period|Death|0|||
163972909|NCT01721057|592271225|FG004|Treatment Period|Death|0|||
163972910|NCT01721057|592271226|FG005|Treatment Period|Death|0|||
163972911|NCT01721057|592271227|FG006|Treatment Period|Death|0|||
163972912|NCT01721057|592271221|FG000|Rescue Period|Adverse Event|0|||
163972913|NCT01721057|592271222|FG001|Rescue Period|Adverse Event|0|||
163972914|NCT01721057|592271223|FG002|Rescue Period|Adverse Event|0|||
163972915|NCT01721057|592271224|FG003|Rescue Period|Adverse Event|1|||
163972916|NCT01721057|592271225|FG004|Rescue Period|Adverse Event|0|||
163972917|NCT01721057|592271226|FG005|Rescue Period|Adverse Event|0|||
163972918|NCT01721057|592271227|FG006|Rescue Period|Adverse Event|0|||
163972919|NCT01721057|592271221|FG000|Rescue Period|Lack of Efficacy|0|||
163972920|NCT01721057|592271222|FG001|Rescue Period|Lack of Efficacy|0|||
163972921|NCT01721057|592271223|FG002|Rescue Period|Lack of Efficacy|0|||
163972922|NCT01721057|592271224|FG003|Rescue Period|Lack of Efficacy|2|||
163972923|NCT01721057|592271225|FG004|Rescue Period|Lack of Efficacy|0|||
163972924|NCT01721057|592271226|FG005|Rescue Period|Lack of Efficacy|0|||
163972925|NCT01721057|592271227|FG006|Rescue Period|Lack of Efficacy|0|||
163972926|NCT03472924|592271230|FG000|Overall Study|Adverse Event|1|||
163972927|NCT03472924|592271231|FG001|Overall Study|Adverse Event|0|||
163972928|NCT02546765|592271233|FG000|Overall Study|Withdrawal by Subject|0|||
163972929|NCT02546765|592271234|FG001|Overall Study|Withdrawal by Subject|1|||
163972930|NCT02546765|592271235|FG002|Overall Study|Withdrawal by Subject|0|||
163972931|NCT02546765|592271236|FG003|Overall Study|Withdrawal by Subject|0|||
163972932|NCT04425720|592271239|FG000|Overall Study|Withdrawal by Subject|0|||
163972933|NCT04425720|592271240|FG001|Overall Study|Withdrawal by Subject|20|||
163972934|NCT00807742|592271241|FG000|Overall Study|Death|9|||
163972935|NCT00807742|592271242|FG001|Overall Study|Death|2|||
163972936|NCT00807742|592271241|FG000|Overall Study|Withdrawal by Subject|2|||
163972937|NCT00807742|592271242|FG001|Overall Study|Withdrawal by Subject|1|||
163972938|NCT00807742|592271241|FG000|Overall Study|Lost to Follow-up|35|||
163972939|NCT00807742|592271242|FG001|Overall Study|Lost to Follow-up|51|||
163972940|NCT02044133|592271243|FG000|Overall Study|Lost to Follow-up|1|||
163972941|NCT02044133|592271244|FG001|Overall Study|Lost to Follow-up|1|||
163972942|NCT02044133|592271243|FG000|Overall Study|Death|1|||
163972943|NCT02044133|592271244|FG001|Overall Study|Death|0|||
163972944|NCT02044133|592271243|FG000|Overall Study|Release|3|||
163972945|NCT02044133|592271244|FG001|Overall Study|Release|4|||
163972946|NCT02044133|592271243|FG000|Overall Study|Transfer|1|||
163972947|NCT02044133|592271244|FG001|Overall Study|Transfer|0|||
163972948|NCT02044133|592271243|FG000|Overall Study|refusal of blood sampling|0|||
163972949|NCT02044133|592271244|FG001|Overall Study|refusal of blood sampling|1|||
163972950|NCT04085523|592271245|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163972951|NCT04085523|592271246|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163972952|NCT04085523|592271247|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163972953|NCT04085523|592271248|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163972954|NCT04085523|592271249|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
163972955|NCT04085523|592271250|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
163972956|NCT05318937|592271255|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163972957|NCT05318937|592271256|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163972958|NCT05318937|592271255|FG000|Overall Study|Lost to Follow-up|0|||
163972959|NCT05318937|592271256|FG001|Overall Study|Lost to Follow-up|1|||
163972960|NCT05318937|592271255|FG000|Overall Study|Withdrawal by Subject|0|||
163972961|NCT05318937|592271256|FG001|Overall Study|Withdrawal by Subject|2|||
163972962|NCT05318937|592271255|FG000|Overall Study|Protocol Violation|0|||
163972963|NCT05318937|592271256|FG001|Overall Study|Protocol Violation|1|||
163972964|NCT02046096|592271257|FG000|Overall Study|Death|28|||
163972965|NCT02046096|592271258|FG001|Overall Study|Death|45|||
163972966|NCT02046096|592271257|FG000|Overall Study|Lost to Follow-up|9|||
163972967|NCT02046096|592271258|FG001|Overall Study|Lost to Follow-up|20|||
163972968|NCT02046096|592271257|FG000|Overall Study|Withdrawal by Subject|5|||
163972969|NCT02046096|592271258|FG001|Overall Study|Withdrawal by Subject|17|||
163972970|NCT02046096|592271257|FG000|Overall Study|Other endpoint|2|||
163972971|NCT02046096|592271258|FG001|Overall Study|Other endpoint|19|||
163972972|NCT04969276|592271259|FG000|Overall Study|Protocol Deviation|0|||
163972973|NCT04969276|592271260|FG001|Overall Study|Protocol Deviation|1|||
163972974|NCT04969276|592271261|FG002|Overall Study|Protocol Deviation|0|||
163972975|NCT04969276|592271259|FG000|Overall Study|Withdrawal by Subject|1|||
163972976|NCT04969276|592271260|FG001|Overall Study|Withdrawal by Subject|10|||
163972977|NCT04969276|592271261|FG002|Overall Study|Withdrawal by Subject|0|||
163972978|NCT04969276|592271259|FG000|Overall Study|Lost to Follow-up|0|||
163972979|NCT04969276|592271260|FG001|Overall Study|Lost to Follow-up|1|||
163972980|NCT04969276|592271261|FG002|Overall Study|Lost to Follow-up|0|||
163972981|NCT00853749|592271267|FG000|Overall Study|Lost to Follow-up|0|||
163972982|NCT00853749|592271268|FG001|Overall Study|Lost to Follow-up|1|||
163972983|NCT00687440|592271269|FG000|Overall Study|Adverse Event|3|||
163972984|NCT00687440|592271269|FG000|Overall Study|Lost to Follow-up|3|||
163972985|NCT00687440|592271269|FG000|Overall Study|Lack of Efficacy|2|||
163972986|NCT00687440|592271269|FG000|Overall Study|Death|2|||
163972987|NCT00687440|592271269|FG000|Overall Study|Other|1|||
163972988|NCT00687440|592271269|FG000|Overall Study|Missing|1|||
163972989|NCT00430482|592271271|FG000|Completed Treatment|Insufficient Treatment|7|||
163972990|NCT00430482|592271272|FG001|Completed Treatment|Insufficient Treatment|11|||
163972991|NCT00583024|592271275|FG000|Overall Study|Lost to Follow-up|4|||
163972992|NCT04259411|592272599|FG000|Overall Study|Death|1|||
163972993|NCT04259411|592272599|FG000|Overall Study|Missed visit|2|||
163972994|NCT00766038|592272602|FG000|Overall Study|Lost to Follow-up|15|||
163972995|NCT00766038|592272603|FG001|Overall Study|Lost to Follow-up|14|||
163972996|NCT00449670|592272604|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
163972997|NCT00449670|592272605|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
163972998|NCT00449670|592272604|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
163972999|NCT00449670|592272605|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
163973000|NCT00449670|592272604|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
163973001|NCT00449670|592272605|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
163973002|NCT00449670|592272604|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
163973003|NCT00449670|592272605|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
163973004|NCT00449670|592272604|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
163973005|NCT00449670|592272605|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
163973006|NCT00449670|592272604|FG000|Booster Phase (Study no.109873)|Other|0|||
163973007|NCT00449670|592272605|FG001|Booster Phase (Study no.109873)|Other|2|||
163973008|NCT01502709|592272609|FG000|Overall Study|Lost to Follow-up|4|||
163973009|NCT01502709|592272610|FG001|Overall Study|Lost to Follow-up|0|||
163973010|NCT03703882|592272611|FG000|Overall Study|Adverse Event|1|||
163973011|NCT03703882|592272612|FG001|Overall Study|Adverse Event|0|||
163973012|NCT03703882|592272611|FG000|Overall Study|Lost to Follow-up|0|||
163973013|NCT03703882|592272612|FG001|Overall Study|Lost to Follow-up|2|||
163973014|NCT03703882|592272611|FG000|Overall Study|Non-compliance with study drug|0|||
163973015|NCT03703882|592272612|FG001|Overall Study|Non-compliance with study drug|1|||
163973016|NCT03703882|592272611|FG000|Overall Study|Physician Decision|0|||
163973017|NCT03703882|592272612|FG001|Overall Study|Physician Decision|1|||
163973018|NCT03703882|592272611|FG000|Overall Study|Progressive disease|1|||
163973019|NCT03703882|592272612|FG001|Overall Study|Progressive disease|0|||
163973020|NCT03703882|592272611|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163973021|NCT03703882|592272612|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163973022|NCT03703882|592272611|FG000|Overall Study|Starting another treatment|0|||
163973023|NCT03703882|592272612|FG001|Overall Study|Starting another treatment|1|||
163973024|NCT03703882|592272611|FG000|Overall Study|noncompliance with study procedures|0|||
163973025|NCT03703882|592272612|FG001|Overall Study|noncompliance with study procedures|1|||
163973026|NCT02263079|592272620|FG000|Overall Study|Physician Decision|1|||
163973027|NCT02263079|592272621|FG001|Overall Study|Physician Decision|0|||
163973028|NCT02263079|592272622|FG002|Overall Study|Physician Decision|0|||
163973029|NCT02263079|592272620|FG000|Overall Study|Withdrawal by Subject|2|||
163973030|NCT02263079|592272621|FG001|Overall Study|Withdrawal by Subject|8|||
163973031|NCT02263079|592272622|FG002|Overall Study|Withdrawal by Subject|0|||
163973032|NCT00840086|592272623|FG000|Overall Study|Adverse Event|1|||
163973033|NCT00840086|592272623|FG000|Overall Study|Protocol Violation|2|||
163973034|NCT00840086|592272623|FG000|Overall Study|Lost to Follow-up|1|||
163973035|NCT03332498|592272624|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
163973036|NCT03332498|592272625|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
163973037|NCT03332498|592272626|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
163973038|NCT00253643|592272629|FG000|Overall Study|Withdrawal by Subject|0|||
163973039|NCT00253643|592272630|FG001|Overall Study|Withdrawal by Subject|0|||
163973040|NCT00253643|592272631|FG002|Overall Study|Withdrawal by Subject|1|||
163973041|NCT00253643|592272632|FG003|Overall Study|Withdrawal by Subject|1|||
163973042|NCT00253643|592272629|FG000|Overall Study|Non-Compliance|0|||
163973043|NCT00253643|592272630|FG001|Overall Study|Non-Compliance|0|||
163973044|NCT00253643|592272631|FG002|Overall Study|Non-Compliance|0|||
163973045|NCT00253643|592272632|FG003|Overall Study|Non-Compliance|2|||
163869061|NCT00980330|591888612|FG000|Overall Study|Adverse Event|0|||
163869062|NCT00980330|591888613|FG001|Overall Study|Adverse Event|0|||
163869063|NCT00980330|591888614|FG002|Overall Study|Adverse Event|0|||
163869064|NCT00980330|591888615|FG003|Overall Study|Adverse Event|1|||
163869065|NCT00980330|591888616|FG004|Overall Study|Adverse Event|0|||
163869066|NCT00980330|591888617|FG005|Overall Study|Adverse Event|0|||
163869067|NCT00980330|591888618|FG006|Overall Study|Adverse Event|0|||
163869068|NCT00980330|591888612|FG000|Overall Study|Lost to Follow-up|1|||
163869069|NCT00980330|591888613|FG001|Overall Study|Lost to Follow-up|1|||
163869070|NCT00980330|591888614|FG002|Overall Study|Lost to Follow-up|4|||
163869071|NCT00980330|591888615|FG003|Overall Study|Lost to Follow-up|2|||
163869072|NCT00980330|591888616|FG004|Overall Study|Lost to Follow-up|1|||
163869073|NCT00980330|591888617|FG005|Overall Study|Lost to Follow-up|1|||
163869074|NCT00980330|591888618|FG006|Overall Study|Lost to Follow-up|2|||
163869075|NCT00980330|591888612|FG000|Overall Study|Withdrawal by Subject|2|||
163869076|NCT00980330|591888613|FG001|Overall Study|Withdrawal by Subject|4|||
163869077|NCT00980330|591888614|FG002|Overall Study|Withdrawal by Subject|4|||
163869078|NCT00980330|591888615|FG003|Overall Study|Withdrawal by Subject|1|||
163869079|NCT00980330|591888616|FG004|Overall Study|Withdrawal by Subject|3|||
163869080|NCT00980330|591888617|FG005|Overall Study|Withdrawal by Subject|2|||
163869081|NCT00980330|591888618|FG006|Overall Study|Withdrawal by Subject|5|||
163869082|NCT00980330|591888612|FG000|Overall Study|(not specified)|2|||
163869083|NCT00980330|591888613|FG001|Overall Study|(not specified)|0|||
163869084|NCT00980330|591888614|FG002|Overall Study|(not specified)|0|||
163869085|NCT00980330|591888615|FG003|Overall Study|(not specified)|1|||
163869086|NCT00980330|591888616|FG004|Overall Study|(not specified)|1|||
163869087|NCT00980330|591888617|FG005|Overall Study|(not specified)|1|||
163869088|NCT00980330|591888618|FG006|Overall Study|(not specified)|0|||
163869089|NCT00346151|591888619|FG000|Overall Study|Withdrawal by Subject|3|||
163973046|NCT05807464|592272635|FG000|Overall Study|Adverse Event|1|||
163973047|NCT04451161|592272638|FG000|Overall Study|Lost to Follow-up|28|||
163973048|NCT04451161|592272639|FG001|Overall Study|Lost to Follow-up|37|||
163973049|NCT04451161|592272640|FG002|Overall Study|Lost to Follow-up|22|||
163973050|NCT04451161|592272641|FG003|Overall Study|Lost to Follow-up|13|||
163973051|NCT04451161|592272642|FG004|Overall Study|Lost to Follow-up|11|||
163973052|NCT04451161|592272643|FG005|Overall Study|Lost to Follow-up|14|||
163973053|NCT04451161|592272638|FG000|Overall Study|Withdrawal by Subject|3|||
163973054|NCT04451161|592272639|FG001|Overall Study|Withdrawal by Subject|0|||
163973055|NCT04451161|592272640|FG002|Overall Study|Withdrawal by Subject|0|||
163973056|NCT04451161|592272641|FG003|Overall Study|Withdrawal by Subject|0|||
163973057|NCT04451161|592272642|FG004|Overall Study|Withdrawal by Subject|2|||
163973058|NCT04451161|592272643|FG005|Overall Study|Withdrawal by Subject|4|||
163973059|NCT03596866|592272644|FG000|Overall Study|Site terminated by Sponsor|64|||
163869090|NCT01075217|591888620|FG000|Overall Study|Adverse Event|1|||
163869091|NCT01075217|591888621|FG001|Overall Study|Adverse Event|1|||
163869092|NCT01075217|591888620|FG000|Overall Study|Physician Decision|1|||
163869093|NCT01075217|591888621|FG001|Overall Study|Physician Decision|0|||
163869094|NCT02448446|591888622|FG000|Overall Study|Withdrawal by Subject|1|||
163869095|NCT02448446|591888623|FG001|Overall Study|Withdrawal by Subject|0|||
163973060|NCT03596866|592272645|FG001|Overall Study|Site terminated by Sponsor|65|||
163973061|NCT03596866|592272644|FG000|Overall Study|Death|37|||
163973062|NCT03596866|592272645|FG001|Overall Study|Death|24|||
163973063|NCT03596866|592272644|FG000|Overall Study|Withdrawal by Subject|4|||
163973064|NCT03596866|592272645|FG001|Overall Study|Withdrawal by Subject|6|||
164203908|NCT01454284|593117829|FG000|Overall Study|Protocol Violation|9|||
164203909|NCT01454284|593117830|FG001|Overall Study|Protocol Violation|6|||
164203910|NCT01454284|593117829|FG000|Overall Study|Withdrawal by Subject|58|||
164203911|NCT01454284|593117830|FG001|Overall Study|Withdrawal by Subject|36|||
164203912|NCT01454284|593117829|FG000|Overall Study|Physician Decision|16|||
164203913|NCT01454284|593117830|FG001|Overall Study|Physician Decision|11|||
164203914|NCT01454284|593117829|FG000|Overall Study|Sponsor Decision|0|||
163869096|NCT03260140|591888624|FG000|Overall Study|Death|4|||
163869097|NCT03260140|591888625|FG001|Overall Study|Death|1|||
163869098|NCT03260140|591888624|FG000|Overall Study|Withdrawal by Subject|1|||
163869099|NCT03260140|591888625|FG001|Overall Study|Withdrawal by Subject|4|||
163869100|NCT00463788|591888626|FG000|Overall Study|Progressive Disease|86|||
163869101|NCT00463788|591888627|FG001|Overall Study|Progressive Disease|42|||
163869102|NCT00463788|591888626|FG000|Overall Study|Adverse Event|6|||
163869103|NCT00463788|591888627|FG001|Overall Study|Adverse Event|2|||
163869104|NCT00463788|591888626|FG000|Overall Study|Withdrawal by Subject|6|||
163869105|NCT00463788|591888627|FG001|Overall Study|Withdrawal by Subject|2|||
163869106|NCT00463788|591888626|FG000|Overall Study|Death|4|||
163869107|NCT00463788|591888627|FG001|Overall Study|Death|3|||
163869108|NCT00463788|591888626|FG000|Overall Study|Symptomatic Deterioration|2|||
163869109|NCT00463788|591888627|FG001|Overall Study|Symptomatic Deterioration|3|||
163869110|NCT00463788|591888626|FG000|Overall Study|Lost to Follow-up|1|||
163869111|NCT00463788|591888627|FG001|Overall Study|Lost to Follow-up|0|||
163869112|NCT00463788|591888626|FG000|Overall Study|Protocol Violation|0|||
163869113|NCT00463788|591888627|FG001|Overall Study|Protocol Violation|1|||
163869114|NCT00463788|591888626|FG000|Overall Study|Other|3|||
163869115|NCT00463788|591888627|FG001|Overall Study|Other|0|||
163869116|NCT00463788|591888626|FG000|Overall Study|Randomized but not treated|1|||
163869117|NCT00463788|591888627|FG001|Overall Study|Randomized but not treated|1|||
163869118|NCT00360698|591888628|FG000|Run-In|Physician Decision|0|||
163869119|NCT00360698|591888629|FG001|Run-In|Physician Decision|1|||
163869120|NCT00360698|591888628|FG000|Run-In|Withdrawal by Subject|0|||
163869121|NCT00360698|591888629|FG001|Run-In|Withdrawal by Subject|2|||
163869122|NCT00360698|591888628|FG000|Run-In|Non compliance with treatment procedure|0|||
163869123|NCT00360698|591888629|FG001|Run-In|Non compliance with treatment procedure|1|||
163869124|NCT00360698|591888628|FG000|Run-In|Sponsor request|0|||
163869125|NCT00360698|591888629|FG001|Run-In|Sponsor request|2|||
163869126|NCT00360698|591888628|FG000|Run-In|Patient did not meet inclusion criteria|0|||
163869127|NCT00360698|591888629|FG001|Run-In|Patient did not meet inclusion criteria|1|||
163869128|NCT00360698|591888628|FG000|Run-In|Patient personal reasons|0|||
163869129|NCT00360698|591888629|FG001|Run-In|Patient personal reasons|2|||
163869130|NCT00360698|591888628|FG000|Run-In|Need of insulin with meals|0|||
163869131|NCT00360698|591888629|FG001|Run-In|Need of insulin with meals|1|||
163869132|NCT00360698|591888628|FG000|Treatment Period|Non compliance with treatment procedure|1|||
163869133|NCT00360698|591888629|FG001|Treatment Period|Non compliance with treatment procedure|0|||
163869134|NCT00360698|591888628|FG000|Treatment Period|Early termination by error|0|||
163869135|NCT00360698|591888629|FG001|Treatment Period|Early termination by error|1|||
163869136|NCT01692938|591888640|FG000|Overall Study|Protocol Deviation|1|||
163869137|NCT01692938|591888641|FG001|Overall Study|Protocol Deviation|1|||
163869138|NCT01692938|591888640|FG000|Overall Study|Study completed prior to site completion|3|||
163869139|NCT01692938|591888641|FG001|Overall Study|Study completed prior to site completion|3|||
163869140|NCT02957136|591888644|FG000|Overall Study|Withdrawal by Subject|2|||
163869141|NCT02957136|591888645|FG001|Overall Study|Withdrawal by Subject|1|||
163869142|NCT02200770|591888649|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
163869143|NCT02200770|591888650|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
163869144|NCT02200770|591888649|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
163869145|NCT02200770|591888650|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
163869146|NCT02200770|591888649|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
163869147|NCT02200770|591888650|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
163869148|NCT02200770|591888649|FG000|Randomized-controlled Period (RCP)|Other|1|||
163869149|NCT02200770|591888650|FG001|Randomized-controlled Period (RCP)|Other|2|||
163869150|NCT02200770|591888649|FG000|Open-label Period (OLP)|Adverse Event|1|||
163869151|NCT02200770|591888650|FG001|Open-label Period (OLP)|Adverse Event|2|||
163869152|NCT02200770|591888649|FG000|Open-label Period (OLP)|Death|1|||
163869153|NCT02200770|591888650|FG001|Open-label Period (OLP)|Death|2|||
163869154|NCT02200770|591888649|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
163869155|NCT02200770|591888650|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
163869156|NCT02200770|591888649|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
163869157|NCT02200770|591888650|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
163869158|NCT02200770|591888649|FG000|Open-label Period (OLP)|Other|6|||
163869159|NCT02200770|591888650|FG001|Open-label Period (OLP)|Other|15|||
163869160|NCT00424645|591888654|FG000|Overall Study|Death|1|||
163869161|NCT00424645|591888655|FG001|Overall Study|Death|0|||
163869162|NCT02555215|591888656|FG000|Overall Study|Other|1|||
163869163|NCT02555215|591888656|FG000|Overall Study|Investigator Decision|2|||
163869164|NCT00529789|591888657|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
163869165|NCT00529789|591888657|FG000|Study Period II/III|Adverse Event|3|||
164314754|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
164314755|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
164314756|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
164314757|NCT00884741|593529761|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
164314758|NCT00884741|593529762|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
164314759|NCT00884741|593529763|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
164314760|NCT00884741|593529764|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
164314761|NCT00884741|593529761|FG000|Randomization|Protocol Violation|0|||
164314762|NCT00884741|593529762|FG001|Randomization|Protocol Violation|0|||
164314763|NCT00884741|593529763|FG002|Randomization|Protocol Violation|8|||
164314764|NCT00884741|593529764|FG003|Randomization|Protocol Violation|8|||
164314765|NCT01324401|593529765|FG000|Overall Study|Withdrawn before any treatment|0|||
164314766|NCT01324401|593529766|FG001|Overall Study|Withdrawn before any treatment|3|||
164314767|NCT01324401|593529765|FG000|Overall Study|Adverse Event|1|||
164314768|NCT01324401|593529766|FG001|Overall Study|Adverse Event|3|||
164314769|NCT01578850|593529767|FG000|Period 1|Insufficient Clinical Response|1|||
164314770|NCT01578850|593529768|FG001|Period 1|Insufficient Clinical Response|0|||
164314771|NCT01578850|593529769|FG002|Period 1|Insufficient Clinical Response|0|||
164314772|NCT01578850|593529767|FG000|Period 1|Adverse Event|11|||
164314773|NCT01578850|593529768|FG001|Period 1|Adverse Event|0|||
164314774|NCT01578850|593529769|FG002|Period 1|Adverse Event|0|||
164314775|NCT01578850|593529767|FG000|Period 1|Death|1|||
164314776|NCT01578850|593529768|FG001|Period 1|Death|0|||
164314777|NCT01578850|593529769|FG002|Period 1|Death|0|||
164314778|NCT01578850|593529767|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
164314779|NCT01578850|593529768|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
164314780|NCT01578850|593529769|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
164314781|NCT01578850|593529767|FG000|Period 1|Withdrawal by Subject|9|||
164314782|NCT01578850|593529768|FG001|Period 1|Withdrawal by Subject|0|||
164314783|NCT01578850|593529769|FG002|Period 1|Withdrawal by Subject|0|||
164314784|NCT01578850|593529767|FG000|Period 1|Study Terminated by Sponsor|3|||
164314785|NCT01578850|593529768|FG001|Period 1|Study Terminated by Sponsor|0|||
163869166|NCT00529789|591888657|FG000|Study Period II/III|Lack of Efficacy|2|||
164314786|NCT01578850|593529769|FG002|Period 1|Study Terminated by Sponsor|0|||
164314787|NCT01578850|593529767|FG000|Period 2|Insufficient Clinical Response|0|||
164314788|NCT01578850|593529768|FG001|Period 2|Insufficient Clinical Response|1|||
164314789|NCT01578850|593529769|FG002|Period 2|Insufficient Clinical Response|0|||
164314790|NCT01578850|593529767|FG000|Period 2|Adverse Event|0|||
164314791|NCT01578850|593529768|FG001|Period 2|Adverse Event|3|||
164314792|NCT01578850|593529769|FG002|Period 2|Adverse Event|6|||
164314793|NCT01578850|593529767|FG000|Period 2|Lost to Follow-up|0|||
164314794|NCT01578850|593529768|FG001|Period 2|Lost to Follow-up|1|||
164314795|NCT01578850|593529769|FG002|Period 2|Lost to Follow-up|2|||
164314796|NCT01578850|593529767|FG000|Period 2|Withdrawal by Subject|0|||
164314797|NCT01578850|593529768|FG001|Period 2|Withdrawal by Subject|2|||
164314798|NCT01578850|593529769|FG002|Period 2|Withdrawal by Subject|2|||
164314799|NCT01578850|593529767|FG000|Period 2|Study Terminated by Sponsor|0|||
164314800|NCT01578850|593529768|FG001|Period 2|Study Terminated by Sponsor|5|||
163869167|NCT00529789|591888657|FG000|Study Period II/III|Withdrawal by Subject|1|||
163869168|NCT00529789|591888657|FG000|Study Period II/III|Protocol Violation|3|||
163869169|NCT00529789|591888657|FG000|Study Period II/III|Physician Decision|3|||
163869170|NCT00529789|591888657|FG000|Study Period II/III|Lost to Follow-up|3|||
163869171|NCT00529789|591888657|FG000|Study Period IV|Parent/Caregiver Decision|1|||
163869172|NCT00529789|591888657|FG000|Study Period IV|Adverse Event|1|||
163869173|NCT00529789|591888657|FG000|Study Period IV|Lack of Efficacy|1|||
163869174|NCT00529789|591888657|FG000|Study Period IV|Lost to Follow-up|3|||
163869175|NCT02204982|591888658|FG000|Overall Study|Patient ineligible-medical monitor|1|||
163869176|NCT02204982|591888659|FG001|Overall Study|Patient ineligible-medical monitor|0|||
163869177|NCT02204982|591888658|FG000|Overall Study|Withdrawal by Subject|1|||
163869178|NCT02204982|591888659|FG001|Overall Study|Withdrawal by Subject|0|||
163869179|NCT02204982|591888658|FG000|Overall Study|Adverse Event|1|||
163869180|NCT02204982|591888659|FG001|Overall Study|Adverse Event|0|||
163869181|NCT02204982|591888658|FG000|Overall Study|Adverse Event and Investigator decision|1|||
163869182|NCT02204982|591888659|FG001|Overall Study|Adverse Event and Investigator decision|0|||
164314801|NCT01578850|593529769|FG002|Period 2|Study Terminated by Sponsor|4|||
164314802|NCT01578850|593529767|FG000|Period 2|Unspecified Reasons|0|||
164314803|NCT01578850|593529768|FG001|Period 2|Unspecified Reasons|1|||
164314804|NCT01578850|593529769|FG002|Period 2|Unspecified Reasons|0|||
164314805|NCT01818752|593529773|FG000|Overall Study|Adverse Event|64|||
163869183|NCT02204982|591888658|FG000|Overall Study|Physician Decision|0|||
163869184|NCT02204982|591888659|FG001|Overall Study|Physician Decision|2|||
163869185|NCT02204982|591888658|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
164314806|NCT01818752|593529774|FG001|Overall Study|Adverse Event|74|||
163869186|NCT02204982|591888659|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
164314807|NCT01818752|593529773|FG000|Overall Study|Death|14|||
164314808|NCT01818752|593529774|FG001|Overall Study|Death|18|||
164314809|NCT01818752|593529773|FG000|Overall Study|Non-compliance|16|||
163869187|NCT02204982|591888658|FG000|Overall Study|Termination of Study bySponsor|0|||
163869188|NCT02204982|591888659|FG001|Overall Study|Termination of Study bySponsor|1|||
163869189|NCT01968226|591888660|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
163869190|NCT00457743|591888663|FG000|Overall Study|Adverse Event|0|||
163869191|NCT00457743|591888664|FG001|Overall Study|Adverse Event|4|||
163869192|NCT00457743|591888665|FG002|Overall Study|Adverse Event|0|||
163869193|NCT00457743|591888663|FG000|Overall Study|Lack of Efficacy|3|||
163869194|NCT00457743|591888664|FG001|Overall Study|Lack of Efficacy|23|||
163869195|NCT00457743|591888665|FG002|Overall Study|Lack of Efficacy|3|||
163869196|NCT00959946|591888666|FG000|Overall Study|Adverse Event|0|||
163869197|NCT00959946|591888667|FG001|Overall Study|Adverse Event|0|||
163869198|NCT00959946|591888668|FG002|Overall Study|Adverse Event|2|||
163869199|NCT00959946|591888669|FG003|Overall Study|Adverse Event|1|||
163869200|NCT00959946|591888670|FG004|Overall Study|Adverse Event|0|||
163869201|NCT00959946|591888671|FG005|Overall Study|Adverse Event|1|||
163869202|NCT00959946|591888672|FG006|Overall Study|Adverse Event|0|||
163869203|NCT00959946|591888673|FG007|Overall Study|Adverse Event|0|||
163869204|NCT00959946|591888666|FG000|Overall Study|Death|0|||
164203915|NCT01454284|593117830|FG001|Overall Study|Sponsor Decision|2|||
164203916|NCT00393367|593117833|FG000|Overall Study|Protocol Violation|2|||
163869205|NCT00959946|591888667|FG001|Overall Study|Death|0|||
163869206|NCT00959946|591888668|FG002|Overall Study|Death|0|||
163869207|NCT00959946|591888669|FG003|Overall Study|Death|0|||
163869208|NCT00959946|591888670|FG004|Overall Study|Death|0|||
163869209|NCT00959946|591888671|FG005|Overall Study|Death|1|||
163869210|NCT00959946|591888672|FG006|Overall Study|Death|0|||
163869211|NCT00959946|591888673|FG007|Overall Study|Death|0|||
163869212|NCT00959946|591888666|FG000|Overall Study|Disease Progression|2|||
163973065|NCT03596866|592272644|FG000|Overall Study|Missing|0|||
164203917|NCT00393367|593117834|FG001|Overall Study|Protocol Violation|5|||
164203918|NCT00393367|593117833|FG000|Overall Study|Withdrawal by Subject|0|||
164203919|NCT00393367|593117834|FG001|Overall Study|Withdrawal by Subject|2|||
164203920|NCT03248037|593117835|FG000|Overall Study|Withdrawal by Subject|6|||
164203921|NCT03248037|593117836|FG001|Overall Study|Withdrawal by Subject|9|||
164203922|NCT03248037|593117835|FG000|Overall Study|Adverse Event|15|||
164203923|NCT03248037|593117836|FG001|Overall Study|Adverse Event|0|||
164203924|NCT02897349|593117840|FG000|Overall Study|Lost to Follow-up|2|||
164203925|NCT02897349|593117841|FG001|Overall Study|Lost to Follow-up|2|||
164203926|NCT02897349|593117840|FG000|Overall Study|Adverse Event|3|||
164203927|NCT02897349|593117841|FG001|Overall Study|Adverse Event|3|||
164203928|NCT02897349|593117840|FG000|Overall Study|Other than listed above|0|||
164203929|NCT02897349|593117841|FG001|Overall Study|Other than listed above|1|||
164203930|NCT02765035|593117848|FG000|First Intervention (90 Days)|Adverse Event|1|||
164203931|NCT02765035|593117849|FG001|First Intervention (90 Days)|Adverse Event|1|||
164203932|NCT02765035|593117848|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
164203933|NCT02765035|593117849|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
164203934|NCT00856180|593117850|FG000|Overall Study|Adverse Event|4|||
164203935|NCT00856180|593117850|FG000|Overall Study|Progressive Disease|16|||
164203936|NCT03895086|593117853|FG000|Overall Study|Early termination study|1|||
164203937|NCT03895086|593117854|FG001|Overall Study|Early termination study|0|||
164203938|NCT01192815|593117855|FG000|Overall Study|Withdrawal by Subject|1|||
164203939|NCT01192815|593117855|FG000|Overall Study|Lack of Efficacy|1|||
164203940|NCT01142336|593117857|FG000|Overall Study|Adverse Event|1|||
164203941|NCT01142336|593117858|FG001|Overall Study|Adverse Event|1|||
164203942|NCT01142336|593117857|FG000|Overall Study|Lost to Follow-up|0|||
164203943|NCT01142336|593117858|FG001|Overall Study|Lost to Follow-up|1|||
164203944|NCT03025035|593117874|FG000|Overall Study|Death|2|||
164203945|NCT03025035|593117874|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
164203946|NCT01218802|593117875|FG000|Overall Study|Lost to Follow-up|5|||
164203947|NCT01218802|593117876|FG001|Overall Study|Lost to Follow-up|6|||
164203948|NCT01218802|593117875|FG000|Overall Study|Withdrawal by Subject|3|||
164203949|NCT01218802|593117876|FG001|Overall Study|Withdrawal by Subject|10|||
164203950|NCT01218802|593117875|FG000|Overall Study|Adverse Event|0|||
164203951|NCT01218802|593117876|FG001|Overall Study|Adverse Event|2|||
164203952|NCT01218802|593117875|FG000|Overall Study|Incarcerated|2|||
164203953|NCT01218802|593117876|FG001|Overall Study|Incarcerated|0|||
164203954|NCT02475369|593117885|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
164203955|NCT02475369|593117886|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
164203956|NCT00471497|593117887|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
164203957|NCT00471497|593117888|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
163869213|NCT00959946|591888667|FG001|Overall Study|Disease Progression|4|||
163869214|NCT00959946|591888668|FG002|Overall Study|Disease Progression|2|||
163869215|NCT00959946|591888669|FG003|Overall Study|Disease Progression|4|||
163869216|NCT00959946|591888670|FG004|Overall Study|Disease Progression|4|||
163869217|NCT00959946|591888671|FG005|Overall Study|Disease Progression|6|||
163973066|NCT03596866|592272645|FG001|Overall Study|Missing|6|||
164314810|NCT01818752|593529774|FG001|Overall Study|Non-compliance|20|||
163869218|NCT00959946|591888672|FG006|Overall Study|Disease Progression|2|||
163869219|NCT00959946|591888673|FG007|Overall Study|Disease Progression|2|||
163869220|NCT00959946|591888666|FG000|Overall Study|Withdrawal by Subject|0|||
163869221|NCT00959946|591888667|FG001|Overall Study|Withdrawal by Subject|0|||
163869222|NCT00959946|591888668|FG002|Overall Study|Withdrawal by Subject|0|||
163869223|NCT00959946|591888669|FG003|Overall Study|Withdrawal by Subject|0|||
163869224|NCT00959946|591888670|FG004|Overall Study|Withdrawal by Subject|0|||
163869225|NCT00959946|591888671|FG005|Overall Study|Withdrawal by Subject|1|||
163869226|NCT00959946|591888672|FG006|Overall Study|Withdrawal by Subject|0|||
163869227|NCT00959946|591888673|FG007|Overall Study|Withdrawal by Subject|0|||
163869228|NCT00841035|591888674|FG000|Phase 1 Overall Study|Physician Decision|13|||
163869229|NCT00433199|591888679|FG000|Double-Blind Period|Adverse Event|0|||
163869230|NCT00433199|591888680|FG001|Double-Blind Period|Adverse Event|25|||
163869231|NCT00433199|591888679|FG000|Double-Blind Period|Lack of Efficacy|0|||
163869232|NCT00433199|591888680|FG001|Double-Blind Period|Lack of Efficacy|2|||
163869233|NCT00433199|591888679|FG000|Double-Blind Period|Lost to Follow-up|2|||
163869234|NCT00433199|591888680|FG001|Double-Blind Period|Lost to Follow-up|5|||
163869235|NCT00433199|591888679|FG000|Double-Blind Period|Withdrawal by Subject|8|||
164314811|NCT01818752|593529773|FG000|Overall Study|Withdrawal by Subject|15|||
164314812|NCT01818752|593529774|FG001|Overall Study|Withdrawal by Subject|14|||
164314813|NCT01818752|593529773|FG000|Overall Study|Physician Decision|9|||
163869236|NCT00433199|591888680|FG001|Double-Blind Period|Withdrawal by Subject|19|||
163869237|NCT00433199|591888679|FG000|Double-Blind Period|Protocol Violation|1|||
163869238|NCT00433199|591888680|FG001|Double-Blind Period|Protocol Violation|10|||
163869239|NCT00433199|591888679|FG000|Double-Blind Period|Administrative|1|||
163869240|NCT00433199|591888680|FG001|Double-Blind Period|Administrative|5|||
163869241|NCT00433199|591888679|FG000|Open-Label Period|Adverse Event|0|||
163869242|NCT00433199|591888680|FG001|Open-Label Period|Adverse Event|19|||
163869243|NCT00433199|591888679|FG000|Open-Label Period|Lack of Efficacy|0|||
163869244|NCT00433199|591888680|FG001|Open-Label Period|Lack of Efficacy|2|||
163869245|NCT00433199|591888679|FG000|Open-Label Period|Lost to Follow-up|0|||
163869246|NCT00433199|591888680|FG001|Open-Label Period|Lost to Follow-up|3|||
163869247|NCT00433199|591888679|FG000|Open-Label Period|Withdrawal by Subject|0|||
163869248|NCT00433199|591888680|FG001|Open-Label Period|Withdrawal by Subject|7|||
163869249|NCT00433199|591888679|FG000|Open-Label Period|Protocol Violation|0|||
163869250|NCT00433199|591888680|FG001|Open-Label Period|Protocol Violation|2|||
163869251|NCT00433199|591888679|FG000|Open-Label Period|Administrative|0|||
163869252|NCT00433199|591888680|FG001|Open-Label Period|Administrative|1|||
163869253|NCT00357097|591888681|FG000|Overall Study|Did not meet inclusion criteria|5|||
163869254|NCT00357097|591888682|FG001|Overall Study|Did not meet inclusion criteria|3|||
163869255|NCT00357097|591888681|FG000|Overall Study|Adverse Event|34|||
163869256|NCT00357097|591888682|FG001|Overall Study|Adverse Event|6|||
163869257|NCT00357097|591888681|FG000|Overall Study|Withdrawal by Subject|8|||
163869258|NCT00357097|591888682|FG001|Overall Study|Withdrawal by Subject|7|||
163869259|NCT00357097|591888681|FG000|Overall Study|Non-compliance|1|||
163869260|NCT00357097|591888682|FG001|Overall Study|Non-compliance|2|||
163869261|NCT00357097|591888681|FG000|Overall Study|Lack of Efficacy|2|||
163869262|NCT00357097|591888682|FG001|Overall Study|Lack of Efficacy|8|||
163869263|NCT00357097|591888681|FG000|Overall Study|Met Exclusion Criteria|3|||
163869264|NCT00357097|591888682|FG001|Overall Study|Met Exclusion Criteria|1|||
163869265|NCT00357097|591888681|FG000|Overall Study|Other|1|||
163869266|NCT00357097|591888682|FG001|Overall Study|Other|1|||
163869267|NCT00357097|591888681|FG000|Overall Study|Increase of RLS Symptoms|0|||
163869268|NCT00357097|591888682|FG001|Overall Study|Increase of RLS Symptoms|1|||
163869269|NCT00658996|591888683|FG000|First Intervention|Positive slit lamp finding|1|||
163869270|NCT00658996|591888684|FG001|First Intervention|Positive slit lamp finding|0|||
163869271|NCT00658996|591888683|FG000|First Intervention|Lack of lenses|0|||
163869272|NCT00658996|591888684|FG001|First Intervention|Lack of lenses|1|||
163973067|NCT03596866|592272644|FG000|Overall Study|Lost to Follow-up|2|||
163973068|NCT03596866|592272645|FG001|Overall Study|Lost to Follow-up|3|||
163973069|NCT03596866|592272644|FG000|Overall Study|Protocol Violation|1|||
164203958|NCT00471497|593117889|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
164203959|NCT00471497|593117887|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
164203960|NCT00471497|593117888|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
164203961|NCT00471497|593117889|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
164203962|NCT00471497|593117887|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
164203963|NCT00471497|593117888|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
164203964|NCT00471497|593117889|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
164203965|NCT00471497|593117887|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
164203966|NCT00471497|593117888|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
164203967|NCT00471497|593117889|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
164314814|NCT01818752|593529774|FG001|Overall Study|Physician Decision|8|||
163869273|NCT00658996|591888683|FG000|Crossover Period|Physician Decision|1|||
163869274|NCT00658996|591888684|FG001|Crossover Period|Physician Decision|0|||
163869275|NCT00658996|591888683|FG000|Crossover Period|Ineligible|1|||
163973070|NCT03596866|592272645|FG001|Overall Study|Protocol Violation|0|||
163973071|NCT03596866|592272644|FG000|Overall Study|Reason Not Specified|14|||
163973072|NCT03596866|592272645|FG001|Overall Study|Reason Not Specified|13|||
163973073|NCT04770532|592272646|FG000|Overall Study|Withdrawal by Subject|0|||
163973074|NCT04770532|592272647|FG001|Overall Study|Withdrawal by Subject|3|||
163973075|NCT04770532|592272646|FG000|Overall Study|Physician Decision|1|||
163973076|NCT04770532|592272647|FG001|Overall Study|Physician Decision|0|||
163973077|NCT04770532|592272646|FG000|Overall Study|Death|2|||
163973078|NCT04770532|592272647|FG001|Overall Study|Death|2|||
163973079|NCT01431274|592272652|FG000|Overall Study|Adverse Event|51|||
163973080|NCT01431274|592272653|FG001|Overall Study|Adverse Event|37|||
163973081|NCT01431274|592272654|FG002|Overall Study|Adverse Event|43|||
163973082|NCT01431274|592272655|FG003|Overall Study|Adverse Event|30|||
163973083|NCT01431274|592272656|FG004|Overall Study|Adverse Event|37|||
163973084|NCT01431274|592272652|FG000|Overall Study|Consent withdrawn not due to AE|29|||
163973085|NCT01431274|592272653|FG001|Overall Study|Consent withdrawn not due to AE|20|||
164203968|NCT00471497|593117887|FG000|Core Treatment Phase|Lost to Follow-up|6|||
164203969|NCT00471497|593117888|FG001|Core Treatment Phase|Lost to Follow-up|6|||
164203970|NCT00471497|593117889|FG002|Core Treatment Phase|Lost to Follow-up|3|||
164203971|NCT00471497|593117887|FG000|Core Treatment Phase|Death|3|||
164203972|NCT00471497|593117888|FG001|Core Treatment Phase|Death|9|||
164203973|NCT00471497|593117889|FG002|Core Treatment Phase|Death|3|||
164203974|NCT00471497|593117887|FG000|Core Treatment Phase|Disease Progression|10|||
164203975|NCT00471497|593117888|FG001|Core Treatment Phase|Disease Progression|2|||
164203976|NCT00471497|593117889|FG002|Core Treatment Phase|Disease Progression|4|||
164203977|NCT00471497|593117887|FG000|Core Treatment Phase|Protocol Violation|6|||
164203978|NCT00471497|593117888|FG001|Core Treatment Phase|Protocol Violation|15|||
164203979|NCT00471497|593117889|FG002|Core Treatment Phase|Protocol Violation|11|||
164203980|NCT00471497|593117887|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
164203981|NCT00471497|593117888|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
164203982|NCT00471497|593117889|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
164203983|NCT00471497|593117887|FG000|Core Treatment Phase|Administrative problems|14|||
164203984|NCT00471497|593117888|FG001|Core Treatment Phase|Administrative problems|14|||
164203985|NCT00471497|593117889|FG002|Core Treatment Phase|Administrative problems|12|||
164203986|NCT00471497|593117887|FG000|Core Treatment Phase|Adverse Event|43|||
164203987|NCT00471497|593117888|FG001|Core Treatment Phase|Adverse Event|53|||
164203988|NCT00471497|593117889|FG002|Core Treatment Phase|Adverse Event|89|||
164203989|NCT00471497|593117887|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
164203990|NCT00471497|593117888|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
164203991|NCT00471497|593117889|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
164203992|NCT00471497|593117887|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
164203993|NCT00471497|593117888|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
164203994|NCT00471497|593117889|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
164203995|NCT00471497|593117887|FG000|Extension Phase|Adverse Event|9|||
164203996|NCT00471497|593117888|FG001|Extension Phase|Adverse Event|5|||
164203997|NCT00471497|593117889|FG002|Extension Phase|Adverse Event|1|||
164203998|NCT00471497|593117887|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
164203999|NCT00471497|593117888|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
164204000|NCT00471497|593117889|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
164204001|NCT00471497|593117887|FG000|Extension Phase|Withdrawal by Subject|3|||
164204002|NCT00471497|593117888|FG001|Extension Phase|Withdrawal by Subject|1|||
164204003|NCT00471497|593117889|FG002|Extension Phase|Withdrawal by Subject|0|||
164204004|NCT00471497|593117887|FG000|Extension Phase|Lost to Follow-up|2|||
164204005|NCT00471497|593117888|FG001|Extension Phase|Lost to Follow-up|0|||
164204006|NCT00471497|593117889|FG002|Extension Phase|Lost to Follow-up|0|||
164204007|NCT00471497|593117887|FG000|Extension Phase|Death|1|||
164204008|NCT00471497|593117888|FG001|Extension Phase|Death|0|||
164204009|NCT00471497|593117889|FG002|Extension Phase|Death|0|||
164204010|NCT00471497|593117887|FG000|Extension Phase|Disease progression|2|||
164204011|NCT00471497|593117888|FG001|Extension Phase|Disease progression|0|||
164314815|NCT01818752|593529773|FG000|Overall Study|Disease Progression|54|||
164314816|NCT01818752|593529774|FG001|Overall Study|Disease Progression|48|||
163973086|NCT01431274|592272654|FG002|Overall Study|Consent withdrawn not due to AE|17|||
163973087|NCT01431274|592272655|FG003|Overall Study|Consent withdrawn not due to AE|20|||
163973088|NCT01431274|592272656|FG004|Overall Study|Consent withdrawn not due to AE|11|||
163973089|NCT01431274|592272652|FG000|Overall Study|Non compliant with protocol|5|||
163973090|NCT01431274|592272653|FG001|Overall Study|Non compliant with protocol|8|||
163973091|NCT01431274|592272654|FG002|Overall Study|Non compliant with protocol|4|||
164204012|NCT00471497|593117889|FG002|Extension Phase|Disease progression|0|||
164204013|NCT00471497|593117887|FG000|Extension Phase|Protocol Violation|2|||
164204014|NCT00471497|593117888|FG001|Extension Phase|Protocol Violation|2|||
163973092|NCT01431274|592272655|FG003|Overall Study|Non compliant with protocol|4|||
163973093|NCT01431274|592272656|FG004|Overall Study|Non compliant with protocol|4|||
164204015|NCT00471497|593117889|FG002|Extension Phase|Protocol Violation|0|||
164204016|NCT01991795|593117891|FG000|Overall Study|Lost to Follow-up|6|||
163869276|NCT00658996|591888684|FG001|Crossover Period|Ineligible|1|||
163869277|NCT00658996|591888683|FG000|Second Intervention|Developed a stye on upper lid|1|||
163869278|NCT00658996|591888684|FG001|Second Intervention|Developed a stye on upper lid|0|||
163869279|NCT00658996|591888683|FG000|Second Intervention|Positive slit lamp finding|0|||
163869280|NCT00658996|591888684|FG001|Second Intervention|Positive slit lamp finding|1|||
163869281|NCT03603717|591888689|FG000|Overall Study|Lost to Follow-up|20|||
163869282|NCT03603717|591888690|FG001|Overall Study|Lost to Follow-up|20|||
163869283|NCT03603717|591888689|FG000|Overall Study|Withdrawal by Subject|16|||
163869284|NCT03603717|591888690|FG001|Overall Study|Withdrawal by Subject|10|||
163869285|NCT01810263|591888693|FG000|Overall Study|Lost to Follow-up|8|||
163869286|NCT01810263|591888694|FG001|Overall Study|Lost to Follow-up|7|||
163869287|NCT00457691|591888695|FG000|Overall Study|Adverse Event|4|||
163869288|NCT00457691|591888696|FG001|Overall Study|Adverse Event|1|||
163869289|NCT00457691|591888695|FG000|Overall Study|Death|163|||
163869290|NCT00457691|591888696|FG001|Overall Study|Death|148|||
163869291|NCT00457691|591888695|FG000|Overall Study|Protocol Violation|1|||
163869292|NCT00457691|591888696|FG001|Overall Study|Protocol Violation|3|||
163869293|NCT00457691|591888695|FG000|Overall Study|Lost to Follow-up|23|||
163869294|NCT00457691|591888696|FG001|Overall Study|Lost to Follow-up|14|||
163869295|NCT00457691|591888695|FG000|Overall Study|Study terminated by Sponsor|1|||
163869296|NCT00457691|591888696|FG001|Overall Study|Study terminated by Sponsor|1|||
163869297|NCT00457691|591888695|FG000|Overall Study|Subject refused (reason other than AE)|14|||
163869298|NCT00457691|591888696|FG001|Overall Study|Subject refused (reason other than AE)|19|||
163869299|NCT00457691|591888695|FG000|Overall Study|Disease progression, study terminated|180|||
163869300|NCT00457691|591888696|FG001|Overall Study|Disease progression, study terminated|196|||
163869301|NCT00840177|591889847|FG000|Overall Study|Adverse Event|5|||
163869302|NCT00840177|591889848|FG001|Overall Study|Adverse Event|1|||
163869303|NCT00840177|591889849|FG002|Overall Study|Adverse Event|1|||
163869304|NCT00840177|591889847|FG000|Overall Study|Refusal unrelated to adverse events|1|||
163869305|NCT00840177|591889848|FG001|Overall Study|Refusal unrelated to adverse events|0|||
163869306|NCT00840177|591889849|FG002|Overall Study|Refusal unrelated to adverse events|1|||
163869307|NCT00840177|591889847|FG000|Overall Study|Progression/relapse|2|||
163869308|NCT00840177|591889848|FG001|Overall Study|Progression/relapse|0|||
163869309|NCT00840177|591889849|FG002|Overall Study|Progression/relapse|0|||
163869310|NCT00840177|591889847|FG000|Overall Study|Death|4|||
163869311|NCT00840177|591889848|FG001|Overall Study|Death|5|||
163869312|NCT00840177|591889849|FG002|Overall Study|Death|5|||
163869313|NCT00840177|591889847|FG000|Overall Study|not protocol specified|6|||
163869314|NCT00840177|591889848|FG001|Overall Study|not protocol specified|3|||
163869315|NCT00840177|591889849|FG002|Overall Study|not protocol specified|0|||
163869316|NCT00840177|591889847|FG000|Overall Study|Ineligible|0|||
163869317|NCT00840177|591889848|FG001|Overall Study|Ineligible|0|||
163869318|NCT00840177|591889849|FG002|Overall Study|Ineligible|3|||
163869319|NCT00840177|591889847|FG000|Overall Study|Did not start treatment|0|||
163869320|NCT00840177|591889848|FG001|Overall Study|Did not start treatment|0|||
163869321|NCT00840177|591889849|FG002|Overall Study|Did not start treatment|1|||
163869322|NCT00722046|591889850|FG000|Overall Study|Adverse Event|0|||
163869323|NCT00722046|591889851|FG001|Overall Study|Adverse Event|1|||
163869324|NCT00722046|591889852|FG002|Overall Study|Adverse Event|2|||
163869325|NCT00722046|591889853|FG003|Overall Study|Adverse Event|1|||
163869326|NCT00722046|591889854|FG004|Overall Study|Adverse Event|2|||
163869327|NCT00722046|591889855|FG005|Overall Study|Adverse Event|1|||
163869328|NCT00722046|591889856|FG006|Overall Study|Adverse Event|0|||
163869329|NCT00722046|591889850|FG000|Overall Study|Death|0|||
163869330|NCT00722046|591889851|FG001|Overall Study|Death|1|||
163869331|NCT00722046|591889852|FG002|Overall Study|Death|0|||
163869332|NCT00722046|591889853|FG003|Overall Study|Death|0|||
163869333|NCT00722046|591889854|FG004|Overall Study|Death|0|||
163869334|NCT00722046|591889855|FG005|Overall Study|Death|0|||
163869335|NCT00722046|591889856|FG006|Overall Study|Death|2|||
163869336|NCT00722046|591889850|FG000|Overall Study|Protocol Violation|1|||
163869337|NCT00722046|591889851|FG001|Overall Study|Protocol Violation|0|||
163869338|NCT00722046|591889852|FG002|Overall Study|Protocol Violation|0|||
163869339|NCT00722046|591889853|FG003|Overall Study|Protocol Violation|0|||
163869340|NCT00722046|591889854|FG004|Overall Study|Protocol Violation|0|||
163869341|NCT00722046|591889855|FG005|Overall Study|Protocol Violation|1|||
163869342|NCT00722046|591889856|FG006|Overall Study|Protocol Violation|0|||
163869343|NCT00722046|591889850|FG000|Overall Study|Withdrawal by Subject|3|||
163869344|NCT00722046|591889851|FG001|Overall Study|Withdrawal by Subject|3|||
163869345|NCT00722046|591889852|FG002|Overall Study|Withdrawal by Subject|4|||
163869346|NCT00722046|591889853|FG003|Overall Study|Withdrawal by Subject|4|||
163869347|NCT00722046|591889854|FG004|Overall Study|Withdrawal by Subject|4|||
163869348|NCT00722046|591889855|FG005|Overall Study|Withdrawal by Subject|7|||
163869349|NCT00722046|591889856|FG006|Overall Study|Withdrawal by Subject|3|||
163869350|NCT00722046|591889850|FG000|Overall Study|Randomized, but not treated|1|||
163869351|NCT00722046|591889851|FG001|Overall Study|Randomized, but not treated|1|||
163869352|NCT00722046|591889852|FG002|Overall Study|Randomized, but not treated|0|||
163869353|NCT00722046|591889853|FG003|Overall Study|Randomized, but not treated|2|||
163869354|NCT00722046|591889854|FG004|Overall Study|Randomized, but not treated|0|||
163869355|NCT00722046|591889855|FG005|Overall Study|Randomized, but not treated|0|||
163869356|NCT00722046|591889856|FG006|Overall Study|Randomized, but not treated|0|||
163869357|NCT00722046|591889850|FG000|Overall Study|Other|0|||
163869358|NCT00722046|591889851|FG001|Overall Study|Other|0|||
163869359|NCT00722046|591889852|FG002|Overall Study|Other|1|||
163869360|NCT00722046|591889853|FG003|Overall Study|Other|1|||
163869361|NCT00722046|591889854|FG004|Overall Study|Other|3|||
163869362|NCT00722046|591889855|FG005|Overall Study|Other|2|||
163869363|NCT00722046|591889856|FG006|Overall Study|Other|1|||
163869364|NCT01318382|591889857|FG000|Overall Study|Physician Decision|2|||
163869365|NCT01318382|591889857|FG000|Overall Study|Device Malfunction|10|||
163869366|NCT01318382|591889857|FG000|Overall Study|Protocol Violation|1|||
163869367|NCT01582100|591889860|FG000|Overall Study|Adverse Event|1|||
163869368|NCT01582100|591889860|FG000|Overall Study|Withdrawal by Subject|1|||
163869369|NCT01078116|591889867|FG000|Overall Study|Lost to Follow-up|17|||
163869370|NCT01078116|591889867|FG000|Overall Study|Adverse Event|5|||
163869371|NCT01078116|591889867|FG000|Overall Study|Withdrawal by Subject|8|||
163869372|NCT01078116|591889867|FG000|Overall Study|Lack of effectiveness|15|||
163869373|NCT01078116|591889867|FG000|Overall Study|Case report form not completed|3|||
163869374|NCT02242487|591889868|FG000|Overall Study|Adverse Event|13|||
163869375|NCT02242487|591889869|FG001|Overall Study|Adverse Event|15|||
163869376|NCT02242487|591889868|FG000|Overall Study|Lack of Efficacy|4|||
163869377|NCT02242487|591889869|FG001|Overall Study|Lack of Efficacy|6|||
163869378|NCT02242487|591889868|FG000|Overall Study|Protocol Violation|2|||
163869379|NCT02242487|591889869|FG001|Overall Study|Protocol Violation|0|||
163869380|NCT02242487|591889868|FG000|Overall Study|Lost to Follow-up|2|||
163869381|NCT02242487|591889869|FG001|Overall Study|Lost to Follow-up|1|||
163869382|NCT02242487|591889868|FG000|Overall Study|Other - Miscellaneous|4|||
163869383|NCT02242487|591889869|FG001|Overall Study|Other - Miscellaneous|6|||
163869384|NCT02242487|591889868|FG000|Overall Study|Withdrawal by Subject|37|||
163869385|NCT02242487|591889869|FG001|Overall Study|Withdrawal by Subject|19|||
163869386|NCT03644849|591889870|FG000|Overall Study|Lost to Follow-up|1|||
163869387|NCT03644849|591889871|FG001|Overall Study|Lost to Follow-up|3|||
163869388|NCT03737240|591889880|FG000|Overall Study|Lost to Follow-up|16|||
163869389|NCT03737240|591889881|FG001|Overall Study|Lost to Follow-up|15|||
163869390|NCT02512965|591889884|FG000|Overall Study|Withdrawal by Subject|0|||
163869391|NCT02512965|591889885|FG001|Overall Study|Withdrawal by Subject|4|||
163869392|NCT02570711|591889889|FG000|Overall Study|Death|1|||
163869393|NCT02570711|591889890|FG001|Overall Study|Death|0|||
163869394|NCT02570711|591889889|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
163869395|NCT02570711|591889890|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
163869396|NCT05001945|591889891|FG000|Overall Study|Adverse Event|0|||
163869397|NCT05001945|591889892|FG001|Overall Study|Adverse Event|0|||
163869398|NCT05001945|591889893|FG002|Overall Study|Adverse Event|0|||
163869399|NCT05001945|591889894|FG003|Overall Study|Adverse Event|1|||
163869400|NCT05001945|591889895|FG004|Overall Study|Adverse Event|0|||
163869401|NCT05001945|591889896|FG005|Overall Study|Adverse Event|0|||
163869402|NCT05001945|591889897|FG006|Overall Study|Adverse Event|0|||
163869403|NCT05001945|591889898|FG007|Overall Study|Adverse Event|0|||
163869404|NCT05001945|591889891|FG000|Overall Study|Lost to Follow-up|0|||
163869405|NCT05001945|591889892|FG001|Overall Study|Lost to Follow-up|1|||
163869406|NCT05001945|591889893|FG002|Overall Study|Lost to Follow-up|1|||
163869407|NCT05001945|591889894|FG003|Overall Study|Lost to Follow-up|2|||
163869408|NCT05001945|591889895|FG004|Overall Study|Lost to Follow-up|0|||
163869409|NCT05001945|591889896|FG005|Overall Study|Lost to Follow-up|1|||
163869410|NCT05001945|591889897|FG006|Overall Study|Lost to Follow-up|0|||
163869411|NCT05001945|591889898|FG007|Overall Study|Lost to Follow-up|0|||
163869412|NCT05001945|591889891|FG000|Overall Study|Protocol Violation|1|||
163869413|NCT05001945|591889892|FG001|Overall Study|Protocol Violation|0|||
163869414|NCT05001945|591889893|FG002|Overall Study|Protocol Violation|1|||
163869415|NCT05001945|591889894|FG003|Overall Study|Protocol Violation|1|||
163869416|NCT05001945|591889895|FG004|Overall Study|Protocol Violation|0|||
163869417|NCT05001945|591889896|FG005|Overall Study|Protocol Violation|1|||
163869418|NCT05001945|591889897|FG006|Overall Study|Protocol Violation|0|||
163869419|NCT05001945|591889898|FG007|Overall Study|Protocol Violation|0|||
163869420|NCT05001945|591889891|FG000|Overall Study|Withdrawal by Subject|0|||
163869421|NCT05001945|591889892|FG001|Overall Study|Withdrawal by Subject|0|||
163869422|NCT05001945|591889893|FG002|Overall Study|Withdrawal by Subject|0|||
163869423|NCT05001945|591889894|FG003|Overall Study|Withdrawal by Subject|1|||
163869424|NCT05001945|591889895|FG004|Overall Study|Withdrawal by Subject|1|||
163869425|NCT05001945|591889896|FG005|Overall Study|Withdrawal by Subject|1|||
163869426|NCT05001945|591889897|FG006|Overall Study|Withdrawal by Subject|0|||
163869427|NCT05001945|591889898|FG007|Overall Study|Withdrawal by Subject|1|||
163869428|NCT05001945|591889891|FG000|Overall Study|Not specified by Investigator|0|||
163869429|NCT05001945|591889892|FG001|Overall Study|Not specified by Investigator|3|||
163869430|NCT05001945|591889893|FG002|Overall Study|Not specified by Investigator|0|||
163869431|NCT05001945|591889894|FG003|Overall Study|Not specified by Investigator|0|||
163869432|NCT05001945|591889895|FG004|Overall Study|Not specified by Investigator|1|||
163869433|NCT05001945|591889896|FG005|Overall Study|Not specified by Investigator|0|||
163973094|NCT01431274|592272652|FG000|Overall Study|Lost to Follow-up|6|||
163973095|NCT01431274|592272653|FG001|Overall Study|Lost to Follow-up|7|||
163973096|NCT01431274|592272654|FG002|Overall Study|Lost to Follow-up|1|||
163973097|NCT01431274|592272655|FG003|Overall Study|Lost to Follow-up|4|||
163973098|NCT01431274|592272656|FG004|Overall Study|Lost to Follow-up|0|||
163973099|NCT01431274|592272652|FG000|Overall Study|Other reason not stated above|6|||
163973100|NCT01431274|592272653|FG001|Overall Study|Other reason not stated above|5|||
163973101|NCT01431274|592272654|FG002|Overall Study|Other reason not stated above|7|||
163973102|NCT01431274|592272655|FG003|Overall Study|Other reason not stated above|2|||
163973103|NCT01431274|592272656|FG004|Overall Study|Other reason not stated above|4|||
163973104|NCT01069172|592272657|FG000|Overall Study|Withdrawal by Subject|1|||
163973105|NCT01069172|592272658|FG001|Overall Study|Withdrawal by Subject|0|||
163973106|NCT04206605|592272661|FG000|Overall Study|Adverse Event|0|||
163973107|NCT04206605|592272662|FG001|Overall Study|Adverse Event|1|||
163973108|NCT04206605|592272661|FG000|Overall Study|Withdrawal by Subject|1|||
163973109|NCT04206605|592272662|FG001|Overall Study|Withdrawal by Subject|0|||
163973110|NCT00003702|592272668|FG000|Overall Study|Ineligible cell types|2|||
163973111|NCT00003702|592272669|FG001|Overall Study|Ineligible cell types|2|||
163973112|NCT00003702|592272668|FG000|Overall Study|Did not meet criteria for persistence|8|||
163973113|NCT00003702|592272669|FG001|Overall Study|Did not meet criteria for persistence|5|||
163973114|NCT00003702|592272668|FG000|Overall Study|WHO score > 6|2|||
163973115|NCT00003702|592272669|FG001|Overall Study|WHO score > 6|1|||
163973116|NCT00003702|592272668|FG000|Overall Study|Inadequate documentation of disease|1|||
163973117|NCT00003702|592272669|FG001|Overall Study|Inadequate documentation of disease|3|||
163973118|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
163973119|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
163973120|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Death|0|||
163973121|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Death|1|||
163973122|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
163973123|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
163973124|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
163973125|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
163973126|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
163973127|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
163973128|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
163973129|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
163973130|NCT00843518|592272670|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
163973131|NCT00843518|592272671|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
163973132|NCT00827606|592272672|FG000|Overall Study|Protocol Violation|4|||
163973133|NCT00827606|592272673|FG001|Overall Study|Protocol Violation|3|||
163973134|NCT00827606|592272672|FG000|Overall Study|Lost to Follow-up|3|||
163973135|NCT00827606|592272673|FG001|Overall Study|Lost to Follow-up|1|||
163973136|NCT00827606|592272672|FG000|Overall Study|Withdrawal by Subject|7|||
163973137|NCT00827606|592272673|FG001|Overall Study|Withdrawal by Subject|6|||
163973138|NCT00827606|592272672|FG000|Overall Study|Pregnancy|0|||
163973139|NCT00827606|592272673|FG001|Overall Study|Pregnancy|1|||
163973140|NCT00827606|592272672|FG000|Overall Study|Other|5|||
163973141|NCT00827606|592272673|FG001|Overall Study|Other|13|||
163973142|NCT00827606|592272672|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
163973143|NCT00827606|592272673|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
163973144|NCT00827606|592272672|FG000|Overall Study|Adverse Event|4|||
163973145|NCT00827606|592272673|FG001|Overall Study|Adverse Event|2|||
163973146|NCT00243386|592272676|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
163973147|NCT00243386|592272677|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
163869434|NCT05001945|591889897|FG006|Overall Study|Not specified by Investigator|0|||
163869435|NCT05001945|591889898|FG007|Overall Study|Not specified by Investigator|0|||
163869436|NCT01369498|591889899|FG000|Overall Study|Lack of Efficacy|9|||
163869437|NCT01369498|591889900|FG001|Overall Study|Lack of Efficacy|9|||
163869438|NCT01369498|591889901|FG002|Overall Study|Lack of Efficacy|1|||
163869439|NCT01369498|591889902|FG003|Overall Study|Lack of Efficacy|3|||
163869440|NCT01369498|591889899|FG000|Overall Study|Adverse Event|1|||
163869441|NCT01369498|591889900|FG001|Overall Study|Adverse Event|2|||
163973148|NCT00243386|592272678|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
163973149|NCT00243386|592272676|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
163973150|NCT00243386|592272677|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
163973151|NCT00243386|592272678|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
163973152|NCT00243386|592272676|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
163973153|NCT00243386|592272677|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
164204017|NCT01991795|593117892|FG001|Overall Study|Lost to Follow-up|4|||
163869442|NCT01369498|591889901|FG002|Overall Study|Adverse Event|0|||
163869443|NCT01369498|591889902|FG003|Overall Study|Adverse Event|1|||
163869444|NCT01369498|591889899|FG000|Overall Study|Withdrawal of Consent|0|||
163869445|NCT01369498|591889900|FG001|Overall Study|Withdrawal of Consent|1|||
163869446|NCT01369498|591889901|FG002|Overall Study|Withdrawal of Consent|1|||
163973154|NCT00243386|592272678|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
163973155|NCT00243386|592272676|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
163973156|NCT00243386|592272677|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
163973157|NCT00243386|592272678|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
163973158|NCT00243386|592272676|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
163973159|NCT00243386|592272677|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
163973160|NCT00243386|592272678|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
163973161|NCT00243386|592272676|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
163973162|NCT00243386|592272677|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
163973163|NCT00243386|592272678|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
163973164|NCT00243386|592272676|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
163973165|NCT00243386|592272677|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
163973166|NCT00243386|592272678|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
163973167|NCT00243386|592272676|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
163973168|NCT00243386|592272677|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
163973169|NCT00243386|592272678|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
163973170|NCT00133991|592272679|FG000|Overall Study|Death|4|||
163973171|NCT04995055|592272683|FG000|Period 1|COVID-19 Related|1|||
163973172|NCT04995055|592272684|FG001|Period 1|COVID-19 Related|0|||
163973173|NCT04995055|592272683|FG000|Period 1|Withdrawal by Subject|0|||
163973174|NCT04995055|592272684|FG001|Period 1|Withdrawal by Subject|1|||
163973175|NCT04995055|592272683|FG000|Period 1|Subject discontinued due to timing|4|||
163973176|NCT04995055|592272684|FG001|Period 1|Subject discontinued due to timing|4|||
163973177|NCT03418129|592272685|FG000|Overall Study|Lost to Follow-up|11|||
163973178|NCT03418129|592272686|FG001|Overall Study|Lost to Follow-up|20|||
163973179|NCT03418129|592272687|FG002|Overall Study|Lost to Follow-up|15|||
163973180|NCT03418129|592272685|FG000|Overall Study|Withdrawal by Subject|3|||
163973181|NCT03418129|592272686|FG001|Overall Study|Withdrawal by Subject|6|||
163973182|NCT03418129|592272687|FG002|Overall Study|Withdrawal by Subject|4|||
163973183|NCT01378858|592272690|FG000|Overall Study|Withdrawal by Subject|4|||
163973184|NCT01378858|592272691|FG001|Overall Study|Withdrawal by Subject|4|||
163973185|NCT02664272|592272692|FG000|Overall Study|Fluoroscopic images not made available|2|||
163973186|NCT04695392|592272693|FG000|Overall Study|Withdrawn by parent/guardian|0|||
163973187|NCT04695392|592272694|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163973188|NCT04695392|592272693|FG000|Overall Study|Withdrawn by physician|0|||
163973189|NCT04695392|592272694|FG001|Overall Study|Withdrawn by physician|1|||
163973190|NCT01202279|592272697|FG000|Overall Study|Adverse Event|8|||
163973191|NCT01202279|592272698|FG001|Overall Study|Adverse Event|6|||
163973192|NCT01202279|592272697|FG000|Overall Study|Withdrawal by Subject|13|||
163973193|NCT01202279|592272698|FG001|Overall Study|Withdrawal by Subject|10|||
163973194|NCT01202279|592272697|FG000|Overall Study|Physician Decision|0|||
163973195|NCT01202279|592272698|FG001|Overall Study|Physician Decision|1|||
163973196|NCT01202279|592272697|FG000|Overall Study|Lost to Follow-up|10|||
163973197|NCT01202279|592272698|FG001|Overall Study|Lost to Follow-up|7|||
163973198|NCT01202279|592272697|FG000|Overall Study|Protocol Violation|1|||
163973199|NCT01202279|592272698|FG001|Overall Study|Protocol Violation|1|||
163973200|NCT01202279|592272697|FG000|Overall Study|study compliance|5|||
163869447|NCT01369498|591889902|FG003|Overall Study|Withdrawal of Consent|1|||
163869448|NCT01369498|591889899|FG000|Overall Study|Death|0|||
163869449|NCT01369498|591889900|FG001|Overall Study|Death|0|||
163869450|NCT01369498|591889901|FG002|Overall Study|Death|1|||
163869451|NCT01369498|591889902|FG003|Overall Study|Death|0|||
163869452|NCT01369498|591889899|FG000|Overall Study|Investigator's Discretion|1|||
163869453|NCT01369498|591889900|FG001|Overall Study|Investigator's Discretion|0|||
163869454|NCT01369498|591889901|FG002|Overall Study|Investigator's Discretion|1|||
163869455|NCT01369498|591889902|FG003|Overall Study|Investigator's Discretion|3|||
163869456|NCT01369498|591889899|FG000|Overall Study|Unknown Reason|1|||
163869457|NCT01369498|591889900|FG001|Overall Study|Unknown Reason|0|||
163869458|NCT01369498|591889901|FG002|Overall Study|Unknown Reason|11|||
163869459|NCT01369498|591889902|FG003|Overall Study|Unknown Reason|6|||
163869460|NCT01369498|591889899|FG000|Overall Study|Disease Progression|0|||
163869461|NCT01369498|591889900|FG001|Overall Study|Disease Progression|0|||
163869462|NCT01369498|591889901|FG002|Overall Study|Disease Progression|0|||
163869463|NCT01369498|591889902|FG003|Overall Study|Disease Progression|1|||
163869464|NCT00545077|591889903|FG000|Overall Study|Treatment not received|5|||
163869465|NCT00545077|591889904|FG001|Overall Study|Treatment not received|1|||
163869466|NCT00545077|591889903|FG000|Overall Study|Disease Progression|131|||
163869467|NCT00545077|591889904|FG001|Overall Study|Disease Progression|98|||
163973201|NCT01202279|592272698|FG001|Overall Study|study compliance|2|||
163973202|NCT02047253|592272699|FG000|Overall Study|Lost to Follow-up|8|||
163973203|NCT03574753|592272700|FG000|Overall Study|Adverse Event|3|||
163869468|NCT00545077|591889903|FG000|Overall Study|Withdrawal by Subject|3|||
163869469|NCT00545077|591889904|FG001|Overall Study|Withdrawal by Subject|14|||
163869470|NCT00545077|591889903|FG000|Overall Study|Physician Decision|6|||
163869471|NCT00545077|591889904|FG001|Overall Study|Physician Decision|3|||
163973204|NCT03574753|592272700|FG000|Overall Study|Progression/relapse|19|||
163973205|NCT03574753|592272700|FG000|Overall Study|Death|1|||
163973206|NCT00609986|592272705|FG000|Overall Study|Did not receive transplant or treatment|8|||
163973207|NCT00609986|592272706|FG001|Overall Study|Did not receive transplant or treatment|3|||
163973208|NCT03159091|592272707|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
163973209|NCT03159091|592272708|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
163973210|NCT03159091|592272707|FG000|Overall Study|Patient has taken no dose of study drug|0|||
163973211|NCT03159091|592272708|FG001|Overall Study|Patient has taken no dose of study drug|1|||
163973212|NCT03520959|592272712|FG000|Overall Study|Study terminated by Sponsor|0|||
163973213|NCT03520959|592272713|FG001|Overall Study|Study terminated by Sponsor|1|||
163973214|NCT00943579|592272720|FG000|Overall Study|Adverse Event|4|||
163973215|NCT00943579|592272721|FG001|Overall Study|Adverse Event|3|||
163973216|NCT00943579|592272720|FG000|Overall Study|Lack of Efficacy|2|||
163973217|NCT00943579|592272721|FG001|Overall Study|Lack of Efficacy|2|||
163973218|NCT00418665|592272722|FG000|Treatment Period|Ineligibility determined|1|||
163973219|NCT00418665|592272723|FG001|Treatment Period|Ineligibility determined|1|||
163973220|NCT00418665|592272724|FG002|Treatment Period|Ineligibility determined|0|||
163973221|NCT00418665|592272722|FG000|Treatment Period|Adverse Event|2|||
163973222|NCT00418665|592272723|FG001|Treatment Period|Adverse Event|2|||
163973223|NCT00418665|592272724|FG002|Treatment Period|Adverse Event|0|||
163973224|NCT00418665|592272722|FG000|Treatment Period|Withdrawal by Subject|0|||
163973225|NCT00418665|592272723|FG001|Treatment Period|Withdrawal by Subject|3|||
163973226|NCT00418665|592272724|FG002|Treatment Period|Withdrawal by Subject|1|||
163973227|NCT00418665|592272722|FG000|Treatment Period|Requirement for alternative therapy|1|||
163973228|NCT00418665|592272723|FG001|Treatment Period|Requirement for alternative therapy|0|||
163973229|NCT00418665|592272724|FG002|Treatment Period|Requirement for alternative therapy|0|||
163973230|NCT00418665|592272722|FG000|Treatment Period|Physician Decision|1|||
163973231|NCT00418665|592272723|FG001|Treatment Period|Physician Decision|0|||
163973232|NCT00418665|592272724|FG002|Treatment Period|Physician Decision|3|||
163973233|NCT00418665|592272722|FG000|Treatment Extension|Adverse Event|1|||
163973234|NCT00418665|592272723|FG001|Treatment Extension|Adverse Event|0|||
163973235|NCT00418665|592272724|FG002|Treatment Extension|Adverse Event|0|||
163973236|NCT00418665|592272722|FG000|Treatment Extension|Withdrawal by Subject|1|||
163973237|NCT00418665|592272723|FG001|Treatment Extension|Withdrawal by Subject|0|||
163973238|NCT00418665|592272724|FG002|Treatment Extension|Withdrawal by Subject|0|||
163869472|NCT00545077|591889903|FG000|Overall Study|Lost to Follow-up|2|||
163869473|NCT00545077|591889904|FG001|Overall Study|Lost to Follow-up|0|||
163869474|NCT00545077|591889903|FG000|Overall Study|Protocol Violation|1|||
163869475|NCT00545077|591889904|FG001|Overall Study|Protocol Violation|0|||
163869476|NCT00545077|591889903|FG000|Overall Study|Adverse Event|0|||
163869477|NCT00545077|591889904|FG001|Overall Study|Adverse Event|31|||
163869478|NCT00545077|591889903|FG000|Overall Study|Death|0|||
163869479|NCT00545077|591889904|FG001|Overall Study|Death|8|||
163869480|NCT00439569|591889909|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
163869481|NCT00439569|591889909|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
163869482|NCT00439569|591889909|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
163869483|NCT01444417|591889910|FG000|Overall Study|Ineligibility Determined|0|||
163869484|NCT01444417|591889911|FG001|Overall Study|Ineligibility Determined|1|||
163869485|NCT01444417|591889910|FG000|Overall Study|Withdrawal by Subject|2|||
163869486|NCT01444417|591889911|FG001|Overall Study|Withdrawal by Subject|0|||
163869487|NCT02755116|591889913|FG000|Overall Study|surgery converted to open, pt admitted|3|||
163869488|NCT02755116|591889914|FG001|Overall Study|surgery converted to open, pt admitted|1|||
163869489|NCT02423291|591889915|FG000|Overall Study|Lack of Efficacy|14|||
163869490|NCT02423291|591889915|FG000|Overall Study|Adverse Event|1|||
163869491|NCT01124734|591889917|FG000|Overall Study|Disease progression|13|||
163869492|NCT01124734|591889917|FG000|Overall Study|Adverse Event|1|||
163869493|NCT01124734|591889917|FG000|Overall Study|Withdrawal by Subject|1|||
163869494|NCT01124734|591889917|FG000|Overall Study|Elected for alternative treatment|2|||
163869495|NCT02214160|591889919|FG000|Overall Study|Withdrawal by Subject|1|||
163869496|NCT02214160|591889920|FG001|Overall Study|Withdrawal by Subject|0|||
163869497|NCT02214160|591889921|FG002|Overall Study|Withdrawal by Subject|6|||
163869498|NCT02214160|591889919|FG000|Overall Study|Death|2|||
163869499|NCT02214160|591889920|FG001|Overall Study|Death|2|||
163869500|NCT02214160|591889921|FG002|Overall Study|Death|1|||
163973239|NCT00418665|592272722|FG000|Treatment Extension|Requirement for alternative therapy|2|||
163973240|NCT00418665|592272723|FG001|Treatment Extension|Requirement for alternative therapy|2|||
163869501|NCT02214160|591889919|FG000|Overall Study|Subject Non-Compliance|0|||
163869502|NCT02214160|591889920|FG001|Overall Study|Subject Non-Compliance|3|||
163869503|NCT02214160|591889921|FG002|Overall Study|Subject Non-Compliance|1|||
163869504|NCT02214160|591889919|FG000|Overall Study|Adverse Event|0|||
163869505|NCT02214160|591889920|FG001|Overall Study|Adverse Event|1|||
163869506|NCT02214160|591889921|FG002|Overall Study|Adverse Event|1|||
163869507|NCT02214160|591889919|FG000|Overall Study|Sponsor Decision|0|||
163869508|NCT02214160|591889920|FG001|Overall Study|Sponsor Decision|2|||
163973241|NCT00418665|592272724|FG002|Treatment Extension|Requirement for alternative therapy|0|||
163973242|NCT00418665|592272722|FG000|Treatment Extension|Physician Decision|2|||
163973243|NCT00418665|592272723|FG001|Treatment Extension|Physician Decision|2|||
163973244|NCT00418665|592272724|FG002|Treatment Extension|Physician Decision|1|||
163973245|NCT00418665|592272722|FG000|Treatment Extension|Death|0|||
163973246|NCT00418665|592272723|FG001|Treatment Extension|Death|0|||
163973247|NCT00418665|592272724|FG002|Treatment Extension|Death|1|||
163973248|NCT01538628|592272727|FG000|Overall Study|Withdrawal by Subject|1|||
163973249|NCT01538628|592272728|FG001|Overall Study|Withdrawal by Subject|1|||
163973250|NCT01538628|592272727|FG000|Overall Study|Lost to Follow-up|0|||
163973251|NCT01538628|592272728|FG001|Overall Study|Lost to Follow-up|1|||
163973252|NCT00402649|592273842|FG000|Overall Study|Lost to Follow-up|1|||
163973253|NCT00402649|592273842|FG000|Overall Study|Withdrawal by Subject|1|||
163973254|NCT01761292|592273848|FG000|Part 1|Adverse Event|1|||
163973255|NCT01761292|592273848|FG000|Part 1|not receiving treatment in Part 1|1|||
163973256|NCT01761292|592273848|FG000|Extension 1|Withdrawal by Subject|1|||
163973257|NCT03577730|592273849|FG000|Overall Study|Physician Decision|3|||
163973258|NCT03577730|592273850|FG001|Overall Study|Physician Decision|1|||
163973259|NCT03577730|592273849|FG000|Overall Study|Did not receive allocated intervention|1|||
163973260|NCT03577730|592273850|FG001|Overall Study|Did not receive allocated intervention|0|||
163973261|NCT05611671|592273852|FG000|Overall Study|Adverse Event|1|||
163973262|NCT05611671|592273853|FG001|Overall Study|Adverse Event|1|||
163973263|NCT05611671|592273854|FG002|Overall Study|Adverse Event|0|||
163973264|NCT05611671|592273855|FG003|Overall Study|Adverse Event|1|||
163973265|NCT05611671|592273852|FG000|Overall Study|Lack of Efficacy|1|||
163973266|NCT05611671|592273853|FG001|Overall Study|Lack of Efficacy|0|||
163973267|NCT05611671|592273854|FG002|Overall Study|Lack of Efficacy|1|||
163973268|NCT05611671|592273855|FG003|Overall Study|Lack of Efficacy|2|||
163973269|NCT05611671|592273852|FG000|Overall Study|Lost to Follow-up|0|||
163973270|NCT05611671|592273853|FG001|Overall Study|Lost to Follow-up|0|||
163973271|NCT05611671|592273854|FG002|Overall Study|Lost to Follow-up|0|||
163973272|NCT05611671|592273855|FG003|Overall Study|Lost to Follow-up|1|||
163973273|NCT05611671|592273852|FG000|Overall Study|Protocol Violation|0|||
163973274|NCT05611671|592273853|FG001|Overall Study|Protocol Violation|1|||
163973275|NCT05611671|592273854|FG002|Overall Study|Protocol Violation|0|||
163973276|NCT05611671|592273855|FG003|Overall Study|Protocol Violation|0|||
163973277|NCT05611671|592273852|FG000|Overall Study|Withdrawal by Subject|2|||
163973278|NCT05611671|592273853|FG001|Overall Study|Withdrawal by Subject|1|||
163973279|NCT05611671|592273854|FG002|Overall Study|Withdrawal by Subject|2|||
163973280|NCT05611671|592273855|FG003|Overall Study|Withdrawal by Subject|1|||
163973281|NCT01368536|592273856|FG000|Overall Study|Adverse Event|5|||
163973282|NCT01368536|592273857|FG001|Overall Study|Adverse Event|6|||
163973283|NCT01368536|592273858|FG002|Overall Study|Adverse Event|8|||
163973284|NCT01368536|592273856|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163973285|NCT01368536|592273857|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163973286|NCT01368536|592273858|FG002|Overall Study|Abnormal laboratory value(s)|2|||
163973287|NCT01368536|592273856|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163973288|NCT01368536|592273857|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163973289|NCT01368536|592273858|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163973290|NCT01368536|592273856|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
163973291|NCT01368536|592273857|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163973292|NCT01368536|592273858|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163973293|NCT01368536|592273856|FG000|Overall Study|No longer required study medication|0|||
163973294|NCT01368536|592273857|FG001|Overall Study|No longer required study medication|0|||
163973295|NCT01368536|592273858|FG002|Overall Study|No longer required study medication|1|||
163973296|NCT01368536|592273856|FG000|Overall Study|Withdrawal by Subject|2|||
163973297|NCT01368536|592273857|FG001|Overall Study|Withdrawal by Subject|5|||
163973298|NCT01368536|592273858|FG002|Overall Study|Withdrawal by Subject|4|||
163973299|NCT01368536|592273856|FG000|Overall Study|Lost to Follow-up|3|||
163973300|NCT01368536|592273857|FG001|Overall Study|Lost to Follow-up|3|||
163973301|NCT01368536|592273858|FG002|Overall Study|Lost to Follow-up|5|||
163973302|NCT01368536|592273856|FG000|Overall Study|Administrative problems|34|||
163973303|NCT01368536|592273857|FG001|Overall Study|Administrative problems|39|||
163973304|NCT01368536|592273858|FG002|Overall Study|Administrative problems|35|||
163973305|NCT01368536|592273856|FG000|Overall Study|Protocol deviation|0|||
163973306|NCT01368536|592273857|FG001|Overall Study|Protocol deviation|3|||
163973307|NCT01368536|592273858|FG002|Overall Study|Protocol deviation|1|||
163973308|NCT00383084|592273865|FG000|Overall Study|Withdrawal by Subject|12|||
163973309|NCT00383084|592273866|FG001|Overall Study|Withdrawal by Subject|10|||
163973310|NCT02113436|592273867|FG000|Period 1: 8 Weeks|Adverse Event|1|||
163973311|NCT02113436|592273868|FG001|Period 1: 8 Weeks|Adverse Event|0|||
163973312|NCT02113436|592273869|FG002|Period 1: 8 Weeks|Adverse Event|0|||
163973313|NCT02113436|592273870|FG003|Period 1: 8 Weeks|Adverse Event|0|||
163973314|NCT02113436|592273867|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
163973315|NCT02113436|592273868|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
163973316|NCT02113436|592273869|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
163973317|NCT02113436|592273870|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
163973318|NCT02113436|592273867|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
164314817|NCT01818752|593529773|FG000|Overall Study|Other|7|||
163869509|NCT02214160|591889921|FG002|Overall Study|Sponsor Decision|0|||
163869510|NCT02214160|591889919|FG000|Overall Study|Protocol Violation|1|||
163869511|NCT02214160|591889920|FG001|Overall Study|Protocol Violation|0|||
163869512|NCT02214160|591889921|FG002|Overall Study|Protocol Violation|0|||
163869513|NCT02214160|591889919|FG000|Overall Study|Physician Decision|0|||
163869514|NCT02214160|591889920|FG001|Overall Study|Physician Decision|0|||
163869515|NCT02214160|591889921|FG002|Overall Study|Physician Decision|1|||
163869516|NCT02423798|591889922|FG000|Overall Study|Withdrawal by Subject|3|||
163869517|NCT01063972|591889923|FG000|Overall Study|Death|12|||
163869518|NCT01063972|591889924|FG001|Overall Study|Death|11|||
163869519|NCT01063972|591889923|FG000|Overall Study|Incarcerated|2|||
163869520|NCT01063972|591889924|FG001|Overall Study|Incarcerated|1|||
163869521|NCT01510717|591889926|FG000|Overall Study|Adverse Event|1|||
163869522|NCT01510717|591889927|FG001|Overall Study|Adverse Event|2|||
163869523|NCT01510717|591889926|FG000|Overall Study|Death|1|||
163869524|NCT01510717|591889927|FG001|Overall Study|Death|0|||
163869525|NCT01510717|591889926|FG000|Overall Study|Lost to Follow-up|0|||
163869526|NCT01510717|591889927|FG001|Overall Study|Lost to Follow-up|1|||
163869527|NCT01510717|591889926|FG000|Overall Study|Withdrawal by Subject|0|||
163869528|NCT01510717|591889927|FG001|Overall Study|Withdrawal by Subject|2|||
163869529|NCT01430611|591889929|FG000|Overall Study|Adverse Event|0|||
163869530|NCT01430611|591889930|FG001|Overall Study|Adverse Event|1|||
163869531|NCT01430611|591889929|FG000|Overall Study|Protocol Violation|1|||
163869532|NCT01430611|591889930|FG001|Overall Study|Protocol Violation|0|||
163869533|NCT01430611|591889929|FG000|Overall Study|Lost to Follow-up|1|||
163869534|NCT01430611|591889930|FG001|Overall Study|Lost to Follow-up|0|||
163869535|NCT01430611|591889929|FG000|Overall Study|Withdrawal by Subject|15|||
163869536|NCT01430611|591889930|FG001|Overall Study|Withdrawal by Subject|14|||
163869537|NCT00939510|591889931|FG000|Overall Study|Withdrawal by Subject|1|||
163869538|NCT01202955|591889932|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
163869539|NCT01202955|591889933|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
163869540|NCT00159783|591889938|FG000|Overall Study|Adverse Event|5|||
163869541|NCT00159783|591889939|FG001|Overall Study|Adverse Event|7|||
163869542|NCT00159783|591889940|FG002|Overall Study|Adverse Event|9|||
163869543|NCT00159783|591889938|FG000|Overall Study|Lack of Efficacy|1|||
163869544|NCT00159783|591889939|FG001|Overall Study|Lack of Efficacy|2|||
163869545|NCT00159783|591889940|FG002|Overall Study|Lack of Efficacy|3|||
163869546|NCT00159783|591889938|FG000|Overall Study|Withdrawal by Subject|7|||
163869547|NCT00159783|591889939|FG001|Overall Study|Withdrawal by Subject|11|||
163869548|NCT00159783|591889940|FG002|Overall Study|Withdrawal by Subject|12|||
163869549|NCT00159783|591889938|FG000|Overall Study|Lost to Follow-up|6|||
163869550|NCT00159783|591889939|FG001|Overall Study|Lost to Follow-up|5|||
163869551|NCT00159783|591889940|FG002|Overall Study|Lost to Follow-up|11|||
163869552|NCT00159783|591889938|FG000|Overall Study|Other|0|||
163869553|NCT00159783|591889939|FG001|Overall Study|Other|2|||
163869554|NCT00159783|591889940|FG002|Overall Study|Other|4|||
163869555|NCT02115139|591889941|FG000|Overall Study|Protocol Violation|1|||
163869556|NCT02115139|591889941|FG000|Overall Study|treatment discontinuation|6|||
163869557|NCT04740164|591889942|FG000|Overall Study|Lack of Efficacy|4|||
163869558|NCT04740164|591889943|FG001|Overall Study|Lack of Efficacy|0|||
163869559|NCT04740164|591889942|FG000|Overall Study|Physician Decision|3|||
163869560|NCT04740164|591889943|FG001|Overall Study|Physician Decision|3|||
163869561|NCT00258895|591889949|FG000|Overall Study|Lost to Follow-up|3|||
163869562|NCT00258895|591889950|FG001|Overall Study|Lost to Follow-up|1|||
163869563|NCT00258895|591889949|FG000|Overall Study|Protocol Violation|6|||
163869564|NCT00258895|591889950|FG001|Overall Study|Protocol Violation|2|||
163869565|NCT00258895|591889949|FG000|Overall Study|Withdrawal by Subject|1|||
163869566|NCT00258895|591889950|FG001|Overall Study|Withdrawal by Subject|0|||
163869567|NCT00442117|591889951|FG000|Overall Study|Adverse Event|3|||
163869568|NCT00442117|591889952|FG001|Overall Study|Adverse Event|2|||
163869569|NCT00442117|591889951|FG000|Overall Study|Lack of Efficacy|2|||
163869570|NCT00442117|591889952|FG001|Overall Study|Lack of Efficacy|6|||
163869571|NCT00442117|591889951|FG000|Overall Study|Lost to Follow-up|1|||
163869572|NCT00442117|591889952|FG001|Overall Study|Lost to Follow-up|2|||
163869573|NCT00442117|591889951|FG000|Overall Study|Withdrawal by Subject|2|||
163869574|NCT00442117|591889952|FG001|Overall Study|Withdrawal by Subject|2|||
163869575|NCT00442117|591889951|FG000|Overall Study|Major Deviation|25|||
163869576|NCT00442117|591889952|FG001|Overall Study|Major Deviation|20|||
163869577|NCT00442117|591889951|FG000|Overall Study|Non compliance with protocol|3|||
163869578|NCT00442117|591889952|FG001|Overall Study|Non compliance with protocol|5|||
163869579|NCT00442117|591889951|FG000|Overall Study|Met Withdrawal Criteria|2|||
163869580|NCT00442117|591889952|FG001|Overall Study|Met Withdrawal Criteria|1|||
163869581|NCT00305695|591889961|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
163869582|NCT00305695|591889962|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
163869583|NCT00305695|591889961|FG000|Overall Study|Did not have baseline scan|1|||
163869584|NCT00305695|591889962|FG001|Overall Study|Did not have baseline scan|1|||
163869585|NCT01121549|591889964|FG000|Overall Study|Adverse Event|10|||
163869586|NCT01121549|591889964|FG000|Overall Study|Lack of Efficacy|11|||
164314818|NCT01818752|593529774|FG001|Overall Study|Other|8|||
163973319|NCT02113436|592273868|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
163973320|NCT02113436|592273869|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
163973321|NCT02113436|592273870|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
163973322|NCT02113436|592273867|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
163973323|NCT02113436|592273868|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
163973324|NCT02113436|592273869|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
163973325|NCT02113436|592273870|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
163973326|NCT02113436|592273867|FG000|Period 2: 16 Weeks|Adverse Event|0|||
163973327|NCT02113436|592273868|FG001|Period 2: 16 Weeks|Adverse Event|0|||
163973328|NCT02113436|592273869|FG002|Period 2: 16 Weeks|Adverse Event|4|||
163973329|NCT02113436|592273870|FG003|Period 2: 16 Weeks|Adverse Event|5|||
163973330|NCT02113436|592273867|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
163973331|NCT02113436|592273868|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
163973332|NCT02113436|592273869|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
163973333|NCT02113436|592273870|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
163973334|NCT02113436|592273867|FG000|Period 2: 16 Weeks|Physician Decision|0|||
163973335|NCT02113436|592273868|FG001|Period 2: 16 Weeks|Physician Decision|0|||
163973336|NCT02113436|592273869|FG002|Period 2: 16 Weeks|Physician Decision|2|||
163973337|NCT02113436|592273870|FG003|Period 2: 16 Weeks|Physician Decision|0|||
163973338|NCT02113436|592273867|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
163973339|NCT02113436|592273868|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
163973340|NCT02113436|592273869|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
163973341|NCT02113436|592273870|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
163973342|NCT01486927|592273871|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
163973343|NCT01486927|592273871|FG000|Overall Study|Physician Decision|1|||
163973344|NCT01486927|592273871|FG000|Overall Study|50 Exposure days not reached|2|||
163973345|NCT01486927|592273871|FG000|Overall Study|Withdrawal by Subject|8|||
163973346|NCT01486927|592273871|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
163973347|NCT01148537|592273875|FG000|Overall Study|Withdrawal by Subject|1|||
163973348|NCT01148537|592273876|FG001|Overall Study|Withdrawal by Subject|0|||
163973349|NCT01148537|592273877|FG002|Overall Study|Withdrawal by Subject|2|||
163973350|NCT01148537|592273875|FG000|Overall Study|Adverse Event|2|||
163973351|NCT01148537|592273876|FG001|Overall Study|Adverse Event|0|||
163973352|NCT01148537|592273877|FG002|Overall Study|Adverse Event|1|||
163973353|NCT05895552|592273878|FG000|Overall Study|Adverse Event|2|||
163973354|NCT05895552|592273879|FG001|Overall Study|Adverse Event|2|||
163973355|NCT05895552|592273880|FG002|Overall Study|Adverse Event|1|||
163973356|NCT05895552|592273878|FG000|Overall Study|Lost to Follow-up|0|||
163973357|NCT05895552|592273879|FG001|Overall Study|Lost to Follow-up|1|||
163973358|NCT05895552|592273880|FG002|Overall Study|Lost to Follow-up|0|||
163973359|NCT05895552|592273878|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163973360|NCT05895552|592273879|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163973361|NCT05895552|592273880|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163973362|NCT05895552|592273878|FG000|Overall Study|Protocol Deviation|0|||
163973363|NCT05895552|592273879|FG001|Overall Study|Protocol Deviation|0|||
163973364|NCT05895552|592273880|FG002|Overall Study|Protocol Deviation|2|||
163973365|NCT05895552|592273878|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
163973366|NCT05895552|592273879|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
163973367|NCT05895552|592273880|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
163973368|NCT05895552|592273878|FG000|Overall Study|Withdrawal by Subject|2|||
163973369|NCT05895552|592273879|FG001|Overall Study|Withdrawal by Subject|2|||
163973370|NCT05895552|592273880|FG002|Overall Study|Withdrawal by Subject|4|||
163973371|NCT03810911|592273881|FG000|Overall Study|Death|1|||
163973372|NCT03810911|592273882|FG001|Overall Study|Death|1|||
163973373|NCT03810911|592273881|FG000|Overall Study|Withdrawal by Subject|1|||
163973374|NCT03810911|592273882|FG001|Overall Study|Withdrawal by Subject|1|||
163973375|NCT05374525|592273883|FG000|Overall Study|Adverse Event|5|||
163973376|NCT05374525|592273884|FG001|Overall Study|Adverse Event|6|||
163973377|NCT05374525|592273883|FG000|Overall Study|Lost to Follow-up|3|||
163973378|NCT05374525|592273884|FG001|Overall Study|Lost to Follow-up|3|||
163973379|NCT05374525|592273883|FG000|Overall Study|Physician Decision|2|||
163973380|NCT05374525|592273884|FG001|Overall Study|Physician Decision|2|||
163973381|NCT05374525|592273883|FG000|Overall Study|Withdrawal by Subject|26|||
163973382|NCT05374525|592273884|FG001|Overall Study|Withdrawal by Subject|8|||
163973383|NCT01349101|592273888|FG000|Overall Study|Disease Progression|1|||
163973384|NCT01349101|592273889|FG001|Overall Study|Disease Progression|1|||
163973385|NCT01349101|592273888|FG000|Overall Study|Death|3|||
163973386|NCT01349101|592273889|FG001|Overall Study|Death|8|||
163973387|NCT00454857|592273890|FG000|Overall Study|Withdrawal by Subject|15|||
163973388|NCT00454857|592273890|FG000|Overall Study|Lost to Follow-up|16|||
163973389|NCT00454857|592273890|FG000|Overall Study|Noncompliance|6|||
163973390|NCT00454857|592273890|FG000|Overall Study|Death|5|||
163973391|NCT00454857|592273890|FG000|Overall Study|Other|11|||
163973392|NCT00454857|592273890|FG000|Overall Study|Reason unknown|1|||
163973393|NCT00829179|592273891|FG000|Overall Study|Withdrawal by Subject|1|||
163973394|NCT02018822|592273896|FG000|Overall Study|filling replaced by crown|0|||
163869587|NCT01121549|591889964|FG000|Overall Study|Lost to Follow-up|12|||
163869588|NCT01121549|591889964|FG000|Overall Study|Did not meet entrance criteria|9|||
163869589|NCT01121549|591889964|FG000|Overall Study|Study terminated by sponsor|197|||
163869590|NCT01121549|591889964|FG000|Overall Study|Pregnancy|1|||
163869591|NCT01121549|591889964|FG000|Overall Study|Protocol Violation|33|||
163869592|NCT01121549|591889964|FG000|Overall Study|Withdrawal by Subject|16|||
163869593|NCT01121549|591889964|FG000|Overall Study|Other|58|||
163869594|NCT03073941|591891430|FG000|Overall Study|Received non-study device intraoperatively|0|||
163869595|NCT03073941|591891431|FG001|Overall Study|Received non-study device intraoperatively|2|||
163869596|NCT03073941|591891430|FG000|Overall Study|Death|1|||
163869597|NCT03073941|591891431|FG001|Overall Study|Death|0|||
163869598|NCT03073941|591891430|FG000|Overall Study|Withdrawal by Subject|1|||
163869599|NCT03073941|591891431|FG001|Overall Study|Withdrawal by Subject|3|||
163869600|NCT03073941|591891430|FG000|Overall Study|Lost to Follow-up|5|||
163869601|NCT03073941|591891431|FG001|Overall Study|Lost to Follow-up|4|||
163869602|NCT03073941|591891430|FG000|Overall Study|Adverse Event|4|||
163869603|NCT03073941|591891431|FG001|Overall Study|Adverse Event|2|||
163869604|NCT03073941|591891430|FG000|Overall Study|Met an exclusion criterion|0|||
163869605|NCT03073941|591891431|FG001|Overall Study|Met an exclusion criterion|1|||
163869606|NCT04250883|591891432|FG000|Overall Study|Lost to Follow-up|1|||
163869607|NCT04250883|591891433|FG001|Overall Study|Lost to Follow-up|0|||
163869608|NCT02763319|591891434|FG000|Overall Study|Adverse Event|12|||
163869609|NCT02763319|591891435|FG001|Overall Study|Adverse Event|3|||
163869610|NCT02763319|591891434|FG000|Overall Study|Death|123|||
163869611|NCT02763319|591891435|FG001|Overall Study|Death|123|||
163869612|NCT02763319|591891434|FG000|Overall Study|Lost to Follow-up|6|||
163869613|NCT02763319|591891435|FG001|Overall Study|Lost to Follow-up|7|||
163869614|NCT02763319|591891434|FG000|Overall Study|Noncompliance with Study Drug|2|||
163869615|NCT02763319|591891435|FG001|Overall Study|Noncompliance with Study Drug|0|||
163869616|NCT02763319|591891434|FG000|Overall Study|"Captured as Other in Database"|29|||
163869617|NCT02763319|591891435|FG001|Overall Study|"Captured as Other in Database"|34|||
163869618|NCT02763319|591891434|FG000|Overall Study|Physician Decision|1|||
163869619|NCT02763319|591891435|FG001|Overall Study|Physician Decision|7|||
163869620|NCT02763319|591891434|FG000|Overall Study|Progressive Disease|24|||
163869621|NCT02763319|591891435|FG001|Overall Study|Progressive Disease|27|||
163869622|NCT02763319|591891434|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
163869623|NCT02763319|591891435|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
163869624|NCT02763319|591891434|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
163869625|NCT02763319|591891435|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
163869626|NCT02763319|591891434|FG000|Overall Study|Withdrawal by Subject|26|||
163869627|NCT02763319|591891435|FG001|Overall Study|Withdrawal by Subject|25|||
163869628|NCT03936660|591891436|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
163869629|NCT03936660|591891437|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
163869630|NCT00925587|591891440|FG000|Overall Study|Protocol Specified Criteria|6|||
163869631|NCT00925587|591891441|FG001|Overall Study|Protocol Specified Criteria|6|||
163869632|NCT00925587|591891440|FG000|Overall Study|Physician Decision|4|||
163869633|NCT00925587|591891441|FG001|Overall Study|Physician Decision|1|||
163869634|NCT00925587|591891440|FG000|Overall Study|Protocol Violation|6|||
163869635|NCT00925587|591891441|FG001|Overall Study|Protocol Violation|4|||
163869636|NCT00925587|591891440|FG000|Overall Study|Withdrawal by Subject|9|||
163869637|NCT00925587|591891441|FG001|Overall Study|Withdrawal by Subject|6|||
163869638|NCT00925587|591891440|FG000|Overall Study|Death|5|||
163869639|NCT00925587|591891441|FG001|Overall Study|Death|5|||
163869640|NCT00925587|591891440|FG000|Overall Study|Adverse Event|6|||
163869641|NCT00925587|591891441|FG001|Overall Study|Adverse Event|2|||
163869642|NCT00925587|591891440|FG000|Overall Study|Lost to Follow-up|0|||
163869643|NCT00925587|591891441|FG001|Overall Study|Lost to Follow-up|1|||
163869644|NCT01460446|591891449|FG000|Overall Study|Non-compliance|2|||
163869645|NCT01460446|591891450|FG001|Overall Study|Non-compliance|9|||
163869646|NCT01460446|591891449|FG000|Overall Study|Consent Withdrawn|0|||
163869647|NCT01460446|591891450|FG001|Overall Study|Consent Withdrawn|4|||
163869648|NCT01460446|591891449|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
164135740|NCT02799095|592861966|FG011|Part A|Withdrawal by Subject|0|||
163869649|NCT01460446|591891450|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
163869650|NCT01460446|591891449|FG000|Overall Study|Surgery/Illness|1|||
163869651|NCT01460446|591891450|FG001|Overall Study|Surgery/Illness|1|||
163869652|NCT01460446|591891449|FG000|Overall Study|Pregnancy|1|||
163869653|NCT01460446|591891450|FG001|Overall Study|Pregnancy|0|||
163869654|NCT01460446|591891449|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
163869655|NCT01460446|591891450|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
164135741|NCT02799095|592861967|FG012|Part A|Withdrawal by Subject|0|||
164135742|NCT02799095|592861968|FG013|Part A|Withdrawal by Subject|0|||
164135743|NCT02799095|592861969|FG014|Part A|Withdrawal by Subject|0|||
164135744|NCT02799095|592861970|FG015|Part A|Withdrawal by Subject|0|||
164135745|NCT02799095|592861971|FG016|Part A|Withdrawal by Subject|0|||
164135746|NCT02799095|592861955|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
163973395|NCT02018822|592273897|FG001|Overall Study|filling replaced by crown|1|||
163973396|NCT02018822|592273898|FG002|Overall Study|filling replaced by crown|0|||
163973397|NCT02018822|592273896|FG000|Overall Study|Physician Decision|0|||
163973398|NCT02018822|592273897|FG001|Overall Study|Physician Decision|1|||
163973399|NCT02018822|592273898|FG002|Overall Study|Physician Decision|1|||
163973400|NCT02018822|592273896|FG000|Overall Study|Lost to Follow-up|6|||
163973401|NCT02018822|592273897|FG001|Overall Study|Lost to Follow-up|6|||
163973402|NCT02018822|592273898|FG002|Overall Study|Lost to Follow-up|5|||
163973403|NCT00271596|592273901|FG000|Overall Study|Protocol Violation|1|||
163973404|NCT00271596|592273902|FG001|Overall Study|Protocol Violation|0|||
163973405|NCT00271596|592273901|FG000|Overall Study|Withdrawal by Subject|0|||
163973406|NCT00271596|592273902|FG001|Overall Study|Withdrawal by Subject|1|||
163973407|NCT04707157|592273903|FG000|Overall Study|Adverse Event|12|||
163973408|NCT04707157|592273904|FG001|Overall Study|Adverse Event|3|||
163973409|NCT04707157|592273903|FG000|Overall Study|Lost to Follow-up|2|||
163973410|NCT04707157|592273904|FG001|Overall Study|Lost to Follow-up|0|||
163973411|NCT04707157|592273903|FG000|Overall Study|Sponsor's decision|1|||
163973412|NCT04707157|592273904|FG001|Overall Study|Sponsor's decision|0|||
163973413|NCT04707157|592273903|FG000|Overall Study|Physician Decision|8|||
163973414|NCT04707157|592273904|FG001|Overall Study|Physician Decision|5|||
163973415|NCT04707157|592273903|FG000|Overall Study|Protocol Deviation|1|||
163973416|NCT04707157|592273904|FG001|Overall Study|Protocol Deviation|0|||
163973417|NCT04707157|592273903|FG000|Overall Study|Withdrawal by Subject|1|||
163973418|NCT04707157|592273904|FG001|Overall Study|Withdrawal by Subject|1|||
163973419|NCT04232553|592273909|FG000|Overall Study|Adverse Event|3|||
163973420|NCT04232553|592273910|FG001|Overall Study|Adverse Event|2|||
163973421|NCT04232553|592273911|FG002|Overall Study|Adverse Event|1|||
163973422|NCT04232553|592273912|FG003|Overall Study|Adverse Event|2|||
163973423|NCT04232553|592273913|FG004|Overall Study|Adverse Event|1|||
163973424|NCT04232553|592273914|FG005|Overall Study|Adverse Event|1|||
163973425|NCT04232553|592273915|FG006|Overall Study|Adverse Event|0|||
163973426|NCT04232553|592273916|FG007|Overall Study|Adverse Event|0|||
163973427|NCT04232553|592273917|FG008|Overall Study|Adverse Event|0|||
163973428|NCT04232553|592273909|FG000|Overall Study|Death|0|||
163973429|NCT04232553|592273910|FG001|Overall Study|Death|1|||
163973430|NCT04232553|592273911|FG002|Overall Study|Death|0|||
163973431|NCT04232553|592273912|FG003|Overall Study|Death|1|||
163973432|NCT04232553|592273913|FG004|Overall Study|Death|0|||
163973433|NCT04232553|592273914|FG005|Overall Study|Death|0|||
163869656|NCT00516321|591891451|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
163869657|NCT00516321|591891452|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
163869658|NCT00516321|591891453|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
163869659|NCT00516321|591891451|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
163869660|NCT00516321|591891452|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
163869661|NCT00516321|591891453|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
163869662|NCT00516321|591891451|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
163869663|NCT00516321|591891452|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
163869664|NCT00516321|591891453|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
163869665|NCT00516321|591891451|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
163869666|NCT00516321|591891452|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
163869667|NCT00516321|591891453|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
163869668|NCT00516321|591891451|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
163869669|NCT00516321|591891452|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
163869670|NCT00516321|591891453|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
163869671|NCT00516321|591891451|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
163869672|NCT00516321|591891452|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
163869673|NCT00516321|591891453|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
163869674|NCT00516321|591891451|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
163869675|NCT00516321|591891452|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
163973434|NCT04232553|592273915|FG006|Overall Study|Death|0|||
163973435|NCT04232553|592273916|FG007|Overall Study|Death|0|||
163869676|NCT00516321|591891453|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
163973436|NCT04232553|592273917|FG008|Overall Study|Death|0|||
163973437|NCT04232553|592273909|FG000|Overall Study|Lack of Efficacy|0|||
163973438|NCT04232553|592273910|FG001|Overall Study|Lack of Efficacy|2|||
163973439|NCT04232553|592273911|FG002|Overall Study|Lack of Efficacy|0|||
163973440|NCT04232553|592273912|FG003|Overall Study|Lack of Efficacy|0|||
163973441|NCT04232553|592273913|FG004|Overall Study|Lack of Efficacy|0|||
163973442|NCT04232553|592273914|FG005|Overall Study|Lack of Efficacy|0|||
163973443|NCT04232553|592273915|FG006|Overall Study|Lack of Efficacy|0|||
163973444|NCT04232553|592273916|FG007|Overall Study|Lack of Efficacy|0|||
163973445|NCT04232553|592273917|FG008|Overall Study|Lack of Efficacy|1|||
163973446|NCT04232553|592273909|FG000|Overall Study|Lost to Follow-up|0|||
163973447|NCT04232553|592273910|FG001|Overall Study|Lost to Follow-up|1|||
163973448|NCT04232553|592273911|FG002|Overall Study|Lost to Follow-up|0|||
163973449|NCT04232553|592273912|FG003|Overall Study|Lost to Follow-up|0|||
163973450|NCT04232553|592273913|FG004|Overall Study|Lost to Follow-up|1|||
163973451|NCT04232553|592273914|FG005|Overall Study|Lost to Follow-up|0|||
163973452|NCT04232553|592273915|FG006|Overall Study|Lost to Follow-up|0|||
163973453|NCT04232553|592273916|FG007|Overall Study|Lost to Follow-up|0|||
163973454|NCT04232553|592273917|FG008|Overall Study|Lost to Follow-up|1|||
163973455|NCT04232553|592273909|FG000|Overall Study|Other - As reported by the investigator|0|||
163973456|NCT04232553|592273910|FG001|Overall Study|Other - As reported by the investigator|1|||
163973457|NCT04232553|592273911|FG002|Overall Study|Other - As reported by the investigator|0|||
163973458|NCT04232553|592273912|FG003|Overall Study|Other - As reported by the investigator|0|||
163973459|NCT04232553|592273913|FG004|Overall Study|Other - As reported by the investigator|0|||
163973460|NCT04232553|592273914|FG005|Overall Study|Other - As reported by the investigator|0|||
163973461|NCT04232553|592273915|FG006|Overall Study|Other - As reported by the investigator|0|||
163973462|NCT04232553|592273916|FG007|Overall Study|Other - As reported by the investigator|0|||
163973463|NCT04232553|592273917|FG008|Overall Study|Other - As reported by the investigator|0|||
163973464|NCT04232553|592273909|FG000|Overall Study|Physician Decision|1|||
163973465|NCT04232553|592273910|FG001|Overall Study|Physician Decision|1|||
163869677|NCT00516321|591891451|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
163869678|NCT00516321|591891452|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
163869679|NCT00516321|591891453|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
163869680|NCT00516321|591891451|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
163869681|NCT00516321|591891452|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
163869682|NCT00516321|591891453|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
163869683|NCT00516321|591891451|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
163869684|NCT00516321|591891452|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
163869685|NCT00516321|591891453|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
163869686|NCT00516321|591891451|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
163869687|NCT00516321|591891452|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
163869688|NCT00516321|591891453|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
163869689|NCT02271854|591891459|FG000|Overall Study|Withdrawal by Subject|2|||
163869690|NCT02271854|591891459|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
163869691|NCT02271854|591891459|FG000|Overall Study|Lost to Follow-up|1|||
163869692|NCT01308567|591891460|FG000|Overall Study|Lost to Follow-up|2|||
163869693|NCT01308567|591891461|FG001|Overall Study|Lost to Follow-up|4|||
163869694|NCT01308567|591891462|FG002|Overall Study|Lost to Follow-up|4|||
163869695|NCT01571596|591891463|FG000|Overall Study|Adverse Event|2|||
163869696|NCT01571596|591891464|FG001|Overall Study|Adverse Event|0|||
163869697|NCT01571596|591891465|FG002|Overall Study|Adverse Event|0|||
163869698|NCT01571596|591891463|FG000|Overall Study|Study Terminated by the Sponsor|0|||
163869699|NCT01571596|591891464|FG001|Overall Study|Study Terminated by the Sponsor|1|||
163869700|NCT01571596|591891465|FG002|Overall Study|Study Terminated by the Sponsor|1|||
163869701|NCT02499159|591891468|FG000|Randomization|Protocol Violation|1|||
163869702|NCT02499159|591891469|FG001|Randomization|Protocol Violation|1|||
163869703|NCT02499159|591891468|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
163869704|NCT02499159|591891469|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
163869705|NCT02499159|591891468|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
163869706|NCT02499159|591891469|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
163869707|NCT02499159|591891468|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
163869708|NCT02499159|591891469|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
163973466|NCT04232553|592273911|FG002|Overall Study|Physician Decision|0|||
163973467|NCT04232553|592273912|FG003|Overall Study|Physician Decision|0|||
163973468|NCT04232553|592273913|FG004|Overall Study|Physician Decision|1|||
163973469|NCT04232553|592273914|FG005|Overall Study|Physician Decision|0|||
163973470|NCT04232553|592273915|FG006|Overall Study|Physician Decision|0|||
163973471|NCT04232553|592273916|FG007|Overall Study|Physician Decision|0|||
163973472|NCT04232553|592273917|FG008|Overall Study|Physician Decision|0|||
163973473|NCT04232553|592273909|FG000|Overall Study|Pregnancy|1|||
163973474|NCT04232553|592273910|FG001|Overall Study|Pregnancy|0|||
163973475|NCT04232553|592273911|FG002|Overall Study|Pregnancy|0|||
163973476|NCT04232553|592273912|FG003|Overall Study|Pregnancy|0|||
163869709|NCT02499159|591891468|FG000|30-Day Follow-Up Phone Call|Other|1|||
163869710|NCT02499159|591891469|FG001|30-Day Follow-Up Phone Call|Other|0|||
163869711|NCT01599793|591891470|FG000|Overall Study|Adverse Event|2|||
163869712|NCT02564744|591891471|FG000|Overall Study|Investigator decision|0|||
163869713|NCT02564744|591891472|FG001|Overall Study|Investigator decision|0|||
163869714|NCT02564744|591891473|FG002|Overall Study|Investigator decision|0|||
163869715|NCT02564744|591891474|FG003|Overall Study|Investigator decision|0|||
163869716|NCT02564744|591891475|FG004|Overall Study|Investigator decision|1|||
163869717|NCT02564744|591891471|FG000|Overall Study|Death|10|||
163973477|NCT04232553|592273913|FG004|Overall Study|Pregnancy|0|||
163973478|NCT04232553|592273914|FG005|Overall Study|Pregnancy|0|||
163973479|NCT04232553|592273915|FG006|Overall Study|Pregnancy|0|||
163973480|NCT04232553|592273916|FG007|Overall Study|Pregnancy|0|||
163973481|NCT04232553|592273917|FG008|Overall Study|Pregnancy|0|||
163973482|NCT04232553|592273909|FG000|Overall Study|Withdrawal by Subject|7|||
163973483|NCT04232553|592273910|FG001|Overall Study|Withdrawal by Subject|5|||
163973484|NCT04232553|592273911|FG002|Overall Study|Withdrawal by Subject|0|||
163973485|NCT04232553|592273912|FG003|Overall Study|Withdrawal by Subject|0|||
163973486|NCT04232553|592273913|FG004|Overall Study|Withdrawal by Subject|2|||
163973487|NCT04232553|592273914|FG005|Overall Study|Withdrawal by Subject|2|||
163973488|NCT04232553|592273915|FG006|Overall Study|Withdrawal by Subject|0|||
163973489|NCT04232553|592273916|FG007|Overall Study|Withdrawal by Subject|2|||
163973490|NCT04232553|592273917|FG008|Overall Study|Withdrawal by Subject|0|||
163973491|NCT02969915|592273918|FG000|Overall Study|Death|104|||
163973492|NCT02969915|592273919|FG001|Overall Study|Death|125|||
163973493|NCT02969915|592273918|FG000|Overall Study|Lost to Follow-up|108|||
163973494|NCT02969915|592273919|FG001|Overall Study|Lost to Follow-up|112|||
163973495|NCT02969915|592273918|FG000|Overall Study|Censored due to COVID-19|481|||
163973496|NCT02969915|592273919|FG001|Overall Study|Censored due to COVID-19|471|||
163973497|NCT03625687|592273924|FG000|Overall Study|Death|1|||
163973498|NCT00974675|592273927|FG000|Overall Study|Adverse Event|2|||
163973499|NCT00974675|592273928|FG001|Overall Study|Adverse Event|1|||
163973500|NCT00974675|592273929|FG002|Overall Study|Adverse Event|1|||
163973501|NCT00974675|592273930|FG003|Overall Study|Adverse Event|1|||
163973502|NCT00974675|592273927|FG000|Overall Study|Physician Decision|0|||
163973503|NCT00974675|592273928|FG001|Overall Study|Physician Decision|0|||
163973504|NCT00974675|592273929|FG002|Overall Study|Physician Decision|1|||
163973505|NCT00974675|592273930|FG003|Overall Study|Physician Decision|0|||
163973506|NCT00974675|592273927|FG000|Overall Study|Participant on holiday; unable to attend|0|||
163973507|NCT00974675|592273928|FG001|Overall Study|Participant on holiday; unable to attend|0|||
163973508|NCT00974675|592273929|FG002|Overall Study|Participant on holiday; unable to attend|0|||
163973509|NCT00974675|592273930|FG003|Overall Study|Participant on holiday; unable to attend|1|||
163973510|NCT01987960|592273933|FG000|Period 1|Adverse Event|24|||
163973511|NCT01987960|592273934|FG001|Period 1|Adverse Event|0|||
163973512|NCT01987960|592273935|FG002|Period 1|Adverse Event|0|||
163973513|NCT01987960|592273936|FG003|Period 1|Adverse Event|0|||
163973514|NCT01987960|592273933|FG000|Period 1|Lack of Efficacy|4|||
163973515|NCT01987960|592273934|FG001|Period 1|Lack of Efficacy|0|||
163973516|NCT01987960|592273935|FG002|Period 1|Lack of Efficacy|0|||
163973517|NCT01987960|592273936|FG003|Period 1|Lack of Efficacy|0|||
163973518|NCT01987960|592273933|FG000|Period 1|Non-compliance with IMP|6|||
163973519|NCT01987960|592273934|FG001|Period 1|Non-compliance with IMP|0|||
163973520|NCT01987960|592273935|FG002|Period 1|Non-compliance with IMP|0|||
163869718|NCT02564744|591891472|FG001|Overall Study|Death|5|||
163869719|NCT02564744|591891473|FG002|Overall Study|Death|4|||
163869720|NCT02564744|591891474|FG003|Overall Study|Death|16|||
163869721|NCT02564744|591891475|FG004|Overall Study|Death|16|||
163869722|NCT02564744|591891471|FG000|Overall Study|End of study Page Missing|0|||
163869723|NCT02564744|591891472|FG001|Overall Study|End of study Page Missing|0|||
163869724|NCT02564744|591891473|FG002|Overall Study|End of study Page Missing|3|||
163869725|NCT02564744|591891474|FG003|Overall Study|End of study Page Missing|3|||
163869726|NCT02564744|591891475|FG004|Overall Study|End of study Page Missing|0|||
163869727|NCT02564744|591891471|FG000|Overall Study|Subject Withdrew Consent|1|||
163869728|NCT02564744|591891472|FG001|Overall Study|Subject Withdrew Consent|1|||
163869729|NCT02564744|591891473|FG002|Overall Study|Subject Withdrew Consent|1|||
163869730|NCT02564744|591891474|FG003|Overall Study|Subject Withdrew Consent|0|||
163869731|NCT02564744|591891475|FG004|Overall Study|Subject Withdrew Consent|2|||
163869732|NCT02564744|591891471|FG000|Overall Study|Lost to Follow-up|0|||
163869733|NCT02564744|591891472|FG001|Overall Study|Lost to Follow-up|1|||
163869734|NCT02564744|591891473|FG002|Overall Study|Lost to Follow-up|0|||
163869735|NCT02564744|591891474|FG003|Overall Study|Lost to Follow-up|0|||
163869736|NCT02564744|591891475|FG004|Overall Study|Lost to Follow-up|1|||
163869737|NCT02564744|591891471|FG000|Overall Study|Reason not specified|1|||
163869738|NCT02564744|591891472|FG001|Overall Study|Reason not specified|0|||
163869739|NCT02564744|591891473|FG002|Overall Study|Reason not specified|0|||
163869740|NCT02564744|591891474|FG003|Overall Study|Reason not specified|0|||
163869741|NCT02564744|591891475|FG004|Overall Study|Reason not specified|0|||
163869742|NCT02675244|591891485|FG000|Overall Study|Death|9|||
163869743|NCT02675244|591891486|FG001|Overall Study|Death|6|||
163869744|NCT02675244|591891485|FG000|Overall Study|Withdrawal by Subject|3|||
164314819|NCT01818752|593529773|FG000|Overall Study|Continuing Treatment|1|||
163869745|NCT02675244|591891486|FG001|Overall Study|Withdrawal by Subject|6|||
163869746|NCT02675244|591891485|FG000|Overall Study|Lost to Follow-up|1|||
163869747|NCT02675244|591891486|FG001|Overall Study|Lost to Follow-up|1|||
163869748|NCT02675244|591891485|FG000|Overall Study|Ongoing at 2 Years|190|||
163869749|NCT02675244|591891486|FG001|Overall Study|Ongoing at 2 Years|185|||
163973521|NCT01987960|592273936|FG003|Period 1|Non-compliance with IMP|0|||
163973522|NCT01987960|592273933|FG000|Period 1|Protocol Violation|12|||
163973523|NCT01987960|592273934|FG001|Period 1|Protocol Violation|0|||
163973524|NCT01987960|592273935|FG002|Period 1|Protocol Violation|0|||
164314820|NCT01818752|593529774|FG001|Overall Study|Continuing Treatment|4|||
163973525|NCT01987960|592273936|FG003|Period 1|Protocol Violation|0|||
163973526|NCT01987960|592273933|FG000|Period 1|Withdrawal by Subject|21|||
163973527|NCT01987960|592273934|FG001|Period 1|Withdrawal by Subject|0|||
163973528|NCT01987960|592273935|FG002|Period 1|Withdrawal by Subject|0|||
163973529|NCT01987960|592273936|FG003|Period 1|Withdrawal by Subject|0|||
163973530|NCT01987960|592273933|FG000|Period 1|Lost to Follow-up|40|||
163973531|NCT01987960|592273934|FG001|Period 1|Lost to Follow-up|0|||
163973532|NCT01987960|592273935|FG002|Period 1|Lost to Follow-up|0|||
163973533|NCT01987960|592273936|FG003|Period 1|Lost to Follow-up|0|||
163973534|NCT01987960|592273933|FG000|Period 1|administrative or other reason|75|||
163973535|NCT01987960|592273934|FG001|Period 1|administrative or other reason|0|||
163973536|NCT01987960|592273935|FG002|Period 1|administrative or other reason|0|||
163973537|NCT01987960|592273936|FG003|Period 1|administrative or other reason|0|||
163973538|NCT01987960|592273933|FG000|Period 1|Withdrawal of consent before treatment|4|||
163973539|NCT01987960|592273934|FG001|Period 1|Withdrawal of consent before treatment|0|||
163973540|NCT01987960|592273935|FG002|Period 1|Withdrawal of consent before treatment|0|||
163973541|NCT01987960|592273936|FG003|Period 1|Withdrawal of consent before treatment|0|||
163973542|NCT01987960|592273933|FG000|Period 2|Adverse Event|0|||
163973543|NCT01987960|592273934|FG001|Period 2|Adverse Event|0|||
163973544|NCT01987960|592273935|FG002|Period 2|Adverse Event|1|||
163973545|NCT01987960|592273936|FG003|Period 2|Adverse Event|0|||
163973546|NCT01987960|592273933|FG000|Period 2|Withdrawal by Subject|0|||
163973547|NCT01987960|592273934|FG001|Period 2|Withdrawal by Subject|0|||
163973548|NCT01987960|592273935|FG002|Period 2|Withdrawal by Subject|1|||
163973549|NCT01987960|592273936|FG003|Period 2|Withdrawal by Subject|0|||
163869750|NCT02652442|591891490|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
163869751|NCT02252042|591891491|FG000|Overall Study|Adverse Event|9|||
163869752|NCT02252042|591891492|FG001|Overall Study|Adverse Event|6|||
163869753|NCT02252042|591891491|FG000|Overall Study|Death|209|||
163869754|NCT02252042|591891492|FG001|Overall Study|Death|217|||
163869755|NCT02252042|591891491|FG000|Overall Study|Physician Decision|0|||
163869756|NCT02252042|591891492|FG001|Overall Study|Physician Decision|2|||
163869757|NCT02252042|591891491|FG000|Overall Study|Transferred to Extension Study|7|||
163869758|NCT02252042|591891492|FG001|Overall Study|Transferred to Extension Study|1|||
163869759|NCT02252042|591891491|FG000|Overall Study|Did Not Continue on Extension Study|7|||
163869760|NCT02252042|591891492|FG001|Overall Study|Did Not Continue on Extension Study|2|||
163869761|NCT02252042|591891491|FG000|Overall Study|Withdrawal by Subject|15|||
163869762|NCT02252042|591891492|FG001|Overall Study|Withdrawal by Subject|20|||
163869763|NCT02593149|591891495|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
163869764|NCT02593149|591891496|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
163869765|NCT02593149|591891495|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
163869766|NCT02593149|591891496|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
163869767|NCT01177670|591891498|FG000|Overall Study|Study Terminated|115|||
163869768|NCT01177670|591891498|FG000|Overall Study|Physician Decision|50|||
163869769|NCT01177670|591891498|FG000|Overall Study|Withdrawal by Subject|4|||
163869770|NCT00979992|591891499|FG000|Overall Study|Ineligible - inadequate pathology|1|||
163869771|NCT00979992|591891499|FG000|Overall Study|Ineligible - wrong cell type|2|||
163869772|NCT00979992|591891499|FG000|Overall Study|Refused - Never Treated|2|||
163869773|NCT01140048|591891501|FG000|Overall Study|Physician Decision|1|||
163869774|NCT01140048|591891501|FG000|Overall Study|Withdrawal by Subject|13|||
163869775|NCT01140048|591891501|FG000|Overall Study|Lost to Follow-up|31|||
163869776|NCT02888080|591891502|FG000|Overall Study|Subject / Guardian decision|1|||
163869777|NCT02888080|591891503|FG001|Overall Study|Subject / Guardian decision|3|||
163869778|NCT02888080|591891502|FG000|Overall Study|New Therapy for study indication|1|||
163869779|NCT02888080|591891503|FG001|Overall Study|New Therapy for study indication|0|||
163869780|NCT02888080|591891502|FG000|Overall Study|Lack of Efficacy|0|||
163869781|NCT02888080|591891503|FG001|Overall Study|Lack of Efficacy|1|||
163869782|NCT02888080|591891502|FG000|Overall Study|Adverse Event|0|||
163869783|NCT02888080|591891503|FG001|Overall Study|Adverse Event|1|||
163869784|NCT04530747|591891505|FG000|Overall Study|Withdrawal by Subject|1|||
163869785|NCT04530747|591891506|FG001|Overall Study|Withdrawal by Subject|0|||
163973550|NCT01987960|592273933|FG000|Period 2|Administrative or other reason|0|||
163973551|NCT01987960|592273934|FG001|Period 2|Administrative or other reason|5|||
163973552|NCT01987960|592273935|FG002|Period 2|Administrative or other reason|7|||
163973553|NCT01987960|592273936|FG003|Period 2|Administrative or other reason|0|||
163973554|NCT01987960|592273933|FG000|Period 3|Adverse Event|0|||
163869786|NCT03292913|591891507|FG000|Overall Study|Death|9|||
163869787|NCT03292913|591891508|FG001|Overall Study|Death|3|||
163869788|NCT03292913|591891507|FG000|Overall Study|Lost to Follow-up|49|||
163869789|NCT03292913|591891508|FG001|Overall Study|Lost to Follow-up|49|||
163869790|NCT03292913|591891507|FG000|Overall Study|Withdrawal by Subject|2|||
163869791|NCT03292913|591891508|FG001|Overall Study|Withdrawal by Subject|0|||
163869792|NCT03292913|591891507|FG000|Overall Study|Clinic closed due to COVID|22|||
163869793|NCT03292913|591891508|FG001|Overall Study|Clinic closed due to COVID|36|||
163973555|NCT01987960|592273934|FG001|Period 3|Adverse Event|0|||
163973556|NCT01987960|592273935|FG002|Period 3|Adverse Event|0|||
163973557|NCT01987960|592273936|FG003|Period 3|Adverse Event|7|||
163973558|NCT01987960|592273933|FG000|Period 3|Non-compliance with IMP|0|||
163973559|NCT01987960|592273934|FG001|Period 3|Non-compliance with IMP|0|||
163973560|NCT01987960|592273935|FG002|Period 3|Non-compliance with IMP|0|||
163973561|NCT01987960|592273936|FG003|Period 3|Non-compliance with IMP|1|||
163973562|NCT01987960|592273933|FG000|Period 3|Protocol Violation|0|||
163973563|NCT01987960|592273934|FG001|Period 3|Protocol Violation|0|||
163973564|NCT01987960|592273935|FG002|Period 3|Protocol Violation|0|||
163973565|NCT01987960|592273936|FG003|Period 3|Protocol Violation|6|||
163973566|NCT01987960|592273933|FG000|Period 3|Withdrawal by Subject|0|||
163973567|NCT01987960|592273934|FG001|Period 3|Withdrawal by Subject|0|||
163973568|NCT01987960|592273935|FG002|Period 3|Withdrawal by Subject|0|||
163973569|NCT01987960|592273936|FG003|Period 3|Withdrawal by Subject|9|||
163973570|NCT01987960|592273933|FG000|Period 3|Lost to Follow-up|0|||
163973571|NCT01987960|592273934|FG001|Period 3|Lost to Follow-up|0|||
163973572|NCT01987960|592273935|FG002|Period 3|Lost to Follow-up|0|||
163973573|NCT01987960|592273936|FG003|Period 3|Lost to Follow-up|5|||
163973574|NCT01987960|592273933|FG000|Period 3|Administrative or other reason|0|||
163973575|NCT01987960|592273934|FG001|Period 3|Administrative or other reason|0|||
163973576|NCT01987960|592273935|FG002|Period 3|Administrative or other reason|0|||
163973577|NCT01987960|592273936|FG003|Period 3|Administrative or other reason|43|||
163973578|NCT00789880|592273938|FG000|Overall Study|Adverse Event|0|||
163973579|NCT00789880|592273939|FG001|Overall Study|Adverse Event|0|||
163973580|NCT00789880|592273940|FG002|Overall Study|Adverse Event|0|||
163973581|NCT00789880|592273941|FG003|Overall Study|Adverse Event|0|||
163973582|NCT00789880|592273942|FG004|Overall Study|Adverse Event|1|||
163973583|NCT00789880|592273943|FG005|Overall Study|Adverse Event|0|||
163973584|NCT00789880|592273938|FG000|Overall Study|Protocol Violation|0|||
163973585|NCT00789880|592273939|FG001|Overall Study|Protocol Violation|1|||
163973586|NCT00789880|592273940|FG002|Overall Study|Protocol Violation|0|||
163973587|NCT00789880|592273941|FG003|Overall Study|Protocol Violation|1|||
163973588|NCT00789880|592273942|FG004|Overall Study|Protocol Violation|0|||
163973589|NCT00789880|592273943|FG005|Overall Study|Protocol Violation|0|||
163973590|NCT00789880|592273938|FG000|Overall Study|Withdrawal by Subject|1|||
163973591|NCT00789880|592273939|FG001|Overall Study|Withdrawal by Subject|0|||
163973592|NCT00789880|592273940|FG002|Overall Study|Withdrawal by Subject|0|||
163973593|NCT00789880|592273941|FG003|Overall Study|Withdrawal by Subject|0|||
163973594|NCT00789880|592273942|FG004|Overall Study|Withdrawal by Subject|2|||
163973595|NCT00789880|592273943|FG005|Overall Study|Withdrawal by Subject|0|||
163973596|NCT01177683|592273944|FG000|Study Treatment|Disease Progressions during treatment|2|||
163973597|NCT01177683|592273945|FG001|Study Treatment|Disease Progressions during treatment|0|||
163973598|NCT01177683|592273946|FG002|Study Treatment|Disease Progressions during treatment|3|||
163973599|NCT01177683|592273944|FG000|Study Treatment|Adverse Event|0|||
163973600|NCT01177683|592273945|FG001|Study Treatment|Adverse Event|1|||
163973601|NCT01177683|592273946|FG002|Study Treatment|Adverse Event|12|||
163973602|NCT01177683|592273944|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
163973603|NCT01177683|592273945|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
163973604|NCT01177683|592273946|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
163973605|NCT01177683|592273944|FG000|Study Treatment|Alternative therapy|0|||
163973606|NCT01177683|592273945|FG001|Study Treatment|Alternative therapy|0|||
163973607|NCT01177683|592273946|FG002|Study Treatment|Alternative therapy|4|||
163973608|NCT01177683|592273944|FG000|Study Treatment|Physician Decision|1|||
163973609|NCT01177683|592273945|FG001|Study Treatment|Physician Decision|0|||
163973610|NCT01177683|592273946|FG002|Study Treatment|Physician Decision|1|||
163973611|NCT01177683|592273944|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
163973612|NCT01177683|592273945|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
163973613|NCT01177683|592273946|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
163973614|NCT01177683|592273944|FG000|Study Treatment|Symptomatic Deterioration|0|||
163973615|NCT01177683|592273945|FG001|Study Treatment|Symptomatic Deterioration|0|||
163973616|NCT01177683|592273946|FG002|Study Treatment|Symptomatic Deterioration|1|||
163973617|NCT01177683|592273944|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
163973618|NCT01177683|592273945|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
163973619|NCT01177683|592273946|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
164204018|NCT01991795|593117891|FG000|Overall Study|Withdrawal by Subject|117|||
164204019|NCT01991795|593117892|FG001|Overall Study|Withdrawal by Subject|94|||
164204020|NCT01991795|593117891|FG000|Overall Study|Site prematurely closed by sponsor|26|||
164204021|NCT01991795|593117892|FG001|Overall Study|Site prematurely closed by sponsor|25|||
164204022|NCT02404545|593117893|FG000|Overall Study|Sponsor Termination|6|||
163973620|NCT01177683|592273944|FG000|Follow up|Patient lost to follow up|0|||
163973621|NCT01177683|592273945|FG001|Follow up|Patient lost to follow up|0|||
163973622|NCT01177683|592273946|FG002|Follow up|Patient lost to follow up|2|||
163973623|NCT01177683|592273944|FG000|Follow up|Death|2|||
163973624|NCT01177683|592273945|FG001|Follow up|Death|1|||
163973625|NCT01177683|592273946|FG002|Follow up|Death|7|||
163973626|NCT01177683|592273944|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
163973627|NCT01177683|592273945|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
164204023|NCT02404545|593117894|FG001|Overall Study|Sponsor Termination|6|||
164204024|NCT02078817|593117897|FG000|Overall Study|Withdrawal by Subject|1|||
164204025|NCT00769561|593117899|FG000|Overall Study|Withdrawal by Subject|2|||
163973628|NCT01177683|592273946|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
163973629|NCT06347731|592273947|FG000|Overall Study|Death|1|||
163973630|NCT06347731|592273947|FG000|Overall Study|Protocol Violation|1|||
163973631|NCT06347731|592273947|FG000|Overall Study|Withdrawal by Subject|2|||
163973632|NCT01436084|592273950|FG000|Overall Study|Disease Progression|2|||
163973633|NCT01436084|592273950|FG000|Overall Study|Withdrawal by Subject|1|||
163973634|NCT01436084|592273950|FG000|Overall Study|Early Closure of Study|1|||
163973635|NCT04066491|592273955|FG000|Overall Study|Randomized, not treated|0|||
163973636|NCT04066491|592273956|FG001|Overall Study|Randomized, not treated|0|||
163973637|NCT04066491|592273957|FG002|Overall Study|Randomized, not treated|2|||
163973638|NCT04506086|592273958|FG000|Overall Study|Withdrawal by Subject|2|||
163973639|NCT05937165|592273959|FG000|Overall Study|Withdrawal by Subject|0|||
163973640|NCT05937165|592273960|FG001|Overall Study|Withdrawal by Subject|1|||
163973641|NCT01357577|592273961|FG000|Overall Study|Lost to Follow-up|20|||
163973642|NCT01357577|592273962|FG001|Overall Study|Lost to Follow-up|16|||
163973643|NCT01357577|592273961|FG000|Overall Study|Withdrawal by Subject|16|||
163973644|NCT01357577|592273962|FG001|Overall Study|Withdrawal by Subject|8|||
163973645|NCT01357577|592273961|FG000|Overall Study|look at data in database?|1|||
163973646|NCT01357577|592273962|FG001|Overall Study|look at data in database?|2|||
163973647|NCT05493280|592273963|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
163973648|NCT05493280|592273964|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
163973649|NCT00307151|592275305|FG000|Overall Study|Death|4|||
163973650|NCT00307151|592275306|FG001|Overall Study|Death|3|||
163973651|NCT00307151|592275307|FG002|Overall Study|Death|10|||
163973652|NCT00307151|592275308|FG003|Overall Study|Death|3|||
163973653|NCT00307151|592275305|FG000|Overall Study|Severe debilitation, unable to continue|1|||
163973654|NCT00307151|592275306|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163973655|NCT00307151|592275307|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163973656|NCT00307151|592275308|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163973657|NCT00307151|592275305|FG000|Overall Study|Subject unable to get to clinic|1|||
163973658|NCT00307151|592275306|FG001|Overall Study|Subject unable to get to clinic|0|||
163973659|NCT00307151|592275307|FG002|Overall Study|Subject unable to get to clinic|6|||
163973660|NCT00307151|592275308|FG003|Overall Study|Subject unable to get to clinic|2|||
163973661|NCT00307151|592275305|FG000|Overall Study|Withdrew consent|0|||
163973662|NCT00307151|592275306|FG001|Overall Study|Withdrew consent|1|||
163973663|NCT00307151|592275307|FG002|Overall Study|Withdrew consent|1|||
163973664|NCT00307151|592275308|FG003|Overall Study|Withdrew consent|3|||
163973665|NCT00307151|592275305|FG000|Overall Study|Not willing to adhere to study reqs|2|||
163973666|NCT00307151|592275306|FG001|Overall Study|Not willing to adhere to study reqs|0|||
163973667|NCT00307151|592275307|FG002|Overall Study|Not willing to adhere to study reqs|2|||
163973668|NCT00307151|592275308|FG003|Overall Study|Not willing to adhere to study reqs|2|||
163973669|NCT00307151|592275305|FG000|Overall Study|Clinic unable to contact subject|3|||
163973670|NCT00307151|592275306|FG001|Overall Study|Clinic unable to contact subject|3|||
163973671|NCT00307151|592275307|FG002|Overall Study|Clinic unable to contact subject|1|||
163973672|NCT00307151|592275308|FG003|Overall Study|Clinic unable to contact subject|1|||
163973673|NCT00075400|592275309|FG000|Overall Study|Ineligible: wrong primary|1|||
163973674|NCT00075400|592275309|FG000|Overall Study|Never treated|2|||
163973675|NCT00516048|592275311|FG000|Overall Study|Death|0|||
163973676|NCT00516048|592275312|FG001|Overall Study|Death|0|||
163973677|NCT00516048|592275313|FG002|Overall Study|Death|1|||
163973678|NCT00516048|592275311|FG000|Overall Study|Subject Decision|0|||
163973679|NCT00516048|592275312|FG001|Overall Study|Subject Decision|2|||
163973680|NCT00516048|592275313|FG002|Overall Study|Subject Decision|0|||
164204026|NCT00769561|593117900|FG001|Overall Study|Withdrawal by Subject|2|||
164204027|NCT00769561|593117899|FG000|Overall Study|Lost to Follow-up|1|||
163973681|NCT01321710|592275314|FG000|Overall Study|Lost to Follow-up|4|||
163973682|NCT01321710|592275315|FG001|Overall Study|Lost to Follow-up|5|||
163973683|NCT01321710|592275316|FG002|Overall Study|Lost to Follow-up|0|||
163973684|NCT02554019|592275317|FG000|Overall Study|Withdrawal by Subject|1|||
164204028|NCT00769561|593117900|FG001|Overall Study|Lost to Follow-up|3|||
164204029|NCT03824561|593117903|FG000|Overall Study|Protocol Violation|19|||
164204030|NCT03092752|593117907|FG000|Overall Study|Aged <40 years|14209|||
164204031|NCT03092752|593117907|FG000|Overall Study|At least one claim with T2DM|61299|||
164204032|NCT03092752|593117907|FG000|Overall Study|Having no claim of study drugs|29282|||
164204033|NCT03092752|593117907|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
164314821|NCT01818752|593529773|FG000|Overall Study|Randomized but not Dosed|7|||
164314822|NCT01818752|593529774|FG001|Overall Study|Randomized but not Dosed|4|||
164314823|NCT04629066|593529775|FG000|Overall Study|Lost to Follow-up|3|||
163973685|NCT02554019|592275318|FG001|Overall Study|Withdrawal by Subject|0|||
163973686|NCT02554019|592275319|FG002|Overall Study|Withdrawal by Subject|2|||
163973687|NCT02554019|592275317|FG000|Overall Study|Adverse Event|1|||
163973688|NCT02554019|592275318|FG001|Overall Study|Adverse Event|0|||
163973689|NCT02554019|592275319|FG002|Overall Study|Adverse Event|0|||
163973690|NCT00390546|592275320|FG000|Overall Study|Renal impairment|1|||
163973691|NCT00390546|592275321|FG001|Overall Study|Renal impairment|0|||
163973692|NCT00390546|592275320|FG000|Overall Study|Physician Decision|5|||
163973693|NCT00390546|592275321|FG001|Overall Study|Physician Decision|5|||
163973694|NCT02463409|592275322|FG000|Overall Study|Withdrawal by Subject|1|||
163973695|NCT02463409|592275322|FG000|Overall Study|Screen failure|1|||
163973696|NCT01308008|592275323|FG000|4 Weeks|Illness, disinterest, time|9|||
163973697|NCT01308008|592275324|FG001|4 Weeks|Illness, disinterest, time|2|||
163973698|NCT01444742|592275325|FG000|Overall Study|Death|1|||
163973699|NCT02187172|592275326|FG000|Overall Study|Lost to Follow-up|1|||
163973700|NCT02187172|592275327|FG001|Overall Study|Lost to Follow-up|2|||
163973701|NCT02187172|592275326|FG000|Overall Study|Lack of Efficacy|1|||
163973702|NCT02187172|592275327|FG001|Overall Study|Lack of Efficacy|2|||
163973703|NCT02187172|592275326|FG000|Overall Study|Adverse Event|0|||
163973704|NCT02187172|592275327|FG001|Overall Study|Adverse Event|1|||
163973705|NCT02187172|592275326|FG000|Overall Study|Physician Decision|1|||
163973706|NCT02187172|592275327|FG001|Overall Study|Physician Decision|1|||
163973707|NCT03179891|592275338|FG000|First Intervention|Withdrawal by Subject|1|||
163973708|NCT03179891|592275339|FG001|First Intervention|Withdrawal by Subject|1|||
163973709|NCT03179891|592275338|FG000|First Intervention|Unspecified reason|1|||
163973710|NCT03179891|592275339|FG001|First Intervention|Unspecified reason|0|||
163973711|NCT03179891|592275338|FG000|First Intervention|Protocol Violation|0|||
163973712|NCT03179891|592275339|FG001|First Intervention|Protocol Violation|1|||
163973713|NCT01648790|592275344|FG000|Treatment 3|Withdrawal by Subject|0|||
163973714|NCT01648790|592275345|FG001|Treatment 3|Withdrawal by Subject|0|||
163973715|NCT01648790|592275346|FG002|Treatment 3|Withdrawal by Subject|0|||
163973716|NCT01648790|592275347|FG003|Treatment 3|Withdrawal by Subject|1|||
163973717|NCT01648790|592275348|FG004|Treatment 3|Withdrawal by Subject|0|||
163973718|NCT02159729|592275352|FG000|Overall Study|Adverse Event|0|||
163973719|NCT02159729|592275353|FG001|Overall Study|Adverse Event|1|||
163973720|NCT02159729|592275352|FG000|Overall Study|Subject's Request|13|||
163973721|NCT02159729|592275353|FG001|Overall Study|Subject's Request|10|||
163973722|NCT02159729|592275352|FG000|Overall Study|Lost to Follow-up|24|||
163973723|NCT02159729|592275353|FG001|Overall Study|Lost to Follow-up|9|||
163973724|NCT02159729|592275352|FG000|Overall Study|Non compliance|2|||
163973725|NCT02159729|592275353|FG001|Overall Study|Non compliance|0|||
163973726|NCT02159729|592275352|FG000|Overall Study|Other Unspecified|3|||
163973727|NCT02159729|592275353|FG001|Overall Study|Other Unspecified|1|||
163973728|NCT02636582|592275354|FG000|Overall Study|Surgical Pathology|1|||
163973729|NCT02636582|592275355|FG001|Overall Study|Surgical Pathology|0|||
163973730|NCT00573430|592275356|FG000|Overall Study|Incorrect enrollment of randomization|0|||
163973731|NCT00573430|592275357|FG001|Overall Study|Incorrect enrollment of randomization|4|||
163973732|NCT00573430|592275358|FG002|Overall Study|Incorrect enrollment of randomization|3|||
163973733|NCT00573430|592275356|FG000|Overall Study|Adverse Event|0|||
163973734|NCT00573430|592275357|FG001|Overall Study|Adverse Event|0|||
163973735|NCT00573430|592275358|FG002|Overall Study|Adverse Event|2|||
163973736|NCT00573430|592275356|FG000|Overall Study|Withdrawal by Subject|1|||
163973737|NCT00573430|592275357|FG001|Overall Study|Withdrawal by Subject|0|||
163973738|NCT00573430|592275358|FG002|Overall Study|Withdrawal by Subject|1|||
163973739|NCT00573430|592275356|FG000|Overall Study|Protocol Violation|0|||
163973740|NCT00573430|592275357|FG001|Overall Study|Protocol Violation|1|||
163973741|NCT00573430|592275358|FG002|Overall Study|Protocol Violation|1|||
163973742|NCT00573430|592275356|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163973743|NCT00573430|592275357|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163973744|NCT00573430|592275358|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
163973745|NCT01278745|592275359|FG000|Overall Study|Death|2|||
163973746|NCT01278745|592275360|FG001|Overall Study|Death|5|||
163973747|NCT01278745|592275361|FG002|Overall Study|Death|7|||
163973748|NCT01278745|592275362|FG003|Overall Study|Death|0|||
163973749|NCT01278745|592275359|FG000|Overall Study|Physician Decision|1|||
163973750|NCT01278745|592275360|FG001|Overall Study|Physician Decision|0|||
163973751|NCT01278745|592275361|FG002|Overall Study|Physician Decision|0|||
163973752|NCT01278745|592275362|FG003|Overall Study|Physician Decision|9|||
163973753|NCT01278745|592275359|FG000|Overall Study|Withdrawal by Subject|1|||
163973754|NCT01278745|592275360|FG001|Overall Study|Withdrawal by Subject|1|||
163973755|NCT01278745|592275361|FG002|Overall Study|Withdrawal by Subject|5|||
163973756|NCT01278745|592275362|FG003|Overall Study|Withdrawal by Subject|1|||
163973757|NCT01278745|592275359|FG000|Overall Study|Sponsor Decision|1|||
163973758|NCT01278745|592275360|FG001|Overall Study|Sponsor Decision|0|||
163973759|NCT01278745|592275361|FG002|Overall Study|Sponsor Decision|62|||
163973760|NCT01278745|592275362|FG003|Overall Study|Sponsor Decision|6|||
163973761|NCT01278745|592275359|FG000|Overall Study|Ineligible|0|||
163973762|NCT01278745|592275360|FG001|Overall Study|Ineligible|0|||
163973763|NCT01278745|592275361|FG002|Overall Study|Ineligible|42|||
163973764|NCT01278745|592275362|FG003|Overall Study|Ineligible|61|||
163973765|NCT01278745|592275359|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
163973766|NCT01278745|592275360|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
163973767|NCT01278745|592275361|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
163973768|NCT01278745|592275362|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
163973769|NCT01843842|592275365|FG000|Overall Study|Do not meet inclusion criteria|1|||
163973770|NCT01843842|592275366|FG001|Overall Study|Do not meet inclusion criteria|1|||
163973771|NCT01376778|592275367|FG000|Overall Study|Lost to Follow-up|3|||
163973772|NCT01376778|592275368|FG001|Overall Study|Lost to Follow-up|2|||
163973773|NCT00632099|592275369|FG000|Overall Study|Lost to Follow-up|3|||
163973774|NCT00632099|592275370|FG001|Overall Study|Lost to Follow-up|3|||
163973775|NCT03374189|592275372|FG000|Overall Study|Lost to Follow-up|1|||
163973776|NCT03374189|592275373|FG001|Overall Study|Lost to Follow-up|0|||
163973777|NCT01517893|592275374|FG000|Overall Study|Withdrawal by Subject|3|||
163973778|NCT01517893|592275375|FG001|Overall Study|Withdrawal by Subject|0|||
163973779|NCT00715026|592275376|FG000|Overall Study|Withdrawal by Subject|5|||
163973780|NCT00715026|592275376|FG000|Overall Study|Lost to Follow-up|3|||
163973781|NCT00715026|592275376|FG000|Overall Study|Protocol Violation|1|||
163973782|NCT00715026|592275376|FG000|Overall Study|Surgery done on non-study consented hip|1|||
163973783|NCT02184195|592275378|FG000|Overall Study|Patient decision|5|||
163973784|NCT02184195|592275379|FG001|Overall Study|Patient decision|2|||
163973785|NCT02184195|592275378|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163973786|NCT02184195|592275379|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163973787|NCT02184195|592275378|FG000|Overall Study|Death|67|||
163973788|NCT02184195|592275379|FG001|Overall Study|Death|44|||
163973789|NCT02184195|592275378|FG000|Overall Study|Lost to Follow-up|1|||
163973790|NCT02184195|592275379|FG001|Overall Study|Lost to Follow-up|5|||
163973791|NCT02184195|592275378|FG000|Overall Study|Other|0|||
163973792|NCT02184195|592275379|FG001|Overall Study|Other|3|||
163973793|NCT00589420|592275380|FG000|Overall Study|screen failure|1|||
163973794|NCT00841568|592275381|FG000|Overall Study|Adverse Event|1|||
163973795|NCT00841568|592275381|FG000|Overall Study|Death|1|||
163973796|NCT00841568|592275381|FG000|Overall Study|Withdrawal by Subject|2|||
163973797|NCT00841568|592275381|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
163973798|NCT03002155|592275382|FG000|Overall Study|Lost to Follow-up|1|||
163973799|NCT03002155|592275383|FG001|Overall Study|Lost to Follow-up|2|||
163973800|NCT03002155|592275382|FG000|Overall Study|Withdrawal by Subject|1|||
163973801|NCT03002155|592275383|FG001|Overall Study|Withdrawal by Subject|0|||
163973802|NCT03002155|592275382|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
163973803|NCT03002155|592275383|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
163973804|NCT01131520|592275389|FG000|Overall Study|Computer problem|1|||
163973805|NCT01131520|592275390|FG001|Overall Study|Computer problem|0|||
163973806|NCT01131520|592275389|FG000|Overall Study|Counselor not available|0|||
163973807|NCT01131520|592275390|FG001|Overall Study|Counselor not available|3|||
163973808|NCT01131520|592275389|FG000|Overall Study|Subject changed history after enrollment|0|||
163973809|NCT01131520|592275390|FG001|Overall Study|Subject changed history after enrollment|1|||
163973810|NCT03302975|592275393|FG000|Overall Study|Lost to Follow-up|4|||
163973811|NCT03834519|592275394|FG000|Overall Study|Lost to Follow-up|2|||
163973812|NCT03834519|592275395|FG001|Overall Study|Lost to Follow-up|1|||
163973813|NCT03834519|592275394|FG000|Overall Study|Withdrawal by Subject|5|||
163973814|NCT03834519|592275395|FG001|Overall Study|Withdrawal by Subject|8|||
163973815|NCT03834519|592275394|FG000|Overall Study|Death|368|||
163973816|NCT03834519|592275395|FG001|Overall Study|Death|174|||
163973817|NCT03834519|592275394|FG000|Overall Study|Physician Decision|5|||
163973818|NCT03834519|592275395|FG001|Overall Study|Physician Decision|1|||
163973819|NCT03834519|592275394|FG000|Overall Study|Sponsor decision|149|||
163973820|NCT03834519|592275395|FG001|Overall Study|Sponsor decision|80|||
163973821|NCT04490018|592275396|FG000|Overall Study|Protocol Violation|0|||
163973822|NCT04490018|592275397|FG001|Overall Study|Protocol Violation|2|||
163973823|NCT04490018|592275398|FG002|Overall Study|Protocol Violation|1|||
163973824|NCT04490018|592275396|FG000|Overall Study|Lost to Follow-up|2|||
163973825|NCT04490018|592275397|FG001|Overall Study|Lost to Follow-up|2|||
163973826|NCT04490018|592275398|FG002|Overall Study|Lost to Follow-up|0|||
164204034|NCT03092752|593117907|FG000|Overall Study|<6 month history|245900|||
164204035|NCT00921024|593117913|FG000|Overall Study|Lost to Follow-up|2|||
164204036|NCT00921024|593117914|FG001|Overall Study|Lost to Follow-up|0|||
164204037|NCT00921024|593117913|FG000|Overall Study|Received concomittant therapy|2|||
164204038|NCT00921024|593117914|FG001|Overall Study|Received concomittant therapy|0|||
164204039|NCT00921024|593117913|FG000|Overall Study|Withdrawal by Subject|0|||
164204040|NCT00921024|593117914|FG001|Overall Study|Withdrawal by Subject|3|||
164204041|NCT06996301|593117918|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
164204042|NCT06996301|593117919|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
163973827|NCT04490018|592275396|FG000|Overall Study|Withdrawal by Subject|2|||
163973828|NCT04490018|592275397|FG001|Overall Study|Withdrawal by Subject|1|||
163973829|NCT04490018|592275398|FG002|Overall Study|Withdrawal by Subject|0|||
163973830|NCT04490018|592275396|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163973831|NCT04490018|592275397|FG001|Overall Study|Withdrawal by parent/guardian|3|||
163973832|NCT04490018|592275398|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163973833|NCT01392677|592275405|FG000|Overall Study|Adverse Event|3|||
164204043|NCT06996301|593117918|FG000|Overall Study|Patients with discordant diagnostic results|107|||
163973834|NCT01392677|592275406|FG001|Overall Study|Adverse Event|1|||
164302991|NCT03205423|593484683|FG001|Overall Study|Physician Decision|2|||
163973835|NCT01392677|592275405|FG000|Overall Study|Withdrawal by Subject|0|||
163973836|NCT01392677|592275406|FG001|Overall Study|Withdrawal by Subject|2|||
163973837|NCT01392677|592275405|FG000|Overall Study|Incorrect enrollment|2|||
163973838|NCT01392677|592275406|FG001|Overall Study|Incorrect enrollment|3|||
163973839|NCT01392677|592275405|FG000|Overall Study|Other reason|3|||
163973840|NCT01392677|592275406|FG001|Overall Study|Other reason|2|||
163973841|NCT03996876|592275407|FG000|Overall Study|Incomplete Data|2|||
163973842|NCT03996876|592275408|FG001|Overall Study|Incomplete Data|4|||
163973843|NCT00121108|592275409|FG000|Overall Study|Lost to Follow-up|10|||
163973844|NCT00121108|592275410|FG001|Overall Study|Lost to Follow-up|22|||
163973845|NCT00121108|592275409|FG000|Overall Study|Withdrawal by Subject|106|||
163973846|NCT00121108|592275410|FG001|Overall Study|Withdrawal by Subject|195|||
163973847|NCT00121108|592275409|FG000|Overall Study|Death|5|||
163973848|NCT00121108|592275410|FG001|Overall Study|Death|8|||
163973849|NCT01380379|592275411|FG000|Overall Study|Pregnancy|1|||
163973850|NCT06608368|592275414|FG000|Overall Study|Family Emergency|0|||
163973851|NCT06608368|592275415|FG001|Overall Study|Family Emergency|1|||
163973852|NCT06608368|592275416|FG002|Overall Study|Family Emergency|0|||
163869794|NCT03950622|591891509|FG000|Overall Study|Withdrawal by Subject|1|||
163869795|NCT03950622|591891510|FG001|Overall Study|Withdrawal by Subject|0|||
163869796|NCT03950622|591891509|FG000|Overall Study|Protocol Deviation|0|||
163869797|NCT03950622|591891510|FG001|Overall Study|Protocol Deviation|1|||
163869798|NCT03950622|591891509|FG000|Overall Study|Physician Decision|1|||
163869799|NCT03950622|591891510|FG001|Overall Study|Physician Decision|0|||
163869800|NCT03950622|591891509|FG000|Overall Study|Lost to Follow-up|5|||
163869801|NCT03950622|591891510|FG001|Overall Study|Lost to Follow-up|5|||
163869802|NCT03950622|591891509|FG000|Overall Study|Death|1|||
163869803|NCT03950622|591891510|FG001|Overall Study|Death|1|||
163869804|NCT03531840|591891517|FG000|Overall Study|Death on study|3|||
163869805|NCT03531840|591891518|FG001|Overall Study|Death on study|2|||
163869806|NCT03531840|591891519|FG002|Overall Study|Death on study|1|||
163869807|NCT03531840|591891520|FG003|Overall Study|Death on study|2|||
163869808|NCT03531840|591891517|FG000|Overall Study|Death during follow up|2|||
163869809|NCT03531840|591891518|FG001|Overall Study|Death during follow up|3|||
163869810|NCT03531840|591891519|FG002|Overall Study|Death during follow up|4|||
163869811|NCT03531840|591891520|FG003|Overall Study|Death during follow up|1|||
163869812|NCT02267824|591891522|FG000|Overall Study|Pregnancy|1|||
163869813|NCT02267824|591891523|FG001|Overall Study|Pregnancy|1|||
163869814|NCT02267824|591891522|FG000|Overall Study|Lost to Follow-up|4|||
163869815|NCT02267824|591891523|FG001|Overall Study|Lost to Follow-up|0|||
163869816|NCT02267824|591891522|FG000|Overall Study|Protocol Violation|3|||
163869817|NCT02267824|591891523|FG001|Overall Study|Protocol Violation|0|||
163869818|NCT02267824|591891522|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
163869819|NCT02267824|591891523|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
163869820|NCT02928224|591891524|FG000|Overall Study|Lost to Follow-up|1|||
163869821|NCT02928224|591891525|FG001|Overall Study|Lost to Follow-up|1|||
163869822|NCT02928224|591891526|FG002|Overall Study|Lost to Follow-up|3|||
163869823|NCT02928224|591891527|FG003|Overall Study|Lost to Follow-up|0|||
163869824|NCT02928224|591891524|FG000|Overall Study|Death|30|||
163869825|NCT02928224|591891525|FG001|Overall Study|Death|209|||
163869826|NCT02928224|591891526|FG002|Overall Study|Death|193|||
163869827|NCT02928224|591891527|FG003|Overall Study|Death|198|||
163869828|NCT02928224|591891524|FG000|Overall Study|Withdrawal by Subject|0|||
163869829|NCT02928224|591891525|FG001|Overall Study|Withdrawal by Subject|3|||
163869830|NCT02928224|591891526|FG002|Overall Study|Withdrawal by Subject|7|||
163869831|NCT02928224|591891527|FG003|Overall Study|Withdrawal by Subject|20|||
163869832|NCT02928224|591891524|FG000|Overall Study|Study participation terminated by sponsor|3|||
163869833|NCT02928224|591891525|FG001|Overall Study|Study participation terminated by sponsor|8|||
163869834|NCT02928224|591891526|FG002|Overall Study|Study participation terminated by sponsor|12|||
163869835|NCT02928224|591891527|FG003|Overall Study|Study participation terminated by sponsor|3|||
163869836|NCT02928224|591891524|FG000|Overall Study|Other|3|||
163869837|NCT02928224|591891525|FG001|Overall Study|Other|3|||
163869838|NCT02928224|591891526|FG002|Overall Study|Other|5|||
163869839|NCT02928224|591891527|FG003|Overall Study|Other|0|||
163869840|NCT02538107|591891528|FG000|Overall Study|Did not receive any Mircera dose|11|||
163869841|NCT02538107|591891528|FG000|Overall Study|Missing|5|||
163869842|NCT02538107|591891528|FG000|Overall Study|Necessity of dialysis|20|||
163869843|NCT02538107|591891528|FG000|Overall Study|Administration of other ESA|11|||
163869844|NCT02538107|591891528|FG000|Overall Study|No further treatment necessary|18|||
163869845|NCT02538107|591891528|FG000|Overall Study|Withdrawal by Subject|17|||
163869846|NCT02538107|591891528|FG000|Overall Study|Death|4|||
163869847|NCT02538107|591891528|FG000|Overall Study|Administrative reason|5|||
163869848|NCT02538107|591891528|FG000|Overall Study|Adverse Event|4|||
163869849|NCT02538107|591891528|FG000|Overall Study|Surgery|1|||
163869850|NCT02538107|591891528|FG000|Overall Study|Other|7|||
163869851|NCT02538107|591891528|FG000|Overall Study|Not recorded|7|||
163869852|NCT01278394|591891529|FG000|Overall Study|Lost to Follow-up|1|||
163973853|NCT06608368|592275414|FG000|Overall Study|Scheduling Issues|0|||
163973854|NCT06608368|592275415|FG001|Overall Study|Scheduling Issues|1|||
163973855|NCT06608368|592275416|FG002|Overall Study|Scheduling Issues|0|||
163973856|NCT03977974|592275417|FG000|Period 2|Adverse Event|0|||
164204044|NCT06996301|593117919|FG001|Overall Study|Patients with discordant diagnostic results|90|||
164204045|NCT06996301|593117918|FG000|Overall Study|Lost to Follow-up|31|||
164204046|NCT06996301|593117919|FG001|Overall Study|Lost to Follow-up|56|||
164204047|NCT06996301|593117918|FG000|Overall Study|Withdrawal by Subject|12|||
164204048|NCT06996301|593117919|FG001|Overall Study|Withdrawal by Subject|7|||
164204049|NCT04030598|593117920|FG000|Overall Study|Voluntary Withdrawal|0|||
163869853|NCT02471755|591891530|FG000|Overall Study|Withdrawal by Subject|1|||
163869854|NCT02471755|591891531|FG001|Overall Study|Withdrawal by Subject|0|||
163869855|NCT02471755|591891530|FG000|Overall Study|Lost to Follow-up|0|||
163869856|NCT02471755|591891531|FG001|Overall Study|Lost to Follow-up|1|||
163869857|NCT00958633|591891534|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
163869858|NCT00958633|591891535|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
163869859|NCT00958633|591891536|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
163869860|NCT00958633|591891534|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
163869861|NCT00958633|591891535|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
163869862|NCT00958633|591891536|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
163869863|NCT00958633|591891534|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
163869864|NCT00958633|591891535|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
163869865|NCT00958633|591891536|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
163869866|NCT00958633|591891534|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
163869867|NCT00958633|591891535|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
163869868|NCT00958633|591891536|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
163869869|NCT00958633|591891534|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
163869870|NCT00958633|591891535|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
163869871|NCT00958633|591891536|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
163869872|NCT00958633|591891534|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
163869873|NCT00958633|591891535|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
163869874|NCT00958633|591891536|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
163869875|NCT00958633|591891534|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
163869876|NCT00958633|591891535|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
163869877|NCT00958633|591891536|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
163869878|NCT00094575|591891540|FG000|Overall Study|Death|146|||
163869879|NCT00094575|591891541|FG001|Overall Study|Death|146|||
163869880|NCT00794118|591891542|FG000|Overall Study|Lost to Follow-up|16|||
163869881|NCT00794118|591891542|FG000|Overall Study|Withdrawal by Subject|9|||
163869882|NCT00794118|591891542|FG000|Overall Study|Changed hospital center|2|||
163869883|NCT01597258|591891545|FG000|Overall Study|No Drug Administration|1|||
163869884|NCT04789408|591891546|FG000|Overall Study|Death|4|||
163869885|NCT04789408|591891547|FG001|Overall Study|Death|3|||
163869886|NCT04789408|591891548|FG002|Overall Study|Death|6|||
163869887|NCT04789408|591891546|FG000|Overall Study|Did not meet eligibility criteria|1|||
163869888|NCT04789408|591891547|FG001|Overall Study|Did not meet eligibility criteria|0|||
163869889|NCT04789408|591891548|FG002|Overall Study|Did not meet eligibility criteria|0|||
163869890|NCT04789408|591891546|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
163869891|NCT04789408|591891547|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
163869892|NCT04789408|591891548|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
163869893|NCT04411056|591893603|FG000|Overall Study|surgery cancelled|1|||
163869894|NCT04411056|591893604|FG001|Overall Study|surgery cancelled|0|||
163869895|NCT04411056|591893603|FG000|Overall Study|Equipment problem during intubation|0|||
164204050|NCT04030598|593117921|FG001|Overall Study|Voluntary Withdrawal|1|||
164204051|NCT04030598|593117922|FG002|Overall Study|Voluntary Withdrawal|0|||
164204052|NCT05117060|593117925|FG000|Overall Study|Adverse Event|3|||
164204053|NCT05117060|593117926|FG001|Overall Study|Adverse Event|5|||
164204054|NCT05117060|593117927|FG002|Overall Study|Adverse Event|6|||
164204055|NCT05117060|593117928|FG003|Overall Study|Adverse Event|1|||
163869896|NCT04411056|591893604|FG001|Overall Study|Equipment problem during intubation|1|||
163869897|NCT04623008|591893605|FG000|Baseline to T2|Withdrawal by Subject|4|||
163869898|NCT04623008|591893606|FG001|Baseline to T2|Withdrawal by Subject|2|||
163869899|NCT04623008|591893605|FG000|Baseline to T3|Withdrawal by Subject|4|||
163869900|NCT04623008|591893606|FG001|Baseline to T3|Withdrawal by Subject|2|||
163869901|NCT03122886|591893618|FG000|Overall Study|Withdrawal by Subject|1|||
163869902|NCT03122886|591893619|FG001|Overall Study|Withdrawal by Subject|2|||
163869903|NCT05985044|591893624|FG000|Overall Study|Death|6|||
163869904|NCT05985044|591893624|FG000|Overall Study|Lost to Follow-up|4|||
163869905|NCT05985044|591893624|FG000|Overall Study|Incapacitation|3|||
163869906|NCT05985044|591893624|FG000|Overall Study|Withdrawal by Subject|2|||
163869907|NCT02279095|591893628|FG000|Overall Study|Non-Compliance|1|||
163869908|NCT02279095|591893628|FG000|Overall Study|Withdrawal by Subject|8|||
164204056|NCT05117060|593117925|FG000|Overall Study|Lost to Follow-up|0|||
163869909|NCT02279095|591893628|FG000|Overall Study|Adverse Event|2|||
163869910|NCT02279095|591893628|FG000|Overall Study|Other|7|||
163869911|NCT02279095|591893628|FG000|Overall Study|Lost to Follow-up|1|||
163869912|NCT05938413|591893629|FG000|Overall Study|Lost to Follow-up|1|||
163869913|NCT05938413|591893630|FG001|Overall Study|Lost to Follow-up|7|||
164204057|NCT05117060|593117926|FG001|Overall Study|Lost to Follow-up|0|||
163869914|NCT05938413|591893629|FG000|Overall Study|Withdrawal by Subject|1|||
163869915|NCT05938413|591893630|FG001|Overall Study|Withdrawal by Subject|1|||
163869916|NCT03312907|591893631|FG000|Overall Study|Adverse Event|1|||
163869917|NCT03312907|591893632|FG001|Overall Study|Adverse Event|6|||
163869918|NCT03312907|591893633|FG002|Overall Study|Adverse Event|1|||
163869919|NCT03312907|591893631|FG000|Overall Study|Protocol Violation|2|||
163869920|NCT03312907|591893632|FG001|Overall Study|Protocol Violation|3|||
163869921|NCT03312907|591893633|FG002|Overall Study|Protocol Violation|4|||
163869922|NCT03312907|591893631|FG000|Overall Study|Lost to Follow-up|2|||
163869923|NCT03312907|591893632|FG001|Overall Study|Lost to Follow-up|3|||
163869924|NCT03312907|591893633|FG002|Overall Study|Lost to Follow-up|2|||
163869925|NCT03312907|591893631|FG000|Overall Study|Physician Decision|3|||
163869926|NCT03312907|591893632|FG001|Overall Study|Physician Decision|4|||
163869927|NCT03312907|591893633|FG002|Overall Study|Physician Decision|2|||
163869928|NCT03312907|591893631|FG000|Overall Study|Withdrawal by Subject|9|||
163869929|NCT03312907|591893632|FG001|Overall Study|Withdrawal by Subject|14|||
163869930|NCT03312907|591893633|FG002|Overall Study|Withdrawal by Subject|10|||
163869931|NCT04688450|591893634|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
163869932|NCT04688450|591893634|FG000|Overall Study|Withdrawal by Subject|1|||
163869933|NCT03481777|591893639|FG000|Overall Study|Withdrawal by Subject|36|||
163869934|NCT03481777|591893640|FG001|Overall Study|Withdrawal by Subject|31|||
163869935|NCT03481777|591893639|FG000|Overall Study|Non stroke = non target population|277|||
163869936|NCT03481777|591893640|FG001|Overall Study|Non stroke = non target population|254|||
163869937|NCT03189524|591893641|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
163869938|NCT03189524|591893642|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
163869939|NCT03189524|591893643|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
163869940|NCT03189524|591893641|FG000|Overall Study|Death|2|||
163869941|NCT03189524|591893642|FG001|Overall Study|Death|2|||
163869942|NCT03189524|591893643|FG002|Overall Study|Death|1|||
163869943|NCT03189524|591893641|FG000|Overall Study|Lost to Follow-up|1|||
163869944|NCT03189524|591893642|FG001|Overall Study|Lost to Follow-up|0|||
163869945|NCT03189524|591893643|FG002|Overall Study|Lost to Follow-up|8|||
163869946|NCT03189524|591893641|FG000|Overall Study|Withdrawal by Subject|1|||
163869947|NCT03189524|591893642|FG001|Overall Study|Withdrawal by Subject|1|||
163869948|NCT03189524|591893643|FG002|Overall Study|Withdrawal by Subject|3|||
163869949|NCT03189524|591893641|FG000|Overall Study|Progressive Disease|0|||
163869950|NCT03189524|591893642|FG001|Overall Study|Progressive Disease|2|||
163869951|NCT03189524|591893643|FG002|Overall Study|Progressive Disease|0|||
163869952|NCT01780298|591893645|FG000|Overall Study|Physician Decision|1|||
163869953|NCT01780298|591893646|FG001|Overall Study|Physician Decision|5|||
163869954|NCT01780298|591893647|FG002|Overall Study|Physician Decision|1|||
163869955|NCT01780298|591893648|FG003|Overall Study|Physician Decision|1|||
163869956|NCT01780298|591893645|FG000|Overall Study|Subject not matched|1|||
163869957|NCT01780298|591893646|FG001|Overall Study|Subject not matched|0|||
163869958|NCT01780298|591893647|FG002|Overall Study|Subject not matched|1|||
163869959|NCT01780298|591893648|FG003|Overall Study|Subject not matched|0|||
163869960|NCT01780298|591893645|FG000|Overall Study|Adverse Event|0|||
163869961|NCT01780298|591893646|FG001|Overall Study|Adverse Event|0|||
163869962|NCT01780298|591893647|FG002|Overall Study|Adverse Event|2|||
163869963|NCT01780298|591893648|FG003|Overall Study|Adverse Event|0|||
163869964|NCT03613740|591893664|FG000|Overall Study|Lost to Follow-up|1|||
163869965|NCT03613740|591893665|FG001|Overall Study|Lost to Follow-up|1|||
163869966|NCT01693120|591893666|FG000|Enrollment|Lost to Follow-up|1|||
163869967|NCT01693120|591893666|FG000|Enrollment|Withdrawal by Subject|10|||
163869968|NCT01693120|591893666|FG000|Enrollment|Protocol Violation|46|||
163869969|NCT01693120|591893666|FG000|Enrollment|Physician Decision|3|||
163869970|NCT01693120|591893666|FG000|Enrollment|Adverse Event|1|||
163869971|NCT01693120|591893666|FG000|Enrollment|Study closed|8|||
163869972|NCT01693120|591893666|FG000|Enrollment|Other|1|||
163869973|NCT01693120|591893666|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
163869974|NCT01693120|591893666|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
163869975|NCT01693120|591893666|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
163869976|NCT01693120|591893666|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
163869977|NCT01693120|591893666|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
163869978|NCT02300298|591893674|FG000|Disposition for Nintedanib|Progressive disease|10|||
163869979|NCT02300298|591893675|FG001|Disposition for Nintedanib|Progressive disease|0|||
163869980|NCT02300298|591893674|FG000|Disposition for Docetaxel|Progressive disease|0|||
163869981|NCT02300298|591893675|FG001|Disposition for Docetaxel|Progressive disease|6|||
163869982|NCT02300298|591893674|FG000|Disposition for Docetaxel|other adverse event|0|||
163869983|NCT02300298|591893675|FG001|Disposition for Docetaxel|other adverse event|4|||
163869984|NCT00774397|591893676|FG000|Overall Study|Adverse Event|1|||
163869985|NCT00774397|591893677|FG001|Overall Study|Adverse Event|3|||
163869986|NCT00774397|591893678|FG002|Overall Study|Adverse Event|16|||
163869987|NCT00774397|591893679|FG003|Overall Study|Adverse Event|8|||
163973857|NCT03977974|592275418|FG001|Period 2|Adverse Event|0|||
163973858|NCT03977974|592275419|FG002|Period 2|Adverse Event|0|||
163973859|NCT03977974|592275420|FG003|Period 2|Adverse Event|0|||
163973860|NCT03977974|592275421|FG004|Period 2|Adverse Event|1|||
163973861|NCT03977974|592275422|FG005|Period 2|Adverse Event|0|||
163973862|NCT03977974|592275423|FG006|Period 2|Adverse Event|0|||
163973863|NCT03977974|592275424|FG007|Period 2|Adverse Event|0|||
163973864|NCT03977974|592275425|FG008|Period 2|Adverse Event|0|||
163973865|NCT03977974|592275426|FG009|Period 2|Adverse Event|0|||
163973866|NCT03977974|592275427|FG010|Period 2|Adverse Event|0|||
163973867|NCT03977974|592275428|FG011|Period 2|Adverse Event|0|||
163973868|NCT03977974|592275429|FG012|Period 2|Adverse Event|0|||
163973869|NCT03080883|592275430|FG000|Overall Study|Withdrawal by Subject|11|||
163973870|NCT03080883|592275431|FG001|Overall Study|Withdrawal by Subject|15|||
163973871|NCT03080883|592275430|FG000|Overall Study|Adverse Event|22|||
163973872|NCT03080883|592275431|FG001|Overall Study|Adverse Event|22|||
163973873|NCT03080883|592275430|FG000|Overall Study|Alternative Therapy|0|||
163973874|NCT03080883|592275431|FG001|Overall Study|Alternative Therapy|3|||
163973875|NCT03080883|592275430|FG000|Overall Study|Other Complicating Disease|9|||
163973876|NCT03080883|592275431|FG001|Overall Study|Other Complicating Disease|5|||
163973877|NCT03080883|592275430|FG000|Overall Study|Death|21|||
163973878|NCT03080883|592275431|FG001|Overall Study|Death|16|||
163973879|NCT03080883|592275430|FG000|Overall Study|Physician Decision|2|||
163973880|NCT03080883|592275431|FG001|Overall Study|Physician Decision|2|||
163973881|NCT03080883|592275430|FG000|Overall Study|Disease Progression|2|||
163973882|NCT03080883|592275431|FG001|Overall Study|Disease Progression|8|||
163973883|NCT03080883|592275430|FG000|Overall Study|Lost to Follow-up|1|||
163973884|NCT03080883|592275431|FG001|Overall Study|Lost to Follow-up|1|||
163973885|NCT00388973|592276658|FG000|Overall Study|Adverse Event|16|||
163973886|NCT00388973|592276659|FG001|Overall Study|Adverse Event|6|||
163973887|NCT00388973|592276658|FG000|Overall Study|Lack of Efficacy|1|||
163973888|NCT00388973|592276659|FG001|Overall Study|Lack of Efficacy|12|||
163973889|NCT00388973|592276658|FG000|Overall Study|Protocol Violation|3|||
163973890|NCT00388973|592276659|FG001|Overall Study|Protocol Violation|0|||
163973891|NCT00388973|592276658|FG000|Overall Study|Withdrawal by Subject|14|||
163973892|NCT00388973|592276659|FG001|Overall Study|Withdrawal by Subject|17|||
163973893|NCT00388973|592276658|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
163973894|NCT00388973|592276659|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
163973895|NCT00388973|592276658|FG000|Overall Study|Did not complete 61 days of treatment|5|||
163973896|NCT00388973|592276659|FG001|Overall Study|Did not complete 61 days of treatment|4|||
163973897|NCT00388973|592276658|FG000|Overall Study|Left region|0|||
163973898|NCT00388973|592276659|FG001|Overall Study|Left region|1|||
163973899|NCT00388973|592276658|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
163973900|NCT00388973|592276659|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
163973901|NCT00666458|592276674|FG000|Overall Study|Adverse Event|8|||
163973902|NCT00666458|592276675|FG001|Overall Study|Adverse Event|7|||
163973903|NCT00666458|592276674|FG000|Overall Study|Withdrawal by Subject|5|||
163973904|NCT00666458|592276675|FG001|Overall Study|Withdrawal by Subject|4|||
163973905|NCT00666458|592276674|FG000|Overall Study|Lost to Follow-up|0|||
163973906|NCT00666458|592276675|FG001|Overall Study|Lost to Follow-up|3|||
163973907|NCT00666458|592276674|FG000|Overall Study|Administrative reason by sponsor|1|||
163973908|NCT00666458|592276675|FG001|Overall Study|Administrative reason by sponsor|1|||
163973909|NCT00666458|592276674|FG000|Overall Study|Incorrect enrollment|7|||
163973910|NCT00666458|592276675|FG001|Overall Study|Incorrect enrollment|1|||
163973911|NCT00666458|592276674|FG000|Overall Study|Study specific discontinuation criteria|14|||
163973912|NCT00666458|592276675|FG001|Overall Study|Study specific discontinuation criteria|7|||
163973913|NCT00666458|592276674|FG000|Overall Study|Severe non-compliance to the protocol|1|||
163973914|NCT00666458|592276675|FG001|Overall Study|Severe non-compliance to the protocol|1|||
163973915|NCT00666458|592276674|FG000|Overall Study|Safety reasons|1|||
163973916|NCT00666458|592276675|FG001|Overall Study|Safety reasons|0|||
163973917|NCT00666458|592276674|FG000|Overall Study|Medical history of anemia|1|||
163973918|NCT00666458|592276675|FG001|Overall Study|Medical history of anemia|0|||
163973919|NCT01999465|592276676|FG000|Overall Study|Lost to Follow-up|0|||
163973920|NCT01999465|592276677|FG001|Overall Study|Lost to Follow-up|2|||
163973921|NCT01999465|592276676|FG000|Overall Study|Protocol Violation|0|||
163973922|NCT01999465|592276677|FG001|Overall Study|Protocol Violation|1|||
163973923|NCT02325219|592276678|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
163973924|NCT02325219|592276679|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
163973925|NCT02325219|592276680|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
163973926|NCT02325219|592276681|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
163973927|NCT02325219|592276682|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
163973928|NCT02325219|592276678|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
163973929|NCT02325219|592276679|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
163973930|NCT02325219|592276680|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163973931|NCT02325219|592276681|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163973932|NCT02325219|592276682|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163973933|NCT02325219|592276678|FG000|Controlled Period (Week 0 - 16)|Other|0|||
163973934|NCT02325219|592276679|FG001|Controlled Period (Week 0 - 16)|Other|0|||
163973935|NCT02325219|592276680|FG002|Controlled Period (Week 0 - 16)|Other|1|||
163973936|NCT02325219|592276681|FG003|Controlled Period (Week 0 - 16)|Other|0|||
163973937|NCT02325219|592276682|FG004|Controlled Period (Week 0 - 16)|Other|0|||
163973938|NCT02325219|592276678|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163973939|NCT02325219|592276679|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163973940|NCT02325219|592276680|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163973941|NCT02325219|592276681|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
163973942|NCT02325219|592276682|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
163973943|NCT02325219|592276678|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163973944|NCT02325219|592276679|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
163973945|NCT02325219|592276680|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163973946|NCT02325219|592276681|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163973947|NCT02325219|592276682|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
163973948|NCT02325219|592276678|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163973949|NCT02325219|592276679|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
163973950|NCT02325219|592276680|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163973951|NCT02325219|592276681|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163973952|NCT02325219|592276682|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163973953|NCT00880399|592276685|FG000|Overall Study|Adverse Event|4|||
163973954|NCT00880399|592276686|FG001|Overall Study|Adverse Event|6|||
163973955|NCT00880399|592276687|FG002|Overall Study|Adverse Event|5|||
163973956|NCT00880399|592276685|FG000|Overall Study|Lack of Efficacy|1|||
163973957|NCT00880399|592276686|FG001|Overall Study|Lack of Efficacy|4|||
163973958|NCT00880399|592276687|FG002|Overall Study|Lack of Efficacy|2|||
163973959|NCT00880399|592276685|FG000|Overall Study|Protocol Violation|4|||
163973960|NCT00880399|592276686|FG001|Overall Study|Protocol Violation|4|||
163973961|NCT00880399|592276687|FG002|Overall Study|Protocol Violation|6|||
163973962|NCT00880399|592276685|FG000|Overall Study|Study closed/terminated|3|||
163973963|NCT00880399|592276686|FG001|Overall Study|Study closed/terminated|7|||
163973964|NCT00880399|592276687|FG002|Overall Study|Study closed/terminated|4|||
163973965|NCT00880399|592276685|FG000|Overall Study|Lost to Follow-up|8|||
163973966|NCT00880399|592276686|FG001|Overall Study|Lost to Follow-up|5|||
163973967|NCT00880399|592276687|FG002|Overall Study|Lost to Follow-up|3|||
163973968|NCT00880399|592276685|FG000|Overall Study|Physician Decision|5|||
163973969|NCT00880399|592276686|FG001|Overall Study|Physician Decision|0|||
163973970|NCT00880399|592276687|FG002|Overall Study|Physician Decision|3|||
163973971|NCT00880399|592276685|FG000|Overall Study|Withdrawal by Subject|6|||
163973972|NCT00880399|592276686|FG001|Overall Study|Withdrawal by Subject|3|||
163973973|NCT00880399|592276687|FG002|Overall Study|Withdrawal by Subject|3|||
163973974|NCT02181816|592276688|FG000|Overall Study|Case Report Forms Uncollected|38|||
163973975|NCT02181816|592276688|FG000|Overall Study|Protocol Deviation|21|||
163973976|NCT00909181|592276689|FG000|Overall Study|Lost to Follow-up|39|||
163973977|NCT00909181|592276690|FG001|Overall Study|Lost to Follow-up|18|||
163973978|NCT00909181|592276691|FG002|Overall Study|Lost to Follow-up|33|||
163973979|NCT02830880|592276692|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
163973980|NCT02830880|592276692|FG000|Overall Study|Death|1|||
163973981|NCT02830880|592276692|FG000|Overall Study|Physician Decision|1|||
163973982|NCT02349048|592276693|FG000|Overall Study|Withdrawal by Subject|4|||
163973983|NCT02349048|592276694|FG001|Overall Study|Withdrawal by Subject|0|||
163973984|NCT02349048|592276693|FG000|Overall Study|Lost to Follow-up|1|||
163973985|NCT02349048|592276694|FG001|Overall Study|Lost to Follow-up|0|||
163973986|NCT00530894|592276700|FG000|Overall Study|Death|84|||
163973987|NCT00530894|592276701|FG001|Overall Study|Death|89|||
163973988|NCT00530894|592276702|FG002|Overall Study|Death|55|||
163973989|NCT00530894|592276703|FG003|Overall Study|Death|89|||
163973990|NCT00530894|592276700|FG000|Overall Study|Lost to Follow-up|1|||
163973991|NCT00530894|592276701|FG001|Overall Study|Lost to Follow-up|3|||
163973992|NCT00530894|592276702|FG002|Overall Study|Lost to Follow-up|0|||
163973993|NCT00530894|592276703|FG003|Overall Study|Lost to Follow-up|0|||
163973994|NCT00530894|592276700|FG000|Overall Study|Withdrawal by Subject|1|||
163973995|NCT00530894|592276701|FG001|Overall Study|Withdrawal by Subject|23|||
163973996|NCT00530894|592276702|FG002|Overall Study|Withdrawal by Subject|0|||
163973997|NCT00530894|592276703|FG003|Overall Study|Withdrawal by Subject|5|||
163973998|NCT00530894|592276700|FG000|Overall Study|Alive and censored prior to 1 year|2|||
163973999|NCT00530894|592276701|FG001|Overall Study|Alive and censored prior to 1 year|0|||
163974000|NCT00530894|592276702|FG002|Overall Study|Alive and censored prior to 1 year|0|||
163974001|NCT00530894|592276703|FG003|Overall Study|Alive and censored prior to 1 year|0|||
163974002|NCT02969187|592276704|FG000|Overall Study|Physician Decision|12|||
163974003|NCT02969187|592276705|FG001|Overall Study|Physician Decision|13|||
163974004|NCT03923426|592276706|FG000|Overall Study|Other|19|||
163974005|NCT03923426|592276706|FG000|Overall Study|Lost to Follow-up|16|||
163974006|NCT03923426|592276706|FG000|Overall Study|Death|107|||
163974007|NCT03923426|592276706|FG000|Overall Study|Incomplete response to question|13|||
163974008|NCT02700412|592276711|FG000|Overall Study|Adverse Event|6|||
163974009|NCT02700412|592276711|FG000|Overall Study|Death|1|||
163869988|NCT00774397|591893680|FG004|Overall Study|Adverse Event|8|||
163869989|NCT00774397|591893681|FG005|Overall Study|Adverse Event|3|||
163869990|NCT00774397|591893682|FG006|Overall Study|Adverse Event|16|||
163869991|NCT00774397|591893676|FG000|Overall Study|Lack of Efficacy|11|||
163869992|NCT00774397|591893677|FG001|Overall Study|Lack of Efficacy|4|||
163869993|NCT00774397|591893678|FG002|Overall Study|Lack of Efficacy|5|||
163869994|NCT00774397|591893679|FG003|Overall Study|Lack of Efficacy|3|||
163869995|NCT00774397|591893680|FG004|Overall Study|Lack of Efficacy|27|||
163869996|NCT00774397|591893681|FG005|Overall Study|Lack of Efficacy|15|||
163869997|NCT00774397|591893682|FG006|Overall Study|Lack of Efficacy|9|||
163869998|NCT00774397|591893676|FG000|Overall Study|Protocol Violation|0|||
163869999|NCT00774397|591893677|FG001|Overall Study|Protocol Violation|1|||
163870000|NCT00774397|591893678|FG002|Overall Study|Protocol Violation|3|||
163870001|NCT00774397|591893679|FG003|Overall Study|Protocol Violation|1|||
163870002|NCT00774397|591893680|FG004|Overall Study|Protocol Violation|2|||
163870003|NCT00774397|591893681|FG005|Overall Study|Protocol Violation|1|||
163870004|NCT00774397|591893682|FG006|Overall Study|Protocol Violation|0|||
163870005|NCT00774397|591893676|FG000|Overall Study|Lost to Follow-up|0|||
163870006|NCT00774397|591893677|FG001|Overall Study|Lost to Follow-up|1|||
163870007|NCT00774397|591893678|FG002|Overall Study|Lost to Follow-up|1|||
163870008|NCT00774397|591893679|FG003|Overall Study|Lost to Follow-up|1|||
163870009|NCT00774397|591893680|FG004|Overall Study|Lost to Follow-up|0|||
163870010|NCT00774397|591893681|FG005|Overall Study|Lost to Follow-up|1|||
163870011|NCT00774397|591893682|FG006|Overall Study|Lost to Follow-up|0|||
163870012|NCT00774397|591893676|FG000|Overall Study|Refused to continue trial medication|1|||
163870013|NCT00774397|591893677|FG001|Overall Study|Refused to continue trial medication|3|||
163870014|NCT00774397|591893678|FG002|Overall Study|Refused to continue trial medication|2|||
163870015|NCT00774397|591893679|FG003|Overall Study|Refused to continue trial medication|2|||
163870016|NCT00774397|591893680|FG004|Overall Study|Refused to continue trial medication|6|||
163870017|NCT00774397|591893681|FG005|Overall Study|Refused to continue trial medication|2|||
163870018|NCT00774397|591893682|FG006|Overall Study|Refused to continue trial medication|3|||
163870019|NCT00774397|591893676|FG000|Overall Study|Not treated|0|||
163870020|NCT00774397|591893677|FG001|Overall Study|Not treated|0|||
163870021|NCT00774397|591893678|FG002|Overall Study|Not treated|0|||
163870022|NCT00774397|591893679|FG003|Overall Study|Not treated|0|||
163870023|NCT00774397|591893680|FG004|Overall Study|Not treated|1|||
163870024|NCT00774397|591893681|FG005|Overall Study|Not treated|0|||
163870025|NCT00774397|591893682|FG006|Overall Study|Not treated|1|||
163870026|NCT00774397|591893676|FG000|Overall Study|Other than those stated above|1|||
163870027|NCT00774397|591893677|FG001|Overall Study|Other than those stated above|1|||
163870028|NCT00774397|591893678|FG002|Overall Study|Other than those stated above|3|||
163870029|NCT00774397|591893679|FG003|Overall Study|Other than those stated above|2|||
163870030|NCT00774397|591893680|FG004|Overall Study|Other than those stated above|2|||
163870031|NCT00774397|591893681|FG005|Overall Study|Other than those stated above|0|||
163870032|NCT00774397|591893682|FG006|Overall Study|Other than those stated above|1|||
163870033|NCT01636687|591893688|FG000|Induction Period|Withdrawal by Subject|1|||
163870034|NCT01636687|591893689|FG001|Induction Period|Withdrawal by Subject|0|||
163870035|NCT01636687|591893690|FG002|Induction Period|Withdrawal by Subject|0|||
163870036|NCT01636687|591893691|FG003|Induction Period|Withdrawal by Subject|0|||
163870037|NCT01636687|591893692|FG004|Induction Period|Withdrawal by Subject|0|||
163870038|NCT01636687|591893688|FG000|Induction Period|Adverse Event|1|||
163870039|NCT01636687|591893689|FG001|Induction Period|Adverse Event|0|||
163870040|NCT01636687|591893690|FG002|Induction Period|Adverse Event|0|||
163870041|NCT01636687|591893691|FG003|Induction Period|Adverse Event|0|||
163870042|NCT01636687|591893692|FG004|Induction Period|Adverse Event|1|||
163870043|NCT01636687|591893688|FG000|Induction Period|Lack of Efficacy|0|||
163870044|NCT01636687|591893689|FG001|Induction Period|Lack of Efficacy|0|||
163870045|NCT01636687|591893690|FG002|Induction Period|Lack of Efficacy|0|||
163870046|NCT01636687|591893691|FG003|Induction Period|Lack of Efficacy|0|||
163870047|NCT01636687|591893692|FG004|Induction Period|Lack of Efficacy|1|||
163870048|NCT01636687|591893688|FG000|Induction Period|Physician Decision|1|||
163870049|NCT01636687|591893689|FG001|Induction Period|Physician Decision|0|||
163870050|NCT01636687|591893690|FG002|Induction Period|Physician Decision|0|||
163870051|NCT01636687|591893691|FG003|Induction Period|Physician Decision|0|||
163870052|NCT01636687|591893692|FG004|Induction Period|Physician Decision|0|||
163870053|NCT01636687|591893688|FG000|Maintenance Period|Withdrawal by Subject|2|||
163870054|NCT01636687|591893689|FG001|Maintenance Period|Withdrawal by Subject|0|||
163870055|NCT01636687|591893690|FG002|Maintenance Period|Withdrawal by Subject|2|||
163870056|NCT01636687|591893691|FG003|Maintenance Period|Withdrawal by Subject|0|||
163870057|NCT01636687|591893692|FG004|Maintenance Period|Withdrawal by Subject|0|||
163870058|NCT01636687|591893688|FG000|Maintenance Period|Adverse Event|1|||
163870059|NCT01636687|591893689|FG001|Maintenance Period|Adverse Event|0|||
163870060|NCT01636687|591893690|FG002|Maintenance Period|Adverse Event|0|||
163870061|NCT01636687|591893691|FG003|Maintenance Period|Adverse Event|0|||
163870062|NCT01636687|591893692|FG004|Maintenance Period|Adverse Event|0|||
163870063|NCT01636687|591893688|FG000|Maintenance Period|Lack of Efficacy|4|||
163870064|NCT01636687|591893689|FG001|Maintenance Period|Lack of Efficacy|1|||
163870065|NCT01636687|591893690|FG002|Maintenance Period|Lack of Efficacy|0|||
163974010|NCT02700412|592276711|FG000|Overall Study|Lack of Efficacy|19|||
163974011|NCT02700412|592276711|FG000|Overall Study|Protocol Violation|5|||
163974012|NCT02700412|592276711|FG000|Overall Study|Withdrawal by Subject|2|||
163974013|NCT04416555|592276713|FG000|Overall Study|Withdrawal by Subject|0|||
163974014|NCT04416555|592276714|FG001|Overall Study|Withdrawal by Subject|3|||
163974015|NCT03462576|592276715|FG000|Overall Study|Protocol Violation|5|||
163974016|NCT03462576|592276716|FG001|Overall Study|Protocol Violation|11|||
163974017|NCT03462576|592276717|FG002|Overall Study|Protocol Violation|7|||
163974018|NCT03462576|592276715|FG000|Overall Study|Device Malfunction|0|||
163974019|NCT03462576|592276716|FG001|Overall Study|Device Malfunction|0|||
163974020|NCT03462576|592276717|FG002|Overall Study|Device Malfunction|1|||
163974021|NCT03201458|592276718|FG000|Overall Study|No longer eligible|2|||
163974022|NCT03201458|592276719|FG001|Overall Study|No longer eligible|5|||
163974023|NCT03201458|592276718|FG000|Overall Study|Health event before starting|1|||
163974024|NCT03201458|592276719|FG001|Overall Study|Health event before starting|0|||
163870066|NCT01636687|591893691|FG003|Maintenance Period|Lack of Efficacy|0|||
163974025|NCT03201458|592276718|FG000|Overall Study|Physician Decision|1|||
163974026|NCT03201458|592276719|FG001|Overall Study|Physician Decision|0|||
163974027|NCT00750737|592276722|FG000|Overall Study|Withdrawal by Subject|3|||
163870067|NCT01636687|591893692|FG004|Maintenance Period|Lack of Efficacy|0|||
163870068|NCT01636687|591893688|FG000|Maintenance Period|Lost to Follow-up|1|||
163870069|NCT01636687|591893689|FG001|Maintenance Period|Lost to Follow-up|1|||
163870070|NCT01636687|591893690|FG002|Maintenance Period|Lost to Follow-up|0|||
163870071|NCT01636687|591893691|FG003|Maintenance Period|Lost to Follow-up|0|||
163870072|NCT01636687|591893692|FG004|Maintenance Period|Lost to Follow-up|1|||
163870073|NCT01636687|591893688|FG000|Maintenance Period|Physician Decision|0|||
163870074|NCT01636687|591893689|FG001|Maintenance Period|Physician Decision|0|||
163870075|NCT01636687|591893690|FG002|Maintenance Period|Physician Decision|0|||
163870076|NCT01636687|591893691|FG003|Maintenance Period|Physician Decision|0|||
163870077|NCT01636687|591893692|FG004|Maintenance Period|Physician Decision|1|||
163870078|NCT01636687|591893688|FG000|Extension Period|technical problems|0|||
163870079|NCT01636687|591893689|FG001|Extension Period|technical problems|1|||
163870080|NCT01636687|591893690|FG002|Extension Period|technical problems|2|||
163870081|NCT01636687|591893691|FG003|Extension Period|technical problems|1|||
163870082|NCT01636687|591893692|FG004|Extension Period|technical problems|0|||
163870083|NCT01636687|591893688|FG000|Extension Period|Adverse Event|4|||
163870084|NCT01636687|591893689|FG001|Extension Period|Adverse Event|3|||
163870085|NCT01636687|591893690|FG002|Extension Period|Adverse Event|2|||
163870086|NCT01636687|591893691|FG003|Extension Period|Adverse Event|1|||
163870087|NCT01636687|591893692|FG004|Extension Period|Adverse Event|0|||
163870088|NCT01636687|591893688|FG000|Extension Period|Lack of Efficacy|7|||
163870089|NCT01636687|591893689|FG001|Extension Period|Lack of Efficacy|0|||
163870090|NCT01636687|591893690|FG002|Extension Period|Lack of Efficacy|2|||
163870091|NCT01636687|591893691|FG003|Extension Period|Lack of Efficacy|1|||
163870092|NCT01636687|591893692|FG004|Extension Period|Lack of Efficacy|0|||
163870093|NCT01636687|591893688|FG000|Extension Period|Lost to Follow-up|1|||
163870094|NCT01636687|591893689|FG001|Extension Period|Lost to Follow-up|0|||
163870095|NCT01636687|591893690|FG002|Extension Period|Lost to Follow-up|1|||
163870096|NCT01636687|591893691|FG003|Extension Period|Lost to Follow-up|0|||
163870097|NCT01636687|591893692|FG004|Extension Period|Lost to Follow-up|0|||
163870098|NCT01636687|591893688|FG000|Extension Period|Physician Decision|1|||
163870099|NCT01636687|591893689|FG001|Extension Period|Physician Decision|0|||
163870100|NCT01636687|591893690|FG002|Extension Period|Physician Decision|0|||
163870101|NCT01636687|591893691|FG003|Extension Period|Physician Decision|1|||
163870102|NCT01636687|591893692|FG004|Extension Period|Physician Decision|0|||
163870103|NCT01636687|591893688|FG000|Extension Period|study terminated by sponsor|33|||
163870104|NCT01636687|591893689|FG001|Extension Period|study terminated by sponsor|50|||
163870105|NCT01636687|591893690|FG002|Extension Period|study terminated by sponsor|17|||
163870106|NCT01636687|591893691|FG003|Extension Period|study terminated by sponsor|23|||
163870107|NCT01636687|591893692|FG004|Extension Period|study terminated by sponsor|0|||
163870108|NCT01636687|591893688|FG000|Extension Period|Withdrawal by Subject|1|||
163870109|NCT01636687|591893689|FG001|Extension Period|Withdrawal by Subject|0|||
163870110|NCT01636687|591893690|FG002|Extension Period|Withdrawal by Subject|1|||
163974028|NCT00750737|592276723|FG001|Overall Study|Withdrawal by Subject|3|||
163974029|NCT00711425|592276727|FG000|Overall Study|Protocol Violation|1|||
163974030|NCT00711425|592276727|FG000|Overall Study|Death|2|||
163974031|NCT00711425|592276727|FG000|Overall Study|Lost to Follow-up|1|||
163974032|NCT00916149|592276728|FG000|Overall Study|Lost to Follow-up|3|||
163974033|NCT00916149|592276729|FG001|Overall Study|Lost to Follow-up|2|||
163974034|NCT00916149|592276730|FG002|Overall Study|Lost to Follow-up|0|||
164135915|NCT02799095|592861971|FG016|Part C|Clinical Progression|0|||
164135916|NCT02799095|592861955|FG000|Part C|Withdrawal by Subject|0|||
164135917|NCT02799095|592861956|FG001|Part C|Withdrawal by Subject|0|||
164135918|NCT02799095|592861957|FG002|Part C|Withdrawal by Subject|0|||
164135919|NCT02799095|592861958|FG003|Part C|Withdrawal by Subject|0|||
164135920|NCT02799095|592861959|FG004|Part C|Withdrawal by Subject|0|||
164135921|NCT02799095|592861960|FG005|Part C|Withdrawal by Subject|0|||
163974035|NCT00916149|592276728|FG000|Overall Study|Unable to place scalp EEG leads|1|||
163974036|NCT00916149|592276729|FG001|Overall Study|Unable to place scalp EEG leads|0|||
163974037|NCT00916149|592276730|FG002|Overall Study|Unable to place scalp EEG leads|0|||
163974038|NCT00545298|592276733|FG000|Overall Study|Issues with Standard of Care|2|||
163974039|NCT00545298|592276734|FG001|Overall Study|Issues with Standard of Care|0|||
163974040|NCT00545298|592276735|FG002|Overall Study|Issues with Standard of Care|1|||
163974041|NCT00978029|592276736|FG000|Overall Study|Adverse Event|1|||
163974042|NCT00978029|592276737|FG001|Overall Study|Adverse Event|2|||
163974043|NCT00978029|592276738|FG002|Overall Study|Adverse Event|5|||
163974044|NCT00978029|592276736|FG000|Overall Study|Withdrawal by Subject|0|||
163974045|NCT00978029|592276737|FG001|Overall Study|Withdrawal by Subject|0|||
163974046|NCT00978029|592276738|FG002|Overall Study|Withdrawal by Subject|1|||
163870111|NCT01636687|591893691|FG003|Extension Period|Withdrawal by Subject|1|||
163870112|NCT01636687|591893692|FG004|Extension Period|Withdrawal by Subject|0|||
163870113|NCT01636687|591893688|FG000|Follow-up Period|Withdrawal by Subject|1|||
163870114|NCT01636687|591893689|FG001|Follow-up Period|Withdrawal by Subject|0|||
163870115|NCT01636687|591893690|FG002|Follow-up Period|Withdrawal by Subject|0|||
163870116|NCT01636687|591893691|FG003|Follow-up Period|Withdrawal by Subject|0|||
163870117|NCT01636687|591893692|FG004|Follow-up Period|Withdrawal by Subject|1|||
163870118|NCT00636207|591893695|FG000|Overall Study|Adverse Event|1|||
163870119|NCT00636207|591893696|FG001|Overall Study|Adverse Event|0|||
163870120|NCT00636207|591893697|FG002|Overall Study|Adverse Event|0|||
163870121|NCT00636207|591893698|FG003|Overall Study|Adverse Event|0|||
163870122|NCT00636207|591893699|FG004|Overall Study|Adverse Event|0|||
163870123|NCT00636207|591893700|FG005|Overall Study|Adverse Event|0|||
163870124|NCT00636207|591893701|FG006|Overall Study|Adverse Event|0|||
163870125|NCT00636207|591893695|FG000|Overall Study|Withdrawal by Subject|0|||
163870126|NCT00636207|591893696|FG001|Overall Study|Withdrawal by Subject|1|||
163870127|NCT00636207|591893697|FG002|Overall Study|Withdrawal by Subject|0|||
163870128|NCT00636207|591893698|FG003|Overall Study|Withdrawal by Subject|0|||
163870129|NCT00636207|591893699|FG004|Overall Study|Withdrawal by Subject|1|||
163870130|NCT00636207|591893700|FG005|Overall Study|Withdrawal by Subject|0|||
163870131|NCT00636207|591893701|FG006|Overall Study|Withdrawal by Subject|0|||
163870132|NCT00666276|591893704|FG000|Overall Study|Protocol Violation|34|||
163870133|NCT01039688|591893705|FG000|Overall Study|Adverse Event|38|||
163870134|NCT01039688|591893706|FG001|Overall Study|Adverse Event|39|||
163870135|NCT01039688|591893707|FG002|Overall Study|Adverse Event|24|||
163870136|NCT01039688|591893705|FG000|Overall Study|Lack of Efficacy|20|||
163870137|NCT01039688|591893706|FG001|Overall Study|Lack of Efficacy|11|||
163870138|NCT01039688|591893707|FG002|Overall Study|Lack of Efficacy|26|||
163870139|NCT01039688|591893705|FG000|Overall Study|Lost to Follow-up|11|||
163870140|NCT01039688|591893706|FG001|Overall Study|Lost to Follow-up|9|||
163870141|NCT01039688|591893707|FG002|Overall Study|Lost to Follow-up|5|||
163870142|NCT01039688|591893705|FG000|Overall Study|Other|13|||
163870143|NCT01039688|591893706|FG001|Overall Study|Other|25|||
163870144|NCT01039688|591893707|FG002|Overall Study|Other|12|||
163870145|NCT01039688|591893705|FG000|Overall Study|Withdrawal by Subject|23|||
163870146|NCT01039688|591893706|FG001|Overall Study|Withdrawal by Subject|27|||
163870147|NCT01039688|591893707|FG002|Overall Study|Withdrawal by Subject|13|||
163870148|NCT01039688|591893705|FG000|Overall Study|Death|2|||
163870149|NCT01039688|591893706|FG001|Overall Study|Death|0|||
163870150|NCT01039688|591893707|FG002|Overall Study|Death|0|||
163870151|NCT02594735|591893708|FG000|Overall Study|Adverse Event|1|||
163870152|NCT03844269|591893710|FG000|Overall Study|Withdrawal pre-intervention|1|||
163870153|NCT03844269|591893710|FG000|Overall Study|Did not complete the intervention|2|||
163870154|NCT00101010|591893716|FG000|Overall Study|Physician Decision|1|||
163870155|NCT04054635|591893725|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
163870156|NCT04054635|591893726|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
163870157|NCT04054635|591893727|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
163870158|NCT04054635|591893725|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
163870159|NCT04054635|591893726|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
163870160|NCT04054635|591893727|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
163870161|NCT00364013|591893728|FG000|Overall Study|Ineligibility determined|4|||
163870162|NCT00364013|591893729|FG001|Overall Study|Ineligibility determined|2|||
163870163|NCT00364013|591893728|FG000|Overall Study|Adverse Event|4|||
163870164|NCT00364013|591893729|FG001|Overall Study|Adverse Event|3|||
163870165|NCT00364013|591893728|FG000|Overall Study|Withdrawal by Subject|13|||
163870166|NCT00364013|591893729|FG001|Overall Study|Withdrawal by Subject|18|||
163870167|NCT00364013|591893728|FG000|Overall Study|Physician Decision|3|||
163870168|NCT00364013|591893729|FG001|Overall Study|Physician Decision|3|||
163870169|NCT00364013|591893728|FG000|Overall Study|Lost to Follow-up|10|||
163870170|NCT00364013|591893729|FG001|Overall Study|Lost to Follow-up|3|||
163974047|NCT00978029|592276736|FG000|Overall Study|Protocol Violation|0|||
163974048|NCT00978029|592276737|FG001|Overall Study|Protocol Violation|1|||
163974049|NCT00978029|592276738|FG002|Overall Study|Protocol Violation|0|||
163974050|NCT01087775|592276739|FG000|Overall Study|failed inclusion criteria|2|||
163974051|NCT01147744|592276741|FG000|Overall Study|Protocol Violation|1|||
163974052|NCT01147744|592276742|FG001|Overall Study|Protocol Violation|0|||
163974053|NCT01147744|592276743|FG002|Overall Study|Protocol Violation|1|||
163974054|NCT01147744|592276744|FG003|Overall Study|Protocol Violation|0|||
163974055|NCT01147744|592276745|FG004|Overall Study|Protocol Violation|1|||
163974056|NCT01147744|592276746|FG005|Overall Study|Protocol Violation|3|||
163974057|NCT01147744|592276747|FG006|Overall Study|Protocol Violation|1|||
163974058|NCT01147744|592276741|FG000|Overall Study|Physician Decision|0|||
163974059|NCT01147744|592276742|FG001|Overall Study|Physician Decision|1|||
163974060|NCT01147744|592276743|FG002|Overall Study|Physician Decision|1|||
163974061|NCT01147744|592276744|FG003|Overall Study|Physician Decision|0|||
163974062|NCT01147744|592276745|FG004|Overall Study|Physician Decision|0|||
163974063|NCT01147744|592276746|FG005|Overall Study|Physician Decision|0|||
163974064|NCT01147744|592276747|FG006|Overall Study|Physician Decision|1|||
163974065|NCT01147744|592276741|FG000|Overall Study|Lack of Efficacy|11|||
163974066|NCT01147744|592276742|FG001|Overall Study|Lack of Efficacy|11|||
163974067|NCT01147744|592276743|FG002|Overall Study|Lack of Efficacy|9|||
163974068|NCT01147744|592276744|FG003|Overall Study|Lack of Efficacy|11|||
163974069|NCT01147744|592276745|FG004|Overall Study|Lack of Efficacy|13|||
163974070|NCT01147744|592276746|FG005|Overall Study|Lack of Efficacy|8|||
163974071|NCT01147744|592276747|FG006|Overall Study|Lack of Efficacy|7|||
163974072|NCT01147744|592276741|FG000|Overall Study|Adverse Event|1|||
163974073|NCT01147744|592276742|FG001|Overall Study|Adverse Event|2|||
163974074|NCT01147744|592276743|FG002|Overall Study|Adverse Event|3|||
163974075|NCT01147744|592276744|FG003|Overall Study|Adverse Event|0|||
163974076|NCT01147744|592276745|FG004|Overall Study|Adverse Event|2|||
163974077|NCT01147744|592276746|FG005|Overall Study|Adverse Event|1|||
163974078|NCT01147744|592276747|FG006|Overall Study|Adverse Event|2|||
163974079|NCT01147744|592276741|FG000|Overall Study|Withdrawal by Subject|8|||
163974080|NCT01147744|592276742|FG001|Overall Study|Withdrawal by Subject|4|||
163974081|NCT01147744|592276743|FG002|Overall Study|Withdrawal by Subject|2|||
163974082|NCT01147744|592276744|FG003|Overall Study|Withdrawal by Subject|2|||
163974083|NCT01147744|592276745|FG004|Overall Study|Withdrawal by Subject|2|||
163974084|NCT01147744|592276746|FG005|Overall Study|Withdrawal by Subject|5|||
163974085|NCT01147744|592276747|FG006|Overall Study|Withdrawal by Subject|2|||
163974086|NCT01147744|592276741|FG000|Overall Study|Lost to Follow-up|0|||
163974087|NCT01147744|592276742|FG001|Overall Study|Lost to Follow-up|1|||
163974088|NCT01147744|592276743|FG002|Overall Study|Lost to Follow-up|0|||
163974089|NCT01147744|592276744|FG003|Overall Study|Lost to Follow-up|0|||
163974090|NCT01147744|592276745|FG004|Overall Study|Lost to Follow-up|0|||
163974091|NCT01147744|592276746|FG005|Overall Study|Lost to Follow-up|0|||
163974092|NCT01147744|592276747|FG006|Overall Study|Lost to Follow-up|0|||
163974093|NCT01147744|592276741|FG000|Overall Study|Sponsor decision to amend protocol|7|||
163974094|NCT01147744|592276742|FG001|Overall Study|Sponsor decision to amend protocol|4|||
163974095|NCT01147744|592276743|FG002|Overall Study|Sponsor decision to amend protocol|2|||
163974096|NCT01147744|592276744|FG003|Overall Study|Sponsor decision to amend protocol|5|||
163974097|NCT01147744|592276745|FG004|Overall Study|Sponsor decision to amend protocol|7|||
163974098|NCT01147744|592276746|FG005|Overall Study|Sponsor decision to amend protocol|2|||
163974099|NCT01147744|592276747|FG006|Overall Study|Sponsor decision to amend protocol|6|||
163974100|NCT01147744|592276741|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163974101|NCT01147744|592276742|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163974102|NCT01147744|592276743|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163974103|NCT01147744|592276744|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163974104|NCT01147744|592276745|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163974105|NCT01147744|592276746|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163974106|NCT01147744|592276747|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163974107|NCT01342484|592276749|FG000|Overall Study|Other Reasons|1|||
163974108|NCT01342484|592276750|FG001|Overall Study|Other Reasons|0|||
163974109|NCT01342484|592276751|FG002|Overall Study|Other Reasons|0|||
163974110|NCT01342484|592276749|FG000|Overall Study|Protocol Violation|0|||
163974111|NCT01342484|592276750|FG001|Overall Study|Protocol Violation|0|||
163974112|NCT01342484|592276751|FG002|Overall Study|Protocol Violation|1|||
163974113|NCT01342484|592276749|FG000|Overall Study|Withdrawal by Subject|1|||
164204058|NCT05117060|593117927|FG002|Overall Study|Lost to Follow-up|0|||
164204059|NCT05117060|593117928|FG003|Overall Study|Lost to Follow-up|1|||
163974114|NCT01342484|592276750|FG001|Overall Study|Withdrawal by Subject|0|||
163974115|NCT01342484|592276751|FG002|Overall Study|Withdrawal by Subject|0|||
163974116|NCT01744665|592276752|FG000|Monitoring Phase|Adverse Event|4|||
163974117|NCT01744665|592276752|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
163974118|NCT01744665|592276752|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
163974119|NCT01744665|592276752|FG000|Monitoring Phase|Withdrawal by Subject|5|||
163974120|NCT01744665|592276752|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
163974121|NCT01744665|592276752|FG000|Consolidation Phase|Adverse Event|2|||
163974122|NCT01744665|592276752|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
163974123|NCT01744665|592276752|FG000|Consolidation Phase|Withdrawal by Subject|4|||
163974124|NCT01744665|592276752|FG000|Consolidation Phase|Administrative problems|9|||
163974125|NCT01744665|592276752|FG000|Re-initiation Phase|Administrative problems|10|||
163870171|NCT00364013|591893728|FG000|Overall Study|Protocol-specified criteria|6|||
163870172|NCT00364013|591893729|FG001|Overall Study|Protocol-specified criteria|6|||
163870173|NCT00364013|591893728|FG000|Overall Study|Other|41|||
163870174|NCT00364013|591893729|FG001|Overall Study|Other|47|||
163870175|NCT00364013|591893728|FG000|Overall Study|Ongoing|20|||
163870176|NCT00364013|591893729|FG001|Overall Study|Ongoing|13|||
163870177|NCT00891930|591893730|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
163870178|NCT00891930|591893730|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
163870179|NCT00891930|591893730|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
163870180|NCT00891930|591893730|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
163870181|NCT00891930|591893730|FG000|Part 2 Panitumumab + AMG479|Death|30|||
163870182|NCT00835770|591893737|FG000|Overall Study|MS Relapse|17|||
163870183|NCT00835770|591893738|FG001|Overall Study|MS Relapse|23|||
163870184|NCT00835770|591893737|FG000|Overall Study|MS Progression|14|||
163870185|NCT00835770|591893738|FG001|Overall Study|MS Progression|9|||
163870186|NCT00835770|591893737|FG000|Overall Study|Adverse Event|113|||
163870187|NCT00835770|591893738|FG001|Overall Study|Adverse Event|124|||
163870188|NCT00835770|591893737|FG000|Overall Study|Lost to Follow-up|22|||
163870189|NCT00835770|591893738|FG001|Overall Study|Lost to Follow-up|19|||
163870190|NCT00835770|591893737|FG000|Overall Study|Consent Withdrawn|144|||
163870191|NCT00835770|591893738|FG001|Overall Study|Consent Withdrawn|156|||
163870192|NCT00835770|591893737|FG000|Overall Study|Investigator Decision|42|||
163870193|NCT00835770|591893738|FG001|Overall Study|Investigator Decision|42|||
163870194|NCT00835770|591893737|FG000|Overall Study|Participant Non-Compliance|11|||
163870195|NCT00835770|591893738|FG001|Overall Study|Participant Non-Compliance|9|||
163870196|NCT00835770|591893737|FG000|Overall Study|Death|4|||
163870197|NCT00835770|591893738|FG001|Overall Study|Death|6|||
163870198|NCT00835770|591893737|FG000|Overall Study|Other|115|||
163870199|NCT00835770|591893738|FG001|Overall Study|Other|104|||
163870200|NCT00835770|591893737|FG000|Overall Study|Other|2|||
163870201|NCT00835770|591893738|FG001|Overall Study|Other|1|||
163870202|NCT01185782|591893739|FG000|Overall Study|Adverse Event|0|||
163870203|NCT01185782|591893740|FG001|Overall Study|Adverse Event|1|||
163870204|NCT01185782|591893739|FG000|Overall Study|Protocol Violation|1|||
163870205|NCT01185782|591893740|FG001|Overall Study|Protocol Violation|0|||
163870206|NCT01185782|591893739|FG000|Overall Study|Poor Response to Treatment|3|||
163870207|NCT01185782|591893740|FG001|Overall Study|Poor Response to Treatment|1|||
163870208|NCT01185782|591893739|FG000|Overall Study|Other|2|||
163870209|NCT01185782|591893740|FG001|Overall Study|Other|5|||
163870210|NCT01185782|591893739|FG000|Overall Study|Randomized but not treated|0|||
163870211|NCT01185782|591893740|FG001|Overall Study|Randomized but not treated|4|||
163870212|NCT02507752|591893741|FG000|Overall Study|Adverse Event|1|||
163974126|NCT01744665|592276752|FG000|Re-initiation Phase|Adverse Event|1|||
163974127|NCT01744665|592276752|FG000|Re-initiation Phase|No longer required treatment|1|||
163974128|NCT01744665|592276752|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
163974129|NCT05998148|592276753|FG000|Allocation|Did not attend any appointments|1|||
163974130|NCT05998148|592276754|FG001|Allocation|Did not attend any appointments|4|||
163974131|NCT05998148|592276753|FG000|Follow-Up|Lost to Follow-up|1|||
163870213|NCT02507752|591893741|FG000|Overall Study|Protocol Violation|6|||
163870214|NCT02507752|591893741|FG000|Overall Study|Lost to Follow-up|7|||
163870215|NCT02507752|591893741|FG000|Overall Study|Infusion reaction at first infusion|1|||
163870216|NCT02507752|591893741|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
163870217|NCT02507752|591893741|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
163870218|NCT01254188|591893746|FG000|Overall Study|Disease Progression|6|||
163974132|NCT05998148|592276754|FG001|Follow-Up|Lost to Follow-up|2|||
163974133|NCT05998148|592276753|FG000|Follow-Up|Change in insurance|1|||
163974134|NCT05998148|592276754|FG001|Follow-Up|Change in insurance|1|||
163870219|NCT01254188|591893746|FG000|Overall Study|Protocol Violation|6|||
163870220|NCT01254188|591893746|FG000|Overall Study|Pregnancy|2|||
163870221|NCT01254188|591893746|FG000|Overall Study|Death|4|||
163870222|NCT01254188|591893746|FG000|Overall Study|Lost to Follow-up|5|||
163870223|NCT01254188|591893746|FG000|Overall Study|Withdrawal by Subject|7|||
163870224|NCT01254188|591893746|FG000|Overall Study|Adverse Event|43|||
163870225|NCT01254188|591893746|FG000|Overall Study|per investigator discretion|20|||
163870226|NCT02202499|591893751|FG000|Overall Study|Cancer diagnosis|0|||
163870227|NCT02202499|591893752|FG001|Overall Study|Cancer diagnosis|0|||
163870228|NCT02202499|591893753|FG002|Overall Study|Cancer diagnosis|1|||
163870229|NCT02202499|591893751|FG000|Overall Study|Moved from area|0|||
163870230|NCT02202499|591893752|FG001|Overall Study|Moved from area|0|||
163870231|NCT02202499|591893753|FG002|Overall Study|Moved from area|1|||
163870232|NCT02202499|591893751|FG000|Overall Study|Declined before randomization|1|||
163870233|NCT02202499|591893752|FG001|Overall Study|Declined before randomization|0|||
163870234|NCT02202499|591893753|FG002|Overall Study|Declined before randomization|0|||
163870235|NCT02202499|591893751|FG000|Overall Study|Auto accident|1|||
163870236|NCT02202499|591893752|FG001|Overall Study|Auto accident|0|||
163870237|NCT02202499|591893753|FG002|Overall Study|Auto accident|0|||
163870238|NCT00535145|591893755|FG000|Phase I|Adverse Event|3|||
164204060|NCT05117060|593117925|FG000|Overall Study|Lack of Efficacy|4|||
163974135|NCT02090413|592276756|FG000|Overall Study|Adverse Event|11|||
163974136|NCT02090413|592276757|FG001|Overall Study|Adverse Event|15|||
163974137|NCT02090413|592276758|FG002|Overall Study|Adverse Event|20|||
163974138|NCT02090413|592276756|FG000|Overall Study|Flushing event|2|||
163974139|NCT02090413|592276757|FG001|Overall Study|Flushing event|0|||
163974140|NCT02090413|592276758|FG002|Overall Study|Flushing event|1|||
163974141|NCT02090413|592276756|FG000|Overall Study|Withdrawal by Subject|2|||
163974142|NCT02090413|592276757|FG001|Overall Study|Withdrawal by Subject|2|||
163974143|NCT02090413|592276758|FG002|Overall Study|Withdrawal by Subject|2|||
163974144|NCT02090413|592276756|FG000|Overall Study|Investigator Decision|1|||
163974145|NCT02090413|592276757|FG001|Overall Study|Investigator Decision|1|||
163974146|NCT02090413|592276758|FG002|Overall Study|Investigator Decision|0|||
163974147|NCT02090413|592276756|FG000|Overall Study|Other|2|||
163974148|NCT02090413|592276757|FG001|Overall Study|Other|1|||
163974149|NCT02090413|592276758|FG002|Overall Study|Other|0|||
163974150|NCT02090413|592276756|FG000|Overall Study|Lost to Follow-up|1|||
163974151|NCT02090413|592276757|FG001|Overall Study|Lost to Follow-up|1|||
163974152|NCT02090413|592276758|FG002|Overall Study|Lost to Follow-up|0|||
163974153|NCT05248295|592276760|FG000|Overall Study|found ineligible|4|||
163974154|NCT05248295|592276761|FG001|Overall Study|found ineligible|1|||
163974155|NCT05248295|592276760|FG000|Overall Study|Withdrawal by Subject|0|||
163974156|NCT05248295|592276761|FG001|Overall Study|Withdrawal by Subject|1|||
163974157|NCT05248295|592276760|FG000|Overall Study|Data loss: audio recording error|1|||
163974158|NCT05248295|592276761|FG001|Overall Study|Data loss: audio recording error|1|||
163974159|NCT01293968|592276762|FG000|Overall Study|non-cooperation|3|||
163974160|NCT01293968|592276763|FG001|Overall Study|non-cooperation|3|||
163974161|NCT01133379|592276764|FG000|Overall Study|Withdrawal by Subject|0|||
163974162|NCT01133379|592276765|FG001|Overall Study|Withdrawal by Subject|1|||
163974163|NCT01133379|592276766|FG002|Overall Study|Withdrawal by Subject|1|||
163974164|NCT01133379|592276764|FG000|Overall Study|Lost to Follow-up|1|||
163974165|NCT01133379|592276765|FG001|Overall Study|Lost to Follow-up|1|||
163974166|NCT01133379|592276766|FG002|Overall Study|Lost to Follow-up|1|||
163974167|NCT00597753|592276775|FG000|Overall Study|Adverse Event|6|||
163974168|NCT00597753|592276776|FG001|Overall Study|Adverse Event|2|||
163974169|NCT00597753|592276775|FG000|Overall Study|Death|55|||
163974170|NCT00597753|592276776|FG001|Overall Study|Death|29|||
163974171|NCT00597753|592276775|FG000|Overall Study|Lack of Efficacy|2|||
163974172|NCT00597753|592276776|FG001|Overall Study|Lack of Efficacy|0|||
163974173|NCT00597753|592276775|FG000|Overall Study|Lost to Follow-up|10|||
163974174|NCT00597753|592276776|FG001|Overall Study|Lost to Follow-up|3|||
163974175|NCT00597753|592276775|FG000|Overall Study|Physician Decision|5|||
163974176|NCT00597753|592276776|FG001|Overall Study|Physician Decision|1|||
163974177|NCT00597753|592276775|FG000|Overall Study|Pregnancy|1|||
163974178|NCT00597753|592276776|FG001|Overall Study|Pregnancy|0|||
163974179|NCT00597753|592276775|FG000|Overall Study|Withdrawal by Subject|35|||
163974180|NCT00597753|592276776|FG001|Overall Study|Withdrawal by Subject|12|||
163974181|NCT00597753|592276775|FG000|Overall Study|Discontinued Dialysis|0|||
163974182|NCT00597753|592276776|FG001|Overall Study|Discontinued Dialysis|1|||
163974183|NCT00597753|592276775|FG000|Overall Study|Never dosed|2|||
163974184|NCT00597753|592276776|FG001|Overall Study|Never dosed|0|||
163974185|NCT00597753|592276775|FG000|Overall Study|Noncompliance|2|||
163974186|NCT00597753|592276776|FG001|Overall Study|Noncompliance|1|||
163974187|NCT00597753|592276775|FG000|Overall Study|Relocation|17|||
163974188|NCT00597753|592276776|FG001|Overall Study|Relocation|6|||
163974189|NCT00597753|592276775|FG000|Overall Study|Renal transplant|10|||
163974190|NCT00597753|592276776|FG001|Overall Study|Renal transplant|3|||
163974191|NCT00597753|592276775|FG000|Overall Study|Site closed by sponsor|19|||
163974192|NCT00597753|592276776|FG001|Overall Study|Site closed by sponsor|7|||
163974193|NCT00597753|592276775|FG000|Overall Study|Site elected to close|2|||
163974194|NCT00597753|592276776|FG001|Overall Study|Site elected to close|4|||
163974195|NCT04649255|592278283|FG000|Overall Study|Death|9|||
163974196|NCT04649255|592278283|FG000|Overall Study|Withdrawal by Subject|1|||
163974197|NCT01652885|592278284|FG000|Overall Study|Adverse Event|1|||
163974198|NCT03723707|592278285|FG000|Overall Study|Death|32|||
163974199|NCT03723707|592278286|FG001|Overall Study|Death|32|||
163974200|NCT03723707|592278285|FG000|Overall Study|Admitted to long term care|12|||
164314824|NCT04629066|593529776|FG001|Overall Study|Lost to Follow-up|2|||
163974201|NCT03723707|592278286|FG001|Overall Study|Admitted to long term care|12|||
163974202|NCT03723707|592278285|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
163974203|NCT03723707|592278286|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
163974204|NCT03723707|592278285|FG000|Overall Study|Lost to Follow-up|40|||
163974205|NCT03723707|592278286|FG001|Overall Study|Lost to Follow-up|22|||
163974206|NCT03723707|592278285|FG000|Overall Study|Discontinued after study closure|24|||
163974207|NCT03723707|592278286|FG001|Overall Study|Discontinued after study closure|12|||
163974208|NCT00075023|592278287|FG000|Pilot Study|Physician Decision|1|||
163974209|NCT00075023|592278288|FG001|Pilot Study|Physician Decision|2|||
163974210|NCT00075023|592278287|FG000|Pilot Study|Withdrawal by Subject|1|||
163974211|NCT00075023|592278288|FG001|Pilot Study|Withdrawal by Subject|0|||
163974212|NCT04342871|592278289|FG000|Overall Study|Death|4|||
163974213|NCT04342871|592278289|FG000|Overall Study|Clinical deterioration/illness progression|2|||
163870239|NCT00535145|591893755|FG000|Phase I|Lost to Follow-up|7|||
163870240|NCT00535145|591893755|FG000|Phase I|Withdrawal by Subject|6|||
163870241|NCT00535145|591893755|FG000|Phase I|(eligibility)|8|||
163870242|NCT00535145|591893755|FG000|Phase I|(protocol violation)|1|||
163870243|NCT00535145|591893755|FG000|Phase I|(PI decision)|1|||
163870244|NCT00535145|591893755|FG000|Phase I|(diagnosis)|3|||
163870245|NCT00535145|591893755|FG000|Phase II|Adverse Event|2|||
163870246|NCT00535145|591893755|FG000|Phase II|Lack of Efficacy|1|||
163870247|NCT00535145|591893755|FG000|Phase II|Lost to Follow-up|5|||
163870248|NCT00535145|591893755|FG000|Phase II|Withdrawal by Subject|5|||
163870249|NCT00535145|591893755|FG000|Phase II|Subject non-compliance|2|||
163870250|NCT05082935|591893758|FG000|Overall Study|Lost to Follow-up|549|||
163870251|NCT05082935|591893759|FG001|Overall Study|Lost to Follow-up|631|||
163870252|NCT05082935|591893758|FG000|Overall Study|Withdrawal by Subject|27|||
163870253|NCT05082935|591893759|FG001|Overall Study|Withdrawal by Subject|58|||
163870254|NCT02544074|591895040|FG000|Overall Study|Withdrawal by Subject|0|||
163870255|NCT02544074|591895041|FG001|Overall Study|Withdrawal by Subject|1|||
163870256|NCT02544074|591895042|FG002|Overall Study|Withdrawal by Subject|0|||
163870257|NCT02544074|591895043|FG003|Overall Study|Withdrawal by Subject|0|||
163870258|NCT02544074|591895044|FG004|Overall Study|Withdrawal by Subject|0|||
163870259|NCT02544074|591895045|FG005|Overall Study|Withdrawal by Subject|0|||
163870260|NCT02544074|591895046|FG006|Overall Study|Withdrawal by Subject|0|||
163870261|NCT02544074|591895047|FG007|Overall Study|Withdrawal by Subject|0|||
163870262|NCT02544074|591895048|FG008|Overall Study|Withdrawal by Subject|0|||
163870263|NCT02544074|591895049|FG009|Overall Study|Withdrawal by Subject|0|||
163870264|NCT02544074|591895050|FG010|Overall Study|Withdrawal by Subject|0|||
163870265|NCT02544074|591895051|FG011|Overall Study|Withdrawal by Subject|0|||
163870266|NCT02544074|591895052|FG012|Overall Study|Withdrawal by Subject|0|||
163870267|NCT02544074|591895053|FG013|Overall Study|Withdrawal by Subject|0|||
163870268|NCT02544074|591895054|FG014|Overall Study|Withdrawal by Subject|0|||
163870269|NCT02544074|591895055|FG015|Overall Study|Withdrawal by Subject|0|||
163870270|NCT02544074|591895056|FG016|Overall Study|Withdrawal by Subject|0|||
163870271|NCT02544074|591895057|FG017|Overall Study|Withdrawal by Subject|0|||
163870272|NCT02544074|591895058|FG018|Overall Study|Withdrawal by Subject|0|||
163870273|NCT02544074|591895059|FG019|Overall Study|Withdrawal by Subject|0|||
163870274|NCT02544074|591895060|FG020|Overall Study|Withdrawal by Subject|0|||
163870275|NCT02544074|591895040|FG000|Overall Study|Tablet error|0|||
163870276|NCT02544074|591895041|FG001|Overall Study|Tablet error|0|||
163870277|NCT02544074|591895042|FG002|Overall Study|Tablet error|0|||
163870278|NCT02544074|591895043|FG003|Overall Study|Tablet error|0|||
163870279|NCT02544074|591895044|FG004|Overall Study|Tablet error|0|||
163870280|NCT02544074|591895045|FG005|Overall Study|Tablet error|1|||
163870281|NCT02544074|591895046|FG006|Overall Study|Tablet error|0|||
163870282|NCT02544074|591895047|FG007|Overall Study|Tablet error|0|||
163870283|NCT02544074|591895048|FG008|Overall Study|Tablet error|0|||
163870284|NCT02544074|591895049|FG009|Overall Study|Tablet error|1|||
163870285|NCT02544074|591895050|FG010|Overall Study|Tablet error|0|||
163870286|NCT02544074|591895051|FG011|Overall Study|Tablet error|0|||
163870287|NCT02544074|591895052|FG012|Overall Study|Tablet error|0|||
163870288|NCT02544074|591895053|FG013|Overall Study|Tablet error|0|||
163870289|NCT02544074|591895054|FG014|Overall Study|Tablet error|0|||
163870290|NCT02544074|591895055|FG015|Overall Study|Tablet error|0|||
163870291|NCT02544074|591895056|FG016|Overall Study|Tablet error|0|||
163870292|NCT02544074|591895057|FG017|Overall Study|Tablet error|0|||
163870293|NCT02544074|591895058|FG018|Overall Study|Tablet error|0|||
163870294|NCT02544074|591895059|FG019|Overall Study|Tablet error|0|||
163870295|NCT02544074|591895060|FG020|Overall Study|Tablet error|0|||
164135922|NCT02799095|592861961|FG006|Part C|Withdrawal by Subject|0|||
164314825|NCT02703337|593529777|FG000|Period One (Part A)|Withdrawal by Subject|0|||
164314826|NCT02703337|593529778|FG001|Period One (Part A)|Withdrawal by Subject|0|||
164314827|NCT02703337|593529779|FG002|Period One (Part A)|Withdrawal by Subject|0|||
164314828|NCT02703337|593529780|FG003|Period One (Part A)|Withdrawal by Subject|0|||
164314829|NCT02703337|593529781|FG004|Period One (Part A)|Withdrawal by Subject|1|||
163870296|NCT05672667|591895061|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
163870297|NCT03873779|591895062|FG000|Overall Study|Withdrawal by Subject|1|||
163870298|NCT02581215|591895063|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
163870299|NCT02581215|591895064|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
163870300|NCT02581215|591895063|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163870301|NCT02581215|591895064|FG001|Overall Study|Eligibility Criteria Not Met|1|||
163870302|NCT04279574|591895067|FG000|Overall Study|Death|1|||
163870303|NCT04279574|591895068|FG001|Overall Study|Death|0|||
163870304|NCT04279574|591895067|FG000|Overall Study|lost restoration, tooth fracture|1|||
163870305|NCT04279574|591895068|FG001|Overall Study|lost restoration, tooth fracture|0|||
163870306|NCT04279574|591895067|FG000|Overall Study|Lost to Follow-up|0|||
163870307|NCT04279574|591895068|FG001|Overall Study|Lost to Follow-up|1|||
163870308|NCT02407249|591895071|FG000|Overall Study|Did not complete 12-month follow-up|13|||
163870309|NCT02407249|591895071|FG000|Overall Study|Not treated|13|||
163870310|NCT01391832|591895072|FG000|Overall Study|Withdrawal by Subject|21|||
163870311|NCT01391832|591895073|FG001|Overall Study|Withdrawal by Subject|22|||
163870312|NCT01391832|591895072|FG000|Overall Study|Lost to Follow-up|0|||
163870313|NCT01391832|591895073|FG001|Overall Study|Lost to Follow-up|1|||
163870314|NCT03345901|591895077|FG000|Overall Study|The study was terminated|18|||
163870315|NCT04252586|591895078|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163870316|NCT04252586|591895078|FG000|Overall Study|Adverse Event|1|||
163870317|NCT04252586|591895078|FG000|Overall Study|Death|2|||
163870318|NCT04252586|591895078|FG000|Overall Study|Study terminated by sponsor|4|||
163870319|NCT04252586|591895078|FG000|Overall Study|Sponsor request|10|||
163870320|NCT04252586|591895078|FG000|Overall Study|Did not complete treatment period|1|||
163870321|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Death|186|||
163870322|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Death|222|||
163870323|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Death|0|||
163870324|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
163870325|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
163870326|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
163870327|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
163870328|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
163870329|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
163870330|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
163870331|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
163870332|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
163870333|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Adverse Event|83|||
163870334|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Adverse Event|100|||
163870335|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Adverse Event|0|||
163870336|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Other|70|||
163870337|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Other|75|||
163870338|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Other|0|||
163870339|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
163870340|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
163870341|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
163870342|NCT00232180|591895079|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
163870343|NCT00232180|591895080|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
163870344|NCT00232180|591895081|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
163870345|NCT00232180|591895079|FG000|Open Label Phase|Death|0|||
163870346|NCT00232180|591895080|FG001|Open Label Phase|Death|0|||
163870347|NCT00232180|591895081|FG002|Open Label Phase|Death|48|||
163870348|NCT00232180|591895079|FG000|Open Label Phase|Lost to Follow-up|0|||
163870349|NCT00232180|591895080|FG001|Open Label Phase|Lost to Follow-up|0|||
163870350|NCT00232180|591895081|FG002|Open Label Phase|Lost to Follow-up|5|||
163870351|NCT00232180|591895079|FG000|Open Label Phase|Protocol Violation|0|||
163870352|NCT00232180|591895080|FG001|Open Label Phase|Protocol Violation|0|||
163870353|NCT00232180|591895081|FG002|Open Label Phase|Protocol Violation|3|||
163870354|NCT00232180|591895079|FG000|Open Label Phase|Study terminated by sponsor|0|||
163870355|NCT00232180|591895080|FG001|Open Label Phase|Study terminated by sponsor|0|||
163870356|NCT00232180|591895081|FG002|Open Label Phase|Study terminated by sponsor|3|||
163870357|NCT00232180|591895079|FG000|Open Label Phase|Withdrawal by Subject|0|||
163870358|NCT00232180|591895080|FG001|Open Label Phase|Withdrawal by Subject|0|||
163870359|NCT00232180|591895081|FG002|Open Label Phase|Withdrawal by Subject|37|||
163870360|NCT00232180|591895079|FG000|Open Label Phase|Other|0|||
163870361|NCT00232180|591895080|FG001|Open Label Phase|Other|0|||
163870362|NCT00232180|591895081|FG002|Open Label Phase|Other|16|||
163870363|NCT00232180|591895079|FG000|Open Label Phase|Adverse Event|0|||
163870364|NCT00232180|591895080|FG001|Open Label Phase|Adverse Event|0|||
163870365|NCT00232180|591895081|FG002|Open Label Phase|Adverse Event|25|||
163870366|NCT00232180|591895079|FG000|Open Label Phase|Laboratory abnormality|0|||
163870367|NCT00232180|591895080|FG001|Open Label Phase|Laboratory abnormality|0|||
163870368|NCT00232180|591895081|FG002|Open Label Phase|Laboratory abnormality|10|||
163870369|NCT00232180|591895079|FG000|Open Label Phase|Randomized but not treated|0|||
163870370|NCT00232180|591895080|FG001|Open Label Phase|Randomized but not treated|0|||
163870371|NCT00232180|591895081|FG002|Open Label Phase|Randomized but not treated|1|||
163870372|NCT02748317|591895082|FG000|Overall Study|Withdrawal by Subject|14|||
163870373|NCT02748317|591895082|FG000|Overall Study|Lost to Follow-up|8|||
163870374|NCT02748317|591895082|FG000|Overall Study|Death|1|||
163870375|NCT03452189|591895083|FG000|First Intervention (3 Months)|Adverse Event|1|||
163870376|NCT03452189|591895084|FG001|First Intervention (3 Months)|Adverse Event|0|||
163870377|NCT03452189|591895083|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
163870378|NCT03452189|591895084|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
163870379|NCT02724592|591895085|FG000|Overall Study|Lost to Follow-up|4|||
163870380|NCT02724592|591895086|FG001|Overall Study|Lost to Follow-up|1|||
163870381|NCT00434304|591895087|FG000|Overall Study|Adverse Event|14|||
163870382|NCT00434304|591895087|FG000|Overall Study|Lack of Efficacy|2|||
163870383|NCT00434304|591895087|FG000|Overall Study|Withdrawal by Subject|4|||
163870384|NCT05262738|591895088|FG000|Overall Study|Withdrawal by Subject|1|||
163870385|NCT05262738|591895089|FG001|Overall Study|Withdrawal by Subject|0|||
163870386|NCT01149369|591895093|FG000|Overall Study|Adverse Event|6|||
163870387|NCT01149369|591895094|FG001|Overall Study|Adverse Event|3|||
163870388|NCT01424397|591895095|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870389|NCT01424397|591895096|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870390|NCT01424397|591895097|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
163870391|NCT01424397|591895098|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870392|NCT01424397|591895099|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870393|NCT01424397|591895100|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870394|NCT01424397|591895101|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870395|NCT01424397|591895102|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870396|NCT01424397|591895103|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870397|NCT01424397|591895104|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870398|NCT01424397|591895105|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870399|NCT01424397|591895106|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
163870400|NCT02767765|591895107|FG000|Overall Study|Adverse Event|4|||
163870401|NCT02767765|591895107|FG000|Overall Study|Death|1|||
163870402|NCT02767765|591895107|FG000|Overall Study|Insufficient response|1|||
163870403|NCT02767765|591895107|FG000|Overall Study|Lost to Follow-up|2|||
163870404|NCT02767765|591895107|FG000|Overall Study|Investigator decision|1|||
163870405|NCT02767765|591895107|FG000|Overall Study|Non-Compliance|1|||
163870406|NCT02767765|591895107|FG000|Overall Study|Withdrawal by Subject|1|||
163870407|NCT01951170|591895108|FG000|Overall Study|Investigator decision|1|||
163870408|NCT01972724|591895116|FG000|Double-Blind|Rescue Criteria Met|1|||
163870409|NCT01972724|591895117|FG001|Double-Blind|Rescue Criteria Met|0|||
163870410|NCT01972724|591895118|FG002|Double-Blind|Rescue Criteria Met|0|||
163870411|NCT01972724|591895116|FG000|Double-Blind|Adverse Event|1|||
163870412|NCT01972724|591895117|FG001|Double-Blind|Adverse Event|0|||
163870413|NCT01972724|591895118|FG002|Double-Blind|Adverse Event|0|||
163870414|NCT01972724|591895116|FG000|Double-Blind|Withdrawal of Consent|2|||
163870415|NCT01972724|591895117|FG001|Double-Blind|Withdrawal of Consent|1|||
163870416|NCT01972724|591895118|FG002|Double-Blind|Withdrawal of Consent|0|||
163870417|NCT01972724|591895116|FG000|Double-Blind|Significant Protocol Deviation|5|||
163870418|NCT01972724|591895117|FG001|Double-Blind|Significant Protocol Deviation|8|||
163870419|NCT01972724|591895118|FG002|Double-Blind|Significant Protocol Deviation|0|||
163870420|NCT01972724|591895116|FG000|Open-Label|Withdrew Consent|0|||
163870421|NCT01972724|591895117|FG001|Open-Label|Withdrew Consent|0|||
163870422|NCT01972724|591895118|FG002|Open-Label|Withdrew Consent|3|||
163870423|NCT01972724|591895116|FG000|Open-Label|Significant Protocol Deviation|0|||
163870424|NCT01972724|591895117|FG001|Open-Label|Significant Protocol Deviation|0|||
163870425|NCT01972724|591895118|FG002|Open-Label|Significant Protocol Deviation|2|||
163870426|NCT00277355|591895119|FG000|Overall Study|Withdrawal by Subject|3|||
163870427|NCT00277355|591895120|FG001|Overall Study|Withdrawal by Subject|3|||
163870428|NCT00277355|591895119|FG000|Overall Study|Lost to Follow-up|2|||
163870429|NCT00277355|591895120|FG001|Overall Study|Lost to Follow-up|2|||
163870430|NCT00277355|591895119|FG000|Overall Study|Adverse Event|5|||
163870431|NCT00277355|591895120|FG001|Overall Study|Adverse Event|0|||
163974214|NCT04342871|592278289|FG000|Overall Study|Did not complete baseline assessments|5|||
163974215|NCT04342871|592278289|FG000|Overall Study|Lost to Follow-up|13|||
163974216|NCT04682405|592278291|FG000|Overall Study|Adverse Event|0|||
163974217|NCT04682405|592278292|FG001|Overall Study|Adverse Event|1|||
163974218|NCT01429584|592278296|FG000|Overall Study|Withdrawal by Subject|1|||
163974219|NCT01429584|592278297|FG001|Overall Study|Withdrawal by Subject|0|||
163870432|NCT00277355|591895119|FG000|Overall Study|Death|3|||
163870433|NCT00277355|591895120|FG001|Overall Study|Death|0|||
163870434|NCT00277355|591895119|FG000|Overall Study|Physician Decision|1|||
163870435|NCT00277355|591895120|FG001|Overall Study|Physician Decision|0|||
163870436|NCT00668863|591895123|FG000|Overall Study|Objective Progression or Relapse|42|||
163974220|NCT01429584|592278296|FG000|Overall Study|Protocol Violation|0|||
163974221|NCT01429584|592278297|FG001|Overall Study|Protocol Violation|1|||
163974222|NCT00750698|592278298|FG000|Overall Study|Withdrawal by Subject|1|||
163974223|NCT00750698|592278299|FG001|Overall Study|Withdrawal by Subject|0|||
163974224|NCT00750698|592278298|FG000|Overall Study|Progressive disease|5|||
163974225|NCT00750698|592278299|FG001|Overall Study|Progressive disease|2|||
164204061|NCT05117060|593117926|FG001|Overall Study|Lack of Efficacy|5|||
164204062|NCT05117060|593117927|FG002|Overall Study|Lack of Efficacy|2|||
164204063|NCT05117060|593117928|FG003|Overall Study|Lack of Efficacy|6|||
164204064|NCT05117060|593117925|FG000|Overall Study|Withdrawal by Subject|8|||
163870437|NCT00668863|591895123|FG000|Overall Study|Adverse Event|13|||
163870438|NCT00668863|591895123|FG000|Overall Study|Study Terminated by Sponsor|8|||
163870439|NCT00668863|591895123|FG000|Overall Study|Global Deterioration of Health Status|4|||
163870440|NCT00668863|591895123|FG000|Overall Study|Withdrawal by Subject|1|||
163870441|NCT00668863|591895123|FG000|Overall Study|Surgery|1|||
163870442|NCT00668863|591895123|FG000|Overall Study|Subject's work scheduling problem|1|||
163974226|NCT01417195|592278302|FG000|Overall Study|Stimulation failure|1|||
163974227|NCT01417195|592278303|FG001|Overall Study|Stimulation failure|0|||
163974228|NCT01417195|592278302|FG000|Overall Study|No embryos for transfer|0|||
163974229|NCT01417195|592278303|FG001|Overall Study|No embryos for transfer|1|||
163974230|NCT01417195|592278302|FG000|Overall Study|No transfer due to risk of OHSS|1|||
163974231|NCT01417195|592278303|FG001|Overall Study|No transfer due to risk of OHSS|0|||
163974232|NCT01417195|592278302|FG000|Overall Study|No transfer due to elevated progesterone|1|||
163974233|NCT01417195|592278303|FG001|Overall Study|No transfer due to elevated progesterone|0|||
163974234|NCT03357731|592278304|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
163974235|NCT03357731|592278305|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
163974236|NCT03357731|592278306|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
163974237|NCT03357731|592278307|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
163974238|NCT03357731|592278308|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
163974239|NCT03357731|592278309|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
163974240|NCT03357731|592278304|FG000|Overall Study|Acute bradycardia and hypotension|0|||
163974241|NCT03357731|592278305|FG001|Overall Study|Acute bradycardia and hypotension|0|||
163974242|NCT03357731|592278306|FG002|Overall Study|Acute bradycardia and hypotension|0|||
163974243|NCT03357731|592278307|FG003|Overall Study|Acute bradycardia and hypotension|1|||
163974244|NCT03357731|592278308|FG004|Overall Study|Acute bradycardia and hypotension|0|||
163974245|NCT03357731|592278309|FG005|Overall Study|Acute bradycardia and hypotension|0|||
163974246|NCT03357731|592278304|FG000|Overall Study|Adverse Event|0|||
163974247|NCT03357731|592278305|FG001|Overall Study|Adverse Event|0|||
163974248|NCT03357731|592278306|FG002|Overall Study|Adverse Event|0|||
163974249|NCT03357731|592278307|FG003|Overall Study|Adverse Event|0|||
163974250|NCT03357731|592278308|FG004|Overall Study|Adverse Event|0|||
163974251|NCT03357731|592278309|FG005|Overall Study|Adverse Event|1|||
163974252|NCT03357731|592278304|FG000|Overall Study|Hypotension|0|||
163974253|NCT03357731|592278305|FG001|Overall Study|Hypotension|0|||
163974254|NCT03357731|592278306|FG002|Overall Study|Hypotension|1|||
163974255|NCT03357731|592278307|FG003|Overall Study|Hypotension|1|||
163974256|NCT03357731|592278308|FG004|Overall Study|Hypotension|0|||
163974257|NCT03357731|592278309|FG005|Overall Study|Hypotension|0|||
163974258|NCT03357731|592278304|FG000|Overall Study|Lost to Follow-up|0|||
163974259|NCT03357731|592278305|FG001|Overall Study|Lost to Follow-up|0|||
163974260|NCT03357731|592278306|FG002|Overall Study|Lost to Follow-up|0|||
163974261|NCT03357731|592278307|FG003|Overall Study|Lost to Follow-up|1|||
163974262|NCT03357731|592278308|FG004|Overall Study|Lost to Follow-up|0|||
163974263|NCT03357731|592278309|FG005|Overall Study|Lost to Follow-up|0|||
163974264|NCT04766021|592278310|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
163974265|NCT04766021|592278310|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
163974266|NCT02634151|592278311|FG000|Overall Study|Withdrawal by Subject|1|||
163974267|NCT02634151|592278312|FG001|Overall Study|Withdrawal by Subject|0|||
163974268|NCT02634151|592278311|FG000|Overall Study|Non-Compliance|0|||
163974269|NCT02634151|592278312|FG001|Overall Study|Non-Compliance|1|||
163974270|NCT02634151|592278311|FG000|Overall Study|Other|0|||
163974271|NCT02634151|592278312|FG001|Overall Study|Other|1|||
163974272|NCT00003535|592278313|FG000|Overall Study|Not evaluable|5|||
163974273|NCT01849874|592278314|FG000|Overall Study|Death|89|||
163974274|NCT01849874|592278315|FG001|Overall Study|Death|42|||
163974275|NCT01849874|592278314|FG000|Overall Study|Withdrawal by Subject|17|||
163974276|NCT01849874|592278315|FG001|Overall Study|Withdrawal by Subject|16|||
163974277|NCT01849874|592278314|FG000|Overall Study|Lost to Follow-up|3|||
163974278|NCT01849874|592278315|FG001|Overall Study|Lost to Follow-up|2|||
163974279|NCT01849874|592278314|FG000|Overall Study|Study Termination By Sponsor|93|||
163974280|NCT01849874|592278315|FG001|Overall Study|Study Termination By Sponsor|48|||
163974281|NCT01849874|592278314|FG000|Overall Study|Completed as per protocol amendment 6|3|||
163974282|NCT01849874|592278315|FG001|Overall Study|Completed as per protocol amendment 6|0|||
163974283|NCT01849874|592278314|FG000|Overall Study|Physician Decision|7|||
163974284|NCT01849874|592278315|FG001|Overall Study|Physician Decision|1|||
163974285|NCT01849874|592278314|FG000|Overall Study|Other|16|||
163974286|NCT01849874|592278315|FG001|Overall Study|Other|4|||
163974287|NCT02347098|592278316|FG000|Overall Study|Death|1|||
163974288|NCT02347098|592278317|FG001|Overall Study|Death|0|||
163974289|NCT02347098|592278316|FG000|Overall Study|Withdrawal by Subject|1|||
163974290|NCT02347098|592278317|FG001|Overall Study|Withdrawal by Subject|0|||
163974291|NCT02347098|592278316|FG000|Overall Study|Lost to Follow-up|2|||
163974292|NCT02347098|592278317|FG001|Overall Study|Lost to Follow-up|2|||
163974293|NCT02347098|592278316|FG000|Overall Study|Refuse Follow-up Visit|1|||
163974294|NCT02347098|592278317|FG001|Overall Study|Refuse Follow-up Visit|5|||
163974295|NCT02347098|592278316|FG000|Overall Study|no visit due to illness|2|||
163974296|NCT02347098|592278317|FG001|Overall Study|no visit due to illness|1|||
163974297|NCT04640272|592278318|FG000|Overall Study|Subject moved out of area|1|||
163974298|NCT02535715|592278322|FG000|Overall Study|Withdrawal by Subject|0|||
163974299|NCT02535715|592278323|FG001|Overall Study|Withdrawal by Subject|0|||
163974300|NCT02535715|592278324|FG002|Overall Study|Withdrawal by Subject|1|||
163974301|NCT04353284|592278325|FG000|Overall Study|Adverse Event|1|||
163974302|NCT04353284|592278326|FG001|Overall Study|Adverse Event|1|||
163974303|NCT04353284|592278325|FG000|Overall Study|Lost to Follow-up|1|||
163974304|NCT04353284|592278326|FG001|Overall Study|Lost to Follow-up|0|||
163974305|NCT03709654|592278327|FG000|Overall Study|Lost to Follow-up|1|||
163974306|NCT03709654|592278328|FG001|Overall Study|Lost to Follow-up|1|||
163974307|NCT03709654|592278327|FG000|Overall Study|Withdrawal by Subject|1|||
163974308|NCT03709654|592278328|FG001|Overall Study|Withdrawal by Subject|1|||
163974309|NCT03709654|592278327|FG000|Overall Study|Adverse Event|1|||
163974310|NCT03709654|592278328|FG001|Overall Study|Adverse Event|0|||
163974311|NCT01040351|592278329|FG000|Overall Study|poor ovarian response|1|||
163974312|NCT01040351|592278330|FG001|Overall Study|poor ovarian response|2|||
163974313|NCT01230242|592278334|FG000|Overall Study|Physician Decision|2|||
163974314|NCT01230242|592278334|FG000|Overall Study|Withdrawal by Subject|1|||
163974315|NCT02256540|592278335|FG000|Overall Study|Withdrawal by Subject|0|||
163974316|NCT02256540|592278336|FG001|Overall Study|Withdrawal by Subject|1|||
163974317|NCT02256540|592278337|FG002|Overall Study|Withdrawal by Subject|1|||
163974318|NCT02256540|592278335|FG000|Overall Study|Back pain preventing exercise|0|||
163974319|NCT02256540|592278336|FG001|Overall Study|Back pain preventing exercise|0|||
163974320|NCT02256540|592278337|FG002|Overall Study|Back pain preventing exercise|1|||
163974321|NCT01438489|592278338|FG000|Overall Study|Lost to Follow-up|4|||
163974322|NCT01438489|592278339|FG001|Overall Study|Lost to Follow-up|2|||
163974323|NCT01438489|592278340|FG002|Overall Study|Lost to Follow-up|2|||
163974324|NCT01438489|592278338|FG000|Overall Study|Withdrawal by Subject|11|||
163974325|NCT01438489|592278339|FG001|Overall Study|Withdrawal by Subject|3|||
163870443|NCT00668863|591895123|FG000|Overall Study|Physician Decision|1|||
163870444|NCT01546753|591895126|FG000|Overall Study|anxiety|1|||
163870445|NCT01546753|591895127|FG001|Overall Study|anxiety|1|||
163870446|NCT01546753|591895126|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
163870447|NCT01546753|591895127|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
163870448|NCT00960141|591895128|FG000|Overall Study|Adverse Event|4|||
163870449|NCT00960141|591895129|FG001|Overall Study|Adverse Event|8|||
163870450|NCT00960141|591895130|FG002|Overall Study|Adverse Event|2|||
163870451|NCT00960141|591895128|FG000|Overall Study|Lack of Efficacy|3|||
163870452|NCT00960141|591895129|FG001|Overall Study|Lack of Efficacy|4|||
163870453|NCT00960141|591895130|FG002|Overall Study|Lack of Efficacy|2|||
163870454|NCT00960141|591895128|FG000|Overall Study|Lost to Follow-up|1|||
163870455|NCT00960141|591895129|FG001|Overall Study|Lost to Follow-up|0|||
163870456|NCT00960141|591895130|FG002|Overall Study|Lost to Follow-up|0|||
163870457|NCT00960141|591895128|FG000|Overall Study|Protocol Violation|1|||
163870458|NCT00960141|591895129|FG001|Overall Study|Protocol Violation|3|||
163870459|NCT00960141|591895130|FG002|Overall Study|Protocol Violation|2|||
163870460|NCT00960141|591895128|FG000|Overall Study|Withdrawal by Subject|1|||
163870461|NCT00960141|591895129|FG001|Overall Study|Withdrawal by Subject|2|||
163870462|NCT00960141|591895130|FG002|Overall Study|Withdrawal by Subject|1|||
163870463|NCT03036813|591895132|FG000|Overall Study|Adverse Event|6|||
163870464|NCT03036813|591895133|FG001|Overall Study|Adverse Event|11|||
163870465|NCT03036813|591895134|FG002|Overall Study|Adverse Event|6|||
163870466|NCT03036813|591895132|FG000|Overall Study|Withdrawal by Subject|12|||
163870467|NCT03036813|591895133|FG001|Overall Study|Withdrawal by Subject|6|||
163870468|NCT03036813|591895134|FG002|Overall Study|Withdrawal by Subject|10|||
163870469|NCT03036813|591895132|FG000|Overall Study|Lost to Follow-up|1|||
163870470|NCT03036813|591895133|FG001|Overall Study|Lost to Follow-up|1|||
163870471|NCT03036813|591895134|FG002|Overall Study|Lost to Follow-up|0|||
163870472|NCT03036813|591895132|FG000|Overall Study|Physician Decision|2|||
163870473|NCT03036813|591895133|FG001|Overall Study|Physician Decision|1|||
163870474|NCT03036813|591895134|FG002|Overall Study|Physician Decision|1|||
163870475|NCT03036813|591895132|FG000|Overall Study|Non-Compliance|1|||
163870476|NCT03036813|591895133|FG001|Overall Study|Non-Compliance|5|||
163870477|NCT03036813|591895134|FG002|Overall Study|Non-Compliance|3|||
163870478|NCT03036813|591895132|FG000|Overall Study|Pregnancy|0|||
163870479|NCT03036813|591895133|FG001|Overall Study|Pregnancy|0|||
163870480|NCT03036813|591895134|FG002|Overall Study|Pregnancy|1|||
163870481|NCT03036813|591895132|FG000|Overall Study|Other|0|||
163870482|NCT03036813|591895133|FG001|Overall Study|Other|3|||
163870483|NCT03036813|591895134|FG002|Overall Study|Other|5|||
163870484|NCT01102231|591895135|FG000|Overall Study|Protocol Violation|3|||
163870485|NCT01102231|591895135|FG000|Overall Study|Lack of Efficacy|2|||
163870486|NCT01102231|591895135|FG000|Overall Study|Death|2|||
163974326|NCT01438489|592278340|FG002|Overall Study|Withdrawal by Subject|8|||
163974327|NCT01438489|592278338|FG000|Overall Study|Death|0|||
163974328|NCT01438489|592278339|FG001|Overall Study|Death|0|||
164302992|NCT04323124|593484686|FG000|Overall Study|Adverse Event|0|||
163870487|NCT01102231|591895135|FG000|Overall Study|Adverse Event|3|||
163870488|NCT01102231|591895135|FG000|Overall Study|Withdrawal by Subject|1|||
163870489|NCT01102231|591895135|FG000|Overall Study|Did not received the treatment|4|||
163870490|NCT01236560|591895142|FG000|Overall Study|Adverse Event|0|||
163870491|NCT01236560|591895143|FG001|Overall Study|Adverse Event|2|||
163870492|NCT01236560|591895144|FG002|Overall Study|Adverse Event|1|||
163974329|NCT01438489|592278340|FG002|Overall Study|Death|1|||
163974330|NCT01438489|592278338|FG000|Overall Study|Sponsor decision|4|||
163974331|NCT01438489|592278339|FG001|Overall Study|Sponsor decision|1|||
163974332|NCT01438489|592278340|FG002|Overall Study|Sponsor decision|4|||
163870493|NCT01236560|591895145|FG003|Overall Study|Adverse Event|3|||
163870494|NCT01236560|591895146|FG004|Overall Study|Adverse Event|0|||
163870495|NCT01236560|591895147|FG005|Overall Study|Adverse Event|0|||
163974333|NCT01438489|592278338|FG000|Overall Study|Subject choice/Subject moved|2|||
163974334|NCT01438489|592278339|FG001|Overall Study|Subject choice/Subject moved|1|||
163974335|NCT01438489|592278340|FG002|Overall Study|Subject choice/Subject moved|1|||
163974336|NCT01438489|592278338|FG000|Overall Study|Investigator decision|0|||
163974337|NCT01438489|592278339|FG001|Overall Study|Investigator decision|1|||
163974338|NCT01438489|592278340|FG002|Overall Study|Investigator decision|0|||
163974339|NCT01438489|592278338|FG000|Overall Study|AE/SAEs|2|||
163974340|NCT01438489|592278339|FG001|Overall Study|AE/SAEs|1|||
163974341|NCT01438489|592278340|FG002|Overall Study|AE/SAEs|1|||
163974342|NCT01438489|592278338|FG000|Overall Study|Received prohibited medication|1|||
163974343|NCT01438489|592278339|FG001|Overall Study|Received prohibited medication|0|||
163974344|NCT01438489|592278340|FG002|Overall Study|Received prohibited medication|0|||
163974345|NCT01438489|592278338|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
163974346|NCT01438489|592278339|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
163974347|NCT01438489|592278340|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
163974348|NCT01438489|592278338|FG000|Overall Study|Inadequate venous access|0|||
163974349|NCT01438489|592278339|FG001|Overall Study|Inadequate venous access|2|||
163974350|NCT01438489|592278340|FG002|Overall Study|Inadequate venous access|0|||
163974351|NCT00766532|592278341|FG000|Overall Study|Protocol Violation|2|||
163974352|NCT03719690|592278345|FG000|Overall Study|Withdrawal by Subject|5|||
163974353|NCT03719690|592278346|FG001|Overall Study|Withdrawal by Subject|10|||
164204065|NCT05117060|593117926|FG001|Overall Study|Withdrawal by Subject|5|||
163870496|NCT01236560|591895142|FG000|Overall Study|Death|0|||
163870497|NCT01236560|591895143|FG001|Overall Study|Death|1|||
163870498|NCT01236560|591895144|FG002|Overall Study|Death|0|||
163870499|NCT01236560|591895145|FG003|Overall Study|Death|1|||
163870500|NCT01236560|591895146|FG004|Overall Study|Death|0|||
163870501|NCT01236560|591895147|FG005|Overall Study|Death|0|||
163870502|NCT01236560|591895142|FG000|Overall Study|Lost to Follow-up|0|||
163870503|NCT01236560|591895143|FG001|Overall Study|Lost to Follow-up|1|||
163870504|NCT01236560|591895144|FG002|Overall Study|Lost to Follow-up|1|||
163870505|NCT01236560|591895145|FG003|Overall Study|Lost to Follow-up|0|||
163870506|NCT01236560|591895146|FG004|Overall Study|Lost to Follow-up|0|||
163870507|NCT01236560|591895147|FG005|Overall Study|Lost to Follow-up|0|||
163870508|NCT01236560|591895142|FG000|Overall Study|Physician Decision|0|||
163870509|NCT01236560|591895143|FG001|Overall Study|Physician Decision|1|||
163870510|NCT01236560|591895144|FG002|Overall Study|Physician Decision|8|||
163870511|NCT01236560|591895145|FG003|Overall Study|Physician Decision|0|||
163870512|NCT01236560|591895146|FG004|Overall Study|Physician Decision|0|||
163870513|NCT01236560|591895147|FG005|Overall Study|Physician Decision|0|||
163870514|NCT01236560|591895142|FG000|Overall Study|Withdrawal by Subject|0|||
163870515|NCT01236560|591895143|FG001|Overall Study|Withdrawal by Subject|0|||
163870516|NCT01236560|591895144|FG002|Overall Study|Withdrawal by Subject|1|||
163870517|NCT01236560|591895145|FG003|Overall Study|Withdrawal by Subject|2|||
163870518|NCT01236560|591895146|FG004|Overall Study|Withdrawal by Subject|0|||
163870519|NCT01236560|591895147|FG005|Overall Study|Withdrawal by Subject|0|||
163870520|NCT01236560|591895142|FG000|Overall Study|Progressive disease|5|||
163870521|NCT01236560|591895143|FG001|Overall Study|Progressive disease|19|||
163870522|NCT01236560|591895144|FG002|Overall Study|Progressive disease|9|||
163870523|NCT01236560|591895145|FG003|Overall Study|Progressive disease|16|||
163870524|NCT01236560|591895146|FG004|Overall Study|Progressive disease|0|||
163870525|NCT01236560|591895147|FG005|Overall Study|Progressive disease|0|||
163870526|NCT00546754|591895148|FG000|Overall Study|Serious Adverse Event|1|||
163870527|NCT00546754|591895149|FG001|Overall Study|Serious Adverse Event|1|||
163870528|NCT00546754|591895148|FG000|Overall Study|Adverse Event|11|||
163870529|NCT00546754|591895149|FG001|Overall Study|Adverse Event|16|||
163870530|NCT00546754|591895148|FG000|Overall Study|Lack of Efficacy|1|||
163870531|NCT00546754|591895149|FG001|Overall Study|Lack of Efficacy|1|||
163870532|NCT00546754|591895148|FG000|Overall Study|Lost to Follow-up|9|||
163870533|NCT00546754|591895149|FG001|Overall Study|Lost to Follow-up|15|||
163870534|NCT00546754|591895148|FG000|Overall Study|Protocol Violation|3|||
163870535|NCT00546754|591895149|FG001|Overall Study|Protocol Violation|0|||
163870536|NCT00546754|591895148|FG000|Overall Study|Withdrawal by Subject|6|||
163870537|NCT00546754|591895149|FG001|Overall Study|Withdrawal by Subject|7|||
163870538|NCT00546754|591895148|FG000|Overall Study|Dyspnea|1|||
163870539|NCT00546754|591895149|FG001|Overall Study|Dyspnea|0|||
163870540|NCT00546754|591895148|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
163870541|NCT00546754|591895149|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
163870542|NCT00546754|591895148|FG000|Overall Study|Hip Replacement|1|||
163870543|NCT00546754|591895149|FG001|Overall Study|Hip Replacement|0|||
163870544|NCT00546754|591895148|FG000|Overall Study|Suicide|1|||
163870545|NCT00546754|591895149|FG001|Overall Study|Suicide|0|||
163870546|NCT00546754|591895148|FG000|Overall Study|Missing Cooperation|1|||
163870547|NCT00546754|591895149|FG001|Overall Study|Missing Cooperation|0|||
163870548|NCT00546754|591895148|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
163870549|NCT00546754|591895149|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
163870550|NCT00546754|591895148|FG000|Overall Study|Patient's Decision|0|||
163974354|NCT03719690|592278345|FG000|Overall Study|Death|40|||
163870551|NCT00546754|591895149|FG001|Overall Study|Patient's Decision|1|||
163870552|NCT00546754|591895148|FG000|Overall Study|Missing|14|||
163870553|NCT00546754|591895149|FG001|Overall Study|Missing|7|||
163870554|NCT01576484|591895152|FG000|Overall Study|Adverse Event|1|||
163870555|NCT01576484|591895153|FG001|Overall Study|Adverse Event|1|||
163870556|NCT01576484|591895152|FG000|Overall Study|Protocol Violation|0|||
163870557|NCT01576484|591895153|FG001|Overall Study|Protocol Violation|2|||
163870558|NCT01576484|591895152|FG000|Overall Study|Sponsor Decision|2|||
163870559|NCT01576484|591895153|FG001|Overall Study|Sponsor Decision|8|||
163870560|NCT01576484|591895152|FG000|Overall Study|Withdrawal by Subject|0|||
163870561|NCT01576484|591895153|FG001|Overall Study|Withdrawal by Subject|3|||
163870562|NCT01576484|591895152|FG000|Overall Study|Other|2|||
163870563|NCT01576484|591895153|FG001|Overall Study|Other|5|||
163870564|NCT00837616|591895158|FG000|Overall Study|Withdrawal by Subject|0|||
163870565|NCT00837616|591895159|FG001|Overall Study|Withdrawal by Subject|1|||
163870566|NCT03512756|591895165|FG000|Part 1|Death|23|||
163870567|NCT03512756|591895166|FG001|Part 1|Death|18|||
163870568|NCT03512756|591895167|FG002|Part 1|Death|0|||
163870569|NCT03512756|591895168|FG003|Part 1|Death|0|||
163870570|NCT03512756|591895165|FG000|Part 1|Lost to Follow-up|0|||
163870571|NCT03512756|591895166|FG001|Part 1|Lost to Follow-up|3|||
163870572|NCT03512756|591895167|FG002|Part 1|Lost to Follow-up|0|||
163870573|NCT03512756|591895168|FG003|Part 1|Lost to Follow-up|0|||
163870574|NCT03512756|591895165|FG000|Part 1|Physician Decision|0|||
163870575|NCT03512756|591895166|FG001|Part 1|Physician Decision|1|||
163870576|NCT03512756|591895167|FG002|Part 1|Physician Decision|0|||
163870577|NCT03512756|591895168|FG003|Part 1|Physician Decision|0|||
163870578|NCT03512756|591895165|FG000|Part 1|Withdrawal by Subject|2|||
163870579|NCT03512756|591895166|FG001|Part 1|Withdrawal by Subject|2|||
163870580|NCT03512756|591895167|FG002|Part 1|Withdrawal by Subject|0|||
163870581|NCT03512756|591895168|FG003|Part 1|Withdrawal by Subject|0|||
163870582|NCT03512756|591895165|FG000|Part 2|Death|0|||
163870583|NCT03512756|591895166|FG001|Part 2|Death|0|||
163870584|NCT03512756|591895167|FG002|Part 2|Death|32|||
163870585|NCT03512756|591895168|FG003|Part 2|Death|21|||
163870586|NCT03512756|591895165|FG000|Part 2|Lost to Follow-up|0|||
163870587|NCT03512756|591895166|FG001|Part 2|Lost to Follow-up|0|||
163870588|NCT03512756|591895167|FG002|Part 2|Lost to Follow-up|1|||
163870589|NCT03512756|591895168|FG003|Part 2|Lost to Follow-up|0|||
163870590|NCT03512756|591895165|FG000|Part 2|Physician Decision|0|||
163870591|NCT03512756|591895166|FG001|Part 2|Physician Decision|0|||
163870592|NCT03512756|591895167|FG002|Part 2|Physician Decision|2|||
163870593|NCT03512756|591895168|FG003|Part 2|Physician Decision|4|||
163870594|NCT03512756|591895165|FG000|Part 2|Study Terminated by Sponsor|0|||
163870595|NCT03512756|591895166|FG001|Part 2|Study Terminated by Sponsor|0|||
163870596|NCT03512756|591895167|FG002|Part 2|Study Terminated by Sponsor|2|||
163870597|NCT03512756|591895168|FG003|Part 2|Study Terminated by Sponsor|6|||
163870598|NCT03512756|591895165|FG000|Part 2|Protocol Violation|0|||
163870599|NCT03512756|591895166|FG001|Part 2|Protocol Violation|0|||
163870600|NCT03512756|591895167|FG002|Part 2|Protocol Violation|1|||
163870601|NCT03512756|591895168|FG003|Part 2|Protocol Violation|0|||
163870602|NCT03512756|591895165|FG000|Part 2|Withdrawal by Subject|0|||
163870603|NCT03512756|591895166|FG001|Part 2|Withdrawal by Subject|0|||
163870604|NCT03512756|591895167|FG002|Part 2|Withdrawal by Subject|3|||
163870605|NCT03512756|591895168|FG003|Part 2|Withdrawal by Subject|9|||
163870606|NCT03473340|591895169|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
163870607|NCT03473340|591895170|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
163870608|NCT03473340|591895169|FG000|Overall Study|Withdrawal by Subject|1|||
163870609|NCT03473340|591895170|FG001|Overall Study|Withdrawal by Subject|0|||
163870610|NCT03473340|591895169|FG000|Overall Study|Lost to Follow-up|1|||
163870611|NCT03473340|591895170|FG001|Overall Study|Lost to Follow-up|2|||
163870612|NCT02079844|591895171|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
163870613|NCT02079844|591895172|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
163870614|NCT02079844|591895173|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
163870615|NCT02079844|591895171|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
163870616|NCT02079844|591895172|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
163870617|NCT02079844|591895173|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
163870618|NCT01420549|591895174|FG000|Overall Study|Adverse Event|1|||
163870619|NCT01420549|591895175|FG001|Overall Study|Adverse Event|1|||
163870620|NCT01420549|591895174|FG000|Overall Study|Lost to Follow-up|2|||
163870621|NCT01420549|591895175|FG001|Overall Study|Lost to Follow-up|2|||
163870622|NCT01420549|591895174|FG000|Overall Study|Protocol Violation|0|||
163870623|NCT01420549|591895175|FG001|Overall Study|Protocol Violation|1|||
163870624|NCT01420549|591895174|FG000|Overall Study|Non-adherence to medication|4|||
163870625|NCT01420549|591895175|FG001|Overall Study|Non-adherence to medication|1|||
163870626|NCT03394885|591895176|FG000|Overall Study|Adverse Event|4|||
163870627|NCT03394885|591895176|FG000|Overall Study|Lack of Efficacy|1|||
163870628|NCT03394885|591895176|FG000|Overall Study|Physician Decision|1|||
163870629|NCT03394885|591895176|FG000|Overall Study|Withdrawal by Subject|8|||
163870630|NCT03394885|591895176|FG000|Overall Study|Alternative Therapy|1|||
163870631|NCT00203411|591895177|FG000|Follow-up|Progressive Disease|4|||
163870632|NCT04980755|591895178|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
163870633|NCT04980755|591895178|FG000|Body Reprogramming Courses|Work commitment|2|||
163870634|NCT04980755|591895178|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
163870635|NCT04980755|591895178|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
163870636|NCT01212991|591895179|FG000|Double-blind|Lost to Follow-up|8|||
163870637|NCT01212991|591895180|FG001|Double-blind|Lost to Follow-up|4|||
163870638|NCT01212991|591895181|FG002|Double-blind|Lost to Follow-up|0|||
163870639|NCT01212991|591895179|FG000|Double-blind|Death|699|||
163870640|NCT01212991|591895180|FG001|Double-blind|Death|550|||
163870641|NCT01212991|591895181|FG002|Double-blind|Death|0|||
163870642|NCT01212991|591895179|FG000|Double-blind|Withdrawal by Subject|16|||
163870643|NCT01212991|591895180|FG001|Double-blind|Withdrawal by Subject|19|||
163870644|NCT01212991|591895181|FG002|Double-blind|Withdrawal by Subject|0|||
163870645|NCT01212991|591895179|FG000|Double-blind|Other|7|||
163870646|NCT01212991|591895180|FG001|Double-blind|Other|0|||
163870647|NCT01212991|591895181|FG002|Double-blind|Other|0|||
163870648|NCT01212991|591895179|FG000|Double-blind|Sponsor decision|142|||
163870649|NCT01212991|591895180|FG001|Double-blind|Sponsor decision|38|||
163870650|NCT01212991|591895181|FG002|Double-blind|Sponsor decision|0|||
163870651|NCT01212991|591895179|FG000|Open-label|Death|0|||
163870652|NCT01212991|591895180|FG001|Open-label|Death|0|||
163870653|NCT01212991|591895181|FG002|Open-label|Death|166|||
163870654|NCT01212991|591895179|FG000|Open-label|Lost to Follow-up|0|||
163870655|NCT01212991|591895180|FG001|Open-label|Lost to Follow-up|0|||
163870656|NCT01212991|591895181|FG002|Open-label|Lost to Follow-up|5|||
163870657|NCT01212991|591895179|FG000|Open-label|Withdrawal by Subject|0|||
163870658|NCT01212991|591895180|FG001|Open-label|Withdrawal by Subject|0|||
163870659|NCT01212991|591895181|FG002|Open-label|Withdrawal by Subject|7|||
163870660|NCT01212991|591895179|FG000|Open-label|Sponsor decision|0|||
163870661|NCT01212991|591895180|FG001|Open-label|Sponsor decision|0|||
163870662|NCT01212991|591895181|FG002|Open-label|Sponsor decision|53|||
163870663|NCT01212991|591895179|FG000|Open-label|Other|0|||
163870664|NCT01212991|591895180|FG001|Open-label|Other|0|||
163870665|NCT01212991|591895181|FG002|Open-label|Other|3|||
163870666|NCT04714320|591896499|FG000|Overall Study|Voluntary Withdrawal|4|||
163870667|NCT04714320|591896500|FG001|Overall Study|Voluntary Withdrawal|1|||
163870668|NCT04714320|591896501|FG002|Overall Study|Voluntary Withdrawal|2|||
163870669|NCT04714320|591896499|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
163870670|NCT04714320|591896500|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
163870671|NCT04714320|591896501|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
163870672|NCT04714320|591896499|FG000|Overall Study|Reason Not Specified|1|||
163870673|NCT04714320|591896500|FG001|Overall Study|Reason Not Specified|3|||
163870674|NCT04714320|591896501|FG002|Overall Study|Reason Not Specified|3|||
163870675|NCT04755660|591896506|FG000|Overall Study|Lost to Follow-up|1|||
163870676|NCT04755660|591896507|FG001|Overall Study|Lost to Follow-up|1|||
163870677|NCT04755660|591896508|FG002|Overall Study|Lost to Follow-up|0|||
163870678|NCT04755660|591896506|FG000|Overall Study|Withdrawal by Subject|0|||
163870679|NCT04755660|591896507|FG001|Overall Study|Withdrawal by Subject|1|||
163870680|NCT04755660|591896508|FG002|Overall Study|Withdrawal by Subject|1|||
163870681|NCT04755660|591896506|FG000|Overall Study|Physician Decision|0|||
163974355|NCT03719690|592278346|FG001|Overall Study|Death|149|||
163974356|NCT03719690|592278345|FG000|Overall Study|Miscellaneous|12|||
163974357|NCT03719690|592278346|FG001|Overall Study|Miscellaneous|56|||
163974358|NCT03719690|592278345|FG000|Overall Study|Lost to Follow-up|2|||
163974359|NCT03719690|592278346|FG001|Overall Study|Lost to Follow-up|18|||
163974360|NCT03719690|592278345|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
163974361|NCT03719690|592278346|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
163974362|NCT02953340|592278354|FG000|Overall Study|Death|0|||
164314830|NCT02703337|593529782|FG005|Period One (Part A)|Withdrawal by Subject|0|||
163870682|NCT04755660|591896507|FG001|Overall Study|Physician Decision|0|||
163870683|NCT04755660|591896508|FG002|Overall Study|Physician Decision|1|||
163870684|NCT04524390|591896510|FG000|Double Blind|Consent Withdrawal by subject|2|||
163870685|NCT04524390|591896511|FG001|Double Blind|Consent Withdrawal by subject|1|||
163870686|NCT04524390|591896512|FG002|Double Blind|Consent Withdrawal by subject|0|||
163870687|NCT04524390|591896510|FG000|Double Blind|Adverse Event|5|||
163870688|NCT04524390|591896511|FG001|Double Blind|Adverse Event|3|||
163870689|NCT04524390|591896512|FG002|Double Blind|Adverse Event|0|||
163870690|NCT04524390|591896510|FG000|Double Blind|Liver Transplant|5|||
163870691|NCT04524390|591896511|FG001|Double Blind|Liver Transplant|6|||
163870692|NCT04524390|591896512|FG002|Double Blind|Liver Transplant|0|||
163870693|NCT04524390|591896510|FG000|Double Blind|Disease Progression|0|||
163870694|NCT04524390|591896511|FG001|Double Blind|Disease Progression|1|||
163870695|NCT04524390|591896512|FG002|Double Blind|Disease Progression|0|||
163870696|NCT04524390|591896510|FG000|Open-Label|Drug interruption criteria|0|||
163870697|NCT04524390|591896511|FG001|Open-Label|Drug interruption criteria|0|||
163870698|NCT04524390|591896512|FG002|Open-Label|Drug interruption criteria|1|||
163870699|NCT04524390|591896510|FG000|Open-Label|Liver Transplant|0|||
163870700|NCT04524390|591896511|FG001|Open-Label|Liver Transplant|0|||
163974363|NCT02953340|592278355|FG001|Overall Study|Death|1|||
164135923|NCT02799095|592861962|FG007|Part C|Withdrawal by Subject|0|||
163870701|NCT04524390|591896512|FG002|Open-Label|Liver Transplant|1|||
163870702|NCT04524390|591896510|FG000|Open-Label|Disease Progression|0|||
163870703|NCT04524390|591896511|FG001|Open-Label|Disease Progression|0|||
163870704|NCT04524390|591896512|FG002|Open-Label|Disease Progression|1|||
163870705|NCT04524390|591896510|FG000|Open-Label|Adverse Event|0|||
163870706|NCT04524390|591896511|FG001|Open-Label|Adverse Event|0|||
163870707|NCT04524390|591896512|FG002|Open-Label|Adverse Event|3|||
163870708|NCT04524390|591896510|FG000|Open-Label|Study Termination by sponsor|0|||
163870709|NCT04524390|591896511|FG001|Open-Label|Study Termination by sponsor|0|||
163870710|NCT04524390|591896512|FG002|Open-Label|Study Termination by sponsor|45|||
163870711|NCT02765100|591896513|FG000|Overall Study|subject found ineligible after baseline|1|||
163870712|NCT02765100|591896514|FG001|Overall Study|subject found ineligible after baseline|1|||
163870713|NCT02765100|591896513|FG000|Overall Study|Lost to Follow-up|0|||
163870714|NCT02765100|591896514|FG001|Overall Study|Lost to Follow-up|1|||
163870715|NCT02597920|591896515|FG000|Overall Study|Worsening of other pre-existing disease|0|||
163870716|NCT02597920|591896516|FG001|Overall Study|Worsening of other pre-existing disease|1|||
163870717|NCT02597920|591896517|FG002|Overall Study|Worsening of other pre-existing disease|0|||
163870718|NCT02597920|591896515|FG000|Overall Study|Other adverse event|20|||
163870719|NCT02597920|591896516|FG001|Overall Study|Other adverse event|30|||
163870720|NCT02597920|591896517|FG002|Overall Study|Other adverse event|0|||
163870721|NCT02597920|591896515|FG000|Overall Study|Lost to Follow-up|7|||
163870722|NCT02597920|591896516|FG001|Overall Study|Lost to Follow-up|9|||
163870723|NCT02597920|591896517|FG002|Overall Study|Lost to Follow-up|0|||
163870724|NCT02597920|591896515|FG000|Overall Study|Refuse to continue in the study|3|||
163870725|NCT02597920|591896516|FG001|Overall Study|Refuse to continue in the study|13|||
163870726|NCT02597920|591896517|FG002|Overall Study|Refuse to continue in the study|1|||
163870727|NCT02597920|591896515|FG000|Overall Study|Other than specified|10|||
163870728|NCT02597920|591896516|FG001|Overall Study|Other than specified|31|||
163870729|NCT02597920|591896517|FG002|Overall Study|Other than specified|5|||
163870730|NCT02597920|591896515|FG000|Overall Study|Other|1|||
163870731|NCT02597920|591896516|FG001|Overall Study|Other|0|||
163870732|NCT02597920|591896517|FG002|Overall Study|Other|0|||
163870733|NCT04532528|591896523|FG000|Overall Study|Adverse Event|12|||
163870734|NCT04532528|591896524|FG001|Overall Study|Adverse Event|17|||
163870735|NCT04532528|591896523|FG000|Overall Study|Withdrawal of consent|16|||
163870736|NCT04532528|591896524|FG001|Overall Study|Withdrawal of consent|17|||
163870737|NCT04532528|591896523|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
163870738|NCT04532528|591896524|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
163870739|NCT04532528|591896523|FG000|Overall Study|Lost to Follow-up|69|||
163870740|NCT04532528|591896524|FG001|Overall Study|Lost to Follow-up|68|||
163870741|NCT04532528|591896523|FG000|Overall Study|Administrative problems|12|||
163870742|NCT04532528|591896524|FG001|Overall Study|Administrative problems|14|||
163870743|NCT04532528|591896523|FG000|Overall Study|Death|3|||
163870744|NCT04532528|591896524|FG001|Overall Study|Death|3|||
163870745|NCT04532528|591896523|FG000|Overall Study|Other|38|||
163870746|NCT04532528|591896524|FG001|Overall Study|Other|46|||
163870747|NCT00244855|591896529|FG000|Overall Study|Withdrawal by Subject|0|||
163870748|NCT00244855|591896530|FG001|Overall Study|Withdrawal by Subject|1|||
163870749|NCT00665444|591896531|FG000|Overall Study|Physician Decision|1|||
163870750|NCT00665444|591896531|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
163870751|NCT01068743|591896532|FG000|Period 3|Adverse Event|0|||
163870752|NCT01068743|591896533|FG001|Period 3|Adverse Event|1|||
163870753|NCT01068743|591896534|FG002|Period 3|Adverse Event|0|||
163870754|NCT01068743|591896535|FG003|Period 3|Adverse Event|0|||
163870755|NCT00293293|591896536|FG000|Overall Study|Withdrawal by Subject|1|||
163870756|NCT00293293|591896537|FG001|Overall Study|Withdrawal by Subject|1|||
163870757|NCT00293293|591896536|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
163870758|NCT00293293|591896537|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
163870759|NCT00293293|591896536|FG000|Overall Study|Patient discontinued chemotherapy|0|||
163870760|NCT00293293|591896537|FG001|Overall Study|Patient discontinued chemotherapy|1|||
163870761|NCT03740009|591896541|FG000|Overall Study|Physician Decision|9|||
163870762|NCT03740009|591896541|FG000|Overall Study|Lost to Follow-up|1|||
163870763|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
163870764|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
163870765|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
163870766|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
163870767|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
163870768|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
163870769|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
163870770|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
163870771|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
163870772|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
163870773|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
163870774|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
163974364|NCT02953340|592278354|FG000|Overall Study|Investigator Decision|3|||
163974365|NCT02953340|592278355|FG001|Overall Study|Investigator Decision|3|||
163974366|NCT02953340|592278354|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
163974367|NCT02953340|592278355|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
163974368|NCT02953340|592278354|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
163974369|NCT02953340|592278355|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
163974370|NCT02953340|592278354|FG000|Overall Study|Withdrawal by Subject|9|||
163974371|NCT02953340|592278355|FG001|Overall Study|Withdrawal by Subject|9|||
163974372|NCT02953340|592278354|FG000|Overall Study|Sponsor decision|0|||
163974373|NCT02953340|592278355|FG001|Overall Study|Sponsor decision|2|||
163974374|NCT02953340|592278354|FG000|Overall Study|Lost to Follow-up|3|||
163974375|NCT02953340|592278355|FG001|Overall Study|Lost to Follow-up|2|||
163974376|NCT02953340|592278354|FG000|Overall Study|Reason not specified|2|||
163974377|NCT02953340|592278355|FG001|Overall Study|Reason not specified|2|||
163974378|NCT00530270|592278358|FG000|Overall Study|Protocol Violation|1|||
163974379|NCT00530270|592278359|FG001|Overall Study|Protocol Violation|0|||
163974380|NCT01923285|592278368|FG000|Overall Study|Withdrawal by Subject|7|||
163974381|NCT01923285|592278369|FG001|Overall Study|Withdrawal by Subject|6|||
163974382|NCT01309659|592278372|FG000|Overall Study|Protocol Violation|0|||
163974383|NCT01309659|592278373|FG001|Overall Study|Protocol Violation|1|||
163974384|NCT03962101|592278374|FG000|Overall Study|Adverse Event|1|||
163974385|NCT03962101|592278374|FG000|Overall Study|Physician Decision|2|||
163974386|NCT03962101|592278374|FG000|Overall Study|Not related to medical events|1|||
163974387|NCT00865904|592278380|FG000|Overall Study|Randomized but not Treated|2|||
163974388|NCT00865904|592278381|FG001|Overall Study|Randomized but not Treated|0|||
163974389|NCT00865904|592278382|FG002|Overall Study|Randomized but not Treated|0|||
163974390|NCT00865904|592278383|FG003|Overall Study|Randomized but not Treated|1|||
163974391|NCT00865904|592278384|FG004|Overall Study|Randomized but not Treated|1|||
163974392|NCT01543828|592278385|FG000|Treatment 2|Lost to Follow-up|1|||
163974393|NCT01543828|592278386|FG001|Treatment 2|Lost to Follow-up|0|||
163974394|NCT03901079|592278389|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
163974395|NCT04607148|592278390|FG000|Overall Study|Withdrawal by Subject|0|||
163974396|NCT04607148|592278391|FG001|Overall Study|Withdrawal by Subject|4|||
163974397|NCT04607148|592278392|FG002|Overall Study|Withdrawal by Subject|2|||
163974398|NCT04607148|592278393|FG003|Overall Study|Withdrawal by Subject|8|||
163974399|NCT04607148|592278390|FG000|Overall Study|Study Terminated by Sponsor|14|||
163974400|NCT04607148|592278391|FG001|Overall Study|Study Terminated by Sponsor|59|||
163974401|NCT04607148|592278392|FG002|Overall Study|Study Terminated by Sponsor|9|||
163974402|NCT04607148|592278393|FG003|Overall Study|Study Terminated by Sponsor|39|||
163974403|NCT04607148|592278390|FG000|Overall Study|Sponsor Decision|0|||
163974404|NCT04607148|592278391|FG001|Overall Study|Sponsor Decision|0|||
163974405|NCT04607148|592278392|FG002|Overall Study|Sponsor Decision|1|||
163974406|NCT04607148|592278393|FG003|Overall Study|Sponsor Decision|0|||
163974407|NCT04607148|592278390|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163974408|NCT04607148|592278391|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163974409|NCT04607148|592278392|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163974410|NCT04607148|592278393|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163974411|NCT04607148|592278390|FG000|Overall Study|Lost to Follow-up|0|||
163974412|NCT04607148|592278391|FG001|Overall Study|Lost to Follow-up|2|||
163974413|NCT04607148|592278392|FG002|Overall Study|Lost to Follow-up|0|||
163974414|NCT04607148|592278393|FG003|Overall Study|Lost to Follow-up|0|||
163974415|NCT04607148|592278390|FG000|Overall Study|Death|0|||
163974416|NCT04607148|592278391|FG001|Overall Study|Death|3|||
163974417|NCT04607148|592278392|FG002|Overall Study|Death|0|||
163974418|NCT04607148|592278393|FG003|Overall Study|Death|1|||
163974419|NCT04607148|592278390|FG000|Overall Study|Adverse Event|0|||
163974420|NCT04607148|592278391|FG001|Overall Study|Adverse Event|1|||
163974421|NCT04607148|592278392|FG002|Overall Study|Adverse Event|0|||
163974422|NCT04607148|592278393|FG003|Overall Study|Adverse Event|0|||
163974423|NCT01820364|592278394|FG000|Part I: LGX818|Death|1|||
163974424|NCT01820364|592278395|FG001|Part I: LGX818|Death|0|||
163974425|NCT01820364|592278394|FG000|Part I: LGX818|Administrative Problems|3|||
163974426|NCT01820364|592278395|FG001|Part I: LGX818|Administrative Problems|0|||
163974427|NCT01820364|592278394|FG000|Part I: LGX818|Adverse Event|6|||
163974428|NCT01820364|592278395|FG001|Part I: LGX818|Adverse Event|0|||
163974429|NCT01820364|592278394|FG000|Part I: LGX818|Disease Progression|4|||
163974430|NCT01820364|592278395|FG001|Part I: LGX818|Disease Progression|0|||
163974431|NCT01820364|592278394|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
163974432|NCT01820364|592278395|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
163974433|NCT00825162|592278401|FG000|Overall Study|Withdrawal by Subject|11|||
163974434|NCT00825162|592278402|FG001|Overall Study|Withdrawal by Subject|13|||
163974435|NCT00825162|592278403|FG002|Overall Study|Withdrawal by Subject|3|||
163974436|NCT00825162|592278401|FG000|Overall Study|Lost to Follow-up|9|||
163974437|NCT00825162|592278402|FG001|Overall Study|Lost to Follow-up|6|||
163974438|NCT00825162|592278403|FG002|Overall Study|Lost to Follow-up|3|||
163974439|NCT00825162|592278401|FG000|Overall Study|Physician Decision|2|||
163974440|NCT00825162|592278402|FG001|Overall Study|Physician Decision|0|||
163974441|NCT00825162|592278403|FG002|Overall Study|Physician Decision|0|||
163974442|NCT00825162|592278401|FG000|Overall Study|Move away from the study area|1|||
163974443|NCT00825162|592278402|FG001|Overall Study|Move away from the study area|0|||
163974444|NCT00825162|592278403|FG002|Overall Study|Move away from the study area|0|||
163974445|NCT00825162|592278401|FG000|Overall Study|Unable to attend the study visit|5|||
163974446|NCT00825162|592278402|FG001|Overall Study|Unable to attend the study visit|2|||
163974447|NCT00825162|592278403|FG002|Overall Study|Unable to attend the study visit|0|||
163974448|NCT02016820|592278411|FG000|Overall Study|Lost to Follow-up|2|||
163974449|NCT02016820|592278412|FG001|Overall Study|Lost to Follow-up|4|||
163974450|NCT00884273|592278413|FG000|Overall Study|Adverse Event|0|||
163974451|NCT00884273|592278414|FG001|Overall Study|Adverse Event|2|||
163974452|NCT00884273|592278413|FG000|Overall Study|Protocol Violation|1|||
163974453|NCT00884273|592278414|FG001|Overall Study|Protocol Violation|3|||
163974454|NCT00884273|592278413|FG000|Overall Study|Practical reasons|1|||
163974455|NCT00884273|592278414|FG001|Overall Study|Practical reasons|0|||
163974456|NCT00258674|592278415|FG000|Overall Study|Death|32|||
163974457|NCT00258674|592278416|FG001|Overall Study|Death|53|||
163974458|NCT00258674|592278417|FG002|Overall Study|Death|34|||
163974459|NCT03710486|592278418|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
163974460|NCT03710486|592278419|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
163974461|NCT03710486|592278418|FG000|Overall Study|Missing|0|||
163974462|NCT03710486|592278419|FG001|Overall Study|Missing|2|||
163974463|NCT01279850|592278420|FG000|Overall Study|Protocol Violation|50|||
163974464|NCT01279850|592278420|FG000|Overall Study|No Drug Administration Information|7|||
163974465|NCT01279850|592278420|FG000|Overall Study|No Visit After Treatment|34|||
163974466|NCT00432042|592278428|FG000|Overall Study|Protocol Violation|2|||
163974467|NCT00432042|592278429|FG001|Overall Study|Protocol Violation|0|||
163974468|NCT00432042|592278430|FG002|Overall Study|Protocol Violation|0|||
163974469|NCT00432042|592278428|FG000|Overall Study|Withdrawal by Subject|0|||
163974470|NCT00432042|592278429|FG001|Overall Study|Withdrawal by Subject|0|||
163974471|NCT00432042|592278430|FG002|Overall Study|Withdrawal by Subject|2|||
163974472|NCT00432042|592278428|FG000|Overall Study|Lost to Follow-up|5|||
163974473|NCT00432042|592278429|FG001|Overall Study|Lost to Follow-up|1|||
163974474|NCT00432042|592278430|FG002|Overall Study|Lost to Follow-up|0|||
163974475|NCT00492752|592278432|FG000|Double Blind Treatment|Death|13|||
163974476|NCT00492752|592278433|FG001|Double Blind Treatment|Death|0|||
163974477|NCT00492752|592278434|FG002|Double Blind Treatment|Death|2|||
163974478|NCT00492752|592278435|FG003|Double Blind Treatment|Death|0|||
163974479|NCT00492752|592278432|FG000|Double Blind Treatment|Adverse Event|1|||
163974480|NCT00492752|592278433|FG001|Double Blind Treatment|Adverse Event|0|||
163974481|NCT00492752|592278434|FG002|Double Blind Treatment|Adverse Event|0|||
163974482|NCT00492752|592278435|FG003|Double Blind Treatment|Adverse Event|0|||
163974483|NCT00492752|592278432|FG000|Double Blind Treatment|Protocol Violation|0|||
163974484|NCT00492752|592278433|FG001|Double Blind Treatment|Protocol Violation|0|||
163974485|NCT00492752|592278434|FG002|Double Blind Treatment|Protocol Violation|1|||
163974486|NCT00492752|592278435|FG003|Double Blind Treatment|Protocol Violation|0|||
163974487|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
163974488|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
163974489|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
163974490|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
163974491|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
163974492|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
163974493|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
163974494|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
163974495|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
163974496|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
163974497|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
163974498|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
163974499|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
163974500|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
163974501|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
163974502|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
163974503|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
163974504|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
163974505|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
163974506|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
163974507|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
163974508|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
163974509|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
163974510|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
163974511|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
163974512|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
163974513|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
163974514|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
163974515|NCT00492752|592278432|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
163974516|NCT00492752|592278433|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
163974517|NCT00492752|592278434|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
163974518|NCT00492752|592278435|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
163974519|NCT02321930|592278439|FG000|Overall Study|Lost to Follow-up|1|||
163974520|NCT01484977|592278440|FG000|Overall Study|Adverse Event|8|||
163974521|NCT01484977|592278440|FG000|Overall Study|Lack of Efficacy|4|||
163974522|NCT01484977|592278440|FG000|Overall Study|Protocol Violation|6|||
163974523|NCT01484977|592278440|FG000|Overall Study|Lost to Follow-up|1|||
163974524|NCT01484977|592278440|FG000|Overall Study|Withdrawal by Subject|4|||
163974525|NCT01484977|592278440|FG000|Overall Study|Subject Protocol Non-compliant|1|||
163974526|NCT01484977|592278440|FG000|Overall Study|Moving Overseas|1|||
163974527|NCT01484977|592278440|FG000|Overall Study|Low White Blood Cell Count|1|||
163974528|NCT01484977|592278440|FG000|Overall Study|Lack of Compliance|1|||
163974529|NCT04857996|592278441|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
163974530|NCT04857996|592278442|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
163974531|NCT04857996|592278441|FG000|Overall Study|Lost to Follow-up|1|||
163974532|NCT04857996|592278442|FG001|Overall Study|Lost to Follow-up|3|||
163974533|NCT04857996|592278441|FG000|Overall Study|Site Closure|1|||
163974534|NCT04857996|592278442|FG001|Overall Study|Site Closure|0|||
163974535|NCT04857996|592278441|FG000|Overall Study|Withdrawal by Subject|1|||
163974536|NCT04857996|592278442|FG001|Overall Study|Withdrawal by Subject|0|||
163974537|NCT01129921|592278443|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
163974538|NCT01129921|592278444|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
163974539|NCT01129921|592278443|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
163974540|NCT01129921|592278444|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
163974541|NCT01129921|592278443|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
163974542|NCT01129921|592278444|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
163974543|NCT01129921|592278443|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
163974544|NCT01129921|592278444|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
163974545|NCT02484911|592279836|FG000|Overall Study|Withdrawal by Subject|2|||
163974546|NCT02484911|592279837|FG001|Overall Study|Withdrawal by Subject|1|||
163974547|NCT02484911|592279836|FG000|Overall Study|Protocol Violation|2|||
163974548|NCT02484911|592279837|FG001|Overall Study|Protocol Violation|1|||
163974549|NCT02222207|592279838|FG000|Overall Study|Death|1|||
163974550|NCT02222207|592279838|FG000|Overall Study|Other reasons|2|||
163974551|NCT02222207|592279838|FG000|Overall Study|Adverse Event|1|||
163974552|NCT01773109|592279839|FG000|Overall Study|Symptomatic Progression|2|||
163974553|NCT01773109|592279839|FG000|Overall Study|Death|1|||
163974554|NCT01239342|592279840|FG000|Overall Study|Adverse Event|1|||
163974555|NCT01239342|592279841|FG001|Overall Study|Adverse Event|0|||
163974556|NCT01239342|592279840|FG000|Overall Study|Withdrawal by Subject|1|||
163974557|NCT01239342|592279841|FG001|Overall Study|Withdrawal by Subject|5|||
163974558|NCT01239342|592279840|FG000|Overall Study|Reason Unknown|1|||
163974559|NCT01239342|592279841|FG001|Overall Study|Reason Unknown|1|||
163974560|NCT02257372|592279844|FG000|Overall Study|Adverse Event|3|||
163974561|NCT02257372|592279845|FG001|Overall Study|Adverse Event|7|||
163974562|NCT02257372|592279844|FG000|Overall Study|Lack of Efficacy|2|||
163870775|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
163870776|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
163870777|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
163870778|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
163870779|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
163870780|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
163870781|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
163870782|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
163870783|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
163870784|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
163870785|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
163870786|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
163870787|NCT01061151|591896542|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
163870788|NCT01061151|591896543|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
163870789|NCT01061151|591896544|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
163870790|NCT01061151|591896545|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
163974563|NCT02257372|592279845|FG001|Overall Study|Lack of Efficacy|1|||
164204066|NCT05117060|593117927|FG002|Overall Study|Withdrawal by Subject|5|||
163974564|NCT02257372|592279844|FG000|Overall Study|Protocol Violation|1|||
163974565|NCT02257372|592279845|FG001|Overall Study|Protocol Violation|1|||
163974566|NCT02257372|592279844|FG000|Overall Study|Lost to Follow-up|0|||
163974567|NCT02257372|592279845|FG001|Overall Study|Lost to Follow-up|1|||
163974568|NCT02257372|592279844|FG000|Overall Study|Withdrew consent|1|||
163974569|NCT02257372|592279845|FG001|Overall Study|Withdrew consent|0|||
163974570|NCT02104583|592279847|FG000|Overall Study|New ICD or CRT-D implanted|2|||
163974571|NCT02104583|592279848|FG001|Overall Study|New ICD or CRT-D implanted|0|||
163974572|NCT02104583|592279849|FG002|Overall Study|New ICD or CRT-D implanted|1|||
163974573|NCT02104583|592279850|FG003|Overall Study|New ICD or CRT-D implanted|0|||
163974574|NCT02104583|592279851|FG004|Overall Study|New ICD or CRT-D implanted|0|||
163974575|NCT02104583|592279847|FG000|Overall Study|Death|2|||
163974576|NCT02104583|592279848|FG001|Overall Study|Death|1|||
163974577|NCT02104583|592279849|FG002|Overall Study|Death|3|||
163974578|NCT02104583|592279850|FG003|Overall Study|Death|3|||
163974579|NCT02104583|592279851|FG004|Overall Study|Death|5|||
163974580|NCT02104583|592279847|FG000|Overall Study|Subject required cardiac ablation|6|||
163974581|NCT02104583|592279848|FG001|Overall Study|Subject required cardiac ablation|4|||
163974582|NCT02104583|592279849|FG002|Overall Study|Subject required cardiac ablation|4|||
163974583|NCT02104583|592279850|FG003|Overall Study|Subject required cardiac ablation|5|||
163974584|NCT02104583|592279851|FG004|Overall Study|Subject required cardiac ablation|4|||
163974585|NCT02104583|592279847|FG000|Overall Study|Subject required prohibited medication|0|||
163974586|NCT02104583|592279848|FG001|Overall Study|Subject required prohibited medication|1|||
163974587|NCT02104583|592279849|FG002|Overall Study|Subject required prohibited medication|1|||
163974588|NCT02104583|592279850|FG003|Overall Study|Subject required prohibited medication|0|||
163974589|NCT02104583|592279851|FG004|Overall Study|Subject required prohibited medication|1|||
163974590|NCT02104583|592279847|FG000|Overall Study|Withdrew Consent|3|||
163974591|NCT02104583|592279848|FG001|Overall Study|Withdrew Consent|2|||
163974592|NCT02104583|592279849|FG002|Overall Study|Withdrew Consent|0|||
163974593|NCT02104583|592279850|FG003|Overall Study|Withdrew Consent|2|||
163974594|NCT02104583|592279851|FG004|Overall Study|Withdrew Consent|1|||
163974595|NCT02104583|592279847|FG000|Overall Study|Investigator's Discretion|1|||
163974596|NCT02104583|592279848|FG001|Overall Study|Investigator's Discretion|0|||
163974597|NCT02104583|592279849|FG002|Overall Study|Investigator's Discretion|0|||
163974598|NCT02104583|592279850|FG003|Overall Study|Investigator's Discretion|0|||
163974599|NCT02104583|592279851|FG004|Overall Study|Investigator's Discretion|0|||
163974600|NCT02104583|592279847|FG000|Overall Study|Protocol Violation|0|||
163974601|NCT02104583|592279848|FG001|Overall Study|Protocol Violation|0|||
163974602|NCT02104583|592279849|FG002|Overall Study|Protocol Violation|1|||
163974603|NCT02104583|592279850|FG003|Overall Study|Protocol Violation|0|||
163974604|NCT02104583|592279851|FG004|Overall Study|Protocol Violation|0|||
163974605|NCT02104583|592279847|FG000|Overall Study|Adverse Event|3|||
163974606|NCT02104583|592279848|FG001|Overall Study|Adverse Event|3|||
163974607|NCT02104583|592279849|FG002|Overall Study|Adverse Event|6|||
163974608|NCT02104583|592279850|FG003|Overall Study|Adverse Event|6|||
163974609|NCT02104583|592279851|FG004|Overall Study|Adverse Event|1|||
163974610|NCT02104583|592279847|FG000|Overall Study|Lost to Follow-up|1|||
163974611|NCT02104583|592279848|FG001|Overall Study|Lost to Follow-up|0|||
163974612|NCT02104583|592279849|FG002|Overall Study|Lost to Follow-up|0|||
163974613|NCT02104583|592279850|FG003|Overall Study|Lost to Follow-up|0|||
163974614|NCT02104583|592279851|FG004|Overall Study|Lost to Follow-up|0|||
163974615|NCT02104583|592279847|FG000|Overall Study|Randomized but Never Treated|0|||
163974616|NCT02104583|592279848|FG001|Overall Study|Randomized but Never Treated|0|||
163974617|NCT02104583|592279849|FG002|Overall Study|Randomized but Never Treated|0|||
163974618|NCT02104583|592279850|FG003|Overall Study|Randomized but Never Treated|1|||
163974619|NCT02104583|592279851|FG004|Overall Study|Randomized but Never Treated|0|||
163974620|NCT00129766|592279853|FG000|Overall Study|Death|3|||
163974621|NCT00129766|592279854|FG001|Overall Study|Death|8|||
163974622|NCT00129766|592279853|FG000|Overall Study|Withdrawal of consent|31|||
163974623|NCT00129766|592279854|FG001|Overall Study|Withdrawal of consent|30|||
163974624|NCT00129766|592279853|FG000|Overall Study|Lost to Follow-up|26|||
163974625|NCT00129766|592279854|FG001|Overall Study|Lost to Follow-up|21|||
163974626|NCT01476475|592279859|FG000|Overall Study|Adverse Event|6|||
163974627|NCT01476475|592279860|FG001|Overall Study|Adverse Event|0|||
163974628|NCT01476475|592279859|FG000|Overall Study|Poor compliance to protocol|1|||
163974629|NCT01476475|592279860|FG001|Overall Study|Poor compliance to protocol|1|||
163974630|NCT01476475|592279859|FG000|Overall Study|Other reasons|4|||
163974631|NCT01476475|592279860|FG001|Overall Study|Other reasons|2|||
163974632|NCT00751400|592279862|FG000|Overall Study|Lost to Follow-up|10|||
163974633|NCT01372384|592279863|FG000|Overall Study|Progression of disease|3|||
163974634|NCT00441974|592279867|FG000|Overall Study|Adverse Event|6|||
163974635|NCT00441974|592279867|FG000|Overall Study|Consent Withdrawn|35|||
163974636|NCT00441974|592279867|FG000|Overall Study|Lost to Follow-up|80|||
163974637|NCT00441974|592279867|FG000|Overall Study|Protocol Violation|7|||
163974638|NCT02576444|592279868|FG000|Overall Study|Death|1|||
163974639|NCT02576444|592279869|FG001|Overall Study|Death|1|||
163974640|NCT02576444|592279870|FG002|Overall Study|Death|0|||
163974641|NCT02576444|592279871|FG003|Overall Study|Death|0|||
163974642|NCT02576444|592279868|FG000|Overall Study|Withdrawal by Subject|0|||
163974643|NCT02576444|592279869|FG001|Overall Study|Withdrawal by Subject|0|||
163974644|NCT02576444|592279870|FG002|Overall Study|Withdrawal by Subject|2|||
163974645|NCT02576444|592279871|FG003|Overall Study|Withdrawal by Subject|0|||
163974646|NCT02576444|592279868|FG000|Overall Study|Adverse Event|0|||
163974647|NCT02576444|592279869|FG001|Overall Study|Adverse Event|0|||
163974648|NCT02576444|592279870|FG002|Overall Study|Adverse Event|1|||
163974649|NCT02576444|592279871|FG003|Overall Study|Adverse Event|0|||
163974650|NCT02576444|592279868|FG000|Overall Study|Physician Decision|0|||
163974651|NCT02576444|592279869|FG001|Overall Study|Physician Decision|0|||
163974652|NCT02576444|592279870|FG002|Overall Study|Physician Decision|1|||
163974653|NCT02576444|592279871|FG003|Overall Study|Physician Decision|0|||
163974654|NCT03370120|592279877|FG000|Overall Study|Adverse event, non-fatal|24|||
163974655|NCT03370120|592279877|FG000|Overall Study|Withdrawal by Subject|6|||
163974656|NCT03370120|592279877|FG000|Overall Study|Lost to Follow-up|1|||
163974657|NCT03370120|592279877|FG000|Overall Study|Lack of Efficacy|37|||
163974658|NCT03370120|592279877|FG000|Overall Study|Per sponsor's instructions|1|||
163974659|NCT03370120|592279877|FG000|Overall Study|Study was terminated by parent company UCB|2|||
163974660|NCT03370120|592279877|FG000|Overall Study|The study was ended by the promoter|3|||
163974661|NCT03370120|592279877|FG000|Overall Study|Discontinuation of drug development|3|||
163974662|NCT03370120|592279877|FG000|Overall Study|End of project|2|||
163974663|NCT03370120|592279877|FG000|Overall Study|Premature study closure|2|||
163974664|NCT03370120|592279877|FG000|Overall Study|Premature program termination|1|||
163974665|NCT03370120|592279877|FG000|Overall Study|Premature study termination|7|||
163974666|NCT03370120|592279877|FG000|Overall Study|Trial terminated by sponsor|2|||
163974667|NCT03370120|592279877|FG000|Overall Study|Trial discontinued by sponsor|2|||
163974668|NCT03370120|592279877|FG000|Overall Study|Study ended|15|||
163974669|NCT03370120|592279877|FG000|Overall Study|Clinical trial has been cancelled|1|||
163974670|NCT03370120|592279877|FG000|Overall Study|End of study per sponsor decision|2|||
163974671|NCT03370120|592279877|FG000|Overall Study|Promoter's decision|2|||
163974672|NCT03370120|592279877|FG000|Overall Study|The trial has been suspended|3|||
163974673|NCT03370120|592279877|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
163974674|NCT03370120|592279877|FG000|Overall Study|Early termination by order of sponsor|2|||
163974675|NCT03370120|592279877|FG000|Overall Study|Discontinuation of the study|5|||
163974676|NCT03370120|592279877|FG000|Overall Study|End of clinical trial discontinuation|1|||
163974677|NCT03370120|592279877|FG000|Overall Study|Because the clinical trial ended halfway|4|||
163974678|NCT03370120|592279877|FG000|Overall Study|Development discontinued|5|||
163974679|NCT03370120|592279877|FG000|Overall Study|Padsenovil program closed|3|||
163974680|NCT03370120|592279877|FG000|Overall Study|End of project|2|||
163974681|NCT03370120|592279877|FG000|Overall Study|Termination of project|1|||
163974682|NCT03370120|592279877|FG000|Overall Study|The study was interrupted by sponsor|4|||
163974683|NCT03370120|592279877|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
163974684|NCT03370120|592279877|FG000|Overall Study|End of sponsor decision|1|||
163974685|NCT03370120|592279877|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
163974686|NCT03370120|592279877|FG000|Overall Study|Early termination of studies|5|||
163974687|NCT03370120|592279877|FG000|Overall Study|This study is ended early|1|||
163974688|NCT03370120|592279877|FG000|Overall Study|End of padsevonil program|2|||
163974689|NCT03370120|592279877|FG000|Overall Study|Decision of sponsor|6|||
163974690|NCT03370120|592279877|FG000|Overall Study|Asked by the sponsor|3|||
163974691|NCT03370120|592279877|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
163974692|NCT03370120|592279877|FG000|Overall Study|PI decision poor compliance from participant|1|||
163974693|NCT03370120|592279877|FG000|Overall Study|Promoter ended the study|3|||
163974694|NCT03370120|592279877|FG000|Overall Study|Premature study close by sponsor's decision|4|||
163974695|NCT03370120|592279877|FG000|Overall Study|Study terminated by sponsor|33|||
163974696|NCT03370120|592279877|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
163974697|NCT03370120|592279877|FG000|Overall Study|Sponsor decision to terminate study|63|||
163974698|NCT03370120|592279877|FG000|Overall Study|Program closure|3|||
163974699|NCT03370120|592279877|FG000|Overall Study|Study ended prematurely|1|||
163974700|NCT03370120|592279877|FG000|Overall Study|Study stopped by sponsor|2|||
163974701|NCT03370120|592279877|FG000|Overall Study|Program termination|55|||
163974702|NCT03370120|592279877|FG000|Overall Study|Sponsor decision|62|||
163974703|NCT03370120|592279877|FG000|Overall Study|Sponsor study closure|10|||
163974704|NCT00928889|592279879|FG000|Overall Study|Lost to Follow-up|3|||
163974705|NCT00928889|592279880|FG001|Overall Study|Lost to Follow-up|1|||
163974706|NCT00928889|592279879|FG000|Overall Study|Protocol Violation|0|||
163974707|NCT00928889|592279880|FG001|Overall Study|Protocol Violation|1|||
163974708|NCT00928889|592279879|FG000|Overall Study|Adverse Event|1|||
163974709|NCT00928889|592279880|FG001|Overall Study|Adverse Event|0|||
163974710|NCT00928889|592279879|FG000|Overall Study|Other|1|||
163974711|NCT00928889|592279880|FG001|Overall Study|Other|0|||
163974712|NCT04712110|592279881|FG000|Overall Study|Lost to Follow-up|0|||
163974713|NCT04712110|592279882|FG001|Overall Study|Lost to Follow-up|1|||
163974714|NCT04712110|592279881|FG000|Overall Study|Withdrawal by Subject|0|||
163974715|NCT04712110|592279882|FG001|Overall Study|Withdrawal by Subject|4|||
163870791|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
163870792|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
163870793|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
163870794|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
163870795|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
163870796|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
163870797|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
163870798|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
163870799|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
163870800|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
163870801|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
163870802|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
163870803|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
163870804|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
163870805|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
163870806|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
163870807|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
163870808|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
163870809|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
163870810|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
163870811|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
163870812|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
163870813|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
163870814|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
163870815|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
163870816|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
163870817|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
163870818|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
163870819|NCT01061151|591896542|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
163870820|NCT01061151|591896543|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
163870821|NCT01061151|591896544|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
163870822|NCT01061151|591896545|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
163870823|NCT03756571|591896555|FG000|Overall Study|Lost to Follow-up|1|||
163870824|NCT03756571|591896556|FG001|Overall Study|Lost to Follow-up|1|||
163870825|NCT02379819|591896557|FG000|Overall Study|Withdrawal by Subject|10|||
163870826|NCT02379819|591896557|FG000|Overall Study|Death|2|||
163870827|NCT02379819|591896557|FG000|Overall Study|Lack of Efficacy|1|||
163870828|NCT02379819|591896557|FG000|Overall Study|Lost to Follow-up|1|||
163870829|NCT00529516|591896558|FG000|Overall Study|Adverse Event|2|||
163870830|NCT00529516|591896559|FG001|Overall Study|Adverse Event|1|||
163870831|NCT00529516|591896560|FG002|Overall Study|Adverse Event|0|||
163870832|NCT00529516|591896558|FG000|Overall Study|Withdrawal by Subject|1|||
163870833|NCT00529516|591896559|FG001|Overall Study|Withdrawal by Subject|1|||
163870834|NCT00529516|591896560|FG002|Overall Study|Withdrawal by Subject|0|||
163870835|NCT00529516|591896558|FG000|Overall Study|Lost to Follow-up|0|||
163870836|NCT00529516|591896559|FG001|Overall Study|Lost to Follow-up|0|||
163870837|NCT00529516|591896560|FG002|Overall Study|Lost to Follow-up|1|||
163870838|NCT03752151|591896561|FG000|Overall Study|Withdrawal by Subject|1|||
163870839|NCT03752151|591896561|FG000|Overall Study|Protocol Violation|1|||
163870840|NCT04056624|591896562|FG000|Overall Study|Withdrawal by Subject|0|||
163870841|NCT04056624|591896563|FG001|Overall Study|Withdrawal by Subject|0|||
163870842|NCT04056624|591896564|FG002|Overall Study|Withdrawal by Subject|1|||
163870843|NCT04056624|591896562|FG000|Overall Study|Protocol Violation|1|||
163870844|NCT04056624|591896563|FG001|Overall Study|Protocol Violation|2|||
163870845|NCT04056624|591896564|FG002|Overall Study|Protocol Violation|0|||
163870846|NCT00703820|591896568|FG000|Overall Study|Adverse Event|12|||
163870847|NCT00703820|591896569|FG001|Overall Study|Adverse Event|17|||
163870848|NCT00703820|591896568|FG000|Overall Study|Death|5|||
163870849|NCT00703820|591896569|FG001|Overall Study|Death|0|||
163870850|NCT00703820|591896568|FG000|Overall Study|Lack of Efficacy|11|||
163870851|NCT00703820|591896569|FG001|Overall Study|Lack of Efficacy|11|||
163870852|NCT00703820|591896568|FG000|Overall Study|Received non-protocol therapy|1|||
164204067|NCT05117060|593117928|FG003|Overall Study|Withdrawal by Subject|6|||
163870853|NCT00703820|591896569|FG001|Overall Study|Received non-protocol therapy|0|||
163870854|NCT00703820|591896568|FG000|Overall Study|Physician Decision|4|||
163870855|NCT00703820|591896569|FG001|Overall Study|Physician Decision|5|||
163870856|NCT00703820|591896568|FG000|Overall Study|Withdrawal by Subject|2|||
163870857|NCT00703820|591896569|FG001|Overall Study|Withdrawal by Subject|1|||
163870858|NCT01007396|591896572|FG000|Overall Study|Lost to Follow-up|47|||
163870859|NCT03451721|591896573|FG000|Overall Study|Death|1|||
164204068|NCT05117060|593117925|FG000|Overall Study|Other|2|||
164204069|NCT05117060|593117926|FG001|Overall Study|Other|1|||
163974716|NCT04712110|592279881|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
163974717|NCT04712110|592279882|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
163974718|NCT01356407|592279883|FG000|Overall Study|Lost to Follow-up|2|||
163974719|NCT01356407|592279884|FG001|Overall Study|Lost to Follow-up|0|||
163974720|NCT01356407|592279883|FG000|Overall Study|Patient Withdrew Consent|2|||
163974721|NCT01356407|592279884|FG001|Overall Study|Patient Withdrew Consent|1|||
163974722|NCT01356407|592279883|FG000|Overall Study|Could not afford IMP administration|0|||
163974723|NCT01356407|592279884|FG001|Overall Study|Could not afford IMP administration|1|||
163974724|NCT01356407|592279883|FG000|Overall Study|Not complete Endoscopy|2|||
163974725|NCT01356407|592279884|FG001|Overall Study|Not complete Endoscopy|2|||
163974726|NCT01197521|592279885|FG000|Overall Study|Not reported|24|||
163974727|NCT01197521|592279886|FG001|Overall Study|Not reported|25|||
163974728|NCT01197521|592279887|FG002|Overall Study|Not reported|21|||
163974729|NCT01197521|592279885|FG000|Overall Study|Enrolment in long term extension|42|||
163974730|NCT01197521|592279886|FG001|Overall Study|Enrolment in long term extension|36|||
163974731|NCT01197521|592279887|FG002|Overall Study|Enrolment in long term extension|87|||
163974732|NCT01197521|592279885|FG000|Overall Study|Severe non-compliance to protocol|1|||
163974733|NCT01197521|592279886|FG001|Overall Study|Severe non-compliance to protocol|3|||
163974734|NCT01197521|592279887|FG002|Overall Study|Severe non-compliance to protocol|3|||
163974735|NCT01197521|592279885|FG000|Overall Study|Lack of therapeutic response|2|||
163974736|NCT01197521|592279886|FG001|Overall Study|Lack of therapeutic response|3|||
163870860|NCT05061693|591896582|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
163870861|NCT05061693|591896583|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
163870862|NCT05061693|591896584|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
163870863|NCT05061693|591896585|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870864|NCT05061693|591896586|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870865|NCT05061693|591896587|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870866|NCT05061693|591896588|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870867|NCT05061693|591896589|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870868|NCT05061693|591896590|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870869|NCT05061693|591896591|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870870|NCT05061693|591896592|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870871|NCT05061693|591896593|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
163870872|NCT05061693|591896582|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
163870873|NCT05061693|591896583|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
163870874|NCT05061693|591896584|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
163870875|NCT05061693|591896585|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
163870876|NCT05061693|591896586|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
163870877|NCT05061693|591896587|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
163870878|NCT05061693|591896588|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
163870879|NCT05061693|591896589|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
163870880|NCT05061693|591896590|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
163870881|NCT05061693|591896591|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
163870882|NCT05061693|591896592|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
163870883|NCT05061693|591896593|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
163870884|NCT05061693|591896582|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
163870885|NCT05061693|591896583|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870886|NCT05061693|591896584|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870887|NCT05061693|591896585|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870888|NCT05061693|591896586|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870889|NCT05061693|591896587|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870890|NCT05061693|591896588|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870891|NCT05061693|591896589|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870892|NCT05061693|591896590|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870893|NCT05061693|591896591|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870894|NCT05061693|591896592|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870895|NCT05061693|591896593|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
163870896|NCT05061693|591896582|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870897|NCT05061693|591896583|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870898|NCT05061693|591896584|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
163870899|NCT05061693|591896585|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870900|NCT05061693|591896586|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870901|NCT05061693|591896587|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870902|NCT05061693|591896588|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870903|NCT05061693|591896589|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870904|NCT05061693|591896590|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870905|NCT05061693|591896591|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870906|NCT05061693|591896592|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163974737|NCT01197521|592279887|FG002|Overall Study|Lack of therapeutic response|4|||
163974738|NCT01197521|592279885|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
163974739|NCT01197521|592279886|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
163974740|NCT01197521|592279887|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
163974741|NCT01197521|592279885|FG000|Overall Study|Lost to Follow-up|3|||
163974742|NCT01197521|592279886|FG001|Overall Study|Lost to Follow-up|2|||
163974743|NCT01197521|592279887|FG002|Overall Study|Lost to Follow-up|2|||
163974744|NCT01197521|592279885|FG000|Overall Study|Adverse Event|25|||
163974745|NCT01197521|592279886|FG001|Overall Study|Adverse Event|28|||
163974746|NCT01197521|592279887|FG002|Overall Study|Adverse Event|24|||
163974747|NCT05879107|592279888|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
163974748|NCT05879107|592279889|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
163974749|NCT05879107|592279888|FG000|Overall Study|Migrated / moved from the study area|1|||
163974750|NCT05879107|592279889|FG001|Overall Study|Migrated / moved from the study area|1|||
163974751|NCT05879107|592279888|FG000|Overall Study|Lost to Follow-up|8|||
163974752|NCT05879107|592279889|FG001|Overall Study|Lost to Follow-up|13|||
163974753|NCT05879107|592279888|FG000|Overall Study|Death|0|||
163974754|NCT05879107|592279889|FG001|Overall Study|Death|2|||
163974755|NCT05879107|592279888|FG000|Overall Study|Other|0|||
163974756|NCT05879107|592279889|FG001|Overall Study|Other|3|||
163974757|NCT00912028|592279892|FG000|Overall Study|Lost to Follow-up|2|||
163974758|NCT00912028|592279893|FG001|Overall Study|Lost to Follow-up|3|||
163974759|NCT00912028|592279894|FG002|Overall Study|Lost to Follow-up|0|||
163974760|NCT00912028|592279895|FG003|Overall Study|Lost to Follow-up|1|||
163974761|NCT00912028|592279896|FG004|Overall Study|Lost to Follow-up|3|||
163974762|NCT00912028|592279892|FG000|Overall Study|Withdrawal by Subject|3|||
163974763|NCT00912028|592279893|FG001|Overall Study|Withdrawal by Subject|0|||
163974764|NCT00912028|592279894|FG002|Overall Study|Withdrawal by Subject|0|||
163974765|NCT00912028|592279895|FG003|Overall Study|Withdrawal by Subject|0|||
163974766|NCT00912028|592279896|FG004|Overall Study|Withdrawal by Subject|0|||
163974767|NCT03029143|592279897|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
163974768|NCT03029143|592279898|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
163974769|NCT03029143|592279899|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
163974770|NCT03029143|592279897|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
163974771|NCT03029143|592279898|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
163974772|NCT03029143|592279899|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
163974773|NCT03029143|592279897|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
163974774|NCT03029143|592279898|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
163974775|NCT03029143|592279899|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
163974776|NCT03029143|592279897|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
163974777|NCT03029143|592279898|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
163974778|NCT03029143|592279899|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
163974779|NCT03029143|592279897|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
163974780|NCT03029143|592279898|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
163974781|NCT03029143|592279899|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
163974782|NCT03029143|592279897|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
163974783|NCT03029143|592279898|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
163974784|NCT03029143|592279899|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
163974785|NCT03029143|592279897|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
163974786|NCT03029143|592279898|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
163974787|NCT03029143|592279899|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
163974788|NCT03029143|592279897|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163974789|NCT03029143|592279898|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163974790|NCT03029143|592279899|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
163974791|NCT03029143|592279897|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
163974792|NCT03029143|592279898|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
163974793|NCT03029143|592279899|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
163974794|NCT03029143|592279897|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163974795|NCT03029143|592279898|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
163974796|NCT03029143|592279899|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
163974797|NCT03029143|592279897|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
163974798|NCT03029143|592279898|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
163974799|NCT03029143|592279899|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
163974800|NCT04744207|592279901|FG000|Treatment|Withdrawal by Subject|2|||
163974801|NCT04744207|592279902|FG001|Treatment|Withdrawal by Subject|0|||
163974802|NCT04744207|592279901|FG000|Treatment|Adverse Event|1|||
163974803|NCT04744207|592279902|FG001|Treatment|Adverse Event|2|||
163974804|NCT02230384|592279903|FG000|Phase 1|Lost to Follow-up|1|||
163974805|NCT02230384|592279904|FG001|Phase 1|Lost to Follow-up|0|||
163974806|NCT02230384|592279903|FG000|Phase 1|Physician Decision|0|||
163974807|NCT02230384|592279904|FG001|Phase 1|Physician Decision|1|||
163974808|NCT02230384|592279903|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
163974809|NCT02230384|592279904|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
163974810|NCT02230384|592279903|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
163974811|NCT02230384|592279904|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
163974812|NCT02230384|592279903|FG000|Phase 2 - Switch|Adverse Event|2|||
163974813|NCT02230384|592279904|FG001|Phase 2 - Switch|Adverse Event|0|||
163974814|NCT00961220|592279905|FG000|Overall Study|Adverse Event|3|||
163974815|NCT00961220|592279905|FG000|Overall Study|Lack of Efficacy|1|||
163974816|NCT00961220|592279905|FG000|Overall Study|No IV access for O6BG|1|||
163974817|NCT00961220|592279905|FG000|Overall Study|O6BG no longer supplied|1|||
163974818|NCT00961220|592279905|FG000|Overall Study|Complete Response prior to 12 courses|1|||
163974819|NCT05376215|592279906|FG000|Overall Study|Withdrawal by Subject|2|||
163974820|NCT05376215|592279907|FG001|Overall Study|Withdrawal by Subject|1|||
163974821|NCT05376215|592279906|FG000|Overall Study|Lost to Follow-up|0|||
163974822|NCT05376215|592279907|FG001|Overall Study|Lost to Follow-up|1|||
163974823|NCT01301950|592279908|FG000|Overall Study|Surgery was cancelled by patient|0|||
163974824|NCT01301950|592279909|FG001|Overall Study|Surgery was cancelled by patient|1|||
163974825|NCT00942175|592279910|FG000|Overall Study|Adverse Event|2|||
163974826|NCT00942175|592279911|FG001|Overall Study|Adverse Event|1|||
163974827|NCT00942175|592279912|FG002|Overall Study|Adverse Event|0|||
163974828|NCT00942175|592279913|FG003|Overall Study|Adverse Event|0|||
163974829|NCT00942175|592279910|FG000|Overall Study|Protocol Violation|0|||
163974830|NCT00942175|592279911|FG001|Overall Study|Protocol Violation|1|||
163974831|NCT00942175|592279912|FG002|Overall Study|Protocol Violation|2|||
163974832|NCT00942175|592279913|FG003|Overall Study|Protocol Violation|0|||
163974833|NCT00942175|592279910|FG000|Overall Study|Pregnancy|0|||
163974834|NCT00942175|592279911|FG001|Overall Study|Pregnancy|0|||
163974835|NCT00942175|592279912|FG002|Overall Study|Pregnancy|0|||
163974836|NCT00942175|592279913|FG003|Overall Study|Pregnancy|1|||
163974837|NCT00942175|592279910|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
163974838|NCT00942175|592279911|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
163974839|NCT00942175|592279912|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
163974840|NCT00942175|592279913|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
163974841|NCT00942175|592279910|FG000|Overall Study|Low Platelet Count|0|||
163974842|NCT00942175|592279911|FG001|Overall Study|Low Platelet Count|2|||
163974843|NCT00942175|592279912|FG002|Overall Study|Low Platelet Count|0|||
163974844|NCT00942175|592279913|FG003|Overall Study|Low Platelet Count|0|||
163974845|NCT04041284|592279916|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
163974846|NCT04041284|592279917|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
163974847|NCT04041284|592279916|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
163974848|NCT04041284|592279917|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
163974849|NCT04041284|592279916|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
163974850|NCT04041284|592279917|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
163974851|NCT04041284|592279916|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
163974852|NCT04041284|592279917|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
163974853|NCT04041284|592279916|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
163974854|NCT04041284|592279917|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
163974855|NCT04041284|592279916|FG000|DB Phase (12 Weeks)|Other than specified|1|||
163974856|NCT04041284|592279917|FG001|DB Phase (12 Weeks)|Other than specified|0|||
163974857|NCT04041284|592279916|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
163974858|NCT04041284|592279917|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
163974859|NCT04041284|592279916|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
163974860|NCT04041284|592279917|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
163974861|NCT04041284|592279916|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
163974862|NCT04041284|592279917|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
163974863|NCT04041284|592279916|FG000|OL Phase (12 Weeks)|Other than specified|6|||
163974864|NCT04041284|592279917|FG001|OL Phase (12 Weeks)|Other than specified|2|||
163974865|NCT02973087|592279924|FG000|Overall Study|Withdrawal by Subject|2|||
163974866|NCT02973087|592279925|FG001|Overall Study|Withdrawal by Subject|1|||
163974867|NCT02973087|592279924|FG000|Overall Study|Adverse Event|1|||
163974868|NCT02973087|592279925|FG001|Overall Study|Adverse Event|0|||
163974869|NCT02973087|592279924|FG000|Overall Study|other|1|||
163974870|NCT02973087|592279925|FG001|Overall Study|other|1|||
163974871|NCT01840579|592279934|FG000|Overall Study|Status not recorded|0|||
163974872|NCT01840579|592279935|FG001|Overall Study|Status not recorded|0|||
163974873|NCT01840579|592279936|FG002|Overall Study|Status not recorded|2|||
163974874|NCT01840579|592279937|FG003|Overall Study|Status not recorded|3|||
163974875|NCT01840579|592279938|FG004|Overall Study|Status not recorded|4|||
163974876|NCT01840579|592279939|FG005|Overall Study|Status not recorded|3|||
163974877|NCT01840579|592279940|FG006|Overall Study|Status not recorded|0|||
163974878|NCT01840579|592279941|FG007|Overall Study|Status not recorded|3|||
163974879|NCT01840579|592279942|FG008|Overall Study|Status not recorded|3|||
163974880|NCT01840579|592279943|FG009|Overall Study|Status not recorded|3|||
163974881|NCT01840579|592279934|FG000|Overall Study|Progressive disease|3|||
163974882|NCT01840579|592279935|FG001|Overall Study|Progressive disease|5|||
163974883|NCT01840579|592279936|FG002|Overall Study|Progressive disease|0|||
163974884|NCT01840579|592279937|FG003|Overall Study|Progressive disease|0|||
163974885|NCT01840579|592279938|FG004|Overall Study|Progressive disease|0|||
163974886|NCT01840579|592279939|FG005|Overall Study|Progressive disease|0|||
163974887|NCT01840579|592279940|FG006|Overall Study|Progressive disease|0|||
163974888|NCT01840579|592279941|FG007|Overall Study|Progressive disease|0|||
163974889|NCT01840579|592279942|FG008|Overall Study|Progressive disease|0|||
163974890|NCT01840579|592279943|FG009|Overall Study|Progressive disease|0|||
163974891|NCT01840579|592279934|FG000|Overall Study|Ongoing in study|0|||
163974892|NCT01840579|592279935|FG001|Overall Study|Ongoing in study|1|||
163974893|NCT01840579|592279936|FG002|Overall Study|Ongoing in study|0|||
163974894|NCT01840579|592279937|FG003|Overall Study|Ongoing in study|0|||
163974895|NCT01840579|592279938|FG004|Overall Study|Ongoing in study|0|||
163974896|NCT01840579|592279939|FG005|Overall Study|Ongoing in study|0|||
163974897|NCT01840579|592279940|FG006|Overall Study|Ongoing in study|0|||
163974898|NCT01840579|592279941|FG007|Overall Study|Ongoing in study|0|||
163974899|NCT01840579|592279942|FG008|Overall Study|Ongoing in study|0|||
163974900|NCT01840579|592279943|FG009|Overall Study|Ongoing in study|0|||
163974901|NCT01840579|592279934|FG000|Overall Study|Death|0|||
163974902|NCT01840579|592279935|FG001|Overall Study|Death|0|||
163974903|NCT01840579|592279936|FG002|Overall Study|Death|0|||
163974904|NCT01840579|592279937|FG003|Overall Study|Death|0|||
163974905|NCT01840579|592279938|FG004|Overall Study|Death|0|||
163974906|NCT01840579|592279939|FG005|Overall Study|Death|1|||
163974907|NCT01840579|592279940|FG006|Overall Study|Death|0|||
163974908|NCT01840579|592279941|FG007|Overall Study|Death|0|||
163974909|NCT01840579|592279942|FG008|Overall Study|Death|0|||
163974910|NCT01840579|592279943|FG009|Overall Study|Death|0|||
163974911|NCT01840579|592279934|FG000|Overall Study|Adverse Event|0|||
163974912|NCT01840579|592279935|FG001|Overall Study|Adverse Event|1|||
163974913|NCT01840579|592279936|FG002|Overall Study|Adverse Event|0|||
163974914|NCT01840579|592279937|FG003|Overall Study|Adverse Event|0|||
163974915|NCT01840579|592279938|FG004|Overall Study|Adverse Event|0|||
163974916|NCT01840579|592279939|FG005|Overall Study|Adverse Event|0|||
163974917|NCT01840579|592279940|FG006|Overall Study|Adverse Event|0|||
163974918|NCT01840579|592279941|FG007|Overall Study|Adverse Event|0|||
163974919|NCT01840579|592279942|FG008|Overall Study|Adverse Event|0|||
163974920|NCT01840579|592279943|FG009|Overall Study|Adverse Event|0|||
163974921|NCT01840579|592279934|FG000|Overall Study|Follow-up ended by Sponsor|0|||
163974922|NCT01840579|592279935|FG001|Overall Study|Follow-up ended by Sponsor|0|||
163974923|NCT01840579|592279936|FG002|Overall Study|Follow-up ended by Sponsor|0|||
163974924|NCT01840579|592279937|FG003|Overall Study|Follow-up ended by Sponsor|0|||
163974925|NCT01840579|592279938|FG004|Overall Study|Follow-up ended by Sponsor|0|||
163974926|NCT01840579|592279939|FG005|Overall Study|Follow-up ended by Sponsor|0|||
163974927|NCT01840579|592279940|FG006|Overall Study|Follow-up ended by Sponsor|2|||
163974928|NCT01840579|592279941|FG007|Overall Study|Follow-up ended by Sponsor|0|||
163974929|NCT01840579|592279942|FG008|Overall Study|Follow-up ended by Sponsor|0|||
163974930|NCT01840579|592279943|FG009|Overall Study|Follow-up ended by Sponsor|0|||
163974931|NCT02437864|592279946|FG000|Overall Study|Protocol Violation|4|||
163974932|NCT02437864|592279947|FG001|Overall Study|Protocol Violation|0|||
163974933|NCT00645593|592279950|FG000|Overall Study|Later found to be ineligible|1|||
163974934|NCT00645593|592279951|FG001|Overall Study|Later found to be ineligible|0|||
163974935|NCT01585272|592279952|FG000|Overall Study|Adverse Event|22|||
163974936|NCT01585272|592279952|FG000|Overall Study|Protocol Violation|7|||
163974937|NCT01585272|592279952|FG000|Overall Study|Withdrawal by Subject|10|||
163974938|NCT03803059|592279953|FG000|Overall Study|Protocol Violation|2|||
163974939|NCT03803059|592279953|FG000|Overall Study|Lost to Follow-up|1|||
163974940|NCT04013529|592279954|FG000|Overall Study|Withdrawal by Subject|1|||
163974941|NCT04013529|592279955|FG001|Overall Study|Withdrawal by Subject|1|||
163974942|NCT02988661|592279956|FG000|Overall Study|Death|2|||
163974943|NCT02988661|592279957|FG001|Overall Study|Death|18|||
163974944|NCT02988661|592279956|FG000|Overall Study|Lost to Follow-up|0|||
163974945|NCT02988661|592279957|FG001|Overall Study|Lost to Follow-up|33|||
163974946|NCT02988661|592279956|FG000|Overall Study|Withdrawal by Subject|0|||
163974947|NCT02988661|592279957|FG001|Overall Study|Withdrawal by Subject|6|||
163974948|NCT02988661|592279956|FG000|Overall Study|Unable to complete the 18-month survey|1|||
163974949|NCT02988661|592279957|FG001|Overall Study|Unable to complete the 18-month survey|27|||
163974950|NCT04050982|592279961|FG000|Overall Study|Did not meet eligibility criteria|0|||
163974951|NCT04050982|592279962|FG001|Overall Study|Did not meet eligibility criteria|1|||
163974952|NCT04050982|592279963|FG002|Overall Study|Did not meet eligibility criteria|0|||
163974953|NCT04050982|592279961|FG000|Overall Study|Withdrawal by Subject|1|||
163974954|NCT04050982|592279962|FG001|Overall Study|Withdrawal by Subject|0|||
163974955|NCT04050982|592279963|FG002|Overall Study|Withdrawal by Subject|0|||
163974956|NCT04050982|592279961|FG000|Overall Study|Unable to enroll on platform|1|||
163974957|NCT04050982|592279962|FG001|Overall Study|Unable to enroll on platform|0|||
163974958|NCT04050982|592279963|FG002|Overall Study|Unable to enroll on platform|0|||
163974959|NCT00747643|592281641|FG000|Overall Study|Withdrawal by Subject|36|||
163974960|NCT00747643|592281642|FG001|Overall Study|Withdrawal by Subject|27|||
163974961|NCT03557281|592281643|FG000|Overall Study|Investigator discretion|0|||
163974962|NCT03557281|592281644|FG001|Overall Study|Investigator discretion|0|||
163974963|NCT03557281|592281645|FG002|Overall Study|Investigator discretion|1|||
163974964|NCT03557281|592281646|FG003|Overall Study|Investigator discretion|0|||
163974965|NCT03557281|592281647|FG004|Overall Study|Investigator discretion|0|||
163974966|NCT03557281|592281643|FG000|Overall Study|Withdrawal by Subject|0|||
163974967|NCT03557281|592281644|FG001|Overall Study|Withdrawal by Subject|1|||
163974968|NCT03557281|592281645|FG002|Overall Study|Withdrawal by Subject|1|||
163974969|NCT03557281|592281646|FG003|Overall Study|Withdrawal by Subject|1|||
163974970|NCT03557281|592281647|FG004|Overall Study|Withdrawal by Subject|2|||
163974971|NCT03557281|592281643|FG000|Overall Study|Randomized, but did not receive treatment|0|||
163974972|NCT03557281|592281644|FG001|Overall Study|Randomized, but did not receive treatment|0|||
163974973|NCT03557281|592281645|FG002|Overall Study|Randomized, but did not receive treatment|0|||
163974974|NCT03557281|592281646|FG003|Overall Study|Randomized, but did not receive treatment|0|||
163974975|NCT03557281|592281647|FG004|Overall Study|Randomized, but did not receive treatment|1|||
163974976|NCT01199042|592281648|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
163974977|NCT01199042|592281648|FG000|At Home (3 Months)|Lost to Follow-up|1|||
163974978|NCT04036708|592281651|FG000|Overall Study|Lost to Follow-up|14|||
163974979|NCT04036708|592281652|FG001|Overall Study|Lost to Follow-up|4|||
163974980|NCT04036708|592281653|FG002|Overall Study|Lost to Follow-up|14|||
163974981|NCT04036708|592281654|FG003|Overall Study|Lost to Follow-up|4|||
163974982|NCT02918864|592281655|FG000|Overall Study|Withdrawal by Subject|1|||
163974983|NCT02918864|592281656|FG001|Overall Study|Withdrawal by Subject|1|||
163974984|NCT02918864|592281655|FG000|Overall Study|Lost to Follow-up|3|||
163974985|NCT02918864|592281656|FG001|Overall Study|Lost to Follow-up|2|||
163974986|NCT01230307|592281658|FG000|Overall Study|LVAD Placement|0|||
163974987|NCT01230307|592281659|FG001|Overall Study|LVAD Placement|2|||
163974988|NCT04773106|592281660|FG000|Overall Study|Withdrawal by Subject|3|||
163974989|NCT04773106|592281660|FG000|Overall Study|Death|1|||
163974990|NCT01349465|592281668|FG000|Overall Study|Adverse Event|1|||
163974991|NCT01349465|592281669|FG001|Overall Study|Adverse Event|0|||
163974992|NCT01349465|592281668|FG000|Overall Study|Death|3|||
163974993|NCT01349465|592281669|FG001|Overall Study|Death|0|||
163974994|NCT01349465|592281668|FG000|Overall Study|Lost to Follow-up|10|||
163974995|NCT01349465|592281669|FG001|Overall Study|Lost to Follow-up|1|||
163974996|NCT01349465|592281668|FG000|Overall Study|Withdrawal by Subject|4|||
163974997|NCT01349465|592281669|FG001|Overall Study|Withdrawal by Subject|2|||
163974998|NCT01349465|592281668|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
163974999|NCT01349465|592281669|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
163975000|NCT04329702|592281672|FG000|Overall Study|illness|3|||
163975001|NCT04329702|592281673|FG001|Overall Study|illness|4|||
163975002|NCT04329702|592281674|FG002|Overall Study|illness|0|||
163975003|NCT04329702|592281672|FG000|Overall Study|Lost to Follow-up|0|||
163975004|NCT04329702|592281673|FG001|Overall Study|Lost to Follow-up|0|||
163975005|NCT04329702|592281674|FG002|Overall Study|Lost to Follow-up|2|||
163975006|NCT04329702|592281672|FG000|Overall Study|Death|0|||
163975007|NCT04329702|592281673|FG001|Overall Study|Death|2|||
163975008|NCT04329702|592281674|FG002|Overall Study|Death|0|||
163975009|NCT01918007|592281677|FG000|Overall Study|Baseline oximetry not acceptable|11|||
163975010|NCT01918007|592281678|FG001|Overall Study|Baseline oximetry not acceptable|7|||
163975011|NCT01918007|592281677|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
163975012|NCT01918007|592281678|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
163975013|NCT01918007|592281677|FG000|Overall Study|Lost to Follow-up|4|||
163975014|NCT01918007|592281678|FG001|Overall Study|Lost to Follow-up|7|||
163975015|NCT01140451|592281679|FG000|Overall Study|Withdrawal by Subject|26|||
163975016|NCT01140451|592281680|FG001|Overall Study|Withdrawal by Subject|33|||
163975017|NCT01140451|592281679|FG000|Overall Study|Adverse Event|2|||
163975018|NCT01140451|592281680|FG001|Overall Study|Adverse Event|6|||
163975019|NCT01140451|592281679|FG000|Overall Study|Physician Decision|5|||
163975020|NCT01140451|592281680|FG001|Overall Study|Physician Decision|3|||
163975021|NCT01140451|592281679|FG000|Overall Study|Lost to Follow-up|2|||
163975022|NCT01140451|592281680|FG001|Overall Study|Lost to Follow-up|0|||
163975023|NCT01140451|592281679|FG000|Overall Study|Participants Planning Pregnancy|3|||
163975024|NCT01140451|592281680|FG001|Overall Study|Participants Planning Pregnancy|0|||
163975025|NCT04206020|592281681|FG000|Overall Study|Adverse Event|1|||
163975026|NCT04206020|592281682|FG001|Overall Study|Adverse Event|4|||
163975027|NCT04206020|592281681|FG000|Overall Study|Protocol Violation|2|||
163975028|NCT04206020|592281682|FG001|Overall Study|Protocol Violation|0|||
163975029|NCT04206020|592281681|FG000|Overall Study|Withdrawal by Subject|2|||
163975030|NCT04206020|592281682|FG001|Overall Study|Withdrawal by Subject|0|||
163975031|NCT04206020|592281681|FG000|Overall Study|Lost to Follow-up|2|||
163975032|NCT04206020|592281682|FG001|Overall Study|Lost to Follow-up|0|||
163975033|NCT04206020|592281681|FG000|Overall Study|Pregnancy|0|||
163975034|NCT04206020|592281682|FG001|Overall Study|Pregnancy|1|||
163975035|NCT04206020|592281681|FG000|Overall Study|Unable to attend visits|1|||
163975036|NCT04206020|592281682|FG001|Overall Study|Unable to attend visits|2|||
163975037|NCT04962022|592281685|FG000|Period 1|Withdrawal by Subject|1|||
163975038|NCT04962022|592281686|FG001|Period 1|Withdrawal by Subject|0|||
163975039|NCT02375724|592281687|FG000|Overall Study|Lack of Efficacy|1|||
163975040|NCT02375724|592281688|FG001|Overall Study|Lack of Efficacy|1|||
164314831|NCT02703337|593529783|FG006|Period One (Part A)|Withdrawal by Subject|0|||
164314832|NCT02703337|593529784|FG007|Period One (Part A)|Withdrawal by Subject|0|||
163870907|NCT05061693|591896593|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
163870908|NCT05061693|591896582|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
163870909|NCT05061693|591896583|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
163870910|NCT05061693|591896584|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
163870911|NCT05061693|591896585|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
163870912|NCT05061693|591896586|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870913|NCT05061693|591896587|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870914|NCT05061693|591896588|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870915|NCT05061693|591896589|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870916|NCT05061693|591896590|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870917|NCT05061693|591896591|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870918|NCT05061693|591896592|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870919|NCT05061693|591896593|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
163870920|NCT05061693|591896582|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
163870921|NCT05061693|591896583|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
163870922|NCT05061693|591896584|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
163870923|NCT05061693|591896585|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
163870924|NCT05061693|591896586|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870925|NCT05061693|591896587|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870926|NCT05061693|591896588|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870927|NCT05061693|591896589|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870928|NCT05061693|591896590|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870929|NCT05061693|591896591|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870930|NCT05061693|591896592|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870931|NCT05061693|591896593|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
163870932|NCT05061693|591896582|FG000|24-week Extension Period|Adverse Event|0|||
163870933|NCT05061693|591896583|FG001|24-week Extension Period|Adverse Event|0|||
163870934|NCT05061693|591896584|FG002|24-week Extension Period|Adverse Event|0|||
163870935|NCT05061693|591896585|FG003|24-week Extension Period|Adverse Event|0|||
163870936|NCT05061693|591896586|FG004|24-week Extension Period|Adverse Event|0|||
163870937|NCT05061693|591896587|FG005|24-week Extension Period|Adverse Event|0|||
163870938|NCT05061693|591896588|FG006|24-week Extension Period|Adverse Event|0|||
163870939|NCT05061693|591896589|FG007|24-week Extension Period|Adverse Event|2|||
163870940|NCT05061693|591896590|FG008|24-week Extension Period|Adverse Event|2|||
163870941|NCT05061693|591896591|FG009|24-week Extension Period|Adverse Event|0|||
163870942|NCT05061693|591896592|FG010|24-week Extension Period|Adverse Event|1|||
163870943|NCT05061693|591896593|FG011|24-week Extension Period|Adverse Event|3|||
163870944|NCT05061693|591896582|FG000|24-week Extension Period|Lack of Efficacy|0|||
163870945|NCT05061693|591896583|FG001|24-week Extension Period|Lack of Efficacy|0|||
163870946|NCT05061693|591896584|FG002|24-week Extension Period|Lack of Efficacy|0|||
163870947|NCT05061693|591896585|FG003|24-week Extension Period|Lack of Efficacy|0|||
163870948|NCT05061693|591896586|FG004|24-week Extension Period|Lack of Efficacy|0|||
163870949|NCT05061693|591896587|FG005|24-week Extension Period|Lack of Efficacy|0|||
163870950|NCT05061693|591896588|FG006|24-week Extension Period|Lack of Efficacy|0|||
163870951|NCT05061693|591896589|FG007|24-week Extension Period|Lack of Efficacy|0|||
163870952|NCT05061693|591896590|FG008|24-week Extension Period|Lack of Efficacy|0|||
163870953|NCT05061693|591896591|FG009|24-week Extension Period|Lack of Efficacy|0|||
163870954|NCT05061693|591896592|FG010|24-week Extension Period|Lack of Efficacy|2|||
163870955|NCT05061693|591896593|FG011|24-week Extension Period|Lack of Efficacy|0|||
163870956|NCT05061693|591896582|FG000|24-week Extension Period|Lost to Follow-up|0|||
163870957|NCT05061693|591896583|FG001|24-week Extension Period|Lost to Follow-up|0|||
163870958|NCT05061693|591896584|FG002|24-week Extension Period|Lost to Follow-up|0|||
163870959|NCT05061693|591896585|FG003|24-week Extension Period|Lost to Follow-up|0|||
163870960|NCT05061693|591896586|FG004|24-week Extension Period|Lost to Follow-up|0|||
163870961|NCT05061693|591896587|FG005|24-week Extension Period|Lost to Follow-up|0|||
163870962|NCT05061693|591896588|FG006|24-week Extension Period|Lost to Follow-up|1|||
163870963|NCT05061693|591896589|FG007|24-week Extension Period|Lost to Follow-up|0|||
163870964|NCT05061693|591896590|FG008|24-week Extension Period|Lost to Follow-up|1|||
163870965|NCT05061693|591896591|FG009|24-week Extension Period|Lost to Follow-up|1|||
163870966|NCT05061693|591896592|FG010|24-week Extension Period|Lost to Follow-up|0|||
163870967|NCT05061693|591896593|FG011|24-week Extension Period|Lost to Follow-up|0|||
163870968|NCT05061693|591896582|FG000|24-week Extension Period|Withdrawal by Subject|0|||
163870969|NCT05061693|591896583|FG001|24-week Extension Period|Withdrawal by Subject|0|||
163870970|NCT05061693|591896584|FG002|24-week Extension Period|Withdrawal by Subject|0|||
163870971|NCT05061693|591896585|FG003|24-week Extension Period|Withdrawal by Subject|0|||
163870972|NCT05061693|591896586|FG004|24-week Extension Period|Withdrawal by Subject|0|||
163870973|NCT05061693|591896587|FG005|24-week Extension Period|Withdrawal by Subject|0|||
163870974|NCT05061693|591896588|FG006|24-week Extension Period|Withdrawal by Subject|0|||
163870975|NCT05061693|591896589|FG007|24-week Extension Period|Withdrawal by Subject|0|||
163870976|NCT05061693|591896590|FG008|24-week Extension Period|Withdrawal by Subject|1|||
163870977|NCT05061693|591896591|FG009|24-week Extension Period|Withdrawal by Subject|2|||
163870978|NCT05061693|591896592|FG010|24-week Extension Period|Withdrawal by Subject|2|||
163870979|NCT05061693|591896593|FG011|24-week Extension Period|Withdrawal by Subject|1|||
163870980|NCT05061693|591896582|FG000|24-week Extension Period|Sponsor Decision|0|||
163870981|NCT05061693|591896583|FG001|24-week Extension Period|Sponsor Decision|0|||
163870982|NCT05061693|591896584|FG002|24-week Extension Period|Sponsor Decision|0|||
163870983|NCT05061693|591896585|FG003|24-week Extension Period|Sponsor Decision|0|||
163870984|NCT05061693|591896586|FG004|24-week Extension Period|Sponsor Decision|0|||
163870985|NCT05061693|591896587|FG005|24-week Extension Period|Sponsor Decision|0|||
163870986|NCT05061693|591896588|FG006|24-week Extension Period|Sponsor Decision|0|||
163870987|NCT05061693|591896589|FG007|24-week Extension Period|Sponsor Decision|1|||
163870988|NCT05061693|591896590|FG008|24-week Extension Period|Sponsor Decision|0|||
163870989|NCT05061693|591896591|FG009|24-week Extension Period|Sponsor Decision|0|||
163870990|NCT05061693|591896592|FG010|24-week Extension Period|Sponsor Decision|0|||
163870991|NCT05061693|591896593|FG011|24-week Extension Period|Sponsor Decision|0|||
163870992|NCT05061693|591896582|FG000|24-week Extension Period|Site Closure|0|||
163870993|NCT05061693|591896583|FG001|24-week Extension Period|Site Closure|0|||
163870994|NCT05061693|591896584|FG002|24-week Extension Period|Site Closure|0|||
163870995|NCT05061693|591896585|FG003|24-week Extension Period|Site Closure|0|||
163870996|NCT05061693|591896586|FG004|24-week Extension Period|Site Closure|0|||
163870997|NCT05061693|591896587|FG005|24-week Extension Period|Site Closure|0|||
163870998|NCT05061693|591896588|FG006|24-week Extension Period|Site Closure|0|||
163870999|NCT05061693|591896589|FG007|24-week Extension Period|Site Closure|0|||
163871000|NCT05061693|591896590|FG008|24-week Extension Period|Site Closure|1|||
163871001|NCT05061693|591896591|FG009|24-week Extension Period|Site Closure|0|||
163871002|NCT05061693|591896592|FG010|24-week Extension Period|Site Closure|0|||
163871003|NCT05061693|591896593|FG011|24-week Extension Period|Site Closure|1|||
163871004|NCT03823911|591896594|FG000|Overall Study|Lost to Follow-up|1|||
163871005|NCT03823911|591896595|FG001|Overall Study|Lost to Follow-up|5|||
163871006|NCT03823911|591896596|FG002|Overall Study|Lost to Follow-up|2|||
163871007|NCT03823911|591896594|FG000|Overall Study|Did not meet eligibility criteria|13|||
163871008|NCT03823911|591896595|FG001|Overall Study|Did not meet eligibility criteria|7|||
163871009|NCT03823911|591896596|FG002|Overall Study|Did not meet eligibility criteria|4|||
163871010|NCT03823911|591896594|FG000|Overall Study|Death|0|||
163871011|NCT03823911|591896595|FG001|Overall Study|Death|1|||
163871012|NCT03823911|591896596|FG002|Overall Study|Death|0|||
163871013|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
163871014|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
163871015|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
163871016|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
163871017|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
163871018|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
163871019|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
163871020|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
163871021|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
163871022|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
163975041|NCT02375724|592281687|FG000|Overall Study|Withdrawal by Subject|1|||
163975042|NCT02375724|592281688|FG001|Overall Study|Withdrawal by Subject|1|||
163975043|NCT02375724|592281687|FG000|Overall Study|Lost to Follow-up|1|||
163975044|NCT02375724|592281688|FG001|Overall Study|Lost to Follow-up|0|||
163975045|NCT02375724|592281687|FG000|Overall Study|Protocol Violation|1|||
163975046|NCT02375724|592281688|FG001|Overall Study|Protocol Violation|0|||
163975047|NCT02375724|592281687|FG000|Overall Study|Adverse Event|2|||
163975048|NCT02375724|592281688|FG001|Overall Study|Adverse Event|4|||
163975049|NCT00631020|592281689|FG000|Overall Study|Lost to Follow-up|7|||
163975050|NCT00631020|592281689|FG000|Overall Study|Incarcerated|1|||
163975051|NCT02614859|592281690|FG000|Overall Study|Physician Decision|0|||
163975052|NCT02614859|592281691|FG001|Overall Study|Physician Decision|1|||
163975053|NCT03548935|592281692|FG000|Overall Study|Withdrawal by Subject|26|||
163975054|NCT03548935|592281693|FG001|Overall Study|Withdrawal by Subject|17|||
163975055|NCT03548935|592281692|FG000|Overall Study|Lost to Follow-up|39|||
163871023|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
163871024|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
163871025|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
163871026|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
163871027|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
163871028|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
163871029|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
163975056|NCT03548935|592281693|FG001|Overall Study|Lost to Follow-up|28|||
163975057|NCT03548935|592281692|FG000|Overall Study|Death|1|||
163975058|NCT03548935|592281693|FG001|Overall Study|Death|1|||
163871030|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
163871031|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
163871032|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
163871033|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
163871034|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
163871035|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
163871036|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
163871037|NCT00311363|591896599|FG000|24-Week Single-Blind Treatment Period|Death|1|||
163871038|NCT00311363|591896600|FG001|24-Week Single-Blind Treatment Period|Death|0|||
163871039|NCT00311363|591896601|FG002|24-Week Single-Blind Treatment Period|Death|0|||
163871040|NCT00311363|591896599|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
163871041|NCT00311363|591896600|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
163871042|NCT00311363|591896601|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
163871043|NCT00311363|591896599|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
163871044|NCT00311363|591896600|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
163871045|NCT00311363|591896601|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
163871046|NCT00311363|591896599|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
163871047|NCT00311363|591896600|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
163871048|NCT00311363|591896601|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
163871049|NCT00311363|591896599|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
163871050|NCT00311363|591896600|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
163871051|NCT00311363|591896601|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
163871052|NCT00311363|591896599|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
163871053|NCT00311363|591896600|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
163871054|NCT00311363|591896601|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
163871055|NCT00311363|591896599|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
163871056|NCT00311363|591896600|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
163871057|NCT00311363|591896601|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
163871058|NCT00396084|591896602|FG000|Overall Study|Adverse Event|0|||
163871059|NCT00396084|591896603|FG001|Overall Study|Adverse Event|0|||
163871060|NCT00396084|591896604|FG002|Overall Study|Adverse Event|0|||
163871061|NCT00396084|591896605|FG003|Overall Study|Adverse Event|0|||
163871062|NCT00396084|591896606|FG004|Overall Study|Adverse Event|1|||
163871063|NCT00396084|591896607|FG005|Overall Study|Adverse Event|2|||
163871064|NCT00396084|591896602|FG000|Overall Study|Withdrawal by Subject|0|||
163871065|NCT00396084|591896603|FG001|Overall Study|Withdrawal by Subject|0|||
163871066|NCT00396084|591896604|FG002|Overall Study|Withdrawal by Subject|0|||
163871067|NCT00396084|591896605|FG003|Overall Study|Withdrawal by Subject|1|||
163871068|NCT00396084|591896606|FG004|Overall Study|Withdrawal by Subject|0|||
163871069|NCT00396084|591896607|FG005|Overall Study|Withdrawal by Subject|0|||
163871070|NCT04009577|591896608|FG000|Core Study|Adverse Event|1|||
163871071|NCT04009577|591896609|FG001|Core Study|Adverse Event|0|||
163871072|NCT04009577|591896610|FG002|Core Study|Adverse Event|2|||
163871073|NCT04009577|591896611|FG003|Core Study|Adverse Event|4|||
163871074|NCT04009577|591896608|FG000|Core Study|Withdrawal by Subject|0|||
163871075|NCT04009577|591896609|FG001|Core Study|Withdrawal by Subject|0|||
163871076|NCT04009577|591896610|FG002|Core Study|Withdrawal by Subject|2|||
163871077|NCT04009577|591896611|FG003|Core Study|Withdrawal by Subject|0|||
163871078|NCT04009577|591896608|FG000|Core Study|Other|0|||
163871079|NCT04009577|591896609|FG001|Core Study|Other|0|||
163871080|NCT04009577|591896610|FG002|Core Study|Other|0|||
163871081|NCT04009577|591896611|FG003|Core Study|Other|1|||
163871082|NCT04009577|591896608|FG000|Extension Phase|Adverse Event|0|||
163871083|NCT04009577|591896609|FG001|Extension Phase|Adverse Event|0|||
163871084|NCT04009577|591896610|FG002|Extension Phase|Adverse Event|0|||
163871085|NCT04009577|591896611|FG003|Extension Phase|Adverse Event|1|||
163871086|NCT04009577|591896608|FG000|Extension Phase|Inadequate therapeutic effect|0|||
163871087|NCT04009577|591896609|FG001|Extension Phase|Inadequate therapeutic effect|0|||
163871088|NCT04009577|591896610|FG002|Extension Phase|Inadequate therapeutic effect|1|||
163871089|NCT04009577|591896611|FG003|Extension Phase|Inadequate therapeutic effect|0|||
163871090|NCT04009577|591896608|FG000|Extension Phase|Withdrawal by Subject|0|||
163871091|NCT04009577|591896609|FG001|Extension Phase|Withdrawal by Subject|0|||
163871092|NCT04009577|591896610|FG002|Extension Phase|Withdrawal by Subject|1|||
163871093|NCT04009577|591896611|FG003|Extension Phase|Withdrawal by Subject|0|||
163871094|NCT04009577|591896608|FG000|Extension Phase|Not Treated|0|||
163871095|NCT04009577|591896609|FG001|Extension Phase|Not Treated|0|||
163871096|NCT04009577|591896610|FG002|Extension Phase|Not Treated|2|||
163975059|NCT00732303|592281694|FG000|Overall Study|Study Terminated|2|||
163871097|NCT04009577|591896611|FG003|Extension Phase|Not Treated|0|||
163871098|NCT01832480|591896612|FG000|Overall Study|Lost to Follow-up|33|||
163871099|NCT01832480|591896613|FG001|Overall Study|Lost to Follow-up|30|||
163871100|NCT01832480|591896612|FG000|Overall Study|Withdrawal by Subject|0|||
163871101|NCT01832480|591896613|FG001|Overall Study|Withdrawal by Subject|2|||
163871102|NCT01832480|591896612|FG000|Overall Study|post randomization ineligible|8|||
163871103|NCT01832480|591896613|FG001|Overall Study|post randomization ineligible|10|||
163871104|NCT02261467|591896615|FG000|Overall Study|Enrolled in Error|1|||
163871105|NCT02261467|591896616|FG001|Overall Study|Enrolled in Error|0|||
163871106|NCT02261467|591896615|FG000|Overall Study|Protocol Violation|0|||
163871107|NCT02261467|591896616|FG001|Overall Study|Protocol Violation|1|||
163871108|NCT02261467|591896615|FG000|Overall Study|Personal Reasons|17|||
163871109|NCT02261467|591896616|FG001|Overall Study|Personal Reasons|22|||
163871110|NCT02261467|591896615|FG000|Overall Study|Lost to Follow-up|2|||
163871111|NCT02261467|591896616|FG001|Overall Study|Lost to Follow-up|13|||
163871112|NCT02261467|591896615|FG000|Overall Study|Adverse Event|1|||
163871113|NCT02261467|591896616|FG001|Overall Study|Adverse Event|1|||
163871114|NCT04305405|591896619|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163871115|NCT04305405|591896620|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163871116|NCT00206375|591896621|FG000|Overall Study|Lost to Follow-up|1|||
163871117|NCT00206375|591896622|FG001|Overall Study|Lost to Follow-up|0|||
163871118|NCT00206375|591896623|FG002|Overall Study|Lost to Follow-up|0|||
163871119|NCT00206375|591896621|FG000|Overall Study|Withdrawal by Subject|2|||
163871120|NCT00206375|591896622|FG001|Overall Study|Withdrawal by Subject|1|||
163871121|NCT00206375|591896623|FG002|Overall Study|Withdrawal by Subject|3|||
163871122|NCT00206375|591896621|FG000|Overall Study|Study terminated due to lack of funds|0|||
163871123|NCT00206375|591896622|FG001|Overall Study|Study terminated due to lack of funds|1|||
163871124|NCT00206375|591896623|FG002|Overall Study|Study terminated due to lack of funds|1|||
163871125|NCT01685606|591896629|FG000|Overall Study|Withdrawal by Subject|1|||
163871126|NCT01787760|591896630|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
163871127|NCT01787760|591896631|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
163871128|NCT01787760|591896632|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
163871129|NCT01787760|591896630|FG000|Overall Study|Decompensated on left exotropia|0|||
163871130|NCT01787760|591896631|FG001|Overall Study|Decompensated on left exotropia|0|||
163871131|NCT01787760|591896632|FG002|Overall Study|Decompensated on left exotropia|1|||
163871132|NCT01787760|591896630|FG000|Overall Study|Dryness|0|||
163871133|NCT01787760|591896631|FG001|Overall Study|Dryness|1|||
163871134|NCT01787760|591896632|FG002|Overall Study|Dryness|0|||
163871135|NCT01787760|591896630|FG000|Overall Study|Relocation|1|||
163871136|NCT01787760|591896631|FG001|Overall Study|Relocation|1|||
163871137|NCT01787760|591896632|FG002|Overall Study|Relocation|0|||
163871138|NCT01787760|591896630|FG000|Overall Study|Lens discomfort|3|||
163871139|NCT01787760|591896631|FG001|Overall Study|Lens discomfort|0|||
163871140|NCT01787760|591896632|FG002|Overall Study|Lens discomfort|0|||
163871141|NCT01787760|591896630|FG000|Overall Study|Lens handling difficulty|1|||
163871142|NCT01787760|591896631|FG001|Overall Study|Lens handling difficulty|2|||
163871143|NCT01787760|591896632|FG002|Overall Study|Lens handling difficulty|0|||
163871144|NCT01787760|591896630|FG000|Overall Study|Protocol Violation|6|||
163871145|NCT01787760|591896631|FG001|Overall Study|Protocol Violation|0|||
163871146|NCT01787760|591896632|FG002|Overall Study|Protocol Violation|1|||
163871147|NCT01787760|591896630|FG000|Overall Study|Withdrawal by Subject|5|||
163871148|NCT01787760|591896631|FG001|Overall Study|Withdrawal by Subject|1|||
163871149|NCT01787760|591896632|FG002|Overall Study|Withdrawal by Subject|2|||
163871150|NCT01787760|591896630|FG000|Overall Study|Lost to Follow-up|1|||
163871151|NCT01787760|591896631|FG001|Overall Study|Lost to Follow-up|0|||
163871152|NCT01787760|591896632|FG002|Overall Study|Lost to Follow-up|1|||
163871153|NCT01787760|591896630|FG000|Overall Study|Stroke|1|||
163871154|NCT01787760|591896631|FG001|Overall Study|Stroke|0|||
163871155|NCT01787760|591896632|FG002|Overall Study|Stroke|0|||
163871156|NCT01787760|591896630|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
163871157|NCT01787760|591896631|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
163871158|NCT01787760|591896632|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
163871159|NCT01787760|591896630|FG000|Overall Study|Unsatisfactory physiological response|2|||
163871160|NCT01787760|591896631|FG001|Overall Study|Unsatisfactory physiological response|4|||
163871161|NCT01787760|591896632|FG002|Overall Study|Unsatisfactory physiological response|0|||
163871162|NCT01787760|591896630|FG000|Overall Study|Unsatisfactory visual response|1|||
163975060|NCT01074190|592281701|FG000|Overall Study|Emergency Cesarean Delivery|1|||
163871163|NCT01787760|591896631|FG001|Overall Study|Unsatisfactory visual response|1|||
163871164|NCT01787760|591896632|FG002|Overall Study|Unsatisfactory visual response|0|||
163871165|NCT01787760|591896630|FG000|Overall Study|Near vision blur|1|||
163871166|NCT01787760|591896631|FG001|Overall Study|Near vision blur|0|||
163871167|NCT01787760|591896632|FG002|Overall Study|Near vision blur|0|||
163871168|NCT01353963|591896633|FG000|Overall Study|Adverse Event|2|||
163871169|NCT02531113|591896640|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
163871170|NCT02531113|591896640|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
163871171|NCT02531113|591896640|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
163871172|NCT02531113|591896640|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
163871173|NCT02531113|591896640|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
163871174|NCT02531113|591896640|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
163871175|NCT02531113|591896640|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
163975061|NCT01074190|592281702|FG001|Overall Study|Emergency Cesarean Delivery|2|||
163975062|NCT01074190|592281703|FG002|Overall Study|Emergency Cesarean Delivery|1|||
163975063|NCT01074190|592281701|FG000|Overall Study|Protocol Violation|2|||
163975064|NCT01074190|592281702|FG001|Overall Study|Protocol Violation|1|||
163975065|NCT01074190|592281703|FG002|Overall Study|Protocol Violation|0|||
163975066|NCT01074190|592281701|FG000|Overall Study|Delivered in under 90 minutes|0|||
163975067|NCT01074190|592281702|FG001|Overall Study|Delivered in under 90 minutes|2|||
163975068|NCT01074190|592281703|FG002|Overall Study|Delivered in under 90 minutes|1|||
163975069|NCT01074190|592281701|FG000|Overall Study|Subject withdrew consent|1|||
163975070|NCT01074190|592281702|FG001|Overall Study|Subject withdrew consent|1|||
163975071|NCT01074190|592281703|FG002|Overall Study|Subject withdrew consent|1|||
163975072|NCT01576549|592281714|FG000|Overall Study|Sponsor Decision|2|||
163975073|NCT00053417|592281715|FG000|Overall Study|Adverse Event|1|||
163975074|NCT00053417|592281716|FG001|Overall Study|Adverse Event|0|||
163975075|NCT00053417|592281717|FG002|Overall Study|Adverse Event|1|||
163975076|NCT00053417|592281718|FG003|Overall Study|Adverse Event|5|||
163975077|NCT00053417|592281715|FG000|Overall Study|Non-Compliance|0|||
163975078|NCT00053417|592281716|FG001|Overall Study|Non-Compliance|0|||
163975079|NCT00053417|592281717|FG002|Overall Study|Non-Compliance|0|||
163975080|NCT00053417|592281718|FG003|Overall Study|Non-Compliance|1|||
163975081|NCT00053417|592281715|FG000|Overall Study|Withdrawal by Subject|0|||
163975082|NCT00053417|592281716|FG001|Overall Study|Withdrawal by Subject|1|||
163975083|NCT00053417|592281717|FG002|Overall Study|Withdrawal by Subject|0|||
163975084|NCT00053417|592281718|FG003|Overall Study|Withdrawal by Subject|0|||
163975085|NCT00053417|592281715|FG000|Overall Study|Lost to Follow-up|1|||
163975086|NCT00053417|592281716|FG001|Overall Study|Lost to Follow-up|1|||
163975087|NCT00053417|592281717|FG002|Overall Study|Lost to Follow-up|0|||
163975088|NCT00053417|592281718|FG003|Overall Study|Lost to Follow-up|0|||
163975089|NCT00804570|592281719|FG000|Overall Study|Adverse Event|14|||
163975090|NCT00804570|592281720|FG001|Overall Study|Adverse Event|7|||
163975091|NCT00804570|592281719|FG000|Overall Study|Lack of Efficacy|0|||
163975092|NCT00804570|592281720|FG001|Overall Study|Lack of Efficacy|1|||
163975093|NCT00804570|592281719|FG000|Overall Study|Lost to Follow-up|18|||
163975094|NCT00804570|592281720|FG001|Overall Study|Lost to Follow-up|21|||
163975095|NCT00804570|592281719|FG000|Overall Study|Entry criteria not met|5|||
163975096|NCT00804570|592281720|FG001|Overall Study|Entry criteria not met|5|||
163975097|NCT00804570|592281719|FG000|Overall Study|Protocol Violation|12|||
163975098|NCT00804570|592281720|FG001|Overall Study|Protocol Violation|16|||
163975099|NCT00804570|592281719|FG000|Overall Study|Physician Decision|1|||
163975100|NCT00804570|592281720|FG001|Overall Study|Physician Decision|2|||
163975101|NCT00804570|592281719|FG000|Overall Study|Sponsor decision|1|||
163975102|NCT00804570|592281720|FG001|Overall Study|Sponsor decision|4|||
163975103|NCT00804570|592281719|FG000|Overall Study|Withdrawal by Subject|21|||
163975104|NCT00804570|592281720|FG001|Overall Study|Withdrawal by Subject|38|||
163975105|NCT00290342|592281721|FG000|Overall Study|Other|0|||
163975106|NCT00290342|592281722|FG001|Overall Study|Other|1|||
163975107|NCT00290342|592281721|FG000|Overall Study|Withdrawal by Subject|6|||
163975108|NCT00290342|592281722|FG001|Overall Study|Withdrawal by Subject|4|||
163975109|NCT00290342|592281721|FG000|Overall Study|Lost to Follow-up|1|||
163975110|NCT00290342|592281722|FG001|Overall Study|Lost to Follow-up|0|||
163975111|NCT01056510|592281723|FG000|Overall Study|Dropout Before Start of Treatment|1|||
163975112|NCT01056510|592281724|FG001|Overall Study|Dropout Before Start of Treatment|1|||
163975113|NCT01056510|592281723|FG000|Overall Study|Withdrawal by Subject|4|||
163975114|NCT01056510|592281724|FG001|Overall Study|Withdrawal by Subject|2|||
163975115|NCT01056510|592281723|FG000|Overall Study|Death|29|||
163975116|NCT01056510|592281724|FG001|Overall Study|Death|34|||
163975117|NCT01056510|592281723|FG000|Overall Study|Noncompliance|1|||
163975118|NCT01056510|592281724|FG001|Overall Study|Noncompliance|3|||
163975119|NCT01056510|592281723|FG000|Overall Study|Physician Decision|4|||
163975120|NCT01056510|592281724|FG001|Overall Study|Physician Decision|5|||
163975121|NCT01056510|592281723|FG000|Overall Study|Lost to Follow-up|5|||
163975122|NCT01056510|592281724|FG001|Overall Study|Lost to Follow-up|6|||
163975123|NCT01056510|592281723|FG000|Overall Study|Other|10|||
163975124|NCT01056510|592281724|FG001|Overall Study|Other|12|||
163975125|NCT01056510|592281723|FG000|Overall Study|Missing|0|||
163975126|NCT01056510|592281724|FG001|Overall Study|Missing|1|||
163975127|NCT02285998|592281725|FG000|Overall Study|Adverse Event|9|||
163975128|NCT02285998|592281726|FG001|Overall Study|Adverse Event|8|||
163975129|NCT02285998|592281725|FG000|Overall Study|Physician Decision|1|||
163975130|NCT02285998|592281726|FG001|Overall Study|Physician Decision|2|||
163975131|NCT02285998|592281725|FG000|Overall Study|Lost to Follow-up|176|||
163975132|NCT02285998|592281726|FG001|Overall Study|Lost to Follow-up|172|||
163975133|NCT02285998|592281725|FG000|Overall Study|Withdrawal by Subject|53|||
163975134|NCT02285998|592281726|FG001|Overall Study|Withdrawal by Subject|61|||
163975135|NCT02285998|592281725|FG000|Overall Study|Other Reasons|7|||
163975136|NCT02285998|592281726|FG001|Overall Study|Other Reasons|10|||
163975137|NCT01793142|592281727|FG000|Overall Study|Randomized not treated|7|||
163975138|NCT02121262|592281732|FG000|Overall Study|Adverse Event|6|||
163975139|NCT02121262|592281733|FG001|Overall Study|Adverse Event|3|||
163975140|NCT02121262|592281732|FG000|Overall Study|Lack of Efficacy|3|||
163975141|NCT02121262|592281733|FG001|Overall Study|Lack of Efficacy|0|||
163975142|NCT02121262|592281732|FG000|Overall Study|Personal Reasons|19|||
163975143|NCT02121262|592281733|FG001|Overall Study|Personal Reasons|5|||
163975144|NCT02121262|592281732|FG000|Overall Study|Protocol Violation|1|||
163975145|NCT02121262|592281733|FG001|Overall Study|Protocol Violation|1|||
163975146|NCT02121262|592281732|FG000|Overall Study|Participant Dropped-out|0|||
163975147|NCT02121262|592281733|FG001|Overall Study|Participant Dropped-out|1|||
163975148|NCT02121262|592281732|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
163975149|NCT02121262|592281733|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
163975150|NCT02121262|592281732|FG000|Overall Study|Consent Withdrawn|1|||
163975151|NCT02121262|592281733|FG001|Overall Study|Consent Withdrawn|0|||
163975152|NCT02716987|592281734|FG000|Overall Study|Ligand synthesis failure|0|||
163975153|NCT02716987|592281735|FG001|Overall Study|Ligand synthesis failure|0|||
163975154|NCT02716987|592281736|FG002|Overall Study|Ligand synthesis failure|1|||
163975155|NCT02716987|592281737|FG003|Overall Study|Ligand synthesis failure|0|||
163975156|NCT02716987|592281738|FG004|Overall Study|Ligand synthesis failure|0|||
163975157|NCT02716987|592281739|FG005|Overall Study|Ligand synthesis failure|0|||
163975158|NCT02716987|592281734|FG000|Overall Study|Withdrawal by Subject|0|||
163975159|NCT02716987|592281735|FG001|Overall Study|Withdrawal by Subject|0|||
163975160|NCT02716987|592281736|FG002|Overall Study|Withdrawal by Subject|0|||
163975161|NCT02716987|592281737|FG003|Overall Study|Withdrawal by Subject|0|||
163975162|NCT02716987|592281738|FG004|Overall Study|Withdrawal by Subject|1|||
163975163|NCT02716987|592281739|FG005|Overall Study|Withdrawal by Subject|1|||
163975164|NCT01553188|592281740|FG000|Overall Study|Patient choice|1|||
163975165|NCT01553188|592281741|FG001|Overall Study|Patient choice|0|||
163975166|NCT01553188|592281742|FG002|Overall Study|Patient choice|0|||
163975167|NCT01553188|592281743|FG003|Overall Study|Patient choice|0|||
163975168|NCT01553188|592281740|FG000|Overall Study|Intercurrent illness and adverse event|0|||
163975169|NCT01553188|592281741|FG001|Overall Study|Intercurrent illness and adverse event|1|||
163975170|NCT01553188|592281742|FG002|Overall Study|Intercurrent illness and adverse event|2|||
163975171|NCT01553188|592281743|FG003|Overall Study|Intercurrent illness and adverse event|0|||
163975172|NCT02829138|592281745|FG000|Overall Study|Withdrawal by Subject|1|||
163975173|NCT02829138|592281746|FG001|Overall Study|Withdrawal by Subject|0|||
163975174|NCT01394627|592281747|FG000|First Intervention (1 Day)|poor intravenous access|0|||
163975175|NCT01394627|592281748|FG001|First Intervention (1 Day)|poor intravenous access|1|||
163975176|NCT01394627|592281747|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
163975177|NCT01394627|592281748|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
163975178|NCT05289570|592281750|FG000|Overall Study|Physician Decision|1|||
163975179|NCT01617070|592281751|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
163975180|NCT00808236|592281753|FG000|Overall Study|Was not resuscitated|50|||
163975181|NCT00808236|592281754|FG001|Overall Study|Was not resuscitated|56|||
163975182|NCT00808236|592281753|FG000|Overall Study|Pre-defined exclusion|13|||
163975183|NCT00808236|592281754|FG001|Overall Study|Pre-defined exclusion|3|||
163975184|NCT00808236|592281753|FG000|Overall Study|Lost to Follow-up|1|||
163975185|NCT00808236|592281754|FG001|Overall Study|Lost to Follow-up|1|||
163975186|NCT00808236|592281753|FG000|Overall Study|Physician Decision|0|||
163975187|NCT00808236|592281754|FG001|Overall Study|Physician Decision|1|||
163975188|NCT00808236|592281753|FG000|Overall Study|Death|18|||
163975189|NCT00808236|592281754|FG001|Overall Study|Death|30|||
163975190|NCT01066585|592281755|FG000|Overall Study|Protocol Violation|1|||
163975191|NCT01066585|592281756|FG001|Overall Study|Protocol Violation|0|||
163975192|NCT01066585|592281755|FG000|Overall Study|Withdrawal by Subject|0|||
163975193|NCT01066585|592281756|FG001|Overall Study|Withdrawal by Subject|3|||
163975194|NCT00964743|592281758|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
163975195|NCT03317795|592281761|FG000|Overall Study|IUD Expulsion|1|||
163975196|NCT03317795|592281762|FG001|Overall Study|IUD Expulsion|0|||
163975197|NCT03317795|592281761|FG000|Overall Study|Lost to Follow-up|1|||
163975198|NCT03317795|592281762|FG001|Overall Study|Lost to Follow-up|3|||
163975199|NCT03317795|592281761|FG000|Overall Study|Treatment change|0|||
163975200|NCT03317795|592281762|FG001|Overall Study|Treatment change|3|||
163975201|NCT03317795|592281761|FG000|Overall Study|Intolerance of medication|0|||
163975202|NCT03317795|592281762|FG001|Overall Study|Intolerance of medication|1|||
163975203|NCT00886600|592281763|FG000|Double-blind Monotherapy|Adverse Event|1|||
163975204|NCT00886600|592281764|FG001|Double-blind Monotherapy|Adverse Event|1|||
163975205|NCT00886600|592281765|FG002|Double-blind Monotherapy|Adverse Event|1|||
163975206|NCT00886600|592281766|FG003|Double-blind Monotherapy|Adverse Event|1|||
163975207|NCT00886600|592281763|FG000|Double-blind Monotherapy|Protocol Violation|0|||
163975208|NCT00886600|592281764|FG001|Double-blind Monotherapy|Protocol Violation|0|||
163975209|NCT00886600|592281765|FG002|Double-blind Monotherapy|Protocol Violation|0|||
163975210|NCT00886600|592281766|FG003|Double-blind Monotherapy|Protocol Violation|1|||
163975211|NCT00886600|592281763|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
163975212|NCT00886600|592281764|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
163975213|NCT00886600|592281765|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
163975214|NCT00886600|592281766|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
163975215|NCT00886600|592281763|FG000|Combination Therapy Period|Adverse Event|0|||
163975216|NCT00886600|592281764|FG001|Combination Therapy Period|Adverse Event|0|||
163975217|NCT00886600|592281765|FG002|Combination Therapy Period|Adverse Event|1|||
163975218|NCT00886600|592281766|FG003|Combination Therapy Period|Adverse Event|0|||
163975219|NCT00886600|592281763|FG000|Combination Therapy Period|Protocol Violation|0|||
163975220|NCT00886600|592281764|FG001|Combination Therapy Period|Protocol Violation|0|||
163975221|NCT00886600|592281765|FG002|Combination Therapy Period|Protocol Violation|1|||
163975222|NCT00886600|592281766|FG003|Combination Therapy Period|Protocol Violation|0|||
163975223|NCT00501007|592281767|FG000|Overall Study|Inclusion criteria not met.|29|||
163975224|NCT00501007|592281768|FG001|Overall Study|Inclusion criteria not met.|25|||
163975225|NCT02424253|592281770|FG000|Overall Study|Other, unspecified|1|||
163975226|NCT02424253|592281771|FG001|Overall Study|Other, unspecified|0|||
163975227|NCT02424253|592281770|FG000|Overall Study|Compliance problems|1|||
163975228|NCT02424253|592281771|FG001|Overall Study|Compliance problems|0|||
163975229|NCT02424253|592281770|FG000|Overall Study|Physician Decision|2|||
163975230|NCT02424253|592281771|FG001|Overall Study|Physician Decision|0|||
163975231|NCT02424253|592281770|FG000|Overall Study|Lack of Efficacy|0|||
163975232|NCT02424253|592281771|FG001|Overall Study|Lack of Efficacy|7|||
163975233|NCT02424253|592281770|FG000|Overall Study|Adverse Event|2|||
163975234|NCT02424253|592281771|FG001|Overall Study|Adverse Event|0|||
163975235|NCT02424253|592281770|FG000|Overall Study|Consent withdrawn by subject|4|||
163975236|NCT02424253|592281771|FG001|Overall Study|Consent withdrawn by subject|1|||
163975237|NCT02424253|592281770|FG000|Overall Study|Lost to Follow-up|1|||
163975238|NCT02424253|592281771|FG001|Overall Study|Lost to Follow-up|1|||
163975239|NCT00473343|592281772|FG000|Overall Study|Adverse Event|9|||
163871176|NCT02531113|591896640|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
163871177|NCT00632424|591896641|FG000|Overall Study|Disease Progression|17|||
163871178|NCT00632424|591896641|FG000|Overall Study|Study Drug Toxicity|1|||
163871179|NCT00801983|591896642|FG000|Period 1|Lost to Follow-up|2|||
163871180|NCT00801983|591896643|FG001|Period 1|Lost to Follow-up|0|||
163871181|NCT00801983|591896642|FG000|Period 1|Withdrawal by Subject|2|||
163871182|NCT00801983|591896643|FG001|Period 1|Withdrawal by Subject|8|||
163871183|NCT00801983|591896642|FG000|Period 2|Withdrawal by Subject|2|||
163871184|NCT00801983|591896643|FG001|Period 2|Withdrawal by Subject|1|||
163871185|NCT04153565|591898234|FG000|Overall Study|Death|13|||
163871186|NCT04723394|591898247|FG000|Overall Study|Adverse Event|0|||
163871187|NCT04723394|591898248|FG001|Overall Study|Adverse Event|3|||
163871188|NCT04723394|591898247|FG000|Overall Study|Death|8|||
163871189|NCT04723394|591898248|FG001|Overall Study|Death|8|||
163871190|NCT04723394|591898247|FG000|Overall Study|Lost to Follow-up|20|||
163871191|NCT04723394|591898248|FG001|Overall Study|Lost to Follow-up|17|||
163871192|NCT04723394|591898247|FG000|Overall Study|Physician Decision|1|||
163871193|NCT04723394|591898248|FG001|Overall Study|Physician Decision|0|||
163871194|NCT04723394|591898247|FG000|Overall Study|Withdrawal by Subject|20|||
163871195|NCT04723394|591898248|FG001|Overall Study|Withdrawal by Subject|34|||
163871196|NCT04723394|591898247|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
163871197|NCT04723394|591898248|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
163871198|NCT00446459|591898249|FG000|8 Months|Protocol Violation|12|||
163871199|NCT00446459|591898249|FG000|12 Months|Protocol Violation|4|||
163871200|NCT00446459|591898249|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
163871201|NCT00858117|591898253|FG000|Treatment on Study|Adverse Event|2|||
163871202|NCT00858117|591898253|FG000|Follow up for 5 Years|Death|4|||
163871203|NCT00858117|591898253|FG000|Follow up for 5 Years|No further data collected for study|9|||
163871204|NCT02647905|591898254|FG000|Overall Study|Lost to Follow-up|1|||
163871205|NCT02647905|591898254|FG000|Overall Study|Withdrawal by Subject|2|||
163871206|NCT00371787|591898255|FG000|Overall Study|Withdrawal by Subject|3|||
163871207|NCT00371787|591898256|FG001|Overall Study|Withdrawal by Subject|1|||
163871208|NCT00077675|591898257|FG000|Overall Study|Adverse Event|1|||
163871209|NCT00077675|591898258|FG001|Overall Study|Adverse Event|2|||
163871210|NCT00077675|591898257|FG000|Overall Study|Lost to Follow-up|6|||
163871211|NCT00077675|591898258|FG001|Overall Study|Lost to Follow-up|3|||
163871212|NCT00077675|591898257|FG000|Overall Study|Withdrawal by Subject|1|||
163975240|NCT00473343|592281772|FG000|Overall Study|Lost to Follow-up|8|||
163975241|NCT00473343|592281772|FG000|Overall Study|Treatment failure|27|||
163871213|NCT00077675|591898258|FG001|Overall Study|Withdrawal by Subject|0|||
163975242|NCT00473343|592281772|FG000|Overall Study|Withdrew consent|3|||
163871214|NCT00077675|591898257|FG000|Overall Study|Other|0|||
163871215|NCT00077675|591898258|FG001|Overall Study|Other|1|||
163975243|NCT00473343|592281772|FG000|Overall Study|Other un-specified reason|3|||
163975244|NCT00578136|592281773|FG000|Overall Study|Not given intervention|1|||
163871216|NCT00077675|591898257|FG000|Overall Study|Never received study treatment|3|||
163871217|NCT00077675|591898258|FG001|Overall Study|Never received study treatment|3|||
163975245|NCT00578136|592281774|FG001|Overall Study|Not given intervention|1|||
163975246|NCT05419128|592281779|FG000|Overall Study|Withdrawal by Subject|1|||
164135924|NCT02799095|592861963|FG008|Part C|Withdrawal by Subject|0|||
163871218|NCT02601820|591898259|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
163871219|NCT02601820|591898259|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
163871220|NCT02601820|591898259|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
163871221|NCT02601820|591898259|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
163871222|NCT00642850|591898265|FG000|Overall Study|Death|7|||
163871223|NCT00642850|591898265|FG000|Overall Study|Adverse Event|2|||
163871224|NCT00642850|591898265|FG000|Overall Study|Lack of Efficacy|1|||
163871225|NCT00642850|591898265|FG000|Overall Study|Protocol Violation|2|||
163871226|NCT00642850|591898265|FG000|Overall Study|Kidney transplantation|8|||
163871227|NCT00642850|591898265|FG000|Overall Study|Blood transfusion|6|||
163871228|NCT00642850|591898265|FG000|Overall Study|Other reasons|7|||
163871229|NCT01236001|591898266|FG000|Overall Study|Adverse Event|5|||
163871230|NCT01236001|591898267|FG001|Overall Study|Adverse Event|14|||
163871231|NCT01236001|591898266|FG000|Overall Study|Lack of Efficacy|6|||
163871232|NCT01236001|591898267|FG001|Overall Study|Lack of Efficacy|6|||
163871233|NCT01236001|591898266|FG000|Overall Study|Lost to Follow-up|6|||
163871234|NCT01236001|591898267|FG001|Overall Study|Lost to Follow-up|1|||
163871235|NCT01236001|591898266|FG000|Overall Study|Incompliance|1|||
163871236|NCT01236001|591898267|FG001|Overall Study|Incompliance|0|||
163871237|NCT01236001|591898266|FG000|Overall Study|Planned Visit After End of Study|0|||
163871238|NCT01236001|591898267|FG001|Overall Study|Planned Visit After End of Study|1|||
163871239|NCT01414738|591898270|FG000|Overall Study|Death|26|||
163871240|NCT01414738|591898270|FG000|Overall Study|Refused testing|5|||
163871241|NCT01414738|591898270|FG000|Overall Study|Lost to Follow-up|2|||
163871242|NCT01414738|591898270|FG000|Overall Study|Refused, disease progression|8|||
163871243|NCT01414738|591898270|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
163871244|NCT01266122|591898271|FG000|Overall Study|Lost to Follow-up|6|||
163871245|NCT01266122|591898272|FG001|Overall Study|Lost to Follow-up|6|||
163871246|NCT02092116|591898274|FG000|Overall Study|Withdrawal by Subject|0|||
163871247|NCT02092116|591898275|FG001|Overall Study|Withdrawal by Subject|3|||
163871248|NCT02092116|591898274|FG000|Overall Study|Adverse Event|0|||
163871249|NCT02092116|591898275|FG001|Overall Study|Adverse Event|1|||
163871250|NCT03076515|591898276|FG000|Overall Study|DMC decision based on interim analysis|25|||
163871251|NCT03076515|591898277|FG001|Overall Study|DMC decision based on interim analysis|29|||
163871252|NCT00174382|591898278|FG000|Overall Study|Death|2|||
163871253|NCT00174382|591898278|FG000|Overall Study|Adverse Event|19|||
163871254|NCT00174382|591898278|FG000|Overall Study|Withdrawal by Subject|6|||
163871255|NCT00174382|591898278|FG000|Overall Study|Protocol Violation|3|||
163871256|NCT00174382|591898278|FG000|Overall Study|Arrived early for last visit in error|1|||
163871257|NCT00174382|591898278|FG000|Overall Study|Subject felt pill not effective enough|1|||
163871258|NCT00174382|591898278|FG000|Overall Study|Lost to Follow-up|1|||
163871259|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
163871260|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
163871261|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
163871262|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
163871263|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
163871264|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
163871265|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
163871266|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
163871267|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163871268|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163871269|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163871270|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163871271|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
163871272|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
163871273|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163871274|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
163871275|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163871276|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163871277|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163871278|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163871279|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163871280|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
163871281|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
163871282|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
163871283|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
163871284|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
163871285|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
163871286|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
163871287|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
163975247|NCT05419128|592281780|FG001|Overall Study|Withdrawal by Subject|1|||
163975248|NCT05419128|592281781|FG002|Overall Study|Withdrawal by Subject|0|||
163871288|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
163871289|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
163871290|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
163871291|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
163871292|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
163871293|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
163975249|NCT05419128|592281782|FG003|Overall Study|Withdrawal by Subject|1|||
163975250|NCT05419128|592281783|FG004|Overall Study|Withdrawal by Subject|1|||
163975251|NCT05419128|592281784|FG005|Overall Study|Withdrawal by Subject|0|||
163975252|NCT05419128|592281779|FG000|Overall Study|Lost to Follow-up|0|||
163975253|NCT05419128|592281780|FG001|Overall Study|Lost to Follow-up|0|||
163975254|NCT05419128|592281781|FG002|Overall Study|Lost to Follow-up|1|||
163975255|NCT05419128|592281782|FG003|Overall Study|Lost to Follow-up|0|||
163975256|NCT05419128|592281783|FG004|Overall Study|Lost to Follow-up|0|||
163975257|NCT05419128|592281784|FG005|Overall Study|Lost to Follow-up|1|||
163975258|NCT00517751|592281785|FG000|Overall Study|Death|3|||
163975259|NCT00517751|592281785|FG000|Overall Study|Withdrawal by Subject|37|||
163975260|NCT00517751|592281785|FG000|Overall Study|Lost to Follow-up|4|||
163975261|NCT00517751|592281785|FG000|Overall Study|patient not over due|6|||
163975262|NCT00517751|592281785|FG000|Overall Study|Patient not due for visit|76|||
163975263|NCT00517751|592281785|FG000|Overall Study|Missing|3|||
163975264|NCT02581202|592281790|FG000|Overall Study|Lack of Efficacy|2|||
163975265|NCT02581202|592281790|FG000|Overall Study|Withdrawal by Subject|4|||
163975266|NCT02581202|592281790|FG000|Overall Study|Lost to Follow-up|5|||
163975267|NCT02581202|592281790|FG000|Overall Study|Pregnancy|3|||
163975268|NCT05885737|592281791|FG000|DB Period|Adverse Event|4|||
163975269|NCT05885737|592281792|FG001|DB Period|Adverse Event|4|||
163975270|NCT05885737|592281791|FG000|DB Period|Lost to Follow-up|0|||
163975271|NCT05885737|592281792|FG001|DB Period|Lost to Follow-up|1|||
163975272|NCT05885737|592281791|FG000|DB Period|Physician Decision|2|||
163975273|NCT05885737|592281792|FG001|DB Period|Physician Decision|0|||
163975274|NCT05885737|592281791|FG000|DB Period|Withdrawal by Subject|12|||
163871294|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
163871295|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
163871296|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
163871297|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
163871298|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
163871299|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871300|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871301|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871302|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
163871303|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871304|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871305|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871306|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
163871307|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163871308|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
163871309|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163871310|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163871311|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
163871312|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
163871313|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
163871314|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
163871315|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
163871316|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163871317|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163871318|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163871319|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163871320|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
163871321|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163871322|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
163871323|NCT03903822|591898279|FG000|Treatment Phase (6 Weeks)|Other|2|||
163871324|NCT03903822|591898280|FG001|Treatment Phase (6 Weeks)|Other|1|||
163871325|NCT03903822|591898281|FG002|Treatment Phase (6 Weeks)|Other|0|||
163871326|NCT03903822|591898282|FG003|Treatment Phase (6 Weeks)|Other|0|||
163871327|NCT03903822|591898283|FG004|Treatment Phase (6 Weeks)|Other|1|||
163871328|NCT03903822|591898284|FG005|Treatment Phase (6 Weeks)|Other|1|||
163871329|NCT03903822|591898285|FG006|Treatment Phase (6 Weeks)|Other|0|||
163871330|NCT03903822|591898286|FG007|Treatment Phase (6 Weeks)|Other|0|||
163871331|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
163975275|NCT05885737|592281792|FG001|DB Period|Withdrawal by Subject|6|||
163871332|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
163975276|NCT05885737|592281791|FG000|DB Period|Other: Unspecified|2|||
163975277|NCT05885737|592281792|FG001|DB Period|Other: Unspecified|2|||
163975278|NCT05885737|592281791|FG000|OLE Period|Adverse Event|3|||
163975279|NCT05885737|592281792|FG001|OLE Period|Adverse Event|2|||
163975280|NCT05885737|592281791|FG000|OLE Period|Physician Decision|1|||
163975281|NCT05885737|592281792|FG001|OLE Period|Physician Decision|0|||
163975282|NCT05885737|592281791|FG000|OLE Period|Withdrawal by Subject|5|||
163975283|NCT05885737|592281792|FG001|OLE Period|Withdrawal by Subject|5|||
163975284|NCT05885737|592281791|FG000|OLE Period|Other: Unspecified|2|||
163975285|NCT05885737|592281792|FG001|OLE Period|Other: Unspecified|1|||
163975286|NCT00609791|592283455|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
163975287|NCT04218201|592283456|FG000|Overall Study|Death|0|||
163975288|NCT04218201|592283457|FG001|Overall Study|Death|0|||
163975289|NCT04218201|592283458|FG002|Overall Study|Death|2|||
163975290|NCT04218201|592283459|FG003|Overall Study|Death|0|||
163975291|NCT04218201|592283456|FG000|Overall Study|Unable to contact participant|4|||
163975292|NCT04218201|592283457|FG001|Overall Study|Unable to contact participant|0|||
163975293|NCT04218201|592283458|FG002|Overall Study|Unable to contact participant|3|||
163975294|NCT04218201|592283459|FG003|Overall Study|Unable to contact participant|0|||
163975295|NCT04218201|592283456|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
163975296|NCT04218201|592283457|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
163975297|NCT04218201|592283458|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
163975298|NCT04218201|592283459|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
163975299|NCT04218201|592283456|FG000|Overall Study|Withdrawal by Subject|2|||
163975300|NCT04218201|592283457|FG001|Overall Study|Withdrawal by Subject|0|||
163975301|NCT04218201|592283458|FG002|Overall Study|Withdrawal by Subject|0|||
163975302|NCT04218201|592283459|FG003|Overall Study|Withdrawal by Subject|0|||
163975303|NCT04218201|592283456|FG000|Overall Study|PCP plans to leave practice|0|||
163975304|NCT04218201|592283457|FG001|Overall Study|PCP plans to leave practice|8|||
163975305|NCT04218201|592283458|FG002|Overall Study|PCP plans to leave practice|0|||
163975306|NCT04218201|592283459|FG003|Overall Study|PCP plans to leave practice|5|||
163975307|NCT04218201|592283456|FG000|Overall Study|Reduced panel|0|||
163975308|NCT04218201|592283457|FG001|Overall Study|Reduced panel|0|||
163975309|NCT04218201|592283458|FG002|Overall Study|Reduced panel|0|||
163975310|NCT04218201|592283459|FG003|Overall Study|Reduced panel|1|||
163975311|NCT04218201|592283456|FG000|Overall Study|No longer interested in participating|0|||
163975312|NCT04218201|592283457|FG001|Overall Study|No longer interested in participating|1|||
163975313|NCT04218201|592283458|FG002|Overall Study|No longer interested in participating|0|||
163975314|NCT04218201|592283459|FG003|Overall Study|No longer interested in participating|0|||
163975315|NCT04129528|592283460|FG000|Overall Study|Adverse Event|1|||
163975316|NCT04129528|592283461|FG001|Overall Study|Adverse Event|0|||
163975317|NCT04129528|592283460|FG000|Overall Study|Physician Decision|1|||
163975318|NCT04129528|592283461|FG001|Overall Study|Physician Decision|1|||
163975319|NCT04129528|592283460|FG000|Overall Study|Withdrawal by Subject|1|||
163975320|NCT04129528|592283461|FG001|Overall Study|Withdrawal by Subject|1|||
163975321|NCT00490568|592283467|FG000|Overall Study|Adverse Event|116|||
163975322|NCT00490568|592283467|FG000|Overall Study|Lost to Follow-up|13|||
164314833|NCT00282308|593529793|FG000|Treatment Period|Lost to Follow-up|1|||
163871333|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
163871334|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
163975323|NCT00490568|592283467|FG000|Overall Study|Protocol Violation|45|||
163975324|NCT00490568|592283467|FG000|Overall Study|Withdrawal by Subject|135|||
163975325|NCT00490568|592283467|FG000|Overall Study|Still in the study at termination|974|||
163871335|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
163871336|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
163871337|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
163871338|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
163871339|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871340|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871341|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871342|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871343|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
163871344|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871345|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871346|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
163871347|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
163871348|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163871349|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163871350|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163871351|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163871352|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
163871353|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
163975326|NCT00490568|592283467|FG000|Overall Study|Other|1|||
163975327|NCT00490568|592283467|FG000|Overall Study|Exclusion criteria met|1|||
163871354|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
163871355|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
163975328|NCT00490568|592283467|FG000|Overall Study|Caregiver related|20|||
163975329|NCT00490568|592283467|FG000|Overall Study|Abnormal ECG|25|||
163975330|NCT00490568|592283467|FG000|Overall Study|Participant refused follow-up|9|||
163975331|NCT00490568|592283467|FG000|Overall Study|Legal representative withdrew consent|1|||
163975332|NCT00490568|592283467|FG000|Overall Study|Disease progression|4|||
163871356|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
163871357|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
163871358|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
163871359|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
163871360|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
163871361|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
163871362|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
163871363|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163871364|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
163871365|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
163871366|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163871367|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163871368|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
163871369|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
163871370|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
163871371|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871372|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871373|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871374|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871375|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871376|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
163871377|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871378|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
163871379|NCT03903822|591898279|FG000|Follow up Phase (4 Weeks)|Other|1|||
163871380|NCT03903822|591898280|FG001|Follow up Phase (4 Weeks)|Other|1|||
163871381|NCT03903822|591898281|FG002|Follow up Phase (4 Weeks)|Other|0|||
163871382|NCT03903822|591898282|FG003|Follow up Phase (4 Weeks)|Other|0|||
163871383|NCT03903822|591898283|FG004|Follow up Phase (4 Weeks)|Other|0|||
163871384|NCT03903822|591898284|FG005|Follow up Phase (4 Weeks)|Other|0|||
163871385|NCT03903822|591898285|FG006|Follow up Phase (4 Weeks)|Other|0|||
163871386|NCT03903822|591898286|FG007|Follow up Phase (4 Weeks)|Other|0|||
163871387|NCT00296036|591898287|FG000|Overall Study|Withdrawal by Subject|1|||
163871388|NCT00296036|591898288|FG001|Overall Study|Withdrawal by Subject|0|||
163871389|NCT00296036|591898289|FG002|Overall Study|Withdrawal by Subject|2|||
163871390|NCT00296036|591898290|FG003|Overall Study|Withdrawal by Subject|1|||
163871391|NCT00296036|591898291|FG004|Overall Study|Withdrawal by Subject|2|||
163871392|NCT00296036|591898292|FG005|Overall Study|Withdrawal by Subject|1|||
163871393|NCT00296036|591898287|FG000|Overall Study|Protocol Violation|0|||
163871394|NCT00296036|591898288|FG001|Overall Study|Protocol Violation|0|||
163871395|NCT00296036|591898289|FG002|Overall Study|Protocol Violation|0|||
163871396|NCT00296036|591898290|FG003|Overall Study|Protocol Violation|0|||
163871397|NCT00296036|591898291|FG004|Overall Study|Protocol Violation|0|||
163871398|NCT00296036|591898292|FG005|Overall Study|Protocol Violation|3|||
163871399|NCT00785512|591898295|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
163871400|NCT00785512|591898296|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
163871401|NCT00785512|591898295|FG000|Overall Study|Adverse Event|0|||
163871402|NCT00785512|591898296|FG001|Overall Study|Adverse Event|0|||
163871403|NCT00785512|591898295|FG000|Overall Study|Lack of Efficacy|0|||
163871404|NCT00785512|591898296|FG001|Overall Study|Lack of Efficacy|2|||
163871405|NCT00785512|591898295|FG000|Overall Study|Withdrawal by Subject|0|||
163871406|NCT00785512|591898296|FG001|Overall Study|Withdrawal by Subject|1|||
163871407|NCT00785512|591898295|FG000|Overall Study|Lost to Follow-up|3|||
163871408|NCT00785512|591898296|FG001|Overall Study|Lost to Follow-up|0|||
163871409|NCT00785512|591898295|FG000|Overall Study|Precedure Refused|0|||
163871410|NCT00785512|591898296|FG001|Overall Study|Precedure Refused|0|||
163871411|NCT00785512|591898295|FG000|Overall Study|IVRS Programing Error|0|||
163871412|NCT00785512|591898296|FG001|Overall Study|IVRS Programing Error|0|||
163871413|NCT00785512|591898295|FG000|Overall Study|Physician Decision|0|||
163871414|NCT00785512|591898296|FG001|Overall Study|Physician Decision|0|||
163871415|NCT00785512|591898295|FG000|Overall Study|Lack of compliance|0|||
163871416|NCT00785512|591898296|FG001|Overall Study|Lack of compliance|1|||
163871417|NCT01792830|591898297|FG000|Overall Study|Withdrawal by Subject|22|||
163871418|NCT01792830|591898298|FG001|Overall Study|Withdrawal by Subject|0|||
163871419|NCT01792830|591898299|FG002|Overall Study|Withdrawal by Subject|0|||
163871420|NCT01792830|591898300|FG003|Overall Study|Withdrawal by Subject|2|||
163871421|NCT01792830|591898301|FG004|Overall Study|Withdrawal by Subject|1|||
163871422|NCT01792830|591898302|FG005|Overall Study|Withdrawal by Subject|1|||
163975333|NCT00490568|592283467|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
163871423|NCT01792830|591898303|FG006|Overall Study|Withdrawal by Subject|1|||
163975334|NCT00490568|592283467|FG000|Overall Study|Investigator decision|3|||
163871424|NCT01792830|591898304|FG007|Overall Study|Withdrawal by Subject|1|||
163871425|NCT01792830|591898305|FG008|Overall Study|Withdrawal by Subject|7|||
163871426|NCT01792830|591898306|FG009|Overall Study|Withdrawal by Subject|0|||
163871427|NCT01792830|591898307|FG010|Overall Study|Withdrawal by Subject|2|||
163975335|NCT00490568|592283467|FG000|Overall Study|Non-Compliance|7|||
163975336|NCT00490568|592283467|FG000|Overall Study|Efficacy related|3|||
163975337|NCT00490568|592283467|FG000|Overall Study|Participant died|1|||
163975338|NCT00490568|592283467|FG000|Overall Study|Participant withdrawal due to surgery|1|||
163975339|NCT03927105|592283470|FG000|Overall Study|Death|1|||
163975340|NCT03927105|592283470|FG000|Overall Study|In observation for potential re-treatment|2|||
163975341|NCT03927105|592283470|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
163975342|NCT02819635|592283473|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
163975343|NCT02819635|592283474|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
163975344|NCT02819635|592283475|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
163975345|NCT02819635|592283476|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
163975346|NCT02819635|592283477|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
163975347|NCT02819635|592283478|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
163975348|NCT02819635|592283479|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
163975349|NCT02819635|592283480|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163975350|NCT02819635|592283481|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163975351|NCT02819635|592283482|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163975352|NCT02819635|592283483|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163975353|NCT02819635|592283484|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
163975354|NCT02819635|592283473|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975355|NCT02819635|592283474|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975356|NCT02819635|592283475|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975357|NCT02819635|592283476|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975358|NCT02819635|592283477|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
163975359|NCT02819635|592283478|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
163975360|NCT02819635|592283479|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
163975361|NCT02819635|592283480|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975362|NCT02819635|592283481|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975363|NCT02819635|592283482|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975364|NCT02819635|592283483|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975365|NCT02819635|592283484|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
163975366|NCT02819635|592283473|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975367|NCT02819635|592283474|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975368|NCT02819635|592283475|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975369|NCT02819635|592283476|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975370|NCT02819635|592283477|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975371|NCT02819635|592283478|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
163975372|NCT02819635|592283479|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
164204070|NCT05117060|593117927|FG002|Overall Study|Other|3|||
164204071|NCT05117060|593117928|FG003|Overall Study|Other|1|||
164204072|NCT03141359|593117929|FG000|Overall Study|Death|32|||
164204073|NCT03141359|593117929|FG000|Overall Study|Still On Study (in follow up)|29|||
164204074|NCT02097823|593117930|FG000|Overall Study|Withdrawal by Subject|1|||
164204075|NCT02097823|593117931|FG001|Overall Study|Withdrawal by Subject|1|||
164204076|NCT01419535|593117932|FG000|Overall Study|could not maintain iv line|1|||
164204077|NCT01419535|593117933|FG001|Overall Study|could not maintain iv line|1|||
164314834|NCT00282308|593529794|FG001|Treatment Period|Lost to Follow-up|0|||
164314835|NCT00282308|593529795|FG002|Treatment Period|Lost to Follow-up|0|||
164314836|NCT00282308|593529793|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
164314837|NCT00282308|593529794|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
164314838|NCT00282308|593529795|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
164314839|NCT00282308|593529793|FG000|Treatment Period|Adverse Event|0|||
164314840|NCT00282308|593529794|FG001|Treatment Period|Adverse Event|2|||
164314841|NCT00282308|593529795|FG002|Treatment Period|Adverse Event|0|||
164314842|NCT00282308|593529793|FG000|Treatment Period|Not Treated with Study Drug|1|||
164314843|NCT00282308|593529794|FG001|Treatment Period|Not Treated with Study Drug|0|||
164314844|NCT00282308|593529795|FG002|Treatment Period|Not Treated with Study Drug|0|||
164314845|NCT00282308|593529793|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
164314846|NCT00282308|593529794|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
164314847|NCT00282308|593529795|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
164314848|NCT00282308|593529793|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
164314849|NCT00282308|593529794|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
164314850|NCT00282308|593529795|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
164314851|NCT00282308|593529793|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
163975373|NCT02819635|592283480|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975374|NCT02819635|592283481|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975375|NCT02819635|592283482|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975376|NCT02819635|592283483|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
164204078|NCT01419535|593117932|FG000|Overall Study|Withdrawal by Subject|0|||
163975377|NCT02819635|592283484|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
163975378|NCT02819635|592283473|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975379|NCT02819635|592283474|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975380|NCT02819635|592283475|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975381|NCT02819635|592283476|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975382|NCT02819635|592283477|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975383|NCT02819635|592283478|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975384|NCT02819635|592283479|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
163975385|NCT02819635|592283480|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975386|NCT02819635|592283481|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975387|NCT02819635|592283482|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975388|NCT02819635|592283483|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975389|NCT02819635|592283484|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
163975390|NCT02819635|592283473|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
163975391|NCT02819635|592283474|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
163975392|NCT02819635|592283475|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
163975393|NCT02819635|592283476|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
163975394|NCT02819635|592283477|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
163975395|NCT02819635|592283478|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
163975396|NCT02819635|592283479|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
163975397|NCT02819635|592283480|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163975398|NCT02819635|592283481|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163975399|NCT02819635|592283482|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163975400|NCT02819635|592283483|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163975401|NCT02819635|592283484|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
163975402|NCT02819635|592283473|FG000|Substudy 2, Part 2|Adverse Event|0|||
163975403|NCT02819635|592283474|FG001|Substudy 2, Part 2|Adverse Event|0|||
163975404|NCT02819635|592283475|FG002|Substudy 2, Part 2|Adverse Event|0|||
163975405|NCT02819635|592283476|FG003|Substudy 2, Part 2|Adverse Event|0|||
163975406|NCT02819635|592283477|FG004|Substudy 2, Part 2|Adverse Event|0|||
163975407|NCT02819635|592283478|FG005|Substudy 2, Part 2|Adverse Event|4|||
163975408|NCT02819635|592283479|FG006|Substudy 2, Part 2|Adverse Event|0|||
163975409|NCT02819635|592283480|FG007|Substudy 2, Part 2|Adverse Event|0|||
163975410|NCT02819635|592283481|FG008|Substudy 2, Part 2|Adverse Event|0|||
163975411|NCT02819635|592283482|FG009|Substudy 2, Part 2|Adverse Event|0|||
163975412|NCT02819635|592283483|FG010|Substudy 2, Part 2|Adverse Event|0|||
163975413|NCT02819635|592283484|FG011|Substudy 2, Part 2|Adverse Event|0|||
163975414|NCT02819635|592283473|FG000|Substudy 2, Part 2|Withdrew consent|0|||
163975415|NCT02819635|592283474|FG001|Substudy 2, Part 2|Withdrew consent|0|||
164204079|NCT01419535|593117933|FG001|Overall Study|Withdrawal by Subject|1|||
164204080|NCT03675308|593119155|FG000|Overall Study|Adverse Event|3|||
164204081|NCT03675308|593119156|FG001|Overall Study|Adverse Event|2|||
164204082|NCT03675308|593119155|FG000|Overall Study|Withdrawal by Subject|6|||
164204083|NCT03675308|593119156|FG001|Overall Study|Withdrawal by Subject|4|||
164204084|NCT03675308|593119155|FG000|Overall Study|Lost to Follow-up|3|||
164204085|NCT03675308|593119156|FG001|Overall Study|Lost to Follow-up|0|||
164204086|NCT03675308|593119155|FG000|Overall Study|Lack of Efficacy|1|||
164204087|NCT03675308|593119156|FG001|Overall Study|Lack of Efficacy|1|||
164204088|NCT03675308|593119155|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
164204089|NCT03675308|593119156|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
164204090|NCT03675308|593119155|FG000|Overall Study|Other|0|||
164204091|NCT03675308|593119156|FG001|Overall Study|Other|1|||
164204092|NCT05722522|593119157|FG000|Overall Study|Adverse Event|0|||
164204093|NCT05722522|593119158|FG001|Overall Study|Adverse Event|1|||
164204094|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
164302993|NCT04323124|593484687|FG001|Overall Study|Adverse Event|0|||
163975416|NCT02819635|592283475|FG002|Substudy 2, Part 2|Withdrew consent|0|||
163975417|NCT02819635|592283476|FG003|Substudy 2, Part 2|Withdrew consent|0|||
163975418|NCT02819635|592283477|FG004|Substudy 2, Part 2|Withdrew consent|0|||
163975419|NCT02819635|592283478|FG005|Substudy 2, Part 2|Withdrew consent|3|||
164135925|NCT02799095|592861964|FG009|Part C|Withdrawal by Subject|0|||
164135926|NCT02799095|592861965|FG010|Part C|Withdrawal by Subject|13|||
164135927|NCT02799095|592861966|FG011|Part C|Withdrawal by Subject|15|||
164135928|NCT02799095|592861967|FG012|Part C|Withdrawal by Subject|13|||
164135929|NCT02799095|592861968|FG013|Part C|Withdrawal by Subject|21|||
164135930|NCT02799095|592861969|FG014|Part C|Withdrawal by Subject|0|||
164135931|NCT02799095|592861970|FG015|Part C|Withdrawal by Subject|12|||
164135932|NCT02799095|592861971|FG016|Part C|Withdrawal by Subject|1|||
164135933|NCT02799095|592861955|FG000|Part C|Physician Decision|0|||
164135934|NCT02799095|592861956|FG001|Part C|Physician Decision|0|||
164135935|NCT02799095|592861957|FG002|Part C|Physician Decision|0|||
164135936|NCT02799095|592861958|FG003|Part C|Physician Decision|0|||
163975420|NCT02819635|592283479|FG006|Substudy 2, Part 2|Withdrew consent|1|||
163975421|NCT02819635|592283480|FG007|Substudy 2, Part 2|Withdrew consent|0|||
163975422|NCT02819635|592283481|FG008|Substudy 2, Part 2|Withdrew consent|0|||
163975423|NCT02819635|592283482|FG009|Substudy 2, Part 2|Withdrew consent|0|||
163975424|NCT02819635|592283483|FG010|Substudy 2, Part 2|Withdrew consent|0|||
163975425|NCT02819635|592283484|FG011|Substudy 2, Part 2|Withdrew consent|0|||
163975426|NCT02819635|592283473|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
163975427|NCT02819635|592283474|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
163975428|NCT02819635|592283475|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
163975429|NCT02819635|592283476|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
163975430|NCT02819635|592283477|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
163975431|NCT02819635|592283478|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
163975432|NCT02819635|592283479|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
163975433|NCT02819635|592283480|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
163975434|NCT02819635|592283481|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
163975435|NCT02819635|592283482|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
163975436|NCT02819635|592283483|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
163975437|NCT02819635|592283484|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
163975438|NCT02819635|592283473|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975439|NCT02819635|592283474|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975440|NCT02819635|592283475|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975441|NCT02819635|592283476|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975442|NCT02819635|592283477|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975443|NCT02819635|592283478|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975444|NCT02819635|592283479|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
163975445|NCT02819635|592283480|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975446|NCT02819635|592283481|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975447|NCT02819635|592283482|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975448|NCT02819635|592283483|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975449|NCT02819635|592283484|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
163975450|NCT02819635|592283473|FG000|Substudy 2, Part 2|Other, not specified|0|||
163975451|NCT02819635|592283474|FG001|Substudy 2, Part 2|Other, not specified|0|||
163975452|NCT02819635|592283475|FG002|Substudy 2, Part 2|Other, not specified|0|||
163975453|NCT02819635|592283476|FG003|Substudy 2, Part 2|Other, not specified|0|||
163975454|NCT02819635|592283477|FG004|Substudy 2, Part 2|Other, not specified|0|||
163975455|NCT02819635|592283478|FG005|Substudy 2, Part 2|Other, not specified|4|||
163975456|NCT02819635|592283479|FG006|Substudy 2, Part 2|Other, not specified|8|||
163975457|NCT02819635|592283480|FG007|Substudy 2, Part 2|Other, not specified|0|||
163975458|NCT02819635|592283481|FG008|Substudy 2, Part 2|Other, not specified|0|||
163975459|NCT02819635|592283482|FG009|Substudy 2, Part 2|Other, not specified|0|||
163975460|NCT02819635|592283483|FG010|Substudy 2, Part 2|Other, not specified|0|||
163975461|NCT02819635|592283484|FG011|Substudy 2, Part 2|Other, not specified|0|||
163975462|NCT02819635|592283473|FG000|Substudy 3|Adverse Event|0|||
163975463|NCT02819635|592283474|FG001|Substudy 3|Adverse Event|0|||
163975464|NCT02819635|592283475|FG002|Substudy 3|Adverse Event|0|||
163975465|NCT02819635|592283476|FG003|Substudy 3|Adverse Event|0|||
163975466|NCT02819635|592283477|FG004|Substudy 3|Adverse Event|0|||
163975467|NCT02819635|592283478|FG005|Substudy 3|Adverse Event|0|||
163975468|NCT02819635|592283479|FG006|Substudy 3|Adverse Event|0|||
163975469|NCT02819635|592283480|FG007|Substudy 3|Adverse Event|0|||
163975470|NCT02819635|592283481|FG008|Substudy 3|Adverse Event|32|||
163975471|NCT02819635|592283482|FG009|Substudy 3|Adverse Event|3|||
163975472|NCT02819635|592283483|FG010|Substudy 3|Adverse Event|12|||
163975473|NCT02819635|592283484|FG011|Substudy 3|Adverse Event|18|||
163975474|NCT02819635|592283473|FG000|Substudy 3|Withdrew consent|0|||
163975475|NCT02819635|592283474|FG001|Substudy 3|Withdrew consent|0|||
163975476|NCT02819635|592283475|FG002|Substudy 3|Withdrew consent|0|||
163975477|NCT02819635|592283476|FG003|Substudy 3|Withdrew consent|0|||
163975478|NCT02819635|592283477|FG004|Substudy 3|Withdrew consent|0|||
163975479|NCT02819635|592283478|FG005|Substudy 3|Withdrew consent|0|||
163975480|NCT02819635|592283479|FG006|Substudy 3|Withdrew consent|0|||
164204095|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
164204096|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
163975481|NCT02819635|592283480|FG007|Substudy 3|Withdrew consent|0|||
163975482|NCT02819635|592283481|FG008|Substudy 3|Withdrew consent|11|||
163975483|NCT02819635|592283482|FG009|Substudy 3|Withdrew consent|1|||
163975484|NCT02819635|592283483|FG010|Substudy 3|Withdrew consent|4|||
163975485|NCT02819635|592283484|FG011|Substudy 3|Withdrew consent|9|||
163975486|NCT02819635|592283473|FG000|Substudy 3|Lost to Follow-up|0|||
163975487|NCT02819635|592283474|FG001|Substudy 3|Lost to Follow-up|0|||
163975488|NCT02819635|592283475|FG002|Substudy 3|Lost to Follow-up|0|||
163975489|NCT02819635|592283476|FG003|Substudy 3|Lost to Follow-up|0|||
163975490|NCT02819635|592283477|FG004|Substudy 3|Lost to Follow-up|0|||
163975491|NCT02819635|592283478|FG005|Substudy 3|Lost to Follow-up|0|||
163975492|NCT02819635|592283479|FG006|Substudy 3|Lost to Follow-up|0|||
163975493|NCT02819635|592283480|FG007|Substudy 3|Lost to Follow-up|0|||
163975494|NCT02819635|592283481|FG008|Substudy 3|Lost to Follow-up|1|||
163871428|NCT01792830|591898297|FG000|Overall Study|Death|3|||
163871429|NCT01792830|591898298|FG001|Overall Study|Death|0|||
163871430|NCT01792830|591898299|FG002|Overall Study|Death|0|||
163871431|NCT01792830|591898300|FG003|Overall Study|Death|1|||
163871432|NCT01792830|591898301|FG004|Overall Study|Death|0|||
163871433|NCT01792830|591898302|FG005|Overall Study|Death|0|||
163871434|NCT01792830|591898303|FG006|Overall Study|Death|1|||
163871435|NCT01792830|591898304|FG007|Overall Study|Death|0|||
163871436|NCT01792830|591898305|FG008|Overall Study|Death|1|||
163871437|NCT01792830|591898306|FG009|Overall Study|Death|0|||
163871438|NCT01792830|591898307|FG010|Overall Study|Death|1|||
163871439|NCT01792830|591898297|FG000|Overall Study|Adverse Event|0|||
163871440|NCT01792830|591898298|FG001|Overall Study|Adverse Event|0|||
163871441|NCT01792830|591898299|FG002|Overall Study|Adverse Event|0|||
163871442|NCT01792830|591898300|FG003|Overall Study|Adverse Event|0|||
163871443|NCT01792830|591898301|FG004|Overall Study|Adverse Event|0|||
163871444|NCT01792830|591898302|FG005|Overall Study|Adverse Event|0|||
163871445|NCT01792830|591898303|FG006|Overall Study|Adverse Event|0|||
163871446|NCT01792830|591898304|FG007|Overall Study|Adverse Event|0|||
163871447|NCT01792830|591898305|FG008|Overall Study|Adverse Event|1|||
163871448|NCT01792830|591898306|FG009|Overall Study|Adverse Event|0|||
163871449|NCT01792830|591898307|FG010|Overall Study|Adverse Event|0|||
163871450|NCT01943799|591898323|FG000|Overall Study|Lost to Follow-up|0|||
163871451|NCT01943799|591898324|FG001|Overall Study|Lost to Follow-up|1|||
163871452|NCT01943799|591898325|FG002|Overall Study|Lost to Follow-up|1|||
163871453|NCT01943799|591898326|FG003|Overall Study|Lost to Follow-up|0|||
163871454|NCT01943799|591898323|FG000|Overall Study|Protocol Violation|1|||
163871455|NCT01943799|591898324|FG001|Overall Study|Protocol Violation|0|||
163871456|NCT01943799|591898325|FG002|Overall Study|Protocol Violation|0|||
163871457|NCT01943799|591898326|FG003|Overall Study|Protocol Violation|0|||
163871458|NCT01943799|591898323|FG000|Overall Study|Withdrawal by Subject|4|||
163871459|NCT01943799|591898324|FG001|Overall Study|Withdrawal by Subject|2|||
163871460|NCT01943799|591898325|FG002|Overall Study|Withdrawal by Subject|1|||
163871461|NCT01943799|591898326|FG003|Overall Study|Withdrawal by Subject|0|||
163871462|NCT05274217|591898327|FG000|Overall Study|Study terminated.|11|||
163871463|NCT05274217|591898328|FG001|Overall Study|Study terminated.|0|||
163871464|NCT01697969|591898329|FG000|Overall Study|Did not meet inc/exc criteria|3|||
163871465|NCT03764475|591898332|FG000|Overall Study|Adverse Event|11|||
163871466|NCT03764475|591898333|FG001|Overall Study|Adverse Event|2|||
163871467|NCT03764475|591898332|FG000|Overall Study|Lost to Follow-up|24|||
163871468|NCT03764475|591898333|FG001|Overall Study|Lost to Follow-up|10|||
163871469|NCT03764475|591898332|FG000|Overall Study|Withdrawal by Subject|26|||
163871470|NCT03764475|591898333|FG001|Overall Study|Withdrawal by Subject|10|||
163871471|NCT03764475|591898332|FG000|Overall Study|Lack of Efficacy|3|||
163871472|NCT03764475|591898333|FG001|Overall Study|Lack of Efficacy|0|||
163871473|NCT03764475|591898332|FG000|Overall Study|COVID-19 Disruption|2|||
163871474|NCT03764475|591898333|FG001|Overall Study|COVID-19 Disruption|0|||
163871475|NCT05510245|591898340|FG000|Overall Study|Withdrawal by Subject|1|||
163871476|NCT05510245|591898341|FG001|Overall Study|Withdrawal by Subject|0|||
163871477|NCT05510245|591898342|FG002|Overall Study|Withdrawal by Subject|0|||
163871478|NCT01373346|591898345|FG000|Overall Study|Death|1|||
163871479|NCT01198028|591898346|FG000|Overall Study|Adverse Event|5|||
163871480|NCT01198028|591898346|FG000|Overall Study|Death|3|||
163871481|NCT01198028|591898346|FG000|Overall Study|Physician Decision|2|||
163871482|NCT01395758|591898348|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
163871483|NCT01395758|591898349|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163871484|NCT01395758|591898350|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163871485|NCT02674750|591898354|FG000|Overall Study|Death|4|||
163871486|NCT02674750|591898355|FG001|Overall Study|Death|5|||
163871487|NCT02674750|591898356|FG002|Overall Study|Death|8|||
163871488|NCT02674750|591898354|FG000|Overall Study|Lost to Follow-up|0|||
163871489|NCT02674750|591898355|FG001|Overall Study|Lost to Follow-up|8|||
163871490|NCT02674750|591898356|FG002|Overall Study|Lost to Follow-up|0|||
163871491|NCT02674750|591898354|FG000|Overall Study|Lack of Efficacy|1|||
163871492|NCT02674750|591898355|FG001|Overall Study|Lack of Efficacy|17|||
163871493|NCT02674750|591898356|FG002|Overall Study|Lack of Efficacy|3|||
163871494|NCT02674750|591898354|FG000|Overall Study|Withdrawal by Subject|0|||
163871495|NCT02674750|591898355|FG001|Overall Study|Withdrawal by Subject|7|||
163871496|NCT02674750|591898356|FG002|Overall Study|Withdrawal by Subject|1|||
163871497|NCT02674750|591898354|FG000|Overall Study|Other|0|||
163871498|NCT02674750|591898355|FG001|Overall Study|Other|8|||
163871499|NCT02674750|591898356|FG002|Overall Study|Other|0|||
163871500|NCT00736853|591898357|FG000|Open-Label Period|Physician Decision|2|||
163871501|NCT00736853|591898358|FG001|Open-Label Period|Physician Decision|0|||
163871502|NCT00736853|591898359|FG002|Open-Label Period|Physician Decision|0|||
163871503|NCT00736853|591898357|FG000|Open-Label Period|Adverse Event|31|||
163871504|NCT00736853|591898358|FG001|Open-Label Period|Adverse Event|0|||
163871505|NCT00736853|591898359|FG002|Open-Label Period|Adverse Event|0|||
163871506|NCT00736853|591898357|FG000|Open-Label Period|Withdrawal by Subject|16|||
163871507|NCT00736853|591898358|FG001|Open-Label Period|Withdrawal by Subject|0|||
163871508|NCT00736853|591898359|FG002|Open-Label Period|Withdrawal by Subject|0|||
163975495|NCT02819635|592283482|FG009|Substudy 3|Lost to Follow-up|0|||
163975496|NCT02819635|592283483|FG010|Substudy 3|Lost to Follow-up|1|||
163975497|NCT02819635|592283484|FG011|Substudy 3|Lost to Follow-up|1|||
163975498|NCT02819635|592283473|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975499|NCT02819635|592283474|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975500|NCT02819635|592283475|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975501|NCT02819635|592283476|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975502|NCT02819635|592283477|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975503|NCT02819635|592283478|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975504|NCT02819635|592283479|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975505|NCT02819635|592283480|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975506|NCT02819635|592283481|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975507|NCT02819635|592283482|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975508|NCT02819635|592283483|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
163975509|NCT02819635|592283484|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
163975510|NCT02819635|592283473|FG000|Substudy 3|Other, not specified|0|||
163975511|NCT02819635|592283474|FG001|Substudy 3|Other, not specified|0|||
163975512|NCT02819635|592283475|FG002|Substudy 3|Other, not specified|0|||
163975513|NCT02819635|592283476|FG003|Substudy 3|Other, not specified|0|||
163975514|NCT02819635|592283477|FG004|Substudy 3|Other, not specified|0|||
163975515|NCT02819635|592283478|FG005|Substudy 3|Other, not specified|0|||
163975516|NCT02819635|592283479|FG006|Substudy 3|Other, not specified|0|||
163975517|NCT02819635|592283480|FG007|Substudy 3|Other, not specified|0|||
163975518|NCT02819635|592283481|FG008|Substudy 3|Other, not specified|202|||
163975519|NCT02819635|592283482|FG009|Substudy 3|Other, not specified|5|||
163975520|NCT02819635|592283483|FG010|Substudy 3|Other, not specified|89|||
163975521|NCT02819635|592283484|FG011|Substudy 3|Other, not specified|39|||
163975522|NCT01081912|592283485|FG000|Conversion/Titration|Adverse Event|47|||
163975523|NCT01081912|592283486|FG001|Conversion/Titration|Adverse Event|0|||
163975524|NCT01081912|592283487|FG002|Conversion/Titration|Adverse Event|0|||
163975525|NCT01081912|592283485|FG000|Conversion/Titration|Lack of Efficacy|17|||
163975526|NCT01081912|592283486|FG001|Conversion/Titration|Lack of Efficacy|0|||
163975527|NCT01081912|592283487|FG002|Conversion/Titration|Lack of Efficacy|0|||
163975528|NCT01081912|592283485|FG000|Conversion/Titration|Lost to Follow-up|5|||
163975529|NCT01081912|592283486|FG001|Conversion/Titration|Lost to Follow-up|0|||
163975530|NCT01081912|592283487|FG002|Conversion/Titration|Lost to Follow-up|0|||
163975531|NCT01081912|592283485|FG000|Conversion/Titration|Physician Decision|2|||
163975532|NCT01081912|592283486|FG001|Conversion/Titration|Physician Decision|0|||
163975533|NCT01081912|592283487|FG002|Conversion/Titration|Physician Decision|0|||
163975534|NCT01081912|592283485|FG000|Conversion/Titration|Protocol Violation|67|||
163975535|NCT01081912|592283486|FG001|Conversion/Titration|Protocol Violation|0|||
163975536|NCT01081912|592283487|FG002|Conversion/Titration|Protocol Violation|0|||
163975537|NCT01081912|592283485|FG000|Conversion/Titration|Withdrawal by Subject|23|||
163975538|NCT01081912|592283486|FG001|Conversion/Titration|Withdrawal by Subject|0|||
163975539|NCT01081912|592283487|FG002|Conversion/Titration|Withdrawal by Subject|0|||
163975540|NCT01081912|592283485|FG000|Conversion/Titration|Non-Compliance|47|||
163975541|NCT01081912|592283486|FG001|Conversion/Titration|Non-Compliance|0|||
163975542|NCT01081912|592283487|FG002|Conversion/Titration|Non-Compliance|0|||
163975543|NCT01081912|592283485|FG000|Maintenance Treatment|Adverse Event|0|||
163975544|NCT01081912|592283486|FG001|Maintenance Treatment|Adverse Event|2|||
163975545|NCT01081912|592283487|FG002|Maintenance Treatment|Adverse Event|12|||
163975546|NCT01081912|592283485|FG000|Maintenance Treatment|Lack of Efficacy|0|||
163975547|NCT01081912|592283486|FG001|Maintenance Treatment|Lack of Efficacy|14|||
163975548|NCT01081912|592283487|FG002|Maintenance Treatment|Lack of Efficacy|64|||
163975549|NCT01081912|592283485|FG000|Maintenance Treatment|Lost to Follow-up|0|||
163975550|NCT01081912|592283486|FG001|Maintenance Treatment|Lost to Follow-up|1|||
163975551|NCT01081912|592283487|FG002|Maintenance Treatment|Lost to Follow-up|0|||
163975552|NCT01081912|592283485|FG000|Maintenance Treatment|Physician Decision|0|||
163975553|NCT01081912|592283486|FG001|Maintenance Treatment|Physician Decision|0|||
163975554|NCT01081912|592283487|FG002|Maintenance Treatment|Physician Decision|1|||
163975555|NCT01081912|592283485|FG000|Maintenance Treatment|Protocol Violation|0|||
163975556|NCT01081912|592283486|FG001|Maintenance Treatment|Protocol Violation|1|||
163975557|NCT01081912|592283487|FG002|Maintenance Treatment|Protocol Violation|2|||
163975558|NCT01081912|592283485|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
163975559|NCT01081912|592283486|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
163975560|NCT01081912|592283487|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
163975561|NCT01081912|592283485|FG000|Maintenance Treatment|Non-Compliance|0|||
163975562|NCT01081912|592283486|FG001|Maintenance Treatment|Non-Compliance|4|||
163975563|NCT01081912|592283487|FG002|Maintenance Treatment|Non-Compliance|7|||
163975564|NCT01081912|592283485|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
163975565|NCT01081912|592283486|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
163975566|NCT01081912|592283487|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
163975567|NCT00783094|592283494|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
163975568|NCT00783094|592283495|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
163975569|NCT00783094|592283496|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
163975570|NCT00783094|592283494|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
163975571|NCT00783094|592283495|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
163975572|NCT00783094|592283496|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
163975573|NCT00783094|592283494|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
163975574|NCT00783094|592283495|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
163975575|NCT00783094|592283496|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
163975576|NCT00783094|592283494|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
163975577|NCT00783094|592283495|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
163975578|NCT00783094|592283496|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
163975579|NCT00783094|592283494|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
163975580|NCT00783094|592283495|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
163975581|NCT00783094|592283496|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
163975582|NCT00783094|592283494|FG000|Open-Label Extension Period|Adverse Event|12|||
163975583|NCT00783094|592283495|FG001|Open-Label Extension Period|Adverse Event|7|||
163975584|NCT00783094|592283496|FG002|Open-Label Extension Period|Adverse Event|16|||
163975585|NCT00783094|592283494|FG000|Open-Label Extension Period|Death|0|||
163975586|NCT00783094|592283495|FG001|Open-Label Extension Period|Death|0|||
163975587|NCT00783094|592283496|FG002|Open-Label Extension Period|Death|1|||
163975588|NCT00783094|592283494|FG000|Open-Label Extension Period|Protocol Violation|4|||
163975589|NCT00783094|592283495|FG001|Open-Label Extension Period|Protocol Violation|5|||
163975590|NCT00783094|592283496|FG002|Open-Label Extension Period|Protocol Violation|7|||
163975591|NCT00783094|592283494|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
163975592|NCT00783094|592283495|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
163975593|NCT00783094|592283496|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
163975594|NCT00783094|592283494|FG000|Open-Label Extension Period|Physician Decision|4|||
163975595|NCT00783094|592283495|FG001|Open-Label Extension Period|Physician Decision|2|||
163975596|NCT00783094|592283496|FG002|Open-Label Extension Period|Physician Decision|3|||
163975597|NCT00783094|592283494|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
163975598|NCT00783094|592283495|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
163975599|NCT00783094|592283496|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
163975600|NCT01324232|592283497|FG000|Overall Study|Protocol Violation|0|||
163975601|NCT01324232|592283498|FG001|Overall Study|Protocol Violation|0|||
163975602|NCT01324232|592283499|FG002|Overall Study|Protocol Violation|0|||
163975603|NCT01324232|592283500|FG003|Overall Study|Protocol Violation|2|||
163975604|NCT01324232|592283497|FG000|Overall Study|Missing|0|||
163975605|NCT01324232|592283498|FG001|Overall Study|Missing|0|||
163975606|NCT01324232|592283499|FG002|Overall Study|Missing|1|||
163975607|NCT01324232|592283500|FG003|Overall Study|Missing|0|||
163975608|NCT01324232|592283497|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
163975609|NCT01324232|592283498|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
163975610|NCT01324232|592283499|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
163975611|NCT01324232|592283500|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
163975612|NCT01324232|592283497|FG000|Overall Study|Lack of Efficacy|2|||
163975613|NCT01324232|592283498|FG001|Overall Study|Lack of Efficacy|1|||
163975614|NCT01324232|592283499|FG002|Overall Study|Lack of Efficacy|2|||
163975615|NCT01324232|592283500|FG003|Overall Study|Lack of Efficacy|2|||
163975616|NCT01324232|592283497|FG000|Overall Study|Participant Refused Medication|0|||
163975617|NCT01324232|592283498|FG001|Overall Study|Participant Refused Medication|1|||
163975618|NCT01324232|592283499|FG002|Overall Study|Participant Refused Medication|0|||
163975619|NCT01324232|592283500|FG003|Overall Study|Participant Refused Medication|0|||
163975620|NCT01324232|592283497|FG000|Overall Study|Intercurrent illness|0|||
163975621|NCT01324232|592283498|FG001|Overall Study|Intercurrent illness|0|||
163975622|NCT01324232|592283499|FG002|Overall Study|Intercurrent illness|0|||
163975623|NCT01324232|592283500|FG003|Overall Study|Intercurrent illness|1|||
163975624|NCT01324232|592283497|FG000|Overall Study|Adverse Event|2|||
163975625|NCT01324232|592283498|FG001|Overall Study|Adverse Event|5|||
163975626|NCT01324232|592283499|FG002|Overall Study|Adverse Event|6|||
163975627|NCT01324232|592283500|FG003|Overall Study|Adverse Event|6|||
163975628|NCT01324232|592283497|FG000|Overall Study|Withdrawal by Subject|0|||
163975629|NCT01324232|592283498|FG001|Overall Study|Withdrawal by Subject|3|||
163975630|NCT01324232|592283499|FG002|Overall Study|Withdrawal by Subject|4|||
163975631|NCT01324232|592283500|FG003|Overall Study|Withdrawal by Subject|0|||
163975632|NCT01324232|592283497|FG000|Overall Study|Lost to Follow-up|1|||
163975633|NCT01324232|592283498|FG001|Overall Study|Lost to Follow-up|0|||
163975634|NCT01324232|592283499|FG002|Overall Study|Lost to Follow-up|0|||
163975635|NCT01324232|592283500|FG003|Overall Study|Lost to Follow-up|0|||
163975636|NCT02513329|592283501|FG000|Overall Study|Lost to Follow-up|5|||
163975637|NCT02513329|592283502|FG001|Overall Study|Lost to Follow-up|2|||
163975638|NCT05440539|592283503|FG000|Overall Study|Lost to Follow-up|4|||
163975639|NCT05440539|592283504|FG001|Overall Study|Lost to Follow-up|4|||
163975640|NCT05440539|592283503|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
163975641|NCT05440539|592283504|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
163975642|NCT01265615|592283505|FG000|Overall Study|Protocol Violation|2|||
163975643|NCT01265615|592283506|FG001|Overall Study|Protocol Violation|2|||
163975644|NCT01265615|592283507|FG002|Overall Study|Protocol Violation|4|||
163975645|NCT01265615|592283508|FG003|Overall Study|Protocol Violation|3|||
163975646|NCT01471015|592283509|FG000|Overall Study|Death|0|||
163975647|NCT01471015|592283510|FG001|Overall Study|Death|1|||
163975648|NCT01471015|592283511|FG002|Overall Study|Death|1|||
163975649|NCT01732796|592283512|FG000|Overall Study|Adverse Event|16|||
163975650|NCT01732796|592283513|FG001|Overall Study|Adverse Event|16|||
163975651|NCT01732796|592283514|FG002|Overall Study|Adverse Event|4|||
163975652|NCT01732796|592283512|FG000|Overall Study|Lack of Efficacy|21|||
163975653|NCT01732796|592283513|FG001|Overall Study|Lack of Efficacy|18|||
163975654|NCT01732796|592283514|FG002|Overall Study|Lack of Efficacy|5|||
163975655|NCT01732796|592283512|FG000|Overall Study|Lost to Follow-up|2|||
163975656|NCT01732796|592283513|FG001|Overall Study|Lost to Follow-up|0|||
163975657|NCT01732796|592283514|FG002|Overall Study|Lost to Follow-up|0|||
163975658|NCT01732796|592283512|FG000|Overall Study|Withdrawal by Subject|6|||
163975659|NCT01732796|592283513|FG001|Overall Study|Withdrawal by Subject|8|||
163975660|NCT01732796|592283514|FG002|Overall Study|Withdrawal by Subject|2|||
163975661|NCT01732796|592283512|FG000|Overall Study|Other reason not defined above|1|||
163975662|NCT01732796|592283513|FG001|Overall Study|Other reason not defined above|0|||
163975663|NCT01732796|592283514|FG002|Overall Study|Other reason not defined above|2|||
163975664|NCT03200366|592283520|FG000|Patient Navigation Intervention Given|Death|0|||
163975665|NCT03200366|592283521|FG001|Patient Navigation Intervention Given|Death|2|||
163975666|NCT03200366|592283522|FG002|Patient Navigation Intervention Given|Death|0|||
163975667|NCT03200366|592283520|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
163975668|NCT03200366|592283521|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
163975669|NCT03200366|592283522|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
163975670|NCT03200366|592283520|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
163975671|NCT03200366|592283521|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
163975672|NCT03200366|592283522|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
163975673|NCT03200366|592283520|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
163975674|NCT03200366|592283521|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
163975675|NCT03200366|592283522|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
163975676|NCT03200366|592283520|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
163975677|NCT03200366|592283521|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
163975678|NCT03200366|592283522|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
163975679|NCT03200366|592283520|FG000|6 Month Post-Baseline Interview|Death|1|||
163975680|NCT03200366|592283521|FG001|6 Month Post-Baseline Interview|Death|1|||
163975681|NCT03200366|592283522|FG002|6 Month Post-Baseline Interview|Death|1|||
163975682|NCT03200366|592283520|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
163975683|NCT03200366|592283521|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
163975684|NCT03200366|592283522|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
163975685|NCT03200366|592283520|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
163975686|NCT03200366|592283521|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
163975687|NCT03200366|592283522|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
163975688|NCT03200366|592283520|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
163975689|NCT03200366|592283521|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
163975690|NCT03200366|592283522|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
163975691|NCT03200366|592283520|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
163975692|NCT03200366|592283521|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
163975693|NCT03200366|592283522|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
163975694|NCT03200366|592283520|FG000|9 Month Post-Baseline Interview|Death|1|||
163975695|NCT03200366|592283521|FG001|9 Month Post-Baseline Interview|Death|1|||
163975696|NCT03200366|592283522|FG002|9 Month Post-Baseline Interview|Death|1|||
163975697|NCT03200366|592283520|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
163975698|NCT03200366|592283521|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
163975699|NCT03200366|592283522|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
163975700|NCT03200366|592283520|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
163975701|NCT03200366|592283521|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
163975702|NCT03200366|592283522|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
163975703|NCT03200366|592283520|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
163975704|NCT03200366|592283521|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
163975705|NCT03200366|592283522|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
163975706|NCT00405067|592283523|FG000|Overall Study|Adverse Event|4|||
163975707|NCT00405067|592283524|FG001|Overall Study|Adverse Event|9|||
163975708|NCT00405067|592283525|FG002|Overall Study|Adverse Event|4|||
163975709|NCT00405067|592283523|FG000|Overall Study|Lost to Follow-up|0|||
163975710|NCT00405067|592283524|FG001|Overall Study|Lost to Follow-up|0|||
163975711|NCT00405067|592283525|FG002|Overall Study|Lost to Follow-up|1|||
163975712|NCT02055820|592283526|FG000|Phase I: Dose-Finding|Death|1|||
163975713|NCT02055820|592283527|FG001|Phase I: Dose-Finding|Death|0|||
163975714|NCT02055820|592283528|FG002|Phase I: Dose-Finding|Death|1|||
163975715|NCT02055820|592283529|FG003|Phase I: Dose-Finding|Death|2|||
163975716|NCT02055820|592283530|FG004|Phase I: Dose-Finding|Death|0|||
163975717|NCT02055820|592283531|FG005|Phase I: Dose-Finding|Death|1|||
163975718|NCT02055820|592283532|FG006|Phase I: Dose-Finding|Death|1|||
163975719|NCT02055820|592283533|FG007|Phase I: Dose-Finding|Death|0|||
163975720|NCT02055820|592283534|FG008|Phase I: Dose-Finding|Death|0|||
163975721|NCT02055820|592283535|FG009|Phase I: Dose-Finding|Death|0|||
163975722|NCT02055820|592283526|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975723|NCT02055820|592283527|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975724|NCT02055820|592283528|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975725|NCT02055820|592283529|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975726|NCT02055820|592283530|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975727|NCT02055820|592283531|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
163975728|NCT02055820|592283532|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975729|NCT02055820|592283533|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975730|NCT02055820|592283534|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975731|NCT02055820|592283535|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
163975732|NCT02055820|592283526|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975733|NCT02055820|592283527|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975734|NCT02055820|592283528|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975735|NCT02055820|592283529|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
163975736|NCT02055820|592283530|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975737|NCT02055820|592283531|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975738|NCT02055820|592283532|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
163975739|NCT02055820|592283533|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975740|NCT02055820|592283534|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975741|NCT02055820|592283535|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
163975742|NCT02055820|592283526|FG000|Phase II: Expansion|Death|0|||
163975743|NCT02055820|592283527|FG001|Phase II: Expansion|Death|0|||
163975744|NCT02055820|592283528|FG002|Phase II: Expansion|Death|0|||
163975745|NCT02055820|592283529|FG003|Phase II: Expansion|Death|0|||
163975746|NCT02055820|592283530|FG004|Phase II: Expansion|Death|33|||
163975747|NCT02055820|592283531|FG005|Phase II: Expansion|Death|0|||
163975748|NCT02055820|592283532|FG006|Phase II: Expansion|Death|0|||
163975749|NCT02055820|592283533|FG007|Phase II: Expansion|Death|0|||
163975750|NCT02055820|592283534|FG008|Phase II: Expansion|Death|0|||
163975751|NCT02055820|592283535|FG009|Phase II: Expansion|Death|0|||
163975752|NCT02055820|592283526|FG000|Phase II: Expansion|Lost to Follow-up|0|||
163975753|NCT02055820|592283527|FG001|Phase II: Expansion|Lost to Follow-up|0|||
163975754|NCT02055820|592283528|FG002|Phase II: Expansion|Lost to Follow-up|0|||
163975755|NCT02055820|592283529|FG003|Phase II: Expansion|Lost to Follow-up|0|||
163975756|NCT02055820|592283530|FG004|Phase II: Expansion|Lost to Follow-up|4|||
163975757|NCT02055820|592283531|FG005|Phase II: Expansion|Lost to Follow-up|0|||
163975758|NCT02055820|592283532|FG006|Phase II: Expansion|Lost to Follow-up|0|||
163975759|NCT02055820|592283533|FG007|Phase II: Expansion|Lost to Follow-up|0|||
163975760|NCT02055820|592283534|FG008|Phase II: Expansion|Lost to Follow-up|0|||
163975761|NCT02055820|592283535|FG009|Phase II: Expansion|Lost to Follow-up|0|||
163975762|NCT02055820|592283526|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
163975763|NCT02055820|592283527|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
163975764|NCT02055820|592283528|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
163975765|NCT02055820|592283529|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
163975766|NCT02055820|592283530|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
163975767|NCT02055820|592283531|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
163975768|NCT02055820|592283532|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
163975769|NCT02055820|592283533|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
163975770|NCT02055820|592283534|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
163975771|NCT02055820|592283535|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
163975772|NCT02285777|592283536|FG000|Overall Study|Withdrawal by Subject|1|||
163975773|NCT02285777|592283537|FG001|Overall Study|Withdrawal by Subject|1|||
163975774|NCT02285777|592283536|FG000|Overall Study|Lost to Follow-up|4|||
163975775|NCT02285777|592283537|FG001|Overall Study|Lost to Follow-up|2|||
163975776|NCT00552175|592283538|FG000|Overall Study|Lack of Efficacy|2|||
163975777|NCT00552175|592283539|FG001|Overall Study|Lack of Efficacy|0|||
163975778|NCT00552175|592283540|FG002|Overall Study|Lack of Efficacy|1|||
163975779|NCT00552175|592283538|FG000|Overall Study|Adverse Event|9|||
163975780|NCT00552175|592283539|FG001|Overall Study|Adverse Event|9|||
163975781|NCT00552175|592283540|FG002|Overall Study|Adverse Event|10|||
163975782|NCT00552175|592283538|FG000|Overall Study|Withdrawal by Subject|2|||
163975783|NCT00552175|592283539|FG001|Overall Study|Withdrawal by Subject|2|||
163975784|NCT00552175|592283540|FG002|Overall Study|Withdrawal by Subject|1|||
163975785|NCT00552175|592283538|FG000|Overall Study|Lost to Follow-up|0|||
163975786|NCT00552175|592283539|FG001|Overall Study|Lost to Follow-up|0|||
163975787|NCT00552175|592283540|FG002|Overall Study|Lost to Follow-up|1|||
163975788|NCT00552175|592283538|FG000|Overall Study|Entry Criteria Not Met|1|||
164135937|NCT02799095|592861959|FG004|Part C|Physician Decision|0|||
163975789|NCT00552175|592283539|FG001|Overall Study|Entry Criteria Not Met|1|||
163975790|NCT00552175|592283540|FG002|Overall Study|Entry Criteria Not Met|0|||
163975791|NCT00552175|592283538|FG000|Overall Study|Reason Not Specified|3|||
163975792|NCT00552175|592283539|FG001|Overall Study|Reason Not Specified|1|||
163975793|NCT00552175|592283540|FG002|Overall Study|Reason Not Specified|1|||
163975794|NCT04677959|592283542|FG000|Overall Study|Adverse Event|1|||
163975795|NCT04677959|592283543|FG001|Overall Study|Adverse Event|9|||
163975796|NCT04677959|592283542|FG000|Overall Study|Withdrawal by Subject|2|||
163975797|NCT04677959|592283543|FG001|Overall Study|Withdrawal by Subject|15|||
163975798|NCT04677959|592283542|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163975799|NCT04677959|592283543|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163975800|NCT04677959|592283542|FG000|Overall Study|Non-compliance with study drug|0|||
163975801|NCT04677959|592283543|FG001|Overall Study|Non-compliance with study drug|2|||
163975802|NCT04677959|592283542|FG000|Overall Study|Protocol deviation|0|||
163975803|NCT04677959|592283543|FG001|Overall Study|Protocol deviation|11|||
163975804|NCT04677959|592283542|FG000|Overall Study|Lost to Follow-up|9|||
163975805|NCT04677959|592283543|FG001|Overall Study|Lost to Follow-up|13|||
163975806|NCT04677959|592283542|FG000|Overall Study|Other than specified|0|||
163975807|NCT04677959|592283543|FG001|Overall Study|Other than specified|8|||
163975808|NCT01399788|592283544|FG000|First Intervention Period|Adverse Event|1|||
163975809|NCT01399788|592283545|FG001|First Intervention Period|Adverse Event|0|||
163975810|NCT02919436|592283546|FG000|Overall Study|Did not undergo surgery|16|||
163975811|NCT02919436|592283547|FG001|Overall Study|Did not undergo surgery|20|||
163975812|NCT02919436|592283546|FG000|Overall Study|Enrolled before trial registration|44|||
163975813|NCT02919436|592283547|FG001|Overall Study|Enrolled before trial registration|33|||
163975814|NCT04718974|592283548|FG000|Overall Study|Death|0|||
163975815|NCT04718974|592283549|FG001|Overall Study|Death|2|||
163975816|NCT04718974|592283548|FG000|Overall Study|Lost to Follow-up|10|||
163975817|NCT04718974|592283549|FG001|Overall Study|Lost to Follow-up|20|||
163975818|NCT04718974|592283548|FG000|Overall Study|Transferred out|2|||
163975819|NCT04718974|592283549|FG001|Overall Study|Transferred out|4|||
163975820|NCT01389752|592283550|FG000|Study Period 1|Sponsor decision|0|||
163975821|NCT01389752|592283551|FG001|Study Period 1|Sponsor decision|2|||
163975822|NCT01389752|592283550|FG000|Study Period 2|Sponsor decision|1|||
163975823|NCT01389752|592283551|FG001|Study Period 2|Sponsor decision|0|||
163975824|NCT02409290|592283552|FG000|Overall Study|Protocol Violation|3|||
163975825|NCT02409290|592283553|FG001|Overall Study|Protocol Violation|6|||
163975826|NCT02409290|592283554|FG002|Overall Study|Protocol Violation|9|||
163975827|NCT02409290|592283555|FG003|Overall Study|Protocol Violation|4|||
163975828|NCT02409290|592283552|FG000|Overall Study|No positive culture/no baseline sample|3|||
163975829|NCT02409290|592283553|FG001|Overall Study|No positive culture/no baseline sample|9|||
163975830|NCT02409290|592283554|FG002|Overall Study|No positive culture/no baseline sample|6|||
163975831|NCT02409290|592283555|FG003|Overall Study|No positive culture/no baseline sample|5|||
163975832|NCT02409290|592283552|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
163975833|NCT02409290|592283553|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
163975834|NCT02409290|592283554|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
163975835|NCT02409290|592283555|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
163975836|NCT02830776|592283556|FG000|Overall Study|Lost to Follow-up|1|||
163975837|NCT03631732|592283570|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
163975838|NCT03631732|592283571|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
163975839|NCT03631732|592283570|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
163975840|NCT03631732|592283571|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
163975841|NCT03631732|592283570|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
163975842|NCT03631732|592283571|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
163975843|NCT03631732|592283570|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
163975844|NCT03631732|592283571|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
163975845|NCT03631732|592283570|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
163975846|NCT03631732|592283571|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
163975847|NCT03631732|592283570|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
163975848|NCT03631732|592283571|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
163975849|NCT03631732|592283570|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
163975850|NCT03631732|592283571|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
163975851|NCT03631732|592283570|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
163975852|NCT03631732|592283571|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
163975853|NCT03631732|592283570|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
163975854|NCT03631732|592283571|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
163975855|NCT03631732|592283570|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
163975856|NCT03631732|592283571|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
164204097|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Death|1|||
163975857|NCT01439204|592283572|FG000|Overall Study|Withdrawal by Subject|0|||
163975858|NCT01439204|592283573|FG001|Overall Study|Withdrawal by Subject|1|||
163975859|NCT01439204|592283572|FG000|Overall Study|Lost to Follow-up|0|||
164314852|NCT00282308|593529794|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
164314853|NCT00282308|593529795|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
164314854|NCT00282308|593529793|FG000|Safety Follow-up Period|Adverse Event|0|||
164314855|NCT00282308|593529794|FG001|Safety Follow-up Period|Adverse Event|0|||
164314856|NCT00282308|593529795|FG002|Safety Follow-up Period|Adverse Event|1|||
163871509|NCT00736853|591898357|FG000|Open-Label Period|Started but not treated|42|||
163871510|NCT00736853|591898358|FG001|Open-Label Period|Started but not treated|0|||
163871511|NCT00736853|591898359|FG002|Open-Label Period|Started but not treated|0|||
163871512|NCT00736853|591898357|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
163871513|NCT00736853|591898358|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
163871514|NCT00736853|591898359|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
163871515|NCT00736853|591898357|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
163871516|NCT00736853|591898358|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
163871517|NCT00736853|591898359|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
163871518|NCT00736853|591898357|FG000|Double-Blind Period|Lack of Efficacy|0|||
163871519|NCT00736853|591898358|FG001|Double-Blind Period|Lack of Efficacy|19|||
163871520|NCT00736853|591898359|FG002|Double-Blind Period|Lack of Efficacy|42|||
163871521|NCT00736853|591898357|FG000|Double-Blind Period|Adverse Event|0|||
163871522|NCT00736853|591898358|FG001|Double-Blind Period|Adverse Event|3|||
163871523|NCT00736853|591898359|FG002|Double-Blind Period|Adverse Event|2|||
163871524|NCT00736853|591898357|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163871525|NCT00736853|591898358|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163871526|NCT00736853|591898359|FG002|Double-Blind Period|Withdrawal by Subject|4|||
163871527|NCT00736853|591898357|FG000|Double-Blind Period|Ineligible to participate the study|0|||
163871528|NCT00736853|591898358|FG001|Double-Blind Period|Ineligible to participate the study|1|||
163871529|NCT00736853|591898359|FG002|Double-Blind Period|Ineligible to participate the study|0|||
163871530|NCT01415349|591898360|FG000|Treatment Period 1|Adverse Event|0|||
163871531|NCT01415349|591898361|FG001|Treatment Period 1|Adverse Event|1|||
163871532|NCT01415349|591898360|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163871533|NCT01415349|591898361|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163871534|NCT02139943|591898362|FG000|Overall Study|Adverse Event|0|||
163871535|NCT02139943|591898363|FG001|Overall Study|Adverse Event|1|||
163871536|NCT02139943|591898364|FG002|Overall Study|Adverse Event|2|||
163871537|NCT02139943|591898362|FG000|Overall Study|Lost to Follow-up|3|||
163871538|NCT02139943|591898363|FG001|Overall Study|Lost to Follow-up|2|||
163871539|NCT02139943|591898364|FG002|Overall Study|Lost to Follow-up|2|||
163871540|NCT02139943|591898362|FG000|Overall Study|Withdrawal by Subject|4|||
163871541|NCT02139943|591898363|FG001|Overall Study|Withdrawal by Subject|3|||
163871542|NCT02139943|591898364|FG002|Overall Study|Withdrawal by Subject|0|||
163871543|NCT02139943|591898362|FG000|Overall Study|Other|0|||
163871544|NCT02139943|591898363|FG001|Overall Study|Other|0|||
163871545|NCT02139943|591898364|FG002|Overall Study|Other|1|||
163871546|NCT02139943|591898362|FG000|Overall Study|Participant wishes to discontinue|2|||
163871547|NCT02139943|591898363|FG001|Overall Study|Participant wishes to discontinue|0|||
163871548|NCT02139943|591898364|FG002|Overall Study|Participant wishes to discontinue|0|||
163871549|NCT02139943|591898362|FG000|Overall Study|Participant in Poor Compliance|1|||
163871550|NCT02139943|591898363|FG001|Overall Study|Participant in Poor Compliance|0|||
163871551|NCT02139943|591898364|FG002|Overall Study|Participant in Poor Compliance|1|||
163871552|NCT02139943|591898362|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
163871553|NCT02139943|591898363|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
163871554|NCT02139943|591898364|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
163871555|NCT01764464|591898365|FG000|First Intervention|Withdrawal by Subject|1|||
163871556|NCT01764464|591898366|FG001|First Intervention|Withdrawal by Subject|0|||
163871557|NCT01764464|591898365|FG000|First Intervention|Lost to Follow-up|1|||
163871558|NCT01764464|591898366|FG001|First Intervention|Lost to Follow-up|0|||
163871559|NCT01764464|591898365|FG000|First Intervention|Adverse Event|0|||
163871560|NCT01764464|591898366|FG001|First Intervention|Adverse Event|2|||
163871561|NCT01764464|591898365|FG000|First Intervention|did not receive study drug|0|||
163871562|NCT01764464|591898366|FG001|First Intervention|did not receive study drug|1|||
163871563|NCT01764464|591898365|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
163871564|NCT01764464|591898366|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
163871565|NCT02918071|591898371|FG000|Overall Study|Withdrawal by Subject|2|||
163871566|NCT02918071|591898371|FG000|Overall Study|Lost to Follow-up|1|||
163871567|NCT01616459|591898372|FG000|Overall Study|Adverse Event|1|||
163871568|NCT01616459|591898373|FG001|Overall Study|Adverse Event|1|||
163871569|NCT01616459|591898374|FG002|Overall Study|Adverse Event|2|||
163871570|NCT01616459|591898375|FG003|Overall Study|Adverse Event|0|||
163871571|NCT01616459|591898372|FG000|Overall Study|Lost to Follow-up|1|||
163871572|NCT01616459|591898373|FG001|Overall Study|Lost to Follow-up|11|||
163871573|NCT01616459|591898374|FG002|Overall Study|Lost to Follow-up|3|||
163871574|NCT01616459|591898375|FG003|Overall Study|Lost to Follow-up|2|||
163871575|NCT01616459|591898372|FG000|Overall Study|Protocol Violation|0|||
163871576|NCT01616459|591898373|FG001|Overall Study|Protocol Violation|0|||
163871577|NCT01616459|591898374|FG002|Overall Study|Protocol Violation|0|||
163871578|NCT01616459|591898375|FG003|Overall Study|Protocol Violation|2|||
163975860|NCT01439204|592283573|FG001|Overall Study|Lost to Follow-up|2|||
163975861|NCT01439204|592283572|FG000|Overall Study|No longer meets study criteria|1|||
163975862|NCT01439204|592283573|FG001|Overall Study|No longer meets study criteria|0|||
163975863|NCT01439204|592283572|FG000|Overall Study|poor/non-compliance|3|||
163975864|NCT01439204|592283573|FG001|Overall Study|poor/non-compliance|0|||
163975865|NCT01251367|592283574|FG000|Overall Study|Protocol Violation|1|||
163975866|NCT01251367|592283574|FG000|Overall Study|Lack of Efficacy|2|||
163975867|NCT01251367|592283574|FG000|Overall Study|Adverse Event|19|||
163975868|NCT01251367|592283574|FG000|Overall Study|Withdrawal by Subject|36|||
163975869|NCT01251367|592283574|FG000|Overall Study|Lost to Follow-up|5|||
163975870|NCT01251367|592283574|FG000|Overall Study|Subject Required Alternative Treatment|7|||
163975871|NCT01251367|592283574|FG000|Overall Study|No Study Drug Available|1|||
163975872|NCT01251367|592283574|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
163975873|NCT01251367|592283574|FG000|Overall Study|End of Study Visit Performed in Error|1|||
163975874|NCT02255409|592283575|FG000|Overall Study|Administrative Reason|3|||
163975875|NCT02255409|592283576|FG001|Overall Study|Administrative Reason|7|||
163975876|NCT02255409|592283575|FG000|Overall Study|Withdrawal by Subject|1|||
163975877|NCT02255409|592283576|FG001|Overall Study|Withdrawal by Subject|5|||
163975878|NCT02255409|592283575|FG000|Overall Study|Lost to Follow-up|10|||
163975879|NCT02255409|592283576|FG001|Overall Study|Lost to Follow-up|19|||
163975880|NCT03917823|592283577|FG000|Overall Study|Lost to Follow-up|1|||
163975881|NCT03917823|592283578|FG001|Overall Study|Lost to Follow-up|1|||
163975882|NCT03917823|592283577|FG000|Overall Study|Withdrawal by Subject|0|||
163975883|NCT03917823|592283578|FG001|Overall Study|Withdrawal by Subject|1|||
163975884|NCT00135668|592283579|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
163975885|NCT00135668|592283580|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
163975886|NCT00135668|592283581|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
163975887|NCT00135668|592283582|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
163975888|NCT02290873|592283587|FG000|Overall Study|Withdrawal by Subject|0|||
163975889|NCT02290873|592283588|FG001|Overall Study|Withdrawal by Subject|1|||
163975890|NCT02290873|592283589|FG002|Overall Study|Withdrawal by Subject|1|||
163975891|NCT02290873|592283587|FG000|Overall Study|Nellcor device error|1|||
163975892|NCT02290873|592283588|FG001|Overall Study|Nellcor device error|0|||
163975893|NCT02290873|592283589|FG002|Overall Study|Nellcor device error|0|||
163975894|NCT02290873|592283587|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
163975895|NCT02290873|592283588|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
163975896|NCT02290873|592283589|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
163975897|NCT02290873|592283587|FG000|Overall Study|Protocol Violation|0|||
163975898|NCT02290873|592283588|FG001|Overall Study|Protocol Violation|0|||
163975899|NCT02290873|592283589|FG002|Overall Study|Protocol Violation|1|||
163975900|NCT02370615|592283590|FG000|Overall Study|Adverse Event|1|||
163975901|NCT02370615|592283591|FG001|Overall Study|Adverse Event|0|||
163975902|NCT03715153|592283592|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
163975903|NCT03715153|592283593|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
163975904|NCT03715153|592283592|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
163975905|NCT03715153|592283593|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
163975906|NCT03715153|592283592|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
163975907|NCT03715153|592283593|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
163975908|NCT03715153|592283592|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
163975909|NCT03715153|592283593|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
163975910|NCT03715153|592283592|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
163975911|NCT03715153|592283593|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
163975912|NCT03715153|592283592|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
163975913|NCT03715153|592283593|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
163975914|NCT04126083|592283594|FG000|Overall Study|Withdrawal by Subject|1|||
163975915|NCT01892163|592283597|FG000|Overall Study|Death|1|||
163975916|NCT01892163|592283598|FG001|Overall Study|Death|1|||
164204098|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Death|1|||
164204099|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Death|0|||
164204100|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
164204101|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
164204102|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
164204103|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
164204104|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
164204105|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
164204106|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
164204107|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
163975917|NCT01892163|592283597|FG000|Overall Study|Lost to Follow-up|1|||
163975918|NCT01892163|592283598|FG001|Overall Study|Lost to Follow-up|0|||
163975919|NCT02577146|592283599|FG000|Overall Study|Lost to Follow-up|8|||
163975920|NCT02577146|592283599|FG000|Overall Study|Physician Decision|3|||
163975921|NCT02577146|592283599|FG000|Overall Study|Screen Failure|17|||
163975922|NCT03116698|592283600|FG000|Overall Study|Adverse Event|1|||
163975923|NCT03116698|592283601|FG001|Overall Study|Adverse Event|1|||
163975924|NCT03116698|592283602|FG002|Overall Study|Adverse Event|1|||
163975925|NCT03116698|592283603|FG003|Overall Study|Adverse Event|0|||
163975926|NCT03116698|592283600|FG000|Overall Study|Withdrawal by Subject|1|||
163975927|NCT03116698|592283601|FG001|Overall Study|Withdrawal by Subject|4|||
163975928|NCT03116698|592283602|FG002|Overall Study|Withdrawal by Subject|5|||
163975929|NCT03116698|592283603|FG003|Overall Study|Withdrawal by Subject|2|||
163975930|NCT03116698|592283600|FG000|Overall Study|Lost to Follow-up|2|||
163975931|NCT03116698|592283601|FG001|Overall Study|Lost to Follow-up|0|||
163975932|NCT03116698|592283602|FG002|Overall Study|Lost to Follow-up|0|||
163975933|NCT03116698|592283603|FG003|Overall Study|Lost to Follow-up|0|||
163975934|NCT03116698|592283600|FG000|Overall Study|Physician Decision|1|||
163975935|NCT03116698|592283601|FG001|Overall Study|Physician Decision|1|||
163975936|NCT03116698|592283602|FG002|Overall Study|Physician Decision|0|||
163975937|NCT03116698|592283603|FG003|Overall Study|Physician Decision|0|||
163975938|NCT03116698|592283600|FG000|Overall Study|Protocol Violation|1|||
163975939|NCT03116698|592283601|FG001|Overall Study|Protocol Violation|0|||
163975940|NCT03116698|592283602|FG002|Overall Study|Protocol Violation|0|||
163975941|NCT03116698|592283603|FG003|Overall Study|Protocol Violation|0|||
163975942|NCT03116698|592283600|FG000|Overall Study|Death|0|||
163975943|NCT03116698|592283601|FG001|Overall Study|Death|0|||
163975944|NCT03116698|592283602|FG002|Overall Study|Death|2|||
163975945|NCT03116698|592283603|FG003|Overall Study|Death|0|||
163975946|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
163975947|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
163975948|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
163975949|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
163975950|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
163975951|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
163975952|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
163975953|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
163975954|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to death|4|||
163975955|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to death|3|||
163975956|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
163975957|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
163975958|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
163975959|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
163975960|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
163975961|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
163975962|NCT02258451|592283604|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
163975963|NCT02258451|592283605|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
163975964|NCT02258451|592283604|FG000|Overall Study|Other reason|1|||
163975965|NCT02258451|592283605|FG001|Overall Study|Other reason|1|||
163975966|NCT02258451|592283604|FG000|Overall Study|Never treated|2|||
163975967|NCT02258451|592283605|FG001|Overall Study|Never treated|3|||
163975968|NCT03021499|592283608|FG000|Overall Study|Adverse Event|1|||
163975969|NCT03021499|592283609|FG001|Overall Study|Adverse Event|0|||
163975970|NCT03021499|592283608|FG000|Overall Study|Death|1|||
163975971|NCT03021499|592283609|FG001|Overall Study|Death|5|||
163975972|NCT03021499|592283608|FG000|Overall Study|Lack of Efficacy|0|||
163975973|NCT03021499|592283609|FG001|Overall Study|Lack of Efficacy|1|||
163975974|NCT03021499|592283608|FG000|Overall Study|Lost to Follow-up|1|||
163975975|NCT03021499|592283609|FG001|Overall Study|Lost to Follow-up|3|||
163975976|NCT03021499|592283608|FG000|Overall Study|Physician Decision|2|||
163975977|NCT03021499|592283609|FG001|Overall Study|Physician Decision|3|||
163975978|NCT03021499|592283608|FG000|Overall Study|Pregnancy|1|||
163975979|NCT03021499|592283609|FG001|Overall Study|Pregnancy|0|||
163975980|NCT03021499|592283608|FG000|Overall Study|Withdrawal by Subject|7|||
163975981|NCT03021499|592283609|FG001|Overall Study|Withdrawal by Subject|14|||
163975982|NCT03021499|592283608|FG000|Overall Study|Prohibited medication required|1|||
163975983|NCT03021499|592283609|FG001|Overall Study|Prohibited medication required|0|||
163975984|NCT03021499|592283608|FG000|Overall Study|Protocol non-compliance|1|||
163975985|NCT03021499|592283609|FG001|Overall Study|Protocol non-compliance|1|||
163975986|NCT03021499|592283608|FG000|Overall Study|None of the above|0|||
163975987|NCT03021499|592283609|FG001|Overall Study|None of the above|4|||
163975988|NCT03021499|592283608|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
163975989|NCT03021499|592283609|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
164204108|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
163975990|NCT00495820|592283610|FG000|Overall Study|Adverse Event|1|||
163975991|NCT00495820|592283611|FG001|Overall Study|Adverse Event|1|||
163975992|NCT00820950|592283612|FG000|Overall Study|Scheduling Conflict|0|||
163975993|NCT00820950|592283613|FG001|Overall Study|Scheduling Conflict|0|||
163975994|NCT00820950|592283614|FG002|Overall Study|Scheduling Conflict|0|||
163975995|NCT00820950|592283615|FG003|Overall Study|Scheduling Conflict|0|||
163975996|NCT00820950|592283616|FG004|Overall Study|Scheduling Conflict|0|||
163975997|NCT00820950|592283617|FG005|Overall Study|Scheduling Conflict|0|||
163975998|NCT00820950|592283618|FG006|Overall Study|Scheduling Conflict|1|||
163975999|NCT00820950|592283619|FG007|Overall Study|Scheduling Conflict|1|||
163976000|NCT00820950|592283620|FG008|Overall Study|Scheduling Conflict|0|||
163976001|NCT00820950|592283621|FG009|Overall Study|Scheduling Conflict|0|||
163976002|NCT00820950|592283612|FG000|Overall Study|Protocol Violation|1|||
163976003|NCT00820950|592283613|FG001|Overall Study|Protocol Violation|1|||
163976004|NCT00820950|592283614|FG002|Overall Study|Protocol Violation|0|||
163976005|NCT00820950|592283615|FG003|Overall Study|Protocol Violation|0|||
163976006|NCT00820950|592283616|FG004|Overall Study|Protocol Violation|0|||
163976007|NCT00820950|592283617|FG005|Overall Study|Protocol Violation|0|||
163976008|NCT00820950|592283618|FG006|Overall Study|Protocol Violation|0|||
163976009|NCT00820950|592283619|FG007|Overall Study|Protocol Violation|0|||
163976010|NCT00820950|592283620|FG008|Overall Study|Protocol Violation|0|||
163976011|NCT00820950|592283621|FG009|Overall Study|Protocol Violation|0|||
163976012|NCT00789529|592285701|FG000|Overall Study|Withdrawal by Subject|0|||
163976013|NCT00789529|592285702|FG001|Overall Study|Withdrawal by Subject|1|||
163976014|NCT00789529|592285701|FG000|Overall Study|Other Reason|1|||
164314857|NCT00282308|593529793|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
164314858|NCT00282308|593529794|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
164314859|NCT00282308|593529795|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
163976015|NCT00789529|592285702|FG001|Overall Study|Other Reason|0|||
163976016|NCT01870401|592285703|FG000|Overall Study|Death|48|||
163976017|NCT01870401|592285704|FG001|Overall Study|Death|24|||
163976018|NCT01870401|592285703|FG000|Overall Study|Withdrawal by Subject|39|||
163976019|NCT01870401|592285704|FG001|Overall Study|Withdrawal by Subject|26|||
163976020|NCT01870401|592285703|FG000|Overall Study|Lost to Follow-up|19|||
163976021|NCT01870401|592285704|FG001|Overall Study|Lost to Follow-up|14|||
163976022|NCT01870401|592285703|FG000|Overall Study|Other|9|||
163976023|NCT01870401|592285704|FG001|Overall Study|Other|7|||
163976024|NCT01870401|592285703|FG000|Overall Study|On-going in the Study|35|||
163976025|NCT01870401|592285704|FG001|Overall Study|On-going in the Study|25|||
163976026|NCT01135498|592285706|FG000|Overall Study|Adverse Event|20|||
163976027|NCT01135498|592285706|FG000|Overall Study|Progressive disease|38|||
163976028|NCT01135498|592285706|FG000|Overall Study|Investigator judgement|25|||
163976029|NCT01135498|592285706|FG000|Overall Study|Withdrawal by Subject|4|||
163976030|NCT01135498|592285706|FG000|Overall Study|Death|1|||
163976031|NCT01135498|592285706|FG000|Overall Study|Ongoing at time of analysis|2|||
163976032|NCT01192022|592285707|FG000|Overall Study|Withdrawal of Consent|3|||
163976033|NCT01192022|592285708|FG001|Overall Study|Withdrawal of Consent|1|||
163976034|NCT01192022|592285709|FG002|Overall Study|Withdrawal of Consent|0|||
163976035|NCT01192022|592285710|FG003|Overall Study|Withdrawal of Consent|0|||
163976036|NCT01192022|592285711|FG004|Overall Study|Withdrawal of Consent|0|||
163976037|NCT01192022|592285707|FG000|Overall Study|Lost to Follow-up|4|||
163976038|NCT01192022|592285708|FG001|Overall Study|Lost to Follow-up|2|||
163976039|NCT01192022|592285709|FG002|Overall Study|Lost to Follow-up|1|||
163976040|NCT01192022|592285710|FG003|Overall Study|Lost to Follow-up|1|||
163976041|NCT01192022|592285711|FG004|Overall Study|Lost to Follow-up|0|||
163976042|NCT01192022|592285707|FG000|Overall Study|Adverse Event|1|||
163976043|NCT01192022|592285708|FG001|Overall Study|Adverse Event|0|||
163976044|NCT01192022|592285709|FG002|Overall Study|Adverse Event|0|||
163976045|NCT01192022|592285710|FG003|Overall Study|Adverse Event|0|||
164314860|NCT00282308|593529793|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
164314861|NCT00282308|593529794|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
164314862|NCT00282308|593529795|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
164314863|NCT00282308|593529793|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
163976046|NCT01192022|592285711|FG004|Overall Study|Adverse Event|0|||
163976047|NCT01192022|592285707|FG000|Overall Study|Fatal Adverse Event|4|||
163976048|NCT01192022|592285708|FG001|Overall Study|Fatal Adverse Event|6|||
163976049|NCT01192022|592285709|FG002|Overall Study|Fatal Adverse Event|0|||
163976050|NCT01192022|592285710|FG003|Overall Study|Fatal Adverse Event|0|||
163976051|NCT01192022|592285711|FG004|Overall Study|Fatal Adverse Event|1|||
163976052|NCT01192022|592285707|FG000|Overall Study|Physician withdrew-patient hardship|1|||
163976053|NCT01192022|592285708|FG001|Overall Study|Physician withdrew-patient hardship|0|||
163976054|NCT01192022|592285709|FG002|Overall Study|Physician withdrew-patient hardship|0|||
163976055|NCT01192022|592285710|FG003|Overall Study|Physician withdrew-patient hardship|0|||
163976056|NCT01192022|592285711|FG004|Overall Study|Physician withdrew-patient hardship|0|||
163976057|NCT01192022|592285707|FG000|Overall Study|Patient too sick from chemotherapy|0|||
163976058|NCT01192022|592285708|FG001|Overall Study|Patient too sick from chemotherapy|1|||
163976059|NCT01192022|592285709|FG002|Overall Study|Patient too sick from chemotherapy|0|||
163976060|NCT01192022|592285710|FG003|Overall Study|Patient too sick from chemotherapy|0|||
163871579|NCT01616459|591898372|FG000|Overall Study|Withdrawal by Subject|2|||
163871580|NCT01616459|591898373|FG001|Overall Study|Withdrawal by Subject|4|||
163871581|NCT01616459|591898374|FG002|Overall Study|Withdrawal by Subject|4|||
163871582|NCT01616459|591898375|FG003|Overall Study|Withdrawal by Subject|4|||
163871583|NCT01616459|591898372|FG000|Overall Study|Other reason|0|||
163871584|NCT01616459|591898373|FG001|Overall Study|Other reason|1|||
163871585|NCT01616459|591898374|FG002|Overall Study|Other reason|1|||
163871586|NCT01616459|591898375|FG003|Overall Study|Other reason|0|||
163871587|NCT03960463|591900379|FG000|Overall Study|Withdrawal by Subject|2|||
163871588|NCT03960463|591900380|FG001|Overall Study|Withdrawal by Subject|0|||
163871589|NCT03237481|591900381|FG000|Overall Study|Lost to Follow-up|1|||
163871590|NCT03237481|591900382|FG001|Overall Study|Lost to Follow-up|0|||
163871591|NCT03237481|591900383|FG002|Overall Study|Lost to Follow-up|0|||
163871592|NCT03237481|591900381|FG000|Overall Study|Protocol Violation|1|||
163871593|NCT03237481|591900382|FG001|Overall Study|Protocol Violation|0|||
163871594|NCT03237481|591900383|FG002|Overall Study|Protocol Violation|0|||
163871595|NCT03237481|591900381|FG000|Overall Study|Withdrawal by Subject|3|||
163871596|NCT03237481|591900382|FG001|Overall Study|Withdrawal by Subject|2|||
163871597|NCT03237481|591900383|FG002|Overall Study|Withdrawal by Subject|1|||
163871598|NCT04201834|591900384|FG000|Overall Study|Screen fail|1|||
163871599|NCT04941287|591900385|FG000|Overall Study|Rapid decline before starting treatment|3|||
163871600|NCT04941287|591900386|FG001|Overall Study|Rapid decline before starting treatment|1|||
163871601|NCT01998984|591900387|FG000|Overall Study|Adverse Event|0|||
163871602|NCT01998984|591900388|FG001|Overall Study|Adverse Event|0|||
163871603|NCT01998984|591900389|FG002|Overall Study|Adverse Event|0|||
163871604|NCT01998984|591900390|FG003|Overall Study|Adverse Event|1|||
163871605|NCT01998984|591900387|FG000|Overall Study|Lost to Follow-up|0|||
163871606|NCT01998984|591900388|FG001|Overall Study|Lost to Follow-up|1|||
163871607|NCT01998984|591900389|FG002|Overall Study|Lost to Follow-up|0|||
163871608|NCT01998984|591900390|FG003|Overall Study|Lost to Follow-up|1|||
163871609|NCT01998984|591900387|FG000|Overall Study|Withdrawal by Subject|0|||
163871610|NCT01998984|591900388|FG001|Overall Study|Withdrawal by Subject|0|||
163871611|NCT01998984|591900389|FG002|Overall Study|Withdrawal by Subject|1|||
163871612|NCT01998984|591900390|FG003|Overall Study|Withdrawal by Subject|0|||
163871613|NCT01998984|591900387|FG000|Overall Study|Other|0|||
163871614|NCT01998984|591900388|FG001|Overall Study|Other|0|||
163871615|NCT01998984|591900389|FG002|Overall Study|Other|0|||
163871616|NCT01998984|591900390|FG003|Overall Study|Other|1|||
163871617|NCT05386238|591900391|FG000|Overall Study|Lost to Follow-up|3|||
163871618|NCT05386238|591900392|FG001|Overall Study|Lost to Follow-up|2|||
163871619|NCT05386238|591900391|FG000|Overall Study|Withdrawal by Subject|0|||
163871620|NCT05386238|591900392|FG001|Overall Study|Withdrawal by Subject|1|||
163871621|NCT04907474|591900393|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
163871622|NCT04907474|591900394|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
163871623|NCT01353313|591900401|FG000|Overall Study|Lost to Follow-up|22|||
163871624|NCT01353313|591900402|FG001|Overall Study|Lost to Follow-up|23|||
163871625|NCT01353313|591900401|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
163871626|NCT01353313|591900402|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
163871627|NCT01631214|591900406|FG000|Overall Study|Withdrawal by Subject|276|||
163871628|NCT01631214|591900407|FG001|Overall Study|Withdrawal by Subject|290|||
163871629|NCT01631214|591900406|FG000|Overall Study|Death|113|||
163871630|NCT01631214|591900407|FG001|Overall Study|Death|106|||
163871631|NCT01631214|591900406|FG000|Overall Study|Lost to Follow-up|54|||
163871632|NCT01631214|591900407|FG001|Overall Study|Lost to Follow-up|40|||
163871633|NCT01631214|591900406|FG000|Overall Study|Adverse Event|45|||
163871634|NCT01631214|591900407|FG001|Overall Study|Adverse Event|45|||
163871635|NCT01631214|591900406|FG000|Overall Study|Other|22|||
163871636|NCT01631214|591900407|FG001|Overall Study|Other|19|||
163871637|NCT01631214|591900406|FG000|Overall Study|Noncompliance|16|||
163871638|NCT01631214|591900407|FG001|Overall Study|Noncompliance|15|||
163871639|NCT01631214|591900406|FG000|Overall Study|Requirement for Alternative Therapy|8|||
163871640|NCT01631214|591900407|FG001|Overall Study|Requirement for Alternative Therapy|3|||
164314864|NCT00282308|593529794|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
163871641|NCT01631214|591900406|FG000|Overall Study|Protocol Deviation|4|||
163871642|NCT01631214|591900407|FG001|Overall Study|Protocol Deviation|3|||
163871643|NCT01631214|591900406|FG000|Overall Study|Ineligibility determined|5|||
163871644|NCT01631214|591900407|FG001|Overall Study|Ineligibility determined|2|||
163871645|NCT01631214|591900406|FG000|Overall Study|Administrative Decision|1|||
163871646|NCT01631214|591900407|FG001|Overall Study|Administrative Decision|0|||
163871647|NCT03575052|591900408|FG000|Overall Study|Adverse Event|6|||
163871648|NCT03575052|591900409|FG001|Overall Study|Adverse Event|10|||
163871649|NCT03575052|591900408|FG000|Overall Study|Not further specified|5|||
163871650|NCT03575052|591900409|FG001|Overall Study|Not further specified|7|||
163871651|NCT03575052|591900408|FG000|Overall Study|Withdrawal by Subject|5|||
163871652|NCT03575052|591900409|FG001|Overall Study|Withdrawal by Subject|6|||
163871653|NCT03575052|591900408|FG000|Overall Study|Lost to Follow-up|3|||
163871654|NCT03575052|591900409|FG001|Overall Study|Lost to Follow-up|0|||
163871655|NCT03575052|591900408|FG000|Overall Study|Death|2|||
163871656|NCT03575052|591900409|FG001|Overall Study|Death|1|||
163871657|NCT03575052|591900408|FG000|Overall Study|Lack of Efficacy|2|||
163871658|NCT03575052|591900409|FG001|Overall Study|Lack of Efficacy|1|||
163871659|NCT03575052|591900408|FG000|Overall Study|Study drug noncompliance|1|||
163871660|NCT03575052|591900409|FG001|Overall Study|Study drug noncompliance|2|||
164204109|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
164204110|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
164204111|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
164204112|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
164204113|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
164204114|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
163871661|NCT03575052|591900408|FG000|Overall Study|Protocol Violation|0|||
163871662|NCT03575052|591900409|FG001|Overall Study|Protocol Violation|2|||
163871663|NCT03575052|591900408|FG000|Overall Study|Physician Decision|1|||
163871664|NCT03575052|591900409|FG001|Overall Study|Physician Decision|0|||
163871665|NCT02991807|591900419|FG000|Overall Study|Withdrawal by Subject|2|||
163871666|NCT02991807|591900420|FG001|Overall Study|Withdrawal by Subject|1|||
163871667|NCT02991807|591900419|FG000|Overall Study|Physician Decision|0|||
163871668|NCT02991807|591900420|FG001|Overall Study|Physician Decision|1|||
163871669|NCT02991807|591900419|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
163871670|NCT02991807|591900420|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
163871671|NCT02566902|591900421|FG000|Overall Study|Protocol Violation|2|||
163871672|NCT02566902|591900422|FG001|Overall Study|Protocol Violation|1|||
163871673|NCT01875848|591900423|FG000|Overall Study|Withdrawal by Subject|2|||
163871674|NCT01875848|591900424|FG001|Overall Study|Withdrawal by Subject|0|||
163871675|NCT02411084|591900425|FG000|Overall Study|Lack of Efficacy|6|||
163871676|NCT02411084|591900426|FG001|Overall Study|Lack of Efficacy|3|||
163871677|NCT02411084|591900425|FG000|Overall Study|Death|5|||
163871678|NCT02411084|591900426|FG001|Overall Study|Death|4|||
163871679|NCT02411084|591900425|FG000|Overall Study|Adverse Event|2|||
163871680|NCT02411084|591900426|FG001|Overall Study|Adverse Event|1|||
163871681|NCT02411084|591900425|FG000|Overall Study|Other reasons|0|||
163871682|NCT02411084|591900426|FG001|Overall Study|Other reasons|5|||
163871683|NCT01622868|591900427|FG000|Overall Study|Protocol Violation|7|||
163871684|NCT01622868|591900428|FG001|Overall Study|Protocol Violation|0|||
163871685|NCT03285763|591900430|FG000|Overall Study|Death|470|||
163871686|NCT03285763|591900430|FG000|Overall Study|Lost to Follow-up|18|||
163871687|NCT03285763|591900430|FG000|Overall Study|Physician Decision|2|||
163871688|NCT03285763|591900430|FG000|Overall Study|Study Terminated By Sponsor|79|||
163871689|NCT03285763|591900430|FG000|Overall Study|Withdrawal by Subject|33|||
163871690|NCT03624972|591900431|FG000|Overall Study|Lost to Follow-up|2|||
163871691|NCT03624972|591900432|FG001|Overall Study|Lost to Follow-up|0|||
163871692|NCT03624972|591900433|FG002|Overall Study|Lost to Follow-up|0|||
163871693|NCT03624972|591900431|FG000|Overall Study|Withdrawal by Subject|0|||
163871694|NCT03624972|591900432|FG001|Overall Study|Withdrawal by Subject|2|||
163871695|NCT03624972|591900433|FG002|Overall Study|Withdrawal by Subject|0|||
163871696|NCT03112174|591900434|FG000|Overall Study|Withdrawal by Subject|3|||
163871697|NCT03112174|591900435|FG001|Overall Study|Withdrawal by Subject|0|||
163871698|NCT03112174|591900436|FG002|Overall Study|Withdrawal by Subject|11|||
163871699|NCT03112174|591900437|FG003|Overall Study|Withdrawal by Subject|9|||
163871700|NCT03112174|591900438|FG004|Overall Study|Withdrawal by Subject|7|||
163871701|NCT03112174|591900434|FG000|Overall Study|Lost to Follow-up|1|||
163871702|NCT03112174|591900435|FG001|Overall Study|Lost to Follow-up|1|||
163871703|NCT03112174|591900436|FG002|Overall Study|Lost to Follow-up|2|||
163871704|NCT03112174|591900437|FG003|Overall Study|Lost to Follow-up|3|||
163871705|NCT03112174|591900438|FG004|Overall Study|Lost to Follow-up|2|||
163871706|NCT03112174|591900434|FG000|Overall Study|Death|8|||
163871707|NCT03112174|591900435|FG001|Overall Study|Death|3|||
163871708|NCT03112174|591900436|FG002|Overall Study|Death|67|||
163871709|NCT03112174|591900437|FG003|Overall Study|Death|73|||
163871710|NCT03112174|591900438|FG004|Overall Study|Death|18|||
163871711|NCT03112174|591900434|FG000|Overall Study|Other, Not Specified|1|||
164204115|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
164204116|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
163871712|NCT03112174|591900435|FG001|Overall Study|Other, Not Specified|0|||
163871713|NCT03112174|591900436|FG002|Overall Study|Other, Not Specified|1|||
164314865|NCT00282308|593529795|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
163871714|NCT03112174|591900437|FG003|Overall Study|Other, Not Specified|2|||
163871715|NCT03112174|591900438|FG004|Overall Study|Other, Not Specified|0|||
163871716|NCT04425629|591900439|FG000|Overall Study|Adverse Event|0|||
163871717|NCT04425629|591900440|FG001|Overall Study|Adverse Event|0|||
163871718|NCT04425629|591900441|FG002|Overall Study|Adverse Event|0|||
163871719|NCT04425629|591900442|FG003|Overall Study|Adverse Event|0|||
163871720|NCT04425629|591900443|FG004|Overall Study|Adverse Event|1|||
163871721|NCT04425629|591900444|FG005|Overall Study|Adverse Event|0|||
163871722|NCT04425629|591900445|FG006|Overall Study|Adverse Event|0|||
163871723|NCT04425629|591900446|FG007|Overall Study|Adverse Event|0|||
163871724|NCT04425629|591900447|FG008|Overall Study|Adverse Event|0|||
163871725|NCT04425629|591900448|FG009|Overall Study|Adverse Event|3|||
163871726|NCT04425629|591900449|FG010|Overall Study|Adverse Event|2|||
163871727|NCT04425629|591900450|FG011|Overall Study|Adverse Event|1|||
163871728|NCT04425629|591900451|FG012|Overall Study|Adverse Event|1|||
163871729|NCT04425629|591900452|FG013|Overall Study|Adverse Event|0|||
163871730|NCT04425629|591900453|FG014|Overall Study|Adverse Event|0|||
163871731|NCT04425629|591900454|FG015|Overall Study|Adverse Event|0|||
163871732|NCT04425629|591900455|FG016|Overall Study|Adverse Event|0|||
163871733|NCT04425629|591900456|FG017|Overall Study|Adverse Event|0|||
163871734|NCT04425629|591900457|FG018|Overall Study|Adverse Event|0|||
163871735|NCT04425629|591900439|FG000|Overall Study|Lost to Follow-up|1|||
163871736|NCT04425629|591900440|FG001|Overall Study|Lost to Follow-up|3|||
163871737|NCT04425629|591900441|FG002|Overall Study|Lost to Follow-up|1|||
163871738|NCT04425629|591900442|FG003|Overall Study|Lost to Follow-up|7|||
163871739|NCT04425629|591900443|FG004|Overall Study|Lost to Follow-up|1|||
163871740|NCT04425629|591900444|FG005|Overall Study|Lost to Follow-up|2|||
163871741|NCT04425629|591900445|FG006|Overall Study|Lost to Follow-up|1|||
163871742|NCT04425629|591900446|FG007|Overall Study|Lost to Follow-up|0|||
163871743|NCT04425629|591900447|FG008|Overall Study|Lost to Follow-up|1|||
163871744|NCT04425629|591900448|FG009|Overall Study|Lost to Follow-up|64|||
163871745|NCT04425629|591900449|FG010|Overall Study|Lost to Follow-up|70|||
163871746|NCT04425629|591900450|FG011|Overall Study|Lost to Follow-up|98|||
163871747|NCT04425629|591900451|FG012|Overall Study|Lost to Follow-up|30|||
163871748|NCT04425629|591900452|FG013|Overall Study|Lost to Follow-up|0|||
163871749|NCT04425629|591900453|FG014|Overall Study|Lost to Follow-up|5|||
163871750|NCT04425629|591900454|FG015|Overall Study|Lost to Follow-up|4|||
163871751|NCT04425629|591900455|FG016|Overall Study|Lost to Follow-up|0|||
163871752|NCT04425629|591900456|FG017|Overall Study|Lost to Follow-up|3|||
163871753|NCT04425629|591900457|FG018|Overall Study|Lost to Follow-up|1|||
163871754|NCT04425629|591900439|FG000|Overall Study|Subject Decision|0|||
163871755|NCT04425629|591900440|FG001|Overall Study|Subject Decision|2|||
163871756|NCT04425629|591900441|FG002|Overall Study|Subject Decision|1|||
163871757|NCT04425629|591900442|FG003|Overall Study|Subject Decision|3|||
163871758|NCT04425629|591900443|FG004|Overall Study|Subject Decision|6|||
163871759|NCT04425629|591900444|FG005|Overall Study|Subject Decision|6|||
163871760|NCT04425629|591900445|FG006|Overall Study|Subject Decision|3|||
163871761|NCT04425629|591900446|FG007|Overall Study|Subject Decision|3|||
163871762|NCT04425629|591900447|FG008|Overall Study|Subject Decision|1|||
163871763|NCT04425629|591900448|FG009|Overall Study|Subject Decision|70|||
163871764|NCT04425629|591900449|FG010|Overall Study|Subject Decision|95|||
163871765|NCT04425629|591900450|FG011|Overall Study|Subject Decision|124|||
163871766|NCT04425629|591900451|FG012|Overall Study|Subject Decision|25|||
163871767|NCT04425629|591900452|FG013|Overall Study|Subject Decision|0|||
163871768|NCT04425629|591900453|FG014|Overall Study|Subject Decision|1|||
163871769|NCT04425629|591900454|FG015|Overall Study|Subject Decision|4|||
163871770|NCT04425629|591900455|FG016|Overall Study|Subject Decision|1|||
163871771|NCT04425629|591900456|FG017|Overall Study|Subject Decision|0|||
163871772|NCT04425629|591900457|FG018|Overall Study|Subject Decision|2|||
163871773|NCT04425629|591900439|FG000|Overall Study|Death|0|||
163871774|NCT04425629|591900440|FG001|Overall Study|Death|0|||
163871775|NCT04425629|591900441|FG002|Overall Study|Death|0|||
163871776|NCT04425629|591900442|FG003|Overall Study|Death|0|||
163871777|NCT04425629|591900443|FG004|Overall Study|Death|0|||
163871778|NCT04425629|591900444|FG005|Overall Study|Death|0|||
163871779|NCT04425629|591900445|FG006|Overall Study|Death|0|||
163871780|NCT04425629|591900446|FG007|Overall Study|Death|0|||
163871781|NCT04425629|591900447|FG008|Overall Study|Death|0|||
163871782|NCT04425629|591900448|FG009|Overall Study|Death|11|||
163871783|NCT04425629|591900449|FG010|Overall Study|Death|2|||
163871784|NCT04425629|591900450|FG011|Overall Study|Death|4|||
163871785|NCT04425629|591900451|FG012|Overall Study|Death|0|||
163871786|NCT04425629|591900452|FG013|Overall Study|Death|0|||
163871787|NCT04425629|591900453|FG014|Overall Study|Death|0|||
163871788|NCT04425629|591900454|FG015|Overall Study|Death|0|||
163871789|NCT04425629|591900455|FG016|Overall Study|Death|0|||
163871790|NCT04425629|591900456|FG017|Overall Study|Death|0|||
163871791|NCT04425629|591900457|FG018|Overall Study|Death|0|||
163871792|NCT04425629|591900439|FG000|Overall Study|Sponsor Request|0|||
163871793|NCT04425629|591900440|FG001|Overall Study|Sponsor Request|0|||
163871794|NCT04425629|591900441|FG002|Overall Study|Sponsor Request|0|||
163871795|NCT04425629|591900442|FG003|Overall Study|Sponsor Request|2|||
163871796|NCT04425629|591900443|FG004|Overall Study|Sponsor Request|2|||
163871797|NCT04425629|591900444|FG005|Overall Study|Sponsor Request|2|||
163871798|NCT04425629|591900445|FG006|Overall Study|Sponsor Request|1|||
163871799|NCT04425629|591900446|FG007|Overall Study|Sponsor Request|0|||
163871800|NCT04425629|591900447|FG008|Overall Study|Sponsor Request|0|||
163871801|NCT04425629|591900448|FG009|Overall Study|Sponsor Request|9|||
163871802|NCT04425629|591900449|FG010|Overall Study|Sponsor Request|9|||
163871803|NCT04425629|591900450|FG011|Overall Study|Sponsor Request|10|||
163871804|NCT04425629|591900451|FG012|Overall Study|Sponsor Request|8|||
163871805|NCT04425629|591900452|FG013|Overall Study|Sponsor Request|0|||
163976061|NCT01192022|592285711|FG004|Overall Study|Patient too sick from chemotherapy|0|||
163976062|NCT01192022|592285707|FG000|Overall Study|Patient needed surgery|0|||
163976063|NCT01192022|592285708|FG001|Overall Study|Patient needed surgery|1|||
163976064|NCT01192022|592285709|FG002|Overall Study|Patient needed surgery|0|||
163976065|NCT01192022|592285710|FG003|Overall Study|Patient needed surgery|0|||
163976066|NCT01192022|592285711|FG004|Overall Study|Patient needed surgery|0|||
163871806|NCT04425629|591900453|FG014|Overall Study|Sponsor Request|0|||
163976067|NCT01192022|592285707|FG000|Overall Study|Parents did not allow all follow up|0|||
163976068|NCT01192022|592285708|FG001|Overall Study|Parents did not allow all follow up|0|||
163976069|NCT01192022|592285709|FG002|Overall Study|Parents did not allow all follow up|0|||
163976070|NCT01192022|592285710|FG003|Overall Study|Parents did not allow all follow up|1|||
163976071|NCT01192022|592285711|FG004|Overall Study|Parents did not allow all follow up|0|||
163976072|NCT01351389|592285712|FG000|Overall Study|Withdrawal by Subject|7|||
163976073|NCT01351389|592285713|FG001|Overall Study|Withdrawal by Subject|0|||
163976074|NCT01351389|592285712|FG000|Overall Study|did not complete intervention|23|||
163976075|NCT01351389|592285713|FG001|Overall Study|did not complete intervention|15|||
163976076|NCT04839978|592285714|FG000|Overall Study|Lost to Follow-up|135|||
163976077|NCT04839978|592285715|FG001|Overall Study|Lost to Follow-up|147|||
163871807|NCT04425629|591900454|FG015|Overall Study|Sponsor Request|1|||
163871808|NCT04425629|591900455|FG016|Overall Study|Sponsor Request|0|||
163871809|NCT04425629|591900456|FG017|Overall Study|Sponsor Request|0|||
163871810|NCT04425629|591900457|FG018|Overall Study|Sponsor Request|0|||
163871811|NCT04425629|591900439|FG000|Overall Study|Physician Decision|0|||
163871812|NCT04425629|591900440|FG001|Overall Study|Physician Decision|0|||
163871813|NCT04425629|591900441|FG002|Overall Study|Physician Decision|0|||
163871814|NCT04425629|591900442|FG003|Overall Study|Physician Decision|0|||
163871815|NCT04425629|591900443|FG004|Overall Study|Physician Decision|0|||
163871816|NCT04425629|591900444|FG005|Overall Study|Physician Decision|0|||
163871817|NCT04425629|591900445|FG006|Overall Study|Physician Decision|0|||
163871818|NCT04425629|591900446|FG007|Overall Study|Physician Decision|0|||
163871819|NCT04425629|591900447|FG008|Overall Study|Physician Decision|0|||
163871820|NCT04425629|591900448|FG009|Overall Study|Physician Decision|4|||
163871821|NCT04425629|591900449|FG010|Overall Study|Physician Decision|3|||
163871822|NCT04425629|591900450|FG011|Overall Study|Physician Decision|5|||
163871823|NCT04425629|591900451|FG012|Overall Study|Physician Decision|1|||
163871824|NCT04425629|591900452|FG013|Overall Study|Physician Decision|0|||
163871825|NCT04425629|591900453|FG014|Overall Study|Physician Decision|0|||
163871826|NCT04425629|591900454|FG015|Overall Study|Physician Decision|1|||
163871827|NCT04425629|591900455|FG016|Overall Study|Physician Decision|0|||
163871828|NCT04425629|591900456|FG017|Overall Study|Physician Decision|0|||
163871829|NCT04425629|591900457|FG018|Overall Study|Physician Decision|0|||
163871830|NCT04425629|591900439|FG000|Overall Study|Lack of Efficacy|0|||
163871831|NCT04425629|591900440|FG001|Overall Study|Lack of Efficacy|0|||
163871832|NCT04425629|591900441|FG002|Overall Study|Lack of Efficacy|0|||
163871833|NCT04425629|591900442|FG003|Overall Study|Lack of Efficacy|0|||
163871834|NCT04425629|591900443|FG004|Overall Study|Lack of Efficacy|0|||
163871835|NCT04425629|591900444|FG005|Overall Study|Lack of Efficacy|0|||
163871836|NCT04425629|591900445|FG006|Overall Study|Lack of Efficacy|0|||
163871837|NCT04425629|591900446|FG007|Overall Study|Lack of Efficacy|0|||
163871838|NCT04425629|591900447|FG008|Overall Study|Lack of Efficacy|0|||
163871839|NCT04425629|591900448|FG009|Overall Study|Lack of Efficacy|0|||
163871840|NCT04425629|591900449|FG010|Overall Study|Lack of Efficacy|1|||
163871841|NCT04425629|591900450|FG011|Overall Study|Lack of Efficacy|0|||
163871842|NCT04425629|591900451|FG012|Overall Study|Lack of Efficacy|0|||
163871843|NCT04425629|591900452|FG013|Overall Study|Lack of Efficacy|0|||
163871844|NCT04425629|591900453|FG014|Overall Study|Lack of Efficacy|0|||
163871845|NCT04425629|591900454|FG015|Overall Study|Lack of Efficacy|0|||
163871846|NCT04425629|591900455|FG016|Overall Study|Lack of Efficacy|0|||
163871847|NCT04425629|591900456|FG017|Overall Study|Lack of Efficacy|0|||
163871848|NCT04425629|591900457|FG018|Overall Study|Lack of Efficacy|0|||
163871849|NCT00610649|591900460|FG000|Overall Study|Adverse Event|1|||
163871850|NCT00610649|591900461|FG001|Overall Study|Adverse Event|0|||
163871851|NCT00610649|591900462|FG002|Overall Study|Adverse Event|0|||
163871852|NCT00610649|591900463|FG003|Overall Study|Adverse Event|0|||
163871853|NCT00610649|591900464|FG004|Overall Study|Adverse Event|0|||
163871854|NCT00610649|591900465|FG005|Overall Study|Adverse Event|0|||
163871855|NCT00610649|591900466|FG006|Overall Study|Adverse Event|0|||
163871856|NCT00610649|591900467|FG007|Overall Study|Adverse Event|0|||
163871857|NCT00610649|591900468|FG008|Overall Study|Adverse Event|0|||
163871858|NCT00610649|591900469|FG009|Overall Study|Adverse Event|0|||
163871859|NCT00610649|591900470|FG010|Overall Study|Adverse Event|1|||
163871860|NCT00610649|591900460|FG000|Overall Study|Family Emergency|0|||
163976078|NCT03551509|592285720|FG000|Overall Study|Lost to Follow-up|0|||
163976079|NCT03551509|592285721|FG001|Overall Study|Lost to Follow-up|1|||
163976080|NCT03551509|592285722|FG002|Overall Study|Lost to Follow-up|0|||
163976081|NCT01902966|592285723|FG000|Overall Study|Death|1|||
163976082|NCT01902966|592285723|FG000|Overall Study|Physician Decision|1|||
163976083|NCT01902966|592285723|FG000|Overall Study|Withdrawal by Subject|1|||
163976084|NCT01549275|592285724|FG000|Overall Study|Lost to Follow-up|1|||
163976085|NCT01549275|592285725|FG001|Overall Study|Lost to Follow-up|0|||
163976086|NCT00122681|592285726|FG000|Overall Study|Adverse Event|20|||
163976087|NCT00122681|592285727|FG001|Overall Study|Adverse Event|16|||
163976088|NCT00122681|592285726|FG000|Overall Study|Lost to Follow-up|1080|||
163976089|NCT00122681|592285727|FG001|Overall Study|Lost to Follow-up|1097|||
163976090|NCT00122681|592285726|FG000|Overall Study|Protocol Violation|7|||
163976091|NCT00122681|592285727|FG001|Overall Study|Protocol Violation|10|||
163976092|NCT00122681|592285726|FG000|Overall Study|Withdrawal by Subject|257|||
163976093|NCT00122681|592285727|FG001|Overall Study|Withdrawal by Subject|251|||
163976094|NCT00122681|592285726|FG000|Overall Study|Personal reasons|150|||
163976095|NCT00122681|592285727|FG001|Overall Study|Personal reasons|147|||
163976096|NCT02004262|592285737|FG000|Overall Study|Death|67|||
164314866|NCT04237116|593529796|FG000|Overall Study|Adverse Event|0|||
164314867|NCT04237116|593529797|FG001|Overall Study|Adverse Event|1|||
164314868|NCT04237116|593529796|FG000|Overall Study|Study terminated by Sponsor|4|||
164314869|NCT04237116|593529797|FG001|Overall Study|Study terminated by Sponsor|1|||
164314870|NCT03212144|593529798|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
164314871|NCT03212144|593529799|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
163976097|NCT02004262|592285738|FG001|Overall Study|Death|64|||
163976098|NCT02004262|592285739|FG002|Overall Study|Death|66|||
163976099|NCT02004262|592285740|FG003|Overall Study|Death|28|||
163976100|NCT02004262|592285741|FG004|Overall Study|Death|29|||
163976101|NCT02004262|592285742|FG005|Overall Study|Death|22|||
163976102|NCT02004262|592285737|FG000|Overall Study|Withdrawal by Subject|1|||
163976103|NCT02004262|592285738|FG001|Overall Study|Withdrawal by Subject|0|||
163976104|NCT02004262|592285739|FG002|Overall Study|Withdrawal by Subject|4|||
163976105|NCT02004262|592285740|FG003|Overall Study|Withdrawal by Subject|0|||
163976106|NCT02004262|592285741|FG004|Overall Study|Withdrawal by Subject|1|||
163976107|NCT02004262|592285742|FG005|Overall Study|Withdrawal by Subject|3|||
163976108|NCT02004262|592285737|FG000|Overall Study|Lost to Follow-up|1|||
163976109|NCT02004262|592285738|FG001|Overall Study|Lost to Follow-up|1|||
163976110|NCT02004262|592285739|FG002|Overall Study|Lost to Follow-up|0|||
163976111|NCT02004262|592285740|FG003|Overall Study|Lost to Follow-up|0|||
163976112|NCT02004262|592285741|FG004|Overall Study|Lost to Follow-up|0|||
163976113|NCT02004262|592285742|FG005|Overall Study|Lost to Follow-up|0|||
163976114|NCT02004262|592285737|FG000|Overall Study|Study Terminated by Sponsor|4|||
163976115|NCT02004262|592285738|FG001|Overall Study|Study Terminated by Sponsor|3|||
163976116|NCT02004262|592285739|FG002|Overall Study|Study Terminated by Sponsor|2|||
163976117|NCT02004262|592285740|FG003|Overall Study|Study Terminated by Sponsor|1|||
163976118|NCT02004262|592285741|FG004|Overall Study|Study Terminated by Sponsor|1|||
163976119|NCT02004262|592285742|FG005|Overall Study|Study Terminated by Sponsor|5|||
163976120|NCT01146873|592285743|FG000|Overall Study|Transfer out|0|||
163976121|NCT01146873|592285744|FG001|Overall Study|Transfer out|6|||
163976122|NCT03703102|592285745|FG000|Overall Study|Adverse Event|4|||
163976123|NCT03703102|592285746|FG001|Overall Study|Adverse Event|3|||
163976124|NCT03703102|592285747|FG002|Overall Study|Adverse Event|7|||
163976125|NCT03703102|592285748|FG003|Overall Study|Adverse Event|3|||
163976126|NCT03703102|592285749|FG004|Overall Study|Adverse Event|13|||
163976127|NCT03703102|592285745|FG000|Overall Study|Lack of Efficacy|4|||
163976128|NCT03703102|592285746|FG001|Overall Study|Lack of Efficacy|0|||
163976129|NCT03703102|592285747|FG002|Overall Study|Lack of Efficacy|1|||
163976130|NCT03703102|592285748|FG003|Overall Study|Lack of Efficacy|4|||
163976131|NCT03703102|592285749|FG004|Overall Study|Lack of Efficacy|1|||
163976132|NCT03703102|592285745|FG000|Overall Study|Lost to Follow-up|0|||
163976133|NCT03703102|592285746|FG001|Overall Study|Lost to Follow-up|0|||
163976134|NCT03703102|592285747|FG002|Overall Study|Lost to Follow-up|1|||
163976135|NCT03703102|592285748|FG003|Overall Study|Lost to Follow-up|2|||
163976136|NCT03703102|592285749|FG004|Overall Study|Lost to Follow-up|2|||
163976137|NCT03703102|592285745|FG000|Overall Study|Physician Decision|2|||
163976138|NCT03703102|592285746|FG001|Overall Study|Physician Decision|2|||
163976139|NCT03703102|592285747|FG002|Overall Study|Physician Decision|2|||
163976140|NCT03703102|592285748|FG003|Overall Study|Physician Decision|2|||
163976141|NCT03703102|592285749|FG004|Overall Study|Physician Decision|4|||
163976142|NCT03703102|592285745|FG000|Overall Study|Withdrawal by Subject|7|||
163976143|NCT03703102|592285746|FG001|Overall Study|Withdrawal by Subject|5|||
163976144|NCT03703102|592285747|FG002|Overall Study|Withdrawal by Subject|5|||
163976145|NCT03703102|592285748|FG003|Overall Study|Withdrawal by Subject|5|||
163976146|NCT03703102|592285749|FG004|Overall Study|Withdrawal by Subject|9|||
163976147|NCT03703102|592285745|FG000|Overall Study|Ineligibility|0|||
163976148|NCT03703102|592285746|FG001|Overall Study|Ineligibility|0|||
163976149|NCT03703102|592285747|FG002|Overall Study|Ineligibility|1|||
163976150|NCT03703102|592285748|FG003|Overall Study|Ineligibility|0|||
163976151|NCT03703102|592285749|FG004|Overall Study|Ineligibility|0|||
163976152|NCT03703102|592285745|FG000|Overall Study|Protocol Deviation|4|||
163976153|NCT03703102|592285746|FG001|Overall Study|Protocol Deviation|4|||
163976154|NCT03703102|592285747|FG002|Overall Study|Protocol Deviation|3|||
163976155|NCT03703102|592285748|FG003|Overall Study|Protocol Deviation|0|||
164314872|NCT03212144|593529798|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
163976156|NCT03703102|592285749|FG004|Overall Study|Protocol Deviation|0|||
163976157|NCT03703102|592285745|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163976158|NCT03703102|592285746|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163976159|NCT03703102|592285747|FG002|Overall Study|Non-Compliance with Study Drug|2|||
163871861|NCT00610649|591900461|FG001|Overall Study|Family Emergency|1|||
163871862|NCT00610649|591900462|FG002|Overall Study|Family Emergency|0|||
164314873|NCT03212144|593529799|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
164314874|NCT00899431|593529800|FG000|Overall Study|Physician Decision|1|||
164314875|NCT00899431|593529801|FG001|Overall Study|Physician Decision|0|||
164314876|NCT00899431|593529802|FG002|Overall Study|Physician Decision|0|||
164314877|NCT00661427|593529806|FG000|Overall Study|Adverse Event|5|||
164314878|NCT00661427|593529807|FG001|Overall Study|Adverse Event|5|||
163871863|NCT00610649|591900463|FG003|Overall Study|Family Emergency|0|||
163871864|NCT00610649|591900464|FG004|Overall Study|Family Emergency|0|||
163871865|NCT00610649|591900465|FG005|Overall Study|Family Emergency|0|||
163871866|NCT00610649|591900466|FG006|Overall Study|Family Emergency|0|||
163871867|NCT00610649|591900467|FG007|Overall Study|Family Emergency|0|||
163871868|NCT00610649|591900468|FG008|Overall Study|Family Emergency|0|||
163871869|NCT00610649|591900469|FG009|Overall Study|Family Emergency|0|||
163871870|NCT00610649|591900470|FG010|Overall Study|Family Emergency|0|||
163871871|NCT00610649|591900460|FG000|Overall Study|Withdrawal by Subject|0|||
163871872|NCT00610649|591900461|FG001|Overall Study|Withdrawal by Subject|0|||
163871873|NCT00610649|591900462|FG002|Overall Study|Withdrawal by Subject|0|||
163871874|NCT00610649|591900463|FG003|Overall Study|Withdrawal by Subject|0|||
163871875|NCT00610649|591900464|FG004|Overall Study|Withdrawal by Subject|0|||
163871876|NCT00610649|591900465|FG005|Overall Study|Withdrawal by Subject|0|||
163871877|NCT00610649|591900466|FG006|Overall Study|Withdrawal by Subject|0|||
163871878|NCT00610649|591900467|FG007|Overall Study|Withdrawal by Subject|0|||
163871879|NCT00610649|591900468|FG008|Overall Study|Withdrawal by Subject|0|||
163871880|NCT00610649|591900469|FG009|Overall Study|Withdrawal by Subject|1|||
163871881|NCT00610649|591900470|FG010|Overall Study|Withdrawal by Subject|0|||
163871882|NCT04259450|591900474|FG000|Overall Study|Adverse event/ Toxicity|0|||
163871883|NCT04259450|591900475|FG001|Overall Study|Adverse event/ Toxicity|3|||
163871884|NCT04259450|591900476|FG002|Overall Study|Adverse event/ Toxicity|0|||
163871885|NCT04259450|591900477|FG003|Overall Study|Adverse event/ Toxicity|1|||
163871886|NCT04259450|591900478|FG004|Overall Study|Adverse event/ Toxicity|0|||
163871887|NCT04259450|591900479|FG005|Overall Study|Adverse event/ Toxicity|0|||
163871888|NCT04259450|591900480|FG006|Overall Study|Adverse event/ Toxicity|0|||
163871889|NCT04259450|591900481|FG007|Overall Study|Adverse event/ Toxicity|1|||
163871890|NCT04259450|591900482|FG008|Overall Study|Adverse event/ Toxicity|0|||
163871891|NCT04259450|591900483|FG009|Overall Study|Adverse event/ Toxicity|3|||
163871892|NCT04259450|591900474|FG000|Overall Study|Disease progression|2|||
163871893|NCT04259450|591900475|FG001|Overall Study|Disease progression|3|||
163871894|NCT04259450|591900476|FG002|Overall Study|Disease progression|4|||
163871895|NCT04259450|591900477|FG003|Overall Study|Disease progression|4|||
163871896|NCT04259450|591900478|FG004|Overall Study|Disease progression|6|||
163871897|NCT04259450|591900479|FG005|Overall Study|Disease progression|6|||
163871898|NCT04259450|591900480|FG006|Overall Study|Disease progression|6|||
163871899|NCT04259450|591900481|FG007|Overall Study|Disease progression|15|||
163871900|NCT04259450|591900482|FG008|Overall Study|Disease progression|6|||
163871901|NCT04259450|591900483|FG009|Overall Study|Disease progression|18|||
163871902|NCT04259450|591900474|FG000|Overall Study|Death|0|||
163871903|NCT04259450|591900475|FG001|Overall Study|Death|0|||
163871904|NCT04259450|591900476|FG002|Overall Study|Death|0|||
163871905|NCT04259450|591900477|FG003|Overall Study|Death|0|||
163871906|NCT04259450|591900478|FG004|Overall Study|Death|0|||
163871907|NCT04259450|591900479|FG005|Overall Study|Death|0|||
163871908|NCT04259450|591900480|FG006|Overall Study|Death|0|||
163871909|NCT04259450|591900481|FG007|Overall Study|Death|1|||
163871910|NCT04259450|591900482|FG008|Overall Study|Death|1|||
163871911|NCT04259450|591900483|FG009|Overall Study|Death|0|||
163871912|NCT04259450|591900474|FG000|Overall Study|Withdrawal by Subject|0|||
163871913|NCT04259450|591900475|FG001|Overall Study|Withdrawal by Subject|0|||
163871914|NCT04259450|591900476|FG002|Overall Study|Withdrawal by Subject|0|||
163871915|NCT04259450|591900477|FG003|Overall Study|Withdrawal by Subject|0|||
163871916|NCT04259450|591900478|FG004|Overall Study|Withdrawal by Subject|0|||
163871917|NCT04259450|591900479|FG005|Overall Study|Withdrawal by Subject|0|||
163871918|NCT04259450|591900480|FG006|Overall Study|Withdrawal by Subject|0|||
163871919|NCT04259450|591900481|FG007|Overall Study|Withdrawal by Subject|1|||
163871920|NCT04259450|591900482|FG008|Overall Study|Withdrawal by Subject|0|||
163976160|NCT03703102|592285748|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163871921|NCT04259450|591900483|FG009|Overall Study|Withdrawal by Subject|0|||
163871922|NCT04259450|591900474|FG000|Overall Study|Other than listed|0|||
163871923|NCT04259450|591900475|FG001|Overall Study|Other than listed|0|||
163871924|NCT04259450|591900476|FG002|Overall Study|Other than listed|0|||
163871925|NCT04259450|591900477|FG003|Overall Study|Other than listed|0|||
163976161|NCT03703102|592285749|FG004|Overall Study|Non-Compliance with Study Drug|4|||
164314879|NCT00661427|593529806|FG000|Overall Study|Patient not treated|0|||
164314880|NCT00661427|593529807|FG001|Overall Study|Patient not treated|2|||
163976162|NCT00876187|592285750|FG000|Overall Study|Adverse Event|14|||
163976163|NCT00876187|592285751|FG001|Overall Study|Adverse Event|12|||
163976164|NCT00876187|592285752|FG002|Overall Study|Adverse Event|19|||
163976165|NCT00876187|592285753|FG003|Overall Study|Adverse Event|29|||
163976166|NCT00876187|592285754|FG004|Overall Study|Adverse Event|10|||
163976167|NCT00876187|592285750|FG000|Overall Study|Lack of Efficacy|59|||
163976168|NCT00876187|592285751|FG001|Overall Study|Lack of Efficacy|34|||
163976169|NCT00876187|592285752|FG002|Overall Study|Lack of Efficacy|45|||
163976170|NCT00876187|592285753|FG003|Overall Study|Lack of Efficacy|34|||
163976171|NCT00876187|592285754|FG004|Overall Study|Lack of Efficacy|59|||
163976172|NCT00876187|592285750|FG000|Overall Study|Lost to Follow-up|9|||
163976173|NCT00876187|592285751|FG001|Overall Study|Lost to Follow-up|10|||
163976174|NCT00876187|592285752|FG002|Overall Study|Lost to Follow-up|8|||
163976175|NCT00876187|592285753|FG003|Overall Study|Lost to Follow-up|8|||
163976176|NCT00876187|592285754|FG004|Overall Study|Lost to Follow-up|11|||
163976177|NCT00876187|592285750|FG000|Overall Study|Protocol Violation|6|||
163976178|NCT00876187|592285751|FG001|Overall Study|Protocol Violation|7|||
163976179|NCT00876187|592285752|FG002|Overall Study|Protocol Violation|7|||
163976180|NCT00876187|592285753|FG003|Overall Study|Protocol Violation|6|||
163976181|NCT00876187|592285754|FG004|Overall Study|Protocol Violation|3|||
163976182|NCT00876187|592285750|FG000|Overall Study|Withdrawal by Subject|16|||
163976183|NCT00876187|592285751|FG001|Overall Study|Withdrawal by Subject|26|||
163976184|NCT00876187|592285752|FG002|Overall Study|Withdrawal by Subject|32|||
163976185|NCT00876187|592285753|FG003|Overall Study|Withdrawal by Subject|38|||
163976186|NCT00876187|592285754|FG004|Overall Study|Withdrawal by Subject|37|||
163976187|NCT00876187|592285750|FG000|Overall Study|Entered extension study|101|||
163976188|NCT00876187|592285751|FG001|Overall Study|Entered extension study|120|||
163976189|NCT00876187|592285752|FG002|Overall Study|Entered extension study|156|||
163976190|NCT00876187|592285753|FG003|Overall Study|Entered extension study|151|||
163976191|NCT00876187|592285754|FG004|Overall Study|Entered extension study|144|||
163976192|NCT00876187|592285750|FG000|Overall Study|Randomized but not treated|3|||
163976193|NCT00876187|592285751|FG001|Overall Study|Randomized but not treated|1|||
163976194|NCT00876187|592285752|FG002|Overall Study|Randomized but not treated|3|||
163976195|NCT00876187|592285753|FG003|Overall Study|Randomized but not treated|2|||
163976196|NCT00876187|592285754|FG004|Overall Study|Randomized but not treated|3|||
163976197|NCT00876187|592285750|FG000|Overall Study|Other|2|||
163976198|NCT00876187|592285751|FG001|Overall Study|Other|5|||
163976199|NCT00876187|592285752|FG002|Overall Study|Other|9|||
163976200|NCT00876187|592285753|FG003|Overall Study|Other|7|||
163976201|NCT00876187|592285754|FG004|Overall Study|Other|4|||
163976202|NCT01379274|592285755|FG000|Overall Study|funding withdrawn|1|||
163976203|NCT03287219|592285761|FG000|Overall Study|Protocol Violation|0|||
163976204|NCT03287219|592285762|FG001|Overall Study|Protocol Violation|2|||
163976205|NCT00957008|592285763|FG000|Overall Study|Withdrawal by Subject|13|||
163976206|NCT00957008|592285764|FG001|Overall Study|Withdrawal by Subject|10|||
163976207|NCT00957008|592285765|FG002|Overall Study|Withdrawal by Subject|12|||
163976208|NCT00957008|592285766|FG003|Overall Study|Withdrawal by Subject|16|||
163976209|NCT00957008|592285763|FG000|Overall Study|Lost to Follow-up|3|||
163976210|NCT00957008|592285764|FG001|Overall Study|Lost to Follow-up|1|||
163976211|NCT00957008|592285765|FG002|Overall Study|Lost to Follow-up|3|||
163976212|NCT00957008|592285766|FG003|Overall Study|Lost to Follow-up|4|||
163976213|NCT00957008|592285763|FG000|Overall Study|Physician Decision|1|||
163976214|NCT00957008|592285764|FG001|Overall Study|Physician Decision|0|||
163976215|NCT00957008|592285765|FG002|Overall Study|Physician Decision|1|||
163976216|NCT00957008|592285766|FG003|Overall Study|Physician Decision|1|||
163976217|NCT00957008|592285763|FG000|Overall Study|Relocated; Family conflict|4|||
163976218|NCT00957008|592285764|FG001|Overall Study|Relocated; Family conflict|1|||
163976219|NCT00957008|592285765|FG002|Overall Study|Relocated; Family conflict|1|||
163976220|NCT00957008|592285766|FG003|Overall Study|Relocated; Family conflict|3|||
163976221|NCT00811135|592285767|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
163976222|NCT00811135|592285767|FG000|Overall Study|Death|3|||
163976223|NCT00811135|592285767|FG000|Overall Study|Protocol Violation|2|||
163976224|NCT00811135|592285767|FG000|Overall Study|Violation of Selection Criteria|1|||
163976225|NCT00811135|592285767|FG000|Overall Study|Refused Treatment|1|||
163976226|NCT00811135|592285767|FG000|Overall Study|Withdrawal by Subject|3|||
164302994|NCT04323124|593484688|FG002|Overall Study|Adverse Event|0|||
163976227|NCT00811135|592285767|FG000|Overall Study|Administrative/Other Unspecified|11|||
163976228|NCT00811135|592285767|FG000|Overall Study|Ongoing|59|||
163976229|NCT01118351|592285768|FG000|Overall Study|Adverse Event|3|||
163976230|NCT01118351|592285768|FG000|Overall Study|Withdrawal by Subject|1|||
163976231|NCT02192827|592285776|FG000|Overall Study|Lost to Follow-up|25|||
163976232|NCT02192827|592285777|FG001|Overall Study|Lost to Follow-up|27|||
163976233|NCT02192827|592285776|FG000|Overall Study|Given additional steroids with admission|13|||
163976234|NCT02192827|592285777|FG001|Overall Study|Given additional steroids with admission|11|||
163976235|NCT03571646|592285779|FG000|Overall Study|Adverse Event|1|||
163976236|NCT03571646|592285780|FG001|Overall Study|Adverse Event|0|||
163976237|NCT03571646|592285779|FG000|Overall Study|Withdrawal by Subject|1|||
163976238|NCT03571646|592285780|FG001|Overall Study|Withdrawal by Subject|1|||
163976239|NCT03972969|592285781|FG000|3-month Follow-up|Death|1|||
163976240|NCT03972969|592285782|FG001|3-month Follow-up|Death|1|||
163976241|NCT03972969|592285783|FG002|3-month Follow-up|Death|0|||
163976242|NCT03972969|592285781|FG000|6-month Follow-up|Death|1|||
163976243|NCT03972969|592285782|FG001|6-month Follow-up|Death|1|||
163976244|NCT03972969|592285783|FG002|6-month Follow-up|Death|1|||
163976245|NCT03972969|592285781|FG000|6-month Follow-up|Lost to Follow-up|2|||
163976246|NCT03972969|592285782|FG001|6-month Follow-up|Lost to Follow-up|2|||
163976247|NCT03972969|592285783|FG002|6-month Follow-up|Lost to Follow-up|2|||
163976248|NCT00283595|592285784|FG000|Overall Study|Withdrawal by Subject|1|||
163976249|NCT00283595|592285785|FG001|Overall Study|Withdrawal by Subject|2|||
163976250|NCT00845728|592285789|FG000|Overall Study|Abnormal laboratory value (s)|2|||
163976251|NCT00845728|592285790|FG001|Overall Study|Abnormal laboratory value (s)|2|||
163976252|NCT00845728|592285789|FG000|Overall Study|Patient's inability to use the device|4|||
163976253|NCT00845728|592285790|FG001|Overall Study|Patient's inability to use the device|6|||
163976254|NCT00845728|592285789|FG000|Overall Study|Abnormal test procedure result (s)|7|||
163976255|NCT00845728|592285790|FG001|Overall Study|Abnormal test procedure result (s)|2|||
163976256|NCT00845728|592285789|FG000|Overall Study|Lost to Follow-up|22|||
163976257|NCT00845728|592285790|FG001|Overall Study|Lost to Follow-up|13|||
163976258|NCT00845728|592285789|FG000|Overall Study|Death|24|||
163976259|NCT00845728|592285790|FG001|Overall Study|Death|26|||
163976260|NCT00845728|592285789|FG000|Overall Study|Administrative Problems|34|||
163976261|NCT00845728|592285790|FG001|Overall Study|Administrative Problems|26|||
163976262|NCT00845728|592285789|FG000|Overall Study|Protocol Violation|36|||
163976263|NCT00845728|592285790|FG001|Overall Study|Protocol Violation|24|||
163976264|NCT00845728|592285789|FG000|Overall Study|Lack of Efficacy|51|||
163976265|NCT00845728|592285790|FG001|Overall Study|Lack of Efficacy|39|||
163976266|NCT00845728|592285789|FG000|Overall Study|Adverse Event|101|||
163976267|NCT00845728|592285790|FG001|Overall Study|Adverse Event|96|||
163976268|NCT00845728|592285789|FG000|Overall Study|Withdrawal by Subject|105|||
163976269|NCT00845728|592285790|FG001|Overall Study|Withdrawal by Subject|108|||
164204117|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
164299681|NCT00551642|593472891|FG000|Treatment Period|Withdrawal by Subject|2|||
163871926|NCT04259450|591900478|FG004|Overall Study|Other than listed|0|||
163871927|NCT04259450|591900479|FG005|Overall Study|Other than listed|0|||
163871928|NCT04259450|591900480|FG006|Overall Study|Other than listed|0|||
163871929|NCT04259450|591900481|FG007|Overall Study|Other than listed|1|||
163871930|NCT04259450|591900482|FG008|Overall Study|Other than listed|1|||
163871931|NCT04259450|591900483|FG009|Overall Study|Other than listed|2|||
163871932|NCT00332241|591900490|FG000|Overall Study|Lack of Efficacy|6|||
163871933|NCT00332241|591900491|FG001|Overall Study|Lack of Efficacy|1|||
163871934|NCT00332241|591900490|FG000|Overall Study|Adverse Event|3|||
163871935|NCT00332241|591900491|FG001|Overall Study|Adverse Event|5|||
163871936|NCT00332241|591900490|FG000|Overall Study|Withdrawal by Subject|2|||
163871937|NCT00332241|591900491|FG001|Overall Study|Withdrawal by Subject|1|||
163871938|NCT00332241|591900490|FG000|Overall Study|Lost to Follow-up|4|||
163871939|NCT00332241|591900491|FG001|Overall Study|Lost to Follow-up|1|||
163871940|NCT00542789|591900493|FG000|Overall Study|Adverse Event|18|||
163871941|NCT00542789|591900494|FG001|Overall Study|Adverse Event|17|||
163871942|NCT00542789|591900493|FG000|Overall Study|Withdrawal by Subject|7|||
163871943|NCT00542789|591900494|FG001|Overall Study|Withdrawal by Subject|3|||
163871944|NCT00542789|591900493|FG000|Overall Study|Protocol Violation|8|||
163871945|NCT00542789|591900494|FG001|Overall Study|Protocol Violation|1|||
163871946|NCT00542789|591900493|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
163871947|NCT00542789|591900494|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
163871948|NCT02584829|591900496|FG000|Overall Study|Physician Decision|1|||
163871949|NCT02584829|591900497|FG001|Overall Study|Physician Decision|0|||
163871950|NCT02584829|591900496|FG000|Overall Study|Withdrawal by Subject|0|||
163871951|NCT02584829|591900497|FG001|Overall Study|Withdrawal by Subject|1|||
163871952|NCT02584829|591900496|FG000|Overall Study|Progressive Disease|0|||
163871953|NCT02584829|591900497|FG001|Overall Study|Progressive Disease|3|||
163871954|NCT02374463|591900498|FG000|Overall Study|Withdrawal by Subject|3|||
163871955|NCT02374463|591900499|FG001|Overall Study|Withdrawal by Subject|3|||
163871956|NCT00106080|591900507|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
163871957|NCT00106080|591900508|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
163871958|NCT01839331|591900509|FG000|Overall Study|Early Termination|3|||
163871959|NCT01839331|591900510|FG001|Overall Study|Early Termination|0|||
163871960|NCT01839331|591900511|FG002|Overall Study|Early Termination|1|||
163871961|NCT01839331|591900512|FG003|Overall Study|Early Termination|2|||
163871962|NCT01839331|591900509|FG000|Overall Study|Protocol Violation|1|||
163871963|NCT01839331|591900510|FG001|Overall Study|Protocol Violation|6|||
163976270|NCT03259074|592285791|FG000|Overall Study|Adverse Event|9|||
163976271|NCT03259074|592285792|FG001|Overall Study|Adverse Event|12|||
163976272|NCT03259074|592285793|FG002|Overall Study|Adverse Event|8|||
163976273|NCT03259074|592285791|FG000|Overall Study|Death|1|||
163976274|NCT03259074|592285792|FG001|Overall Study|Death|1|||
163976275|NCT03259074|592285793|FG002|Overall Study|Death|3|||
163976276|NCT03259074|592285791|FG000|Overall Study|Lost to Follow-up|2|||
163976277|NCT03259074|592285792|FG001|Overall Study|Lost to Follow-up|4|||
163976278|NCT03259074|592285793|FG002|Overall Study|Lost to Follow-up|3|||
163871964|NCT01839331|591900511|FG002|Overall Study|Protocol Violation|4|||
163871965|NCT01839331|591900512|FG003|Overall Study|Protocol Violation|3|||
163871966|NCT00761605|591900515|FG000|Overall Study|Adverse Event|26|||
163871967|NCT00761605|591900515|FG000|Overall Study|Death|2|||
163871968|NCT00761605|591900515|FG000|Overall Study|Lack of Efficacy|26|||
163871969|NCT00761605|591900515|FG000|Overall Study|Lost to Follow-up|29|||
163871970|NCT00761605|591900515|FG000|Overall Study|Withdrawal by Subject|37|||
163871971|NCT00761605|591900515|FG000|Overall Study|Other|21|||
163871972|NCT03074331|591900516|FG000|Overall Study|Enrolled but Not Treated|1|||
163871973|NCT03074331|591900516|FG000|Overall Study|Lost to Follow-up|5|||
163871974|NCT03074331|591900516|FG000|Overall Study|Withdrew Consent|1|||
163871975|NCT00350792|591900518|FG000|Overall Study|Adverse Event|11|||
163871976|NCT00350792|591900518|FG000|Overall Study|Death from Study Disease|1|||
163871977|NCT00350792|591900518|FG000|Overall Study|Death from Study Drug Toxicity|1|||
163871978|NCT00350792|591900518|FG000|Overall Study|Death Not Study Drug Related|2|||
163871979|NCT00350792|591900518|FG000|Overall Study|Protocol Violation|1|||
163871980|NCT00350792|591900518|FG000|Overall Study|Withdrawal by Subject|4|||
163871981|NCT00350792|591900518|FG000|Overall Study|Physician Decision|2|||
163871982|NCT00350792|591900518|FG000|Overall Study|Lack of Efficacy|11|||
163871983|NCT04594759|591900519|FG000|Overall Study|Lost to Follow-up|3|||
163871984|NCT03811574|591900520|FG000|Overall Study|Withdrawal by Subject|2|||
163871985|NCT03811574|591900521|FG001|Overall Study|Withdrawal by Subject|4|||
163871986|NCT03811574|591900522|FG002|Overall Study|Withdrawal by Subject|0|||
163871987|NCT03485950|591900525|FG000|Overall Study|Adverse Event|1|||
163871988|NCT03485950|591900526|FG001|Overall Study|Adverse Event|0|||
163871989|NCT03485950|591900525|FG000|Overall Study|Death|3|||
163871990|NCT03485950|591900526|FG001|Overall Study|Death|2|||
163871991|NCT03485950|591900525|FG000|Overall Study|Withdrawal by Subject|3|||
163871992|NCT03485950|591900526|FG001|Overall Study|Withdrawal by Subject|0|||
163871993|NCT03144674|591900529|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
163871994|NCT03144674|591900530|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
163871995|NCT03144674|591900531|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
163871996|NCT03144674|591900532|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
163871997|NCT03144674|591900529|FG000|Overall Study|Death|3|||
163871998|NCT03144674|591900530|FG001|Overall Study|Death|2|||
163871999|NCT03144674|591900531|FG002|Overall Study|Death|6|||
163872000|NCT03144674|591900532|FG003|Overall Study|Death|24|||
163872001|NCT03144674|591900529|FG000|Overall Study|Lost to Follow-up|0|||
163872002|NCT03144674|591900530|FG001|Overall Study|Lost to Follow-up|1|||
163872003|NCT03144674|591900531|FG002|Overall Study|Lost to Follow-up|0|||
163872004|NCT03144674|591900532|FG003|Overall Study|Lost to Follow-up|4|||
163872005|NCT03144674|591900529|FG000|Overall Study|Withdrawal by Participant|0|||
163872006|NCT03144674|591900530|FG001|Overall Study|Withdrawal by Participant|0|||
163872007|NCT03144674|591900531|FG002|Overall Study|Withdrawal by Participant|2|||
163872008|NCT03144674|591900532|FG003|Overall Study|Withdrawal by Participant|6|||
163872009|NCT03144674|591900529|FG000|Overall Study|Discharged from the Trust|0|||
163872010|NCT03144674|591900530|FG001|Overall Study|Discharged from the Trust|0|||
163872011|NCT03144674|591900531|FG002|Overall Study|Discharged from the Trust|1|||
163872012|NCT03144674|591900532|FG003|Overall Study|Discharged from the Trust|0|||
163872013|NCT03144674|591900529|FG000|Overall Study|Exclusion Criteria Met|0|||
163872014|NCT03144674|591900530|FG001|Overall Study|Exclusion Criteria Met|0|||
163872015|NCT03144674|591900531|FG002|Overall Study|Exclusion Criteria Met|1|||
163872016|NCT03144674|591900532|FG003|Overall Study|Exclusion Criteria Met|0|||
163872017|NCT03144674|591900529|FG000|Overall Study|Changed Physicians|0|||
163872018|NCT03144674|591900530|FG001|Overall Study|Changed Physicians|0|||
163872019|NCT03144674|591900531|FG002|Overall Study|Changed Physicians|0|||
163872020|NCT03144674|591900532|FG003|Overall Study|Changed Physicians|1|||
163872021|NCT03144674|591900529|FG000|Overall Study|Removed for Safety|0|||
163872022|NCT03144674|591900530|FG001|Overall Study|Removed for Safety|0|||
163872023|NCT03144674|591900531|FG002|Overall Study|Removed for Safety|0|||
163872024|NCT03144674|591900532|FG003|Overall Study|Removed for Safety|1|||
163872025|NCT03144674|591900529|FG000|Overall Study|Site Closed|0|||
163872026|NCT03144674|591900530|FG001|Overall Study|Site Closed|0|||
163872027|NCT03144674|591900531|FG002|Overall Study|Site Closed|0|||
163872028|NCT03144674|591900532|FG003|Overall Study|Site Closed|1|||
163872029|NCT03144674|591900529|FG000|Overall Study|Histological Criteria Not Met|0|||
163872030|NCT03144674|591900530|FG001|Overall Study|Histological Criteria Not Met|0|||
163872031|NCT03144674|591900531|FG002|Overall Study|Histological Criteria Not Met|0|||
163872032|NCT03144674|591900532|FG003|Overall Study|Histological Criteria Not Met|1|||
163872033|NCT03144674|591900529|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
163872034|NCT03144674|591900530|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
163872035|NCT03144674|591900531|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
163872036|NCT03144674|591900532|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
163976279|NCT03259074|592285791|FG000|Overall Study|New Therapy For Study Indication|1|||
163872037|NCT03144674|591900529|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
163872038|NCT03144674|591900530|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
163872039|NCT03144674|591900531|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
163976280|NCT03259074|592285792|FG001|Overall Study|New Therapy For Study Indication|2|||
164314881|NCT01821560|593529808|FG000|Overall Study|Lost to Follow-up|5|||
164314882|NCT01821560|593529809|FG001|Overall Study|Lost to Follow-up|5|||
164314883|NCT01821560|593529808|FG000|Overall Study|Withdrawal by Subject|1|||
164314884|NCT01821560|593529809|FG001|Overall Study|Withdrawal by Subject|1|||
163872040|NCT03144674|591900532|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
163872041|NCT01565148|591900533|FG000|Overall Study|Withdrawal by Subject|1|||
163872042|NCT01565148|591900534|FG001|Overall Study|Withdrawal by Subject|1|||
163872043|NCT01565148|591900535|FG002|Overall Study|Withdrawal by Subject|1|||
163872044|NCT01565148|591900536|FG003|Overall Study|Withdrawal by Subject|2|||
163872045|NCT01565148|591900533|FG000|Overall Study|Lost to Follow-up|4|||
163872046|NCT01565148|591900534|FG001|Overall Study|Lost to Follow-up|4|||
163872047|NCT01565148|591900535|FG002|Overall Study|Lost to Follow-up|0|||
163872048|NCT01565148|591900536|FG003|Overall Study|Lost to Follow-up|3|||
163872049|NCT01565148|591900533|FG000|Overall Study|Rescue Therapy|8|||
163872050|NCT01565148|591900534|FG001|Overall Study|Rescue Therapy|5|||
163872051|NCT01565148|591900535|FG002|Overall Study|Rescue Therapy|5|||
163872052|NCT01565148|591900536|FG003|Overall Study|Rescue Therapy|8|||
163872053|NCT01565148|591900533|FG000|Overall Study|Death|0|||
163872054|NCT01565148|591900534|FG001|Overall Study|Death|0|||
163872055|NCT01565148|591900535|FG002|Overall Study|Death|1|||
163872056|NCT01565148|591900536|FG003|Overall Study|Death|0|||
163872057|NCT01565148|591900533|FG000|Overall Study|Physician Decision|2|||
163872058|NCT01565148|591900534|FG001|Overall Study|Physician Decision|5|||
163872059|NCT01565148|591900535|FG002|Overall Study|Physician Decision|0|||
163872060|NCT01565148|591900536|FG003|Overall Study|Physician Decision|0|||
163872061|NCT01759771|591900537|FG000|Overall Study|Withdrawal by Subject|1|||
163872062|NCT01759771|591900538|FG001|Overall Study|Withdrawal by Subject|1|||
163872063|NCT00529659|591900541|FG000|Overall Study|Adverse Event|8|||
163872064|NCT00529659|591900542|FG001|Overall Study|Adverse Event|7|||
163872065|NCT00529659|591900541|FG000|Overall Study|Lost to Follow-up|0|||
163872066|NCT00529659|591900542|FG001|Overall Study|Lost to Follow-up|2|||
163872067|NCT00529659|591900541|FG000|Overall Study|Physician Decision|0|||
163872068|NCT00529659|591900542|FG001|Overall Study|Physician Decision|2|||
163872069|NCT00529659|591900541|FG000|Overall Study|Protocol Violation|2|||
163872070|NCT00529659|591900542|FG001|Overall Study|Protocol Violation|6|||
163872071|NCT00529659|591900541|FG000|Overall Study|Withdrawal by Subject|1|||
163872072|NCT00529659|591900542|FG001|Overall Study|Withdrawal by Subject|6|||
163872073|NCT01692730|591900543|FG000|Overall Study|Lost to Follow-up|225|||
163872074|NCT01692730|591900544|FG001|Overall Study|Lost to Follow-up|227|||
163872075|NCT01041417|591900545|FG000|Overall Study|Adverse Event|5|||
163872076|NCT01041417|591900546|FG001|Overall Study|Adverse Event|2|||
163872077|NCT01041417|591900545|FG000|Overall Study|Lost to Follow-up|1|||
163872078|NCT01041417|591900546|FG001|Overall Study|Lost to Follow-up|1|||
163872079|NCT01041417|591900545|FG000|Overall Study|Death|1|||
163872080|NCT01041417|591900546|FG001|Overall Study|Death|0|||
163872081|NCT03783026|591901746|FG000|Treatment Phase|Adverse Event|15|||
163872082|NCT03783026|591901746|FG000|Treatment Phase|Lack of Efficacy|11|||
163872083|NCT03783026|591901746|FG000|Treatment Phase|Withdrawal by Subject|6|||
163872084|NCT03783026|591901746|FG000|Treatment Phase|Lost to Follow-up|2|||
163872085|NCT03783026|591901746|FG000|Treatment Phase|Protocol Deviation|8|||
163872086|NCT03783026|591901746|FG000|Treatment Phase|Did Not Receive Treatment|1|||
163872087|NCT03783026|591901746|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
163872088|NCT04814186|591901747|FG000|Treatment Phase|Adverse Event|1|||
163872089|NCT04814186|591901747|FG000|Treatment Phase|Death|6|||
163872090|NCT04814186|591901747|FG000|Treatment Phase|Withdrawal by Subject|2|||
163872091|NCT04814186|591901747|FG000|Treatment Phase|Other|1|||
163872092|NCT04814186|591901747|FG000|Follow-Up Phase|Adverse Event|1|||
163872093|NCT04814186|591901747|FG000|Follow-Up Phase|Death|6|||
163872094|NCT04814186|591901747|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
163872095|NCT04814186|591901747|FG000|Follow-Up Phase|Other|1|||
163872096|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
163872097|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
163872098|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
163872099|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
163872100|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
163872101|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
163976281|NCT03259074|592285793|FG002|Overall Study|New Therapy For Study Indication|2|||
163976282|NCT03259074|592285791|FG000|Overall Study|Physician Decision|4|||
164314885|NCT01821560|593529808|FG000|Overall Study|Protocol Violation|0|||
163872102|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
163872103|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
163872104|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
163872105|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
163872106|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
163872107|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
164314886|NCT01821560|593529809|FG001|Overall Study|Protocol Violation|1|||
164314887|NCT01338298|593529810|FG000|Overall Study|Withdrawal by Subject|1|||
164314888|NCT01338298|593529811|FG001|Overall Study|Withdrawal by Subject|1|||
164314889|NCT01338298|593529810|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
164314890|NCT01338298|593529811|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
164314891|NCT01338298|593529810|FG000|Overall Study|Administrative error|0|||
164314892|NCT01338298|593529811|FG001|Overall Study|Administrative error|1|||
163872108|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163872109|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
163872110|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
163872111|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163872112|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163872113|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
163872114|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
163872115|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
163872116|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
163872117|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
163872118|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
163872119|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
163872120|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163872121|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
163872122|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163872123|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163872124|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163872125|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
163872126|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
163872127|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163872128|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163872129|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163872130|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163872131|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
163872132|NCT04043455|591901763|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163872133|NCT04043455|591901764|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
163872134|NCT04043455|591901765|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163872135|NCT04043455|591901766|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163872136|NCT04043455|591901767|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163872137|NCT04043455|591901768|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
163872138|NCT04043455|591901763|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
163872139|NCT04043455|591901764|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
163872140|NCT04043455|591901765|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
163872141|NCT04043455|591901766|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
163872142|NCT04043455|591901767|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
163872143|NCT04043455|591901768|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
163872144|NCT04043455|591901763|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163872145|NCT04043455|591901764|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163872146|NCT04043455|591901765|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163872147|NCT04043455|591901766|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
163872148|NCT04043455|591901767|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
163872149|NCT04043455|591901768|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
163872150|NCT04043455|591901763|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163872151|NCT04043455|591901764|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163872152|NCT04043455|591901765|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163872153|NCT04043455|591901766|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163872154|NCT04043455|591901767|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
163872155|NCT04043455|591901768|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
163872156|NCT04043455|591901763|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163872157|NCT04043455|591901764|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163872158|NCT04043455|591901765|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163872159|NCT04043455|591901766|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
163976283|NCT03259074|592285792|FG001|Overall Study|Physician Decision|12|||
164314893|NCT01338298|593529810|FG000|Overall Study|Positive symptom worsening|1|||
164314894|NCT01338298|593529811|FG001|Overall Study|Positive symptom worsening|0|||
164314895|NCT01338298|593529810|FG000|Overall Study|Depressive symptoms and nausea|1|||
164314896|NCT01338298|593529811|FG001|Overall Study|Depressive symptoms and nausea|0|||
164314897|NCT01338298|593529810|FG000|Overall Study|Non-adherence|1|||
164314898|NCT01338298|593529811|FG001|Overall Study|Non-adherence|0|||
164314899|NCT02872285|593529812|FG000|Overall Study|Withdrawal by Subject|2|||
164314900|NCT02872285|593529813|FG001|Overall Study|Withdrawal by Subject|0|||
164314901|NCT02872285|593529812|FG000|Overall Study|Lost to Follow-up|2|||
163872160|NCT04043455|591901767|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
163872161|NCT04043455|591901768|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
163872162|NCT03422276|591901769|FG000|Overall Study|Withdrawal by Subject|21|||
163872163|NCT03422276|591901770|FG001|Overall Study|Withdrawal by Subject|25|||
163872164|NCT03422276|591901771|FG002|Overall Study|Withdrawal by Subject|14|||
163872165|NCT03422276|591901772|FG003|Overall Study|Withdrawal by Subject|16|||
163872166|NCT03422276|591901769|FG000|Overall Study|Death|14|||
163872167|NCT03422276|591901770|FG001|Overall Study|Death|21|||
163872168|NCT03422276|591901771|FG002|Overall Study|Death|3|||
163872169|NCT03422276|591901772|FG003|Overall Study|Death|1|||
163872170|NCT03422276|591901769|FG000|Overall Study|Discontinued, ineligible|4|||
163872171|NCT03422276|591901770|FG001|Overall Study|Discontinued, ineligible|3|||
163872172|NCT03422276|591901771|FG002|Overall Study|Discontinued, ineligible|0|||
163872173|NCT03422276|591901772|FG003|Overall Study|Discontinued, ineligible|0|||
163872174|NCT03422276|591901769|FG000|Overall Study|Lost to Follow-up|15|||
163872175|NCT03422276|591901770|FG001|Overall Study|Lost to Follow-up|8|||
163872176|NCT03422276|591901771|FG002|Overall Study|Lost to Follow-up|13|||
163872177|NCT03422276|591901772|FG003|Overall Study|Lost to Follow-up|4|||
163872178|NCT03422276|591901769|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
163872179|NCT03422276|591901770|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
163872180|NCT03422276|591901771|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
163872181|NCT03422276|591901772|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
163872182|NCT03422276|591901769|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
163872183|NCT03422276|591901770|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
163872184|NCT03422276|591901771|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
163872185|NCT03422276|591901772|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
163872186|NCT03422276|591901769|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
163872187|NCT03422276|591901770|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
163872188|NCT03422276|591901771|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
163872189|NCT03422276|591901772|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
163872190|NCT03422276|591901769|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
163872191|NCT03422276|591901770|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
163872192|NCT03422276|591901771|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
163872193|NCT03422276|591901772|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
163872194|NCT03422276|591901769|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
163872195|NCT03422276|591901770|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
163872196|NCT03422276|591901771|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
163872197|NCT03422276|591901772|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
163872198|NCT05194917|591901773|FG000|Overall Study|Lost to Follow-up|7|||
163872199|NCT05194917|591901774|FG001|Overall Study|Lost to Follow-up|5|||
163872200|NCT05194917|591901775|FG002|Overall Study|Lost to Follow-up|6|||
163872201|NCT05194917|591901776|FG003|Overall Study|Lost to Follow-up|5|||
163872202|NCT04922021|591901777|FG000|Overall Study|Withdrawal by Subject|4|||
163872203|NCT04922021|591901778|FG001|Overall Study|Withdrawal by Subject|10|||
163872204|NCT04922021|591901777|FG000|Overall Study|Adverse Event|2|||
163872205|NCT04922021|591901778|FG001|Overall Study|Adverse Event|2|||
163872206|NCT04922021|591901777|FG000|Overall Study|Lack of Efficacy|0|||
163872207|NCT04922021|591901778|FG001|Overall Study|Lack of Efficacy|1|||
163872208|NCT04922021|591901777|FG000|Overall Study|Multiple reasons|1|||
163872209|NCT04922021|591901778|FG001|Overall Study|Multiple reasons|0|||
163872210|NCT04104321|591901794|FG000|Overall Study|didn't take the study drug|3|||
163872211|NCT02652260|591901799|FG000|Base Study|Pregnancy|0|||
163872212|NCT02652260|591901800|FG001|Base Study|Pregnancy|1|||
163872213|NCT02652260|591901799|FG000|Base Study|Withdrawal by Subject|0|||
163872214|NCT02652260|591901800|FG001|Base Study|Withdrawal by Subject|1|||
163872215|NCT02652260|591901799|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
163872216|NCT02652260|591901800|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
163872217|NCT02652260|591901799|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
163872218|NCT02652260|591901800|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
163872219|NCT02652260|591901799|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
163872220|NCT02652260|591901800|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
163872221|NCT02652260|591901799|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
163872222|NCT02652260|591901800|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
163976284|NCT03259074|592285793|FG002|Overall Study|Physician Decision|10|||
163976285|NCT03259074|592285791|FG000|Overall Study|Pregnancy|1|||
163976286|NCT03259074|592285792|FG001|Overall Study|Pregnancy|1|||
163976287|NCT03259074|592285793|FG002|Overall Study|Pregnancy|0|||
163976288|NCT03259074|592285791|FG000|Overall Study|Progressive Disease|1|||
163976289|NCT03259074|592285792|FG001|Overall Study|Progressive Disease|0|||
163976290|NCT03259074|592285793|FG002|Overall Study|Progressive Disease|0|||
163976291|NCT03259074|592285791|FG000|Overall Study|Protocol Deviation|1|||
163976292|NCT03259074|592285792|FG001|Overall Study|Protocol Deviation|1|||
163976293|NCT03259074|592285793|FG002|Overall Study|Protocol Deviation|3|||
163976294|NCT03259074|592285791|FG000|Overall Study|Subject/Guardian Decision|13|||
163976295|NCT03259074|592285792|FG001|Overall Study|Subject/Guardian Decision|16|||
163976296|NCT03259074|592285793|FG002|Overall Study|Subject/Guardian Decision|14|||
163976297|NCT04081363|592285794|FG000|Overall Study|Withdrawal by Subject|1|||
163976298|NCT04081363|592285795|FG001|Overall Study|Withdrawal by Subject|0|||
163976299|NCT00705783|592285799|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
163976300|NCT00705783|592285800|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
163976301|NCT00705783|592285801|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
163976302|NCT00705783|592285799|FG000|Conversion Phase|Lost to Follow-up|13|||
163976303|NCT00705783|592285800|FG001|Conversion Phase|Lost to Follow-up|0|||
163976304|NCT00705783|592285801|FG002|Conversion Phase|Lost to Follow-up|0|||
163976305|NCT00705783|592285799|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
163976306|NCT00705783|592285800|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
163976307|NCT00705783|592285801|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
163976308|NCT00705783|592285799|FG000|Conversion Phase|Withdrawn by Investigator|4|||
164314902|NCT02872285|593529813|FG001|Overall Study|Lost to Follow-up|2|||
164314903|NCT02872285|593529812|FG000|Overall Study|Discontinued due to back surgery|1|||
164314904|NCT02872285|593529813|FG001|Overall Study|Discontinued due to back surgery|0|||
164314905|NCT05477108|593529814|FG000|Overall Study|Participants randomized, not treated|1|||
164314906|NCT05477108|593529815|FG001|Overall Study|Participants randomized, not treated|1|||
164314907|NCT05477108|593529816|FG002|Overall Study|Participants randomized, not treated|1|||
164314908|NCT05477108|593529814|FG000|Overall Study|Physician Decision|0|||
164314909|NCT05477108|593529815|FG001|Overall Study|Physician Decision|0|||
163976309|NCT00705783|592285800|FG001|Conversion Phase|Withdrawn by Investigator|0|||
163976310|NCT00705783|592285801|FG002|Conversion Phase|Withdrawn by Investigator|0|||
163976311|NCT00705783|592285799|FG000|Conversion Phase|Withdrew Consent|24|||
163976312|NCT00705783|592285800|FG001|Conversion Phase|Withdrew Consent|0|||
163976313|NCT00705783|592285801|FG002|Conversion Phase|Withdrew Consent|0|||
163976314|NCT00705783|592285799|FG000|Conversion Phase|Protocol Deviation|2|||
163976315|NCT00705783|592285800|FG001|Conversion Phase|Protocol Deviation|0|||
163976316|NCT00705783|592285801|FG002|Conversion Phase|Protocol Deviation|0|||
163976317|NCT00705783|592285799|FG000|Conversion Phase|Adverse Event|11|||
163976318|NCT00705783|592285800|FG001|Conversion Phase|Adverse Event|0|||
164314910|NCT05477108|593529816|FG002|Overall Study|Physician Decision|1|||
164314911|NCT05477108|593529814|FG000|Overall Study|withdrawn from study|0|||
164314912|NCT05477108|593529815|FG001|Overall Study|withdrawn from study|0|||
164314913|NCT05477108|593529816|FG002|Overall Study|withdrawn from study|1|||
164314914|NCT01253577|593529817|FG000|Overall Study|Lost to Follow-up|3|||
164314915|NCT02970942|593529818|FG000|Overall Study|Death|0|||
164314916|NCT02970942|593529819|FG001|Overall Study|Death|1|||
163976319|NCT00705783|592285801|FG002|Conversion Phase|Adverse Event|0|||
163976320|NCT00705783|592285799|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
163976321|NCT00705783|592285800|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163976322|NCT00705783|592285801|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163976323|NCT00705783|592285799|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
163976324|NCT00705783|592285800|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163976325|NCT00705783|592285801|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163976326|NCT00705783|592285799|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
163976327|NCT00705783|592285800|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
163976328|NCT00705783|592285801|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
163976329|NCT00705783|592285799|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
163976330|NCT00705783|592285800|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
163976331|NCT00705783|592285801|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
164314917|NCT02970942|593529820|FG002|Overall Study|Death|0|||
164314918|NCT02970942|593529821|FG003|Overall Study|Death|0|||
163976332|NCT00705783|592285799|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
163976333|NCT00705783|592285800|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163976334|NCT00705783|592285801|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163976335|NCT00705783|592285799|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
163976336|NCT00705783|592285800|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163976337|NCT00705783|592285801|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163976338|NCT00705783|592285799|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
163976339|NCT00705783|592285800|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
163976340|NCT00705783|592285801|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
163976341|NCT00705783|592285799|FG000|Oral Stabilization Phase|Adverse Event|14|||
164314919|NCT02970942|593529818|FG000|Overall Study|Lost to Follow-up|1|||
163976342|NCT00705783|592285800|FG001|Oral Stabilization Phase|Adverse Event|0|||
163976343|NCT00705783|592285801|FG002|Oral Stabilization Phase|Adverse Event|0|||
163976344|NCT00705783|592285799|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
163976345|NCT00705783|592285800|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163976346|NCT00705783|592285801|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163976347|NCT00705783|592285799|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
163976348|NCT00705783|592285800|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163976349|NCT00705783|592285801|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163976350|NCT00705783|592285799|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
163872223|NCT02652260|591901799|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
163976351|NCT00705783|592285800|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
163976352|NCT00705783|592285801|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
163976353|NCT00705783|592285799|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
163976354|NCT00705783|592285800|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
163976355|NCT00705783|592285801|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
163976356|NCT00705783|592285799|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
163976357|NCT00705783|592285800|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
163976358|NCT00705783|592285801|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
163976359|NCT00705783|592285799|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
163976360|NCT00705783|592285800|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
163976361|NCT00705783|592285801|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
163976362|NCT00705783|592285799|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
163976363|NCT00705783|592285800|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
163976364|NCT00705783|592285801|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
163976365|NCT00705783|592285799|FG000|Depot Stabilization Phase|Adverse Event|17|||
163976366|NCT00705783|592285800|FG001|Depot Stabilization Phase|Adverse Event|0|||
163976367|NCT00705783|592285801|FG002|Depot Stabilization Phase|Adverse Event|0|||
163976368|NCT00705783|592285799|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
163872224|NCT02652260|591901800|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
163872225|NCT02652260|591901799|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
163872226|NCT02652260|591901800|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
163872227|NCT02652260|591901799|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
163872228|NCT02652260|591901800|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
163872229|NCT02652260|591901799|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
163872230|NCT02652260|591901800|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
163872231|NCT02652260|591901799|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
163872232|NCT02652260|591901800|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
163872233|NCT02652260|591901799|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
163872234|NCT02652260|591901800|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
163872235|NCT02652260|591901799|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
163872236|NCT02652260|591901800|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
163872237|NCT02652260|591901799|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
163872238|NCT02652260|591901800|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
163872239|NCT04300647|591901801|FG000|Pre-Crossover|Death|19|||
163872240|NCT04300647|591901802|FG001|Pre-Crossover|Death|58|||
163872241|NCT04300647|591901803|FG002|Pre-Crossover|Death|0|||
163872242|NCT04300647|591901801|FG000|Pre-Crossover|Lost to Follow-up|0|||
163872243|NCT04300647|591901802|FG001|Pre-Crossover|Lost to Follow-up|3|||
163872244|NCT04300647|591901803|FG002|Pre-Crossover|Lost to Follow-up|0|||
163872245|NCT04300647|591901801|FG000|Pre-Crossover|Withdrawal by Subject|2|||
163872246|NCT04300647|591901802|FG001|Pre-Crossover|Withdrawal by Subject|4|||
163872247|NCT04300647|591901803|FG002|Pre-Crossover|Withdrawal by Subject|0|||
163872248|NCT04300647|591901801|FG000|Pre-Crossover|On-going in Study|24|||
163872249|NCT04300647|591901802|FG001|Pre-Crossover|On-going in Study|61|||
163872250|NCT04300647|591901803|FG002|Pre-Crossover|On-going in Study|0|||
163872251|NCT04300647|591901801|FG000|Post-Crossover|Death|0|||
163872252|NCT04300647|591901802|FG001|Post-Crossover|Death|0|||
163872253|NCT04300647|591901803|FG002|Post-Crossover|Death|3|||
163872254|NCT04300647|591901801|FG000|Post-Crossover|Lost to Follow-up|0|||
163872255|NCT04300647|591901802|FG001|Post-Crossover|Lost to Follow-up|0|||
163872256|NCT04300647|591901803|FG002|Post-Crossover|Lost to Follow-up|1|||
163872257|NCT04300647|591901801|FG000|Post-Crossover|Withdrawal by Subject|0|||
163872258|NCT04300647|591901802|FG001|Post-Crossover|Withdrawal by Subject|0|||
163872259|NCT04300647|591901803|FG002|Post-Crossover|Withdrawal by Subject|1|||
163872260|NCT04300647|591901801|FG000|Post-Crossover|On-going in Study|0|||
163872261|NCT04300647|591901802|FG001|Post-Crossover|On-going in Study|0|||
163872262|NCT04300647|591901803|FG002|Post-Crossover|On-going in Study|8|||
163872263|NCT05056246|591901804|FG000|Overall Study|Adverse Event|0|||
163976369|NCT00705783|592285800|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163976370|NCT00705783|592285801|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163976371|NCT00705783|592285799|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
163976372|NCT00705783|592285800|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
164314920|NCT02970942|593529819|FG001|Overall Study|Lost to Follow-up|0|||
164314921|NCT02970942|593529820|FG002|Overall Study|Lost to Follow-up|2|||
164314922|NCT02970942|593529821|FG003|Overall Study|Lost to Follow-up|1|||
164314923|NCT02970942|593529818|FG000|Overall Study|Withdrawal by Subject|3|||
164314924|NCT02970942|593529819|FG001|Overall Study|Withdrawal by Subject|5|||
164314925|NCT02970942|593529820|FG002|Overall Study|Withdrawal by Subject|3|||
164314926|NCT02970942|593529821|FG003|Overall Study|Withdrawal by Subject|2|||
163872264|NCT05056246|591901805|FG001|Overall Study|Adverse Event|0|||
163872265|NCT05056246|591901806|FG002|Overall Study|Adverse Event|0|||
163872266|NCT05056246|591901807|FG003|Overall Study|Adverse Event|0|||
163872267|NCT05056246|591901808|FG004|Overall Study|Adverse Event|1|||
163872268|NCT05056246|591901804|FG000|Overall Study|Lost to Follow-up|0|||
163872269|NCT05056246|591901805|FG001|Overall Study|Lost to Follow-up|0|||
163872270|NCT05056246|591901806|FG002|Overall Study|Lost to Follow-up|0|||
163872271|NCT05056246|591901807|FG003|Overall Study|Lost to Follow-up|2|||
163872272|NCT05056246|591901808|FG004|Overall Study|Lost to Follow-up|0|||
163872273|NCT05056246|591901804|FG000|Overall Study|Withdrawal by Subject|0|||
163872274|NCT05056246|591901805|FG001|Overall Study|Withdrawal by Subject|1|||
163872275|NCT05056246|591901806|FG002|Overall Study|Withdrawal by Subject|0|||
163872276|NCT05056246|591901807|FG003|Overall Study|Withdrawal by Subject|0|||
163872277|NCT05056246|591901808|FG004|Overall Study|Withdrawal by Subject|0|||
163872278|NCT00978042|591901809|FG000|Initial Treatment Period|Treated in Error|0|||
163872279|NCT00978042|591901810|FG001|Initial Treatment Period|Treated in Error|3|||
163872280|NCT00978042|591901809|FG000|Initial Treatment Period|Ineligibility|1|||
163872281|NCT00978042|591901810|FG001|Initial Treatment Period|Ineligibility|0|||
163872282|NCT00978042|591901809|FG000|Initial Treatment Period|Lost to Follow-up|21|||
163872283|NCT00978042|591901810|FG001|Initial Treatment Period|Lost to Follow-up|3|||
163872284|NCT00978042|591901809|FG000|Initial Treatment Period|Adverse Event|2|||
163872285|NCT00978042|591901810|FG001|Initial Treatment Period|Adverse Event|0|||
163872286|NCT00978042|591901809|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
163872287|NCT00978042|591901810|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
163872288|NCT00978042|591901809|FG000|Initial Treatment Period|Consent withdrawn|22|||
163872289|NCT00978042|591901810|FG001|Initial Treatment Period|Consent withdrawn|9|||
163872290|NCT00978042|591901809|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
163872291|NCT00978042|591901810|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
163872292|NCT03051165|591901812|FG000|Overall Study|Withdrawal by Subject|1|||
163872293|NCT03051165|591901812|FG000|Overall Study|Early termination of study|12|||
163872294|NCT03283371|591901813|FG000|Placebo-controlled|Adverse Event|1|||
163872295|NCT03283371|591901814|FG001|Placebo-controlled|Adverse Event|1|||
163872296|NCT03283371|591901815|FG002|Placebo-controlled|Adverse Event|0|||
163872297|NCT03283371|591901816|FG003|Placebo-controlled|Adverse Event|0|||
163872298|NCT03283371|591901813|FG000|Placebo-controlled|Lack of Efficacy|1|||
163872299|NCT03283371|591901814|FG001|Placebo-controlled|Lack of Efficacy|0|||
163872300|NCT03283371|591901815|FG002|Placebo-controlled|Lack of Efficacy|0|||
163872301|NCT03283371|591901816|FG003|Placebo-controlled|Lack of Efficacy|0|||
163872302|NCT03283371|591901813|FG000|Placebo-controlled|Withdrawal by Subject|1|||
163872303|NCT03283371|591901814|FG001|Placebo-controlled|Withdrawal by Subject|1|||
163872304|NCT03283371|591901815|FG002|Placebo-controlled|Withdrawal by Subject|0|||
163872305|NCT03283371|591901816|FG003|Placebo-controlled|Withdrawal by Subject|0|||
163872306|NCT03283371|591901813|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
163872307|NCT03283371|591901814|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
163872308|NCT03283371|591901815|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
163872309|NCT03283371|591901816|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
163872310|NCT03283371|591901813|FG000|Open-label Phase|Adverse Event|0|||
163872311|NCT03283371|591901814|FG001|Open-label Phase|Adverse Event|0|||
163872312|NCT03283371|591901815|FG002|Open-label Phase|Adverse Event|2|||
163872313|NCT03283371|591901816|FG003|Open-label Phase|Adverse Event|0|||
163872314|NCT03283371|591901813|FG000|Open-label Phase|Withdrawal by Subject|0|||
163872315|NCT03283371|591901814|FG001|Open-label Phase|Withdrawal by Subject|0|||
163872316|NCT03283371|591901815|FG002|Open-label Phase|Withdrawal by Subject|1|||
163872317|NCT03283371|591901816|FG003|Open-label Phase|Withdrawal by Subject|0|||
163872318|NCT03283371|591901813|FG000|Open-label Phase|Other|0|||
163872319|NCT03283371|591901814|FG001|Open-label Phase|Other|0|||
163872320|NCT03283371|591901815|FG002|Open-label Phase|Other|1|||
163872321|NCT03283371|591901816|FG003|Open-label Phase|Other|1|||
163872322|NCT01290341|591901817|FG000|Overall Study|Protocol Violation|7|||
163872323|NCT01290341|591901818|FG001|Overall Study|Protocol Violation|3|||
163872324|NCT01290341|591901817|FG000|Overall Study|Adverse Event|1|||
163872325|NCT01290341|591901818|FG001|Overall Study|Adverse Event|0|||
163872326|NCT01290341|591901817|FG000|Overall Study|Lost to Follow-up|21|||
163872327|NCT01290341|591901818|FG001|Overall Study|Lost to Follow-up|10|||
164314927|NCT01065454|593529824|FG000|Treatment|Adverse Event|7|||
163872328|NCT01290341|591901817|FG000|Overall Study|Withdrawal by Subject|19|||
163872329|NCT01290341|591901818|FG001|Overall Study|Withdrawal by Subject|5|||
163872330|NCT01290341|591901817|FG000|Overall Study|Negative baseline culture and others|44|||
164135938|NCT02799095|592861960|FG005|Part C|Physician Decision|0|||
164314928|NCT01065454|593529825|FG001|Treatment|Adverse Event|4|||
164314929|NCT01065454|593529826|FG002|Treatment|Adverse Event|3|||
163872331|NCT01290341|591901818|FG001|Overall Study|Negative baseline culture and others|11|||
163872332|NCT03684044|591901830|FG000|Overall Study|Adverse Event|3|||
163872333|NCT03684044|591901831|FG001|Overall Study|Adverse Event|0|||
163872334|NCT03684044|591901830|FG000|Overall Study|Death|4|||
163872335|NCT03684044|591901831|FG001|Overall Study|Death|7|||
163872336|NCT03684044|591901830|FG000|Overall Study|Lost to Follow-up|3|||
163872337|NCT03684044|591901831|FG001|Overall Study|Lost to Follow-up|2|||
163872338|NCT03684044|591901830|FG000|Overall Study|Patient Not Available|0|||
163872339|NCT03684044|591901831|FG001|Overall Study|Patient Not Available|2|||
163872340|NCT03684044|591901830|FG000|Overall Study|Physician Decision|1|||
163872341|NCT03684044|591901831|FG001|Overall Study|Physician Decision|0|||
163872342|NCT03684044|591901830|FG000|Overall Study|Withdrawal by Subject|11|||
163872343|NCT03684044|591901831|FG001|Overall Study|Withdrawal by Subject|9|||
163872344|NCT03703336|591901832|FG000|Overall Study|Parent withdrew consent|29|||
163872345|NCT03703336|591901833|FG001|Overall Study|Parent withdrew consent|8|||
163872346|NCT03703336|591901832|FG000|Overall Study|Migration|3|||
163872347|NCT03703336|591901833|FG001|Overall Study|Migration|3|||
163872348|NCT03703336|591901832|FG000|Overall Study|Protocol Violation|3|||
163872349|NCT03703336|591901833|FG001|Overall Study|Protocol Violation|1|||
163872350|NCT03703336|591901832|FG000|Overall Study|Physician Decision|2|||
163872351|NCT03703336|591901833|FG001|Overall Study|Physician Decision|0|||
163872352|NCT03703336|591901832|FG000|Overall Study|Adverse Event|0|||
163872353|NCT03703336|591901833|FG001|Overall Study|Adverse Event|2|||
163872354|NCT03703336|591901832|FG000|Overall Study|Lost to Follow-up|1|||
163872355|NCT03703336|591901833|FG001|Overall Study|Lost to Follow-up|0|||
163872356|NCT00595413|591901834|FG000|Overall Study|Adverse Event|0|||
163872357|NCT00595413|591901835|FG001|Overall Study|Adverse Event|2|||
163872358|NCT00595413|591901836|FG002|Overall Study|Adverse Event|1|||
163872359|NCT00595413|591901837|FG003|Overall Study|Adverse Event|1|||
163872360|NCT00595413|591901834|FG000|Overall Study|Lost to Follow-up|2|||
163872361|NCT00595413|591901835|FG001|Overall Study|Lost to Follow-up|2|||
163872362|NCT00595413|591901836|FG002|Overall Study|Lost to Follow-up|1|||
163872363|NCT00595413|591901837|FG003|Overall Study|Lost to Follow-up|3|||
163872364|NCT00595413|591901834|FG000|Overall Study|Death|0|||
163872365|NCT00595413|591901835|FG001|Overall Study|Death|0|||
163872366|NCT00595413|591901836|FG002|Overall Study|Death|1|||
163872367|NCT00595413|591901837|FG003|Overall Study|Death|0|||
163872368|NCT00595413|591901834|FG000|Overall Study|Other|5|||
163872369|NCT00595413|591901835|FG001|Overall Study|Other|1|||
163872370|NCT00595413|591901836|FG002|Overall Study|Other|5|||
163872371|NCT00595413|591901837|FG003|Overall Study|Other|0|||
163872372|NCT00807937|591901838|FG000|Overall Study|Adverse Event|12|||
163872373|NCT00807937|591901839|FG001|Overall Study|Adverse Event|12|||
163872374|NCT00807937|591901840|FG002|Overall Study|Adverse Event|5|||
163872375|NCT00807937|591901841|FG003|Overall Study|Adverse Event|4|||
163872376|NCT00807937|591901838|FG000|Overall Study|Protocol Violation|4|||
163872377|NCT00807937|591901839|FG001|Overall Study|Protocol Violation|5|||
163872378|NCT00807937|591901840|FG002|Overall Study|Protocol Violation|3|||
163872379|NCT00807937|591901841|FG003|Overall Study|Protocol Violation|3|||
163872380|NCT00807937|591901838|FG000|Overall Study|Withdrawal by Subject|5|||
163872381|NCT00807937|591901839|FG001|Overall Study|Withdrawal by Subject|4|||
163872382|NCT00807937|591901840|FG002|Overall Study|Withdrawal by Subject|1|||
163872383|NCT00807937|591901841|FG003|Overall Study|Withdrawal by Subject|4|||
163872384|NCT00807937|591901838|FG000|Overall Study|Lost to Follow-up|4|||
163872385|NCT00807937|591901839|FG001|Overall Study|Lost to Follow-up|0|||
163872386|NCT00807937|591901840|FG002|Overall Study|Lost to Follow-up|2|||
163872387|NCT00807937|591901841|FG003|Overall Study|Lost to Follow-up|1|||
163872388|NCT00807937|591901838|FG000|Overall Study|Lack of Efficacy|0|||
163872389|NCT00807937|591901839|FG001|Overall Study|Lack of Efficacy|0|||
163872390|NCT00807937|591901840|FG002|Overall Study|Lack of Efficacy|1|||
163872391|NCT00807937|591901841|FG003|Overall Study|Lack of Efficacy|2|||
163872392|NCT00807937|591901838|FG000|Overall Study|Intake of prohibited medicine|0|||
163872393|NCT00807937|591901839|FG001|Overall Study|Intake of prohibited medicine|0|||
163872394|NCT00807937|591901840|FG002|Overall Study|Intake of prohibited medicine|2|||
163872395|NCT00807937|591901841|FG003|Overall Study|Intake of prohibited medicine|0|||
163872396|NCT00807937|591901838|FG000|Overall Study|All other reasons (not provided)|2|||
163872397|NCT00807937|591901839|FG001|Overall Study|All other reasons (not provided)|4|||
163872398|NCT00807937|591901840|FG002|Overall Study|All other reasons (not provided)|0|||
163872399|NCT00807937|591901841|FG003|Overall Study|All other reasons (not provided)|1|||
163872400|NCT04629950|591901844|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
163872401|NCT04629950|591901845|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
163872402|NCT04629950|591901846|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
163872403|NCT04629950|591901847|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
163872404|NCT04629950|591901844|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
163872405|NCT04629950|591901845|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
163872406|NCT04629950|591901846|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
163976373|NCT00705783|592285801|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163976374|NCT00705783|592285799|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
163976375|NCT00705783|592285800|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
163976376|NCT00705783|592285801|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
163976377|NCT00705783|592285799|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
163976378|NCT00705783|592285800|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
163976379|NCT00705783|592285801|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
163976380|NCT00705783|592285799|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
163976381|NCT00705783|592285800|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
163976382|NCT00705783|592285801|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
163976383|NCT00705783|592285799|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
163976384|NCT00705783|592285800|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
163872407|NCT04629950|591901847|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
163872408|NCT04629950|591901844|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
163872409|NCT04629950|591901845|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
163872410|NCT04629950|591901846|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
163872411|NCT04629950|591901847|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
163872412|NCT04629950|591901844|FG000|Extension Study|Withdrawal by Subject|0|||
163872413|NCT04629950|591901845|FG001|Extension Study|Withdrawal by Subject|0|||
163872414|NCT04629950|591901846|FG002|Extension Study|Withdrawal by Subject|1|||
163872415|NCT04629950|591901847|FG003|Extension Study|Withdrawal by Subject|0|||
163872416|NCT04629950|591901844|FG000|Extension Study|Adverse Event|0|||
163872417|NCT04629950|591901845|FG001|Extension Study|Adverse Event|0|||
163872418|NCT04629950|591901846|FG002|Extension Study|Adverse Event|0|||
163872419|NCT04629950|591901847|FG003|Extension Study|Adverse Event|1|||
163872420|NCT03233633|591901848|FG000|Overall Study|Adverse Event|2|||
163872421|NCT03233633|591901848|FG000|Overall Study|Less Than 3 Days of Data|6|||
163872422|NCT02708108|591901849|FG000|Overall Study|Death|1|||
163872423|NCT02708108|591901850|FG001|Overall Study|Death|2|||
163872424|NCT02708108|591901849|FG000|Overall Study|Regimen change|1|||
163872425|NCT02708108|591901850|FG001|Overall Study|Regimen change|0|||
163872426|NCT02708108|591901849|FG000|Overall Study|No MRD and no imaging available|0|||
163872427|NCT02708108|591901850|FG001|Overall Study|No MRD and no imaging available|1|||
163872428|NCT02568683|591901852|FG000|Overall Study|Death|0|||
163872429|NCT02568683|591901853|FG001|Overall Study|Death|2|||
163872430|NCT02568683|591901852|FG000|Overall Study|Withdrew Consent|1|||
163872431|NCT02568683|591901853|FG001|Overall Study|Withdrew Consent|0|||
163872432|NCT02568683|591901852|FG000|Overall Study|Study Terminated By Sponsor|5|||
163872433|NCT02568683|591901853|FG001|Overall Study|Study Terminated By Sponsor|2|||
163872434|NCT01561989|591901856|FG000|Overall Study|accural target not met.|5|||
163872435|NCT01561989|591901857|FG001|Overall Study|accural target not met.|6|||
163872436|NCT04556981|591901859|FG000|Overall Study|Death|0|||
163872437|NCT04556981|591901860|FG001|Overall Study|Death|1|||
163872438|NCT04556981|591901859|FG000|Overall Study|Lost to Follow-up|2|||
163872439|NCT04556981|591901860|FG001|Overall Study|Lost to Follow-up|11|||
163872440|NCT04556981|591901859|FG000|Overall Study|Moved from the study area|1|||
163872441|NCT04556981|591901860|FG001|Overall Study|Moved from the study area|4|||
163872442|NCT04556981|591901859|FG000|Overall Study|Withdrawal by Subject|2|||
163872443|NCT04556981|591901860|FG001|Overall Study|Withdrawal by Subject|2|||
163872444|NCT04556981|591901859|FG000|Overall Study|Other|2|||
163872445|NCT04556981|591901860|FG001|Overall Study|Other|1|||
163872446|NCT00580866|591901861|FG000|Overall Study|Lost to Follow-up|2|||
163872447|NCT00580866|591901862|FG001|Overall Study|Lost to Follow-up|2|||
163872448|NCT02477605|591901869|FG000|Overall Study|Discontinued prior to treatment|1|||
163872449|NCT02477605|591901870|FG001|Overall Study|Discontinued prior to treatment|0|||
163872450|NCT02477605|591901869|FG000|Overall Study|Lost to Follow-up|0|||
163872451|NCT02477605|591901870|FG001|Overall Study|Lost to Follow-up|2|||
163872452|NCT02477605|591901869|FG000|Overall Study|Withdrawal by Subject|0|||
163872453|NCT02477605|591901870|FG001|Overall Study|Withdrawal by Subject|1|||
163872454|NCT02477605|591901869|FG000|Overall Study|Administered gas during surgery|0|||
163872455|NCT02477605|591901870|FG001|Overall Study|Administered gas during surgery|1|||
163872456|NCT02574455|591901871|FG000|Overall Study|Death|197|||
163872457|NCT02574455|591901872|FG001|Overall Study|Death|210|||
163872458|NCT02574455|591901871|FG000|Overall Study|Withdrawal of Consent|11|||
163872459|NCT02574455|591901872|FG001|Overall Study|Withdrawal of Consent|28|||
163872460|NCT02574455|591901871|FG000|Overall Study|Lost to Follow-up|4|||
163872461|NCT02574455|591901872|FG001|Overall Study|Lost to Follow-up|4|||
163872462|NCT02574455|591901871|FG000|Overall Study|Sponsor's Decision|55|||
163976385|NCT00705783|592285801|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
163976386|NCT00705783|592285799|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
163872463|NCT02574455|591901872|FG001|Overall Study|Sponsor's Decision|20|||
163872464|NCT00970359|591901879|FG000|Overall Study|Not Treated|4|||
163872465|NCT01388361|591901880|FG000|Overall Study|Adverse Event|0|||
163872466|NCT01388361|591901881|FG001|Overall Study|Adverse Event|5|||
163872467|NCT01388361|591901882|FG002|Overall Study|Adverse Event|1|||
163872468|NCT01388361|591901880|FG000|Overall Study|Protocol Violation|0|||
163872469|NCT01388361|591901881|FG001|Overall Study|Protocol Violation|0|||
163872470|NCT01388361|591901882|FG002|Overall Study|Protocol Violation|2|||
163872471|NCT01388361|591901880|FG000|Overall Study|Withdrawal criteria|12|||
163872472|NCT01388361|591901881|FG001|Overall Study|Withdrawal criteria|7|||
163872473|NCT01388361|591901882|FG002|Overall Study|Withdrawal criteria|10|||
163872474|NCT01388361|591901880|FG000|Overall Study|Unclassified|0|||
163872475|NCT01388361|591901881|FG001|Overall Study|Unclassified|0|||
163872476|NCT01388361|591901882|FG002|Overall Study|Unclassified|1|||
163872477|NCT01499199|591901888|FG000|Overall Study|Adverse Event|1|||
163872478|NCT01499199|591901888|FG000|Overall Study|Lack of Efficacy|1|||
163872479|NCT01199705|591901889|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
163872480|NCT01239316|591901890|FG000|Overall Study|Progression/Relapse|11|||
163872481|NCT01239316|591901890|FG000|Overall Study|Adverse Event|1|||
163872482|NCT05505045|591903869|FG000|Overall Study|Withdrawal by Subject|2|||
163872483|NCT05505045|591903870|FG001|Overall Study|Withdrawal by Subject|1|||
163872484|NCT01643070|591903871|FG000|Overall Study|Withdrawal by Subject|3|||
163872485|NCT01643070|591903872|FG001|Overall Study|Withdrawal by Subject|1|||
163872486|NCT01643070|591903871|FG000|Overall Study|Death|1|||
163872487|NCT01643070|591903872|FG001|Overall Study|Death|0|||
163872488|NCT01643070|591903871|FG000|Overall Study|Pregressive disease|0|||
163872489|NCT01643070|591903872|FG001|Overall Study|Pregressive disease|2|||
163872490|NCT04842500|591903873|FG000|Overall Study|Withdrawal by Subject|4|||
163872491|NCT04842500|591903874|FG001|Overall Study|Withdrawal by Subject|1|||
163872492|NCT04842500|591903875|FG002|Overall Study|Withdrawal by Subject|2|||
163872493|NCT04842500|591903876|FG003|Overall Study|Withdrawal by Subject|3|||
163872494|NCT04842500|591903873|FG000|Overall Study|Protocol Violation|1|||
163872495|NCT04842500|591903874|FG001|Overall Study|Protocol Violation|0|||
163872496|NCT04842500|591903875|FG002|Overall Study|Protocol Violation|0|||
163872497|NCT04842500|591903876|FG003|Overall Study|Protocol Violation|1|||
163872498|NCT02980276|591903877|FG000|Overall Study|Withdrawal by Subject|4|||
163872499|NCT02980276|591903878|FG001|Overall Study|Withdrawal by Subject|4|||
163872500|NCT02980276|591903877|FG000|Overall Study|Physician Decision|0|||
163872501|NCT02980276|591903878|FG001|Overall Study|Physician Decision|1|||
163872502|NCT02980276|591903877|FG000|Overall Study|Lost to Follow-up|18|||
163872503|NCT02980276|591903878|FG001|Overall Study|Lost to Follow-up|18|||
163872504|NCT02980276|591903877|FG000|Overall Study|Death|1|||
163872505|NCT02980276|591903878|FG001|Overall Study|Death|0|||
163872506|NCT02980276|591903877|FG000|Overall Study|Miscellaneous other|10|||
163872507|NCT02980276|591903878|FG001|Overall Study|Miscellaneous other|4|||
163872508|NCT04139668|591903880|FG000|Overall Study|Withdrawal by Subject|1|||
163872509|NCT02824029|591903883|FG000|Overall Study|Didn't receive treatment|2|||
163872510|NCT02824029|591903883|FG000|Overall Study|Patient decision to discontinue treatment|3|||
163872511|NCT02824029|591903883|FG000|Overall Study|Non-compliant|5|||
163872512|NCT02824029|591903883|FG000|Overall Study|Progression of disease|15|||
163872513|NCT02824029|591903883|FG000|Overall Study|Inadequate response to therapy|2|||
163872514|NCT02824029|591903883|FG000|Overall Study|Possible progression per treating physician|1|||
163872515|NCT04440176|591903884|FG000|Overall Study|Withdrawal by Subject|5|||
163872516|NCT04440176|591903885|FG001|Overall Study|Withdrawal by Subject|3|||
163872517|NCT04440176|591903884|FG000|Overall Study|Withdrawal by parent/guardian|4|||
163872518|NCT04440176|591903885|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163872519|NCT04440176|591903884|FG000|Overall Study|Adverse Event|2|||
163872520|NCT04440176|591903885|FG001|Overall Study|Adverse Event|6|||
163872521|NCT04440176|591903884|FG000|Overall Study|Lost to Follow-up|22|||
163872522|NCT04440176|591903885|FG001|Overall Study|Lost to Follow-up|23|||
163872523|NCT04440176|591903884|FG000|Overall Study|Medication error without associated adverse event|0|||
163872524|NCT04440176|591903885|FG001|Overall Study|Medication error without associated adverse event|1|||
163872525|NCT04440176|591903884|FG000|Overall Study|No longer met eligibility criteria|7|||
163872526|NCT04440176|591903885|FG001|Overall Study|No longer met eligibility criteria|1|||
163872527|NCT04440176|591903884|FG000|Overall Study|Other|1|||
163872528|NCT04440176|591903885|FG001|Overall Study|Other|2|||
163872529|NCT04440176|591903884|FG000|Overall Study|Protocol deviation|6|||
163872530|NCT04440176|591903885|FG001|Overall Study|Protocol deviation|8|||
163872531|NCT04440176|591903884|FG000|Overall Study|Randomized but not vaccinated|6|||
163872532|NCT04440176|591903885|FG001|Overall Study|Randomized but not vaccinated|3|||
163872533|NCT04188379|591903886|FG000|Overall Study|Withdrawal by Subject|10|||
163872534|NCT04188379|591903887|FG001|Overall Study|Withdrawal by Subject|3|||
163872535|NCT04188379|591903886|FG000|Overall Study|Physician Decision|0|||
163872536|NCT04188379|591903887|FG001|Overall Study|Physician Decision|1|||
163872537|NCT04188379|591903886|FG000|Overall Study|Adverse Event|3|||
163872538|NCT04188379|591903887|FG001|Overall Study|Adverse Event|1|||
163872539|NCT04188379|591903886|FG000|Overall Study|Pregnancy|1|||
163872540|NCT04188379|591903887|FG001|Overall Study|Pregnancy|0|||
163872541|NCT04188379|591903886|FG000|Overall Study|Lack of Efficacy|8|||
163872542|NCT04188379|591903887|FG001|Overall Study|Lack of Efficacy|5|||
163872543|NCT04188379|591903886|FG000|Overall Study|Other|0|||
163872544|NCT04188379|591903887|FG001|Overall Study|Other|3|||
163976387|NCT00705783|592285800|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
163976388|NCT00705783|592285801|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
163976389|NCT00705783|592285799|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
163976390|NCT00705783|592285800|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
163976391|NCT00705783|592285801|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
163976392|NCT00705783|592285799|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
163976393|NCT00705783|592285800|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
163976394|NCT00705783|592285801|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
163976395|NCT00705783|592285799|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
163976396|NCT00705783|592285800|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
163976397|NCT00705783|592285801|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
163976398|NCT00705783|592285799|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
163976399|NCT00705783|592285800|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
163976400|NCT00705783|592285801|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
163976401|NCT02182687|592285802|FG000|Overall Study|Withdrawal by Subject|4|||
163976402|NCT02182687|592285803|FG001|Overall Study|Withdrawal by Subject|0|||
163976403|NCT02182687|592285802|FG000|Overall Study|Adverse Event|1|||
163976404|NCT02182687|592285803|FG001|Overall Study|Adverse Event|0|||
163976405|NCT02182687|592285802|FG000|Overall Study|Lost to Follow-up|0|||
163976406|NCT02182687|592285803|FG001|Overall Study|Lost to Follow-up|1|||
163976407|NCT04251910|592285807|FG000|Overall Study|Covid 19 lockdown|0|||
163976408|NCT04251910|592285808|FG001|Overall Study|Covid 19 lockdown|5|||
163976409|NCT04251910|592285809|FG002|Overall Study|Covid 19 lockdown|0|||
163976410|NCT04251910|592285810|FG003|Overall Study|Covid 19 lockdown|4|||
163976411|NCT04251910|592285811|FG004|Overall Study|Covid 19 lockdown|0|||
163976412|NCT04251910|592285812|FG005|Overall Study|Covid 19 lockdown|0|||
163976413|NCT04251910|592285807|FG000|Overall Study|Assisted living facility was closed|0|||
163976414|NCT04251910|592285808|FG001|Overall Study|Assisted living facility was closed|0|||
163976415|NCT04251910|592285809|FG002|Overall Study|Assisted living facility was closed|0|||
163976416|NCT04251910|592285810|FG003|Overall Study|Assisted living facility was closed|0|||
163976417|NCT04251910|592285811|FG004|Overall Study|Assisted living facility was closed|1|||
163976418|NCT04251910|592285812|FG005|Overall Study|Assisted living facility was closed|0|||
163976419|NCT03451084|592285820|FG000|Overall Study|Withdrawal by Subject|2|||
163976420|NCT03451084|592285821|FG001|Overall Study|Withdrawal by Subject|1|||
163976421|NCT03451084|592285822|FG002|Overall Study|Withdrawal by Subject|2|||
163976422|NCT03451084|592285823|FG003|Overall Study|Withdrawal by Subject|1|||
163976423|NCT03451084|592285820|FG000|Overall Study|Disease recurrence|0|||
163976424|NCT03451084|592285821|FG001|Overall Study|Disease recurrence|2|||
163976425|NCT03451084|592285822|FG002|Overall Study|Disease recurrence|0|||
163976426|NCT03451084|592285823|FG003|Overall Study|Disease recurrence|0|||
163976427|NCT03451084|592285820|FG000|Overall Study|Lack of Efficacy|0|||
163976428|NCT03451084|592285821|FG001|Overall Study|Lack of Efficacy|3|||
163976429|NCT03451084|592285822|FG002|Overall Study|Lack of Efficacy|0|||
163976430|NCT03451084|592285823|FG003|Overall Study|Lack of Efficacy|1|||
163976431|NCT03451084|592285820|FG000|Overall Study|Death|1|||
163976432|NCT03451084|592285821|FG001|Overall Study|Death|0|||
163976433|NCT03451084|592285822|FG002|Overall Study|Death|2|||
163976434|NCT03451084|592285823|FG003|Overall Study|Death|0|||
163976435|NCT03451084|592285820|FG000|Overall Study|Physician Decision|0|||
163976436|NCT03451084|592285821|FG001|Overall Study|Physician Decision|0|||
163976437|NCT03451084|592285822|FG002|Overall Study|Physician Decision|2|||
163976438|NCT03451084|592285823|FG003|Overall Study|Physician Decision|2|||
163976439|NCT03451084|592285820|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
163976440|NCT03451084|592285821|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
163976441|NCT03451084|592285822|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
163976442|NCT03451084|592285823|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
163976443|NCT04544475|592285828|FG000|Overall Study|Withdrawal by Subject|1|||
163976444|NCT04544475|592285829|FG001|Overall Study|Withdrawal by Subject|3|||
163976445|NCT01765920|592285830|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
163976446|NCT01765920|592285831|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
163976447|NCT01765920|592285830|FG000|Overall Study|Patient code disclosure|0|||
163976448|NCT01765920|592285831|FG001|Overall Study|Patient code disclosure|1|||
163976449|NCT03223428|592285832|FG000|Overall Study|No longer taking Xermelo|27|||
163976450|NCT03223428|592285832|FG000|Overall Study|Declined Consent|1|||
163976451|NCT03223428|592285832|FG000|Overall Study|Non-responders|56|||
163976452|NCT03223428|592285832|FG000|Overall Study|Withdrawal by Subject|14|||
163976453|NCT02025907|592285833|FG000|Overall Study|Lack of Efficacy|1|||
163976454|NCT02025907|592285834|FG001|Overall Study|Lack of Efficacy|0|||
163976455|NCT02025907|592285833|FG000|Overall Study|Withdrawal by Subject|15|||
163976456|NCT02025907|592285834|FG001|Overall Study|Withdrawal by Subject|8|||
163976457|NCT02025907|592285833|FG000|Overall Study|Protocol Violation|2|||
163976458|NCT02025907|592285834|FG001|Overall Study|Protocol Violation|0|||
163976459|NCT02025907|592285833|FG000|Overall Study|Physician Decision|2|||
163976460|NCT02025907|592285834|FG001|Overall Study|Physician Decision|0|||
163976461|NCT02025907|592285833|FG000|Overall Study|Lost to Follow-up|2|||
163976462|NCT02025907|592285834|FG001|Overall Study|Lost to Follow-up|2|||
163976463|NCT02025907|592285833|FG000|Overall Study|Adverse Event|3|||
163976464|NCT02025907|592285834|FG001|Overall Study|Adverse Event|1|||
163976465|NCT02025907|592285833|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
163976466|NCT02025907|592285834|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
163976467|NCT00777101|592285835|FG000|Overall Study|Death|48|||
163976468|NCT00777101|592285836|FG001|Overall Study|Death|43|||
163976469|NCT00777101|592285835|FG000|Overall Study|Withdrawal by Subject|11|||
163976470|NCT00777101|592285836|FG001|Overall Study|Withdrawal by Subject|6|||
163976471|NCT00777101|592285835|FG000|Overall Study|Lost to Follow-up|2|||
163976472|NCT00777101|592285836|FG001|Overall Study|Lost to Follow-up|1|||
163976473|NCT00777101|592285835|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163976474|NCT00777101|592285836|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163976475|NCT00777101|592285835|FG000|Overall Study|Failed to Return|0|||
163976476|NCT00777101|592285836|FG001|Overall Study|Failed to Return|1|||
163976477|NCT02411539|592285840|FG000|Overall Study|Lost to Follow-up|2|||
163976478|NCT02411539|592285841|FG001|Overall Study|Lost to Follow-up|0|||
163976479|NCT02411539|592285840|FG000|Overall Study|Confounding medical condition|0|||
163976480|NCT02411539|592285841|FG001|Overall Study|Confounding medical condition|1|||
163976481|NCT00282334|592285846|FG000|Overall Study|Withdrawal by Subject|8|||
163976482|NCT00282334|592285847|FG001|Overall Study|Withdrawal by Subject|5|||
163976483|NCT01422915|592285852|FG000|Overall Study|Adverse Event|1|||
163976484|NCT01265797|592285853|FG000|Run-in Month|Withdrawal by Subject|0|||
163976485|NCT01265797|592285854|FG001|Run-in Month|Withdrawal by Subject|4|||
163976486|NCT01265797|592285853|FG000|Run-in Month|1st seizure during run-in month|0|||
163976487|NCT01265797|592285854|FG001|Run-in Month|1st seizure during run-in month|1|||
163976488|NCT01265797|592285853|FG000|Blinded Month|Lack of Efficacy|5|||
163976489|NCT01265797|592285854|FG001|Blinded Month|Lack of Efficacy|0|||
163976490|NCT01265797|592285853|FG000|Blinded Month|Lost to Follow-up|1|||
163976491|NCT01265797|592285854|FG001|Blinded Month|Lost to Follow-up|0|||
163976492|NCT01265797|592285853|FG000|Blinded Month|Protocol Violation|2|||
163976493|NCT01265797|592285854|FG001|Blinded Month|Protocol Violation|1|||
163976494|NCT01265797|592285853|FG000|Blinded Month|Adverse Event|2|||
163976495|NCT01265797|592285854|FG001|Blinded Month|Adverse Event|0|||
163976496|NCT01265797|592285853|FG000|Blinded Month|Diary data incomplete|0|||
163976497|NCT01265797|592285854|FG001|Blinded Month|Diary data incomplete|1|||
163976498|NCT01265797|592285853|FG000|Open Label Month|Lost to Follow-up|0|||
163976499|NCT01265797|592285854|FG001|Open Label Month|Lost to Follow-up|1|||
163976500|NCT00583362|592285860|FG000|Overall Study|Adverse Event|44|||
163976501|NCT00583362|592285860|FG000|Overall Study|Lack of Efficacy|22|||
163976502|NCT00583362|592285860|FG000|Overall Study|Lost to Follow-up|4|||
163976503|NCT00583362|592285860|FG000|Overall Study|Non-compliance with study drug|28|||
163976504|NCT00583362|592285860|FG000|Overall Study|Pregnancy|7|||
163976505|NCT00583362|592285860|FG000|Overall Study|Miscommunication of visit window|5|||
163976506|NCT00583362|592285860|FG000|Overall Study|Current site closed|7|||
163976507|NCT00583362|592285860|FG000|Overall Study|Subject not dosed in LBSL99|1|||
163976508|NCT00583362|592285860|FG000|Overall Study|Subject moved out of the country/state|2|||
163976509|NCT00583362|592285860|FG000|Overall Study|Missed visits due to staff changes|1|||
163976510|NCT00583362|592285860|FG000|Overall Study|Misunderstanding of protocol|1|||
163976511|NCT00583362|592285860|FG000|Overall Study|Behavioral problems and non-compliance|1|||
163976512|NCT00583362|592285860|FG000|Overall Study|Sponsor request due to missed doses|1|||
163976513|NCT00583362|592285860|FG000|Overall Study|Physician Decision|19|||
163976514|NCT00583362|592285860|FG000|Overall Study|Protocol Violation|2|||
163976515|NCT00583362|592285860|FG000|Overall Study|Withdrawal by Subject|57|||
163976516|NCT00506883|592285866|FG000|Overall Study|Lost to Follow-up|1|||
163976517|NCT00506883|592285867|FG001|Overall Study|Lost to Follow-up|1|||
163976518|NCT00506883|592285868|FG002|Overall Study|Lost to Follow-up|1|||
163976519|NCT00506883|592285866|FG000|Overall Study|Withdrawal by Subject|1|||
163976520|NCT00506883|592285867|FG001|Overall Study|Withdrawal by Subject|0|||
163976521|NCT00506883|592285868|FG002|Overall Study|Withdrawal by Subject|1|||
163976522|NCT00506883|592285866|FG000|Overall Study|Lack of Efficacy|0|||
163976523|NCT00506883|592285867|FG001|Overall Study|Lack of Efficacy|1|||
163976524|NCT00506883|592285868|FG002|Overall Study|Lack of Efficacy|1|||
163976525|NCT00506883|592285866|FG000|Overall Study|Other|5|||
163976526|NCT00506883|592285867|FG001|Overall Study|Other|1|||
163976527|NCT00506883|592285868|FG002|Overall Study|Other|1|||
163976528|NCT00455013|592285869|FG000|Short Term Period|Adverse Event|2|||
163976529|NCT00455013|592285870|FG001|Short Term Period|Adverse Event|5|||
163976530|NCT00455013|592285871|FG002|Short Term Period|Adverse Event|0|||
163976531|NCT00455013|592285869|FG000|Short Term Period|Withdrawal by Subject|0|||
163976532|NCT00455013|592285870|FG001|Short Term Period|Withdrawal by Subject|0|||
163976533|NCT00455013|592285871|FG002|Short Term Period|Withdrawal by Subject|1|||
163976534|NCT00455013|592285869|FG000|Short Term Period|Lack of Efficacy|4|||
163976535|NCT00455013|592285870|FG001|Short Term Period|Lack of Efficacy|0|||
163976536|NCT00455013|592285871|FG002|Short Term Period|Lack of Efficacy|0|||
163976537|NCT00455013|592285869|FG000|Short Term Period|Other|0|||
163976538|NCT00455013|592285870|FG001|Short Term Period|Other|0|||
163976539|NCT00455013|592285871|FG002|Short Term Period|Other|1|||
163976540|NCT00455013|592285869|FG000|Long Term Extension (LTE)|Adverse Event|0|||
163976541|NCT00455013|592285870|FG001|Long Term Extension (LTE)|Adverse Event|1|||
163976542|NCT00455013|592285871|FG002|Long Term Extension (LTE)|Adverse Event|1|||
163976543|NCT00455013|592285869|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
163976544|NCT00455013|592285870|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
163976545|NCT00455013|592285871|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
163976546|NCT00455013|592285869|FG000|Long Term Extension (LTE)|Death|1|||
163976547|NCT00455013|592285870|FG001|Long Term Extension (LTE)|Death|1|||
163976548|NCT00455013|592285871|FG002|Long Term Extension (LTE)|Death|0|||
163976549|NCT00455013|592285869|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
163976550|NCT00455013|592285870|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
163976551|NCT00455013|592285871|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
163976552|NCT00455013|592285869|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
163976553|NCT00455013|592285870|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
163976554|NCT00455013|592285871|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
163976555|NCT00455013|592285869|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
163976556|NCT00455013|592285870|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
163976557|NCT00455013|592285871|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
163976558|NCT00455013|592285869|FG000|Long Term Extension (LTE)|non-specified|0|||
163976559|NCT00455013|592285870|FG001|Long Term Extension (LTE)|non-specified|0|||
163976560|NCT00455013|592285871|FG002|Long Term Extension (LTE)|non-specified|1|||
163976561|NCT00078325|592285872|FG000|Overall Study|Adverse Event|15|||
163976562|NCT00078325|592285873|FG001|Overall Study|Adverse Event|10|||
163976563|NCT00078325|592285874|FG002|Overall Study|Adverse Event|5|||
163976564|NCT00078325|592285872|FG000|Overall Study|Protocol Violation|2|||
163976565|NCT00078325|592285873|FG001|Overall Study|Protocol Violation|2|||
163976566|NCT00078325|592285874|FG002|Overall Study|Protocol Violation|0|||
163976567|NCT00078325|592285872|FG000|Overall Study|Withdrawal by Subject|1|||
163976568|NCT00078325|592285873|FG001|Overall Study|Withdrawal by Subject|5|||
163976569|NCT00078325|592285874|FG002|Overall Study|Withdrawal by Subject|3|||
163976570|NCT00078325|592285872|FG000|Overall Study|Lost to Follow-up|0|||
163976571|NCT00078325|592285873|FG001|Overall Study|Lost to Follow-up|1|||
163976572|NCT00078325|592285874|FG002|Overall Study|Lost to Follow-up|1|||
163976573|NCT00078325|592285872|FG000|Overall Study|Physician Decision|2|||
163976574|NCT00078325|592285873|FG001|Overall Study|Physician Decision|0|||
163976575|NCT00078325|592285874|FG002|Overall Study|Physician Decision|1|||
163976576|NCT00078325|592285872|FG000|Overall Study|Miscellaneous|1|||
163976577|NCT00078325|592285873|FG001|Overall Study|Miscellaneous|1|||
163976578|NCT00078325|592285874|FG002|Overall Study|Miscellaneous|1|||
163976579|NCT01473563|592285875|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
163976580|NCT01519765|592285876|FG000|Overall Study|Adverse Event|0|||
163976581|NCT01519765|592285877|FG001|Overall Study|Adverse Event|1|||
163976582|NCT01519765|592285876|FG000|Overall Study|Lack of Efficacy|2|||
163976583|NCT01519765|592285877|FG001|Overall Study|Lack of Efficacy|0|||
163976584|NCT01519765|592285876|FG000|Overall Study|Protocol Violation|1|||
163976585|NCT01519765|592285877|FG001|Overall Study|Protocol Violation|0|||
163976586|NCT01519765|592285876|FG000|Overall Study|Withdrawal by Subject|0|||
163976587|NCT01519765|592285877|FG001|Overall Study|Withdrawal by Subject|1|||
163976588|NCT03610724|592285878|FG000|Overall Study|Death|17|||
163976589|NCT03610724|592285878|FG000|Overall Study|Lost to Follow-up|1|||
163976590|NCT03610724|592285878|FG000|Overall Study|Physician Decision|1|||
163976591|NCT03610724|592285878|FG000|Overall Study|Died prior to infusion|1|||
163976592|NCT05513625|592285884|FG000|Overall Study|Withdrawal by Subject|1|||
163976593|NCT00754793|592285885|FG000|Overall Study|voluntary withdrawn from study|0|||
163976594|NCT00754793|592285886|FG001|Overall Study|voluntary withdrawn from study|1|||
163976595|NCT02943564|592285887|FG000|Overall Study|Miscellaneous Reasons|0|||
163976596|NCT02943564|592285888|FG001|Overall Study|Miscellaneous Reasons|0|||
163976597|NCT02943564|592285889|FG002|Overall Study|Miscellaneous Reasons|3|||
163976598|NCT02943564|592285887|FG000|Overall Study|Site terminated by sponsor|0|||
163976599|NCT02943564|592285888|FG001|Overall Study|Site terminated by sponsor|1|||
163976600|NCT02943564|592285889|FG002|Overall Study|Site terminated by sponsor|0|||
163976601|NCT02943564|592285887|FG000|Overall Study|Non-compliance with study drug|0|||
163976602|NCT02943564|592285888|FG001|Overall Study|Non-compliance with study drug|1|||
163976603|NCT02943564|592285889|FG002|Overall Study|Non-compliance with study drug|0|||
163976604|NCT02943564|592285887|FG000|Overall Study|Pregnancy|0|||
163976605|NCT02943564|592285888|FG001|Overall Study|Pregnancy|1|||
163976606|NCT02943564|592285889|FG002|Overall Study|Pregnancy|1|||
163976607|NCT02943564|592285887|FG000|Overall Study|Protocol Violation|2|||
163976608|NCT02943564|592285888|FG001|Overall Study|Protocol Violation|2|||
163976609|NCT02943564|592285889|FG002|Overall Study|Protocol Violation|2|||
163976610|NCT02943564|592285887|FG000|Overall Study|Lost to Follow-up|1|||
163976611|NCT02943564|592285888|FG001|Overall Study|Lost to Follow-up|0|||
163976612|NCT02943564|592285889|FG002|Overall Study|Lost to Follow-up|0|||
163976613|NCT02943564|592285887|FG000|Overall Study|Withdrawal by Subject|6|||
163976614|NCT02943564|592285888|FG001|Overall Study|Withdrawal by Subject|5|||
163976615|NCT02943564|592285889|FG002|Overall Study|Withdrawal by Subject|2|||
163976616|NCT02943564|592285887|FG000|Overall Study|Adverse Event|1|||
163976617|NCT02943564|592285888|FG001|Overall Study|Adverse Event|2|||
163976618|NCT02943564|592285889|FG002|Overall Study|Adverse Event|1|||
163976619|NCT02943564|592285887|FG000|Overall Study|Lack of Efficacy|0|||
163976620|NCT02943564|592285888|FG001|Overall Study|Lack of Efficacy|1|||
163976621|NCT02943564|592285889|FG002|Overall Study|Lack of Efficacy|0|||
163976622|NCT00932360|592285890|FG000|Washout (One Week)|Withdrawal by Subject|0|||
163976623|NCT00932360|592285891|FG001|Washout (One Week)|Withdrawal by Subject|0|||
163976624|NCT00932360|592285892|FG002|Washout (One Week)|Withdrawal by Subject|0|||
163976625|NCT00932360|592285893|FG003|Washout (One Week)|Withdrawal by Subject|0|||
163976626|NCT00932360|592285894|FG004|Washout (One Week)|Withdrawal by Subject|2|||
163976627|NCT00932360|592285895|FG005|Washout (One Week)|Withdrawal by Subject|0|||
163976628|NCT02536313|592285896|FG000|Overall Study|Lack of Efficacy|0|||
163976629|NCT02536313|592285897|FG001|Overall Study|Lack of Efficacy|1|||
163976630|NCT00917150|592285898|FG000|Overall Study|Adverse Event|12|||
163976631|NCT00917150|592285899|FG001|Overall Study|Adverse Event|7|||
163976632|NCT00917150|592285900|FG002|Overall Study|Adverse Event|12|||
163976633|NCT00917150|592285901|FG003|Overall Study|Adverse Event|11|||
163976634|NCT00917150|592285898|FG000|Overall Study|Death|1|||
163976635|NCT00917150|592285899|FG001|Overall Study|Death|4|||
163976636|NCT00917150|592285900|FG002|Overall Study|Death|3|||
163976637|NCT00917150|592285901|FG003|Overall Study|Death|2|||
163976638|NCT00917150|592285898|FG000|Overall Study|Lost to Follow-up|1|||
163976639|NCT00917150|592285899|FG001|Overall Study|Lost to Follow-up|0|||
163976640|NCT00917150|592285900|FG002|Overall Study|Lost to Follow-up|4|||
163976641|NCT00917150|592285901|FG003|Overall Study|Lost to Follow-up|2|||
163976642|NCT00917150|592285898|FG000|Overall Study|Physician Decision|0|||
163976643|NCT00917150|592285899|FG001|Overall Study|Physician Decision|2|||
163976644|NCT00917150|592285900|FG002|Overall Study|Physician Decision|0|||
163976645|NCT00917150|592285901|FG003|Overall Study|Physician Decision|1|||
163976646|NCT00917150|592285898|FG000|Overall Study|Protocol Violation|5|||
163976647|NCT00917150|592285899|FG001|Overall Study|Protocol Violation|5|||
163976648|NCT00917150|592285900|FG002|Overall Study|Protocol Violation|3|||
163976649|NCT00917150|592285901|FG003|Overall Study|Protocol Violation|5|||
163976650|NCT00917150|592285898|FG000|Overall Study|Withdrawal by Subject|15|||
163976651|NCT00917150|592285899|FG001|Overall Study|Withdrawal by Subject|16|||
163976652|NCT00917150|592285900|FG002|Overall Study|Withdrawal by Subject|18|||
163976653|NCT00917150|592285901|FG003|Overall Study|Withdrawal by Subject|11|||
163976654|NCT00917150|592285898|FG000|Overall Study|Other than specified|3|||
163976655|NCT00917150|592285899|FG001|Overall Study|Other than specified|3|||
163976656|NCT00917150|592285900|FG002|Overall Study|Other than specified|2|||
163976657|NCT00917150|592285901|FG003|Overall Study|Other than specified|2|||
163976658|NCT04143009|592285903|FG000|Pilot Trial|Lost to Follow-up|0|||
163976659|NCT04143009|592285904|FG001|Pilot Trial|Lost to Follow-up|1|||
163976660|NCT04143009|592285905|FG002|Pilot Trial|Lost to Follow-up|1|||
163976661|NCT00874120|592287186|FG000|First Intervention|Adverse Event|0|||
163976662|NCT00874120|592287187|FG001|First Intervention|Adverse Event|1|||
163976663|NCT00874120|592287186|FG000|First Intervention|Withdrawal by Subject|2|||
163976664|NCT00874120|592287187|FG001|First Intervention|Withdrawal by Subject|0|||
163976665|NCT00874120|592287186|FG000|First Intervention|Lost to Follow-up|0|||
163976666|NCT00874120|592287187|FG001|First Intervention|Lost to Follow-up|1|||
163976667|NCT00874120|592287186|FG000|First Intervention|Protocol Violation|3|||
163976668|NCT00874120|592287187|FG001|First Intervention|Protocol Violation|0|||
163976669|NCT00874120|592287186|FG000|First Intervention|positive drug test|1|||
163976670|NCT00874120|592287187|FG001|First Intervention|positive drug test|0|||
163976671|NCT00874120|592287186|FG000|Second Intervention|Withdrawal by Subject|1|||
163976672|NCT00874120|592287187|FG001|Second Intervention|Withdrawal by Subject|0|||
163976673|NCT00874120|592287186|FG000|Second Intervention|Protocol Violation|1|||
163976674|NCT00874120|592287187|FG001|Second Intervention|Protocol Violation|0|||
163976675|NCT00105443|592287193|FG000|Double-Blind Treatment|Adverse Event|1|||
163976676|NCT00105443|592287194|FG001|Double-Blind Treatment|Adverse Event|0|||
163976677|NCT00105443|592287195|FG002|Double-Blind Treatment|Adverse Event|0|||
163976678|NCT00105443|592287196|FG003|Double-Blind Treatment|Adverse Event|0|||
163976679|NCT00105443|592287193|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
163976680|NCT00105443|592287194|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
163976681|NCT00105443|592287195|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
163976682|NCT00105443|592287196|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
163976683|NCT00105443|592287193|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
163976684|NCT00105443|592287194|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
163976685|NCT00105443|592287195|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
163976686|NCT00105443|592287196|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
163976687|NCT00105443|592287193|FG000|Double-Blind Treatment|Physician Decision|1|||
163976688|NCT00105443|592287194|FG001|Double-Blind Treatment|Physician Decision|0|||
163976689|NCT00105443|592287195|FG002|Double-Blind Treatment|Physician Decision|2|||
163976690|NCT00105443|592287196|FG003|Double-Blind Treatment|Physician Decision|0|||
163976691|NCT00105443|592287193|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
163976692|NCT00105443|592287194|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
163976693|NCT00105443|592287195|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
163976694|NCT00105443|592287196|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
163976695|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
163976696|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
164314930|NCT01065454|593529827|FG003|Treatment|Adverse Event|6|||
163976697|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
163976698|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
163976699|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
163976700|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
163976701|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
163976702|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
163976703|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
163976704|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
163976705|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
163976706|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
163976707|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
163976708|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
163976709|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
163976710|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
163976711|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
163976712|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
163976713|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
163976714|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
163976715|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
163976716|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
163976717|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
163976718|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
163976719|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
163976720|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
163976721|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
163976722|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
163976723|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
163976724|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
163976725|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
163976726|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
163976727|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
163976728|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
163976729|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
163976730|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
163976731|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
163976732|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
163976733|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
163976734|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
163976735|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
163976736|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
163976737|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
163976738|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
163976739|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
163976740|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
163976741|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
163976742|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
163976743|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
164204118|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
164204119|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
164204120|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
164204121|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
164204122|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
164204123|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
164204124|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Other|10|||
164204125|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Other|4|||
164204126|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Other|0|||
163976744|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
163976745|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
163976746|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
163976747|NCT00105443|592287193|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
163976748|NCT00105443|592287194|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
163976749|NCT00105443|592287195|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
163976750|NCT00105443|592287196|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
163976751|NCT01623271|592287199|FG000|Overall Study|Withdrawal by Subject|2|||
163976752|NCT02037295|592287202|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
163976753|NCT02037295|592287203|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
163976754|NCT02037295|592287204|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
163976755|NCT02037295|592287205|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
163976756|NCT02770547|592287209|FG000|Overall Study|Patient non-compliant|1|||
163976757|NCT02770547|592287210|FG001|Overall Study|Patient non-compliant|0|||
163976758|NCT02770547|592287209|FG000|Overall Study|Adverse Event|0|||
163976759|NCT02770547|592287210|FG001|Overall Study|Adverse Event|1|||
163976760|NCT00661531|592287211|FG000|Overall Study|Withdrawal by Subject|3|||
163976761|NCT03134599|592287213|FG000|Week 1|Lost to Follow-up|0|||
163976762|NCT03134599|592287214|FG001|Week 1|Lost to Follow-up|0|||
163976763|NCT03134599|592287215|FG002|Week 1|Lost to Follow-up|0|||
163976764|NCT03134599|592287216|FG003|Week 1|Lost to Follow-up|0|||
163976765|NCT03134599|592287217|FG004|Week 1|Lost to Follow-up|1|||
163976766|NCT03134599|592287218|FG005|Week 1|Lost to Follow-up|0|||
163976767|NCT03134599|592287213|FG000|Week 2|Lost to Follow-up|1|||
163976768|NCT03134599|592287214|FG001|Week 2|Lost to Follow-up|0|||
163976769|NCT03134599|592287215|FG002|Week 2|Lost to Follow-up|0|||
163976770|NCT03134599|592287216|FG003|Week 2|Lost to Follow-up|1|||
163976771|NCT03134599|592287217|FG004|Week 2|Lost to Follow-up|1|||
163976772|NCT03134599|592287218|FG005|Week 2|Lost to Follow-up|0|||
163976773|NCT03134599|592287213|FG000|Week 3|Lost to Follow-up|0|||
163976774|NCT03134599|592287214|FG001|Week 3|Lost to Follow-up|0|||
163976775|NCT03134599|592287215|FG002|Week 3|Lost to Follow-up|0|||
163976776|NCT03134599|592287216|FG003|Week 3|Lost to Follow-up|1|||
163976777|NCT03134599|592287217|FG004|Week 3|Lost to Follow-up|0|||
163976778|NCT03134599|592287218|FG005|Week 3|Lost to Follow-up|1|||
163976779|NCT00393887|592287219|FG000|Overall Study|Physician Decision|5|||
163976780|NCT00393887|592287220|FG001|Overall Study|Physician Decision|0|||
163976781|NCT00393887|592287219|FG000|Overall Study|Lost to Follow-up|11|||
163976782|NCT00393887|592287220|FG001|Overall Study|Lost to Follow-up|9|||
163976783|NCT02311153|592287221|FG000|Overall Study|Lost to Follow-up|5|||
163976784|NCT02311153|592287222|FG001|Overall Study|Lost to Follow-up|7|||
163976785|NCT01967628|592287223|FG000|Overall Study|Withdrawal by Subject|2|||
163976786|NCT01967628|592287224|FG001|Overall Study|Withdrawal by Subject|0|||
163976787|NCT01967628|592287223|FG000|Overall Study|Unable to complete bronchoscopy|4|||
163976788|NCT01967628|592287224|FG001|Overall Study|Unable to complete bronchoscopy|6|||
163976789|NCT01967628|592287223|FG000|Overall Study|Lost to Follow-up|1|||
163976790|NCT01967628|592287224|FG001|Overall Study|Lost to Follow-up|0|||
163976791|NCT01967628|592287223|FG000|Overall Study|Low protein concentration in sample|20|||
163976792|NCT01967628|592287224|FG001|Overall Study|Low protein concentration in sample|25|||
163976793|NCT00838331|592287225|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
163976794|NCT01445951|592287226|FG000|Overall Study|Adverse Event|16|||
163976795|NCT01445951|592287227|FG001|Overall Study|Adverse Event|9|||
163976796|NCT01445951|592287228|FG002|Overall Study|Adverse Event|0|||
163976797|NCT01445951|592287226|FG000|Overall Study|Protocol Violation|2|||
163976798|NCT01445951|592287227|FG001|Overall Study|Protocol Violation|2|||
163976799|NCT01445951|592287228|FG002|Overall Study|Protocol Violation|2|||
163976800|NCT01445951|592287226|FG000|Overall Study|Withdrawal by Subject|21|||
163976801|NCT01445951|592287227|FG001|Overall Study|Withdrawal by Subject|16|||
163976802|NCT01445951|592287228|FG002|Overall Study|Withdrawal by Subject|8|||
163976803|NCT01445951|592287226|FG000|Overall Study|Physician Decision|3|||
163976804|NCT01445951|592287227|FG001|Overall Study|Physician Decision|1|||
163976805|NCT01445951|592287228|FG002|Overall Study|Physician Decision|0|||
164204127|NCT04006457|593119159|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
164204128|NCT04006457|593119160|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
163976806|NCT01445951|592287226|FG000|Overall Study|Lost to Follow-up|1|||
163976807|NCT01445951|592287227|FG001|Overall Study|Lost to Follow-up|2|||
163976808|NCT01445951|592287228|FG002|Overall Study|Lost to Follow-up|4|||
163976809|NCT01445951|592287226|FG000|Overall Study|Pregnancy|0|||
163976810|NCT01445951|592287227|FG001|Overall Study|Pregnancy|1|||
163976811|NCT01445951|592287228|FG002|Overall Study|Pregnancy|4|||
163976812|NCT01445951|592287226|FG000|Overall Study|Death|0|||
163976813|NCT01445951|592287227|FG001|Overall Study|Death|0|||
163976814|NCT01445951|592287228|FG002|Overall Study|Death|1|||
163976815|NCT01445951|592287226|FG000|Overall Study|Non-compliance with study drug|1|||
163976816|NCT01445951|592287227|FG001|Overall Study|Non-compliance with study drug|2|||
163976817|NCT01445951|592287228|FG002|Overall Study|Non-compliance with study drug|0|||
163976818|NCT01445951|592287226|FG000|Overall Study|Non-compliance with protocol|0|||
164314931|NCT01065454|593529824|FG000|Treatment|Death|1|||
164314932|NCT01065454|593529825|FG001|Treatment|Death|0|||
164314933|NCT01065454|593529826|FG002|Treatment|Death|0|||
164314934|NCT01065454|593529827|FG003|Treatment|Death|0|||
164314935|NCT01065454|593529824|FG000|Treatment|Non-compliance|1|||
164314936|NCT01065454|593529825|FG001|Treatment|Non-compliance|0|||
164314937|NCT01065454|593529826|FG002|Treatment|Non-compliance|0|||
164314938|NCT01065454|593529827|FG003|Treatment|Non-compliance|1|||
164314939|NCT01065454|593529824|FG000|Treatment|Protocol Decision|0|||
164314940|NCT01065454|593529825|FG001|Treatment|Protocol Decision|0|||
164314941|NCT01065454|593529826|FG002|Treatment|Protocol Decision|3|||
164314942|NCT01065454|593529827|FG003|Treatment|Protocol Decision|2|||
164314943|NCT01065454|593529824|FG000|Treatment|Protocol Violation|1|||
164314944|NCT01065454|593529825|FG001|Treatment|Protocol Violation|0|||
164314945|NCT01065454|593529826|FG002|Treatment|Protocol Violation|1|||
164314946|NCT01065454|593529827|FG003|Treatment|Protocol Violation|0|||
164314947|NCT01065454|593529824|FG000|Treatment|Withdrawal by Subject|3|||
164314948|NCT01065454|593529825|FG001|Treatment|Withdrawal by Subject|1|||
164314949|NCT01065454|593529826|FG002|Treatment|Withdrawal by Subject|2|||
164314950|NCT01065454|593529827|FG003|Treatment|Withdrawal by Subject|3|||
164314951|NCT01065454|593529824|FG000|Follow up|Adverse Event|1|||
164314952|NCT01065454|593529825|FG001|Follow up|Adverse Event|0|||
164314953|NCT01065454|593529826|FG002|Follow up|Adverse Event|0|||
164314954|NCT01065454|593529827|FG003|Follow up|Adverse Event|1|||
164314955|NCT01065454|593529824|FG000|Follow up|Death|0|||
164314956|NCT01065454|593529825|FG001|Follow up|Death|1|||
164314957|NCT01065454|593529826|FG002|Follow up|Death|1|||
164314958|NCT01065454|593529827|FG003|Follow up|Death|0|||
164314959|NCT01065454|593529824|FG000|Follow up|Lost to Follow-up|0|||
164314960|NCT01065454|593529825|FG001|Follow up|Lost to Follow-up|0|||
164314961|NCT01065454|593529826|FG002|Follow up|Lost to Follow-up|0|||
164314962|NCT01065454|593529827|FG003|Follow up|Lost to Follow-up|1|||
164314963|NCT01065454|593529824|FG000|Follow up|Progressive disease|0|||
164314964|NCT01065454|593529825|FG001|Follow up|Progressive disease|0|||
164314965|NCT01065454|593529826|FG002|Follow up|Progressive disease|0|||
164314966|NCT01065454|593529827|FG003|Follow up|Progressive disease|1|||
164314967|NCT01065454|593529824|FG000|Follow up|Withdrawal by Subject|1|||
164314968|NCT01065454|593529825|FG001|Follow up|Withdrawal by Subject|1|||
164314969|NCT01065454|593529826|FG002|Follow up|Withdrawal by Subject|1|||
164314970|NCT01065454|593529827|FG003|Follow up|Withdrawal by Subject|0|||
164314971|NCT01065454|593529824|FG000|Follow up|study ongoing|37|||
164314972|NCT01065454|593529825|FG001|Follow up|study ongoing|22|||
164314973|NCT01065454|593529826|FG002|Follow up|study ongoing|15|||
164314974|NCT01065454|593529827|FG003|Follow up|study ongoing|41|||
164314975|NCT03374202|593529828|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
164314976|NCT03374202|593529829|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
164314977|NCT03374202|593529830|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
164314978|NCT03374202|593529828|FG000|Five Year Long Term Follow Up|Death|0|||
164314979|NCT03374202|593529829|FG001|Five Year Long Term Follow Up|Death|1|||
164314980|NCT03374202|593529830|FG002|Five Year Long Term Follow Up|Death|0|||
164314981|NCT01604278|593531421|FG000|Overall Study|Lack of Efficacy|0|||
164314982|NCT01604278|593531422|FG001|Overall Study|Lack of Efficacy|1|||
164314983|NCT01604278|593531421|FG000|Overall Study|Lost to Follow-up|1|||
164314984|NCT01604278|593531422|FG001|Overall Study|Lost to Follow-up|0|||
164314985|NCT01604278|593531421|FG000|Overall Study|Administrative problems|2|||
164314986|NCT01604278|593531422|FG001|Overall Study|Administrative problems|1|||
164314987|NCT01604278|593531421|FG000|Overall Study|Withdrawal by Subject|3|||
163872545|NCT05288283|591903888|FG000|Overall Study|Study Terminated Early|1|||
163872546|NCT05288283|591903889|FG001|Overall Study|Study Terminated Early|1|||
163872547|NCT03990649|591903894|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
163872548|NCT03990649|591903895|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
163872549|NCT03990649|591903896|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
163872550|NCT03990649|591903894|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
163872551|NCT03990649|591903895|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
163872552|NCT03990649|591903896|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
163872553|NCT03990649|591903894|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
163872554|NCT03990649|591903895|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
163872555|NCT03990649|591903896|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
164135939|NCT02799095|592861961|FG006|Part C|Physician Decision|0|||
164314988|NCT01604278|593531422|FG001|Overall Study|Withdrawal by Subject|3|||
164314989|NCT01604278|593531421|FG000|Overall Study|Adverse Event|3|||
164314990|NCT01604278|593531422|FG001|Overall Study|Adverse Event|5|||
164314991|NCT01604278|593531421|FG000|Overall Study|Protocol Deviation|5|||
164314992|NCT01604278|593531422|FG001|Overall Study|Protocol Deviation|3|||
164314993|NCT00361634|593531436|FG000|Overall Study|Lost to Follow-up|1|||
163872556|NCT03990649|591903894|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
164314994|NCT00361634|593531436|FG000|Overall Study|Withdrawal by Subject|1|||
164314995|NCT00505076|593531437|FG000|Overall Study|Adverse Event|1|||
164314996|NCT00505076|593531438|FG001|Overall Study|Adverse Event|0|||
164314997|NCT00505076|593531439|FG002|Overall Study|Adverse Event|1|||
164314998|NCT00505076|593531437|FG000|Overall Study|Protocol Violation|2|||
164314999|NCT00505076|593531438|FG001|Overall Study|Protocol Violation|1|||
164315000|NCT00505076|593531439|FG002|Overall Study|Protocol Violation|2|||
164315001|NCT00505076|593531437|FG000|Overall Study|Withdrawal by Subject|0|||
164315002|NCT00505076|593531438|FG001|Overall Study|Withdrawal by Subject|1|||
164315003|NCT00505076|593531439|FG002|Overall Study|Withdrawal by Subject|2|||
164315004|NCT02500056|593531440|FG000|Overall Study|Lost to Follow-up|3|||
164315005|NCT02500056|593531441|FG001|Overall Study|Lost to Follow-up|7|||
164315006|NCT02500056|593531440|FG000|Overall Study|Recurrence|1|||
164315007|NCT02500056|593531441|FG001|Overall Study|Recurrence|0|||
164315008|NCT02500056|593531440|FG000|Overall Study|Death|3|||
164315009|NCT02500056|593531441|FG001|Overall Study|Death|1|||
164315010|NCT03232333|593531446|FG000|Overall Study|Infection or Osteomyelitis|9|||
164315011|NCT03232333|593531446|FG000|Overall Study|Lost to Follow-up|4|||
164315012|NCT03232333|593531446|FG000|Overall Study|Withdrawal by Subject|2|||
164315013|NCT01155011|593531449|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
164315014|NCT01155011|593531450|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
164315015|NCT01155011|593531449|FG000|Baseline to 6 Months|investigator decision, moved|4|||
164315016|NCT01155011|593531450|FG001|Baseline to 6 Months|investigator decision, moved|5|||
164315017|NCT01155011|593531449|FG000|Baseline to 6 Months|Death|0|||
164315018|NCT01155011|593531450|FG001|Baseline to 6 Months|Death|1|||
164315019|NCT01155011|593531449|FG000|6 to 12 Months|Withdrawal by Subject|8|||
164315020|NCT01155011|593531450|FG001|6 to 12 Months|Withdrawal by Subject|5|||
164315021|NCT01155011|593531449|FG000|6 to 12 Months|Death|1|||
164315022|NCT01155011|593531450|FG001|6 to 12 Months|Death|5|||
164315023|NCT01087736|593531451|FG000|Overall Study|Lost to Follow-up|1|||
164315024|NCT01087736|593531452|FG001|Overall Study|Lost to Follow-up|0|||
164315025|NCT01087736|593531451|FG000|Overall Study|Death|0|||
164315026|NCT01087736|593531452|FG001|Overall Study|Death|1|||
164315027|NCT01087736|593531451|FG000|Overall Study|Withdrawal by Subject|0|||
164315028|NCT01087736|593531452|FG001|Overall Study|Withdrawal by Subject|1|||
164315029|NCT01253811|593531453|FG000|Overall Study|Withdrawal criteria|1|||
163872557|NCT03990649|591903895|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
163872558|NCT03990649|591903896|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
163872559|NCT03990649|591903894|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
163872560|NCT03990649|591903895|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
163872561|NCT03990649|591903896|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
163872562|NCT03990649|591903894|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
163872563|NCT03990649|591903895|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
163872564|NCT03990649|591903896|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
163872565|NCT03990649|591903894|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
163872566|NCT03990649|591903895|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
163872567|NCT03990649|591903896|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
163872568|NCT03050814|591903897|FG000|Overall Study|Screen failures|0|||
163872569|NCT03050814|591903898|FG001|Overall Study|Screen failures|0|||
163872570|NCT03050814|591903899|FG002|Overall Study|Screen failures|4|||
163872571|NCT04512482|591903902|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
163872572|NCT04512482|591903903|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
163872573|NCT05119855|591903904|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
163872574|NCT05119855|591903905|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
163872575|NCT05119855|591903904|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
163872576|NCT05119855|591903905|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
163872577|NCT05119855|591903904|FG000|Overall Study|Lost to Follow-up|6|||
163872578|NCT05119855|591903905|FG001|Overall Study|Lost to Follow-up|8|||
163872579|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
163872580|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
163872581|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
163872582|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
163872583|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
163872584|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163872585|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163872586|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
163872587|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163872588|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
163872589|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
163872590|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
163872591|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
163872592|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
163872593|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
163872594|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
164135940|NCT02799095|592861962|FG007|Part C|Physician Decision|0|||
163976819|NCT01445951|592287227|FG001|Overall Study|Non-compliance with protocol|1|||
163976820|NCT01445951|592287228|FG002|Overall Study|Non-compliance with protocol|0|||
163976821|NCT01445951|592287226|FG000|Overall Study|Sponsor decision - subject travel|0|||
163976822|NCT01445951|592287227|FG001|Overall Study|Sponsor decision - subject travel|1|||
163976823|NCT01445951|592287228|FG002|Overall Study|Sponsor decision - subject travel|0|||
163976824|NCT01445951|592287226|FG000|Overall Study|Cough|0|||
163976825|NCT01445951|592287227|FG001|Overall Study|Cough|1|||
163976826|NCT01445951|592287228|FG002|Overall Study|Cough|0|||
163976827|NCT02739620|592287231|FG000|Overall Study|Lost to Follow-up|3|||
163976828|NCT02739620|592287232|FG001|Overall Study|Lost to Follow-up|1|||
163976829|NCT02739620|592287231|FG000|Overall Study|Adverse Event|0|||
163976830|NCT02739620|592287232|FG001|Overall Study|Adverse Event|1|||
163976831|NCT00786565|592287233|FG000|Enrollment Prior to Surgery|Site Closed|3|||
163976832|NCT00786565|592287233|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
163976833|NCT00786565|592287233|FG000|Post Surgery|Abnormal macular pucker|1|||
163976834|NCT00786565|592287233|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
163976835|NCT00993265|592287236|FG000|Overall Study|Adverse Event|1|||
163976836|NCT00993265|592287237|FG001|Overall Study|Adverse Event|0|||
163976837|NCT00993265|592287236|FG000|Overall Study|Changed dose of concomitant drug|2|||
163976838|NCT00993265|592287237|FG001|Overall Study|Changed dose of concomitant drug|0|||
163976839|NCT00993265|592287236|FG000|Overall Study|Non-compliant with study medication|1|||
163976840|NCT00993265|592287237|FG001|Overall Study|Non-compliant with study medication|0|||
163976841|NCT03765138|592287238|FG000|Overall Study|Lost to Follow-up|1|||
163976842|NCT00781911|592287239|FG000|Overall Study|Adverse Event|4|||
163976843|NCT00781911|592287240|FG001|Overall Study|Adverse Event|4|||
163976844|NCT00781911|592287239|FG000|Overall Study|Withdrawal by Subject|1|||
163976845|NCT00781911|592287240|FG001|Overall Study|Withdrawal by Subject|2|||
164315030|NCT00759564|593531454|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
163976846|NCT00781911|592287239|FG000|Overall Study|Physician Decision|0|||
163976847|NCT00781911|592287240|FG001|Overall Study|Physician Decision|2|||
163976848|NCT00781911|592287239|FG000|Overall Study|Sponsor Decision|1|||
163976849|NCT00781911|592287240|FG001|Overall Study|Sponsor Decision|0|||
163976850|NCT00219284|592287241|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
163976851|NCT00219284|592287242|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
163976852|NCT00219284|592287241|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
163976853|NCT00219284|592287242|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
163976854|NCT00219284|592287241|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
163976855|NCT00219284|592287242|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
163976856|NCT00219284|592287241|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
163976857|NCT00219284|592287242|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
163976858|NCT00219284|592287241|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
164315031|NCT00759564|593531455|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
164315032|NCT00759564|593531456|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
164315033|NCT00759564|593531457|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
164315034|NCT00759564|593531458|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
164315035|NCT01565343|593531461|FG000|Overall Study|Administrative decision/technical issues|1|||
164315036|NCT01565343|593531462|FG001|Overall Study|Administrative decision/technical issues|0|||
164315037|NCT01565343|593531463|FG002|Overall Study|Administrative decision/technical issues|0|||
164315038|NCT02059291|593531468|FG000|Epoch 2|Lack of Efficacy|0|||
164315039|NCT02059291|593531469|FG001|Epoch 2|Lack of Efficacy|0|||
164315040|NCT02059291|593531470|FG002|Epoch 2|Lack of Efficacy|0|||
164315041|NCT02059291|593531471|FG003|Epoch 2|Lack of Efficacy|1|||
164315042|NCT02059291|593531472|FG004|Epoch 2|Lack of Efficacy|0|||
164315043|NCT02059291|593531473|FG005|Epoch 2|Lack of Efficacy|1|||
164315044|NCT02059291|593531474|FG006|Epoch 2|Lack of Efficacy|0|||
164315045|NCT02059291|593531475|FG007|Epoch 2|Lack of Efficacy|0|||
164315046|NCT02059291|593531476|FG008|Epoch 2|Lack of Efficacy|0|||
164315047|NCT02059291|593531477|FG009|Epoch 2|Lack of Efficacy|0|||
164315048|NCT02059291|593531478|FG010|Epoch 2|Lack of Efficacy|0|||
164315049|NCT02059291|593531479|FG011|Epoch 2|Lack of Efficacy|0|||
164315050|NCT02059291|593531480|FG012|Epoch 2|Lack of Efficacy|0|||
164315051|NCT02059291|593531481|FG013|Epoch 2|Lack of Efficacy|0|||
164315052|NCT02059291|593531482|FG014|Epoch 2|Lack of Efficacy|0|||
164315053|NCT02059291|593531483|FG015|Epoch 2|Lack of Efficacy|0|||
164315054|NCT02059291|593531484|FG016|Epoch 2|Lack of Efficacy|0|||
163976859|NCT00219284|592287242|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
163976860|NCT00219284|592287241|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
163976861|NCT00219284|592287242|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
163976862|NCT00219284|592287241|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
163976863|NCT00219284|592287242|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
163976864|NCT00219284|592287241|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
163976865|NCT00219284|592287242|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
163976866|NCT00219284|592287241|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
163976867|NCT00219284|592287242|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
164315055|NCT02059291|593531485|FG017|Epoch 2|Lack of Efficacy|0|||
164315056|NCT02059291|593531486|FG018|Epoch 2|Lack of Efficacy|0|||
164315057|NCT02059291|593531487|FG019|Epoch 2|Lack of Efficacy|0|||
164204129|NCT04006457|593119161|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
164204130|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
164204131|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
164204132|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
164204133|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
164204134|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
164204135|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
164204136|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
164204137|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
164204138|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
164204139|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
164204140|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
164204141|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
164204142|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
164204143|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
164204144|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
164204145|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Other|2|||
164204146|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Other|3|||
164204147|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Other|0|||
164204148|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
164204149|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
164204150|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
164204151|NCT04006457|593119159|FG000|Main Study: Treatment Period 2|Ongoing|86|||
164204152|NCT04006457|593119160|FG001|Main Study: Treatment Period 2|Ongoing|96|||
164204153|NCT04006457|593119161|FG002|Main Study: Treatment Period 2|Ongoing|0|||
164204154|NCT04006457|593119159|FG000|Main Study Observation Period|Adverse Event|1|||
164204155|NCT04006457|593119160|FG001|Main Study Observation Period|Adverse Event|1|||
164204156|NCT04006457|593119161|FG002|Main Study Observation Period|Adverse Event|0|||
164204157|NCT04006457|593119159|FG000|Main Study Observation Period|Lost to Follow-up|0|||
164204158|NCT04006457|593119160|FG001|Main Study Observation Period|Lost to Follow-up|1|||
164204159|NCT04006457|593119161|FG002|Main Study Observation Period|Lost to Follow-up|0|||
164204160|NCT04006457|593119159|FG000|Main Study Observation Period|Pregnancy|1|||
164204161|NCT04006457|593119160|FG001|Main Study Observation Period|Pregnancy|0|||
164204162|NCT04006457|593119161|FG002|Main Study Observation Period|Pregnancy|0|||
164204163|NCT04006457|593119159|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
164204164|NCT04006457|593119160|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
164204165|NCT04006457|593119161|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
164204166|NCT04006457|593119159|FG000|Main Study Observation Period|Other|8|||
164204167|NCT04006457|593119160|FG001|Main Study Observation Period|Other|16|||
164204168|NCT04006457|593119161|FG002|Main Study Observation Period|Other|0|||
164204169|NCT04006457|593119159|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
164204170|NCT04006457|593119160|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
164204171|NCT04006457|593119161|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
164204172|NCT04006457|593119159|FG000|Main Study Observation Period|Ongoing|2|||
164204173|NCT04006457|593119160|FG001|Main Study Observation Period|Ongoing|1|||
164204174|NCT04006457|593119161|FG002|Main Study Observation Period|Ongoing|0|||
164204175|NCT04006457|593119159|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
164204176|NCT04006457|593119160|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
164204177|NCT04006457|593119161|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
164204178|NCT05918055|593119162|FG000|Phase I - Dose Level 1|Ineligible|0|||
164204179|NCT05918055|593119163|FG001|Phase I - Dose Level 1|Ineligible|0|||
164204180|NCT05918055|593119164|FG002|Phase I - Dose Level 1|Ineligible|1|||
164204181|NCT05918055|593119162|FG000|Phase I - Dose Level -1|Physician Decision|1|||
164204182|NCT05918055|593119163|FG001|Phase I - Dose Level -1|Physician Decision|0|||
164204183|NCT05918055|593119164|FG002|Phase I - Dose Level -1|Physician Decision|0|||
164204184|NCT00109343|593119167|FG000|Overall Study|Adverse Event|1|||
164204185|NCT00109343|593119168|FG001|Overall Study|Adverse Event|0|||
164204186|NCT00109343|593119169|FG002|Overall Study|Adverse Event|2|||
164204187|NCT00109343|593119167|FG000|Overall Study|Lack of Efficacy|1|||
164204188|NCT00109343|593119168|FG001|Overall Study|Lack of Efficacy|0|||
164204189|NCT00109343|593119169|FG002|Overall Study|Lack of Efficacy|0|||
164204190|NCT00109343|593119167|FG000|Overall Study|Lost to Follow-up|35|||
164204191|NCT00109343|593119168|FG001|Overall Study|Lost to Follow-up|20|||
164204192|NCT00109343|593119169|FG002|Overall Study|Lost to Follow-up|14|||
164204193|NCT00109343|593119167|FG000|Overall Study|Protocol Violation|1|||
164204194|NCT00109343|593119168|FG001|Overall Study|Protocol Violation|2|||
164204195|NCT00109343|593119169|FG002|Overall Study|Protocol Violation|2|||
164204196|NCT00109343|593119167|FG000|Overall Study|Withdrawal by Subject|15|||
164204197|NCT00109343|593119168|FG001|Overall Study|Withdrawal by Subject|11|||
164204198|NCT00109343|593119169|FG002|Overall Study|Withdrawal by Subject|10|||
164204199|NCT00109343|593119167|FG000|Overall Study|Subject Moved|6|||
164204200|NCT00109343|593119168|FG001|Overall Study|Subject Moved|2|||
164204201|NCT00109343|593119169|FG002|Overall Study|Subject Moved|1|||
164204202|NCT00109343|593119167|FG000|Overall Study|Other|5|||
164204203|NCT00109343|593119168|FG001|Overall Study|Other|2|||
164204204|NCT00109343|593119169|FG002|Overall Study|Other|1|||
164204205|NCT04460885|593119170|FG000|Overall Study|Withdrawal by Subject|6|||
164204206|NCT04460885|593119171|FG001|Overall Study|Withdrawal by Subject|8|||
164204207|NCT04460885|593119170|FG000|Overall Study|Site closure|1|||
164204208|NCT04460885|593119171|FG001|Overall Study|Site closure|0|||
164204209|NCT04460885|593119170|FG000|Overall Study|Death|5|||
164204210|NCT04460885|593119171|FG001|Overall Study|Death|4|||
164204211|NCT04460885|593119170|FG000|Overall Study|Physician Decision|2|||
164204212|NCT04460885|593119171|FG001|Overall Study|Physician Decision|1|||
164204213|NCT04460885|593119170|FG000|Overall Study|Lost to Follow-up|4|||
164204214|NCT04460885|593119171|FG001|Overall Study|Lost to Follow-up|4|||
164204215|NCT01721798|593119174|FG000|Overall Study|Death|0|||
164204216|NCT01721798|593119175|FG001|Overall Study|Death|0|||
164204217|NCT01721798|593119176|FG002|Overall Study|Death|1|||
164204218|NCT01721798|593119177|FG003|Overall Study|Death|1|||
164204219|NCT01721798|593119174|FG000|Overall Study|Lost to Follow-up|2|||
164204220|NCT01721798|593119175|FG001|Overall Study|Lost to Follow-up|2|||
164204221|NCT01721798|593119176|FG002|Overall Study|Lost to Follow-up|9|||
164204222|NCT01721798|593119177|FG003|Overall Study|Lost to Follow-up|9|||
164204223|NCT01721798|593119174|FG000|Overall Study|Pregnancy|0|||
164204224|NCT01721798|593119175|FG001|Overall Study|Pregnancy|0|||
164204225|NCT01721798|593119176|FG002|Overall Study|Pregnancy|1|||
164204226|NCT01721798|593119177|FG003|Overall Study|Pregnancy|1|||
164204227|NCT01721798|593119174|FG000|Overall Study|Withdrawal by Subject|1|||
164204228|NCT01721798|593119175|FG001|Overall Study|Withdrawal by Subject|0|||
164204229|NCT01721798|593119176|FG002|Overall Study|Withdrawal by Subject|2|||
164204230|NCT01721798|593119177|FG003|Overall Study|Withdrawal by Subject|1|||
164204231|NCT01721798|593119174|FG000|Overall Study|Not eligible for 24 month visit|1|||
164204232|NCT01721798|593119175|FG001|Overall Study|Not eligible for 24 month visit|0|||
164204233|NCT01721798|593119176|FG002|Overall Study|Not eligible for 24 month visit|8|||
164204234|NCT01721798|593119177|FG003|Overall Study|Not eligible for 24 month visit|7|||
164204235|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
164204236|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
164204237|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
164204238|NCT00961064|593119178|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
164204239|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
164204240|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
164204241|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
164204242|NCT00961064|593119178|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
164204243|NCT01408641|593119179|FG000|Overall Study|Physician Decision|1|||
164204244|NCT01408641|593119180|FG001|Overall Study|Physician Decision|0|||
164204245|NCT02842866|593119181|FG000|Overall Study|Serious Adverse Event|0|||
164204246|NCT02842866|593119182|FG001|Overall Study|Serious Adverse Event|1|||
164204247|NCT02842866|593119181|FG000|Overall Study|Protocol Violation|4|||
164204248|NCT02842866|593119182|FG001|Overall Study|Protocol Violation|2|||
164204249|NCT02842866|593119181|FG000|Overall Study|Lost to Follow-up|2|||
164204250|NCT02842866|593119182|FG001|Overall Study|Lost to Follow-up|0|||
164204251|NCT02842866|593119181|FG000|Overall Study|Withdrawal by Subject|1|||
164204252|NCT02842866|593119182|FG001|Overall Study|Withdrawal by Subject|0|||
164204253|NCT01432327|593119183|FG000|Posttest 3 Months|depression|3|||
164204254|NCT01432327|593119184|FG001|Posttest 3 Months|depression|0|||
164204255|NCT01432327|593119185|FG002|Posttest 3 Months|depression|0|||
164204256|NCT01432327|593119186|FG003|Posttest 3 Months|depression|0|||
164204257|NCT01432327|593119183|FG000|Posttest 3 Months|Lost to Follow-up|1|||
164204258|NCT01432327|593119184|FG001|Posttest 3 Months|Lost to Follow-up|0|||
164204259|NCT01432327|593119185|FG002|Posttest 3 Months|Lost to Follow-up|2|||
164204260|NCT01432327|593119186|FG003|Posttest 3 Months|Lost to Follow-up|1|||
164204261|NCT01432327|593119183|FG000|Posttest 3 Months|Allergic reaction|0|||
164204262|NCT01432327|593119184|FG001|Posttest 3 Months|Allergic reaction|2|||
164204263|NCT01432327|593119185|FG002|Posttest 3 Months|Allergic reaction|0|||
164204264|NCT01432327|593119186|FG003|Posttest 3 Months|Allergic reaction|0|||
164204265|NCT01432327|593119183|FG000|Posttest 6 Months|Lost to Follow-up|0|||
164204266|NCT01432327|593119184|FG001|Posttest 6 Months|Lost to Follow-up|0|||
164204267|NCT01432327|593119185|FG002|Posttest 6 Months|Lost to Follow-up|3|||
164204268|NCT01432327|593119186|FG003|Posttest 6 Months|Lost to Follow-up|2|||
164204269|NCT01432327|593119183|FG000|Posttest 6 Months|Allergic reaction|0|||
164204270|NCT01432327|593119184|FG001|Posttest 6 Months|Allergic reaction|0|||
164204271|NCT01432327|593119185|FG002|Posttest 6 Months|Allergic reaction|1|||
164204272|NCT01432327|593119186|FG003|Posttest 6 Months|Allergic reaction|0|||
164204273|NCT01432327|593119183|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
164204274|NCT01432327|593119184|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
164204275|NCT01432327|593119185|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
164204276|NCT01432327|593119186|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
164204277|NCT01432327|593119183|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
164204278|NCT01432327|593119184|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
164204279|NCT01432327|593119185|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
164204280|NCT01432327|593119186|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
164204281|NCT01432327|593119183|FG000|Posttest 1 Year|Lost to Follow-up|0|||
164204282|NCT01432327|593119184|FG001|Posttest 1 Year|Lost to Follow-up|0|||
164204283|NCT01432327|593119185|FG002|Posttest 1 Year|Lost to Follow-up|4|||
164204284|NCT01432327|593119186|FG003|Posttest 1 Year|Lost to Follow-up|2|||
164204285|NCT01432327|593119183|FG000|Posttest 1 Year|Allergic reaction|0|||
164204286|NCT01432327|593119184|FG001|Posttest 1 Year|Allergic reaction|0|||
164204287|NCT01432327|593119185|FG002|Posttest 1 Year|Allergic reaction|1|||
164204288|NCT01432327|593119186|FG003|Posttest 1 Year|Allergic reaction|1|||
164204289|NCT05001620|593119189|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
164204290|NCT05001620|593119190|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
164204291|NCT00819039|593119191|FG000|Overall Study|Physician Decision|1|||
164204292|NCT00819039|593119192|FG001|Overall Study|Physician Decision|0|||
164204293|NCT00819039|593119193|FG002|Overall Study|Physician Decision|1|||
164204294|NCT00819039|593119191|FG000|Overall Study|Protocol Violation|1|||
164204295|NCT00819039|593119192|FG001|Overall Study|Protocol Violation|0|||
164204296|NCT00819039|593119193|FG002|Overall Study|Protocol Violation|0|||
164204297|NCT04796415|593119194|FG000|Overall Study|not interested|12|||
164204298|NCT04796415|593119194|FG000|Overall Study|health issue|8|||
164204299|NCT04796415|593119194|FG000|Overall Study|Other|4|||
164204300|NCT04796415|593119194|FG000|Overall Study|discharged from home health service|3|||
164204301|NCT04796415|593119194|FG000|Overall Study|re-hospitalization|2|||
164204302|NCT04796415|593119194|FG000|Overall Study|moving to nursing home|1|||
164204303|NCT04796415|593119194|FG000|Overall Study|lost contact|1|||
164204304|NCT04009837|593119198|FG000|Overall Study|Withdrawal by Subject|5|||
164204305|NCT04009837|593119199|FG001|Overall Study|Withdrawal by Subject|4|||
164204306|NCT04009837|593119198|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
164204307|NCT04009837|593119199|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
164204308|NCT04649359|593119200|FG000|Overall Study|Withdrawal by Subject|7|||
164204309|NCT04649359|593119201|FG001|Overall Study|Withdrawal by Subject|7|||
164204310|NCT04649359|593119200|FG000|Overall Study|Death|41|||
164204311|NCT04649359|593119201|FG001|Overall Study|Death|26|||
164204312|NCT04649359|593119200|FG000|Overall Study|Ongoing in the study|75|||
164204313|NCT04649359|593119201|FG001|Overall Study|Ongoing in the study|31|||
164204314|NCT03307174|593119205|FG000|Overall Study|Unplanned ICU Administrion|5|||
164204315|NCT03307174|593119206|FG001|Overall Study|Unplanned ICU Administrion|3|||
164204316|NCT03307174|593119205|FG000|Overall Study|Aborted Surgery|1|||
164204317|NCT03307174|593119206|FG001|Overall Study|Aborted Surgery|2|||
164204318|NCT03307174|593119205|FG000|Overall Study|Hypotension|6|||
164204319|NCT03307174|593119206|FG001|Overall Study|Hypotension|0|||
164204320|NCT03307174|593119205|FG000|Overall Study|Nonfunctional epidural|1|||
164204321|NCT03307174|593119206|FG001|Overall Study|Nonfunctional epidural|1|||
164204322|NCT03307174|593119205|FG000|Overall Study|Planned epidural removal|1|||
164204323|NCT03307174|593119206|FG001|Overall Study|Planned epidural removal|0|||
164204324|NCT03307174|593119205|FG000|Overall Study|Intrathecal catheter placement|0|||
164204325|NCT03307174|593119206|FG001|Overall Study|Intrathecal catheter placement|1|||
164204326|NCT05911841|593119207|FG000|Induction Period|Study Terminated by Sponsor|2|||
164204327|NCT05911841|593119208|FG001|Induction Period|Study Terminated by Sponsor|0|||
164204328|NCT05911841|593119209|FG002|Induction Period|Study Terminated by Sponsor|14|||
164204329|NCT05911841|593119210|FG003|Induction Period|Study Terminated by Sponsor|6|||
164204330|NCT05911841|593119211|FG004|Induction Period|Study Terminated by Sponsor|0|||
164204331|NCT05911841|593119212|FG005|Induction Period|Study Terminated by Sponsor|0|||
164204332|NCT05911841|593119213|FG006|Induction Period|Study Terminated by Sponsor|0|||
164204333|NCT05911841|593119214|FG007|Induction Period|Study Terminated by Sponsor|0|||
164204334|NCT05911841|593119215|FG008|Induction Period|Study Terminated by Sponsor|0|||
164204335|NCT05911841|593119216|FG009|Induction Period|Study Terminated by Sponsor|0|||
164204336|NCT05911841|593119207|FG000|Induction Period|Withdrawal by Subject|4|||
164204337|NCT05911841|593119208|FG001|Induction Period|Withdrawal by Subject|3|||
164204338|NCT05911841|593119209|FG002|Induction Period|Withdrawal by Subject|4|||
164204339|NCT05911841|593119210|FG003|Induction Period|Withdrawal by Subject|6|||
164204340|NCT05911841|593119211|FG004|Induction Period|Withdrawal by Subject|0|||
164204341|NCT05911841|593119212|FG005|Induction Period|Withdrawal by Subject|0|||
164204342|NCT05911841|593119213|FG006|Induction Period|Withdrawal by Subject|0|||
164204343|NCT05911841|593119214|FG007|Induction Period|Withdrawal by Subject|0|||
164204344|NCT05911841|593119215|FG008|Induction Period|Withdrawal by Subject|0|||
164204345|NCT05911841|593119216|FG009|Induction Period|Withdrawal by Subject|0|||
164204346|NCT05911841|593119207|FG000|Induction Period|Lack of Efficacy|3|||
164204347|NCT05911841|593119208|FG001|Induction Period|Lack of Efficacy|0|||
164204348|NCT05911841|593119209|FG002|Induction Period|Lack of Efficacy|3|||
164204349|NCT05911841|593119210|FG003|Induction Period|Lack of Efficacy|3|||
164204350|NCT05911841|593119211|FG004|Induction Period|Lack of Efficacy|0|||
164204351|NCT05911841|593119212|FG005|Induction Period|Lack of Efficacy|0|||
164204352|NCT05911841|593119213|FG006|Induction Period|Lack of Efficacy|0|||
164204353|NCT05911841|593119214|FG007|Induction Period|Lack of Efficacy|0|||
163976868|NCT01357655|592287243|FG000|Overall Study|Administrative Reason by Sponsor|45|||
163976869|NCT01357655|592287244|FG001|Overall Study|Administrative Reason by Sponsor|0|||
163976870|NCT01357655|592287243|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163976871|NCT01357655|592287244|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
163976872|NCT01357655|592287243|FG000|Overall Study|Disease Progression|1|||
163976873|NCT01357655|592287244|FG001|Overall Study|Disease Progression|0|||
163976874|NCT01357655|592287243|FG000|Overall Study|Lost to Follow-up|2|||
163976875|NCT01357655|592287244|FG001|Overall Study|Lost to Follow-up|0|||
163976876|NCT01357655|592287243|FG000|Overall Study|Maximum Clinical Benefit|2|||
163976877|NCT01357655|592287244|FG001|Overall Study|Maximum Clinical Benefit|0|||
163976878|NCT01357655|592287243|FG000|Overall Study|Reason Unspecified|1|||
163976879|NCT01357655|592287244|FG001|Overall Study|Reason Unspecified|0|||
163976880|NCT01357655|592287243|FG000|Overall Study|Study Drug Toxicity|11|||
163976881|NCT01357655|592287244|FG001|Overall Study|Study Drug Toxicity|0|||
163976882|NCT01357655|592287243|FG000|Overall Study|Subject Withdrew Consent|1|||
163976883|NCT01357655|592287244|FG001|Overall Study|Subject Withdrew Consent|0|||
163976884|NCT05003622|592287245|FG000|Overall Study|Progressive disease|2|||
163976885|NCT05003622|592287245|FG000|Overall Study|Withdrawal by Subject|1|||
163976886|NCT01692275|592287246|FG000|Overall Study|Lost to Follow-up|57|||
163976887|NCT01692275|592287247|FG001|Overall Study|Lost to Follow-up|48|||
163976888|NCT01692275|592287246|FG000|Overall Study|Withdrawal by Subject|9|||
163976889|NCT01692275|592287247|FG001|Overall Study|Withdrawal by Subject|11|||
163976890|NCT01624662|592287253|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
163976891|NCT01624662|592287254|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
163976892|NCT01624662|592287255|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
163976893|NCT01624662|592287256|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
163976894|NCT01624662|592287253|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
163976895|NCT01624662|592287254|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
163976896|NCT01624662|592287255|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
163976897|NCT01624662|592287256|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
163976898|NCT01624662|592287253|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163976899|NCT01624662|592287254|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
163976900|NCT01624662|592287255|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163976901|NCT01624662|592287256|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163976902|NCT01624662|592287253|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
163976903|NCT01624662|592287254|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
163976904|NCT01624662|592287255|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
163976905|NCT01624662|592287256|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
163976906|NCT01624662|592287253|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163976907|NCT01624662|592287254|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163976908|NCT01624662|592287255|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
163976909|NCT01624662|592287256|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163976910|NCT01624662|592287253|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163976911|NCT01624662|592287254|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
163976912|NCT01624662|592287255|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163976913|NCT01624662|592287256|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163976914|NCT01624662|592287253|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163976915|NCT01624662|592287254|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163976916|NCT01624662|592287255|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
163872595|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
163872596|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
163872597|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
163872598|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
163872599|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
163872600|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
163872601|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
163976917|NCT01624662|592287256|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163976918|NCT00361270|592287257|FG000|Overall Study|Death|0|||
163976919|NCT00361270|592287258|FG001|Overall Study|Death|0|||
163976920|NCT00361270|592287259|FG002|Overall Study|Death|0|||
163976921|NCT00361270|592287260|FG003|Overall Study|Death|2|||
163976922|NCT00361270|592287257|FG000|Overall Study|Lost to Follow-up|4|||
163976923|NCT00361270|592287258|FG001|Overall Study|Lost to Follow-up|1|||
163976924|NCT00361270|592287259|FG002|Overall Study|Lost to Follow-up|0|||
163976925|NCT00361270|592287260|FG003|Overall Study|Lost to Follow-up|0|||
163976926|NCT00361270|592287257|FG000|Overall Study|Physician Decision|0|||
163976927|NCT00361270|592287258|FG001|Overall Study|Physician Decision|0|||
163976928|NCT00361270|592287259|FG002|Overall Study|Physician Decision|1|||
163976929|NCT00361270|592287260|FG003|Overall Study|Physician Decision|0|||
163976930|NCT00361270|592287257|FG000|Overall Study|Protocol Violation|9|||
163976931|NCT00361270|592287258|FG001|Overall Study|Protocol Violation|4|||
163976932|NCT00361270|592287259|FG002|Overall Study|Protocol Violation|5|||
163976933|NCT00361270|592287260|FG003|Overall Study|Protocol Violation|4|||
164315058|NCT02059291|593531488|FG020|Epoch 2|Lack of Efficacy|0|||
164315059|NCT02059291|593531489|FG021|Epoch 2|Lack of Efficacy|0|||
164315060|NCT02059291|593531490|FG022|Epoch 2|Lack of Efficacy|0|||
164315061|NCT02059291|593531491|FG023|Epoch 2|Lack of Efficacy|0|||
164315062|NCT02059291|593531492|FG024|Epoch 2|Lack of Efficacy|0|||
164315063|NCT02059291|593531468|FG000|Epoch 2|Adverse Event|0|||
164315064|NCT02059291|593531469|FG001|Epoch 2|Adverse Event|0|||
164315065|NCT02059291|593531470|FG002|Epoch 2|Adverse Event|1|||
164315066|NCT02059291|593531471|FG003|Epoch 2|Adverse Event|1|||
164315067|NCT02059291|593531472|FG004|Epoch 2|Adverse Event|0|||
163976934|NCT00361270|592287257|FG000|Overall Study|Withdrawal by Subject|6|||
163976935|NCT00361270|592287258|FG001|Overall Study|Withdrawal by Subject|6|||
163976936|NCT00361270|592287259|FG002|Overall Study|Withdrawal by Subject|3|||
163976937|NCT00361270|592287260|FG003|Overall Study|Withdrawal by Subject|7|||
163976938|NCT00361270|592287257|FG000|Overall Study|Afraid of Hypnosis|1|||
163976939|NCT00361270|592287258|FG001|Overall Study|Afraid of Hypnosis|2|||
163976940|NCT00361270|592287259|FG002|Overall Study|Afraid of Hypnosis|0|||
163976941|NCT00361270|592287260|FG003|Overall Study|Afraid of Hypnosis|0|||
163976942|NCT00361270|592287257|FG000|Overall Study|Problems with Transportation|4|||
163976943|NCT00361270|592287258|FG001|Overall Study|Problems with Transportation|0|||
163976944|NCT00361270|592287259|FG002|Overall Study|Problems with Transportation|0|||
163976945|NCT00361270|592287260|FG003|Overall Study|Problems with Transportation|0|||
163976946|NCT00361270|592287257|FG000|Overall Study|Adverse Event|0|||
163976947|NCT00361270|592287258|FG001|Overall Study|Adverse Event|1|||
163976948|NCT00361270|592287259|FG002|Overall Study|Adverse Event|1|||
163976949|NCT00361270|592287260|FG003|Overall Study|Adverse Event|0|||
163976950|NCT00278993|592287268|FG000|Overall Study|Adverse Event|24|||
163976951|NCT00278993|592287268|FG000|Overall Study|Withdrawal by Subject|5|||
163976952|NCT00278993|592287268|FG000|Overall Study|Progressive Disease|65|||
163976953|NCT00278993|592287268|FG000|Overall Study|Physician Decision|9|||
163976954|NCT00278993|592287268|FG000|Overall Study|Not Otherwise Specified|4|||
163976955|NCT00470054|592287269|FG000|Overall Study|Ineligible|1|||
163976956|NCT01439555|592287270|FG000|Overall Study|Protocol Violation|1|||
163976957|NCT04194528|592287275|FG000|Overall Study|Adverse Event|1|||
163976958|NCT03921424|592287282|FG000|Overall Study|Lost to Follow-up|0|||
163976959|NCT03921424|592287283|FG001|Overall Study|Lost to Follow-up|1|||
163976960|NCT03921424|592287282|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
163976961|NCT03921424|592287283|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
163976962|NCT01246583|592287286|FG000|Overall Study|Lost to Follow-up|0|||
163976963|NCT01246583|592287287|FG001|Overall Study|Lost to Follow-up|0|||
163976964|NCT01246583|592287288|FG002|Overall Study|Lost to Follow-up|0|||
163976965|NCT01246583|592287289|FG003|Overall Study|Lost to Follow-up|1|||
163976966|NCT01246583|592287286|FG000|Overall Study|Protocol Violation|0|||
163976967|NCT01246583|592287287|FG001|Overall Study|Protocol Violation|0|||
163976968|NCT01246583|592287288|FG002|Overall Study|Protocol Violation|1|||
163976969|NCT01246583|592287289|FG003|Overall Study|Protocol Violation|0|||
163976970|NCT01246583|592287286|FG000|Overall Study|Withdrawal by Subject|1|||
163976971|NCT01246583|592287287|FG001|Overall Study|Withdrawal by Subject|0|||
163976972|NCT01246583|592287288|FG002|Overall Study|Withdrawal by Subject|0|||
163976973|NCT01246583|592287289|FG003|Overall Study|Withdrawal by Subject|0|||
163976974|NCT02595450|592287290|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
163976975|NCT02595450|592287290|FG000|Overall Study|Enrolled, but not treated|8|||
163976976|NCT05264740|592287292|FG000|Baseline|Withdrawal by Subject|0|||
163976977|NCT05264740|592287293|FG001|Baseline|Withdrawal by Subject|1|||
164315068|NCT02059291|593531473|FG005|Epoch 2|Adverse Event|0|||
164315069|NCT02059291|593531474|FG006|Epoch 2|Adverse Event|0|||
164315070|NCT02059291|593531475|FG007|Epoch 2|Adverse Event|1|||
163976978|NCT05264740|592287292|FG000|Follow Up 1|Lost to Follow-up|1|||
163976979|NCT05264740|592287293|FG001|Follow Up 1|Lost to Follow-up|1|||
163976980|NCT05264740|592287292|FG000|Follow Up 1|Withdrawal by Subject|0|||
163976981|NCT05264740|592287293|FG001|Follow Up 1|Withdrawal by Subject|1|||
164315071|NCT02059291|593531476|FG008|Epoch 2|Adverse Event|1|||
164315072|NCT02059291|593531477|FG009|Epoch 2|Adverse Event|0|||
164315073|NCT02059291|593531478|FG010|Epoch 2|Adverse Event|0|||
163976982|NCT05264740|592287292|FG000|Follow Up 2|Lost to Follow-up|1|||
163976983|NCT05264740|592287293|FG001|Follow Up 2|Lost to Follow-up|4|||
163976984|NCT05264740|592287292|FG000|Follow Up 3|Lost to Follow-up|7|||
163976985|NCT05264740|592287293|FG001|Follow Up 3|Lost to Follow-up|4|||
163976986|NCT00102960|592287296|FG000|Overall Study|Death|23|||
163976987|NCT00102960|592287297|FG001|Overall Study|Death|11|||
163976988|NCT00102960|592287298|FG002|Overall Study|Death|11|||
163976989|NCT00102960|592287296|FG000|Overall Study|Lost to Follow-up|6|||
163976990|NCT00102960|592287297|FG001|Overall Study|Lost to Follow-up|12|||
164315074|NCT02059291|593531479|FG011|Epoch 2|Adverse Event|0|||
163976991|NCT00102960|592287298|FG002|Overall Study|Lost to Follow-up|16|||
164315075|NCT02059291|593531480|FG012|Epoch 2|Adverse Event|0|||
164315076|NCT02059291|593531481|FG013|Epoch 2|Adverse Event|0|||
164315077|NCT02059291|593531482|FG014|Epoch 2|Adverse Event|0|||
163872602|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
163872603|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
163872604|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163872605|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163872606|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
163872607|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163872608|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
163872609|NCT04759833|591903907|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163872610|NCT04759833|591903908|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
163872611|NCT04759833|591903909|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163872612|NCT04759833|591903910|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163872613|NCT04759833|591903911|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
163872614|NCT04759833|591903907|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
163872615|NCT04759833|591903908|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
163872616|NCT04759833|591903909|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
163872617|NCT04759833|591903910|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
163872618|NCT04759833|591903911|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
163872619|NCT04759833|591903907|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163872620|NCT04759833|591903908|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163872621|NCT04759833|591903909|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163872622|NCT04759833|591903910|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
163872623|NCT04759833|591903911|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
163872624|NCT04759833|591903907|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
163872625|NCT04759833|591903908|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
163872626|NCT04759833|591903909|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
163872627|NCT04759833|591903910|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
163872628|NCT04759833|591903911|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
163872629|NCT04759833|591903907|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
163872630|NCT04759833|591903908|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
163872631|NCT04759833|591903909|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
163872632|NCT04759833|591903910|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
163872633|NCT04759833|591903911|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
163872634|NCT04759833|591903907|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
163872635|NCT04759833|591903908|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
163872636|NCT04759833|591903909|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
163872637|NCT04759833|591903910|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
163872638|NCT04759833|591903911|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
163872639|NCT04759833|591903907|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
163872640|NCT04759833|591903908|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
163872641|NCT04759833|591903909|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
163872642|NCT04759833|591903910|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
163872643|NCT04759833|591903911|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
163872644|NCT00508924|591903912|FG000|Overall Study|Protocol Violation|0|||
163872645|NCT00508924|591903913|FG001|Overall Study|Protocol Violation|0|||
163872646|NCT00508924|591903914|FG002|Overall Study|Protocol Violation|1|||
163872647|NCT00508924|591903915|FG003|Overall Study|Protocol Violation|1|||
163872648|NCT00630058|591903917|FG000|Overall Study|Adverse Event|1|||
163872649|NCT00630058|591903918|FG001|Overall Study|Adverse Event|1|||
163872650|NCT00630058|591903917|FG000|Overall Study|Withdrawal by Subject|0|||
163872651|NCT00630058|591903918|FG001|Overall Study|Withdrawal by Subject|1|||
164315078|NCT02059291|593531483|FG015|Epoch 2|Adverse Event|0|||
164315079|NCT02059291|593531484|FG016|Epoch 2|Adverse Event|0|||
164315080|NCT02059291|593531485|FG017|Epoch 2|Adverse Event|0|||
164315081|NCT02059291|593531486|FG018|Epoch 2|Adverse Event|0|||
164315082|NCT02059291|593531487|FG019|Epoch 2|Adverse Event|0|||
164315083|NCT02059291|593531488|FG020|Epoch 2|Adverse Event|0|||
164315084|NCT02059291|593531489|FG021|Epoch 2|Adverse Event|0|||
164315085|NCT02059291|593531490|FG022|Epoch 2|Adverse Event|0|||
164315086|NCT02059291|593531491|FG023|Epoch 2|Adverse Event|0|||
164315087|NCT02059291|593531492|FG024|Epoch 2|Adverse Event|0|||
164315088|NCT02059291|593531468|FG000|Epoch 2|Withdrawal by Subject|0|||
164315089|NCT02059291|593531469|FG001|Epoch 2|Withdrawal by Subject|1|||
164315090|NCT02059291|593531470|FG002|Epoch 2|Withdrawal by Subject|0|||
164315091|NCT02059291|593531471|FG003|Epoch 2|Withdrawal by Subject|0|||
164315092|NCT02059291|593531472|FG004|Epoch 2|Withdrawal by Subject|0|||
163872652|NCT00630058|591903917|FG000|Overall Study|stopping criteria|3|||
163872653|NCT00630058|591903918|FG001|Overall Study|stopping criteria|2|||
163872654|NCT00391898|591903925|FG000|Overall Study|Adverse Event|3|||
163872655|NCT00391898|591903926|FG001|Overall Study|Adverse Event|0|||
163872656|NCT00391898|591903925|FG000|Overall Study|Other|8|||
163872657|NCT00391898|591903926|FG001|Overall Study|Other|10|||
163872658|NCT05489484|591903927|FG000|Overall Study|withdrawn|1|||
163872659|NCT02529995|591903928|FG000|Part A|Ongoing Study at Data Cut-off|14|||
163872660|NCT02529995|591903929|FG001|Part A|Ongoing Study at Data Cut-off|16|||
163872661|NCT02529995|591903928|FG000|Part A|Discontinued Study|1|||
163872662|NCT02529995|591903929|FG001|Part A|Discontinued Study|0|||
163872663|NCT02529995|591903928|FG000|Part B|Ongoing Study at Data Cut-off|0|||
163872664|NCT02529995|591903929|FG001|Part B|Ongoing Study at Data Cut-off|7|||
163872665|NCT02529995|591903928|FG000|Part B|Discontinued Study|6|||
163872666|NCT02529995|591903929|FG001|Part B|Discontinued Study|5|||
163872667|NCT02706717|591903930|FG000|Overall Study|Withdrawal by Subject|1|||
163872668|NCT02706717|591903931|FG001|Overall Study|Withdrawal by Subject|8|||
163872669|NCT02706717|591903930|FG000|Overall Study|Lost to Follow-up|0|||
163872670|NCT02706717|591903931|FG001|Overall Study|Lost to Follow-up|1|||
163872671|NCT02706717|591903930|FG000|Overall Study|Physician Decision|0|||
163872672|NCT02706717|591903931|FG001|Overall Study|Physician Decision|1|||
163872673|NCT02706717|591903930|FG000|Overall Study|Death|0|||
163872674|NCT02706717|591903931|FG001|Overall Study|Death|1|||
163872675|NCT00444600|591903932|FG000|Overall Study|Death|7|||
163872676|NCT00444600|591903933|FG001|Overall Study|Death|5|||
163872677|NCT00444600|591903934|FG002|Overall Study|Death|3|||
163872678|NCT00444600|591903935|FG003|Overall Study|Death|2|||
163872679|NCT00444600|591903932|FG000|Overall Study|Dropped|11|||
163872680|NCT00444600|591903933|FG001|Overall Study|Dropped|11|||
163872681|NCT00444600|591903934|FG002|Overall Study|Dropped|7|||
163872682|NCT00444600|591903935|FG003|Overall Study|Dropped|7|||
163872683|NCT00444600|591903932|FG000|Overall Study|Missed visit|1|||
163872684|NCT00444600|591903933|FG001|Overall Study|Missed visit|0|||
163872685|NCT00444600|591903934|FG002|Overall Study|Missed visit|0|||
163872686|NCT00444600|591903935|FG003|Overall Study|Missed visit|1|||
163872687|NCT05132478|591903936|FG000|Overall Study|did not complete survey after consent|1|||
163872688|NCT05132478|591903937|FG001|Overall Study|did not complete survey after consent|1|||
163872689|NCT05132478|591903936|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
163872690|NCT05132478|591903937|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
163872691|NCT02549170|591903938|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
163872692|NCT02549170|591903939|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
163872693|NCT02549170|591903940|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
163872694|NCT02549170|591903941|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
163872695|NCT02549170|591903942|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
163872696|NCT02549170|591903938|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
163872697|NCT02549170|591903939|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
163872698|NCT02549170|591903940|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
163872699|NCT02549170|591903941|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
163872700|NCT02549170|591903942|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
163872701|NCT02549170|591903938|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
163872702|NCT02549170|591903939|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
163872703|NCT02549170|591903940|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
163872704|NCT02549170|591903941|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
163872705|NCT02549170|591903942|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
163872706|NCT02988817|591903943|FG000|Overall Study|Withdrawal by Subject|1|||
163872707|NCT02988817|591903944|FG001|Overall Study|Withdrawal by Subject|0|||
163872708|NCT02988817|591903945|FG002|Overall Study|Withdrawal by Subject|0|||
163872709|NCT02988817|591903946|FG003|Overall Study|Withdrawal by Subject|1|||
163872710|NCT02988817|591903947|FG004|Overall Study|Withdrawal by Subject|3|||
163872711|NCT02988817|591903948|FG005|Overall Study|Withdrawal by Subject|1|||
163872712|NCT02988817|591903949|FG006|Overall Study|Withdrawal by Subject|2|||
163872713|NCT02988817|591903950|FG007|Overall Study|Withdrawal by Subject|1|||
163872714|NCT02988817|591903951|FG008|Overall Study|Withdrawal by Subject|1|||
163872715|NCT02988817|591903952|FG009|Overall Study|Withdrawal by Subject|1|||
163872716|NCT02988817|591903953|FG010|Overall Study|Withdrawal by Subject|1|||
163872717|NCT02988817|591903954|FG011|Overall Study|Withdrawal by Subject|12|||
163872718|NCT02988817|591903955|FG012|Overall Study|Withdrawal by Subject|6|||
163872719|NCT02988817|591903956|FG013|Overall Study|Withdrawal by Subject|6|||
163872720|NCT02988817|591903957|FG014|Overall Study|Withdrawal by Subject|4|||
163976992|NCT00102960|592287296|FG000|Overall Study|Withdrawal by Subject|1|||
163976993|NCT00102960|592287297|FG001|Overall Study|Withdrawal by Subject|0|||
163976994|NCT00102960|592287298|FG002|Overall Study|Withdrawal by Subject|1|||
163976995|NCT01423851|592287299|FG000|Whole Study|Disease progression|2|||
163976996|NCT01423851|592287300|FG001|Whole Study|Disease progression|1|||
163976997|NCT01423851|592287301|FG002|Whole Study|Disease progression|1|||
163976998|NCT01423851|592287302|FG003|Whole Study|Disease progression|4|||
163976999|NCT01423851|592287303|FG004|Whole Study|Disease progression|1|||
163977000|NCT01423851|592287304|FG005|Whole Study|Disease progression|3|||
163977001|NCT01423851|592287305|FG006|Whole Study|Disease progression|1|||
163977002|NCT01423851|592287306|FG007|Whole Study|Disease progression|4|||
163977003|NCT01423851|592287307|FG008|Whole Study|Disease progression|0|||
163977004|NCT01423851|592287308|FG009|Whole Study|Disease progression|2|||
163977005|NCT01423851|592287309|FG010|Whole Study|Disease progression|10|||
163977006|NCT01423851|592287299|FG000|Whole Study|Physician Decision|0|||
164315093|NCT02059291|593531473|FG005|Epoch 2|Withdrawal by Subject|1|||
164315094|NCT02059291|593531474|FG006|Epoch 2|Withdrawal by Subject|0|||
164315095|NCT02059291|593531475|FG007|Epoch 2|Withdrawal by Subject|0|||
164315096|NCT02059291|593531476|FG008|Epoch 2|Withdrawal by Subject|1|||
164315097|NCT02059291|593531477|FG009|Epoch 2|Withdrawal by Subject|0|||
164315098|NCT02059291|593531478|FG010|Epoch 2|Withdrawal by Subject|0|||
164315099|NCT02059291|593531479|FG011|Epoch 2|Withdrawal by Subject|0|||
164315100|NCT02059291|593531480|FG012|Epoch 2|Withdrawal by Subject|0|||
164315101|NCT02059291|593531481|FG013|Epoch 2|Withdrawal by Subject|0|||
164315102|NCT02059291|593531482|FG014|Epoch 2|Withdrawal by Subject|0|||
164315103|NCT02059291|593531483|FG015|Epoch 2|Withdrawal by Subject|0|||
164315104|NCT02059291|593531484|FG016|Epoch 2|Withdrawal by Subject|0|||
164315105|NCT02059291|593531485|FG017|Epoch 2|Withdrawal by Subject|0|||
164315106|NCT02059291|593531486|FG018|Epoch 2|Withdrawal by Subject|0|||
164315107|NCT02059291|593531487|FG019|Epoch 2|Withdrawal by Subject|0|||
164315108|NCT02059291|593531488|FG020|Epoch 2|Withdrawal by Subject|0|||
164315109|NCT02059291|593531489|FG021|Epoch 2|Withdrawal by Subject|0|||
164315110|NCT02059291|593531490|FG022|Epoch 2|Withdrawal by Subject|0|||
164315111|NCT02059291|593531491|FG023|Epoch 2|Withdrawal by Subject|0|||
164315112|NCT02059291|593531492|FG024|Epoch 2|Withdrawal by Subject|0|||
164315113|NCT02059291|593531468|FG000|Epoch 3|Physician Decision|0|||
164315114|NCT02059291|593531469|FG001|Epoch 3|Physician Decision|0|||
164315115|NCT02059291|593531470|FG002|Epoch 3|Physician Decision|0|||
164315116|NCT02059291|593531471|FG003|Epoch 3|Physician Decision|0|||
164315117|NCT02059291|593531472|FG004|Epoch 3|Physician Decision|0|||
164315118|NCT02059291|593531473|FG005|Epoch 3|Physician Decision|0|||
164315119|NCT02059291|593531474|FG006|Epoch 3|Physician Decision|0|||
164315120|NCT02059291|593531475|FG007|Epoch 3|Physician Decision|0|||
164315121|NCT02059291|593531476|FG008|Epoch 3|Physician Decision|0|||
164315122|NCT02059291|593531477|FG009|Epoch 3|Physician Decision|0|||
164315123|NCT02059291|593531478|FG010|Epoch 3|Physician Decision|0|||
164315124|NCT02059291|593531479|FG011|Epoch 3|Physician Decision|0|||
164315125|NCT02059291|593531480|FG012|Epoch 3|Physician Decision|0|||
164315126|NCT02059291|593531481|FG013|Epoch 3|Physician Decision|1|||
164315127|NCT02059291|593531482|FG014|Epoch 3|Physician Decision|0|||
164315128|NCT02059291|593531483|FG015|Epoch 3|Physician Decision|1|||
164315129|NCT02059291|593531484|FG016|Epoch 3|Physician Decision|0|||
164315130|NCT02059291|593531485|FG017|Epoch 3|Physician Decision|0|||
164315131|NCT02059291|593531486|FG018|Epoch 3|Physician Decision|0|||
164315132|NCT02059291|593531487|FG019|Epoch 3|Physician Decision|0|||
164315133|NCT02059291|593531488|FG020|Epoch 3|Physician Decision|0|||
164315134|NCT02059291|593531489|FG021|Epoch 3|Physician Decision|0|||
164315135|NCT02059291|593531490|FG022|Epoch 3|Physician Decision|0|||
164315136|NCT02059291|593531491|FG023|Epoch 3|Physician Decision|0|||
164315137|NCT02059291|593531492|FG024|Epoch 3|Physician Decision|0|||
163977007|NCT01423851|592287300|FG001|Whole Study|Physician Decision|1|||
163977008|NCT01423851|592287301|FG002|Whole Study|Physician Decision|2|||
163977009|NCT01423851|592287302|FG003|Whole Study|Physician Decision|0|||
163977010|NCT01423851|592287303|FG004|Whole Study|Physician Decision|2|||
164315138|NCT02059291|593531468|FG000|Epoch 3|Adverse Event|0|||
164315139|NCT02059291|593531469|FG001|Epoch 3|Adverse Event|0|||
164315140|NCT02059291|593531470|FG002|Epoch 3|Adverse Event|0|||
164315141|NCT02059291|593531471|FG003|Epoch 3|Adverse Event|0|||
164315142|NCT02059291|593531472|FG004|Epoch 3|Adverse Event|0|||
164315143|NCT02059291|593531473|FG005|Epoch 3|Adverse Event|0|||
164315144|NCT02059291|593531474|FG006|Epoch 3|Adverse Event|0|||
164315145|NCT02059291|593531475|FG007|Epoch 3|Adverse Event|0|||
164315146|NCT02059291|593531476|FG008|Epoch 3|Adverse Event|0|||
163977011|NCT01423851|592287304|FG005|Whole Study|Physician Decision|0|||
163977012|NCT01423851|592287305|FG006|Whole Study|Physician Decision|2|||
164315147|NCT02059291|593531477|FG009|Epoch 3|Adverse Event|0|||
164315148|NCT02059291|593531478|FG010|Epoch 3|Adverse Event|0|||
164315149|NCT02059291|593531479|FG011|Epoch 3|Adverse Event|0|||
164315150|NCT02059291|593531480|FG012|Epoch 3|Adverse Event|0|||
164315151|NCT02059291|593531481|FG013|Epoch 3|Adverse Event|0|||
164315152|NCT02059291|593531482|FG014|Epoch 3|Adverse Event|0|||
164315153|NCT02059291|593531483|FG015|Epoch 3|Adverse Event|1|||
164315154|NCT02059291|593531484|FG016|Epoch 3|Adverse Event|0|||
164315155|NCT02059291|593531485|FG017|Epoch 3|Adverse Event|0|||
164315156|NCT02059291|593531486|FG018|Epoch 3|Adverse Event|0|||
164315157|NCT02059291|593531487|FG019|Epoch 3|Adverse Event|0|||
164315158|NCT02059291|593531488|FG020|Epoch 3|Adverse Event|0|||
164315159|NCT02059291|593531489|FG021|Epoch 3|Adverse Event|0|||
164315160|NCT02059291|593531490|FG022|Epoch 3|Adverse Event|0|||
164315161|NCT02059291|593531491|FG023|Epoch 3|Adverse Event|0|||
164315162|NCT02059291|593531492|FG024|Epoch 3|Adverse Event|0|||
164315163|NCT02059291|593531468|FG000|Epoch 3|Lack of Efficacy|0|||
164315164|NCT02059291|593531469|FG001|Epoch 3|Lack of Efficacy|0|||
164315165|NCT02059291|593531470|FG002|Epoch 3|Lack of Efficacy|0|||
164315166|NCT02059291|593531471|FG003|Epoch 3|Lack of Efficacy|0|||
164315167|NCT02059291|593531472|FG004|Epoch 3|Lack of Efficacy|0|||
164315168|NCT02059291|593531473|FG005|Epoch 3|Lack of Efficacy|0|||
164315169|NCT02059291|593531474|FG006|Epoch 3|Lack of Efficacy|0|||
163977013|NCT01423851|592287306|FG007|Whole Study|Physician Decision|1|||
163977014|NCT01423851|592287307|FG008|Whole Study|Physician Decision|3|||
163977015|NCT01423851|592287308|FG009|Whole Study|Physician Decision|4|||
163977016|NCT01423851|592287309|FG010|Whole Study|Physician Decision|12|||
163977017|NCT01423851|592287299|FG000|Whole Study|Withdrawal by Subject|1|||
163977018|NCT01423851|592287300|FG001|Whole Study|Withdrawal by Subject|1|||
163977019|NCT01423851|592287301|FG002|Whole Study|Withdrawal by Subject|0|||
163977020|NCT01423851|592287302|FG003|Whole Study|Withdrawal by Subject|0|||
163977021|NCT01423851|592287303|FG004|Whole Study|Withdrawal by Subject|0|||
163977022|NCT01423851|592287304|FG005|Whole Study|Withdrawal by Subject|0|||
163977023|NCT01423851|592287305|FG006|Whole Study|Withdrawal by Subject|0|||
163977024|NCT01423851|592287306|FG007|Whole Study|Withdrawal by Subject|0|||
163977025|NCT01423851|592287307|FG008|Whole Study|Withdrawal by Subject|2|||
163977026|NCT01423851|592287308|FG009|Whole Study|Withdrawal by Subject|0|||
163977027|NCT01423851|592287309|FG010|Whole Study|Withdrawal by Subject|4|||
163977028|NCT01423851|592287299|FG000|Whole Study|Adverse Event|0|||
163977029|NCT01423851|592287300|FG001|Whole Study|Adverse Event|0|||
163977030|NCT01423851|592287301|FG002|Whole Study|Adverse Event|0|||
164315170|NCT02059291|593531475|FG007|Epoch 3|Lack of Efficacy|0|||
164315171|NCT02059291|593531476|FG008|Epoch 3|Lack of Efficacy|0|||
164315172|NCT02059291|593531477|FG009|Epoch 3|Lack of Efficacy|0|||
164315173|NCT02059291|593531478|FG010|Epoch 3|Lack of Efficacy|0|||
164315174|NCT02059291|593531479|FG011|Epoch 3|Lack of Efficacy|0|||
164315175|NCT02059291|593531480|FG012|Epoch 3|Lack of Efficacy|0|||
164315176|NCT02059291|593531481|FG013|Epoch 3|Lack of Efficacy|0|||
164315177|NCT02059291|593531482|FG014|Epoch 3|Lack of Efficacy|0|||
164315178|NCT02059291|593531483|FG015|Epoch 3|Lack of Efficacy|3|||
164315179|NCT02059291|593531484|FG016|Epoch 3|Lack of Efficacy|0|||
164315180|NCT02059291|593531485|FG017|Epoch 3|Lack of Efficacy|0|||
164315181|NCT02059291|593531486|FG018|Epoch 3|Lack of Efficacy|0|||
164315182|NCT02059291|593531487|FG019|Epoch 3|Lack of Efficacy|0|||
163977031|NCT01423851|592287302|FG003|Whole Study|Adverse Event|2|||
163977032|NCT01423851|592287303|FG004|Whole Study|Adverse Event|0|||
163977033|NCT01423851|592287304|FG005|Whole Study|Adverse Event|0|||
163977034|NCT01423851|592287305|FG006|Whole Study|Adverse Event|0|||
163977035|NCT01423851|592287306|FG007|Whole Study|Adverse Event|3|||
163977036|NCT01423851|592287307|FG008|Whole Study|Adverse Event|3|||
164315183|NCT02059291|593531488|FG020|Epoch 3|Lack of Efficacy|0|||
164315184|NCT02059291|593531489|FG021|Epoch 3|Lack of Efficacy|0|||
164315185|NCT02059291|593531490|FG022|Epoch 3|Lack of Efficacy|0|||
164315186|NCT02059291|593531491|FG023|Epoch 3|Lack of Efficacy|0|||
164315187|NCT02059291|593531492|FG024|Epoch 3|Lack of Efficacy|0|||
163977037|NCT01423851|592287308|FG009|Whole Study|Adverse Event|2|||
163977038|NCT01423851|592287309|FG010|Whole Study|Adverse Event|3|||
163977039|NCT01395394|592288652|FG000|Baseline Study Visit|Protocol Violation|1|||
163977040|NCT01395394|592288653|FG001|Baseline Study Visit|Protocol Violation|0|||
163977041|NCT01395394|592288654|FG002|Baseline Study Visit|Protocol Violation|0|||
163977042|NCT02356562|592288655|FG000|Overall Study|Withdrawal by Subject|0|||
164315188|NCT02059291|593531468|FG000|Epoch 3|Withdrawal by Subject|0|||
164315189|NCT02059291|593531469|FG001|Epoch 3|Withdrawal by Subject|0|||
164315190|NCT02059291|593531470|FG002|Epoch 3|Withdrawal by Subject|0|||
163977043|NCT02356562|592288656|FG001|Overall Study|Withdrawal by Subject|1|||
163977044|NCT02356562|592288655|FG000|Overall Study|Re-entered treatment in a previous study|1|||
163977045|NCT02356562|592288656|FG001|Overall Study|Re-entered treatment in a previous study|0|||
163977046|NCT02356562|592288655|FG000|Overall Study|site closure|1|||
163977047|NCT02356562|592288656|FG001|Overall Study|site closure|0|||
163977048|NCT00150592|592288657|FG000|Overall Study|Adverse Event|4|||
164315191|NCT02059291|593531471|FG003|Epoch 3|Withdrawal by Subject|0|||
164315192|NCT02059291|593531472|FG004|Epoch 3|Withdrawal by Subject|0|||
164315193|NCT02059291|593531473|FG005|Epoch 3|Withdrawal by Subject|0|||
164315194|NCT02059291|593531474|FG006|Epoch 3|Withdrawal by Subject|0|||
164315195|NCT02059291|593531475|FG007|Epoch 3|Withdrawal by Subject|0|||
164315196|NCT02059291|593531476|FG008|Epoch 3|Withdrawal by Subject|0|||
164315197|NCT02059291|593531477|FG009|Epoch 3|Withdrawal by Subject|0|||
164315198|NCT02059291|593531478|FG010|Epoch 3|Withdrawal by Subject|0|||
164315199|NCT02059291|593531479|FG011|Epoch 3|Withdrawal by Subject|0|||
164315200|NCT02059291|593531480|FG012|Epoch 3|Withdrawal by Subject|0|||
163977049|NCT00150592|592288658|FG001|Overall Study|Adverse Event|1|||
163977050|NCT00150592|592288657|FG000|Overall Study|Protocol Violation|1|||
164315201|NCT02059291|593531481|FG013|Epoch 3|Withdrawal by Subject|0|||
164315202|NCT02059291|593531482|FG014|Epoch 3|Withdrawal by Subject|0|||
164315203|NCT02059291|593531483|FG015|Epoch 3|Withdrawal by Subject|1|||
164315204|NCT02059291|593531484|FG016|Epoch 3|Withdrawal by Subject|0|||
164315205|NCT02059291|593531485|FG017|Epoch 3|Withdrawal by Subject|0|||
164315206|NCT02059291|593531486|FG018|Epoch 3|Withdrawal by Subject|0|||
164315207|NCT02059291|593531487|FG019|Epoch 3|Withdrawal by Subject|0|||
164315208|NCT02059291|593531488|FG020|Epoch 3|Withdrawal by Subject|0|||
164315209|NCT02059291|593531489|FG021|Epoch 3|Withdrawal by Subject|0|||
164315210|NCT02059291|593531490|FG022|Epoch 3|Withdrawal by Subject|0|||
164315211|NCT02059291|593531491|FG023|Epoch 3|Withdrawal by Subject|0|||
164315212|NCT02059291|593531492|FG024|Epoch 3|Withdrawal by Subject|0|||
164315213|NCT02059291|593531468|FG000|Epoch 4|Adverse Event|0|||
164315214|NCT02059291|593531469|FG001|Epoch 4|Adverse Event|0|||
164315215|NCT02059291|593531470|FG002|Epoch 4|Adverse Event|0|||
164315216|NCT02059291|593531471|FG003|Epoch 4|Adverse Event|0|||
164315217|NCT02059291|593531472|FG004|Epoch 4|Adverse Event|0|||
164315218|NCT02059291|593531473|FG005|Epoch 4|Adverse Event|0|||
164315219|NCT02059291|593531474|FG006|Epoch 4|Adverse Event|0|||
164315220|NCT02059291|593531475|FG007|Epoch 4|Adverse Event|0|||
164315221|NCT02059291|593531476|FG008|Epoch 4|Adverse Event|0|||
164315222|NCT02059291|593531477|FG009|Epoch 4|Adverse Event|0|||
164315223|NCT02059291|593531478|FG010|Epoch 4|Adverse Event|0|||
164315224|NCT02059291|593531479|FG011|Epoch 4|Adverse Event|0|||
164315225|NCT02059291|593531480|FG012|Epoch 4|Adverse Event|0|||
164315226|NCT02059291|593531481|FG013|Epoch 4|Adverse Event|0|||
164315227|NCT02059291|593531482|FG014|Epoch 4|Adverse Event|0|||
164315228|NCT02059291|593531483|FG015|Epoch 4|Adverse Event|0|||
164315229|NCT02059291|593531484|FG016|Epoch 4|Adverse Event|1|||
164315230|NCT02059291|593531485|FG017|Epoch 4|Adverse Event|0|||
164315231|NCT02059291|593531486|FG018|Epoch 4|Adverse Event|0|||
164315232|NCT02059291|593531487|FG019|Epoch 4|Adverse Event|0|||
164315233|NCT02059291|593531488|FG020|Epoch 4|Adverse Event|0|||
164315234|NCT02059291|593531489|FG021|Epoch 4|Adverse Event|0|||
164315235|NCT02059291|593531490|FG022|Epoch 4|Adverse Event|1|||
163977051|NCT00150592|592288658|FG001|Overall Study|Protocol Violation|0|||
163977052|NCT00150592|592288657|FG000|Overall Study|Withdrawal by Subject|1|||
163977053|NCT00150592|592288658|FG001|Overall Study|Withdrawal by Subject|2|||
163977054|NCT00150592|592288657|FG000|Overall Study|Non-compliance|1|||
163977055|NCT00150592|592288658|FG001|Overall Study|Non-compliance|0|||
163977056|NCT00412750|592288661|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163977057|NCT00412750|592288662|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163977058|NCT00412750|592288663|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163977059|NCT00412750|592288661|FG000|Overall Study|Administrative problems|21|||
163977060|NCT00412750|592288662|FG001|Overall Study|Administrative problems|17|||
163977061|NCT00412750|592288663|FG002|Overall Study|Administrative problems|14|||
163977062|NCT00412750|592288661|FG000|Overall Study|Adverse Event|8|||
163977063|NCT00412750|592288662|FG001|Overall Study|Adverse Event|3|||
163977064|NCT00412750|592288663|FG002|Overall Study|Adverse Event|3|||
163977065|NCT00412750|592288661|FG000|Overall Study|Lost to Follow-up|1|||
163977066|NCT00412750|592288662|FG001|Overall Study|Lost to Follow-up|0|||
163977067|NCT00412750|592288663|FG002|Overall Study|Lost to Follow-up|1|||
163977068|NCT00412750|592288661|FG000|Overall Study|Withdrawal by Subject|0|||
163977069|NCT00412750|592288662|FG001|Overall Study|Withdrawal by Subject|1|||
163977070|NCT00412750|592288663|FG002|Overall Study|Withdrawal by Subject|2|||
163977071|NCT00412750|592288661|FG000|Overall Study|Lack of Efficacy|0|||
163977072|NCT00412750|592288662|FG001|Overall Study|Lack of Efficacy|0|||
163977073|NCT00412750|592288663|FG002|Overall Study|Lack of Efficacy|3|||
163977074|NCT01823679|592288668|FG000|Overall Study|Death|1|||
163977075|NCT01157078|592288669|FG000|Overall Study|Withdrawal by Subject|12|||
163977076|NCT01157078|592288670|FG001|Overall Study|Withdrawal by Subject|14|||
164315236|NCT02059291|593531491|FG023|Epoch 4|Adverse Event|0|||
164315237|NCT02059291|593531492|FG024|Epoch 4|Adverse Event|0|||
164315238|NCT02059291|593531468|FG000|Epoch 4|Pregnancy|0|||
164315239|NCT02059291|593531469|FG001|Epoch 4|Pregnancy|0|||
164315240|NCT02059291|593531470|FG002|Epoch 4|Pregnancy|0|||
164315241|NCT02059291|593531471|FG003|Epoch 4|Pregnancy|0|||
163977077|NCT01157078|592288669|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163977078|NCT01157078|592288670|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
163977079|NCT01157078|592288669|FG000|Overall Study|Adverse Event|6|||
163977080|NCT01157078|592288670|FG001|Overall Study|Adverse Event|6|||
164315242|NCT02059291|593531472|FG004|Epoch 4|Pregnancy|0|||
164315243|NCT02059291|593531473|FG005|Epoch 4|Pregnancy|0|||
164315244|NCT02059291|593531474|FG006|Epoch 4|Pregnancy|0|||
164315245|NCT02059291|593531475|FG007|Epoch 4|Pregnancy|0|||
164315246|NCT02059291|593531476|FG008|Epoch 4|Pregnancy|0|||
164315247|NCT02059291|593531477|FG009|Epoch 4|Pregnancy|0|||
164315248|NCT02059291|593531478|FG010|Epoch 4|Pregnancy|0|||
164315249|NCT02059291|593531479|FG011|Epoch 4|Pregnancy|0|||
164315250|NCT02059291|593531480|FG012|Epoch 4|Pregnancy|0|||
164315251|NCT02059291|593531481|FG013|Epoch 4|Pregnancy|0|||
164315252|NCT02059291|593531482|FG014|Epoch 4|Pregnancy|0|||
164315253|NCT02059291|593531483|FG015|Epoch 4|Pregnancy|0|||
164315254|NCT02059291|593531484|FG016|Epoch 4|Pregnancy|1|||
164315255|NCT02059291|593531485|FG017|Epoch 4|Pregnancy|0|||
164315256|NCT02059291|593531486|FG018|Epoch 4|Pregnancy|0|||
164315257|NCT02059291|593531487|FG019|Epoch 4|Pregnancy|0|||
164315258|NCT02059291|593531488|FG020|Epoch 4|Pregnancy|0|||
164315259|NCT02059291|593531489|FG021|Epoch 4|Pregnancy|0|||
163872721|NCT02988817|591903958|FG015|Overall Study|Withdrawal by Subject|5|||
163872722|NCT02988817|591903959|FG016|Overall Study|Withdrawal by Subject|4|||
163872723|NCT02988817|591903960|FG017|Overall Study|Withdrawal by Subject|11|||
163872724|NCT02988817|591903961|FG018|Overall Study|Withdrawal by Subject|4|||
163872725|NCT02988817|591903962|FG019|Overall Study|Withdrawal by Subject|2|||
163872726|NCT02988817|591903943|FG000|Overall Study|Death|0|||
163872727|NCT02988817|591903944|FG001|Overall Study|Death|1|||
163872728|NCT02988817|591903945|FG002|Overall Study|Death|3|||
163872729|NCT02988817|591903946|FG003|Overall Study|Death|1|||
163872730|NCT02988817|591903947|FG004|Overall Study|Death|6|||
163872731|NCT02988817|591903948|FG005|Overall Study|Death|10|||
163872732|NCT02988817|591903949|FG006|Overall Study|Death|1|||
163872733|NCT02988817|591903950|FG007|Overall Study|Death|2|||
163872734|NCT02988817|591903951|FG008|Overall Study|Death|1|||
163872735|NCT02988817|591903952|FG009|Overall Study|Death|5|||
163872736|NCT02988817|591903953|FG010|Overall Study|Death|1|||
163872737|NCT02988817|591903954|FG011|Overall Study|Death|8|||
163872738|NCT02988817|591903955|FG012|Overall Study|Death|9|||
163872739|NCT02988817|591903956|FG013|Overall Study|Death|17|||
163872740|NCT02988817|591903957|FG014|Overall Study|Death|18|||
163872741|NCT02988817|591903958|FG015|Overall Study|Death|30|||
163872742|NCT02988817|591903959|FG016|Overall Study|Death|17|||
163872743|NCT02988817|591903960|FG017|Overall Study|Death|38|||
163872744|NCT02988817|591903961|FG018|Overall Study|Death|14|||
163872745|NCT02988817|591903962|FG019|Overall Study|Death|16|||
163872746|NCT02988817|591903943|FG000|Overall Study|Other|0|||
163872747|NCT02988817|591903944|FG001|Overall Study|Other|0|||
163872748|NCT02988817|591903945|FG002|Overall Study|Other|0|||
163872749|NCT02988817|591903946|FG003|Overall Study|Other|1|||
163872750|NCT02988817|591903947|FG004|Overall Study|Other|1|||
163872751|NCT02988817|591903948|FG005|Overall Study|Other|0|||
163872752|NCT02988817|591903949|FG006|Overall Study|Other|0|||
163872753|NCT02988817|591903950|FG007|Overall Study|Other|0|||
163872754|NCT02988817|591903951|FG008|Overall Study|Other|0|||
163872755|NCT02988817|591903952|FG009|Overall Study|Other|0|||
163872756|NCT02988817|591903953|FG010|Overall Study|Other|0|||
163872757|NCT02988817|591903954|FG011|Overall Study|Other|0|||
163872758|NCT02988817|591903955|FG012|Overall Study|Other|0|||
163872759|NCT02988817|591903956|FG013|Overall Study|Other|0|||
163872760|NCT02988817|591903957|FG014|Overall Study|Other|0|||
163872761|NCT02988817|591903958|FG015|Overall Study|Other|1|||
163872762|NCT02988817|591903959|FG016|Overall Study|Other|0|||
163872763|NCT02988817|591903960|FG017|Overall Study|Other|0|||
163872764|NCT02988817|591903961|FG018|Overall Study|Other|0|||
163872765|NCT02988817|591903962|FG019|Overall Study|Other|0|||
163872766|NCT02988817|591903943|FG000|Overall Study|Lost to Follow-up|0|||
163872767|NCT02988817|591903944|FG001|Overall Study|Lost to Follow-up|0|||
163872768|NCT02988817|591903945|FG002|Overall Study|Lost to Follow-up|0|||
163872769|NCT02988817|591903946|FG003|Overall Study|Lost to Follow-up|0|||
163872770|NCT02988817|591903947|FG004|Overall Study|Lost to Follow-up|0|||
163872771|NCT02988817|591903948|FG005|Overall Study|Lost to Follow-up|0|||
163872772|NCT02988817|591903949|FG006|Overall Study|Lost to Follow-up|0|||
163872773|NCT02988817|591903950|FG007|Overall Study|Lost to Follow-up|0|||
163872774|NCT02988817|591903951|FG008|Overall Study|Lost to Follow-up|1|||
163872775|NCT02988817|591903952|FG009|Overall Study|Lost to Follow-up|0|||
163872776|NCT02988817|591903953|FG010|Overall Study|Lost to Follow-up|1|||
163872777|NCT02988817|591903954|FG011|Overall Study|Lost to Follow-up|1|||
163872778|NCT02988817|591903955|FG012|Overall Study|Lost to Follow-up|0|||
163872779|NCT02988817|591903956|FG013|Overall Study|Lost to Follow-up|0|||
163872780|NCT02988817|591903957|FG014|Overall Study|Lost to Follow-up|1|||
163872781|NCT02988817|591903958|FG015|Overall Study|Lost to Follow-up|1|||
163872782|NCT02988817|591903959|FG016|Overall Study|Lost to Follow-up|2|||
163872783|NCT02988817|591903960|FG017|Overall Study|Lost to Follow-up|3|||
163872784|NCT02988817|591903961|FG018|Overall Study|Lost to Follow-up|0|||
163872785|NCT02988817|591903962|FG019|Overall Study|Lost to Follow-up|0|||
163872786|NCT02988817|591903943|FG000|Overall Study|Sponsor decision|0|||
163872787|NCT02988817|591903944|FG001|Overall Study|Sponsor decision|0|||
163872788|NCT02988817|591903945|FG002|Overall Study|Sponsor decision|0|||
163872789|NCT02988817|591903946|FG003|Overall Study|Sponsor decision|0|||
163872790|NCT02988817|591903947|FG004|Overall Study|Sponsor decision|0|||
163872791|NCT02988817|591903948|FG005|Overall Study|Sponsor decision|0|||
163872792|NCT02988817|591903949|FG006|Overall Study|Sponsor decision|0|||
164315260|NCT02059291|593531490|FG022|Epoch 4|Pregnancy|0|||
164315261|NCT02059291|593531491|FG023|Epoch 4|Pregnancy|0|||
164315262|NCT02059291|593531492|FG024|Epoch 4|Pregnancy|0|||
164315263|NCT02059291|593531468|FG000|Epoch 4|Withdrawal by Subject|0|||
164315264|NCT02059291|593531469|FG001|Epoch 4|Withdrawal by Subject|0|||
164315265|NCT02059291|593531470|FG002|Epoch 4|Withdrawal by Subject|0|||
164315266|NCT02059291|593531471|FG003|Epoch 4|Withdrawal by Subject|0|||
164315267|NCT02059291|593531472|FG004|Epoch 4|Withdrawal by Subject|0|||
164315268|NCT02059291|593531473|FG005|Epoch 4|Withdrawal by Subject|0|||
164315269|NCT02059291|593531474|FG006|Epoch 4|Withdrawal by Subject|0|||
164315270|NCT02059291|593531475|FG007|Epoch 4|Withdrawal by Subject|0|||
164315271|NCT02059291|593531476|FG008|Epoch 4|Withdrawal by Subject|0|||
164315272|NCT02059291|593531477|FG009|Epoch 4|Withdrawal by Subject|0|||
164315273|NCT02059291|593531478|FG010|Epoch 4|Withdrawal by Subject|0|||
164315274|NCT02059291|593531479|FG011|Epoch 4|Withdrawal by Subject|0|||
164315275|NCT02059291|593531480|FG012|Epoch 4|Withdrawal by Subject|0|||
164315276|NCT02059291|593531481|FG013|Epoch 4|Withdrawal by Subject|0|||
164315277|NCT02059291|593531482|FG014|Epoch 4|Withdrawal by Subject|0|||
164315278|NCT02059291|593531483|FG015|Epoch 4|Withdrawal by Subject|0|||
164315279|NCT02059291|593531484|FG016|Epoch 4|Withdrawal by Subject|0|||
164315280|NCT02059291|593531485|FG017|Epoch 4|Withdrawal by Subject|0|||
164315281|NCT02059291|593531486|FG018|Epoch 4|Withdrawal by Subject|0|||
164315282|NCT02059291|593531487|FG019|Epoch 4|Withdrawal by Subject|0|||
164315283|NCT02059291|593531488|FG020|Epoch 4|Withdrawal by Subject|1|||
164315284|NCT02059291|593531489|FG021|Epoch 4|Withdrawal by Subject|0|||
164315285|NCT02059291|593531490|FG022|Epoch 4|Withdrawal by Subject|0|||
163977081|NCT01157078|592288669|FG000|Overall Study|Severe non-compliance to protocol|2|||
163977082|NCT01157078|592288670|FG001|Overall Study|Severe non-compliance to protocol|4|||
164315286|NCT02059291|593531491|FG023|Epoch 4|Withdrawal by Subject|0|||
164315287|NCT02059291|593531492|FG024|Epoch 4|Withdrawal by Subject|0|||
164315288|NCT02059291|593531468|FG000|Epoch 4|Lack of Efficacy|0|||
164315289|NCT02059291|593531469|FG001|Epoch 4|Lack of Efficacy|0|||
164315290|NCT02059291|593531470|FG002|Epoch 4|Lack of Efficacy|0|||
164315291|NCT02059291|593531471|FG003|Epoch 4|Lack of Efficacy|0|||
164315292|NCT02059291|593531472|FG004|Epoch 4|Lack of Efficacy|0|||
164315293|NCT02059291|593531473|FG005|Epoch 4|Lack of Efficacy|0|||
164315294|NCT02059291|593531474|FG006|Epoch 4|Lack of Efficacy|0|||
164315295|NCT02059291|593531475|FG007|Epoch 4|Lack of Efficacy|0|||
164315296|NCT02059291|593531476|FG008|Epoch 4|Lack of Efficacy|0|||
164315297|NCT02059291|593531477|FG009|Epoch 4|Lack of Efficacy|0|||
164315298|NCT02059291|593531478|FG010|Epoch 4|Lack of Efficacy|0|||
164315299|NCT02059291|593531479|FG011|Epoch 4|Lack of Efficacy|0|||
164315300|NCT02059291|593531480|FG012|Epoch 4|Lack of Efficacy|0|||
164315301|NCT02059291|593531481|FG013|Epoch 4|Lack of Efficacy|0|||
164315302|NCT02059291|593531482|FG014|Epoch 4|Lack of Efficacy|0|||
164315303|NCT02059291|593531483|FG015|Epoch 4|Lack of Efficacy|0|||
164315304|NCT02059291|593531484|FG016|Epoch 4|Lack of Efficacy|0|||
164315305|NCT02059291|593531485|FG017|Epoch 4|Lack of Efficacy|0|||
164315306|NCT02059291|593531486|FG018|Epoch 4|Lack of Efficacy|0|||
164315307|NCT02059291|593531487|FG019|Epoch 4|Lack of Efficacy|0|||
164315308|NCT02059291|593531488|FG020|Epoch 4|Lack of Efficacy|0|||
164315309|NCT02059291|593531489|FG021|Epoch 4|Lack of Efficacy|0|||
164315310|NCT02059291|593531490|FG022|Epoch 4|Lack of Efficacy|0|||
164315311|NCT02059291|593531491|FG023|Epoch 4|Lack of Efficacy|1|||
164315312|NCT02059291|593531492|FG024|Epoch 4|Lack of Efficacy|0|||
164315313|NCT04975438|593531498|FG000|Overall Study|Lost to Follow-up|1|||
164315314|NCT04975438|593531499|FG001|Overall Study|Lost to Follow-up|0|||
164315315|NCT04975438|593531500|FG002|Overall Study|Lost to Follow-up|1|||
164315316|NCT04975438|593531501|FG003|Overall Study|Lost to Follow-up|0|||
163977083|NCT01157078|592288669|FG000|Overall Study|Condition under investigation worsened|0|||
163977084|NCT01157078|592288670|FG001|Overall Study|Condition under investigation worsened|1|||
163977085|NCT01157078|592288669|FG000|Overall Study|Lack of Efficacy|2|||
164204354|NCT05911841|593119215|FG008|Induction Period|Lack of Efficacy|0|||
164204355|NCT05911841|593119216|FG009|Induction Period|Lack of Efficacy|0|||
164204356|NCT05911841|593119207|FG000|Induction Period|Adverse Event|3|||
164204357|NCT05911841|593119208|FG001|Induction Period|Adverse Event|1|||
164204358|NCT05911841|593119209|FG002|Induction Period|Adverse Event|2|||
164204359|NCT05911841|593119210|FG003|Induction Period|Adverse Event|0|||
164204360|NCT05911841|593119211|FG004|Induction Period|Adverse Event|0|||
164204361|NCT05911841|593119212|FG005|Induction Period|Adverse Event|0|||
163977086|NCT01157078|592288670|FG001|Overall Study|Lack of Efficacy|0|||
164204362|NCT05911841|593119213|FG006|Induction Period|Adverse Event|0|||
164315317|NCT04975438|593531498|FG000|Overall Study|Withdrawal by Subject|1|||
164315318|NCT04975438|593531499|FG001|Overall Study|Withdrawal by Subject|0|||
164315319|NCT04975438|593531500|FG002|Overall Study|Withdrawal by Subject|0|||
164315320|NCT04975438|593531501|FG003|Overall Study|Withdrawal by Subject|0|||
164315321|NCT04973436|593531502|FG000|Overall Study|Lost to Follow-up|3|||
163977087|NCT01157078|592288669|FG000|Overall Study|Study-specific withdrawal criteria|2|||
163977088|NCT01157078|592288670|FG001|Overall Study|Study-specific withdrawal criteria|2|||
163977089|NCT01157078|592288669|FG000|Overall Study|Lost to Follow-up|7|||
163977090|NCT01157078|592288670|FG001|Overall Study|Lost to Follow-up|5|||
164204363|NCT05911841|593119214|FG007|Induction Period|Adverse Event|0|||
164315322|NCT04973436|593531502|FG000|Overall Study|Withdrawal by Subject|1|||
164315323|NCT04973436|593531502|FG000|Overall Study|Death|2|||
164315324|NCT01276054|593531506|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
164315325|NCT01276054|593531507|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
164204364|NCT05911841|593119215|FG008|Induction Period|Adverse Event|0|||
164204365|NCT05911841|593119216|FG009|Induction Period|Adverse Event|0|||
164204366|NCT05911841|593119207|FG000|Induction Period|Assigned Treatment by Mistake|0|||
164204367|NCT05911841|593119208|FG001|Induction Period|Assigned Treatment by Mistake|1|||
163872793|NCT02988817|591903950|FG007|Overall Study|Sponsor decision|0|||
163872794|NCT02988817|591903951|FG008|Overall Study|Sponsor decision|0|||
164204368|NCT05911841|593119209|FG002|Induction Period|Assigned Treatment by Mistake|0|||
164204369|NCT05911841|593119210|FG003|Induction Period|Assigned Treatment by Mistake|1|||
164204370|NCT05911841|593119211|FG004|Induction Period|Assigned Treatment by Mistake|0|||
164204371|NCT05911841|593119212|FG005|Induction Period|Assigned Treatment by Mistake|0|||
164204372|NCT05911841|593119213|FG006|Induction Period|Assigned Treatment by Mistake|0|||
163872795|NCT02988817|591903952|FG009|Overall Study|Sponsor decision|0|||
163872796|NCT02988817|591903953|FG010|Overall Study|Sponsor decision|0|||
163872797|NCT02988817|591903954|FG011|Overall Study|Sponsor decision|1|||
163872798|NCT02988817|591903955|FG012|Overall Study|Sponsor decision|1|||
163872799|NCT02988817|591903956|FG013|Overall Study|Sponsor decision|2|||
163977091|NCT01157078|592288669|FG000|Overall Study|Other|2|||
164204373|NCT05911841|593119214|FG007|Induction Period|Assigned Treatment by Mistake|0|||
164204374|NCT05911841|593119215|FG008|Induction Period|Assigned Treatment by Mistake|0|||
164204375|NCT05911841|593119216|FG009|Induction Period|Assigned Treatment by Mistake|0|||
164204376|NCT05911841|593119207|FG000|Induction Period|Lost to Follow-up|0|||
164204377|NCT05911841|593119208|FG001|Induction Period|Lost to Follow-up|0|||
164204378|NCT05911841|593119209|FG002|Induction Period|Lost to Follow-up|1|||
164204379|NCT05911841|593119210|FG003|Induction Period|Lost to Follow-up|1|||
164204380|NCT05911841|593119211|FG004|Induction Period|Lost to Follow-up|0|||
164204381|NCT05911841|593119212|FG005|Induction Period|Lost to Follow-up|0|||
164204382|NCT05911841|593119213|FG006|Induction Period|Lost to Follow-up|0|||
164204383|NCT05911841|593119214|FG007|Induction Period|Lost to Follow-up|0|||
164204384|NCT05911841|593119215|FG008|Induction Period|Lost to Follow-up|0|||
164204385|NCT05911841|593119216|FG009|Induction Period|Lost to Follow-up|0|||
164204386|NCT05911841|593119207|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
164204387|NCT05911841|593119208|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
164204388|NCT05911841|593119209|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
164204389|NCT05911841|593119210|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
164204390|NCT05911841|593119211|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
164204391|NCT05911841|593119212|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
164204392|NCT05911841|593119213|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
164204393|NCT05911841|593119214|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
164204394|NCT05911841|593119215|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
164204395|NCT05911841|593119216|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
164204396|NCT05911841|593119207|FG000|Maintenance Period|Lack of Efficacy|0|||
164204397|NCT05911841|593119208|FG001|Maintenance Period|Lack of Efficacy|0|||
164204398|NCT05911841|593119209|FG002|Maintenance Period|Lack of Efficacy|0|||
164204399|NCT05911841|593119210|FG003|Maintenance Period|Lack of Efficacy|0|||
164204400|NCT05911841|593119211|FG004|Maintenance Period|Lack of Efficacy|1|||
164204401|NCT05911841|593119212|FG005|Maintenance Period|Lack of Efficacy|0|||
164204402|NCT05911841|593119213|FG006|Maintenance Period|Lack of Efficacy|1|||
164204403|NCT05911841|593119214|FG007|Maintenance Period|Lack of Efficacy|0|||
164204404|NCT05911841|593119215|FG008|Maintenance Period|Lack of Efficacy|0|||
164204405|NCT05911841|593119216|FG009|Maintenance Period|Lack of Efficacy|0|||
164204406|NCT05911841|593119207|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
164204407|NCT05911841|593119208|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
164204408|NCT05911841|593119209|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
164204409|NCT05911841|593119210|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
164204410|NCT05911841|593119211|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
164204411|NCT05911841|593119212|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
164204412|NCT05911841|593119213|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
164204413|NCT05911841|593119214|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
164204414|NCT05911841|593119215|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
164204415|NCT05911841|593119216|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
164204416|NCT05911841|593119207|FG000|Maintenance Period|Withdrawal by Subject|0|||
164204417|NCT05911841|593119208|FG001|Maintenance Period|Withdrawal by Subject|0|||
164204418|NCT05911841|593119209|FG002|Maintenance Period|Withdrawal by Subject|0|||
164204419|NCT05911841|593119210|FG003|Maintenance Period|Withdrawal by Subject|0|||
164204420|NCT05911841|593119211|FG004|Maintenance Period|Withdrawal by Subject|0|||
164204421|NCT05911841|593119212|FG005|Maintenance Period|Withdrawal by Subject|1|||
164204422|NCT05911841|593119213|FG006|Maintenance Period|Withdrawal by Subject|0|||
164204423|NCT05911841|593119214|FG007|Maintenance Period|Withdrawal by Subject|1|||
164204424|NCT05911841|593119215|FG008|Maintenance Period|Withdrawal by Subject|0|||
164204425|NCT05911841|593119216|FG009|Maintenance Period|Withdrawal by Subject|0|||
164204426|NCT05911841|593119207|FG000|Maintenance Period|Adverse Event|0|||
164204427|NCT05911841|593119208|FG001|Maintenance Period|Adverse Event|0|||
163872800|NCT02988817|591903957|FG014|Overall Study|Sponsor decision|2|||
163872801|NCT02988817|591903958|FG015|Overall Study|Sponsor decision|6|||
163977092|NCT01157078|592288670|FG001|Overall Study|Other|4|||
164315326|NCT05405257|593531511|FG000|Overall Study|Withdrawal by Subject|1|||
164315327|NCT01788215|593531514|FG000|Overall Study|Withdrawal by Subject|0|||
164315328|NCT01788215|593531515|FG001|Overall Study|Withdrawal by Subject|1|||
164315329|NCT01788215|593531514|FG000|Overall Study|Lost to Follow-up|2|||
164315330|NCT01788215|593531515|FG001|Overall Study|Lost to Follow-up|0|||
164315331|NCT03116152|593531516|FG000|Overall Study|Disease Progression|49|||
164315332|NCT03116152|593531517|FG001|Overall Study|Disease Progression|47|||
164315333|NCT03116152|593531516|FG000|Overall Study|Death|5|||
164315334|NCT03116152|593531517|FG001|Overall Study|Death|2|||
164315335|NCT03116152|593531516|FG000|Overall Study|Adverse Event|21|||
164315336|NCT03116152|593531517|FG001|Overall Study|Adverse Event|7|||
164315337|NCT03116152|593531516|FG000|Overall Study|Protocol Violation|2|||
164315338|NCT03116152|593531517|FG001|Overall Study|Protocol Violation|2|||
163977093|NCT01611974|592288671|FG000|Overall Study|Death|10|||
163977094|NCT01611974|592288672|FG001|Overall Study|Death|12|||
163977095|NCT01611974|592288673|FG002|Overall Study|Death|10|||
163977096|NCT01611974|592288671|FG000|Overall Study|Lost to Follow-up|0|||
163977097|NCT01611974|592288672|FG001|Overall Study|Lost to Follow-up|1|||
163977098|NCT01611974|592288673|FG002|Overall Study|Lost to Follow-up|0|||
163977099|NCT01611974|592288671|FG000|Overall Study|Physician Decision|5|||
163977100|NCT01611974|592288672|FG001|Overall Study|Physician Decision|1|||
163977101|NCT01611974|592288673|FG002|Overall Study|Physician Decision|2|||
163977102|NCT01611974|592288671|FG000|Overall Study|Withdrawal by Subject|0|||
163977103|NCT01611974|592288672|FG001|Overall Study|Withdrawal by Subject|1|||
163977104|NCT01611974|592288673|FG002|Overall Study|Withdrawal by Subject|4|||
163977105|NCT00522431|592288674|FG000|Overall Study|Adverse Event|5|||
163977106|NCT00522431|592288674|FG000|Overall Study|Protocol Violation|2|||
163977107|NCT00522431|592288674|FG000|Overall Study|Withdrawal by Subject|2|||
163977108|NCT00522431|592288674|FG000|Overall Study|Subject non-compliance|1|||
163977109|NCT00522431|592288674|FG000|Overall Study|Other/unknown|1|||
163977110|NCT00132132|592288676|FG000|Overall Study|Lost to Follow-up|7|||
163977111|NCT00132132|592288677|FG001|Overall Study|Lost to Follow-up|2|||
163977112|NCT02145741|592288678|FG000|Overall Study|Progressive disease|3|||
163977113|NCT02145741|592288679|FG001|Overall Study|Progressive disease|6|||
163977114|NCT02145741|592288680|FG002|Overall Study|Progressive disease|6|||
163977115|NCT02145741|592288678|FG000|Overall Study|quality issue with the administered drug|3|||
163977116|NCT02145741|592288679|FG001|Overall Study|quality issue with the administered drug|0|||
163977117|NCT02145741|592288680|FG002|Overall Study|quality issue with the administered drug|0|||
163977118|NCT03776175|592288681|FG000|Treatment Period (42 Days)|Adverse Event|0|||
163977119|NCT03776175|592288682|FG001|Treatment Period (42 Days)|Adverse Event|1|||
163977120|NCT03776175|592288683|FG002|Treatment Period (42 Days)|Adverse Event|1|||
163977121|NCT03776175|592288684|FG003|Treatment Period (42 Days)|Adverse Event|0|||
163977122|NCT03776175|592288681|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
163977123|NCT03776175|592288682|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
163977124|NCT03776175|592288683|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
163977125|NCT03776175|592288684|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
163977126|NCT03776175|592288681|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
163977127|NCT03776175|592288682|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
163977128|NCT03776175|592288683|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
163977129|NCT03776175|592288684|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
163977130|NCT03776175|592288681|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
163977131|NCT03776175|592288682|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
163977132|NCT03776175|592288683|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
163977133|NCT03776175|592288684|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
163977134|NCT03776175|592288681|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
163977135|NCT03776175|592288682|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
163977136|NCT03776175|592288683|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
163977137|NCT03776175|592288684|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
163977138|NCT03776175|592288681|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
164315339|NCT03116152|593531516|FG000|Overall Study|Withdrawal by Subject|0|||
164315340|NCT03116152|593531517|FG001|Overall Study|Withdrawal by Subject|1|||
164315341|NCT03116152|593531516|FG000|Overall Study|Physician Decision|3|||
163977139|NCT03776175|592288682|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
163977140|NCT03776175|592288683|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
164315342|NCT03116152|593531517|FG001|Overall Study|Physician Decision|2|||
164315343|NCT03116152|593531516|FG000|Overall Study|other|11|||
164315344|NCT03116152|593531517|FG001|Overall Study|other|34|||
164315345|NCT00275340|593531518|FG000|Overall Study|Lost to Follow-up|2|||
163977141|NCT03776175|592288684|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
163977142|NCT01496885|592288685|FG000|Overall Study|Lost to Follow-up|13|||
164315346|NCT00275340|593531519|FG001|Overall Study|Lost to Follow-up|4|||
163977143|NCT01496885|592288685|FG000|Overall Study|Withdrawal by Subject|7|||
164006619|NCT00847613|592391041|FG000|Overall Study|Ongoing at cut-off date|250|||
164315347|NCT00862641|593531522|FG000|Overall Study|Randomized, but drug not received|1|||
164315348|NCT00862641|593531523|FG001|Overall Study|Randomized, but drug not received|4|||
163977144|NCT01496885|592288685|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
163977145|NCT01496885|592288685|FG000|Overall Study|Death|1|||
163977146|NCT03273166|592288686|FG000|Overall Study|Withdrawn prior to Completion|31|||
163977147|NCT01294670|592288687|FG000|Overall Study|Not treated|1|||
163977148|NCT01294670|592288688|FG001|Overall Study|Not treated|0|||
163977149|NCT01294670|592288689|FG002|Overall Study|Not treated|0|||
163977150|NCT01294670|592288690|FG003|Overall Study|Not treated|0|||
163977151|NCT01294670|592288691|FG004|Overall Study|Not treated|0|||
163977152|NCT03808077|592288692|FG000|Overall Study|Physician Decision|2|||
163977153|NCT03808077|592288693|FG001|Overall Study|Physician Decision|3|||
163977154|NCT03808077|592288692|FG000|Overall Study|Withdrawal by Subject|1|||
163977155|NCT03808077|592288693|FG001|Overall Study|Withdrawal by Subject|0|||
163977156|NCT03808077|592288692|FG000|Overall Study|Equipment Issues|2|||
163977157|NCT03808077|592288693|FG001|Overall Study|Equipment Issues|1|||
163977158|NCT02412787|592288694|FG000|Overall Study|Withdrawal by Subject|9|||
163977159|NCT02412787|592288694|FG000|Overall Study|Participation Terminated by Investigator|1|||
163977160|NCT02412787|592288694|FG000|Overall Study|Site Terminated by Sponsor|21|||
163977161|NCT02412787|592288694|FG000|Overall Study|Technical Problems|1|||
163977162|NCT02412787|592288694|FG000|Overall Study|Reason Not Specified|1|||
163977163|NCT03246958|592288695|FG000|Overall Study|Withdrawal by Subject|0|||
163977164|NCT03246958|592288696|FG001|Overall Study|Withdrawal by Subject|1|||
163977165|NCT03246958|592288697|FG002|Overall Study|Withdrawal by Subject|0|||
163977166|NCT03246958|592288698|FG003|Overall Study|Withdrawal by Subject|0|||
163977167|NCT03246958|592288699|FG004|Overall Study|Withdrawal by Subject|0|||
163977168|NCT03246958|592288700|FG005|Overall Study|Withdrawal by Subject|1|||
163977169|NCT03246958|592288701|FG006|Overall Study|Withdrawal by Subject|0|||
163977170|NCT03246958|592288695|FG000|Overall Study|Progression|13|||
163977171|NCT03246958|592288696|FG001|Overall Study|Progression|9|||
163977172|NCT03246958|592288697|FG002|Overall Study|Progression|3|||
163872802|NCT02988817|591903959|FG016|Overall Study|Sponsor decision|2|||
163872803|NCT02988817|591903960|FG017|Overall Study|Sponsor decision|3|||
163872804|NCT02988817|591903961|FG018|Overall Study|Sponsor decision|2|||
163872805|NCT02988817|591903962|FG019|Overall Study|Sponsor decision|7|||
163872806|NCT02988817|591903943|FG000|Overall Study|Physician Decision|0|||
163872807|NCT02988817|591903944|FG001|Overall Study|Physician Decision|0|||
163872808|NCT02988817|591903945|FG002|Overall Study|Physician Decision|0|||
163872809|NCT02988817|591903946|FG003|Overall Study|Physician Decision|0|||
163872810|NCT02988817|591903947|FG004|Overall Study|Physician Decision|0|||
163872811|NCT02988817|591903948|FG005|Overall Study|Physician Decision|0|||
163872812|NCT02988817|591903949|FG006|Overall Study|Physician Decision|0|||
163872813|NCT02988817|591903950|FG007|Overall Study|Physician Decision|0|||
163872814|NCT02988817|591903951|FG008|Overall Study|Physician Decision|0|||
163872815|NCT02988817|591903952|FG009|Overall Study|Physician Decision|0|||
163872816|NCT02988817|591903953|FG010|Overall Study|Physician Decision|0|||
163872817|NCT02988817|591903954|FG011|Overall Study|Physician Decision|0|||
163872818|NCT02988817|591903955|FG012|Overall Study|Physician Decision|0|||
163872819|NCT02988817|591903956|FG013|Overall Study|Physician Decision|0|||
163872820|NCT02988817|591903957|FG014|Overall Study|Physician Decision|0|||
163872821|NCT02988817|591903958|FG015|Overall Study|Physician Decision|1|||
163872822|NCT02988817|591903959|FG016|Overall Study|Physician Decision|0|||
163872823|NCT02988817|591903960|FG017|Overall Study|Physician Decision|0|||
163872824|NCT02988817|591903961|FG018|Overall Study|Physician Decision|1|||
163872825|NCT02988817|591903962|FG019|Overall Study|Physician Decision|1|||
163872826|NCT00421889|591903964|FG000|Overall Study|Adverse Event|1|||
163872827|NCT00421889|591903965|FG001|Overall Study|Adverse Event|0|||
163872828|NCT00421889|591903966|FG002|Overall Study|Adverse Event|1|||
163872829|NCT00421889|591903967|FG003|Overall Study|Adverse Event|1|||
163872830|NCT00421889|591903968|FG004|Overall Study|Adverse Event|1|||
163872831|NCT00421889|591903969|FG005|Overall Study|Adverse Event|4|||
163872832|NCT00421889|591903970|FG006|Overall Study|Adverse Event|1|||
163872833|NCT00421889|591903971|FG007|Overall Study|Adverse Event|0|||
163872834|NCT00421889|591903972|FG008|Overall Study|Adverse Event|2|||
163872835|NCT00421889|591903964|FG000|Overall Study|Withdrawal by Subject|1|||
163872836|NCT00421889|591903965|FG001|Overall Study|Withdrawal by Subject|3|||
163872837|NCT00421889|591903966|FG002|Overall Study|Withdrawal by Subject|0|||
163872838|NCT00421889|591903967|FG003|Overall Study|Withdrawal by Subject|0|||
163977173|NCT03246958|592288698|FG003|Overall Study|Progression|2|||
163977174|NCT03246958|592288699|FG004|Overall Study|Progression|1|||
163977175|NCT03246958|592288700|FG005|Overall Study|Progression|2|||
163977176|NCT03246958|592288701|FG006|Overall Study|Progression|1|||
163977177|NCT03246958|592288695|FG000|Overall Study|Adverse Event|2|||
163977178|NCT03246958|592288696|FG001|Overall Study|Adverse Event|2|||
163872839|NCT00421889|591903968|FG004|Overall Study|Withdrawal by Subject|2|||
163872840|NCT00421889|591903969|FG005|Overall Study|Withdrawal by Subject|0|||
163872841|NCT00421889|591903970|FG006|Overall Study|Withdrawal by Subject|0|||
163872842|NCT00421889|591903971|FG007|Overall Study|Withdrawal by Subject|0|||
163872843|NCT00421889|591903972|FG008|Overall Study|Withdrawal by Subject|0|||
163872844|NCT00421889|591903964|FG000|Overall Study|Death|0|||
163977179|NCT03246958|592288697|FG002|Overall Study|Adverse Event|0|||
164315349|NCT00862641|593531524|FG002|Overall Study|Randomized, but drug not received|1|||
164315350|NCT00862641|593531525|FG003|Overall Study|Randomized, but drug not received|4|||
164315351|NCT02365480|593531526|FG000|Overall Study|Withdrawal by Subject|2|||
164315352|NCT02365480|593531527|FG001|Overall Study|Withdrawal by Subject|0|||
164315353|NCT01419197|593531531|FG000|Overall Study|Death|247|||
164315354|NCT01419197|593531532|FG001|Overall Study|Death|122|||
164315355|NCT01419197|593531531|FG000|Overall Study|Physician Decision|4|||
164315356|NCT01419197|593531532|FG001|Overall Study|Physician Decision|4|||
164315357|NCT01419197|593531531|FG000|Overall Study|Non-compliance|3|||
164204428|NCT05911841|593119209|FG002|Maintenance Period|Adverse Event|0|||
164315358|NCT01419197|593531532|FG001|Overall Study|Non-compliance|1|||
164315359|NCT01419197|593531531|FG000|Overall Study|Withdrawal by Subject|33|||
164315360|NCT01419197|593531532|FG001|Overall Study|Withdrawal by Subject|32|||
164315361|NCT01419197|593531531|FG000|Overall Study|Study Completed by Sponsor|103|||
164315362|NCT01419197|593531532|FG001|Overall Study|Study Completed by Sponsor|34|||
164315363|NCT01419197|593531531|FG000|Overall Study|Reason Not Specified|0|||
164315364|NCT01419197|593531532|FG001|Overall Study|Reason Not Specified|1|||
164315365|NCT01419197|593531531|FG000|Overall Study|Lost to Follow-up|14|||
163977180|NCT03246958|592288698|FG003|Overall Study|Adverse Event|1|||
163977181|NCT03246958|592288699|FG004|Overall Study|Adverse Event|1|||
163977182|NCT03246958|592288700|FG005|Overall Study|Adverse Event|0|||
163977183|NCT03246958|592288701|FG006|Overall Study|Adverse Event|2|||
163977184|NCT03246958|592288695|FG000|Overall Study|Death|0|||
163977185|NCT03246958|592288696|FG001|Overall Study|Death|1|||
163977186|NCT03246958|592288697|FG002|Overall Study|Death|0|||
163977187|NCT03246958|592288698|FG003|Overall Study|Death|0|||
163977188|NCT03246958|592288699|FG004|Overall Study|Death|0|||
163977189|NCT03246958|592288700|FG005|Overall Study|Death|0|||
163977190|NCT03246958|592288701|FG006|Overall Study|Death|0|||
163977191|NCT03246958|592288695|FG000|Overall Study|Physician Decision|0|||
163977192|NCT03246958|592288696|FG001|Overall Study|Physician Decision|0|||
163977193|NCT03246958|592288697|FG002|Overall Study|Physician Decision|0|||
163977194|NCT03246958|592288698|FG003|Overall Study|Physician Decision|1|||
163977195|NCT03246958|592288699|FG004|Overall Study|Physician Decision|0|||
163977196|NCT03246958|592288700|FG005|Overall Study|Physician Decision|0|||
163977197|NCT03246958|592288701|FG006|Overall Study|Physician Decision|0|||
163977198|NCT03246958|592288695|FG000|Overall Study|Never start treatment|1|||
163977199|NCT03246958|592288696|FG001|Overall Study|Never start treatment|0|||
164204429|NCT05911841|593119210|FG003|Maintenance Period|Adverse Event|0|||
164204430|NCT05911841|593119211|FG004|Maintenance Period|Adverse Event|0|||
164204431|NCT05911841|593119212|FG005|Maintenance Period|Adverse Event|0|||
164204432|NCT05911841|593119213|FG006|Maintenance Period|Adverse Event|0|||
164204433|NCT05911841|593119214|FG007|Maintenance Period|Adverse Event|1|||
164204434|NCT05911841|593119215|FG008|Maintenance Period|Adverse Event|0|||
164204435|NCT05911841|593119216|FG009|Maintenance Period|Adverse Event|0|||
164204436|NCT05911841|593119207|FG000|Escape Period|Adverse Event|0|||
164204437|NCT05911841|593119208|FG001|Escape Period|Adverse Event|0|||
164204438|NCT05911841|593119209|FG002|Escape Period|Adverse Event|0|||
164204439|NCT05911841|593119210|FG003|Escape Period|Adverse Event|0|||
164204440|NCT05911841|593119211|FG004|Escape Period|Adverse Event|0|||
164204441|NCT05911841|593119212|FG005|Escape Period|Adverse Event|0|||
164204442|NCT05911841|593119213|FG006|Escape Period|Adverse Event|0|||
164204443|NCT05911841|593119214|FG007|Escape Period|Adverse Event|0|||
164204444|NCT05911841|593119215|FG008|Escape Period|Adverse Event|0|||
164204445|NCT05911841|593119216|FG009|Escape Period|Adverse Event|1|||
164204446|NCT05911841|593119207|FG000|Escape Period|Lack of Efficacy|0|||
164204447|NCT05911841|593119208|FG001|Escape Period|Lack of Efficacy|0|||
164204448|NCT05911841|593119209|FG002|Escape Period|Lack of Efficacy|0|||
164204449|NCT05911841|593119210|FG003|Escape Period|Lack of Efficacy|0|||
164204450|NCT05911841|593119211|FG004|Escape Period|Lack of Efficacy|0|||
164204451|NCT05911841|593119212|FG005|Escape Period|Lack of Efficacy|0|||
164204452|NCT05911841|593119213|FG006|Escape Period|Lack of Efficacy|0|||
164204453|NCT05911841|593119214|FG007|Escape Period|Lack of Efficacy|0|||
164204454|NCT05911841|593119215|FG008|Escape Period|Lack of Efficacy|0|||
164204455|NCT05911841|593119216|FG009|Escape Period|Lack of Efficacy|31|||
163977200|NCT03246958|592288697|FG002|Overall Study|Never start treatment|0|||
163977201|NCT03246958|592288698|FG003|Overall Study|Never start treatment|0|||
163977202|NCT03246958|592288699|FG004|Overall Study|Never start treatment|0|||
163977203|NCT03246958|592288700|FG005|Overall Study|Never start treatment|0|||
164204456|NCT05911841|593119207|FG000|Escape Period|Lost to Follow-up|0|||
164204457|NCT05911841|593119208|FG001|Escape Period|Lost to Follow-up|0|||
164204458|NCT05911841|593119209|FG002|Escape Period|Lost to Follow-up|0|||
164204459|NCT05911841|593119210|FG003|Escape Period|Lost to Follow-up|0|||
164204460|NCT05911841|593119211|FG004|Escape Period|Lost to Follow-up|0|||
164315366|NCT01419197|593531532|FG001|Overall Study|Lost to Follow-up|4|||
164315367|NCT00146848|593531536|FG000|Pre-randomization|Death|19|||
164315368|NCT00146848|593531537|FG001|Pre-randomization|Death|0|||
164204461|NCT05911841|593119212|FG005|Escape Period|Lost to Follow-up|0|||
164204462|NCT05911841|593119213|FG006|Escape Period|Lost to Follow-up|0|||
164204463|NCT05911841|593119214|FG007|Escape Period|Lost to Follow-up|0|||
164315369|NCT00146848|593531538|FG002|Pre-randomization|Death|0|||
163977204|NCT03246958|592288701|FG006|Overall Study|Never start treatment|0|||
163977205|NCT03246958|592288695|FG000|Overall Study|Over enrollment|0|||
163977206|NCT03246958|592288696|FG001|Overall Study|Over enrollment|2|||
163977207|NCT03246958|592288697|FG002|Overall Study|Over enrollment|0|||
163977208|NCT03246958|592288698|FG003|Overall Study|Over enrollment|0|||
163977209|NCT03246958|592288699|FG004|Overall Study|Over enrollment|0|||
163977210|NCT03246958|592288700|FG005|Overall Study|Over enrollment|0|||
163977211|NCT03246958|592288701|FG006|Overall Study|Over enrollment|0|||
163977212|NCT01650636|592288708|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
163977213|NCT01650636|592288709|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
163977214|NCT01650636|592288708|FG000|Washout up to 5 Months|Physician Decision|2|||
163977215|NCT01650636|592288709|FG001|Washout up to 5 Months|Physician Decision|2|||
163977216|NCT01650636|592288708|FG000|Washout up to 5 Months|Death|1|||
163977217|NCT01650636|592288709|FG001|Washout up to 5 Months|Death|0|||
163977218|NCT01650636|592288708|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
163977219|NCT01650636|592288709|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
163977220|NCT01650636|592288708|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
163977221|NCT01650636|592288709|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
163977222|NCT01650636|592288708|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
163977223|NCT01650636|592288709|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
163977224|NCT01560780|592288710|FG000|Overall Study|Death|2|||
163977225|NCT01560780|592288711|FG001|Overall Study|Death|1|||
163977226|NCT01560780|592288710|FG000|Overall Study|Patient Preference|11|||
163977227|NCT01560780|592288711|FG001|Overall Study|Patient Preference|11|||
163977228|NCT00930761|592288712|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
163977229|NCT00930761|592288713|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
163977230|NCT00930761|592288712|FG000|Overall Study|less than 3 music therapy sessions|0|||
163977231|NCT00930761|592288713|FG001|Overall Study|less than 3 music therapy sessions|3|||
164204464|NCT05911841|593119215|FG008|Escape Period|Lost to Follow-up|0|||
164204465|NCT05911841|593119216|FG009|Escape Period|Lost to Follow-up|1|||
164204466|NCT05911841|593119207|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204467|NCT05911841|593119208|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204468|NCT05911841|593119209|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204469|NCT05911841|593119210|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204470|NCT05911841|593119211|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204471|NCT05911841|593119212|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204472|NCT05911841|593119213|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204473|NCT05911841|593119214|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204474|NCT05911841|593119215|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
164204475|NCT05911841|593119216|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
164204476|NCT05911841|593119207|FG000|Escape Period|Site Terminated by Sponsor|0|||
164204477|NCT05911841|593119208|FG001|Escape Period|Site Terminated by Sponsor|0|||
164204478|NCT05911841|593119209|FG002|Escape Period|Site Terminated by Sponsor|0|||
164204479|NCT05911841|593119210|FG003|Escape Period|Site Terminated by Sponsor|0|||
164204480|NCT05911841|593119211|FG004|Escape Period|Site Terminated by Sponsor|0|||
164204481|NCT05911841|593119212|FG005|Escape Period|Site Terminated by Sponsor|0|||
164204482|NCT05911841|593119213|FG006|Escape Period|Site Terminated by Sponsor|0|||
164204483|NCT05911841|593119214|FG007|Escape Period|Site Terminated by Sponsor|0|||
164204484|NCT05911841|593119215|FG008|Escape Period|Site Terminated by Sponsor|0|||
164204485|NCT05911841|593119216|FG009|Escape Period|Site Terminated by Sponsor|1|||
164204486|NCT05911841|593119207|FG000|Escape Period|Study Terminated by Sponsor|0|||
164204487|NCT05911841|593119208|FG001|Escape Period|Study Terminated by Sponsor|0|||
164204488|NCT05911841|593119209|FG002|Escape Period|Study Terminated by Sponsor|0|||
164204489|NCT05911841|593119210|FG003|Escape Period|Study Terminated by Sponsor|0|||
164204490|NCT05911841|593119211|FG004|Escape Period|Study Terminated by Sponsor|0|||
164204491|NCT05911841|593119212|FG005|Escape Period|Study Terminated by Sponsor|0|||
164204492|NCT05911841|593119213|FG006|Escape Period|Study Terminated by Sponsor|0|||
164204493|NCT05911841|593119214|FG007|Escape Period|Study Terminated by Sponsor|0|||
164204494|NCT05911841|593119215|FG008|Escape Period|Study Terminated by Sponsor|0|||
164204495|NCT05911841|593119216|FG009|Escape Period|Study Terminated by Sponsor|34|||
164204496|NCT05911841|593119207|FG000|Escape Period|Withdrawal by Subject|0|||
164204497|NCT05911841|593119208|FG001|Escape Period|Withdrawal by Subject|0|||
164204498|NCT05911841|593119209|FG002|Escape Period|Withdrawal by Subject|0|||
163977232|NCT01970995|592288715|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
163977233|NCT01970995|592288716|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
164204499|NCT05911841|593119210|FG003|Escape Period|Withdrawal by Subject|0|||
164204500|NCT05911841|593119211|FG004|Escape Period|Withdrawal by Subject|0|||
163977234|NCT01970995|592288717|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
164204501|NCT05911841|593119212|FG005|Escape Period|Withdrawal by Subject|0|||
164204502|NCT05911841|593119213|FG006|Escape Period|Withdrawal by Subject|0|||
163977235|NCT01970995|592288715|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
164315370|NCT00146848|593531536|FG000|Pre-randomization|Lost to Follow-up|70|||
163977236|NCT01970995|592288716|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
163977237|NCT01970995|592288717|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
164315371|NCT00146848|593531537|FG001|Pre-randomization|Lost to Follow-up|0|||
163977238|NCT03699007|592288718|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
163977239|NCT03699007|592288719|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
163977240|NCT03699007|592288718|FG000|6-month Follow Up|Lost to Follow-up|2|||
163977241|NCT03699007|592288719|FG001|6-month Follow Up|Lost to Follow-up|3|||
163977242|NCT00414453|592288720|FG000|Overall Study|Abnormal lab work|16|||
163977243|NCT01709435|592288721|FG000|Overall Study|Adverse Event|1|||
163977244|NCT01709435|592288722|FG001|Overall Study|Adverse Event|1|||
163977245|NCT01709435|592288723|FG002|Overall Study|Adverse Event|1|||
163977246|NCT01709435|592288724|FG003|Overall Study|Adverse Event|0|||
163977247|NCT01709435|592288725|FG004|Overall Study|Adverse Event|0|||
163977248|NCT01709435|592288726|FG005|Overall Study|Adverse Event|1|||
163977249|NCT01709435|592288721|FG000|Overall Study|Lack of Efficacy|5|||
163977250|NCT01709435|592288722|FG001|Overall Study|Lack of Efficacy|7|||
163977251|NCT01709435|592288723|FG002|Overall Study|Lack of Efficacy|2|||
163977252|NCT01709435|592288724|FG003|Overall Study|Lack of Efficacy|2|||
163977253|NCT01709435|592288725|FG004|Overall Study|Lack of Efficacy|6|||
163977254|NCT01709435|592288726|FG005|Overall Study|Lack of Efficacy|3|||
163977255|NCT01709435|592288721|FG000|Overall Study|Physician Decision|0|||
163977256|NCT01709435|592288722|FG001|Overall Study|Physician Decision|1|||
163977257|NCT01709435|592288723|FG002|Overall Study|Physician Decision|0|||
163977258|NCT01709435|592288724|FG003|Overall Study|Physician Decision|1|||
163977259|NCT01709435|592288725|FG004|Overall Study|Physician Decision|2|||
163977260|NCT01709435|592288726|FG005|Overall Study|Physician Decision|0|||
163977261|NCT01709435|592288721|FG000|Overall Study|Withdrawal by Subject|0|||
163977262|NCT01709435|592288722|FG001|Overall Study|Withdrawal by Subject|0|||
163977263|NCT01709435|592288723|FG002|Overall Study|Withdrawal by Subject|3|||
163977264|NCT01709435|592288724|FG003|Overall Study|Withdrawal by Subject|0|||
164315372|NCT00146848|593531538|FG002|Pre-randomization|Lost to Follow-up|0|||
164315373|NCT00146848|593531536|FG000|Pre-randomization|Physician Decision|8|||
164315374|NCT00146848|593531537|FG001|Pre-randomization|Physician Decision|0|||
164315375|NCT00146848|593531538|FG002|Pre-randomization|Physician Decision|0|||
164315376|NCT00146848|593531536|FG000|Pre-randomization|Protocol Violation|172|||
164315377|NCT00146848|593531537|FG001|Pre-randomization|Protocol Violation|0|||
164315378|NCT00146848|593531538|FG002|Pre-randomization|Protocol Violation|0|||
163977265|NCT01709435|592288725|FG004|Overall Study|Withdrawal by Subject|2|||
163977266|NCT01709435|592288726|FG005|Overall Study|Withdrawal by Subject|2|||
163977267|NCT01157364|592288727|FG000|Overall Study|Other Reasons|1|||
163977268|NCT01157364|592288728|FG001|Overall Study|Other Reasons|1|||
163977269|NCT01157364|592288729|FG002|Overall Study|Other Reasons|2|||
163977270|NCT01157364|592288730|FG003|Overall Study|Other Reasons|1|||
163977271|NCT01157364|592288731|FG004|Overall Study|Other Reasons|0|||
163977272|NCT01157364|592288732|FG005|Overall Study|Other Reasons|0|||
163977273|NCT01157364|592288727|FG000|Overall Study|Personal Reasons|0|||
163977274|NCT01157364|592288728|FG001|Overall Study|Personal Reasons|2|||
163977275|NCT01157364|592288729|FG002|Overall Study|Personal Reasons|0|||
163977276|NCT01157364|592288730|FG003|Overall Study|Personal Reasons|0|||
163977277|NCT01157364|592288731|FG004|Overall Study|Personal Reasons|1|||
163977278|NCT01157364|592288732|FG005|Overall Study|Personal Reasons|1|||
163977279|NCT01157364|592288727|FG000|Overall Study|Lost to Follow-up|1|||
163977280|NCT01157364|592288728|FG001|Overall Study|Lost to Follow-up|0|||
163977281|NCT01157364|592288729|FG002|Overall Study|Lost to Follow-up|1|||
163977282|NCT01157364|592288730|FG003|Overall Study|Lost to Follow-up|0|||
163977283|NCT01157364|592288731|FG004|Overall Study|Lost to Follow-up|0|||
163977284|NCT01157364|592288732|FG005|Overall Study|Lost to Follow-up|0|||
163977285|NCT01157364|592288727|FG000|Overall Study|Lack of Efficacy|0|||
163977286|NCT01157364|592288728|FG001|Overall Study|Lack of Efficacy|0|||
163977287|NCT01157364|592288729|FG002|Overall Study|Lack of Efficacy|0|||
164315379|NCT00146848|593531536|FG000|Pre-randomization|Withdrawal by Subject|40|||
164315380|NCT00146848|593531537|FG001|Pre-randomization|Withdrawal by Subject|0|||
164315381|NCT00146848|593531538|FG002|Pre-randomization|Withdrawal by Subject|0|||
163977288|NCT01157364|592288730|FG003|Overall Study|Lack of Efficacy|1|||
163977289|NCT01157364|592288731|FG004|Overall Study|Lack of Efficacy|0|||
163977290|NCT01157364|592288732|FG005|Overall Study|Lack of Efficacy|0|||
163977291|NCT01157364|592288727|FG000|Overall Study|Adverse Event|0|||
163977292|NCT01157364|592288728|FG001|Overall Study|Adverse Event|1|||
163977293|NCT01157364|592288729|FG002|Overall Study|Adverse Event|1|||
163977294|NCT01157364|592288730|FG003|Overall Study|Adverse Event|0|||
163977295|NCT01157364|592288731|FG004|Overall Study|Adverse Event|1|||
163977296|NCT01157364|592288732|FG005|Overall Study|Adverse Event|0|||
163977297|NCT01780662|592288735|FG000|Overall Study|Adverse Event|1|||
163977298|NCT01780662|592288736|FG001|Overall Study|Adverse Event|0|||
163977299|NCT01780662|592288737|FG002|Overall Study|Adverse Event|2|||
163977300|NCT01780662|592288735|FG000|Overall Study|Physician Decision|0|||
163977301|NCT01780662|592288736|FG001|Overall Study|Physician Decision|5|||
163872845|NCT00421889|591903965|FG001|Overall Study|Death|0|||
163872846|NCT00421889|591903966|FG002|Overall Study|Death|0|||
163872847|NCT00421889|591903967|FG003|Overall Study|Death|0|||
163872848|NCT00421889|591903968|FG004|Overall Study|Death|1|||
163872849|NCT00421889|591903969|FG005|Overall Study|Death|1|||
163872850|NCT00421889|591903970|FG006|Overall Study|Death|0|||
163872851|NCT00421889|591903971|FG007|Overall Study|Death|0|||
163872852|NCT00421889|591903972|FG008|Overall Study|Death|0|||
163872853|NCT00421889|591903964|FG000|Overall Study|Progressive disease|3|||
163872854|NCT00421889|591903965|FG001|Overall Study|Progressive disease|2|||
163872855|NCT00421889|591903966|FG002|Overall Study|Progressive disease|2|||
163872856|NCT00421889|591903967|FG003|Overall Study|Progressive disease|3|||
163872857|NCT00421889|591903968|FG004|Overall Study|Progressive disease|2|||
163872858|NCT00421889|591903969|FG005|Overall Study|Progressive disease|21|||
163872859|NCT00421889|591903970|FG006|Overall Study|Progressive disease|3|||
163872860|NCT00421889|591903971|FG007|Overall Study|Progressive disease|1|||
163872861|NCT00421889|591903972|FG008|Overall Study|Progressive disease|5|||
163872862|NCT00421889|591903964|FG000|Overall Study|Patient/Investigator request|0|||
163872863|NCT00421889|591903965|FG001|Overall Study|Patient/Investigator request|0|||
163872864|NCT00421889|591903966|FG002|Overall Study|Patient/Investigator request|0|||
163872865|NCT00421889|591903967|FG003|Overall Study|Patient/Investigator request|0|||
163872866|NCT00421889|591903968|FG004|Overall Study|Patient/Investigator request|0|||
163872867|NCT00421889|591903969|FG005|Overall Study|Patient/Investigator request|9|||
163872868|NCT00421889|591903970|FG006|Overall Study|Patient/Investigator request|0|||
163872869|NCT00421889|591903971|FG007|Overall Study|Patient/Investigator request|1|||
163977302|NCT01780662|592288737|FG002|Overall Study|Physician Decision|7|||
164204503|NCT05911841|593119214|FG007|Escape Period|Withdrawal by Subject|0|||
163872870|NCT00421889|591903972|FG008|Overall Study|Patient/Investigator request|3|||
163872871|NCT00421889|591903964|FG000|Overall Study|Lost to Follow-up|0|||
163872872|NCT00421889|591903965|FG001|Overall Study|Lost to Follow-up|0|||
163872873|NCT00421889|591903966|FG002|Overall Study|Lost to Follow-up|0|||
163872874|NCT00421889|591903967|FG003|Overall Study|Lost to Follow-up|0|||
163872875|NCT00421889|591903968|FG004|Overall Study|Lost to Follow-up|0|||
163872876|NCT00421889|591903969|FG005|Overall Study|Lost to Follow-up|0|||
163872877|NCT00421889|591903970|FG006|Overall Study|Lost to Follow-up|0|||
163872878|NCT00421889|591903971|FG007|Overall Study|Lost to Follow-up|0|||
163872879|NCT00421889|591903972|FG008|Overall Study|Lost to Follow-up|1|||
163872880|NCT00111813|591903973|FG000|Overall Study|Adverse Event|1|||
163872881|NCT00111813|591903974|FG001|Overall Study|Adverse Event|2|||
163872882|NCT00111813|591903975|FG002|Overall Study|Adverse Event|4|||
163872883|NCT00111813|591903976|FG003|Overall Study|Adverse Event|2|||
163872884|NCT00111813|591903977|FG004|Overall Study|Adverse Event|2|||
163872885|NCT00111813|591903978|FG005|Overall Study|Adverse Event|2|||
163872886|NCT00111813|591903973|FG000|Overall Study|Progressive disease|2|||
163872887|NCT00111813|591903974|FG001|Overall Study|Progressive disease|1|||
163872888|NCT00111813|591903975|FG002|Overall Study|Progressive disease|5|||
163872889|NCT00111813|591903976|FG003|Overall Study|Progressive disease|3|||
163872890|NCT00111813|591903977|FG004|Overall Study|Progressive disease|4|||
163977303|NCT01780662|592288735|FG000|Overall Study|Protocol Violation|0|||
164204504|NCT05911841|593119215|FG008|Escape Period|Withdrawal by Subject|0|||
164204505|NCT05911841|593119216|FG009|Escape Period|Withdrawal by Subject|10|||
164204506|NCT05595369|593119217|FG000|Overall Study|Adverse Event|2|||
164204507|NCT05595369|593119218|FG001|Overall Study|Adverse Event|0|||
164204508|NCT05595369|593119219|FG002|Overall Study|Adverse Event|0|||
164204509|NCT05595369|593119217|FG000|Overall Study|Lost to Follow-up|11|||
164204510|NCT05595369|593119218|FG001|Overall Study|Lost to Follow-up|10|||
164204511|NCT05595369|593119219|FG002|Overall Study|Lost to Follow-up|10|||
164204512|NCT05595369|593119217|FG000|Overall Study|Physician Decision|1|||
164204513|NCT05595369|593119218|FG001|Overall Study|Physician Decision|0|||
164204514|NCT05595369|593119219|FG002|Overall Study|Physician Decision|0|||
164204515|NCT05595369|593119217|FG000|Overall Study|Withdrawal by Subject|5|||
164204516|NCT05595369|593119218|FG001|Overall Study|Withdrawal by Subject|7|||
164204517|NCT05595369|593119219|FG002|Overall Study|Withdrawal by Subject|6|||
164204518|NCT05595369|593119217|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164204519|NCT05595369|593119218|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
164204520|NCT05595369|593119219|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
164204521|NCT05595369|593119217|FG000|Overall Study|Study Drug Non-compliance|0|||
164204522|NCT05595369|593119218|FG001|Overall Study|Study Drug Non-compliance|1|||
163872891|NCT00111813|591903978|FG005|Overall Study|Progressive disease|3|||
163872892|NCT00111813|591903973|FG000|Overall Study|Lack of Efficacy|0|||
163872893|NCT00111813|591903974|FG001|Overall Study|Lack of Efficacy|0|||
163977304|NCT01780662|592288736|FG001|Overall Study|Protocol Violation|1|||
164204523|NCT05595369|593119219|FG002|Overall Study|Study Drug Non-compliance|0|||
163872894|NCT00111813|591903975|FG002|Overall Study|Lack of Efficacy|0|||
163872895|NCT00111813|591903976|FG003|Overall Study|Lack of Efficacy|0|||
163977305|NCT01780662|592288737|FG002|Overall Study|Protocol Violation|0|||
164204524|NCT05595369|593119217|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
164204525|NCT05595369|593119218|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
163977306|NCT01780662|592288735|FG000|Overall Study|Ineligible|0|||
163977307|NCT01780662|592288736|FG001|Overall Study|Ineligible|0|||
163977308|NCT01780662|592288737|FG002|Overall Study|Ineligible|1|||
163872896|NCT00111813|591903977|FG004|Overall Study|Lack of Efficacy|0|||
163872897|NCT00111813|591903978|FG005|Overall Study|Lack of Efficacy|1|||
163872898|NCT00111813|591903973|FG000|Overall Study|Other|0|||
163872899|NCT00111813|591903974|FG001|Overall Study|Other|0|||
163872900|NCT00111813|591903975|FG002|Overall Study|Other|1|||
163872901|NCT00111813|591903976|FG003|Overall Study|Other|0|||
163872902|NCT00111813|591903977|FG004|Overall Study|Other|0|||
163872903|NCT00111813|591903978|FG005|Overall Study|Other|0|||
163872904|NCT01610297|591903979|FG000|Overall Study|Lost to Follow-up|1|||
163872905|NCT00818246|591903980|FG000|Overall Study|Impossible to match pictures|5|||
163872906|NCT00409838|591903981|FG000|Short-term Period|Adverse Event|0|||
163872907|NCT00409838|591903982|FG001|Short-term Period|Adverse Event|1|||
163872908|NCT00409838|591903981|FG000|Short-term Period|Lost to Follow-up|0|||
163872909|NCT00409838|591903982|FG001|Short-term Period|Lost to Follow-up|1|||
163872910|NCT00409838|591903981|FG000|Short-term Period|Withdrawal by Subject|2|||
163872911|NCT00409838|591903982|FG001|Short-term Period|Withdrawal by Subject|3|||
163872912|NCT00409838|591903981|FG000|Short-term Period|Never Treated|1|||
163872913|NCT00409838|591903982|FG001|Short-term Period|Never Treated|0|||
163872914|NCT00409838|591903981|FG000|Long-term Extension Period|Adverse Event|10|||
163872915|NCT00409838|591903982|FG001|Long-term Extension Period|Adverse Event|0|||
163872916|NCT00409838|591903981|FG000|Long-term Extension Period|Death|1|||
163872917|NCT00409838|591903982|FG001|Long-term Extension Period|Death|0|||
163872918|NCT00409838|591903981|FG000|Long-term Extension Period|Lack of Efficacy|2|||
163872919|NCT00409838|591903982|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163872920|NCT00409838|591903981|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
163872921|NCT00409838|591903982|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
163977309|NCT01263639|592288738|FG000|Overall Study|Lost to Follow-up|66|||
163977310|NCT01263639|592288739|FG001|Overall Study|Lost to Follow-up|70|||
163977311|NCT01263639|592288738|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
164204526|NCT05595369|593119219|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
164204527|NCT02592824|593119225|FG000|Overall Study|Protocol Violation|5|||
164204528|NCT02592824|593119226|FG001|Overall Study|Protocol Violation|3|||
164204529|NCT02592824|593119225|FG000|Overall Study|Lost to Follow-up|2|||
164204530|NCT02592824|593119226|FG001|Overall Study|Lost to Follow-up|1|||
164204531|NCT02855268|593119227|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
164204532|NCT02855268|593119228|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
164204533|NCT02855268|593119227|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
164204534|NCT02855268|593119228|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
164204535|NCT02855268|593119227|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
164204536|NCT02855268|593119228|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
164204537|NCT02855268|593119227|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
164204538|NCT02855268|593119228|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
164302995|NCT04323124|593484689|FG003|Overall Study|Adverse Event|0|||
163872922|NCT00409838|591903981|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
163872923|NCT00409838|591903982|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
163872924|NCT00409838|591903981|FG000|Long-term Extension Period|Pregnancy|1|||
163872925|NCT00409838|591903982|FG001|Long-term Extension Period|Pregnancy|0|||
163872926|NCT05368831|591903987|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
163872927|NCT03565315|591903988|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
163872928|NCT03565315|591903989|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
164302996|NCT04323124|593484690|FG004|Overall Study|Adverse Event|0|||
164302997|NCT04323124|593484691|FG005|Overall Study|Adverse Event|1|||
164302998|NCT04323124|593484692|FG006|Overall Study|Adverse Event|0|||
164302999|NCT04323124|593484693|FG007|Overall Study|Adverse Event|1|||
164303000|NCT04323124|593484694|FG008|Overall Study|Adverse Event|1|||
164303001|NCT04323124|593484695|FG009|Overall Study|Adverse Event|0|||
164303002|NCT04323124|593484696|FG010|Overall Study|Adverse Event|0|||
164303003|NCT04323124|593484697|FG011|Overall Study|Adverse Event|0|||
164303004|NCT04323124|593484698|FG012|Overall Study|Adverse Event|0|||
164303005|NCT04323124|593484699|FG013|Overall Study|Adverse Event|0|||
164303006|NCT04323124|593484700|FG014|Overall Study|Adverse Event|0|||
164303007|NCT04323124|593484686|FG000|Overall Study|Other|0|||
164303008|NCT04323124|593484687|FG001|Overall Study|Other|0|||
164303009|NCT04323124|593484688|FG002|Overall Study|Other|0|||
164303010|NCT04323124|593484689|FG003|Overall Study|Other|0|||
164303011|NCT04323124|593484690|FG004|Overall Study|Other|1|||
164303012|NCT04323124|593484691|FG005|Overall Study|Other|0|||
164303013|NCT04323124|593484692|FG006|Overall Study|Other|0|||
164303014|NCT04323124|593484693|FG007|Overall Study|Other|0|||
164303015|NCT04323124|593484694|FG008|Overall Study|Other|1|||
164303016|NCT04323124|593484695|FG009|Overall Study|Other|0|||
164303017|NCT04323124|593484696|FG010|Overall Study|Other|0|||
164303018|NCT04323124|593484697|FG011|Overall Study|Other|0|||
164303019|NCT04323124|593484698|FG012|Overall Study|Other|0|||
164303020|NCT04323124|593484699|FG013|Overall Study|Other|0|||
164315382|NCT00146848|593531536|FG000|Post-randomization|Lost to Follow-up|12|||
164315383|NCT00146848|593531537|FG001|Post-randomization|Lost to Follow-up|15|||
164315384|NCT00146848|593531538|FG002|Post-randomization|Lost to Follow-up|12|||
164315385|NCT00146848|593531536|FG000|Post-randomization|Withdrawn|26|||
164315386|NCT00146848|593531537|FG001|Post-randomization|Withdrawn|32|||
164315387|NCT00146848|593531538|FG002|Post-randomization|Withdrawn|27|||
164315388|NCT02395172|593531539|FG000|Overall Study|Participants randomized but not treated|3|||
164315389|NCT02395172|593531540|FG001|Overall Study|Participants randomized but not treated|31|||
164315390|NCT02032238|593531541|FG000|Overall Study|Lost to Follow-up|2|||
164315391|NCT02032238|593531542|FG001|Overall Study|Lost to Follow-up|0|||
164315392|NCT00653939|593531543|FG000|Overall Study|Adverse Event|1|||
164315393|NCT00653939|593531544|FG001|Overall Study|Adverse Event|3|||
164315394|NCT00653939|593531543|FG000|Overall Study|Withdrawal by Subject|3|||
164315395|NCT00653939|593531544|FG001|Overall Study|Withdrawal by Subject|3|||
164315396|NCT00653939|593531543|FG000|Overall Study|Physician Decision|4|||
164315397|NCT00653939|593531544|FG001|Overall Study|Physician Decision|0|||
164315398|NCT00653939|593531543|FG000|Overall Study|Disease Progression|2|||
164315399|NCT00653939|593531544|FG001|Overall Study|Disease Progression|3|||
164315400|NCT00653939|593531543|FG000|Overall Study|Other|2|||
164315401|NCT00653939|593531544|FG001|Overall Study|Other|6|||
164315402|NCT00717236|593531545|FG000|Double-Blind Period|Adverse Event|33|||
164315403|NCT00717236|593531546|FG001|Double-Blind Period|Adverse Event|6|||
164315404|NCT00717236|593531545|FG000|Double-Blind Period|Lack of Efficacy|6|||
164315405|NCT00717236|593531546|FG001|Double-Blind Period|Lack of Efficacy|6|||
164315406|NCT00717236|593531545|FG000|Double-Blind Period|Lost to Follow-up|3|||
164315407|NCT00717236|593531546|FG001|Double-Blind Period|Lost to Follow-up|5|||
164315408|NCT00717236|593531545|FG000|Double-Blind Period|Withdrawal by Subject|10|||
164315409|NCT00717236|593531546|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164315410|NCT00717236|593531545|FG000|Double-Blind Period|Loss of efficacy|3|||
164315411|NCT00717236|593531546|FG001|Double-Blind Period|Loss of efficacy|0|||
164315412|NCT00717236|593531545|FG000|Double-Blind Period|Other: Death|1|||
164315413|NCT00717236|593531546|FG001|Double-Blind Period|Other: Death|0|||
164315414|NCT00717236|593531545|FG000|Double-Blind Period|Other: Pregnancy|1|||
164315415|NCT00717236|593531546|FG001|Double-Blind Period|Other: Pregnancy|0|||
164315416|NCT00717236|593531545|FG000|Double-Blind Period|Other: Protocol Violation|2|||
164315417|NCT00717236|593531546|FG001|Double-Blind Period|Other: Protocol Violation|0|||
164315418|NCT00717236|593531545|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
164315419|NCT00717236|593531546|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
164315420|NCT00717236|593531545|FG000|Double-Blind Period|Other: Site withdrew|2|||
164315421|NCT00717236|593531546|FG001|Double-Blind Period|Other: Site withdrew|0|||
164315422|NCT00717236|593531545|FG000|Double-Blind Period|Other: Screening failure|1|||
164315423|NCT00717236|593531546|FG001|Double-Blind Period|Other: Screening failure|0|||
164315424|NCT00717236|593531545|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
163872929|NCT03565315|591903990|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
164204539|NCT02855268|593119227|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
164204540|NCT02855268|593119228|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
164204541|NCT02855268|593119227|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
164204542|NCT02855268|593119228|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
164204543|NCT00465517|593119231|FG000|Overall Study|Adverse Event|7|||
164204544|NCT00465517|593119232|FG001|Overall Study|Adverse Event|3|||
164204545|NCT00465517|593119231|FG000|Overall Study|Lost to Follow-up|1|||
164204546|NCT00465517|593119232|FG001|Overall Study|Lost to Follow-up|0|||
164204547|NCT00465517|593119231|FG000|Overall Study|Withdrawal by Subject|4|||
164204548|NCT00465517|593119232|FG001|Overall Study|Withdrawal by Subject|1|||
164204549|NCT01286129|593119233|FG000|Overall Study|Withdrawal by Subject|4|||
164204550|NCT01286129|593119234|FG001|Overall Study|Withdrawal by Subject|1|||
164204551|NCT01286129|593119233|FG000|Overall Study|Could not comply with study requirements|4|||
164204552|NCT01286129|593119234|FG001|Overall Study|Could not comply with study requirements|4|||
164204553|NCT00111761|593119237|FG000|Part 1|Physician Decision|0|||
164204554|NCT00111761|593119238|FG001|Part 1|Physician Decision|1|||
164204555|NCT00111761|593119237|FG000|Part 1|Death|0|||
164204556|NCT00111761|593119238|FG001|Part 1|Death|2|||
164204557|NCT00111761|593119237|FG000|Part 1|Other|0|||
164204558|NCT00111761|593119238|FG001|Part 1|Other|1|||
164204559|NCT00111761|593119237|FG000|Part 1|Withdrawal by Subject|0|||
164204560|NCT00111761|593119238|FG001|Part 1|Withdrawal by Subject|1|||
164204561|NCT00111761|593119237|FG000|Part 2|Adverse Event|1|||
164204562|NCT00111761|593119238|FG001|Part 2|Adverse Event|0|||
164204563|NCT00111761|593119237|FG000|Part 2|Physician Decision|1|||
164204564|NCT00111761|593119238|FG001|Part 2|Physician Decision|0|||
164204565|NCT00111761|593119237|FG000|Part 2|Death|1|||
164315425|NCT00717236|593531546|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
164315426|NCT00717236|593531545|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
164315427|NCT00717236|593531546|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
164315428|NCT00717236|593531545|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
164204566|NCT00111761|593119238|FG001|Part 2|Death|0|||
164204567|NCT00111761|593119237|FG000|Part 2|Disease progression|3|||
163977312|NCT01263639|592288739|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
163977313|NCT00183274|592288740|FG000|Phase 1: Open-Label|Adverse Event|31|||
163977314|NCT00183274|592288741|FG001|Phase 1: Open-Label|Adverse Event|0|||
163977315|NCT00183274|592288742|FG002|Phase 1: Open-Label|Adverse Event|0|||
163977316|NCT00183274|592288743|FG003|Phase 1: Open-Label|Adverse Event|0|||
163977317|NCT00183274|592288744|FG004|Phase 1: Open-Label|Adverse Event|0|||
163977318|NCT00183274|592288745|FG005|Phase 1: Open-Label|Adverse Event|0|||
163977319|NCT00183274|592288740|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
163977320|NCT00183274|592288741|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
163977321|NCT00183274|592288742|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
163977322|NCT00183274|592288743|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
163977323|NCT00183274|592288744|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
163977324|NCT00183274|592288745|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
163977325|NCT00183274|592288740|FG000|Phase 1: Open-Label|Protocol Violation|11|||
163977326|NCT00183274|592288741|FG001|Phase 1: Open-Label|Protocol Violation|0|||
163977327|NCT00183274|592288742|FG002|Phase 1: Open-Label|Protocol Violation|0|||
163977328|NCT00183274|592288743|FG003|Phase 1: Open-Label|Protocol Violation|0|||
163977329|NCT00183274|592288744|FG004|Phase 1: Open-Label|Protocol Violation|0|||
163977330|NCT00183274|592288745|FG005|Phase 1: Open-Label|Protocol Violation|0|||
163977331|NCT00183274|592288740|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
163977332|NCT00183274|592288741|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
163977333|NCT00183274|592288742|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
163977334|NCT00183274|592288743|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
163977335|NCT00183274|592288744|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
163977336|NCT00183274|592288745|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
163977337|NCT00183274|592288740|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
163977338|NCT00183274|592288741|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
163977339|NCT00183274|592288742|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
163977340|NCT00183274|592288743|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
163977341|NCT00183274|592288744|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
163977342|NCT00183274|592288745|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
163977343|NCT00183274|592288740|FG000|Phase 1: Open-Label|Other|9|||
163977344|NCT00183274|592288741|FG001|Phase 1: Open-Label|Other|0|||
163977345|NCT00183274|592288742|FG002|Phase 1: Open-Label|Other|0|||
163977346|NCT00183274|592288743|FG003|Phase 1: Open-Label|Other|0|||
163977347|NCT00183274|592288744|FG004|Phase 1: Open-Label|Other|0|||
163977348|NCT00183274|592288745|FG005|Phase 1: Open-Label|Other|0|||
163977349|NCT00183274|592288740|FG000|Phase 2: Double-Blind|Relapsed|0|||
163977350|NCT00183274|592288741|FG001|Phase 2: Double-Blind|Relapsed|8|||
163977351|NCT00183274|592288742|FG002|Phase 2: Double-Blind|Relapsed|29|||
163977352|NCT00183274|592288743|FG003|Phase 2: Double-Blind|Relapsed|0|||
163977353|NCT00183274|592288744|FG004|Phase 2: Double-Blind|Relapsed|0|||
163977354|NCT00183274|592288745|FG005|Phase 2: Double-Blind|Relapsed|0|||
164204568|NCT00111761|593119238|FG001|Part 2|Disease progression|0|||
164204569|NCT00111761|593119237|FG000|Part 2|Protocol-specified criteria|1|||
164204570|NCT00111761|593119238|FG001|Part 2|Protocol-specified criteria|0|||
164204571|NCT00111761|593119237|FG000|Part 2|Other|1|||
164204572|NCT00111761|593119238|FG001|Part 2|Other|0|||
164204573|NCT02029417|593119241|FG000|Overall Study|Death|1|||
164204574|NCT02029417|593119241|FG000|Overall Study|Adverse Event|1|||
164204575|NCT00071981|593119242|FG000|Overall Study|Lack of Efficacy|37|||
164204576|NCT00071981|593119243|FG001|Overall Study|Lack of Efficacy|29|||
164204577|NCT00071981|593119244|FG002|Overall Study|Lack of Efficacy|30|||
164204578|NCT00071981|593119245|FG003|Overall Study|Lack of Efficacy|43|||
164204579|NCT00071981|593119242|FG000|Overall Study|Adverse Event|4|||
164204580|NCT00071981|593119243|FG001|Overall Study|Adverse Event|4|||
164204581|NCT00071981|593119244|FG002|Overall Study|Adverse Event|3|||
164204582|NCT00071981|593119245|FG003|Overall Study|Adverse Event|1|||
164204583|NCT00071981|593119242|FG000|Overall Study|Death|0|||
164204584|NCT00071981|593119243|FG001|Overall Study|Death|0|||
164204585|NCT00071981|593119244|FG002|Overall Study|Death|1|||
164204586|NCT00071981|593119245|FG003|Overall Study|Death|1|||
164204587|NCT00071981|593119242|FG000|Overall Study|Withdrawal by Subject|3|||
163977355|NCT00183274|592288740|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163977356|NCT00183274|592288741|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
163977357|NCT00183274|592288742|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
163977358|NCT00183274|592288743|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163977359|NCT00183274|592288744|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
164204588|NCT00071981|593119243|FG001|Overall Study|Withdrawal by Subject|1|||
164204589|NCT00071981|593119244|FG002|Overall Study|Withdrawal by Subject|0|||
164204590|NCT00071981|593119245|FG003|Overall Study|Withdrawal by Subject|0|||
164204591|NCT00071981|593119242|FG000|Overall Study|No protocol therapy|2|||
164204592|NCT00071981|593119243|FG001|Overall Study|No protocol therapy|5|||
164204593|NCT00071981|593119244|FG002|Overall Study|No protocol therapy|1|||
163977360|NCT00183274|592288745|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
163977361|NCT00183274|592288740|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
163977362|NCT00183274|592288741|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
163977363|NCT00183274|592288742|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
164315429|NCT00717236|593531546|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
164315430|NCT00717236|593531545|FG000|Double-Blind Period|Other: History of cancer|1|||
164315431|NCT00717236|593531546|FG001|Double-Blind Period|Other: History of cancer|0|||
164315432|NCT00717236|593531545|FG000|Double-Blind Period|Other: Sponsor request|1|||
164315433|NCT00717236|593531546|FG001|Double-Blind Period|Other: Sponsor request|0|||
164315434|NCT00717236|593531545|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
164315435|NCT00717236|593531546|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
164315436|NCT00717236|593531545|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
164315437|NCT00717236|593531546|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
164315438|NCT00717236|593531545|FG000|Double-Blind Period|Other: Subject moved|1|||
164315439|NCT00717236|593531546|FG001|Double-Blind Period|Other: Subject moved|1|||
164315440|NCT00717236|593531545|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
164315441|NCT00717236|593531546|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
164315442|NCT00717236|593531545|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
164315443|NCT00717236|593531546|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
164315444|NCT00717236|593531545|FG000|Double-Blind Period|Other: Transportation problems|0|||
164315445|NCT00717236|593531546|FG001|Double-Blind Period|Other: Transportation problems|1|||
164315446|NCT00717236|593531545|FG000|Double-Blind Period|Other: Investigator Decision|0|||
163872930|NCT03565315|591903991|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
163872931|NCT01170962|591903992|FG000|Treatment Period|Lack of Efficacy|96|||
163872932|NCT01170962|591903993|FG001|Treatment Period|Lack of Efficacy|91|||
163872933|NCT01170962|591903994|FG002|Treatment Period|Lack of Efficacy|7|||
163872934|NCT01170962|591903992|FG000|Treatment Period|Adverse Event|11|||
163872935|NCT01170962|591903993|FG001|Treatment Period|Adverse Event|12|||
163872936|NCT01170962|591903994|FG002|Treatment Period|Adverse Event|3|||
163872937|NCT01170962|591903992|FG000|Treatment Period|Withdrawal by Subject|2|||
163872938|NCT01170962|591903993|FG001|Treatment Period|Withdrawal by Subject|1|||
163872939|NCT01170962|591903994|FG002|Treatment Period|Withdrawal by Subject|0|||
163872940|NCT01170962|591903992|FG000|Treatment Period|Lost to Follow-up|1|||
163872941|NCT01170962|591903993|FG001|Treatment Period|Lost to Follow-up|1|||
163872942|NCT01170962|591903994|FG002|Treatment Period|Lost to Follow-up|1|||
163872943|NCT01170962|591903992|FG000|Treatment Period|Participant no longer meets criteria|0|||
163872944|NCT01170962|591903993|FG001|Treatment Period|Participant no longer meets criteria|1|||
163872945|NCT01170962|591903994|FG002|Treatment Period|Participant no longer meets criteria|0|||
163872946|NCT01170962|591903992|FG000|Treatment Period|Request to discontinue treatment|7|||
163872947|NCT01170962|591903993|FG001|Treatment Period|Request to discontinue treatment|3|||
163872948|NCT01170962|591903994|FG002|Treatment Period|Request to discontinue treatment|1|||
163872949|NCT01170962|591903992|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
163872950|NCT01170962|591903993|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
163872951|NCT01170962|591903994|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
163872952|NCT01170962|591903992|FG000|Follow up Period|Withdrawal by Subject|14|||
163872953|NCT01170962|591903993|FG001|Follow up Period|Withdrawal by Subject|10|||
163872954|NCT01170962|591903994|FG002|Follow up Period|Withdrawal by Subject|2|||
163872955|NCT01170962|591903992|FG000|Follow up Period|Lost to Follow-up|13|||
163872956|NCT01170962|591903993|FG001|Follow up Period|Lost to Follow-up|8|||
163872957|NCT01170962|591903994|FG002|Follow up Period|Lost to Follow-up|1|||
163872958|NCT01170962|591903992|FG000|Follow up Period|Death|2|||
163872959|NCT01170962|591903993|FG001|Follow up Period|Death|2|||
163872960|NCT01170962|591903994|FG002|Follow up Period|Death|0|||
163872961|NCT01170962|591903992|FG000|Follow up Period|Others|10|||
163872962|NCT01170962|591903993|FG001|Follow up Period|Others|7|||
163872963|NCT01170962|591903994|FG002|Follow up Period|Others|3|||
163872964|NCT03887650|591903995|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
163872965|NCT03887650|591903996|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
163872966|NCT03887650|591903995|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
163872967|NCT03887650|591903996|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
163872968|NCT03887650|591903995|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
163872969|NCT03887650|591903996|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
163872970|NCT01083316|591903997|FG000|Overall Study|Adverse Event|2|||
163872971|NCT01083316|591903997|FG000|Overall Study|Withdrawal by Subject|1|||
163872972|NCT04200365|591903998|FG000|Overall Study|Adverse Event|2|||
163872973|NCT04200365|591903998|FG000|Overall Study|Progressive Disease|4|||
163872974|NCT04200365|591903998|FG000|Overall Study|Lack of Efficacy|1|||
163872975|NCT04200365|591903998|FG000|Overall Study|Study Closure|4|||
163872976|NCT03942042|591903999|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
163872977|NCT03942042|591904000|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
163872978|NCT03942042|591903999|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
163872979|NCT03942042|591904000|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
163872980|NCT00933400|591904006|FG000|Overall Study|Withdrawal by Subject|21|||
163872981|NCT00933400|591904007|FG001|Overall Study|Withdrawal by Subject|1|||
163872982|NCT01849055|591904008|FG000|Overall Study|Withdrawal by Subject|0|||
163872983|NCT01849055|591904009|FG001|Overall Study|Withdrawal by Subject|0|||
164315447|NCT00717236|593531546|FG001|Double-Blind Period|Other: Investigator Decision|1|||
164315448|NCT00717236|593531545|FG000|Open-Label Period|Adverse Event|29|||
164315449|NCT00717236|593531546|FG001|Open-Label Period|Adverse Event|4|||
164315450|NCT00717236|593531545|FG000|Open-Label Period|Lack of Efficacy|30|||
164315451|NCT00717236|593531546|FG001|Open-Label Period|Lack of Efficacy|8|||
164315452|NCT00717236|593531545|FG000|Open-Label Period|Lost to Follow-up|28|||
164315453|NCT00717236|593531546|FG001|Open-Label Period|Lost to Follow-up|4|||
164315454|NCT00717236|593531545|FG000|Open-Label Period|Withdrawal by Subject|20|||
164315455|NCT00717236|593531546|FG001|Open-Label Period|Withdrawal by Subject|2|||
164315456|NCT00717236|593531545|FG000|Open-Label Period|Loss of Efficacy|6|||
164315457|NCT00717236|593531546|FG001|Open-Label Period|Loss of Efficacy|1|||
164315458|NCT00717236|593531545|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
164315459|NCT00717236|593531546|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
164315460|NCT00717236|593531545|FG000|Open-Label Period|Other: Lack of Compliance|1|||
164315461|NCT00717236|593531546|FG001|Open-Label Period|Other: Lack of Compliance|1|||
164315462|NCT00717236|593531545|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
164315463|NCT00717236|593531546|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
164315464|NCT00717236|593531545|FG000|Open-Label Period|Other: Moved|1|||
164315465|NCT00717236|593531546|FG001|Open-Label Period|Other: Moved|0|||
164315466|NCT00717236|593531545|FG000|Open-Label Period|Other: Investigator Decision|1|||
164315467|NCT00717236|593531546|FG001|Open-Label Period|Other: Investigator Decision|0|||
164315468|NCT00717236|593531545|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
164315469|NCT00717236|593531546|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
164315470|NCT00717236|593531545|FG000|Open-Label Period|Other: Sponsor Request|3|||
164315471|NCT00717236|593531546|FG001|Open-Label Period|Other: Sponsor Request|0|||
164315472|NCT00717236|593531545|FG000|Open-Label Period|Other: Cataract Surgery|1|||
164315473|NCT00717236|593531546|FG001|Open-Label Period|Other: Cataract Surgery|0|||
164315474|NCT00717236|593531545|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
164315475|NCT00717236|593531546|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
164315476|NCT00717236|593531545|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
164315477|NCT00717236|593531546|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
164315478|NCT00717236|593531545|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
164315479|NCT00717236|593531546|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
164315480|NCT01105767|593531547|FG000|Overall Study|Lost to Follow-up|1160|||
164315481|NCT01105767|593531548|FG001|Overall Study|Lost to Follow-up|1614|||
164315482|NCT01105767|593531549|FG002|Overall Study|Lost to Follow-up|1184|||
164315483|NCT00029146|593531552|FG000|Overall Study|Lost to Follow-up|2|||
164315484|NCT00029146|593531553|FG001|Overall Study|Lost to Follow-up|1|||
164315485|NCT02720042|593531561|FG000|Overall Study|Death|3|||
164315486|NCT02720042|593531561|FG000|Overall Study|Lost to Follow-up|4|||
164315487|NCT02720042|593531561|FG000|Overall Study|Withdrawal by Subject|1|||
164315488|NCT02720042|593531561|FG000|Overall Study|Physician Decision|3|||
164315489|NCT02720042|593531561|FG000|Overall Study|Phasix Mesh explanted|1|||
164315490|NCT02720042|593531561|FG000|Overall Study|unable due to non-study-related illness|3|||
164315491|NCT03704636|593531562|FG000|Overall Study|Inadequate Venous Flow|3|||
164315492|NCT00509145|593531565|FG000|Overall Study|Death|0|||
164315493|NCT00509145|593531566|FG001|Overall Study|Death|2|||
164315494|NCT00509145|593531565|FG000|Overall Study|Adverse Event|42|||
164315495|NCT00509145|593531566|FG001|Overall Study|Adverse Event|28|||
164315496|NCT00509145|593531565|FG000|Overall Study|Withdrawal by Subject|32|||
164315497|NCT00509145|593531566|FG001|Overall Study|Withdrawal by Subject|38|||
164315498|NCT00509145|593531565|FG000|Overall Study|Physician Decision|11|||
164315499|NCT00509145|593531566|FG001|Overall Study|Physician Decision|14|||
164315500|NCT00509145|593531565|FG000|Overall Study|Protocol Violation|1|||
164315501|NCT00509145|593531566|FG001|Overall Study|Protocol Violation|6|||
164315502|NCT00509145|593531565|FG000|Overall Study|Pregnancy|3|||
164315503|NCT00509145|593531566|FG001|Overall Study|Pregnancy|8|||
164315504|NCT00509145|593531565|FG000|Overall Study|Lost to Follow-up|6|||
164315505|NCT00509145|593531566|FG001|Overall Study|Lost to Follow-up|5|||
164315506|NCT00509145|593531565|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
164315507|NCT00509145|593531566|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
164315508|NCT00509145|593531565|FG000|Overall Study|Other|6|||
164315509|NCT00509145|593531566|FG001|Overall Study|Other|6|||
164315510|NCT03500224|593531567|FG000|Overall Study|Withdrawal by Subject|2|||
164315511|NCT01994889|593531570|FG000|Overall Study|Adverse Event|5|||
164315512|NCT01994889|593531571|FG001|Overall Study|Adverse Event|12|||
164315513|NCT01994889|593531572|FG002|Overall Study|Adverse Event|11|||
164315514|NCT01994889|593531570|FG000|Overall Study|Cardiac Device Implantation|0|||
164315515|NCT01994889|593531571|FG001|Overall Study|Cardiac Device Implantation|2|||
164315516|NCT01994889|593531572|FG002|Overall Study|Cardiac Device Implantation|0|||
164315517|NCT01994889|593531570|FG000|Overall Study|Organ Transplantation|1|||
164315518|NCT01994889|593531571|FG001|Overall Study|Organ Transplantation|5|||
164315519|NCT01994889|593531572|FG002|Overall Study|Organ Transplantation|5|||
164315520|NCT01994889|593531570|FG000|Overall Study|No longer willing to participate|8|||
164315521|NCT01994889|593531571|FG001|Overall Study|No longer willing to participate|17|||
163977364|NCT00183274|592288743|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
164204594|NCT00071981|593119245|FG003|Overall Study|No protocol therapy|0|||
164204595|NCT00071981|593119242|FG000|Overall Study|others (not specified in the study)|0|||
164204596|NCT00071981|593119243|FG001|Overall Study|others (not specified in the study)|2|||
163977365|NCT00183274|592288744|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
164204597|NCT00071981|593119244|FG002|Overall Study|others (not specified in the study)|2|||
164204598|NCT00071981|593119245|FG003|Overall Study|others (not specified in the study)|0|||
164204599|NCT04458922|593119246|FG000|Overall Study|Withdrawal by Subject|1|||
164204600|NCT04458922|593119247|FG001|Overall Study|Withdrawal by Subject|0|||
164204601|NCT04458922|593119248|FG002|Overall Study|Withdrawal by Subject|2|||
164204602|NCT04458922|593119246|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
164204603|NCT04458922|593119247|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
164204604|NCT04458922|593119248|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
164204605|NCT04458922|593119246|FG000|Overall Study|Adverse Event|1|||
164204606|NCT04458922|593119247|FG001|Overall Study|Adverse Event|0|||
164204607|NCT04458922|593119248|FG002|Overall Study|Adverse Event|0|||
164204608|NCT04458922|593119246|FG000|Overall Study|Started new study|0|||
164204609|NCT04458922|593119247|FG001|Overall Study|Started new study|0|||
164204610|NCT04458922|593119248|FG002|Overall Study|Started new study|1|||
164204611|NCT04458922|593119246|FG000|Overall Study|Progressive disease|6|||
164204612|NCT04458922|593119247|FG001|Overall Study|Progressive disease|8|||
164315522|NCT01994889|593531572|FG002|Overall Study|No longer willing to participate|37|||
164315523|NCT01994889|593531570|FG000|Overall Study|Lost to Follow-up|0|||
163977366|NCT00183274|592288745|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
163977367|NCT00183274|592288740|FG000|Phase 3: Double-Blind|Relapsed|0|||
163977368|NCT00183274|592288741|FG001|Phase 3: Double-Blind|Relapsed|0|||
163977369|NCT00183274|592288742|FG002|Phase 3: Double-Blind|Relapsed|0|||
163977370|NCT00183274|592288743|FG003|Phase 3: Double-Blind|Relapsed|1|||
163977371|NCT00183274|592288744|FG004|Phase 3: Double-Blind|Relapsed|11|||
163977372|NCT00183274|592288745|FG005|Phase 3: Double-Blind|Relapsed|2|||
163977373|NCT03975920|592288750|FG000|Overall Study|Lost to Follow-up|1|||
163977374|NCT03975920|592288751|FG001|Overall Study|Lost to Follow-up|2|||
163977375|NCT03975920|592288750|FG000|Overall Study|Protocol Violation|1|||
163977376|NCT03975920|592288751|FG001|Overall Study|Protocol Violation|1|||
163977377|NCT03975920|592288750|FG000|Overall Study|Did not complete survey|2|||
163977378|NCT03975920|592288751|FG001|Overall Study|Did not complete survey|1|||
163977379|NCT00586495|592288752|FG000|Treatment Period|Adverse Event|11|||
163977380|NCT00586495|592288752|FG000|Treatment Period|Death|1|||
163977381|NCT00586495|592288752|FG000|Treatment Period|Protocol Violation|1|||
163977382|NCT00586495|592288752|FG000|Treatment Period|Withdrawal by Subject|1|||
163977383|NCT00586495|592288752|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
163977384|NCT00586495|592288752|FG000|Treatment Period|Switch to commercial drug|10|||
163977385|NCT00586495|592288752|FG000|Follow-up|Death|40|||
163977386|NCT00586495|592288752|FG000|Follow-up|Lost to Follow-up|1|||
163977387|NCT00586495|592288752|FG000|Follow-up|Withdrawal by Subject|4|||
163977388|NCT00586495|592288752|FG000|Follow-up|Protocol driven decision point|37|||
163977389|NCT00586495|592288752|FG000|Follow-up|Switch to commercial drug|10|||
163977390|NCT03882970|592288755|FG000|Overall Study|Adverse Event|5|||
163977391|NCT03882970|592288756|FG001|Overall Study|Adverse Event|7|||
163977392|NCT03882970|592288757|FG002|Overall Study|Adverse Event|3|||
163977393|NCT03882970|592288758|FG003|Overall Study|Adverse Event|1|||
163977394|NCT03882970|592288755|FG000|Overall Study|Death|1|||
163977395|NCT03882970|592288756|FG001|Overall Study|Death|2|||
163977396|NCT03882970|592288757|FG002|Overall Study|Death|1|||
163977397|NCT03882970|592288758|FG003|Overall Study|Death|1|||
163977398|NCT03882970|592288755|FG000|Overall Study|Lost to Follow-up|8|||
163977399|NCT03882970|592288756|FG001|Overall Study|Lost to Follow-up|9|||
163977400|NCT03882970|592288757|FG002|Overall Study|Lost to Follow-up|5|||
163977401|NCT03882970|592288758|FG003|Overall Study|Lost to Follow-up|5|||
163977402|NCT03882970|592288755|FG000|Overall Study|Physician Decision|0|||
163977403|NCT03882970|592288756|FG001|Overall Study|Physician Decision|2|||
163977404|NCT03882970|592288757|FG002|Overall Study|Physician Decision|2|||
163977405|NCT03882970|592288758|FG003|Overall Study|Physician Decision|2|||
163977406|NCT03882970|592288755|FG000|Overall Study|Protocol Violation|2|||
163977407|NCT03882970|592288756|FG001|Overall Study|Protocol Violation|0|||
163977408|NCT03882970|592288757|FG002|Overall Study|Protocol Violation|0|||
163977409|NCT03882970|592288758|FG003|Overall Study|Protocol Violation|0|||
163977410|NCT03882970|592288755|FG000|Overall Study|Withdrawal by Subject|8|||
163977411|NCT03882970|592288756|FG001|Overall Study|Withdrawal by Subject|17|||
163977412|NCT03882970|592288757|FG002|Overall Study|Withdrawal by Subject|7|||
163977413|NCT03882970|592288758|FG003|Overall Study|Withdrawal by Subject|22|||
164204613|NCT04458922|593119248|FG002|Overall Study|Progressive disease|2|||
164204614|NCT04458922|593119246|FG000|Overall Study|Death|1|||
164204615|NCT04458922|593119247|FG001|Overall Study|Death|0|||
164204616|NCT04458922|593119248|FG002|Overall Study|Death|2|||
164204617|NCT04458922|593119246|FG000|Overall Study|Participant started chemotherapy|0|||
164315524|NCT01994889|593531571|FG001|Overall Study|Lost to Follow-up|1|||
163977414|NCT03882970|592288755|FG000|Overall Study|Personal Reason|2|||
163872984|NCT01849055|591904010|FG002|Overall Study|Withdrawal by Subject|1|||
163872985|NCT01849055|591904011|FG003|Overall Study|Withdrawal by Subject|0|||
163872986|NCT01849055|591904012|FG004|Overall Study|Withdrawal by Subject|0|||
163872987|NCT01849055|591904013|FG005|Overall Study|Withdrawal by Subject|0|||
163872988|NCT01199575|591904014|FG000|Overall Study|Withdrawal by Subject|5|||
163872989|NCT00223795|591904016|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
163872990|NCT00223795|591904017|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
163872991|NCT00223795|591904016|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
164204618|NCT04458922|593119247|FG001|Overall Study|Participant started chemotherapy|1|||
164204619|NCT04458922|593119248|FG002|Overall Study|Participant started chemotherapy|0|||
164204620|NCT01981616|593119252|FG000|Overall Study|Adverse Event|0|||
164204621|NCT01981616|593119253|FG001|Overall Study|Adverse Event|1|||
164204622|NCT01981616|593119252|FG000|Overall Study|Protocol Violation|1|||
164204623|NCT01981616|593119253|FG001|Overall Study|Protocol Violation|0|||
164204624|NCT05079321|593119255|FG000|Overall Study|Withdrawal by Subject|2|||
164204625|NCT05079321|593119256|FG001|Overall Study|Withdrawal by Subject|2|||
164204626|NCT05079321|593119255|FG000|Overall Study|Lost to Follow-up|0|||
164204627|NCT05079321|593119256|FG001|Overall Study|Lost to Follow-up|1|||
164204628|NCT01081626|593119257|FG000|Overall Study|Dosing error|1|||
164204629|NCT01081626|593119258|FG001|Overall Study|Dosing error|1|||
164204630|NCT01081626|593119257|FG000|Overall Study|Missing Estradiol|25|||
164204631|NCT01081626|593119258|FG001|Overall Study|Missing Estradiol|28|||
164204632|NCT01081626|593119257|FG000|Overall Study|Low antral follicle count|1|||
164204633|NCT01081626|593119258|FG001|Overall Study|Low antral follicle count|0|||
164204634|NCT01081626|593119257|FG000|Overall Study|Overstimulation|0|||
164204635|NCT01081626|593119258|FG001|Overall Study|Overstimulation|1|||
164204636|NCT01081626|593119257|FG000|Overall Study|Lost to Follow-up|0|||
164204637|NCT01081626|593119258|FG001|Overall Study|Lost to Follow-up|1|||
164204638|NCT01081626|593119257|FG000|Overall Study|Other|33|||
164204639|NCT01081626|593119258|FG001|Overall Study|Other|30|||
164204640|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Other than specified|2|||
164204641|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Other than specified|4|||
164204642|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
164204643|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
164204644|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Pregnancy|0|||
164204645|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Pregnancy|2|||
164204646|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Physician Decision|1|||
164204647|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Physician Decision|1|||
164204648|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
164204649|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
164204650|NCT02003144|593119259|FG000|Open Label Maintenance Phase|Adverse Event|2|||
164204651|NCT02003144|593119260|FG001|Open Label Maintenance Phase|Adverse Event|1|||
164204652|NCT02074514|593119264|FG000|Overall Study|Lack of Efficacy|3|||
164204653|NCT02074514|593119265|FG001|Overall Study|Lack of Efficacy|2|||
164204654|NCT02074514|593119264|FG000|Overall Study|Lost to Follow-up|0|||
164204655|NCT02074514|593119265|FG001|Overall Study|Lost to Follow-up|1|||
164204656|NCT02074514|593119264|FG000|Overall Study|Withdrew Consent|0|||
164204657|NCT02074514|593119265|FG001|Overall Study|Withdrew Consent|1|||
164204658|NCT00666237|593119268|FG000|Overall Study|Death|5|||
164204659|NCT00666237|593119269|FG001|Overall Study|Death|5|||
164204660|NCT00666237|593119268|FG000|Overall Study|Lost to Follow-up|29|||
164204661|NCT00666237|593119269|FG001|Overall Study|Lost to Follow-up|25|||
164204662|NCT02839707|593119271|FG000|Phase I|Not eligible for analysis|9|||
164204663|NCT02839707|593119272|FG001|Phase I|Not eligible for analysis|0|||
164204664|NCT02839707|593119273|FG002|Phase I|Not eligible for analysis|0|||
164204665|NCT02839707|593119271|FG000|Phase II|Not treated according to protocol|4|||
164204666|NCT02839707|593119272|FG001|Phase II|Not treated according to protocol|0|||
164204667|NCT02839707|593119273|FG002|Phase II|Not treated according to protocol|2|||
164204668|NCT02839707|593119271|FG000|Phase III|Not treated according to protocol|0|||
164204669|NCT02839707|593119272|FG001|Phase III|Not treated according to protocol|0|||
164204670|NCT02839707|593119273|FG002|Phase III|Not treated according to protocol|4|||
164204671|NCT04530630|593121080|FG000|Overall Study|Physician Decision|1|||
164204672|NCT01288430|593121087|FG000|Part 1|Progressive disease|2|||
164204673|NCT01288430|593121088|FG001|Part 1|Progressive disease|1|||
164204674|NCT01288430|593121089|FG002|Part 1|Progressive disease|1|||
164204675|NCT01288430|593121090|FG003|Part 1|Progressive disease|6|||
164204676|NCT01288430|593121091|FG004|Part 1|Progressive disease|2|||
164204677|NCT01288430|593121092|FG005|Part 1|Progressive disease|4|||
164204678|NCT01288430|593121093|FG006|Part 1|Progressive disease|2|||
164204679|NCT01288430|593121094|FG007|Part 1|Progressive disease|0|||
164204680|NCT01288430|593121095|FG008|Part 1|Progressive disease|0|||
164204681|NCT01288430|593121096|FG009|Part 1|Progressive disease|0|||
164204682|NCT01288430|593121087|FG000|Part 1|Clinical disease progression|0|||
164204683|NCT01288430|593121088|FG001|Part 1|Clinical disease progression|0|||
164204684|NCT01288430|593121089|FG002|Part 1|Clinical disease progression|1|||
164204685|NCT01288430|593121090|FG003|Part 1|Clinical disease progression|0|||
164315525|NCT01994889|593531572|FG002|Overall Study|Lost to Follow-up|0|||
164315526|NCT01994889|593531570|FG000|Overall Study|Protocol Violation|0|||
164315527|NCT01994889|593531571|FG001|Overall Study|Protocol Violation|1|||
164315528|NCT01994889|593531572|FG002|Overall Study|Protocol Violation|1|||
164315529|NCT01994889|593531570|FG000|Overall Study|Death|14|||
164315530|NCT01994889|593531571|FG001|Overall Study|Death|25|||
164315531|NCT01994889|593531572|FG002|Overall Study|Death|38|||
164315532|NCT00335764|593531573|FG000|Overall Study|wrong histology|1|||
164315533|NCT00335764|593531574|FG001|Overall Study|wrong histology|0|||
164315534|NCT00335764|593531575|FG002|Overall Study|wrong histology|0|||
164315535|NCT00335764|593531576|FG003|Overall Study|wrong histology|0|||
164315536|NCT00335764|593531577|FG004|Overall Study|wrong histology|1|||
164315537|NCT00929643|593531578|FG000|Overall Study|Protocol Violation|2|||
164315538|NCT00145977|593531582|FG000|Overall Study|Lack of Efficacy|0|||
164315539|NCT00145977|593531583|FG001|Overall Study|Lack of Efficacy|4|||
164315540|NCT00145977|593531582|FG000|Overall Study|Lost to Follow-up|1|||
164315541|NCT00145977|593531583|FG001|Overall Study|Lost to Follow-up|0|||
164315542|NCT00145977|593531582|FG000|Overall Study|Withdrawal by Subject|1|||
164315543|NCT00145977|593531583|FG001|Overall Study|Withdrawal by Subject|0|||
164315544|NCT02717832|593531593|FG000|Overall Study|Inability to place IV|3|||
164315545|NCT01215097|593531594|FG000|Overall Study|Adverse Event|1|||
164315546|NCT01215097|593531595|FG001|Overall Study|Adverse Event|3|||
164315547|NCT01215097|593531594|FG000|Overall Study|Protocol Violation|0|||
164315548|NCT01215097|593531595|FG001|Overall Study|Protocol Violation|2|||
164315549|NCT01215097|593531594|FG000|Overall Study|Lost to Follow-up|2|||
164315550|NCT01215097|593531595|FG001|Overall Study|Lost to Follow-up|0|||
164315551|NCT01215097|593531594|FG000|Overall Study|Withdrawal by Subject|6|||
164315552|NCT01215097|593531595|FG001|Overall Study|Withdrawal by Subject|3|||
164315553|NCT01215097|593531594|FG000|Overall Study|Lack of Efficacy|0|||
164315554|NCT01215097|593531595|FG001|Overall Study|Lack of Efficacy|3|||
164315555|NCT01215097|593531594|FG000|Overall Study|patient's refusal to come|2|||
164315556|NCT01215097|593531595|FG001|Overall Study|patient's refusal to come|2|||
164315557|NCT01215097|593531594|FG000|Overall Study|patient's private reason|1|||
164315558|NCT01215097|593531595|FG001|Overall Study|patient's private reason|1|||
164315559|NCT01325337|593533115|FG000|Overall Study|Adverse Event|0|||
164315560|NCT01325337|593533116|FG001|Overall Study|Adverse Event|2|||
164315561|NCT01325337|593533117|FG002|Overall Study|Adverse Event|2|||
164315562|NCT01325337|593533118|FG003|Overall Study|Adverse Event|1|||
164315563|NCT01325337|593533119|FG004|Overall Study|Adverse Event|2|||
164315564|NCT01325337|593533115|FG000|Overall Study|Lost to Follow-up|2|||
164315565|NCT01325337|593533116|FG001|Overall Study|Lost to Follow-up|2|||
164315566|NCT01325337|593533117|FG002|Overall Study|Lost to Follow-up|2|||
164315567|NCT01325337|593533118|FG003|Overall Study|Lost to Follow-up|1|||
164315568|NCT01325337|593533119|FG004|Overall Study|Lost to Follow-up|2|||
164315569|NCT01325337|593533115|FG000|Overall Study|Personal Reasons|2|||
164315570|NCT01325337|593533116|FG001|Overall Study|Personal Reasons|5|||
164315571|NCT01325337|593533117|FG002|Overall Study|Personal Reasons|4|||
164315572|NCT01325337|593533118|FG003|Overall Study|Personal Reasons|8|||
164315573|NCT01325337|593533119|FG004|Overall Study|Personal Reasons|3|||
164315574|NCT01325337|593533115|FG000|Overall Study|Withdrawal by Subject|1|||
164315575|NCT01325337|593533116|FG001|Overall Study|Withdrawal by Subject|0|||
164315576|NCT01325337|593533117|FG002|Overall Study|Withdrawal by Subject|1|||
164315577|NCT01325337|593533118|FG003|Overall Study|Withdrawal by Subject|0|||
164315578|NCT01325337|593533119|FG004|Overall Study|Withdrawal by Subject|1|||
164315579|NCT02338232|593533140|FG000|Overall Study|Screen Failure|3|||
164315580|NCT02338232|593533140|FG000|Overall Study|Withdrawal by Subject|6|||
164315581|NCT02338232|593533140|FG000|Overall Study|Adverse Event|2|||
164315582|NCT03890666|593533141|FG000|Overall Study|Withdrawal by Subject|0|||
164315583|NCT03890666|593533142|FG001|Overall Study|Withdrawal by Subject|1|||
164315584|NCT03890666|593533141|FG000|Overall Study|Protocol deviation|1|||
164315585|NCT03890666|593533142|FG001|Overall Study|Protocol deviation|4|||
164315586|NCT03890666|593533141|FG000|Overall Study|Lost to Follow-up|2|||
164315587|NCT03890666|593533142|FG001|Overall Study|Lost to Follow-up|5|||
164315588|NCT03890666|593533141|FG000|Overall Study|Other than specified|1|||
164315589|NCT03890666|593533142|FG001|Overall Study|Other than specified|8|||
164315590|NCT01105065|593533143|FG000|Overall Study|Adverse Event|5|||
164315591|NCT01105065|593533143|FG000|Overall Study|Technical Problems|1|||
164315592|NCT02122783|593533147|FG000|Overall Study|Adverse Event|0|||
164315593|NCT02122783|593533148|FG001|Overall Study|Adverse Event|1|||
164315594|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
163977415|NCT03882970|592288756|FG001|Overall Study|Personal Reason|3|||
164315595|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
163977416|NCT03882970|592288757|FG002|Overall Study|Personal Reason|1|||
163977417|NCT03882970|592288758|FG003|Overall Study|Personal Reason|3|||
164315596|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
164315597|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
164315598|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
164315599|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
164315600|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
164315601|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
164315602|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
164315603|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
164315604|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
164315605|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
164315606|NCT00322621|593533149|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
164315607|NCT00322621|593533150|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
164315608|NCT00322621|593533151|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
164315609|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
164315610|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
164315611|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
164315612|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
164315613|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
164315614|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
164315615|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
164315616|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
164315617|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
164315618|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
164315619|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
164315620|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
164315621|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
164315622|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
164315623|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
164315624|NCT00322621|593533149|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
164315625|NCT00322621|593533150|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
164315626|NCT00322621|593533151|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
164315627|NCT01781299|593533157|FG000|Overall Study|Withdrawal by Subject|0|||
164315628|NCT01781299|593533158|FG001|Overall Study|Withdrawal by Subject|1|||
164315629|NCT01798849|593533159|FG000|Overall Study|Physician Decision|0|||
164315630|NCT01798849|593533160|FG001|Overall Study|Physician Decision|0|||
164315631|NCT01798849|593533161|FG002|Overall Study|Physician Decision|1|||
164315632|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
164315633|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
164315634|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
164315635|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
164315636|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
164315637|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
164315638|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
164315639|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
164315640|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
164315641|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
164315642|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
164315643|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
164315644|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
164315645|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
164315646|NCT00612105|593533162|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
164315647|NCT00612105|593533163|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
164315648|NCT00612105|593533162|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
164315649|NCT00612105|593533163|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
164315650|NCT00612105|593533162|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
164315651|NCT00612105|593533163|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
164315652|NCT00612105|593533162|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
164315653|NCT00612105|593533163|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
164315654|NCT00612105|593533162|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
164315655|NCT00612105|593533163|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
164315656|NCT00475982|593533164|FG000|Overall Study|surgery rescheduled|7|||
164315657|NCT00475982|593533165|FG001|Overall Study|surgery rescheduled|3|||
164315658|NCT00743106|593533166|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
164315659|NCT00743106|593533167|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
164315660|NCT02410343|593533172|FG000|Core Period (24 Weeks)|Adverse Event|1|||
164315661|NCT02410343|593533173|FG001|Core Period (24 Weeks)|Adverse Event|0|||
164315662|NCT02410343|593533172|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
164315663|NCT02410343|593533173|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
164315664|NCT02410343|593533172|FG000|Extension Period (12 Months)|Adverse Event|1|||
164315665|NCT02410343|593533173|FG001|Extension Period (12 Months)|Adverse Event|0|||
164315666|NCT02410343|593533172|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
164315667|NCT02410343|593533173|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
164315668|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
164315669|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
164315670|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
164315671|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
164315672|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
164315673|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
164315674|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
164315675|NCT00946985|593533174|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
164315676|NCT00946985|593533174|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
164315677|NCT00271505|593533175|FG000|Overall Study|Screen Failure|3|||
164315678|NCT00271505|593533175|FG000|Overall Study|Adverse Event|1|||
164315679|NCT00271505|593533175|FG000|Overall Study|Death|1|||
164315680|NCT04556383|593533176|FG000|PCP|Lack of Efficacy|28|||
164315681|NCT04556383|593533177|FG001|PCP|Lack of Efficacy|23|||
164315682|NCT04556383|593533178|FG002|PCP|Lack of Efficacy|23|||
164315683|NCT04556383|593533179|FG003|PCP|Lack of Efficacy|0|||
164315684|NCT04556383|593533176|FG000|PCP|Study terminated by sponsor|15|||
164315685|NCT04556383|593533177|FG001|PCP|Study terminated by sponsor|13|||
164315686|NCT04556383|593533178|FG002|PCP|Study terminated by sponsor|16|||
164315687|NCT04556383|593533179|FG003|PCP|Study terminated by sponsor|0|||
164315688|NCT04556383|593533176|FG000|PCP|Withdrawal by Subject|8|||
164315689|NCT04556383|593533177|FG001|PCP|Withdrawal by Subject|6|||
164315690|NCT04556383|593533178|FG002|PCP|Withdrawal by Subject|6|||
164315691|NCT04556383|593533179|FG003|PCP|Withdrawal by Subject|0|||
164315692|NCT04556383|593533176|FG000|PCP|Adverse Event|1|||
164315693|NCT04556383|593533177|FG001|PCP|Adverse Event|7|||
164315694|NCT04556383|593533178|FG002|PCP|Adverse Event|7|||
164315695|NCT04556383|593533179|FG003|PCP|Adverse Event|0|||
164315696|NCT04556383|593533176|FG000|PCP|Other, Not Specified|1|||
164315697|NCT04556383|593533177|FG001|PCP|Other, Not Specified|2|||
164315698|NCT04556383|593533178|FG002|PCP|Other, Not Specified|1|||
164315699|NCT04556383|593533179|FG003|PCP|Other, Not Specified|0|||
164315700|NCT04556383|593533176|FG000|PCP|Protocol Violation|1|||
164315701|NCT04556383|593533177|FG001|PCP|Protocol Violation|0|||
164315702|NCT04556383|593533178|FG002|PCP|Protocol Violation|1|||
164315703|NCT04556383|593533179|FG003|PCP|Protocol Violation|0|||
164315704|NCT04556383|593533176|FG000|PCP|Lost to Follow-up|1|||
164315705|NCT04556383|593533177|FG001|PCP|Lost to Follow-up|0|||
164315706|NCT04556383|593533178|FG002|PCP|Lost to Follow-up|0|||
164315707|NCT04556383|593533179|FG003|PCP|Lost to Follow-up|0|||
164315708|NCT04556383|593533176|FG000|PCP|Physician Decision|0|||
164315709|NCT04556383|593533177|FG001|PCP|Physician Decision|1|||
164315710|NCT04556383|593533178|FG002|PCP|Physician Decision|0|||
164315711|NCT04556383|593533179|FG003|PCP|Physician Decision|0|||
164315712|NCT04556383|593533176|FG000|PCP|Site terminated by sponsor|0|||
164315713|NCT04556383|593533177|FG001|PCP|Site terminated by sponsor|1|||
164315714|NCT04556383|593533178|FG002|PCP|Site terminated by sponsor|0|||
164315715|NCT04556383|593533179|FG003|PCP|Site terminated by sponsor|0|||
164315716|NCT04556383|593533176|FG000|OLE|Study terminated by sponsor|0|||
164315717|NCT04556383|593533177|FG001|OLE|Study terminated by sponsor|0|||
164315718|NCT04556383|593533178|FG002|OLE|Study terminated by sponsor|0|||
164315719|NCT04556383|593533179|FG003|OLE|Study terminated by sponsor|68|||
164315720|NCT04556383|593533176|FG000|OLE|Withdrawal by Subject|0|||
164315721|NCT04556383|593533177|FG001|OLE|Withdrawal by Subject|0|||
164315722|NCT04556383|593533178|FG002|OLE|Withdrawal by Subject|0|||
164315723|NCT04556383|593533179|FG003|OLE|Withdrawal by Subject|10|||
164315724|NCT04556383|593533176|FG000|OLE|Lack of Efficacy|0|||
164315725|NCT04556383|593533177|FG001|OLE|Lack of Efficacy|0|||
164315726|NCT04556383|593533178|FG002|OLE|Lack of Efficacy|0|||
164315727|NCT04556383|593533179|FG003|OLE|Lack of Efficacy|7|||
164315728|NCT04556383|593533176|FG000|OLE|Adverse Event|0|||
164315729|NCT04556383|593533177|FG001|OLE|Adverse Event|0|||
164315730|NCT04556383|593533178|FG002|OLE|Adverse Event|0|||
164315731|NCT04556383|593533179|FG003|OLE|Adverse Event|2|||
164315732|NCT04556383|593533176|FG000|OLE|Other, Not Specified|0|||
164315733|NCT04556383|593533177|FG001|OLE|Other, Not Specified|0|||
164315734|NCT04556383|593533178|FG002|OLE|Other, Not Specified|0|||
164315735|NCT04556383|593533179|FG003|OLE|Other, Not Specified|2|||
164315736|NCT04556383|593533176|FG000|OLE|Death|0|||
164315737|NCT04556383|593533177|FG001|OLE|Death|0|||
164315738|NCT04556383|593533178|FG002|OLE|Death|0|||
164315739|NCT04556383|593533179|FG003|OLE|Death|1|||
164315740|NCT04556383|593533176|FG000|OLE|Lost to Follow-up|0|||
164315741|NCT04556383|593533177|FG001|OLE|Lost to Follow-up|0|||
164315742|NCT04556383|593533178|FG002|OLE|Lost to Follow-up|0|||
164315743|NCT04556383|593533179|FG003|OLE|Lost to Follow-up|1|||
164315744|NCT00539188|593533180|FG000|Overall Study|Withdrawal by Subject|1|||
164315745|NCT00539188|593533181|FG001|Overall Study|Withdrawal by Subject|0|||
164315746|NCT00539188|593533180|FG000|Overall Study|Lost to Follow-up|2|||
164315747|NCT00539188|593533181|FG001|Overall Study|Lost to Follow-up|1|||
164315748|NCT04784442|593533182|FG000|Overall Study|Adverse Event|1|||
164315749|NCT04784442|593533183|FG001|Overall Study|Adverse Event|0|||
164315750|NCT04784442|593533184|FG002|Overall Study|Adverse Event|2|||
164204686|NCT01288430|593121091|FG004|Part 1|Clinical disease progression|0|||
164204687|NCT01288430|593121092|FG005|Part 1|Clinical disease progression|2|||
164204688|NCT01288430|593121093|FG006|Part 1|Clinical disease progression|2|||
164204689|NCT01288430|593121094|FG007|Part 1|Clinical disease progression|0|||
164204690|NCT01288430|593121095|FG008|Part 1|Clinical disease progression|0|||
164204691|NCT01288430|593121096|FG009|Part 1|Clinical disease progression|0|||
164204692|NCT01288430|593121087|FG000|Part 1|Death due to disease progression|0|||
164204693|NCT01288430|593121088|FG001|Part 1|Death due to disease progression|0|||
164204694|NCT01288430|593121089|FG002|Part 1|Death due to disease progression|0|||
164204695|NCT01288430|593121090|FG003|Part 1|Death due to disease progression|0|||
164204696|NCT01288430|593121091|FG004|Part 1|Death due to disease progression|1|||
164204697|NCT01288430|593121092|FG005|Part 1|Death due to disease progression|0|||
164204698|NCT01288430|593121093|FG006|Part 1|Death due to disease progression|0|||
164204699|NCT01288430|593121094|FG007|Part 1|Death due to disease progression|0|||
164204700|NCT01288430|593121095|FG008|Part 1|Death due to disease progression|0|||
164204701|NCT01288430|593121096|FG009|Part 1|Death due to disease progression|0|||
164204702|NCT01288430|593121087|FG000|Part 1|Adverse Event|0|||
164204703|NCT01288430|593121088|FG001|Part 1|Adverse Event|0|||
164204704|NCT01288430|593121089|FG002|Part 1|Adverse Event|3|||
164204705|NCT01288430|593121090|FG003|Part 1|Adverse Event|1|||
164204706|NCT01288430|593121091|FG004|Part 1|Adverse Event|0|||
164204707|NCT01288430|593121092|FG005|Part 1|Adverse Event|0|||
164204708|NCT01288430|593121093|FG006|Part 1|Adverse Event|2|||
164204709|NCT01288430|593121094|FG007|Part 1|Adverse Event|0|||
164204710|NCT01288430|593121095|FG008|Part 1|Adverse Event|0|||
164204711|NCT01288430|593121096|FG009|Part 1|Adverse Event|0|||
164204712|NCT01288430|593121087|FG000|Part 1|Other|0|||
164204713|NCT01288430|593121088|FG001|Part 1|Other|2|||
164204714|NCT01288430|593121089|FG002|Part 1|Other|0|||
164204715|NCT01288430|593121090|FG003|Part 1|Other|0|||
164204716|NCT01288430|593121091|FG004|Part 1|Other|0|||
164204717|NCT01288430|593121092|FG005|Part 1|Other|0|||
164204718|NCT01288430|593121093|FG006|Part 1|Other|1|||
164204719|NCT01288430|593121094|FG007|Part 1|Other|0|||
164204720|NCT01288430|593121095|FG008|Part 1|Other|0|||
164204721|NCT01288430|593121096|FG009|Part 1|Other|0|||
164204722|NCT01288430|593121087|FG000|Part 2|Progressive disease|0|||
164204723|NCT01288430|593121088|FG001|Part 2|Progressive disease|0|||
164204724|NCT01288430|593121089|FG002|Part 2|Progressive disease|0|||
164204725|NCT01288430|593121090|FG003|Part 2|Progressive disease|0|||
164204726|NCT01288430|593121091|FG004|Part 2|Progressive disease|0|||
164204727|NCT01288430|593121092|FG005|Part 2|Progressive disease|0|||
164204728|NCT01288430|593121093|FG006|Part 2|Progressive disease|0|||
164204729|NCT01288430|593121094|FG007|Part 2|Progressive disease|8|||
164204730|NCT01288430|593121095|FG008|Part 2|Progressive disease|7|||
164204731|NCT01288430|593121096|FG009|Part 2|Progressive disease|2|||
164204732|NCT01288430|593121087|FG000|Part 2|Clinical disease progression|0|||
164204733|NCT01288430|593121088|FG001|Part 2|Clinical disease progression|0|||
164204734|NCT01288430|593121089|FG002|Part 2|Clinical disease progression|0|||
164204735|NCT01288430|593121090|FG003|Part 2|Clinical disease progression|0|||
164204736|NCT01288430|593121091|FG004|Part 2|Clinical disease progression|0|||
164204737|NCT01288430|593121092|FG005|Part 2|Clinical disease progression|0|||
164204738|NCT01288430|593121093|FG006|Part 2|Clinical disease progression|0|||
164204739|NCT01288430|593121094|FG007|Part 2|Clinical disease progression|2|||
164204740|NCT01288430|593121095|FG008|Part 2|Clinical disease progression|0|||
164204741|NCT01288430|593121096|FG009|Part 2|Clinical disease progression|0|||
164204742|NCT01288430|593121087|FG000|Part 2|Withdrawal by Subject|0|||
164204743|NCT01288430|593121088|FG001|Part 2|Withdrawal by Subject|0|||
164315751|NCT04784442|593533185|FG003|Overall Study|Adverse Event|1|||
164204744|NCT01288430|593121089|FG002|Part 2|Withdrawal by Subject|0|||
164204745|NCT01288430|593121090|FG003|Part 2|Withdrawal by Subject|0|||
164204746|NCT01288430|593121091|FG004|Part 2|Withdrawal by Subject|0|||
164204747|NCT01288430|593121092|FG005|Part 2|Withdrawal by Subject|0|||
164204748|NCT01288430|593121093|FG006|Part 2|Withdrawal by Subject|0|||
164204749|NCT01288430|593121094|FG007|Part 2|Withdrawal by Subject|1|||
164204750|NCT01288430|593121095|FG008|Part 2|Withdrawal by Subject|4|||
164204751|NCT01288430|593121096|FG009|Part 2|Withdrawal by Subject|0|||
164204752|NCT01288430|593121087|FG000|Part 2|Adverse Event|0|||
164204753|NCT01288430|593121088|FG001|Part 2|Adverse Event|0|||
164204754|NCT01288430|593121089|FG002|Part 2|Adverse Event|0|||
164204755|NCT01288430|593121090|FG003|Part 2|Adverse Event|0|||
164204756|NCT01288430|593121091|FG004|Part 2|Adverse Event|0|||
164204757|NCT01288430|593121092|FG005|Part 2|Adverse Event|0|||
164204758|NCT01288430|593121093|FG006|Part 2|Adverse Event|0|||
164204759|NCT01288430|593121094|FG007|Part 2|Adverse Event|1|||
164204760|NCT01288430|593121095|FG008|Part 2|Adverse Event|1|||
164204761|NCT01288430|593121096|FG009|Part 2|Adverse Event|0|||
164204762|NCT01288430|593121087|FG000|Part 2|Other|0|||
164204763|NCT01288430|593121088|FG001|Part 2|Other|0|||
164204764|NCT01288430|593121089|FG002|Part 2|Other|0|||
164204765|NCT01288430|593121090|FG003|Part 2|Other|0|||
164204766|NCT01288430|593121091|FG004|Part 2|Other|0|||
164204767|NCT01288430|593121092|FG005|Part 2|Other|0|||
164315752|NCT04784442|593533182|FG000|Overall Study|Protocol Violation|1|||
164315753|NCT04784442|593533183|FG001|Overall Study|Protocol Violation|0|||
164315754|NCT04784442|593533184|FG002|Overall Study|Protocol Violation|0|||
164315755|NCT04784442|593533185|FG003|Overall Study|Protocol Violation|0|||
164315756|NCT04784442|593533182|FG000|Overall Study|Non-compliance with study drug|1|||
164315757|NCT04784442|593533183|FG001|Overall Study|Non-compliance with study drug|0|||
164315758|NCT04784442|593533184|FG002|Overall Study|Non-compliance with study drug|0|||
164315759|NCT04784442|593533185|FG003|Overall Study|Non-compliance with study drug|0|||
164315760|NCT02259088|593533187|FG000|Overall Study|Adverse Event|6|||
164315761|NCT02259088|593533188|FG001|Overall Study|Adverse Event|4|||
164315762|NCT02259088|593533187|FG000|Overall Study|Lost to Follow-up|2|||
164315763|NCT02259088|593533188|FG001|Overall Study|Lost to Follow-up|0|||
164315764|NCT02259088|593533187|FG000|Overall Study|Death|2|||
164315765|NCT02259088|593533188|FG001|Overall Study|Death|0|||
164315766|NCT02259088|593533187|FG000|Overall Study|Physician Decision|5|||
164315767|NCT02259088|593533188|FG001|Overall Study|Physician Decision|2|||
164315768|NCT02259088|593533187|FG000|Overall Study|Protocol deviation|5|||
164315769|NCT02259088|593533188|FG001|Overall Study|Protocol deviation|0|||
164315770|NCT02259088|593533187|FG000|Overall Study|Subject/guardian decision|8|||
164315771|NCT02259088|593533188|FG001|Overall Study|Subject/guardian decision|8|||
164315772|NCT03060551|593533189|FG000|Overall Study|Withdrawal by Subject|1|||
164315773|NCT03060551|593533189|FG000|Overall Study|Adverse Event|1|||
164315774|NCT01214395|593533197|FG000|Overall Study|All patients had infection|5|||
164315775|NCT03698591|593533201|FG000|Overall Study|Withdrawal by Subject|2|||
164315776|NCT03698591|593533202|FG001|Overall Study|Withdrawal by Subject|2|||
164315777|NCT03698591|593533201|FG000|Overall Study|Failed drug screen|1|||
164315778|NCT03698591|593533202|FG001|Overall Study|Failed drug screen|1|||
164315779|NCT03698591|593533201|FG000|Overall Study|Failed health screen|0|||
164315780|NCT03698591|593533202|FG001|Overall Study|Failed health screen|1|||
164315781|NCT03698591|593533201|FG000|Overall Study|Ineligible for financial compensation|1|||
164315782|NCT03698591|593533202|FG001|Overall Study|Ineligible for financial compensation|0|||
164315783|NCT03698591|593533201|FG000|Overall Study|Equipment Error|1|||
164315784|NCT03698591|593533202|FG001|Overall Study|Equipment Error|0|||
164315785|NCT03698591|593533201|FG000|Overall Study|Could not establish TMS dosage|0|||
164315786|NCT03698591|593533202|FG001|Overall Study|Could not establish TMS dosage|1|||
164315787|NCT02660983|593533211|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
164315788|NCT02660983|593533212|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
164315789|NCT02660983|593533211|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
164315790|NCT02660983|593533212|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
164315791|NCT02660983|593533211|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
164315792|NCT02660983|593533212|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
164315793|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
164315794|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
164315795|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
164315796|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
164315797|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
164315798|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
164315799|NCT02660983|593533211|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
164315800|NCT02660983|593533212|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
164315801|NCT01165216|593533221|FG000|Overall Study|Adverse Event|6|||
164315802|NCT01165216|593533222|FG001|Overall Study|Adverse Event|3|||
164315803|NCT01165216|593533221|FG000|Overall Study|Withdrawal by Subject|1|||
164315804|NCT01165216|593533222|FG001|Overall Study|Withdrawal by Subject|1|||
163872992|NCT00223795|591904017|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
163872993|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
163872994|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163872995|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163872996|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163872997|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
163872998|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
163872999|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163873000|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163873001|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163873002|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
163873003|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
163873004|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163873005|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163873006|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163873007|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
163977418|NCT02863809|592288759|FG000|Overall Study|Adverse Event|8|||
164315805|NCT01165216|593533221|FG000|Overall Study|Disease progression|1|||
164315806|NCT01165216|593533222|FG001|Overall Study|Disease progression|3|||
164315807|NCT00243841|593533226|FG000|Overall Study|Physician Decision|0|||
164315808|NCT00243841|593533227|FG001|Overall Study|Physician Decision|0|||
164315809|NCT00243841|593533228|FG002|Overall Study|Physician Decision|1|||
164315810|NCT00243841|593533229|FG003|Overall Study|Physician Decision|0|||
164315811|NCT00243841|593533230|FG004|Overall Study|Physician Decision|0|||
164315812|NCT00243841|593533231|FG005|Overall Study|Physician Decision|2|||
164315813|NCT00363545|593533232|FG000|Overall Study|Serious Adverse Event|0|||
164315814|NCT00363545|593533233|FG001|Overall Study|Serious Adverse Event|1|||
164315815|NCT00363545|593533232|FG000|Overall Study|Withdrawal by Subject|12|||
164315816|NCT00363545|593533233|FG001|Overall Study|Withdrawal by Subject|15|||
164315817|NCT00363545|593533232|FG000|Overall Study|Migrated/moved from study area|3|||
164315818|NCT00363545|593533233|FG001|Overall Study|Migrated/moved from study area|6|||
164315819|NCT00363545|593533232|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
164315820|NCT00363545|593533233|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
164315821|NCT00363545|593533232|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
164315822|NCT00363545|593533233|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
164315823|NCT00363545|593533232|FG000|Overall Study|Others|1|||
164315824|NCT00363545|593533233|FG001|Overall Study|Others|0|||
164315825|NCT00721968|593533234|FG000|Overall Study|Lost to Follow-up|2|||
164315826|NCT00721968|593533235|FG001|Overall Study|Lost to Follow-up|0|||
164315827|NCT01064947|593533236|FG000|Overall Study|negative culture|41|||
164315828|NCT06457204|593533241|FG000|Washout|Adverse Event|0|||
164315829|NCT06457204|593533242|FG001|Washout|Adverse Event|2|||
164315830|NCT01457352|593533243|FG000|Period 1|Adverse Event|2|||
164315831|NCT01457352|593533244|FG001|Period 1|Adverse Event|0|||
164315832|NCT01457352|593533243|FG000|Period 1|Withdrawal by Subject|2|||
164315833|NCT01457352|593533244|FG001|Period 1|Withdrawal by Subject|0|||
164315834|NCT01457352|593533243|FG000|Period 1|Physician Decision|2|||
164315835|NCT01457352|593533244|FG001|Period 1|Physician Decision|0|||
164315836|NCT01457352|593533243|FG000|Period 1|MS related disease progression|1|||
164315837|NCT01457352|593533244|FG001|Period 1|MS related disease progression|0|||
164315838|NCT01457352|593533243|FG000|Period 1|Withdrawn|1|||
164315839|NCT01457352|593533244|FG001|Period 1|Withdrawn|0|||
164315840|NCT01457352|593533243|FG000|Period 1|withdrew per sponsor|1|||
164315841|NCT01457352|593533244|FG001|Period 1|withdrew per sponsor|0|||
164315842|NCT01457352|593533243|FG000|Period 1|Protocol Violation|4|||
164315843|NCT01457352|593533244|FG001|Period 1|Protocol Violation|0|||
164315844|NCT01457352|593533243|FG000|Period 1|Did not meet eligibility criteria|3|||
164315845|NCT01457352|593533244|FG001|Period 1|Did not meet eligibility criteria|0|||
164315846|NCT01457352|593533243|FG000|Period 2|Withdrawal by Subject|23|||
164315847|NCT01457352|593533244|FG001|Period 2|Withdrawal by Subject|0|||
164315848|NCT01457352|593533243|FG000|Period 2|Adverse Event|22|||
164315849|NCT01457352|593533244|FG001|Period 2|Adverse Event|0|||
164315850|NCT01457352|593533243|FG000|Period 2|no analysis|10|||
164315851|NCT01457352|593533244|FG001|Period 2|no analysis|0|||
164315852|NCT01457352|593533243|FG000|Period 2|Lack of Efficacy|8|||
164315853|NCT01457352|593533244|FG001|Period 2|Lack of Efficacy|0|||
164315854|NCT01457352|593533243|FG000|Period 2|Protocol Violation|4|||
164315855|NCT01457352|593533244|FG001|Period 2|Protocol Violation|0|||
164315856|NCT01457352|593533243|FG000|Period 2|Sponsor's withdrawal|7|||
164315857|NCT01457352|593533244|FG001|Period 2|Sponsor's withdrawal|0|||
164315858|NCT01457352|593533243|FG000|Period 2|Lost to Follow-up|1|||
164315859|NCT01457352|593533244|FG001|Period 2|Lost to Follow-up|0|||
163873008|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
163873009|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163873010|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163873011|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163873012|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
163873013|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
163873014|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163873015|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163873016|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
164315860|NCT01457352|593533243|FG000|Period 2|dose change|1|||
164315861|NCT01457352|593533244|FG001|Period 2|dose change|0|||
164315862|NCT01457352|593533243|FG000|Period 2|Physician Decision|1|||
164315863|NCT01457352|593533244|FG001|Period 2|Physician Decision|0|||
163977419|NCT02863809|592288760|FG001|Overall Study|Adverse Event|8|||
163977420|NCT02863809|592288759|FG000|Overall Study|Withdrawal by Subject|0|||
164315864|NCT01457352|593533243|FG000|Period 2|Did not meet eligibility criteria|3|||
164315865|NCT01457352|593533244|FG001|Period 2|Did not meet eligibility criteria|0|||
164315866|NCT01457352|593533243|FG000|Period 3|Adverse Event|1|||
164315867|NCT01457352|593533244|FG001|Period 3|Adverse Event|1|||
164315868|NCT01457352|593533243|FG000|Period 3|Withdrawal by Subject|0|||
164315869|NCT01457352|593533244|FG001|Period 3|Withdrawal by Subject|2|||
163977421|NCT02863809|592288760|FG001|Overall Study|Withdrawal by Subject|1|||
163977422|NCT02863809|592288759|FG000|Overall Study|Lost to Follow-up|1|||
163977423|NCT02863809|592288760|FG001|Overall Study|Lost to Follow-up|1|||
163977424|NCT02863809|592288759|FG000|Overall Study|Death|1|||
163977425|NCT02863809|592288760|FG001|Overall Study|Death|0|||
163977426|NCT01046877|592288763|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
163977427|NCT01046877|592288763|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
163977428|NCT01081249|592288764|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
163977429|NCT01081249|592288765|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
164315870|NCT01457352|593533243|FG000|Period 3|incorrect treatment|0|||
164315871|NCT01457352|593533244|FG001|Period 3|incorrect treatment|1|||
164315872|NCT01457352|593533243|FG000|Period 3|Sponsor's withdrawal|0|||
164315873|NCT01457352|593533244|FG001|Period 3|Sponsor's withdrawal|1|||
164315874|NCT01601652|593533245|FG000|Overall Study|Death|1|||
164315875|NCT04614324|593533256|FG000|Overall Study|Lost to Follow-up|3|||
164315876|NCT04614324|593533256|FG000|Overall Study|Physician Decision|1|||
164315877|NCT04614324|593533256|FG000|Overall Study|Withdrawal by Subject|2|||
164315878|NCT04614324|593533256|FG000|Overall Study|Remaining in Follow up|123|||
164315879|NCT03865316|593535473|FG000|Overall Study|Procedure Cancelled|4|||
164315880|NCT03865316|593535473|FG000|Overall Study|Equipment failure|4|||
164315881|NCT03658876|593535474|FG000|Overall Study|Protocol Violation|3|||
164315882|NCT03658876|593535475|FG001|Overall Study|Protocol Violation|2|||
164315883|NCT03658876|593535474|FG000|Overall Study|Withdrawal by Subject|2|||
164315884|NCT03658876|593535475|FG001|Overall Study|Withdrawal by Subject|0|||
164315885|NCT03658876|593535474|FG000|Overall Study|Death|0|||
164315886|NCT03658876|593535475|FG001|Overall Study|Death|1|||
164315887|NCT03658876|593535474|FG000|Overall Study|Intercurrent illness|6|||
164315888|NCT03658876|593535475|FG001|Overall Study|Intercurrent illness|4|||
164315889|NCT03658876|593535474|FG000|Overall Study|Transplantation/other operation|1|||
164315890|NCT03658876|593535475|FG001|Overall Study|Transplantation/other operation|5|||
164315891|NCT01948193|593535476|FG000|Overall Study|Serious event|2|||
164315892|NCT01948193|593535476|FG000|Overall Study|Lost to Follow-up|7|||
164315893|NCT01330017|593535477|FG000|Overall Study|Adverse Event|0|||
164315894|NCT01330017|593535478|FG001|Overall Study|Adverse Event|1|||
164315895|NCT01330017|593535479|FG002|Overall Study|Adverse Event|1|||
164315896|NCT01330017|593535480|FG003|Overall Study|Adverse Event|4|||
164315897|NCT01330017|593535481|FG004|Overall Study|Adverse Event|0|||
164315898|NCT01330017|593535477|FG000|Overall Study|Withdrawal by Subject|0|||
164315899|NCT01330017|593535478|FG001|Overall Study|Withdrawal by Subject|0|||
164315900|NCT01330017|593535479|FG002|Overall Study|Withdrawal by Subject|1|||
164315901|NCT01330017|593535480|FG003|Overall Study|Withdrawal by Subject|0|||
164315902|NCT01330017|593535481|FG004|Overall Study|Withdrawal by Subject|1|||
164315903|NCT01330017|593535477|FG000|Overall Study|Lost to Follow-up|0|||
164315904|NCT01330017|593535478|FG001|Overall Study|Lost to Follow-up|0|||
164315905|NCT01330017|593535479|FG002|Overall Study|Lost to Follow-up|1|||
164315906|NCT01330017|593535480|FG003|Overall Study|Lost to Follow-up|0|||
164315907|NCT01330017|593535481|FG004|Overall Study|Lost to Follow-up|0|||
164315908|NCT01330017|593535477|FG000|Overall Study|Protocol Violation|0|||
164315909|NCT01330017|593535478|FG001|Overall Study|Protocol Violation|0|||
164315910|NCT01330017|593535479|FG002|Overall Study|Protocol Violation|0|||
164315911|NCT01330017|593535480|FG003|Overall Study|Protocol Violation|1|||
164315912|NCT01330017|593535481|FG004|Overall Study|Protocol Violation|0|||
164315913|NCT01330017|593535477|FG000|Overall Study|Unknown Reason|5|||
164315914|NCT01330017|593535478|FG001|Overall Study|Unknown Reason|3|||
164315915|NCT01330017|593535479|FG002|Overall Study|Unknown Reason|5|||
164315916|NCT01330017|593535480|FG003|Overall Study|Unknown Reason|7|||
164315917|NCT01330017|593535481|FG004|Overall Study|Unknown Reason|2|||
164315918|NCT03137069|593535484|FG000|Overall Study|Withdrawal by Subject|1|||
164315919|NCT03137069|593535485|FG001|Overall Study|Withdrawal by Subject|2|||
164315920|NCT03137069|593535486|FG002|Overall Study|Withdrawal by Subject|2|||
163977430|NCT02813694|592288770|FG000|Overall Study|Physician Decision|0|||
163977431|NCT02813694|592288771|FG001|Overall Study|Physician Decision|1|||
163977432|NCT02813694|592288770|FG000|Overall Study|Withdrawal by Subject|10|||
163977433|NCT02813694|592288771|FG001|Overall Study|Withdrawal by Subject|9|||
163977434|NCT02813694|592288770|FG000|Overall Study|Lost to Follow-up|1|||
163977435|NCT02813694|592288771|FG001|Overall Study|Lost to Follow-up|1|||
163977436|NCT02813694|592288770|FG000|Overall Study|Death|3|||
164315921|NCT03137069|593535487|FG003|Overall Study|Withdrawal by Subject|2|||
164315922|NCT03137069|593535488|FG004|Overall Study|Withdrawal by Subject|0|||
164315923|NCT03137069|593535489|FG005|Overall Study|Withdrawal by Subject|0|||
164315924|NCT03137069|593535484|FG000|Overall Study|Adverse Event|0|||
164315925|NCT03137069|593535485|FG001|Overall Study|Adverse Event|3|||
164315926|NCT03137069|593535486|FG002|Overall Study|Adverse Event|1|||
164315927|NCT03137069|593535487|FG003|Overall Study|Adverse Event|1|||
164315928|NCT03137069|593535488|FG004|Overall Study|Adverse Event|0|||
164315929|NCT03137069|593535489|FG005|Overall Study|Adverse Event|1|||
164315930|NCT03137069|593535484|FG000|Overall Study|Protocol Violation|0|||
164315931|NCT03137069|593535485|FG001|Overall Study|Protocol Violation|1|||
164315932|NCT03137069|593535486|FG002|Overall Study|Protocol Violation|0|||
164315933|NCT03137069|593535487|FG003|Overall Study|Protocol Violation|1|||
164315934|NCT03137069|593535488|FG004|Overall Study|Protocol Violation|1|||
164315935|NCT03137069|593535489|FG005|Overall Study|Protocol Violation|1|||
164315936|NCT03137069|593535484|FG000|Overall Study|Physician Decision|0|||
164315937|NCT03137069|593535485|FG001|Overall Study|Physician Decision|0|||
164315938|NCT03137069|593535486|FG002|Overall Study|Physician Decision|0|||
164315939|NCT03137069|593535487|FG003|Overall Study|Physician Decision|1|||
164315940|NCT03137069|593535488|FG004|Overall Study|Physician Decision|0|||
164315941|NCT03137069|593535489|FG005|Overall Study|Physician Decision|0|||
164315942|NCT03137069|593535484|FG000|Overall Study|Study Terminated by Sponsor|0|||
164315943|NCT03137069|593535485|FG001|Overall Study|Study Terminated by Sponsor|0|||
164315944|NCT03137069|593535486|FG002|Overall Study|Study Terminated by Sponsor|0|||
164315945|NCT03137069|593535487|FG003|Overall Study|Study Terminated by Sponsor|0|||
164315946|NCT03137069|593535488|FG004|Overall Study|Study Terminated by Sponsor|1|||
164315947|NCT03137069|593535489|FG005|Overall Study|Study Terminated by Sponsor|0|||
164315948|NCT03137069|593535484|FG000|Overall Study|Data Entry Error|0|||
164315949|NCT03137069|593535485|FG001|Overall Study|Data Entry Error|0|||
164315950|NCT03137069|593535486|FG002|Overall Study|Data Entry Error|0|||
164315951|NCT03137069|593535487|FG003|Overall Study|Data Entry Error|1|||
164315952|NCT03137069|593535488|FG004|Overall Study|Data Entry Error|0|||
164315953|NCT03137069|593535489|FG005|Overall Study|Data Entry Error|0|||
164315954|NCT01106092|593535491|FG000|Overall Study|Withdrawal by Subject|0|||
164315955|NCT01106092|593535492|FG001|Overall Study|Withdrawal by Subject|0|||
164315956|NCT01106092|593535493|FG002|Overall Study|Withdrawal by Subject|0|||
164315957|NCT01106092|593535494|FG003|Overall Study|Withdrawal by Subject|1|||
164315958|NCT02434471|593535497|FG000|Overall Study|Physician Decision|9|||
164315959|NCT00369629|593535502|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
164315960|NCT00369629|593535503|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
164315961|NCT00369629|593535504|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
164315962|NCT00369629|593535505|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
164315963|NCT00369629|593535502|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
164315964|NCT00369629|593535503|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
164315965|NCT00369629|593535504|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
164315966|NCT00369629|593535505|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
164315967|NCT00369629|593535502|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
164315968|NCT00369629|593535503|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
164315969|NCT00369629|593535504|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
164315970|NCT00369629|593535505|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
164315971|NCT00369629|593535502|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
164315972|NCT00369629|593535503|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
164315973|NCT00369629|593535504|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
164315974|NCT00369629|593535505|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
164315975|NCT00369629|593535502|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
164315976|NCT00369629|593535503|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
164315977|NCT00369629|593535504|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
164315978|NCT00369629|593535505|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
164315979|NCT00369629|593535502|FG000|Completed 4 More Cycles|Progressive disease|2|||
164315980|NCT00369629|593535503|FG001|Completed 4 More Cycles|Progressive disease|1|||
164315981|NCT00369629|593535504|FG002|Completed 4 More Cycles|Progressive disease|2|||
164315982|NCT00369629|593535505|FG003|Completed 4 More Cycles|Progressive disease|0|||
164315983|NCT00369629|593535502|FG000|Follow up for 1 Year|Death|2|||
164315984|NCT00369629|593535503|FG001|Follow up for 1 Year|Death|1|||
164315985|NCT00369629|593535504|FG002|Follow up for 1 Year|Death|1|||
164315986|NCT00369629|593535505|FG003|Follow up for 1 Year|Death|0|||
164315987|NCT00369629|593535502|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
164315988|NCT00369629|593535503|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
163873017|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
163873018|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
163873019|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
163873020|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
163873021|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
164315989|NCT00369629|593535504|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
164315990|NCT00369629|593535505|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
164315991|NCT00369629|593535502|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
164315992|NCT00369629|593535503|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
164315993|NCT00369629|593535504|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
164315994|NCT00369629|593535505|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
164315995|NCT04839562|593535506|FG000|Overall Study|Withdrawal by Subject|0|||
164315996|NCT04839562|593535507|FG001|Overall Study|Withdrawal by Subject|1|||
163873022|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
164315997|NCT04839562|593535506|FG000|Overall Study|Physician Decision|0|||
164315998|NCT04839562|593535507|FG001|Overall Study|Physician Decision|1|||
164315999|NCT00877773|593535512|FG000|Overall Study|Disease Progression|44|||
164316000|NCT00668733|593535515|FG000|Overall Study|Lost to Follow-up|2|||
164316001|NCT00668733|593535516|FG001|Overall Study|Lost to Follow-up|3|||
164316002|NCT00668733|593535515|FG000|Overall Study|Withdrawal by Subject|0|||
164316003|NCT00668733|593535516|FG001|Overall Study|Withdrawal by Subject|4|||
164316004|NCT01122264|593535519|FG000|Overall Study|Adverse Event|6|||
164316005|NCT01122264|593535520|FG001|Overall Study|Adverse Event|5|||
164316006|NCT01122264|593535521|FG002|Overall Study|Adverse Event|7|||
164316007|NCT01122264|593535519|FG000|Overall Study|Death|1|||
164316008|NCT01122264|593535520|FG001|Overall Study|Death|0|||
164316009|NCT01122264|593535521|FG002|Overall Study|Death|0|||
164316010|NCT01122264|593535519|FG000|Overall Study|Lost to Follow-up|5|||
164316011|NCT01122264|593535520|FG001|Overall Study|Lost to Follow-up|9|||
164316012|NCT01122264|593535521|FG002|Overall Study|Lost to Follow-up|13|||
164316013|NCT01122264|593535519|FG000|Overall Study|Entry Criteria Not Met|1|||
164316014|NCT01122264|593535520|FG001|Overall Study|Entry Criteria Not Met|0|||
164316015|NCT01122264|593535521|FG002|Overall Study|Entry Criteria Not Met|0|||
164316016|NCT01122264|593535519|FG000|Overall Study|Protocol Violation|7|||
164316017|NCT01122264|593535520|FG001|Overall Study|Protocol Violation|7|||
164316018|NCT01122264|593535521|FG002|Overall Study|Protocol Violation|9|||
164316019|NCT01122264|593535519|FG000|Overall Study|Withdrawal by Subject|6|||
164316020|NCT01122264|593535520|FG001|Overall Study|Withdrawal by Subject|6|||
164316021|NCT01122264|593535521|FG002|Overall Study|Withdrawal by Subject|16|||
164316022|NCT01122264|593535519|FG000|Overall Study|Physician Decision|3|||
164316023|NCT01122264|593535520|FG001|Overall Study|Physician Decision|1|||
164316024|NCT01122264|593535521|FG002|Overall Study|Physician Decision|1|||
164316025|NCT01122264|593535519|FG000|Overall Study|Lack of Efficacy|3|||
164316026|NCT01122264|593535520|FG001|Overall Study|Lack of Efficacy|1|||
164316027|NCT01122264|593535521|FG002|Overall Study|Lack of Efficacy|1|||
164316028|NCT00097981|593535522|FG000|Overall Study|Adverse Event|31|||
164316029|NCT00097981|593535523|FG001|Overall Study|Adverse Event|44|||
164316030|NCT00097981|593535522|FG000|Overall Study|Withdrawal by Subject|10|||
164316031|NCT00097981|593535523|FG001|Overall Study|Withdrawal by Subject|8|||
164316032|NCT00097981|593535522|FG000|Overall Study|Protocol Violation|1|||
164316033|NCT00097981|593535523|FG001|Overall Study|Protocol Violation|1|||
164316034|NCT00097981|593535522|FG000|Overall Study|Death|2|||
164316035|NCT00097981|593535523|FG001|Overall Study|Death|4|||
164316036|NCT00097981|593535522|FG000|Overall Study|Physician Decision|7|||
164316037|NCT00097981|593535523|FG001|Overall Study|Physician Decision|1|||
164316038|NCT00097981|593535522|FG000|Overall Study|Disease Progression|8|||
164316039|NCT00097981|593535523|FG001|Overall Study|Disease Progression|2|||
164316040|NCT00097981|593535522|FG000|Overall Study|Transplant planned|28|||
164316041|NCT00097981|593535523|FG001|Overall Study|Transplant planned|27|||
164316042|NCT00097981|593535522|FG000|Overall Study|Other|19|||
164316043|NCT00097981|593535523|FG001|Overall Study|Other|13|||
164316044|NCT03135119|593535524|FG000|Overall Study|Lost to Follow-up|2|||
164316045|NCT03135119|593535525|FG001|Overall Study|Lost to Follow-up|0|||
164316046|NCT03135119|593535524|FG000|Overall Study|Physician Decision|1|||
164316047|NCT03135119|593535525|FG001|Overall Study|Physician Decision|1|||
164316048|NCT03135119|593535524|FG000|Overall Study|COVID-19 Shutdown|2|||
164316049|NCT03135119|593535525|FG001|Overall Study|COVID-19 Shutdown|2|||
164316050|NCT01836276|593535526|FG000|Overall Study|Lost to Follow-up|28|||
164316051|NCT01836276|593535527|FG001|Overall Study|Lost to Follow-up|51|||
164316052|NCT00796445|593535536|FG000|Overall Study|Protocol Violation|5|||
164316053|NCT00796445|593535537|FG001|Overall Study|Protocol Violation|3|||
163977437|NCT02813694|592288771|FG001|Overall Study|Death|3|||
163977438|NCT02813694|592288770|FG000|Overall Study|Randomized- did not receive study drug|2|||
163977439|NCT02813694|592288771|FG001|Overall Study|Randomized- did not receive study drug|0|||
164316054|NCT00796445|593535536|FG000|Overall Study|Adverse event, serious fatal|10|||
164316055|NCT00796445|593535537|FG001|Overall Study|Adverse event, serious fatal|5|||
164316056|NCT00796445|593535536|FG000|Overall Study|Adverse event, non-fatal|4|||
164316057|NCT00796445|593535537|FG001|Overall Study|Adverse event, non-fatal|0|||
164316058|NCT00796445|593535536|FG000|Overall Study|Disease progression/recurrence|537|||
164316059|NCT00796445|593535537|FG001|Overall Study|Disease progression/recurrence|268|||
164316060|NCT00796445|593535536|FG000|Overall Study|Other|10|||
164316061|NCT00796445|593535537|FG001|Overall Study|Other|7|||
164316062|NCT00796445|593535536|FG000|Overall Study|Withdrawal by Subject|18|||
164316063|NCT00796445|593535537|FG001|Overall Study|Withdrawal by Subject|9|||
164316064|NCT00796445|593535536|FG000|Overall Study|Invalid Informed Consent Form|1|||
164316065|NCT00796445|593535537|FG001|Overall Study|Invalid Informed Consent Form|0|||
164316066|NCT02208063|593535538|FG000|Overall Study|Death|3|||
164316067|NCT02208063|593535539|FG001|Overall Study|Death|5|||
164316068|NCT02208063|593535538|FG000|Overall Study|Not Specified in report|3|||
163977440|NCT02813694|592288770|FG000|Overall Study|Patient hospitalized|1|||
164316069|NCT02208063|593535539|FG001|Overall Study|Not Specified in report|4|||
164316070|NCT02208063|593535538|FG000|Overall Study|Withdrawal by Subject|5|||
164316071|NCT02208063|593535539|FG001|Overall Study|Withdrawal by Subject|2|||
164316072|NCT02208063|593535538|FG000|Overall Study|Lost to Follow-up|1|||
164316073|NCT02208063|593535539|FG001|Overall Study|Lost to Follow-up|0|||
164316074|NCT00388583|593535540|FG000|Overall Study|Protocol Violation|1|||
164316075|NCT00388583|593535541|FG001|Overall Study|Protocol Violation|0|||
164316076|NCT00388583|593535540|FG000|Overall Study|Withdrawal by Subject|3|||
164316077|NCT00388583|593535541|FG001|Overall Study|Withdrawal by Subject|3|||
164316078|NCT00388583|593535540|FG000|Overall Study|Serious Adverse Event|2|||
164316079|NCT00388583|593535541|FG001|Overall Study|Serious Adverse Event|0|||
164316080|NCT00388583|593535540|FG000|Overall Study|Did not receive vaccine|0|||
164316081|NCT00388583|593535541|FG001|Overall Study|Did not receive vaccine|1|||
164316082|NCT00913458|593535542|FG000|Phase 1|Non-Responder|54|||
164316083|NCT00913458|593535543|FG001|Phase 1|Non-Responder|0|||
164316084|NCT00913458|593535544|FG002|Phase 1|Non-Responder|0|||
164316085|NCT00913458|593535545|FG003|Phase 1|Non-Responder|0|||
164316086|NCT00913458|593535546|FG004|Phase 1|Non-Responder|0|||
164316087|NCT00913458|593535547|FG005|Phase 1|Non-Responder|0|||
164316088|NCT00913458|593535548|FG006|Phase 1|Non-Responder|0|||
164316089|NCT00913458|593535542|FG000|Phase 1|Subject Request|17|||
164316090|NCT00913458|593535543|FG001|Phase 1|Subject Request|0|||
164316091|NCT00913458|593535544|FG002|Phase 1|Subject Request|0|||
164316092|NCT00913458|593535545|FG003|Phase 1|Subject Request|0|||
164316093|NCT00913458|593535546|FG004|Phase 1|Subject Request|0|||
164316094|NCT00913458|593535547|FG005|Phase 1|Subject Request|0|||
164316095|NCT00913458|593535548|FG006|Phase 1|Subject Request|0|||
164316096|NCT00913458|593535542|FG000|Phase 1|Adverse Event|20|||
164316097|NCT00913458|593535543|FG001|Phase 1|Adverse Event|0|||
164316098|NCT00913458|593535544|FG002|Phase 1|Adverse Event|0|||
164316099|NCT00913458|593535545|FG003|Phase 1|Adverse Event|0|||
164316100|NCT00913458|593535546|FG004|Phase 1|Adverse Event|0|||
164316101|NCT00913458|593535547|FG005|Phase 1|Adverse Event|0|||
164316102|NCT00913458|593535548|FG006|Phase 1|Adverse Event|0|||
164316103|NCT00913458|593535542|FG000|Phase 1|Lost to Follow-up|2|||
164316104|NCT00913458|593535543|FG001|Phase 1|Lost to Follow-up|0|||
164316105|NCT00913458|593535544|FG002|Phase 1|Lost to Follow-up|0|||
164316106|NCT00913458|593535545|FG003|Phase 1|Lost to Follow-up|0|||
164316107|NCT00913458|593535546|FG004|Phase 1|Lost to Follow-up|0|||
164316108|NCT00913458|593535547|FG005|Phase 1|Lost to Follow-up|0|||
164316109|NCT00913458|593535548|FG006|Phase 1|Lost to Follow-up|0|||
164316110|NCT00913458|593535542|FG000|Phase 1|Protocol Violation|10|||
164316111|NCT00913458|593535543|FG001|Phase 1|Protocol Violation|0|||
163873023|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
163873024|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163873025|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
164204768|NCT01288430|593121093|FG006|Part 2|Other|0|||
164204769|NCT01288430|593121094|FG007|Part 2|Other|0|||
164204770|NCT01288430|593121095|FG008|Part 2|Other|0|||
164204771|NCT01288430|593121096|FG009|Part 2|Other|1|||
164204772|NCT05507437|593121097|FG000|Overall Study|Withdrawal by Subject|1|||
164204773|NCT05507437|593121098|FG001|Overall Study|Withdrawal by Subject|1|||
164204774|NCT05507437|593121097|FG000|Overall Study|Death|3|||
164204775|NCT05507437|593121098|FG001|Overall Study|Death|0|||
164204776|NCT06583096|593121099|FG000|Overall Study|Lost to Follow-up|4|||
164204777|NCT06583096|593121100|FG001|Overall Study|Lost to Follow-up|10|||
164204778|NCT06583096|593121099|FG000|Overall Study|Withdrawal by Subject|0|||
164204779|NCT06583096|593121100|FG001|Overall Study|Withdrawal by Subject|2|||
164204780|NCT05172609|593121101|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
164204781|NCT05172609|593121102|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
164204782|NCT05172609|593121101|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
164204783|NCT05172609|593121102|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
164204784|NCT05172609|593121101|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
164204785|NCT05172609|593121102|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
164204786|NCT05610605|593121105|FG000|6-month Assessment|Death|1|||
164204787|NCT05610605|593121106|FG001|6-month Assessment|Death|1|||
164204788|NCT05610605|593121105|FG000|6-month Assessment|Lost to Follow-up|20|||
164204789|NCT05610605|593121106|FG001|6-month Assessment|Lost to Follow-up|0|||
164204790|NCT05610605|593121105|FG000|6-month Assessment|Institutionalized|1|||
164204791|NCT05610605|593121106|FG001|6-month Assessment|Institutionalized|2|||
164204792|NCT05610605|593121105|FG000|12-month Assessment|Death|2|||
164204793|NCT05610605|593121106|FG001|12-month Assessment|Death|1|||
164204794|NCT05610605|593121105|FG000|12-month Assessment|Lost to Follow-up|1|||
164204795|NCT05610605|593121106|FG001|12-month Assessment|Lost to Follow-up|4|||
164204796|NCT05610605|593121105|FG000|12-month Assessment|Institutionalized|2|||
164204797|NCT05610605|593121106|FG001|12-month Assessment|Institutionalized|1|||
164204798|NCT00753519|593121107|FG000|Overall Study|Withdrawal by Subject|0|||
164204799|NCT00753519|593121108|FG001|Overall Study|Withdrawal by Subject|2|||
164204800|NCT00042289|593121109|FG000|Overall Study|Lost to Follow-up|3|||
164204801|NCT00042289|593121110|FG001|Overall Study|Lost to Follow-up|0|||
164316112|NCT00913458|593535544|FG002|Phase 1|Protocol Violation|0|||
164316113|NCT00913458|593535545|FG003|Phase 1|Protocol Violation|0|||
164316114|NCT00913458|593535546|FG004|Phase 1|Protocol Violation|0|||
164316115|NCT00913458|593535547|FG005|Phase 1|Protocol Violation|0|||
164316116|NCT00913458|593535548|FG006|Phase 1|Protocol Violation|0|||
164316117|NCT00913458|593535542|FG000|Phase 1|Sponsor|2|||
164316118|NCT00913458|593535543|FG001|Phase 1|Sponsor|0|||
164316119|NCT00913458|593535544|FG002|Phase 1|Sponsor|0|||
164316120|NCT00913458|593535545|FG003|Phase 1|Sponsor|0|||
164316121|NCT00913458|593535546|FG004|Phase 1|Sponsor|0|||
164316122|NCT00913458|593535547|FG005|Phase 1|Sponsor|0|||
164316123|NCT00913458|593535548|FG006|Phase 1|Sponsor|0|||
164316124|NCT00913458|593535542|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
164316125|NCT00913458|593535543|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
164316126|NCT00913458|593535544|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
164316127|NCT00913458|593535545|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
164316128|NCT00913458|593535546|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
164316129|NCT00913458|593535547|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
164316130|NCT00913458|593535548|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
164316131|NCT00913458|593535542|FG000|Phase 2|Non-Responder|0|||
164316132|NCT00913458|593535543|FG001|Phase 2|Non-Responder|5|||
164316133|NCT00913458|593535544|FG002|Phase 2|Non-Responder|7|||
164316134|NCT00913458|593535545|FG003|Phase 2|Non-Responder|12|||
164316135|NCT00913458|593535546|FG004|Phase 2|Non-Responder|0|||
164316136|NCT00913458|593535547|FG005|Phase 2|Non-Responder|0|||
164316137|NCT00913458|593535548|FG006|Phase 2|Non-Responder|0|||
164316138|NCT00913458|593535542|FG000|Phase 2|Subject Request|0|||
164316139|NCT00913458|593535543|FG001|Phase 2|Subject Request|0|||
164316140|NCT00913458|593535544|FG002|Phase 2|Subject Request|1|||
164316141|NCT00913458|593535545|FG003|Phase 2|Subject Request|2|||
164316142|NCT00913458|593535546|FG004|Phase 2|Subject Request|0|||
164316143|NCT00913458|593535547|FG005|Phase 2|Subject Request|0|||
164316144|NCT00913458|593535548|FG006|Phase 2|Subject Request|0|||
164316145|NCT00913458|593535542|FG000|Phase 2|Adverse Event|0|||
164316146|NCT00913458|593535543|FG001|Phase 2|Adverse Event|3|||
164316147|NCT00913458|593535544|FG002|Phase 2|Adverse Event|0|||
164316148|NCT00913458|593535545|FG003|Phase 2|Adverse Event|1|||
164316149|NCT00913458|593535546|FG004|Phase 2|Adverse Event|0|||
164316150|NCT00913458|593535547|FG005|Phase 2|Adverse Event|0|||
164316151|NCT00913458|593535548|FG006|Phase 2|Adverse Event|0|||
164316152|NCT00913458|593535542|FG000|Phase 2|Lost to Follow-up|0|||
164316153|NCT00913458|593535543|FG001|Phase 2|Lost to Follow-up|0|||
164316154|NCT00913458|593535544|FG002|Phase 2|Lost to Follow-up|0|||
164316155|NCT00913458|593535545|FG003|Phase 2|Lost to Follow-up|1|||
164316156|NCT00913458|593535546|FG004|Phase 2|Lost to Follow-up|0|||
164316157|NCT00913458|593535547|FG005|Phase 2|Lost to Follow-up|0|||
164316158|NCT00913458|593535548|FG006|Phase 2|Lost to Follow-up|0|||
164316159|NCT00913458|593535542|FG000|Phase 2|Protocol Violation|0|||
164316160|NCT00913458|593535543|FG001|Phase 2|Protocol Violation|2|||
164316161|NCT00913458|593535544|FG002|Phase 2|Protocol Violation|0|||
164316162|NCT00913458|593535545|FG003|Phase 2|Protocol Violation|0|||
164316163|NCT00913458|593535546|FG004|Phase 2|Protocol Violation|0|||
164316164|NCT00913458|593535547|FG005|Phase 2|Protocol Violation|0|||
164316165|NCT00913458|593535548|FG006|Phase 2|Protocol Violation|0|||
164316166|NCT00913458|593535542|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
164316167|NCT00913458|593535543|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
164316168|NCT00913458|593535544|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
164316169|NCT00913458|593535545|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
164316170|NCT00913458|593535546|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
164316171|NCT00913458|593535547|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
164316172|NCT00913458|593535548|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
164316173|NCT00913458|593535542|FG000|Phase 3|Adverse Event|0|||
164316174|NCT00913458|593535543|FG001|Phase 3|Adverse Event|0|||
164316175|NCT00913458|593535544|FG002|Phase 3|Adverse Event|0|||
164316176|NCT00913458|593535545|FG003|Phase 3|Adverse Event|0|||
164316177|NCT00913458|593535546|FG004|Phase 3|Adverse Event|5|||
164316178|NCT00913458|593535547|FG005|Phase 3|Adverse Event|4|||
164316179|NCT00913458|593535548|FG006|Phase 3|Adverse Event|1|||
164316180|NCT00913458|593535542|FG000|Phase 3|Lost to Follow-up|0|||
164316181|NCT00913458|593535543|FG001|Phase 3|Lost to Follow-up|0|||
164316182|NCT00913458|593535544|FG002|Phase 3|Lost to Follow-up|0|||
164316183|NCT00913458|593535545|FG003|Phase 3|Lost to Follow-up|0|||
164316184|NCT00913458|593535546|FG004|Phase 3|Lost to Follow-up|2|||
164316185|NCT00913458|593535547|FG005|Phase 3|Lost to Follow-up|0|||
164316186|NCT00913458|593535548|FG006|Phase 3|Lost to Follow-up|0|||
164316187|NCT00913458|593535542|FG000|Phase 3|Non-Responder|0|||
164316188|NCT00913458|593535543|FG001|Phase 3|Non-Responder|0|||
164316189|NCT00913458|593535544|FG002|Phase 3|Non-Responder|0|||
164316190|NCT00913458|593535545|FG003|Phase 3|Non-Responder|0|||
164316191|NCT00913458|593535546|FG004|Phase 3|Non-Responder|0|||
164316192|NCT00913458|593535547|FG005|Phase 3|Non-Responder|1|||
164316193|NCT00913458|593535548|FG006|Phase 3|Non-Responder|3|||
164316194|NCT00913458|593535542|FG000|Phase 3|Withdrawal by Subject|0|||
164316195|NCT00913458|593535543|FG001|Phase 3|Withdrawal by Subject|0|||
164316196|NCT00913458|593535544|FG002|Phase 3|Withdrawal by Subject|0|||
164316197|NCT00913458|593535545|FG003|Phase 3|Withdrawal by Subject|0|||
164316198|NCT00913458|593535546|FG004|Phase 3|Withdrawal by Subject|1|||
163873026|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163873027|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
163873028|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
163873029|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163873030|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163873031|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163873032|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
163873033|NCT02409667|591904025|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
164204802|NCT00042289|593121111|FG002|Overall Study|Lost to Follow-up|0|||
164204803|NCT00042289|593121112|FG003|Overall Study|Lost to Follow-up|1|||
164204804|NCT00042289|593121113|FG004|Overall Study|Lost to Follow-up|3|||
164204805|NCT00042289|593121114|FG005|Overall Study|Lost to Follow-up|3|||
164204806|NCT00042289|593121115|FG006|Overall Study|Lost to Follow-up|6|||
164204807|NCT00042289|593121116|FG007|Overall Study|Lost to Follow-up|1|||
164204808|NCT00042289|593121117|FG008|Overall Study|Lost to Follow-up|1|||
164204809|NCT00042289|593121118|FG009|Overall Study|Lost to Follow-up|0|||
164204810|NCT00042289|593121119|FG010|Overall Study|Lost to Follow-up|0|||
164204811|NCT00042289|593121120|FG011|Overall Study|Lost to Follow-up|0|||
164204812|NCT00042289|593121121|FG012|Overall Study|Lost to Follow-up|0|||
164204813|NCT00042289|593121122|FG013|Overall Study|Lost to Follow-up|0|||
164204814|NCT00042289|593121123|FG014|Overall Study|Lost to Follow-up|0|||
164204815|NCT00042289|593121124|FG015|Overall Study|Lost to Follow-up|1|||
164204816|NCT00042289|593121125|FG016|Overall Study|Lost to Follow-up|1|||
164204817|NCT00042289|593121126|FG017|Overall Study|Lost to Follow-up|0|||
164204818|NCT00042289|593121127|FG018|Overall Study|Lost to Follow-up|3|||
164204819|NCT00042289|593121128|FG019|Overall Study|Lost to Follow-up|2|||
164204820|NCT00042289|593121129|FG020|Overall Study|Lost to Follow-up|0|||
164204821|NCT00042289|593121130|FG021|Overall Study|Lost to Follow-up|0|||
164204822|NCT00042289|593121131|FG022|Overall Study|Lost to Follow-up|0|||
164204823|NCT00042289|593121132|FG023|Overall Study|Lost to Follow-up|0|||
164204824|NCT00042289|593121133|FG024|Overall Study|Lost to Follow-up|0|||
164204825|NCT00042289|593121134|FG025|Overall Study|Lost to Follow-up|0|||
164204826|NCT00042289|593121135|FG026|Overall Study|Lost to Follow-up|2|||
164204827|NCT00042289|593121136|FG027|Overall Study|Lost to Follow-up|2|||
164204828|NCT00042289|593121137|FG028|Overall Study|Lost to Follow-up|2|||
164204829|NCT00042289|593121138|FG029|Overall Study|Lost to Follow-up|0|||
164204830|NCT00042289|593121139|FG030|Overall Study|Lost to Follow-up|0|||
164204831|NCT00042289|593121140|FG031|Overall Study|Lost to Follow-up|2|||
164204832|NCT00042289|593121141|FG032|Overall Study|Lost to Follow-up|1|||
164204833|NCT00042289|593121142|FG033|Overall Study|Lost to Follow-up|1|||
164204834|NCT00042289|593121143|FG034|Overall Study|Lost to Follow-up|1|||
164204835|NCT00042289|593121144|FG035|Overall Study|Lost to Follow-up|2|||
164204836|NCT00042289|593121145|FG036|Overall Study|Lost to Follow-up|1|||
164204837|NCT00042289|593121146|FG037|Overall Study|Lost to Follow-up|1|||
164204838|NCT00042289|593121147|FG038|Overall Study|Lost to Follow-up|0|||
164204839|NCT00042289|593121148|FG039|Overall Study|Lost to Follow-up|5|||
164204840|NCT00042289|593121149|FG040|Overall Study|Lost to Follow-up|0|||
164135941|NCT02799095|592861963|FG008|Part C|Physician Decision|0|||
164135942|NCT02799095|592861964|FG009|Part C|Physician Decision|0|||
164135943|NCT02799095|592861965|FG010|Part C|Physician Decision|1|||
164135944|NCT02799095|592861966|FG011|Part C|Physician Decision|0|||
164135945|NCT02799095|592861967|FG012|Part C|Physician Decision|0|||
164135946|NCT02799095|592861968|FG013|Part C|Physician Decision|0|||
164135947|NCT02799095|592861969|FG014|Part C|Physician Decision|0|||
164135948|NCT02799095|592861970|FG015|Part C|Physician Decision|0|||
164135949|NCT02799095|592861971|FG016|Part C|Physician Decision|0|||
164135950|NCT02799095|592861955|FG000|Part C|Other|0|||
164135951|NCT02799095|592861956|FG001|Part C|Other|0|||
164135952|NCT02799095|592861957|FG002|Part C|Other|0|||
164135953|NCT02799095|592861958|FG003|Part C|Other|0|||
164135954|NCT02799095|592861959|FG004|Part C|Other|0|||
164135955|NCT02799095|592861960|FG005|Part C|Other|0|||
164135956|NCT02799095|592861961|FG006|Part C|Other|0|||
164135957|NCT02799095|592861962|FG007|Part C|Other|0|||
164135958|NCT02799095|592861963|FG008|Part C|Other|0|||
164135959|NCT02799095|592861964|FG009|Part C|Other|0|||
164135960|NCT02799095|592861965|FG010|Part C|Other|0|||
164135961|NCT02799095|592861966|FG011|Part C|Other|2|||
164135962|NCT02799095|592861967|FG012|Part C|Other|2|||
164135963|NCT02799095|592861968|FG013|Part C|Other|0|||
164135964|NCT02799095|592861969|FG014|Part C|Other|0|||
164135965|NCT02799095|592861970|FG015|Part C|Other|0|||
164135966|NCT02799095|592861971|FG016|Part C|Other|0|||
164135967|NCT04994483|592861972|FG000|Overall Study|Adverse Event|26|||
164135968|NCT04994483|592861973|FG001|Overall Study|Adverse Event|17|||
164135969|NCT04994483|592861972|FG000|Overall Study|Lost to Follow-up|6|||
164135970|NCT04994483|592861973|FG001|Overall Study|Lost to Follow-up|10|||
164135971|NCT04994483|592861972|FG000|Overall Study|Noncompliance with study drug|8|||
164135972|NCT04994483|592861973|FG001|Overall Study|Noncompliance with study drug|5|||
164135973|NCT04994483|592861972|FG000|Overall Study|Physician Decision|5|||
164135974|NCT04994483|592861973|FG001|Overall Study|Physician Decision|0|||
164316199|NCT00913458|593535547|FG005|Phase 3|Withdrawal by Subject|2|||
164316200|NCT00913458|593535548|FG006|Phase 3|Withdrawal by Subject|0|||
164316201|NCT00913458|593535542|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
164316202|NCT00913458|593535543|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
164316203|NCT00913458|593535544|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
164316204|NCT00913458|593535545|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
164316205|NCT00913458|593535546|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
164316206|NCT00913458|593535547|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
164316207|NCT00913458|593535548|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
164316208|NCT02366091|593535549|FG000|Overall Study|Withdrawal by Subject|3|||
164316209|NCT02366091|593535550|FG001|Overall Study|Withdrawal by Subject|7|||
164316210|NCT02366091|593535551|FG002|Overall Study|Withdrawal by Subject|3|||
164316211|NCT02366091|593535552|FG003|Overall Study|Withdrawal by Subject|1|||
164316212|NCT05194579|593535553|FG000|Overall Study|Lost to Follow-up|2|||
164316213|NCT05194579|593535554|FG001|Overall Study|Lost to Follow-up|3|||
164316214|NCT05194579|593535553|FG000|Overall Study|Withdrawal by Subject|3|||
164316215|NCT05194579|593535554|FG001|Overall Study|Withdrawal by Subject|4|||
164316216|NCT05194579|593535553|FG000|Overall Study|Refused further study procedures|0|||
164316217|NCT05194579|593535554|FG001|Overall Study|Refused further study procedures|1|||
164316218|NCT05194579|593535553|FG000|Overall Study|Protocol deviation|1|||
164316219|NCT05194579|593535554|FG001|Overall Study|Protocol deviation|0|||
164316220|NCT00638183|593535556|FG000|Overall Study|Adverse Event|23|||
164316221|NCT00638183|593535556|FG000|Overall Study|Lack of Efficacy|14|||
164316222|NCT00638183|593535556|FG000|Overall Study|Physician Decision|9|||
164316223|NCT00638183|593535556|FG000|Overall Study|Lost to Follow-up|46|||
164316224|NCT00638183|593535556|FG000|Overall Study|Other reason not defined above|27|||
164316225|NCT02350764|593535557|FG000|Overall Study|Adverse Event|4|||
164316226|NCT02350764|593535557|FG000|Overall Study|Death|3|||
164316227|NCT02350764|593535557|FG000|Overall Study|Physician Decision|2|||
164316228|NCT02350764|593535557|FG000|Overall Study|Withdrawal by Subject|2|||
164316229|NCT03180619|593535558|FG000|Overall Study|Withdrew Consent|5|||
164316230|NCT03180619|593535559|FG001|Overall Study|Withdrew Consent|0|||
164316231|NCT03180619|593535560|FG002|Overall Study|Withdrew Consent|2|||
164316232|NCT03180619|593535558|FG000|Overall Study|Death|2|||
164316233|NCT03180619|593535559|FG001|Overall Study|Death|1|||
164316234|NCT03180619|593535560|FG002|Overall Study|Death|2|||
164316235|NCT03180619|593535558|FG000|Overall Study|Adverse Event|2|||
164316236|NCT03180619|593535559|FG001|Overall Study|Adverse Event|0|||
164316237|NCT03180619|593535560|FG002|Overall Study|Adverse Event|1|||
164316238|NCT03180619|593535558|FG000|Overall Study|Investigator's discretion|2|||
164316239|NCT03180619|593535559|FG001|Overall Study|Investigator's discretion|0|||
164316240|NCT03180619|593535560|FG002|Overall Study|Investigator's discretion|1|||
164316241|NCT02743611|593535561|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
164316242|NCT02743611|593535562|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
164316243|NCT02743611|593535563|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
164316244|NCT02743611|593535564|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
164316245|NCT01433289|593535565|FG000|Overall Study|Pregnancy|0|||
164316246|NCT01433289|593535566|FG001|Overall Study|Pregnancy|1|||
164316247|NCT01433289|593535567|FG002|Overall Study|Pregnancy|0|||
164316248|NCT01433289|593535568|FG003|Overall Study|Pregnancy|0|||
163873034|NCT02409667|591904026|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163873035|NCT02409667|591904027|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163873036|NCT02409667|591904028|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163873037|NCT02409667|591904029|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
163873038|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
163873039|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
163873040|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
163873041|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
163873042|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
163873043|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163873044|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163873045|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
163873046|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
163873047|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
164316249|NCT00729469|593535569|FG000|Overall Study|Adverse Event|14|||
164316250|NCT00729469|593535570|FG001|Overall Study|Adverse Event|25|||
164316251|NCT00729469|593535569|FG000|Overall Study|Lost to Follow-up|9|||
164316252|NCT00729469|593535570|FG001|Overall Study|Lost to Follow-up|9|||
164316253|NCT00729469|593535569|FG000|Overall Study|Protocol Violation|2|||
164316254|NCT00729469|593535570|FG001|Overall Study|Protocol Violation|1|||
164316255|NCT00729469|593535569|FG000|Overall Study|Withdrawal by Subject|19|||
164316256|NCT00729469|593535570|FG001|Overall Study|Withdrawal by Subject|8|||
164316257|NCT00729469|593535569|FG000|Overall Study|Other-Not mentioned|9|||
164316258|NCT00729469|593535570|FG001|Overall Study|Other-Not mentioned|4|||
164136052|NCT02906930|592862020|FG003|Overall Study|Lost to Follow-up|2|||
164316259|NCT01989208|593535574|FG000|200 mg (7 Days)|Protocol Violation|0|||
164316260|NCT01989208|593535575|FG001|200 mg (7 Days)|Protocol Violation|1|||
164316261|NCT00566696|593535576|FG000|Overall Study|Met Exclusion Criteria|2|||
164316262|NCT00566696|593535576|FG000|Overall Study|Muromonab not available|1|||
164316263|NCT00566696|593535576|FG000|Overall Study|Health Status Change|1|||
164316264|NCT00566696|593535576|FG000|Overall Study|Physician Decision|1|||
164316265|NCT00566696|593535576|FG000|Overall Study|Non-Patient Donors|37|||
164316266|NCT00706342|593535577|FG000|Overall Study|Adverse Event|3|||
163873048|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
163873049|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
163873050|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
163873051|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
163873052|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
163873053|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
163873054|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
163873055|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
163873056|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
163873057|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
163873058|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
163873059|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
163873060|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
163873061|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
163873062|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
163873063|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
163873064|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
163873065|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
163873066|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
163873067|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
163873068|NCT02409667|591904025|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
163873069|NCT02409667|591904026|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
163873070|NCT02409667|591904027|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
163873071|NCT02409667|591904028|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
163873072|NCT02409667|591904029|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
163873073|NCT01925339|591904030|FG000|Overall Study|Adverse Event|2|||
163873074|NCT01925339|591904031|FG001|Overall Study|Adverse Event|0|||
163873075|NCT02769858|591904034|FG000|Overall Study|Withdrawal by Subject|2|||
163873076|NCT04939246|591904035|FG000|After Treatment|Death|4|||
163873077|NCT04939246|591904035|FG000|After Treatment|Lost to Follow-up|1|||
163873078|NCT04939246|591904035|FG000|After Treatment|Discharged to hospice|2|||
163900052|NCT00571649|592005601|FG000|Follow-up Period|Lost to Follow-up|95|||
163900053|NCT00571649|592005602|FG001|Follow-up Period|Lost to Follow-up|92|||
163900054|NCT00571649|592005601|FG000|Follow-up Period|Patient convenience|136|||
163900055|NCT00571649|592005602|FG001|Follow-up Period|Patient convenience|121|||
163900056|NCT00571649|592005601|FG000|Follow-up Period|Protocol Violation|5|||
163900057|NCT00571649|592005602|FG001|Follow-up Period|Protocol Violation|12|||
163900058|NCT01566890|592005607|FG000|Overall Study|Adverse Event|1|||
163900059|NCT01566890|592005608|FG001|Overall Study|Adverse Event|0|||
163900060|NCT01566890|592005609|FG002|Overall Study|Adverse Event|0|||
163900061|NCT01566890|592005610|FG003|Overall Study|Adverse Event|0|||
163900062|NCT01566890|592005611|FG004|Overall Study|Adverse Event|0|||
163900063|NCT01566890|592005607|FG000|Overall Study|Withdrawal by Subject|3|||
163900064|NCT01566890|592005608|FG001|Overall Study|Withdrawal by Subject|1|||
163900065|NCT01566890|592005609|FG002|Overall Study|Withdrawal by Subject|1|||
163900066|NCT01566890|592005610|FG003|Overall Study|Withdrawal by Subject|1|||
163900067|NCT01566890|592005611|FG004|Overall Study|Withdrawal by Subject|0|||
163900068|NCT01566890|592005607|FG000|Overall Study|Screen failure|6|||
163900069|NCT01566890|592005608|FG001|Overall Study|Screen failure|0|||
163900070|NCT01566890|592005609|FG002|Overall Study|Screen failure|1|||
163900071|NCT01566890|592005610|FG003|Overall Study|Screen failure|1|||
163900072|NCT01566890|592005611|FG004|Overall Study|Screen failure|0|||
163900073|NCT01566890|592005607|FG000|Overall Study|Incomplete CEU data|1|||
163900074|NCT01566890|592005608|FG001|Overall Study|Incomplete CEU data|3|||
163900075|NCT01566890|592005609|FG002|Overall Study|Incomplete CEU data|5|||
164316267|NCT00706342|593535577|FG000|Overall Study|Not responding to treatment|2|||
164316268|NCT00706342|593535577|FG000|Overall Study|Withdrawn due to failure to respond|1|||
164316269|NCT00706342|593535577|FG000|Overall Study|Death|1|||
163900076|NCT01566890|592005610|FG003|Overall Study|Incomplete CEU data|8|||
163900077|NCT01566890|592005611|FG004|Overall Study|Incomplete CEU data|0|||
163900078|NCT01566890|592005607|FG000|Overall Study|Lost to Follow-up|0|||
163900079|NCT01566890|592005608|FG001|Overall Study|Lost to Follow-up|0|||
163900080|NCT01566890|592005609|FG002|Overall Study|Lost to Follow-up|4|||
163900081|NCT01566890|592005610|FG003|Overall Study|Lost to Follow-up|4|||
163873079|NCT03554265|591906828|FG000|Overall Study|Withdrawal by Subject|2|||
163873080|NCT03554265|591906829|FG001|Overall Study|Withdrawal by Subject|2|||
163873081|NCT03554265|591906830|FG002|Overall Study|Withdrawal by Subject|3|||
163873082|NCT03554265|591906828|FG000|Overall Study|Physician Decision|0|||
163873083|NCT03554265|591906829|FG001|Overall Study|Physician Decision|0|||
163873084|NCT03554265|591906830|FG002|Overall Study|Physician Decision|1|||
163873085|NCT03025789|591906831|FG000|Overall Study|Lack of Efficacy|6|||
163873086|NCT03025789|591906832|FG001|Overall Study|Lack of Efficacy|1|||
163873087|NCT03025789|591906831|FG000|Overall Study|Death|1|||
163873088|NCT03025789|591906832|FG001|Overall Study|Death|0|||
163873089|NCT03025789|591906831|FG000|Overall Study|Withdrawal by Subject|0|||
163873090|NCT03025789|591906832|FG001|Overall Study|Withdrawal by Subject|2|||
163873091|NCT02723955|591906833|FG000|Escalation Phase|Death|1|||
163873092|NCT02723955|591906834|FG001|Escalation Phase|Death|1|||
163873093|NCT02723955|591906835|FG002|Escalation Phase|Death|2|||
163873094|NCT02723955|591906836|FG003|Escalation Phase|Death|7|||
163873095|NCT02723955|591906837|FG004|Escalation Phase|Death|18|||
163873096|NCT02723955|591906838|FG005|Escalation Phase|Death|17|||
163873097|NCT02723955|591906839|FG006|Escalation Phase|Death|11|||
163873098|NCT02723955|591906840|FG007|Escalation Phase|Death|21|||
163873099|NCT02723955|591906841|FG008|Escalation Phase|Death|3|||
163873100|NCT02723955|591906842|FG009|Escalation Phase|Death|0|||
163873101|NCT02723955|591906843|FG010|Escalation Phase|Death|0|||
163873102|NCT02723955|591906844|FG011|Escalation Phase|Death|0|||
163873103|NCT02723955|591906845|FG012|Escalation Phase|Death|2|||
163873104|NCT02723955|591906846|FG013|Escalation Phase|Death|4|||
163873105|NCT02723955|591906847|FG014|Escalation Phase|Death|5|||
163873106|NCT02723955|591906848|FG015|Escalation Phase|Death|6|||
163873107|NCT02723955|591906849|FG016|Escalation Phase|Death|6|||
163873108|NCT02723955|591906850|FG017|Escalation Phase|Death|7|||
163873109|NCT02723955|591906851|FG018|Escalation Phase|Death|1|||
163873110|NCT02723955|591906852|FG019|Escalation Phase|Death|3|||
163873111|NCT02723955|591906853|FG020|Escalation Phase|Death|13|||
163873112|NCT02723955|591906854|FG021|Escalation Phase|Death|3|||
163873113|NCT02723955|591906855|FG022|Escalation Phase|Death|2|||
163873114|NCT02723955|591906856|FG023|Escalation Phase|Death|4|||
163873115|NCT02723955|591906857|FG024|Escalation Phase|Death|31|||
163873116|NCT02723955|591906858|FG025|Escalation Phase|Death|7|||
163873117|NCT02723955|591906859|FG026|Escalation Phase|Death|13|||
163873118|NCT02723955|591906860|FG027|Escalation Phase|Death|0|||
163873119|NCT02723955|591906861|FG028|Escalation Phase|Death|1|||
163873120|NCT02723955|591906862|FG029|Escalation Phase|Death|0|||
163873121|NCT02723955|591906863|FG030|Escalation Phase|Death|0|||
163873122|NCT02723955|591906864|FG031|Escalation Phase|Death|0|||
164204841|NCT00042289|593121150|FG041|Overall Study|Lost to Follow-up|2|||
164204842|NCT00042289|593121151|FG042|Overall Study|Lost to Follow-up|2|||
164204843|NCT00042289|593121152|FG043|Overall Study|Lost to Follow-up|0|||
164204844|NCT00042289|593121153|FG044|Overall Study|Lost to Follow-up|0|||
164204845|NCT00042289|593121154|FG045|Overall Study|Lost to Follow-up|1|||
164204846|NCT00042289|593121155|FG046|Overall Study|Lost to Follow-up|0|||
164204847|NCT00042289|593121109|FG000|Overall Study|Other reason|0|||
164204848|NCT00042289|593121110|FG001|Overall Study|Other reason|0|||
164204849|NCT00042289|593121111|FG002|Overall Study|Other reason|0|||
164204850|NCT00042289|593121112|FG003|Overall Study|Other reason|2|||
164204851|NCT00042289|593121113|FG004|Overall Study|Other reason|0|||
164204852|NCT00042289|593121114|FG005|Overall Study|Other reason|0|||
164204853|NCT00042289|593121115|FG006|Overall Study|Other reason|0|||
164204854|NCT00042289|593121116|FG007|Overall Study|Other reason|0|||
164204855|NCT00042289|593121117|FG008|Overall Study|Other reason|0|||
164204856|NCT00042289|593121118|FG009|Overall Study|Other reason|0|||
164204857|NCT00042289|593121119|FG010|Overall Study|Other reason|0|||
164204858|NCT00042289|593121120|FG011|Overall Study|Other reason|0|||
164204859|NCT00042289|593121121|FG012|Overall Study|Other reason|0|||
164204860|NCT00042289|593121122|FG013|Overall Study|Other reason|0|||
164204861|NCT00042289|593121123|FG014|Overall Study|Other reason|0|||
164204862|NCT00042289|593121124|FG015|Overall Study|Other reason|0|||
163873123|NCT02723955|591906865|FG032|Escalation Phase|Death|0|||
163873124|NCT02723955|591906866|FG033|Escalation Phase|Death|0|||
163873125|NCT02723955|591906867|FG034|Escalation Phase|Death|0|||
163873126|NCT02723955|591906868|FG035|Escalation Phase|Death|0|||
163873127|NCT02723955|591906869|FG036|Escalation Phase|Death|0|||
163873128|NCT02723955|591906870|FG037|Escalation Phase|Death|0|||
164204863|NCT00042289|593121125|FG016|Overall Study|Other reason|0|||
164204864|NCT00042289|593121126|FG017|Overall Study|Other reason|0|||
164204865|NCT00042289|593121127|FG018|Overall Study|Other reason|1|||
164204866|NCT00042289|593121128|FG019|Overall Study|Other reason|0|||
164204867|NCT00042289|593121129|FG020|Overall Study|Other reason|0|||
163873129|NCT02723955|591906871|FG038|Escalation Phase|Death|0|||
163873130|NCT02723955|591906872|FG039|Escalation Phase|Death|0|||
164204868|NCT00042289|593121130|FG021|Overall Study|Other reason|0|||
163873131|NCT02723955|591906873|FG040|Escalation Phase|Death|0|||
163873132|NCT02723955|591906874|FG041|Escalation Phase|Death|0|||
163873133|NCT02723955|591906875|FG042|Escalation Phase|Death|0|||
164204869|NCT00042289|593121131|FG022|Overall Study|Other reason|0|||
164316270|NCT00706342|593535577|FG000|Overall Study|Withdrew from the study on his own.|1|||
164316271|NCT00706342|593535577|FG000|Overall Study|Investigator discretion|2|||
164316272|NCT00706342|593535577|FG000|Overall Study|Non-responder Week 12|1|||
164316273|NCT00706342|593535577|FG000|Overall Study|Ongoing|6|||
164316274|NCT00706342|593535577|FG000|Overall Study|WIthdrawal of consent|1|||
164316275|NCT00119678|593535578|FG000|Double-blind Treatment Period|Death|1|||
164316276|NCT00119678|593535579|FG001|Double-blind Treatment Period|Death|0|||
164316277|NCT00119678|593535578|FG000|Double-blind Treatment Period|Adverse Event|7|||
164316278|NCT00119678|593535579|FG001|Double-blind Treatment Period|Adverse Event|1|||
164316279|NCT00119678|593535578|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
164316280|NCT00119678|593535579|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
164316281|NCT00119678|593535578|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164316282|NCT00119678|593535579|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
164316283|NCT00119678|593535578|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
164316284|NCT00119678|593535579|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
164316285|NCT00119678|593535578|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
164316286|NCT00119678|593535579|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
164316287|NCT00119678|593535578|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
164316288|NCT00119678|593535579|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
164316289|NCT00119678|593535578|FG000|Double-blind Treatment Period|Pregnancy|0|||
164316290|NCT00119678|593535579|FG001|Double-blind Treatment Period|Pregnancy|2|||
164316291|NCT00119678|593535578|FG000|Double-blind Treatment Period|Not treated|1|||
164316292|NCT00119678|593535579|FG001|Double-blind Treatment Period|Not treated|2|||
164316293|NCT00119678|593535578|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
164316294|NCT00119678|593535579|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
164316295|NCT00119678|593535578|FG000|Open-label Treatment Period|Death|1|||
164316296|NCT00119678|593535579|FG001|Open-label Treatment Period|Death|0|||
164316297|NCT00119678|593535578|FG000|Open-label Treatment Period|Adverse Event|3|||
164316298|NCT00119678|593535579|FG001|Open-label Treatment Period|Adverse Event|0|||
164316299|NCT00119678|593535578|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
164316300|NCT00119678|593535579|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
164316301|NCT00119678|593535578|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
164316302|NCT00119678|593535579|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164316303|NCT00119678|593535578|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
164316304|NCT00119678|593535579|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
164316305|NCT00119678|593535578|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
164316306|NCT00119678|593535579|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
163873134|NCT02723955|591906833|FG000|Escalation Phase|Lost to Follow-up|0|||
163873135|NCT02723955|591906834|FG001|Escalation Phase|Lost to Follow-up|0|||
163873136|NCT02723955|591906835|FG002|Escalation Phase|Lost to Follow-up|0|||
163873137|NCT02723955|591906836|FG003|Escalation Phase|Lost to Follow-up|0|||
163873138|NCT02723955|591906837|FG004|Escalation Phase|Lost to Follow-up|0|||
163873139|NCT02723955|591906838|FG005|Escalation Phase|Lost to Follow-up|2|||
163873140|NCT02723955|591906839|FG006|Escalation Phase|Lost to Follow-up|1|||
163873141|NCT02723955|591906840|FG007|Escalation Phase|Lost to Follow-up|1|||
163873142|NCT02723955|591906841|FG008|Escalation Phase|Lost to Follow-up|1|||
163873143|NCT02723955|591906842|FG009|Escalation Phase|Lost to Follow-up|0|||
163873144|NCT02723955|591906843|FG010|Escalation Phase|Lost to Follow-up|0|||
163873145|NCT02723955|591906844|FG011|Escalation Phase|Lost to Follow-up|0|||
163873146|NCT02723955|591906845|FG012|Escalation Phase|Lost to Follow-up|1|||
163873147|NCT02723955|591906846|FG013|Escalation Phase|Lost to Follow-up|0|||
163873148|NCT02723955|591906847|FG014|Escalation Phase|Lost to Follow-up|0|||
163873149|NCT02723955|591906848|FG015|Escalation Phase|Lost to Follow-up|0|||
163873150|NCT02723955|591906849|FG016|Escalation Phase|Lost to Follow-up|1|||
164204870|NCT00042289|593121132|FG023|Overall Study|Other reason|1|||
164204871|NCT00042289|593121133|FG024|Overall Study|Other reason|0|||
164204872|NCT00042289|593121134|FG025|Overall Study|Other reason|0|||
164204873|NCT00042289|593121135|FG026|Overall Study|Other reason|1|||
164204874|NCT00042289|593121136|FG027|Overall Study|Other reason|0|||
164204875|NCT00042289|593121137|FG028|Overall Study|Other reason|3|||
164204876|NCT00042289|593121138|FG029|Overall Study|Other reason|0|||
164204877|NCT00042289|593121139|FG030|Overall Study|Other reason|0|||
164204878|NCT00042289|593121140|FG031|Overall Study|Other reason|1|||
164204879|NCT00042289|593121141|FG032|Overall Study|Other reason|0|||
164204880|NCT00042289|593121142|FG033|Overall Study|Other reason|1|||
164204881|NCT00042289|593121143|FG034|Overall Study|Other reason|0|||
164204882|NCT00042289|593121144|FG035|Overall Study|Other reason|2|||
164204883|NCT00042289|593121145|FG036|Overall Study|Other reason|0|||
164204884|NCT00042289|593121146|FG037|Overall Study|Other reason|0|||
163873151|NCT02723955|591906850|FG017|Escalation Phase|Lost to Follow-up|2|||
163873152|NCT02723955|591906851|FG018|Escalation Phase|Lost to Follow-up|0|||
163873153|NCT02723955|591906852|FG019|Escalation Phase|Lost to Follow-up|1|||
164204885|NCT00042289|593121147|FG038|Overall Study|Other reason|0|||
164316307|NCT00119678|593535578|FG000|Open-label Treatment Period|Pregnancy|1|||
164316308|NCT00119678|593535579|FG001|Open-label Treatment Period|Pregnancy|0|||
164316309|NCT00119678|593535578|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
164316310|NCT00119678|593535579|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
164316311|NCT03567343|593535580|FG000|Overall Study|Lost to Follow-up|2|||
164316312|NCT03567343|593535581|FG001|Overall Study|Lost to Follow-up|1|||
164316313|NCT03567343|593535580|FG000|Overall Study|No longer eligible|2|||
164204886|NCT00042289|593121148|FG039|Overall Study|Other reason|0|||
164204887|NCT00042289|593121149|FG040|Overall Study|Other reason|0|||
164204888|NCT00042289|593121150|FG041|Overall Study|Other reason|0|||
164204889|NCT00042289|593121151|FG042|Overall Study|Other reason|0|||
164204890|NCT00042289|593121152|FG043|Overall Study|Other reason|1|||
164204891|NCT00042289|593121153|FG044|Overall Study|Other reason|0|||
164204892|NCT00042289|593121154|FG045|Overall Study|Other reason|0|||
164204893|NCT00042289|593121155|FG046|Overall Study|Other reason|0|||
164204894|NCT00042289|593121109|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164316314|NCT03567343|593535581|FG001|Overall Study|No longer eligible|1|||
164316315|NCT03567343|593535580|FG000|Overall Study|Adverse Event|1|||
164316316|NCT03567343|593535581|FG001|Overall Study|Adverse Event|0|||
164316317|NCT03567343|593535580|FG000|Overall Study|Protocol Violation|1|||
164316318|NCT03567343|593535581|FG001|Overall Study|Protocol Violation|1|||
164316319|NCT01134705|593535582|FG000|Overall Study|Adverse Event|1|||
164316320|NCT01134705|593535583|FG001|Overall Study|Adverse Event|7|||
164316321|NCT01134705|593535582|FG000|Overall Study|Withdrawal by Subject|6|||
164316322|NCT01134705|593535583|FG001|Overall Study|Withdrawal by Subject|6|||
164316323|NCT01134705|593535582|FG000|Overall Study|Pregnancy|1|||
164316324|NCT01134705|593535583|FG001|Overall Study|Pregnancy|0|||
164316325|NCT01134705|593535582|FG000|Overall Study|Lost to Follow-up|5|||
164316326|NCT01134705|593535583|FG001|Overall Study|Lost to Follow-up|2|||
164316327|NCT01134705|593535582|FG000|Overall Study|Protocol Violation|1|||
164316328|NCT01134705|593535583|FG001|Overall Study|Protocol Violation|1|||
164316329|NCT01134705|593535582|FG000|Overall Study|Other|1|||
164316330|NCT01134705|593535583|FG001|Overall Study|Other|6|||
164316331|NCT00246740|593535584|FG000|Initial Enrollment|Death|1|||
164316332|NCT00246740|593535585|FG001|Initial Enrollment|Death|0|||
164316333|NCT00246740|593535584|FG000|Initial Enrollment|Additional surgery scheduled|0|||
164316334|NCT00246740|593535585|FG001|Initial Enrollment|Additional surgery scheduled|2|||
164316335|NCT00246740|593535584|FG000|Initial Enrollment|Surgery schedule change|4|||
164316336|NCT00246740|593535585|FG001|Initial Enrollment|Surgery schedule change|4|||
164316337|NCT00246740|593535584|FG000|Initial Enrollment|Other|1|||
164316338|NCT00246740|593535585|FG001|Initial Enrollment|Other|2|||
164316339|NCT00101452|593535586|FG000|Overall Study|Adverse Event|2|||
164316340|NCT00101452|593535587|FG001|Overall Study|Adverse Event|0|||
164316341|NCT00101452|593535588|FG002|Overall Study|Adverse Event|1|||
164316342|NCT00101452|593535586|FG000|Overall Study|Lost to Follow-up|13|||
164316343|NCT00101452|593535587|FG001|Overall Study|Lost to Follow-up|8|||
164316344|NCT00101452|593535588|FG002|Overall Study|Lost to Follow-up|14|||
164316345|NCT00101452|593535586|FG000|Overall Study|Withdrawal by Subject|10|||
164316346|NCT00101452|593535587|FG001|Overall Study|Withdrawal by Subject|14|||
164316347|NCT00101452|593535588|FG002|Overall Study|Withdrawal by Subject|9|||
164316348|NCT00101452|593535586|FG000|Overall Study|Baseline Fail|2|||
164316349|NCT00101452|593535587|FG001|Overall Study|Baseline Fail|1|||
164316350|NCT00101452|593535588|FG002|Overall Study|Baseline Fail|2|||
164316351|NCT00101452|593535586|FG000|Overall Study|Physician Decision|0|||
164316352|NCT00101452|593535587|FG001|Overall Study|Physician Decision|3|||
164316353|NCT00101452|593535588|FG002|Overall Study|Physician Decision|2|||
164316354|NCT00101452|593535586|FG000|Overall Study|Protocol Violation|2|||
164316355|NCT00101452|593535587|FG001|Overall Study|Protocol Violation|1|||
164316356|NCT00101452|593535588|FG002|Overall Study|Protocol Violation|3|||
164316357|NCT00101452|593535586|FG000|Overall Study|Other|15|||
164316358|NCT00101452|593535587|FG001|Overall Study|Other|16|||
164316359|NCT00101452|593535588|FG002|Overall Study|Other|12|||
164316360|NCT01510769|593535589|FG000|Overall Study|Adverse Event|7|||
164316361|NCT01510769|593535590|FG001|Overall Study|Adverse Event|6|||
164316362|NCT01510769|593535591|FG002|Overall Study|Adverse Event|4|||
164316363|NCT01510769|593535589|FG000|Overall Study|Gout Flare|0|||
164316364|NCT01510769|593535590|FG001|Overall Study|Gout Flare|3|||
164316365|NCT01510769|593535591|FG002|Overall Study|Gout Flare|1|||
164316366|NCT01510769|593535589|FG000|Overall Study|Protocol Violation|11|||
164316367|NCT01510769|593535590|FG001|Overall Study|Protocol Violation|10|||
164316368|NCT01510769|593535591|FG002|Overall Study|Protocol Violation|9|||
164316369|NCT01510769|593535589|FG000|Overall Study|Lost to Follow-up|5|||
164316370|NCT01510769|593535590|FG001|Overall Study|Lost to Follow-up|1|||
164204895|NCT00042289|593121110|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164204896|NCT00042289|593121111|FG002|Overall Study|Severe debilitation, unable to continue|0|||
164316371|NCT01510769|593535591|FG002|Overall Study|Lost to Follow-up|5|||
164316372|NCT01510769|593535589|FG000|Overall Study|Withdrawal by Subject|3|||
164316373|NCT01510769|593535590|FG001|Overall Study|Withdrawal by Subject|4|||
164316374|NCT01510769|593535591|FG002|Overall Study|Withdrawal by Subject|3|||
164316375|NCT01510769|593535589|FG000|Overall Study|Death|1|||
163873154|NCT02723955|591906853|FG020|Escalation Phase|Lost to Follow-up|2|||
163873155|NCT02723955|591906854|FG021|Escalation Phase|Lost to Follow-up|1|||
163873156|NCT02723955|591906855|FG022|Escalation Phase|Lost to Follow-up|0|||
163873157|NCT02723955|591906856|FG023|Escalation Phase|Lost to Follow-up|0|||
163873158|NCT02723955|591906857|FG024|Escalation Phase|Lost to Follow-up|1|||
163873159|NCT02723955|591906858|FG025|Escalation Phase|Lost to Follow-up|1|||
163873160|NCT02723955|591906859|FG026|Escalation Phase|Lost to Follow-up|3|||
163873161|NCT02723955|591906860|FG027|Escalation Phase|Lost to Follow-up|0|||
163873162|NCT02723955|591906861|FG028|Escalation Phase|Lost to Follow-up|1|||
163873163|NCT02723955|591906862|FG029|Escalation Phase|Lost to Follow-up|0|||
163977441|NCT02813694|592288771|FG001|Overall Study|Patient hospitalized|0|||
163977442|NCT02980224|592288775|FG000|Overall Study|Adverse Event|4|||
163977443|NCT02980224|592288776|FG001|Overall Study|Adverse Event|1|||
163977444|NCT02980224|592288775|FG000|Overall Study|Withdrawal by Subject|0|||
164204897|NCT00042289|593121112|FG003|Overall Study|Severe debilitation, unable to continue|0|||
164204898|NCT00042289|593121113|FG004|Overall Study|Severe debilitation, unable to continue|0|||
164204899|NCT00042289|593121114|FG005|Overall Study|Severe debilitation, unable to continue|0|||
163873164|NCT02723955|591906863|FG030|Escalation Phase|Lost to Follow-up|0|||
163873165|NCT02723955|591906864|FG031|Escalation Phase|Lost to Follow-up|0|||
163873166|NCT02723955|591906865|FG032|Escalation Phase|Lost to Follow-up|0|||
163873167|NCT02723955|591906866|FG033|Escalation Phase|Lost to Follow-up|0|||
163873168|NCT02723955|591906867|FG034|Escalation Phase|Lost to Follow-up|0|||
163873169|NCT02723955|591906868|FG035|Escalation Phase|Lost to Follow-up|0|||
163873170|NCT02723955|591906869|FG036|Escalation Phase|Lost to Follow-up|0|||
163873171|NCT02723955|591906870|FG037|Escalation Phase|Lost to Follow-up|0|||
163873172|NCT02723955|591906871|FG038|Escalation Phase|Lost to Follow-up|0|||
163873173|NCT02723955|591906872|FG039|Escalation Phase|Lost to Follow-up|0|||
163873174|NCT02723955|591906873|FG040|Escalation Phase|Lost to Follow-up|0|||
163873175|NCT02723955|591906874|FG041|Escalation Phase|Lost to Follow-up|0|||
163873176|NCT02723955|591906875|FG042|Escalation Phase|Lost to Follow-up|0|||
163873177|NCT02723955|591906833|FG000|Escalation Phase|Physician Decision|0|||
163873178|NCT02723955|591906834|FG001|Escalation Phase|Physician Decision|0|||
163873179|NCT02723955|591906835|FG002|Escalation Phase|Physician Decision|0|||
163873180|NCT02723955|591906836|FG003|Escalation Phase|Physician Decision|0|||
163873181|NCT02723955|591906837|FG004|Escalation Phase|Physician Decision|0|||
163873182|NCT02723955|591906838|FG005|Escalation Phase|Physician Decision|2|||
163873183|NCT02723955|591906839|FG006|Escalation Phase|Physician Decision|0|||
163873184|NCT02723955|591906840|FG007|Escalation Phase|Physician Decision|0|||
163873185|NCT02723955|591906841|FG008|Escalation Phase|Physician Decision|0|||
163873186|NCT02723955|591906842|FG009|Escalation Phase|Physician Decision|0|||
163873187|NCT02723955|591906843|FG010|Escalation Phase|Physician Decision|0|||
163873188|NCT02723955|591906844|FG011|Escalation Phase|Physician Decision|0|||
163873189|NCT02723955|591906845|FG012|Escalation Phase|Physician Decision|0|||
163873190|NCT02723955|591906846|FG013|Escalation Phase|Physician Decision|0|||
163873191|NCT02723955|591906847|FG014|Escalation Phase|Physician Decision|0|||
164204900|NCT00042289|593121115|FG006|Overall Study|Severe debilitation, unable to continue|0|||
164204901|NCT00042289|593121116|FG007|Overall Study|Severe debilitation, unable to continue|0|||
164204902|NCT00042289|593121117|FG008|Overall Study|Severe debilitation, unable to continue|0|||
164204903|NCT00042289|593121118|FG009|Overall Study|Severe debilitation, unable to continue|0|||
164204904|NCT00042289|593121119|FG010|Overall Study|Severe debilitation, unable to continue|0|||
164204905|NCT00042289|593121120|FG011|Overall Study|Severe debilitation, unable to continue|0|||
164204906|NCT00042289|593121121|FG012|Overall Study|Severe debilitation, unable to continue|0|||
164204907|NCT00042289|593121122|FG013|Overall Study|Severe debilitation, unable to continue|0|||
164204908|NCT00042289|593121123|FG014|Overall Study|Severe debilitation, unable to continue|0|||
164204909|NCT00042289|593121124|FG015|Overall Study|Severe debilitation, unable to continue|0|||
164204910|NCT00042289|593121125|FG016|Overall Study|Severe debilitation, unable to continue|0|||
164204911|NCT00042289|593121126|FG017|Overall Study|Severe debilitation, unable to continue|0|||
164204912|NCT00042289|593121127|FG018|Overall Study|Severe debilitation, unable to continue|0|||
164204913|NCT00042289|593121128|FG019|Overall Study|Severe debilitation, unable to continue|0|||
163873192|NCT02723955|591906848|FG015|Escalation Phase|Physician Decision|0|||
163873193|NCT02723955|591906849|FG016|Escalation Phase|Physician Decision|0|||
163873194|NCT02723955|591906850|FG017|Escalation Phase|Physician Decision|0|||
163873195|NCT02723955|591906851|FG018|Escalation Phase|Physician Decision|0|||
163873196|NCT02723955|591906852|FG019|Escalation Phase|Physician Decision|0|||
163873197|NCT02723955|591906853|FG020|Escalation Phase|Physician Decision|0|||
163873198|NCT02723955|591906854|FG021|Escalation Phase|Physician Decision|0|||
163873199|NCT02723955|591906855|FG022|Escalation Phase|Physician Decision|0|||
163873200|NCT02723955|591906856|FG023|Escalation Phase|Physician Decision|0|||
163977445|NCT02980224|592288776|FG001|Overall Study|Withdrawal by Subject|2|||
163873201|NCT02723955|591906857|FG024|Escalation Phase|Physician Decision|0|||
163873202|NCT02723955|591906858|FG025|Escalation Phase|Physician Decision|0|||
163873203|NCT02723955|591906859|FG026|Escalation Phase|Physician Decision|2|||
164204914|NCT00042289|593121129|FG020|Overall Study|Severe debilitation, unable to continue|0|||
164316376|NCT01510769|593535590|FG001|Overall Study|Death|1|||
164316377|NCT01510769|593535591|FG002|Overall Study|Death|0|||
164316378|NCT02674204|593535592|FG000|Overall Study|Adverse Event|1|||
164316379|NCT02674204|593535593|FG001|Overall Study|Adverse Event|0|||
164316380|NCT02466659|593535596|FG000|Overall Study|Lost to Follow-up|5|||
164316381|NCT02466659|593535597|FG001|Overall Study|Lost to Follow-up|2|||
164316382|NCT01536392|593535598|FG000|Overall Study|Adverse Event|2|||
164316383|NCT01536392|593535599|FG001|Overall Study|Adverse Event|2|||
164316384|NCT01536392|593535598|FG000|Overall Study|Physician Decision|2|||
164316385|NCT01536392|593535599|FG001|Overall Study|Physician Decision|3|||
164316386|NCT01536392|593535598|FG000|Overall Study|Withdrawal by Subject|3|||
164316387|NCT01536392|593535599|FG001|Overall Study|Withdrawal by Subject|6|||
164316388|NCT01536392|593535598|FG000|Overall Study|Non Compliance|3|||
164316389|NCT01536392|593535599|FG001|Overall Study|Non Compliance|4|||
163873204|NCT02723955|591906860|FG027|Escalation Phase|Physician Decision|0|||
163873205|NCT02723955|591906861|FG028|Escalation Phase|Physician Decision|0|||
164316390|NCT01536392|593535598|FG000|Overall Study|Completed therapy early|3|||
164316391|NCT01536392|593535599|FG001|Overall Study|Completed therapy early|0|||
164316392|NCT02874144|593535600|FG000|Overall Study|Lost to Follow-up|3|||
164316393|NCT02874144|593535601|FG001|Overall Study|Lost to Follow-up|5|||
164316394|NCT00486811|593535603|FG000|Overall Study|Adverse Event|28|||
164316395|NCT00486811|593535604|FG001|Overall Study|Adverse Event|60|||
164316396|NCT00486811|593535605|FG002|Overall Study|Adverse Event|135|||
164316397|NCT00486811|593535603|FG000|Overall Study|Lack of Efficacy|34|||
164316398|NCT00486811|593535604|FG001|Overall Study|Lack of Efficacy|14|||
164316399|NCT00486811|593535605|FG002|Overall Study|Lack of Efficacy|7|||
164316400|NCT00486811|593535603|FG000|Overall Study|Lost to Follow-up|4|||
164316401|NCT00486811|593535604|FG001|Overall Study|Lost to Follow-up|6|||
164316402|NCT00486811|593535605|FG002|Overall Study|Lost to Follow-up|4|||
164316403|NCT00486811|593535603|FG000|Overall Study|Withdrawal by Subject|33|||
164316404|NCT00486811|593535604|FG001|Overall Study|Withdrawal by Subject|44|||
164316405|NCT00486811|593535605|FG002|Overall Study|Withdrawal by Subject|58|||
164316406|NCT00486811|593535603|FG000|Overall Study|Study drug non-compliant|5|||
164316407|NCT00486811|593535604|FG001|Overall Study|Study drug non-compliant|6|||
164316408|NCT00486811|593535605|FG002|Overall Study|Study drug non-compliant|3|||
164316409|NCT00486811|593535603|FG000|Overall Study|All other|18|||
164316410|NCT00486811|593535604|FG001|Overall Study|All other|11|||
164316411|NCT00486811|593535605|FG002|Overall Study|All other|7|||
164316412|NCT00852371|593535611|FG000|Overall Study|Lost to Follow-up|2|||
164316413|NCT00852371|593535612|FG001|Overall Study|Lost to Follow-up|3|||
164316414|NCT00852371|593535613|FG002|Overall Study|Lost to Follow-up|4|||
164316415|NCT00852371|593535614|FG003|Overall Study|Lost to Follow-up|2|||
164316416|NCT01711216|593535615|FG000|Overall Study|Adverse Event|4|||
164316417|NCT01711216|593535615|FG000|Overall Study|Pregnancy|56|||
164316418|NCT01711216|593535615|FG000|Overall Study|Withdrawal by Subject|6|||
164316419|NCT01711216|593535615|FG000|Overall Study|Lost to Follow-up|46|||
164316420|NCT01711216|593535615|FG000|Overall Study|variety of other minor reasons|83|||
164316421|NCT01711216|593535615|FG000|Overall Study|no reason specified|22|||
164316422|NCT02228980|593535616|FG000|Overall Study|Adverse Event|14|||
164316423|NCT02228980|593535617|FG001|Overall Study|Adverse Event|0|||
164316424|NCT02228980|593535618|FG002|Overall Study|Adverse Event|0|||
163873206|NCT02723955|591906862|FG029|Escalation Phase|Physician Decision|0|||
164316425|NCT02228980|593535619|FG003|Overall Study|Adverse Event|0|||
164316426|NCT02228980|593535616|FG000|Overall Study|Protocol Violation|7|||
164316427|NCT02228980|593535617|FG001|Overall Study|Protocol Violation|0|||
164316428|NCT02228980|593535618|FG002|Overall Study|Protocol Violation|0|||
164316429|NCT02228980|593535619|FG003|Overall Study|Protocol Violation|0|||
164316430|NCT02228980|593535616|FG000|Overall Study|Withdrawal by Subject|3|||
164316431|NCT02228980|593535617|FG001|Overall Study|Withdrawal by Subject|3|||
164316432|NCT02228980|593535618|FG002|Overall Study|Withdrawal by Subject|2|||
164316433|NCT02228980|593535619|FG003|Overall Study|Withdrawal by Subject|3|||
164316434|NCT02744040|593535620|FG000|Overall Study|Withdrawal by Subject|3|||
164316435|NCT02744040|593535621|FG001|Overall Study|Withdrawal by Subject|2|||
164316436|NCT02744040|593535622|FG002|Overall Study|Withdrawal by Subject|2|||
164316437|NCT02744040|593535620|FG000|Overall Study|Physician Decision|0|||
164316438|NCT02744040|593535621|FG001|Overall Study|Physician Decision|8|||
164316439|NCT02744040|593535622|FG002|Overall Study|Physician Decision|13|||
164316440|NCT02744040|593535620|FG000|Overall Study|Lost to Follow-up|3|||
164316441|NCT02744040|593535621|FG001|Overall Study|Lost to Follow-up|1|||
163873207|NCT02723955|591906863|FG030|Escalation Phase|Physician Decision|0|||
164316442|NCT02744040|593535622|FG002|Overall Study|Lost to Follow-up|7|||
164316443|NCT00715910|593535623|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
164316444|NCT00715910|593535624|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
164316445|NCT00715910|593535625|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
164316446|NCT00715910|593535626|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
164316447|NCT00715910|593535627|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
163873208|NCT02723955|591906864|FG031|Escalation Phase|Physician Decision|0|||
164316448|NCT00715910|593535628|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
164316449|NCT00715910|593535623|FG000|Booster and ESFU Phase|Other|0|||
163873209|NCT02723955|591906865|FG032|Escalation Phase|Physician Decision|0|||
164204915|NCT00042289|593121130|FG021|Overall Study|Severe debilitation, unable to continue|1|||
164204916|NCT00042289|593121131|FG022|Overall Study|Severe debilitation, unable to continue|0|||
164204917|NCT00042289|593121132|FG023|Overall Study|Severe debilitation, unable to continue|1|||
164204918|NCT00042289|593121133|FG024|Overall Study|Severe debilitation, unable to continue|0|||
164204919|NCT00042289|593121134|FG025|Overall Study|Severe debilitation, unable to continue|0|||
164204920|NCT00042289|593121135|FG026|Overall Study|Severe debilitation, unable to continue|0|||
164204921|NCT00042289|593121136|FG027|Overall Study|Severe debilitation, unable to continue|1|||
164204922|NCT00042289|593121137|FG028|Overall Study|Severe debilitation, unable to continue|0|||
164204923|NCT00042289|593121138|FG029|Overall Study|Severe debilitation, unable to continue|0|||
164204924|NCT00042289|593121139|FG030|Overall Study|Severe debilitation, unable to continue|0|||
164204925|NCT00042289|593121140|FG031|Overall Study|Severe debilitation, unable to continue|1|||
164204926|NCT00042289|593121141|FG032|Overall Study|Severe debilitation, unable to continue|1|||
164204927|NCT00042289|593121142|FG033|Overall Study|Severe debilitation, unable to continue|0|||
164204928|NCT00042289|593121143|FG034|Overall Study|Severe debilitation, unable to continue|0|||
164204929|NCT00042289|593121144|FG035|Overall Study|Severe debilitation, unable to continue|0|||
164204930|NCT00042289|593121145|FG036|Overall Study|Severe debilitation, unable to continue|0|||
164204931|NCT00042289|593121146|FG037|Overall Study|Severe debilitation, unable to continue|0|||
164204932|NCT00042289|593121147|FG038|Overall Study|Severe debilitation, unable to continue|0|||
164204933|NCT00042289|593121148|FG039|Overall Study|Severe debilitation, unable to continue|0|||
164204934|NCT00042289|593121149|FG040|Overall Study|Severe debilitation, unable to continue|0|||
164204935|NCT00042289|593121150|FG041|Overall Study|Severe debilitation, unable to continue|0|||
164204936|NCT00042289|593121151|FG042|Overall Study|Severe debilitation, unable to continue|0|||
164204937|NCT00042289|593121152|FG043|Overall Study|Severe debilitation, unable to continue|0|||
164204938|NCT00042289|593121153|FG044|Overall Study|Severe debilitation, unable to continue|0|||
164204939|NCT00042289|593121154|FG045|Overall Study|Severe debilitation, unable to continue|0|||
164204940|NCT00042289|593121155|FG046|Overall Study|Severe debilitation, unable to continue|0|||
164204941|NCT00042289|593121109|FG000|Overall Study|Site closed|0|||
164204942|NCT00042289|593121110|FG001|Overall Study|Site closed|0|||
164204943|NCT00042289|593121111|FG002|Overall Study|Site closed|0|||
164204944|NCT00042289|593121112|FG003|Overall Study|Site closed|0|||
164204945|NCT00042289|593121113|FG004|Overall Study|Site closed|0|||
164204946|NCT00042289|593121114|FG005|Overall Study|Site closed|0|||
164204947|NCT00042289|593121115|FG006|Overall Study|Site closed|0|||
164204948|NCT00042289|593121116|FG007|Overall Study|Site closed|0|||
164204949|NCT00042289|593121117|FG008|Overall Study|Site closed|0|||
164204950|NCT00042289|593121118|FG009|Overall Study|Site closed|0|||
164204951|NCT00042289|593121119|FG010|Overall Study|Site closed|0|||
164204952|NCT00042289|593121120|FG011|Overall Study|Site closed|0|||
164204953|NCT00042289|593121121|FG012|Overall Study|Site closed|0|||
164204954|NCT00042289|593121122|FG013|Overall Study|Site closed|0|||
164204955|NCT00042289|593121123|FG014|Overall Study|Site closed|0|||
164204956|NCT00042289|593121124|FG015|Overall Study|Site closed|0|||
164204957|NCT00042289|593121125|FG016|Overall Study|Site closed|0|||
164204958|NCT00042289|593121126|FG017|Overall Study|Site closed|0|||
164204959|NCT00042289|593121127|FG018|Overall Study|Site closed|0|||
164204960|NCT00042289|593121128|FG019|Overall Study|Site closed|0|||
164204961|NCT00042289|593121129|FG020|Overall Study|Site closed|0|||
164204962|NCT00042289|593121130|FG021|Overall Study|Site closed|0|||
164204963|NCT00042289|593121131|FG022|Overall Study|Site closed|0|||
164204964|NCT00042289|593121132|FG023|Overall Study|Site closed|0|||
164204965|NCT00042289|593121133|FG024|Overall Study|Site closed|0|||
164204966|NCT00042289|593121134|FG025|Overall Study|Site closed|0|||
164204967|NCT00042289|593121135|FG026|Overall Study|Site closed|0|||
164204968|NCT00042289|593121136|FG027|Overall Study|Site closed|0|||
164204969|NCT00042289|593121137|FG028|Overall Study|Site closed|0|||
164204970|NCT00042289|593121138|FG029|Overall Study|Site closed|0|||
164204971|NCT00042289|593121139|FG030|Overall Study|Site closed|0|||
164204972|NCT00042289|593121140|FG031|Overall Study|Site closed|3|||
164204973|NCT00042289|593121141|FG032|Overall Study|Site closed|0|||
164204974|NCT00042289|593121142|FG033|Overall Study|Site closed|0|||
164204975|NCT00042289|593121143|FG034|Overall Study|Site closed|0|||
164204976|NCT00042289|593121144|FG035|Overall Study|Site closed|0|||
164204977|NCT00042289|593121145|FG036|Overall Study|Site closed|1|||
164204978|NCT00042289|593121146|FG037|Overall Study|Site closed|0|||
164204979|NCT00042289|593121147|FG038|Overall Study|Site closed|0|||
164204980|NCT00042289|593121148|FG039|Overall Study|Site closed|0|||
164204981|NCT00042289|593121149|FG040|Overall Study|Site closed|0|||
164204982|NCT00042289|593121150|FG041|Overall Study|Site closed|0|||
164204983|NCT00042289|593121151|FG042|Overall Study|Site closed|1|||
164204984|NCT00042289|593121152|FG043|Overall Study|Site closed|0|||
164204985|NCT00042289|593121153|FG044|Overall Study|Site closed|0|||
164204986|NCT00042289|593121154|FG045|Overall Study|Site closed|0|||
164204987|NCT00042289|593121155|FG046|Overall Study|Site closed|0|||
164204988|NCT00042289|593121109|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
164204989|NCT00042289|593121110|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
164204990|NCT00042289|593121111|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
164303021|NCT04323124|593484700|FG014|Overall Study|Other|0|||
164204991|NCT00042289|593121112|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
164204992|NCT00042289|593121113|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
164204993|NCT00042289|593121114|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
164204994|NCT00042289|593121115|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
164204995|NCT00042289|593121116|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
164204996|NCT00042289|593121117|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
164204997|NCT00042289|593121118|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
164204998|NCT00042289|593121119|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
164204999|NCT00042289|593121120|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
164205000|NCT00042289|593121121|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
164205001|NCT00042289|593121122|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
164205002|NCT00042289|593121123|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
164205003|NCT00042289|593121124|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
164205004|NCT00042289|593121125|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
164205005|NCT00042289|593121126|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
164205006|NCT00042289|593121127|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
164205007|NCT00042289|593121128|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
164205008|NCT00042289|593121129|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
164205009|NCT00042289|593121130|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
164205010|NCT00042289|593121131|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
164205011|NCT00042289|593121132|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
164205012|NCT00042289|593121133|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
164205013|NCT00042289|593121134|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
164205014|NCT00042289|593121135|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
164205015|NCT00042289|593121136|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
164205016|NCT00042289|593121137|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
164205017|NCT00042289|593121138|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
164205018|NCT00042289|593121139|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
164205019|NCT00042289|593121140|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
164205020|NCT00042289|593121141|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
164205021|NCT00042289|593121142|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
164205022|NCT00042289|593121143|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
164205023|NCT00042289|593121144|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
164205024|NCT00042289|593121145|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
164205025|NCT00042289|593121146|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
164205026|NCT00042289|593121147|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
164205027|NCT00042289|593121148|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
164205028|NCT00042289|593121149|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
164205029|NCT00042289|593121150|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
164205030|NCT00042289|593121151|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
164205031|NCT00042289|593121152|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
164205032|NCT00042289|593121153|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
164205033|NCT00042289|593121154|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
164205034|NCT00042289|593121155|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
164205035|NCT00042289|593121109|FG000|Overall Study|Protocol Violation|0|||
164205036|NCT00042289|593121110|FG001|Overall Study|Protocol Violation|0|||
164205037|NCT00042289|593121111|FG002|Overall Study|Protocol Violation|0|||
164205038|NCT00042289|593121112|FG003|Overall Study|Protocol Violation|0|||
164205039|NCT00042289|593121113|FG004|Overall Study|Protocol Violation|0|||
164205040|NCT00042289|593121114|FG005|Overall Study|Protocol Violation|1|||
164205041|NCT00042289|593121115|FG006|Overall Study|Protocol Violation|0|||
164205042|NCT00042289|593121116|FG007|Overall Study|Protocol Violation|1|||
164205043|NCT00042289|593121117|FG008|Overall Study|Protocol Violation|0|||
164205044|NCT00042289|593121118|FG009|Overall Study|Protocol Violation|0|||
164205045|NCT00042289|593121119|FG010|Overall Study|Protocol Violation|0|||
164205046|NCT00042289|593121120|FG011|Overall Study|Protocol Violation|0|||
164205047|NCT00042289|593121121|FG012|Overall Study|Protocol Violation|0|||
164205048|NCT00042289|593121122|FG013|Overall Study|Protocol Violation|0|||
164205049|NCT00042289|593121123|FG014|Overall Study|Protocol Violation|0|||
164205050|NCT00042289|593121124|FG015|Overall Study|Protocol Violation|0|||
164205051|NCT00042289|593121125|FG016|Overall Study|Protocol Violation|0|||
164205052|NCT00042289|593121126|FG017|Overall Study|Protocol Violation|0|||
164205053|NCT00042289|593121127|FG018|Overall Study|Protocol Violation|0|||
164205054|NCT00042289|593121128|FG019|Overall Study|Protocol Violation|0|||
164205055|NCT00042289|593121129|FG020|Overall Study|Protocol Violation|0|||
164205056|NCT00042289|593121130|FG021|Overall Study|Protocol Violation|0|||
163873210|NCT02723955|591906866|FG033|Escalation Phase|Physician Decision|0|||
164316450|NCT00715910|593535624|FG001|Booster and ESFU Phase|Other|0|||
164316451|NCT00715910|593535625|FG002|Booster and ESFU Phase|Other|0|||
164316452|NCT00715910|593535626|FG003|Booster and ESFU Phase|Other|5|||
164316453|NCT00715910|593535627|FG004|Booster and ESFU Phase|Other|1|||
164316454|NCT00715910|593535628|FG005|Booster and ESFU Phase|Other|0|||
164316455|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316456|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316457|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316458|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
164316459|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
164316460|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316461|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316462|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316463|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316464|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
164316465|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316466|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316467|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316468|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316469|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
164316470|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316471|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316472|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316473|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316474|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
164316475|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
164316476|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316477|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316478|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316479|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
164316480|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316481|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316482|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316483|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316484|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
164316485|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316486|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316487|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
164316488|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316489|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
164316490|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316491|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316492|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316493|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316494|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
164316495|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316496|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163873211|NCT02723955|591906867|FG034|Escalation Phase|Physician Decision|0|||
163873212|NCT02723955|591906868|FG035|Escalation Phase|Physician Decision|0|||
163873213|NCT02723955|591906869|FG036|Escalation Phase|Physician Decision|0|||
163873214|NCT02723955|591906870|FG037|Escalation Phase|Physician Decision|0|||
163873215|NCT02723955|591906871|FG038|Escalation Phase|Physician Decision|0|||
163873216|NCT02723955|591906872|FG039|Escalation Phase|Physician Decision|0|||
163873217|NCT02723955|591906873|FG040|Escalation Phase|Physician Decision|0|||
163873218|NCT02723955|591906874|FG041|Escalation Phase|Physician Decision|0|||
163873219|NCT02723955|591906875|FG042|Escalation Phase|Physician Decision|0|||
163873220|NCT02723955|591906833|FG000|Escalation Phase|Withdrawal by Subject|0|||
163873221|NCT02723955|591906834|FG001|Escalation Phase|Withdrawal by Subject|0|||
163873222|NCT02723955|591906835|FG002|Escalation Phase|Withdrawal by Subject|0|||
163977446|NCT00606320|592288777|FG000|Overall Study|Adverse Event|3|||
163977447|NCT00606320|592288777|FG000|Overall Study|Lack of Efficacy|5|||
164316497|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316498|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316499|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
164316500|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316501|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316502|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316503|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
163873223|NCT02723955|591906836|FG003|Escalation Phase|Withdrawal by Subject|0|||
163873224|NCT02723955|591906837|FG004|Escalation Phase|Withdrawal by Subject|1|||
163873225|NCT02723955|591906838|FG005|Escalation Phase|Withdrawal by Subject|1|||
163873226|NCT02723955|591906839|FG006|Escalation Phase|Withdrawal by Subject|1|||
164205057|NCT00042289|593121131|FG022|Overall Study|Protocol Violation|0|||
164205058|NCT00042289|593121132|FG023|Overall Study|Protocol Violation|1|||
164205059|NCT00042289|593121133|FG024|Overall Study|Protocol Violation|1|||
164205060|NCT00042289|593121134|FG025|Overall Study|Protocol Violation|0|||
164205061|NCT00042289|593121135|FG026|Overall Study|Protocol Violation|2|||
164205062|NCT00042289|593121136|FG027|Overall Study|Protocol Violation|0|||
164205063|NCT00042289|593121137|FG028|Overall Study|Protocol Violation|0|||
164205064|NCT00042289|593121138|FG029|Overall Study|Protocol Violation|0|||
164205065|NCT00042289|593121139|FG030|Overall Study|Protocol Violation|1|||
164205066|NCT00042289|593121140|FG031|Overall Study|Protocol Violation|0|||
164205067|NCT00042289|593121141|FG032|Overall Study|Protocol Violation|0|||
164205068|NCT00042289|593121142|FG033|Overall Study|Protocol Violation|0|||
164205069|NCT00042289|593121143|FG034|Overall Study|Protocol Violation|0|||
164205070|NCT00042289|593121144|FG035|Overall Study|Protocol Violation|0|||
164205071|NCT00042289|593121145|FG036|Overall Study|Protocol Violation|0|||
164205072|NCT00042289|593121146|FG037|Overall Study|Protocol Violation|0|||
164205073|NCT00042289|593121147|FG038|Overall Study|Protocol Violation|0|||
164205074|NCT00042289|593121148|FG039|Overall Study|Protocol Violation|0|||
164205075|NCT00042289|593121149|FG040|Overall Study|Protocol Violation|0|||
164205076|NCT00042289|593121150|FG041|Overall Study|Protocol Violation|1|||
164205077|NCT00042289|593121151|FG042|Overall Study|Protocol Violation|1|||
164205078|NCT00042289|593121152|FG043|Overall Study|Protocol Violation|1|||
164205079|NCT00042289|593121153|FG044|Overall Study|Protocol Violation|0|||
164205080|NCT00042289|593121154|FG045|Overall Study|Protocol Violation|0|||
164205081|NCT00042289|593121155|FG046|Overall Study|Protocol Violation|0|||
164205082|NCT00042289|593121109|FG000|Overall Study|Withdrawal by Subject|4|||
164205083|NCT00042289|593121110|FG001|Overall Study|Withdrawal by Subject|1|||
164205084|NCT00042289|593121111|FG002|Overall Study|Withdrawal by Subject|0|||
164205085|NCT00042289|593121112|FG003|Overall Study|Withdrawal by Subject|2|||
164205086|NCT00042289|593121113|FG004|Overall Study|Withdrawal by Subject|0|||
164205087|NCT00042289|593121114|FG005|Overall Study|Withdrawal by Subject|2|||
164205088|NCT00042289|593121115|FG006|Overall Study|Withdrawal by Subject|0|||
164205089|NCT00042289|593121116|FG007|Overall Study|Withdrawal by Subject|0|||
164205090|NCT00042289|593121117|FG008|Overall Study|Withdrawal by Subject|0|||
164205091|NCT00042289|593121118|FG009|Overall Study|Withdrawal by Subject|1|||
164205092|NCT00042289|593121119|FG010|Overall Study|Withdrawal by Subject|0|||
164205093|NCT00042289|593121120|FG011|Overall Study|Withdrawal by Subject|0|||
164205094|NCT00042289|593121121|FG012|Overall Study|Withdrawal by Subject|2|||
164205095|NCT00042289|593121122|FG013|Overall Study|Withdrawal by Subject|0|||
164205096|NCT00042289|593121123|FG014|Overall Study|Withdrawal by Subject|0|||
164205097|NCT00042289|593121124|FG015|Overall Study|Withdrawal by Subject|0|||
164205098|NCT00042289|593121125|FG016|Overall Study|Withdrawal by Subject|0|||
164205099|NCT00042289|593121126|FG017|Overall Study|Withdrawal by Subject|0|||
164205100|NCT00042289|593121127|FG018|Overall Study|Withdrawal by Subject|0|||
164205101|NCT00042289|593121128|FG019|Overall Study|Withdrawal by Subject|0|||
164205102|NCT00042289|593121129|FG020|Overall Study|Withdrawal by Subject|0|||
164205103|NCT00042289|593121130|FG021|Overall Study|Withdrawal by Subject|1|||
164205104|NCT00042289|593121131|FG022|Overall Study|Withdrawal by Subject|1|||
164205105|NCT00042289|593121132|FG023|Overall Study|Withdrawal by Subject|1|||
164205106|NCT00042289|593121133|FG024|Overall Study|Withdrawal by Subject|0|||
164205107|NCT00042289|593121134|FG025|Overall Study|Withdrawal by Subject|0|||
164205108|NCT00042289|593121135|FG026|Overall Study|Withdrawal by Subject|1|||
164205109|NCT00042289|593121136|FG027|Overall Study|Withdrawal by Subject|0|||
164205110|NCT00042289|593121137|FG028|Overall Study|Withdrawal by Subject|2|||
164205111|NCT00042289|593121138|FG029|Overall Study|Withdrawal by Subject|0|||
164205112|NCT00042289|593121139|FG030|Overall Study|Withdrawal by Subject|0|||
164205113|NCT00042289|593121140|FG031|Overall Study|Withdrawal by Subject|1|||
164205114|NCT00042289|593121141|FG032|Overall Study|Withdrawal by Subject|2|||
164205115|NCT00042289|593121142|FG033|Overall Study|Withdrawal by Subject|1|||
164205116|NCT00042289|593121143|FG034|Overall Study|Withdrawal by Subject|0|||
164205117|NCT00042289|593121144|FG035|Overall Study|Withdrawal by Subject|0|||
164205118|NCT00042289|593121145|FG036|Overall Study|Withdrawal by Subject|0|||
164205119|NCT00042289|593121146|FG037|Overall Study|Withdrawal by Subject|1|||
164205120|NCT00042289|593121147|FG038|Overall Study|Withdrawal by Subject|0|||
164205121|NCT00042289|593121148|FG039|Overall Study|Withdrawal by Subject|0|||
164205122|NCT00042289|593121149|FG040|Overall Study|Withdrawal by Subject|0|||
164205123|NCT00042289|593121150|FG041|Overall Study|Withdrawal by Subject|0|||
164205124|NCT00042289|593121151|FG042|Overall Study|Withdrawal by Subject|1|||
164205125|NCT00042289|593121152|FG043|Overall Study|Withdrawal by Subject|0|||
164205126|NCT00042289|593121153|FG044|Overall Study|Withdrawal by Subject|0|||
164205127|NCT00042289|593121154|FG045|Overall Study|Withdrawal by Subject|0|||
164205128|NCT00042289|593121155|FG046|Overall Study|Withdrawal by Subject|0|||
164205129|NCT00548327|593121160|FG000|Overall Study|Adverse Event|0|||
164205130|NCT00548327|593121161|FG001|Overall Study|Adverse Event|1|||
164205131|NCT01673386|593121162|FG000|Overall Study|Study terminated by sponsor|16|||
164205132|NCT01673386|593121163|FG001|Overall Study|Study terminated by sponsor|22|||
164205133|NCT01673386|593121162|FG000|Overall Study|Adverse Event|5|||
164316504|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
164316505|NCT01185353|593535629|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
164316506|NCT01185353|593535630|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316507|NCT01185353|593535631|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316508|NCT01185353|593535632|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316509|NCT01185353|593535633|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
164316510|NCT01185353|593535634|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316511|NCT01185353|593535635|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316512|NCT01185353|593535636|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316513|NCT01185353|593535637|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316514|NCT01185353|593535638|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
164316515|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316516|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316517|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
164316518|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316519|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316520|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
164316521|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316522|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316523|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316524|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
164316525|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316526|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
164316527|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316528|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
164316529|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316530|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316531|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316532|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316533|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316534|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
164316535|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316536|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316537|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316538|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
164316539|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316540|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316541|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
164316542|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316543|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316544|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
164316545|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316546|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316547|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
164316548|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
164316549|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316550|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
164316551|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
164316552|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316553|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316554|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
164316555|NCT01185353|593535629|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316556|NCT01185353|593535630|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316557|NCT01185353|593535631|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316558|NCT01185353|593535632|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316559|NCT01185353|593535633|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316560|NCT01185353|593535634|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316561|NCT01185353|593535635|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
164316562|NCT01185353|593535636|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316563|NCT01185353|593535637|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316564|NCT01185353|593535638|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
164316565|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316566|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316567|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316568|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316569|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316570|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316571|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
164316572|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
164316573|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
164316574|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
164316575|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316576|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316577|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316578|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316579|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316580|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316581|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
164316582|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
164316583|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
164316584|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
164316585|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316586|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316587|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316588|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316589|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316590|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316591|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
164316592|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
164316593|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
164316594|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
164316595|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316596|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316597|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316598|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316599|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316600|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316601|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316602|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316603|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
164316604|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
164316605|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Death|0|||
164316606|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Death|0|||
164316607|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Death|0|||
164316608|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Death|0|||
164316609|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Death|0|||
164316610|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Death|0|||
164316611|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Death|0|||
164316612|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Death|0|||
164316613|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Death|0|||
164316614|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Death|1|||
164316615|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316616|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316617|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316618|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163873227|NCT02723955|591906840|FG007|Escalation Phase|Withdrawal by Subject|1|||
163873228|NCT02723955|591906841|FG008|Escalation Phase|Withdrawal by Subject|0|||
163873229|NCT02723955|591906842|FG009|Escalation Phase|Withdrawal by Subject|0|||
163873230|NCT02723955|591906843|FG010|Escalation Phase|Withdrawal by Subject|0|||
163873231|NCT02723955|591906844|FG011|Escalation Phase|Withdrawal by Subject|0|||
163873232|NCT02723955|591906845|FG012|Escalation Phase|Withdrawal by Subject|1|||
163873233|NCT02723955|591906846|FG013|Escalation Phase|Withdrawal by Subject|0|||
163873234|NCT02723955|591906847|FG014|Escalation Phase|Withdrawal by Subject|0|||
163873235|NCT02723955|591906848|FG015|Escalation Phase|Withdrawal by Subject|0|||
163873236|NCT02723955|591906849|FG016|Escalation Phase|Withdrawal by Subject|1|||
163873237|NCT02723955|591906850|FG017|Escalation Phase|Withdrawal by Subject|0|||
163873238|NCT02723955|591906851|FG018|Escalation Phase|Withdrawal by Subject|0|||
163873239|NCT02723955|591906852|FG019|Escalation Phase|Withdrawal by Subject|0|||
163873240|NCT02723955|591906853|FG020|Escalation Phase|Withdrawal by Subject|0|||
163873241|NCT02723955|591906854|FG021|Escalation Phase|Withdrawal by Subject|0|||
163977448|NCT00606320|592288777|FG000|Overall Study|Physician Decision|7|||
164316619|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316620|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316621|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316622|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
164316623|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
163873242|NCT02723955|591906855|FG022|Escalation Phase|Withdrawal by Subject|0|||
163873243|NCT02723955|591906856|FG023|Escalation Phase|Withdrawal by Subject|2|||
163977449|NCT00606320|592288777|FG000|Overall Study|Protocol Violation|8|||
164316624|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
164316625|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316626|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
163873244|NCT02723955|591906857|FG024|Escalation Phase|Withdrawal by Subject|0|||
163873245|NCT02723955|591906858|FG025|Escalation Phase|Withdrawal by Subject|1|||
163873246|NCT02723955|591906859|FG026|Escalation Phase|Withdrawal by Subject|0|||
163873247|NCT02723955|591906860|FG027|Escalation Phase|Withdrawal by Subject|0|||
163873248|NCT02723955|591906861|FG028|Escalation Phase|Withdrawal by Subject|1|||
163873249|NCT02723955|591906862|FG029|Escalation Phase|Withdrawal by Subject|0|||
163873250|NCT02723955|591906863|FG030|Escalation Phase|Withdrawal by Subject|0|||
163873251|NCT02723955|591906864|FG031|Escalation Phase|Withdrawal by Subject|0|||
163873252|NCT02723955|591906865|FG032|Escalation Phase|Withdrawal by Subject|0|||
163873253|NCT02723955|591906866|FG033|Escalation Phase|Withdrawal by Subject|0|||
163873254|NCT02723955|591906867|FG034|Escalation Phase|Withdrawal by Subject|0|||
163873255|NCT02723955|591906868|FG035|Escalation Phase|Withdrawal by Subject|0|||
163873256|NCT02723955|591906869|FG036|Escalation Phase|Withdrawal by Subject|0|||
163873257|NCT02723955|591906870|FG037|Escalation Phase|Withdrawal by Subject|0|||
163873258|NCT02723955|591906871|FG038|Escalation Phase|Withdrawal by Subject|0|||
163873259|NCT02723955|591906872|FG039|Escalation Phase|Withdrawal by Subject|0|||
163873260|NCT02723955|591906873|FG040|Escalation Phase|Withdrawal by Subject|0|||
163873261|NCT02723955|591906874|FG041|Escalation Phase|Withdrawal by Subject|0|||
163873262|NCT02723955|591906875|FG042|Escalation Phase|Withdrawal by Subject|0|||
163873263|NCT02723955|591906833|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873264|NCT02723955|591906834|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873265|NCT02723955|591906835|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873266|NCT02723955|591906836|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873267|NCT02723955|591906837|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
163873268|NCT02723955|591906838|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
163873269|NCT02723955|591906839|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
163873270|NCT02723955|591906840|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
163873271|NCT02723955|591906841|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
163873272|NCT02723955|591906842|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873273|NCT02723955|591906843|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873274|NCT02723955|591906844|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873275|NCT02723955|591906845|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873276|NCT02723955|591906846|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873277|NCT02723955|591906847|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873278|NCT02723955|591906848|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873279|NCT02723955|591906849|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873280|NCT02723955|591906850|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873281|NCT02723955|591906851|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873282|NCT02723955|591906852|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873283|NCT02723955|591906853|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873284|NCT02723955|591906854|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873285|NCT02723955|591906855|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873286|NCT02723955|591906856|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873287|NCT02723955|591906857|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873288|NCT02723955|591906858|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873289|NCT02723955|591906859|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873290|NCT02723955|591906860|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873291|NCT02723955|591906861|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873292|NCT02723955|591906862|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873293|NCT02723955|591906863|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873294|NCT02723955|591906864|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873295|NCT02723955|591906865|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873296|NCT02723955|591906866|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873297|NCT02723955|591906867|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163977450|NCT00606320|592288777|FG000|Overall Study|Withdrawal by Subject|10|||
163977451|NCT00606320|592288777|FG000|Overall Study|Progression to depressive phase|4|||
163977452|NCT00939783|592288779|FG000|Overall Study|Death|6|||
163977453|NCT00939783|592288779|FG000|Overall Study|Adverse Event|39|||
163873298|NCT02723955|591906868|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873299|NCT02723955|591906869|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873300|NCT02723955|591906870|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164205134|NCT01673386|593121163|FG001|Overall Study|Adverse Event|2|||
164205135|NCT01673386|593121162|FG000|Overall Study|Progressive disease|4|||
164205136|NCT01673386|593121163|FG001|Overall Study|Progressive disease|1|||
164205137|NCT01673386|593121162|FG000|Overall Study|Withdrawal by Subject|0|||
164205138|NCT01673386|593121163|FG001|Overall Study|Withdrawal by Subject|2|||
164205139|NCT00274456|593121167|FG000|Overall Study|Still on treatment|2|||
164205140|NCT00274456|593121168|FG001|Overall Study|Still on treatment|3|||
164205141|NCT00274456|593121169|FG002|Overall Study|Still on treatment|5|||
164205142|NCT00274456|593121170|FG003|Overall Study|Still on treatment|1|||
164205143|NCT00274456|593121167|FG000|Overall Study|Unacceptable toxicity|10|||
164205144|NCT00274456|593121168|FG001|Overall Study|Unacceptable toxicity|5|||
164205145|NCT00274456|593121169|FG002|Overall Study|Unacceptable toxicity|12|||
164205146|NCT00274456|593121170|FG003|Overall Study|Unacceptable toxicity|16|||
164205147|NCT00274456|593121167|FG000|Overall Study|Adverse Event|0|||
164205148|NCT00274456|593121168|FG001|Overall Study|Adverse Event|1|||
164205149|NCT00274456|593121169|FG002|Overall Study|Adverse Event|2|||
164205150|NCT00274456|593121170|FG003|Overall Study|Adverse Event|2|||
164205151|NCT00274456|593121167|FG000|Overall Study|Physician Decision|7|||
164205152|NCT00274456|593121168|FG001|Overall Study|Physician Decision|5|||
164205153|NCT00274456|593121169|FG002|Overall Study|Physician Decision|6|||
164205154|NCT00274456|593121170|FG003|Overall Study|Physician Decision|13|||
164205155|NCT00274456|593121167|FG000|Overall Study|Lost to Follow-up|0|||
164205156|NCT00274456|593121168|FG001|Overall Study|Lost to Follow-up|0|||
164205157|NCT00274456|593121169|FG002|Overall Study|Lost to Follow-up|1|||
164205158|NCT00274456|593121170|FG003|Overall Study|Lost to Follow-up|0|||
164205159|NCT00274456|593121167|FG000|Overall Study|Withdrawal by Subject|18|||
164205160|NCT00274456|593121168|FG001|Overall Study|Withdrawal by Subject|13|||
164205161|NCT00274456|593121169|FG002|Overall Study|Withdrawal by Subject|9|||
164205162|NCT00274456|593121170|FG003|Overall Study|Withdrawal by Subject|13|||
164205163|NCT00336544|593121175|FG000|Overall Study|Lack of Efficacy|8|||
164205164|NCT00336544|593121176|FG001|Overall Study|Lack of Efficacy|5|||
164205165|NCT00336544|593121175|FG000|Overall Study|Adverse Event|4|||
164205166|NCT00336544|593121176|FG001|Overall Study|Adverse Event|9|||
164205167|NCT00336544|593121175|FG000|Overall Study|Withdrawal by Subject|4|||
164205168|NCT00336544|593121176|FG001|Overall Study|Withdrawal by Subject|3|||
164205169|NCT00336544|593121175|FG000|Overall Study|Other|3|||
164205170|NCT00336544|593121176|FG001|Overall Study|Other|5|||
164205171|NCT00576758|593121177|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
164205172|NCT00576758|593121178|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
164205173|NCT00576758|593121177|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
164205174|NCT00576758|593121178|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
164205175|NCT00576758|593121177|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
164205176|NCT00576758|593121178|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
164205177|NCT00576758|593121177|FG000|Induction Treatment Period|Death|1|||
164205178|NCT00576758|593121178|FG001|Induction Treatment Period|Death|0|||
164205179|NCT00576758|593121177|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
164205180|NCT00576758|593121178|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
164205181|NCT00576758|593121177|FG000|Induction Treatment Period|Withdrew consent|1|||
164205182|NCT00576758|593121178|FG001|Induction Treatment Period|Withdrew consent|0|||
164205183|NCT00576758|593121177|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
164205184|NCT00576758|593121178|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
164205185|NCT00576758|593121177|FG000|Extension Treatment Period|Death|1|||
164205186|NCT00576758|593121178|FG001|Extension Treatment Period|Death|1|||
164205187|NCT00576758|593121177|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
164205188|NCT00576758|593121178|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
164205189|NCT00576758|593121177|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
164205190|NCT00576758|593121178|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
164205191|NCT00576758|593121177|FG000|Extension Treatment Period|Administrative/Other|3|||
164205192|NCT00576758|593121178|FG001|Extension Treatment Period|Administrative/Other|1|||
164205193|NCT00576758|593121177|FG000|Follow-up Period|Administrative/Other|6|||
164205194|NCT00576758|593121178|FG001|Follow-up Period|Administrative/Other|8|||
164205195|NCT00576758|593121177|FG000|Follow-up Period|Death|3|||
164205196|NCT00576758|593121178|FG001|Follow-up Period|Death|3|||
164205197|NCT00576758|593121177|FG000|Follow-up Period|Insufficient therapeutic response|16|||
164205198|NCT00576758|593121178|FG001|Follow-up Period|Insufficient therapeutic response|5|||
164205199|NCT00576758|593121177|FG000|Follow-up Period|Withdrew consent|2|||
164205200|NCT00576758|593121178|FG001|Follow-up Period|Withdrew consent|1|||
164205201|NCT03427411|593121179|FG000|Overall Study|Screen failure - platelets too low|0|||
164205202|NCT03427411|593121180|FG001|Overall Study|Screen failure - platelets too low|1|||
163977454|NCT00939783|592288779|FG000|Overall Study|Study Terminated by Sponsor|498|||
163977455|NCT00939783|592288779|FG000|Overall Study|Withdrawal by Subject|78|||
163977456|NCT00939783|592288779|FG000|Overall Study|Other|16|||
163977457|NCT00939783|592288779|FG000|Overall Study|Lost to Follow-up|8|||
164205203|NCT01712178|593121181|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
164205204|NCT01712178|593121182|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
164205205|NCT01712178|593121181|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
164205206|NCT01712178|593121182|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
164205207|NCT01712178|593121181|FG000|Overall Study|Lost to Follow-up|0|||
164205208|NCT01712178|593121182|FG001|Overall Study|Lost to Follow-up|1|||
164205209|NCT00486044|593121183|FG000|Overall Study|Withdrawal by Subject|2|||
164205210|NCT00486044|593121184|FG001|Overall Study|Withdrawal by Subject|1|||
164205211|NCT00486044|593121183|FG000|Overall Study|Adverse Event|0|||
164205212|NCT00486044|593121184|FG001|Overall Study|Adverse Event|1|||
164205213|NCT00486044|593121183|FG000|Overall Study|Lost to Follow-up|0|||
164205214|NCT00486044|593121184|FG001|Overall Study|Lost to Follow-up|1|||
164205215|NCT02701634|593121185|FG000|Overall Study|Adverse Event|2|||
164205216|NCT02701634|593121186|FG001|Overall Study|Adverse Event|3|||
164205217|NCT02701634|593121185|FG000|Overall Study|Death|1|||
164205218|NCT02701634|593121186|FG001|Overall Study|Death|0|||
164205219|NCT02701634|593121185|FG000|Overall Study|Investigator's Discretion|7|||
164205220|NCT02701634|593121186|FG001|Overall Study|Investigator's Discretion|4|||
164205221|NCT02701634|593121185|FG000|Overall Study|Study terminated by Sponsor|15|||
164205222|NCT02701634|593121186|FG001|Overall Study|Study terminated by Sponsor|17|||
164205223|NCT02701634|593121185|FG000|Overall Study|Withdrew Consent|6|||
164205224|NCT02701634|593121186|FG001|Overall Study|Withdrew Consent|7|||
164205225|NCT02701634|593121185|FG000|Overall Study|Randomized but not treated|1|||
164205226|NCT02701634|593121186|FG001|Overall Study|Randomized but not treated|0|||
164205227|NCT01206764|593121187|FG000|Overall Study|Adverse Event|20|||
164205228|NCT01206764|593121187|FG000|Overall Study|Abnormal laboratory value|2|||
164205229|NCT01206764|593121187|FG000|Overall Study|Abnormal test procedure result|1|||
164205230|NCT01206764|593121187|FG000|Overall Study|Patient withdrew consent|5|||
164205231|NCT01206764|593121187|FG000|Overall Study|Lost to Follow-up|6|||
164205232|NCT01206764|593121187|FG000|Overall Study|Death|11|||
164205233|NCT01206764|593121187|FG000|Overall Study|New cancer therapy|2|||
164205234|NCT01206764|593121187|FG000|Overall Study|Disease progression|88|||
164205235|NCT01206764|593121187|FG000|Overall Study|Protocol deviation|3|||
164205236|NCT04494646|593121188|FG000|Overall Study|Adverse Event|0|||
164205237|NCT04494646|593121189|FG001|Overall Study|Adverse Event|1|||
164205238|NCT04494646|593121188|FG000|Overall Study|Withdrawal by Subject|0|||
164205239|NCT04494646|593121189|FG001|Overall Study|Withdrawal by Subject|1|||
164205240|NCT00537277|593121190|FG000|Overall Study|Adverse Event|1|||
164205241|NCT00537277|593121190|FG000|Overall Study|Lack of Efficacy|2|||
164205242|NCT00537277|593121190|FG000|Overall Study|Lost to Follow-up|12|||
164205243|NCT00537277|593121190|FG000|Overall Study|Protocol Violation|11|||
164205244|NCT00537277|593121190|FG000|Overall Study|Unclassified|4|||
164205245|NCT00537277|593121190|FG000|Overall Study|Inability to tolerate trial medication|4|||
164205246|NCT00537277|593121190|FG000|Overall Study|Non-compliance with trial procedures|15|||
164205247|NCT05282823|593121191|FG000|Overall Study|Withdrawal by Subject|9|||
164205248|NCT05282823|593121191|FG000|Overall Study|Adverse Event|1|||
164205249|NCT05282823|593121191|FG000|Overall Study|did not meet protocol criteria|2|||
164205250|NCT05282823|593121191|FG000|Overall Study|Withdrawal by Subject|7|||
164205251|NCT00997893|593121192|FG000|Overall Study|Adverse Event|1|||
164205252|NCT00997893|593121193|FG001|Overall Study|Adverse Event|0|||
164205253|NCT00997893|593121194|FG002|Overall Study|Adverse Event|0|||
164205254|NCT00997893|593121192|FG000|Overall Study|Unable to meet study timelines|1|||
164205255|NCT00997893|593121193|FG001|Overall Study|Unable to meet study timelines|0|||
164205256|NCT00997893|593121194|FG002|Overall Study|Unable to meet study timelines|0|||
164205257|NCT00997893|593121192|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
164205258|NCT00997893|593121193|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
164205259|NCT00997893|593121194|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
164205260|NCT03620162|593121195|FG000|Overall Study|Physician Decision|4|||
164205261|NCT03620162|593121196|FG001|Overall Study|Physician Decision|0|||
164205262|NCT03620162|593121197|FG002|Overall Study|Physician Decision|1|||
164205263|NCT03620162|593121198|FG003|Overall Study|Physician Decision|0|||
164205264|NCT03620162|593121199|FG004|Overall Study|Physician Decision|2|||
164205265|NCT03620162|593121195|FG000|Overall Study|Lost to Follow-up|2|||
164205266|NCT03620162|593121196|FG001|Overall Study|Lost to Follow-up|6|||
164205267|NCT03620162|593121197|FG002|Overall Study|Lost to Follow-up|7|||
164205268|NCT03620162|593121198|FG003|Overall Study|Lost to Follow-up|3|||
164205269|NCT03620162|593121199|FG004|Overall Study|Lost to Follow-up|2|||
163977458|NCT00939783|592288779|FG000|Overall Study|Protocol Violation|3|||
164205270|NCT03620162|593121195|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
164205271|NCT03620162|593121196|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
164205272|NCT03620162|593121197|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
164205273|NCT03620162|593121198|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
164316627|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316628|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316629|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316630|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316631|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316632|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316633|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
164316634|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
164316635|NCT01185353|593535629|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316636|NCT01185353|593535630|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316637|NCT01185353|593535631|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316638|NCT01185353|593535632|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316639|NCT01185353|593535633|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316640|NCT01185353|593535634|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316641|NCT01185353|593535635|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316642|NCT01185353|593535636|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316643|NCT01185353|593535637|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
164316644|NCT01185353|593535638|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
164316645|NCT01185353|593535629|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316646|NCT01185353|593535630|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316647|NCT01185353|593535631|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316648|NCT01185353|593535632|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316649|NCT01185353|593535633|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316650|NCT01185353|593535634|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316651|NCT01185353|593535635|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316652|NCT01185353|593535636|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
164316653|NCT01185353|593535637|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
164316654|NCT01185353|593535638|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
164316655|NCT01185353|593535629|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316656|NCT01185353|593535630|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316657|NCT01185353|593535631|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316658|NCT01185353|593535632|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316659|NCT01185353|593535633|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316660|NCT01185353|593535634|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316661|NCT01185353|593535635|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
164316662|NCT01185353|593535636|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
164316663|NCT01185353|593535637|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
164316664|NCT01185353|593535638|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
164316665|NCT01185353|593535629|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316666|NCT01185353|593535630|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316667|NCT01185353|593535631|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316668|NCT01185353|593535632|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316669|NCT01185353|593535633|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316670|NCT01185353|593535634|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316671|NCT01185353|593535635|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316672|NCT01185353|593535636|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
164316673|NCT01185353|593535637|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
164316674|NCT01185353|593535638|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
164316675|NCT01030666|593535639|FG000|Overall Study|Lost to Follow-up|3|||
164316676|NCT01030666|593535640|FG001|Overall Study|Lost to Follow-up|2|||
164316677|NCT01144299|593535643|FG000|Overall Study|Lost to Follow-up|1|||
164316678|NCT01144299|593535644|FG001|Overall Study|Lost to Follow-up|0|||
164316679|NCT01144299|593535643|FG000|Overall Study|Withdrawal by Subject|1|||
164316680|NCT01144299|593535644|FG001|Overall Study|Withdrawal by Subject|0|||
164316681|NCT00334113|593535647|FG000|Overall Study|Lost to Follow-up|2|||
164316682|NCT00334113|593535648|FG001|Overall Study|Lost to Follow-up|2|||
164316683|NCT00334113|593535647|FG000|Overall Study|Withdrawal by Subject|0|||
164316684|NCT00334113|593535648|FG001|Overall Study|Withdrawal by Subject|1|||
164316685|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
164316686|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
164316687|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
164316688|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
164316689|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Other|2|||
164316690|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
164316691|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
164316692|NCT02509026|593535651|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
164316693|NCT02509026|593535651|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
164316694|NCT02509026|593535651|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
164316695|NCT02509026|593535651|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
164316696|NCT02509026|593535651|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
164316697|NCT02509026|593535651|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
164316698|NCT04303195|593535652|FG000|Overall Study|Adverse Event|1|||
164316699|NCT04303195|593535653|FG001|Overall Study|Adverse Event|3|||
164316700|NCT04303195|593535654|FG002|Overall Study|Adverse Event|7|||
164316701|NCT04303195|593535655|FG003|Overall Study|Adverse Event|0|||
164316702|NCT04303195|593535652|FG000|Overall Study|Lost to Follow-up|1|||
164316703|NCT04303195|593535653|FG001|Overall Study|Lost to Follow-up|0|||
164316704|NCT04303195|593535654|FG002|Overall Study|Lost to Follow-up|1|||
164316705|NCT04303195|593535655|FG003|Overall Study|Lost to Follow-up|4|||
164316706|NCT04303195|593535652|FG000|Overall Study|Withdrawal by Subject|3|||
164316707|NCT04303195|593535653|FG001|Overall Study|Withdrawal by Subject|1|||
164316708|NCT04303195|593535654|FG002|Overall Study|Withdrawal by Subject|1|||
164316709|NCT04303195|593535655|FG003|Overall Study|Withdrawal by Subject|1|||
164316710|NCT04303195|593535652|FG000|Overall Study|No study drug administered or protocol deviation|0|||
164316711|NCT04303195|593535653|FG001|Overall Study|No study drug administered or protocol deviation|2|||
164316712|NCT04303195|593535654|FG002|Overall Study|No study drug administered or protocol deviation|0|||
164316713|NCT04303195|593535655|FG003|Overall Study|No study drug administered or protocol deviation|2|||
164316714|NCT01808092|593535657|FG000|Overall Study|Death|39|||
164316715|NCT01808092|593535658|FG001|Overall Study|Death|29|||
164316716|NCT01808092|593535657|FG000|Overall Study|Lost to Follow-up|3|||
164316717|NCT01808092|593535658|FG001|Overall Study|Lost to Follow-up|7|||
164316718|NCT01808092|593535657|FG000|Overall Study|Withdrawal by Subject|9|||
164316719|NCT01808092|593535658|FG001|Overall Study|Withdrawal by Subject|4|||
164316720|NCT01808092|593535657|FG000|Overall Study|Other Eligibility criteria|3|||
164316721|NCT01808092|593535658|FG001|Overall Study|Other Eligibility criteria|5|||
164316722|NCT01097005|593535661|FG000|Overall Study|Case Report Form not collected|18|||
164316723|NCT01097005|593535661|FG000|Overall Study|Subjects cannot visit the hospital|1|||
164316724|NCT01097005|593535661|FG000|Overall Study|Poor medication compliance|1|||
164316725|NCT01097005|593535661|FG000|Overall Study|No examination data available|244|||
164316726|NCT01097005|593535661|FG000|Overall Study|Deviation from exclusion criteria|37|||
164316727|NCT01097005|593535661|FG000|Overall Study|Adverse Event|14|||
164316728|NCT01097005|593535661|FG000|Overall Study|Discontinuance by complication|50|||
164316729|NCT03425253|593535662|FG000|Overall Study|Adverse Event|2|||
164316730|NCT03425253|593535662|FG000|Overall Study|Lost to Follow-up|3|||
164316731|NCT03425253|593535662|FG000|Overall Study|Withdrew Consent|6|||
164316732|NCT03425253|593535662|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
164316733|NCT04174365|593535663|FG000|Overall Study|Lost to Follow-up|1|||
164316734|NCT04174365|593535664|FG001|Overall Study|Lost to Follow-up|2|||
164316735|NCT04174365|593535663|FG000|Overall Study|Adverse Event|2|||
164316736|NCT04174365|593535664|FG001|Overall Study|Adverse Event|1|||
164316737|NCT04174365|593535663|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
164316738|NCT04174365|593535664|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
164316739|NCT04174365|593535663|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
164316740|NCT04174365|593535664|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
164316741|NCT04174365|593535663|FG000|Overall Study|Protocol Deviation|1|||
164316742|NCT04174365|593535664|FG001|Overall Study|Protocol Deviation|0|||
164316743|NCT04174365|593535663|FG000|Overall Study|Lack of Efficacy|0|||
164316744|NCT04174365|593535664|FG001|Overall Study|Lack of Efficacy|2|||
164316745|NCT04174365|593535663|FG000|Overall Study|Disease Relapse|1|||
164316746|NCT04174365|593535664|FG001|Overall Study|Disease Relapse|0|||
164316747|NCT04174365|593535663|FG000|Overall Study|Reason Not Specified|0|||
164316748|NCT04174365|593535664|FG001|Overall Study|Reason Not Specified|1|||
164316749|NCT03472547|593535665|FG000|Overall Study|Withdrawal by Subject|30|||
164316750|NCT05141448|593535666|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316751|NCT05141448|593535667|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
164316752|NCT05141448|593535668|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316753|NCT05141448|593535669|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316754|NCT05141448|593535670|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316755|NCT05141448|593535671|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164316756|NCT05141448|593535666|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316757|NCT05141448|593535667|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316758|NCT05141448|593535668|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316759|NCT05141448|593535669|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316760|NCT05141448|593535670|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
164316761|NCT05141448|593535671|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164316762|NCT05141448|593535666|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316763|NCT05141448|593535667|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
164316764|NCT05141448|593535668|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316765|NCT05141448|593535669|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316766|NCT05141448|593535670|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164316767|NCT05141448|593535671|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
163873301|NCT02723955|591906871|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873302|NCT02723955|591906872|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873303|NCT02723955|591906873|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873304|NCT02723955|591906874|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873305|NCT02723955|591906875|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
163873306|NCT02723955|591906833|FG000|Escalation Phase|Site Closed|0|||
163873307|NCT02723955|591906834|FG001|Escalation Phase|Site Closed|0|||
163873308|NCT02723955|591906835|FG002|Escalation Phase|Site Closed|0|||
163873309|NCT02723955|591906836|FG003|Escalation Phase|Site Closed|0|||
163873310|NCT02723955|591906837|FG004|Escalation Phase|Site Closed|0|||
163873311|NCT02723955|591906838|FG005|Escalation Phase|Site Closed|0|||
163873312|NCT02723955|591906839|FG006|Escalation Phase|Site Closed|0|||
163977459|NCT00939783|592288779|FG000|Overall Study|Enrolled but not treated|1|||
164205274|NCT03620162|593121199|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
164205275|NCT00112957|593121202|FG000|Overall Study|Progressive disease|18|||
164205276|NCT00112957|593121202|FG000|Overall Study|Physician Decision|1|||
164205277|NCT05352815|593121205|FG000|Overall Study|Withdrawal by Subject|28|||
164205278|NCT05352815|593121206|FG001|Overall Study|Withdrawal by Subject|24|||
164205279|NCT05352815|593121205|FG000|Overall Study|Lost to Follow-up|4|||
164205280|NCT05352815|593121206|FG001|Overall Study|Lost to Follow-up|7|||
164205281|NCT05352815|593121205|FG000|Overall Study|Death|2|||
164205282|NCT05352815|593121206|FG001|Overall Study|Death|3|||
164205283|NCT05352815|593121205|FG000|Overall Study|Site closure|1|||
164205284|NCT05352815|593121206|FG001|Overall Study|Site closure|0|||
164205285|NCT00961415|593121209|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
164205286|NCT00961415|593121210|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
164205287|NCT00961415|593121211|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
164205288|NCT00961415|593121209|FG000|Induction Treatment Phase|Death|77|||
164205289|NCT00961415|593121210|FG001|Induction Treatment Phase|Death|0|||
164205290|NCT00961415|593121211|FG002|Induction Treatment Phase|Death|0|||
164205291|NCT00961415|593121209|FG000|Induction Treatment Phase|Protocol Violation|1|||
164205292|NCT00961415|593121210|FG001|Induction Treatment Phase|Protocol Violation|0|||
164205293|NCT00961415|593121211|FG002|Induction Treatment Phase|Protocol Violation|0|||
164205294|NCT00961415|593121209|FG000|Induction Treatment Phase|Physician Decision|2|||
164205295|NCT00961415|593121210|FG001|Induction Treatment Phase|Physician Decision|0|||
164205296|NCT00961415|593121211|FG002|Induction Treatment Phase|Physician Decision|0|||
164205297|NCT00961415|593121209|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
164205298|NCT00961415|593121210|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
164205299|NCT00961415|593121211|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
164205300|NCT00961415|593121209|FG000|Induction Treatment Phase|Other Reason|5|||
164205301|NCT00961415|593121210|FG001|Induction Treatment Phase|Other Reason|0|||
164205302|NCT00961415|593121211|FG002|Induction Treatment Phase|Other Reason|0|||
164205303|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Death|0|||
164205304|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Death|42|||
164205305|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Death|34|||
164205306|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Investigators decision|0|||
164205307|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Investigators decision|2|||
164205308|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Investigators decision|0|||
164205309|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164205310|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
164205311|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
164205312|NCT00961415|593121209|FG000|Maintenance Treatment Phase|Other reason|0|||
164205313|NCT00961415|593121210|FG001|Maintenance Treatment Phase|Other reason|1|||
164205314|NCT00961415|593121211|FG002|Maintenance Treatment Phase|Other reason|3|||
164205315|NCT00226655|593121212|FG000|Overall Study|Death|13|||
164205316|NCT00226655|593121212|FG000|Overall Study|Withdrawal by Subject|15|||
164205317|NCT00226655|593121212|FG000|Overall Study|Adverse Event|35|||
164205318|NCT00226655|593121212|FG000|Overall Study|Physician Decision|6|||
164205319|NCT00226655|593121212|FG000|Overall Study|Clinical deterioration|10|||
164205320|NCT02309359|593121213|FG000|Overall Study|Adverse Event|4|||
164205321|NCT02309359|593121214|FG001|Overall Study|Adverse Event|5|||
164205322|NCT02309359|593121215|FG002|Overall Study|Adverse Event|5|||
164205323|NCT02309359|593121216|FG003|Overall Study|Adverse Event|4|||
164205324|NCT02309359|593121217|FG004|Overall Study|Adverse Event|4|||
164205325|NCT02309359|593121213|FG000|Overall Study|Death|1|||
164205326|NCT02309359|593121214|FG001|Overall Study|Death|0|||
164205327|NCT02309359|593121215|FG002|Overall Study|Death|0|||
163977460|NCT04839380|592288780|FG000|Overall Study|Withdrawal by Subject|2|||
164205328|NCT02309359|593121216|FG003|Overall Study|Death|0|||
164205329|NCT02309359|593121217|FG004|Overall Study|Death|0|||
164205330|NCT02309359|593121213|FG000|Overall Study|Withdrawal by Subject|2|||
164205331|NCT02309359|593121214|FG001|Overall Study|Withdrawal by Subject|2|||
164205332|NCT02309359|593121215|FG002|Overall Study|Withdrawal by Subject|4|||
164205333|NCT02309359|593121216|FG003|Overall Study|Withdrawal by Subject|4|||
163977461|NCT04839380|592288780|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
163977462|NCT01549002|592288784|FG000|Overall Study|Excessive pain|0|||
164205334|NCT02309359|593121217|FG004|Overall Study|Withdrawal by Subject|0|||
164205335|NCT02309359|593121213|FG000|Overall Study|Lack of Efficacy|3|||
164205336|NCT02309359|593121214|FG001|Overall Study|Lack of Efficacy|1|||
164205337|NCT02309359|593121215|FG002|Overall Study|Lack of Efficacy|0|||
164205338|NCT02309359|593121216|FG003|Overall Study|Lack of Efficacy|0|||
164205339|NCT02309359|593121217|FG004|Overall Study|Lack of Efficacy|3|||
164205340|NCT02309359|593121213|FG000|Overall Study|Lost to Follow-up|0|||
164205341|NCT02309359|593121214|FG001|Overall Study|Lost to Follow-up|0|||
164205342|NCT02309359|593121215|FG002|Overall Study|Lost to Follow-up|0|||
164205343|NCT02309359|593121216|FG003|Overall Study|Lost to Follow-up|1|||
164205344|NCT02309359|593121217|FG004|Overall Study|Lost to Follow-up|0|||
164205345|NCT02309359|593121213|FG000|Overall Study|Other|2|||
164205346|NCT02309359|593121214|FG001|Overall Study|Other|0|||
164205347|NCT02309359|593121215|FG002|Overall Study|Other|2|||
164205348|NCT02309359|593121216|FG003|Overall Study|Other|3|||
164205349|NCT02309359|593121217|FG004|Overall Study|Other|2|||
164205350|NCT05144945|593121219|FG000|Overall Study|Withdrawal by Subject|1|||
164205351|NCT05144945|593121220|FG001|Overall Study|Withdrawal by Subject|0|||
164205352|NCT06129149|593121222|FG000|Overall Study|Death|1|||
164205353|NCT01704261|593121223|FG000|Overall Study|Withdrawal by Subject|12|||
164205354|NCT01704261|593121224|FG001|Overall Study|Withdrawal by Subject|15|||
164205355|NCT01704261|593121223|FG000|Overall Study|Lost to Follow-up|1|||
164205356|NCT01704261|593121224|FG001|Overall Study|Lost to Follow-up|0|||
164205357|NCT02391337|593121225|FG000|6 Months Follow-up|Death|5|||
164205358|NCT02391337|593121226|FG001|6 Months Follow-up|Death|4|||
164205359|NCT02391337|593121225|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
164205360|NCT02391337|593121226|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
164205361|NCT02391337|593121225|FG000|12 Months Follow-up|Death|2|||
164205362|NCT02391337|593121226|FG001|12 Months Follow-up|Death|0|||
164205363|NCT02391337|593121225|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
164205364|NCT02391337|593121226|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
164205365|NCT02391337|593121225|FG000|12 Months Follow-up|Lost to Follow-up|0|||
164205366|NCT02391337|593121226|FG001|12 Months Follow-up|Lost to Follow-up|2|||
164205367|NCT00726609|593121228|FG000|Overall Study|Adverse Event|10|||
164205368|NCT00726609|593121228|FG000|Overall Study|Withdrawal by Subject|2|||
164205369|NCT00726609|593121228|FG000|Overall Study|Lack of Efficacy|25|||
164205370|NCT00726609|593121228|FG000|Overall Study|Other|16|||
164205371|NCT00726609|593121228|FG000|Overall Study|Missing|42|||
164205372|NCT00726609|593121228|FG000|Overall Study|Other|3|||
164205373|NCT00746551|593121232|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
164205374|NCT00746551|593121233|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
164205375|NCT00746551|593121232|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
164205376|NCT00746551|593121233|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
164205377|NCT00746551|593121232|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
164205378|NCT00746551|593121233|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
164205379|NCT00465179|593121237|FG000|Overall Study|Adverse Event|4|||
164205380|NCT00465179|593121237|FG000|Overall Study|Withdrawal by Subject|2|||
164205381|NCT00465179|593121237|FG000|Overall Study|Progression of Disease|47|||
164205382|NCT02867592|593121241|FG000|Overall Study|Adverse Event|3|||
164205383|NCT02867592|593121242|FG001|Overall Study|Adverse Event|0|||
164205384|NCT02867592|593121243|FG002|Overall Study|Adverse Event|2|||
164205385|NCT02867592|593121244|FG003|Overall Study|Adverse Event|1|||
164205386|NCT02867592|593121245|FG004|Overall Study|Adverse Event|1|||
164205387|NCT02867592|593121246|FG005|Overall Study|Adverse Event|5|||
164205388|NCT02867592|593121241|FG000|Overall Study|Death|0|||
164205389|NCT02867592|593121242|FG001|Overall Study|Death|0|||
164205390|NCT02867592|593121243|FG002|Overall Study|Death|0|||
164205391|NCT02867592|593121244|FG003|Overall Study|Death|1|||
164205392|NCT02867592|593121245|FG004|Overall Study|Death|0|||
164205393|NCT02867592|593121246|FG005|Overall Study|Death|1|||
164205394|NCT02867592|593121241|FG000|Overall Study|Lack of Efficacy|8|||
164205395|NCT02867592|593121242|FG001|Overall Study|Lack of Efficacy|10|||
164205396|NCT02867592|593121243|FG002|Overall Study|Lack of Efficacy|8|||
164205397|NCT02867592|593121244|FG003|Overall Study|Lack of Efficacy|8|||
164205398|NCT02867592|593121245|FG004|Overall Study|Lack of Efficacy|12|||
164205399|NCT02867592|593121246|FG005|Overall Study|Lack of Efficacy|17|||
163977463|NCT01549002|592288785|FG001|Overall Study|Excessive pain|2|||
164205400|NCT02867592|593121241|FG000|Overall Study|Physician Decision|1|||
164205401|NCT02867592|593121242|FG001|Overall Study|Physician Decision|2|||
164205402|NCT02867592|593121243|FG002|Overall Study|Physician Decision|2|||
164205403|NCT02867592|593121244|FG003|Overall Study|Physician Decision|0|||
164205404|NCT02867592|593121245|FG004|Overall Study|Physician Decision|5|||
164205405|NCT02867592|593121246|FG005|Overall Study|Physician Decision|1|||
164205406|NCT02867592|593121241|FG000|Overall Study|Protocol Violation|0|||
164205407|NCT02867592|593121242|FG001|Overall Study|Protocol Violation|0|||
164205408|NCT02867592|593121243|FG002|Overall Study|Protocol Violation|0|||
164205409|NCT02867592|593121244|FG003|Overall Study|Protocol Violation|0|||
164205410|NCT02867592|593121245|FG004|Overall Study|Protocol Violation|1|||
164316768|NCT05141448|593535666|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316769|NCT05141448|593535667|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316770|NCT05141448|593535668|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316771|NCT05141448|593535669|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316772|NCT05141448|593535670|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164316773|NCT05141448|593535671|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
164316774|NCT05141448|593535666|FG000|Period 2|COVID-19 Related|0|||
164316775|NCT05141448|593535667|FG001|Period 2|COVID-19 Related|0|||
164316776|NCT05141448|593535668|FG002|Period 2|COVID-19 Related|0|||
164316777|NCT05141448|593535669|FG003|Period 2|COVID-19 Related|1|||
164316778|NCT05141448|593535670|FG004|Period 2|COVID-19 Related|0|||
164316779|NCT05141448|593535671|FG005|Period 2|COVID-19 Related|1|||
164316780|NCT05141448|593535666|FG000|3|Covid-19 related|2|||
164316781|NCT05141448|593535667|FG001|3|Covid-19 related|0|||
164316782|NCT05141448|593535668|FG002|3|Covid-19 related|0|||
164316783|NCT05141448|593535669|FG003|3|Covid-19 related|0|||
164316784|NCT05141448|593535670|FG004|3|Covid-19 related|0|||
164316785|NCT05141448|593535671|FG005|3|Covid-19 related|1|||
164316786|NCT05141448|593535666|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
164316787|NCT05141448|593535667|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
164316788|NCT05141448|593535668|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
164316789|NCT05141448|593535669|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
164316790|NCT05141448|593535670|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
164316791|NCT05141448|593535671|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
164316792|NCT04627285|593535672|FG000|Overall Study|Adverse Event|0|||
164316793|NCT04627285|593535673|FG001|Overall Study|Adverse Event|2|||
164316794|NCT04627285|593535672|FG000|Overall Study|Lost to Follow-up|1|||
164316795|NCT04627285|593535673|FG001|Overall Study|Lost to Follow-up|0|||
164316796|NCT04627285|593535672|FG000|Overall Study|Withdrawal by Subject|1|||
164316797|NCT04627285|593535673|FG001|Overall Study|Withdrawal by Subject|1|||
164316798|NCT04627285|593535672|FG000|Overall Study|Sponsor decision|5|||
164316799|NCT04627285|593535673|FG001|Overall Study|Sponsor decision|0|||
164316800|NCT04627285|593535672|FG000|Overall Study|Participant left country; aunt informed the site|0|||
164316801|NCT04627285|593535673|FG001|Overall Study|Participant left country; aunt informed the site|1|||
164316802|NCT02907892|593537711|FG000|Overall Study|Lost to Follow-up|27|||
164316803|NCT02907892|593537712|FG001|Overall Study|Lost to Follow-up|40|||
164316804|NCT01347580|593537713|FG000|Overall Study|Withdrawal by Subject|13|||
164316805|NCT01347580|593537714|FG001|Overall Study|Withdrawal by Subject|23|||
164316806|NCT01347580|593537713|FG000|Overall Study|Death|30|||
164316807|NCT01347580|593537714|FG001|Overall Study|Death|19|||
164316808|NCT01347580|593537713|FG000|Overall Study|Protocol Violation|10|||
164316809|NCT01347580|593537714|FG001|Overall Study|Protocol Violation|7|||
164316810|NCT01347580|593537713|FG000|Overall Study|Lost to Follow-up|3|||
164316811|NCT01347580|593537714|FG001|Overall Study|Lost to Follow-up|1|||
164316812|NCT01347580|593537713|FG000|Overall Study|Had other reason|9|||
164316813|NCT01347580|593537714|FG001|Overall Study|Had other reason|6|||
164316814|NCT01964755|593537715|FG000|Overall Study|Death|2|||
164316815|NCT00412373|593537718|FG000|Overall Study|Adverse Event|8|||
164316816|NCT00412373|593537719|FG001|Overall Study|Adverse Event|13|||
164316817|NCT00412373|593537718|FG000|Overall Study|Lack of Efficacy|16|||
164316818|NCT00412373|593537719|FG001|Overall Study|Lack of Efficacy|22|||
164316819|NCT00412373|593537718|FG000|Overall Study|Lost to Follow-up|7|||
164316820|NCT00412373|593537719|FG001|Overall Study|Lost to Follow-up|13|||
164316821|NCT00412373|593537718|FG000|Overall Study|Withdrawal by Subject|8|||
164316822|NCT00412373|593537719|FG001|Overall Study|Withdrawal by Subject|27|||
164316823|NCT00412373|593537718|FG000|Overall Study|Other|2|||
164316824|NCT00412373|593537719|FG001|Overall Study|Other|2|||
164316825|NCT00422513|593537720|FG000|Overall Study|Lack of Efficacy|4|||
164316826|NCT00422513|593537721|FG001|Overall Study|Lack of Efficacy|5|||
164316827|NCT00422513|593537720|FG000|Overall Study|Protocol Violation|23|||
164316828|NCT00422513|593537721|FG001|Overall Study|Protocol Violation|7|||
164316829|NCT00422513|593537720|FG000|Overall Study|Refused Treatment|4|||
164316830|NCT00422513|593537721|FG001|Overall Study|Refused Treatment|2|||
164316831|NCT00422513|593537720|FG000|Overall Study|Withdrawal by Subject|2|||
164316832|NCT00422513|593537721|FG001|Overall Study|Withdrawal by Subject|1|||
164316833|NCT00422513|593537720|FG000|Overall Study|early termination of the study|67|||
164316834|NCT00422513|593537721|FG001|Overall Study|early termination of the study|80|||
164316835|NCT00422513|593537720|FG000|Overall Study|Adverse Event|4|||
164316836|NCT00422513|593537721|FG001|Overall Study|Adverse Event|4|||
164316837|NCT00422513|593537720|FG000|Overall Study|Death|3|||
164316838|NCT00422513|593537721|FG001|Overall Study|Death|7|||
164316839|NCT01478048|593537722|FG000|Overall Study|Disease Progression|52|||
164316840|NCT01478048|593537723|FG001|Overall Study|Disease Progression|35|||
164316841|NCT01478048|593537722|FG000|Overall Study|study drug toxicity|11|||
164316842|NCT01478048|593537723|FG001|Overall Study|study drug toxicity|14|||
164316843|NCT01478048|593537722|FG000|Overall Study|Adverse Event|2|||
164316844|NCT01478048|593537723|FG001|Overall Study|Adverse Event|11|||
163873313|NCT02723955|591906840|FG007|Escalation Phase|Site Closed|0|||
163873314|NCT02723955|591906841|FG008|Escalation Phase|Site Closed|0|||
163873315|NCT02723955|591906842|FG009|Escalation Phase|Site Closed|0|||
164205411|NCT02867592|593121246|FG005|Overall Study|Protocol Violation|1|||
164205412|NCT02867592|593121241|FG000|Overall Study|Withdrawal by Subject|0|||
164205413|NCT02867592|593121242|FG001|Overall Study|Withdrawal by Subject|1|||
164205414|NCT02867592|593121243|FG002|Overall Study|Withdrawal by Subject|0|||
164205415|NCT02867592|593121244|FG003|Overall Study|Withdrawal by Subject|1|||
164205416|NCT02867592|593121245|FG004|Overall Study|Withdrawal by Subject|3|||
164205417|NCT02867592|593121246|FG005|Overall Study|Withdrawal by Subject|3|||
164205418|NCT02867592|593121241|FG000|Overall Study|Ineligible|1|||
164205419|NCT02867592|593121242|FG001|Overall Study|Ineligible|1|||
164205420|NCT02867592|593121243|FG002|Overall Study|Ineligible|0|||
164205421|NCT02867592|593121244|FG003|Overall Study|Ineligible|0|||
164205422|NCT02867592|593121245|FG004|Overall Study|Ineligible|2|||
164205423|NCT02867592|593121246|FG005|Overall Study|Ineligible|0|||
164205424|NCT02867592|593121241|FG000|Overall Study|No Treatment|1|||
164205425|NCT02867592|593121242|FG001|Overall Study|No Treatment|0|||
164205426|NCT02867592|593121243|FG002|Overall Study|No Treatment|0|||
164205427|NCT02867592|593121244|FG003|Overall Study|No Treatment|0|||
164205428|NCT02867592|593121245|FG004|Overall Study|No Treatment|0|||
164205429|NCT02867592|593121246|FG005|Overall Study|No Treatment|0|||
164205430|NCT02867592|593121241|FG000|Overall Study|Still on Therapy|0|||
164205431|NCT02867592|593121242|FG001|Overall Study|Still on Therapy|0|||
164205432|NCT02867592|593121243|FG002|Overall Study|Still on Therapy|0|||
164205433|NCT02867592|593121244|FG003|Overall Study|Still on Therapy|0|||
164205434|NCT02867592|593121245|FG004|Overall Study|Still on Therapy|1|||
164205435|NCT02867592|593121246|FG005|Overall Study|Still on Therapy|0|||
164205436|NCT02867592|593121241|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205437|NCT02867592|593121242|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205438|NCT02867592|593121243|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205439|NCT02867592|593121244|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205440|NCT02867592|593121245|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
164205441|NCT02867592|593121246|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
164205442|NCT02867592|593121241|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
164205443|NCT02867592|593121242|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
164205444|NCT02867592|593121243|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
164205445|NCT02867592|593121244|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
164205446|NCT02867592|593121245|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
164205447|NCT02867592|593121246|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
164205448|NCT00909870|593121247|FG000|Overall Study|Adverse Event|13|||
164205449|NCT00909870|593121248|FG001|Overall Study|Adverse Event|7|||
164205450|NCT00909870|593121247|FG000|Overall Study|Protocol Violation|1|||
164205451|NCT00909870|593121248|FG001|Overall Study|Protocol Violation|2|||
164205452|NCT00909870|593121247|FG000|Overall Study|Withdrawal by Subject|5|||
164205453|NCT00909870|593121248|FG001|Overall Study|Withdrawal by Subject|8|||
164205454|NCT00909870|593121247|FG000|Overall Study|Lost to Follow-up|3|||
164205455|NCT00909870|593121248|FG001|Overall Study|Lost to Follow-up|3|||
164205456|NCT00909870|593121247|FG000|Overall Study|Physician Decision|0|||
164205457|NCT00909870|593121248|FG001|Overall Study|Physician Decision|2|||
164205458|NCT00909870|593121247|FG000|Overall Study|Other|1|||
164205459|NCT00909870|593121248|FG001|Overall Study|Other|5|||
164205460|NCT01420536|593121257|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
164205461|NCT01420536|593121258|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
164205462|NCT04711005|593121261|FG000|Overall Study|Withdrawal by Subject|0|||
164205463|NCT04711005|593121262|FG001|Overall Study|Withdrawal by Subject|0|||
164205464|NCT04711005|593121263|FG002|Overall Study|Withdrawal by Subject|0|||
164205465|NCT04711005|593121264|FG003|Overall Study|Withdrawal by Subject|0|||
164205466|NCT04711005|593121265|FG004|Overall Study|Withdrawal by Subject|0|||
164205467|NCT04711005|593121266|FG005|Overall Study|Withdrawal by Subject|0|||
164205468|NCT04711005|593121267|FG006|Overall Study|Withdrawal by Subject|0|||
164205469|NCT04711005|593121268|FG007|Overall Study|Withdrawal by Subject|1|||
164205470|NCT04711005|593121269|FG008|Overall Study|Withdrawal by Subject|0|||
164205471|NCT04711005|593121270|FG009|Overall Study|Withdrawal by Subject|0|||
164205472|NCT04711005|593121261|FG000|Overall Study|Physician Decision|0|||
164205473|NCT04711005|593121262|FG001|Overall Study|Physician Decision|0|||
164205474|NCT04711005|593121263|FG002|Overall Study|Physician Decision|0|||
164205475|NCT04711005|593121264|FG003|Overall Study|Physician Decision|0|||
164205476|NCT04711005|593121265|FG004|Overall Study|Physician Decision|0|||
164205477|NCT04711005|593121266|FG005|Overall Study|Physician Decision|0|||
164205478|NCT04711005|593121267|FG006|Overall Study|Physician Decision|0|||
163873316|NCT02723955|591906843|FG010|Escalation Phase|Site Closed|0|||
164316845|NCT01478048|593537722|FG000|Overall Study|subject request to discontinue treatment|3|||
164316846|NCT01478048|593537723|FG001|Overall Study|subject request to discontinue treatment|5|||
164316847|NCT01478048|593537722|FG000|Overall Study|Withdrawal by Subject|2|||
164316848|NCT01478048|593537723|FG001|Overall Study|Withdrawal by Subject|5|||
164316849|NCT01478048|593537722|FG000|Overall Study|non-specified|6|||
164316850|NCT01478048|593537723|FG001|Overall Study|non-specified|4|||
164316851|NCT01478048|593537722|FG000|Overall Study|poor/non-compliance|0|||
164316852|NCT01478048|593537723|FG001|Overall Study|poor/non-compliance|1|||
164316853|NCT01478048|593537722|FG000|Overall Study|no longer meets study criteria|1|||
164316854|NCT01478048|593537723|FG001|Overall Study|no longer meets study criteria|0|||
164316855|NCT01369329|593537725|FG000|Overall Study|Withdrawal by Subject|8|||
164316856|NCT01369329|593537726|FG001|Overall Study|Withdrawal by Subject|6|||
164316857|NCT01369329|593537727|FG002|Overall Study|Withdrawal by Subject|10|||
164316858|NCT01369329|593537725|FG000|Overall Study|Lost to Follow-up|2|||
164316859|NCT01369329|593537726|FG001|Overall Study|Lost to Follow-up|2|||
164316860|NCT01369329|593537727|FG002|Overall Study|Lost to Follow-up|2|||
164316861|NCT01369329|593537725|FG000|Overall Study|Other|2|||
164316862|NCT01369329|593537726|FG001|Overall Study|Other|3|||
164316863|NCT01369329|593537727|FG002|Overall Study|Other|2|||
164316864|NCT03032380|593537728|FG000|Overall Study|Adverse Event|0|||
164316865|NCT03032380|593537729|FG001|Overall Study|Adverse Event|1|||
164316866|NCT03032380|593537728|FG000|Overall Study|Lack of Efficacy|1|||
164316867|NCT03032380|593537729|FG001|Overall Study|Lack of Efficacy|0|||
164316868|NCT03032380|593537728|FG000|Overall Study|Withdrawal by Subject|2|||
164316869|NCT03032380|593537729|FG001|Overall Study|Withdrawal by Subject|3|||
164316870|NCT03032380|593537728|FG000|Overall Study|Recovery|0|||
164316871|NCT03032380|593537729|FG001|Overall Study|Recovery|1|||
164316872|NCT03032380|593537728|FG000|Overall Study|Death|39|||
164316873|NCT03032380|593537729|FG001|Overall Study|Death|34|||
164316874|NCT03032380|593537728|FG000|Overall Study|Other - Miscellaneous|0|||
164316875|NCT03032380|593537729|FG001|Overall Study|Other - Miscellaneous|1|||
164316876|NCT02937584|593537730|FG000|Period 1|Adverse Event|1|||
164316877|NCT02937584|593537731|FG001|Period 1|Adverse Event|2|||
164316878|NCT02937584|593537730|FG000|Washout|Adverse Event|0|||
164316879|NCT02937584|593537731|FG001|Washout|Adverse Event|1|||
164316880|NCT01883453|593537732|FG000|Overall Study|No episode of common cold|25|||
164316881|NCT01883453|593537733|FG001|Overall Study|No episode of common cold|23|||
164316882|NCT02238080|593537734|FG000|Overall Study|Death|13|||
164316883|NCT02238080|593537734|FG000|Overall Study|Treatment interrupted|6|||
164316884|NCT02238080|593537734|FG000|Overall Study|Withdrawal by Subject|2|||
164316885|NCT02238080|593537734|FG000|Overall Study|Other|4|||
164316886|NCT00701662|593537735|FG000|Overall Study|Lack of Efficacy|1|||
164316887|NCT02267317|593537738|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
164316888|NCT02267317|593537739|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316889|NCT02267317|593537740|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316890|NCT02267317|593537741|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316891|NCT02267317|593537742|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316892|NCT02267317|593537743|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
164316893|NCT02267317|593537738|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
164316894|NCT02267317|593537739|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316895|NCT02267317|593537740|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316896|NCT02267317|593537741|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316897|NCT02267317|593537742|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316898|NCT02267317|593537743|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
164316899|NCT03595618|593537744|FG000|Overall Study|Adverse Event|16|||
164316900|NCT03595618|593537745|FG001|Overall Study|Adverse Event|17|||
164316901|NCT03595618|593537746|FG002|Overall Study|Adverse Event|20|||
164316902|NCT03595618|593537747|FG003|Overall Study|Adverse Event|8|||
164316903|NCT03595618|593537744|FG000|Overall Study|Withdrawal by Subject|12|||
164316904|NCT03595618|593537745|FG001|Overall Study|Withdrawal by Subject|14|||
164316905|NCT03595618|593537746|FG002|Overall Study|Withdrawal by Subject|14|||
164316906|NCT03595618|593537747|FG003|Overall Study|Withdrawal by Subject|10|||
164316907|NCT03595618|593537744|FG000|Overall Study|Lost to Follow-up|6|||
164316908|NCT03595618|593537745|FG001|Overall Study|Lost to Follow-up|4|||
164316909|NCT03595618|593537746|FG002|Overall Study|Lost to Follow-up|5|||
164316910|NCT03595618|593537747|FG003|Overall Study|Lost to Follow-up|6|||
164316911|NCT03595618|593537744|FG000|Overall Study|Protocol Violation|2|||
164316912|NCT03595618|593537745|FG001|Overall Study|Protocol Violation|0|||
164316913|NCT03595618|593537746|FG002|Overall Study|Protocol Violation|6|||
164316914|NCT03595618|593537747|FG003|Overall Study|Protocol Violation|2|||
164316915|NCT03595618|593537744|FG000|Overall Study|Physician Decision|0|||
164316916|NCT03595618|593537745|FG001|Overall Study|Physician Decision|0|||
164316917|NCT03595618|593537746|FG002|Overall Study|Physician Decision|1|||
164316918|NCT03595618|593537747|FG003|Overall Study|Physician Decision|2|||
164316919|NCT03595618|593537744|FG000|Overall Study|Miscellaneous|7|||
164316920|NCT03595618|593537745|FG001|Overall Study|Miscellaneous|5|||
164316921|NCT03595618|593537746|FG002|Overall Study|Miscellaneous|10|||
164316922|NCT03595618|593537747|FG003|Overall Study|Miscellaneous|6|||
164316923|NCT02279407|593537748|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
164316924|NCT02279407|593537749|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
164316925|NCT02279407|593537750|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
164316926|NCT02279407|593537751|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
164316927|NCT02279407|593537748|FG000|Overall Study|Withdrawal by Subject|1|||
164316928|NCT02279407|593537749|FG001|Overall Study|Withdrawal by Subject|0|||
164316929|NCT02279407|593537750|FG002|Overall Study|Withdrawal by Subject|1|||
164316930|NCT02279407|593537751|FG003|Overall Study|Withdrawal by Subject|1|||
164316931|NCT02279407|593537748|FG000|Overall Study|Adverse Event|1|||
164316932|NCT02279407|593537749|FG001|Overall Study|Adverse Event|1|||
164316933|NCT02279407|593537750|FG002|Overall Study|Adverse Event|2|||
164316934|NCT02279407|593537751|FG003|Overall Study|Adverse Event|0|||
164316935|NCT03996369|593537758|FG000|Overall Study|Protocol deviation|1|||
164316936|NCT03996369|593537759|FG001|Overall Study|Protocol deviation|1|||
164316937|NCT03996369|593537758|FG000|Overall Study|Physician Decision|4|||
164316938|NCT03996369|593537759|FG001|Overall Study|Physician Decision|2|||
164316939|NCT03996369|593537758|FG000|Overall Study|Participant decision|0|||
164316940|NCT03996369|593537759|FG001|Overall Study|Participant decision|1|||
164316941|NCT03996369|593537758|FG000|Overall Study|Lack of Efficacy|4|||
164316942|NCT03996369|593537759|FG001|Overall Study|Lack of Efficacy|0|||
164316943|NCT03996369|593537758|FG000|Overall Study|Adverse Event|9|||
164316944|NCT03996369|593537759|FG001|Overall Study|Adverse Event|0|||
164316945|NCT03996369|593537758|FG000|Overall Study|Withdrawal by Subject|6|||
164316946|NCT03996369|593537759|FG001|Overall Study|Withdrawal by Subject|8|||
164316947|NCT03996369|593537758|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
164316948|NCT03996369|593537759|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
164316949|NCT03996369|593537758|FG000|Overall Study|Lost to Follow-up|0|||
164316950|NCT03996369|593537759|FG001|Overall Study|Lost to Follow-up|1|||
164316951|NCT01782469|593537760|FG000|Overall Study|Lost to Follow-up|1|||
164316952|NCT01038869|593537761|FG000|Overall Study|Withdrawal by Subject|1|||
164316953|NCT01038869|593537761|FG000|Overall Study|Lost to Follow-up|6|||
164316954|NCT04136444|593537762|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
164316955|NCT04136444|593537763|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
164316956|NCT02238067|593537764|FG000|Overall Study|Not completed survey at Month 6|45|||
164316957|NCT02213133|593537765|FG000|Overall Study|Participant discontinued study therapy|2|||
164316958|NCT02213133|593537766|FG001|Overall Study|Participant discontinued study therapy|0|||
164316959|NCT02213133|593537767|FG002|Overall Study|Participant discontinued study therapy|0|||
164316960|NCT02213133|593537765|FG000|Overall Study|Participant withdrew informed consent|2|||
164316961|NCT02213133|593537766|FG001|Overall Study|Participant withdrew informed consent|1|||
164316962|NCT02213133|593537767|FG002|Overall Study|Participant withdrew informed consent|2|||
164316963|NCT02213133|593537765|FG000|Overall Study|Disease progression|11|||
164316964|NCT02213133|593537766|FG001|Overall Study|Disease progression|2|||
164316965|NCT02213133|593537767|FG002|Overall Study|Disease progression|0|||
164316966|NCT02213133|593537765|FG000|Overall Study|Adverse Event (AE)|1|||
164316967|NCT02213133|593537766|FG001|Overall Study|Adverse Event (AE)|0|||
164316968|NCT02213133|593537767|FG002|Overall Study|Adverse Event (AE)|0|||
164316969|NCT02213133|593537765|FG000|Overall Study|Death|16|||
164316970|NCT02213133|593537766|FG001|Overall Study|Death|2|||
164316971|NCT02213133|593537767|FG002|Overall Study|Death|1|||
164316972|NCT02213133|593537765|FG000|Overall Study|Other|5|||
164316973|NCT02213133|593537766|FG001|Overall Study|Other|0|||
164316974|NCT02213133|593537767|FG002|Overall Study|Other|0|||
164316975|NCT01224782|593537768|FG000|Overall Study|Lost to Follow-up|177|||
164316976|NCT01224782|593537768|FG000|Overall Study|Withdrawal by Subject|16|||
164316977|NCT01224782|593537768|FG000|Overall Study|Death|14|||
164316978|NCT01224782|593537768|FG000|Overall Study|Improvement|13|||
164316979|NCT01224782|593537768|FG000|Overall Study|Adverse Event|12|||
164316980|NCT01224782|593537768|FG000|Overall Study|Adverse Reaction|11|||
164316981|NCT01224782|593537768|FG000|Overall Study|Noncompliance|10|||
163873317|NCT02723955|591906844|FG011|Escalation Phase|Site Closed|0|||
163873318|NCT02723955|591906845|FG012|Escalation Phase|Site Closed|0|||
163873319|NCT02723955|591906846|FG013|Escalation Phase|Site Closed|0|||
163873320|NCT02723955|591906847|FG014|Escalation Phase|Site Closed|0|||
163873321|NCT02723955|591906848|FG015|Escalation Phase|Site Closed|1|||
164316982|NCT01224782|593537768|FG000|Overall Study|Other|4|||
164316983|NCT01224782|593537768|FG000|Overall Study|Start of Dialysis|3|||
163873322|NCT02723955|591906849|FG016|Escalation Phase|Site Closed|0|||
163873323|NCT02723955|591906850|FG017|Escalation Phase|Site Closed|2|||
164316984|NCT01224782|593537768|FG000|Overall Study|Change of Treatment|1|||
163873324|NCT02723955|591906851|FG018|Escalation Phase|Site Closed|0|||
164316985|NCT01224782|593537768|FG000|Overall Study|Financial Reasons|1|||
164316986|NCT01224782|593537768|FG000|Overall Study|Deterioration|1|||
164316987|NCT01224782|593537768|FG000|Overall Study|Transplantation|1|||
164316988|NCT01960907|593537769|FG000|Overall Study|Death|4|||
164316989|NCT01960907|593537770|FG001|Overall Study|Death|3|||
164316990|NCT01960907|593537769|FG000|Overall Study|Withdrawal by Subject|32|||
163873325|NCT02723955|591906852|FG019|Escalation Phase|Site Closed|0|||
164316991|NCT01960907|593537770|FG001|Overall Study|Withdrawal by Subject|42|||
164316992|NCT00783198|593537776|FG000|Overall Study|Adverse Event|15|||
164316993|NCT00783198|593537777|FG001|Overall Study|Adverse Event|19|||
164316994|NCT00783198|593537778|FG002|Overall Study|Adverse Event|3|||
164316995|NCT00783198|593537776|FG000|Overall Study|Lost to Follow-up|11|||
164316996|NCT00783198|593537777|FG001|Overall Study|Lost to Follow-up|1|||
164316997|NCT00783198|593537778|FG002|Overall Study|Lost to Follow-up|7|||
164316998|NCT00783198|593537776|FG000|Overall Study|Withdrawal by Subject|22|||
164316999|NCT00783198|593537777|FG001|Overall Study|Withdrawal by Subject|14|||
164317000|NCT00783198|593537778|FG002|Overall Study|Withdrawal by Subject|20|||
164317001|NCT00783198|593537776|FG000|Overall Study|Noncompliance with protocol|7|||
164317002|NCT00783198|593537777|FG001|Overall Study|Noncompliance with protocol|7|||
164317003|NCT00783198|593537778|FG002|Overall Study|Noncompliance with protocol|10|||
164317004|NCT00783198|593537776|FG000|Overall Study|Did not meet protocol eligibility|0|||
164317005|NCT00783198|593537777|FG001|Overall Study|Did not meet protocol eligibility|1|||
164317006|NCT00783198|593537778|FG002|Overall Study|Did not meet protocol eligibility|0|||
164317007|NCT00783198|593537776|FG000|Overall Study|Administrative|2|||
164317008|NCT00783198|593537777|FG001|Overall Study|Administrative|1|||
164317009|NCT00783198|593537778|FG002|Overall Study|Administrative|2|||
164317010|NCT01546623|593537781|FG000|Overall Study|Adverse Event|2|||
164317011|NCT01546623|593537782|FG001|Overall Study|Adverse Event|3|||
164317012|NCT01546623|593537781|FG000|Overall Study|Major Protocol Deviation|1|||
164317013|NCT01546623|593537782|FG001|Overall Study|Major Protocol Deviation|1|||
164317014|NCT01546623|593537781|FG000|Overall Study|High Prostate specific antigen|2|||
164317015|NCT01546623|593537782|FG001|Overall Study|High Prostate specific antigen|1|||
164317016|NCT01546623|593537781|FG000|Overall Study|Did Not Receive Study Drug|1|||
164317017|NCT01546623|593537782|FG001|Overall Study|Did Not Receive Study Drug|1|||
164317018|NCT04525885|593537783|FG000|Overall Study|Screen Failure|1|||
164317019|NCT04525885|593537784|FG001|Overall Study|Screen Failure|0|||
164317020|NCT04525885|593537785|FG002|Overall Study|Screen Failure|0|||
164317021|NCT04525885|593537783|FG000|Overall Study|Withdrawal by Subject|14|||
164317022|NCT04525885|593537784|FG001|Overall Study|Withdrawal by Subject|6|||
164317023|NCT04525885|593537785|FG002|Overall Study|Withdrawal by Subject|20|||
164317024|NCT04525885|593537783|FG000|Overall Study|Physician Decision|1|||
164317025|NCT04525885|593537784|FG001|Overall Study|Physician Decision|0|||
164317026|NCT04525885|593537785|FG002|Overall Study|Physician Decision|1|||
164317027|NCT02756806|593537786|FG000|Overall Study|Study terminated early|5|||
164317028|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
164317029|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
164317030|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
164317031|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
164317032|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
164317033|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
164317034|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
164317035|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
164317036|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
164317037|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164317038|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
164317039|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164317040|NCT03158285|593537787|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
164317041|NCT03158285|593537788|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
164317042|NCT03158285|593537789|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
164317043|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
164317044|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
164317045|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
164317046|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
164317047|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
164317048|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
164317049|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
164317050|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
164317051|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
164317052|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
164317053|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
164317054|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
164317055|NCT03158285|593537787|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
164317056|NCT03158285|593537788|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
164317057|NCT03158285|593537789|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
164317058|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
164317059|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
164317060|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
164317061|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
164317062|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
164317063|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
164317064|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
164317065|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
164317066|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
164317067|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
164317068|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
164317069|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
164317070|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Death|1|||
164317071|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Death|0|||
164317072|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Death|0|||
164317073|NCT03158285|593537787|FG000|Active Treatment Period: Week 52-100|Other|4|||
164317074|NCT03158285|593537788|FG001|Active Treatment Period: Week 52-100|Other|1|||
164317075|NCT03158285|593537789|FG002|Active Treatment Period: Week 52-100|Other|0|||
164317076|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
164317077|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317078|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317079|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
164317080|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
164317081|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
164317082|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
164317083|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
164317084|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
164317085|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
164317086|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
164317087|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
164317088|NCT01642615|593537792|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
164317089|NCT01642615|593537793|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
164317090|NCT01642615|593537794|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
164317091|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
164317092|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
164317093|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
164317094|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
164317095|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
164317096|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
164317097|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317098|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
164317099|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
164317100|NCT01642615|593537792|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
164317101|NCT01642615|593537793|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
164317102|NCT01642615|593537794|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
164317103|NCT00750152|593537795|FG000|Overall Study|Adverse Event|2|||
164317104|NCT00750152|593537796|FG001|Overall Study|Adverse Event|1|||
164317105|NCT00750152|593537795|FG000|Overall Study|Lost to Follow-up|8|||
164317106|NCT00750152|593537796|FG001|Overall Study|Lost to Follow-up|13|||
164317107|NCT00750152|593537795|FG000|Overall Study|Withdrawal by Subject|3|||
164317108|NCT00750152|593537796|FG001|Overall Study|Withdrawal by Subject|3|||
164317109|NCT00750152|593537795|FG000|Overall Study|Physician Decision|1|||
164317110|NCT00750152|593537796|FG001|Overall Study|Physician Decision|1|||
164317111|NCT00750152|593537795|FG000|Overall Study|Non-compliance|0|||
164317112|NCT00750152|593537796|FG001|Overall Study|Non-compliance|1|||
164317113|NCT00750152|593537795|FG000|Overall Study|Termination by sponsor|1|||
164317114|NCT00750152|593537796|FG001|Overall Study|Termination by sponsor|0|||
164317115|NCT00750152|593537795|FG000|Overall Study|Other|7|||
164317116|NCT00750152|593537796|FG001|Overall Study|Other|8|||
164317117|NCT00978757|593537801|FG000|Overall Study|Physician Decision|1|||
164317118|NCT00978757|593537802|FG001|Overall Study|Physician Decision|3|||
164317119|NCT01028300|593537803|FG000|Overall Study|Study Terminated|4|||
164317120|NCT00402740|593537804|FG000|Overall Study|Withdrawal by Subject|18|||
164317121|NCT00402740|593537804|FG000|Overall Study|Death|50|||
164317122|NCT00402740|593537804|FG000|Overall Study|Lost to Follow-up|6|||
164317123|NCT00402740|593537804|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
164317124|NCT00402740|593537804|FG000|Overall Study|Subject disposition unknown.|1|||
164317125|NCT00946153|593537807|FG000|Phase 2|Adverse Event|0|||
164317126|NCT00946153|593537808|FG001|Phase 2|Adverse Event|0|||
164317127|NCT00946153|593537809|FG002|Phase 2|Adverse Event|0|||
164317128|NCT00946153|593537810|FG003|Phase 2|Adverse Event|0|||
164317129|NCT00946153|593537811|FG004|Phase 2|Adverse Event|6|||
164317130|NCT00946153|593537807|FG000|Phase 2|Need more reduction of dose|0|||
164317131|NCT00946153|593537808|FG001|Phase 2|Need more reduction of dose|0|||
164317132|NCT00946153|593537809|FG002|Phase 2|Need more reduction of dose|0|||
164317133|NCT00946153|593537810|FG003|Phase 2|Need more reduction of dose|0|||
164317134|NCT00946153|593537811|FG004|Phase 2|Need more reduction of dose|2|||
164317135|NCT00946153|593537807|FG000|Phase 2|Physician Decision|0|||
164317136|NCT00946153|593537808|FG001|Phase 2|Physician Decision|0|||
164317137|NCT00946153|593537809|FG002|Phase 2|Physician Decision|0|||
164317138|NCT00946153|593537810|FG003|Phase 2|Physician Decision|0|||
164317139|NCT00946153|593537811|FG004|Phase 2|Physician Decision|1|||
164317140|NCT00946153|593537807|FG000|Phase 2|14 days washout for recovery due to AE|0|||
164317141|NCT00946153|593537808|FG001|Phase 2|14 days washout for recovery due to AE|0|||
164317142|NCT00946153|593537809|FG002|Phase 2|14 days washout for recovery due to AE|0|||
164317143|NCT00946153|593537810|FG003|Phase 2|14 days washout for recovery due to AE|0|||
164317144|NCT00946153|593537811|FG004|Phase 2|14 days washout for recovery due to AE|4|||
164317145|NCT04002908|593537822|FG000|Overall Study|Death|41|||
164317146|NCT04002908|593537823|FG001|Overall Study|Death|0|||
164317147|NCT04002908|593537824|FG002|Overall Study|Death|0|||
164317148|NCT04002908|593537825|FG003|Overall Study|Death|0|||
164317149|NCT04002908|593537822|FG000|Overall Study|Withdrawal by Subject|112|||
164317150|NCT04002908|593537823|FG001|Overall Study|Withdrawal by Subject|0|||
164317151|NCT04002908|593537824|FG002|Overall Study|Withdrawal by Subject|0|||
164317152|NCT04002908|593537825|FG003|Overall Study|Withdrawal by Subject|0|||
164317153|NCT04002908|593537822|FG000|Overall Study|Lost to Follow-up|72|||
164317154|NCT04002908|593537823|FG001|Overall Study|Lost to Follow-up|0|||
164317155|NCT04002908|593537824|FG002|Overall Study|Lost to Follow-up|0|||
164317156|NCT04002908|593537825|FG003|Overall Study|Lost to Follow-up|0|||
164317157|NCT04002908|593537822|FG000|Overall Study|Infant died, so mother withdrawn|34|||
164317158|NCT04002908|593537823|FG001|Overall Study|Infant died, so mother withdrawn|0|||
164317159|NCT04002908|593537824|FG002|Overall Study|Infant died, so mother withdrawn|0|||
164317160|NCT04002908|593537825|FG003|Overall Study|Infant died, so mother withdrawn|0|||
164317161|NCT01011309|593537826|FG000|Overall Study|Adverse Event|2|||
164317162|NCT01011309|593537827|FG001|Overall Study|Adverse Event|1|||
164317163|NCT01011309|593537828|FG002|Overall Study|Adverse Event|2|||
164317164|NCT01011309|593537826|FG000|Overall Study|Lack of Efficacy|0|||
164317165|NCT01011309|593537827|FG001|Overall Study|Lack of Efficacy|1|||
164317166|NCT01011309|593537828|FG002|Overall Study|Lack of Efficacy|0|||
164317167|NCT01011309|593537826|FG000|Overall Study|Protocol Violation|0|||
164317168|NCT01011309|593537827|FG001|Overall Study|Protocol Violation|1|||
164317169|NCT01011309|593537828|FG002|Overall Study|Protocol Violation|3|||
164317170|NCT00006289|593537833|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
164317171|NCT00006289|593537834|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
164317172|NCT00006289|593537833|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
164317173|NCT00006289|593537834|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
164317174|NCT04359901|593537842|FG000|Overall Study|Withdrawal by Subject|0|||
164317175|NCT04359901|593537843|FG001|Overall Study|Withdrawal by Subject|1|||
164317176|NCT04359901|593537842|FG000|Overall Study|Death|6|||
164317177|NCT04359901|593537843|FG001|Overall Study|Death|2|||
164317178|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317179|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
164317180|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317181|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
164317182|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317183|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
164317184|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
164317185|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
164317186|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
164317187|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
164317188|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317189|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
164317190|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317191|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317192|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317193|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317194|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317195|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
164317196|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317197|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
164317198|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317199|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317200|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317201|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
164317202|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
164317203|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
164317204|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
164317205|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Other|0|||
164317206|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Other|0|||
164317207|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Other|1|||
164317208|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Other|1|||
164317209|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Other|0|||
164317210|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Other|0|||
164317211|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Other|0|||
164317212|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Other|1|||
164317213|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Other|0|||
164317214|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|Death|0|||
164317215|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|Death|0|||
164317216|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|Death|0|||
164317217|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|Death|0|||
164317218|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|Death|0|||
164317219|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|Death|1|||
164317220|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|Death|0|||
164317221|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|Death|0|||
164317222|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|Death|0|||
164317223|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317224|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317225|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317226|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317227|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317228|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
164317229|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
164317230|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317231|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
164317232|NCT00557856|593537844|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
164317233|NCT00557856|593537845|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317234|NCT00557856|593537846|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317235|NCT00557856|593537847|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317236|NCT00557856|593537848|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317237|NCT00557856|593537849|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317238|NCT00557856|593537850|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317239|NCT00557856|593537851|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317240|NCT00557856|593537852|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
164317241|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317242|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317243|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317244|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317245|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317246|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317247|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317248|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
164317249|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
164317250|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317251|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317252|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317253|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317254|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317255|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317256|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
163873326|NCT02723955|591906853|FG020|Escalation Phase|Site Closed|1|||
163873327|NCT02723955|591906854|FG021|Escalation Phase|Site Closed|0|||
163873328|NCT02723955|591906855|FG022|Escalation Phase|Site Closed|0|||
163873329|NCT02723955|591906856|FG023|Escalation Phase|Site Closed|0|||
163873330|NCT02723955|591906857|FG024|Escalation Phase|Site Closed|3|||
163873331|NCT02723955|591906858|FG025|Escalation Phase|Site Closed|1|||
163873332|NCT02723955|591906859|FG026|Escalation Phase|Site Closed|3|||
163873333|NCT02723955|591906860|FG027|Escalation Phase|Site Closed|1|||
163873334|NCT02723955|591906861|FG028|Escalation Phase|Site Closed|1|||
163873335|NCT02723955|591906862|FG029|Escalation Phase|Site Closed|0|||
163873336|NCT02723955|591906863|FG030|Escalation Phase|Site Closed|0|||
163873337|NCT02723955|591906864|FG031|Escalation Phase|Site Closed|0|||
163873338|NCT02723955|591906865|FG032|Escalation Phase|Site Closed|0|||
164317257|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
164317258|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
164317259|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
163977464|NCT01549002|592288784|FG000|Overall Study|Moderate sedation required|0|||
163977465|NCT01549002|592288785|FG001|Overall Study|Moderate sedation required|2|||
163977466|NCT00749996|592288786|FG000|Overall Study|Lost to Follow-up|7|||
164317260|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
163977467|NCT00749996|592288787|FG001|Overall Study|Lost to Follow-up|4|||
163977468|NCT00749996|592288786|FG000|Overall Study|Withdrawal by Subject|5|||
163977469|NCT00749996|592288787|FG001|Overall Study|Withdrawal by Subject|4|||
163977470|NCT00749996|592288786|FG000|Overall Study|Protocol Violation|2|||
163977471|NCT00749996|592288787|FG001|Overall Study|Protocol Violation|3|||
163977472|NCT00749996|592288786|FG000|Overall Study|Physician Decision|2|||
163977473|NCT00749996|592288787|FG001|Overall Study|Physician Decision|0|||
163977474|NCT00749996|592288786|FG000|Overall Study|Pregnancy|0|||
163977475|NCT00749996|592288787|FG001|Overall Study|Pregnancy|2|||
163977476|NCT00749996|592288786|FG000|Overall Study|Adverse Event|1|||
163977477|NCT00749996|592288787|FG001|Overall Study|Adverse Event|0|||
163977478|NCT00749996|592288786|FG000|Overall Study|Death|1|||
163977479|NCT00749996|592288787|FG001|Overall Study|Death|0|||
163977480|NCT00996944|592288788|FG000|Double-blind Treatment Period|Adverse Event|2|||
163977481|NCT00996944|592288789|FG001|Double-blind Treatment Period|Adverse Event|1|||
163977482|NCT00996944|592288788|FG000|Double-blind Treatment Period|Protocol Violation|1|||
164317261|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
164317262|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
164317263|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
164317264|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
164317265|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
164317266|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
164317267|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
164317268|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Other|0|||
164317269|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Other|0|||
164317270|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Other|0|||
164317271|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Other|0|||
164317272|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Other|0|||
164317273|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Other|0|||
164317274|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Other|0|||
164317275|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Other|0|||
164317276|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Other|1|||
164317277|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|Death|0|||
164317278|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|Death|0|||
164317279|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|Death|0|||
164317280|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|Death|0|||
164317281|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|Death|0|||
164317282|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|Death|0|||
164317283|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|Death|0|||
164317284|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|Death|0|||
164317285|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|Death|2|||
164317286|NCT00557856|593537844|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317287|NCT00557856|593537845|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317288|NCT00557856|593537846|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317289|NCT00557856|593537847|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317290|NCT00557856|593537848|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
163977483|NCT00996944|592288789|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163977484|NCT00996944|592288788|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
163977485|NCT00996944|592288789|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
163977486|NCT00996944|592288788|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
163977487|NCT00996944|592288789|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163977488|NCT00996944|592288788|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
163977489|NCT00996944|592288789|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
163977490|NCT03775421|592288792|FG000|Overall Study|Lost to Follow-up|2|||
163977491|NCT03775421|592288792|FG000|Overall Study|Withdrawal by Subject|10|||
163977492|NCT03775421|592288792|FG000|Overall Study|Physician Decision|3|||
163977493|NCT03775421|592288792|FG000|Overall Study|Death|1|||
164317291|NCT00557856|593537849|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317292|NCT00557856|593537850|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
164317293|NCT00557856|593537851|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
163977494|NCT03775421|592288792|FG000|Overall Study|Study Terminated by Sponsor|94|||
164317294|NCT00557856|593537852|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
164317295|NCT03255083|593537853|FG000|Overall Study|Clinical progression|1|||
164317296|NCT03255083|593537854|FG001|Overall Study|Clinical progression|0|||
164317297|NCT03255083|593537855|FG002|Overall Study|Clinical progression|0|||
164317298|NCT03255083|593537856|FG003|Overall Study|Clinical progression|0|||
164317299|NCT03255083|593537853|FG000|Overall Study|Adverse Event|0|||
163977495|NCT01227044|592288795|FG000|Overall Study|Lost to Follow-up|5|||
163977496|NCT01227044|592288796|FG001|Overall Study|Lost to Follow-up|7|||
163977497|NCT01227044|592288795|FG000|Overall Study|Discontinued Intervention|1|||
163977498|NCT01227044|592288796|FG001|Overall Study|Discontinued Intervention|2|||
163977499|NCT02250274|592288798|FG000|Overall Study|Insufficient blood draw amount|7|||
163977500|NCT02250274|592288799|FG001|Overall Study|Insufficient blood draw amount|6|||
163977501|NCT04247061|592288800|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
163977502|NCT04247061|592288800|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
163977503|NCT04247061|592288800|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
163977504|NCT01378104|592288803|FG000|Overall Study|Adverse Event|8|||
163977505|NCT01378104|592288804|FG001|Overall Study|Adverse Event|8|||
163977506|NCT01378104|592288803|FG000|Overall Study|Lack of Efficacy|7|||
163977507|NCT01378104|592288804|FG001|Overall Study|Lack of Efficacy|5|||
163977508|NCT01378104|592288803|FG000|Overall Study|Withdrawal by Subject|12|||
163977509|NCT01378104|592288804|FG001|Overall Study|Withdrawal by Subject|13|||
163977510|NCT02287623|592288805|FG000|Overall Study|Protocol Violation|0|||
163977511|NCT02287623|592288806|FG001|Overall Study|Protocol Violation|1|||
163977512|NCT00205855|592288817|FG000|Overall Study|Only received temporary implants|16|||
163977513|NCT00205855|592288817|FG000|Overall Study|Withdrawal by Subject|5|||
163977514|NCT02039375|592288827|FG000|Overall Study|Lost to Follow-up|2|||
163977515|NCT03891264|592288829|FG000|Overall Study|Adverse Event|1|||
163977516|NCT03891264|592288829|FG000|Overall Study|Withdrawal by Subject|2|||
163977517|NCT03891264|592288829|FG000|Overall Study|Physician Decision|2|||
163977518|NCT01924182|592288830|FG000|Overall Study|Withdrawal by Subject|1|||
163977519|NCT01924182|592288831|FG001|Overall Study|Withdrawal by Subject|0|||
163977520|NCT03040999|592290848|FG000|Overall Study|Lost to Follow-up|2|||
163977521|NCT03040999|592290849|FG001|Overall Study|Lost to Follow-up|2|||
163977522|NCT03040999|592290848|FG000|Overall Study|Withdrawal by Subject|12|||
163977523|NCT03040999|592290849|FG001|Overall Study|Withdrawal by Subject|13|||
163977524|NCT03040999|592290848|FG000|Overall Study|Death|155|||
163977525|NCT03040999|592290849|FG001|Overall Study|Death|171|||
163977526|NCT03040999|592290848|FG000|Overall Study|Physician Decision|0|||
163977527|NCT03040999|592290849|FG001|Overall Study|Physician Decision|3|||
163977528|NCT05121480|592290850|FG000|Overall Study|Lack of Efficacy|2|||
163977529|NCT05121480|592290851|FG001|Overall Study|Lack of Efficacy|2|||
163977530|NCT05121480|592290852|FG002|Overall Study|Lack of Efficacy|1|||
163977531|NCT05121480|592290853|FG003|Overall Study|Lack of Efficacy|4|||
163977532|NCT05121480|592290854|FG004|Overall Study|Lack of Efficacy|0|||
163977533|NCT05121480|592290855|FG005|Overall Study|Lack of Efficacy|1|||
163977534|NCT05121480|592290856|FG006|Overall Study|Lack of Efficacy|0|||
163977535|NCT05121480|592290857|FG007|Overall Study|Lack of Efficacy|2|||
163977536|NCT05121480|592290850|FG000|Overall Study|Treatment Failure|0|||
163977537|NCT05121480|592290851|FG001|Overall Study|Treatment Failure|2|||
163977538|NCT05121480|592290852|FG002|Overall Study|Treatment Failure|0|||
163977539|NCT05121480|592290853|FG003|Overall Study|Treatment Failure|1|||
163977540|NCT05121480|592290854|FG004|Overall Study|Treatment Failure|0|||
163977541|NCT05121480|592290855|FG005|Overall Study|Treatment Failure|0|||
163977542|NCT05121480|592290856|FG006|Overall Study|Treatment Failure|0|||
163977543|NCT05121480|592290857|FG007|Overall Study|Treatment Failure|0|||
163977544|NCT05121480|592290850|FG000|Overall Study|Adverse Event|0|||
163977545|NCT05121480|592290851|FG001|Overall Study|Adverse Event|1|||
163977546|NCT05121480|592290852|FG002|Overall Study|Adverse Event|0|||
163977547|NCT05121480|592290853|FG003|Overall Study|Adverse Event|5|||
163977548|NCT05121480|592290854|FG004|Overall Study|Adverse Event|3|||
163873339|NCT02723955|591906866|FG033|Escalation Phase|Site Closed|0|||
163873340|NCT02723955|591906867|FG034|Escalation Phase|Site Closed|0|||
163873341|NCT02723955|591906868|FG035|Escalation Phase|Site Closed|0|||
163873342|NCT02723955|591906869|FG036|Escalation Phase|Site Closed|0|||
163873343|NCT02723955|591906870|FG037|Escalation Phase|Site Closed|0|||
163873344|NCT02723955|591906871|FG038|Escalation Phase|Site Closed|0|||
163873345|NCT02723955|591906872|FG039|Escalation Phase|Site Closed|0|||
163873346|NCT02723955|591906873|FG040|Escalation Phase|Site Closed|0|||
163873347|NCT02723955|591906874|FG041|Escalation Phase|Site Closed|0|||
163873348|NCT02723955|591906875|FG042|Escalation Phase|Site Closed|0|||
163873349|NCT02723955|591906833|FG000|Expansion Phase|Death|0|||
163873350|NCT02723955|591906834|FG001|Expansion Phase|Death|0|||
163873351|NCT02723955|591906835|FG002|Expansion Phase|Death|0|||
163873352|NCT02723955|591906836|FG003|Expansion Phase|Death|0|||
163873353|NCT02723955|591906837|FG004|Expansion Phase|Death|0|||
163873354|NCT02723955|591906838|FG005|Expansion Phase|Death|0|||
163977549|NCT05121480|592290855|FG005|Overall Study|Adverse Event|2|||
163977550|NCT05121480|592290856|FG006|Overall Study|Adverse Event|0|||
163977551|NCT05121480|592290857|FG007|Overall Study|Adverse Event|4|||
163977552|NCT05121480|592290850|FG000|Overall Study|Withdrawal by Subject|4|||
163977553|NCT05121480|592290851|FG001|Overall Study|Withdrawal by Subject|9|||
163873355|NCT02723955|591906839|FG006|Expansion Phase|Death|0|||
163873356|NCT02723955|591906840|FG007|Expansion Phase|Death|0|||
163873357|NCT02723955|591906841|FG008|Expansion Phase|Death|0|||
163977554|NCT05121480|592290852|FG002|Overall Study|Withdrawal by Subject|1|||
163977555|NCT05121480|592290853|FG003|Overall Study|Withdrawal by Subject|8|||
163977556|NCT05121480|592290854|FG004|Overall Study|Withdrawal by Subject|0|||
163977557|NCT05121480|592290855|FG005|Overall Study|Withdrawal by Subject|9|||
163977558|NCT05121480|592290856|FG006|Overall Study|Withdrawal by Subject|0|||
163977559|NCT05121480|592290857|FG007|Overall Study|Withdrawal by Subject|4|||
163977560|NCT05121480|592290850|FG000|Overall Study|Non-compliance with the protocol|0|||
163977561|NCT05121480|592290851|FG001|Overall Study|Non-compliance with the protocol|0|||
163977562|NCT05121480|592290852|FG002|Overall Study|Non-compliance with the protocol|0|||
163977563|NCT05121480|592290853|FG003|Overall Study|Non-compliance with the protocol|0|||
163977564|NCT05121480|592290854|FG004|Overall Study|Non-compliance with the protocol|1|||
163977565|NCT05121480|592290855|FG005|Overall Study|Non-compliance with the protocol|6|||
163977566|NCT05121480|592290856|FG006|Overall Study|Non-compliance with the protocol|0|||
163977567|NCT05121480|592290857|FG007|Overall Study|Non-compliance with the protocol|1|||
163977568|NCT05121480|592290850|FG000|Overall Study|Lost to Follow-up|0|||
164205479|NCT04711005|593121268|FG007|Overall Study|Physician Decision|2|||
164205480|NCT04711005|593121269|FG008|Overall Study|Physician Decision|1|||
164205481|NCT04711005|593121270|FG009|Overall Study|Physician Decision|0|||
164205482|NCT00764790|593121271|FG000|Overall Study|Protocol Violation|0|||
164205483|NCT00764790|593121272|FG001|Overall Study|Protocol Violation|0|||
164205484|NCT00764790|593121273|FG002|Overall Study|Protocol Violation|1|||
164205485|NCT00764790|593121271|FG000|Overall Study|Withdrawal by Subject|10|||
164205486|NCT00764790|593121272|FG001|Overall Study|Withdrawal by Subject|12|||
164205487|NCT00764790|593121273|FG002|Overall Study|Withdrawal by Subject|6|||
164205488|NCT00764790|593121271|FG000|Overall Study|Lost to Follow-up|28|||
164205489|NCT00764790|593121272|FG001|Overall Study|Lost to Follow-up|29|||
164205490|NCT00764790|593121273|FG002|Overall Study|Lost to Follow-up|23|||
164205491|NCT03191552|593121274|FG000|Overall Study|Lost to Follow-up|1|||
164205492|NCT03191552|593121275|FG001|Overall Study|Lost to Follow-up|0|||
164205493|NCT03191552|593121276|FG002|Overall Study|Lost to Follow-up|0|||
164205494|NCT03191552|593121274|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
164205495|NCT03191552|593121275|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
164205496|NCT03191552|593121276|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
164205497|NCT00788671|593122615|FG000|Overall Study|Death|2|||
164205498|NCT00788671|593122615|FG000|Overall Study|Unable to biopsy|1|||
164205499|NCT00788671|593122615|FG000|Overall Study|Withdrawal by Subject|4|||
164205500|NCT00788671|593122615|FG000|Overall Study|IUD expulsed|1|||
164205501|NCT00788671|593122615|FG000|Overall Study|Lost to follow up|2|||
164205502|NCT04780659|593122616|FG000|Overall Study|Adverse event, serious fatal|3|||
164205503|NCT04780659|593122617|FG001|Overall Study|Adverse event, serious fatal|0|||
164205504|NCT04780659|593122616|FG000|Overall Study|Withdrawal by Subject|3|||
164205505|NCT04780659|593122617|FG001|Overall Study|Withdrawal by Subject|0|||
164205506|NCT04780659|593122616|FG000|Overall Study|Physician Decision|1|||
164205507|NCT04780659|593122617|FG001|Overall Study|Physician Decision|0|||
164205508|NCT04780659|593122616|FG000|Overall Study|Died in original disease|2|||
164205509|NCT04780659|593122617|FG001|Overall Study|Died in original disease|0|||
164205510|NCT04780659|593122616|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
164205511|NCT04780659|593122617|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
164205512|NCT03729362|593122618|FG000|Overall Study|Withdrawal by Subject|2|||
164205513|NCT03729362|593122619|FG001|Overall Study|Withdrawal by Subject|0|||
164205514|NCT03729362|593122618|FG000|Overall Study|Physician Decision|1|||
164205515|NCT03729362|593122619|FG001|Overall Study|Physician Decision|0|||
164205516|NCT03729362|593122618|FG000|Overall Study|COVID-19 Pandemic|1|||
164205517|NCT03729362|593122619|FG001|Overall Study|COVID-19 Pandemic|0|||
164205518|NCT03729362|593122618|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
164205519|NCT03729362|593122619|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
164205520|NCT03729362|593122618|FG000|Overall Study|Adverse Event|0|||
164205521|NCT03729362|593122619|FG001|Overall Study|Adverse Event|1|||
164205522|NCT03729362|593122618|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
164205523|NCT03729362|593122619|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
164205524|NCT03405870|593122620|FG000|Overall Study|Withdrawal|1|||
164205525|NCT03405870|593122621|FG001|Overall Study|Withdrawal|0|||
164205526|NCT03405870|593122622|FG002|Overall Study|Withdrawal|1|||
164205527|NCT03405870|593122623|FG003|Overall Study|Withdrawal|0|||
164205528|NCT03405870|593122624|FG004|Overall Study|Withdrawal|0|||
164205529|NCT03405870|593122625|FG005|Overall Study|Withdrawal|0|||
164205530|NCT03405870|593122626|FG006|Overall Study|Withdrawal|1|||
164205531|NCT03405870|593122627|FG007|Overall Study|Withdrawal|0|||
164205532|NCT02807259|593122630|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
164205533|NCT02807259|593122631|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
164205534|NCT02807259|593122630|FG000|Midline (3 Months)|migration, refusal, not available|30|||
163977569|NCT05121480|592290851|FG001|Overall Study|Lost to Follow-up|4|||
164205535|NCT02807259|593122631|FG001|Midline (3 Months)|migration, refusal, not available|34|||
164205536|NCT02807259|593122630|FG000|Endline (3 Months)|migration, refusal, not available|35|||
164205537|NCT02807259|593122631|FG001|Endline (3 Months)|migration, refusal, not available|87|||
163977570|NCT05121480|592290852|FG002|Overall Study|Lost to Follow-up|1|||
163977571|NCT05121480|592290853|FG003|Overall Study|Lost to Follow-up|3|||
164317300|NCT03255083|593537854|FG001|Overall Study|Adverse Event|1|||
164317301|NCT03255083|593537855|FG002|Overall Study|Adverse Event|0|||
164317302|NCT03255083|593537856|FG003|Overall Study|Adverse Event|0|||
164317303|NCT03255083|593537853|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
164317304|NCT03255083|593537854|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
164317305|NCT03255083|593537855|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
164317306|NCT03255083|593537856|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
164317307|NCT03255083|593537853|FG000|Overall Study|Withdrawal by Subject|1|||
164317308|NCT03255083|593537854|FG001|Overall Study|Withdrawal by Subject|1|||
164317309|NCT03255083|593537855|FG002|Overall Study|Withdrawal by Subject|1|||
164317310|NCT03255083|593537856|FG003|Overall Study|Withdrawal by Subject|0|||
164317311|NCT05601544|593537857|FG000|Phase 2 Period 1|Adverse Event|0|||
164317312|NCT05601544|593537858|FG001|Phase 2 Period 1|Adverse Event|1|||
164317313|NCT05601544|593537859|FG002|Phase 2 Period 1|Adverse Event|0|||
164317314|NCT05601544|593537860|FG003|Phase 2 Period 1|Adverse Event|0|||
164317315|NCT05601544|593537861|FG004|Phase 2 Period 1|Adverse Event|0|||
164317316|NCT05601544|593537862|FG005|Phase 2 Period 1|Adverse Event|0|||
164317317|NCT02537015|593537869|FG000|Overall Study|Adverse Event|3|||
164317318|NCT02537015|593537869|FG000|Overall Study|Withdrawal by Subject|2|||
164317319|NCT02537015|593537869|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164317320|NCT02626624|593537877|FG000|Overall Study|Adverse Event|1|||
164317321|NCT02626624|593537877|FG000|Overall Study|Lost to Follow-up|3|||
164317322|NCT02626624|593537877|FG000|Overall Study|Protocol Violation|4|||
164317323|NCT02626624|593537877|FG000|Overall Study|Death|2|||
164317324|NCT02043899|593539188|FG000|Overall Study|Adverse Event|3|||
164317325|NCT02043899|593539188|FG000|Overall Study|Physician Decision|1|||
164317326|NCT02043899|593539188|FG000|Overall Study|Withdrawal by Subject|2|||
164317327|NCT02043899|593539188|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
164317328|NCT02043899|593539188|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
164317329|NCT02043899|593539188|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
164317330|NCT02043899|593539188|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
164317331|NCT02043899|593539188|FG000|Overall Study|Treatment delayed|1|||
164317332|NCT01771809|593539190|FG000|Overall Study|Adverse Event|4|||
164317333|NCT01771809|593539191|FG001|Overall Study|Adverse Event|12|||
164317334|NCT01771809|593539190|FG000|Overall Study|Protocol Violation|0|||
164317335|NCT01771809|593539191|FG001|Overall Study|Protocol Violation|1|||
164317336|NCT01771809|593539190|FG000|Overall Study|Withdrawal by Subject|34|||
164317337|NCT01771809|593539191|FG001|Overall Study|Withdrawal by Subject|42|||
164317338|NCT01771809|593539190|FG000|Overall Study|Lost to Follow-up|1|||
164317339|NCT01771809|593539191|FG001|Overall Study|Lost to Follow-up|3|||
164317340|NCT01771809|593539190|FG000|Overall Study|Other (Insufficient clinical response)|22|||
164317341|NCT01771809|593539191|FG001|Overall Study|Other (Insufficient clinical response)|20|||
164317342|NCT01771809|593539190|FG000|Overall Study|Death|1|||
164317343|NCT01771809|593539191|FG001|Overall Study|Death|0|||
164317344|NCT01771809|593539190|FG000|Overall Study|Other (other)|9|||
164317345|NCT01771809|593539191|FG001|Overall Study|Other (other)|5|||
164205538|NCT01171534|593122632|FG000|Overall Study|Lost to Follow-up|0|||
164205539|NCT01171534|593122633|FG001|Overall Study|Lost to Follow-up|2|||
164317346|NCT00362180|593539192|FG000|Treated Period|Withdrawal by Subject|1|||
164317347|NCT00362180|593539193|FG001|Treated Period|Withdrawal by Subject|0|||
164317348|NCT00362180|593539194|FG002|Treated Period|Withdrawal by Subject|0|||
164317349|NCT00362180|593539195|FG003|Treated Period|Withdrawal by Subject|0|||
164317350|NCT00362180|593539196|FG004|Treated Period|Withdrawal by Subject|0|||
164317351|NCT00362180|593539197|FG005|Treated Period|Withdrawal by Subject|0|||
164317352|NCT00362180|593539198|FG006|Treated Period|Withdrawal by Subject|0|||
164317353|NCT00362180|593539199|FG007|Treated Period|Withdrawal by Subject|0|||
164317354|NCT00362180|593539200|FG008|Treated Period|Withdrawal by Subject|0|||
164317355|NCT00362180|593539192|FG000|Treated Period|Adverse Event|0|||
164317356|NCT00362180|593539193|FG001|Treated Period|Adverse Event|0|||
164317357|NCT00362180|593539194|FG002|Treated Period|Adverse Event|0|||
164317358|NCT00362180|593539195|FG003|Treated Period|Adverse Event|0|||
164317359|NCT00362180|593539196|FG004|Treated Period|Adverse Event|0|||
164317360|NCT00362180|593539197|FG005|Treated Period|Adverse Event|1|||
164317361|NCT00362180|593539198|FG006|Treated Period|Adverse Event|0|||
164205540|NCT01171534|593122632|FG000|Overall Study|screen failure|0|||
164205541|NCT01171534|593122633|FG001|Overall Study|screen failure|1|||
164205542|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
164205543|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
164205544|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
164205545|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
164205546|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
164205547|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
164205548|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
164205549|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
164205550|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
164317362|NCT00362180|593539199|FG007|Treated Period|Adverse Event|1|||
164317363|NCT00362180|593539200|FG008|Treated Period|Adverse Event|0|||
164317364|NCT02600871|593539203|FG000|Overall Study|Lost to Follow-up|13|||
164317365|NCT02600871|593539204|FG001|Overall Study|Lost to Follow-up|10|||
164317366|NCT00348933|593539211|FG000|Overall Study|Withdrawal by Subject|10|||
164317367|NCT00348933|593539211|FG000|Overall Study|Lost to Follow-up|6|||
164317368|NCT00348933|593539211|FG000|Overall Study|Protocol Violation|2|||
164317369|NCT00348933|593539211|FG000|Overall Study|Adverse Event|7|||
164317370|NCT01489111|593539212|FG000|Overall Study|Withdrawal criterion|1|||
164317371|NCT00003472|593539219|FG000|Overall Study|Not evaluable|3|||
164317372|NCT00874939|593539220|FG000|Overall Study|Study terminated|4|||
164317373|NCT02870933|593539221|FG000|Overall Study|Death|2|||
164317374|NCT02870933|593539222|FG001|Overall Study|Death|1|||
164317375|NCT02870933|593539221|FG000|Overall Study|Withdrawal by Subject|0|||
164317376|NCT02870933|593539222|FG001|Overall Study|Withdrawal by Subject|1|||
164317377|NCT02168387|593539223|FG000|Overall Study|Planned exubation|6|||
164317378|NCT02168387|593539224|FG001|Overall Study|Planned exubation|3|||
164317379|NCT02168387|593539223|FG000|Overall Study|Death|1|||
164317380|NCT02168387|593539224|FG001|Overall Study|Death|0|||
164317381|NCT01659554|593539225|FG000|Overall Study|Study Termination|4|||
164317382|NCT00603590|593539226|FG000|Overall Study|Did not attend study clinic|39|||
164317383|NCT00603590|593539227|FG001|Overall Study|Did not attend study clinic|30|||
164317384|NCT00603590|593539226|FG000|Overall Study|Refused blood test|5|||
164317385|NCT00603590|593539227|FG001|Overall Study|Refused blood test|1|||
164317386|NCT00603590|593539226|FG000|Overall Study|Patient discontinued study drug|22|||
164317387|NCT00603590|593539227|FG001|Overall Study|Patient discontinued study drug|15|||
164317388|NCT00603590|593539226|FG000|Overall Study|Adverse Event|2|||
164317389|NCT00603590|593539227|FG001|Overall Study|Adverse Event|0|||
164317390|NCT00603590|593539226|FG000|Overall Study|Lost to Follow-up|8|||
164317391|NCT00603590|593539227|FG001|Overall Study|Lost to Follow-up|4|||
164317392|NCT00603590|593539226|FG000|Overall Study|Cardiovascular event|0|||
164317393|NCT00603590|593539227|FG001|Overall Study|Cardiovascular event|1|||
164317394|NCT00910624|593539228|FG000|Treatment Phase|Adverse Event|2|||
164317395|NCT00910624|593539229|FG001|Treatment Phase|Adverse Event|6|||
164317396|NCT00910624|593539230|FG002|Treatment Phase|Adverse Event|6|||
164317397|NCT00910624|593539231|FG003|Treatment Phase|Adverse Event|0|||
164317398|NCT00910624|593539228|FG000|Treatment Phase|Treatment Failure|23|||
164317399|NCT00910624|593539229|FG001|Treatment Phase|Treatment Failure|10|||
164317400|NCT00910624|593539230|FG002|Treatment Phase|Treatment Failure|0|||
164317401|NCT00910624|593539231|FG003|Treatment Phase|Treatment Failure|0|||
164317402|NCT00910624|593539228|FG000|Treatment Phase|Lost to Follow-up|0|||
164317403|NCT00910624|593539229|FG001|Treatment Phase|Lost to Follow-up|0|||
164317404|NCT00910624|593539230|FG002|Treatment Phase|Lost to Follow-up|1|||
164317405|NCT00910624|593539231|FG003|Treatment Phase|Lost to Follow-up|0|||
164317406|NCT00910624|593539228|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
164317407|NCT00910624|593539229|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
164317408|NCT00910624|593539230|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
164317409|NCT00910624|593539231|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
164317410|NCT00910624|593539228|FG000|Treatment Phase|Withdrawal by Subject|2|||
164317411|NCT00910624|593539229|FG001|Treatment Phase|Withdrawal by Subject|1|||
164317412|NCT00910624|593539230|FG002|Treatment Phase|Withdrawal by Subject|0|||
164317413|NCT00910624|593539231|FG003|Treatment Phase|Withdrawal by Subject|0|||
164317414|NCT00910624|593539228|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
164317415|NCT00910624|593539229|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
164317416|NCT00910624|593539230|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
164317417|NCT00910624|593539231|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
164317418|NCT00910624|593539228|FG000|Follow-Up Phase|Adverse Event|0|||
164317419|NCT00910624|593539229|FG001|Follow-Up Phase|Adverse Event|0|||
164317420|NCT00910624|593539230|FG002|Follow-Up Phase|Adverse Event|1|||
164317421|NCT00910624|593539231|FG003|Follow-Up Phase|Adverse Event|0|||
164317422|NCT00910624|593539228|FG000|Follow-Up Phase|Lost to Follow-up|3|||
164317423|NCT00910624|593539229|FG001|Follow-Up Phase|Lost to Follow-up|1|||
164317424|NCT00910624|593539230|FG002|Follow-Up Phase|Lost to Follow-up|2|||
164317425|NCT00910624|593539231|FG003|Follow-Up Phase|Lost to Follow-up|0|||
164317426|NCT00910624|593539228|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
164317427|NCT00910624|593539229|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
164317428|NCT00910624|593539230|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
164317429|NCT00910624|593539231|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
164317430|NCT00910624|593539228|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
164317431|NCT00910624|593539229|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
164317432|NCT00910624|593539230|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
164317433|NCT00910624|593539231|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
164317434|NCT00910624|593539228|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
164317435|NCT00910624|593539229|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
164317436|NCT00910624|593539230|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
164317437|NCT00910624|593539231|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
164317438|NCT00910624|593539228|FG000|Follow-Up Phase|Administrative|0|||
164317439|NCT00910624|593539229|FG001|Follow-Up Phase|Administrative|1|||
164317440|NCT00910624|593539230|FG002|Follow-Up Phase|Administrative|1|||
164317441|NCT00910624|593539231|FG003|Follow-Up Phase|Administrative|0|||
164317442|NCT03005873|593539235|FG000|Overall Study|Prohibited medication use post radnomization|1|||
164317443|NCT03005873|593539236|FG001|Overall Study|Prohibited medication use post radnomization|1|||
164317444|NCT03005873|593539237|FG002|Overall Study|Prohibited medication use post radnomization|1|||
164317445|NCT03005873|593539235|FG000|Overall Study|Withdrew consent|0|||
164317446|NCT03005873|593539236|FG001|Overall Study|Withdrew consent|1|||
164317447|NCT03005873|593539237|FG002|Overall Study|Withdrew consent|2|||
164317448|NCT03005873|593539235|FG000|Overall Study|Lost to Follow-up|0|||
164317449|NCT03005873|593539236|FG001|Overall Study|Lost to Follow-up|1|||
164317450|NCT03005873|593539237|FG002|Overall Study|Lost to Follow-up|0|||
164317451|NCT03005873|593539235|FG000|Overall Study|Ineligible post randomization|0|||
164317452|NCT03005873|593539236|FG001|Overall Study|Ineligible post randomization|0|||
164317453|NCT03005873|593539237|FG002|Overall Study|Ineligible post randomization|1|||
164317454|NCT04585009|593539238|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
164317455|NCT04585009|593539239|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317456|NCT04585009|593539240|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317457|NCT04585009|593539241|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317458|NCT04585009|593539242|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317459|NCT04585009|593539243|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317460|NCT04585009|593539244|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317461|NCT04585009|593539245|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317462|NCT04585009|593539246|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317463|NCT04585009|593539247|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317464|NCT04585009|593539248|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317465|NCT04585009|593539249|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
164317466|NCT04585009|593539238|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
164317467|NCT04585009|593539239|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317468|NCT04585009|593539240|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317469|NCT04585009|593539241|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317470|NCT04585009|593539242|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317471|NCT04585009|593539243|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317472|NCT04585009|593539244|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317473|NCT04585009|593539245|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317474|NCT04585009|593539246|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317475|NCT04585009|593539247|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317476|NCT04585009|593539248|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317477|NCT04585009|593539249|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
164317478|NCT04585009|593539238|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317479|NCT04585009|593539239|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317480|NCT04585009|593539240|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317481|NCT04585009|593539241|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317482|NCT04585009|593539242|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317483|NCT04585009|593539243|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317484|NCT04585009|593539244|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317485|NCT04585009|593539245|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
164317486|NCT04585009|593539246|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317487|NCT04585009|593539247|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317488|NCT04585009|593539248|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317489|NCT04585009|593539249|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
164317490|NCT04585009|593539238|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317491|NCT04585009|593539239|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317492|NCT04585009|593539240|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317493|NCT04585009|593539241|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317494|NCT04585009|593539242|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
164317495|NCT04585009|593539243|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317496|NCT04585009|593539244|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317497|NCT04585009|593539245|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317498|NCT04585009|593539246|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317499|NCT04585009|593539247|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317500|NCT04585009|593539248|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
164317501|NCT04585009|593539249|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
163977572|NCT05121480|592290854|FG004|Overall Study|Lost to Follow-up|1|||
164317502|NCT04585009|593539238|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317503|NCT04585009|593539239|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317504|NCT04585009|593539240|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317505|NCT04585009|593539241|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317506|NCT04585009|593539242|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317507|NCT04585009|593539243|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317508|NCT04585009|593539244|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317509|NCT04585009|593539245|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317510|NCT04585009|593539246|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317511|NCT04585009|593539247|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
164317512|NCT04585009|593539248|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317513|NCT04585009|593539249|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
164317514|NCT04585009|593539238|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317515|NCT04585009|593539239|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317516|NCT04585009|593539240|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
163977573|NCT05121480|592290855|FG005|Overall Study|Lost to Follow-up|1|||
163977574|NCT05121480|592290856|FG006|Overall Study|Lost to Follow-up|1|||
163977575|NCT05121480|592290857|FG007|Overall Study|Lost to Follow-up|4|||
163977576|NCT05121480|592290850|FG000|Overall Study|Physician Decision|0|||
163977577|NCT05121480|592290851|FG001|Overall Study|Physician Decision|0|||
163977578|NCT05121480|592290852|FG002|Overall Study|Physician Decision|0|||
163977579|NCT05121480|592290853|FG003|Overall Study|Physician Decision|0|||
163977580|NCT05121480|592290854|FG004|Overall Study|Physician Decision|0|||
163977581|NCT05121480|592290855|FG005|Overall Study|Physician Decision|1|||
163977582|NCT05121480|592290856|FG006|Overall Study|Physician Decision|0|||
163977583|NCT05121480|592290857|FG007|Overall Study|Physician Decision|1|||
163977584|NCT05121480|592290850|FG000|Overall Study|Other Reason|0|||
163977585|NCT05121480|592290851|FG001|Overall Study|Other Reason|0|||
163977586|NCT05121480|592290852|FG002|Overall Study|Other Reason|0|||
163977587|NCT05121480|592290853|FG003|Overall Study|Other Reason|0|||
163977588|NCT05121480|592290854|FG004|Overall Study|Other Reason|0|||
163977589|NCT05121480|592290855|FG005|Overall Study|Other Reason|1|||
163977590|NCT05121480|592290856|FG006|Overall Study|Other Reason|1|||
163977591|NCT05121480|592290857|FG007|Overall Study|Other Reason|1|||
163977592|NCT01964352|592290864|FG000|Overall Study|Adverse Event|13|||
163977593|NCT01964352|592290865|FG001|Overall Study|Adverse Event|3|||
163977594|NCT01964352|592290866|FG002|Overall Study|Adverse Event|4|||
163977595|NCT01964352|592290867|FG003|Overall Study|Adverse Event|3|||
163977596|NCT01964352|592290864|FG000|Overall Study|Lack of Efficacy|6|||
163977597|NCT01964352|592290865|FG001|Overall Study|Lack of Efficacy|0|||
163977598|NCT01964352|592290866|FG002|Overall Study|Lack of Efficacy|0|||
163977599|NCT01964352|592290867|FG003|Overall Study|Lack of Efficacy|0|||
163977600|NCT01964352|592290864|FG000|Overall Study|Protocol Violation|2|||
163977601|NCT01964352|592290865|FG001|Overall Study|Protocol Violation|4|||
163977602|NCT01964352|592290866|FG002|Overall Study|Protocol Violation|0|||
163977603|NCT01964352|592290867|FG003|Overall Study|Protocol Violation|2|||
163977604|NCT01964352|592290864|FG000|Overall Study|Lost to Follow-up|1|||
163977605|NCT01964352|592290865|FG001|Overall Study|Lost to Follow-up|0|||
163977606|NCT01964352|592290866|FG002|Overall Study|Lost to Follow-up|0|||
163977607|NCT01964352|592290867|FG003|Overall Study|Lost to Follow-up|1|||
163977608|NCT01964352|592290864|FG000|Overall Study|Withdrawal by Subject|4|||
163977609|NCT01964352|592290865|FG001|Overall Study|Withdrawal by Subject|2|||
163977610|NCT01964352|592290866|FG002|Overall Study|Withdrawal by Subject|1|||
163977611|NCT01964352|592290867|FG003|Overall Study|Withdrawal by Subject|0|||
163977612|NCT01964352|592290864|FG000|Overall Study|Other than stated above|0|||
163977613|NCT01964352|592290865|FG001|Overall Study|Other than stated above|2|||
163977614|NCT01964352|592290866|FG002|Overall Study|Other than stated above|1|||
163977615|NCT01964352|592290867|FG003|Overall Study|Other than stated above|2|||
163977616|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
163977617|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
163977618|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
163977619|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
163977620|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
163977621|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
163977622|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
163977623|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
163977624|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
163977625|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
163977626|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
163977627|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
163977628|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
163977629|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
163977630|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
163977631|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
164317517|NCT04585009|593539241|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317518|NCT04585009|593539242|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317519|NCT04585009|593539243|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317520|NCT04585009|593539244|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317521|NCT04585009|593539245|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317522|NCT04585009|593539246|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317523|NCT04585009|593539247|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317524|NCT04585009|593539248|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
164317525|NCT04585009|593539249|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
164317526|NCT03699475|593539250|FG000|Overall Study|Death|1|||
164317527|NCT04618770|593539257|FG000|Overall Study|Censored from Analysis|12|||
164317528|NCT04618770|593539257|FG000|Overall Study|Early Termination|25|||
164317529|NCT00422084|593539260|FG000|Overall Study|Adverse Event|21|||
164317530|NCT00422084|593539261|FG001|Overall Study|Adverse Event|7|||
164317531|NCT00422084|593539260|FG000|Overall Study|Withdrawal by Subject|12|||
164317532|NCT00422084|593539261|FG001|Overall Study|Withdrawal by Subject|9|||
164317533|NCT00422084|593539260|FG000|Overall Study|Lost to Follow-up|14|||
164317534|NCT00422084|593539261|FG001|Overall Study|Lost to Follow-up|9|||
164317535|NCT00422084|593539260|FG000|Overall Study|Protocol Violation|4|||
164317536|NCT00422084|593539261|FG001|Overall Study|Protocol Violation|1|||
164317537|NCT00422084|593539260|FG000|Overall Study|Lack of Efficacy|40|||
164317538|NCT00422084|593539261|FG001|Overall Study|Lack of Efficacy|42|||
164317539|NCT00422084|593539260|FG000|Overall Study|P. vivax infection|3|||
164317540|NCT00422084|593539261|FG001|Overall Study|P. vivax infection|6|||
164317541|NCT00422084|593539260|FG000|Overall Study|Cyesis|1|||
164317542|NCT00422084|593539261|FG001|Overall Study|Cyesis|0|||
164317543|NCT00422084|593539260|FG000|Overall Study|Withdrawn from study accidentally|1|||
164317544|NCT00422084|593539261|FG001|Overall Study|Withdrawn from study accidentally|0|||
164317545|NCT00422084|593539260|FG000|Overall Study|Non-compliance|1|||
164317546|NCT00422084|593539261|FG001|Overall Study|Non-compliance|0|||
164317547|NCT00422084|593539260|FG000|Overall Study|Re-location|0|||
164317548|NCT00422084|593539261|FG001|Overall Study|Re-location|1|||
164317549|NCT00422084|593539260|FG000|Overall Study|Not defined|1|||
164317550|NCT00422084|593539261|FG001|Overall Study|Not defined|1|||
164317551|NCT01579812|593539262|FG000|Overall Study|Ineligible after treatment start|40|||
164317552|NCT01579812|593539262|FG000|Overall Study|Patient choice|3|||
164317553|NCT01579812|593539262|FG000|Overall Study|Noncompliance|3|||
164317554|NCT01579812|593539262|FG000|Overall Study|Withdrawal by Subject|6|||
164317555|NCT00653432|593539263|FG000|Overall Study|Adverse Event|4|||
164317556|NCT00653432|593539264|FG001|Overall Study|Adverse Event|1|||
164317557|NCT00653432|593539263|FG000|Overall Study|Withdrawal by Subject|4|||
164317558|NCT00653432|593539264|FG001|Overall Study|Withdrawal by Subject|5|||
164317559|NCT00653432|593539263|FG000|Overall Study|Lost to Follow-up|7|||
164317560|NCT00653432|593539264|FG001|Overall Study|Lost to Follow-up|6|||
164317561|NCT00653432|593539263|FG000|Overall Study|Use/Need of Con Therapy|2|||
164317562|NCT00653432|593539264|FG001|Overall Study|Use/Need of Con Therapy|1|||
164317563|NCT00653432|593539263|FG000|Overall Study|Other - Reason Not Provided|5|||
164317564|NCT00653432|593539264|FG001|Overall Study|Other - Reason Not Provided|3|||
164317565|NCT00357760|593539265|FG000|Overall Study|Disease progression|44|||
164317566|NCT00357760|593539266|FG001|Overall Study|Disease progression|17|||
164317567|NCT00357760|593539265|FG000|Overall Study|Adverse Event|10|||
164317568|NCT00357760|593539266|FG001|Overall Study|Adverse Event|7|||
164317569|NCT00357760|593539265|FG000|Overall Study|Death|0|||
164317570|NCT00357760|593539266|FG001|Overall Study|Death|3|||
164317571|NCT00357760|593539265|FG000|Overall Study|Alternative therapy|1|||
164317572|NCT00357760|593539266|FG001|Overall Study|Alternative therapy|0|||
164317573|NCT00357760|593539265|FG000|Overall Study|Withdrawal by Subject|0|||
164317574|NCT00357760|593539266|FG001|Overall Study|Withdrawal by Subject|2|||
164317575|NCT00357760|593539265|FG000|Overall Study|Never started treatment|2|||
164317576|NCT00357760|593539266|FG001|Overall Study|Never started treatment|1|||
164317577|NCT00357760|593539265|FG000|Overall Study|Ineligible|0|||
164317578|NCT00357760|593539266|FG001|Overall Study|Ineligible|2|||
164317579|NCT00357760|593539265|FG000|Overall Study|Physician Decision|2|||
163873358|NCT02723955|591906842|FG009|Expansion Phase|Death|25|||
163873359|NCT02723955|591906843|FG010|Expansion Phase|Death|69|||
163873360|NCT02723955|591906844|FG011|Expansion Phase|Death|48|||
163873361|NCT02723955|591906845|FG012|Expansion Phase|Death|0|||
163873362|NCT02723955|591906846|FG013|Expansion Phase|Death|0|||
164317580|NCT00357760|593539266|FG001|Overall Study|Physician Decision|1|||
164317581|NCT00357760|593539265|FG000|Overall Study|Protocol Violation|0|||
164317582|NCT00357760|593539266|FG001|Overall Study|Protocol Violation|1|||
164317583|NCT00357760|593539265|FG000|Overall Study|To receive hospice care|0|||
163873363|NCT02723955|591906847|FG014|Expansion Phase|Death|0|||
163873364|NCT02723955|591906848|FG015|Expansion Phase|Death|0|||
164317584|NCT00357760|593539266|FG001|Overall Study|To receive hospice care|1|||
163873365|NCT02723955|591906849|FG016|Expansion Phase|Death|0|||
163873366|NCT02723955|591906850|FG017|Expansion Phase|Death|0|||
164317585|NCT02353143|593539267|FG000|Overall Study|Withdrawal by Subject|1|||
164317586|NCT02353143|593539268|FG001|Overall Study|Withdrawal by Subject|0|||
164317587|NCT02353143|593539269|FG002|Overall Study|Withdrawal by Subject|0|||
164317588|NCT02353143|593539270|FG003|Overall Study|Withdrawal by Subject|0|||
164317589|NCT02353143|593539271|FG004|Overall Study|Withdrawal by Subject|1|||
164317590|NCT02353143|593539272|FG005|Overall Study|Withdrawal by Subject|0|||
164317591|NCT02353143|593539273|FG006|Overall Study|Withdrawal by Subject|0|||
164317592|NCT02353143|593539274|FG007|Overall Study|Withdrawal by Subject|1|||
164317593|NCT02353143|593539275|FG008|Overall Study|Withdrawal by Subject|1|||
164317594|NCT02353143|593539267|FG000|Overall Study|Lack of Efficacy|2|||
164317595|NCT02353143|593539268|FG001|Overall Study|Lack of Efficacy|1|||
164317596|NCT02353143|593539269|FG002|Overall Study|Lack of Efficacy|2|||
164317597|NCT02353143|593539270|FG003|Overall Study|Lack of Efficacy|4|||
164317598|NCT02353143|593539271|FG004|Overall Study|Lack of Efficacy|13|||
164317599|NCT02353143|593539272|FG005|Overall Study|Lack of Efficacy|2|||
164317600|NCT02353143|593539273|FG006|Overall Study|Lack of Efficacy|2|||
164317601|NCT02353143|593539274|FG007|Overall Study|Lack of Efficacy|2|||
164317602|NCT02353143|593539275|FG008|Overall Study|Lack of Efficacy|1|||
164317603|NCT02353143|593539267|FG000|Overall Study|reason not specified|1|||
164317604|NCT02353143|593539268|FG001|Overall Study|reason not specified|2|||
164317605|NCT02353143|593539269|FG002|Overall Study|reason not specified|0|||
164317606|NCT02353143|593539270|FG003|Overall Study|reason not specified|0|||
164317607|NCT02353143|593539271|FG004|Overall Study|reason not specified|6|||
164317608|NCT02353143|593539272|FG005|Overall Study|reason not specified|1|||
164317609|NCT02353143|593539273|FG006|Overall Study|reason not specified|0|||
164317610|NCT02353143|593539274|FG007|Overall Study|reason not specified|3|||
164317611|NCT02353143|593539275|FG008|Overall Study|reason not specified|1|||
164317612|NCT02353143|593539267|FG000|Overall Study|Physician Decision|0|||
164317613|NCT02353143|593539268|FG001|Overall Study|Physician Decision|4|||
164317614|NCT02353143|593539269|FG002|Overall Study|Physician Decision|2|||
164317615|NCT02353143|593539270|FG003|Overall Study|Physician Decision|3|||
164317616|NCT02353143|593539271|FG004|Overall Study|Physician Decision|4|||
164317617|NCT02353143|593539272|FG005|Overall Study|Physician Decision|0|||
164317618|NCT02353143|593539273|FG006|Overall Study|Physician Decision|1|||
164317619|NCT02353143|593539274|FG007|Overall Study|Physician Decision|2|||
164317620|NCT02353143|593539275|FG008|Overall Study|Physician Decision|0|||
164317621|NCT02353143|593539267|FG000|Overall Study|Adverse Event|0|||
164317622|NCT02353143|593539268|FG001|Overall Study|Adverse Event|0|||
164317623|NCT02353143|593539269|FG002|Overall Study|Adverse Event|1|||
164317624|NCT02353143|593539270|FG003|Overall Study|Adverse Event|0|||
164317625|NCT02353143|593539271|FG004|Overall Study|Adverse Event|1|||
164317626|NCT02353143|593539272|FG005|Overall Study|Adverse Event|1|||
164317627|NCT02353143|593539273|FG006|Overall Study|Adverse Event|0|||
164317628|NCT02353143|593539274|FG007|Overall Study|Adverse Event|0|||
164317629|NCT02353143|593539275|FG008|Overall Study|Adverse Event|0|||
164317630|NCT02353143|593539267|FG000|Overall Study|patient receiving other treatment for AML|0|||
164317631|NCT02353143|593539268|FG001|Overall Study|patient receiving other treatment for AML|0|||
164317632|NCT02353143|593539269|FG002|Overall Study|patient receiving other treatment for AML|1|||
164317633|NCT02353143|593539270|FG003|Overall Study|patient receiving other treatment for AML|0|||
164317634|NCT02353143|593539271|FG004|Overall Study|patient receiving other treatment for AML|0|||
164317635|NCT02353143|593539272|FG005|Overall Study|patient receiving other treatment for AML|0|||
164317636|NCT02353143|593539273|FG006|Overall Study|patient receiving other treatment for AML|0|||
164317637|NCT02353143|593539274|FG007|Overall Study|patient receiving other treatment for AML|0|||
164317638|NCT02353143|593539275|FG008|Overall Study|patient receiving other treatment for AML|0|||
164317639|NCT02353143|593539267|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
164317640|NCT02353143|593539268|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
164317641|NCT02353143|593539269|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
164317642|NCT02353143|593539270|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
164317643|NCT02353143|593539271|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
164317644|NCT02353143|593539272|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
164317645|NCT02353143|593539273|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
164317646|NCT02353143|593539274|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
164317647|NCT02353143|593539275|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
164317648|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
164317649|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
164317650|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
164317651|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
164317652|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
164317653|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
164317654|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164317655|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
163977632|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
164317656|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
164317657|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164317658|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
163873367|NCT02723955|591906851|FG018|Expansion Phase|Death|0|||
163873368|NCT02723955|591906852|FG019|Expansion Phase|Death|0|||
163873369|NCT02723955|591906853|FG020|Expansion Phase|Death|0|||
163873370|NCT02723955|591906854|FG021|Expansion Phase|Death|0|||
163873371|NCT02723955|591906855|FG022|Expansion Phase|Death|0|||
163873372|NCT02723955|591906856|FG023|Expansion Phase|Death|0|||
163873373|NCT02723955|591906857|FG024|Expansion Phase|Death|0|||
163873374|NCT02723955|591906858|FG025|Expansion Phase|Death|0|||
163873375|NCT02723955|591906859|FG026|Expansion Phase|Death|0|||
164317659|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164317660|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317661|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317662|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
164317663|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317664|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
164317665|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
164317666|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
164317667|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317668|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317669|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317670|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317671|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
164317672|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
164317673|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
164317674|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
164317675|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
163873376|NCT02723955|591906860|FG027|Expansion Phase|Death|0|||
163873377|NCT02723955|591906861|FG028|Expansion Phase|Death|0|||
163873378|NCT02723955|591906862|FG029|Expansion Phase|Death|12|||
163873379|NCT02723955|591906863|FG030|Expansion Phase|Death|202|||
163873380|NCT02723955|591906864|FG031|Expansion Phase|Death|31|||
163873381|NCT02723955|591906865|FG032|Expansion Phase|Death|17|||
163873382|NCT02723955|591906866|FG033|Expansion Phase|Death|2|||
163873383|NCT02723955|591906867|FG034|Expansion Phase|Death|3|||
163873384|NCT02723955|591906868|FG035|Expansion Phase|Death|3|||
163873385|NCT02723955|591906869|FG036|Expansion Phase|Death|1|||
163873386|NCT02723955|591906870|FG037|Expansion Phase|Death|0|||
163873387|NCT02723955|591906871|FG038|Expansion Phase|Death|0|||
163873388|NCT02723955|591906872|FG039|Expansion Phase|Death|0|||
163873389|NCT02723955|591906873|FG040|Expansion Phase|Death|0|||
163873390|NCT02723955|591906874|FG041|Expansion Phase|Death|0|||
163873391|NCT02723955|591906875|FG042|Expansion Phase|Death|0|||
163873392|NCT02723955|591906833|FG000|Expansion Phase|Lost to Follow-up|0|||
163873393|NCT02723955|591906834|FG001|Expansion Phase|Lost to Follow-up|0|||
163873394|NCT02723955|591906835|FG002|Expansion Phase|Lost to Follow-up|0|||
163873395|NCT02723955|591906836|FG003|Expansion Phase|Lost to Follow-up|0|||
163873396|NCT02723955|591906837|FG004|Expansion Phase|Lost to Follow-up|0|||
163873397|NCT02723955|591906838|FG005|Expansion Phase|Lost to Follow-up|0|||
163873398|NCT02723955|591906839|FG006|Expansion Phase|Lost to Follow-up|0|||
163873399|NCT02723955|591906840|FG007|Expansion Phase|Lost to Follow-up|0|||
163873400|NCT02723955|591906841|FG008|Expansion Phase|Lost to Follow-up|0|||
163873401|NCT02723955|591906842|FG009|Expansion Phase|Lost to Follow-up|0|||
163873402|NCT02723955|591906843|FG010|Expansion Phase|Lost to Follow-up|4|||
163873403|NCT02723955|591906844|FG011|Expansion Phase|Lost to Follow-up|1|||
163873404|NCT02723955|591906845|FG012|Expansion Phase|Lost to Follow-up|0|||
163873405|NCT02723955|591906846|FG013|Expansion Phase|Lost to Follow-up|0|||
163873406|NCT02723955|591906847|FG014|Expansion Phase|Lost to Follow-up|0|||
163873407|NCT02723955|591906848|FG015|Expansion Phase|Lost to Follow-up|0|||
163873408|NCT02723955|591906849|FG016|Expansion Phase|Lost to Follow-up|0|||
163977633|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
163873409|NCT02723955|591906850|FG017|Expansion Phase|Lost to Follow-up|0|||
163873410|NCT02723955|591906851|FG018|Expansion Phase|Lost to Follow-up|0|||
163873411|NCT02723955|591906852|FG019|Expansion Phase|Lost to Follow-up|0|||
163873412|NCT02723955|591906853|FG020|Expansion Phase|Lost to Follow-up|0|||
163873413|NCT02723955|591906854|FG021|Expansion Phase|Lost to Follow-up|0|||
163873414|NCT02723955|591906855|FG022|Expansion Phase|Lost to Follow-up|0|||
163873415|NCT02723955|591906856|FG023|Expansion Phase|Lost to Follow-up|0|||
163977634|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
163873416|NCT02723955|591906857|FG024|Expansion Phase|Lost to Follow-up|0|||
163873417|NCT02723955|591906858|FG025|Expansion Phase|Lost to Follow-up|0|||
163873418|NCT02723955|591906859|FG026|Expansion Phase|Lost to Follow-up|0|||
163873419|NCT02723955|591906860|FG027|Expansion Phase|Lost to Follow-up|0|||
163873420|NCT02723955|591906861|FG028|Expansion Phase|Lost to Follow-up|0|||
163873421|NCT02723955|591906862|FG029|Expansion Phase|Lost to Follow-up|1|||
163873422|NCT02723955|591906863|FG030|Expansion Phase|Lost to Follow-up|19|||
163873423|NCT02723955|591906864|FG031|Expansion Phase|Lost to Follow-up|2|||
163873424|NCT02723955|591906865|FG032|Expansion Phase|Lost to Follow-up|1|||
163873425|NCT02723955|591906866|FG033|Expansion Phase|Lost to Follow-up|0|||
163977635|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
163977636|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
163977637|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
163977638|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
163977639|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
163977640|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
163977641|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
163977642|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
163977643|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
163977644|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
163977645|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
163977646|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
163977647|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
163977648|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
163977649|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
163977650|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
163977651|NCT02831673|592290868|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
163977652|NCT02831673|592290869|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
163977653|NCT02831673|592290870|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
163977654|NCT02831673|592290871|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
163977655|NCT02831673|592290872|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
163977656|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163977657|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163977658|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
163977659|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
163977660|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
163977661|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163977662|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163977663|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
163977664|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
163977665|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
163977666|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163977667|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163977668|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163977669|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
163977670|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
163977671|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
163977672|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
163977673|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
163977674|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
164205551|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
164205552|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
164205553|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
164205554|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
164205555|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
164205556|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
164205557|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
164205558|NCT00849056|593122634|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
164205559|NCT00849056|593122635|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
164205560|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
164205561|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
164205562|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
164205563|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
164205564|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
164205565|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
164205566|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
164205567|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
164205568|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
164205569|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
164205570|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
164205571|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
164205572|NCT00849056|593122634|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
164205573|NCT00849056|593122635|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
164205574|NCT04588259|593122636|FG000|Run-in period|Run-in failure|0|||
164205575|NCT04588259|593122637|FG001|Run-in period|Run-in failure|23|||
163977675|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
163977676|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163977677|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163977678|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
163977679|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
163977680|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
163977681|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163977682|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163977683|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
163977684|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
163977685|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
163977686|NCT02831673|592290868|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163977687|NCT02831673|592290869|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163977688|NCT02831673|592290870|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
163977689|NCT02831673|592290871|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
163977690|NCT02831673|592290872|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
163977691|NCT02831673|592290868|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
164317676|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
164317677|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
164317678|NCT00600119|593539276|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
164317679|NCT00600119|593539277|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
164317680|NCT00600119|593539278|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317681|NCT00600119|593539279|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317682|NCT00600119|593539280|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317683|NCT00600119|593539281|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
164317684|NCT00600119|593539276|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
164317685|NCT00600119|593539277|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164317686|NCT00600119|593539278|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164317687|NCT00600119|593539279|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
164317688|NCT00600119|593539280|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
164317689|NCT00600119|593539281|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
164317690|NCT00600119|593539276|FG000|Double-blind Treatment Period|Other|0|||
164317691|NCT00600119|593539277|FG001|Double-blind Treatment Period|Other|0|||
163873426|NCT02723955|591906867|FG034|Expansion Phase|Lost to Follow-up|0|||
163873427|NCT02723955|591906868|FG035|Expansion Phase|Lost to Follow-up|0|||
163873428|NCT02723955|591906869|FG036|Expansion Phase|Lost to Follow-up|0|||
163873429|NCT02723955|591906870|FG037|Expansion Phase|Lost to Follow-up|0|||
163873430|NCT02723955|591906871|FG038|Expansion Phase|Lost to Follow-up|0|||
163873431|NCT02723955|591906872|FG039|Expansion Phase|Lost to Follow-up|0|||
163873432|NCT02723955|591906873|FG040|Expansion Phase|Lost to Follow-up|0|||
163873433|NCT02723955|591906874|FG041|Expansion Phase|Lost to Follow-up|0|||
163873434|NCT02723955|591906875|FG042|Expansion Phase|Lost to Follow-up|0|||
163873435|NCT02723955|591906833|FG000|Expansion Phase|Physician Decision|0|||
163873436|NCT02723955|591906834|FG001|Expansion Phase|Physician Decision|0|||
163873437|NCT02723955|591906835|FG002|Expansion Phase|Physician Decision|0|||
163873438|NCT02723955|591906836|FG003|Expansion Phase|Physician Decision|0|||
163873439|NCT02723955|591906837|FG004|Expansion Phase|Physician Decision|0|||
163873440|NCT02723955|591906838|FG005|Expansion Phase|Physician Decision|0|||
163873441|NCT02723955|591906839|FG006|Expansion Phase|Physician Decision|0|||
163873442|NCT02723955|591906840|FG007|Expansion Phase|Physician Decision|0|||
163873443|NCT02723955|591906841|FG008|Expansion Phase|Physician Decision|0|||
163873444|NCT02723955|591906842|FG009|Expansion Phase|Physician Decision|0|||
163873445|NCT02723955|591906843|FG010|Expansion Phase|Physician Decision|0|||
163873446|NCT02723955|591906844|FG011|Expansion Phase|Physician Decision|0|||
163873447|NCT02723955|591906845|FG012|Expansion Phase|Physician Decision|0|||
163873448|NCT02723955|591906846|FG013|Expansion Phase|Physician Decision|0|||
163873449|NCT02723955|591906847|FG014|Expansion Phase|Physician Decision|0|||
163873450|NCT02723955|591906848|FG015|Expansion Phase|Physician Decision|0|||
163873451|NCT02723955|591906849|FG016|Expansion Phase|Physician Decision|0|||
163873452|NCT02723955|591906850|FG017|Expansion Phase|Physician Decision|0|||
163873453|NCT02723955|591906851|FG018|Expansion Phase|Physician Decision|0|||
163873454|NCT02723955|591906852|FG019|Expansion Phase|Physician Decision|0|||
163873455|NCT02723955|591906853|FG020|Expansion Phase|Physician Decision|0|||
163873456|NCT02723955|591906854|FG021|Expansion Phase|Physician Decision|0|||
163873457|NCT02723955|591906855|FG022|Expansion Phase|Physician Decision|0|||
163873458|NCT02723955|591906856|FG023|Expansion Phase|Physician Decision|0|||
163873459|NCT02723955|591906857|FG024|Expansion Phase|Physician Decision|0|||
163873460|NCT02723955|591906858|FG025|Expansion Phase|Physician Decision|0|||
163873461|NCT02723955|591906859|FG026|Expansion Phase|Physician Decision|0|||
163873462|NCT02723955|591906860|FG027|Expansion Phase|Physician Decision|0|||
164317692|NCT00600119|593539278|FG002|Double-blind Treatment Period|Other|0|||
164317693|NCT00600119|593539279|FG003|Double-blind Treatment Period|Other|0|||
164317694|NCT00600119|593539280|FG004|Double-blind Treatment Period|Other|2|||
164317695|NCT00600119|593539281|FG005|Double-blind Treatment Period|Other|1|||
164317696|NCT00600119|593539276|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317697|NCT00600119|593539277|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
164317698|NCT00600119|593539278|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317699|NCT00600119|593539279|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317700|NCT00600119|593539280|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
164317701|NCT00600119|593539281|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
164317702|NCT00600119|593539276|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317703|NCT00600119|593539277|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
163977692|NCT02831673|592290869|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
163977693|NCT02831673|592290870|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
163977694|NCT02831673|592290871|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
163977695|NCT02831673|592290872|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
163977696|NCT02831673|592290868|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163977697|NCT02831673|592290869|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163977698|NCT02831673|592290870|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163977699|NCT02831673|592290871|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
163977700|NCT02831673|592290872|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
164317704|NCT00600119|593539278|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
163977701|NCT02831673|592290868|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163977702|NCT02831673|592290869|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163977703|NCT02831673|592290870|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163977704|NCT02831673|592290871|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
163977705|NCT02831673|592290872|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
163977706|NCT02831673|592290868|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163977707|NCT02831673|592290869|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163977708|NCT02831673|592290870|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163977709|NCT02831673|592290871|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
163977710|NCT02831673|592290872|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
163977711|NCT02831673|592290868|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163977712|NCT02831673|592290869|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163977713|NCT02831673|592290870|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163977714|NCT02831673|592290871|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
163977715|NCT02831673|592290872|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
163977716|NCT00001379|592290873|FG000|Initial Treatment|Disease progression|21|||
163977717|NCT00001379|592290874|FG001|Initial Treatment|Disease progression|3|||
163977718|NCT00001379|592290875|FG002|Initial Treatment|Disease progression|0|||
163977719|NCT00001379|592290876|FG003|Initial Treatment|Disease progression|0|||
163977720|NCT00001379|592290873|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
163977721|NCT00001379|592290874|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
163977722|NCT00001379|592290875|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
163977723|NCT00001379|592290876|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
163977724|NCT00001379|592290873|FG000|Initial Treatment|Received alternative treatment|2|||
163977725|NCT00001379|592290874|FG001|Initial Treatment|Received alternative treatment|1|||
163977726|NCT00001379|592290875|FG002|Initial Treatment|Received alternative treatment|0|||
163977727|NCT00001379|592290876|FG003|Initial Treatment|Received alternative treatment|0|||
163977728|NCT00001379|592290873|FG000|Initial Treatment|Refused further treatment|2|||
163977729|NCT00001379|592290874|FG001|Initial Treatment|Refused further treatment|0|||
163977730|NCT00001379|592290875|FG002|Initial Treatment|Refused further treatment|0|||
163977731|NCT00001379|592290876|FG003|Initial Treatment|Refused further treatment|0|||
163977732|NCT00001379|592290873|FG000|Initial Treatment|Did not receive protocol treatment|0|||
163977733|NCT00001379|592290874|FG001|Initial Treatment|Did not receive protocol treatment|0|||
163977734|NCT00001379|592290875|FG002|Initial Treatment|Did not receive protocol treatment|5|||
164317705|NCT00600119|593539279|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317706|NCT00600119|593539280|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317707|NCT00600119|593539281|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
164317708|NCT00600119|593539276|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
164317709|NCT00600119|593539277|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
164317710|NCT00600119|593539278|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
163977735|NCT00001379|592290876|FG003|Initial Treatment|Did not receive protocol treatment|0|||
164317711|NCT00600119|593539279|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
164317712|NCT00600119|593539280|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
163977736|NCT00001379|592290873|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
163977737|NCT00001379|592290874|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
163977738|NCT00001379|592290875|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
163977739|NCT00001379|592290876|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
163977740|NCT00001379|592290873|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
163977741|NCT00001379|592290874|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
163977742|NCT00001379|592290875|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
163977743|NCT00001379|592290876|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
164205576|NCT04588259|593122636|FG000|Run-in period|Withdrawn before randomisation|0|||
164205577|NCT04588259|593122637|FG001|Run-in period|Withdrawn before randomisation|8|||
164205578|NCT04588259|593122636|FG000|Treatment period|Withdrawal by Subject|6|||
164205579|NCT04588259|593122637|FG001|Treatment period|Withdrawal by Subject|6|||
164205580|NCT02100631|593122641|FG000|Overall Study|Withdrawal by Subject|1|||
164205581|NCT02100631|593122642|FG001|Overall Study|Withdrawal by Subject|0|||
164205582|NCT02100631|593122643|FG002|Overall Study|Withdrawal by Subject|0|||
164205583|NCT02100631|593122641|FG000|Overall Study|Lost to Follow-up|3|||
164205584|NCT02100631|593122642|FG001|Overall Study|Lost to Follow-up|4|||
164205585|NCT02100631|593122643|FG002|Overall Study|Lost to Follow-up|0|||
164205586|NCT02100631|593122641|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
164205587|NCT02100631|593122642|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
164205588|NCT02100631|593122643|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
164205589|NCT04476043|593122644|FG000|Overall Study|Withdrawal by Subject|1|||
164205590|NCT04476043|593122645|FG001|Overall Study|Withdrawal by Subject|3|||
164205591|NCT04476043|593122646|FG002|Overall Study|Withdrawal by Subject|4|||
164205592|NCT04476043|593122647|FG003|Overall Study|Withdrawal by Subject|1|||
164205593|NCT04476043|593122644|FG000|Overall Study|Lost to Follow-up|1|||
164205594|NCT04476043|593122645|FG001|Overall Study|Lost to Follow-up|1|||
164205595|NCT04476043|593122646|FG002|Overall Study|Lost to Follow-up|2|||
164205596|NCT04476043|593122647|FG003|Overall Study|Lost to Follow-up|1|||
164205597|NCT04476043|593122644|FG000|Overall Study|Adverse Event|2|||
164205598|NCT04476043|593122645|FG001|Overall Study|Adverse Event|0|||
164205599|NCT04476043|593122646|FG002|Overall Study|Adverse Event|1|||
164205600|NCT04476043|593122647|FG003|Overall Study|Adverse Event|0|||
164205601|NCT04476043|593122644|FG000|Overall Study|Protocol Violation|0|||
164205602|NCT04476043|593122645|FG001|Overall Study|Protocol Violation|1|||
164205603|NCT04476043|593122646|FG002|Overall Study|Protocol Violation|0|||
164205604|NCT04476043|593122647|FG003|Overall Study|Protocol Violation|0|||
164205605|NCT00715208|593122648|FG000|Overall Study|Withdrawal by Subject|1|||
164205606|NCT00715208|593122649|FG001|Overall Study|Withdrawal by Subject|1|||
164205607|NCT00715208|593122648|FG000|Overall Study|Adverse Event|0|||
164205608|NCT00715208|593122649|FG001|Overall Study|Adverse Event|6|||
164205609|NCT00715208|593122648|FG000|Overall Study|Lack of Efficacy|0|||
164205610|NCT00715208|593122649|FG001|Overall Study|Lack of Efficacy|2|||
164205611|NCT01648764|593122650|FG000|Overall Study|Progressive Disease|0|||
164205612|NCT01648764|593122651|FG001|Overall Study|Progressive Disease|1|||
164205613|NCT01648764|593122652|FG002|Overall Study|Progressive Disease|0|||
164205614|NCT01648764|593122653|FG003|Overall Study|Progressive Disease|0|||
164205615|NCT01648764|593122654|FG004|Overall Study|Progressive Disease|0|||
164205616|NCT01648764|593122655|FG005|Overall Study|Progressive Disease|1|||
164205617|NCT01648764|593122656|FG006|Overall Study|Progressive Disease|1|||
164205618|NCT01648764|593122657|FG007|Overall Study|Progressive Disease|0|||
164205619|NCT01648764|593122658|FG008|Overall Study|Progressive Disease|0|||
164205620|NCT01648764|593122659|FG009|Overall Study|Progressive Disease|2|||
164205621|NCT01648764|593122660|FG010|Overall Study|Progressive Disease|0|||
164205622|NCT01648764|593122661|FG011|Overall Study|Progressive Disease|1|||
164205623|NCT01648764|593122662|FG012|Overall Study|Progressive Disease|2|||
164205624|NCT01648764|593122663|FG013|Overall Study|Progressive Disease|1|||
164205625|NCT01648764|593122650|FG000|Overall Study|Adverse Event|0|||
164205626|NCT01648764|593122651|FG001|Overall Study|Adverse Event|0|||
164205627|NCT01648764|593122652|FG002|Overall Study|Adverse Event|0|||
164205628|NCT01648764|593122653|FG003|Overall Study|Adverse Event|0|||
164205629|NCT01648764|593122654|FG004|Overall Study|Adverse Event|0|||
164205630|NCT01648764|593122655|FG005|Overall Study|Adverse Event|1|||
164205631|NCT01648764|593122656|FG006|Overall Study|Adverse Event|0|||
164205632|NCT01648764|593122657|FG007|Overall Study|Adverse Event|0|||
164205633|NCT01648764|593122658|FG008|Overall Study|Adverse Event|0|||
164205634|NCT01648764|593122659|FG009|Overall Study|Adverse Event|1|||
164205635|NCT01648764|593122660|FG010|Overall Study|Adverse Event|0|||
164205636|NCT01648764|593122661|FG011|Overall Study|Adverse Event|3|||
164205637|NCT01648764|593122662|FG012|Overall Study|Adverse Event|1|||
164205638|NCT01648764|593122663|FG013|Overall Study|Adverse Event|1|||
164205639|NCT01648764|593122650|FG000|Overall Study|Death|0|||
164205640|NCT01648764|593122651|FG001|Overall Study|Death|0|||
164205641|NCT01648764|593122652|FG002|Overall Study|Death|0|||
164205642|NCT01648764|593122653|FG003|Overall Study|Death|0|||
164317713|NCT00600119|593539281|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
164317714|NCT00600119|593539276|FG000|Double-blind Treatment Period|Physician Decision|2|||
164317715|NCT00600119|593539277|FG001|Double-blind Treatment Period|Physician Decision|0|||
164317716|NCT00600119|593539278|FG002|Double-blind Treatment Period|Physician Decision|0|||
164317717|NCT00600119|593539279|FG003|Double-blind Treatment Period|Physician Decision|0|||
164317718|NCT00600119|593539280|FG004|Double-blind Treatment Period|Physician Decision|0|||
164317719|NCT00600119|593539281|FG005|Double-blind Treatment Period|Physician Decision|0|||
164317720|NCT00600119|593539276|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164317721|NCT00600119|593539277|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164317722|NCT00600119|593539278|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164317723|NCT00600119|593539279|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164317724|NCT00600119|593539280|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
164317725|NCT00600119|593539281|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
164317726|NCT00600119|593539276|FG000|Double-blind Treatment Period|Adverse Event|1|||
164317727|NCT00600119|593539277|FG001|Double-blind Treatment Period|Adverse Event|1|||
164317728|NCT00600119|593539278|FG002|Double-blind Treatment Period|Adverse Event|0|||
164317729|NCT00600119|593539279|FG003|Double-blind Treatment Period|Adverse Event|1|||
164317730|NCT00600119|593539280|FG004|Double-blind Treatment Period|Adverse Event|2|||
164317731|NCT00600119|593539281|FG005|Double-blind Treatment Period|Adverse Event|10|||
164317732|NCT00600119|593539276|FG000|Follow-up Period|Adverse Event|0|||
164317733|NCT00600119|593539277|FG001|Follow-up Period|Adverse Event|0|||
164317734|NCT00600119|593539278|FG002|Follow-up Period|Adverse Event|0|||
164317735|NCT00600119|593539279|FG003|Follow-up Period|Adverse Event|0|||
164317736|NCT00600119|593539280|FG004|Follow-up Period|Adverse Event|0|||
164317737|NCT00600119|593539281|FG005|Follow-up Period|Adverse Event|1|||
164317738|NCT00600119|593539276|FG000|Follow-up Period|Other|1|||
163977744|NCT00001379|592290873|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
163977745|NCT00001379|592290874|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
163977746|NCT00001379|592290875|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
163977747|NCT00001379|592290876|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
163977748|NCT00001379|592290873|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
163977749|NCT00001379|592290874|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
163977750|NCT00001379|592290875|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
163977751|NCT00001379|592290876|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
163977752|NCT00001379|592290873|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
163977753|NCT00001379|592290874|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
163977754|NCT00001379|592290875|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
163977755|NCT00001379|592290876|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
163977756|NCT00264875|592290877|FG000|Overall Study|Adverse Event|6|||
163977757|NCT00264875|592290877|FG000|Overall Study|Lost to Follow-up|6|||
163977758|NCT00264875|592290877|FG000|Overall Study|Protocol Violation|11|||
163977759|NCT00264875|592290877|FG000|Overall Study|Withdrawal by Subject|7|||
163977760|NCT01500278|592290879|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
163977761|NCT01500278|592290880|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
163977762|NCT01500278|592290879|FG000|Week 0 - Week 12|Protocol Violation|10|||
163977763|NCT01500278|592290880|FG001|Week 0 - Week 12|Protocol Violation|16|||
163977764|NCT01500278|592290879|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
163977765|NCT01500278|592290880|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
163977766|NCT01500278|592290879|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
163977767|NCT01500278|592290880|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
163977768|NCT01500278|592290879|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
163977769|NCT01500278|592290880|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
163977770|NCT01500278|592290879|FG000|Week 0 - Week 12|Patient decision|1|||
163977771|NCT01500278|592290880|FG001|Week 0 - Week 12|Patient decision|0|||
163977772|NCT01500278|592290879|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
163977773|NCT01500278|592290880|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
163977774|NCT01500278|592290879|FG000|Week 0 - Week 12|Investigator decision|1|||
163977775|NCT01500278|592290880|FG001|Week 0 - Week 12|Investigator decision|0|||
163977776|NCT01500278|592290879|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
163977777|NCT01500278|592290880|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
163977778|NCT01500278|592290879|FG000|Week 0 - Week 12|Sponsor decision|1|||
163977779|NCT01500278|592290880|FG001|Week 0 - Week 12|Sponsor decision|0|||
163977780|NCT01500278|592290879|FG000|Week 0 - Week 12|Personal reason|0|||
163977781|NCT01500278|592290880|FG001|Week 0 - Week 12|Personal reason|1|||
163977782|NCT01500278|592290879|FG000|Week 0 - Week 12|Other serious disease|0|||
163977783|NCT01500278|592290880|FG001|Week 0 - Week 12|Other serious disease|1|||
164136053|NCT02906930|592862017|FG000|Overall Study|Death|0|||
164317739|NCT00600119|593539277|FG001|Follow-up Period|Other|0|||
164317740|NCT00600119|593539278|FG002|Follow-up Period|Other|0|||
164317741|NCT00600119|593539279|FG003|Follow-up Period|Other|0|||
164317742|NCT00600119|593539280|FG004|Follow-up Period|Other|0|||
164317743|NCT00600119|593539281|FG005|Follow-up Period|Other|0|||
164317744|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
164317745|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
164317746|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
164317747|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
164317748|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
164317749|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
164317750|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
164317751|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
163977784|NCT01500278|592290879|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
163977785|NCT01500278|592290880|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
163977786|NCT01500278|592290879|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
163977787|NCT01500278|592290880|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
163977788|NCT01500278|592290879|FG000|Week 13 - Week 104|Protocol Violation|6|||
163977789|NCT01500278|592290880|FG001|Week 13 - Week 104|Protocol Violation|6|||
163977790|NCT01500278|592290879|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
163977791|NCT01500278|592290880|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
163977792|NCT01500278|592290879|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
163977793|NCT01500278|592290880|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
163977794|NCT01500278|592290879|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
163977795|NCT01500278|592290880|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
163977796|NCT01500278|592290879|FG000|Week 13 - Week 104|Non/bad compliance|7|||
163977797|NCT01500278|592290880|FG001|Week 13 - Week 104|Non/bad compliance|5|||
164317752|NCT04740905|593539282|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
164317753|NCT04740905|593539283|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
164317754|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
164317755|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
164317756|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
164317757|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
164317758|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
164317759|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
164317760|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
164317761|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
164317762|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
164317763|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
164317764|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
164317765|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
164317766|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
164317767|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
164317768|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
164317769|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
164317770|NCT04740905|593539282|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
164317771|NCT04740905|593539283|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
164317772|NCT00561977|593539284|FG000|Overall Study|Withdrawal by Subject|0|||
164317773|NCT00561977|593539285|FG001|Overall Study|Withdrawal by Subject|2|||
164317774|NCT00561977|593539286|FG002|Overall Study|Withdrawal by Subject|1|||
164317775|NCT00561977|593539284|FG000|Overall Study|Pregnancy|0|||
164317776|NCT00561977|593539285|FG001|Overall Study|Pregnancy|1|||
164317777|NCT00561977|593539286|FG002|Overall Study|Pregnancy|1|||
164317778|NCT03077087|593539287|FG000|Overall Study|Physician Decision|2|||
164317779|NCT01989468|593539288|FG000|Overall Study|Adverse Event|10|||
164317780|NCT01989468|593539289|FG001|Overall Study|Adverse Event|15|||
164317781|NCT01989468|593539290|FG002|Overall Study|Adverse Event|4|||
164317782|NCT01989468|593539291|FG003|Overall Study|Adverse Event|5|||
164317783|NCT01989468|593539292|FG004|Overall Study|Adverse Event|4|||
164317784|NCT01989468|593539288|FG000|Overall Study|Lack of Efficacy|11|||
164317785|NCT01989468|593539289|FG001|Overall Study|Lack of Efficacy|11|||
164317786|NCT01989468|593539290|FG002|Overall Study|Lack of Efficacy|7|||
164317787|NCT01989468|593539291|FG003|Overall Study|Lack of Efficacy|4|||
164317788|NCT01989468|593539292|FG004|Overall Study|Lack of Efficacy|2|||
163977798|NCT01500278|592290879|FG000|Week 13 - Week 104|Recurrent infections|1|||
163977799|NCT01500278|592290880|FG001|Week 13 - Week 104|Recurrent infections|0|||
163977800|NCT01500278|592290879|FG000|Week 13 - Week 104|False positive test|1|||
163977801|NCT01500278|592290880|FG001|Week 13 - Week 104|False positive test|2|||
163977802|NCT01500278|592290879|FG000|Week 13 - Week 104|Sponsor request|4|||
163977803|NCT01500278|592290880|FG001|Week 13 - Week 104|Sponsor request|0|||
164317789|NCT01989468|593539288|FG000|Overall Study|Lost to Follow-up|5|||
164317790|NCT01989468|593539289|FG001|Overall Study|Lost to Follow-up|2|||
164317791|NCT01989468|593539290|FG002|Overall Study|Lost to Follow-up|0|||
164317792|NCT01989468|593539291|FG003|Overall Study|Lost to Follow-up|1|||
164317793|NCT01989468|593539292|FG004|Overall Study|Lost to Follow-up|1|||
164317794|NCT01989468|593539288|FG000|Overall Study|Physician Decision|4|||
164317795|NCT01989468|593539289|FG001|Overall Study|Physician Decision|1|||
164317796|NCT01989468|593539290|FG002|Overall Study|Physician Decision|0|||
164317797|NCT01989468|593539291|FG003|Overall Study|Physician Decision|1|||
164317798|NCT01989468|593539292|FG004|Overall Study|Physician Decision|0|||
164317799|NCT01989468|593539288|FG000|Overall Study|Pregnancy|0|||
164317800|NCT01989468|593539289|FG001|Overall Study|Pregnancy|1|||
164317801|NCT01989468|593539290|FG002|Overall Study|Pregnancy|0|||
164317802|NCT01989468|593539291|FG003|Overall Study|Pregnancy|0|||
164317803|NCT01989468|593539292|FG004|Overall Study|Pregnancy|0|||
164317804|NCT01989468|593539288|FG000|Overall Study|Technical Problems|3|||
164317805|NCT01989468|593539289|FG001|Overall Study|Technical Problems|1|||
164317806|NCT01989468|593539290|FG002|Overall Study|Technical Problems|3|||
164317807|NCT01989468|593539291|FG003|Overall Study|Technical Problems|1|||
164317808|NCT01989468|593539292|FG004|Overall Study|Technical Problems|0|||
164317809|NCT01989468|593539288|FG000|Overall Study|Subject Guardian Decision|11|||
164317810|NCT01989468|593539289|FG001|Overall Study|Subject Guardian Decision|6|||
164317811|NCT01989468|593539290|FG002|Overall Study|Subject Guardian Decision|4|||
163873463|NCT02723955|591906861|FG028|Expansion Phase|Physician Decision|0|||
163873464|NCT02723955|591906862|FG029|Expansion Phase|Physician Decision|0|||
163873465|NCT02723955|591906863|FG030|Expansion Phase|Physician Decision|1|||
163873466|NCT02723955|591906864|FG031|Expansion Phase|Physician Decision|1|||
163873467|NCT02723955|591906865|FG032|Expansion Phase|Physician Decision|0|||
163873468|NCT02723955|591906866|FG033|Expansion Phase|Physician Decision|0|||
163873469|NCT02723955|591906867|FG034|Expansion Phase|Physician Decision|0|||
163873470|NCT02723955|591906868|FG035|Expansion Phase|Physician Decision|0|||
163873471|NCT02723955|591906869|FG036|Expansion Phase|Physician Decision|0|||
163873472|NCT02723955|591906870|FG037|Expansion Phase|Physician Decision|0|||
163873473|NCT02723955|591906871|FG038|Expansion Phase|Physician Decision|0|||
163873474|NCT02723955|591906872|FG039|Expansion Phase|Physician Decision|0|||
163873475|NCT02723955|591906873|FG040|Expansion Phase|Physician Decision|0|||
163873476|NCT02723955|591906874|FG041|Expansion Phase|Physician Decision|0|||
163873477|NCT02723955|591906875|FG042|Expansion Phase|Physician Decision|0|||
163873478|NCT02723955|591906833|FG000|Expansion Phase|Withdrawal by Subject|0|||
163873479|NCT02723955|591906834|FG001|Expansion Phase|Withdrawal by Subject|0|||
163873480|NCT02723955|591906835|FG002|Expansion Phase|Withdrawal by Subject|0|||
163873481|NCT02723955|591906836|FG003|Expansion Phase|Withdrawal by Subject|0|||
163873482|NCT02723955|591906837|FG004|Expansion Phase|Withdrawal by Subject|0|||
163873483|NCT02723955|591906838|FG005|Expansion Phase|Withdrawal by Subject|0|||
163873484|NCT02723955|591906839|FG006|Expansion Phase|Withdrawal by Subject|0|||
163873485|NCT02723955|591906840|FG007|Expansion Phase|Withdrawal by Subject|0|||
163873486|NCT02723955|591906841|FG008|Expansion Phase|Withdrawal by Subject|0|||
163873487|NCT02723955|591906842|FG009|Expansion Phase|Withdrawal by Subject|2|||
163873488|NCT02723955|591906843|FG010|Expansion Phase|Withdrawal by Subject|1|||
163873489|NCT02723955|591906844|FG011|Expansion Phase|Withdrawal by Subject|0|||
163873490|NCT02723955|591906845|FG012|Expansion Phase|Withdrawal by Subject|0|||
163873491|NCT02723955|591906846|FG013|Expansion Phase|Withdrawal by Subject|0|||
163873492|NCT02723955|591906847|FG014|Expansion Phase|Withdrawal by Subject|0|||
163900082|NCT01566890|592005611|FG004|Overall Study|Lost to Follow-up|0|||
163900083|NCT01566890|592005607|FG000|Overall Study|Other|0|||
163900084|NCT01566890|592005608|FG001|Overall Study|Other|0|||
163900085|NCT01566890|592005609|FG002|Overall Study|Other|0|||
163900086|NCT01566890|592005610|FG003|Overall Study|Other|0|||
163900087|NCT01566890|592005611|FG004|Overall Study|Other|7|||
163900088|NCT02397096|592005614|FG000|Day 1 to Week 24|Adverse Event|7|||
163900089|NCT02397096|592005615|FG001|Day 1 to Week 24|Adverse Event|1|||
163900090|NCT02397096|592005614|FG000|Day 1 to Week 24|Death|1|||
163900091|NCT02397096|592005615|FG001|Day 1 to Week 24|Death|0|||
163900092|NCT02397096|592005614|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
163900093|NCT02397096|592005615|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
163900094|NCT02397096|592005614|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
163900095|NCT02397096|592005615|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
163900096|NCT02397096|592005614|FG000|Day 1 to Week 24|Physician Decision|2|||
163900097|NCT02397096|592005615|FG001|Day 1 to Week 24|Physician Decision|3|||
163900098|NCT02397096|592005614|FG000|Day 1 to Week 24|Protocol Violation|1|||
163900099|NCT02397096|592005615|FG001|Day 1 to Week 24|Protocol Violation|4|||
163900100|NCT02397096|592005614|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
163900101|NCT02397096|592005615|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
163900102|NCT02397096|592005614|FG000|Day 1 to Week 24|Randomized, not treated|3|||
163900103|NCT02397096|592005615|FG001|Day 1 to Week 24|Randomized, not treated|0|||
163900104|NCT02397096|592005614|FG000|Week 24 to Week 48|Adverse Event|6|||
163900105|NCT02397096|592005615|FG001|Week 24 to Week 48|Adverse Event|2|||
163900106|NCT02397096|592005614|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
163900107|NCT02397096|592005615|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
163900108|NCT02397096|592005614|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
163900109|NCT02397096|592005615|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
163900110|NCT02397096|592005614|FG000|Week 24 to Week 48|Physician Decision|2|||
163900111|NCT02397096|592005615|FG001|Week 24 to Week 48|Physician Decision|1|||
163900112|NCT02397096|592005614|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
163900113|NCT02397096|592005615|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
163873493|NCT02723955|591906848|FG015|Expansion Phase|Withdrawal by Subject|0|||
163873494|NCT02723955|591906849|FG016|Expansion Phase|Withdrawal by Subject|0|||
163873495|NCT02723955|591906850|FG017|Expansion Phase|Withdrawal by Subject|0|||
163873496|NCT02723955|591906851|FG018|Expansion Phase|Withdrawal by Subject|0|||
163873497|NCT02723955|591906852|FG019|Expansion Phase|Withdrawal by Subject|0|||
163873498|NCT02723955|591906853|FG020|Expansion Phase|Withdrawal by Subject|0|||
163873499|NCT02723955|591906854|FG021|Expansion Phase|Withdrawal by Subject|0|||
163873500|NCT02723955|591906855|FG022|Expansion Phase|Withdrawal by Subject|0|||
163873501|NCT02723955|591906856|FG023|Expansion Phase|Withdrawal by Subject|0|||
163873502|NCT02723955|591906857|FG024|Expansion Phase|Withdrawal by Subject|0|||
163873503|NCT02723955|591906858|FG025|Expansion Phase|Withdrawal by Subject|0|||
163873504|NCT02723955|591906859|FG026|Expansion Phase|Withdrawal by Subject|0|||
163873505|NCT02723955|591906860|FG027|Expansion Phase|Withdrawal by Subject|0|||
163873506|NCT02723955|591906861|FG028|Expansion Phase|Withdrawal by Subject|0|||
163873507|NCT02723955|591906862|FG029|Expansion Phase|Withdrawal by Subject|0|||
163873508|NCT02723955|591906863|FG030|Expansion Phase|Withdrawal by Subject|8|||
163873509|NCT02723955|591906864|FG031|Expansion Phase|Withdrawal by Subject|4|||
163873510|NCT02723955|591906865|FG032|Expansion Phase|Withdrawal by Subject|0|||
163873511|NCT02723955|591906866|FG033|Expansion Phase|Withdrawal by Subject|0|||
163873512|NCT02723955|591906867|FG034|Expansion Phase|Withdrawal by Subject|0|||
163873513|NCT02723955|591906868|FG035|Expansion Phase|Withdrawal by Subject|1|||
163873514|NCT02723955|591906869|FG036|Expansion Phase|Withdrawal by Subject|0|||
163873515|NCT02723955|591906870|FG037|Expansion Phase|Withdrawal by Subject|0|||
163873516|NCT02723955|591906871|FG038|Expansion Phase|Withdrawal by Subject|0|||
163873517|NCT02723955|591906872|FG039|Expansion Phase|Withdrawal by Subject|0|||
163873518|NCT02723955|591906873|FG040|Expansion Phase|Withdrawal by Subject|0|||
163873519|NCT02723955|591906874|FG041|Expansion Phase|Withdrawal by Subject|0|||
163873520|NCT02723955|591906875|FG042|Expansion Phase|Withdrawal by Subject|0|||
163873521|NCT02723955|591906833|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873522|NCT02723955|591906834|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873523|NCT02723955|591906835|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873524|NCT02723955|591906836|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873525|NCT02723955|591906837|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873526|NCT02723955|591906838|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873527|NCT02723955|591906839|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873528|NCT02723955|591906840|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873529|NCT02723955|591906841|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873530|NCT02723955|591906842|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
163873531|NCT02723955|591906843|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
163873532|NCT02723955|591906844|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
163873533|NCT02723955|591906845|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873534|NCT02723955|591906846|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873535|NCT02723955|591906847|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873536|NCT02723955|591906848|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873537|NCT02723955|591906849|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873538|NCT02723955|591906850|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873539|NCT02723955|591906851|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873540|NCT02723955|591906852|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873541|NCT02723955|591906853|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873542|NCT02723955|591906854|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873543|NCT02723955|591906855|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873544|NCT02723955|591906856|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873545|NCT02723955|591906857|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873546|NCT02723955|591906858|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873547|NCT02723955|591906859|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873548|NCT02723955|591906860|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873549|NCT02723955|591906861|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873550|NCT02723955|591906862|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873551|NCT02723955|591906863|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
164136054|NCT02906930|592862018|FG001|Overall Study|Death|0|||
164317812|NCT01989468|593539291|FG003|Overall Study|Subject Guardian Decision|4|||
164317813|NCT01989468|593539292|FG004|Overall Study|Subject Guardian Decision|1|||
164317814|NCT01989468|593539288|FG000|Overall Study|Death|3|||
164317815|NCT01989468|593539289|FG001|Overall Study|Death|0|||
164317816|NCT01989468|593539290|FG002|Overall Study|Death|1|||
164317817|NCT01989468|593539291|FG003|Overall Study|Death|0|||
164317818|NCT01989468|593539292|FG004|Overall Study|Death|0|||
164317819|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317820|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317821|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317822|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317823|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317824|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
164317825|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
164317826|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317827|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317828|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
164317829|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317830|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317831|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317832|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
164317833|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
164317834|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317835|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317836|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317837|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317838|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317839|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
164317840|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
164317841|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
164317842|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
164317843|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
164317844|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
164317845|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
164317846|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
164317847|NCT00065429|593539295|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317848|NCT00065429|593539296|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317849|NCT00065429|593539297|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317850|NCT00065429|593539298|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
164317851|NCT00065429|593539299|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
164317852|NCT00065429|593539300|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
164317853|NCT00065429|593539301|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
164317854|NCT00065429|593539295|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317855|NCT00065429|593539296|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317856|NCT00065429|593539297|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317857|NCT00065429|593539298|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317858|NCT00065429|593539299|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
164317859|NCT00065429|593539300|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317860|NCT00065429|593539301|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
164317861|NCT00065429|593539295|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317862|NCT00065429|593539296|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317863|NCT00065429|593539297|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317864|NCT00065429|593539298|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317865|NCT00065429|593539299|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
164317866|NCT00065429|593539300|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317867|NCT00065429|593539301|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
164317868|NCT00977080|593539302|FG000|Overall Study|Adverse Event|2|||
164317869|NCT00977080|593539303|FG001|Overall Study|Adverse Event|7|||
164317870|NCT00977080|593539304|FG002|Overall Study|Adverse Event|7|||
164317871|NCT00977080|593539305|FG003|Overall Study|Adverse Event|7|||
164317872|NCT00977080|593539302|FG000|Overall Study|Withdrawal by Subject|1|||
164317873|NCT00977080|593539303|FG001|Overall Study|Withdrawal by Subject|5|||
164317874|NCT00977080|593539304|FG002|Overall Study|Withdrawal by Subject|1|||
164317875|NCT00977080|593539305|FG003|Overall Study|Withdrawal by Subject|5|||
164317876|NCT00977080|593539302|FG000|Overall Study|Protocol Violation|7|||
164317877|NCT00977080|593539303|FG001|Overall Study|Protocol Violation|3|||
164317878|NCT00977080|593539304|FG002|Overall Study|Protocol Violation|4|||
164317879|NCT00977080|593539305|FG003|Overall Study|Protocol Violation|3|||
164317880|NCT00977080|593539302|FG000|Overall Study|Noncompliance|0|||
164317881|NCT00977080|593539303|FG001|Overall Study|Noncompliance|2|||
164317882|NCT00977080|593539304|FG002|Overall Study|Noncompliance|1|||
164317883|NCT00977080|593539305|FG003|Overall Study|Noncompliance|0|||
164317884|NCT00977080|593539302|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
164317885|NCT00977080|593539303|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
164317886|NCT00977080|593539304|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
164317887|NCT00977080|593539305|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
164317888|NCT00977080|593539302|FG000|Overall Study|Required kidney transplantation|1|||
164317889|NCT00977080|593539303|FG001|Overall Study|Required kidney transplantation|3|||
164317890|NCT00977080|593539304|FG002|Overall Study|Required kidney transplantation|3|||
164317891|NCT00977080|593539305|FG003|Overall Study|Required kidney transplantation|1|||
164317892|NCT00977080|593539302|FG000|Overall Study|Travel for family reasons|1|||
164317893|NCT00977080|593539303|FG001|Overall Study|Travel for family reasons|0|||
164317894|NCT00977080|593539304|FG002|Overall Study|Travel for family reasons|0|||
164317895|NCT00977080|593539305|FG003|Overall Study|Travel for family reasons|0|||
164317896|NCT01950013|593539308|FG000|Overall Study|Withdrawal by Subject|0|||
164317897|NCT01950013|593539309|FG001|Overall Study|Withdrawal by Subject|2|||
164317898|NCT01950013|593539310|FG002|Overall Study|Withdrawal by Subject|0|||
164317899|NCT01765218|593539311|FG000|Overall Study|Protocol Violation|1|||
164317900|NCT01765218|593539312|FG001|Overall Study|Protocol Violation|2|||
164317901|NCT00313781|593539313|FG000|Before Crossover|Death|22|||
164317902|NCT00313781|593539314|FG001|Before Crossover|Death|8|||
164317903|NCT00313781|593539315|FG002|Before Crossover|Death|0|||
164317904|NCT00313781|593539313|FG000|Before Crossover|Lost to Follow-up|0|||
164317905|NCT00313781|593539314|FG001|Before Crossover|Lost to Follow-up|3|||
164317906|NCT00313781|593539315|FG002|Before Crossover|Lost to Follow-up|0|||
164317907|NCT00313781|593539313|FG000|Before Crossover|Withdrawal by Subject|3|||
164317908|NCT00313781|593539314|FG001|Before Crossover|Withdrawal by Subject|1|||
164317909|NCT00313781|593539315|FG002|Before Crossover|Withdrawal by Subject|0|||
164317910|NCT00313781|593539313|FG000|Before Crossover|Other|45|||
164317911|NCT00313781|593539314|FG001|Before Crossover|Other|30|||
164317912|NCT00313781|593539315|FG002|Before Crossover|Other|0|||
164317913|NCT00313781|593539313|FG000|Before Crossover|Crossover|0|||
164317914|NCT00313781|593539314|FG001|Before Crossover|Crossover|37|||
164317915|NCT00313781|593539315|FG002|Before Crossover|Crossover|0|||
164317916|NCT00313781|593539313|FG000|Before Crossover|Randomized, not treated|5|||
164317917|NCT00313781|593539314|FG001|Before Crossover|Randomized, not treated|0|||
164317918|NCT00313781|593539315|FG002|Before Crossover|Randomized, not treated|0|||
164317919|NCT00313781|593539313|FG000|After Crossover|Death|0|||
164317920|NCT00313781|593539314|FG001|After Crossover|Death|0|||
164317921|NCT00313781|593539315|FG002|After Crossover|Death|6|||
164317922|NCT00313781|593539313|FG000|After Crossover|Withdrawal by Subject|0|||
164317923|NCT00313781|593539314|FG001|After Crossover|Withdrawal by Subject|0|||
164317924|NCT00313781|593539315|FG002|After Crossover|Withdrawal by Subject|3|||
164317925|NCT00313781|593539313|FG000|After Crossover|Other|0|||
164317926|NCT00313781|593539314|FG001|After Crossover|Other|0|||
164317927|NCT00313781|593539315|FG002|After Crossover|Other|18|||
164317928|NCT03148691|593539316|FG000|Overall Study|Protocol Violation|1|||
164317929|NCT03148691|593539317|FG001|Overall Study|Protocol Violation|2|||
164317930|NCT03148691|593539318|FG002|Overall Study|Protocol Violation|7|||
164317931|NCT03148691|593539316|FG000|Overall Study|Lost to Follow-up|0|||
164317932|NCT03148691|593539317|FG001|Overall Study|Lost to Follow-up|0|||
164317933|NCT03148691|593539318|FG002|Overall Study|Lost to Follow-up|1|||
164317934|NCT03148691|593539316|FG000|Overall Study|Other|1|||
164317935|NCT03148691|593539317|FG001|Overall Study|Other|0|||
164317936|NCT03148691|593539318|FG002|Overall Study|Other|0|||
164317937|NCT03148691|593539316|FG000|Overall Study|Withdrawal by Subject|1|||
164317938|NCT03148691|593539317|FG001|Overall Study|Withdrawal by Subject|0|||
164317939|NCT03148691|593539318|FG002|Overall Study|Withdrawal by Subject|0|||
164317940|NCT01590758|593539319|FG000|Overall Study|Withdrawal by Subject|0|||
164317941|NCT01590758|593539320|FG001|Overall Study|Withdrawal by Subject|3|||
164317942|NCT01590758|593539319|FG000|Overall Study|Physician Decision|1|||
164317943|NCT01590758|593539320|FG001|Overall Study|Physician Decision|2|||
164317944|NCT01590758|593539319|FG000|Overall Study|Lost to Follow-up|4|||
164317945|NCT01590758|593539320|FG001|Overall Study|Lost to Follow-up|2|||
164317946|NCT02929498|593539321|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
164317947|NCT02929498|593539322|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
164317948|NCT02929498|593539323|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
164317949|NCT02929498|593539321|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
163977804|NCT01500278|592290879|FG000|Week 13 - Week 104|Withdrawn in error|1|||
164317950|NCT02929498|593539322|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
164317951|NCT02929498|593539323|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
164317952|NCT00096356|593539324|FG000|Overall Study|Adverse Event|11|||
164317953|NCT00096356|593539325|FG001|Overall Study|Adverse Event|9|||
164317954|NCT00096356|593539324|FG000|Overall Study|Physician Decision|5|||
164317955|NCT00096356|593539325|FG001|Overall Study|Physician Decision|3|||
164317956|NCT00096356|593539324|FG000|Overall Study|Withdrawal by Subject|17|||
164317957|NCT00096356|593539325|FG001|Overall Study|Withdrawal by Subject|23|||
164317958|NCT00096356|593539324|FG000|Overall Study|Lack of Efficacy|1|||
164317959|NCT00096356|593539325|FG001|Overall Study|Lack of Efficacy|0|||
164317960|NCT00096356|593539324|FG000|Overall Study|multiple reasons|10|||
164317961|NCT00096356|593539325|FG001|Overall Study|multiple reasons|18|||
164317962|NCT01181986|593539326|FG000|Phase 1|Lost to Follow-up|0|||
164317963|NCT01181986|593539327|FG001|Phase 1|Lost to Follow-up|1|||
164317964|NCT01181986|593539328|FG002|Phase 1|Lost to Follow-up|1|||
164317965|NCT01181986|593539326|FG000|Phase 1|Adverse Event|0|||
164317966|NCT01181986|593539327|FG001|Phase 1|Adverse Event|0|||
164317967|NCT01181986|593539328|FG002|Phase 1|Adverse Event|1|||
164317968|NCT01181986|593539326|FG000|Phase 1|Protocol Violation|1|||
164317969|NCT01181986|593539327|FG001|Phase 1|Protocol Violation|0|||
164317970|NCT01181986|593539328|FG002|Phase 1|Protocol Violation|0|||
164317971|NCT01181986|593539326|FG000|Phase 2|Adverse Event|0|||
164317972|NCT01181986|593539327|FG001|Phase 2|Adverse Event|3|||
164317973|NCT01181986|593539328|FG002|Phase 2|Adverse Event|0|||
164317974|NCT01181986|593539326|FG000|Phase 2|Medical condition|0|||
164317975|NCT01181986|593539327|FG001|Phase 2|Medical condition|1|||
164317976|NCT01181986|593539328|FG002|Phase 2|Medical condition|0|||
164317977|NCT00530504|593539329|FG000|Overall Study|Death|54|||
164317978|NCT00530504|593539329|FG000|Overall Study|Lost to Follow-up|26|||
164317979|NCT00530504|593539329|FG000|Overall Study|Withdrawal by Subject|39|||
164317980|NCT00530504|593539329|FG000|Overall Study|Exited study due to other reasons|33|||
164317981|NCT05009979|593539330|FG000|Overall Study|Withdrawal by Subject|1|||
164317982|NCT00576420|593540808|FG000|Overall Study|Death|0|||
164317983|NCT00576420|593540809|FG001|Overall Study|Death|0|||
164317984|NCT00576420|593540810|FG002|Overall Study|Death|1|||
164317985|NCT02616146|593540811|FG000|Overall Study|Adverse Event|64|||
164317986|NCT02616146|593540812|FG001|Overall Study|Adverse Event|24|||
164317987|NCT02616146|593540811|FG000|Overall Study|Lost to Follow-up|23|||
164317988|NCT02616146|593540812|FG001|Overall Study|Lost to Follow-up|13|||
164317989|NCT02616146|593540811|FG000|Overall Study|Non-compliance with study protocol|2|||
164317990|NCT02616146|593540812|FG001|Overall Study|Non-compliance with study protocol|0|||
164317991|NCT02616146|593540811|FG000|Overall Study|Non-compliance with study drug|4|||
164317992|NCT02616146|593540812|FG001|Overall Study|Non-compliance with study drug|2|||
164317993|NCT02616146|593540811|FG000|Overall Study|Pregnancy|2|||
164317994|NCT02616146|593540812|FG001|Overall Study|Pregnancy|2|||
164317995|NCT02616146|593540811|FG000|Overall Study|Pregnancy wish|3|||
164317996|NCT02616146|593540812|FG001|Overall Study|Pregnancy wish|0|||
164317997|NCT02616146|593540811|FG000|Overall Study|Protocol Violation|6|||
164317998|NCT02616146|593540812|FG001|Overall Study|Protocol Violation|3|||
164317999|NCT02616146|593540811|FG000|Overall Study|Study terminated by sponsor|1372|||
164318000|NCT02616146|593540812|FG001|Overall Study|Study terminated by sponsor|432|||
164318001|NCT02616146|593540811|FG000|Overall Study|Participant moved|4|||
164318002|NCT02616146|593540812|FG001|Overall Study|Participant moved|3|||
164318003|NCT02616146|593540811|FG000|Overall Study|Withdrawal by Subject|30|||
164318004|NCT02616146|593540812|FG001|Overall Study|Withdrawal by Subject|24|||
164318005|NCT02616146|593540811|FG000|Overall Study|Physician Decision|2|||
164318006|NCT02616146|593540812|FG001|Overall Study|Physician Decision|1|||
164318007|NCT01221272|593540813|FG000|Period 1|Adverse Event|2|||
164318008|NCT01221272|593540814|FG001|Period 1|Adverse Event|0|||
164318009|NCT01221272|593540813|FG000|Period 1|Consent Withdrawal|0|||
164318010|NCT01221272|593540814|FG001|Period 1|Consent Withdrawal|1|||
164318011|NCT01221272|593540813|FG000|Period 1|Significant Dosing Noncompliance|0|||
164318012|NCT01221272|593540814|FG001|Period 1|Significant Dosing Noncompliance|1|||
164318013|NCT01221272|593540813|FG000|Period 2|Adverse Event|0|||
164318014|NCT01221272|593540814|FG001|Period 2|Adverse Event|2|||
164318015|NCT01340872|593540815|FG000|Double-blind Phase|Adverse Event|6|||
164318016|NCT01340872|593540816|FG001|Double-blind Phase|Adverse Event|4|||
164318017|NCT01340872|593540817|FG002|Double-blind Phase|Adverse Event|0|||
164318018|NCT01340872|593540818|FG003|Double-blind Phase|Adverse Event|0|||
164318019|NCT01340872|593540815|FG000|Double-blind Phase|Withdrawal by Subject|3|||
164318020|NCT01340872|593540816|FG001|Double-blind Phase|Withdrawal by Subject|5|||
164318021|NCT01340872|593540817|FG002|Double-blind Phase|Withdrawal by Subject|0|||
164318022|NCT01340872|593540818|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164318023|NCT01340872|593540815|FG000|Double-blind Phase|Lost to Follow-up|0|||
164318024|NCT01340872|593540816|FG001|Double-blind Phase|Lost to Follow-up|1|||
164318025|NCT01340872|593540817|FG002|Double-blind Phase|Lost to Follow-up|0|||
164318026|NCT01340872|593540818|FG003|Double-blind Phase|Lost to Follow-up|0|||
164318027|NCT01340872|593540815|FG000|Double-blind Phase|Protocol Violation|0|||
164318028|NCT01340872|593540816|FG001|Double-blind Phase|Protocol Violation|1|||
164318029|NCT01340872|593540817|FG002|Double-blind Phase|Protocol Violation|0|||
164318030|NCT01340872|593540818|FG003|Double-blind Phase|Protocol Violation|0|||
164318031|NCT01340872|593540815|FG000|Open-label Phase|Physician Decision|0|||
164318032|NCT01340872|593540816|FG001|Open-label Phase|Physician Decision|0|||
164318033|NCT01340872|593540817|FG002|Open-label Phase|Physician Decision|2|||
164318034|NCT01340872|593540818|FG003|Open-label Phase|Physician Decision|1|||
164318035|NCT01340872|593540815|FG000|Open-label Phase|Pregnancy|0|||
164318036|NCT01340872|593540816|FG001|Open-label Phase|Pregnancy|0|||
164318037|NCT01340872|593540817|FG002|Open-label Phase|Pregnancy|1|||
164318038|NCT01340872|593540818|FG003|Open-label Phase|Pregnancy|0|||
164318039|NCT01340872|593540815|FG000|Open-label Phase|Adverse Event|0|||
164318040|NCT01340872|593540816|FG001|Open-label Phase|Adverse Event|0|||
164318041|NCT01340872|593540817|FG002|Open-label Phase|Adverse Event|8|||
164318042|NCT01340872|593540818|FG003|Open-label Phase|Adverse Event|4|||
164318043|NCT01340872|593540815|FG000|Open-label Phase|Withdrawal by Subject|0|||
164318044|NCT01340872|593540816|FG001|Open-label Phase|Withdrawal by Subject|0|||
164318045|NCT01340872|593540817|FG002|Open-label Phase|Withdrawal by Subject|1|||
164318046|NCT01340872|593540818|FG003|Open-label Phase|Withdrawal by Subject|6|||
164318047|NCT01340872|593540815|FG000|Open-label Phase|Worsening of IBD|0|||
164318048|NCT01340872|593540816|FG001|Open-label Phase|Worsening of IBD|0|||
164318049|NCT01340872|593540817|FG002|Open-label Phase|Worsening of IBD|1|||
164318050|NCT01340872|593540818|FG003|Open-label Phase|Worsening of IBD|0|||
164318051|NCT03039621|593540823|FG000|Overall Study|Violation of inclusion criteria|3|||
164318052|NCT03039621|593540824|FG001|Overall Study|Violation of inclusion criteria|2|||
164318053|NCT03039621|593540823|FG000|Overall Study|Non-compliance with protocol requirement|4|||
164318054|NCT03039621|593540824|FG001|Overall Study|Non-compliance with protocol requirement|5|||
164318055|NCT03039621|593540823|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
164318056|NCT03039621|593540824|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
164318057|NCT03039621|593540823|FG000|Overall Study|Violation of non-inclusion criteria|1|||
164318058|NCT03039621|593540824|FG001|Overall Study|Violation of non-inclusion criteria|2|||
164318059|NCT02522624|593540825|FG000|Overall Study|Technical failure|1|||
164318060|NCT02522624|593540826|FG001|Overall Study|Technical failure|0|||
164318061|NCT03254108|593540827|FG000|Overall Study|Adverse Event|0|||
164318062|NCT03254108|593540828|FG001|Overall Study|Adverse Event|2|||
164318063|NCT03254108|593540829|FG002|Overall Study|Adverse Event|0|||
164318064|NCT03254108|593540830|FG003|Overall Study|Adverse Event|1|||
164318065|NCT03254108|593540831|FG004|Overall Study|Adverse Event|1|||
164318066|NCT03254108|593540827|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164318067|NCT03254108|593540828|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
163873552|NCT02723955|591906864|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873553|NCT02723955|591906865|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873554|NCT02723955|591906866|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873555|NCT02723955|591906867|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873556|NCT02723955|591906868|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873557|NCT02723955|591906869|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873558|NCT02723955|591906870|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163900114|NCT02397096|592005614|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
163900115|NCT02397096|592005615|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
163900116|NCT02397096|592005614|FG000|Study Extension 1|Adverse Event|7|||
163900117|NCT02397096|592005615|FG001|Study Extension 1|Adverse Event|5|||
163900118|NCT02397096|592005614|FG000|Study Extension 1|Death|1|||
163900119|NCT02397096|592005615|FG001|Study Extension 1|Death|0|||
163900120|NCT02397096|592005614|FG000|Study Extension 1|Lack of Efficacy|2|||
163900121|NCT02397096|592005615|FG001|Study Extension 1|Lack of Efficacy|5|||
163900122|NCT02397096|592005614|FG000|Study Extension 1|Lost to Follow-up|2|||
163900123|NCT02397096|592005615|FG001|Study Extension 1|Lost to Follow-up|3|||
163900124|NCT02397096|592005614|FG000|Study Extension 1|Non-compliance with study drug|3|||
163900125|NCT02397096|592005615|FG001|Study Extension 1|Non-compliance with study drug|0|||
163900126|NCT02397096|592005614|FG000|Study Extension 1|Physician Decision|4|||
163900127|NCT02397096|592005615|FG001|Study Extension 1|Physician Decision|2|||
163900128|NCT02397096|592005614|FG000|Study Extension 1|Pregnancy|1|||
163900129|NCT02397096|592005615|FG001|Study Extension 1|Pregnancy|0|||
163900130|NCT02397096|592005614|FG000|Study Extension 1|Protocol Violation|0|||
163900131|NCT02397096|592005615|FG001|Study Extension 1|Protocol Violation|1|||
163900132|NCT02397096|592005614|FG000|Study Extension 1|Withdrawal by Subject|21|||
163900133|NCT02397096|592005615|FG001|Study Extension 1|Withdrawal by Subject|7|||
163900134|NCT02397096|592005614|FG000|Study Extension 2|Adverse Event|3|||
163900135|NCT02397096|592005615|FG001|Study Extension 2|Adverse Event|3|||
163900136|NCT02397096|592005614|FG000|Study Extension 2|Availability of study medication locally|152|||
163900137|NCT02397096|592005615|FG001|Study Extension 2|Availability of study medication locally|64|||
163900138|NCT02397096|592005614|FG000|Study Extension 2|Death|2|||
163900139|NCT02397096|592005615|FG001|Study Extension 2|Death|0|||
163900140|NCT02397096|592005614|FG000|Study Extension 2|Lack of Efficacy|1|||
163900141|NCT02397096|592005615|FG001|Study Extension 2|Lack of Efficacy|0|||
163900142|NCT02397096|592005614|FG000|Study Extension 2|Lost to Follow-up|2|||
163900143|NCT02397096|592005615|FG001|Study Extension 2|Lost to Follow-up|1|||
163900144|NCT02397096|592005614|FG000|Study Extension 2|Non-compliance with study drug|1|||
163900145|NCT02397096|592005615|FG001|Study Extension 2|Non-compliance with study drug|0|||
163900146|NCT02397096|592005614|FG000|Study Extension 2|Physician Decision|2|||
163900147|NCT02397096|592005615|FG001|Study Extension 2|Physician Decision|5|||
163900148|NCT02397096|592005614|FG000|Study Extension 2|Pregnancy|1|||
163900149|NCT02397096|592005615|FG001|Study Extension 2|Pregnancy|0|||
163900150|NCT02397096|592005614|FG000|Study Extension 2|Withdrawal by Subject|10|||
163900151|NCT02397096|592005615|FG001|Study Extension 2|Withdrawal by Subject|3|||
163900152|NCT02397096|592005614|FG000|Study Extension 3|Adverse Event|1|||
163977805|NCT01500278|592290880|FG001|Week 13 - Week 104|Withdrawn in error|0|||
163977806|NCT01500278|592290879|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
163977807|NCT01500278|592290880|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
163977808|NCT01500278|592290879|FG000|Week 13 - Week 104|Protocol deviation|1|||
163977809|NCT01500278|592290880|FG001|Week 13 - Week 104|Protocol deviation|0|||
163977810|NCT01500278|592290879|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
163977811|NCT01500278|592290880|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
163977812|NCT01500278|592290879|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
163977813|NCT01500278|592290880|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
163977814|NCT01500278|592290879|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
163977815|NCT01500278|592290880|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
163977816|NCT01500278|592290879|FG000|Week 13 - Week 104|Relocation|0|||
163977817|NCT01500278|592290880|FG001|Week 13 - Week 104|Relocation|1|||
163977818|NCT01500278|592290879|FG000|Week 13 - Week 104|Sponsor decision|0|||
163977819|NCT01500278|592290880|FG001|Week 13 - Week 104|Sponsor decision|2|||
163977820|NCT01500278|592290879|FG000|Week 13 - Week 104|Medical monitor decision|0|||
163977821|NCT01500278|592290880|FG001|Week 13 - Week 104|Medical monitor decision|2|||
163977822|NCT01500278|592290879|FG000|Week 13 - Week 104|Personal reason|0|||
163977823|NCT01500278|592290880|FG001|Week 13 - Week 104|Personal reason|1|||
163977824|NCT01500278|592290879|FG000|Week 13 - Week 104|Not completed|0|||
163977825|NCT01500278|592290880|FG001|Week 13 - Week 104|Not completed|1|||
163977826|NCT01500278|592290879|FG000|Week 13 - Week 104|Death|2|||
163977827|NCT01500278|592290880|FG001|Week 13 - Week 104|Death|4|||
163977828|NCT01500278|592290879|FG000|Week 13 - Week 104|Adverse Event|54|||
163977829|NCT01500278|592290880|FG001|Week 13 - Week 104|Adverse Event|54|||
163977830|NCT00143312|592290883|FG000|Overall Study|Death|11|||
163977831|NCT00143312|592290883|FG000|Overall Study|Adverse Event|2|||
163977832|NCT00143312|592290883|FG000|Overall Study|Lost to Follow-up|1|||
163977833|NCT00143312|592290883|FG000|Overall Study|Other|1|||
163977834|NCT00143312|592290883|FG000|Overall Study|Withdrawal by Subject|1|||
163977835|NCT00607386|592290884|FG000|Overall Study|Physician Decision|1|||
163977836|NCT00879645|592290887|FG000|Overall Study|Adverse Event|1|||
163977837|NCT00879645|592290888|FG001|Overall Study|Adverse Event|0|||
163977838|NCT00879645|592290889|FG002|Overall Study|Adverse Event|0|||
163977839|NCT00879645|592290890|FG003|Overall Study|Adverse Event|0|||
163977840|NCT00446511|592290891|FG000|Overall Study|Adverse Event|7|||
163977841|NCT00446511|592290892|FG001|Overall Study|Adverse Event|2|||
163977842|NCT00446511|592290893|FG002|Overall Study|Adverse Event|3|||
163977843|NCT00446511|592290894|FG003|Overall Study|Adverse Event|1|||
163977844|NCT00446511|592290891|FG000|Overall Study|Protocol Violation|0|||
163977845|NCT00446511|592290892|FG001|Overall Study|Protocol Violation|0|||
163977846|NCT00446511|592290893|FG002|Overall Study|Protocol Violation|0|||
163977847|NCT00446511|592290894|FG003|Overall Study|Protocol Violation|1|||
163977848|NCT00446511|592290891|FG000|Overall Study|Withdrawal by Subject|0|||
163977849|NCT00446511|592290892|FG001|Overall Study|Withdrawal by Subject|0|||
163977850|NCT00446511|592290893|FG002|Overall Study|Withdrawal by Subject|0|||
163977851|NCT00446511|592290894|FG003|Overall Study|Withdrawal by Subject|3|||
164205643|NCT01648764|593122654|FG004|Overall Study|Death|0|||
163977852|NCT00446511|592290891|FG000|Overall Study|Administrative Problems|3|||
164205644|NCT01648764|593122655|FG005|Overall Study|Death|0|||
164205645|NCT01648764|593122656|FG006|Overall Study|Death|1|||
164205646|NCT01648764|593122657|FG007|Overall Study|Death|0|||
164205647|NCT01648764|593122658|FG008|Overall Study|Death|0|||
164205648|NCT01648764|593122659|FG009|Overall Study|Death|0|||
164205649|NCT01648764|593122660|FG010|Overall Study|Death|0|||
164205650|NCT01648764|593122661|FG011|Overall Study|Death|0|||
164205651|NCT01648764|593122662|FG012|Overall Study|Death|0|||
164205652|NCT01648764|593122663|FG013|Overall Study|Death|1|||
164205653|NCT01648764|593122650|FG000|Overall Study|Withdrawal by Subject|0|||
164205654|NCT01648764|593122651|FG001|Overall Study|Withdrawal by Subject|0|||
164205655|NCT01648764|593122652|FG002|Overall Study|Withdrawal by Subject|0|||
164205656|NCT01648764|593122653|FG003|Overall Study|Withdrawal by Subject|0|||
164205657|NCT01648764|593122654|FG004|Overall Study|Withdrawal by Subject|0|||
164205658|NCT01648764|593122655|FG005|Overall Study|Withdrawal by Subject|0|||
164205659|NCT01648764|593122656|FG006|Overall Study|Withdrawal by Subject|2|||
164205660|NCT01648764|593122657|FG007|Overall Study|Withdrawal by Subject|0|||
164205661|NCT01648764|593122658|FG008|Overall Study|Withdrawal by Subject|0|||
164205662|NCT01648764|593122659|FG009|Overall Study|Withdrawal by Subject|0|||
164205663|NCT01648764|593122660|FG010|Overall Study|Withdrawal by Subject|0|||
164205664|NCT01648764|593122661|FG011|Overall Study|Withdrawal by Subject|0|||
164205665|NCT01648764|593122662|FG012|Overall Study|Withdrawal by Subject|1|||
164205666|NCT01648764|593122663|FG013|Overall Study|Withdrawal by Subject|0|||
164205667|NCT01648764|593122650|FG000|Overall Study|Investigator Decision|0|||
164205668|NCT01648764|593122651|FG001|Overall Study|Investigator Decision|0|||
164205669|NCT01648764|593122652|FG002|Overall Study|Investigator Decision|0|||
164205670|NCT01648764|593122653|FG003|Overall Study|Investigator Decision|0|||
164205671|NCT01648764|593122654|FG004|Overall Study|Investigator Decision|0|||
164318068|NCT03254108|593540829|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164318069|NCT03254108|593540830|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
164318070|NCT03254108|593540831|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
164318071|NCT01142089|593540834|FG000|Overall Study|Physician Decision|1|||
164318072|NCT01142089|593540835|FG001|Overall Study|Physician Decision|0|||
164318073|NCT01142089|593540834|FG000|Overall Study|Withdrawal by Subject|1|||
164318074|NCT01142089|593540835|FG001|Overall Study|Withdrawal by Subject|2|||
164318075|NCT01142089|593540834|FG000|Overall Study|Use of prohibited medications|0|||
164318076|NCT01142089|593540835|FG001|Overall Study|Use of prohibited medications|1|||
164318077|NCT01142089|593540834|FG000|Overall Study|Noncompliance with study procedures|2|||
164318078|NCT01142089|593540835|FG001|Overall Study|Noncompliance with study procedures|1|||
164318079|NCT01142089|593540834|FG000|Overall Study|Patient required rescue medication|8|||
164318080|NCT01142089|593540835|FG001|Overall Study|Patient required rescue medication|17|||
164318081|NCT01974765|593540836|FG000|Overall Study|Withdrawal by Subject|1|||
164318082|NCT01974765|593540836|FG000|Overall Study|Death|1|||
164318083|NCT01974765|593540836|FG000|Overall Study|Adverse Event|2|||
164318084|NCT04531462|593540837|FG000|Overall Study|Withdrawal by Subject|3|||
164318085|NCT04531462|593540838|FG001|Overall Study|Withdrawal by Subject|1|||
164318086|NCT04531462|593540837|FG000|Overall Study|Adverse Event|3|||
164318087|NCT04531462|593540838|FG001|Overall Study|Adverse Event|3|||
164318088|NCT01350544|593540840|FG000|Overall Study|Administrative Withdrawal|0|||
164318089|NCT01350544|593540841|FG001|Overall Study|Administrative Withdrawal|1|||
164318090|NCT01350544|593540840|FG000|Overall Study|Death|1|||
164318091|NCT01350544|593540841|FG001|Overall Study|Death|2|||
164318092|NCT01350544|593540840|FG000|Overall Study|Moved out of LA County|2|||
164318093|NCT01350544|593540841|FG001|Overall Study|Moved out of LA County|2|||
164318094|NCT01350544|593540840|FG000|Overall Study|Medical Issues|1|||
164318095|NCT01350544|593540841|FG001|Overall Study|Medical Issues|1|||
164318096|NCT01350544|593540840|FG000|Overall Study|Withdrawal by Subject|0|||
164318097|NCT01350544|593540841|FG001|Overall Study|Withdrawal by Subject|1|||
164318098|NCT01350544|593540840|FG000|Overall Study|Incarceration|1|||
164205672|NCT01648764|593122655|FG005|Overall Study|Investigator Decision|0|||
164205673|NCT01648764|593122656|FG006|Overall Study|Investigator Decision|1|||
164205674|NCT01648764|593122657|FG007|Overall Study|Investigator Decision|0|||
164205675|NCT01648764|593122658|FG008|Overall Study|Investigator Decision|0|||
163977853|NCT00446511|592290892|FG001|Overall Study|Administrative Problems|0|||
163977854|NCT00446511|592290893|FG002|Overall Study|Administrative Problems|4|||
163977855|NCT00446511|592290894|FG003|Overall Study|Administrative Problems|1|||
163977856|NCT02700997|592290895|FG000|Overall Study|Did not undergo CT imaging|1|||
163977857|NCT02700997|592290895|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
163977858|NCT01073267|592290896|FG000|Overall Study|Disease Progression|3|||
164205676|NCT01648764|593122659|FG009|Overall Study|Investigator Decision|0|||
164205677|NCT01648764|593122660|FG010|Overall Study|Investigator Decision|0|||
164205678|NCT01648764|593122661|FG011|Overall Study|Investigator Decision|1|||
164205679|NCT01648764|593122662|FG012|Overall Study|Investigator Decision|0|||
164318099|NCT01350544|593540841|FG001|Overall Study|Incarceration|0|||
164318100|NCT01350544|593540840|FG000|Overall Study|Lost to Follow-up|18|||
164205680|NCT01648764|593122663|FG013|Overall Study|Investigator Decision|0|||
164205681|NCT00903968|593122664|FG000|Overall Study|Adverse Event|0|||
164205682|NCT00903968|593122665|FG001|Overall Study|Adverse Event|0|||
164205683|NCT00903968|593122666|FG002|Overall Study|Adverse Event|0|||
164205684|NCT00903968|593122667|FG003|Overall Study|Adverse Event|0|||
164205685|NCT00903968|593122668|FG004|Overall Study|Adverse Event|0|||
164205686|NCT00903968|593122669|FG005|Overall Study|Adverse Event|0|||
164205687|NCT00903968|593122670|FG006|Overall Study|Adverse Event|1|||
164205688|NCT00903968|593122671|FG007|Overall Study|Adverse Event|8|||
164205689|NCT00903968|593122664|FG000|Overall Study|DLT|0|||
164205690|NCT00903968|593122665|FG001|Overall Study|DLT|0|||
164205691|NCT00903968|593122666|FG002|Overall Study|DLT|0|||
164318101|NCT01350544|593540841|FG001|Overall Study|Lost to Follow-up|15|||
164318102|NCT01444092|593540842|FG000|Overall Study|Adverse Event|8|||
164318103|NCT01444092|593540842|FG000|Overall Study|Protocol Violation|1|||
164318104|NCT01444092|593540842|FG000|Overall Study|Withdrawal by Subject|1|||
164318105|NCT01444092|593540842|FG000|Overall Study|Other Eligibility criteria|7|||
164318106|NCT05338671|593540845|FG000|Overall Study|Lost to Follow-up|2|||
164318107|NCT05338671|593540846|FG001|Overall Study|Lost to Follow-up|2|||
164318108|NCT05338671|593540845|FG000|Overall Study|Root canal completed in a single visit|1|||
164318109|NCT05338671|593540846|FG001|Overall Study|Root canal completed in a single visit|0|||
164318110|NCT03859973|593540847|FG000|Overall Study|Other reason than listed|3|||
164318111|NCT03859973|593540848|FG001|Overall Study|Other reason than listed|2|||
163977859|NCT04770389|592290897|FG000|Overall Study|Adverse Event|1|||
163977860|NCT04770389|592290898|FG001|Overall Study|Adverse Event|2|||
164205692|NCT00903968|593122667|FG003|Overall Study|DLT|0|||
164205693|NCT00903968|593122668|FG004|Overall Study|DLT|0|||
164205694|NCT00903968|593122669|FG005|Overall Study|DLT|0|||
164205695|NCT00903968|593122670|FG006|Overall Study|DLT|2|||
164205696|NCT00903968|593122671|FG007|Overall Study|DLT|0|||
163977861|NCT04770389|592290899|FG002|Overall Study|Adverse Event|0|||
164205697|NCT00903968|593122664|FG000|Overall Study|Withdrawal by Subject|1|||
164205698|NCT00903968|593122665|FG001|Overall Study|Withdrawal by Subject|0|||
164205699|NCT00903968|593122666|FG002|Overall Study|Withdrawal by Subject|1|||
164205700|NCT00903968|593122667|FG003|Overall Study|Withdrawal by Subject|0|||
164205701|NCT00903968|593122668|FG004|Overall Study|Withdrawal by Subject|1|||
164205702|NCT00903968|593122669|FG005|Overall Study|Withdrawal by Subject|1|||
164205703|NCT00903968|593122670|FG006|Overall Study|Withdrawal by Subject|0|||
164205704|NCT00903968|593122671|FG007|Overall Study|Withdrawal by Subject|4|||
164205705|NCT00903968|593122664|FG000|Overall Study|Non-Compliance|0|||
164205706|NCT00903968|593122665|FG001|Overall Study|Non-Compliance|0|||
164205707|NCT00903968|593122666|FG002|Overall Study|Non-Compliance|0|||
164205708|NCT00903968|593122667|FG003|Overall Study|Non-Compliance|0|||
164205709|NCT00903968|593122668|FG004|Overall Study|Non-Compliance|0|||
164205710|NCT00903968|593122669|FG005|Overall Study|Non-Compliance|1|||
164205711|NCT00903968|593122670|FG006|Overall Study|Non-Compliance|0|||
164205712|NCT00903968|593122671|FG007|Overall Study|Non-Compliance|0|||
164205713|NCT00903968|593122664|FG000|Overall Study|Physician Decision|0|||
164205714|NCT00903968|593122665|FG001|Overall Study|Physician Decision|0|||
164205715|NCT00903968|593122666|FG002|Overall Study|Physician Decision|0|||
164205716|NCT00903968|593122667|FG003|Overall Study|Physician Decision|0|||
164205717|NCT00903968|593122668|FG004|Overall Study|Physician Decision|0|||
164205718|NCT00903968|593122669|FG005|Overall Study|Physician Decision|1|||
164205719|NCT00903968|593122670|FG006|Overall Study|Physician Decision|0|||
164205720|NCT00903968|593122671|FG007|Overall Study|Physician Decision|0|||
164205721|NCT00903968|593122664|FG000|Overall Study|Progressive Disease|2|||
164205722|NCT00903968|593122665|FG001|Overall Study|Progressive Disease|3|||
164205723|NCT00903968|593122666|FG002|Overall Study|Progressive Disease|2|||
164205724|NCT00903968|593122667|FG003|Overall Study|Progressive Disease|3|||
164205725|NCT00903968|593122668|FG004|Overall Study|Progressive Disease|3|||
164205726|NCT00903968|593122669|FG005|Overall Study|Progressive Disease|3|||
164205727|NCT00903968|593122670|FG006|Overall Study|Progressive Disease|0|||
164205728|NCT00903968|593122671|FG007|Overall Study|Progressive Disease|18|||
164205729|NCT00903968|593122664|FG000|Overall Study|Lack of Efficacy|0|||
164205730|NCT00903968|593122665|FG001|Overall Study|Lack of Efficacy|0|||
164205731|NCT00903968|593122666|FG002|Overall Study|Lack of Efficacy|0|||
164205732|NCT00903968|593122667|FG003|Overall Study|Lack of Efficacy|0|||
164205733|NCT00903968|593122668|FG004|Overall Study|Lack of Efficacy|0|||
164205734|NCT00903968|593122669|FG005|Overall Study|Lack of Efficacy|0|||
164205735|NCT00903968|593122670|FG006|Overall Study|Lack of Efficacy|0|||
164205736|NCT00903968|593122671|FG007|Overall Study|Lack of Efficacy|3|||
164205737|NCT01294046|593122672|FG000|Overall Study|Infection and surgical explant|1|||
164205738|NCT01294046|593122672|FG000|Overall Study|Eligibility criteria expanded|1|||
164205739|NCT01294046|593122672|FG000|Overall Study|Stimulation response inadqequate|1|||
164205740|NCT03738696|593122678|FG000|Overall Study|Withdrawal by Subject|0|||
164205741|NCT03738696|593122679|FG001|Overall Study|Withdrawal by Subject|1|||
164205742|NCT03738696|593122678|FG000|Overall Study|Lost to Follow-up|8|||
164205743|NCT03738696|593122679|FG001|Overall Study|Lost to Follow-up|14|||
164205744|NCT03801252|593122682|FG000|Overall Study|Protocol Violation|1|||
164205745|NCT03801252|593122683|FG001|Overall Study|Protocol Violation|2|||
164205746|NCT02690727|593122684|FG000|Overall Study|Adverse Event|2|||
163977862|NCT04770389|592290900|FG003|Overall Study|Adverse Event|1|||
163977863|NCT04770389|592290897|FG000|Overall Study|Withdrawal by Subject|0|||
163977864|NCT04770389|592290898|FG001|Overall Study|Withdrawal by Subject|2|||
163977865|NCT04770389|592290899|FG002|Overall Study|Withdrawal by Subject|1|||
163977866|NCT04770389|592290900|FG003|Overall Study|Withdrawal by Subject|0|||
163977867|NCT04770389|592290897|FG000|Overall Study|Failed attempt to draw blood|1|||
163977868|NCT04770389|592290898|FG001|Overall Study|Failed attempt to draw blood|0|||
163977869|NCT04770389|592290899|FG002|Overall Study|Failed attempt to draw blood|0|||
163977870|NCT04770389|592290900|FG003|Overall Study|Failed attempt to draw blood|0|||
163977871|NCT04770389|592290897|FG000|Overall Study|Left the country|0|||
163977872|NCT04770389|592290898|FG001|Overall Study|Left the country|0|||
163977873|NCT04770389|592290899|FG002|Overall Study|Left the country|1|||
163977874|NCT04770389|592290900|FG003|Overall Study|Left the country|2|||
163977875|NCT04770389|592290897|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
163977876|NCT04770389|592290898|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
163977877|NCT04770389|592290899|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
163977878|NCT04770389|592290900|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
164205747|NCT02690727|593122685|FG001|Overall Study|Adverse Event|2|||
164205748|NCT04757636|593122686|FG000|Overall Study|Adverse Event|25|||
164205749|NCT04757636|593122687|FG001|Overall Study|Adverse Event|8|||
164205750|NCT04757636|593122688|FG002|Overall Study|Adverse Event|11|||
164205751|NCT04757636|593122686|FG000|Overall Study|Death|9|||
164205752|NCT04757636|593122687|FG001|Overall Study|Death|12|||
164205753|NCT04757636|593122688|FG002|Overall Study|Death|6|||
164205754|NCT04757636|593122686|FG000|Overall Study|Lack of Efficacy|2|||
164205755|NCT04757636|593122687|FG001|Overall Study|Lack of Efficacy|0|||
164205756|NCT04757636|593122688|FG002|Overall Study|Lack of Efficacy|0|||
164318112|NCT03859973|593540847|FG000|Overall Study|COVID-19 related, not due to AE|3|||
164318113|NCT03859973|593540848|FG001|Overall Study|COVID-19 related, not due to AE|4|||
164318114|NCT03859973|593540847|FG000|Overall Study|Withdrawal by Subject|8|||
164318115|NCT03859973|593540848|FG001|Overall Study|Withdrawal by Subject|9|||
164318116|NCT03859973|593540847|FG000|Overall Study|Lost to Follow-up|2|||
164318117|NCT03859973|593540848|FG001|Overall Study|Lost to Follow-up|3|||
164318118|NCT03859973|593540847|FG000|Overall Study|Protocol Violation|1|||
164318119|NCT03859973|593540848|FG001|Overall Study|Protocol Violation|3|||
164318120|NCT03859973|593540847|FG000|Overall Study|Adverse Event|3|||
164318121|NCT03859973|593540848|FG001|Overall Study|Adverse Event|5|||
164318122|NCT00640224|593540849|FG000|Overall Study|Lost to Follow-up|5|||
164318123|NCT00640224|593540850|FG001|Overall Study|Lost to Follow-up|2|||
164318124|NCT00640224|593540851|FG002|Overall Study|Lost to Follow-up|0|||
164318125|NCT00640224|593540852|FG003|Overall Study|Lost to Follow-up|0|||
164318126|NCT00640224|593540849|FG000|Overall Study|Withdrawal by Subject|1|||
164318127|NCT00640224|593540850|FG001|Overall Study|Withdrawal by Subject|0|||
164318128|NCT00640224|593540851|FG002|Overall Study|Withdrawal by Subject|0|||
164318129|NCT00640224|593540852|FG003|Overall Study|Withdrawal by Subject|0|||
164318130|NCT00640224|593540849|FG000|Overall Study|Headaches|0|||
164318131|NCT00640224|593540850|FG001|Overall Study|Headaches|1|||
164318132|NCT00640224|593540851|FG002|Overall Study|Headaches|0|||
164318133|NCT00640224|593540852|FG003|Overall Study|Headaches|0|||
164318134|NCT01252667|593540853|FG000|Overall Study|Transplant aborted post-conditioning|0|||
164318135|NCT01252667|593540854|FG001|Overall Study|Transplant aborted post-conditioning|0|||
164318136|NCT01252667|593540855|FG002|Overall Study|Transplant aborted post-conditioning|0|||
164318137|NCT01252667|593540856|FG003|Overall Study|Transplant aborted post-conditioning|0|||
164318138|NCT01252667|593540857|FG004|Overall Study|Transplant aborted post-conditioning|0|||
164318139|NCT01252667|593540858|FG005|Overall Study|Transplant aborted post-conditioning|1|||
164318140|NCT04644315|593540859|FG000|Overall Study|Subject withdrawal of consent|1|||
164318141|NCT00294762|593540860|FG000|Overall Study|Did not receive study treatment|3|||
164318142|NCT00294762|593540861|FG001|Overall Study|Did not receive study treatment|3|||
164318143|NCT01738646|593540862|FG000|Overall Study|Still Receiving Treatment|2|||
164318144|NCT03642132|593540864|FG000|Chemotherapy Period|Adverse Event|1|||
164318145|NCT03642132|593540865|FG001|Chemotherapy Period|Adverse Event|1|||
164318146|NCT03642132|593540866|FG002|Chemotherapy Period|Adverse Event|0|||
164318147|NCT03642132|593540864|FG000|Chemotherapy Period|Physician's decision|4|||
164318148|NCT03642132|593540865|FG001|Chemotherapy Period|Physician's decision|1|||
164318149|NCT03642132|593540866|FG002|Chemotherapy Period|Physician's decision|0|||
164318150|NCT03642132|593540864|FG000|Chemotherapy Period|Progressive disease|0|||
164318151|NCT03642132|593540865|FG001|Chemotherapy Period|Progressive disease|0|||
163873559|NCT02723955|591906871|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873560|NCT02723955|591906872|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873561|NCT02723955|591906873|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873562|NCT02723955|591906874|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873563|NCT02723955|591906875|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
163873564|NCT02723955|591906833|FG000|Expansion Phase|Site Closed|0|||
163873565|NCT02723955|591906834|FG001|Expansion Phase|Site Closed|0|||
163873566|NCT02723955|591906835|FG002|Expansion Phase|Site Closed|0|||
163873567|NCT02723955|591906836|FG003|Expansion Phase|Site Closed|0|||
163873568|NCT02723955|591906837|FG004|Expansion Phase|Site Closed|0|||
163873569|NCT02723955|591906838|FG005|Expansion Phase|Site Closed|0|||
163873570|NCT02723955|591906839|FG006|Expansion Phase|Site Closed|0|||
163873571|NCT02723955|591906840|FG007|Expansion Phase|Site Closed|0|||
163873572|NCT02723955|591906841|FG008|Expansion Phase|Site Closed|0|||
163873573|NCT02723955|591906842|FG009|Expansion Phase|Site Closed|1|||
163873574|NCT02723955|591906843|FG010|Expansion Phase|Site Closed|2|||
163873575|NCT02723955|591906844|FG011|Expansion Phase|Site Closed|6|||
163873576|NCT02723955|591906845|FG012|Expansion Phase|Site Closed|0|||
163873577|NCT02723955|591906846|FG013|Expansion Phase|Site Closed|0|||
163873578|NCT02723955|591906847|FG014|Expansion Phase|Site Closed|0|||
163873579|NCT02723955|591906848|FG015|Expansion Phase|Site Closed|0|||
163873580|NCT02723955|591906849|FG016|Expansion Phase|Site Closed|0|||
163873581|NCT02723955|591906850|FG017|Expansion Phase|Site Closed|0|||
163873582|NCT02723955|591906851|FG018|Expansion Phase|Site Closed|0|||
163873583|NCT02723955|591906852|FG019|Expansion Phase|Site Closed|0|||
163873584|NCT02723955|591906853|FG020|Expansion Phase|Site Closed|0|||
163873585|NCT02723955|591906854|FG021|Expansion Phase|Site Closed|0|||
163873586|NCT02723955|591906855|FG022|Expansion Phase|Site Closed|0|||
163873587|NCT02723955|591906856|FG023|Expansion Phase|Site Closed|0|||
163873588|NCT02723955|591906857|FG024|Expansion Phase|Site Closed|0|||
163873589|NCT02723955|591906858|FG025|Expansion Phase|Site Closed|0|||
163873590|NCT02723955|591906859|FG026|Expansion Phase|Site Closed|0|||
163873591|NCT02723955|591906860|FG027|Expansion Phase|Site Closed|0|||
164318152|NCT03642132|593540866|FG002|Chemotherapy Period|Progressive disease|1|||
164318153|NCT03642132|593540864|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
164318154|NCT03642132|593540865|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
164318155|NCT03642132|593540866|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
164318156|NCT03642132|593540864|FG000|Chemotherapy Period|Other|1|||
164318157|NCT03642132|593540865|FG001|Chemotherapy Period|Other|0|||
164318158|NCT03642132|593540866|FG002|Chemotherapy Period|Other|2|||
164318159|NCT03642132|593540864|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
163977879|NCT04770389|592290897|FG000|Overall Study|Lost to Follow-up|0|||
163977880|NCT04770389|592290898|FG001|Overall Study|Lost to Follow-up|0|||
163977881|NCT04770389|592290899|FG002|Overall Study|Lost to Follow-up|0|||
163977882|NCT04770389|592290900|FG003|Overall Study|Lost to Follow-up|1|||
163977883|NCT04770389|592290897|FG000|Overall Study|Moved away from study site|0|||
163977884|NCT04770389|592290898|FG001|Overall Study|Moved away from study site|1|||
163977885|NCT04770389|592290899|FG002|Overall Study|Moved away from study site|0|||
163977886|NCT04770389|592290900|FG003|Overall Study|Moved away from study site|0|||
163977887|NCT00794157|592290901|FG000|Overall Study|Adverse Event|4|||
163977888|NCT00794157|592290902|FG001|Overall Study|Adverse Event|1|||
163977889|NCT00794157|592290903|FG002|Overall Study|Adverse Event|8|||
163977890|NCT00794157|592290901|FG000|Overall Study|Subject withdrew consent|2|||
163977891|NCT00794157|592290902|FG001|Overall Study|Subject withdrew consent|0|||
163977892|NCT00794157|592290903|FG002|Overall Study|Subject withdrew consent|3|||
163977893|NCT00794157|592290901|FG000|Overall Study|Lost to Follow-up|2|||
163977894|NCT00794157|592290902|FG001|Overall Study|Lost to Follow-up|0|||
163977895|NCT00794157|592290903|FG002|Overall Study|Lost to Follow-up|1|||
163977896|NCT00794157|592290901|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163977897|NCT00794157|592290902|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163977898|NCT00794157|592290903|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163977899|NCT00794157|592290901|FG000|Overall Study|Administrative problems|1|||
163977900|NCT00794157|592290902|FG001|Overall Study|Administrative problems|7|||
163977901|NCT00794157|592290903|FG002|Overall Study|Administrative problems|4|||
163977902|NCT00794157|592290901|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163977903|NCT00794157|592290902|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163977904|NCT00794157|592290903|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163977905|NCT00794157|592290901|FG000|Overall Study|Protocol deviation|0|||
164318160|NCT03642132|593540865|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
164318161|NCT03642132|593540866|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
164318162|NCT03642132|593540864|FG000|Maintenance Period|Adverse Event|1|||
164318163|NCT03642132|593540865|FG001|Maintenance Period|Adverse Event|2|||
164318164|NCT03642132|593540866|FG002|Maintenance Period|Adverse Event|0|||
164318165|NCT03642132|593540864|FG000|Maintenance Period|Non-compliance with study drug|0|||
163977906|NCT00794157|592290902|FG001|Overall Study|Protocol deviation|1|||
163977907|NCT00794157|592290903|FG002|Overall Study|Protocol deviation|1|||
163977908|NCT02970292|592290908|FG000|Overall Study|Physician Decision|1|||
163977909|NCT02970292|592290909|FG001|Overall Study|Physician Decision|1|||
163977910|NCT02970292|592290908|FG000|Overall Study|Withdrawal by Subject|11|||
163977911|NCT02970292|592290909|FG001|Overall Study|Withdrawal by Subject|5|||
163977912|NCT02970292|592290908|FG000|Overall Study|Noncompliance with study drug|2|||
163977913|NCT02970292|592290909|FG001|Overall Study|Noncompliance with study drug|2|||
163977914|NCT02970292|592290908|FG000|Overall Study|Adverse Event|5|||
163977915|NCT02970292|592290909|FG001|Overall Study|Adverse Event|0|||
163977916|NCT02970292|592290908|FG000|Overall Study|Lack of Efficacy|1|||
163977917|NCT02970292|592290909|FG001|Overall Study|Lack of Efficacy|0|||
163977918|NCT02970292|592290908|FG000|Overall Study|Lost to Follow-up|1|||
163977919|NCT02970292|592290909|FG001|Overall Study|Lost to Follow-up|0|||
163977920|NCT02970292|592290908|FG000|Overall Study|Protocol Violation|2|||
163977921|NCT02970292|592290909|FG001|Overall Study|Protocol Violation|0|||
163977922|NCT02970292|592290908|FG000|Overall Study|Other|1|||
163977923|NCT02970292|592290909|FG001|Overall Study|Other|0|||
163977924|NCT00814892|592290910|FG000|Overall Study|Disease Progression|1|||
163977925|NCT00814892|592290910|FG000|Overall Study|Study Termination|1|||
163977926|NCT00531752|592290912|FG000|First Double-blind Intervention Period|Adverse Event|2|||
164318166|NCT03642132|593540865|FG001|Maintenance Period|Non-compliance with study drug|0|||
164318167|NCT03642132|593540866|FG002|Maintenance Period|Non-compliance with study drug|1|||
164318168|NCT03642132|593540864|FG000|Maintenance Period|Physician's decision|2|||
163977927|NCT00531752|592290913|FG001|First Double-blind Intervention Period|Adverse Event|0|||
163977928|NCT00531752|592290914|FG002|First Double-blind Intervention Period|Adverse Event|1|||
163977929|NCT00531752|592290915|FG003|First Double-blind Intervention Period|Adverse Event|1|||
163977930|NCT00531752|592290912|FG000|First Double-blind Intervention Period|Other|1|||
163977931|NCT00531752|592290913|FG001|First Double-blind Intervention Period|Other|4|||
163977932|NCT00531752|592290914|FG002|First Double-blind Intervention Period|Other|4|||
163977933|NCT00531752|592290915|FG003|First Double-blind Intervention Period|Other|0|||
163977934|NCT00531752|592290912|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
163977935|NCT00531752|592290913|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
163977936|NCT00531752|592290914|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
163977937|NCT00531752|592290915|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
163977938|NCT00531752|592290912|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
164318169|NCT03642132|593540865|FG001|Maintenance Period|Physician's decision|2|||
164318170|NCT03642132|593540866|FG002|Maintenance Period|Physician's decision|2|||
164318171|NCT03642132|593540864|FG000|Maintenance Period|Progressive disease|9|||
164318172|NCT03642132|593540865|FG001|Maintenance Period|Progressive disease|3|||
164318173|NCT03642132|593540866|FG002|Maintenance Period|Progressive disease|6|||
164318174|NCT03642132|593540864|FG000|Maintenance Period|Other|0|||
164318175|NCT03642132|593540865|FG001|Maintenance Period|Other|0|||
164318176|NCT03642132|593540866|FG002|Maintenance Period|Other|3|||
164318177|NCT03642132|593540864|FG000|Maintenance Period|Withdrawal by Subject|1|||
164318178|NCT03642132|593540865|FG001|Maintenance Period|Withdrawal by Subject|1|||
164318179|NCT03642132|593540866|FG002|Maintenance Period|Withdrawal by Subject|2|||
164318180|NCT03642132|593540864|FG000|Follow-up Period|Other|0|||
164318181|NCT03642132|593540865|FG001|Follow-up Period|Other|0|||
164318182|NCT03642132|593540866|FG002|Follow-up Period|Other|1|||
164318183|NCT03642132|593540864|FG000|Follow-up Period|Withdrawal by Subject|1|||
164318184|NCT03642132|593540865|FG001|Follow-up Period|Withdrawal by Subject|2|||
164318185|NCT03642132|593540866|FG002|Follow-up Period|Withdrawal by Subject|0|||
164318186|NCT03642132|593540864|FG000|Follow-up Period|Study terminated by sponsor|1|||
164318187|NCT03642132|593540865|FG001|Follow-up Period|Study terminated by sponsor|0|||
164318188|NCT03642132|593540866|FG002|Follow-up Period|Study terminated by sponsor|1|||
164318189|NCT03642132|593540864|FG000|Follow-up Period|Lack of Efficacy|1|||
164318190|NCT03642132|593540865|FG001|Follow-up Period|Lack of Efficacy|0|||
164318191|NCT03642132|593540866|FG002|Follow-up Period|Lack of Efficacy|0|||
164318192|NCT03642132|593540864|FG000|Follow-up Period|Death|1|||
164318193|NCT03642132|593540865|FG001|Follow-up Period|Death|0|||
164318194|NCT03642132|593540866|FG002|Follow-up Period|Death|2|||
164318195|NCT03642132|593540864|FG000|Follow-up Period|Adverse Event|1|||
164318196|NCT03642132|593540865|FG001|Follow-up Period|Adverse Event|0|||
164318197|NCT03642132|593540866|FG002|Follow-up Period|Adverse Event|0|||
164318198|NCT04493892|593540872|FG000|Overall Study|Withdrawal by Subject|15|||
164318199|NCT02577887|593540873|FG000|Overall Study|Death|93|||
164318200|NCT02577887|593540873|FG000|Overall Study|Protocol Violation|125|||
164318201|NCT02577887|593540873|FG000|Overall Study|Withdrawal by Subject|80|||
164318202|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
164318203|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Adverse Event|9|||
164318204|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Death|4|||
164318205|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
164318206|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
164318207|NCT00159822|593540874|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
164318208|NCT00159822|593540874|FG000|Post-treatment Follow-up Period|Death|1|||
164318209|NCT00159822|593540874|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
164318210|NCT00159822|593540874|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
164318211|NCT00864916|593540879|FG000|Overall Study|Lost to Follow-up|4|||
164318212|NCT00864916|593540880|FG001|Overall Study|Lost to Follow-up|4|||
164318213|NCT00864916|593540879|FG000|Overall Study|Protocol Violation|1|||
164318214|NCT00864916|593540880|FG001|Overall Study|Protocol Violation|0|||
164318215|NCT00864916|593540879|FG000|Overall Study|Withdrawal by Subject|1|||
164318216|NCT00864916|593540880|FG001|Overall Study|Withdrawal by Subject|0|||
164318217|NCT03774823|593540882|FG000|Overall Study|Withdrawal by Subject|1|||
164318218|NCT03774823|593540883|FG001|Overall Study|Withdrawal by Subject|1|||
164318219|NCT02946931|593540886|FG000|Overall Study|Did not require collection of CRFs|588|||
164318220|NCT02946931|593540886|FG000|Overall Study|Other than listed|37|||
164318221|NCT02946931|593540886|FG000|Overall Study|Discharge from hospital|118|||
163977939|NCT00531752|592290913|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
164318222|NCT02946931|593540886|FG000|Overall Study|Adverse Event|81|||
164318223|NCT02946931|593540886|FG000|Overall Study|CRFs not valid|1|||
164318224|NCT02946931|593540886|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
164318225|NCT00869778|593540890|FG000|Overall Study|Adverse Event|2|||
164318226|NCT00869778|593540891|FG001|Overall Study|Adverse Event|0|||
164318227|NCT00869778|593540892|FG002|Overall Study|Adverse Event|0|||
164318228|NCT00869778|593540890|FG000|Overall Study|Withdrawal by Subject|3|||
164318229|NCT00869778|593540891|FG001|Overall Study|Withdrawal by Subject|4|||
164318230|NCT00869778|593540892|FG002|Overall Study|Withdrawal by Subject|5|||
164318231|NCT00869778|593540890|FG000|Overall Study|Pregnancy|1|||
164318232|NCT00869778|593540891|FG001|Overall Study|Pregnancy|0|||
164318233|NCT00869778|593540892|FG002|Overall Study|Pregnancy|0|||
164318234|NCT00869778|593540890|FG000|Overall Study|Protocol Violation|5|||
164318235|NCT00869778|593540891|FG001|Overall Study|Protocol Violation|3|||
164318236|NCT00869778|593540892|FG002|Overall Study|Protocol Violation|5|||
164318237|NCT00869778|593540890|FG000|Overall Study|Unblinding|1|||
164318238|NCT00869778|593540891|FG001|Overall Study|Unblinding|0|||
164318239|NCT00869778|593540892|FG002|Overall Study|Unblinding|0|||
164318240|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
164318241|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
164318242|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Adverse Event|7|||
164318243|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Adverse Event|6|||
164318244|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
164318245|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
164318246|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Physician Decision|4|||
164318247|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Physician Decision|4|||
164318248|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
164318249|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
164318250|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
164318251|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
164318252|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
163873592|NCT02723955|591906861|FG028|Expansion Phase|Site Closed|0|||
163873593|NCT02723955|591906862|FG029|Expansion Phase|Site Closed|0|||
163873594|NCT02723955|591906863|FG030|Expansion Phase|Site Closed|8|||
163873595|NCT02723955|591906864|FG031|Expansion Phase|Site Closed|4|||
163873596|NCT02723955|591906865|FG032|Expansion Phase|Site Closed|2|||
163873597|NCT02723955|591906866|FG033|Expansion Phase|Site Closed|2|||
163873598|NCT02723955|591906867|FG034|Expansion Phase|Site Closed|0|||
163873599|NCT02723955|591906868|FG035|Expansion Phase|Site Closed|0|||
163873600|NCT02723955|591906869|FG036|Expansion Phase|Site Closed|0|||
163873601|NCT02723955|591906870|FG037|Expansion Phase|Site Closed|0|||
163873602|NCT02723955|591906871|FG038|Expansion Phase|Site Closed|0|||
163873603|NCT02723955|591906872|FG039|Expansion Phase|Site Closed|0|||
163873604|NCT02723955|591906873|FG040|Expansion Phase|Site Closed|0|||
163873605|NCT02723955|591906874|FG041|Expansion Phase|Site Closed|0|||
163873606|NCT02723955|591906875|FG042|Expansion Phase|Site Closed|0|||
163873607|NCT02723955|591906833|FG000|Crossover/ Re-treatment Phase|Death|0|||
163873608|NCT02723955|591906834|FG001|Crossover/ Re-treatment Phase|Death|0|||
163873609|NCT02723955|591906835|FG002|Crossover/ Re-treatment Phase|Death|0|||
163873610|NCT02723955|591906836|FG003|Crossover/ Re-treatment Phase|Death|0|||
163873611|NCT02723955|591906837|FG004|Crossover/ Re-treatment Phase|Death|0|||
163873612|NCT02723955|591906838|FG005|Crossover/ Re-treatment Phase|Death|0|||
163873613|NCT02723955|591906839|FG006|Crossover/ Re-treatment Phase|Death|0|||
163873614|NCT02723955|591906840|FG007|Crossover/ Re-treatment Phase|Death|0|||
163873615|NCT02723955|591906841|FG008|Crossover/ Re-treatment Phase|Death|0|||
163873616|NCT02723955|591906842|FG009|Crossover/ Re-treatment Phase|Death|0|||
163873617|NCT02723955|591906843|FG010|Crossover/ Re-treatment Phase|Death|0|||
163873618|NCT02723955|591906844|FG011|Crossover/ Re-treatment Phase|Death|0|||
163873619|NCT02723955|591906845|FG012|Crossover/ Re-treatment Phase|Death|0|||
163873620|NCT02723955|591906846|FG013|Crossover/ Re-treatment Phase|Death|0|||
163873621|NCT02723955|591906847|FG014|Crossover/ Re-treatment Phase|Death|0|||
163873622|NCT02723955|591906848|FG015|Crossover/ Re-treatment Phase|Death|0|||
163873623|NCT02723955|591906849|FG016|Crossover/ Re-treatment Phase|Death|0|||
163873624|NCT02723955|591906850|FG017|Crossover/ Re-treatment Phase|Death|0|||
163873625|NCT02723955|591906851|FG018|Crossover/ Re-treatment Phase|Death|0|||
163873626|NCT02723955|591906852|FG019|Crossover/ Re-treatment Phase|Death|0|||
163873627|NCT02723955|591906853|FG020|Crossover/ Re-treatment Phase|Death|0|||
163873628|NCT02723955|591906854|FG021|Crossover/ Re-treatment Phase|Death|0|||
163873629|NCT02723955|591906855|FG022|Crossover/ Re-treatment Phase|Death|0|||
163873630|NCT02723955|591906856|FG023|Crossover/ Re-treatment Phase|Death|0|||
163873631|NCT02723955|591906857|FG024|Crossover/ Re-treatment Phase|Death|0|||
163873632|NCT02723955|591906858|FG025|Crossover/ Re-treatment Phase|Death|0|||
163873633|NCT02723955|591906859|FG026|Crossover/ Re-treatment Phase|Death|0|||
163873634|NCT02723955|591906860|FG027|Crossover/ Re-treatment Phase|Death|0|||
163873635|NCT02723955|591906861|FG028|Crossover/ Re-treatment Phase|Death|0|||
163873636|NCT02723955|591906862|FG029|Crossover/ Re-treatment Phase|Death|0|||
163873637|NCT02723955|591906863|FG030|Crossover/ Re-treatment Phase|Death|0|||
163873638|NCT02723955|591906864|FG031|Crossover/ Re-treatment Phase|Death|0|||
163873639|NCT02723955|591906865|FG032|Crossover/ Re-treatment Phase|Death|0|||
163873640|NCT02723955|591906866|FG033|Crossover/ Re-treatment Phase|Death|0|||
163873641|NCT02723955|591906867|FG034|Crossover/ Re-treatment Phase|Death|0|||
163873642|NCT02723955|591906868|FG035|Crossover/ Re-treatment Phase|Death|0|||
163873643|NCT02723955|591906869|FG036|Crossover/ Re-treatment Phase|Death|0|||
163873644|NCT02723955|591906870|FG037|Crossover/ Re-treatment Phase|Death|1|||
163873645|NCT02723955|591906871|FG038|Crossover/ Re-treatment Phase|Death|14|||
163873646|NCT02723955|591906872|FG039|Crossover/ Re-treatment Phase|Death|32|||
163873647|NCT02723955|591906873|FG040|Crossover/ Re-treatment Phase|Death|2|||
163873648|NCT02723955|591906874|FG041|Crossover/ Re-treatment Phase|Death|1|||
163873649|NCT02723955|591906875|FG042|Crossover/ Re-treatment Phase|Death|0|||
163873650|NCT02723955|591906833|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873651|NCT02723955|591906834|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873652|NCT02723955|591906835|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873653|NCT02723955|591906836|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873654|NCT02723955|591906837|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873655|NCT02723955|591906838|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873656|NCT02723955|591906839|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873657|NCT02723955|591906840|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163900153|NCT02397096|592005615|FG001|Study Extension 3|Adverse Event|0|||
164318253|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
164318254|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Non-compliance|1|||
164318255|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Non-compliance|0|||
164318256|NCT00470834|593540893|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
164318257|NCT00470834|593540894|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
164318258|NCT00470834|593540893|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
164318259|NCT00470834|593540894|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
164318260|NCT00470834|593540893|FG000|Extension Period (24 Months)|Adverse Event|3|||
164318261|NCT00470834|593540894|FG001|Extension Period (24 Months)|Adverse Event|4|||
164318262|NCT00470834|593540893|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
164318263|NCT00470834|593540894|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
164318264|NCT00470834|593540893|FG000|Extension Period (24 Months)|Physician Decision|4|||
164318265|NCT00470834|593540894|FG001|Extension Period (24 Months)|Physician Decision|3|||
164318266|NCT00470834|593540893|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
164318267|NCT00470834|593540894|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
164318268|NCT00470834|593540893|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
164318269|NCT00470834|593540894|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
164318270|NCT00470834|593540893|FG000|Extension Period (24 Months)|Non-compliance|0|||
164318271|NCT00470834|593540894|FG001|Extension Period (24 Months)|Non-compliance|1|||
164318272|NCT00470834|593540893|FG000|Extension Period (24 Months)|Disease Progression|0|||
164318273|NCT00470834|593540894|FG001|Extension Period (24 Months)|Disease Progression|1|||
164318274|NCT03051620|593540895|FG000|Overall Study|Lost to Follow-up|6|||
164318275|NCT03051620|593540895|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
164318276|NCT00393510|593540896|FG000|Overall Study|Physician Decision|3|||
164318277|NCT00393510|593540897|FG001|Overall Study|Physician Decision|9|||
164318278|NCT01534182|593540898|FG000|Overall Study|Administrative problems|1|||
164318279|NCT01534182|593540899|FG001|Overall Study|Administrative problems|0|||
164318280|NCT01534182|593540898|FG000|Overall Study|Withdrawal by Subject|4|||
164318281|NCT01534182|593540899|FG001|Overall Study|Withdrawal by Subject|7|||
164318282|NCT01534182|593540898|FG000|Overall Study|Adverse Event|7|||
164318283|NCT01534182|593540899|FG001|Overall Study|Adverse Event|3|||
164318284|NCT02412488|593540900|FG000|Overall Study|Lost to Follow-up|10|||
164318285|NCT02412488|593540900|FG000|Overall Study|Withdrawal by Subject|5|||
164318286|NCT02412488|593540900|FG000|Overall Study|Physician Decision|1|||
164318287|NCT02412488|593540900|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
164318288|NCT02412488|593540900|FG000|Overall Study|Reveal LINQ explant|1|||
164318289|NCT00674154|593540901|FG000|Overall Study|Withdrawal by Subject|3|||
164318290|NCT00674154|593540902|FG001|Overall Study|Withdrawal by Subject|1|||
164318291|NCT00674154|593540901|FG000|Overall Study|Did not want parathyroidectomy|0|||
164318292|NCT00674154|593540902|FG001|Overall Study|Did not want parathyroidectomy|2|||
163977940|NCT00531752|592290914|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
164205757|NCT04757636|593122686|FG000|Overall Study|Lost to Follow-up|1|||
164205758|NCT04757636|593122687|FG001|Overall Study|Lost to Follow-up|6|||
164205759|NCT04757636|593122688|FG002|Overall Study|Lost to Follow-up|7|||
164205760|NCT04757636|593122686|FG000|Overall Study|Physician Decision|1|||
164205761|NCT04757636|593122687|FG001|Overall Study|Physician Decision|3|||
164205762|NCT04757636|593122688|FG002|Overall Study|Physician Decision|4|||
164205763|NCT04757636|593122686|FG000|Overall Study|Withdrawal by Subject|20|||
164205764|NCT04757636|593122687|FG001|Overall Study|Withdrawal by Subject|23|||
164205765|NCT04757636|593122688|FG002|Overall Study|Withdrawal by Subject|18|||
164205766|NCT04757636|593122686|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
164205767|NCT04757636|593122687|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
164205768|NCT04757636|593122688|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
164205769|NCT04757636|593122686|FG000|Overall Study|Study Terminated by Sponsor|103|||
164205770|NCT04757636|593122687|FG001|Overall Study|Study Terminated by Sponsor|104|||
164205771|NCT04757636|593122688|FG002|Overall Study|Study Terminated by Sponsor|114|||
164205772|NCT04757636|593122686|FG000|Overall Study|Sponsor Decision|0|||
164205773|NCT04757636|593122687|FG001|Overall Study|Sponsor Decision|0|||
164205774|NCT04757636|593122688|FG002|Overall Study|Sponsor Decision|1|||
164205775|NCT04757636|593122686|FG000|Overall Study|Randomized in Error|0|||
164205776|NCT04757636|593122687|FG001|Overall Study|Randomized in Error|0|||
164205777|NCT04757636|593122688|FG002|Overall Study|Randomized in Error|2|||
164205778|NCT01732692|593122692|FG000|Overall Study|Adverse Event|0|||
164205779|NCT01732692|593122693|FG001|Overall Study|Adverse Event|1|||
163977941|NCT00531752|592290915|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
163977942|NCT00531752|592290912|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
164205780|NCT01027949|593122694|FG000|Overall Study|Death|174|||
164205781|NCT01027949|593122694|FG000|Overall Study|Progressive Disease|163|||
164205782|NCT01027949|593122694|FG000|Overall Study|Adverse Event|172|||
164205783|NCT01027949|593122694|FG000|Overall Study|Withdrawal by Subject|113|||
164205784|NCT01027949|593122694|FG000|Overall Study|Lost to Follow-up|17|||
164205785|NCT01027949|593122694|FG000|Overall Study|Protocol Violation|13|||
164318293|NCT00816023|593540903|FG000|Overall Study|Lost to Follow-up|1|||
164318294|NCT00816023|593540904|FG001|Overall Study|Lost to Follow-up|1|||
164318295|NCT00816023|593540905|FG002|Overall Study|Lost to Follow-up|0|||
164318296|NCT00816023|593540906|FG003|Overall Study|Lost to Follow-up|0|||
164318297|NCT00816023|593540903|FG000|Overall Study|Withdrawal by Subject|1|||
164318298|NCT00816023|593540904|FG001|Overall Study|Withdrawal by Subject|0|||
164318299|NCT00816023|593540905|FG002|Overall Study|Withdrawal by Subject|0|||
164318300|NCT00816023|593540906|FG003|Overall Study|Withdrawal by Subject|0|||
164318301|NCT00816023|593540903|FG000|Overall Study|Physician Decision|0|||
164318302|NCT00816023|593540904|FG001|Overall Study|Physician Decision|0|||
164318303|NCT00816023|593540905|FG002|Overall Study|Physician Decision|1|||
164318304|NCT00816023|593540906|FG003|Overall Study|Physician Decision|0|||
164318305|NCT00816023|593540903|FG000|Overall Study|assessments complete prior to window|1|||
164318306|NCT00816023|593540904|FG001|Overall Study|assessments complete prior to window|1|||
164318307|NCT00816023|593540905|FG002|Overall Study|assessments complete prior to window|2|||
163873658|NCT02723955|591906841|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873659|NCT02723955|591906842|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873660|NCT02723955|591906843|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873661|NCT02723955|591906844|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873662|NCT02723955|591906845|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873663|NCT02723955|591906846|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873664|NCT02723955|591906847|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873665|NCT02723955|591906848|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873666|NCT02723955|591906849|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873667|NCT02723955|591906850|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873668|NCT02723955|591906851|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873669|NCT02723955|591906852|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873670|NCT02723955|591906853|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873671|NCT02723955|591906854|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873672|NCT02723955|591906855|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873673|NCT02723955|591906856|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873674|NCT02723955|591906857|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873675|NCT02723955|591906858|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873676|NCT02723955|591906859|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873677|NCT02723955|591906860|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873678|NCT02723955|591906861|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873679|NCT02723955|591906862|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873680|NCT02723955|591906863|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873681|NCT02723955|591906864|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873682|NCT02723955|591906865|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873683|NCT02723955|591906866|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873684|NCT02723955|591906867|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873685|NCT02723955|591906868|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873686|NCT02723955|591906869|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873687|NCT02723955|591906870|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873688|NCT02723955|591906871|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873689|NCT02723955|591906872|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
163873690|NCT02723955|591906873|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873691|NCT02723955|591906874|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873692|NCT02723955|591906875|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
163873693|NCT02723955|591906833|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873694|NCT02723955|591906834|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873695|NCT02723955|591906835|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873696|NCT02723955|591906836|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873697|NCT02723955|591906837|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873698|NCT02723955|591906838|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873699|NCT02723955|591906839|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873700|NCT02723955|591906840|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873701|NCT02723955|591906841|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873702|NCT02723955|591906842|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873703|NCT02723955|591906843|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873704|NCT02723955|591906844|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873705|NCT02723955|591906845|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873706|NCT02723955|591906846|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873707|NCT02723955|591906847|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873708|NCT02723955|591906848|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873709|NCT02723955|591906849|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873710|NCT02723955|591906850|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873711|NCT02723955|591906851|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873712|NCT02723955|591906852|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
164318308|NCT00816023|593540906|FG003|Overall Study|assessments complete prior to window|1|||
164318309|NCT00816023|593540903|FG000|Overall Study|Randomized Not Treated|6|||
163977943|NCT00531752|592290913|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
163977944|NCT00531752|592290914|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
163977945|NCT00531752|592290915|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
163977946|NCT00531752|592290912|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
163977947|NCT00531752|592290913|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
163977948|NCT00531752|592290914|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
163977949|NCT00531752|592290915|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
163977950|NCT00531752|592290912|FG000|Second Double-blind Intervention Period|Other|1|||
163977951|NCT00531752|592290913|FG001|Second Double-blind Intervention Period|Other|1|||
163977952|NCT00531752|592290914|FG002|Second Double-blind Intervention Period|Other|0|||
163977953|NCT00531752|592290915|FG003|Second Double-blind Intervention Period|Other|0|||
163977954|NCT00531752|592290912|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163977955|NCT00531752|592290913|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163977956|NCT00531752|592290914|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
163977957|NCT00531752|592290915|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
163977958|NCT00531752|592290912|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163977959|NCT00531752|592290913|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163977960|NCT00531752|592290914|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
163977961|NCT00531752|592290915|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
163977962|NCT04486950|592290916|FG000|Overall Study|Lost to Follow-up|0|||
163977963|NCT04486950|592290917|FG001|Overall Study|Lost to Follow-up|0|||
163977964|NCT04486950|592290918|FG002|Overall Study|Lost to Follow-up|0|||
163977965|NCT04486950|592290919|FG003|Overall Study|Lost to Follow-up|0|||
163977966|NCT04486950|592290920|FG004|Overall Study|Lost to Follow-up|0|||
163977967|NCT04486950|592290921|FG005|Overall Study|Lost to Follow-up|1|||
163977968|NCT04486950|592290922|FG006|Overall Study|Lost to Follow-up|0|||
163977969|NCT02821715|592290923|FG000|Overall Study|Protocol Violation|1|||
163977970|NCT02821715|592290924|FG001|Overall Study|Protocol Violation|0|||
163977971|NCT02821715|592290925|FG002|Overall Study|Protocol Violation|0|||
163977972|NCT02821715|592290926|FG003|Overall Study|Protocol Violation|0|||
163977973|NCT02821715|592290927|FG004|Overall Study|Protocol Violation|0|||
163977974|NCT02821715|592290928|FG005|Overall Study|Protocol Violation|0|||
163977975|NCT00640328|592290929|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163977976|NCT00640328|592290930|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
163977977|NCT00640328|592290931|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163977978|NCT00640328|592290932|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163977979|NCT00640328|592290933|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163977980|NCT00640328|592290934|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
163977981|NCT00640328|592290929|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163977982|NCT00640328|592290930|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163977983|NCT00640328|592290931|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163977984|NCT00640328|592290932|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163977985|NCT00640328|592290933|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
163977986|NCT00640328|592290934|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
163977987|NCT00640328|592290929|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163977988|NCT00640328|592290930|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163977989|NCT00640328|592290931|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
163977990|NCT00640328|592290932|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163977991|NCT00640328|592290933|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163977992|NCT00640328|592290934|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
163977993|NCT00640328|592290929|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163977994|NCT00640328|592290930|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
163977995|NCT00640328|592290931|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163873713|NCT02723955|591906853|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873714|NCT02723955|591906854|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873715|NCT02723955|591906855|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873716|NCT02723955|591906856|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873717|NCT02723955|591906857|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873718|NCT02723955|591906858|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873719|NCT02723955|591906859|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873720|NCT02723955|591906860|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
163977996|NCT00640328|592290932|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
163977997|NCT00640328|592290933|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163873721|NCT02723955|591906861|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873722|NCT02723955|591906862|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
163977998|NCT00640328|592290934|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
163977999|NCT02374099|592290937|FG000|Overall Study|Adverse Event|1|||
163978000|NCT02374099|592290938|FG001|Overall Study|Adverse Event|0|||
163978001|NCT02374099|592290937|FG000|Overall Study|Progressive Disease|35|||
163978002|NCT02374099|592290938|FG001|Overall Study|Progressive Disease|40|||
163978003|NCT02374099|592290937|FG000|Overall Study|Withdrawal by Subject|5|||
163978004|NCT02374099|592290938|FG001|Overall Study|Withdrawal by Subject|1|||
163978005|NCT02374099|592290937|FG000|Overall Study|Miscellaneous|2|||
163978006|NCT02374099|592290938|FG001|Overall Study|Miscellaneous|3|||
163978007|NCT02374099|592290937|FG000|Overall Study|Randomized, but not treated|2|||
163978008|NCT02374099|592290938|FG001|Overall Study|Randomized, but not treated|1|||
163978009|NCT02374099|592290937|FG000|Overall Study|Study Terminated by Sponsor|3|||
163978010|NCT02374099|592290938|FG001|Overall Study|Study Terminated by Sponsor|4|||
163978011|NCT01033825|592290939|FG000|Overall Study|Withdrawal by Subject|2|||
163978012|NCT01033825|592290940|FG001|Overall Study|Withdrawal by Subject|3|||
163978013|NCT01033825|592290941|FG002|Overall Study|Withdrawal by Subject|2|||
163978014|NCT01033825|592290942|FG003|Overall Study|Withdrawal by Subject|1|||
163978015|NCT01033825|592290943|FG004|Overall Study|Withdrawal by Subject|1|||
163978016|NCT01033825|592290944|FG005|Overall Study|Withdrawal by Subject|0|||
163978017|NCT01033825|592290945|FG006|Overall Study|Withdrawal by Subject|0|||
163978018|NCT01033825|592290939|FG000|Overall Study|Adverse Event|0|||
163978019|NCT01033825|592290940|FG001|Overall Study|Adverse Event|0|||
163978020|NCT01033825|592290941|FG002|Overall Study|Adverse Event|0|||
163978021|NCT01033825|592290942|FG003|Overall Study|Adverse Event|1|||
163978022|NCT01033825|592290943|FG004|Overall Study|Adverse Event|0|||
163978023|NCT01033825|592290944|FG005|Overall Study|Adverse Event|0|||
163978024|NCT01033825|592290945|FG006|Overall Study|Adverse Event|0|||
163978025|NCT01033825|592290939|FG000|Overall Study|Protocol Violation|1|||
163978026|NCT01033825|592290940|FG001|Overall Study|Protocol Violation|0|||
163978027|NCT01033825|592290941|FG002|Overall Study|Protocol Violation|0|||
163978028|NCT01033825|592290942|FG003|Overall Study|Protocol Violation|0|||
163978029|NCT01033825|592290943|FG004|Overall Study|Protocol Violation|0|||
163978030|NCT01033825|592290944|FG005|Overall Study|Protocol Violation|0|||
163978031|NCT01033825|592290945|FG006|Overall Study|Protocol Violation|0|||
163978032|NCT01033825|592290939|FG000|Overall Study|Other|0|||
163978033|NCT01033825|592290940|FG001|Overall Study|Other|0|||
163978034|NCT01033825|592290941|FG002|Overall Study|Other|0|||
163978035|NCT01033825|592290942|FG003|Overall Study|Other|0|||
163978036|NCT01033825|592290943|FG004|Overall Study|Other|1|||
163978037|NCT01033825|592290944|FG005|Overall Study|Other|0|||
163978038|NCT01033825|592290945|FG006|Overall Study|Other|0|||
163978039|NCT04294719|592290946|FG000|Overall Study|Withdrawal by Subject|1|||
163978040|NCT01883635|592290947|FG000|Overall Study|Withdrawal by Subject|4|||
163978041|NCT01883635|592290948|FG001|Overall Study|Withdrawal by Subject|0|||
163978042|NCT01464307|592290952|FG000|Main Period|Death|0|||
163978043|NCT01464307|592290953|FG001|Main Period|Death|1|||
163978044|NCT01464307|592290952|FG000|Main Period|Adverse Event|6|||
163978045|NCT01464307|592290953|FG001|Main Period|Adverse Event|1|||
163978046|NCT01464307|592290952|FG000|Main Period|Lack of Efficacy|2|||
163978047|NCT01464307|592290953|FG001|Main Period|Lack of Efficacy|0|||
163978048|NCT01464307|592290952|FG000|Main Period|Withdrawal by Subject|5|||
163978049|NCT01464307|592290953|FG001|Main Period|Withdrawal by Subject|2|||
163978050|NCT01464307|592290952|FG000|Main Period|Predefined discontinuation criteria|2|||
163978051|NCT01464307|592290953|FG001|Main Period|Predefined discontinuation criteria|1|||
163978052|NCT01464307|592290952|FG000|Open-Label Extension Period|Adverse Event|15|||
163978053|NCT01464307|592290953|FG001|Open-Label Extension Period|Adverse Event|0|||
163978054|NCT01464307|592290952|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
163978055|NCT01464307|592290953|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
163978056|NCT01464307|592290952|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
163978057|NCT01464307|592290953|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
164318310|NCT00816023|593540904|FG001|Overall Study|Randomized Not Treated|4|||
163978058|NCT01464307|592290952|FG000|Open-Label Extension Period|Death|1|||
163978059|NCT01464307|592290953|FG001|Open-Label Extension Period|Death|0|||
163978060|NCT01464307|592290952|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
163978061|NCT01464307|592290953|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
163978062|NCT01464307|592290952|FG000|Open-Label Extension Period|Non-compliance|9|||
163978063|NCT01464307|592290953|FG001|Open-Label Extension Period|Non-compliance|0|||
163978064|NCT01464307|592290952|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
164136055|NCT02906930|592862019|FG002|Overall Study|Death|1|||
164136056|NCT02906930|592862020|FG003|Overall Study|Death|0|||
164136057|NCT02906930|592862017|FG000|Overall Study|Other|1|||
164136058|NCT02906930|592862018|FG001|Overall Study|Other|2|||
164136059|NCT02906930|592862019|FG002|Overall Study|Other|1|||
164136060|NCT02906930|592862020|FG003|Overall Study|Other|2|||
164136061|NCT00540293|592862021|FG000|Overall Study|Adverse event related to study drug|10|||
164136062|NCT00540293|592862021|FG000|Overall Study|Adverse event not related to study drug|7|||
164136063|NCT00540293|592862021|FG000|Overall Study|Withdrawal by Subject|6|||
164136064|NCT00540293|592862021|FG000|Overall Study|Protocol violation, & subject schedule|12|||
164136065|NCT03537599|592862022|FG000|Overall Study|Disease Progression|2|||
164136066|NCT03537599|592862023|FG001|Overall Study|Disease Progression|1|||
164136067|NCT03537599|592862022|FG000|Overall Study|Death|0|||
164318311|NCT00816023|593540905|FG002|Overall Study|Randomized Not Treated|6|||
164318312|NCT00816023|593540906|FG003|Overall Study|Randomized Not Treated|11|||
164318313|NCT00441116|593540910|FG000|Overall Study|Adverse Event|1|||
164318314|NCT00441116|593540911|FG001|Overall Study|Adverse Event|1|||
164318315|NCT00441116|593540910|FG000|Overall Study|Withdrawal by Subject|1|||
164318316|NCT00441116|593540911|FG001|Overall Study|Withdrawal by Subject|0|||
164318317|NCT00441116|593540910|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
164318318|NCT00441116|593540911|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
164318319|NCT02925338|593540912|FG000|Overall Study|Death|0|||
164318320|NCT02925338|593540913|FG001|Overall Study|Death|2|||
164318321|NCT02925338|593540914|FG002|Overall Study|Death|1|||
164318322|NCT02925338|593540915|FG003|Overall Study|Death|0|||
164318323|NCT02925338|593540916|FG004|Overall Study|Death|0|||
164318324|NCT02925338|593540912|FG000|Overall Study|Lost to Follow-up|30|||
164318325|NCT02925338|593540913|FG001|Overall Study|Lost to Follow-up|10|||
164318326|NCT02925338|593540914|FG002|Overall Study|Lost to Follow-up|1|||
164318327|NCT02925338|593540915|FG003|Overall Study|Lost to Follow-up|16|||
164318328|NCT02925338|593540916|FG004|Overall Study|Lost to Follow-up|3|||
164318329|NCT02925338|593540912|FG000|Overall Study|Withdrawal by Subject|3|||
164318330|NCT02925338|593540913|FG001|Overall Study|Withdrawal by Subject|0|||
164318331|NCT02925338|593540914|FG002|Overall Study|Withdrawal by Subject|3|||
164318332|NCT02925338|593540915|FG003|Overall Study|Withdrawal by Subject|2|||
164318333|NCT02925338|593540916|FG004|Overall Study|Withdrawal by Subject|2|||
164318334|NCT02925338|593540912|FG000|Overall Study|Missing|38|||
164318335|NCT02925338|593540913|FG001|Overall Study|Missing|27|||
164318336|NCT02925338|593540914|FG002|Overall Study|Missing|0|||
164318337|NCT02925338|593540915|FG003|Overall Study|Missing|3|||
164318338|NCT02925338|593540916|FG004|Overall Study|Missing|2|||
164318339|NCT02925338|593540912|FG000|Overall Study|Participant's Decision|11|||
164318340|NCT02925338|593540913|FG001|Overall Study|Participant's Decision|7|||
164318341|NCT02925338|593540914|FG002|Overall Study|Participant's Decision|3|||
164318342|NCT02925338|593540915|FG003|Overall Study|Participant's Decision|8|||
164318343|NCT02925338|593540916|FG004|Overall Study|Participant's Decision|1|||
164318344|NCT02925338|593540912|FG000|Overall Study|Treatment Discontinuation|144|||
164318345|NCT02925338|593540913|FG001|Overall Study|Treatment Discontinuation|65|||
164318346|NCT02925338|593540914|FG002|Overall Study|Treatment Discontinuation|56|||
164318347|NCT02925338|593540915|FG003|Overall Study|Treatment Discontinuation|131|||
164318348|NCT02925338|593540916|FG004|Overall Study|Treatment Discontinuation|22|||
164318349|NCT00636363|593540919|FG000|Overall Study|Conjunctivitis|0|||
164318350|NCT00636363|593540920|FG001|Overall Study|Conjunctivitis|0|||
164318351|NCT00636363|593540921|FG002|Overall Study|Conjunctivitis|1|||
164318352|NCT00636363|593540919|FG000|Overall Study|Adverse Event|0|||
164318353|NCT00636363|593540920|FG001|Overall Study|Adverse Event|0|||
164318354|NCT00636363|593540921|FG002|Overall Study|Adverse Event|1|||
164318355|NCT00636363|593540919|FG000|Overall Study|Positive slit lamp finding|0|||
164318356|NCT00636363|593540920|FG001|Overall Study|Positive slit lamp finding|2|||
164318357|NCT00636363|593540921|FG002|Overall Study|Positive slit lamp finding|1|||
164318358|NCT00636363|593540919|FG000|Overall Study|Study related symptoms/complaints|8|||
164318359|NCT00636363|593540920|FG001|Overall Study|Study related symptoms/complaints|7|||
164318360|NCT00636363|593540921|FG002|Overall Study|Study related symptoms/complaints|4|||
164318361|NCT00636363|593540919|FG000|Overall Study|Met ineligibility criteria|0|||
164318362|NCT00636363|593540920|FG001|Overall Study|Met ineligibility criteria|0|||
164318363|NCT00636363|593540921|FG002|Overall Study|Met ineligibility criteria|3|||
164318364|NCT00636363|593540919|FG000|Overall Study|Missed > 1 visit|0|||
164318365|NCT00636363|593540920|FG001|Overall Study|Missed > 1 visit|1|||
164318366|NCT00636363|593540921|FG002|Overall Study|Missed > 1 visit|3|||
164318367|NCT00636363|593540919|FG000|Overall Study|Lack of motivation|1|||
164318368|NCT00636363|593540920|FG001|Overall Study|Lack of motivation|0|||
164318369|NCT00636363|593540921|FG002|Overall Study|Lack of motivation|1|||
164318370|NCT00636363|593540919|FG000|Overall Study|Protocol Violation|0|||
164318371|NCT00636363|593540920|FG001|Overall Study|Protocol Violation|3|||
164318372|NCT00636363|593540921|FG002|Overall Study|Protocol Violation|0|||
164318373|NCT00636363|593540919|FG000|Overall Study|Lost to Follow-up|3|||
164318374|NCT00636363|593540920|FG001|Overall Study|Lost to Follow-up|4|||
164318375|NCT00636363|593540921|FG002|Overall Study|Lost to Follow-up|2|||
164318376|NCT00636363|593540919|FG000|Overall Study|Withdrawal by Subject|1|||
164318377|NCT00636363|593540920|FG001|Overall Study|Withdrawal by Subject|3|||
164318378|NCT00636363|593540921|FG002|Overall Study|Withdrawal by Subject|2|||
164318379|NCT00835731|593540926|FG000|Overall Study|Withdrawal by Subject|1|||
164318380|NCT00835731|593540927|FG001|Overall Study|Withdrawal by Subject|0|||
164318381|NCT00835731|593540926|FG000|Overall Study|Physician Decision|1|||
164318382|NCT00835731|593540927|FG001|Overall Study|Physician Decision|1|||
164318383|NCT00348881|593540928|FG000|Overall Study|Lost to Follow-up|12|||
164318384|NCT00348881|593540929|FG001|Overall Study|Lost to Follow-up|6|||
164318385|NCT00348881|593540928|FG000|Overall Study|Withdrawal by Subject|3|||
164318386|NCT00348881|593540929|FG001|Overall Study|Withdrawal by Subject|4|||
164318387|NCT00348881|593540928|FG000|Overall Study|Adverse Event|2|||
164318388|NCT00348881|593540929|FG001|Overall Study|Adverse Event|0|||
164318389|NCT00348881|593540928|FG000|Overall Study|Serious Adverse Event|0|||
163978065|NCT01464307|592290953|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
163978066|NCT03099187|592290958|FG000|Double-blind Treatment|Adverse Event|19|||
164205786|NCT01027949|593122694|FG000|Overall Study|PI Decision|8|||
164205787|NCT01027949|593122694|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
164205788|NCT01027949|593122694|FG000|Overall Study|Non-compliance with Study Procedures|7|||
164205789|NCT01027949|593122694|FG000|Overall Study|Lung Transplant|5|||
163978067|NCT03099187|592290959|FG001|Double-blind Treatment|Adverse Event|1|||
163978068|NCT03099187|592290960|FG002|Double-blind Treatment|Adverse Event|0|||
163978069|NCT03099187|592290961|FG003|Double-blind Treatment|Adverse Event|0|||
163978070|NCT03099187|592290958|FG000|Double-blind Treatment|Death|1|||
163978071|NCT03099187|592290959|FG001|Double-blind Treatment|Death|3|||
163978072|NCT03099187|592290960|FG002|Double-blind Treatment|Death|0|||
163978073|NCT03099187|592290961|FG003|Double-blind Treatment|Death|0|||
163978074|NCT03099187|592290958|FG000|Double-blind Treatment|Lack of Efficacy|1|||
163978075|NCT03099187|592290959|FG001|Double-blind Treatment|Lack of Efficacy|0|||
163978076|NCT03099187|592290960|FG002|Double-blind Treatment|Lack of Efficacy|0|||
163978077|NCT03099187|592290961|FG003|Double-blind Treatment|Lack of Efficacy|0|||
163978078|NCT03099187|592290958|FG000|Double-blind Treatment|Physician Decision|2|||
163978079|NCT03099187|592290959|FG001|Double-blind Treatment|Physician Decision|1|||
163978080|NCT03099187|592290960|FG002|Double-blind Treatment|Physician Decision|0|||
163978081|NCT03099187|592290961|FG003|Double-blind Treatment|Physician Decision|0|||
163978082|NCT03099187|592290958|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
163978083|NCT03099187|592290959|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
163978084|NCT03099187|592290960|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
163978085|NCT03099187|592290961|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
163978086|NCT03099187|592290958|FG000|Double-blind Treatment|Lung transplantation|0|||
163978087|NCT03099187|592290959|FG001|Double-blind Treatment|Lung transplantation|1|||
163978088|NCT03099187|592290960|FG002|Double-blind Treatment|Lung transplantation|0|||
163978089|NCT03099187|592290961|FG003|Double-blind Treatment|Lung transplantation|0|||
163978090|NCT03099187|592290958|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
163978091|NCT03099187|592290959|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
163978092|NCT03099187|592290960|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
163978093|NCT03099187|592290961|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
163978094|NCT03099187|592290958|FG000|Double-blind Treatment|Disease progression|0|||
163978095|NCT03099187|592290959|FG001|Double-blind Treatment|Disease progression|1|||
163978096|NCT03099187|592290960|FG002|Double-blind Treatment|Disease progression|0|||
163978097|NCT03099187|592290961|FG003|Double-blind Treatment|Disease progression|0|||
163978098|NCT03099187|592290958|FG000|Double-blind Treatment|Randomization error|0|||
163978099|NCT03099187|592290959|FG001|Double-blind Treatment|Randomization error|2|||
163978100|NCT03099187|592290960|FG002|Double-blind Treatment|Randomization error|0|||
163978101|NCT03099187|592290961|FG003|Double-blind Treatment|Randomization error|0|||
163978102|NCT03099187|592290958|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
163978103|NCT03099187|592290959|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
163978104|NCT03099187|592290960|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
163978105|NCT03099187|592290961|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
164205790|NCT01027949|593122694|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
164205791|NCT01027949|593122694|FG000|Overall Study|Use of Excluded Medication|2|||
164205792|NCT01027949|593122694|FG000|Overall Study|Patient Self-discontinuation|1|||
164205793|NCT01027949|593122694|FG000|Overall Study|Pregnancy|1|||
164205794|NCT01027949|593122694|FG000|Overall Study|Surgery|1|||
164205795|NCT00656617|593122697|FG000|Overall Study|Adverse Event|1|||
164205796|NCT00656617|593122697|FG000|Overall Study|Death|2|||
164205797|NCT00656617|593122697|FG000|Overall Study|Insurance Issues|2|||
164205798|NCT00656617|593122697|FG000|Overall Study|Move to different clinical trial|2|||
164205799|NCT02030600|593122698|FG000|Treatment Period 1|Adverse Event|5|||
164205800|NCT02030600|593122699|FG001|Treatment Period 1|Adverse Event|7|||
164205801|NCT02030600|593122698|FG000|Treatment Period 1|Lack of Efficacy|0|||
164205802|NCT02030600|593122699|FG001|Treatment Period 1|Lack of Efficacy|1|||
164205803|NCT02030600|593122698|FG000|Treatment Period 1|Lost to Follow-up|11|||
164205804|NCT02030600|593122699|FG001|Treatment Period 1|Lost to Follow-up|3|||
164205805|NCT02030600|593122698|FG000|Treatment Period 1|Protocol Violation|22|||
164205806|NCT02030600|593122699|FG001|Treatment Period 1|Protocol Violation|17|||
164205807|NCT02030600|593122698|FG000|Treatment Period 1|Withdrawal by Subject|13|||
164205808|NCT02030600|593122699|FG001|Treatment Period 1|Withdrawal by Subject|17|||
164205809|NCT02030600|593122698|FG000|Treatment Period 1|Casebook Unsigned|1|||
163978106|NCT03099187|592290958|FG000|12-month Safety Follow-up|Adverse Event|0|||
163978107|NCT03099187|592290959|FG001|12-month Safety Follow-up|Adverse Event|0|||
163978108|NCT03099187|592290960|FG002|12-month Safety Follow-up|Adverse Event|5|||
164205810|NCT02030600|593122699|FG001|Treatment Period 1|Casebook Unsigned|0|||
164205811|NCT02030600|593122698|FG000|Treatment Period 1|Unclassified|1|||
164205812|NCT02030600|593122699|FG001|Treatment Period 1|Unclassified|0|||
164205813|NCT02030600|593122698|FG000|Treatment Period 2|Adverse Event|4|||
164205814|NCT02030600|593122699|FG001|Treatment Period 2|Adverse Event|4|||
164318390|NCT00348881|593540929|FG001|Overall Study|Serious Adverse Event|2|||
164318391|NCT05092360|593540937|FG000|Overall Study|Withdrawal by Subject|21|||
164318392|NCT05092360|593540938|FG001|Overall Study|Withdrawal by Subject|4|||
164318393|NCT05092360|593540939|FG002|Overall Study|Withdrawal by Subject|9|||
164318394|NCT05092360|593540940|FG003|Overall Study|Withdrawal by Subject|26|||
164318395|NCT05092360|593540937|FG000|Overall Study|Death|97|||
164318396|NCT05092360|593540938|FG001|Overall Study|Death|14|||
164318397|NCT05092360|593540939|FG002|Overall Study|Death|31|||
164318398|NCT05092360|593540940|FG003|Overall Study|Death|101|||
164318399|NCT05092360|593540937|FG000|Overall Study|Lost to Follow-up|1|||
163978109|NCT03099187|592290961|FG003|12-month Safety Follow-up|Adverse Event|12|||
163978110|NCT03099187|592290958|FG000|12-month Safety Follow-up|Death|0|||
163978111|NCT03099187|592290959|FG001|12-month Safety Follow-up|Death|0|||
163978112|NCT03099187|592290960|FG002|12-month Safety Follow-up|Death|7|||
163978113|NCT03099187|592290961|FG003|12-month Safety Follow-up|Death|9|||
163978114|NCT03099187|592290958|FG000|12-month Safety Follow-up|Lung transplantation|0|||
163978115|NCT03099187|592290959|FG001|12-month Safety Follow-up|Lung transplantation|0|||
163978116|NCT03099187|592290960|FG002|12-month Safety Follow-up|Lung transplantation|2|||
163978117|NCT03099187|592290961|FG003|12-month Safety Follow-up|Lung transplantation|1|||
163978118|NCT03099187|592290958|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
163978119|NCT03099187|592290959|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
163978120|NCT03099187|592290960|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
163978121|NCT03099187|592290961|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
163978122|NCT03099187|592290958|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
163978123|NCT03099187|592290959|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
163978124|NCT03099187|592290960|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
163978125|NCT03099187|592290961|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
163978126|NCT03099187|592290958|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
163978127|NCT03099187|592290959|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
163978128|NCT03099187|592290960|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
163978129|NCT03099187|592290961|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
163978130|NCT03099187|592290958|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
163978131|NCT03099187|592290959|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
163978132|NCT03099187|592290960|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
163978133|NCT03099187|592290961|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
163978134|NCT03885089|592290962|FG000|Overall Study|No informed consent for publication of study results|2|||
163978135|NCT03349099|592290963|FG000|Overall Study|Physician Decision|3|||
163978136|NCT03349099|592290964|FG001|Overall Study|Physician Decision|4|||
163978137|NCT03349099|592290963|FG000|Overall Study|Stone migrated from the kidney|1|||
163978138|NCT03349099|592290964|FG001|Overall Study|Stone migrated from the kidney|0|||
163978139|NCT00894556|592290966|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
163978140|NCT00894556|592290967|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
163978141|NCT00894556|592290968|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
163978142|NCT00894556|592290969|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
163978143|NCT00894556|592290966|FG000|Treatment Phase|Lost to Follow-up|2|||
163978144|NCT00894556|592290967|FG001|Treatment Phase|Lost to Follow-up|3|||
163978145|NCT00894556|592290968|FG002|Treatment Phase|Lost to Follow-up|1|||
163978146|NCT00894556|592290969|FG003|Treatment Phase|Lost to Follow-up|0|||
163978147|NCT00894556|592290966|FG000|Treatment Phase|Lack of Qualifying Event|2|||
163978148|NCT00894556|592290967|FG001|Treatment Phase|Lack of Qualifying Event|1|||
163978149|NCT00894556|592290968|FG002|Treatment Phase|Lack of Qualifying Event|0|||
163978150|NCT00894556|592290969|FG003|Treatment Phase|Lack of Qualifying Event|0|||
163978151|NCT04869345|592290970|FG000|Overall Study|Lost to Follow-up|8|||
164205815|NCT02030600|593122698|FG000|Treatment Period 2|Lack of Efficacy|2|||
164205816|NCT02030600|593122699|FG001|Treatment Period 2|Lack of Efficacy|1|||
164205817|NCT02030600|593122698|FG000|Treatment Period 2|Lost to Follow-up|4|||
164205818|NCT02030600|593122699|FG001|Treatment Period 2|Lost to Follow-up|2|||
164205819|NCT02030600|593122698|FG000|Treatment Period 2|Protocol Violation|1|||
164205820|NCT02030600|593122699|FG001|Treatment Period 2|Protocol Violation|2|||
164205821|NCT02030600|593122698|FG000|Treatment Period 2|Withdrawal by Subject|13|||
164205822|NCT02030600|593122699|FG001|Treatment Period 2|Withdrawal by Subject|9|||
164205823|NCT02030600|593122698|FG000|Treatment Period 2|Unclassified|1|||
164205824|NCT02030600|593122699|FG001|Treatment Period 2|Unclassified|0|||
164205825|NCT00091819|593122702|FG000|Overall Study|Adverse Event|1|||
164205826|NCT00091819|593122703|FG001|Overall Study|Adverse Event|1|||
164205827|NCT00091819|593122702|FG000|Overall Study|Death|4|||
164205828|NCT00091819|593122703|FG001|Overall Study|Death|5|||
164205829|NCT00091819|593122702|FG000|Overall Study|Lost to Follow-up|26|||
163978152|NCT04869345|592290971|FG001|Overall Study|Lost to Follow-up|3|||
163978153|NCT00528021|592290979|FG000|Overall Study|Lack of Efficacy|17|||
163978154|NCT00528021|592290980|FG001|Overall Study|Lack of Efficacy|13|||
164205830|NCT00091819|593122703|FG001|Overall Study|Lost to Follow-up|23|||
164318400|NCT05092360|593540938|FG001|Overall Study|Lost to Follow-up|2|||
164318401|NCT05092360|593540939|FG002|Overall Study|Lost to Follow-up|2|||
164318402|NCT05092360|593540940|FG003|Overall Study|Lost to Follow-up|2|||
163978155|NCT00528021|592290981|FG002|Overall Study|Lack of Efficacy|7|||
163978156|NCT00528021|592290982|FG003|Overall Study|Lack of Efficacy|9|||
163978157|NCT05054114|592290992|FG000|Overall Study|Protocol Violation|13|||
163978158|NCT05054114|592290993|FG001|Overall Study|Protocol Violation|1|||
163978159|NCT05054114|592290992|FG000|Overall Study|Pregnancy|0|||
163978160|NCT05054114|592290993|FG001|Overall Study|Pregnancy|1|||
163978161|NCT04294901|592290998|FG000|Overall Study|Death|86|||
163978162|NCT04294901|592290999|FG001|Overall Study|Death|110|||
163978163|NCT04294901|592290998|FG000|Overall Study|Provider did not have historical control patients|581|||
163978164|NCT04294901|592290999|FG001|Overall Study|Provider did not have historical control patients|0|||
163978165|NCT04294901|592290998|FG000|Overall Study|Provider did not have intervention patients|0|||
163978166|NCT04294901|592290999|FG001|Overall Study|Provider did not have intervention patients|98|||
163978167|NCT03077685|592291000|FG000|Overall Study|Lost to Follow-up|0|||
163978168|NCT03077685|592291001|FG001|Overall Study|Lost to Follow-up|0|||
163978169|NCT03077685|592291002|FG002|Overall Study|Lost to Follow-up|0|||
163978170|NCT03077685|592291003|FG003|Overall Study|Lost to Follow-up|0|||
163978171|NCT03077685|592291004|FG004|Overall Study|Lost to Follow-up|1|||
163978172|NCT03077685|592291000|FG000|Overall Study|Death|0|||
163978173|NCT03077685|592291001|FG001|Overall Study|Death|0|||
164205831|NCT00091819|593122702|FG000|Overall Study|Withdrawal by Subject|5|||
164205832|NCT00091819|593122703|FG001|Overall Study|Withdrawal by Subject|8|||
164205833|NCT00091819|593122702|FG000|Overall Study|Protocol Violation|1|||
164205834|NCT00091819|593122703|FG001|Overall Study|Protocol Violation|2|||
164205835|NCT00091819|593122702|FG000|Overall Study|Other|2|||
164205836|NCT00091819|593122703|FG001|Overall Study|Other|3|||
164205837|NCT00091819|593122702|FG000|Overall Study|Never received study treatment|3|||
164205838|NCT00091819|593122703|FG001|Overall Study|Never received study treatment|4|||
164205839|NCT02606253|593122704|FG000|Overall Study|Adverse Event|2|||
164205840|NCT02606253|593122705|FG001|Overall Study|Adverse Event|0|||
164205841|NCT02606253|593122706|FG002|Overall Study|Adverse Event|0|||
164205842|NCT02606253|593122704|FG000|Overall Study|Protocol Violation|2|||
164205843|NCT02606253|593122705|FG001|Overall Study|Protocol Violation|1|||
164205844|NCT02606253|593122706|FG002|Overall Study|Protocol Violation|0|||
164205845|NCT02606253|593122704|FG000|Overall Study|Physician Decision|1|||
164205846|NCT02606253|593122705|FG001|Overall Study|Physician Decision|1|||
164205847|NCT02606253|593122706|FG002|Overall Study|Physician Decision|0|||
164205848|NCT00701363|593122707|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
164205849|NCT00701363|593122708|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
164205850|NCT00701363|593122709|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
164205851|NCT00701363|593122710|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
164205852|NCT00701363|593122707|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
164205853|NCT00701363|593122708|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
164205854|NCT00701363|593122709|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
164205855|NCT00701363|593122710|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
164205856|NCT00701363|593122707|FG000|Treatment Phase 1|Adverse Event|7|||
164205857|NCT00701363|593122708|FG001|Treatment Phase 1|Adverse Event|0|||
164205858|NCT00701363|593122709|FG002|Treatment Phase 1|Adverse Event|0|||
164205859|NCT00701363|593122710|FG003|Treatment Phase 1|Adverse Event|0|||
164205860|NCT00701363|593122707|FG000|Treatment Phase 1|Protocol Violation|1|||
164205861|NCT00701363|593122708|FG001|Treatment Phase 1|Protocol Violation|0|||
164205862|NCT00701363|593122709|FG002|Treatment Phase 1|Protocol Violation|0|||
164205863|NCT00701363|593122710|FG003|Treatment Phase 1|Protocol Violation|0|||
164205864|NCT00701363|593122707|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
164205865|NCT00701363|593122708|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
164205866|NCT00701363|593122709|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
164205867|NCT00701363|593122710|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
164205868|NCT00701363|593122707|FG000|Treatment Phase 1|Lack of Efficacy|1|||
164205869|NCT00701363|593122708|FG001|Treatment Phase 1|Lack of Efficacy|0|||
164205870|NCT00701363|593122709|FG002|Treatment Phase 1|Lack of Efficacy|0|||
164205871|NCT00701363|593122710|FG003|Treatment Phase 1|Lack of Efficacy|0|||
164205872|NCT00701363|593122707|FG000|Treatment Phase 2|Adverse Event|0|||
164205873|NCT00701363|593122708|FG001|Treatment Phase 2|Adverse Event|0|||
164205874|NCT00701363|593122709|FG002|Treatment Phase 2|Adverse Event|1|||
164205875|NCT00701363|593122710|FG003|Treatment Phase 2|Adverse Event|0|||
164205876|NCT00701363|593122707|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
164205877|NCT00701363|593122708|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
164205878|NCT00701363|593122709|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
164205879|NCT00701363|593122710|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
164205880|NCT03426878|593122711|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
164205881|NCT03426878|593122711|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
164205882|NCT03426878|593122711|FG000|Overall Study|Declined to receive results|3|||
164205883|NCT03426878|593122711|FG000|Overall Study|Received negative results by mailed letter|65|||
163978174|NCT03077685|592291002|FG002|Overall Study|Death|1|||
163978175|NCT03077685|592291003|FG003|Overall Study|Death|1|||
163978176|NCT03077685|592291004|FG004|Overall Study|Death|3|||
163978177|NCT03077685|592291000|FG000|Overall Study|Withdrawal by Subject|0|||
164318403|NCT05092360|593540937|FG000|Overall Study|Study terminated by sponsor|65|||
164318404|NCT05092360|593540938|FG001|Overall Study|Study terminated by sponsor|7|||
164318405|NCT05092360|593540939|FG002|Overall Study|Study terminated by sponsor|13|||
164318406|NCT05092360|593540940|FG003|Overall Study|Study terminated by sponsor|61|||
164318407|NCT01675167|593540941|FG000|Open-label Titration Phase|Adverse Event|81|||
164318408|NCT01675167|593540942|FG001|Open-label Titration Phase|Adverse Event|0|||
164318409|NCT01675167|593540943|FG002|Open-label Titration Phase|Adverse Event|0|||
164318410|NCT01675167|593540941|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
164318411|NCT01675167|593540942|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
164318412|NCT01675167|593540943|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
164318413|NCT01675167|593540941|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
164318414|NCT01675167|593540942|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
164318415|NCT01675167|593540943|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
164318416|NCT01675167|593540941|FG000|Open-label Titration Phase|Protocol Violation|43|||
164318417|NCT01675167|593540942|FG001|Open-label Titration Phase|Protocol Violation|0|||
164318418|NCT01675167|593540943|FG002|Open-label Titration Phase|Protocol Violation|0|||
164318419|NCT01675167|593540941|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
164318420|NCT01675167|593540942|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
164318421|NCT01675167|593540943|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
164318422|NCT01675167|593540941|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
164318423|NCT01675167|593540942|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
164318424|NCT01675167|593540943|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
164318425|NCT01675167|593540941|FG000|Open-label Titration Phase|Other|55|||
164318426|NCT01675167|593540942|FG001|Open-label Titration Phase|Other|0|||
164318427|NCT01675167|593540943|FG002|Open-label Titration Phase|Other|0|||
164318428|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
164318429|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
164318430|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
164318431|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164318432|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
164318433|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
164318434|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164318435|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Adverse Event|5|||
164318436|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Adverse Event|13|||
164318437|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
164318438|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
164318439|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
164318440|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164318441|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
164318442|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
164318443|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
164318444|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
164318445|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
164318446|NCT01675167|593540941|FG000|Double-blind Treatment Phase|Other|0|||
164318447|NCT01675167|593540942|FG001|Double-blind Treatment Phase|Other|7|||
164318448|NCT01675167|593540943|FG002|Double-blind Treatment Phase|Other|5|||
164318449|NCT03952039|593540946|FG000|Overall Study|Adverse Event|22|||
164318450|NCT03952039|593540947|FG001|Overall Study|Adverse Event|8|||
164318451|NCT03952039|593540946|FG000|Overall Study|Withdrawal by Participant|17|||
164318452|NCT03952039|593540947|FG001|Overall Study|Withdrawal by Participant|12|||
164318453|NCT03952039|593540946|FG000|Overall Study|Death|13|||
164318454|NCT03952039|593540947|FG001|Overall Study|Death|6|||
164318455|NCT03952039|593540946|FG000|Overall Study|Lack of Efficacy|12|||
164318456|NCT03952039|593540947|FG001|Overall Study|Lack of Efficacy|2|||
164318457|NCT03952039|593540946|FG000|Overall Study|Physician Decision|9|||
164318458|NCT03952039|593540947|FG001|Overall Study|Physician Decision|3|||
164318459|NCT03952039|593540946|FG000|Overall Study|Progressive Disease|6|||
164318460|NCT03952039|593540947|FG001|Overall Study|Progressive Disease|4|||
164318461|NCT03952039|593540946|FG000|Overall Study|Other Reasons|12|||
164318462|NCT03952039|593540947|FG001|Overall Study|Other Reasons|4|||
163873723|NCT02723955|591906863|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873724|NCT02723955|591906864|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873725|NCT02723955|591906865|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873726|NCT02723955|591906866|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873727|NCT02723955|591906867|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
164318463|NCT01246466|593542070|FG000|Overall Study|Death|1|||
164318464|NCT01246466|593542070|FG000|Overall Study|Withdrawal by Subject|1|||
164318465|NCT02855541|593542078|FG000|Overall Study|Change in health status|2|||
164318466|NCT02855541|593542078|FG000|Overall Study|Withdrawal by Subject|2|||
164318467|NCT03085914|593542079|FG000|Overall Study|Death|6|||
164318468|NCT03085914|593542080|FG001|Overall Study|Death|6|||
164318469|NCT03085914|593542081|FG002|Overall Study|Death|4|||
164318470|NCT03085914|593542082|FG003|Overall Study|Death|1|||
164318471|NCT03085914|593542083|FG004|Overall Study|Death|5|||
164318472|NCT03085914|593542084|FG005|Overall Study|Death|2|||
164318473|NCT03085914|593542085|FG006|Overall Study|Death|2|||
164318474|NCT03085914|593542079|FG000|Overall Study|Withdrawal by Subject|1|||
164318475|NCT03085914|593542080|FG001|Overall Study|Withdrawal by Subject|1|||
164318476|NCT03085914|593542081|FG002|Overall Study|Withdrawal by Subject|2|||
164318477|NCT03085914|593542082|FG003|Overall Study|Withdrawal by Subject|2|||
164318478|NCT03085914|593542083|FG004|Overall Study|Withdrawal by Subject|2|||
164318479|NCT03085914|593542084|FG005|Overall Study|Withdrawal by Subject|0|||
164318480|NCT03085914|593542085|FG006|Overall Study|Withdrawal by Subject|1|||
164318481|NCT03085914|593542079|FG000|Overall Study|Lost to Follow-up|0|||
164318482|NCT03085914|593542080|FG001|Overall Study|Lost to Follow-up|0|||
164318483|NCT03085914|593542081|FG002|Overall Study|Lost to Follow-up|1|||
164318484|NCT03085914|593542082|FG003|Overall Study|Lost to Follow-up|0|||
164318485|NCT03085914|593542083|FG004|Overall Study|Lost to Follow-up|0|||
164318486|NCT03085914|593542084|FG005|Overall Study|Lost to Follow-up|1|||
164318487|NCT03085914|593542085|FG006|Overall Study|Lost to Follow-up|1|||
164318488|NCT03085914|593542079|FG000|Overall Study|Reason was not specified,|2|||
164318489|NCT03085914|593542080|FG001|Overall Study|Reason was not specified,|2|||
164318490|NCT03085914|593542081|FG002|Overall Study|Reason was not specified,|2|||
164318491|NCT03085914|593542082|FG003|Overall Study|Reason was not specified,|3|||
164318492|NCT03085914|593542083|FG004|Overall Study|Reason was not specified,|3|||
164318493|NCT03085914|593542084|FG005|Overall Study|Reason was not specified,|3|||
164318494|NCT03085914|593542085|FG006|Overall Study|Reason was not specified,|6|||
164318495|NCT03085914|593542079|FG000|Overall Study|Progressive Disease|0|||
164318496|NCT03085914|593542080|FG001|Overall Study|Progressive Disease|0|||
164318497|NCT03085914|593542081|FG002|Overall Study|Progressive Disease|2|||
164318498|NCT03085914|593542082|FG003|Overall Study|Progressive Disease|2|||
164318499|NCT03085914|593542083|FG004|Overall Study|Progressive Disease|1|||
164318500|NCT03085914|593542084|FG005|Overall Study|Progressive Disease|1|||
164318501|NCT03085914|593542085|FG006|Overall Study|Progressive Disease|1|||
164318502|NCT03085914|593542079|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164318503|NCT03085914|593542080|FG001|Overall Study|Study Terminated by the Sponsor|0|||
164318504|NCT03085914|593542081|FG002|Overall Study|Study Terminated by the Sponsor|0|||
164318505|NCT03085914|593542082|FG003|Overall Study|Study Terminated by the Sponsor|1|||
164318506|NCT03085914|593542083|FG004|Overall Study|Study Terminated by the Sponsor|2|||
164318507|NCT03085914|593542084|FG005|Overall Study|Study Terminated by the Sponsor|1|||
164318508|NCT03085914|593542085|FG006|Overall Study|Study Terminated by the Sponsor|0|||
164318509|NCT01561898|593542089|FG000|Overall Study|Withdrawal by Subject|0|||
164318510|NCT01561898|593542090|FG001|Overall Study|Withdrawal by Subject|8|||
164318511|NCT01561898|593542091|FG002|Overall Study|Withdrawal by Subject|12|||
164318512|NCT01561898|593542092|FG003|Overall Study|Withdrawal by Subject|5|||
164318513|NCT01561898|593542089|FG000|Overall Study|Lack of Efficacy|0|||
164318514|NCT01561898|593542090|FG001|Overall Study|Lack of Efficacy|8|||
164318515|NCT01561898|593542091|FG002|Overall Study|Lack of Efficacy|10|||
164318516|NCT01561898|593542092|FG003|Overall Study|Lack of Efficacy|5|||
164318517|NCT01561898|593542089|FG000|Overall Study|Worsening of complications|0|||
164318518|NCT01561898|593542090|FG001|Overall Study|Worsening of complications|1|||
164318519|NCT01561898|593542091|FG002|Overall Study|Worsening of complications|0|||
164318520|NCT01561898|593542092|FG003|Overall Study|Worsening of complications|0|||
164318521|NCT01561898|593542089|FG000|Overall Study|Lost to Follow-up|0|||
164318522|NCT01561898|593542090|FG001|Overall Study|Lost to Follow-up|0|||
164318523|NCT01561898|593542091|FG002|Overall Study|Lost to Follow-up|1|||
164318524|NCT01561898|593542092|FG003|Overall Study|Lost to Follow-up|0|||
164318525|NCT01561898|593542089|FG000|Overall Study|Adverse Event|1|||
164318526|NCT01561898|593542090|FG001|Overall Study|Adverse Event|19|||
164318527|NCT01561898|593542091|FG002|Overall Study|Adverse Event|14|||
164318528|NCT01561898|593542092|FG003|Overall Study|Adverse Event|9|||
164318529|NCT01561898|593542089|FG000|Overall Study|Physician Decision|1|||
164318530|NCT01561898|593542090|FG001|Overall Study|Physician Decision|5|||
163873728|NCT02723955|591906868|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
164318531|NCT01561898|593542091|FG002|Overall Study|Physician Decision|7|||
164318532|NCT01561898|593542092|FG003|Overall Study|Physician Decision|1|||
164318533|NCT03874429|593542093|FG000|Overall Study|Adverse Event|2|||
164318534|NCT03874429|593542094|FG001|Overall Study|Adverse Event|2|||
164318535|NCT03874429|593542093|FG000|Overall Study|Lack of Efficacy|0|||
164318536|NCT03874429|593542094|FG001|Overall Study|Lack of Efficacy|1|||
164318537|NCT03874429|593542093|FG000|Overall Study|Covid-19 pandemic|4|||
164318538|NCT03874429|593542094|FG001|Overall Study|Covid-19 pandemic|2|||
164318539|NCT00331552|593542095|FG000|Period 3: Phase II|Neurological Symptoms|1|||
164318540|NCT00331552|593542096|FG001|Period 3: Phase II|Neurological Symptoms|0|||
164318541|NCT00331552|593542095|FG000|Period 3: Phase II|Severe Nausea|1|||
164318542|NCT00331552|593542096|FG001|Period 3: Phase II|Severe Nausea|0|||
164318543|NCT01445548|593542097|FG000|Overall Study|Adverse Event|1|||
164318544|NCT03560518|593542098|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
164318545|NCT03560518|593542099|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
164318546|NCT03560518|593542100|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
163978178|NCT03077685|592291001|FG001|Overall Study|Withdrawal by Subject|0|||
163978179|NCT03077685|592291002|FG002|Overall Study|Withdrawal by Subject|0|||
163978180|NCT03077685|592291003|FG003|Overall Study|Withdrawal by Subject|2|||
164205884|NCT03426878|593122711|FG000|Overall Study|Lost to Follow-up|177|||
164205885|NCT03704064|593122712|FG000|Overall Study|Lost to Follow-up|8|||
164205886|NCT03704064|593122713|FG001|Overall Study|Lost to Follow-up|4|||
164205887|NCT03704064|593122712|FG000|Overall Study|Withdrawal by Subject|1|||
164205888|NCT03704064|593122713|FG001|Overall Study|Withdrawal by Subject|1|||
164205889|NCT03704064|593122712|FG000|Overall Study|No longer available for study visits|0|||
164205890|NCT03704064|593122713|FG001|Overall Study|No longer available for study visits|1|||
164205891|NCT03704064|593122712|FG000|Overall Study|Censoring event|1|||
164205892|NCT03704064|593122713|FG001|Overall Study|Censoring event|0|||
164205893|NCT00262925|593122717|FG000|Overall Study|Lack of Efficacy|3|||
164205894|NCT00262925|593122717|FG000|Overall Study|Adverse Event|4|||
164205895|NCT00262925|593122717|FG000|Overall Study|Death|2|||
164205896|NCT00262925|593122717|FG000|Overall Study|alternative therapy|1|||
164205897|NCT00262925|593122717|FG000|Overall Study|Other|1|||
164205898|NCT04682301|593122718|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
164205899|NCT04682301|593122718|FG000|Overall Study|Death|2|||
164205900|NCT04220021|593122719|FG000|Overall Study|Withdrawal by Subject|11|||
164205901|NCT04220021|593122719|FG000|Overall Study|Physician Decision|2|||
164205902|NCT04220021|593122719|FG000|Overall Study|Non-study related illness|5|||
164205903|NCT04935879|593122722|FG000|Overall Study|Adverse Event|2|||
164205904|NCT04935879|593122723|FG001|Overall Study|Adverse Event|1|||
164205905|NCT04935879|593122722|FG000|Overall Study|Lost to Follow-up|1|||
164205906|NCT04935879|593122723|FG001|Overall Study|Lost to Follow-up|1|||
164205907|NCT04935879|593122722|FG000|Overall Study|Pregnancy|2|||
164205908|NCT04935879|593122723|FG001|Overall Study|Pregnancy|3|||
164205909|NCT04935879|593122722|FG000|Overall Study|Withdrawal by Subject|8|||
164205910|NCT04935879|593122723|FG001|Overall Study|Withdrawal by Subject|6|||
164205911|NCT04935879|593122722|FG000|Overall Study|Other|3|||
164205912|NCT04935879|593122723|FG001|Overall Study|Other|3|||
164205913|NCT01652690|593122724|FG000|Overall Study|Withdrawal by Subject|16|||
164205914|NCT01652690|593122725|FG001|Overall Study|Withdrawal by Subject|4|||
164205915|NCT01652690|593122724|FG000|Overall Study|Other|8|||
164205916|NCT01652690|593122725|FG001|Overall Study|Other|9|||
164205917|NCT01652690|593122724|FG000|Overall Study|Lost to Follow-up|6|||
164205918|NCT01652690|593122725|FG001|Overall Study|Lost to Follow-up|6|||
164205919|NCT01652690|593122724|FG000|Overall Study|Death|5|||
164205920|NCT01652690|593122725|FG001|Overall Study|Death|2|||
164205921|NCT03533751|593122726|FG000|Overall Study|Withdrawal by Subject|12|||
164205922|NCT03533751|593122727|FG001|Overall Study|Withdrawal by Subject|6|||
164205923|NCT03533751|593122728|FG002|Overall Study|Withdrawal by Subject|11|||
164205924|NCT03533751|593122729|FG003|Overall Study|Withdrawal by Subject|9|||
164205925|NCT03533751|593122730|FG004|Overall Study|Withdrawal by Subject|10|||
164205926|NCT03533751|593122726|FG000|Overall Study|Adverse Event|4|||
164205927|NCT03533751|593122727|FG001|Overall Study|Adverse Event|7|||
164205928|NCT03533751|593122728|FG002|Overall Study|Adverse Event|2|||
164205929|NCT03533751|593122729|FG003|Overall Study|Adverse Event|4|||
164205930|NCT03533751|593122730|FG004|Overall Study|Adverse Event|5|||
164205931|NCT03533751|593122726|FG000|Overall Study|Physician Decision|0|||
164205932|NCT03533751|593122727|FG001|Overall Study|Physician Decision|2|||
164205933|NCT03533751|593122728|FG002|Overall Study|Physician Decision|1|||
164205934|NCT03533751|593122729|FG003|Overall Study|Physician Decision|2|||
164205935|NCT03533751|593122730|FG004|Overall Study|Physician Decision|1|||
164205936|NCT03533751|593122726|FG000|Overall Study|Sponsor Decision|0|||
164205937|NCT03533751|593122727|FG001|Overall Study|Sponsor Decision|0|||
164205938|NCT03533751|593122728|FG002|Overall Study|Sponsor Decision|1|||
164205939|NCT03533751|593122729|FG003|Overall Study|Sponsor Decision|1|||
164205940|NCT03533751|593122730|FG004|Overall Study|Sponsor Decision|0|||
164205941|NCT03533751|593122726|FG000|Overall Study|Lost to Follow-up|3|||
164205942|NCT03533751|593122727|FG001|Overall Study|Lost to Follow-up|7|||
164205943|NCT03533751|593122728|FG002|Overall Study|Lost to Follow-up|6|||
164205944|NCT03533751|593122729|FG003|Overall Study|Lost to Follow-up|4|||
164205945|NCT03533751|593122730|FG004|Overall Study|Lost to Follow-up|3|||
164205946|NCT03533751|593122726|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
164205947|NCT03533751|593122727|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
164205948|NCT03533751|593122728|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
164205949|NCT03533751|593122729|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
164205950|NCT03533751|593122730|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
164205951|NCT03533751|593122726|FG000|Overall Study|Other|0|||
164205952|NCT03533751|593122727|FG001|Overall Study|Other|2|||
164205953|NCT03533751|593122728|FG002|Overall Study|Other|1|||
164205954|NCT03533751|593122729|FG003|Overall Study|Other|0|||
164205955|NCT03533751|593122730|FG004|Overall Study|Other|3|||
164205956|NCT01884597|593122732|FG000|Overall Study|Adverse Event|0|||
164205957|NCT01884597|593122733|FG001|Overall Study|Adverse Event|0|||
163978181|NCT03077685|592291004|FG004|Overall Study|Withdrawal by Subject|1|||
163978182|NCT03077685|592291000|FG000|Overall Study|Physician Decision|0|||
164318547|NCT03560518|593542098|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
164318548|NCT03560518|593542099|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
164318549|NCT03560518|593542100|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
164318550|NCT03560518|593542098|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164318551|NCT03560518|593542099|FG001|Double Blind Treatment Period|Protocol Violation|2|||
164318552|NCT03560518|593542100|FG002|Double Blind Treatment Period|Protocol Violation|0|||
164318553|NCT03560518|593542098|FG000|Double Blind Treatment Period|Pregnancy|0|||
164318554|NCT03560518|593542099|FG001|Double Blind Treatment Period|Pregnancy|2|||
164318555|NCT03560518|593542100|FG002|Double Blind Treatment Period|Pregnancy|0|||
164318556|NCT03560518|593542098|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
164318557|NCT03560518|593542099|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
164318558|NCT03560518|593542100|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
164318559|NCT03560518|593542098|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
164318560|NCT03560518|593542099|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
164318561|NCT03560518|593542100|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
164318562|NCT03560518|593542098|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
164318563|NCT03560518|593542099|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
164318564|NCT03560518|593542100|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
164318565|NCT03560518|593542098|FG000|Double Blind Treatment Period|Adverse Event|0|||
164318566|NCT03560518|593542099|FG001|Double Blind Treatment Period|Adverse Event|3|||
164318567|NCT03560518|593542100|FG002|Double Blind Treatment Period|Adverse Event|1|||
164318568|NCT00958438|593542102|FG000|Overall Study|Protocol Violation|3|||
164318569|NCT00958438|593542103|FG001|Overall Study|Protocol Violation|2|||
164318570|NCT00958438|593542104|FG002|Overall Study|Protocol Violation|2|||
164318571|NCT00958438|593542102|FG000|Overall Study|Withdrawal by Subject|4|||
164318572|NCT00958438|593542103|FG001|Overall Study|Withdrawal by Subject|2|||
164318573|NCT00958438|593542104|FG002|Overall Study|Withdrawal by Subject|1|||
164318574|NCT00958438|593542102|FG000|Overall Study|Adverse Event|0|||
164318575|NCT00958438|593542103|FG001|Overall Study|Adverse Event|3|||
164318576|NCT00958438|593542104|FG002|Overall Study|Adverse Event|0|||
164318577|NCT00958438|593542102|FG000|Overall Study|Physician Decision|1|||
164318578|NCT00958438|593542103|FG001|Overall Study|Physician Decision|0|||
164318579|NCT00958438|593542104|FG002|Overall Study|Physician Decision|1|||
164318580|NCT00958438|593542102|FG000|Overall Study|Other than specified above|2|||
164318581|NCT00958438|593542103|FG001|Overall Study|Other than specified above|3|||
164318582|NCT00958438|593542104|FG002|Overall Study|Other than specified above|2|||
164318583|NCT02788279|593542105|FG000|Overall Study|Death|62|||
164318584|NCT02788279|593542106|FG001|Overall Study|Death|136|||
164318585|NCT02788279|593542107|FG002|Overall Study|Death|72|||
164318586|NCT02788279|593542105|FG000|Overall Study|Withdrawal by Subject|10|||
164318587|NCT02788279|593542106|FG001|Overall Study|Withdrawal by Subject|15|||
164318588|NCT02788279|593542107|FG002|Overall Study|Withdrawal by Subject|5|||
164318589|NCT02788279|593542105|FG000|Overall Study|Lost to Follow-up|0|||
164318590|NCT02788279|593542106|FG001|Overall Study|Lost to Follow-up|3|||
164318591|NCT02788279|593542107|FG002|Overall Study|Lost to Follow-up|2|||
163978183|NCT03077685|592291001|FG001|Overall Study|Physician Decision|0|||
163978184|NCT03077685|592291002|FG002|Overall Study|Physician Decision|1|||
163978185|NCT03077685|592291003|FG003|Overall Study|Physician Decision|0|||
163978186|NCT03077685|592291004|FG004|Overall Study|Physician Decision|3|||
163978187|NCT03077685|592291000|FG000|Overall Study|Disease Progression|1|||
163978188|NCT03077685|592291001|FG001|Overall Study|Disease Progression|0|||
163978189|NCT03077685|592291002|FG002|Overall Study|Disease Progression|0|||
163978190|NCT03077685|592291003|FG003|Overall Study|Disease Progression|2|||
163978191|NCT03077685|592291004|FG004|Overall Study|Disease Progression|1|||
163978192|NCT03077685|592291000|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
163978193|NCT03077685|592291001|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
164318592|NCT02788279|593542105|FG000|Overall Study|Sponsor decision|18|||
164318593|NCT02788279|593542106|FG001|Overall Study|Sponsor decision|29|||
164318594|NCT02788279|593542107|FG002|Overall Study|Sponsor decision|11|||
164318595|NCT00329849|593542108|FG000|Overall Study|Withdrawal by Subject|6|||
164318596|NCT00329849|593542109|FG001|Overall Study|Withdrawal by Subject|4|||
164318597|NCT05277337|593542114|FG000|Overall Study|Lost to Follow-up|2|||
164318598|NCT05277337|593542115|FG001|Overall Study|Lost to Follow-up|0|||
163978194|NCT03077685|592291002|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
163978195|NCT03077685|592291003|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
163978196|NCT03077685|592291004|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
163978197|NCT03077685|592291000|FG000|Overall Study|Subject entered hospice care|0|||
163978198|NCT03077685|592291001|FG001|Overall Study|Subject entered hospice care|0|||
163978199|NCT03077685|592291002|FG002|Overall Study|Subject entered hospice care|0|||
163978200|NCT03077685|592291003|FG003|Overall Study|Subject entered hospice care|0|||
163978201|NCT03077685|592291004|FG004|Overall Study|Subject entered hospice care|1|||
164318599|NCT05277337|593542114|FG000|Overall Study|Withdrawal by Subject|1|||
164318600|NCT05277337|593542115|FG001|Overall Study|Withdrawal by Subject|0|||
164318601|NCT01185301|593542116|FG000|Overall Study|Adverse Event|3|||
164318602|NCT01185301|593542117|FG001|Overall Study|Adverse Event|0|||
164318603|NCT01185301|593542118|FG002|Overall Study|Adverse Event|2|||
164318604|NCT01185301|593542119|FG003|Overall Study|Adverse Event|3|||
164318605|NCT01185301|593542116|FG000|Overall Study|Withdrawal by Subject|7|||
164318606|NCT01185301|593542117|FG001|Overall Study|Withdrawal by Subject|5|||
164318607|NCT01185301|593542118|FG002|Overall Study|Withdrawal by Subject|2|||
164318608|NCT01185301|593542119|FG003|Overall Study|Withdrawal by Subject|3|||
164318609|NCT01185301|593542116|FG000|Overall Study|Lost to Follow-up|2|||
164318610|NCT01185301|593542117|FG001|Overall Study|Lost to Follow-up|0|||
164318611|NCT01185301|593542118|FG002|Overall Study|Lost to Follow-up|0|||
164318612|NCT01185301|593542119|FG003|Overall Study|Lost to Follow-up|1|||
164318613|NCT01185301|593542116|FG000|Overall Study|Other Reason|3|||
164318614|NCT01185301|593542117|FG001|Overall Study|Other Reason|2|||
164318615|NCT01185301|593542118|FG002|Overall Study|Other Reason|2|||
164318616|NCT01185301|593542119|FG003|Overall Study|Other Reason|2|||
164318617|NCT04987944|593542120|FG000|Overall Study|Adverse Event|0|||
164318618|NCT04987944|593542121|FG001|Overall Study|Adverse Event|1|||
164318619|NCT04987944|593542120|FG000|Overall Study|Withdrawal by Subject|0|||
164318620|NCT04987944|593542121|FG001|Overall Study|Withdrawal by Subject|1|||
164318621|NCT00409175|593542126|FG000|Overall Study|Adverse Event|4|||
164318622|NCT00409175|593542127|FG001|Overall Study|Adverse Event|3|||
164318623|NCT00409175|593542126|FG000|Overall Study|Withdrawal by Subject|1|||
164318624|NCT00409175|593542127|FG001|Overall Study|Withdrawal by Subject|2|||
164318625|NCT00409175|593542126|FG000|Overall Study|Negative genotype|0|||
164318626|NCT00409175|593542127|FG001|Overall Study|Negative genotype|1|||
164318627|NCT00409175|593542126|FG000|Overall Study|Liver transplantation|13|||
164318628|NCT00409175|593542127|FG001|Overall Study|Liver transplantation|13|||
164318629|NCT03339297|593542130|FG000|Overall Study|Relapse of Hematologic Disease|1|||
164318630|NCT03339297|593542131|FG001|Overall Study|Relapse of Hematologic Disease|0|||
164318631|NCT03339297|593542130|FG000|Overall Study|Death|10|||
164318632|NCT03339297|593542131|FG001|Overall Study|Death|7|||
164318633|NCT03339297|593542130|FG000|Overall Study|Hepatic Candidosis|1|||
164318634|NCT03339297|593542131|FG001|Overall Study|Hepatic Candidosis|0|||
164318635|NCT03339297|593542130|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
164318636|NCT03339297|593542131|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
164318637|NCT03339297|593542130|FG000|Overall Study|Consent Withdrawn by Participant|3|||
164318638|NCT03339297|593542131|FG001|Overall Study|Consent Withdrawn by Participant|3|||
164318639|NCT03339297|593542130|FG000|Overall Study|Disease Relapse|2|||
164318640|NCT03339297|593542131|FG001|Overall Study|Disease Relapse|0|||
164318641|NCT03339297|593542130|FG000|Overall Study|Physician Decision|1|||
164318642|NCT03339297|593542131|FG001|Overall Study|Physician Decision|1|||
164318643|NCT03339297|593542130|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
164318644|NCT03339297|593542131|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
164318645|NCT03339297|593542130|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
164318646|NCT03339297|593542131|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
164318647|NCT03339297|593542130|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
164318648|NCT03339297|593542131|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
164318649|NCT03339297|593542130|FG000|Overall Study|Adverse Event, Non-fatal|1|||
164318650|NCT03339297|593542131|FG001|Overall Study|Adverse Event, Non-fatal|0|||
164318651|NCT03339297|593542130|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
164318652|NCT03339297|593542131|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
164318653|NCT03339297|593542130|FG000|Overall Study|Patient Was Not Eligible|1|||
164318654|NCT03339297|593542131|FG001|Overall Study|Patient Was Not Eligible|0|||
164318655|NCT03726996|593542132|FG000|Overall Study|Parent's decision|2|||
164318656|NCT03726996|593542132|FG000|Overall Study|Study early termination|2|||
164318657|NCT03531632|593542137|FG000|Overall Study|Adverse Event|0|||
164318658|NCT03531632|593542138|FG001|Overall Study|Adverse Event|0|||
164318659|NCT03531632|593542139|FG002|Overall Study|Adverse Event|1|||
164318660|NCT03531632|593542137|FG000|Overall Study|Death|4|||
164318661|NCT03531632|593542138|FG001|Overall Study|Death|0|||
164318662|NCT03531632|593542139|FG002|Overall Study|Death|14|||
164318663|NCT03531632|593542137|FG000|Overall Study|Study Terminated|1|||
164318664|NCT03531632|593542138|FG001|Overall Study|Study Terminated|3|||
164318665|NCT03531632|593542139|FG002|Overall Study|Study Terminated|11|||
164318666|NCT03241368|593542144|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
164318667|NCT03241368|593542144|FG000|Overall Study|Lost to Follow-up|1|||
163873729|NCT02723955|591906869|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
164318668|NCT03241368|593542144|FG000|Overall Study|Physician Decision|6|||
164318669|NCT03241368|593542144|FG000|Overall Study|Withdrawal by Subject|6|||
164318670|NCT03241368|593542144|FG000|Overall Study|Protocol Violation|1|||
163873730|NCT02723955|591906870|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
164318671|NCT01119937|593542145|FG000|Overall Study|Adverse Event|11|||
164318672|NCT01119937|593542146|FG001|Overall Study|Adverse Event|5|||
164318673|NCT01119937|593542145|FG000|Overall Study|Protocol deviation|3|||
164318674|NCT01119937|593542146|FG001|Overall Study|Protocol deviation|1|||
164318675|NCT01119937|593542145|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164318676|NCT01119937|593542146|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164318677|NCT01119937|593542145|FG000|Overall Study|Withdrawal by Subject|2|||
164318678|NCT01119937|593542146|FG001|Overall Study|Withdrawal by Subject|1|||
164318679|NCT01566214|593542147|FG000|Overall Study|Lost to Follow-up|3|||
164318680|NCT01566214|593542148|FG001|Overall Study|Lost to Follow-up|0|||
164318681|NCT02112045|593542151|FG000|Overall Study|Withdrawal by Subject|1|||
164318682|NCT02112045|593542152|FG001|Overall Study|Withdrawal by Subject|0|||
164318683|NCT00627445|593542153|FG000|Overall Study|Adverse Event|3|||
164318684|NCT00627445|593542154|FG001|Overall Study|Adverse Event|3|||
164318685|NCT00627445|593542153|FG000|Overall Study|Lack of Efficacy|0|||
164318686|NCT00627445|593542154|FG001|Overall Study|Lack of Efficacy|1|||
164318687|NCT00627445|593542153|FG000|Overall Study|Other|6|||
164318688|NCT00627445|593542154|FG001|Overall Study|Other|8|||
164318689|NCT03554486|593542157|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
164318690|NCT03554486|593542158|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
164318691|NCT03554486|593542159|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
164318692|NCT03554486|593542157|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
164318693|NCT03554486|593542158|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
164318694|NCT03554486|593542159|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
164318695|NCT03554486|593542157|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164318696|NCT03554486|593542158|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164318697|NCT03554486|593542159|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164318698|NCT01616693|593542162|FG000|Evaluated for Safety|Physician Decision|1|||
164318699|NCT01616693|593542163|FG001|Evaluated for Safety|Physician Decision|0|||
164318700|NCT01616693|593542164|FG002|Evaluated for Safety|Physician Decision|1|||
164318701|NCT01616693|593542165|FG003|Evaluated for Safety|Physician Decision|0|||
164318702|NCT01616693|593542162|FG000|Received Both Vaccines|Adverse Event|2|||
164318703|NCT01616693|593542163|FG001|Received Both Vaccines|Adverse Event|0|||
164318704|NCT01616693|593542164|FG002|Received Both Vaccines|Adverse Event|0|||
164318705|NCT01616693|593542165|FG003|Received Both Vaccines|Adverse Event|0|||
164318706|NCT01616693|593542162|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
164318707|NCT01616693|593542163|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
164318708|NCT01616693|593542164|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
164318709|NCT01616693|593542165|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
164318710|NCT01616693|593542162|FG000|Received Both Vaccines|Lost to Follow-up|4|||
164318711|NCT01616693|593542163|FG001|Received Both Vaccines|Lost to Follow-up|3|||
164318712|NCT01616693|593542164|FG002|Received Both Vaccines|Lost to Follow-up|4|||
164318713|NCT01616693|593542165|FG003|Received Both Vaccines|Lost to Follow-up|4|||
164318714|NCT01616693|593542162|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
164318715|NCT01616693|593542163|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
164318716|NCT01616693|593542164|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
164318717|NCT01616693|593542165|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
164318718|NCT00321646|593542167|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
164318719|NCT00321646|593542167|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
164318720|NCT00321646|593542167|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
164318721|NCT01008423|593542168|FG000|Overall Study|Adverse Event|13|||
164318722|NCT01008423|593542169|FG001|Overall Study|Adverse Event|6|||
164318723|NCT01008423|593542168|FG000|Overall Study|Withdrawal by Subject|4|||
164318724|NCT01008423|593542169|FG001|Overall Study|Withdrawal by Subject|7|||
164318725|NCT01008423|593542168|FG000|Overall Study|Lost to Follow-up|0|||
164318726|NCT01008423|593542169|FG001|Overall Study|Lost to Follow-up|2|||
164318727|NCT01008423|593542168|FG000|Overall Study|Low Cortisol|0|||
164318728|NCT01008423|593542169|FG001|Overall Study|Low Cortisol|1|||
164318729|NCT01008423|593542168|FG000|Overall Study|Lack of Efficacy|0|||
164318730|NCT01008423|593542169|FG001|Overall Study|Lack of Efficacy|5|||
164318731|NCT01008423|593542168|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
163873731|NCT02723955|591906871|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
163873732|NCT02723955|591906872|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
163873733|NCT02723955|591906873|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873734|NCT02723955|591906874|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
163873735|NCT02723955|591906875|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
163873736|NCT02723955|591906833|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
163873737|NCT02723955|591906834|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
163873738|NCT02723955|591906835|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
163873739|NCT02723955|591906836|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
163873740|NCT02723955|591906837|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
163873741|NCT02723955|591906838|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
163873742|NCT02723955|591906839|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
163873743|NCT02723955|591906840|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
164318732|NCT01008423|593542169|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
164318733|NCT01008423|593542168|FG000|Overall Study|Personal Conflict|1|||
164318734|NCT01008423|593542169|FG001|Overall Study|Personal Conflict|0|||
164318735|NCT01008423|593542168|FG000|Overall Study|Other|0|||
164318736|NCT01008423|593542169|FG001|Overall Study|Other|1|||
164318737|NCT02034409|593542171|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
163873744|NCT02723955|591906841|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
163873745|NCT02723955|591906842|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
163873746|NCT02723955|591906843|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
163873747|NCT02723955|591906844|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
163873748|NCT02723955|591906845|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
163873749|NCT02723955|591906846|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
163873750|NCT02723955|591906847|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
163873751|NCT02723955|591906848|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
163873752|NCT02723955|591906849|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
163873753|NCT02723955|591906850|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
163978202|NCT02116777|592291005|FG000|Overall Study|Adverse Event|0|||
163978203|NCT02116777|592291006|FG001|Overall Study|Adverse Event|0|||
163978204|NCT02116777|592291007|FG002|Overall Study|Adverse Event|0|||
163978205|NCT02116777|592291008|FG003|Overall Study|Adverse Event|0|||
163978206|NCT02116777|592291009|FG004|Overall Study|Adverse Event|2|||
163978207|NCT02116777|592291010|FG005|Overall Study|Adverse Event|2|||
163978208|NCT02116777|592291011|FG006|Overall Study|Adverse Event|0|||
163978209|NCT02116777|592291005|FG000|Overall Study|Death|0|||
164205958|NCT01884597|593122734|FG002|Overall Study|Adverse Event|1|||
163978210|NCT02116777|592291006|FG001|Overall Study|Death|0|||
163978211|NCT02116777|592291007|FG002|Overall Study|Death|0|||
163978212|NCT02116777|592291008|FG003|Overall Study|Death|1|||
163978213|NCT02116777|592291009|FG004|Overall Study|Death|0|||
163978214|NCT02116777|592291010|FG005|Overall Study|Death|0|||
163978215|NCT02116777|592291011|FG006|Overall Study|Death|0|||
163978216|NCT02116777|592291005|FG000|Overall Study|Lack of Efficacy|3|||
163873754|NCT02723955|591906851|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
163873755|NCT02723955|591906852|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
163873756|NCT02723955|591906853|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
163873757|NCT02723955|591906854|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
163873758|NCT02723955|591906855|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
163873759|NCT02723955|591906856|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
163873760|NCT02723955|591906857|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
163873761|NCT02723955|591906858|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
163873762|NCT02723955|591906859|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
163873763|NCT02723955|591906860|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
163978217|NCT02116777|592291006|FG001|Overall Study|Lack of Efficacy|3|||
164205959|NCT01884597|593122732|FG000|Overall Study|Lack of Efficacy|1|||
164205960|NCT01884597|593122733|FG001|Overall Study|Lack of Efficacy|0|||
164205961|NCT01884597|593122734|FG002|Overall Study|Lack of Efficacy|0|||
164205962|NCT01884597|593122732|FG000|Overall Study|Death|0|||
164205963|NCT01884597|593122733|FG001|Overall Study|Death|1|||
164205964|NCT01884597|593122734|FG002|Overall Study|Death|0|||
164205965|NCT05965752|593122735|FG000|Overall Study|Adverse Event|0|||
164205966|NCT05965752|593122736|FG001|Overall Study|Adverse Event|1|||
164205967|NCT05965752|593122737|FG002|Overall Study|Adverse Event|0|||
164205968|NCT05965752|593122738|FG003|Overall Study|Adverse Event|1|||
164205969|NCT05965752|593122739|FG004|Overall Study|Adverse Event|3|||
164205970|NCT05965752|593122735|FG000|Overall Study|Lost to Follow-up|2|||
164205971|NCT05965752|593122736|FG001|Overall Study|Lost to Follow-up|0|||
164205972|NCT05965752|593122737|FG002|Overall Study|Lost to Follow-up|1|||
164205973|NCT05965752|593122738|FG003|Overall Study|Lost to Follow-up|1|||
164205974|NCT05965752|593122739|FG004|Overall Study|Lost to Follow-up|1|||
164205975|NCT05965752|593122735|FG000|Overall Study|Withdrawal by Subject|2|||
164205976|NCT05965752|593122736|FG001|Overall Study|Withdrawal by Subject|2|||
164205977|NCT05965752|593122737|FG002|Overall Study|Withdrawal by Subject|1|||
164205978|NCT05965752|593122738|FG003|Overall Study|Withdrawal by Subject|5|||
164205979|NCT05965752|593122739|FG004|Overall Study|Withdrawal by Subject|0|||
164205980|NCT05965752|593122735|FG000|Overall Study|Disease Relapse|1|||
164205981|NCT05965752|593122736|FG001|Overall Study|Disease Relapse|0|||
164205982|NCT05965752|593122737|FG002|Overall Study|Disease Relapse|1|||
164205983|NCT05965752|593122738|FG003|Overall Study|Disease Relapse|0|||
164205984|NCT05965752|593122739|FG004|Overall Study|Disease Relapse|0|||
164205985|NCT05965752|593122735|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164205986|NCT05965752|593122736|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
164205987|NCT05965752|593122737|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164205988|NCT05965752|593122738|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
164205989|NCT05965752|593122739|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
164205990|NCT05965752|593122735|FG000|Overall Study|Unable to Return for Study Visits|0|||
163873764|NCT02723955|591906861|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
163873765|NCT02723955|591906862|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
163873766|NCT02723955|591906863|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
164205991|NCT05965752|593122736|FG001|Overall Study|Unable to Return for Study Visits|1|||
163978218|NCT02116777|592291007|FG002|Overall Study|Lack of Efficacy|3|||
163978219|NCT02116777|592291008|FG003|Overall Study|Lack of Efficacy|8|||
163978220|NCT02116777|592291009|FG004|Overall Study|Lack of Efficacy|4|||
163978221|NCT02116777|592291010|FG005|Overall Study|Lack of Efficacy|1|||
163978222|NCT02116777|592291011|FG006|Overall Study|Lack of Efficacy|9|||
163978223|NCT02116777|592291005|FG000|Overall Study|Physician Decision|0|||
163978224|NCT02116777|592291006|FG001|Overall Study|Physician Decision|0|||
163978225|NCT02116777|592291007|FG002|Overall Study|Physician Decision|0|||
163978226|NCT02116777|592291008|FG003|Overall Study|Physician Decision|2|||
163978227|NCT02116777|592291009|FG004|Overall Study|Physician Decision|0|||
163978228|NCT02116777|592291010|FG005|Overall Study|Physician Decision|0|||
163978229|NCT02116777|592291011|FG006|Overall Study|Physician Decision|0|||
163978230|NCT02116777|592291005|FG000|Overall Study|Protocol Violation|0|||
163978231|NCT02116777|592291006|FG001|Overall Study|Protocol Violation|0|||
163978232|NCT02116777|592291007|FG002|Overall Study|Protocol Violation|0|||
163978233|NCT02116777|592291008|FG003|Overall Study|Protocol Violation|1|||
163978234|NCT02116777|592291009|FG004|Overall Study|Protocol Violation|0|||
163978235|NCT02116777|592291010|FG005|Overall Study|Protocol Violation|0|||
163978236|NCT02116777|592291011|FG006|Overall Study|Protocol Violation|0|||
163978237|NCT02116777|592291005|FG000|Overall Study|Withdrawal by Subject|0|||
163978238|NCT02116777|592291006|FG001|Overall Study|Withdrawal by Subject|0|||
163978239|NCT02116777|592291007|FG002|Overall Study|Withdrawal by Subject|0|||
163978240|NCT02116777|592291008|FG003|Overall Study|Withdrawal by Subject|1|||
163978241|NCT02116777|592291009|FG004|Overall Study|Withdrawal by Subject|0|||
163978242|NCT02116777|592291010|FG005|Overall Study|Withdrawal by Subject|0|||
163978243|NCT02116777|592291011|FG006|Overall Study|Withdrawal by Subject|0|||
163978244|NCT01934556|592291014|FG000|Overall Study|Withdrawal by Subject|0|||
163978245|NCT01934556|592291015|FG001|Overall Study|Withdrawal by Subject|1|||
163978246|NCT01934556|592291016|FG002|Overall Study|Withdrawal by Subject|1|||
163978247|NCT01934556|592291014|FG000|Overall Study|Lost to Follow-up|4|||
163978248|NCT01934556|592291015|FG001|Overall Study|Lost to Follow-up|10|||
164205992|NCT05965752|593122737|FG002|Overall Study|Unable to Return for Study Visits|0|||
164205993|NCT05965752|593122738|FG003|Overall Study|Unable to Return for Study Visits|3|||
164205994|NCT05965752|593122739|FG004|Overall Study|Unable to Return for Study Visits|1|||
164205995|NCT05965752|593122735|FG000|Overall Study|Early Termination|0|||
164205996|NCT05965752|593122736|FG001|Overall Study|Early Termination|0|||
164205997|NCT05965752|593122737|FG002|Overall Study|Early Termination|1|||
164205998|NCT05965752|593122738|FG003|Overall Study|Early Termination|0|||
164205999|NCT05965752|593122739|FG004|Overall Study|Early Termination|0|||
164206000|NCT05965752|593122735|FG000|Overall Study|Reported Unwanted Symptoms|0|||
164206001|NCT05965752|593122736|FG001|Overall Study|Reported Unwanted Symptoms|0|||
164206002|NCT05965752|593122737|FG002|Overall Study|Reported Unwanted Symptoms|0|||
164206003|NCT05965752|593122738|FG003|Overall Study|Reported Unwanted Symptoms|0|||
164206004|NCT05965752|593122739|FG004|Overall Study|Reported Unwanted Symptoms|1|||
164206005|NCT05965752|593122735|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206006|NCT05965752|593122736|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206007|NCT05965752|593122737|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206008|NCT05965752|593122738|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
164206009|NCT05965752|593122739|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
164206010|NCT00834041|593122741|FG000|Overall Study|Withdrawal by Subject|1|||
164206011|NCT00834041|593122742|FG001|Overall Study|Withdrawal by Subject|0|||
164206012|NCT00834041|593122741|FG000|Overall Study|Lost to Follow-up|0|||
164206013|NCT00834041|593122742|FG001|Overall Study|Lost to Follow-up|1|||
164206014|NCT02634710|593122743|FG000|Overall Study|Death|4|||
164206015|NCT03454555|593124880|FG000|Overall Study|Death|6|||
164206016|NCT03454555|593124881|FG001|Overall Study|Death|6|||
164206017|NCT03454555|593124880|FG000|Overall Study|Lost to Follow-up|31|||
164206018|NCT03454555|593124881|FG001|Overall Study|Lost to Follow-up|12|||
164206019|NCT03454555|593124880|FG000|Overall Study|Physician Decision|2|||
164206020|NCT03454555|593124881|FG001|Overall Study|Physician Decision|6|||
164206021|NCT03454555|593124880|FG000|Overall Study|Withdrawal by Subject|34|||
164206022|NCT03454555|593124881|FG001|Overall Study|Withdrawal by Subject|5|||
164206023|NCT03454555|593124880|FG000|Overall Study|Ineligible|1|||
164206024|NCT03454555|593124881|FG001|Overall Study|Ineligible|5|||
164206025|NCT03834961|593124884|FG000|Overall Study|Lack of Efficacy|1|||
164206026|NCT03834961|593124885|FG001|Overall Study|Lack of Efficacy|1|||
164206027|NCT03834961|593124886|FG002|Overall Study|Lack of Efficacy|0|||
164206028|NCT03834961|593124884|FG000|Overall Study|Physician Decision|0|||
164206029|NCT03834961|593124885|FG001|Overall Study|Physician Decision|1|||
164206030|NCT03834961|593124886|FG002|Overall Study|Physician Decision|0|||
164206031|NCT05493111|593124887|FG000|Overall Study|Adverse Event|3|||
164206032|NCT05493111|593124888|FG001|Overall Study|Adverse Event|4|||
164206033|NCT05493111|593124887|FG000|Overall Study|Withdrawal of Consent|19|||
164206034|NCT05493111|593124888|FG001|Overall Study|Withdrawal of Consent|10|||
164206035|NCT05493111|593124887|FG000|Overall Study|Non-compliance|1|||
164206036|NCT05493111|593124888|FG001|Overall Study|Non-compliance|1|||
164206037|NCT05493111|593124887|FG000|Overall Study|Lost to Follow-up|8|||
164206038|NCT05493111|593124888|FG001|Overall Study|Lost to Follow-up|1|||
164206039|NCT05493111|593124887|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
164206040|NCT05493111|593124888|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
164206041|NCT05493111|593124887|FG000|Overall Study|Withdrawal by Subject|1|||
164206042|NCT05493111|593124888|FG001|Overall Study|Withdrawal by Subject|1|||
163978249|NCT01934556|592291016|FG002|Overall Study|Lost to Follow-up|7|||
163978250|NCT01934556|592291014|FG000|Overall Study|Death|1|||
163978251|NCT01934556|592291015|FG001|Overall Study|Death|5|||
163978252|NCT01934556|592291016|FG002|Overall Study|Death|2|||
163978253|NCT03770260|592291886|FG000|Overall Study|Disease progression|0|||
163978254|NCT03770260|592291887|FG001|Overall Study|Disease progression|1|||
163978255|NCT03770260|592291888|FG002|Overall Study|Disease progression|0|||
163978256|NCT03770260|592291889|FG003|Overall Study|Disease progression|0|||
163978257|NCT00477165|592291893|FG000|Overall Study|Adverse Event|7|||
163978258|NCT00477165|592291894|FG001|Overall Study|Adverse Event|2|||
163978259|NCT02135692|592291898|FG000|Overall Study|Adverse Event|3|||
164206043|NCT01140906|593124891|FG000|Overall Study|Adverse Event|7|||
164206044|NCT01140906|593124892|FG001|Overall Study|Adverse Event|10|||
164206045|NCT01140906|593124893|FG002|Overall Study|Adverse Event|17|||
164206046|NCT01140906|593124894|FG003|Overall Study|Adverse Event|7|||
164206047|NCT01140906|593124891|FG000|Overall Study|Lack of Efficacy|6|||
164206048|NCT01140906|593124892|FG001|Overall Study|Lack of Efficacy|8|||
164206049|NCT01140906|593124893|FG002|Overall Study|Lack of Efficacy|2|||
164206050|NCT01140906|593124894|FG003|Overall Study|Lack of Efficacy|1|||
164206051|NCT01140906|593124891|FG000|Overall Study|Non-compliance|0|||
164206052|NCT01140906|593124892|FG001|Overall Study|Non-compliance|1|||
164206053|NCT01140906|593124893|FG002|Overall Study|Non-compliance|0|||
164206054|NCT01140906|593124894|FG003|Overall Study|Non-compliance|1|||
164206055|NCT01140906|593124891|FG000|Overall Study|Protocol Violation|5|||
164206056|NCT01140906|593124892|FG001|Overall Study|Protocol Violation|3|||
164206057|NCT01140906|593124893|FG002|Overall Study|Protocol Violation|2|||
164206058|NCT01140906|593124894|FG003|Overall Study|Protocol Violation|1|||
164206059|NCT01140906|593124891|FG000|Overall Study|Withdrawal of consent|6|||
163873767|NCT02723955|591906864|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
163873768|NCT02723955|591906865|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
163873769|NCT02723955|591906866|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
163873770|NCT02723955|591906867|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
163873771|NCT02723955|591906868|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
163873772|NCT02723955|591906869|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
163873773|NCT02723955|591906870|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
163873774|NCT02723955|591906871|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
163873775|NCT02723955|591906872|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
163873776|NCT02723955|591906873|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
163873777|NCT02723955|591906874|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
163978260|NCT02135692|592291898|FG000|Overall Study|Lack of Efficacy|2|||
164206060|NCT01140906|593124892|FG001|Overall Study|Withdrawal of consent|6|||
163978261|NCT02135692|592291898|FG000|Overall Study|Protocol Violation|2|||
163978262|NCT02135692|592291898|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
163978263|NCT02135692|592291898|FG000|Overall Study|Product commercially available|159|||
163978264|NCT02135692|592291898|FG000|Overall Study|Study closed/terminated|153|||
163978265|NCT02135692|592291898|FG000|Overall Study|Lost to Follow-up|4|||
163978266|NCT02135692|592291898|FG000|Overall Study|Withdrawal by Subject|15|||
163978267|NCT01097746|592291900|FG000|Overall Study|Adverse Event|4|||
163978268|NCT01097746|592291900|FG000|Overall Study|taken off study before any treatment given|1|||
163978269|NCT01514682|592291901|FG000|Overall Study|Withdrawal by Subject|2|||
163978270|NCT01514682|592291902|FG001|Overall Study|Withdrawal by Subject|3|||
163978271|NCT01514682|592291901|FG000|Overall Study|Physician Decision|4|||
163978272|NCT01514682|592291902|FG001|Overall Study|Physician Decision|3|||
163978273|NCT00769002|592291903|FG000|Overall Study|Study was not completed, no data|9|||
163978274|NCT00769002|592291904|FG001|Overall Study|Study was not completed, no data|9|||
163978275|NCT00960661|592291905|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
163978276|NCT00960661|592291906|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
163978277|NCT00960661|592291907|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
163978278|NCT00960661|592291905|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
163978279|NCT00960661|592291906|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
163978280|NCT00960661|592291907|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
163978281|NCT00960661|592291905|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
163978282|NCT00960661|592291906|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
163978283|NCT00960661|592291907|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
163978284|NCT00960661|592291905|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
163978285|NCT00960661|592291906|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
163978286|NCT00960661|592291907|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
163978287|NCT00960661|592291905|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
163978288|NCT00960661|592291906|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
163978289|NCT00960661|592291907|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
163978290|NCT00960661|592291905|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
163978291|NCT00960661|592291906|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
163978292|NCT00960661|592291907|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
164206061|NCT01140906|593124893|FG002|Overall Study|Withdrawal of consent|2|||
163978293|NCT00960661|592291905|FG000|Interventional Phase|Adverse Event|0|||
163978294|NCT00960661|592291906|FG001|Interventional Phase|Adverse Event|17|||
163978295|NCT00960661|592291907|FG002|Interventional Phase|Adverse Event|8|||
163978296|NCT00960661|592291905|FG000|Interventional Phase|Death|0|||
164318738|NCT02034409|593542172|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
164318739|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
164318740|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
164318741|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
164318742|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
164318743|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
164318744|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
164318745|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
164318746|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
164318747|NCT02034409|593542171|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
164318748|NCT02034409|593542172|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
164318749|NCT02342418|593542173|FG000|Overall Study|Adverse Event|0|||
164318750|NCT02342418|593542174|FG001|Overall Study|Adverse Event|1|||
164318751|NCT01699867|593542175|FG000|Overall Study|Screening Failure|3|||
163978297|NCT00960661|592291906|FG001|Interventional Phase|Death|1|||
164318752|NCT04255394|593542176|FG000|Overall Study|Death|35|||
164318753|NCT04255394|593542177|FG001|Overall Study|Death|25|||
164318754|NCT04255394|593542176|FG000|Overall Study|Device removed|2|||
164318755|NCT04255394|593542177|FG001|Overall Study|Device removed|10|||
164318756|NCT04255394|593542176|FG000|Overall Study|Withdrawal by Subject|9|||
164318757|NCT04255394|593542177|FG001|Overall Study|Withdrawal by Subject|8|||
164318758|NCT04255394|593542176|FG000|Overall Study|Screen Failure/Not treated|12|||
164318759|NCT04255394|593542177|FG001|Overall Study|Screen Failure/Not treated|8|||
164318760|NCT04255394|593542176|FG000|Overall Study|Lost to Follow-up|123|||
164318761|NCT04255394|593542177|FG001|Overall Study|Lost to Follow-up|265|||
164318762|NCT04255394|593542176|FG000|Overall Study|Adverse Event|1|||
164318763|NCT04255394|593542177|FG001|Overall Study|Adverse Event|3|||
164318764|NCT01375075|593542184|FG000|Overall Study|Adverse Event|0|||
164318765|NCT01375075|593542185|FG001|Overall Study|Adverse Event|0|||
164318766|NCT01375075|593542186|FG002|Overall Study|Adverse Event|3|||
164318767|NCT01375075|593542187|FG003|Overall Study|Adverse Event|1|||
164318768|NCT01375075|593542188|FG004|Overall Study|Adverse Event|0|||
164318769|NCT01375075|593542189|FG005|Overall Study|Adverse Event|1|||
164318770|NCT01375075|593542184|FG000|Overall Study|Entry Criterion Not Met|1|||
164318771|NCT01375075|593542185|FG001|Overall Study|Entry Criterion Not Met|0|||
164318772|NCT01375075|593542186|FG002|Overall Study|Entry Criterion Not Met|0|||
164318773|NCT01375075|593542187|FG003|Overall Study|Entry Criterion Not Met|0|||
164318774|NCT01375075|593542188|FG004|Overall Study|Entry Criterion Not Met|0|||
164318775|NCT01375075|593542189|FG005|Overall Study|Entry Criterion Not Met|1|||
164318776|NCT01375075|593542184|FG000|Overall Study|Withdrawal by Subject|0|||
164318777|NCT01375075|593542185|FG001|Overall Study|Withdrawal by Subject|1|||
164318778|NCT01375075|593542186|FG002|Overall Study|Withdrawal by Subject|0|||
164318779|NCT01375075|593542187|FG003|Overall Study|Withdrawal by Subject|0|||
164318780|NCT01375075|593542188|FG004|Overall Study|Withdrawal by Subject|0|||
164318781|NCT01375075|593542189|FG005|Overall Study|Withdrawal by Subject|1|||
164318782|NCT00831493|593542190|FG000|Overall Study|Intractable nausea and vomiting|1|||
164318783|NCT00129311|593542197|FG000|Overall Study|Withdrawal by Subject|12|||
164318784|NCT00129311|593542198|FG001|Overall Study|Withdrawal by Subject|19|||
164318785|NCT01525225|593542201|FG000|Enrollment|No longer met study criteria|1|||
164318786|NCT01525225|593542201|FG000|Enrollment|Other|1|||
164318787|NCT01182844|593542202|FG000|Overall Study|Withdrawal by Subject|0|||
164318788|NCT01182844|593542203|FG001|Overall Study|Withdrawal by Subject|2|||
164318789|NCT01379508|593542204|FG000|Treatment to Week 104|Adverse Event|2|||
164318790|NCT01379508|593542205|FG001|Treatment to Week 104|Adverse Event|0|||
164318791|NCT01379508|593542206|FG002|Treatment to Week 104|Adverse Event|5|||
164318792|NCT01379508|593542207|FG003|Treatment to Week 104|Adverse Event|0|||
163978298|NCT00960661|592291907|FG002|Interventional Phase|Death|0|||
163978299|NCT00960661|592291905|FG000|Interventional Phase|Lost to Follow-up|0|||
163978300|NCT00960661|592291906|FG001|Interventional Phase|Lost to Follow-up|0|||
164318793|NCT01379508|593542204|FG000|Treatment to Week 104|Abnormal lab value|1|||
164318794|NCT01379508|593542205|FG001|Treatment to Week 104|Abnormal lab value|0|||
164318795|NCT01379508|593542206|FG002|Treatment to Week 104|Abnormal lab value|0|||
164318796|NCT01379508|593542207|FG003|Treatment to Week 104|Abnormal lab value|0|||
164318797|NCT01379508|593542204|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
164318798|NCT01379508|593542205|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
164318799|NCT01379508|593542206|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
164318800|NCT01379508|593542207|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
164318801|NCT01379508|593542204|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
164318802|NCT01379508|593542205|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
164318803|NCT01379508|593542206|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
164318804|NCT01379508|593542207|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
164318805|NCT01379508|593542204|FG000|Treatment to Week 104|Lost to Follow-up|5|||
164318806|NCT01379508|593542205|FG001|Treatment to Week 104|Lost to Follow-up|0|||
164318807|NCT01379508|593542206|FG002|Treatment to Week 104|Lost to Follow-up|3|||
164318808|NCT01379508|593542207|FG003|Treatment to Week 104|Lost to Follow-up|0|||
164318809|NCT01379508|593542204|FG000|Treatment to Week 104|Administrative problems|3|||
164318810|NCT01379508|593542205|FG001|Treatment to Week 104|Administrative problems|1|||
164318811|NCT01379508|593542206|FG002|Treatment to Week 104|Administrative problems|0|||
164318812|NCT01379508|593542207|FG003|Treatment to Week 104|Administrative problems|0|||
164318813|NCT01379508|593542204|FG000|Treatment to Week 104|Protocol Violation|1|||
164318814|NCT01379508|593542205|FG001|Treatment to Week 104|Protocol Violation|1|||
164318815|NCT01379508|593542206|FG002|Treatment to Week 104|Protocol Violation|1|||
164318816|NCT01379508|593542207|FG003|Treatment to Week 104|Protocol Violation|0|||
164318817|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
164318818|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
164318819|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
164318820|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
164318821|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
164318822|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
164318823|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
164318824|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
164318825|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
164318826|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
164318827|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
164318828|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
164318829|NCT01379508|593542204|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
164318830|NCT01379508|593542205|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
164318831|NCT01379508|593542206|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
164318832|NCT01379508|593542207|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
164136068|NCT03537599|592862023|FG001|Overall Study|Death|1|||
164206062|NCT01140906|593124894|FG003|Overall Study|Withdrawal of consent|2|||
164206063|NCT01140906|593124891|FG000|Overall Study|Lost to Follow-up|1|||
164206064|NCT01140906|593124892|FG001|Overall Study|Lost to Follow-up|1|||
164206065|NCT01140906|593124893|FG002|Overall Study|Lost to Follow-up|0|||
164206066|NCT01140906|593124894|FG003|Overall Study|Lost to Follow-up|2|||
164206067|NCT01140906|593124891|FG000|Overall Study|Administrative or other reason|0|||
164206068|NCT01140906|593124892|FG001|Overall Study|Administrative or other reason|5|||
164206069|NCT01140906|593124893|FG002|Overall Study|Administrative or other reason|3|||
164206070|NCT01140906|593124894|FG003|Overall Study|Administrative or other reason|2|||
164206071|NCT04889040|593124895|FG000|Overall Study|Withdrawal by Subject|3|||
164206072|NCT04889040|593124896|FG001|Overall Study|Withdrawal by Subject|3|||
164206073|NCT04889040|593124895|FG000|Overall Study|Lost to Follow-up|0|||
164206074|NCT04889040|593124896|FG001|Overall Study|Lost to Follow-up|1|||
164206075|NCT04889040|593124895|FG000|Overall Study|Adverse Event|2|||
164206076|NCT04889040|593124896|FG001|Overall Study|Adverse Event|1|||
164206077|NCT01155323|593124901|FG000|First Intervention|exclusion criteria|1|||
164206078|NCT01155323|593124902|FG001|First Intervention|exclusion criteria|1|||
164206079|NCT01155323|593124901|FG000|Second Intervention|Lost to Follow-up|1|||
164206080|NCT01155323|593124902|FG001|Second Intervention|Lost to Follow-up|1|||
164206081|NCT01208051|593124905|FG000|Total Enrollment|Withdrawal by Subject|0|||
164206082|NCT01208051|593124906|FG001|Total Enrollment|Withdrawal by Subject|1|||
164318833|NCT02055365|593544499|FG000|Overall Study|Prematurely Withdrawn|1|||
164318834|NCT03603509|593544503|FG000|Overall Study|Lost to Follow-up|3|||
164318835|NCT03603509|593544504|FG001|Overall Study|Lost to Follow-up|4|||
164318836|NCT02656680|593544507|FG000|Overall Study|Lost to Follow-up|0|||
164136069|NCT04713553|592862024|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
164136070|NCT04713553|592862025|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
164136071|NCT04713553|592862026|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
164136072|NCT04713553|592862027|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
164136073|NCT04713553|592862028|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
164136074|NCT04713553|592862029|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
164136075|NCT04713553|592862030|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
164136076|NCT04713553|592862024|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164136077|NCT04713553|592862025|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164136078|NCT04713553|592862026|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164136079|NCT04713553|592862027|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
164136080|NCT04713553|592862028|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164136081|NCT04713553|592862029|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164136082|NCT04713553|592862030|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
164136083|NCT04713553|592862024|FG000|Primary Study (2 Months)|Other|1|||
164136084|NCT04713553|592862025|FG001|Primary Study (2 Months)|Other|2|||
164136085|NCT04713553|592862026|FG002|Primary Study (2 Months)|Other|0|||
163978301|NCT00960661|592291907|FG002|Interventional Phase|Lost to Follow-up|2|||
163978302|NCT00960661|592291905|FG000|Interventional Phase|entry criteria not met|0|||
163978303|NCT00960661|592291906|FG001|Interventional Phase|entry criteria not met|3|||
163978304|NCT00960661|592291907|FG002|Interventional Phase|entry criteria not met|0|||
164206083|NCT01208051|593124907|FG002|Total Enrollment|Withdrawal by Subject|0|||
164206084|NCT01208051|593124908|FG003|Total Enrollment|Withdrawal by Subject|0|||
164206085|NCT01208051|593124909|FG004|Total Enrollment|Withdrawal by Subject|2|||
164206086|NCT01208051|593124905|FG000|Total Enrollment|Brain metastases|0|||
164206087|NCT01208051|593124906|FG001|Total Enrollment|Brain metastases|0|||
164206088|NCT01208051|593124907|FG002|Total Enrollment|Brain metastases|1|||
164206089|NCT01208051|593124908|FG003|Total Enrollment|Brain metastases|0|||
164206090|NCT01208051|593124909|FG004|Total Enrollment|Brain metastases|0|||
164206091|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
164206092|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
164206093|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
164206094|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
164206095|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
164206096|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
164206097|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
164206098|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
164206099|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
164206100|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
164206101|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
164206102|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
164206103|NCT02349386|593124910|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
164206104|NCT02349386|593124911|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
164206105|NCT02349386|593124912|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
164206106|NCT02349386|593124913|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
164206107|NCT02349386|593124910|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
164206108|NCT02349386|593124911|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
164206109|NCT02349386|593124912|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
164206110|NCT02349386|593124913|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
164206111|NCT02349386|593124910|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
164206112|NCT02349386|593124911|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
164206113|NCT02349386|593124912|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
164206114|NCT02349386|593124913|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
164206115|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
164206116|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
164206117|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
164206118|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
164206119|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
164206120|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
164206121|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
164206122|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
164206123|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
164318837|NCT02656680|593544508|FG001|Overall Study|Lost to Follow-up|1|||
163873778|NCT02723955|591906875|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
163873779|NCT04999085|591906876|FG000|Overall Study|Death|1|||
163873780|NCT05057897|591906877|FG000|Overall Study|Site closure|2|||
163873781|NCT05057897|591906878|FG001|Overall Study|Site closure|2|||
163873782|NCT05057897|591906877|FG000|Overall Study|Death|1|||
163873783|NCT05057897|591906878|FG001|Overall Study|Death|0|||
163873784|NCT03088813|591906881|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
163873785|NCT03088813|591906882|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
163873786|NCT03088813|591906883|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
163873787|NCT03088813|591906884|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
163873788|NCT03088813|591906881|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
163873789|NCT03088813|591906882|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
163873790|NCT03088813|591906883|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
163873791|NCT03088813|591906884|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
163873792|NCT03088813|591906881|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
163873793|NCT03088813|591906882|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
163873794|NCT03088813|591906883|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
163873795|NCT03088813|591906884|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
163873796|NCT03088813|591906881|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
163873797|NCT03088813|591906882|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
164206124|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
164206125|NCT00973973|593124914|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
164206126|NCT00973973|593124915|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
164206127|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
164206128|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
164206129|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
164206130|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
164206131|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
164206132|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
164206133|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
164206134|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
164206135|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
164206136|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
164206137|NCT00973973|593124914|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
164206138|NCT00973973|593124915|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
164206139|NCT02471339|593124916|FG000|Overall Study|Did not provide follow-up data|2|||
164206140|NCT02471339|593124917|FG001|Overall Study|Did not provide follow-up data|0|||
164206141|NCT06057064|593124918|FG000|Overall Study|Death|2|||
164206142|NCT06057064|593124919|FG001|Overall Study|Death|0|||
164206143|NCT06057064|593124918|FG000|Overall Study|Physician Decision|1|||
164206144|NCT06057064|593124919|FG001|Overall Study|Physician Decision|0|||
164206145|NCT06057064|593124918|FG000|Overall Study|Withdrawal by Subject|1|||
164206146|NCT06057064|593124919|FG001|Overall Study|Withdrawal by Subject|1|||
164206147|NCT00851591|593124921|FG000|Overall Study|Withdrawal by Subject|2|||
164206148|NCT00851591|593124922|FG001|Overall Study|Withdrawal by Subject|0|||
164206149|NCT02736617|593124925|FG000|Treatment|Adverse Event|1|||
164206150|NCT02736617|593124925|FG000|Treatment|Lack of Efficacy|1|||
164206151|NCT02736617|593124925|FG000|Treatment|Withdrawal by Subject|1|||
164206152|NCT02736617|593124925|FG000|Maintenance|Lack of Efficacy|4|||
164206153|NCT02736617|593124925|FG000|Maintenance|Physician Decision|1|||
164206154|NCT00481676|593124932|FG000|Overall Study|Adverse Event|0|||
164206155|NCT00481676|593124933|FG001|Overall Study|Adverse Event|1|||
164206156|NCT00481676|593124932|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164206157|NCT00481676|593124933|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164206158|NCT00481676|593124932|FG000|Overall Study|Administrative problem|1|||
164206159|NCT00481676|593124933|FG001|Overall Study|Administrative problem|0|||
164206160|NCT02911116|593124934|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164206161|NCT02911116|593124935|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164206162|NCT02911116|593124934|FG000|Overall Study|Lost to Follow-up|0|||
164206163|NCT02911116|593124935|FG001|Overall Study|Lost to Follow-up|1|||
164206164|NCT01240694|593124936|FG000|Overall Study|Adverse Event|9|||
164206165|NCT01240694|593124936|FG000|Overall Study|Lack of Efficacy|6|||
164206166|NCT01240694|593124936|FG000|Overall Study|Withdrawal by Subject|6|||
164206167|NCT01240694|593124936|FG000|Overall Study|Protocol Violation|2|||
164206168|NCT01240694|593124936|FG000|Overall Study|Lost to Follow-up|2|||
164206169|NCT01240694|593124936|FG000|Overall Study|Other than specified|3|||
164206170|NCT01240694|593124936|FG000|Overall Study|Withdrawn due to early study termination|107|||
164206171|NCT01513590|593124937|FG000|Overall Study|Adverse Event|2|||
164206172|NCT01513590|593124938|FG001|Overall Study|Adverse Event|3|||
164206173|NCT01513590|593124937|FG000|Overall Study|Withdrawal Criteria|3|||
164206174|NCT01513590|593124938|FG001|Overall Study|Withdrawal Criteria|0|||
164206175|NCT01513590|593124937|FG000|Overall Study|Unclassified|5|||
164206176|NCT01513590|593124938|FG001|Overall Study|Unclassified|10|||
164206177|NCT02110693|593124939|FG000|Overall Study|Withdrawal by Subject|6|||
164206178|NCT02110693|593124940|FG001|Overall Study|Withdrawal by Subject|7|||
164206179|NCT02110693|593124939|FG000|Overall Study|skipped assessment|15|||
164206180|NCT02110693|593124940|FG001|Overall Study|skipped assessment|18|||
164206181|NCT02110693|593124939|FG000|Overall Study|technical difficulties|6|||
164206182|NCT02110693|593124940|FG001|Overall Study|technical difficulties|4|||
164206183|NCT02110693|593124939|FG000|Overall Study|Other|1|||
164206184|NCT02110693|593124940|FG001|Overall Study|Other|0|||
164318838|NCT02656680|593544509|FG002|Overall Study|Lost to Follow-up|7|||
164318839|NCT01258998|593544510|FG000|Overall Study|Ineligible|1|||
163978305|NCT00960661|592291905|FG000|Interventional Phase|Protocol Violation|0|||
164206185|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
164206186|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
164206187|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
164206188|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
164206189|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
164206190|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
164206191|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
164206192|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
164206193|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
164318840|NCT01143389|593544511|FG000|Overall Study|Lost to Follow-up|26|||
163978306|NCT00960661|592291906|FG001|Interventional Phase|Protocol Violation|7|||
163978307|NCT00960661|592291907|FG002|Interventional Phase|Protocol Violation|2|||
163978308|NCT00960661|592291905|FG000|Interventional Phase|Withdrawal by Subject|0|||
163978309|NCT00960661|592291906|FG001|Interventional Phase|Withdrawal by Subject|18|||
163978310|NCT00960661|592291907|FG002|Interventional Phase|Withdrawal by Subject|29|||
163978311|NCT00960661|592291905|FG000|Interventional Phase|Physician Decision|0|||
163978312|NCT00960661|592291906|FG001|Interventional Phase|Physician Decision|3|||
163978313|NCT00960661|592291907|FG002|Interventional Phase|Physician Decision|5|||
164206194|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
164206195|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Death|3|||
164206196|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Death|1|||
164206197|NCT01056276|593124941|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
164206198|NCT01056276|593124942|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
164206199|NCT01056276|593124941|FG000|Maintenance Therapy|Toxicity|0|||
164206200|NCT01056276|593124942|FG001|Maintenance Therapy|Toxicity|2|||
164206201|NCT01056276|593124941|FG000|Maintenance Therapy|Progressive Disease|0|||
164206202|NCT01056276|593124942|FG001|Maintenance Therapy|Progressive Disease|9|||
164206203|NCT01056276|593124941|FG000|Maintenance Therapy|Physician Decision|0|||
164206204|NCT01056276|593124942|FG001|Maintenance Therapy|Physician Decision|1|||
164206205|NCT01056276|593124941|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
164206206|NCT01056276|593124942|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
164206207|NCT01056276|593124941|FG000|Maintenance Therapy|Intercurrent Illness|0|||
164206208|NCT01056276|593124942|FG001|Maintenance Therapy|Intercurrent Illness|1|||
164206209|NCT01056276|593124941|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
164206210|NCT01056276|593124942|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
164206211|NCT01881425|593124943|FG000|Overall Study|Death|5|||
164206212|NCT01881425|593124944|FG001|Overall Study|Death|1|||
164206213|NCT01881425|593124943|FG000|Overall Study|Withdrawal by Subject|8|||
164206214|NCT01881425|593124944|FG001|Overall Study|Withdrawal by Subject|3|||
164206215|NCT01881425|593124943|FG000|Overall Study|Physician Decision|2|||
164206216|NCT01881425|593124944|FG001|Overall Study|Physician Decision|1|||
164206217|NCT01881425|593124943|FG000|Overall Study|Adverse Event|3|||
164206218|NCT01881425|593124944|FG001|Overall Study|Adverse Event|0|||
164206219|NCT01881425|593124943|FG000|Overall Study|General Anesthesia panic attack|0|||
164206220|NCT01881425|593124944|FG001|Overall Study|General Anesthesia panic attack|1|||
164206221|NCT01881425|593124943|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
164206222|NCT01881425|593124944|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
164206223|NCT01881425|593124943|FG000|Overall Study|Lost to Follow-up|7|||
164206224|NCT01881425|593124944|FG001|Overall Study|Lost to Follow-up|2|||
164206225|NCT04154956|593124949|FG000|Overall Study|Death|109|||
164206226|NCT04154956|593124950|FG001|Overall Study|Death|110|||
164206227|NCT04154956|593124949|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
164206228|NCT04154956|593124950|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
164206229|NCT04154956|593124949|FG000|Overall Study|Withdrawal by Subject|1|||
164206230|NCT04154956|593124950|FG001|Overall Study|Withdrawal by Subject|7|||
164206231|NCT04154956|593124949|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
164206232|NCT04154956|593124950|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
164206233|NCT04424901|593124951|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
164206234|NCT04424901|593124952|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
164206235|NCT00147238|593124953|FG000|Overall Study|Inevaluable|8|||
164206236|NCT04810962|593124954|FG000|Overall Study|Adverse Event|0|||
164206237|NCT04810962|593124955|FG001|Overall Study|Adverse Event|1|||
164206238|NCT04810962|593124954|FG000|Overall Study|Lost to Follow-up|2|||
164206239|NCT04810962|593124955|FG001|Overall Study|Lost to Follow-up|1|||
164206240|NCT04810962|593124954|FG000|Overall Study|Physician Decision|1|||
164206241|NCT04810962|593124955|FG001|Overall Study|Physician Decision|0|||
164206242|NCT04810962|593124954|FG000|Overall Study|Withdrawal by Subject|1|||
164206243|NCT04810962|593124955|FG001|Overall Study|Withdrawal by Subject|3|||
164206244|NCT04810962|593124954|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
164206245|NCT04810962|593124955|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
164206246|NCT01348269|593124956|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
164206247|NCT01348269|593124957|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
163978314|NCT00960661|592291905|FG000|Interventional Phase|sponsor decision|0|||
163978315|NCT00960661|592291906|FG001|Interventional Phase|sponsor decision|1|||
164206248|NCT01348269|593124956|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
164206249|NCT01348269|593124957|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
164206250|NCT01348269|593124956|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
164206251|NCT01348269|593124957|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
164206252|NCT00805532|593124958|FG000|Overall Study|invalid data|0|||
164206253|NCT00805532|593124959|FG001|Overall Study|invalid data|1|||
164206254|NCT00920816|593124960|FG000|Overall Study|Death|116|||
164206255|NCT00920816|593124961|FG001|Overall Study|Death|63|||
164206256|NCT00920816|593124962|FG002|Overall Study|Death|8|||
164206257|NCT00920816|593124963|FG003|Overall Study|Death|3|||
164206258|NCT00920816|593124960|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
164206259|NCT00920816|593124961|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
164206260|NCT00920816|593124962|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
164206261|NCT00920816|593124963|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
164318841|NCT01143389|593544512|FG001|Overall Study|Lost to Follow-up|25|||
164318842|NCT04966910|593544513|FG000|Baseline|Participant did not complete measure|0|||
164318843|NCT04966910|593544514|FG001|Baseline|Participant did not complete measure|0|||
164318844|NCT04966910|593544515|FG002|Baseline|Participant did not complete measure|1|||
164318845|NCT04966910|593544516|FG003|Baseline|Participant did not complete measure|0|||
164318846|NCT04966910|593544513|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
164318847|NCT04966910|593544514|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
164318848|NCT04966910|593544515|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
164318849|NCT04966910|593544516|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
164318850|NCT04966910|593544513|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
164318851|NCT04966910|593544514|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
164318852|NCT04966910|593544515|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
164318853|NCT04966910|593544516|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
164318854|NCT04966910|593544513|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
164318855|NCT04966910|593544514|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
164318856|NCT04966910|593544515|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
164318857|NCT04966910|593544516|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
164318858|NCT00002931|593544517|FG000|Overall Study|rapidly progressing disease during|2|||
164318859|NCT00504582|593544524|FG000|Overall Study|Lost to Follow-up|1|||
164318860|NCT00504582|593544525|FG001|Overall Study|Lost to Follow-up|0|||
164318861|NCT00504582|593544526|FG002|Overall Study|Lost to Follow-up|0|||
164318862|NCT02716896|593544527|FG000|Overall Study|Physician Decision|0|||
164318863|NCT02716896|593544528|FG001|Overall Study|Physician Decision|1|||
163978316|NCT00960661|592291907|FG002|Interventional Phase|sponsor decision|0|||
164206262|NCT00920816|593124960|FG000|Overall Study|Global deterioration of health status|2|||
164206263|NCT00920816|593124961|FG001|Overall Study|Global deterioration of health status|0|||
164206264|NCT00920816|593124962|FG002|Overall Study|Global deterioration of health status|0|||
164206265|NCT00920816|593124963|FG003|Overall Study|Global deterioration of health status|0|||
164206266|NCT00920816|593124960|FG000|Overall Study|Objective progression or relapse|6|||
164206267|NCT00920816|593124961|FG001|Overall Study|Objective progression or relapse|2|||
164206268|NCT00920816|593124962|FG002|Overall Study|Objective progression or relapse|0|||
164206269|NCT00920816|593124963|FG003|Overall Study|Objective progression or relapse|0|||
164206270|NCT00920816|593124960|FG000|Overall Study|Other|26|||
164206271|NCT00920816|593124961|FG001|Overall Study|Other|15|||
164206272|NCT00920816|593124962|FG002|Overall Study|Other|1|||
164206273|NCT00920816|593124963|FG003|Overall Study|Other|2|||
164206274|NCT00920816|593124960|FG000|Overall Study|Lost to Follow-up|11|||
164206275|NCT00920816|593124961|FG001|Overall Study|Lost to Follow-up|2|||
164206276|NCT00920816|593124962|FG002|Overall Study|Lost to Follow-up|0|||
164206277|NCT00920816|593124963|FG003|Overall Study|Lost to Follow-up|0|||
164206278|NCT00920816|593124960|FG000|Overall Study|Adverse Event|1|||
164206279|NCT00920816|593124961|FG001|Overall Study|Adverse Event|1|||
164206280|NCT00920816|593124962|FG002|Overall Study|Adverse Event|1|||
164206281|NCT00920816|593124963|FG003|Overall Study|Adverse Event|0|||
164206282|NCT00920816|593124960|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
164206283|NCT00920816|593124961|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
164206284|NCT00920816|593124962|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
164206285|NCT00920816|593124963|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
164206286|NCT00920816|593124960|FG000|Overall Study|Randomized but not treated|3|||
164206287|NCT00920816|593124961|FG001|Overall Study|Randomized but not treated|0|||
164206288|NCT00920816|593124962|FG002|Overall Study|Randomized but not treated|0|||
164206289|NCT00920816|593124963|FG003|Overall Study|Randomized but not treated|0|||
164206290|NCT01180777|593124964|FG000|Overall Study|Protocol Violation|6|||
164206291|NCT01180777|593124964|FG000|Overall Study|Poor lens fit|4|||
164206292|NCT01180777|593124964|FG000|Overall Study|Lost to Follow-up|1|||
164206293|NCT01180777|593124964|FG000|Overall Study|Adverse Event|1|||
164318864|NCT01757691|593544530|FG000|Overall Study|Administrative problems|2|||
164206294|NCT03185208|593124965|FG000|Overall Study|Did not start study medication|0|||
164206295|NCT03185208|593124966|FG001|Overall Study|Did not start study medication|3|||
164206296|NCT03834350|593124967|FG000|Overall Study|Withdrawal by Subject|1|||
164318865|NCT01757691|593544531|FG001|Overall Study|Administrative problems|0|||
164318866|NCT02054481|593544534|FG000|Overall Study|Adverse Event|1|||
164206297|NCT02765165|593124968|FG000|Treatment Period|Progressive disease|3|||
164206298|NCT02765165|593124969|FG001|Treatment Period|Progressive disease|2|||
164206299|NCT02765165|593124970|FG002|Treatment Period|Progressive disease|3|||
164206300|NCT02765165|593124971|FG003|Treatment Period|Progressive disease|3|||
164318867|NCT02054481|593544535|FG001|Overall Study|Adverse Event|1|||
164318868|NCT02054481|593544536|FG002|Overall Study|Adverse Event|0|||
164318869|NCT02054481|593544537|FG003|Overall Study|Adverse Event|1|||
164318870|NCT02054481|593544534|FG000|Overall Study|Lost to Follow-up|1|||
164318871|NCT02054481|593544535|FG001|Overall Study|Lost to Follow-up|0|||
164318872|NCT02054481|593544536|FG002|Overall Study|Lost to Follow-up|0|||
164318873|NCT02054481|593544537|FG003|Overall Study|Lost to Follow-up|0|||
164318874|NCT02054481|593544534|FG000|Overall Study|Other reason|2|||
164318875|NCT02054481|593544535|FG001|Overall Study|Other reason|1|||
164318876|NCT02054481|593544536|FG002|Overall Study|Other reason|2|||
164318877|NCT02054481|593544537|FG003|Overall Study|Other reason|0|||
164318878|NCT01713933|593544552|FG000|Overall Study|Lost to Follow-up|2|||
164318879|NCT01713933|593544552|FG000|Overall Study|Withdrawal by Subject|3|||
164318880|NCT01713933|593544552|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
164318881|NCT00528970|593544553|FG000|Overall Study|Adverse Event|6|||
164318882|NCT00528970|593544554|FG001|Overall Study|Adverse Event|8|||
164318883|NCT00528970|593544555|FG002|Overall Study|Adverse Event|5|||
164318884|NCT00528970|593544553|FG000|Overall Study|Lost to Follow-up|0|||
164318885|NCT00528970|593544554|FG001|Overall Study|Lost to Follow-up|0|||
164318886|NCT00528970|593544555|FG002|Overall Study|Lost to Follow-up|1|||
164318887|NCT00528970|593544553|FG000|Overall Study|Other than specified|2|||
164318888|NCT00528970|593544554|FG001|Overall Study|Other than specified|3|||
164318889|NCT00528970|593544555|FG002|Overall Study|Other than specified|3|||
164318890|NCT00528970|593544553|FG000|Overall Study|Protocol Violation|2|||
164318891|NCT00528970|593544554|FG001|Overall Study|Protocol Violation|1|||
164318892|NCT00528970|593544555|FG002|Overall Study|Protocol Violation|4|||
164318893|NCT00528970|593544553|FG000|Overall Study|Lack of Efficacy|0|||
164318894|NCT00528970|593544554|FG001|Overall Study|Lack of Efficacy|0|||
164318895|NCT00528970|593544555|FG002|Overall Study|Lack of Efficacy|1|||
164318896|NCT00528970|593544553|FG000|Overall Study|Withdrawal by Subject|4|||
164318897|NCT00528970|593544554|FG001|Overall Study|Withdrawal by Subject|3|||
164318898|NCT00528970|593544555|FG002|Overall Study|Withdrawal by Subject|5|||
164318899|NCT00528970|593544553|FG000|Overall Study|Randomized but not treated|0|||
164318900|NCT00528970|593544554|FG001|Overall Study|Randomized but not treated|0|||
164318901|NCT00528970|593544555|FG002|Overall Study|Randomized but not treated|1|||
164318902|NCT02882152|593544556|FG000|Overall Study|Lost to Follow-up|1|||
164318903|NCT02882152|593544557|FG001|Overall Study|Lost to Follow-up|0|||
164318904|NCT01104376|593544560|FG000|Overall Study|Withdrawal by Subject|15|||
164318905|NCT01104376|593544560|FG000|Overall Study|Consented but excluded after labs|13|||
164318906|NCT00797966|593544561|FG000|Phase A|Lost to Follow-up|0|||
164318907|NCT00797966|593544562|FG001|Phase A|Lost to Follow-up|0|||
164318908|NCT00797966|593544563|FG002|Phase A|Lost to Follow-up|0|||
164318909|NCT00797966|593544564|FG003|Phase A|Lost to Follow-up|0|||
163873798|NCT03088813|591906883|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
163873799|NCT03088813|591906884|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
163873800|NCT03088813|591906881|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
163873801|NCT03088813|591906882|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
163873802|NCT03088813|591906883|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
163873803|NCT03088813|591906884|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
163873804|NCT03088813|591906881|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
163873805|NCT03088813|591906882|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
163873806|NCT03088813|591906883|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
163873807|NCT03088813|591906884|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
163873808|NCT03088813|591906881|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
163873809|NCT03088813|591906882|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
163873810|NCT03088813|591906883|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
163873811|NCT03088813|591906884|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
163873812|NCT02152137|591906885|FG000|Overall Study|Withdrawal by Subject|1|||
163873813|NCT02152137|591906885|FG000|Overall Study|Originally assigned to Arm B|3|||
163873814|NCT04878354|591906886|FG000|Overall Study|Adverse Event|4|||
163978317|NCT00960661|592291905|FG000|Interventional Phase|Lack of Efficacy|0|||
163978318|NCT00960661|592291906|FG001|Interventional Phase|Lack of Efficacy|2|||
163978319|NCT00960661|592291907|FG002|Interventional Phase|Lack of Efficacy|0|||
164318910|NCT00797966|593544565|FG004|Phase A|Lost to Follow-up|33|||
164318911|NCT00797966|593544566|FG005|Phase A|Lost to Follow-up|0|||
164318912|NCT00797966|593544561|FG000|Phase A|Adverse Event|0|||
164318913|NCT00797966|593544562|FG001|Phase A|Adverse Event|0|||
164318914|NCT00797966|593544563|FG002|Phase A|Adverse Event|0|||
164318915|NCT00797966|593544564|FG003|Phase A|Adverse Event|0|||
164318916|NCT00797966|593544565|FG004|Phase A|Adverse Event|46|||
164318917|NCT00797966|593544566|FG005|Phase A|Adverse Event|0|||
164318918|NCT00797966|593544561|FG000|Phase A|Met withdrawal criteria|0|||
164318919|NCT00797966|593544562|FG001|Phase A|Met withdrawal criteria|0|||
164318920|NCT00797966|593544563|FG002|Phase A|Met withdrawal criteria|0|||
164318921|NCT00797966|593544564|FG003|Phase A|Met withdrawal criteria|0|||
164318922|NCT00797966|593544565|FG004|Phase A|Met withdrawal criteria|4|||
164318923|NCT00797966|593544566|FG005|Phase A|Met withdrawal criteria|0|||
163873815|NCT04878354|591906887|FG001|Overall Study|Adverse Event|13|||
163873816|NCT04878354|591906886|FG000|Overall Study|Withdrawal by Subject|14|||
163873817|NCT04878354|591906887|FG001|Overall Study|Withdrawal by Subject|12|||
163873818|NCT04878354|591906886|FG000|Overall Study|Lost to Follow-up|4|||
163873819|NCT04878354|591906887|FG001|Overall Study|Lost to Follow-up|1|||
163873820|NCT04878354|591906886|FG000|Overall Study|Lack of Efficacy|1|||
163873821|NCT04878354|591906887|FG001|Overall Study|Lack of Efficacy|0|||
163873822|NCT04878354|591906886|FG000|Overall Study|Protocol Violation|0|||
163873823|NCT04878354|591906887|FG001|Overall Study|Protocol Violation|1|||
163873824|NCT04878354|591906886|FG000|Overall Study|"Reason stated as other in CRF"|2|||
163873825|NCT04878354|591906887|FG001|Overall Study|"Reason stated as other in CRF"|3|||
163873826|NCT01903811|591906902|FG000|Overall Study|No measurable disease|1|||
163873827|NCT01903811|591906903|FG001|Overall Study|No measurable disease|1|||
163873828|NCT01903811|591906902|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
163873829|NCT01903811|591906903|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
163873830|NCT01903811|591906902|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
163873831|NCT01903811|591906903|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
163873832|NCT01903811|591906902|FG000|Overall Study|Withdrawal by Subject|0|||
163873833|NCT01903811|591906903|FG001|Overall Study|Withdrawal by Subject|1|||
163873834|NCT04540913|591906904|FG000|Overall Study|Withdrawal by Subject|14|||
163873835|NCT04540913|591906905|FG001|Overall Study|Withdrawal by Subject|3|||
163873836|NCT05613205|591906906|FG000|Overall Study|Lost to Follow-up|0|||
163873837|NCT05613205|591906907|FG001|Overall Study|Lost to Follow-up|0|||
163873838|NCT05613205|591906908|FG002|Overall Study|Lost to Follow-up|1|||
163873839|NCT05613205|591906909|FG003|Overall Study|Lost to Follow-up|1|||
163873840|NCT05613205|591906910|FG004|Overall Study|Lost to Follow-up|0|||
163873841|NCT05613205|591906906|FG000|Overall Study|Withdrawal by Subject|0|||
163873842|NCT05613205|591906907|FG001|Overall Study|Withdrawal by Subject|0|||
163873843|NCT05613205|591906908|FG002|Overall Study|Withdrawal by Subject|1|||
163873844|NCT05613205|591906909|FG003|Overall Study|Withdrawal by Subject|1|||
163873845|NCT05613205|591906910|FG004|Overall Study|Withdrawal by Subject|0|||
163873846|NCT03602014|591906911|FG000|Overall Study|Lost to Follow-up|2|||
163873847|NCT03602014|591906912|FG001|Overall Study|Lost to Follow-up|0|||
163873848|NCT03602014|591906913|FG002|Overall Study|Lost to Follow-up|0|||
163873849|NCT01939899|591906918|FG000|Lead-in Dose Finding Phase|Death|0|||
163873850|NCT01939899|591906919|FG001|Lead-in Dose Finding Phase|Death|3|||
163873851|NCT01939899|591906920|FG002|Lead-in Dose Finding Phase|Death|1|||
163873852|NCT01939899|591906921|FG003|Lead-in Dose Finding Phase|Death|0|||
163873853|NCT01939899|591906922|FG004|Lead-in Dose Finding Phase|Death|0|||
163873854|NCT01939899|591906918|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
163873855|NCT01939899|591906919|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
163873856|NCT01939899|591906920|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
163873857|NCT01939899|591906921|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
163873858|NCT01939899|591906922|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
163873859|NCT01939899|591906918|FG000|Lead-in Dose Finding Phase|Other|0|||
163873860|NCT01939899|591906919|FG001|Lead-in Dose Finding Phase|Other|0|||
163873861|NCT01939899|591906920|FG002|Lead-in Dose Finding Phase|Other|1|||
163873862|NCT01939899|591906921|FG003|Lead-in Dose Finding Phase|Other|0|||
163873863|NCT01939899|591906922|FG004|Lead-in Dose Finding Phase|Other|0|||
163873864|NCT01939899|591906918|FG000|Phase 2|Withdrawal by Subject|0|||
163873865|NCT01939899|591906919|FG001|Phase 2|Withdrawal by Subject|0|||
163873866|NCT01939899|591906920|FG002|Phase 2|Withdrawal by Subject|0|||
163873867|NCT01939899|591906921|FG003|Phase 2|Withdrawal by Subject|2|||
163873868|NCT01939899|591906922|FG004|Phase 2|Withdrawal by Subject|0|||
163873869|NCT01939899|591906918|FG000|Phase 2|Disease Progression|0|||
163873870|NCT01939899|591906919|FG001|Phase 2|Disease Progression|0|||
163873871|NCT01939899|591906920|FG002|Phase 2|Disease Progression|0|||
163873872|NCT01939899|591906921|FG003|Phase 2|Disease Progression|9|||
163873873|NCT01939899|591906922|FG004|Phase 2|Disease Progression|1|||
163873874|NCT01854385|591906924|FG000|Pre-Treatment|Withdrawal by Subject|4|||
163873875|NCT01854385|591906924|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
163978320|NCT02699892|592291908|FG000|Overall Study|Other|36|||
163978321|NCT00711100|592291909|FG000|Overall Study|Lack of Efficacy|5|||
164318924|NCT00797966|593544561|FG000|Phase A|Physician Decision|0|||
164318925|NCT00797966|593544562|FG001|Phase A|Physician Decision|0|||
164318926|NCT00797966|593544563|FG002|Phase A|Physician Decision|0|||
163873876|NCT01854385|591906924|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
163873877|NCT01854385|591906924|FG000|Pre-Treatment|Unable to come for study visits|1|||
163873878|NCT01854385|591906924|FG000|Treatment|Lost to Follow-up|1|||
163873879|NCT02932579|591906925|FG000|Overall Study|Withdrawal by Subject|4|||
163873880|NCT02932579|591906926|FG001|Overall Study|Withdrawal by Subject|1|||
163873881|NCT02121002|591906928|FG000|Overall Study|Physician Decision|2|||
163873882|NCT02121002|591906929|FG001|Overall Study|Physician Decision|0|||
163873883|NCT02121002|591906930|FG002|Overall Study|Physician Decision|0|||
163873884|NCT02121002|591906928|FG000|Overall Study|Withdrawal by Subject|3|||
163873885|NCT02121002|591906929|FG001|Overall Study|Withdrawal by Subject|1|||
163978322|NCT00711100|592291909|FG000|Overall Study|Withdrawal by Subject|8|||
164206301|NCT02765165|593124972|FG004|Treatment Period|Progressive disease|4|||
164206302|NCT02765165|593124973|FG005|Treatment Period|Progressive disease|2|||
164206303|NCT02765165|593124974|FG006|Treatment Period|Progressive disease|2|||
164206304|NCT02765165|593124968|FG000|Treatment Period|Physician Decision|0|||
164206305|NCT02765165|593124969|FG001|Treatment Period|Physician Decision|1|||
164206306|NCT02765165|593124970|FG002|Treatment Period|Physician Decision|0|||
164206307|NCT02765165|593124971|FG003|Treatment Period|Physician Decision|0|||
164206308|NCT02765165|593124972|FG004|Treatment Period|Physician Decision|0|||
164206309|NCT02765165|593124973|FG005|Treatment Period|Physician Decision|0|||
164206310|NCT02765165|593124974|FG006|Treatment Period|Physician Decision|0|||
164206311|NCT02765165|593124968|FG000|Treatment Period|Adverse Event|0|||
164206312|NCT02765165|593124969|FG001|Treatment Period|Adverse Event|1|||
164206313|NCT02765165|593124970|FG002|Treatment Period|Adverse Event|0|||
163873886|NCT02121002|591906930|FG002|Overall Study|Withdrawal by Subject|4|||
163873887|NCT02121002|591906928|FG000|Overall Study|Protocol Violation|1|||
163873888|NCT02121002|591906929|FG001|Overall Study|Protocol Violation|2|||
163873889|NCT02121002|591906930|FG002|Overall Study|Protocol Violation|4|||
163873890|NCT02121002|591906928|FG000|Overall Study|Concomitant therapy|0|||
163873891|NCT02121002|591906929|FG001|Overall Study|Concomitant therapy|1|||
163873892|NCT02121002|591906930|FG002|Overall Study|Concomitant therapy|1|||
163873893|NCT02121002|591906928|FG000|Overall Study|Others|1|||
163873894|NCT02121002|591906929|FG001|Overall Study|Others|0|||
163873895|NCT02121002|591906930|FG002|Overall Study|Others|1|||
163873896|NCT02590432|591906931|FG000|Open-label Treatment Period|Adverse Event|97|||
164136086|NCT04713553|592862027|FG003|Primary Study (2 Months)|Other|0|||
164136087|NCT04713553|592862028|FG004|Primary Study (2 Months)|Other|1|||
164136088|NCT04713553|592862029|FG005|Primary Study (2 Months)|Other|0|||
164136089|NCT04713553|592862030|FG006|Primary Study (2 Months)|Other|0|||
164136090|NCT04713553|592862024|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
164136091|NCT04713553|592862025|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
164136092|NCT04713553|592862026|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
164136093|NCT04713553|592862027|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
164136094|NCT04713553|592862028|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
164136095|NCT04713553|592862029|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
164136096|NCT04713553|592862030|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
164136097|NCT04713553|592862024|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
164136098|NCT04713553|592862025|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
164136099|NCT04713553|592862026|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
164136100|NCT04713553|592862027|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
164136101|NCT04713553|592862028|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
164136102|NCT04713553|592862029|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
164136103|NCT04713553|592862030|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
164136104|NCT01682863|592862031|FG000|Overall Study|Subject/guardian decision|19|||
164136105|NCT01682863|592862032|FG001|Overall Study|Subject/guardian decision|12|||
164136106|NCT01682863|592862033|FG002|Overall Study|Subject/guardian decision|10|||
164136107|NCT01682863|592862031|FG000|Overall Study|Lost to Follow-up|5|||
164136108|NCT01682863|592862032|FG001|Overall Study|Lost to Follow-up|1|||
164136109|NCT01682863|592862033|FG002|Overall Study|Lost to Follow-up|6|||
164136110|NCT01682863|592862031|FG000|Overall Study|Death|1|||
164136111|NCT01682863|592862032|FG001|Overall Study|Death|3|||
164136112|NCT01682863|592862033|FG002|Overall Study|Death|4|||
164136113|NCT01682863|592862031|FG000|Overall Study|Protocol deviation|1|||
164136114|NCT01682863|592862032|FG001|Overall Study|Protocol deviation|0|||
164136115|NCT01682863|592862033|FG002|Overall Study|Protocol deviation|1|||
164136116|NCT01682863|592862031|FG000|Overall Study|Technical problems|1|||
164136117|NCT01682863|592862032|FG001|Overall Study|Technical problems|0|||
164136118|NCT01682863|592862033|FG002|Overall Study|Technical problems|0|||
164136119|NCT01682863|592862031|FG000|Overall Study|Adverse Event|0|||
164136120|NCT01682863|592862032|FG001|Overall Study|Adverse Event|1|||
164136121|NCT01682863|592862033|FG002|Overall Study|Adverse Event|2|||
164136122|NCT01682863|592862031|FG000|Overall Study|Physician Decision|0|||
164136123|NCT01682863|592862032|FG001|Overall Study|Physician Decision|0|||
164136124|NCT01682863|592862033|FG002|Overall Study|Physician Decision|1|||
164136125|NCT00977379|592862034|FG000|Overall Study|Withdrawal by Subject|1|||
164136126|NCT00977379|592862035|FG001|Overall Study|Withdrawal by Subject|1|||
164136127|NCT00977379|592862034|FG000|Overall Study|Death|7|||
164136128|NCT00977379|592862035|FG001|Overall Study|Death|9|||
164136129|NCT00977379|592862034|FG000|Overall Study|Premature Study Termination|4|||
164136130|NCT00977379|592862035|FG001|Overall Study|Premature Study Termination|0|||
164136131|NCT00977379|592862034|FG000|Overall Study|Participant Moving House|0|||
164136132|NCT00977379|592862035|FG001|Overall Study|Participant Moving House|1|||
164136133|NCT00977379|592862034|FG000|Overall Study|Randomization Error|0|||
164136134|NCT00977379|592862035|FG001|Overall Study|Randomization Error|1|||
164136135|NCT00918138|592862036|FG000|Overall Study|Subject withdrew consent|1|||
164136136|NCT00918138|592862037|FG001|Overall Study|Subject withdrew consent|1|||
163978323|NCT01929408|592291912|FG000|Overall Study|received HCT as initial treatment|8|||
163978324|NCT00652366|592291922|FG000|Overall Study|Adverse Event|8|||
164318927|NCT00797966|593544564|FG003|Phase A|Physician Decision|0|||
164318928|NCT00797966|593544565|FG004|Phase A|Physician Decision|13|||
164318929|NCT00797966|593544566|FG005|Phase A|Physician Decision|0|||
164318930|NCT00797966|593544561|FG000|Phase A|Withdrawal by Subject|0|||
164318931|NCT00797966|593544562|FG001|Phase A|Withdrawal by Subject|0|||
164318932|NCT00797966|593544563|FG002|Phase A|Withdrawal by Subject|0|||
164318933|NCT00797966|593544564|FG003|Phase A|Withdrawal by Subject|0|||
164318934|NCT00797966|593544565|FG004|Phase A|Withdrawal by Subject|33|||
164318935|NCT00797966|593544566|FG005|Phase A|Withdrawal by Subject|0|||
164318936|NCT00797966|593544561|FG000|Phase A|Protocol deviation|0|||
164318937|NCT00797966|593544562|FG001|Phase A|Protocol deviation|0|||
164318938|NCT00797966|593544563|FG002|Phase A|Protocol deviation|0|||
164318939|NCT00797966|593544564|FG003|Phase A|Protocol deviation|0|||
164318940|NCT00797966|593544565|FG004|Phase A|Protocol deviation|56|||
164318941|NCT00797966|593544566|FG005|Phase A|Protocol deviation|0|||
164318942|NCT00797966|593544561|FG000|Phase B|Lost to Follow-up|0|||
164318943|NCT00797966|593544562|FG001|Phase B|Lost to Follow-up|1|||
164318944|NCT00797966|593544563|FG002|Phase B|Lost to Follow-up|3|||
164318945|NCT00797966|593544564|FG003|Phase B|Lost to Follow-up|0|||
164318946|NCT00797966|593544565|FG004|Phase B|Lost to Follow-up|0|||
164318947|NCT00797966|593544566|FG005|Phase B|Lost to Follow-up|0|||
164318948|NCT00797966|593544561|FG000|Phase B|Adverse Event|2|||
164318949|NCT00797966|593544562|FG001|Phase B|Adverse Event|1|||
164318950|NCT00797966|593544563|FG002|Phase B|Adverse Event|3|||
164318951|NCT00797966|593544564|FG003|Phase B|Adverse Event|1|||
164318952|NCT00797966|593544565|FG004|Phase B|Adverse Event|0|||
164318953|NCT00797966|593544566|FG005|Phase B|Adverse Event|0|||
164318954|NCT00797966|593544561|FG000|Phase B|Met Withdrawal Criteria|3|||
164318955|NCT00797966|593544562|FG001|Phase B|Met Withdrawal Criteria|3|||
164318956|NCT00797966|593544563|FG002|Phase B|Met Withdrawal Criteria|6|||
164318957|NCT00797966|593544564|FG003|Phase B|Met Withdrawal Criteria|1|||
164318958|NCT00797966|593544565|FG004|Phase B|Met Withdrawal Criteria|0|||
164318959|NCT00797966|593544566|FG005|Phase B|Met Withdrawal Criteria|0|||
164318960|NCT00797966|593544561|FG000|Phase B|Physician Decision|1|||
164318961|NCT00797966|593544562|FG001|Phase B|Physician Decision|0|||
164318962|NCT00797966|593544563|FG002|Phase B|Physician Decision|3|||
164318963|NCT00797966|593544564|FG003|Phase B|Physician Decision|1|||
164318964|NCT00797966|593544565|FG004|Phase B|Physician Decision|0|||
164318965|NCT00797966|593544566|FG005|Phase B|Physician Decision|0|||
164318966|NCT00797966|593544561|FG000|Phase B|Withdrawal by Subject|1|||
164318967|NCT00797966|593544562|FG001|Phase B|Withdrawal by Subject|4|||
164318968|NCT00797966|593544563|FG002|Phase B|Withdrawal by Subject|3|||
164318969|NCT00797966|593544564|FG003|Phase B|Withdrawal by Subject|3|||
164318970|NCT00797966|593544565|FG004|Phase B|Withdrawal by Subject|0|||
164318971|NCT00797966|593544566|FG005|Phase B|Withdrawal by Subject|0|||
164318972|NCT00797966|593544561|FG000|Phase B|Protocol Deviation|4|||
164318973|NCT00797966|593544562|FG001|Phase B|Protocol Deviation|8|||
164318974|NCT00797966|593544563|FG002|Phase B|Protocol Deviation|2|||
164318975|NCT00797966|593544564|FG003|Phase B|Protocol Deviation|6|||
164318976|NCT00797966|593544565|FG004|Phase B|Protocol Deviation|0|||
164318977|NCT00797966|593544566|FG005|Phase B|Protocol Deviation|0|||
163978325|NCT00652366|592291923|FG001|Overall Study|Adverse Event|4|||
163978326|NCT00652366|592291924|FG002|Overall Study|Adverse Event|7|||
163978327|NCT00652366|592291925|FG003|Overall Study|Adverse Event|17|||
163978328|NCT00652366|592291926|FG004|Overall Study|Adverse Event|13|||
163978329|NCT00652366|592291922|FG000|Overall Study|Death|5|||
163978330|NCT00652366|592291923|FG001|Overall Study|Death|4|||
163978331|NCT00652366|592291924|FG002|Overall Study|Death|1|||
163978332|NCT00652366|592291925|FG003|Overall Study|Death|8|||
163978333|NCT00652366|592291926|FG004|Overall Study|Death|5|||
163978334|NCT00652366|592291922|FG000|Overall Study|Lack of Efficacy|84|||
164318978|NCT00797966|593544561|FG000|Phase B|Lack of Efficacy|0|||
164318979|NCT00797966|593544562|FG001|Phase B|Lack of Efficacy|1|||
164318980|NCT00797966|593544563|FG002|Phase B|Lack of Efficacy|1|||
164318981|NCT00797966|593544564|FG003|Phase B|Lack of Efficacy|4|||
164318982|NCT00797966|593544565|FG004|Phase B|Lack of Efficacy|0|||
164318983|NCT00797966|593544566|FG005|Phase B|Lack of Efficacy|0|||
164318984|NCT00797966|593544561|FG000|Phase A+|Lost to Follow-up|0|||
164318985|NCT00797966|593544562|FG001|Phase A+|Lost to Follow-up|0|||
164318986|NCT00797966|593544563|FG002|Phase A+|Lost to Follow-up|0|||
164318987|NCT00797966|593544564|FG003|Phase A+|Lost to Follow-up|0|||
164318988|NCT00797966|593544565|FG004|Phase A+|Lost to Follow-up|0|||
164318989|NCT00797966|593544566|FG005|Phase A+|Lost to Follow-up|9|||
163978335|NCT00652366|592291923|FG001|Overall Study|Lack of Efficacy|58|||
163978336|NCT00652366|592291924|FG002|Overall Study|Lack of Efficacy|53|||
164318990|NCT00797966|593544561|FG000|Phase A+|Met withdrawal criteria|0|||
164318991|NCT00797966|593544562|FG001|Phase A+|Met withdrawal criteria|0|||
164318992|NCT00797966|593544563|FG002|Phase A+|Met withdrawal criteria|0|||
164318993|NCT00797966|593544564|FG003|Phase A+|Met withdrawal criteria|0|||
164318994|NCT00797966|593544565|FG004|Phase A+|Met withdrawal criteria|0|||
164318995|NCT00797966|593544566|FG005|Phase A+|Met withdrawal criteria|5|||
164318996|NCT00797966|593544561|FG000|Phase A+|Withdrawal by Subject|0|||
164318997|NCT00797966|593544562|FG001|Phase A+|Withdrawal by Subject|0|||
164318998|NCT00797966|593544563|FG002|Phase A+|Withdrawal by Subject|0|||
164318999|NCT00797966|593544564|FG003|Phase A+|Withdrawal by Subject|0|||
164319000|NCT00797966|593544565|FG004|Phase A+|Withdrawal by Subject|0|||
164319001|NCT00797966|593544566|FG005|Phase A+|Withdrawal by Subject|6|||
164319002|NCT00797966|593544561|FG000|Phase A+|Adverse Event|0|||
164319003|NCT00797966|593544562|FG001|Phase A+|Adverse Event|0|||
164319004|NCT00797966|593544563|FG002|Phase A+|Adverse Event|0|||
164319005|NCT00797966|593544564|FG003|Phase A+|Adverse Event|0|||
164319006|NCT00797966|593544565|FG004|Phase A+|Adverse Event|0|||
164319007|NCT00797966|593544566|FG005|Phase A+|Adverse Event|4|||
164319008|NCT00797966|593544561|FG000|Phase A+|Protocol deviation|0|||
164319009|NCT00797966|593544562|FG001|Phase A+|Protocol deviation|0|||
164319010|NCT00797966|593544563|FG002|Phase A+|Protocol deviation|0|||
164319011|NCT00797966|593544564|FG003|Phase A+|Protocol deviation|0|||
164319012|NCT00797966|593544565|FG004|Phase A+|Protocol deviation|0|||
164319013|NCT00797966|593544566|FG005|Phase A+|Protocol deviation|4|||
164319014|NCT01002820|593544570|FG000|Overall Study|Adverse Event|1|||
164319015|NCT01002820|593544570|FG000|Overall Study|Withdrawal by Subject|2|||
164319016|NCT01002820|593544570|FG000|Overall Study|Lack of Efficacy|1|||
164319017|NCT01673347|593544571|FG000|Overall Study|failure of allograft|7|||
164319018|NCT01430754|593544574|FG000|Run-In Phase|Circadian Period Ineligible|24|||
164319019|NCT01430754|593544575|FG001|Run-In Phase|Circadian Period Ineligible|0|||
164319020|NCT01430754|593544574|FG000|Run-In Phase|Protocol Violation|6|||
164319021|NCT01430754|593544575|FG001|Run-In Phase|Protocol Violation|0|||
164319022|NCT01430754|593544574|FG000|Run-In Phase|Adverse Event|2|||
164319023|NCT01430754|593544575|FG001|Run-In Phase|Adverse Event|0|||
164319024|NCT01430754|593544574|FG000|Run-In Phase|Other|2|||
164319025|NCT01430754|593544575|FG001|Run-In Phase|Other|0|||
164319026|NCT01430754|593544574|FG000|Run-In Phase|Withdrawal by Subject|2|||
164319027|NCT01430754|593544575|FG001|Run-In Phase|Withdrawal by Subject|0|||
164319028|NCT01430754|593544574|FG000|Run-In Phase|Lost to Follow-up|1|||
164206314|NCT02765165|593124971|FG003|Treatment Period|Adverse Event|0|||
164206315|NCT02765165|593124972|FG004|Treatment Period|Adverse Event|0|||
164206316|NCT02765165|593124973|FG005|Treatment Period|Adverse Event|0|||
164319029|NCT01430754|593544575|FG001|Run-In Phase|Lost to Follow-up|0|||
164319030|NCT00895011|593544576|FG000|Overall Study|Withdrawal by Subject|14|||
164319031|NCT00895011|593544577|FG001|Overall Study|Withdrawal by Subject|7|||
164319032|NCT00895011|593544578|FG002|Overall Study|Withdrawal by Subject|2|||
164319033|NCT00895011|593544576|FG000|Overall Study|Lost to Follow-up|5|||
164206317|NCT02765165|593124974|FG006|Treatment Period|Adverse Event|0|||
164206318|NCT02765165|593124968|FG000|Treatment Period|Withdrawal by Subject|0|||
164206319|NCT02765165|593124969|FG001|Treatment Period|Withdrawal by Subject|0|||
164206320|NCT02765165|593124970|FG002|Treatment Period|Withdrawal by Subject|0|||
164206321|NCT02765165|593124971|FG003|Treatment Period|Withdrawal by Subject|0|||
164206322|NCT02765165|593124972|FG004|Treatment Period|Withdrawal by Subject|2|||
164206323|NCT02765165|593124973|FG005|Treatment Period|Withdrawal by Subject|0|||
164206324|NCT02765165|593124974|FG006|Treatment Period|Withdrawal by Subject|0|||
164206325|NCT02765165|593124968|FG000|Treatment Period|Study terminated|0|||
164206326|NCT02765165|593124969|FG001|Treatment Period|Study terminated|0|||
164206327|NCT02765165|593124970|FG002|Treatment Period|Study terminated|0|||
164206328|NCT02765165|593124971|FG003|Treatment Period|Study terminated|0|||
164206329|NCT02765165|593124972|FG004|Treatment Period|Study terminated|0|||
164206330|NCT02765165|593124973|FG005|Treatment Period|Study terminated|1|||
164206331|NCT02765165|593124974|FG006|Treatment Period|Study terminated|2|||
164206332|NCT02765165|593124968|FG000|Post-treatment Follow-up|Death|1|||
164206333|NCT02765165|593124969|FG001|Post-treatment Follow-up|Death|2|||
164206334|NCT02765165|593124970|FG002|Post-treatment Follow-up|Death|1|||
164206335|NCT02765165|593124971|FG003|Post-treatment Follow-up|Death|1|||
164206336|NCT02765165|593124972|FG004|Post-treatment Follow-up|Death|1|||
164206337|NCT02765165|593124973|FG005|Post-treatment Follow-up|Death|1|||
164206338|NCT02765165|593124974|FG006|Post-treatment Follow-up|Death|0|||
164206339|NCT02765165|593124968|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
164206340|NCT02765165|593124969|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
164206341|NCT02765165|593124970|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
164319034|NCT00895011|593544577|FG001|Overall Study|Lost to Follow-up|4|||
164319035|NCT00895011|593544578|FG002|Overall Study|Lost to Follow-up|1|||
164319036|NCT00895011|593544576|FG000|Overall Study|Protocol Violation|3|||
164319037|NCT00895011|593544577|FG001|Overall Study|Protocol Violation|1|||
164319038|NCT00895011|593544578|FG002|Overall Study|Protocol Violation|3|||
164206342|NCT02765165|593124971|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
164206343|NCT02765165|593124972|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
164206344|NCT02765165|593124973|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
164206345|NCT02765165|593124974|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
164319039|NCT00895011|593544576|FG000|Overall Study|Adverse Event|1|||
164319040|NCT00895011|593544577|FG001|Overall Study|Adverse Event|2|||
164319041|NCT00895011|593544578|FG002|Overall Study|Adverse Event|2|||
164319042|NCT00895011|593544576|FG000|Overall Study|schedule conflict|1|||
164206346|NCT02765165|593124968|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206347|NCT02765165|593124969|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206348|NCT02765165|593124970|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
164206349|NCT02765165|593124971|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206350|NCT02765165|593124972|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206351|NCT02765165|593124973|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206352|NCT02765165|593124974|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
164206353|NCT02765165|593124968|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206354|NCT02765165|593124969|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206355|NCT02765165|593124970|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
164206356|NCT02765165|593124971|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
164206357|NCT02765165|593124972|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206358|NCT02765165|593124973|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206359|NCT02765165|593124974|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
164206360|NCT02765165|593124968|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206361|NCT02765165|593124969|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
164206362|NCT02765165|593124970|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206363|NCT02765165|593124971|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206364|NCT02765165|593124972|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
164319043|NCT00895011|593544577|FG001|Overall Study|schedule conflict|0|||
164319044|NCT00895011|593544578|FG002|Overall Study|schedule conflict|0|||
164319045|NCT02661178|593544586|FG000|Part 1|Protocol Violation|1|||
164319046|NCT02661178|593544587|FG001|Part 1|Protocol Violation|0|||
164319047|NCT02661178|593544588|FG002|Part 1|Protocol Violation|0|||
164319048|NCT02661178|593544589|FG003|Part 1|Protocol Violation|0|||
164319049|NCT02661178|593544590|FG004|Part 1|Protocol Violation|0|||
164319050|NCT02661178|593544591|FG005|Part 1|Protocol Violation|0|||
164319051|NCT02661178|593544592|FG006|Part 1|Protocol Violation|0|||
164319052|NCT02661178|593544593|FG007|Part 1|Protocol Violation|0|||
164319053|NCT02661178|593544594|FG008|Part 1|Protocol Violation|0|||
164319054|NCT02661178|593544595|FG009|Part 1|Protocol Violation|0|||
164319055|NCT02661178|593544596|FG010|Part 1|Protocol Violation|0|||
164319056|NCT02661178|593544597|FG011|Part 1|Protocol Violation|0|||
164319057|NCT02661178|593544598|FG012|Part 1|Protocol Violation|0|||
164319058|NCT02661178|593544599|FG013|Part 1|Protocol Violation|0|||
164319059|NCT02661178|593544600|FG014|Part 1|Protocol Violation|0|||
164319060|NCT02278471|593544601|FG000|Overall Study|Lost to Follow-up|6|||
164319061|NCT02278471|593544602|FG001|Overall Study|Lost to Follow-up|15|||
164319062|NCT02278471|593544601|FG000|Overall Study|Death|2|||
164319063|NCT02278471|593544602|FG001|Overall Study|Death|2|||
164319064|NCT02278471|593544601|FG000|Overall Study|Withdrawal by Subject|0|||
164319065|NCT02278471|593544602|FG001|Overall Study|Withdrawal by Subject|3|||
164319066|NCT04391049|593544603|FG000|Overall Study|Protocol Violation|1|||
164319067|NCT01242813|593544604|FG000|Overall Study|Lost to Follow-up|2|||
164319068|NCT00275821|593544606|FG000|Overall Study|Adverse Event|4|||
164319069|NCT00275821|593544607|FG001|Overall Study|Adverse Event|12|||
164319070|NCT00275821|593544608|FG002|Overall Study|Adverse Event|5|||
164319071|NCT00275821|593544606|FG000|Overall Study|Administrative problems|3|||
164319072|NCT00275821|593544607|FG001|Overall Study|Administrative problems|4|||
164319073|NCT00275821|593544608|FG002|Overall Study|Administrative problems|4|||
164319074|NCT00275821|593544606|FG000|Overall Study|Withdrawal by Subject|0|||
164319075|NCT00275821|593544607|FG001|Overall Study|Withdrawal by Subject|2|||
164319076|NCT00275821|593544608|FG002|Overall Study|Withdrawal by Subject|1|||
164319077|NCT00275821|593544606|FG000|Overall Study|Lost to Follow-up|0|||
164319078|NCT00275821|593544607|FG001|Overall Study|Lost to Follow-up|1|||
164319079|NCT00275821|593544608|FG002|Overall Study|Lost to Follow-up|1|||
164319080|NCT00275821|593544606|FG000|Overall Study|Death|0|||
164319081|NCT00275821|593544607|FG001|Overall Study|Death|2|||
164319082|NCT00275821|593544608|FG002|Overall Study|Death|1|||
164319083|NCT00275821|593544606|FG000|Overall Study|Lack of Efficacy|2|||
164206365|NCT02765165|593124973|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
164206366|NCT02765165|593124974|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
164319084|NCT00275821|593544607|FG001|Overall Study|Lack of Efficacy|1|||
164319085|NCT00275821|593544608|FG002|Overall Study|Lack of Efficacy|0|||
164319086|NCT00275821|593544606|FG000|Overall Study|Protocol Violation|5|||
164319087|NCT00275821|593544607|FG001|Overall Study|Protocol Violation|1|||
164319088|NCT00275821|593544608|FG002|Overall Study|Protocol Violation|0|||
164319089|NCT01215916|593544609|FG000|Overall Study|Progressive Disease|0|||
164319090|NCT01215916|593544610|FG001|Overall Study|Progressive Disease|2|||
164319091|NCT01215916|593544611|FG002|Overall Study|Progressive Disease|1|||
163873897|NCT02590432|591906932|FG001|Open-label Treatment Period|Adverse Event|79|||
163873898|NCT02590432|591906933|FG002|Open-label Treatment Period|Adverse Event|0|||
163873899|NCT02590432|591906934|FG003|Open-label Treatment Period|Adverse Event|0|||
163873900|NCT02590432|591906935|FG004|Open-label Treatment Period|Adverse Event|0|||
164319092|NCT01215916|593544612|FG003|Overall Study|Progressive Disease|2|||
164319093|NCT01215916|593544613|FG004|Overall Study|Progressive Disease|5|||
164319094|NCT01215916|593544614|FG005|Overall Study|Progressive Disease|4|||
164206367|NCT02765165|593124968|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206368|NCT02765165|593124969|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206369|NCT02765165|593124970|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206370|NCT02765165|593124971|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
164206371|NCT02765165|593124972|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
164206372|NCT02765165|593124973|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
164206373|NCT02765165|593124974|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
164206374|NCT01189266|593124975|FG000|Overall Study|Adverse Event|1|||
164206375|NCT01189266|593124976|FG001|Overall Study|Adverse Event|0|||
164206376|NCT01189266|593124977|FG002|Overall Study|Adverse Event|5|||
164206377|NCT01189266|593124975|FG000|Overall Study|Death|0|||
164206378|NCT01189266|593124976|FG001|Overall Study|Death|0|||
164206379|NCT01189266|593124977|FG002|Overall Study|Death|5|||
164206380|NCT01189266|593124975|FG000|Overall Study|Lack of Efficacy|4|||
164206381|NCT01189266|593124976|FG001|Overall Study|Lack of Efficacy|5|||
164206382|NCT01189266|593124977|FG002|Overall Study|Lack of Efficacy|44|||
164206383|NCT01189266|593124975|FG000|Overall Study|Physician Decision|0|||
164206384|NCT01189266|593124976|FG001|Overall Study|Physician Decision|0|||
164206385|NCT01189266|593124977|FG002|Overall Study|Physician Decision|1|||
164206386|NCT01189266|593124975|FG000|Overall Study|Protocol Violation|0|||
164206387|NCT01189266|593124976|FG001|Overall Study|Protocol Violation|1|||
164206388|NCT01189266|593124977|FG002|Overall Study|Protocol Violation|1|||
164206389|NCT01189266|593124975|FG000|Overall Study|Withdrawal by Subject|0|||
164206390|NCT01189266|593124976|FG001|Overall Study|Withdrawal by Subject|0|||
164206391|NCT01189266|593124977|FG002|Overall Study|Withdrawal by Subject|1|||
164206392|NCT01189266|593124975|FG000|Overall Study|Patient refuses further therapy|1|||
164206393|NCT01189266|593124976|FG001|Overall Study|Patient refuses further therapy|0|||
164206394|NCT01189266|593124977|FG002|Overall Study|Patient refuses further therapy|7|||
164206395|NCT01189266|593124975|FG000|Overall Study|No treatment|0|||
164206396|NCT01189266|593124976|FG001|Overall Study|No treatment|0|||
164206397|NCT01189266|593124977|FG002|Overall Study|No treatment|1|||
164206398|NCT00321763|593124978|FG000|Overall Study|Adverse Event|1|||
164206399|NCT00321763|593124979|FG001|Overall Study|Adverse Event|1|||
164206400|NCT00321763|593124980|FG002|Overall Study|Adverse Event|0|||
164206401|NCT00321763|593124981|FG003|Overall Study|Adverse Event|1|||
164206402|NCT00321763|593124978|FG000|Overall Study|Withdrawal by Subject|2|||
164206403|NCT00321763|593124979|FG001|Overall Study|Withdrawal by Subject|0|||
164206404|NCT00321763|593124980|FG002|Overall Study|Withdrawal by Subject|1|||
164206405|NCT00321763|593124981|FG003|Overall Study|Withdrawal by Subject|0|||
164206406|NCT00321763|593124978|FG000|Overall Study|Lost to Follow-up|3|||
164206407|NCT00321763|593124979|FG001|Overall Study|Lost to Follow-up|1|||
164206408|NCT00321763|593124980|FG002|Overall Study|Lost to Follow-up|5|||
164206409|NCT00321763|593124981|FG003|Overall Study|Lost to Follow-up|4|||
164206410|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
164206411|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
164206412|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
164206413|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
164206414|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
164206415|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
164206416|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
164206417|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
164206418|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
164206419|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
164206420|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
164206421|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
164206422|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
164206423|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
164206424|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
164206425|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
164206426|NCT00410163|593124982|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
164206427|NCT00410163|593124983|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
164206428|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
164206429|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
164206430|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
164206431|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
164206432|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
164206433|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
164206434|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
164206435|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
164206436|NCT00410163|593124982|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
164206437|NCT00410163|593124983|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
164206438|NCT01572792|593124989|FG000|Lead-in Study|Lost to Follow-up|5|||
164206439|NCT01572792|593124990|FG001|Lead-in Study|Lost to Follow-up|9|||
164206440|NCT01572792|593124991|FG002|Lead-in Study|Lost to Follow-up|4|||
164206441|NCT01572792|593124992|FG003|Lead-in Study|Lost to Follow-up|2|||
164206442|NCT01572792|593124993|FG004|Lead-in Study|Lost to Follow-up|4|||
164206443|NCT01572792|593124989|FG000|Lead-in Study|Withdrawal by Subject|22|||
164206444|NCT01572792|593124990|FG001|Lead-in Study|Withdrawal by Subject|11|||
164206445|NCT01572792|593124991|FG002|Lead-in Study|Withdrawal by Subject|12|||
164206446|NCT01572792|593124992|FG003|Lead-in Study|Withdrawal by Subject|24|||
164206447|NCT01572792|593124993|FG004|Lead-in Study|Withdrawal by Subject|11|||
164206448|NCT01572792|593124989|FG000|Lead-in Study|Protocol Violation|19|||
164206449|NCT01572792|593124990|FG001|Lead-in Study|Protocol Violation|10|||
164206450|NCT01572792|593124991|FG002|Lead-in Study|Protocol Violation|12|||
164206451|NCT01572792|593124992|FG003|Lead-in Study|Protocol Violation|13|||
164206452|NCT01572792|593124993|FG004|Lead-in Study|Protocol Violation|21|||
164206453|NCT01572792|593124989|FG000|Lead-in Study|Lack of Efficacy|20|||
164206454|NCT01572792|593124990|FG001|Lead-in Study|Lack of Efficacy|5|||
164206455|NCT01572792|593124991|FG002|Lead-in Study|Lack of Efficacy|4|||
164206456|NCT01572792|593124992|FG003|Lead-in Study|Lack of Efficacy|8|||
164206457|NCT01572792|593124993|FG004|Lead-in Study|Lack of Efficacy|10|||
164206458|NCT01572792|593124989|FG000|Lead-in Study|Adverse Event|21|||
164206459|NCT01572792|593124990|FG001|Lead-in Study|Adverse Event|21|||
164206460|NCT01572792|593124991|FG002|Lead-in Study|Adverse Event|22|||
164206461|NCT01572792|593124992|FG003|Lead-in Study|Adverse Event|16|||
164206462|NCT01572792|593124993|FG004|Lead-in Study|Adverse Event|14|||
164319095|NCT01215916|593544615|FG006|Overall Study|Progressive Disease|5|||
164319096|NCT01215916|593544616|FG007|Overall Study|Progressive Disease|3|||
164319097|NCT01215916|593544617|FG008|Overall Study|Progressive Disease|1|||
164319098|NCT01215916|593544609|FG000|Overall Study|Adverse Event|1|||
164319099|NCT01215916|593544610|FG001|Overall Study|Adverse Event|1|||
164319100|NCT01215916|593544611|FG002|Overall Study|Adverse Event|0|||
164319101|NCT01215916|593544612|FG003|Overall Study|Adverse Event|1|||
164319102|NCT01215916|593544613|FG004|Overall Study|Adverse Event|0|||
164319103|NCT01215916|593544614|FG005|Overall Study|Adverse Event|0|||
164319104|NCT01215916|593544615|FG006|Overall Study|Adverse Event|3|||
164319105|NCT01215916|593544616|FG007|Overall Study|Adverse Event|0|||
164319106|NCT01215916|593544617|FG008|Overall Study|Adverse Event|0|||
164319107|NCT01215916|593544609|FG000|Overall Study|Withdrawal by Subject|0|||
164319108|NCT01215916|593544610|FG001|Overall Study|Withdrawal by Subject|1|||
164319109|NCT01215916|593544611|FG002|Overall Study|Withdrawal by Subject|1|||
164319110|NCT01215916|593544612|FG003|Overall Study|Withdrawal by Subject|2|||
164319111|NCT01215916|593544613|FG004|Overall Study|Withdrawal by Subject|0|||
164319112|NCT01215916|593544614|FG005|Overall Study|Withdrawal by Subject|0|||
164319113|NCT01215916|593544615|FG006|Overall Study|Withdrawal by Subject|1|||
164319114|NCT01215916|593544616|FG007|Overall Study|Withdrawal by Subject|0|||
164319115|NCT01215916|593544617|FG008|Overall Study|Withdrawal by Subject|0|||
164319116|NCT01215916|593544609|FG000|Overall Study|Death|0|||
164319117|NCT01215916|593544610|FG001|Overall Study|Death|1|||
164319118|NCT01215916|593544611|FG002|Overall Study|Death|0|||
164319119|NCT01215916|593544612|FG003|Overall Study|Death|0|||
164319120|NCT01215916|593544613|FG004|Overall Study|Death|1|||
164319121|NCT01215916|593544614|FG005|Overall Study|Death|0|||
164319122|NCT01215916|593544615|FG006|Overall Study|Death|0|||
164319123|NCT01215916|593544616|FG007|Overall Study|Death|0|||
164319124|NCT01215916|593544617|FG008|Overall Study|Death|1|||
164319125|NCT01215916|593544609|FG000|Overall Study|Physician Decision|0|||
164319126|NCT01215916|593544610|FG001|Overall Study|Physician Decision|0|||
164319127|NCT01215916|593544611|FG002|Overall Study|Physician Decision|1|||
164319128|NCT01215916|593544612|FG003|Overall Study|Physician Decision|1|||
164319129|NCT01215916|593544613|FG004|Overall Study|Physician Decision|0|||
164319130|NCT01215916|593544614|FG005|Overall Study|Physician Decision|0|||
164319131|NCT01215916|593544615|FG006|Overall Study|Physician Decision|0|||
164319132|NCT01215916|593544616|FG007|Overall Study|Physician Decision|0|||
164319133|NCT01215916|593544617|FG008|Overall Study|Physician Decision|0|||
164319134|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
164319135|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164206463|NCT01572792|593124989|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
164206464|NCT01572792|593124990|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
164206465|NCT01572792|593124991|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
164206466|NCT01572792|593124992|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
164319136|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319137|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319138|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319139|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
164319140|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
164319141|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319142|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319143|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319144|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319145|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
164319146|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
164319147|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319148|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319149|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319150|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319151|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
164319152|NCT01133990|593544619|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
164319153|NCT01133990|593544620|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319154|NCT01133990|593544621|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319155|NCT01133990|593544622|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319156|NCT01133990|593544623|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319157|NCT01133990|593544624|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
164319158|NCT02683746|593544625|FG000|Overall Study|Adverse Event|3|||
164319159|NCT02683746|593544626|FG001|Overall Study|Adverse Event|2|||
164319160|NCT02683746|593544625|FG000|Overall Study|Lost to Follow-up|5|||
164319161|NCT02683746|593544626|FG001|Overall Study|Lost to Follow-up|6|||
164319162|NCT02683746|593544625|FG000|Overall Study|Withdrawal by Subject|6|||
164319163|NCT02683746|593544626|FG001|Overall Study|Withdrawal by Subject|5|||
164319164|NCT02683746|593544625|FG000|Overall Study|Physician Decision|2|||
164319165|NCT02683746|593544626|FG001|Overall Study|Physician Decision|1|||
164319166|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
164319167|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164319168|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164319169|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
164319170|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
164319171|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
164319172|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
164319173|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164319174|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164319175|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
164319176|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
164319177|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
164319178|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319179|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319180|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319181|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164319182|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
164319183|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
164319184|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319185|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
164319186|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319187|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319188|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
164319189|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
164319190|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
164319191|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164319192|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164319193|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164319194|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164319195|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164319196|NCT01328444|593544641|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164319197|NCT01328444|593544642|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
164319198|NCT01328444|593544643|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164319199|NCT01328444|593544644|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
164319200|NCT01328444|593544645|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164319201|NCT01328444|593544646|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164319202|NCT01328444|593544641|FG000|Washout Period (14 Days)|Adverse Event|1|||
164319203|NCT01328444|593544642|FG001|Washout Period (14 Days)|Adverse Event|1|||
164319204|NCT01328444|593544643|FG002|Washout Period (14 Days)|Adverse Event|0|||
164319205|NCT01328444|593544644|FG003|Washout Period (14 Days)|Adverse Event|1|||
164319206|NCT01328444|593544645|FG004|Washout Period (14 Days)|Adverse Event|1|||
163873901|NCT02590432|591906936|FG005|Open-label Treatment Period|Adverse Event|0|||
163873902|NCT02590432|591906937|FG006|Open-label Treatment Period|Adverse Event|0|||
163873903|NCT02590432|591906938|FG007|Open-label Treatment Period|Adverse Event|0|||
164319207|NCT01328444|593544646|FG005|Washout Period (14 Days)|Adverse Event|2|||
164319208|NCT01328444|593544641|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
164206467|NCT01572792|593124993|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
164206468|NCT01572792|593124989|FG000|Extension Study|Lost to Follow-up|6|||
164206469|NCT01572792|593124990|FG001|Extension Study|Lost to Follow-up|2|||
164206470|NCT01572792|593124991|FG002|Extension Study|Lost to Follow-up|0|||
164206471|NCT01572792|593124992|FG003|Extension Study|Lost to Follow-up|3|||
164206472|NCT01572792|593124993|FG004|Extension Study|Lost to Follow-up|3|||
164206473|NCT01572792|593124989|FG000|Extension Study|Withdrawal by Subject|7|||
164206474|NCT01572792|593124990|FG001|Extension Study|Withdrawal by Subject|6|||
164206475|NCT01572792|593124991|FG002|Extension Study|Withdrawal by Subject|11|||
164206476|NCT01572792|593124992|FG003|Extension Study|Withdrawal by Subject|8|||
164206477|NCT01572792|593124993|FG004|Extension Study|Withdrawal by Subject|14|||
164206478|NCT01572792|593124989|FG000|Extension Study|Protocol Violation|0|||
164206479|NCT01572792|593124990|FG001|Extension Study|Protocol Violation|4|||
164206480|NCT01572792|593124991|FG002|Extension Study|Protocol Violation|3|||
164206481|NCT01572792|593124992|FG003|Extension Study|Protocol Violation|4|||
164206482|NCT01572792|593124993|FG004|Extension Study|Protocol Violation|3|||
164206483|NCT01572792|593124989|FG000|Extension Study|Lack of Efficacy|2|||
164206484|NCT01572792|593124990|FG001|Extension Study|Lack of Efficacy|3|||
164206485|NCT01572792|593124991|FG002|Extension Study|Lack of Efficacy|3|||
164206486|NCT01572792|593124992|FG003|Extension Study|Lack of Efficacy|2|||
164206487|NCT01572792|593124993|FG004|Extension Study|Lack of Efficacy|2|||
164206488|NCT01572792|593124989|FG000|Extension Study|Adverse Event|7|||
164319209|NCT01328444|593544642|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
164319210|NCT01328444|593544643|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
164319211|NCT01328444|593544644|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
164319212|NCT01328444|593544645|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
163873904|NCT02590432|591906939|FG008|Open-label Treatment Period|Adverse Event|0|||
163873905|NCT02590432|591906931|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
163873906|NCT02590432|591906932|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
163873907|NCT02590432|591906933|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
163873908|NCT02590432|591906934|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
163873909|NCT02590432|591906935|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
163873910|NCT02590432|591906936|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
163873911|NCT02590432|591906937|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
163873912|NCT02590432|591906938|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
163873913|NCT02590432|591906939|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
163873914|NCT02590432|591906931|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
163873915|NCT02590432|591906932|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
163873916|NCT02590432|591906933|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
163873917|NCT02590432|591906934|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
163873918|NCT02590432|591906935|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
163873919|NCT02590432|591906936|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
163873920|NCT02590432|591906937|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
163873921|NCT02590432|591906938|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
163873922|NCT02590432|591906939|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
163873923|NCT02590432|591906931|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
163873924|NCT02590432|591906932|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
163873925|NCT02590432|591906933|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163873926|NCT02590432|591906934|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
163873927|NCT02590432|591906935|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
163873928|NCT02590432|591906936|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
163873929|NCT02590432|591906937|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
163873930|NCT02590432|591906938|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
163873931|NCT02590432|591906939|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
163873932|NCT02590432|591906931|FG000|Open-label Treatment Period|Protocol Violation|10|||
163873933|NCT02590432|591906932|FG001|Open-label Treatment Period|Protocol Violation|4|||
163873934|NCT02590432|591906933|FG002|Open-label Treatment Period|Protocol Violation|0|||
163873935|NCT02590432|591906934|FG003|Open-label Treatment Period|Protocol Violation|0|||
163873936|NCT02590432|591906935|FG004|Open-label Treatment Period|Protocol Violation|0|||
163873937|NCT02590432|591906936|FG005|Open-label Treatment Period|Protocol Violation|0|||
163873938|NCT02590432|591906937|FG006|Open-label Treatment Period|Protocol Violation|0|||
163873939|NCT02590432|591906938|FG007|Open-label Treatment Period|Protocol Violation|0|||
163873940|NCT02590432|591906939|FG008|Open-label Treatment Period|Protocol Violation|0|||
163873941|NCT02590432|591906931|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
163873942|NCT02590432|591906932|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
164206489|NCT01572792|593124990|FG001|Extension Study|Adverse Event|6|||
164206490|NCT01572792|593124991|FG002|Extension Study|Adverse Event|5|||
164206491|NCT01572792|593124992|FG003|Extension Study|Adverse Event|6|||
164206492|NCT01572792|593124993|FG004|Extension Study|Adverse Event|4|||
164319213|NCT01328444|593544646|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
163978337|NCT00652366|592291925|FG003|Overall Study|Lack of Efficacy|133|||
163978338|NCT00652366|592291926|FG004|Overall Study|Lack of Efficacy|13|||
164206493|NCT01572792|593124989|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
164206494|NCT01572792|593124990|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
164206495|NCT01572792|593124991|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
164206496|NCT01572792|593124992|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
164206497|NCT01572792|593124993|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
164206498|NCT03530696|593124994|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
164206499|NCT03530696|593124995|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
164206500|NCT04759131|593124996|FG000|Overall Study|Investigator's discretion|1|||
164206501|NCT04759131|593124997|FG001|Overall Study|Investigator's discretion|0|||
164206502|NCT04759131|593124996|FG000|Overall Study|Subject withdrawal|1|||
164206503|NCT04759131|593124997|FG001|Overall Study|Subject withdrawal|0|||
164206504|NCT03692949|593124998|FG000|Overall Study|Lost to Follow-up|0|||
164206505|NCT03692949|593124999|FG001|Overall Study|Lost to Follow-up|0|||
164206506|NCT03692949|593125000|FG002|Overall Study|Lost to Follow-up|0|||
164206507|NCT03692949|593125001|FG003|Overall Study|Lost to Follow-up|0|||
164206508|NCT03692949|593125002|FG004|Overall Study|Lost to Follow-up|0|||
164206509|NCT03692949|593125003|FG005|Overall Study|Lost to Follow-up|0|||
164206510|NCT03692949|593125004|FG006|Overall Study|Lost to Follow-up|0|||
164206511|NCT03692949|593125005|FG007|Overall Study|Lost to Follow-up|1|||
164206512|NCT00833755|593125009|FG000|Overall Study|Physician Decision|4|||
164206513|NCT00833755|593125010|FG001|Overall Study|Physician Decision|4|||
164206514|NCT00833755|593125011|FG002|Overall Study|Physician Decision|2|||
164206515|NCT00833755|593125012|FG003|Overall Study|Physician Decision|6|||
164206516|NCT00833755|593125009|FG000|Overall Study|Subject had scheduling issues|0|||
164206517|NCT00833755|593125010|FG001|Overall Study|Subject had scheduling issues|1|||
164206518|NCT00833755|593125011|FG002|Overall Study|Subject had scheduling issues|0|||
164206519|NCT00833755|593125012|FG003|Overall Study|Subject had scheduling issues|0|||
164206520|NCT00560404|593125014|FG000|Overall Study|Adverse Event|2|||
164206521|NCT00560404|593125015|FG001|Overall Study|Adverse Event|3|||
164206522|NCT00560404|593125014|FG000|Overall Study|Death|3|||
164206523|NCT00560404|593125015|FG001|Overall Study|Death|3|||
164206524|NCT00560404|593125014|FG000|Overall Study|Protocol Violation|12|||
164206525|NCT00560404|593125015|FG001|Overall Study|Protocol Violation|7|||
164206526|NCT00560404|593125014|FG000|Overall Study|Administrative Reasons|1|||
164206527|NCT00560404|593125015|FG001|Overall Study|Administrative Reasons|1|||
164206528|NCT00560404|593125014|FG000|Overall Study|Withdrew Consent|4|||
164206529|NCT00560404|593125015|FG001|Overall Study|Withdrew Consent|0|||
164206530|NCT00560404|593125014|FG000|Overall Study|Failure to return|1|||
164206531|NCT00560404|593125015|FG001|Overall Study|Failure to return|2|||
164206532|NCT00560404|593125014|FG000|Overall Study|Other withdrawal reason|13|||
164206533|NCT00560404|593125015|FG001|Overall Study|Other withdrawal reason|5|||
164206534|NCT02642042|593125022|FG000|Overall Study|Adverse Event|22|||
164206535|NCT02642042|593125022|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164206536|NCT02642042|593125022|FG000|Overall Study|Progression/Relapse|28|||
164206537|NCT02642042|593125022|FG000|Overall Study|Death|1|||
164206538|NCT02642042|593125022|FG000|Overall Study|Not Protocol Specified|2|||
164206539|NCT04108468|593125023|FG000|Overall Study|Physician Decision|0|||
164206540|NCT04108468|593125024|FG001|Overall Study|Physician Decision|1|||
164206541|NCT04108468|593125023|FG000|Overall Study|Lost to Follow-up|0|||
164206542|NCT04108468|593125024|FG001|Overall Study|Lost to Follow-up|1|||
164206543|NCT04108468|593125023|FG000|Overall Study|Non-compliance|1|||
164206544|NCT04108468|593125024|FG001|Overall Study|Non-compliance|1|||
164206545|NCT04108468|593125023|FG000|Overall Study|Unable to attend final visit|2|||
164206546|NCT04108468|593125024|FG001|Overall Study|Unable to attend final visit|0|||
164206547|NCT04108468|593125023|FG000|Overall Study|Missed study medication|0|||
164206548|NCT04108468|593125024|FG001|Overall Study|Missed study medication|1|||
163873943|NCT02590432|591906933|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873944|NCT02590432|591906934|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873945|NCT02590432|591906935|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873946|NCT02590432|591906936|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873947|NCT02590432|591906937|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873948|NCT02590432|591906938|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873949|NCT02590432|591906939|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
163873950|NCT02590432|591906931|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
163873951|NCT02590432|591906932|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
164206549|NCT03260023|593125025|FG000|Overall Study|Adverse Event|0|||
164206550|NCT03260023|593125026|FG001|Overall Study|Adverse Event|0|||
164206551|NCT03260023|593125027|FG002|Overall Study|Adverse Event|4|||
164206552|NCT03260023|593125028|FG003|Overall Study|Adverse Event|4|||
164206553|NCT03260023|593125029|FG004|Overall Study|Adverse Event|4|||
164206554|NCT03260023|593125030|FG005|Overall Study|Adverse Event|1|||
164206555|NCT03260023|593125031|FG006|Overall Study|Adverse Event|2|||
164206556|NCT03260023|593125025|FG000|Overall Study|Clinical Progression|0|||
164206557|NCT03260023|593125026|FG001|Overall Study|Clinical Progression|1|||
164206558|NCT03260023|593125027|FG002|Overall Study|Clinical Progression|3|||
164206559|NCT03260023|593125028|FG003|Overall Study|Clinical Progression|1|||
164206560|NCT03260023|593125029|FG004|Overall Study|Clinical Progression|0|||
164206561|NCT03260023|593125030|FG005|Overall Study|Clinical Progression|0|||
164206562|NCT03260023|593125031|FG006|Overall Study|Clinical Progression|0|||
164206563|NCT03260023|593125025|FG000|Overall Study|Physician Decision|0|||
164206564|NCT03260023|593125026|FG001|Overall Study|Physician Decision|0|||
164206565|NCT03260023|593125027|FG002|Overall Study|Physician Decision|0|||
164206566|NCT03260023|593125028|FG003|Overall Study|Physician Decision|1|||
164206567|NCT03260023|593125029|FG004|Overall Study|Physician Decision|1|||
163978339|NCT00652366|592291922|FG000|Overall Study|Violation of Selection Criteria|0|||
163978340|NCT00652366|592291923|FG001|Overall Study|Violation of Selection Criteria|0|||
163978341|NCT00652366|592291924|FG002|Overall Study|Violation of Selection Criteria|1|||
163978342|NCT00652366|592291925|FG003|Overall Study|Violation of Selection Criteria|0|||
163978343|NCT00652366|592291926|FG004|Overall Study|Violation of Selection Criteria|0|||
164206568|NCT03260023|593125030|FG005|Overall Study|Physician Decision|0|||
164206569|NCT03260023|593125031|FG006|Overall Study|Physician Decision|0|||
164206570|NCT03260023|593125025|FG000|Overall Study|Withdrawal by Subject|0|||
164206571|NCT03260023|593125026|FG001|Overall Study|Withdrawal by Subject|0|||
164206572|NCT03260023|593125027|FG002|Overall Study|Withdrawal by Subject|0|||
164206573|NCT03260023|593125028|FG003|Overall Study|Withdrawal by Subject|0|||
164206574|NCT03260023|593125029|FG004|Overall Study|Withdrawal by Subject|3|||
164206575|NCT03260023|593125030|FG005|Overall Study|Withdrawal by Subject|0|||
164206576|NCT03260023|593125031|FG006|Overall Study|Withdrawal by Subject|0|||
164206577|NCT03260023|593125025|FG000|Overall Study|Under trial intervention|0|||
164206578|NCT03260023|593125026|FG001|Overall Study|Under trial intervention|0|||
164206579|NCT03260023|593125027|FG002|Overall Study|Under trial intervention|2|||
164206580|NCT03260023|593125028|FG003|Overall Study|Under trial intervention|5|||
164206581|NCT03260023|593125029|FG004|Overall Study|Under trial intervention|3|||
164206582|NCT03260023|593125030|FG005|Overall Study|Under trial intervention|0|||
164206583|NCT03260023|593125031|FG006|Overall Study|Under trial intervention|0|||
164206584|NCT05035407|593125034|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
164206585|NCT05035407|593125035|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206586|NCT05035407|593125036|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206587|NCT05035407|593125037|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206588|NCT05035407|593125038|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206589|NCT05035407|593125039|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
164206590|NCT04513366|593125040|FG000|Treatment Phase|Withdrawal by Subject|6|||
164206591|NCT04513366|593125041|FG001|Treatment Phase|Withdrawal by Subject|8|||
164206592|NCT04513366|593125042|FG002|Treatment Phase|Withdrawal by Subject|3|||
164206593|NCT04513366|593125040|FG000|Treatment Phase|Lost to Follow-up|1|||
164206594|NCT04513366|593125041|FG001|Treatment Phase|Lost to Follow-up|2|||
164206595|NCT04513366|593125042|FG002|Treatment Phase|Lost to Follow-up|5|||
164206596|NCT04513366|593125040|FG000|Treatment Phase|Other than Specified|1|||
164206597|NCT04513366|593125041|FG001|Treatment Phase|Other than Specified|0|||
164206598|NCT04513366|593125042|FG002|Treatment Phase|Other than Specified|2|||
164206599|NCT04513366|593125040|FG000|Treatment Phase|Physician Decision|2|||
164206600|NCT04513366|593125041|FG001|Treatment Phase|Physician Decision|0|||
164206601|NCT04513366|593125042|FG002|Treatment Phase|Physician Decision|0|||
164206602|NCT04513366|593125040|FG000|Treatment Phase|Adverse Event|0|||
164206603|NCT04513366|593125041|FG001|Treatment Phase|Adverse Event|1|||
164206604|NCT04513366|593125042|FG002|Treatment Phase|Adverse Event|1|||
164206605|NCT04513366|593125040|FG000|Extension Phase|Withdrawal by Subject|3|||
164206606|NCT04513366|593125041|FG001|Extension Phase|Withdrawal by Subject|1|||
164206607|NCT04513366|593125042|FG002|Extension Phase|Withdrawal by Subject|1|||
164206608|NCT04513366|593125040|FG000|Extension Phase|Other than Specified|4|||
164206609|NCT04513366|593125041|FG001|Extension Phase|Other than Specified|0|||
164206610|NCT04513366|593125042|FG002|Extension Phase|Other than Specified|1|||
164206611|NCT04513366|593125040|FG000|Extension Phase|Lost to Follow-up|1|||
164206612|NCT04513366|593125041|FG001|Extension Phase|Lost to Follow-up|1|||
164206613|NCT04513366|593125042|FG002|Extension Phase|Lost to Follow-up|1|||
164206614|NCT04513366|593125040|FG000|Extension Phase|Sponsor Decision|0|||
164206615|NCT04513366|593125041|FG001|Extension Phase|Sponsor Decision|1|||
164206616|NCT04513366|593125042|FG002|Extension Phase|Sponsor Decision|0|||
164206617|NCT04513366|593125040|FG000|Extension Phase|Death|0|||
164206618|NCT04513366|593125041|FG001|Extension Phase|Death|1|||
164206619|NCT04513366|593125042|FG002|Extension Phase|Death|0|||
164206620|NCT04513366|593125040|FG000|Extension Phase|Adverse Event|0|||
164206621|NCT04513366|593125041|FG001|Extension Phase|Adverse Event|0|||
164206622|NCT04513366|593125042|FG002|Extension Phase|Adverse Event|1|||
164206623|NCT06121609|593125044|FG000|Overall Study|Lack of Efficacy|0|||
163978344|NCT00652366|592291922|FG000|Overall Study|Protocol Violation|1|||
164206624|NCT06121609|593125045|FG001|Overall Study|Lack of Efficacy|0|||
164206625|NCT06121609|593125046|FG002|Overall Study|Lack of Efficacy|45|||
164206626|NCT03344757|593125047|FG000|Overall Study|Withdrawal by Subject|18|||
164319214|NCT01328444|593544641|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
163873952|NCT02590432|591906933|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873953|NCT02590432|591906934|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873954|NCT02590432|591906935|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873955|NCT02590432|591906936|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873956|NCT02590432|591906937|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873957|NCT02590432|591906938|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873958|NCT02590432|591906939|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
163873959|NCT02590432|591906931|FG000|Double-blind Treatment Period|Adverse Event|0|||
163873960|NCT02590432|591906932|FG001|Double-blind Treatment Period|Adverse Event|0|||
163873961|NCT02590432|591906933|FG002|Double-blind Treatment Period|Adverse Event|14|||
163873962|NCT02590432|591906934|FG003|Double-blind Treatment Period|Adverse Event|12|||
163873963|NCT02590432|591906935|FG004|Double-blind Treatment Period|Adverse Event|6|||
163873964|NCT02590432|591906936|FG005|Double-blind Treatment Period|Adverse Event|22|||
163873965|NCT02590432|591906937|FG006|Double-blind Treatment Period|Adverse Event|20|||
163873966|NCT02590432|591906938|FG007|Double-blind Treatment Period|Adverse Event|0|||
163873967|NCT02590432|591906939|FG008|Double-blind Treatment Period|Adverse Event|0|||
163873968|NCT02590432|591906931|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
163873969|NCT02590432|591906932|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
163873970|NCT02590432|591906933|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
163873971|NCT02590432|591906934|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
163873972|NCT02590432|591906935|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
163873973|NCT02590432|591906936|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
163873974|NCT02590432|591906937|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
163873975|NCT02590432|591906938|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
163873976|NCT02590432|591906939|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
163873977|NCT02590432|591906931|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
163873978|NCT02590432|591906932|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
163873979|NCT02590432|591906933|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
163873980|NCT02590432|591906934|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
163873981|NCT02590432|591906935|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
163873982|NCT02590432|591906936|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
163873983|NCT02590432|591906937|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
163873984|NCT02590432|591906938|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
163873985|NCT02590432|591906939|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
163873986|NCT02590432|591906931|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
163873987|NCT02590432|591906932|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163873988|NCT02590432|591906933|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
163873989|NCT02590432|591906934|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163873990|NCT02590432|591906935|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
163873991|NCT02590432|591906936|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
163873992|NCT02590432|591906937|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
163873993|NCT02590432|591906938|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
163873994|NCT02590432|591906939|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
163873995|NCT02590432|591906931|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163873996|NCT02590432|591906932|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163873997|NCT02590432|591906933|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163873998|NCT02590432|591906934|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163873999|NCT02590432|591906935|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163874000|NCT02590432|591906936|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
163874001|NCT02590432|591906937|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163978345|NCT00652366|592291923|FG001|Overall Study|Protocol Violation|0|||
164319215|NCT01328444|593544642|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319216|NCT01328444|593544643|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319217|NCT01328444|593544644|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319218|NCT01328444|593544645|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
164319219|NCT01328444|593544646|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
164319220|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
164319221|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164319222|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164319223|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164319224|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
164319225|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164319226|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
164319227|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164319228|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164319229|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
164319230|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
164206627|NCT03344757|593125048|FG001|Overall Study|Withdrawal by Subject|16|||
164206628|NCT03344757|593125047|FG000|Overall Study|Lost to Follow-up|0|||
164206629|NCT03344757|593125048|FG001|Overall Study|Lost to Follow-up|2|||
164206630|NCT00269152|593125049|FG000|Overall Study|Adverse Event|9|||
164206631|NCT00269152|593125050|FG001|Overall Study|Adverse Event|3|||
164206632|NCT00269152|593125049|FG000|Overall Study|Withdrawal by Subject|7|||
164206633|NCT00269152|593125050|FG001|Overall Study|Withdrawal by Subject|3|||
164319231|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
164319232|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
164319233|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319234|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319235|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319236|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
164319237|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
164319238|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164319239|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164319240|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164319241|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
164319242|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
164319243|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
164206634|NCT00269152|593125049|FG000|Overall Study|Physician Decision|2|||
164206635|NCT00269152|593125050|FG001|Overall Study|Physician Decision|3|||
164206636|NCT00269152|593125049|FG000|Overall Study|Protocol Violation|0|||
164206637|NCT00269152|593125050|FG001|Overall Study|Protocol Violation|1|||
164206638|NCT00848497|593125051|FG000|Overall Study|Screen failure|2|||
164206639|NCT00848497|593125052|FG001|Overall Study|Screen failure|0|||
164206640|NCT00848497|593125051|FG000|Overall Study|Withdrawal by Subject|0|||
164206641|NCT00848497|593125052|FG001|Overall Study|Withdrawal by Subject|1|||
164206642|NCT01832766|593125053|FG000|Washout|Lost to Follow-up|0|||
164206643|NCT01832766|593125054|FG001|Washout|Lost to Follow-up|1|||
164206644|NCT03054428|593125057|FG000|Overall Study|Physician Decision|0|||
164206645|NCT03054428|593125058|FG001|Overall Study|Physician Decision|1|||
164206646|NCT03054428|593125059|FG002|Overall Study|Physician Decision|1|||
164206647|NCT03054428|593125057|FG000|Overall Study|Lack of Efficacy|3|||
164206648|NCT03054428|593125058|FG001|Overall Study|Lack of Efficacy|1|||
164206649|NCT03054428|593125059|FG002|Overall Study|Lack of Efficacy|0|||
164206650|NCT03054428|593125057|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
164206651|NCT03054428|593125058|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
164206652|NCT03054428|593125059|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
164206653|NCT03054428|593125057|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
164206654|NCT03054428|593125058|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
164319244|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
164319245|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
163874002|NCT02590432|591906938|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163874003|NCT02590432|591906939|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
163874004|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874005|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874006|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874007|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874008|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874009|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874010|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
163874011|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
163874012|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
163874013|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874014|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874015|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874016|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874017|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874018|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874019|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
164206655|NCT03054428|593125059|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
164206656|NCT03054428|593125057|FG000|Overall Study|Transitioned to OLE study|76|||
164206657|NCT03054428|593125058|FG001|Overall Study|Transitioned to OLE study|76|||
164206658|NCT03054428|593125059|FG002|Overall Study|Transitioned to OLE study|73|||
164206659|NCT03054428|593125057|FG000|Overall Study|Withdrawal by Subject|3|||
163874020|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
163874021|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
163874022|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
164206660|NCT03054428|593125058|FG001|Overall Study|Withdrawal by Subject|2|||
163874023|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163874024|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163874025|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163874026|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163874027|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163874028|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
163874029|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
163874030|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
163874031|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163978346|NCT00652366|592291924|FG002|Overall Study|Protocol Violation|0|||
163978347|NCT00652366|592291925|FG003|Overall Study|Protocol Violation|0|||
163978348|NCT00652366|592291926|FG004|Overall Study|Protocol Violation|0|||
163978349|NCT00652366|592291922|FG000|Overall Study|Refused treatment|3|||
163978350|NCT00652366|592291923|FG001|Overall Study|Refused treatment|7|||
163978351|NCT00652366|592291924|FG002|Overall Study|Refused treatment|6|||
163978352|NCT00652366|592291925|FG003|Overall Study|Refused treatment|17|||
163978353|NCT00652366|592291926|FG004|Overall Study|Refused treatment|5|||
163978354|NCT00652366|592291922|FG000|Overall Study|Other|5|||
163978355|NCT00652366|592291923|FG001|Overall Study|Other|2|||
163978356|NCT00652366|592291924|FG002|Overall Study|Other|3|||
163978357|NCT00652366|592291925|FG003|Overall Study|Other|4|||
163978358|NCT00652366|592291926|FG004|Overall Study|Other|0|||
163978359|NCT03873714|592291927|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
164206661|NCT03054428|593125059|FG002|Overall Study|Withdrawal by Subject|3|||
164206662|NCT03054428|593125057|FG000|Overall Study|Lost to Follow-up|0|||
164206663|NCT03054428|593125058|FG001|Overall Study|Lost to Follow-up|0|||
164206664|NCT03054428|593125059|FG002|Overall Study|Lost to Follow-up|1|||
164206665|NCT03225287|593125062|FG000|Overall Study|Adverse Event|0|||
164206666|NCT03225287|593125063|FG001|Overall Study|Adverse Event|0|||
164206667|NCT03225287|593125064|FG002|Overall Study|Adverse Event|1|||
164206668|NCT03225287|593125062|FG000|Overall Study|Protocol non-compliance|0|||
164206669|NCT03225287|593125063|FG001|Overall Study|Protocol non-compliance|0|||
164206670|NCT03225287|593125064|FG002|Overall Study|Protocol non-compliance|1|||
164206671|NCT03225287|593125062|FG000|Overall Study|Subject withdraws consent|3|||
164206672|NCT03225287|593125063|FG001|Overall Study|Subject withdraws consent|0|||
164206673|NCT03225287|593125064|FG002|Overall Study|Subject withdraws consent|0|||
164206674|NCT03225287|593125062|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
164206675|NCT03225287|593125063|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
164206676|NCT03225287|593125064|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
164206677|NCT03225287|593125062|FG000|Overall Study|Trial drug not effective|0|||
164206678|NCT03225287|593125063|FG001|Overall Study|Trial drug not effective|1|||
164206679|NCT03225287|593125064|FG002|Overall Study|Trial drug not effective|0|||
164206680|NCT03225287|593125062|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
164206681|NCT03225287|593125063|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
164206682|NCT03225287|593125064|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
164206683|NCT03225287|593125062|FG000|Overall Study|Stem cell transplantation|0|||
164206684|NCT03225287|593125063|FG001|Overall Study|Stem cell transplantation|1|||
164206685|NCT03225287|593125064|FG002|Overall Study|Stem cell transplantation|0|||
164206686|NCT06070610|593125066|FG000|Washout period|Adverse Event|1|||
164206687|NCT06070610|593125066|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
164206688|NCT01499810|593125067|FG000|Overall Study|Lost to Follow-up|10|||
164206689|NCT01499810|593125067|FG000|Overall Study|Protocol Violation|1|||
164206690|NCT01499810|593125067|FG000|Overall Study|Withdrawal by Subject|1|||
164206691|NCT03836053|593126506|FG000|Overall Study|Protocol-specified criteria|0|||
164206692|NCT03836053|593126507|FG001|Overall Study|Protocol-specified criteria|2|||
164206693|NCT03836053|593126508|FG002|Overall Study|Protocol-specified criteria|1|||
164206694|NCT03836053|593126506|FG000|Overall Study|Death|1|||
164206695|NCT03836053|593126507|FG001|Overall Study|Death|6|||
164206696|NCT03836053|593126508|FG002|Overall Study|Death|4|||
164206697|NCT03836053|593126506|FG000|Overall Study|Withdrawal of consent from study|0|||
164206698|NCT03836053|593126507|FG001|Overall Study|Withdrawal of consent from study|0|||
164206699|NCT03836053|593126508|FG002|Overall Study|Withdrawal of consent from study|1|||
164206700|NCT03836053|593126506|FG000|Overall Study|Decision by sponsor|0|||
164206701|NCT03836053|593126507|FG001|Overall Study|Decision by sponsor|2|||
164206702|NCT03836053|593126508|FG002|Overall Study|Decision by sponsor|4|||
164206703|NCT03846479|593126509|FG000|Overall Study|Death|8|||
164206704|NCT03846479|593126509|FG000|Overall Study|Lost to Follow-up|1|||
164206705|NCT02332707|593126510|FG000|Overall Study|Adverse Event|0|||
164206706|NCT02332707|593126511|FG001|Overall Study|Adverse Event|0|||
163978360|NCT01970501|592291928|FG000|Overall Study|Discontinuation of study by sponsor|16|||
163978361|NCT01970501|592291929|FG001|Overall Study|Discontinuation of study by sponsor|14|||
163978362|NCT01970501|592291928|FG000|Overall Study|Withdrawal by Subject|6|||
164206707|NCT02332707|593126512|FG002|Overall Study|Adverse Event|0|||
164206708|NCT02332707|593126513|FG003|Overall Study|Adverse Event|0|||
163978363|NCT01970501|592291929|FG001|Overall Study|Withdrawal by Subject|7|||
164206709|NCT02332707|593126514|FG004|Overall Study|Adverse Event|0|||
164206710|NCT02332707|593126515|FG005|Overall Study|Adverse Event|0|||
164206711|NCT02332707|593126516|FG006|Overall Study|Adverse Event|0|||
164206712|NCT02332707|593126517|FG007|Overall Study|Adverse Event|0|||
164206713|NCT02332707|593126518|FG008|Overall Study|Adverse Event|0|||
164206714|NCT02332707|593126519|FG009|Overall Study|Adverse Event|0|||
164206715|NCT02332707|593126520|FG010|Overall Study|Adverse Event|0|||
164206716|NCT02332707|593126521|FG011|Overall Study|Adverse Event|0|||
164206717|NCT02332707|593126522|FG012|Overall Study|Adverse Event|1|||
164206718|NCT02332707|593126523|FG013|Overall Study|Adverse Event|0|||
164206719|NCT02332707|593126524|FG014|Overall Study|Adverse Event|0|||
164206720|NCT02332707|593126525|FG015|Overall Study|Adverse Event|0|||
164206721|NCT02332707|593126526|FG016|Overall Study|Adverse Event|0|||
164206722|NCT02332707|593126527|FG017|Overall Study|Adverse Event|0|||
164206723|NCT02332707|593126510|FG000|Overall Study|Lost to Follow-up|0|||
164206724|NCT02332707|593126511|FG001|Overall Study|Lost to Follow-up|0|||
164206725|NCT02332707|593126512|FG002|Overall Study|Lost to Follow-up|0|||
164206726|NCT02332707|593126513|FG003|Overall Study|Lost to Follow-up|0|||
164206727|NCT02332707|593126514|FG004|Overall Study|Lost to Follow-up|0|||
164206728|NCT02332707|593126515|FG005|Overall Study|Lost to Follow-up|1|||
164206729|NCT02332707|593126516|FG006|Overall Study|Lost to Follow-up|0|||
164206730|NCT02332707|593126517|FG007|Overall Study|Lost to Follow-up|0|||
164319246|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164319247|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164319248|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
164319249|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
164319250|NCT01328444|593544641|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319251|NCT01328444|593544642|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319252|NCT01328444|593544643|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319253|NCT01328444|593544644|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164319254|NCT01328444|593544645|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164319255|NCT01328444|593544646|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164319256|NCT03316911|593544647|FG000|Overall Study|Lost to Follow-up|33|||
164319257|NCT03316911|593544648|FG001|Overall Study|Lost to Follow-up|29|||
164319258|NCT01270802|593544649|FG000|Overall Study|Withdrawal by Subject|1|||
164319259|NCT01270802|593544650|FG001|Overall Study|Withdrawal by Subject|0|||
164206731|NCT02332707|593126518|FG008|Overall Study|Lost to Follow-up|0|||
164206732|NCT02332707|593126519|FG009|Overall Study|Lost to Follow-up|0|||
164206733|NCT02332707|593126520|FG010|Overall Study|Lost to Follow-up|2|||
164206734|NCT02332707|593126521|FG011|Overall Study|Lost to Follow-up|0|||
164206735|NCT02332707|593126522|FG012|Overall Study|Lost to Follow-up|3|||
164206736|NCT02332707|593126523|FG013|Overall Study|Lost to Follow-up|0|||
164206737|NCT02332707|593126524|FG014|Overall Study|Lost to Follow-up|0|||
164206738|NCT02332707|593126525|FG015|Overall Study|Lost to Follow-up|0|||
164206739|NCT02332707|593126526|FG016|Overall Study|Lost to Follow-up|0|||
164206740|NCT02332707|593126527|FG017|Overall Study|Lost to Follow-up|0|||
164206741|NCT02332707|593126510|FG000|Overall Study|Physician Decision|0|||
164206742|NCT02332707|593126511|FG001|Overall Study|Physician Decision|0|||
164206743|NCT02332707|593126512|FG002|Overall Study|Physician Decision|0|||
164206744|NCT02332707|593126513|FG003|Overall Study|Physician Decision|1|||
164206745|NCT02332707|593126514|FG004|Overall Study|Physician Decision|0|||
164206746|NCT02332707|593126515|FG005|Overall Study|Physician Decision|0|||
164206747|NCT02332707|593126516|FG006|Overall Study|Physician Decision|0|||
164206748|NCT02332707|593126517|FG007|Overall Study|Physician Decision|0|||
164206749|NCT02332707|593126518|FG008|Overall Study|Physician Decision|0|||
164319260|NCT01270802|593544649|FG000|Overall Study|Adverse Event|1|||
164319261|NCT01270802|593544650|FG001|Overall Study|Adverse Event|0|||
164319262|NCT01270802|593544649|FG000|Overall Study|Lost to Follow-up|0|||
164206750|NCT02332707|593126519|FG009|Overall Study|Physician Decision|0|||
164206751|NCT02332707|593126520|FG010|Overall Study|Physician Decision|0|||
164206752|NCT02332707|593126521|FG011|Overall Study|Physician Decision|0|||
164206753|NCT02332707|593126522|FG012|Overall Study|Physician Decision|1|||
164206754|NCT02332707|593126523|FG013|Overall Study|Physician Decision|0|||
164206755|NCT02332707|593126524|FG014|Overall Study|Physician Decision|0|||
164319263|NCT01270802|593544650|FG001|Overall Study|Lost to Follow-up|1|||
164319264|NCT04620798|593544653|FG000|Overall Study|Lost to Follow-up|126|||
164319265|NCT04620798|593544654|FG001|Overall Study|Lost to Follow-up|138|||
164319266|NCT03222492|593544660|FG000|Overall Study|Withdrawal by Subject|0|||
164319267|NCT03222492|593544661|FG001|Overall Study|Withdrawal by Subject|0|||
164319268|NCT03222492|593544662|FG002|Overall Study|Withdrawal by Subject|1|||
164206756|NCT02332707|593126525|FG015|Overall Study|Physician Decision|0|||
164206757|NCT02332707|593126526|FG016|Overall Study|Physician Decision|0|||
164206758|NCT02332707|593126527|FG017|Overall Study|Physician Decision|0|||
164206759|NCT02332707|593126510|FG000|Overall Study|Withdrawal by Subject|0|||
164206760|NCT02332707|593126511|FG001|Overall Study|Withdrawal by Subject|0|||
164206761|NCT02332707|593126512|FG002|Overall Study|Withdrawal by Subject|1|||
164206762|NCT02332707|593126513|FG003|Overall Study|Withdrawal by Subject|0|||
164206763|NCT02332707|593126514|FG004|Overall Study|Withdrawal by Subject|0|||
163978364|NCT01970501|592291928|FG000|Overall Study|Adverse Event|2|||
163978365|NCT01970501|592291929|FG001|Overall Study|Adverse Event|4|||
163978366|NCT01970501|592291928|FG000|Overall Study|Death|1|||
163874032|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163978367|NCT01970501|592291929|FG001|Overall Study|Death|3|||
163978368|NCT01970501|592291928|FG000|Overall Study|Physician Decision|2|||
163978369|NCT01970501|592291929|FG001|Overall Study|Physician Decision|0|||
163978370|NCT00708123|592291930|FG000|Period 1|Protocol Violation|0|||
163978371|NCT00708123|592291931|FG001|Period 1|Protocol Violation|1|||
163978372|NCT00708123|592291932|FG002|Period 1|Protocol Violation|0|||
163874033|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163874034|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163874035|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163874036|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163874037|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163874038|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
163874039|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
163978373|NCT00708123|592291933|FG003|Period 1|Protocol Violation|1|||
163978374|NCT00708123|592291934|FG004|Period 1|Protocol Violation|0|||
163978375|NCT00708123|592291930|FG000|Period 1|Adverse Event|0|||
164206764|NCT02332707|593126515|FG005|Overall Study|Withdrawal by Subject|0|||
163874040|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874041|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874042|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874043|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874044|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874045|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874046|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874047|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
163874048|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
163874049|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874050|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874051|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874052|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874053|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874054|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874055|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874056|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
163874057|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
163874058|NCT02590432|591906931|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874059|NCT02590432|591906932|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874060|NCT02590432|591906933|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874061|NCT02590432|591906934|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874062|NCT02590432|591906935|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874063|NCT02590432|591906936|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874064|NCT02590432|591906937|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874065|NCT02590432|591906938|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
163874066|NCT02590432|591906939|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
163874067|NCT04788641|591906941|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
163874068|NCT04788641|591906942|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
163874069|NCT04788641|591906943|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
163874070|NCT04788641|591906944|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
163874071|NCT04788641|591906941|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
163874072|NCT04788641|591906942|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
163978376|NCT00708123|592291931|FG001|Period 1|Adverse Event|0|||
163978377|NCT00708123|592291932|FG002|Period 1|Adverse Event|1|||
163978378|NCT00708123|592291933|FG003|Period 1|Adverse Event|0|||
163978379|NCT00708123|592291934|FG004|Period 1|Adverse Event|0|||
164206765|NCT02332707|593126516|FG006|Overall Study|Withdrawal by Subject|0|||
164206766|NCT02332707|593126517|FG007|Overall Study|Withdrawal by Subject|0|||
164206767|NCT02332707|593126518|FG008|Overall Study|Withdrawal by Subject|0|||
164206768|NCT02332707|593126519|FG009|Overall Study|Withdrawal by Subject|3|||
164206769|NCT02332707|593126520|FG010|Overall Study|Withdrawal by Subject|0|||
164206770|NCT02332707|593126521|FG011|Overall Study|Withdrawal by Subject|0|||
164206771|NCT02332707|593126522|FG012|Overall Study|Withdrawal by Subject|0|||
164319269|NCT03222492|593544663|FG003|Overall Study|Withdrawal by Subject|0|||
164319270|NCT03222492|593544660|FG000|Overall Study|COVID-19 related|0|||
164319271|NCT03222492|593544661|FG001|Overall Study|COVID-19 related|0|||
164319272|NCT03222492|593544662|FG002|Overall Study|COVID-19 related|1|||
164319273|NCT03222492|593544663|FG003|Overall Study|COVID-19 related|0|||
164319274|NCT02486627|593544667|FG000|Overall Study|Death|1|||
164319275|NCT02486627|593544668|FG001|Overall Study|Death|0|||
164319276|NCT02486627|593544667|FG000|Overall Study|Other Unspecified|0|||
164319277|NCT02486627|593544668|FG001|Overall Study|Other Unspecified|2|||
164319278|NCT02486627|593544667|FG000|Overall Study|Consent Withdrawn by Participant|4|||
164319279|NCT02486627|593544668|FG001|Overall Study|Consent Withdrawn by Participant|3|||
164319280|NCT02486627|593544667|FG000|Overall Study|Significant Participant Noncompliance|1|||
164319281|NCT02486627|593544668|FG001|Overall Study|Significant Participant Noncompliance|1|||
164319282|NCT02486627|593544667|FG000|Overall Study|Lost to Follow-up|1|||
164319283|NCT02486627|593544668|FG001|Overall Study|Lost to Follow-up|3|||
164319284|NCT05395091|593544670|FG000|Baseline to Month 12|Adverse Event|7|||
164319285|NCT05395091|593544671|FG001|Baseline to Month 12|Adverse Event|2|||
164319286|NCT05395091|593544672|FG002|Baseline to Month 12|Adverse Event|0|||
164319287|NCT05395091|593544670|FG000|Baseline to Month 12|Death|3|||
164319288|NCT05395091|593544671|FG001|Baseline to Month 12|Death|1|||
164319289|NCT05395091|593544672|FG002|Baseline to Month 12|Death|0|||
164319290|NCT05395091|593544670|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
164319291|NCT05395091|593544671|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
164319292|NCT05395091|593544672|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
164319293|NCT05395091|593544670|FG000|Baseline to Month 12|Protocol Violation|2|||
164319294|NCT05395091|593544671|FG001|Baseline to Month 12|Protocol Violation|3|||
164319295|NCT05395091|593544672|FG002|Baseline to Month 12|Protocol Violation|0|||
164319296|NCT05395091|593544670|FG000|Baseline to Month 12|Physician Decision|1|||
164319297|NCT05395091|593544671|FG001|Baseline to Month 12|Physician Decision|0|||
164319298|NCT05395091|593544672|FG002|Baseline to Month 12|Physician Decision|0|||
164319299|NCT05395091|593544670|FG000|Month 12 to Month 18|Death|1|||
164319300|NCT05395091|593544671|FG001|Month 12 to Month 18|Death|0|||
164319301|NCT05395091|593544672|FG002|Month 12 to Month 18|Death|0|||
164319302|NCT05395091|593544670|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
164319303|NCT05395091|593544671|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
164319304|NCT05395091|593544672|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
164319305|NCT05395091|593544670|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
164319306|NCT05395091|593544671|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
164319307|NCT05395091|593544672|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
164319308|NCT05395091|593544670|FG000|Month 12 to Month 18|Other reasons|0|||
164319309|NCT05395091|593544671|FG001|Month 12 to Month 18|Other reasons|0|||
164319310|NCT05395091|593544672|FG002|Month 12 to Month 18|Other reasons|1|||
164319311|NCT00832624|593544677|FG000|Overall Study|Study Terminated|10|||
164319312|NCT00548184|593544678|FG000|Overall Study|Adverse Event|3|||
164319313|NCT00548184|593544678|FG000|Overall Study|took other drug|1|||
164319314|NCT00548184|593544678|FG000|Overall Study|Found Her2 negative|1|||
164319315|NCT00796523|593544681|FG000|Overall Study|Lost to Follow-up|9|||
164319316|NCT00796523|593544682|FG001|Overall Study|Lost to Follow-up|7|||
164319317|NCT02431260|593544686|FG000|Overall Study|Subject Decision|0|||
164319318|NCT02431260|593544687|FG001|Overall Study|Subject Decision|1|||
164319319|NCT02431260|593544688|FG002|Overall Study|Subject Decision|1|||
164319320|NCT02431260|593544689|FG003|Overall Study|Subject Decision|0|||
164319321|NCT02431260|593544690|FG004|Overall Study|Subject Decision|0|||
164319322|NCT02431260|593544691|FG005|Overall Study|Subject Decision|0|||
164319323|NCT02431260|593544692|FG006|Overall Study|Subject Decision|0|||
164319324|NCT02431260|593544693|FG007|Overall Study|Subject Decision|0|||
164319325|NCT02431260|593544694|FG008|Overall Study|Subject Decision|1|||
164319326|NCT02431260|593544695|FG009|Overall Study|Subject Decision|1|||
164319327|NCT02431260|593544696|FG010|Overall Study|Subject Decision|0|||
164319328|NCT02431260|593544697|FG011|Overall Study|Subject Decision|1|||
164319329|NCT02431260|593544698|FG012|Overall Study|Subject Decision|0|||
164319330|NCT02431260|593544699|FG013|Overall Study|Subject Decision|0|||
164319331|NCT02431260|593544686|FG000|Overall Study|Death|4|||
164319332|NCT02431260|593544687|FG001|Overall Study|Death|4|||
164319333|NCT02431260|593544688|FG002|Overall Study|Death|3|||
164319334|NCT02431260|593544689|FG003|Overall Study|Death|4|||
164319335|NCT02431260|593544690|FG004|Overall Study|Death|2|||
164319336|NCT02431260|593544691|FG005|Overall Study|Death|2|||
164319337|NCT02431260|593544692|FG006|Overall Study|Death|3|||
164319338|NCT02431260|593544693|FG007|Overall Study|Death|1|||
164319339|NCT02431260|593544694|FG008|Overall Study|Death|6|||
163978380|NCT00708123|592291930|FG000|Period 2|Protocol Violation|0|||
164319340|NCT02431260|593544695|FG009|Overall Study|Death|6|||
164319341|NCT02431260|593544696|FG010|Overall Study|Death|3|||
164319342|NCT02431260|593544697|FG011|Overall Study|Death|2|||
164319343|NCT02431260|593544698|FG012|Overall Study|Death|5|||
164319344|NCT02431260|593544699|FG013|Overall Study|Death|1|||
164319345|NCT02431260|593544686|FG000|Overall Study|Lost to Follow-up|0|||
164319346|NCT02431260|593544687|FG001|Overall Study|Lost to Follow-up|0|||
164319347|NCT02431260|593544688|FG002|Overall Study|Lost to Follow-up|0|||
164319348|NCT02431260|593544689|FG003|Overall Study|Lost to Follow-up|0|||
164319349|NCT02431260|593544690|FG004|Overall Study|Lost to Follow-up|0|||
164206772|NCT02332707|593126523|FG013|Overall Study|Withdrawal by Subject|0|||
164206773|NCT02332707|593126524|FG014|Overall Study|Withdrawal by Subject|0|||
164206774|NCT02332707|593126525|FG015|Overall Study|Withdrawal by Subject|0|||
164206775|NCT02332707|593126526|FG016|Overall Study|Withdrawal by Subject|0|||
164206776|NCT02332707|593126527|FG017|Overall Study|Withdrawal by Subject|0|||
164206777|NCT01473134|593126528|FG000|Overall Study|Lost to Follow-up|21|||
164206778|NCT01473134|593126529|FG001|Overall Study|Lost to Follow-up|13|||
164206779|NCT01473134|593126528|FG000|Overall Study|Protocol Violation|32|||
164206780|NCT01473134|593126529|FG001|Overall Study|Protocol Violation|19|||
164206781|NCT01473134|593126528|FG000|Overall Study|Withdrawal by Subject|1|||
164206782|NCT01473134|593126529|FG001|Overall Study|Withdrawal by Subject|2|||
164206783|NCT01473134|593126528|FG000|Overall Study|Death|0|||
164206784|NCT01473134|593126529|FG001|Overall Study|Death|1|||
164206785|NCT01473134|593126528|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
164206786|NCT01473134|593126529|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
164206787|NCT00375752|593126532|FG000|Overall Study|Lack of Efficacy|4|||
164206788|NCT00375752|593126533|FG001|Overall Study|Lack of Efficacy|4|||
164319350|NCT02431260|593544691|FG005|Overall Study|Lost to Follow-up|1|||
163978381|NCT00708123|592291931|FG001|Period 2|Protocol Violation|0|||
163978382|NCT00708123|592291932|FG002|Period 2|Protocol Violation|0|||
163978383|NCT00708123|592291933|FG003|Period 2|Protocol Violation|1|||
163978384|NCT00708123|592291934|FG004|Period 2|Protocol Violation|0|||
163978385|NCT00708123|592291930|FG000|Period 2|Other Reason|1|||
163978386|NCT00708123|592291931|FG001|Period 2|Other Reason|0|||
163978387|NCT00708123|592291932|FG002|Period 2|Other Reason|0|||
163978388|NCT00708123|592291933|FG003|Period 2|Other Reason|0|||
163978389|NCT00708123|592291934|FG004|Period 2|Other Reason|0|||
163978390|NCT00708123|592291930|FG000|Period 3|Lost to Follow-up|0|||
163978391|NCT00708123|592291931|FG001|Period 3|Lost to Follow-up|0|||
163978392|NCT00708123|592291932|FG002|Period 3|Lost to Follow-up|1|||
163978393|NCT00708123|592291933|FG003|Period 3|Lost to Follow-up|1|||
163978394|NCT00708123|592291934|FG004|Period 3|Lost to Follow-up|0|||
163978395|NCT00708123|592291930|FG000|Period 4|Protocol Violation|0|||
163874073|NCT04788641|591906943|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
163874074|NCT04788641|591906944|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
163874075|NCT04788641|591906941|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
163874076|NCT04788641|591906942|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
163874077|NCT04788641|591906943|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
163874078|NCT04788641|591906944|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
163874079|NCT01250769|591906945|FG000|Overall Study|Withdrawal by Subject|0|||
163874080|NCT01250769|591906946|FG001|Overall Study|Withdrawal by Subject|1|||
163874081|NCT01250769|591906947|FG002|Overall Study|Withdrawal by Subject|1|||
163874082|NCT01250769|591906948|FG003|Overall Study|Withdrawal by Subject|0|||
163874083|NCT01250769|591906945|FG000|Overall Study|Adverse Event|0|||
164319351|NCT02431260|593544692|FG006|Overall Study|Lost to Follow-up|0|||
164319352|NCT02431260|593544693|FG007|Overall Study|Lost to Follow-up|0|||
164319353|NCT02431260|593544694|FG008|Overall Study|Lost to Follow-up|0|||
164319354|NCT02431260|593544695|FG009|Overall Study|Lost to Follow-up|0|||
164319355|NCT02431260|593544696|FG010|Overall Study|Lost to Follow-up|0|||
164319356|NCT02431260|593544697|FG011|Overall Study|Lost to Follow-up|0|||
164319357|NCT02431260|593544698|FG012|Overall Study|Lost to Follow-up|0|||
164319358|NCT02431260|593544699|FG013|Overall Study|Lost to Follow-up|0|||
164319359|NCT02431260|593544686|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164319360|NCT02431260|593544687|FG001|Overall Study|Study Terminated by the Sponsor|0|||
164319361|NCT02431260|593544688|FG002|Overall Study|Study Terminated by the Sponsor|2|||
164319362|NCT02431260|593544689|FG003|Overall Study|Study Terminated by the Sponsor|1|||
164319363|NCT02431260|593544690|FG004|Overall Study|Study Terminated by the Sponsor|1|||
164319364|NCT02431260|593544691|FG005|Overall Study|Study Terminated by the Sponsor|0|||
164319365|NCT02431260|593544692|FG006|Overall Study|Study Terminated by the Sponsor|1|||
164319366|NCT02431260|593544693|FG007|Overall Study|Study Terminated by the Sponsor|2|||
164319367|NCT02431260|593544694|FG008|Overall Study|Study Terminated by the Sponsor|1|||
164319368|NCT02431260|593544695|FG009|Overall Study|Study Terminated by the Sponsor|1|||
164319369|NCT02431260|593544696|FG010|Overall Study|Study Terminated by the Sponsor|1|||
164319370|NCT02431260|593544697|FG011|Overall Study|Study Terminated by the Sponsor|0|||
164319371|NCT02431260|593544698|FG012|Overall Study|Study Terminated by the Sponsor|4|||
163874084|NCT01250769|591906946|FG001|Overall Study|Adverse Event|0|||
163874085|NCT01250769|591906947|FG002|Overall Study|Adverse Event|1|||
163978396|NCT00708123|592291931|FG001|Period 4|Protocol Violation|1|||
163978397|NCT00708123|592291932|FG002|Period 4|Protocol Violation|0|||
163978398|NCT00708123|592291933|FG003|Period 4|Protocol Violation|0|||
163978399|NCT00708123|592291934|FG004|Period 4|Protocol Violation|0|||
163978400|NCT00845650|592291935|FG000|Overall Study|Withdrawal by Subject|0|||
164206789|NCT00375752|593126532|FG000|Overall Study|Adverse Event|1|||
164206790|NCT00375752|593126533|FG001|Overall Study|Adverse Event|6|||
164319372|NCT02431260|593544699|FG013|Overall Study|Study Terminated by the Sponsor|0|||
164319373|NCT02431260|593544686|FG000|Overall Study|Physician Decision|0|||
163978401|NCT00845650|592291936|FG001|Overall Study|Withdrawal by Subject|0|||
164206791|NCT00375752|593126532|FG000|Overall Study|Withdrawal by Subject|6|||
164206792|NCT00375752|593126533|FG001|Overall Study|Withdrawal by Subject|1|||
164206793|NCT00375752|593126532|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
164206794|NCT00375752|593126533|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
164206795|NCT00375752|593126532|FG000|Overall Study|Protocol Violation|0|||
164206796|NCT00375752|593126533|FG001|Overall Study|Protocol Violation|2|||
164206797|NCT00375752|593126532|FG000|Overall Study|Administrative Problems|0|||
164206798|NCT00375752|593126533|FG001|Overall Study|Administrative Problems|1|||
164206799|NCT01649765|593126538|FG000|Overall Study|Adverse Event|5|||
164206800|NCT01649765|593126539|FG001|Overall Study|Adverse Event|3|||
164206801|NCT01649765|593126538|FG000|Overall Study|Lack of Efficacy|1|||
164206802|NCT01649765|593126539|FG001|Overall Study|Lack of Efficacy|1|||
164206803|NCT01649765|593126538|FG000|Overall Study|Physician Decision|0|||
164206804|NCT01649765|593126539|FG001|Overall Study|Physician Decision|3|||
164206805|NCT01649765|593126538|FG000|Overall Study|Protocol Violation|1|||
164206806|NCT01649765|593126539|FG001|Overall Study|Protocol Violation|0|||
164206807|NCT01649765|593126538|FG000|Overall Study|Withdrawal by Subject|2|||
164206808|NCT01649765|593126539|FG001|Overall Study|Withdrawal by Subject|1|||
164206809|NCT02469233|593126540|FG000|Overall Study|Death|1|||
164206810|NCT02469233|593126541|FG001|Overall Study|Death|1|||
164206811|NCT02469233|593126540|FG000|Overall Study|Lost to post or 6 month follow up|7|||
164206812|NCT02469233|593126541|FG001|Overall Study|Lost to post or 6 month follow up|2|||
164206813|NCT00855582|593126546|FG000|Overall Study|Adverse Event|2|||
164206814|NCT00855582|593126547|FG001|Overall Study|Adverse Event|6|||
164206815|NCT00855582|593126548|FG002|Overall Study|Adverse Event|3|||
164206816|NCT00855582|593126546|FG000|Overall Study|Death|1|||
164206817|NCT00855582|593126547|FG001|Overall Study|Death|0|||
164206818|NCT00855582|593126548|FG002|Overall Study|Death|0|||
164206819|NCT00855582|593126546|FG000|Overall Study|Lack of Efficacy|1|||
164206820|NCT00855582|593126547|FG001|Overall Study|Lack of Efficacy|3|||
164206821|NCT00855582|593126548|FG002|Overall Study|Lack of Efficacy|8|||
164206822|NCT00855582|593126546|FG000|Overall Study|Lost to Follow-up|1|||
164206823|NCT00855582|593126547|FG001|Overall Study|Lost to Follow-up|3|||
164206824|NCT00855582|593126548|FG002|Overall Study|Lost to Follow-up|1|||
164206825|NCT00855582|593126546|FG000|Overall Study|Physician Decision|0|||
164206826|NCT00855582|593126547|FG001|Overall Study|Physician Decision|0|||
164206827|NCT00855582|593126548|FG002|Overall Study|Physician Decision|1|||
164206828|NCT00855582|593126546|FG000|Overall Study|Protocol Violation|6|||
164206829|NCT00855582|593126547|FG001|Overall Study|Protocol Violation|2|||
164206830|NCT00855582|593126548|FG002|Overall Study|Protocol Violation|6|||
164206831|NCT00855582|593126546|FG000|Overall Study|Entry Criteria Not Met|8|||
164206832|NCT00855582|593126547|FG001|Overall Study|Entry Criteria Not Met|6|||
164206833|NCT00855582|593126548|FG002|Overall Study|Entry Criteria Not Met|3|||
164206834|NCT00855582|593126546|FG000|Overall Study|Withdrawal by Subject|7|||
164206835|NCT00855582|593126547|FG001|Overall Study|Withdrawal by Subject|4|||
164206836|NCT00855582|593126548|FG002|Overall Study|Withdrawal by Subject|8|||
164206837|NCT03813654|593126549|FG000|Overall Study|Protocol Violation|0|||
164206838|NCT03813654|593126550|FG001|Overall Study|Protocol Violation|1|||
164206839|NCT03813654|593126551|FG002|Overall Study|Protocol Violation|2|||
164206840|NCT03813654|593126549|FG000|Overall Study|Withdrawal by Subject|1|||
164206841|NCT03813654|593126550|FG001|Overall Study|Withdrawal by Subject|0|||
164206842|NCT03813654|593126551|FG002|Overall Study|Withdrawal by Subject|0|||
164206843|NCT02832037|593126552|FG000|Overall Study|Administrative reasons|0|||
164206844|NCT02832037|593126553|FG001|Overall Study|Administrative reasons|0|||
164206845|NCT02832037|593126554|FG002|Overall Study|Administrative reasons|1|||
164206846|NCT02832037|593126555|FG003|Overall Study|Administrative reasons|0|||
164206847|NCT02832037|593126556|FG004|Overall Study|Administrative reasons|0|||
164206848|NCT02832037|593126552|FG000|Overall Study|Protocol Violation|3|||
164206849|NCT02832037|593126553|FG001|Overall Study|Protocol Violation|0|||
164206850|NCT02832037|593126554|FG002|Overall Study|Protocol Violation|4|||
164206851|NCT02832037|593126555|FG003|Overall Study|Protocol Violation|1|||
164206852|NCT02832037|593126556|FG004|Overall Study|Protocol Violation|2|||
164206853|NCT02832037|593126552|FG000|Overall Study|Lost to Follow-up|2|||
164206854|NCT02832037|593126553|FG001|Overall Study|Lost to Follow-up|0|||
164206855|NCT02832037|593126554|FG002|Overall Study|Lost to Follow-up|3|||
164206856|NCT02832037|593126555|FG003|Overall Study|Lost to Follow-up|0|||
164206857|NCT02832037|593126556|FG004|Overall Study|Lost to Follow-up|5|||
164206858|NCT02832037|593126552|FG000|Overall Study|Withdrawal by Subject|9|||
164206859|NCT02832037|593126553|FG001|Overall Study|Withdrawal by Subject|8|||
164206860|NCT02832037|593126554|FG002|Overall Study|Withdrawal by Subject|0|||
164206861|NCT02832037|593126555|FG003|Overall Study|Withdrawal by Subject|4|||
164206862|NCT02832037|593126556|FG004|Overall Study|Withdrawal by Subject|8|||
164206863|NCT02832037|593126552|FG000|Overall Study|Adverse Event|5|||
164206864|NCT02832037|593126553|FG001|Overall Study|Adverse Event|4|||
164206865|NCT02832037|593126554|FG002|Overall Study|Adverse Event|0|||
164206866|NCT02832037|593126555|FG003|Overall Study|Adverse Event|2|||
164206867|NCT02832037|593126556|FG004|Overall Study|Adverse Event|4|||
164206868|NCT04727749|593126561|FG000|Overall Study|Lost to Follow-up|10|||
164206869|NCT04727749|593126562|FG001|Overall Study|Lost to Follow-up|3|||
164206870|NCT02378181|593126563|FG000|Overall Study|Lost to Follow-up|2|||
164206871|NCT02378181|593126564|FG001|Overall Study|Lost to Follow-up|5|||
164206872|NCT02378181|593126563|FG000|Overall Study|Withdrawal by Subject|1|||
164206873|NCT02378181|593126564|FG001|Overall Study|Withdrawal by Subject|1|||
164206874|NCT02378181|593126563|FG000|Overall Study|Incarcerated|0|||
164206875|NCT02378181|593126564|FG001|Overall Study|Incarcerated|1|||
164206876|NCT01859741|593126565|FG000|Overall Study|Death|3|||
164206877|NCT01859741|593126566|FG001|Overall Study|Death|2|||
164206878|NCT01859741|593126567|FG002|Overall Study|Death|4|||
164206879|NCT01859741|593126568|FG003|Overall Study|Death|3|||
164206880|NCT01859741|593126569|FG004|Overall Study|Death|5|||
164206881|NCT01859741|593126570|FG005|Overall Study|Death|4|||
164206882|NCT01859741|593126571|FG006|Overall Study|Death|51|||
164206883|NCT01859741|593126572|FG007|Overall Study|Death|51|||
164206884|NCT01859741|593126565|FG000|Overall Study|Lost to Follow-up|0|||
164206885|NCT01859741|593126566|FG001|Overall Study|Lost to Follow-up|0|||
164206886|NCT01859741|593126567|FG002|Overall Study|Lost to Follow-up|0|||
164206887|NCT01859741|593126568|FG003|Overall Study|Lost to Follow-up|0|||
164206888|NCT01859741|593126569|FG004|Overall Study|Lost to Follow-up|0|||
164206889|NCT01859741|593126570|FG005|Overall Study|Lost to Follow-up|1|||
164206890|NCT01859741|593126571|FG006|Overall Study|Lost to Follow-up|0|||
164206891|NCT01859741|593126572|FG007|Overall Study|Lost to Follow-up|4|||
164206892|NCT01859741|593126565|FG000|Overall Study|Withdrawal by Subject|0|||
164206893|NCT01859741|593126566|FG001|Overall Study|Withdrawal by Subject|1|||
164206894|NCT01859741|593126567|FG002|Overall Study|Withdrawal by Subject|2|||
164206895|NCT01859741|593126568|FG003|Overall Study|Withdrawal by Subject|0|||
164206896|NCT01859741|593126569|FG004|Overall Study|Withdrawal by Subject|0|||
164206897|NCT01859741|593126570|FG005|Overall Study|Withdrawal by Subject|1|||
164206898|NCT01859741|593126571|FG006|Overall Study|Withdrawal by Subject|1|||
163874086|NCT01250769|591906948|FG003|Overall Study|Adverse Event|0|||
163874087|NCT04872738|591906949|FG000|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|152|||
163874088|NCT04872738|591906950|FG001|Booster Survey|Did not respond or did not receive booster dose at the time of survey distribution|15|||
163874089|NCT04191499|591906951|FG000|Overall Study|Adverse Event|1|||
164206899|NCT01859741|593126572|FG007|Overall Study|Withdrawal by Subject|1|||
164206900|NCT01859741|593126565|FG000|Overall Study|Study Terminated by Sponsor|0|||
164206901|NCT01859741|593126566|FG001|Overall Study|Study Terminated by Sponsor|0|||
164206902|NCT01859741|593126567|FG002|Overall Study|Study Terminated by Sponsor|0|||
164206903|NCT01859741|593126568|FG003|Overall Study|Study Terminated by Sponsor|0|||
164206904|NCT01859741|593126569|FG004|Overall Study|Study Terminated by Sponsor|1|||
164206905|NCT01859741|593126570|FG005|Overall Study|Study Terminated by Sponsor|0|||
163874090|NCT04191499|591906952|FG001|Overall Study|Adverse Event|0|||
163874091|NCT04191499|591906951|FG000|Overall Study|Death|42|||
163874092|NCT04191499|591906952|FG001|Overall Study|Death|55|||
163874093|NCT04191499|591906951|FG000|Overall Study|Lost to Follow-up|4|||
163874094|NCT04191499|591906952|FG001|Overall Study|Lost to Follow-up|1|||
163874095|NCT04191499|591906951|FG000|Overall Study|Physician Decision|1|||
163874096|NCT04191499|591906952|FG001|Overall Study|Physician Decision|0|||
163874097|NCT04191499|591906951|FG000|Overall Study|Progressive Disease|1|||
163874098|NCT04191499|591906952|FG001|Overall Study|Progressive Disease|0|||
163874099|NCT04191499|591906951|FG000|Overall Study|Symptomatic Deterioration|1|||
163874100|NCT04191499|591906952|FG001|Overall Study|Symptomatic Deterioration|0|||
164206906|NCT01859741|593126571|FG006|Overall Study|Study Terminated by Sponsor|16|||
164206907|NCT01859741|593126572|FG007|Overall Study|Study Terminated by Sponsor|14|||
164206908|NCT01859741|593126565|FG000|Overall Study|Other|0|||
164206909|NCT01859741|593126566|FG001|Overall Study|Other|0|||
164206910|NCT01859741|593126567|FG002|Overall Study|Other|0|||
164206911|NCT01859741|593126568|FG003|Overall Study|Other|0|||
164206912|NCT01859741|593126569|FG004|Overall Study|Other|0|||
164206913|NCT01859741|593126570|FG005|Overall Study|Other|0|||
164206914|NCT01859741|593126571|FG006|Overall Study|Other|2|||
164206915|NCT01859741|593126572|FG007|Overall Study|Other|0|||
164206916|NCT02412657|593126574|FG000|Overall Study|Lost to Follow-up|1|||
164206917|NCT02412657|593126575|FG001|Overall Study|Lost to Follow-up|0|||
164206918|NCT02412657|593126576|FG002|Overall Study|Lost to Follow-up|0|||
164206919|NCT02412657|593126574|FG000|Overall Study|Protocol Violation|0|||
164206920|NCT02412657|593126575|FG001|Overall Study|Protocol Violation|2|||
164206921|NCT02412657|593126576|FG002|Overall Study|Protocol Violation|3|||
164206922|NCT04167462|593126580|FG000|Overall Study|Other reasons|3|||
164206923|NCT04167462|593126581|FG001|Overall Study|Other reasons|2|||
164206924|NCT04167462|593126580|FG000|Overall Study|Withdrawal by Subject|6|||
164319374|NCT02431260|593544687|FG001|Overall Study|Physician Decision|0|||
163874101|NCT04191499|591906951|FG000|Overall Study|Withdrawal by Subject|7|||
163874102|NCT04191499|591906952|FG001|Overall Study|Withdrawal by Subject|11|||
164206925|NCT04167462|593126581|FG001|Overall Study|Withdrawal by Subject|7|||
164206926|NCT04167462|593126580|FG000|Overall Study|Adverse Event|4|||
164206927|NCT04167462|593126581|FG001|Overall Study|Adverse Event|0|||
164206928|NCT04167462|593126580|FG000|Overall Study|Pregnancy|1|||
164206929|NCT04167462|593126581|FG001|Overall Study|Pregnancy|0|||
164319375|NCT02431260|593544688|FG002|Overall Study|Physician Decision|0|||
164206930|NCT04167462|593126580|FG000|Overall Study|Lack of Efficacy|0|||
164206931|NCT04167462|593126581|FG001|Overall Study|Lack of Efficacy|1|||
164206932|NCT02320396|593126582|FG000|Overall Study|Adverse Event|2|||
164206933|NCT02320396|593126583|FG001|Overall Study|Adverse Event|2|||
164206934|NCT02320396|593126582|FG000|Overall Study|Pregnancy|0|||
164206935|NCT02320396|593126583|FG001|Overall Study|Pregnancy|1|||
164206936|NCT02320396|593126582|FG000|Overall Study|Protocol Violation|0|||
164206937|NCT02320396|593126583|FG001|Overall Study|Protocol Violation|1|||
164206938|NCT02320396|593126582|FG000|Overall Study|Withdrawal by Subject|2|||
164206939|NCT02320396|593126583|FG001|Overall Study|Withdrawal by Subject|0|||
164206940|NCT02382939|593126590|FG000|Overall Study|Adverse Event|1|||
164206941|NCT02382939|593126591|FG001|Overall Study|Adverse Event|1|||
164206942|NCT02382939|593126590|FG000|Overall Study|Withdrawal by Subject|2|||
164206943|NCT02382939|593126591|FG001|Overall Study|Withdrawal by Subject|2|||
164206944|NCT00142415|593126592|FG000|Overall Study|Physician Decision|0|||
164206945|NCT00142415|593126593|FG001|Overall Study|Physician Decision|0|||
164206946|NCT00142415|593126594|FG002|Overall Study|Physician Decision|0|||
164206947|NCT00142415|593126595|FG003|Overall Study|Physician Decision|0|||
164206948|NCT00142415|593126596|FG004|Overall Study|Physician Decision|1|||
164206949|NCT00142415|593126597|FG005|Overall Study|Physician Decision|2|||
164206950|NCT01129128|593126602|FG000|Overall Study|Lost to Follow-up|2|||
164206951|NCT01129128|593126603|FG001|Overall Study|Lost to Follow-up|2|||
164206952|NCT01129128|593126604|FG002|Overall Study|Lost to Follow-up|1|||
164206953|NCT01129128|593126602|FG000|Overall Study|Protocol Violation|0|||
164206954|NCT01129128|593126603|FG001|Overall Study|Protocol Violation|1|||
164206955|NCT01129128|593126604|FG002|Overall Study|Protocol Violation|0|||
164206956|NCT01129128|593126602|FG000|Overall Study|Withdrawal by Subject|0|||
164206957|NCT01129128|593126603|FG001|Overall Study|Withdrawal by Subject|1|||
164206958|NCT01129128|593126604|FG002|Overall Study|Withdrawal by Subject|3|||
164206959|NCT01129128|593126602|FG000|Overall Study|Physician Decision|1|||
164206960|NCT01129128|593126603|FG001|Overall Study|Physician Decision|0|||
164206961|NCT01129128|593126604|FG002|Overall Study|Physician Decision|0|||
164206962|NCT01311661|593126607|FG000|Overall Study|Adverse Event|2|||
164206963|NCT01311661|593126607|FG000|Overall Study|Protocol Violation|3|||
164206964|NCT01311661|593126607|FG000|Overall Study|Withdrawal by Subject|2|||
164206965|NCT01900314|593126608|FG000|Overall Study|Lost to Follow-up|1|||
164206966|NCT01900314|593126609|FG001|Overall Study|Lost to Follow-up|0|||
164206967|NCT01900314|593126608|FG000|Overall Study|Protocol Violation|0|||
164206968|NCT01900314|593126609|FG001|Overall Study|Protocol Violation|1|||
164206969|NCT01900314|593126608|FG000|Overall Study|Withdrawal by Subject|3|||
164206970|NCT01900314|593126609|FG001|Overall Study|Withdrawal by Subject|3|||
164206971|NCT03197129|593126620|FG000|Overall Study|did not answer the VPT: shyness|4|||
164206972|NCT03197129|593126621|FG001|Overall Study|did not answer the VPT: shyness|5|||
164206973|NCT00289276|593126622|FG000|Second Part of FAST Study (Expansion)|Death|0|||
164206974|NCT00289276|593126623|FG001|Second Part of FAST Study (Expansion)|Death|2|||
164206975|NCT00289276|593126622|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
164206976|NCT00289276|593126623|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
164206977|NCT00869960|593126624|FG000|Overall Study|Lost to Follow-up|2|||
164206978|NCT04848480|593126625|FG000|Main Phase (26 Weeks)|Death|1|||
164206979|NCT04848480|593126626|FG001|Main Phase (26 Weeks)|Death|0|||
164206980|NCT04848480|593126625|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
164206981|NCT04848480|593126626|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
164206982|NCT04848480|593126625|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
164206983|NCT04848480|593126626|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
164206984|NCT04848480|593126625|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
164206985|NCT04848480|593126626|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
164206986|NCT04848480|593126625|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
164206987|NCT04848480|593126626|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
164206988|NCT04848480|593126625|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
164206989|NCT04848480|593126626|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
164206990|NCT05219162|593126627|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
164206991|NCT05219162|593126627|FG000|Overall Study|Withdrawal by Subject|23|||
164206992|NCT02908347|593126630|FG000|Overall Study|Adverse Event|0|||
164206993|NCT02908347|593126631|FG001|Overall Study|Adverse Event|1|||
164206994|NCT02908347|593126630|FG000|Overall Study|Lost to Follow-up|1|||
164206995|NCT02908347|593126631|FG001|Overall Study|Lost to Follow-up|0|||
164206996|NCT02783690|593126632|FG000|Overall Study|Withdrawal by Subject|3|||
164206997|NCT02783690|593126633|FG001|Overall Study|Withdrawal by Subject|3|||
164206998|NCT05516758|593126634|FG000|Overall Study|Adverse Event|5|||
164206999|NCT05516758|593126635|FG001|Overall Study|Adverse Event|1|||
164207000|NCT05516758|593126636|FG002|Overall Study|Adverse Event|3|||
164207001|NCT05516758|593126637|FG003|Overall Study|Adverse Event|0|||
164207002|NCT05516758|593126638|FG004|Overall Study|Adverse Event|1|||
164207003|NCT05516758|593126639|FG005|Overall Study|Adverse Event|3|||
164207004|NCT05516758|593126640|FG006|Overall Study|Adverse Event|5|||
164207005|NCT05516758|593126634|FG000|Overall Study|Assigned treatment by mistake|1|||
164207006|NCT05516758|593126635|FG001|Overall Study|Assigned treatment by mistake|0|||
164207007|NCT05516758|593126636|FG002|Overall Study|Assigned treatment by mistake|0|||
164207008|NCT05516758|593126637|FG003|Overall Study|Assigned treatment by mistake|0|||
164207009|NCT05516758|593126638|FG004|Overall Study|Assigned treatment by mistake|1|||
164207010|NCT05516758|593126639|FG005|Overall Study|Assigned treatment by mistake|0|||
164207011|NCT05516758|593126640|FG006|Overall Study|Assigned treatment by mistake|0|||
164207012|NCT05516758|593126634|FG000|Overall Study|Lack of Efficacy|6|||
164207013|NCT05516758|593126635|FG001|Overall Study|Lack of Efficacy|0|||
164207014|NCT05516758|593126636|FG002|Overall Study|Lack of Efficacy|2|||
164207015|NCT05516758|593126637|FG003|Overall Study|Lack of Efficacy|0|||
163874103|NCT04191499|591906951|FG000|Overall Study|Ongoing in the study|104|||
163874104|NCT04191499|591906952|FG001|Overall Study|Ongoing in the study|97|||
163874105|NCT03951805|591906953|FG000|Overall Study|Adverse Event|1|||
163874106|NCT03951805|591906954|FG001|Overall Study|Adverse Event|0|||
163874107|NCT03951805|591906955|FG002|Overall Study|Adverse Event|0|||
163874108|NCT03951805|591906956|FG003|Overall Study|Adverse Event|0|||
163874109|NCT05524454|591906957|FG000|Overall Study|Withdrawal by Subject|1|||
163874110|NCT05999435|591906958|FG000|Overall Study|Adverse Event|1|||
164207016|NCT05516758|593126638|FG004|Overall Study|Lack of Efficacy|3|||
164207017|NCT05516758|593126639|FG005|Overall Study|Lack of Efficacy|6|||
164207018|NCT05516758|593126640|FG006|Overall Study|Lack of Efficacy|3|||
164207019|NCT05516758|593126634|FG000|Overall Study|Lost to Follow-up|2|||
163874111|NCT05999435|591906959|FG001|Overall Study|Adverse Event|0|||
163874112|NCT05999435|591906960|FG002|Overall Study|Adverse Event|0|||
163874113|NCT05999435|591906958|FG000|Overall Study|Withdrawal by Subject|2|||
163874114|NCT05999435|591906959|FG001|Overall Study|Withdrawal by Subject|1|||
164207020|NCT05516758|593126635|FG001|Overall Study|Lost to Follow-up|0|||
164207021|NCT05516758|593126636|FG002|Overall Study|Lost to Follow-up|2|||
164207022|NCT05516758|593126637|FG003|Overall Study|Lost to Follow-up|0|||
164207023|NCT05516758|593126638|FG004|Overall Study|Lost to Follow-up|3|||
164207024|NCT05516758|593126639|FG005|Overall Study|Lost to Follow-up|2|||
164207025|NCT05516758|593126640|FG006|Overall Study|Lost to Follow-up|1|||
164207026|NCT05516758|593126634|FG000|Overall Study|Other- As reported by the site|2|||
164207027|NCT05516758|593126635|FG001|Overall Study|Other- As reported by the site|1|||
164207028|NCT05516758|593126636|FG002|Overall Study|Other- As reported by the site|8|||
164207029|NCT05516758|593126637|FG003|Overall Study|Other- As reported by the site|1|||
164207030|NCT05516758|593126638|FG004|Overall Study|Other- As reported by the site|2|||
164207031|NCT05516758|593126639|FG005|Overall Study|Other- As reported by the site|3|||
164207032|NCT05516758|593126640|FG006|Overall Study|Other- As reported by the site|8|||
164207033|NCT05516758|593126634|FG000|Overall Study|Physician Decision|1|||
164207034|NCT05516758|593126635|FG001|Overall Study|Physician Decision|0|||
164207035|NCT05516758|593126636|FG002|Overall Study|Physician Decision|7|||
164207036|NCT05516758|593126637|FG003|Overall Study|Physician Decision|0|||
164207037|NCT05516758|593126638|FG004|Overall Study|Physician Decision|1|||
164207038|NCT05516758|593126639|FG005|Overall Study|Physician Decision|1|||
164207039|NCT05516758|593126640|FG006|Overall Study|Physician Decision|2|||
164207040|NCT05516758|593126634|FG000|Overall Study|Protocol Deviation|1|||
164207041|NCT05516758|593126635|FG001|Overall Study|Protocol Deviation|0|||
164207042|NCT05516758|593126636|FG002|Overall Study|Protocol Deviation|0|||
164207043|NCT05516758|593126637|FG003|Overall Study|Protocol Deviation|0|||
164207044|NCT05516758|593126638|FG004|Overall Study|Protocol Deviation|0|||
164207045|NCT05516758|593126639|FG005|Overall Study|Protocol Deviation|1|||
164207046|NCT05516758|593126640|FG006|Overall Study|Protocol Deviation|5|||
164207047|NCT05516758|593126634|FG000|Overall Study|Withdrawal by Subject|11|||
164207048|NCT05516758|593126635|FG001|Overall Study|Withdrawal by Subject|1|||
164207049|NCT05516758|593126636|FG002|Overall Study|Withdrawal by Subject|15|||
164207050|NCT05516758|593126637|FG003|Overall Study|Withdrawal by Subject|2|||
164207051|NCT05516758|593126638|FG004|Overall Study|Withdrawal by Subject|7|||
164207052|NCT05516758|593126639|FG005|Overall Study|Withdrawal by Subject|7|||
164207053|NCT05516758|593126640|FG006|Overall Study|Withdrawal by Subject|6|||
164207054|NCT05516758|593126634|FG000|Overall Study|Death|1|||
164207055|NCT05516758|593126635|FG001|Overall Study|Death|0|||
164207056|NCT05516758|593126636|FG002|Overall Study|Death|0|||
164207057|NCT05516758|593126637|FG003|Overall Study|Death|0|||
164207058|NCT05516758|593126638|FG004|Overall Study|Death|0|||
164207059|NCT05516758|593126639|FG005|Overall Study|Death|0|||
164207060|NCT05516758|593126640|FG006|Overall Study|Death|0|||
164207061|NCT05516758|593126634|FG000|Overall Study|Non-compliance With Study Drug|0|||
164207062|NCT05516758|593126635|FG001|Overall Study|Non-compliance With Study Drug|0|||
164207063|NCT05516758|593126636|FG002|Overall Study|Non-compliance With Study Drug|1|||
163874115|NCT05999435|591906960|FG002|Overall Study|Withdrawal by Subject|0|||
163874116|NCT01198145|591906963|FG000|Overall Study|Withdrawal by Subject|1|||
163874117|NCT01198145|591906964|FG001|Overall Study|Withdrawal by Subject|1|||
164207064|NCT05516758|593126637|FG003|Overall Study|Non-compliance With Study Drug|0|||
164207065|NCT05516758|593126638|FG004|Overall Study|Non-compliance With Study Drug|0|||
164207066|NCT05516758|593126639|FG005|Overall Study|Non-compliance With Study Drug|0|||
164207067|NCT05516758|593126640|FG006|Overall Study|Non-compliance With Study Drug|0|||
164207068|NCT05516758|593126634|FG000|Overall Study|Site Terminated by Sponsor|2|||
164319376|NCT02431260|593544689|FG003|Overall Study|Physician Decision|0|||
164319377|NCT02431260|593544690|FG004|Overall Study|Physician Decision|0|||
164319378|NCT02431260|593544691|FG005|Overall Study|Physician Decision|1|||
164319379|NCT02431260|593544692|FG006|Overall Study|Physician Decision|0|||
164319380|NCT02431260|593544693|FG007|Overall Study|Physician Decision|0|||
164319381|NCT02431260|593544694|FG008|Overall Study|Physician Decision|0|||
164319382|NCT02431260|593544695|FG009|Overall Study|Physician Decision|0|||
164319383|NCT02431260|593544696|FG010|Overall Study|Physician Decision|0|||
164319384|NCT02431260|593544697|FG011|Overall Study|Physician Decision|0|||
164319385|NCT02431260|593544698|FG012|Overall Study|Physician Decision|0|||
164319386|NCT02431260|593544699|FG013|Overall Study|Physician Decision|0|||
164319387|NCT02431260|593544686|FG000|Overall Study|Other Unspecified|0|||
164319388|NCT02431260|593544687|FG001|Overall Study|Other Unspecified|0|||
164319389|NCT02431260|593544688|FG002|Overall Study|Other Unspecified|0|||
164319390|NCT02431260|593544689|FG003|Overall Study|Other Unspecified|0|||
163874118|NCT00603954|591906965|FG000|Overall Study|Protocol Violation|1|||
163874119|NCT00603954|591906966|FG001|Overall Study|Protocol Violation|2|||
163874120|NCT04705480|591906967|FG000|Overall Study|Withdrawal by Subject|1|||
163874121|NCT04705480|591906968|FG001|Overall Study|Withdrawal by Subject|0|||
163874122|NCT04705480|591906969|FG002|Overall Study|Withdrawal by Subject|1|||
163874123|NCT04705480|591906967|FG000|Overall Study|Protocol Violation|2|||
163874124|NCT04705480|591906968|FG001|Overall Study|Protocol Violation|0|||
163874125|NCT04705480|591906969|FG002|Overall Study|Protocol Violation|2|||
163874126|NCT04705480|591906967|FG000|Overall Study|Decision to discharge before intervention|2|||
163874127|NCT04705480|591906968|FG001|Overall Study|Decision to discharge before intervention|0|||
163874128|NCT04705480|591906969|FG002|Overall Study|Decision to discharge before intervention|0|||
163874129|NCT04970654|591906970|FG000|Overall Study|Withdrawal by parents/guardian|1|||
163874130|NCT04970654|591906971|FG001|Overall Study|Withdrawal by parents/guardian|2|||
163874131|NCT04970654|591906970|FG000|Overall Study|Unclassified|2|||
163874132|NCT04970654|591906971|FG001|Overall Study|Unclassified|1|||
163874133|NCT04970654|591906970|FG000|Overall Study|Lost to Follow-up|1|||
163874134|NCT04970654|591906971|FG001|Overall Study|Lost to Follow-up|0|||
163874135|NCT02528188|591906972|FG000|Overall Study|Adverse Event|23|||
163874136|NCT02528188|591906973|FG001|Overall Study|Adverse Event|22|||
163874137|NCT02528188|591906974|FG002|Overall Study|Adverse Event|8|||
163874138|NCT02528188|591906972|FG000|Overall Study|Protocol Violation|4|||
163874139|NCT02528188|591906973|FG001|Overall Study|Protocol Violation|6|||
163874140|NCT02528188|591906974|FG002|Overall Study|Protocol Violation|4|||
163874141|NCT02528188|591906972|FG000|Overall Study|Lack of Efficacy|19|||
163874142|NCT02528188|591906973|FG001|Overall Study|Lack of Efficacy|21|||
163874143|NCT02528188|591906974|FG002|Overall Study|Lack of Efficacy|22|||
163874144|NCT02528188|591906972|FG000|Overall Study|Withdrawal by Subject|97|||
163874145|NCT02528188|591906973|FG001|Overall Study|Withdrawal by Subject|104|||
163874146|NCT02528188|591906974|FG002|Overall Study|Withdrawal by Subject|100|||
163874147|NCT02528188|591906972|FG000|Overall Study|Lost to Follow-up|25|||
163874148|NCT02528188|591906973|FG001|Overall Study|Lost to Follow-up|21|||
163874149|NCT02528188|591906974|FG002|Overall Study|Lost to Follow-up|31|||
163874150|NCT02528188|591906972|FG000|Overall Study|Death|4|||
163874151|NCT02528188|591906973|FG001|Overall Study|Death|4|||
163874152|NCT02528188|591906974|FG002|Overall Study|Death|0|||
163874153|NCT02528188|591906972|FG000|Overall Study|Other|89|||
163874154|NCT02528188|591906973|FG001|Overall Study|Other|91|||
163874155|NCT02528188|591906974|FG002|Overall Study|Other|74|||
163874156|NCT02528188|591906972|FG000|Overall Study|Randomized but not treated|6|||
163874157|NCT02528188|591906973|FG001|Overall Study|Randomized but not treated|7|||
163874158|NCT02528188|591906974|FG002|Overall Study|Randomized but not treated|12|||
163874159|NCT02299375|591906977|FG000|Overall Study|Adverse Event, serious fatal|1|||
163874160|NCT02299375|591906978|FG001|Overall Study|Adverse Event, serious fatal|3|||
163874161|NCT02299375|591906977|FG000|Overall Study|Adverse Event, non-fatal|8|||
163874162|NCT02299375|591906978|FG001|Overall Study|Adverse Event, non-fatal|9|||
163874163|NCT02299375|591906977|FG000|Overall Study|Lack of Efficacy|1|||
163874164|NCT02299375|591906978|FG001|Overall Study|Lack of Efficacy|3|||
163874165|NCT02299375|591906977|FG000|Overall Study|Protocol Violation|1|||
163874166|NCT02299375|591906978|FG001|Overall Study|Protocol Violation|3|||
163978402|NCT00845650|592291937|FG002|Overall Study|Withdrawal by Subject|0|||
164319391|NCT02431260|593544690|FG004|Overall Study|Other Unspecified|0|||
163874167|NCT02299375|591906977|FG000|Overall Study|Other: Met stopping criteria|1|||
163874168|NCT02299375|591906978|FG001|Overall Study|Other: Met stopping criteria|0|||
163874169|NCT02299375|591906977|FG000|Overall Study|Other: Study closed/terminated|66|||
163874170|NCT02299375|591906978|FG001|Overall Study|Other: Study closed/terminated|55|||
163874171|NCT02299375|591906977|FG000|Overall Study|Lost to Follow-up|0|||
163874172|NCT02299375|591906978|FG001|Overall Study|Lost to Follow-up|2|||
163874173|NCT02299375|591906977|FG000|Overall Study|Physician Decision|1|||
163874174|NCT02299375|591906978|FG001|Overall Study|Physician Decision|1|||
164319392|NCT02431260|593544691|FG005|Overall Study|Other Unspecified|0|||
164319393|NCT02431260|593544692|FG006|Overall Study|Other Unspecified|0|||
164319394|NCT02431260|593544693|FG007|Overall Study|Other Unspecified|0|||
164319395|NCT02431260|593544694|FG008|Overall Study|Other Unspecified|0|||
164319396|NCT02431260|593544695|FG009|Overall Study|Other Unspecified|0|||
164319397|NCT02431260|593544696|FG010|Overall Study|Other Unspecified|0|||
164319398|NCT02431260|593544697|FG011|Overall Study|Other Unspecified|1|||
164319399|NCT02431260|593544698|FG012|Overall Study|Other Unspecified|1|||
164319400|NCT02431260|593544699|FG013|Overall Study|Other Unspecified|0|||
164319401|NCT03288142|593544702|FG000|Overall Study|Lost to Follow-up|22|||
164319402|NCT03288142|593544703|FG001|Overall Study|Lost to Follow-up|15|||
164319403|NCT02270944|593544704|FG000|Overall Study|Lost to Follow-up|9|||
164319404|NCT02270944|593544705|FG001|Overall Study|Lost to Follow-up|4|||
164319405|NCT02270944|593544704|FG000|Overall Study|Withdrawal by Subject|2|||
164319406|NCT02270944|593544705|FG001|Overall Study|Withdrawal by Subject|1|||
164319407|NCT00384111|593544708|FG000|Overall Study|Disease Progression|3|||
164319408|NCT00384111|593544708|FG000|Overall Study|Adverse Event|1|||
164319409|NCT00384111|593544708|FG000|Overall Study|Investigator Decision|3|||
164319410|NCT00384111|593544708|FG000|Overall Study|Study Terminated by the Sponsor|19|||
164319411|NCT01551420|593544709|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
164319412|NCT01551420|593544710|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
164319413|NCT01551420|593544709|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
164319414|NCT01551420|593544710|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
164319415|NCT01551420|593544709|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
164319416|NCT01551420|593544710|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
164319417|NCT01551420|593544709|FG000|Screened for Part B Eligibility|Declined participation|8|||
164319418|NCT01551420|593544710|FG001|Screened for Part B Eligibility|Declined participation|1|||
164319419|NCT01551420|593544709|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
164319420|NCT01551420|593544710|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
164319421|NCT01551420|593544709|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
164319422|NCT01551420|593544710|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
163874175|NCT02299375|591906977|FG000|Overall Study|Withdrawal by Subject|1|||
163874176|NCT02299375|591906978|FG001|Overall Study|Withdrawal by Subject|4|||
163874177|NCT00704184|591906981|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
163874178|NCT00704184|591906982|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
164136137|NCT00918138|592862036|FG000|Overall Study|Death|1|||
164136138|NCT00918138|592862037|FG001|Overall Study|Death|0|||
164136139|NCT03972163|592862038|FG000|Overall Study|Death|0|||
164136140|NCT03972163|592862039|FG001|Overall Study|Death|1|||
164136141|NCT01199471|592862040|FG000|Overall Study|Protocol Violation|4|||
164136142|NCT01199471|592862040|FG000|Overall Study|Withdrawal by Subject|1|||
164136143|NCT01199471|592862040|FG000|Overall Study|Physician Decision|1|||
164136144|NCT04053465|592862043|FG000|Overall Study|Withdrawal by Subject|4|||
164136145|NCT04053465|592862044|FG001|Overall Study|Withdrawal by Subject|4|||
164136146|NCT02085135|592862045|FG000|Overall Study|Adverse Event|4|||
164136147|NCT02085135|592862046|FG001|Overall Study|Adverse Event|7|||
164136148|NCT02085135|592862045|FG000|Overall Study|Lost to Follow-up|2|||
164136149|NCT02085135|592862046|FG001|Overall Study|Lost to Follow-up|2|||
164136150|NCT02085135|592862045|FG000|Overall Study|Withdrawal by Subject|3|||
164136151|NCT02085135|592862046|FG001|Overall Study|Withdrawal by Subject|0|||
164136152|NCT02085135|592862045|FG000|Overall Study|Lack of Efficacy|2|||
164136153|NCT02085135|592862046|FG001|Overall Study|Lack of Efficacy|0|||
164136154|NCT01212588|592862049|FG000|Overall Study|Physician Decision|0|||
164136155|NCT01212588|592862050|FG001|Overall Study|Physician Decision|1|||
164136156|NCT01212588|592862049|FG000|Overall Study|Protocol Violation|1|||
164136157|NCT01212588|592862050|FG001|Overall Study|Protocol Violation|1|||
164136158|NCT02885181|592862051|FG000|Overall Study|Investigator's Discretion|0|||
164136159|NCT02885181|592862052|FG001|Overall Study|Investigator's Discretion|1|||
164136160|NCT02885181|592862053|FG002|Overall Study|Investigator's Discretion|0|||
164136161|NCT02885181|592862054|FG003|Overall Study|Investigator's Discretion|1|||
164136162|NCT02885181|592862051|FG000|Overall Study|Adverse Event|0|||
164136163|NCT02885181|592862052|FG001|Overall Study|Adverse Event|0|||
164136164|NCT02885181|592862053|FG002|Overall Study|Adverse Event|0|||
164136165|NCT02885181|592862054|FG003|Overall Study|Adverse Event|1|||
164136166|NCT02885181|592862051|FG000|Overall Study|Withdrawal by Subject|0|||
164136167|NCT02885181|592862052|FG001|Overall Study|Withdrawal by Subject|0|||
164136168|NCT02885181|592862053|FG002|Overall Study|Withdrawal by Subject|0|||
164136169|NCT02885181|592862054|FG003|Overall Study|Withdrawal by Subject|1|||
164136170|NCT00742924|592862059|FG000|Overall Study|Adverse Event|0|||
164136171|NCT00742924|592862060|FG001|Overall Study|Adverse Event|0|||
164136172|NCT00742924|592862061|FG002|Overall Study|Adverse Event|1|||
164136173|NCT00742924|592862062|FG003|Overall Study|Adverse Event|1|||
164136174|NCT00742924|592862059|FG000|Overall Study|Lack of Efficacy|5|||
164136175|NCT00742924|592862060|FG001|Overall Study|Lack of Efficacy|1|||
164136176|NCT00742924|592862061|FG002|Overall Study|Lack of Efficacy|2|||
164136177|NCT00742924|592862062|FG003|Overall Study|Lack of Efficacy|4|||
164136178|NCT00742924|592862059|FG000|Overall Study|Physician Decision|0|||
164136179|NCT00742924|592862060|FG001|Overall Study|Physician Decision|0|||
164136180|NCT00742924|592862061|FG002|Overall Study|Physician Decision|0|||
164136181|NCT00742924|592862062|FG003|Overall Study|Physician Decision|1|||
164319423|NCT01551420|593544709|FG000|Home Use (Part B)|Withdrawal by staff|0|||
164319424|NCT01551420|593544710|FG001|Home Use (Part B)|Withdrawal by staff|1|||
164319425|NCT04463069|593544711|FG000|Overall Study|Withdrawal by Subject|2|||
164319426|NCT04463069|593544712|FG001|Overall Study|Withdrawal by Subject|10|||
164319427|NCT04463069|593544711|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
164319428|NCT04463069|593544712|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
164319429|NCT00311584|593544713|FG000|Overall Study|Death|1|||
164319430|NCT00311584|593544714|FG001|Overall Study|Death|0|||
164319431|NCT00311584|593544713|FG000|Overall Study|Lack of Efficacy|12|||
164319432|NCT00311584|593544714|FG001|Overall Study|Lack of Efficacy|15|||
164319433|NCT00311584|593544713|FG000|Overall Study|Physician Decision|4|||
164319434|NCT00311584|593544714|FG001|Overall Study|Physician Decision|5|||
164319435|NCT00311584|593544713|FG000|Overall Study|Withdrawal by Subject|1|||
164319436|NCT00311584|593544714|FG001|Overall Study|Withdrawal by Subject|1|||
164319437|NCT00311584|593544713|FG000|Overall Study|ineligible|2|||
164319438|NCT00311584|593544714|FG001|Overall Study|ineligible|2|||
164319439|NCT03073733|593544715|FG000|Overall Study|Lost to Follow-up|1|||
164319440|NCT03073733|593544716|FG001|Overall Study|Lost to Follow-up|0|||
164319441|NCT03073733|593544717|FG002|Overall Study|Lost to Follow-up|0|||
164319442|NCT03073733|593544715|FG000|Overall Study|Physician Decision|0|||
164319443|NCT03073733|593544716|FG001|Overall Study|Physician Decision|1|||
164319444|NCT03073733|593544717|FG002|Overall Study|Physician Decision|0|||
164319445|NCT03073733|593544715|FG000|Overall Study|Withdrawal by Subject|0|||
164319446|NCT03073733|593544716|FG001|Overall Study|Withdrawal by Subject|0|||
164319447|NCT03073733|593544717|FG002|Overall Study|Withdrawal by Subject|1|||
164319448|NCT02276027|593546868|FG000|Overall Study|Death|1|||
164319449|NCT02276027|593546869|FG001|Overall Study|Death|0|||
164319450|NCT02276027|593546870|FG002|Overall Study|Death|0|||
164319451|NCT02276027|593546871|FG003|Overall Study|Death|2|||
164319452|NCT02276027|593546868|FG000|Overall Study|Physician Decision|0|||
164319453|NCT02276027|593546869|FG001|Overall Study|Physician Decision|0|||
164319454|NCT02276027|593546870|FG002|Overall Study|Physician Decision|0|||
164319455|NCT02276027|593546871|FG003|Overall Study|Physician Decision|1|||
164319456|NCT02276027|593546868|FG000|Overall Study|Progressive disease|1|||
164319457|NCT02276027|593546869|FG001|Overall Study|Progressive disease|13|||
164319458|NCT02276027|593546870|FG002|Overall Study|Progressive disease|12|||
164319459|NCT02276027|593546871|FG003|Overall Study|Progressive disease|14|||
164319460|NCT02276027|593546868|FG000|Overall Study|Subject/guardian decision|0|||
164319461|NCT02276027|593546869|FG001|Overall Study|Subject/guardian decision|1|||
164319462|NCT02276027|593546870|FG002|Overall Study|Subject/guardian decision|0|||
164319463|NCT02276027|593546871|FG003|Overall Study|Subject/guardian decision|3|||
164319464|NCT02276027|593546868|FG000|Overall Study|Adverse Event|0|||
164319465|NCT02276027|593546869|FG001|Overall Study|Adverse Event|2|||
164319466|NCT02276027|593546870|FG002|Overall Study|Adverse Event|8|||
164319467|NCT02276027|593546871|FG003|Overall Study|Adverse Event|2|||
164319468|NCT02446171|593546872|FG000|Overall Study|Withdrawal by Subject|0|||
164319469|NCT02446171|593546873|FG001|Overall Study|Withdrawal by Subject|0|||
164319470|NCT02446171|593546874|FG002|Overall Study|Withdrawal by Subject|2|||
164319471|NCT02446171|593546875|FG003|Overall Study|Withdrawal by Subject|0|||
164319472|NCT01264081|593546876|FG000|Participants Screened|Screening failures|30|||
164319473|NCT01264081|593546876|FG000|Started Treatment|Withdrawal by Subject|1|||
164319474|NCT01264081|593546876|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
164319475|NCT01727700|593546877|FG000|Overall Study|Adverse Event|0|||
164319476|NCT01727700|593546878|FG001|Overall Study|Adverse Event|7|||
164319477|NCT01727700|593546879|FG002|Overall Study|Adverse Event|1|||
164319478|NCT01727700|593546877|FG000|Overall Study|Particpant withdrew consent|0|||
164319479|NCT01727700|593546878|FG001|Overall Study|Particpant withdrew consent|3|||
164319480|NCT01727700|593546879|FG002|Overall Study|Particpant withdrew consent|1|||
164319481|NCT01727700|593546877|FG000|Overall Study|Protocol Violation|2|||
164319482|NCT01727700|593546878|FG001|Overall Study|Protocol Violation|0|||
164319483|NCT01727700|593546879|FG002|Overall Study|Protocol Violation|0|||
164319484|NCT01909791|593546882|FG000|Overall Study|Death|9|||
164319485|NCT01909791|593546883|FG001|Overall Study|Death|8|||
164319486|NCT01909791|593546884|FG002|Overall Study|Death|4|||
164319487|NCT01909791|593546882|FG000|Overall Study|Withdrawal by Subject|5|||
164319488|NCT01909791|593546883|FG001|Overall Study|Withdrawal by Subject|9|||
164319489|NCT01909791|593546884|FG002|Overall Study|Withdrawal by Subject|13|||
164319490|NCT01909791|593546882|FG000|Overall Study|Lost to Follow-up|5|||
164319491|NCT01909791|593546883|FG001|Overall Study|Lost to Follow-up|11|||
164319492|NCT01909791|593546884|FG002|Overall Study|Lost to Follow-up|10|||
164319493|NCT01909791|593546882|FG000|Overall Study|Missed Visit|2|||
164319494|NCT01909791|593546883|FG001|Overall Study|Missed Visit|0|||
164319495|NCT01909791|593546884|FG002|Overall Study|Missed Visit|1|||
164319496|NCT01009840|593546885|FG000|Overall Study|Lost to Follow-up|1|||
164319497|NCT01009840|593546885|FG000|Overall Study|Adverse Event|4|||
164319498|NCT01009840|593546885|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
164319499|NCT01009840|593546885|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
164319500|NCT01009840|593546885|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
164319501|NCT01122394|593546892|FG000|Overall Study|Withdrawal by Subject|1|||
164319502|NCT01122394|593546893|FG001|Overall Study|Withdrawal by Subject|1|||
164319503|NCT01122394|593546892|FG000|Overall Study|Lost to Follow-up|2|||
164319504|NCT01122394|593546893|FG001|Overall Study|Lost to Follow-up|2|||
164319505|NCT01122394|593546892|FG000|Overall Study|Adverse Event|0|||
164319506|NCT01122394|593546893|FG001|Overall Study|Adverse Event|1|||
164319507|NCT03739242|593546894|FG000|Overall Study|Withdrawal by Subject|1|||
164319508|NCT03739242|593546895|FG001|Overall Study|Withdrawal by Subject|1|||
164319509|NCT03739242|593546894|FG000|Overall Study|Protocol Violation|0|||
164319510|NCT03739242|593546895|FG001|Overall Study|Protocol Violation|1|||
164319511|NCT00039871|593546896|FG000|Overall Study|Adverse Event|165|||
164319512|NCT00039871|593546896|FG000|Overall Study|Lost to Follow-up|18|||
163874179|NCT00704184|591906983|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
163874180|NCT00704184|591906984|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
163874181|NCT00704184|591906985|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
163874182|NCT00704184|591906981|FG000|Open-Label Treatment|Adverse Event|0|||
163874183|NCT00704184|591906982|FG001|Open-Label Treatment|Adverse Event|0|||
163874184|NCT00704184|591906983|FG002|Open-Label Treatment|Adverse Event|2|||
163874185|NCT00704184|591906984|FG003|Open-Label Treatment|Adverse Event|0|||
163874186|NCT00704184|591906985|FG004|Open-Label Treatment|Adverse Event|1|||
163874187|NCT00704184|591906981|FG000|Open-Label Treatment|Lack of Efficacy|0|||
163874188|NCT00704184|591906982|FG001|Open-Label Treatment|Lack of Efficacy|2|||
163874189|NCT00704184|591906983|FG002|Open-Label Treatment|Lack of Efficacy|2|||
163874190|NCT00704184|591906984|FG003|Open-Label Treatment|Lack of Efficacy|2|||
163874191|NCT00704184|591906985|FG004|Open-Label Treatment|Lack of Efficacy|1|||
163874192|NCT00704184|591906981|FG000|Open-Label Treatment|Physician Decision|0|||
163874193|NCT00704184|591906982|FG001|Open-Label Treatment|Physician Decision|0|||
163874194|NCT00704184|591906983|FG002|Open-Label Treatment|Physician Decision|0|||
163874195|NCT00704184|591906984|FG003|Open-Label Treatment|Physician Decision|0|||
163874196|NCT00704184|591906985|FG004|Open-Label Treatment|Physician Decision|1|||
163874197|NCT00704184|591906981|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
163874198|NCT00704184|591906982|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
163874199|NCT00704184|591906983|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
163874200|NCT00704184|591906984|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
163874201|NCT00704184|591906985|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
163874202|NCT00716859|591906988|FG000|Overall Study|Adverse Event|4|||
163874203|NCT00716859|591906989|FG001|Overall Study|Adverse Event|1|||
163874204|NCT00716859|591906988|FG000|Overall Study|Lack of Efficacy|3|||
163874205|NCT00716859|591906989|FG001|Overall Study|Lack of Efficacy|0|||
163874206|NCT00716859|591906988|FG000|Overall Study|Withdrawal by Subject|1|||
163874207|NCT00716859|591906989|FG001|Overall Study|Withdrawal by Subject|3|||
163874208|NCT00716859|591906988|FG000|Overall Study|Not treated|1|||
163874209|NCT00716859|591906989|FG001|Overall Study|Not treated|1|||
163874210|NCT02178098|591906990|FG000|Overall Study|Withdrawal by Subject|0|||
163874211|NCT02178098|591906991|FG001|Overall Study|Withdrawal by Subject|6|||
163874212|NCT02178098|591906990|FG000|Overall Study|Adverse Event|1|||
163874213|NCT02178098|591906991|FG001|Overall Study|Adverse Event|2|||
163874214|NCT02178098|591906990|FG000|Overall Study|Protocol Violation|1|||
163874215|NCT02178098|591906991|FG001|Overall Study|Protocol Violation|1|||
163874216|NCT02178098|591906990|FG000|Overall Study|Lost to Follow-up|0|||
163874217|NCT02178098|591906991|FG001|Overall Study|Lost to Follow-up|1|||
163874218|NCT02178098|591906990|FG000|Overall Study|Sponsor Request|1|||
163874219|NCT02178098|591906991|FG001|Overall Study|Sponsor Request|0|||
163874220|NCT02178098|591906990|FG000|Overall Study|Other|2|||
163874221|NCT02178098|591906991|FG001|Overall Study|Other|2|||
163874222|NCT01109524|591906997|FG000|Overall Study|Disease Progression|29|||
163874223|NCT01109524|591906997|FG000|Overall Study|Study Drug toxicity|6|||
163874224|NCT01109524|591906997|FG000|Overall Study|Adverse Event|4|||
163874225|NCT01109524|591906997|FG000|Overall Study|Withdrawal by Subject|2|||
163874226|NCT01109524|591906997|FG000|Overall Study|Maximum clinical benefit|3|||
163874227|NCT01109524|591906997|FG000|Overall Study|Death|2|||
163874228|NCT01109524|591906997|FG000|Overall Study|No longer meets criteria|2|||
163874229|NCT01109524|591906997|FG000|Overall Study|Participant requested to end treatment|4|||
163874230|NCT01109524|591906997|FG000|Overall Study|Other|5|||
163874231|NCT00411216|591906998|FG000|Overall Study|Ten participants were entered into the c|0|||
163874232|NCT00411216|591906999|FG001|Overall Study|Ten participants were entered into the c|2|||
163874233|NCT01205048|591907000|FG000|Overall Study|Withdrawal by Subject|14|||
163874234|NCT01205048|591907000|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
163874235|NCT01205048|591907000|FG000|Overall Study|Lost to Follow-up|4|||
163874236|NCT01205048|591907000|FG000|Overall Study|Other|2|||
163874237|NCT00823472|591907001|FG000|Overall Study|Physician Decision|24|||
164319513|NCT00039871|593546896|FG000|Overall Study|Protocol Violation|24|||
163874238|NCT00823472|591907002|FG001|Overall Study|Physician Decision|28|||
163874239|NCT01251354|591907015|FG000|Overall Study|Adverse Event|1|||
163874240|NCT01251354|591907015|FG000|Overall Study|Investigator's Decision|1|||
164319514|NCT00039871|593546896|FG000|Overall Study|Withdrawal by Subject|97|||
164319515|NCT00039871|593546896|FG000|Overall Study|Did not meet eligibility criteria|11|||
164319516|NCT00039871|593546896|FG000|Overall Study|Administrative|1|||
164319517|NCT00039871|593546896|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
164319518|NCT00039871|593546896|FG000|Overall Study|Never entered follow-up|7|||
164319519|NCT02446743|593546897|FG000|Overall Study|Withdrawal by Subject|1|||
164319520|NCT02446743|593546898|FG001|Overall Study|Withdrawal by Subject|1|||
164319521|NCT02446743|593546897|FG000|Overall Study|Lost to Follow-up|1|||
164319522|NCT02446743|593546898|FG001|Overall Study|Lost to Follow-up|0|||
164319523|NCT02446743|593546897|FG000|Overall Study|Adverse Event|1|||
164319524|NCT02446743|593546898|FG001|Overall Study|Adverse Event|1|||
164319525|NCT02446743|593546897|FG000|Overall Study|Other|2|||
164319526|NCT02446743|593546898|FG001|Overall Study|Other|3|||
164319527|NCT03086967|593546899|FG000|Overall Study|Screen Failure|2|||
164319528|NCT03086967|593546900|FG001|Overall Study|Screen Failure|2|||
164319529|NCT02478398|593546901|FG000|Overall Study|Adverse Event|20|||
164319530|NCT02478398|593546902|FG001|Overall Study|Adverse Event|5|||
164319531|NCT02478398|593546901|FG000|Overall Study|Lost to Follow-up|5|||
164319532|NCT02478398|593546902|FG001|Overall Study|Lost to Follow-up|4|||
164319533|NCT02478398|593546901|FG000|Overall Study|Non-Compliance With Study Drug|5|||
164319534|NCT02478398|593546902|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164319535|NCT02478398|593546901|FG000|Overall Study|Protocol Violation|3|||
164319536|NCT02478398|593546902|FG001|Overall Study|Protocol Violation|1|||
164319537|NCT02478398|593546901|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
164319538|NCT02478398|593546902|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
164319539|NCT02478398|593546901|FG000|Overall Study|Withdrawal By Participant|10|||
164319540|NCT02478398|593546902|FG001|Overall Study|Withdrawal By Participant|4|||
164319541|NCT01475071|593546910|FG000|Overall Study|Physician Decision|1|||
164319542|NCT01475071|593546910|FG000|Overall Study|Withdrawal by Subject|6|||
164319543|NCT01475071|593546910|FG000|Overall Study|Lost to Follow-up|1|||
164319544|NCT02230527|593546911|FG000|Overall Study|Withdrawal by Subject|1|||
164319545|NCT02230527|593546912|FG001|Overall Study|Withdrawal by Subject|1|||
164319546|NCT02230527|593546911|FG000|Overall Study|Death|1|||
164319547|NCT02230527|593546912|FG001|Overall Study|Death|0|||
164319548|NCT02230527|593546911|FG000|Overall Study|Lost to Follow-up|2|||
164319549|NCT02230527|593546912|FG001|Overall Study|Lost to Follow-up|1|||
164319550|NCT02230527|593546911|FG000|Overall Study|Other|1|||
164319551|NCT02230527|593546912|FG001|Overall Study|Other|0|||
164319552|NCT01752036|593546913|FG000|Overall Study|Death|2|||
164319553|NCT01011478|593546914|FG000|Overall Study|No follow up data|12|||
164319554|NCT01011478|593546915|FG001|Overall Study|No follow up data|7|||
164319555|NCT01205581|593546919|FG000|Overall Study|Withdrawal by Subject|1|||
164319556|NCT01205581|593546920|FG001|Overall Study|Withdrawal by Subject|0|||
164319557|NCT01205581|593546921|FG002|Overall Study|Withdrawal by Subject|0|||
164319558|NCT01205581|593546922|FG003|Overall Study|Withdrawal by Subject|0|||
164319559|NCT01205581|593546923|FG004|Overall Study|Withdrawal by Subject|0|||
164319560|NCT01205581|593546924|FG005|Overall Study|Withdrawal by Subject|0|||
164319561|NCT03337490|593546925|FG000|Overall Study|Withdrawal by Subject|1|||
164319562|NCT03337490|593546926|FG001|Overall Study|Withdrawal by Subject|0|||
164319563|NCT03337490|593546927|FG002|Overall Study|Withdrawal by Subject|0|||
164319564|NCT03337490|593546925|FG000|Overall Study|Lack of Efficacy|10|||
164319565|NCT03337490|593546926|FG001|Overall Study|Lack of Efficacy|12|||
164319566|NCT03337490|593546927|FG002|Overall Study|Lack of Efficacy|35|||
164319567|NCT03337490|593546925|FG000|Overall Study|Physician Decision|0|||
164319568|NCT03337490|593546926|FG001|Overall Study|Physician Decision|1|||
164319569|NCT03337490|593546927|FG002|Overall Study|Physician Decision|0|||
164319570|NCT03337490|593546925|FG000|Overall Study|Lost to Follow-up|0|||
164319571|NCT03337490|593546926|FG001|Overall Study|Lost to Follow-up|1|||
164319572|NCT03337490|593546927|FG002|Overall Study|Lost to Follow-up|0|||
164319573|NCT00917644|593546928|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
164319574|NCT00917644|593546929|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
163978403|NCT00845650|592291938|FG003|Overall Study|Withdrawal by Subject|0|||
163978404|NCT00845650|592291939|FG004|Overall Study|Withdrawal by Subject|2|||
164319575|NCT00917644|593546928|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
163978405|NCT00845650|592291940|FG005|Overall Study|Withdrawal by Subject|0|||
163978406|NCT00845650|592291935|FG000|Overall Study|Lost to Follow-up|0|||
164319576|NCT00917644|593546929|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
164319577|NCT00917644|593546928|FG000|Period 2: Second Intervention|family emergency|1|||
164319578|NCT00917644|593546929|FG001|Period 2: Second Intervention|family emergency|0|||
164319579|NCT02108262|593546936|FG000|Overall Study|Non-compliance|0|||
164319580|NCT02108262|593546937|FG001|Overall Study|Non-compliance|2|||
164319581|NCT02108262|593546938|FG002|Overall Study|Non-compliance|1|||
164319582|NCT02108262|593546939|FG003|Overall Study|Non-compliance|1|||
164319583|NCT02108262|593546936|FG000|Overall Study|Randomized by error/screen failure|0|||
164319584|NCT02108262|593546937|FG001|Overall Study|Randomized by error/screen failure|0|||
164319585|NCT02108262|593546938|FG002|Overall Study|Randomized by error/screen failure|1|||
164319586|NCT02108262|593546939|FG003|Overall Study|Randomized by error/screen failure|0|||
164319587|NCT02108262|593546936|FG000|Overall Study|Distance to center|0|||
164319588|NCT02108262|593546937|FG001|Overall Study|Distance to center|1|||
164207069|NCT05516758|593126635|FG001|Overall Study|Site Terminated by Sponsor|0|||
164207070|NCT05516758|593126636|FG002|Overall Study|Site Terminated by Sponsor|0|||
164207071|NCT05516758|593126637|FG003|Overall Study|Site Terminated by Sponsor|0|||
164207072|NCT05516758|593126638|FG004|Overall Study|Site Terminated by Sponsor|0|||
164207073|NCT05516758|593126639|FG005|Overall Study|Site Terminated by Sponsor|0|||
164207074|NCT05516758|593126640|FG006|Overall Study|Site Terminated by Sponsor|0|||
164207075|NCT05516758|593126634|FG000|Overall Study|Study Terminated by Sponsor|4|||
164207076|NCT05516758|593126635|FG001|Overall Study|Study Terminated by Sponsor|0|||
164207077|NCT05516758|593126636|FG002|Overall Study|Study Terminated by Sponsor|3|||
164207078|NCT05516758|593126637|FG003|Overall Study|Study Terminated by Sponsor|0|||
164207079|NCT05516758|593126638|FG004|Overall Study|Study Terminated by Sponsor|2|||
164207080|NCT05516758|593126639|FG005|Overall Study|Study Terminated by Sponsor|3|||
164207081|NCT05516758|593126640|FG006|Overall Study|Study Terminated by Sponsor|0|||
164207082|NCT05516758|593126634|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
164207083|NCT05516758|593126635|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207084|NCT05516758|593126636|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
164207085|NCT05516758|593126637|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207086|NCT05516758|593126638|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
164207087|NCT05516758|593126639|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207088|NCT05516758|593126640|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
164207089|NCT05516758|593126634|FG000|Overall Study|Other|0|||
164207090|NCT05516758|593126635|FG001|Overall Study|Other|0|||
163874241|NCT01251354|591907015|FG000|Overall Study|Disease Progression|4|||
163874242|NCT01853748|591908530|FG000|Allocation|Withdrawal by Subject|1|||
163874243|NCT01853748|591908531|FG001|Allocation|Withdrawal by Subject|13|||
163874244|NCT01853748|591908530|FG000|Allocation|not sufficient to receive intervention|0|||
163874245|NCT01853748|591908531|FG001|Allocation|not sufficient to receive intervention|1|||
163874246|NCT01853748|591908530|FG000|Follow-Up|Withdrawal by Subject|7|||
163874247|NCT01853748|591908531|FG001|Follow-Up|Withdrawal by Subject|6|||
163874248|NCT01853748|591908530|FG000|Follow-Up|Adverse Event|67|||
163874249|NCT01853748|591908531|FG001|Follow-Up|Adverse Event|7|||
163874250|NCT01853748|591908530|FG000|Follow-Up|not available for data collection|16|||
163874251|NCT01853748|591908531|FG001|Follow-Up|not available for data collection|4|||
163874252|NCT00780416|591908536|FG000|Overall Study|Physician Decision|3|||
163874253|NCT00780416|591908537|FG001|Overall Study|Physician Decision|3|||
163874254|NCT00780416|591908536|FG000|Overall Study|Protocol Violation|1|||
163874255|NCT00780416|591908537|FG001|Overall Study|Protocol Violation|0|||
163874256|NCT00780416|591908536|FG000|Overall Study|Withdrawal by Subject|8|||
163874257|NCT00780416|591908537|FG001|Overall Study|Withdrawal by Subject|6|||
163874258|NCT02916706|591908538|FG000|Overall Study|Adverse Event|0|||
163874259|NCT02916706|591908539|FG001|Overall Study|Adverse Event|1|||
163874260|NCT02916706|591908538|FG000|Overall Study|Lost to Follow-up|0|||
163874261|NCT02916706|591908539|FG001|Overall Study|Lost to Follow-up|1|||
163874262|NCT02916706|591908538|FG000|Overall Study|Physician Decision|1|||
163874263|NCT02916706|591908539|FG001|Overall Study|Physician Decision|0|||
163874264|NCT02916706|591908538|FG000|Overall Study|Protocol Violation|3|||
163874265|NCT02916706|591908539|FG001|Overall Study|Protocol Violation|1|||
163874266|NCT02916706|591908538|FG000|Overall Study|Withdrawal by Subject|6|||
163874267|NCT02916706|591908539|FG001|Overall Study|Withdrawal by Subject|9|||
163874268|NCT02916706|591908538|FG000|Overall Study|Other|5|||
163874269|NCT02916706|591908539|FG001|Overall Study|Other|19|||
163874270|NCT02118961|591908549|FG000|Overall Study|Withdrawal by Subject|1|||
163874271|NCT02118961|591908550|FG001|Overall Study|Withdrawal by Subject|0|||
163874272|NCT03103321|591908551|FG000|Overall Study|Protocol Violation|1|||
163874273|NCT03103321|591908552|FG001|Overall Study|Protocol Violation|1|||
163874274|NCT03103321|591908553|FG002|Overall Study|Protocol Violation|1|||
163874275|NCT03103321|591908554|FG003|Overall Study|Protocol Violation|0|||
163874276|NCT03885037|591908559|FG000|Overall Study|Protocol Violation|16|||
163874277|NCT01492686|591908560|FG000|Double-blind Phase|Adverse Event|0|||
163874278|NCT01492686|591908561|FG001|Double-blind Phase|Adverse Event|2|||
163874279|NCT01492686|591908560|FG000|Double-blind Phase|Physician Decision|0|||
163874280|NCT01492686|591908561|FG001|Double-blind Phase|Physician Decision|1|||
163874281|NCT01492686|591908560|FG000|Double-blind Phase|Withdrawal by Subject|0|||
163874282|NCT01492686|591908561|FG001|Double-blind Phase|Withdrawal by Subject|2|||
163874283|NCT01492686|591908560|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
163874284|NCT01492686|591908561|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
163874285|NCT01492686|591908560|FG000|Open-label Phase|Adverse Event|1|||
163874286|NCT01492686|591908561|FG001|Open-label Phase|Adverse Event|2|||
163874287|NCT01492686|591908560|FG000|Open-label Phase|Physician Decision|1|||
163874288|NCT01492686|591908561|FG001|Open-label Phase|Physician Decision|0|||
164207091|NCT05516758|593126636|FG002|Overall Study|Other|0|||
164207092|NCT05516758|593126637|FG003|Overall Study|Other|0|||
164207093|NCT05516758|593126638|FG004|Overall Study|Other|0|||
164207094|NCT05516758|593126639|FG005|Overall Study|Other|0|||
163874289|NCT01492686|591908560|FG000|Open-label Phase|Withdrawal by Subject|6|||
163874290|NCT01492686|591908561|FG001|Open-label Phase|Withdrawal by Subject|7|||
164207095|NCT05516758|593126640|FG006|Overall Study|Other|1|||
164207096|NCT01316575|593126641|FG000|Overall Study|Withdrawal by Subject|2|||
164207097|NCT01316575|593126642|FG001|Overall Study|Withdrawal by Subject|0|||
164207098|NCT01316575|593126641|FG000|Overall Study|Required alternate treatment|0|||
164207099|NCT01316575|593126642|FG001|Overall Study|Required alternate treatment|1|||
164207100|NCT00402831|593126643|FG000|Overall Study|Lost to Follow-up|1|||
164207101|NCT00402831|593126644|FG001|Overall Study|Lost to Follow-up|2|||
164207102|NCT00402831|593126643|FG000|Overall Study|Non-compliance with protocol|0|||
164207103|NCT00402831|593126644|FG001|Overall Study|Non-compliance with protocol|1|||
164207104|NCT04585893|593126645|FG000|Overall Study|Death|1|||
163874291|NCT01492686|591908560|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
163874292|NCT01492686|591908561|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
163874293|NCT03314987|591908564|FG000|Overall Study|Lost to Follow-up|13|||
163874294|NCT03314987|591908565|FG001|Overall Study|Lost to Follow-up|13|||
163874295|NCT02992925|591908566|FG000|Cohort 2|Physician Decision|0|||
163874296|NCT02992925|591908567|FG001|Cohort 2|Physician Decision|0|||
163874297|NCT02992925|591908568|FG002|Cohort 2|Physician Decision|1|||
163874298|NCT02992925|591908569|FG003|Cohort 2|Physician Decision|0|||
163874299|NCT02992925|591908566|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
163874300|NCT02992925|591908567|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
163874301|NCT02992925|591908568|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
163874302|NCT02992925|591908569|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
163874303|NCT05678998|591908570|FG000|Overall Study|Withdrawal by Subject|1|||
163874304|NCT05678998|591908571|FG001|Overall Study|Withdrawal by Subject|1|||
163874305|NCT05678998|591908572|FG002|Overall Study|Withdrawal by Subject|3|||
163874306|NCT05678998|591908573|FG003|Overall Study|Withdrawal by Subject|0|||
163874307|NCT05678998|591908574|FG004|Overall Study|Withdrawal by Subject|1|||
163874308|NCT05678998|591908570|FG000|Overall Study|Lost to Follow-up|0|||
163874309|NCT05678998|591908571|FG001|Overall Study|Lost to Follow-up|0|||
163874310|NCT05678998|591908572|FG002|Overall Study|Lost to Follow-up|0|||
163874311|NCT05678998|591908573|FG003|Overall Study|Lost to Follow-up|0|||
163874312|NCT05678998|591908574|FG004|Overall Study|Lost to Follow-up|1|||
163874313|NCT05678998|591908570|FG000|Overall Study|Death|0|||
163874314|NCT05678998|591908571|FG001|Overall Study|Death|0|||
163874315|NCT05678998|591908572|FG002|Overall Study|Death|0|||
163874316|NCT05678998|591908573|FG003|Overall Study|Death|3|||
163874317|NCT05678998|591908574|FG004|Overall Study|Death|4|||
163874318|NCT05678998|591908570|FG000|Overall Study|Other|0|||
163874319|NCT05678998|591908571|FG001|Overall Study|Other|0|||
163874320|NCT05678998|591908572|FG002|Overall Study|Other|0|||
163874321|NCT05678998|591908573|FG003|Overall Study|Other|2|||
163874322|NCT05678998|591908574|FG004|Overall Study|Other|1|||
163874323|NCT05773313|591908577|FG000|Overall Study|Lost to Follow-up|3|||
163874324|NCT05137236|591908578|FG000|Part A|Other than Specified|1|||
163874325|NCT05137236|591908579|FG001|Part A|Other than Specified|0|||
163874326|NCT05137236|591908580|FG002|Part A|Other than Specified|0|||
163874327|NCT05137236|591908581|FG003|Part A|Other than Specified|0|||
163874328|NCT05137236|591908582|FG004|Part A|Other than Specified|0|||
163874329|NCT05137236|591908583|FG005|Part A|Other than Specified|0|||
163978407|NCT00845650|592291936|FG001|Overall Study|Lost to Follow-up|0|||
163978408|NCT00845650|592291937|FG002|Overall Study|Lost to Follow-up|3|||
163978409|NCT00845650|592291938|FG003|Overall Study|Lost to Follow-up|1|||
163978410|NCT00845650|592291939|FG004|Overall Study|Lost to Follow-up|0|||
163978411|NCT00845650|592291940|FG005|Overall Study|Lost to Follow-up|1|||
163978412|NCT00845650|592291935|FG000|Overall Study|Sponsor hold on dosing|0|||
163978413|NCT00845650|592291936|FG001|Overall Study|Sponsor hold on dosing|0|||
163978414|NCT00845650|592291937|FG002|Overall Study|Sponsor hold on dosing|0|||
163978415|NCT00845650|592291938|FG003|Overall Study|Sponsor hold on dosing|0|||
163978416|NCT00845650|592291939|FG004|Overall Study|Sponsor hold on dosing|1|||
163978417|NCT00845650|592291940|FG005|Overall Study|Sponsor hold on dosing|1|||
164207105|NCT04585893|593126646|FG001|Overall Study|Death|0|||
164207106|NCT01366092|593126647|FG000|Overall Study|Progressive cGVHD|2|||
164207107|NCT01366092|593126647|FG000|Overall Study|Physician Decision|1|||
164207108|NCT01366092|593126647|FG000|Overall Study|Withdrawal by Subject|1|||
164207109|NCT04761822|593127751|FG000|Overall Study|Adverse Event|3|||
163874330|NCT05137236|591908584|FG006|Part A|Other than Specified|0|||
163874331|NCT05137236|591908585|FG007|Part A|Other than Specified|0|||
163874332|NCT05137236|591908578|FG000|Part A|Withdrawal by Subject|0|||
163978418|NCT00845650|592291935|FG000|Overall Study|Unable to access IV line|1|||
163978419|NCT00845650|592291936|FG001|Overall Study|Unable to access IV line|0|||
164207110|NCT04761822|593127752|FG001|Overall Study|Adverse Event|1|||
164207111|NCT04761822|593127753|FG002|Overall Study|Adverse Event|1|||
164207112|NCT04761822|593127754|FG003|Overall Study|Adverse Event|3|||
164207113|NCT04761822|593127751|FG000|Overall Study|Lost to Follow-up|1|||
164207114|NCT04761822|593127752|FG001|Overall Study|Lost to Follow-up|0|||
164207115|NCT04761822|593127753|FG002|Overall Study|Lost to Follow-up|2|||
164207116|NCT04761822|593127754|FG003|Overall Study|Lost to Follow-up|3|||
164207117|NCT04761822|593127751|FG000|Overall Study|Physician Decision|0|||
164207118|NCT04761822|593127752|FG001|Overall Study|Physician Decision|1|||
164207119|NCT04761822|593127753|FG002|Overall Study|Physician Decision|0|||
164319589|NCT02108262|593546938|FG002|Overall Study|Distance to center|1|||
164319590|NCT02108262|593546939|FG003|Overall Study|Distance to center|0|||
164319591|NCT02108262|593546936|FG000|Overall Study|Adverse Event|0|||
164319592|NCT02108262|593546937|FG001|Overall Study|Adverse Event|11|||
164319593|NCT02108262|593546938|FG002|Overall Study|Adverse Event|6|||
164319594|NCT02108262|593546939|FG003|Overall Study|Adverse Event|12|||
164319595|NCT02108262|593546936|FG000|Overall Study|Death|0|||
164319596|NCT02108262|593546937|FG001|Overall Study|Death|2|||
164319597|NCT02108262|593546938|FG002|Overall Study|Death|2|||
164319598|NCT02108262|593546939|FG003|Overall Study|Death|1|||
164319599|NCT02108262|593546936|FG000|Overall Study|Lost to Follow-up|0|||
164319600|NCT02108262|593546937|FG001|Overall Study|Lost to Follow-up|0|||
164319601|NCT02108262|593546938|FG002|Overall Study|Lost to Follow-up|1|||
164319602|NCT02108262|593546939|FG003|Overall Study|Lost to Follow-up|0|||
164319603|NCT02108262|593546936|FG000|Overall Study|Physician Decision|0|||
164319604|NCT02108262|593546937|FG001|Overall Study|Physician Decision|0|||
164319605|NCT02108262|593546938|FG002|Overall Study|Physician Decision|2|||
164319606|NCT02108262|593546939|FG003|Overall Study|Physician Decision|0|||
164319607|NCT02108262|593546936|FG000|Overall Study|Withdrawal by Subject|0|||
164319608|NCT02108262|593546937|FG001|Overall Study|Withdrawal by Subject|7|||
164319609|NCT02108262|593546938|FG002|Overall Study|Withdrawal by Subject|3|||
164319610|NCT02108262|593546939|FG003|Overall Study|Withdrawal by Subject|4|||
164319611|NCT02108262|593546936|FG000|Overall Study|Due to key hepatic values|0|||
164319612|NCT02108262|593546937|FG001|Overall Study|Due to key hepatic values|1|||
164319613|NCT02108262|593546938|FG002|Overall Study|Due to key hepatic values|0|||
164319614|NCT02108262|593546939|FG003|Overall Study|Due to key hepatic values|0|||
164319615|NCT02108262|593546936|FG000|Overall Study|Unable to contact patient|0|||
164319616|NCT02108262|593546937|FG001|Overall Study|Unable to contact patient|3|||
164319617|NCT02108262|593546938|FG002|Overall Study|Unable to contact patient|1|||
164319618|NCT02108262|593546939|FG003|Overall Study|Unable to contact patient|2|||
164319619|NCT02108262|593546936|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
164319620|NCT02108262|593546937|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
164319621|NCT02108262|593546938|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
164319622|NCT02108262|593546939|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
164319623|NCT02108262|593546936|FG000|Overall Study|Patient did not want another infusion|0|||
164319624|NCT02108262|593546937|FG001|Overall Study|Patient did not want another infusion|3|||
164319625|NCT02108262|593546938|FG002|Overall Study|Patient did not want another infusion|3|||
164319626|NCT02108262|593546939|FG003|Overall Study|Patient did not want another infusion|2|||
164319627|NCT02108262|593546936|FG000|Overall Study|Vacation|0|||
164319628|NCT02108262|593546937|FG001|Overall Study|Vacation|1|||
164319629|NCT02108262|593546938|FG002|Overall Study|Vacation|0|||
164319630|NCT02108262|593546939|FG003|Overall Study|Vacation|0|||
164319631|NCT02108262|593546936|FG000|Overall Study|Patient decision|0|||
163874333|NCT05137236|591908579|FG001|Part A|Withdrawal by Subject|4|||
163874334|NCT05137236|591908580|FG002|Part A|Withdrawal by Subject|1|||
163874335|NCT05137236|591908581|FG003|Part A|Withdrawal by Subject|1|||
163874336|NCT05137236|591908582|FG004|Part A|Withdrawal by Subject|3|||
163874337|NCT05137236|591908583|FG005|Part A|Withdrawal by Subject|2|||
163874338|NCT05137236|591908584|FG006|Part A|Withdrawal by Subject|0|||
163874339|NCT05137236|591908585|FG007|Part A|Withdrawal by Subject|0|||
163874340|NCT05137236|591908578|FG000|Part A|Lost to Follow-up|5|||
163874341|NCT05137236|591908579|FG001|Part A|Lost to Follow-up|7|||
163874342|NCT05137236|591908580|FG002|Part A|Lost to Follow-up|1|||
163874343|NCT05137236|591908581|FG003|Part A|Lost to Follow-up|3|||
163874344|NCT05137236|591908582|FG004|Part A|Lost to Follow-up|3|||
163874345|NCT05137236|591908583|FG005|Part A|Lost to Follow-up|8|||
163874346|NCT05137236|591908584|FG006|Part A|Lost to Follow-up|0|||
163978420|NCT00845650|592291937|FG002|Overall Study|Unable to access IV line|0|||
164319632|NCT02108262|593546937|FG001|Overall Study|Patient decision|7|||
164319633|NCT02108262|593546938|FG002|Overall Study|Patient decision|9|||
164319634|NCT02108262|593546939|FG003|Overall Study|Patient decision|14|||
164319635|NCT02108262|593546936|FG000|Overall Study|Missed IV due to pharmacy error|0|||
164319636|NCT02108262|593546937|FG001|Overall Study|Missed IV due to pharmacy error|0|||
163874347|NCT05137236|591908585|FG007|Part A|Lost to Follow-up|0|||
163978421|NCT00845650|592291938|FG003|Overall Study|Unable to access IV line|0|||
163978422|NCT00845650|592291939|FG004|Overall Study|Unable to access IV line|0|||
164319637|NCT02108262|593546938|FG002|Overall Study|Missed IV due to pharmacy error|1|||
164319638|NCT02108262|593546939|FG003|Overall Study|Missed IV due to pharmacy error|0|||
164319639|NCT01238588|593546945|FG000|Overall Study|Withdrawal by Subject|1|||
164319640|NCT01238588|593546945|FG000|Overall Study|Physician Decision|2|||
164319641|NCT01915303|593546950|FG000|Core Phase|Adverse Event|7|||
164319642|NCT01915303|593546950|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
164319643|NCT01915303|593546950|FG000|Core Phase|Death|2|||
164319644|NCT01915303|593546950|FG000|Core Phase|Protocol Violation|2|||
164319645|NCT01915303|593546950|FG000|Core Phase|Abnormal lab value|1|||
163874348|NCT05137236|591908578|FG000|Part B|Withdrawal by Subject|0|||
163874349|NCT05137236|591908579|FG001|Part B|Withdrawal by Subject|0|||
163978423|NCT00845650|592291940|FG005|Overall Study|Unable to access IV line|0|||
164319646|NCT01915303|593546950|FG000|Core Phase|Withdrawal by Subject|1|||
164319647|NCT01915303|593546950|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
164319648|NCT01915303|593546950|FG000|Extension Phase|Withdrawal by Subject|4|||
164319649|NCT01915303|593546950|FG000|Extension Phase|Adverse Event|3|||
164319650|NCT01915303|593546950|FG000|Extension Phase|Death|1|||
164319651|NCT01915303|593546950|FG000|Extension Phase|Protocol Violation|1|||
164319652|NCT02509117|593546952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319653|NCT02509117|593546953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
164319654|NCT02509117|593546954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319655|NCT02509117|593546955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319656|NCT02509117|593546956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319657|NCT02509117|593546957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319658|NCT02509117|593546958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319659|NCT02509117|593546959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319660|NCT02509117|593546960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319661|NCT02509117|593546961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
164319662|NCT02509117|593546952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319663|NCT02509117|593546953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319664|NCT02509117|593546954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319665|NCT02509117|593546955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319666|NCT02509117|593546956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319667|NCT02509117|593546957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319668|NCT02509117|593546958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319669|NCT02509117|593546959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319670|NCT02509117|593546960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
164319671|NCT02509117|593546961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
164319672|NCT02509117|593546952|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319673|NCT02509117|593546953|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319674|NCT02509117|593546954|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319675|NCT02509117|593546955|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319676|NCT02509117|593546956|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319677|NCT02509117|593546957|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319678|NCT02509117|593546958|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319679|NCT02509117|593546959|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319680|NCT02509117|593546960|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
164319681|NCT02509117|593546961|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
164319682|NCT00280748|593546970|FG000|Overall Study|Decline in performance|3|||
163978424|NCT00677014|592291944|FG000|Overall Study|Lost to Follow-up|20|||
164319683|NCT00280748|593546970|FG000|Overall Study|Extra-cranial disease progression|1|||
164319684|NCT01433250|593546971|FG000|Overall Study|Protocol Violation|0|||
164319685|NCT01433250|593546972|FG001|Overall Study|Protocol Violation|1|||
164319686|NCT01433250|593546971|FG000|Overall Study|Withdrawal by Subject|3|||
164319687|NCT01433250|593546972|FG001|Overall Study|Withdrawal by Subject|2|||
164319688|NCT02576145|593546973|FG000|Overall Study|Adverse Event|1|||
164319689|NCT02576145|593546974|FG001|Overall Study|Adverse Event|0|||
164319690|NCT02576145|593546973|FG000|Overall Study|Withdrawal by Subject|1|||
164319691|NCT02576145|593546974|FG001|Overall Study|Withdrawal by Subject|0|||
164319692|NCT02576145|593546973|FG000|Overall Study|Acute rejection|1|||
164319693|NCT02576145|593546974|FG001|Overall Study|Acute rejection|0|||
164319694|NCT02576145|593546973|FG000|Overall Study|Tetanus Titers Decreased|0|||
164319695|NCT02576145|593546974|FG001|Overall Study|Tetanus Titers Decreased|1|||
164319696|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
164319697|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
163978425|NCT00677014|592291945|FG001|Overall Study|Lost to Follow-up|12|||
163978426|NCT00677014|592291946|FG002|Overall Study|Lost to Follow-up|24|||
163978427|NCT00677014|592291944|FG000|Overall Study|Death|6|||
163978428|NCT00677014|592291945|FG001|Overall Study|Death|15|||
163978429|NCT00677014|592291946|FG002|Overall Study|Death|7|||
164136332|NCT01629966|592862134|FG002|Overall Study|Pregnancy|0|||
164136333|NCT01629966|592862132|FG000|Overall Study|Lost to Follow-up|10|||
164136334|NCT01629966|592862133|FG001|Overall Study|Lost to Follow-up|13|||
164136335|NCT01629966|592862134|FG002|Overall Study|Lost to Follow-up|9|||
164136336|NCT01629966|592862132|FG000|Overall Study|Withdrawal by Subject|8|||
164136337|NCT01629966|592862133|FG001|Overall Study|Withdrawal by Subject|9|||
164136338|NCT01629966|592862134|FG002|Overall Study|Withdrawal by Subject|16|||
164136339|NCT01629966|592862132|FG000|Overall Study|Protocol Violation|7|||
164136340|NCT01629966|592862133|FG001|Overall Study|Protocol Violation|9|||
164136341|NCT01629966|592862134|FG002|Overall Study|Protocol Violation|7|||
164319698|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
164319699|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
164319700|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
164319701|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
164319702|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
164319703|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
164319704|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
164319705|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
164319706|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
164319707|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
164319708|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
164319709|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
164319710|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
164319711|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
164319712|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
164319713|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
164319714|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
164319715|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
164319716|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
164319717|NCT01227824|593546975|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
164319718|NCT01227824|593546976|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
164319719|NCT01227824|593546977|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
164319720|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
164319721|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
164319722|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
164319723|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
164319724|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
164319725|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
164319726|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
164319727|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
164319728|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
164319729|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
164319730|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
164319731|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
164319732|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
164319733|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
164319734|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
164319735|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
164319736|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
164319737|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
164319738|NCT01227824|593546975|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
164319739|NCT01227824|593546976|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
164319740|NCT01227824|593546977|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
164319741|NCT00995566|593546982|FG000|Overall Study|Adverse Event|2|||
164319742|NCT00995566|593546982|FG000|Overall Study|Early study termination|52|||
164319743|NCT00821509|593546985|FG000|Overall Study|Withdrawal by Subject|12|||
164319744|NCT00821509|593546986|FG001|Overall Study|Withdrawal by Subject|11|||
164319745|NCT00821509|593546987|FG002|Overall Study|Withdrawal by Subject|34|||
164319746|NCT03612856|593546988|FG000|Pre-dose Period|Physician Decision|0|||
164319747|NCT03612856|593546989|FG001|Pre-dose Period|Physician Decision|1|||
164319748|NCT03612856|593546990|FG002|Pre-dose Period|Physician Decision|1|||
164319749|NCT03612856|593546988|FG000|Pre-dose Period|Withdrawal by Subject|0|||
164319750|NCT03612856|593546989|FG001|Pre-dose Period|Withdrawal by Subject|1|||
164319751|NCT03612856|593546990|FG002|Pre-dose Period|Withdrawal by Subject|0|||
164319752|NCT01576159|593546991|FG000|Overall Study|Withdrawal by Subject|0|||
164319753|NCT01576159|593546992|FG001|Overall Study|Withdrawal by Subject|1|||
164319754|NCT01576159|593546993|FG002|Overall Study|Withdrawal by Subject|0|||
164319755|NCT01576159|593546994|FG003|Overall Study|Withdrawal by Subject|0|||
164319756|NCT01576159|593546991|FG000|Overall Study|Physician Decision|0|||
164319757|NCT01576159|593546992|FG001|Overall Study|Physician Decision|0|||
164319758|NCT01576159|593546993|FG002|Overall Study|Physician Decision|1|||
164319759|NCT01576159|593546994|FG003|Overall Study|Physician Decision|0|||
164319760|NCT01576159|593546991|FG000|Overall Study|Lost to Follow-up|0|||
164319761|NCT01576159|593546992|FG001|Overall Study|Lost to Follow-up|0|||
164319762|NCT01576159|593546993|FG002|Overall Study|Lost to Follow-up|0|||
163978430|NCT00677014|592291944|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
164319763|NCT01576159|593546994|FG003|Overall Study|Lost to Follow-up|1|||
164319764|NCT01576159|593546991|FG000|Overall Study|Protocol Violation|1|||
164319765|NCT01576159|593546992|FG001|Overall Study|Protocol Violation|0|||
164319766|NCT01576159|593546993|FG002|Overall Study|Protocol Violation|0|||
164319767|NCT01576159|593546994|FG003|Overall Study|Protocol Violation|0|||
164319768|NCT01454778|593546996|FG000|Overall Study|Lost to Follow-up|2|||
164319769|NCT01454778|593546996|FG000|Overall Study|Death|1|||
164319770|NCT01227629|593546998|FG000|Overall Study|Adverse Event|2|||
164319771|NCT01227629|593546999|FG001|Overall Study|Adverse Event|2|||
164319772|NCT01227629|593547000|FG002|Overall Study|Adverse Event|1|||
163874350|NCT05137236|591908580|FG002|Part B|Withdrawal by Subject|0|||
163874351|NCT05137236|591908581|FG003|Part B|Withdrawal by Subject|0|||
163874352|NCT05137236|591908582|FG004|Part B|Withdrawal by Subject|0|||
163874353|NCT05137236|591908583|FG005|Part B|Withdrawal by Subject|0|||
163874354|NCT05137236|591908584|FG006|Part B|Withdrawal by Subject|0|||
163874355|NCT05137236|591908585|FG007|Part B|Withdrawal by Subject|2|||
163874356|NCT05137236|591908578|FG000|Part B|Lost to Follow-up|0|||
163874357|NCT05137236|591908579|FG001|Part B|Lost to Follow-up|0|||
163874358|NCT05137236|591908580|FG002|Part B|Lost to Follow-up|0|||
163874359|NCT05137236|591908581|FG003|Part B|Lost to Follow-up|0|||
163874360|NCT05137236|591908582|FG004|Part B|Lost to Follow-up|0|||
163874361|NCT05137236|591908583|FG005|Part B|Lost to Follow-up|0|||
163874362|NCT05137236|591908584|FG006|Part B|Lost to Follow-up|5|||
163874363|NCT05137236|591908585|FG007|Part B|Lost to Follow-up|5|||
163874364|NCT05137236|591908578|FG000|Part B|Death|0|||
163874365|NCT05137236|591908579|FG001|Part B|Death|0|||
163874366|NCT05137236|591908580|FG002|Part B|Death|0|||
163874367|NCT05137236|591908581|FG003|Part B|Death|0|||
163874368|NCT05137236|591908582|FG004|Part B|Death|0|||
163874369|NCT05137236|591908583|FG005|Part B|Death|0|||
163874370|NCT05137236|591908584|FG006|Part B|Death|0|||
163874371|NCT05137236|591908585|FG007|Part B|Death|2|||
163874372|NCT01534494|591908586|FG000|Overall Study|Withdrawal by Subject|1|||
163874373|NCT00802464|591908587|FG000|Month 0 - Month 8|Adverse Event|0|||
163874374|NCT00802464|591908588|FG001|Month 0 - Month 8|Adverse Event|1|||
163874375|NCT00802464|591908589|FG002|Month 0 - Month 8|Adverse Event|1|||
163874376|NCT00802464|591908590|FG003|Month 0 - Month 8|Adverse Event|2|||
163874377|NCT00802464|591908587|FG000|Month 0 - Month 8|Protocol Violation|0|||
163874378|NCT00802464|591908588|FG001|Month 0 - Month 8|Protocol Violation|0|||
163874379|NCT00802464|591908589|FG002|Month 0 - Month 8|Protocol Violation|1|||
163874380|NCT00802464|591908590|FG003|Month 0 - Month 8|Protocol Violation|0|||
163874381|NCT00802464|591908587|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
163874382|NCT00802464|591908588|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
163874383|NCT00802464|591908589|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
163874384|NCT00802464|591908590|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
163874385|NCT00802464|591908587|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
163874386|NCT00802464|591908588|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
163874387|NCT00802464|591908589|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
163874388|NCT00802464|591908590|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
163874389|NCT00802464|591908587|FG000|Month 0 - Month 8|Other|0|||
163874390|NCT00802464|591908588|FG001|Month 0 - Month 8|Other|0|||
163874391|NCT00802464|591908589|FG002|Month 0 - Month 8|Other|1|||
163874392|NCT00802464|591908590|FG003|Month 0 - Month 8|Other|0|||
163874393|NCT00802464|591908587|FG000|Month 8 - Month 14|Adverse Event|0|||
163874394|NCT00802464|591908588|FG001|Month 8 - Month 14|Adverse Event|1|||
163874395|NCT00802464|591908589|FG002|Month 8 - Month 14|Adverse Event|0|||
163874396|NCT00802464|591908590|FG003|Month 8 - Month 14|Adverse Event|0|||
163874397|NCT00802464|591908587|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
163874398|NCT00802464|591908588|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
163874399|NCT00802464|591908589|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
163874400|NCT00802464|591908590|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
163874401|NCT00802464|591908587|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
163874402|NCT00802464|591908588|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
163874403|NCT00802464|591908589|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
163874404|NCT00802464|591908590|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
164319773|NCT01227629|593547001|FG003|Overall Study|Adverse Event|6|||
163874405|NCT00402246|591908591|FG000|Overall Study|Death|62|||
163874406|NCT00402246|591908592|FG001|Overall Study|Death|58|||
164076448|NCT03202511|592645716|FG000|Overall Study|Withdrawal by Subject|1|||
164076449|NCT03202511|592645717|FG001|Overall Study|Withdrawal by Subject|0|||
164319774|NCT01227629|593547002|FG004|Overall Study|Adverse Event|1|||
164319775|NCT01227629|593547003|FG005|Overall Study|Adverse Event|1|||
163874407|NCT00402246|591908591|FG000|Overall Study|Lost to Follow-up|20|||
163874408|NCT00402246|591908592|FG001|Overall Study|Lost to Follow-up|28|||
163874409|NCT00402246|591908591|FG000|Overall Study|Withdrawal by Subject|72|||
163874410|NCT00402246|591908592|FG001|Overall Study|Withdrawal by Subject|87|||
163874411|NCT00402246|591908591|FG000|Overall Study|Physician Decision|24|||
163874412|NCT00402246|591908592|FG001|Overall Study|Physician Decision|26|||
163874413|NCT00402246|591908591|FG000|Overall Study|Protocol Violation|25|||
163874414|NCT00402246|591908592|FG001|Overall Study|Protocol Violation|24|||
164076450|NCT00686790|592645718|FG000|Overall Study|Adverse Event|2|||
164319776|NCT01227629|593547004|FG006|Overall Study|Adverse Event|6|||
163874415|NCT00402246|591908591|FG000|Overall Study|Missed Final Visit|1|||
163874416|NCT00402246|591908592|FG001|Overall Study|Missed Final Visit|2|||
163874417|NCT00402246|591908591|FG000|Overall Study|Insurance Issues|2|||
163874418|NCT00402246|591908592|FG001|Overall Study|Insurance Issues|1|||
163874419|NCT00402246|591908591|FG000|Overall Study|Heart Transplant|0|||
163874420|NCT00402246|591908592|FG001|Overall Study|Heart Transplant|1|||
163874421|NCT00402246|591908591|FG000|Overall Study|Patient's device explanted|6|||
163874422|NCT00402246|591908592|FG001|Overall Study|Patient's device explanted|2|||
163874423|NCT00402246|591908591|FG000|Overall Study|Center Closure|5|||
163874424|NCT00402246|591908592|FG001|Overall Study|Center Closure|3|||
163874425|NCT00402246|591908591|FG000|Overall Study|Deterioriating Condition|3|||
163874426|NCT00402246|591908592|FG001|Overall Study|Deterioriating Condition|2|||
163874427|NCT00431834|591908594|FG000|Overall Study|Withdrawal by Subject|7|||
163874428|NCT00431834|591908594|FG000|Overall Study|Death|3|||
163874429|NCT00431834|591908594|FG000|Overall Study|Missed Endpoint Visit|2|||
163874430|NCT00431834|591908594|FG000|Overall Study|Lost to Follow-up|1|||
163874431|NCT02622568|591908599|FG000|Overall Study|Lost to Follow-up|5|||
163874432|NCT02622568|591908600|FG001|Overall Study|Lost to Follow-up|5|||
163874433|NCT02015520|591908605|FG000|Overall Study|Lack of Efficacy|1|||
163874434|NCT02015520|591908606|FG001|Overall Study|Lack of Efficacy|0|||
163874435|NCT02015520|591908607|FG002|Overall Study|Lack of Efficacy|3|||
163874436|NCT02015520|591908608|FG003|Overall Study|Lack of Efficacy|2|||
163874437|NCT02015520|591908605|FG000|Overall Study|Adverse Event|0|||
163874438|NCT02015520|591908606|FG001|Overall Study|Adverse Event|0|||
163874439|NCT02015520|591908607|FG002|Overall Study|Adverse Event|0|||
163874440|NCT02015520|591908608|FG003|Overall Study|Adverse Event|1|||
163874441|NCT02015520|591908605|FG000|Overall Study|Withdrawal by Subject|2|||
163874442|NCT02015520|591908606|FG001|Overall Study|Withdrawal by Subject|2|||
163874443|NCT02015520|591908607|FG002|Overall Study|Withdrawal by Subject|1|||
163874444|NCT02015520|591908608|FG003|Overall Study|Withdrawal by Subject|0|||
163874445|NCT02015520|591908605|FG000|Overall Study|Death|1|||
163874446|NCT02015520|591908606|FG001|Overall Study|Death|0|||
163874447|NCT02015520|591908607|FG002|Overall Study|Death|0|||
163874448|NCT02015520|591908608|FG003|Overall Study|Death|0|||
163874449|NCT02015520|591908605|FG000|Overall Study|Lost to Follow-up|0|||
163874450|NCT02015520|591908606|FG001|Overall Study|Lost to Follow-up|0|||
163874451|NCT02015520|591908607|FG002|Overall Study|Lost to Follow-up|1|||
163874452|NCT02015520|591908608|FG003|Overall Study|Lost to Follow-up|0|||
163874453|NCT02015520|591908605|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
163874454|NCT02015520|591908606|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
163874455|NCT02015520|591908607|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
163874456|NCT02015520|591908608|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
163874457|NCT02015520|591908605|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
163874458|NCT02015520|591908606|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
163874459|NCT02015520|591908607|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
163874460|NCT02015520|591908608|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
163874461|NCT00415519|591908615|FG000|Overall Study|Adverse Event|1|||
163874462|NCT00415519|591908616|FG001|Overall Study|Adverse Event|0|||
163874463|NCT00415519|591908615|FG000|Overall Study|Withdrawal by Subject|2|||
163874464|NCT00415519|591908616|FG001|Overall Study|Withdrawal by Subject|0|||
163874465|NCT00415519|591908615|FG000|Overall Study|Patient's convenience|1|||
163874466|NCT00415519|591908616|FG001|Overall Study|Patient's convenience|0|||
163874467|NCT04163718|591908617|FG000|Overall Study|Study terminated|12|||
163874468|NCT01985334|591908620|FG000|Overall Study|Administrative problems|1|||
163874469|NCT01985334|591908621|FG001|Overall Study|Administrative problems|1|||
163874470|NCT01985334|591908622|FG002|Overall Study|Administrative problems|0|||
163874471|NCT01985334|591908623|FG003|Overall Study|Administrative problems|2|||
163874472|NCT01985334|591908624|FG004|Overall Study|Administrative problems|0|||
163874473|NCT01985334|591908625|FG005|Overall Study|Administrative problems|1|||
163874474|NCT01985334|591908626|FG006|Overall Study|Administrative problems|1|||
163874475|NCT01985334|591908627|FG007|Overall Study|Administrative problems|3|||
163874476|NCT01985334|591908620|FG000|Overall Study|Death|1|||
163874477|NCT01985334|591908621|FG001|Overall Study|Death|0|||
163874478|NCT01985334|591908622|FG002|Overall Study|Death|0|||
163874479|NCT01985334|591908623|FG003|Overall Study|Death|3|||
163874480|NCT01985334|591908624|FG004|Overall Study|Death|0|||
163874481|NCT01985334|591908625|FG005|Overall Study|Death|0|||
163874482|NCT01985334|591908626|FG006|Overall Study|Death|1|||
163874483|NCT01985334|591908627|FG007|Overall Study|Death|2|||
163874484|NCT01985334|591908620|FG000|Overall Study|Worsening of disease|0|||
163874485|NCT01985334|591908621|FG001|Overall Study|Worsening of disease|0|||
163874486|NCT01985334|591908622|FG002|Overall Study|Worsening of disease|0|||
163874487|NCT01985334|591908623|FG003|Overall Study|Worsening of disease|1|||
163874488|NCT01985334|591908624|FG004|Overall Study|Worsening of disease|0|||
163874489|NCT01985334|591908625|FG005|Overall Study|Worsening of disease|3|||
163874490|NCT01985334|591908626|FG006|Overall Study|Worsening of disease|0|||
163874491|NCT01985334|591908627|FG007|Overall Study|Worsening of disease|1|||
163874492|NCT01985334|591908620|FG000|Overall Study|Other|2|||
163874493|NCT01985334|591908621|FG001|Overall Study|Other|9|||
164319777|NCT01227629|593547005|FG007|Overall Study|Adverse Event|6|||
164319778|NCT01227629|593547006|FG008|Overall Study|Adverse Event|4|||
164319779|NCT01227629|593547007|FG009|Overall Study|Adverse Event|0|||
164319780|NCT01227629|593546998|FG000|Overall Study|Protocol Violation|0|||
164319781|NCT01227629|593546999|FG001|Overall Study|Protocol Violation|0|||
164319782|NCT01227629|593547000|FG002|Overall Study|Protocol Violation|0|||
164319783|NCT01227629|593547001|FG003|Overall Study|Protocol Violation|1|||
164319784|NCT01227629|593547002|FG004|Overall Study|Protocol Violation|0|||
164319785|NCT01227629|593547003|FG005|Overall Study|Protocol Violation|0|||
164319786|NCT01227629|593547004|FG006|Overall Study|Protocol Violation|0|||
164319787|NCT01227629|593547005|FG007|Overall Study|Protocol Violation|0|||
164319788|NCT01227629|593547006|FG008|Overall Study|Protocol Violation|0|||
164319789|NCT01227629|593547007|FG009|Overall Study|Protocol Violation|0|||
164319790|NCT01227629|593546998|FG000|Overall Study|Lost to Follow-up|0|||
164319791|NCT01227629|593546999|FG001|Overall Study|Lost to Follow-up|0|||
164319792|NCT01227629|593547000|FG002|Overall Study|Lost to Follow-up|0|||
164319793|NCT01227629|593547001|FG003|Overall Study|Lost to Follow-up|0|||
164319794|NCT01227629|593547002|FG004|Overall Study|Lost to Follow-up|1|||
164319795|NCT01227629|593547003|FG005|Overall Study|Lost to Follow-up|0|||
164319796|NCT01227629|593547004|FG006|Overall Study|Lost to Follow-up|0|||
164319797|NCT01227629|593547005|FG007|Overall Study|Lost to Follow-up|0|||
164319798|NCT01227629|593547006|FG008|Overall Study|Lost to Follow-up|0|||
164319799|NCT01227629|593547007|FG009|Overall Study|Lost to Follow-up|0|||
164319800|NCT01227629|593546998|FG000|Overall Study|Withdrawal by Subject|0|||
164319801|NCT01227629|593546999|FG001|Overall Study|Withdrawal by Subject|0|||
164319802|NCT01227629|593547000|FG002|Overall Study|Withdrawal by Subject|0|||
164319803|NCT01227629|593547001|FG003|Overall Study|Withdrawal by Subject|0|||
164319804|NCT01227629|593547002|FG004|Overall Study|Withdrawal by Subject|0|||
164319805|NCT01227629|593547003|FG005|Overall Study|Withdrawal by Subject|0|||
164319806|NCT01227629|593547004|FG006|Overall Study|Withdrawal by Subject|2|||
164319807|NCT01227629|593547005|FG007|Overall Study|Withdrawal by Subject|0|||
164319808|NCT01227629|593547006|FG008|Overall Study|Withdrawal by Subject|0|||
164319809|NCT01227629|593547007|FG009|Overall Study|Withdrawal by Subject|1|||
164319810|NCT01227629|593546998|FG000|Overall Study|Other|0|||
164319811|NCT01227629|593546999|FG001|Overall Study|Other|0|||
164319812|NCT01227629|593547000|FG002|Overall Study|Other|0|||
164319813|NCT01227629|593547001|FG003|Overall Study|Other|1|||
164319814|NCT01227629|593547002|FG004|Overall Study|Other|0|||
164319815|NCT01227629|593547003|FG005|Overall Study|Other|0|||
164319816|NCT01227629|593547004|FG006|Overall Study|Other|0|||
164319817|NCT01227629|593547005|FG007|Overall Study|Other|0|||
164319818|NCT01227629|593547006|FG008|Overall Study|Other|2|||
164319819|NCT01227629|593547007|FG009|Overall Study|Other|1|||
164319820|NCT03224598|593548273|FG000|Overall Study|Lost to Follow-up|0|||
164319821|NCT03224598|593548274|FG001|Overall Study|Lost to Follow-up|2|||
164319822|NCT03224598|593548275|FG002|Overall Study|Lost to Follow-up|0|||
164319823|NCT03224598|593548273|FG000|Overall Study|Other|0|||
164319824|NCT03224598|593548274|FG001|Overall Study|Other|1|||
164319825|NCT03224598|593548275|FG002|Overall Study|Other|0|||
164319826|NCT03328182|593548278|FG000|Overall Study|Withdrawal by Subject|1|||
164319827|NCT03328182|593548278|FG000|Overall Study|Protocol Violation|2|||
163874494|NCT01985334|591908622|FG002|Overall Study|Other|7|||
163874495|NCT01985334|591908623|FG003|Overall Study|Other|17|||
163874496|NCT01985334|591908624|FG004|Overall Study|Other|4|||
163874497|NCT01985334|591908625|FG005|Overall Study|Other|8|||
163874498|NCT01985334|591908626|FG006|Overall Study|Other|4|||
163874499|NCT01985334|591908627|FG007|Overall Study|Other|7|||
163874500|NCT01985334|591908620|FG000|Overall Study|Protocol deviation|6|||
163978431|NCT00677014|592291945|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
164319828|NCT03328182|593548278|FG000|Overall Study|No Product Evaluated|1|||
164319829|NCT02320903|593548279|FG000|Overall Study|Withdrawal by Subject|0|||
164319830|NCT02320903|593548280|FG001|Overall Study|Withdrawal by Subject|9|||
164319831|NCT02320903|593548281|FG002|Overall Study|Withdrawal by Subject|9|||
164319832|NCT02320903|593548279|FG000|Overall Study|Exited therapy; no longer eligible|8|||
164319833|NCT02320903|593548280|FG001|Overall Study|Exited therapy; no longer eligible|2|||
164319834|NCT02320903|593548281|FG002|Overall Study|Exited therapy; no longer eligible|2|||
164319835|NCT02320903|593548279|FG000|Overall Study|Lost to Follow-up|0|||
164319836|NCT02320903|593548280|FG001|Overall Study|Lost to Follow-up|5|||
164319837|NCT02320903|593548281|FG002|Overall Study|Lost to Follow-up|5|||
164319838|NCT00773383|593548282|FG000|Overall Study|Adverse Event|4|||
164319839|NCT00773383|593548282|FG000|Overall Study|Death|1|||
164319840|NCT00773383|593548282|FG000|Overall Study|Progression of Disease|23|||
164319841|NCT00773383|593548282|FG000|Overall Study|Other|2|||
164319842|NCT00773383|593548282|FG000|Overall Study|No study dose received|1|||
163874501|NCT01985334|591908621|FG001|Overall Study|Protocol deviation|31|||
163874502|NCT01985334|591908622|FG002|Overall Study|Protocol deviation|25|||
163874503|NCT01985334|591908623|FG003|Overall Study|Protocol deviation|84|||
164319843|NCT01012219|593548285|FG000|Period 1|Withdrawal by Subject|1|||
164319844|NCT01012219|593548285|FG000|Period 2|Withdrawal by Subject|1|||
164319845|NCT03811093|593548288|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
164319846|NCT03811093|593548289|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
164319847|NCT03811093|593548288|FG000|Overall Study|Unable to measure body fat percentage|2|||
164319848|NCT03811093|593548289|FG001|Overall Study|Unable to measure body fat percentage|0|||
164319849|NCT01095094|593548291|FG000|Overall Study|Withdrawal by Subject|1|||
164319850|NCT01095094|593548291|FG000|Overall Study|Death|1|||
164319851|NCT01095094|593548291|FG000|Overall Study|Physician Decision|1|||
164319852|NCT00464490|593548294|FG000|Overall Study|Physician Decision|11|||
164319853|NCT00464490|593548295|FG001|Overall Study|Physician Decision|11|||
164319854|NCT03188042|593548298|FG000|Overall Study|Withdrawal by Subject|1|||
164319855|NCT03188042|593548299|FG001|Overall Study|Withdrawal by Subject|1|||
164319856|NCT01328366|593548303|FG000|Overall Study|Death|1|||
164319857|NCT01328366|593548303|FG000|Overall Study|Withdrawal by Subject|2|||
164319858|NCT01328366|593548303|FG000|Overall Study|Lost to Follow-up|7|||
164319859|NCT00137839|593548307|FG000|Overall Study|Adverse Event|7|||
164319860|NCT00137839|593548307|FG000|Overall Study|Physician Decision|7|||
164319861|NCT00137839|593548307|FG000|Overall Study|Death|8|||
164319862|NCT00137839|593548307|FG000|Overall Study|Disease Progression|60|||
164319863|NCT00137839|593548307|FG000|Overall Study|Not Start Treatment|1|||
164319864|NCT00137839|593548307|FG000|Overall Study|Prolonged Treatment Delay|1|||
164319865|NCT03860935|593548312|FG000|Overall Study|Withdrawal of Consent|15|||
164319866|NCT03860935|593548313|FG001|Overall Study|Withdrawal of Consent|6|||
164319867|NCT03860935|593548312|FG000|Overall Study|Death|75|||
164319868|NCT03860935|593548313|FG001|Overall Study|Death|51|||
164319869|NCT03361176|593548317|FG000|Overall Study|Lost to Follow-up|1|||
164319870|NCT03361176|593548318|FG001|Overall Study|Lost to Follow-up|2|||
164319871|NCT03361176|593548317|FG000|Overall Study|Adverse Event|0|||
164319872|NCT03361176|593548318|FG001|Overall Study|Adverse Event|2|||
164319873|NCT03361176|593548317|FG000|Overall Study|Withdrawal by Subject|0|||
164319874|NCT03361176|593548318|FG001|Overall Study|Withdrawal by Subject|1|||
164319875|NCT01437995|593548321|FG000|Overall Study|Lost to Follow-up|11|||
164319876|NCT01437995|593548322|FG001|Overall Study|Lost to Follow-up|18|||
164319877|NCT01437995|593548323|FG002|Overall Study|Lost to Follow-up|20|||
164319878|NCT04456673|593548324|FG000|Overall Study|Adverse Event|7|||
164319879|NCT04456673|593548325|FG001|Overall Study|Adverse Event|14|||
164319880|NCT04456673|593548324|FG000|Overall Study|Poor compliance to protocol|1|||
164319881|NCT04456673|593548325|FG001|Overall Study|Poor compliance to protocol|0|||
164319882|NCT04456673|593548324|FG000|Overall Study|Withdrawal by Subject|31|||
164319883|NCT04456673|593548325|FG001|Overall Study|Withdrawal by Subject|23|||
164319884|NCT04456673|593548324|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
164319885|NCT04456673|593548325|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
164319886|NCT02160002|593548326|FG000|Overall Study|Withdrawal by Subject|2|||
164319887|NCT02160002|593548327|FG001|Overall Study|Withdrawal by Subject|1|||
164319888|NCT04418661|593548328|FG000|Overall Study|Adverse Event|0|||
164319889|NCT04418661|593548329|FG001|Overall Study|Adverse Event|1|||
164319890|NCT04418661|593548330|FG002|Overall Study|Adverse Event|5|||
164319891|NCT04418661|593548331|FG003|Overall Study|Adverse Event|3|||
164319892|NCT04418661|593548332|FG004|Overall Study|Adverse Event|0|||
164319893|NCT04418661|593548333|FG005|Overall Study|Adverse Event|2|||
164319894|NCT04418661|593548328|FG000|Overall Study|Progressive disease|4|||
164319895|NCT04418661|593548329|FG001|Overall Study|Progressive disease|11|||
164319896|NCT04418661|593548330|FG002|Overall Study|Progressive disease|6|||
164319897|NCT04418661|593548331|FG003|Overall Study|Progressive disease|11|||
164319898|NCT04418661|593548332|FG004|Overall Study|Progressive disease|1|||
164319899|NCT04418661|593548333|FG005|Overall Study|Progressive disease|12|||
164319900|NCT04418661|593548328|FG000|Overall Study|Withdrawal by Subject|0|||
164319901|NCT04418661|593548329|FG001|Overall Study|Withdrawal by Subject|1|||
164319902|NCT04418661|593548330|FG002|Overall Study|Withdrawal by Subject|0|||
164319903|NCT04418661|593548331|FG003|Overall Study|Withdrawal by Subject|1|||
164319904|NCT04418661|593548332|FG004|Overall Study|Withdrawal by Subject|0|||
164319905|NCT04418661|593548333|FG005|Overall Study|Withdrawal by Subject|0|||
164319906|NCT04418661|593548328|FG000|Overall Study|Other|0|||
164319907|NCT04418661|593548329|FG001|Overall Study|Other|0|||
164319908|NCT04418661|593548330|FG002|Overall Study|Other|1|||
164319909|NCT04418661|593548331|FG003|Overall Study|Other|3|||
164319910|NCT04418661|593548332|FG004|Overall Study|Other|0|||
164319911|NCT04418661|593548333|FG005|Overall Study|Other|1|||
164319912|NCT01689532|593548334|FG000|Overall Study|Adverse Event|9|||
164319913|NCT01689532|593548335|FG001|Overall Study|Adverse Event|5|||
164319914|NCT01689532|593548334|FG000|Overall Study|Lack of Efficacy|2|||
164319915|NCT01689532|593548335|FG001|Overall Study|Lack of Efficacy|2|||
164319916|NCT01689532|593548334|FG000|Overall Study|Withdrawal by Subject|1|||
164319917|NCT01689532|593548335|FG001|Overall Study|Withdrawal by Subject|2|||
164319918|NCT01689532|593548334|FG000|Overall Study|Physician Decision|2|||
164319919|NCT01689532|593548335|FG001|Overall Study|Physician Decision|0|||
164319920|NCT01363349|593548336|FG000|Overall Study|Adverse Event|6|||
164319921|NCT01363349|593548337|FG001|Overall Study|Adverse Event|7|||
164319922|NCT01363349|593548336|FG000|Overall Study|Lack of Efficacy|3|||
164319923|NCT01363349|593548337|FG001|Overall Study|Lack of Efficacy|10|||
164319924|NCT01363349|593548336|FG000|Overall Study|Non compliance/Protocol deviations|2|||
164319925|NCT01363349|593548337|FG001|Overall Study|Non compliance/Protocol deviations|2|||
164319926|NCT01363349|593548336|FG000|Overall Study|Withdrawal by Subject|14|||
164319927|NCT01363349|593548337|FG001|Overall Study|Withdrawal by Subject|6|||
164319928|NCT01363349|593548336|FG000|Overall Study|Lost to Follow-up|5|||
164319929|NCT01363349|593548337|FG001|Overall Study|Lost to Follow-up|6|||
164319930|NCT01363349|593548336|FG000|Overall Study|Not reported|36|||
164319931|NCT01363349|593548337|FG001|Overall Study|Not reported|37|||
164319932|NCT01363349|593548336|FG000|Overall Study|missing|1|||
164319933|NCT01363349|593548337|FG001|Overall Study|missing|2|||
164319934|NCT04449029|593548349|FG000|Overall Study|Adverse Event|0|||
164319935|NCT04449029|593548350|FG001|Overall Study|Adverse Event|1|||
164319936|NCT04449029|593548351|FG002|Overall Study|Adverse Event|1|||
164319937|NCT04449029|593548352|FG003|Overall Study|Adverse Event|0|||
164319938|NCT04449029|593548353|FG004|Overall Study|Adverse Event|1|||
164319939|NCT04449029|593548354|FG005|Overall Study|Adverse Event|0|||
164319940|NCT04449029|593548355|FG006|Overall Study|Adverse Event|1|||
164319941|NCT04449029|593548356|FG007|Overall Study|Adverse Event|0|||
164319942|NCT04449029|593548349|FG000|Overall Study|Lost to Follow-up|0|||
164319943|NCT04449029|593548350|FG001|Overall Study|Lost to Follow-up|1|||
164319944|NCT04449029|593548351|FG002|Overall Study|Lost to Follow-up|0|||
164319945|NCT04449029|593548352|FG003|Overall Study|Lost to Follow-up|0|||
164319946|NCT04449029|593548353|FG004|Overall Study|Lost to Follow-up|0|||
164319947|NCT04449029|593548354|FG005|Overall Study|Lost to Follow-up|0|||
164319948|NCT04449029|593548355|FG006|Overall Study|Lost to Follow-up|0|||
164319949|NCT04449029|593548356|FG007|Overall Study|Lost to Follow-up|0|||
164319950|NCT04449029|593548349|FG000|Overall Study|Protocol Violation|0|||
164319951|NCT04449029|593548350|FG001|Overall Study|Protocol Violation|1|||
164319952|NCT04449029|593548351|FG002|Overall Study|Protocol Violation|0|||
164319953|NCT04449029|593548352|FG003|Overall Study|Protocol Violation|0|||
164319954|NCT04449029|593548353|FG004|Overall Study|Protocol Violation|0|||
164319955|NCT04449029|593548354|FG005|Overall Study|Protocol Violation|0|||
164319956|NCT04449029|593548355|FG006|Overall Study|Protocol Violation|0|||
164319957|NCT04449029|593548356|FG007|Overall Study|Protocol Violation|0|||
164319958|NCT04449029|593548349|FG000|Overall Study|Physician Decision|0|||
164319959|NCT04449029|593548350|FG001|Overall Study|Physician Decision|0|||
164319960|NCT04449029|593548351|FG002|Overall Study|Physician Decision|0|||
164319961|NCT04449029|593548352|FG003|Overall Study|Physician Decision|0|||
164319962|NCT04449029|593548353|FG004|Overall Study|Physician Decision|0|||
164319963|NCT04449029|593548354|FG005|Overall Study|Physician Decision|1|||
164319964|NCT04449029|593548355|FG006|Overall Study|Physician Decision|0|||
164319965|NCT04449029|593548356|FG007|Overall Study|Physician Decision|0|||
164319966|NCT04449029|593548349|FG000|Overall Study|Withdrawal by Subject|3|||
164319967|NCT04449029|593548350|FG001|Overall Study|Withdrawal by Subject|0|||
164319968|NCT04449029|593548351|FG002|Overall Study|Withdrawal by Subject|1|||
164319969|NCT04449029|593548352|FG003|Overall Study|Withdrawal by Subject|1|||
164319970|NCT04449029|593548353|FG004|Overall Study|Withdrawal by Subject|5|||
164319971|NCT04449029|593548354|FG005|Overall Study|Withdrawal by Subject|1|||
164319972|NCT04449029|593548355|FG006|Overall Study|Withdrawal by Subject|4|||
164319973|NCT04449029|593548356|FG007|Overall Study|Withdrawal by Subject|0|||
164319974|NCT01073462|593548358|FG000|Overall Study|Death|14|||
164319975|NCT01073462|593548358|FG000|Overall Study|Kidney transplant|10|||
163874504|NCT01985334|591908624|FG004|Overall Study|Protocol deviation|17|||
163874505|NCT01985334|591908625|FG005|Overall Study|Protocol deviation|47|||
163874506|NCT01985334|591908626|FG006|Overall Study|Protocol deviation|15|||
163874507|NCT01985334|591908627|FG007|Overall Study|Protocol deviation|42|||
163874508|NCT01985334|591908620|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
163874509|NCT01985334|591908621|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
163874510|NCT01985334|591908622|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
163874511|NCT01985334|591908623|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
163874512|NCT01985334|591908624|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
163874513|NCT01985334|591908625|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
163874514|NCT01985334|591908626|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
163874515|NCT01985334|591908627|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
163874516|NCT01985334|591908620|FG000|Overall Study|Subject withdrawal of consent|3|||
163874517|NCT01985334|591908621|FG001|Overall Study|Subject withdrawal of consent|6|||
163874518|NCT01985334|591908622|FG002|Overall Study|Subject withdrawal of consent|2|||
163874519|NCT01985334|591908623|FG003|Overall Study|Subject withdrawal of consent|28|||
163874520|NCT01985334|591908624|FG004|Overall Study|Subject withdrawal of consent|4|||
163874521|NCT01985334|591908625|FG005|Overall Study|Subject withdrawal of consent|19|||
164076451|NCT00686790|592645718|FG000|Overall Study|Withdrawal by Subject|1|||
163874522|NCT01985334|591908626|FG006|Overall Study|Subject withdrawal of consent|0|||
164076452|NCT00686790|592645718|FG000|Overall Study|Death|1|||
164319976|NCT01073462|593548358|FG000|Overall Study|Low parathyroid hormone levels|8|||
164319977|NCT01073462|593548358|FG000|Overall Study|Serious adverse event|2|||
164319978|NCT01073462|593548358|FG000|Overall Study|Lost to Follow-up|7|||
164319979|NCT00247611|593548361|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
164319980|NCT00247611|593548362|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
164319981|NCT00247611|593548361|FG000|Baselined|Completed baseline only|9|||
164319982|NCT00247611|593548362|FG001|Baselined|Completed baseline only|8|||
164319983|NCT00834080|593548363|FG000|Overall Study|Adverse Event|7|||
164319984|NCT00834080|593548363|FG000|Overall Study|Lost to Follow-up|7|||
164319985|NCT00834080|593548363|FG000|Overall Study|Withdrawal by Subject|5|||
164319986|NCT00834080|593548363|FG000|Overall Study|Other - Pregnancy|1|||
164319987|NCT00834080|593548363|FG000|Overall Study|Other - False positive tests of the UDS|1|||
164319988|NCT00834080|593548363|FG000|Overall Study|Physician Decision|1|||
164319989|NCT00834080|593548363|FG000|Overall Study|Subject Relocated|1|||
164319990|NCT04345367|593548365|FG000|Overall Study|Other|3|||
164319991|NCT04345367|593548366|FG001|Overall Study|Other|4|||
164319992|NCT04345367|593548365|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
164319993|NCT04345367|593548366|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
164319994|NCT04345367|593548365|FG000|Overall Study|Withdrawal by Subject|11|||
164319995|NCT04345367|593548366|FG001|Overall Study|Withdrawal by Subject|11|||
164319996|NCT04345367|593548365|FG000|Overall Study|Protocol Violation|4|||
164319997|NCT04345367|593548366|FG001|Overall Study|Protocol Violation|3|||
164319998|NCT04345367|593548365|FG000|Overall Study|Lost to Follow-up|2|||
164319999|NCT04345367|593548366|FG001|Overall Study|Lost to Follow-up|4|||
164320000|NCT04345367|593548365|FG000|Overall Study|Lack of Efficacy|2|||
164320001|NCT04345367|593548366|FG001|Overall Study|Lack of Efficacy|0|||
164320002|NCT04345367|593548365|FG000|Overall Study|Death|2|||
164320003|NCT04345367|593548366|FG001|Overall Study|Death|0|||
164320004|NCT04345367|593548365|FG000|Overall Study|Adverse Event|10|||
164320005|NCT04345367|593548366|FG001|Overall Study|Adverse Event|9|||
164320006|NCT00439738|593548370|FG000|Overall Study|Withdrawal by Subject|16|||
164320007|NCT00439738|593548371|FG001|Overall Study|Withdrawal by Subject|13|||
164320008|NCT00439738|593548370|FG000|Overall Study|Adverse Event|6|||
164320009|NCT00439738|593548371|FG001|Overall Study|Adverse Event|4|||
164320010|NCT00439738|593548370|FG000|Overall Study|Lost to Follow-up|5|||
164320011|NCT00439738|593548371|FG001|Overall Study|Lost to Follow-up|6|||
164320012|NCT00439738|593548370|FG000|Overall Study|Protocol Violation|6|||
164320013|NCT00439738|593548371|FG001|Overall Study|Protocol Violation|3|||
164320014|NCT00439738|593548370|FG000|Overall Study|Lack of Efficacy|2|||
164320015|NCT00439738|593548371|FG001|Overall Study|Lack of Efficacy|2|||
164320016|NCT00439738|593548370|FG000|Overall Study|Abnormal Lab Values|1|||
164320017|NCT00439738|593548371|FG001|Overall Study|Abnormal Lab Values|0|||
164320018|NCT00781885|593548374|FG000|Overall Study|Physician Decision|1|||
164320019|NCT01755026|593548375|FG000|Overall Study|Adverse Event|1|||
164320020|NCT01755026|593548376|FG001|Overall Study|Adverse Event|0|||
164320021|NCT01755026|593548375|FG000|Overall Study|Withdrawal by Subject|1|||
164320022|NCT01755026|593548376|FG001|Overall Study|Withdrawal by Subject|1|||
164320023|NCT03836001|593548377|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
164320024|NCT03836001|593548378|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
164320025|NCT03836001|593548379|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
164320026|NCT03836001|593548377|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
164320027|NCT03836001|593548378|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
164320028|NCT03836001|593548379|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
164320029|NCT03836001|593548377|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
164320030|NCT03836001|593548378|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
164320031|NCT03836001|593548379|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
164320032|NCT03836001|593548377|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
164320033|NCT03836001|593548378|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
164320034|NCT03836001|593548379|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
164320035|NCT00392379|593548382|FG000|Overall Study|Withdrawal by Subject|17|||
164320036|NCT00392379|593548383|FG001|Overall Study|Withdrawal by Subject|28|||
164320037|NCT00392379|593548382|FG000|Overall Study|Lost to Follow-up|4|||
164320038|NCT00392379|593548383|FG001|Overall Study|Lost to Follow-up|9|||
164320039|NCT00392379|593548382|FG000|Overall Study|Adverse Event|1|||
164320040|NCT00392379|593548383|FG001|Overall Study|Adverse Event|1|||
164320041|NCT01700387|593548389|FG000|Overall Study|Withdrawal by Subject|1|||
164320042|NCT01700387|593548390|FG001|Overall Study|Withdrawal by Subject|2|||
164320043|NCT01700387|593548389|FG000|Overall Study|Adverse Event|1|||
164320044|NCT01700387|593548390|FG001|Overall Study|Adverse Event|1|||
164320045|NCT01700387|593548389|FG000|Overall Study|Lost to Follow-up|2|||
164320046|NCT01700387|593548390|FG001|Overall Study|Lost to Follow-up|1|||
164320047|NCT02730793|593548393|FG000|Overall Study|Physician Decision|0|||
164320048|NCT02730793|593548394|FG001|Overall Study|Physician Decision|1|||
164320049|NCT02730793|593548393|FG000|Overall Study|Withdrawal by Subject|0|||
164320050|NCT02730793|593548394|FG001|Overall Study|Withdrawal by Subject|1|||
164320051|NCT02365233|593548395|FG000|Overall Study|IRB withheld the data|1|||
164320052|NCT02365233|593548396|FG001|Overall Study|IRB withheld the data|2|||
164320053|NCT02365233|593548397|FG002|Overall Study|IRB withheld the data|2|||
164320054|NCT00934843|593548398|FG000|Overall Study|Protocol Violation|0|||
164320055|NCT00934843|593548399|FG001|Overall Study|Protocol Violation|1|||
164320056|NCT00160667|593548400|FG000|Overall Study|Adverse Event|3|||
164320057|NCT00160667|593548401|FG001|Overall Study|Adverse Event|1|||
164320058|NCT00160667|593548402|FG002|Overall Study|Adverse Event|4|||
164320059|NCT00160667|593548400|FG000|Overall Study|Withdrawal by Subject|2|||
164320060|NCT00160667|593548401|FG001|Overall Study|Withdrawal by Subject|0|||
164320061|NCT00160667|593548402|FG002|Overall Study|Withdrawal by Subject|1|||
164320062|NCT00160667|593548400|FG000|Overall Study|Lack of Efficacy|0|||
164320063|NCT00160667|593548401|FG001|Overall Study|Lack of Efficacy|1|||
164320064|NCT00160667|593548402|FG002|Overall Study|Lack of Efficacy|0|||
164320065|NCT00160667|593548400|FG000|Overall Study|Protocol Violation|0|||
164320066|NCT00160667|593548401|FG001|Overall Study|Protocol Violation|1|||
164320067|NCT00160667|593548402|FG002|Overall Study|Protocol Violation|0|||
164320068|NCT00160667|593548400|FG000|Overall Study|Patient decision|0|||
164320069|NCT00160667|593548401|FG001|Overall Study|Patient decision|0|||
164320070|NCT00160667|593548402|FG002|Overall Study|Patient decision|1|||
164320071|NCT00336583|593550100|FG000|Overall Study|Lost to Follow-up|1|||
164320072|NCT00336583|593550100|FG000|Overall Study|Death|1|||
164320073|NCT00003830|593550101|FG000|Overall Study|No follow up data|3|||
164320074|NCT00003830|593550102|FG001|Overall Study|No follow up data|0|||
164320075|NCT00003830|593550101|FG000|Overall Study|Sentinel node positive patients|829|||
164320076|NCT00003830|593550102|FG001|Overall Study|Sentinel node positive patients|793|||
164320077|NCT00883688|593550103|FG000|Overall Study|Ineligible|2|||
164320078|NCT04461600|593550104|FG000|Overall Study|Death|6|||
164320079|NCT04461600|593550105|FG001|Overall Study|Death|5|||
164320080|NCT04461600|593550104|FG000|Overall Study|Withdrawal by Subject|0|||
164320081|NCT04461600|593550105|FG001|Overall Study|Withdrawal by Subject|1|||
163978432|NCT00677014|592291946|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
163978433|NCT01326546|592291949|FG000|Overall Study|Lost to Follow-up|8|||
163978434|NCT01326546|592291950|FG001|Overall Study|Lost to Follow-up|7|||
163978435|NCT01326546|592291949|FG000|Overall Study|Protocol Violation|3|||
163978436|NCT01326546|592291950|FG001|Overall Study|Protocol Violation|4|||
163978437|NCT01326546|592291949|FG000|Overall Study|Pregnancy|0|||
163978438|NCT01326546|592291950|FG001|Overall Study|Pregnancy|1|||
163978439|NCT01326546|592291949|FG000|Overall Study|Adverse Event|1|||
164320082|NCT00704522|593550107|FG000|Overall Study|Lack of Efficacy|65|||
164320083|NCT00704522|593550108|FG001|Overall Study|Lack of Efficacy|17|||
164320084|NCT00704522|593550107|FG000|Overall Study|Failure to appear again at hospital|56|||
164320085|NCT00704522|593550108|FG001|Overall Study|Failure to appear again at hospital|10|||
164320086|NCT00704522|593550107|FG000|Overall Study|Withdrawal by Subject|17|||
164320087|NCT00704522|593550108|FG001|Overall Study|Withdrawal by Subject|8|||
164320088|NCT00704522|593550107|FG000|Overall Study|Adverse Event|9|||
164320089|NCT00704522|593550108|FG001|Overall Study|Adverse Event|1|||
164320090|NCT00704522|593550107|FG000|Overall Study|Undefined causes|9|||
164320091|NCT00704522|593550108|FG001|Overall Study|Undefined causes|7|||
164320092|NCT00704522|593550107|FG000|Overall Study|No information on therapy end|27|||
164320093|NCT00704522|593550108|FG001|Overall Study|No information on therapy end|2|||
164320094|NCT04896229|593550110|FG000|Overall Study|Lost to Follow-up|113|||
164320095|NCT04896229|593550111|FG001|Overall Study|Lost to Follow-up|113|||
164320096|NCT04395001|593550112|FG000|Overall Study|Lost to Follow-up|8|||
164320097|NCT04395001|593550113|FG001|Overall Study|Lost to Follow-up|9|||
164320098|NCT04395001|593550114|FG002|Overall Study|Lost to Follow-up|5|||
164320099|NCT04395001|593550112|FG000|Overall Study|Withdrawal by Subject|3|||
164320100|NCT04395001|593550113|FG001|Overall Study|Withdrawal by Subject|1|||
163978440|NCT01326546|592291950|FG001|Overall Study|Adverse Event|0|||
163978441|NCT01326546|592291949|FG000|Overall Study|Withdrawal by Subject|5|||
163978442|NCT01326546|592291950|FG001|Overall Study|Withdrawal by Subject|1|||
163978443|NCT00081159|592291954|FG000|Overall Study|Withdrawal by Subject|0|||
163978444|NCT00081159|592291955|FG001|Overall Study|Withdrawal by Subject|3|||
163978445|NCT00081159|592291954|FG000|Overall Study|Myelosuppression prior to treatment|0|||
163978446|NCT00081159|592291955|FG001|Overall Study|Myelosuppression prior to treatment|1|||
163978447|NCT00081159|592291954|FG000|Overall Study|Lost to Follow-up|2|||
164320101|NCT04395001|593550114|FG002|Overall Study|Withdrawal by Subject|3|||
164320102|NCT04395001|593550112|FG000|Overall Study|missed appointment|7|||
164320103|NCT04395001|593550113|FG001|Overall Study|missed appointment|4|||
164320104|NCT04395001|593550114|FG002|Overall Study|missed appointment|1|||
164320105|NCT00635024|593550115|FG000|Overall Study|Adverse Event|1|||
164320106|NCT01958489|593550116|FG000|Period 2|Adverse Event|0|||
164320107|NCT01958489|593550117|FG001|Period 2|Adverse Event|1|||
163978448|NCT00081159|592291955|FG001|Overall Study|Lost to Follow-up|1|||
163978449|NCT01714687|592291956|FG000|Overall Study|Withdrawal by Subject|1|||
163978450|NCT01714687|592291957|FG001|Overall Study|Withdrawal by Subject|0|||
164320108|NCT00992589|593550118|FG000|Open-Label Phase|Adverse Event|4|||
164320109|NCT00992589|593550119|FG001|Open-Label Phase|Adverse Event|0|||
164320110|NCT00992589|593550120|FG002|Open-Label Phase|Adverse Event|0|||
164320111|NCT00992589|593550121|FG003|Open-Label Phase|Adverse Event|0|||
164320112|NCT00992589|593550118|FG000|Open-Label Phase|Withdrawal by Subject|20|||
164320113|NCT00992589|593550119|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164320114|NCT00992589|593550120|FG002|Open-Label Phase|Withdrawal by Subject|0|||
163978451|NCT01714687|592291956|FG000|Overall Study|Lost to Follow-up|2|||
163978452|NCT01714687|592291957|FG001|Overall Study|Lost to Follow-up|4|||
163978453|NCT00923130|592291960|FG000|Overall Study|Stopped treatment due to progression|17|||
163978454|NCT00923130|592291960|FG000|Overall Study|Death|1|||
163978455|NCT00923130|592291960|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
163978456|NCT00923130|592291960|FG000|Overall Study|Switched to alternative treatment|2|||
163978457|NCT00923130|592291960|FG000|Overall Study|Refused further treatment|2|||
163978458|NCT00788372|592291961|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
163978459|NCT00788372|592291961|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
163978460|NCT00788372|592291961|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
163978461|NCT00788372|592291961|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
163978462|NCT00788372|592291961|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
163978463|NCT00788372|592291961|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
163978464|NCT00788372|592291961|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
163978465|NCT03693625|592291962|FG000|Overall Study|Adverse Event|2|||
163978466|NCT03693625|592291963|FG001|Overall Study|Adverse Event|0|||
163978467|NCT03693625|592291962|FG000|Overall Study|Study Terminated By Sponsor|20|||
163978468|NCT03693625|592291963|FG001|Overall Study|Study Terminated By Sponsor|7|||
163978469|NCT03693625|592291962|FG000|Overall Study|Withdrawal by Subject|1|||
163978470|NCT03693625|592291963|FG001|Overall Study|Withdrawal by Subject|1|||
163978471|NCT00761514|592291967|FG000|Overall Study|Adverse Event|1|||
163978472|NCT00761514|592291967|FG000|Overall Study|Withdrawal by Subject|2|||
163978473|NCT00761514|592291967|FG000|Overall Study|Lost to Follow-up|1|||
163978474|NCT00761514|592291967|FG000|Overall Study|Health insurance didn't cover study drug|1|||
163978475|NCT00761514|592291967|FG000|Overall Study|Problem complying with study visit|1|||
163978476|NCT00761514|592291967|FG000|Overall Study|Unable to pay for medications|1|||
163978477|NCT02457637|592291968|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
163978478|NCT01035905|592291969|FG000|Overall Study|Lack of Efficacy|1|||
163978479|NCT01035905|592291970|FG001|Overall Study|Lack of Efficacy|1|||
163978480|NCT00159861|592291971|FG000|Core Study - 16 Weeks|Death|3|||
163978481|NCT00159861|592291972|FG001|Core Study - 16 Weeks|Death|0|||
163978482|NCT00159861|592291971|FG000|Core Study - 16 Weeks|Adverse Event|12|||
163978483|NCT00159861|592291972|FG001|Core Study - 16 Weeks|Adverse Event|6|||
163978484|NCT00159861|592291971|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
163978485|NCT00159861|592291972|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
163978486|NCT00159861|592291971|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
163978487|NCT00159861|592291972|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
163978488|NCT00159861|592291971|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
163978489|NCT00159861|592291972|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
163978490|NCT00159861|592291971|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
163978491|NCT00159861|592291972|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
163978492|NCT00159861|592291971|FG000|Extension Study - up to 3 Years|Death|24|||
163978493|NCT00159861|592291972|FG001|Extension Study - up to 3 Years|Death|28|||
163978494|NCT00159861|592291971|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
163978495|NCT00159861|592291972|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
163978496|NCT00159861|592291971|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
163978497|NCT00159861|592291972|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
163978498|NCT00159861|592291971|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
163978499|NCT00159861|592291972|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
163978500|NCT00159861|592291971|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
163978501|NCT00159861|592291972|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
163978502|NCT01210690|592291975|FG000|Overall Study|Adverse Event|7|||
163978503|NCT01210690|592291975|FG000|Overall Study|Lack of Efficacy|12|||
163978504|NCT01210690|592291975|FG000|Overall Study|Lost to Follow-up|3|||
163978505|NCT01210690|592291975|FG000|Overall Study|Disease Remission|1|||
163978506|NCT01210690|592291975|FG000|Overall Study|Withdrawal by Subject|1|||
163978507|NCT01210690|592291975|FG000|Overall Study|Patient refused to swallow|1|||
163978508|NCT01210690|592291975|FG000|Overall Study|Patient could not take glucose|1|||
163978509|NCT01979536|592291976|FG000|Overall Study|Physician Decision|2|||
163978510|NCT01979536|592291977|FG001|Overall Study|Physician Decision|3|||
163978511|NCT01979536|592291976|FG000|Overall Study|Withdrawal by Subject|0|||
163978512|NCT01979536|592291977|FG001|Overall Study|Withdrawal by Subject|1|||
163978513|NCT01979536|592291976|FG000|Overall Study|Refusal|0|||
163978514|NCT01979536|592291977|FG001|Overall Study|Refusal|1|||
163978515|NCT01979536|592291976|FG000|Overall Study|Relapse|0|||
163978516|NCT01979536|592291977|FG001|Overall Study|Relapse|1|||
163978517|NCT01979536|592291976|FG000|Overall Study|Study terminated by Sponsor|0|||
163978518|NCT01979536|592291977|FG001|Overall Study|Study terminated by Sponsor|1|||
163978519|NCT01979536|592291976|FG000|Overall Study|Did not start treatment|0|||
163978520|NCT01979536|592291977|FG001|Overall Study|Did not start treatment|1|||
163978521|NCT01806779|592291979|FG000|Overall Study|Physician Decision|2|||
163978522|NCT01806779|592291980|FG001|Overall Study|Physician Decision|0|||
163978523|NCT01806779|592291981|FG002|Overall Study|Physician Decision|1|||
163978524|NCT01806779|592291979|FG000|Overall Study|Lack of Efficacy|1|||
164320115|NCT00992589|593550121|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164320116|NCT00992589|593550118|FG000|Open-Label Phase|Lost to Follow-up|1|||
164320117|NCT00992589|593550119|FG001|Open-Label Phase|Lost to Follow-up|0|||
164320118|NCT00992589|593550120|FG002|Open-Label Phase|Lost to Follow-up|0|||
164320119|NCT00992589|593550121|FG003|Open-Label Phase|Lost to Follow-up|0|||
164320120|NCT00992589|593550118|FG000|Open-Label Phase|Protocol Violation|3|||
164320121|NCT00992589|593550119|FG001|Open-Label Phase|Protocol Violation|0|||
164320122|NCT00992589|593550120|FG002|Open-Label Phase|Protocol Violation|0|||
164320123|NCT00992589|593550121|FG003|Open-Label Phase|Protocol Violation|0|||
164320124|NCT00992589|593550118|FG000|Open-Label Phase|Physician Decision|4|||
164320125|NCT00992589|593550119|FG001|Open-Label Phase|Physician Decision|0|||
164320126|NCT00992589|593550120|FG002|Open-Label Phase|Physician Decision|0|||
164320127|NCT00992589|593550121|FG003|Open-Label Phase|Physician Decision|0|||
164320128|NCT00992589|593550118|FG000|Open-Label Phase|Other|45|||
164320129|NCT00992589|593550119|FG001|Open-Label Phase|Other|0|||
164320130|NCT00992589|593550120|FG002|Open-Label Phase|Other|0|||
164320131|NCT00992589|593550121|FG003|Open-Label Phase|Other|0|||
164320132|NCT00992589|593550118|FG000|Double-Blind Phase|Adverse Event|0|||
164320133|NCT00992589|593550119|FG001|Double-Blind Phase|Adverse Event|6|||
164320134|NCT00992589|593550120|FG002|Double-Blind Phase|Adverse Event|2|||
164320135|NCT00992589|593550121|FG003|Double-Blind Phase|Adverse Event|3|||
164320136|NCT00992589|593550118|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164320137|NCT00992589|593550119|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
164320138|NCT00992589|593550120|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
164320139|NCT00992589|593550121|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
164320140|NCT00992589|593550118|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164320141|NCT00992589|593550119|FG001|Double-Blind Phase|Lost to Follow-up|0|||
164320142|NCT00992589|593550120|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164320143|NCT00992589|593550121|FG003|Double-Blind Phase|Lost to Follow-up|2|||
164320144|NCT00992589|593550118|FG000|Double-Blind Phase|Other|0|||
164320145|NCT00992589|593550119|FG001|Double-Blind Phase|Other|1|||
164320146|NCT00992589|593550120|FG002|Double-Blind Phase|Other|6|||
164320147|NCT00992589|593550121|FG003|Double-Blind Phase|Other|3|||
164320148|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
164320149|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320150|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320151|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320152|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320153|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320154|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320155|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320156|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
164320157|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Adverse Event|5|||
164320158|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Adverse Event|0|||
164320159|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Adverse Event|0|||
164320160|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Adverse Event|0|||
164320161|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Adverse Event|0|||
164320162|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Adverse Event|0|||
164320163|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Adverse Event|0|||
164320164|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Adverse Event|0|||
164320165|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Adverse Event|0|||
164320166|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
163874523|NCT01985334|591908627|FG007|Overall Study|Subject withdrawal of consent|20|||
163874524|NCT01985334|591908620|FG000|Overall Study|Adverse Event|0|||
163874525|NCT01985334|591908621|FG001|Overall Study|Adverse Event|8|||
163874526|NCT01985334|591908622|FG002|Overall Study|Adverse Event|2|||
163874527|NCT01985334|591908623|FG003|Overall Study|Adverse Event|26|||
163874528|NCT01985334|591908624|FG004|Overall Study|Adverse Event|3|||
163874529|NCT01985334|591908625|FG005|Overall Study|Adverse Event|18|||
163978525|NCT01806779|592291980|FG001|Overall Study|Lack of Efficacy|1|||
163874530|NCT01985334|591908626|FG006|Overall Study|Adverse Event|3|||
163874531|NCT01985334|591908627|FG007|Overall Study|Adverse Event|15|||
163978526|NCT01806779|592291981|FG002|Overall Study|Lack of Efficacy|0|||
163874532|NCT01985334|591908620|FG000|Overall Study|Other|4|||
163978527|NCT01806779|592291979|FG000|Overall Study|Lost to Follow-up|19|||
163978528|NCT01806779|592291980|FG001|Overall Study|Lost to Follow-up|20|||
164320167|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320168|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320169|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320170|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320171|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320172|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
163978529|NCT01806779|592291981|FG002|Overall Study|Lost to Follow-up|0|||
164320173|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320174|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
164320175|NCT00045942|593550122|FG000|PKC412A2104 (Core)|Death|1|||
164320176|NCT00045942|593550123|FG001|PKC412A2104 (Core)|Death|0|||
163978530|NCT01806779|592291979|FG000|Overall Study|Withdrawal by Subject|20|||
164320177|NCT00045942|593550124|FG002|PKC412A2104 (Core)|Death|0|||
163978531|NCT01806779|592291980|FG001|Overall Study|Withdrawal by Subject|23|||
163978532|NCT01806779|592291981|FG002|Overall Study|Withdrawal by Subject|22|||
163978533|NCT00805480|592291982|FG000|Overall Study|Withdrawal by Subject|13|||
163978534|NCT00805480|592291983|FG001|Overall Study|Withdrawal by Subject|5|||
163978535|NCT00805480|592291984|FG002|Overall Study|Withdrawal by Subject|11|||
163978536|NCT00805480|592291985|FG003|Overall Study|Withdrawal by Subject|5|||
163978537|NCT00805480|592291982|FG000|Overall Study|Lost to Follow-up|1|||
163978538|NCT00805480|592291983|FG001|Overall Study|Lost to Follow-up|2|||
163978539|NCT00805480|592291984|FG002|Overall Study|Lost to Follow-up|0|||
163978540|NCT00805480|592291985|FG003|Overall Study|Lost to Follow-up|0|||
163978541|NCT00805480|592291982|FG000|Overall Study|Adverse Event|0|||
163978542|NCT00805480|592291983|FG001|Overall Study|Adverse Event|0|||
163978543|NCT00805480|592291984|FG002|Overall Study|Adverse Event|1|||
163978544|NCT00805480|592291985|FG003|Overall Study|Adverse Event|0|||
163978545|NCT05038020|592291986|FG000|Overall Study|Early Termination|3|||
163978546|NCT05038020|592291987|FG001|Overall Study|Early Termination|0|||
163978547|NCT00733954|592291990|FG000|Overall Study|Lost to Follow-up|5|||
163978548|NCT00733954|592291991|FG001|Overall Study|Lost to Follow-up|2|||
163978549|NCT00733954|592291990|FG000|Overall Study|Protocol Violation|1|||
163978550|NCT00733954|592291991|FG001|Overall Study|Protocol Violation|0|||
163978551|NCT00733954|592291990|FG000|Overall Study|Withdrawal by Subject|2|||
163978552|NCT00733954|592291991|FG001|Overall Study|Withdrawal by Subject|0|||
163978553|NCT02663453|592291992|FG000|Overall Study|Death|4|||
163978554|NCT02663453|592291993|FG001|Overall Study|Death|4|||
163978555|NCT02663453|592291992|FG000|Overall Study|Withdrawal by Subject|1|||
163978556|NCT02663453|592291993|FG001|Overall Study|Withdrawal by Subject|0|||
163978557|NCT03416153|592291994|FG000|Overall Study|Physician Decision|1|||
163978558|NCT03416153|592291995|FG001|Overall Study|Physician Decision|1|||
163978559|NCT03416153|592291994|FG000|Overall Study|Withdrawal by Subject|1|||
163978560|NCT03416153|592291995|FG001|Overall Study|Withdrawal by Subject|0|||
163978561|NCT03468855|592293497|FG000|Overall Study|Adverse Event|2|||
163978562|NCT03468855|592293497|FG000|Overall Study|Lost to Follow-up|5|||
163978563|NCT03468855|592293497|FG000|Overall Study|Withdrawal by Subject|3|||
163978564|NCT03468855|592293497|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
163978565|NCT01908101|592293498|FG000|Overall Study|Physician Decision|1|||
163978566|NCT01908101|592293498|FG000|Overall Study|Withdrawal by Subject|1|||
163978567|NCT01908101|592293498|FG000|Overall Study|Incorrect Diagnosis|2|||
164320178|NCT00045942|593550125|FG003|PKC412A2104 (Core)|Death|0|||
164320179|NCT00045942|593550126|FG004|PKC412A2104 (Core)|Death|0|||
164320180|NCT00045942|593550127|FG005|PKC412A2104 (Core)|Death|0|||
163978568|NCT01908101|592293498|FG000|Overall Study|Incorrect Starting Dose|1|||
163978569|NCT01908101|592293498|FG000|Overall Study|Did not complete the first cycle|4|||
163978570|NCT01394939|592293499|FG000|Overall Study|Adverse Event|1|||
163978571|NCT01394939|592293500|FG001|Overall Study|Adverse Event|3|||
163978572|NCT01394939|592293501|FG002|Overall Study|Adverse Event|0|||
163978573|NCT01394939|592293502|FG003|Overall Study|Adverse Event|2|||
163978574|NCT01394939|592293499|FG000|Overall Study|Death|0|||
163978575|NCT01394939|592293500|FG001|Overall Study|Death|2|||
163978576|NCT01394939|592293501|FG002|Overall Study|Death|0|||
163978577|NCT01394939|592293502|FG003|Overall Study|Death|0|||
163978578|NCT01394939|592293499|FG000|Overall Study|Physician Decision|0|||
163978579|NCT01394939|592293500|FG001|Overall Study|Physician Decision|1|||
163978580|NCT01394939|592293501|FG002|Overall Study|Physician Decision|0|||
163978581|NCT01394939|592293502|FG003|Overall Study|Physician Decision|0|||
163978582|NCT01394939|592293499|FG000|Overall Study|Withdrawal by Subject|0|||
163978583|NCT01394939|592293500|FG001|Overall Study|Withdrawal by Subject|2|||
163978584|NCT01394939|592293501|FG002|Overall Study|Withdrawal by Subject|0|||
163978585|NCT01394939|592293502|FG003|Overall Study|Withdrawal by Subject|2|||
163978586|NCT01394939|592293499|FG000|Overall Study|Others|0|||
163978587|NCT01394939|592293500|FG001|Overall Study|Others|2|||
163978588|NCT01394939|592293501|FG002|Overall Study|Others|0|||
163978589|NCT01394939|592293502|FG003|Overall Study|Others|3|||
163978590|NCT02068547|592293505|FG000|Overall Study|Lost to Follow-up|3|||
163978591|NCT02068547|592293506|FG001|Overall Study|Lost to Follow-up|3|||
164320181|NCT00045942|593550128|FG006|PKC412A2104 (Core)|Death|0|||
164320182|NCT00045942|593550129|FG007|PKC412A2104 (Core)|Death|0|||
163978592|NCT02068547|592293505|FG000|Overall Study|Physician Decision|1|||
163978593|NCT02068547|592293506|FG001|Overall Study|Physician Decision|0|||
164320183|NCT00045942|593550130|FG008|PKC412A2104 (Core)|Death|0|||
163978594|NCT03657043|592293507|FG000|Overall Study|Withdrawal by Subject|1|||
163978595|NCT03657043|592293508|FG001|Overall Study|Withdrawal by Subject|1|||
163978596|NCT03657043|592293509|FG002|Overall Study|Withdrawal by Subject|0|||
163978597|NCT03657043|592293510|FG003|Overall Study|Withdrawal by Subject|0|||
163978598|NCT03657043|592293511|FG004|Overall Study|Withdrawal by Subject|4|||
163978599|NCT03657043|592293507|FG000|Overall Study|Study closure by Sponsor|0|||
163978600|NCT03657043|592293508|FG001|Overall Study|Study closure by Sponsor|2|||
163978601|NCT03657043|592293509|FG002|Overall Study|Study closure by Sponsor|0|||
163978602|NCT03657043|592293510|FG003|Overall Study|Study closure by Sponsor|0|||
164320184|NCT00045942|593550122|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
164320185|NCT00045942|593550123|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
164320186|NCT00045942|593550124|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
164320187|NCT00045942|593550125|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
164320188|NCT00045942|593550126|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
164320189|NCT00045942|593550127|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
164320190|NCT00045942|593550128|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
164320191|NCT00045942|593550129|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
164320192|NCT00045942|593550130|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
164320193|NCT00045942|593550122|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
164320194|NCT00045942|593550123|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
164320195|NCT00045942|593550124|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
164320196|NCT00045942|593550125|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
164320197|NCT00045942|593550126|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
164320198|NCT00045942|593550127|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
164320199|NCT00045942|593550128|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
164320200|NCT00045942|593550129|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
164320201|NCT00045942|593550130|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
164320202|NCT00045942|593550122|FG000|PKC412A2104E1|Lack of Efficacy|0|||
164320203|NCT00045942|593550123|FG001|PKC412A2104E1|Lack of Efficacy|11|||
164320204|NCT00045942|593550124|FG002|PKC412A2104E1|Lack of Efficacy|11|||
164320205|NCT00045942|593550125|FG003|PKC412A2104E1|Lack of Efficacy|23|||
164320206|NCT00045942|593550126|FG004|PKC412A2104E1|Lack of Efficacy|17|||
164320207|NCT00045942|593550127|FG005|PKC412A2104E1|Lack of Efficacy|0|||
164320208|NCT00045942|593550128|FG006|PKC412A2104E1|Lack of Efficacy|0|||
164320209|NCT00045942|593550129|FG007|PKC412A2104E1|Lack of Efficacy|0|||
164320210|NCT00045942|593550130|FG008|PKC412A2104E1|Lack of Efficacy|0|||
164320211|NCT00045942|593550122|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
164320212|NCT00045942|593550123|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
163874533|NCT01985334|591908621|FG001|Overall Study|Other|2|||
163874534|NCT01985334|591908622|FG002|Overall Study|Other|3|||
163874535|NCT01985334|591908623|FG003|Overall Study|Other|10|||
163874536|NCT01985334|591908624|FG004|Overall Study|Other|1|||
163874537|NCT01985334|591908625|FG005|Overall Study|Other|6|||
163874538|NCT01985334|591908626|FG006|Overall Study|Other|2|||
163874539|NCT01985334|591908627|FG007|Overall Study|Other|2|||
163874540|NCT01985334|591908620|FG000|Overall Study|Medication non-compliance|0|||
163874541|NCT01985334|591908621|FG001|Overall Study|Medication non-compliance|4|||
163874542|NCT01985334|591908622|FG002|Overall Study|Medication non-compliance|1|||
163874543|NCT01985334|591908623|FG003|Overall Study|Medication non-compliance|6|||
163874544|NCT01985334|591908624|FG004|Overall Study|Medication non-compliance|2|||
163874545|NCT01985334|591908625|FG005|Overall Study|Medication non-compliance|3|||
163874546|NCT01985334|591908626|FG006|Overall Study|Medication non-compliance|1|||
163874547|NCT01985334|591908627|FG007|Overall Study|Medication non-compliance|3|||
163874548|NCT01985334|591908620|FG000|Overall Study|Use of prohibited treatment|1|||
163874549|NCT01985334|591908621|FG001|Overall Study|Use of prohibited treatment|4|||
163874550|NCT01985334|591908622|FG002|Overall Study|Use of prohibited treatment|1|||
163874551|NCT01985334|591908623|FG003|Overall Study|Use of prohibited treatment|2|||
163874552|NCT01985334|591908624|FG004|Overall Study|Use of prohibited treatment|1|||
163874553|NCT01985334|591908625|FG005|Overall Study|Use of prohibited treatment|6|||
163874554|NCT01985334|591908626|FG006|Overall Study|Use of prohibited treatment|2|||
163874555|NCT01985334|591908627|FG007|Overall Study|Use of prohibited treatment|0|||
163874556|NCT01985334|591908620|FG000|Overall Study|Investigator decision|0|||
163874557|NCT01985334|591908621|FG001|Overall Study|Investigator decision|3|||
163874558|NCT01985334|591908622|FG002|Overall Study|Investigator decision|0|||
163874559|NCT01985334|591908623|FG003|Overall Study|Investigator decision|7|||
163874560|NCT01985334|591908624|FG004|Overall Study|Investigator decision|1|||
163874561|NCT01985334|591908625|FG005|Overall Study|Investigator decision|1|||
163874562|NCT01985334|591908626|FG006|Overall Study|Investigator decision|0|||
163874563|NCT01985334|591908627|FG007|Overall Study|Investigator decision|4|||
163874564|NCT01985334|591908620|FG000|Overall Study|Lost to Follow-up|0|||
163874565|NCT01985334|591908621|FG001|Overall Study|Lost to Follow-up|2|||
163874566|NCT01985334|591908622|FG002|Overall Study|Lost to Follow-up|0|||
163874567|NCT01985334|591908623|FG003|Overall Study|Lost to Follow-up|3|||
163874568|NCT01985334|591908624|FG004|Overall Study|Lost to Follow-up|1|||
163874569|NCT01985334|591908625|FG005|Overall Study|Lost to Follow-up|4|||
164320213|NCT00045942|593550124|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
164320214|NCT00045942|593550125|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
163874570|NCT01985334|591908626|FG006|Overall Study|Lost to Follow-up|0|||
163874571|NCT01985334|591908627|FG007|Overall Study|Lost to Follow-up|3|||
163874572|NCT05529979|591908628|FG000|Overall Study|Lost to Follow-up|6|||
164320215|NCT00045942|593550126|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
163874573|NCT05529979|591908628|FG000|Overall Study|Physician Decision|1|||
163874574|NCT05529979|591908628|FG000|Overall Study|non-feasibility cases|4|||
163874575|NCT05529979|591908628|FG000|Overall Study|Lack of Efficacy|3|||
163874576|NCT05529979|591908628|FG000|Overall Study|ablation not performed|1|||
164320216|NCT00045942|593550127|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
164320217|NCT00045942|593550128|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
163978603|NCT03657043|592293511|FG004|Overall Study|Study closure by Sponsor|17|||
163978604|NCT03657043|592293507|FG000|Overall Study|Lost to Follow-up|0|||
163978605|NCT03657043|592293508|FG001|Overall Study|Lost to Follow-up|0|||
163978606|NCT03657043|592293509|FG002|Overall Study|Lost to Follow-up|0|||
163978607|NCT03657043|592293510|FG003|Overall Study|Lost to Follow-up|0|||
163978608|NCT03657043|592293511|FG004|Overall Study|Lost to Follow-up|4|||
163978609|NCT03657043|592293507|FG000|Overall Study|Death|6|||
163978610|NCT03657043|592293508|FG001|Overall Study|Death|5|||
163978611|NCT03657043|592293509|FG002|Overall Study|Death|0|||
163978612|NCT03657043|592293510|FG003|Overall Study|Death|0|||
163978613|NCT03657043|592293511|FG004|Overall Study|Death|53|||
163978614|NCT03657043|592293507|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
163978615|NCT03657043|592293508|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
163978616|NCT03657043|592293509|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
163978617|NCT03657043|592293510|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
163978618|NCT03657043|592293511|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
163978619|NCT03657043|592293507|FG000|Overall Study|Adverse Event|0|||
163978620|NCT03657043|592293508|FG001|Overall Study|Adverse Event|0|||
163978621|NCT03657043|592293509|FG002|Overall Study|Adverse Event|0|||
163978622|NCT03657043|592293510|FG003|Overall Study|Adverse Event|0|||
163978623|NCT03657043|592293511|FG004|Overall Study|Adverse Event|2|||
163978624|NCT03657043|592293507|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
163978625|NCT03657043|592293508|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
163978626|NCT03657043|592293509|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
163978627|NCT03657043|592293510|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
163978628|NCT03657043|592293511|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
163978629|NCT03657043|592293507|FG000|Overall Study|Withdrawal - declined follow-up|0|||
163978630|NCT03657043|592293508|FG001|Overall Study|Withdrawal - declined follow-up|0|||
163978631|NCT03657043|592293509|FG002|Overall Study|Withdrawal - declined follow-up|0|||
163978632|NCT03657043|592293510|FG003|Overall Study|Withdrawal - declined follow-up|0|||
163978633|NCT03657043|592293511|FG004|Overall Study|Withdrawal - declined follow-up|1|||
163978634|NCT00880893|592293512|FG000|Overall Study|Protocol Violation|13|||
163978635|NCT00880893|592293513|FG001|Overall Study|Protocol Violation|1|||
163978636|NCT00880893|592293512|FG000|Overall Study|Withdrawal by Subject|15|||
163978637|NCT00880893|592293513|FG001|Overall Study|Withdrawal by Subject|11|||
163978638|NCT00880893|592293512|FG000|Overall Study|Lost to Follow-up|76|||
163978639|NCT00880893|592293513|FG001|Overall Study|Lost to Follow-up|33|||
163978640|NCT00880893|592293512|FG000|Overall Study|Serious adverse event|3|||
163978641|NCT00880893|592293513|FG001|Overall Study|Serious adverse event|0|||
163978642|NCT01736579|592293517|FG000|Overall Study|Termination of Study by Sponsor|2|||
163978643|NCT01736579|592293518|FG001|Overall Study|Termination of Study by Sponsor|2|||
163978644|NCT01995071|592293519|FG000|Overall Study|Adverse Event|0|||
163978645|NCT01995071|592293520|FG001|Overall Study|Adverse Event|0|||
163978646|NCT01995071|592293521|FG002|Overall Study|Adverse Event|0|||
163978647|NCT01995071|592293522|FG003|Overall Study|Adverse Event|0|||
163978648|NCT01995071|592293523|FG004|Overall Study|Adverse Event|0|||
163978649|NCT01995071|592293524|FG005|Overall Study|Adverse Event|0|||
163978650|NCT01995071|592293525|FG006|Overall Study|Adverse Event|1|||
163978651|NCT01995071|592293526|FG007|Overall Study|Adverse Event|0|||
163978652|NCT01995071|592293527|FG008|Overall Study|Adverse Event|0|||
163978653|NCT01995071|592293528|FG009|Overall Study|Adverse Event|0|||
163978654|NCT01995071|592293529|FG010|Overall Study|Adverse Event|0|||
163978655|NCT01995071|592293530|FG011|Overall Study|Adverse Event|0|||
163978656|NCT01995071|592293519|FG000|Overall Study|Moved|0|||
163978657|NCT01995071|592293520|FG001|Overall Study|Moved|0|||
163978658|NCT01995071|592293521|FG002|Overall Study|Moved|1|||
164320218|NCT00045942|593550129|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
164320219|NCT00045942|593550130|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
164320220|NCT00045942|593550122|FG000|PKC412A2104E1|Adverse Event|0|||
163978659|NCT01995071|592293522|FG003|Overall Study|Moved|0|||
163978660|NCT01995071|592293523|FG004|Overall Study|Moved|1|||
163978661|NCT01995071|592293524|FG005|Overall Study|Moved|0|||
163978662|NCT01995071|592293525|FG006|Overall Study|Moved|0|||
163978663|NCT01995071|592293526|FG007|Overall Study|Moved|0|||
164320221|NCT00045942|593550123|FG001|PKC412A2104E1|Adverse Event|1|||
163978664|NCT01995071|592293527|FG008|Overall Study|Moved|0|||
163978665|NCT01995071|592293528|FG009|Overall Study|Moved|0|||
163978666|NCT01995071|592293529|FG010|Overall Study|Moved|1|||
163978667|NCT01995071|592293530|FG011|Overall Study|Moved|0|||
163978668|NCT01995071|592293519|FG000|Overall Study|Lost to Follow-up|1|||
163978669|NCT01995071|592293520|FG001|Overall Study|Lost to Follow-up|0|||
163978670|NCT01995071|592293521|FG002|Overall Study|Lost to Follow-up|0|||
163978671|NCT01995071|592293522|FG003|Overall Study|Lost to Follow-up|0|||
163978672|NCT01995071|592293523|FG004|Overall Study|Lost to Follow-up|0|||
163978673|NCT01995071|592293524|FG005|Overall Study|Lost to Follow-up|0|||
163978674|NCT01995071|592293525|FG006|Overall Study|Lost to Follow-up|0|||
163978675|NCT01995071|592293526|FG007|Overall Study|Lost to Follow-up|1|||
163978676|NCT01995071|592293527|FG008|Overall Study|Lost to Follow-up|1|||
163978677|NCT01995071|592293528|FG009|Overall Study|Lost to Follow-up|0|||
163874577|NCT00093015|591908629|FG000|Overall Study|Withdrawal by Subject|194|||
163874578|NCT00093015|591908630|FG001|Overall Study|Withdrawal by Subject|171|||
163874579|NCT00093015|591908629|FG000|Overall Study|Lost to Follow-up|96|||
163874580|NCT00093015|591908630|FG001|Overall Study|Lost to Follow-up|108|||
163874581|NCT00093015|591908629|FG000|Overall Study|Death|375|||
163874582|NCT00093015|591908630|FG001|Overall Study|Death|385|||
163874583|NCT03403413|591908633|FG000|Overall Study|Lack of Efficacy|2|||
163874584|NCT02924064|591908634|FG000|Overall Study|Adverse Event|2|||
163874585|NCT02924064|591908635|FG001|Overall Study|Adverse Event|2|||
163874586|NCT02924064|591908634|FG000|Overall Study|Lost to Follow-up|0|||
163874587|NCT02924064|591908635|FG001|Overall Study|Lost to Follow-up|2|||
163874588|NCT02924064|591908634|FG000|Overall Study|Physician Decision|0|||
163874589|NCT02924064|591908635|FG001|Overall Study|Physician Decision|2|||
163874590|NCT02924064|591908634|FG000|Overall Study|Protocol Violation|1|||
163874591|NCT02924064|591908635|FG001|Overall Study|Protocol Violation|3|||
163874592|NCT02924064|591908634|FG000|Overall Study|Withdrawal by Subject|4|||
163874593|NCT02924064|591908635|FG001|Overall Study|Withdrawal by Subject|5|||
163874594|NCT02924064|591908634|FG000|Overall Study|Other|17|||
163874595|NCT02924064|591908635|FG001|Overall Study|Other|29|||
163874596|NCT00529100|591908638|FG000|Overall Study|Adverse Event|0|||
163874597|NCT00529100|591908639|FG001|Overall Study|Adverse Event|5|||
163874598|NCT00529100|591908638|FG000|Overall Study|Protocol Violation|0|||
163978678|NCT01995071|592293529|FG010|Overall Study|Lost to Follow-up|0|||
163978679|NCT01995071|592293530|FG011|Overall Study|Lost to Follow-up|0|||
164207120|NCT04761822|593127754|FG003|Overall Study|Physician Decision|0|||
164207121|NCT04761822|593127751|FG000|Overall Study|Withdrawal by Subject|3|||
164207122|NCT04761822|593127752|FG001|Overall Study|Withdrawal by Subject|8|||
164207123|NCT04761822|593127753|FG002|Overall Study|Withdrawal by Subject|1|||
164207124|NCT04761822|593127754|FG003|Overall Study|Withdrawal by Subject|11|||
164207125|NCT04761822|593127751|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
164207126|NCT04761822|593127752|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
164207127|NCT04761822|593127753|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
164207128|NCT04761822|593127754|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
164207129|NCT04761822|593127751|FG000|Overall Study|Participant requested unblinding|0|||
164207130|NCT04761822|593127752|FG001|Overall Study|Participant requested unblinding|0|||
164207131|NCT04761822|593127753|FG002|Overall Study|Participant requested unblinding|0|||
164207132|NCT04761822|593127754|FG003|Overall Study|Participant requested unblinding|1|||
164207133|NCT06217380|593127755|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
164207134|NCT06217380|593127755|FG000|Overall Study|Physician Decision|1|||
164207135|NCT06217380|593127755|FG000|Overall Study|Withdrawal by Subject|2|||
164207136|NCT02394275|593127757|FG000|Overall Study|Adverse Event|22|||
164207137|NCT02394275|593127757|FG000|Overall Study|Lost to Follow-up|7|||
164207138|NCT02471183|593127759|FG000|Main Treatment Period|Adverse Event|1|||
164207139|NCT02471183|593127759|FG000|Main Treatment Period|Withdrawal by Subject|1|||
164207140|NCT02471183|593127759|FG000|Extended Treatment Period|Lack of Efficacy|1|||
164207141|NCT00614393|593127761|FG000|Overall Study|Adverse Event|20|||
164207142|NCT00614393|593127762|FG001|Overall Study|Adverse Event|2|||
164207143|NCT00614393|593127763|FG002|Overall Study|Adverse Event|3|||
164207144|NCT00614393|593127764|FG003|Overall Study|Adverse Event|13|||
164207145|NCT00614393|593127765|FG004|Overall Study|Adverse Event|21|||
164207146|NCT00614393|593127761|FG000|Overall Study|Lost to Follow-up|0|||
164207147|NCT00614393|593127762|FG001|Overall Study|Lost to Follow-up|0|||
164207148|NCT00614393|593127763|FG002|Overall Study|Lost to Follow-up|0|||
164207149|NCT00614393|593127764|FG003|Overall Study|Lost to Follow-up|1|||
164207150|NCT00614393|593127765|FG004|Overall Study|Lost to Follow-up|2|||
164207151|NCT00614393|593127761|FG000|Overall Study|Physician Decision|17|||
164207152|NCT00614393|593127762|FG001|Overall Study|Physician Decision|0|||
164207153|NCT00614393|593127763|FG002|Overall Study|Physician Decision|1|||
164207154|NCT00614393|593127764|FG003|Overall Study|Physician Decision|8|||
164207155|NCT00614393|593127765|FG004|Overall Study|Physician Decision|9|||
164207156|NCT00614393|593127761|FG000|Overall Study|Progressive Disease|118|||
164207157|NCT00614393|593127762|FG001|Overall Study|Progressive Disease|5|||
164207158|NCT00614393|593127763|FG002|Overall Study|Progressive Disease|5|||
164207159|NCT00614393|593127764|FG003|Overall Study|Progressive Disease|138|||
164207160|NCT00614393|593127765|FG004|Overall Study|Progressive Disease|130|||
164207161|NCT00614393|593127761|FG000|Overall Study|Protocol Violation|1|||
164207162|NCT00614393|593127762|FG001|Overall Study|Protocol Violation|0|||
164207163|NCT00614393|593127763|FG002|Overall Study|Protocol Violation|0|||
164207164|NCT00614393|593127764|FG003|Overall Study|Protocol Violation|0|||
163874599|NCT00529100|591908639|FG001|Overall Study|Protocol Violation|1|||
163874600|NCT00529100|591908638|FG000|Overall Study|Progressive Disease|0|||
163874601|NCT00529100|591908639|FG001|Overall Study|Progressive Disease|1|||
163874602|NCT00529100|591908638|FG000|Overall Study|Withdrawal by Subject|0|||
163874603|NCT00529100|591908639|FG001|Overall Study|Withdrawal by Subject|1|||
164207165|NCT00614393|593127765|FG004|Overall Study|Protocol Violation|0|||
164207166|NCT00614393|593127761|FG000|Overall Study|Terminated by Sponsor|0|||
163978680|NCT01995071|592293519|FG000|Overall Study|Incarcerated|0|||
164207167|NCT00614393|593127762|FG001|Overall Study|Terminated by Sponsor|0|||
164207168|NCT00614393|593127763|FG002|Overall Study|Terminated by Sponsor|0|||
163874604|NCT00529100|591908638|FG000|Overall Study|Participant Ineligibility|0|||
163874605|NCT00529100|591908639|FG001|Overall Study|Participant Ineligibility|1|||
163874606|NCT04982315|591908644|FG000|Overall Study|Death|1|||
163874607|NCT04982315|591908645|FG001|Overall Study|Death|0|||
163874608|NCT04982315|591908646|FG002|Overall Study|Death|1|||
163874609|NCT04982315|591908644|FG000|Overall Study|Lack of Efficacy|0|||
163874610|NCT04982315|591908645|FG001|Overall Study|Lack of Efficacy|0|||
163874611|NCT04982315|591908646|FG002|Overall Study|Lack of Efficacy|2|||
163874612|NCT04982315|591908644|FG000|Overall Study|Withdrawal by Subject|24|||
163874613|NCT04982315|591908645|FG001|Overall Study|Withdrawal by Subject|1|||
163874614|NCT04982315|591908646|FG002|Overall Study|Withdrawal by Subject|2|||
163874615|NCT04982315|591908644|FG000|Overall Study|Dealing with health/life issues|3|||
163874616|NCT04982315|591908645|FG001|Overall Study|Dealing with health/life issues|4|||
163874617|NCT04982315|591908646|FG002|Overall Study|Dealing with health/life issues|7|||
163874618|NCT04982315|591908644|FG000|Overall Study|Privacy concerns|1|||
163874619|NCT04982315|591908645|FG001|Overall Study|Privacy concerns|0|||
163874620|NCT04982315|591908646|FG002|Overall Study|Privacy concerns|0|||
163874621|NCT04982315|591908644|FG000|Overall Study|Withdrawal by research team|0|||
163874622|NCT04982315|591908645|FG001|Overall Study|Withdrawal by research team|0|||
163874623|NCT04982315|591908646|FG002|Overall Study|Withdrawal by research team|1|||
163874624|NCT00781274|591908652|FG000|Overall Study|Withdrawal by Subject|2|||
163874625|NCT00861692|591908661|FG000|Overall Study|Death|6|||
163874626|NCT06429163|591908662|FG000|Overall Study|uterine fibroid type 7|1|||
163874627|NCT06429163|591908663|FG001|Overall Study|uterine fibroid type 7|1|||
163874628|NCT06429163|591908664|FG002|Overall Study|uterine fibroid type 7|1|||
163874629|NCT06429163|591908662|FG000|Overall Study|severe adhesions|1|||
163874630|NCT06429163|591908663|FG001|Overall Study|severe adhesions|2|||
163874631|NCT06429163|591908664|FG002|Overall Study|severe adhesions|1|||
163874632|NCT06429163|591908662|FG000|Overall Study|conversion to laparotomy|0|||
163874633|NCT06429163|591908663|FG001|Overall Study|conversion to laparotomy|1|||
163874634|NCT06429163|591908664|FG002|Overall Study|conversion to laparotomy|0|||
163874635|NCT06429163|591908662|FG000|Overall Study|concomitant procedure|1|||
163874636|NCT06429163|591908663|FG001|Overall Study|concomitant procedure|0|||
163874637|NCT06429163|591908664|FG002|Overall Study|concomitant procedure|0|||
163874638|NCT01626885|591908665|FG000|Overall Study|Adverse Event|8|||
163874639|NCT01626885|591908665|FG000|Overall Study|Withdrawal by Subject|4|||
163874640|NCT01466192|591908668|FG000|Overall Study|Physician Decision|1|||
163874641|NCT01466192|591908668|FG000|Overall Study|Withdrawal by Subject|3|||
163874642|NCT02321514|591908672|FG000|Overall Study|Death|15|||
163874643|NCT02321514|591908672|FG000|Overall Study|Missed Visit|7|||
163874644|NCT02321514|591908672|FG000|Overall Study|Study Exit|3|||
163874645|NCT00591214|591908673|FG000|Overall Study|Physician Decision|7|||
163874646|NCT00591214|591908673|FG000|Overall Study|Withdrawal by Subject|1|||
163874647|NCT03671811|591908675|FG000|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|4|||
163874648|NCT03671811|591908676|FG001|Overall Study|Did not complete treatment (n=5), Disenrolled (n=1), Did not have hysterectomy (n=1)|3|||
163874649|NCT04992390|591908677|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
164207169|NCT00614393|593127764|FG003|Overall Study|Terminated by Sponsor|0|||
164207170|NCT00614393|593127765|FG004|Overall Study|Terminated by Sponsor|1|||
164207171|NCT00614393|593127761|FG000|Overall Study|Withdrawal by Subject|20|||
164207172|NCT00614393|593127762|FG001|Overall Study|Withdrawal by Subject|1|||
164207173|NCT00614393|593127763|FG002|Overall Study|Withdrawal by Subject|1|||
164207174|NCT00614393|593127764|FG003|Overall Study|Withdrawal by Subject|16|||
164207175|NCT00614393|593127765|FG004|Overall Study|Withdrawal by Subject|13|||
164207176|NCT00614393|593127761|FG000|Overall Study|Other|4|||
164207177|NCT00614393|593127762|FG001|Overall Study|Other|0|||
164207178|NCT00614393|593127763|FG002|Overall Study|Other|0|||
164207179|NCT00614393|593127764|FG003|Overall Study|Other|4|||
164207180|NCT00614393|593127765|FG004|Overall Study|Other|2|||
164207181|NCT00614393|593127761|FG000|Overall Study|Not Treated|0|||
164207182|NCT00614393|593127762|FG001|Overall Study|Not Treated|0|||
164207183|NCT00614393|593127763|FG002|Overall Study|Not Treated|0|||
163874650|NCT04992390|591908678|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
163874651|NCT04992390|591908679|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
163874652|NCT04992390|591908677|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
163874653|NCT04992390|591908678|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
163874654|NCT04992390|591908679|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
163874655|NCT04992390|591908677|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
164207184|NCT00614393|593127764|FG003|Overall Study|Not Treated|0|||
164207185|NCT00614393|593127765|FG004|Overall Study|Not Treated|2|||
164207186|NCT03286504|593127773|FG000|Overall Study|Lost to Follow-up|19|||
164207187|NCT03286504|593127774|FG001|Overall Study|Lost to Follow-up|16|||
164207188|NCT00141921|593127776|FG000|Overall Study|Remain on Study|28|||
164207189|NCT00141921|593127776|FG000|Overall Study|Withdrawal by Subject|42|||
164207190|NCT00141921|593127776|FG000|Overall Study|Lost to Follow-up|19|||
164320222|NCT00045942|593550124|FG002|PKC412A2104E1|Adverse Event|1|||
164320223|NCT00045942|593550125|FG003|PKC412A2104E1|Adverse Event|3|||
164320224|NCT00045942|593550126|FG004|PKC412A2104E1|Adverse Event|6|||
164320225|NCT00045942|593550127|FG005|PKC412A2104E1|Adverse Event|0|||
164320226|NCT00045942|593550128|FG006|PKC412A2104E1|Adverse Event|0|||
164320227|NCT00045942|593550129|FG007|PKC412A2104E1|Adverse Event|0|||
164320228|NCT00045942|593550130|FG008|PKC412A2104E1|Adverse Event|0|||
164320229|NCT00045942|593550122|FG000|PKC412A2104E1|Death|0|||
164320230|NCT00045942|593550123|FG001|PKC412A2104E1|Death|4|||
164320231|NCT00045942|593550124|FG002|PKC412A2104E1|Death|1|||
164320232|NCT00045942|593550125|FG003|PKC412A2104E1|Death|1|||
164320233|NCT00045942|593550126|FG004|PKC412A2104E1|Death|1|||
164320234|NCT00045942|593550127|FG005|PKC412A2104E1|Death|0|||
164320235|NCT00045942|593550128|FG006|PKC412A2104E1|Death|0|||
164320236|NCT00045942|593550129|FG007|PKC412A2104E1|Death|0|||
164320237|NCT00045942|593550130|FG008|PKC412A2104E1|Death|0|||
164320238|NCT00045942|593550122|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320239|NCT00045942|593550123|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320240|NCT00045942|593550124|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
164320241|NCT00045942|593550125|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
164320242|NCT00045942|593550126|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320243|NCT00045942|593550127|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320244|NCT00045942|593550128|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320245|NCT00045942|593550129|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320246|NCT00045942|593550130|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
164320247|NCT00045942|593550122|FG000|PKC412A2104E2|Lost to Follow-up|0|||
164320248|NCT00045942|593550123|FG001|PKC412A2104E2|Lost to Follow-up|0|||
164320249|NCT00045942|593550124|FG002|PKC412A2104E2|Lost to Follow-up|0|||
164320250|NCT00045942|593550125|FG003|PKC412A2104E2|Lost to Follow-up|0|||
164320251|NCT00045942|593550126|FG004|PKC412A2104E2|Lost to Follow-up|0|||
164320252|NCT00045942|593550127|FG005|PKC412A2104E2|Lost to Follow-up|0|||
164320253|NCT00045942|593550128|FG006|PKC412A2104E2|Lost to Follow-up|0|||
164320254|NCT00045942|593550129|FG007|PKC412A2104E2|Lost to Follow-up|3|||
164320255|NCT00045942|593550130|FG008|PKC412A2104E2|Lost to Follow-up|0|||
163874656|NCT04992390|591908678|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
163874657|NCT04992390|591908679|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
163874658|NCT04992390|591908677|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
163874659|NCT04992390|591908678|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
163874660|NCT04992390|591908679|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
163874661|NCT04992390|591908677|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
163874662|NCT04992390|591908678|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
163874663|NCT04992390|591908679|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
163874664|NCT04992390|591908677|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
163874665|NCT04992390|591908678|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
163874666|NCT04992390|591908679|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
163874667|NCT04992390|591908677|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
163874668|NCT04992390|591908678|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
163874669|NCT04992390|591908679|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
163874670|NCT04992390|591908677|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
163874671|NCT04992390|591908678|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
163874672|NCT04992390|591908679|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
163874673|NCT04992390|591908677|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
163874674|NCT04992390|591908678|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
163874675|NCT04992390|591908679|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
163874676|NCT04992390|591908677|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
163874677|NCT04992390|591908678|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
163874678|NCT04992390|591908679|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
163874679|NCT04992390|591908677|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
163874680|NCT04992390|591908678|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
163874681|NCT04992390|591908679|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
163874682|NCT04992390|591908677|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
163874683|NCT04992390|591908678|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
163874684|NCT04992390|591908679|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
163874685|NCT04992390|591908677|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
163874686|NCT04992390|591908678|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
163874687|NCT04992390|591908679|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
163874688|NCT04992390|591908677|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
163874689|NCT04992390|591908678|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
163874690|NCT04992390|591908679|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
163874691|NCT04992390|591908677|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
163874692|NCT04992390|591908678|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
163874693|NCT04992390|591908679|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
163978681|NCT01995071|592293520|FG001|Overall Study|Incarcerated|0|||
163978682|NCT01995071|592293521|FG002|Overall Study|Incarcerated|0|||
163978683|NCT01995071|592293522|FG003|Overall Study|Incarcerated|0|||
163978684|NCT01995071|592293523|FG004|Overall Study|Incarcerated|0|||
163978685|NCT01995071|592293524|FG005|Overall Study|Incarcerated|0|||
163978686|NCT01995071|592293525|FG006|Overall Study|Incarcerated|0|||
163978687|NCT01995071|592293526|FG007|Overall Study|Incarcerated|1|||
163978688|NCT01995071|592293527|FG008|Overall Study|Incarcerated|0|||
163978689|NCT01995071|592293528|FG009|Overall Study|Incarcerated|0|||
163978690|NCT01995071|592293529|FG010|Overall Study|Incarcerated|0|||
163978691|NCT01995071|592293530|FG011|Overall Study|Incarcerated|0|||
163978692|NCT01979523|592293532|FG000|Overall Study|Withdrawal by Subject|1|||
163978693|NCT01979523|592293533|FG001|Overall Study|Withdrawal by Subject|0|||
163978694|NCT02495844|592293540|FG000|Overall Study|Lack of Efficacy|1|||
163978695|NCT02495844|592293541|FG001|Overall Study|Lack of Efficacy|2|||
163978696|NCT02495844|592293540|FG000|Overall Study|AE, non-fatal|0|||
163978697|NCT02495844|592293541|FG001|Overall Study|AE, non-fatal|1|||
163978698|NCT02495844|592293540|FG000|Overall Study|Hepatitis Positivity|0|||
164320256|NCT00045942|593550122|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
164320257|NCT00045942|593550123|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
164320258|NCT00045942|593550124|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
164320259|NCT00045942|593550125|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
164320260|NCT00045942|593550126|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
164320261|NCT00045942|593550127|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
164320262|NCT00045942|593550128|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
164320263|NCT00045942|593550129|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
164320264|NCT00045942|593550130|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
164320265|NCT00045942|593550122|FG000|PKC412A2104E2|Lack of Efficacy|0|||
164320266|NCT00045942|593550123|FG001|PKC412A2104E2|Lack of Efficacy|0|||
164320267|NCT00045942|593550124|FG002|PKC412A2104E2|Lack of Efficacy|0|||
164320268|NCT00045942|593550125|FG003|PKC412A2104E2|Lack of Efficacy|0|||
163978699|NCT02495844|592293541|FG001|Overall Study|Hepatitis Positivity|1|||
163978700|NCT00493870|592293546|FG000|Overall Study|Lost to Follow-up|12|||
163978701|NCT00493870|592293547|FG001|Overall Study|Lost to Follow-up|15|||
163978702|NCT00647556|592293548|FG000|Overall Study|Adverse Event|0|||
163978703|NCT00647556|592293549|FG001|Overall Study|Adverse Event|1|||
163978704|NCT00647556|592293548|FG000|Overall Study|Lost to Follow-up|1|||
163978705|NCT00647556|592293549|FG001|Overall Study|Lost to Follow-up|0|||
163978706|NCT00647556|592293548|FG000|Overall Study|Protocol Violation|0|||
163978707|NCT00647556|592293549|FG001|Overall Study|Protocol Violation|1|||
163978708|NCT00647556|592293548|FG000|Overall Study|Withdrawal by Subject|1|||
163978709|NCT00647556|592293549|FG001|Overall Study|Withdrawal by Subject|0|||
163978710|NCT00647556|592293548|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
163978711|NCT00647556|592293549|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
163978712|NCT02646982|592293550|FG000|Overall Study|Adverse Event|1|||
163978713|NCT02646982|592293551|FG001|Overall Study|Adverse Event|1|||
163978714|NCT02646982|592293550|FG000|Overall Study|Withdrawal by Subject|2|||
163978715|NCT02646982|592293551|FG001|Overall Study|Withdrawal by Subject|1|||
163978716|NCT00623480|592293552|FG000|Overall Study|Lost to Follow-up|0|||
163978717|NCT00623480|592293553|FG001|Overall Study|Lost to Follow-up|1|||
163978718|NCT00623480|592293552|FG000|Overall Study|Withdrawal by Subject|2|||
163978719|NCT00623480|592293553|FG001|Overall Study|Withdrawal by Subject|4|||
163978720|NCT00623480|592293552|FG000|Overall Study|Lack of Efficacy|1|||
163978721|NCT00623480|592293553|FG001|Overall Study|Lack of Efficacy|0|||
163978722|NCT00623480|592293552|FG000|Overall Study|Non-compliant with study medication|4|||
163978723|NCT00623480|592293553|FG001|Overall Study|Non-compliant with study medication|0|||
163978724|NCT00623480|592293552|FG000|Overall Study|Protocol Violation|0|||
163978725|NCT00623480|592293553|FG001|Overall Study|Protocol Violation|1|||
163978726|NCT00623480|592293552|FG000|Overall Study|Site closed by sponsor|0|||
163978727|NCT00623480|592293553|FG001|Overall Study|Site closed by sponsor|1|||
163978728|NCT01594853|592293554|FG000|Overall Study|Withdrawal by Subject|1|||
163978729|NCT01594853|592293555|FG001|Overall Study|Withdrawal by Subject|1|||
163978730|NCT01594853|592293554|FG000|Overall Study|Lost to Follow-up|1|||
164320269|NCT00045942|593550126|FG004|PKC412A2104E2|Lack of Efficacy|0|||
164320270|NCT00045942|593550127|FG005|PKC412A2104E2|Lack of Efficacy|3|||
164320271|NCT00045942|593550128|FG006|PKC412A2104E2|Lack of Efficacy|2|||
164320272|NCT00045942|593550129|FG007|PKC412A2104E2|Lack of Efficacy|2|||
164320273|NCT00045942|593550130|FG008|PKC412A2104E2|Lack of Efficacy|6|||
164320274|NCT00045942|593550122|FG000|PKC412A2104E2|Adverse Event|0|||
163978731|NCT01594853|592293555|FG001|Overall Study|Lost to Follow-up|1|||
164320275|NCT00045942|593550123|FG001|PKC412A2104E2|Adverse Event|0|||
164320276|NCT00045942|593550124|FG002|PKC412A2104E2|Adverse Event|0|||
164320277|NCT00045942|593550125|FG003|PKC412A2104E2|Adverse Event|0|||
163978732|NCT01594853|592293554|FG000|Overall Study|noncompliance with exercise|0|||
163978733|NCT01594853|592293555|FG001|Overall Study|noncompliance with exercise|1|||
163978734|NCT04677712|592293557|FG000|Overall Study|Lost to Follow-up|0|||
163978735|NCT04677712|592293558|FG001|Overall Study|Lost to Follow-up|1|||
163978736|NCT04677712|592293559|FG002|Overall Study|Lost to Follow-up|0|||
163978737|NCT04677712|592293560|FG003|Overall Study|Lost to Follow-up|0|||
163978738|NCT04677712|592293561|FG004|Overall Study|Lost to Follow-up|0|||
164320278|NCT00045942|593550126|FG004|PKC412A2104E2|Adverse Event|0|||
164320279|NCT00045942|593550127|FG005|PKC412A2104E2|Adverse Event|4|||
164320280|NCT00045942|593550128|FG006|PKC412A2104E2|Adverse Event|3|||
164320281|NCT00045942|593550129|FG007|PKC412A2104E2|Adverse Event|1|||
164320282|NCT00045942|593550130|FG008|PKC412A2104E2|Adverse Event|0|||
164320283|NCT00045942|593550122|FG000|PKC412A2104E2|Death|0|||
164320284|NCT00045942|593550123|FG001|PKC412A2104E2|Death|0|||
164320285|NCT00045942|593550124|FG002|PKC412A2104E2|Death|0|||
164320286|NCT00045942|593550125|FG003|PKC412A2104E2|Death|0|||
164320287|NCT00045942|593550126|FG004|PKC412A2104E2|Death|0|||
164320288|NCT00045942|593550127|FG005|PKC412A2104E2|Death|1|||
164320289|NCT00045942|593550128|FG006|PKC412A2104E2|Death|2|||
164320290|NCT00045942|593550129|FG007|PKC412A2104E2|Death|0|||
164320291|NCT00045942|593550130|FG008|PKC412A2104E2|Death|0|||
164320292|NCT05508074|593550131|FG000|Overall Study|Death|2|||
164320293|NCT05508074|593550132|FG001|Overall Study|Death|5|||
164320294|NCT05508074|593550131|FG000|Overall Study|Withdrawal by Subject|1|||
164320295|NCT05508074|593550132|FG001|Overall Study|Withdrawal by Subject|2|||
164320296|NCT05508074|593550131|FG000|Overall Study|Adverse Event|0|||
164320297|NCT05508074|593550132|FG001|Overall Study|Adverse Event|1|||
164320298|NCT05508074|593550131|FG000|Overall Study|Physician Decision|0|||
164320299|NCT05508074|593550132|FG001|Overall Study|Physician Decision|1|||
164320300|NCT05508074|593550131|FG000|Overall Study|wrongly randomized|0|||
164320301|NCT05508074|593550132|FG001|Overall Study|wrongly randomized|1|||
164320302|NCT05508074|593550131|FG000|Overall Study|non-compliance|0|||
164320303|NCT05508074|593550132|FG001|Overall Study|non-compliance|1|||
164320304|NCT02142387|593550133|FG000|Overall Study|<19 years old|49|||
164320305|NCT02142387|593550134|FG001|Overall Study|<19 years old|326|||
164320306|NCT02142387|593550133|FG000|Overall Study|non-cardiac etiology|504|||
164320307|NCT02142387|593550134|FG001|Overall Study|non-cardiac etiology|3431|||
164320308|NCT02142387|593550133|FG000|Overall Study|CPR not performed|74|||
164320309|NCT02142387|593550134|FG001|Overall Study|CPR not performed|473|||
164320310|NCT02142387|593550133|FG000|Overall Study|witnessed by paramedic|139|||
164320311|NCT02142387|593550134|FG001|Overall Study|witnessed by paramedic|917|||
164320312|NCT02142387|593550133|FG000|Overall Study|incomplete data|1|||
164320313|NCT02142387|593550134|FG001|Overall Study|incomplete data|9|||
164320314|NCT02142387|593550133|FG000|Overall Study|occurred not at home|298|||
164320315|NCT02142387|593550134|FG001|Overall Study|occurred not at home|2474|||
164320316|NCT01101308|593550135|FG000|Period 1|Adverse Event|2|||
164320317|NCT01101308|593550136|FG001|Period 1|Adverse Event|1|||
164320318|NCT01101308|593550135|FG000|Period 1|Positive for cotinine|1|||
164320319|NCT01101308|593550136|FG001|Period 1|Positive for cotinine|0|||
164320320|NCT02984943|593550137|FG000|Overall Study|Withdrawal by Subject|3|||
164320321|NCT02984943|593550137|FG000|Overall Study|Physician Decision|1|||
164320322|NCT02282345|593550140|FG000|Overall Study|Progression|0|||
164320323|NCT02282345|593550141|FG001|Overall Study|Progression|1|||
164320324|NCT02296138|593550142|FG000|Overall Study|Adverse Event|348|||
164320325|NCT02296138|593550143|FG001|Overall Study|Adverse Event|259|||
164320326|NCT02296138|593550142|FG000|Overall Study|Lack of Efficacy|59|||
164320327|NCT02296138|593550143|FG001|Overall Study|Lack of Efficacy|37|||
164320328|NCT02296138|593550142|FG000|Overall Study|Protocol Violation|35|||
164320329|NCT02296138|593550143|FG001|Overall Study|Protocol Violation|36|||
163874694|NCT04992390|591908677|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
163874695|NCT04992390|591908678|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
163874696|NCT04992390|591908679|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
163874697|NCT06938230|591908680|FG000|Overall Study|Lost to Follow-up|56|||
163874698|NCT06938230|591908681|FG001|Overall Study|Lost to Follow-up|18|||
163874699|NCT05096819|591909767|FG000|Overall Study|Withdrawal by Subject|3|||
163874700|NCT05096819|591909768|FG001|Overall Study|Withdrawal by Subject|0|||
163874701|NCT03324984|591909769|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
163874702|NCT03324984|591909770|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
163874703|NCT03358875|591909773|FG000|Overall Study|Death|409|||
163874704|NCT03358875|591909774|FG001|Overall Study|Death|223|||
164320330|NCT02296138|593550142|FG000|Overall Study|Lost to Follow-up|9|||
164320331|NCT02296138|593550143|FG001|Overall Study|Lost to Follow-up|12|||
164320332|NCT02296138|593550142|FG000|Overall Study|Withdrawal by Subject|184|||
164320333|NCT02296138|593550143|FG001|Overall Study|Withdrawal by Subject|131|||
164320334|NCT02296138|593550142|FG000|Overall Study|Not Treated|1|||
164320335|NCT02296138|593550143|FG001|Overall Study|Not Treated|1|||
164320336|NCT02296138|593550142|FG000|Overall Study|Patients with data irregularities|10|||
164320337|NCT02296138|593550143|FG001|Overall Study|Patients with data irregularities|11|||
164320338|NCT02296138|593550142|FG000|Overall Study|Other than specified|15|||
164320339|NCT02296138|593550143|FG001|Overall Study|Other than specified|13|||
164320340|NCT00711516|593550144|FG000|Overall Study|Adverse Event|1|||
164320341|NCT00711516|593550145|FG001|Overall Study|Adverse Event|1|||
164320342|NCT00711516|593550144|FG000|Overall Study|Withdrawal by Subject|0|||
164320343|NCT00711516|593550145|FG001|Overall Study|Withdrawal by Subject|1|||
164320344|NCT00711516|593550144|FG000|Overall Study|Protocol Violation|0|||
164320345|NCT00711516|593550145|FG001|Overall Study|Protocol Violation|1|||
164320346|NCT04575597|593550146|FG000|Overall Study|Death|0|||
164320347|NCT04575597|593550147|FG001|Overall Study|Death|0|||
164320348|NCT04575597|593550148|FG002|Overall Study|Death|0|||
164320349|NCT04575597|593550149|FG003|Overall Study|Death|1|||
164320350|NCT04575597|593550150|FG004|Overall Study|Death|3|||
164320351|NCT04575597|593550151|FG005|Overall Study|Death|14|||
164320352|NCT04575597|593550146|FG000|Overall Study|Lost to Follow-up|2|||
164320353|NCT04575597|593550147|FG001|Overall Study|Lost to Follow-up|1|||
164320354|NCT04575597|593550148|FG002|Overall Study|Lost to Follow-up|1|||
164320355|NCT04575597|593550149|FG003|Overall Study|Lost to Follow-up|2|||
164320356|NCT04575597|593550150|FG004|Overall Study|Lost to Follow-up|10|||
164320357|NCT04575597|593550151|FG005|Overall Study|Lost to Follow-up|8|||
164320358|NCT04575597|593550146|FG000|Overall Study|Withdrawal by Subject|2|||
164320359|NCT04575597|593550147|FG001|Overall Study|Withdrawal by Subject|2|||
164320360|NCT04575597|593550148|FG002|Overall Study|Withdrawal by Subject|4|||
163874705|NCT03358875|591909773|FG000|Overall Study|Study Closed by Sponsor|66|||
163874706|NCT03358875|591909774|FG001|Overall Study|Study Closed by Sponsor|29|||
163874707|NCT03358875|591909773|FG000|Overall Study|Withdrawal by Subject|13|||
163874708|NCT03358875|591909774|FG001|Overall Study|Withdrawal by Subject|16|||
163874709|NCT03358875|591909773|FG000|Overall Study|Lost to Follow-up|13|||
163874710|NCT03358875|591909774|FG001|Overall Study|Lost to Follow-up|2|||
163874711|NCT03358875|591909773|FG000|Overall Study|Miscellaneous|33|||
163874712|NCT03358875|591909774|FG001|Overall Study|Miscellaneous|0|||
163874713|NCT03358875|591909773|FG000|Overall Study|Remained on Study|1|||
163874714|NCT03358875|591909774|FG001|Overall Study|Remained on Study|0|||
163874715|NCT04337372|591909776|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
163874716|NCT04337372|591909777|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
163874717|NCT04337372|591909778|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
163874718|NCT04337372|591909779|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
163874719|NCT04337372|591909776|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
163874720|NCT04337372|591909777|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
163874721|NCT04337372|591909778|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
163874722|NCT04337372|591909779|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
163874723|NCT04337372|591909776|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
163874724|NCT04337372|591909777|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
163874725|NCT04337372|591909778|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
163874726|NCT04337372|591909779|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
163874727|NCT04337372|591909776|FG000|Day 2: EEG Measures|Protocol Violation|6|||
163874728|NCT04337372|591909777|FG001|Day 2: EEG Measures|Protocol Violation|6|||
163874729|NCT04337372|591909778|FG002|Day 2: EEG Measures|Protocol Violation|5|||
163874730|NCT04337372|591909779|FG003|Day 2: EEG Measures|Protocol Violation|17|||
163874731|NCT06375421|591909786|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
163874732|NCT06375421|591909787|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
163874733|NCT06375421|591909788|FG002|First Intervention (1 Week)|Withdrawal by Subject|1|||
163874734|NCT06375421|591909789|FG003|First Intervention (1 Week)|Withdrawal by Subject|0|||
163874735|NCT03584516|591909795|FG000|Part 1|Death|2|||
163874736|NCT03584516|591909796|FG001|Part 1|Death|3|||
163874737|NCT03584516|591909797|FG002|Part 1|Death|0|||
163874738|NCT03584516|591909798|FG003|Part 1|Death|0|||
163874739|NCT03584516|591909799|FG004|Part 1|Death|0|||
163874740|NCT03584516|591909800|FG005|Part 1|Death|0|||
163874741|NCT03584516|591909795|FG000|Part 1|Withdrawal by Subject|2|||
163874742|NCT03584516|591909796|FG001|Part 1|Withdrawal by Subject|0|||
163874743|NCT03584516|591909797|FG002|Part 1|Withdrawal by Subject|0|||
163874744|NCT03584516|591909798|FG003|Part 1|Withdrawal by Subject|0|||
163874745|NCT03584516|591909799|FG004|Part 1|Withdrawal by Subject|0|||
163874746|NCT03584516|591909800|FG005|Part 1|Withdrawal by Subject|0|||
163874747|NCT03584516|591909795|FG000|Part 1|Lost to Follow-up|1|||
163874748|NCT03584516|591909796|FG001|Part 1|Lost to Follow-up|0|||
163874749|NCT03584516|591909797|FG002|Part 1|Lost to Follow-up|0|||
163874750|NCT03584516|591909798|FG003|Part 1|Lost to Follow-up|0|||
163874751|NCT03584516|591909799|FG004|Part 1|Lost to Follow-up|0|||
163874752|NCT03584516|591909800|FG005|Part 1|Lost to Follow-up|0|||
163874753|NCT03584516|591909795|FG000|Part 1|Study Terminated by Sponsor|0|||
163874754|NCT03584516|591909796|FG001|Part 1|Study Terminated by Sponsor|2|||
163874755|NCT03584516|591909797|FG002|Part 1|Study Terminated by Sponsor|0|||
163874756|NCT03584516|591909798|FG003|Part 1|Study Terminated by Sponsor|0|||
163874757|NCT03584516|591909799|FG004|Part 1|Study Terminated by Sponsor|0|||
163874758|NCT03584516|591909800|FG005|Part 1|Study Terminated by Sponsor|0|||
163874759|NCT03584516|591909795|FG000|Part 1 Expansion|Death|0|||
163874760|NCT03584516|591909796|FG001|Part 1 Expansion|Death|0|||
163874761|NCT03584516|591909797|FG002|Part 1 Expansion|Death|9|||
164320361|NCT04575597|593550149|FG003|Overall Study|Withdrawal by Subject|2|||
164320362|NCT04575597|593550150|FG004|Overall Study|Withdrawal by Subject|25|||
164320363|NCT04575597|593550151|FG005|Overall Study|Withdrawal by Subject|28|||
164320364|NCT04575597|593550146|FG000|Overall Study|Not Recorded|0|||
164320365|NCT04575597|593550147|FG001|Overall Study|Not Recorded|0|||
164320366|NCT04575597|593550148|FG002|Overall Study|Not Recorded|0|||
164320367|NCT04575597|593550149|FG003|Overall Study|Not Recorded|0|||
164320368|NCT04575597|593550150|FG004|Overall Study|Not Recorded|0|||
164320369|NCT04575597|593550151|FG005|Overall Study|Not Recorded|2|||
164320370|NCT04575597|593550146|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320371|NCT04575597|593550147|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320372|NCT04575597|593550148|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320373|NCT04575597|593550149|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164320374|NCT04575597|593550150|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
164320375|NCT04575597|593550151|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164320376|NCT02095132|593550153|FG000|Overall Study|Adverse Event|0|||
164320377|NCT02095132|593550154|FG001|Overall Study|Adverse Event|0|||
164320378|NCT02095132|593550155|FG002|Overall Study|Adverse Event|0|||
164320379|NCT02095132|593550156|FG003|Overall Study|Adverse Event|0|||
164320380|NCT02095132|593550157|FG004|Overall Study|Adverse Event|1|||
164320381|NCT02095132|593550158|FG005|Overall Study|Adverse Event|0|||
164320382|NCT02095132|593550159|FG006|Overall Study|Adverse Event|1|||
164320383|NCT02095132|593550160|FG007|Overall Study|Adverse Event|0|||
164320384|NCT02095132|593550161|FG008|Overall Study|Adverse Event|0|||
164320385|NCT02095132|593550153|FG000|Overall Study|Death|0|||
164320386|NCT02095132|593550154|FG001|Overall Study|Death|0|||
164320387|NCT02095132|593550155|FG002|Overall Study|Death|0|||
164320388|NCT02095132|593550156|FG003|Overall Study|Death|0|||
164320389|NCT02095132|593550157|FG004|Overall Study|Death|0|||
164320390|NCT02095132|593550158|FG005|Overall Study|Death|0|||
164320391|NCT02095132|593550159|FG006|Overall Study|Death|1|||
164320392|NCT02095132|593550160|FG007|Overall Study|Death|0|||
164320393|NCT02095132|593550161|FG008|Overall Study|Death|0|||
164320394|NCT02095132|593550153|FG000|Overall Study|Lack of Efficacy|3|||
164320395|NCT02095132|593550154|FG001|Overall Study|Lack of Efficacy|5|||
164320396|NCT02095132|593550155|FG002|Overall Study|Lack of Efficacy|2|||
164320397|NCT02095132|593550156|FG003|Overall Study|Lack of Efficacy|8|||
164320398|NCT02095132|593550157|FG004|Overall Study|Lack of Efficacy|3|||
164320399|NCT02095132|593550158|FG005|Overall Study|Lack of Efficacy|6|||
164320400|NCT02095132|593550159|FG006|Overall Study|Lack of Efficacy|10|||
164320401|NCT02095132|593550160|FG007|Overall Study|Lack of Efficacy|9|||
164320402|NCT02095132|593550161|FG008|Overall Study|Lack of Efficacy|8|||
164320403|NCT02095132|593550153|FG000|Overall Study|Physician Decision|1|||
164320404|NCT02095132|593550154|FG001|Overall Study|Physician Decision|0|||
164320405|NCT02095132|593550155|FG002|Overall Study|Physician Decision|0|||
164320406|NCT02095132|593550156|FG003|Overall Study|Physician Decision|0|||
164320407|NCT02095132|593550157|FG004|Overall Study|Physician Decision|0|||
164320408|NCT02095132|593550158|FG005|Overall Study|Physician Decision|0|||
164320409|NCT02095132|593550159|FG006|Overall Study|Physician Decision|1|||
164320410|NCT02095132|593550160|FG007|Overall Study|Physician Decision|0|||
164320411|NCT02095132|593550161|FG008|Overall Study|Physician Decision|2|||
164320412|NCT02095132|593550153|FG000|Overall Study|Withdrawal by Subject|0|||
164320413|NCT02095132|593550154|FG001|Overall Study|Withdrawal by Subject|0|||
164320414|NCT02095132|593550155|FG002|Overall Study|Withdrawal by Subject|2|||
164320415|NCT02095132|593550156|FG003|Overall Study|Withdrawal by Subject|2|||
164320416|NCT02095132|593550157|FG004|Overall Study|Withdrawal by Subject|3|||
164320417|NCT02095132|593550158|FG005|Overall Study|Withdrawal by Subject|0|||
164320418|NCT02095132|593550159|FG006|Overall Study|Withdrawal by Subject|5|||
164320419|NCT02095132|593550160|FG007|Overall Study|Withdrawal by Subject|0|||
163874762|NCT03584516|591909798|FG003|Part 1 Expansion|Death|8|||
163874763|NCT03584516|591909799|FG004|Part 1 Expansion|Death|4|||
163874764|NCT03584516|591909800|FG005|Part 1 Expansion|Death|5|||
163874765|NCT03584516|591909795|FG000|Part 1 Expansion|Lost to Follow-up|0|||
163874766|NCT03584516|591909796|FG001|Part 1 Expansion|Lost to Follow-up|0|||
163874767|NCT03584516|591909797|FG002|Part 1 Expansion|Lost to Follow-up|0|||
163874768|NCT03584516|591909798|FG003|Part 1 Expansion|Lost to Follow-up|1|||
163874769|NCT03584516|591909799|FG004|Part 1 Expansion|Lost to Follow-up|0|||
164320420|NCT02095132|593550161|FG008|Overall Study|Withdrawal by Subject|0|||
164320421|NCT04905498|593550164|FG000|Overall Study|Lost to Follow-up|0|||
164320422|NCT04905498|593550165|FG001|Overall Study|Lost to Follow-up|2|||
164320423|NCT04905498|593550164|FG000|Overall Study|COVID lockdown|1|||
164320424|NCT04905498|593550165|FG001|Overall Study|COVID lockdown|0|||
164320425|NCT01029405|593550166|FG000|Overall Study|Withdrawal by Subject|0|||
164320426|NCT01029405|593550167|FG001|Overall Study|Withdrawal by Subject|1|||
164320427|NCT01029405|593550168|FG002|Overall Study|Withdrawal by Subject|2|||
164320428|NCT01029405|593550169|FG003|Overall Study|Withdrawal by Subject|0|||
164320429|NCT01029405|593550166|FG000|Overall Study|Protocol Violation|0|||
164320430|NCT01029405|593550167|FG001|Overall Study|Protocol Violation|0|||
164320431|NCT01029405|593550168|FG002|Overall Study|Protocol Violation|0|||
164320432|NCT01029405|593550169|FG003|Overall Study|Protocol Violation|1|||
164320433|NCT01029405|593550166|FG000|Overall Study|Adverse Event|0|||
164320434|NCT01029405|593550167|FG001|Overall Study|Adverse Event|0|||
164320435|NCT01029405|593550168|FG002|Overall Study|Adverse Event|1|||
164320436|NCT01029405|593550169|FG003|Overall Study|Adverse Event|1|||
164320437|NCT01029405|593550166|FG000|Overall Study|Lost to Follow-up|2|||
164320438|NCT01029405|593550167|FG001|Overall Study|Lost to Follow-up|1|||
164320439|NCT01029405|593550168|FG002|Overall Study|Lost to Follow-up|1|||
164320440|NCT01029405|593550169|FG003|Overall Study|Lost to Follow-up|2|||
164320441|NCT01029405|593550166|FG000|Overall Study|Other|0|||
164320442|NCT01029405|593550167|FG001|Overall Study|Other|1|||
164320443|NCT01029405|593550168|FG002|Overall Study|Other|0|||
164320444|NCT01029405|593550169|FG003|Overall Study|Other|1|||
164320445|NCT01268579|593550170|FG000|Overall Study|Adverse Event|1|||
164320446|NCT01268579|593550170|FG000|Overall Study|Withdrawal by Subject|2|||
164320447|NCT03312751|593550171|FG000|Overall Study|Death|7|||
164320448|NCT03312751|593550172|FG001|Overall Study|Death|9|||
164320449|NCT03312751|593550171|FG000|Overall Study|Study discontinuation due to other reason|0|||
164320450|NCT03312751|593550172|FG001|Overall Study|Study discontinuation due to other reason|1|||
164320451|NCT02692651|593550173|FG000|Study Treatment|Death|7|||
164320452|NCT02692651|593550174|FG001|Study Treatment|Death|3|||
164320453|NCT02692651|593550173|FG000|Study Treatment|comfort care|1|||
164320454|NCT02692651|593550174|FG001|Study Treatment|comfort care|1|||
164320455|NCT02692651|593550173|FG000|Study Treatment|Protocol violation per treating team preference|8|||
164320456|NCT02692651|593550174|FG001|Study Treatment|Protocol violation per treating team preference|6|||
164320457|NCT02692651|593550173|FG000|Post Study Treatment Follow-up|Death|4|||
164320458|NCT02692651|593550174|FG001|Post Study Treatment Follow-up|Death|4|||
164320459|NCT03490981|593550175|FG000|Overall Study|Lost to Follow-up|1|||
164320460|NCT03490981|593550176|FG001|Overall Study|Lost to Follow-up|2|||
164320461|NCT02480712|593550183|FG000|Overall Study|Enrolled but Never Treated|1|||
164320462|NCT02480712|593550183|FG000|Overall Study|Lost to Follow-up|5|||
164320463|NCT02480712|593550183|FG000|Overall Study|Withdrew Consent|3|||
164320464|NCT02480712|593550183|FG000|Overall Study|Death|1|||
164320465|NCT02480712|593550183|FG000|Overall Study|Lack of Efficacy|1|||
164320466|NCT01860846|593550184|FG000|Overall Study|Lost to Follow-up|33|||
164320467|NCT00466687|593550185|FG000|Overall Study|Adverse Event|1|||
164320468|NCT00466687|593550185|FG000|Overall Study|Other complicating illness|3|||
164320469|NCT00466687|593550185|FG000|Overall Study|Withdrawal by Subject|1|||
164320470|NCT00466687|593550185|FG000|Overall Study|Disease progression|29|||
164320471|NCT02586506|593550186|FG000|Overall Study|Protocol Violation|6|||
164320472|NCT02586506|593550186|FG000|Overall Study|Lost to Follow-up|1|||
164320473|NCT02586506|593550186|FG000|Overall Study|Other Reason|2|||
164320474|NCT00770146|593550187|FG000|Treatment Period|Withdrawal by Subject|6|||
164320475|NCT00770146|593550188|FG001|Treatment Period|Withdrawal by Subject|13|||
164320476|NCT00770146|593550187|FG000|Treatment Period|Adverse Event|2|||
164320477|NCT00770146|593550188|FG001|Treatment Period|Adverse Event|26|||
164320478|NCT00770146|593550187|FG000|Treatment Period|Other|1|||
164320479|NCT00770146|593550188|FG001|Treatment Period|Other|5|||
164320480|NCT00770146|593550187|FG000|Treatment Period|Protocol non-compliance|0|||
164320481|NCT00770146|593550188|FG001|Treatment Period|Protocol non-compliance|1|||
164320482|NCT00770146|593550187|FG000|Follow-up Period|Withdrawal by Subject|7|||
164320483|NCT00770146|593550188|FG001|Follow-up Period|Withdrawal by Subject|13|||
164320484|NCT00770146|593550187|FG000|Follow-up Period|Adverse Event|0|||
164320485|NCT00770146|593550188|FG001|Follow-up Period|Adverse Event|2|||
164320486|NCT00770146|593550187|FG000|Follow-up Period|Other|4|||
164320487|NCT00770146|593550188|FG001|Follow-up Period|Other|5|||
164320488|NCT01525901|593550189|FG000|Period 2: 12 Weeks|Adverse Event|0|||
164320489|NCT01525901|593550190|FG001|Period 2: 12 Weeks|Adverse Event|1|||
164320490|NCT01525901|593550191|FG002|Period 2: 12 Weeks|Adverse Event|0|||
164320491|NCT01525901|593550192|FG003|Period 2: 12 Weeks|Adverse Event|0|||
164320492|NCT01509053|593550193|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
164320493|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
164320494|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
163874770|NCT03584516|591909800|FG005|Part 1 Expansion|Lost to Follow-up|0|||
163874771|NCT03584516|591909795|FG000|Part 1 Expansion|Physician Decision|0|||
163874772|NCT03584516|591909796|FG001|Part 1 Expansion|Physician Decision|0|||
163874773|NCT03584516|591909797|FG002|Part 1 Expansion|Physician Decision|4|||
163874774|NCT03584516|591909798|FG003|Part 1 Expansion|Physician Decision|3|||
163874775|NCT03584516|591909799|FG004|Part 1 Expansion|Physician Decision|2|||
163874776|NCT03584516|591909800|FG005|Part 1 Expansion|Physician Decision|3|||
164320495|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
164320496|NCT01509053|593550193|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
164320497|NCT01509053|593550193|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
164320498|NCT01284491|593550195|FG000|Overall Study|Study termination|13|||
164320499|NCT01978938|593550196|FG000|Overall Study|Lost to Follow-up|12|||
164320500|NCT01978938|593550197|FG001|Overall Study|Lost to Follow-up|6|||
164320501|NCT01978938|593550196|FG000|Overall Study|Withdrawal by Subject|8|||
164320502|NCT01978938|593550197|FG001|Overall Study|Withdrawal by Subject|4|||
164320503|NCT01978938|593550196|FG000|Overall Study|Adverse Event, non-fatal|2|||
164320504|NCT01978938|593550197|FG001|Overall Study|Adverse Event, non-fatal|1|||
164320505|NCT01978938|593550196|FG000|Overall Study|Participant noncompliance|1|||
163874777|NCT03584516|591909795|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
163874778|NCT03584516|591909796|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
164320506|NCT01978938|593550197|FG001|Overall Study|Participant noncompliance|1|||
164320507|NCT01978938|593550196|FG000|Overall Study|Did not meet inclusion criteria|0|||
163978739|NCT04677712|592293562|FG005|Overall Study|Lost to Follow-up|0|||
164320508|NCT01978938|593550197|FG001|Overall Study|Did not meet inclusion criteria|1|||
164320509|NCT01978938|593550196|FG000|Overall Study|Previously scheduled procedure|0|||
163874779|NCT03584516|591909797|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
163874780|NCT03584516|591909798|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
163874781|NCT03584516|591909799|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
163874782|NCT03584516|591909800|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
163874783|NCT03584516|591909795|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
163874784|NCT03584516|591909796|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
163874785|NCT03584516|591909797|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
163874786|NCT03584516|591909798|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
163874787|NCT03584516|591909799|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
163874788|NCT03584516|591909800|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
163874789|NCT03584516|591909795|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163874790|NCT03584516|591909796|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163874791|NCT03584516|591909797|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163874792|NCT03584516|591909798|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
163874793|NCT03584516|591909799|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163874794|NCT03584516|591909800|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
163874795|NCT03584516|591909795|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163874796|NCT03584516|591909796|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163874797|NCT03584516|591909797|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163874798|NCT03584516|591909798|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163874799|NCT03584516|591909799|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
163874800|NCT03584516|591909800|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
163874801|NCT05760313|591909807|FG000|Overall Study|Withdrawal by Subject|0|||
163874802|NCT05760313|591909808|FG001|Overall Study|Withdrawal by Subject|0|||
163874803|NCT05760313|591909809|FG002|Overall Study|Withdrawal by Subject|1|||
163874804|NCT05760313|591909807|FG000|Overall Study|Other|1|||
163874805|NCT05760313|591909808|FG001|Overall Study|Other|0|||
163874806|NCT05760313|591909809|FG002|Overall Study|Other|0|||
163874807|NCT00956007|591909810|FG000|Overall Study|Protocol Violation|27|||
163874808|NCT00956007|591909811|FG001|Overall Study|Protocol Violation|23|||
163874809|NCT05228470|591909812|FG000|Overall Study|Death|6|||
163874810|NCT05228470|591909813|FG001|Overall Study|Death|11|||
163874811|NCT05228470|591909812|FG000|Overall Study|Withdrawal by Subject|1|||
163874812|NCT05228470|591909813|FG001|Overall Study|Withdrawal by Subject|8|||
163874813|NCT05228470|591909812|FG000|Overall Study|Ongoing|1|||
163874814|NCT05228470|591909813|FG001|Overall Study|Ongoing|11|||
163874815|NCT05552963|591909814|FG000|Overall Study|Lost to Follow-up|1|||
163874816|NCT05552963|591909814|FG000|Overall Study|Study catheter was inserted, but PF energy was not delivered due to ECG interference|1|||
163874817|NCT01471691|591909815|FG000|Overall Study|Lack of Efficacy|0|||
163874818|NCT01471691|591909816|FG001|Overall Study|Lack of Efficacy|1|||
163874819|NCT01808339|591909817|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874820|NCT01808339|591909818|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874821|NCT01808339|591909819|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874822|NCT01808339|591909820|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
163874823|NCT01808339|591909821|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
163874824|NCT01808339|591909822|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
163874825|NCT01808339|591909817|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163874826|NCT01808339|591909818|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163874827|NCT01808339|591909819|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163874828|NCT01808339|591909820|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
163874829|NCT01808339|591909821|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163874830|NCT01808339|591909822|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
163874831|NCT01808339|591909817|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874832|NCT01808339|591909818|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874833|NCT01808339|591909819|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
163874834|NCT01808339|591909820|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163978740|NCT00847912|592293568|FG000|Overall Study|Protocol Violation|6|||
163978741|NCT00847912|592293569|FG001|Overall Study|Protocol Violation|7|||
163978742|NCT00847912|592293568|FG000|Overall Study|Withdrawal by Subject|3|||
163978743|NCT00847912|592293569|FG001|Overall Study|Withdrawal by Subject|6|||
163978744|NCT02083380|592293571|FG000|Overall Study|Lack of Efficacy|68|||
163874835|NCT01808339|591909821|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874836|NCT01808339|591909822|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
163874837|NCT05054725|591909824|FG000|Overall Study|Withdrawal by Subject|3|||
163874838|NCT05054725|591909825|FG001|Overall Study|Withdrawal by Subject|4|||
163978745|NCT02083380|592293572|FG001|Overall Study|Lack of Efficacy|79|||
164320510|NCT01978938|593550197|FG001|Overall Study|Previously scheduled procedure|1|||
164320511|NCT02694757|593550198|FG000|Overall Study|Lack of Efficacy|3|||
164320512|NCT02650921|593550199|FG000|Overall Study|Withdrawal by Subject|4|||
164320513|NCT02650921|593550199|FG000|Overall Study|Lost to Follow-up|2|||
164320514|NCT02650921|593550199|FG000|Overall Study|Adverse Event|1|||
164320515|NCT02650921|593550199|FG000|Overall Study|Due to Medical Condition|1|||
164320516|NCT00783302|593550200|FG000|Overall Study|Lost to Follow-up|17|||
164320517|NCT00783302|593550200|FG000|Overall Study|Technical Problems|11|||
164320518|NCT00783302|593550200|FG000|Overall Study|Protocol Violation|3|||
164320519|NCT00783302|593550200|FG000|Overall Study|Physician Decision|1|||
164320520|NCT00783302|593550200|FG000|Overall Study|Withdrawal by Subject|3|||
164320521|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
164320522|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
164320523|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
164320524|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
164320525|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
164320526|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
164320527|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
164320528|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
164320529|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
164320530|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
164320531|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
164320532|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
164320533|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
164320534|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
164320535|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
164320536|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
164320537|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
164320538|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
164320539|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
164320540|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
164320541|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
164320542|NCT01087788|593550201|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
164320543|NCT01087788|593550202|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
164320544|NCT01087788|593550203|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
164320545|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
164320546|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
164320547|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
164320548|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
164320549|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
164320550|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
164320551|NCT01087788|593550201|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
164320552|NCT01087788|593550202|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
164320553|NCT01087788|593550203|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
164320554|NCT01087788|593550201|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
164320555|NCT01087788|593550202|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
164320556|NCT01087788|593550203|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
164320557|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
164320558|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
164320559|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
164320560|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
164320561|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
164320562|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
164320563|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
164320564|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
164320565|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
164320566|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
164320567|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
164320568|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
164320569|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
164320570|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
164320571|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
164320572|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
164320573|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
164320574|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
164320575|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
164320576|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
164320577|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
164320578|NCT01087788|593550201|FG000|24-weeks Dose-blind Period|Patient moved|0|||
164320579|NCT01087788|593550202|FG001|24-weeks Dose-blind Period|Patient moved|0|||
164320580|NCT01087788|593550203|FG002|24-weeks Dose-blind Period|Patient moved|1|||
164320581|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
163978746|NCT02083380|592293573|FG002|Overall Study|Lack of Efficacy|64|||
163978747|NCT02083380|592293571|FG000|Overall Study|Withdrawal by Subject|9|||
163978748|NCT02083380|592293572|FG001|Overall Study|Withdrawal by Subject|3|||
163978749|NCT02083380|592293573|FG002|Overall Study|Withdrawal by Subject|7|||
163978750|NCT02083380|592293571|FG000|Overall Study|Physician Decision|1|||
163978751|NCT02083380|592293572|FG001|Overall Study|Physician Decision|6|||
163978752|NCT02083380|592293573|FG002|Overall Study|Physician Decision|3|||
163978753|NCT02083380|592293571|FG000|Overall Study|Adverse Event|0|||
163978754|NCT02083380|592293572|FG001|Overall Study|Adverse Event|0|||
163978755|NCT02083380|592293573|FG002|Overall Study|Adverse Event|1|||
163978756|NCT02083380|592293571|FG000|Overall Study|Lost to Follow-up|5|||
163978757|NCT02083380|592293572|FG001|Overall Study|Lost to Follow-up|3|||
163978758|NCT02083380|592293573|FG002|Overall Study|Lost to Follow-up|3|||
163978759|NCT02083380|592293571|FG000|Overall Study|Other|8|||
163978760|NCT02083380|592293572|FG001|Overall Study|Other|4|||
163978761|NCT02083380|592293573|FG002|Overall Study|Other|6|||
163978762|NCT01577186|592293577|FG000|Overall Study|Adverse Event|23|||
163978763|NCT01577186|592293577|FG000|Overall Study|Death|1|||
163978764|NCT01577186|592293577|FG000|Overall Study|Lost to Follow-up|28|||
163978765|NCT01577186|592293577|FG000|Overall Study|Withdrawal by Subject|35|||
163978766|NCT01577186|592293577|FG000|Overall Study|Insufficient Response|18|||
163978767|NCT01577186|592293577|FG000|Overall Study|Ineligible to Continue|15|||
163978768|NCT01577186|592293577|FG000|Overall Study|Non-Compliant|8|||
163978769|NCT01577186|592293577|FG000|Overall Study|Other|2|||
163978770|NCT01032915|592293578|FG000|Overall Study|Adverse Event|2|||
163978771|NCT01032915|592293579|FG001|Overall Study|Adverse Event|2|||
163978772|NCT01032915|592293580|FG002|Overall Study|Adverse Event|1|||
163978773|NCT01032915|592293581|FG003|Overall Study|Adverse Event|1|||
163978774|NCT01032915|592293578|FG000|Overall Study|Abnormal test procedure result|0|||
163978775|NCT01032915|592293579|FG001|Overall Study|Abnormal test procedure result|0|||
163978776|NCT01032915|592293580|FG002|Overall Study|Abnormal test procedure result|1|||
163978777|NCT01032915|592293581|FG003|Overall Study|Abnormal test procedure result|0|||
163978778|NCT01032915|592293578|FG000|Overall Study|Withdrawal by Subject|0|||
163978779|NCT01032915|592293579|FG001|Overall Study|Withdrawal by Subject|3|||
163978780|NCT01032915|592293580|FG002|Overall Study|Withdrawal by Subject|1|||
163978781|NCT01032915|592293581|FG003|Overall Study|Withdrawal by Subject|1|||
163978782|NCT01032915|592293578|FG000|Overall Study|Administrative reasons|5|||
163978783|NCT01032915|592293579|FG001|Overall Study|Administrative reasons|6|||
163978784|NCT01032915|592293580|FG002|Overall Study|Administrative reasons|4|||
163978785|NCT01032915|592293581|FG003|Overall Study|Administrative reasons|4|||
163978786|NCT01032915|592293578|FG000|Overall Study|Protocol Violation|1|||
163978787|NCT01032915|592293579|FG001|Overall Study|Protocol Violation|0|||
163978788|NCT01032915|592293580|FG002|Overall Study|Protocol Violation|0|||
163978789|NCT01032915|592293581|FG003|Overall Study|Protocol Violation|1|||
163978790|NCT02915523|592293583|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
163978791|NCT02915523|592293584|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
163978792|NCT02915523|592293585|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
163978793|NCT02915523|592293586|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
163978794|NCT02915523|592293583|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
163978795|NCT02915523|592293584|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
163978796|NCT02915523|592293585|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
163978797|NCT02915523|592293586|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
163978798|NCT02915523|592293583|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
163978799|NCT02915523|592293584|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
163978800|NCT02915523|592293585|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
163978801|NCT02915523|592293586|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
163978802|NCT02915523|592293583|FG000|Expansion Phase (Phase 2)|Death|0|||
163978803|NCT02915523|592293584|FG001|Expansion Phase (Phase 2)|Death|0|||
163978804|NCT02915523|592293585|FG002|Expansion Phase (Phase 2)|Death|26|||
163978805|NCT02915523|592293586|FG003|Expansion Phase (Phase 2)|Death|53|||
164076453|NCT00686790|592645718|FG000|Overall Study|Lost to Follow-up|12|||
163978806|NCT02915523|592293583|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
163978807|NCT02915523|592293584|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
163978808|NCT02915523|592293585|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
163978809|NCT02915523|592293586|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
164076454|NCT03862625|592645721|FG000|Overall Study|Lost to Follow-up|0|||
163978810|NCT02915523|592293583|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
163978811|NCT02915523|592293584|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
163978812|NCT02915523|592293585|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
163978813|NCT02915523|592293586|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
163978814|NCT02915523|592293583|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
163978815|NCT02915523|592293584|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
164320582|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
163978816|NCT02915523|592293585|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
163978817|NCT02915523|592293586|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
163978818|NCT02797808|592293587|FG000|Overall Study|Withdrawal by Subject|1|||
164320583|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
164320584|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
164320585|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
164320586|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
164320587|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
164320588|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
164320589|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
164320590|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
164320591|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
164320592|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
164320593|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
164320594|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
164320595|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
164320596|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
164320597|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
164320598|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
164320599|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
164320600|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
164320601|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
164320602|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
164320603|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
164320604|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
164320605|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
164320606|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
164320607|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
164320608|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
164320609|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
164320610|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
164320611|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
164320612|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
164320613|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
164320614|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
164320615|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
164320616|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
164320617|NCT01087788|593550201|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
164320618|NCT01087788|593550202|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
164320619|NCT01087788|593550203|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
164320620|NCT01806662|593550204|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
164320621|NCT01806662|593550205|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
164320622|NCT01806662|593550204|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
164320623|NCT01806662|593550205|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
164320624|NCT01806662|593550204|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
164320625|NCT01806662|593550205|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
164320626|NCT01806662|593550204|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
164320627|NCT01806662|593550205|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
164320628|NCT00043550|593550206|FG000|Overall Study|Withdrawal by Subject|22|||
164320629|NCT00043550|593550207|FG001|Overall Study|Withdrawal by Subject|12|||
163978819|NCT02797808|592293588|FG001|Overall Study|Withdrawal by Subject|1|||
163978820|NCT02797808|592293587|FG000|Overall Study|Physician Decision|6|||
163978821|NCT02797808|592293588|FG001|Overall Study|Physician Decision|2|||
163978822|NCT03221751|592293589|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
163978823|NCT03221751|592293590|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
163978824|NCT00535132|592293593|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
163978825|NCT00535132|592293594|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
164320630|NCT00043550|593550208|FG002|Overall Study|Withdrawal by Subject|20|||
163978826|NCT00535132|592293593|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
164320631|NCT01917656|593550209|FG000|Overall Study|Adverse Event|11|||
164320632|NCT01917656|593550210|FG001|Overall Study|Adverse Event|0|||
164320633|NCT01917656|593550209|FG000|Overall Study|Withdrawal criteria|8|||
163978827|NCT00535132|592293594|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
164320634|NCT01917656|593550210|FG001|Overall Study|Withdrawal criteria|14|||
164320635|NCT01917656|593550209|FG000|Overall Study|Unclassified|0|||
163978828|NCT00708500|592293606|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
164320636|NCT01917656|593550210|FG001|Overall Study|Unclassified|3|||
164320637|NCT01917656|593550209|FG000|Overall Study|Withdrawal by Subject|4|||
164076455|NCT03862625|592645722|FG001|Overall Study|Lost to Follow-up|1|||
163978829|NCT00708500|592293607|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
163978830|NCT00708500|592293608|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
163978831|NCT00708500|592293606|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
163978832|NCT00708500|592293607|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
163978833|NCT00708500|592293608|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
163978834|NCT00708500|592293606|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
163978835|NCT00708500|592293607|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
163978836|NCT00708500|592293608|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
163978837|NCT00708500|592293606|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
163978838|NCT00708500|592293607|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
163978839|NCT00708500|592293608|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
163978840|NCT00708500|592293606|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
163978841|NCT00708500|592293607|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
163978842|NCT00708500|592293608|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
163978843|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
163978844|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
163978845|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
163978846|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
163978847|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
163978848|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
163978849|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
163978850|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
163978851|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
163978852|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
163978853|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
163978854|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
163978855|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
163978856|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
163978857|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
163978858|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
163978859|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
163978860|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
163978861|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
163978862|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
163978863|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
163978864|NCT00708500|592293606|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
163978865|NCT00708500|592293607|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
163978866|NCT00708500|592293608|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
163978867|NCT00708500|592293606|FG000|FOLLOWUP|Adverse Event|0|||
163978868|NCT00708500|592293607|FG001|FOLLOWUP|Adverse Event|1|||
163978869|NCT00708500|592293608|FG002|FOLLOWUP|Adverse Event|0|||
163978870|NCT00708500|592293606|FG000|FOLLOWUP|Lost to Follow-up|1|||
163978871|NCT00708500|592293607|FG001|FOLLOWUP|Lost to Follow-up|6|||
163978872|NCT00708500|592293608|FG002|FOLLOWUP|Lost to Follow-up|4|||
163978873|NCT00708500|592293606|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
163978874|NCT00708500|592293607|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
163978875|NCT00708500|592293608|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
163978876|NCT00708500|592293606|FG000|FOLLOWUP|Subject withdrew consent|31|||
163978877|NCT00708500|592293607|FG001|FOLLOWUP|Subject withdrew consent|4|||
163978878|NCT00708500|592293608|FG002|FOLLOWUP|Subject withdrew consent|5|||
163978879|NCT00708500|592293606|FG000|FOLLOWUP|Non-compliance with protocol|5|||
164207191|NCT00141921|593127776|FG000|Overall Study|Noncompliance|17|||
164207192|NCT00141921|593127776|FG000|Overall Study|Disease Progression|7|||
164207193|NCT00141921|593127776|FG000|Overall Study|Protocol Deviation|7|||
164207194|NCT00141921|593127776|FG000|Overall Study|Adverse Event|5|||
164207195|NCT00141921|593127776|FG000|Overall Study|Administrative Decision|2|||
164207196|NCT00141921|593127776|FG000|Overall Study|Pregnancy|4|||
164207197|NCT00141921|593127776|FG000|Overall Study|Ineligibility Determined|2|||
164207198|NCT00141921|593127776|FG000|Overall Study|Other|8|||
164207199|NCT03320369|593127777|FG000|Overall Study|Adverse Event|1|||
164207200|NCT03320369|593127777|FG000|Overall Study|Withdrawal by Subject|2|||
164207201|NCT01461551|593127779|FG000|Overall Study|Physician Decision|2|||
164207202|NCT01461551|593127780|FG001|Overall Study|Physician Decision|1|||
164207203|NCT01461551|593127781|FG002|Overall Study|Physician Decision|2|||
163978880|NCT00708500|592293607|FG001|FOLLOWUP|Non-compliance with protocol|0|||
163978881|NCT00708500|592293608|FG002|FOLLOWUP|Non-compliance with protocol|1|||
164207204|NCT02326883|593127782|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
164207205|NCT02326883|593127783|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
163978882|NCT00794677|592293622|FG000|First Intervention|Withdrawal by Subject|2|||
163978883|NCT00794677|592293623|FG001|First Intervention|Withdrawal by Subject|0|||
163978884|NCT01029366|592293624|FG000|Overall Study|Withdrawal by Subject|1|||
163978885|NCT01029366|592293625|FG001|Overall Study|Withdrawal by Subject|0|||
163978886|NCT01029366|592293624|FG000|Overall Study|Death|1|||
163978887|NCT01029366|592293625|FG001|Overall Study|Death|1|||
163978888|NCT01029366|592293624|FG000|Overall Study|disease progression|2|||
163978889|NCT01029366|592293625|FG001|Overall Study|disease progression|0|||
163978890|NCT01029366|592293624|FG000|Overall Study|manufacturing failure|0|||
163978891|NCT01029366|592293625|FG001|Overall Study|manufacturing failure|1|||
163978892|NCT03681119|592293630|FG000|Overall Study|No specific reason|4|||
163978893|NCT03681119|592293631|FG001|Overall Study|No specific reason|0|||
163978894|NCT03681119|592293630|FG000|Overall Study|Sickness|2|||
163978895|NCT03681119|592293631|FG001|Overall Study|Sickness|0|||
163978896|NCT02941627|592293640|FG000|Overall Study|Death|1|||
163978897|NCT02941627|592293640|FG000|Overall Study|Surgical failure|1|||
163978898|NCT02941627|592293640|FG000|Overall Study|cholesteatoma prevented implantation|1|||
163978899|NCT00563186|592293641|FG000|Overall Study|LOS<48 hours|97|||
163978900|NCT00563186|592293642|FG001|Overall Study|LOS<48 hours|74|||
163978901|NCT00563186|592293641|FG000|Overall Study|Incomplete data|1|||
163978902|NCT00563186|592293642|FG001|Overall Study|Incomplete data|1|||
163978903|NCT02595723|592293643|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
163978904|NCT02595723|592293644|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
163978905|NCT02595723|592293645|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
163978906|NCT02595723|592293643|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
163978907|NCT02595723|592293644|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
163978908|NCT02595723|592293645|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
163978909|NCT01136655|592293646|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
163978910|NCT01136655|592293646|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
163978911|NCT01136655|592293646|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
163978912|NCT01136655|592293646|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
163978913|NCT01265550|592293647|FG000|Pre Randomization|Withdrawal by Subject|0|||
163978914|NCT01265550|592293648|FG001|Pre Randomization|Withdrawal by Subject|0|||
163978915|NCT01265550|592293649|FG002|Pre Randomization|Withdrawal by Subject|0|||
163978916|NCT01265550|592293650|FG003|Pre Randomization|Withdrawal by Subject|70|||
163978917|NCT01265550|592293647|FG000|Pre Randomization|Technical Exclusions|0|||
163978918|NCT01265550|592293648|FG001|Pre Randomization|Technical Exclusions|0|||
163978919|NCT01265550|592293649|FG002|Pre Randomization|Technical Exclusions|0|||
163978920|NCT01265550|592293650|FG003|Pre Randomization|Technical Exclusions|54|||
163978921|NCT01265550|592293647|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
163978922|NCT01265550|592293648|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
163978923|NCT01265550|592293649|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
163978924|NCT01265550|592293650|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
163978925|NCT01265550|592293647|FG000|Pre Randomization|Non-GERD organic disorders|0|||
163978926|NCT01265550|592293648|FG001|Pre Randomization|Non-GERD organic disorders|0|||
163978927|NCT01265550|592293649|FG002|Pre Randomization|Non-GERD organic disorders|0|||
163978928|NCT01265550|592293650|FG003|Pre Randomization|Non-GERD organic disorders|23|||
163978929|NCT01265550|592293647|FG000|Pre Randomization|Functional heartburn|0|||
163978930|NCT01265550|592293648|FG001|Pre Randomization|Functional heartburn|0|||
163978931|NCT01265550|592293649|FG002|Pre Randomization|Functional heartburn|0|||
163978932|NCT01265550|592293650|FG003|Pre Randomization|Functional heartburn|99|||
163978933|NCT00391222|592293653|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
163978934|NCT00391222|592293654|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
163978935|NCT00391222|592293655|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
163978936|NCT00391222|592293656|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
163978937|NCT00391222|592293653|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
163978938|NCT00391222|592293654|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
163978939|NCT00391222|592293655|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
163978940|NCT00391222|592293656|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
163978941|NCT00391222|592293653|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
163978942|NCT00391222|592293654|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
163978943|NCT00391222|592293655|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
163978944|NCT00391222|592293656|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
163978945|NCT00391222|592293653|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
163978946|NCT00391222|592293654|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
163978947|NCT00391222|592293655|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
163978948|NCT00391222|592293656|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
163978949|NCT00391222|592293653|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
163978950|NCT00391222|592293654|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
164207206|NCT02326883|593127784|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
164207207|NCT05853120|593127785|FG000|Overall Study|Lost to Follow-up|4|||
163978951|NCT00391222|592293655|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
164207208|NCT05853120|593127786|FG001|Overall Study|Lost to Follow-up|4|||
163874839|NCT05054725|591909824|FG000|Overall Study|Sponsor's Decision to Terminate the Study|0|||
163874840|NCT05054725|591909825|FG001|Overall Study|Sponsor's Decision to Terminate the Study|3|||
163874841|NCT05054725|591909824|FG000|Overall Study|Death|1|||
163874842|NCT05054725|591909825|FG001|Overall Study|Death|21|||
163874843|NCT05054725|591909824|FG000|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|0|||
163874844|NCT05054725|591909825|FG001|Overall Study|Sponsor amended protocol to terminate Long Term Follow Up (LTFU)|3|||
163874845|NCT05054725|591909824|FG000|Overall Study|PI's decision that there is no benefit from LTFU|0|||
163874846|NCT05054725|591909825|FG001|Overall Study|PI's decision that there is no benefit from LTFU|6|||
163874847|NCT05054725|591909824|FG000|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|0|||
163874848|NCT05054725|591909825|FG001|Overall Study|Due to AE#17 - Angiosarcoma of the breast with possible relation to study drug|1|||
163874849|NCT05054725|591909824|FG000|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|0|||
163874850|NCT05054725|591909825|FG001|Overall Study|Agreed between patient and PI as safety follow up is not for benefit of the patient|1|||
163874851|NCT05054725|591909824|FG000|Overall Study|Physician discretion due to subject progression|0|||
163874852|NCT05054725|591909825|FG001|Overall Study|Physician discretion due to subject progression|1|||
163874853|NCT03674411|591909826|FG000|Overall Study|Non-treatment|4|||
163874854|NCT03674411|591909827|FG001|Overall Study|Non-treatment|0|||
163874855|NCT00780910|591909828|FG000|Overall Study|Adverse Event|2|||
163874856|NCT04929483|591909832|FG000|Main Study (24 Weeks)|Adverse Event|1|||
163874857|NCT04929483|591909833|FG001|Main Study (24 Weeks)|Adverse Event|6|||
163874858|NCT04929483|591909834|FG002|Main Study (24 Weeks)|Adverse Event|2|||
163874859|NCT04929483|591909835|FG003|Main Study (24 Weeks)|Adverse Event|1|||
164207209|NCT05853120|593127785|FG000|Overall Study|Physician Decision|3|||
164207210|NCT05853120|593127786|FG001|Overall Study|Physician Decision|0|||
164207211|NCT05853120|593127785|FG000|Overall Study|Withdrawal by Subject|5|||
164207212|NCT05853120|593127786|FG001|Overall Study|Withdrawal by Subject|2|||
164207213|NCT00790036|593127787|FG000|Overall Study|Abnormal lab values|3|||
164207214|NCT00790036|593127788|FG001|Overall Study|Abnormal lab values|2|||
164207215|NCT00790036|593127787|FG000|Overall Study|Administrative problems|5|||
164207216|NCT00790036|593127788|FG001|Overall Study|Administrative problems|9|||
164207217|NCT00790036|593127787|FG000|Overall Study|Adverse Event|113|||
164207218|NCT00790036|593127788|FG001|Overall Study|Adverse Event|44|||
164207219|NCT00790036|593127787|FG000|Overall Study|Death|1|||
164207220|NCT00790036|593127788|FG001|Overall Study|Death|0|||
164207221|NCT00790036|593127787|FG000|Overall Study|Disease progression|24|||
164207222|NCT00790036|593127788|FG001|Overall Study|Disease progression|48|||
164207223|NCT00790036|593127787|FG000|Overall Study|Lost to Follow-up|1|||
164207224|NCT00790036|593127788|FG001|Overall Study|Lost to Follow-up|2|||
164207225|NCT00790036|593127787|FG000|Overall Study|Protocol Violation|10|||
164207226|NCT00790036|593127788|FG001|Overall Study|Protocol Violation|2|||
164207227|NCT00790036|593127787|FG000|Overall Study|Withdrawal by Subject|18|||
164207228|NCT00790036|593127788|FG001|Overall Study|Withdrawal by Subject|7|||
164207229|NCT00790036|593127787|FG000|Overall Study|Subject/guardian decision|20|||
164207230|NCT00790036|593127788|FG001|Overall Study|Subject/guardian decision|7|||
164207231|NCT04428151|593127791|FG000|Overall Study|Death|100|||
164207232|NCT04428151|593127792|FG001|Overall Study|Death|86|||
164207233|NCT04428151|593127793|FG002|Overall Study|Death|57|||
164207234|NCT04428151|593127791|FG000|Overall Study|Lost to Follow-up|1|||
164207235|NCT04428151|593127792|FG001|Overall Study|Lost to Follow-up|1|||
164207236|NCT04428151|593127793|FG002|Overall Study|Lost to Follow-up|0|||
164207237|NCT04428151|593127791|FG000|Overall Study|Withdrawal by Subject|2|||
164207238|NCT04428151|593127792|FG001|Overall Study|Withdrawal by Subject|2|||
164207239|NCT04428151|593127793|FG002|Overall Study|Withdrawal by Subject|3|||
164207240|NCT04428151|593127791|FG000|Overall Study|Participant Ongoing in Study|41|||
164207241|NCT04428151|593127792|FG001|Overall Study|Participant Ongoing in Study|53|||
164207242|NCT04428151|593127793|FG002|Overall Study|Participant Ongoing in Study|28|||
164207243|NCT02187783|593127794|FG000|Overall Study|Adverse Event|8|||
164207244|NCT02187783|593127794|FG000|Overall Study|Death|3|||
164207245|NCT02187783|593127794|FG000|Overall Study|Progressive disease|80|||
164207246|NCT02187783|593127794|FG000|Overall Study|Protocol Violation|3|||
164207247|NCT02187783|593127794|FG000|Overall Study|Physician Decision|2|||
164207248|NCT02187783|593127794|FG000|Overall Study|Withdrawal by Subject|9|||
164207249|NCT02187783|593127794|FG000|Overall Study|Study terminated by sponsor|1|||
164207250|NCT00171249|593127795|FG000|Overall Study|Withdrawal by Subject|2|||
164076456|NCT02082912|592645723|FG000|Overall Study|Physician Decision|0|||
164207251|NCT00171249|593127796|FG001|Overall Study|Withdrawal by Subject|0|||
164207252|NCT00171249|593127797|FG002|Overall Study|Withdrawal by Subject|0|||
164207253|NCT00171249|593127798|FG003|Overall Study|Withdrawal by Subject|6|||
164207254|NCT00171249|593127799|FG004|Overall Study|Withdrawal by Subject|0|||
164207255|NCT00171249|593127800|FG005|Overall Study|Withdrawal by Subject|0|||
164207256|NCT00171249|593127801|FG006|Overall Study|Withdrawal by Subject|0|||
164207257|NCT00171249|593127795|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
164207258|NCT00171249|593127796|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
163978952|NCT00391222|592293656|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
163978953|NCT00391222|592293653|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
164207259|NCT00171249|593127797|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
164207260|NCT00171249|593127798|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
164207261|NCT00171249|593127799|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164207262|NCT00171249|593127800|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
164207263|NCT00171249|593127801|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164207264|NCT00171249|593127795|FG000|Overall Study|Death|7|||
164207265|NCT00171249|593127796|FG001|Overall Study|Death|1|||
164207266|NCT00171249|593127797|FG002|Overall Study|Death|0|||
164207267|NCT00171249|593127798|FG003|Overall Study|Death|4|||
164207268|NCT00171249|593127799|FG004|Overall Study|Death|0|||
164207269|NCT00171249|593127800|FG005|Overall Study|Death|3|||
164207270|NCT00171249|593127801|FG006|Overall Study|Death|1|||
164207271|NCT00171249|593127795|FG000|Overall Study|Other|10|||
164207272|NCT00171249|593127796|FG001|Overall Study|Other|0|||
164207273|NCT00171249|593127797|FG002|Overall Study|Other|0|||
164207274|NCT00171249|593127798|FG003|Overall Study|Other|43|||
164207275|NCT00171249|593127799|FG004|Overall Study|Other|0|||
164207276|NCT00171249|593127800|FG005|Overall Study|Other|2|||
164207277|NCT00171249|593127801|FG006|Overall Study|Other|0|||
164207278|NCT00171249|593127795|FG000|Overall Study|No Longer Requires Study Drug|4|||
164207279|NCT00171249|593127796|FG001|Overall Study|No Longer Requires Study Drug|0|||
164207280|NCT00171249|593127797|FG002|Overall Study|No Longer Requires Study Drug|0|||
164207281|NCT00171249|593127798|FG003|Overall Study|No Longer Requires Study Drug|3|||
164207282|NCT00171249|593127799|FG004|Overall Study|No Longer Requires Study Drug|0|||
164207283|NCT00171249|593127800|FG005|Overall Study|No Longer Requires Study Drug|5|||
164207284|NCT00171249|593127801|FG006|Overall Study|No Longer Requires Study Drug|0|||
164207285|NCT00171249|593127795|FG000|Overall Study|Administrative Problems|1|||
164207286|NCT00171249|593127796|FG001|Overall Study|Administrative Problems|0|||
164207287|NCT00171249|593127797|FG002|Overall Study|Administrative Problems|0|||
164207288|NCT00171249|593127798|FG003|Overall Study|Administrative Problems|2|||
164207289|NCT00171249|593127799|FG004|Overall Study|Administrative Problems|0|||
164207290|NCT00171249|593127800|FG005|Overall Study|Administrative Problems|0|||
164207291|NCT00171249|593127801|FG006|Overall Study|Administrative Problems|0|||
164207292|NCT00171249|593127795|FG000|Overall Study|Adverse Event|3|||
164207293|NCT00171249|593127796|FG001|Overall Study|Adverse Event|1|||
164207294|NCT00171249|593127797|FG002|Overall Study|Adverse Event|0|||
164207295|NCT00171249|593127798|FG003|Overall Study|Adverse Event|15|||
164207296|NCT00171249|593127799|FG004|Overall Study|Adverse Event|0|||
164207297|NCT00171249|593127800|FG005|Overall Study|Adverse Event|2|||
164207298|NCT00171249|593127801|FG006|Overall Study|Adverse Event|0|||
164207299|NCT00171249|593127795|FG000|Overall Study|Lost to Follow-up|5|||
164207300|NCT00171249|593127796|FG001|Overall Study|Lost to Follow-up|0|||
164207301|NCT00171249|593127797|FG002|Overall Study|Lost to Follow-up|0|||
164207302|NCT00171249|593127798|FG003|Overall Study|Lost to Follow-up|9|||
164207303|NCT00171249|593127799|FG004|Overall Study|Lost to Follow-up|0|||
164207304|NCT00171249|593127800|FG005|Overall Study|Lost to Follow-up|0|||
164207305|NCT00171249|593127801|FG006|Overall Study|Lost to Follow-up|0|||
164207306|NCT00392223|593127802|FG000|Overall Study|Adverse Event|5|||
164207307|NCT00392223|593127803|FG001|Overall Study|Adverse Event|4|||
164207308|NCT00392223|593127802|FG000|Overall Study|Lost to Follow-up|1|||
164207309|NCT00392223|593127803|FG001|Overall Study|Lost to Follow-up|4|||
164207310|NCT00392223|593127802|FG000|Overall Study|Protocol Violation|0|||
164207311|NCT00392223|593127803|FG001|Overall Study|Protocol Violation|3|||
164207312|NCT00392223|593127802|FG000|Overall Study|Withdrawal by Subject|3|||
164207313|NCT00392223|593127803|FG001|Overall Study|Withdrawal by Subject|2|||
164207314|NCT02792504|593127809|FG000|Overall Study|Lost to Follow-up|24|||
164207315|NCT02792504|593127809|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
164207316|NCT01114724|593127816|FG000|Overall Study|Death|8|||
164207317|NCT01114724|593127816|FG000|Overall Study|Lost to Follow-up|1|||
164207318|NCT01114724|593127816|FG000|Overall Study|Withdrawal by Subject|1|||
164207319|NCT02814526|593127817|FG000|Overall Study|Adverse Event|4|||
164207320|NCT02814526|593127818|FG001|Overall Study|Adverse Event|3|||
164207321|NCT02814526|593127817|FG000|Overall Study|Death|1|||
164207322|NCT02814526|593127818|FG001|Overall Study|Death|1|||
164207323|NCT02814526|593127817|FG000|Overall Study|Lost to Follow-up|3|||
164207324|NCT02814526|593127818|FG001|Overall Study|Lost to Follow-up|4|||
164207325|NCT02814526|593127817|FG000|Overall Study|non site physician decision|1|||
164207326|NCT02814526|593127818|FG001|Overall Study|non site physician decision|0|||
164207327|NCT02814526|593127817|FG000|Overall Study|participant noncompliance|1|||
164207328|NCT02814526|593127818|FG001|Overall Study|participant noncompliance|1|||
163978954|NCT00391222|592293654|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
164207329|NCT02814526|593127817|FG000|Overall Study|Withdrawal by Subject|20|||
164207330|NCT02814526|593127818|FG001|Overall Study|Withdrawal by Subject|14|||
164207331|NCT02814526|593127817|FG000|Overall Study|safety risk|2|||
164207332|NCT02814526|593127818|FG001|Overall Study|safety risk|1|||
164207333|NCT02814526|593127817|FG000|Overall Study|early termination-study terminated|1|||
164320638|NCT01917656|593550210|FG001|Overall Study|Withdrawal by Subject|3|||
164320639|NCT01917656|593550209|FG000|Overall Study|Lost to Follow-up|3|||
164320640|NCT01917656|593550210|FG001|Overall Study|Lost to Follow-up|4|||
164320641|NCT02285062|593550211|FG000|Pre-Treatment Period|Protocol Violation|0|||
164320642|NCT02285062|593550212|FG001|Pre-Treatment Period|Protocol Violation|2|||
164320643|NCT02285062|593550211|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
164320644|NCT02285062|593550212|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164320645|NCT00436501|593550213|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
164320646|NCT00436501|593550214|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
164320647|NCT00436501|593550213|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
164320648|NCT00436501|593550214|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
164320649|NCT03011892|593550227|FG000|Double Blind (DB) Period|Adverse Event|0|||
164320650|NCT03011892|593550228|FG001|Double Blind (DB) Period|Adverse Event|1|||
164320651|NCT03011892|593550229|FG002|Double Blind (DB) Period|Adverse Event|1|||
164320652|NCT03011892|593550230|FG003|Double Blind (DB) Period|Adverse Event|0|||
164320653|NCT03011892|593550231|FG004|Double Blind (DB) Period|Adverse Event|0|||
164320654|NCT03011892|593550232|FG005|Double Blind (DB) Period|Adverse Event|0|||
164320655|NCT03011892|593550233|FG006|Double Blind (DB) Period|Adverse Event|0|||
164320656|NCT03011892|593550234|FG007|Double Blind (DB) Period|Adverse Event|0|||
164320657|NCT03011892|593550235|FG008|Double Blind (DB) Period|Adverse Event|0|||
164320658|NCT03011892|593550236|FG009|Double Blind (DB) Period|Adverse Event|0|||
164320659|NCT03011892|593550237|FG010|Double Blind (DB) Period|Adverse Event|0|||
164320660|NCT03011892|593550238|FG011|Double Blind (DB) Period|Adverse Event|0|||
164320661|NCT03011892|593550227|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
164320662|NCT03011892|593550228|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
164320663|NCT03011892|593550229|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
164320664|NCT03011892|593550230|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
164320665|NCT03011892|593550231|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
164320666|NCT03011892|593550232|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
164320667|NCT03011892|593550233|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
164320668|NCT03011892|593550234|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
164320669|NCT03011892|593550235|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
164320670|NCT03011892|593550236|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
164320671|NCT03011892|593550237|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
164320672|NCT03011892|593550238|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
164320673|NCT03011892|593550227|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
164320674|NCT03011892|593550228|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
164320675|NCT03011892|593550229|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
164320676|NCT03011892|593550230|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
164320677|NCT03011892|593550231|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
164320678|NCT03011892|593550232|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
164320679|NCT03011892|593550233|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
164320680|NCT03011892|593550234|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
164320681|NCT03011892|593550235|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
164320682|NCT03011892|593550236|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
164320683|NCT03011892|593550237|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
164320684|NCT03011892|593550238|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
164320685|NCT03011892|593550227|FG000|Double Blind (DB) Period|Other|1|||
164320686|NCT03011892|593550228|FG001|Double Blind (DB) Period|Other|1|||
164320687|NCT03011892|593550229|FG002|Double Blind (DB) Period|Other|1|||
164320688|NCT03011892|593550230|FG003|Double Blind (DB) Period|Other|0|||
164320689|NCT03011892|593550231|FG004|Double Blind (DB) Period|Other|1|||
164320690|NCT03011892|593550232|FG005|Double Blind (DB) Period|Other|0|||
164320691|NCT03011892|593550233|FG006|Double Blind (DB) Period|Other|0|||
164320692|NCT03011892|593550234|FG007|Double Blind (DB) Period|Other|0|||
164320693|NCT03011892|593550235|FG008|Double Blind (DB) Period|Other|0|||
164320694|NCT03011892|593550236|FG009|Double Blind (DB) Period|Other|0|||
164320695|NCT03011892|593550237|FG010|Double Blind (DB) Period|Other|0|||
164320696|NCT03011892|593550238|FG011|Double Blind (DB) Period|Other|0|||
164320697|NCT03011892|593550227|FG000|Double Blind (DB) Period|Physician Decision|1|||
164320698|NCT03011892|593550228|FG001|Double Blind (DB) Period|Physician Decision|0|||
164320699|NCT03011892|593550229|FG002|Double Blind (DB) Period|Physician Decision|1|||
163978955|NCT00391222|592293655|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
163978956|NCT00391222|592293656|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
163978957|NCT00391222|592293653|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
164320700|NCT03011892|593550230|FG003|Double Blind (DB) Period|Physician Decision|0|||
164320701|NCT03011892|593550231|FG004|Double Blind (DB) Period|Physician Decision|0|||
164320702|NCT03011892|593550232|FG005|Double Blind (DB) Period|Physician Decision|0|||
164320703|NCT03011892|593550233|FG006|Double Blind (DB) Period|Physician Decision|0|||
164320704|NCT03011892|593550234|FG007|Double Blind (DB) Period|Physician Decision|0|||
164320705|NCT03011892|593550235|FG008|Double Blind (DB) Period|Physician Decision|0|||
164320706|NCT03011892|593550236|FG009|Double Blind (DB) Period|Physician Decision|0|||
164207334|NCT02814526|593127818|FG001|Overall Study|early termination-study terminated|2|||
164207335|NCT02814526|593127817|FG000|Overall Study|Other|0|||
164207336|NCT02814526|593127818|FG001|Overall Study|Other|4|||
164207337|NCT06178991|593127821|FG000|Overall Study|Withdrawal by Subject|2|||
164207338|NCT06178991|593127822|FG001|Overall Study|Withdrawal by Subject|6|||
164207339|NCT06178991|593127823|FG002|Overall Study|Withdrawal by Subject|44|||
164207340|NCT06178991|593127824|FG003|Overall Study|Withdrawal by Subject|23|||
164207341|NCT06178991|593127825|FG004|Overall Study|Withdrawal by Subject|7|||
164207342|NCT06178991|593127826|FG005|Overall Study|Withdrawal by Subject|7|||
164207343|NCT06178991|593127827|FG006|Overall Study|Withdrawal by Subject|7|||
164207344|NCT06178991|593127828|FG007|Overall Study|Withdrawal by Subject|5|||
164207345|NCT06178991|593127821|FG000|Overall Study|Lost to Follow-up|2|||
164207346|NCT06178991|593127822|FG001|Overall Study|Lost to Follow-up|4|||
164207347|NCT06178991|593127823|FG002|Overall Study|Lost to Follow-up|133|||
164207348|NCT06178991|593127824|FG003|Overall Study|Lost to Follow-up|65|||
164207349|NCT06178991|593127825|FG004|Overall Study|Lost to Follow-up|68|||
164207350|NCT06178991|593127826|FG005|Overall Study|Lost to Follow-up|57|||
164207351|NCT06178991|593127827|FG006|Overall Study|Lost to Follow-up|25|||
164207352|NCT06178991|593127828|FG007|Overall Study|Lost to Follow-up|18|||
164207353|NCT06178991|593127821|FG000|Overall Study|Death|1|||
164207354|NCT06178991|593127822|FG001|Overall Study|Death|0|||
164207355|NCT06178991|593127823|FG002|Overall Study|Death|2|||
164207356|NCT06178991|593127824|FG003|Overall Study|Death|1|||
164207357|NCT06178991|593127825|FG004|Overall Study|Death|1|||
164207358|NCT06178991|593127826|FG005|Overall Study|Death|0|||
164207359|NCT06178991|593127827|FG006|Overall Study|Death|1|||
164207360|NCT06178991|593127828|FG007|Overall Study|Death|1|||
164207361|NCT06178991|593127821|FG000|Overall Study|Randomized but not Vaccinated|4|||
164207362|NCT06178991|593127822|FG001|Overall Study|Randomized but not Vaccinated|1|||
164207363|NCT06178991|593127823|FG002|Overall Study|Randomized but not Vaccinated|15|||
164207364|NCT06178991|593127824|FG003|Overall Study|Randomized but not Vaccinated|9|||
164207365|NCT06178991|593127825|FG004|Overall Study|Randomized but not Vaccinated|8|||
164207366|NCT06178991|593127826|FG005|Overall Study|Randomized but not Vaccinated|4|||
164207367|NCT06178991|593127827|FG006|Overall Study|Randomized but not Vaccinated|2|||
164207368|NCT06178991|593127828|FG007|Overall Study|Randomized but not Vaccinated|2|||
164207369|NCT06178991|593127821|FG000|Overall Study|Other: Unspecified|0|||
164207370|NCT06178991|593127822|FG001|Overall Study|Other: Unspecified|1|||
164207371|NCT06178991|593127823|FG002|Overall Study|Other: Unspecified|7|||
164207372|NCT06178991|593127824|FG003|Overall Study|Other: Unspecified|6|||
164207373|NCT06178991|593127825|FG004|Overall Study|Other: Unspecified|1|||
164207374|NCT06178991|593127826|FG005|Overall Study|Other: Unspecified|1|||
164207375|NCT06178991|593127827|FG006|Overall Study|Other: Unspecified|1|||
164207376|NCT06178991|593127828|FG007|Overall Study|Other: Unspecified|0|||
164207377|NCT06178991|593127821|FG000|Overall Study|Physician Decision|0|||
164207378|NCT06178991|593127822|FG001|Overall Study|Physician Decision|0|||
164207379|NCT06178991|593127823|FG002|Overall Study|Physician Decision|2|||
164207380|NCT06178991|593127824|FG003|Overall Study|Physician Decision|0|||
164207381|NCT06178991|593127825|FG004|Overall Study|Physician Decision|2|||
164207382|NCT06178991|593127826|FG005|Overall Study|Physician Decision|1|||
164207383|NCT06178991|593127827|FG006|Overall Study|Physician Decision|0|||
164207384|NCT06178991|593127828|FG007|Overall Study|Physician Decision|0|||
164207385|NCT06178991|593127821|FG000|Overall Study|Protocol Violation|0|||
164207386|NCT06178991|593127822|FG001|Overall Study|Protocol Violation|0|||
164207387|NCT06178991|593127823|FG002|Overall Study|Protocol Violation|1|||
164207388|NCT06178991|593127824|FG003|Overall Study|Protocol Violation|0|||
164207389|NCT06178991|593127825|FG004|Overall Study|Protocol Violation|0|||
164207390|NCT06178991|593127826|FG005|Overall Study|Protocol Violation|0|||
164207391|NCT06178991|593127827|FG006|Overall Study|Protocol Violation|0|||
164207392|NCT06178991|593127828|FG007|Overall Study|Protocol Violation|0|||
164207393|NCT03415178|593127831|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
164207394|NCT03415178|593127832|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
164207395|NCT03415178|593127831|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
164207396|NCT03415178|593127832|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
164207397|NCT02485860|593127834|FG000|Overall Study|Lost to Follow-up|4|||
164207398|NCT02485860|593127835|FG001|Overall Study|Lost to Follow-up|1|||
164207399|NCT02485860|593127834|FG000|Overall Study|Physician Decision|1|||
164207400|NCT02485860|593127835|FG001|Overall Study|Physician Decision|2|||
164207401|NCT02485860|593127834|FG000|Overall Study|Health context (COVID-19)|1|||
164207402|NCT02485860|593127835|FG001|Overall Study|Health context (COVID-19)|0|||
164207403|NCT02273167|593127838|FG000|Overall Study|Adverse Event|1|||
164207404|NCT02273167|593127839|FG001|Overall Study|Adverse Event|0|||
164207405|NCT02273167|593127840|FG002|Overall Study|Adverse Event|0|||
164207406|NCT02273167|593127838|FG000|Overall Study|Protocol Violation|3|||
164207407|NCT02273167|593127839|FG001|Overall Study|Protocol Violation|1|||
164207408|NCT02273167|593127840|FG002|Overall Study|Protocol Violation|1|||
164207409|NCT02273167|593127838|FG000|Overall Study|Lost to Follow-up|0|||
164207410|NCT02273167|593127839|FG001|Overall Study|Lost to Follow-up|1|||
164207411|NCT02273167|593127840|FG002|Overall Study|Lost to Follow-up|1|||
164207412|NCT02273167|593127838|FG000|Overall Study|Withdrawal by Subject|10|||
164320707|NCT03011892|593550237|FG010|Double Blind (DB) Period|Physician Decision|0|||
164320708|NCT03011892|593550238|FG011|Double Blind (DB) Period|Physician Decision|0|||
164320709|NCT03011892|593550227|FG000|Double Blind (DB) Period|Pregnancy|0|||
164320710|NCT03011892|593550228|FG001|Double Blind (DB) Period|Pregnancy|0|||
164320711|NCT03011892|593550229|FG002|Double Blind (DB) Period|Pregnancy|0|||
164320712|NCT03011892|593550230|FG003|Double Blind (DB) Period|Pregnancy|0|||
164320713|NCT03011892|593550231|FG004|Double Blind (DB) Period|Pregnancy|1|||
164320714|NCT03011892|593550232|FG005|Double Blind (DB) Period|Pregnancy|0|||
164320715|NCT03011892|593550233|FG006|Double Blind (DB) Period|Pregnancy|0|||
164320716|NCT03011892|593550234|FG007|Double Blind (DB) Period|Pregnancy|0|||
164320717|NCT03011892|593550235|FG008|Double Blind (DB) Period|Pregnancy|0|||
164320718|NCT03011892|593550236|FG009|Double Blind (DB) Period|Pregnancy|0|||
164320719|NCT03011892|593550237|FG010|Double Blind (DB) Period|Pregnancy|0|||
164320720|NCT03011892|593550238|FG011|Double Blind (DB) Period|Pregnancy|0|||
164320721|NCT03011892|593550227|FG000|Double Blind (DB) Period|Protocol Violation|1|||
164320722|NCT03011892|593550228|FG001|Double Blind (DB) Period|Protocol Violation|0|||
164320723|NCT03011892|593550229|FG002|Double Blind (DB) Period|Protocol Violation|0|||
164320724|NCT03011892|593550230|FG003|Double Blind (DB) Period|Protocol Violation|0|||
164320725|NCT03011892|593550231|FG004|Double Blind (DB) Period|Protocol Violation|0|||
164320726|NCT03011892|593550232|FG005|Double Blind (DB) Period|Protocol Violation|0|||
164320727|NCT03011892|593550233|FG006|Double Blind (DB) Period|Protocol Violation|0|||
164320728|NCT03011892|593550234|FG007|Double Blind (DB) Period|Protocol Violation|0|||
164320729|NCT03011892|593550235|FG008|Double Blind (DB) Period|Protocol Violation|0|||
164320730|NCT03011892|593550236|FG009|Double Blind (DB) Period|Protocol Violation|0|||
164320731|NCT03011892|593550237|FG010|Double Blind (DB) Period|Protocol Violation|0|||
164320732|NCT03011892|593550238|FG011|Double Blind (DB) Period|Protocol Violation|0|||
164320733|NCT03011892|593550227|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
164320734|NCT03011892|593550228|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
164320735|NCT03011892|593550229|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
164320736|NCT03011892|593550230|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
164320737|NCT03011892|593550231|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
164320738|NCT03011892|593550232|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
164320739|NCT03011892|593550233|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320740|NCT03011892|593550234|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320741|NCT03011892|593550235|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320742|NCT03011892|593550236|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320743|NCT03011892|593550237|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320744|NCT03011892|593550238|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
164320745|NCT03011892|593550227|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
164320746|NCT03011892|593550228|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
164320747|NCT03011892|593550229|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
164320748|NCT03011892|593550230|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
164320749|NCT03011892|593550231|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
164320750|NCT03011892|593550232|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
164320751|NCT03011892|593550233|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
164320752|NCT03011892|593550234|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
164320753|NCT03011892|593550235|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
164320754|NCT03011892|593550236|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
164320755|NCT03011892|593550237|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
164320756|NCT03011892|593550238|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
164320757|NCT03011892|593550227|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
164320758|NCT03011892|593550228|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
164320759|NCT03011892|593550229|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
163874860|NCT04929483|591909836|FG004|Main Study (24 Weeks)|Adverse Event|0|||
163874861|NCT04929483|591909837|FG005|Main Study (24 Weeks)|Adverse Event|0|||
163874862|NCT04929483|591909832|FG000|Main Study (24 Weeks)|Withdrawal by Subject|0|||
163874863|NCT04929483|591909833|FG001|Main Study (24 Weeks)|Withdrawal by Subject|3|||
163874864|NCT04929483|591909834|FG002|Main Study (24 Weeks)|Withdrawal by Subject|3|||
163874865|NCT04929483|591909835|FG003|Main Study (24 Weeks)|Withdrawal by Subject|3|||
163874866|NCT04929483|591909836|FG004|Main Study (24 Weeks)|Withdrawal by Subject|0|||
163874867|NCT04929483|591909837|FG005|Main Study (24 Weeks)|Withdrawal by Subject|0|||
164320760|NCT03011892|593550230|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
164320761|NCT03011892|593550231|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
163874868|NCT04929483|591909832|FG000|Main Study (24 Weeks)|Lost to Follow-up|0|||
163874869|NCT04929483|591909833|FG001|Main Study (24 Weeks)|Lost to Follow-up|2|||
163874870|NCT04929483|591909834|FG002|Main Study (24 Weeks)|Lost to Follow-up|0|||
163874871|NCT04929483|591909835|FG003|Main Study (24 Weeks)|Lost to Follow-up|2|||
163874872|NCT04929483|591909836|FG004|Main Study (24 Weeks)|Lost to Follow-up|0|||
163874873|NCT04929483|591909837|FG005|Main Study (24 Weeks)|Lost to Follow-up|0|||
163874874|NCT04929483|591909832|FG000|Main Study (24 Weeks)|Physician Decision|0|||
163874875|NCT04929483|591909833|FG001|Main Study (24 Weeks)|Physician Decision|2|||
164320762|NCT03011892|593550232|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
164320763|NCT03011892|593550233|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
164320764|NCT03011892|593550234|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
164320765|NCT03011892|593550235|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
164320766|NCT03011892|593550236|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
164320767|NCT03011892|593550237|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
164320768|NCT03011892|593550238|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
164320769|NCT03011892|593550227|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
164320770|NCT03011892|593550228|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
164320771|NCT03011892|593550229|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
164320772|NCT03011892|593550230|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
164320773|NCT03011892|593550231|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
164320774|NCT03011892|593550232|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
164320775|NCT03011892|593550233|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
164320776|NCT03011892|593550234|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
164320777|NCT03011892|593550235|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
164320778|NCT03011892|593550236|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
164320779|NCT03011892|593550237|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
164320780|NCT03011892|593550238|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
164320781|NCT03011892|593550227|FG000|Open Label (OL) Period|Reason not specified|0|||
164320782|NCT03011892|593550228|FG001|Open Label (OL) Period|Reason not specified|0|||
164320783|NCT03011892|593550229|FG002|Open Label (OL) Period|Reason not specified|0|||
164320784|NCT03011892|593550230|FG003|Open Label (OL) Period|Reason not specified|0|||
164320785|NCT03011892|593550231|FG004|Open Label (OL) Period|Reason not specified|0|||
164320786|NCT03011892|593550232|FG005|Open Label (OL) Period|Reason not specified|0|||
164320787|NCT03011892|593550233|FG006|Open Label (OL) Period|Reason not specified|0|||
164320788|NCT03011892|593550234|FG007|Open Label (OL) Period|Reason not specified|1|||
164320789|NCT03011892|593550235|FG008|Open Label (OL) Period|Reason not specified|0|||
164320790|NCT03011892|593550236|FG009|Open Label (OL) Period|Reason not specified|0|||
164320791|NCT03011892|593550237|FG010|Open Label (OL) Period|Reason not specified|0|||
164320792|NCT03011892|593550238|FG011|Open Label (OL) Period|Reason not specified|0|||
164320793|NCT00608569|593550239|FG000|Overall Study|Death|4|||
164320794|NCT00608569|593550240|FG001|Overall Study|Death|3|||
164320795|NCT00608569|593550239|FG000|Overall Study|Lost to Follow-up|4|||
164320796|NCT00608569|593550240|FG001|Overall Study|Lost to Follow-up|5|||
164320797|NCT00608569|593550239|FG000|Overall Study|Withdrawal by Subject|1|||
164320798|NCT00608569|593550240|FG001|Overall Study|Withdrawal by Subject|0|||
164320799|NCT00608569|593550239|FG000|Overall Study|Adverse Event|1|||
163874876|NCT04929483|591909834|FG002|Main Study (24 Weeks)|Physician Decision|0|||
163874877|NCT04929483|591909835|FG003|Main Study (24 Weeks)|Physician Decision|0|||
163874878|NCT04929483|591909836|FG004|Main Study (24 Weeks)|Physician Decision|0|||
163874879|NCT04929483|591909837|FG005|Main Study (24 Weeks)|Physician Decision|0|||
163874880|NCT04929483|591909832|FG000|Main Study (24 Weeks)|Protocol Violation|0|||
163874881|NCT04929483|591909833|FG001|Main Study (24 Weeks)|Protocol Violation|0|||
163874882|NCT04929483|591909834|FG002|Main Study (24 Weeks)|Protocol Violation|1|||
163874883|NCT04929483|591909835|FG003|Main Study (24 Weeks)|Protocol Violation|0|||
163874884|NCT04929483|591909836|FG004|Main Study (24 Weeks)|Protocol Violation|0|||
163874885|NCT04929483|591909837|FG005|Main Study (24 Weeks)|Protocol Violation|0|||
163874886|NCT04929483|591909832|FG000|Main Study (24 Weeks)|Randomized in error|0|||
163874887|NCT04929483|591909833|FG001|Main Study (24 Weeks)|Randomized in error|1|||
163874888|NCT04929483|591909834|FG002|Main Study (24 Weeks)|Randomized in error|0|||
164207413|NCT02273167|593127839|FG001|Overall Study|Withdrawal by Subject|12|||
164207414|NCT02273167|593127840|FG002|Overall Study|Withdrawal by Subject|11|||
164207415|NCT02273167|593127838|FG000|Overall Study|Various|10|||
164207416|NCT02273167|593127839|FG001|Overall Study|Various|9|||
164207417|NCT02273167|593127840|FG002|Overall Study|Various|8|||
164207418|NCT03082729|593127841|FG000|Overall Study|Lost to Follow-up|7|||
164207419|NCT03082729|593127841|FG000|Overall Study|Physician Decision|2|||
164207420|NCT03082729|593127841|FG000|Overall Study|Withdrawal by Subject|1|||
164207421|NCT03082729|593127841|FG000|Overall Study|Lack of Efficacy|9|||
164207422|NCT03082729|593127841|FG000|Overall Study|Adverse Event|4|||
164207423|NCT03082729|593127841|FG000|Overall Study|Protocol Violation|6|||
164207424|NCT03082729|593127841|FG000|Overall Study|Fear of study procedure|1|||
164207425|NCT03082729|593127841|FG000|Overall Study|Scheduling conflict|1|||
164207426|NCT01416571|593127845|FG000|Overall Study|Lost to Follow-up|2|||
164207427|NCT03608163|593127846|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
164207428|NCT03608163|593127847|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
164207429|NCT03353220|593127853|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
164207430|NCT03353220|593127854|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
164207431|NCT03586479|593127855|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
163874889|NCT04929483|591909835|FG003|Main Study (24 Weeks)|Randomized in error|2|||
164207432|NCT03586479|593127856|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
164320800|NCT00608569|593550240|FG001|Overall Study|Adverse Event|0|||
164207433|NCT03586479|593127857|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
164207434|NCT03586479|593127855|FG000|Overall Study|Protocol Violation|2|||
164207435|NCT03586479|593127856|FG001|Overall Study|Protocol Violation|0|||
164207436|NCT03586479|593127857|FG002|Overall Study|Protocol Violation|0|||
164207437|NCT03586479|593127855|FG000|Overall Study|Lost to Follow-up|1|||
164207438|NCT03586479|593127856|FG001|Overall Study|Lost to Follow-up|1|||
164207439|NCT03586479|593127857|FG002|Overall Study|Lost to Follow-up|2|||
164207440|NCT03586479|593127855|FG000|Overall Study|Behavioral Issues|1|||
163874890|NCT04929483|591909836|FG004|Main Study (24 Weeks)|Randomized in error|0|||
163874891|NCT04929483|591909837|FG005|Main Study (24 Weeks)|Randomized in error|0|||
163874892|NCT04929483|591909832|FG000|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163874893|NCT04929483|591909833|FG001|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163874894|NCT04929483|591909834|FG002|Extension Study (24 Weeks)|Withdrawal by Subject|3|||
164207441|NCT03586479|593127856|FG001|Overall Study|Behavioral Issues|0|||
164207442|NCT03586479|593127857|FG002|Overall Study|Behavioral Issues|0|||
164207443|NCT01799889|593129805|FG000|Overall Study|Adverse Event|4|||
164207444|NCT01799889|593129806|FG001|Overall Study|Adverse Event|4|||
164207445|NCT01799889|593129807|FG002|Overall Study|Adverse Event|5|||
164207446|NCT01799889|593129808|FG003|Overall Study|Adverse Event|1|||
164207447|NCT01799889|593129809|FG004|Overall Study|Adverse Event|11|||
164207448|NCT01799889|593129810|FG005|Overall Study|Adverse Event|1|||
164207449|NCT01799889|593129811|FG006|Overall Study|Adverse Event|5|||
164207450|NCT01799889|593129812|FG007|Overall Study|Adverse Event|2|||
164207451|NCT01799889|593129813|FG008|Overall Study|Adverse Event|3|||
164207452|NCT01799889|593129814|FG009|Overall Study|Adverse Event|1|||
164207453|NCT01799889|593129815|FG010|Overall Study|Adverse Event|1|||
164207454|NCT01799889|593129816|FG011|Overall Study|Adverse Event|0|||
164207455|NCT01799889|593129805|FG000|Overall Study|Death|1|||
164207456|NCT01799889|593129806|FG001|Overall Study|Death|0|||
164207457|NCT01799889|593129807|FG002|Overall Study|Death|5|||
164207458|NCT01799889|593129808|FG003|Overall Study|Death|3|||
164207459|NCT01799889|593129809|FG004|Overall Study|Death|1|||
164207460|NCT01799889|593129810|FG005|Overall Study|Death|0|||
164207461|NCT01799889|593129811|FG006|Overall Study|Death|0|||
164207462|NCT01799889|593129812|FG007|Overall Study|Death|0|||
164207463|NCT01799889|593129813|FG008|Overall Study|Death|1|||
164207464|NCT01799889|593129814|FG009|Overall Study|Death|0|||
164207465|NCT01799889|593129815|FG010|Overall Study|Death|1|||
164207466|NCT01799889|593129816|FG011|Overall Study|Death|0|||
164207467|NCT01799889|593129805|FG000|Overall Study|Lack of Efficacy|1|||
164207468|NCT01799889|593129806|FG001|Overall Study|Lack of Efficacy|1|||
164207469|NCT01799889|593129807|FG002|Overall Study|Lack of Efficacy|0|||
164207470|NCT01799889|593129808|FG003|Overall Study|Lack of Efficacy|1|||
164207471|NCT01799889|593129809|FG004|Overall Study|Lack of Efficacy|2|||
164207472|NCT01799889|593129810|FG005|Overall Study|Lack of Efficacy|2|||
164207473|NCT01799889|593129811|FG006|Overall Study|Lack of Efficacy|0|||
164207474|NCT01799889|593129812|FG007|Overall Study|Lack of Efficacy|0|||
164207475|NCT01799889|593129813|FG008|Overall Study|Lack of Efficacy|2|||
164207476|NCT01799889|593129814|FG009|Overall Study|Lack of Efficacy|0|||
164207477|NCT01799889|593129815|FG010|Overall Study|Lack of Efficacy|1|||
164207478|NCT01799889|593129816|FG011|Overall Study|Lack of Efficacy|0|||
164207479|NCT01799889|593129805|FG000|Overall Study|Lost to Follow-up|0|||
164207480|NCT01799889|593129806|FG001|Overall Study|Lost to Follow-up|1|||
164207481|NCT01799889|593129807|FG002|Overall Study|Lost to Follow-up|0|||
164207482|NCT01799889|593129808|FG003|Overall Study|Lost to Follow-up|0|||
164207483|NCT01799889|593129809|FG004|Overall Study|Lost to Follow-up|0|||
164207484|NCT01799889|593129810|FG005|Overall Study|Lost to Follow-up|0|||
164207485|NCT01799889|593129811|FG006|Overall Study|Lost to Follow-up|0|||
164207486|NCT01799889|593129812|FG007|Overall Study|Lost to Follow-up|0|||
164207487|NCT01799889|593129813|FG008|Overall Study|Lost to Follow-up|0|||
164207488|NCT01799889|593129814|FG009|Overall Study|Lost to Follow-up|0|||
164207489|NCT01799889|593129815|FG010|Overall Study|Lost to Follow-up|0|||
164076457|NCT02082912|592645724|FG001|Overall Study|Physician Decision|1|||
164207490|NCT01799889|593129816|FG011|Overall Study|Lost to Follow-up|0|||
164207491|NCT01799889|593129805|FG000|Overall Study|Physician Decision|3|||
164207492|NCT01799889|593129806|FG001|Overall Study|Physician Decision|2|||
164207493|NCT01799889|593129807|FG002|Overall Study|Physician Decision|4|||
164207494|NCT01799889|593129808|FG003|Overall Study|Physician Decision|4|||
164207495|NCT01799889|593129809|FG004|Overall Study|Physician Decision|5|||
164207496|NCT01799889|593129810|FG005|Overall Study|Physician Decision|5|||
164207497|NCT01799889|593129811|FG006|Overall Study|Physician Decision|5|||
164207498|NCT01799889|593129812|FG007|Overall Study|Physician Decision|2|||
164207499|NCT01799889|593129813|FG008|Overall Study|Physician Decision|6|||
164207500|NCT01799889|593129814|FG009|Overall Study|Physician Decision|0|||
164207501|NCT01799889|593129815|FG010|Overall Study|Physician Decision|0|||
164207502|NCT01799889|593129816|FG011|Overall Study|Physician Decision|1|||
164207503|NCT01799889|593129805|FG000|Overall Study|Progressive Disease|30|||
164207504|NCT01799889|593129806|FG001|Overall Study|Progressive Disease|26|||
164207505|NCT01799889|593129807|FG002|Overall Study|Progressive Disease|25|||
164207506|NCT01799889|593129808|FG003|Overall Study|Progressive Disease|30|||
164207507|NCT01799889|593129809|FG004|Overall Study|Progressive Disease|23|||
164136342|NCT01629966|592862132|FG000|Overall Study|Lack of Efficacy|5|||
164320801|NCT00608569|593550239|FG000|Overall Study|Unable to adhere with study requirements|0|||
164320802|NCT00608569|593550240|FG001|Overall Study|Unable to adhere with study requirements|1|||
164320803|NCT02312687|593550254|FG000|Overall Study|Other, Not Specified|1|||
164320804|NCT00906971|593550257|FG000|Overall Study|Withdrawal by Subject|8|||
164320805|NCT00906971|593550258|FG001|Overall Study|Withdrawal by Subject|2|||
164320806|NCT00906971|593550257|FG000|Overall Study|Lost to Follow-up|0|||
164320807|NCT00906971|593550258|FG001|Overall Study|Lost to Follow-up|1|||
163874895|NCT04929483|591909835|FG003|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163874896|NCT04929483|591909836|FG004|Extension Study (24 Weeks)|Withdrawal by Subject|2|||
163874897|NCT04929483|591909837|FG005|Extension Study (24 Weeks)|Withdrawal by Subject|0|||
163874898|NCT04929483|591909832|FG000|Extension Study (24 Weeks)|Lost to Follow-up|0|||
163874899|NCT04929483|591909833|FG001|Extension Study (24 Weeks)|Lost to Follow-up|1|||
163874900|NCT04929483|591909834|FG002|Extension Study (24 Weeks)|Lost to Follow-up|1|||
163874901|NCT04929483|591909835|FG003|Extension Study (24 Weeks)|Lost to Follow-up|0|||
163874902|NCT04929483|591909836|FG004|Extension Study (24 Weeks)|Lost to Follow-up|1|||
163874903|NCT04929483|591909837|FG005|Extension Study (24 Weeks)|Lost to Follow-up|0|||
163874904|NCT04929483|591909832|FG000|Extension Study (24 Weeks)|Other than specified|1|||
163874905|NCT04929483|591909833|FG001|Extension Study (24 Weeks)|Other than specified|0|||
163874906|NCT04929483|591909834|FG002|Extension Study (24 Weeks)|Other than specified|1|||
163874907|NCT04929483|591909835|FG003|Extension Study (24 Weeks)|Other than specified|0|||
163874908|NCT04929483|591909836|FG004|Extension Study (24 Weeks)|Other than specified|1|||
163874909|NCT04929483|591909837|FG005|Extension Study (24 Weeks)|Other than specified|0|||
163874910|NCT04929483|591909832|FG000|Extension Study (24 Weeks)|Adverse Event|0|||
163874911|NCT04929483|591909833|FG001|Extension Study (24 Weeks)|Adverse Event|2|||
163874912|NCT04929483|591909834|FG002|Extension Study (24 Weeks)|Adverse Event|3|||
163874913|NCT04929483|591909835|FG003|Extension Study (24 Weeks)|Adverse Event|0|||
163874914|NCT04929483|591909836|FG004|Extension Study (24 Weeks)|Adverse Event|0|||
163874915|NCT04929483|591909837|FG005|Extension Study (24 Weeks)|Adverse Event|0|||
163874916|NCT04083781|591909842|FG000|Main Part|Physician Decision|0|||
163874917|NCT04083781|591909843|FG001|Main Part|Physician Decision|1|||
163874918|NCT04083781|591909844|FG002|Main Part|Physician Decision|2|||
163874919|NCT04083781|591909845|FG003|Main Part|Physician Decision|0|||
163874920|NCT04083781|591909842|FG000|Main Part|Death|1|||
163874921|NCT04083781|591909843|FG001|Main Part|Death|3|||
163874922|NCT04083781|591909844|FG002|Main Part|Death|1|||
163874923|NCT04083781|591909845|FG003|Main Part|Death|0|||
163874924|NCT04083781|591909842|FG000|Main Part|Withdrawal by Subject|5|||
163874925|NCT04083781|591909843|FG001|Main Part|Withdrawal by Subject|2|||
163874926|NCT04083781|591909844|FG002|Main Part|Withdrawal by Subject|3|||
163874927|NCT04083781|591909845|FG003|Main Part|Withdrawal by Subject|7|||
163874928|NCT04083781|591909842|FG000|Extension Part|Physician Decision|0|||
163874929|NCT04083781|591909843|FG001|Extension Part|Physician Decision|0|||
163874930|NCT04083781|591909844|FG002|Extension Part|Physician Decision|0|||
163874931|NCT04083781|591909845|FG003|Extension Part|Physician Decision|1|||
163874932|NCT04083781|591909842|FG000|Extension Part|Death|0|||
163874933|NCT04083781|591909843|FG001|Extension Part|Death|1|||
163874934|NCT04083781|591909844|FG002|Extension Part|Death|0|||
163874935|NCT04083781|591909845|FG003|Extension Part|Death|1|||
163874936|NCT04083781|591909842|FG000|Extension Part|Withdrawal by Subject|0|||
163874937|NCT04083781|591909843|FG001|Extension Part|Withdrawal by Subject|1|||
163874938|NCT04083781|591909844|FG002|Extension Part|Withdrawal by Subject|0|||
163874939|NCT04083781|591909845|FG003|Extension Part|Withdrawal by Subject|0|||
163874940|NCT04083781|591909842|FG000|Extension Part|Ongoing|13|||
163874941|NCT04083781|591909843|FG001|Extension Part|Ongoing|25|||
163874942|NCT04083781|591909844|FG002|Extension Part|Ongoing|15|||
163874943|NCT04083781|591909845|FG003|Extension Part|Ongoing|51|||
163874944|NCT01143337|591909846|FG000|Overall Study|Adverse Event|3|||
163874945|NCT01143337|591909847|FG001|Overall Study|Adverse Event|9|||
163874946|NCT01143337|591909848|FG002|Overall Study|Adverse Event|5|||
163874947|NCT01143337|591909846|FG000|Overall Study|Lack of Efficacy|6|||
163874948|NCT01143337|591909847|FG001|Overall Study|Lack of Efficacy|2|||
163874949|NCT01143337|591909848|FG002|Overall Study|Lack of Efficacy|1|||
163874950|NCT01143337|591909846|FG000|Overall Study|Protocol Violation|1|||
163874951|NCT01143337|591909847|FG001|Overall Study|Protocol Violation|0|||
163874952|NCT01143337|591909848|FG002|Overall Study|Protocol Violation|0|||
163874953|NCT01143337|591909846|FG000|Overall Study|Withdrawal by Subject|0|||
163874954|NCT01143337|591909847|FG001|Overall Study|Withdrawal by Subject|0|||
163874955|NCT01143337|591909848|FG002|Overall Study|Withdrawal by Subject|1|||
163874956|NCT01143337|591909846|FG000|Overall Study|Other reason|0|||
163874957|NCT01143337|591909847|FG001|Overall Study|Other reason|0|||
163874958|NCT01143337|591909848|FG002|Overall Study|Other reason|5|||
163874959|NCT05600283|591909851|FG000|Overall Study|Withdrawal by Subject|3|||
163874960|NCT05600283|591909852|FG001|Overall Study|Withdrawal by Subject|8|||
163874961|NCT05600283|591909851|FG000|Overall Study|Invalid Vaginal Swab|2|||
163874962|NCT05600283|591909852|FG001|Overall Study|Invalid Vaginal Swab|2|||
164320808|NCT00545129|593550259|FG000|Overall Study|Lack of Efficacy|2|||
164320809|NCT00545129|593550260|FG001|Overall Study|Lack of Efficacy|5|||
163978958|NCT00391222|592293654|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
163978959|NCT00391222|592293655|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
163978960|NCT00391222|592293656|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
163978961|NCT00391222|592293653|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
164320810|NCT00545129|593550259|FG000|Overall Study|Death|2|||
164320811|NCT00545129|593550260|FG001|Overall Study|Death|1|||
164320812|NCT00545129|593550259|FG000|Overall Study|Adverse Event|1|||
164320813|NCT00545129|593550260|FG001|Overall Study|Adverse Event|1|||
164320814|NCT00545129|593550259|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
164320815|NCT00545129|593550260|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
164320816|NCT00545129|593550259|FG000|Overall Study|Other|3|||
164320817|NCT00545129|593550260|FG001|Overall Study|Other|3|||
164320818|NCT03678870|593550261|FG000|Overall Study|prescribed non- protocol medications|10|||
164320819|NCT03678870|593550262|FG001|Overall Study|prescribed non- protocol medications|6|||
164320820|NCT03678870|593550261|FG000|Overall Study|Lost to Follow-up|3|||
164320821|NCT03678870|593550262|FG001|Overall Study|Lost to Follow-up|2|||
164320822|NCT03104816|593550264|FG000|Overall Study|Lack of Efficacy|0|||
164320823|NCT03104816|593550265|FG001|Overall Study|Lack of Efficacy|2|||
164320824|NCT03104816|593550266|FG002|Overall Study|Lack of Efficacy|0|||
164320825|NCT03104816|593550264|FG000|Overall Study|Protocol Violation|2|||
164320826|NCT03104816|593550265|FG001|Overall Study|Protocol Violation|0|||
164320827|NCT03104816|593550266|FG002|Overall Study|Protocol Violation|2|||
164320828|NCT01426789|593550267|FG000|Part 1|Protocol deviation|0|||
164320829|NCT01426789|593550268|FG001|Part 1|Protocol deviation|1|||
164320830|NCT01426789|593550269|FG002|Part 1|Protocol deviation|0|||
164320831|NCT01426789|593550270|FG003|Part 1|Protocol deviation|0|||
164320832|NCT01426789|593550271|FG004|Part 1|Protocol deviation|0|||
164320833|NCT01426789|593550272|FG005|Part 1|Protocol deviation|0|||
164320834|NCT01426789|593550267|FG000|Part 1|Lost to Follow-up|1|||
164320835|NCT01426789|593550268|FG001|Part 1|Lost to Follow-up|2|||
164320836|NCT01426789|593550269|FG002|Part 1|Lost to Follow-up|0|||
164320837|NCT01426789|593550270|FG003|Part 1|Lost to Follow-up|0|||
164320838|NCT01426789|593550271|FG004|Part 1|Lost to Follow-up|0|||
164320839|NCT01426789|593550272|FG005|Part 1|Lost to Follow-up|0|||
164320840|NCT01426789|593550267|FG000|Part 1|Lack of Efficacy|2|||
164320841|NCT01426789|593550268|FG001|Part 1|Lack of Efficacy|1|||
164320842|NCT01426789|593550269|FG002|Part 1|Lack of Efficacy|0|||
164320843|NCT01426789|593550270|FG003|Part 1|Lack of Efficacy|0|||
164320844|NCT01426789|593550271|FG004|Part 1|Lack of Efficacy|0|||
164320845|NCT01426789|593550272|FG005|Part 1|Lack of Efficacy|0|||
164320846|NCT01426789|593550267|FG000|Part 1|Adverse Event|3|||
164320847|NCT01426789|593550268|FG001|Part 1|Adverse Event|0|||
164320848|NCT01426789|593550269|FG002|Part 1|Adverse Event|0|||
164320849|NCT01426789|593550270|FG003|Part 1|Adverse Event|0|||
164320850|NCT01426789|593550271|FG004|Part 1|Adverse Event|0|||
164320851|NCT01426789|593550272|FG005|Part 1|Adverse Event|0|||
164320852|NCT01426789|593550267|FG000|Part 2|Protocol deviation|0|||
164320853|NCT01426789|593550268|FG001|Part 2|Protocol deviation|0|||
164320854|NCT01426789|593550269|FG002|Part 2|Protocol deviation|1|||
164320855|NCT01426789|593550270|FG003|Part 2|Protocol deviation|0|||
164320856|NCT01426789|593550271|FG004|Part 2|Protocol deviation|0|||
164320857|NCT01426789|593550272|FG005|Part 2|Protocol deviation|0|||
164320858|NCT01426789|593550267|FG000|Part 2|Death|0|||
164320859|NCT01426789|593550268|FG001|Part 2|Death|0|||
164320860|NCT01426789|593550269|FG002|Part 2|Death|1|||
164320861|NCT01426789|593550270|FG003|Part 2|Death|0|||
164320862|NCT01426789|593550271|FG004|Part 2|Death|1|||
164320863|NCT01426789|593550272|FG005|Part 2|Death|0|||
164320864|NCT01426789|593550267|FG000|Part 2|Administrative problems|0|||
164320865|NCT01426789|593550268|FG001|Part 2|Administrative problems|0|||
164320866|NCT01426789|593550269|FG002|Part 2|Administrative problems|2|||
164320867|NCT01426789|593550270|FG003|Part 2|Administrative problems|0|||
164320868|NCT01426789|593550271|FG004|Part 2|Administrative problems|1|||
164320869|NCT01426789|593550272|FG005|Part 2|Administrative problems|0|||
164320870|NCT01426789|593550267|FG000|Part 2|Lost to Follow-up|0|||
164320871|NCT01426789|593550268|FG001|Part 2|Lost to Follow-up|0|||
164320872|NCT01426789|593550269|FG002|Part 2|Lost to Follow-up|4|||
164320873|NCT01426789|593550270|FG003|Part 2|Lost to Follow-up|0|||
164320874|NCT01426789|593550271|FG004|Part 2|Lost to Follow-up|1|||
163978962|NCT00391222|592293654|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
163978963|NCT00391222|592293655|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
164320875|NCT01426789|593550272|FG005|Part 2|Lost to Follow-up|0|||
164320876|NCT01426789|593550267|FG000|Part 2|Withdrawal by Subject|0|||
164320877|NCT01426789|593550268|FG001|Part 2|Withdrawal by Subject|0|||
164320878|NCT01426789|593550269|FG002|Part 2|Withdrawal by Subject|0|||
164320879|NCT01426789|593550270|FG003|Part 2|Withdrawal by Subject|1|||
164320880|NCT01426789|593550271|FG004|Part 2|Withdrawal by Subject|2|||
164320881|NCT01426789|593550272|FG005|Part 2|Withdrawal by Subject|0|||
164320882|NCT01426789|593550267|FG000|Part 2|Lack of Efficacy|0|||
164320883|NCT01426789|593550268|FG001|Part 2|Lack of Efficacy|0|||
164320884|NCT01426789|593550269|FG002|Part 2|Lack of Efficacy|5|||
164320885|NCT01426789|593550270|FG003|Part 2|Lack of Efficacy|0|||
164320886|NCT01426789|593550271|FG004|Part 2|Lack of Efficacy|2|||
164320887|NCT01426789|593550272|FG005|Part 2|Lack of Efficacy|0|||
164320888|NCT01426789|593550267|FG000|Part 2|Adverse Event|0|||
164320889|NCT01426789|593550268|FG001|Part 2|Adverse Event|0|||
164320890|NCT01426789|593550269|FG002|Part 2|Adverse Event|2|||
164320891|NCT01426789|593550270|FG003|Part 2|Adverse Event|0|||
164320892|NCT01426789|593550271|FG004|Part 2|Adverse Event|1|||
164320893|NCT01426789|593550272|FG005|Part 2|Adverse Event|0|||
164320894|NCT01895361|593552089|FG000|Overall Study|Adverse Event|1|||
164320895|NCT01895361|593552090|FG001|Overall Study|Adverse Event|1|||
164320896|NCT01895361|593552091|FG002|Overall Study|Adverse Event|3|||
164320897|NCT01895361|593552089|FG000|Overall Study|Death|2|||
164320898|NCT01895361|593552090|FG001|Overall Study|Death|1|||
163978964|NCT00391222|592293656|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
163978965|NCT00391222|592293653|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
163978966|NCT00391222|592293654|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
163978967|NCT00391222|592293655|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
164320899|NCT01895361|593552091|FG002|Overall Study|Death|2|||
164320900|NCT01895361|593552089|FG000|Overall Study|Lost to Follow-up|4|||
164320901|NCT01895361|593552090|FG001|Overall Study|Lost to Follow-up|4|||
164320902|NCT01895361|593552091|FG002|Overall Study|Lost to Follow-up|6|||
164320903|NCT01895361|593552089|FG000|Overall Study|Non-compliance with study|1|||
164320904|NCT01895361|593552090|FG001|Overall Study|Non-compliance with study|3|||
164320905|NCT01895361|593552091|FG002|Overall Study|Non-compliance with study|1|||
164320906|NCT01895361|593552089|FG000|Overall Study|Physician Decision|2|||
164320907|NCT01895361|593552090|FG001|Overall Study|Physician Decision|2|||
164320908|NCT01895361|593552091|FG002|Overall Study|Physician Decision|2|||
164320909|NCT01895361|593552089|FG000|Overall Study|Withdrawal by Subject|7|||
164320910|NCT01895361|593552090|FG001|Overall Study|Withdrawal by Subject|6|||
164320911|NCT01895361|593552091|FG002|Overall Study|Withdrawal by Subject|6|||
164320912|NCT01895361|593552089|FG000|Overall Study|Lack of Efficacy|0|||
164320913|NCT01895361|593552090|FG001|Overall Study|Lack of Efficacy|1|||
164320914|NCT01895361|593552091|FG002|Overall Study|Lack of Efficacy|0|||
164320915|NCT01895361|593552089|FG000|Overall Study|Reasons different from categories above|7|||
164320916|NCT01895361|593552090|FG001|Overall Study|Reasons different from categories above|3|||
164320917|NCT01895361|593552091|FG002|Overall Study|Reasons different from categories above|4|||
164320918|NCT02677324|593552092|FG000|Overall Study|Disease Progression|6|||
164320919|NCT02677324|593552092|FG000|Overall Study|Inability to Swallow pills|1|||
164320920|NCT02677324|593552092|FG000|Overall Study|Non-compliance|1|||
164320921|NCT02677324|593552092|FG000|Overall Study|Lack of Efficacy|1|||
164320922|NCT02677324|593552092|FG000|Overall Study|Medical insurance coverage|1|||
164320923|NCT02677324|593552092|FG000|Overall Study|Adverse Event|1|||
164320924|NCT02677324|593552092|FG000|Overall Study|IgM Myeloma diagnosis|1|||
164320925|NCT00282464|593552093|FG000|Overall Study|Adverse Event|26|||
164320926|NCT00282464|593552094|FG001|Overall Study|Adverse Event|20|||
164320927|NCT00282464|593552093|FG000|Overall Study|Lack of Efficacy|8|||
164320928|NCT00282464|593552094|FG001|Overall Study|Lack of Efficacy|8|||
164320929|NCT00282464|593552093|FG000|Overall Study|Lost to Follow-up|10|||
164320930|NCT00282464|593552094|FG001|Overall Study|Lost to Follow-up|10|||
164320931|NCT00282464|593552093|FG000|Overall Study|Withdrawal by Subject|24|||
164320932|NCT00282464|593552094|FG001|Overall Study|Withdrawal by Subject|10|||
164320933|NCT00282464|593552093|FG000|Overall Study|laboratory abnormality|1|||
164320934|NCT00282464|593552094|FG001|Overall Study|laboratory abnormality|2|||
164320935|NCT00282464|593552093|FG000|Overall Study|Protocol Violation|0|||
164320936|NCT00282464|593552094|FG001|Overall Study|Protocol Violation|7|||
164320937|NCT00282464|593552093|FG000|Overall Study|Patient moved|1|||
164320938|NCT00282464|593552094|FG001|Overall Study|Patient moved|0|||
164320939|NCT00282464|593552093|FG000|Overall Study|patient non-compliant|3|||
164320940|NCT00282464|593552094|FG001|Overall Study|patient non-compliant|0|||
164320941|NCT00282464|593552093|FG000|Overall Study|patient no show|0|||
164320942|NCT00282464|593552094|FG001|Overall Study|patient no show|1|||
164320943|NCT00282464|593552093|FG000|Overall Study|patient incarcerated|0|||
164320944|NCT00282464|593552094|FG001|Overall Study|patient incarcerated|1|||
163978968|NCT00391222|592293656|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
164320945|NCT00282464|593552093|FG000|Overall Study|family crisis|0|||
164320946|NCT00282464|593552094|FG001|Overall Study|family crisis|1|||
164320947|NCT00282464|593552093|FG000|Overall Study|dispensed wrong kit|0|||
164320948|NCT00282464|593552094|FG001|Overall Study|dispensed wrong kit|1|||
164320949|NCT00282464|593552093|FG000|Overall Study|dropped due to missed visits|0|||
164320950|NCT00282464|593552094|FG001|Overall Study|dropped due to missed visits|1|||
164320951|NCT00475423|593552095|FG000|Overall Study|Protocol Violation|5|||
164320952|NCT00475423|593552095|FG000|Overall Study|Adverse Event|4|||
163978969|NCT00391222|592293653|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
163978970|NCT00391222|592293654|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
164320953|NCT00475423|593552095|FG000|Overall Study|Withdrawal by Subject|6|||
164320954|NCT00475423|593552095|FG000|Overall Study|Lack of Efficacy|8|||
164320955|NCT00475423|593552095|FG000|Overall Study|Death|1|||
164320956|NCT00475423|593552095|FG000|Overall Study|Reason not specified|1|||
164320957|NCT00475423|593552095|FG000|Overall Study|Lost to Follow-up|7|||
164320958|NCT05463198|593552096|FG000|Overall Study|Withdrawal by Subject|19|||
163978971|NCT00391222|592293655|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
163978972|NCT00391222|592293656|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
163978973|NCT00391222|592293653|FG000|Period III (Double-Blind Treatment)|Other|6|||
163978974|NCT00391222|592293654|FG001|Period III (Double-Blind Treatment)|Other|1|||
163978975|NCT00391222|592293655|FG002|Period III (Double-Blind Treatment)|Other|6|||
163978976|NCT00391222|592293656|FG003|Period III (Double-Blind Treatment)|Other|0|||
163978977|NCT01181011|592293658|FG000|Overall Study|Adverse Event|2|||
163978978|NCT01181011|592293658|FG000|Overall Study|Lost to Follow-up|1|||
163978979|NCT00401375|592293659|FG000|Overall Study|Protocol Violation|2|||
163978980|NCT00401375|592293660|FG001|Overall Study|Protocol Violation|2|||
163978981|NCT00401375|592293661|FG002|Overall Study|Protocol Violation|1|||
163978982|NCT00401375|592293659|FG000|Overall Study|Adverse Event|6|||
163978983|NCT00401375|592293660|FG001|Overall Study|Adverse Event|11|||
163978984|NCT00401375|592293661|FG002|Overall Study|Adverse Event|10|||
163978985|NCT00401375|592293659|FG000|Overall Study|Withdrawal by Subject|9|||
163978986|NCT00401375|592293660|FG001|Overall Study|Withdrawal by Subject|7|||
163978987|NCT00401375|592293661|FG002|Overall Study|Withdrawal by Subject|7|||
163978988|NCT00401375|592293659|FG000|Overall Study|Lost to Follow-up|0|||
163978989|NCT00401375|592293660|FG001|Overall Study|Lost to Follow-up|1|||
163978990|NCT00401375|592293661|FG002|Overall Study|Lost to Follow-up|1|||
163978991|NCT00401375|592293659|FG000|Overall Study|Other than specified|2|||
163978992|NCT00401375|592293660|FG001|Overall Study|Other than specified|1|||
163978993|NCT00401375|592293661|FG002|Overall Study|Other than specified|3|||
163978994|NCT00401375|592293659|FG000|Overall Study|Randomized but not treated|3|||
163978995|NCT00401375|592293660|FG001|Overall Study|Randomized but not treated|3|||
163978996|NCT00401375|592293661|FG002|Overall Study|Randomized but not treated|3|||
163978997|NCT00950664|592293662|FG000|First Intervention|Lost to Follow-up|1|||
163978998|NCT00950664|592293663|FG001|First Intervention|Lost to Follow-up|3|||
163978999|NCT00950664|592293662|FG000|First Intervention|Withdrawal by Subject|2|||
163979000|NCT00950664|592293663|FG001|First Intervention|Withdrawal by Subject|2|||
163979001|NCT03152019|592293664|FG000|Overall Study|Adverse Event|0|||
163979002|NCT03152019|592293665|FG001|Overall Study|Adverse Event|1|||
163979003|NCT04703075|592293666|FG000|Overall Study|Adverse Event|11|||
163979004|NCT04703075|592293667|FG001|Overall Study|Adverse Event|7|||
163979005|NCT04703075|592293666|FG000|Overall Study|Lost to Follow-up|6|||
163979006|NCT04703075|592293667|FG001|Overall Study|Lost to Follow-up|12|||
164320959|NCT05463198|593552096|FG000|Overall Study|Procedure Notes Missing|18|||
164320960|NCT01214174|593552097|FG000|Overall Study|Withdrawal by Subject|0|||
164320961|NCT01214174|593552098|FG001|Overall Study|Withdrawal by Subject|0|||
164320962|NCT01214174|593552099|FG002|Overall Study|Withdrawal by Subject|1|||
164320963|NCT02239120|593552102|FG000|Overall Study|Death|56|||
164320964|NCT02239120|593552103|FG001|Overall Study|Death|58|||
164320965|NCT02239120|593552102|FG000|Overall Study|Lost to Follow-up|19|||
164320966|NCT02239120|593552103|FG001|Overall Study|Lost to Follow-up|14|||
164320967|NCT00420641|593552107|FG000|Overall Study|Adverse Event|3|||
164320968|NCT00420641|593552108|FG001|Overall Study|Adverse Event|25|||
164320969|NCT00420641|593552109|FG002|Overall Study|Adverse Event|10|||
164320970|NCT00420641|593552107|FG000|Overall Study|Lost to Follow-up|2|||
164320971|NCT00420641|593552108|FG001|Overall Study|Lost to Follow-up|4|||
164320972|NCT00420641|593552109|FG002|Overall Study|Lost to Follow-up|2|||
164320973|NCT00420641|593552107|FG000|Overall Study|Protocol Violation|8|||
164320974|NCT00420641|593552108|FG001|Overall Study|Protocol Violation|8|||
164320975|NCT00420641|593552109|FG002|Overall Study|Protocol Violation|7|||
164320976|NCT00420641|593552107|FG000|Overall Study|Withdrawal by Subject|15|||
164320977|NCT00420641|593552108|FG001|Overall Study|Withdrawal by Subject|21|||
164320978|NCT00420641|593552109|FG002|Overall Study|Withdrawal by Subject|14|||
164320979|NCT00420641|593552107|FG000|Overall Study|Lack of Efficacy|6|||
164320980|NCT00420641|593552108|FG001|Overall Study|Lack of Efficacy|5|||
164320981|NCT00420641|593552109|FG002|Overall Study|Lack of Efficacy|4|||
163979007|NCT04703075|592293666|FG000|Overall Study|Physician Decision|3|||
163979008|NCT04703075|592293667|FG001|Overall Study|Physician Decision|0|||
163979009|NCT04703075|592293666|FG000|Overall Study|Moved|0|||
163979010|NCT04703075|592293667|FG001|Overall Study|Moved|2|||
163979011|NCT04703075|592293666|FG000|Overall Study|Index INH Resistant|0|||
163979012|NCT04703075|592293667|FG001|Overall Study|Index INH Resistant|1|||
164320982|NCT00420641|593552107|FG000|Overall Study|Non-compliance|7|||
164320983|NCT00420641|593552108|FG001|Overall Study|Non-compliance|5|||
163979013|NCT04703075|592293666|FG000|Overall Study|Lack of Efficacy|6|||
164320984|NCT00420641|593552109|FG002|Overall Study|Non-compliance|4|||
164320985|NCT00420641|593552107|FG000|Overall Study|Other|4|||
164320986|NCT00420641|593552108|FG001|Overall Study|Other|4|||
164320987|NCT00420641|593552109|FG002|Overall Study|Other|3|||
164320988|NCT02815280|593552121|FG000|Double-Blind Phase|Adverse Event|1|||
163979014|NCT04703075|592293667|FG001|Overall Study|Lack of Efficacy|18|||
163979015|NCT01187953|592293668|FG000|Overall Study|Death|11|||
163979016|NCT01187953|592293669|FG001|Overall Study|Death|13|||
163979017|NCT01187953|592293668|FG000|Overall Study|Adverse Event|1|||
163979018|NCT01187953|592293669|FG001|Overall Study|Adverse Event|2|||
164320989|NCT02815280|593552122|FG001|Double-Blind Phase|Adverse Event|1|||
164207508|NCT01799889|593129810|FG005|Overall Study|Progressive Disease|9|||
164207509|NCT01799889|593129811|FG006|Overall Study|Progressive Disease|8|||
164207510|NCT01799889|593129812|FG007|Overall Study|Progressive Disease|13|||
164207511|NCT01799889|593129813|FG008|Overall Study|Progressive Disease|18|||
164207512|NCT01799889|593129814|FG009|Overall Study|Progressive Disease|5|||
164207513|NCT01799889|593129815|FG010|Overall Study|Progressive Disease|3|||
164207514|NCT01799889|593129816|FG011|Overall Study|Progressive Disease|1|||
164207515|NCT01799889|593129805|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
164207516|NCT01799889|593129806|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
164207517|NCT01799889|593129807|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
164207518|NCT01799889|593129808|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
164207519|NCT01799889|593129809|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
164207520|NCT01799889|593129810|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
164207521|NCT01799889|593129811|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
164207522|NCT01799889|593129812|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
164207523|NCT01799889|593129813|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
164207524|NCT01799889|593129814|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
164207525|NCT01799889|593129815|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
164207526|NCT01799889|593129816|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
164207527|NCT01799889|593129805|FG000|Overall Study|Study Terminated By Sponsor|1|||
164207528|NCT01799889|593129806|FG001|Overall Study|Study Terminated By Sponsor|0|||
164207529|NCT01799889|593129807|FG002|Overall Study|Study Terminated By Sponsor|0|||
164207530|NCT01799889|593129808|FG003|Overall Study|Study Terminated By Sponsor|0|||
164207531|NCT01799889|593129809|FG004|Overall Study|Study Terminated By Sponsor|2|||
164207532|NCT01799889|593129810|FG005|Overall Study|Study Terminated By Sponsor|1|||
164207533|NCT01799889|593129811|FG006|Overall Study|Study Terminated By Sponsor|0|||
164207534|NCT01799889|593129812|FG007|Overall Study|Study Terminated By Sponsor|2|||
164207535|NCT01799889|593129813|FG008|Overall Study|Study Terminated By Sponsor|1|||
164207536|NCT01799889|593129814|FG009|Overall Study|Study Terminated By Sponsor|1|||
164207537|NCT01799889|593129815|FG010|Overall Study|Study Terminated By Sponsor|0|||
164207538|NCT01799889|593129816|FG011|Overall Study|Study Terminated By Sponsor|0|||
164207539|NCT01799889|593129805|FG000|Overall Study|Withdrawal by Subject|1|||
164207540|NCT01799889|593129806|FG001|Overall Study|Withdrawal by Subject|6|||
164207541|NCT01799889|593129807|FG002|Overall Study|Withdrawal by Subject|4|||
164207542|NCT01799889|593129808|FG003|Overall Study|Withdrawal by Subject|0|||
164207543|NCT01799889|593129809|FG004|Overall Study|Withdrawal by Subject|5|||
164207544|NCT01799889|593129810|FG005|Overall Study|Withdrawal by Subject|1|||
164207545|NCT01799889|593129811|FG006|Overall Study|Withdrawal by Subject|3|||
164207546|NCT01799889|593129812|FG007|Overall Study|Withdrawal by Subject|1|||
164207547|NCT01799889|593129813|FG008|Overall Study|Withdrawal by Subject|2|||
164207548|NCT01799889|593129814|FG009|Overall Study|Withdrawal by Subject|1|||
164207549|NCT01799889|593129815|FG010|Overall Study|Withdrawal by Subject|1|||
164207550|NCT01799889|593129816|FG011|Overall Study|Withdrawal by Subject|1|||
164207551|NCT01799889|593129805|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164207552|NCT01799889|593129806|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164207553|NCT01799889|593129807|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164207554|NCT01799889|593129808|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164207555|NCT01799889|593129809|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164207556|NCT01799889|593129810|FG005|Overall Study|Non-Compliance With Study Drug|1|||
164207557|NCT01799889|593129811|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164207558|NCT01799889|593129812|FG007|Overall Study|Non-Compliance With Study Drug|0|||
164207559|NCT01799889|593129813|FG008|Overall Study|Non-Compliance With Study Drug|0|||
164207560|NCT01799889|593129814|FG009|Overall Study|Non-Compliance With Study Drug|0|||
164207561|NCT01799889|593129815|FG010|Overall Study|Non-Compliance With Study Drug|0|||
164207562|NCT01799889|593129816|FG011|Overall Study|Non-Compliance With Study Drug|0|||
164207563|NCT01431976|593129817|FG000|Overall Study|Adverse Event|6|||
164207564|NCT01431976|593129817|FG000|Overall Study|Lack of Efficacy|2|||
164207565|NCT01431976|593129817|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
164207566|NCT01431976|593129817|FG000|Overall Study|Physician Decision|1|||
164207567|NCT01431976|593129817|FG000|Overall Study|Withdrawal by Subject|1|||
164207568|NCT01294514|593129820|FG000|Overall Study|Excluded due to Arrhythmia|1|||
164207569|NCT01963611|593129821|FG000|Overall Study|Adverse Event|1|||
164207570|NCT01963611|593129822|FG001|Overall Study|Adverse Event|1|||
164207571|NCT01963611|593129823|FG002|Overall Study|Adverse Event|3|||
164207572|NCT01963611|593129824|FG003|Overall Study|Adverse Event|4|||
164207573|NCT01963611|593129825|FG004|Overall Study|Adverse Event|3|||
164207574|NCT01963611|593129821|FG000|Overall Study|Protocol Violation|0|||
164207575|NCT01963611|593129822|FG001|Overall Study|Protocol Violation|0|||
164207576|NCT01963611|593129823|FG002|Overall Study|Protocol Violation|0|||
164207577|NCT01963611|593129824|FG003|Overall Study|Protocol Violation|1|||
164207578|NCT01963611|593129825|FG004|Overall Study|Protocol Violation|0|||
164207579|NCT01963611|593129821|FG000|Overall Study|Lack of Efficacy|0|||
164207580|NCT01963611|593129822|FG001|Overall Study|Lack of Efficacy|0|||
164207581|NCT01963611|593129823|FG002|Overall Study|Lack of Efficacy|0|||
164207582|NCT01963611|593129824|FG003|Overall Study|Lack of Efficacy|1|||
164320990|NCT02815280|593552121|FG000|Double-Blind Phase|Lost to Follow-up|10|||
164320991|NCT02815280|593552122|FG001|Double-Blind Phase|Lost to Follow-up|9|||
164320992|NCT02815280|593552121|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
164320993|NCT02815280|593552122|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
164320994|NCT02815280|593552121|FG000|Double-Blind Phase|Protocol Violation|2|||
164320995|NCT02815280|593552122|FG001|Double-Blind Phase|Protocol Violation|2|||
164320996|NCT02815280|593552121|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
164320997|NCT02815280|593552122|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
164320998|NCT02815280|593552121|FG000|Open-Label Phase|Adverse Event|2|||
164320999|NCT02815280|593552122|FG001|Open-Label Phase|Adverse Event|3|||
164321000|NCT02815280|593552121|FG000|Open-Label Phase|Lost to Follow-up|18|||
164321001|NCT02815280|593552122|FG001|Open-Label Phase|Lost to Follow-up|9|||
164321002|NCT02815280|593552121|FG000|Open-Label Phase|Withdrawal by Subject|33|||
164321003|NCT02815280|593552122|FG001|Open-Label Phase|Withdrawal by Subject|18|||
164321004|NCT02815280|593552121|FG000|Open-Label Phase|Protocol Violation|3|||
164321005|NCT02815280|593552122|FG001|Open-Label Phase|Protocol Violation|0|||
164321006|NCT02815280|593552121|FG000|Open-Label Phase|Administrative|26|||
164321007|NCT02815280|593552122|FG001|Open-Label Phase|Administrative|12|||
164321008|NCT02815280|593552121|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
164321009|NCT02815280|593552122|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
164321010|NCT01944839|593552138|FG000|Overall Study|Physician Decision|2|||
164321011|NCT01944839|593552139|FG001|Overall Study|Physician Decision|2|||
164321012|NCT01944839|593552138|FG000|Overall Study|Protocol Violation|0|||
164321013|NCT01944839|593552139|FG001|Overall Study|Protocol Violation|1|||
164321014|NCT01944839|593552138|FG000|Overall Study|Adverse Event|10|||
164321015|NCT01944839|593552139|FG001|Overall Study|Adverse Event|5|||
164321016|NCT01944839|593552138|FG000|Overall Study|Withdrawal by Subject|9|||
164321017|NCT01944839|593552139|FG001|Overall Study|Withdrawal by Subject|17|||
164321018|NCT01944839|593552138|FG000|Overall Study|Lost to Follow-up|1|||
164321019|NCT01944839|593552139|FG001|Overall Study|Lost to Follow-up|0|||
164321020|NCT01944839|593552138|FG000|Overall Study|Subject non-compliance|0|||
164321021|NCT01944839|593552139|FG001|Overall Study|Subject non-compliance|3|||
164321022|NCT00609362|593552140|FG000|Overall Study|Withdrawal by Subject|2|||
164321023|NCT00609362|593552141|FG001|Overall Study|Withdrawal by Subject|1|||
164321024|NCT00609362|593552140|FG000|Overall Study|Adverse Event|1|||
164321025|NCT00609362|593552141|FG001|Overall Study|Adverse Event|0|||
164321026|NCT05093790|593552142|FG000|Overall Study|Failure to meet continuation criteria|0|||
164321027|NCT05093790|593552143|FG001|Overall Study|Failure to meet continuation criteria|0|||
164321028|NCT05093790|593552144|FG002|Overall Study|Failure to meet continuation criteria|1|||
164321029|NCT05093790|593552145|FG003|Overall Study|Failure to meet continuation criteria|0|||
164321030|NCT05093790|593552142|FG000|Overall Study|Adverse Event|1|||
164321031|NCT05093790|593552143|FG001|Overall Study|Adverse Event|0|||
164321032|NCT05093790|593552144|FG002|Overall Study|Adverse Event|0|||
164321033|NCT05093790|593552145|FG003|Overall Study|Adverse Event|0|||
164321034|NCT00548405|593552146|FG000|Overall Study|Adverse Event|6|||
164321035|NCT00548405|593552147|FG001|Overall Study|Adverse Event|2|||
164321036|NCT00548405|593552148|FG002|Overall Study|Adverse Event|0|||
164321037|NCT00548405|593552146|FG000|Overall Study|Lack of Efficacy|6|||
164321038|NCT00548405|593552147|FG001|Overall Study|Lack of Efficacy|0|||
164321039|NCT00548405|593552148|FG002|Overall Study|Lack of Efficacy|0|||
164321040|NCT00548405|593552146|FG000|Overall Study|Physician Decision|3|||
164321041|NCT00548405|593552147|FG001|Overall Study|Physician Decision|4|||
164321042|NCT00548405|593552148|FG002|Overall Study|Physician Decision|1|||
164321043|NCT00548405|593552146|FG000|Overall Study|Pregnancy|1|||
164321044|NCT00548405|593552147|FG001|Overall Study|Pregnancy|0|||
164321045|NCT00548405|593552148|FG002|Overall Study|Pregnancy|0|||
164321046|NCT00548405|593552146|FG000|Overall Study|Protocol Violation|1|||
164321047|NCT00548405|593552147|FG001|Overall Study|Protocol Violation|0|||
164321048|NCT00548405|593552148|FG002|Overall Study|Protocol Violation|0|||
164321049|NCT00548405|593552146|FG000|Overall Study|Withdrawal by Subject|36|||
164321050|NCT00548405|593552147|FG001|Overall Study|Withdrawal by Subject|12|||
164321051|NCT00548405|593552148|FG002|Overall Study|Withdrawal by Subject|5|||
164321052|NCT00548405|593552146|FG000|Overall Study|Lost to Follow-up|1|||
164321053|NCT00548405|593552147|FG001|Overall Study|Lost to Follow-up|1|||
164321054|NCT00548405|593552148|FG002|Overall Study|Lost to Follow-up|2|||
164321055|NCT00548405|593552146|FG000|Overall Study|Death|0|||
164321056|NCT00548405|593552147|FG001|Overall Study|Death|1|||
164321057|NCT00548405|593552148|FG002|Overall Study|Death|1|||
164321058|NCT00548405|593552146|FG000|Overall Study|Sponsor decision|1|||
164321059|NCT00548405|593552147|FG001|Overall Study|Sponsor decision|0|||
164321060|NCT00548405|593552148|FG002|Overall Study|Sponsor decision|0|||
164321061|NCT00548405|593552146|FG000|Overall Study|Randomized but not treated|1|||
164321062|NCT00548405|593552147|FG001|Overall Study|Randomized but not treated|0|||
164321063|NCT00548405|593552148|FG002|Overall Study|Randomized but not treated|0|||
164321064|NCT01624870|593552154|FG000|Overall Study|Death|19|||
164321065|NCT01624870|593552154|FG000|Overall Study|Withdrawal by Subject|1|||
164207583|NCT01963611|593129825|FG004|Overall Study|Lack of Efficacy|0|||
164207584|NCT01963611|593129821|FG000|Overall Study|Withdrawal by Subject|3|||
164207585|NCT01963611|593129822|FG001|Overall Study|Withdrawal by Subject|2|||
164207586|NCT01963611|593129823|FG002|Overall Study|Withdrawal by Subject|1|||
164207587|NCT01963611|593129824|FG003|Overall Study|Withdrawal by Subject|1|||
164207588|NCT01963611|593129825|FG004|Overall Study|Withdrawal by Subject|3|||
164207589|NCT01963611|593129821|FG000|Overall Study|Other|47|||
164207590|NCT01963611|593129822|FG001|Overall Study|Other|46|||
164207591|NCT01963611|593129823|FG002|Overall Study|Other|48|||
164207592|NCT01963611|593129824|FG003|Overall Study|Other|45|||
164207593|NCT01963611|593129825|FG004|Overall Study|Other|45|||
164207594|NCT01126424|593129830|FG000|Overall Study|Adverse Event|0|||
164207595|NCT01126424|593129831|FG001|Overall Study|Adverse Event|0|||
164207596|NCT01126424|593129832|FG002|Overall Study|Adverse Event|0|||
164207597|NCT01126424|593129833|FG003|Overall Study|Adverse Event|0|||
164207598|NCT01126424|593129834|FG004|Overall Study|Adverse Event|1|||
164207599|NCT01126424|593129835|FG005|Overall Study|Adverse Event|0|||
164207600|NCT01126424|593129830|FG000|Overall Study|Withdrawal by Subject|0|||
164207601|NCT01126424|593129831|FG001|Overall Study|Withdrawal by Subject|0|||
164207602|NCT01126424|593129832|FG002|Overall Study|Withdrawal by Subject|1|||
164207603|NCT01126424|593129833|FG003|Overall Study|Withdrawal by Subject|3|||
164207604|NCT01126424|593129834|FG004|Overall Study|Withdrawal by Subject|1|||
164207605|NCT01126424|593129835|FG005|Overall Study|Withdrawal by Subject|0|||
164207606|NCT02127671|593129836|FG000|Overall Study|Death|2|||
164207607|NCT02127671|593129837|FG001|Overall Study|Death|2|||
164207608|NCT02127671|593129836|FG000|Overall Study|Lost to Follow-up|4|||
164207609|NCT02127671|593129837|FG001|Overall Study|Lost to Follow-up|2|||
164207610|NCT02127671|593129836|FG000|Overall Study|Physician Decision|1|||
164207611|NCT02127671|593129837|FG001|Overall Study|Physician Decision|0|||
164207612|NCT02127671|593129836|FG000|Overall Study|incarceration|0|||
164207613|NCT02127671|593129837|FG001|Overall Study|incarceration|1|||
164207614|NCT02127671|593129836|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
164207615|NCT02127671|593129837|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
164207616|NCT00782067|593129838|FG000|Overall Study|Adverse Event|35|||
164207617|NCT00782067|593129838|FG000|Overall Study|Subject withdrew consent|11|||
164207618|NCT00782067|593129838|FG000|Overall Study|Lost to Follow-up|2|||
164207619|NCT00782067|593129838|FG000|Overall Study|Administrative problems|14|||
164207620|NCT00782067|593129838|FG000|Overall Study|Death|9|||
164207621|NCT00782067|593129838|FG000|Overall Study|Disease progression|43|||
164207622|NCT00782067|593129838|FG000|Overall Study|Protocol deviation|2|||
164207623|NCT02328105|593129839|FG000|Overall Study|Death|6|||
164207624|NCT02328105|593129839|FG000|Overall Study|Withdrawal by Subject|1|||
164207625|NCT02328105|593129839|FG000|Overall Study|Still On Study in Follow-Up|4|||
164207626|NCT01013753|593129844|FG000|Overall Study|Adverse Event|8|||
164207627|NCT01013753|593129844|FG000|Overall Study|Protocol Violation|3|||
164207628|NCT01013753|593129844|FG000|Overall Study|Lost to Follow-up|1|||
164207629|NCT01013753|593129844|FG000|Overall Study|Withdrawal by Subject|2|||
164207630|NCT01013753|593129844|FG000|Overall Study|Other|2|||
164207631|NCT00303186|593129855|FG000|Overall Study|Other|52|||
164207632|NCT01283386|593129856|FG000|Overall Study|Death|2|||
164207633|NCT01283386|593129857|FG001|Overall Study|Death|0|||
164207634|NCT01283386|593129856|FG000|Overall Study|Withdrawal by Subject|2|||
164207635|NCT01283386|593129857|FG001|Overall Study|Withdrawal by Subject|1|||
164207636|NCT01283386|593129856|FG000|Overall Study|Relapse of underlying disease|1|||
164207637|NCT01283386|593129857|FG001|Overall Study|Relapse of underlying disease|3|||
164207638|NCT01283386|593129856|FG000|Overall Study|Progression of underlying disease|2|||
164207639|NCT01283386|593129857|FG001|Overall Study|Progression of underlying disease|7|||
164207640|NCT01283386|593129856|FG000|Overall Study|Reason not specified|1|||
164207641|NCT01283386|593129857|FG001|Overall Study|Reason not specified|0|||
164207642|NCT01283386|593129856|FG000|Overall Study|Protocol Violation|0|||
164207643|NCT01283386|593129857|FG001|Overall Study|Protocol Violation|1|||
164207644|NCT02469857|593129858|FG000|Overall Study|Death|24|||
164207645|NCT02469857|593129859|FG001|Overall Study|Death|29|||
164207646|NCT02469857|593129858|FG000|Overall Study|Discontinuation|1|||
164207647|NCT02469857|593129859|FG001|Overall Study|Discontinuation|3|||
164207648|NCT01137786|593129860|FG000|Overall Study|Lost to Follow-up|0|||
164207649|NCT01137786|593129861|FG001|Overall Study|Lost to Follow-up|2|||
164207650|NCT01137786|593129860|FG000|Overall Study|Withdrawal by Subject|1|||
164207651|NCT01137786|593129861|FG001|Overall Study|Withdrawal by Subject|1|||
164207652|NCT01531153|593129862|FG000|Overall Study|Withdrawal by Subject|10|||
164207653|NCT01531153|593129863|FG001|Overall Study|Withdrawal by Subject|9|||
164207654|NCT01531153|593129864|FG002|Overall Study|Withdrawal by Subject|15|||
164207655|NCT00297167|593129865|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
164207656|NCT00297167|593129866|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
164207657|NCT00297167|593129867|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
164207658|NCT00297167|593129865|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
164207659|NCT00297167|593129866|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
164207660|NCT00297167|593129867|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
164321066|NCT01624870|593552154|FG000|Overall Study|CoreValve not implanted|6|||
164321067|NCT01624870|593552154|FG000|Overall Study|Lost to follow up|1|||
164321068|NCT05027971|593552159|FG000|Overall Study|Physician Decision|7|||
164321069|NCT05027971|593552160|FG001|Overall Study|Physician Decision|3|||
164321070|NCT05027971|593552159|FG000|Overall Study|Lost to Follow-up|1|||
164321071|NCT05027971|593552160|FG001|Overall Study|Lost to Follow-up|1|||
164321072|NCT05027971|593552159|FG000|Overall Study|Withdrawal by Subject|0|||
164321073|NCT05027971|593552160|FG001|Overall Study|Withdrawal by Subject|2|||
164321074|NCT05027971|593552159|FG000|Overall Study|Non-study fiber used.|0|||
164321075|NCT05027971|593552160|FG001|Overall Study|Non-study fiber used.|1|||
164321076|NCT05027971|593552159|FG000|Overall Study|Protocol Violation|0|||
164321077|NCT05027971|593552160|FG001|Overall Study|Protocol Violation|2|||
164321078|NCT02025556|593552161|FG000|Overall Study|Adverse Event|0|||
164321079|NCT02025556|593552162|FG001|Overall Study|Adverse Event|4|||
164321080|NCT02025556|593552163|FG002|Overall Study|Adverse Event|2|||
164321081|NCT02025556|593552161|FG000|Overall Study|Lack of Efficacy|2|||
164321082|NCT02025556|593552162|FG001|Overall Study|Lack of Efficacy|1|||
164321083|NCT02025556|593552163|FG002|Overall Study|Lack of Efficacy|0|||
164321084|NCT02025556|593552161|FG000|Overall Study|Protocol Violation|2|||
164321085|NCT02025556|593552162|FG001|Overall Study|Protocol Violation|1|||
164321086|NCT02025556|593552163|FG002|Overall Study|Protocol Violation|0|||
164321087|NCT02025556|593552161|FG000|Overall Study|Withdrawal by Subject|0|||
164321088|NCT02025556|593552162|FG001|Overall Study|Withdrawal by Subject|3|||
164321089|NCT02025556|593552163|FG002|Overall Study|Withdrawal by Subject|6|||
164321090|NCT02025556|593552161|FG000|Overall Study|Lost to Follow-up|2|||
164321091|NCT02025556|593552162|FG001|Overall Study|Lost to Follow-up|4|||
164207661|NCT03416179|593129868|FG000|Overall Study|Death|90|||
164207662|NCT03416179|593129869|FG001|Overall Study|Death|87|||
164207663|NCT03416179|593129870|FG002|Overall Study|Death|117|||
164207664|NCT03416179|593129871|FG003|Overall Study|Death|113|||
164207665|NCT03416179|593129868|FG000|Overall Study|Withdrawal by Subject|15|||
164207666|NCT03416179|593129869|FG001|Overall Study|Withdrawal by Subject|20|||
164207667|NCT03416179|593129870|FG002|Overall Study|Withdrawal by Subject|6|||
164207668|NCT03416179|593129871|FG003|Overall Study|Withdrawal by Subject|9|||
164207669|NCT03416179|593129868|FG000|Overall Study|Lost to Follow-up|1|||
164207670|NCT03416179|593129869|FG001|Overall Study|Lost to Follow-up|1|||
164207671|NCT03416179|593129870|FG002|Overall Study|Lost to Follow-up|0|||
164207672|NCT03416179|593129871|FG003|Overall Study|Lost to Follow-up|3|||
164207673|NCT03416179|593129868|FG000|Overall Study|Study participation terminated by Sponsor|93|||
164207674|NCT03416179|593129869|FG001|Overall Study|Study participation terminated by Sponsor|91|||
164207675|NCT03416179|593129870|FG002|Overall Study|Study participation terminated by Sponsor|26|||
164207676|NCT03416179|593129871|FG003|Overall Study|Study participation terminated by Sponsor|31|||
164207677|NCT03416179|593129868|FG000|Overall Study|Other|2|||
164207678|NCT03416179|593129869|FG001|Overall Study|Other|3|||
164207679|NCT03416179|593129870|FG002|Overall Study|Other|1|||
164207680|NCT03416179|593129871|FG003|Overall Study|Other|0|||
164207681|NCT01385176|593129872|FG000|Randomization Phase|Death|1|||
164207682|NCT01385176|593129873|FG001|Randomization Phase|Death|2|||
164207683|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Death|1|||
164207684|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Death|2|||
164207685|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Physician Decision|0|||
164207686|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Physician Decision|1|||
164207687|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
164207688|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
164207689|NCT01385176|593129872|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
164207690|NCT01385176|593129873|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
164207691|NCT00284856|593129874|FG000|Overall Study|Adverse Event|3|||
164207692|NCT00284856|593129875|FG001|Overall Study|Adverse Event|3|||
164207693|NCT00284856|593129876|FG002|Overall Study|Adverse Event|3|||
164207694|NCT00284856|593129874|FG000|Overall Study|Lack of Efficacy|2|||
164207695|NCT00284856|593129875|FG001|Overall Study|Lack of Efficacy|1|||
164207696|NCT00284856|593129876|FG002|Overall Study|Lack of Efficacy|8|||
164207697|NCT00284856|593129874|FG000|Overall Study|Lost to Follow-up|25|||
164321092|NCT02025556|593552163|FG002|Overall Study|Lost to Follow-up|0|||
164207698|NCT00284856|593129875|FG001|Overall Study|Lost to Follow-up|21|||
164207699|NCT00284856|593129876|FG002|Overall Study|Lost to Follow-up|22|||
164207700|NCT00284856|593129874|FG000|Overall Study|Protocol Violation|5|||
164207701|NCT00284856|593129875|FG001|Overall Study|Protocol Violation|4|||
164207702|NCT00284856|593129876|FG002|Overall Study|Protocol Violation|5|||
164207703|NCT00284856|593129874|FG000|Overall Study|Withdrawal by Subject|12|||
164207704|NCT00284856|593129875|FG001|Overall Study|Withdrawal by Subject|16|||
164321093|NCT02025556|593552161|FG000|Overall Study|Reason not reported|0|||
164321094|NCT02025556|593552162|FG001|Overall Study|Reason not reported|0|||
164321095|NCT02025556|593552163|FG002|Overall Study|Reason not reported|1|||
164321096|NCT02582684|593552165|FG000|Overall Study|Unable to contact subject/parent|4|||
164207705|NCT00284856|593129876|FG002|Overall Study|Withdrawal by Subject|18|||
164207706|NCT00284856|593129874|FG000|Overall Study|Other|4|||
164207707|NCT00284856|593129875|FG001|Overall Study|Other|5|||
164321097|NCT02582684|593552165|FG000|Overall Study|Subject not able to get to clinic|10|||
164321098|NCT02582684|593552165|FG000|Overall Study|Subject withdrew consent|1|||
164321099|NCT02582684|593552165|FG000|Overall Study|Found to be ineligible after enrollment|2|||
164321100|NCT01878149|593552166|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
164321101|NCT01878149|593552167|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
164321102|NCT04672252|593552170|FG000|Overall Study|Protocol Violation|1|||
164321103|NCT04672252|593552171|FG001|Overall Study|Protocol Violation|0|||
164321104|NCT01587898|593552172|FG000|Overall Study|Adverse Event|1|||
164321105|NCT01587898|593552173|FG001|Overall Study|Adverse Event|1|||
164321106|NCT01587898|593552174|FG002|Overall Study|Adverse Event|0|||
164321107|NCT01587898|593552175|FG003|Overall Study|Adverse Event|0|||
164321108|NCT01587898|593552172|FG000|Overall Study|Protocol Violation|0|||
164321109|NCT01587898|593552173|FG001|Overall Study|Protocol Violation|2|||
164321110|NCT01587898|593552174|FG002|Overall Study|Protocol Violation|1|||
164321111|NCT01587898|593552175|FG003|Overall Study|Protocol Violation|1|||
164321112|NCT01587898|593552172|FG000|Overall Study|Lost to Follow-up|0|||
164321113|NCT01587898|593552173|FG001|Overall Study|Lost to Follow-up|0|||
164321114|NCT01587898|593552174|FG002|Overall Study|Lost to Follow-up|0|||
164321115|NCT01587898|593552175|FG003|Overall Study|Lost to Follow-up|1|||
164321116|NCT01587898|593552172|FG000|Overall Study|Withdrawal by Subject|2|||
164321117|NCT01587898|593552173|FG001|Overall Study|Withdrawal by Subject|1|||
164321118|NCT01587898|593552174|FG002|Overall Study|Withdrawal by Subject|0|||
164321119|NCT01587898|593552175|FG003|Overall Study|Withdrawal by Subject|0|||
164321120|NCT01587898|593552172|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
164321121|NCT01587898|593552173|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
164321122|NCT01587898|593552174|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
164321123|NCT01587898|593552175|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
164321124|NCT00796991|593552176|FG000|Overall Study|Adverse Event|0|||
164321125|NCT00796991|593552177|FG001|Overall Study|Adverse Event|0|||
164321126|NCT00796991|593552178|FG002|Overall Study|Adverse Event|1|||
164321127|NCT00796991|593552176|FG000|Overall Study|Death|2|||
164321128|NCT00796991|593552177|FG001|Overall Study|Death|0|||
164321129|NCT00796991|593552178|FG002|Overall Study|Death|0|||
164321130|NCT00796991|593552176|FG000|Overall Study|Disease Progression|10|||
164321131|NCT00796991|593552177|FG001|Overall Study|Disease Progression|9|||
164321132|NCT00796991|593552178|FG002|Overall Study|Disease Progression|7|||
164321133|NCT00796991|593552176|FG000|Overall Study|Study Drug Toxicity|3|||
164321134|NCT00796991|593552177|FG001|Overall Study|Study Drug Toxicity|3|||
164321135|NCT00796991|593552178|FG002|Overall Study|Study Drug Toxicity|5|||
164321136|NCT00796991|593552176|FG000|Overall Study|Withdrawal by Subject|0|||
164321137|NCT00796991|593552177|FG001|Overall Study|Withdrawal by Subject|0|||
164321138|NCT00796991|593552178|FG002|Overall Study|Withdrawal by Subject|1|||
164321139|NCT02437110|593552181|FG000|Screening|Lost to Follow-up|3|||
164321140|NCT02437110|593552181|FG000|Screening|Physician Decision|1|||
164321141|NCT02437110|593552181|FG000|ART|Adverse Event|3|||
164321142|NCT02437110|593552181|FG000|ART|Protocol Violation|3|||
164321143|NCT02437110|593552181|FG000|ART|Withdrawal by Subject|4|||
164321144|NCT02437110|593552181|FG000|ART|Lost to follow-up prior to start of intervention|1|||
164321145|NCT02437110|593552181|FG000|ART|Physician decision prior to start of intervention|2|||
164321146|NCT02437110|593552181|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
164321147|NCT02437110|593552181|FG000|Post-ART|Lost to Follow-up|3|||
164321148|NCT02437110|593552181|FG000|Post-ART|Protocol Violation|4|||
164321149|NCT02437110|593552181|FG000|Post-ART|Withdrawal by Subject|3|||
164321150|NCT00171834|593552182|FG000|Overall Study|Adverse Event|2|||
164321151|NCT00171834|593552183|FG001|Overall Study|Adverse Event|1|||
164321152|NCT00171834|593552184|FG002|Overall Study|Adverse Event|3|||
164321153|NCT00171834|593552185|FG003|Overall Study|Adverse Event|2|||
164321154|NCT00171834|593552186|FG004|Overall Study|Adverse Event|2|||
164321155|NCT00171834|593552187|FG005|Overall Study|Adverse Event|15|||
164321156|NCT00171834|593552188|FG006|Overall Study|Adverse Event|1|||
164321157|NCT00171834|593552182|FG000|Overall Study|Withdrawal by Subject|0|||
164321158|NCT00171834|593552183|FG001|Overall Study|Withdrawal by Subject|2|||
164321159|NCT00171834|593552184|FG002|Overall Study|Withdrawal by Subject|0|||
164321160|NCT00171834|593552185|FG003|Overall Study|Withdrawal by Subject|1|||
164321161|NCT00171834|593552186|FG004|Overall Study|Withdrawal by Subject|1|||
164321162|NCT00171834|593552187|FG005|Overall Study|Withdrawal by Subject|1|||
164321163|NCT00171834|593552188|FG006|Overall Study|Withdrawal by Subject|0|||
164321164|NCT00171834|593552182|FG000|Overall Study|Death from study indication|0|||
164321165|NCT00171834|593552183|FG001|Overall Study|Death from study indication|1|||
164321166|NCT00171834|593552184|FG002|Overall Study|Death from study indication|0|||
164321167|NCT00171834|593552185|FG003|Overall Study|Death from study indication|0|||
164321168|NCT00171834|593552186|FG004|Overall Study|Death from study indication|1|||
164321169|NCT00171834|593552187|FG005|Overall Study|Death from study indication|0|||
164321170|NCT00171834|593552188|FG006|Overall Study|Death from study indication|0|||
164321171|NCT00171834|593552182|FG000|Overall Study|Disease Progression|4|||
164321172|NCT00171834|593552183|FG001|Overall Study|Disease Progression|8|||
164321173|NCT00171834|593552184|FG002|Overall Study|Disease Progression|8|||
164321174|NCT00171834|593552185|FG003|Overall Study|Disease Progression|9|||
164321175|NCT00171834|593552186|FG004|Overall Study|Disease Progression|2|||
164321176|NCT00171834|593552187|FG005|Overall Study|Disease Progression|18|||
164321177|NCT00171834|593552188|FG006|Overall Study|Disease Progression|3|||
164321178|NCT00171834|593552182|FG000|Overall Study|Treatment Duration Completed|0|||
164321179|NCT00171834|593552183|FG001|Overall Study|Treatment Duration Completed|0|||
164321180|NCT00171834|593552184|FG002|Overall Study|Treatment Duration Completed|1|||
164321181|NCT00171834|593552185|FG003|Overall Study|Treatment Duration Completed|0|||
164321182|NCT00171834|593552186|FG004|Overall Study|Treatment Duration Completed|2|||
164321183|NCT00171834|593552187|FG005|Overall Study|Treatment Duration Completed|1|||
164321184|NCT00171834|593552188|FG006|Overall Study|Treatment Duration Completed|0|||
164321185|NCT01261780|593552189|FG000|Overall Study|Withdrawal by Subject|1|||
164321186|NCT01261780|593552190|FG001|Overall Study|Withdrawal by Subject|0|||
164321187|NCT01261780|593552189|FG000|Overall Study|Event not related to subject|1|||
164321188|NCT01261780|593552190|FG001|Overall Study|Event not related to subject|2|||
164321189|NCT01239732|593552191|FG000|Overall Study|Termination of study per protocol|667|||
164321190|NCT01239732|593552191|FG000|Overall Study|Death|226|||
164321191|NCT01239732|593552191|FG000|Overall Study|Withdrawal by Subject|87|||
164321192|NCT01239732|593552191|FG000|Overall Study|Adverse Event|6|||
164321193|NCT01239732|593552191|FG000|Overall Study|Protocol Violation|3|||
164321194|NCT01239732|593552191|FG000|Overall Study|Participant non compliance|5|||
164321195|NCT01239732|593552191|FG000|Overall Study|Study termination by sponsor|2|||
164321196|NCT01239732|593552191|FG000|Overall Study|Investigator's decision|4|||
164321197|NCT01239732|593552191|FG000|Overall Study|Treatment failure|2|||
164321198|NCT01239732|593552191|FG000|Overall Study|Other|19|||
164321199|NCT00927940|593552192|FG000|Overall Study|Death|1|||
164321200|NCT03007888|593552193|FG000|First Intervention (14 Days)|Adverse Event|1|||
164321201|NCT03007888|593552194|FG001|First Intervention (14 Days)|Adverse Event|0|||
164321202|NCT04658940|593552196|FG000|Overall Study|Withdrawal by Subject|1|||
164321203|NCT00827931|593552200|FG000|Overall Study|Death|3|||
164321204|NCT00827931|593552201|FG001|Overall Study|Death|5|||
164321205|NCT00827931|593552200|FG000|Overall Study|Adverse Event|1|||
164321206|NCT00827931|593552201|FG001|Overall Study|Adverse Event|0|||
164321207|NCT00827931|593552200|FG000|Overall Study|Lost to Follow-up|1|||
164321208|NCT00827931|593552201|FG001|Overall Study|Lost to Follow-up|0|||
164321209|NCT00827931|593552200|FG000|Overall Study|Withdrawal by Subject|0|||
164321210|NCT00827931|593552201|FG001|Overall Study|Withdrawal by Subject|1|||
164321211|NCT00827931|593552200|FG000|Overall Study|Other|1|||
164321212|NCT00827931|593552201|FG001|Overall Study|Other|0|||
164321213|NCT02015221|593552202|FG000|Overall Study|Withdrawal by Subject|8|||
164321214|NCT02015221|593552203|FG001|Overall Study|Withdrawal by Subject|6|||
164321215|NCT02015221|593552202|FG000|Overall Study|Lost to Follow-up|1|||
164321216|NCT02015221|593552203|FG001|Overall Study|Lost to Follow-up|0|||
164321217|NCT03579602|593552204|FG000|Overall Study|Subject unable to receive study drug|0|||
164321218|NCT03579602|593552205|FG001|Overall Study|Subject unable to receive study drug|2|||
164321219|NCT03579602|593552204|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
164321220|NCT03579602|593552205|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
164321221|NCT01306929|593552206|FG000|Overall Study|Withdrawal by Subject|23|||
164321222|NCT01306929|593552206|FG000|Overall Study|Adverse Event|21|||
164321223|NCT01306929|593552206|FG000|Overall Study|Physician Decision|13|||
164321224|NCT01306929|593552206|FG000|Overall Study|Death|8|||
164321225|NCT01306929|593552206|FG000|Overall Study|Withdrawal by parent/guardian|5|||
164321226|NCT01306929|593552206|FG000|Overall Study|Protocol Violation|3|||
164321227|NCT01306929|593552206|FG000|Overall Study|Non-compliance with study drug|2|||
164321228|NCT01306929|593552206|FG000|Overall Study|Lost to Follow-up|2|||
164321229|NCT01306929|593552206|FG000|Overall Study|Various|17|||
164321230|NCT01870076|593552207|FG000|Overall Study|Withdrawal by Subject|1|||
164321231|NCT01870076|593552208|FG001|Overall Study|Withdrawal by Subject|0|||
164321232|NCT01870076|593552209|FG002|Overall Study|Withdrawal by Subject|1|||
164321233|NCT01870076|593552210|FG003|Overall Study|Withdrawal by Subject|0|||
164321234|NCT03041129|593552211|FG000|Overall Study|Withdrawal by Subject|2|||
164321235|NCT03041129|593552212|FG001|Overall Study|Withdrawal by Subject|0|||
164321236|NCT03041129|593552213|FG002|Overall Study|Withdrawal by Subject|0|||
163874963|NCT05600283|591909851|FG000|Overall Study|Missing Clinician Collection|3|||
163874964|NCT05600283|591909852|FG001|Overall Study|Missing Clinician Collection|6|||
163874965|NCT05600283|591909851|FG000|Overall Study|Screen Failure|1|||
164321237|NCT03041129|593552214|FG003|Overall Study|Withdrawal by Subject|0|||
164321238|NCT00483756|593552219|FG000|Overall Study|Death|2|||
164321239|NCT00483756|593552220|FG001|Overall Study|Death|0|||
163874966|NCT05600283|591909852|FG001|Overall Study|Screen Failure|2|||
163874967|NCT05600283|591909851|FG000|Overall Study|Sample Lost in Transit|1|||
164321240|NCT00483756|593552221|FG002|Overall Study|Death|1|||
164321241|NCT00483756|593552219|FG000|Overall Study|Adverse Event|19|||
164321242|NCT00483756|593552220|FG001|Overall Study|Adverse Event|38|||
164321243|NCT00483756|593552221|FG002|Overall Study|Adverse Event|40|||
164321244|NCT00483756|593552219|FG000|Overall Study|Lack of Efficacy|1|||
164321245|NCT00483756|593552220|FG001|Overall Study|Lack of Efficacy|0|||
164321246|NCT00483756|593552221|FG002|Overall Study|Lack of Efficacy|0|||
164321247|NCT00483756|593552219|FG000|Overall Study|Lost to Follow-up|3|||
164321248|NCT00483756|593552220|FG001|Overall Study|Lost to Follow-up|1|||
164321249|NCT00483756|593552221|FG002|Overall Study|Lost to Follow-up|0|||
164321250|NCT00483756|593552219|FG000|Overall Study|Withdrawal by Subject|5|||
164321251|NCT00483756|593552220|FG001|Overall Study|Withdrawal by Subject|3|||
164321252|NCT00483756|593552221|FG002|Overall Study|Withdrawal by Subject|4|||
164321253|NCT00483756|593552219|FG000|Overall Study|Other|2|||
164321254|NCT00483756|593552220|FG001|Overall Study|Other|4|||
164321255|NCT00483756|593552221|FG002|Overall Study|Other|3|||
164321256|NCT00483756|593552219|FG000|Overall Study|Randomized, Not Treated|1|||
164321257|NCT00483756|593552220|FG001|Overall Study|Randomized, Not Treated|4|||
164321258|NCT00483756|593552221|FG002|Overall Study|Randomized, Not Treated|4|||
164321259|NCT00807573|593552226|FG000|Overall Study|Withdrawal by Subject|1|||
164321260|NCT00807573|593552226|FG000|Overall Study|Adverse Event|1|||
164321261|NCT01007253|593552230|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
164321262|NCT01007253|593552231|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
164321263|NCT01007253|593552232|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
163874968|NCT05600283|591909852|FG001|Overall Study|Sample Lost in Transit|0|||
163874969|NCT00068601|591909853|FG000|Overall Study|Ineligible|11|||
163874970|NCT00068601|591909854|FG001|Overall Study|Ineligible|13|||
164076458|NCT02614703|592645725|FG000|Overall Study|Withdrawal by Subject|7|||
164076459|NCT02614703|592645726|FG001|Overall Study|Withdrawal by Subject|1|||
164076460|NCT00782275|592645728|FG000|Overall Study|Adverse Event|11|||
164076461|NCT00782275|592645728|FG000|Overall Study|Withdrawal by Subject|1|||
164076462|NCT00782275|592645728|FG000|Overall Study|Progressive Disease|21|||
164076463|NCT00782275|592645728|FG000|Overall Study|Physician Decision|4|||
164076464|NCT00782275|592645728|FG000|Overall Study|Not started treatment|1|||
164076465|NCT00782275|592645728|FG000|Overall Study|Other|3|||
164076466|NCT04378010|592645729|FG000|Overall Study|Adverse Event|8|||
164076467|NCT04378010|592645730|FG001|Overall Study|Adverse Event|14|||
164076468|NCT04378010|592645731|FG002|Overall Study|Adverse Event|4|||
164076469|NCT04378010|592645729|FG000|Overall Study|Withdrawal by Subject|0|||
164076470|NCT04378010|592645730|FG001|Overall Study|Withdrawal by Subject|2|||
164076471|NCT04378010|592645731|FG002|Overall Study|Withdrawal by Subject|1|||
164076472|NCT04378010|592645729|FG000|Overall Study|Protocol Violation|2|||
164076473|NCT04378010|592645730|FG001|Overall Study|Protocol Violation|1|||
164076474|NCT04378010|592645731|FG002|Overall Study|Protocol Violation|4|||
164076475|NCT04378010|592645729|FG000|Overall Study|Study terminated by Sponsor|22|||
164076476|NCT04378010|592645730|FG001|Overall Study|Study terminated by Sponsor|16|||
164076477|NCT04378010|592645731|FG002|Overall Study|Study terminated by Sponsor|22|||
164076478|NCT04378010|592645729|FG000|Overall Study|Subject inability to complete study visit|0|||
164076479|NCT04378010|592645730|FG001|Overall Study|Subject inability to complete study visit|0|||
164076480|NCT04378010|592645731|FG002|Overall Study|Subject inability to complete study visit|1|||
164076481|NCT04378010|592645729|FG000|Overall Study|Subject never dosed|0|||
164076482|NCT04378010|592645730|FG001|Overall Study|Subject never dosed|1|||
164076483|NCT04378010|592645731|FG002|Overall Study|Subject never dosed|0|||
164076484|NCT01792284|592645732|FG000|Lead-in Period|Adverse Event|15|||
164076485|NCT01792284|592645733|FG001|Lead-in Period|Adverse Event|0|||
164076486|NCT01792284|592645734|FG002|Lead-in Period|Adverse Event|0|||
164076487|NCT01792284|592645732|FG000|Lead-in Period|Lost to Follow-up|2|||
164076488|NCT01792284|592645733|FG001|Lead-in Period|Lost to Follow-up|0|||
164076489|NCT01792284|592645734|FG002|Lead-in Period|Lost to Follow-up|0|||
164076490|NCT01792284|592645732|FG000|Lead-in Period|Protocol Violation|1|||
164076491|NCT01792284|592645733|FG001|Lead-in Period|Protocol Violation|0|||
164076492|NCT01792284|592645734|FG002|Lead-in Period|Protocol Violation|0|||
164076493|NCT01792284|592645732|FG000|Lead-in Period|Withdrawal by Subject|10|||
164076494|NCT01792284|592645733|FG001|Lead-in Period|Withdrawal by Subject|0|||
164076495|NCT01792284|592645734|FG002|Lead-in Period|Withdrawal by Subject|0|||
164076496|NCT01792284|592645732|FG000|Lead-in Period|Physician Decision|1|||
164076497|NCT01792284|592645733|FG001|Lead-in Period|Physician Decision|0|||
164076498|NCT01792284|592645734|FG002|Lead-in Period|Physician Decision|0|||
164076499|NCT01792284|592645732|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
164076500|NCT01792284|592645733|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
164076501|NCT01792284|592645734|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
164076502|NCT01792284|592645732|FG000|Randomization Period 1|Withdrawal by Subject|0|||
164076503|NCT01792284|592645733|FG001|Randomization Period 1|Withdrawal by Subject|1|||
164076504|NCT01792284|592645734|FG002|Randomization Period 1|Withdrawal by Subject|1|||
164076505|NCT01792284|592645732|FG000|Randomization Period 1|Physician Decision|0|||
164076506|NCT01792284|592645733|FG001|Randomization Period 1|Physician Decision|1|||
164076507|NCT01792284|592645734|FG002|Randomization Period 1|Physician Decision|1|||
164076508|NCT01792284|592645732|FG000|Randomization Period 1|Adverse Event|0|||
164076509|NCT01792284|592645733|FG001|Randomization Period 1|Adverse Event|0|||
164076510|NCT01792284|592645734|FG002|Randomization Period 1|Adverse Event|2|||
164321264|NCT01007253|593552233|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
164321265|NCT01159431|593552236|FG000|Overall Study|Adverse Event|1|||
163874971|NCT00068601|591909853|FG000|Overall Study|Not evaluable: withdrew consent|5|||
164321266|NCT01159431|593552237|FG001|Overall Study|Adverse Event|2|||
164207708|NCT00284856|593129876|FG002|Overall Study|Other|4|||
164207709|NCT01056536|593129877|FG000|Overall Study|Lost to Follow-up|202|||
164207710|NCT01056536|593129878|FG001|Overall Study|Lost to Follow-up|116|||
164207711|NCT01056536|593129879|FG002|Overall Study|Lost to Follow-up|248|||
164207712|NCT01285518|593129880|FG000|Overall Study|Lost to Follow-up|0|||
164207713|NCT01285518|593129881|FG001|Overall Study|Lost to Follow-up|0|||
164207714|NCT01285518|593129882|FG002|Overall Study|Lost to Follow-up|0|||
164207715|NCT01285518|593129883|FG003|Overall Study|Lost to Follow-up|0|||
164207716|NCT01285518|593129884|FG004|Overall Study|Lost to Follow-up|0|||
164207717|NCT01285518|593129885|FG005|Overall Study|Lost to Follow-up|1|||
164207718|NCT01285518|593129886|FG006|Overall Study|Lost to Follow-up|0|||
164207719|NCT01285518|593129887|FG007|Overall Study|Lost to Follow-up|0|||
164207720|NCT00639509|593129894|FG000|Overall Study|Death|1|||
164207721|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Adverse Event|6|||
164207722|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Adverse Event|15|||
164207723|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Adverse Event|0|||
164207724|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Death|0|||
164207725|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Death|2|||
164207726|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Death|0|||
164207727|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
164207728|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
164207729|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
164207730|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
164207731|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
164207732|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
164207733|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Physician Decision|1|||
164207734|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Physician Decision|1|||
164207735|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Physician Decision|0|||
164207736|NCT02921256|593129895|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
164207737|NCT02921256|593129896|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
164207738|NCT02921256|593129897|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
164207739|NCT02921256|593129895|FG000|Arm Ib v Arm III|Adverse Event|9|||
164207740|NCT02921256|593129896|FG001|Arm Ib v Arm III|Adverse Event|0|||
164207741|NCT02921256|593129897|FG002|Arm Ib v Arm III|Adverse Event|4|||
164207742|NCT02921256|593129895|FG000|Arm Ib v Arm III|Death|1|||
164207743|NCT02921256|593129896|FG001|Arm Ib v Arm III|Death|0|||
164207744|NCT02921256|593129897|FG002|Arm Ib v Arm III|Death|1|||
164207745|NCT02921256|593129895|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
164207746|NCT02921256|593129896|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
164207747|NCT02921256|593129897|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
164207748|NCT02921256|593129895|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
164207749|NCT02921256|593129896|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
164207750|NCT02921256|593129897|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
164207751|NCT02921256|593129895|FG000|Arm Ib v Arm III|Physician Decision|4|||
164207752|NCT02921256|593129896|FG001|Arm Ib v Arm III|Physician Decision|0|||
164207753|NCT02921256|593129897|FG002|Arm Ib v Arm III|Physician Decision|1|||
164207754|NCT02921256|593129895|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
164207755|NCT02921256|593129896|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
164207756|NCT02921256|593129897|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
164207757|NCT03507790|593129898|FG000|Overall Study|Adverse Event|0|||
164207758|NCT03507790|593129899|FG001|Overall Study|Adverse Event|11|||
164207759|NCT03507790|593129900|FG002|Overall Study|Adverse Event|3|||
164207760|NCT03507790|593129898|FG000|Overall Study|Withdrawal by Subject|2|||
164207761|NCT03507790|593129899|FG001|Overall Study|Withdrawal by Subject|0|||
164207762|NCT03507790|593129900|FG002|Overall Study|Withdrawal by Subject|0|||
164207763|NCT03507790|593129898|FG000|Overall Study|Subject moved to another location|1|||
164207764|NCT03507790|593129899|FG001|Overall Study|Subject moved to another location|2|||
164207765|NCT03507790|593129900|FG002|Overall Study|Subject moved to another location|0|||
164207766|NCT03507790|593129898|FG000|Overall Study|Non-compliance with study drug|0|||
164207767|NCT03507790|593129899|FG001|Overall Study|Non-compliance with study drug|0|||
164207768|NCT03507790|593129900|FG002|Overall Study|Non-compliance with study drug|1|||
164207769|NCT03507790|593129898|FG000|Overall Study|COVID 19 Pandemic|0|||
164207770|NCT03507790|593129899|FG001|Overall Study|COVID 19 Pandemic|1|||
164207771|NCT03507790|593129900|FG002|Overall Study|COVID 19 Pandemic|0|||
164207772|NCT03507790|593129898|FG000|Overall Study|Lost to Follow-up|0|||
164207773|NCT03507790|593129899|FG001|Overall Study|Lost to Follow-up|1|||
164207774|NCT03507790|593129900|FG002|Overall Study|Lost to Follow-up|0|||
164207775|NCT03507790|593129898|FG000|Overall Study|Discontinuation of the trial at the site|1|||
164207776|NCT03507790|593129899|FG001|Overall Study|Discontinuation of the trial at the site|1|||
164207777|NCT03507790|593129900|FG002|Overall Study|Discontinuation of the trial at the site|0|||
164207778|NCT03507790|593129898|FG000|Overall Study|Randomized in error|0|||
164207779|NCT03507790|593129899|FG001|Overall Study|Randomized in error|0|||
164207780|NCT03507790|593129900|FG002|Overall Study|Randomized in error|1|||
164207781|NCT00157755|593129901|FG000|Overall Study|Death|2|||
164207782|NCT00157755|593129902|FG001|Overall Study|Death|3|||
164207783|NCT00157755|593129903|FG002|Overall Study|Death|3|||
164321267|NCT01159431|593552236|FG000|Overall Study|non-compliance|1|||
164207784|NCT00157755|593129904|FG003|Overall Study|Death|2|||
164207785|NCT00157755|593129905|FG004|Overall Study|Death|0|||
164321268|NCT01159431|593552237|FG001|Overall Study|non-compliance|1|||
164321269|NCT01159431|593552236|FG000|Overall Study|Lack of Efficacy|0|||
164321270|NCT01159431|593552237|FG001|Overall Study|Lack of Efficacy|3|||
164321271|NCT03976648|593552238|FG000|Overall Study|Adverse Event|0|||
164321272|NCT03976648|593552239|FG001|Overall Study|Adverse Event|2|||
164321273|NCT03976648|593552238|FG000|Overall Study|Study terminated by sponsor|21|||
164321274|NCT03976648|593552239|FG001|Overall Study|Study terminated by sponsor|8|||
164321275|NCT03645434|593552240|FG000|Period 1|Adverse Event|0|||
164321276|NCT03645434|593552241|FG001|Period 1|Adverse Event|0|||
164321277|NCT03645434|593552242|FG002|Period 1|Adverse Event|0|||
164321278|NCT03645434|593552243|FG003|Period 1|Adverse Event|1|||
164321279|NCT03645434|593552244|FG004|Period 1|Adverse Event|0|||
164321280|NCT03645434|593552245|FG005|Period 1|Adverse Event|0|||
164321281|NCT03645434|593552240|FG000|Period 1|COPD exacerbation|0|||
164321282|NCT03645434|593552241|FG001|Period 1|COPD exacerbation|0|||
164321283|NCT03645434|593552242|FG002|Period 1|COPD exacerbation|0|||
164321284|NCT03645434|593552243|FG003|Period 1|COPD exacerbation|0|||
164321285|NCT03645434|593552244|FG004|Period 1|COPD exacerbation|1|||
164321286|NCT03645434|593552245|FG005|Period 1|COPD exacerbation|0|||
164321287|NCT00881868|593552246|FG000|Overall Study|Adverse Event|0|||
164321288|NCT00881868|593552247|FG001|Overall Study|Adverse Event|1|||
164321289|NCT00881868|593552246|FG000|Overall Study|Lost to Follow-up|2|||
164321290|NCT00881868|593552247|FG001|Overall Study|Lost to Follow-up|1|||
164321291|NCT00881868|593552246|FG000|Overall Study|Physician Decision|4|||
164321292|NCT00881868|593552247|FG001|Overall Study|Physician Decision|0|||
164321293|NCT00881868|593552246|FG000|Overall Study|Protocol Violation|2|||
164321294|NCT00881868|593552247|FG001|Overall Study|Protocol Violation|0|||
164321295|NCT02880956|593552250|FG000|Overall Study|Adverse Event|3|||
164321296|NCT02880956|593552251|FG001|Overall Study|Adverse Event|6|||
164321297|NCT02880956|593552252|FG002|Overall Study|Adverse Event|5|||
164321298|NCT02880956|593552253|FG003|Overall Study|Adverse Event|4|||
164321299|NCT02880956|593552250|FG000|Overall Study|Withdrawal by Subject|9|||
164321300|NCT02880956|593552251|FG001|Overall Study|Withdrawal by Subject|4|||
164321301|NCT02880956|593552252|FG002|Overall Study|Withdrawal by Subject|6|||
164321302|NCT02880956|593552253|FG003|Overall Study|Withdrawal by Subject|11|||
164321303|NCT02880956|593552250|FG000|Overall Study|Lost to Follow-up|0|||
164321304|NCT02880956|593552251|FG001|Overall Study|Lost to Follow-up|1|||
164321305|NCT02880956|593552252|FG002|Overall Study|Lost to Follow-up|0|||
164321306|NCT02880956|593552253|FG003|Overall Study|Lost to Follow-up|0|||
164321307|NCT02880956|593552250|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164321308|NCT02880956|593552251|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
164321309|NCT02880956|593552252|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
164321310|NCT02880956|593552253|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
164321311|NCT02880956|593552250|FG000|Overall Study|Other, Not Specified|4|||
164321312|NCT02880956|593552251|FG001|Overall Study|Other, Not Specified|2|||
164321313|NCT02880956|593552252|FG002|Overall Study|Other, Not Specified|0|||
164321314|NCT02880956|593552253|FG003|Overall Study|Other, Not Specified|3|||
164321315|NCT02081859|593552254|FG000|Overall Study|No fertilization|2|||
164321316|NCT02081859|593552255|FG001|Overall Study|No fertilization|2|||
164321317|NCT02081859|593552254|FG000|Overall Study|No sperm|1|||
164321318|NCT02081859|593552255|FG001|Overall Study|No sperm|0|||
164321319|NCT02081859|593552254|FG000|Overall Study|Unanticipated freeze all cycle|2|||
164321320|NCT02081859|593552255|FG001|Overall Study|Unanticipated freeze all cycle|6|||
164321321|NCT02081859|593552254|FG000|Overall Study|< 4 embryos|27|||
164321322|NCT02081859|593552255|FG001|Overall Study|< 4 embryos|23|||
164321323|NCT02081859|593552254|FG000|Overall Study|Other reasons|2|||
164321324|NCT02081859|593552255|FG001|Overall Study|Other reasons|0|||
164321325|NCT00884377|593554097|FG000|Overall Study|Withdrawal by Subject|1|||
164321326|NCT00884377|593554098|FG001|Overall Study|Withdrawal by Subject|0|||
164321327|NCT00884377|593554097|FG000|Overall Study|Could not confirm diagnosis|1|||
164321328|NCT00884377|593554098|FG001|Overall Study|Could not confirm diagnosis|0|||
164321329|NCT00884377|593554097|FG000|Overall Study|Physician Decision|0|||
164321330|NCT00884377|593554098|FG001|Overall Study|Physician Decision|1|||
164321331|NCT05347147|593554099|FG000|Overall Study|Lost to Follow-up|0|||
164321332|NCT05347147|593554100|FG001|Overall Study|Lost to Follow-up|1|||
164321333|NCT05347147|593554099|FG000|Overall Study|Sponsor request|3|||
164321334|NCT05347147|593554100|FG001|Overall Study|Sponsor request|3|||
164321335|NCT05347147|593554099|FG000|Overall Study|Study termination|2|||
164321336|NCT05347147|593554100|FG001|Overall Study|Study termination|1|||
164321337|NCT03718299|593554105|FG000|Overall Study|Adverse Event|1|||
164321338|NCT03718299|593554105|FG000|Overall Study|Withdrawal by Subject|6|||
164321339|NCT03718299|593554105|FG000|Overall Study|Physician Decision|2|||
164321340|NCT03718299|593554105|FG000|Overall Study|Lost to Follow-up|1|||
164321341|NCT04389970|593554107|FG000|Overall Study|Lost to Follow-up|1|||
164321342|NCT03123185|593554108|FG000|Overall Study|Withdrawal by Subject|0|||
164321343|NCT03123185|593554109|FG001|Overall Study|Withdrawal by Subject|0|||
164321344|NCT03123185|593554110|FG002|Overall Study|Withdrawal by Subject|0|||
164321345|NCT03123185|593554111|FG003|Overall Study|Withdrawal by Subject|0|||
164321346|NCT03123185|593554112|FG004|Overall Study|Withdrawal by Subject|0|||
164321347|NCT03123185|593554113|FG005|Overall Study|Withdrawal by Subject|0|||
164321348|NCT03123185|593554114|FG006|Overall Study|Withdrawal by Subject|0|||
164321349|NCT03123185|593554115|FG007|Overall Study|Withdrawal by Subject|0|||
164321350|NCT03123185|593554116|FG008|Overall Study|Withdrawal by Subject|0|||
164321351|NCT03123185|593554117|FG009|Overall Study|Withdrawal by Subject|0|||
164321352|NCT03123185|593554118|FG010|Overall Study|Withdrawal by Subject|0|||
164321353|NCT03123185|593554119|FG011|Overall Study|Withdrawal by Subject|0|||
164321354|NCT03123185|593554120|FG012|Overall Study|Withdrawal by Subject|1|||
164321355|NCT03123185|593554121|FG013|Overall Study|Withdrawal by Subject|0|||
164321356|NCT06400251|593554130|FG000|Overall Study|Never Start Protocol Therapy|1|||
164321357|NCT06400251|593554130|FG000|Overall Study|Ineligible|2|||
164321358|NCT06400251|593554130|FG000|Overall Study|Mutation Status Not Confirmed|3|||
164321359|NCT06400251|593554130|FG000|Overall Study|Disease Progression|25|||
164321360|NCT06400251|593554130|FG000|Overall Study|Adverse Event|1|||
164321361|NCT06400251|593554130|FG000|Overall Study|Complicating Disease|1|||
164321362|NCT06400251|593554130|FG000|Overall Study|Physician Decision|2|||
164321363|NCT02217527|593554131|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
164321364|NCT02217527|593554132|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
164321365|NCT02217527|593554131|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
164321366|NCT02217527|593554132|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
164321367|NCT06390839|593554139|FG000|Overall Study|Ineligible|2|||
164321368|NCT06390839|593554139|FG000|Overall Study|Never start protocol therapy|3|||
164321369|NCT06390839|593554139|FG000|Overall Study|Adverse Event|1|||
164321370|NCT06390839|593554139|FG000|Overall Study|Alternative therapy|2|||
164321371|NCT06390839|593554139|FG000|Overall Study|Death|3|||
164321372|NCT06390839|593554139|FG000|Overall Study|Disease progression|28|||
164321373|NCT06390839|593554139|FG000|Overall Study|Withdrawal by Subject|2|||
164321374|NCT06390839|593554139|FG000|Overall Study|Complicating disease|1|||
164321375|NCT06390839|593554139|FG000|Overall Study|Noncompliance|1|||
164321376|NCT01738477|593554144|FG000|Overall Study|Lost to Follow-up|1|||
164321377|NCT01738477|593554145|FG001|Overall Study|Lost to Follow-up|4|||
164321378|NCT00502203|593554146|FG000|Overall Study|Inevaluable|1|||
164321379|NCT02720094|593554147|FG000|Overall Study|Ongoing|2210|||
164321380|NCT02720094|593554148|FG001|Overall Study|Ongoing|2203|||
164321381|NCT02720094|593554147|FG000|Overall Study|Scheduled exit visit/end of study|2|||
164321382|NCT02720094|593554148|FG001|Overall Study|Scheduled exit visit/end of study|1|||
164321383|NCT02720094|593554147|FG000|Overall Study|Death|4|||
164321384|NCT02720094|593554148|FG001|Overall Study|Death|7|||
164321385|NCT02720094|593554147|FG000|Overall Study|Withdrawal by Subject|55|||
164321386|NCT02720094|593554148|FG001|Overall Study|Withdrawal by Subject|56|||
164321387|NCT02720094|593554147|FG000|Overall Study|Lost to Follow-up|2|||
164321388|NCT02720094|593554148|FG001|Overall Study|Lost to Follow-up|7|||
164321389|NCT02720094|593554147|FG000|Overall Study|Physician Decision|1|||
164321390|NCT02720094|593554148|FG001|Overall Study|Physician Decision|3|||
164321391|NCT02720094|593554147|FG000|Overall Study|Inappropriate enrollment|1|||
164321392|NCT02720094|593554148|FG001|Overall Study|Inappropriate enrollment|3|||
164321393|NCT02720094|593554147|FG000|Overall Study|Relocation|1|||
164321394|NCT02720094|593554148|FG001|Overall Study|Relocation|1|||
164321395|NCT03735238|593554153|FG000|Overall Study|Did not want to participate in research|3|||
164321396|NCT03735238|593554153|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
164321397|NCT02660138|593554154|FG000|Overall Study|Adverse Event|0|||
164321398|NCT02660138|593554155|FG001|Overall Study|Adverse Event|3|||
164321399|NCT02660138|593554156|FG002|Overall Study|Adverse Event|2|||
164321400|NCT02660138|593554154|FG000|Overall Study|Lack of Efficacy|1|||
164321401|NCT02660138|593554155|FG001|Overall Study|Lack of Efficacy|2|||
164321402|NCT02660138|593554156|FG002|Overall Study|Lack of Efficacy|1|||
164321403|NCT02660138|593554154|FG000|Overall Study|Withdrawal by Subject|7|||
164321404|NCT02660138|593554155|FG001|Overall Study|Withdrawal by Subject|6|||
164321405|NCT02660138|593554156|FG002|Overall Study|Withdrawal by Subject|6|||
164321406|NCT02660138|593554154|FG000|Overall Study|Lost to Follow-up|4|||
164321407|NCT02660138|593554155|FG001|Overall Study|Lost to Follow-up|4|||
164321408|NCT02660138|593554156|FG002|Overall Study|Lost to Follow-up|1|||
164321409|NCT02660138|593554154|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
164321410|NCT02660138|593554155|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
164321411|NCT02660138|593554156|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
164321412|NCT02660138|593554154|FG000|Overall Study|Other|1|||
164321413|NCT02660138|593554155|FG001|Overall Study|Other|1|||
164321414|NCT02660138|593554156|FG002|Overall Study|Other|0|||
164321415|NCT02660138|593554154|FG000|Overall Study|Not treated|0|||
164321416|NCT02660138|593554155|FG001|Overall Study|Not treated|1|||
164321417|NCT02660138|593554156|FG002|Overall Study|Not treated|0|||
164321418|NCT00308581|593554160|FG000|Induction Phase|Adverse Event|0|||
164321419|NCT00308581|593554161|FG001|Induction Phase|Adverse Event|0|||
164321420|NCT00308581|593554162|FG002|Induction Phase|Adverse Event|37|||
164321421|NCT00308581|593554160|FG000|Induction Phase|Lack of Efficacy|0|||
164321422|NCT00308581|593554161|FG001|Induction Phase|Lack of Efficacy|0|||
164321423|NCT00308581|593554162|FG002|Induction Phase|Lack of Efficacy|121|||
164076511|NCT01792284|592645732|FG000|Randomization Period 1|Lost to Follow-up|0|||
164076512|NCT01792284|592645733|FG001|Randomization Period 1|Lost to Follow-up|0|||
164076513|NCT01792284|592645734|FG002|Randomization Period 1|Lost to Follow-up|1|||
164076514|NCT01792284|592645732|FG000|Randomization Period 2|Protocol Violation|0|||
164076515|NCT01792284|592645733|FG001|Randomization Period 2|Protocol Violation|1|||
164076516|NCT01792284|592645734|FG002|Randomization Period 2|Protocol Violation|0|||
164076517|NCT01792284|592645732|FG000|Randomization Period 2|Withdrawal by Subject|0|||
164076518|NCT01792284|592645733|FG001|Randomization Period 2|Withdrawal by Subject|2|||
164076519|NCT01792284|592645734|FG002|Randomization Period 2|Withdrawal by Subject|0|||
164076520|NCT02019979|592645735|FG000|Overall Study|study terminated|14|||
164076521|NCT00379587|592645737|FG000|Overall Study|Lost to Follow-up|2|||
164076522|NCT00534092|592645739|FG000|Overall Study|Lost to Follow-up|1|||
164076523|NCT00534092|592645740|FG001|Overall Study|Lost to Follow-up|0|||
164076524|NCT00534092|592645739|FG000|Overall Study|personal reasons/family concerns|1|||
164076525|NCT00534092|592645740|FG001|Overall Study|personal reasons/family concerns|0|||
164076526|NCT01169649|592645741|FG000|Overall Study|Patient Not Treated|3|||
164076527|NCT01244815|592645745|FG000|Overall Study|Not Treated|0|||
164076528|NCT01244815|592645746|FG001|Overall Study|Not Treated|1|||
164076529|NCT01244815|592645747|FG002|Overall Study|Not Treated|0|||
164076530|NCT01244815|592645748|FG003|Overall Study|Not Treated|0|||
164076531|NCT01244815|592645745|FG000|Overall Study|Adverse Event|4|||
164076532|NCT01244815|592645746|FG001|Overall Study|Adverse Event|7|||
164076533|NCT01244815|592645747|FG002|Overall Study|Adverse Event|5|||
164207786|NCT00157755|593129906|FG005|Overall Study|Death|0|||
164207787|NCT00157755|593129901|FG000|Overall Study|Lost to Follow-up|0|||
164207788|NCT00157755|593129902|FG001|Overall Study|Lost to Follow-up|0|||
164207789|NCT00157755|593129903|FG002|Overall Study|Lost to Follow-up|1|||
164207790|NCT00157755|593129904|FG003|Overall Study|Lost to Follow-up|0|||
164207791|NCT00157755|593129905|FG004|Overall Study|Lost to Follow-up|0|||
164207792|NCT00157755|593129906|FG005|Overall Study|Lost to Follow-up|0|||
164207793|NCT00157755|593129901|FG000|Overall Study|Withdrawal by Subject|0|||
164207794|NCT00157755|593129902|FG001|Overall Study|Withdrawal by Subject|0|||
164207795|NCT00157755|593129903|FG002|Overall Study|Withdrawal by Subject|1|||
164207796|NCT00157755|593129904|FG003|Overall Study|Withdrawal by Subject|1|||
164207797|NCT00157755|593129905|FG004|Overall Study|Withdrawal by Subject|1|||
164207798|NCT00157755|593129906|FG005|Overall Study|Withdrawal by Subject|2|||
164207799|NCT00157755|593129901|FG000|Overall Study|Explant due to infection|0|||
164207800|NCT00157755|593129902|FG001|Overall Study|Explant due to infection|0|||
164207801|NCT00157755|593129903|FG002|Overall Study|Explant due to infection|1|||
164207802|NCT00157755|593129904|FG003|Overall Study|Explant due to infection|0|||
164207803|NCT00157755|593129905|FG004|Overall Study|Explant due to infection|0|||
164207804|NCT00157755|593129906|FG005|Overall Study|Explant due to infection|0|||
164207805|NCT00157755|593129901|FG000|Overall Study|Medical reason|0|||
164207806|NCT00157755|593129902|FG001|Overall Study|Medical reason|0|||
164207807|NCT00157755|593129903|FG002|Overall Study|Medical reason|1|||
164207808|NCT00157755|593129904|FG003|Overall Study|Medical reason|1|||
164207809|NCT00157755|593129905|FG004|Overall Study|Medical reason|0|||
164207810|NCT00157755|593129906|FG005|Overall Study|Medical reason|0|||
164207811|NCT00157755|593129901|FG000|Overall Study|Study site closure|0|||
164207812|NCT00157755|593129902|FG001|Overall Study|Study site closure|1|||
164207813|NCT00157755|593129903|FG002|Overall Study|Study site closure|0|||
164207814|NCT00157755|593129904|FG003|Overall Study|Study site closure|0|||
164207815|NCT00157755|593129905|FG004|Overall Study|Study site closure|0|||
164207816|NCT00157755|593129906|FG005|Overall Study|Study site closure|0|||
164207817|NCT00157755|593129901|FG000|Overall Study|Subject non-compliance|0|||
164207818|NCT00157755|593129902|FG001|Overall Study|Subject non-compliance|0|||
164207819|NCT00157755|593129903|FG002|Overall Study|Subject non-compliance|0|||
164207820|NCT00157755|593129904|FG003|Overall Study|Subject non-compliance|0|||
164207821|NCT00157755|593129905|FG004|Overall Study|Subject non-compliance|0|||
164207822|NCT00157755|593129906|FG005|Overall Study|Subject non-compliance|1|||
164207823|NCT00157755|593129901|FG000|Overall Study|Study completion|0|||
164207824|NCT00157755|593129902|FG001|Overall Study|Study completion|0|||
164207825|NCT00157755|593129903|FG002|Overall Study|Study completion|0|||
164207826|NCT00157755|593129904|FG003|Overall Study|Study completion|0|||
164207827|NCT00157755|593129905|FG004|Overall Study|Study completion|1|||
164207828|NCT00157755|593129906|FG005|Overall Study|Study completion|2|||
164207829|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
164207830|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
164207831|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
164076534|NCT01244815|592645748|FG003|Overall Study|Adverse Event|5|||
164076535|NCT01244815|592645745|FG000|Overall Study|Treatment Failure|0|||
164076536|NCT01244815|592645746|FG001|Overall Study|Treatment Failure|0|||
164321424|NCT00308581|593554160|FG000|Induction Phase|Withdrawal by Subject|0|||
164207832|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
164207833|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Death|38|||
164207834|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Death|10|||
164207835|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
164321425|NCT00308581|593554161|FG001|Induction Phase|Withdrawal by Subject|0|||
164321426|NCT00308581|593554162|FG002|Induction Phase|Withdrawal by Subject|5|||
164321427|NCT00308581|593554160|FG000|Induction Phase|Unknown reason|0|||
164321428|NCT00308581|593554161|FG001|Induction Phase|Unknown reason|0|||
164321429|NCT00308581|593554162|FG002|Induction Phase|Unknown reason|3|||
164321430|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Adverse Event|10|||
164321431|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Adverse Event|17|||
164321432|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Adverse Event|0|||
164321433|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
164321434|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
164321435|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
164321436|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
164321437|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
164321438|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
164321439|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
164321440|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
164321441|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
164321442|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
164321443|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
164321444|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
164321445|NCT00308581|593554160|FG000|Randomized Maintenance Phase|Unknown reason|3|||
164321446|NCT00308581|593554161|FG001|Randomized Maintenance Phase|Unknown reason|0|||
164321447|NCT00308581|593554162|FG002|Randomized Maintenance Phase|Unknown reason|0|||
164321448|NCT00899353|593554165|FG000|Overall Study|Adverse Event|2|||
164321449|NCT00899353|593554165|FG000|Overall Study|Lost to Follow-up|1|||
164321450|NCT00899353|593554165|FG000|Overall Study|Withdrawal by Subject|2|||
164321451|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
164321452|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
164321453|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
164321454|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
164321455|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
164321456|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
164321457|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
164321458|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
164321459|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
164321460|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
164321461|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
164321462|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
164321463|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
164321464|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
164321465|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
164321466|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
164321467|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
164321468|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
163979019|NCT01187953|592293668|FG000|Overall Study|Lost to Follow-up|0|||
164321469|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
164321470|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
164321471|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
164321472|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
164321473|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
164321474|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
164321475|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
164321476|NCT00095147|593554174|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
164321477|NCT00095147|593554175|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
164321478|NCT00095147|593554176|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
164321479|NCT00095147|593554177|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
164321480|NCT00095147|593554178|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
164321481|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
164321482|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
164321483|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
163979020|NCT01187953|592293669|FG001|Overall Study|Lost to Follow-up|3|||
163979021|NCT01187953|592293668|FG000|Overall Study|Withdrawal by Subject|3|||
163979022|NCT01187953|592293669|FG001|Overall Study|Withdrawal by Subject|3|||
163979023|NCT01783678|592295291|FG000|Overall Study|Randomized but Not Treated|0|||
163979024|NCT01783678|592295292|FG001|Overall Study|Randomized but Not Treated|0|||
164321484|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
164321485|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
164321486|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
164321487|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
163979025|NCT01783678|592295293|FG002|Overall Study|Randomized but Not Treated|0|||
164321488|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
164321489|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
164321490|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
164321491|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
164321492|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
164321493|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
164207836|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
164207837|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
164207838|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
164207839|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
164207840|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
164321494|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
164321495|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
164321496|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
164321497|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
164321498|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
164321499|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
164321500|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
164321501|NCT00095147|593554174|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
164321502|NCT00095147|593554175|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
164321503|NCT00095147|593554176|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
164321504|NCT00095147|593554177|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
164321505|NCT00095147|593554178|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
164321506|NCT00095147|593554174|FG000|Long-term Extension Period|Death|0|||
164321507|NCT00095147|593554175|FG001|Long-term Extension Period|Death|0|||
164321508|NCT00095147|593554176|FG002|Long-term Extension Period|Death|0|||
164321509|NCT00095147|593554177|FG003|Long-term Extension Period|Death|0|||
164321510|NCT00095147|593554178|FG004|Long-term Extension Period|Death|3|||
164321511|NCT00095147|593554174|FG000|Long-term Extension Period|Adverse Event|0|||
164321512|NCT00095147|593554175|FG001|Long-term Extension Period|Adverse Event|0|||
164321513|NCT00095147|593554176|FG002|Long-term Extension Period|Adverse Event|0|||
164321514|NCT00095147|593554177|FG003|Long-term Extension Period|Adverse Event|0|||
164321515|NCT00095147|593554178|FG004|Long-term Extension Period|Adverse Event|11|||
164321516|NCT00095147|593554174|FG000|Long-term Extension Period|Lack of Efficacy|0|||
164321517|NCT00095147|593554175|FG001|Long-term Extension Period|Lack of Efficacy|0|||
163874972|NCT00068601|591909854|FG001|Overall Study|Not evaluable: withdrew consent|4|||
163874973|NCT00068601|591909853|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
163874974|NCT00068601|591909854|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
163874975|NCT00068601|591909853|FG000|Overall Study|Death|11|||
163874976|NCT00068601|591909854|FG001|Overall Study|Death|3|||
163874977|NCT00068601|591909853|FG000|Overall Study|Lost to Follow-up|3|||
163874978|NCT00068601|591909854|FG001|Overall Study|Lost to Follow-up|2|||
163874979|NCT00068601|591909853|FG000|Overall Study|Missing primary outcome data|30|||
164207841|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
164207842|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
164207843|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
164207844|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
164207845|NCT02421939|593129907|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
164207846|NCT02421939|593129908|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
164207847|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
164207848|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
164207849|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
164207850|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
164207851|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Death|118|||
164207852|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Death|65|||
164207853|NCT02421939|593129907|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
164207854|NCT02421939|593129908|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
163874980|NCT00068601|591909854|FG001|Overall Study|Missing primary outcome data|34|||
163874981|NCT01061671|591909855|FG000|Overall Study|Withdrawal by Subject|16|||
163874982|NCT01061671|591909856|FG001|Overall Study|Withdrawal by Subject|20|||
163874983|NCT01061671|591909855|FG000|Overall Study|Lost to Follow-up|3|||
163874984|NCT01061671|591909856|FG001|Overall Study|Lost to Follow-up|5|||
163874985|NCT01061671|591909855|FG000|Overall Study|Death|28|||
163874986|NCT01061671|591909856|FG001|Overall Study|Death|30|||
163874987|NCT02468128|591909857|FG000|Overall Study|Protocol Violation|6|||
163874988|NCT02468128|591909858|FG001|Overall Study|Protocol Violation|6|||
163874989|NCT00440011|591909859|FG000|Overall Study|Adverse Event|2|||
163874990|NCT00440011|591909860|FG001|Overall Study|Adverse Event|0|||
164207855|NCT00671788|593129909|FG000|Overall Study|Adverse Event|8|||
164321518|NCT00095147|593554176|FG002|Long-term Extension Period|Lack of Efficacy|0|||
163979026|NCT01783678|592295294|FG003|Overall Study|Randomized but Not Treated|1|||
163979027|NCT01783678|592295295|FG004|Overall Study|Randomized but Not Treated|0|||
163979028|NCT01783678|592295296|FG005|Overall Study|Randomized but Not Treated|0|||
163979029|NCT01783678|592295291|FG000|Overall Study|Lack of Efficacy|1|||
163979030|NCT01783678|592295292|FG001|Overall Study|Lack of Efficacy|13|||
163979031|NCT01783678|592295293|FG002|Overall Study|Lack of Efficacy|1|||
163979032|NCT01783678|592295294|FG003|Overall Study|Lack of Efficacy|3|||
163979033|NCT01783678|592295295|FG004|Overall Study|Lack of Efficacy|6|||
163979034|NCT01783678|592295296|FG005|Overall Study|Lack of Efficacy|5|||
163979035|NCT01783678|592295291|FG000|Overall Study|Lost to Follow-up|0|||
163979036|NCT01783678|592295292|FG001|Overall Study|Lost to Follow-up|4|||
163979037|NCT01783678|592295293|FG002|Overall Study|Lost to Follow-up|0|||
163979038|NCT01783678|592295294|FG003|Overall Study|Lost to Follow-up|2|||
163979039|NCT01783678|592295295|FG004|Overall Study|Lost to Follow-up|1|||
163979040|NCT01783678|592295296|FG005|Overall Study|Lost to Follow-up|0|||
163979041|NCT01783678|592295291|FG000|Overall Study|Withdrew Consent|1|||
163979042|NCT01783678|592295292|FG001|Overall Study|Withdrew Consent|1|||
163979043|NCT01783678|592295293|FG002|Overall Study|Withdrew Consent|0|||
163979044|NCT01783678|592295294|FG003|Overall Study|Withdrew Consent|2|||
163979045|NCT01783678|592295295|FG004|Overall Study|Withdrew Consent|0|||
163979046|NCT01783678|592295296|FG005|Overall Study|Withdrew Consent|0|||
163979047|NCT02404103|592295297|FG000|Overall Study|Adverse Event|1|||
163979048|NCT02404103|592295298|FG001|Overall Study|Adverse Event|0|||
163979049|NCT02404103|592295297|FG000|Overall Study|Lost to Follow-up|3|||
163979050|NCT02404103|592295298|FG001|Overall Study|Lost to Follow-up|3|||
163979051|NCT01408147|592295299|FG000|Overall Study|Withdrawal by Subject|0|||
163979052|NCT01408147|592295300|FG001|Overall Study|Withdrawal by Subject|1|||
163979053|NCT00621504|592295301|FG000|Overall Study|Adverse Event|1|||
163979054|NCT00621504|592295302|FG001|Overall Study|Adverse Event|3|||
163979055|NCT00621504|592295301|FG000|Overall Study|At the request of sponsor/investigator|1|||
163979056|NCT00621504|592295302|FG001|Overall Study|At the request of sponsor/investigator|0|||
163979057|NCT00621504|592295301|FG000|Overall Study|Withdrew consent|9|||
163979058|NCT00621504|592295302|FG001|Overall Study|Withdrew consent|6|||
163979059|NCT00621504|592295301|FG000|Overall Study|Lost to Follow-up|8|||
163979060|NCT00621504|592295302|FG001|Overall Study|Lost to Follow-up|10|||
163979061|NCT00621504|592295301|FG000|Overall Study|Other|1|||
163979062|NCT00621504|592295302|FG001|Overall Study|Other|0|||
163979063|NCT00621504|592295301|FG000|Overall Study|Death|6|||
163979064|NCT00621504|592295302|FG001|Overall Study|Death|6|||
163979065|NCT03311711|592295305|FG000|Overall Study|Death|1|||
163979066|NCT03311711|592295306|FG001|Overall Study|Death|0|||
163979067|NCT03311711|592295307|FG002|Overall Study|Death|0|||
163979068|NCT03311711|592295308|FG003|Overall Study|Death|0|||
163979069|NCT03311711|592295309|FG004|Overall Study|Death|0|||
163979070|NCT03311711|592295310|FG005|Overall Study|Death|0|||
163979071|NCT03311711|592295311|FG006|Overall Study|Death|1|||
163979072|NCT03311711|592295312|FG007|Overall Study|Death|0|||
163979073|NCT03311711|592295313|FG008|Overall Study|Death|1|||
163979074|NCT03311711|592295314|FG009|Overall Study|Death|0|||
163979075|NCT03311711|592295305|FG000|Overall Study|Death of dyad partner|0|||
163979076|NCT03311711|592295306|FG001|Overall Study|Death of dyad partner|1|||
163979077|NCT03311711|592295307|FG002|Overall Study|Death of dyad partner|0|||
163979078|NCT03311711|592295308|FG003|Overall Study|Death of dyad partner|0|||
163979079|NCT03311711|592295309|FG004|Overall Study|Death of dyad partner|0|||
163979080|NCT03311711|592295310|FG005|Overall Study|Death of dyad partner|0|||
163979081|NCT03311711|592295311|FG006|Overall Study|Death of dyad partner|0|||
163874991|NCT00440011|591909859|FG000|Overall Study|Lost to Follow-up|0|||
163874992|NCT00440011|591909860|FG001|Overall Study|Lost to Follow-up|2|||
163874993|NCT00440011|591909859|FG000|Overall Study|Protocol Violation|1|||
163874994|NCT00440011|591909860|FG001|Overall Study|Protocol Violation|1|||
163874995|NCT00440011|591909859|FG000|Overall Study|Withdrawal by Subject|1|||
163874996|NCT00440011|591909860|FG001|Overall Study|Withdrawal by Subject|0|||
163874997|NCT00419341|591909866|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
163874998|NCT00419341|591909866|FG000|Wash in/Wash Out Period|Adverse Event|2|||
163874999|NCT00419341|591909866|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
163875000|NCT00419341|591909866|FG000|Efficacy Period|Withdrawal by Subject|6|||
163875001|NCT00419341|591909866|FG000|Efficacy Period|Protocol Violation|1|||
163979082|NCT03311711|592295312|FG007|Overall Study|Death of dyad partner|1|||
163979083|NCT03311711|592295313|FG008|Overall Study|Death of dyad partner|0|||
163979084|NCT03311711|592295314|FG009|Overall Study|Death of dyad partner|1|||
163875002|NCT00419341|591909866|FG000|Efficacy Period|Lost to Follow-up|1|||
163979085|NCT03311711|592295305|FG000|Overall Study|Lost to Follow-up|2|||
163979086|NCT03311711|592295306|FG001|Overall Study|Lost to Follow-up|2|||
163979087|NCT03311711|592295307|FG002|Overall Study|Lost to Follow-up|0|||
163979088|NCT03311711|592295308|FG003|Overall Study|Lost to Follow-up|0|||
163979089|NCT03311711|592295309|FG004|Overall Study|Lost to Follow-up|0|||
163979090|NCT03311711|592295310|FG005|Overall Study|Lost to Follow-up|0|||
163979091|NCT03311711|592295311|FG006|Overall Study|Lost to Follow-up|1|||
163979092|NCT03311711|592295312|FG007|Overall Study|Lost to Follow-up|1|||
163979093|NCT03311711|592295313|FG008|Overall Study|Lost to Follow-up|0|||
163979094|NCT03311711|592295314|FG009|Overall Study|Lost to Follow-up|0|||
163979095|NCT03311711|592295305|FG000|Overall Study|Withdrawal by Subject|1|||
163979096|NCT03311711|592295306|FG001|Overall Study|Withdrawal by Subject|1|||
163979097|NCT03311711|592295307|FG002|Overall Study|Withdrawal by Subject|0|||
163979098|NCT03311711|592295308|FG003|Overall Study|Withdrawal by Subject|0|||
163979099|NCT03311711|592295309|FG004|Overall Study|Withdrawal by Subject|0|||
163979100|NCT03311711|592295310|FG005|Overall Study|Withdrawal by Subject|0|||
163979101|NCT03311711|592295311|FG006|Overall Study|Withdrawal by Subject|3|||
163979102|NCT03311711|592295312|FG007|Overall Study|Withdrawal by Subject|3|||
163979103|NCT03311711|592295313|FG008|Overall Study|Withdrawal by Subject|0|||
163979104|NCT03311711|592295314|FG009|Overall Study|Withdrawal by Subject|0|||
163979105|NCT02229552|592295315|FG000|Baseline|Withdrawal by Subject|6|||
163979106|NCT02229552|592295315|FG000|1-year Follow up|Withdrawal by Subject|7|||
163979107|NCT02229552|592295315|FG000|1-year Follow up|Lost to Follow-up|18|||
163979108|NCT02229552|592295315|FG000|2-Year Follow up|Withdrawal by Subject|9|||
163979109|NCT02229552|592295315|FG000|2-Year Follow up|Lost to Follow-up|17|||
163979110|NCT00706134|592295320|FG000|Overall Study|Adverse Event|8|||
163979111|NCT00706134|592295321|FG001|Overall Study|Adverse Event|7|||
163979112|NCT00706134|592295322|FG002|Overall Study|Adverse Event|2|||
163979113|NCT00706134|592295323|FG003|Overall Study|Adverse Event|3|||
163979114|NCT00706134|592295320|FG000|Overall Study|Lost to Follow-up|0|||
163979115|NCT00706134|592295321|FG001|Overall Study|Lost to Follow-up|1|||
163979116|NCT00706134|592295322|FG002|Overall Study|Lost to Follow-up|0|||
163979117|NCT00706134|592295323|FG003|Overall Study|Lost to Follow-up|0|||
163979118|NCT00706134|592295320|FG000|Overall Study|Protocol Violation|0|||
163979119|NCT00706134|592295321|FG001|Overall Study|Protocol Violation|6|||
163979120|NCT00706134|592295322|FG002|Overall Study|Protocol Violation|0|||
163979121|NCT00706134|592295323|FG003|Overall Study|Protocol Violation|3|||
163979122|NCT00706134|592295320|FG000|Overall Study|Withdrawal by Subject|1|||
163979123|NCT00706134|592295321|FG001|Overall Study|Withdrawal by Subject|2|||
163979124|NCT00706134|592295322|FG002|Overall Study|Withdrawal by Subject|1|||
163979125|NCT00706134|592295323|FG003|Overall Study|Withdrawal by Subject|0|||
163979126|NCT00706134|592295320|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
163979127|NCT00706134|592295321|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163979128|NCT00706134|592295322|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
163979129|NCT00706134|592295323|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
163979130|NCT00706134|592295320|FG000|Overall Study|Did not meet study criteria|2|||
163979131|NCT00706134|592295321|FG001|Overall Study|Did not meet study criteria|0|||
163979132|NCT00706134|592295322|FG002|Overall Study|Did not meet study criteria|0|||
163979133|NCT00706134|592295323|FG003|Overall Study|Did not meet study criteria|0|||
163979134|NCT00772954|592295335|FG000|Overall Study|Adverse Event|0|||
163979135|NCT00772954|592295336|FG001|Overall Study|Adverse Event|0|||
163979136|NCT00772954|592295337|FG002|Overall Study|Adverse Event|1|||
163979137|NCT01661140|592295342|FG000|Open-Label Period|Adverse Event|44|||
163979138|NCT01661140|592295343|FG001|Open-Label Period|Adverse Event|0|||
163979139|NCT01661140|592295344|FG002|Open-Label Period|Adverse Event|0|||
163979140|NCT01661140|592295342|FG000|Open-Label Period|Protocol Violation|3|||
163979141|NCT01661140|592295343|FG001|Open-Label Period|Protocol Violation|0|||
163979142|NCT01661140|592295344|FG002|Open-Label Period|Protocol Violation|0|||
163979143|NCT01661140|592295342|FG000|Open-Label Period|Withdrawal by Subject|5|||
163979144|NCT01661140|592295343|FG001|Open-Label Period|Withdrawal by Subject|0|||
163979145|NCT01661140|592295344|FG002|Open-Label Period|Withdrawal by Subject|0|||
163979146|NCT01661140|592295342|FG000|Open-Label Period|Investigator Decision|3|||
163979147|NCT01661140|592295343|FG001|Open-Label Period|Investigator Decision|0|||
163979148|NCT01661140|592295344|FG002|Open-Label Period|Investigator Decision|0|||
163979149|NCT01661140|592295342|FG000|Open-Label Period|Death|1|||
163979150|NCT01661140|592295343|FG001|Open-Label Period|Death|0|||
163979151|NCT01661140|592295344|FG002|Open-Label Period|Death|0|||
163979152|NCT01661140|592295342|FG000|Open-Label Period|Administrative/Other|1|||
163979153|NCT01661140|592295343|FG001|Open-Label Period|Administrative/Other|0|||
163979154|NCT01661140|592295344|FG002|Open-Label Period|Administrative/Other|0|||
163979155|NCT01661140|592295342|FG000|Open-Label Period|Sponsor termination|16|||
163979156|NCT01661140|592295343|FG001|Open-Label Period|Sponsor termination|0|||
163979157|NCT01661140|592295344|FG002|Open-Label Period|Sponsor termination|0|||
163979158|NCT01661140|592295342|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
163979159|NCT01661140|592295343|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
163979160|NCT01661140|592295344|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
163979161|NCT01661140|592295342|FG000|Open-Label Period|Lost to Follow-up|2|||
163979162|NCT01661140|592295343|FG001|Open-Label Period|Lost to Follow-up|0|||
163979163|NCT01661140|592295344|FG002|Open-Label Period|Lost to Follow-up|0|||
163979164|NCT01661140|592295342|FG000|Double-Blind Period|Refused Treatment|0|||
163979165|NCT01661140|592295343|FG001|Double-Blind Period|Refused Treatment|0|||
163979166|NCT01661140|592295344|FG002|Double-Blind Period|Refused Treatment|1|||
163979167|NCT01661140|592295342|FG000|Double-Blind Period|Adverse Event|0|||
163979168|NCT01661140|592295343|FG001|Double-Blind Period|Adverse Event|16|||
163979169|NCT01661140|592295344|FG002|Double-Blind Period|Adverse Event|18|||
164207856|NCT00671788|593129909|FG000|Overall Study|Refused further treatment|3|||
163979170|NCT01661140|592295342|FG000|Double-Blind Period|Protocol Violation|0|||
163979171|NCT01661140|592295343|FG001|Double-Blind Period|Protocol Violation|2|||
163979172|NCT01661140|592295344|FG002|Double-Blind Period|Protocol Violation|3|||
163979173|NCT01661140|592295342|FG000|Double-Blind Period|Withdrawal by Subject|0|||
163979174|NCT01661140|592295343|FG001|Double-Blind Period|Withdrawal by Subject|1|||
163979175|NCT01661140|592295344|FG002|Double-Blind Period|Withdrawal by Subject|3|||
163979176|NCT01661140|592295342|FG000|Double-Blind Period|Investigator's Decision|0|||
163979177|NCT01661140|592295343|FG001|Double-Blind Period|Investigator's Decision|1|||
163979178|NCT01661140|592295344|FG002|Double-Blind Period|Investigator's Decision|2|||
163979179|NCT01661140|592295342|FG000|Double-Blind Period|Sponsor Termination|0|||
163979180|NCT01661140|592295343|FG001|Double-Blind Period|Sponsor Termination|14|||
163979181|NCT01661140|592295344|FG002|Double-Blind Period|Sponsor Termination|17|||
163979182|NCT01661140|592295342|FG000|Double-Blind Period|Administrative/Other|0|||
163979183|NCT01661140|592295343|FG001|Double-Blind Period|Administrative/Other|7|||
163979184|NCT01661140|592295344|FG002|Double-Blind Period|Administrative/Other|6|||
163979185|NCT01391000|592295345|FG000|Overall Study|Lost to Follow-up|2|||
163979186|NCT01391000|592295346|FG001|Overall Study|Lost to Follow-up|0|||
163979187|NCT03860961|592295347|FG000|Overall Study|Withdrawal by Subject|6|||
163979188|NCT03860961|592295348|FG001|Overall Study|Withdrawal by Subject|11|||
163979189|NCT03860961|592295347|FG000|Overall Study|Death|10|||
163979190|NCT03860961|592295348|FG001|Overall Study|Death|6|||
163979191|NCT03860961|592295347|FG000|Overall Study|Incomplete two-year data|4|||
163979192|NCT03860961|592295348|FG001|Overall Study|Incomplete two-year data|0|||
163979193|NCT02239939|592295349|FG000|Overall Study|Adverse Event|1|||
163979194|NCT02239939|592295350|FG001|Overall Study|Adverse Event|0|||
163979195|NCT02239939|592295349|FG000|Overall Study|Withdrawal by Subject|1|||
163979196|NCT02239939|592295350|FG001|Overall Study|Withdrawal by Subject|1|||
163979197|NCT02239939|592295349|FG000|Overall Study|Lost to Follow-up|0|||
163979198|NCT02239939|592295350|FG001|Overall Study|Lost to Follow-up|1|||
163979199|NCT01659320|592295351|FG000|Overall Study|Withdrawal by Subject|2|||
163979200|NCT01659320|592295351|FG000|Overall Study|Physician Decision|1|||
163979201|NCT00590590|592295352|FG000|Overall Study|Lack of Efficacy|1|||
163979202|NCT00590590|592295353|FG001|Overall Study|Lack of Efficacy|2|||
163979203|NCT00590590|592295354|FG002|Overall Study|Lack of Efficacy|0|||
163979204|NCT00590590|592295352|FG000|Overall Study|Adverse Event|1|||
163979205|NCT00590590|592295353|FG001|Overall Study|Adverse Event|0|||
163979206|NCT00590590|592295354|FG002|Overall Study|Adverse Event|0|||
163979207|NCT00590590|592295352|FG000|Overall Study|Protocol Violation|0|||
163979208|NCT00590590|592295353|FG001|Overall Study|Protocol Violation|0|||
163979209|NCT00590590|592295354|FG002|Overall Study|Protocol Violation|2|||
163979210|NCT00590590|592295352|FG000|Overall Study|Lost to Follow-up|4|||
163979211|NCT00590590|592295353|FG001|Overall Study|Lost to Follow-up|1|||
163979212|NCT00590590|592295354|FG002|Overall Study|Lost to Follow-up|2|||
163979213|NCT00590590|592295352|FG000|Overall Study|Withdrawal by Subject|0|||
163979214|NCT00590590|592295353|FG001|Overall Study|Withdrawal by Subject|1|||
163979215|NCT00590590|592295354|FG002|Overall Study|Withdrawal by Subject|1|||
163979216|NCT00590590|592295352|FG000|Overall Study|Did not complete due to study closure|1|||
163979217|NCT00590590|592295353|FG001|Overall Study|Did not complete due to study closure|1|||
163979218|NCT00590590|592295354|FG002|Overall Study|Did not complete due to study closure|1|||
163979219|NCT00590590|592295352|FG000|Overall Study|Did not complete study|0|||
163979220|NCT00590590|592295353|FG001|Overall Study|Did not complete study|1|||
163979221|NCT00590590|592295354|FG002|Overall Study|Did not complete study|0|||
163979222|NCT00272038|592295356|FG000|Overall Study|withdrew before they received 2 cycles|7|||
163979223|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
163979224|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
163979225|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
163979226|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
163979227|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
163979228|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
163979229|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
163979230|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
163979231|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
163979232|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
163979233|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
163979234|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
163979235|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
163979236|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
163979237|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
163979238|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
163979239|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
163979240|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
163979241|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
163979242|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
163979243|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
163979244|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
163979245|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
163979246|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
163979247|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
163979248|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
163979249|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
163979250|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
163979251|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
163979252|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
163979253|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
163979254|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
163979255|NCT03605680|592295357|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
163979256|NCT03605680|592295358|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
163979257|NCT03605680|592295359|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
163979258|NCT03605680|592295360|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
163979259|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
163979260|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
163979261|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
163979262|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
163979263|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
163979264|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
163979265|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
163979266|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
163979267|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164321519|NCT00095147|593554177|FG003|Long-term Extension Period|Lack of Efficacy|0|||
164321520|NCT00095147|593554178|FG004|Long-term Extension Period|Lack of Efficacy|9|||
164321521|NCT00095147|593554174|FG000|Long-term Extension Period|Lost to Follow-up|0|||
163979268|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163979269|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
163979270|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
163979271|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
163979272|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163979273|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
163979274|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
163979275|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
163979276|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
163979277|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
163979278|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
163979279|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
163979280|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
163979281|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
163979282|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
163979283|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
163979284|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163979285|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
163979286|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
163979287|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
163979288|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
163979289|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
163979290|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
163979291|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
163979292|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
163979293|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
163979294|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
163979295|NCT03605680|592295357|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
163979296|NCT03605680|592295358|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
164076537|NCT01244815|592645747|FG002|Overall Study|Treatment Failure|0|||
164321522|NCT00095147|593554175|FG001|Long-term Extension Period|Lost to Follow-up|0|||
164321523|NCT00095147|593554176|FG002|Long-term Extension Period|Lost to Follow-up|0|||
164321524|NCT00095147|593554177|FG003|Long-term Extension Period|Lost to Follow-up|0|||
164321525|NCT00095147|593554178|FG004|Long-term Extension Period|Lost to Follow-up|6|||
163979297|NCT03605680|592295359|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
163979298|NCT03605680|592295360|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
163979299|NCT03189446|592295361|FG000|Overall Study|Adverse Event|2|||
163979300|NCT03189446|592295361|FG000|Overall Study|Withdrawal by Subject|2|||
163979301|NCT03189446|592295361|FG000|Overall Study|Physician Decision|1|||
163979302|NCT05594173|592295362|FG000|Overall Study|Adverse Event|1|||
163979303|NCT05594173|592295362|FG000|Overall Study|COVID-19 Pandemic|2|||
163979304|NCT00883337|592295363|FG000|Core Treatment Period|Adverse Event|9|||
163979305|NCT00883337|592295364|FG001|Core Treatment Period|Adverse Event|12|||
163979306|NCT00883337|592295365|FG002|Core Treatment Period|Adverse Event|22|||
163979307|NCT00883337|592295363|FG000|Core Treatment Period|Lack of Efficacy|7|||
163979308|NCT00883337|592295364|FG001|Core Treatment Period|Lack of Efficacy|4|||
163979309|NCT00883337|592295365|FG002|Core Treatment Period|Lack of Efficacy|2|||
163979310|NCT00883337|592295363|FG000|Core Treatment Period|Lost to Follow-up|1|||
163979311|NCT00883337|592295364|FG001|Core Treatment Period|Lost to Follow-up|1|||
163979312|NCT00883337|592295365|FG002|Core Treatment Period|Lost to Follow-up|0|||
163979313|NCT00883337|592295363|FG000|Core Treatment Period|Withdrawal by Subject|2|||
163979314|NCT00883337|592295364|FG001|Core Treatment Period|Withdrawal by Subject|2|||
163979315|NCT00883337|592295365|FG002|Core Treatment Period|Withdrawal by Subject|6|||
163979316|NCT00883337|592295363|FG000|Core Treatment Period|Wish to be pregnant|1|||
163979317|NCT00883337|592295364|FG001|Core Treatment Period|Wish to be pregnant|2|||
163979318|NCT00883337|592295365|FG002|Core Treatment Period|Wish to be pregnant|1|||
163979319|NCT00883337|592295363|FG000|Core Treatment Period|Poor compliance to protocol|0|||
163979320|NCT00883337|592295364|FG001|Core Treatment Period|Poor compliance to protocol|0|||
163979321|NCT00883337|592295365|FG002|Core Treatment Period|Poor compliance to protocol|1|||
163979322|NCT00883337|592295363|FG000|Core Treatment Period|Other than above|0|||
163979323|NCT00883337|592295364|FG001|Core Treatment Period|Other than above|1|||
163979324|NCT00883337|592295365|FG002|Core Treatment Period|Other than above|1|||
163979325|NCT00883337|592295363|FG000|Extension Treatment Period|Adverse Event|8|||
163979326|NCT00883337|592295364|FG001|Extension Treatment Period|Adverse Event|5|||
163979327|NCT00883337|592295365|FG002|Extension Treatment Period|Adverse Event|5|||
163979328|NCT00883337|592295363|FG000|Extension Treatment Period|Lack of Efficacy|8|||
163979329|NCT00883337|592295364|FG001|Extension Treatment Period|Lack of Efficacy|8|||
163979330|NCT00883337|592295365|FG002|Extension Treatment Period|Lack of Efficacy|8|||
163979331|NCT00883337|592295363|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
163979332|NCT00883337|592295364|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
163979333|NCT00883337|592295365|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
163979334|NCT00883337|592295363|FG000|Extension Treatment Period|Lost to Follow-up|1|||
163979335|NCT00883337|592295364|FG001|Extension Treatment Period|Lost to Follow-up|0|||
163979336|NCT00883337|592295365|FG002|Extension Treatment Period|Lost to Follow-up|0|||
163979337|NCT00883337|592295363|FG000|Extension Treatment Period|Other than above|10|||
163979338|NCT00883337|592295364|FG001|Extension Treatment Period|Other than above|9|||
163979339|NCT00883337|592295365|FG002|Extension Treatment Period|Other than above|5|||
163979340|NCT00763139|592295366|FG000|Overall Study|Adverse Event|4|||
163979341|NCT00763139|592295367|FG001|Overall Study|Adverse Event|2|||
163979342|NCT00763139|592295366|FG000|Overall Study|Withdrawal by Subject|0|||
163979343|NCT00763139|592295367|FG001|Overall Study|Withdrawal by Subject|1|||
163979344|NCT00763139|592295366|FG000|Overall Study|med change not allowed by protocol|1|||
163979345|NCT00763139|592295367|FG001|Overall Study|med change not allowed by protocol|0|||
163979346|NCT05634577|592295368|FG000|Overall Study|Lost to Follow-up|1|||
163979347|NCT05634577|592295368|FG000|Overall Study|Withdrawal by Subject|1|||
163979348|NCT03468309|592295369|FG000|Overall Study|Lost to Follow-up|4|||
163979349|NCT03468309|592295369|FG000|Overall Study|Withdrawal by Subject|2|||
163979350|NCT03865706|592295373|FG000|Overall Study|Death|0|||
163979351|NCT03865706|592295374|FG001|Overall Study|Death|3|||
163979352|NCT03865706|592295375|FG002|Overall Study|Death|1|||
163979353|NCT02095535|592295376|FG000|Recruitment|Protocol Violation|2|||
163979354|NCT02631200|592295379|FG000|First Period|Death|1|||
163979355|NCT02631200|592295380|FG001|First Period|Death|2|||
163979356|NCT02631200|592295379|FG000|First Period|Patient ill-health|2|||
163979357|NCT02631200|592295380|FG001|First Period|Patient ill-health|4|||
163979358|NCT02631200|592295379|FG000|First Period|Withdrawal by Subject|4|||
163979359|NCT02631200|592295380|FG001|First Period|Withdrawal by Subject|1|||
163979360|NCT02631200|592295379|FG000|Deferred Period|Death|0|||
163979361|NCT02631200|592295380|FG001|Deferred Period|Death|1|||
164076538|NCT01244815|592645748|FG003|Overall Study|Treatment Failure|1|||
163979362|NCT02631200|592295379|FG000|Deferred Period|Received kidney transplant|0|||
163979363|NCT02631200|592295380|FG001|Deferred Period|Received kidney transplant|1|||
163979364|NCT02631200|592295379|FG000|Deferred Period|Withdrawal by Subject|0|||
163979365|NCT02631200|592295380|FG001|Deferred Period|Withdrawal by Subject|2|||
163979366|NCT02631200|592295379|FG000|Deferred Period|Lost to Follow-up|0|||
163979367|NCT02631200|592295380|FG001|Deferred Period|Lost to Follow-up|1|||
163979368|NCT01877187|592295382|FG000|Overall Study|Death|2|||
163979369|NCT01877187|592295382|FG000|Overall Study|Withdrawal by Subject|4|||
163979370|NCT01877187|592295382|FG000|Overall Study|Lost to Follow-up|3|||
163979371|NCT01877187|592295382|FG000|Overall Study|Declining clinical status|11|||
163979372|NCT01877187|592295382|FG000|Overall Study|Liver transplant|2|||
163979373|NCT02669017|592295384|FG000|Overall Study|Death|1|||
163979374|NCT02669017|592295385|FG001|Overall Study|Death|2|||
163979375|NCT02669017|592295386|FG002|Overall Study|Death|2|||
163979376|NCT02669017|592295387|FG003|Overall Study|Death|3|||
163979377|NCT02669017|592295388|FG004|Overall Study|Death|8|||
163979378|NCT02669017|592295389|FG005|Overall Study|Death|18|||
163979379|NCT02669017|592295390|FG006|Overall Study|Death|10|||
163979380|NCT02669017|592295391|FG007|Overall Study|Death|47|||
163979381|NCT02669017|592295392|FG008|Overall Study|Death|20|||
163979382|NCT02669017|592295384|FG000|Overall Study|Withdrawal by Subject|0|||
163979383|NCT02669017|592295385|FG001|Overall Study|Withdrawal by Subject|0|||
163979384|NCT02669017|592295386|FG002|Overall Study|Withdrawal by Subject|0|||
163979385|NCT02669017|592295387|FG003|Overall Study|Withdrawal by Subject|1|||
163979386|NCT02669017|592295388|FG004|Overall Study|Withdrawal by Subject|2|||
163979387|NCT02669017|592295389|FG005|Overall Study|Withdrawal by Subject|0|||
163979388|NCT02669017|592295390|FG006|Overall Study|Withdrawal by Subject|0|||
163979389|NCT02669017|592295391|FG007|Overall Study|Withdrawal by Subject|2|||
163979390|NCT02669017|592295392|FG008|Overall Study|Withdrawal by Subject|2|||
163979391|NCT02669017|592295384|FG000|Overall Study|Lost to Follow-up|0|||
163979392|NCT02669017|592295385|FG001|Overall Study|Lost to Follow-up|0|||
163979393|NCT02669017|592295386|FG002|Overall Study|Lost to Follow-up|0|||
163979394|NCT02669017|592295387|FG003|Overall Study|Lost to Follow-up|0|||
163979395|NCT02669017|592295388|FG004|Overall Study|Lost to Follow-up|0|||
163979396|NCT02669017|592295389|FG005|Overall Study|Lost to Follow-up|0|||
163979397|NCT02669017|592295390|FG006|Overall Study|Lost to Follow-up|0|||
163979398|NCT02669017|592295391|FG007|Overall Study|Lost to Follow-up|0|||
163979399|NCT02669017|592295392|FG008|Overall Study|Lost to Follow-up|1|||
163979400|NCT02669017|592295384|FG000|Overall Study|Miscellaneous|0|||
163979401|NCT02669017|592295385|FG001|Overall Study|Miscellaneous|0|||
163979402|NCT02669017|592295386|FG002|Overall Study|Miscellaneous|0|||
163979403|NCT02669017|592295387|FG003|Overall Study|Miscellaneous|0|||
163979404|NCT02669017|592295388|FG004|Overall Study|Miscellaneous|2|||
163979405|NCT02669017|592295389|FG005|Overall Study|Miscellaneous|1|||
163979406|NCT02669017|592295390|FG006|Overall Study|Miscellaneous|1|||
163979407|NCT02669017|592295391|FG007|Overall Study|Miscellaneous|13|||
163979408|NCT02669017|592295392|FG008|Overall Study|Miscellaneous|2|||
163979409|NCT04091087|592295393|FG000|Overall Study|Not treated|1|||
163979410|NCT04091087|592295394|FG001|Overall Study|Not treated|0|||
163979411|NCT04091087|592295393|FG000|Overall Study|Adverse Event|4|||
163979412|NCT04091087|592295394|FG001|Overall Study|Adverse Event|4|||
163979413|NCT04091087|592295393|FG000|Overall Study|Protocol Violation|0|||
163979414|NCT04091087|592295394|FG001|Overall Study|Protocol Violation|1|||
163979415|NCT04091087|592295393|FG000|Overall Study|Withdrawal by Subject|5|||
163979416|NCT04091087|592295394|FG001|Overall Study|Withdrawal by Subject|2|||
163979417|NCT04152161|592295395|FG000|Overall Study|Death|0|||
163979418|NCT04152161|592295396|FG001|Overall Study|Death|1|||
163979419|NCT04152161|592295395|FG000|Overall Study|Physician Decision|0|||
163979420|NCT04152161|592295396|FG001|Overall Study|Physician Decision|1|||
163979421|NCT04152161|592295395|FG000|Overall Study|Lost to Follow-up|9|||
163979422|NCT04152161|592295396|FG001|Overall Study|Lost to Follow-up|3|||
163979423|NCT04152161|592295395|FG000|Overall Study|Protocol Violation|1|||
163979424|NCT04152161|592295396|FG001|Overall Study|Protocol Violation|0|||
163979425|NCT04152161|592295395|FG000|Overall Study|Withdrawal by Subject|29|||
163979426|NCT04152161|592295396|FG001|Overall Study|Withdrawal by Subject|28|||
163979427|NCT04152161|592295395|FG000|Overall Study|Sponsor termination of study|750|||
163979428|NCT04152161|592295396|FG001|Overall Study|Sponsor termination of study|755|||
163979429|NCT04152161|592295395|FG000|Overall Study|Other|20|||
163979430|NCT04152161|592295396|FG001|Overall Study|Other|18|||
163979431|NCT03363321|592295398|FG000|Overall Study|Withdrawal by Subject|0|||
163979432|NCT03363321|592295399|FG001|Overall Study|Withdrawal by Subject|1|||
163979433|NCT03363321|592295400|FG002|Overall Study|Withdrawal by Subject|0|||
163979434|NCT03363321|592295401|FG003|Overall Study|Withdrawal by Subject|1|||
163979435|NCT03363321|592295402|FG004|Overall Study|Withdrawal by Subject|0|||
163979436|NCT00915681|592295403|FG000|Overall Study|Screening failures|46|||
163979437|NCT02590588|592295410|FG000|Overall Study|Adverse Event|1|||
163979438|NCT01098071|592295414|FG000|Overall Study|Surgery (adenoidectomy)|2|||
163979439|NCT01098071|592295414|FG000|Overall Study|Lost to Follow-up|13|||
164321526|NCT00095147|593554174|FG000|Long-term Extension Period|Withdrawal of consent|0|||
163979440|NCT00382993|592295419|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
164076539|NCT01244815|592645745|FG000|Overall Study|Lost to Follow-up|3|||
163979441|NCT00382993|592295420|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
163979442|NCT00382993|592295419|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
163979443|NCT00382993|592295420|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
163979444|NCT00382993|592295419|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
163979445|NCT00382993|592295420|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
163979446|NCT00382993|592295419|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
163979447|NCT00382993|592295420|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
163979448|NCT00382993|592295419|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
163979449|NCT00382993|592295420|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
163979450|NCT00382993|592295419|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
163979451|NCT00382993|592295420|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
163979452|NCT00382993|592295419|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
163979453|NCT00382993|592295420|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
163979454|NCT00382993|592295419|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
163979455|NCT00382993|592295420|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
163979456|NCT00382993|592295419|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
163979457|NCT00382993|592295420|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
163979458|NCT00382993|592295419|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
163979459|NCT00382993|592295420|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
163979460|NCT01965262|592295438|FG000|Second Intervention (7 Days)|Discontinued|0|||
163979461|NCT01965262|592295439|FG001|Second Intervention (7 Days)|Discontinued|1|||
163979462|NCT01965262|592295438|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
163979463|NCT01965262|592295439|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
163979464|NCT01965262|592295438|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
163979465|NCT01965262|592295439|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
163979466|NCT00906087|592295445|FG000|Initial Washout|Withdrawal by Subject|1|||
163979467|NCT00906087|592295445|FG000|Initial Washout|Physician Decision|1|||
163979468|NCT00440947|592295446|FG000|36-Week Induction Phase|Adverse Event|16|||
163979469|NCT00440947|592295447|FG001|36-Week Induction Phase|Adverse Event|0|||
163979470|NCT00440947|592295448|FG002|36-Week Induction Phase|Adverse Event|0|||
163979471|NCT00440947|592295449|FG003|36-Week Induction Phase|Adverse Event|0|||
163979472|NCT00440947|592295450|FG004|36-Week Induction Phase|Adverse Event|0|||
163979473|NCT00440947|592295446|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
163979474|NCT00440947|592295447|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163979475|NCT00440947|592295448|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163979476|NCT00440947|592295449|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163979477|NCT00440947|592295450|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
163979478|NCT00440947|592295446|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
163979479|NCT00440947|592295447|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163979480|NCT00440947|592295448|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163979481|NCT00440947|592295449|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163979482|NCT00440947|592295450|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
163979483|NCT00440947|592295446|FG000|36-Week Induction Phase|Non-compliance|10|||
163979484|NCT00440947|592295447|FG001|36-Week Induction Phase|Non-compliance|0|||
163979485|NCT00440947|592295448|FG002|36-Week Induction Phase|Non-compliance|0|||
163979486|NCT00440947|592295449|FG003|36-Week Induction Phase|Non-compliance|0|||
163979487|NCT00440947|592295450|FG004|36-Week Induction Phase|Non-compliance|0|||
163979488|NCT00440947|592295446|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
163979489|NCT00440947|592295447|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
163979490|NCT00440947|592295448|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
163979491|NCT00440947|592295449|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
163979492|NCT00440947|592295450|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
163979493|NCT00440947|592295446|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
163979494|NCT00440947|592295447|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
163979495|NCT00440947|592295448|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
163979496|NCT00440947|592295449|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
163979497|NCT00440947|592295450|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
163979498|NCT00440947|592295446|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
163979499|NCT00440947|592295447|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163979500|NCT00440947|592295448|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163979501|NCT00440947|592295449|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163979502|NCT00440947|592295450|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
163979503|NCT00440947|592295446|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
163979504|NCT00440947|592295447|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
163979505|NCT00440947|592295448|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
163979506|NCT00440947|592295449|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
163979507|NCT00440947|592295450|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
163979508|NCT00440947|592295446|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
163979509|NCT00440947|592295447|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163979510|NCT00440947|592295448|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163979511|NCT00440947|592295449|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163979512|NCT00440947|592295450|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
163979513|NCT00440947|592295446|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
164207857|NCT00671788|593129909|FG000|Overall Study|Ineligible|1|||
164207858|NCT00671788|593129909|FG000|Overall Study|MD Decision|1|||
164207859|NCT00671788|593129909|FG000|Overall Study|Other|1|||
164207860|NCT02966834|593129910|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207861|NCT02966834|593129911|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207862|NCT02966834|593129912|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207863|NCT02966834|593129913|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207864|NCT02966834|593129914|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
164207865|NCT02966834|593129915|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
164207866|NCT02966834|593129910|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
164207867|NCT02966834|593129911|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207868|NCT02966834|593129912|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207869|NCT02966834|593129913|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207870|NCT02966834|593129914|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207871|NCT02966834|593129915|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164207872|NCT02966834|593129910|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
164207873|NCT02966834|593129911|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
164207874|NCT02966834|593129912|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
164207875|NCT02966834|593129913|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
164207876|NCT02966834|593129914|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
163979514|NCT00440947|592295447|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163979515|NCT00440947|592295448|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163979516|NCT00440947|592295449|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163979517|NCT00440947|592295450|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
163979518|NCT00440947|592295446|FG000|36-Week Induction Phase|Incarceration|3|||
163979519|NCT00440947|592295447|FG001|36-Week Induction Phase|Incarceration|0|||
163979520|NCT00440947|592295448|FG002|36-Week Induction Phase|Incarceration|0|||
163979521|NCT00440947|592295449|FG003|36-Week Induction Phase|Incarceration|0|||
163979522|NCT00440947|592295450|FG004|36-Week Induction Phase|Incarceration|0|||
163979523|NCT00440947|592295446|FG000|36-Week Induction Phase|Pregnancy|1|||
163979524|NCT00440947|592295447|FG001|36-Week Induction Phase|Pregnancy|0|||
163979525|NCT00440947|592295448|FG002|36-Week Induction Phase|Pregnancy|0|||
163979526|NCT00440947|592295449|FG003|36-Week Induction Phase|Pregnancy|0|||
163979527|NCT00440947|592295450|FG004|36-Week Induction Phase|Pregnancy|0|||
163979528|NCT00440947|592295446|FG000|48-Week Randomization Phase|Adverse Event|0|||
163979529|NCT00440947|592295447|FG001|48-Week Randomization Phase|Adverse Event|2|||
163979530|NCT00440947|592295448|FG002|48-Week Randomization Phase|Adverse Event|5|||
163979531|NCT00440947|592295449|FG003|48-Week Randomization Phase|Adverse Event|0|||
163979532|NCT00440947|592295450|FG004|48-Week Randomization Phase|Adverse Event|0|||
163979533|NCT00440947|592295446|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
163979534|NCT00440947|592295447|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
163979535|NCT00440947|592295448|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
163979536|NCT00440947|592295449|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
163979537|NCT00440947|592295450|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
163979538|NCT00440947|592295446|FG000|48-Week Randomization Phase|Non-compliance|0|||
163979539|NCT00440947|592295447|FG001|48-Week Randomization Phase|Non-compliance|3|||
163979540|NCT00440947|592295448|FG002|48-Week Randomization Phase|Non-compliance|4|||
163979541|NCT00440947|592295449|FG003|48-Week Randomization Phase|Non-compliance|0|||
163979542|NCT00440947|592295450|FG004|48-Week Randomization Phase|Non-compliance|0|||
163979543|NCT00440947|592295446|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
163979544|NCT00440947|592295447|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
163979545|NCT00440947|592295448|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
163979546|NCT00440947|592295449|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
163979547|NCT00440947|592295450|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
163979548|NCT00440947|592295446|FG000|48-Week Randomization Phase|Protocol Violation|0|||
163979549|NCT00440947|592295447|FG001|48-Week Randomization Phase|Protocol Violation|0|||
163979550|NCT00440947|592295448|FG002|48-Week Randomization Phase|Protocol Violation|1|||
163979551|NCT00440947|592295449|FG003|48-Week Randomization Phase|Protocol Violation|0|||
163979552|NCT00440947|592295450|FG004|48-Week Randomization Phase|Protocol Violation|0|||
163979553|NCT00440947|592295446|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
164207877|NCT02966834|593129915|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
163979554|NCT00440947|592295447|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
163979555|NCT00440947|592295448|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
163979556|NCT00440947|592295449|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
163979557|NCT00440947|592295450|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
163979558|NCT00440947|592295446|FG000|48-Week Randomization Phase|Pregnancy|0|||
163979559|NCT00440947|592295447|FG001|48-Week Randomization Phase|Pregnancy|0|||
163979560|NCT00440947|592295448|FG002|48-Week Randomization Phase|Pregnancy|1|||
163979561|NCT00440947|592295449|FG003|48-Week Randomization Phase|Pregnancy|0|||
163979562|NCT00440947|592295450|FG004|48-Week Randomization Phase|Pregnancy|0|||
163979563|NCT00440947|592295446|FG000|48-Week Randomization Phase|Incarceration|0|||
163979564|NCT00440947|592295447|FG001|48-Week Randomization Phase|Incarceration|3|||
163979565|NCT00440947|592295448|FG002|48-Week Randomization Phase|Incarceration|0|||
163979566|NCT00440947|592295449|FG003|48-Week Randomization Phase|Incarceration|0|||
163979567|NCT00440947|592295450|FG004|48-Week Randomization Phase|Incarceration|0|||
163979568|NCT00440947|592295446|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163979569|NCT00440947|592295447|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
163979570|NCT00440947|592295448|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163979571|NCT00440947|592295449|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163979572|NCT00440947|592295450|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
163979573|NCT00440947|592295446|FG000|48-Week Randomization Phase|Physician Decision|0|||
163979574|NCT00440947|592295447|FG001|48-Week Randomization Phase|Physician Decision|2|||
163979575|NCT00440947|592295448|FG002|48-Week Randomization Phase|Physician Decision|0|||
163979576|NCT00440947|592295449|FG003|48-Week Randomization Phase|Physician Decision|0|||
163979577|NCT00440947|592295450|FG004|48-Week Randomization Phase|Physician Decision|0|||
163979578|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
163979579|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
163979580|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
163979581|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
163979582|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
163979583|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
163979584|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
163979585|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
163979586|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
163979587|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
163979588|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
163979589|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
163979590|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
163979591|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
163979592|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
163979593|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
163979594|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
163979595|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
163979596|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
163979597|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
163979598|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
163979599|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
163979600|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
163979601|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
163979602|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
163979603|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
163979604|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
163979605|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
163979606|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
163979607|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
163979608|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
163979609|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
163979610|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
163979611|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
163979612|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
163979613|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
163979614|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
163979615|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
163979616|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
163979617|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
163979618|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
163979619|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
163979620|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
163979621|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
164321527|NCT00095147|593554175|FG001|Long-term Extension Period|Withdrawal of consent|0|||
164321528|NCT00095147|593554176|FG002|Long-term Extension Period|Withdrawal of consent|0|||
163979622|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
163979623|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
163979624|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
163979625|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
163979626|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
163979627|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
163979628|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
163979629|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
164207878|NCT02966834|593129910|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
164207879|NCT02966834|593129911|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
164207880|NCT02966834|593129912|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
164207881|NCT02966834|593129913|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
164207882|NCT02966834|593129914|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
164207883|NCT02966834|593129915|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
164207884|NCT02966834|593129910|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164207885|NCT02966834|593129911|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164207886|NCT02966834|593129912|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164207887|NCT02966834|593129913|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
163979630|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
163979631|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
163979632|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
163979633|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Other|0|||
163979634|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Other|0|||
163979635|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Other|0|||
163979636|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Other|1|||
163979637|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Other|0|||
163979638|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
163979639|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
163979640|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
163979641|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
163979642|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
163979643|NCT00440947|592295446|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163979644|NCT00440947|592295447|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163979645|NCT00440947|592295448|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163979646|NCT00440947|592295449|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
163979647|NCT00440947|592295450|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
163979648|NCT02898259|592295451|FG000|Overall Study|Adverse Event|0|||
163979649|NCT02898259|592295452|FG001|Overall Study|Adverse Event|0|||
163979650|NCT02898259|592295453|FG002|Overall Study|Adverse Event|1|||
163979651|NCT02898259|592295454|FG003|Overall Study|Adverse Event|0|||
163979652|NCT02898259|592295455|FG004|Overall Study|Adverse Event|0|||
163979653|NCT02898259|592295451|FG000|Overall Study|Lack of Efficacy|1|||
163979654|NCT02898259|592295452|FG001|Overall Study|Lack of Efficacy|1|||
163979655|NCT02898259|592295453|FG002|Overall Study|Lack of Efficacy|3|||
163979656|NCT02898259|592295454|FG003|Overall Study|Lack of Efficacy|0|||
163979657|NCT02898259|592295455|FG004|Overall Study|Lack of Efficacy|0|||
163979658|NCT02898259|592295451|FG000|Overall Study|Lost to Follow-up|0|||
163979659|NCT02898259|592295452|FG001|Overall Study|Lost to Follow-up|0|||
163979660|NCT02898259|592295453|FG002|Overall Study|Lost to Follow-up|1|||
163979661|NCT02898259|592295454|FG003|Overall Study|Lost to Follow-up|0|||
163979662|NCT02898259|592295455|FG004|Overall Study|Lost to Follow-up|0|||
163979663|NCT02898259|592295451|FG000|Overall Study|Transformation before study began|0|||
163979664|NCT02898259|592295452|FG001|Overall Study|Transformation before study began|0|||
163979665|NCT02898259|592295453|FG002|Overall Study|Transformation before study began|0|||
163979666|NCT02898259|592295454|FG003|Overall Study|Transformation before study began|1|||
163979667|NCT02898259|592295455|FG004|Overall Study|Transformation before study began|0|||
163979668|NCT01834274|592295461|FG000|Overall Study|Study Termination|41|||
163979669|NCT01834274|592295462|FG001|Overall Study|Study Termination|38|||
163979670|NCT01834274|592295461|FG000|Overall Study|Withdrawal by Subject|1|||
163979671|NCT01834274|592295462|FG001|Overall Study|Withdrawal by Subject|1|||
163979672|NCT01834274|592295461|FG000|Overall Study|Lost to Follow-up|3|||
163979673|NCT01834274|592295462|FG001|Overall Study|Lost to Follow-up|1|||
163979674|NCT01834274|592295461|FG000|Overall Study|Other|2|||
163979675|NCT01834274|592295462|FG001|Overall Study|Other|1|||
163979676|NCT01827670|592295465|FG000|Overall Study|Withdrawal of Consent|3|||
163979677|NCT01827670|592295466|FG001|Overall Study|Withdrawal of Consent|2|||
163979678|NCT01827670|592295465|FG000|Overall Study|Lost to Follow-up|0|||
163979679|NCT01827670|592295466|FG001|Overall Study|Lost to Follow-up|1|||
163979680|NCT00769184|592295469|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
163979681|NCT00769184|592295470|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
163979682|NCT00769184|592295469|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
163979683|NCT00769184|592295470|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
163979684|NCT00769184|592295469|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
163979685|NCT00769184|592295470|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
164207888|NCT02966834|593129914|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163979686|NCT00517829|592295471|FG000|Overall Study|Adverse Event|22|||
163979687|NCT00517829|592295472|FG001|Overall Study|Adverse Event|34|||
164076540|NCT01244815|592645746|FG001|Overall Study|Lost to Follow-up|2|||
164076541|NCT01244815|592645747|FG002|Overall Study|Lost to Follow-up|3|||
164076542|NCT01244815|592645748|FG003|Overall Study|Lost to Follow-up|2|||
164076543|NCT01244815|592645745|FG000|Overall Study|Withdrawal by Subject|0|||
164076544|NCT01244815|592645746|FG001|Overall Study|Withdrawal by Subject|2|||
164076545|NCT01244815|592645747|FG002|Overall Study|Withdrawal by Subject|0|||
164076546|NCT01244815|592645748|FG003|Overall Study|Withdrawal by Subject|3|||
164076547|NCT01244815|592645745|FG000|Overall Study|Protocol Violation|7|||
164076548|NCT01244815|592645746|FG001|Overall Study|Protocol Violation|4|||
164076549|NCT01244815|592645747|FG002|Overall Study|Protocol Violation|3|||
164076550|NCT01244815|592645748|FG003|Overall Study|Protocol Violation|1|||
164076551|NCT01244815|592645745|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164076552|NCT01244815|592645746|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
164076553|NCT01244815|592645747|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
164076554|NCT01244815|592645748|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
164076555|NCT02041494|592645750|FG000|Overall Study|Death|1|||
164076556|NCT02041494|592645751|FG001|Overall Study|Death|3|||
164076557|NCT02041494|592645750|FG000|Overall Study|Lost to Follow-up|2|||
164076558|NCT02041494|592645751|FG001|Overall Study|Lost to Follow-up|6|||
164076559|NCT02041494|592645750|FG000|Overall Study|study terminated|16|||
164076560|NCT02041494|592645751|FG001|Overall Study|study terminated|11|||
164076561|NCT01238822|592645757|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
164076562|NCT02487979|592645760|FG000|Overall Study|Physician Decision|2|||
164076563|NCT02487979|592645760|FG000|Overall Study|Withdrawal by Subject|2|||
164076564|NCT02487979|592645760|FG000|Overall Study|Progressive Disease|17|||
164076565|NCT00447694|592645761|FG000|Overall Study|Adverse Event|2|||
164076566|NCT00447694|592645761|FG000|Overall Study|Abnormal laboratory value|1|||
164076567|NCT00447694|592645761|FG000|Overall Study|Abnormal test procedure result|1|||
164076568|NCT00447694|592645761|FG000|Overall Study|Withdrawal by Subject|2|||
164076569|NCT02410837|592645762|FG000|Overall Study|Death|387|||
164207889|NCT02966834|593129915|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
163875003|NCT00419341|591909866|FG000|Efficacy Period|Non-compliance|1|||
163875004|NCT00419341|591909866|FG000|Efficacy Period|Termination of study site|1|||
163875005|NCT00331136|591909867|FG000|Overall Study|Adverse Event|3|||
163875006|NCT00331136|591909868|FG001|Overall Study|Adverse Event|5|||
163875007|NCT00331136|591909869|FG002|Overall Study|Adverse Event|0|||
163875008|NCT00331136|591909870|FG003|Overall Study|Adverse Event|1|||
163875009|NCT00331136|591909867|FG000|Overall Study|Withdrawal by Subject|0|||
163875010|NCT00331136|591909868|FG001|Overall Study|Withdrawal by Subject|1|||
163875011|NCT00331136|591909869|FG002|Overall Study|Withdrawal by Subject|0|||
163875012|NCT00331136|591909870|FG003|Overall Study|Withdrawal by Subject|0|||
163875013|NCT00331136|591909867|FG000|Overall Study|Lost to Follow-up|0|||
163875014|NCT00331136|591909868|FG001|Overall Study|Lost to Follow-up|1|||
163875015|NCT00331136|591909869|FG002|Overall Study|Lost to Follow-up|0|||
163979688|NCT00517829|592295471|FG000|Overall Study|Disease Progression|39|||
163979689|NCT00517829|592295472|FG001|Overall Study|Disease Progression|32|||
163979690|NCT00517829|592295471|FG000|Overall Study|Patient Request|6|||
163979691|NCT00517829|592295472|FG001|Overall Study|Patient Request|5|||
163979692|NCT00517829|592295471|FG000|Overall Study|Investigator Request|5|||
163979693|NCT00517829|592295472|FG001|Overall Study|Investigator Request|3|||
163979694|NCT00517829|592295471|FG000|Overall Study|Other|3|||
163979695|NCT00517829|592295472|FG001|Overall Study|Other|1|||
163979696|NCT00385255|592295473|FG000|Overall Study|Serious Adverse Event|1|||
163979697|NCT00385255|592295474|FG001|Overall Study|Serious Adverse Event|2|||
163979698|NCT00385255|592295473|FG000|Overall Study|Protocol Violation|0|||
163979699|NCT00385255|592295474|FG001|Overall Study|Protocol Violation|4|||
163979700|NCT00385255|592295473|FG000|Overall Study|Withdrawal by Subject|0|||
163979701|NCT00385255|592295474|FG001|Overall Study|Withdrawal by Subject|8|||
163979702|NCT00385255|592295473|FG000|Overall Study|Migrated/moved from study area|0|||
163979703|NCT00385255|592295474|FG001|Overall Study|Migrated/moved from study area|1|||
163979704|NCT00385255|592295473|FG000|Overall Study|Lost to Follow-up|20|||
163979705|NCT00385255|592295474|FG001|Overall Study|Lost to Follow-up|58|||
163979706|NCT00835237|592295479|FG000|Overall Study|Lost to Follow-up|4|||
163979707|NCT00835237|592295480|FG001|Overall Study|Lost to Follow-up|0|||
163979708|NCT00835237|592295479|FG000|Overall Study|Withdrawal by Subject|2|||
163979709|NCT00835237|592295480|FG001|Overall Study|Withdrawal by Subject|0|||
163979710|NCT03436862|592295483|FG000|Overall Study|Adverse Event|4|||
163979711|NCT03436862|592295483|FG000|Overall Study|Progressive Disease|2|||
163979712|NCT00606086|592295484|FG000|Overall Study|Adverse Event|1|||
163979713|NCT00606086|592295485|FG001|Overall Study|Adverse Event|1|||
163979714|NCT00606086|592295484|FG000|Overall Study|Lost to Follow-up|4|||
163979715|NCT00606086|592295485|FG001|Overall Study|Lost to Follow-up|8|||
163979716|NCT00606086|592295484|FG000|Overall Study|Protocol Violation|1|||
163979717|NCT00606086|592295485|FG001|Overall Study|Protocol Violation|0|||
163875016|NCT00331136|591909870|FG003|Overall Study|Lost to Follow-up|0|||
164076570|NCT02410837|592645762|FG000|Overall Study|Lost to Follow-up|50|||
164076571|NCT02410837|592645762|FG000|Overall Study|Withdrawal by Subject|44|||
164076572|NCT02410837|592645762|FG000|Overall Study|Physician Decision|6|||
164207890|NCT02966834|593129910|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207891|NCT02966834|593129911|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207892|NCT02966834|593129912|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207893|NCT02966834|593129913|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
164207894|NCT02966834|593129914|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207895|NCT02966834|593129915|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
164207896|NCT01925417|593129925|FG000|Overall Study|Withdrawal by Subject|2|||
164207897|NCT01925417|593129925|FG000|Overall Study|Death|1|||
164207898|NCT00655889|593129926|FG000|Overall Study|Inadequate cell growth|1|||
164207899|NCT00655889|593129926|FG000|Overall Study|Protocol Violation|1|||
164207900|NCT01093846|593129927|FG000|Overall Study|Adverse Event|0|||
164207901|NCT01093846|593129928|FG001|Overall Study|Adverse Event|0|||
164207902|NCT01093846|593129929|FG002|Overall Study|Adverse Event|1|||
164207903|NCT01093846|593129927|FG000|Overall Study|Lack of Efficacy|0|||
164207904|NCT01093846|593129928|FG001|Overall Study|Lack of Efficacy|0|||
164207905|NCT01093846|593129929|FG002|Overall Study|Lack of Efficacy|4|||
164207906|NCT01093846|593129927|FG000|Overall Study|Condition no longer required study drug|1|||
164207907|NCT01093846|593129928|FG001|Overall Study|Condition no longer required study drug|1|||
164207908|NCT01093846|593129929|FG002|Overall Study|Condition no longer required study drug|1|||
164207909|NCT01093846|593129927|FG000|Overall Study|Administrative Problems|18|||
164207910|NCT01093846|593129928|FG001|Overall Study|Administrative Problems|17|||
164207911|NCT01093846|593129929|FG002|Overall Study|Administrative Problems|15|||
164207912|NCT02781324|593129931|FG000|Overall Study|Withdrawal by Subject|1|||
164207913|NCT02781324|593129932|FG001|Overall Study|Withdrawal by Subject|0|||
164207914|NCT02781324|593129931|FG000|Overall Study|Physician Decision|1|||
164207915|NCT02781324|593129932|FG001|Overall Study|Physician Decision|2|||
164207916|NCT00661388|593129933|FG000|Overall Study|Adverse Event|14|||
164207917|NCT00661388|593129933|FG000|Overall Study|Protocol Violation|7|||
164207918|NCT00661388|593129933|FG000|Overall Study|Renal transplantation|1|||
164207919|NCT00661388|593129933|FG000|Overall Study|Dialysis initiation|1|||
164207920|NCT00661388|593129933|FG000|Overall Study|Administrative reasons|1|||
164207921|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
164207922|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
164207923|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Death|1|||
164207924|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Death|3|||
164207925|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
164207926|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
164207927|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
164207928|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
164207929|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
164207930|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
164207931|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
163979718|NCT00606086|592295484|FG000|Overall Study|Withdrawal by Subject|5|||
163979719|NCT00606086|592295485|FG001|Overall Study|Withdrawal by Subject|3|||
163979720|NCT00606086|592295484|FG000|Overall Study|Non-compliance|0|||
163979721|NCT00606086|592295485|FG001|Overall Study|Non-compliance|1|||
163979722|NCT00606086|592295484|FG000|Overall Study|Randomized, not treated|1|||
163979723|NCT00606086|592295485|FG001|Overall Study|Randomized, not treated|2|||
163979724|NCT00550680|592295491|FG000|Overall Study|Administrative Reasons|1|||
163979725|NCT00550680|592295491|FG000|Overall Study|Adverse Event|5|||
163979726|NCT00550680|592295491|FG000|Overall Study|Death|3|||
163979727|NCT00550680|592295491|FG000|Overall Study|Early Improvement|1|||
163979728|NCT00550680|592295491|FG000|Overall Study|Lost to Follow-up|3|||
163979729|NCT00550680|592295491|FG000|Overall Study|Lack of Efficacy|1|||
163979730|NCT00550680|592295491|FG000|Overall Study|Other|10|||
163979731|NCT00550680|592295491|FG000|Overall Study|Protocol Violation|7|||
163979732|NCT00550680|592295491|FG000|Overall Study|Refused Treatment|19|||
163979733|NCT00550680|592295491|FG000|Overall Study|Screen Failure|6|||
163979734|NCT05032157|592297234|FG000|Overall Study|Adverse Event|12|||
163979735|NCT05032157|592297235|FG001|Overall Study|Adverse Event|7|||
163979736|NCT05032157|592297234|FG000|Overall Study|Pregnancy|0|||
163979737|NCT05032157|592297235|FG001|Overall Study|Pregnancy|2|||
163979738|NCT05032157|592297234|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163979739|NCT05032157|592297235|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
163979740|NCT05032157|592297234|FG000|Overall Study|Protocol Deviation|8|||
163979741|NCT05032157|592297235|FG001|Overall Study|Protocol Deviation|4|||
164207932|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
163979742|NCT05032157|592297234|FG000|Overall Study|Lost to Follow-up|1|||
163979743|NCT05032157|592297235|FG001|Overall Study|Lost to Follow-up|3|||
163979744|NCT05032157|592297234|FG000|Overall Study|Physician Decision|7|||
163979745|NCT05032157|592297235|FG001|Overall Study|Physician Decision|2|||
163979746|NCT05032157|592297234|FG000|Overall Study|Patient Decision|38|||
163979747|NCT05032157|592297235|FG001|Overall Study|Patient Decision|19|||
163979748|NCT02627495|592297236|FG000|Overall Study|Withdrawal by Subject|4|||
164076573|NCT02410837|592645762|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
164207933|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
164321529|NCT00095147|593554177|FG003|Long-term Extension Period|Withdrawal of consent|0|||
164321530|NCT00095147|593554178|FG004|Long-term Extension Period|Withdrawal of consent|12|||
164321531|NCT00095147|593554174|FG000|Long-term Extension Period|Pregnancy|0|||
164321532|NCT00095147|593554175|FG001|Long-term Extension Period|Pregnancy|0|||
164321533|NCT00095147|593554176|FG002|Long-term Extension Period|Pregnancy|0|||
164321534|NCT00095147|593554177|FG003|Long-term Extension Period|Pregnancy|0|||
164321535|NCT00095147|593554178|FG004|Long-term Extension Period|Pregnancy|1|||
164321536|NCT00095147|593554174|FG000|Long-term Extension Period|No longer meets study criteria|0|||
164321537|NCT00095147|593554175|FG001|Long-term Extension Period|No longer meets study criteria|0|||
164321538|NCT00095147|593554176|FG002|Long-term Extension Period|No longer meets study criteria|0|||
164321539|NCT00095147|593554177|FG003|Long-term Extension Period|No longer meets study criteria|0|||
164321540|NCT00095147|593554178|FG004|Long-term Extension Period|No longer meets study criteria|1|||
164321541|NCT00095147|593554174|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
164321542|NCT00095147|593554175|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
164321543|NCT00095147|593554176|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
164321544|NCT00095147|593554177|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
164321545|NCT00095147|593554178|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
164321546|NCT00095147|593554174|FG000|Long-term Extension Period|Leaving country|0|||
164321547|NCT00095147|593554175|FG001|Long-term Extension Period|Leaving country|0|||
164321548|NCT00095147|593554176|FG002|Long-term Extension Period|Leaving country|0|||
164321549|NCT00095147|593554177|FG003|Long-term Extension Period|Leaving country|0|||
164321550|NCT00095147|593554178|FG004|Long-term Extension Period|Leaving country|1|||
164321551|NCT02395302|593554179|FG000|Overall Study|Screen Failure|3|||
164321552|NCT02395302|593554179|FG000|Overall Study|Run In Failure|7|||
164321553|NCT02395302|593554179|FG000|Overall Study|Withdrawal by Subject|2|||
164321554|NCT02395302|593554179|FG000|Overall Study|Physician Decision|2|||
164321555|NCT04604132|593554180|FG000|Overall Study|Adverse Event|2|||
164321556|NCT04604132|593554181|FG001|Overall Study|Adverse Event|0|||
164321557|NCT04604132|593554182|FG002|Overall Study|Adverse Event|0|||
163875017|NCT00331136|591909867|FG000|Overall Study|Protocol Violation|1|||
163875018|NCT00331136|591909868|FG001|Overall Study|Protocol Violation|0|||
163875019|NCT00331136|591909869|FG002|Overall Study|Protocol Violation|0|||
163875020|NCT00331136|591909870|FG003|Overall Study|Protocol Violation|0|||
163875021|NCT00331136|591909867|FG000|Overall Study|Not treated|1|||
163875022|NCT00331136|591909868|FG001|Overall Study|Not treated|0|||
163875023|NCT00331136|591909869|FG002|Overall Study|Not treated|0|||
163875024|NCT00331136|591909870|FG003|Overall Study|Not treated|0|||
163875025|NCT00621296|591909871|FG000|Overall Study|Adverse Event|2|||
163875026|NCT00621296|591909871|FG000|Overall Study|Lack of Efficacy|1|||
163875027|NCT00621296|591909871|FG000|Overall Study|Physician Decision|7|||
163875028|NCT00621296|591909871|FG000|Overall Study|Unmatch Criteria|1|||
163875029|NCT00621296|591909871|FG000|Overall Study|Stopping Criteria|3|||
163875030|NCT04166058|591909872|FG000|Overall Study|Adverse Event|1|||
163875031|NCT04166058|591909873|FG001|Overall Study|Adverse Event|1|||
163875032|NCT04166058|591909874|FG002|Overall Study|Adverse Event|0|||
163875033|NCT04166058|591909875|FG003|Overall Study|Adverse Event|0|||
163875034|NCT04166058|591909872|FG000|Overall Study|Withdrawal by Subject|4|||
163875035|NCT04166058|591909873|FG001|Overall Study|Withdrawal by Subject|4|||
163875036|NCT04166058|591909874|FG002|Overall Study|Withdrawal by Subject|1|||
163875037|NCT04166058|591909875|FG003|Overall Study|Withdrawal by Subject|10|||
163875038|NCT04166058|591909872|FG000|Overall Study|Lost to Follow-up|9|||
163875039|NCT04166058|591909873|FG001|Overall Study|Lost to Follow-up|2|||
163875040|NCT04166058|591909874|FG002|Overall Study|Lost to Follow-up|1|||
163875041|NCT04166058|591909875|FG003|Overall Study|Lost to Follow-up|1|||
163875042|NCT04166058|591909872|FG000|Overall Study|Pregnancy|1|||
163875043|NCT04166058|591909873|FG001|Overall Study|Pregnancy|0|||
163875044|NCT04166058|591909874|FG002|Overall Study|Pregnancy|0|||
163875045|NCT04166058|591909875|FG003|Overall Study|Pregnancy|0|||
163875046|NCT04166058|591909872|FG000|Overall Study|Physician Decision|2|||
163875047|NCT04166058|591909873|FG001|Overall Study|Physician Decision|0|||
163875048|NCT04166058|591909874|FG002|Overall Study|Physician Decision|0|||
163875049|NCT04166058|591909875|FG003|Overall Study|Physician Decision|2|||
163875050|NCT04166058|591909872|FG000|Overall Study|Protocol Violation|1|||
163875051|NCT04166058|591909873|FG001|Overall Study|Protocol Violation|0|||
163875052|NCT04166058|591909874|FG002|Overall Study|Protocol Violation|0|||
163979749|NCT02543528|592297241|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163875053|NCT04166058|591909875|FG003|Overall Study|Protocol Violation|0|||
163979750|NCT02543528|592297242|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163875054|NCT04166058|591909872|FG000|Overall Study|Lack of Efficacy|2|||
163875055|NCT04166058|591909873|FG001|Overall Study|Lack of Efficacy|0|||
163875056|NCT04166058|591909874|FG002|Overall Study|Lack of Efficacy|0|||
163875057|NCT04166058|591909875|FG003|Overall Study|Lack of Efficacy|0|||
163979751|NCT02543528|592297243|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
163875058|NCT04166058|591909872|FG000|Overall Study|Other|1|||
163875059|NCT04166058|591909873|FG001|Overall Study|Other|0|||
163875060|NCT04166058|591909874|FG002|Overall Study|Other|0|||
163875061|NCT04166058|591909875|FG003|Overall Study|Other|1|||
163875062|NCT04166058|591909872|FG000|Overall Study|Non-compliance with study drug|0|||
163875063|NCT04166058|591909873|FG001|Overall Study|Non-compliance with study drug|0|||
164076574|NCT01169987|592645763|FG000|Overall Study|Withdrawal by Subject|3|||
164076575|NCT01169987|592645763|FG000|Overall Study|Lost to Follow-up|24|||
164076576|NCT01169987|592645763|FG000|Overall Study|Other|4|||
164076577|NCT00386100|592645765|FG000|Overall Study|Did not receive study medication|6|||
164207934|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
164207935|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
164076578|NCT00386100|592645766|FG001|Overall Study|Did not receive study medication|4|||
164076579|NCT00386100|592645765|FG000|Overall Study|Adverse Event|15|||
164076580|NCT00386100|592645766|FG001|Overall Study|Adverse Event|25|||
164076581|NCT00386100|592645765|FG000|Overall Study|Death|0|||
164076582|NCT00386100|592645766|FG001|Overall Study|Death|1|||
164076583|NCT00386100|592645765|FG000|Overall Study|Insufficient therapeutic effect|30|||
164076584|NCT00386100|592645766|FG001|Overall Study|Insufficient therapeutic effect|6|||
164076585|NCT00386100|592645765|FG000|Overall Study|Lost to Follow-up|29|||
164076586|NCT00386100|592645766|FG001|Overall Study|Lost to Follow-up|29|||
164076587|NCT00386100|592645765|FG000|Overall Study|Non-compliance|18|||
164076588|NCT00386100|592645766|FG001|Overall Study|Non-compliance|19|||
164076589|NCT00386100|592645765|FG000|Overall Study|Protocol Violation|5|||
164076590|NCT00386100|592645766|FG001|Overall Study|Protocol Violation|3|||
164076591|NCT00386100|592645765|FG000|Overall Study|Withdrawal by Subject|32|||
164076592|NCT00386100|592645766|FG001|Overall Study|Withdrawal by Subject|31|||
164076593|NCT00386100|592645765|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
164076594|NCT00386100|592645766|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
164076595|NCT00386100|592645765|FG000|Overall Study|BMD <2.5|1|||
164076596|NCT00386100|592645766|FG001|Overall Study|BMD <2.5|0|||
164076597|NCT00386100|592645765|FG000|Overall Study|Consecutive elevated Hba1C|1|||
164076598|NCT00386100|592645766|FG001|Overall Study|Consecutive elevated Hba1C|0|||
164076599|NCT00386100|592645765|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
164076600|NCT00386100|592645766|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
164076601|NCT00386100|592645765|FG000|Overall Study|Laboratory findings|1|||
164076602|NCT00386100|592645766|FG001|Overall Study|Laboratory findings|0|||
164076603|NCT00386100|592645765|FG000|Overall Study|Participant's concern due to CPK levels|1|||
164076604|NCT00386100|592645766|FG001|Overall Study|Participant's concern due to CPK levels|0|||
164076605|NCT00386100|592645765|FG000|Overall Study|Participant moving out of state|2|||
164076606|NCT00386100|592645766|FG001|Overall Study|Participant moving out of state|0|||
164076607|NCT00386100|592645765|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
164076608|NCT00386100|592645766|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
164076609|NCT00386100|592645765|FG000|Overall Study|Didn't meet entry criteria|1|||
164076610|NCT00386100|592645766|FG001|Overall Study|Didn't meet entry criteria|1|||
164076611|NCT00386100|592645765|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
164076612|NCT00386100|592645766|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
164076613|NCT00386100|592645765|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
164076614|NCT00386100|592645766|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
164076615|NCT00386100|592645765|FG000|Overall Study|Bad metabolic control & patient security|1|||
164076616|NCT00386100|592645766|FG001|Overall Study|Bad metabolic control & patient security|0|||
164076617|NCT00386100|592645765|FG000|Overall Study|Bone loss by DXA bone scan|1|||
164076618|NCT00386100|592645766|FG001|Overall Study|Bone loss by DXA bone scan|0|||
164076619|NCT00386100|592645765|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
164076620|NCT00386100|592645766|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
164076621|NCT00386100|592645765|FG000|Overall Study|7.6% bone loss|1|||
164076622|NCT00386100|592645766|FG001|Overall Study|7.6% bone loss|0|||
164076623|NCT00386100|592645765|FG000|Overall Study|Osteoporosis|0|||
164076624|NCT00386100|592645766|FG001|Overall Study|Osteoporosis|1|||
164076625|NCT00386100|592645765|FG000|Overall Study|Positive pregnancy test|1|||
164076626|NCT00386100|592645766|FG001|Overall Study|Positive pregnancy test|3|||
164076627|NCT00386100|592645765|FG000|Overall Study|Out of country for 5 months|1|||
164076628|NCT00386100|592645766|FG001|Overall Study|Out of country for 5 months|0|||
164076629|NCT00386100|592645765|FG000|Overall Study|Hb1Ac >8%|0|||
164076630|NCT00386100|592645766|FG001|Overall Study|Hb1Ac >8%|1|||
164076631|NCT00386100|592645765|FG000|Overall Study|Participant randomized in error|1|||
164076632|NCT00386100|592645766|FG001|Overall Study|Participant randomized in error|0|||
164076633|NCT00849524|592645773|FG000|Overall Study|Lack of Efficacy|3|||
164076634|NCT01825876|592645776|FG000|Period 2|Withdrawal by Subject|0|||
164076635|NCT01825876|592645777|FG001|Period 2|Withdrawal by Subject|1|||
164076636|NCT01027884|592645782|FG000|Overall Study|Adverse Event|2|||
164076637|NCT01027884|592645783|FG001|Overall Study|Adverse Event|1|||
164076638|NCT01027884|592645782|FG000|Overall Study|Protocol Violation|1|||
164076639|NCT01027884|592645783|FG001|Overall Study|Protocol Violation|0|||
164076640|NCT01027884|592645782|FG000|Overall Study|Non-compliance|1|||
164076641|NCT01027884|592645783|FG001|Overall Study|Non-compliance|1|||
164076642|NCT01027884|592645782|FG000|Overall Study|Withdrawal by Subject|0|||
164076643|NCT01027884|592645783|FG001|Overall Study|Withdrawal by Subject|1|||
164076644|NCT01027884|592645782|FG000|Overall Study|Lost to Follow-up|0|||
164321558|NCT04604132|593554183|FG003|Overall Study|Adverse Event|1|||
164321559|NCT04604132|593554184|FG004|Overall Study|Adverse Event|2|||
164321560|NCT04604132|593554180|FG000|Overall Study|Study terminated by sponsor|0|||
164321561|NCT04604132|593554181|FG001|Overall Study|Study terminated by sponsor|0|||
164321562|NCT04604132|593554182|FG002|Overall Study|Study terminated by sponsor|0|||
164321563|NCT04604132|593554183|FG003|Overall Study|Study terminated by sponsor|0|||
164321564|NCT04604132|593554184|FG004|Overall Study|Study terminated by sponsor|1|||
164321565|NCT04604132|593554180|FG000|Overall Study|Progressive disease: Clinical progression|0|||
164321566|NCT04604132|593554181|FG001|Overall Study|Progressive disease: Clinical progression|0|||
164321567|NCT04604132|593554182|FG002|Overall Study|Progressive disease: Clinical progression|1|||
164321568|NCT04604132|593554183|FG003|Overall Study|Progressive disease: Clinical progression|0|||
164321569|NCT04604132|593554184|FG004|Overall Study|Progressive disease: Clinical progression|0|||
164321570|NCT04604132|593554180|FG000|Overall Study|Progressive disease: Radiological progression|8|||
164321571|NCT04604132|593554181|FG001|Overall Study|Progressive disease: Radiological progression|7|||
164321572|NCT04604132|593554182|FG002|Overall Study|Progressive disease: Radiological progression|10|||
164321573|NCT04604132|593554183|FG003|Overall Study|Progressive disease: Radiological progression|4|||
164321574|NCT04604132|593554184|FG004|Overall Study|Progressive disease: Radiological progression|3|||
164321575|NCT04604132|593554180|FG000|Overall Study|Death|3|||
164321576|NCT04604132|593554181|FG001|Overall Study|Death|1|||
164321577|NCT04604132|593554182|FG002|Overall Study|Death|2|||
164321578|NCT04604132|593554183|FG003|Overall Study|Death|1|||
164321579|NCT04604132|593554184|FG004|Overall Study|Death|0|||
164321580|NCT00952380|593554185|FG000|Overall Study|Other|0|||
164321581|NCT00952380|593554186|FG001|Overall Study|Other|0|||
164321582|NCT00952380|593554187|FG002|Overall Study|Other|0|||
164321583|NCT00952380|593554188|FG003|Overall Study|Other|0|||
164321584|NCT00952380|593554189|FG004|Overall Study|Other|1|||
164321585|NCT00952380|593554185|FG000|Overall Study|Withdrawal by Subject|0|||
164321586|NCT00952380|593554186|FG001|Overall Study|Withdrawal by Subject|0|||
164321587|NCT00952380|593554187|FG002|Overall Study|Withdrawal by Subject|1|||
164321588|NCT00952380|593554188|FG003|Overall Study|Withdrawal by Subject|0|||
164321589|NCT00952380|593554189|FG004|Overall Study|Withdrawal by Subject|2|||
164321590|NCT00952380|593554185|FG000|Overall Study|Adverse Event|0|||
164321591|NCT00952380|593554186|FG001|Overall Study|Adverse Event|1|||
164321592|NCT00952380|593554187|FG002|Overall Study|Adverse Event|0|||
164321593|NCT00952380|593554188|FG003|Overall Study|Adverse Event|0|||
164321594|NCT00952380|593554189|FG004|Overall Study|Adverse Event|3|||
164321595|NCT00952380|593554185|FG000|Overall Study|Physician Decision|0|||
164321596|NCT00952380|593554186|FG001|Overall Study|Physician Decision|0|||
164321597|NCT00952380|593554187|FG002|Overall Study|Physician Decision|1|||
164321598|NCT00952380|593554188|FG003|Overall Study|Physician Decision|2|||
164321599|NCT00952380|593554189|FG004|Overall Study|Physician Decision|0|||
164321600|NCT00952380|593554185|FG000|Overall Study|Non-compliant to protocol|0|||
164321601|NCT00952380|593554186|FG001|Overall Study|Non-compliant to protocol|0|||
164321602|NCT00952380|593554187|FG002|Overall Study|Non-compliant to protocol|0|||
164321603|NCT00952380|593554188|FG003|Overall Study|Non-compliant to protocol|1|||
164321604|NCT00952380|593554189|FG004|Overall Study|Non-compliant to protocol|0|||
164321605|NCT03400956|593554190|FG000|Treatment Period 1|Adverse Event|0|||
164321606|NCT03400956|593554191|FG001|Treatment Period 1|Adverse Event|1|||
164321607|NCT03400956|593554192|FG002|Treatment Period 1|Adverse Event|0|||
164321608|NCT03400956|593554190|FG000|Treatment Period 1|Lost to Follow-up|0|||
164321609|NCT03400956|593554191|FG001|Treatment Period 1|Lost to Follow-up|0|||
164321610|NCT03400956|593554192|FG002|Treatment Period 1|Lost to Follow-up|1|||
164321611|NCT03400956|593554190|FG000|Treatment Period 1|Protocol Violation|0|||
164321612|NCT03400956|593554191|FG001|Treatment Period 1|Protocol Violation|2|||
164321613|NCT03400956|593554192|FG002|Treatment Period 1|Protocol Violation|0|||
164321614|NCT03400956|593554190|FG000|Treatment Period 1|Study terminated by sponsor|3|||
164321615|NCT03400956|593554191|FG001|Treatment Period 1|Study terminated by sponsor|1|||
164321616|NCT03400956|593554192|FG002|Treatment Period 1|Study terminated by sponsor|1|||
164321617|NCT03400956|593554190|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164321618|NCT03400956|593554191|FG001|Treatment Period 1|Withdrawal by Subject|2|||
164321619|NCT03400956|593554192|FG002|Treatment Period 1|Withdrawal by Subject|4|||
164321620|NCT03400956|593554190|FG000|Treatment Period 1|Other|1|||
164321621|NCT03400956|593554191|FG001|Treatment Period 1|Other|2|||
164321622|NCT03400956|593554192|FG002|Treatment Period 1|Other|3|||
164321623|NCT03400956|593554190|FG000|Post-treatment Period 1|Adverse Event|0|||
164321624|NCT03400956|593554191|FG001|Post-treatment Period 1|Adverse Event|0|||
164321625|NCT03400956|593554192|FG002|Post-treatment Period 1|Adverse Event|1|||
164321626|NCT03400956|593554190|FG000|Post-treatment Period 1|Physician Decision|2|||
164321627|NCT03400956|593554191|FG001|Post-treatment Period 1|Physician Decision|3|||
164321628|NCT03400956|593554192|FG002|Post-treatment Period 1|Physician Decision|0|||
164321629|NCT03400956|593554190|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
164321630|NCT03400956|593554191|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
164321631|NCT03400956|593554192|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
164321632|NCT03400956|593554190|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
164321633|NCT03400956|593554191|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
164321634|NCT03400956|593554192|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
164321635|NCT03400956|593554190|FG000|Post-treatment Period 1|Other|4|||
164321636|NCT03400956|593554191|FG001|Post-treatment Period 1|Other|3|||
164321637|NCT03400956|593554192|FG002|Post-treatment Period 1|Other|4|||
164321638|NCT03400956|593554190|FG000|Treatment Period 2|Adverse Event|2|||
164076645|NCT01027884|592645783|FG001|Overall Study|Lost to Follow-up|1|||
164076646|NCT01027884|592645782|FG000|Overall Study|Spinal fixation surgery|0|||
164321639|NCT03400956|593554191|FG001|Treatment Period 2|Adverse Event|1|||
164321640|NCT03400956|593554192|FG002|Treatment Period 2|Adverse Event|1|||
164321641|NCT03400956|593554190|FG000|Treatment Period 2|Lost to Follow-up|1|||
164321642|NCT03400956|593554191|FG001|Treatment Period 2|Lost to Follow-up|1|||
164321643|NCT03400956|593554192|FG002|Treatment Period 2|Lost to Follow-up|0|||
164321644|NCT03400956|593554190|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164321645|NCT03400956|593554191|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164321646|NCT03400956|593554192|FG002|Treatment Period 2|Withdrawal by Subject|3|||
164321647|NCT03400956|593554190|FG000|Treatment Period 2|Other|1|||
164321648|NCT03400956|593554191|FG001|Treatment Period 2|Other|1|||
164321649|NCT03400956|593554192|FG002|Treatment Period 2|Other|0|||
164321650|NCT03400956|593554190|FG000|Follow-up Period|Withdrawal by Subject|0|||
164321651|NCT03400956|593554191|FG001|Follow-up Period|Withdrawal by Subject|0|||
164321652|NCT03400956|593554192|FG002|Follow-up Period|Withdrawal by Subject|1|||
164321653|NCT03400956|593554190|FG000|Follow-up Period|Other|0|||
164321654|NCT03400956|593554191|FG001|Follow-up Period|Other|0|||
164321655|NCT03400956|593554192|FG002|Follow-up Period|Other|1|||
164321656|NCT02048241|593554194|FG000|Overall Study|Withdrawal by Subject|0|||
164321657|NCT02048241|593554195|FG001|Overall Study|Withdrawal by Subject|1|||
164321658|NCT00534313|593554196|FG000|Short-term Period|Adverse Event|1|||
164321659|NCT00534313|593554197|FG001|Short-term Period|Adverse Event|2|||
164321660|NCT00534313|593554198|FG002|Short-term Period|Adverse Event|1|||
164321661|NCT00534313|593554199|FG003|Short-term Period|Adverse Event|3|||
164321662|NCT00534313|593554196|FG000|Short-term Period|Lack of Efficacy|3|||
164321663|NCT00534313|593554197|FG001|Short-term Period|Lack of Efficacy|4|||
164321664|NCT00534313|593554198|FG002|Short-term Period|Lack of Efficacy|0|||
164321665|NCT00534313|593554199|FG003|Short-term Period|Lack of Efficacy|3|||
164321666|NCT00534313|593554196|FG000|Short-term Period|Participant not meeting study criteria|0|||
164321667|NCT00534313|593554197|FG001|Short-term Period|Participant not meeting study criteria|0|||
164321668|NCT00534313|593554198|FG002|Short-term Period|Participant not meeting study criteria|0|||
164321669|NCT00534313|593554199|FG003|Short-term Period|Participant not meeting study criteria|1|||
164076647|NCT01027884|592645783|FG001|Overall Study|Spinal fixation surgery|3|||
164207936|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
164076648|NCT03636542|592645784|FG000|Overall Study|Lost to Follow-up|1|||
164076649|NCT03636542|592645785|FG001|Overall Study|Lost to Follow-up|1|||
164207937|NCT00362232|593131557|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
164207938|NCT00362232|593131558|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
164207939|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
164207940|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
164207941|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
164207942|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
164207943|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
164207944|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
164207945|NCT00362232|593131557|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
164207946|NCT00362232|593131558|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
164207947|NCT05020015|593131561|FG000|Overall Study|Ongoing on study|1|||
164207948|NCT05020015|593131562|FG001|Overall Study|Ongoing on study|3|||
164207949|NCT05020015|593131563|FG002|Overall Study|Ongoing on study|4|||
164207950|NCT05020015|593131564|FG003|Overall Study|Ongoing on study|7|||
164207951|NCT05020015|593131561|FG000|Overall Study|Death|2|||
164207952|NCT05020015|593131562|FG001|Overall Study|Death|3|||
164207953|NCT05020015|593131563|FG002|Overall Study|Death|4|||
164207954|NCT05020015|593131564|FG003|Overall Study|Death|0|||
164207955|NCT05020015|593131561|FG000|Overall Study|Withdrawal by Subject|0|||
164207956|NCT05020015|593131562|FG001|Overall Study|Withdrawal by Subject|0|||
164207957|NCT05020015|593131563|FG002|Overall Study|Withdrawal by Subject|1|||
164207958|NCT05020015|593131564|FG003|Overall Study|Withdrawal by Subject|0|||
164207959|NCT05020015|593131561|FG000|Overall Study|Reason Not Specified|0|||
164207960|NCT05020015|593131562|FG001|Overall Study|Reason Not Specified|0|||
164207961|NCT05020015|593131563|FG002|Overall Study|Reason Not Specified|2|||
164321670|NCT00534313|593554196|FG000|Short-term Period|Participant withdrew consent|2|||
164321671|NCT00534313|593554197|FG001|Short-term Period|Participant withdrew consent|0|||
164321672|NCT00534313|593554198|FG002|Short-term Period|Participant withdrew consent|0|||
164321673|NCT00534313|593554199|FG003|Short-term Period|Participant withdrew consent|2|||
164321674|NCT00534313|593554196|FG000|Short-term Period|Pregnancy|0|||
164321675|NCT00534313|593554197|FG001|Short-term Period|Pregnancy|0|||
164076650|NCT03636542|592645784|FG000|Overall Study|Physician Decision|0|||
164321676|NCT00534313|593554198|FG002|Short-term Period|Pregnancy|1|||
164321677|NCT00534313|593554199|FG003|Short-term Period|Pregnancy|0|||
164207962|NCT05020015|593131564|FG003|Overall Study|Reason Not Specified|0|||
164076651|NCT03636542|592645785|FG001|Overall Study|Physician Decision|1|||
164076652|NCT03636542|592645784|FG000|Overall Study|Withdrawal by Subject|1|||
164076653|NCT03636542|592645785|FG001|Overall Study|Withdrawal by Subject|0|||
164321678|NCT00534313|593554196|FG000|Long-term Period|Adverse Event|2|||
164321679|NCT00534313|593554197|FG001|Long-term Period|Adverse Event|1|||
164321680|NCT00534313|593554198|FG002|Long-term Period|Adverse Event|0|||
164321681|NCT00534313|593554199|FG003|Long-term Period|Adverse Event|1|||
164321682|NCT00534313|593554196|FG000|Long-term Period|Lack of Efficacy|14|||
164321683|NCT00534313|593554197|FG001|Long-term Period|Lack of Efficacy|10|||
164321684|NCT00534313|593554198|FG002|Long-term Period|Lack of Efficacy|14|||
164321685|NCT00534313|593554199|FG003|Long-term Period|Lack of Efficacy|12|||
164321686|NCT00534313|593554196|FG000|Long-term Period|Lost to Follow-up|1|||
164321687|NCT00534313|593554197|FG001|Long-term Period|Lost to Follow-up|2|||
164321688|NCT00534313|593554198|FG002|Long-term Period|Lost to Follow-up|0|||
164321689|NCT00534313|593554199|FG003|Long-term Period|Lost to Follow-up|0|||
164321690|NCT00534313|593554196|FG000|Long-term Period|Withdrawal by Subject|2|||
164321691|NCT00534313|593554197|FG001|Long-term Period|Withdrawal by Subject|2|||
164321692|NCT00534313|593554198|FG002|Long-term Period|Withdrawal by Subject|0|||
164321693|NCT00534313|593554199|FG003|Long-term Period|Withdrawal by Subject|0|||
164321694|NCT00534313|593554196|FG000|Long-term Period|No longer meets study criteria|0|||
164321695|NCT00534313|593554197|FG001|Long-term Period|No longer meets study criteria|1|||
164321696|NCT00534313|593554198|FG002|Long-term Period|No longer meets study criteria|0|||
163875064|NCT04166058|591909874|FG002|Overall Study|Non-compliance with study drug|0|||
163875065|NCT04166058|591909875|FG003|Overall Study|Non-compliance with study drug|2|||
164076654|NCT03670537|592645786|FG000|Overall Study|Protocol Violation|1|||
164076655|NCT02059187|592645789|FG000|Overall Study|Adverse Event|0|||
164076656|NCT02059187|592645790|FG001|Overall Study|Adverse Event|3|||
164076657|NCT02059187|592645789|FG000|Overall Study|Death|1|||
164076658|NCT02059187|592645790|FG001|Overall Study|Death|1|||
164076659|NCT02059187|592645789|FG000|Overall Study|Lost to Follow-up|9|||
164076660|NCT02059187|592645790|FG001|Overall Study|Lost to Follow-up|8|||
164207963|NCT02233413|593131565|FG000|Overall Study|Lost to Follow-up|7|||
164207964|NCT02233413|593131566|FG001|Overall Study|Lost to Follow-up|9|||
164207965|NCT02233413|593131565|FG000|Overall Study|Withdrawal by Subject|4|||
164207966|NCT02233413|593131566|FG001|Overall Study|Withdrawal by Subject|5|||
164207967|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
164207968|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
164207969|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
164207970|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
164207971|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
164207972|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
164207973|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
164207974|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
164207975|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
164207976|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
164207977|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
164207978|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
164207979|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
164207980|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
164207981|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
164207982|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
164207983|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
164207984|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
164207985|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
164207986|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
164207987|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
164207988|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
164207989|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
164207990|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
164207991|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
164207992|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
164207993|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
164076661|NCT02059187|592645789|FG000|Overall Study|Non-compliance with study drug|1|||
164076662|NCT02059187|592645790|FG001|Overall Study|Non-compliance with study drug|0|||
164076663|NCT02059187|592645789|FG000|Overall Study|Physician Decision|1|||
163875066|NCT02998528|591909876|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
164076664|NCT02059187|592645790|FG001|Overall Study|Physician Decision|2|||
164076665|NCT02059187|592645789|FG000|Overall Study|Protocol Violation|1|||
164076666|NCT02059187|592645790|FG001|Overall Study|Protocol Violation|0|||
164076667|NCT02059187|592645789|FG000|Overall Study|Withdrawal by Subject|12|||
164076668|NCT02059187|592645790|FG001|Overall Study|Withdrawal by Subject|8|||
164076669|NCT03751020|592645791|FG000|Overall Study|Withdrawal by Subject|2|||
164076670|NCT03751020|592645792|FG001|Overall Study|Withdrawal by Subject|0|||
164076671|NCT03751020|592645793|FG002|Overall Study|Withdrawal by Subject|0|||
164076672|NCT03751020|592645791|FG000|Overall Study|Lost to Follow-up|7|||
164076673|NCT03751020|592645792|FG001|Overall Study|Lost to Follow-up|4|||
164076674|NCT03751020|592645793|FG002|Overall Study|Lost to Follow-up|10|||
164076675|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
164076676|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
164076677|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
164076678|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
164076679|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
164076680|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
164076681|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
164076682|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
164076683|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
164076684|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
164076685|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
164076686|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
164321697|NCT00534313|593554199|FG003|Long-term Period|No longer meets study criteria|0|||
164321698|NCT00534313|593554196|FG000|Long-term Period|Poor compliance/noncompliance|0|||
164321699|NCT00534313|593554197|FG001|Long-term Period|Poor compliance/noncompliance|1|||
164321700|NCT00534313|593554198|FG002|Long-term Period|Poor compliance/noncompliance|1|||
164321701|NCT00534313|593554199|FG003|Long-term Period|Poor compliance/noncompliance|0|||
164321702|NCT00534313|593554196|FG000|Long-term Period|Administrative reason by sponsor|17|||
164321703|NCT00534313|593554197|FG001|Long-term Period|Administrative reason by sponsor|15|||
164321704|NCT00534313|593554198|FG002|Long-term Period|Administrative reason by sponsor|26|||
164321705|NCT00534313|593554199|FG003|Long-term Period|Administrative reason by sponsor|18|||
164321706|NCT00534313|593554196|FG000|Long-term Period|Other|1|||
164321707|NCT00534313|593554197|FG001|Long-term Period|Other|2|||
164321708|NCT00534313|593554198|FG002|Long-term Period|Other|2|||
164321709|NCT00534313|593554199|FG003|Long-term Period|Other|2|||
164321710|NCT00402233|593554200|FG000|Overall Study|Adverse Event|1|||
164321711|NCT00402233|593554201|FG001|Overall Study|Adverse Event|7|||
164321712|NCT00402233|593554202|FG002|Overall Study|Adverse Event|9|||
164321713|NCT00402233|593554203|FG003|Overall Study|Adverse Event|9|||
164321714|NCT00402233|593554200|FG000|Overall Study|Protocol Violation|0|||
164321715|NCT00402233|593554201|FG001|Overall Study|Protocol Violation|1|||
164321716|NCT00402233|593554202|FG002|Overall Study|Protocol Violation|0|||
164321717|NCT00402233|593554203|FG003|Overall Study|Protocol Violation|0|||
164321718|NCT00402233|593554200|FG000|Overall Study|Withdrawal by Subject|2|||
164321719|NCT00402233|593554201|FG001|Overall Study|Withdrawal by Subject|1|||
164321720|NCT00402233|593554202|FG002|Overall Study|Withdrawal by Subject|2|||
164321721|NCT00402233|593554203|FG003|Overall Study|Withdrawal by Subject|2|||
164321722|NCT00402233|593554200|FG000|Overall Study|Worsening of disease under study|2|||
164321723|NCT00402233|593554201|FG001|Overall Study|Worsening of disease under study|0|||
164321724|NCT00402233|593554202|FG002|Overall Study|Worsening of disease under study|0|||
164321725|NCT00402233|593554203|FG003|Overall Study|Worsening of disease under study|0|||
164321726|NCT00402233|593554200|FG000|Overall Study|Worsening of other pre-existing disease|0|||
164321727|NCT00402233|593554201|FG001|Overall Study|Worsening of other pre-existing disease|1|||
164321728|NCT00402233|593554202|FG002|Overall Study|Worsening of other pre-existing disease|0|||
164321729|NCT00402233|593554203|FG003|Overall Study|Worsening of other pre-existing disease|0|||
164321730|NCT00492063|593554207|FG000|Overall Study|Death|0|||
164321731|NCT00492063|593554208|FG001|Overall Study|Death|0|||
164321732|NCT00492063|593554209|FG002|Overall Study|Death|1|||
164321733|NCT00492063|593554210|FG003|Overall Study|Death|2|||
164321734|NCT00492063|593554207|FG000|Overall Study|Withdrawal by Subject|4|||
164321735|NCT00492063|593554208|FG001|Overall Study|Withdrawal by Subject|3|||
164321736|NCT00492063|593554209|FG002|Overall Study|Withdrawal by Subject|5|||
164321737|NCT00492063|593554210|FG003|Overall Study|Withdrawal by Subject|4|||
164321738|NCT00492063|593554207|FG000|Overall Study|Lost to Follow-up|6|||
164076687|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
164076688|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
164321739|NCT00492063|593554208|FG001|Overall Study|Lost to Follow-up|11|||
164321740|NCT00492063|593554209|FG002|Overall Study|Lost to Follow-up|5|||
164321741|NCT00492063|593554210|FG003|Overall Study|Lost to Follow-up|3|||
164321742|NCT00492063|593554207|FG000|Overall Study|Protocol Violation|0|||
164321743|NCT00492063|593554208|FG001|Overall Study|Protocol Violation|0|||
164321744|NCT00492063|593554209|FG002|Overall Study|Protocol Violation|0|||
164321745|NCT00492063|593554210|FG003|Overall Study|Protocol Violation|1|||
164321746|NCT00495040|593554211|FG000|Overall Study|Withdrawal by Subject|3|||
164321747|NCT01829243|593554215|FG000|First Intervention|Screen Failure|4|||
163875067|NCT02998528|591909877|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
164207994|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
164207995|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
164207996|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
164207997|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
164207998|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
164207999|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
164208000|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
164208001|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
164208002|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
164208003|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
164208004|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
164208005|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
164208006|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
164208007|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
164208008|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
164208009|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
164208010|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
164208011|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
164208012|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
164208013|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
164208014|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
164208015|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
164208016|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
164208017|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
164208018|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
164208019|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
164208020|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
164208021|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
164208022|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
164208023|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
164208024|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
164208025|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
164208026|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
164208027|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
164208028|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
164208029|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
164208030|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
164208031|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
164208032|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
164208033|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
164208034|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
164208035|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
164208036|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
164208037|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
164208038|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
164208039|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
164208040|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
164208041|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
164208042|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
164208043|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
164208044|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
164208045|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
164208046|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
164208047|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
164208048|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
164208049|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
164208050|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
164208051|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
164208052|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
164208053|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
164208054|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
163875068|NCT02998528|591909878|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
164208055|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
164208056|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
164208057|NCT00090103|593131567|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
164208058|NCT00090103|593131568|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
164208059|NCT00090103|593131569|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
164208060|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
164208061|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
164208062|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
164208063|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
164208064|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
164208065|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
164208066|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
164208067|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
164208068|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
164208069|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
164208070|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
164208071|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
164208072|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
164208073|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
164208074|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
164208075|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
164208076|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
164208077|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
164208078|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
164208079|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
164208080|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
164208081|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
164208082|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
164208083|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
164208084|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
164208085|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
164208086|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
164208087|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
164208088|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
164208089|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
164208090|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
164208091|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
164208092|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
164208093|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
164208094|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
164208095|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
164208096|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
164208097|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
164208098|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
164208099|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
164208100|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
164208101|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
164208102|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
164208103|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
164208104|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
164208105|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
164208106|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
164208107|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
164208108|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Death|1|||
164208109|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Death|0|||
164208110|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Death|1|||
164208111|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
164208112|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
164208113|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
164208114|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
164208115|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
164208116|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
164208117|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
164321748|NCT01829243|593554216|FG001|First Intervention|Screen Failure|2|||
164321749|NCT02282293|593554219|FG000|Overall Study|Lost to Follow-up|2|||
164321750|NCT02282293|593554220|FG001|Overall Study|Lost to Follow-up|2|||
164321751|NCT02282293|593554219|FG000|Overall Study|Unable to comply with study procedures|1|||
164321752|NCT02282293|593554220|FG001|Overall Study|Unable to comply with study procedures|0|||
164321753|NCT02282293|593554219|FG000|Overall Study|Moved out of study area|0|||
164321754|NCT02282293|593554220|FG001|Overall Study|Moved out of study area|1|||
164321755|NCT00053898|593554221|FG000|Overall Study|No follow-up data from any source|9|||
164321756|NCT00053898|593554222|FG001|Overall Study|No follow-up data from any source|12|||
164321757|NCT00053898|593554221|FG000|Overall Study|Follow-up from telephone contact only|5|||
164321758|NCT00053898|593554222|FG001|Overall Study|Follow-up from telephone contact only|1|||
164321759|NCT03985878|593554226|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
164321760|NCT03985878|593554226|FG000|Overall Study|Study Terminated by Sponsor|12|||
164321761|NCT03985878|593554226|FG000|Overall Study|Withdrawal by Subject|1|||
164321762|NCT01894568|593554227|FG000|Overall Study|Adverse Event|2|||
164321763|NCT01894568|593554228|FG001|Overall Study|Adverse Event|3|||
164321764|NCT01894568|593554227|FG000|Overall Study|Protocol required discontinuation|2|||
164321765|NCT01894568|593554228|FG001|Overall Study|Protocol required discontinuation|1|||
164321766|NCT01894568|593554227|FG000|Overall Study|Withdrawal by Subject|5|||
164321767|NCT01894568|593554228|FG001|Overall Study|Withdrawal by Subject|5|||
164321768|NCT01894568|593554227|FG000|Overall Study|Physician Decision|1|||
164321769|NCT01894568|593554228|FG001|Overall Study|Physician Decision|0|||
164321770|NCT01894568|593554227|FG000|Overall Study|Lost to Follow-up|0|||
164321771|NCT01894568|593554228|FG001|Overall Study|Lost to Follow-up|1|||
164321772|NCT01089361|593554230|FG000|Overall Study|Death|1|||
164321773|NCT01089361|593554231|FG001|Overall Study|Death|0|||
164321774|NCT01514370|593554232|FG000|Overall Study|Protocol Violation|2|||
163875069|NCT02998528|591909876|FG000|Randomization Period|Participant withdrew consent|0|||
163875070|NCT02998528|591909877|FG001|Randomization Period|Participant withdrew consent|3|||
163875071|NCT02998528|591909878|FG002|Randomization Period|Participant withdrew consent|0|||
163875072|NCT02998528|591909876|FG000|Randomization Period|Participant no longer meets study criteria|1|||
163875073|NCT02998528|591909877|FG001|Randomization Period|Participant no longer meets study criteria|3|||
163875074|NCT02998528|591909878|FG002|Randomization Period|Participant no longer meets study criteria|2|||
163875075|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
163875076|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
163875077|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
163875078|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
163875079|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
163875080|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
163875081|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
163875082|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
163875083|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
163875084|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
163875085|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
163875086|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
163875087|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
163875088|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
163875089|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
163875090|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Death|1|||
163875091|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Death|0|||
163875092|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Death|0|||
163875093|NCT02998528|591909876|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
163875094|NCT02998528|591909877|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
163875095|NCT02998528|591909878|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
163875096|NCT02998528|591909876|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
163875097|NCT02998528|591909877|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
163875098|NCT02998528|591909878|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
163875099|NCT02998528|591909876|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
163875100|NCT02998528|591909877|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
163875101|NCT02998528|591909878|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
163979752|NCT02543528|592297244|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
164321775|NCT01514370|593554233|FG001|Overall Study|Protocol Violation|3|||
164321776|NCT01514370|593554232|FG000|Overall Study|Lost to Follow-up|0|||
164321777|NCT01514370|593554233|FG001|Overall Study|Lost to Follow-up|2|||
164321778|NCT01514370|593554232|FG000|Overall Study|Withdrawal by Subject|2|||
164321779|NCT01514370|593554233|FG001|Overall Study|Withdrawal by Subject|1|||
164321780|NCT01514370|593554232|FG000|Overall Study|Adverse Event|1|||
164321781|NCT01514370|593554233|FG001|Overall Study|Adverse Event|3|||
164321782|NCT01514370|593554232|FG000|Overall Study|Other|6|||
164321783|NCT01514370|593554233|FG001|Overall Study|Other|7|||
164321784|NCT00169442|593554234|FG000|Overall Study|Withdrawal by Subject|0|||
164321785|NCT00169442|593554235|FG001|Overall Study|Withdrawal by Subject|0|||
164321786|NCT00169442|593554236|FG002|Overall Study|Withdrawal by Subject|1|||
164321787|NCT00169442|593554237|FG003|Overall Study|Withdrawal by Subject|0|||
164321788|NCT00169442|593554238|FG004|Overall Study|Withdrawal by Subject|0|||
164321789|NCT00169442|593554239|FG005|Overall Study|Withdrawal by Subject|0|||
164321790|NCT00169442|593554234|FG000|Overall Study|Migrated/moved from study area|0|||
164321791|NCT00169442|593554235|FG001|Overall Study|Migrated/moved from study area|0|||
164321792|NCT00169442|593554236|FG002|Overall Study|Migrated/moved from study area|0|||
164321793|NCT00169442|593554237|FG003|Overall Study|Migrated/moved from study area|0|||
164321794|NCT00169442|593554238|FG004|Overall Study|Migrated/moved from study area|0|||
164321795|NCT00169442|593554239|FG005|Overall Study|Migrated/moved from study area|2|||
164321796|NCT00169442|593554234|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321797|NCT00169442|593554235|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321798|NCT00169442|593554236|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321799|NCT00169442|593554237|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321800|NCT00169442|593554238|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
164321801|NCT00169442|593554239|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164321802|NCT00169442|593554234|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
163875102|NCT02998528|591909876|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
164321803|NCT00169442|593554235|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
164321804|NCT00169442|593554236|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321805|NCT00169442|593554237|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321806|NCT00169442|593554238|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321807|NCT00169442|593554239|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
164321808|NCT03353740|593554242|FG000|Overall Study|Images for these participants not viable|52|||
164321809|NCT02232880|593554244|FG000|Overall Study|study stopped prior to randomization|1|||
164321810|NCT02519855|593555433|FG000|Overall Study|Adverse Event|0|||
164321811|NCT02519855|593555434|FG001|Overall Study|Adverse Event|1|||
164321812|NCT02519855|593555433|FG000|Overall Study|Lost to Follow-up|3|||
164321813|NCT02519855|593555434|FG001|Overall Study|Lost to Follow-up|3|||
164321814|NCT00640835|593555438|FG000|Overall Study|Adverse Event|5|||
164321815|NCT00640835|593555439|FG001|Overall Study|Adverse Event|3|||
164321816|NCT00640835|593555438|FG000|Overall Study|Withdrawal by Subject|12|||
164321817|NCT00640835|593555439|FG001|Overall Study|Withdrawal by Subject|14|||
164321818|NCT00640835|593555438|FG000|Overall Study|Physician Decision|10|||
164321819|NCT00640835|593555439|FG001|Overall Study|Physician Decision|14|||
164321820|NCT00640835|593555438|FG000|Overall Study|Sponsor's Decision|11|||
164321821|NCT00640835|593555439|FG001|Overall Study|Sponsor's Decision|7|||
164321822|NCT00640835|593555438|FG000|Overall Study|Protocol Violation|2|||
164321823|NCT00640835|593555439|FG001|Overall Study|Protocol Violation|2|||
164321824|NCT00640835|593555438|FG000|Overall Study|Lost to Follow-up|17|||
164321825|NCT00640835|593555439|FG001|Overall Study|Lost to Follow-up|13|||
164321826|NCT00640835|593555438|FG000|Overall Study|Other Reason|19|||
164321827|NCT00640835|593555439|FG001|Overall Study|Other Reason|4|||
164321828|NCT05954143|593555444|FG000|Overall Study|Progressive Disease|1|||
164321829|NCT05954143|593555445|FG001|Overall Study|Progressive Disease|0|||
164321830|NCT05954143|593555444|FG000|Overall Study|Physician Decision|1|||
164321831|NCT05954143|593555445|FG001|Overall Study|Physician Decision|0|||
164321832|NCT05954143|593555444|FG000|Overall Study|Study Terminated by Sponsor|2|||
164321833|NCT05954143|593555445|FG001|Overall Study|Study Terminated by Sponsor|4|||
164321834|NCT05954143|593555444|FG000|Overall Study|Death|1|||
164321835|NCT05954143|593555445|FG001|Overall Study|Death|0|||
164321836|NCT05954143|593555444|FG000|Overall Study|Withdrawal by Subject|0|||
164321837|NCT05954143|593555445|FG001|Overall Study|Withdrawal by Subject|1|||
164321838|NCT05954143|593555444|FG000|Overall Study|Other|1|||
164321839|NCT05954143|593555445|FG001|Overall Study|Other|0|||
164321840|NCT00713310|593555446|FG000|Overall Study|Adverse Event|5|||
164321841|NCT00713310|593555447|FG001|Overall Study|Adverse Event|2|||
164321842|NCT00713310|593555446|FG000|Overall Study|Lack of Efficacy|0|||
164321843|NCT00713310|593555447|FG001|Overall Study|Lack of Efficacy|2|||
164321844|NCT00713310|593555446|FG000|Overall Study|Withdrawal by Subject|0|||
164321845|NCT00713310|593555447|FG001|Overall Study|Withdrawal by Subject|2|||
164321846|NCT00686634|593555448|FG000|Overall Study|Protocol Violation|6|||
164321847|NCT04369924|593555450|FG000|Overall Study|Lost to Follow-up|302|||
164321848|NCT04369924|593555451|FG001|Overall Study|Lost to Follow-up|339|||
163875103|NCT02998528|591909877|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
163875104|NCT02998528|591909878|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
163875105|NCT02998528|591909876|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
164321849|NCT01653132|593555454|FG000|First Intervention|Protocol Violation|1|||
164321850|NCT01653132|593555455|FG001|First Intervention|Protocol Violation|0|||
164321851|NCT03828370|593555456|FG000|3 Month Follow-up|Lost to Follow-up|4|||
164321852|NCT03828370|593555457|FG001|3 Month Follow-up|Lost to Follow-up|12|||
164136343|NCT01629966|592862133|FG001|Overall Study|Lack of Efficacy|2|||
164208118|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
164208119|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
164208120|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
164208121|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
164208122|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
164208123|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
164208124|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
164208125|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
164208126|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
164208127|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
164208128|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
164208129|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
164208130|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
164208131|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
164208132|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Depression|0|||
164208133|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Depression|1|||
164208134|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Depression|0|||
164208135|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
164208136|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
164208137|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
164208138|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Jailed|0|||
164208139|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Jailed|1|||
164208140|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Jailed|0|||
164208141|NCT00090103|593131567|FG000|16-Week Safety Follow-up Period|Other|0|||
164208142|NCT00090103|593131568|FG001|16-Week Safety Follow-up Period|Other|1|||
164208143|NCT00090103|593131569|FG002|16-Week Safety Follow-up Period|Other|0|||
164208144|NCT06633965|593131572|FG000|Overall Study|Withdrawal by Subject|0|||
164208145|NCT06633965|593131573|FG001|Overall Study|Withdrawal by Subject|1|||
164208146|NCT00947544|593131578|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
164208147|NCT00947544|593131579|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
164208148|NCT00300053|593131584|FG000|Overall Study|Patient/Caregiver Preference|2|||
164208149|NCT00300053|593131585|FG001|Overall Study|Patient/Caregiver Preference|2|||
164208150|NCT00300053|593131586|FG002|Overall Study|Patient/Caregiver Preference|3|||
164208151|NCT00300053|593131584|FG000|Overall Study|Death|0|||
164208152|NCT00300053|593131585|FG001|Overall Study|Death|0|||
164208153|NCT00300053|593131586|FG002|Overall Study|Death|3|||
164208154|NCT00300053|593131584|FG000|Overall Study|Lost to Follow-up|0|||
164208155|NCT00300053|593131585|FG001|Overall Study|Lost to Follow-up|1|||
164208156|NCT00300053|593131586|FG002|Overall Study|Lost to Follow-up|0|||
164208157|NCT02566005|593131587|FG000|Overall Study|vaginal bleeding|0|||
164208158|NCT02566005|593131588|FG001|Overall Study|vaginal bleeding|1|||
164208159|NCT02566005|593131587|FG000|Overall Study|received foley|8|||
164208160|NCT02566005|593131588|FG001|Overall Study|received foley|0|||
164208161|NCT02566005|593131587|FG000|Overall Study|did not receive foley|0|||
164208162|NCT02566005|593131588|FG001|Overall Study|did not receive foley|1|||
164208163|NCT02566005|593131587|FG000|Overall Study|labor after randomization|0|||
164208164|NCT02566005|593131588|FG001|Overall Study|labor after randomization|4|||
164208165|NCT02472405|593131589|FG000|Overall Study|Lost to Follow-up|9|||
164208166|NCT02472405|593131589|FG000|Overall Study|Adverse Event|1|||
164208167|NCT03095287|593131590|FG000|Overall Study|Treatment Failure|1|||
164208168|NCT03095287|593131590|FG000|Overall Study|Adverse Event|1|||
164208169|NCT01134042|593131593|FG000|Overall Study|Adverse Event|3|||
164208170|NCT01134042|593131594|FG001|Overall Study|Adverse Event|7|||
164208171|NCT01134042|593131595|FG002|Overall Study|Adverse Event|2|||
164208172|NCT01134042|593131593|FG000|Overall Study|Lack of Efficacy|21|||
164208173|NCT01134042|593131594|FG001|Overall Study|Lack of Efficacy|6|||
164208174|NCT01134042|593131595|FG002|Overall Study|Lack of Efficacy|18|||
164208175|NCT01134042|593131593|FG000|Overall Study|Protocol Violation|5|||
164208176|NCT01134042|593131594|FG001|Overall Study|Protocol Violation|3|||
164208177|NCT01134042|593131595|FG002|Overall Study|Protocol Violation|5|||
164208178|NCT01134042|593131593|FG000|Overall Study|Lost to Follow-up|2|||
164208179|NCT01134042|593131594|FG001|Overall Study|Lost to Follow-up|0|||
164208180|NCT01134042|593131595|FG002|Overall Study|Lost to Follow-up|1|||
164208181|NCT01134042|593131593|FG000|Overall Study|Physician Decision|4|||
164208182|NCT01134042|593131594|FG001|Overall Study|Physician Decision|8|||
164208183|NCT01134042|593131595|FG002|Overall Study|Physician Decision|1|||
164208184|NCT01134042|593131593|FG000|Overall Study|Withdrawal by Subject|13|||
164208185|NCT01134042|593131594|FG001|Overall Study|Withdrawal by Subject|4|||
164208186|NCT01134042|593131595|FG002|Overall Study|Withdrawal by Subject|7|||
164208187|NCT03345004|593131596|FG000|Overall Study|Physician Decision|1|||
164208188|NCT03345004|593131597|FG001|Overall Study|Physician Decision|0|||
164208189|NCT03345004|593131596|FG000|Overall Study|Withdrawal by Subject|0|||
164208190|NCT03345004|593131597|FG001|Overall Study|Withdrawal by Subject|1|||
164208191|NCT05350423|593131598|FG000|Overall Study|Lost to Follow-up|3|||
164208192|NCT05350423|593131599|FG001|Overall Study|Lost to Follow-up|3|||
163875106|NCT02998528|591909877|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
163875107|NCT02998528|591909878|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
163875108|NCT02998528|591909876|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
164208193|NCT05350423|593131598|FG000|Overall Study|screen failure|5|||
163875109|NCT02998528|591909877|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
163875110|NCT02998528|591909878|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
163875111|NCT02692417|591909879|FG000|Overall Study|Withdrawal by Subject|5|||
163875112|NCT02692417|591909880|FG001|Overall Study|Withdrawal by Subject|1|||
163875113|NCT02692417|591909879|FG000|Overall Study|Adverse Event|1|||
163875114|NCT02692417|591909880|FG001|Overall Study|Adverse Event|0|||
163875115|NCT01753570|591909885|FG000|Overall Study|Adverse Event|1|||
163875116|NCT01753570|591909886|FG001|Overall Study|Adverse Event|0|||
163875117|NCT01753570|591909887|FG002|Overall Study|Adverse Event|1|||
163875118|NCT01753570|591909885|FG000|Overall Study|Physician Decision|0|||
163875119|NCT01753570|591909886|FG001|Overall Study|Physician Decision|1|||
163875120|NCT01753570|591909887|FG002|Overall Study|Physician Decision|0|||
163875121|NCT01753570|591909885|FG000|Overall Study|Withdrawal by Subject|1|||
163875122|NCT01753570|591909886|FG001|Overall Study|Withdrawal by Subject|4|||
163875123|NCT01753570|591909887|FG002|Overall Study|Withdrawal by Subject|0|||
163875124|NCT05308316|591909888|FG000|Overall Study|Withdrawal by Subject|2|||
163875125|NCT05308316|591909888|FG000|Overall Study|Physician Decision|1|||
163875126|NCT03997916|591909892|FG000|Overall Study|Protocol Violation|35|||
163875127|NCT04310735|591911537|FG000|Overall Study|Withdrawal by Subject|1|||
163875128|NCT04310735|591911538|FG001|Overall Study|Withdrawal by Subject|3|||
163875129|NCT04310735|591911539|FG002|Overall Study|Withdrawal by Subject|8|||
163875130|NCT04310735|591911537|FG000|Overall Study|Equipment malfunction|0|||
163875131|NCT04310735|591911538|FG001|Overall Study|Equipment malfunction|1|||
163875132|NCT04310735|591911539|FG002|Overall Study|Equipment malfunction|0|||
163875133|NCT03012841|591911540|FG000|Overall Study|Protocol Violation|0|||
163875134|NCT03012841|591911541|FG001|Overall Study|Protocol Violation|10|||
163875135|NCT03012841|591911540|FG000|Overall Study|Lost to Follow-up|6|||
163875136|NCT03012841|591911541|FG001|Overall Study|Lost to Follow-up|1|||
163875137|NCT03012841|591911540|FG000|Overall Study|Withdrawal by Subject|6|||
163875138|NCT03012841|591911541|FG001|Overall Study|Withdrawal by Subject|0|||
163875139|NCT03012841|591911540|FG000|Overall Study|Unable to complete 12 month visit|6|||
163875140|NCT03012841|591911541|FG001|Overall Study|Unable to complete 12 month visit|0|||
163875141|NCT03012841|591911540|FG000|Overall Study|Subject relocation|1|||
163875142|NCT03012841|591911541|FG001|Overall Study|Subject relocation|0|||
163875143|NCT03012841|591911540|FG000|Overall Study|Seasonal winter travel|1|||
163875144|NCT03012841|591911541|FG001|Overall Study|Seasonal winter travel|0|||
164076689|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
164076690|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
164076691|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
164076692|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
164208194|NCT05350423|593131599|FG001|Overall Study|screen failure|6|||
164208195|NCT02097277|593131600|FG000|Overall Study|Subject no longer meets study criteria|0|||
164208196|NCT02097277|593131601|FG001|Overall Study|Subject no longer meets study criteria|1|||
164208197|NCT02097277|593131602|FG002|Overall Study|Subject no longer meets study criteria|0|||
164208198|NCT02097277|593131603|FG003|Overall Study|Subject no longer meets study criteria|1|||
164208199|NCT02097277|593131604|FG004|Overall Study|Subject no longer meets study criteria|0|||
164208200|NCT02097277|593131600|FG000|Overall Study|Subject request to discontinue treatment|0|||
164208201|NCT02097277|593131601|FG001|Overall Study|Subject request to discontinue treatment|0|||
164208202|NCT02097277|593131602|FG002|Overall Study|Subject request to discontinue treatment|0|||
164208203|NCT02097277|593131603|FG003|Overall Study|Subject request to discontinue treatment|0|||
164208204|NCT02097277|593131604|FG004|Overall Study|Subject request to discontinue treatment|1|||
164208205|NCT02097277|593131600|FG000|Overall Study|Lost to Follow-up|0|||
164208206|NCT02097277|593131601|FG001|Overall Study|Lost to Follow-up|1|||
164208207|NCT02097277|593131602|FG002|Overall Study|Lost to Follow-up|1|||
164208208|NCT02097277|593131603|FG003|Overall Study|Lost to Follow-up|0|||
164208209|NCT02097277|593131604|FG004|Overall Study|Lost to Follow-up|0|||
164208210|NCT02097277|593131600|FG000|Overall Study|Withdrawal by Subject|2|||
164208211|NCT02097277|593131601|FG001|Overall Study|Withdrawal by Subject|1|||
164208212|NCT02097277|593131602|FG002|Overall Study|Withdrawal by Subject|0|||
164208213|NCT02097277|593131603|FG003|Overall Study|Withdrawal by Subject|1|||
164208214|NCT02097277|593131604|FG004|Overall Study|Withdrawal by Subject|0|||
164208215|NCT02097277|593131600|FG000|Overall Study|Adverse Event|0|||
163875145|NCT03012841|591911540|FG000|Overall Study|Physician Decision|0|||
163875146|NCT03012841|591911541|FG001|Overall Study|Physician Decision|2|||
163875147|NCT03012841|591911540|FG000|Overall Study|No ablation performed|0|||
163875148|NCT03012841|591911541|FG001|Overall Study|No ablation performed|2|||
163875149|NCT03012841|591911540|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
163875150|NCT03012841|591911541|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
163875151|NCT03012841|591911540|FG000|Overall Study|Insurance change|0|||
164208216|NCT02097277|593131601|FG001|Overall Study|Adverse Event|0|||
164208217|NCT02097277|593131602|FG002|Overall Study|Adverse Event|1|||
164208218|NCT02097277|593131603|FG003|Overall Study|Adverse Event|2|||
164208219|NCT02097277|593131604|FG004|Overall Study|Adverse Event|0|||
164208220|NCT01091259|593131609|FG000|Overall Study|Adverse Event|3|||
164208221|NCT01091259|593131609|FG000|Overall Study|Lack of Efficacy|2|||
164208222|NCT00984867|593131619|FG000|Overall Study|Adverse Event|3|||
164208223|NCT00984867|593131620|FG001|Overall Study|Adverse Event|7|||
164208224|NCT00984867|593131619|FG000|Overall Study|Death|1|||
164208225|NCT00984867|593131620|FG001|Overall Study|Death|0|||
164208226|NCT00984867|593131619|FG000|Overall Study|Withdrawal by Subject|13|||
164208227|NCT00984867|593131620|FG001|Overall Study|Withdrawal by Subject|4|||
164208228|NCT00984867|593131619|FG000|Overall Study|Lost to Follow-up|3|||
164208229|NCT00984867|593131620|FG001|Overall Study|Lost to Follow-up|4|||
164208230|NCT00984867|593131619|FG000|Overall Study|Poor/non-compliance|0|||
164208231|NCT00984867|593131620|FG001|Overall Study|Poor/non-compliance|1|||
164208232|NCT00984867|593131619|FG000|Overall Study|Subject no longer meets study criteria|1|||
164208233|NCT00984867|593131620|FG001|Overall Study|Subject no longer meets study criteria|1|||
164208234|NCT00984867|593131619|FG000|Overall Study|site closing|1|||
164208235|NCT00984867|593131620|FG001|Overall Study|site closing|0|||
164208236|NCT00984867|593131619|FG000|Overall Study|lack of efficacy and subject compliance|1|||
164208237|NCT00984867|593131620|FG001|Overall Study|lack of efficacy and subject compliance|0|||
164208238|NCT00671060|593131621|FG000|Overall Study|Protocol Violation|1|||
164208239|NCT00671060|593131622|FG001|Overall Study|Protocol Violation|0|||
164208240|NCT00671060|593131621|FG000|Overall Study|Physician Decision|0|||
164208241|NCT00671060|593131622|FG001|Overall Study|Physician Decision|1|||
164208242|NCT01541748|593131623|FG000|Overall Study|Lost to Follow-up|17|||
164208243|NCT01541748|593131623|FG000|Overall Study|Moved out of state|1|||
164208244|NCT01541748|593131623|FG000|Overall Study|Withdrawal by Subject|7|||
164208245|NCT01541748|593131623|FG000|Overall Study|Screen failure|5|||
164208246|NCT01541748|593131623|FG000|Overall Study|Did not receive study device|1|||
164208247|NCT00626639|593131631|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
164208248|NCT00626639|593131632|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
164208249|NCT01155141|593131633|FG000|Overall Study|Withdrawal by Subject|1|||
164208250|NCT01155141|593131633|FG000|Overall Study|Screen Failure|1|||
164208251|NCT03473197|593131634|FG000|Overall Study|Adverse Event|4|||
164208252|NCT03473197|593131634|FG000|Overall Study|Lost to Follow-up|1|||
164208253|NCT03473197|593131634|FG000|Overall Study|Withdrawal by Subject|5|||
164208254|NCT00785629|593131635|FG000|Overall Study|Adverse Event|2|||
164208255|NCT00785629|593131636|FG001|Overall Study|Adverse Event|1|||
164208256|NCT00785629|593131637|FG002|Overall Study|Adverse Event|1|||
164208257|NCT00785629|593131638|FG003|Overall Study|Adverse Event|5|||
164208258|NCT00785629|593131635|FG000|Overall Study|Protocol Violation|1|||
164208259|NCT00785629|593131636|FG001|Overall Study|Protocol Violation|2|||
164208260|NCT00785629|593131637|FG002|Overall Study|Protocol Violation|4|||
164208261|NCT00785629|593131638|FG003|Overall Study|Protocol Violation|5|||
164208262|NCT00785629|593131635|FG000|Overall Study|administrative decision|5|||
164208263|NCT00785629|593131636|FG001|Overall Study|administrative decision|1|||
164208264|NCT00785629|593131637|FG002|Overall Study|administrative decision|3|||
164208265|NCT00785629|593131638|FG003|Overall Study|administrative decision|4|||
164208266|NCT00785629|593131635|FG000|Overall Study|Withdrawal by Subject|0|||
164208267|NCT00785629|593131636|FG001|Overall Study|Withdrawal by Subject|1|||
164208268|NCT00785629|593131637|FG002|Overall Study|Withdrawal by Subject|2|||
164208269|NCT00785629|593131638|FG003|Overall Study|Withdrawal by Subject|2|||
164208270|NCT02020941|593131641|FG000|Overall Study|Adverse Event|1|||
164208271|NCT02020941|593131641|FG000|Overall Study|Physician Decision|2|||
164208272|NCT02020941|593131641|FG000|Overall Study|Withdrawal by Subject|1|||
164208273|NCT02020941|593131641|FG000|Overall Study|Disease Progression|4|||
164208274|NCT02107898|593131644|FG000|Overall Study|Adverse Event|4|||
164208275|NCT02107898|593131645|FG001|Overall Study|Adverse Event|7|||
164208276|NCT02107898|593131644|FG000|Overall Study|Poor compliance to protocol|0|||
164208277|NCT02107898|593131645|FG001|Overall Study|Poor compliance to protocol|1|||
164208278|NCT02107898|593131644|FG000|Overall Study|Participant moved|0|||
164208279|NCT02107898|593131645|FG001|Overall Study|Participant moved|2|||
164208280|NCT02107898|593131644|FG000|Overall Study|Consent withdrawn by participant|2|||
164208281|NCT02107898|593131645|FG001|Overall Study|Consent withdrawn by participant|1|||
164208282|NCT02107898|593131644|FG000|Overall Study|Randomized but not treated|0|||
164208283|NCT02107898|593131645|FG001|Overall Study|Randomized but not treated|1|||
164208284|NCT03329989|593131646|FG000|Overall Study|Withdrawal by Subject|9|||
164208285|NCT03329989|593131646|FG000|Overall Study|Lost to Follow-up|8|||
164208286|NCT03329989|593131646|FG000|Overall Study|Adverse Event|5|||
164208287|NCT03329989|593131646|FG000|Overall Study|Protocol Violation|1|||
164208288|NCT00879658|593131648|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164208289|NCT00879658|593131649|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164208290|NCT00879658|593131650|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164208291|NCT00879658|593131651|FG003|Overall Study|Abnormal laboratory value(s)|1|||
164208292|NCT00879658|593131652|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164321853|NCT03828370|593555456|FG000|9 Month Follow up|Lost to Follow-up|12|||
164321854|NCT03828370|593555457|FG001|9 Month Follow up|Lost to Follow-up|20|||
164321855|NCT01209832|593555458|FG000|Period 1|Sponsor Decision and was not dosed|1|||
164321856|NCT01209832|593555458|FG000|Period 2|Sponsor Decision|1|||
164321857|NCT00761150|593555459|FG000|Open-label Period|Adverse Event|36|||
164321858|NCT00761150|593555460|FG001|Open-label Period|Adverse Event|0|||
164321859|NCT00761150|593555461|FG002|Open-label Period|Adverse Event|0|||
164321860|NCT00761150|593555459|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
164321861|NCT00761150|593555460|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
164321862|NCT00761150|593555461|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
164076693|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
164076694|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
164076695|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
164076696|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
164076697|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
164076698|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
164076699|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
164076700|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
164076701|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
164076702|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
164076703|NCT00528879|592645794|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
164076704|NCT00528879|592645795|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
164076705|NCT00528879|592645796|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
164076706|NCT00528879|592645797|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
164076707|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
164076708|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
164076709|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
164076710|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
164076711|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
164076712|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
164076713|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
164076714|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
164076715|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
164076716|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
164076717|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
164076718|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
164076719|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
164076720|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
164076721|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
164076722|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
164076723|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
164076724|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
164321863|NCT00761150|593555459|FG000|Open-label Period|Lost to Follow-up|7|||
164321864|NCT00761150|593555460|FG001|Open-label Period|Lost to Follow-up|0|||
164321865|NCT00761150|593555461|FG002|Open-label Period|Lost to Follow-up|0|||
164321866|NCT00761150|593555459|FG000|Open-label Period|Lack of Efficacy|4|||
164321867|NCT00761150|593555460|FG001|Open-label Period|Lack of Efficacy|0|||
164321868|NCT00761150|593555461|FG002|Open-label Period|Lack of Efficacy|0|||
164321869|NCT00761150|593555459|FG000|Open-label Period|Withdrawal by Subject|5|||
164321870|NCT00761150|593555460|FG001|Open-label Period|Withdrawal by Subject|0|||
164321871|NCT00761150|593555461|FG002|Open-label Period|Withdrawal by Subject|0|||
164321872|NCT00761150|593555459|FG000|Open-label Period|Noncompliance|2|||
164321873|NCT00761150|593555460|FG001|Open-label Period|Noncompliance|0|||
164321874|NCT00761150|593555461|FG002|Open-label Period|Noncompliance|0|||
164321875|NCT00761150|593555459|FG000|Open-label Period|Other|5|||
164321876|NCT00761150|593555460|FG001|Open-label Period|Other|0|||
164321877|NCT00761150|593555461|FG002|Open-label Period|Other|0|||
164321878|NCT00761150|593555459|FG000|Double-blind Period|Lack of Efficacy|0|||
164321879|NCT00761150|593555460|FG001|Double-blind Period|Lack of Efficacy|2|||
164321880|NCT00761150|593555461|FG002|Double-blind Period|Lack of Efficacy|19|||
164321881|NCT00761150|593555459|FG000|Double-blind Period|Adverse Event|0|||
164321882|NCT00761150|593555460|FG001|Double-blind Period|Adverse Event|3|||
164321883|NCT00761150|593555461|FG002|Double-blind Period|Adverse Event|3|||
164321884|NCT00761150|593555459|FG000|Double-blind Period|Withdrawal by Subject|0|||
164321885|NCT00761150|593555460|FG001|Double-blind Period|Withdrawal by Subject|3|||
164076725|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
164321886|NCT00761150|593555461|FG002|Double-blind Period|Withdrawal by Subject|2|||
164321887|NCT00761150|593555459|FG000|Double-blind Period|Lost to Follow-up|0|||
164321888|NCT00761150|593555460|FG001|Double-blind Period|Lost to Follow-up|2|||
164321889|NCT00761150|593555461|FG002|Double-blind Period|Lost to Follow-up|1|||
164076726|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
164076727|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
164076728|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
164076729|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
164076730|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
164076731|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
164076732|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
164076733|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
164076734|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
164076735|NCT00528879|592645794|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
164076736|NCT00528879|592645795|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
164076737|NCT00528879|592645796|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
164076738|NCT00528879|592645797|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
164076739|NCT01159769|592645798|FG000|Overall Study|Adverse Event|1|||
164076740|NCT02555618|592645799|FG000|Overall Study|Sponsor's Circumstances|1|||
164076741|NCT02555618|592645800|FG001|Overall Study|Sponsor's Circumstances|0|||
164076742|NCT02217345|592645801|FG000|Overall Study|Lost to Follow-up|2|||
164076743|NCT02217345|592645802|FG001|Overall Study|Lost to Follow-up|1|||
164076744|NCT02217345|592645801|FG000|Overall Study|Withdrawal by Subject|3|||
164076745|NCT02217345|592645802|FG001|Overall Study|Withdrawal by Subject|2|||
164076746|NCT02217345|592645801|FG000|Overall Study|Adverse Event|2|||
164076747|NCT02217345|592645802|FG001|Overall Study|Adverse Event|1|||
164076748|NCT02217345|592645801|FG000|Overall Study|Physician Decision|0|||
164076749|NCT02217345|592645802|FG001|Overall Study|Physician Decision|1|||
164076750|NCT00845026|592645803|FG000|Study Period III|Adverse Event|23|||
164076751|NCT00845026|592645804|FG001|Study Period III|Adverse Event|19|||
164076752|NCT00845026|592645803|FG000|Study Period III|Perceived lack of efficacy|27|||
164136344|NCT01629966|592862134|FG002|Overall Study|Lack of Efficacy|4|||
164136345|NCT01629966|592862132|FG000|Overall Study|Adverse Event|11|||
164136346|NCT01629966|592862133|FG001|Overall Study|Adverse Event|18|||
164136347|NCT01629966|592862134|FG002|Overall Study|Adverse Event|30|||
164136348|NCT01150890|592862135|FG000|Overall Study|Other|0|||
164136349|NCT01150890|592862136|FG001|Overall Study|Other|1|||
164136350|NCT01150890|592862137|FG002|Overall Study|Other|0|||
164136351|NCT01150890|592862138|FG003|Overall Study|Other|2|||
164136352|NCT01150890|592862135|FG000|Overall Study|Pregnancy|0|||
164136353|NCT01150890|592862136|FG001|Overall Study|Pregnancy|0|||
164136354|NCT01150890|592862137|FG002|Overall Study|Pregnancy|0|||
164136355|NCT01150890|592862138|FG003|Overall Study|Pregnancy|1|||
164136356|NCT01150890|592862135|FG000|Overall Study|Administrative Decision|4|||
164136357|NCT01150890|592862136|FG001|Overall Study|Administrative Decision|4|||
164136358|NCT01150890|592862137|FG002|Overall Study|Administrative Decision|5|||
164136359|NCT01150890|592862138|FG003|Overall Study|Administrative Decision|6|||
164136360|NCT01150890|592862135|FG000|Overall Study|Ineligibility determined|0|||
164136361|NCT01150890|592862136|FG001|Overall Study|Ineligibility determined|1|||
164136362|NCT01150890|592862137|FG002|Overall Study|Ineligibility determined|0|||
164136363|NCT01150890|592862138|FG003|Overall Study|Ineligibility determined|0|||
164136364|NCT01150890|592862135|FG000|Overall Study|Adverse Event|0|||
164136365|NCT01150890|592862136|FG001|Overall Study|Adverse Event|0|||
164136366|NCT01150890|592862137|FG002|Overall Study|Adverse Event|2|||
164136367|NCT01150890|592862138|FG003|Overall Study|Adverse Event|0|||
164136368|NCT01150890|592862135|FG000|Overall Study|Withdrawal by Subject|0|||
164136369|NCT01150890|592862136|FG001|Overall Study|Withdrawal by Subject|0|||
164136370|NCT01150890|592862137|FG002|Overall Study|Withdrawal by Subject|2|||
164136371|NCT01150890|592862138|FG003|Overall Study|Withdrawal by Subject|1|||
164136372|NCT01150890|592862135|FG000|Overall Study|Disease progression|0|||
164136373|NCT01150890|592862136|FG001|Overall Study|Disease progression|7|||
164136374|NCT01150890|592862137|FG002|Overall Study|Disease progression|3|||
164136375|NCT01150890|592862138|FG003|Overall Study|Disease progression|7|||
164136376|NCT03118570|592862139|FG000|Overall Study|Adverse Event|2|||
164136377|NCT03118570|592862140|FG001|Overall Study|Adverse Event|0|||
164136378|NCT03118570|592862141|FG002|Overall Study|Adverse Event|0|||
164136379|NCT03118570|592862142|FG003|Overall Study|Adverse Event|0|||
164136380|NCT03118570|592862143|FG004|Overall Study|Adverse Event|3|||
164136381|NCT03118570|592862139|FG000|Overall Study|Withdrawal by Subject|0|||
164136382|NCT03118570|592862140|FG001|Overall Study|Withdrawal by Subject|1|||
164136383|NCT03118570|592862141|FG002|Overall Study|Withdrawal by Subject|4|||
164136384|NCT03118570|592862142|FG003|Overall Study|Withdrawal by Subject|0|||
164136385|NCT03118570|592862143|FG004|Overall Study|Withdrawal by Subject|1|||
164136386|NCT03118570|592862139|FG000|Overall Study|Lost to Follow-up|2|||
164136387|NCT03118570|592862140|FG001|Overall Study|Lost to Follow-up|3|||
164136388|NCT03118570|592862141|FG002|Overall Study|Lost to Follow-up|1|||
164136389|NCT03118570|592862142|FG003|Overall Study|Lost to Follow-up|0|||
164136390|NCT03118570|592862143|FG004|Overall Study|Lost to Follow-up|1|||
164136391|NCT03118570|592862139|FG000|Overall Study|Other, Not Specified|1|||
164208293|NCT00879658|593131653|FG005|Overall Study|Abnormal laboratory value(s)|0|||
164208294|NCT00879658|593131654|FG006|Overall Study|Abnormal laboratory value(s)|0|||
164208295|NCT00879658|593131648|FG000|Overall Study|Administrative problems|2|||
164208296|NCT00879658|593131649|FG001|Overall Study|Administrative problems|1|||
164208297|NCT00879658|593131650|FG002|Overall Study|Administrative problems|0|||
164208298|NCT00879658|593131651|FG003|Overall Study|Administrative problems|1|||
164208299|NCT00879658|593131652|FG004|Overall Study|Administrative problems|0|||
164208300|NCT00879658|593131653|FG005|Overall Study|Administrative problems|0|||
164208301|NCT00879658|593131654|FG006|Overall Study|Administrative problems|0|||
164208302|NCT00879658|593131648|FG000|Overall Study|Adverse Event|6|||
164208303|NCT00879658|593131649|FG001|Overall Study|Adverse Event|4|||
164208304|NCT00879658|593131650|FG002|Overall Study|Adverse Event|3|||
164208305|NCT00879658|593131651|FG003|Overall Study|Adverse Event|1|||
164208306|NCT00879658|593131652|FG004|Overall Study|Adverse Event|2|||
163979753|NCT02543528|592297245|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
163979754|NCT02543528|592297241|FG000|Adaptation Period|Lens Handling Difficultes|0|||
163979755|NCT02543528|592297242|FG001|Adaptation Period|Lens Handling Difficultes|0|||
163979756|NCT02543528|592297243|FG002|Adaptation Period|Lens Handling Difficultes|0|||
163979757|NCT02543528|592297244|FG003|Adaptation Period|Lens Handling Difficultes|0|||
163979758|NCT02543528|592297245|FG004|Adaptation Period|Lens Handling Difficultes|8|||
163979759|NCT02543528|592297241|FG000|Adaptation Period|Lost to Follow-up|0|||
163979760|NCT02543528|592297242|FG001|Adaptation Period|Lost to Follow-up|0|||
163979761|NCT02543528|592297243|FG002|Adaptation Period|Lost to Follow-up|0|||
163979762|NCT02543528|592297244|FG003|Adaptation Period|Lost to Follow-up|0|||
163979763|NCT02543528|592297245|FG004|Adaptation Period|Lost to Follow-up|14|||
163979764|NCT02543528|592297241|FG000|Adaptation Period|Adverse Event|0|||
163979765|NCT02543528|592297242|FG001|Adaptation Period|Adverse Event|0|||
163979766|NCT02543528|592297243|FG002|Adaptation Period|Adverse Event|0|||
163979767|NCT02543528|592297244|FG003|Adaptation Period|Adverse Event|0|||
163979768|NCT02543528|592297245|FG004|Adaptation Period|Adverse Event|2|||
163979769|NCT02543528|592297241|FG000|Extended Wear Period|Adverse Event|17|||
163979770|NCT02543528|592297242|FG001|Extended Wear Period|Adverse Event|11|||
163979771|NCT02543528|592297243|FG002|Extended Wear Period|Adverse Event|16|||
163979772|NCT02543528|592297244|FG003|Extended Wear Period|Adverse Event|3|||
163979773|NCT02543528|592297245|FG004|Extended Wear Period|Adverse Event|0|||
163979774|NCT02543528|592297241|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
163979775|NCT02543528|592297242|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
163979776|NCT02543528|592297243|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
163979777|NCT02543528|592297244|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
163979778|NCT02543528|592297245|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
163979779|NCT02543528|592297241|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
163979780|NCT02543528|592297242|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163979781|NCT02543528|592297243|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163979782|NCT02543528|592297244|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163979783|NCT02543528|592297245|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
163979784|NCT02543528|592297241|FG000|Extended Wear Period|Lost to Follow-up|0|||
163979785|NCT02543528|592297242|FG001|Extended Wear Period|Lost to Follow-up|1|||
163979786|NCT02543528|592297243|FG002|Extended Wear Period|Lost to Follow-up|2|||
163979787|NCT02543528|592297244|FG003|Extended Wear Period|Lost to Follow-up|1|||
163979788|NCT02543528|592297245|FG004|Extended Wear Period|Lost to Follow-up|0|||
163979789|NCT02543528|592297241|FG000|Extended Wear Period|Withdrawal by Subject|10|||
163979790|NCT02543528|592297242|FG001|Extended Wear Period|Withdrawal by Subject|9|||
163979791|NCT02543528|592297243|FG002|Extended Wear Period|Withdrawal by Subject|4|||
163979792|NCT02543528|592297244|FG003|Extended Wear Period|Withdrawal by Subject|5|||
163979793|NCT02543528|592297245|FG004|Extended Wear Period|Withdrawal by Subject|0|||
163979794|NCT02049944|592297246|FG000|Overall Study|Protocol Violation|2|||
163979795|NCT01042600|592297247|FG000|Overall Study|Ineligible|1|||
163979796|NCT01042600|592297248|FG001|Overall Study|Ineligible|0|||
164208307|NCT00879658|593131653|FG005|Overall Study|Adverse Event|0|||
164208308|NCT00879658|593131654|FG006|Overall Study|Adverse Event|0|||
164208309|NCT00879658|593131648|FG000|Overall Study|Protocol Violation|1|||
164208310|NCT00879658|593131649|FG001|Overall Study|Protocol Violation|0|||
164208311|NCT00879658|593131650|FG002|Overall Study|Protocol Violation|0|||
164208312|NCT00879658|593131651|FG003|Overall Study|Protocol Violation|0|||
164208313|NCT00879658|593131652|FG004|Overall Study|Protocol Violation|0|||
164208314|NCT00879658|593131653|FG005|Overall Study|Protocol Violation|0|||
164208315|NCT00879658|593131654|FG006|Overall Study|Protocol Violation|0|||
164208316|NCT00879658|593131648|FG000|Overall Study|Withdrawal by Subject|3|||
163979797|NCT00631371|592297251|FG000|Overall Study|Lost to Follow-up|24|||
164208317|NCT00879658|593131649|FG001|Overall Study|Withdrawal by Subject|0|||
164208318|NCT00879658|593131650|FG002|Overall Study|Withdrawal by Subject|2|||
164208319|NCT00879658|593131651|FG003|Overall Study|Withdrawal by Subject|0|||
164208320|NCT00879658|593131652|FG004|Overall Study|Withdrawal by Subject|0|||
164208321|NCT00879658|593131653|FG005|Overall Study|Withdrawal by Subject|1|||
164208322|NCT00879658|593131654|FG006|Overall Study|Withdrawal by Subject|0|||
164321890|NCT00761150|593555459|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
164321891|NCT00761150|593555460|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
164321892|NCT00761150|593555461|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
164321893|NCT00761150|593555459|FG000|Double-blind Period|Noncompliance|0|||
164321894|NCT00761150|593555460|FG001|Double-blind Period|Noncompliance|1|||
164321895|NCT00761150|593555461|FG002|Double-blind Period|Noncompliance|0|||
164321896|NCT00761150|593555459|FG000|Double-blind Period|Other|0|||
164321897|NCT00761150|593555460|FG001|Double-blind Period|Other|3|||
164321898|NCT00761150|593555461|FG002|Double-blind Period|Other|3|||
164321899|NCT01925989|593555462|FG000|Period 1|Sponsor Decision|1|||
164321900|NCT01925989|593555463|FG001|Period 1|Sponsor Decision|1|||
164321901|NCT01925989|593555464|FG002|Period 1|Sponsor Decision|0|||
164321902|NCT01925989|593555462|FG000|Period 1|Withdrawal by Subject|0|||
164321903|NCT01925989|593555463|FG001|Period 1|Withdrawal by Subject|1|||
164321904|NCT01925989|593555464|FG002|Period 1|Withdrawal by Subject|0|||
164321905|NCT00046891|593555467|FG000|Overall Study|Cancels|5|||
164321906|NCT00046891|593555468|FG001|Overall Study|Cancels|9|||
164321907|NCT00046891|593555467|FG000|Overall Study|Ineligible|1|||
164321908|NCT00046891|593555468|FG001|Overall Study|Ineligible|1|||
164321909|NCT00046891|593555467|FG000|Overall Study|Withdrawal by Subject|18|||
164321910|NCT00046891|593555468|FG001|Overall Study|Withdrawal by Subject|15|||
164321911|NCT00046891|593555467|FG000|Overall Study|Adverse Event|5|||
164321912|NCT00046891|593555468|FG001|Overall Study|Adverse Event|5|||
164321913|NCT02496676|593555472|FG000|Phase 1 - Period 1|Adverse Event|0|||
164321914|NCT02496676|593555473|FG001|Phase 1 - Period 1|Adverse Event|1|||
164321915|NCT02496676|593555472|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
164321916|NCT02496676|593555473|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
164321917|NCT01009281|593555474|FG000|Overall Study|Administrative problems|7|||
164321918|NCT00924170|593555475|FG000|Overall Study|Refused further treatment|0|||
164321919|NCT00924170|593555476|FG001|Overall Study|Refused further treatment|1|||
164321920|NCT00924170|593555475|FG000|Overall Study|Physician Decision|0|||
164321921|NCT00924170|593555476|FG001|Overall Study|Physician Decision|1|||
164076753|NCT00845026|592645804|FG001|Study Period III|Perceived lack of efficacy|15|||
164076754|NCT00845026|592645803|FG000|Study Period III|Withdrawal by Subject|19|||
164076755|NCT00845026|592645804|FG001|Study Period III|Withdrawal by Subject|15|||
164076756|NCT00845026|592645803|FG000|Study Period III|Entry Criteria not met|8|||
164076757|NCT00845026|592645804|FG001|Study Period III|Entry Criteria not met|11|||
164076758|NCT00845026|592645803|FG000|Study Period III|Lost to Follow-up|4|||
164076759|NCT00845026|592645804|FG001|Study Period III|Lost to Follow-up|5|||
164076760|NCT00845026|592645803|FG000|Study Period III|Protocol Violation|8|||
164321922|NCT00924170|593555475|FG000|Overall Study|Progressive disease|3|||
164321923|NCT00924170|593555476|FG001|Overall Study|Progressive disease|6|||
164321924|NCT00924170|593555475|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
164321925|NCT00924170|593555476|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
164321926|NCT00924170|593555475|FG000|Overall Study|Death|1|||
164321927|NCT00924170|593555476|FG001|Overall Study|Death|0|||
164321928|NCT03901456|593555479|FG000|Overall Study|Withdrawal by Subject|0|||
164321929|NCT03901456|593555480|FG001|Overall Study|Withdrawal by Subject|0|||
164076761|NCT00845026|592645804|FG001|Study Period III|Protocol Violation|1|||
164076762|NCT00845026|592645803|FG000|Study Period III|Scheduled conflict|3|||
164076763|NCT00845026|592645804|FG001|Study Period III|Scheduled conflict|1|||
164076764|NCT00845026|592645803|FG000|Study Period III|Subject is moving or has moved|2|||
164076765|NCT00845026|592645804|FG001|Study Period III|Subject is moving or has moved|4|||
164076766|NCT00845026|592645803|FG000|Study Period III|Transportation issues|1|||
164076767|NCT00845026|592645804|FG001|Study Period III|Transportation issues|1|||
164076768|NCT00845026|592645803|FG000|Study Period IV|Adverse Event|4|||
164321930|NCT03901456|593555481|FG002|Overall Study|Withdrawal by Subject|1|||
164321931|NCT03901456|593555479|FG000|Overall Study|Lost to Follow-up|0|||
164321932|NCT03901456|593555480|FG001|Overall Study|Lost to Follow-up|1|||
164321933|NCT03901456|593555481|FG002|Overall Study|Lost to Follow-up|0|||
164321934|NCT05318183|593555482|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
164321935|NCT05318183|593555483|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
164321936|NCT05318183|593555482|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
164321937|NCT05318183|593555483|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164321938|NCT05318183|593555482|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
164321939|NCT05318183|593555483|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
164076769|NCT00845026|592645804|FG001|Study Period IV|Adverse Event|0|||
164076770|NCT00845026|592645803|FG000|Study Period IV|Perceived lack of efficacy|2|||
164076771|NCT00845026|592645804|FG001|Study Period IV|Perceived lack of efficacy|1|||
164076772|NCT00845026|592645803|FG000|Study Period IV|Protocol Violation|3|||
164321940|NCT05318183|593555482|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164321941|NCT05318183|593555483|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
164076773|NCT00845026|592645804|FG001|Study Period IV|Protocol Violation|1|||
164076774|NCT00845026|592645803|FG000|Study Period IV|Lost to Follow-up|1|||
164076775|NCT00845026|592645804|FG001|Study Period IV|Lost to Follow-up|0|||
164076776|NCT00845026|592645803|FG000|Study Period IV|Withdrawal by Subject|4|||
164208323|NCT00879658|593131648|FG000|Overall Study|Lack of Efficacy|0|||
164208324|NCT00879658|593131649|FG001|Overall Study|Lack of Efficacy|0|||
164208325|NCT00879658|593131650|FG002|Overall Study|Lack of Efficacy|2|||
164208326|NCT00879658|593131651|FG003|Overall Study|Lack of Efficacy|0|||
164208327|NCT00879658|593131652|FG004|Overall Study|Lack of Efficacy|0|||
164208328|NCT00879658|593131653|FG005|Overall Study|Lack of Efficacy|0|||
164208329|NCT00879658|593131654|FG006|Overall Study|Lack of Efficacy|0|||
164208330|NCT00879658|593131648|FG000|Overall Study|misrandomized (never received study med)|0|||
164208331|NCT00879658|593131649|FG001|Overall Study|misrandomized (never received study med)|0|||
163875152|NCT03012841|591911541|FG001|Overall Study|Insurance change|1|||
163875153|NCT05696080|591911542|FG000|Overall Study|Lost to Follow-up|2|||
163875154|NCT05696080|591911543|FG001|Overall Study|Lost to Follow-up|1|||
163875155|NCT05696080|591911542|FG000|Overall Study|Physician Decision|1|||
163875156|NCT05696080|591911543|FG001|Overall Study|Physician Decision|0|||
163875157|NCT05696080|591911542|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163875158|NCT05696080|591911543|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
163875159|NCT05696080|591911542|FG000|Overall Study|Withdrawal by Subject|12|||
163875160|NCT05696080|591911543|FG001|Overall Study|Withdrawal by Subject|0|||
163875161|NCT03398200|591911544|FG000|Overall Study|Withdrawal by Subject|0|||
163875162|NCT03398200|591911545|FG001|Overall Study|Withdrawal by Subject|1|||
163875163|NCT04065048|591911546|FG000|Overall Study|Withdrawal by Subject|1|||
163875164|NCT04065048|591911547|FG001|Overall Study|Withdrawal by Subject|2|||
163875165|NCT04065048|591911548|FG002|Overall Study|Withdrawal by Subject|1|||
163875166|NCT04065048|591911549|FG003|Overall Study|Withdrawal by Subject|1|||
163875167|NCT04065048|591911546|FG000|Overall Study|Adverse Event|1|||
163875168|NCT04065048|591911547|FG001|Overall Study|Adverse Event|0|||
163875169|NCT04065048|591911548|FG002|Overall Study|Adverse Event|1|||
163875170|NCT04065048|591911549|FG003|Overall Study|Adverse Event|0|||
163875171|NCT03397108|591911550|FG000|Overall Study|Lost to Follow-up|15|||
163875172|NCT03397108|591911551|FG001|Overall Study|Lost to Follow-up|0|||
163875173|NCT03397108|591911550|FG000|Overall Study|Insufficient milk production|3|||
163875174|NCT03397108|591911551|FG001|Overall Study|Insufficient milk production|2|||
163875175|NCT03397108|591911550|FG000|Overall Study|Withdrawal by Subject|2|||
163875176|NCT03397108|591911551|FG001|Overall Study|Withdrawal by Subject|0|||
163875177|NCT04607044|591911554|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
163875178|NCT04607044|591911554|FG000|Overall Study|Adverse Event|1|||
163875179|NCT04607044|591911554|FG000|Overall Study|Did not receive study device|3|||
163875180|NCT04607044|591911554|FG000|Overall Study|Death|1|||
163875181|NCT05403801|591911555|FG000|Overall Study|Withdrawal by Subject|2|||
163875182|NCT01704079|591911558|FG000|Overall Study|Withdrawal by Subject|5|||
163875183|NCT01704079|591911559|FG001|Overall Study|Withdrawal by Subject|7|||
163875184|NCT01704079|591911558|FG000|Overall Study|Lost to Follow-up|2|||
163875185|NCT01704079|591911559|FG001|Overall Study|Lost to Follow-up|5|||
163875186|NCT01704079|591911558|FG000|Overall Study|Adverse Event|4|||
163875187|NCT01704079|591911559|FG001|Overall Study|Adverse Event|7|||
163875188|NCT01704079|591911558|FG000|Overall Study|Protocol Violation|1|||
163875189|NCT01704079|591911559|FG001|Overall Study|Protocol Violation|0|||
163875190|NCT01704079|591911558|FG000|Overall Study|Subject noncompliance|2|||
163875191|NCT01704079|591911559|FG001|Overall Study|Subject noncompliance|3|||
163875192|NCT01704079|591911558|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
163875193|NCT01704079|591911559|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
163875194|NCT05846646|591911560|FG000|Overall Study|Physician Decision|1|||
163875195|NCT05846646|591911561|FG001|Overall Study|Physician Decision|0|||
163875196|NCT05846646|591911562|FG002|Overall Study|Physician Decision|0|||
163875197|NCT05846646|591911560|FG000|Overall Study|Lack of Efficacy|1|||
163875198|NCT05846646|591911561|FG001|Overall Study|Lack of Efficacy|1|||
163875199|NCT05846646|591911562|FG002|Overall Study|Lack of Efficacy|0|||
163875200|NCT05846646|591911560|FG000|Overall Study|Early Study Termination|1|||
163875201|NCT05846646|591911561|FG001|Overall Study|Early Study Termination|2|||
163875202|NCT05846646|591911562|FG002|Overall Study|Early Study Termination|0|||
163875203|NCT01443845|591911568|FG000|Overall Study|Protocol Violation|43|||
163875204|NCT01443845|591911569|FG001|Overall Study|Protocol Violation|45|||
163875205|NCT01443845|591911568|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
163875206|NCT01443845|591911569|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
163875207|NCT01443845|591911568|FG000|Overall Study|Deterioration in pulmonary function|1|||
163875208|NCT01443845|591911569|FG001|Overall Study|Deterioration in pulmonary function|4|||
163875209|NCT01443845|591911568|FG000|Overall Study|Lack of Efficacy|10|||
163875210|NCT01443845|591911569|FG001|Overall Study|Lack of Efficacy|5|||
163875211|NCT01443845|591911568|FG000|Overall Study|Adverse Event|64|||
163875212|NCT01443845|591911569|FG001|Overall Study|Adverse Event|138|||
163875213|NCT01443845|591911568|FG000|Overall Study|Withdrawal by Subject|63|||
163875214|NCT01443845|591911569|FG001|Overall Study|Withdrawal by Subject|67|||
163875215|NCT01443845|591911568|FG000|Overall Study|Military Conflict - Site Terminated|20|||
163875216|NCT01443845|591911569|FG001|Overall Study|Military Conflict - Site Terminated|21|||
163875217|NCT01443845|591911568|FG000|Overall Study|Lost to Follow-up|9|||
164208332|NCT00879658|593131650|FG002|Overall Study|misrandomized (never received study med)|0|||
164076777|NCT00845026|592645804|FG001|Study Period IV|Withdrawal by Subject|1|||
164321942|NCT04098224|593555484|FG000|Overall Study|Adverse Event|1|||
164321943|NCT04098224|593555485|FG001|Overall Study|Adverse Event|0|||
164321944|NCT04098224|593555484|FG000|Overall Study|Physician Decision|1|||
164321945|NCT04098224|593555485|FG001|Overall Study|Physician Decision|0|||
164321946|NCT04098224|593555484|FG000|Overall Study|Patient not required enteral feeding|1|||
164321947|NCT04098224|593555485|FG001|Overall Study|Patient not required enteral feeding|0|||
164321948|NCT04098224|593555484|FG000|Overall Study|Patient failure nasogastric tube|1|||
164321949|NCT04098224|593555485|FG001|Overall Study|Patient failure nasogastric tube|0|||
164321950|NCT04098224|593555484|FG000|Overall Study|Patient early extubation|1|||
164321951|NCT04098224|593555485|FG001|Overall Study|Patient early extubation|3|||
164321952|NCT01203852|593555489|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
164321953|NCT01203852|593555489|FG000|Washout 2 Weeks|Physician Decision|46|||
164321954|NCT00899392|593555490|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
164321955|NCT00899392|593555491|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
164321956|NCT01431638|593555492|FG000|Overall Study|Adverse Event|1|||
164321957|NCT01431638|593555493|FG001|Overall Study|Adverse Event|3|||
164321958|NCT01431638|593555494|FG002|Overall Study|Adverse Event|1|||
164321959|NCT01431638|593555492|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164321960|NCT01431638|593555493|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164321961|NCT01431638|593555494|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
164321962|NCT01431638|593555492|FG000|Overall Study|Participants condition no longer requires study drug|0|||
164321963|NCT01431638|593555493|FG001|Overall Study|Participants condition no longer requires study drug|1|||
164321964|NCT01431638|593555494|FG002|Overall Study|Participants condition no longer requires study drug|0|||
164321965|NCT01431638|593555492|FG000|Overall Study|Participant withdrew consent|14|||
164321966|NCT01431638|593555493|FG001|Overall Study|Participant withdrew consent|5|||
164321967|NCT01431638|593555494|FG002|Overall Study|Participant withdrew consent|8|||
164321968|NCT01431638|593555492|FG000|Overall Study|Lost to Follow-up|7|||
164321969|NCT01431638|593555493|FG001|Overall Study|Lost to Follow-up|9|||
164321970|NCT01431638|593555494|FG002|Overall Study|Lost to Follow-up|7|||
164321971|NCT01431638|593555492|FG000|Overall Study|Administrative problems|1|||
164321972|NCT01431638|593555493|FG001|Overall Study|Administrative problems|4|||
164321973|NCT01431638|593555494|FG002|Overall Study|Administrative problems|6|||
164321974|NCT01431638|593555492|FG000|Overall Study|Death|1|||
164321975|NCT01431638|593555493|FG001|Overall Study|Death|0|||
164321976|NCT01431638|593555494|FG002|Overall Study|Death|0|||
164321977|NCT01431638|593555492|FG000|Overall Study|Protocol deviation|1|||
164321978|NCT01431638|593555493|FG001|Overall Study|Protocol deviation|1|||
164321979|NCT01431638|593555494|FG002|Overall Study|Protocol deviation|4|||
164321980|NCT01431638|593555492|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
164321981|NCT01431638|593555493|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
164321982|NCT01431638|593555494|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
164321983|NCT01381562|593555495|FG000|Overall Study|Adverse Event|0|||
164321984|NCT01381562|593555496|FG001|Overall Study|Adverse Event|1|||
164321985|NCT01381562|593555497|FG002|Overall Study|Adverse Event|0|||
164321986|NCT03709576|593555506|FG000|Overall Study|progression prior to enrollment|1|||
164321987|NCT01947855|593555507|FG000|Overall Study|Withdrawal by Subject|1|||
164321988|NCT01947855|593555508|FG001|Overall Study|Withdrawal by Subject|0|||
164321989|NCT01947855|593555509|FG002|Overall Study|Withdrawal by Subject|0|||
164321990|NCT00710762|593555510|FG000|Overall Study|Progressive disease|27|||
164321991|NCT00710762|593555511|FG001|Overall Study|Progressive disease|30|||
164321992|NCT00710762|593555510|FG000|Overall Study|Adverse Event other disease worsening|2|||
164321993|NCT00710762|593555511|FG001|Overall Study|Adverse Event other disease worsening|1|||
164321994|NCT00710762|593555510|FG000|Overall Study|Other Adverse Event|7|||
164321995|NCT00710762|593555511|FG001|Overall Study|Other Adverse Event|7|||
164321996|NCT00710762|593555510|FG000|Overall Study|Lost to Follow-up|1|||
164321997|NCT00710762|593555511|FG001|Overall Study|Lost to Follow-up|0|||
164321998|NCT00710762|593555510|FG000|Overall Study|Reason other than listed above|2|||
164321999|NCT00710762|593555511|FG001|Overall Study|Reason other than listed above|2|||
164322000|NCT00592774|593555512|FG000|Overall Study|Adverse Event|5|||
164322001|NCT00592774|593555513|FG001|Overall Study|Adverse Event|19|||
164322002|NCT00592774|593555514|FG002|Overall Study|Adverse Event|2|||
164322003|NCT00592774|593555515|FG003|Overall Study|Adverse Event|14|||
164322004|NCT00592774|593555516|FG004|Overall Study|Adverse Event|8|||
164322005|NCT00592774|593555512|FG000|Overall Study|Protocol Violation|0|||
164322006|NCT00592774|593555513|FG001|Overall Study|Protocol Violation|1|||
164322007|NCT00592774|593555514|FG002|Overall Study|Protocol Violation|0|||
164322008|NCT00592774|593555515|FG003|Overall Study|Protocol Violation|0|||
164322009|NCT00592774|593555516|FG004|Overall Study|Protocol Violation|1|||
164322010|NCT00592774|593555512|FG000|Overall Study|Withdrawal by Subject|3|||
164322011|NCT00592774|593555513|FG001|Overall Study|Withdrawal by Subject|7|||
164322012|NCT00592774|593555514|FG002|Overall Study|Withdrawal by Subject|0|||
164322013|NCT00592774|593555515|FG003|Overall Study|Withdrawal by Subject|0|||
164136547|NCT00389831|592862186|FG001|Overall Study|Other reasons|2|||
164322014|NCT00592774|593555516|FG004|Overall Study|Withdrawal by Subject|0|||
164322015|NCT00592774|593555512|FG000|Overall Study|Lack of Efficacy|3|||
164322016|NCT00592774|593555513|FG001|Overall Study|Lack of Efficacy|3|||
164322017|NCT00592774|593555514|FG002|Overall Study|Lack of Efficacy|0|||
164322018|NCT00592774|593555515|FG003|Overall Study|Lack of Efficacy|0|||
164322019|NCT00592774|593555516|FG004|Overall Study|Lack of Efficacy|2|||
164322020|NCT00592774|593555512|FG000|Overall Study|Physician Decision|0|||
164322021|NCT00592774|593555513|FG001|Overall Study|Physician Decision|1|||
164076778|NCT00845026|592645803|FG000|Study Period IV|Entry Criteria Not Met|1|||
164076779|NCT00845026|592645804|FG001|Study Period IV|Entry Criteria Not Met|0|||
164076780|NCT00845026|592645803|FG000|Study Period IV|Subject is moving or has moved|0|||
164076781|NCT00845026|592645804|FG001|Study Period IV|Subject is moving or has moved|1|||
164076782|NCT00845026|592645803|FG000|Study Period IV|Scheduling conflict|1|||
164076783|NCT00845026|592645804|FG001|Study Period IV|Scheduling conflict|0|||
164076784|NCT01325532|592645805|FG000|Overall Study|Withdrawal by Subject|2|||
164076785|NCT01325532|592645806|FG001|Overall Study|Withdrawal by Subject|0|||
164076786|NCT00061945|592645813|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
164076787|NCT00061945|592645814|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
164076788|NCT00061945|592645813|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
164076789|NCT00061945|592645814|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
164076790|NCT00061945|592645813|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
164076791|NCT00061945|592645814|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
164076792|NCT00061945|592645813|FG000|Course IV: Alemtuzumab|Early exits|6|||
164076793|NCT00061945|592645814|FG001|Course IV: Alemtuzumab|Early exits|15|||
164076794|NCT03672396|592645815|FG000|Overall Study|Withdrawal by Subject|4|||
164076795|NCT03672396|592645815|FG000|Overall Study|Physician Decision|1|||
164322022|NCT00592774|593555514|FG002|Overall Study|Physician Decision|1|||
164322023|NCT00592774|593555515|FG003|Overall Study|Physician Decision|0|||
164322024|NCT00592774|593555516|FG004|Overall Study|Physician Decision|1|||
164322025|NCT00592774|593555512|FG000|Overall Study|Other|0|||
164322026|NCT00592774|593555513|FG001|Overall Study|Other|1|||
164322027|NCT00592774|593555514|FG002|Overall Study|Other|1|||
164322028|NCT00592774|593555515|FG003|Overall Study|Other|0|||
164322029|NCT00592774|593555516|FG004|Overall Study|Other|2|||
164322030|NCT01892384|593555517|FG000|Overall Study|Withdrawal by Subject|1|||
164322031|NCT01892384|593555518|FG001|Overall Study|Withdrawal by Subject|1|||
164322032|NCT01892384|593555519|FG002|Overall Study|Withdrawal by Subject|0|||
164322033|NCT01892384|593555520|FG003|Overall Study|Withdrawal by Subject|0|||
164322034|NCT01700439|593555521|FG000|Overall Study|Lost to Follow-up|47|||
164322035|NCT01700439|593555521|FG000|Overall Study|Withdrawal by Subject|183|||
164322036|NCT01700439|593555521|FG000|Overall Study|Death|186|||
164322037|NCT00621621|593555522|FG000|Overall Study|Subjects were exited at EP study|30|||
164322038|NCT00621621|593555523|FG001|Overall Study|Subjects were exited at EP study|0|||
164322039|NCT02889562|593555527|FG000|Overall Study|Physician Decision|0|||
164322040|NCT02889562|593555528|FG001|Overall Study|Physician Decision|1|||
164322041|NCT02889562|593555527|FG000|Overall Study|Withdrawal by Subject|0|||
164322042|NCT02889562|593555528|FG001|Overall Study|Withdrawal by Subject|1|||
164322043|NCT04054947|593555532|FG000|Overall Study|Withdrawal by Subject|1|||
164322044|NCT04054947|593555533|FG001|Overall Study|Withdrawal by Subject|0|||
164322045|NCT04054947|593555532|FG000|Overall Study|Lost to Follow-up|2|||
164322046|NCT04054947|593555533|FG001|Overall Study|Lost to Follow-up|5|||
164322047|NCT01606878|593555534|FG000|Overall Study|Adverse Event|1|||
164322048|NCT01606878|593555535|FG001|Overall Study|Adverse Event|1|||
164322049|NCT01606878|593555536|FG002|Overall Study|Adverse Event|0|||
164322050|NCT01606878|593555537|FG003|Overall Study|Adverse Event|0|||
164322051|NCT01606878|593555538|FG004|Overall Study|Adverse Event|0|||
164322052|NCT01606878|593555539|FG005|Overall Study|Adverse Event|0|||
164322053|NCT01606878|593555540|FG006|Overall Study|Adverse Event|1|||
164322054|NCT01606878|593555541|FG007|Overall Study|Adverse Event|0|||
164322055|NCT01606878|593555542|FG008|Overall Study|Adverse Event|1|||
164322056|NCT01606878|593555543|FG009|Overall Study|Adverse Event|3|||
163875218|NCT01443845|591911569|FG001|Overall Study|Lost to Follow-up|13|||
163875219|NCT02461628|591911570|FG000|Overall Study|Refused to complete survey|4|||
164322057|NCT01606878|593555544|FG010|Overall Study|Adverse Event|0|||
164322058|NCT01606878|593555534|FG000|Overall Study|Lack of Efficacy|1|||
164322059|NCT01606878|593555535|FG001|Overall Study|Lack of Efficacy|1|||
164322060|NCT01606878|593555536|FG002|Overall Study|Lack of Efficacy|1|||
164322061|NCT01606878|593555537|FG003|Overall Study|Lack of Efficacy|2|||
164322062|NCT01606878|593555538|FG004|Overall Study|Lack of Efficacy|1|||
164322063|NCT01606878|593555539|FG005|Overall Study|Lack of Efficacy|2|||
164322064|NCT01606878|593555540|FG006|Overall Study|Lack of Efficacy|1|||
164322065|NCT01606878|593555541|FG007|Overall Study|Lack of Efficacy|2|||
163875220|NCT02461628|591911571|FG001|Overall Study|Refused to complete survey|7|||
164322066|NCT01606878|593555542|FG008|Overall Study|Lack of Efficacy|2|||
164322067|NCT01606878|593555543|FG009|Overall Study|Lack of Efficacy|0|||
163875221|NCT02462759|591911574|FG000|Part 1: Double Blind|Death|1|||
164076796|NCT03672396|592645815|FG000|Overall Study|Adverse Event|1|||
164076797|NCT01364298|592645816|FG000|Overall Study|Adverse Event|3|||
164322068|NCT01606878|593555544|FG010|Overall Study|Lack of Efficacy|1|||
164322069|NCT01606878|593555534|FG000|Overall Study|Physician Decision|1|||
164322070|NCT01606878|593555535|FG001|Overall Study|Physician Decision|0|||
164322071|NCT01606878|593555536|FG002|Overall Study|Physician Decision|2|||
164322072|NCT01606878|593555537|FG003|Overall Study|Physician Decision|1|||
164322073|NCT01606878|593555538|FG004|Overall Study|Physician Decision|1|||
164322074|NCT01606878|593555539|FG005|Overall Study|Physician Decision|1|||
164322075|NCT01606878|593555540|FG006|Overall Study|Physician Decision|2|||
164322076|NCT01606878|593555541|FG007|Overall Study|Physician Decision|0|||
164322077|NCT01606878|593555542|FG008|Overall Study|Physician Decision|1|||
164322078|NCT01606878|593555543|FG009|Overall Study|Physician Decision|0|||
164322079|NCT01606878|593555544|FG010|Overall Study|Physician Decision|0|||
164322080|NCT01606878|593555534|FG000|Overall Study|Withdrawal by Subject|3|||
164322081|NCT01606878|593555535|FG001|Overall Study|Withdrawal by Subject|2|||
164322082|NCT01606878|593555536|FG002|Overall Study|Withdrawal by Subject|2|||
164322083|NCT01606878|593555537|FG003|Overall Study|Withdrawal by Subject|0|||
164322084|NCT01606878|593555538|FG004|Overall Study|Withdrawal by Subject|1|||
164322085|NCT01606878|593555539|FG005|Overall Study|Withdrawal by Subject|1|||
164322086|NCT01606878|593555540|FG006|Overall Study|Withdrawal by Subject|2|||
164322087|NCT01606878|593555541|FG007|Overall Study|Withdrawal by Subject|1|||
164322088|NCT01606878|593555542|FG008|Overall Study|Withdrawal by Subject|2|||
164322089|NCT01606878|593555543|FG009|Overall Study|Withdrawal by Subject|0|||
164322090|NCT01606878|593555544|FG010|Overall Study|Withdrawal by Subject|2|||
164322091|NCT03720652|593555545|FG000|Overall Study|Withdrawal by Subject|2|||
164322092|NCT03720652|593555546|FG001|Overall Study|Withdrawal by Subject|7|||
164322093|NCT03720652|593555545|FG000|Overall Study|Lost to Follow-up|0|||
164322094|NCT03720652|593555546|FG001|Overall Study|Lost to Follow-up|4|||
164322095|NCT01155167|593555550|FG000|Overall Study|Insufficient ultrasound data|2|||
164322096|NCT01155167|593555551|FG001|Overall Study|Insufficient ultrasound data|0|||
164322097|NCT01155167|593555550|FG000|Overall Study|Access site changed to femoral artery|1|||
164322098|NCT01155167|593555551|FG001|Overall Study|Access site changed to femoral artery|0|||
164322099|NCT00167778|593555552|FG000|Overall Study|Withdrawal by Subject|1|||
164322100|NCT02654717|593555553|FG000|Overall Study|Adverse Event|2|||
164322101|NCT02654717|593555554|FG001|Overall Study|Adverse Event|2|||
164322102|NCT02654717|593555553|FG000|Overall Study|Protocol Violation|1|||
164322103|NCT02654717|593555554|FG001|Overall Study|Protocol Violation|2|||
164322104|NCT02654717|593555553|FG000|Overall Study|Withdrawal by Subject|0|||
164322105|NCT02654717|593555554|FG001|Overall Study|Withdrawal by Subject|1|||
164322106|NCT02654717|593555553|FG000|Overall Study|Non-permitted medication|3|||
164322107|NCT02654717|593555554|FG001|Overall Study|Non-permitted medication|0|||
164322108|NCT00960570|593555555|FG000|21 Day Washout Period|Adverse Event|1|||
164322109|NCT00960570|593555555|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
164322110|NCT00960570|593555555|FG000|1 Day Period Between Dosing|Adverse Event|2|||
164322111|NCT00960570|593555555|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
164322112|NCT00853970|593555556|FG000|Overall Study|Withdrawal by Subject|2|||
164322113|NCT00853970|593555557|FG001|Overall Study|Withdrawal by Subject|1|||
164322114|NCT00853970|593555556|FG000|Overall Study|Cancelled surgery|4|||
164322115|NCT00853970|593555557|FG001|Overall Study|Cancelled surgery|2|||
164322116|NCT04085367|593557149|FG000|Overall Study|Adverse Event|1|||
164322117|NCT04085367|593557150|FG001|Overall Study|Adverse Event|1|||
164322118|NCT04085367|593557149|FG000|Overall Study|Withdrawal by Subject|13|||
164322119|NCT04085367|593557150|FG001|Overall Study|Withdrawal by Subject|4|||
164322120|NCT04085367|593557149|FG000|Overall Study|Lost to Follow-up|3|||
164322121|NCT04085367|593557150|FG001|Overall Study|Lost to Follow-up|1|||
164322122|NCT04085367|593557149|FG000|Overall Study|Other unspecified|2|||
164322123|NCT04085367|593557150|FG001|Overall Study|Other unspecified|1|||
164322124|NCT04085367|593557149|FG000|Overall Study|Status Unknown|1|||
164322125|NCT04085367|593557150|FG001|Overall Study|Status Unknown|1|||
164322126|NCT00910247|593557152|FG000|Overall Study|Adverse Event|15|||
164322127|NCT00910247|593557152|FG000|Overall Study|Death|2|||
164322128|NCT00910247|593557152|FG000|Overall Study|Lost to Follow-up|10|||
164076798|NCT01364298|592645817|FG001|Overall Study|Adverse Event|4|||
164322129|NCT00910247|593557152|FG000|Overall Study|Physician Decision|3|||
164322130|NCT00910247|593557152|FG000|Overall Study|Protocol Violation|10|||
164322131|NCT00910247|593557152|FG000|Overall Study|Withdrawal by Subject|25|||
164322132|NCT00910247|593557152|FG000|Overall Study|Not collected|4|||
164322133|NCT00625742|593557153|FG000|Overall Study|Disease Progression|2|||
164322134|NCT00625742|593557153|FG000|Overall Study|Withdrawal by Subject|1|||
164322135|NCT00625742|593557153|FG000|Overall Study|Adverse Event|4|||
164322136|NCT00625742|593557153|FG000|Overall Study|Lost to Follow-up|4|||
164322137|NCT00625742|593557153|FG000|Overall Study|Ineligible|1|||
164322138|NCT03387150|593557154|FG000|Overall Study|Withdrawal by Subject|3|||
164322139|NCT03387150|593557155|FG001|Overall Study|Withdrawal by Subject|0|||
164322140|NCT03387150|593557156|FG002|Overall Study|Withdrawal by Subject|3|||
164322141|NCT03387150|593557157|FG003|Overall Study|Withdrawal by Subject|4|||
164322142|NCT03387150|593557158|FG004|Overall Study|Withdrawal by Subject|1|||
164322143|NCT03387150|593557159|FG005|Overall Study|Withdrawal by Subject|2|||
164322144|NCT03387150|593557160|FG006|Overall Study|Withdrawal by Subject|0|||
164322145|NCT03387150|593557154|FG000|Overall Study|Lost to Follow-up|3|||
164322146|NCT03387150|593557155|FG001|Overall Study|Lost to Follow-up|2|||
164322147|NCT03387150|593557156|FG002|Overall Study|Lost to Follow-up|2|||
164322148|NCT03387150|593557157|FG003|Overall Study|Lost to Follow-up|3|||
164322149|NCT03387150|593557158|FG004|Overall Study|Lost to Follow-up|3|||
164322150|NCT03387150|593557159|FG005|Overall Study|Lost to Follow-up|3|||
164322151|NCT03387150|593557160|FG006|Overall Study|Lost to Follow-up|0|||
164322152|NCT03387150|593557154|FG000|Overall Study|Participant unable to adhere to visit|0|||
164322153|NCT03387150|593557155|FG001|Overall Study|Participant unable to adhere to visit|1|||
164322154|NCT03387150|593557156|FG002|Overall Study|Participant unable to adhere to visit|0|||
164322155|NCT03387150|593557157|FG003|Overall Study|Participant unable to adhere to visit|0|||
164322156|NCT03387150|593557158|FG004|Overall Study|Participant unable to adhere to visit|2|||
164322157|NCT03387150|593557159|FG005|Overall Study|Participant unable to adhere to visit|2|||
164322158|NCT03387150|593557160|FG006|Overall Study|Participant unable to adhere to visit|0|||
164322159|NCT04006119|593557161|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
164322160|NCT04006119|593557161|FG000|End of Treatment Veledimex|Adverse Event|2|||
164322161|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
164322162|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
164322163|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
164322164|NCT04006119|593557161|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
164322165|NCT02919969|593557162|FG000|Overall Study|Lack of Efficacy|22|||
164322166|NCT02919969|593557162|FG000|Overall Study|Death|4|||
164322167|NCT02919969|593557162|FG000|Overall Study|Physician Decision|3|||
164322168|NCT02919969|593557162|FG000|Overall Study|Withdrawal by Subject|2|||
164322169|NCT01842633|593557163|FG000|Overall Study|Screen Failure|1|||
164322170|NCT01842633|593557164|FG001|Overall Study|Screen Failure|0|||
164322171|NCT01842633|593557165|FG002|Overall Study|Screen Failure|0|||
164322172|NCT01842633|593557163|FG000|Overall Study|Adverse Event|1|||
164322173|NCT01842633|593557164|FG001|Overall Study|Adverse Event|1|||
164322174|NCT01842633|593557165|FG002|Overall Study|Adverse Event|0|||
164322175|NCT01842633|593557163|FG000|Overall Study|Withdrawal by Subject|0|||
164322176|NCT01842633|593557164|FG001|Overall Study|Withdrawal by Subject|1|||
164322177|NCT01842633|593557165|FG002|Overall Study|Withdrawal by Subject|0|||
164322178|NCT01842633|593557163|FG000|Overall Study|Technical issues|1|||
164322179|NCT01842633|593557164|FG001|Overall Study|Technical issues|0|||
164322180|NCT01842633|593557165|FG002|Overall Study|Technical issues|0|||
164322181|NCT02093351|593557169|FG000|Part A|Adverse Event|0|||
164322182|NCT02093351|593557170|FG001|Part A|Adverse Event|1|||
164322183|NCT02093351|593557171|FG002|Part A|Adverse Event|1|||
164322184|NCT02093351|593557172|FG003|Part A|Adverse Event|0|||
164322185|NCT02093351|593557169|FG000|Part A|Condition under investigation worsened|2|||
164322186|NCT02093351|593557170|FG001|Part A|Condition under investigation worsened|0|||
164322187|NCT02093351|593557171|FG002|Part A|Condition under investigation worsened|2|||
164322188|NCT02093351|593557172|FG003|Part A|Condition under investigation worsened|0|||
164322189|NCT02093351|593557169|FG000|Part A|Death|0|||
164322190|NCT02093351|593557170|FG001|Part A|Death|1|||
164322191|NCT02093351|593557171|FG002|Part A|Death|0|||
164322192|NCT02093351|593557172|FG003|Part A|Death|0|||
164322193|NCT02093351|593557169|FG000|Part B|Patient decision|0|||
164322194|NCT02093351|593557170|FG001|Part B|Patient decision|0|||
164322195|NCT02093351|593557171|FG002|Part B|Patient decision|0|||
164322196|NCT02093351|593557172|FG003|Part B|Patient decision|3|||
164322197|NCT02093351|593557169|FG000|Part B|Disease progression|0|||
164322198|NCT02093351|593557170|FG001|Part B|Disease progression|0|||
164322199|NCT02093351|593557171|FG002|Part B|Disease progression|0|||
164322200|NCT02093351|593557172|FG003|Part B|Disease progression|4|||
164322201|NCT02093351|593557169|FG000|Part B|Complete response|0|||
164322202|NCT02093351|593557170|FG001|Part B|Complete response|0|||
164322203|NCT02093351|593557171|FG002|Part B|Complete response|0|||
164322204|NCT02093351|593557172|FG003|Part B|Complete response|1|||
164322205|NCT02093351|593557169|FG000|Part B|Adverse event + disease progression|0|||
164322206|NCT02093351|593557170|FG001|Part B|Adverse event + disease progression|0|||
164322207|NCT02093351|593557171|FG002|Part B|Adverse event + disease progression|0|||
164322208|NCT02093351|593557172|FG003|Part B|Adverse event + disease progression|1|||
164322209|NCT02093351|593557169|FG000|Part B|Lack of therapeutic response|0|||
164322210|NCT02093351|593557170|FG001|Part B|Lack of therapeutic response|0|||
164322211|NCT02093351|593557171|FG002|Part B|Lack of therapeutic response|0|||
164322212|NCT02093351|593557172|FG003|Part B|Lack of therapeutic response|12|||
164322213|NCT02093351|593557169|FG000|Part B|Condition under investigation worsened|0|||
164322214|NCT02093351|593557170|FG001|Part B|Condition under investigation worsened|0|||
164322215|NCT02093351|593557171|FG002|Part B|Condition under investigation worsened|0|||
164322216|NCT02093351|593557172|FG003|Part B|Condition under investigation worsened|39|||
164322217|NCT02093351|593557169|FG000|Part B|Adverse Event|0|||
164322218|NCT02093351|593557170|FG001|Part B|Adverse Event|0|||
164322219|NCT02093351|593557171|FG002|Part B|Adverse Event|0|||
164322220|NCT02093351|593557172|FG003|Part B|Adverse Event|2|||
164322221|NCT02093351|593557169|FG000|Part B|Death|0|||
164322222|NCT02093351|593557170|FG001|Part B|Death|0|||
164322223|NCT02093351|593557171|FG002|Part B|Death|0|||
164322224|NCT02093351|593557172|FG003|Part B|Death|1|||
164322225|NCT03565367|593557173|FG000|Overall Study|No scan due to technical issues|4|||
164322226|NCT03565367|593557174|FG001|Overall Study|No scan due to technical issues|0|||
164322227|NCT01099709|593557177|FG000|Period 1|Withdrawal by Subject|0|||
164322228|NCT01099709|593557178|FG001|Period 1|Withdrawal by Subject|1|||
164322229|NCT01099709|593557177|FG000|Period 1|Positive cotinine test|0|||
164322230|NCT01099709|593557178|FG001|Period 1|Positive cotinine test|1|||
164322231|NCT01099709|593557177|FG000|Period 1|Adverse Event|1|||
164322232|NCT01099709|593557178|FG001|Period 1|Adverse Event|0|||
164322233|NCT00706849|593557179|FG000|Treatment Period|Adverse Event|0|||
164322234|NCT00706849|593557180|FG001|Treatment Period|Adverse Event|9|||
164322235|NCT00706849|593557179|FG000|Treatment Period|Other|0|||
164322236|NCT00706849|593557180|FG001|Treatment Period|Other|1|||
164322237|NCT00706849|593557179|FG000|Follow-up Period|Withdrawal by Subject|0|||
164322238|NCT00706849|593557180|FG001|Follow-up Period|Withdrawal by Subject|2|||
164322239|NCT00706849|593557179|FG000|Follow-up Period|Protocol non-compliance|0|||
164322240|NCT00706849|593557180|FG001|Follow-up Period|Protocol non-compliance|1|||
164322241|NCT01611454|593557182|FG000|Overall Study|Lack of Efficacy|18|||
164322242|NCT01611454|593557183|FG001|Overall Study|Lack of Efficacy|10|||
164322243|NCT00920907|593557184|FG000|Induction Period|Adverse Event|0|||
164322244|NCT00920907|593557185|FG001|Induction Period|Adverse Event|2|||
164322245|NCT00920907|593557184|FG000|Induction Period|Death|1|||
164322246|NCT00920907|593557185|FG001|Induction Period|Death|1|||
164322247|NCT00920907|593557184|FG000|Induction Period|Disease Progression|12|||
164322248|NCT00920907|593557185|FG001|Induction Period|Disease Progression|11|||
164322249|NCT00920907|593557184|FG000|Induction Period|Study Drug Toxicity|8|||
164322250|NCT00920907|593557185|FG001|Induction Period|Study Drug Toxicity|6|||
164322251|NCT00920907|593557184|FG000|Induction Period|No longer meets study criteria|0|||
164322252|NCT00920907|593557185|FG001|Induction Period|No longer meets study criteria|1|||
164322253|NCT00920907|593557184|FG000|Induction Period|Withdrawal by Subject|1|||
164322254|NCT00920907|593557185|FG001|Induction Period|Withdrawal by Subject|1|||
164322255|NCT00920907|593557184|FG000|Maintenance Period|Disease Progression|3|||
164322256|NCT00920907|593557185|FG001|Maintenance Period|Disease Progression|7|||
164322257|NCT00920907|593557184|FG000|Maintenance Period|Administrative (study closure)|7|||
164322258|NCT00920907|593557185|FG001|Maintenance Period|Administrative (study closure)|2|||
164322259|NCT00920907|593557184|FG000|Maintenance Period|Study Drug Toxicity|0|||
164322260|NCT00920907|593557185|FG001|Maintenance Period|Study Drug Toxicity|2|||
164322261|NCT00920907|593557184|FG000|Maintenance Period|Death|1|||
164322262|NCT00920907|593557185|FG001|Maintenance Period|Death|1|||
164322263|NCT00920907|593557184|FG000|Maintenance Period|Withdrawal by Subject|1|||
164322264|NCT00920907|593557185|FG001|Maintenance Period|Withdrawal by Subject|0|||
164322265|NCT00920907|593557184|FG000|Maintenance Period|Adverse Event|0|||
164322266|NCT00920907|593557185|FG001|Maintenance Period|Adverse Event|1|||
164322267|NCT02616601|593557186|FG000|Overall Study|Withdrawal by Subject|4|||
164322268|NCT02616601|593557187|FG001|Overall Study|Withdrawal by Subject|4|||
164322269|NCT02616601|593557188|FG002|Overall Study|Withdrawal by Subject|3|||
164322270|NCT02616601|593557186|FG000|Overall Study|Adverse Event|2|||
164322271|NCT02616601|593557187|FG001|Overall Study|Adverse Event|0|||
164322272|NCT02616601|593557188|FG002|Overall Study|Adverse Event|2|||
164322273|NCT02616601|593557186|FG000|Overall Study|Death|1|||
164322274|NCT02616601|593557187|FG001|Overall Study|Death|0|||
164322275|NCT02616601|593557188|FG002|Overall Study|Death|0|||
164322276|NCT02616601|593557186|FG000|Overall Study|Lost to Follow-up|1|||
164322277|NCT02616601|593557187|FG001|Overall Study|Lost to Follow-up|0|||
164322278|NCT02616601|593557188|FG002|Overall Study|Lost to Follow-up|1|||
164322279|NCT02616601|593557186|FG000|Overall Study|Non-Compliance with Test Article|1|||
164322280|NCT02616601|593557187|FG001|Overall Study|Non-Compliance with Test Article|0|||
164322281|NCT02616601|593557188|FG002|Overall Study|Non-Compliance with Test Article|1|||
164322282|NCT01275339|593557189|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
164322283|NCT01275339|593557190|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
164322284|NCT01275339|593557191|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
164322285|NCT01275339|593557192|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
164322286|NCT01275339|593557189|FG000|Overall Study|Withdrawal by Subject|0|||
164322287|NCT01275339|593557190|FG001|Overall Study|Withdrawal by Subject|0|||
164322288|NCT01275339|593557191|FG002|Overall Study|Withdrawal by Subject|1|||
164322289|NCT01275339|593557192|FG003|Overall Study|Withdrawal by Subject|0|||
164322290|NCT00923364|593557195|FG000|Overall Study|Death|3|||
164322291|NCT00923364|593557196|FG001|Overall Study|Death|0|||
164322292|NCT00923364|593557195|FG000|Overall Study|Did not go to transplant|1|||
164322293|NCT00923364|593557196|FG001|Overall Study|Did not go to transplant|0|||
164322294|NCT04352127|593557197|FG000|Overall Study|Unable to obtain readings|4|||
164322295|NCT04352127|593557198|FG001|Overall Study|Unable to obtain readings|1|||
164322296|NCT03023046|593557201|FG000|Overall Study|Withdrawal by Subject|1|||
164322297|NCT01249118|593557204|FG000|First Washout Period|Physician Decision|0|||
164322298|NCT01249118|593557205|FG001|First Washout Period|Physician Decision|1|||
164322299|NCT01249118|593557206|FG002|First Washout Period|Physician Decision|0|||
164322300|NCT00880685|593557207|FG000|Memantine 10mg|Lost to Follow-up|2|||
164322301|NCT00880685|593557207|FG000|Memantine 20mg|Withdrawal by Subject|1|||
164322302|NCT04179890|593557208|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
164322303|NCT04179890|593557209|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
164322304|NCT04179890|593557208|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
164322305|NCT04179890|593557209|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
164322306|NCT04179890|593557208|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
164322307|NCT04179890|593557209|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
164322308|NCT04179890|593557208|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
164322309|NCT04179890|593557209|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
164322310|NCT04179890|593557208|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
164322311|NCT04179890|593557209|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
164322312|NCT04179890|593557208|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
164322313|NCT04179890|593557209|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
164322314|NCT04179890|593557208|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
164322315|NCT04179890|593557209|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
164322316|NCT04179890|593557208|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
164322317|NCT04179890|593557209|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
164322318|NCT04179890|593557208|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
164322319|NCT04179890|593557209|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
164322320|NCT04535167|593557211|FG000|Treatment|Adverse Event|0|||
164322321|NCT04535167|593557212|FG001|Treatment|Adverse Event|0|||
164322322|NCT04535167|593557213|FG002|Treatment|Adverse Event|0|||
164322323|NCT04535167|593557214|FG003|Treatment|Adverse Event|0|||
164322324|NCT04535167|593557215|FG004|Treatment|Adverse Event|0|||
164322325|NCT04535167|593557216|FG005|Treatment|Adverse Event|0|||
164322326|NCT04535167|593557217|FG006|Treatment|Adverse Event|1|||
164322327|NCT04535167|593557211|FG000|Follow-Up|Death|0|||
164322328|NCT04535167|593557212|FG001|Follow-Up|Death|0|||
164322329|NCT04535167|593557213|FG002|Follow-Up|Death|0|||
164322330|NCT04535167|593557214|FG003|Follow-Up|Death|0|||
164322331|NCT04535167|593557215|FG004|Follow-Up|Death|0|||
164322332|NCT04535167|593557216|FG005|Follow-Up|Death|0|||
164322333|NCT04535167|593557217|FG006|Follow-Up|Death|1|||
164322334|NCT04535167|593557211|FG000|Follow-Up|Lost to Follow-up|0|||
164322335|NCT04535167|593557212|FG001|Follow-Up|Lost to Follow-up|0|||
164322336|NCT04535167|593557213|FG002|Follow-Up|Lost to Follow-up|0|||
164322337|NCT04535167|593557214|FG003|Follow-Up|Lost to Follow-up|1|||
164322338|NCT04535167|593557215|FG004|Follow-Up|Lost to Follow-up|0|||
164322339|NCT04535167|593557216|FG005|Follow-Up|Lost to Follow-up|0|||
164322340|NCT04535167|593557217|FG006|Follow-Up|Lost to Follow-up|0|||
164322341|NCT00978432|593557218|FG000|Overall Study|Withdrawal by Subject|0|||
164322342|NCT00978432|593557219|FG001|Overall Study|Withdrawal by Subject|0|||
164322343|NCT00978432|593557220|FG002|Overall Study|Withdrawal by Subject|1|||
164322344|NCT00978432|593557218|FG000|Overall Study|Lack of Efficacy|1|||
164322345|NCT00978432|593557219|FG001|Overall Study|Lack of Efficacy|1|||
164322346|NCT00978432|593557220|FG002|Overall Study|Lack of Efficacy|3|||
164322347|NCT00978432|593557218|FG000|Overall Study|Adverse Event|2|||
164322348|NCT00978432|593557219|FG001|Overall Study|Adverse Event|0|||
164322349|NCT00978432|593557220|FG002|Overall Study|Adverse Event|1|||
164322350|NCT04656275|593557223|FG000|Overall Study|Study terminated by sponsor|2|||
164322351|NCT04656275|593557224|FG001|Overall Study|Study terminated by sponsor|4|||
164322352|NCT00329901|593557225|FG000|Overall Study|Withdrawal by Subject|4|||
164322353|NCT00329901|593557226|FG001|Overall Study|Withdrawal by Subject|3|||
164322354|NCT00329901|593557227|FG002|Overall Study|Withdrawal by Subject|2|||
164322355|NCT00329901|593557225|FG000|Overall Study|Lost to Follow-up|2|||
164322356|NCT00329901|593557226|FG001|Overall Study|Lost to Follow-up|0|||
164076799|NCT01364298|592645816|FG000|Overall Study|Lack of adherence to treatment|1|||
164322357|NCT00329901|593557227|FG002|Overall Study|Lost to Follow-up|1|||
164322358|NCT00329901|593557225|FG000|Overall Study|Protocol Violation|1|||
164322359|NCT00329901|593557226|FG001|Overall Study|Protocol Violation|0|||
164322360|NCT00329901|593557227|FG002|Overall Study|Protocol Violation|1|||
164322361|NCT00329901|593557225|FG000|Overall Study|Unable to classify|2|||
164322362|NCT00329901|593557226|FG001|Overall Study|Unable to classify|2|||
164322363|NCT00329901|593557227|FG002|Overall Study|Unable to classify|0|||
164322364|NCT05028361|593557228|FG000|Overall Study|Withdrawal by Subject|1|||
164322365|NCT05028361|593557229|FG001|Overall Study|Withdrawal by Subject|0|||
164322366|NCT01993836|593557230|FG000|Overall Study|Surgery Cancelled|3|||
164322367|NCT01993836|593557231|FG001|Overall Study|Surgery Cancelled|0|||
164322368|NCT01993836|593557232|FG002|Overall Study|Surgery Cancelled|0|||
164322369|NCT01993836|593557230|FG000|Overall Study|Physician Decision|2|||
164322370|NCT01993836|593557231|FG001|Overall Study|Physician Decision|1|||
164322371|NCT01993836|593557232|FG002|Overall Study|Physician Decision|0|||
164322372|NCT01993836|593557230|FG000|Overall Study|Death|0|||
164322373|NCT01993836|593557231|FG001|Overall Study|Death|2|||
164322374|NCT01993836|593557232|FG002|Overall Study|Death|0|||
164322375|NCT01993836|593557230|FG000|Overall Study|Withdrawal by Subject|12|||
164322376|NCT01993836|593557231|FG001|Overall Study|Withdrawal by Subject|10|||
164322377|NCT01993836|593557232|FG002|Overall Study|Withdrawal by Subject|5|||
164322378|NCT02195687|593557233|FG000|Overall Study|Personal Reasons|1|||
164322379|NCT02195687|593557234|FG001|Overall Study|Personal Reasons|1|||
164322380|NCT02195687|593557233|FG000|Overall Study|Lost to Follow-up|4|||
164322381|NCT02195687|593557234|FG001|Overall Study|Lost to Follow-up|1|||
164322382|NCT00779259|593557235|FG000|Quinine Alone|Adverse Event|2|||
164322383|NCT00924781|593557238|FG000|Overall Study|Study terminated by sponsor|12|||
164322384|NCT00924781|593557239|FG001|Overall Study|Study terminated by sponsor|10|||
164322385|NCT03459690|593557245|FG000|Overall Study|Lost to Follow-up|0|||
164322386|NCT03459690|593557246|FG001|Overall Study|Lost to Follow-up|1|||
164322387|NCT03459690|593557245|FG000|Overall Study|Withdrawal by Subject|1|||
164322388|NCT03459690|593557246|FG001|Overall Study|Withdrawal by Subject|1|||
164322389|NCT02963831|593557247|FG000|Overall Study|Progressive Disease|3|||
164322390|NCT02963831|593557248|FG001|Overall Study|Progressive Disease|3|||
164322391|NCT02963831|593557249|FG002|Overall Study|Progressive Disease|16|||
164322392|NCT02963831|593557250|FG003|Overall Study|Progressive Disease|27|||
164322393|NCT02963831|593557247|FG000|Overall Study|Withdrawal by Subject|1|||
164322394|NCT02963831|593557248|FG001|Overall Study|Withdrawal by Subject|0|||
164322395|NCT02963831|593557249|FG002|Overall Study|Withdrawal by Subject|2|||
164322396|NCT02963831|593557250|FG003|Overall Study|Withdrawal by Subject|4|||
164322397|NCT02963831|593557247|FG000|Overall Study|Adverse Event|0|||
164322398|NCT02963831|593557248|FG001|Overall Study|Adverse Event|1|||
164322399|NCT02963831|593557249|FG002|Overall Study|Adverse Event|1|||
164322400|NCT02963831|593557250|FG003|Overall Study|Adverse Event|2|||
164322401|NCT02963831|593557247|FG000|Overall Study|Death|0|||
164322402|NCT02963831|593557248|FG001|Overall Study|Death|0|||
164322403|NCT02963831|593557249|FG002|Overall Study|Death|0|||
164322404|NCT02963831|593557250|FG003|Overall Study|Death|2|||
164322405|NCT02536404|593557255|FG000|Overall Study|Adverse Event|5|||
164322406|NCT02536404|593557256|FG001|Overall Study|Adverse Event|0|||
164322407|NCT02536404|593557255|FG000|Overall Study|Withdrawal by Subject|4|||
164322408|NCT02536404|593557256|FG001|Overall Study|Withdrawal by Subject|1|||
164322409|NCT02536404|593557255|FG000|Overall Study|Physician Decision|10|||
164322410|NCT02536404|593557256|FG001|Overall Study|Physician Decision|0|||
164322411|NCT02536404|593557255|FG000|Overall Study|Sponsor decision|1|||
164322412|NCT02536404|593557256|FG001|Overall Study|Sponsor decision|0|||
164322413|NCT02514473|593557257|FG000|Overall Study|Adverse Event|0|||
164322414|NCT02514473|593557258|FG001|Overall Study|Adverse Event|2|||
164322415|NCT02514473|593557257|FG000|Overall Study|Withdrawal by Subject|2|||
164322416|NCT02514473|593557258|FG001|Overall Study|Withdrawal by Subject|1|||
164322417|NCT02514473|593557257|FG000|Overall Study|Lost to Follow-up|0|||
164322418|NCT02514473|593557258|FG001|Overall Study|Lost to Follow-up|1|||
164322419|NCT02514473|593557257|FG000|Overall Study|Other|1|||
164322420|NCT02514473|593557258|FG001|Overall Study|Other|1|||
164322421|NCT02158364|593557259|FG000|Overall Study|Case report forms uncollected|10|||
164322422|NCT02158364|593557259|FG000|Overall Study|Protocol Deviation|50|||
164322423|NCT04381988|593557260|FG000|Overall Study|The study was terminated|4|||
164322424|NCT04381988|593557261|FG001|Overall Study|The study was terminated|0|||
164322425|NCT02106923|593557262|FG000|Overall Study|Protocol Violation|0|||
164322426|NCT02106923|593557263|FG001|Overall Study|Protocol Violation|0|||
164322427|NCT02106923|593557264|FG002|Overall Study|Protocol Violation|0|||
164322428|NCT02106923|593557265|FG003|Overall Study|Protocol Violation|0|||
164322429|NCT02106923|593557266|FG004|Overall Study|Protocol Violation|0|||
164322430|NCT02106923|593557267|FG005|Overall Study|Protocol Violation|1|||
164322431|NCT03485495|593557268|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
164322432|NCT03485495|593557269|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
164322433|NCT03915860|593557270|FG000|Overall Study|Adverse Event|3|||
164322434|NCT03915860|593557270|FG000|Overall Study|Withdrawal by Subject|6|||
164322435|NCT03915860|593557270|FG000|Overall Study|Lost to Follow-up|2|||
164322436|NCT03915860|593557270|FG000|Overall Study|Other than specified|3|||
164322437|NCT01107379|593557274|FG000|Overall Study|Withdrawal by Subject|18|||
164322438|NCT01107379|593557274|FG000|Overall Study|Lost to Follow-up|3|||
164322439|NCT04559529|593557275|FG000|First Intervention (1 Day)|Adverse Event|0|||
164322440|NCT04559529|593557276|FG001|First Intervention (1 Day)|Adverse Event|0|||
164322441|NCT04559529|593557277|FG002|First Intervention (1 Day)|Adverse Event|0|||
164322442|NCT04559529|593557278|FG003|First Intervention (1 Day)|Adverse Event|1|||
164322443|NCT04559529|593557275|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
164322444|NCT04559529|593557276|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
164322445|NCT04559529|593557277|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
164322446|NCT04559529|593557278|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
164322447|NCT04559529|593557275|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
164322448|NCT04559529|593557276|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
164322449|NCT04559529|593557277|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
164322450|NCT04559529|593557278|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
164322451|NCT00732940|593557282|FG000|Overall Study|Withdrawal by Subject|1|||
164322452|NCT00732940|593557283|FG001|Overall Study|Withdrawal by Subject|2|||
164322453|NCT00732940|593557282|FG000|Overall Study|Adverse Event|0|||
164322454|NCT00732940|593557283|FG001|Overall Study|Adverse Event|1|||
164322455|NCT00732940|593557282|FG000|Overall Study|Lost to Follow-up|1|||
164322456|NCT00732940|593557283|FG001|Overall Study|Lost to Follow-up|0|||
164322457|NCT01642732|593557284|FG000|Overall Study|Withdrawal by Subject|1|||
164322458|NCT01589770|593557289|FG000|Overall Study|EGFR <60ml/min|6|||
164322459|NCT01589770|593557290|FG001|Overall Study|EGFR <60ml/min|4|||
164322460|NCT01589770|593557289|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
164322461|NCT01589770|593557290|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
164322462|NCT00890045|593557300|FG000|Overall Study|Death|0|||
164322463|NCT00890045|593557301|FG001|Overall Study|Death|1|||
164322464|NCT00890045|593557300|FG000|Overall Study|Did not receive HeRO Graft|0|||
164322465|NCT00890045|593557301|FG001|Overall Study|Did not receive HeRO Graft|2|||
164322466|NCT00890045|593557300|FG000|Overall Study|Lost to Follow-up|5|||
164322467|NCT00890045|593557301|FG001|Overall Study|Lost to Follow-up|7|||
164322468|NCT00510653|593557302|FG000|Overall Study|Withdrawal by Subject|8|||
164322469|NCT00510653|593557302|FG000|Overall Study|Monetary|3|||
164322470|NCT01077375|593557306|FG000|Overall Study|Adverse Event|2|||
164322471|NCT01077375|593557307|FG001|Overall Study|Adverse Event|15|||
164322472|NCT01077375|593557306|FG000|Overall Study|Lack of Efficacy|6|||
164322473|NCT01077375|593557307|FG001|Overall Study|Lack of Efficacy|8|||
164322474|NCT01077375|593557306|FG000|Overall Study|Withdrawal by Subject|0|||
164322475|NCT01077375|593557307|FG001|Overall Study|Withdrawal by Subject|6|||
164322476|NCT01077375|593557306|FG000|Overall Study|Lost to Follow-up|2|||
164322477|NCT01077375|593557307|FG001|Overall Study|Lost to Follow-up|5|||
164322478|NCT01077375|593557306|FG000|Overall Study|Other Reason|0|||
164322479|NCT01077375|593557307|FG001|Overall Study|Other Reason|1|||
164322480|NCT03021564|593557311|FG000|Overall Study|Death|84|||
164322481|NCT03021564|593557312|FG001|Overall Study|Death|466|||
164322482|NCT03021564|593557311|FG000|Overall Study|Lost to Follow-up|0|||
164322483|NCT03021564|593557312|FG001|Overall Study|Lost to Follow-up|2|||
164322484|NCT02520089|593557315|FG000|Overall Study|Lost to Follow-up|3|||
164322485|NCT02520089|593557316|FG001|Overall Study|Lost to Follow-up|4|||
164322486|NCT01981551|593557319|FG000|Overall Study|Refused further treatment|8|||
164322487|NCT01981551|593557319|FG000|Overall Study|Adverse Event|1|||
164322488|NCT01451437|593557322|FG000|Overall Study|Adverse Event|0|||
164322489|NCT01451437|593557323|FG001|Overall Study|Adverse Event|0|||
164322490|NCT01451437|593557324|FG002|Overall Study|Adverse Event|0|||
164322491|NCT01451437|593557325|FG003|Overall Study|Adverse Event|0|||
164322492|NCT01451437|593557326|FG004|Overall Study|Adverse Event|0|||
164322493|NCT01451437|593557327|FG005|Overall Study|Adverse Event|1|||
164322494|NCT01451437|593557328|FG006|Overall Study|Adverse Event|1|||
164322495|NCT01451437|593557329|FG007|Overall Study|Adverse Event|2|||
164322496|NCT01451437|593557330|FG008|Overall Study|Adverse Event|1|||
164322497|NCT01451437|593557322|FG000|Overall Study|Physician Decision|1|||
164322498|NCT01451437|593557323|FG001|Overall Study|Physician Decision|1|||
164322499|NCT01451437|593557324|FG002|Overall Study|Physician Decision|2|||
164322500|NCT01451437|593557325|FG003|Overall Study|Physician Decision|0|||
164322501|NCT01451437|593557326|FG004|Overall Study|Physician Decision|0|||
164322502|NCT01451437|593557327|FG005|Overall Study|Physician Decision|0|||
164322503|NCT01451437|593557328|FG006|Overall Study|Physician Decision|0|||
164322504|NCT01451437|593557329|FG007|Overall Study|Physician Decision|0|||
164322505|NCT01451437|593557330|FG008|Overall Study|Physician Decision|0|||
164322506|NCT01451437|593557322|FG000|Overall Study|Disease Progression|0|||
164076800|NCT01364298|592645817|FG001|Overall Study|Lack of adherence to treatment|3|||
164322507|NCT01451437|593557323|FG001|Overall Study|Disease Progression|0|||
164322508|NCT01451437|593557324|FG002|Overall Study|Disease Progression|1|||
164322509|NCT01451437|593557325|FG003|Overall Study|Disease Progression|1|||
164322510|NCT01451437|593557326|FG004|Overall Study|Disease Progression|3|||
164322511|NCT01451437|593557327|FG005|Overall Study|Disease Progression|2|||
164322512|NCT01451437|593557328|FG006|Overall Study|Disease Progression|3|||
164322513|NCT01451437|593557329|FG007|Overall Study|Disease Progression|1|||
164322514|NCT01451437|593557330|FG008|Overall Study|Disease Progression|3|||
164322515|NCT01451437|593557322|FG000|Overall Study|Protocol Violation|0|||
164322516|NCT01451437|593557323|FG001|Overall Study|Protocol Violation|0|||
164322517|NCT01451437|593557324|FG002|Overall Study|Protocol Violation|0|||
164322518|NCT01451437|593557325|FG003|Overall Study|Protocol Violation|0|||
164322519|NCT01451437|593557326|FG004|Overall Study|Protocol Violation|0|||
164322520|NCT01451437|593557327|FG005|Overall Study|Protocol Violation|0|||
164076801|NCT01364298|592645816|FG000|Overall Study|Lack of Efficacy|1|||
164076802|NCT01364298|592645817|FG001|Overall Study|Lack of Efficacy|0|||
164076803|NCT01364298|592645816|FG000|Overall Study|Lost to Follow-up|5|||
164076804|NCT01364298|592645817|FG001|Overall Study|Lost to Follow-up|10|||
164322521|NCT01451437|593557328|FG006|Overall Study|Protocol Violation|1|||
164322522|NCT01451437|593557329|FG007|Overall Study|Protocol Violation|0|||
164322523|NCT01451437|593557330|FG008|Overall Study|Protocol Violation|0|||
164322524|NCT01451437|593557322|FG000|Overall Study|Withdrawal by Subject|0|||
164322525|NCT01451437|593557323|FG001|Overall Study|Withdrawal by Subject|0|||
164322526|NCT01451437|593557324|FG002|Overall Study|Withdrawal by Subject|0|||
164322527|NCT01451437|593557325|FG003|Overall Study|Withdrawal by Subject|0|||
164322528|NCT01451437|593557326|FG004|Overall Study|Withdrawal by Subject|1|||
164322529|NCT01451437|593557327|FG005|Overall Study|Withdrawal by Subject|0|||
164322530|NCT01451437|593557328|FG006|Overall Study|Withdrawal by Subject|1|||
164322531|NCT01451437|593557329|FG007|Overall Study|Withdrawal by Subject|0|||
164322532|NCT01451437|593557330|FG008|Overall Study|Withdrawal by Subject|0|||
164322533|NCT00130442|593558935|FG000|Overall Study|Withdrawal by Subject|0|||
164322534|NCT00130442|593558936|FG001|Overall Study|Withdrawal by Subject|1|||
164322535|NCT00130442|593558935|FG000|Overall Study|did not meet criteria|1|||
164322536|NCT00130442|593558936|FG001|Overall Study|did not meet criteria|1|||
164322537|NCT00814333|593558937|FG000|Enrollment|Lost to Follow-up|1|||
164322538|NCT00814333|593558938|FG001|Enrollment|Lost to Follow-up|0|||
164322539|NCT02233946|593558939|FG000|Baseline|Withdrawal by Subject|2|||
164322540|NCT02233946|593558940|FG001|Baseline|Withdrawal by Subject|0|||
164322541|NCT02233946|593558939|FG000|3-months Follow-up|Lost to Follow-up|53|||
164322542|NCT02233946|593558940|FG001|3-months Follow-up|Lost to Follow-up|29|||
164322543|NCT02233946|593558939|FG000|6-months Follow-up|Lost to Follow-up|21|||
164322544|NCT02233946|593558940|FG001|6-months Follow-up|Lost to Follow-up|2|||
164322545|NCT02233946|593558939|FG000|9-month Follow-up|Lost to Follow-up|20|||
164322546|NCT02233946|593558940|FG001|9-month Follow-up|Lost to Follow-up|11|||
164322547|NCT02233946|593558939|FG000|12-month Follow-up|Lost to Follow-up|28|||
164322548|NCT02233946|593558940|FG001|12-month Follow-up|Lost to Follow-up|11|||
164322549|NCT01527357|593558941|FG000|Overall Study|Death|8|||
164322550|NCT01527357|593558942|FG001|Overall Study|Death|2|||
164322551|NCT01527357|593558941|FG000|Overall Study|Lost to Follow-up|6|||
164322552|NCT01527357|593558942|FG001|Overall Study|Lost to Follow-up|4|||
164322553|NCT01527357|593558941|FG000|Overall Study|Withdrew Consent|1|||
164322554|NCT01527357|593558942|FG001|Overall Study|Withdrew Consent|1|||
164322555|NCT01527357|593558941|FG000|Overall Study|Non-compliance|0|||
164322556|NCT01527357|593558942|FG001|Overall Study|Non-compliance|1|||
164322557|NCT01527357|593558941|FG000|Overall Study|No Day 29 Visit|0|||
164322558|NCT01527357|593558942|FG001|Overall Study|No Day 29 Visit|1|||
164322559|NCT01527357|593558941|FG000|Overall Study|Did Not Receive Treatment|2|||
164322560|NCT01527357|593558942|FG001|Overall Study|Did Not Receive Treatment|0|||
164322561|NCT02927067|593558943|FG000|Overall Study|Withdrawn Consent|20|||
164322562|NCT02927067|593558944|FG001|Overall Study|Withdrawn Consent|12|||
164322563|NCT02927067|593558943|FG000|Overall Study|Death|18|||
164322564|NCT02927067|593558944|FG001|Overall Study|Death|31|||
164322565|NCT02927067|593558943|FG000|Overall Study|Adverse Event|13|||
164322566|NCT02927067|593558944|FG001|Overall Study|Adverse Event|10|||
164322567|NCT02927067|593558943|FG000|Overall Study|Noncompliance|5|||
164322568|NCT02927067|593558944|FG001|Overall Study|Noncompliance|2|||
164322569|NCT02927067|593558943|FG000|Overall Study|Reason not Specified|4|||
164322570|NCT02927067|593558944|FG001|Overall Study|Reason not Specified|6|||
164322571|NCT02292784|593558945|FG000|Overall Study|Lost to Follow-up|1|||
164322572|NCT02292784|593558946|FG001|Overall Study|Lost to Follow-up|17|||
164322573|NCT02292784|593558947|FG002|Overall Study|Lost to Follow-up|18|||
164322574|NCT02292784|593558945|FG000|Overall Study|Withdrawal by Subject|0|||
164322575|NCT02292784|593558946|FG001|Overall Study|Withdrawal by Subject|3|||
164322576|NCT02292784|593558947|FG002|Overall Study|Withdrawal by Subject|3|||
164322577|NCT00622739|593558948|FG000|Overall Study|Physician Decision|1|||
164322578|NCT00622739|593558949|FG001|Overall Study|Physician Decision|0|||
164322579|NCT00622739|593558948|FG000|Overall Study|Adverse Event|1|||
164322580|NCT00622739|593558949|FG001|Overall Study|Adverse Event|2|||
164322581|NCT00622739|593558948|FG000|Overall Study|Lack of Efficacy|0|||
164322582|NCT00622739|593558949|FG001|Overall Study|Lack of Efficacy|2|||
164322583|NCT00622739|593558948|FG000|Overall Study|Withdrawal by Subject|0|||
164076805|NCT01364298|592645816|FG000|Overall Study|Withdrawal by Subject|3|||
164076806|NCT01364298|592645817|FG001|Overall Study|Withdrawal by Subject|3|||
164322584|NCT00622739|593558949|FG001|Overall Study|Withdrawal by Subject|1|||
164322585|NCT00622739|593558948|FG000|Overall Study|Lost to Follow-up|0|||
164322586|NCT00622739|593558949|FG001|Overall Study|Lost to Follow-up|1|||
164322587|NCT00134784|593558950|FG000|Overall Study|Withdrawal by Subject|2|||
164076807|NCT01364298|592645816|FG000|Overall Study|Other|1|||
164322588|NCT00134784|593558951|FG001|Overall Study|Withdrawal by Subject|2|||
164322589|NCT00134784|593558952|FG002|Overall Study|Withdrawal by Subject|2|||
164322590|NCT00134784|593558953|FG003|Overall Study|Withdrawal by Subject|1|||
164322591|NCT03384693|593558954|FG000|Overall Study|Adverse Event|3|||
164322592|NCT03621475|593558955|FG000|Overall Study|No longer required restraints at initiation|0|||
164322593|NCT03621475|593558956|FG001|Overall Study|No longer required restraints at initiation|1|||
164322594|NCT00371761|593558957|FG000|Overall Study|Adverse Event|1|||
164322595|NCT00371761|593558958|FG001|Overall Study|Adverse Event|1|||
164322596|NCT00371761|593558957|FG000|Overall Study|Withdrawal by Subject|1|||
164322597|NCT00371761|593558958|FG001|Overall Study|Withdrawal by Subject|3|||
164322598|NCT00371761|593558957|FG000|Overall Study|Investigator Judgment|2|||
164322599|NCT00371761|593558958|FG001|Overall Study|Investigator Judgment|3|||
164322600|NCT00371761|593558957|FG000|Overall Study|Study termination|4|||
164322601|NCT00371761|593558958|FG001|Overall Study|Study termination|3|||
164322602|NCT00718081|593558960|FG000|Overall Study|Adverse Event|0|||
164322603|NCT00718081|593558961|FG001|Overall Study|Adverse Event|1|||
164322604|NCT00718081|593558962|FG002|Overall Study|Adverse Event|0|||
164322605|NCT00718081|593558960|FG000|Overall Study|Lack of Efficacy|7|||
164322606|NCT00718081|593558961|FG001|Overall Study|Lack of Efficacy|3|||
164322607|NCT00718081|593558962|FG002|Overall Study|Lack of Efficacy|21|||
164322608|NCT01397825|593558963|FG000|Overall Study|Progressive Disease|10|||
164322609|NCT01397825|593558964|FG001|Overall Study|Progressive Disease|3|||
164322610|NCT01397825|593558965|FG002|Overall Study|Progressive Disease|11|||
164322611|NCT01397825|593558966|FG003|Overall Study|Progressive Disease|1|||
164322612|NCT01397825|593558967|FG004|Overall Study|Progressive Disease|0|||
164322613|NCT01397825|593558963|FG000|Overall Study|Symptomatic Deterioration|2|||
164322614|NCT01397825|593558964|FG001|Overall Study|Symptomatic Deterioration|0|||
164322615|NCT01397825|593558965|FG002|Overall Study|Symptomatic Deterioration|4|||
164322616|NCT01397825|593558966|FG003|Overall Study|Symptomatic Deterioration|0|||
164322617|NCT01397825|593558967|FG004|Overall Study|Symptomatic Deterioration|0|||
164322618|NCT01397825|593558963|FG000|Overall Study|Adverse Event|0|||
164322619|NCT01397825|593558964|FG001|Overall Study|Adverse Event|1|||
164322620|NCT01397825|593558965|FG002|Overall Study|Adverse Event|5|||
164322621|NCT01397825|593558966|FG003|Overall Study|Adverse Event|1|||
164322622|NCT01397825|593558967|FG004|Overall Study|Adverse Event|0|||
164322623|NCT01397825|593558963|FG000|Overall Study|Withdrawal by Subject|1|||
164322624|NCT01397825|593558964|FG001|Overall Study|Withdrawal by Subject|0|||
164322625|NCT01397825|593558965|FG002|Overall Study|Withdrawal by Subject|5|||
164322626|NCT01397825|593558966|FG003|Overall Study|Withdrawal by Subject|1|||
164322627|NCT01397825|593558967|FG004|Overall Study|Withdrawal by Subject|0|||
164322628|NCT01931670|593558969|FG000|Treatment Period|Exclusionary Medication Received|1|||
164322629|NCT01931670|593558970|FG001|Treatment Period|Exclusionary Medication Received|1|||
164322630|NCT01931670|593558971|FG002|Treatment Period|Exclusionary Medication Received|1|||
164322631|NCT01931670|593558969|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
164322632|NCT01931670|593558970|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
164322633|NCT01931670|593558971|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
164322634|NCT01931670|593558969|FG000|Treatment Period|Subject Noncompliant|4|||
164322635|NCT01931670|593558970|FG001|Treatment Period|Subject Noncompliant|9|||
163979798|NCT00631371|592297252|FG001|Overall Study|Lost to Follow-up|19|||
163979799|NCT00631371|592297251|FG000|Overall Study|Other reason|5|||
163979800|NCT00631371|592297252|FG001|Overall Study|Other reason|12|||
163979801|NCT00631371|592297251|FG000|Overall Study|subject request|38|||
163979802|NCT00631371|592297252|FG001|Overall Study|subject request|45|||
163979803|NCT00631371|592297251|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
163979804|NCT00631371|592297252|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
163979805|NCT00631371|592297251|FG000|Overall Study|Death|263|||
163979806|NCT00631371|592297252|FG001|Overall Study|Death|239|||
163979807|NCT03325673|592297256|FG000|Overall Study|Adverse Event|4|||
163979808|NCT03325673|592297257|FG001|Overall Study|Adverse Event|0|||
163979809|NCT02559687|592297261|FG000|Overall Study|Death|112|||
163979810|NCT02559687|592297261|FG000|Overall Study|Sponsor Decision|5|||
163979811|NCT02559687|592297261|FG000|Overall Study|Withdrawal by Subject|4|||
163979812|NCT01780831|592297262|FG000|Overall Study|Withdrawal by Subject|0|||
163979813|NCT01780831|592297263|FG001|Overall Study|Withdrawal by Subject|0|||
163979814|NCT01780831|592297264|FG002|Overall Study|Withdrawal by Subject|4|||
163979815|NCT01780831|592297265|FG003|Overall Study|Withdrawal by Subject|0|||
163979816|NCT01780831|592297262|FG000|Overall Study|Lost to Follow-up|0|||
163979817|NCT01780831|592297263|FG001|Overall Study|Lost to Follow-up|0|||
163979818|NCT01780831|592297264|FG002|Overall Study|Lost to Follow-up|0|||
163979819|NCT01780831|592297265|FG003|Overall Study|Lost to Follow-up|1|||
163979820|NCT01784861|592297276|FG000|Overall Study|Adverse Event|0|||
163979821|NCT01784861|592297277|FG001|Overall Study|Adverse Event|0|||
163979822|NCT01784861|592297278|FG002|Overall Study|Adverse Event|1|||
164322636|NCT01931670|593558971|FG002|Treatment Period|Subject Noncompliant|5|||
164322637|NCT01931670|593558969|FG000|Treatment Period|Adverse Event|19|||
164322638|NCT01931670|593558970|FG001|Treatment Period|Adverse Event|8|||
164322639|NCT01931670|593558971|FG002|Treatment Period|Adverse Event|21|||
164322640|NCT01931670|593558969|FG000|Treatment Period|Lack of Efficacy|11|||
163979823|NCT01784861|592297279|FG003|Overall Study|Adverse Event|2|||
163979824|NCT01784861|592297280|FG004|Overall Study|Adverse Event|1|||
163979825|NCT01784861|592297281|FG005|Overall Study|Adverse Event|0|||
164076808|NCT01364298|592645817|FG001|Overall Study|Other|3|||
164076809|NCT03712228|592645820|FG000|Treatment Period 1|Lack of Efficacy|0|||
164076810|NCT03712228|592645821|FG001|Treatment Period 1|Lack of Efficacy|0|||
164076811|NCT03712228|592645822|FG002|Treatment Period 1|Lack of Efficacy|0|||
164076812|NCT03712228|592645823|FG003|Treatment Period 1|Lack of Efficacy|0|||
164076813|NCT03712228|592645824|FG004|Treatment Period 1|Lack of Efficacy|0|||
164076814|NCT03712228|592645825|FG005|Treatment Period 1|Lack of Efficacy|1|||
164076815|NCT03712228|592645820|FG000|Treatment Period 2|Pregnancy|0|||
164076816|NCT03712228|592645821|FG001|Treatment Period 2|Pregnancy|0|||
164076817|NCT03712228|592645822|FG002|Treatment Period 2|Pregnancy|0|||
164076818|NCT03712228|592645823|FG003|Treatment Period 2|Pregnancy|1|||
164076819|NCT03712228|592645824|FG004|Treatment Period 2|Pregnancy|0|||
164076820|NCT03712228|592645825|FG005|Treatment Period 2|Pregnancy|0|||
164076821|NCT03712228|592645820|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164076822|NCT03712228|592645821|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164076823|NCT03712228|592645822|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164076824|NCT03712228|592645823|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164076825|NCT03712228|592645824|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164076826|NCT03712228|592645825|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164076827|NCT01964105|592645826|FG000|Overall Study|Lost to Follow-up|2|||
164076828|NCT01964105|592645827|FG001|Overall Study|Lost to Follow-up|13|||
164076829|NCT01964105|592645828|FG002|Overall Study|Lost to Follow-up|0|||
164076830|NCT01254045|592645831|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
164076831|NCT01254045|592645832|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164076832|NCT01254045|592645833|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164076833|NCT01254045|592645834|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164076834|NCT01254045|592645835|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164076835|NCT01254045|592645836|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
164076836|NCT00597207|592645837|FG000|Overall Study|Lost to Follow-up|5|||
164076837|NCT00597207|592645838|FG001|Overall Study|Lost to Follow-up|7|||
164076838|NCT00520351|592645839|FG000|First Intervention|Withdrawal by Subject|1|||
164076839|NCT00520351|592645840|FG001|First Intervention|Withdrawal by Subject|1|||
164076840|NCT01021137|592645843|FG000|Overall Study|Lost to Follow-up|9|||
164076841|NCT01021137|592645844|FG001|Overall Study|Lost to Follow-up|4|||
164076842|NCT01021137|592645845|FG002|Overall Study|Lost to Follow-up|2|||
164076843|NCT01021137|592645846|FG003|Overall Study|Lost to Follow-up|6|||
164076844|NCT01021137|592645843|FG000|Overall Study|Withdrawal by Subject|1|||
164076845|NCT01021137|592645844|FG001|Overall Study|Withdrawal by Subject|0|||
164076846|NCT01021137|592645845|FG002|Overall Study|Withdrawal by Subject|0|||
164076847|NCT01021137|592645846|FG003|Overall Study|Withdrawal by Subject|3|||
164076848|NCT00725725|592645847|FG000|Overall Study|Adverse Event|1|||
164076849|NCT00725725|592645848|FG001|Overall Study|Adverse Event|3|||
164076850|NCT00725725|592645849|FG002|Overall Study|Adverse Event|2|||
164322641|NCT01931670|593558970|FG001|Treatment Period|Lack of Efficacy|2|||
164322642|NCT01931670|593558971|FG002|Treatment Period|Lack of Efficacy|2|||
164322643|NCT01931670|593558969|FG000|Treatment Period|Pregnancy|7|||
164322644|NCT01931670|593558970|FG001|Treatment Period|Pregnancy|2|||
164322645|NCT01931670|593558971|FG002|Treatment Period|Pregnancy|0|||
164322646|NCT01931670|593558969|FG000|Treatment Period|Other|8|||
164322647|NCT01931670|593558970|FG001|Treatment Period|Other|7|||
163875222|NCT02462759|591911575|FG001|Part 1: Double Blind|Death|0|||
163875223|NCT02462759|591911576|FG002|Part 1: Double Blind|Death|0|||
163875224|NCT00520546|591911580|FG000|Overall Study|Withdrawal by Subject|1|||
163875225|NCT00520546|591911580|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
163875226|NCT05052996|591911581|FG000|Overall Study|Still on study|0|||
163875227|NCT05052996|591911582|FG001|Overall Study|Still on study|0|||
163875228|NCT05052996|591911583|FG002|Overall Study|Still on study|47|||
163875229|NCT05052996|591911584|FG003|Overall Study|Still on study|44|||
163875230|NCT05052996|591911581|FG000|Overall Study|Cohort terminated by sponsor|21|||
163875231|NCT05052996|591911582|FG001|Overall Study|Cohort terminated by sponsor|12|||
163875232|NCT05052996|591911583|FG002|Overall Study|Cohort terminated by sponsor|0|||
163875233|NCT05052996|591911584|FG003|Overall Study|Cohort terminated by sponsor|0|||
163875234|NCT05052996|591911581|FG000|Overall Study|Withdrew consent|1|||
163875235|NCT05052996|591911582|FG001|Overall Study|Withdrew consent|0|||
163875236|NCT05052996|591911583|FG002|Overall Study|Withdrew consent|1|||
163875237|NCT05052996|591911584|FG003|Overall Study|Withdrew consent|2|||
163875238|NCT05052996|591911581|FG000|Overall Study|Lost to Follow-up|1|||
163875239|NCT05052996|591911582|FG001|Overall Study|Lost to Follow-up|0|||
163875240|NCT05052996|591911583|FG002|Overall Study|Lost to Follow-up|0|||
163875241|NCT05052996|591911584|FG003|Overall Study|Lost to Follow-up|2|||
163875242|NCT05052996|591911581|FG000|Overall Study|Adverse Event|0|||
164076851|NCT00725725|592645847|FG000|Overall Study|Lost to Follow-up|2|||
164076852|NCT00725725|592645848|FG001|Overall Study|Lost to Follow-up|0|||
164076853|NCT00725725|592645849|FG002|Overall Study|Lost to Follow-up|2|||
164076854|NCT00725725|592645847|FG000|Overall Study|Withdrawal by Subject|1|||
164076855|NCT00725725|592645848|FG001|Overall Study|Withdrawal by Subject|0|||
164322648|NCT01931670|593558971|FG002|Treatment Period|Other|2|||
164322649|NCT01931670|593558969|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
164322650|NCT01931670|593558970|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
164322651|NCT01931670|593558971|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
164322652|NCT01931670|593558969|FG000|Treatment Period|Lost to Follow-up|19|||
164322653|NCT01931670|593558970|FG001|Treatment Period|Lost to Follow-up|5|||
164322654|NCT01931670|593558971|FG002|Treatment Period|Lost to Follow-up|7|||
164322655|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
164322656|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
164322657|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
164322658|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
164322659|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
164322660|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
164322661|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
164322662|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
164322663|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
164322664|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
164322665|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
164322666|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
164322667|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
164322668|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
164322669|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
164322670|NCT01931670|593558969|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
164322671|NCT01931670|593558970|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
164322672|NCT01931670|593558971|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
164322673|NCT00976508|593558975|FG000|Overall Study|Death|7|||
164322674|NCT00976508|593558976|FG001|Overall Study|Death|1|||
164322675|NCT00976508|593558975|FG000|Overall Study|Lost to Follow-up|1|||
164322676|NCT00976508|593558976|FG001|Overall Study|Lost to Follow-up|0|||
164322677|NCT00976508|593558975|FG000|Overall Study|Withdrawal by Subject|1|||
164322678|NCT00976508|593558976|FG001|Overall Study|Withdrawal by Subject|0|||
164322679|NCT00976508|593558975|FG000|Overall Study|Disease Progression|4|||
164322680|NCT00976508|593558976|FG001|Overall Study|Disease Progression|4|||
164322681|NCT00976508|593558975|FG000|Overall Study|Subject Enrolled in Hospice|1|||
164322682|NCT00976508|593558976|FG001|Overall Study|Subject Enrolled in Hospice|0|||
164322683|NCT00976508|593558975|FG000|Overall Study|Terminated by the Sponsor|0|||
164322684|NCT00976508|593558976|FG001|Overall Study|Terminated by the Sponsor|1|||
164322685|NCT01992159|593558977|FG000|Overall Study|Withdrawal by Subject|4|||
164322686|NCT01992159|593558978|FG001|Overall Study|Withdrawal by Subject|7|||
164322687|NCT01992159|593558979|FG002|Overall Study|Withdrawal by Subject|0|||
164322688|NCT01992159|593558980|FG003|Overall Study|Withdrawal by Subject|3|||
164322689|NCT01992159|593558977|FG000|Overall Study|Adverse Event|0|||
163875243|NCT05052996|591911582|FG001|Overall Study|Adverse Event|0|||
163875244|NCT05052996|591911583|FG002|Overall Study|Adverse Event|2|||
163875245|NCT05052996|591911584|FG003|Overall Study|Adverse Event|0|||
163875246|NCT05052996|591911581|FG000|Overall Study|Randomized but never treated|0|||
163875247|NCT05052996|591911582|FG001|Overall Study|Randomized but never treated|0|||
163875248|NCT05052996|591911583|FG002|Overall Study|Randomized but never treated|1|||
163875249|NCT05052996|591911584|FG003|Overall Study|Randomized but never treated|1|||
163875250|NCT05052996|591911581|FG000|Overall Study|Protocol Violation|1|||
163875251|NCT05052996|591911582|FG001|Overall Study|Protocol Violation|0|||
163875252|NCT05052996|591911583|FG002|Overall Study|Protocol Violation|0|||
163875253|NCT05052996|591911584|FG003|Overall Study|Protocol Violation|0|||
163875254|NCT01695954|591911585|FG000|Overall Study|Withdrawal by Subject|4|||
163875255|NCT01695954|591911586|FG001|Overall Study|Withdrawal by Subject|0|||
163875256|NCT01695954|591911585|FG000|Overall Study|Adverse Event|0|||
163875257|NCT01695954|591911586|FG001|Overall Study|Adverse Event|2|||
163875258|NCT02088853|591911587|FG000|Overall Study|Pregnancy|1|||
163875259|NCT02088853|591911588|FG001|Overall Study|Pregnancy|0|||
163875260|NCT04704284|591911594|FG000|Overall Study|Withdrawal by Subject|1|||
163875261|NCT01248936|591911598|FG000|Overall Study|Sponsor Decision|259|||
163875262|NCT01248936|591911598|FG000|Overall Study|Progression of Disease|50|||
164322690|NCT01992159|593558978|FG001|Overall Study|Adverse Event|1|||
164322691|NCT01992159|593558979|FG002|Overall Study|Adverse Event|0|||
164322692|NCT01992159|593558980|FG003|Overall Study|Adverse Event|1|||
164322693|NCT01992159|593558977|FG000|Overall Study|Death|0|||
164322694|NCT01992159|593558978|FG001|Overall Study|Death|0|||
164322695|NCT01992159|593558979|FG002|Overall Study|Death|1|||
164322696|NCT01992159|593558980|FG003|Overall Study|Death|0|||
164322697|NCT00470158|593558981|FG000|Overall Study|Death|0|||
163875263|NCT01248936|591911598|FG000|Overall Study|Death|26|||
163875264|NCT01248936|591911598|FG000|Overall Study|Withdrawal of Consent|20|||
163875265|NCT01248936|591911598|FG000|Overall Study|Adverse Event|8|||
163875266|NCT01248936|591911598|FG000|Overall Study|Lost to Follow-up|7|||
163875267|NCT01248936|591911598|FG000|Overall Study|Refused Treatment|1|||
164076856|NCT00725725|592645849|FG002|Overall Study|Withdrawal by Subject|1|||
164208333|NCT00879658|593131651|FG003|Overall Study|misrandomized (never received study med)|1|||
164208334|NCT00879658|593131652|FG004|Overall Study|misrandomized (never received study med)|0|||
164208335|NCT00879658|593131653|FG005|Overall Study|misrandomized (never received study med)|0|||
164208336|NCT00879658|593131654|FG006|Overall Study|misrandomized (never received study med)|0|||
164208337|NCT01035138|593131664|FG000|Overall Study|Adverse Event|4|||
164208338|NCT01035138|593131665|FG001|Overall Study|Adverse Event|0|||
164208339|NCT01035138|593131666|FG002|Overall Study|Adverse Event|2|||
164208340|NCT01035138|593131664|FG000|Overall Study|Caregiver Decision|2|||
164208341|NCT01035138|593131665|FG001|Overall Study|Caregiver Decision|0|||
164208342|NCT01035138|593131666|FG002|Overall Study|Caregiver Decision|1|||
164208343|NCT01035138|593131664|FG000|Overall Study|Withdrawal by Subject|1|||
164208344|NCT01035138|593131665|FG001|Overall Study|Withdrawal by Subject|0|||
164208345|NCT01035138|593131666|FG002|Overall Study|Withdrawal by Subject|0|||
164208346|NCT01035138|593131664|FG000|Overall Study|Physician Decision|0|||
164208347|NCT01035138|593131665|FG001|Overall Study|Physician Decision|0|||
164208348|NCT01035138|593131666|FG002|Overall Study|Physician Decision|1|||
164208349|NCT01035138|593131664|FG000|Overall Study|Sponsor Decision|66|||
164208350|NCT01035138|593131665|FG001|Overall Study|Sponsor Decision|60|||
164208351|NCT01035138|593131666|FG002|Overall Study|Sponsor Decision|42|||
164208352|NCT01035138|593131664|FG000|Overall Study|Lost to Follow-up|0|||
164208353|NCT01035138|593131665|FG001|Overall Study|Lost to Follow-up|0|||
164208354|NCT01035138|593131666|FG002|Overall Study|Lost to Follow-up|1|||
164208355|NCT01101178|593131670|FG000|Period 1|Withdrawal by Subject|1|||
164208356|NCT01101178|593131671|FG001|Period 1|Withdrawal by Subject|2|||
164208357|NCT01101178|593131670|FG000|Period 1|Positive drug screen|1|||
164208358|NCT01101178|593131671|FG001|Period 1|Positive drug screen|1|||
164208359|NCT01101178|593131670|FG000|Period 1|Adverse Event|2|||
164208360|NCT01101178|593131671|FG001|Period 1|Adverse Event|1|||
164208361|NCT01101178|593131670|FG000|Period 2|Withdrawal by Subject|0|||
164208362|NCT01101178|593131671|FG001|Period 2|Withdrawal by Subject|1|||
164208363|NCT01850641|593131672|FG000|Overall Study|Physician Decision|1|||
164208364|NCT01850641|593131672|FG000|Overall Study|Decrease in serum phosphorus|1|||
164208365|NCT01850641|593131672|FG000|Overall Study|Decrease in serum calcium|2|||
164208366|NCT01850641|593131672|FG000|Overall Study|Increase in serum ferritin|1|||
164208367|NCT00141817|593131673|FG000|Overall Study|Protocol Violation|0|||
164208368|NCT00141817|593131674|FG001|Overall Study|Protocol Violation|0|||
164208369|NCT00141817|593131675|FG002|Overall Study|Protocol Violation|1|||
164208370|NCT00141817|593131676|FG003|Overall Study|Protocol Violation|0|||
164208371|NCT00141817|593131673|FG000|Overall Study|Parent request|1|||
164208372|NCT00141817|593131674|FG001|Overall Study|Parent request|0|||
164208373|NCT00141817|593131675|FG002|Overall Study|Parent request|0|||
164208374|NCT00141817|593131676|FG003|Overall Study|Parent request|0|||
164208375|NCT00127803|593131677|FG000|Overall Study|Adverse Event|2|||
164208376|NCT00127803|593131678|FG001|Overall Study|Adverse Event|0|||
164208377|NCT00127803|593131679|FG002|Overall Study|Adverse Event|0|||
164208378|NCT00127803|593131680|FG003|Overall Study|Adverse Event|0|||
164208379|NCT00127803|593131677|FG000|Overall Study|Withdrawal by Subject|1|||
164208380|NCT00127803|593131678|FG001|Overall Study|Withdrawal by Subject|0|||
164208381|NCT00127803|593131679|FG002|Overall Study|Withdrawal by Subject|0|||
164208382|NCT00127803|593131680|FG003|Overall Study|Withdrawal by Subject|0|||
164208383|NCT00127803|593131677|FG000|Overall Study|Lost to Follow-up|0|||
164208384|NCT00127803|593131678|FG001|Overall Study|Lost to Follow-up|0|||
164208385|NCT00127803|593131679|FG002|Overall Study|Lost to Follow-up|0|||
164208386|NCT00127803|593131680|FG003|Overall Study|Lost to Follow-up|1|||
164208387|NCT04739800|593131684|FG000|Overall Study|Adverse Event|2|||
164208388|NCT04739800|593131685|FG001|Overall Study|Adverse Event|1|||
164208389|NCT04739800|593131686|FG002|Overall Study|Adverse Event|4|||
164208390|NCT04739800|593131687|FG003|Overall Study|Adverse Event|5|||
164208391|NCT04739800|593131684|FG000|Overall Study|Never Treated|2|||
164208392|NCT04739800|593131685|FG001|Overall Study|Never Treated|0|||
164208393|NCT04739800|593131686|FG002|Overall Study|Never Treated|1|||
164208394|NCT04739800|593131687|FG003|Overall Study|Never Treated|1|||
164208395|NCT04739800|593131684|FG000|Overall Study|On Treatment|5|||
164208396|NCT04739800|593131685|FG001|Overall Study|On Treatment|9|||
164208397|NCT04739800|593131686|FG002|Overall Study|On Treatment|9|||
164208398|NCT04739800|593131687|FG003|Overall Study|On Treatment|9|||
164208399|NCT04739800|593131684|FG000|Overall Study|Symptomatic Deterioration|1|||
164208400|NCT04739800|593131685|FG001|Overall Study|Symptomatic Deterioration|1|||
164208401|NCT04739800|593131686|FG002|Overall Study|Symptomatic Deterioration|3|||
164208402|NCT04739800|593131687|FG003|Overall Study|Symptomatic Deterioration|0|||
164208403|NCT04739800|593131684|FG000|Overall Study|Withdrawal by Subject|1|||
164208404|NCT04739800|593131685|FG001|Overall Study|Withdrawal by Subject|2|||
164208405|NCT04739800|593131686|FG002|Overall Study|Withdrawal by Subject|1|||
164208406|NCT04739800|593131687|FG003|Overall Study|Withdrawal by Subject|3|||
164208407|NCT04739800|593131684|FG000|Overall Study|Other Reason|1|||
164208408|NCT04739800|593131685|FG001|Overall Study|Other Reason|3|||
164208409|NCT04739800|593131686|FG002|Overall Study|Other Reason|5|||
164208410|NCT04739800|593131687|FG003|Overall Study|Other Reason|4|||
164322698|NCT00470158|593558982|FG001|Overall Study|Death|0|||
164322699|NCT00470158|593558983|FG002|Overall Study|Death|0|||
164322700|NCT00470158|593558984|FG003|Overall Study|Death|0|||
164322701|NCT00470158|593558985|FG004|Overall Study|Death|2|||
164322702|NCT00470158|593558981|FG000|Overall Study|Lost to Follow-up|7|||
164322703|NCT00470158|593558982|FG001|Overall Study|Lost to Follow-up|8|||
164322704|NCT00470158|593558983|FG002|Overall Study|Lost to Follow-up|8|||
164322705|NCT00470158|593558984|FG003|Overall Study|Lost to Follow-up|5|||
164322706|NCT00470158|593558985|FG004|Overall Study|Lost to Follow-up|4|||
164322707|NCT00470158|593558981|FG000|Overall Study|Protocol Violation|1|||
164322708|NCT00470158|593558982|FG001|Overall Study|Protocol Violation|0|||
164322709|NCT00470158|593558983|FG002|Overall Study|Protocol Violation|0|||
164322710|NCT00470158|593558984|FG003|Overall Study|Protocol Violation|0|||
164322711|NCT00470158|593558985|FG004|Overall Study|Protocol Violation|0|||
164322712|NCT00997438|593558986|FG000|Overall Study|Blood draw difficulty|2|||
164322713|NCT00997438|593558987|FG001|Overall Study|Blood draw difficulty|0|||
164322714|NCT00997438|593558988|FG002|Overall Study|Blood draw difficulty|1|||
164322715|NCT00997438|593558986|FG000|Overall Study|Withdrawal by Subject|1|||
164322716|NCT00997438|593558987|FG001|Overall Study|Withdrawal by Subject|1|||
164322717|NCT00997438|593558988|FG002|Overall Study|Withdrawal by Subject|0|||
164322718|NCT00997438|593558986|FG000|Overall Study|Exclusion criteria at visit 1|2|||
164322719|NCT00997438|593558987|FG001|Overall Study|Exclusion criteria at visit 1|2|||
164322720|NCT00997438|593558988|FG002|Overall Study|Exclusion criteria at visit 1|3|||
164322721|NCT01236118|593558989|FG000|Overall Study|Adverse Event|2|||
164322722|NCT01236118|593558990|FG001|Overall Study|Adverse Event|0|||
164322723|NCT01236118|593558991|FG002|Overall Study|Adverse Event|2|||
164322724|NCT01236118|593558989|FG000|Overall Study|Physician Decision|0|||
164322725|NCT01236118|593558990|FG001|Overall Study|Physician Decision|1|||
164322726|NCT01236118|593558991|FG002|Overall Study|Physician Decision|0|||
164322727|NCT01236118|593558989|FG000|Overall Study|Withdrawal by Subject|0|||
164322728|NCT01236118|593558990|FG001|Overall Study|Withdrawal by Subject|0|||
164322729|NCT01236118|593558991|FG002|Overall Study|Withdrawal by Subject|1|||
164322730|NCT00095238|593558992|FG000|Overall Study|Lack of Efficacy|9|||
164322731|NCT00095238|593558993|FG001|Overall Study|Lack of Efficacy|9|||
164322732|NCT00095238|593558992|FG000|Overall Study|Adverse Event|331|||
164322733|NCT00095238|593558993|FG001|Overall Study|Adverse Event|287|||
164322734|NCT00095238|593558992|FG000|Overall Study|Subject Withdrew Consent|208|||
164322735|NCT00095238|593558993|FG001|Overall Study|Subject Withdrew Consent|223|||
164322736|NCT00095238|593558992|FG000|Overall Study|Death|154|||
164322737|NCT00095238|593558993|FG001|Overall Study|Death|170|||
164322738|NCT00095238|593558992|FG000|Overall Study|Lost to Follow-up|19|||
164322739|NCT00095238|593558993|FG001|Overall Study|Lost to Follow-up|24|||
164322740|NCT00095238|593558992|FG000|Overall Study|Noncompliance|44|||
164322741|NCT00095238|593558993|FG001|Overall Study|Noncompliance|45|||
164322742|NCT00095238|593558992|FG000|Overall Study|No longer met study criteria|4|||
164322743|NCT00095238|593558993|FG001|Overall Study|No longer met study criteria|5|||
164322744|NCT00095238|593558992|FG000|Overall Study|Study terminated by sponsor|0|||
164322745|NCT00095238|593558993|FG001|Overall Study|Study terminated by sponsor|1|||
164322746|NCT00095238|593558992|FG000|Overall Study|Missing|1|||
164322747|NCT00095238|593558993|FG001|Overall Study|Missing|0|||
164322748|NCT00095238|593558992|FG000|Overall Study|Other Reasons|87|||
164322749|NCT00095238|593558993|FG001|Overall Study|Other Reasons|88|||
164322750|NCT02579928|593558994|FG000|Overall Study|Withdrawal by Subject|1|||
164322751|NCT02579928|593558995|FG001|Overall Study|Withdrawal by Subject|0|||
164322752|NCT04300751|593558996|FG000|Overall Study|Withdrawal by Subject|1|||
164322753|NCT03754972|593558999|FG000|Overall Study|Protocol Violation|25|||
164322754|NCT02311582|593559000|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
164322755|NCT02311582|593559001|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
164322756|NCT02311582|593559002|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
164322757|NCT02311582|593559003|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
164322758|NCT02311582|593559004|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
164322759|NCT03404960|593559006|FG000|Overall Study|Adverse Event|0|||
164322760|NCT03404960|593559007|FG001|Overall Study|Adverse Event|2|||
164322761|NCT03404960|593559006|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
164322762|NCT03404960|593559007|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
164322763|NCT03404960|593559006|FG000|Overall Study|Bowel obstruction|0|||
164322764|NCT03404960|593559007|FG001|Overall Study|Bowel obstruction|1|||
164322765|NCT03404960|593559006|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
163979826|NCT01784861|592297276|FG000|Overall Study|Withdrawal by Subject|0|||
163979827|NCT01784861|592297277|FG001|Overall Study|Withdrawal by Subject|0|||
164322766|NCT03404960|593559007|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
164322767|NCT05171816|593559015|FG000|Overall Study|Death|18|||
164322768|NCT05171816|593559016|FG001|Overall Study|Death|16|||
164322769|NCT04902326|593559018|FG000|Overall Study|Withdrawal by Subject|1|||
164322770|NCT04902326|593559019|FG001|Overall Study|Withdrawal by Subject|3|||
164322771|NCT04902326|593559020|FG002|Overall Study|Withdrawal by Subject|0|||
164322772|NCT04902326|593559021|FG003|Overall Study|Withdrawal by Subject|1|||
164322773|NCT04902326|593559018|FG000|Overall Study|Lost to Follow-up|14|||
164322774|NCT04902326|593559019|FG001|Overall Study|Lost to Follow-up|14|||
164322775|NCT04902326|593559020|FG002|Overall Study|Lost to Follow-up|14|||
164322776|NCT04902326|593559021|FG003|Overall Study|Lost to Follow-up|6|||
164322777|NCT01857310|593559024|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
164322778|NCT01857310|593559025|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
164322779|NCT02360605|593559026|FG000|Overall Study|Withdrawal by Subject|4|||
164322780|NCT02360605|593559027|FG001|Overall Study|Withdrawal by Subject|9|||
164322781|NCT02360605|593559026|FG000|Overall Study|Lost to Follow-up|7|||
164322782|NCT02360605|593559027|FG001|Overall Study|Lost to Follow-up|8|||
164322783|NCT02360605|593559026|FG000|Overall Study|Death|0|||
164322784|NCT02360605|593559027|FG001|Overall Study|Death|1|||
164322785|NCT00290407|593559028|FG000|Overall Study|Physician Decision|2|||
164322786|NCT00868517|593559039|FG000|Overall Study|Withdrawal by Subject|3|||
164322787|NCT00868517|593559040|FG001|Overall Study|Withdrawal by Subject|3|||
164322788|NCT00868517|593559041|FG002|Overall Study|Withdrawal by Subject|2|||
164322789|NCT00868517|593559039|FG000|Overall Study|Protocol Violation|1|||
164322790|NCT00868517|593559040|FG001|Overall Study|Protocol Violation|1|||
164322791|NCT00868517|593559041|FG002|Overall Study|Protocol Violation|0|||
164322792|NCT01721577|593559042|FG000|Overall Study|Lack of Efficacy|1|||
164322793|NCT01721577|593559043|FG001|Overall Study|Lack of Efficacy|0|||
164322794|NCT01721577|593559042|FG000|Overall Study|Death|1|||
164322795|NCT01721577|593559043|FG001|Overall Study|Death|0|||
164322796|NCT01721577|593559042|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
164322797|NCT01721577|593559043|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
164322798|NCT01721577|593559042|FG000|Overall Study|Adverse Event|0|||
164322799|NCT01721577|593559043|FG001|Overall Study|Adverse Event|2|||
164322800|NCT05442775|593559044|FG000|Overall Study|Trial terminated|61|||
164322801|NCT05442775|593559044|FG000|Overall Study|Lack of Efficacy|4|||
164322802|NCT05442775|593559044|FG000|Overall Study|Withdrawal by Subject|4|||
164322803|NCT05442775|593559044|FG000|Overall Study|Death|1|||
164322804|NCT05442775|593559044|FG000|Overall Study|Participant removed at Sponsor request|1|||
164322805|NCT01055496|593559046|FG000|Overall Study|Withdrawal by Subject|2|||
164322806|NCT01055496|593559047|FG001|Overall Study|Withdrawal by Subject|4|||
164322807|NCT01055496|593559046|FG000|Overall Study|Death|13|||
164322808|NCT01055496|593559047|FG001|Overall Study|Death|23|||
164322809|NCT01055496|593559046|FG000|Overall Study|Lost to Follow-up|0|||
164322810|NCT01055496|593559047|FG001|Overall Study|Lost to Follow-up|2|||
164322811|NCT01055496|593559046|FG000|Overall Study|Other - Unspecified|0|||
164322812|NCT01055496|593559047|FG001|Overall Study|Other - Unspecified|1|||
164322813|NCT00584740|593559048|FG000|Overall Study|Adverse Event|1|||
164322814|NCT00584740|593559049|FG001|Overall Study|Adverse Event|1|||
164322815|NCT00584740|593559048|FG000|Overall Study|Lack of Efficacy|8|||
164322816|NCT00584740|593559049|FG001|Overall Study|Lack of Efficacy|2|||
164322817|NCT00584740|593559048|FG000|Overall Study|Withdrawal by Subject|3|||
164322818|NCT00584740|593559049|FG001|Overall Study|Withdrawal by Subject|2|||
164322819|NCT00584740|593559048|FG000|Overall Study|Lost to Follow-up|0|||
164322820|NCT00584740|593559049|FG001|Overall Study|Lost to Follow-up|1|||
164322821|NCT00969280|593559051|FG000|Overall Study|Protocol Violation|2|||
164322822|NCT00969280|593559052|FG001|Overall Study|Protocol Violation|1|||
164322823|NCT00969280|593559051|FG000|Overall Study|Withdrawal by Subject|0|||
164322824|NCT00969280|593559052|FG001|Overall Study|Withdrawal by Subject|1|||
164322825|NCT00969280|593559051|FG000|Overall Study|infection of influenza A(H1N1)|0|||
164322826|NCT00969280|593559052|FG001|Overall Study|infection of influenza A(H1N1)|1|||
164322827|NCT00821327|593559053|FG000|Overall Study|Adverse Event|13|||
164322828|NCT00821327|593559053|FG000|Overall Study|Patient Request|1|||
164322829|NCT00821327|593559053|FG000|Overall Study|Investigator Request|2|||
164322830|NCT00821327|593559053|FG000|Overall Study|Sponsor Request|1|||
164322831|NCT00821327|593559053|FG000|Overall Study|Disease Progression|13|||
164322832|NCT00821327|593559053|FG000|Overall Study|Other/Unknown|5|||
164322833|NCT00217464|593559054|FG000|Overall Study|Progression|15|||
164322834|NCT00217464|593559054|FG000|Overall Study|Other|2|||
163875268|NCT01248936|591911598|FG000|Overall Study|Other reason|3|||
163875269|NCT03930420|591911599|FG000|Overall Study|Withdrawal by Subject|7|||
164322835|NCT00459979|593559055|FG000|Overall Study|Withdrawal by Subject|1|||
164322836|NCT00459979|593559055|FG000|Overall Study|Protocol Violation|1|||
163875270|NCT03930420|591911600|FG001|Overall Study|Withdrawal by Subject|9|||
163875271|NCT05609032|591911601|FG000|Overall Study|Lost to Follow-up|3|||
163875272|NCT05609032|591911602|FG001|Overall Study|Lost to Follow-up|1|||
163875273|NCT05609032|591911601|FG000|Overall Study|Withdrawal by Subject|1|||
164322837|NCT00278915|593559056|FG000|Overall Study|Disease progression|1|||
164322838|NCT05214573|593559057|FG000|Overall Study|Physician Decision|5924|||
164322839|NCT05214573|593559058|FG001|Overall Study|Physician Decision|0|||
164322840|NCT00814801|593559059|FG000|Overall Study|Adverse Event|15|||
164322841|NCT00814801|593559060|FG001|Overall Study|Adverse Event|16|||
164322842|NCT00814801|593559061|FG002|Overall Study|Adverse Event|19|||
164322843|NCT00814801|593559059|FG000|Overall Study|Withdrawal by Subject|9|||
164322844|NCT00814801|593559060|FG001|Overall Study|Withdrawal by Subject|11|||
164322845|NCT00814801|593559061|FG002|Overall Study|Withdrawal by Subject|14|||
164322846|NCT00814801|593559059|FG000|Overall Study|Inappropriate as a subject|1|||
164322847|NCT00814801|593559060|FG001|Overall Study|Inappropriate as a subject|1|||
164322848|NCT00814801|593559061|FG002|Overall Study|Inappropriate as a subject|1|||
164322849|NCT00814801|593559059|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
164322850|NCT00814801|593559060|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
164322851|NCT00814801|593559061|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
164322852|NCT00814801|593559059|FG000|Overall Study|Missing or change of caregiver|6|||
164322853|NCT00814801|593559060|FG001|Overall Study|Missing or change of caregiver|2|||
164322854|NCT00814801|593559061|FG002|Overall Study|Missing or change of caregiver|4|||
164322855|NCT00814801|593559059|FG000|Overall Study|Non-compliance|0|||
164322856|NCT00814801|593559060|FG001|Overall Study|Non-compliance|1|||
164322857|NCT00814801|593559061|FG002|Overall Study|Non-compliance|1|||
164322858|NCT00814801|593559059|FG000|Overall Study|Other|2|||
164322859|NCT00814801|593559060|FG001|Overall Study|Other|6|||
164322860|NCT00814801|593559061|FG002|Overall Study|Other|4|||
164322861|NCT01037088|593559067|FG000|Overall Study|Withdrawal by Subject|3|||
164322862|NCT02216812|593559068|FG000|Overall Study|Lost to Follow-up|10|||
164322863|NCT02216812|593559069|FG001|Overall Study|Lost to Follow-up|5|||
164322864|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
164322865|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
164322866|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
164322867|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
164322868|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
164322869|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
164322870|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
164322871|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
164322872|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
164322873|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
164322874|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
164322875|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
164322876|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
164322877|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
164322878|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
164322879|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
164322880|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
164322881|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
164322882|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
164322883|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
164322884|NCT01986933|593559070|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322885|NCT01986933|593559071|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322886|NCT01986933|593559072|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322887|NCT01986933|593559073|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
164322888|NCT01986933|593559074|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
164322889|NCT01986933|593559070|FG000|Active-to-active (Part B)|Adverse Event|0|||
164322890|NCT01986933|593559071|FG001|Active-to-active (Part B)|Adverse Event|2|||
164322891|NCT01986933|593559072|FG002|Active-to-active (Part B)|Adverse Event|0|||
164322892|NCT01986933|593559073|FG003|Active-to-active (Part B)|Adverse Event|1|||
164322893|NCT01986933|593559074|FG004|Active-to-active (Part B)|Adverse Event|3|||
164322894|NCT01986933|593559070|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
164322895|NCT01986933|593559071|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
164322896|NCT01986933|593559072|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
164322897|NCT01986933|593559073|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
164322898|NCT01986933|593559074|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
164322899|NCT01986933|593559070|FG000|Active-to-active (Part B)|Pregnancy|0|||
164322900|NCT01986933|593559071|FG001|Active-to-active (Part B)|Pregnancy|0|||
164322901|NCT01986933|593559072|FG002|Active-to-active (Part B)|Pregnancy|0|||
164322902|NCT01986933|593559073|FG003|Active-to-active (Part B)|Pregnancy|0|||
164322903|NCT01986933|593559074|FG004|Active-to-active (Part B)|Pregnancy|1|||
164322904|NCT01986933|593559070|FG000|Active-to-active (Part B)|Physician Decision|0|||
164322905|NCT01986933|593559071|FG001|Active-to-active (Part B)|Physician Decision|0|||
164322906|NCT01986933|593559072|FG002|Active-to-active (Part B)|Physician Decision|1|||
164322907|NCT01986933|593559073|FG003|Active-to-active (Part B)|Physician Decision|1|||
164322908|NCT01986933|593559074|FG004|Active-to-active (Part B)|Physician Decision|0|||
164322909|NCT01986933|593559070|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
163979828|NCT01784861|592297278|FG002|Overall Study|Withdrawal by Subject|0|||
163979829|NCT01784861|592297279|FG003|Overall Study|Withdrawal by Subject|1|||
163979830|NCT01784861|592297280|FG004|Overall Study|Withdrawal by Subject|0|||
163979831|NCT01784861|592297281|FG005|Overall Study|Withdrawal by Subject|0|||
164322910|NCT01986933|593559071|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
164322911|NCT01986933|593559072|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
163979832|NCT01784861|592297276|FG000|Overall Study|Physician Decision|0|||
164322912|NCT01986933|593559073|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
164322913|NCT01986933|593559074|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
164322914|NCT01986933|593559070|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
164322915|NCT01986933|593559071|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
164322916|NCT01986933|593559072|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
164322917|NCT01986933|593559073|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
164322918|NCT01986933|593559074|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
164322919|NCT01986933|593559070|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
164322920|NCT01986933|593559071|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
164322921|NCT01986933|593559072|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
164322922|NCT01986933|593559073|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
164322923|NCT01986933|593559074|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
164322924|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
164322925|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
164322926|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
164322927|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
164322928|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
164322929|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322930|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322931|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322932|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
164322933|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
164322934|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
164322935|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
164322936|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
164322937|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
164322938|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
164322939|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
164322940|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
164322941|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
164322942|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
164322943|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
164322944|NCT01986933|593559070|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322945|NCT01986933|593559071|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
164322946|NCT01986933|593559072|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322947|NCT01986933|593559073|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322948|NCT01986933|593559074|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
164322949|NCT01077154|593559075|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
164322950|NCT01077154|593559076|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
164322951|NCT01077154|593559075|FG000|Overall Study|Withdrawal by Subject|369|||
164322952|NCT01077154|593559076|FG001|Overall Study|Withdrawal by Subject|385|||
164322953|NCT01077154|593559075|FG000|Overall Study|Death|215|||
164322954|NCT01077154|593559076|FG001|Overall Study|Death|214|||
164322955|NCT01077154|593559075|FG000|Overall Study|Lost to Follow-up|43|||
164322956|NCT01077154|593559076|FG001|Overall Study|Lost to Follow-up|35|||
164322957|NCT01077154|593559075|FG000|Overall Study|Noncompliance|22|||
164322958|NCT01077154|593559076|FG001|Overall Study|Noncompliance|20|||
164322959|NCT01077154|593559075|FG000|Overall Study|Disease Progression|18|||
164322960|NCT01077154|593559076|FG001|Overall Study|Disease Progression|20|||
164322961|NCT01077154|593559075|FG000|Overall Study|Ineligibility Determined|10|||
164322962|NCT01077154|593559076|FG001|Overall Study|Ineligibility Determined|14|||
164322963|NCT01077154|593559075|FG000|Overall Study|Other|14|||
164322964|NCT01077154|593559076|FG001|Overall Study|Other|11|||
164322965|NCT01077154|593559075|FG000|Overall Study|Adverse Event|9|||
164322966|NCT01077154|593559076|FG001|Overall Study|Adverse Event|9|||
164322967|NCT01077154|593559075|FG000|Overall Study|Administrative Decision|1|||
164322968|NCT01077154|593559076|FG001|Overall Study|Administrative Decision|6|||
164322969|NCT01077154|593559075|FG000|Overall Study|Protocol Deviation|1|||
164322970|NCT01077154|593559076|FG001|Overall Study|Protocol Deviation|0|||
164322971|NCT00604214|593559077|FG000|Baseline to Day 28|Death|223|||
164322972|NCT00604214|593559078|FG001|Baseline to Day 28|Death|202|||
164322973|NCT00604214|593559077|FG000|Baseline to Day 28|Lost to Follow-up|2|||
164322974|NCT00604214|593559078|FG001|Baseline to Day 28|Lost to Follow-up|4|||
164322975|NCT00604214|593559077|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
164322976|NCT00604214|593559078|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
164322977|NCT00604214|593559077|FG000|Day 29 to Day 90|Death|64|||
164322978|NCT00604214|593559078|FG001|Day 29 to Day 90|Death|67|||
164322979|NCT00604214|593559077|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
164322980|NCT00604214|593559078|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
164322981|NCT00604214|593559077|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
164322982|NCT00604214|593559078|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
164322983|NCT00604214|593559077|FG000|Day 91 to Day 180|Death|19|||
164322984|NCT00604214|593559078|FG001|Day 91 to Day 180|Death|23|||
164322985|NCT00604214|593559077|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
164322986|NCT00604214|593559078|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
164322987|NCT00604214|593559077|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
164322988|NCT00604214|593559078|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
164322989|NCT00534599|593559079|FG000|Overall Study|Adverse Event|25|||
164322990|NCT00534599|593559080|FG001|Overall Study|Adverse Event|4|||
164322991|NCT00534599|593559079|FG000|Overall Study|Incorrect enrollment|2|||
164322992|NCT00534599|593559080|FG001|Overall Study|Incorrect enrollment|1|||
164322993|NCT00534599|593559079|FG000|Overall Study|Mis-randomization|2|||
164322994|NCT00534599|593559080|FG001|Overall Study|Mis-randomization|2|||
164322995|NCT00534599|593559079|FG000|Overall Study|Developed study-specific d/c criteria|5|||
164322996|NCT00534599|593559080|FG001|Overall Study|Developed study-specific d/c criteria|0|||
164322997|NCT00534599|593559079|FG000|Overall Study|Lack of Efficacy|0|||
164322998|NCT00534599|593559080|FG001|Overall Study|Lack of Efficacy|1|||
164322999|NCT00534599|593559079|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
164323000|NCT00534599|593559080|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
164323001|NCT00534599|593559079|FG000|Overall Study|Protocol Violation|1|||
164323002|NCT00534599|593559080|FG001|Overall Study|Protocol Violation|3|||
164323003|NCT00534599|593559079|FG000|Overall Study|Lost to Follow-up|11|||
164323004|NCT00534599|593559080|FG001|Overall Study|Lost to Follow-up|14|||
164323005|NCT00534599|593559079|FG000|Overall Study|Withdrawal by Subject|4|||
164323006|NCT00534599|593559080|FG001|Overall Study|Withdrawal by Subject|6|||
164323007|NCT00534599|593559079|FG000|Overall Study|Other|7|||
164323008|NCT00534599|593559080|FG001|Overall Study|Other|0|||
164323009|NCT04285580|593560675|FG000|Overall Study|Protocol Violation|0|||
164323010|NCT04285580|593560676|FG001|Overall Study|Protocol Violation|1|||
164323011|NCT01879579|593560677|FG000|Overall Study|Phone incompatible with texting platform|3|||
164323012|NCT01879579|593560678|FG001|Overall Study|Phone incompatible with texting platform|0|||
164323013|NCT01879579|593560677|FG000|Overall Study|Did not enroll in texting platform|1|||
164323014|NCT01879579|593560678|FG001|Overall Study|Did not enroll in texting platform|0|||
164323015|NCT01879579|593560677|FG000|Overall Study|Did not initiate insulin treatment|1|||
164323016|NCT01879579|593560678|FG001|Overall Study|Did not initiate insulin treatment|0|||
164323017|NCT01879579|593560677|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
164076857|NCT00725725|592645847|FG000|Overall Study|Protocol Violation|0|||
164323018|NCT01879579|593560678|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
164323019|NCT01879579|593560677|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
164323020|NCT01879579|593560678|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
164323021|NCT00815516|593560688|FG000|Overall Study|Death|3|||
164323022|NCT00815516|593560689|FG001|Overall Study|Death|1|||
164323023|NCT00815516|593560688|FG000|Overall Study|Physician Decision|1|||
164323024|NCT00815516|593560689|FG001|Overall Study|Physician Decision|0|||
164323025|NCT06460493|593560694|FG000|Overall Study|Withdrawal by Subject|2|||
164323026|NCT00075270|593560699|FG000|Overall Study|Withdrawal by Subject|28|||
164323027|NCT00075270|593560700|FG001|Overall Study|Withdrawal by Subject|21|||
164323028|NCT00075270|593560699|FG000|Overall Study|Lost to Follow-up|25|||
164323029|NCT00075270|593560700|FG001|Overall Study|Lost to Follow-up|28|||
163875274|NCT05609032|591911602|FG001|Overall Study|Withdrawal by Subject|0|||
163875275|NCT00609336|591911603|FG000|Overall Study|Protocol Violation|3|||
163875276|NCT00609336|591911603|FG000|Overall Study|Death|1|||
163875277|NCT00609336|591911603|FG000|Overall Study|LA or Met at Surgery|9|||
163875278|NCT00567489|591911604|FG000|Overall Study|Adverse Event|6|||
163875279|NCT00567489|591911605|FG001|Overall Study|Adverse Event|14|||
163875280|NCT00567489|591911604|FG000|Overall Study|Physician Decision|0|||
163875281|NCT00567489|591911605|FG001|Overall Study|Physician Decision|4|||
163875282|NCT00567489|591911604|FG000|Overall Study|Withdrawal by Subject|0|||
163875283|NCT00567489|591911605|FG001|Overall Study|Withdrawal by Subject|2|||
163875284|NCT00567489|591911604|FG000|Overall Study|Renal Transplantation|0|||
163875285|NCT00567489|591911605|FG001|Overall Study|Renal Transplantation|3|||
163875286|NCT00567489|591911604|FG000|Overall Study|Other|1|||
163875287|NCT00567489|591911605|FG001|Overall Study|Other|0|||
163875288|NCT02372253|591911620|FG000|Overall Study|Non Compliance|2|||
163875289|NCT02372253|591911621|FG001|Overall Study|Non Compliance|0|||
163875290|NCT01803555|591911622|FG000|Overall Study|Adverse Event|3|||
163875291|NCT01803555|591911623|FG001|Overall Study|Adverse Event|2|||
163875292|NCT01803555|591911622|FG000|Overall Study|Withdrawal by Subject|3|||
163875293|NCT01803555|591911623|FG001|Overall Study|Withdrawal by Subject|3|||
163875294|NCT01803555|591911622|FG000|Overall Study|Non-compliance|1|||
163875295|NCT01803555|591911623|FG001|Overall Study|Non-compliance|1|||
163875296|NCT01803555|591911622|FG000|Overall Study|Protocol Violation|3|||
163875297|NCT01803555|591911623|FG001|Overall Study|Protocol Violation|5|||
163875298|NCT01803555|591911622|FG000|Overall Study|Lost to Follow-up|0|||
163875299|NCT01803555|591911623|FG001|Overall Study|Lost to Follow-up|2|||
163875300|NCT01803555|591911622|FG000|Overall Study|Other than specified|3|||
164323030|NCT00075270|593560699|FG000|Overall Study|Protocol Violation|0|||
164323031|NCT00075270|593560700|FG001|Overall Study|Protocol Violation|2|||
164323032|NCT00075270|593560699|FG000|Overall Study|Death|198|||
164323033|NCT00075270|593560700|FG001|Overall Study|Death|215|||
164323034|NCT00075270|593560699|FG000|Overall Study|Other/Unknown|9|||
164323035|NCT00075270|593560700|FG001|Overall Study|Other/Unknown|5|||
164323036|NCT00075270|593560699|FG000|Overall Study|Missing|26|||
164323037|NCT00075270|593560700|FG001|Overall Study|Missing|13|||
164323038|NCT00246571|593560701|FG000|Overall Study|Adverse Event|7|||
164323039|NCT00246571|593560702|FG001|Overall Study|Adverse Event|0|||
164323040|NCT00246571|593560701|FG000|Overall Study|Protocol Violation|0|||
164323041|NCT00246571|593560702|FG001|Overall Study|Protocol Violation|1|||
164323042|NCT00246571|593560701|FG000|Overall Study|Withdrawal by Subject|2|||
164323043|NCT00246571|593560702|FG001|Overall Study|Withdrawal by Subject|3|||
164323044|NCT00246571|593560701|FG000|Overall Study|Lack of Efficacy|84|||
164323045|NCT00246571|593560702|FG001|Overall Study|Lack of Efficacy|21|||
164323046|NCT00246571|593560701|FG000|Overall Study|Death|17|||
164323047|NCT00246571|593560702|FG001|Overall Study|Death|3|||
164323048|NCT00246571|593560701|FG000|Overall Study|Sponsor|0|||
164323049|NCT00246571|593560702|FG001|Overall Study|Sponsor|1|||
164323050|NCT00246571|593560701|FG000|Overall Study|Did not meet entrance criteria|2|||
164323051|NCT00246571|593560702|FG001|Overall Study|Did not meet entrance criteria|1|||
164323052|NCT00246571|593560701|FG000|Overall Study|Laboratory abnormalities|1|||
164323053|NCT00246571|593560702|FG001|Overall Study|Laboratory abnormalities|0|||
164323054|NCT00246571|593560701|FG000|Overall Study|Crossover participants|0|||
164323055|NCT00246571|593560702|FG001|Overall Study|Crossover participants|74|||
164323056|NCT00775203|593560703|FG000|Overall Study|Adverse Event|25|||
164323057|NCT00775203|593560704|FG001|Overall Study|Adverse Event|6|||
164323058|NCT00775203|593560703|FG000|Overall Study|Lack of Efficacy|8|||
164323059|NCT00775203|593560704|FG001|Overall Study|Lack of Efficacy|9|||
164323060|NCT00775203|593560703|FG000|Overall Study|Withdrawal by Subject|11|||
164323061|NCT00775203|593560704|FG001|Overall Study|Withdrawal by Subject|9|||
164323062|NCT00775203|593560703|FG000|Overall Study|Lost to Follow-up|11|||
164323063|NCT00775203|593560704|FG001|Overall Study|Lost to Follow-up|15|||
164323064|NCT00775203|593560703|FG000|Overall Study|Administrative reason|2|||
164323065|NCT00775203|593560704|FG001|Overall Study|Administrative reason|0|||
164323066|NCT00775203|593560703|FG000|Overall Study|Noncompliance|4|||
164323067|NCT00775203|593560704|FG001|Overall Study|Noncompliance|2|||
164323068|NCT00775203|593560703|FG000|Overall Study|Protocol Violation|0|||
164323069|NCT00775203|593560704|FG001|Overall Study|Protocol Violation|1|||
164323070|NCT00775203|593560703|FG000|Overall Study|Entered other study|1|||
164323071|NCT00775203|593560704|FG001|Overall Study|Entered other study|0|||
164323072|NCT00775203|593560703|FG000|Overall Study|Physician Decision|0|||
164323073|NCT00775203|593560704|FG001|Overall Study|Physician Decision|1|||
164323074|NCT02987660|593560705|FG000|Overall Study|Study terminated by sponsor|10|||
164323075|NCT02987660|593560706|FG001|Overall Study|Study terminated by sponsor|10|||
164323076|NCT03422627|593560707|FG000|Overall Study|Protocol-specified Criteria|1|||
164323077|NCT03422627|593560708|FG001|Overall Study|Protocol-specified Criteria|1|||
164323078|NCT03422627|593560709|FG002|Overall Study|Protocol-specified Criteria|0|||
164323079|NCT03422627|593560710|FG003|Overall Study|Protocol-specified Criteria|0|||
164323080|NCT03422627|593560711|FG004|Overall Study|Protocol-specified Criteria|2|||
164323081|NCT03422627|593560707|FG000|Overall Study|Requirement for Alternative Therapy|1|||
164323082|NCT03422627|593560708|FG001|Overall Study|Requirement for Alternative Therapy|1|||
164323083|NCT03422627|593560709|FG002|Overall Study|Requirement for Alternative Therapy|2|||
164323084|NCT03422627|593560710|FG003|Overall Study|Requirement for Alternative Therapy|0|||
164323085|NCT03422627|593560711|FG004|Overall Study|Requirement for Alternative Therapy|0|||
164323086|NCT03422627|593560707|FG000|Overall Study|Disease Progression|1|||
164323087|NCT03422627|593560708|FG001|Overall Study|Disease Progression|0|||
164323088|NCT03422627|593560709|FG002|Overall Study|Disease Progression|1|||
164323089|NCT03422627|593560710|FG003|Overall Study|Disease Progression|2|||
164323090|NCT03422627|593560711|FG004|Overall Study|Disease Progression|0|||
164323091|NCT03422627|593560707|FG000|Overall Study|Adverse Event|2|||
164323092|NCT03422627|593560708|FG001|Overall Study|Adverse Event|1|||
164323093|NCT03422627|593560709|FG002|Overall Study|Adverse Event|0|||
163875301|NCT01803555|591911623|FG001|Overall Study|Other than specified|5|||
163875302|NCT03201562|591911624|FG000|Overall Study|Physician Decision|0|||
163875303|NCT03201562|591911625|FG001|Overall Study|Physician Decision|0|||
163875304|NCT03201562|591911626|FG002|Overall Study|Physician Decision|1|||
164208411|NCT03573297|593131690|FG000|Open Label Treatment Period|Adverse Event|67|||
164208412|NCT03573297|593131691|FG001|Open Label Treatment Period|Adverse Event|0|||
164208413|NCT03573297|593131692|FG002|Open Label Treatment Period|Adverse Event|0|||
164208414|NCT03573297|593131693|FG003|Open Label Treatment Period|Adverse Event|0|||
164208415|NCT03573297|593131690|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
164208416|NCT03573297|593131691|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
164208417|NCT03573297|593131692|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
164208418|NCT03573297|593131693|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
164208419|NCT03573297|593131690|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
164208420|NCT03573297|593131691|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
164208421|NCT03573297|593131692|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
164208422|NCT03573297|593131693|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
164323094|NCT03422627|593560710|FG003|Overall Study|Adverse Event|0|||
164323095|NCT03422627|593560711|FG004|Overall Study|Adverse Event|2|||
163875305|NCT03201562|591911624|FG000|Overall Study|Adverse Event|0|||
164323096|NCT03422627|593560707|FG000|Overall Study|Ineligibility Determined|0|||
164323097|NCT03422627|593560708|FG001|Overall Study|Ineligibility Determined|1|||
164323098|NCT03422627|593560709|FG002|Overall Study|Ineligibility Determined|0|||
164323099|NCT03422627|593560710|FG003|Overall Study|Ineligibility Determined|0|||
164323100|NCT03422627|593560711|FG004|Overall Study|Ineligibility Determined|0|||
164323101|NCT03422627|593560707|FG000|Overall Study|Death|0|||
164323102|NCT03422627|593560708|FG001|Overall Study|Death|1|||
164323103|NCT03422627|593560709|FG002|Overall Study|Death|1|||
164323104|NCT03422627|593560710|FG003|Overall Study|Death|0|||
164323105|NCT03422627|593560711|FG004|Overall Study|Death|0|||
164323106|NCT03422627|593560707|FG000|Overall Study|Withdrawal by Subject|0|||
164323107|NCT03422627|593560708|FG001|Overall Study|Withdrawal by Subject|0|||
164323108|NCT03422627|593560709|FG002|Overall Study|Withdrawal by Subject|0|||
164323109|NCT03422627|593560710|FG003|Overall Study|Withdrawal by Subject|1|||
164323110|NCT03422627|593560711|FG004|Overall Study|Withdrawal by Subject|0|||
164323111|NCT05247398|593560712|FG000|Overall Study|Withdrawal by Subject|1|||
164323112|NCT04251156|593560713|FG000|Overall Study|Lost to Follow-up|1|||
164323113|NCT04251156|593560714|FG001|Overall Study|Lost to Follow-up|1|||
164323114|NCT04251156|593560713|FG000|Overall Study|Withdrawal by Subject|4|||
164323115|NCT04251156|593560714|FG001|Overall Study|Withdrawal by Subject|4|||
164323116|NCT02937571|593560715|FG000|Overall Study|Adverse Event|0|||
164323117|NCT02937571|593560716|FG001|Overall Study|Adverse Event|0|||
164323118|NCT02937571|593560717|FG002|Overall Study|Adverse Event|4|||
164323119|NCT02937571|593560715|FG000|Overall Study|Withdrawal by Subject|0|||
164323120|NCT02937571|593560716|FG001|Overall Study|Withdrawal by Subject|0|||
164323121|NCT02937571|593560717|FG002|Overall Study|Withdrawal by Subject|3|||
164323122|NCT03675321|593560718|FG000|Overall Study|Lack of Efficacy|2|||
164323123|NCT03675321|593560719|FG001|Overall Study|Lack of Efficacy|2|||
164323124|NCT03675321|593560718|FG000|Overall Study|Withdrawal by Subject|1|||
164323125|NCT03675321|593560719|FG001|Overall Study|Withdrawal by Subject|3|||
164323126|NCT00934648|593560725|FG000|Overall Study|Failure to return|8|||
164323127|NCT00934648|593560725|FG000|Overall Study|Withdrawal by Subject|1|||
164323128|NCT01155479|593560730|FG000|Part I|Adverse Event|13|||
164323129|NCT01155479|593560731|FG001|Part I|Adverse Event|8|||
164323130|NCT01155479|593560732|FG002|Part I|Adverse Event|18|||
164323131|NCT01155479|593560733|FG003|Part I|Adverse Event|7|||
164323132|NCT01155479|593560734|FG004|Part I|Adverse Event|6|||
164323133|NCT01155479|593560730|FG000|Part I|Administrative|2|||
164323134|NCT01155479|593560731|FG001|Part I|Administrative|2|||
164323135|NCT01155479|593560732|FG002|Part I|Administrative|2|||
164323136|NCT01155479|593560733|FG003|Part I|Administrative|0|||
164323137|NCT01155479|593560734|FG004|Part I|Administrative|0|||
164323138|NCT01155479|593560730|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
164323139|NCT01155479|593560731|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
164323140|NCT01155479|593560732|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
164323141|NCT01155479|593560733|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
164323142|NCT01155479|593560734|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
164323143|NCT01155479|593560730|FG000|Part I|Withdrawal by Subject|11|||
164323144|NCT01155479|593560731|FG001|Part I|Withdrawal by Subject|13|||
164323145|NCT01155479|593560732|FG002|Part I|Withdrawal by Subject|8|||
164323146|NCT01155479|593560733|FG003|Part I|Withdrawal by Subject|8|||
164323147|NCT01155479|593560734|FG004|Part I|Withdrawal by Subject|9|||
164323148|NCT01155479|593560730|FG000|Part I|Lost to Follow-up|0|||
164323149|NCT01155479|593560731|FG001|Part I|Lost to Follow-up|0|||
164323150|NCT01155479|593560732|FG002|Part I|Lost to Follow-up|1|||
164323151|NCT01155479|593560733|FG003|Part I|Lost to Follow-up|1|||
164323152|NCT01155479|593560734|FG004|Part I|Lost to Follow-up|0|||
164323153|NCT01155479|593560730|FG000|Part I|Treatment Failure|3|||
164323154|NCT01155479|593560731|FG001|Part I|Treatment Failure|0|||
164323155|NCT01155479|593560732|FG002|Part I|Treatment Failure|3|||
164323156|NCT01155479|593560733|FG003|Part I|Treatment Failure|1|||
164323157|NCT01155479|593560734|FG004|Part I|Treatment Failure|2|||
163875306|NCT03201562|591911625|FG001|Overall Study|Adverse Event|0|||
164323158|NCT01155479|593560730|FG000|Part I|Did Not Receive Treatment|4|||
164323159|NCT01155479|593560731|FG001|Part I|Did Not Receive Treatment|2|||
164323160|NCT01155479|593560732|FG002|Part I|Did Not Receive Treatment|2|||
164323161|NCT01155479|593560733|FG003|Part I|Did Not Receive Treatment|6|||
164323162|NCT01155479|593560734|FG004|Part I|Did Not Receive Treatment|1|||
164323163|NCT01155479|593560730|FG000|Part I|Non-Compliance with Protocol|2|||
164323164|NCT01155479|593560731|FG001|Part I|Non-Compliance with Protocol|1|||
164323165|NCT01155479|593560732|FG002|Part I|Non-Compliance with Protocol|3|||
164323166|NCT01155479|593560733|FG003|Part I|Non-Compliance with Protocol|3|||
164323167|NCT01155479|593560734|FG004|Part I|Non-Compliance with Protocol|2|||
164323168|NCT01155479|593560730|FG000|Part II|Adverse Event|7|||
164323169|NCT01155479|593560731|FG001|Part II|Adverse Event|6|||
164323170|NCT01155479|593560732|FG002|Part II|Adverse Event|8|||
164323171|NCT01155479|593560733|FG003|Part II|Adverse Event|3|||
164323172|NCT01155479|593560734|FG004|Part II|Adverse Event|4|||
164323173|NCT01155479|593560730|FG000|Part II|Administrative|43|||
164323174|NCT01155479|593560731|FG001|Part II|Administrative|49|||
164323175|NCT01155479|593560732|FG002|Part II|Administrative|36|||
164323176|NCT01155479|593560733|FG003|Part II|Administrative|38|||
164323177|NCT01155479|593560734|FG004|Part II|Administrative|46|||
164323178|NCT01155479|593560730|FG000|Part II|Withdrawal by Subject|8|||
164323179|NCT01155479|593560731|FG001|Part II|Withdrawal by Subject|4|||
164323180|NCT01155479|593560732|FG002|Part II|Withdrawal by Subject|12|||
164323181|NCT01155479|593560733|FG003|Part II|Withdrawal by Subject|7|||
164323182|NCT01155479|593560734|FG004|Part II|Withdrawal by Subject|3|||
164323183|NCT01155479|593560730|FG000|Part II|Lost to Follow-up|1|||
164323184|NCT01155479|593560731|FG001|Part II|Lost to Follow-up|0|||
164323185|NCT01155479|593560732|FG002|Part II|Lost to Follow-up|0|||
164323186|NCT01155479|593560733|FG003|Part II|Lost to Follow-up|0|||
164323187|NCT01155479|593560734|FG004|Part II|Lost to Follow-up|1|||
164323188|NCT01155479|593560730|FG000|Part II|Treatment Failure|0|||
164323189|NCT01155479|593560731|FG001|Part II|Treatment Failure|1|||
164323190|NCT01155479|593560732|FG002|Part II|Treatment Failure|2|||
164323191|NCT01155479|593560733|FG003|Part II|Treatment Failure|0|||
164323192|NCT01155479|593560734|FG004|Part II|Treatment Failure|1|||
164323193|NCT01155479|593560730|FG000|Part II|Non-Compliance with Protocol|0|||
164323194|NCT01155479|593560731|FG001|Part II|Non-Compliance with Protocol|1|||
164323195|NCT01155479|593560732|FG002|Part II|Non-Compliance with Protocol|0|||
164323196|NCT01155479|593560733|FG003|Part II|Non-Compliance with Protocol|2|||
164323197|NCT01155479|593560734|FG004|Part II|Non-Compliance with Protocol|0|||
164323198|NCT01933789|593560737|FG000|Overall Study|Death|0|||
164323199|NCT01933789|593560738|FG001|Overall Study|Death|0|||
164323200|NCT01933789|593560739|FG002|Overall Study|Death|0|||
164323201|NCT01933789|593560740|FG003|Overall Study|Death|0|||
164323202|NCT01933789|593560741|FG004|Overall Study|Death|21|||
164323203|NCT01933789|593560742|FG005|Overall Study|Death|32|||
164323204|NCT01933789|593560743|FG006|Overall Study|Death|0|||
164323205|NCT01933789|593560744|FG007|Overall Study|Death|0|||
164323206|NCT01933789|593560745|FG008|Overall Study|Death|0|||
164323207|NCT01933789|593560737|FG000|Overall Study|Lost to Follow-up|0|||
164323208|NCT01933789|593560738|FG001|Overall Study|Lost to Follow-up|0|||
164323209|NCT01933789|593560739|FG002|Overall Study|Lost to Follow-up|0|||
164323210|NCT01933789|593560740|FG003|Overall Study|Lost to Follow-up|1|||
164323211|NCT01933789|593560741|FG004|Overall Study|Lost to Follow-up|8|||
164323212|NCT01933789|593560742|FG005|Overall Study|Lost to Follow-up|9|||
164323213|NCT01933789|593560743|FG006|Overall Study|Lost to Follow-up|1|||
164323214|NCT01933789|593560744|FG007|Overall Study|Lost to Follow-up|4|||
164323215|NCT01933789|593560745|FG008|Overall Study|Lost to Follow-up|0|||
164323216|NCT01933789|593560737|FG000|Overall Study|Withdrawal by Subject|2|||
164323217|NCT01933789|593560738|FG001|Overall Study|Withdrawal by Subject|1|||
164323218|NCT01933789|593560739|FG002|Overall Study|Withdrawal by Subject|0|||
164323219|NCT01933789|593560740|FG003|Overall Study|Withdrawal by Subject|0|||
164323220|NCT01933789|593560741|FG004|Overall Study|Withdrawal by Subject|17|||
164323221|NCT01933789|593560742|FG005|Overall Study|Withdrawal by Subject|16|||
164323222|NCT01933789|593560743|FG006|Overall Study|Withdrawal by Subject|1|||
164323223|NCT01933789|593560744|FG007|Overall Study|Withdrawal by Subject|4|||
164323224|NCT01933789|593560745|FG008|Overall Study|Withdrawal by Subject|0|||
164323225|NCT01933789|593560737|FG000|Overall Study|Became Ineligible|4|||
164323226|NCT01933789|593560738|FG001|Overall Study|Became Ineligible|0|||
163875307|NCT03201562|591911626|FG002|Overall Study|Adverse Event|1|||
163875308|NCT03201562|591911624|FG000|Overall Study|Lost to Follow-up|0|||
163875309|NCT03201562|591911625|FG001|Overall Study|Lost to Follow-up|1|||
164323227|NCT01933789|593560739|FG002|Overall Study|Became Ineligible|0|||
164323228|NCT01933789|593560740|FG003|Overall Study|Became Ineligible|0|||
164323229|NCT01933789|593560741|FG004|Overall Study|Became Ineligible|13|||
164323230|NCT01933789|593560742|FG005|Overall Study|Became Ineligible|10|||
164323231|NCT01933789|593560743|FG006|Overall Study|Became Ineligible|13|||
164323232|NCT01933789|593560744|FG007|Overall Study|Became Ineligible|6|||
164323233|NCT01933789|593560745|FG008|Overall Study|Became Ineligible|0|||
164323234|NCT01966432|593560749|FG000|Overall Study|Lost to Follow-up|3|||
164323235|NCT01966432|593560750|FG001|Overall Study|Lost to Follow-up|2|||
164323236|NCT01966432|593560751|FG002|Overall Study|Lost to Follow-up|5|||
164323237|NCT01966432|593560749|FG000|Overall Study|Withdrawal by Subject|1|||
164323238|NCT01966432|593560750|FG001|Overall Study|Withdrawal by Subject|3|||
164323239|NCT01966432|593560751|FG002|Overall Study|Withdrawal by Subject|0|||
164323240|NCT01966432|593560749|FG000|Overall Study|Subject Incarcerated|0|||
164323241|NCT01966432|593560750|FG001|Overall Study|Subject Incarcerated|0|||
164323242|NCT01966432|593560751|FG002|Overall Study|Subject Incarcerated|1|||
164323243|NCT01966432|593560749|FG000|Overall Study|SBIRT program ended|1|||
164323244|NCT01966432|593560750|FG001|Overall Study|SBIRT program ended|8|||
164323245|NCT01966432|593560751|FG002|Overall Study|SBIRT program ended|20|||
164323246|NCT03562767|593560754|FG000|Overall Study|Physician Decision|2|||
164323247|NCT03562767|593560755|FG001|Overall Study|Physician Decision|0|||
164323248|NCT03562767|593560756|FG002|Overall Study|Physician Decision|0|||
164323249|NCT03562767|593560754|FG000|Overall Study|Logistic Reason|1|||
164323250|NCT03562767|593560755|FG001|Overall Study|Logistic Reason|3|||
164323251|NCT03562767|593560756|FG002|Overall Study|Logistic Reason|0|||
164323252|NCT02518464|593560759|FG000|Overall Study|Adverse Event|2|||
164323253|NCT01120067|593560760|FG000|Overall Study|Lost to Follow-up|3|||
164323254|NCT01120067|593560761|FG001|Overall Study|Lost to Follow-up|1|||
164323255|NCT01120067|593560760|FG000|Overall Study|fail to engage >3 sessions|2|||
164323256|NCT01120067|593560761|FG001|Overall Study|fail to engage >3 sessions|0|||
164323257|NCT03761797|593560762|FG000|Overall Study|Changing hospital|11|||
164323258|NCT03761797|593560762|FG000|Overall Study|Improvement/remission|6|||
164323259|NCT03761797|593560762|FG000|Overall Study|Withdrawal by Subject|19|||
164323260|NCT03761797|593560762|FG000|Overall Study|Lost to Follow-up|33|||
164323261|NCT03761797|593560762|FG000|Overall Study|Adverse Event|37|||
164323262|NCT03761797|593560762|FG000|Overall Study|Case report form (CRF) not collected|5|||
164323263|NCT03761797|593560762|FG000|Overall Study|No patient visit after entry|13|||
164323264|NCT03761797|593560762|FG000|Overall Study|Switch to other diabetes medication|10|||
164323265|NCT03761797|593560762|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
164323266|NCT03761797|593560762|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
164323267|NCT03761797|593560762|FG000|Overall Study|Insufficient effectives|2|||
164323268|NCT03761797|593560762|FG000|Overall Study|Excessive alcohol intake|1|||
164323269|NCT00266877|593560763|FG000|Overall Study|Death|1|||
164323270|NCT00266877|593560764|FG001|Overall Study|Death|1|||
164323271|NCT00266877|593560765|FG002|Overall Study|Death|1|||
164323272|NCT00266877|593560763|FG000|Overall Study|Adverse Event|6|||
164323273|NCT00266877|593560764|FG001|Overall Study|Adverse Event|4|||
164323274|NCT00266877|593560765|FG002|Overall Study|Adverse Event|1|||
164323275|NCT00266877|593560763|FG000|Overall Study|Physician Decision|2|||
164323276|NCT00266877|593560764|FG001|Overall Study|Physician Decision|1|||
164323277|NCT00266877|593560765|FG002|Overall Study|Physician Decision|1|||
164323278|NCT00266877|593560763|FG000|Overall Study|Withdrawal by Subject|3|||
164323279|NCT00266877|593560764|FG001|Overall Study|Withdrawal by Subject|1|||
164323280|NCT00266877|593560765|FG002|Overall Study|Withdrawal by Subject|1|||
164323281|NCT00266877|593560763|FG000|Overall Study|Disease Progression|72|||
164323282|NCT00266877|593560764|FG001|Overall Study|Disease Progression|37|||
164323283|NCT00266877|593560765|FG002|Overall Study|Disease Progression|23|||
164323284|NCT00266877|593560763|FG000|Overall Study|Symptomatic Deterioration|6|||
164323285|NCT00266877|593560764|FG001|Overall Study|Symptomatic Deterioration|3|||
164323286|NCT00266877|593560765|FG002|Overall Study|Symptomatic Deterioration|1|||
164323287|NCT00266877|593560763|FG000|Overall Study|Hospitalization|1|||
164323288|NCT00266877|593560764|FG001|Overall Study|Hospitalization|0|||
164323289|NCT00266877|593560765|FG002|Overall Study|Hospitalization|0|||
164323290|NCT00266877|593560763|FG000|Overall Study|Concomitant Radiotherapy|0|||
164323291|NCT00266877|593560764|FG001|Overall Study|Concomitant Radiotherapy|1|||
164323292|NCT00266877|593560765|FG002|Overall Study|Concomitant Radiotherapy|0|||
164323293|NCT00527488|593560769|FG000|Overall Study|Withdrawn prior to dosing|0|||
164323294|NCT00527488|593560770|FG001|Overall Study|Withdrawn prior to dosing|1|||
164323295|NCT00527488|593560771|FG002|Overall Study|Withdrawn prior to dosing|1|||
164323296|NCT00527488|593560772|FG003|Overall Study|Withdrawn prior to dosing|0|||
164323297|NCT03036800|593560773|FG000|Overall Study|Protocol Violation|1|||
164323298|NCT03036800|593560774|FG001|Overall Study|Protocol Violation|0|||
164323299|NCT03036800|593560773|FG000|Overall Study|Non-compliance|1|||
164323300|NCT03036800|593560774|FG001|Overall Study|Non-compliance|0|||
164323301|NCT03036800|593560773|FG000|Overall Study|Lost to Follow-up|1|||
164323302|NCT03036800|593560774|FG001|Overall Study|Lost to Follow-up|0|||
164323303|NCT03036800|593560773|FG000|Overall Study|Death|1|||
164323304|NCT03036800|593560774|FG001|Overall Study|Death|0|||
164323305|NCT03036800|593560773|FG000|Overall Study|Tolerance|5|||
164323306|NCT03036800|593560774|FG001|Overall Study|Tolerance|0|||
164323307|NCT03036800|593560773|FG000|Overall Study|Unknown/no reason given|50|||
164323308|NCT03036800|593560774|FG001|Overall Study|Unknown/no reason given|39|||
164323309|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
164323310|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
164323311|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
164323312|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
164323313|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
164323314|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
164323315|NCT04030026|593560775|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
164323316|NCT04030026|593560776|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
164323317|NCT04030026|593560775|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
164323318|NCT04030026|593560776|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
164323319|NCT04030026|593560775|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
164323320|NCT04030026|593560776|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
164323321|NCT04030026|593560775|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
164323322|NCT04030026|593560776|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
164323323|NCT02545543|593560777|FG000|Overall Study|Lost to Follow-up|67|||
164323324|NCT02545543|593560778|FG001|Overall Study|Lost to Follow-up|25|||
164323325|NCT02545543|593560777|FG000|Overall Study|Physician Decision|3|||
164323326|NCT02545543|593560778|FG001|Overall Study|Physician Decision|0|||
164323327|NCT02545543|593560777|FG000|Overall Study|Withdrawal by Subject|9|||
164323328|NCT02545543|593560778|FG001|Overall Study|Withdrawal by Subject|8|||
164323329|NCT02545543|593560777|FG000|Overall Study|Noncomplaince|1|||
164323330|NCT02545543|593560778|FG001|Overall Study|Noncomplaince|0|||
164323331|NCT02545543|593560777|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
164323332|NCT02545543|593560778|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
164323333|NCT00811642|593560783|FG000|Overall Study|Adverse Event|3|||
164323334|NCT00811642|593560783|FG000|Overall Study|Protocol Violation|1|||
164323335|NCT00811642|593560783|FG000|Overall Study|Death|2|||
164323336|NCT00811642|593560783|FG000|Overall Study|Withdrawal by Subject|7|||
164323337|NCT00811642|593560783|FG000|Overall Study|Cumulative use of antifungal agent|2|||
164323338|NCT01395784|593560792|FG000|Overall Study|Lost to Follow-up|7|||
164323339|NCT01395784|593560792|FG000|Overall Study|Withdrawal by Subject|3|||
164323340|NCT01395784|593560792|FG000|Overall Study|Physician Decision|5|||
164323341|NCT05772702|593560793|FG000|Overall Study|Adverse Event|1|||
164323342|NCT04268823|593560794|FG000|Overall Study|Adverse Event|1|||
164323343|NCT04268823|593560795|FG001|Overall Study|Adverse Event|0|||
164323344|NCT04268823|593560794|FG000|Overall Study|Participant Decision|1|||
164323345|NCT04268823|593560795|FG001|Overall Study|Participant Decision|0|||
164323346|NCT00562627|593562012|FG000|Overall Study|Protocol Violation|1|||
164323347|NCT00562627|593562013|FG001|Overall Study|Protocol Violation|1|||
164323348|NCT00562627|593562014|FG002|Overall Study|Protocol Violation|1|||
164323349|NCT01107418|593562015|FG000|Overall Study|Disease Progression|45|||
164323350|NCT01107418|593562015|FG000|Overall Study|Adverse Event|3|||
164323351|NCT01107418|593562015|FG000|Overall Study|Withdrawal by Subject|1|||
164323352|NCT01107418|593562015|FG000|Overall Study|Study Closing|1|||
164323353|NCT01107418|593562015|FG000|Overall Study|Started Other Therapy|1|||
164323354|NCT01107418|593562015|FG000|Overall Study|Entered Extension Study|1|||
164323355|NCT05710185|593562016|FG000|Overall Study|Adverse Event|1|||
164323356|NCT05710185|593562016|FG000|Overall Study|Lack of Efficacy|1|||
164323357|NCT02316548|593562017|FG000|Overall Study|Protocol Violation|0|||
164323358|NCT02316548|593562018|FG001|Overall Study|Protocol Violation|1|||
164323359|NCT03269552|593562019|FG000|Overall Study|Adverse Event|2|||
164323360|NCT01343823|593562020|FG000|Overall Study|Study Terminated|1|||
164323361|NCT01343823|593562021|FG001|Overall Study|Study Terminated|0|||
164323362|NCT01343823|593562022|FG002|Overall Study|Study Terminated|0|||
164323363|NCT01343823|593562023|FG003|Overall Study|Study Terminated|1|||
164323364|NCT01343823|593562020|FG000|Overall Study|Withdrawal by Subject|1|||
164323365|NCT01343823|593562021|FG001|Overall Study|Withdrawal by Subject|0|||
164323366|NCT01343823|593562022|FG002|Overall Study|Withdrawal by Subject|0|||
164323367|NCT01343823|593562023|FG003|Overall Study|Withdrawal by Subject|0|||
164323368|NCT03468543|593562028|FG000|Overall Study|Protocol stopping rules met|3|||
164323369|NCT04972630|593562029|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
164323370|NCT04972630|593562030|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
164323371|NCT04972630|593562031|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
164323372|NCT04214288|593562034|FG000|Overall Study|Ongoing in the study|41|||
164323373|NCT04214288|593562035|FG001|Overall Study|Ongoing in the study|51|||
164323374|NCT04214288|593562036|FG002|Overall Study|Ongoing in the study|12|||
164323375|NCT04214288|593562037|FG003|Overall Study|Ongoing in the study|39|||
164323376|NCT04214288|593562034|FG000|Overall Study|Adverse Event|1|||
164323377|NCT04214288|593562035|FG001|Overall Study|Adverse Event|0|||
164323378|NCT04214288|593562036|FG002|Overall Study|Adverse Event|0|||
164323379|NCT04214288|593562037|FG003|Overall Study|Adverse Event|0|||
164323380|NCT04214288|593562034|FG000|Overall Study|Death|22|||
164323381|NCT04214288|593562035|FG001|Overall Study|Death|13|||
164323382|NCT04214288|593562036|FG002|Overall Study|Death|7|||
164323383|NCT04214288|593562037|FG003|Overall Study|Death|19|||
164323384|NCT04214288|593562034|FG000|Overall Study|Lost to Follow-up|1|||
164323385|NCT04214288|593562035|FG001|Overall Study|Lost to Follow-up|2|||
164323386|NCT04214288|593562036|FG002|Overall Study|Lost to Follow-up|1|||
164323387|NCT04214288|593562037|FG003|Overall Study|Lost to Follow-up|0|||
164323388|NCT04214288|593562034|FG000|Overall Study|Other|1|||
164323389|NCT04214288|593562035|FG001|Overall Study|Other|2|||
164323390|NCT04214288|593562036|FG002|Overall Study|Other|0|||
163875310|NCT03201562|591911626|FG002|Overall Study|Lost to Follow-up|2|||
164323391|NCT04214288|593562037|FG003|Overall Study|Other|6|||
164323392|NCT04214288|593562034|FG000|Overall Study|Protocol Violation|0|||
164323393|NCT04214288|593562035|FG001|Overall Study|Protocol Violation|1|||
164323394|NCT04214288|593562036|FG002|Overall Study|Protocol Violation|0|||
164323395|NCT04214288|593562037|FG003|Overall Study|Protocol Violation|0|||
164323396|NCT04214288|593562034|FG000|Overall Study|Withdrawal by Subject|8|||
164323397|NCT04214288|593562035|FG001|Overall Study|Withdrawal by Subject|4|||
164323398|NCT04214288|593562036|FG002|Overall Study|Withdrawal by Subject|0|||
164323399|NCT04214288|593562037|FG003|Overall Study|Withdrawal by Subject|9|||
164323400|NCT02455557|593562039|FG000|Overall Study|Withdrawal by Subject|2|||
164323401|NCT02278341|593562040|FG000|Overall Study|Randomized but never received study drug|1|||
164323402|NCT02278341|593562041|FG001|Overall Study|Randomized but never received study drug|1|||
164323403|NCT02278341|593562040|FG000|Overall Study|Adverse Event|3|||
164323404|NCT02278341|593562041|FG001|Overall Study|Adverse Event|0|||
164323405|NCT02278341|593562040|FG000|Overall Study|Death|68|||
164323406|NCT02278341|593562041|FG001|Overall Study|Death|56|||
164323407|NCT02278341|593562040|FG000|Overall Study|Withdrawal by Subject|30|||
164208423|NCT03573297|593131690|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
164208424|NCT03573297|593131691|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
164208425|NCT03573297|593131692|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
164208426|NCT03573297|593131693|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
164208427|NCT03573297|593131690|FG000|Open Label Treatment Period|Pregnancy|1|||
163875311|NCT03892564|591911631|FG000|Overall Study|Withdrawal by Subject|2|||
164208428|NCT03573297|593131691|FG001|Open Label Treatment Period|Pregnancy|0|||
164208429|NCT03573297|593131692|FG002|Open Label Treatment Period|Pregnancy|0|||
164208430|NCT03573297|593131693|FG003|Open Label Treatment Period|Pregnancy|0|||
164208431|NCT03573297|593131690|FG000|Open Label Treatment Period|Protocol Violation|17|||
164208432|NCT03573297|593131691|FG001|Open Label Treatment Period|Protocol Violation|0|||
164208433|NCT03573297|593131692|FG002|Open Label Treatment Period|Protocol Violation|0|||
164208434|NCT03573297|593131693|FG003|Open Label Treatment Period|Protocol Violation|0|||
164208435|NCT03573297|593131690|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
164208436|NCT03573297|593131691|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
164208437|NCT03573297|593131692|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
164208438|NCT03573297|593131693|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
164208439|NCT03573297|593131690|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
164208440|NCT03573297|593131691|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
164208441|NCT03573297|593131692|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
164208442|NCT03573297|593131693|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
164208443|NCT03573297|593131690|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
164208444|NCT03573297|593131691|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
164208445|NCT03573297|593131692|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
164208446|NCT03573297|593131693|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
164208447|NCT03573297|593131690|FG000|Open Label Treatment Period|Other, Not Specified|7|||
164208448|NCT03573297|593131691|FG001|Open Label Treatment Period|Other, Not Specified|0|||
164208449|NCT03573297|593131692|FG002|Open Label Treatment Period|Other, Not Specified|0|||
164208450|NCT03573297|593131693|FG003|Open Label Treatment Period|Other, Not Specified|0|||
164208451|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
164208452|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
164208453|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
164208454|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
164208455|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164208456|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164208457|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Adverse Event|5|||
164208458|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Adverse Event|1|||
164208459|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164208460|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
164208461|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
164208462|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
164208463|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164208464|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
164208465|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
164208466|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
164208467|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164208468|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
164208469|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
164208470|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
164208471|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164208472|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
164208473|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
164208474|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
164208475|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
164208476|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
164208477|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
164208478|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
164208479|NCT03573297|593131690|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
164208480|NCT03573297|593131691|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
164208481|NCT03573297|593131692|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
164208482|NCT03573297|593131693|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
164208483|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
164208484|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
164208485|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
164208486|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Death|0|||
163875312|NCT04019444|591911632|FG000|Overall Study|Withdrawal by Subject|0|||
164323408|NCT02278341|593562041|FG001|Overall Study|Withdrawal by Subject|19|||
164323409|NCT02278341|593562040|FG000|Overall Study|Lost to Follow-up|0|||
164323410|NCT02278341|593562041|FG001|Overall Study|Lost to Follow-up|1|||
164323411|NCT02278341|593562040|FG000|Overall Study|Physician Decision|1|||
164323412|NCT02278341|593562041|FG001|Overall Study|Physician Decision|1|||
164323413|NCT02278341|593562040|FG000|Overall Study|Miscellaneous|15|||
164323414|NCT02278341|593562041|FG001|Overall Study|Miscellaneous|14|||
164323415|NCT01129024|593562042|FG000|Overall Study|Physician Decision|5|||
164323416|NCT01129024|593562042|FG000|Overall Study|Study Terminated by Sponsor|8|||
164323417|NCT01129024|593562042|FG000|Overall Study|Withdrawal by Subject|2|||
164323418|NCT01129024|593562042|FG000|Overall Study|Lack of Efficacy|3|||
164323419|NCT01129024|593562042|FG000|Overall Study|Needed a Platelet Transfusion|1|||
164323420|NCT02361580|593562044|FG000|Overall Study|Lost to Follow-up|6|||
164323421|NCT02361580|593562045|FG001|Overall Study|Lost to Follow-up|3|||
164323422|NCT02047318|593562046|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
164323423|NCT02047318|593562046|FG000|Core Study Period|Adverse Event|1|||
164323424|NCT02047318|593562046|FG000|Core Study Period|Withdrawal by caregiver|3|||
164323425|NCT02047318|593562046|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
164323426|NCT01487577|593562047|FG000|Overall Study|Became ineligible after signing consent|1|||
164323427|NCT01479985|593562048|FG000|Overall Study|Tablet malfunction, no data saved|1|||
164323428|NCT01479985|593562049|FG001|Overall Study|Tablet malfunction, no data saved|1|||
164323429|NCT01479985|593562048|FG000|Overall Study|No decisional conflict scale responses|0|||
164323430|NCT01479985|593562049|FG001|Overall Study|No decisional conflict scale responses|2|||
164323431|NCT01479985|593562048|FG000|Overall Study|No post-visit survey|5|||
164323432|NCT01479985|593562049|FG001|Overall Study|No post-visit survey|3|||
164323433|NCT00708201|593562050|FG000|Overall Study|Adverse Event|4|||
164323434|NCT00708201|593562051|FG001|Overall Study|Adverse Event|4|||
164323435|NCT00708201|593562050|FG000|Overall Study|Withdrawal by Subject|1|||
164323436|NCT00708201|593562051|FG001|Overall Study|Withdrawal by Subject|1|||
164323437|NCT00708201|593562050|FG000|Overall Study|Lost to Follow-up|2|||
164323438|NCT00708201|593562051|FG001|Overall Study|Lost to Follow-up|0|||
164323439|NCT00708201|593562050|FG000|Overall Study|Protocol Violation|0|||
164323440|NCT00708201|593562051|FG001|Overall Study|Protocol Violation|1|||
164323441|NCT00761748|593562052|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
164323442|NCT00761748|593562053|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
164323443|NCT00761748|593562052|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
164323444|NCT00761748|593562053|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
164323445|NCT02554279|593562054|FG000|Overall Study|Adverse Event|2|||
164323446|NCT02554279|593562055|FG001|Overall Study|Adverse Event|5|||
164323447|NCT02554279|593562054|FG000|Overall Study|Lost to Follow-up|3|||
164323448|NCT02554279|593562055|FG001|Overall Study|Lost to Follow-up|2|||
164323449|NCT02554279|593562054|FG000|Overall Study|Withdrawal by Subject|6|||
164323450|NCT02554279|593562055|FG001|Overall Study|Withdrawal by Subject|4|||
164323451|NCT02554279|593562054|FG000|Overall Study|Protocol Violation|2|||
164323452|NCT02554279|593562055|FG001|Overall Study|Protocol Violation|1|||
164323453|NCT02554279|593562054|FG000|Overall Study|Other reason|19|||
164323454|NCT02554279|593562055|FG001|Overall Study|Other reason|6|||
164323455|NCT00812487|593562056|FG000|Overall Study|Lost to Follow-up|2|||
164323456|NCT00812487|593562057|FG001|Overall Study|Lost to Follow-up|0|||
164323457|NCT00812487|593562056|FG000|Overall Study|Withdrawal by Subject|3|||
164323458|NCT00812487|593562057|FG001|Overall Study|Withdrawal by Subject|2|||
164323459|NCT00812487|593562056|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
164323460|NCT00812487|593562057|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
164323461|NCT00812487|593562056|FG000|Overall Study|Protocol Violation|0|||
164323462|NCT00812487|593562057|FG001|Overall Study|Protocol Violation|1|||
164323463|NCT00998764|593562058|FG000|Overall Study|Lack of Efficacy|3|||
164323464|NCT00998764|593562059|FG001|Overall Study|Lack of Efficacy|6|||
164323465|NCT00998764|593562058|FG000|Overall Study|Adverse Event|17|||
164323466|NCT00998764|593562059|FG001|Overall Study|Adverse Event|12|||
164323467|NCT00998764|593562058|FG000|Overall Study|Withdrawal by Subject|19|||
164323468|NCT00998764|593562059|FG001|Overall Study|Withdrawal by Subject|25|||
164323469|NCT00998764|593562058|FG000|Overall Study|Physician Decision|3|||
164323470|NCT00998764|593562059|FG001|Overall Study|Physician Decision|3|||
164076858|NCT00725725|592645848|FG001|Overall Study|Protocol Violation|1|||
164323471|NCT00998764|593562058|FG000|Overall Study|Death|3|||
164323472|NCT00998764|593562059|FG001|Overall Study|Death|1|||
164323473|NCT00998764|593562058|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
164323474|NCT00998764|593562059|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
164323475|NCT00998764|593562058|FG000|Overall Study|Protocol Violation|0|||
164323476|NCT00998764|593562059|FG001|Overall Study|Protocol Violation|1|||
164323477|NCT00998764|593562058|FG000|Overall Study|Failed to Return|1|||
164323478|NCT00998764|593562059|FG001|Overall Study|Failed to Return|1|||
164323479|NCT00998764|593562058|FG000|Overall Study|Lost to Follow-up|1|||
164323480|NCT00998764|593562059|FG001|Overall Study|Lost to Follow-up|1|||
164323481|NCT00998764|593562058|FG000|Overall Study|Loss of Caregiver|0|||
164323482|NCT00998764|593562059|FG001|Overall Study|Loss of Caregiver|3|||
164323483|NCT00998764|593562058|FG000|Overall Study|Other|4|||
164323484|NCT00998764|593562059|FG001|Overall Study|Other|4|||
164323485|NCT00998764|593562058|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
164323486|NCT00998764|593562059|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
164323487|NCT04761627|593562062|FG000|Run-in Period|Death|1|||
164323488|NCT04761627|593562063|FG001|Run-in Period|Death|0|||
164323489|NCT04761627|593562064|FG002|Run-in Period|Death|0|||
164323490|NCT04761627|593562062|FG000|Run-in Period|Required alternative therapy|2|||
164323491|NCT04761627|593562063|FG001|Run-in Period|Required alternative therapy|0|||
164323492|NCT04761627|593562064|FG002|Run-in Period|Required alternative therapy|0|||
164323493|NCT04761627|593562062|FG000|Run-in Period|Lost to Follow-up|2|||
164323494|NCT04761627|593562063|FG001|Run-in Period|Lost to Follow-up|0|||
164323495|NCT04761627|593562064|FG002|Run-in Period|Lost to Follow-up|0|||
164323496|NCT04761627|593562062|FG000|Run-in Period|Protocol Violation|3|||
164323497|NCT04761627|593562063|FG001|Run-in Period|Protocol Violation|0|||
164323498|NCT04761627|593562064|FG002|Run-in Period|Protocol Violation|0|||
164323499|NCT04761627|593562062|FG000|Run-in Period|Abnormal liver function|1|||
164323500|NCT04761627|593562063|FG001|Run-in Period|Abnormal liver function|0|||
164323501|NCT04761627|593562064|FG002|Run-in Period|Abnormal liver function|0|||
164323502|NCT04761627|593562062|FG000|Run-in Period|Adverse Event|6|||
164323503|NCT04761627|593562063|FG001|Run-in Period|Adverse Event|0|||
164323504|NCT04761627|593562064|FG002|Run-in Period|Adverse Event|0|||
164323505|NCT04761627|593562062|FG000|Run-in Period|Withdrawal by Subject|7|||
164323506|NCT04761627|593562063|FG001|Run-in Period|Withdrawal by Subject|0|||
164323507|NCT04761627|593562064|FG002|Run-in Period|Withdrawal by Subject|0|||
164323508|NCT04761627|593562062|FG000|Run-in Period|Did not meet PASI 50|15|||
164323509|NCT04761627|593562063|FG001|Run-in Period|Did not meet PASI 50|0|||
164323510|NCT04761627|593562064|FG002|Run-in Period|Did not meet PASI 50|0|||
164323511|NCT04761627|593562062|FG000|Run-in Period|Study site closure|2|||
164323512|NCT04761627|593562063|FG001|Run-in Period|Study site closure|0|||
164323513|NCT04761627|593562064|FG002|Run-in Period|Study site closure|0|||
164323514|NCT04761627|593562062|FG000|Run-in Period|Pregnancy|2|||
164323515|NCT04761627|593562063|FG001|Run-in Period|Pregnancy|0|||
164323516|NCT04761627|593562064|FG002|Run-in Period|Pregnancy|0|||
164323517|NCT04761627|593562062|FG000|Post-randomization Period|Military service|0|||
164323518|NCT04761627|593562063|FG001|Post-randomization Period|Military service|1|||
164323519|NCT04761627|593562064|FG002|Post-randomization Period|Military service|0|||
164323520|NCT04761627|593562062|FG000|Post-randomization Period|Adverse Event|0|||
164323521|NCT04761627|593562063|FG001|Post-randomization Period|Adverse Event|4|||
164323522|NCT04761627|593562064|FG002|Post-randomization Period|Adverse Event|2|||
164323523|NCT04761627|593562062|FG000|Post-randomization Period|Lost to Follow-up|0|||
164323524|NCT04761627|593562063|FG001|Post-randomization Period|Lost to Follow-up|6|||
164323525|NCT04761627|593562064|FG002|Post-randomization Period|Lost to Follow-up|6|||
164323526|NCT04761627|593562062|FG000|Post-randomization Period|Withdrawal by Subject|0|||
164323527|NCT04761627|593562063|FG001|Post-randomization Period|Withdrawal by Subject|7|||
164323528|NCT04761627|593562064|FG002|Post-randomization Period|Withdrawal by Subject|6|||
164323529|NCT04761627|593562062|FG000|Post-randomization Period|Pregnancy|0|||
164323530|NCT04761627|593562063|FG001|Post-randomization Period|Pregnancy|0|||
164323531|NCT04761627|593562064|FG002|Post-randomization Period|Pregnancy|1|||
164323532|NCT04761627|593562062|FG000|Post-randomization Period|Study site closure|0|||
164323533|NCT04761627|593562063|FG001|Post-randomization Period|Study site closure|0|||
164323534|NCT04761627|593562064|FG002|Post-randomization Period|Study site closure|1|||
164323535|NCT04761627|593562062|FG000|Post-randomization Period|Family planning|0|||
164323536|NCT04761627|593562063|FG001|Post-randomization Period|Family planning|1|||
164323537|NCT04761627|593562064|FG002|Post-randomization Period|Family planning|0|||
164323538|NCT01634178|593562065|FG000|Treatment Period 1|Adverse Event|0|||
164323539|NCT01634178|593562066|FG001|Treatment Period 1|Adverse Event|1|||
164323540|NCT01634178|593562065|FG000|Treatment Period 2|Adverse Event|1|||
164323541|NCT01634178|593562066|FG001|Treatment Period 2|Adverse Event|0|||
164323542|NCT01117792|593562067|FG000|Overall Study|Death|1|||
163979833|NCT01784861|592297277|FG001|Overall Study|Physician Decision|0|||
164323543|NCT01117792|593562067|FG000|Overall Study|Adverse Event|3|||
164323544|NCT05867342|593562068|FG000|Overall Study|Investigator Decision|3|||
164323545|NCT05867342|593562069|FG001|Overall Study|Investigator Decision|3|||
164323546|NCT00723203|593562070|FG000|Overall Study|Withdrawal by Subject|3|||
164323547|NCT01150474|593562075|FG000|Overall Study|Withdrawal by Subject|5|||
164323548|NCT01150474|593562076|FG001|Overall Study|Withdrawal by Subject|2|||
164323549|NCT01150474|593562075|FG000|Overall Study|Cancer found|1|||
164323550|NCT01150474|593562076|FG001|Overall Study|Cancer found|0|||
163979834|NCT01784861|592297278|FG002|Overall Study|Physician Decision|0|||
163979835|NCT01784861|592297279|FG003|Overall Study|Physician Decision|2|||
164323551|NCT01150474|593562075|FG000|Overall Study|Multiple Studies|0|||
164323552|NCT01150474|593562076|FG001|Overall Study|Multiple Studies|1|||
164323553|NCT01150474|593562075|FG000|Overall Study|Rectotomy|1|||
163979836|NCT01784861|592297280|FG004|Overall Study|Physician Decision|0|||
164323554|NCT01150474|593562076|FG001|Overall Study|Rectotomy|0|||
163979837|NCT01784861|592297281|FG005|Overall Study|Physician Decision|1|||
164323555|NCT01150474|593562075|FG000|Overall Study|Drug did not arrive in time|1|||
164323556|NCT01150474|593562076|FG001|Overall Study|Drug did not arrive in time|0|||
164323557|NCT01150474|593562075|FG000|Overall Study|Drug not administered|1|||
164323558|NCT01150474|593562076|FG001|Overall Study|Drug not administered|0|||
164323559|NCT01150474|593562075|FG000|Overall Study|Surgery Changed|1|||
164323560|NCT01150474|593562076|FG001|Overall Study|Surgery Changed|0|||
164323561|NCT04231981|593562077|FG000|Overall Study|Adverse Event|1|||
164323562|NCT04231981|593562077|FG000|Overall Study|Death|16|||
164323563|NCT04231981|593562077|FG000|Overall Study|Lost to Follow-up|1|||
164323564|NCT02581943|593562078|FG000|Overall Study|Death|5|||
164323565|NCT02581943|593562079|FG001|Overall Study|Death|2|||
164323566|NCT02581943|593562078|FG000|Overall Study|Disease Progression|12|||
164323567|NCT02581943|593562079|FG001|Overall Study|Disease Progression|15|||
164323568|NCT02581943|593562078|FG000|Overall Study|Withdrawal by Subject|1|||
164323569|NCT02581943|593562079|FG001|Overall Study|Withdrawal by Subject|2|||
164323570|NCT01470989|593562080|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
163875313|NCT04019444|591911633|FG001|Overall Study|Withdrawal by Subject|1|||
164323571|NCT01470989|593562081|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
164323572|NCT01470989|593562080|FG000|Overall Study|Adverse Event|2|||
164323573|NCT01470989|593562081|FG001|Overall Study|Adverse Event|5|||
164323574|NCT01470989|593562080|FG000|Overall Study|Abnormal laboratory value|1|||
164323575|NCT01470989|593562081|FG001|Overall Study|Abnormal laboratory value|1|||
164323576|NCT01470989|593562080|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164323577|NCT01470989|593562081|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164323578|NCT01470989|593562080|FG000|Overall Study|Withdrawal by Subject|19|||
164323579|NCT01470989|593562081|FG001|Overall Study|Withdrawal by Subject|17|||
164323580|NCT01470989|593562080|FG000|Overall Study|Lost to Follow-up|18|||
164323581|NCT01470989|593562081|FG001|Overall Study|Lost to Follow-up|13|||
164323582|NCT01470989|593562080|FG000|Overall Study|Administrative problems|2|||
164323583|NCT01470989|593562081|FG001|Overall Study|Administrative problems|4|||
164323584|NCT01470989|593562080|FG000|Overall Study|Death|2|||
164323585|NCT01470989|593562081|FG001|Overall Study|Death|2|||
164323586|NCT01470989|593562080|FG000|Overall Study|Protocol deviation|1|||
164323587|NCT01470989|593562081|FG001|Overall Study|Protocol deviation|2|||
164323588|NCT01233687|593562082|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
164323589|NCT01233687|593562082|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
164323590|NCT01233687|593562082|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
164323591|NCT02197234|593562085|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
164323592|NCT02197234|593562085|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
164323593|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
164323594|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
164323595|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
164323596|NCT02197234|593562085|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
164323597|NCT03783702|593562086|FG000|Overall Study|Lost to Follow-up|6|||
164323598|NCT03783702|593562087|FG001|Overall Study|Lost to Follow-up|8|||
164323599|NCT03783702|593562086|FG000|Overall Study|Protocol Violation|1|||
164323600|NCT03783702|593562087|FG001|Overall Study|Protocol Violation|3|||
164323601|NCT02119676|593562088|FG000|Overall Study|Adverse Event|9|||
164323602|NCT02119676|593562089|FG001|Overall Study|Adverse Event|17|||
164323603|NCT02119676|593562090|FG002|Overall Study|Adverse Event|10|||
164323604|NCT02119676|593562091|FG003|Overall Study|Adverse Event|10|||
164323605|NCT02119676|593562088|FG000|Overall Study|Disease progression|53|||
164323606|NCT02119676|593562089|FG001|Overall Study|Disease progression|55|||
164323607|NCT02119676|593562090|FG002|Overall Study|Disease progression|68|||
164323608|NCT02119676|593562091|FG003|Overall Study|Disease progression|73|||
164323609|NCT02119676|593562088|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
164323610|NCT02119676|593562089|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
164323611|NCT02119676|593562090|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
164323612|NCT02119676|593562091|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
164323613|NCT02119676|593562088|FG000|Overall Study|Physician Decision|4|||
164323614|NCT02119676|593562089|FG001|Overall Study|Physician Decision|2|||
164323615|NCT02119676|593562090|FG002|Overall Study|Physician Decision|3|||
164323616|NCT02119676|593562091|FG003|Overall Study|Physician Decision|2|||
164323617|NCT02119676|593562088|FG000|Overall Study|Death|9|||
164323618|NCT02119676|593562089|FG001|Overall Study|Death|3|||
164323619|NCT02119676|593562090|FG002|Overall Study|Death|2|||
164323620|NCT02119676|593562091|FG003|Overall Study|Death|1|||
163875314|NCT04019444|591911634|FG002|Overall Study|Withdrawal by Subject|0|||
164323621|NCT02119676|593562088|FG000|Overall Study|Noncompliance|0|||
164323622|NCT02119676|593562089|FG001|Overall Study|Noncompliance|1|||
164323623|NCT02119676|593562090|FG002|Overall Study|Noncompliance|0|||
164323624|NCT02119676|593562091|FG003|Overall Study|Noncompliance|0|||
164323625|NCT02119676|593562088|FG000|Overall Study|Lost to Follow-up|0|||
163875315|NCT04019444|591911635|FG003|Overall Study|Withdrawal by Subject|1|||
163875316|NCT04019444|591911632|FG000|Overall Study|Solicited Event|0|||
164323626|NCT02119676|593562089|FG001|Overall Study|Lost to Follow-up|0|||
164323627|NCT02119676|593562090|FG002|Overall Study|Lost to Follow-up|1|||
164323628|NCT02119676|593562091|FG003|Overall Study|Lost to Follow-up|0|||
164323629|NCT02119676|593562088|FG000|Overall Study|Protocol deviation|0|||
164323630|NCT02119676|593562089|FG001|Overall Study|Protocol deviation|0|||
164323631|NCT02119676|593562090|FG002|Overall Study|Protocol deviation|1|||
164323632|NCT02119676|593562091|FG003|Overall Study|Protocol deviation|0|||
164323633|NCT02119676|593562088|FG000|Overall Study|Other, unspecified|2|||
164323634|NCT02119676|593562089|FG001|Overall Study|Other, unspecified|1|||
164323635|NCT02119676|593562090|FG002|Overall Study|Other, unspecified|3|||
164323636|NCT02119676|593562091|FG003|Overall Study|Other, unspecified|4|||
164323637|NCT02119676|593562088|FG000|Overall Study|Did not receive study med|2|||
164323638|NCT02119676|593562089|FG001|Overall Study|Did not receive study med|2|||
164323639|NCT02119676|593562090|FG002|Overall Study|Did not receive study med|4|||
164323640|NCT02119676|593562091|FG003|Overall Study|Did not receive study med|5|||
164323641|NCT00219544|593562092|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
164323642|NCT00219544|593562093|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
164323643|NCT00219544|593562092|FG000|Single Blind Treatment Period|Adverse Event|9|||
164323644|NCT00219544|593562093|FG001|Single Blind Treatment Period|Adverse Event|0|||
164323645|NCT00219544|593562092|FG000|Single Blind Treatment Period|Protocol Violation|4|||
164323646|NCT00219544|593562093|FG001|Single Blind Treatment Period|Protocol Violation|0|||
164323647|NCT00219544|593562092|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
164323648|NCT00219544|593562093|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
164323649|NCT00219544|593562092|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
164323650|NCT00219544|593562093|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
164323651|NCT00219544|593562092|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
164323652|NCT00219544|593562093|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
164323653|NCT00989573|593562094|FG000|Overall Study|Adverse Event|8|||
164323654|NCT00989573|593562095|FG001|Overall Study|Adverse Event|12|||
164323655|NCT00989573|593562096|FG002|Overall Study|Adverse Event|4|||
164323656|NCT00989573|593562094|FG000|Overall Study|Physician Decision|0|||
164323657|NCT00989573|593562095|FG001|Overall Study|Physician Decision|2|||
164323658|NCT00989573|593562096|FG002|Overall Study|Physician Decision|0|||
164323659|NCT00989573|593562094|FG000|Overall Study|Protocol Violation|1|||
164323660|NCT00989573|593562095|FG001|Overall Study|Protocol Violation|1|||
164323661|NCT00989573|593562096|FG002|Overall Study|Protocol Violation|1|||
164323662|NCT00989573|593562094|FG000|Overall Study|Withdrawal by Subject|4|||
164323663|NCT00989573|593562095|FG001|Overall Study|Withdrawal by Subject|7|||
164323664|NCT00989573|593562096|FG002|Overall Study|Withdrawal by Subject|3|||
164323665|NCT03473548|593562098|FG000|Overall Study|Did not attempt HST testing|3|||
164323666|NCT03473548|593562099|FG001|Overall Study|Did not attempt HST testing|0|||
164323667|NCT02207946|593562106|FG000|Overall Study|Lost to Follow-up|1|||
164323668|NCT02207946|593562107|FG001|Overall Study|Lost to Follow-up|0|||
164323669|NCT02207946|593562106|FG000|Overall Study|Adverse Event|0|||
164323670|NCT02207946|593562107|FG001|Overall Study|Adverse Event|1|||
164323671|NCT02829944|593562108|FG000|Overall Study|Physician Decision|0|||
164323672|NCT02829944|593562109|FG001|Overall Study|Physician Decision|1|||
164323673|NCT02829944|593562108|FG000|Overall Study|Screen Failure|2|||
164323674|NCT02829944|593562109|FG001|Overall Study|Screen Failure|2|||
164323675|NCT02829944|593562108|FG000|Overall Study|Inadequate Neuraxial Block|1|||
164323676|NCT02829944|593562109|FG001|Overall Study|Inadequate Neuraxial Block|1|||
164323677|NCT02829944|593562108|FG000|Overall Study|Withdrawal by Subject|2|||
164323678|NCT02829944|593562109|FG001|Overall Study|Withdrawal by Subject|1|||
164323679|NCT02829944|593562108|FG000|Overall Study|Catheter Displacement|1|||
164323680|NCT02829944|593562109|FG001|Overall Study|Catheter Displacement|0|||
164323681|NCT02829944|593562108|FG000|Overall Study|Catheter broke|0|||
164323682|NCT02829944|593562109|FG001|Overall Study|Catheter broke|1|||
164323683|NCT02829944|593562108|FG000|Overall Study|Staff unavailable|0|||
164323684|NCT02829944|593562109|FG001|Overall Study|Staff unavailable|1|||
164323685|NCT05856760|593562110|FG000|Overall Study|Adverse Event|2|||
164323686|NCT05856760|593562110|FG000|Overall Study|Physician Decision|1|||
164323687|NCT05856760|593562110|FG000|Overall Study|Protocol Violation|1|||
164323688|NCT05856760|593562110|FG000|Overall Study|Withdrawal by Subject|3|||
164323689|NCT04675151|593562111|FG000|Overall Study|Protocol Violation|1|||
164323690|NCT04675151|593562112|FG001|Overall Study|Protocol Violation|0|||
164323691|NCT04675151|593562113|FG002|Overall Study|Protocol Violation|0|||
164323692|NCT04675151|593562114|FG003|Overall Study|Protocol Violation|1|||
164323693|NCT04035486|593562115|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
164323694|NCT04035486|593562116|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
164323695|NCT04035486|593562117|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
164323696|NCT04035486|593562118|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
164323697|NCT04035486|593562115|FG000|Overall Study|Death|6|||
164323698|NCT04035486|593562116|FG001|Overall Study|Death|3|||
164323699|NCT04035486|593562117|FG002|Overall Study|Death|70|||
164323700|NCT04035486|593562118|FG003|Overall Study|Death|77|||
164323701|NCT04035486|593562115|FG000|Overall Study|Screen Failure|0|||
164323702|NCT04035486|593562116|FG001|Overall Study|Screen Failure|0|||
164323703|NCT04035486|593562117|FG002|Overall Study|Screen Failure|1|||
163875317|NCT04019444|591911633|FG001|Overall Study|Solicited Event|0|||
164208487|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Death|0|||
164208488|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Death|1|||
164208489|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
164208490|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
164208491|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
164208492|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
164208493|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
164208494|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
164208495|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
164208496|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
164208497|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
164208498|NCT02696798|593131696|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
164208499|NCT02696798|593131697|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
164208500|NCT02696798|593131698|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
164208501|NCT02696798|593131696|FG000|Extended Treatment Period|Adverse Event|1|||
164208502|NCT02696798|593131697|FG001|Extended Treatment Period|Adverse Event|4|||
164208503|NCT02696798|593131698|FG002|Extended Treatment Period|Adverse Event|5|||
164208504|NCT02696798|593131696|FG000|Extended Treatment Period|Lack of Efficacy|7|||
164208505|NCT02696798|593131697|FG001|Extended Treatment Period|Lack of Efficacy|2|||
164208506|NCT02696798|593131698|FG002|Extended Treatment Period|Lack of Efficacy|2|||
164208507|NCT02696798|593131696|FG000|Extended Treatment Period|Lost to Follow-up|1|||
164208508|NCT02696798|593131697|FG001|Extended Treatment Period|Lost to Follow-up|0|||
164208509|NCT02696798|593131698|FG002|Extended Treatment Period|Lost to Follow-up|0|||
164208510|NCT02696798|593131696|FG000|Extended Treatment Period|Physician Decision|0|||
164208511|NCT02696798|593131697|FG001|Extended Treatment Period|Physician Decision|1|||
164208512|NCT02696798|593131698|FG002|Extended Treatment Period|Physician Decision|0|||
164208513|NCT02696798|593131696|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
164208514|NCT02696798|593131697|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
164208515|NCT02696798|593131698|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
164208516|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
164208517|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
164208518|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
164208519|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
164208520|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
164208521|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
164208522|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
164208523|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
164208524|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
164208525|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
164208526|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
164208527|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
164208528|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
164208529|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
164208530|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
164208531|NCT02696798|593131696|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
164208532|NCT02696798|593131697|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
164208533|NCT02696798|593131698|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
164208534|NCT04880850|593131699|FG000|Overall Study|Death|2|||
164208535|NCT04880850|593131700|FG001|Overall Study|Death|1|||
164208536|NCT04880850|593131699|FG000|Overall Study|Lost to Follow-up|3|||
164208537|NCT04880850|593131700|FG001|Overall Study|Lost to Follow-up|6|||
164208538|NCT04880850|593131699|FG000|Overall Study|Physician Decision|2|||
164208539|NCT04880850|593131700|FG001|Overall Study|Physician Decision|1|||
164208540|NCT04880850|593131699|FG000|Overall Study|Withdrawal by Subject|9|||
164208541|NCT04880850|593131700|FG001|Overall Study|Withdrawal by Subject|10|||
164208542|NCT04091451|593131701|FG000|Overall Study|Adverse Event|15|||
164208543|NCT04091451|593131702|FG001|Overall Study|Adverse Event|10|||
164208544|NCT04091451|593131701|FG000|Overall Study|Lost to Follow-up|8|||
164208545|NCT04091451|593131702|FG001|Overall Study|Lost to Follow-up|8|||
164208546|NCT04091451|593131701|FG000|Overall Study|Protocol Violation|5|||
164208547|NCT04091451|593131702|FG001|Overall Study|Protocol Violation|4|||
164208548|NCT04091451|593131701|FG000|Overall Study|Withdrawal by Subject|21|||
164208549|NCT04091451|593131702|FG001|Overall Study|Withdrawal by Subject|27|||
164208550|NCT04091451|593131701|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
164208551|NCT04091451|593131702|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
164208552|NCT04091451|593131701|FG000|Overall Study|Migrated/moved from the study area|3|||
164208553|NCT04091451|593131702|FG001|Overall Study|Migrated/moved from the study area|5|||
164208554|NCT04091451|593131701|FG000|Overall Study|Suspected HZ episode|1|||
164208555|NCT04091451|593131702|FG001|Overall Study|Suspected HZ episode|0|||
164208556|NCT03907488|593131703|FG000|Overall Study|Adverse Event|20|||
164208557|NCT03907488|593131704|FG001|Overall Study|Adverse Event|20|||
164323704|NCT04035486|593562118|FG003|Overall Study|Screen Failure|1|||
164208558|NCT03907488|593131703|FG000|Overall Study|Withdrawal by Subject|9|||
164208559|NCT03907488|593131704|FG001|Overall Study|Withdrawal by Subject|13|||
164208560|NCT03907488|593131703|FG000|Overall Study|Lack of Efficacy|0|||
164208561|NCT03907488|593131704|FG001|Overall Study|Lack of Efficacy|9|||
164208562|NCT03907488|593131703|FG000|Overall Study|Death|3|||
164208563|NCT03907488|593131704|FG001|Overall Study|Death|8|||
164208564|NCT03907488|593131703|FG000|Overall Study|not protocol specified|5|||
164208565|NCT03907488|593131704|FG001|Overall Study|not protocol specified|8|||
164208566|NCT03907488|593131703|FG000|Overall Study|Ineligible|9|||
164208567|NCT03907488|593131704|FG001|Overall Study|Ineligible|15|||
164208568|NCT03074500|593131706|FG000|Overall Study|Lost to Follow-up|1|||
164208569|NCT03074500|593131707|FG001|Overall Study|Lost to Follow-up|0|||
164208570|NCT03074500|593131708|FG002|Overall Study|Lost to Follow-up|0|||
164208571|NCT03074500|593131706|FG000|Overall Study|Lack of Efficacy|0|||
164208572|NCT03074500|593131707|FG001|Overall Study|Lack of Efficacy|1|||
164208573|NCT03074500|593131708|FG002|Overall Study|Lack of Efficacy|0|||
164208574|NCT03074500|593131706|FG000|Overall Study|Adverse Event|0|||
164208575|NCT03074500|593131707|FG001|Overall Study|Adverse Event|0|||
164208576|NCT03074500|593131708|FG002|Overall Study|Adverse Event|1|||
164208577|NCT03321721|593131709|FG000|Overall Study|Lost to Follow-up|4|||
164208578|NCT03321721|593131710|FG001|Overall Study|Lost to Follow-up|8|||
164208579|NCT03321721|593131711|FG002|Overall Study|Lost to Follow-up|11|||
164208580|NCT00634504|593133402|FG000|Overall Study|Protocol Violation|1|||
164208581|NCT00634504|593133403|FG001|Overall Study|Protocol Violation|0|||
164208582|NCT00937950|593133404|FG000|Overall Study|Withdrawal by Subject|23|||
164208583|NCT00937950|593133404|FG000|Overall Study|Migrated/moved from study area|27|||
164208584|NCT00937950|593133404|FG000|Overall Study|Lost to Follow-up|144|||
164208585|NCT00937950|593133404|FG000|Overall Study|Missing confirmed|4|||
164208586|NCT00937950|593133404|FG000|Overall Study|Other|18|||
164208587|NCT03483103|593133409|FG000|Pre-Treatment Phase|Other reasons|1|||
164208588|NCT03483103|593133409|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
164208589|NCT03483103|593133409|FG000|Pre-Treatment Phase|Disease-related complications|1|||
164208590|NCT03483103|593133409|FG000|Pre-Treatment Phase|Death|5|||
164208591|NCT03483103|593133409|FG000|Treatment Phase|Withdrawal by Subject|7|||
164208592|NCT03483103|593133409|FG000|Treatment Phase|Other reasons|1|||
164208593|NCT03483103|593133409|FG000|Treatment Phase|Death|23|||
164208594|NCT03483103|593133409|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
164208595|NCT03483103|593133409|FG000|Treatment Phase|Received nonconforming product|1|||
164208596|NCT02475213|593133410|FG000|Overall Study|Adverse Event|2|||
164208597|NCT02475213|593133411|FG001|Overall Study|Adverse Event|0|||
164208598|NCT02475213|593133412|FG002|Overall Study|Adverse Event|0|||
164208599|NCT02475213|593133413|FG003|Overall Study|Adverse Event|1|||
164208600|NCT02475213|593133414|FG004|Overall Study|Adverse Event|1|||
164208601|NCT02475213|593133415|FG005|Overall Study|Adverse Event|4|||
164208602|NCT02475213|593133416|FG006|Overall Study|Adverse Event|6|||
164208603|NCT02475213|593133417|FG007|Overall Study|Adverse Event|2|||
164208604|NCT02475213|593133410|FG000|Overall Study|Physician Decision|1|||
164208605|NCT02475213|593133411|FG001|Overall Study|Physician Decision|1|||
164208606|NCT02475213|593133412|FG002|Overall Study|Physician Decision|1|||
164208607|NCT02475213|593133413|FG003|Overall Study|Physician Decision|0|||
164208608|NCT02475213|593133414|FG004|Overall Study|Physician Decision|0|||
164208609|NCT02475213|593133415|FG005|Overall Study|Physician Decision|1|||
164208610|NCT02475213|593133416|FG006|Overall Study|Physician Decision|4|||
164208611|NCT02475213|593133417|FG007|Overall Study|Physician Decision|0|||
164208612|NCT02475213|593133410|FG000|Overall Study|Progressive Disease|3|||
164208613|NCT02475213|593133411|FG001|Overall Study|Progressive Disease|2|||
164208614|NCT02475213|593133412|FG002|Overall Study|Progressive Disease|2|||
164208615|NCT02475213|593133413|FG003|Overall Study|Progressive Disease|13|||
164208616|NCT02475213|593133414|FG004|Overall Study|Progressive Disease|15|||
164208617|NCT02475213|593133415|FG005|Overall Study|Progressive Disease|25|||
164208618|NCT02475213|593133416|FG006|Overall Study|Progressive Disease|30|||
164208619|NCT02475213|593133417|FG007|Overall Study|Progressive Disease|10|||
164208620|NCT02475213|593133410|FG000|Overall Study|Death|0|||
164208621|NCT02475213|593133411|FG001|Overall Study|Death|0|||
164208622|NCT02475213|593133412|FG002|Overall Study|Death|0|||
164208623|NCT02475213|593133413|FG003|Overall Study|Death|0|||
164208624|NCT02475213|593133414|FG004|Overall Study|Death|0|||
164208625|NCT02475213|593133415|FG005|Overall Study|Death|4|||
164208626|NCT02475213|593133416|FG006|Overall Study|Death|1|||
164208627|NCT02475213|593133417|FG007|Overall Study|Death|0|||
164208628|NCT02475213|593133410|FG000|Overall Study|Protocol Violation|0|||
164208629|NCT02475213|593133411|FG001|Overall Study|Protocol Violation|0|||
164208630|NCT02475213|593133412|FG002|Overall Study|Protocol Violation|0|||
164208631|NCT02475213|593133413|FG003|Overall Study|Protocol Violation|0|||
164208632|NCT02475213|593133414|FG004|Overall Study|Protocol Violation|1|||
164208633|NCT02475213|593133415|FG005|Overall Study|Protocol Violation|0|||
164208634|NCT02475213|593133416|FG006|Overall Study|Protocol Violation|0|||
164208635|NCT02475213|593133417|FG007|Overall Study|Protocol Violation|0|||
164208636|NCT02475213|593133410|FG000|Overall Study|Withdrawal by Subject|0|||
164208637|NCT02475213|593133411|FG001|Overall Study|Withdrawal by Subject|0|||
164208638|NCT02475213|593133412|FG002|Overall Study|Withdrawal by Subject|0|||
164323705|NCT04035486|593562115|FG000|Overall Study|Withdrawal by Subject|1|||
164323706|NCT04035486|593562116|FG001|Overall Study|Withdrawal by Subject|1|||
164323707|NCT04035486|593562117|FG002|Overall Study|Withdrawal by Subject|11|||
164323708|NCT04035486|593562118|FG003|Overall Study|Withdrawal by Subject|9|||
164323709|NCT01730937|593562119|FG000|Overall Study|Protocol Violation|5|||
164323710|NCT01730937|593562120|FG001|Overall Study|Protocol Violation|11|||
164323711|NCT03947684|593562121|FG000|Overall Study|Lost to Follow-up|13|||
164323712|NCT03947684|593562122|FG001|Overall Study|Lost to Follow-up|5|||
164323713|NCT03947684|593562123|FG002|Overall Study|Lost to Follow-up|1|||
164323714|NCT03947684|593562121|FG000|Overall Study|Withdrawal by Subject|11|||
164323715|NCT03947684|593562122|FG001|Overall Study|Withdrawal by Subject|4|||
164323716|NCT03947684|593562123|FG002|Overall Study|Withdrawal by Subject|0|||
164323717|NCT03947684|593562121|FG000|Overall Study|Physician Decision|1|||
164323718|NCT03947684|593562122|FG001|Overall Study|Physician Decision|0|||
164323719|NCT03947684|593562123|FG002|Overall Study|Physician Decision|0|||
164323720|NCT03947684|593562121|FG000|Overall Study|Lack of adherence to study protocol|2|||
164323721|NCT03947684|593562122|FG001|Overall Study|Lack of adherence to study protocol|0|||
164323722|NCT03947684|593562123|FG002|Overall Study|Lack of adherence to study protocol|0|||
164323723|NCT05313009|593563187|FG000|Overall Study|Death|1|||
164323724|NCT05313009|593563188|FG001|Overall Study|Death|0|||
164323725|NCT02186301|593563189|FG000|Overall Study|Progressive Disease|7|||
164323726|NCT02186301|593563190|FG001|Overall Study|Progressive Disease|22|||
164323727|NCT02186301|593563191|FG002|Overall Study|Progressive Disease|27|||
164323728|NCT02186301|593563189|FG000|Overall Study|Adverse Event|5|||
164323729|NCT02186301|593563190|FG001|Overall Study|Adverse Event|5|||
164323730|NCT02186301|593563191|FG002|Overall Study|Adverse Event|5|||
164323731|NCT02186301|593563189|FG000|Overall Study|Death|1|||
164323732|NCT02186301|593563190|FG001|Overall Study|Death|0|||
164323733|NCT02186301|593563191|FG002|Overall Study|Death|0|||
164323734|NCT02186301|593563189|FG000|Overall Study|Withdrawal by Subject|5|||
164323735|NCT02186301|593563190|FG001|Overall Study|Withdrawal by Subject|1|||
164323736|NCT02186301|593563191|FG002|Overall Study|Withdrawal by Subject|3|||
164323737|NCT02186301|593563189|FG000|Overall Study|Physician Decision|1|||
164323738|NCT02186301|593563190|FG001|Overall Study|Physician Decision|0|||
164323739|NCT02186301|593563191|FG002|Overall Study|Physician Decision|1|||
164323740|NCT02186301|593563189|FG000|Overall Study|Study Terminated by Sponsor|1|||
164323741|NCT02186301|593563190|FG001|Overall Study|Study Terminated by Sponsor|0|||
164323742|NCT02186301|593563191|FG002|Overall Study|Study Terminated by Sponsor|11|||
164323743|NCT02186301|593563189|FG000|Overall Study|Protocol Deviation|0|||
164323744|NCT02186301|593563190|FG001|Overall Study|Protocol Deviation|2|||
164323745|NCT02186301|593563191|FG002|Overall Study|Protocol Deviation|0|||
164323746|NCT02186301|593563189|FG000|Overall Study|Missing|0|||
164323747|NCT02186301|593563190|FG001|Overall Study|Missing|0|||
164323748|NCT02186301|593563191|FG002|Overall Study|Missing|2|||
164323749|NCT02186301|593563189|FG000|Overall Study|Other|0|||
164323750|NCT02186301|593563190|FG001|Overall Study|Other|0|||
164323751|NCT02186301|593563191|FG002|Overall Study|Other|1|||
164323752|NCT00749580|593563192|FG000|Overall Study|Lost to Follow-up|4|||
164323753|NCT00749580|593563193|FG001|Overall Study|Lost to Follow-up|8|||
164323754|NCT00749580|593563192|FG000|Overall Study|Adverse Event|0|||
164323755|NCT00749580|593563193|FG001|Overall Study|Adverse Event|1|||
164323756|NCT05128929|593563194|FG000|Overall Study|Adverse Event|0|||
164323757|NCT05128929|593563195|FG001|Overall Study|Adverse Event|1|||
164323758|NCT03553836|593563196|FG000|Overall Study|Ongoing in Study|460|||
164323759|NCT03553836|593563197|FG001|Overall Study|Ongoing in Study|459|||
164323760|NCT03553836|593563196|FG000|Overall Study|Withdrawal by Subject|9|||
164323761|NCT03553836|593563197|FG001|Overall Study|Withdrawal by Subject|10|||
164323762|NCT03553836|593563196|FG000|Overall Study|Lost to Follow-up|1|||
164323763|NCT03553836|593563197|FG001|Overall Study|Lost to Follow-up|3|||
164323764|NCT03553836|593563196|FG000|Overall Study|Death|17|||
164323765|NCT03553836|593563197|FG001|Overall Study|Death|17|||
164323766|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
164323767|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
164323768|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
164323769|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
164323770|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
164323771|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
164323772|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
164323773|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
164323774|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
164323775|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
164323776|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
164323777|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
164323778|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
164323779|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
164323780|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
164323781|NCT00274924|593563198|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
164323782|NCT00274924|593563199|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
164323783|NCT00274924|593563200|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
164323784|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
164323785|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
164323786|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
164323787|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
164323788|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
164323789|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
164323790|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
164323791|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
164323792|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
164323793|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
164323794|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
164323795|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
164323796|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
164323797|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
164323798|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
164323799|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
164323800|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
164323801|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
164323802|NCT00274924|593563198|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
164323803|NCT00274924|593563199|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
164323804|NCT00274924|593563200|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
164323805|NCT01903525|593563203|FG000|Overall Study|Lost to Follow-up|5|||
164323806|NCT01903525|593563204|FG001|Overall Study|Lost to Follow-up|9|||
164323807|NCT01903525|593563203|FG000|Overall Study|Adverse Event|0|||
164323808|NCT01903525|593563204|FG001|Overall Study|Adverse Event|1|||
164323809|NCT04365257|593563205|FG000|Overall Study|Physician Decision|1|||
164323810|NCT04365257|593563206|FG001|Overall Study|Physician Decision|0|||
164323811|NCT04365257|593563205|FG000|Overall Study|Patient Noncompliance|1|||
164323812|NCT04365257|593563206|FG001|Overall Study|Patient Noncompliance|0|||
164323813|NCT04365257|593563205|FG000|Overall Study|Withdrawal by Subject|0|||
164323814|NCT04365257|593563206|FG001|Overall Study|Withdrawal by Subject|1|||
164323815|NCT02129777|593563211|FG000|Double-Blind Period|Adverse Event|0|||
164323816|NCT02129777|593563212|FG001|Double-Blind Period|Adverse Event|0|||
164323817|NCT02129777|593563213|FG002|Double-Blind Period|Adverse Event|0|||
164323818|NCT02129777|593563214|FG003|Double-Blind Period|Adverse Event|0|||
164323819|NCT02129777|593563215|FG004|Double-Blind Period|Adverse Event|1|||
164323820|NCT02129777|593563216|FG005|Double-Blind Period|Adverse Event|0|||
164323821|NCT02129777|593563217|FG006|Double-Blind Period|Adverse Event|0|||
164323822|NCT02129777|593563211|FG000|Double-Blind Period|Lost to Follow-up|1|||
164323823|NCT02129777|593563212|FG001|Double-Blind Period|Lost to Follow-up|1|||
164323824|NCT02129777|593563213|FG002|Double-Blind Period|Lost to Follow-up|1|||
164323825|NCT02129777|593563214|FG003|Double-Blind Period|Lost to Follow-up|2|||
164323826|NCT02129777|593563215|FG004|Double-Blind Period|Lost to Follow-up|0|||
164323827|NCT02129777|593563216|FG005|Double-Blind Period|Lost to Follow-up|0|||
164323828|NCT02129777|593563217|FG006|Double-Blind Period|Lost to Follow-up|0|||
164323829|NCT02129777|593563211|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164323830|NCT02129777|593563212|FG001|Double-Blind Period|Withdrawal by Subject|4|||
164323831|NCT02129777|593563213|FG002|Double-Blind Period|Withdrawal by Subject|3|||
164323832|NCT02129777|593563214|FG003|Double-Blind Period|Withdrawal by Subject|2|||
164323833|NCT02129777|593563215|FG004|Double-Blind Period|Withdrawal by Subject|3|||
164323834|NCT02129777|593563216|FG005|Double-Blind Period|Withdrawal by Subject|0|||
164323835|NCT02129777|593563217|FG006|Double-Blind Period|Withdrawal by Subject|0|||
164323836|NCT02129777|593563211|FG000|Double-Blind Period|Pregnancy|0|||
164323837|NCT02129777|593563212|FG001|Double-Blind Period|Pregnancy|0|||
164323838|NCT02129777|593563213|FG002|Double-Blind Period|Pregnancy|0|||
164323839|NCT02129777|593563214|FG003|Double-Blind Period|Pregnancy|0|||
164323840|NCT02129777|593563215|FG004|Double-Blind Period|Pregnancy|1|||
164323841|NCT02129777|593563216|FG005|Double-Blind Period|Pregnancy|0|||
164323842|NCT02129777|593563217|FG006|Double-Blind Period|Pregnancy|0|||
164323843|NCT02129777|593563211|FG000|Double-Blind Period|Lack of Efficacy|3|||
164323844|NCT02129777|593563212|FG001|Double-Blind Period|Lack of Efficacy|1|||
164323845|NCT02129777|593563213|FG002|Double-Blind Period|Lack of Efficacy|0|||
164323846|NCT02129777|593563214|FG003|Double-Blind Period|Lack of Efficacy|3|||
164323847|NCT02129777|593563215|FG004|Double-Blind Period|Lack of Efficacy|2|||
164323848|NCT02129777|593563216|FG005|Double-Blind Period|Lack of Efficacy|0|||
163875318|NCT04019444|591911634|FG002|Overall Study|Solicited Event|2|||
164323849|NCT02129777|593563217|FG006|Double-Blind Period|Lack of Efficacy|0|||
164323850|NCT02129777|593563211|FG000|Double-Blind Period|Other|1|||
164323851|NCT02129777|593563212|FG001|Double-Blind Period|Other|2|||
164323852|NCT02129777|593563213|FG002|Double-Blind Period|Other|0|||
164323853|NCT02129777|593563214|FG003|Double-Blind Period|Other|0|||
164323854|NCT02129777|593563215|FG004|Double-Blind Period|Other|0|||
164323855|NCT02129777|593563216|FG005|Double-Blind Period|Other|0|||
164208639|NCT02475213|593133413|FG003|Overall Study|Withdrawal by Subject|1|||
164208640|NCT02475213|593133414|FG004|Overall Study|Withdrawal by Subject|0|||
164208641|NCT02475213|593133415|FG005|Overall Study|Withdrawal by Subject|2|||
164208642|NCT02475213|593133416|FG006|Overall Study|Withdrawal by Subject|2|||
164208643|NCT02475213|593133417|FG007|Overall Study|Withdrawal by Subject|0|||
164208644|NCT02475213|593133410|FG000|Overall Study|Other|0|||
164208645|NCT02475213|593133411|FG001|Overall Study|Other|0|||
164208646|NCT02475213|593133412|FG002|Overall Study|Other|0|||
164208647|NCT02475213|593133413|FG003|Overall Study|Other|1|||
164208648|NCT02475213|593133414|FG004|Overall Study|Other|3|||
164208649|NCT02475213|593133415|FG005|Overall Study|Other|1|||
164208650|NCT02475213|593133416|FG006|Overall Study|Other|0|||
164208651|NCT02475213|593133417|FG007|Overall Study|Other|0|||
164208652|NCT00505921|593133418|FG000|Overall Study|Ineligible|1|||
164208653|NCT00505921|593133418|FG000|Overall Study|Failed to Mobilize|8|||
164208654|NCT00630292|593133419|FG000|Overall Study|Withdrawal by Subject|1|||
164208655|NCT00717886|593133421|FG000|Overall Study|Withdrawal by Subject|3|||
164208656|NCT00717886|593133421|FG000|Overall Study|Treatment Failure|1|||
164208657|NCT01369433|593133422|FG000|Overall Study|Adverse Event|31|||
164208658|NCT01369433|593133423|FG001|Overall Study|Adverse Event|1|||
164208659|NCT01369433|593133422|FG000|Overall Study|Required significant surgical procedure|1|||
164208660|NCT01369433|593133423|FG001|Overall Study|Required significant surgical procedure|0|||
164208661|NCT01369433|593133422|FG000|Overall Study|Non-compliance|1|||
164208662|NCT01369433|593133423|FG001|Overall Study|Non-compliance|0|||
164208663|NCT01369433|593133422|FG000|Overall Study|Withdrawal by Subject|5|||
164208664|NCT01369433|593133423|FG001|Overall Study|Withdrawal by Subject|2|||
164208665|NCT01369433|593133422|FG000|Overall Study|Study terminated by Sponsor|67|||
164208666|NCT01369433|593133423|FG001|Overall Study|Study terminated by Sponsor|0|||
164208667|NCT01369433|593133422|FG000|Overall Study|Lost to Follow-up|1|||
164208668|NCT01369433|593133423|FG001|Overall Study|Lost to Follow-up|0|||
164208669|NCT01369433|593133422|FG000|Overall Study|Death|5|||
164208670|NCT01369433|593133423|FG001|Overall Study|Death|0|||
164208671|NCT01369433|593133422|FG000|Overall Study|Investigator discretion|6|||
164208672|NCT01369433|593133423|FG001|Overall Study|Investigator discretion|1|||
164208673|NCT01369433|593133422|FG000|Overall Study|Progressive Disease|92|||
164208674|NCT01369433|593133423|FG001|Overall Study|Progressive Disease|12|||
164208675|NCT01553851|593133424|FG000|Overall Study|Adverse Event|2|||
164208676|NCT01553851|593133424|FG000|Overall Study|constipation|1|||
164208677|NCT00797563|593133425|FG000|Overall Study|Adverse Event|1|||
164208678|NCT02313155|593133432|FG000|Overall Study|Lost to Follow-up|0|||
164208679|NCT02313155|593133433|FG001|Overall Study|Lost to Follow-up|1|||
164208680|NCT03822416|593133437|FG000|Overall Study|Lost to Follow-up|1|||
164208681|NCT03822416|593133438|FG001|Overall Study|Lost to Follow-up|0|||
164208682|NCT03822416|593133437|FG000|Overall Study|Withdrawal by Subject|0|||
164208683|NCT03822416|593133438|FG001|Overall Study|Withdrawal by Subject|1|||
164208684|NCT04666298|593133439|FG000|Overall Study|Subject decision|1|||
164208685|NCT04666298|593133440|FG001|Overall Study|Subject decision|0|||
164208686|NCT04666298|593133441|FG002|Overall Study|Subject decision|0|||
164208687|NCT04666298|593133442|FG003|Overall Study|Subject decision|2|||
164208688|NCT04666298|593133439|FG000|Overall Study|Death|1|||
164208689|NCT04666298|593133440|FG001|Overall Study|Death|0|||
164208690|NCT04666298|593133441|FG002|Overall Study|Death|0|||
164208691|NCT04666298|593133442|FG003|Overall Study|Death|0|||
164208692|NCT04666298|593133439|FG000|Overall Study|Lost to Follow-up|0|||
164208693|NCT04666298|593133440|FG001|Overall Study|Lost to Follow-up|0|||
164208694|NCT04666298|593133441|FG002|Overall Study|Lost to Follow-up|0|||
164208695|NCT04666298|593133442|FG003|Overall Study|Lost to Follow-up|1|||
164208696|NCT04666298|593133439|FG000|Overall Study|Physician Decision|0|||
164208697|NCT04666298|593133440|FG001|Overall Study|Physician Decision|0|||
164208698|NCT04666298|593133441|FG002|Overall Study|Physician Decision|0|||
164208699|NCT04666298|593133442|FG003|Overall Study|Physician Decision|1|||
164208700|NCT04666298|593133439|FG000|Overall Study|Protocol deviation|0|||
164208701|NCT04666298|593133440|FG001|Overall Study|Protocol deviation|0|||
164208702|NCT04666298|593133441|FG002|Overall Study|Protocol deviation|1|||
164208703|NCT04666298|593133442|FG003|Overall Study|Protocol deviation|0|||
164208704|NCT00844519|593133443|FG000|Overall Study|Withdrawal by Subject|1|||
164208705|NCT00844519|593133444|FG001|Overall Study|Withdrawal by Subject|1|||
164208706|NCT00844519|593133443|FG000|Overall Study|Adverse Event|1|||
164208707|NCT00844519|593133444|FG001|Overall Study|Adverse Event|0|||
164208708|NCT01303419|593133445|FG000|Overall Study|Discontinuation of study|60|||
164208709|NCT01303419|593133445|FG000|Overall Study|Did not complete both imaging methods|5|||
164208710|NCT01303419|593133445|FG000|Overall Study|Did not meet all I/E after screening|31|||
164208711|NCT06438601|593133446|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
164208712|NCT06438601|593133447|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
164208713|NCT06438601|593133446|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
164208714|NCT06438601|593133447|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
164208715|NCT03329001|593133448|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208716|NCT03329001|593133449|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164323856|NCT02129777|593563217|FG006|Double-Blind Period|Other|0|||
164323857|NCT02129777|593563211|FG000|Open-Label Period|Lack of Efficacy|0|||
164323858|NCT02129777|593563212|FG001|Open-Label Period|Lack of Efficacy|0|||
164323859|NCT02129777|593563213|FG002|Open-Label Period|Lack of Efficacy|0|||
164323860|NCT02129777|593563214|FG003|Open-Label Period|Lack of Efficacy|0|||
164323861|NCT02129777|593563215|FG004|Open-Label Period|Lack of Efficacy|0|||
164323862|NCT02129777|593563216|FG005|Open-Label Period|Lack of Efficacy|0|||
164323863|NCT02129777|593563217|FG006|Open-Label Period|Lack of Efficacy|5|||
164323864|NCT02129777|593563211|FG000|Open-Label Period|Lost to Follow-up|0|||
164323865|NCT02129777|593563212|FG001|Open-Label Period|Lost to Follow-up|0|||
164323866|NCT02129777|593563213|FG002|Open-Label Period|Lost to Follow-up|0|||
164323867|NCT02129777|593563214|FG003|Open-Label Period|Lost to Follow-up|0|||
164323868|NCT02129777|593563215|FG004|Open-Label Period|Lost to Follow-up|0|||
164323869|NCT02129777|593563216|FG005|Open-Label Period|Lost to Follow-up|1|||
164323870|NCT02129777|593563217|FG006|Open-Label Period|Lost to Follow-up|1|||
164323871|NCT02129777|593563211|FG000|Open-Label Period|Withdrawal by Subject|0|||
164323872|NCT02129777|593563212|FG001|Open-Label Period|Withdrawal by Subject|0|||
164323873|NCT02129777|593563213|FG002|Open-Label Period|Withdrawal by Subject|0|||
164323874|NCT02129777|593563214|FG003|Open-Label Period|Withdrawal by Subject|0|||
164323875|NCT02129777|593563215|FG004|Open-Label Period|Withdrawal by Subject|0|||
164323876|NCT02129777|593563216|FG005|Open-Label Period|Withdrawal by Subject|1|||
164323877|NCT02129777|593563217|FG006|Open-Label Period|Withdrawal by Subject|3|||
164323878|NCT02129777|593563211|FG000|Open-Label Period|Study Termination|0|||
164323879|NCT02129777|593563212|FG001|Open-Label Period|Study Termination|0|||
164323880|NCT02129777|593563213|FG002|Open-Label Period|Study Termination|0|||
164323881|NCT02129777|593563214|FG003|Open-Label Period|Study Termination|0|||
164323882|NCT02129777|593563215|FG004|Open-Label Period|Study Termination|0|||
164323883|NCT02129777|593563216|FG005|Open-Label Period|Study Termination|10|||
164323884|NCT02129777|593563217|FG006|Open-Label Period|Study Termination|39|||
164323885|NCT02915874|593563219|FG000|Overall Study|Lost to Follow-up|5|||
164323886|NCT02915874|593563220|FG001|Overall Study|Lost to Follow-up|4|||
164323887|NCT02915874|593563219|FG000|Overall Study|Withdrawal by Subject|1|||
164323888|NCT02915874|593563220|FG001|Overall Study|Withdrawal by Subject|1|||
164323889|NCT02915874|593563219|FG000|Overall Study|Started New Anxiety Medication|0|||
164323890|NCT02915874|593563220|FG001|Overall Study|Started New Anxiety Medication|1|||
164323891|NCT01609478|593563227|FG000|Overall Study|Adverse Event|3|||
164323892|NCT01609478|593563228|FG001|Overall Study|Adverse Event|1|||
164323893|NCT01609478|593563229|FG002|Overall Study|Adverse Event|5|||
164323894|NCT01609478|593563227|FG000|Overall Study|Protocol Deviation|0|||
164323895|NCT01609478|593563228|FG001|Overall Study|Protocol Deviation|1|||
164323896|NCT01609478|593563229|FG002|Overall Study|Protocol Deviation|1|||
164323897|NCT01609478|593563227|FG000|Overall Study|Non-Compliance with study treatment|1|||
164323898|NCT01609478|593563228|FG001|Overall Study|Non-Compliance with study treatment|0|||
164323899|NCT01609478|593563229|FG002|Overall Study|Non-Compliance with study treatment|0|||
164323900|NCT01609478|593563227|FG000|Overall Study|Physician Decision|1|||
164323901|NCT01609478|593563228|FG001|Overall Study|Physician Decision|0|||
164323902|NCT01609478|593563229|FG002|Overall Study|Physician Decision|1|||
164323903|NCT01609478|593563227|FG000|Overall Study|Withdrawal by Subject|2|||
164323904|NCT01609478|593563228|FG001|Overall Study|Withdrawal by Subject|0|||
164323905|NCT01609478|593563229|FG002|Overall Study|Withdrawal by Subject|2|||
164323906|NCT04973137|593563230|FG000|Double Blind Phase|Adverse Event|4|||
164323907|NCT04973137|593563231|FG001|Double Blind Phase|Adverse Event|0|||
164323908|NCT04973137|593563230|FG000|Double Blind Phase|Death|25|||
164323909|NCT04973137|593563231|FG001|Double Blind Phase|Death|15|||
164323910|NCT04973137|593563230|FG000|Double Blind Phase|Physician Decision|5|||
164323911|NCT04973137|593563231|FG001|Double Blind Phase|Physician Decision|1|||
164323912|NCT04973137|593563230|FG000|Double Blind Phase|Withdrawal by Subject|6|||
164323913|NCT04973137|593563231|FG001|Double Blind Phase|Withdrawal by Subject|1|||
164323914|NCT04973137|593563230|FG000|Double Blind Phase|Other|2|||
164323915|NCT04973137|593563231|FG001|Double Blind Phase|Other|2|||
164323916|NCT04973137|593563230|FG000|Open Label Extension Phase|Death|3|||
164323917|NCT04973137|593563231|FG001|Open Label Extension Phase|Death|0|||
164323918|NCT04973137|593563230|FG000|Open Label Extension Phase|Physician Decision|0|||
164323919|NCT04973137|593563231|FG001|Open Label Extension Phase|Physician Decision|1|||
164323920|NCT04973137|593563230|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
164323921|NCT04973137|593563231|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
164323922|NCT04973137|593563230|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
164323923|NCT04973137|593563231|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
164323924|NCT04973137|593563230|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
164323925|NCT04973137|593563231|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
164323926|NCT04391569|593563234|FG000|Overall Study|Death|15|||
164323927|NCT04391569|593563235|FG001|Overall Study|Death|10|||
164323928|NCT04391569|593563234|FG000|Overall Study|Withdrawal by Subject|1|||
164323929|NCT04391569|593563235|FG001|Overall Study|Withdrawal by Subject|0|||
164323930|NCT04391569|593563234|FG000|Overall Study|Lost to Follow-up|3|||
164323931|NCT04391569|593563235|FG001|Overall Study|Lost to Follow-up|2|||
164323932|NCT04391569|593563234|FG000|Overall Study|Lack of Efficacy|0|||
164323933|NCT04391569|593563235|FG001|Overall Study|Lack of Efficacy|1|||
164323934|NCT04391569|593563234|FG000|Overall Study|Participant discharged to hospice facility|0|||
164323935|NCT04391569|593563235|FG001|Overall Study|Participant discharged to hospice facility|1|||
164323936|NCT04391569|593563234|FG000|Overall Study|Participant family decision|1|||
164323937|NCT04391569|593563235|FG001|Overall Study|Participant family decision|0|||
164323938|NCT04391569|593563234|FG000|Overall Study|Participant discharged prematurely|1|||
164323939|NCT04391569|593563235|FG001|Overall Study|Participant discharged prematurely|0|||
164323940|NCT01903252|593563252|FG000|Double-Blind Induction|Adverse Event|20|||
164323941|NCT01903252|593563253|FG001|Double-Blind Induction|Adverse Event|18|||
164323942|NCT01903252|593563254|FG002|Double-Blind Induction|Adverse Event|0|||
164323943|NCT01903252|593563255|FG003|Double-Blind Induction|Adverse Event|0|||
164323944|NCT01903252|593563256|FG004|Double-Blind Induction|Adverse Event|0|||
164323945|NCT01903252|593563257|FG005|Double-Blind Induction|Adverse Event|0|||
164323946|NCT01903252|593563252|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
164323947|NCT01903252|593563253|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
164323948|NCT01903252|593563254|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
164323949|NCT01903252|593563255|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
164323950|NCT01903252|593563256|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
164323951|NCT01903252|593563257|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
164323952|NCT01903252|593563252|FG000|Double-Blind Induction|Physician Decision|2|||
164323953|NCT01903252|593563253|FG001|Double-Blind Induction|Physician Decision|3|||
164323954|NCT01903252|593563254|FG002|Double-Blind Induction|Physician Decision|0|||
164323955|NCT01903252|593563255|FG003|Double-Blind Induction|Physician Decision|0|||
164323956|NCT01903252|593563256|FG004|Double-Blind Induction|Physician Decision|0|||
164323957|NCT01903252|593563257|FG005|Double-Blind Induction|Physician Decision|0|||
164323958|NCT01903252|593563252|FG000|Double-Blind Induction|non-compliance,|7|||
164323959|NCT01903252|593563253|FG001|Double-Blind Induction|non-compliance,|7|||
164323960|NCT01903252|593563254|FG002|Double-Blind Induction|non-compliance,|0|||
164323961|NCT01903252|593563255|FG003|Double-Blind Induction|non-compliance,|0|||
164323962|NCT01903252|593563256|FG004|Double-Blind Induction|non-compliance,|0|||
164323963|NCT01903252|593563257|FG005|Double-Blind Induction|non-compliance,|0|||
164323964|NCT01903252|593563252|FG000|Extended Induction, Open-Label|Adverse Event|0|||
164323965|NCT01903252|593563253|FG001|Extended Induction, Open-Label|Adverse Event|0|||
164323966|NCT01903252|593563254|FG002|Extended Induction, Open-Label|Adverse Event|17|||
164323967|NCT01903252|593563255|FG003|Extended Induction, Open-Label|Adverse Event|0|||
164323968|NCT01903252|593563256|FG004|Extended Induction, Open-Label|Adverse Event|0|||
164323969|NCT01903252|593563257|FG005|Extended Induction, Open-Label|Adverse Event|0|||
164323970|NCT01903252|593563252|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323971|NCT01903252|593563253|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323972|NCT01903252|593563254|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
164323973|NCT01903252|593563255|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323974|NCT01903252|593563256|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323975|NCT01903252|593563257|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
164323976|NCT01903252|593563252|FG000|Extended Induction, Open-Label|Physician Decision|0|||
164323977|NCT01903252|593563253|FG001|Extended Induction, Open-Label|Physician Decision|0|||
164323978|NCT01903252|593563254|FG002|Extended Induction, Open-Label|Physician Decision|1|||
164323979|NCT01903252|593563255|FG003|Extended Induction, Open-Label|Physician Decision|0|||
164323980|NCT01903252|593563256|FG004|Extended Induction, Open-Label|Physician Decision|0|||
164323981|NCT01903252|593563257|FG005|Extended Induction, Open-Label|Physician Decision|0|||
164323982|NCT01903252|593563252|FG000|Maintenance, Open-Label|Adverse Event|0|||
164323983|NCT01903252|593563253|FG001|Maintenance, Open-Label|Adverse Event|0|||
164323984|NCT01903252|593563254|FG002|Maintenance, Open-Label|Adverse Event|0|||
164323985|NCT01903252|593563255|FG003|Maintenance, Open-Label|Adverse Event|3|||
164323986|NCT01903252|593563256|FG004|Maintenance, Open-Label|Adverse Event|9|||
164323987|NCT01903252|593563257|FG005|Maintenance, Open-Label|Adverse Event|14|||
164323988|NCT01903252|593563252|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
164323989|NCT01903252|593563253|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
164323990|NCT01903252|593563254|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
164323991|NCT01903252|593563255|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
164323992|NCT01903252|593563256|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
164323993|NCT01903252|593563257|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
164323994|NCT01903252|593563252|FG000|Maintenance, Open-Label|Other|0|||
164323995|NCT01903252|593563253|FG001|Maintenance, Open-Label|Other|0|||
164323996|NCT01903252|593563254|FG002|Maintenance, Open-Label|Other|0|||
164323997|NCT01903252|593563255|FG003|Maintenance, Open-Label|Other|2|||
164323998|NCT01903252|593563256|FG004|Maintenance, Open-Label|Other|6|||
163875319|NCT04019444|591911635|FG003|Overall Study|Solicited Event|0|||
163875320|NCT04578106|591911636|FG000|Follow-up after 1 year|Lost to Follow-up|1|||
163875321|NCT04690556|591911642|FG000|Overall Study|Adverse Event|6|||
163875322|NCT04690556|591911643|FG001|Overall Study|Adverse Event|4|||
163875323|NCT04690556|591911642|FG000|Overall Study|Death|3|||
163875324|NCT04690556|591911643|FG001|Overall Study|Death|4|||
164208717|NCT03329001|593133450|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
164208718|NCT03329001|593133451|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
164208719|NCT03329001|593133452|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208720|NCT03329001|593133453|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208721|NCT03329001|593133454|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208722|NCT03329001|593133455|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
164208723|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208724|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208725|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208726|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
164208727|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208728|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208729|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208730|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
164208731|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208732|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208733|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208734|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
164208735|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208736|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208737|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208738|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
164208739|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208740|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208741|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208742|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
164208743|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208744|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208745|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208746|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
164208747|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208748|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208749|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
164208750|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208751|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208752|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208753|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208754|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
164208755|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208756|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208757|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
164208758|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208759|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208760|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208761|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208762|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
164208763|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208764|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208765|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
164208766|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208767|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208768|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208769|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164299682|NCT00551642|593472892|FG001|Treatment Period|Withdrawal by Subject|1|||
164323999|NCT01903252|593563257|FG005|Maintenance, Open-Label|Other|2|||
164324000|NCT00645788|593563267|FG000|Overall Study|Did not receive study drug|1|||
164324001|NCT00645788|593563268|FG001|Overall Study|Did not receive study drug|1|||
164324002|NCT00645788|593563269|FG002|Overall Study|Did not receive study drug|0|||
164324003|NCT00645788|593563270|FG003|Overall Study|Did not receive study drug|0|||
164324004|NCT00645788|593563267|FG000|Overall Study|Adverse Event|4|||
164324005|NCT00645788|593563268|FG001|Overall Study|Adverse Event|9|||
164324006|NCT00645788|593563269|FG002|Overall Study|Adverse Event|5|||
164324007|NCT00645788|593563270|FG003|Overall Study|Adverse Event|3|||
164324008|NCT00645788|593563267|FG000|Overall Study|Lost to Follow-up|1|||
164324009|NCT00645788|593563268|FG001|Overall Study|Lost to Follow-up|0|||
164324010|NCT00645788|593563269|FG002|Overall Study|Lost to Follow-up|0|||
164324011|NCT00645788|593563270|FG003|Overall Study|Lost to Follow-up|0|||
164324012|NCT00645788|593563267|FG000|Overall Study|Protocol Violation|1|||
164324013|NCT00645788|593563268|FG001|Overall Study|Protocol Violation|0|||
164324014|NCT00645788|593563269|FG002|Overall Study|Protocol Violation|2|||
164324015|NCT00645788|593563270|FG003|Overall Study|Protocol Violation|0|||
164324016|NCT00645788|593563267|FG000|Overall Study|Withdrawal by Subject|0|||
164324017|NCT00645788|593563268|FG001|Overall Study|Withdrawal by Subject|1|||
164324018|NCT00645788|593563269|FG002|Overall Study|Withdrawal by Subject|0|||
164324019|NCT00645788|593563270|FG003|Overall Study|Withdrawal by Subject|2|||
164324020|NCT00645788|593563267|FG000|Overall Study|Pulmonary exacerbation|13|||
164324021|NCT00645788|593563268|FG001|Overall Study|Pulmonary exacerbation|16|||
164324022|NCT00645788|593563269|FG002|Overall Study|Pulmonary exacerbation|11|||
164324023|NCT00645788|593563270|FG003|Overall Study|Pulmonary exacerbation|9|||
164324024|NCT01924429|593563271|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
164324025|NCT01924429|593563272|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
164324026|NCT00327470|593563275|FG000|Overall Study|Randomized, but not treated|0|||
164324027|NCT00327470|593563276|FG001|Overall Study|Randomized, but not treated|2|||
164324028|NCT00327470|593563275|FG000|Overall Study|Adverse Event|9|||
164324029|NCT00327470|593563276|FG001|Overall Study|Adverse Event|14|||
164324030|NCT00327470|593563275|FG000|Overall Study|Lack of Efficacy|7|||
164324031|NCT00327470|593563276|FG001|Overall Study|Lack of Efficacy|19|||
164324032|NCT00327470|593563275|FG000|Overall Study|Other|5|||
164324033|NCT00327470|593563276|FG001|Overall Study|Other|9|||
164324034|NCT00327470|593563275|FG000|Overall Study|Lost to Follow-up|1|||
164324035|NCT00327470|593563276|FG001|Overall Study|Lost to Follow-up|3|||
164324036|NCT00327470|593563275|FG000|Overall Study|Withdrawal by Subject|6|||
164324037|NCT00327470|593563276|FG001|Overall Study|Withdrawal by Subject|12|||
164324038|NCT00327470|593563275|FG000|Overall Study|Death|1|||
164324039|NCT00327470|593563276|FG001|Overall Study|Death|4|||
164324040|NCT01445886|593563286|FG000|Overall Study|Lost to Follow-up|2|||
164324041|NCT01445886|593563286|FG000|Overall Study|Protocol Violation|3|||
164324042|NCT01163032|593563287|FG000|Randomization Phase|Withdrawal by Subject|2|||
164324043|NCT01163032|593563288|FG001|Randomization Phase|Withdrawal by Subject|3|||
164324044|NCT01163032|593563289|FG002|Randomization Phase|Withdrawal by Subject|0|||
164324045|NCT01163032|593563287|FG000|Randomization Phase|Adverse Event|3|||
164324046|NCT01163032|593563288|FG001|Randomization Phase|Adverse Event|3|||
164324047|NCT01163032|593563289|FG002|Randomization Phase|Adverse Event|0|||
164324048|NCT01163032|593563287|FG000|Randomization Phase|Protocol Violation|0|||
164324049|NCT01163032|593563288|FG001|Randomization Phase|Protocol Violation|1|||
164324050|NCT01163032|593563289|FG002|Randomization Phase|Protocol Violation|0|||
164324051|NCT01163032|593563287|FG000|Randomization Phase|Various*|5|||
164324052|NCT01163032|593563288|FG001|Randomization Phase|Various*|4|||
164324053|NCT01163032|593563289|FG002|Randomization Phase|Various*|0|||
164324054|NCT01163032|593563287|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
164324055|NCT01163032|593563288|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
164324056|NCT01163032|593563289|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
164324057|NCT01163032|593563287|FG000|Open Label Extension Phase|Adverse Event|0|||
164324058|NCT01163032|593563288|FG001|Open Label Extension Phase|Adverse Event|0|||
164324059|NCT01163032|593563289|FG002|Open Label Extension Phase|Adverse Event|3|||
164324060|NCT01163032|593563287|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
164324061|NCT01163032|593563288|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
164324062|NCT01163032|593563289|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
164324063|NCT01163032|593563287|FG000|Open Label Extension Phase|Protocol Violation|0|||
164324064|NCT01163032|593563288|FG001|Open Label Extension Phase|Protocol Violation|0|||
164324065|NCT01163032|593563289|FG002|Open Label Extension Phase|Protocol Violation|1|||
164324066|NCT01163032|593563287|FG000|Open Label Extension Phase|Study Termination|0|||
164324067|NCT01163032|593563288|FG001|Open Label Extension Phase|Study Termination|0|||
164324068|NCT01163032|593563289|FG002|Open Label Extension Phase|Study Termination|7|||
164324069|NCT01163032|593563287|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
164324070|NCT01163032|593563288|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
164324071|NCT01163032|593563289|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
164324072|NCT03764033|593563299|FG000|Treatment Phase|Withdrawal by Subject|8|||
164324073|NCT03764033|593563300|FG001|Treatment Phase|Withdrawal by Subject|3|||
164355614|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
163979838|NCT02599961|592297282|FG000|Overall Study|Withdrawal by Subject|1|||
163979839|NCT02599961|592297282|FG000|Overall Study|Subject Non-Compliance|2|||
163979840|NCT02599961|592297282|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
163979841|NCT02599961|592297282|FG000|Overall Study|Other, Not Specified|3|||
163979842|NCT01857869|592297283|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
163979843|NCT01857869|592297284|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
163979844|NCT01857869|592297285|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
163979845|NCT01857869|592297286|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
164324074|NCT03764033|593563299|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
164324075|NCT03764033|593563300|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
164324076|NCT03764033|593563299|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
164324077|NCT03764033|593563300|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
164324078|NCT04594369|593563301|FG000|Overall Study|Adverse Event|10|||
164324079|NCT04594369|593563302|FG001|Overall Study|Adverse Event|10|||
163875325|NCT04690556|591911642|FG000|Overall Study|Lost to Follow-up|3|||
163875326|NCT04690556|591911643|FG001|Overall Study|Lost to Follow-up|2|||
163875327|NCT04690556|591911642|FG000|Overall Study|Protocol Violation|1|||
163875328|NCT04690556|591911643|FG001|Overall Study|Protocol Violation|4|||
163875329|NCT04690556|591911642|FG000|Overall Study|Physician Decision|2|||
163875330|NCT04690556|591911643|FG001|Overall Study|Physician Decision|0|||
163875331|NCT04690556|591911642|FG000|Overall Study|Withdrawal by Subject|25|||
163875332|NCT04690556|591911643|FG001|Overall Study|Withdrawal by Subject|17|||
163875333|NCT04690556|591911642|FG000|Overall Study|Prohibited medications and other reasons|3|||
163875334|NCT04690556|591911643|FG001|Overall Study|Prohibited medications and other reasons|1|||
163875335|NCT00497198|591911644|FG000|Overall Study|Adverse Event|4|||
163875336|NCT00497198|591911645|FG001|Overall Study|Adverse Event|2|||
163875337|NCT00497198|591911644|FG000|Overall Study|Physician Decision|1|||
163875338|NCT00497198|591911645|FG001|Overall Study|Physician Decision|2|||
163875339|NCT00497198|591911644|FG000|Overall Study|Withdrawal by Subject|0|||
163875340|NCT00497198|591911645|FG001|Overall Study|Withdrawal by Subject|1|||
163875341|NCT03891758|591911648|FG000|Overall Study|Adverse Event|2|||
163875342|NCT03891758|591911649|FG001|Overall Study|Adverse Event|0|||
163875343|NCT03891758|591911648|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163875344|NCT03891758|591911649|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163875345|NCT04434729|591911652|FG000|Overall Study|Adverse Event|1|||
163875346|NCT04434729|591911652|FG000|Overall Study|Physician Decision|1|||
163875347|NCT00975819|591911653|FG000|Overall Study|Lack of Efficacy|8|||
163875348|NCT00975819|591911653|FG000|Overall Study|Adverse Event|2|||
163875349|NCT00975819|591911653|FG000|Overall Study|Physician Decision|2|||
163875350|NCT00975819|591911653|FG000|Overall Study|Withdrawal by Subject|2|||
163875351|NCT00975819|591911653|FG000|Overall Study|Protocol Violation|1|||
163875352|NCT01968109|591911654|FG000|Overall Study|DISEASE PROGRESSION|4|||
163875353|NCT01968109|591911655|FG001|Overall Study|DISEASE PROGRESSION|4|||
163875354|NCT01968109|591911656|FG002|Overall Study|DISEASE PROGRESSION|3|||
163875355|NCT01968109|591911657|FG003|Overall Study|DISEASE PROGRESSION|9|||
163875356|NCT01968109|591911658|FG004|Overall Study|DISEASE PROGRESSION|5|||
163875357|NCT01968109|591911659|FG005|Overall Study|DISEASE PROGRESSION|6|||
163875358|NCT01968109|591911660|FG006|Overall Study|DISEASE PROGRESSION|6|||
163875359|NCT01968109|591911661|FG007|Overall Study|DISEASE PROGRESSION|6|||
163875360|NCT01968109|591911662|FG008|Overall Study|DISEASE PROGRESSION|4|||
163875361|NCT01968109|591911663|FG009|Overall Study|DISEASE PROGRESSION|5|||
163875362|NCT01968109|591911664|FG010|Overall Study|DISEASE PROGRESSION|8|||
163875363|NCT01968109|591911665|FG011|Overall Study|DISEASE PROGRESSION|4|||
163875364|NCT01968109|591911666|FG012|Overall Study|DISEASE PROGRESSION|7|||
163875365|NCT01968109|591911667|FG013|Overall Study|DISEASE PROGRESSION|14|||
163875366|NCT01968109|591911668|FG014|Overall Study|DISEASE PROGRESSION|14|||
163875367|NCT01968109|591911669|FG015|Overall Study|DISEASE PROGRESSION|13|||
163875368|NCT01968109|591911670|FG016|Overall Study|DISEASE PROGRESSION|34|||
163875369|NCT01968109|591911671|FG017|Overall Study|DISEASE PROGRESSION|20|||
163875370|NCT01968109|591911672|FG018|Overall Study|DISEASE PROGRESSION|54|||
163875371|NCT01968109|591911673|FG019|Overall Study|DISEASE PROGRESSION|46|||
163875372|NCT01968109|591911674|FG020|Overall Study|DISEASE PROGRESSION|77|||
163875373|NCT01968109|591911675|FG021|Overall Study|DISEASE PROGRESSION|25|||
163875374|NCT01968109|591911676|FG022|Overall Study|DISEASE PROGRESSION|47|||
163875375|NCT01968109|591911677|FG023|Overall Study|DISEASE PROGRESSION|125|||
163875376|NCT01968109|591911678|FG024|Overall Study|DISEASE PROGRESSION|155|||
163875377|NCT01968109|591911679|FG025|Overall Study|DISEASE PROGRESSION|63|||
163875378|NCT01968109|591911680|FG026|Overall Study|DISEASE PROGRESSION|65|||
163875379|NCT01968109|591911681|FG027|Overall Study|DISEASE PROGRESSION|137|||
163875380|NCT01968109|591911682|FG028|Overall Study|DISEASE PROGRESSION|35|||
163875381|NCT01968109|591911683|FG029|Overall Study|DISEASE PROGRESSION|23|||
163875382|NCT01968109|591911684|FG030|Overall Study|DISEASE PROGRESSION|71|||
163875383|NCT01968109|591911654|FG000|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875384|NCT01968109|591911655|FG001|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875385|NCT01968109|591911656|FG002|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875386|NCT01968109|591911657|FG003|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163979846|NCT01857869|592297287|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
163979847|NCT01857869|592297288|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
163979848|NCT01857869|592297289|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
163979849|NCT01857869|592297290|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
163979850|NCT01857869|592297291|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
163979851|NCT01857869|592297292|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
163979852|NCT01857869|592297283|FG000|Primary/Challenge Phase|Pregnancy|1|||
163979853|NCT01857869|592297284|FG001|Primary/Challenge Phase|Pregnancy|0|||
163979854|NCT01857869|592297285|FG002|Primary/Challenge Phase|Pregnancy|0|||
164324080|NCT04594369|593563303|FG002|Overall Study|Adverse Event|9|||
164324081|NCT04594369|593563301|FG000|Overall Study|Death|2|||
163979855|NCT01857869|592297286|FG003|Primary/Challenge Phase|Pregnancy|0|||
163979856|NCT01857869|592297287|FG004|Primary/Challenge Phase|Pregnancy|0|||
163979857|NCT01857869|592297288|FG005|Primary/Challenge Phase|Pregnancy|0|||
163979858|NCT01857869|592297289|FG006|Primary/Challenge Phase|Pregnancy|0|||
163979859|NCT01857869|592297290|FG007|Primary/Challenge Phase|Pregnancy|0|||
163979860|NCT01857869|592297291|FG008|Primary/Challenge Phase|Pregnancy|0|||
163979861|NCT01857869|592297292|FG009|Primary/Challenge Phase|Pregnancy|0|||
163979862|NCT01857869|592297283|FG000|Primary/Challenge Phase|Protocol Violation|1|||
163979863|NCT01857869|592297284|FG001|Primary/Challenge Phase|Protocol Violation|0|||
163979864|NCT01857869|592297285|FG002|Primary/Challenge Phase|Protocol Violation|0|||
163979865|NCT01857869|592297286|FG003|Primary/Challenge Phase|Protocol Violation|0|||
163979866|NCT01857869|592297287|FG004|Primary/Challenge Phase|Protocol Violation|0|||
163979867|NCT01857869|592297288|FG005|Primary/Challenge Phase|Protocol Violation|0|||
163979868|NCT01857869|592297289|FG006|Primary/Challenge Phase|Protocol Violation|0|||
163979869|NCT01857869|592297290|FG007|Primary/Challenge Phase|Protocol Violation|0|||
163979870|NCT01857869|592297291|FG008|Primary/Challenge Phase|Protocol Violation|0|||
164324082|NCT04594369|593563302|FG001|Overall Study|Death|4|||
164324083|NCT04594369|593563303|FG002|Overall Study|Death|8|||
164324084|NCT04594369|593563301|FG000|Overall Study|Lost to Follow-up|10|||
164324085|NCT04594369|593563302|FG001|Overall Study|Lost to Follow-up|2|||
164324086|NCT04594369|593563303|FG002|Overall Study|Lost to Follow-up|4|||
164324087|NCT04594369|593563301|FG000|Overall Study|Physician Decision|2|||
164324088|NCT04594369|593563302|FG001|Overall Study|Physician Decision|2|||
164324089|NCT04594369|593563303|FG002|Overall Study|Physician Decision|3|||
164324090|NCT04594369|593563301|FG000|Overall Study|Protocol deviation|1|||
163875387|NCT01968109|591911658|FG004|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163979871|NCT01857869|592297292|FG009|Primary/Challenge Phase|Protocol Violation|0|||
164324091|NCT04594369|593563302|FG001|Overall Study|Protocol deviation|3|||
164324092|NCT04594369|593563303|FG002|Overall Study|Protocol deviation|2|||
163875388|NCT01968109|591911659|FG005|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875389|NCT01968109|591911660|FG006|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875390|NCT01968109|591911661|FG007|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875391|NCT01968109|591911662|FG008|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875392|NCT01968109|591911663|FG009|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875393|NCT01968109|591911664|FG010|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875394|NCT01968109|591911665|FG011|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875395|NCT01968109|591911666|FG012|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875396|NCT01968109|591911667|FG013|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875397|NCT01968109|591911668|FG014|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875398|NCT01968109|591911669|FG015|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875399|NCT01968109|591911670|FG016|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875400|NCT01968109|591911671|FG017|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875401|NCT01968109|591911672|FG018|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|1|||
163875402|NCT01968109|591911673|FG019|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875403|NCT01968109|591911674|FG020|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163875404|NCT01968109|591911675|FG021|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
163875405|NCT01968109|591911676|FG022|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163875406|NCT01968109|591911677|FG023|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|4|||
163875407|NCT01968109|591911678|FG024|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|7|||
163875408|NCT01968109|591911679|FG025|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163875409|NCT01968109|591911680|FG026|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
163875410|NCT01968109|591911681|FG027|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164324093|NCT04594369|593563301|FG000|Overall Study|Withdrawal by Subject|40|||
164324094|NCT04594369|593563302|FG001|Overall Study|Withdrawal by Subject|32|||
164324095|NCT04594369|593563303|FG002|Overall Study|Withdrawal by Subject|37|||
163979872|NCT01857869|592297283|FG000|Primary/Challenge Phase|Other|1|||
163979873|NCT01857869|592297284|FG001|Primary/Challenge Phase|Other|1|||
163979874|NCT01857869|592297285|FG002|Primary/Challenge Phase|Other|0|||
164324096|NCT04594369|593563301|FG000|Overall Study|Reason not specified|60|||
164324097|NCT04594369|593563302|FG001|Overall Study|Reason not specified|56|||
163875411|NCT01968109|591911682|FG028|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|8|||
163875412|NCT01968109|591911683|FG029|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|12|||
163875413|NCT01968109|591911684|FG030|Overall Study|SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
163875414|NCT01968109|591911654|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
163875415|NCT01968109|591911655|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
163875416|NCT01968109|591911656|FG002|Overall Study|STUDY DRUG TOXICITY|1|||
163875417|NCT01968109|591911657|FG003|Overall Study|STUDY DRUG TOXICITY|2|||
163875418|NCT01968109|591911658|FG004|Overall Study|STUDY DRUG TOXICITY|1|||
163875419|NCT01968109|591911659|FG005|Overall Study|STUDY DRUG TOXICITY|1|||
163875420|NCT01968109|591911660|FG006|Overall Study|STUDY DRUG TOXICITY|1|||
163875421|NCT01968109|591911661|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
163875422|NCT01968109|591911662|FG008|Overall Study|STUDY DRUG TOXICITY|2|||
163875423|NCT01968109|591911663|FG009|Overall Study|STUDY DRUG TOXICITY|1|||
163875424|NCT01968109|591911664|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
163875425|NCT01968109|591911665|FG011|Overall Study|STUDY DRUG TOXICITY|2|||
163875426|NCT01968109|591911666|FG012|Overall Study|STUDY DRUG TOXICITY|0|||
163875427|NCT01968109|591911667|FG013|Overall Study|STUDY DRUG TOXICITY|2|||
163875428|NCT01968109|591911668|FG014|Overall Study|STUDY DRUG TOXICITY|2|||
163875429|NCT01968109|591911669|FG015|Overall Study|STUDY DRUG TOXICITY|4|||
163875430|NCT01968109|591911670|FG016|Overall Study|STUDY DRUG TOXICITY|11|||
163875431|NCT01968109|591911671|FG017|Overall Study|STUDY DRUG TOXICITY|3|||
163875432|NCT01968109|591911672|FG018|Overall Study|STUDY DRUG TOXICITY|4|||
163875433|NCT01968109|591911673|FG019|Overall Study|STUDY DRUG TOXICITY|9|||
163875434|NCT01968109|591911674|FG020|Overall Study|STUDY DRUG TOXICITY|6|||
163875435|NCT01968109|591911675|FG021|Overall Study|STUDY DRUG TOXICITY|4|||
163875436|NCT01968109|591911676|FG022|Overall Study|STUDY DRUG TOXICITY|3|||
163875437|NCT01968109|591911677|FG023|Overall Study|STUDY DRUG TOXICITY|8|||
163875438|NCT01968109|591911678|FG024|Overall Study|STUDY DRUG TOXICITY|9|||
163875439|NCT01968109|591911679|FG025|Overall Study|STUDY DRUG TOXICITY|8|||
163875440|NCT01968109|591911680|FG026|Overall Study|STUDY DRUG TOXICITY|3|||
163875441|NCT01968109|591911681|FG027|Overall Study|STUDY DRUG TOXICITY|9|||
163875442|NCT01968109|591911682|FG028|Overall Study|STUDY DRUG TOXICITY|14|||
163875443|NCT01968109|591911683|FG029|Overall Study|STUDY DRUG TOXICITY|21|||
163875444|NCT01968109|591911684|FG030|Overall Study|STUDY DRUG TOXICITY|9|||
163875445|NCT01968109|591911654|FG000|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875446|NCT01968109|591911655|FG001|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875447|NCT01968109|591911656|FG002|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875448|NCT01968109|591911657|FG003|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875449|NCT01968109|591911658|FG004|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875450|NCT01968109|591911659|FG005|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875451|NCT01968109|591911660|FG006|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875452|NCT01968109|591911661|FG007|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875453|NCT01968109|591911662|FG008|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875454|NCT01968109|591911663|FG009|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875455|NCT01968109|591911664|FG010|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875456|NCT01968109|591911665|FG011|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875457|NCT01968109|591911666|FG012|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875458|NCT01968109|591911667|FG013|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875459|NCT01968109|591911668|FG014|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875460|NCT01968109|591911669|FG015|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875461|NCT01968109|591911670|FG016|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875462|NCT01968109|591911671|FG017|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875463|NCT01968109|591911672|FG018|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875464|NCT01968109|591911673|FG019|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875465|NCT01968109|591911674|FG020|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875466|NCT01968109|591911675|FG021|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875467|NCT01968109|591911676|FG022|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875468|NCT01968109|591911677|FG023|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163875469|NCT01968109|591911678|FG024|Overall Study|SUBJECT WITHDREW CONSENT|3|||
163875470|NCT01968109|591911679|FG025|Overall Study|SUBJECT WITHDREW CONSENT|2|||
163875471|NCT01968109|591911680|FG026|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875472|NCT01968109|591911681|FG027|Overall Study|SUBJECT WITHDREW CONSENT|4|||
163875473|NCT01968109|591911682|FG028|Overall Study|SUBJECT WITHDREW CONSENT|0|||
163979875|NCT01857869|592297286|FG003|Primary/Challenge Phase|Other|0|||
163979876|NCT01857869|592297287|FG004|Primary/Challenge Phase|Other|0|||
163875474|NCT01968109|591911683|FG029|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875475|NCT01968109|591911684|FG030|Overall Study|SUBJECT WITHDREW CONSENT|1|||
163875476|NCT01968109|591911654|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875477|NCT01968109|591911655|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875478|NCT01968109|591911656|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875479|NCT01968109|591911657|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875480|NCT01968109|591911658|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875481|NCT01968109|591911659|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875482|NCT01968109|591911660|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875483|NCT01968109|591911661|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163979877|NCT01857869|592297288|FG005|Primary/Challenge Phase|Other|0|||
164208770|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
164208771|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208772|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208773|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
164208774|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208775|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208776|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208777|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208778|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
164208779|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208780|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208781|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
164208782|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
164299683|NCT03337308|593472893|FG000|Overall Study|Adverse Event|2|||
164299684|NCT03337308|593472894|FG001|Overall Study|Adverse Event|3|||
164324098|NCT04594369|593563303|FG002|Overall Study|Reason not specified|43|||
164324099|NCT01006603|593563304|FG000|Overall Study|Withdrawal by Subject|17|||
164324100|NCT01006603|593563305|FG001|Overall Study|Withdrawal by Subject|19|||
164324101|NCT01006603|593563304|FG000|Overall Study|Lost to Follow-up|0|||
164324102|NCT01006603|593563305|FG001|Overall Study|Lost to Follow-up|1|||
164324103|NCT01006603|593563304|FG000|Overall Study|Safety reason|1|||
164324104|NCT01006603|593563305|FG001|Overall Study|Safety reason|1|||
164324105|NCT01006603|593563304|FG000|Overall Study|Protocol Violation|1|||
164324106|NCT01006603|593563305|FG001|Overall Study|Protocol Violation|3|||
164324107|NCT01006603|593563304|FG000|Overall Study|Incorrect enrolment|0|||
164324108|NCT01006603|593563305|FG001|Overall Study|Incorrect enrolment|2|||
164324109|NCT01006603|593563304|FG000|Overall Study|Adverse Event|15|||
164324110|NCT01006603|593563305|FG001|Overall Study|Adverse Event|7|||
164324111|NCT01006603|593563304|FG000|Overall Study|Death|1|||
164324112|NCT01006603|593563305|FG001|Overall Study|Death|1|||
164324113|NCT01006603|593563304|FG000|Overall Study|Study specific discontinuation criteria|33|||
164324114|NCT01006603|593563305|FG001|Overall Study|Study specific discontinuation criteria|34|||
164324115|NCT01006603|593563304|FG000|Overall Study|Other|3|||
164324116|NCT01006603|593563305|FG001|Overall Study|Other|7|||
164324117|NCT03875235|593563307|FG000|Overall Study|Ongoing study treatment|63|||
164324118|NCT03875235|593563308|FG001|Overall Study|Ongoing study treatment|20|||
164324119|NCT03875235|593563307|FG000|Overall Study|Off treatment|77|||
164324120|NCT03875235|593563308|FG001|Overall Study|Off treatment|91|||
164324121|NCT03875235|593563307|FG000|Overall Study|Withdrawal by Subject|3|||
164324122|NCT03875235|593563308|FG001|Overall Study|Withdrawal by Subject|10|||
164324123|NCT03875235|593563307|FG000|Overall Study|Death|198|||
164324124|NCT03875235|593563308|FG001|Overall Study|Death|223|||
164324125|NCT02003365|593565115|FG000|Overall Study|Lost to Follow-up|0|||
164324126|NCT02003365|593565116|FG001|Overall Study|Lost to Follow-up|0|||
164324127|NCT02003365|593565117|FG002|Overall Study|Lost to Follow-up|1|||
164324128|NCT02582255|593565122|FG000|Overall Study|Protocol Violation|0|||
164324129|NCT02582255|593565123|FG001|Overall Study|Protocol Violation|3|||
164324130|NCT01709578|593565124|FG000|Overall Study|Rescued and entered in long term safety|63|||
164324131|NCT01709578|593565125|FG001|Overall Study|Rescued and entered in long term safety|25|||
164324132|NCT01709578|593565126|FG002|Overall Study|Rescued and entered in long term safety|26|||
164324133|NCT01709578|593565124|FG000|Overall Study|Adverse Event|9|||
164324134|NCT01709578|593565125|FG001|Overall Study|Adverse Event|18|||
164324135|NCT01709578|593565126|FG002|Overall Study|Adverse Event|17|||
164324136|NCT01709578|593565124|FG000|Overall Study|Lack of Efficacy|5|||
163875484|NCT01968109|591911662|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163875485|NCT01968109|591911663|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163875486|NCT01968109|591911664|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875487|NCT01968109|591911665|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163875488|NCT01968109|591911666|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
164076859|NCT00725725|592645849|FG002|Overall Study|Protocol Violation|0|||
164299685|NCT03337308|593472895|FG002|Overall Study|Adverse Event|3|||
164299686|NCT03337308|593472896|FG003|Overall Study|Adverse Event|1|||
164299687|NCT03337308|593472893|FG000|Overall Study|Lost to Follow-up|1|||
164299688|NCT03337308|593472894|FG001|Overall Study|Lost to Follow-up|2|||
164299689|NCT03337308|593472895|FG002|Overall Study|Lost to Follow-up|0|||
164299690|NCT03337308|593472896|FG003|Overall Study|Lost to Follow-up|0|||
164299691|NCT03337308|593472893|FG000|Overall Study|Withdrawal by Subject|2|||
164299692|NCT03337308|593472894|FG001|Overall Study|Withdrawal by Subject|1|||
164299693|NCT03337308|593472895|FG002|Overall Study|Withdrawal by Subject|2|||
164299694|NCT03337308|593472896|FG003|Overall Study|Withdrawal by Subject|1|||
164299695|NCT03337308|593472893|FG000|Overall Study|Protocol Violation|0|||
164299696|NCT03337308|593472894|FG001|Overall Study|Protocol Violation|1|||
164208783|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208784|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208785|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
163979878|NCT01857869|592297289|FG006|Primary/Challenge Phase|Other|0|||
164208786|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
164208787|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208788|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208789|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
164208790|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208791|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208792|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208793|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208794|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
164208795|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208796|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208797|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
164208798|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
164208799|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208800|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208801|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208802|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
164208803|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208804|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208805|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
164208806|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
164208807|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208808|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208809|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208810|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
164208811|NCT03329001|593133448|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208812|NCT03329001|593133449|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208813|NCT03329001|593133450|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
164208814|NCT03329001|593133451|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
164208815|NCT03329001|593133452|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208816|NCT03329001|593133453|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208817|NCT03329001|593133454|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208818|NCT03329001|593133455|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
164208819|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208820|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208821|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208822|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
164208823|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208824|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208825|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208826|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
164208827|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208828|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208829|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208830|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
164208831|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208832|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208833|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208834|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
164208835|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208836|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208837|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
164299697|NCT03337308|593472895|FG002|Overall Study|Protocol Violation|0|||
163979879|NCT01857869|592297290|FG007|Primary/Challenge Phase|Other|0|||
163979880|NCT01857869|592297291|FG008|Primary/Challenge Phase|Other|0|||
163979881|NCT01857869|592297292|FG009|Primary/Challenge Phase|Other|0|||
163979882|NCT01857869|592297283|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979883|NCT01857869|592297284|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979884|NCT01857869|592297285|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
164076860|NCT04288115|592645851|FG000|Overall Study|Withdrawal by Subject|0|||
164324137|NCT01709578|593565125|FG001|Overall Study|Lack of Efficacy|4|||
164324138|NCT01709578|593565126|FG002|Overall Study|Lack of Efficacy|2|||
164324139|NCT01709578|593565124|FG000|Overall Study|Poor compliance to protocol|1|||
164324140|NCT01709578|593565125|FG001|Overall Study|Poor compliance to protocol|2|||
164324141|NCT01709578|593565126|FG002|Overall Study|Poor compliance to protocol|1|||
164324142|NCT01709578|593565124|FG000|Overall Study|Other, not related to safety or efficacy|2|||
164324143|NCT01709578|593565125|FG001|Overall Study|Other, not related to safety or efficacy|7|||
164324144|NCT01709578|593565126|FG002|Overall Study|Other, not related to safety or efficacy|5|||
164324145|NCT04050371|593565127|FG000|Overall Study|Withdrawal by Subject|1|||
164324146|NCT04050371|593565128|FG001|Overall Study|Withdrawal by Subject|0|||
163875489|NCT01968109|591911667|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163875490|NCT01968109|591911668|FG014|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875491|NCT01968109|591911669|FG015|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163875492|NCT01968109|591911670|FG016|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163875493|NCT01968109|591911671|FG017|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163875494|NCT01968109|591911672|FG018|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163875495|NCT01968109|591911673|FG019|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163875496|NCT01968109|591911674|FG020|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163875497|NCT01968109|591911675|FG021|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163875498|NCT01968109|591911676|FG022|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163875499|NCT01968109|591911677|FG023|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163875500|NCT01968109|591911678|FG024|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|5|||
163875501|NCT01968109|591911679|FG025|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|6|||
163875502|NCT01968109|591911680|FG026|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163875503|NCT01968109|591911681|FG027|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|2|||
163875504|NCT01968109|591911682|FG028|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163875505|NCT01968109|591911683|FG029|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|4|||
163875506|NCT01968109|591911684|FG030|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|3|||
163875507|NCT01968109|591911654|FG000|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875508|NCT01968109|591911655|FG001|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875509|NCT01968109|591911656|FG002|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875510|NCT01968109|591911657|FG003|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875511|NCT01968109|591911658|FG004|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875512|NCT01968109|591911659|FG005|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875513|NCT01968109|591911660|FG006|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875514|NCT01968109|591911661|FG007|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875515|NCT01968109|591911662|FG008|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875516|NCT01968109|591911663|FG009|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875517|NCT01968109|591911664|FG010|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875518|NCT01968109|591911665|FG011|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875519|NCT01968109|591911666|FG012|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875520|NCT01968109|591911667|FG013|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875521|NCT01968109|591911668|FG014|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875522|NCT01968109|591911669|FG015|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
163875523|NCT01968109|591911670|FG016|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
163875524|NCT01968109|591911671|FG017|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875525|NCT01968109|591911672|FG018|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875526|NCT01968109|591911673|FG019|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875527|NCT01968109|591911674|FG020|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|3|||
163875528|NCT01968109|591911675|FG021|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875529|NCT01968109|591911676|FG022|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875530|NCT01968109|591911677|FG023|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|10|||
163875531|NCT01968109|591911678|FG024|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|5|||
163875532|NCT01968109|591911679|FG025|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875533|NCT01968109|591911680|FG026|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875534|NCT01968109|591911681|FG027|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|2|||
163875535|NCT01968109|591911682|FG028|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875536|NCT01968109|591911683|FG029|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|0|||
163875537|NCT01968109|591911684|FG030|Overall Study|COMPLETED TREATMENT AS PER PROTOCOL|1|||
163875538|NCT01968109|591911654|FG000|Overall Study|OTHER REASONS|0|||
163875539|NCT01968109|591911655|FG001|Overall Study|OTHER REASONS|0|||
163875540|NCT01968109|591911656|FG002|Overall Study|OTHER REASONS|0|||
163875541|NCT01968109|591911657|FG003|Overall Study|OTHER REASONS|1|||
163875542|NCT01968109|591911658|FG004|Overall Study|OTHER REASONS|0|||
163875543|NCT01968109|591911659|FG005|Overall Study|OTHER REASONS|0|||
163875544|NCT01968109|591911660|FG006|Overall Study|OTHER REASONS|0|||
163875545|NCT01968109|591911661|FG007|Overall Study|OTHER REASONS|0|||
163875546|NCT01968109|591911662|FG008|Overall Study|OTHER REASONS|0|||
164076861|NCT04288115|592645852|FG001|Overall Study|Withdrawal by Subject|1|||
164324147|NCT00597701|593565129|FG000|Overall Study|Withdrawal by Subject|5|||
164324148|NCT00597701|593565130|FG001|Overall Study|Withdrawal by Subject|5|||
164324149|NCT00597701|593565129|FG000|Overall Study|Death|0|||
164324150|NCT00597701|593565130|FG001|Overall Study|Death|1|||
164324151|NCT00597701|593565129|FG000|Overall Study|Physician Decision|2|||
164324152|NCT00597701|593565130|FG001|Overall Study|Physician Decision|0|||
164324153|NCT00597701|593565129|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
164324154|NCT00597701|593565130|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
164324155|NCT04078178|593565135|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
164324156|NCT04078178|593565136|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
164324157|NCT04078178|593565135|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
164324158|NCT04078178|593565136|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
164324159|NCT04078178|593565135|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
164324160|NCT04078178|593565136|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
164324161|NCT04078178|593565135|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
164324162|NCT04078178|593565136|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
164324163|NCT04078178|593565135|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
164324164|NCT04078178|593565136|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
164324165|NCT04617795|593565137|FG000|Main Study|Lost to Follow-up|1|||
164324166|NCT04617795|593565138|FG001|Main Study|Lost to Follow-up|0|||
164324167|NCT04850313|593565139|FG000|Overall Study|Withdrawal by Subject|0|||
164324168|NCT04850313|593565140|FG001|Overall Study|Withdrawal by Subject|1|||
164324169|NCT03505671|593565145|FG000|Overall Study|Withdrawal by Subject|2|||
164324170|NCT03505671|593565146|FG001|Overall Study|Withdrawal by Subject|1|||
164324171|NCT03505671|593565145|FG000|Overall Study|Lost to Follow-up|1|||
164324172|NCT03505671|593565146|FG001|Overall Study|Lost to Follow-up|0|||
164324173|NCT02038829|593565147|FG000|Washout Period 1|Death|0|||
164324174|NCT02038829|593565148|FG001|Washout Period 1|Death|0|||
164324175|NCT02038829|593565149|FG002|Washout Period 1|Death|0|||
164324176|NCT02038829|593565150|FG003|Washout Period 1|Death|0|||
164324177|NCT02038829|593565151|FG004|Washout Period 1|Death|1|||
164324178|NCT02038829|593565152|FG005|Washout Period 1|Death|0|||
164324179|NCT02038829|593565153|FG006|Washout Period 1|Death|0|||
164324180|NCT02038829|593565154|FG007|Washout Period 1|Death|0|||
164324181|NCT02038829|593565155|FG008|Washout Period 1|Death|0|||
164324182|NCT02038829|593565156|FG009|Washout Period 1|Death|0|||
164324183|NCT02038829|593565157|FG010|Washout Period 1|Death|0|||
164324184|NCT02038829|593565158|FG011|Washout Period 1|Death|0|||
164324185|NCT02038829|593565147|FG000|Treatment Period 2|Adverse Event|0|||
164324186|NCT02038829|593565148|FG001|Treatment Period 2|Adverse Event|0|||
164324187|NCT02038829|593565149|FG002|Treatment Period 2|Adverse Event|0|||
164324188|NCT02038829|593565150|FG003|Treatment Period 2|Adverse Event|0|||
164324189|NCT02038829|593565151|FG004|Treatment Period 2|Adverse Event|0|||
164324190|NCT02038829|593565152|FG005|Treatment Period 2|Adverse Event|0|||
164324191|NCT02038829|593565153|FG006|Treatment Period 2|Adverse Event|0|||
163875547|NCT01968109|591911663|FG009|Overall Study|OTHER REASONS|0|||
163875548|NCT01968109|591911664|FG010|Overall Study|OTHER REASONS|0|||
163875549|NCT01968109|591911665|FG011|Overall Study|OTHER REASONS|1|||
163875550|NCT01968109|591911666|FG012|Overall Study|OTHER REASONS|0|||
163875551|NCT01968109|591911667|FG013|Overall Study|OTHER REASONS|0|||
163875552|NCT01968109|591911668|FG014|Overall Study|OTHER REASONS|1|||
163875553|NCT01968109|591911669|FG015|Overall Study|OTHER REASONS|1|||
163875554|NCT01968109|591911670|FG016|Overall Study|OTHER REASONS|1|||
163875555|NCT01968109|591911671|FG017|Overall Study|OTHER REASONS|0|||
163875556|NCT01968109|591911672|FG018|Overall Study|OTHER REASONS|0|||
163875557|NCT01968109|591911673|FG019|Overall Study|OTHER REASONS|0|||
163875558|NCT01968109|591911674|FG020|Overall Study|OTHER REASONS|0|||
163875559|NCT01968109|591911675|FG021|Overall Study|OTHER REASONS|2|||
163875560|NCT01968109|591911676|FG022|Overall Study|OTHER REASONS|0|||
163875561|NCT01968109|591911677|FG023|Overall Study|OTHER REASONS|0|||
163875562|NCT01968109|591911678|FG024|Overall Study|OTHER REASONS|3|||
163875563|NCT01968109|591911679|FG025|Overall Study|OTHER REASONS|0|||
163875564|NCT01968109|591911680|FG026|Overall Study|OTHER REASONS|3|||
163875565|NCT01968109|591911681|FG027|Overall Study|OTHER REASONS|3|||
163875566|NCT01968109|591911682|FG028|Overall Study|OTHER REASONS|6|||
164324192|NCT02038829|593565154|FG007|Treatment Period 2|Adverse Event|0|||
164324193|NCT02038829|593565155|FG008|Treatment Period 2|Adverse Event|0|||
164324194|NCT02038829|593565156|FG009|Treatment Period 2|Adverse Event|0|||
163875567|NCT01968109|591911683|FG029|Overall Study|OTHER REASONS|7|||
163875568|NCT01968109|591911684|FG030|Overall Study|OTHER REASONS|3|||
163875569|NCT01968109|591911654|FG000|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875570|NCT01968109|591911655|FG001|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875571|NCT01968109|591911656|FG002|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875572|NCT01968109|591911657|FG003|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
164324195|NCT02038829|593565157|FG010|Treatment Period 2|Adverse Event|1|||
164324196|NCT02038829|593565158|FG011|Treatment Period 2|Adverse Event|0|||
164324197|NCT02038829|593565147|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164324198|NCT02038829|593565148|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164324199|NCT02038829|593565149|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164324200|NCT02038829|593565150|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164208838|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208839|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208840|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208841|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208842|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
164208843|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208844|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208845|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
164208846|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
164208847|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208848|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208849|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208850|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
164208851|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208852|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208853|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
164208854|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208855|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208856|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208857|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208858|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
164208859|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208860|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208861|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
164208862|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208863|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208864|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208865|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208866|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
164208867|NCT03329001|593133448|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208868|NCT03329001|593133449|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208869|NCT03329001|593133450|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208870|NCT03329001|593133451|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
164208871|NCT03329001|593133452|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208872|NCT03329001|593133453|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164324201|NCT02038829|593565151|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164324202|NCT02038829|593565152|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164324203|NCT02038829|593565153|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164324204|NCT02038829|593565154|FG007|Treatment Period 2|Withdrawal by Subject|0|||
164324205|NCT02038829|593565155|FG008|Treatment Period 2|Withdrawal by Subject|0|||
163979885|NCT01857869|592297286|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
163979886|NCT01857869|592297287|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979887|NCT01857869|592297288|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979888|NCT01857869|592297289|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979889|NCT01857869|592297290|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979890|NCT01857869|592297291|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979891|NCT01857869|592297292|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
163979892|NCT01857869|592297283|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979893|NCT01857869|592297284|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979894|NCT01857869|592297285|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979895|NCT01857869|592297286|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
163979896|NCT01857869|592297287|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979897|NCT01857869|592297288|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979898|NCT01857869|592297289|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979899|NCT01857869|592297290|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979900|NCT01857869|592297291|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979901|NCT01857869|592297292|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
163979902|NCT03016325|592297312|FG000|Treatment Period|Participant withdrew consent|0|||
163979903|NCT03016325|592297313|FG001|Treatment Period|Participant withdrew consent|1|||
163979904|NCT03016325|592297314|FG002|Treatment Period|Participant withdrew consent|0|||
164208873|NCT03329001|593133454|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208874|NCT03329001|593133455|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
164208875|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208876|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208877|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208878|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208879|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208880|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
164208881|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208882|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
164208883|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208884|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208885|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208886|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208887|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
164208888|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208889|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208890|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
164208891|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208892|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208893|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208894|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208895|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
164208896|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
164208897|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208898|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
164208899|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208900|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208901|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208902|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208903|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
164208904|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208905|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208906|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
164208907|NCT03329001|593133448|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208908|NCT03329001|593133449|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
163875573|NCT01968109|591911658|FG004|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875574|NCT01968109|591911659|FG005|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875575|NCT01968109|591911660|FG006|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875576|NCT01968109|591911661|FG007|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875577|NCT01968109|591911662|FG008|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875578|NCT01968109|591911663|FG009|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875579|NCT01968109|591911664|FG010|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875580|NCT01968109|591911665|FG011|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875581|NCT01968109|591911666|FG012|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875582|NCT01968109|591911667|FG013|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875583|NCT01968109|591911668|FG014|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875584|NCT01968109|591911669|FG015|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875585|NCT01968109|591911670|FG016|Overall Study|MAXIMUM CLINICAL BENEFIT|5|||
163875586|NCT01968109|591911671|FG017|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
163875587|NCT01968109|591911672|FG018|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875588|NCT01968109|591911673|FG019|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163875589|NCT01968109|591911674|FG020|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
163875590|NCT01968109|591911675|FG021|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875591|NCT01968109|591911676|FG022|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875592|NCT01968109|591911677|FG023|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875593|NCT01968109|591911678|FG024|Overall Study|MAXIMUM CLINICAL BENEFIT|1|||
163875594|NCT01968109|591911679|FG025|Overall Study|MAXIMUM CLINICAL BENEFIT|0|||
163875595|NCT01968109|591911680|FG026|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163875596|NCT01968109|591911681|FG027|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163875597|NCT01968109|591911682|FG028|Overall Study|MAXIMUM CLINICAL BENEFIT|3|||
163875598|NCT01968109|591911683|FG029|Overall Study|MAXIMUM CLINICAL BENEFIT|6|||
163979905|NCT03016325|592297315|FG003|Treatment Period|Participant withdrew consent|0|||
163979906|NCT03016325|592297316|FG004|Treatment Period|Participant withdrew consent|0|||
163979907|NCT03016325|592297317|FG005|Treatment Period|Participant withdrew consent|0|||
163875599|NCT01968109|591911684|FG030|Overall Study|MAXIMUM CLINICAL BENEFIT|2|||
163875600|NCT01968109|591911654|FG000|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875601|NCT01968109|591911655|FG001|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875602|NCT01968109|591911656|FG002|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163979908|NCT03016325|592297318|FG006|Treatment Period|Participant withdrew consent|0|||
163979909|NCT03016325|592297319|FG007|Treatment Period|Participant withdrew consent|0|||
163979910|NCT03016325|592297312|FG000|Treatment Period|Death|0|||
163979911|NCT03016325|592297313|FG001|Treatment Period|Death|0|||
163979912|NCT03016325|592297314|FG002|Treatment Period|Death|0|||
163979913|NCT03016325|592297315|FG003|Treatment Period|Death|0|||
163979914|NCT03016325|592297316|FG004|Treatment Period|Death|2|||
163979915|NCT03016325|592297317|FG005|Treatment Period|Death|0|||
163979916|NCT03016325|592297318|FG006|Treatment Period|Death|0|||
163979917|NCT03016325|592297319|FG007|Treatment Period|Death|0|||
163979918|NCT03016325|592297312|FG000|Treatment Period|Participant refuses assessments|0|||
163979919|NCT03016325|592297313|FG001|Treatment Period|Participant refuses assessments|0|||
163979920|NCT03016325|592297314|FG002|Treatment Period|Participant refuses assessments|1|||
163979921|NCT03016325|592297315|FG003|Treatment Period|Participant refuses assessments|0|||
163979922|NCT03016325|592297316|FG004|Treatment Period|Participant refuses assessments|0|||
163979923|NCT03016325|592297317|FG005|Treatment Period|Participant refuses assessments|0|||
163979924|NCT03016325|592297318|FG006|Treatment Period|Participant refuses assessments|0|||
163979925|NCT03016325|592297319|FG007|Treatment Period|Participant refuses assessments|0|||
163979926|NCT03016325|592297312|FG000|32-Day Follow-Up Period|Death|2|||
163979927|NCT03016325|592297313|FG001|32-Day Follow-Up Period|Death|0|||
163979928|NCT03016325|592297314|FG002|32-Day Follow-Up Period|Death|5|||
163979929|NCT03016325|592297315|FG003|32-Day Follow-Up Period|Death|6|||
163979930|NCT03016325|592297316|FG004|32-Day Follow-Up Period|Death|3|||
163979931|NCT03016325|592297317|FG005|32-Day Follow-Up Period|Death|0|||
163979932|NCT03016325|592297318|FG006|32-Day Follow-Up Period|Death|0|||
163979933|NCT03016325|592297319|FG007|32-Day Follow-Up Period|Death|0|||
163979934|NCT03016325|592297312|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
163979935|NCT03016325|592297313|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
163979936|NCT03016325|592297314|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
163979937|NCT03016325|592297315|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
163979938|NCT03016325|592297316|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
163979939|NCT03016325|592297317|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
163979940|NCT03016325|592297318|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
163979941|NCT03016325|592297319|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
163979942|NCT03016325|592297312|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
163979943|NCT03016325|592297313|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
163979944|NCT03016325|592297314|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
163979945|NCT03016325|592297315|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
163979946|NCT03016325|592297316|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
163979947|NCT03016325|592297317|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
163979948|NCT03016325|592297318|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
163979949|NCT03016325|592297319|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
163979950|NCT03016325|592297312|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
163979951|NCT03016325|592297313|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
163979952|NCT03016325|592297314|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
163979953|NCT03016325|592297315|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
163979954|NCT03016325|592297316|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
163979955|NCT03016325|592297317|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
163979956|NCT03016325|592297318|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
163979957|NCT03016325|592297319|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
163979958|NCT03016325|592297312|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
163979959|NCT03016325|592297313|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
163979960|NCT03016325|592297314|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
163979961|NCT03016325|592297315|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
163979962|NCT03016325|592297316|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
163979963|NCT03016325|592297317|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
163979964|NCT03016325|592297318|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
163979965|NCT03016325|592297319|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
163979966|NCT03016325|592297312|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163979967|NCT03016325|592297313|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163979968|NCT03016325|592297314|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
163979969|NCT03016325|592297315|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163979970|NCT03016325|592297316|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164208909|NCT03329001|593133450|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208910|NCT03329001|593133451|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208911|NCT03329001|593133452|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
163979971|NCT03016325|592297317|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
164076862|NCT04288115|592645851|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
164090398|NCT03384745|592693434|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
163979972|NCT03016325|592297318|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163979973|NCT03016325|592297319|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
163979974|NCT03016325|592297312|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163979975|NCT03016325|592297313|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
163979976|NCT03016325|592297314|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163979977|NCT03016325|592297315|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163979978|NCT03016325|592297316|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
164208912|NCT03329001|593133453|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
164208913|NCT03329001|593133454|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208914|NCT03329001|593133455|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
164208915|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208916|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208917|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208918|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208919|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208920|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
164208921|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
164208922|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
164208923|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208924|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208925|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208926|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208927|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208928|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208929|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
164208930|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
164208931|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208932|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208933|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208934|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208935|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208936|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
164208937|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
164208938|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
164208939|NCT03329001|593133448|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208940|NCT03329001|593133449|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208941|NCT03329001|593133450|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208942|NCT03329001|593133451|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208943|NCT03329001|593133452|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208944|NCT03329001|593133453|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
164208945|NCT03329001|593133454|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
164208946|NCT03329001|593133455|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
164208947|NCT02178956|593133456|FG000|Overall Study|Lost to Follow-up|4|||
164208948|NCT02178956|593133457|FG001|Overall Study|Lost to Follow-up|4|||
164208949|NCT02178956|593133456|FG000|Overall Study|Sponsor terminated study|49|||
164208950|NCT02178956|593133457|FG001|Overall Study|Sponsor terminated study|58|||
164208951|NCT02178956|593133456|FG000|Overall Study|Withdrawal by Subject|15|||
164208952|NCT02178956|593133457|FG001|Overall Study|Withdrawal by Subject|11|||
164208953|NCT02178956|593133456|FG000|Overall Study|Various Reasons|3|||
164208954|NCT02178956|593133457|FG001|Overall Study|Various Reasons|5|||
164208955|NCT02709369|593133461|FG000|Overall Study|Lost to Follow-up|15|||
164208956|NCT02709369|593133461|FG000|Overall Study|Withdrawal by Subject|10|||
164208957|NCT02709369|593133461|FG000|Overall Study|Did not received intervention|2|||
164208958|NCT01341470|593133462|FG000|Overall Study|Sponsor decision|0|||
164208959|NCT01341470|593133463|FG001|Overall Study|Sponsor decision|0|||
164208960|NCT01341470|593133464|FG002|Overall Study|Sponsor decision|1|||
164208961|NCT01341470|593133465|FG003|Overall Study|Sponsor decision|1|||
164208962|NCT01341470|593133466|FG004|Overall Study|Sponsor decision|0|||
164208963|NCT01341470|593133467|FG005|Overall Study|Sponsor decision|1|||
164208964|NCT01136915|593133469|FG000|Overall Study|Lost to Follow-up|2|||
164208965|NCT01136915|593133470|FG001|Overall Study|Lost to Follow-up|0|||
164208966|NCT01136915|593133469|FG000|Overall Study|Exclusion criterion met|0|||
164208967|NCT01136915|593133470|FG001|Overall Study|Exclusion criterion met|1|||
164208968|NCT03282097|593133471|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
164208969|NCT03282097|593133472|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
164208970|NCT03282097|593133471|FG000|Intervention Visit Complete|Patient Death|13|||
164208971|NCT03282097|593133472|FG001|Intervention Visit Complete|Patient Death|15|||
164208972|NCT03282097|593133471|FG000|Intervention Visit Complete|Caregiver Death|0|||
164208973|NCT03282097|593133472|FG001|Intervention Visit Complete|Caregiver Death|3|||
164208974|NCT03282097|593133471|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
163875603|NCT01968109|591911657|FG003|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875604|NCT01968109|591911658|FG004|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875605|NCT01968109|591911659|FG005|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875606|NCT01968109|591911660|FG006|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875607|NCT01968109|591911661|FG007|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875608|NCT01968109|591911662|FG008|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875609|NCT01968109|591911663|FG009|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875610|NCT01968109|591911664|FG010|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875611|NCT01968109|591911665|FG011|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875612|NCT01968109|591911666|FG012|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875613|NCT01968109|591911667|FG013|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875614|NCT01968109|591911668|FG014|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875615|NCT01968109|591911669|FG015|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875616|NCT01968109|591911670|FG016|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875617|NCT01968109|591911671|FG017|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875618|NCT01968109|591911672|FG018|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875619|NCT01968109|591911673|FG019|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875620|NCT01968109|591911674|FG020|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|1|||
163875621|NCT01968109|591911675|FG021|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875622|NCT01968109|591911676|FG022|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875623|NCT01968109|591911677|FG023|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|3|||
163875624|NCT01968109|591911678|FG024|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875625|NCT01968109|591911679|FG025|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875626|NCT01968109|591911680|FG026|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875627|NCT01968109|591911681|FG027|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875628|NCT01968109|591911682|FG028|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875629|NCT01968109|591911683|FG029|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875630|NCT01968109|591911684|FG030|Overall Study|SUBJECT NO LONGER MEETS STUDY CRITERIA|0|||
163875631|NCT01968109|591911654|FG000|Overall Study|Death|0|||
163875632|NCT01968109|591911655|FG001|Overall Study|Death|0|||
163875633|NCT01968109|591911656|FG002|Overall Study|Death|0|||
163875634|NCT01968109|591911657|FG003|Overall Study|Death|0|||
163875635|NCT01968109|591911658|FG004|Overall Study|Death|0|||
163875636|NCT01968109|591911659|FG005|Overall Study|Death|0|||
163875637|NCT01968109|591911660|FG006|Overall Study|Death|0|||
163875638|NCT01968109|591911661|FG007|Overall Study|Death|0|||
163875639|NCT01968109|591911662|FG008|Overall Study|Death|0|||
163875640|NCT01968109|591911663|FG009|Overall Study|Death|0|||
163875641|NCT01968109|591911664|FG010|Overall Study|Death|0|||
163875642|NCT01968109|591911665|FG011|Overall Study|Death|0|||
163875643|NCT01968109|591911666|FG012|Overall Study|Death|0|||
163875644|NCT01968109|591911667|FG013|Overall Study|Death|0|||
163875645|NCT01968109|591911668|FG014|Overall Study|Death|0|||
163875646|NCT01968109|591911669|FG015|Overall Study|Death|0|||
163875647|NCT01968109|591911670|FG016|Overall Study|Death|0|||
163875648|NCT01968109|591911671|FG017|Overall Study|Death|0|||
163875649|NCT01968109|591911672|FG018|Overall Study|Death|0|||
163875650|NCT01968109|591911673|FG019|Overall Study|Death|0|||
163875651|NCT01968109|591911674|FG020|Overall Study|Death|0|||
163875652|NCT01968109|591911675|FG021|Overall Study|Death|1|||
163875653|NCT01968109|591911676|FG022|Overall Study|Death|0|||
163875654|NCT01968109|591911677|FG023|Overall Study|Death|0|||
163875655|NCT01968109|591911678|FG024|Overall Study|Death|0|||
163875656|NCT01968109|591911679|FG025|Overall Study|Death|0|||
164208975|NCT03282097|593133472|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
164208976|NCT03282097|593133471|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
164208977|NCT03282097|593133472|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
164208978|NCT03282097|593133471|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
164208979|NCT03282097|593133472|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
164208980|NCT03282097|593133471|FG000|Primary Outcome Data Collection Complete|Missing|2|||
164355615|NCT01535053|593676480|FG000|Overall Study|Ineligible|1|||
163875657|NCT01968109|591911680|FG026|Overall Study|Death|0|||
163875658|NCT01968109|591911681|FG027|Overall Study|Death|0|||
163875659|NCT01968109|591911682|FG028|Overall Study|Death|0|||
163875660|NCT01968109|591911683|FG029|Overall Study|Death|0|||
163875661|NCT01968109|591911684|FG030|Overall Study|Death|1|||
163875662|NCT03899792|591911691|FG000|Phase 2|Ongoing Treatment|0|||
163875663|NCT03899792|591911692|FG001|Phase 2|Ongoing Treatment|13|||
163875664|NCT03899792|591911693|FG002|Phase 2|Ongoing Treatment|14|||
163875665|NCT03899792|591911694|FG003|Phase 2|Ongoing Treatment|2|||
163875666|NCT03899792|591911691|FG000|Phase 2|Death|0|||
163875667|NCT03899792|591911692|FG001|Phase 2|Death|0|||
163875668|NCT03899792|591911693|FG002|Phase 2|Death|0|||
164208981|NCT03282097|593133472|FG001|Primary Outcome Data Collection Complete|Missing|3|||
164208982|NCT03282097|593133471|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
163979979|NCT03016325|592297317|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163979980|NCT03016325|592297318|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163979981|NCT03016325|592297319|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
163979982|NCT03016325|592297312|FG000|182-Day Follow-Up Period|Death|3|||
163979983|NCT03016325|592297313|FG001|182-Day Follow-Up Period|Death|3|||
163979984|NCT03016325|592297314|FG002|182-Day Follow-Up Period|Death|11|||
163979985|NCT03016325|592297315|FG003|182-Day Follow-Up Period|Death|12|||
163979986|NCT03016325|592297316|FG004|182-Day Follow-Up Period|Death|9|||
163979987|NCT03016325|592297317|FG005|182-Day Follow-Up Period|Death|0|||
163979988|NCT03016325|592297318|FG006|182-Day Follow-Up Period|Death|0|||
163979989|NCT03016325|592297319|FG007|182-Day Follow-Up Period|Death|1|||
163979990|NCT03016325|592297312|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
164076863|NCT04288115|592645852|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
164076864|NCT00729365|592645853|FG000|Overall Study|Physician Decision|33|||
164076865|NCT00729365|592645854|FG001|Overall Study|Physician Decision|6|||
164076866|NCT00729365|592645855|FG002|Overall Study|Physician Decision|7|||
164076867|NCT00928135|592645858|FG000|Overall Study|Withdrawal by Subject|1|||
163979991|NCT03016325|592297313|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979992|NCT03016325|592297314|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979993|NCT03016325|592297315|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979994|NCT03016325|592297316|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979995|NCT03016325|592297317|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979996|NCT03016325|592297318|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979997|NCT03016325|592297319|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
163979998|NCT03016325|592297312|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
163979999|NCT03016325|592297313|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
163980000|NCT03016325|592297314|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
163980001|NCT03016325|592297315|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
163980002|NCT03016325|592297316|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
163980003|NCT03016325|592297317|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
163980004|NCT03016325|592297318|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
163980005|NCT03016325|592297319|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
163980006|NCT03016325|592297312|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163980007|NCT03016325|592297313|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163980008|NCT03016325|592297314|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163980009|NCT03016325|592297315|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163980010|NCT03016325|592297316|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
163980011|NCT03016325|592297317|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
164076868|NCT00928135|592645859|FG001|Overall Study|Withdrawal by Subject|0|||
163875669|NCT03899792|591911694|FG003|Phase 2|Death|4|||
163875670|NCT03899792|591911691|FG000|Phase 2|Lost to Follow-up|0|||
163875671|NCT03899792|591911692|FG001|Phase 2|Lost to Follow-up|1|||
163875672|NCT03899792|591911693|FG002|Phase 2|Lost to Follow-up|1|||
163875673|NCT03899792|591911694|FG003|Phase 2|Lost to Follow-up|0|||
163875674|NCT03899792|591911691|FG000|Phase 2|Withdrawal by Subject|0|||
163875675|NCT03899792|591911692|FG001|Phase 2|Withdrawal by Subject|1|||
163875676|NCT03899792|591911693|FG002|Phase 2|Withdrawal by Subject|0|||
163875677|NCT03899792|591911694|FG003|Phase 2|Withdrawal by Subject|0|||
163875678|NCT00330681|591911695|FG000|Overall Study|Adverse Event|3|||
163875679|NCT00330681|591911696|FG001|Overall Study|Adverse Event|6|||
163875680|NCT00330681|591911695|FG000|Overall Study|Protocol Violation|0|||
163875681|NCT00330681|591911696|FG001|Overall Study|Protocol Violation|1|||
163875682|NCT00330681|591911695|FG000|Overall Study|Withdrawal by Subject|5|||
163875683|NCT00330681|591911696|FG001|Overall Study|Withdrawal by Subject|5|||
163875684|NCT00330681|591911695|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
163875685|NCT00330681|591911696|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
163875686|NCT03954184|591912825|FG000|Overall Study|Lost to Follow-up|500|||
163875687|NCT03954184|591912826|FG001|Overall Study|Lost to Follow-up|0|||
163875688|NCT05307783|591912827|FG000|Overall Study|Death|7|||
163875689|NCT05307783|591912827|FG000|Overall Study|Lost to Follow-up|4|||
164076869|NCT04556838|592645864|FG000|Overall Study|Withdrawal by Subject|3|||
163875690|NCT04883645|591912828|FG000|Overall Study|Death|1|||
164076870|NCT04556838|592645865|FG001|Overall Study|Withdrawal by Subject|1|||
164076871|NCT04556838|592645866|FG002|Overall Study|Withdrawal by Subject|2|||
163875691|NCT03460236|591912830|FG000|Overall Study|failed radiographic screening|16|||
163875692|NCT03460236|591912830|FG000|Overall Study|Withdrawal by Subject|11|||
163875693|NCT06194214|591912831|FG000|Overall Study|Adverse Event|1|||
163875694|NCT04869982|591912832|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
163875695|NCT04869982|591912833|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
163875696|NCT04869982|591912832|FG000|Overall Study|Migrated / moved from the study area|1|||
164324206|NCT02038829|593565156|FG009|Treatment Period 2|Withdrawal by Subject|0|||
164324207|NCT02038829|593565157|FG010|Treatment Period 2|Withdrawal by Subject|0|||
163875697|NCT04869982|591912833|FG001|Overall Study|Migrated / moved from the study area|1|||
163875698|NCT04869982|591912832|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
163875699|NCT04869982|591912833|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
163875700|NCT04869982|591912832|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
163875701|NCT04869982|591912833|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
163875702|NCT04869982|591912832|FG000|Overall Study|Solicited adverse event|2|||
163875703|NCT04869982|591912833|FG001|Overall Study|Solicited adverse event|1|||
163875704|NCT04608045|591912834|FG000|Overall Study|Physician Decision|1|||
163875705|NCT02473250|591912836|FG000|Overall Study|Lost to Follow-up|10|||
163875706|NCT02473250|591912836|FG000|Overall Study|Physician Decision|5|||
163875707|NCT02473250|591912836|FG000|Overall Study|Did not tolerate medication washout|3|||
163875708|NCT02473250|591912836|FG000|Overall Study|Antidepressant effect of divalproex|2|||
163875709|NCT05215847|591912837|FG000|Overall Study|Lost to Follow-up|1|||
163875710|NCT04847999|591912838|FG000|Overall Study|Lost to Follow-up|0|||
163875711|NCT04847999|591912839|FG001|Overall Study|Lost to Follow-up|1|||
163875712|NCT04300231|591912853|FG000|Overall Study|Protocol Violation|4|||
163875713|NCT04300231|591912854|FG001|Overall Study|Protocol Violation|3|||
163875714|NCT04300231|591912855|FG002|Overall Study|Protocol Violation|0|||
163875715|NCT04300231|591912856|FG003|Overall Study|Protocol Violation|2|||
163875716|NCT06023082|591912857|FG000|Overall Study|Withdrawal by Subject|2|||
163875717|NCT06023082|591912857|FG000|Overall Study|Lost to Follow-up|15|||
163875718|NCT06023082|591912857|FG000|Overall Study|Side effects|5|||
163875719|NCT05986565|591912858|FG000|Overall Study|Lost to Follow-up|8|||
163875720|NCT05986565|591912859|FG001|Overall Study|Lost to Follow-up|3|||
163875721|NCT05986565|591912858|FG000|Overall Study|Withdrawal by Subject|0|||
163875722|NCT05986565|591912859|FG001|Overall Study|Withdrawal by Subject|1|||
163875723|NCT00670046|591912862|FG000|Overall Study|Lost to Follow-up|1|||
163875724|NCT00670046|591912863|FG001|Overall Study|Lost to Follow-up|1|||
163875725|NCT00670046|591912862|FG000|Overall Study|Withdrawal by Subject|0|||
163875726|NCT00670046|591912863|FG001|Overall Study|Withdrawal by Subject|1|||
163875727|NCT02006758|591912872|FG000|Overall Study|Protocol Violation|1|||
163875728|NCT02006758|591912872|FG000|Overall Study|Death|1|||
163875729|NCT02006758|591912872|FG000|Overall Study|Lost to Follow-up|4|||
163875730|NCT02006758|591912872|FG000|Overall Study|Withdrawal by Subject|4|||
163875731|NCT02006758|591912872|FG000|Overall Study|Procedurally excluded|1|||
163875732|NCT02006758|591912872|FG000|Overall Study|Other|2|||
163875733|NCT00914589|591912873|FG000|Overall Study|Adverse Event|1|||
163875734|NCT00914589|591912874|FG001|Overall Study|Adverse Event|0|||
163875735|NCT00914589|591912875|FG002|Overall Study|Adverse Event|1|||
163875736|NCT00914589|591912873|FG000|Overall Study|Protocol Violation|8|||
163875737|NCT00914589|591912874|FG001|Overall Study|Protocol Violation|6|||
163875738|NCT00914589|591912875|FG002|Overall Study|Protocol Violation|3|||
163875739|NCT00914589|591912873|FG000|Overall Study|unclassified|16|||
163875740|NCT00914589|591912874|FG001|Overall Study|unclassified|9|||
163875741|NCT00914589|591912875|FG002|Overall Study|unclassified|7|||
163875742|NCT00914589|591912873|FG000|Overall Study|Death|0|||
163875743|NCT00914589|591912874|FG001|Overall Study|Death|1|||
163875744|NCT00914589|591912875|FG002|Overall Study|Death|1|||
163875745|NCT02101281|591912877|FG000|Overall Study|Adverse Event|0|||
163875746|NCT02101281|591912878|FG001|Overall Study|Adverse Event|1|||
163875747|NCT05575076|591912879|FG000|Overall Study|Adverse Event|24|||
163875748|NCT05575076|591912879|FG000|Overall Study|Death|7|||
163875749|NCT05575076|591912879|FG000|Overall Study|Lost to Follow-up|16|||
163875750|NCT05575076|591912879|FG000|Overall Study|Non-Compliance|3|||
163875751|NCT05575076|591912879|FG000|Overall Study|Physician Decision|6|||
163875752|NCT05575076|591912879|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
163875753|NCT05575076|591912879|FG000|Overall Study|Withdrawal by Subject|71|||
163875754|NCT05575076|591912879|FG000|Overall Study|Study Terminated by Sponsor|630|||
163875755|NCT05575076|591912879|FG000|Overall Study|Other|17|||
163875756|NCT00510887|591912880|FG000|Overall Study|Lost to Follow-up|1|||
163875757|NCT01736215|591912890|FG000|Overall Study|Early termination of erythropoietin use|1|||
163875758|NCT01736215|591912890|FG000|Overall Study|Adverse Event|4|||
163875759|NCT01736215|591912890|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
163875760|NCT01736215|591912890|FG000|Overall Study|Insufficient data to perform analysis|8|||
163875761|NCT03447249|591912891|FG000|Overall Study|Adverse Event|1|||
163875762|NCT03447249|591912892|FG001|Overall Study|Adverse Event|0|||
163875763|NCT03447249|591912891|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163875764|NCT03447249|591912892|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
163875765|NCT03447249|591912891|FG000|Overall Study|Other|3|||
163875766|NCT03447249|591912892|FG001|Overall Study|Other|0|||
163980012|NCT03016325|592297318|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163980013|NCT03016325|592297319|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
163875767|NCT02376790|591912893|FG000|Overall Study|Withdrawal by Subject|43|||
163875768|NCT02376790|591912894|FG001|Overall Study|Withdrawal by Subject|36|||
163875769|NCT02376790|591912895|FG002|Overall Study|Withdrawal by Subject|37|||
164324208|NCT02038829|593565158|FG011|Treatment Period 2|Withdrawal by Subject|0|||
164324209|NCT02038829|593565147|FG000|Washout Period 2|Adverse Event|0|||
164324210|NCT02038829|593565148|FG001|Washout Period 2|Adverse Event|0|||
164324211|NCT02038829|593565149|FG002|Washout Period 2|Adverse Event|0|||
164324212|NCT02038829|593565150|FG003|Washout Period 2|Adverse Event|0|||
164324213|NCT02038829|593565151|FG004|Washout Period 2|Adverse Event|0|||
164324214|NCT02038829|593565152|FG005|Washout Period 2|Adverse Event|0|||
164324215|NCT02038829|593565153|FG006|Washout Period 2|Adverse Event|0|||
164324216|NCT02038829|593565154|FG007|Washout Period 2|Adverse Event|0|||
164324217|NCT02038829|593565155|FG008|Washout Period 2|Adverse Event|1|||
164324218|NCT02038829|593565156|FG009|Washout Period 2|Adverse Event|0|||
164324219|NCT02038829|593565157|FG010|Washout Period 2|Adverse Event|0|||
164324220|NCT02038829|593565158|FG011|Washout Period 2|Adverse Event|0|||
164324221|NCT02038829|593565147|FG000|Washout Period 2|Withdrawal by Subject|0|||
164324222|NCT02038829|593565148|FG001|Washout Period 2|Withdrawal by Subject|0|||
164324223|NCT02038829|593565149|FG002|Washout Period 2|Withdrawal by Subject|0|||
163875770|NCT02376790|591912893|FG000|Overall Study|Decision by Sponsor|2|||
164324224|NCT02038829|593565150|FG003|Washout Period 2|Withdrawal by Subject|0|||
164324225|NCT02038829|593565151|FG004|Washout Period 2|Withdrawal by Subject|0|||
163875771|NCT02376790|591912894|FG001|Overall Study|Decision by Sponsor|1|||
163875772|NCT02376790|591912895|FG002|Overall Study|Decision by Sponsor|4|||
163875773|NCT02376790|591912893|FG000|Overall Study|Lost to Follow-up|15|||
163875774|NCT02376790|591912894|FG001|Overall Study|Lost to Follow-up|10|||
163875775|NCT02376790|591912895|FG002|Overall Study|Lost to Follow-up|12|||
163875776|NCT00988858|591912896|FG000|Overall Study|Adverse Event|7|||
163875777|NCT00988858|591912896|FG000|Overall Study|Death|1|||
163875778|NCT00988858|591912896|FG000|Overall Study|Physician Decision|1|||
163875779|NCT00988858|591912896|FG000|Overall Study|Sponsor Decision|1|||
163875780|NCT02238483|591912897|FG000|Overall Study|Withdrawal by Subject|2|||
163875781|NCT02238483|591912898|FG001|Overall Study|Withdrawal by Subject|7|||
163875782|NCT02238483|591912897|FG000|Overall Study|Lost to Follow-up|1|||
163875783|NCT02238483|591912898|FG001|Overall Study|Lost to Follow-up|1|||
163875784|NCT02238483|591912897|FG000|Overall Study|Protocol Violation|1|||
163875785|NCT02238483|591912898|FG001|Overall Study|Protocol Violation|2|||
163875786|NCT02238483|591912897|FG000|Overall Study|Death|1|||
163875787|NCT02238483|591912898|FG001|Overall Study|Death|0|||
163875788|NCT02238483|591912897|FG000|Overall Study|Adverse Event|7|||
163875789|NCT02238483|591912898|FG001|Overall Study|Adverse Event|3|||
163875790|NCT02238483|591912897|FG000|Overall Study|Withdrawn due to physician decision|1|||
163875791|NCT02238483|591912898|FG001|Overall Study|Withdrawn due to physician decision|0|||
163875792|NCT02238483|591912897|FG000|Overall Study|Completion status not recorded|1|||
163875793|NCT02238483|591912898|FG001|Overall Study|Completion status not recorded|1|||
163875794|NCT02238483|591912897|FG000|Overall Study|Illness in family member|1|||
163875795|NCT02238483|591912898|FG001|Overall Study|Illness in family member|0|||
163875796|NCT02538341|591912899|FG000|Overall Study|Lost to Follow-up|51|||
163875797|NCT02538341|591912900|FG001|Overall Study|Lost to Follow-up|46|||
163875798|NCT02538341|591912899|FG000|Overall Study|Withdrawal by Subject|3|||
163875799|NCT02538341|591912900|FG001|Overall Study|Withdrawal by Subject|1|||
163875800|NCT02538341|591912899|FG000|Overall Study|Death|2|||
163875801|NCT02538341|591912900|FG001|Overall Study|Death|0|||
163875802|NCT01551355|591912903|FG000|Overall Study|Lost to Follow-up|51|||
163875803|NCT01551355|591912904|FG001|Overall Study|Lost to Follow-up|49|||
163875804|NCT01551355|591912905|FG002|Overall Study|Lost to Follow-up|34|||
163875805|NCT01551355|591912906|FG003|Overall Study|Lost to Follow-up|24|||
163875806|NCT01551355|591912907|FG004|Overall Study|Lost to Follow-up|9|||
163875807|NCT01551355|591912908|FG005|Overall Study|Lost to Follow-up|6|||
163875808|NCT00031694|591912909|FG000|Overall Study|Adverse Event|12|||
163875809|NCT00031694|591912909|FG000|Overall Study|Death|2|||
163875810|NCT00031694|591912909|FG000|Overall Study|Withdrawal by Subject|5|||
163875811|NCT01538719|591912910|FG000|Overall Study|Lost to Follow-up|2|||
163875812|NCT01538719|591912911|FG001|Overall Study|Lost to Follow-up|0|||
163875813|NCT01255670|591912918|FG000|Overall Study|Adverse Event|10|||
163875814|NCT01255670|591912919|FG001|Overall Study|Adverse Event|10|||
164324226|NCT02038829|593565152|FG005|Washout Period 2|Withdrawal by Subject|1|||
163875815|NCT01255670|591912918|FG000|Overall Study|Lost to Follow-up|16|||
163875816|NCT01255670|591912919|FG001|Overall Study|Lost to Follow-up|10|||
163980014|NCT03016325|592297312|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
163980015|NCT03016325|592297313|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
163980016|NCT03016325|592297314|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
164324227|NCT02038829|593565153|FG006|Washout Period 2|Withdrawal by Subject|0|||
163875817|NCT03664960|591912920|FG000|Overall Study|Adverse Event|0|||
163875818|NCT03664960|591912921|FG001|Overall Study|Adverse Event|3|||
163875819|NCT03664960|591912920|FG000|Overall Study|Lost to Follow-up|3|||
163875820|NCT03664960|591912921|FG001|Overall Study|Lost to Follow-up|2|||
164324228|NCT02038829|593565154|FG007|Washout Period 2|Withdrawal by Subject|0|||
164324229|NCT02038829|593565155|FG008|Washout Period 2|Withdrawal by Subject|0|||
164324230|NCT02038829|593565156|FG009|Washout Period 2|Withdrawal by Subject|0|||
163875821|NCT03664960|591912920|FG000|Overall Study|Physician Decision|1|||
163875822|NCT03664960|591912921|FG001|Overall Study|Physician Decision|0|||
164208983|NCT03282097|593133472|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
164208984|NCT03282097|593133471|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
164208985|NCT03282097|593133472|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
164208986|NCT03282097|593133471|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
164208987|NCT03282097|593133472|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
164208988|NCT03916926|593133474|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
164208989|NCT03916926|593133475|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
164208990|NCT03916926|593133474|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
164208991|NCT03916926|593133475|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
164208992|NCT03916926|593133474|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
164208993|NCT03916926|593133475|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
164208994|NCT03916926|593133474|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
164208995|NCT03916926|593133475|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
164208996|NCT03034967|593133481|FG000|Overall Study|Withdrawal by Subject|9|||
164208997|NCT03034967|593133482|FG001|Overall Study|Withdrawal by Subject|2|||
164208998|NCT03034967|593133483|FG002|Overall Study|Withdrawal by Subject|6|||
164208999|NCT03034967|593133484|FG003|Overall Study|Withdrawal by Subject|6|||
164209000|NCT03034967|593133485|FG004|Overall Study|Withdrawal by Subject|9|||
164209001|NCT03034967|593133486|FG005|Overall Study|Withdrawal by Subject|2|||
164209002|NCT03034967|593133481|FG000|Overall Study|Physician Decision|1|||
164209003|NCT03034967|593133482|FG001|Overall Study|Physician Decision|0|||
164209004|NCT03034967|593133483|FG002|Overall Study|Physician Decision|1|||
164209005|NCT03034967|593133484|FG003|Overall Study|Physician Decision|1|||
164209006|NCT03034967|593133485|FG004|Overall Study|Physician Decision|1|||
164209007|NCT03034967|593133486|FG005|Overall Study|Physician Decision|0|||
164209008|NCT03034967|593133481|FG000|Overall Study|Lost to Follow-up|0|||
164209009|NCT03034967|593133482|FG001|Overall Study|Lost to Follow-up|0|||
164209010|NCT03034967|593133483|FG002|Overall Study|Lost to Follow-up|0|||
164209011|NCT03034967|593133484|FG003|Overall Study|Lost to Follow-up|1|||
164209012|NCT03034967|593133485|FG004|Overall Study|Lost to Follow-up|0|||
164209013|NCT03034967|593133486|FG005|Overall Study|Lost to Follow-up|2|||
164209014|NCT03034967|593133481|FG000|Overall Study|Liver function test abnormality|0|||
164209015|NCT03034967|593133482|FG001|Overall Study|Liver function test abnormality|0|||
164209016|NCT03034967|593133483|FG002|Overall Study|Liver function test abnormality|1|||
164209017|NCT03034967|593133484|FG003|Overall Study|Liver function test abnormality|0|||
164209018|NCT03034967|593133485|FG004|Overall Study|Liver function test abnormality|0|||
164209019|NCT03034967|593133486|FG005|Overall Study|Liver function test abnormality|0|||
164209020|NCT03034967|593133481|FG000|Overall Study|Protocol Violation|1|||
164209021|NCT03034967|593133482|FG001|Overall Study|Protocol Violation|0|||
164209022|NCT03034967|593133483|FG002|Overall Study|Protocol Violation|0|||
164209023|NCT03034967|593133484|FG003|Overall Study|Protocol Violation|0|||
164209024|NCT03034967|593133485|FG004|Overall Study|Protocol Violation|0|||
164209025|NCT03034967|593133486|FG005|Overall Study|Protocol Violation|2|||
164209026|NCT03034967|593133481|FG000|Overall Study|Lack of Efficacy|0|||
164209027|NCT03034967|593133482|FG001|Overall Study|Lack of Efficacy|1|||
164209028|NCT03034967|593133483|FG002|Overall Study|Lack of Efficacy|2|||
164209029|NCT03034967|593133484|FG003|Overall Study|Lack of Efficacy|1|||
164209030|NCT03034967|593133485|FG004|Overall Study|Lack of Efficacy|1|||
164209031|NCT03034967|593133486|FG005|Overall Study|Lack of Efficacy|0|||
164209032|NCT03034967|593133481|FG000|Overall Study|Adverse Event, non-fatal|3|||
164209033|NCT03034967|593133482|FG001|Overall Study|Adverse Event, non-fatal|1|||
164324231|NCT02038829|593565157|FG010|Washout Period 2|Withdrawal by Subject|0|||
164324232|NCT02038829|593565158|FG011|Washout Period 2|Withdrawal by Subject|0|||
163875823|NCT03664960|591912920|FG000|Overall Study|Withdrawal by Subject|3|||
163875824|NCT03664960|591912921|FG001|Overall Study|Withdrawal by Subject|14|||
163875825|NCT03664960|591912920|FG000|Overall Study|Sponsor Decision|1|||
163875826|NCT03664960|591912921|FG001|Overall Study|Sponsor Decision|1|||
163875827|NCT03664960|591912920|FG000|Overall Study|Other|1|||
163875828|NCT03664960|591912921|FG001|Overall Study|Other|2|||
164209034|NCT03034967|593133483|FG002|Overall Study|Adverse Event, non-fatal|2|||
164209035|NCT03034967|593133484|FG003|Overall Study|Adverse Event, non-fatal|0|||
164209036|NCT03034967|593133485|FG004|Overall Study|Adverse Event, non-fatal|2|||
164209037|NCT03034967|593133486|FG005|Overall Study|Adverse Event, non-fatal|8|||
164209038|NCT03034967|593133481|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
164209039|NCT03034967|593133482|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
164209040|NCT03034967|593133483|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
164209041|NCT03034967|593133484|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
164209042|NCT03034967|593133485|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
164209043|NCT03034967|593133486|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
164209044|NCT03806296|593133487|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
164209045|NCT03806296|593133488|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
164324233|NCT02038829|593565147|FG000|Treatment Period 4|Adverse Event|0|||
163875829|NCT03807778|591912924|FG000|Overall Study|Adverse Event|0|||
163875830|NCT03807778|591912925|FG001|Overall Study|Adverse Event|0|||
164209046|NCT03806296|593133489|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
164209047|NCT03806296|593133487|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
164209048|NCT03806296|593133488|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
164209049|NCT03806296|593133489|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
164209050|NCT03806296|593133487|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
164209051|NCT03806296|593133488|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
164209052|NCT03806296|593133489|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
164209053|NCT02763566|593133501|FG000|Overall Study|Lost to Follow-up|1|||
164209054|NCT02763566|593133502|FG001|Overall Study|Lost to Follow-up|4|||
164209055|NCT02763566|593133503|FG002|Overall Study|Lost to Follow-up|0|||
164209056|NCT02763566|593133504|FG003|Overall Study|Lost to Follow-up|1|||
164209057|NCT02763566|593133501|FG000|Overall Study|On study treatment at study conclusion|114|||
164209058|NCT02763566|593133502|FG001|Overall Study|On study treatment at study conclusion|34|||
164209059|NCT02763566|593133503|FG002|Overall Study|On study treatment at study conclusion|54|||
164209060|NCT02763566|593133504|FG003|Overall Study|On study treatment at study conclusion|13|||
164209061|NCT02763566|593133501|FG000|Overall Study|Withdrawal by Subject|3|||
164209062|NCT02763566|593133502|FG001|Overall Study|Withdrawal by Subject|1|||
164209063|NCT02763566|593133503|FG002|Overall Study|Withdrawal by Subject|0|||
164209064|NCT02763566|593133504|FG003|Overall Study|Withdrawal by Subject|0|||
164209065|NCT04896385|593133505|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
164209066|NCT04896385|593133506|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
164209067|NCT04896385|593133507|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
164209068|NCT04896385|593133508|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
164209069|NCT04896385|593133505|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
164209070|NCT04896385|593133506|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
164209071|NCT04896385|593133507|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
164209072|NCT04896385|593133508|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
164209073|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
164209074|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
164209075|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
164209076|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
164209077|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
164209078|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
164209079|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
164209080|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
164209081|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
164209082|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
164209083|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
164209084|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
164209085|NCT04896385|593133505|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
164209086|NCT04896385|593133506|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
164209087|NCT04896385|593133507|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
164209088|NCT04896385|593133508|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
164209089|NCT05291689|593133511|FG000|Overall Study|Adverse Event|3|||
164209090|NCT05291689|593133511|FG000|Overall Study|Lack of Efficacy|10|||
164209091|NCT05291689|593133511|FG000|Overall Study|Withdrawal by Subject|4|||
164209092|NCT01931098|593133512|FG000|Overall Study|Withdrawal by Subject|0|||
164209093|NCT01931098|593133513|FG001|Overall Study|Withdrawal by Subject|1|||
164209094|NCT01931098|593133512|FG000|Overall Study|Enrolled in different protocol|0|||
164209095|NCT01931098|593133513|FG001|Overall Study|Enrolled in different protocol|1|||
164209096|NCT01931098|593133512|FG000|Overall Study|Unable to begin trmt:active infection|0|||
164209097|NCT01931098|593133513|FG001|Overall Study|Unable to begin trmt:active infection|1|||
164209098|NCT01931098|593133512|FG000|Overall Study|Refused further treatment|0|||
164209099|NCT01931098|593133513|FG001|Overall Study|Refused further treatment|1|||
164209100|NCT02612155|593133514|FG000|Overall Study|Death|1|||
164209101|NCT02612155|593133515|FG001|Overall Study|Death|1|||
164209102|NCT02612155|593133514|FG000|Overall Study|Lost to Follow-up|2|||
164209103|NCT02612155|593133515|FG001|Overall Study|Lost to Follow-up|2|||
164324234|NCT02038829|593565148|FG001|Treatment Period 4|Adverse Event|1|||
164324235|NCT02038829|593565149|FG002|Treatment Period 4|Adverse Event|0|||
164324236|NCT02038829|593565150|FG003|Treatment Period 4|Adverse Event|0|||
164324237|NCT02038829|593565151|FG004|Treatment Period 4|Adverse Event|0|||
164324238|NCT02038829|593565152|FG005|Treatment Period 4|Adverse Event|0|||
164324239|NCT02038829|593565153|FG006|Treatment Period 4|Adverse Event|0|||
164324240|NCT02038829|593565154|FG007|Treatment Period 4|Adverse Event|0|||
164324241|NCT02038829|593565155|FG008|Treatment Period 4|Adverse Event|0|||
164324242|NCT02038829|593565156|FG009|Treatment Period 4|Adverse Event|0|||
164324243|NCT02038829|593565157|FG010|Treatment Period 4|Adverse Event|0|||
164324244|NCT02038829|593565158|FG011|Treatment Period 4|Adverse Event|0|||
163875831|NCT03807778|591912926|FG002|Overall Study|Adverse Event|3|||
164209104|NCT05233761|593133516|FG000|Treatment Period A|Withdrawal by Subject|12|||
163875832|NCT03807778|591912927|FG003|Overall Study|Adverse Event|5|||
164209105|NCT05233761|593133517|FG001|Treatment Period A|Withdrawal by Subject|10|||
164209106|NCT05233761|593133516|FG000|Treatment Period A|Lost to Follow-up|6|||
164209107|NCT05233761|593133517|FG001|Treatment Period A|Lost to Follow-up|12|||
164209108|NCT05233761|593133516|FG000|Treatment Period A|Protocol Violation|8|||
164209109|NCT05233761|593133517|FG001|Treatment Period A|Protocol Violation|15|||
164209110|NCT04235374|593133518|FG000|Overall Study|Death|91|||
164209111|NCT04235374|593133519|FG001|Overall Study|Death|91|||
164209112|NCT04235374|593133518|FG000|Overall Study|Refused|2|||
164209113|NCT04235374|593133519|FG001|Overall Study|Refused|2|||
164209114|NCT04235374|593133518|FG000|Overall Study|Unavailable|12|||
164209115|NCT04235374|593133519|FG001|Overall Study|Unavailable|3|||
164209116|NCT04235374|593133518|FG000|Overall Study|Withdrawal by Subject|0|||
164209117|NCT04235374|593133519|FG001|Overall Study|Withdrawal by Subject|1|||
164209118|NCT04235374|593133518|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
164209119|NCT04235374|593133519|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
164209120|NCT01551173|593133520|FG000|Overall Study|Withdrawal by Subject|11|||
164209121|NCT01551173|593133521|FG001|Overall Study|Withdrawal by Subject|16|||
164209122|NCT01551173|593133520|FG000|Overall Study|Adverse Event|7|||
164209123|NCT01551173|593133521|FG001|Overall Study|Adverse Event|6|||
164209124|NCT01551173|593133520|FG000|Overall Study|Lost to Follow-up|5|||
164209125|NCT01551173|593133521|FG001|Overall Study|Lost to Follow-up|7|||
164209126|NCT01551173|593133520|FG000|Overall Study|Other|5|||
164209127|NCT01551173|593133521|FG001|Overall Study|Other|3|||
164209128|NCT01394276|593133524|FG000|Overall Study|Related Adverse event (AEs)|15|||
164209129|NCT01394276|593133524|FG000|Overall Study|Not related AEs|9|||
164209130|NCT01394276|593133524|FG000|Overall Study|Remission of disease|2|||
164209131|NCT01394276|593133524|FG000|Overall Study|Insufficient therapeutic effect|17|||
164209132|NCT01394276|593133524|FG000|Overall Study|Insufficient compliance|9|||
164209133|NCT01394276|593133524|FG000|Overall Study|Lost to Follow-up|5|||
164209134|NCT01394276|593133524|FG000|Overall Study|Participant moved to another site|1|||
164209135|NCT01394276|593133524|FG000|Overall Study|Pregnancy|1|||
164209136|NCT01394276|593133524|FG000|Overall Study|unavailability of drug at the Hospital|2|||
164209137|NCT01394276|593133524|FG000|Overall Study|Symptoms of concurrent diseases|1|||
164209138|NCT04530344|593133525|FG000|Overall Study|Lost to Follow-up|3|||
164209139|NCT04530344|593133526|FG001|Overall Study|Lost to Follow-up|3|||
164209140|NCT04530344|593133527|FG002|Overall Study|Lost to Follow-up|3|||
164209141|NCT04530344|593133528|FG003|Overall Study|Lost to Follow-up|10|||
164209142|NCT04530344|593133525|FG000|Overall Study|Withdrawal by Subject|14|||
164209143|NCT04530344|593133526|FG001|Overall Study|Withdrawal by Subject|5|||
164209144|NCT04530344|593133527|FG002|Overall Study|Withdrawal by Subject|18|||
164209145|NCT04530344|593133528|FG003|Overall Study|Withdrawal by Subject|33|||
164209146|NCT04530344|593133525|FG000|Overall Study|Adverse Event|0|||
164209147|NCT04530344|593133526|FG001|Overall Study|Adverse Event|0|||
164209148|NCT04530344|593133527|FG002|Overall Study|Adverse Event|0|||
164209149|NCT04530344|593133528|FG003|Overall Study|Adverse Event|1|||
164209150|NCT04530344|593133525|FG000|Overall Study|Lack of Efficacy|0|||
164209151|NCT04530344|593133526|FG001|Overall Study|Lack of Efficacy|0|||
164209152|NCT04530344|593133527|FG002|Overall Study|Lack of Efficacy|0|||
164209153|NCT04530344|593133528|FG003|Overall Study|Lack of Efficacy|1|||
164209154|NCT04530344|593133525|FG000|Overall Study|Physician Decision|0|||
164209155|NCT04530344|593133526|FG001|Overall Study|Physician Decision|0|||
164209156|NCT04530344|593133527|FG002|Overall Study|Physician Decision|1|||
164209157|NCT04530344|593133528|FG003|Overall Study|Physician Decision|1|||
164209158|NCT04530344|593133525|FG000|Overall Study|Pregnancy|0|||
164209159|NCT04530344|593133526|FG001|Overall Study|Pregnancy|0|||
164209160|NCT04530344|593133527|FG002|Overall Study|Pregnancy|2|||
163980017|NCT03016325|592297315|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
163980018|NCT03016325|592297316|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
163980019|NCT03016325|592297317|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
163980020|NCT03016325|592297318|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
163980021|NCT03016325|592297319|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
163980022|NCT03016325|592297312|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163980023|NCT03016325|592297313|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163980024|NCT03016325|592297314|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163980025|NCT03016325|592297315|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
163980026|NCT03016325|592297316|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
163980027|NCT03016325|592297317|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164209161|NCT04530344|593133528|FG003|Overall Study|Pregnancy|1|||
164209162|NCT04530344|593133525|FG000|Overall Study|Protocol Violation|0|||
164209163|NCT04530344|593133526|FG001|Overall Study|Protocol Violation|0|||
164209164|NCT04530344|593133527|FG002|Overall Study|Protocol Violation|0|||
164209165|NCT04530344|593133528|FG003|Overall Study|Protocol Violation|1|||
164209166|NCT04530344|593133525|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
164209167|NCT04530344|593133526|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
163980028|NCT03016325|592297318|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164209168|NCT04530344|593133527|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
164299698|NCT03337308|593472896|FG003|Overall Study|Protocol Violation|0|||
164209169|NCT04530344|593133528|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
164209170|NCT04530344|593133525|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
164209171|NCT04530344|593133526|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
164209172|NCT04530344|593133527|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
164209173|NCT04530344|593133528|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
164209174|NCT04530344|593133525|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
164209175|NCT04530344|593133526|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
164209176|NCT04530344|593133527|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
164209177|NCT04530344|593133528|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
164209178|NCT04530344|593133525|FG000|Overall Study|Personal Reasons|0|||
164209179|NCT04530344|593133526|FG001|Overall Study|Personal Reasons|0|||
164209180|NCT04530344|593133527|FG002|Overall Study|Personal Reasons|0|||
164209181|NCT04530344|593133528|FG003|Overall Study|Personal Reasons|1|||
164209182|NCT04530344|593133525|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
164209183|NCT04530344|593133526|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
164209184|NCT04530344|593133527|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
164209185|NCT04530344|593133528|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
164209186|NCT04478266|593133530|FG000|Overall Study|Adverse Event|20|||
164209187|NCT04478266|593133531|FG001|Overall Study|Adverse Event|21|||
164209188|NCT04478266|593133530|FG000|Overall Study|Progressive disease|146|||
164209189|NCT04478266|593133531|FG001|Overall Study|Progressive disease|168|||
164209190|NCT04478266|593133530|FG000|Overall Study|Poor compliance to protocol|1|||
164209191|NCT04478266|593133531|FG001|Overall Study|Poor compliance to protocol|0|||
164209192|NCT04478266|593133530|FG000|Overall Study|Withdrawal by Subject|19|||
164209193|NCT04478266|593133531|FG001|Overall Study|Withdrawal by Subject|16|||
164209194|NCT04478266|593133530|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
164209195|NCT04478266|593133531|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
164209196|NCT04478266|593133530|FG000|Overall Study|Study terminated by sponsor|33|||
164209197|NCT04478266|593133531|FG001|Overall Study|Study terminated by sponsor|35|||
164209198|NCT04478266|593133530|FG000|Overall Study|Other: unspecified|5|||
164209199|NCT04478266|593133531|FG001|Overall Study|Other: unspecified|7|||
164209200|NCT04478266|593133530|FG000|Overall Study|Randomized but not treated|1|||
164209201|NCT04478266|593133531|FG001|Overall Study|Randomized but not treated|1|||
164209202|NCT04058717|593133532|FG000|Randomization Period|Lost to Follow-up|2|||
164209203|NCT04058717|593133533|FG001|Randomization Period|Lost to Follow-up|3|||
164209204|NCT04058717|593133534|FG002|Randomization Period|Lost to Follow-up|4|||
164209205|NCT04058717|593133535|FG003|Randomization Period|Lost to Follow-up|4|||
164209206|NCT04058717|593133532|FG000|Randomization Period|Withdrawal by Subject|1|||
164209207|NCT04058717|593133533|FG001|Randomization Period|Withdrawal by Subject|3|||
164209208|NCT04058717|593133534|FG002|Randomization Period|Withdrawal by Subject|3|||
164209209|NCT04058717|593133535|FG003|Randomization Period|Withdrawal by Subject|3|||
164209210|NCT04058717|593133532|FG000|Randomization Period|PI decision|0|||
164209211|NCT04058717|593133533|FG001|Randomization Period|PI decision|1|||
164209212|NCT04058717|593133534|FG002|Randomization Period|PI decision|0|||
164209213|NCT04058717|593133535|FG003|Randomization Period|PI decision|0|||
164209214|NCT02799602|593133536|FG000|Overall Study|Protocol Violation|1|||
164209215|NCT02799602|593133537|FG001|Overall Study|Protocol Violation|0|||
164209216|NCT02799602|593133536|FG000|Overall Study|Physician Decision|5|||
164209217|NCT02799602|593133537|FG001|Overall Study|Physician Decision|6|||
163875833|NCT03807778|591912924|FG000|Overall Study|Progressive Disease|4|||
163875834|NCT03807778|591912925|FG001|Overall Study|Progressive Disease|2|||
163875835|NCT03807778|591912926|FG002|Overall Study|Progressive Disease|8|||
163875836|NCT03807778|591912927|FG003|Overall Study|Progressive Disease|15|||
163875837|NCT03807778|591912924|FG000|Overall Study|Symptomatic Deterioration|0|||
163875838|NCT03807778|591912925|FG001|Overall Study|Symptomatic Deterioration|1|||
163875839|NCT03807778|591912926|FG002|Overall Study|Symptomatic Deterioration|0|||
163875840|NCT03807778|591912927|FG003|Overall Study|Symptomatic Deterioration|1|||
163875841|NCT03807778|591912924|FG000|Overall Study|Withdrawal by Subject|0|||
163875842|NCT03807778|591912925|FG001|Overall Study|Withdrawal by Subject|1|||
163875843|NCT03807778|591912926|FG002|Overall Study|Withdrawal by Subject|0|||
163875844|NCT03807778|591912927|FG003|Overall Study|Withdrawal by Subject|1|||
163875845|NCT03807778|591912924|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
163980029|NCT03016325|592297319|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
164209218|NCT02799602|593133536|FG000|Overall Study|Lost to Follow-up|4|||
164209219|NCT02799602|593133537|FG001|Overall Study|Lost to Follow-up|2|||
164209220|NCT02799602|593133536|FG000|Overall Study|Additional primary malignancy|11|||
164209221|NCT02799602|593133537|FG001|Overall Study|Additional primary malignancy|6|||
164209222|NCT02799602|593133536|FG000|Overall Study|Non-compliance with study drug|14|||
164209223|NCT02799602|593133537|FG001|Overall Study|Non-compliance with study drug|12|||
164324245|NCT02038829|593565147|FG000|Washout Period 4|Adverse Event|0|||
163875846|NCT03807778|591912925|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
163875847|NCT03807778|591912926|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
164076872|NCT04556838|592645864|FG000|Overall Study|Adverse Event|0|||
164209224|NCT02799602|593133536|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
164209225|NCT02799602|593133537|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
164209226|NCT02799602|593133536|FG000|Overall Study|Withdrawal by Subject|26|||
164209227|NCT02799602|593133537|FG001|Overall Study|Withdrawal by Subject|40|||
164209228|NCT02799602|593133536|FG000|Overall Study|Progressive disease - clinical progression|131|||
164209229|NCT02799602|593133537|FG001|Overall Study|Progressive disease - clinical progression|276|||
164209230|NCT02799602|593133536|FG000|Overall Study|Progressive disease - radiological progression|90|||
164209231|NCT02799602|593133537|FG001|Overall Study|Progressive disease - radiological progression|133|||
164209232|NCT02799602|593133536|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
164209233|NCT02799602|593133537|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
164209234|NCT02799602|593133536|FG000|Overall Study|Death|9|||
164209235|NCT02799602|593133537|FG001|Overall Study|Death|5|||
164209236|NCT02799602|593133536|FG000|Overall Study|Other|287|||
164209237|NCT02799602|593133537|FG001|Overall Study|Other|118|||
164209238|NCT02799602|593133536|FG000|Overall Study|Study drug never administered|0|||
164209239|NCT02799602|593133537|FG001|Overall Study|Study drug never administered|3|||
164209240|NCT04809974|593135177|FG000|Lead-in Phase|Withdrawal by Subject|3|||
164209241|NCT04809974|593135178|FG001|Lead-in Phase|Withdrawal by Subject|0|||
164209242|NCT04809974|593135179|FG002|Lead-in Phase|Withdrawal by Subject|0|||
164209243|NCT04809974|593135177|FG000|Lead-in Phase|No longer eligible|11|||
164209244|NCT04809974|593135178|FG001|Lead-in Phase|No longer eligible|0|||
164209245|NCT04809974|593135179|FG002|Lead-in Phase|No longer eligible|0|||
164209246|NCT04809974|593135177|FG000|Randomized Phase|Lost to Follow-up|0|||
164209247|NCT04809974|593135178|FG001|Randomized Phase|Lost to Follow-up|1|||
164209248|NCT04809974|593135179|FG002|Randomized Phase|Lost to Follow-up|5|||
164209249|NCT04809974|593135177|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
164209250|NCT04809974|593135178|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
164209251|NCT04809974|593135179|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
164209252|NCT04809974|593135177|FG000|Randomized Phase|Adverse Event|0|||
164209253|NCT04809974|593135178|FG001|Randomized Phase|Adverse Event|1|||
164209254|NCT04809974|593135179|FG002|Randomized Phase|Adverse Event|4|||
164209255|NCT04809974|593135177|FG000|Randomized Phase|Withdrawal by Subject|0|||
164209256|NCT04809974|593135178|FG001|Randomized Phase|Withdrawal by Subject|0|||
164209257|NCT04809974|593135179|FG002|Randomized Phase|Withdrawal by Subject|5|||
164209258|NCT04338581|593135180|FG000|Overall Study|Lack of Efficacy|1|||
164209259|NCT04338581|593135181|FG001|Overall Study|Lack of Efficacy|0|||
164209260|NCT04338581|593135180|FG000|Overall Study|Withdrawal by Subject|4|||
164209261|NCT04338581|593135181|FG001|Overall Study|Withdrawal by Subject|4|||
164209262|NCT04338581|593135180|FG000|Overall Study|Prohibited Medication|1|||
164209263|NCT04338581|593135181|FG001|Overall Study|Prohibited Medication|0|||
164209264|NCT00549055|593135182|FG000|Overall Study|Adverse Event|4|||
164209265|NCT00549055|593135182|FG000|Overall Study|Lack of Efficacy|18|||
164209266|NCT00549055|593135182|FG000|Overall Study|Stabilization|5|||
164209267|NCT00549055|593135182|FG000|Overall Study|Progression to fibrosis|2|||
164209268|NCT00549055|593135182|FG000|Overall Study|Decrease of size|1|||
164209269|NCT00549055|593135182|FG000|Overall Study|Active choroidal neovascula increased|1|||
164209270|NCT00549055|593135182|FG000|Overall Study|Vitreous hemorrhage|1|||
164209271|NCT00549055|593135182|FG000|Overall Study|Growth choroidal neovascularisation|1|||
164209272|NCT00549055|593135182|FG000|Overall Study|Choroidal neovascularization|1|||
164209273|NCT00549055|593135182|FG000|Overall Study|Very low visual acuity (VA)|1|||
164209274|NCT00770809|593135183|FG000|Overall Study|Adverse Event|9|||
164209275|NCT00770809|593135184|FG001|Overall Study|Adverse Event|1|||
164209276|NCT00770809|593135185|FG002|Overall Study|Adverse Event|12|||
164209277|NCT00770809|593135183|FG000|Overall Study|Death|1|||
164209278|NCT00770809|593135184|FG001|Overall Study|Death|0|||
164209279|NCT00770809|593135185|FG002|Overall Study|Death|0|||
164209280|NCT00770809|593135183|FG000|Overall Study|Withdrawal by Subject|3|||
164209281|NCT00770809|593135184|FG001|Overall Study|Withdrawal by Subject|3|||
164209282|NCT00770809|593135185|FG002|Overall Study|Withdrawal by Subject|7|||
164209283|NCT00770809|593135183|FG000|Overall Study|Progression|2|||
164209284|NCT00770809|593135184|FG001|Overall Study|Progression|2|||
164209285|NCT00770809|593135185|FG002|Overall Study|Progression|0|||
164209286|NCT00770809|593135183|FG000|Overall Study|Complicating illness|0|||
164209287|NCT00770809|593135184|FG001|Overall Study|Complicating illness|0|||
164209288|NCT00770809|593135185|FG002|Overall Study|Complicating illness|1|||
164209289|NCT00770809|593135183|FG000|Overall Study|Other Medical Reasons|2|||
163980030|NCT03016325|592297312|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
164076873|NCT04556838|592645865|FG001|Overall Study|Adverse Event|1|||
164209290|NCT00770809|593135184|FG001|Overall Study|Other Medical Reasons|4|||
164209291|NCT00770809|593135185|FG002|Overall Study|Other Medical Reasons|3|||
164209292|NCT00770367|593135188|FG000|First Intervention|Withdrawal by Subject|0|||
164209293|NCT00770367|593135189|FG001|First Intervention|Withdrawal by Subject|2|||
164209294|NCT00770367|593135188|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
164076874|NCT04556838|592645866|FG002|Overall Study|Adverse Event|1|||
164076875|NCT04556838|592645864|FG000|Overall Study|Lost to Follow-up|0|||
164076876|NCT04556838|592645865|FG001|Overall Study|Lost to Follow-up|0|||
164076877|NCT04556838|592645866|FG002|Overall Study|Lost to Follow-up|2|||
164076878|NCT04556838|592645864|FG000|Overall Study|Subject travel|0|||
164076879|NCT04556838|592645865|FG001|Overall Study|Subject travel|1|||
164076880|NCT04556838|592645866|FG002|Overall Study|Subject travel|0|||
164076881|NCT04556838|592645864|FG000|Overall Study|Physician Decision|1|||
164076882|NCT04556838|592645865|FG001|Overall Study|Physician Decision|0|||
164076883|NCT04556838|592645866|FG002|Overall Study|Physician Decision|0|||
164076884|NCT03877237|592647786|FG000|Overall Study|Adverse Event|1|||
164076885|NCT03877237|592647787|FG001|Overall Study|Adverse Event|2|||
164076886|NCT03877237|592647786|FG000|Overall Study|Death|3|||
164076887|NCT03877237|592647787|FG001|Overall Study|Death|2|||
164076888|NCT03877237|592647786|FG000|Overall Study|Physician Decision|1|||
164076889|NCT03877237|592647787|FG001|Overall Study|Physician Decision|0|||
164076890|NCT03877237|592647786|FG000|Overall Study|Withdrawal by Subject|0|||
164076891|NCT03877237|592647787|FG001|Overall Study|Withdrawal by Subject|2|||
164076892|NCT00382291|592647788|FG000|Overall Study|Adverse Event|1|||
164076893|NCT00382291|592647789|FG001|Overall Study|Adverse Event|2|||
164076894|NCT00382291|592647790|FG002|Overall Study|Adverse Event|2|||
164076895|NCT00382291|592647788|FG000|Overall Study|Protocol Violation|1|||
164076896|NCT00382291|592647789|FG001|Overall Study|Protocol Violation|0|||
164076897|NCT00382291|592647790|FG002|Overall Study|Protocol Violation|0|||
164076898|NCT00382291|592647788|FG000|Overall Study|Temporary study suspension|2|||
164076899|NCT00382291|592647789|FG001|Overall Study|Temporary study suspension|2|||
164076900|NCT00382291|592647790|FG002|Overall Study|Temporary study suspension|5|||
164076901|NCT00382291|592647788|FG000|Overall Study|Withdrawal by Subject|0|||
164076902|NCT00382291|592647789|FG001|Overall Study|Withdrawal by Subject|2|||
164076903|NCT00382291|592647790|FG002|Overall Study|Withdrawal by Subject|0|||
164076904|NCT00382291|592647788|FG000|Overall Study|Physician Decision|0|||
164076905|NCT00382291|592647789|FG001|Overall Study|Physician Decision|1|||
164076906|NCT00382291|592647790|FG002|Overall Study|Physician Decision|0|||
164076907|NCT00382291|592647788|FG000|Overall Study|Lack of Efficacy|0|||
164076908|NCT00382291|592647789|FG001|Overall Study|Lack of Efficacy|0|||
164076909|NCT00382291|592647790|FG002|Overall Study|Lack of Efficacy|1|||
164076910|NCT02266706|592647791|FG000|Overall Study|Withdrawal by Subject|0|||
164076911|NCT02266706|592647792|FG001|Overall Study|Withdrawal by Subject|1|||
164076912|NCT02266706|592647793|FG002|Overall Study|Withdrawal by Subject|1|||
164076913|NCT02266706|592647794|FG003|Overall Study|Withdrawal by Subject|0|||
164076914|NCT02266706|592647795|FG004|Overall Study|Withdrawal by Subject|0|||
164076915|NCT02266706|592647796|FG005|Overall Study|Withdrawal by Subject|1|||
164076916|NCT02266706|592647797|FG006|Overall Study|Withdrawal by Subject|0|||
164076917|NCT02266706|592647798|FG007|Overall Study|Withdrawal by Subject|0|||
164076918|NCT02266706|592647799|FG008|Overall Study|Withdrawal by Subject|0|||
164076919|NCT02266706|592647791|FG000|Overall Study|Screen failure|0|||
164076920|NCT02266706|592647792|FG001|Overall Study|Screen failure|0|||
164076921|NCT02266706|592647793|FG002|Overall Study|Screen failure|0|||
164076922|NCT02266706|592647794|FG003|Overall Study|Screen failure|0|||
164076923|NCT02266706|592647795|FG004|Overall Study|Screen failure|0|||
164076924|NCT02266706|592647796|FG005|Overall Study|Screen failure|1|||
164076925|NCT02266706|592647797|FG006|Overall Study|Screen failure|1|||
164076926|NCT02266706|592647798|FG007|Overall Study|Screen failure|0|||
164076927|NCT02266706|592647799|FG008|Overall Study|Screen failure|0|||
164076928|NCT02266706|592647791|FG000|Overall Study|Enrollment in another study|0|||
164076929|NCT02266706|592647792|FG001|Overall Study|Enrollment in another study|0|||
164076930|NCT02266706|592647793|FG002|Overall Study|Enrollment in another study|0|||
164076931|NCT02266706|592647794|FG003|Overall Study|Enrollment in another study|1|||
164076932|NCT02266706|592647795|FG004|Overall Study|Enrollment in another study|0|||
164076933|NCT02266706|592647796|FG005|Overall Study|Enrollment in another study|0|||
164076934|NCT02266706|592647797|FG006|Overall Study|Enrollment in another study|0|||
164076935|NCT02266706|592647798|FG007|Overall Study|Enrollment in another study|0|||
164076936|NCT02266706|592647799|FG008|Overall Study|Enrollment in another study|0|||
164076937|NCT02270983|592647801|FG000|Overall Study|Adverse Event|3|||
164209295|NCT00770367|593135189|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
164209296|NCT00770367|593135188|FG000|Second Intervention|Lost to Follow-up|2|||
164209297|NCT00770367|593135189|FG001|Second Intervention|Lost to Follow-up|0|||
164076938|NCT02270983|592647802|FG001|Overall Study|Adverse Event|2|||
164076939|NCT02270983|592647803|FG002|Overall Study|Adverse Event|6|||
164076940|NCT02270983|592647801|FG000|Overall Study|Lack of Efficacy|2|||
164076941|NCT02270983|592647802|FG001|Overall Study|Lack of Efficacy|1|||
164076942|NCT02270983|592647803|FG002|Overall Study|Lack of Efficacy|1|||
164076943|NCT02270983|592647801|FG000|Overall Study|Withdrawal by Subject|1|||
164076944|NCT02270983|592647802|FG001|Overall Study|Withdrawal by Subject|0|||
164076945|NCT02270983|592647803|FG002|Overall Study|Withdrawal by Subject|2|||
164076946|NCT02270983|592647801|FG000|Overall Study|Lost to Follow-up|1|||
164076947|NCT02270983|592647802|FG001|Overall Study|Lost to Follow-up|1|||
164076948|NCT02270983|592647803|FG002|Overall Study|Lost to Follow-up|2|||
164076949|NCT02270983|592647801|FG000|Overall Study|Protocol Violation|1|||
164209298|NCT00435942|593135190|FG000|Overall Study|Death|17|||
164209299|NCT00435942|593135191|FG001|Overall Study|Death|10|||
164209300|NCT00435942|593135190|FG000|Overall Study|Withdrawal by Subject|2|||
164209301|NCT00435942|593135191|FG001|Overall Study|Withdrawal by Subject|0|||
164209302|NCT00435942|593135190|FG000|Overall Study|Lost to Follow-up|0|||
164209303|NCT00435942|593135191|FG001|Overall Study|Lost to Follow-up|16|||
164209304|NCT00435942|593135190|FG000|Overall Study|Conversion to Open Repair|1|||
164209305|NCT00435942|593135191|FG001|Overall Study|Conversion to Open Repair|0|||
164209306|NCT00435942|593135190|FG000|Overall Study|Technical Failure|3|||
164209307|NCT00435942|593135191|FG001|Overall Study|Technical Failure|0|||
164209308|NCT00435942|593135190|FG000|Overall Study|Other|0|||
164209309|NCT00435942|593135191|FG001|Overall Study|Other|1|||
164209310|NCT01898130|593135192|FG000|Treatment|Withdrawal by Subject|2|||
164209311|NCT01898130|593135192|FG000|Treatment|Progressive Disease|4|||
164209312|NCT01898130|593135192|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
164209313|NCT04115059|593135193|FG000|Overall Study|Withdrawal by Subject|1|||
164209314|NCT04115059|593135193|FG000|Overall Study|Lack of Efficacy|2|||
164209315|NCT04491994|593135194|FG000|Overall Study|Withdrawal by Subject|10|||
164209316|NCT04491994|593135195|FG001|Overall Study|Withdrawal by Subject|5|||
164209317|NCT04491994|593135194|FG000|Overall Study|developed fever > 3 days|4|||
164209318|NCT04491994|593135195|FG001|Overall Study|developed fever > 3 days|1|||
164209319|NCT04491994|593135194|FG000|Overall Study|Protocol Violation|11|||
164209320|NCT04491994|593135195|FG001|Overall Study|Protocol Violation|2|||
164209321|NCT04491994|593135194|FG000|Overall Study|Lost to Follow-up|4|||
164209322|NCT04491994|593135195|FG001|Overall Study|Lost to Follow-up|3|||
164209323|NCT03575364|593135201|FG000|Overall Study|Death|45|||
164209324|NCT03575364|593135201|FG000|Overall Study|Lost to Follow-up|114|||
164209325|NCT03575364|593135201|FG000|Overall Study|Withdrawal by Subject|21|||
164209326|NCT03575364|593135201|FG000|Overall Study|Physician Decision|11|||
164209327|NCT03575364|593135201|FG000|Overall Study|Subject Refused Follow-up|13|||
164209328|NCT03575364|593135201|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
164209329|NCT03575364|593135201|FG000|Overall Study|Patient moved out of the state|1|||
164209330|NCT03575364|593135201|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
164209331|NCT03575364|593135201|FG000|Overall Study|Patient is lost to follow up|1|||
164209332|NCT03575364|593135201|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
164209333|NCT02567188|593135202|FG000|Overall Study|Death|10|||
164209334|NCT02567188|593135202|FG000|Overall Study|Terminated Mircera Treatment|9|||
164209335|NCT02567188|593135202|FG000|Overall Study|Lost to Follow-up|5|||
164209336|NCT02567188|593135202|FG000|Overall Study|Adverse Event|1|||
164209337|NCT02567188|593135202|FG000|Overall Study|Withdrawal by Subject|1|||
164209338|NCT02567188|593135202|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
164209339|NCT02567188|593135202|FG000|Overall Study|Moved and Changed Clinic|1|||
164209340|NCT02567188|593135202|FG000|Overall Study|Started Hemodialysis|2|||
164209341|NCT02567188|593135202|FG000|Overall Study|Protocol Violation|5|||
164209342|NCT01033136|593135203|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
164209343|NCT01033136|593135204|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
164209344|NCT05383209|593135205|FG000|Overall Study|Adverse Event: Non-ocular|0|||
164209345|NCT05383209|593135206|FG001|Overall Study|Adverse Event: Non-ocular|1|||
164209346|NCT05383209|593135207|FG002|Overall Study|Adverse Event: Non-ocular|0|||
164209347|NCT05383209|593135205|FG000|Overall Study|Lost to Follow-up|2|||
164209348|NCT05383209|593135206|FG001|Overall Study|Lost to Follow-up|1|||
164209349|NCT05383209|593135207|FG002|Overall Study|Lost to Follow-up|4|||
164209350|NCT05383209|593135205|FG000|Overall Study|Withdrawal by Subject|2|||
164209351|NCT05383209|593135206|FG001|Overall Study|Withdrawal by Subject|0|||
164209352|NCT05383209|593135207|FG002|Overall Study|Withdrawal by Subject|1|||
163875848|NCT03807778|591912927|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
163875849|NCT01207492|591912928|FG000|Overall Study|Still on study|1|||
163875850|NCT01207492|591912928|FG000|Overall Study|Withdrawal by Subject|9|||
163875851|NCT01207492|591912928|FG000|Overall Study|Physician Decision|1|||
163875852|NCT01207492|591912928|FG000|Overall Study|Progressive disease|3|||
163875853|NCT01207492|591912928|FG000|Overall Study|Toxicity|1|||
163875854|NCT03582722|591912929|FG000|Overall Study|Lost to Follow-up|1|||
163875855|NCT03582722|591912930|FG001|Overall Study|Lost to Follow-up|4|||
163875856|NCT03582722|591912929|FG000|Overall Study|Withdrawal by Subject|3|||
163875857|NCT03582722|591912930|FG001|Overall Study|Withdrawal by Subject|3|||
163875858|NCT00424463|591912931|FG000|Overall Study|Adverse Event|2|||
163875859|NCT00424463|591912932|FG001|Overall Study|Adverse Event|3|||
163875860|NCT00424463|591912933|FG002|Overall Study|Adverse Event|2|||
163875861|NCT00424463|591912931|FG000|Overall Study|Physician Decision|0|||
164209353|NCT05383209|593135205|FG000|Overall Study|Death|1|||
164209354|NCT05383209|593135206|FG001|Overall Study|Death|0|||
164209355|NCT05383209|593135207|FG002|Overall Study|Death|0|||
164209356|NCT05383209|593135205|FG000|Overall Study|Other|0|||
164209357|NCT05383209|593135206|FG001|Overall Study|Other|1|||
164209358|NCT05383209|593135207|FG002|Overall Study|Other|0|||
164209359|NCT00933933|593135209|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
163875862|NCT00424463|591912932|FG001|Overall Study|Physician Decision|2|||
164076950|NCT02270983|592647802|FG001|Overall Study|Protocol Violation|1|||
164076951|NCT02270983|592647803|FG002|Overall Study|Protocol Violation|1|||
164076952|NCT02270983|592647801|FG000|Overall Study|family emergency|0|||
164076953|NCT02270983|592647802|FG001|Overall Study|family emergency|1|||
164076954|NCT02270983|592647803|FG002|Overall Study|family emergency|0|||
164076955|NCT02270983|592647801|FG000|Overall Study|study procedure non-compliance|1|||
164076956|NCT02270983|592647802|FG001|Overall Study|study procedure non-compliance|0|||
164076957|NCT02270983|592647803|FG002|Overall Study|study procedure non-compliance|0|||
164076958|NCT02270983|592647801|FG000|Overall Study|moved away from study site|0|||
164076959|NCT02270983|592647802|FG001|Overall Study|moved away from study site|1|||
164076960|NCT02270983|592647803|FG002|Overall Study|moved away from study site|0|||
164076961|NCT03237611|592647805|FG000|Overall Study|Withdrawal by Subject|1|||
164076962|NCT03237611|592647805|FG000|Overall Study|Ineligible|1|||
164076963|NCT02919475|592647809|FG000|Overall Study|Adverse Event|3|||
164076964|NCT02919475|592647810|FG001|Overall Study|Adverse Event|3|||
164076965|NCT02919475|592647811|FG002|Overall Study|Adverse Event|3|||
164076966|NCT02919475|592647812|FG003|Overall Study|Adverse Event|9|||
164076967|NCT02919475|592647813|FG004|Overall Study|Adverse Event|2|||
164076968|NCT02919475|592647809|FG000|Overall Study|Death|0|||
164076969|NCT02919475|592647810|FG001|Overall Study|Death|1|||
164076970|NCT02919475|592647811|FG002|Overall Study|Death|0|||
164076971|NCT02919475|592647812|FG003|Overall Study|Death|0|||
164076972|NCT02919475|592647813|FG004|Overall Study|Death|0|||
164076973|NCT02919475|592647809|FG000|Overall Study|Lost to Follow-up|0|||
164076974|NCT02919475|592647810|FG001|Overall Study|Lost to Follow-up|0|||
164076975|NCT02919475|592647811|FG002|Overall Study|Lost to Follow-up|0|||
164076976|NCT02919475|592647812|FG003|Overall Study|Lost to Follow-up|1|||
164076977|NCT02919475|592647813|FG004|Overall Study|Lost to Follow-up|0|||
164076978|NCT02919475|592647809|FG000|Overall Study|Withdrawal by Subject|2|||
164076979|NCT02919475|592647810|FG001|Overall Study|Withdrawal by Subject|3|||
164076980|NCT02919475|592647811|FG002|Overall Study|Withdrawal by Subject|1|||
164076981|NCT02919475|592647812|FG003|Overall Study|Withdrawal by Subject|2|||
164076982|NCT02919475|592647813|FG004|Overall Study|Withdrawal by Subject|2|||
164076983|NCT02919475|592647809|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164076984|NCT02919475|592647810|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164076985|NCT02919475|592647811|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164076986|NCT02919475|592647812|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164076987|NCT02919475|592647813|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164076988|NCT00275028|592647814|FG000|Overall Study|Withdrew consent before treatment began|1|||
164076989|NCT00275028|592647814|FG000|Overall Study|Withdrawal by Subject|5|||
164076990|NCT00275028|592647814|FG000|Overall Study|Adverse Event|9|||
164076991|NCT00275028|592647814|FG000|Overall Study|Progressive Disease|30|||
164076992|NCT00275028|592647814|FG000|Overall Study|Physician Decision|2|||
164076993|NCT02323295|592647819|FG000|Overall Study|Adverse Event|0|||
164076994|NCT02323295|592647820|FG001|Overall Study|Adverse Event|1|||
164076995|NCT02323295|592647819|FG000|Overall Study|Withdrawal by Subject|0|||
164076996|NCT02323295|592647820|FG001|Overall Study|Withdrawal by Subject|1|||
164076997|NCT02323295|592647819|FG000|Overall Study|Patient did not have surgery as planned.|0|||
164076998|NCT02323295|592647820|FG001|Overall Study|Patient did not have surgery as planned.|1|||
164076999|NCT02370784|592647823|FG000|Overall Study|Patient started prohibited medication|0|||
164077000|NCT02370784|592647824|FG001|Overall Study|Patient started prohibited medication|1|||
164077001|NCT01059071|592647825|FG000|Overall Study|Lack of Efficacy|1|||
164077002|NCT01059071|592647826|FG001|Overall Study|Lack of Efficacy|4|||
164077003|NCT01059071|592647827|FG002|Overall Study|Lack of Efficacy|2|||
164077004|NCT01059071|592647828|FG003|Overall Study|Lack of Efficacy|3|||
164077005|NCT01059071|592647825|FG000|Overall Study|Withdrawal by Subject|1|||
164077006|NCT01059071|592647826|FG001|Overall Study|Withdrawal by Subject|0|||
164077007|NCT01059071|592647827|FG002|Overall Study|Withdrawal by Subject|0|||
164077008|NCT01059071|592647828|FG003|Overall Study|Withdrawal by Subject|2|||
164077009|NCT01059071|592647825|FG000|Overall Study|Physician Decision|0|||
164077010|NCT01059071|592647826|FG001|Overall Study|Physician Decision|0|||
164077011|NCT01059071|592647827|FG002|Overall Study|Physician Decision|0|||
164077012|NCT01059071|592647828|FG003|Overall Study|Physician Decision|1|||
164077013|NCT02962882|592647829|FG000|Overall Study|Adverse Event|2|||
164077014|NCT02962882|592647829|FG000|Overall Study|Withdrawal by Subject|2|||
164077015|NCT02962882|592647829|FG000|Overall Study|Transfer from ICU|32|||
164077016|NCT04741503|592647830|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
164077017|NCT04741503|592647831|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
164077018|NCT04741503|592647832|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
164077019|NCT04741503|592647830|FG000|Initial Enrollment|Overquotas removed|0|||
164077020|NCT04741503|592647831|FG001|Initial Enrollment|Overquotas removed|0|||
164077021|NCT04741503|592647832|FG002|Initial Enrollment|Overquotas removed|186|||
164077022|NCT04741503|592647830|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
164136548|NCT00389831|592862185|FG000|Overall Study|Lost to Follow-up|0|||
164136549|NCT00389831|592862186|FG001|Overall Study|Lost to Follow-up|1|||
164209360|NCT00933933|593135210|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
164209361|NCT00933933|593135211|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
164209362|NCT00933933|593135209|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
164209363|NCT00933933|593135210|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
164209364|NCT00933933|593135211|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
164209365|NCT01138046|593135214|FG000|Overall Study|Withdrawal due to death|6|||
164209366|NCT01104766|593135218|FG000|Overall Study|Did not meet inc/exc criteria|1|||
164209367|NCT01104766|593135219|FG001|Overall Study|Did not meet inc/exc criteria|0|||
164209368|NCT01104766|593135220|FG002|Overall Study|Did not meet inc/exc criteria|0|||
164209369|NCT01104766|593135221|FG003|Overall Study|Did not meet inc/exc criteria|0|||
164209370|NCT01104766|593135218|FG000|Overall Study|Adverse Event|17|||
164209371|NCT01104766|593135219|FG001|Overall Study|Adverse Event|15|||
164209372|NCT01104766|593135220|FG002|Overall Study|Adverse Event|20|||
164209373|NCT01104766|593135221|FG003|Overall Study|Adverse Event|14|||
164209374|NCT01104766|593135218|FG000|Overall Study|Lack of Efficacy|20|||
164209375|NCT01104766|593135219|FG001|Overall Study|Lack of Efficacy|15|||
164209376|NCT01104766|593135220|FG002|Overall Study|Lack of Efficacy|14|||
164209377|NCT01104766|593135221|FG003|Overall Study|Lack of Efficacy|8|||
164209378|NCT01104766|593135218|FG000|Overall Study|Protocol Violation|2|||
164209379|NCT01104766|593135219|FG001|Overall Study|Protocol Violation|0|||
164209380|NCT01104766|593135220|FG002|Overall Study|Protocol Violation|0|||
164209381|NCT01104766|593135221|FG003|Overall Study|Protocol Violation|0|||
164209382|NCT01104766|593135218|FG000|Overall Study|Withdrawal by Subject|17|||
164209383|NCT01104766|593135219|FG001|Overall Study|Withdrawal by Subject|19|||
164209384|NCT01104766|593135220|FG002|Overall Study|Withdrawal by Subject|25|||
164209385|NCT01104766|593135221|FG003|Overall Study|Withdrawal by Subject|15|||
164209386|NCT01104766|593135218|FG000|Overall Study|Lost to Follow-up|1|||
164209387|NCT01104766|593135219|FG001|Overall Study|Lost to Follow-up|2|||
164209388|NCT01104766|593135220|FG002|Overall Study|Lost to Follow-up|1|||
164209389|NCT01104766|593135221|FG003|Overall Study|Lost to Follow-up|1|||
164209390|NCT05452239|593135224|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
164209391|NCT05452239|593135225|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
164209392|NCT05452239|593135224|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
164209393|NCT05452239|593135225|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
164209394|NCT05452239|593135224|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
164209395|NCT05452239|593135225|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
164209396|NCT05452239|593135224|FG000|Placebo-controlled Period|Randomized but not treated|2|||
164209397|NCT05452239|593135225|FG001|Placebo-controlled Period|Randomized but not treated|2|||
164209398|NCT05452239|593135224|FG000|Placebo-controlled Period|Other than specified|1|||
164209399|NCT05452239|593135225|FG001|Placebo-controlled Period|Other than specified|1|||
164209400|NCT05452239|593135224|FG000|Open-label Period|Withdrawal by Subject|2|||
164209401|NCT05452239|593135225|FG001|Open-label Period|Withdrawal by Subject|1|||
164209402|NCT05452239|593135224|FG000|Open-label Period|Lost to Follow-up|3|||
164209403|NCT05452239|593135225|FG001|Open-label Period|Lost to Follow-up|0|||
164209404|NCT05452239|593135224|FG000|Open-label Period|Other than specified|1|||
164209405|NCT05452239|593135225|FG001|Open-label Period|Other than specified|2|||
164209406|NCT03965923|593135226|FG000|Overall Study|Withdrawal by Subject|1|||
164209407|NCT03965923|593135227|FG001|Overall Study|Withdrawal by Subject|2|||
164209408|NCT03965923|593135228|FG002|Overall Study|Withdrawal by Subject|3|||
164209409|NCT03965923|593135229|FG003|Overall Study|Withdrawal by Subject|1|||
164209410|NCT03965923|593135230|FG004|Overall Study|Withdrawal by Subject|2|||
164209411|NCT03965923|593135231|FG005|Overall Study|Withdrawal by Subject|0|||
164209412|NCT03965923|593135232|FG006|Overall Study|Withdrawal by Subject|4|||
164209413|NCT03965923|593135233|FG007|Overall Study|Withdrawal by Subject|3|||
164209414|NCT03965923|593135234|FG008|Overall Study|Withdrawal by Subject|4|||
164209415|NCT03965923|593135235|FG009|Overall Study|Withdrawal by Subject|0|||
164209416|NCT03965923|593135236|FG010|Overall Study|Withdrawal by Subject|2|||
164209417|NCT03965923|593135237|FG011|Overall Study|Withdrawal by Subject|0|||
164209418|NCT03965923|593135226|FG000|Overall Study|Lost to Follow-up|2|||
164209419|NCT03965923|593135227|FG001|Overall Study|Lost to Follow-up|1|||
164209420|NCT03965923|593135228|FG002|Overall Study|Lost to Follow-up|1|||
164209421|NCT03965923|593135229|FG003|Overall Study|Lost to Follow-up|0|||
164209422|NCT03965923|593135230|FG004|Overall Study|Lost to Follow-up|2|||
164209423|NCT03965923|593135231|FG005|Overall Study|Lost to Follow-up|1|||
164209424|NCT03965923|593135232|FG006|Overall Study|Lost to Follow-up|2|||
164209425|NCT03965923|593135233|FG007|Overall Study|Lost to Follow-up|1|||
164209426|NCT03965923|593135234|FG008|Overall Study|Lost to Follow-up|0|||
163875863|NCT00424463|591912933|FG002|Overall Study|Physician Decision|2|||
163875864|NCT00424463|591912931|FG000|Overall Study|Withdrawal by Subject|4|||
163875865|NCT00424463|591912932|FG001|Overall Study|Withdrawal by Subject|2|||
163875866|NCT00424463|591912933|FG002|Overall Study|Withdrawal by Subject|5|||
163875867|NCT00424463|591912931|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
163875868|NCT00424463|591912932|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
163875869|NCT00424463|591912933|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
164209427|NCT03965923|593135235|FG009|Overall Study|Lost to Follow-up|2|||
164209428|NCT03965923|593135236|FG010|Overall Study|Lost to Follow-up|0|||
164209429|NCT03965923|593135237|FG011|Overall Study|Lost to Follow-up|0|||
164209430|NCT03965923|593135226|FG000|Overall Study|Death|0|||
164209431|NCT03965923|593135227|FG001|Overall Study|Death|0|||
164209432|NCT03965923|593135228|FG002|Overall Study|Death|0|||
164209433|NCT03965923|593135229|FG003|Overall Study|Death|0|||
164209434|NCT03965923|593135230|FG004|Overall Study|Death|0|||
164077023|NCT04741503|592647831|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
164077024|NCT04741503|592647832|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
164077025|NCT00881959|592647843|FG000|Overall Study|Lost to Follow-up|2|||
164077026|NCT00881959|592647844|FG001|Overall Study|Lost to Follow-up|4|||
164077027|NCT02791659|592647845|FG000|Overall Study|Protocol Violation|0|||
164077028|NCT02791659|592647846|FG001|Overall Study|Protocol Violation|1|||
164077029|NCT01904383|592647847|FG000|Overall Study|CRF not collected|117|||
164077030|NCT01904383|592647847|FG000|Overall Study|Reason not listed|147|||
164077031|NCT01904383|592647847|FG000|Overall Study|Lost to Follow-up|674|||
164077032|NCT01904383|592647847|FG000|Overall Study|Lack of Efficacy|370|||
164077033|NCT01904383|592647847|FG000|Overall Study|Improvement|141|||
164077034|NCT01904383|592647847|FG000|Overall Study|Adverse Event|271|||
164077035|NCT01904383|592647847|FG000|Overall Study|No patient visit after entry|54|||
164077036|NCT04313283|592647850|FG000|Overall Study|did not complete intervention|4|||
164077037|NCT04356573|592647851|FG000|Overall Study|Didn't Qualify|1|||
164077038|NCT04356573|592647852|FG001|Overall Study|Didn't Qualify|0|||
164077039|NCT00472446|592647855|FG000|Overall Study|Protocol Violation|0|||
164077040|NCT00472446|592647856|FG001|Overall Study|Protocol Violation|0|||
164077041|NCT00472446|592647857|FG002|Overall Study|Protocol Violation|0|||
164077042|NCT00472446|592647858|FG003|Overall Study|Protocol Violation|1|||
164077043|NCT00472446|592647855|FG000|Overall Study|Reintervention|0|||
164077044|NCT00472446|592647856|FG001|Overall Study|Reintervention|0|||
164077045|NCT00472446|592647857|FG002|Overall Study|Reintervention|1|||
164077046|NCT00472446|592647858|FG003|Overall Study|Reintervention|1|||
164077047|NCT00472446|592647855|FG000|Overall Study|Questionnaires not returned|5|||
164077048|NCT00472446|592647856|FG001|Overall Study|Questionnaires not returned|6|||
164077049|NCT00472446|592647857|FG002|Overall Study|Questionnaires not returned|6|||
164077050|NCT00472446|592647858|FG003|Overall Study|Questionnaires not returned|4|||
164077051|NCT03211156|592647859|FG000|Overall Study|Withdrawal by Subject|0|||
164077052|NCT03211156|592647860|FG001|Overall Study|Withdrawal by Subject|2|||
164077053|NCT03211156|592647859|FG000|Overall Study|Lost to Follow-up|1|||
164077054|NCT03211156|592647860|FG001|Overall Study|Lost to Follow-up|1|||
164077055|NCT03211156|592647859|FG000|Overall Study|Adverse Event|1|||
164077056|NCT03211156|592647860|FG001|Overall Study|Adverse Event|0|||
164077057|NCT00837577|592647862|FG000|Double-blind Period|Clinical Adverse Event|1|||
164077058|NCT00837577|592647863|FG001|Double-blind Period|Clinical Adverse Event|0|||
164077059|NCT00837577|592647862|FG000|Double-blind Period|Withdrawal by Subject|1|||
164077060|NCT00837577|592647863|FG001|Double-blind Period|Withdrawal by Subject|0|||
164077061|NCT00837577|592647862|FG000|Open-label Period|Clinical Adverse Event|2|||
164077062|NCT00837577|592647863|FG001|Open-label Period|Clinical Adverse Event|2|||
164077063|NCT00837577|592647862|FG000|Open-label Period|Laboratory Adverse Event|0|||
164077064|NCT00837577|592647863|FG001|Open-label Period|Laboratory Adverse Event|1|||
164324246|NCT02038829|593565148|FG001|Washout Period 4|Adverse Event|0|||
164324247|NCT02038829|593565149|FG002|Washout Period 4|Adverse Event|0|||
164324248|NCT02038829|593565150|FG003|Washout Period 4|Adverse Event|0|||
163875870|NCT00424463|591912931|FG000|Overall Study|Patient's convenience|0|||
163875871|NCT00424463|591912932|FG001|Overall Study|Patient's convenience|0|||
164077065|NCT00837577|592647862|FG000|Open-label Period|Lack of Efficacy|4|||
164077066|NCT00837577|592647863|FG001|Open-label Period|Lack of Efficacy|3|||
164077067|NCT00837577|592647862|FG000|Open-label Period|Withdrawal by Subject|1|||
164077068|NCT00837577|592647863|FG001|Open-label Period|Withdrawal by Subject|2|||
164077069|NCT00837577|592647862|FG000|Open-label Period|Other Reason|1|||
164077070|NCT00837577|592647863|FG001|Open-label Period|Other Reason|1|||
164077071|NCT02624518|592647864|FG000|Overall Study|Physician Decision|1|||
164077072|NCT00272961|592647865|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
164077073|NCT00272961|592647866|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164077074|NCT00272961|592647867|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164077075|NCT00272961|592647868|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164077076|NCT00272961|592647869|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
164077077|NCT00272961|592647865|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
164077078|NCT00272961|592647866|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164077079|NCT00272961|592647867|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164209435|NCT03965923|593135231|FG005|Overall Study|Death|0|||
164209436|NCT03965923|593135232|FG006|Overall Study|Death|0|||
164209437|NCT03965923|593135233|FG007|Overall Study|Death|1|||
164209438|NCT03965923|593135234|FG008|Overall Study|Death|4|||
164209439|NCT03965923|593135235|FG009|Overall Study|Death|0|||
164324249|NCT02038829|593565151|FG004|Washout Period 4|Adverse Event|0|||
164324250|NCT02038829|593565152|FG005|Washout Period 4|Adverse Event|0|||
164324251|NCT02038829|593565153|FG006|Washout Period 4|Adverse Event|1|||
164324252|NCT02038829|593565154|FG007|Washout Period 4|Adverse Event|0|||
164324253|NCT02038829|593565155|FG008|Washout Period 4|Adverse Event|0|||
164324254|NCT02038829|593565156|FG009|Washout Period 4|Adverse Event|0|||
164324255|NCT02038829|593565157|FG010|Washout Period 4|Adverse Event|0|||
164324256|NCT02038829|593565158|FG011|Washout Period 4|Adverse Event|0|||
164324257|NCT02038829|593565147|FG000|Treatment Period 6|Adverse Event|0|||
164324258|NCT02038829|593565148|FG001|Treatment Period 6|Adverse Event|0|||
164324259|NCT02038829|593565149|FG002|Treatment Period 6|Adverse Event|1|||
164324260|NCT02038829|593565150|FG003|Treatment Period 6|Adverse Event|0|||
164324261|NCT02038829|593565151|FG004|Treatment Period 6|Adverse Event|0|||
164324262|NCT02038829|593565152|FG005|Treatment Period 6|Adverse Event|0|||
164324263|NCT02038829|593565153|FG006|Treatment Period 6|Adverse Event|0|||
164324264|NCT02038829|593565154|FG007|Treatment Period 6|Adverse Event|0|||
164324265|NCT02038829|593565155|FG008|Treatment Period 6|Adverse Event|0|||
164324266|NCT02038829|593565156|FG009|Treatment Period 6|Adverse Event|0|||
164324267|NCT02038829|593565157|FG010|Treatment Period 6|Adverse Event|0|||
164324268|NCT02038829|593565158|FG011|Treatment Period 6|Adverse Event|0|||
164324269|NCT04393298|593565159|FG000|Overall Study|Adverse Event|0|||
164324270|NCT04393298|593565160|FG001|Overall Study|Adverse Event|0|||
164324271|NCT04393298|593565161|FG002|Overall Study|Adverse Event|0|||
164324272|NCT04393298|593565162|FG003|Overall Study|Adverse Event|0|||
164324273|NCT04393298|593565163|FG004|Overall Study|Adverse Event|1|||
164324274|NCT04393298|593565164|FG005|Overall Study|Adverse Event|0|||
164324275|NCT04393298|593565165|FG006|Overall Study|Adverse Event|0|||
164324276|NCT04393298|593565166|FG007|Overall Study|Adverse Event|0|||
164324277|NCT04393298|593565167|FG008|Overall Study|Adverse Event|2|||
164324278|NCT04393298|593565168|FG009|Overall Study|Adverse Event|0|||
164324279|NCT04393298|593565169|FG010|Overall Study|Adverse Event|0|||
164324280|NCT04393298|593565170|FG011|Overall Study|Adverse Event|0|||
164324281|NCT04393298|593565171|FG012|Overall Study|Adverse Event|1|||
164324282|NCT04393298|593565172|FG013|Overall Study|Adverse Event|1|||
164324283|NCT04393298|593565173|FG014|Overall Study|Adverse Event|0|||
164324284|NCT04393298|593565159|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324285|NCT04393298|593565160|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324286|NCT04393298|593565161|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
164324287|NCT04393298|593565162|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324288|NCT04393298|593565163|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324289|NCT04393298|593565164|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324290|NCT04393298|593565165|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324291|NCT04393298|593565166|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324292|NCT04393298|593565167|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324293|NCT04393298|593565168|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324294|NCT04393298|593565169|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324295|NCT04393298|593565170|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324296|NCT04393298|593565171|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324297|NCT04393298|593565172|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
164324298|NCT04393298|593565173|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
164324299|NCT04393298|593565159|FG000|Overall Study|Lack of Efficacy|0|||
164324300|NCT04393298|593565160|FG001|Overall Study|Lack of Efficacy|0|||
164324301|NCT04393298|593565161|FG002|Overall Study|Lack of Efficacy|0|||
164324302|NCT04393298|593565162|FG003|Overall Study|Lack of Efficacy|0|||
164324303|NCT04393298|593565163|FG004|Overall Study|Lack of Efficacy|0|||
163875872|NCT00424463|591912933|FG002|Overall Study|Patient's convenience|1|||
163875873|NCT03570892|591912935|FG000|Overall Study|Death|51|||
163875874|NCT03570892|591912936|FG001|Overall Study|Death|45|||
163875875|NCT03570892|591912935|FG000|Overall Study|Subject decision|5|||
163875876|NCT03570892|591912936|FG001|Overall Study|Subject decision|3|||
163875877|NCT03570892|591912935|FG000|Overall Study|Protocol Violation|1|||
163875878|NCT03570892|591912936|FG001|Overall Study|Protocol Violation|4|||
163875879|NCT03570892|591912935|FG000|Overall Study|Physician Decision|0|||
164324304|NCT04393298|593565164|FG005|Overall Study|Lack of Efficacy|0|||
164324305|NCT04393298|593565165|FG006|Overall Study|Lack of Efficacy|0|||
164324306|NCT04393298|593565166|FG007|Overall Study|Lack of Efficacy|0|||
164324307|NCT04393298|593565167|FG008|Overall Study|Lack of Efficacy|0|||
164324308|NCT04393298|593565168|FG009|Overall Study|Lack of Efficacy|0|||
164324309|NCT04393298|593565169|FG010|Overall Study|Lack of Efficacy|0|||
164324310|NCT04393298|593565170|FG011|Overall Study|Lack of Efficacy|0|||
164324311|NCT04393298|593565171|FG012|Overall Study|Lack of Efficacy|0|||
164324312|NCT04393298|593565172|FG013|Overall Study|Lack of Efficacy|0|||
164324313|NCT04393298|593565173|FG014|Overall Study|Lack of Efficacy|1|||
164324314|NCT04393298|593565159|FG000|Overall Study|Progression|1|||
163875880|NCT03570892|591912936|FG001|Overall Study|Physician Decision|2|||
163875881|NCT05028582|591912937|FG000|Overall Study|Lost to Follow-up|11|||
163875882|NCT05028582|591912938|FG001|Overall Study|Lost to Follow-up|9|||
164324315|NCT04393298|593565160|FG001|Overall Study|Progression|0|||
164324316|NCT04393298|593565161|FG002|Overall Study|Progression|0|||
164324317|NCT04393298|593565162|FG003|Overall Study|Progression|0|||
164324318|NCT04393298|593565163|FG004|Overall Study|Progression|0|||
163980031|NCT03016325|592297313|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
163980032|NCT03016325|592297314|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163980033|NCT03016325|592297315|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163980034|NCT03016325|592297316|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163980035|NCT03016325|592297317|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163980036|NCT03016325|592297318|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163980037|NCT03016325|592297319|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
163980038|NCT03016325|592297312|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163980039|NCT03016325|592297313|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163980040|NCT03016325|592297314|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163980041|NCT03016325|592297315|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163980042|NCT03016325|592297316|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
163980043|NCT03016325|592297317|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
163980044|NCT03016325|592297318|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
163980045|NCT03016325|592297319|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
163980046|NCT02728830|592297320|FG000|Overall Study|Exclusionary Surgery|9|||
163980047|NCT02728830|592297320|FG000|Overall Study|Exclusionary Pathology|6|||
163980048|NCT02728830|592297320|FG000|Overall Study|Physician Decision|3|||
163980049|NCT02728830|592297320|FG000|Overall Study|Withdrawal by Subject|2|||
163980050|NCT02728830|592297320|FG000|Overall Study|Lost to Follow-up|1|||
163980051|NCT02728830|592297320|FG000|Overall Study|Exclusionary Lab Values|1|||
163980052|NCT02728830|592297320|FG000|Overall Study|Contraindicated Illness|1|||
163980053|NCT02728830|592297320|FG000|Overall Study|Language Barrier|1|||
163980054|NCT01152021|592297321|FG000|Overall Study|Adverse Event|4|||
163980055|NCT01152021|592297322|FG001|Overall Study|Adverse Event|4|||
163980056|NCT01152021|592297321|FG000|Overall Study|Study drug had expired|1|||
163980057|NCT01152021|592297322|FG001|Overall Study|Study drug had expired|0|||
163980058|NCT01152021|592297321|FG000|Overall Study|Physician Decision|1|||
163980059|NCT01152021|592297322|FG001|Overall Study|Physician Decision|1|||
163980060|NCT01152021|592297321|FG000|Overall Study|No access to study drug in Pharmacy|0|||
163980061|NCT01152021|592297322|FG001|Overall Study|No access to study drug in Pharmacy|1|||
163980062|NCT01087905|592297323|FG000|Overall Study|Lost to Follow-up|24|||
163980063|NCT01087905|592297324|FG001|Overall Study|Lost to Follow-up|28|||
163980064|NCT01087905|592297325|FG002|Overall Study|Lost to Follow-up|18|||
163980065|NCT01087905|592297326|FG003|Overall Study|Lost to Follow-up|31|||
163980066|NCT01087905|592297327|FG004|Overall Study|Lost to Follow-up|27|||
163980067|NCT01087905|592297328|FG005|Overall Study|Lost to Follow-up|25|||
163980068|NCT01087905|592297329|FG006|Overall Study|Lost to Follow-up|20|||
163980069|NCT01087905|592297330|FG007|Overall Study|Lost to Follow-up|24|||
163980070|NCT01087905|592297323|FG000|Overall Study|Withdrawal by Subject|5|||
164209440|NCT03965923|593135236|FG010|Overall Study|Death|4|||
164209441|NCT03965923|593135237|FG011|Overall Study|Death|0|||
164209442|NCT03965923|593135226|FG000|Overall Study|Other reason|0|||
164209443|NCT03965923|593135227|FG001|Overall Study|Other reason|0|||
164209444|NCT03965923|593135228|FG002|Overall Study|Other reason|0|||
164209445|NCT03965923|593135229|FG003|Overall Study|Other reason|1|||
164209446|NCT03965923|593135230|FG004|Overall Study|Other reason|0|||
164209447|NCT03965923|593135231|FG005|Overall Study|Other reason|0|||
164209448|NCT03965923|593135232|FG006|Overall Study|Other reason|0|||
164209449|NCT03965923|593135233|FG007|Overall Study|Other reason|0|||
164209450|NCT03965923|593135234|FG008|Overall Study|Other reason|0|||
164209451|NCT03965923|593135235|FG009|Overall Study|Other reason|0|||
164209452|NCT03965923|593135236|FG010|Overall Study|Other reason|2|||
164209453|NCT03965923|593135237|FG011|Overall Study|Other reason|0|||
164209454|NCT02755090|593135238|FG000|Overall Study|equipment malfunction|1|||
164209455|NCT02755090|593135239|FG001|Overall Study|equipment malfunction|0|||
164209456|NCT00207740|593135240|FG000|Overall Study|Adverse Event|4|||
164209457|NCT00207740|593135241|FG001|Overall Study|Adverse Event|14|||
164209458|NCT00207740|593135242|FG002|Overall Study|Adverse Event|14|||
164209459|NCT00207740|593135243|FG003|Overall Study|Adverse Event|11|||
163980071|NCT01087905|592297324|FG001|Overall Study|Withdrawal by Subject|4|||
163980072|NCT01087905|592297325|FG002|Overall Study|Withdrawal by Subject|4|||
163980073|NCT01087905|592297326|FG003|Overall Study|Withdrawal by Subject|5|||
163980074|NCT01087905|592297327|FG004|Overall Study|Withdrawal by Subject|4|||
164209460|NCT00207740|593135240|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164209461|NCT00207740|593135241|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164209462|NCT00207740|593135242|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164209463|NCT00207740|593135243|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
164209464|NCT00207740|593135240|FG000|Overall Study|Lost to Follow-up|0|||
164324319|NCT04393298|593565164|FG005|Overall Study|Progression|0|||
164324320|NCT04393298|593565165|FG006|Overall Study|Progression|0|||
164209465|NCT00207740|593135241|FG001|Overall Study|Lost to Follow-up|2|||
164209466|NCT00207740|593135242|FG002|Overall Study|Lost to Follow-up|1|||
164209467|NCT00207740|593135243|FG003|Overall Study|Lost to Follow-up|1|||
164209468|NCT00207740|593135240|FG000|Overall Study|Death|0|||
164209469|NCT00207740|593135241|FG001|Overall Study|Death|0|||
164209470|NCT00207740|593135242|FG002|Overall Study|Death|0|||
164209471|NCT00207740|593135243|FG003|Overall Study|Death|1|||
164209472|NCT00207740|593135240|FG000|Overall Study|Sponsor Directive|22|||
164209473|NCT00207740|593135241|FG001|Overall Study|Sponsor Directive|15|||
164209474|NCT00207740|593135242|FG002|Overall Study|Sponsor Directive|16|||
164209475|NCT00207740|593135243|FG003|Overall Study|Sponsor Directive|21|||
164324321|NCT04393298|593565166|FG007|Overall Study|Progression|0|||
164209476|NCT00207740|593135240|FG000|Overall Study|Other|2|||
164209477|NCT00207740|593135241|FG001|Overall Study|Other|10|||
164209478|NCT00207740|593135242|FG002|Overall Study|Other|7|||
164209479|NCT00207740|593135243|FG003|Overall Study|Other|5|||
164209480|NCT01402700|593135247|FG000|Overall Study|Death|3|||
164209481|NCT01402700|593135247|FG000|Overall Study|Withdrawal by Subject|3|||
164209482|NCT01402700|593135247|FG000|Overall Study|Missed Visit|1|||
164209483|NCT01933594|593135248|FG000|Overall Study|Lost to Follow-up|1|||
164209484|NCT01933594|593135249|FG001|Overall Study|Lost to Follow-up|0|||
164209485|NCT01933594|593135250|FG002|Overall Study|Lost to Follow-up|0|||
164209486|NCT01933594|593135251|FG003|Overall Study|Lost to Follow-up|0|||
164209487|NCT01933594|593135252|FG004|Overall Study|Lost to Follow-up|1|||
164209488|NCT01933594|593135253|FG005|Overall Study|Lost to Follow-up|0|||
164209489|NCT01933594|593135248|FG000|Overall Study|Ineligible for subsequent study step|0|||
164209490|NCT01933594|593135249|FG001|Overall Study|Ineligible for subsequent study step|0|||
164209491|NCT01933594|593135250|FG002|Overall Study|Ineligible for subsequent study step|0|||
164209492|NCT01933594|593135251|FG003|Overall Study|Ineligible for subsequent study step|0|||
164209493|NCT01933594|593135252|FG004|Overall Study|Ineligible for subsequent study step|1|||
164209494|NCT01933594|593135253|FG005|Overall Study|Ineligible for subsequent study step|0|||
164209495|NCT03314935|593135254|FG000|Phase 1|Death|4|||
164209496|NCT03314935|593135255|FG001|Phase 1|Death|2|||
164209497|NCT03314935|593135256|FG002|Phase 1|Death|5|||
164209498|NCT03314935|593135257|FG003|Phase 1|Death|4|||
164209499|NCT03314935|593135258|FG004|Phase 1|Death|3|||
164209500|NCT03314935|593135259|FG005|Phase 1|Death|4|||
164209501|NCT03314935|593135260|FG006|Phase 1|Death|5|||
164209502|NCT03314935|593135261|FG007|Phase 1|Death|4|||
164209503|NCT03314935|593135262|FG008|Phase 1|Death|3|||
164209504|NCT03314935|593135263|FG009|Phase 1|Death|0|||
164209505|NCT03314935|593135264|FG010|Phase 1|Death|0|||
164209506|NCT03314935|593135265|FG011|Phase 1|Death|0|||
164209507|NCT03314935|593135266|FG012|Phase 1|Death|0|||
164209508|NCT03314935|593135267|FG013|Phase 1|Death|0|||
164209509|NCT03314935|593135268|FG014|Phase 1|Death|0|||
164209510|NCT03314935|593135254|FG000|Phase 1|Withdrawal by Subject|2|||
164209511|NCT03314935|593135255|FG001|Phase 1|Withdrawal by Subject|1|||
164209512|NCT03314935|593135256|FG002|Phase 1|Withdrawal by Subject|1|||
164209513|NCT03314935|593135257|FG003|Phase 1|Withdrawal by Subject|2|||
164209514|NCT03314935|593135258|FG004|Phase 1|Withdrawal by Subject|1|||
164209515|NCT03314935|593135259|FG005|Phase 1|Withdrawal by Subject|0|||
164209516|NCT03314935|593135260|FG006|Phase 1|Withdrawal by Subject|1|||
164324322|NCT04393298|593565167|FG008|Overall Study|Progression|0|||
164324323|NCT04393298|593565168|FG009|Overall Study|Progression|0|||
164324324|NCT04393298|593565169|FG010|Overall Study|Progression|1|||
164209517|NCT03314935|593135261|FG007|Phase 1|Withdrawal by Subject|0|||
164209518|NCT03314935|593135262|FG008|Phase 1|Withdrawal by Subject|1|||
164209519|NCT03314935|593135263|FG009|Phase 1|Withdrawal by Subject|0|||
164209520|NCT03314935|593135264|FG010|Phase 1|Withdrawal by Subject|0|||
164209521|NCT03314935|593135265|FG011|Phase 1|Withdrawal by Subject|0|||
164209522|NCT03314935|593135266|FG012|Phase 1|Withdrawal by Subject|0|||
164209523|NCT03314935|593135267|FG013|Phase 1|Withdrawal by Subject|0|||
164209524|NCT03314935|593135268|FG014|Phase 1|Withdrawal by Subject|0|||
164209525|NCT03314935|593135254|FG000|Phase 1|Progressive Disease|2|||
164209526|NCT03314935|593135255|FG001|Phase 1|Progressive Disease|0|||
164209527|NCT03314935|593135256|FG002|Phase 1|Progressive Disease|0|||
164209528|NCT03314935|593135257|FG003|Phase 1|Progressive Disease|1|||
164209529|NCT03314935|593135258|FG004|Phase 1|Progressive Disease|0|||
164209530|NCT03314935|593135259|FG005|Phase 1|Progressive Disease|0|||
164209531|NCT03314935|593135260|FG006|Phase 1|Progressive Disease|0|||
164209532|NCT03314935|593135261|FG007|Phase 1|Progressive Disease|0|||
164209533|NCT03314935|593135262|FG008|Phase 1|Progressive Disease|0|||
164209534|NCT03314935|593135263|FG009|Phase 1|Progressive Disease|0|||
164209535|NCT03314935|593135264|FG010|Phase 1|Progressive Disease|0|||
164209536|NCT03314935|593135265|FG011|Phase 1|Progressive Disease|0|||
164209537|NCT03314935|593135266|FG012|Phase 1|Progressive Disease|0|||
164209538|NCT03314935|593135267|FG013|Phase 1|Progressive Disease|0|||
164209539|NCT03314935|593135268|FG014|Phase 1|Progressive Disease|0|||
164209540|NCT03314935|593135254|FG000|Phase 1|Study Terminated by Sponsor|0|||
164209541|NCT03314935|593135255|FG001|Phase 1|Study Terminated by Sponsor|1|||
164209542|NCT03314935|593135256|FG002|Phase 1|Study Terminated by Sponsor|0|||
164324325|NCT04393298|593565170|FG011|Overall Study|Progression|1|||
164209543|NCT03314935|593135257|FG003|Phase 1|Study Terminated by Sponsor|0|||
164209544|NCT03314935|593135258|FG004|Phase 1|Study Terminated by Sponsor|0|||
164209545|NCT03314935|593135259|FG005|Phase 1|Study Terminated by Sponsor|0|||
164209546|NCT03314935|593135260|FG006|Phase 1|Study Terminated by Sponsor|0|||
164209547|NCT03314935|593135261|FG007|Phase 1|Study Terminated by Sponsor|0|||
164209548|NCT03314935|593135262|FG008|Phase 1|Study Terminated by Sponsor|1|||
164209549|NCT03314935|593135263|FG009|Phase 1|Study Terminated by Sponsor|0|||
164209550|NCT03314935|593135264|FG010|Phase 1|Study Terminated by Sponsor|0|||
164209551|NCT03314935|593135265|FG011|Phase 1|Study Terminated by Sponsor|0|||
164209552|NCT03314935|593135266|FG012|Phase 1|Study Terminated by Sponsor|0|||
164209553|NCT03314935|593135267|FG013|Phase 1|Study Terminated by Sponsor|0|||
164209554|NCT03314935|593135268|FG014|Phase 1|Study Terminated by Sponsor|0|||
164209555|NCT03314935|593135254|FG000|Phase 1|"Captured as Other in Database"|0|||
164209556|NCT03314935|593135255|FG001|Phase 1|"Captured as Other in Database"|2|||
164209557|NCT03314935|593135256|FG002|Phase 1|"Captured as Other in Database"|0|||
164209558|NCT03314935|593135257|FG003|Phase 1|"Captured as Other in Database"|0|||
164209559|NCT03314935|593135258|FG004|Phase 1|"Captured as Other in Database"|0|||
164209560|NCT03314935|593135259|FG005|Phase 1|"Captured as Other in Database"|0|||
164209561|NCT03314935|593135260|FG006|Phase 1|"Captured as Other in Database"|1|||
164209562|NCT03314935|593135261|FG007|Phase 1|"Captured as Other in Database"|1|||
164209563|NCT03314935|593135262|FG008|Phase 1|"Captured as Other in Database"|1|||
164209564|NCT03314935|593135263|FG009|Phase 1|"Captured as Other in Database"|0|||
164209565|NCT03314935|593135264|FG010|Phase 1|"Captured as Other in Database"|0|||
164209566|NCT03314935|593135265|FG011|Phase 1|"Captured as Other in Database"|0|||
164209567|NCT03314935|593135266|FG012|Phase 1|"Captured as Other in Database"|0|||
164209568|NCT03314935|593135267|FG013|Phase 1|"Captured as Other in Database"|0|||
164209569|NCT03314935|593135268|FG014|Phase 1|"Captured as Other in Database"|0|||
164209570|NCT03314935|593135254|FG000|Phase 1|Lost to Follow-up|0|||
164209571|NCT03314935|593135255|FG001|Phase 1|Lost to Follow-up|0|||
164209572|NCT03314935|593135256|FG002|Phase 1|Lost to Follow-up|0|||
164324326|NCT04393298|593565171|FG012|Overall Study|Progression|0|||
164324327|NCT04393298|593565172|FG013|Overall Study|Progression|0|||
164324328|NCT04393298|593565173|FG014|Overall Study|Progression|0|||
164209573|NCT03314935|593135257|FG003|Phase 1|Lost to Follow-up|0|||
164209574|NCT03314935|593135258|FG004|Phase 1|Lost to Follow-up|0|||
164209575|NCT03314935|593135259|FG005|Phase 1|Lost to Follow-up|0|||
164209576|NCT03314935|593135260|FG006|Phase 1|Lost to Follow-up|0|||
164209577|NCT03314935|593135261|FG007|Phase 1|Lost to Follow-up|0|||
164209578|NCT03314935|593135262|FG008|Phase 1|Lost to Follow-up|1|||
164209579|NCT03314935|593135263|FG009|Phase 1|Lost to Follow-up|0|||
164209580|NCT03314935|593135264|FG010|Phase 1|Lost to Follow-up|0|||
164209581|NCT03314935|593135265|FG011|Phase 1|Lost to Follow-up|0|||
164209582|NCT03314935|593135266|FG012|Phase 1|Lost to Follow-up|0|||
164209583|NCT03314935|593135267|FG013|Phase 1|Lost to Follow-up|0|||
164209584|NCT03314935|593135268|FG014|Phase 1|Lost to Follow-up|0|||
164209585|NCT03314935|593135254|FG000|Phase 2|Death|0|||
164209586|NCT03314935|593135255|FG001|Phase 2|Death|0|||
164209587|NCT03314935|593135256|FG002|Phase 2|Death|0|||
164209588|NCT03314935|593135257|FG003|Phase 2|Death|0|||
164209589|NCT03314935|593135258|FG004|Phase 2|Death|0|||
164209590|NCT03314935|593135259|FG005|Phase 2|Death|0|||
164209591|NCT03314935|593135260|FG006|Phase 2|Death|0|||
164209592|NCT03314935|593135261|FG007|Phase 2|Death|0|||
164324329|NCT04393298|593565159|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
164324330|NCT04393298|593565160|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209593|NCT03314935|593135262|FG008|Phase 2|Death|0|||
164209594|NCT03314935|593135263|FG009|Phase 2|Death|5|||
164209595|NCT03314935|593135264|FG010|Phase 2|Death|20|||
164209596|NCT03314935|593135265|FG011|Phase 2|Death|6|||
164209597|NCT03314935|593135266|FG012|Phase 2|Death|7|||
164209598|NCT03314935|593135267|FG013|Phase 2|Death|6|||
164209599|NCT03314935|593135268|FG014|Phase 2|Death|17|||
164209600|NCT03314935|593135254|FG000|Phase 2|Withdrawal by Subject|0|||
164209601|NCT03314935|593135255|FG001|Phase 2|Withdrawal by Subject|0|||
164209602|NCT03314935|593135256|FG002|Phase 2|Withdrawal by Subject|0|||
164209603|NCT03314935|593135257|FG003|Phase 2|Withdrawal by Subject|0|||
164209604|NCT03314935|593135258|FG004|Phase 2|Withdrawal by Subject|0|||
164209605|NCT03314935|593135259|FG005|Phase 2|Withdrawal by Subject|0|||
164209606|NCT03314935|593135260|FG006|Phase 2|Withdrawal by Subject|0|||
164209607|NCT03314935|593135261|FG007|Phase 2|Withdrawal by Subject|0|||
164209608|NCT03314935|593135262|FG008|Phase 2|Withdrawal by Subject|0|||
164209609|NCT03314935|593135263|FG009|Phase 2|Withdrawal by Subject|1|||
164209610|NCT03314935|593135264|FG010|Phase 2|Withdrawal by Subject|4|||
164209611|NCT03314935|593135265|FG011|Phase 2|Withdrawal by Subject|0|||
164209612|NCT03314935|593135266|FG012|Phase 2|Withdrawal by Subject|1|||
164209613|NCT03314935|593135267|FG013|Phase 2|Withdrawal by Subject|0|||
164209614|NCT03314935|593135268|FG014|Phase 2|Withdrawal by Subject|1|||
164209615|NCT03314935|593135254|FG000|Phase 2|Progressive Disease|0|||
164209616|NCT03314935|593135255|FG001|Phase 2|Progressive Disease|0|||
164209617|NCT03314935|593135256|FG002|Phase 2|Progressive Disease|0|||
164209618|NCT03314935|593135257|FG003|Phase 2|Progressive Disease|0|||
164209619|NCT03314935|593135258|FG004|Phase 2|Progressive Disease|0|||
164355616|NCT01535053|593676481|FG001|Overall Study|Ineligible|2|||
164209620|NCT03314935|593135259|FG005|Phase 2|Progressive Disease|0|||
164209621|NCT03314935|593135260|FG006|Phase 2|Progressive Disease|0|||
164209622|NCT03314935|593135261|FG007|Phase 2|Progressive Disease|0|||
164209623|NCT03314935|593135262|FG008|Phase 2|Progressive Disease|0|||
164209624|NCT03314935|593135263|FG009|Phase 2|Progressive Disease|1|||
164209625|NCT03314935|593135264|FG010|Phase 2|Progressive Disease|1|||
164209626|NCT03314935|593135265|FG011|Phase 2|Progressive Disease|1|||
164209627|NCT03314935|593135266|FG012|Phase 2|Progressive Disease|2|||
164209628|NCT03314935|593135267|FG013|Phase 2|Progressive Disease|0|||
164209629|NCT03314935|593135268|FG014|Phase 2|Progressive Disease|1|||
164209630|NCT03314935|593135254|FG000|Phase 2|Study Terminated by Sponsor|0|||
164209631|NCT03314935|593135255|FG001|Phase 2|Study Terminated by Sponsor|0|||
164209632|NCT03314935|593135256|FG002|Phase 2|Study Terminated by Sponsor|0|||
164209633|NCT03314935|593135257|FG003|Phase 2|Study Terminated by Sponsor|0|||
164209634|NCT03314935|593135258|FG004|Phase 2|Study Terminated by Sponsor|0|||
164209635|NCT03314935|593135259|FG005|Phase 2|Study Terminated by Sponsor|0|||
164209636|NCT03314935|593135260|FG006|Phase 2|Study Terminated by Sponsor|0|||
164209637|NCT03314935|593135261|FG007|Phase 2|Study Terminated by Sponsor|0|||
164209638|NCT03314935|593135262|FG008|Phase 2|Study Terminated by Sponsor|0|||
164209639|NCT03314935|593135263|FG009|Phase 2|Study Terminated by Sponsor|0|||
164209640|NCT03314935|593135264|FG010|Phase 2|Study Terminated by Sponsor|7|||
164209641|NCT03314935|593135265|FG011|Phase 2|Study Terminated by Sponsor|2|||
164209642|NCT03314935|593135266|FG012|Phase 2|Study Terminated by Sponsor|1|||
164209643|NCT03314935|593135267|FG013|Phase 2|Study Terminated by Sponsor|4|||
164209644|NCT03314935|593135268|FG014|Phase 2|Study Terminated by Sponsor|4|||
164209645|NCT03314935|593135254|FG000|Phase 2|Lost to Follow-up|0|||
164209646|NCT03314935|593135255|FG001|Phase 2|Lost to Follow-up|0|||
164209647|NCT03314935|593135256|FG002|Phase 2|Lost to Follow-up|0|||
164209648|NCT03314935|593135257|FG003|Phase 2|Lost to Follow-up|0|||
164209649|NCT03314935|593135258|FG004|Phase 2|Lost to Follow-up|0|||
164209650|NCT03314935|593135259|FG005|Phase 2|Lost to Follow-up|0|||
164209651|NCT03314935|593135260|FG006|Phase 2|Lost to Follow-up|0|||
164209652|NCT03314935|593135261|FG007|Phase 2|Lost to Follow-up|0|||
164209653|NCT03314935|593135262|FG008|Phase 2|Lost to Follow-up|0|||
164209654|NCT03314935|593135263|FG009|Phase 2|Lost to Follow-up|1|||
164209655|NCT03314935|593135264|FG010|Phase 2|Lost to Follow-up|0|||
164209656|NCT03314935|593135265|FG011|Phase 2|Lost to Follow-up|0|||
164209657|NCT03314935|593135266|FG012|Phase 2|Lost to Follow-up|0|||
164209658|NCT03314935|593135267|FG013|Phase 2|Lost to Follow-up|0|||
164209659|NCT03314935|593135268|FG014|Phase 2|Lost to Follow-up|1|||
164209660|NCT03314935|593135254|FG000|Phase 2|Physician Decision|0|||
164209661|NCT03314935|593135255|FG001|Phase 2|Physician Decision|0|||
164209662|NCT03314935|593135256|FG002|Phase 2|Physician Decision|0|||
164209663|NCT03314935|593135257|FG003|Phase 2|Physician Decision|0|||
164209664|NCT03314935|593135258|FG004|Phase 2|Physician Decision|0|||
164209665|NCT03314935|593135259|FG005|Phase 2|Physician Decision|0|||
163875883|NCT05028582|591912937|FG000|Overall Study|Withdrawal by Subject|9|||
163875884|NCT05028582|591912938|FG001|Overall Study|Withdrawal by Subject|10|||
163875885|NCT05028582|591912937|FG000|Overall Study|Adverse Event|5|||
163875886|NCT05028582|591912938|FG001|Overall Study|Adverse Event|2|||
163875887|NCT05028582|591912937|FG000|Overall Study|Miscellaneous|3|||
163875888|NCT05028582|591912938|FG001|Overall Study|Miscellaneous|2|||
163875889|NCT05028582|591912937|FG000|Overall Study|Lack of Efficacy|3|||
163875890|NCT05028582|591912938|FG001|Overall Study|Lack of Efficacy|1|||
163875891|NCT05028582|591912937|FG000|Overall Study|Physician Decision|0|||
163875892|NCT05028582|591912938|FG001|Overall Study|Physician Decision|1|||
163875893|NCT02576509|591914691|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
163875894|NCT02576509|591914692|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
163875895|NCT02576509|591914691|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
163875896|NCT02576509|591914692|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
163875897|NCT02576509|591914691|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
163875898|NCT02576509|591914692|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
163875899|NCT02576509|591914691|FG000|Treatment Period|Disease progression|263|||
163875900|NCT02576509|591914692|FG001|Treatment Period|Disease progression|244|||
163875901|NCT02576509|591914691|FG000|Treatment Period|Study drug toxicity|37|||
163980075|NCT01087905|592297328|FG005|Overall Study|Withdrawal by Subject|3|||
163875902|NCT02576509|591914692|FG001|Treatment Period|Study drug toxicity|41|||
163875903|NCT02576509|591914691|FG000|Treatment Period|Death|1|||
163875904|NCT02576509|591914692|FG001|Treatment Period|Death|1|||
164209666|NCT03314935|593135260|FG006|Phase 2|Physician Decision|0|||
163875905|NCT02576509|591914691|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
164209667|NCT03314935|593135261|FG007|Phase 2|Physician Decision|0|||
164209668|NCT03314935|593135262|FG008|Phase 2|Physician Decision|0|||
164209669|NCT03314935|593135263|FG009|Phase 2|Physician Decision|0|||
164209670|NCT03314935|593135264|FG010|Phase 2|Physician Decision|1|||
164209671|NCT03314935|593135265|FG011|Phase 2|Physician Decision|0|||
164209672|NCT03314935|593135266|FG012|Phase 2|Physician Decision|0|||
164209673|NCT03314935|593135267|FG013|Phase 2|Physician Decision|0|||
164209674|NCT03314935|593135268|FG014|Phase 2|Physician Decision|0|||
164209675|NCT05252702|593135272|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
164209676|NCT05252702|593135272|FG000|Overall Study|Death|16|||
164209677|NCT05252702|593135272|FG000|Overall Study|System explant|5|||
164209678|NCT05252702|593135272|FG000|Overall Study|Lost to Follow-up|1|||
164209679|NCT05252702|593135272|FG000|Overall Study|Withdrawn by investigator|1|||
164209680|NCT05252702|593135272|FG000|Overall Study|Visit not due|306|||
164209681|NCT05252702|593135272|FG000|Overall Study|Visit within window but not completed|92|||
164209682|NCT05252702|593135272|FG000|Overall Study|Unsuccessful implant|1|||
164209683|NCT04153864|593135273|FG000|Overall Study|Withdrawal by Subject|21|||
164209684|NCT04153864|593135274|FG001|Overall Study|Withdrawal by Subject|7|||
164209685|NCT04153864|593135275|FG002|Overall Study|Withdrawal by Subject|23|||
164209686|NCT04153864|593135276|FG003|Overall Study|Withdrawal by Subject|2|||
164209687|NCT04153864|593135273|FG000|Overall Study|Lost to Follow-up|4|||
164209688|NCT04153864|593135274|FG001|Overall Study|Lost to Follow-up|0|||
164209689|NCT04153864|593135275|FG002|Overall Study|Lost to Follow-up|3|||
164209690|NCT04153864|593135276|FG003|Overall Study|Lost to Follow-up|0|||
164209691|NCT04153864|593135273|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
164209692|NCT04153864|593135274|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
164209693|NCT04153864|593135275|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
164209694|NCT04153864|593135276|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
164209695|NCT05352399|593135289|FG000|Overall Study|Discontinued intervention|6|||
164209696|NCT06354257|593135290|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164209697|NCT06354257|593135290|FG000|Treatment Period 2|Adverse Event|1|||
164209698|NCT02401230|593135291|FG000|Overall Study|Adverse Event|3|||
164209699|NCT02401230|593135292|FG001|Overall Study|Adverse Event|2|||
164209700|NCT02401230|593135293|FG002|Overall Study|Adverse Event|0|||
164209701|NCT02401230|593135291|FG000|Overall Study|Withdrawal by Subject|2|||
164209702|NCT02401230|593135292|FG001|Overall Study|Withdrawal by Subject|1|||
164209703|NCT02401230|593135293|FG002|Overall Study|Withdrawal by Subject|1|||
164209704|NCT02401230|593135291|FG000|Overall Study|Lost to Follow-up|1|||
164209705|NCT02401230|593135292|FG001|Overall Study|Lost to Follow-up|3|||
164209706|NCT02401230|593135293|FG002|Overall Study|Lost to Follow-up|3|||
164209707|NCT02657551|593135294|FG000|Overall Study|Adverse Event|2|||
164209708|NCT02657551|593135294|FG000|Overall Study|Withdrawal by Subject|1|||
164209709|NCT02657551|593135294|FG000|Overall Study|Non-Compliance|1|||
164209710|NCT02657551|593135294|FG000|Overall Study|Progression / Relapse|4|||
164209711|NCT02164916|593135298|FG000|Overall Study|Adverse Event|3|||
164209712|NCT02164916|593135299|FG001|Overall Study|Adverse Event|8|||
164209713|NCT02164916|593135298|FG000|Overall Study|Death|1|||
164209714|NCT02164916|593135299|FG001|Overall Study|Death|1|||
164209715|NCT02164916|593135298|FG000|Overall Study|Refusal unrelated to adverse event|3|||
164209716|NCT02164916|593135299|FG001|Overall Study|Refusal unrelated to adverse event|7|||
164209717|NCT02164916|593135298|FG000|Overall Study|Progression|37|||
164209718|NCT02164916|593135299|FG001|Overall Study|Progression|26|||
164209719|NCT02164916|593135298|FG000|Overall Study|Not protocol specified|5|||
164209720|NCT02164916|593135299|FG001|Overall Study|Not protocol specified|1|||
164209721|NCT02164916|593135298|FG000|Overall Study|Reason under review|1|||
164209722|NCT02164916|593135299|FG001|Overall Study|Reason under review|6|||
164209723|NCT02164916|593135298|FG000|Overall Study|Not eligible|2|||
164209724|NCT02164916|593135299|FG001|Overall Study|Not eligible|5|||
164209725|NCT00296517|593135300|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
164209726|NCT00296517|593135301|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
164209727|NCT00296517|593135300|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
164209728|NCT00296517|593135301|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
164209729|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
164209730|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
164209731|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
164209732|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
164209733|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
164209734|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
164209735|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
164209736|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
164209737|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
164209738|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
164209739|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
164209740|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
164209741|NCT00296517|593135300|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
164209742|NCT00296517|593135301|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
164209743|NCT00964782|593135304|FG000|Overall Study|Lost to Follow-up|1|||
164209744|NCT00964782|593135305|FG001|Overall Study|Lost to Follow-up|0|||
164209745|NCT00596635|593135307|FG000|Overall Study|Lost to Follow-up|0|||
164209746|NCT00596635|593135308|FG001|Overall Study|Lost to Follow-up|2|||
164209747|NCT00596635|593135309|FG002|Overall Study|Lost to Follow-up|0|||
164209748|NCT00596635|593135307|FG000|Overall Study|Treatment for symptomatic UTI|4|||
164209749|NCT00596635|593135308|FG001|Overall Study|Treatment for symptomatic UTI|6|||
164209750|NCT00596635|593135309|FG002|Overall Study|Treatment for symptomatic UTI|3|||
164209751|NCT00596635|593135307|FG000|Overall Study|Hip fracture|2|||
164209752|NCT00596635|593135308|FG001|Overall Study|Hip fracture|3|||
164209753|NCT00596635|593135309|FG002|Overall Study|Hip fracture|3|||
164209754|NCT00596635|593135307|FG000|Overall Study|Could not provide urine specimen|1|||
164209755|NCT00596635|593135308|FG001|Overall Study|Could not provide urine specimen|2|||
164209756|NCT00596635|593135309|FG002|Overall Study|Could not provide urine specimen|2|||
164209757|NCT00846365|593135314|FG000|Overall Study|Adverse Event|20|||
164209758|NCT00846365|593135315|FG001|Overall Study|Adverse Event|30|||
164209759|NCT00846365|593135316|FG002|Overall Study|Adverse Event|11|||
164209760|NCT00846365|593135314|FG000|Overall Study|Protocol Violation|5|||
164209761|NCT00846365|593135315|FG001|Overall Study|Protocol Violation|4|||
164209762|NCT00846365|593135316|FG002|Overall Study|Protocol Violation|0|||
164209763|NCT00846365|593135314|FG000|Overall Study|Lost to Follow-up|8|||
164209764|NCT00846365|593135315|FG001|Overall Study|Lost to Follow-up|2|||
164209765|NCT00846365|593135316|FG002|Overall Study|Lost to Follow-up|5|||
164209766|NCT00846365|593135314|FG000|Overall Study|Withdrawal by Subject|11|||
164209767|NCT00846365|593135315|FG001|Overall Study|Withdrawal by Subject|11|||
164209768|NCT00846365|593135316|FG002|Overall Study|Withdrawal by Subject|9|||
164209769|NCT00846365|593135314|FG000|Overall Study|Pregnancy|1|||
164209770|NCT00846365|593135315|FG001|Overall Study|Pregnancy|0|||
164209771|NCT00846365|593135316|FG002|Overall Study|Pregnancy|0|||
164209772|NCT00846365|593135314|FG000|Overall Study|Lack of Efficacy|1|||
164209773|NCT00846365|593135315|FG001|Overall Study|Lack of Efficacy|1|||
164209774|NCT00846365|593135316|FG002|Overall Study|Lack of Efficacy|2|||
164209775|NCT00846365|593135314|FG000|Overall Study|Other|9|||
164209776|NCT00846365|593135315|FG001|Overall Study|Other|1|||
164209777|NCT00846365|593135316|FG002|Overall Study|Other|6|||
164077080|NCT00272961|592647868|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164077081|NCT00272961|592647869|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
164077082|NCT00272961|592647865|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
164077083|NCT00272961|592647866|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164077084|NCT00272961|592647867|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164077085|NCT00272961|592647868|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164077086|NCT00272961|592647869|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
164077087|NCT00272961|592647865|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
164077088|NCT00272961|592647866|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164077089|NCT00272961|592647867|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164077090|NCT00272961|592647868|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164077091|NCT00272961|592647869|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
164077092|NCT00272961|592647865|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
164077093|NCT00272961|592647866|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
164077094|NCT00272961|592647867|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
164077095|NCT00272961|592647868|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
164077096|NCT00272961|592647869|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
164077097|NCT00272961|592647865|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
164077098|NCT00272961|592647866|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
164077099|NCT00272961|592647867|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
164077100|NCT00272961|592647868|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
164077101|NCT00272961|592647869|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
164077102|NCT00272961|592647865|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
164077103|NCT00272961|592647866|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
164077104|NCT00272961|592647867|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
164077105|NCT00272961|592647868|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
164077106|NCT00272961|592647869|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
164077107|NCT00272961|592647865|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
164209778|NCT00720759|593135317|FG000|Overall Study|Lost to Follow-up|0|||
164209779|NCT00720759|593135318|FG001|Overall Study|Lost to Follow-up|1|||
164209780|NCT00720759|593135319|FG002|Overall Study|Lost to Follow-up|1|||
164209781|NCT00720759|593135320|FG003|Overall Study|Lost to Follow-up|0|||
164077108|NCT00272961|592647866|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
164077109|NCT00272961|592647867|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
164077110|NCT00272961|592647868|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
164077111|NCT00272961|592647869|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
164077112|NCT01507831|592647870|FG000|Overall Study|Randomized but not treated|0|||
164209782|NCT02318940|593135321|FG000|Overall Study|lost the record|1|||
164209783|NCT02318940|593135322|FG001|Overall Study|lost the record|0|||
164324331|NCT04393298|593565161|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209784|NCT01047319|593135323|FG000|Overall Study|Teva requested participant withdrawal|3|||
164209785|NCT01047319|593135324|FG001|Overall Study|Teva requested participant withdrawal|0|||
164209786|NCT01047319|593135325|FG002|Overall Study|Teva requested participant withdrawal|1|||
164209787|NCT01047319|593135323|FG000|Overall Study|Protocol Violation|3|||
164209788|NCT01047319|593135324|FG001|Overall Study|Protocol Violation|2|||
164209789|NCT01047319|593135325|FG002|Overall Study|Protocol Violation|4|||
164209790|NCT01047319|593135323|FG000|Overall Study|Lack of Efficacy|4|||
164209791|NCT01047319|593135324|FG001|Overall Study|Lack of Efficacy|3|||
164209792|NCT01047319|593135325|FG002|Overall Study|Lack of Efficacy|3|||
164209793|NCT01047319|593135323|FG000|Overall Study|Death|5|||
164209794|NCT01047319|593135324|FG001|Overall Study|Death|1|||
164209795|NCT01047319|593135325|FG002|Overall Study|Death|5|||
164209796|NCT01047319|593135323|FG000|Overall Study|Pregnancy|13|||
164209797|NCT01047319|593135324|FG001|Overall Study|Pregnancy|8|||
164209798|NCT01047319|593135325|FG002|Overall Study|Pregnancy|8|||
164209799|NCT01047319|593135323|FG000|Overall Study|Physician Decision|12|||
164209800|NCT01047319|593135324|FG001|Overall Study|Physician Decision|9|||
164209801|NCT01047319|593135325|FG002|Overall Study|Physician Decision|10|||
164209802|NCT01047319|593135323|FG000|Overall Study|Lost to Follow-up|14|||
164209803|NCT01047319|593135324|FG001|Overall Study|Lost to Follow-up|10|||
164209804|NCT01047319|593135325|FG002|Overall Study|Lost to Follow-up|10|||
164209805|NCT01047319|593135323|FG000|Overall Study|Adverse Event|16|||
164209806|NCT01047319|593135324|FG001|Overall Study|Adverse Event|27|||
164209807|NCT01047319|593135325|FG002|Overall Study|Adverse Event|21|||
164209808|NCT01047319|593135323|FG000|Overall Study|Withdrawal by Subject|77|||
164209809|NCT01047319|593135324|FG001|Overall Study|Withdrawal by Subject|75|||
164209810|NCT01047319|593135325|FG002|Overall Study|Withdrawal by Subject|87|||
164209811|NCT01047319|593135323|FG000|Overall Study|Study terminated by Sponsor|198|||
164209812|NCT01047319|593135324|FG001|Overall Study|Study terminated by Sponsor|215|||
164209813|NCT01047319|593135325|FG002|Overall Study|Study terminated by Sponsor|203|||
164209814|NCT01277861|593135338|FG000|Overall Study|Physician Decision|2|||
164209815|NCT01277861|593135339|FG001|Overall Study|Physician Decision|2|||
164209816|NCT05032196|593135340|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209817|NCT05032196|593135341|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
164209818|NCT05032196|593135342|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209819|NCT05032196|593135343|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209820|NCT05032196|593135344|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209821|NCT05032196|593135345|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
164209822|NCT05032196|593135340|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209823|NCT05032196|593135341|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209824|NCT05032196|593135342|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209825|NCT05032196|593135343|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
164209826|NCT05032196|593135344|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209827|NCT05032196|593135345|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
164209828|NCT05032196|593135340|FG000|Period 2 (Multidose)|Physician Decision|0|||
164209829|NCT05032196|593135341|FG001|Period 2 (Multidose)|Physician Decision|0|||
164209830|NCT05032196|593135342|FG002|Period 2 (Multidose)|Physician Decision|0|||
164209831|NCT05032196|593135343|FG003|Period 2 (Multidose)|Physician Decision|0|||
164209832|NCT05032196|593135344|FG004|Period 2 (Multidose)|Physician Decision|1|||
164209833|NCT05032196|593135345|FG005|Period 2 (Multidose)|Physician Decision|0|||
164209834|NCT00857389|593135346|FG000|Overall Study|Did not proceed to transplant|2|||
164209835|NCT04817410|593136991|FG000|Overall Study|Withdrawal by Subject|5|||
164209836|NCT04817410|593136991|FG000|Overall Study|Physician Decision|3|||
164209837|NCT03595748|593136992|FG000|Overall Study|Death|11|||
164209838|NCT03595748|593136993|FG001|Overall Study|Death|12|||
164209839|NCT03595748|593136992|FG000|Overall Study|Withdrawal by Subject|28|||
164209840|NCT03595748|593136993|FG001|Overall Study|Withdrawal by Subject|29|||
163875906|NCT02576509|591914692|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
163875907|NCT02576509|591914691|FG000|Treatment Period|Participant request to stop treatment|8|||
163875908|NCT02576509|591914692|FG001|Treatment Period|Participant request to stop treatment|18|||
163875909|NCT02576509|591914691|FG000|Treatment Period|Participant withdrew consent|3|||
163875910|NCT02576509|591914692|FG001|Treatment Period|Participant withdrew consent|7|||
163875911|NCT02576509|591914691|FG000|Treatment Period|Lost to Follow-up|0|||
163875912|NCT02576509|591914692|FG001|Treatment Period|Lost to Follow-up|1|||
163875913|NCT02576509|591914691|FG000|Treatment Period|Maximum clinical benefit|1|||
163875914|NCT02576509|591914692|FG001|Treatment Period|Maximum clinical benefit|0|||
163875915|NCT02576509|591914691|FG000|Treatment Period|Poor/non-compliance|1|||
163875916|NCT02576509|591914692|FG001|Treatment Period|Poor/non-compliance|1|||
163875917|NCT02576509|591914691|FG000|Treatment Period|Participant no longer meets criteria|1|||
163875918|NCT02576509|591914692|FG001|Treatment Period|Participant no longer meets criteria|0|||
163875919|NCT02576509|591914691|FG000|Treatment Period|Other reason|12|||
163875920|NCT02576509|591914692|FG001|Treatment Period|Other reason|8|||
164209841|NCT03595748|593136992|FG000|Overall Study|Protocol Violation|0|||
164209842|NCT03595748|593136993|FG001|Overall Study|Protocol Violation|1|||
164209843|NCT02328014|593136994|FG000|Overall Study|Adverse Event|1|||
164209844|NCT02328014|593136995|FG001|Overall Study|Adverse Event|0|||
164209845|NCT02328014|593136996|FG002|Overall Study|Adverse Event|0|||
164209846|NCT02328014|593136997|FG003|Overall Study|Adverse Event|1|||
164209847|NCT02328014|593136994|FG000|Overall Study|Death|0|||
164209848|NCT02328014|593136995|FG001|Overall Study|Death|0|||
164209849|NCT02328014|593136996|FG002|Overall Study|Death|0|||
164209850|NCT02328014|593136997|FG003|Overall Study|Death|4|||
163875921|NCT02576509|591914691|FG000|Treatment Period|NOT REPORTED|1|||
163875922|NCT02576509|591914692|FG001|Treatment Period|NOT REPORTED|0|||
164077113|NCT01507831|592647871|FG001|Overall Study|Randomized but not treated|3|||
164077114|NCT01507831|592647870|FG000|Overall Study|Adverse Event|48|||
164077115|NCT01507831|592647871|FG001|Overall Study|Adverse Event|113|||
164077116|NCT01507831|592647870|FG000|Overall Study|Death|6|||
164077117|NCT01507831|592647871|FG001|Overall Study|Death|2|||
164077118|NCT01507831|592647870|FG000|Overall Study|Poor compliance to protocol|38|||
164077119|NCT01507831|592647871|FG001|Overall Study|Poor compliance to protocol|60|||
164077120|NCT01507831|592647870|FG000|Overall Study|Physician Decision|0|||
164077121|NCT01507831|592647871|FG001|Overall Study|Physician Decision|4|||
164077122|NCT01507831|592647870|FG000|Overall Study|Participant moved|5|||
164077123|NCT01507831|592647871|FG001|Overall Study|Participant moved|19|||
164077124|NCT01507831|592647870|FG000|Overall Study|Consent withdrawn by participant|34|||
164077125|NCT01507831|592647871|FG001|Overall Study|Consent withdrawn by participant|72|||
164077126|NCT01507831|592647870|FG000|Overall Study|Related to study drug administration|5|||
164077127|NCT01507831|592647871|FG001|Overall Study|Related to study drug administration|14|||
164077128|NCT01507831|592647870|FG000|Overall Study|Last visit outside protocol visit window|51|||
164077129|NCT01507831|592647871|FG001|Overall Study|Last visit outside protocol visit window|143|||
164077130|NCT01507831|592647870|FG000|Overall Study|Selection criteria finally not met|0|||
164077131|NCT01507831|592647871|FG001|Overall Study|Selection criteria finally not met|1|||
164077132|NCT01507831|592647870|FG000|Overall Study|Site closure|0|||
164077133|NCT01507831|592647871|FG001|Overall Study|Site closure|3|||
164077134|NCT01507831|592647870|FG000|Overall Study|Potential lost to follow-up|3|||
164077135|NCT01507831|592647871|FG001|Overall Study|Potential lost to follow-up|0|||
164077136|NCT01507831|592647870|FG000|Overall Study|Other|3|||
164077137|NCT01507831|592647871|FG001|Overall Study|Other|6|||
164077138|NCT03652961|592647872|FG000|Overall Study|Lost to Follow-up|3|||
164077139|NCT03652961|592647872|FG000|Overall Study|Screen Failure|1|||
164077140|NCT01280981|592647875|FG000|Overall Study|Withdrawal by Subject|11|||
164077141|NCT01280981|592647875|FG000|Overall Study|Protocol Violation|2|||
164077142|NCT01280981|592647875|FG000|Overall Study|Lack of Efficacy|13|||
164077143|NCT01280981|592647875|FG000|Overall Study|Lost to Follow-up|3|||
164077144|NCT01280981|592647875|FG000|Overall Study|Adverse Event|6|||
164077145|NCT01280981|592647875|FG000|Overall Study|Irregular or discontinued menses|3|||
164077146|NCT01280981|592647875|FG000|Overall Study|Failed to return|45|||
164077147|NCT01280981|592647875|FG000|Overall Study|Non-compliance with protocol|3|||
164077148|NCT01280981|592647875|FG000|Overall Study|Withdrawal of consent|3|||
164077149|NCT01280981|592647875|FG000|Overall Study|Elective surgery|2|||
164077150|NCT01280981|592647875|FG000|Overall Study|Study site closure|1|||
164077151|NCT01610167|592647878|FG000|Overall Study|Scheduling conflict.|0|||
164209851|NCT02328014|593136994|FG000|Overall Study|Physician Decision|0|||
164209852|NCT02328014|593136995|FG001|Overall Study|Physician Decision|0|||
164209853|NCT02328014|593136996|FG002|Overall Study|Physician Decision|0|||
163875923|NCT02576509|591914691|FG000|Treatment Period|Administrative reason by sponsor|0|||
163875924|NCT02576509|591914692|FG001|Treatment Period|Administrative reason by sponsor|1|||
163875925|NCT04527146|591914693|FG000|Overall Study|Withdrawal by Subject|12|||
163875926|NCT04527146|591914694|FG001|Overall Study|Withdrawal by Subject|15|||
163875927|NCT04527146|591914695|FG002|Overall Study|Withdrawal by Subject|7|||
163875928|NCT04527146|591914696|FG003|Overall Study|Withdrawal by Subject|16|||
163875929|NCT04527146|591914693|FG000|Overall Study|Lost to Follow-up|13|||
163875930|NCT04527146|591914694|FG001|Overall Study|Lost to Follow-up|9|||
163875931|NCT04527146|591914695|FG002|Overall Study|Lost to Follow-up|16|||
163875932|NCT04527146|591914696|FG003|Overall Study|Lost to Follow-up|13|||
163875933|NCT04527146|591914693|FG000|Overall Study|Death|0|||
163875934|NCT04527146|591914694|FG001|Overall Study|Death|1|||
163875935|NCT04527146|591914695|FG002|Overall Study|Death|1|||
163875936|NCT04527146|591914696|FG003|Overall Study|Death|0|||
163875937|NCT04527146|591914693|FG000|Overall Study|Adverse Event|0|||
163875938|NCT04527146|591914694|FG001|Overall Study|Adverse Event|0|||
163875939|NCT04527146|591914695|FG002|Overall Study|Adverse Event|1|||
163875940|NCT04527146|591914696|FG003|Overall Study|Adverse Event|0|||
163875941|NCT04527146|591914693|FG000|Overall Study|Ineligible after randomization|2|||
164077152|NCT01610167|592647879|FG001|Overall Study|Scheduling conflict.|0|||
164077153|NCT01610167|592647880|FG002|Overall Study|Scheduling conflict.|2|||
164077154|NCT03276962|592647885|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
164077155|NCT03276962|592647886|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
164077156|NCT03276962|592647887|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
163875942|NCT04527146|591914694|FG001|Overall Study|Ineligible after randomization|0|||
163875943|NCT04527146|591914695|FG002|Overall Study|Ineligible after randomization|2|||
163875944|NCT04527146|591914696|FG003|Overall Study|Ineligible after randomization|2|||
163875945|NCT04527146|591914693|FG000|Overall Study|Moved to a different group|6|||
163875946|NCT04527146|591914694|FG001|Overall Study|Moved to a different group|3|||
163875947|NCT04527146|591914695|FG002|Overall Study|Moved to a different group|0|||
164077157|NCT03276962|592647888|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
164209854|NCT02328014|593136997|FG003|Overall Study|Physician Decision|1|||
164209855|NCT02328014|593136994|FG000|Overall Study|Disease Progression|1|||
164209856|NCT02328014|593136995|FG001|Overall Study|Disease Progression|0|||
164209857|NCT02328014|593136996|FG002|Overall Study|Disease Progression|1|||
164324332|NCT04393298|593565162|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324333|NCT04393298|593565163|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324334|NCT04393298|593565164|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324335|NCT04393298|593565165|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209858|NCT02328014|593136997|FG003|Overall Study|Disease Progression|3|||
164209859|NCT02328014|593136994|FG000|Overall Study|Study Terminated by Sponsor|4|||
164209860|NCT02328014|593136995|FG001|Overall Study|Study Terminated by Sponsor|1|||
164209861|NCT02328014|593136996|FG002|Overall Study|Study Terminated by Sponsor|1|||
164209862|NCT02328014|593136997|FG003|Overall Study|Study Terminated by Sponsor|0|||
164209863|NCT02328014|593136994|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
164209864|NCT02328014|593136995|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
164209865|NCT02328014|593136996|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
164209866|NCT02328014|593136997|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
164209867|NCT02328014|593136994|FG000|Overall Study|Withdrawal by Subject|0|||
164209868|NCT02328014|593136995|FG001|Overall Study|Withdrawal by Subject|0|||
164209869|NCT02328014|593136996|FG002|Overall Study|Withdrawal by Subject|0|||
164209870|NCT02328014|593136997|FG003|Overall Study|Withdrawal by Subject|1|||
164209871|NCT05028569|593137014|FG000|Double-Blind Phase|Death|0|||
164209872|NCT05028569|593137015|FG001|Double-Blind Phase|Death|0|||
164209873|NCT05028569|593137016|FG002|Double-Blind Phase|Death|0|||
164209874|NCT05028569|593137017|FG003|Double-Blind Phase|Death|1|||
164209875|NCT05028569|593137018|FG004|Double-Blind Phase|Death|0|||
164209876|NCT05028569|593137019|FG005|Double-Blind Phase|Death|0|||
164209877|NCT05028569|593137020|FG006|Double-Blind Phase|Death|0|||
164209878|NCT05028569|593137014|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164209879|NCT05028569|593137015|FG001|Double-Blind Phase|Lost to Follow-up|6|||
164209880|NCT05028569|593137016|FG002|Double-Blind Phase|Lost to Follow-up|3|||
164209881|NCT05028569|593137017|FG003|Double-Blind Phase|Lost to Follow-up|9|||
164209882|NCT05028569|593137018|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164209883|NCT05028569|593137019|FG005|Double-Blind Phase|Lost to Follow-up|0|||
164209884|NCT05028569|593137020|FG006|Double-Blind Phase|Lost to Follow-up|0|||
164209885|NCT05028569|593137014|FG000|Double-Blind Phase|Protocol Deviation|0|||
164209886|NCT05028569|593137015|FG001|Double-Blind Phase|Protocol Deviation|2|||
164209887|NCT05028569|593137016|FG002|Double-Blind Phase|Protocol Deviation|0|||
164209888|NCT05028569|593137017|FG003|Double-Blind Phase|Protocol Deviation|0|||
164209889|NCT05028569|593137018|FG004|Double-Blind Phase|Protocol Deviation|0|||
164209890|NCT05028569|593137019|FG005|Double-Blind Phase|Protocol Deviation|0|||
164209891|NCT05028569|593137020|FG006|Double-Blind Phase|Protocol Deviation|0|||
164209892|NCT05028569|593137014|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164209893|NCT05028569|593137015|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
164209894|NCT05028569|593137016|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
164209895|NCT05028569|593137017|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
164209896|NCT05028569|593137018|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164209897|NCT05028569|593137019|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
164209898|NCT05028569|593137020|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
164209899|NCT05028569|593137014|FG000|Double-Blind Phase|Other, not specified|0|||
164209900|NCT05028569|593137015|FG001|Double-Blind Phase|Other, not specified|5|||
164209901|NCT05028569|593137016|FG002|Double-Blind Phase|Other, not specified|4|||
164209902|NCT05028569|593137017|FG003|Double-Blind Phase|Other, not specified|6|||
164209903|NCT05028569|593137018|FG004|Double-Blind Phase|Other, not specified|0|||
164209904|NCT05028569|593137019|FG005|Double-Blind Phase|Other, not specified|0|||
164209905|NCT05028569|593137020|FG006|Double-Blind Phase|Other, not specified|0|||
163875948|NCT04527146|591914696|FG003|Overall Study|Moved to a different group|2|||
163875949|NCT05510232|591914697|FG000|Overall Study|Withdrawal by Subject|2|||
163875950|NCT05510232|591914698|FG001|Overall Study|Withdrawal by Subject|7|||
163875951|NCT05510232|591914699|FG002|Overall Study|Withdrawal by Subject|6|||
163875952|NCT05687903|591914708|FG000|Overall Study|Protocol Deviation|1|||
163875953|NCT05687903|591914709|FG001|Overall Study|Protocol Deviation|1|||
163875954|NCT05687903|591914710|FG002|Overall Study|Protocol Deviation|0|||
163875955|NCT05687903|591914711|FG003|Overall Study|Protocol Deviation|1|||
164209906|NCT05028569|593137014|FG000|Open-Label Phase|Death|0|||
164209907|NCT05028569|593137015|FG001|Open-Label Phase|Death|0|||
164209908|NCT05028569|593137016|FG002|Open-Label Phase|Death|0|||
164209909|NCT05028569|593137017|FG003|Open-Label Phase|Death|0|||
164209910|NCT05028569|593137018|FG004|Open-Label Phase|Death|0|||
164209911|NCT05028569|593137019|FG005|Open-Label Phase|Death|0|||
164209912|NCT05028569|593137020|FG006|Open-Label Phase|Death|1|||
164324336|NCT04393298|593565166|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324337|NCT04393298|593565167|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
164209913|NCT05028569|593137014|FG000|Open-Label Phase|Lost to Follow-up|0|||
164324338|NCT04393298|593565168|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
163875956|NCT05687903|591914712|FG004|Overall Study|Protocol Deviation|0|||
163875957|NCT04468776|591914713|FG000|Overall Study|Lost to Follow-up|4|||
164209914|NCT05028569|593137015|FG001|Open-Label Phase|Lost to Follow-up|0|||
164209915|NCT05028569|593137016|FG002|Open-Label Phase|Lost to Follow-up|0|||
164209916|NCT05028569|593137017|FG003|Open-Label Phase|Lost to Follow-up|0|||
164209917|NCT05028569|593137018|FG004|Open-Label Phase|Lost to Follow-up|5|||
164209918|NCT05028569|593137019|FG005|Open-Label Phase|Lost to Follow-up|5|||
164209919|NCT05028569|593137020|FG006|Open-Label Phase|Lost to Follow-up|4|||
164209920|NCT05028569|593137014|FG000|Open-Label Phase|Protocol Deviation|0|||
164209921|NCT05028569|593137015|FG001|Open-Label Phase|Protocol Deviation|0|||
164209922|NCT05028569|593137016|FG002|Open-Label Phase|Protocol Deviation|0|||
164209923|NCT05028569|593137017|FG003|Open-Label Phase|Protocol Deviation|0|||
164209924|NCT05028569|593137018|FG004|Open-Label Phase|Protocol Deviation|1|||
164209925|NCT05028569|593137019|FG005|Open-Label Phase|Protocol Deviation|0|||
164209926|NCT05028569|593137020|FG006|Open-Label Phase|Protocol Deviation|0|||
164209927|NCT05028569|593137014|FG000|Open-Label Phase|Pregnancy|0|||
164209928|NCT05028569|593137015|FG001|Open-Label Phase|Pregnancy|0|||
164209929|NCT05028569|593137016|FG002|Open-Label Phase|Pregnancy|0|||
164209930|NCT05028569|593137017|FG003|Open-Label Phase|Pregnancy|0|||
164209931|NCT05028569|593137018|FG004|Open-Label Phase|Pregnancy|0|||
164209932|NCT05028569|593137019|FG005|Open-Label Phase|Pregnancy|1|||
164209933|NCT05028569|593137020|FG006|Open-Label Phase|Pregnancy|0|||
164209934|NCT05028569|593137014|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164209935|NCT05028569|593137015|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164209936|NCT05028569|593137016|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164209937|NCT05028569|593137017|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164209938|NCT05028569|593137018|FG004|Open-Label Phase|Withdrawal by Subject|15|||
164209939|NCT05028569|593137019|FG005|Open-Label Phase|Withdrawal by Subject|8|||
164209940|NCT05028569|593137020|FG006|Open-Label Phase|Withdrawal by Subject|13|||
164209941|NCT05028569|593137014|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
164209942|NCT05028569|593137015|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
164209943|NCT05028569|593137016|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
164209944|NCT05028569|593137017|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
164209945|NCT05028569|593137018|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
164209946|NCT05028569|593137019|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
164209947|NCT05028569|593137020|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
164209948|NCT05028569|593137014|FG000|Open-Label Phase|Other, not specified|0|||
164077158|NCT03276962|592647889|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
164077159|NCT03276962|592647885|FG000|Overall Study|Protocol Deviation|2|||
164077160|NCT03276962|592647886|FG001|Overall Study|Protocol Deviation|0|||
164077161|NCT03276962|592647887|FG002|Overall Study|Protocol Deviation|1|||
164077162|NCT03276962|592647888|FG003|Overall Study|Protocol Deviation|2|||
164077163|NCT03276962|592647889|FG004|Overall Study|Protocol Deviation|1|||
164077164|NCT03276962|592647885|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
164077165|NCT03276962|592647886|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
164077166|NCT03276962|592647887|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
164077167|NCT03276962|592647888|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
164077168|NCT03276962|592647889|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
164077169|NCT03276962|592647885|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
164077170|NCT03276962|592647886|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
164077171|NCT03276962|592647887|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
164077172|NCT03276962|592647888|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
164077173|NCT03276962|592647889|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
164077174|NCT03276962|592647885|FG000|Overall Study|Lost to Follow-up|10|||
164077175|NCT03276962|592647886|FG001|Overall Study|Lost to Follow-up|10|||
164077176|NCT03276962|592647887|FG002|Overall Study|Lost to Follow-up|4|||
164077177|NCT03276962|592647888|FG003|Overall Study|Lost to Follow-up|6|||
164077178|NCT03276962|592647889|FG004|Overall Study|Lost to Follow-up|10|||
164077179|NCT03276962|592647885|FG000|Overall Study|Other|0|||
164077180|NCT03276962|592647886|FG001|Overall Study|Other|2|||
164077181|NCT03276962|592647887|FG002|Overall Study|Other|0|||
164077182|NCT03276962|592647888|FG003|Overall Study|Other|2|||
164077183|NCT03276962|592647889|FG004|Overall Study|Other|1|||
164077184|NCT01358708|592647890|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
164077185|NCT01358708|592647891|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164077186|NCT01358708|592647890|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
164077187|NCT01358708|592647891|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
164209949|NCT05028569|593137015|FG001|Open-Label Phase|Other, not specified|0|||
164209950|NCT05028569|593137016|FG002|Open-Label Phase|Other, not specified|0|||
164077188|NCT03056001|592647895|FG000|Overall Study|Death|24|||
164077189|NCT02766400|592647902|FG000|Overall Study|Death|1|||
164077190|NCT02766400|592647903|FG001|Overall Study|Death|2|||
164077191|NCT02766400|592647902|FG000|Overall Study|Withdrawal by Subject|1|||
164209951|NCT05028569|593137017|FG003|Open-Label Phase|Other, not specified|0|||
164209952|NCT05028569|593137018|FG004|Open-Label Phase|Other, not specified|6|||
164209953|NCT05028569|593137019|FG005|Open-Label Phase|Other, not specified|5|||
164209954|NCT05028569|593137020|FG006|Open-Label Phase|Other, not specified|7|||
164209955|NCT05028569|593137014|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209956|NCT05028569|593137015|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209957|NCT05028569|593137016|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209958|NCT05028569|593137017|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209959|NCT05028569|593137018|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209960|NCT05028569|593137019|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
164209961|NCT05028569|593137020|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
164209962|NCT05028569|593137014|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209963|NCT05028569|593137015|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209964|NCT05028569|593137016|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209965|NCT05028569|593137017|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209966|NCT05028569|593137018|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209967|NCT05028569|593137019|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
164209968|NCT05028569|593137020|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
164209969|NCT04609553|593137021|FG000|Overall Study|Lost to Follow-up|27|||
164209970|NCT04609553|593137022|FG001|Overall Study|Lost to Follow-up|31|||
164209971|NCT04609553|593137023|FG002|Overall Study|Lost to Follow-up|24|||
164209972|NCT04609553|593137021|FG000|Overall Study|Discontinued|12|||
164209973|NCT04609553|593137022|FG001|Overall Study|Discontinued|10|||
164209974|NCT04609553|593137023|FG002|Overall Study|Discontinued|9|||
164209975|NCT00764517|593137034|FG000|Overall Study|Adverse Event|9|||
164209976|NCT00764517|593137035|FG001|Overall Study|Adverse Event|3|||
164209977|NCT00764517|593137034|FG000|Overall Study|Death|3|||
164209978|NCT00764517|593137035|FG001|Overall Study|Death|11|||
164209979|NCT00764517|593137034|FG000|Overall Study|Physician Decision|3|||
164209980|NCT00764517|593137035|FG001|Overall Study|Physician Decision|0|||
164209981|NCT02362451|593137038|FG000|Overall Study|Withdrawal by Subject|0|||
164209982|NCT02362451|593137039|FG001|Overall Study|Withdrawal by Subject|1|||
164209983|NCT02362451|593137038|FG000|Overall Study|Lack of Efficacy|2|||
164209984|NCT02362451|593137039|FG001|Overall Study|Lack of Efficacy|0|||
164209985|NCT02362451|593137038|FG000|Overall Study|Progression|1|||
164209986|NCT02362451|593137039|FG001|Overall Study|Progression|0|||
164209987|NCT02362451|593137038|FG000|Overall Study|Participant chose other therapy.|1|||
164209988|NCT02362451|593137039|FG001|Overall Study|Participant chose other therapy.|0|||
164209989|NCT00460798|593137040|FG000|Overall Study|Death|59|||
164209990|NCT00460798|593137040|FG000|Overall Study|Adverse Event|27|||
164209991|NCT00460798|593137040|FG000|Overall Study|Lost to Follow-up|19|||
164209992|NCT00460798|593137040|FG000|Overall Study|Progressive Disease|99|||
164209993|NCT00460798|593137040|FG000|Overall Study|Other|27|||
164209994|NCT00460798|593137040|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
164209995|NCT00460798|593137040|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
164209996|NCT03517137|593137046|FG000|Overall Study|Lack of Efficacy|1|||
164209997|NCT03517137|593137046|FG000|Overall Study|Adverse Event|2|||
164209998|NCT03517137|593137046|FG000|Overall Study|Withdrawal by Subject|2|||
164209999|NCT03517137|593137046|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
164210000|NCT01186770|593137047|FG000|Overall Study|Ineligibility|0|||
163875958|NCT04468776|591914714|FG001|Overall Study|Lost to Follow-up|3|||
163875959|NCT04468776|591914715|FG002|Overall Study|Lost to Follow-up|4|||
163875960|NCT04468776|591914713|FG000|Overall Study|Withdrawal by Subject|1|||
163875961|NCT04468776|591914714|FG001|Overall Study|Withdrawal by Subject|10|||
163875962|NCT04468776|591914715|FG002|Overall Study|Withdrawal by Subject|4|||
163875963|NCT04468776|591914713|FG000|Overall Study|Physician Decision|0|||
163875964|NCT04468776|591914714|FG001|Overall Study|Physician Decision|1|||
163875965|NCT04468776|591914715|FG002|Overall Study|Physician Decision|1|||
163875966|NCT04840199|591914718|FG000|Overall Study|Study Terminated by Sponsor|8|||
163875967|NCT04840199|591914719|FG001|Overall Study|Study Terminated by Sponsor|9|||
163875968|NCT04840199|591914718|FG000|Overall Study|Lost to Follow-up|0|||
163875969|NCT04840199|591914719|FG001|Overall Study|Lost to Follow-up|2|||
163875970|NCT04840199|591914718|FG000|Overall Study|Withdrawal by Subject|2|||
163875971|NCT04840199|591914719|FG001|Overall Study|Withdrawal by Subject|0|||
163875972|NCT04840199|591914718|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
163875973|NCT04840199|591914719|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
163875974|NCT03433339|591914720|FG000|Overall Study|Lost to Follow-up|2|||
163875975|NCT03433339|591914721|FG001|Overall Study|Lost to Follow-up|0|||
163875976|NCT03433339|591914720|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
163875977|NCT03433339|591914721|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
163875978|NCT03433339|591914720|FG000|Overall Study|Withdrawal by Subject|0|||
163875979|NCT03433339|591914721|FG001|Overall Study|Withdrawal by Subject|2|||
163875980|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
164077192|NCT02766400|592647903|FG001|Overall Study|Withdrawal by Subject|0|||
164077193|NCT03499249|592647909|FG000|Overall Study|Physician Decision|1|||
164077194|NCT01374906|592647910|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164077195|NCT01374906|592647911|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164077196|NCT01374906|592647910|FG000|Overall Study|Administrative problems|2|||
164077197|NCT01374906|592647911|FG001|Overall Study|Administrative problems|2|||
164077198|NCT01374906|592647910|FG000|Overall Study|Adverse Event|10|||
164077199|NCT01374906|592647911|FG001|Overall Study|Adverse Event|11|||
164077200|NCT01374906|592647910|FG000|Overall Study|Death|0|||
164077201|NCT01374906|592647911|FG001|Overall Study|Death|2|||
164077202|NCT01374906|592647910|FG000|Overall Study|Protocol Violation|2|||
164077203|NCT01374906|592647911|FG001|Overall Study|Protocol Violation|2|||
164077204|NCT01374906|592647910|FG000|Overall Study|Withdrawal by Subject|15|||
164077205|NCT01374906|592647911|FG001|Overall Study|Withdrawal by Subject|9|||
164077206|NCT01374906|592647910|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
164077207|NCT01374906|592647911|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
164077208|NCT02475980|592647916|FG000|Overall Study|Lost to Follow-up|4|||
164077209|NCT02475980|592647916|FG000|Overall Study|Withdrawal by Subject|1|||
164077210|NCT01458119|592647924|FG000|Overall Study|Physician Decision|4|||
164077211|NCT01458119|592647924|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
164077212|NCT01458119|592647924|FG000|Overall Study|Pregnancy|1|||
164077213|NCT01458119|592647924|FG000|Overall Study|Death|2|||
164077214|NCT01458119|592647924|FG000|Overall Study|Adverse Event|1|||
164077215|NCT01458119|592647924|FG000|Overall Study|Consent Withdrawn by Participant|8|||
164077216|NCT01458119|592647924|FG000|Overall Study|Non-compliance With Study Drug|3|||
164077217|NCT03033069|592647925|FG000|Overall Study|Adverse Event|6|||
164077218|NCT03033069|592647926|FG001|Overall Study|Adverse Event|7|||
164077219|NCT03033069|592647927|FG002|Overall Study|Adverse Event|4|||
164077220|NCT03033069|592647928|FG003|Overall Study|Adverse Event|6|||
164077221|NCT03033069|592647925|FG000|Overall Study|Lack of Efficacy|0|||
164077222|NCT03033069|592647926|FG001|Overall Study|Lack of Efficacy|0|||
164077223|NCT03033069|592647927|FG002|Overall Study|Lack of Efficacy|1|||
164077224|NCT03033069|592647928|FG003|Overall Study|Lack of Efficacy|0|||
164077225|NCT03033069|592647925|FG000|Overall Study|Lost to Follow-up|6|||
164077226|NCT03033069|592647926|FG001|Overall Study|Lost to Follow-up|5|||
164077227|NCT03033069|592647927|FG002|Overall Study|Lost to Follow-up|5|||
164077228|NCT03033069|592647928|FG003|Overall Study|Lost to Follow-up|6|||
164077229|NCT03033069|592647925|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164077230|NCT03033069|592647926|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164077231|NCT03033069|592647927|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164077232|NCT03033069|592647928|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164077233|NCT03033069|592647925|FG000|Overall Study|Protocol Deviation|0|||
164077234|NCT03033069|592647926|FG001|Overall Study|Protocol Deviation|1|||
164077235|NCT03033069|592647927|FG002|Overall Study|Protocol Deviation|0|||
164077236|NCT03033069|592647928|FG003|Overall Study|Protocol Deviation|0|||
164077237|NCT03033069|592647925|FG000|Overall Study|Withdrawal by Subject|10|||
164077238|NCT03033069|592647926|FG001|Overall Study|Withdrawal by Subject|10|||
164077239|NCT03033069|592647927|FG002|Overall Study|Withdrawal by Subject|11|||
164077240|NCT03033069|592647928|FG003|Overall Study|Withdrawal by Subject|6|||
164077241|NCT03033069|592647925|FG000|Overall Study|Withdrawal By Caregiver|1|||
164077242|NCT03033069|592647926|FG001|Overall Study|Withdrawal By Caregiver|0|||
164077243|NCT03033069|592647927|FG002|Overall Study|Withdrawal By Caregiver|0|||
164210001|NCT01186770|593137048|FG001|Overall Study|Ineligibility|0|||
164210002|NCT01186770|593137049|FG002|Overall Study|Ineligibility|2|||
164210003|NCT01186770|593137050|FG003|Overall Study|Ineligibility|0|||
164210004|NCT01186770|593137047|FG000|Overall Study|Protocol Violation|7|||
164210005|NCT01186770|593137048|FG001|Overall Study|Protocol Violation|9|||
164210006|NCT01186770|593137049|FG002|Overall Study|Protocol Violation|12|||
164210007|NCT01186770|593137050|FG003|Overall Study|Protocol Violation|14|||
164210008|NCT01186770|593137047|FG000|Overall Study|Adverse Event|2|||
164210009|NCT01186770|593137048|FG001|Overall Study|Adverse Event|9|||
164210010|NCT01186770|593137049|FG002|Overall Study|Adverse Event|7|||
164210011|NCT01186770|593137050|FG003|Overall Study|Adverse Event|9|||
164077244|NCT03033069|592647928|FG003|Overall Study|Withdrawal By Caregiver|0|||
164077245|NCT03033069|592647925|FG000|Overall Study|Reason not Specified|0|||
164210012|NCT01186770|593137047|FG000|Overall Study|Withdrawal by Subject|15|||
164077246|NCT03033069|592647926|FG001|Overall Study|Reason not Specified|1|||
164077247|NCT03033069|592647927|FG002|Overall Study|Reason not Specified|0|||
164077248|NCT03033069|592647928|FG003|Overall Study|Reason not Specified|1|||
164077249|NCT00430638|592647929|FG000|Overall Study|Adverse Event|15|||
164077250|NCT00430638|592647930|FG001|Overall Study|Adverse Event|15|||
164210013|NCT01186770|593137048|FG001|Overall Study|Withdrawal by Subject|13|||
164210014|NCT01186770|593137049|FG002|Overall Study|Withdrawal by Subject|11|||
164077251|NCT00430638|592647929|FG000|Overall Study|Uncontrolled blood pressure|48|||
164077252|NCT00430638|592647930|FG001|Overall Study|Uncontrolled blood pressure|13|||
164077253|NCT00430638|592647929|FG000|Overall Study|Lost to Follow-up|1|||
164077254|NCT00430638|592647930|FG001|Overall Study|Lost to Follow-up|7|||
164077255|NCT00430638|592647929|FG000|Overall Study|Protocol Violation|6|||
164210015|NCT01186770|593137050|FG003|Overall Study|Withdrawal by Subject|17|||
164210016|NCT01186770|593137047|FG000|Overall Study|Lost to Follow-up|10|||
164210017|NCT01186770|593137048|FG001|Overall Study|Lost to Follow-up|6|||
164210018|NCT01186770|593137049|FG002|Overall Study|Lost to Follow-up|14|||
164210019|NCT01186770|593137050|FG003|Overall Study|Lost to Follow-up|9|||
164210020|NCT01186770|593137047|FG000|Overall Study|Insufficient response to treatment|7|||
164210021|NCT01186770|593137048|FG001|Overall Study|Insufficient response to treatment|8|||
164210022|NCT01186770|593137049|FG002|Overall Study|Insufficient response to treatment|5|||
164210023|NCT01186770|593137050|FG003|Overall Study|Insufficient response to treatment|7|||
164210024|NCT01186770|593137047|FG000|Overall Study|Other than specified|0|||
164210025|NCT01186770|593137048|FG001|Overall Study|Other than specified|1|||
164210026|NCT01186770|593137049|FG002|Overall Study|Other than specified|1|||
163980076|NCT01087905|592297329|FG006|Overall Study|Withdrawal by Subject|3|||
163980077|NCT01087905|592297330|FG007|Overall Study|Withdrawal by Subject|5|||
163980078|NCT00513500|592297331|FG000|Overall Study|Lost to Follow-up|35|||
163980079|NCT00513500|592297332|FG001|Overall Study|Lost to Follow-up|39|||
163980080|NCT00513500|592297331|FG000|Overall Study|Death|2|||
163980081|NCT00513500|592297332|FG001|Overall Study|Death|1|||
163980082|NCT00513500|592297331|FG000|Overall Study|Hospitalized|4|||
163980083|NCT00513500|592297332|FG001|Overall Study|Hospitalized|14|||
163980084|NCT04288154|592297333|FG000|Overall Study|Withdrawal by Subject|9|||
163980085|NCT04288154|592297334|FG001|Overall Study|Withdrawal by Subject|9|||
163980086|NCT00790907|592297339|FG000|Overall Study|Adverse Event|9|||
163980087|NCT00790907|592297340|FG001|Overall Study|Adverse Event|7|||
163980088|NCT00790907|592297341|FG002|Overall Study|Adverse Event|6|||
163980089|NCT00790907|592297339|FG000|Overall Study|Physician Decision|304|||
163980090|NCT00790907|592297340|FG001|Overall Study|Physician Decision|271|||
163980091|NCT00790907|592297341|FG002|Overall Study|Physician Decision|255|||
163980092|NCT00790907|592297339|FG000|Overall Study|Withdrawal by Subject|1|||
163980093|NCT00790907|592297340|FG001|Overall Study|Withdrawal by Subject|7|||
163980094|NCT00790907|592297341|FG002|Overall Study|Withdrawal by Subject|5|||
163980095|NCT00790907|592297339|FG000|Overall Study|Bleeding Event|11|||
163980096|NCT00790907|592297340|FG001|Overall Study|Bleeding Event|16|||
163980097|NCT00790907|592297341|FG002|Overall Study|Bleeding Event|21|||
163980098|NCT00790907|592297339|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
163980099|NCT00790907|592297340|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
163980100|NCT00790907|592297341|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
163980101|NCT00790907|592297339|FG000|Overall Study|Qualifying Condition Not Present|29|||
163980102|NCT00790907|592297340|FG001|Overall Study|Qualifying Condition Not Present|14|||
163980103|NCT00790907|592297341|FG002|Overall Study|Qualifying Condition Not Present|16|||
163980104|NCT00790907|592297339|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
163980105|NCT00790907|592297340|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
163980106|NCT00790907|592297341|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
163980107|NCT00790907|592297339|FG000|Overall Study|Did Not Receive Study Drug|10|||
163980108|NCT00790907|592297340|FG001|Overall Study|Did Not Receive Study Drug|0|||
163980109|NCT00790907|592297341|FG002|Overall Study|Did Not Receive Study Drug|0|||
163980110|NCT01902290|592297342|FG000|Overall Study|Withdrawal by Subject|19|||
163980111|NCT01902290|592297343|FG001|Overall Study|Withdrawal by Subject|27|||
163980112|NCT01902290|592297342|FG000|Overall Study|Lost to Follow-up|2|||
163980113|NCT01902290|592297343|FG001|Overall Study|Lost to Follow-up|2|||
163980114|NCT01902290|592297342|FG000|Overall Study|Death|1|||
163980115|NCT01902290|592297343|FG001|Overall Study|Death|0|||
163980116|NCT01902290|592297342|FG000|Overall Study|Sponsor Decision|26|||
163980117|NCT01902290|592297343|FG001|Overall Study|Sponsor Decision|24|||
163980118|NCT00774345|592297344|FG000|Pre-treatment|Other reasons|2|||
164210027|NCT01186770|593137050|FG003|Overall Study|Other than specified|2|||
164210028|NCT02441283|593137051|FG000|Overall Study|Withdrew consent|15|||
163980119|NCT00774345|592297345|FG001|Pre-treatment|Other reasons|0|||
163980120|NCT00774345|592297344|FG000|Treatment|Adverse Event|61|||
163980121|NCT00774345|592297345|FG001|Treatment|Adverse Event|15|||
163980122|NCT00774345|592297344|FG000|Treatment|Progressive Disease without histologic transformation|51|||
163980123|NCT00774345|592297345|FG001|Treatment|Progressive Disease without histologic transformation|111|||
163980124|NCT00774345|592297344|FG000|Treatment|Progressive Disease with histologic transformation|4|||
164077256|NCT00430638|592647930|FG001|Overall Study|Protocol Violation|4|||
164077257|NCT00430638|592647929|FG000|Overall Study|Withdrawal by Subject|4|||
164077258|NCT00430638|592647930|FG001|Overall Study|Withdrawal by Subject|6|||
164210029|NCT02441283|593137051|FG000|Overall Study|Lost to Follow-up|42|||
164077259|NCT00430638|592647929|FG000|Overall Study|Non-compliant|2|||
164077260|NCT00430638|592647930|FG001|Overall Study|Non-compliant|1|||
164077261|NCT00430638|592647929|FG000|Overall Study|Other|2|||
164077262|NCT00430638|592647930|FG001|Overall Study|Other|2|||
164210030|NCT02441283|593137051|FG000|Overall Study|Death|1|||
164355617|NCT00512707|593676482|FG000|Overall Study|Lost to Follow-up|5|||
163980125|NCT00774345|592297345|FG001|Treatment|Progressive Disease with histologic transformation|2|||
163980126|NCT00774345|592297344|FG000|Treatment|Withdrawal by Subject|5|||
164077263|NCT01529749|592647931|FG000|Overall Study|Lost to Follow-up|0|||
164077264|NCT01529749|592647932|FG001|Overall Study|Lost to Follow-up|1|||
164210031|NCT02441283|593137051|FG000|Overall Study|Other, not specified|32|||
164210032|NCT02472353|593137054|FG000|Overall Study|Lost to Follow-up|1|||
164210033|NCT02472353|593137055|FG001|Overall Study|Lost to Follow-up|1|||
164210034|NCT02472353|593137054|FG000|Overall Study|Withdrawal by Subject|2|||
164210035|NCT02472353|593137055|FG001|Overall Study|Withdrawal by Subject|1|||
164210036|NCT02472353|593137054|FG000|Overall Study|Study Termination|1|||
164210037|NCT02472353|593137055|FG001|Overall Study|Study Termination|4|||
164210038|NCT02101294|593137056|FG000|Overall Study|Withdrawal by Subject|5|||
164210039|NCT02101294|593137056|FG000|Overall Study|Lost to Follow-up|6|||
164210040|NCT00688597|593137057|FG000|Overall Study|Adverse Event|2|||
164210041|NCT00688597|593137058|FG001|Overall Study|Adverse Event|0|||
164210042|NCT00688597|593137059|FG002|Overall Study|Adverse Event|0|||
164210043|NCT00688597|593137057|FG000|Overall Study|Physician Decision|1|||
164210044|NCT00688597|593137058|FG001|Overall Study|Physician Decision|0|||
164210045|NCT00688597|593137059|FG002|Overall Study|Physician Decision|0|||
164210046|NCT00689936|593137060|FG000|Active Treatment Phase|Adverse Event|68|||
164210047|NCT00689936|593137061|FG001|Active Treatment Phase|Adverse Event|71|||
164210048|NCT00689936|593137062|FG002|Active Treatment Phase|Adverse Event|76|||
164210049|NCT00689936|593137060|FG000|Active Treatment Phase|Disease Progression|273|||
164210050|NCT00689936|593137061|FG001|Active Treatment Phase|Disease Progression|362|||
164210051|NCT00689936|593137062|FG002|Active Treatment Phase|Disease Progression|339|||
164210052|NCT00689936|593137060|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
164210053|NCT00689936|593137061|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
164210054|NCT00689936|593137062|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
164210055|NCT00689936|593137060|FG000|Active Treatment Phase|Death|60|||
164210056|NCT00689936|593137061|FG001|Active Treatment Phase|Death|28|||
164210057|NCT00689936|593137062|FG002|Active Treatment Phase|Death|37|||
164210058|NCT00689936|593137060|FG000|Active Treatment Phase|Lost to Follow-up|0|||
164210059|NCT00689936|593137061|FG001|Active Treatment Phase|Lost to Follow-up|2|||
164210060|NCT00689936|593137062|FG002|Active Treatment Phase|Lost to Follow-up|2|||
164210061|NCT00689936|593137060|FG000|Active Treatment Phase|Protocol Violation|2|||
164210062|NCT00689936|593137061|FG001|Active Treatment Phase|Protocol Violation|2|||
164210063|NCT00689936|593137062|FG002|Active Treatment Phase|Protocol Violation|4|||
164210064|NCT00689936|593137060|FG000|Active Treatment Phase|Study Close Out|64|||
164210065|NCT00689936|593137061|FG001|Active Treatment Phase|Study Close Out|26|||
164210066|NCT00689936|593137062|FG002|Active Treatment Phase|Study Close Out|21|||
164210067|NCT00689936|593137060|FG000|Active Treatment Phase|Miscellaneous|52|||
164210068|NCT00689936|593137061|FG001|Active Treatment Phase|Miscellaneous|34|||
164210069|NCT00689936|593137062|FG002|Active Treatment Phase|Miscellaneous|47|||
164210070|NCT00689936|593137060|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
164210071|NCT00689936|593137061|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
164210072|NCT00689936|593137062|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
164210073|NCT01995201|593137063|FG000|From Baseline Until Week 24|Adverse Event|4|||
164210074|NCT01995201|593137064|FG001|From Baseline Until Week 24|Adverse Event|15|||
164210075|NCT01995201|593137065|FG002|From Baseline Until Week 24|Adverse Event|0|||
164210076|NCT01995201|593137066|FG003|From Baseline Until Week 24|Adverse Event|0|||
164210077|NCT01995201|593137067|FG004|From Baseline Until Week 24|Adverse Event|0|||
164210078|NCT01995201|593137068|FG005|From Baseline Until Week 24|Adverse Event|0|||
164210079|NCT01995201|593137069|FG006|From Baseline Until Week 24|Adverse Event|0|||
164210080|NCT01995201|593137063|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210081|NCT01995201|593137064|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
164210082|NCT01995201|593137065|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210083|NCT01995201|593137066|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210084|NCT01995201|593137067|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210085|NCT01995201|593137068|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210086|NCT01995201|593137069|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
164210087|NCT01995201|593137063|FG000|From Baseline Until Week 24|Death|0|||
164210088|NCT01995201|593137064|FG001|From Baseline Until Week 24|Death|1|||
163875981|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
164210089|NCT01995201|593137065|FG002|From Baseline Until Week 24|Death|0|||
163875982|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
163875983|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
163875984|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
164210090|NCT01995201|593137066|FG003|From Baseline Until Week 24|Death|0|||
164210091|NCT01995201|593137067|FG004|From Baseline Until Week 24|Death|0|||
164210092|NCT01995201|593137068|FG005|From Baseline Until Week 24|Death|0|||
164210093|NCT01995201|593137069|FG006|From Baseline Until Week 24|Death|0|||
164210094|NCT01995201|593137063|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
163875985|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164210095|NCT01995201|593137064|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
164210096|NCT01995201|593137065|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
164210097|NCT01995201|593137066|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
163875986|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164210098|NCT01995201|593137067|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
164210099|NCT01995201|593137068|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
164210100|NCT01995201|593137069|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
164210101|NCT01995201|593137063|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
164210102|NCT01995201|593137064|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
164210103|NCT01995201|593137065|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
164210104|NCT01995201|593137066|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
164210105|NCT01995201|593137067|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
164210106|NCT01995201|593137068|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
164210107|NCT01995201|593137069|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
164210108|NCT01995201|593137063|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
164210109|NCT01995201|593137064|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
164210110|NCT01995201|593137065|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210111|NCT01995201|593137066|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210112|NCT01995201|593137067|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210113|NCT01995201|593137068|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
164077265|NCT01529749|592647933|FG002|Overall Study|Lost to Follow-up|1|||
164077266|NCT01529749|592647934|FG003|Overall Study|Lost to Follow-up|0|||
164077267|NCT01529749|592647931|FG000|Overall Study|Physician Decision|0|||
164077268|NCT01529749|592647932|FG001|Overall Study|Physician Decision|0|||
164077269|NCT01529749|592647933|FG002|Overall Study|Physician Decision|0|||
164077270|NCT01529749|592647934|FG003|Overall Study|Physician Decision|1|||
164077271|NCT01529749|592647931|FG000|Overall Study|Withdrawal by Subject|0|||
164077272|NCT01529749|592647932|FG001|Overall Study|Withdrawal by Subject|1|||
164077273|NCT01529749|592647933|FG002|Overall Study|Withdrawal by Subject|1|||
164077274|NCT01529749|592647934|FG003|Overall Study|Withdrawal by Subject|0|||
164077275|NCT01529749|592647931|FG000|Overall Study|Protocol Violation|0|||
164077276|NCT01529749|592647932|FG001|Overall Study|Protocol Violation|0|||
164077277|NCT01529749|592647933|FG002|Overall Study|Protocol Violation|0|||
164077278|NCT01529749|592647934|FG003|Overall Study|Protocol Violation|1|||
164077279|NCT00789828|592647935|FG000|Core Period (48 Weeks)|Administrative problems|0|||
164077280|NCT00789828|592647936|FG001|Core Period (48 Weeks)|Administrative problems|1|||
164077281|NCT00789828|592647935|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
164077282|NCT00789828|592647936|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
164077283|NCT00789828|592647935|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
164077284|NCT00789828|592647936|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
164077285|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
164077286|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
164077287|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
164077288|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
164077289|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
164210114|NCT01995201|593137069|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
164210115|NCT01995201|593137063|FG000|From Baseline Until Week 24|Physician Decision|0|||
164210116|NCT01995201|593137064|FG001|From Baseline Until Week 24|Physician Decision|2|||
164210117|NCT01995201|593137065|FG002|From Baseline Until Week 24|Physician Decision|0|||
164210118|NCT01995201|593137066|FG003|From Baseline Until Week 24|Physician Decision|0|||
164210119|NCT01995201|593137067|FG004|From Baseline Until Week 24|Physician Decision|0|||
164210120|NCT01995201|593137068|FG005|From Baseline Until Week 24|Physician Decision|0|||
164210121|NCT01995201|593137069|FG006|From Baseline Until Week 24|Physician Decision|0|||
164210122|NCT01995201|593137063|FG000|From Baseline Until Week 24|Protocol Violation|0|||
164210123|NCT01995201|593137064|FG001|From Baseline Until Week 24|Protocol Violation|9|||
164210124|NCT01995201|593137065|FG002|From Baseline Until Week 24|Protocol Violation|0|||
163980127|NCT00774345|592297345|FG001|Treatment|Withdrawal by Subject|2|||
163980128|NCT00774345|592297344|FG000|Treatment|Lost to Follow-up|1|||
163980129|NCT00774345|592297345|FG001|Treatment|Lost to Follow-up|1|||
163980130|NCT00774345|592297344|FG000|Treatment|Death|4|||
163980131|NCT00774345|592297345|FG001|Treatment|Death|0|||
163980132|NCT00774345|592297344|FG000|Treatment|Other Reasons|32|||
163980133|NCT00774345|592297345|FG001|Treatment|Other Reasons|26|||
163980134|NCT02873936|592297347|FG000|Overall Study|Withdrew Consent|4|||
163980135|NCT02873936|592297348|FG001|Overall Study|Withdrew Consent|11|||
163980136|NCT02873936|592297349|FG002|Overall Study|Withdrew Consent|20|||
163980137|NCT02873936|592297347|FG000|Overall Study|Investigator's Discretion|3|||
163980138|NCT02873936|592297348|FG001|Overall Study|Investigator's Discretion|5|||
163980139|NCT02873936|592297349|FG002|Overall Study|Investigator's Discretion|4|||
163980140|NCT02873936|592297347|FG000|Overall Study|Adverse Event|3|||
163980141|NCT02873936|592297348|FG001|Overall Study|Adverse Event|5|||
163980142|NCT02873936|592297349|FG002|Overall Study|Adverse Event|3|||
163980143|NCT02873936|592297347|FG000|Overall Study|Protocol Violation|0|||
163980144|NCT02873936|592297348|FG001|Overall Study|Protocol Violation|1|||
163980145|NCT02873936|592297349|FG002|Overall Study|Protocol Violation|3|||
163980146|NCT02873936|592297347|FG000|Overall Study|Lost to Follow-up|1|||
163980147|NCT02873936|592297348|FG001|Overall Study|Lost to Follow-up|1|||
163980148|NCT02873936|592297349|FG002|Overall Study|Lost to Follow-up|1|||
164324339|NCT04393298|593565169|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
163875987|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
164210125|NCT01995201|593137066|FG003|From Baseline Until Week 24|Protocol Violation|0|||
163875988|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
163875989|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
163875990|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163875991|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163875992|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163875993|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
163875994|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
163980149|NCT02873936|592297347|FG000|Overall Study|Non-compliance With Study Drug|1|||
163980150|NCT02873936|592297348|FG001|Overall Study|Non-compliance With Study Drug|0|||
163980151|NCT02873936|592297349|FG002|Overall Study|Non-compliance With Study Drug|1|||
164210126|NCT01995201|593137067|FG004|From Baseline Until Week 24|Protocol Violation|0|||
164210127|NCT01995201|593137068|FG005|From Baseline Until Week 24|Protocol Violation|0|||
164210128|NCT01995201|593137069|FG006|From Baseline Until Week 24|Protocol Violation|0|||
164210129|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Adverse Event|0|||
164210130|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Adverse Event|0|||
164210131|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Adverse Event|2|||
164210132|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Adverse Event|1|||
164210133|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Adverse Event|1|||
164210134|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Adverse Event|3|||
164210135|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Adverse Event|1|||
164210136|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Death|0|||
164210137|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Death|0|||
164210138|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Death|0|||
164210139|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Death|0|||
164210140|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Death|0|||
164210141|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Death|2|||
164210142|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Death|0|||
164210143|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210144|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210145|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
164210146|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210147|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
164210148|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
164210149|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
164210150|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210151|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210152|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210153|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210154|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
164210155|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
164210156|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
164210157|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210158|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210159|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
164210160|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210161|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
164210162|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210163|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
164210164|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Physician Decision|0|||
164210165|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Physician Decision|0|||
164210166|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Physician Decision|0|||
164210167|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Physician Decision|0|||
164210168|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Physician Decision|1|||
164210169|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Physician Decision|0|||
164210170|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Physician Decision|0|||
164210171|NCT01995201|593137063|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
164210172|NCT01995201|593137064|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
164210173|NCT01995201|593137065|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
164210174|NCT01995201|593137066|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
164210175|NCT01995201|593137067|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
164210176|NCT01995201|593137068|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
164210177|NCT01995201|593137069|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
164210178|NCT06001866|593137076|FG000|Overall Study|Withdrawal by Subject|0|||
164210179|NCT06001866|593137077|FG001|Overall Study|Withdrawal by Subject|2|||
164210180|NCT06001866|593137076|FG000|Overall Study|Protocol Violation|0|||
164210181|NCT06001866|593137077|FG001|Overall Study|Protocol Violation|2|||
164210182|NCT04703192|593137078|FG000|Overall Study|Withdrawal by Subject|2|||
164210183|NCT04703192|593137079|FG001|Overall Study|Withdrawal by Subject|0|||
164210184|NCT04703192|593137078|FG000|Overall Study|Death|3|||
164210185|NCT04703192|593137079|FG001|Overall Study|Death|1|||
164210186|NCT04703192|593137078|FG000|Overall Study|Adverse Event|13|||
164210187|NCT04703192|593137079|FG001|Overall Study|Adverse Event|2|||
164210188|NCT04703192|593137078|FG000|Overall Study|Progressive or Relapsed Disease|46|||
164210189|NCT04703192|593137079|FG001|Overall Study|Progressive or Relapsed Disease|7|||
164210190|NCT04703192|593137078|FG000|Overall Study|Clinical Progression|19|||
164210191|NCT04703192|593137079|FG001|Overall Study|Clinical Progression|8|||
164210192|NCT04703192|593137078|FG000|Overall Study|Lost to Follow-up|1|||
164210193|NCT04703192|593137079|FG001|Overall Study|Lost to Follow-up|0|||
164210194|NCT04703192|593137078|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
164210195|NCT04703192|593137079|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
164210196|NCT04703192|593137078|FG000|Overall Study|Other|5|||
164210197|NCT04703192|593137079|FG001|Overall Study|Other|1|||
164210198|NCT04797169|593137080|FG000|Overall Study|Lost to Follow-up|84|||
164210199|NCT04797169|593137081|FG001|Overall Study|Lost to Follow-up|67|||
164210200|NCT04797169|593137080|FG000|Overall Study|Pregnancy|1|||
164210201|NCT04797169|593137081|FG001|Overall Study|Pregnancy|3|||
164210202|NCT04797169|593137080|FG000|Overall Study|Withdrawal by Subject|27|||
164210203|NCT04797169|593137081|FG001|Overall Study|Withdrawal by Subject|35|||
164210204|NCT04725188|593137082|FG000|Overall Study|Death|72|||
164210205|NCT04725188|593137083|FG001|Overall Study|Death|69|||
164210206|NCT04725188|593137084|FG002|Overall Study|Death|76|||
164210207|NCT04725188|593137082|FG000|Overall Study|Lost to Follow-up|1|||
164210208|NCT04725188|593137083|FG001|Overall Study|Lost to Follow-up|0|||
164210209|NCT04725188|593137084|FG002|Overall Study|Lost to Follow-up|1|||
164210210|NCT04725188|593137082|FG000|Overall Study|Withdrawal by Subject|2|||
164210211|NCT04725188|593137083|FG001|Overall Study|Withdrawal by Subject|2|||
164210212|NCT04725188|593137084|FG002|Overall Study|Withdrawal by Subject|1|||
163980152|NCT02873936|592297347|FG000|Overall Study|Randomized but not Dosed|1|||
163980153|NCT02873936|592297348|FG001|Overall Study|Randomized but not Dosed|0|||
164210213|NCT04725188|593137082|FG000|Overall Study|Sponsor Decision|12|||
164210214|NCT04725188|593137083|FG001|Overall Study|Sponsor Decision|12|||
164210215|NCT04725188|593137084|FG002|Overall Study|Sponsor Decision|7|||
164210216|NCT00390013|593137086|FG000|Phase 1|tired|0|||
164210217|NCT00390013|593137087|FG001|Phase 1|tired|0|||
164210218|NCT00390013|593137088|FG002|Phase 1|tired|0|||
164210219|NCT00390013|593137089|FG003|Phase 1|tired|1|||
164210220|NCT00390013|593137086|FG000|Phase 2 First Treatment|tired|1|||
164210221|NCT00390013|593137087|FG001|Phase 2 First Treatment|tired|0|||
164210222|NCT00390013|593137088|FG002|Phase 2 First Treatment|tired|0|||
164210223|NCT00390013|593137089|FG003|Phase 2 First Treatment|tired|0|||
164210224|NCT00390013|593137086|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
164210225|NCT00390013|593137087|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
164210226|NCT00390013|593137088|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
164210227|NCT00390013|593137089|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
164210228|NCT03839641|593137090|FG000|Overall Study|Withdrawal by Subject|1|||
164210229|NCT03839641|593137091|FG001|Overall Study|Withdrawal by Subject|1|||
164210230|NCT03188822|593137099|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
164210231|NCT03188822|593137099|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
164210232|NCT04537299|593137100|FG000|Overall Study|Withdrawal by Subject|2|||
164324340|NCT04393298|593565170|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
163980154|NCT02873936|592297349|FG002|Overall Study|Randomized but not Dosed|0|||
163980155|NCT01015768|592297350|FG000|Overall Study|Some subject data unuseable|4|||
163980156|NCT01015768|592297351|FG001|Overall Study|Some subject data unuseable|4|||
164210233|NCT04537299|593137101|FG001|Overall Study|Withdrawal by Subject|0|||
164210234|NCT04537299|593137100|FG000|Overall Study|Protocol Violation|1|||
164210235|NCT04537299|593137101|FG001|Overall Study|Protocol Violation|1|||
164210236|NCT00876343|593137114|FG000|Overall Study|Adverse Event|7|||
164210237|NCT00876343|593137115|FG001|Overall Study|Adverse Event|8|||
164210238|NCT00876343|593137116|FG002|Overall Study|Adverse Event|2|||
164210239|NCT00876343|593137114|FG000|Overall Study|Withdrawal by Subject|4|||
164210240|NCT00876343|593137115|FG001|Overall Study|Withdrawal by Subject|4|||
164210241|NCT00876343|593137116|FG002|Overall Study|Withdrawal by Subject|3|||
164210242|NCT00876343|593137114|FG000|Overall Study|Lack of Efficacy|0|||
164210243|NCT00876343|593137115|FG001|Overall Study|Lack of Efficacy|0|||
164355618|NCT00512707|593676483|FG001|Overall Study|Lost to Follow-up|11|||
163980157|NCT01627860|592297352|FG000|Overall Study|Adverse Event|9|||
164210244|NCT00876343|593137116|FG002|Overall Study|Lack of Efficacy|1|||
164210245|NCT00876343|593137114|FG000|Overall Study|Protocol Violation|4|||
164210246|NCT00876343|593137115|FG001|Overall Study|Protocol Violation|1|||
164210247|NCT00876343|593137116|FG002|Overall Study|Protocol Violation|1|||
164210248|NCT00876343|593137114|FG000|Overall Study|Physician Decision|0|||
164210249|NCT00876343|593137115|FG001|Overall Study|Physician Decision|1|||
164210250|NCT00876343|593137116|FG002|Overall Study|Physician Decision|1|||
164210251|NCT00876343|593137114|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
164210252|NCT00876343|593137115|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
164210253|NCT00876343|593137116|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
164210254|NCT00876343|593137114|FG000|Overall Study|Change of residence or other commitments|2|||
164210255|NCT00876343|593137115|FG001|Overall Study|Change of residence or other commitments|2|||
164210256|NCT00876343|593137116|FG002|Overall Study|Change of residence or other commitments|3|||
164210257|NCT00924898|593137119|FG000|Overall Study|Withdrawal by Subject|2|||
164210258|NCT01901562|593137123|FG000|Overall Study|Protocol Violation|5|||
164210259|NCT01901562|593137123|FG000|Overall Study|Excluded intraoperatively|4|||
164210260|NCT00294658|593137124|FG000|Overall Study|Death|0|||
164210261|NCT00294658|593137125|FG001|Overall Study|Death|1|||
164210262|NCT00294658|593137124|FG000|Overall Study|Lost to Follow-up|4|||
164210263|NCT00294658|593137125|FG001|Overall Study|Lost to Follow-up|0|||
164210264|NCT00294658|593137124|FG000|Overall Study|Physician Decision|1|||
164210265|NCT00294658|593137125|FG001|Overall Study|Physician Decision|2|||
164210266|NCT00294658|593137124|FG000|Overall Study|Pregnancy|0|||
164210267|NCT00294658|593137125|FG001|Overall Study|Pregnancy|1|||
164210268|NCT00294658|593137124|FG000|Overall Study|Withdrawal by Subject|0|||
164210269|NCT00294658|593137125|FG001|Overall Study|Withdrawal by Subject|4|||
164210270|NCT00294658|593137124|FG000|Overall Study|Found to have invasive thymoma|1|||
164210271|NCT00294658|593137125|FG001|Overall Study|Found to have invasive thymoma|0|||
164210272|NCT00294658|593137124|FG000|Overall Study|Patient and family were not satisfied|0|||
164210273|NCT00294658|593137125|FG001|Overall Study|Patient and family were not satisfied|1|||
164210274|NCT01771107|593137132|FG000|Overall Study|Adverse Event|1|||
164210275|NCT01771107|593137133|FG001|Overall Study|Adverse Event|3|||
164210276|NCT01771107|593137132|FG000|Overall Study|Withdrawal by Subject|0|||
164210277|NCT01771107|593137133|FG001|Overall Study|Withdrawal by Subject|2|||
164210278|NCT01771107|593137132|FG000|Overall Study|Lost to Follow-up|0|||
164210279|NCT01771107|593137133|FG001|Overall Study|Lost to Follow-up|1|||
164210280|NCT01771107|593137132|FG000|Overall Study|participant moved|0|||
164210281|NCT01771107|593137133|FG001|Overall Study|participant moved|1|||
164210282|NCT01771107|593137132|FG000|Overall Study|Other|0|||
164210283|NCT01771107|593137133|FG001|Overall Study|Other|1|||
164210284|NCT04717557|593137137|FG000|Overall Study|Withdrawal by Subject|2|||
164210285|NCT04717557|593137138|FG001|Overall Study|Withdrawal by Subject|0|||
164210286|NCT04717557|593137137|FG000|Overall Study|Death|1|||
164210287|NCT04717557|593137138|FG001|Overall Study|Death|0|||
164210288|NCT01654276|593137139|FG000|Overall Study|Lack of Efficacy|1|||
164210289|NCT01654276|593137139|FG000|Overall Study|Lost to Follow-up|4|||
164210290|NCT01654276|593137139|FG000|Overall Study|Withdrawal by Subject|1|||
164210291|NCT00831844|593137145|FG000|Overall Study|Adverse Event|2|||
164210292|NCT00831844|593137146|FG001|Overall Study|Adverse Event|0|||
164210293|NCT00831844|593137147|FG002|Overall Study|Adverse Event|0|||
164210294|NCT00831844|593137148|FG003|Overall Study|Adverse Event|0|||
164210295|NCT00831844|593137149|FG004|Overall Study|Adverse Event|1|||
164210296|NCT00831844|593137150|FG005|Overall Study|Adverse Event|1|||
164210297|NCT00831844|593137151|FG006|Overall Study|Adverse Event|2|||
164210298|NCT00831844|593137152|FG007|Overall Study|Adverse Event|0|||
164210299|NCT00831844|593137153|FG008|Overall Study|Adverse Event|0|||
164210300|NCT00831844|593137154|FG009|Overall Study|Adverse Event|0|||
164210301|NCT00831844|593137145|FG000|Overall Study|Death|0|||
164210302|NCT00831844|593137146|FG001|Overall Study|Death|0|||
164210303|NCT00831844|593137147|FG002|Overall Study|Death|0|||
164210304|NCT00831844|593137148|FG003|Overall Study|Death|1|||
164210305|NCT00831844|593137149|FG004|Overall Study|Death|0|||
164210306|NCT00831844|593137150|FG005|Overall Study|Death|0|||
164210307|NCT00831844|593137151|FG006|Overall Study|Death|0|||
164210308|NCT00831844|593137152|FG007|Overall Study|Death|0|||
164210309|NCT00831844|593137153|FG008|Overall Study|Death|0|||
163875995|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163875996|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163875997|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163875998|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
163875999|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
163876000|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163876001|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
164210310|NCT00831844|593137154|FG009|Overall Study|Death|0|||
163980158|NCT01627860|592297353|FG001|Overall Study|Adverse Event|4|||
164210311|NCT00831844|593137145|FG000|Overall Study|Lack of Efficacy|8|||
164210312|NCT00831844|593137146|FG001|Overall Study|Lack of Efficacy|10|||
164210313|NCT00831844|593137147|FG002|Overall Study|Lack of Efficacy|15|||
164210314|NCT00831844|593137148|FG003|Overall Study|Lack of Efficacy|8|||
164210315|NCT00831844|593137149|FG004|Overall Study|Lack of Efficacy|11|||
164210316|NCT00831844|593137150|FG005|Overall Study|Lack of Efficacy|17|||
164210317|NCT00831844|593137151|FG006|Overall Study|Lack of Efficacy|8|||
164210318|NCT00831844|593137152|FG007|Overall Study|Lack of Efficacy|9|||
164210319|NCT00831844|593137153|FG008|Overall Study|Lack of Efficacy|7|||
164210320|NCT00831844|593137154|FG009|Overall Study|Lack of Efficacy|0|||
164210321|NCT00831844|593137145|FG000|Overall Study|Physician Decision|0|||
164210322|NCT00831844|593137146|FG001|Overall Study|Physician Decision|1|||
164210323|NCT00831844|593137147|FG002|Overall Study|Physician Decision|3|||
164210324|NCT00831844|593137148|FG003|Overall Study|Physician Decision|1|||
164210325|NCT00831844|593137149|FG004|Overall Study|Physician Decision|1|||
164324341|NCT04393298|593565171|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324342|NCT04393298|593565172|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
164324343|NCT04393298|593565173|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
163876002|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163876003|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
163876004|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
163876005|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163876006|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163876007|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163876008|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
163876009|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
163980159|NCT01627860|592297352|FG000|Overall Study|Withdrawal by Subject|2|||
163980160|NCT01627860|592297353|FG001|Overall Study|Withdrawal by Subject|1|||
164324344|NCT04393298|593565159|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163980161|NCT01627860|592297352|FG000|Overall Study|Seizure frequency doubled|0|||
163980162|NCT01627860|592297353|FG001|Overall Study|Seizure frequency doubled|1|||
163980163|NCT01627860|592297352|FG000|Overall Study|Protocol Violation|1|||
163980164|NCT01627860|592297353|FG001|Overall Study|Protocol Violation|0|||
163980165|NCT01225731|592297354|FG000|Part 1|Did not meet eligibility criteria|1|||
163980166|NCT01225731|592297355|FG001|Part 1|Did not meet eligibility criteria|0|||
163980167|NCT01225731|592297356|FG002|Part 1|Did not meet eligibility criteria|0|||
163980168|NCT01225731|592297357|FG003|Part 1|Did not meet eligibility criteria|0|||
163980169|NCT01225731|592297358|FG004|Part 1|Did not meet eligibility criteria|1|||
163980170|NCT01225731|592297359|FG005|Part 1|Did not meet eligibility criteria|0|||
163980171|NCT01225731|592297360|FG006|Part 1|Did not meet eligibility criteria|0|||
163980172|NCT01225731|592297361|FG007|Part 1|Did not meet eligibility criteria|0|||
163980173|NCT01225731|592297362|FG008|Part 1|Did not meet eligibility criteria|0|||
163980174|NCT01225731|592297363|FG009|Part 1|Did not meet eligibility criteria|0|||
163980175|NCT01225731|592297364|FG010|Part 1|Did not meet eligibility criteria|0|||
163980176|NCT01225731|592297365|FG011|Part 1|Did not meet eligibility criteria|0|||
163980177|NCT01225731|592297366|FG012|Part 1|Did not meet eligibility criteria|0|||
163980178|NCT01225731|592297354|FG000|Part 1|Adverse Event|1|||
163980179|NCT01225731|592297355|FG001|Part 1|Adverse Event|2|||
163980180|NCT01225731|592297356|FG002|Part 1|Adverse Event|1|||
163980181|NCT01225731|592297357|FG003|Part 1|Adverse Event|1|||
163980182|NCT01225731|592297358|FG004|Part 1|Adverse Event|1|||
163980183|NCT01225731|592297359|FG005|Part 1|Adverse Event|0|||
163980184|NCT01225731|592297360|FG006|Part 1|Adverse Event|0|||
163980185|NCT01225731|592297361|FG007|Part 1|Adverse Event|0|||
163980186|NCT01225731|592297362|FG008|Part 1|Adverse Event|0|||
163980187|NCT01225731|592297363|FG009|Part 1|Adverse Event|0|||
163980188|NCT01225731|592297364|FG010|Part 1|Adverse Event|0|||
163980189|NCT01225731|592297365|FG011|Part 1|Adverse Event|0|||
163980190|NCT01225731|592297366|FG012|Part 1|Adverse Event|0|||
163980191|NCT01225731|592297354|FG000|Part 1|Withdrawal by Subject|0|||
163980192|NCT01225731|592297355|FG001|Part 1|Withdrawal by Subject|3|||
163980193|NCT01225731|592297356|FG002|Part 1|Withdrawal by Subject|0|||
163980194|NCT01225731|592297357|FG003|Part 1|Withdrawal by Subject|0|||
163980195|NCT01225731|592297358|FG004|Part 1|Withdrawal by Subject|4|||
163980196|NCT01225731|592297359|FG005|Part 1|Withdrawal by Subject|0|||
163980197|NCT01225731|592297360|FG006|Part 1|Withdrawal by Subject|0|||
163980198|NCT01225731|592297361|FG007|Part 1|Withdrawal by Subject|0|||
163980199|NCT01225731|592297362|FG008|Part 1|Withdrawal by Subject|0|||
163980200|NCT01225731|592297363|FG009|Part 1|Withdrawal by Subject|0|||
163980201|NCT01225731|592297364|FG010|Part 1|Withdrawal by Subject|0|||
163980202|NCT01225731|592297365|FG011|Part 1|Withdrawal by Subject|0|||
163980203|NCT01225731|592297366|FG012|Part 1|Withdrawal by Subject|0|||
163980204|NCT01225731|592297354|FG000|Part 1|Protocol Violation|0|||
163980205|NCT01225731|592297355|FG001|Part 1|Protocol Violation|0|||
163980206|NCT01225731|592297356|FG002|Part 1|Protocol Violation|0|||
163980207|NCT01225731|592297357|FG003|Part 1|Protocol Violation|1|||
163980208|NCT01225731|592297358|FG004|Part 1|Protocol Violation|0|||
163980209|NCT01225731|592297359|FG005|Part 1|Protocol Violation|0|||
163980210|NCT01225731|592297360|FG006|Part 1|Protocol Violation|0|||
163980211|NCT01225731|592297361|FG007|Part 1|Protocol Violation|0|||
163980212|NCT01225731|592297362|FG008|Part 1|Protocol Violation|0|||
163980213|NCT01225731|592297363|FG009|Part 1|Protocol Violation|0|||
163980214|NCT01225731|592297364|FG010|Part 1|Protocol Violation|0|||
163980215|NCT01225731|592297365|FG011|Part 1|Protocol Violation|0|||
163876010|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163980216|NCT01225731|592297366|FG012|Part 1|Protocol Violation|0|||
163980217|NCT01225731|592297354|FG000|Part 2|Protocol Violation|0|||
163980218|NCT01225731|592297355|FG001|Part 2|Protocol Violation|0|||
163980219|NCT01225731|592297356|FG002|Part 2|Protocol Violation|0|||
163980220|NCT01225731|592297357|FG003|Part 2|Protocol Violation|0|||
163980221|NCT01225731|592297358|FG004|Part 2|Protocol Violation|0|||
163980222|NCT01225731|592297359|FG005|Part 2|Protocol Violation|1|||
163980223|NCT01225731|592297360|FG006|Part 2|Protocol Violation|0|||
163980224|NCT01225731|592297361|FG007|Part 2|Protocol Violation|0|||
163980225|NCT01225731|592297362|FG008|Part 2|Protocol Violation|1|||
164210326|NCT00831844|593137150|FG005|Overall Study|Physician Decision|1|||
164210327|NCT00831844|593137151|FG006|Overall Study|Physician Decision|0|||
164210328|NCT00831844|593137152|FG007|Overall Study|Physician Decision|0|||
164210329|NCT00831844|593137153|FG008|Overall Study|Physician Decision|1|||
164210330|NCT00831844|593137154|FG009|Overall Study|Physician Decision|0|||
164210331|NCT00831844|593137145|FG000|Overall Study|Withdrawal by Subject|0|||
164210332|NCT00831844|593137146|FG001|Overall Study|Withdrawal by Subject|0|||
164210333|NCT00831844|593137147|FG002|Overall Study|Withdrawal by Subject|1|||
164210334|NCT00831844|593137148|FG003|Overall Study|Withdrawal by Subject|0|||
164210335|NCT00831844|593137149|FG004|Overall Study|Withdrawal by Subject|0|||
164210336|NCT00831844|593137150|FG005|Overall Study|Withdrawal by Subject|0|||
164210337|NCT00831844|593137151|FG006|Overall Study|Withdrawal by Subject|0|||
164210338|NCT00831844|593137152|FG007|Overall Study|Withdrawal by Subject|1|||
164210339|NCT00831844|593137153|FG008|Overall Study|Withdrawal by Subject|1|||
164210340|NCT00831844|593137154|FG009|Overall Study|Withdrawal by Subject|0|||
164210341|NCT00831844|593137145|FG000|Overall Study|Ineligible|0|||
164210342|NCT00831844|593137146|FG001|Overall Study|Ineligible|1|||
164210343|NCT00831844|593137147|FG002|Overall Study|Ineligible|1|||
164210344|NCT00831844|593137148|FG003|Overall Study|Ineligible|0|||
164210345|NCT00831844|593137149|FG004|Overall Study|Ineligible|1|||
164210346|NCT00831844|593137150|FG005|Overall Study|Ineligible|0|||
164210347|NCT00831844|593137151|FG006|Overall Study|Ineligible|0|||
164210348|NCT00831844|593137152|FG007|Overall Study|Ineligible|0|||
164210349|NCT00831844|593137153|FG008|Overall Study|Ineligible|0|||
164210350|NCT00831844|593137154|FG009|Overall Study|Ineligible|0|||
164210351|NCT01192178|593137155|FG000|Overall Study|Withdrawal by Subject|6|||
164210352|NCT01192178|593137156|FG001|Overall Study|Withdrawal by Subject|10|||
164210353|NCT01192178|593137155|FG000|Overall Study|Protocol Violation|10|||
164210354|NCT01192178|593137156|FG001|Overall Study|Protocol Violation|3|||
164210355|NCT01192178|593137155|FG000|Overall Study|Physician Decision|2|||
164210356|NCT01192178|593137156|FG001|Overall Study|Physician Decision|4|||
164210357|NCT01192178|593137155|FG000|Overall Study|Lost to Follow-up|3|||
164210358|NCT01192178|593137156|FG001|Overall Study|Lost to Follow-up|3|||
164210359|NCT01192178|593137155|FG000|Overall Study|Adverse Event|2|||
164210360|NCT01192178|593137156|FG001|Overall Study|Adverse Event|1|||
164210361|NCT01192178|593137155|FG000|Overall Study|Lack of Efficacy|1|||
164210362|NCT01192178|593137156|FG001|Overall Study|Lack of Efficacy|2|||
164210363|NCT01143324|593137159|FG000|Overall Study|Lost to Follow-up|11|||
164210364|NCT01143324|593137159|FG000|Overall Study|Withdrawal by Subject|4|||
164210365|NCT01143324|593137159|FG000|Overall Study|Explant of the device|4|||
164210366|NCT00858988|593137160|FG000|Analysis|Lactulose unable to be detected in urine|2|||
164210367|NCT00858988|593137161|FG001|Analysis|Lactulose unable to be detected in urine|1|||
164210368|NCT00976027|593138187|FG000|Overall Study|Serious Adverse Event|36|||
164210369|NCT00976027|593138188|FG001|Overall Study|Serious Adverse Event|17|||
164210370|NCT00976027|593138187|FG000|Overall Study|Adverse Event|0|||
164210371|NCT00976027|593138188|FG001|Overall Study|Adverse Event|2|||
164210372|NCT00976027|593138187|FG000|Overall Study|Protocol Violation|60|||
164210373|NCT00976027|593138188|FG001|Overall Study|Protocol Violation|27|||
164210374|NCT00976027|593138187|FG000|Overall Study|Lost to Follow-up|208|||
164210375|NCT00976027|593138188|FG001|Overall Study|Lost to Follow-up|103|||
164210376|NCT00976027|593138187|FG000|Overall Study|Withdrawal by Subject|107|||
164210377|NCT00976027|593138188|FG001|Overall Study|Withdrawal by Subject|66|||
164210378|NCT03805841|593138189|FG000|Overall Study|Clinical Progression|2|||
164210379|NCT03805841|593138190|FG001|Overall Study|Clinical Progression|0|||
164210380|NCT03805841|593138191|FG002|Overall Study|Clinical Progression|0|||
164210381|NCT03805841|593138189|FG000|Overall Study|Death|0|||
164210382|NCT03805841|593138190|FG001|Overall Study|Death|3|||
164210383|NCT03805841|593138191|FG002|Overall Study|Death|1|||
164210384|NCT03805841|593138189|FG000|Overall Study|Lost to Follow-up|0|||
164210385|NCT03805841|593138190|FG001|Overall Study|Lost to Follow-up|0|||
164210386|NCT03805841|593138191|FG002|Overall Study|Lost to Follow-up|1|||
164210387|NCT03805841|593138189|FG000|Overall Study|Withdrawal by Subject|2|||
164210388|NCT03805841|593138190|FG001|Overall Study|Withdrawal by Subject|3|||
164210389|NCT03805841|593138191|FG002|Overall Study|Withdrawal by Subject|0|||
164210390|NCT03805841|593138189|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
164210391|NCT03805841|593138190|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
164210392|NCT03805841|593138191|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
164210393|NCT03621592|593138192|FG000|Overall Study|Lost to Follow-up|1|||
164210394|NCT03621592|593138193|FG001|Overall Study|Lost to Follow-up|0|||
164210395|NCT03621592|593138192|FG000|Overall Study|Lack of Improvement|1|||
164210396|NCT03621592|593138193|FG001|Overall Study|Lack of Improvement|0|||
163980226|NCT01225731|592297363|FG009|Part 2|Protocol Violation|0|||
164210397|NCT03621592|593138192|FG000|Overall Study|Preference to receive wound care closer to home|1|||
164210398|NCT03621592|593138193|FG001|Overall Study|Preference to receive wound care closer to home|0|||
164210399|NCT03621592|593138192|FG000|Overall Study|Lack of healing|0|||
164210400|NCT03621592|593138193|FG001|Overall Study|Lack of healing|2|||
164210401|NCT02629159|593138194|FG000|Overall Study|Adverse Event|17|||
164210402|NCT02629159|593138195|FG001|Overall Study|Adverse Event|20|||
163980227|NCT01225731|592297364|FG010|Part 2|Protocol Violation|0|||
164324345|NCT04393298|593565160|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
164324346|NCT04393298|593565161|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
163980228|NCT01225731|592297365|FG011|Part 2|Protocol Violation|0|||
163980229|NCT01225731|592297366|FG012|Part 2|Protocol Violation|0|||
163980230|NCT01225731|592297354|FG000|Part 2|Adverse Event|0|||
163980231|NCT01225731|592297355|FG001|Part 2|Adverse Event|0|||
163980232|NCT01225731|592297356|FG002|Part 2|Adverse Event|0|||
163980233|NCT01225731|592297357|FG003|Part 2|Adverse Event|0|||
163980234|NCT01225731|592297358|FG004|Part 2|Adverse Event|0|||
163980235|NCT01225731|592297359|FG005|Part 2|Adverse Event|0|||
163980236|NCT01225731|592297360|FG006|Part 2|Adverse Event|4|||
164077290|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
164077291|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
164077292|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
164324347|NCT04393298|593565162|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324348|NCT04393298|593565163|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324349|NCT04393298|593565164|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324350|NCT04393298|593565165|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324351|NCT04393298|593565166|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324352|NCT04393298|593565167|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324353|NCT04393298|593565168|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324354|NCT04393298|593565169|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324355|NCT04393298|593565170|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324356|NCT04393298|593565171|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324357|NCT04393298|593565172|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324358|NCT04393298|593565173|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
164324359|NCT04393298|593565159|FG000|Overall Study|Clinical Progression|0|||
164324360|NCT04393298|593565160|FG001|Overall Study|Clinical Progression|2|||
164324361|NCT04393298|593565161|FG002|Overall Study|Clinical Progression|0|||
164324362|NCT04393298|593565162|FG003|Overall Study|Clinical Progression|0|||
164324363|NCT04393298|593565163|FG004|Overall Study|Clinical Progression|0|||
164077293|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|Death|1|||
164077294|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|Death|0|||
164077295|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
164077296|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
164077297|NCT00789828|592647935|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
164077298|NCT00789828|592647936|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
164077299|NCT02623426|592647937|FG000|Overall Study|Lost to Follow-up|0|||
164077300|NCT02623426|592647938|FG001|Overall Study|Lost to Follow-up|0|||
164324364|NCT04393298|593565164|FG005|Overall Study|Clinical Progression|0|||
164324365|NCT04393298|593565165|FG006|Overall Study|Clinical Progression|0|||
164324366|NCT04393298|593565166|FG007|Overall Study|Clinical Progression|0|||
164324367|NCT04393298|593565167|FG008|Overall Study|Clinical Progression|0|||
164324368|NCT04393298|593565168|FG009|Overall Study|Clinical Progression|0|||
164324369|NCT04393298|593565169|FG010|Overall Study|Clinical Progression|0|||
164324370|NCT04393298|593565170|FG011|Overall Study|Clinical Progression|0|||
164324371|NCT04393298|593565171|FG012|Overall Study|Clinical Progression|0|||
164324372|NCT04393298|593565172|FG013|Overall Study|Clinical Progression|0|||
164324373|NCT04393298|593565173|FG014|Overall Study|Clinical Progression|0|||
164324374|NCT04393298|593565159|FG000|Overall Study|Disease Progression|0|||
164324375|NCT04393298|593565160|FG001|Overall Study|Disease Progression|1|||
164324376|NCT04393298|593565161|FG002|Overall Study|Disease Progression|0|||
164324377|NCT04393298|593565162|FG003|Overall Study|Disease Progression|0|||
164324378|NCT04393298|593565163|FG004|Overall Study|Disease Progression|0|||
164324379|NCT04393298|593565164|FG005|Overall Study|Disease Progression|3|||
164324380|NCT04393298|593565165|FG006|Overall Study|Disease Progression|2|||
164324381|NCT04393298|593565166|FG007|Overall Study|Disease Progression|1|||
164324382|NCT04393298|593565167|FG008|Overall Study|Disease Progression|2|||
164324383|NCT04393298|593565168|FG009|Overall Study|Disease Progression|1|||
164324384|NCT04393298|593565169|FG010|Overall Study|Disease Progression|0|||
164324385|NCT04393298|593565170|FG011|Overall Study|Disease Progression|3|||
164324386|NCT04393298|593565171|FG012|Overall Study|Disease Progression|0|||
164324387|NCT04393298|593565172|FG013|Overall Study|Disease Progression|0|||
164324388|NCT04393298|593565173|FG014|Overall Study|Disease Progression|1|||
164324389|NCT04393298|593565159|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164077301|NCT02623426|592647939|FG002|Overall Study|Lost to Follow-up|1|||
164077302|NCT02623426|592647937|FG000|Overall Study|Withdrawal by Subject|1|||
164324390|NCT04393298|593565160|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164077303|NCT02623426|592647938|FG001|Overall Study|Withdrawal by Subject|2|||
163980237|NCT01225731|592297361|FG007|Part 2|Adverse Event|4|||
163980238|NCT01225731|592297362|FG008|Part 2|Adverse Event|2|||
163980239|NCT01225731|592297363|FG009|Part 2|Adverse Event|0|||
164324391|NCT04393298|593565161|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
164324392|NCT04393298|593565162|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324393|NCT04393298|593565163|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324394|NCT04393298|593565164|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163980240|NCT01225731|592297364|FG010|Part 2|Adverse Event|0|||
163980241|NCT01225731|592297365|FG011|Part 2|Adverse Event|0|||
163980242|NCT01225731|592297366|FG012|Part 2|Adverse Event|0|||
163980243|NCT01225731|592297354|FG000|Part 2|Lack of Efficacy|0|||
163980244|NCT01225731|592297355|FG001|Part 2|Lack of Efficacy|0|||
163980245|NCT01225731|592297356|FG002|Part 2|Lack of Efficacy|0|||
163980246|NCT01225731|592297357|FG003|Part 2|Lack of Efficacy|0|||
163980247|NCT01225731|592297358|FG004|Part 2|Lack of Efficacy|0|||
163980248|NCT01225731|592297359|FG005|Part 2|Lack of Efficacy|1|||
163980249|NCT01225731|592297360|FG006|Part 2|Lack of Efficacy|0|||
163980250|NCT01225731|592297361|FG007|Part 2|Lack of Efficacy|12|||
163980251|NCT01225731|592297362|FG008|Part 2|Lack of Efficacy|3|||
163980252|NCT01225731|592297363|FG009|Part 2|Lack of Efficacy|0|||
163980253|NCT01225731|592297364|FG010|Part 2|Lack of Efficacy|0|||
163980254|NCT01225731|592297365|FG011|Part 2|Lack of Efficacy|0|||
163980255|NCT01225731|592297366|FG012|Part 2|Lack of Efficacy|0|||
163980256|NCT01225731|592297354|FG000|Part 2|Pregnancy|0|||
163980257|NCT01225731|592297355|FG001|Part 2|Pregnancy|0|||
163980258|NCT01225731|592297356|FG002|Part 2|Pregnancy|0|||
163980259|NCT01225731|592297357|FG003|Part 2|Pregnancy|0|||
163980260|NCT01225731|592297358|FG004|Part 2|Pregnancy|0|||
163980261|NCT01225731|592297359|FG005|Part 2|Pregnancy|0|||
163980262|NCT01225731|592297360|FG006|Part 2|Pregnancy|1|||
163980263|NCT01225731|592297361|FG007|Part 2|Pregnancy|0|||
163980264|NCT01225731|592297362|FG008|Part 2|Pregnancy|1|||
163980265|NCT01225731|592297363|FG009|Part 2|Pregnancy|0|||
163876011|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163876012|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163876013|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
163876014|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
163876015|NCT01898494|591914725|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163876016|NCT01898494|591914726|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163876017|NCT01898494|591914727|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163876018|NCT01898494|591914728|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
163876019|NCT01898494|591914729|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
163876020|NCT01898494|591914725|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
163876021|NCT01898494|591914726|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
163876022|NCT01898494|591914727|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
163876023|NCT01898494|591914728|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
163876024|NCT01898494|591914729|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
163876025|NCT01898494|591914725|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
163876026|NCT01898494|591914726|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
163876027|NCT01898494|591914727|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
163876028|NCT01898494|591914728|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
163876029|NCT01898494|591914729|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
163876030|NCT01898494|591914725|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
163876031|NCT01898494|591914726|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
163876032|NCT01898494|591914727|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
163876033|NCT01898494|591914728|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
163876034|NCT01898494|591914729|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
163876035|NCT01898494|591914725|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163876036|NCT01898494|591914726|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
163876037|NCT01898494|591914727|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163876038|NCT01898494|591914728|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163876039|NCT01898494|591914729|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
163876040|NCT01898494|591914725|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163876041|NCT01898494|591914726|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163876042|NCT01898494|591914727|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
163876043|NCT01898494|591914728|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163876044|NCT01898494|591914729|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
163876045|NCT01898494|591914725|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
163980266|NCT01225731|592297364|FG010|Part 2|Pregnancy|0|||
163980267|NCT01225731|592297365|FG011|Part 2|Pregnancy|0|||
164324395|NCT04393298|593565165|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163980268|NCT01225731|592297366|FG012|Part 2|Pregnancy|0|||
164324396|NCT04393298|593565166|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
163980269|NCT01225731|592297354|FG000|Part 2|Lost to Follow-up|0|||
163980270|NCT01225731|592297355|FG001|Part 2|Lost to Follow-up|0|||
163980271|NCT01225731|592297356|FG002|Part 2|Lost to Follow-up|0|||
163980272|NCT01225731|592297357|FG003|Part 2|Lost to Follow-up|0|||
163980273|NCT01225731|592297358|FG004|Part 2|Lost to Follow-up|0|||
163980274|NCT01225731|592297359|FG005|Part 2|Lost to Follow-up|0|||
163980275|NCT01225731|592297360|FG006|Part 2|Lost to Follow-up|0|||
164210403|NCT02629159|593138196|FG002|Overall Study|Adverse Event|22|||
164210404|NCT02629159|593138194|FG000|Overall Study|Withdrawal by Subject|22|||
164210405|NCT02629159|593138195|FG001|Overall Study|Withdrawal by Subject|11|||
164210406|NCT02629159|593138196|FG002|Overall Study|Withdrawal by Subject|15|||
164210407|NCT02629159|593138194|FG000|Overall Study|Lost to Follow-up|7|||
164210408|NCT02629159|593138195|FG001|Overall Study|Lost to Follow-up|4|||
164210409|NCT02629159|593138196|FG002|Overall Study|Lost to Follow-up|5|||
164210410|NCT02629159|593138194|FG000|Overall Study|Lack of Efficacy|4|||
164210411|NCT02629159|593138195|FG001|Overall Study|Lack of Efficacy|0|||
164210412|NCT02629159|593138196|FG002|Overall Study|Lack of Efficacy|1|||
164210413|NCT02629159|593138194|FG000|Overall Study|Other|6|||
164210414|NCT02629159|593138195|FG001|Overall Study|Other|4|||
164210415|NCT02629159|593138196|FG002|Overall Study|Other|8|||
164210416|NCT05722015|593138197|FG000|Overall Study|Death|57|||
164210417|NCT05722015|593138198|FG001|Overall Study|Death|37|||
164210418|NCT05722015|593138197|FG000|Overall Study|Lost to Follow-up|1|||
164210419|NCT05722015|593138198|FG001|Overall Study|Lost to Follow-up|0|||
164210420|NCT05722015|593138197|FG000|Overall Study|Withdrawal by Subject|5|||
164210421|NCT05722015|593138198|FG001|Overall Study|Withdrawal by Subject|1|||
164210422|NCT05722015|593138197|FG000|Overall Study|Participants Ongoing|188|||
164210423|NCT05722015|593138198|FG001|Overall Study|Participants Ongoing|88|||
164210424|NCT02685735|593138199|FG000|Overall Study|Surgery Cancelled|4|||
164210425|NCT02685735|593138200|FG001|Overall Study|Surgery Cancelled|9|||
164210426|NCT02685735|593138199|FG000|Overall Study|Adverse Event|10|||
164210427|NCT02685735|593138200|FG001|Overall Study|Adverse Event|3|||
164210428|NCT02685735|593138199|FG000|Overall Study|Preop testing found to be incomplete|2|||
164210429|NCT02685735|593138200|FG001|Overall Study|Preop testing found to be incomplete|2|||
164210430|NCT02685735|593138199|FG000|Overall Study|Withdrawal by Subject|1|||
164210431|NCT02685735|593138200|FG001|Overall Study|Withdrawal by Subject|2|||
164210432|NCT02685735|593138199|FG000|Overall Study|Death|1|||
164210433|NCT02685735|593138200|FG001|Overall Study|Death|0|||
164210434|NCT04133909|593138203|FG000|Overall Study|Death|11|||
164210435|NCT04133909|593138204|FG001|Overall Study|Death|11|||
164210436|NCT04133909|593138203|FG000|Overall Study|Adverse Event|4|||
164210437|NCT04133909|593138204|FG001|Overall Study|Adverse Event|5|||
164210438|NCT04133909|593138203|FG000|Overall Study|Lost to Follow-up|3|||
164210439|NCT04133909|593138204|FG001|Overall Study|Lost to Follow-up|5|||
164210440|NCT04133909|593138203|FG000|Overall Study|Physician Decision|4|||
164210441|NCT04133909|593138204|FG001|Overall Study|Physician Decision|7|||
164210442|NCT04133909|593138203|FG000|Overall Study|Withdrawal by Subject|40|||
164210443|NCT04133909|593138204|FG001|Overall Study|Withdrawal by Subject|35|||
164210444|NCT04133909|593138203|FG000|Overall Study|Lack of Efficacy|2|||
164210445|NCT04133909|593138204|FG001|Overall Study|Lack of Efficacy|7|||
164210446|NCT04133909|593138203|FG000|Overall Study|Randomized in error|1|||
164210447|NCT04133909|593138204|FG001|Overall Study|Randomized in error|1|||
164210448|NCT05020743|593138205|FG000|Overall Study|Enrollment in Interventional Study|2|||
164210449|NCT05020743|593138206|FG001|Overall Study|Enrollment in Interventional Study|9|||
164210450|NCT05020743|593138207|FG002|Overall Study|Enrollment in Interventional Study|0|||
164210451|NCT05020743|593138205|FG000|Overall Study|Withdrawal by Subject|0|||
164210452|NCT05020743|593138206|FG001|Overall Study|Withdrawal by Subject|3|||
164210453|NCT05020743|593138207|FG002|Overall Study|Withdrawal by Subject|1|||
164210454|NCT05020743|593138205|FG000|Overall Study|Lost to Follow-up|1|||
164210455|NCT05020743|593138206|FG001|Overall Study|Lost to Follow-up|0|||
164210456|NCT05020743|593138207|FG002|Overall Study|Lost to Follow-up|0|||
164210457|NCT05020743|593138205|FG000|Overall Study|Study Termination by Sponsor|10|||
164210458|NCT05020743|593138206|FG001|Overall Study|Study Termination by Sponsor|11|||
164210459|NCT05020743|593138207|FG002|Overall Study|Study Termination by Sponsor|10|||
164210460|NCT02003924|593138208|FG000|Double-blind Phase|Lost to Follow-up|2|||
164210461|NCT02003924|593138209|FG001|Double-blind Phase|Lost to Follow-up|1|||
164210462|NCT02003924|593138210|FG002|Double-blind Phase|Lost to Follow-up|0|||
163876046|NCT01898494|591914726|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
163876047|NCT01898494|591914727|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
163876048|NCT01898494|591914728|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
163876049|NCT01898494|591914729|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
163876050|NCT02819843|591914732|FG000|Overall Study|Disease progression before RT|0|||
163876051|NCT02819843|591914733|FG001|Overall Study|Disease progression before RT|1|||
163876052|NCT04732494|591914734|FG000|Overall Study|Death|39|||
163876053|NCT04732494|591914735|FG001|Overall Study|Death|36|||
164210463|NCT02003924|593138208|FG000|Double-blind Phase|Protocol Violation|1|||
164210464|NCT02003924|593138209|FG001|Double-blind Phase|Protocol Violation|2|||
164210465|NCT02003924|593138210|FG002|Double-blind Phase|Protocol Violation|0|||
164210466|NCT02003924|593138208|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
164210467|NCT02003924|593138209|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
164210468|NCT02003924|593138210|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
164210469|NCT02003924|593138208|FG000|Double-blind Phase|Disease Progression|229|||
163876054|NCT04732494|591914734|FG000|Overall Study|Study Closed by Sponsor|20|||
164210470|NCT02003924|593138209|FG001|Double-blind Phase|Disease Progression|247|||
164210471|NCT02003924|593138210|FG002|Double-blind Phase|Disease Progression|0|||
164210472|NCT02003924|593138208|FG000|Double-blind Phase|Adverse Event|120|||
164210473|NCT02003924|593138209|FG001|Double-blind Phase|Adverse Event|31|||
164210474|NCT02003924|593138210|FG002|Double-blind Phase|Adverse Event|0|||
164210475|NCT02003924|593138208|FG000|Double-blind Phase|Randomized But not Treated|3|||
164210476|NCT02003924|593138209|FG001|Double-blind Phase|Randomized But not Treated|3|||
164210477|NCT02003924|593138210|FG002|Double-blind Phase|Randomized But not Treated|0|||
164210478|NCT02003924|593138208|FG000|Double-blind Phase|Other|29|||
164210479|NCT02003924|593138209|FG001|Double-blind Phase|Other|50|||
164210480|NCT02003924|593138210|FG002|Double-blind Phase|Other|0|||
164210481|NCT02003924|593138208|FG000|Open-label Phase|Lost to Follow-up|0|||
164210482|NCT02003924|593138209|FG001|Open-label Phase|Lost to Follow-up|0|||
164210483|NCT02003924|593138210|FG002|Open-label Phase|Lost to Follow-up|1|||
164210484|NCT02003924|593138208|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
164210485|NCT02003924|593138209|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
164210486|NCT02003924|593138210|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
164210487|NCT02003924|593138208|FG000|Open-label Phase|Disease Progression|59|||
164210488|NCT02003924|593138209|FG001|Open-label Phase|Disease Progression|0|||
164210489|NCT02003924|593138210|FG002|Open-label Phase|Disease Progression|5|||
164210490|NCT02003924|593138208|FG000|Open-label Phase|Adverse Event|25|||
164210491|NCT02003924|593138209|FG001|Open-label Phase|Adverse Event|0|||
164210492|NCT02003924|593138210|FG002|Open-label Phase|Adverse Event|10|||
164210493|NCT02003924|593138208|FG000|Open-label Phase|Other|7|||
164210494|NCT02003924|593138209|FG001|Open-label Phase|Other|0|||
164210495|NCT02003924|593138210|FG002|Open-label Phase|Other|0|||
164210496|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Death|288|||
164210497|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Death|174|||
164210498|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Death|4|||
164210499|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
164210500|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
164210501|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
164210502|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
164210503|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
164210504|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
164210505|NCT02003924|593138208|FG000|Long-term Follow-up Phase|Other|5|||
164210506|NCT02003924|593138209|FG001|Long-term Follow-up Phase|Other|2|||
164210507|NCT02003924|593138210|FG002|Long-term Follow-up Phase|Other|1|||
164210508|NCT02340949|593138211|FG000|Overall Study|Adverse Event|4|||
164210509|NCT02340949|593138212|FG001|Overall Study|Adverse Event|2|||
164210510|NCT02340949|593138211|FG000|Overall Study|Withdrawal by Subject|2|||
164210511|NCT02340949|593138212|FG001|Overall Study|Withdrawal by Subject|0|||
164210512|NCT02340949|593138211|FG000|Overall Study|Progression disease|6|||
164210513|NCT02340949|593138212|FG001|Overall Study|Progression disease|2|||
164210514|NCT02340949|593138211|FG000|Overall Study|Death|3|||
164210515|NCT02340949|593138212|FG001|Overall Study|Death|0|||
164210516|NCT02340949|593138211|FG000|Overall Study|Physician Decision|1|||
164210517|NCT02340949|593138212|FG001|Overall Study|Physician Decision|0|||
164210518|NCT03980223|593138213|FG000|Overall Study|Lost to Follow-up|3|||
164210519|NCT03980223|593138214|FG001|Overall Study|Lost to Follow-up|7|||
164210520|NCT03980223|593138215|FG002|Overall Study|Lost to Follow-up|10|||
164210521|NCT03980223|593138216|FG003|Overall Study|Lost to Follow-up|8|||
164210522|NCT03980223|593138213|FG000|Overall Study|Withdrawal by Subject|0|||
164210523|NCT03980223|593138214|FG001|Overall Study|Withdrawal by Subject|0|||
164210524|NCT03980223|593138215|FG002|Overall Study|Withdrawal by Subject|1|||
164210525|NCT03980223|593138216|FG003|Overall Study|Withdrawal by Subject|2|||
164210526|NCT03980223|593138213|FG000|Overall Study|Physician Decision|0|||
164210527|NCT03980223|593138214|FG001|Overall Study|Physician Decision|0|||
164210528|NCT03980223|593138215|FG002|Overall Study|Physician Decision|1|||
164210529|NCT03980223|593138216|FG003|Overall Study|Physician Decision|0|||
164210530|NCT03980223|593138213|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
164210531|NCT03980223|593138214|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
163876055|NCT04732494|591914735|FG001|Overall Study|Study Closed by Sponsor|15|||
163876056|NCT04732494|591914734|FG000|Overall Study|Withdrawal by Subject|2|||
164210532|NCT03980223|593138215|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
164210533|NCT03980223|593138216|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
164210534|NCT02460289|593138220|FG000|Overall Study|Adverse Event|1|||
164210535|NCT02460289|593138220|FG000|Overall Study|Withdrawal by Subject|8|||
164210536|NCT02460289|593138220|FG000|Overall Study|Lost to Follow-up|1|||
164210537|NCT01155570|593138221|FG000|Overall Study|Adverse Event|39|||
164210538|NCT01155570|593138221|FG000|Overall Study|Lack of Efficacy|46|||
164210539|NCT01155570|593138221|FG000|Overall Study|Participant's Economic Reasons|17|||
163876057|NCT04732494|591914735|FG001|Overall Study|Withdrawal by Subject|7|||
164210540|NCT01155570|593138221|FG000|Overall Study|No Hospital Visits|7|||
163876058|NCT04732494|591914734|FG000|Overall Study|Lost to Follow-up|1|||
163876059|NCT04732494|591914735|FG001|Overall Study|Lost to Follow-up|5|||
164210541|NCT01155570|593138221|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
164210542|NCT01155570|593138221|FG000|Overall Study|Adverse Event + Other Reasons|7|||
164210543|NCT01155570|593138221|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
164210544|NCT01155570|593138221|FG000|Overall Study|Other Reasons|23|||
164210545|NCT01922934|593138222|FG000|Eligible Patients|Death|0|||
164210546|NCT01922934|593138223|FG001|Eligible Patients|Death|7|||
164210547|NCT01922934|593138222|FG000|Eligible Patients|Physician Decision|17|||
164210548|NCT01922934|593138223|FG001|Eligible Patients|Physician Decision|0|||
164210549|NCT01922934|593138222|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
164210550|NCT01922934|593138223|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
164210551|NCT01922934|593138222|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
164210552|NCT01922934|593138223|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
164210553|NCT01922934|593138222|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
164210554|NCT01922934|593138223|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
164210555|NCT01922934|593138222|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
164210556|NCT01922934|593138223|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
164210557|NCT02916927|593138224|FG000|Overall Study|Discharged prior to study drug receipt|0|||
164210558|NCT02916927|593138225|FG001|Overall Study|Discharged prior to study drug receipt|2|||
164210559|NCT02916927|593138224|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
164210560|NCT02916927|593138225|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
164210561|NCT02916927|593138224|FG000|Overall Study|Withdrawal before first time point|1|||
164210562|NCT02916927|593138225|FG001|Overall Study|Withdrawal before first time point|0|||
164210563|NCT02774889|593138228|FG000|Overall Study|Lost to Follow-up|2|||
164210564|NCT02774889|593138229|FG001|Overall Study|Lost to Follow-up|1|||
164210565|NCT01020123|593138230|FG000|Main Period|Withdrawal by Subject|6|||
164210566|NCT01020123|593138231|FG001|Main Period|Withdrawal by Subject|5|||
164210567|NCT01020123|593138232|FG002|Main Period|Withdrawal by Subject|3|||
164210568|NCT01020123|593138233|FG003|Main Period|Withdrawal by Subject|1|||
164210569|NCT01020123|593138234|FG004|Main Period|Withdrawal by Subject|6|||
164210570|NCT01020123|593138235|FG005|Main Period|Withdrawal by Subject|3|||
164210571|NCT01020123|593138236|FG006|Main Period|Withdrawal by Subject|2|||
164210572|NCT01020123|593138230|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
164210573|NCT01020123|593138231|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
164210574|NCT01020123|593138232|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
164210575|NCT01020123|593138233|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
164210576|NCT01020123|593138234|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
164210577|NCT01020123|593138235|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
164210578|NCT01020123|593138236|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
164210579|NCT01020123|593138230|FG000|Main Period|Adverse Event|5|||
164210580|NCT01020123|593138231|FG001|Main Period|Adverse Event|2|||
164210581|NCT01020123|593138232|FG002|Main Period|Adverse Event|2|||
164210582|NCT01020123|593138233|FG003|Main Period|Adverse Event|1|||
164210583|NCT01020123|593138234|FG004|Main Period|Adverse Event|1|||
164210584|NCT01020123|593138235|FG005|Main Period|Adverse Event|2|||
164210585|NCT01020123|593138236|FG006|Main Period|Adverse Event|1|||
164210586|NCT01020123|593138230|FG000|Main Period|Protocol Violation|4|||
164210587|NCT01020123|593138231|FG001|Main Period|Protocol Violation|4|||
164210588|NCT01020123|593138232|FG002|Main Period|Protocol Violation|2|||
164210589|NCT01020123|593138233|FG003|Main Period|Protocol Violation|5|||
164210590|NCT01020123|593138234|FG004|Main Period|Protocol Violation|2|||
164210591|NCT01020123|593138235|FG005|Main Period|Protocol Violation|3|||
164210592|NCT01020123|593138236|FG006|Main Period|Protocol Violation|2|||
164210593|NCT01020123|593138230|FG000|Main Period|Lost to Follow-up|0|||
164210594|NCT01020123|593138231|FG001|Main Period|Lost to Follow-up|2|||
164210595|NCT01020123|593138232|FG002|Main Period|Lost to Follow-up|0|||
164324397|NCT04393298|593565167|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324398|NCT04393298|593565168|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324399|NCT04393298|593565169|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164210596|NCT01020123|593138233|FG003|Main Period|Lost to Follow-up|0|||
164210597|NCT01020123|593138234|FG004|Main Period|Lost to Follow-up|0|||
164210598|NCT01020123|593138235|FG005|Main Period|Lost to Follow-up|0|||
164210599|NCT01020123|593138236|FG006|Main Period|Lost to Follow-up|0|||
164210600|NCT01020123|593138230|FG000|Main Period|Unclasified|2|||
163876060|NCT03055858|591914736|FG000|Overall Study|Death|9|||
164210601|NCT01020123|593138231|FG001|Main Period|Unclasified|0|||
164210602|NCT01020123|593138232|FG002|Main Period|Unclasified|1|||
164210603|NCT01020123|593138233|FG003|Main Period|Unclasified|0|||
164210604|NCT01020123|593138234|FG004|Main Period|Unclasified|1|||
164210605|NCT01020123|593138235|FG005|Main Period|Unclasified|3|||
164210606|NCT01020123|593138236|FG006|Main Period|Unclasified|6|||
164210607|NCT01020123|593138230|FG000|Extention Period|Withdrawal by Subject|2|||
164324400|NCT04393298|593565170|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324401|NCT04393298|593565171|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164210608|NCT01020123|593138231|FG001|Extention Period|Withdrawal by Subject|1|||
164210609|NCT01020123|593138232|FG002|Extention Period|Withdrawal by Subject|1|||
164210610|NCT01020123|593138233|FG003|Extention Period|Withdrawal by Subject|0|||
164210611|NCT01020123|593138234|FG004|Extention Period|Withdrawal by Subject|0|||
164210612|NCT01020123|593138235|FG005|Extention Period|Withdrawal by Subject|0|||
164210613|NCT01020123|593138236|FG006|Extention Period|Withdrawal by Subject|0|||
164210614|NCT01020123|593138230|FG000|Extention Period|Adverse Event|0|||
164210615|NCT01020123|593138231|FG001|Extention Period|Adverse Event|0|||
164210616|NCT01020123|593138232|FG002|Extention Period|Adverse Event|0|||
164210617|NCT01020123|593138233|FG003|Extention Period|Adverse Event|1|||
164210618|NCT01020123|593138234|FG004|Extention Period|Adverse Event|0|||
164210619|NCT01020123|593138235|FG005|Extention Period|Adverse Event|0|||
164210620|NCT01020123|593138236|FG006|Extention Period|Adverse Event|0|||
164210621|NCT01020123|593138230|FG000|Extention Period|Protocol Violation|1|||
164210622|NCT01020123|593138231|FG001|Extention Period|Protocol Violation|1|||
164210623|NCT01020123|593138232|FG002|Extention Period|Protocol Violation|1|||
164210624|NCT01020123|593138233|FG003|Extention Period|Protocol Violation|0|||
164210625|NCT01020123|593138234|FG004|Extention Period|Protocol Violation|0|||
164210626|NCT01020123|593138235|FG005|Extention Period|Protocol Violation|0|||
164210627|NCT01020123|593138236|FG006|Extention Period|Protocol Violation|1|||
164210628|NCT01020123|593138230|FG000|Extention Period|Lost to Follow-up|0|||
164210629|NCT01020123|593138231|FG001|Extention Period|Lost to Follow-up|0|||
164210630|NCT01020123|593138232|FG002|Extention Period|Lost to Follow-up|0|||
164210631|NCT01020123|593138233|FG003|Extention Period|Lost to Follow-up|0|||
164210632|NCT01020123|593138234|FG004|Extention Period|Lost to Follow-up|0|||
164210633|NCT01020123|593138235|FG005|Extention Period|Lost to Follow-up|2|||
164210634|NCT01020123|593138236|FG006|Extention Period|Lost to Follow-up|0|||
164210635|NCT01349595|593138237|FG000|Overall Study|Lack of funding|2|||
164210636|NCT01349595|593138238|FG001|Overall Study|Lack of funding|2|||
164210637|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
164210638|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
164210639|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
164210640|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
164210641|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
164210642|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
164210643|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
164210644|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
164210645|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
164210646|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
164210647|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
164210648|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
164210649|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
164210650|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
164210651|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
164210652|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
164210653|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
164210654|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
164210655|NCT01069939|593138239|FG000|Randomised and Included in the Analyses|Removal|1|||
164210656|NCT01069939|593138240|FG001|Randomised and Included in the Analyses|Removal|0|||
164210657|NCT00658528|593138241|FG000|Overall Study|Adverse Event|5|||
164210658|NCT00658528|593138242|FG001|Overall Study|Adverse Event|7|||
164210659|NCT00658528|593138241|FG000|Overall Study|Lost to Follow-up|14|||
164210660|NCT00658528|593138242|FG001|Overall Study|Lost to Follow-up|22|||
164210661|NCT00658528|593138241|FG000|Overall Study|Withdrawal by Subject|8|||
164210662|NCT00658528|593138242|FG001|Overall Study|Withdrawal by Subject|6|||
164324402|NCT04393298|593565172|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164077304|NCT02623426|592647939|FG002|Overall Study|Withdrawal by Subject|2|||
164077305|NCT02094937|592647940|FG000|8 Weeks in Period 1|Adverse Event|9|||
164077306|NCT02094937|592647941|FG001|8 Weeks in Period 1|Adverse Event|0|||
164077307|NCT02094937|592647942|FG002|8 Weeks in Period 1|Adverse Event|0|||
164077308|NCT02094937|592647943|FG003|8 Weeks in Period 1|Adverse Event|0|||
164210663|NCT00658528|593138241|FG000|Overall Study|Withdrawal of consent|5|||
164210664|NCT00658528|593138242|FG001|Overall Study|Withdrawal of consent|6|||
164210665|NCT00658528|593138241|FG000|Overall Study|Other|8|||
164210666|NCT00658528|593138242|FG001|Overall Study|Other|4|||
164210667|NCT01706328|593138251|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
164210668|NCT01706328|593138252|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164210669|NCT01706328|593138253|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164324403|NCT04393298|593565173|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
164324404|NCT04393298|593565159|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324405|NCT04393298|593565160|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
164077309|NCT02094937|592647940|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
164324406|NCT04393298|593565161|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
164210670|NCT01706328|593138251|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
164210671|NCT01706328|593138252|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164210672|NCT01706328|593138253|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164210673|NCT01706328|593138251|FG000|2-week Run-in Period|Physician Decision|4|||
164210674|NCT01706328|593138252|FG001|2-week Run-in Period|Physician Decision|0|||
164210675|NCT01706328|593138253|FG002|2-week Run-in Period|Physician Decision|0|||
164210676|NCT01706328|593138251|FG000|2-week Run-in Period|Adverse Event|4|||
164210677|NCT01706328|593138252|FG001|2-week Run-in Period|Adverse Event|0|||
164210678|NCT01706328|593138253|FG002|2-week Run-in Period|Adverse Event|0|||
164210679|NCT01706328|593138251|FG000|2-week Run-in Period|Lost to Follow-up|2|||
164210680|NCT01706328|593138252|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164210681|NCT01706328|593138253|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164210682|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
164210683|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
164210684|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
164210685|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
164210686|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
164210687|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
164210688|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
164210689|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
164210690|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
164210691|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
164210692|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
164210693|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
164210694|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
164210695|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
164210696|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
164210697|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
164210698|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
164210699|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
164210700|NCT01706328|593138251|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164210701|NCT01706328|593138252|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
164210702|NCT01706328|593138253|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
164210703|NCT04603066|593138255|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
164210704|NCT04603066|593138256|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
164210705|NCT05759338|593138257|FG000|Overall Study|Withdrawal by Subject|3|||
164210706|NCT04409002|593138258|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
164210707|NCT06481579|593138259|FG000|Overall Study|Death|1|||
164210708|NCT06481579|593138260|FG001|Overall Study|Death|0|||
164210709|NCT06481579|593138259|FG000|Overall Study|Withdrawal by Subject|3|||
164210710|NCT06481579|593138260|FG001|Overall Study|Withdrawal by Subject|0|||
164210711|NCT06481579|593138259|FG000|Overall Study|Other|1|||
164210712|NCT06481579|593138260|FG001|Overall Study|Other|1|||
164210713|NCT04611126|593138261|FG000|Overall Study|TIL expansion unsuccessful|1|||
164210714|NCT04611126|593138262|FG001|Overall Study|TIL expansion unsuccessful|0|||
164324407|NCT04393298|593565162|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324408|NCT04393298|593565163|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324409|NCT04393298|593565164|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324410|NCT04393298|593565165|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324411|NCT04393298|593565166|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324412|NCT04393298|593565167|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324413|NCT04393298|593565168|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324414|NCT04393298|593565169|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324415|NCT04393298|593565170|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324416|NCT04393298|593565171|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324417|NCT04393298|593565172|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
164077310|NCT02094937|592647941|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
164077311|NCT02094937|592647942|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
164210715|NCT05260008|593138263|FG000|Overall Study|Physician Decision|0|||
164210716|NCT05260008|593138264|FG001|Overall Study|Physician Decision|1|||
164210717|NCT05260008|593138265|FG002|Overall Study|Physician Decision|0|||
164210718|NCT05260008|593138266|FG003|Overall Study|Physician Decision|0|||
164210719|NCT01157845|593138269|FG000|Overall Study|Lost to Follow-up|5|||
164210720|NCT01157845|593138269|FG000|Overall Study|Withdrawal by Subject|12|||
164210721|NCT01157845|593138269|FG000|Overall Study|Physician Decision|3|||
164210722|NCT01157845|593138269|FG000|Overall Study|Protocol Violation|13|||
164210723|NCT01157845|593138269|FG000|Overall Study|Study was ended|1|||
164210724|NCT01157845|593138269|FG000|Overall Study|Device malfunction|1|||
164210725|NCT04584788|593138270|FG000|Overall Study|Physician Decision|8|||
164210726|NCT04584788|593138270|FG000|Overall Study|Withdrawal by Subject|1|||
164210727|NCT04584788|593138270|FG000|Overall Study|Adverse Event|3|||
164210728|NCT03311555|593138271|FG000|Overall Study|Adverse Event|1|||
164210729|NCT04284774|593138277|FG000|Overall Study|Progressive disease|5|||
164210730|NCT01240746|593140211|FG000|Overall Study|Adverse Event|2|||
164210731|NCT01240746|593140212|FG001|Overall Study|Adverse Event|0|||
164210732|NCT01240746|593140213|FG002|Overall Study|Adverse Event|10|||
164210733|NCT01240746|593140211|FG000|Overall Study|Lost to Follow-up|23|||
164210734|NCT01240746|593140212|FG001|Overall Study|Lost to Follow-up|20|||
164210735|NCT01240746|593140213|FG002|Overall Study|Lost to Follow-up|102|||
164210736|NCT01240746|593140211|FG000|Overall Study|Protocol Violation|24|||
164210737|NCT01240746|593140212|FG001|Overall Study|Protocol Violation|15|||
164210738|NCT01240746|593140213|FG002|Overall Study|Protocol Violation|72|||
164210739|NCT01240746|593140211|FG000|Overall Study|Withdrawal by Subject|10|||
164210740|NCT01240746|593140212|FG001|Overall Study|Withdrawal by Subject|13|||
164210741|NCT01240746|593140213|FG002|Overall Study|Withdrawal by Subject|59|||
164210742|NCT01136954|593140214|FG000|Overall Study|Adverse Event|3|||
164210743|NCT01136954|593140215|FG001|Overall Study|Adverse Event|2|||
164210744|NCT01136954|593140214|FG000|Overall Study|Withdrawal by Subject|6|||
164210745|NCT01136954|593140215|FG001|Overall Study|Withdrawal by Subject|2|||
164210746|NCT01136954|593140214|FG000|Overall Study|Lack of Efficacy|14|||
164210747|NCT01136954|593140215|FG001|Overall Study|Lack of Efficacy|13|||
164210748|NCT01136954|593140214|FG000|Overall Study|Physician Decision|0|||
164210749|NCT01136954|593140215|FG001|Overall Study|Physician Decision|1|||
164210750|NCT01136954|593140214|FG000|Overall Study|Other|1|||
164210751|NCT01136954|593140215|FG001|Overall Study|Other|3|||
164210752|NCT04190225|593140232|FG000|Overall Study|Lost to Follow-up|2|||
164210753|NCT04190225|593140233|FG001|Overall Study|Lost to Follow-up|3|||
164210754|NCT04190225|593140232|FG000|Overall Study|Withdrawal by Subject|3|||
164210755|NCT04190225|593140233|FG001|Overall Study|Withdrawal by Subject|2|||
164210756|NCT04190225|593140232|FG000|Overall Study|Unrelated health condition|2|||
164210757|NCT04190225|593140233|FG001|Overall Study|Unrelated health condition|0|||
164210758|NCT01732783|593140236|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
164210759|NCT01732783|593140237|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
164210760|NCT01732783|593140238|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
164210761|NCT01732783|593140236|FG000|Overall Study|Death|13|||
164210762|NCT01732783|593140237|FG001|Overall Study|Death|4|||
164210763|NCT01732783|593140238|FG002|Overall Study|Death|1|||
164210764|NCT01732783|593140236|FG000|Overall Study|Lost to Follow-up|7|||
164210765|NCT01732783|593140237|FG001|Overall Study|Lost to Follow-up|1|||
164210766|NCT01732783|593140238|FG002|Overall Study|Lost to Follow-up|1|||
164210767|NCT01732783|593140236|FG000|Overall Study|Administrative Decision|8|||
164210768|NCT01732783|593140237|FG001|Overall Study|Administrative Decision|2|||
164210769|NCT01732783|593140238|FG002|Overall Study|Administrative Decision|1|||
164210770|NCT01732783|593140236|FG000|Overall Study|Withdrawal by Subject|1|||
164210771|NCT01732783|593140237|FG001|Overall Study|Withdrawal by Subject|0|||
164210772|NCT01732783|593140238|FG002|Overall Study|Withdrawal by Subject|0|||
164210773|NCT04429971|593140239|FG000|Overall Study|Lost to Follow-up|7|||
164210774|NCT04429971|593140240|FG001|Overall Study|Lost to Follow-up|8|||
164210775|NCT03331562|593140241|FG000|Overall Study|Adverse Event|2|||
164210776|NCT03331562|593140242|FG001|Overall Study|Adverse Event|0|||
164210777|NCT03331562|593140241|FG000|Overall Study|Death|1|||
164210778|NCT03331562|593140242|FG001|Overall Study|Death|0|||
164210779|NCT03718000|593140250|FG000|Overall Study|Relocation|2|||
164210780|NCT03718000|593140251|FG001|Overall Study|Relocation|4|||
164210781|NCT03718000|593140250|FG000|Overall Study|Pregnancy|0|||
164324418|NCT04393298|593565173|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
164324419|NCT04393298|593565159|FG000|Overall Study|Progressive Disease (PD)|0|||
163980276|NCT01225731|592297361|FG007|Part 2|Lost to Follow-up|3|||
164210782|NCT03718000|593140251|FG001|Overall Study|Pregnancy|1|||
164210783|NCT05522751|593140257|FG000|Overall Study|Adverse Event|1|||
164210784|NCT04044690|593140259|FG000|Period 1|Lack of Efficacy|1|||
164210785|NCT04044690|593140260|FG001|Period 1|Lack of Efficacy|1|||
164210786|NCT04044690|593140259|FG000|Period 1|Adverse Event|4|||
164210787|NCT04044690|593140260|FG001|Period 1|Adverse Event|2|||
164324420|NCT04393298|593565160|FG001|Overall Study|Progressive Disease (PD)|0|||
164324421|NCT04393298|593565161|FG002|Overall Study|Progressive Disease (PD)|0|||
164324422|NCT04393298|593565162|FG003|Overall Study|Progressive Disease (PD)|3|||
163980277|NCT01225731|592297362|FG008|Part 2|Lost to Follow-up|1|||
163980278|NCT01225731|592297363|FG009|Part 2|Lost to Follow-up|0|||
163980279|NCT01225731|592297364|FG010|Part 2|Lost to Follow-up|0|||
164210788|NCT04044690|593140259|FG000|Period 1|Physician Decision|0|||
164210789|NCT04044690|593140260|FG001|Period 1|Physician Decision|1|||
164210790|NCT04044690|593140259|FG000|Period 1|Withdrawal by Subject|2|||
164210791|NCT04044690|593140260|FG001|Period 1|Withdrawal by Subject|5|||
164210792|NCT04044690|593140259|FG000|Period 1|Protocol Deviation|2|||
164324423|NCT04393298|593565163|FG004|Overall Study|Progressive Disease (PD)|0|||
164210793|NCT04044690|593140260|FG001|Period 1|Protocol Deviation|0|||
164210794|NCT04044690|593140259|FG000|Period 1|Site Terminated by Sponsor|0|||
164210795|NCT04044690|593140260|FG001|Period 1|Site Terminated by Sponsor|1|||
164210796|NCT04044690|593140259|FG000|Period 1|Study Terminated by Sponsor|0|||
164210797|NCT04044690|593140260|FG001|Period 1|Study Terminated by Sponsor|1|||
164210798|NCT04044690|593140259|FG000|Period 1|Death|1|||
164210799|NCT04044690|593140260|FG001|Period 1|Death|1|||
164210800|NCT04044690|593140259|FG000|Period 1|Other: Unspecified|1|||
164210801|NCT04044690|593140260|FG001|Period 1|Other: Unspecified|0|||
164210802|NCT04044690|593140259|FG000|Period 2|Lack of Efficacy|0|||
164210803|NCT04044690|593140260|FG001|Period 2|Lack of Efficacy|1|||
164210804|NCT04044690|593140259|FG000|Period 2|Adverse Event|0|||
164210805|NCT04044690|593140260|FG001|Period 2|Adverse Event|1|||
164210806|NCT04044690|593140259|FG000|Period 2|Physician Decision|0|||
164210807|NCT04044690|593140260|FG001|Period 2|Physician Decision|2|||
164210808|NCT04044690|593140259|FG000|Period 2|Withdrawal by Subject|5|||
164210809|NCT04044690|593140260|FG001|Period 2|Withdrawal by Subject|5|||
164210810|NCT04044690|593140259|FG000|Period 2|Lost to Follow-up|0|||
164210811|NCT04044690|593140260|FG001|Period 2|Lost to Follow-up|1|||
164210812|NCT04044690|593140259|FG000|Period 2|Site Terminated by Sponsor|1|||
164210813|NCT04044690|593140260|FG001|Period 2|Site Terminated by Sponsor|3|||
164210814|NCT04044690|593140259|FG000|Period 2|Study Terminated by Sponsor|8|||
164210815|NCT04044690|593140260|FG001|Period 2|Study Terminated by Sponsor|3|||
164210816|NCT04044690|593140259|FG000|Period 2|Death|1|||
164210817|NCT04044690|593140260|FG001|Period 2|Death|0|||
164210818|NCT04044690|593140259|FG000|Period 2|Other: Unspecified|1|||
164210819|NCT04044690|593140260|FG001|Period 2|Other: Unspecified|1|||
164210820|NCT04044690|593140259|FG000|Period 3|Site Terminated by Sponsor|1|||
164210821|NCT04044690|593140260|FG001|Period 3|Site Terminated by Sponsor|2|||
164210822|NCT04044690|593140259|FG000|Period 3|Study Terminated by Sponsor|24|||
164210823|NCT04044690|593140260|FG001|Period 3|Study Terminated by Sponsor|18|||
164210824|NCT04044690|593140259|FG000|Period 3|Missing|0|||
164210825|NCT04044690|593140260|FG001|Period 3|Missing|2|||
164210826|NCT01582451|593140266|FG000|Overall Study|Adverse Event|1|||
164210827|NCT01582451|593140267|FG001|Overall Study|Adverse Event|3|||
164210828|NCT01582451|593140266|FG000|Overall Study|Death|3|||
164210829|NCT01582451|593140267|FG001|Overall Study|Death|3|||
164210830|NCT01582451|593140266|FG000|Overall Study|Lost to Follow-up|0|||
164324424|NCT04393298|593565164|FG005|Overall Study|Progressive Disease (PD)|0|||
164324425|NCT04393298|593565165|FG006|Overall Study|Progressive Disease (PD)|0|||
164324426|NCT04393298|593565166|FG007|Overall Study|Progressive Disease (PD)|0|||
164324427|NCT04393298|593565167|FG008|Overall Study|Progressive Disease (PD)|0|||
164324428|NCT04393298|593565168|FG009|Overall Study|Progressive Disease (PD)|0|||
164324429|NCT04393298|593565169|FG010|Overall Study|Progressive Disease (PD)|0|||
164324430|NCT04393298|593565170|FG011|Overall Study|Progressive Disease (PD)|0|||
164324431|NCT04393298|593565171|FG012|Overall Study|Progressive Disease (PD)|0|||
164324432|NCT04393298|593565172|FG013|Overall Study|Progressive Disease (PD)|0|||
164324433|NCT04393298|593565173|FG014|Overall Study|Progressive Disease (PD)|0|||
164324434|NCT04393298|593565159|FG000|Overall Study|Started a New Cancer Treatment|0|||
164324435|NCT04393298|593565160|FG001|Overall Study|Started a New Cancer Treatment|0|||
164324436|NCT04393298|593565161|FG002|Overall Study|Started a New Cancer Treatment|0|||
164324437|NCT04393298|593565162|FG003|Overall Study|Started a New Cancer Treatment|0|||
164324438|NCT04393298|593565163|FG004|Overall Study|Started a New Cancer Treatment|1|||
164324439|NCT04393298|593565164|FG005|Overall Study|Started a New Cancer Treatment|0|||
164324440|NCT04393298|593565165|FG006|Overall Study|Started a New Cancer Treatment|0|||
164324441|NCT04393298|593565166|FG007|Overall Study|Started a New Cancer Treatment|0|||
164324442|NCT04393298|593565167|FG008|Overall Study|Started a New Cancer Treatment|0|||
164324443|NCT04393298|593565168|FG009|Overall Study|Started a New Cancer Treatment|0|||
164324444|NCT04393298|593565169|FG010|Overall Study|Started a New Cancer Treatment|0|||
163876061|NCT03055858|591914736|FG000|Overall Study|Withdrawal by Subject|11|||
163876062|NCT03055858|591914736|FG000|Overall Study|Lost to Follow-up|6|||
163876063|NCT03055858|591914736|FG000|Overall Study|Missed Follow-Up Visits|18|||
163876064|NCT02728557|591914737|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
163876065|NCT02728557|591914738|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
163876066|NCT02728557|591914737|FG000|Overall Study|Dissatisfaction with research tasks|0|||
163876067|NCT02728557|591914738|FG001|Overall Study|Dissatisfaction with research tasks|1|||
164210831|NCT01582451|593140267|FG001|Overall Study|Lost to Follow-up|2|||
164210832|NCT01582451|593140266|FG000|Overall Study|Protocol Violation|11|||
164210833|NCT01582451|593140267|FG001|Overall Study|Protocol Violation|3|||
164324445|NCT04393298|593565170|FG011|Overall Study|Started a New Cancer Treatment|0|||
164210834|NCT01582451|593140266|FG000|Overall Study|Withdrawal by Subject|13|||
164210835|NCT01582451|593140267|FG001|Overall Study|Withdrawal by Subject|9|||
164210836|NCT01582451|593140266|FG000|Overall Study|Physician Decision|3|||
164210837|NCT01582451|593140267|FG001|Overall Study|Physician Decision|0|||
164324446|NCT04393298|593565171|FG012|Overall Study|Started a New Cancer Treatment|0|||
164324447|NCT04393298|593565172|FG013|Overall Study|Started a New Cancer Treatment|0|||
164210838|NCT01582451|593140266|FG000|Overall Study|Sponsor Decision|1|||
164210839|NCT01582451|593140267|FG001|Overall Study|Sponsor Decision|0|||
164210840|NCT00716417|593140270|FG000|Overall Study|Adverse Event|0|||
164210841|NCT00716417|593140271|FG001|Overall Study|Adverse Event|0|||
164210842|NCT00716417|593140272|FG002|Overall Study|Adverse Event|2|||
164210843|NCT00716417|593140273|FG003|Overall Study|Adverse Event|1|||
164210844|NCT00716417|593140274|FG004|Overall Study|Adverse Event|0|||
164210845|NCT00716417|593140275|FG005|Overall Study|Adverse Event|0|||
164210846|NCT00716417|593140276|FG006|Overall Study|Adverse Event|3|||
164210847|NCT00716417|593140277|FG007|Overall Study|Adverse Event|1|||
164210848|NCT00716417|593140278|FG008|Overall Study|Adverse Event|0|||
164210849|NCT00716417|593140279|FG009|Overall Study|Adverse Event|3|||
164210850|NCT00716417|593140270|FG000|Overall Study|Withdrawal by Subject|0|||
164210851|NCT00716417|593140271|FG001|Overall Study|Withdrawal by Subject|1|||
164210852|NCT00716417|593140272|FG002|Overall Study|Withdrawal by Subject|0|||
164210853|NCT00716417|593140273|FG003|Overall Study|Withdrawal by Subject|2|||
164210854|NCT00716417|593140274|FG004|Overall Study|Withdrawal by Subject|0|||
164210855|NCT00716417|593140275|FG005|Overall Study|Withdrawal by Subject|0|||
164210856|NCT00716417|593140276|FG006|Overall Study|Withdrawal by Subject|1|||
164210857|NCT00716417|593140277|FG007|Overall Study|Withdrawal by Subject|0|||
164210858|NCT00716417|593140278|FG008|Overall Study|Withdrawal by Subject|0|||
164210859|NCT00716417|593140279|FG009|Overall Study|Withdrawal by Subject|0|||
164210860|NCT00716417|593140270|FG000|Overall Study|Progressive disease|3|||
164210861|NCT00716417|593140271|FG001|Overall Study|Progressive disease|5|||
164210862|NCT00716417|593140272|FG002|Overall Study|Progressive disease|3|||
164210863|NCT00716417|593140273|FG003|Overall Study|Progressive disease|8|||
164210864|NCT00716417|593140274|FG004|Overall Study|Progressive disease|0|||
164210865|NCT00716417|593140275|FG005|Overall Study|Progressive disease|3|||
164210866|NCT00716417|593140276|FG006|Overall Study|Progressive disease|3|||
164210867|NCT00716417|593140277|FG007|Overall Study|Progressive disease|1|||
164210868|NCT00716417|593140278|FG008|Overall Study|Progressive disease|5|||
164210869|NCT00716417|593140279|FG009|Overall Study|Progressive disease|0|||
164210870|NCT00716417|593140270|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
164210871|NCT00716417|593140271|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
164210872|NCT00716417|593140272|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
164210873|NCT00716417|593140273|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
164210874|NCT00716417|593140274|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
164210875|NCT00716417|593140275|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
164210876|NCT00716417|593140276|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
164210877|NCT00716417|593140277|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
164210878|NCT00716417|593140278|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
164210879|NCT00716417|593140279|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
164210880|NCT00716417|593140270|FG000|Overall Study|On patient request due to toxicities|0|||
164210881|NCT00716417|593140271|FG001|Overall Study|On patient request due to toxicities|0|||
164210882|NCT00716417|593140272|FG002|Overall Study|On patient request due to toxicities|0|||
164210883|NCT00716417|593140273|FG003|Overall Study|On patient request due to toxicities|0|||
164210884|NCT00716417|593140274|FG004|Overall Study|On patient request due to toxicities|0|||
164210885|NCT00716417|593140275|FG005|Overall Study|On patient request due to toxicities|0|||
164210886|NCT00716417|593140276|FG006|Overall Study|On patient request due to toxicities|0|||
164210887|NCT00716417|593140277|FG007|Overall Study|On patient request due to toxicities|1|||
164210888|NCT00716417|593140278|FG008|Overall Study|On patient request due to toxicities|0|||
164210889|NCT00716417|593140279|FG009|Overall Study|On patient request due to toxicities|0|||
164210890|NCT00487188|593140280|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
164210891|NCT00487188|593140281|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
164210892|NCT00487188|593140282|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
164210893|NCT00487188|593140280|FG000|Induction Phase|Adverse Event|5|||
164210894|NCT00487188|593140281|FG001|Induction Phase|Adverse Event|0|||
164210895|NCT00487188|593140282|FG002|Induction Phase|Adverse Event|0|||
164210896|NCT00487188|593140280|FG000|Induction Phase|Lack of Efficacy|0|||
164210897|NCT00487188|593140281|FG001|Induction Phase|Lack of Efficacy|1|||
164210898|NCT00487188|593140282|FG002|Induction Phase|Lack of Efficacy|0|||
164210899|NCT00487188|593140280|FG000|Induction Phase|Protocol Violation|1|||
164210900|NCT00487188|593140281|FG001|Induction Phase|Protocol Violation|0|||
164210901|NCT00487188|593140282|FG002|Induction Phase|Protocol Violation|0|||
164324448|NCT04393298|593565173|FG014|Overall Study|Started a New Cancer Treatment|0|||
163876068|NCT02728557|591914737|FG000|Overall Study|Scheduling or change in availability|1|||
163876069|NCT02728557|591914738|FG001|Overall Study|Scheduling or change in availability|1|||
164210902|NCT00487188|593140280|FG000|Induction Phase|Refused Treatment|1|||
164210903|NCT00487188|593140281|FG001|Induction Phase|Refused Treatment|2|||
164210904|NCT00487188|593140282|FG002|Induction Phase|Refused Treatment|0|||
164210905|NCT00487188|593140280|FG000|Induction Phase|Lost to Follow-up|2|||
164210906|NCT00487188|593140281|FG001|Induction Phase|Lost to Follow-up|2|||
164210907|NCT00487188|593140282|FG002|Induction Phase|Lost to Follow-up|0|||
164210908|NCT00487188|593140280|FG000|Induction Phase|Administrative|0|||
164210909|NCT00487188|593140281|FG001|Induction Phase|Administrative|1|||
164210910|NCT00487188|593140282|FG002|Induction Phase|Administrative|0|||
164210911|NCT00487188|593140280|FG000|Maintenance Phase|Adverse Event|1|||
164210912|NCT00487188|593140281|FG001|Maintenance Phase|Adverse Event|0|||
164210913|NCT00487188|593140282|FG002|Maintenance Phase|Adverse Event|0|||
164210914|NCT00487188|593140280|FG000|Maintenance Phase|Death|1|||
164210915|NCT00487188|593140281|FG001|Maintenance Phase|Death|0|||
164210916|NCT00487188|593140282|FG002|Maintenance Phase|Death|0|||
164210917|NCT00487188|593140280|FG000|Maintenance Phase|Lost to Follow-up|1|||
164210918|NCT00487188|593140281|FG001|Maintenance Phase|Lost to Follow-up|0|||
164210919|NCT00487188|593140282|FG002|Maintenance Phase|Lost to Follow-up|0|||
164210920|NCT00487188|593140280|FG000|Maintenance Phase|Administrative|0|||
164210921|NCT00487188|593140281|FG001|Maintenance Phase|Administrative|0|||
164210922|NCT00487188|593140282|FG002|Maintenance Phase|Administrative|1|||
164210923|NCT03881371|593140283|FG000|Overall Study|Adverse Event|8|||
164210924|NCT03881371|593140284|FG001|Overall Study|Adverse Event|9|||
164210925|NCT03881371|593140283|FG000|Overall Study|Death|1|||
164210926|NCT03881371|593140284|FG001|Overall Study|Death|0|||
164210927|NCT03881371|593140283|FG000|Overall Study|Lost to Follow-up|1|||
164210928|NCT03881371|593140284|FG001|Overall Study|Lost to Follow-up|0|||
164210929|NCT03881371|593140283|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164210930|NCT03881371|593140284|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164324449|NCT04393298|593565159|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324450|NCT04393298|593565160|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324451|NCT04393298|593565161|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324452|NCT04393298|593565162|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324453|NCT04393298|593565163|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
164324454|NCT04393298|593565164|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324455|NCT04393298|593565165|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324456|NCT04393298|593565166|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324457|NCT04393298|593565167|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324458|NCT04393298|593565168|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324459|NCT04393298|593565169|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324460|NCT04393298|593565170|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324461|NCT04393298|593565171|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324462|NCT04393298|593565172|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324463|NCT04393298|593565173|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
164324464|NCT04393298|593565159|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324465|NCT04393298|593565160|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324466|NCT04393298|593565161|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324467|NCT04393298|593565162|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324468|NCT04393298|593565163|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324469|NCT04393298|593565164|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
164324470|NCT04393298|593565165|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324471|NCT04393298|593565166|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324472|NCT04393298|593565167|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324473|NCT04393298|593565168|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324474|NCT04393298|593565169|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324475|NCT04393298|593565170|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324476|NCT04393298|593565171|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324477|NCT04393298|593565172|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324478|NCT04393298|593565173|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
164324479|NCT04393298|593565159|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324480|NCT04393298|593565160|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324481|NCT04393298|593565161|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324482|NCT04393298|593565162|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324483|NCT04393298|593565163|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163876070|NCT03416010|591914739|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
164210931|NCT03881371|593140283|FG000|Overall Study|Physician Decision|3|||
164210932|NCT03881371|593140284|FG001|Overall Study|Physician Decision|3|||
164324484|NCT04393298|593565164|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
164324485|NCT04393298|593565165|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
163876071|NCT03416010|591914740|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
163876072|NCT03416010|591914739|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
163876073|NCT03416010|591914740|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
163876074|NCT03416010|591914739|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
163876075|NCT03416010|591914740|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
164210933|NCT03881371|593140283|FG000|Overall Study|Withdrawal by Subject|2|||
164210934|NCT03881371|593140284|FG001|Overall Study|Withdrawal by Subject|10|||
164210935|NCT03881371|593140283|FG000|Overall Study|Discontinuation from Study|1|||
164210936|NCT03881371|593140284|FG001|Overall Study|Discontinuation from Study|0|||
164210937|NCT05376358|593140290|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
164324486|NCT04393298|593565166|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164210938|NCT05376358|593140291|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
164210939|NCT05376358|593140290|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
164210940|NCT05376358|593140291|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
164210941|NCT05376358|593140290|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
164210942|NCT05376358|593140291|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
164210943|NCT05376358|593140290|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
164210944|NCT05376358|593140291|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
164210945|NCT05376358|593140290|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
164210946|NCT05376358|593140291|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
164210947|NCT05376358|593140290|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
164210948|NCT05376358|593140291|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
164210949|NCT04225832|593140292|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
164210950|NCT04225832|593140293|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
164210951|NCT04225832|593140292|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
164210952|NCT04225832|593140293|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
164210953|NCT00311168|593140294|FG000|First Intervention|Withdrawal by Subject|2|||
164210954|NCT00311168|593140295|FG001|First Intervention|Withdrawal by Subject|2|||
164210955|NCT00311168|593140294|FG000|First Intervention|Lost to Follow-up|1|||
164210956|NCT00311168|593140295|FG001|First Intervention|Lost to Follow-up|1|||
164210957|NCT00311168|593140294|FG000|First Intervention|Protocol Violation|1|||
164210958|NCT00311168|593140295|FG001|First Intervention|Protocol Violation|1|||
164210959|NCT00311168|593140294|FG000|First Intervention|Adverse Event|1|||
164210960|NCT00311168|593140295|FG001|First Intervention|Adverse Event|0|||
164210961|NCT00311168|593140294|FG000|First Intervention|Other|2|||
164210962|NCT00311168|593140295|FG001|First Intervention|Other|2|||
164210963|NCT00311168|593140294|FG000|Second Intervention|Lost to Follow-up|9|||
164210964|NCT00311168|593140295|FG001|Second Intervention|Lost to Follow-up|2|||
164210965|NCT00311168|593140294|FG000|Second Intervention|Withdrawal by Subject|0|||
164210966|NCT00311168|593140295|FG001|Second Intervention|Withdrawal by Subject|1|||
164210967|NCT00311168|593140294|FG000|Second Intervention|Other|1|||
164210968|NCT00311168|593140295|FG001|Second Intervention|Other|1|||
164210969|NCT05472142|593140296|FG000|Total Participants|Lost to Follow-up|312|||
164210970|NCT05472142|593140297|FG001|Total Participants|Lost to Follow-up|0|||
164210971|NCT05472142|593140296|FG000|Clinic Patients|Lost to Follow-up|312|||
164210972|NCT05472142|593140297|FG001|Clinic Patients|Lost to Follow-up|0|||
164210973|NCT02452190|593140298|FG000|Overall Study|Withdrawal by Sponsor|1|||
164324487|NCT04393298|593565167|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324488|NCT04393298|593565168|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324489|NCT04393298|593565169|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324490|NCT04393298|593565170|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324491|NCT04393298|593565171|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324492|NCT04393298|593565172|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
164324493|NCT04393298|593565173|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
164324494|NCT04393298|593565159|FG000|Overall Study|Death|0|||
164324495|NCT04393298|593565160|FG001|Overall Study|Death|0|||
164324496|NCT04393298|593565161|FG002|Overall Study|Death|0|||
164324497|NCT04393298|593565162|FG003|Overall Study|Death|0|||
164324498|NCT04393298|593565163|FG004|Overall Study|Death|0|||
164324499|NCT04393298|593565164|FG005|Overall Study|Death|1|||
164324500|NCT04393298|593565165|FG006|Overall Study|Death|1|||
164324501|NCT04393298|593565166|FG007|Overall Study|Death|0|||
164324502|NCT04393298|593565167|FG008|Overall Study|Death|1|||
164324503|NCT04393298|593565168|FG009|Overall Study|Death|1|||
164324504|NCT04393298|593565169|FG010|Overall Study|Death|0|||
164324505|NCT04393298|593565170|FG011|Overall Study|Death|1|||
164324506|NCT04393298|593565171|FG012|Overall Study|Death|1|||
164324507|NCT04393298|593565172|FG013|Overall Study|Death|0|||
164324508|NCT04393298|593565173|FG014|Overall Study|Death|1|||
164324509|NCT04393298|593565159|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324510|NCT04393298|593565160|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324511|NCT04393298|593565161|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
163876076|NCT03416010|591914739|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
163876077|NCT03416010|591914740|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
163876078|NCT03416010|591914739|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
164324512|NCT04393298|593565162|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324513|NCT04393298|593565163|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324514|NCT04393298|593565164|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
164210974|NCT02452190|593140299|FG001|Overall Study|Withdrawal by Sponsor|3|||
164210975|NCT02452190|593140298|FG000|Overall Study|Pregnancy|1|||
164210976|NCT02452190|593140299|FG001|Overall Study|Pregnancy|0|||
164210977|NCT02452190|593140298|FG000|Overall Study|Investigator's Decision|2|||
164210978|NCT02452190|593140299|FG001|Overall Study|Investigator's Decision|0|||
164210979|NCT02452190|593140298|FG000|Overall Study|Lack of Efficacy|3|||
164210980|NCT02452190|593140299|FG001|Overall Study|Lack of Efficacy|1|||
164210981|NCT02452190|593140298|FG000|Overall Study|Lost to Follow-up|4|||
164210982|NCT02452190|593140299|FG001|Overall Study|Lost to Follow-up|3|||
164210983|NCT02452190|593140298|FG000|Overall Study|Adverse Event|2|||
164210984|NCT02452190|593140299|FG001|Overall Study|Adverse Event|5|||
164210985|NCT02452190|593140298|FG000|Overall Study|Withdrawal by Subject|20|||
164210986|NCT02452190|593140299|FG001|Overall Study|Withdrawal by Subject|11|||
164210987|NCT02452190|593140298|FG000|Overall Study|Noncompliance with study drug|1|||
164210988|NCT02452190|593140299|FG001|Overall Study|Noncompliance with study drug|0|||
164210989|NCT02452190|593140298|FG000|Overall Study|Participant traveled abroad|1|||
164210990|NCT02452190|593140299|FG001|Overall Study|Participant traveled abroad|0|||
164210991|NCT02452190|593140298|FG000|Overall Study|Death|0|||
164210992|NCT02452190|593140299|FG001|Overall Study|Death|1|||
164210993|NCT06001021|593140302|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
164210994|NCT06001021|593140303|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
164210995|NCT06001021|593140304|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
164210996|NCT06001021|593140305|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
164210997|NCT06001021|593140306|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
164210998|NCT06001021|593140307|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
164210999|NCT06001021|593140308|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
164211000|NCT06001021|593140302|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
164211001|NCT06001021|593140303|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211002|NCT06001021|593140304|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211003|NCT06001021|593140305|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
164211004|NCT06001021|593140306|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
164211005|NCT06001021|593140307|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211006|NCT06001021|593140308|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
164211007|NCT03112603|593140311|FG000|End of Randomization Period|Lost to Follow-up|3|||
164211008|NCT03112603|593140312|FG001|End of Randomization Period|Lost to Follow-up|0|||
164211009|NCT03112603|593140313|FG002|End of Randomization Period|Lost to Follow-up|0|||
164211010|NCT03112603|593140311|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
164211011|NCT03112603|593140312|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
164211012|NCT03112603|593140313|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
164211013|NCT03112603|593140311|FG000|End of Randomization Period|Physician Decision|43|||
164211014|NCT03112603|593140312|FG001|End of Randomization Period|Physician Decision|18|||
163876079|NCT03416010|591914740|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
163876080|NCT03416010|591914739|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
164211015|NCT03112603|593140313|FG002|End of Randomization Period|Physician Decision|0|||
164211016|NCT03112603|593140311|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
164211017|NCT03112603|593140312|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
164211018|NCT03112603|593140313|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
164211019|NCT03112603|593140311|FG000|End of Randomization Period|Death|10|||
163876081|NCT03416010|591914740|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
163876082|NCT03416010|591914739|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
163876083|NCT03416010|591914740|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
163876084|NCT03948763|591914741|FG000|Overall Study|Sponsor's decision|0|||
163876085|NCT03948763|591914742|FG001|Overall Study|Sponsor's decision|2|||
163876086|NCT03948763|591914743|FG002|Overall Study|Sponsor's decision|6|||
163876087|NCT03948763|591914744|FG003|Overall Study|Sponsor's decision|4|||
163876088|NCT03948763|591914745|FG004|Overall Study|Sponsor's decision|0|||
163876089|NCT03948763|591914741|FG000|Overall Study|Physician Decision|0|||
163876090|NCT03948763|591914742|FG001|Overall Study|Physician Decision|0|||
163876091|NCT03948763|591914743|FG002|Overall Study|Physician Decision|1|||
163876092|NCT03948763|591914744|FG003|Overall Study|Physician Decision|0|||
163876093|NCT03948763|591914745|FG004|Overall Study|Physician Decision|0|||
163876094|NCT03948763|591914741|FG000|Overall Study|Lost to Follow-up|0|||
163876095|NCT03948763|591914742|FG001|Overall Study|Lost to Follow-up|0|||
163876096|NCT03948763|591914743|FG002|Overall Study|Lost to Follow-up|0|||
163876097|NCT03948763|591914744|FG003|Overall Study|Lost to Follow-up|0|||
164211020|NCT03112603|593140312|FG001|End of Randomization Period|Death|7|||
164211021|NCT03112603|593140313|FG002|End of Randomization Period|Death|0|||
164211022|NCT03112603|593140311|FG000|End of Randomization Period|Disease Relapse|12|||
164211023|NCT03112603|593140312|FG001|End of Randomization Period|Disease Relapse|7|||
164211024|NCT03112603|593140313|FG002|End of Randomization Period|Disease Relapse|0|||
163876098|NCT03948763|591914745|FG004|Overall Study|Lost to Follow-up|1|||
163876099|NCT03948763|591914741|FG000|Overall Study|Death|2|||
163876100|NCT03948763|591914742|FG001|Overall Study|Death|12|||
164324515|NCT04393298|593565165|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324516|NCT04393298|593565166|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324517|NCT04393298|593565167|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324518|NCT04393298|593565168|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324519|NCT04393298|593565169|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324520|NCT04393298|593565170|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324521|NCT04393298|593565171|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324522|NCT04393298|593565172|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324523|NCT04393298|593565173|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
164324524|NCT04393298|593565159|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
164324525|NCT04393298|593565160|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
164324526|NCT04393298|593565161|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
164324527|NCT04393298|593565162|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
164324528|NCT04393298|593565163|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
164324529|NCT04393298|593565164|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
164324530|NCT04393298|593565165|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
164324531|NCT04393298|593565166|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
164324532|NCT04393298|593565167|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
164324533|NCT04393298|593565168|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
164324534|NCT04393298|593565169|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
164324535|NCT04393298|593565170|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
164324536|NCT04393298|593565171|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
164324537|NCT04393298|593565172|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
164324538|NCT04393298|593565173|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
164324539|NCT04393298|593565159|FG000|Overall Study|Patient Passed Away|0|||
164324540|NCT04393298|593565160|FG001|Overall Study|Patient Passed Away|0|||
164324541|NCT04393298|593565161|FG002|Overall Study|Patient Passed Away|0|||
164324542|NCT04393298|593565162|FG003|Overall Study|Patient Passed Away|0|||
164324543|NCT04393298|593565163|FG004|Overall Study|Patient Passed Away|0|||
164324544|NCT04393298|593565164|FG005|Overall Study|Patient Passed Away|0|||
164324545|NCT04393298|593565165|FG006|Overall Study|Patient Passed Away|0|||
164324546|NCT04393298|593565166|FG007|Overall Study|Patient Passed Away|1|||
164324547|NCT04393298|593565167|FG008|Overall Study|Patient Passed Away|0|||
164324548|NCT04393298|593565168|FG009|Overall Study|Patient Passed Away|0|||
164324549|NCT04393298|593565169|FG010|Overall Study|Patient Passed Away|0|||
164324550|NCT04393298|593565170|FG011|Overall Study|Patient Passed Away|0|||
164324551|NCT04393298|593565171|FG012|Overall Study|Patient Passed Away|0|||
164324552|NCT04393298|593565172|FG013|Overall Study|Patient Passed Away|0|||
164324553|NCT04393298|593565173|FG014|Overall Study|Patient Passed Away|0|||
164324554|NCT04393298|593565159|FG000|Overall Study|Patient Deceased|0|||
164324555|NCT04393298|593565160|FG001|Overall Study|Patient Deceased|0|||
164324556|NCT04393298|593565161|FG002|Overall Study|Patient Deceased|0|||
164324557|NCT04393298|593565162|FG003|Overall Study|Patient Deceased|0|||
164324558|NCT04393298|593565163|FG004|Overall Study|Patient Deceased|0|||
164324559|NCT04393298|593565164|FG005|Overall Study|Patient Deceased|0|||
164324560|NCT04393298|593565165|FG006|Overall Study|Patient Deceased|0|||
164324561|NCT04393298|593565166|FG007|Overall Study|Patient Deceased|1|||
164324562|NCT04393298|593565167|FG008|Overall Study|Patient Deceased|0|||
164324563|NCT04393298|593565168|FG009|Overall Study|Patient Deceased|0|||
164324564|NCT04393298|593565169|FG010|Overall Study|Patient Deceased|0|||
164324565|NCT04393298|593565170|FG011|Overall Study|Patient Deceased|0|||
164324566|NCT04393298|593565171|FG012|Overall Study|Patient Deceased|0|||
164324567|NCT04393298|593565172|FG013|Overall Study|Patient Deceased|0|||
164324568|NCT04393298|593565173|FG014|Overall Study|Patient Deceased|0|||
164324569|NCT04393298|593565159|FG000|Overall Study|Patient Discharged to Hospice|0|||
164324570|NCT04393298|593565160|FG001|Overall Study|Patient Discharged to Hospice|0|||
164324571|NCT04393298|593565161|FG002|Overall Study|Patient Discharged to Hospice|0|||
164324572|NCT04393298|593565162|FG003|Overall Study|Patient Discharged to Hospice|0|||
163980280|NCT01225731|592297365|FG011|Part 2|Lost to Follow-up|0|||
163980281|NCT01225731|592297366|FG012|Part 2|Lost to Follow-up|0|||
163980282|NCT01225731|592297354|FG000|Part 2|Physician Decision|0|||
163980283|NCT01225731|592297355|FG001|Part 2|Physician Decision|0|||
164324573|NCT04393298|593565163|FG004|Overall Study|Patient Discharged to Hospice|0|||
164324574|NCT04393298|593565164|FG005|Overall Study|Patient Discharged to Hospice|0|||
163980284|NCT01225731|592297356|FG002|Part 2|Physician Decision|0|||
163980285|NCT01225731|592297357|FG003|Part 2|Physician Decision|0|||
164324575|NCT04393298|593565165|FG006|Overall Study|Patient Discharged to Hospice|0|||
164324576|NCT04393298|593565166|FG007|Overall Study|Patient Discharged to Hospice|0|||
164324577|NCT04393298|593565167|FG008|Overall Study|Patient Discharged to Hospice|1|||
164324578|NCT04393298|593565168|FG009|Overall Study|Patient Discharged to Hospice|0|||
164324579|NCT04393298|593565169|FG010|Overall Study|Patient Discharged to Hospice|0|||
164324580|NCT04393298|593565170|FG011|Overall Study|Patient Discharged to Hospice|0|||
163980286|NCT01225731|592297358|FG004|Part 2|Physician Decision|0|||
164324581|NCT04393298|593565171|FG012|Overall Study|Patient Discharged to Hospice|0|||
164324582|NCT04393298|593565172|FG013|Overall Study|Patient Discharged to Hospice|0|||
164324583|NCT04393298|593565173|FG014|Overall Study|Patient Discharged to Hospice|0|||
164324584|NCT04393298|593565159|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324585|NCT04393298|593565160|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324586|NCT04393298|593565161|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324587|NCT04393298|593565162|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324588|NCT04393298|593565163|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324589|NCT04393298|593565164|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324590|NCT04393298|593565165|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324591|NCT04393298|593565166|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324592|NCT04393298|593565167|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324593|NCT04393298|593565168|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
164324594|NCT04393298|593565169|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324595|NCT04393298|593565170|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324596|NCT04393298|593565171|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324597|NCT04393298|593565172|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324598|NCT04393298|593565173|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
164324599|NCT04393298|593565159|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
164324600|NCT04393298|593565160|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
164324601|NCT04393298|593565161|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
164324602|NCT04393298|593565162|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
164324603|NCT04393298|593565163|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
164324604|NCT04393298|593565164|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
164324605|NCT04393298|593565165|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
164324606|NCT04393298|593565166|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
164324607|NCT04393298|593565167|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
164324608|NCT04393298|593565168|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
164324609|NCT04393298|593565169|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
164324610|NCT04393298|593565170|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
164324611|NCT04393298|593565171|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
164324612|NCT04393298|593565172|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
164324613|NCT04393298|593565173|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
164324614|NCT00807027|593565181|FG000|Overall Study|Withdrawal by Subject|13|||
164324615|NCT00807027|593565182|FG001|Overall Study|Withdrawal by Subject|14|||
164324616|NCT00807027|593565181|FG000|Overall Study|Protocol Violation|1|||
164324617|NCT00807027|593565182|FG001|Overall Study|Protocol Violation|1|||
164324618|NCT00807027|593565181|FG000|Overall Study|Adverse Event|2|||
164324619|NCT00807027|593565182|FG001|Overall Study|Adverse Event|2|||
164324620|NCT05660850|593565186|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
164324621|NCT05660850|593565187|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
164324622|NCT05660850|593565188|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
164324623|NCT05660850|593565189|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
164324624|NCT02604017|593565190|FG000|Overall Study|Withdrew Consent|0|||
164324625|NCT02604017|593565191|FG001|Overall Study|Withdrew Consent|2|||
164324626|NCT02604017|593565190|FG000|Overall Study|Lost to Follow-up|5|||
164324627|NCT02604017|593565191|FG001|Overall Study|Lost to Follow-up|6|||
164324628|NCT02604017|593565190|FG000|Overall Study|Other|1|||
164324629|NCT02604017|593565191|FG001|Overall Study|Other|0|||
164324630|NCT01653782|593565197|FG000|Overall Study|Withdrawal by Subject|9|||
164324631|NCT01653782|593565198|FG001|Overall Study|Withdrawal by Subject|15|||
164324632|NCT01653782|593565199|FG002|Overall Study|Withdrawal by Subject|4|||
164324633|NCT01653782|593565197|FG000|Overall Study|Lost to Follow-up|7|||
164324634|NCT01653782|593565198|FG001|Overall Study|Lost to Follow-up|3|||
164324635|NCT01653782|593565199|FG002|Overall Study|Lost to Follow-up|2|||
164324636|NCT01315236|593565203|FG000|Double-blind Phase|Death|1|||
164324637|NCT01315236|593565204|FG001|Double-blind Phase|Death|0|||
164324638|NCT01315236|593565203|FG000|Double-blind Phase|Adverse Event|1|||
164324639|NCT01315236|593565204|FG001|Double-blind Phase|Adverse Event|0|||
164324640|NCT01315236|593565203|FG000|Double-blind Phase|Withdrawal of Consent|1|||
164324641|NCT01315236|593565204|FG001|Double-blind Phase|Withdrawal of Consent|0|||
164324642|NCT01315236|593565203|FG000|Double-blind Phase|Lost to Follow-up|1|||
164324643|NCT01315236|593565204|FG001|Double-blind Phase|Lost to Follow-up|0|||
164324644|NCT01315236|593565203|FG000|Open-label Phase|Death|1|||
164324645|NCT01315236|593565204|FG001|Open-label Phase|Death|0|||
164324646|NCT01315236|593565203|FG000|Open-label Phase|Adverse Event|0|||
164324647|NCT01315236|593565204|FG001|Open-label Phase|Adverse Event|1|||
164324648|NCT01315236|593565203|FG000|Open-label Phase|Other|0|||
164324649|NCT01315236|593565204|FG001|Open-label Phase|Other|1|||
164324650|NCT01315236|593565203|FG000|12-Month Follow-up Period|Death|0|||
164324651|NCT01315236|593565204|FG001|12-Month Follow-up Period|Death|1|||
164324652|NCT01315236|593565203|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
164324653|NCT01315236|593565204|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
164324654|NCT02497976|593565207|FG000|Overall Study|Withdrawal by Subject|2|||
164324655|NCT02497976|593565208|FG001|Overall Study|Withdrawal by Subject|0|||
164324656|NCT02497976|593565207|FG000|Overall Study|Moved out of area|0|||
164324657|NCT02497976|593565208|FG001|Overall Study|Moved out of area|1|||
164324658|NCT00058539|593565212|FG000|Overall Study|Disease progression|24|||
164324659|NCT00058539|593565212|FG000|Overall Study|Adverse Event|3|||
164324660|NCT00058539|593565212|FG000|Overall Study|Withdrawal by Subject|5|||
164324661|NCT00058539|593565212|FG000|Overall Study|Physician Decision|9|||
164324662|NCT00058539|593565212|FG000|Overall Study|Death|1|||
164324663|NCT01673282|593565216|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
164324664|NCT01673282|593565217|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
164324665|NCT01673282|593565216|FG000|Overall Study|Lack of Efficacy|9|||
164324666|NCT01673282|593565217|FG001|Overall Study|Lack of Efficacy|2|||
164324667|NCT01673282|593565216|FG000|Overall Study|Lost to Follow-up|11|||
164324668|NCT01673282|593565217|FG001|Overall Study|Lost to Follow-up|10|||
164324669|NCT01673282|593565216|FG000|Overall Study|Withdrawal by Subject|3|||
164324670|NCT01673282|593565217|FG001|Overall Study|Withdrawal by Subject|3|||
164324671|NCT01673282|593565216|FG000|Overall Study|Other|1|||
164324672|NCT01673282|593565217|FG001|Overall Study|Other|6|||
164324673|NCT02483533|593565218|FG000|Overall Study|Lack of Efficacy|50|||
164324674|NCT02483533|593565219|FG001|Overall Study|Lack of Efficacy|50|||
164324675|NCT01323920|593565220|FG000|Overall Study|Death|5|||
164324676|NCT01323920|593565220|FG000|Overall Study|Withdrawal by Subject|1|||
164324677|NCT00768469|593565221|FG000|Overall Study|Adverse Event|0|||
164324678|NCT00768469|593565222|FG001|Overall Study|Adverse Event|2|||
164324679|NCT00768469|593565221|FG000|Overall Study|Disease Progression|3|||
164324680|NCT00768469|593565222|FG001|Overall Study|Disease Progression|4|||
164324681|NCT00768469|593565221|FG000|Overall Study|Withdrawal by Subject|0|||
164324682|NCT00768469|593565222|FG001|Overall Study|Withdrawal by Subject|1|||
164324683|NCT05040971|593565223|FG000|Overall Study|Withdrawal by Subject|0|||
164324684|NCT05040971|593565224|FG001|Overall Study|Withdrawal by Subject|2|||
164324685|NCT05040971|593565223|FG000|Overall Study|Lost to Follow-up|8|||
164324686|NCT05040971|593565224|FG001|Overall Study|Lost to Follow-up|3|||
164324687|NCT05040971|593565223|FG000|Overall Study|Death|2|||
164324688|NCT05040971|593565224|FG001|Overall Study|Death|0|||
164324689|NCT01293799|593565228|FG000|Overall Study|Kidney transplantation|109|||
164324690|NCT01293799|593565229|FG001|Overall Study|Kidney transplantation|96|||
164324691|NCT01293799|593565228|FG000|Overall Study|Transfer to hemodialysis|70|||
164324692|NCT01293799|593565229|FG001|Overall Study|Transfer to hemodialysis|90|||
164324693|NCT01293799|593565228|FG000|Overall Study|Death|27|||
164324694|NCT01293799|593565229|FG001|Overall Study|Death|29|||
163980287|NCT01225731|592297359|FG005|Part 2|Physician Decision|0|||
163980288|NCT01225731|592297360|FG006|Part 2|Physician Decision|0|||
163980289|NCT01225731|592297361|FG007|Part 2|Physician Decision|2|||
163980290|NCT01225731|592297362|FG008|Part 2|Physician Decision|2|||
163980291|NCT01225731|592297363|FG009|Part 2|Physician Decision|0|||
163980292|NCT01225731|592297364|FG010|Part 2|Physician Decision|0|||
163980293|NCT01225731|592297365|FG011|Part 2|Physician Decision|0|||
163980294|NCT01225731|592297366|FG012|Part 2|Physician Decision|0|||
163980295|NCT01225731|592297354|FG000|Part 2|Withdrawal by Subject|0|||
163980296|NCT01225731|592297355|FG001|Part 2|Withdrawal by Subject|0|||
163980297|NCT01225731|592297356|FG002|Part 2|Withdrawal by Subject|0|||
163980298|NCT01225731|592297357|FG003|Part 2|Withdrawal by Subject|0|||
163980299|NCT01225731|592297358|FG004|Part 2|Withdrawal by Subject|0|||
163980300|NCT01225731|592297359|FG005|Part 2|Withdrawal by Subject|1|||
163980301|NCT01225731|592297360|FG006|Part 2|Withdrawal by Subject|3|||
163980302|NCT01225731|592297361|FG007|Part 2|Withdrawal by Subject|4|||
163980303|NCT01225731|592297362|FG008|Part 2|Withdrawal by Subject|1|||
163980304|NCT01225731|592297363|FG009|Part 2|Withdrawal by Subject|0|||
163980305|NCT01225731|592297364|FG010|Part 2|Withdrawal by Subject|0|||
163980306|NCT01225731|592297365|FG011|Part 2|Withdrawal by Subject|0|||
163980307|NCT01225731|592297366|FG012|Part 2|Withdrawal by Subject|0|||
163980308|NCT01225731|592297354|FG000|Part 3|Adverse Event|0|||
163980309|NCT01225731|592297355|FG001|Part 3|Adverse Event|0|||
164077312|NCT02094937|592647943|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
164077313|NCT02094937|592647940|FG000|8 Weeks in Period 1|Protocol Violation|2|||
164324695|NCT01293799|593565228|FG000|Overall Study|Transfer to assisted PD|24|||
164324696|NCT01293799|593565229|FG001|Overall Study|Transfer to assisted PD|18|||
164324697|NCT01293799|593565228|FG000|Overall Study|Withdrawal by Subject|26|||
164324698|NCT01293799|593565229|FG001|Overall Study|Withdrawal by Subject|0|||
163980310|NCT01225731|592297356|FG002|Part 3|Adverse Event|0|||
163980311|NCT01225731|592297357|FG003|Part 3|Adverse Event|0|||
163980312|NCT01225731|592297358|FG004|Part 3|Adverse Event|0|||
163980313|NCT01225731|592297359|FG005|Part 3|Adverse Event|0|||
163980314|NCT01225731|592297360|FG006|Part 3|Adverse Event|0|||
163980315|NCT01225731|592297361|FG007|Part 3|Adverse Event|0|||
164324699|NCT01293799|593565228|FG000|Overall Study|Investigator decision|5|||
164324700|NCT01293799|593565229|FG001|Overall Study|Investigator decision|2|||
164324701|NCT01293799|593565228|FG000|Overall Study|Kidney function improved|6|||
164324702|NCT01293799|593565229|FG001|Overall Study|Kidney function improved|7|||
164324703|NCT01293799|593565228|FG000|Overall Study|Other causes|6|||
164324704|NCT01293799|593565229|FG001|Overall Study|Other causes|3|||
164324705|NCT06066697|593565239|FG000|Overall Study|Lost to Follow-up|5|||
164324706|NCT06066697|593565240|FG001|Overall Study|Lost to Follow-up|0|||
164324707|NCT00938886|593565241|FG000|Overall Study|Death|0|||
164324708|NCT00938886|593565242|FG001|Overall Study|Death|1|||
164324709|NCT00938886|593565241|FG000|Overall Study|Withdrawal by Subject|4|||
164324710|NCT00938886|593565242|FG001|Overall Study|Withdrawal by Subject|7|||
164324711|NCT00938886|593565241|FG000|Overall Study|Lost to Follow-up|3|||
164324712|NCT00938886|593565242|FG001|Overall Study|Lost to Follow-up|2|||
164324713|NCT02283177|593565243|FG000|Overall Study|Withdrawal by Subject|1|||
164324714|NCT02283177|593565244|FG001|Overall Study|Withdrawal by Subject|1|||
164324715|NCT01101191|593565245|FG000|Period 1|Withdrawal by Subject|1|||
164324716|NCT01101191|593565246|FG001|Period 1|Withdrawal by Subject|0|||
164324717|NCT01101191|593565245|FG000|Period 1|Adverse Event|1|||
164324718|NCT01101191|593565246|FG001|Period 1|Adverse Event|2|||
164324719|NCT03044574|593565247|FG000|Overall Study|Lost to Follow-up|37|||
164324720|NCT03044574|593565248|FG001|Overall Study|Lost to Follow-up|45|||
164324721|NCT01146860|593565249|FG000|Overall Study|Withdrawal by Subject|0|||
164324722|NCT01146860|593565250|FG001|Overall Study|Withdrawal by Subject|1|||
164324723|NCT04779216|593565251|FG000|Overall Study|Lost to Follow-up|1|||
164324724|NCT04779216|593565252|FG001|Overall Study|Lost to Follow-up|0|||
164324725|NCT04779216|593565251|FG000|Overall Study|Withdrawal by Subject|1|||
164324726|NCT04779216|593565252|FG001|Overall Study|Withdrawal by Subject|0|||
164324727|NCT02674854|593565258|FG000|Overall Study|Adverse Event|17|||
164324728|NCT02674854|593565259|FG001|Overall Study|Adverse Event|15|||
164324729|NCT02674854|593565260|FG002|Overall Study|Adverse Event|5|||
164324730|NCT02674854|593565258|FG000|Overall Study|Withdrawal by Subject|1|||
164324731|NCT02674854|593565259|FG001|Overall Study|Withdrawal by Subject|5|||
164324732|NCT02674854|593565260|FG002|Overall Study|Withdrawal by Subject|4|||
164324733|NCT02674854|593565258|FG000|Overall Study|No-compliant subject|1|||
164324734|NCT02674854|593565259|FG001|Overall Study|No-compliant subject|0|||
164324735|NCT02674854|593565260|FG002|Overall Study|No-compliant subject|1|||
164324736|NCT02674854|593565258|FG000|Overall Study|Lost to Follow-up|1|||
164324737|NCT02674854|593565259|FG001|Overall Study|Lost to Follow-up|0|||
164324738|NCT02674854|593565260|FG002|Overall Study|Lost to Follow-up|2|||
164324739|NCT02674854|593565258|FG000|Overall Study|Lack of Efficacy|0|||
164324740|NCT02674854|593565259|FG001|Overall Study|Lack of Efficacy|3|||
164324741|NCT02674854|593565260|FG002|Overall Study|Lack of Efficacy|0|||
164324742|NCT02674854|593565258|FG000|Overall Study|Disallowed Concurrent Medication|2|||
164324743|NCT02674854|593565259|FG001|Overall Study|Disallowed Concurrent Medication|2|||
164324744|NCT02674854|593565260|FG002|Overall Study|Disallowed Concurrent Medication|0|||
164324745|NCT02674854|593565258|FG000|Overall Study|Protocol Violation|1|||
164324746|NCT02674854|593565259|FG001|Overall Study|Protocol Violation|1|||
164324747|NCT02674854|593565260|FG002|Overall Study|Protocol Violation|2|||
164324748|NCT02674854|593565258|FG000|Overall Study|Death|0|||
164324749|NCT02674854|593565259|FG001|Overall Study|Death|1|||
164324750|NCT02674854|593565260|FG002|Overall Study|Death|0|||
164324751|NCT02674854|593565258|FG000|Overall Study|Subject missed V6.2|1|||
164324752|NCT02674854|593565259|FG001|Overall Study|Subject missed V6.2|0|||
164324753|NCT02674854|593565260|FG002|Overall Study|Subject missed V6.2|0|||
164324754|NCT02635646|593565261|FG000|Overall Study|Lost to Follow-up|24|||
164324755|NCT02635646|593565262|FG001|Overall Study|Lost to Follow-up|25|||
164324756|NCT02635646|593565261|FG000|Overall Study|Pregnancy|1|||
164324757|NCT02635646|593565262|FG001|Overall Study|Pregnancy|1|||
164324758|NCT00879879|593565269|FG000|Overall Study|Death|1|||
164324759|NCT00879879|593565269|FG000|Overall Study|Withdrawal by Subject|1|||
164324760|NCT00879879|593565269|FG000|Overall Study|Physician Decision|1|||
164324761|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
164324762|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
164324763|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
164324764|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
164324765|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
164324766|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
163876101|NCT03948763|591914743|FG002|Overall Study|Death|13|||
164324767|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324768|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
164324769|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324770|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324771|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324772|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
164324773|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
164324774|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
164324775|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
164324776|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
164324777|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
164324778|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
164324779|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324780|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
164324781|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324782|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324783|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324784|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
164324785|NCT00745615|593565272|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324786|NCT00745615|593565273|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
164324787|NCT00745615|593565274|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324788|NCT00745615|593565275|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164077314|NCT02094937|592647941|FG001|8 Weeks in Period 1|Protocol Violation|0|||
164077315|NCT02094937|592647942|FG002|8 Weeks in Period 1|Protocol Violation|0|||
164077316|NCT02094937|592647943|FG003|8 Weeks in Period 1|Protocol Violation|0|||
164077317|NCT02094937|592647940|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
164077318|NCT02094937|592647941|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
164077319|NCT02094937|592647942|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
164077320|NCT02094937|592647943|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
164077321|NCT02094937|592647940|FG000|8 Weeks in Period 1|Physician Decision|1|||
164077322|NCT02094937|592647941|FG001|8 Weeks in Period 1|Physician Decision|0|||
164077323|NCT02094937|592647942|FG002|8 Weeks in Period 1|Physician Decision|0|||
164077324|NCT02094937|592647943|FG003|8 Weeks in Period 1|Physician Decision|0|||
164077325|NCT02094937|592647940|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
164077326|NCT02094937|592647941|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
164077327|NCT02094937|592647942|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
164324789|NCT00745615|593565276|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324790|NCT00745615|593565277|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
164324791|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324792|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324793|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324794|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
164324795|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
164324796|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
164324797|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324798|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324799|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324800|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
164324801|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
164077328|NCT02094937|592647943|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
164077329|NCT02094937|592647940|FG000|12 Weeks in Period 2|Adverse Event|0|||
164077330|NCT02094937|592647941|FG001|12 Weeks in Period 2|Adverse Event|2|||
164077331|NCT02094937|592647942|FG002|12 Weeks in Period 2|Adverse Event|4|||
164077332|NCT02094937|592647943|FG003|12 Weeks in Period 2|Adverse Event|1|||
164077333|NCT02094937|592647940|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
164077334|NCT02094937|592647941|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
164077335|NCT02094937|592647942|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
164077336|NCT02094937|592647943|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
164077337|NCT02094937|592647940|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
164077338|NCT02094937|592647941|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
164077339|NCT02094937|592647942|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
164077340|NCT02094937|592647943|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
164077341|NCT02094937|592647940|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
164077342|NCT02094937|592647941|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
164324802|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
164324803|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324804|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324805|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324806|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
164324807|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
164324808|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
164324809|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324810|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324811|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324812|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
164324813|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
164077343|NCT02094937|592647942|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
164077344|NCT02094937|592647943|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
164077345|NCT02094937|592647940|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
164077346|NCT02094937|592647941|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
164077347|NCT02094937|592647942|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
164077348|NCT02094937|592647943|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
164077349|NCT05458895|592647944|FG000|Overall Study|Withdrawal by Subject|8|||
164077350|NCT05458895|592647944|FG000|Overall Study|Lost to Follow-up|17|||
164077351|NCT05458895|592647944|FG000|Overall Study|Pregnancy|2|||
164077352|NCT05458895|592647944|FG000|Overall Study|Withdrawal by Study Team|1|||
164077353|NCT04639310|592647945|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
164077354|NCT04639310|592647946|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
164077355|NCT05166421|592647947|FG000|Overall Study|Other|3|||
164077356|NCT05166421|592647948|FG001|Overall Study|Other|1|||
164077357|NCT05166421|592647949|FG002|Overall Study|Other|1|||
164077358|NCT05166421|592647947|FG000|Overall Study|Withdrawal by Subject|5|||
164077359|NCT05166421|592647948|FG001|Overall Study|Withdrawal by Subject|3|||
164077360|NCT05166421|592647949|FG002|Overall Study|Withdrawal by Subject|6|||
164077361|NCT05166421|592647947|FG000|Overall Study|Lost to Follow-up|4|||
164077362|NCT05166421|592647948|FG001|Overall Study|Lost to Follow-up|1|||
164077363|NCT05166421|592647949|FG002|Overall Study|Lost to Follow-up|7|||
164077364|NCT03770000|592649913|FG000|Overall Study|Premature discontinuation due to PD|0|||
164077365|NCT03770000|592649914|FG001|Overall Study|Premature discontinuation due to PD|0|||
164077366|NCT03770000|592649915|FG002|Overall Study|Premature discontinuation due to PD|1|||
164077367|NCT03770000|592649916|FG003|Overall Study|Premature discontinuation due to PD|3|||
164077368|NCT03770000|592649917|FG004|Overall Study|Premature discontinuation due to PD|2|||
164077369|NCT02290028|592649919|FG000|Overall Study|Death|217|||
164077370|NCT02290028|592649919|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
164211025|NCT03112603|593140311|FG000|End of Randomization Period|Lack of Efficacy|25|||
164211026|NCT03112603|593140312|FG001|End of Randomization Period|Lack of Efficacy|77|||
164211027|NCT03112603|593140313|FG002|End of Randomization Period|Lack of Efficacy|0|||
164211028|NCT03112603|593140311|FG000|End of Randomization Period|Adverse Event|32|||
164211029|NCT03112603|593140312|FG001|End of Randomization Period|Adverse Event|12|||
164211030|NCT03112603|593140313|FG002|End of Randomization Period|Adverse Event|0|||
164211031|NCT03112603|593140311|FG000|End of Cross Over Period|Death|0|||
164211032|NCT03112603|593140312|FG001|End of Cross Over Period|Death|0|||
164211033|NCT03112603|593140313|FG002|End of Cross Over Period|Death|2|||
164211034|NCT03112603|593140311|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
164211035|NCT03112603|593140312|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
164211036|NCT03112603|593140313|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
164211037|NCT03112603|593140311|FG000|End of Cross Over Period|Physician Decision|0|||
164211038|NCT03112603|593140312|FG001|End of Cross Over Period|Physician Decision|0|||
164211039|NCT03112603|593140313|FG002|End of Cross Over Period|Physician Decision|29|||
164211040|NCT03112603|593140311|FG000|End of Cross Over Period|Lack of Efficacy|0|||
164211041|NCT03112603|593140312|FG001|End of Cross Over Period|Lack of Efficacy|0|||
164211042|NCT03112603|593140313|FG002|End of Cross Over Period|Lack of Efficacy|8|||
164211043|NCT03112603|593140311|FG000|End of Cross Over Period|Adverse Event|0|||
164211044|NCT03112603|593140312|FG001|End of Cross Over Period|Adverse Event|0|||
164211045|NCT03112603|593140313|FG002|End of Cross Over Period|Adverse Event|6|||
164211046|NCT03112603|593140311|FG000|End of Cross Over Period|Disease Relapse|0|||
164211047|NCT03112603|593140312|FG001|End of Cross Over Period|Disease Relapse|0|||
164211048|NCT03112603|593140313|FG002|End of Cross Over Period|Disease Relapse|2|||
164211049|NCT04092777|593140314|FG000|Overall Study|Lost to Follow-up|28|||
164211050|NCT04092777|593140315|FG001|Overall Study|Lost to Follow-up|46|||
164211051|NCT04092777|593140314|FG000|Overall Study|Withdrawal by Subject|8|||
164211052|NCT04092777|593140315|FG001|Overall Study|Withdrawal by Subject|5|||
164211053|NCT02278354|593140316|FG000|Overall Study|Lost to Follow-up|2|||
164211054|NCT02278354|593140317|FG001|Overall Study|Lost to Follow-up|2|||
164211055|NCT02278354|593140316|FG000|Overall Study|Withdrawal by Subject|0|||
164211056|NCT02278354|593140317|FG001|Overall Study|Withdrawal by Subject|1|||
164211057|NCT02278354|593140316|FG000|Overall Study|<10 professional fights|2|||
164211058|NCT02278354|593140317|FG001|Overall Study|<10 professional fights|0|||
164211059|NCT01925794|593140321|FG000|180 Days|Death|2|||
164211060|NCT01925794|593140321|FG000|180 Days|Withdrawal by Subject|2|||
164211061|NCT01925794|593140321|FG000|270 Days|Death|2|||
164211062|NCT01925794|593140321|FG000|270 Days|Protocol Violation|3|||
164211063|NCT03126110|593140322|FG000|Phase 1|Death|2|||
164211064|NCT03126110|593140323|FG001|Phase 1|Death|2|||
164211065|NCT03126110|593140324|FG002|Phase 1|Death|4|||
164211066|NCT03126110|593140325|FG003|Phase 1|Death|3|||
164211067|NCT03126110|593140326|FG004|Phase 1|Death|4|||
164211068|NCT03126110|593140327|FG005|Phase 1|Death|4|||
164324814|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
164077371|NCT02290028|592649919|FG000|Overall Study|No longer under care of study physician|76|||
164077372|NCT02290028|592649919|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
164077373|NCT02290028|592649919|FG000|Overall Study|Withdrawal by Subject|52|||
164077374|NCT02290028|592649919|FG000|Overall Study|Study site closure|44|||
164211069|NCT03126110|593140328|FG006|Phase 1|Death|3|||
164211070|NCT03126110|593140329|FG007|Phase 1|Death|4|||
164211071|NCT03126110|593140330|FG008|Phase 1|Death|5|||
164324815|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164324816|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164324817|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
163980316|NCT01225731|592297362|FG008|Part 3|Adverse Event|0|||
163980317|NCT01225731|592297363|FG009|Part 3|Adverse Event|0|||
163980318|NCT01225731|592297364|FG010|Part 3|Adverse Event|1|||
163980319|NCT01225731|592297365|FG011|Part 3|Adverse Event|1|||
163980320|NCT01225731|592297366|FG012|Part 3|Adverse Event|0|||
163980321|NCT01225731|592297354|FG000|Part 3|Lost to Follow-up|0|||
163980322|NCT01225731|592297355|FG001|Part 3|Lost to Follow-up|0|||
163980323|NCT01225731|592297356|FG002|Part 3|Lost to Follow-up|0|||
163980324|NCT01225731|592297357|FG003|Part 3|Lost to Follow-up|0|||
163980325|NCT01225731|592297358|FG004|Part 3|Lost to Follow-up|0|||
163980326|NCT01225731|592297359|FG005|Part 3|Lost to Follow-up|0|||
163980327|NCT01225731|592297360|FG006|Part 3|Lost to Follow-up|0|||
163980328|NCT01225731|592297361|FG007|Part 3|Lost to Follow-up|0|||
163980329|NCT01225731|592297362|FG008|Part 3|Lost to Follow-up|0|||
163980330|NCT01225731|592297363|FG009|Part 3|Lost to Follow-up|0|||
163980331|NCT01225731|592297364|FG010|Part 3|Lost to Follow-up|1|||
163980332|NCT01225731|592297365|FG011|Part 3|Lost to Follow-up|2|||
163980333|NCT01225731|592297366|FG012|Part 3|Lost to Follow-up|1|||
163980334|NCT01225731|592297354|FG000|Part 3|Physician Decision|0|||
163980335|NCT01225731|592297355|FG001|Part 3|Physician Decision|0|||
163980336|NCT01225731|592297356|FG002|Part 3|Physician Decision|0|||
163980337|NCT01225731|592297357|FG003|Part 3|Physician Decision|0|||
163980338|NCT01225731|592297358|FG004|Part 3|Physician Decision|0|||
163980339|NCT01225731|592297359|FG005|Part 3|Physician Decision|0|||
163980340|NCT01225731|592297360|FG006|Part 3|Physician Decision|0|||
163980341|NCT01225731|592297361|FG007|Part 3|Physician Decision|0|||
163980342|NCT01225731|592297362|FG008|Part 3|Physician Decision|0|||
163980343|NCT01225731|592297363|FG009|Part 3|Physician Decision|0|||
163980344|NCT01225731|592297364|FG010|Part 3|Physician Decision|0|||
163980345|NCT01225731|592297365|FG011|Part 3|Physician Decision|1|||
163980346|NCT01225731|592297366|FG012|Part 3|Physician Decision|2|||
163980347|NCT01225731|592297354|FG000|Part 3|Withdrawal by Subject|0|||
163980348|NCT01225731|592297355|FG001|Part 3|Withdrawal by Subject|0|||
163980349|NCT01225731|592297356|FG002|Part 3|Withdrawal by Subject|0|||
163980350|NCT01225731|592297357|FG003|Part 3|Withdrawal by Subject|0|||
163980351|NCT01225731|592297358|FG004|Part 3|Withdrawal by Subject|0|||
163980352|NCT01225731|592297359|FG005|Part 3|Withdrawal by Subject|0|||
163980353|NCT01225731|592297360|FG006|Part 3|Withdrawal by Subject|0|||
163980354|NCT01225731|592297361|FG007|Part 3|Withdrawal by Subject|0|||
163980355|NCT01225731|592297362|FG008|Part 3|Withdrawal by Subject|0|||
163980356|NCT01225731|592297363|FG009|Part 3|Withdrawal by Subject|0|||
163980357|NCT01225731|592297364|FG010|Part 3|Withdrawal by Subject|4|||
163980358|NCT01225731|592297365|FG011|Part 3|Withdrawal by Subject|6|||
163980359|NCT01225731|592297366|FG012|Part 3|Withdrawal by Subject|4|||
163980360|NCT00577642|592297367|FG000|Overall Study|Clinical Disease Progression|1|||
163980361|NCT02054897|592297368|FG000|Overall Study|Withdrawal by Subject|2|||
163980362|NCT02054897|592297369|FG001|Overall Study|Withdrawal by Subject|0|||
163980363|NCT02054897|592297370|FG002|Overall Study|Withdrawal by Subject|2|||
163980364|NCT02054897|592297368|FG000|Overall Study|Missing follow-up information|3|||
163980365|NCT02054897|592297369|FG001|Overall Study|Missing follow-up information|5|||
163980366|NCT02054897|592297370|FG002|Overall Study|Missing follow-up information|3|||
163980367|NCT02054897|592297368|FG000|Overall Study|Lost to Follow-up|4|||
163980368|NCT02054897|592297369|FG001|Overall Study|Lost to Follow-up|2|||
163980369|NCT02054897|592297370|FG002|Overall Study|Lost to Follow-up|7|||
163980370|NCT02054897|592297368|FG000|Overall Study|Randomized but not exposed|1|||
163980371|NCT02054897|592297369|FG001|Overall Study|Randomized but not exposed|0|||
163980372|NCT02054897|592297370|FG002|Overall Study|Randomized but not exposed|0|||
163980373|NCT00542269|592297371|FG000|Overall Study|Adverse Event|10|||
163980374|NCT00542269|592297372|FG001|Overall Study|Adverse Event|4|||
163980375|NCT00542269|592297373|FG002|Overall Study|Adverse Event|5|||
163980376|NCT00542269|592297371|FG000|Overall Study|Protocol Violation|1|||
163980377|NCT00542269|592297372|FG001|Overall Study|Protocol Violation|1|||
163980378|NCT00542269|592297373|FG002|Overall Study|Protocol Violation|0|||
163980379|NCT00542269|592297371|FG000|Overall Study|Withdrawal by Subject|1|||
163980380|NCT00542269|592297372|FG001|Overall Study|Withdrawal by Subject|0|||
163980381|NCT00542269|592297373|FG002|Overall Study|Withdrawal by Subject|0|||
163980382|NCT00542269|592297371|FG000|Overall Study|Administrative problems|1|||
163980383|NCT00542269|592297372|FG001|Overall Study|Administrative problems|1|||
163980384|NCT00542269|592297373|FG002|Overall Study|Administrative problems|1|||
163980385|NCT02069899|592297374|FG000|Overall Study|Adverse Event|6|||
163980386|NCT02069899|592297375|FG001|Overall Study|Adverse Event|0|||
163980387|NCT02069899|592297376|FG002|Overall Study|Adverse Event|1|||
163980388|NCT02069899|592297374|FG000|Overall Study|Withdrawal by Participant|2|||
163980389|NCT02069899|592297375|FG001|Overall Study|Withdrawal by Participant|0|||
163980390|NCT02069899|592297376|FG002|Overall Study|Withdrawal by Participant|0|||
163980391|NCT02069899|592297374|FG000|Overall Study|Lost to Follow-up|1|||
163980392|NCT02069899|592297375|FG001|Overall Study|Lost to Follow-up|0|||
163980393|NCT02069899|592297376|FG002|Overall Study|Lost to Follow-up|1|||
163980394|NCT02069899|592297374|FG000|Overall Study|Other|4|||
163980395|NCT02069899|592297375|FG001|Overall Study|Other|0|||
163980396|NCT02069899|592297376|FG002|Overall Study|Other|0|||
163980397|NCT02069899|592297374|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
163980398|NCT02069899|592297375|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
163980399|NCT02069899|592297376|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
163980400|NCT02069899|592297374|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
163980401|NCT02069899|592297375|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
163980402|NCT02069899|592297376|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
163980403|NCT00490451|592297377|FG000|Overall Study|Adverse Event|3|||
163980404|NCT00490451|592297378|FG001|Overall Study|Adverse Event|3|||
163980405|NCT00490451|592297377|FG000|Overall Study|Death|3|||
163980406|NCT00490451|592297378|FG001|Overall Study|Death|1|||
163980407|NCT00490451|592297377|FG000|Overall Study|Withdrawal by Subject|2|||
163980408|NCT00490451|592297378|FG001|Overall Study|Withdrawal by Subject|0|||
163980409|NCT00490451|592297377|FG000|Overall Study|Investigator Decision|1|||
163980410|NCT00490451|592297378|FG001|Overall Study|Investigator Decision|0|||
163980411|NCT00490451|592297377|FG000|Overall Study|Protocol Violation|1|||
164077375|NCT02290028|592649919|FG000|Overall Study|Lost to Follow-up|34|||
164077376|NCT02290028|592649919|FG000|Overall Study|Miscellaneous|10|||
164077377|NCT02290028|592649919|FG000|Overall Study|Transition to EP PASSION|1295|||
164077378|NCT02290028|592649919|FG000|Overall Study|Planned study completion at 12 months|257|||
164077379|NCT00833547|592649920|FG000|Overall Study|Withdrawal by Subject|2|||
164077380|NCT00833547|592649921|FG001|Overall Study|Withdrawal by Subject|2|||
164077381|NCT00566098|592649923|FG000|Collection of MILs|Withdrawal by Subject|1|||
164077382|NCT00566098|592649923|FG000|Collection of MILs|Relapsed|1|||
164077383|NCT00566098|592649923|FG000|Generation of MILs Product|Relapsed|1|||
164077384|NCT00566098|592649923|FG000|Administration of ASCT+MILs|Death|10|||
164077385|NCT00566098|592649923|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
164077386|NCT02236754|592649924|FG000|Overall Study|Withdrawal by Subject|1|||
164077387|NCT02236754|592649925|FG001|Overall Study|Withdrawal by Subject|0|||
164077388|NCT01326702|592649926|FG000|Overall Study|Other|1|||
164077389|NCT01326702|592649927|FG001|Overall Study|Other|0|||
164077390|NCT01326702|592649928|FG002|Overall Study|Other|0|||
164077391|NCT01326702|592649929|FG003|Overall Study|Other|0|||
164077392|NCT01326702|592649930|FG004|Overall Study|Other|0|||
164077393|NCT01326702|592649931|FG005|Overall Study|Other|1|||
164077394|NCT01326702|592649932|FG006|Overall Study|Other|0|||
164077395|NCT01326702|592649926|FG000|Overall Study|progressive disease|1|||
164077396|NCT01326702|592649927|FG001|Overall Study|progressive disease|1|||
164077397|NCT01326702|592649928|FG002|Overall Study|progressive disease|3|||
164077398|NCT01326702|592649929|FG003|Overall Study|progressive disease|1|||
164077399|NCT01326702|592649930|FG004|Overall Study|progressive disease|3|||
164077400|NCT01326702|592649931|FG005|Overall Study|progressive disease|2|||
164077401|NCT01326702|592649932|FG006|Overall Study|progressive disease|3|||
164077402|NCT01326702|592649926|FG000|Overall Study|Death|0|||
164077403|NCT01326702|592649927|FG001|Overall Study|Death|1|||
164077404|NCT01326702|592649928|FG002|Overall Study|Death|0|||
164077405|NCT01326702|592649929|FG003|Overall Study|Death|0|||
164077406|NCT01326702|592649930|FG004|Overall Study|Death|0|||
164077407|NCT01326702|592649931|FG005|Overall Study|Death|0|||
164077408|NCT01326702|592649932|FG006|Overall Study|Death|0|||
164077409|NCT01326702|592649926|FG000|Overall Study|Adverse Event|0|||
164077410|NCT01326702|592649927|FG001|Overall Study|Adverse Event|0|||
164077411|NCT01326702|592649928|FG002|Overall Study|Adverse Event|1|||
164077412|NCT01326702|592649929|FG003|Overall Study|Adverse Event|1|||
164077413|NCT01326702|592649930|FG004|Overall Study|Adverse Event|0|||
164077414|NCT01326702|592649931|FG005|Overall Study|Adverse Event|3|||
164077415|NCT01326702|592649932|FG006|Overall Study|Adverse Event|1|||
164077416|NCT01326702|592649926|FG000|Overall Study|Withdrawal by Subject|0|||
164077417|NCT01326702|592649927|FG001|Overall Study|Withdrawal by Subject|0|||
164077418|NCT01326702|592649928|FG002|Overall Study|Withdrawal by Subject|1|||
163980412|NCT00490451|592297378|FG001|Overall Study|Protocol Violation|0|||
163980413|NCT00490451|592297377|FG000|Overall Study|Progressive Disease|53|||
163980414|NCT00490451|592297378|FG001|Overall Study|Progressive Disease|34|||
163980415|NCT01119248|592297381|FG000|Overall Study|Physician Decision|5|||
164077419|NCT01326702|592649929|FG003|Overall Study|Withdrawal by Subject|0|||
164077420|NCT01326702|592649930|FG004|Overall Study|Withdrawal by Subject|1|||
164077421|NCT01326702|592649931|FG005|Overall Study|Withdrawal by Subject|1|||
164077422|NCT01326702|592649932|FG006|Overall Study|Withdrawal by Subject|3|||
164077423|NCT01326702|592649926|FG000|Overall Study|Not Treated|0|||
164077424|NCT01326702|592649927|FG001|Overall Study|Not Treated|0|||
164077425|NCT01326702|592649928|FG002|Overall Study|Not Treated|0|||
164077426|NCT01326702|592649929|FG003|Overall Study|Not Treated|1|||
164077427|NCT01326702|592649930|FG004|Overall Study|Not Treated|0|||
164077428|NCT01326702|592649931|FG005|Overall Study|Not Treated|1|||
164077429|NCT01326702|592649932|FG006|Overall Study|Not Treated|0|||
164077430|NCT00830063|592649933|FG000|Overall Study|Adverse Event|7|||
164324818|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
164324819|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
164324820|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
164324821|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324822|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324823|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324824|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
164324825|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
164324826|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
164324827|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324828|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324829|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324830|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324831|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
164324832|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
164324833|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324834|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324835|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324836|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324837|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
164324838|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
164324839|NCT00745615|593565272|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324840|NCT00745615|593565273|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324841|NCT00745615|593565274|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324842|NCT00745615|593565275|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
164324843|NCT00745615|593565276|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
164324844|NCT00745615|593565277|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
164324845|NCT00570232|593565278|FG000|Overall Study|Adverse Event|10|||
164324846|NCT00570232|593565278|FG000|Overall Study|discontinued due to medical condition|3|||
164324847|NCT00570232|593565278|FG000|Overall Study|discontinued due to recurrence|8|||
164324848|NCT00570232|593565278|FG000|Overall Study|discontinued due to noncompliance|2|||
164324849|NCT01076075|593565279|FG000|Overall Study|Adverse Event|3|||
164324850|NCT01076075|593565280|FG001|Overall Study|Adverse Event|9|||
164324851|NCT01076075|593565279|FG000|Overall Study|Lack of Efficacy|5|||
164324852|NCT01076075|593565280|FG001|Overall Study|Lack of Efficacy|4|||
164324853|NCT01076075|593565279|FG000|Overall Study|Lost to Follow-up|6|||
164324854|NCT01076075|593565280|FG001|Overall Study|Lost to Follow-up|5|||
164324855|NCT01076075|593565279|FG000|Overall Study|other|19|||
164324856|NCT01076075|593565280|FG001|Overall Study|other|9|||
164324857|NCT01076075|593565279|FG000|Overall Study|Protocol Violation|0|||
164324858|NCT01076075|593565280|FG001|Overall Study|Protocol Violation|1|||
164324859|NCT01076075|593565279|FG000|Overall Study|Withdrawal by Subject|8|||
164324860|NCT01076075|593565280|FG001|Overall Study|Withdrawal by Subject|19|||
164324861|NCT02751931|593565281|FG000|Overall Study|Adverse Event|3|||
164324862|NCT02751931|593565282|FG001|Overall Study|Adverse Event|0|||
164324863|NCT02751931|593565281|FG000|Overall Study|Other: Miscelleneous|10|||
164324864|NCT02751931|593565282|FG001|Overall Study|Other: Miscelleneous|8|||
164324865|NCT04090411|593565283|FG000|Induction Period|Adverse Event|3|||
164324866|NCT04090411|593565284|FG001|Induction Period|Adverse Event|1|||
164324867|NCT04090411|593565285|FG002|Induction Period|Adverse Event|1|||
164324868|NCT04090411|593565286|FG003|Induction Period|Adverse Event|1|||
164324869|NCT04090411|593565287|FG004|Induction Period|Adverse Event|0|||
164324870|NCT04090411|593565288|FG005|Induction Period|Adverse Event|0|||
164324871|NCT04090411|593565289|FG006|Induction Period|Adverse Event|0|||
164324872|NCT04090411|593565290|FG007|Induction Period|Adverse Event|0|||
164324873|NCT04090411|593565291|FG008|Induction Period|Adverse Event|0|||
164324874|NCT04090411|593565292|FG009|Induction Period|Adverse Event|0|||
164324875|NCT04090411|593565293|FG010|Induction Period|Adverse Event|0|||
164324876|NCT04090411|593565294|FG011|Induction Period|Adverse Event|0|||
164324877|NCT04090411|593565295|FG012|Induction Period|Adverse Event|0|||
163876102|NCT03948763|591914744|FG003|Overall Study|Death|10|||
163876103|NCT03948763|591914745|FG004|Overall Study|Death|11|||
163876104|NCT03948763|591914741|FG000|Overall Study|Withdrawal by Subject|1|||
163876105|NCT03948763|591914742|FG001|Overall Study|Withdrawal by Subject|1|||
164324878|NCT04090411|593565283|FG000|Induction Period|Lack of Efficacy|0|||
164324879|NCT04090411|593565284|FG001|Induction Period|Lack of Efficacy|0|||
164324880|NCT04090411|593565285|FG002|Induction Period|Lack of Efficacy|1|||
164324881|NCT04090411|593565286|FG003|Induction Period|Lack of Efficacy|1|||
164324882|NCT04090411|593565287|FG004|Induction Period|Lack of Efficacy|0|||
164324883|NCT04090411|593565288|FG005|Induction Period|Lack of Efficacy|0|||
164324884|NCT04090411|593565289|FG006|Induction Period|Lack of Efficacy|0|||
164324885|NCT04090411|593565290|FG007|Induction Period|Lack of Efficacy|0|||
164324886|NCT04090411|593565291|FG008|Induction Period|Lack of Efficacy|0|||
164324887|NCT04090411|593565292|FG009|Induction Period|Lack of Efficacy|0|||
163876106|NCT03948763|591914743|FG002|Overall Study|Withdrawal by Subject|0|||
163980416|NCT01967550|592297382|FG000|Overall Study|Withdrawal by Subject|1|||
163980417|NCT01967550|592297383|FG001|Overall Study|Withdrawal by Subject|0|||
163980418|NCT01967550|592297382|FG000|Overall Study|Adverse Event|2|||
163980419|NCT01967550|592297383|FG001|Overall Study|Adverse Event|0|||
163980420|NCT01967550|592297382|FG000|Overall Study|Protocol Violation|2|||
163980421|NCT01967550|592297383|FG001|Overall Study|Protocol Violation|1|||
163980422|NCT01967550|592297382|FG000|Overall Study|Non Compliance|0|||
163980423|NCT01967550|592297383|FG001|Overall Study|Non Compliance|1|||
163980424|NCT01273883|592297386|FG000|First Intervention|Adverse Event|2|||
163980425|NCT01273883|592297387|FG001|First Intervention|Adverse Event|1|||
163980426|NCT01273883|592297386|FG000|Second Intervention|Lost to Follow-up|1|||
163980427|NCT01273883|592297387|FG001|Second Intervention|Lost to Follow-up|1|||
163980428|NCT01273883|592297386|FG000|Second Intervention|Lack of Efficacy|1|||
163980429|NCT01273883|592297387|FG001|Second Intervention|Lack of Efficacy|0|||
163980430|NCT01553136|592297388|FG000|Overall Study|Adverse Event|3|||
163980431|NCT01553136|592297389|FG001|Overall Study|Adverse Event|2|||
163980432|NCT01553136|592297388|FG000|Overall Study|Withdrawal by Subject|2|||
163980433|NCT01553136|592297389|FG001|Overall Study|Withdrawal by Subject|3|||
163980434|NCT01553136|592297388|FG000|Overall Study|Lost to Follow-up|4|||
163980435|NCT01553136|592297389|FG001|Overall Study|Lost to Follow-up|10|||
163980436|NCT01553136|592297388|FG000|Overall Study|Physician Decision|2|||
163980437|NCT01553136|592297389|FG001|Overall Study|Physician Decision|3|||
163980438|NCT01553136|592297388|FG000|Overall Study|Scheduling Difficulties|5|||
163980439|NCT01553136|592297389|FG001|Overall Study|Scheduling Difficulties|4|||
163980440|NCT00333359|592297394|FG000|Overall Study|Adverse Event|29|||
163980441|NCT00333359|592297395|FG001|Overall Study|Adverse Event|35|||
163980442|NCT00333359|592297394|FG000|Overall Study|Withdrawal by Subject|19|||
163980443|NCT00333359|592297395|FG001|Overall Study|Withdrawal by Subject|37|||
163980444|NCT00333359|592297394|FG000|Overall Study|Physician Decision|2|||
163980445|NCT00333359|592297395|FG001|Overall Study|Physician Decision|2|||
163980446|NCT00333359|592297394|FG000|Overall Study|Protocol Non-compliance|2|||
163980447|NCT00333359|592297395|FG001|Overall Study|Protocol Non-compliance|8|||
163980448|NCT00333359|592297394|FG000|Overall Study|Lost to Follow-up|15|||
163980449|NCT00333359|592297395|FG001|Overall Study|Lost to Follow-up|25|||
163980450|NCT00333359|592297394|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
163980451|NCT00333359|592297395|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
163980452|NCT00333359|592297394|FG000|Overall Study|Treatment Failure|3|||
163980453|NCT00333359|592297395|FG001|Overall Study|Treatment Failure|8|||
163980454|NCT00333359|592297394|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
163980455|NCT00333359|592297395|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
163980456|NCT01452152|592297398|FG000|Overall Study|Study termination by sponsor|5|||
163980457|NCT01452152|592297399|FG001|Overall Study|Study termination by sponsor|0|||
163980458|NCT01452152|592297400|FG002|Overall Study|Study termination by sponsor|4|||
163980459|NCT04099251|592299544|FG000|Pre-Treatment|Other reasons|1|||
163980460|NCT04099251|592299545|FG001|Pre-Treatment|Other reasons|0|||
163980461|NCT04099251|592299544|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
163980462|NCT04099251|592299545|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
163980463|NCT04099251|592299544|FG000|Blinded Treatment Phase|Other reasons|16|||
163980464|NCT04099251|592299545|FG001|Blinded Treatment Phase|Other reasons|7|||
163980465|NCT04099251|592299544|FG000|Blinded Treatment Phase|Disease recurrence|26|||
163980466|NCT04099251|592299545|FG001|Blinded Treatment Phase|Disease recurrence|41|||
163980467|NCT04099251|592299544|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
163980468|NCT04099251|592299545|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
163980469|NCT04099251|592299544|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
163980470|NCT04099251|592299545|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
163980471|NCT04099251|592299544|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
163980472|NCT04099251|592299545|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
163980473|NCT04099251|592299544|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
163980474|NCT04099251|592299545|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
163980475|NCT04099251|592299544|FG000|Blinded Treatment Phase|Death|6|||
164077431|NCT00830063|592649934|FG001|Overall Study|Adverse Event|13|||
164077432|NCT00830063|592649935|FG002|Overall Study|Adverse Event|16|||
164077433|NCT00830063|592649936|FG003|Overall Study|Adverse Event|13|||
164211072|NCT03126110|593140331|FG009|Phase 1|Death|2|||
163980476|NCT04099251|592299545|FG001|Blinded Treatment Phase|Death|2|||
163980477|NCT04099251|592299544|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
163980478|NCT04099251|592299545|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
163980479|NCT04099251|592299544|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
163980480|NCT04099251|592299545|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
163980481|NCT04099251|592299544|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
163980482|NCT04099251|592299545|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
163980483|NCT04099251|592299544|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
164077434|NCT00830063|592649933|FG000|Overall Study|Death|1|||
163980484|NCT04099251|592299545|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
164211073|NCT03126110|593140332|FG010|Phase 1|Death|6|||
163980485|NCT04099251|592299544|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
163980486|NCT04099251|592299545|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
163980487|NCT04099251|592299544|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
163980488|NCT04099251|592299545|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
163980489|NCT04099251|592299544|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
163980490|NCT04099251|592299545|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
163980491|NCT04099251|592299544|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
163980492|NCT04099251|592299545|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
163980493|NCT04099251|592299544|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
163980494|NCT04099251|592299545|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
163980495|NCT04311502|592299546|FG000|Overall Study|Death|1|||
163980496|NCT04311502|592299547|FG001|Overall Study|Death|1|||
164211074|NCT03126110|593140333|FG011|Phase 1|Death|0|||
164211075|NCT03126110|593140334|FG012|Phase 1|Death|0|||
164211076|NCT03126110|593140335|FG013|Phase 1|Death|0|||
164211077|NCT03126110|593140336|FG014|Phase 1|Death|0|||
164211078|NCT03126110|593140337|FG015|Phase 1|Death|0|||
164211079|NCT03126110|593140338|FG016|Phase 1|Death|0|||
164211080|NCT03126110|593140322|FG000|Phase 1|Lost to Follow-up|0|||
164211081|NCT03126110|593140323|FG001|Phase 1|Lost to Follow-up|1|||
164211082|NCT03126110|593140324|FG002|Phase 1|Lost to Follow-up|0|||
164211083|NCT03126110|593140325|FG003|Phase 1|Lost to Follow-up|0|||
164211084|NCT03126110|593140326|FG004|Phase 1|Lost to Follow-up|0|||
164211085|NCT03126110|593140327|FG005|Phase 1|Lost to Follow-up|0|||
164211086|NCT03126110|593140328|FG006|Phase 1|Lost to Follow-up|0|||
164211087|NCT03126110|593140329|FG007|Phase 1|Lost to Follow-up|0|||
164211088|NCT03126110|593140330|FG008|Phase 1|Lost to Follow-up|1|||
164211089|NCT03126110|593140331|FG009|Phase 1|Lost to Follow-up|0|||
164211090|NCT03126110|593140332|FG010|Phase 1|Lost to Follow-up|0|||
164211091|NCT03126110|593140333|FG011|Phase 1|Lost to Follow-up|0|||
164211092|NCT03126110|593140334|FG012|Phase 1|Lost to Follow-up|0|||
164211093|NCT03126110|593140335|FG013|Phase 1|Lost to Follow-up|0|||
164211094|NCT03126110|593140336|FG014|Phase 1|Lost to Follow-up|0|||
164211095|NCT03126110|593140337|FG015|Phase 1|Lost to Follow-up|0|||
164211096|NCT03126110|593140338|FG016|Phase 1|Lost to Follow-up|0|||
164211097|NCT03126110|593140322|FG000|Phase 1|Withdrawal by Subject|1|||
164211098|NCT03126110|593140323|FG001|Phase 1|Withdrawal by Subject|0|||
164211099|NCT03126110|593140324|FG002|Phase 1|Withdrawal by Subject|0|||
164211100|NCT03126110|593140325|FG003|Phase 1|Withdrawal by Subject|1|||
164211101|NCT03126110|593140326|FG004|Phase 1|Withdrawal by Subject|1|||
164211102|NCT03126110|593140327|FG005|Phase 1|Withdrawal by Subject|0|||
164211103|NCT03126110|593140328|FG006|Phase 1|Withdrawal by Subject|0|||
164211104|NCT03126110|593140329|FG007|Phase 1|Withdrawal by Subject|0|||
164211105|NCT03126110|593140330|FG008|Phase 1|Withdrawal by Subject|2|||
164211106|NCT03126110|593140331|FG009|Phase 1|Withdrawal by Subject|1|||
164211107|NCT03126110|593140332|FG010|Phase 1|Withdrawal by Subject|0|||
164211108|NCT03126110|593140333|FG011|Phase 1|Withdrawal by Subject|0|||
164211109|NCT03126110|593140334|FG012|Phase 1|Withdrawal by Subject|0|||
164211110|NCT03126110|593140335|FG013|Phase 1|Withdrawal by Subject|0|||
164211111|NCT03126110|593140336|FG014|Phase 1|Withdrawal by Subject|0|||
164211112|NCT03126110|593140337|FG015|Phase 1|Withdrawal by Subject|0|||
164211113|NCT03126110|593140338|FG016|Phase 1|Withdrawal by Subject|0|||
164211114|NCT03126110|593140322|FG000|Phase 1|Safety follow-up no longer necessary|1|||
164211115|NCT03126110|593140323|FG001|Phase 1|Safety follow-up no longer necessary|0|||
164211116|NCT03126110|593140324|FG002|Phase 1|Safety follow-up no longer necessary|0|||
164211117|NCT03126110|593140325|FG003|Phase 1|Safety follow-up no longer necessary|0|||
164211118|NCT03126110|593140326|FG004|Phase 1|Safety follow-up no longer necessary|0|||
164211119|NCT03126110|593140327|FG005|Phase 1|Safety follow-up no longer necessary|0|||
164211120|NCT03126110|593140328|FG006|Phase 1|Safety follow-up no longer necessary|0|||
164211121|NCT03126110|593140329|FG007|Phase 1|Safety follow-up no longer necessary|0|||
164211122|NCT03126110|593140330|FG008|Phase 1|Safety follow-up no longer necessary|0|||
164211123|NCT03126110|593140331|FG009|Phase 1|Safety follow-up no longer necessary|0|||
164211124|NCT03126110|593140332|FG010|Phase 1|Safety follow-up no longer necessary|0|||
164211125|NCT03126110|593140333|FG011|Phase 1|Safety follow-up no longer necessary|0|||
164211126|NCT03126110|593140334|FG012|Phase 1|Safety follow-up no longer necessary|0|||
164211127|NCT03126110|593140335|FG013|Phase 1|Safety follow-up no longer necessary|0|||
164211128|NCT03126110|593140336|FG014|Phase 1|Safety follow-up no longer necessary|0|||
164211129|NCT03126110|593140337|FG015|Phase 1|Safety follow-up no longer necessary|0|||
164211130|NCT03126110|593140338|FG016|Phase 1|Safety follow-up no longer necessary|0|||
164211131|NCT03126110|593140322|FG000|Phase 1|Survival follow-up no longer necessary|0|||
164211132|NCT03126110|593140323|FG001|Phase 1|Survival follow-up no longer necessary|0|||
164211133|NCT03126110|593140324|FG002|Phase 1|Survival follow-up no longer necessary|1|||
164211134|NCT03126110|593140325|FG003|Phase 1|Survival follow-up no longer necessary|0|||
164211135|NCT03126110|593140326|FG004|Phase 1|Survival follow-up no longer necessary|0|||
164211136|NCT03126110|593140327|FG005|Phase 1|Survival follow-up no longer necessary|0|||
164211137|NCT03126110|593140328|FG006|Phase 1|Survival follow-up no longer necessary|0|||
164324888|NCT04090411|593565293|FG010|Induction Period|Lack of Efficacy|0|||
164324889|NCT04090411|593565294|FG011|Induction Period|Lack of Efficacy|0|||
164324890|NCT04090411|593565295|FG012|Induction Period|Lack of Efficacy|0|||
164324891|NCT04090411|593565283|FG000|Induction Period|Physician Decision|0|||
164324892|NCT04090411|593565284|FG001|Induction Period|Physician Decision|0|||
164324893|NCT04090411|593565285|FG002|Induction Period|Physician Decision|1|||
164324894|NCT04090411|593565286|FG003|Induction Period|Physician Decision|0|||
164324895|NCT04090411|593565287|FG004|Induction Period|Physician Decision|0|||
164324896|NCT04090411|593565288|FG005|Induction Period|Physician Decision|0|||
164324897|NCT04090411|593565289|FG006|Induction Period|Physician Decision|0|||
164324898|NCT04090411|593565290|FG007|Induction Period|Physician Decision|0|||
164324899|NCT04090411|593565291|FG008|Induction Period|Physician Decision|0|||
164324900|NCT04090411|593565292|FG009|Induction Period|Physician Decision|0|||
164324901|NCT04090411|593565293|FG010|Induction Period|Physician Decision|0|||
164324902|NCT04090411|593565294|FG011|Induction Period|Physician Decision|0|||
164324903|NCT04090411|593565295|FG012|Induction Period|Physician Decision|0|||
164324904|NCT04090411|593565283|FG000|Induction Period|Protocol Violation|0|||
164324905|NCT04090411|593565284|FG001|Induction Period|Protocol Violation|0|||
164324906|NCT04090411|593565285|FG002|Induction Period|Protocol Violation|0|||
164324907|NCT04090411|593565286|FG003|Induction Period|Protocol Violation|1|||
164324908|NCT04090411|593565287|FG004|Induction Period|Protocol Violation|0|||
164324909|NCT04090411|593565288|FG005|Induction Period|Protocol Violation|0|||
164324910|NCT04090411|593565289|FG006|Induction Period|Protocol Violation|0|||
164324911|NCT04090411|593565290|FG007|Induction Period|Protocol Violation|0|||
164324912|NCT04090411|593565291|FG008|Induction Period|Protocol Violation|0|||
164324913|NCT04090411|593565292|FG009|Induction Period|Protocol Violation|0|||
164324914|NCT04090411|593565293|FG010|Induction Period|Protocol Violation|0|||
164324915|NCT04090411|593565294|FG011|Induction Period|Protocol Violation|0|||
164324916|NCT04090411|593565295|FG012|Induction Period|Protocol Violation|0|||
164324917|NCT04090411|593565283|FG000|Induction Period|Withdrawal by Subject|2|||
164324918|NCT04090411|593565284|FG001|Induction Period|Withdrawal by Subject|0|||
164324919|NCT04090411|593565285|FG002|Induction Period|Withdrawal by Subject|1|||
164324920|NCT04090411|593565286|FG003|Induction Period|Withdrawal by Subject|5|||
164324921|NCT04090411|593565287|FG004|Induction Period|Withdrawal by Subject|0|||
164324922|NCT04090411|593565288|FG005|Induction Period|Withdrawal by Subject|0|||
164324923|NCT04090411|593565289|FG006|Induction Period|Withdrawal by Subject|0|||
164324924|NCT04090411|593565290|FG007|Induction Period|Withdrawal by Subject|0|||
164324925|NCT04090411|593565291|FG008|Induction Period|Withdrawal by Subject|0|||
164324926|NCT04090411|593565292|FG009|Induction Period|Withdrawal by Subject|0|||
164324927|NCT04090411|593565293|FG010|Induction Period|Withdrawal by Subject|0|||
164324928|NCT04090411|593565294|FG011|Induction Period|Withdrawal by Subject|0|||
164324929|NCT04090411|593565295|FG012|Induction Period|Withdrawal by Subject|0|||
164324930|NCT04090411|593565283|FG000|Chronic Period|Adverse Event|0|||
164324931|NCT04090411|593565284|FG001|Chronic Period|Adverse Event|0|||
164324932|NCT04090411|593565285|FG002|Chronic Period|Adverse Event|0|||
164324933|NCT04090411|593565286|FG003|Chronic Period|Adverse Event|0|||
164324934|NCT04090411|593565287|FG004|Chronic Period|Adverse Event|0|||
164324935|NCT04090411|593565288|FG005|Chronic Period|Adverse Event|1|||
164324936|NCT04090411|593565289|FG006|Chronic Period|Adverse Event|0|||
164324937|NCT04090411|593565290|FG007|Chronic Period|Adverse Event|3|||
164324938|NCT04090411|593565291|FG008|Chronic Period|Adverse Event|0|||
164324939|NCT04090411|593565292|FG009|Chronic Period|Adverse Event|0|||
164324940|NCT04090411|593565293|FG010|Chronic Period|Adverse Event|5|||
164324941|NCT04090411|593565294|FG011|Chronic Period|Adverse Event|1|||
164324942|NCT04090411|593565295|FG012|Chronic Period|Adverse Event|1|||
164324943|NCT04090411|593565283|FG000|Chronic Period|Lack of Efficacy|0|||
164324944|NCT04090411|593565284|FG001|Chronic Period|Lack of Efficacy|0|||
163876107|NCT03948763|591914744|FG003|Overall Study|Withdrawal by Subject|2|||
163876108|NCT03948763|591914745|FG004|Overall Study|Withdrawal by Subject|4|||
163876109|NCT06629454|591914746|FG000|Overall Study|Withdraw by Clinician Decision|1|||
163876110|NCT05136404|591914747|FG000|Period 1|Adverse Event|0|||
163876111|NCT05136404|591914748|FG001|Period 1|Adverse Event|1|||
164324945|NCT04090411|593565285|FG002|Chronic Period|Lack of Efficacy|0|||
164324946|NCT04090411|593565286|FG003|Chronic Period|Lack of Efficacy|0|||
163876112|NCT05136404|591914749|FG002|Period 1|Adverse Event|1|||
163876113|NCT05136404|591914747|FG000|Period 2|Inappropriate Behavior|0|||
164324947|NCT04090411|593565287|FG004|Chronic Period|Lack of Efficacy|0|||
164324948|NCT04090411|593565288|FG005|Chronic Period|Lack of Efficacy|0|||
164324949|NCT04090411|593565289|FG006|Chronic Period|Lack of Efficacy|1|||
164324950|NCT04090411|593565290|FG007|Chronic Period|Lack of Efficacy|4|||
164324951|NCT04090411|593565291|FG008|Chronic Period|Lack of Efficacy|2|||
164324952|NCT04090411|593565292|FG009|Chronic Period|Lack of Efficacy|2|||
164324953|NCT04090411|593565293|FG010|Chronic Period|Lack of Efficacy|2|||
163876114|NCT05136404|591914748|FG001|Period 2|Inappropriate Behavior|0|||
164324954|NCT04090411|593565294|FG011|Chronic Period|Lack of Efficacy|1|||
164324955|NCT04090411|593565295|FG012|Chronic Period|Lack of Efficacy|2|||
163876115|NCT05136404|591914749|FG002|Period 2|Inappropriate Behavior|1|||
164324956|NCT04090411|593565283|FG000|Chronic Period|Relocation|0|||
164077435|NCT00830063|592649934|FG001|Overall Study|Death|0|||
164077436|NCT00830063|592649935|FG002|Overall Study|Death|0|||
164077437|NCT00830063|592649936|FG003|Overall Study|Death|0|||
164077438|NCT00830063|592649933|FG000|Overall Study|Lost to Follow-up|0|||
164077439|NCT00830063|592649934|FG001|Overall Study|Lost to Follow-up|0|||
164077440|NCT00830063|592649935|FG002|Overall Study|Lost to Follow-up|3|||
164077441|NCT00830063|592649936|FG003|Overall Study|Lost to Follow-up|1|||
164077442|NCT00830063|592649933|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
164077443|NCT00830063|592649934|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
164077444|NCT00830063|592649935|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
164077445|NCT00830063|592649936|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
164077446|NCT00830063|592649933|FG000|Overall Study|Lack of Efficacy|51|||
164077447|NCT00830063|592649934|FG001|Overall Study|Lack of Efficacy|23|||
164077448|NCT00830063|592649935|FG002|Overall Study|Lack of Efficacy|25|||
164077449|NCT00830063|592649936|FG003|Overall Study|Lack of Efficacy|32|||
164077450|NCT00830063|592649933|FG000|Overall Study|Other|5|||
164077451|NCT00830063|592649934|FG001|Overall Study|Other|5|||
164077452|NCT00830063|592649935|FG002|Overall Study|Other|8|||
164077453|NCT00830063|592649936|FG003|Overall Study|Other|6|||
164077454|NCT00830063|592649933|FG000|Overall Study|Withdrawal by Subject|16|||
164077455|NCT00830063|592649934|FG001|Overall Study|Withdrawal by Subject|10|||
164077456|NCT00830063|592649935|FG002|Overall Study|Withdrawal by Subject|16|||
164077457|NCT00830063|592649936|FG003|Overall Study|Withdrawal by Subject|13|||
164077458|NCT00830063|592649933|FG000|Overall Study|Protocol Violation|1|||
164077459|NCT00830063|592649934|FG001|Overall Study|Protocol Violation|0|||
164077460|NCT00830063|592649935|FG002|Overall Study|Protocol Violation|3|||
164077461|NCT00830063|592649936|FG003|Overall Study|Protocol Violation|2|||
164077462|NCT00830063|592649933|FG000|Overall Study|Randomized But Not Treated|0|||
164077463|NCT00830063|592649934|FG001|Overall Study|Randomized But Not Treated|2|||
164077464|NCT00830063|592649935|FG002|Overall Study|Randomized But Not Treated|0|||
164077465|NCT00830063|592649936|FG003|Overall Study|Randomized But Not Treated|2|||
164077466|NCT01847313|592649937|FG000|Overall Study|Death|0|||
164077467|NCT01847313|592649938|FG001|Overall Study|Death|1|||
164077468|NCT01847313|592649937|FG000|Overall Study|Withdrawal by Subject|0|||
164077469|NCT01847313|592649938|FG001|Overall Study|Withdrawal by Subject|1|||
164077470|NCT00598559|592649939|FG000|Overall Study|Adverse Event|11|||
164077471|NCT00598559|592649940|FG001|Overall Study|Adverse Event|7|||
164077472|NCT00598559|592649941|FG002|Overall Study|Adverse Event|0|||
164077473|NCT00598559|592649939|FG000|Overall Study|Withdrawal by Subject|2|||
164077474|NCT00598559|592649940|FG001|Overall Study|Withdrawal by Subject|2|||
164077475|NCT00598559|592649941|FG002|Overall Study|Withdrawal by Subject|0|||
164077476|NCT00598559|592649939|FG000|Overall Study|Protocol Non-compliance|1|||
164077477|NCT00598559|592649940|FG001|Overall Study|Protocol Non-compliance|0|||
164077478|NCT00598559|592649941|FG002|Overall Study|Protocol Non-compliance|0|||
164077479|NCT00598559|592649939|FG000|Overall Study|Early discharge from hospital|9|||
164077480|NCT00598559|592649940|FG001|Overall Study|Early discharge from hospital|12|||
164077481|NCT00598559|592649941|FG002|Overall Study|Early discharge from hospital|3|||
164077482|NCT00598559|592649939|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
164077483|NCT00598559|592649940|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
164077484|NCT00598559|592649941|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
164077485|NCT03763331|592649944|FG000|Overall Study|Lost to Follow-up|1|||
164077486|NCT03763331|592649945|FG001|Overall Study|Lost to Follow-up|0|||
164077487|NCT03763331|592649944|FG000|Overall Study|Withdrawal by Subject|1|||
164077488|NCT03763331|592649945|FG001|Overall Study|Withdrawal by Subject|0|||
164077489|NCT03763331|592649944|FG000|Overall Study|Non-compliance|0|||
164077490|NCT03763331|592649945|FG001|Overall Study|Non-compliance|3|||
164077491|NCT01155063|592649946|FG000|Overall Study|Adverse Event|1|||
164077492|NCT01155063|592649946|FG000|Overall Study|Withdrawal by Subject|1|||
164077493|NCT01155063|592649946|FG000|Overall Study|Study terminated by sponsor|87|||
164077494|NCT00936884|592649947|FG000|Double-blind|Withdrawal by Subject|6|||
164077495|NCT00936884|592649948|FG001|Double-blind|Withdrawal by Subject|4|||
164077496|NCT00936884|592649949|FG002|Double-blind|Withdrawal by Subject|0|||
164077497|NCT00936884|592649947|FG000|Double-blind|Death|2|||
164077498|NCT00936884|592649948|FG001|Double-blind|Death|1|||
164211138|NCT03126110|593140329|FG007|Phase 1|Survival follow-up no longer necessary|0|||
164211139|NCT03126110|593140330|FG008|Phase 1|Survival follow-up no longer necessary|0|||
164211140|NCT03126110|593140331|FG009|Phase 1|Survival follow-up no longer necessary|0|||
164211141|NCT03126110|593140332|FG010|Phase 1|Survival follow-up no longer necessary|0|||
164211142|NCT03126110|593140333|FG011|Phase 1|Survival follow-up no longer necessary|0|||
164211143|NCT03126110|593140334|FG012|Phase 1|Survival follow-up no longer necessary|0|||
164211144|NCT03126110|593140335|FG013|Phase 1|Survival follow-up no longer necessary|0|||
164077499|NCT00936884|592649949|FG002|Double-blind|Death|0|||
164077500|NCT00936884|592649947|FG000|Double-blind|Lack of Efficacy|1|||
164077501|NCT00936884|592649948|FG001|Double-blind|Lack of Efficacy|1|||
164077502|NCT00936884|592649949|FG002|Double-blind|Lack of Efficacy|0|||
164077503|NCT00936884|592649947|FG000|Double-blind|Adverse Event|1|||
164077504|NCT00936884|592649948|FG001|Double-blind|Adverse Event|0|||
164211145|NCT03126110|593140336|FG014|Phase 1|Survival follow-up no longer necessary|0|||
164211146|NCT03126110|593140337|FG015|Phase 1|Survival follow-up no longer necessary|0|||
164211147|NCT03126110|593140338|FG016|Phase 1|Survival follow-up no longer necessary|0|||
164211148|NCT03126110|593140322|FG000|Phase 2|Study terminated by the sponsor|0|||
164211149|NCT03126110|593140323|FG001|Phase 2|Study terminated by the sponsor|0|||
164211150|NCT03126110|593140324|FG002|Phase 2|Study terminated by the sponsor|0|||
164211151|NCT03126110|593140325|FG003|Phase 2|Study terminated by the sponsor|0|||
164211152|NCT03126110|593140326|FG004|Phase 2|Study terminated by the sponsor|0|||
164211153|NCT03126110|593140327|FG005|Phase 2|Study terminated by the sponsor|0|||
164211154|NCT03126110|593140328|FG006|Phase 2|Study terminated by the sponsor|0|||
164211155|NCT03126110|593140329|FG007|Phase 2|Study terminated by the sponsor|0|||
164211156|NCT03126110|593140330|FG008|Phase 2|Study terminated by the sponsor|0|||
164211157|NCT03126110|593140331|FG009|Phase 2|Study terminated by the sponsor|0|||
164211158|NCT03126110|593140332|FG010|Phase 2|Study terminated by the sponsor|0|||
164211159|NCT03126110|593140333|FG011|Phase 2|Study terminated by the sponsor|0|||
164211160|NCT03126110|593140334|FG012|Phase 2|Study terminated by the sponsor|0|||
164211161|NCT03126110|593140335|FG013|Phase 2|Study terminated by the sponsor|4|||
164211162|NCT03126110|593140336|FG014|Phase 2|Study terminated by the sponsor|0|||
164211163|NCT03126110|593140337|FG015|Phase 2|Study terminated by the sponsor|0|||
164211164|NCT03126110|593140338|FG016|Phase 2|Study terminated by the sponsor|0|||
164211165|NCT03126110|593140322|FG000|Phase 2|Withdrawal by Subject|0|||
164211166|NCT03126110|593140323|FG001|Phase 2|Withdrawal by Subject|0|||
164211167|NCT03126110|593140324|FG002|Phase 2|Withdrawal by Subject|0|||
164211168|NCT03126110|593140325|FG003|Phase 2|Withdrawal by Subject|0|||
164211169|NCT03126110|593140326|FG004|Phase 2|Withdrawal by Subject|0|||
164211170|NCT03126110|593140327|FG005|Phase 2|Withdrawal by Subject|0|||
164211171|NCT03126110|593140328|FG006|Phase 2|Withdrawal by Subject|0|||
164211172|NCT03126110|593140329|FG007|Phase 2|Withdrawal by Subject|0|||
164211173|NCT03126110|593140330|FG008|Phase 2|Withdrawal by Subject|0|||
164211174|NCT03126110|593140331|FG009|Phase 2|Withdrawal by Subject|0|||
164211175|NCT03126110|593140332|FG010|Phase 2|Withdrawal by Subject|0|||
164211176|NCT03126110|593140333|FG011|Phase 2|Withdrawal by Subject|1|||
164211177|NCT03126110|593140334|FG012|Phase 2|Withdrawal by Subject|3|||
164211178|NCT03126110|593140335|FG013|Phase 2|Withdrawal by Subject|3|||
164211179|NCT03126110|593140336|FG014|Phase 2|Withdrawal by Subject|2|||
164211180|NCT03126110|593140337|FG015|Phase 2|Withdrawal by Subject|1|||
164211181|NCT03126110|593140338|FG016|Phase 2|Withdrawal by Subject|0|||
164211182|NCT03126110|593140322|FG000|Phase 2|Lost to Follow-up|0|||
164211183|NCT03126110|593140323|FG001|Phase 2|Lost to Follow-up|0|||
164211184|NCT03126110|593140324|FG002|Phase 2|Lost to Follow-up|0|||
164211185|NCT03126110|593140325|FG003|Phase 2|Lost to Follow-up|0|||
164211186|NCT03126110|593140326|FG004|Phase 2|Lost to Follow-up|0|||
164211187|NCT03126110|593140327|FG005|Phase 2|Lost to Follow-up|0|||
164211188|NCT03126110|593140328|FG006|Phase 2|Lost to Follow-up|0|||
164211189|NCT03126110|593140329|FG007|Phase 2|Lost to Follow-up|0|||
164211190|NCT03126110|593140330|FG008|Phase 2|Lost to Follow-up|0|||
163876116|NCT05136404|591914747|FG000|Period 3|Adverse Event|0|||
163876117|NCT05136404|591914748|FG001|Period 3|Adverse Event|0|||
163876118|NCT05136404|591914749|FG002|Period 3|Adverse Event|1|||
163876119|NCT01820260|591914757|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876120|NCT01820260|591914758|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876121|NCT01820260|591914759|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876122|NCT01820260|591914760|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876123|NCT01820260|591914761|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876124|NCT01820260|591914762|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876125|NCT01820260|591914763|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
163876126|NCT01820260|591914764|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876127|NCT01820260|591914765|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876128|NCT01820260|591914766|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876129|NCT01820260|591914767|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876130|NCT01820260|591914768|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876131|NCT01820260|591914769|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876132|NCT01820260|591914770|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
163876133|NCT01820260|591914757|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876134|NCT01820260|591914758|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876135|NCT01820260|591914759|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876136|NCT01820260|591914760|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876137|NCT01820260|591914761|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876138|NCT01820260|591914762|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
164211191|NCT03126110|593140331|FG009|Phase 2|Lost to Follow-up|0|||
164211192|NCT03126110|593140332|FG010|Phase 2|Lost to Follow-up|0|||
164211193|NCT03126110|593140333|FG011|Phase 2|Lost to Follow-up|1|||
164211194|NCT03126110|593140334|FG012|Phase 2|Lost to Follow-up|1|||
164211195|NCT03126110|593140335|FG013|Phase 2|Lost to Follow-up|1|||
164211196|NCT03126110|593140336|FG014|Phase 2|Lost to Follow-up|2|||
164211197|NCT03126110|593140337|FG015|Phase 2|Lost to Follow-up|0|||
164211198|NCT03126110|593140338|FG016|Phase 2|Lost to Follow-up|0|||
164211199|NCT03126110|593140322|FG000|Phase 2|Death|0|||
164211200|NCT03126110|593140323|FG001|Phase 2|Death|0|||
164211201|NCT03126110|593140324|FG002|Phase 2|Death|0|||
163876139|NCT01820260|591914763|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876140|NCT01820260|591914764|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876141|NCT01820260|591914765|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876142|NCT01820260|591914766|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
163876143|NCT01820260|591914767|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876144|NCT01820260|591914768|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876145|NCT01820260|591914769|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876146|NCT01820260|591914770|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
163876147|NCT05444192|591914771|FG000|Overall Study|Lost to Follow-up|1|||
163876148|NCT05444192|591914772|FG001|Overall Study|Lost to Follow-up|0|||
163876149|NCT00505934|591914776|FG000|Overall Study|Adverse Event|1|||
163876150|NCT00505934|591914776|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
163876151|NCT00505934|591914776|FG000|Overall Study|Other: IV dose needed to be changed|1|||
163876152|NCT01046136|591914777|FG000|Overall Study|Withdrawal by Subject|0|||
163876153|NCT01046136|591914778|FG001|Overall Study|Withdrawal by Subject|4|||
163876154|NCT01046136|591914777|FG000|Overall Study|Physician Decision|1|||
163876155|NCT01046136|591914778|FG001|Overall Study|Physician Decision|1|||
163876156|NCT01046136|591914777|FG000|Overall Study|Lost to Follow-up|3|||
163876157|NCT01046136|591914778|FG001|Overall Study|Lost to Follow-up|3|||
163876158|NCT02058108|591914779|FG000|Overall Study|Abnormal Laboratory Values|0|||
163876159|NCT02058108|591914780|FG001|Overall Study|Abnormal Laboratory Values|1|||
163876160|NCT02058108|591914779|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
163876161|NCT02058108|591914780|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
163876162|NCT02058108|591914779|FG000|Overall Study|No longer requires study drug|0|||
163876163|NCT02058108|591914780|FG001|Overall Study|No longer requires study drug|1|||
163876164|NCT02058108|591914779|FG000|Overall Study|Withdrawal by Subject|1|||
163876165|NCT02058108|591914780|FG001|Overall Study|Withdrawal by Subject|0|||
163876166|NCT02058108|591914779|FG000|Overall Study|Administrative problems|3|||
163876167|NCT02058108|591914780|FG001|Overall Study|Administrative problems|3|||
163876168|NCT02058108|591914779|FG000|Overall Study|Protocol Violation|0|||
163876169|NCT02058108|591914780|FG001|Overall Study|Protocol Violation|1|||
163876170|NCT01376700|591914784|FG000|Overall Study|Sponsor terminated study early|8|||
163876171|NCT01376700|591914784|FG000|Overall Study|Low or high titer inhibitor|8|||
163876172|NCT00727909|591914785|FG000|Overall Study|Withdrawal by Subject|5|||
163876173|NCT00727909|591914786|FG001|Overall Study|Withdrawal by Subject|11|||
163876174|NCT00727909|591914787|FG002|Overall Study|Withdrawal by Subject|8|||
163876175|NCT00727909|591914788|FG003|Overall Study|Withdrawal by Subject|5|||
163876176|NCT00727909|591914785|FG000|Overall Study|Death|0|||
163876177|NCT00727909|591914786|FG001|Overall Study|Death|0|||
163876178|NCT00727909|591914787|FG002|Overall Study|Death|1|||
163876179|NCT00727909|591914788|FG003|Overall Study|Death|0|||
163876180|NCT01696773|591914789|FG000|Days 15-27, Washout|Adverse Event|1|||
163876181|NCT01696773|591914790|FG001|Days 15-27, Washout|Adverse Event|0|||
163876182|NCT05623345|591914791|FG000|Overall Study|Withdrawal by Subject|14|||
163876183|NCT05623345|591914792|FG001|Overall Study|Withdrawal by Subject|0|||
163876184|NCT05623345|591914793|FG002|Overall Study|Withdrawal by Subject|9|||
163876185|NCT05623345|591914794|FG003|Overall Study|Withdrawal by Subject|20|||
163876186|NCT05623345|591914791|FG000|Overall Study|Lost to Follow-up|3|||
163876187|NCT05623345|591914792|FG001|Overall Study|Lost to Follow-up|0|||
164211202|NCT03126110|593140325|FG003|Phase 2|Death|0|||
164211203|NCT03126110|593140326|FG004|Phase 2|Death|0|||
164211204|NCT03126110|593140327|FG005|Phase 2|Death|0|||
164211205|NCT03126110|593140328|FG006|Phase 2|Death|0|||
164211206|NCT03126110|593140329|FG007|Phase 2|Death|0|||
164211207|NCT03126110|593140330|FG008|Phase 2|Death|0|||
164211208|NCT03126110|593140331|FG009|Phase 2|Death|0|||
164211209|NCT03126110|593140332|FG010|Phase 2|Death|0|||
164211210|NCT03126110|593140333|FG011|Phase 2|Death|6|||
164211211|NCT03126110|593140334|FG012|Phase 2|Death|12|||
164211212|NCT03126110|593140335|FG013|Phase 2|Death|25|||
164211213|NCT03126110|593140336|FG014|Phase 2|Death|11|||
164211214|NCT03126110|593140337|FG015|Phase 2|Death|3|||
164211215|NCT03126110|593140338|FG016|Phase 2|Death|2|||
164211216|NCT03126110|593140322|FG000|Phase 2|Progressive Disease|0|||
164211217|NCT03126110|593140323|FG001|Phase 2|Progressive Disease|0|||
164211218|NCT03126110|593140324|FG002|Phase 2|Progressive Disease|0|||
164211219|NCT03126110|593140325|FG003|Phase 2|Progressive Disease|0|||
163876188|NCT05623345|591914793|FG002|Overall Study|Lost to Follow-up|7|||
163876189|NCT05623345|591914794|FG003|Overall Study|Lost to Follow-up|2|||
163876190|NCT05623345|591914791|FG000|Overall Study|Termination of Study By Sponsor|37|||
163876191|NCT05623345|591914792|FG001|Overall Study|Termination of Study By Sponsor|4|||
164211220|NCT03126110|593140326|FG004|Phase 2|Progressive Disease|0|||
164211221|NCT03126110|593140327|FG005|Phase 2|Progressive Disease|0|||
164211222|NCT03126110|593140328|FG006|Phase 2|Progressive Disease|0|||
164211223|NCT03126110|593140329|FG007|Phase 2|Progressive Disease|0|||
164324957|NCT04090411|593565284|FG001|Chronic Period|Relocation|0|||
164324958|NCT04090411|593565285|FG002|Chronic Period|Relocation|0|||
164324959|NCT04090411|593565286|FG003|Chronic Period|Relocation|0|||
164324960|NCT04090411|593565287|FG004|Chronic Period|Relocation|0|||
164324961|NCT04090411|593565288|FG005|Chronic Period|Relocation|0|||
164324962|NCT04090411|593565289|FG006|Chronic Period|Relocation|0|||
164324963|NCT04090411|593565290|FG007|Chronic Period|Relocation|1|||
164324964|NCT04090411|593565291|FG008|Chronic Period|Relocation|0|||
164324965|NCT04090411|593565292|FG009|Chronic Period|Relocation|0|||
164324966|NCT04090411|593565293|FG010|Chronic Period|Relocation|0|||
164324967|NCT04090411|593565294|FG011|Chronic Period|Relocation|0|||
164324968|NCT04090411|593565295|FG012|Chronic Period|Relocation|0|||
164324969|NCT04090411|593565283|FG000|Chronic Period|Physician Decision|0|||
164324970|NCT04090411|593565284|FG001|Chronic Period|Physician Decision|0|||
164324971|NCT04090411|593565285|FG002|Chronic Period|Physician Decision|0|||
164324972|NCT04090411|593565286|FG003|Chronic Period|Physician Decision|0|||
164324973|NCT04090411|593565287|FG004|Chronic Period|Physician Decision|1|||
164324974|NCT04090411|593565288|FG005|Chronic Period|Physician Decision|0|||
164324975|NCT04090411|593565289|FG006|Chronic Period|Physician Decision|0|||
164324976|NCT04090411|593565290|FG007|Chronic Period|Physician Decision|1|||
164324977|NCT04090411|593565291|FG008|Chronic Period|Physician Decision|0|||
164324978|NCT04090411|593565292|FG009|Chronic Period|Physician Decision|0|||
164324979|NCT04090411|593565293|FG010|Chronic Period|Physician Decision|0|||
164324980|NCT04090411|593565294|FG011|Chronic Period|Physician Decision|1|||
164324981|NCT04090411|593565295|FG012|Chronic Period|Physician Decision|1|||
164324982|NCT04090411|593565283|FG000|Chronic Period|Protocol Violation|0|||
164324983|NCT04090411|593565284|FG001|Chronic Period|Protocol Violation|0|||
164324984|NCT04090411|593565285|FG002|Chronic Period|Protocol Violation|0|||
164324985|NCT04090411|593565286|FG003|Chronic Period|Protocol Violation|0|||
164324986|NCT04090411|593565287|FG004|Chronic Period|Protocol Violation|0|||
164324987|NCT04090411|593565288|FG005|Chronic Period|Protocol Violation|0|||
164324988|NCT04090411|593565289|FG006|Chronic Period|Protocol Violation|0|||
164324989|NCT04090411|593565290|FG007|Chronic Period|Protocol Violation|0|||
164324990|NCT04090411|593565291|FG008|Chronic Period|Protocol Violation|0|||
164324991|NCT04090411|593565292|FG009|Chronic Period|Protocol Violation|0|||
164324992|NCT04090411|593565293|FG010|Chronic Period|Protocol Violation|0|||
164324993|NCT04090411|593565294|FG011|Chronic Period|Protocol Violation|0|||
164324994|NCT04090411|593565295|FG012|Chronic Period|Protocol Violation|1|||
164324995|NCT04090411|593565283|FG000|Chronic Period|Withdrawal by Subject|0|||
164324996|NCT04090411|593565284|FG001|Chronic Period|Withdrawal by Subject|0|||
164324997|NCT04090411|593565285|FG002|Chronic Period|Withdrawal by Subject|0|||
164324998|NCT04090411|593565286|FG003|Chronic Period|Withdrawal by Subject|0|||
164324999|NCT04090411|593565287|FG004|Chronic Period|Withdrawal by Subject|0|||
164325000|NCT04090411|593565288|FG005|Chronic Period|Withdrawal by Subject|1|||
164325001|NCT04090411|593565289|FG006|Chronic Period|Withdrawal by Subject|1|||
164325002|NCT04090411|593565290|FG007|Chronic Period|Withdrawal by Subject|3|||
164325003|NCT04090411|593565291|FG008|Chronic Period|Withdrawal by Subject|3|||
164325004|NCT04090411|593565292|FG009|Chronic Period|Withdrawal by Subject|3|||
164325005|NCT04090411|593565293|FG010|Chronic Period|Withdrawal by Subject|1|||
164325006|NCT04090411|593565294|FG011|Chronic Period|Withdrawal by Subject|3|||
164325007|NCT04090411|593565295|FG012|Chronic Period|Withdrawal by Subject|0|||
163980497|NCT04311502|592299548|FG002|Overall Study|Death|1|||
163980498|NCT04311502|592299546|FG000|Overall Study|Lost to Follow-up|2|||
163980499|NCT04311502|592299547|FG001|Overall Study|Lost to Follow-up|3|||
163980500|NCT04311502|592299548|FG002|Overall Study|Lost to Follow-up|0|||
163980501|NCT04311502|592299546|FG000|Overall Study|Participant is in prison|1|||
163980502|NCT04311502|592299547|FG001|Overall Study|Participant is in prison|0|||
163980503|NCT04311502|592299548|FG002|Overall Study|Participant is in prison|0|||
163980504|NCT04311502|592299546|FG000|Overall Study|Participant moved out of country|1|||
163980505|NCT04311502|592299547|FG001|Overall Study|Participant moved out of country|0|||
163980506|NCT04311502|592299548|FG002|Overall Study|Participant moved out of country|0|||
163980507|NCT04311502|592299546|FG000|Overall Study|Withdrawal by Subject|2|||
163980508|NCT04311502|592299547|FG001|Overall Study|Withdrawal by Subject|0|||
164077505|NCT00936884|592649949|FG002|Double-blind|Adverse Event|0|||
164077506|NCT00936884|592649947|FG000|Double-blind|Physician Decision|1|||
164325008|NCT02477696|593565302|FG000|Overall Study|Death|89|||
164325009|NCT02477696|593565303|FG001|Overall Study|Death|106|||
164325010|NCT02477696|593565302|FG000|Overall Study|Lost to Follow-up|7|||
164325011|NCT02477696|593565303|FG001|Overall Study|Lost to Follow-up|5|||
163980509|NCT04311502|592299548|FG002|Overall Study|Withdrawal by Subject|0|||
163980510|NCT04311502|592299546|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
164325012|NCT02477696|593565302|FG000|Overall Study|Withdrawal by Subject|37|||
164325013|NCT02477696|593565303|FG001|Overall Study|Withdrawal by Subject|34|||
164325014|NCT02477696|593565302|FG000|Overall Study|Physician Decision|7|||
164325015|NCT02477696|593565303|FG001|Overall Study|Physician Decision|9|||
164325016|NCT02477696|593565302|FG000|Overall Study|Study terminated by sponsor|103|||
164325017|NCT02477696|593565303|FG001|Overall Study|Study terminated by sponsor|99|||
164325018|NCT02477696|593565302|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
164325019|NCT02477696|593565303|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
163980511|NCT04311502|592299547|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
163980512|NCT04311502|592299548|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
163980513|NCT03451773|592299549|FG000|Overall Study|Death on study|1|||
164211224|NCT03126110|593140330|FG008|Phase 2|Progressive Disease|0|||
163980514|NCT03451773|592299550|FG001|Overall Study|Death on study|5|||
163980515|NCT03451773|592299549|FG000|Overall Study|Death during follow-up period|0|||
163980516|NCT03451773|592299550|FG001|Overall Study|Death during follow-up period|1|||
163980517|NCT01339559|592299552|FG000|Overall Study|Adverse Event|92|||
163980518|NCT01339559|592299552|FG000|Overall Study|Death|5|||
163980519|NCT01339559|592299552|FG000|Overall Study|Lack of Efficacy|164|||
163980520|NCT01339559|592299552|FG000|Overall Study|Lost to Follow-up|22|||
163980521|NCT01339559|592299552|FG000|Overall Study|Subject choice|89|||
163980522|NCT01339559|592299552|FG000|Overall Study|Protocol Violation|15|||
163980523|NCT01339559|592299552|FG000|Overall Study|Study closure at site|1|||
163980524|NCT01339559|592299552|FG000|Overall Study|Incarcerated|2|||
163980525|NCT01339559|592299552|FG000|Overall Study|Epilepsy surgery|1|||
163980526|NCT01339559|592299552|FG000|Overall Study|Pregnancy planned|2|||
163980527|NCT01339559|592299552|FG000|Overall Study|Left the country|1|||
163980528|NCT01339559|592299552|FG000|Overall Study|Investigator decision|2|||
163980529|NCT01339559|592299552|FG000|Overall Study|Patient didn't wish to continue|1|||
163980530|NCT01339559|592299552|FG000|Overall Study|PI decision|1|||
163980531|NCT00971945|592299553|FG000|Overall Study|Progressive Disease|3|||
163980532|NCT00971945|592299553|FG000|Overall Study|Change in treatment policy|1|||
163980533|NCT00971945|592299553|FG000|Overall Study|Other reasons|2|||
163980534|NCT03354663|592299554|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
163980535|NCT03354663|592299554|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
163980536|NCT03354663|592299554|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
163980537|NCT03354663|592299554|FG000|Completed 30-day Visit|Missed Visit|1|||
163980538|NCT03691974|592299555|FG000|Overall Study|Physician Decision|1|||
163980539|NCT03691974|592299556|FG001|Overall Study|Physician Decision|0|||
163980540|NCT03691974|592299555|FG000|Overall Study|Adverse Event|1|||
163980541|NCT03691974|592299556|FG001|Overall Study|Adverse Event|0|||
163980542|NCT03691974|592299555|FG000|Overall Study|Withdrawal by Subject|11|||
163980543|NCT03691974|592299556|FG001|Overall Study|Withdrawal by Subject|9|||
163980544|NCT03691974|592299555|FG000|Overall Study|Protocol Violation|1|||
163980545|NCT03691974|592299556|FG001|Overall Study|Protocol Violation|0|||
163980546|NCT03691974|592299555|FG000|Overall Study|Lost to Follow-up|8|||
163980547|NCT03691974|592299556|FG001|Overall Study|Lost to Follow-up|7|||
163980548|NCT00513409|592299560|FG000|Overall Study|Adverse Event|0|||
163980549|NCT00513409|592299561|FG001|Overall Study|Adverse Event|1|||
163980550|NCT00513409|592299560|FG000|Overall Study|Withdrawal by Subject|0|||
163980551|NCT00513409|592299561|FG001|Overall Study|Withdrawal by Subject|2|||
163980552|NCT00513409|592299560|FG000|Overall Study|Lost to Follow-up|0|||
163980553|NCT00513409|592299561|FG001|Overall Study|Lost to Follow-up|1|||
163980554|NCT00513409|592299560|FG000|Overall Study|Physician Decision|1|||
163980555|NCT00513409|592299561|FG001|Overall Study|Physician Decision|0|||
163980556|NCT00513409|592299560|FG000|Overall Study|Visit 3 not done|1|||
163980557|NCT00513409|592299561|FG001|Overall Study|Visit 3 not done|2|||
163980558|NCT01049035|592299562|FG000|Overall Study|Serious adverse event|0|||
163980559|NCT01049035|592299563|FG001|Overall Study|Serious adverse event|1|||
163980560|NCT01049035|592299564|FG002|Overall Study|Serious adverse event|1|||
164211225|NCT03126110|593140331|FG009|Phase 2|Progressive Disease|0|||
164211226|NCT03126110|593140332|FG010|Phase 2|Progressive Disease|0|||
164211227|NCT03126110|593140333|FG011|Phase 2|Progressive Disease|0|||
164211228|NCT03126110|593140334|FG012|Phase 2|Progressive Disease|0|||
164211229|NCT03126110|593140335|FG013|Phase 2|Progressive Disease|1|||
164211230|NCT03126110|593140336|FG014|Phase 2|Progressive Disease|0|||
164211231|NCT03126110|593140337|FG015|Phase 2|Progressive Disease|0|||
164211232|NCT03126110|593140338|FG016|Phase 2|Progressive Disease|0|||
164211233|NCT03126110|593140322|FG000|Phase 2|Started new treatment|0|||
164211234|NCT03126110|593140323|FG001|Phase 2|Started new treatment|0|||
164211235|NCT03126110|593140324|FG002|Phase 2|Started new treatment|0|||
164211236|NCT03126110|593140325|FG003|Phase 2|Started new treatment|0|||
164211237|NCT03126110|593140326|FG004|Phase 2|Started new treatment|0|||
164211238|NCT03126110|593140327|FG005|Phase 2|Started new treatment|0|||
164211239|NCT03126110|593140328|FG006|Phase 2|Started new treatment|0|||
164211240|NCT03126110|593140329|FG007|Phase 2|Started new treatment|0|||
164211241|NCT03126110|593140330|FG008|Phase 2|Started new treatment|0|||
164211242|NCT03126110|593140331|FG009|Phase 2|Started new treatment|0|||
164211243|NCT03126110|593140332|FG010|Phase 2|Started new treatment|0|||
164211244|NCT03126110|593140333|FG011|Phase 2|Started new treatment|0|||
164211245|NCT03126110|593140334|FG012|Phase 2|Started new treatment|0|||
164211246|NCT03126110|593140335|FG013|Phase 2|Started new treatment|0|||
164211247|NCT03126110|593140336|FG014|Phase 2|Started new treatment|1|||
164211248|NCT03126110|593140337|FG015|Phase 2|Started new treatment|0|||
164211249|NCT03126110|593140338|FG016|Phase 2|Started new treatment|0|||
163980561|NCT01049035|592299565|FG003|Overall Study|Serious adverse event|2|||
164211250|NCT00314145|593140339|FG000|Overall Study|Withdrawal by Subject|8|||
164211251|NCT00314145|593140340|FG001|Overall Study|Withdrawal by Subject|10|||
164077507|NCT00936884|592649948|FG001|Double-blind|Physician Decision|0|||
164077508|NCT00936884|592649949|FG002|Double-blind|Physician Decision|0|||
164077509|NCT00936884|592649947|FG000|Double-blind|No post baseline diary entry|1|||
164077510|NCT00936884|592649948|FG001|Double-blind|No post baseline diary entry|0|||
164077511|NCT00936884|592649949|FG002|Double-blind|No post baseline diary entry|0|||
164077512|NCT00936884|592649947|FG000|Double-blind|Did not receive study drug|0|||
164077513|NCT00936884|592649948|FG001|Double-blind|Did not receive study drug|1|||
164077514|NCT00936884|592649949|FG002|Double-blind|Did not receive study drug|0|||
164077515|NCT01663714|592649950|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
164077516|NCT01663714|592649950|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
164077517|NCT01663714|592649950|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
164077518|NCT01663714|592649950|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
164077519|NCT01663714|592649950|FG000|Long-Term Follow-Up|Death|4|||
164077520|NCT01663714|592649950|FG000|Long-Term Follow-Up|Non-compliance|1|||
164077521|NCT00597584|592649951|FG000|Overall Study|Adverse Event|4|||
164077522|NCT00597584|592649952|FG001|Overall Study|Adverse Event|2|||
164077523|NCT00597584|592649951|FG000|Overall Study|Death|53|||
164077524|NCT00597584|592649952|FG001|Overall Study|Death|30|||
164077525|NCT00597584|592649951|FG000|Overall Study|Lack of Efficacy|1|||
164077526|NCT00597584|592649952|FG001|Overall Study|Lack of Efficacy|0|||
164077527|NCT00597584|592649951|FG000|Overall Study|Lost to Follow-up|2|||
164077528|NCT00597584|592649952|FG001|Overall Study|Lost to Follow-up|4|||
164077529|NCT00597584|592649951|FG000|Overall Study|Physician Decision|3|||
164077530|NCT00597584|592649952|FG001|Overall Study|Physician Decision|0|||
164077531|NCT00597584|592649951|FG000|Overall Study|Pregnancy|2|||
164077532|NCT00597584|592649952|FG001|Overall Study|Pregnancy|0|||
164077533|NCT00597584|592649951|FG000|Overall Study|Withdrawal by Subject|44|||
164077534|NCT00597584|592649952|FG001|Overall Study|Withdrawal by Subject|12|||
164077535|NCT00597584|592649951|FG000|Overall Study|Discontinued Dialysis|0|||
164077536|NCT00597584|592649952|FG001|Overall Study|Discontinued Dialysis|1|||
164077537|NCT00597584|592649951|FG000|Overall Study|Lost ability to consent|1|||
164077538|NCT00597584|592649952|FG001|Overall Study|Lost ability to consent|1|||
164077539|NCT00597584|592649951|FG000|Overall Study|Never dosed|1|||
164077540|NCT00597584|592649952|FG001|Overall Study|Never dosed|0|||
164077541|NCT00597584|592649951|FG000|Overall Study|Relocation|8|||
164077542|NCT00597584|592649952|FG001|Overall Study|Relocation|6|||
164077543|NCT00597584|592649951|FG000|Overall Study|Renal transplant|9|||
164077544|NCT00597584|592649952|FG001|Overall Study|Renal transplant|7|||
164077545|NCT02280421|592649953|FG000|Washout (2 Weeks)|Adverse Event|0|||
164077546|NCT02280421|592649954|FG001|Washout (2 Weeks)|Adverse Event|1|||
164077547|NCT02280421|592649953|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
164077548|NCT02280421|592649954|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
164077549|NCT03840811|592649961|FG000|Overall Study|Lost to Follow-up|0|||
164077550|NCT03840811|592649962|FG001|Overall Study|Lost to Follow-up|0|||
164077551|NCT03840811|592649963|FG002|Overall Study|Lost to Follow-up|1|||
164077552|NCT04126733|592649976|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
164077553|NCT04126733|592649976|FG000|Treatment Period|Adverse Event|8|||
164077554|NCT04126733|592649976|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
164077555|NCT04126733|592649976|FG000|Treatment Period|Physician Decision|5|||
164077556|NCT04126733|592649976|FG000|Treatment Period|Death|1|||
164077557|NCT04126733|592649976|FG000|Treatment Period|Other Reasons|2|||
164077558|NCT04126733|592649976|FG000|Active Follow-up Period|Death|13|||
164077559|NCT04126733|592649976|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
164077560|NCT04126733|592649976|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
164077561|NCT04126733|592649976|FG000|Active Follow-up Period|Other Reasons|1|||
164077562|NCT04126733|592649976|FG000|Long-term Follow-up Period|Death|22|||
164077563|NCT04126733|592649976|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
164077564|NCT04126733|592649976|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
164077565|NCT03870997|592649977|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
164077566|NCT03870997|592649978|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
164077567|NCT03870997|592649979|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
164077568|NCT03870997|592649980|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
164077569|NCT03870997|592649981|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
164077570|NCT03870997|592649982|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
164077571|NCT03726437|592649983|FG000|Overall Study|Lost to Follow-up|85|||
164077572|NCT03726437|592649984|FG001|Overall Study|Lost to Follow-up|76|||
164077573|NCT01889862|592649993|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
164325020|NCT02477696|593565302|FG000|Overall Study|Missing/Unknown|2|||
164077574|NCT01889862|592649994|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164077575|NCT01889862|592649995|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164077576|NCT01889862|592649996|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164077577|NCT01889862|592649997|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
164077578|NCT01889862|592649993|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
164077579|NCT01889862|592649994|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164077580|NCT01889862|592649995|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164077581|NCT01889862|592649996|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164325021|NCT02477696|593565303|FG001|Overall Study|Missing/Unknown|0|||
164325022|NCT04770753|593566011|FG000|Overall Study|Randomized, never treated|1|||
164325023|NCT04770753|593566012|FG001|Overall Study|Randomized, never treated|1|||
164325024|NCT04770753|593566011|FG000|Overall Study|Withdrawal by Subject|3|||
164325025|NCT04770753|593566012|FG001|Overall Study|Withdrawal by Subject|1|||
164325026|NCT04770753|593566011|FG000|Overall Study|Adverse Event|2|||
164325027|NCT04770753|593566012|FG001|Overall Study|Adverse Event|0|||
164325028|NCT04770753|593566011|FG000|Overall Study|Pregnancy|1|||
164325029|NCT04770753|593566012|FG001|Overall Study|Pregnancy|0|||
163876192|NCT05623345|591914793|FG002|Overall Study|Termination of Study By Sponsor|40|||
163876193|NCT05623345|591914794|FG003|Overall Study|Termination of Study By Sponsor|38|||
163876194|NCT01121991|591914798|FG000|Overall Study|Lack of Ovarian Response|2|||
163876195|NCT01121991|591914798|FG000|Overall Study|No Oocytes Retrieved|3|||
163876196|NCT01121991|591914798|FG000|Overall Study|No Fertilization|1|||
163876197|NCT02740231|591914799|FG000|Overall Study|Withdrawal by Subject|1|||
163876198|NCT02740231|591914800|FG001|Overall Study|Withdrawal by Subject|1|||
163876199|NCT02740231|591914801|FG002|Overall Study|Withdrawal by Subject|1|||
163876200|NCT02740231|591914802|FG003|Overall Study|Withdrawal by Subject|0|||
163876201|NCT02740231|591914799|FG000|Overall Study|Lack of Efficacy|0|||
163876202|NCT02740231|591914800|FG001|Overall Study|Lack of Efficacy|1|||
163876203|NCT02740231|591914801|FG002|Overall Study|Lack of Efficacy|0|||
163876204|NCT02740231|591914802|FG003|Overall Study|Lack of Efficacy|4|||
163876205|NCT02740231|591914799|FG000|Overall Study|Lost to Follow-up|1|||
163876206|NCT02740231|591914800|FG001|Overall Study|Lost to Follow-up|3|||
163876207|NCT02740231|591914801|FG002|Overall Study|Lost to Follow-up|0|||
163876208|NCT02740231|591914802|FG003|Overall Study|Lost to Follow-up|3|||
163876209|NCT02740231|591914799|FG000|Overall Study|Adverse Event|0|||
163876210|NCT02740231|591914800|FG001|Overall Study|Adverse Event|1|||
163876211|NCT02740231|591914801|FG002|Overall Study|Adverse Event|0|||
163876212|NCT02740231|591914802|FG003|Overall Study|Adverse Event|1|||
163876213|NCT00243503|591914803|FG000|Overall Study|Adverse Event|11|||
163876214|NCT00243503|591914803|FG000|Overall Study|Withdrawal by Subject|1|||
163876215|NCT00243503|591914803|FG000|Overall Study|Lack of Efficacy|44|||
163876216|NCT00243503|591914803|FG000|Overall Study|Death|1|||
164211252|NCT00314145|593140339|FG000|Overall Study|Lost to Follow-up|5|||
163876217|NCT00243503|591914803|FG000|Overall Study|Other|1|||
163876218|NCT04110054|591914804|FG000|Overall Study|COVID-19 reason other than AE|0|||
163876219|NCT04110054|591914805|FG001|Overall Study|COVID-19 reason other than AE|0|||
163876220|NCT04110054|591914806|FG002|Overall Study|COVID-19 reason other than AE|2|||
163876221|NCT04110054|591914807|FG003|Overall Study|COVID-19 reason other than AE|0|||
163876222|NCT04110054|591914804|FG000|Overall Study|Withdrawal by Subject|0|||
164211253|NCT00314145|593140340|FG001|Overall Study|Lost to Follow-up|12|||
164211254|NCT00314145|593140339|FG000|Overall Study|Physician Decision|3|||
164211255|NCT00314145|593140340|FG001|Overall Study|Physician Decision|4|||
164211256|NCT00314145|593140339|FG000|Overall Study|Adverse Event|0|||
164211257|NCT00314145|593140340|FG001|Overall Study|Adverse Event|3|||
164211258|NCT00314145|593140339|FG000|Overall Study|Protocol Violation|3|||
164211259|NCT00314145|593140340|FG001|Overall Study|Protocol Violation|0|||
164211260|NCT00314145|593140339|FG000|Overall Study|Sponsor Decision|2|||
164211261|NCT00314145|593140340|FG001|Overall Study|Sponsor Decision|0|||
164211262|NCT02382380|593140342|FG000|Overall Study|Withdrawal by Subject|2|||
164211263|NCT02382380|593140343|FG001|Overall Study|Withdrawal by Subject|2|||
164211264|NCT02382380|593140342|FG000|Overall Study|Lost to Follow-up|0|||
164211265|NCT02382380|593140343|FG001|Overall Study|Lost to Follow-up|1|||
164211266|NCT01295944|593140344|FG000|Overall Study|Switched to alternative treatment|1|||
164211267|NCT01295944|593140344|FG000|Overall Study|Ineligible|9|||
164211268|NCT01295944|593140344|FG000|Overall Study|Withdrawal by Subject|1|||
164211269|NCT01295944|593140344|FG000|Overall Study|Participant chose to be treated in Peru|1|||
164211270|NCT01295944|593140344|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
164211271|NCT01295944|593140344|FG000|Overall Study|Physician Decision|1|||
164211272|NCT01295944|593140344|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
164211273|NCT01295944|593140344|FG000|Overall Study|Disease progression|4|||
164211274|NCT01295944|593140344|FG000|Overall Study|Transferred care before starting new treatment|1|||
164211275|NCT03785366|593140345|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
164211276|NCT03785366|593140346|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
164325030|NCT04770753|593566011|FG000|Overall Study|Other un-specified|1|||
163876223|NCT04110054|591914805|FG001|Overall Study|Withdrawal by Subject|3|||
163876224|NCT04110054|591914806|FG002|Overall Study|Withdrawal by Subject|2|||
163876225|NCT04110054|591914807|FG003|Overall Study|Withdrawal by Subject|0|||
163876226|NCT04110054|591914804|FG000|Overall Study|Adverse Event|1|||
164077582|NCT01889862|592649997|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
164211277|NCT03785366|593140345|FG000|Overall Study|Lost to Follow-up|1|||
164211278|NCT03785366|593140346|FG001|Overall Study|Lost to Follow-up|0|||
164325031|NCT04770753|593566012|FG001|Overall Study|Other un-specified|0|||
163876227|NCT04110054|591914805|FG001|Overall Study|Adverse Event|1|||
163876228|NCT04110054|591914806|FG002|Overall Study|Adverse Event|4|||
164077583|NCT01889862|592649993|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
164325032|NCT05859698|593566014|FG000|Overall Study|Adverse Event|1|||
164325033|NCT05859698|593566014|FG000|Overall Study|Death|1|||
164325034|NCT05859698|593566014|FG000|Overall Study|Physician Decision|1|||
164325035|NCT05859698|593566014|FG000|Overall Study|Lost to Follow-up|2|||
164325036|NCT05859698|593566014|FG000|Overall Study|Other Than Specified|2|||
164325037|NCT05859698|593566014|FG000|Overall Study|Withdrawal by Subject|1|||
164325038|NCT05900999|593566015|FG000|Overall Study|Withdrawal by Subject|9|||
164325039|NCT05900999|593566015|FG000|Overall Study|transfer to another facility; too complex of a therapy schedule; physician withdrawal|3|||
164325040|NCT04527549|593566017|FG000|Overall Study|Withdrawal by Subject|1|||
164325041|NCT04527549|593566018|FG001|Overall Study|Withdrawal by Subject|1|||
164325042|NCT05411367|593566023|FG000|Overall Study|Adverse Event|9|||
164325043|NCT05411367|593566024|FG001|Overall Study|Adverse Event|3|||
164325044|NCT05411367|593566023|FG000|Overall Study|Protocol Violation|0|||
164325045|NCT05411367|593566024|FG001|Overall Study|Protocol Violation|2|||
164325046|NCT05411367|593566023|FG000|Overall Study|Administrative Reasons|2|||
164325047|NCT05411367|593566024|FG001|Overall Study|Administrative Reasons|1|||
164325048|NCT05411367|593566023|FG000|Overall Study|Withdrawal by Subject|3|||
164325049|NCT05411367|593566024|FG001|Overall Study|Withdrawal by Subject|4|||
164325050|NCT05411367|593566023|FG000|Overall Study|Inclusion Criteria Not Met|0|||
164325051|NCT05411367|593566024|FG001|Overall Study|Inclusion Criteria Not Met|1|||
164325052|NCT02032823|593566025|FG000|Overall Study|Death|75|||
164325053|NCT02032823|593566026|FG001|Overall Study|Death|109|||
164325054|NCT02032823|593566025|FG000|Overall Study|Lost to Follow-up|18|||
164325055|NCT02032823|593566026|FG001|Overall Study|Lost to Follow-up|17|||
164325056|NCT02032823|593566025|FG000|Overall Study|Withdrawal by Subject|70|||
164325057|NCT02032823|593566026|FG001|Overall Study|Withdrawal by Subject|53|||
164325058|NCT02032823|593566025|FG000|Overall Study|Ongoing study at data cut-off|755|||
164325059|NCT02032823|593566026|FG001|Overall Study|Ongoing study at data cut-off|731|||
164325060|NCT02032823|593566025|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
164325061|NCT02032823|593566026|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
164325062|NCT02411448|593566027|FG000|Overall Study|Withdrawal by Subject|1|||
164325063|NCT02411448|593566028|FG001|Overall Study|Withdrawal by Subject|14|||
164325064|NCT02411448|593566029|FG002|Overall Study|Withdrawal by Subject|9|||
164325065|NCT02411448|593566027|FG000|Overall Study|Other|0|||
164325066|NCT02411448|593566028|FG001|Overall Study|Other|2|||
164325067|NCT02411448|593566029|FG002|Overall Study|Other|0|||
164325068|NCT02411448|593566027|FG000|Overall Study|Did not receive study treatment|0|||
164325069|NCT02411448|593566028|FG001|Overall Study|Did not receive study treatment|3|||
164325070|NCT02411448|593566029|FG002|Overall Study|Did not receive study treatment|0|||
164325071|NCT02411448|593566027|FG000|Overall Study|Alive on study treatment|3|||
164325072|NCT02411448|593566028|FG001|Overall Study|Alive on study treatment|64|||
164325073|NCT02411448|593566029|FG002|Overall Study|Alive on study treatment|43|||
164325074|NCT02616562|593566031|FG000|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325075|NCT02616562|593566032|FG001|Main Period (26 Weeks)|Withdrawal by parent/guardian|1|||
164325076|NCT02616562|593566033|FG002|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325077|NCT02616562|593566034|FG003|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325078|NCT02616562|593566035|FG004|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325079|NCT02616562|593566036|FG005|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325080|NCT02616562|593566037|FG006|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325081|NCT02616562|593566038|FG007|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325082|NCT02616562|593566039|FG008|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325083|NCT02616562|593566040|FG009|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325084|NCT02616562|593566041|FG010|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325085|NCT02616562|593566042|FG011|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325086|NCT02616562|593566043|FG012|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325087|NCT02616562|593566044|FG013|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325088|NCT02616562|593566045|FG014|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325089|NCT02616562|593566046|FG015|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325090|NCT02616562|593566047|FG016|Main Period (26 Weeks)|Withdrawal by parent/guardian|0|||
164325091|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325092|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325093|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325094|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325095|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325096|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325097|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325098|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325099|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325100|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|1|||
164325101|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164211279|NCT03785366|593140345|FG000|Overall Study|Partial IUD Expulsion|0|||
164211280|NCT03785366|593140346|FG001|Overall Study|Partial IUD Expulsion|2|||
164211281|NCT03785366|593140345|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
164211282|NCT03785366|593140346|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
164211283|NCT03240874|593140347|FG000|Overall Study|Lost to Follow-up|0|||
164211284|NCT03240874|593140348|FG001|Overall Study|Lost to Follow-up|2|||
164211285|NCT03240874|593140349|FG002|Overall Study|Lost to Follow-up|4|||
164211286|NCT03240874|593140350|FG003|Overall Study|Lost to Follow-up|1|||
164211287|NCT04958707|593140351|FG000|Post Intervention|Withdrawal by Subject|1|||
164211288|NCT04958707|593140352|FG001|Post Intervention|Withdrawal by Subject|0|||
164211289|NCT04958707|593140353|FG002|Post Intervention|Withdrawal by Subject|0|||
164211290|NCT04958707|593140351|FG000|3 Months Follow- up|Lost to Follow-up|0|||
164211291|NCT04958707|593140352|FG001|3 Months Follow- up|Lost to Follow-up|3|||
164211292|NCT04958707|593140353|FG002|3 Months Follow- up|Lost to Follow-up|0|||
164211293|NCT04958707|593140351|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
164211294|NCT04958707|593140352|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
164211295|NCT04958707|593140353|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
164211296|NCT02783274|593140357|FG000|Overall Study|Withdrawal by Subject|16|||
164211297|NCT02783274|593140357|FG000|Overall Study|Physician Decision|6|||
164211298|NCT02783274|593140357|FG000|Overall Study|Death|9|||
164211299|NCT02783274|593140357|FG000|Overall Study|Lost to Follow-up|22|||
164211300|NCT02783274|593140357|FG000|Overall Study|Other|22|||
164211301|NCT05567172|593140358|FG000|Overall Study|Death|3|||
164211302|NCT02246777|593140361|FG000|Overall Study|Adverse Event|2|||
164211303|NCT02246777|593140361|FG000|Overall Study|Change of residence|1|||
164211304|NCT00927472|593140362|FG000|Overall Study|Withdrawal by Subject|10|||
164211305|NCT00927472|593140363|FG001|Overall Study|Withdrawal by Subject|11|||
164211306|NCT00927472|593140362|FG000|Overall Study|Lost to Follow-up|1|||
164211307|NCT00927472|593140363|FG001|Overall Study|Lost to Follow-up|6|||
164211308|NCT00927472|593140362|FG000|Overall Study|Protocol Violation|0|||
164211309|NCT00927472|593140363|FG001|Overall Study|Protocol Violation|1|||
164211310|NCT00927472|593140362|FG000|Overall Study|Post treatment Assessment out of window|0|||
164211311|NCT00927472|593140363|FG001|Overall Study|Post treatment Assessment out of window|4|||
164211312|NCT04707469|593140364|FG000|Overall Study|Site closure|0|||
164211313|NCT04707469|593140365|FG001|Overall Study|Site closure|2|||
164211314|NCT04707469|593140366|FG002|Overall Study|Site closure|0|||
164211315|NCT04707469|593140364|FG000|Overall Study|Physician Decision|2|||
164211316|NCT04707469|593140365|FG001|Overall Study|Physician Decision|2|||
164211317|NCT04707469|593140366|FG002|Overall Study|Physician Decision|2|||
164211318|NCT04707469|593140364|FG000|Overall Study|Death|1|||
164211319|NCT04707469|593140365|FG001|Overall Study|Death|6|||
164211320|NCT04707469|593140366|FG002|Overall Study|Death|2|||
164211321|NCT04707469|593140364|FG000|Overall Study|Lost to Follow-up|9|||
164211322|NCT04707469|593140365|FG001|Overall Study|Lost to Follow-up|19|||
164211323|NCT04707469|593140366|FG002|Overall Study|Lost to Follow-up|14|||
164211324|NCT04707469|593140364|FG000|Overall Study|Withdrawal by Subject|17|||
164211325|NCT04707469|593140365|FG001|Overall Study|Withdrawal by Subject|16|||
164211326|NCT04707469|593140366|FG002|Overall Study|Withdrawal by Subject|12|||
164211327|NCT04635423|593140379|FG000|Overall Study|Ongoing|493|||
164211328|NCT04635423|593140380|FG001|Overall Study|Ongoing|501|||
164211329|NCT04635423|593140379|FG000|Overall Study|Withdrawal by Subject|36|||
164211330|NCT04635423|593140380|FG001|Overall Study|Withdrawal by Subject|29|||
164211331|NCT00830765|593140384|FG000|Overall Study|Protocol Violation|3|||
164211332|NCT00830765|593140385|FG001|Overall Study|Protocol Violation|2|||
164211333|NCT01811238|593140386|FG000|Overall Study|Withdrawal by Subject|42|||
164211334|NCT01811238|593140386|FG000|Overall Study|Adverse Event|25|||
164211335|NCT01811238|593140386|FG000|Overall Study|Protocol Violation|4|||
164211336|NCT01811238|593140386|FG000|Overall Study|Lack of Efficacy|4|||
164211337|NCT01811238|593140386|FG000|Overall Study|subject refused study medication|6|||
164325102|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325103|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325104|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325105|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164211338|NCT01977846|593140387|FG000|Total Study - Prospective|Death|0|||
164211339|NCT01977846|593140388|FG001|Total Study - Prospective|Death|1|||
164211340|NCT01977846|593140387|FG000|Total Study - Prospective|Lost to Follow-up|0|||
164211341|NCT01977846|593140388|FG001|Total Study - Prospective|Lost to Follow-up|8|||
164211342|NCT01977846|593140387|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
164211343|NCT01977846|593140388|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
164211344|NCT01977846|593140387|FG000|Total Study - Prospective|Not available at time of visit|0|||
164211345|NCT01977846|593140388|FG001|Total Study - Prospective|Not available at time of visit|5|||
164211346|NCT01977846|593140387|FG000|Total Study - Prospective|No show|0|||
164211347|NCT01977846|593140388|FG001|Total Study - Prospective|No show|1|||
164211348|NCT01977846|593140387|FG000|Total Study - Prospective|Protocol Violation|0|||
164211349|NCT01977846|593140388|FG001|Total Study - Prospective|Protocol Violation|1|||
163876229|NCT04110054|591914807|FG003|Overall Study|Adverse Event|3|||
163876230|NCT01000480|591914809|FG000|Induction Phase|Adverse Event|2|||
164211350|NCT00724945|593140389|FG000|Period 1|non-compliance|1|||
164211351|NCT00724945|593140390|FG001|Period 1|non-compliance|0|||
164211352|NCT00724945|593140389|FG000|Period 1|Adverse Event|1|||
164211353|NCT00724945|593140390|FG001|Period 1|Adverse Event|1|||
164211354|NCT00724945|593140389|FG000|Period 1|Lost to Follow-up|1|||
164211355|NCT00724945|593140390|FG001|Period 1|Lost to Follow-up|0|||
164211356|NCT00724945|593140389|FG000|Period 2|lens comfort issue|3|||
164211357|NCT00724945|593140390|FG001|Period 2|lens comfort issue|0|||
164211358|NCT00724945|593140389|FG000|Period 2|lens physiology issue|1|||
164211359|NCT00724945|593140390|FG001|Period 2|lens physiology issue|0|||
164211360|NCT05166876|593140391|FG000|Overall Study|Withdrawal by Subject|1|||
164211361|NCT05166876|593140392|FG001|Overall Study|Withdrawal by Subject|0|||
164211362|NCT05166876|593140393|FG002|Overall Study|Withdrawal by Subject|0|||
164211363|NCT03479905|593140398|FG000|Overall Study|Other airway method used|4|||
164211364|NCT03479905|593140399|FG001|Overall Study|Other airway method used|5|||
164211365|NCT03479905|593140400|FG002|Overall Study|Other airway method used|5|||
164211366|NCT01147458|593140401|FG000|First Intervention|Study terminated by sponsor|8|||
164211367|NCT01147458|593140402|FG001|First Intervention|Study terminated by sponsor|8|||
164211368|NCT01147458|593140403|FG002|First Intervention|Study terminated by sponsor|7|||
164211369|NCT01147458|593140404|FG003|First Intervention|Study terminated by sponsor|8|||
164211370|NCT01147458|593140401|FG000|First Intervention|Protocol Violation|2|||
164211371|NCT01147458|593140402|FG001|First Intervention|Protocol Violation|3|||
164211372|NCT01147458|593140403|FG002|First Intervention|Protocol Violation|2|||
164211373|NCT01147458|593140404|FG003|First Intervention|Protocol Violation|3|||
164211374|NCT01147458|593140401|FG000|First Intervention|Withdrawal by Subject|3|||
164211375|NCT01147458|593140402|FG001|First Intervention|Withdrawal by Subject|0|||
164211376|NCT01147458|593140403|FG002|First Intervention|Withdrawal by Subject|1|||
164211377|NCT01147458|593140404|FG003|First Intervention|Withdrawal by Subject|0|||
164211378|NCT01147458|593140401|FG000|First Intervention|Adverse Event|0|||
164211379|NCT01147458|593140402|FG001|First Intervention|Adverse Event|3|||
164211380|NCT01147458|593140403|FG002|First Intervention|Adverse Event|2|||
164211381|NCT01147458|593140404|FG003|First Intervention|Adverse Event|3|||
164211382|NCT01147458|593140401|FG000|First Intervention|Other|1|||
164211383|NCT01147458|593140402|FG001|First Intervention|Other|2|||
164211384|NCT01147458|593140403|FG002|First Intervention|Other|0|||
164211385|NCT01147458|593140404|FG003|First Intervention|Other|0|||
164211386|NCT01147458|593140401|FG000|Second Intervention|Study terminated by sponsor|7|||
164211387|NCT01147458|593140402|FG001|Second Intervention|Study terminated by sponsor|5|||
164211388|NCT01147458|593140403|FG002|Second Intervention|Study terminated by sponsor|5|||
164211389|NCT01147458|593140404|FG003|Second Intervention|Study terminated by sponsor|3|||
164211390|NCT01147458|593140401|FG000|Second Intervention|Protocol Violation|0|||
164211391|NCT01147458|593140402|FG001|Second Intervention|Protocol Violation|1|||
164211392|NCT01147458|593140403|FG002|Second Intervention|Protocol Violation|1|||
164211393|NCT01147458|593140404|FG003|Second Intervention|Protocol Violation|0|||
164211394|NCT01147458|593140401|FG000|Second Intervention|Withdrawal by Subject|0|||
164211395|NCT01147458|593140402|FG001|Second Intervention|Withdrawal by Subject|1|||
164211396|NCT01147458|593140403|FG002|Second Intervention|Withdrawal by Subject|0|||
164211397|NCT01147458|593140404|FG003|Second Intervention|Withdrawal by Subject|0|||
164211398|NCT01147458|593140401|FG000|Second Intervention|Adverse Event|2|||
164211399|NCT01147458|593140402|FG001|Second Intervention|Adverse Event|0|||
164211400|NCT01147458|593140403|FG002|Second Intervention|Adverse Event|1|||
164211401|NCT01147458|593140404|FG003|Second Intervention|Adverse Event|1|||
164211402|NCT01147458|593140401|FG000|Second Intervention|Other|0|||
164211403|NCT01147458|593140402|FG001|Second Intervention|Other|0|||
164211404|NCT01147458|593140403|FG002|Second Intervention|Other|1|||
164211405|NCT01147458|593140404|FG003|Second Intervention|Other|0|||
164211406|NCT02811159|593140416|FG000|Treatment Course 1|Lost to Follow-up|1|||
164211407|NCT00143507|593142472|FG000|Overall Study|Death|572|||
164211408|NCT00143507|593142473|FG001|Overall Study|Death|547|||
164211409|NCT00143507|593142472|FG000|Overall Study|Withdrawal by Subject|114|||
164211410|NCT00143507|593142473|FG001|Overall Study|Withdrawal by Subject|102|||
164211411|NCT00143507|593142472|FG000|Overall Study|Lost to Follow-up|1|||
164211412|NCT00143507|593142473|FG001|Overall Study|Lost to Follow-up|0|||
164211413|NCT00143507|593142472|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
164325106|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164325107|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|Withdrawal by parent/guardian|0|||
164211414|NCT00143507|593142473|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
164211415|NCT00177671|593142474|FG000|Overall Study|Withdrawal by Subject|5|||
164211416|NCT00177671|593142475|FG001|Overall Study|Withdrawal by Subject|6|||
164211417|NCT00177671|593142474|FG000|Overall Study|medical complications|2|||
164211418|NCT00177671|593142475|FG001|Overall Study|medical complications|0|||
164211419|NCT00177671|593142474|FG000|Overall Study|Adverse Event|6|||
164211420|NCT00177671|593142475|FG001|Overall Study|Adverse Event|0|||
164211421|NCT00177671|593142474|FG000|Overall Study|Physician Decision|12|||
164211422|NCT00177671|593142475|FG001|Overall Study|Physician Decision|8|||
164355619|NCT00512707|593676482|FG000|Overall Study|Developed skin irritation|2|||
164211423|NCT00690898|593142476|FG000|SCREENING|Screen failure|18|||
164211424|NCT00690898|593142476|FG000|TREATMENT|Adverse Event|3|||
164325108|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325109|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325110|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325111|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325112|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325113|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325114|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325115|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325116|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
164325117|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|1|||
164325118|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325119|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325120|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325121|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325122|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325123|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325124|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|treatment discontinued before visit 5|0|||
164325125|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325126|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325127|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325128|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325129|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325130|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325131|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325132|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325133|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325134|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|Lost to Follow-up|1|||
163980562|NCT01049035|592299566|FG004|Overall Study|Serious adverse event|0|||
163980563|NCT01049035|592299567|FG005|Overall Study|Serious adverse event|0|||
163980564|NCT01049035|592299568|FG006|Overall Study|Serious adverse event|0|||
163980565|NCT01049035|592299562|FG000|Overall Study|Other adverse event (AE)|0|||
163980566|NCT01049035|592299563|FG001|Overall Study|Other adverse event (AE)|0|||
164136630|NCT00265395|592864985|FG000|Overall Study|Adverse Event|3|||
164136631|NCT00265395|592864986|FG001|Overall Study|Adverse Event|6|||
164136632|NCT00265395|592864985|FG000|Overall Study|Lost to Follow-up|2|||
164136633|NCT00265395|592864986|FG001|Overall Study|Lost to Follow-up|1|||
164136634|NCT00265395|592864985|FG000|Overall Study|Withdrawal by Subject|1|||
164136635|NCT00265395|592864986|FG001|Overall Study|Withdrawal by Subject|6|||
164136636|NCT00265395|592864985|FG000|Overall Study|Protocol Violation|2|||
164136637|NCT00265395|592864986|FG001|Overall Study|Protocol Violation|2|||
164136638|NCT00265395|592864985|FG000|Overall Study|Lack of Efficacy|0|||
164136639|NCT00265395|592864986|FG001|Overall Study|Lack of Efficacy|1|||
164136640|NCT00265395|592864985|FG000|Overall Study|Administrative|0|||
164136641|NCT00265395|592864986|FG001|Overall Study|Administrative|1|||
164136642|NCT03400943|592864987|FG000|Treatment Period 1|Adverse Event|0|||
164136643|NCT03400943|592864988|FG001|Treatment Period 1|Adverse Event|0|||
164136644|NCT03400943|592864989|FG002|Treatment Period 1|Adverse Event|0|||
164136645|NCT03400943|592864990|FG003|Treatment Period 1|Adverse Event|1|||
164136646|NCT03400943|592864987|FG000|Treatment Period 1|Lost to Follow-up|1|||
164136647|NCT03400943|592864988|FG001|Treatment Period 1|Lost to Follow-up|0|||
164136648|NCT03400943|592864989|FG002|Treatment Period 1|Lost to Follow-up|0|||
164136649|NCT03400943|592864990|FG003|Treatment Period 1|Lost to Follow-up|0|||
164136650|NCT03400943|592864987|FG000|Treatment Period 1|Protocol Violation|0|||
164136651|NCT03400943|592864988|FG001|Treatment Period 1|Protocol Violation|1|||
164136652|NCT03400943|592864989|FG002|Treatment Period 1|Protocol Violation|1|||
164136653|NCT03400943|592864990|FG003|Treatment Period 1|Protocol Violation|0|||
164136654|NCT03400943|592864987|FG000|Treatment Period 1|Study terminated by sponsor|2|||
164136655|NCT03400943|592864988|FG001|Treatment Period 1|Study terminated by sponsor|0|||
164136656|NCT03400943|592864989|FG002|Treatment Period 1|Study terminated by sponsor|0|||
164136657|NCT03400943|592864990|FG003|Treatment Period 1|Study terminated by sponsor|1|||
164136658|NCT03400943|592864987|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164136659|NCT03400943|592864988|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164136660|NCT03400943|592864989|FG002|Treatment Period 1|Withdrawal by Subject|3|||
164136661|NCT03400943|592864990|FG003|Treatment Period 1|Withdrawal by Subject|1|||
164136662|NCT03400943|592864987|FG000|Treatment Period 1|Other|2|||
164136663|NCT03400943|592864988|FG001|Treatment Period 1|Other|1|||
164136664|NCT03400943|592864989|FG002|Treatment Period 1|Other|2|||
164136665|NCT03400943|592864990|FG003|Treatment Period 1|Other|2|||
164211425|NCT00690898|593142476|FG000|TREATMENT|Lack of Efficacy|18|||
164211426|NCT00690898|593142476|FG000|TREATMENT|Withdrawal by Subject|4|||
164211427|NCT00690898|593142476|FG000|TREATMENT|Other (not otherwise specified)|1|||
164211428|NCT00356590|593142478|FG000|Overall Study|Adverse Event|54|||
164211429|NCT00356590|593142478|FG000|Overall Study|Death|10|||
164211430|NCT00356590|593142478|FG000|Overall Study|Lost to Follow-up|35|||
164211431|NCT00356590|593142478|FG000|Overall Study|Physician Decision|46|||
164211432|NCT00356590|593142478|FG000|Overall Study|Withdrawal by Subject|41|||
164211433|NCT00356590|593142478|FG000|Overall Study|Completed month 12 only|2|||
164211434|NCT00356590|593142478|FG000|Overall Study|Protocol issues|6|||
164211435|NCT00356590|593142478|FG000|Overall Study|Response status|28|||
164211436|NCT00356590|593142478|FG000|Overall Study|Other|52|||
164211437|NCT01496456|593142479|FG000|Overall Study|Protocol Violation|1|||
164211438|NCT01496456|593142479|FG000|Overall Study|Lost to Follow-up|7|||
164211439|NCT04919161|593142480|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
164211440|NCT04919161|593142481|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
164211441|NCT04919161|593142480|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
164211442|NCT04919161|593142481|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
164211443|NCT04919161|593142480|FG000|Overall Study|Acute ankle sprain after session 1|0|||
164211444|NCT04919161|593142481|FG001|Overall Study|Acute ankle sprain after session 1|1|||
164211445|NCT02239328|593142482|FG000|Overall Study|Benign disease noted at time of surgery|6|||
164211446|NCT02239328|593142482|FG000|Overall Study|Equipment or website malfunction|2|||
164211447|NCT01838876|593142484|FG000|Overall Study|Adverse Event|49|||
164211448|NCT01838876|593142484|FG000|Overall Study|Insufficient Therapeutic Response|10|||
164211449|NCT01838876|593142484|FG000|Overall Study|Protocol Violation|34|||
164211450|NCT01838876|593142484|FG000|Overall Study|Withdrawal of Consent|33|||
164211451|NCT01838876|593142484|FG000|Overall Study|Lost to Follow-up|21|||
164211452|NCT01838876|593142484|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
164211453|NCT01838876|593142484|FG000|Overall Study|Reason not Specified|7|||
164211454|NCT01838876|593142484|FG000|Overall Study|Did not meet eligibility criteria|78|||
164211455|NCT01682031|593142485|FG000|Overall Study|Withdrawal by Subject|0|||
164211456|NCT01682031|593142486|FG001|Overall Study|Withdrawal by Subject|1|||
164211457|NCT01682031|593142485|FG000|Overall Study|Adverse Event|0|||
164211458|NCT01682031|593142486|FG001|Overall Study|Adverse Event|2|||
164211459|NCT01682031|593142485|FG000|Overall Study|MRI results indicate increased nodul|0|||
164211460|NCT01682031|593142486|FG001|Overall Study|MRI results indicate increased nodul|1|||
164211461|NCT01682031|593142485|FG000|Overall Study|Patient could not swallow tablets|1|||
164211462|NCT01682031|593142486|FG001|Overall Study|Patient could not swallow tablets|0|||
164211463|NCT01682031|593142485|FG000|Overall Study|Patient stopped selenium on his own|0|||
164211464|NCT01682031|593142486|FG001|Overall Study|Patient stopped selenium on his own|1|||
164211465|NCT00963235|593142489|FG000|Overall Study|Withdrawal by Subject|22|||
164211466|NCT00963235|593142489|FG000|Overall Study|Lost to Follow-up|14|||
164211467|NCT00963235|593142489|FG000|Overall Study|Failed to return|9|||
164211468|NCT00963235|593142489|FG000|Overall Study|Protocol Violation|7|||
164211469|NCT00963235|593142489|FG000|Overall Study|Adverse Event|5|||
164211470|NCT00963235|593142489|FG000|Overall Study|Physician Decision|2|||
164211471|NCT00963235|593142489|FG000|Overall Study|Other|1|||
164211472|NCT01756235|593142490|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
164211473|NCT02327078|593142495|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
164211474|NCT02327078|593142496|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
164211475|NCT02327078|593142497|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
164211476|NCT02327078|593142498|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
164211477|NCT02327078|593142499|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
164211478|NCT02327078|593142500|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
164211479|NCT02327078|593142501|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
164211480|NCT02327078|593142502|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
164211481|NCT02327078|593142503|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
164211482|NCT02327078|593142495|FG000|Overall Study|Death|2|||
164211483|NCT02327078|593142496|FG001|Overall Study|Death|4|||
164211484|NCT02327078|593142497|FG002|Overall Study|Death|10|||
164211485|NCT02327078|593142498|FG003|Overall Study|Death|6|||
164211486|NCT02327078|593142499|FG004|Overall Study|Death|4|||
164211487|NCT02327078|593142500|FG005|Overall Study|Death|3|||
164211488|NCT02327078|593142501|FG006|Overall Study|Death|2|||
164211489|NCT02327078|593142502|FG007|Overall Study|Death|51|||
164211490|NCT02327078|593142503|FG008|Overall Study|Death|97|||
164211491|NCT02327078|593142495|FG000|Overall Study|Lost to Follow-up|0|||
164211492|NCT02327078|593142496|FG001|Overall Study|Lost to Follow-up|1|||
164211493|NCT02327078|593142497|FG002|Overall Study|Lost to Follow-up|1|||
164211494|NCT02327078|593142498|FG003|Overall Study|Lost to Follow-up|0|||
164211495|NCT02327078|593142499|FG004|Overall Study|Lost to Follow-up|0|||
164211496|NCT02327078|593142500|FG005|Overall Study|Lost to Follow-up|0|||
164211497|NCT02327078|593142501|FG006|Overall Study|Lost to Follow-up|0|||
164077584|NCT01889862|592649994|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164211498|NCT02327078|593142502|FG007|Overall Study|Lost to Follow-up|2|||
164211499|NCT02327078|593142503|FG008|Overall Study|Lost to Follow-up|5|||
164211500|NCT02327078|593142495|FG000|Overall Study|Site Terminated by Sponsor|1|||
164211501|NCT02327078|593142496|FG001|Overall Study|Site Terminated by Sponsor|0|||
164211502|NCT02327078|593142497|FG002|Overall Study|Site Terminated by Sponsor|1|||
164211503|NCT02327078|593142498|FG003|Overall Study|Site Terminated by Sponsor|4|||
164211504|NCT02327078|593142499|FG004|Overall Study|Site Terminated by Sponsor|0|||
164211505|NCT02327078|593142500|FG005|Overall Study|Site Terminated by Sponsor|0|||
164211506|NCT02327078|593142501|FG006|Overall Study|Site Terminated by Sponsor|0|||
164211507|NCT02327078|593142502|FG007|Overall Study|Site Terminated by Sponsor|11|||
164211508|NCT02327078|593142503|FG008|Overall Study|Site Terminated by Sponsor|25|||
164211509|NCT02327078|593142495|FG000|Overall Study|Physician Decision|0|||
164211510|NCT02327078|593142496|FG001|Overall Study|Physician Decision|0|||
164211511|NCT02327078|593142497|FG002|Overall Study|Physician Decision|0|||
164211512|NCT02327078|593142498|FG003|Overall Study|Physician Decision|1|||
164211513|NCT02327078|593142499|FG004|Overall Study|Physician Decision|0|||
164211514|NCT02327078|593142500|FG005|Overall Study|Physician Decision|0|||
164211515|NCT02327078|593142501|FG006|Overall Study|Physician Decision|0|||
164211516|NCT02327078|593142502|FG007|Overall Study|Physician Decision|0|||
164211517|NCT02327078|593142503|FG008|Overall Study|Physician Decision|1|||
164211518|NCT02327078|593142495|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211519|NCT02327078|593142496|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211520|NCT02327078|593142497|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211521|NCT02327078|593142498|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
164211522|NCT02327078|593142499|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
164211523|NCT02327078|593142500|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
164211524|NCT02327078|593142501|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
164211525|NCT02327078|593142502|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
164211526|NCT02327078|593142503|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
164211527|NCT02327078|593142495|FG000|Overall Study|Reason not Specified|0|||
164211528|NCT02327078|593142496|FG001|Overall Study|Reason not Specified|0|||
164211529|NCT02327078|593142497|FG002|Overall Study|Reason not Specified|0|||
164211530|NCT02327078|593142498|FG003|Overall Study|Reason not Specified|0|||
164211531|NCT02327078|593142499|FG004|Overall Study|Reason not Specified|0|||
164211532|NCT02327078|593142500|FG005|Overall Study|Reason not Specified|0|||
164211533|NCT02327078|593142501|FG006|Overall Study|Reason not Specified|0|||
164211534|NCT02327078|593142502|FG007|Overall Study|Reason not Specified|5|||
164211535|NCT02327078|593142503|FG008|Overall Study|Reason not Specified|12|||
164211536|NCT03330197|593142507|FG000|Overall Study|Adverse Event|0|||
164211537|NCT03330197|593142508|FG001|Overall Study|Adverse Event|1|||
164211538|NCT03330197|593142507|FG000|Overall Study|Withdrawal by Subject|0|||
164211539|NCT03330197|593142508|FG001|Overall Study|Withdrawal by Subject|1|||
164211540|NCT03765073|593142509|FG000|Stage 1|Lost to Follow-up|1|||
164211541|NCT03765073|593142510|FG001|Stage 1|Lost to Follow-up|0|||
164211542|NCT03765073|593142511|FG002|Stage 1|Lost to Follow-up|0|||
164211543|NCT03765073|593142512|FG003|Stage 1|Lost to Follow-up|0|||
164211544|NCT03765073|593142513|FG004|Stage 1|Lost to Follow-up|0|||
164211545|NCT03765073|593142514|FG005|Stage 1|Lost to Follow-up|0|||
164211546|NCT03765073|593142515|FG006|Stage 1|Lost to Follow-up|0|||
164211547|NCT03765073|593142516|FG007|Stage 1|Lost to Follow-up|0|||
164211548|NCT03765073|593142517|FG008|Stage 1|Lost to Follow-up|0|||
164211549|NCT03765073|593142518|FG009|Stage 1|Lost to Follow-up|0|||
164211550|NCT03765073|593142519|FG010|Stage 1|Lost to Follow-up|0|||
164211551|NCT03765073|593142520|FG011|Stage 1|Lost to Follow-up|0|||
164211552|NCT03765073|593142521|FG012|Stage 1|Lost to Follow-up|0|||
164211553|NCT03765073|593142522|FG013|Stage 1|Lost to Follow-up|0|||
164211554|NCT03765073|593142523|FG014|Stage 1|Lost to Follow-up|0|||
164211555|NCT03765073|593142524|FG015|Stage 1|Lost to Follow-up|0|||
164211556|NCT03765073|593142525|FG016|Stage 1|Lost to Follow-up|0|||
164211557|NCT03765073|593142526|FG017|Stage 1|Lost to Follow-up|0|||
164211558|NCT03765073|593142527|FG018|Stage 1|Lost to Follow-up|0|||
164211559|NCT03765073|593142528|FG019|Stage 1|Lost to Follow-up|0|||
164211560|NCT03765073|593142529|FG020|Stage 1|Lost to Follow-up|0|||
164211561|NCT03765073|593142509|FG000|Stage 1|Withdrawal by participant|0|||
164211562|NCT03765073|593142510|FG001|Stage 1|Withdrawal by participant|1|||
164211563|NCT03765073|593142511|FG002|Stage 1|Withdrawal by participant|0|||
164211564|NCT03765073|593142512|FG003|Stage 1|Withdrawal by participant|0|||
164211565|NCT03765073|593142513|FG004|Stage 1|Withdrawal by participant|0|||
164211566|NCT03765073|593142514|FG005|Stage 1|Withdrawal by participant|0|||
164211567|NCT03765073|593142515|FG006|Stage 1|Withdrawal by participant|0|||
164211568|NCT03765073|593142516|FG007|Stage 1|Withdrawal by participant|0|||
164077585|NCT01889862|592649995|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164211569|NCT03765073|593142517|FG008|Stage 1|Withdrawal by participant|0|||
164211570|NCT03765073|593142518|FG009|Stage 1|Withdrawal by participant|0|||
164211571|NCT03765073|593142519|FG010|Stage 1|Withdrawal by participant|0|||
164211572|NCT03765073|593142520|FG011|Stage 1|Withdrawal by participant|0|||
164211573|NCT03765073|593142521|FG012|Stage 1|Withdrawal by participant|0|||
164211574|NCT03765073|593142522|FG013|Stage 1|Withdrawal by participant|0|||
164211575|NCT03765073|593142523|FG014|Stage 1|Withdrawal by participant|0|||
164211576|NCT03765073|593142524|FG015|Stage 1|Withdrawal by participant|0|||
164211577|NCT03765073|593142525|FG016|Stage 1|Withdrawal by participant|0|||
164211578|NCT03765073|593142526|FG017|Stage 1|Withdrawal by participant|0|||
164211579|NCT03765073|593142527|FG018|Stage 1|Withdrawal by participant|0|||
164211580|NCT03765073|593142528|FG019|Stage 1|Withdrawal by participant|0|||
164211581|NCT03765073|593142529|FG020|Stage 1|Withdrawal by participant|0|||
164211582|NCT03765073|593142509|FG000|Stage 2|Death|0|||
164211583|NCT03765073|593142510|FG001|Stage 2|Death|0|||
164211584|NCT03765073|593142511|FG002|Stage 2|Death|0|||
164211585|NCT03765073|593142512|FG003|Stage 2|Death|0|||
164211586|NCT03765073|593142513|FG004|Stage 2|Death|0|||
164211587|NCT03765073|593142514|FG005|Stage 2|Death|0|||
164211588|NCT03765073|593142515|FG006|Stage 2|Death|0|||
164211589|NCT03765073|593142516|FG007|Stage 2|Death|0|||
164211590|NCT03765073|593142517|FG008|Stage 2|Death|0|||
164211591|NCT03765073|593142518|FG009|Stage 2|Death|1|||
164211592|NCT03765073|593142519|FG010|Stage 2|Death|0|||
164211593|NCT03765073|593142520|FG011|Stage 2|Death|1|||
164211594|NCT03765073|593142521|FG012|Stage 2|Death|0|||
164211595|NCT03765073|593142522|FG013|Stage 2|Death|0|||
164211596|NCT03765073|593142523|FG014|Stage 2|Death|0|||
164211597|NCT03765073|593142524|FG015|Stage 2|Death|0|||
164211598|NCT03765073|593142525|FG016|Stage 2|Death|2|||
164211599|NCT03765073|593142526|FG017|Stage 2|Death|0|||
164211600|NCT03765073|593142527|FG018|Stage 2|Death|0|||
164211601|NCT03765073|593142528|FG019|Stage 2|Death|0|||
164211602|NCT03765073|593142529|FG020|Stage 2|Death|0|||
164211603|NCT03765073|593142509|FG000|Stage 2|Lost to Follow-up|0|||
164211604|NCT03765073|593142510|FG001|Stage 2|Lost to Follow-up|0|||
164211605|NCT03765073|593142511|FG002|Stage 2|Lost to Follow-up|0|||
164211606|NCT03765073|593142512|FG003|Stage 2|Lost to Follow-up|5|||
164211607|NCT03765073|593142513|FG004|Stage 2|Lost to Follow-up|1|||
164211608|NCT03765073|593142514|FG005|Stage 2|Lost to Follow-up|0|||
164211609|NCT03765073|593142515|FG006|Stage 2|Lost to Follow-up|3|||
164211610|NCT03765073|593142516|FG007|Stage 2|Lost to Follow-up|3|||
164211611|NCT03765073|593142517|FG008|Stage 2|Lost to Follow-up|1|||
164211612|NCT03765073|593142518|FG009|Stage 2|Lost to Follow-up|6|||
164211613|NCT03765073|593142519|FG010|Stage 2|Lost to Follow-up|5|||
164211614|NCT03765073|593142520|FG011|Stage 2|Lost to Follow-up|1|||
164211615|NCT03765073|593142521|FG012|Stage 2|Lost to Follow-up|1|||
164211616|NCT03765073|593142522|FG013|Stage 2|Lost to Follow-up|3|||
164211617|NCT03765073|593142523|FG014|Stage 2|Lost to Follow-up|3|||
164211618|NCT03765073|593142524|FG015|Stage 2|Lost to Follow-up|1|||
164211619|NCT03765073|593142525|FG016|Stage 2|Lost to Follow-up|6|||
164211620|NCT03765073|593142526|FG017|Stage 2|Lost to Follow-up|0|||
164211621|NCT03765073|593142527|FG018|Stage 2|Lost to Follow-up|0|||
164211622|NCT03765073|593142528|FG019|Stage 2|Lost to Follow-up|0|||
164211623|NCT03765073|593142529|FG020|Stage 2|Lost to Follow-up|0|||
164211624|NCT03765073|593142509|FG000|Stage 2|Other|0|||
164211625|NCT03765073|593142510|FG001|Stage 2|Other|0|||
164211626|NCT03765073|593142511|FG002|Stage 2|Other|0|||
164211627|NCT03765073|593142512|FG003|Stage 2|Other|0|||
164211628|NCT03765073|593142513|FG004|Stage 2|Other|0|||
164211629|NCT03765073|593142514|FG005|Stage 2|Other|0|||
164211630|NCT03765073|593142515|FG006|Stage 2|Other|0|||
164211631|NCT03765073|593142516|FG007|Stage 2|Other|1|||
164211632|NCT03765073|593142517|FG008|Stage 2|Other|1|||
164211633|NCT03765073|593142518|FG009|Stage 2|Other|3|||
164211634|NCT03765073|593142519|FG010|Stage 2|Other|0|||
164211635|NCT03765073|593142520|FG011|Stage 2|Other|0|||
164211636|NCT03765073|593142521|FG012|Stage 2|Other|0|||
164211637|NCT03765073|593142522|FG013|Stage 2|Other|0|||
164211638|NCT03765073|593142523|FG014|Stage 2|Other|0|||
164211639|NCT03765073|593142524|FG015|Stage 2|Other|1|||
164211640|NCT03765073|593142525|FG016|Stage 2|Other|2|||
163876231|NCT01000480|591914809|FG000|Induction Phase|Lost to Follow-up|1|||
164077586|NCT01889862|592649996|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164077587|NCT01889862|592649997|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
164211641|NCT03765073|593142526|FG017|Stage 2|Other|0|||
164211642|NCT03765073|593142527|FG018|Stage 2|Other|0|||
164211643|NCT03765073|593142528|FG019|Stage 2|Other|0|||
164211644|NCT03765073|593142529|FG020|Stage 2|Other|0|||
164211645|NCT03765073|593142509|FG000|Stage 2|Withdrawal by parent/guardian|0|||
164211646|NCT03765073|593142510|FG001|Stage 2|Withdrawal by parent/guardian|0|||
164211647|NCT03765073|593142511|FG002|Stage 2|Withdrawal by parent/guardian|0|||
163876232|NCT01000480|591914809|FG000|Induction Phase|Physician Decision|1|||
164211648|NCT03765073|593142512|FG003|Stage 2|Withdrawal by parent/guardian|0|||
164211649|NCT03765073|593142513|FG004|Stage 2|Withdrawal by parent/guardian|0|||
164211650|NCT03765073|593142514|FG005|Stage 2|Withdrawal by parent/guardian|0|||
164211651|NCT03765073|593142515|FG006|Stage 2|Withdrawal by parent/guardian|0|||
164211652|NCT03765073|593142516|FG007|Stage 2|Withdrawal by parent/guardian|0|||
164211653|NCT03765073|593142517|FG008|Stage 2|Withdrawal by parent/guardian|0|||
164211654|NCT03765073|593142518|FG009|Stage 2|Withdrawal by parent/guardian|0|||
164211655|NCT03765073|593142519|FG010|Stage 2|Withdrawal by parent/guardian|3|||
164211656|NCT03765073|593142520|FG011|Stage 2|Withdrawal by parent/guardian|3|||
164211657|NCT03765073|593142521|FG012|Stage 2|Withdrawal by parent/guardian|3|||
164211658|NCT03765073|593142522|FG013|Stage 2|Withdrawal by parent/guardian|1|||
164211659|NCT03765073|593142523|FG014|Stage 2|Withdrawal by parent/guardian|1|||
164211660|NCT03765073|593142524|FG015|Stage 2|Withdrawal by parent/guardian|0|||
164211661|NCT03765073|593142525|FG016|Stage 2|Withdrawal by parent/guardian|3|||
164211662|NCT03765073|593142526|FG017|Stage 2|Withdrawal by parent/guardian|0|||
164211663|NCT03765073|593142527|FG018|Stage 2|Withdrawal by parent/guardian|0|||
164211664|NCT03765073|593142528|FG019|Stage 2|Withdrawal by parent/guardian|0|||
164211665|NCT03765073|593142529|FG020|Stage 2|Withdrawal by parent/guardian|0|||
164211666|NCT03765073|593142509|FG000|Stage 2|Withdrawal by Subject|0|||
164211667|NCT03765073|593142510|FG001|Stage 2|Withdrawal by Subject|0|||
164211668|NCT03765073|593142511|FG002|Stage 2|Withdrawal by Subject|0|||
164211669|NCT03765073|593142512|FG003|Stage 2|Withdrawal by Subject|3|||
164211670|NCT03765073|593142513|FG004|Stage 2|Withdrawal by Subject|3|||
164211671|NCT03765073|593142514|FG005|Stage 2|Withdrawal by Subject|3|||
164211672|NCT03765073|593142515|FG006|Stage 2|Withdrawal by Subject|0|||
164211673|NCT03765073|593142516|FG007|Stage 2|Withdrawal by Subject|1|||
164211674|NCT03765073|593142517|FG008|Stage 2|Withdrawal by Subject|0|||
164211675|NCT03765073|593142518|FG009|Stage 2|Withdrawal by Subject|5|||
164211676|NCT03765073|593142519|FG010|Stage 2|Withdrawal by Subject|0|||
164211677|NCT03765073|593142520|FG011|Stage 2|Withdrawal by Subject|0|||
164211678|NCT03765073|593142521|FG012|Stage 2|Withdrawal by Subject|0|||
164211679|NCT03765073|593142522|FG013|Stage 2|Withdrawal by Subject|0|||
164211680|NCT03765073|593142523|FG014|Stage 2|Withdrawal by Subject|0|||
164211681|NCT03765073|593142524|FG015|Stage 2|Withdrawal by Subject|0|||
164211682|NCT03765073|593142525|FG016|Stage 2|Withdrawal by Subject|0|||
164211683|NCT03765073|593142526|FG017|Stage 2|Withdrawal by Subject|0|||
164211684|NCT03765073|593142527|FG018|Stage 2|Withdrawal by Subject|0|||
164211685|NCT03765073|593142528|FG019|Stage 2|Withdrawal by Subject|0|||
164211686|NCT03765073|593142529|FG020|Stage 2|Withdrawal by Subject|0|||
164211687|NCT03765073|593142509|FG000|Stage 3|Adverse Event|0|||
164211688|NCT03765073|593142510|FG001|Stage 3|Adverse Event|0|||
164211689|NCT03765073|593142511|FG002|Stage 3|Adverse Event|0|||
164211690|NCT03765073|593142512|FG003|Stage 3|Adverse Event|0|||
164211691|NCT03765073|593142513|FG004|Stage 3|Adverse Event|0|||
164211692|NCT03765073|593142514|FG005|Stage 3|Adverse Event|0|||
164211693|NCT03765073|593142515|FG006|Stage 3|Adverse Event|0|||
164211694|NCT03765073|593142516|FG007|Stage 3|Adverse Event|0|||
164211695|NCT03765073|593142517|FG008|Stage 3|Adverse Event|0|||
164211696|NCT03765073|593142518|FG009|Stage 3|Adverse Event|0|||
164211697|NCT03765073|593142519|FG010|Stage 3|Adverse Event|0|||
164211698|NCT03765073|593142520|FG011|Stage 3|Adverse Event|0|||
164211699|NCT03765073|593142521|FG012|Stage 3|Adverse Event|0|||
164211700|NCT03765073|593142522|FG013|Stage 3|Adverse Event|0|||
164211701|NCT03765073|593142523|FG014|Stage 3|Adverse Event|0|||
164211702|NCT03765073|593142524|FG015|Stage 3|Adverse Event|0|||
164211703|NCT03765073|593142525|FG016|Stage 3|Adverse Event|0|||
164211704|NCT03765073|593142526|FG017|Stage 3|Adverse Event|0|||
164211705|NCT03765073|593142527|FG018|Stage 3|Adverse Event|1|||
164211706|NCT03765073|593142528|FG019|Stage 3|Adverse Event|0|||
164211707|NCT03765073|593142529|FG020|Stage 3|Adverse Event|0|||
164211708|NCT03765073|593142509|FG000|Stage 3|Death|0|||
164211709|NCT03765073|593142510|FG001|Stage 3|Death|0|||
164211710|NCT03765073|593142511|FG002|Stage 3|Death|0|||
164211711|NCT03765073|593142512|FG003|Stage 3|Death|0|||
164211712|NCT03765073|593142513|FG004|Stage 3|Death|0|||
164211713|NCT03765073|593142514|FG005|Stage 3|Death|0|||
164211714|NCT03765073|593142515|FG006|Stage 3|Death|0|||
164211715|NCT03765073|593142516|FG007|Stage 3|Death|0|||
164211716|NCT03765073|593142517|FG008|Stage 3|Death|0|||
164211717|NCT03765073|593142518|FG009|Stage 3|Death|0|||
164211718|NCT03765073|593142519|FG010|Stage 3|Death|0|||
164211719|NCT03765073|593142520|FG011|Stage 3|Death|0|||
164211720|NCT03765073|593142521|FG012|Stage 3|Death|0|||
164211721|NCT03765073|593142522|FG013|Stage 3|Death|0|||
164211722|NCT03765073|593142523|FG014|Stage 3|Death|0|||
164211723|NCT03765073|593142524|FG015|Stage 3|Death|0|||
164211724|NCT03765073|593142525|FG016|Stage 3|Death|0|||
164211725|NCT03765073|593142526|FG017|Stage 3|Death|0|||
164211726|NCT03765073|593142527|FG018|Stage 3|Death|0|||
164211727|NCT03765073|593142528|FG019|Stage 3|Death|3|||
164211728|NCT03765073|593142529|FG020|Stage 3|Death|2|||
164211729|NCT03765073|593142509|FG000|Stage 3|Lost to Follow-up|0|||
164211730|NCT03765073|593142510|FG001|Stage 3|Lost to Follow-up|0|||
164211731|NCT03765073|593142511|FG002|Stage 3|Lost to Follow-up|0|||
164211732|NCT03765073|593142512|FG003|Stage 3|Lost to Follow-up|0|||
164211733|NCT03765073|593142513|FG004|Stage 3|Lost to Follow-up|0|||
164211734|NCT03765073|593142514|FG005|Stage 3|Lost to Follow-up|0|||
164211735|NCT03765073|593142515|FG006|Stage 3|Lost to Follow-up|0|||
164211736|NCT03765073|593142516|FG007|Stage 3|Lost to Follow-up|0|||
164211737|NCT03765073|593142517|FG008|Stage 3|Lost to Follow-up|0|||
164211738|NCT03765073|593142518|FG009|Stage 3|Lost to Follow-up|0|||
164211739|NCT03765073|593142519|FG010|Stage 3|Lost to Follow-up|0|||
164211740|NCT03765073|593142520|FG011|Stage 3|Lost to Follow-up|0|||
164211741|NCT03765073|593142521|FG012|Stage 3|Lost to Follow-up|0|||
164211742|NCT03765073|593142522|FG013|Stage 3|Lost to Follow-up|0|||
164211743|NCT03765073|593142523|FG014|Stage 3|Lost to Follow-up|0|||
164211744|NCT03765073|593142524|FG015|Stage 3|Lost to Follow-up|0|||
164211745|NCT03765073|593142525|FG016|Stage 3|Lost to Follow-up|0|||
164211746|NCT03765073|593142526|FG017|Stage 3|Lost to Follow-up|8|||
164211747|NCT03765073|593142527|FG018|Stage 3|Lost to Follow-up|5|||
164211748|NCT03765073|593142528|FG019|Stage 3|Lost to Follow-up|7|||
164211749|NCT03765073|593142529|FG020|Stage 3|Lost to Follow-up|4|||
164211750|NCT03765073|593142509|FG000|Stage 3|No longer meets eligibility criteria|0|||
164211751|NCT03765073|593142510|FG001|Stage 3|No longer meets eligibility criteria|0|||
164211752|NCT03765073|593142511|FG002|Stage 3|No longer meets eligibility criteria|0|||
164211753|NCT03765073|593142512|FG003|Stage 3|No longer meets eligibility criteria|0|||
164211754|NCT03765073|593142513|FG004|Stage 3|No longer meets eligibility criteria|0|||
164211755|NCT03765073|593142514|FG005|Stage 3|No longer meets eligibility criteria|0|||
164211756|NCT03765073|593142515|FG006|Stage 3|No longer meets eligibility criteria|0|||
164211757|NCT03765073|593142516|FG007|Stage 3|No longer meets eligibility criteria|0|||
164211758|NCT03765073|593142517|FG008|Stage 3|No longer meets eligibility criteria|0|||
164211759|NCT03765073|593142518|FG009|Stage 3|No longer meets eligibility criteria|0|||
164211760|NCT03765073|593142519|FG010|Stage 3|No longer meets eligibility criteria|0|||
164211761|NCT03765073|593142520|FG011|Stage 3|No longer meets eligibility criteria|0|||
164211762|NCT03765073|593142521|FG012|Stage 3|No longer meets eligibility criteria|0|||
164211763|NCT03765073|593142522|FG013|Stage 3|No longer meets eligibility criteria|0|||
164211764|NCT03765073|593142523|FG014|Stage 3|No longer meets eligibility criteria|0|||
164211765|NCT03765073|593142524|FG015|Stage 3|No longer meets eligibility criteria|0|||
164211766|NCT03765073|593142525|FG016|Stage 3|No longer meets eligibility criteria|0|||
164211767|NCT03765073|593142526|FG017|Stage 3|No longer meets eligibility criteria|0|||
164211768|NCT03765073|593142527|FG018|Stage 3|No longer meets eligibility criteria|1|||
164211769|NCT03765073|593142528|FG019|Stage 3|No longer meets eligibility criteria|0|||
164211770|NCT03765073|593142529|FG020|Stage 3|No longer meets eligibility criteria|1|||
164211771|NCT03765073|593142509|FG000|Stage 3|Other|0|||
164211772|NCT03765073|593142510|FG001|Stage 3|Other|0|||
164211773|NCT03765073|593142511|FG002|Stage 3|Other|0|||
164211774|NCT03765073|593142512|FG003|Stage 3|Other|0|||
164211775|NCT03765073|593142513|FG004|Stage 3|Other|0|||
164211776|NCT03765073|593142514|FG005|Stage 3|Other|0|||
164211777|NCT03765073|593142515|FG006|Stage 3|Other|0|||
164211778|NCT03765073|593142516|FG007|Stage 3|Other|0|||
164211779|NCT03765073|593142517|FG008|Stage 3|Other|0|||
164211780|NCT03765073|593142518|FG009|Stage 3|Other|0|||
164211781|NCT03765073|593142519|FG010|Stage 3|Other|0|||
164211782|NCT03765073|593142520|FG011|Stage 3|Other|0|||
164211783|NCT03765073|593142521|FG012|Stage 3|Other|0|||
164211784|NCT03765073|593142522|FG013|Stage 3|Other|0|||
164211785|NCT03765073|593142523|FG014|Stage 3|Other|0|||
164211786|NCT03765073|593142524|FG015|Stage 3|Other|0|||
164211787|NCT03765073|593142525|FG016|Stage 3|Other|0|||
164211788|NCT03765073|593142526|FG017|Stage 3|Other|1|||
164211789|NCT03765073|593142527|FG018|Stage 3|Other|2|||
164211790|NCT03765073|593142528|FG019|Stage 3|Other|2|||
164211791|NCT03765073|593142529|FG020|Stage 3|Other|2|||
164211792|NCT03765073|593142509|FG000|Stage 3|Withdrawal by parent/guardian|0|||
164211793|NCT03765073|593142510|FG001|Stage 3|Withdrawal by parent/guardian|0|||
164211794|NCT03765073|593142511|FG002|Stage 3|Withdrawal by parent/guardian|0|||
164211795|NCT03765073|593142512|FG003|Stage 3|Withdrawal by parent/guardian|0|||
164211796|NCT03765073|593142513|FG004|Stage 3|Withdrawal by parent/guardian|0|||
164211797|NCT03765073|593142514|FG005|Stage 3|Withdrawal by parent/guardian|0|||
164211798|NCT03765073|593142515|FG006|Stage 3|Withdrawal by parent/guardian|0|||
164211799|NCT03765073|593142516|FG007|Stage 3|Withdrawal by parent/guardian|0|||
164211800|NCT03765073|593142517|FG008|Stage 3|Withdrawal by parent/guardian|0|||
164211801|NCT03765073|593142518|FG009|Stage 3|Withdrawal by parent/guardian|0|||
164211802|NCT03765073|593142519|FG010|Stage 3|Withdrawal by parent/guardian|0|||
164211803|NCT03765073|593142520|FG011|Stage 3|Withdrawal by parent/guardian|0|||
164211804|NCT03765073|593142521|FG012|Stage 3|Withdrawal by parent/guardian|0|||
164211805|NCT03765073|593142522|FG013|Stage 3|Withdrawal by parent/guardian|0|||
164211806|NCT03765073|593142523|FG014|Stage 3|Withdrawal by parent/guardian|0|||
164211807|NCT03765073|593142524|FG015|Stage 3|Withdrawal by parent/guardian|0|||
164211808|NCT03765073|593142525|FG016|Stage 3|Withdrawal by parent/guardian|0|||
164211809|NCT03765073|593142526|FG017|Stage 3|Withdrawal by parent/guardian|0|||
164211810|NCT03765073|593142527|FG018|Stage 3|Withdrawal by parent/guardian|0|||
164211811|NCT03765073|593142528|FG019|Stage 3|Withdrawal by parent/guardian|6|||
164211812|NCT03765073|593142529|FG020|Stage 3|Withdrawal by parent/guardian|9|||
164325135|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164211813|NCT03765073|593142509|FG000|Stage 3|Withdrawal by Subject|0|||
164211814|NCT03765073|593142510|FG001|Stage 3|Withdrawal by Subject|0|||
164211815|NCT03765073|593142511|FG002|Stage 3|Withdrawal by Subject|0|||
164211816|NCT03765073|593142512|FG003|Stage 3|Withdrawal by Subject|0|||
164211817|NCT03765073|593142513|FG004|Stage 3|Withdrawal by Subject|0|||
164211818|NCT03765073|593142514|FG005|Stage 3|Withdrawal by Subject|0|||
164211819|NCT03765073|593142515|FG006|Stage 3|Withdrawal by Subject|0|||
164211820|NCT03765073|593142516|FG007|Stage 3|Withdrawal by Subject|0|||
164211821|NCT03765073|593142517|FG008|Stage 3|Withdrawal by Subject|0|||
164211822|NCT03765073|593142518|FG009|Stage 3|Withdrawal by Subject|0|||
164211823|NCT03765073|593142519|FG010|Stage 3|Withdrawal by Subject|0|||
164137041|NCT03334617|592865131|FG011|Overall Study|Adverse Event|0|||
164137042|NCT03334617|592865132|FG012|Overall Study|Adverse Event|1|||
164137043|NCT03334617|592865133|FG013|Overall Study|Adverse Event|0|||
164137044|NCT03334617|592865134|FG014|Overall Study|Adverse Event|0|||
164137045|NCT03334617|592865135|FG015|Overall Study|Adverse Event|0|||
164137046|NCT03334617|592865136|FG016|Overall Study|Adverse Event|0|||
164137047|NCT03334617|592865137|FG017|Overall Study|Adverse Event|0|||
164137048|NCT03334617|592865138|FG018|Overall Study|Adverse Event|0|||
164137049|NCT03334617|592865139|FG019|Overall Study|Adverse Event|0|||
164137050|NCT03334617|592865140|FG020|Overall Study|Adverse Event|0|||
164137051|NCT03334617|592865141|FG021|Overall Study|Adverse Event|0|||
164137052|NCT03334617|592865120|FG000|Overall Study|Death|18|||
164137053|NCT03334617|592865121|FG001|Overall Study|Death|18|||
164137054|NCT03334617|592865122|FG002|Overall Study|Death|20|||
164137055|NCT03334617|592865123|FG003|Overall Study|Death|21|||
164137056|NCT03334617|592865124|FG004|Overall Study|Death|20|||
164137057|NCT03334617|592865125|FG005|Overall Study|Death|16|||
164137058|NCT03334617|592865126|FG006|Overall Study|Death|28|||
164137059|NCT03334617|592865127|FG007|Overall Study|Death|35|||
164137060|NCT03334617|592865128|FG008|Overall Study|Death|47|||
164137061|NCT03334617|592865129|FG009|Overall Study|Death|0|||
164137062|NCT03334617|592865130|FG010|Overall Study|Death|19|||
164137063|NCT03334617|592865131|FG011|Overall Study|Death|6|||
164137064|NCT03334617|592865132|FG012|Overall Study|Death|20|||
164137065|NCT03334617|592865133|FG013|Overall Study|Death|22|||
164137066|NCT03334617|592865134|FG014|Overall Study|Death|17|||
164137067|NCT03334617|592865135|FG015|Overall Study|Death|18|||
164137068|NCT03334617|592865136|FG016|Overall Study|Death|12|||
164137069|NCT03334617|592865137|FG017|Overall Study|Death|15|||
164137070|NCT03334617|592865138|FG018|Overall Study|Death|16|||
164137071|NCT03334617|592865139|FG019|Overall Study|Death|27|||
164137072|NCT03334617|592865140|FG020|Overall Study|Death|14|||
164137073|NCT03334617|592865141|FG021|Overall Study|Death|27|||
164137074|NCT03334617|592865120|FG000|Overall Study|Lost to Follow-up|0|||
164137075|NCT03334617|592865121|FG001|Overall Study|Lost to Follow-up|0|||
164137076|NCT03334617|592865122|FG002|Overall Study|Lost to Follow-up|0|||
164137077|NCT03334617|592865123|FG003|Overall Study|Lost to Follow-up|1|||
164137078|NCT03334617|592865124|FG004|Overall Study|Lost to Follow-up|0|||
164137079|NCT03334617|592865125|FG005|Overall Study|Lost to Follow-up|1|||
164137080|NCT03334617|592865126|FG006|Overall Study|Lost to Follow-up|0|||
164137081|NCT03334617|592865127|FG007|Overall Study|Lost to Follow-up|0|||
164137082|NCT03334617|592865128|FG008|Overall Study|Lost to Follow-up|1|||
164137083|NCT03334617|592865129|FG009|Overall Study|Lost to Follow-up|0|||
164137084|NCT03334617|592865130|FG010|Overall Study|Lost to Follow-up|0|||
164137085|NCT03334617|592865131|FG011|Overall Study|Lost to Follow-up|0|||
164137086|NCT03334617|592865132|FG012|Overall Study|Lost to Follow-up|0|||
164137087|NCT03334617|592865133|FG013|Overall Study|Lost to Follow-up|0|||
164137088|NCT03334617|592865134|FG014|Overall Study|Lost to Follow-up|0|||
164137089|NCT03334617|592865135|FG015|Overall Study|Lost to Follow-up|0|||
164137090|NCT03334617|592865136|FG016|Overall Study|Lost to Follow-up|0|||
164137091|NCT03334617|592865137|FG017|Overall Study|Lost to Follow-up|0|||
164137092|NCT03334617|592865138|FG018|Overall Study|Lost to Follow-up|0|||
164137093|NCT03334617|592865139|FG019|Overall Study|Lost to Follow-up|0|||
164137094|NCT03334617|592865140|FG020|Overall Study|Lost to Follow-up|0|||
164137095|NCT03334617|592865141|FG021|Overall Study|Lost to Follow-up|0|||
164137096|NCT03334617|592865120|FG000|Overall Study|Withdrawal by Subject|0|||
164137097|NCT03334617|592865121|FG001|Overall Study|Withdrawal by Subject|1|||
164137098|NCT03334617|592865122|FG002|Overall Study|Withdrawal by Subject|0|||
164137099|NCT03334617|592865123|FG003|Overall Study|Withdrawal by Subject|0|||
164137100|NCT03334617|592865124|FG004|Overall Study|Withdrawal by Subject|1|||
164137101|NCT03334617|592865125|FG005|Overall Study|Withdrawal by Subject|1|||
164137102|NCT03334617|592865126|FG006|Overall Study|Withdrawal by Subject|1|||
164137103|NCT03334617|592865127|FG007|Overall Study|Withdrawal by Subject|2|||
164137104|NCT03334617|592865128|FG008|Overall Study|Withdrawal by Subject|0|||
164137105|NCT03334617|592865129|FG009|Overall Study|Withdrawal by Subject|0|||
164137106|NCT03334617|592865130|FG010|Overall Study|Withdrawal by Subject|0|||
164137107|NCT03334617|592865131|FG011|Overall Study|Withdrawal by Subject|1|||
164137108|NCT03334617|592865132|FG012|Overall Study|Withdrawal by Subject|1|||
164137109|NCT03334617|592865133|FG013|Overall Study|Withdrawal by Subject|0|||
164137110|NCT03334617|592865134|FG014|Overall Study|Withdrawal by Subject|2|||
164137111|NCT03334617|592865135|FG015|Overall Study|Withdrawal by Subject|1|||
164137112|NCT03334617|592865136|FG016|Overall Study|Withdrawal by Subject|0|||
164137113|NCT03334617|592865137|FG017|Overall Study|Withdrawal by Subject|1|||
164137114|NCT03334617|592865138|FG018|Overall Study|Withdrawal by Subject|1|||
164137115|NCT03334617|592865139|FG019|Overall Study|Withdrawal by Subject|1|||
164137116|NCT03334617|592865140|FG020|Overall Study|Withdrawal by Subject|0|||
164137117|NCT03334617|592865141|FG021|Overall Study|Withdrawal by Subject|1|||
164137118|NCT03334617|592865120|FG000|Overall Study|Other|1|||
164211824|NCT03765073|593142520|FG011|Stage 3|Withdrawal by Subject|0|||
164211825|NCT03765073|593142521|FG012|Stage 3|Withdrawal by Subject|0|||
164211826|NCT03765073|593142522|FG013|Stage 3|Withdrawal by Subject|0|||
164211827|NCT03765073|593142523|FG014|Stage 3|Withdrawal by Subject|0|||
164211828|NCT03765073|593142524|FG015|Stage 3|Withdrawal by Subject|0|||
164211829|NCT03765073|593142525|FG016|Stage 3|Withdrawal by Subject|0|||
164211830|NCT03765073|593142526|FG017|Stage 3|Withdrawal by Subject|8|||
164211831|NCT03765073|593142527|FG018|Stage 3|Withdrawal by Subject|11|||
164211832|NCT03765073|593142528|FG019|Stage 3|Withdrawal by Subject|0|||
164211833|NCT03765073|593142529|FG020|Stage 3|Withdrawal by Subject|0|||
164211834|NCT02550795|593142537|FG000|Overall Study|Physician Decision|0|||
164211835|NCT02550795|593142538|FG001|Overall Study|Physician Decision|1|||
164211836|NCT02550795|593142539|FG002|Overall Study|Physician Decision|0|||
164211837|NCT02802228|593142540|FG000|Overall Study|Withdrawal by Subject|2|||
164211838|NCT02802228|593142541|FG001|Overall Study|Withdrawal by Subject|0|||
164211839|NCT02802228|593142540|FG000|Overall Study|Lost to Follow-up|1|||
164211840|NCT02802228|593142541|FG001|Overall Study|Lost to Follow-up|0|||
164211841|NCT02802228|593142540|FG000|Overall Study|Adverse Event|1|||
164211842|NCT02802228|593142541|FG001|Overall Study|Adverse Event|0|||
164211843|NCT02802228|593142540|FG000|Overall Study|Physician Decision|1|||
164211844|NCT02802228|593142541|FG001|Overall Study|Physician Decision|0|||
164211845|NCT00695019|593142544|FG000|Overall Study|Withdrawal by Subject|8|||
164211846|NCT00695019|593142545|FG001|Overall Study|Withdrawal by Subject|6|||
164211847|NCT00695019|593142546|FG002|Overall Study|Withdrawal by Subject|4|||
164211848|NCT00695019|593142544|FG000|Overall Study|Protocol Violation|1|||
164211849|NCT00695019|593142545|FG001|Overall Study|Protocol Violation|3|||
164211850|NCT00695019|593142546|FG002|Overall Study|Protocol Violation|1|||
164211851|NCT00695019|593142544|FG000|Overall Study|Lack of Efficacy|0|||
164211852|NCT00695019|593142545|FG001|Overall Study|Lack of Efficacy|0|||
164211853|NCT00695019|593142546|FG002|Overall Study|Lack of Efficacy|1|||
164211854|NCT00695019|593142544|FG000|Overall Study|Various|4|||
164211855|NCT00695019|593142545|FG001|Overall Study|Various|5|||
164211856|NCT00695019|593142546|FG002|Overall Study|Various|4|||
164211857|NCT01564407|593142556|FG000|Overall Study|Lost to Follow-up|0|||
164211858|NCT01564407|593142557|FG001|Overall Study|Lost to Follow-up|1|||
164211859|NCT01564407|593142558|FG002|Overall Study|Lost to Follow-up|0|||
164211860|NCT01564407|593142559|FG003|Overall Study|Lost to Follow-up|0|||
164211861|NCT01564407|593142560|FG004|Overall Study|Lost to Follow-up|0|||
164211862|NCT01564407|593142556|FG000|Overall Study|Withdrawal by Subject|0|||
164211863|NCT01564407|593142557|FG001|Overall Study|Withdrawal by Subject|1|||
164211864|NCT01564407|593142558|FG002|Overall Study|Withdrawal by Subject|0|||
164211865|NCT01564407|593142559|FG003|Overall Study|Withdrawal by Subject|0|||
164211866|NCT01564407|593142560|FG004|Overall Study|Withdrawal by Subject|0|||
164211867|NCT01564407|593142556|FG000|Overall Study|funding lost, study ended|0|||
164211868|NCT01564407|593142557|FG001|Overall Study|funding lost, study ended|0|||
164211869|NCT01564407|593142558|FG002|Overall Study|funding lost, study ended|0|||
164211870|NCT01564407|593142559|FG003|Overall Study|funding lost, study ended|1|||
164211871|NCT01564407|593142560|FG004|Overall Study|funding lost, study ended|0|||
164211872|NCT04063163|593142563|FG000|Overall Study|Death|281|||
164211873|NCT04063163|593142564|FG001|Overall Study|Death|166|||
164211874|NCT04063163|593142563|FG000|Overall Study|Lost to Follow-up|12|||
164211875|NCT04063163|593142564|FG001|Overall Study|Lost to Follow-up|8|||
164211876|NCT04063163|593142563|FG000|Overall Study|Withdrawal by Subject|19|||
164211877|NCT04063163|593142564|FG001|Overall Study|Withdrawal by Subject|10|||
164211878|NCT00580840|593142567|FG000|Run-in|Adverse Event|17|||
164211879|NCT00580840|593142568|FG001|Run-in|Adverse Event|0|||
164211880|NCT00580840|593142569|FG002|Run-in|Adverse Event|0|||
164211881|NCT00580840|593142570|FG003|Run-in|Adverse Event|0|||
164211882|NCT00580840|593142567|FG000|Run-in|Lack of Efficacy|93|||
164211883|NCT00580840|593142568|FG001|Run-in|Lack of Efficacy|0|||
164211884|NCT00580840|593142569|FG002|Run-in|Lack of Efficacy|0|||
164211885|NCT00580840|593142570|FG003|Run-in|Lack of Efficacy|0|||
164211886|NCT00580840|593142567|FG000|Run-in|Loss of Efficacy|1|||
164211887|NCT00580840|593142568|FG001|Run-in|Loss of Efficacy|0|||
164211888|NCT00580840|593142569|FG002|Run-in|Loss of Efficacy|0|||
164211889|NCT00580840|593142570|FG003|Run-in|Loss of Efficacy|0|||
164211890|NCT00580840|593142567|FG000|Run-in|Lost to Follow-up|4|||
164325136|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164211891|NCT00580840|593142568|FG001|Run-in|Lost to Follow-up|0|||
164211892|NCT00580840|593142569|FG002|Run-in|Lost to Follow-up|0|||
163876233|NCT01000480|591914809|FG000|Induction Phase|Entry Criteria Not Met|3|||
164211893|NCT00580840|593142570|FG003|Run-in|Lost to Follow-up|0|||
163876234|NCT01000480|591914809|FG000|Concurrent Therapy Phase|Adverse Event|4|||
164211894|NCT00580840|593142567|FG000|Run-in|Withdrawal by Subject|5|||
164211895|NCT00580840|593142568|FG001|Run-in|Withdrawal by Subject|0|||
164211896|NCT00580840|593142569|FG002|Run-in|Withdrawal by Subject|0|||
164211897|NCT00580840|593142570|FG003|Run-in|Withdrawal by Subject|0|||
164211898|NCT00580840|593142567|FG000|Run-in|Other: Per Sponsor Request|2|||
164211899|NCT00580840|593142568|FG001|Run-in|Other: Per Sponsor Request|0|||
164211900|NCT00580840|593142569|FG002|Run-in|Other: Per Sponsor Request|0|||
164211901|NCT00580840|593142570|FG003|Run-in|Other: Per Sponsor Request|0|||
164211902|NCT00580840|593142567|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
164211903|NCT00580840|593142568|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
164211904|NCT00580840|593142569|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
164211905|NCT00580840|593142570|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
164211906|NCT00580840|593142567|FG000|Run-in|Other: Exclusionary Lab Value|1|||
164211907|NCT00580840|593142568|FG001|Run-in|Other: Exclusionary Lab Value|0|||
164211908|NCT00580840|593142569|FG002|Run-in|Other: Exclusionary Lab Value|0|||
164211909|NCT00580840|593142570|FG003|Run-in|Other: Exclusionary Lab Value|0|||
164211910|NCT00580840|593142567|FG000|Double-Blind|Adverse Event|0|||
164211911|NCT00580840|593142568|FG001|Double-Blind|Adverse Event|3|||
164211912|NCT00580840|593142569|FG002|Double-Blind|Adverse Event|4|||
164211913|NCT00580840|593142570|FG003|Double-Blind|Adverse Event|1|||
164211914|NCT00580840|593142567|FG000|Double-Blind|Loss of Efficacy|0|||
164211915|NCT00580840|593142568|FG001|Double-Blind|Loss of Efficacy|1|||
164211916|NCT00580840|593142569|FG002|Double-Blind|Loss of Efficacy|2|||
164211917|NCT00580840|593142570|FG003|Double-Blind|Loss of Efficacy|10|||
164211918|NCT00580840|593142567|FG000|Double-Blind|Lost to Follow-up|0|||
164211919|NCT00580840|593142568|FG001|Double-Blind|Lost to Follow-up|1|||
164211920|NCT00580840|593142569|FG002|Double-Blind|Lost to Follow-up|0|||
164211921|NCT00580840|593142570|FG003|Double-Blind|Lost to Follow-up|2|||
164211922|NCT00580840|593142567|FG000|Double-Blind|Withdrawal by Subject|0|||
164211923|NCT00580840|593142568|FG001|Double-Blind|Withdrawal by Subject|1|||
164211924|NCT00580840|593142569|FG002|Double-Blind|Withdrawal by Subject|2|||
164211925|NCT00580840|593142570|FG003|Double-Blind|Withdrawal by Subject|2|||
164211926|NCT00580840|593142567|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
164211927|NCT00580840|593142568|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
164211928|NCT00580840|593142569|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
164211929|NCT00580840|593142570|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
164211930|NCT00580840|593142567|FG000|Double-Blind|Other: Forbidden Medication|0|||
164211931|NCT00580840|593142568|FG001|Double-Blind|Other: Forbidden Medication|0|||
164211932|NCT00580840|593142569|FG002|Double-Blind|Other: Forbidden Medication|1|||
164211933|NCT00580840|593142570|FG003|Double-Blind|Other: Forbidden Medication|0|||
164211934|NCT04435626|593142573|FG000|Overall Study|Lost to Follow-up|1|||
164211935|NCT04435626|593142574|FG001|Overall Study|Lost to Follow-up|5|||
164211936|NCT04435626|593142573|FG000|Overall Study|Withdrawal by Subject|6|||
164211937|NCT04435626|593142574|FG001|Overall Study|Withdrawal by Subject|7|||
164211938|NCT04435626|593142573|FG000|Overall Study|major GCP violations|8|||
164211939|NCT04435626|593142574|FG001|Overall Study|major GCP violations|7|||
164211940|NCT01160614|593142580|FG000|Overall Study|Withdrawal by Subject|0|||
164211941|NCT01160614|593142581|FG001|Overall Study|Withdrawal by Subject|2|||
164211942|NCT00984399|593142582|FG000|Overall Study|Adverse Event|0|||
164211943|NCT00984399|593142583|FG001|Overall Study|Adverse Event|1|||
164211944|NCT00984399|593142582|FG000|Overall Study|Physician Decision|1|||
164211945|NCT00984399|593142583|FG001|Overall Study|Physician Decision|0|||
164211946|NCT00984399|593142582|FG000|Overall Study|Withdrawal by Subject|1|||
164211947|NCT00984399|593142583|FG001|Overall Study|Withdrawal by Subject|1|||
164211948|NCT00984399|593142582|FG000|Overall Study|Protocol Violation|0|||
164211949|NCT00984399|593142583|FG001|Overall Study|Protocol Violation|1|||
164211950|NCT00984399|593142582|FG000|Overall Study|Pts did not start treatment|2|||
164211951|NCT00984399|593142583|FG001|Overall Study|Pts did not start treatment|2|||
164211952|NCT05049122|593142584|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
164211953|NCT05049122|593142584|FG000|Overall Study|Participant moved|1|||
164211954|NCT05049122|593142584|FG000|Overall Study|At the direction of the doctor|1|||
164211955|NCT05248386|593142586|FG000|Overall Study|Technical problems|0|||
164211956|NCT05248386|593142587|FG001|Overall Study|Technical problems|1|||
164211957|NCT05248386|593142586|FG000|Overall Study|Withdrawal by Subject|15|||
164211958|NCT05248386|593142587|FG001|Overall Study|Withdrawal by Subject|10|||
164211959|NCT05248386|593142586|FG000|Overall Study|Physician Decision|0|||
164211960|NCT05248386|593142587|FG001|Overall Study|Physician Decision|1|||
164211961|NCT05248386|593142586|FG000|Overall Study|Adverse Event|2|||
164211962|NCT05248386|593142587|FG001|Overall Study|Adverse Event|4|||
164211963|NCT05248386|593142586|FG000|Overall Study|Other|1|||
164211964|NCT05248386|593142587|FG001|Overall Study|Other|0|||
164211965|NCT05248386|593142586|FG000|Overall Study|Lack of Efficacy|14|||
164211966|NCT05248386|593142587|FG001|Overall Study|Lack of Efficacy|12|||
164211967|NCT01723774|593142588|FG000|Neoadjuvant|Ki67 > 10%|4|||
164211968|NCT01723774|593142589|FG001|Neoadjuvant|Ki67 > 10%|0|||
164211969|NCT01723774|593142590|FG002|Neoadjuvant|Ki67 > 10%|10|||
164211970|NCT01723774|593142591|FG003|Neoadjuvant|Ki67 > 10%|0|||
164211971|NCT01723774|593142588|FG000|Neoadjuvant|Withdrawal by Subject|3|||
164211972|NCT01723774|593142589|FG001|Neoadjuvant|Withdrawal by Subject|1|||
164211973|NCT01723774|593142590|FG002|Neoadjuvant|Withdrawal by Subject|0|||
164211974|NCT01723774|593142591|FG003|Neoadjuvant|Withdrawal by Subject|0|||
164211975|NCT01723774|593142588|FG000|Neoadjuvant|Disease progression|0|||
164211976|NCT01723774|593142589|FG001|Neoadjuvant|Disease progression|1|||
164211977|NCT01723774|593142590|FG002|Neoadjuvant|Disease progression|1|||
164211978|NCT01723774|593142591|FG003|Neoadjuvant|Disease progression|0|||
164211979|NCT01723774|593142588|FG000|Neoadjuvant|Adverse Event|0|||
164325137|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325138|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325139|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325140|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325141|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|Lost to Follow-up|0|||
164325142|NCT02616562|593566031|FG000|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325143|NCT02616562|593566032|FG001|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325144|NCT02616562|593566033|FG002|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325145|NCT02616562|593566034|FG003|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325146|NCT02616562|593566035|FG004|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325147|NCT02616562|593566036|FG005|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325148|NCT02616562|593566037|FG006|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325149|NCT02616562|593566038|FG007|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325150|NCT02616562|593566039|FG008|Safety Extension Period (104 Weeks)|Protocol Violation|1|||
164325151|NCT02616562|593566040|FG009|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325152|NCT02616562|593566041|FG010|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325153|NCT02616562|593566042|FG011|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325154|NCT02616562|593566043|FG012|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325155|NCT02616562|593566044|FG013|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325156|NCT02616562|593566045|FG014|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325157|NCT02616562|593566046|FG015|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325158|NCT02616562|593566047|FG016|Safety Extension Period (104 Weeks)|Protocol Violation|0|||
164325159|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325160|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325161|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325162|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325163|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325164|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325165|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325166|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325167|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325168|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325169|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325170|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|4|||
164325171|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325172|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325173|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|1|||
164325174|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325175|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by parent/guardian|0|||
164325176|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325177|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325178|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325179|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325180|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325181|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325182|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325183|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325184|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325185|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325186|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325187|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Protocol Violation|1|||
164325188|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325189|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325190|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325191|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325192|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Protocol Violation|0|||
164325193|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325194|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325195|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325196|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325197|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325198|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164077588|NCT01889862|592649993|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
164211980|NCT01723774|593142589|FG001|Neoadjuvant|Adverse Event|1|||
164211981|NCT01723774|593142590|FG002|Neoadjuvant|Adverse Event|2|||
164211982|NCT01723774|593142591|FG003|Neoadjuvant|Adverse Event|0|||
164211983|NCT01723774|593142588|FG000|Neoadjuvant|High estradiol|0|||
164211984|NCT01723774|593142589|FG001|Neoadjuvant|High estradiol|1|||
164211985|NCT01723774|593142590|FG002|Neoadjuvant|High estradiol|0|||
164211986|NCT01723774|593142591|FG003|Neoadjuvant|High estradiol|0|||
164211987|NCT01910441|593142592|FG000|Overall Study|Sponsor decision|0|||
164211988|NCT01910441|593142593|FG001|Overall Study|Sponsor decision|2|||
164211989|NCT01910441|593142592|FG000|Overall Study|Lost to Follow-up|6|||
164211990|NCT01910441|593142593|FG001|Overall Study|Lost to Follow-up|5|||
164211991|NCT01910441|593142592|FG000|Overall Study|Withdrawal by Subject|0|||
164211992|NCT01910441|593142593|FG001|Overall Study|Withdrawal by Subject|1|||
164211993|NCT01910441|593142592|FG000|Overall Study|Non-compliance|0|||
164211994|NCT01910441|593142593|FG001|Overall Study|Non-compliance|1|||
164211995|NCT01910441|593142592|FG000|Overall Study|Adverse Event|1|||
164211996|NCT01910441|593142593|FG001|Overall Study|Adverse Event|0|||
164211997|NCT01910441|593142592|FG000|Overall Study|Physician Decision|0|||
164211998|NCT01910441|593142593|FG001|Overall Study|Physician Decision|1|||
164211999|NCT02964182|593142594|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212000|NCT02964182|593142595|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
164212001|NCT02964182|593142596|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212002|NCT02964182|593142597|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212003|NCT02964182|593142598|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212004|NCT02964182|593142599|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
164212005|NCT02964182|593142600|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212006|NCT02964182|593142601|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
164212007|NCT02964182|593142594|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212008|NCT02964182|593142595|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212009|NCT02964182|593142596|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212010|NCT02964182|593142597|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212011|NCT02964182|593142598|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212012|NCT02964182|593142599|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
164212013|NCT02964182|593142600|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212014|NCT02964182|593142601|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
164212015|NCT02964182|593142594|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212016|NCT02964182|593142595|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
164212017|NCT02964182|593142596|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212018|NCT02964182|593142597|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212019|NCT02964182|593142598|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212020|NCT02964182|593142599|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
164212021|NCT02964182|593142600|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212022|NCT02964182|593142601|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
164212023|NCT02964182|593142594|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212024|NCT02964182|593142595|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212025|NCT02964182|593142596|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
164212026|NCT02964182|593142597|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
164212027|NCT02964182|593142598|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212028|NCT02964182|593142599|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212029|NCT02964182|593142600|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
164212030|NCT02964182|593142601|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
164212031|NCT02964182|593142594|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212032|NCT02964182|593142595|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212033|NCT02964182|593142596|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
164212034|NCT02964182|593142597|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
164212035|NCT02964182|593142598|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212036|NCT02964182|593142599|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212037|NCT02964182|593142600|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
164212038|NCT02964182|593142601|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
164212039|NCT02964182|593142594|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212040|NCT02964182|593142595|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212041|NCT02964182|593142596|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
164212042|NCT02964182|593142597|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
164212043|NCT02964182|593142598|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212044|NCT02964182|593142599|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212045|NCT02964182|593142600|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164325199|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325200|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325201|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164212046|NCT02964182|593142601|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
164212047|NCT02964182|593142594|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164325202|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164212048|NCT02964182|593142595|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164325203|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164212049|NCT02964182|593142596|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
164212050|NCT02964182|593142597|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
163876235|NCT01000480|591914809|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
163876236|NCT01000480|591914809|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
163876237|NCT01000480|591914809|FG000|Concurrent Therapy Phase|Physician Decision|1|||
163876238|NCT03988023|591914810|FG000|Overall Study|Non-compliance|3|||
163876239|NCT03988023|591914811|FG001|Overall Study|Non-compliance|0|||
164137119|NCT03334617|592865121|FG001|Overall Study|Other|2|||
164137120|NCT03334617|592865122|FG002|Overall Study|Other|0|||
164137121|NCT03334617|592865123|FG003|Overall Study|Other|1|||
164137122|NCT03334617|592865124|FG004|Overall Study|Other|1|||
164137123|NCT03334617|592865125|FG005|Overall Study|Other|0|||
164137124|NCT03334617|592865126|FG006|Overall Study|Other|2|||
164137125|NCT03334617|592865127|FG007|Overall Study|Other|1|||
164137126|NCT03334617|592865128|FG008|Overall Study|Other|8|||
164137127|NCT03334617|592865129|FG009|Overall Study|Other|0|||
164137128|NCT03334617|592865130|FG010|Overall Study|Other|3|||
164137129|NCT03334617|592865131|FG011|Overall Study|Other|1|||
164137130|NCT03334617|592865132|FG012|Overall Study|Other|3|||
164137131|NCT03334617|592865133|FG013|Overall Study|Other|1|||
164137132|NCT03334617|592865134|FG014|Overall Study|Other|1|||
164137133|NCT03334617|592865135|FG015|Overall Study|Other|3|||
164137134|NCT03334617|592865136|FG016|Overall Study|Other|3|||
164137135|NCT03334617|592865137|FG017|Overall Study|Other|3|||
164137136|NCT03334617|592865138|FG018|Overall Study|Other|7|||
164137137|NCT03334617|592865139|FG019|Overall Study|Other|4|||
164137138|NCT03334617|592865140|FG020|Overall Study|Other|1|||
164137139|NCT03334617|592865141|FG021|Overall Study|Other|4|||
164137140|NCT03334617|592865120|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
164137141|NCT03334617|592865121|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
164137142|NCT03334617|592865122|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
164137143|NCT03334617|592865123|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
164137144|NCT03334617|592865124|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
164137145|NCT03334617|592865125|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
164137146|NCT03334617|592865126|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
164137147|NCT03334617|592865127|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
164137148|NCT03334617|592865128|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
164137149|NCT03334617|592865129|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
164137150|NCT03334617|592865130|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
164137151|NCT03334617|592865131|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
164137152|NCT03334617|592865132|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
164137153|NCT03334617|592865133|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
164137154|NCT03334617|592865134|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
164137155|NCT03334617|592865135|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
164137156|NCT03334617|592865136|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
164137157|NCT03334617|592865137|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
164137158|NCT03334617|592865138|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
164137159|NCT03334617|592865139|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
164137160|NCT03334617|592865140|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
164137161|NCT03334617|592865141|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
164137162|NCT03657342|592865143|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
164137163|NCT03657342|592865144|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
164137164|NCT03657342|592865143|FG000|Overall Study|Withdrawal by Subject|4|||
164137165|NCT03657342|592865144|FG001|Overall Study|Withdrawal by Subject|4|||
164137166|NCT03657342|592865143|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
164137167|NCT03657342|592865144|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
164137168|NCT03657342|592865143|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
164137169|NCT03657342|592865144|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
164137170|NCT00827632|592865145|FG000|Overall Study|Lost to Follow-up|8|||
164137171|NCT00827632|592865146|FG001|Overall Study|Lost to Follow-up|12|||
164137172|NCT00827632|592865145|FG000|Overall Study|Early withdrawal|14|||
164137173|NCT00827632|592865146|FG001|Overall Study|Early withdrawal|11|||
164137174|NCT00911807|592865161|FG000|Overall Study|Adverse Event|2|||
164137175|NCT00911807|592865162|FG001|Overall Study|Adverse Event|1|||
164137176|NCT00911807|592865163|FG002|Overall Study|Adverse Event|5|||
164137177|NCT00911807|592865161|FG000|Overall Study|Death|0|||
164137178|NCT00911807|592865162|FG001|Overall Study|Death|0|||
164137179|NCT00911807|592865163|FG002|Overall Study|Death|1|||
164137180|NCT00911807|592865161|FG000|Overall Study|Protocol Violation|6|||
164137181|NCT00911807|592865162|FG001|Overall Study|Protocol Violation|4|||
164137182|NCT00911807|592865163|FG002|Overall Study|Protocol Violation|9|||
164137183|NCT00911807|592865161|FG000|Overall Study|Withdrawal by Subject|8|||
164212051|NCT02964182|593142598|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164212052|NCT02964182|593142599|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164212053|NCT02964182|593142600|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
164212054|NCT02964182|593142601|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
164212055|NCT05845619|593142602|FG000|Overall Study|duplicate enrollment|2|||
164212056|NCT05845619|593142603|FG001|Overall Study|duplicate enrollment|2|||
164212057|NCT05845619|593142604|FG002|Overall Study|duplicate enrollment|1|||
164212058|NCT03636477|593142608|FG000|Overall Study|Adverse Event|0|||
164212059|NCT03636477|593142609|FG001|Overall Study|Adverse Event|0|||
164325204|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Adverse Event|1|||
164325205|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325206|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325207|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325208|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325209|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Adverse Event|0|||
164325210|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325211|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325212|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325213|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325214|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325215|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325216|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325217|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325218|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325219|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325220|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
164325221|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325222|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325223|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
164325224|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|1|||
164325225|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325226|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Withdrawal by Subject|0|||
164325227|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325228|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325229|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325230|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325231|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325232|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325233|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325234|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325235|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325236|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325237|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|1|||
164325238|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325239|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325240|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325241|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325242|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325243|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Growth velocity in 9 months is 1 cm (1.3 CM/Y)|0|||
164325244|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325245|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325246|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325247|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325248|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325249|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325250|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164212060|NCT03636477|593142610|FG002|Overall Study|Adverse Event|1|||
163980567|NCT01049035|592299564|FG002|Overall Study|Other adverse event (AE)|0|||
164212061|NCT04967222|593142611|FG000|Randomized|Lost to Follow-up|0|||
164212062|NCT04967222|593142612|FG001|Randomized|Lost to Follow-up|1|||
164212063|NCT04967222|593142613|FG002|Randomized|Lost to Follow-up|1|||
164212064|NCT04967222|593142611|FG000|Randomized|Physician Decision|0|||
164212065|NCT04967222|593142612|FG001|Randomized|Physician Decision|0|||
164212066|NCT04967222|593142613|FG002|Randomized|Physician Decision|1|||
164212067|NCT04967222|593142611|FG000|Randomized|Withdrawal by Subject|0|||
164212068|NCT04967222|593142612|FG001|Randomized|Withdrawal by Subject|0|||
164212069|NCT04967222|593142613|FG002|Randomized|Withdrawal by Subject|2|||
164212070|NCT04967222|593142611|FG000|Randomized|abnormal finding in MRI|0|||
164212071|NCT04967222|593142612|FG001|Randomized|abnormal finding in MRI|2|||
164212072|NCT04967222|593142613|FG002|Randomized|abnormal finding in MRI|0|||
164212073|NCT05168800|593142621|FG000|Time 1 Survey|Did not start T1 survey|182|||
164212074|NCT05168800|593142622|FG001|Time 1 Survey|Did not start T1 survey|150|||
164212075|NCT05168800|593142623|FG002|Time 1 Survey|Did not start T1 survey|140|||
164212076|NCT05168800|593142621|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
164212077|NCT05168800|593142622|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
164212078|NCT05168800|593142623|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
164212079|NCT05168800|593142621|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
164212080|NCT05168800|593142622|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
164212081|NCT05168800|593142623|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
164212082|NCT05168800|593142621|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
164212083|NCT05168800|593142622|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
164212084|NCT05168800|593142623|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
164212085|NCT05168800|593142621|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
164212086|NCT05168800|593142622|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
164212087|NCT05168800|593142623|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
164212088|NCT05168800|593142621|FG000|Time 1 Survey|Withdrawal by Subject|6|||
164212089|NCT05168800|593142622|FG001|Time 1 Survey|Withdrawal by Subject|3|||
164212090|NCT05168800|593142623|FG002|Time 1 Survey|Withdrawal by Subject|2|||
164212091|NCT05168800|593142621|FG000|Time 2 Survey|Already excluded at Time 1|228|||
164212092|NCT05168800|593142622|FG001|Time 2 Survey|Already excluded at Time 1|202|||
164212093|NCT05168800|593142623|FG002|Time 2 Survey|Already excluded at Time 1|173|||
164212094|NCT05168800|593142621|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
164212095|NCT05168800|593142622|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
164212096|NCT05168800|593142623|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
164212097|NCT05168800|593142621|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
164212098|NCT05168800|593142622|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
164212099|NCT05168800|593142623|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
164212100|NCT05168800|593142621|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
164212101|NCT05168800|593142622|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
164212102|NCT05168800|593142623|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
164212103|NCT05168800|593142621|FG000|Time 2 Survey|Withdrawal by Subject|1|||
164212104|NCT05168800|593142622|FG001|Time 2 Survey|Withdrawal by Subject|0|||
164212105|NCT05168800|593142623|FG002|Time 2 Survey|Withdrawal by Subject|1|||
164212106|NCT05168800|593142621|FG000|Time 3 Survey|Already excluded at Time 1|228|||
164212107|NCT05168800|593142622|FG001|Time 3 Survey|Already excluded at Time 1|200|||
164212108|NCT05168800|593142623|FG002|Time 3 Survey|Already excluded at Time 1|173|||
164212109|NCT05168800|593142621|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
164212110|NCT05168800|593142622|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
164212111|NCT05168800|593142623|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
164212112|NCT05168800|593142621|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
164212113|NCT05168800|593142622|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
164212114|NCT05168800|593142623|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
164212115|NCT05168800|593142621|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
164212116|NCT05168800|593142622|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
164212117|NCT05168800|593142623|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
164212118|NCT04279522|593142624|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
164212119|NCT04279522|593142625|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
164212120|NCT04279522|593142624|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
164212121|NCT04279522|593142625|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
164212122|NCT04279522|593142624|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
164212123|NCT04279522|593142625|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
164212124|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
164212125|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
164212126|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
164212127|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
164212128|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Physician Decision|0|||
164212129|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Physician Decision|3|||
164212130|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Adverse Event|0|||
164212131|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Adverse Event|1|||
164212132|NCT04279522|593142624|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
164325251|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325252|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325253|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325254|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325255|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|1|||
164325256|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
163876240|NCT03988023|591914810|FG000|Overall Study|Withdrawal by Subject|39|||
163876241|NCT03988023|591914811|FG001|Overall Study|Withdrawal by Subject|37|||
164212133|NCT04279522|593142625|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
164212134|NCT03036254|593142632|FG000|Overall Study|Adverse Event|6|||
164212135|NCT03036254|593142633|FG001|Overall Study|Adverse Event|4|||
164212136|NCT03036254|593142632|FG000|Overall Study|Death|3|||
164212137|NCT03036254|593142633|FG001|Overall Study|Death|1|||
164212138|NCT03036254|593142632|FG000|Overall Study|Lack of Efficacy|5|||
164212139|NCT03036254|593142633|FG001|Overall Study|Lack of Efficacy|1|||
164212140|NCT03036254|593142632|FG000|Overall Study|Withdrawal by Subject|3|||
164212141|NCT03036254|593142633|FG001|Overall Study|Withdrawal by Subject|5|||
164212142|NCT01802281|593142642|FG000|Overall Study|Death|1|||
164212143|NCT01802281|593142643|FG001|Overall Study|Death|2|||
164212144|NCT01802281|593142642|FG000|Overall Study|Withdrawal by Subject|2|||
164212145|NCT01802281|593142643|FG001|Overall Study|Withdrawal by Subject|1|||
164212146|NCT01802281|593142642|FG000|Overall Study|Ineligible|5|||
164212147|NCT01802281|593142643|FG001|Overall Study|Ineligible|3|||
164212148|NCT05556057|593142644|FG000|Overall Study|Lost to Follow-up|5|||
164212149|NCT05556057|593142645|FG001|Overall Study|Lost to Follow-up|4|||
164212150|NCT05556057|593142644|FG000|Overall Study|Withdrawal by Subject|0|||
164212151|NCT05556057|593142645|FG001|Overall Study|Withdrawal by Subject|2|||
164212152|NCT03488524|593142646|FG000|Overall Study|Withdrawal by Subject|51|||
164212153|NCT03488524|593142646|FG000|Overall Study|Death|19|||
164212154|NCT03488524|593142646|FG000|Overall Study|Study Sponsor|11|||
164212155|NCT03488524|593142646|FG000|Overall Study|Physician Decision|4|||
164212156|NCT03488524|593142646|FG000|Overall Study|Lost to Follow-up|3|||
164212157|NCT00315445|593142647|FG000|Overall Study|Adverse Event|7|||
164212158|NCT00315445|593142648|FG001|Overall Study|Adverse Event|12|||
164212159|NCT00315445|593142649|FG002|Overall Study|Adverse Event|15|||
164212160|NCT00315445|593142647|FG000|Overall Study|Lack of Efficacy|16|||
164212161|NCT00315445|593142648|FG001|Overall Study|Lack of Efficacy|1|||
164212162|NCT00315445|593142649|FG002|Overall Study|Lack of Efficacy|7|||
164212163|NCT00315445|593142647|FG000|Overall Study|Lost to Follow-up|1|||
164212164|NCT00315445|593142648|FG001|Overall Study|Lost to Follow-up|0|||
164212165|NCT00315445|593142649|FG002|Overall Study|Lost to Follow-up|1|||
164212166|NCT00315445|593142647|FG000|Overall Study|Protocol Violation|2|||
164212167|NCT00315445|593142648|FG001|Overall Study|Protocol Violation|0|||
164212168|NCT00315445|593142649|FG002|Overall Study|Protocol Violation|1|||
164212169|NCT00315445|593142647|FG000|Overall Study|Other|1|||
163876242|NCT03988023|591914810|FG000|Overall Study|Adverse Event|0|||
163876243|NCT03988023|591914811|FG001|Overall Study|Adverse Event|2|||
163876244|NCT03988023|591914810|FG000|Overall Study|Physician Decision|0|||
163876245|NCT03988023|591914811|FG001|Overall Study|Physician Decision|1|||
164212170|NCT00315445|593142648|FG001|Overall Study|Other|3|||
164212171|NCT00315445|593142649|FG002|Overall Study|Other|0|||
164212172|NCT02390284|593142650|FG000|Overall Study|Physician Decision|0|||
164212173|NCT02390284|593142651|FG001|Overall Study|Physician Decision|0|||
164212174|NCT02390284|593142652|FG002|Overall Study|Physician Decision|9|||
163876246|NCT03988023|591914810|FG000|Overall Study|Lost to Follow-up|5|||
163876247|NCT03988023|591914811|FG001|Overall Study|Lost to Follow-up|8|||
163876248|NCT03988023|591914810|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
164137499|NCT02563106|592866863|FG000|Overall Study|Physician Decision|3|||
164137500|NCT02563106|592866864|FG001|Overall Study|Physician Decision|1|||
164137501|NCT02563106|592866863|FG000|Overall Study|Other reason - not specified|2|||
164137502|NCT02563106|592866864|FG001|Overall Study|Other reason - not specified|1|||
164137503|NCT01136967|592866869|FG000|Overall Study|Adverse Event|9|||
164137504|NCT01136967|592866870|FG001|Overall Study|Adverse Event|12|||
164137505|NCT01136967|592866869|FG000|Overall Study|Participant Choice|8|||
164137506|NCT01136967|592866870|FG001|Overall Study|Participant Choice|3|||
164137507|NCT01136967|592866869|FG000|Overall Study|Lost to Follow-up|0|||
164137508|NCT01136967|592866870|FG001|Overall Study|Lost to Follow-up|1|||
164137509|NCT01136967|592866869|FG000|Overall Study|Withdrawal by Subject|1|||
164137510|NCT01136967|592866870|FG001|Overall Study|Withdrawal by Subject|2|||
164137511|NCT01136967|592866869|FG000|Overall Study|Clinical Progression|3|||
164137512|NCT01136967|592866870|FG001|Overall Study|Clinical Progression|5|||
164137513|NCT01136967|592866869|FG000|Overall Study|Radiation|1|||
164137514|NCT01136967|592866870|FG001|Overall Study|Radiation|0|||
164137515|NCT01136967|592866869|FG000|Overall Study|Non-compliance|1|||
164137516|NCT01136967|592866870|FG001|Overall Study|Non-compliance|0|||
164137517|NCT01136967|592866869|FG000|Overall Study|Investigator's Choice|1|||
164325257|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325258|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325259|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325260|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Subject was discontinued from trial|0|||
164325261|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325262|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325263|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325264|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325265|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325266|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325267|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325268|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164077589|NCT01889862|592649994|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164077590|NCT01889862|592649995|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164077591|NCT01889862|592649996|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164077592|NCT01889862|592649997|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
164077593|NCT01889862|592649993|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164077594|NCT01889862|592649994|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164077595|NCT01889862|592649995|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
164077596|NCT01889862|592649996|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164077597|NCT01889862|592649997|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
164077598|NCT01889862|592649993|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164077599|NCT01889862|592649994|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164077600|NCT01889862|592649995|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164077601|NCT01889862|592649996|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
164077602|NCT01889862|592649997|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
164077603|NCT01889862|592649993|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164077604|NCT01889862|592649994|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164077605|NCT01889862|592649995|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
164325269|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325270|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325271|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325272|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|1|||
164325273|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325274|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325275|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325276|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325277|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Principal Investigator's decision|0|||
164325278|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325279|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325280|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325281|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325282|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325283|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325284|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325285|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325286|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325287|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325288|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325289|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325290|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325291|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|1|||
164325292|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325293|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325294|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Lost to Follow-up|0|||
164325295|NCT02616562|593566031|FG000|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325296|NCT02616562|593566032|FG001|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325297|NCT02616562|593566033|FG002|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325298|NCT02616562|593566034|FG003|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325299|NCT02616562|593566035|FG004|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325300|NCT02616562|593566036|FG005|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325301|NCT02616562|593566037|FG006|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325302|NCT02616562|593566038|FG007|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164077606|NCT01889862|592649996|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
163876249|NCT03988023|591914811|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
163876250|NCT03988023|591914810|FG000|Overall Study|Lack of Efficacy|3|||
163876251|NCT03988023|591914811|FG001|Overall Study|Lack of Efficacy|1|||
163876252|NCT03988023|591914810|FG000|Overall Study|COVID-19 pandemic|225|||
163876253|NCT03988023|591914811|FG001|Overall Study|COVID-19 pandemic|227|||
163876254|NCT03655262|591914812|FG000|Overall Study|Withdrawal by Subject|0|||
163876255|NCT03655262|591914813|FG001|Overall Study|Withdrawal by Subject|0|||
163876256|NCT03655262|591914814|FG002|Overall Study|Withdrawal by Subject|1|||
163980568|NCT01049035|592299565|FG003|Overall Study|Other adverse event (AE)|1|||
164212175|NCT01299909|593142653|FG000|Overall Study|Lost to Follow-up|22|||
164212176|NCT01299909|593142654|FG001|Overall Study|Lost to Follow-up|18|||
164212177|NCT01299909|593142655|FG002|Overall Study|Lost to Follow-up|17|||
164212178|NCT02293499|593144081|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
164212179|NCT02293499|593144082|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
164212180|NCT02293499|593144083|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
164212181|NCT02293499|593144081|FG000|Intervention - Camp|Withdrawal by Subject|3|||
164212182|NCT02293499|593144082|FG001|Intervention - Camp|Withdrawal by Subject|6|||
164212183|NCT02293499|593144083|FG002|Intervention - Camp|Withdrawal by Subject|2|||
164212184|NCT02293499|593144081|FG000|Intervention - Camp|these are those not showing up at camp|24|||
164212185|NCT02293499|593144082|FG001|Intervention - Camp|these are those not showing up at camp|28|||
164212186|NCT02293499|593144083|FG002|Intervention - Camp|these are those not showing up at camp|4|||
164212187|NCT02293499|593144081|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
164212188|NCT02293499|593144082|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
164212189|NCT02293499|593144083|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
164212190|NCT02293499|593144081|FG000|3 Month Follow Up|Lost to Follow-up|14|||
164212191|NCT02293499|593144082|FG001|3 Month Follow Up|Lost to Follow-up|15|||
164212192|NCT02293499|593144083|FG002|3 Month Follow Up|Lost to Follow-up|6|||
164212193|NCT02293499|593144081|FG000|6 Month Follow Up|Lost to Follow-up|17|||
164212194|NCT02293499|593144082|FG001|6 Month Follow Up|Lost to Follow-up|27|||
164212195|NCT02293499|593144083|FG002|6 Month Follow Up|Lost to Follow-up|6|||
164212196|NCT02293499|593144081|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
164212197|NCT02293499|593144082|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
164212198|NCT02293499|593144083|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
164212199|NCT02293499|593144081|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
164212200|NCT02293499|593144082|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
164212201|NCT02293499|593144083|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
164212202|NCT02293499|593144081|FG000|9 Month Follow Up|Lost to Follow-up|24|||
164212203|NCT02293499|593144082|FG001|9 Month Follow Up|Lost to Follow-up|28|||
164212204|NCT02293499|593144083|FG002|9 Month Follow Up|Lost to Follow-up|4|||
164212205|NCT02293499|593144081|FG000|12 Month Follow Up|Lost to Follow-up|26|||
164212206|NCT02293499|593144082|FG001|12 Month Follow Up|Lost to Follow-up|25|||
164212207|NCT02293499|593144083|FG002|12 Month Follow Up|Lost to Follow-up|6|||
164212208|NCT02293499|593144081|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
164212209|NCT02293499|593144082|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
164212210|NCT02293499|593144083|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
164212211|NCT02293499|593144081|FG000|15 Month Follow Up|Lost to Follow-up|22|||
164212212|NCT02293499|593144082|FG001|15 Month Follow Up|Lost to Follow-up|22|||
164212213|NCT02293499|593144083|FG002|15 Month Follow Up|Lost to Follow-up|7|||
164212214|NCT03915067|593144084|FG000|Overall Study|Adverse Event|0|||
164212215|NCT03915067|593144085|FG001|Overall Study|Adverse Event|0|||
164212216|NCT03915067|593144086|FG002|Overall Study|Adverse Event|1|||
164212217|NCT03915067|593144084|FG000|Overall Study|Withdrawal by Subject|4|||
164212218|NCT03915067|593144085|FG001|Overall Study|Withdrawal by Subject|3|||
164212219|NCT03915067|593144086|FG002|Overall Study|Withdrawal by Subject|0|||
164212220|NCT03915067|593144084|FG000|Overall Study|Lost to Follow-up|3|||
164212221|NCT03915067|593144085|FG001|Overall Study|Lost to Follow-up|2|||
164212222|NCT03915067|593144086|FG002|Overall Study|Lost to Follow-up|0|||
164212223|NCT03915067|593144084|FG000|Overall Study|Protocol Deviation|0|||
164212224|NCT03915067|593144085|FG001|Overall Study|Protocol Deviation|0|||
164212225|NCT03915067|593144086|FG002|Overall Study|Protocol Deviation|1|||
164212226|NCT03915067|593144084|FG000|Overall Study|Covid-19 Related Issues|2|||
164212227|NCT03915067|593144085|FG001|Overall Study|Covid-19 Related Issues|4|||
164212228|NCT03915067|593144086|FG002|Overall Study|Covid-19 Related Issues|4|||
164212229|NCT03915067|593144084|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
164212230|NCT03915067|593144085|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
164212231|NCT03915067|593144086|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
163980569|NCT01049035|592299566|FG004|Overall Study|Other adverse event (AE)|0|||
164212232|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
164212233|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
163876257|NCT03733119|591914815|FG000|Overall Study|Physician Decision|2|||
164212234|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
164212235|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
164212236|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
164212237|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212238|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
164212239|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212240|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212241|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
164212242|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Death|0|||
164212243|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Death|0|||
164212244|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Death|1|||
164212245|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Death|0|||
164212246|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Death|0|||
164212247|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
164212248|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
164212249|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
164212250|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
164212251|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
164212252|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Other|2|||
164212253|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Other|1|||
164212254|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Other|0|||
164212255|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Other|0|||
164212256|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Other|0|||
164212257|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212258|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212259|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
164212260|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164077607|NCT01889862|592649997|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
164077608|NCT01889862|592649993|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164077609|NCT01889862|592649994|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164077610|NCT01889862|592649995|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164077611|NCT01889862|592649996|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
164077612|NCT01889862|592649997|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
164077613|NCT01889862|592649993|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164077614|NCT01889862|592649994|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164077615|NCT01889862|592649995|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164077616|NCT01889862|592649996|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
164077617|NCT01889862|592649997|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
164077618|NCT01889862|592649993|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164077619|NCT01889862|592649994|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164077620|NCT01889862|592649995|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164077621|NCT01889862|592649996|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
164077622|NCT01889862|592649997|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
164077623|NCT00033631|592649998|FG000|Overall Study|Protocol Violation|14|||
164077624|NCT00033631|592649999|FG001|Overall Study|Protocol Violation|11|||
164077625|NCT00033631|592649998|FG000|Overall Study|Withdrawal by Subject|4|||
164077626|NCT00033631|592649999|FG001|Overall Study|Withdrawal by Subject|4|||
164077627|NCT00667719|592650002|FG000|Overall Study|Adverse Event|39|||
164077628|NCT00667719|592650002|FG000|Overall Study|Abnormal Test Procedure|1|||
164077629|NCT00667719|592650002|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164077630|NCT00667719|592650002|FG000|Overall Study|Protocol Violation|3|||
164077631|NCT00667719|592650002|FG000|Overall Study|Withdrawal by Subject|17|||
164077632|NCT00667719|592650002|FG000|Overall Study|Lost to Follow-up|8|||
164077633|NCT01827371|592650003|FG000|Overall Study|Adverse Event|0|||
164077634|NCT01827371|592650004|FG001|Overall Study|Adverse Event|0|||
164077635|NCT01827371|592650005|FG002|Overall Study|Adverse Event|4|||
164077636|NCT01827371|592650006|FG003|Overall Study|Adverse Event|2|||
164077637|NCT01827371|592650003|FG000|Overall Study|Lost to Follow-up|0|||
164077638|NCT01827371|592650004|FG001|Overall Study|Lost to Follow-up|2|||
164077639|NCT01827371|592650005|FG002|Overall Study|Lost to Follow-up|0|||
164077640|NCT01827371|592650006|FG003|Overall Study|Lost to Follow-up|4|||
164077641|NCT01827371|592650003|FG000|Overall Study|Protocol Violation|1|||
164077642|NCT01827371|592650004|FG001|Overall Study|Protocol Violation|0|||
164077643|NCT01827371|592650005|FG002|Overall Study|Protocol Violation|0|||
164212261|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
164212262|NCT03317496|593144087|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
164212263|NCT03317496|593144088|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
164212264|NCT03317496|593144089|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
164077644|NCT01827371|592650006|FG003|Overall Study|Protocol Violation|0|||
164077645|NCT01827371|592650003|FG000|Overall Study|Withdrawal by Subject|1|||
164077646|NCT01827371|592650004|FG001|Overall Study|Withdrawal by Subject|2|||
164077647|NCT01827371|592650005|FG002|Overall Study|Withdrawal by Subject|2|||
164077648|NCT01827371|592650006|FG003|Overall Study|Withdrawal by Subject|3|||
164077649|NCT01827371|592650003|FG000|Overall Study|Physician Decision|0|||
164077650|NCT01827371|592650004|FG001|Overall Study|Physician Decision|1|||
164077651|NCT01827371|592650005|FG002|Overall Study|Physician Decision|0|||
164077652|NCT01827371|592650006|FG003|Overall Study|Physician Decision|1|||
164212265|NCT03317496|593144090|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
164212266|NCT03317496|593144091|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
164325303|NCT02616562|593566039|FG008|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325304|NCT02616562|593566040|FG009|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325305|NCT02616562|593566041|FG010|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325306|NCT02616562|593566042|FG011|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325307|NCT02616562|593566043|FG012|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325308|NCT02616562|593566044|FG013|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325309|NCT02616562|593566045|FG014|Long Term Safety Extension (208 Weeks)|Adult height reached|1|||
164325310|NCT02616562|593566046|FG015|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325311|NCT02616562|593566047|FG016|Long Term Safety Extension (208 Weeks)|Adult height reached|0|||
164325312|NCT02616562|593566031|FG000|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325313|NCT02616562|593566032|FG001|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325314|NCT02616562|593566033|FG002|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325315|NCT02616562|593566034|FG003|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325316|NCT02616562|593566035|FG004|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325317|NCT02616562|593566036|FG005|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325318|NCT02616562|593566037|FG006|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325319|NCT02616562|593566038|FG007|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325320|NCT02616562|593566039|FG008|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325321|NCT02616562|593566040|FG009|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325322|NCT02616562|593566041|FG010|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325323|NCT02616562|593566042|FG011|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325324|NCT02616562|593566043|FG012|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325325|NCT02616562|593566044|FG013|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325326|NCT02616562|593566045|FG014|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|0|||
164325327|NCT02616562|593566046|FG015|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|5|||
164325328|NCT02616562|593566047|FG016|Extension After Week 364 (78 Weeks)|Somapacitan available in their country|16|||
163876258|NCT03733119|591914816|FG001|Overall Study|Physician Decision|1|||
163876259|NCT03733119|591914815|FG000|Overall Study|ineligible to treat per protocol|0|||
164212267|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
164212268|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
164212269|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
164212270|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
164212271|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
164212272|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
164212273|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212274|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212275|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212276|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
164212277|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212278|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212279|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
164212280|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212281|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
164212282|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
164212283|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
164212284|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
164212285|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
164212286|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
164212287|NCT03317496|593144087|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
164212288|NCT03317496|593144088|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
164212289|NCT03317496|593144089|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
164212290|NCT03317496|593144090|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
164212291|NCT03317496|593144091|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
164212292|NCT03317496|593144087|FG000|Phase 2: Treatment|Adverse Event|0|||
164077653|NCT01827371|592650003|FG000|Overall Study|Temporary study halt to vaccinations|11|||
164077654|NCT01827371|592650004|FG001|Overall Study|Temporary study halt to vaccinations|2|||
164212293|NCT03317496|593144088|FG001|Phase 2: Treatment|Adverse Event|0|||
164212294|NCT03317496|593144089|FG002|Phase 2: Treatment|Adverse Event|0|||
164212295|NCT03317496|593144090|FG003|Phase 2: Treatment|Adverse Event|0|||
164212296|NCT03317496|593144091|FG004|Phase 2: Treatment|Adverse Event|6|||
163876260|NCT03733119|591914816|FG001|Overall Study|ineligible to treat per protocol|1|||
164212297|NCT03317496|593144087|FG000|Phase 2: Treatment|Progressive disease|0|||
164212298|NCT03317496|593144088|FG001|Phase 2: Treatment|Progressive disease|0|||
164325329|NCT03326206|593566055|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
164325330|NCT03326206|593566056|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
164325331|NCT03326206|593566055|FG000|Overall Study - 24 months|Death|8|||
164325332|NCT03326206|593566056|FG001|Overall Study - 24 months|Death|92|||
164325333|NCT03326206|593566055|FG000|Overall Study - 24 months|Observational data not available|43|||
164325334|NCT03326206|593566056|FG001|Overall Study - 24 months|Observational data not available|2879|||
164325335|NCT03326206|593566055|FG000|12 months|Unable to match cases with controls|17|||
164325336|NCT03326206|593566056|FG001|12 months|Unable to match cases with controls|22721|||
164325337|NCT03326206|593566055|FG000|12 months|Death|2|||
164325338|NCT03326206|593566056|FG001|12 months|Death|50|||
164325339|NCT03326206|593566055|FG000|12 months|Observational data not available|49|||
164325340|NCT03326206|593566056|FG001|12 months|Observational data not available|2921|||
164325341|NCT01958827|593566057|FG000|Overall Study|Adverse Event|3|||
164325342|NCT01958827|593566057|FG000|Overall Study|Lack of Efficacy|6|||
164325343|NCT01958827|593566057|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
164325344|NCT04770779|593566058|FG000|Overall Study|Randomized, never treated|0|||
164325345|NCT04770779|593566059|FG001|Overall Study|Randomized, never treated|1|||
164325346|NCT04770779|593566058|FG000|Overall Study|Adverse Event|9|||
164077655|NCT01827371|592650005|FG002|Overall Study|Temporary study halt to vaccinations|5|||
164077656|NCT01827371|592650006|FG003|Overall Study|Temporary study halt to vaccinations|13|||
164077657|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077658|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077659|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077660|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
164077661|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077662|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077663|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077664|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077665|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077666|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
164077667|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164077668|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164077669|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Adverse Event|1|||
164077670|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Adverse Event|1|||
164077671|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Adverse Event|1|||
164077672|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Adverse Event|1|||
164077673|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Adverse Event|0|||
164077674|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Adverse Event|0|||
164077675|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Adverse Event|0|||
164077676|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Adverse Event|0|||
164077677|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
164077678|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
164077679|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
164077680|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
164077681|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
164077682|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
164077683|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
164077684|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
164077685|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
164077686|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
164077687|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164077688|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164077689|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
164077690|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
164077691|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
164077692|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
164077693|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
164077694|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
164077695|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
164077696|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
164077697|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
164077698|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
164077699|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164077700|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164077701|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164077702|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164325347|NCT04770779|593566059|FG001|Overall Study|Adverse Event|1|||
164077703|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
163876261|NCT02554786|591914819|FG000|Overall Study|Subject/guardian decision|29|||
164212299|NCT03317496|593144089|FG002|Phase 2: Treatment|Progressive disease|0|||
164212300|NCT03317496|593144090|FG003|Phase 2: Treatment|Progressive disease|0|||
164212301|NCT03317496|593144091|FG004|Phase 2: Treatment|Progressive disease|22|||
164212302|NCT03317496|593144087|FG000|Phase 2: Treatment|Other|0|||
164212303|NCT03317496|593144088|FG001|Phase 2: Treatment|Other|0|||
164212304|NCT03317496|593144089|FG002|Phase 2: Treatment|Other|0|||
164212305|NCT03317496|593144090|FG003|Phase 2: Treatment|Other|0|||
164212306|NCT03317496|593144091|FG004|Phase 2: Treatment|Other|4|||
164212307|NCT03317496|593144087|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
164212308|NCT03317496|593144088|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
164212309|NCT03317496|593144089|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
164212310|NCT03317496|593144090|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
164212311|NCT03317496|593144091|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
164212312|NCT03317496|593144087|FG000|Phase 2: Treatment|Physician Decision|0|||
164212313|NCT03317496|593144088|FG001|Phase 2: Treatment|Physician Decision|0|||
164212314|NCT03317496|593144089|FG002|Phase 2: Treatment|Physician Decision|0|||
164212315|NCT03317496|593144090|FG003|Phase 2: Treatment|Physician Decision|0|||
164212316|NCT03317496|593144091|FG004|Phase 2: Treatment|Physician Decision|1|||
164212317|NCT03317496|593144087|FG000|Phase 2: Treatment|Death|0|||
164212318|NCT03317496|593144088|FG001|Phase 2: Treatment|Death|0|||
164212319|NCT03317496|593144089|FG002|Phase 2: Treatment|Death|0|||
164212320|NCT03317496|593144090|FG003|Phase 2: Treatment|Death|0|||
164212321|NCT03317496|593144091|FG004|Phase 2: Treatment|Death|1|||
164212322|NCT03317496|593144087|FG000|Phase 2: Follow-up|Death|0|||
164212323|NCT03317496|593144088|FG001|Phase 2: Follow-up|Death|0|||
164212324|NCT03317496|593144089|FG002|Phase 2: Follow-up|Death|0|||
164212325|NCT03317496|593144090|FG003|Phase 2: Follow-up|Death|0|||
164212326|NCT03317496|593144091|FG004|Phase 2: Follow-up|Death|24|||
164212327|NCT03317496|593144087|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
164212328|NCT03317496|593144088|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
164212329|NCT03317496|593144089|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
164212330|NCT03317496|593144090|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
164212331|NCT03317496|593144091|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
164212332|NCT03317496|593144087|FG000|Phase 2: Follow-up|Other|0|||
164212333|NCT03317496|593144088|FG001|Phase 2: Follow-up|Other|0|||
164212334|NCT03317496|593144089|FG002|Phase 2: Follow-up|Other|0|||
164212335|NCT03317496|593144090|FG003|Phase 2: Follow-up|Other|0|||
164212336|NCT03317496|593144091|FG004|Phase 2: Follow-up|Other|1|||
164212337|NCT03317496|593144087|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212338|NCT03317496|593144088|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212339|NCT03317496|593144089|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212340|NCT03317496|593144090|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
164212341|NCT03317496|593144091|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
164212342|NCT02693418|593144092|FG000|Overall Study|Lost to Follow-up|1|||
164212343|NCT02693418|593144093|FG001|Overall Study|Lost to Follow-up|2|||
164212344|NCT02693418|593144094|FG002|Overall Study|Lost to Follow-up|0|||
164212345|NCT02693418|593144095|FG003|Overall Study|Lost to Follow-up|0|||
164212346|NCT02693418|593144096|FG004|Overall Study|Lost to Follow-up|0|||
164212347|NCT02693418|593144092|FG000|Overall Study|Menses during study period|0|||
164212348|NCT02693418|593144093|FG001|Overall Study|Menses during study period|0|||
164212349|NCT02693418|593144094|FG002|Overall Study|Menses during study period|2|||
164212350|NCT02693418|593144095|FG003|Overall Study|Menses during study period|0|||
164212351|NCT02693418|593144096|FG004|Overall Study|Menses during study period|0|||
164212352|NCT01750346|593144097|FG000|Overall Study|Adverse Event|1|||
164212353|NCT01750346|593144098|FG001|Overall Study|Adverse Event|0|||
164212354|NCT01750346|593144099|FG002|Overall Study|Adverse Event|0|||
164212355|NCT02034591|593144102|FG000|Overall Study|Withdrawal by Subject|0|||
164212356|NCT02034591|593144103|FG001|Overall Study|Withdrawal by Subject|0|||
164212357|NCT02034591|593144104|FG002|Overall Study|Withdrawal by Subject|0|||
164212358|NCT02034591|593144105|FG003|Overall Study|Withdrawal by Subject|0|||
164212359|NCT02034591|593144106|FG004|Overall Study|Withdrawal by Subject|1|||
164212360|NCT02034591|593144107|FG005|Overall Study|Withdrawal by Subject|0|||
164212361|NCT00599313|593144108|FG000|Overall Study|Adverse Event|19|||
164212362|NCT00599313|593144108|FG000|Overall Study|Disease Progression|12|||
164212363|NCT00599313|593144108|FG000|Overall Study|Patient Request|4|||
164212364|NCT00599313|593144108|FG000|Overall Study|Ineligible|1|||
164212365|NCT02782468|593144109|FG000|Overall Study|Progressive Disease|2|||
164212366|NCT02782468|593144110|FG001|Overall Study|Progressive Disease|5|||
164212367|NCT02782468|593144111|FG002|Overall Study|Progressive Disease|0|||
164212368|NCT02782468|593144112|FG003|Overall Study|Progressive Disease|4|||
164212369|NCT02782468|593144109|FG000|Overall Study|Adverse Event|0|||
164212370|NCT02782468|593144110|FG001|Overall Study|Adverse Event|2|||
164212371|NCT02782468|593144111|FG002|Overall Study|Adverse Event|2|||
164212372|NCT02782468|593144112|FG003|Overall Study|Adverse Event|3|||
164212373|NCT02782468|593144109|FG000|Overall Study|Other|0|||
164212374|NCT02782468|593144110|FG001|Overall Study|Other|0|||
164212375|NCT02782468|593144111|FG002|Overall Study|Other|1|||
164212376|NCT02782468|593144112|FG003|Overall Study|Other|1|||
164212377|NCT02782468|593144109|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
164212378|NCT02782468|593144110|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
164212379|NCT02782468|593144111|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
164212380|NCT02782468|593144112|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
164212381|NCT02782468|593144109|FG000|Overall Study|Symptomatic Deterioration|0|||
164212382|NCT02782468|593144110|FG001|Overall Study|Symptomatic Deterioration|0|||
164212383|NCT02782468|593144111|FG002|Overall Study|Symptomatic Deterioration|0|||
164212384|NCT02782468|593144112|FG003|Overall Study|Symptomatic Deterioration|1|||
164212385|NCT02782468|593144109|FG000|Overall Study|Withdrawal by Subject|1|||
164212386|NCT02782468|593144110|FG001|Overall Study|Withdrawal by Subject|0|||
164212387|NCT02782468|593144111|FG002|Overall Study|Withdrawal by Subject|0|||
164212388|NCT02782468|593144112|FG003|Overall Study|Withdrawal by Subject|0|||
164212389|NCT00712920|593144114|FG000|Overall Study|Adverse Event|3|||
164212390|NCT00712920|593144115|FG001|Overall Study|Adverse Event|4|||
164212391|NCT00712920|593144116|FG002|Overall Study|Adverse Event|7|||
164212392|NCT00712920|593144114|FG000|Overall Study|Withdrawal by Subject|4|||
164212393|NCT00712920|593144115|FG001|Overall Study|Withdrawal by Subject|2|||
164212394|NCT00712920|593144116|FG002|Overall Study|Withdrawal by Subject|1|||
164212395|NCT00712920|593144114|FG000|Overall Study|Lost to Follow-up|1|||
164212396|NCT00712920|593144115|FG001|Overall Study|Lost to Follow-up|4|||
164212397|NCT00712920|593144116|FG002|Overall Study|Lost to Follow-up|0|||
164212398|NCT00712920|593144114|FG000|Overall Study|Lack of Efficacy|1|||
164212399|NCT00712920|593144115|FG001|Overall Study|Lack of Efficacy|0|||
164212400|NCT00712920|593144116|FG002|Overall Study|Lack of Efficacy|1|||
164212401|NCT00712920|593144114|FG000|Overall Study|Other|5|||
164212402|NCT00712920|593144115|FG001|Overall Study|Other|7|||
164212403|NCT00712920|593144116|FG002|Overall Study|Other|3|||
164212404|NCT00712920|593144114|FG000|Overall Study|Non-compliance|3|||
164212405|NCT00712920|593144115|FG001|Overall Study|Non-compliance|0|||
164212406|NCT00712920|593144116|FG002|Overall Study|Non-compliance|0|||
164212407|NCT02489773|593144117|FG000|Overall Study|Lost to Follow-up|4|||
164212408|NCT02489773|593144118|FG001|Overall Study|Lost to Follow-up|1|||
164212409|NCT02489773|593144117|FG000|Overall Study|Physician Decision|1|||
164212410|NCT02489773|593144118|FG001|Overall Study|Physician Decision|0|||
164212411|NCT02489773|593144117|FG000|Overall Study|Withdrawal by Subject|1|||
164212412|NCT02489773|593144118|FG001|Overall Study|Withdrawal by Subject|0|||
164212413|NCT02489773|593144117|FG000|Overall Study|Leave the country or the state|1|||
164212414|NCT02489773|593144118|FG001|Overall Study|Leave the country or the state|1|||
164212415|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
164212416|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
164212417|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
164212418|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
164212419|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
164212420|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
164212421|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212422|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212423|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
164212424|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
164212425|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
164212426|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
164212427|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
164212428|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
164212429|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
164212430|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
164212431|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212432|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
164212433|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212434|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
164212435|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
163876262|NCT02554786|591914820|FG001|Overall Study|Subject/guardian decision|17|||
163876263|NCT02554786|591914821|FG002|Overall Study|Subject/guardian decision|18|||
163876264|NCT02554786|591914822|FG003|Overall Study|Subject/guardian decision|30|||
163876265|NCT02554786|591914823|FG004|Overall Study|Subject/guardian decision|20|||
164212436|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
164212437|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
164212438|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
164212439|NCT00620542|593144120|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
164212440|NCT00620542|593144121|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
164212441|NCT00620542|593144122|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
164212442|NCT00620542|593144123|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
164212443|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
164212444|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
164212445|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
164212446|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
163876266|NCT02554786|591914819|FG000|Overall Study|Lost to Follow-up|4|||
164325348|NCT04770779|593566058|FG000|Overall Study|Withdrawal by Subject|7|||
164325349|NCT04770779|593566059|FG001|Overall Study|Withdrawal by Subject|1|||
164325350|NCT04770779|593566058|FG000|Overall Study|Pregnancy|0|||
164325351|NCT04770779|593566059|FG001|Overall Study|Pregnancy|1|||
164325352|NCT03692052|593566060|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
164325353|NCT03692052|593566060|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
164325354|NCT03692052|593566060|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
164325355|NCT03692052|593566060|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
164325356|NCT01163318|593566061|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
164325357|NCT01163318|593566061|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
164325358|NCT01163318|593566061|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
164325359|NCT01163318|593566061|FG000|Overall Study|Participants Without Case Report Form|7|||
164325360|NCT01163318|593566061|FG000|Overall Study|Multiple Reasons Per Participant|224|||
164325361|NCT03587727|593566062|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
164325362|NCT03587727|593566062|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
164325363|NCT04562480|593566493|FG000|Overall Study|Withdrawal by Subject|1|||
164325364|NCT04001829|593566496|FG000|Overall Study|Never start protocol therapy|5|||
164325365|NCT04001829|593566497|FG001|Overall Study|Never start protocol therapy|5|||
164325366|NCT04001829|593566496|FG000|Overall Study|Adverse Event|11|||
164325367|NCT04001829|593566497|FG001|Overall Study|Adverse Event|7|||
164325368|NCT04001829|593566496|FG000|Overall Study|Alternative therapy|1|||
164325369|NCT04001829|593566497|FG001|Overall Study|Alternative therapy|2|||
164325370|NCT04001829|593566496|FG000|Overall Study|Disease progression/relapse|2|||
164325371|NCT04001829|593566497|FG001|Overall Study|Disease progression/relapse|1|||
164325372|NCT04001829|593566496|FG000|Overall Study|Other complicating disease|1|||
164325373|NCT04001829|593566497|FG001|Overall Study|Other complicating disease|0|||
164325374|NCT04001829|593566496|FG000|Overall Study|Withdrawal by Subject|1|||
164325375|NCT04001829|593566497|FG001|Overall Study|Withdrawal by Subject|4|||
164325376|NCT04001829|593566496|FG000|Overall Study|Ineligible|2|||
164325377|NCT04001829|593566497|FG001|Overall Study|Ineligible|2|||
164325378|NCT04001829|593566496|FG000|Overall Study|Reason missing due to delinquent data|1|||
164325379|NCT04001829|593566497|FG001|Overall Study|Reason missing due to delinquent data|0|||
164325380|NCT05388058|593566498|FG000|Initial Treatment|Withdrawal by Subject|0|||
164325381|NCT05388058|593566499|FG001|Initial Treatment|Withdrawal by Subject|1|||
164325382|NCT05388058|593566498|FG000|Initial Treatment|Ineligible|0|||
164325383|NCT05388058|593566499|FG001|Initial Treatment|Ineligible|1|||
164325384|NCT04831216|593566503|FG000|Overall Study|Lost to Follow-up|32|||
164325385|NCT03470441|593566505|FG000|Overall Study|Death|0|||
164325386|NCT03470441|593566506|FG001|Overall Study|Death|1|||
164325387|NCT03470441|593566507|FG002|Overall Study|Death|1|||
164325388|NCT03470441|593566508|FG003|Overall Study|Death|0|||
164325389|NCT03470441|593566505|FG000|Overall Study|Adverse Event|0|||
164325390|NCT03470441|593566506|FG001|Overall Study|Adverse Event|0|||
164325391|NCT03470441|593566507|FG002|Overall Study|Adverse Event|0|||
164325392|NCT03470441|593566508|FG003|Overall Study|Adverse Event|1|||
164325393|NCT03470441|593566505|FG000|Overall Study|Withdrawal by Subject|1|||
164325394|NCT03470441|593566506|FG001|Overall Study|Withdrawal by Subject|4|||
164325395|NCT03470441|593566507|FG002|Overall Study|Withdrawal by Subject|1|||
164325396|NCT03470441|593566508|FG003|Overall Study|Withdrawal by Subject|3|||
164325397|NCT02656706|593566509|FG000|Overall Study|Insurance Denial|1|||
164325398|NCT05076266|593566510|FG000|Overall Study|Survey not complete - Participant refusal|2|||
164325399|NCT05076266|593566511|FG001|Overall Study|Survey not complete - Participant refusal|0|||
164325400|NCT05169567|593566512|FG000|Overall Study|On study treatment|116|||
164325401|NCT05169567|593566513|FG001|Overall Study|On study treatment|128|||
164325402|NCT05169567|593566512|FG000|Overall Study|Lost to Follow-up|1|||
164325403|NCT05169567|593566513|FG001|Overall Study|Lost to Follow-up|0|||
164325404|NCT05169567|593566512|FG000|Overall Study|Withdrawal by Subject|25|||
164325405|NCT05169567|593566513|FG001|Overall Study|Withdrawal by Subject|21|||
164325406|NCT04576455|593566516|FG000|Overall Study|Ongoing in the Study|48|||
164325407|NCT04576455|593566517|FG001|Overall Study|Ongoing in the Study|58|||
164325408|NCT04576455|593566516|FG000|Overall Study|Death|83|||
164325409|NCT04576455|593566517|FG001|Overall Study|Death|77|||
164325410|NCT04576455|593566516|FG000|Overall Study|Lost to Follow-up|4|||
164325411|NCT04576455|593566517|FG001|Overall Study|Lost to Follow-up|5|||
164325412|NCT04576455|593566516|FG000|Overall Study|Withdrawal by Subject|16|||
164325413|NCT04576455|593566517|FG001|Overall Study|Withdrawal by Subject|12|||
164325414|NCT04449055|593566518|FG000|Overall Study|Lost to Follow-up|2|||
164325415|NCT04449055|593566519|FG001|Overall Study|Lost to Follow-up|1|||
164325416|NCT04449055|593566518|FG000|Overall Study|Missed 4 treatments--removed by PI|1|||
164325417|NCT04449055|593566519|FG001|Overall Study|Missed 4 treatments--removed by PI|1|||
164325418|NCT04449055|593566518|FG000|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|1|||
164325419|NCT04449055|593566519|FG001|Overall Study|Could not refrain from methamphetamine for 24 hours before treatment--removed by PI|0|||
164325420|NCT04449055|593566518|FG000|Overall Study|Incarcerated|1|||
164325421|NCT04449055|593566519|FG001|Overall Study|Incarcerated|0|||
164325422|NCT06596005|593566520|FG000|Overall Study|Withdrawal by Subject|2|||
164212447|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
164212448|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
164212449|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
164212450|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
164212451|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
164212452|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
164212453|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
164212454|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
164212455|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
164212456|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
164212457|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
164212458|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
164212459|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
164212460|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
164212461|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
164212462|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
164212463|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
164212464|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
164212465|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
164212466|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
164212467|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
164212468|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
164212469|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
164212470|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
164212471|NCT00620542|593144120|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
164212472|NCT00620542|593144121|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
164212473|NCT00620542|593144122|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
164212474|NCT00620542|593144123|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
164212475|NCT02879695|593144126|FG000|Overall Study|Did not start study treatment|2|||
164212476|NCT02879695|593144127|FG001|Overall Study|Did not start study treatment|0|||
164212477|NCT02879695|593144128|FG002|Overall Study|Did not start study treatment|3|||
164212478|NCT02879695|593144129|FG003|Overall Study|Did not start study treatment|0|||
164212479|NCT02572167|593144130|FG000|Overall Study|Withdrawal by Subject|0|||
164212480|NCT02572167|593144131|FG001|Overall Study|Withdrawal by Subject|3|||
164212481|NCT02572167|593144132|FG002|Overall Study|Withdrawal by Subject|0|||
164212482|NCT02572167|593144130|FG000|Overall Study|Lost to Follow-up|2|||
164212483|NCT02572167|593144131|FG001|Overall Study|Lost to Follow-up|5|||
164212484|NCT02572167|593144132|FG002|Overall Study|Lost to Follow-up|3|||
164212485|NCT02572167|593144130|FG000|Overall Study|Death|0|||
164212486|NCT02572167|593144131|FG001|Overall Study|Death|8|||
164212487|NCT02572167|593144132|FG002|Overall Study|Death|3|||
164212488|NCT02572167|593144130|FG000|Overall Study|Did not meet inclusion criteria|0|||
164212489|NCT02572167|593144131|FG001|Overall Study|Did not meet inclusion criteria|0|||
164212490|NCT02572167|593144132|FG002|Overall Study|Did not meet inclusion criteria|1|||
164212491|NCT02572167|593144130|FG000|Overall Study|Study closure by Sponsor|4|||
164212492|NCT02572167|593144131|FG001|Overall Study|Study closure by Sponsor|40|||
164212493|NCT02572167|593144132|FG002|Overall Study|Study closure by Sponsor|24|||
164212494|NCT00005047|593144133|FG000|Overall Study|Withdrawal by Subject|12|||
164212495|NCT00005047|593144134|FG001|Overall Study|Withdrawal by Subject|0|||
164212496|NCT00005047|593144135|FG002|Overall Study|Withdrawal by Subject|0|||
164212497|NCT00005047|593144136|FG003|Overall Study|Withdrawal by Subject|0|||
164325423|NCT06596005|593566521|FG001|Overall Study|Withdrawal by Subject|2|||
164325424|NCT06596005|593566522|FG002|Overall Study|Withdrawal by Subject|1|||
163876267|NCT02554786|591914820|FG001|Overall Study|Lost to Follow-up|3|||
163876268|NCT02554786|591914821|FG002|Overall Study|Lost to Follow-up|4|||
164212498|NCT00005047|593144133|FG000|Overall Study|Adverse Event|5|||
163876269|NCT02554786|591914822|FG003|Overall Study|Lost to Follow-up|2|||
163876270|NCT02554786|591914823|FG004|Overall Study|Lost to Follow-up|2|||
163876271|NCT02554786|591914819|FG000|Overall Study|Protocol deviation|1|||
163876272|NCT02554786|591914820|FG001|Overall Study|Protocol deviation|3|||
163876273|NCT02554786|591914821|FG002|Overall Study|Protocol deviation|3|||
163876274|NCT02554786|591914822|FG003|Overall Study|Protocol deviation|4|||
163876275|NCT02554786|591914823|FG004|Overall Study|Protocol deviation|2|||
163876276|NCT02554786|591914819|FG000|Overall Study|Technical problems|1|||
163876277|NCT02554786|591914820|FG001|Overall Study|Technical problems|1|||
163876278|NCT02554786|591914821|FG002|Overall Study|Technical problems|0|||
163876279|NCT02554786|591914822|FG003|Overall Study|Technical problems|2|||
163876280|NCT02554786|591914823|FG004|Overall Study|Technical problems|1|||
163876281|NCT02554786|591914819|FG000|Overall Study|Adverse Event|0|||
163876282|NCT02554786|591914820|FG001|Overall Study|Adverse Event|0|||
163876283|NCT02554786|591914821|FG002|Overall Study|Adverse Event|0|||
163876284|NCT02554786|591914822|FG003|Overall Study|Adverse Event|0|||
163876285|NCT02554786|591914823|FG004|Overall Study|Adverse Event|2|||
163876286|NCT02554786|591914819|FG000|Overall Study|Death|0|||
164212499|NCT00005047|593144134|FG001|Overall Study|Adverse Event|0|||
164212500|NCT00005047|593144135|FG002|Overall Study|Adverse Event|0|||
164212501|NCT00005047|593144136|FG003|Overall Study|Adverse Event|0|||
164212502|NCT00005047|593144133|FG000|Overall Study|Lost to Follow-up|1|||
164212503|NCT00005047|593144134|FG001|Overall Study|Lost to Follow-up|0|||
164212504|NCT00005047|593144135|FG002|Overall Study|Lost to Follow-up|0|||
164212505|NCT00005047|593144136|FG003|Overall Study|Lost to Follow-up|0|||
164212506|NCT00005047|593144133|FG000|Overall Study|Lack of Efficacy|1|||
164212507|NCT00005047|593144134|FG001|Overall Study|Lack of Efficacy|0|||
164212508|NCT00005047|593144135|FG002|Overall Study|Lack of Efficacy|0|||
164212509|NCT00005047|593144136|FG003|Overall Study|Lack of Efficacy|0|||
164212510|NCT05523297|593144138|FG000|Overall Study|Death|7|||
164212511|NCT05523297|593144139|FG001|Overall Study|Death|8|||
164212512|NCT05523297|593144138|FG000|Overall Study|Lost to Follow-up|2|||
164212513|NCT05523297|593144139|FG001|Overall Study|Lost to Follow-up|1|||
164212514|NCT03168672|593144142|FG000|Overall Study|Withdrawal by Subject|13|||
164212515|NCT03168672|593144142|FG000|Overall Study|Death|3|||
164212516|NCT03168672|593144142|FG000|Overall Study|Investigator's Decision|137|||
164212517|NCT03168672|593144142|FG000|Overall Study|Adverse Event|1|||
164212518|NCT03168672|593144142|FG000|Overall Study|Other|2|||
164212519|NCT03168672|593144142|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
164212520|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
164212521|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
164212522|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
164212523|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
164212524|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
164212525|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
164212526|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
164212527|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
164212528|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
164212529|NCT00433537|593144143|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
164212530|NCT00433537|593144144|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
164212531|NCT00433537|593144145|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
164212532|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
164212533|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
164212534|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
164212535|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
164212536|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
164212537|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
164212538|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
164212539|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
164212540|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
164212541|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
164212542|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
164212543|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
164212544|NCT00433537|593144143|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
164212545|NCT00433537|593144144|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
164212546|NCT00433537|593144145|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
164212547|NCT04556097|593144146|FG000|Overall Study|Death|0|||
164212548|NCT04556097|593144147|FG001|Overall Study|Death|5|||
164212549|NCT04556097|593144148|FG002|Overall Study|Death|0|||
164212550|NCT04556097|593144149|FG003|Overall Study|Death|0|||
164212551|NCT04556097|593144146|FG000|Overall Study|No caregiver|43|||
164212552|NCT04556097|593144147|FG001|Overall Study|No caregiver|53|||
164212553|NCT04556097|593144148|FG002|Overall Study|No caregiver|0|||
164212554|NCT04556097|593144149|FG003|Overall Study|No caregiver|0|||
164212555|NCT04556097|593144146|FG000|Overall Study|Ineligible, SNF|2|||
164212556|NCT04556097|593144147|FG001|Overall Study|Ineligible, SNF|2|||
164212557|NCT04556097|593144148|FG002|Overall Study|Ineligible, SNF|0|||
164212558|NCT04556097|593144149|FG003|Overall Study|Ineligible, SNF|0|||
164212559|NCT04556097|593144146|FG000|Overall Study|Ineligible, health|3|||
164212560|NCT04556097|593144147|FG001|Overall Study|Ineligible, health|4|||
164212561|NCT04556097|593144148|FG002|Overall Study|Ineligible, health|0|||
164212562|NCT04556097|593144149|FG003|Overall Study|Ineligible, health|0|||
164212563|NCT04556097|593144146|FG000|Overall Study|Ineligible, language|0|||
164212564|NCT04556097|593144147|FG001|Overall Study|Ineligible, language|1|||
164212565|NCT04556097|593144148|FG002|Overall Study|Ineligible, language|0|||
164212566|NCT04556097|593144149|FG003|Overall Study|Ineligible, language|0|||
164212567|NCT04556097|593144146|FG000|Overall Study|Ineligible, no longer in care management|0|||
164212568|NCT04556097|593144147|FG001|Overall Study|Ineligible, no longer in care management|2|||
164212569|NCT04556097|593144148|FG002|Overall Study|Ineligible, no longer in care management|1|||
164212570|NCT04556097|593144149|FG003|Overall Study|Ineligible, no longer in care management|0|||
164212571|NCT04556097|593144146|FG000|Overall Study|No dementia|13|||
164212572|NCT04556097|593144147|FG001|Overall Study|No dementia|3|||
163980570|NCT01049035|592299567|FG005|Overall Study|Other adverse event (AE)|0|||
163980571|NCT01049035|592299568|FG006|Overall Study|Other adverse event (AE)|0|||
163980572|NCT01049035|592299562|FG000|Overall Study|Non-compliance with the protocol|12|||
163980573|NCT01049035|592299563|FG001|Overall Study|Non-compliance with the protocol|6|||
163980574|NCT01049035|592299564|FG002|Overall Study|Non-compliance with the protocol|14|||
163980575|NCT01049035|592299565|FG003|Overall Study|Non-compliance with the protocol|5|||
163980576|NCT01049035|592299566|FG004|Overall Study|Non-compliance with the protocol|3|||
163980577|NCT01049035|592299567|FG005|Overall Study|Non-compliance with the protocol|4|||
163980578|NCT01049035|592299568|FG006|Overall Study|Non-compliance with the protocol|10|||
163980579|NCT01049035|592299562|FG000|Overall Study|Lost to Follow-up|5|||
163980580|NCT01049035|592299563|FG001|Overall Study|Lost to Follow-up|4|||
163980581|NCT01049035|592299564|FG002|Overall Study|Lost to Follow-up|4|||
163980582|NCT01049035|592299565|FG003|Overall Study|Lost to Follow-up|1|||
163980583|NCT01049035|592299566|FG004|Overall Study|Lost to Follow-up|0|||
163980584|NCT01049035|592299567|FG005|Overall Study|Lost to Follow-up|3|||
163980585|NCT01049035|592299568|FG006|Overall Study|Lost to Follow-up|3|||
163980586|NCT01049035|592299562|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
163980587|NCT01049035|592299563|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
163980588|NCT01049035|592299564|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
163980589|NCT01049035|592299565|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
163980590|NCT01049035|592299566|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
163980591|NCT01049035|592299567|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
163980592|NCT01049035|592299568|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
163980593|NCT00746252|592299569|FG000|Overall Study|weight gain >7.5 %|1|||
163980594|NCT00746252|592299570|FG001|Overall Study|weight gain >7.5 %|2|||
163980595|NCT01137773|592299571|FG000|Overall Study|Death|3|||
163980596|NCT01137773|592299572|FG001|Overall Study|Death|3|||
163980597|NCT01137773|592299571|FG000|Overall Study|Lost to Follow-up|6|||
163980598|NCT01137773|592299572|FG001|Overall Study|Lost to Follow-up|0|||
163980599|NCT03548051|592299574|FG000|Overall Study|Death|1|||
163980600|NCT03548051|592299575|FG001|Overall Study|Death|1|||
163980601|NCT03548051|592299574|FG000|Overall Study|Withdrawal by Subject|1|||
163980602|NCT03548051|592299575|FG001|Overall Study|Withdrawal by Subject|0|||
163980603|NCT00082888|592299576|FG000|Overall Study|Ineligible|1|||
163980604|NCT00082888|592299577|FG001|Overall Study|Ineligible|0|||
163980605|NCT00082888|592299578|FG002|Overall Study|Ineligible|0|||
163980606|NCT00817531|592299580|FG000|Overall Study|Adverse Event|1|||
163980607|NCT00817531|592299580|FG000|Overall Study|Lack of Efficacy|1|||
163980608|NCT00812214|592299581|FG000|Overall Study|Lost to Follow-up|3|||
163980609|NCT00812214|592299582|FG001|Overall Study|Lost to Follow-up|1|||
163980610|NCT02684981|592299585|FG000|Overall Study|Permanently discontinued the treatment|157|||
163980611|NCT02684981|592299586|FG001|Overall Study|Permanently discontinued the treatment|161|||
163980612|NCT02684981|592299587|FG002|Overall Study|Permanently discontinued the treatment|110|||
163980613|NCT02684981|592299585|FG000|Overall Study|Other|83|||
163980614|NCT02684981|592299586|FG001|Overall Study|Other|49|||
163980615|NCT02684981|592299587|FG002|Overall Study|Other|17|||
163980616|NCT00820898|592299590|FG000|Overall Study|Inelgible - wrong primary site|1|||
163980617|NCT00452699|592299593|FG000|Overall Study|Adverse Event|10|||
163980618|NCT00452699|592299594|FG001|Overall Study|Adverse Event|3|||
163980619|NCT00452699|592299593|FG000|Overall Study|Lack of Efficacy|6|||
163980620|NCT00452699|592299594|FG001|Overall Study|Lack of Efficacy|4|||
163980621|NCT00452699|592299593|FG000|Overall Study|Lost to Follow-up|6|||
163980622|NCT00452699|592299594|FG001|Overall Study|Lost to Follow-up|9|||
163980623|NCT00452699|592299593|FG000|Overall Study|Protocol Violation|21|||
163980624|NCT00452699|592299594|FG001|Overall Study|Protocol Violation|25|||
163980625|NCT00452699|592299593|FG000|Overall Study|Withdrawal by Subject|26|||
163980626|NCT00452699|592299594|FG001|Overall Study|Withdrawal by Subject|25|||
163980627|NCT00452699|592299593|FG000|Overall Study|Other|12|||
163980628|NCT00452699|592299594|FG001|Overall Study|Other|7|||
163980629|NCT02921971|592299595|FG000|Overall Study|Adverse Event|1|||
163980630|NCT02921971|592299596|FG001|Overall Study|Adverse Event|2|||
163980631|NCT02921971|592299595|FG000|Overall Study|Lack of Efficacy|3|||
163980632|NCT02921971|592299596|FG001|Overall Study|Lack of Efficacy|1|||
163980633|NCT02921971|592299595|FG000|Overall Study|Other than specified above|2|||
163980634|NCT02921971|592299596|FG001|Overall Study|Other than specified above|1|||
163980635|NCT00326898|592299597|FG000|Overall Study|Disease progression|52|||
163980636|NCT00326898|592299598|FG001|Overall Study|Disease progression|54|||
163980637|NCT00326898|592299599|FG002|Overall Study|Disease progression|102|||
163980638|NCT00326898|592299597|FG000|Overall Study|Adverse Event|124|||
163980639|NCT00326898|592299598|FG001|Overall Study|Adverse Event|128|||
164212573|NCT04556097|593144148|FG002|Overall Study|No dementia|0|||
163980640|NCT00326898|592299599|FG002|Overall Study|Adverse Event|33|||
163980641|NCT00326898|592299597|FG000|Overall Study|Death|2|||
163980642|NCT00326898|592299598|FG001|Overall Study|Death|0|||
163980643|NCT00326898|592299599|FG002|Overall Study|Death|0|||
163980644|NCT00326898|592299597|FG000|Overall Study|Withdrawal by Subject|134|||
163980645|NCT00326898|592299598|FG001|Overall Study|Withdrawal by Subject|128|||
163980646|NCT00326898|592299599|FG002|Overall Study|Withdrawal by Subject|32|||
164212574|NCT04556097|593144149|FG003|Overall Study|No dementia|0|||
164212575|NCT04556097|593144146|FG000|Overall Study|Missing identifier|2|||
164212576|NCT04556097|593144147|FG001|Overall Study|Missing identifier|4|||
164212577|NCT04556097|593144148|FG002|Overall Study|Missing identifier|0|||
164212578|NCT04556097|593144149|FG003|Overall Study|Missing identifier|0|||
164212579|NCT04556097|593144146|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
164212580|NCT04556097|593144147|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
164212581|NCT04556097|593144148|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
164212582|NCT04556097|593144149|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
164212583|NCT05436613|593144150|FG000|Overall Study|Lost to Follow-up|9|||
164212584|NCT05436613|593144150|FG000|Overall Study|Withdrawal by Subject|3|||
164212585|NCT05317546|593144153|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
164212586|NCT05317546|593144154|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
164212587|NCT05350202|593144155|FG000|Visit 1 - Baseline|Not-treated|18|||
164212588|NCT05350202|593144156|FG001|Visit 1 - Baseline|Not-treated|0|||
164212589|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
164212590|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
164212591|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
164212592|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
164212593|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
164212594|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
164212595|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
164212596|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
164212597|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
164212598|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
164212599|NCT05350202|593144155|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
164212600|NCT05350202|593144156|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
164212601|NCT04364646|593144163|FG000|Overall Study|Lost to Follow-up|1|||
164212602|NCT04364646|593144164|FG001|Overall Study|Lost to Follow-up|0|||
164212603|NCT04364646|593144163|FG000|Overall Study|Withdrawal by Subject|7|||
164212604|NCT04364646|593144164|FG001|Overall Study|Withdrawal by Subject|14|||
164212605|NCT04364646|593144163|FG000|Overall Study|Protocol Violation|4|||
164212606|NCT04364646|593144164|FG001|Overall Study|Protocol Violation|5|||
164212607|NCT02555878|593144181|FG000|Overall Study|Lost to Follow-up|2|||
164212608|NCT02555878|593144182|FG001|Overall Study|Lost to Follow-up|3|||
164212609|NCT02555878|593144181|FG000|Overall Study|Withdrawal by Subject|48|||
164212610|NCT02555878|593144182|FG001|Overall Study|Withdrawal by Subject|48|||
164212611|NCT02555878|593144181|FG000|Overall Study|Adverse Event|12|||
164212612|NCT02555878|593144182|FG001|Overall Study|Adverse Event|8|||
164212613|NCT02555878|593144181|FG000|Overall Study|Death|74|||
164212614|NCT02555878|593144182|FG001|Overall Study|Death|59|||
164212615|NCT02555878|593144181|FG000|Overall Study|Protocol Violation|1|||
164212616|NCT02555878|593144182|FG001|Overall Study|Protocol Violation|2|||
164212617|NCT02555878|593144181|FG000|Overall Study|Physician Decision|12|||
164212618|NCT02555878|593144182|FG001|Overall Study|Physician Decision|13|||
164212619|NCT02555878|593144181|FG000|Overall Study|Other|17|||
164212620|NCT02555878|593144182|FG001|Overall Study|Other|17|||
164212621|NCT00765076|593144183|FG000|Overall Study|Adverse Event|1|||
164212622|NCT00765076|593144184|FG001|Overall Study|Adverse Event|0|||
164212623|NCT00765076|593144185|FG002|Overall Study|Adverse Event|0|||
164212624|NCT00765076|593144183|FG000|Overall Study|Withdrawal by Subject|0|||
164212625|NCT00765076|593144184|FG001|Overall Study|Withdrawal by Subject|0|||
164212626|NCT00765076|593144185|FG002|Overall Study|Withdrawal by Subject|1|||
164325425|NCT06596005|593566520|FG000|Overall Study|Other|0|||
164325426|NCT06596005|593566521|FG001|Overall Study|Other|2|||
164325427|NCT06596005|593566522|FG002|Overall Study|Other|0|||
164325428|NCT02445391|593566523|FG000|Overall Study|No active protocol treatment|3|||
164325429|NCT02445391|593566524|FG001|Overall Study|No active protocol treatment|0|||
164325430|NCT02445391|593566525|FG002|Overall Study|No active protocol treatment|0|||
164212627|NCT01164475|593144186|FG000|Overall Study|Lack of Efficacy|1|||
164212628|NCT01164475|593144187|FG001|Overall Study|Lack of Efficacy|0|||
164212629|NCT01164475|593144186|FG000|Overall Study|Other|0|||
164212630|NCT01164475|593144187|FG001|Overall Study|Other|1|||
164212631|NCT01164475|593144186|FG000|Overall Study|Progressive disease|0|||
164325431|NCT02445391|593566523|FG000|Overall Study|Adverse Event|0|||
164325432|NCT02445391|593566524|FG001|Overall Study|Adverse Event|21|||
164212632|NCT01164475|593144187|FG001|Overall Study|Progressive disease|1|||
164212633|NCT01164475|593144186|FG000|Overall Study|Protocol Violation|1|||
164212634|NCT01164475|593144187|FG001|Overall Study|Protocol Violation|0|||
164212635|NCT02335944|593144188|FG000|Treatment Phase|Progressive Disease|2|||
164212636|NCT02335944|593144189|FG001|Treatment Phase|Progressive Disease|5|||
164212637|NCT02335944|593144190|FG002|Treatment Phase|Progressive Disease|2|||
164212638|NCT02335944|593144191|FG003|Treatment Phase|Progressive Disease|11|||
164212639|NCT02335944|593144192|FG004|Treatment Phase|Progressive Disease|4|||
164325433|NCT02445391|593566525|FG002|Overall Study|Adverse Event|12|||
164325434|NCT02445391|593566523|FG000|Overall Study|Alternative therapy|0|||
164325435|NCT02445391|593566524|FG001|Overall Study|Alternative therapy|0|||
164325436|NCT02445391|593566525|FG002|Overall Study|Alternative therapy|1|||
164325437|NCT02445391|593566523|FG000|Overall Study|Disease progression|0|||
164325438|NCT02445391|593566524|FG001|Overall Study|Disease progression|7|||
164325439|NCT02445391|593566525|FG002|Overall Study|Disease progression|22|||
164325440|NCT02445391|593566523|FG000|Overall Study|Complicating disease|0|||
164325441|NCT02445391|593566524|FG001|Overall Study|Complicating disease|2|||
164325442|NCT02445391|593566525|FG002|Overall Study|Complicating disease|1|||
164325443|NCT02445391|593566523|FG000|Overall Study|Withdrawal by Subject|0|||
164325444|NCT02445391|593566524|FG001|Overall Study|Withdrawal by Subject|4|||
164325445|NCT02445391|593566525|FG002|Overall Study|Withdrawal by Subject|9|||
164325446|NCT02445391|593566523|FG000|Overall Study|Financial issue|0|||
164325447|NCT02445391|593566524|FG001|Overall Study|Financial issue|0|||
164325448|NCT02445391|593566525|FG002|Overall Study|Financial issue|2|||
164325449|NCT02445391|593566523|FG000|Overall Study|Still on treatment|0|||
164325450|NCT02445391|593566524|FG001|Overall Study|Still on treatment|7|||
164325451|NCT02445391|593566525|FG002|Overall Study|Still on treatment|16|||
164325452|NCT02445391|593566523|FG000|Overall Study|Not start protocol therapy|0|||
164325453|NCT02445391|593566524|FG001|Overall Study|Not start protocol therapy|12|||
164325454|NCT02445391|593566525|FG002|Overall Study|Not start protocol therapy|9|||
164325455|NCT03516942|593566526|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
164325456|NCT03516942|593566526|FG000|Registration through baseline survey com|Death|8|||
164325457|NCT03516942|593566526|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
164325458|NCT03516942|593566526|FG000|T0: Baseline|LOST|13|||
164325459|NCT03516942|593566526|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
164325460|NCT03516942|593566526|FG000|T1: 3 Months Survey|Death|10|||
164325461|NCT03516942|593566526|FG000|T1: 3 Months Survey|Lost|163|||
164325462|NCT03516942|593566526|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
164325463|NCT03516942|593566526|FG000|T2: 6 Month Survey|Death|14|||
164325464|NCT03516942|593566526|FG000|T2: 6 Month Survey|Lost|180|||
164325465|NCT03516942|593566526|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
164325466|NCT03516942|593566526|FG000|T3: 12 Month Survey|Death|19|||
164325467|NCT03516942|593566526|FG000|T3: 12 Month Survey|Lost|209|||
164325468|NCT02275910|593566760|FG000|Overall Study|Subject Choice|0|||
164325469|NCT02275910|593566761|FG001|Overall Study|Subject Choice|0|||
164325470|NCT02275910|593566762|FG002|Overall Study|Subject Choice|0|||
164325471|NCT02275910|593566763|FG003|Overall Study|Subject Choice|0|||
164325472|NCT02275910|593566764|FG004|Overall Study|Subject Choice|0|||
164325473|NCT02275910|593566765|FG005|Overall Study|Subject Choice|0|||
164325474|NCT02275910|593566766|FG006|Overall Study|Subject Choice|0|||
164325475|NCT02275910|593566767|FG007|Overall Study|Subject Choice|0|||
164325476|NCT02275910|593566768|FG008|Overall Study|Subject Choice|1|||
164325477|NCT02275910|593566769|FG009|Overall Study|Subject Choice|0|||
164325478|NCT02275910|593566770|FG010|Overall Study|Subject Choice|0|||
164325479|NCT02275910|593566771|FG011|Overall Study|Subject Choice|0|||
164325480|NCT02275910|593566760|FG000|Overall Study|Radiological Disease Progression|0|||
164325481|NCT02275910|593566761|FG001|Overall Study|Radiological Disease Progression|0|||
164325482|NCT02275910|593566762|FG002|Overall Study|Radiological Disease Progression|0|||
164325483|NCT02275910|593566763|FG003|Overall Study|Radiological Disease Progression|0|||
164325484|NCT02275910|593566764|FG004|Overall Study|Radiological Disease Progression|0|||
164325485|NCT02275910|593566765|FG005|Overall Study|Radiological Disease Progression|0|||
164325486|NCT02275910|593566766|FG006|Overall Study|Radiological Disease Progression|1|||
164325487|NCT02275910|593566767|FG007|Overall Study|Radiological Disease Progression|1|||
164325488|NCT02275910|593566768|FG008|Overall Study|Radiological Disease Progression|0|||
164325489|NCT02275910|593566769|FG009|Overall Study|Radiological Disease Progression|1|||
164325490|NCT02275910|593566770|FG010|Overall Study|Radiological Disease Progression|0|||
164325491|NCT02275910|593566771|FG011|Overall Study|Radiological Disease Progression|0|||
164325492|NCT03961555|593566772|FG000|Overall Study|Lost to Follow-up|0|||
164325493|NCT03961555|593566773|FG001|Overall Study|Lost to Follow-up|0|||
164325494|NCT03961555|593566774|FG002|Overall Study|Lost to Follow-up|1|||
164325495|NCT03961555|593566775|FG003|Overall Study|Lost to Follow-up|0|||
164325496|NCT03961555|593566772|FG000|Overall Study|Withdrawal by Subject|0|||
164325497|NCT03961555|593566773|FG001|Overall Study|Withdrawal by Subject|0|||
164325498|NCT03961555|593566774|FG002|Overall Study|Withdrawal by Subject|2|||
164325499|NCT03961555|593566775|FG003|Overall Study|Withdrawal by Subject|4|||
164325500|NCT03961555|593566772|FG000|Overall Study|Death|0|||
164325501|NCT03961555|593566773|FG001|Overall Study|Death|1|||
164325502|NCT03961555|593566774|FG002|Overall Study|Death|0|||
164325503|NCT03961555|593566775|FG003|Overall Study|Death|0|||
164325504|NCT03961555|593566772|FG000|Overall Study|Other|0|||
164325505|NCT03961555|593566773|FG001|Overall Study|Other|0|||
164325506|NCT03961555|593566774|FG002|Overall Study|Other|2|||
164325507|NCT03961555|593566775|FG003|Overall Study|Other|2|||
164325508|NCT03961555|593566772|FG000|Overall Study|No treatment received|0|||
164325509|NCT03961555|593566773|FG001|Overall Study|No treatment received|0|||
164325510|NCT03961555|593566774|FG002|Overall Study|No treatment received|1|||
164325511|NCT03961555|593566775|FG003|Overall Study|No treatment received|0|||
164325512|NCT05222555|593566778|FG000|Overall Study|Ongoing|2|||
164212640|NCT02335944|593144193|FG005|Treatment Phase|Progressive Disease|25|||
164212641|NCT02335944|593144194|FG006|Treatment Phase|Progressive Disease|2|||
164212642|NCT02335944|593144195|FG007|Treatment Phase|Progressive Disease|30|||
164212643|NCT02335944|593144196|FG008|Treatment Phase|Progressive Disease|27|||
164212644|NCT02335944|593144197|FG009|Treatment Phase|Progressive Disease|0|||
164212645|NCT02335944|593144188|FG000|Treatment Phase|Adverse Event|2|||
164212646|NCT02335944|593144189|FG001|Treatment Phase|Adverse Event|0|||
164212647|NCT02335944|593144190|FG002|Treatment Phase|Adverse Event|0|||
164212648|NCT02335944|593144191|FG003|Treatment Phase|Adverse Event|2|||
163876287|NCT02554786|591914820|FG001|Overall Study|Death|0|||
163876288|NCT02554786|591914821|FG002|Overall Study|Death|0|||
163876289|NCT02554786|591914822|FG003|Overall Study|Death|1|||
163876290|NCT02554786|591914823|FG004|Overall Study|Death|0|||
164212649|NCT02335944|593144192|FG004|Treatment Phase|Adverse Event|1|||
164212650|NCT02335944|593144193|FG005|Treatment Phase|Adverse Event|15|||
164212651|NCT02335944|593144194|FG006|Treatment Phase|Adverse Event|0|||
164212652|NCT02335944|593144195|FG007|Treatment Phase|Adverse Event|5|||
164212653|NCT02335944|593144196|FG008|Treatment Phase|Adverse Event|7|||
164212654|NCT02335944|593144197|FG009|Treatment Phase|Adverse Event|0|||
164212655|NCT02335944|593144188|FG000|Treatment Phase|Physician Decision|0|||
164212656|NCT02335944|593144189|FG001|Treatment Phase|Physician Decision|0|||
164212657|NCT02335944|593144190|FG002|Treatment Phase|Physician Decision|0|||
164212658|NCT02335944|593144191|FG003|Treatment Phase|Physician Decision|1|||
164212659|NCT02335944|593144192|FG004|Treatment Phase|Physician Decision|0|||
164212660|NCT02335944|593144193|FG005|Treatment Phase|Physician Decision|6|||
164212661|NCT02335944|593144194|FG006|Treatment Phase|Physician Decision|1|||
164212662|NCT02335944|593144195|FG007|Treatment Phase|Physician Decision|2|||
164212663|NCT02335944|593144196|FG008|Treatment Phase|Physician Decision|1|||
164212664|NCT02335944|593144197|FG009|Treatment Phase|Physician Decision|0|||
164212665|NCT02335944|593144188|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
164212666|NCT02335944|593144189|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
164212667|NCT02335944|593144190|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
164212668|NCT02335944|593144191|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
164212669|NCT02335944|593144192|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
164212670|NCT02335944|593144193|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
164212671|NCT02335944|593144194|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
164212672|NCT02335944|593144195|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
164212673|NCT02335944|593144196|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
164212674|NCT02335944|593144197|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
164212675|NCT02335944|593144188|FG000|Treatment Phase|Subject/Guardian Decision|0|||
164212676|NCT02335944|593144189|FG001|Treatment Phase|Subject/Guardian Decision|0|||
164212677|NCT02335944|593144190|FG002|Treatment Phase|Subject/Guardian Decision|1|||
164212678|NCT02335944|593144191|FG003|Treatment Phase|Subject/Guardian Decision|0|||
164212679|NCT02335944|593144192|FG004|Treatment Phase|Subject/Guardian Decision|0|||
164212680|NCT02335944|593144193|FG005|Treatment Phase|Subject/Guardian Decision|1|||
164212681|NCT02335944|593144194|FG006|Treatment Phase|Subject/Guardian Decision|0|||
164212682|NCT02335944|593144195|FG007|Treatment Phase|Subject/Guardian Decision|4|||
164212683|NCT02335944|593144196|FG008|Treatment Phase|Subject/Guardian Decision|0|||
164212684|NCT02335944|593144197|FG009|Treatment Phase|Subject/Guardian Decision|0|||
164212685|NCT02335944|593144188|FG000|Post-treatment Follow-up|Progressive Disease|0|||
164212686|NCT02335944|593144189|FG001|Post-treatment Follow-up|Progressive Disease|0|||
164212687|NCT02335944|593144190|FG002|Post-treatment Follow-up|Progressive Disease|0|||
164212688|NCT02335944|593144191|FG003|Post-treatment Follow-up|Progressive Disease|1|||
164212689|NCT02335944|593144192|FG004|Post-treatment Follow-up|Progressive Disease|0|||
164212690|NCT02335944|593144193|FG005|Post-treatment Follow-up|Progressive Disease|9|||
164212691|NCT02335944|593144194|FG006|Post-treatment Follow-up|Progressive Disease|0|||
164212692|NCT02335944|593144195|FG007|Post-treatment Follow-up|Progressive Disease|2|||
164212693|NCT02335944|593144196|FG008|Post-treatment Follow-up|Progressive Disease|3|||
164212694|NCT02335944|593144197|FG009|Post-treatment Follow-up|Progressive Disease|0|||
164212695|NCT02335944|593144188|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212696|NCT02335944|593144189|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212697|NCT02335944|593144190|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212698|NCT02335944|593144191|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212699|NCT02335944|593144192|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212700|NCT02335944|593144193|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
164212701|NCT02335944|593144194|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
163876291|NCT02554786|591914819|FG000|Overall Study|Non-compliance with study treatment|0|||
163876292|NCT02554786|591914820|FG001|Overall Study|Non-compliance with study treatment|1|||
164212702|NCT02335944|593144195|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212703|NCT02335944|593144196|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212704|NCT02335944|593144197|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
164212705|NCT02335944|593144188|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
163876293|NCT02554786|591914821|FG002|Overall Study|Non-compliance with study treatment|1|||
164325513|NCT05222555|593566779|FG001|Overall Study|Ongoing|18|||
164325514|NCT05222555|593566778|FG000|Overall Study|Adverse Event|1|||
164325515|NCT05222555|593566779|FG001|Overall Study|Adverse Event|1|||
164325516|NCT05222555|593566778|FG000|Overall Study|Death|0|||
164325517|NCT05222555|593566779|FG001|Overall Study|Death|6|||
164325518|NCT05222555|593566778|FG000|Overall Study|Withdrawal by Subject|0|||
164325519|NCT05222555|593566779|FG001|Overall Study|Withdrawal by Subject|11|||
164325520|NCT00076024|593567870|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
164325521|NCT00076024|593567871|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
164325522|NCT00076024|593567872|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
164325523|NCT00076024|593567873|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
164325524|NCT00076024|593567870|FG000|Phase 1, Lead-in|Adverse Event|1|||
164325525|NCT00076024|593567871|FG001|Phase 1, Lead-in|Adverse Event|0|||
164325526|NCT00076024|593567872|FG002|Phase 1, Lead-in|Adverse Event|0|||
164325527|NCT00076024|593567873|FG003|Phase 1, Lead-in|Adverse Event|0|||
164325528|NCT00076024|593567870|FG000|Phase 1, Lead-in|Clinical progression|1|||
164325529|NCT00076024|593567871|FG001|Phase 1, Lead-in|Clinical progression|0|||
164325530|NCT00076024|593567872|FG002|Phase 1, Lead-in|Clinical progression|0|||
164325531|NCT00076024|593567873|FG003|Phase 1, Lead-in|Clinical progression|0|||
164325532|NCT00076024|593567870|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
164325533|NCT00076024|593567871|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
164325534|NCT00076024|593567872|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
164325535|NCT00076024|593567873|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
164325536|NCT00076024|593567870|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
164325537|NCT00076024|593567871|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
164325538|NCT00076024|593567872|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
164325539|NCT00076024|593567873|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
164325540|NCT00076024|593567870|FG000|Phase 2, Double-blind|Adverse Event|0|||
164325541|NCT00076024|593567871|FG001|Phase 2, Double-blind|Adverse Event|25|||
164325542|NCT00076024|593567872|FG002|Phase 2, Double-blind|Adverse Event|6|||
164325543|NCT00076024|593567873|FG003|Phase 2, Double-blind|Adverse Event|0|||
164325544|NCT00076024|593567870|FG000|Phase 2, Double-blind|Un-specified|0|||
164325545|NCT00076024|593567871|FG001|Phase 2, Double-blind|Un-specified|14|||
164325546|NCT00076024|593567872|FG002|Phase 2, Double-blind|Un-specified|6|||
164325547|NCT00076024|593567873|FG003|Phase 2, Double-blind|Un-specified|0|||
164325548|NCT00076024|593567870|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
164325549|NCT00076024|593567871|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
164325550|NCT00076024|593567872|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
164325551|NCT00076024|593567873|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
164325552|NCT00076024|593567870|FG000|Phase 2, Open-label|Adverse Event|0|||
164325553|NCT00076024|593567871|FG001|Phase 2, Open-label|Adverse Event|0|||
164325554|NCT00076024|593567872|FG002|Phase 2, Open-label|Adverse Event|0|||
163876294|NCT02554786|591914822|FG003|Overall Study|Non-compliance with study treatment|0|||
163876295|NCT02554786|591914823|FG004|Overall Study|Non-compliance with study treatment|1|||
163876296|NCT02554786|591914819|FG000|Overall Study|Physician Decision|0|||
163876297|NCT02554786|591914820|FG001|Overall Study|Physician Decision|1|||
163876298|NCT02554786|591914821|FG002|Overall Study|Physician Decision|4|||
163876299|NCT02554786|591914822|FG003|Overall Study|Physician Decision|1|||
163876300|NCT02554786|591914823|FG004|Overall Study|Physician Decision|1|||
163876301|NCT02554786|591914819|FG000|Overall Study|Pregnancy|0|||
163876302|NCT02554786|591914820|FG001|Overall Study|Pregnancy|0|||
163876303|NCT02554786|591914821|FG002|Overall Study|Pregnancy|0|||
163876304|NCT02554786|591914822|FG003|Overall Study|Pregnancy|1|||
163876305|NCT02554786|591914823|FG004|Overall Study|Pregnancy|1|||
164325555|NCT00076024|593567873|FG003|Phase 2, Open-label|Adverse Event|2|||
164325556|NCT00076024|593567870|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
164325557|NCT00076024|593567871|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
164325558|NCT00076024|593567872|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
164325559|NCT00076024|593567873|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
164325560|NCT00076024|593567870|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
164325561|NCT00076024|593567871|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
164325562|NCT00076024|593567872|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
164325563|NCT00076024|593567873|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
164325564|NCT00076024|593567870|FG000|Phase 2, Open-label|Other|0|||
164325565|NCT00076024|593567871|FG001|Phase 2, Open-label|Other|0|||
163876306|NCT04583423|591914834|FG000|Overall Study|Lost to Follow-up|0|||
163876307|NCT04583423|591914835|FG001|Overall Study|Lost to Follow-up|1|||
163876308|NCT04583423|591914836|FG002|Overall Study|Lost to Follow-up|0|||
163876309|NCT04583423|591914837|FG003|Overall Study|Lost to Follow-up|2|||
164325566|NCT00076024|593567872|FG002|Phase 2, Open-label|Other|0|||
164325567|NCT00076024|593567873|FG003|Phase 2, Open-label|Other|2|||
164325568|NCT01155219|593567880|FG000|Overall Study|Adverse Event|3|||
164325569|NCT01155219|593567881|FG001|Overall Study|Adverse Event|1|||
164325570|NCT01155219|593567880|FG000|Overall Study|non-medical reason|1|||
164325571|NCT01155219|593567881|FG001|Overall Study|non-medical reason|2|||
163876310|NCT04583423|591914834|FG000|Overall Study|Study Terminated by Sponsor|32|||
163876311|NCT04583423|591914835|FG001|Overall Study|Study Terminated by Sponsor|35|||
164325572|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Adverse Event|2|||
164212706|NCT02335944|593144189|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212707|NCT02335944|593144190|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212708|NCT02335944|593144191|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212709|NCT02335944|593144192|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212710|NCT02335944|593144193|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212711|NCT02335944|593144194|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212712|NCT02335944|593144195|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
164212713|NCT02335944|593144196|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212714|NCT02335944|593144197|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
164212715|NCT02335944|593144188|FG000|Post-treatment Follow-up|Adverse Event|0|||
164212716|NCT02335944|593144189|FG001|Post-treatment Follow-up|Adverse Event|0|||
164212717|NCT02335944|593144190|FG002|Post-treatment Follow-up|Adverse Event|0|||
164212718|NCT02335944|593144191|FG003|Post-treatment Follow-up|Adverse Event|0|||
164212719|NCT02335944|593144192|FG004|Post-treatment Follow-up|Adverse Event|0|||
164212720|NCT02335944|593144193|FG005|Post-treatment Follow-up|Adverse Event|1|||
164212721|NCT02335944|593144194|FG006|Post-treatment Follow-up|Adverse Event|0|||
164212722|NCT02335944|593144195|FG007|Post-treatment Follow-up|Adverse Event|0|||
164212723|NCT02335944|593144196|FG008|Post-treatment Follow-up|Adverse Event|0|||
164212724|NCT02335944|593144197|FG009|Post-treatment Follow-up|Adverse Event|0|||
164212725|NCT02335944|593144188|FG000|Post-treatment Follow-up|Death|0|||
164212726|NCT02335944|593144189|FG001|Post-treatment Follow-up|Death|0|||
164212727|NCT02335944|593144190|FG002|Post-treatment Follow-up|Death|0|||
164212728|NCT02335944|593144191|FG003|Post-treatment Follow-up|Death|1|||
164212729|NCT02335944|593144192|FG004|Post-treatment Follow-up|Death|0|||
164212730|NCT02335944|593144193|FG005|Post-treatment Follow-up|Death|1|||
164212731|NCT02335944|593144194|FG006|Post-treatment Follow-up|Death|0|||
164212732|NCT02335944|593144195|FG007|Post-treatment Follow-up|Death|0|||
164212733|NCT02335944|593144196|FG008|Post-treatment Follow-up|Death|0|||
164212734|NCT02335944|593144197|FG009|Post-treatment Follow-up|Death|0|||
164212735|NCT02335944|593144188|FG000|Post-treatment Follow-up|Physician Decision|1|||
164212736|NCT02335944|593144189|FG001|Post-treatment Follow-up|Physician Decision|0|||
164212737|NCT02335944|593144190|FG002|Post-treatment Follow-up|Physician Decision|0|||
164212738|NCT02335944|593144191|FG003|Post-treatment Follow-up|Physician Decision|0|||
164212739|NCT02335944|593144192|FG004|Post-treatment Follow-up|Physician Decision|0|||
164212740|NCT02335944|593144193|FG005|Post-treatment Follow-up|Physician Decision|0|||
164212741|NCT02335944|593144194|FG006|Post-treatment Follow-up|Physician Decision|0|||
164212742|NCT02335944|593144195|FG007|Post-treatment Follow-up|Physician Decision|1|||
164212743|NCT02335944|593144196|FG008|Post-treatment Follow-up|Physician Decision|0|||
164212744|NCT02335944|593144197|FG009|Post-treatment Follow-up|Physician Decision|0|||
164212745|NCT00832975|593144198|FG000|Overall Study|Lost to Follow-up|7|||
164212746|NCT00832975|593144198|FG000|Overall Study|Protocol Violation|6|||
164212747|NCT00832975|593144198|FG000|Overall Study|Death|5|||
164212748|NCT00832975|593144198|FG000|Overall Study|Physician Decision|4|||
164212749|NCT00832975|593144198|FG000|Overall Study|Withdrawal by Subject|3|||
164212750|NCT00832975|593144198|FG000|Overall Study|Other reasons|14|||
164212751|NCT06081829|593144205|FG000|Overall Study|Participants still on-study|8|||
164212752|NCT06081829|593144205|FG000|Overall Study|Death|4|||
164212753|NCT04835441|593144206|FG000|Overall Study|Physician Decision|4|||
164212754|NCT04835441|593144207|FG001|Overall Study|Physician Decision|4|||
164212755|NCT04835441|593144206|FG000|Overall Study|Other|1|||
164212756|NCT04835441|593144207|FG001|Overall Study|Other|1|||
164212757|NCT04835441|593144206|FG000|Overall Study|Lost to Follow-up|0|||
164212758|NCT04835441|593144207|FG001|Overall Study|Lost to Follow-up|1|||
164212759|NCT01991314|593145535|FG000|Overall Study|Adverse Event|5|||
164212760|NCT01991314|593145536|FG001|Overall Study|Adverse Event|1|||
164212761|NCT01991314|593145535|FG000|Overall Study|Lost to Follow-up|6|||
164212762|NCT01991314|593145536|FG001|Overall Study|Lost to Follow-up|10|||
164212763|NCT00970944|593145538|FG000|Overall Study|Death|1|||
164212764|NCT00970944|593145539|FG001|Overall Study|Death|0|||
164212765|NCT00970944|593145538|FG000|Overall Study|Physician Decision|0|||
164212766|NCT00970944|593145539|FG001|Overall Study|Physician Decision|2|||
164212767|NCT02008370|593145540|FG000|Overall Study|Lost to Follow-up|7|||
164212768|NCT00662259|593145541|FG000|Overall Study|Adverse Event|2|||
164212769|NCT00662259|593145542|FG001|Overall Study|Adverse Event|0|||
164212770|NCT00972738|593145543|FG000|Overall Study|Adverse Event|7|||
164212771|NCT00972738|593145544|FG001|Overall Study|Adverse Event|1|||
164212772|NCT00972738|593145545|FG002|Overall Study|Adverse Event|8|||
164212773|NCT00972738|593145543|FG000|Overall Study|Protocol Violation|2|||
164212774|NCT00972738|593145544|FG001|Overall Study|Protocol Violation|1|||
164212775|NCT00972738|593145545|FG002|Overall Study|Protocol Violation|3|||
164212776|NCT00972738|593145543|FG000|Overall Study|Lost to Follow-up|1|||
164212777|NCT00972738|593145544|FG001|Overall Study|Lost to Follow-up|0|||
164212778|NCT00972738|593145545|FG002|Overall Study|Lost to Follow-up|1|||
164212779|NCT00972738|593145543|FG000|Overall Study|Lack of Efficacy|5|||
164212780|NCT00972738|593145544|FG001|Overall Study|Lack of Efficacy|1|||
164212781|NCT00972738|593145545|FG002|Overall Study|Lack of Efficacy|11|||
164212782|NCT00972738|593145543|FG000|Overall Study|Withdrawal by Subject|5|||
164212783|NCT00972738|593145544|FG001|Overall Study|Withdrawal by Subject|1|||
163980647|NCT00326898|592299597|FG000|Overall Study|Alternative therapy|1|||
163980648|NCT00326898|592299598|FG001|Overall Study|Alternative therapy|0|||
164212784|NCT00972738|593145545|FG002|Overall Study|Withdrawal by Subject|4|||
164212785|NCT00972738|593145543|FG000|Overall Study|Moved|0|||
164212786|NCT00972738|593145544|FG001|Overall Study|Moved|0|||
164212787|NCT00972738|593145545|FG002|Overall Study|Moved|1|||
164212788|NCT00972738|593145543|FG000|Overall Study|Other|1|||
164212789|NCT00972738|593145544|FG001|Overall Study|Other|2|||
164212790|NCT00972738|593145545|FG002|Overall Study|Other|1|||
164212791|NCT01001104|593145548|FG000|Overall Study|Adverse Event|2|||
163980649|NCT00326898|592299599|FG002|Overall Study|Alternative therapy|0|||
163980650|NCT00326898|592299597|FG000|Overall Study|Other complicating disease|5|||
163980651|NCT00326898|592299598|FG001|Overall Study|Other complicating disease|5|||
163980652|NCT00326898|592299599|FG002|Overall Study|Other complicating disease|4|||
163980653|NCT00326898|592299597|FG000|Overall Study|Other/Missing/Unknown|33|||
164212792|NCT01001104|593145549|FG001|Overall Study|Adverse Event|1|||
164212793|NCT01001104|593145550|FG002|Overall Study|Adverse Event|0|||
164212794|NCT01001104|593145551|FG003|Overall Study|Adverse Event|0|||
164212795|NCT01001104|593145548|FG000|Overall Study|Lost to Follow-up|0|||
164212796|NCT01001104|593145549|FG001|Overall Study|Lost to Follow-up|0|||
164212797|NCT01001104|593145550|FG002|Overall Study|Lost to Follow-up|1|||
164212798|NCT01001104|593145551|FG003|Overall Study|Lost to Follow-up|0|||
164212799|NCT01001104|593145548|FG000|Overall Study|Entry Criteria Not Met|0|||
164212800|NCT01001104|593145549|FG001|Overall Study|Entry Criteria Not Met|0|||
164212801|NCT01001104|593145550|FG002|Overall Study|Entry Criteria Not Met|0|||
164212802|NCT01001104|593145551|FG003|Overall Study|Entry Criteria Not Met|1|||
164212803|NCT01001104|593145548|FG000|Overall Study|Withdrawal by Subject|0|||
164212804|NCT01001104|593145549|FG001|Overall Study|Withdrawal by Subject|0|||
164325573|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Adverse Event|0|||
164325574|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
164325575|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
164325576|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
164325577|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
164325578|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
164325579|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164325580|NCT03052764|593567882|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
164325581|NCT03052764|593567883|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
164325582|NCT01314911|593567884|FG000|Overall Study|Lost to Follow-up|3|||
164325583|NCT01314911|593567885|FG001|Overall Study|Lost to Follow-up|2|||
164325584|NCT01314911|593567884|FG000|Overall Study|Withdrawal by Subject|1|||
164325585|NCT01314911|593567885|FG001|Overall Study|Withdrawal by Subject|3|||
164325586|NCT01314911|593567884|FG000|Overall Study|Received Non-randomized Study Drug|0|||
164325587|NCT01314911|593567885|FG001|Overall Study|Received Non-randomized Study Drug|1|||
164325588|NCT01314911|593567884|FG000|Overall Study|Never Started Treatment|1|||
164325589|NCT01314911|593567885|FG001|Overall Study|Never Started Treatment|0|||
164325590|NCT03150485|593567889|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164325591|NCT03150485|593567890|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164325592|NCT03150485|593567891|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
164325593|NCT03150485|593567892|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
164325594|NCT03150485|593567893|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
164325595|NCT03150485|593567894|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
164325596|NCT01695005|593567896|FG000|Overall Study|Lost to Follow-up|0|||
164325597|NCT01695005|593567897|FG001|Overall Study|Lost to Follow-up|1|||
164325598|NCT01695005|593567898|FG002|Overall Study|Lost to Follow-up|1|||
164325599|NCT01695005|593567899|FG003|Overall Study|Lost to Follow-up|0|||
164325600|NCT01695005|593567900|FG004|Overall Study|Lost to Follow-up|0|||
164325601|NCT01695005|593567901|FG005|Overall Study|Lost to Follow-up|1|||
164325602|NCT01695005|593567902|FG006|Overall Study|Lost to Follow-up|1|||
164325603|NCT01695005|593567903|FG007|Overall Study|Lost to Follow-up|1|||
164325604|NCT01695005|593567904|FG008|Overall Study|Lost to Follow-up|3|||
164212805|NCT01001104|593145550|FG002|Overall Study|Withdrawal by Subject|0|||
164212806|NCT01001104|593145551|FG003|Overall Study|Withdrawal by Subject|2|||
164212807|NCT01121926|593145556|FG000|First Intervention Period|Adverse Event|1|||
164212808|NCT01121926|593145557|FG001|First Intervention Period|Adverse Event|0|||
164212809|NCT01121926|593145556|FG000|Washout Period|Adverse Event|0|||
164212810|NCT01121926|593145557|FG001|Washout Period|Adverse Event|1|||
164325605|NCT01695005|593567905|FG009|Overall Study|Lost to Follow-up|3|||
163980654|NCT00326898|592299598|FG001|Overall Study|Other/Missing/Unknown|28|||
163980655|NCT00326898|592299599|FG002|Overall Study|Other/Missing/Unknown|32|||
163980656|NCT03847987|592299600|FG000|Overall Study|Lost to Follow-up|1|||
164212811|NCT01121926|593145556|FG000|Washout Period|Positive pregnancy test|0|||
164325606|NCT01695005|593567906|FG010|Overall Study|Lost to Follow-up|8|||
164325607|NCT01695005|593567907|FG011|Overall Study|Lost to Follow-up|5|||
164325608|NCT01695005|593567908|FG012|Overall Study|Lost to Follow-up|2|||
164325609|NCT01695005|593567909|FG013|Overall Study|Lost to Follow-up|5|||
164325610|NCT01695005|593567910|FG014|Overall Study|Lost to Follow-up|0|||
164325611|NCT01695005|593567911|FG015|Overall Study|Lost to Follow-up|4|||
164325612|NCT01695005|593567912|FG016|Overall Study|Lost to Follow-up|0|||
164325613|NCT01695005|593567913|FG017|Overall Study|Lost to Follow-up|0|||
164325614|NCT01695005|593567914|FG018|Overall Study|Lost to Follow-up|0|||
164325615|NCT01695005|593567915|FG019|Overall Study|Lost to Follow-up|1|||
164325616|NCT01695005|593567916|FG020|Overall Study|Lost to Follow-up|1|||
164325617|NCT01695005|593567917|FG021|Overall Study|Lost to Follow-up|0|||
164325618|NCT01695005|593567918|FG022|Overall Study|Lost to Follow-up|2|||
164325619|NCT01695005|593567919|FG023|Overall Study|Lost to Follow-up|4|||
164325620|NCT01695005|593567920|FG024|Overall Study|Lost to Follow-up|2|||
164325621|NCT01695005|593567921|FG025|Overall Study|Lost to Follow-up|0|||
164325622|NCT01695005|593567922|FG026|Overall Study|Lost to Follow-up|0|||
164325623|NCT01695005|593567923|FG027|Overall Study|Lost to Follow-up|0|||
164325624|NCT01695005|593567924|FG028|Overall Study|Lost to Follow-up|1|||
164325625|NCT01695005|593567896|FG000|Overall Study|Withdrawal by Subject|0|||
164325626|NCT01695005|593567897|FG001|Overall Study|Withdrawal by Subject|0|||
164325627|NCT01695005|593567898|FG002|Overall Study|Withdrawal by Subject|0|||
164325628|NCT01695005|593567899|FG003|Overall Study|Withdrawal by Subject|2|||
164212812|NCT01121926|593145557|FG001|Washout Period|Positive pregnancy test|1|||
164212813|NCT02175758|593145558|FG000|Treatment Phase|Lost to Follow-up|0|||
164212814|NCT02175758|593145559|FG001|Treatment Phase|Lost to Follow-up|1|||
164212815|NCT02175758|593145560|FG002|Treatment Phase|Lost to Follow-up|0|||
164212816|NCT02175758|593145561|FG003|Treatment Phase|Lost to Follow-up|0|||
164212817|NCT02175758|593145562|FG004|Treatment Phase|Lost to Follow-up|0|||
164212818|NCT02175758|593145563|FG005|Treatment Phase|Lost to Follow-up|0|||
164212819|NCT02175758|593145558|FG000|Treatment Phase|Adverse Event|0|||
164212820|NCT02175758|593145559|FG001|Treatment Phase|Adverse Event|0|||
164212821|NCT02175758|593145560|FG002|Treatment Phase|Adverse Event|0|||
164212822|NCT02175758|593145561|FG003|Treatment Phase|Adverse Event|0|||
164212823|NCT02175758|593145562|FG004|Treatment Phase|Adverse Event|1|||
164212824|NCT02175758|593145563|FG005|Treatment Phase|Adverse Event|0|||
164212825|NCT02636283|593145564|FG000|Overall Study|Adverse Event|2|||
164212826|NCT02636283|593145565|FG001|Overall Study|Adverse Event|0|||
164212827|NCT02636283|593145564|FG000|Overall Study|Trial Terminated Prematurely|0|||
164212828|NCT02636283|593145565|FG001|Overall Study|Trial Terminated Prematurely|3|||
164212829|NCT01879852|593145568|FG000|Overall Study|Withdrawal by Subject|2|||
164212830|NCT01879852|593145569|FG001|Overall Study|Withdrawal by Subject|0|||
164212831|NCT02696616|593145571|FG000|Overall Study|Adverse Event|0|||
164212832|NCT02696616|593145572|FG001|Overall Study|Adverse Event|1|||
164212833|NCT02696616|593145573|FG002|Overall Study|Adverse Event|0|||
164212834|NCT02696616|593145574|FG003|Overall Study|Adverse Event|0|||
164212835|NCT02696616|593145575|FG004|Overall Study|Adverse Event|0|||
164212836|NCT02696616|593145576|FG005|Overall Study|Adverse Event|0|||
164212837|NCT02696616|593145577|FG006|Overall Study|Adverse Event|0|||
164212838|NCT01625182|593145579|FG000|Overall Study|Administrative problems|1|||
164212839|NCT01625182|593145580|FG001|Overall Study|Administrative problems|0|||
164212840|NCT01625182|593145579|FG000|Overall Study|Protocol deviation|0|||
164212841|NCT01625182|593145580|FG001|Overall Study|Protocol deviation|2|||
164212842|NCT01625182|593145579|FG000|Overall Study|Adverse Event|2|||
164212843|NCT01625182|593145580|FG001|Overall Study|Adverse Event|0|||
164212844|NCT01625182|593145579|FG000|Overall Study|Withdrawal by Subject|5|||
164212845|NCT01625182|593145580|FG001|Overall Study|Withdrawal by Subject|1|||
164212846|NCT01625182|593145579|FG000|Overall Study|Lack of Efficacy|12|||
164212847|NCT01625182|593145580|FG001|Overall Study|Lack of Efficacy|8|||
164212848|NCT01500083|593145581|FG000|Overall Study|Adverse Event|4|||
164212849|NCT01500083|593145582|FG001|Overall Study|Adverse Event|17|||
164212850|NCT01500083|593145581|FG000|Overall Study|Death|0|||
164212851|NCT01500083|593145582|FG001|Overall Study|Death|2|||
164212852|NCT01500083|593145581|FG000|Overall Study|Lost to Follow-up|1|||
164212853|NCT01500083|593145582|FG001|Overall Study|Lost to Follow-up|0|||
164212854|NCT01500083|593145581|FG000|Overall Study|Withdrawal of Consent|0|||
164212855|NCT01500083|593145582|FG001|Overall Study|Withdrawal of Consent|1|||
164212856|NCT01500083|593145581|FG000|Overall Study|Disease Progression|2|||
164212857|NCT01500083|593145582|FG001|Overall Study|Disease Progression|10|||
164212858|NCT01500083|593145581|FG000|Overall Study|Investigator Discretion|3|||
164212859|NCT01500083|593145582|FG001|Overall Study|Investigator Discretion|8|||
164212860|NCT01500083|593145581|FG000|Overall Study|Other Reasons|2|||
164212861|NCT01500083|593145582|FG001|Overall Study|Other Reasons|5|||
164212862|NCT00741611|593145583|FG000|Overall Study|Death|0|||
164212863|NCT00741611|593145584|FG001|Overall Study|Death|0|||
164212864|NCT00741611|593145585|FG002|Overall Study|Death|1|||
164212865|NCT00741611|593145583|FG000|Overall Study|Withdrawal by Subject|0|||
164212866|NCT00741611|593145584|FG001|Overall Study|Withdrawal by Subject|2|||
164212867|NCT00741611|593145585|FG002|Overall Study|Withdrawal by Subject|2|||
164212868|NCT01970371|593145586|FG000|Overall Study|Death|8|||
164325629|NCT01695005|593567900|FG004|Overall Study|Withdrawal by Subject|0|||
164212869|NCT01970371|593145587|FG001|Overall Study|Death|13|||
164212870|NCT01970371|593145588|FG002|Overall Study|Death|12|||
164325630|NCT01695005|593567901|FG005|Overall Study|Withdrawal by Subject|1|||
164212871|NCT01970371|593145586|FG000|Overall Study|Lost to Follow-up|0|||
164212872|NCT01970371|593145587|FG001|Overall Study|Lost to Follow-up|0|||
164212873|NCT01970371|593145588|FG002|Overall Study|Lost to Follow-up|1|||
164212874|NCT01555931|593145589|FG000|Overall Study|Lost to Follow-up|2|||
164212875|NCT01555931|593145590|FG001|Overall Study|Lost to Follow-up|5|||
164212876|NCT01922011|593145591|FG000|Overall Study|Protocol Violation|0|||
164212877|NCT01922011|593145592|FG001|Overall Study|Protocol Violation|1|||
164212878|NCT01922011|593145591|FG000|Overall Study|Physician Decision|0|||
164212879|NCT01922011|593145592|FG001|Overall Study|Physician Decision|1|||
164212880|NCT01922011|593145591|FG000|Overall Study|Parent/Guardian Decision|3|||
164212881|NCT01922011|593145592|FG001|Overall Study|Parent/Guardian Decision|0|||
164212882|NCT01922011|593145591|FG000|Overall Study|Lost to Follow-up|0|||
164212883|NCT01922011|593145592|FG001|Overall Study|Lost to Follow-up|1|||
164212884|NCT01922011|593145591|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
164212885|NCT01922011|593145592|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
164212886|NCT01922011|593145591|FG000|Overall Study|Not Treated|1|||
164212887|NCT01922011|593145592|FG001|Overall Study|Not Treated|0|||
164212888|NCT01922011|593145591|FG000|Overall Study|Lack of willing home health agency|1|||
164212889|NCT01922011|593145592|FG001|Overall Study|Lack of willing home health agency|0|||
164212890|NCT01922011|593145591|FG000|Overall Study|Randomized in error|1|||
164212891|NCT01922011|593145592|FG001|Overall Study|Randomized in error|0|||
164212892|NCT01510756|593145593|FG000|Overall Study|Death|1|||
164212893|NCT01510756|593145593|FG000|Overall Study|Lack of Efficacy|2|||
164212894|NCT01510756|593145593|FG000|Overall Study|Physician Decision|1|||
164212895|NCT04398134|593145600|FG000|Overall Study|Adverse Event|0|||
164212896|NCT04398134|593145601|FG001|Overall Study|Adverse Event|0|||
164212897|NCT04398134|593145602|FG002|Overall Study|Adverse Event|1|||
164212898|NCT04398134|593145603|FG003|Overall Study|Adverse Event|0|||
164212899|NCT04398134|593145600|FG000|Overall Study|Withdrawal by Subject|2|||
164212900|NCT04398134|593145601|FG001|Overall Study|Withdrawal by Subject|0|||
164212901|NCT04398134|593145602|FG002|Overall Study|Withdrawal by Subject|0|||
164212902|NCT04398134|593145603|FG003|Overall Study|Withdrawal by Subject|1|||
164212903|NCT04398134|593145600|FG000|Overall Study|Study Terminated by Sponsor|30|||
164212904|NCT04398134|593145601|FG001|Overall Study|Study Terminated by Sponsor|11|||
164212905|NCT04398134|593145602|FG002|Overall Study|Study Terminated by Sponsor|32|||
164212906|NCT04398134|593145603|FG003|Overall Study|Study Terminated by Sponsor|11|||
164212907|NCT02225587|593145606|FG000|Overall Study|Adverse Event|5|||
164212908|NCT02225587|593145607|FG001|Overall Study|Adverse Event|5|||
164212909|NCT02225587|593145606|FG000|Overall Study|Lost to Follow-up|5|||
164212910|NCT02225587|593145607|FG001|Overall Study|Lost to Follow-up|5|||
164212911|NCT02225587|593145606|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164212912|NCT02225587|593145607|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164212913|NCT02225587|593145606|FG000|Overall Study|Physician Decision|2|||
164212914|NCT02225587|593145607|FG001|Overall Study|Physician Decision|0|||
164212915|NCT02225587|593145606|FG000|Overall Study|Protocol Violation|1|||
164212916|NCT02225587|593145607|FG001|Overall Study|Protocol Violation|0|||
164212917|NCT02225587|593145606|FG000|Overall Study|Participant Moved|1|||
164212918|NCT02225587|593145607|FG001|Overall Study|Participant Moved|0|||
164212919|NCT02225587|593145606|FG000|Overall Study|Withdrawal by Subject|13|||
164212920|NCT02225587|593145607|FG001|Overall Study|Withdrawal by Subject|28|||
164212921|NCT03483584|593145610|FG000|Overall Study|Lost to Follow-up|40|||
164212922|NCT03483584|593145611|FG001|Overall Study|Lost to Follow-up|7|||
164212923|NCT03483584|593145610|FG000|Overall Study|Withdrawal by Subject|4|||
164212924|NCT03483584|593145611|FG001|Overall Study|Withdrawal by Subject|1|||
164212925|NCT01525589|593145618|FG000|Overall Study|Non-treatment-related AE|1|||
164212926|NCT01525589|593145619|FG001|Overall Study|Non-treatment-related AE|0|||
164212927|NCT01525589|593145620|FG002|Overall Study|Non-treatment-related AE|0|||
164212928|NCT01525589|593145618|FG000|Overall Study|Progressive disease|48|||
164212929|NCT01525589|593145619|FG001|Overall Study|Progressive disease|15|||
164212930|NCT01525589|593145620|FG002|Overall Study|Progressive disease|29|||
164212931|NCT01525589|593145618|FG000|Overall Study|Never treated|2|||
164212932|NCT01525589|593145619|FG001|Overall Study|Never treated|0|||
164212933|NCT01525589|593145620|FG002|Overall Study|Never treated|0|||
164212934|NCT01525589|593145618|FG000|Overall Study|Physician Decision|4|||
164212935|NCT01525589|593145619|FG001|Overall Study|Physician Decision|2|||
164212936|NCT01525589|593145620|FG002|Overall Study|Physician Decision|2|||
164212937|NCT01525589|593145618|FG000|Overall Study|Death|0|||
164212938|NCT01525589|593145619|FG001|Overall Study|Death|0|||
164212939|NCT01525589|593145620|FG002|Overall Study|Death|2|||
164212940|NCT01525589|593145618|FG000|Overall Study|Treatment-related AE|1|||
164212941|NCT01525589|593145619|FG001|Overall Study|Treatment-related AE|1|||
164212942|NCT01525589|593145620|FG002|Overall Study|Treatment-related AE|2|||
164212943|NCT01525589|593145618|FG000|Overall Study|Other reasons|0|||
163876312|NCT04583423|591914836|FG002|Overall Study|Study Terminated by Sponsor|36|||
164212944|NCT01525589|593145619|FG001|Overall Study|Other reasons|1|||
164212945|NCT01525589|593145620|FG002|Overall Study|Other reasons|0|||
164212946|NCT01525589|593145618|FG000|Overall Study|Withdrawal by Subject|0|||
164212947|NCT01525589|593145619|FG001|Overall Study|Withdrawal by Subject|1|||
164212948|NCT01525589|593145620|FG002|Overall Study|Withdrawal by Subject|0|||
164212949|NCT02924376|593145621|FG000|Overall Study|Progressive Disease|4|||
164212950|NCT02924376|593145622|FG001|Overall Study|Progressive Disease|0|||
164325631|NCT01695005|593567902|FG006|Overall Study|Withdrawal by Subject|0|||
164325632|NCT01695005|593567903|FG007|Overall Study|Withdrawal by Subject|1|||
164325633|NCT01695005|593567904|FG008|Overall Study|Withdrawal by Subject|0|||
164325634|NCT01695005|593567905|FG009|Overall Study|Withdrawal by Subject|1|||
164325635|NCT01695005|593567906|FG010|Overall Study|Withdrawal by Subject|2|||
164325636|NCT01695005|593567907|FG011|Overall Study|Withdrawal by Subject|1|||
164325637|NCT01695005|593567908|FG012|Overall Study|Withdrawal by Subject|1|||
164325638|NCT01695005|593567909|FG013|Overall Study|Withdrawal by Subject|0|||
164325639|NCT01695005|593567910|FG014|Overall Study|Withdrawal by Subject|0|||
164325640|NCT01695005|593567911|FG015|Overall Study|Withdrawal by Subject|0|||
164325641|NCT01695005|593567912|FG016|Overall Study|Withdrawal by Subject|0|||
164325642|NCT01695005|593567913|FG017|Overall Study|Withdrawal by Subject|0|||
164325643|NCT01695005|593567914|FG018|Overall Study|Withdrawal by Subject|2|||
164325644|NCT01695005|593567915|FG019|Overall Study|Withdrawal by Subject|0|||
164325645|NCT01695005|593567916|FG020|Overall Study|Withdrawal by Subject|1|||
164325646|NCT01695005|593567917|FG021|Overall Study|Withdrawal by Subject|0|||
164325647|NCT01695005|593567918|FG022|Overall Study|Withdrawal by Subject|0|||
164325648|NCT01695005|593567919|FG023|Overall Study|Withdrawal by Subject|0|||
164325649|NCT01695005|593567920|FG024|Overall Study|Withdrawal by Subject|1|||
164325650|NCT01695005|593567921|FG025|Overall Study|Withdrawal by Subject|0|||
164325651|NCT01695005|593567922|FG026|Overall Study|Withdrawal by Subject|0|||
164325652|NCT01695005|593567923|FG027|Overall Study|Withdrawal by Subject|1|||
164325653|NCT01695005|593567924|FG028|Overall Study|Withdrawal by Subject|0|||
164325654|NCT04478123|593567925|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
164325655|NCT04478123|593567925|FG000|Overall Study|NE|1|||
164325656|NCT00478881|593567926|FG000|Overall Study|Adverse Event|31|||
164325657|NCT00478881|593567927|FG001|Overall Study|Adverse Event|12|||
164325658|NCT00478881|593567926|FG000|Overall Study|Lack of Efficacy|0|||
164325659|NCT00478881|593567927|FG001|Overall Study|Lack of Efficacy|3|||
164325660|NCT00478881|593567926|FG000|Overall Study|Lost to Follow-up|0|||
164325661|NCT00478881|593567927|FG001|Overall Study|Lost to Follow-up|1|||
164325662|NCT00478881|593567926|FG000|Overall Study|Protocol Violation|2|||
164325663|NCT00478881|593567927|FG001|Overall Study|Protocol Violation|2|||
164325664|NCT00478881|593567926|FG000|Overall Study|Withdrawal by Subject|6|||
164325665|NCT00478881|593567927|FG001|Overall Study|Withdrawal by Subject|2|||
164325666|NCT00478881|593567926|FG000|Overall Study|Non-Compliance with Study Medication|0|||
164325667|NCT00478881|593567927|FG001|Overall Study|Non-Compliance with Study Medication|2|||
164325668|NCT04950608|593567931|FG000|Overall Study|Withdrawal by Subject|2|||
164325669|NCT04950608|593567931|FG000|Overall Study|Physician Decision|3|||
164325670|NCT04104438|593567932|FG000|Overall Study|Death|2|||
164325671|NCT04104438|593567933|FG001|Overall Study|Death|1|||
164325672|NCT04104438|593567934|FG002|Overall Study|Death|2|||
164325673|NCT04104438|593567932|FG000|Overall Study|Adverse Event|0|||
164325674|NCT04104438|593567933|FG001|Overall Study|Adverse Event|3|||
164325675|NCT04104438|593567934|FG002|Overall Study|Adverse Event|0|||
164325676|NCT04104438|593567932|FG000|Overall Study|Withdrawal by Subject|0|||
164325677|NCT04104438|593567933|FG001|Overall Study|Withdrawal by Subject|1|||
164325678|NCT04104438|593567934|FG002|Overall Study|Withdrawal by Subject|0|||
164325679|NCT04104438|593567932|FG000|Overall Study|Disenrolled due to noncompliance|0|||
164325680|NCT04104438|593567933|FG001|Overall Study|Disenrolled due to noncompliance|1|||
164325681|NCT04104438|593567934|FG002|Overall Study|Disenrolled due to noncompliance|0|||
164325682|NCT04104438|593567932|FG000|Overall Study|stopped due to possible operation|0|||
164325683|NCT04104438|593567933|FG001|Overall Study|stopped due to possible operation|1|||
164325684|NCT04104438|593567934|FG002|Overall Study|stopped due to possible operation|0|||
164325685|NCT04104438|593567932|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
164325686|NCT04104438|593567933|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
164325687|NCT04104438|593567934|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
164325688|NCT01282203|593567937|FG000|Overall Study|Adverse Event|1|||
164325689|NCT03977454|593567938|FG000|Overall Study|immediate postoperative revision|2|||
164325690|NCT03977454|593567939|FG001|Overall Study|immediate postoperative revision|2|||
164325691|NCT00930982|593567940|FG000|Overall Study|Adverse Event|19|||
163980657|NCT03847987|592299601|FG001|Overall Study|Lost to Follow-up|0|||
164325692|NCT00930982|593567941|FG001|Overall Study|Adverse Event|23|||
164325693|NCT00930982|593567940|FG000|Overall Study|Protocol Violation|1|||
164325694|NCT00930982|593567941|FG001|Overall Study|Protocol Violation|5|||
164325695|NCT00930982|593567940|FG000|Overall Study|Withdrawal by Subject|1|||
164325696|NCT00930982|593567941|FG001|Overall Study|Withdrawal by Subject|1|||
164325697|NCT00518973|593567942|FG000|Overall Study|Withdrawal by Subject|3|||
164325698|NCT00518973|593567943|FG001|Overall Study|Withdrawal by Subject|2|||
164325699|NCT00582816|593567944|FG000|Overall Study|Engraftment Failure|3|||
164325700|NCT01923168|593567945|FG000|Overall Study|Protocol Violation|1|||
164325701|NCT01923168|593567946|FG001|Overall Study|Protocol Violation|1|||
164325702|NCT01923168|593567947|FG002|Overall Study|Protocol Violation|0|||
164325703|NCT01923168|593567945|FG000|Overall Study|Subject/guardian decision|14|||
164325704|NCT01923168|593567946|FG001|Overall Study|Subject/guardian decision|14|||
164325705|NCT01923168|593567947|FG002|Overall Study|Subject/guardian decision|4|||
164212951|NCT02924376|593145623|FG002|Overall Study|Progressive Disease|1|||
164212952|NCT02924376|593145624|FG003|Overall Study|Progressive Disease|0|||
164212953|NCT02924376|593145621|FG000|Overall Study|Death|73|||
164212954|NCT02924376|593145622|FG001|Overall Study|Death|18|||
164212955|NCT02924376|593145623|FG002|Overall Study|Death|15|||
164212956|NCT02924376|593145624|FG003|Overall Study|Death|2|||
164212957|NCT02924376|593145621|FG000|Overall Study|Lost to Follow-up|3|||
164212958|NCT02924376|593145622|FG001|Overall Study|Lost to Follow-up|0|||
164212959|NCT02924376|593145623|FG002|Overall Study|Lost to Follow-up|0|||
164212960|NCT02924376|593145624|FG003|Overall Study|Lost to Follow-up|0|||
164212961|NCT02924376|593145621|FG000|Overall Study|Study Terminated by Sponsor|19|||
164212962|NCT02924376|593145622|FG001|Overall Study|Study Terminated by Sponsor|0|||
164212963|NCT02924376|593145623|FG002|Overall Study|Study Terminated by Sponsor|0|||
164212964|NCT02924376|593145624|FG003|Overall Study|Study Terminated by Sponsor|0|||
164212965|NCT02924376|593145621|FG000|Overall Study|Physician Decision|1|||
164212966|NCT02924376|593145622|FG001|Overall Study|Physician Decision|0|||
164212967|NCT02924376|593145623|FG002|Overall Study|Physician Decision|0|||
164212968|NCT02924376|593145624|FG003|Overall Study|Physician Decision|0|||
164212969|NCT02924376|593145621|FG000|Overall Study|Withdrawal by Subject|7|||
164212970|NCT02924376|593145622|FG001|Overall Study|Withdrawal by Subject|2|||
164212971|NCT02924376|593145623|FG002|Overall Study|Withdrawal by Subject|1|||
164212972|NCT02924376|593145624|FG003|Overall Study|Withdrawal by Subject|0|||
164212973|NCT02924376|593145621|FG000|Overall Study|Rolled Over to Another Study|1|||
164212974|NCT02924376|593145622|FG001|Overall Study|Rolled Over to Another Study|0|||
164212975|NCT02924376|593145623|FG002|Overall Study|Rolled Over to Another Study|0|||
164212976|NCT02924376|593145624|FG003|Overall Study|Rolled Over to Another Study|0|||
164212977|NCT03608033|593145625|FG000|Treatment Period|Death|0|||
164212978|NCT03608033|593145626|FG001|Treatment Period|Death|1|||
164212979|NCT03608033|593145625|FG000|Treatment Period|Adverse Event|1|||
164212980|NCT03608033|593145626|FG001|Treatment Period|Adverse Event|5|||
164212981|NCT03608033|593145625|FG000|Treatment Period|Lack of Efficacy|4|||
164212982|NCT03608033|593145626|FG001|Treatment Period|Lack of Efficacy|3|||
164212983|NCT03608033|593145625|FG000|Treatment Period|Lost to Follow-up|2|||
164212984|NCT03608033|593145626|FG001|Treatment Period|Lost to Follow-up|6|||
164212985|NCT03608033|593145625|FG000|Treatment Period|Physician Decision|6|||
164212986|NCT03608033|593145626|FG001|Treatment Period|Physician Decision|10|||
164212987|NCT03608033|593145625|FG000|Treatment Period|Pregnancy|1|||
164212988|NCT03608033|593145626|FG001|Treatment Period|Pregnancy|0|||
164212989|NCT03608033|593145625|FG000|Treatment Period|Protocol Violation|1|||
164212990|NCT03608033|593145626|FG001|Treatment Period|Protocol Violation|2|||
164212991|NCT03608033|593145625|FG000|Treatment Period|Withdrawal by Subject|46|||
164212992|NCT03608033|593145626|FG001|Treatment Period|Withdrawal by Subject|45|||
164212993|NCT03608033|593145625|FG000|Treatment Period|Study terminated by sponsor|82|||
164212994|NCT03608033|593145626|FG001|Treatment Period|Study terminated by sponsor|68|||
164212995|NCT03608033|593145625|FG000|Treatment Period|Site Terminated by Sponsor|1|||
164212996|NCT03608033|593145626|FG001|Treatment Period|Site Terminated by Sponsor|0|||
164212997|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Adverse Event|1|||
164212998|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Adverse Event|0|||
164212999|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
164213000|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
164213001|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
164213002|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
164213003|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
164213004|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
164213005|NCT03608033|593145625|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
164213006|NCT03608033|593145626|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
164213007|NCT05253807|593145628|FG000|Overall Study|Death|1|||
164213008|NCT05253807|593145629|FG001|Overall Study|Death|4|||
164213009|NCT05253807|593145628|FG000|Overall Study|Withdrawal by Subject|1|||
164213010|NCT05253807|593145629|FG001|Overall Study|Withdrawal by Subject|0|||
164213011|NCT05253807|593145628|FG000|Overall Study|Study Terminated by Sponsor|1|||
164213012|NCT05253807|593145629|FG001|Overall Study|Study Terminated by Sponsor|1|||
164213013|NCT02360579|593145631|FG000|Initial|Death|16|||
164213014|NCT02360579|593145632|FG001|Initial|Death|49|||
164213015|NCT02360579|593145633|FG002|Initial|Death|0|||
164213016|NCT02360579|593145634|FG003|Initial|Death|71|||
163980658|NCT03847987|592299600|FG000|Overall Study|Adverse Event|2|||
163980659|NCT03847987|592299601|FG001|Overall Study|Adverse Event|0|||
163980660|NCT02721355|592299604|FG000|Overall Study|Lost to Follow-up|6|||
163980661|NCT02721355|592299605|FG001|Overall Study|Lost to Follow-up|1|||
163980662|NCT00356278|592299606|FG000|Overall Study|Withdrawal by Subject|25|||
164213017|NCT02360579|593145631|FG000|Initial|Lost to Follow-up|0|||
164213018|NCT02360579|593145632|FG001|Initial|Lost to Follow-up|4|||
164213019|NCT02360579|593145633|FG002|Initial|Lost to Follow-up|0|||
164213020|NCT02360579|593145634|FG003|Initial|Lost to Follow-up|1|||
164213021|NCT02360579|593145631|FG000|Initial|Withdrawal by Subject|0|||
163980663|NCT00356278|592299607|FG001|Overall Study|Withdrawal by Subject|15|||
164213022|NCT02360579|593145632|FG001|Initial|Withdrawal by Subject|0|||
164213023|NCT02360579|593145633|FG002|Initial|Withdrawal by Subject|0|||
164213024|NCT02360579|593145634|FG003|Initial|Withdrawal by Subject|3|||
164213025|NCT02360579|593145631|FG000|Initial|Other|7|||
164213026|NCT02360579|593145632|FG001|Initial|Other|0|||
164213027|NCT02360579|593145633|FG002|Initial|Other|0|||
164213028|NCT02360579|593145634|FG003|Initial|Other|0|||
164213029|NCT02360579|593145631|FG000|Initial|Did not receive TIL|8|||
164213030|NCT02360579|593145632|FG001|Initial|Did not receive TIL|11|||
164213031|NCT02360579|593145633|FG002|Initial|Did not receive TIL|0|||
164213032|NCT02360579|593145634|FG003|Initial|Did not receive TIL|22|||
164213033|NCT02360579|593145631|FG000|Retreatment|Death|0|||
164213034|NCT02360579|593145632|FG001|Retreatment|Death|0|||
164213035|NCT02360579|593145633|FG002|Retreatment|Death|11|||
164213036|NCT02360579|593145634|FG003|Retreatment|Death|0|||
164213037|NCT06455111|593145637|FG000|Overall Study|Withdrawal by Subject|11|||
164213038|NCT06455111|593145638|FG001|Overall Study|Withdrawal by Subject|4|||
164213039|NCT01793935|593146313|FG000|Overall Study|Pregnancy|1|||
164213040|NCT01793935|593146314|FG001|Overall Study|Pregnancy|0|||
164213041|NCT01793935|593146313|FG000|Overall Study|Protocol Violation|2|||
164213042|NCT01793935|593146314|FG001|Overall Study|Protocol Violation|1|||
164213043|NCT01793935|593146313|FG000|Overall Study|Adverse Event|2|||
164213044|NCT01793935|593146314|FG001|Overall Study|Adverse Event|0|||
164213045|NCT01793935|593146313|FG000|Overall Study|Patient did not take study medication|1|||
164213046|NCT01793935|593146314|FG001|Overall Study|Patient did not take study medication|1|||
164213047|NCT01793935|593146313|FG000|Overall Study|Lost to Follow-up|0|||
164213048|NCT01793935|593146314|FG001|Overall Study|Lost to Follow-up|1|||
164213049|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Other|4|||
164213050|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Other|1|||
164213051|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
164213052|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164213053|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
164213054|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
164213055|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
164213056|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164213057|NCT03439514|593146320|FG000|Double-Blind Treatment Period|Death|1|||
164213058|NCT03439514|593146321|FG001|Double-Blind Treatment Period|Death|2|||
164213059|NCT01481779|593146325|FG000|Overall Study|Adverse Event|23|||
164213060|NCT01481779|593146326|FG001|Overall Study|Adverse Event|5|||
164213061|NCT01481779|593146325|FG000|Overall Study|Lost to Follow-up|3|||
164213062|NCT01481779|593146326|FG001|Overall Study|Lost to Follow-up|2|||
164213063|NCT01481779|593146325|FG000|Overall Study|Protocol Violation|2|||
164213064|NCT01481779|593146326|FG001|Overall Study|Protocol Violation|3|||
164213065|NCT01481779|593146325|FG000|Overall Study|Withdrawal by Subject|26|||
164213066|NCT01481779|593146326|FG001|Overall Study|Withdrawal by Subject|13|||
164213067|NCT01481779|593146325|FG000|Overall Study|Physician Decision|13|||
164213068|NCT01481779|593146326|FG001|Overall Study|Physician Decision|4|||
164213069|NCT01481779|593146325|FG000|Overall Study|Sponsor Decision|3|||
164213070|NCT01481779|593146326|FG001|Overall Study|Sponsor Decision|1|||
164213071|NCT01697579|593146328|FG000|Base Study-Cycle 1|Adverse Event|1|||
164213072|NCT01697579|593146329|FG001|Base Study-Cycle 1|Adverse Event|0|||
164213073|NCT01697579|593146330|FG002|Base Study-Cycle 1|Adverse Event|0|||
164213074|NCT01697579|593146331|FG003|Base Study-Cycle 1|Adverse Event|0|||
164213075|NCT01697579|593146332|FG004|Base Study-Cycle 1|Adverse Event|0|||
164213076|NCT01697579|593146333|FG005|Base Study-Cycle 1|Adverse Event|0|||
164213077|NCT01697579|593146334|FG006|Base Study-Cycle 1|Adverse Event|0|||
164213078|NCT01697579|593146328|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
164213079|NCT01697579|593146329|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213080|NCT01697579|593146330|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213081|NCT01697579|593146331|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213082|NCT01697579|593146332|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213083|NCT01697579|593146333|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213084|NCT01697579|593146334|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
164213085|NCT01697579|593146328|FG000|Base Study-Cycle 1|Protocol Violation|0|||
164213086|NCT01697579|593146329|FG001|Base Study-Cycle 1|Protocol Violation|0|||
164213087|NCT01697579|593146330|FG002|Base Study-Cycle 1|Protocol Violation|0|||
164213088|NCT01697579|593146331|FG003|Base Study-Cycle 1|Protocol Violation|0|||
164213089|NCT01697579|593146332|FG004|Base Study-Cycle 1|Protocol Violation|3|||
164213090|NCT01697579|593146333|FG005|Base Study-Cycle 1|Protocol Violation|0|||
164213091|NCT01697579|593146334|FG006|Base Study-Cycle 1|Protocol Violation|0|||
164213092|NCT01697579|593146328|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213093|NCT01697579|593146329|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
164213094|NCT01697579|593146330|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213095|NCT01697579|593146331|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213096|NCT01697579|593146332|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213097|NCT01697579|593146333|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213098|NCT01697579|593146334|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
164213099|NCT01697579|593146328|FG000|Base Study-Cycle 1|Technical Problems|0|||
164213100|NCT01697579|593146329|FG001|Base Study-Cycle 1|Technical Problems|0|||
164213101|NCT01697579|593146330|FG002|Base Study-Cycle 1|Technical Problems|1|||
164213102|NCT01697579|593146331|FG003|Base Study-Cycle 1|Technical Problems|1|||
164213103|NCT01697579|593146332|FG004|Base Study-Cycle 1|Technical Problems|0|||
164213104|NCT01697579|593146333|FG005|Base Study-Cycle 1|Technical Problems|0|||
164213105|NCT01697579|593146334|FG006|Base Study-Cycle 1|Technical Problems|0|||
164213106|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Death|0|||
164213107|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Death|0|||
164213108|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Death|0|||
164213109|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Death|0|||
164213110|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Death|0|||
164213111|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Death|0|||
164213112|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Death|2|||
164213113|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213114|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213115|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213116|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213117|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164213118|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
164213119|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
164213120|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213121|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213122|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213123|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213124|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
164213125|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
164213126|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
164213127|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213128|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213129|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213130|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213131|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213132|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
164213133|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
164213134|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213135|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213136|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213137|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213138|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
164213139|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
164213140|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
164213141|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213142|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213143|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213144|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213145|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213146|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
164213147|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
164213148|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213149|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213150|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213151|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213152|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
164213153|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
164213154|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
164213155|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213156|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
163980664|NCT00356278|592299608|FG002|Overall Study|Withdrawal by Subject|19|||
163980665|NCT01268293|592299616|FG000|Overall Study|Disease progression|7|||
163980666|NCT01268293|592299616|FG000|Overall Study|Adverse Event|1|||
164213157|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213158|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213159|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
164213160|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
164213161|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
163980667|NCT01268293|592299616|FG000|Overall Study|Subject choice|1|||
163980668|NCT02597855|592299617|FG000|Overall Study|Lost to Follow-up|2|||
164213162|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213163|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213164|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213165|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213166|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213167|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
164213168|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
164213169|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213170|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213171|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213172|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213173|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213174|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
164213175|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
164213176|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213177|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213178|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213179|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213180|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213181|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
164213182|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
164213183|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213184|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213185|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213186|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213187|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
164213188|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
164213189|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
164213190|NCT01697579|593146328|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213191|NCT01697579|593146329|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213192|NCT01697579|593146330|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213193|NCT01697579|593146331|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213194|NCT01697579|593146332|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213195|NCT01697579|593146333|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
164213196|NCT01697579|593146334|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
164213197|NCT04225039|593146336|FG000|Overall Study|Withdrawal by Subject|1|||
164213198|NCT04225039|593146337|FG001|Overall Study|Withdrawal by Subject|0|||
164213199|NCT04225039|593146338|FG002|Overall Study|Withdrawal by Subject|0|||
164213200|NCT04225039|593146339|FG003|Overall Study|Withdrawal by Subject|1|||
164213201|NCT04225039|593146336|FG000|Overall Study|Currently active on study treatment|0|||
164213202|NCT04225039|593146337|FG001|Overall Study|Currently active on study treatment|1|||
164213203|NCT04225039|593146338|FG002|Overall Study|Currently active on study treatment|0|||
164213204|NCT04225039|593146339|FG003|Overall Study|Currently active on study treatment|0|||
164213205|NCT04225039|593146336|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
164213206|NCT04225039|593146337|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
164213207|NCT04225039|593146338|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
164213208|NCT04225039|593146339|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
164213209|NCT04225039|593146336|FG000|Overall Study|Ineligible for treatment|0|||
164213210|NCT04225039|593146337|FG001|Overall Study|Ineligible for treatment|0|||
164213211|NCT04225039|593146338|FG002|Overall Study|Ineligible for treatment|0|||
164213212|NCT04225039|593146339|FG003|Overall Study|Ineligible for treatment|4|||
164213213|NCT00975923|593146340|FG000|Overall Study|Withdrawal by Subject|0|||
164213214|NCT00975923|593146341|FG001|Overall Study|Withdrawal by Subject|1|||
164213215|NCT01964404|593146342|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
164213216|NCT01964404|593146343|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
164213217|NCT01964404|593146344|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
164213218|NCT01964404|593146345|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
163980669|NCT02597855|592299618|FG001|Overall Study|Lost to Follow-up|1|||
164213219|NCT01964404|593146346|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
164213220|NCT01964404|593146347|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
164213221|NCT01964404|593146348|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
164213222|NCT01964404|593146349|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
164213223|NCT01964404|593146350|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
164213224|NCT01964404|593146351|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
164213225|NCT01964404|593146342|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
164213226|NCT01964404|593146343|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
164213227|NCT01964404|593146344|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
164213228|NCT01964404|593146345|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
164213229|NCT01964404|593146346|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213230|NCT01964404|593146347|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213231|NCT01964404|593146348|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213232|NCT01964404|593146349|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213233|NCT01964404|593146350|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213234|NCT01964404|593146351|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213235|NCT01964404|593146342|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
164213236|NCT01964404|593146343|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
164213237|NCT01964404|593146344|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213238|NCT01964404|593146345|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
164213239|NCT01964404|593146346|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213240|NCT01964404|593146347|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213241|NCT01964404|593146348|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213242|NCT01964404|593146349|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213243|NCT01964404|593146350|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213244|NCT01964404|593146351|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
164213245|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
164213246|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
164213247|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
164213248|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
164213249|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
164213250|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
163980670|NCT00713700|592299623|FG000|Overall Study|Lost to Follow-up|3|||
163980671|NCT00713700|592299623|FG000|Overall Study|Withdrawal by Subject|1|||
163980672|NCT00781456|592299624|FG000|Overall Study|Adverse Event|3|||
163980673|NCT00781456|592299625|FG001|Overall Study|Adverse Event|3|||
163980674|NCT00781456|592299624|FG000|Overall Study|Withdrawal by Subject|3|||
163980675|NCT00781456|592299625|FG001|Overall Study|Withdrawal by Subject|5|||
163980676|NCT00781456|592299624|FG000|Overall Study|Protocol Violation|4|||
163980677|NCT00781456|592299625|FG001|Overall Study|Protocol Violation|1|||
163980678|NCT00781456|592299624|FG000|Overall Study|Noncompliance With Protocol|1|||
163980679|NCT00781456|592299625|FG001|Overall Study|Noncompliance With Protocol|1|||
163980680|NCT00781456|592299624|FG000|Overall Study|Lost to Follow-up|10|||
164213251|NCT00325416|593146354|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
164213252|NCT00325416|593146355|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
164213253|NCT00325416|593146354|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
164213254|NCT00325416|593146355|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
164213255|NCT00325416|593146354|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
164213256|NCT00325416|593146355|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
164325706|NCT01923168|593567945|FG000|Overall Study|Adverse Event|12|||
164325707|NCT01923168|593567946|FG001|Overall Study|Adverse Event|12|||
164325708|NCT01923168|593567947|FG002|Overall Study|Adverse Event|0|||
163980681|NCT00781456|592299625|FG001|Overall Study|Lost to Follow-up|5|||
163980682|NCT00781456|592299624|FG000|Overall Study|Other Reason, Unknown|0|||
163980683|NCT00781456|592299625|FG001|Overall Study|Other Reason, Unknown|1|||
163980684|NCT01777152|592299627|FG000|Overall Study|Withdrawal by Subject|22|||
163980685|NCT01777152|592299628|FG001|Overall Study|Withdrawal by Subject|16|||
163980686|NCT01777152|592299627|FG000|Overall Study|Lost to Follow-up|3|||
163980687|NCT01777152|592299628|FG001|Overall Study|Lost to Follow-up|5|||
163980688|NCT01777152|592299627|FG000|Overall Study|Death|68|||
163980689|NCT01777152|592299628|FG001|Overall Study|Death|89|||
163980690|NCT01777152|592299627|FG000|Overall Study|Not eligible, no study drug received|1|||
163980691|NCT01777152|592299628|FG001|Overall Study|Not eligible, no study drug received|0|||
163980692|NCT01777152|592299627|FG000|Overall Study|Change of diagnosis|1|||
163980693|NCT01777152|592299628|FG001|Overall Study|Change of diagnosis|0|||
163980694|NCT03548558|592299629|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
163980695|NCT03548558|592299630|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
163980696|NCT03548558|592299631|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163980697|NCT03548558|592299632|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
163980698|NCT03548558|592299633|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
164213257|NCT06239610|593146356|FG000|Overall Study|no usable migration data for minimum of one day|11|||
163980699|NCT03548558|592299634|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163980700|NCT03548558|592299635|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
163980701|NCT03548558|592299629|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
163980702|NCT03548558|592299630|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
164213258|NCT02916771|593146357|FG000|Overall Study|Withdrawal by Subject|9|||
164213259|NCT02916771|593146357|FG000|Overall Study|Physician Decision|1|||
164213260|NCT02916771|593146357|FG000|Overall Study|Began treatment for another active malignancy|1|||
164213261|NCT03682848|593146365|FG000|Overall Study|Withdrawal by Subject|3|||
164213262|NCT03682848|593146365|FG000|Overall Study|Site closed|5|||
164213263|NCT03682848|593146365|FG000|Overall Study|Protocol Deviation|1|||
164213264|NCT03682848|593146365|FG000|Overall Study|Adverse Event|2|||
164213265|NCT03682848|593146365|FG000|Overall Study|Lack of Efficacy|1|||
164325709|NCT01923168|593567945|FG000|Overall Study|Physician Decision|6|||
164213266|NCT02872714|593146366|FG000|Overall Study|Progressive Disease|1|||
164213267|NCT02872714|593146367|FG001|Overall Study|Progressive Disease|2|||
164213268|NCT02872714|593146368|FG002|Overall Study|Progressive Disease|0|||
164213269|NCT02872714|593146369|FG003|Overall Study|Progressive Disease|0|||
164213270|NCT02872714|593146370|FG004|Overall Study|Progressive Disease|0|||
164213271|NCT02872714|593146366|FG000|Overall Study|Death|87|||
164213272|NCT02872714|593146367|FG001|Overall Study|Death|36|||
164213273|NCT02872714|593146368|FG002|Overall Study|Death|8|||
164213274|NCT02872714|593146369|FG003|Overall Study|Death|81|||
164213275|NCT02872714|593146370|FG004|Overall Study|Death|2|||
164213276|NCT02872714|593146366|FG000|Overall Study|Lost to Follow-up|2|||
164213277|NCT02872714|593146367|FG001|Overall Study|Lost to Follow-up|1|||
164213278|NCT02872714|593146368|FG002|Overall Study|Lost to Follow-up|0|||
164213279|NCT02872714|593146369|FG003|Overall Study|Lost to Follow-up|3|||
164213280|NCT02872714|593146370|FG004|Overall Study|Lost to Follow-up|0|||
164213281|NCT02872714|593146366|FG000|Overall Study|Physician Decision|0|||
164213282|NCT02872714|593146367|FG001|Overall Study|Physician Decision|0|||
164213283|NCT02872714|593146368|FG002|Overall Study|Physician Decision|0|||
164213284|NCT02872714|593146369|FG003|Overall Study|Physician Decision|1|||
164213285|NCT02872714|593146370|FG004|Overall Study|Physician Decision|0|||
164213286|NCT02872714|593146366|FG000|Overall Study|Withdrawal by Subject|1|||
164213287|NCT02872714|593146367|FG001|Overall Study|Withdrawal by Subject|3|||
164213288|NCT02872714|593146368|FG002|Overall Study|Withdrawal by Subject|0|||
164213289|NCT02872714|593146369|FG003|Overall Study|Withdrawal by Subject|2|||
164213290|NCT02872714|593146370|FG004|Overall Study|Withdrawal by Subject|0|||
164213291|NCT02872714|593146366|FG000|Overall Study|Captured as Other|2|||
164213292|NCT02872714|593146367|FG001|Overall Study|Captured as Other|0|||
164213293|NCT02872714|593146368|FG002|Overall Study|Captured as Other|0|||
164213294|NCT02872714|593146369|FG003|Overall Study|Captured as Other|1|||
164213295|NCT02872714|593146370|FG004|Overall Study|Captured as Other|0|||
164213296|NCT06717399|593146371|FG000|Overall Study|Death|1|||
164213297|NCT03043573|593146372|FG000|Overall Study|Lost to Follow-up|3|||
164213298|NCT03043573|593146373|FG001|Overall Study|Lost to Follow-up|3|||
164213299|NCT03043573|593146372|FG000|Overall Study|Physician Decision|0|||
164213300|NCT03043573|593146373|FG001|Overall Study|Physician Decision|5|||
164213301|NCT03043573|593146372|FG000|Overall Study|Withdrawal by Subject|0|||
164213302|NCT03043573|593146373|FG001|Overall Study|Withdrawal by Subject|4|||
164213303|NCT02337686|593146374|FG000|Overall Study|Adverse Event|1|||
164213304|NCT02145390|593146375|FG000|Overall Study|Withdrawal by Subject|1|||
164213305|NCT03580928|593146379|FG000|Overall Study|Death|0|||
164213306|NCT03580928|593146380|FG001|Overall Study|Death|3|||
164213307|NCT03580928|593146379|FG000|Overall Study|Withdrawal by Subject|2|||
164213308|NCT03580928|593146380|FG001|Overall Study|Withdrawal by Subject|1|||
164213309|NCT03580928|593146379|FG000|Overall Study|Lost to Follow-up|2|||
164213310|NCT03580928|593146380|FG001|Overall Study|Lost to Follow-up|0|||
164213311|NCT03580928|593146379|FG000|Overall Study|Progressive Disease|0|||
164213312|NCT03580928|593146380|FG001|Overall Study|Progressive Disease|1|||
164213313|NCT00479232|593147728|FG000|Overall Study|Adverse Event|0|||
164213314|NCT00479232|593147729|FG001|Overall Study|Adverse Event|0|||
164213315|NCT00479232|593147730|FG002|Overall Study|Adverse Event|5|||
164213316|NCT00479232|593147731|FG003|Overall Study|Adverse Event|0|||
164213317|NCT00479232|593147732|FG004|Overall Study|Adverse Event|0|||
164213318|NCT00479232|593147733|FG005|Overall Study|Adverse Event|10|||
164213319|NCT00479232|593147728|FG000|Overall Study|Deviation from Protocol|0|||
164213320|NCT00479232|593147729|FG001|Overall Study|Deviation from Protocol|0|||
164213321|NCT00479232|593147730|FG002|Overall Study|Deviation from Protocol|1|||
164213322|NCT00479232|593147731|FG003|Overall Study|Deviation from Protocol|0|||
164213323|NCT00479232|593147732|FG004|Overall Study|Deviation from Protocol|0|||
164213324|NCT00479232|593147733|FG005|Overall Study|Deviation from Protocol|0|||
164213325|NCT00479232|593147728|FG000|Overall Study|Lack of Efficacy|0|||
164213326|NCT00479232|593147729|FG001|Overall Study|Lack of Efficacy|0|||
164213327|NCT00479232|593147730|FG002|Overall Study|Lack of Efficacy|2|||
164213328|NCT00479232|593147731|FG003|Overall Study|Lack of Efficacy|0|||
164213329|NCT00479232|593147732|FG004|Overall Study|Lack of Efficacy|0|||
164213330|NCT00479232|593147733|FG005|Overall Study|Lack of Efficacy|4|||
164213331|NCT00479232|593147728|FG000|Overall Study|Physician Decision|0|||
164213332|NCT00479232|593147729|FG001|Overall Study|Physician Decision|0|||
164213333|NCT00479232|593147730|FG002|Overall Study|Physician Decision|2|||
164213334|NCT00479232|593147731|FG003|Overall Study|Physician Decision|0|||
164213335|NCT00479232|593147732|FG004|Overall Study|Physician Decision|0|||
164213336|NCT00479232|593147733|FG005|Overall Study|Physician Decision|1|||
164213337|NCT00479232|593147728|FG000|Overall Study|Progressive Disease|3|||
164213338|NCT00479232|593147729|FG001|Overall Study|Progressive Disease|1|||
164213339|NCT00479232|593147730|FG002|Overall Study|Progressive Disease|12|||
164213340|NCT00479232|593147731|FG003|Overall Study|Progressive Disease|3|||
164213341|NCT00479232|593147732|FG004|Overall Study|Progressive Disease|3|||
164213342|NCT00479232|593147733|FG005|Overall Study|Progressive Disease|12|||
164213343|NCT00479232|593147728|FG000|Overall Study|Withdrew Consent|0|||
164213344|NCT00479232|593147729|FG001|Overall Study|Withdrew Consent|2|||
164213345|NCT00479232|593147730|FG002|Overall Study|Withdrew Consent|6|||
164213346|NCT00479232|593147731|FG003|Overall Study|Withdrew Consent|0|||
164213347|NCT00479232|593147732|FG004|Overall Study|Withdrew Consent|1|||
164213348|NCT00479232|593147733|FG005|Overall Study|Withdrew Consent|3|||
164213349|NCT00484159|593147736|FG000|Overall Study|Lost to Follow-up|1|||
164213350|NCT00484159|593147737|FG001|Overall Study|Lost to Follow-up|1|||
164213351|NCT00484159|593147738|FG002|Overall Study|Lost to Follow-up|0|||
164213352|NCT05977868|593147739|FG000|Overall Study|Withdrawal by Subject|1|||
164213353|NCT05977868|593147740|FG001|Overall Study|Withdrawal by Subject|2|||
164213354|NCT05977868|593147739|FG000|Overall Study|Transitioned to comfort care|1|||
164213355|NCT05977868|593147740|FG001|Overall Study|Transitioned to comfort care|0|||
164213356|NCT00876395|593147741|FG000|Overall Study|Untreated|8|||
164213357|NCT00876395|593147742|FG001|Overall Study|Untreated|1|||
164213358|NCT00876395|593147741|FG000|Overall Study|Adverse Event|63|||
164213359|NCT00876395|593147742|FG001|Overall Study|Adverse Event|11|||
164213360|NCT00876395|593147741|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164213361|NCT00876395|593147742|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164213362|NCT00876395|593147741|FG000|Overall Study|Disease progression|259|||
164213363|NCT00876395|593147742|FG001|Overall Study|Disease progression|162|||
164213364|NCT00876395|593147741|FG000|Overall Study|New cancer therapy|25|||
164213365|NCT00876395|593147742|FG001|Overall Study|New cancer therapy|7|||
164213366|NCT00876395|593147741|FG000|Overall Study|Protocol Violation|5|||
164213367|NCT00876395|593147742|FG001|Overall Study|Protocol Violation|2|||
164213368|NCT00876395|593147741|FG000|Overall Study|Withdrawal by Subject|66|||
164213369|NCT00876395|593147742|FG001|Overall Study|Withdrawal by Subject|33|||
164213370|NCT00876395|593147741|FG000|Overall Study|Lost to Follow-up|2|||
164213371|NCT00876395|593147742|FG001|Overall Study|Lost to Follow-up|0|||
164213372|NCT00876395|593147741|FG000|Overall Study|Administrative problems|39|||
164213373|NCT00876395|593147742|FG001|Overall Study|Administrative problems|23|||
164213374|NCT00876395|593147741|FG000|Overall Study|Death|12|||
164213375|NCT00876395|593147742|FG001|Overall Study|Death|0|||
164213376|NCT01239680|593147745|FG000|Overall Study|Withdrawal by Subject|2|||
164213377|NCT01239680|593147746|FG001|Overall Study|Withdrawal by Subject|0|||
164213378|NCT00639379|593147747|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
164213379|NCT00639379|593147748|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
164213380|NCT00639379|593147747|FG000|Period 1 - 2 Weeks|lens issue|3|||
164213381|NCT00639379|593147748|FG001|Period 1 - 2 Weeks|lens issue|0|||
164213382|NCT01797185|593147753|FG000|Overall Study|Adverse Event|5|||
164213383|NCT01797185|593147754|FG001|Overall Study|Adverse Event|15|||
164213384|NCT01797185|593147755|FG002|Overall Study|Adverse Event|6|||
164213385|NCT01797185|593147753|FG000|Overall Study|Withdrawal by Subject|6|||
164213386|NCT01797185|593147754|FG001|Overall Study|Withdrawal by Subject|9|||
164213387|NCT01797185|593147755|FG002|Overall Study|Withdrawal by Subject|5|||
164213388|NCT01797185|593147753|FG000|Overall Study|Site terminated|8|||
164213389|NCT01797185|593147754|FG001|Overall Study|Site terminated|4|||
164213390|NCT01797185|593147755|FG002|Overall Study|Site terminated|0|||
164213391|NCT01797185|593147753|FG000|Overall Study|Lost to Follow-up|2|||
164213392|NCT01797185|593147754|FG001|Overall Study|Lost to Follow-up|6|||
164213393|NCT01797185|593147755|FG002|Overall Study|Lost to Follow-up|1|||
164213394|NCT01797185|593147753|FG000|Overall Study|Withdrawn per sponsor|5|||
164213395|NCT01797185|593147754|FG001|Overall Study|Withdrawn per sponsor|0|||
164213396|NCT01797185|593147755|FG002|Overall Study|Withdrawn per sponsor|0|||
164213397|NCT01797185|593147753|FG000|Overall Study|Physician Decision|1|||
164213398|NCT01797185|593147754|FG001|Overall Study|Physician Decision|3|||
164213399|NCT01797185|593147755|FG002|Overall Study|Physician Decision|0|||
164213400|NCT01797185|593147753|FG000|Overall Study|Protocol Violation|1|||
164213401|NCT01797185|593147754|FG001|Overall Study|Protocol Violation|1|||
164213402|NCT01797185|593147755|FG002|Overall Study|Protocol Violation|0|||
164213403|NCT01787838|593147756|FG000|Overall Study|refused|1413|||
164213404|NCT01033942|593147760|FG000|Overall Study|Withdrawal by Subject|1|||
164213405|NCT01033942|593147761|FG001|Overall Study|Withdrawal by Subject|1|||
164213406|NCT01033942|593147762|FG002|Overall Study|Withdrawal by Subject|1|||
164213407|NCT01033942|593147760|FG000|Overall Study|Lost to Follow-up|1|||
164213408|NCT01033942|593147761|FG001|Overall Study|Lost to Follow-up|0|||
164213409|NCT01033942|593147762|FG002|Overall Study|Lost to Follow-up|0|||
164213410|NCT01033942|593147760|FG000|Overall Study|Enrolled in Extension Study|0|||
164213411|NCT01033942|593147761|FG001|Overall Study|Enrolled in Extension Study|3|||
164213412|NCT01033942|593147762|FG002|Overall Study|Enrolled in Extension Study|0|||
164213413|NCT02260986|593147770|FG000|Overall Study|Adverse Event|24|||
164213414|NCT02260986|593147771|FG001|Overall Study|Adverse Event|0|||
164213415|NCT02260986|593147772|FG002|Overall Study|Adverse Event|11|||
164213416|NCT02260986|593147770|FG000|Overall Study|Lack of Efficacy|27|||
164213417|NCT02260986|593147771|FG001|Overall Study|Lack of Efficacy|3|||
164213418|NCT02260986|593147772|FG002|Overall Study|Lack of Efficacy|0|||
164213419|NCT02260986|593147770|FG000|Overall Study|Protocol Violation|14|||
164213420|NCT02260986|593147771|FG001|Overall Study|Protocol Violation|5|||
164213421|NCT02260986|593147772|FG002|Overall Study|Protocol Violation|16|||
164213422|NCT02260986|593147770|FG000|Overall Study|Car accident|0|||
164213423|NCT02260986|593147771|FG001|Overall Study|Car accident|0|||
164213424|NCT02260986|593147772|FG002|Overall Study|Car accident|1|||
164213425|NCT02260986|593147770|FG000|Overall Study|Withdrawal by Subject|17|||
164213426|NCT02260986|593147771|FG001|Overall Study|Withdrawal by Subject|4|||
164213427|NCT02260986|593147772|FG002|Overall Study|Withdrawal by Subject|9|||
164213428|NCT02260986|593147770|FG000|Overall Study|Incorrect randomization|0|||
164213429|NCT02260986|593147771|FG001|Overall Study|Incorrect randomization|1|||
164213430|NCT02260986|593147772|FG002|Overall Study|Incorrect randomization|0|||
164213431|NCT02260986|593147770|FG000|Overall Study|Lack of investigation product supply|2|||
164213432|NCT02260986|593147771|FG001|Overall Study|Lack of investigation product supply|0|||
164213433|NCT02260986|593147772|FG002|Overall Study|Lack of investigation product supply|1|||
164213434|NCT02260986|593147770|FG000|Overall Study|Lost to Follow-up|4|||
164213435|NCT02260986|593147771|FG001|Overall Study|Lost to Follow-up|0|||
164213436|NCT02260986|593147772|FG002|Overall Study|Lost to Follow-up|3|||
164213437|NCT02260986|593147770|FG000|Overall Study|Pregnancy|2|||
164213438|NCT02260986|593147771|FG001|Overall Study|Pregnancy|0|||
164213439|NCT02260986|593147772|FG002|Overall Study|Pregnancy|0|||
164213440|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Adverse Event|2|||
163980703|NCT03548558|592299631|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
163980704|NCT03548558|592299632|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
163980705|NCT03548558|592299633|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
163980706|NCT03548558|592299634|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
163980707|NCT03548558|592299635|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
163980708|NCT03548558|592299629|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
164213441|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
164213442|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
164213443|NCT02536794|593147774|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
164213444|NCT02536794|593147774|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
164213445|NCT02536794|593147774|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
164213446|NCT00313170|593147775|FG000|Overall Study|Death|2|||
164213447|NCT00313170|593147776|FG001|Overall Study|Death|4|||
164213448|NCT00313170|593147777|FG002|Overall Study|Death|2|||
164213449|NCT00313170|593147775|FG000|Overall Study|Adverse Event|1|||
164213450|NCT00313170|593147776|FG001|Overall Study|Adverse Event|2|||
164213451|NCT00313170|593147777|FG002|Overall Study|Adverse Event|0|||
164213452|NCT00313170|593147775|FG000|Overall Study|Disease progression|31|||
164213453|NCT00313170|593147776|FG001|Overall Study|Disease progression|26|||
164213454|NCT00313170|593147777|FG002|Overall Study|Disease progression|27|||
164213455|NCT00313170|593147775|FG000|Overall Study|Withdrawal by Subject|1|||
164213456|NCT00313170|593147776|FG001|Overall Study|Withdrawal by Subject|0|||
164213457|NCT00313170|593147777|FG002|Overall Study|Withdrawal by Subject|1|||
164213458|NCT00313170|593147775|FG000|Overall Study|Incorrect enrollment|0|||
164213459|NCT00313170|593147776|FG001|Overall Study|Incorrect enrollment|2|||
164213460|NCT00313170|593147777|FG002|Overall Study|Incorrect enrollment|1|||
164213461|NCT00313170|593147775|FG000|Overall Study|Lost to Follow-up|0|||
164213462|NCT00313170|593147776|FG001|Overall Study|Lost to Follow-up|0|||
164213463|NCT00313170|593147777|FG002|Overall Study|Lost to Follow-up|1|||
164213464|NCT00313170|593147775|FG000|Overall Study|Progression (investigators opinion)|1|||
164213465|NCT00313170|593147776|FG001|Overall Study|Progression (investigators opinion)|0|||
164213466|NCT00313170|593147777|FG002|Overall Study|Progression (investigators opinion)|0|||
164213467|NCT00817063|593147778|FG000|Overall Study|Adverse Event|32|||
164213468|NCT00817063|593147779|FG001|Overall Study|Adverse Event|13|||
164213469|NCT00817063|593147778|FG000|Overall Study|Death|1|||
164213470|NCT00817063|593147779|FG001|Overall Study|Death|1|||
164213471|NCT00817063|593147778|FG000|Overall Study|Lack of Efficacy|33|||
164213472|NCT00817063|593147779|FG001|Overall Study|Lack of Efficacy|86|||
164213473|NCT00817063|593147778|FG000|Overall Study|Failure to Return|13|||
164213474|NCT00817063|593147779|FG001|Overall Study|Failure to Return|12|||
164213475|NCT00817063|593147778|FG000|Overall Study|Violation of Selection at Entry|7|||
164213476|NCT00817063|593147779|FG001|Overall Study|Violation of Selection at Entry|4|||
164213477|NCT00817063|593147778|FG000|Overall Study|Protocol Violation|3|||
164213478|NCT00817063|593147779|FG001|Overall Study|Protocol Violation|8|||
164213479|NCT00817063|593147778|FG000|Overall Study|Withdrawal by Subject|17|||
164213480|NCT00817063|593147779|FG001|Overall Study|Withdrawal by Subject|37|||
164213481|NCT00817063|593147778|FG000|Overall Study|Early Improvement|19|||
164213482|NCT00817063|593147779|FG001|Overall Study|Early Improvement|4|||
164213483|NCT00817063|593147778|FG000|Overall Study|Administrative|10|||
164213484|NCT00817063|593147779|FG001|Overall Study|Administrative|4|||
164213485|NCT00817063|593147778|FG000|Overall Study|Abnormality of Laboratory Test|2|||
164213486|NCT00817063|593147779|FG001|Overall Study|Abnormality of Laboratory Test|1|||
164213487|NCT00529035|593147780|FG000|Overall Study|Withdrawal by Subject|1|||
164213488|NCT01521364|593147781|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
164213489|NCT01521364|593147781|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
164213490|NCT03418675|593147782|FG000|Overall Study|Lost to Follow-up|13|||
164213491|NCT03418675|593147783|FG001|Overall Study|Lost to Follow-up|10|||
164213492|NCT03418675|593147782|FG000|Overall Study|Adverse Event|2|||
164213493|NCT03418675|593147783|FG001|Overall Study|Adverse Event|0|||
163980709|NCT03548558|592299630|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
164213494|NCT02115386|593147784|FG000|Overall Study|Protocol Violation|1|||
164213495|NCT02115386|593147784|FG000|Overall Study|Administrative - trial was terminated|6|||
164213496|NCT02493855|593147785|FG000|Overall Study|Non-compliance|1|||
164213497|NCT02493855|593147786|FG001|Overall Study|Non-compliance|0|||
164213498|NCT02493855|593147787|FG002|Overall Study|Non-compliance|0|||
164213499|NCT02493855|593147785|FG000|Overall Study|Adverse Event|0|||
164213500|NCT02493855|593147786|FG001|Overall Study|Adverse Event|1|||
164213501|NCT02493855|593147787|FG002|Overall Study|Adverse Event|0|||
164213502|NCT02493855|593147785|FG000|Overall Study|Withdrawal by Subject|1|||
164213503|NCT02493855|593147786|FG001|Overall Study|Withdrawal by Subject|0|||
164213504|NCT02493855|593147787|FG002|Overall Study|Withdrawal by Subject|0|||
164213505|NCT03086343|593147788|FG000|Period 1|Adverse Event|7|||
164213506|NCT03086343|593147789|FG001|Period 1|Adverse Event|7|||
164213507|NCT03086343|593147790|FG002|Period 1|Adverse Event|0|||
163980710|NCT03548558|592299631|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
163980711|NCT03548558|592299632|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
163980712|NCT03548558|592299633|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
163980713|NCT03548558|592299634|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
163980714|NCT03548558|592299635|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
163980715|NCT03548558|592299629|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163980716|NCT03548558|592299630|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163980717|NCT03548558|592299631|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163980718|NCT03548558|592299632|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
163980719|NCT03548558|592299633|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
163980720|NCT03548558|592299634|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
163980721|NCT03548558|592299635|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
163980722|NCT03548558|592299629|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163980723|NCT03548558|592299630|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163980724|NCT03548558|592299631|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163980725|NCT03548558|592299632|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
163980726|NCT03548558|592299633|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
163980727|NCT03548558|592299634|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
163980728|NCT03548558|592299635|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
163980729|NCT03548558|592299629|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163980730|NCT03548558|592299630|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163980731|NCT03548558|592299631|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163980732|NCT03548558|592299632|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
163980733|NCT03548558|592299633|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
163980734|NCT03548558|592299634|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
163980735|NCT03548558|592299635|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
163980736|NCT03446885|592299638|FG000|Overall Study|Lost to Follow-up|1|||
163980737|NCT03446885|592299639|FG001|Overall Study|Lost to Follow-up|0|||
163980738|NCT03446885|592299638|FG000|Overall Study|Did not complete entire visit|1|||
163980739|NCT03446885|592299639|FG001|Overall Study|Did not complete entire visit|0|||
163980740|NCT01709149|592299647|FG000|Open-label Lead-in Phase|Adverse Event|109|||
163980741|NCT01709149|592299648|FG001|Open-label Lead-in Phase|Adverse Event|0|||
163980742|NCT01709149|592299649|FG002|Open-label Lead-in Phase|Adverse Event|0|||
163980743|NCT01709149|592299647|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
164213508|NCT03086343|593147791|FG003|Period 1|Adverse Event|1|||
164213509|NCT03086343|593147788|FG000|Period 1|Withdrawal by Subject|6|||
164213510|NCT03086343|593147789|FG001|Period 1|Withdrawal by Subject|10|||
164213511|NCT03086343|593147790|FG002|Period 1|Withdrawal by Subject|0|||
164213512|NCT03086343|593147791|FG003|Period 1|Withdrawal by Subject|0|||
164213513|NCT03086343|593147788|FG000|Period 1|Lost to Follow-up|1|||
164213514|NCT03086343|593147789|FG001|Period 1|Lost to Follow-up|3|||
164213515|NCT03086343|593147790|FG002|Period 1|Lost to Follow-up|1|||
164077704|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
164213516|NCT03086343|593147791|FG003|Period 1|Lost to Follow-up|0|||
164213517|NCT03086343|593147788|FG000|Period 1|Other, Not Specified|10|||
164213518|NCT03086343|593147789|FG001|Period 1|Other, Not Specified|12|||
164213519|NCT03086343|593147790|FG002|Period 1|Other, Not Specified|2|||
164213520|NCT03086343|593147791|FG003|Period 1|Other, Not Specified|1|||
164213521|NCT03086343|593147788|FG000|Period 1|Missing|1|||
164213522|NCT03086343|593147789|FG001|Period 1|Missing|0|||
164213523|NCT03086343|593147790|FG002|Period 1|Missing|0|||
164213524|NCT03086343|593147791|FG003|Period 1|Missing|0|||
164213525|NCT03086343|593147788|FG000|Period 2|Adverse Event|20|||
164213526|NCT03086343|593147789|FG001|Period 2|Adverse Event|11|||
164213527|NCT03086343|593147790|FG002|Period 2|Adverse Event|1|||
164213528|NCT03086343|593147791|FG003|Period 2|Adverse Event|2|||
164213529|NCT03086343|593147788|FG000|Period 2|Withdrawal by Subject|15|||
164213530|NCT03086343|593147789|FG001|Period 2|Withdrawal by Subject|25|||
164213531|NCT03086343|593147790|FG002|Period 2|Withdrawal by Subject|2|||
164213532|NCT03086343|593147791|FG003|Period 2|Withdrawal by Subject|2|||
164325710|NCT01923168|593567946|FG001|Overall Study|Physician Decision|9|||
164325711|NCT01923168|593567947|FG002|Overall Study|Physician Decision|5|||
164325712|NCT01923168|593567945|FG000|Overall Study|Progressive disease|4|||
164325713|NCT01923168|593567946|FG001|Overall Study|Progressive disease|3|||
164325714|NCT01923168|593567947|FG002|Overall Study|Progressive disease|7|||
164325715|NCT01923168|593567945|FG000|Overall Study|Death|0|||
164325716|NCT01923168|593567946|FG001|Overall Study|Death|0|||
164325717|NCT01923168|593567947|FG002|Overall Study|Death|1|||
164325718|NCT04193410|593567948|FG000|Overall Study|Lost to Follow-up|7|||
164325719|NCT04193410|593567949|FG001|Overall Study|Lost to Follow-up|6|||
164325720|NCT02241889|593567954|FG000|Overall Study|device issues|0|||
164325721|NCT02241889|593567955|FG001|Overall Study|device issues|0|||
164325722|NCT02241889|593567956|FG002|Overall Study|device issues|1|||
164325723|NCT02241889|593567957|FG003|Overall Study|device issues|0|||
164325724|NCT02241889|593567958|FG004|Overall Study|device issues|0|||
164137807|NCT00696787|592866939|FG002|Overall Study|Lack of Efficacy|0|||
164137808|NCT00696787|592866937|FG000|Overall Study|Lost to Follow-up|4|||
164137809|NCT00696787|592866938|FG001|Overall Study|Lost to Follow-up|0|||
164137810|NCT00696787|592866939|FG002|Overall Study|Lost to Follow-up|3|||
164137811|NCT00696787|592866937|FG000|Overall Study|Withdrawal by Subject|0|||
164137812|NCT00696787|592866938|FG001|Overall Study|Withdrawal by Subject|3|||
164137813|NCT00696787|592866939|FG002|Overall Study|Withdrawal by Subject|2|||
164137814|NCT00696787|592866937|FG000|Overall Study|Failed to return|1|||
164137815|NCT00696787|592866938|FG001|Overall Study|Failed to return|3|||
164137816|NCT00696787|592866939|FG002|Overall Study|Failed to return|1|||
164137817|NCT01346293|592866940|FG000|Overall Study|Protocol Violation|30|||
164137818|NCT01346293|592866941|FG001|Overall Study|Protocol Violation|9|||
164137819|NCT01346293|592866940|FG000|Overall Study|Lost to Follow-up|21|||
164137820|NCT01346293|592866941|FG001|Overall Study|Lost to Follow-up|8|||
164137821|NCT01346293|592866940|FG000|Overall Study|Withdrawal by Subject|15|||
164137822|NCT01346293|592866941|FG001|Overall Study|Withdrawal by Subject|4|||
164137823|NCT01346293|592866940|FG000|Overall Study|Other|1|||
164137824|NCT01346293|592866941|FG001|Overall Study|Other|0|||
164137825|NCT01844505|592866942|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
164137826|NCT01844505|592866943|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
164137827|NCT01844505|592866944|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
164137828|NCT01844505|592866942|FG000|Treatment Period|Other Reasons|120|||
164137829|NCT01844505|592866943|FG001|Treatment Period|Other Reasons|136|||
164137830|NCT01844505|592866944|FG002|Treatment Period|Other Reasons|58|||
164137831|NCT01844505|592866942|FG000|Treatment Period|Lost to Follow-up|9|||
164137832|NCT01844505|592866943|FG001|Treatment Period|Lost to Follow-up|11|||
164137833|NCT01844505|592866944|FG002|Treatment Period|Lost to Follow-up|6|||
164137834|NCT01844505|592866942|FG000|Treatment Period|Death|175|||
164137835|NCT01844505|592866943|FG001|Treatment Period|Death|154|||
164137836|NCT01844505|592866944|FG002|Treatment Period|Death|228|||
164137837|NCT02730351|592866945|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
164137838|NCT02730351|592866946|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
164137839|NCT02730351|592866945|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
164137840|NCT02730351|592866946|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
164137841|NCT02730351|592866945|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
164137842|NCT02730351|592866946|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
164137843|NCT02730351|592866945|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
164137844|NCT02730351|592866946|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
164137845|NCT02730351|592866945|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
164137846|NCT02730351|592866946|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
164137847|NCT00128830|592866947|FG000|Overall Study|Adverse Event|10|||
164137848|NCT00128830|592866947|FG000|Overall Study|Withdrawal by Subject|14|||
164137849|NCT00128830|592866947|FG000|Overall Study|Lost to Follow-up|4|||
164137850|NCT00128830|592866947|FG000|Overall Study|Reached a virologic endpoint|29|||
164137851|NCT00128830|592866947|FG000|Overall Study|Non-compliant|4|||
164137852|NCT00128830|592866947|FG000|Overall Study|Discontinued or ineligible for study|2|||
164137853|NCT00128830|592866947|FG000|Overall Study|Other|9|||
164137854|NCT00311402|592866948|FG000|Overall Study|Adverse Event|118|||
164137855|NCT00311402|592866949|FG001|Overall Study|Adverse Event|105|||
164137856|NCT00311402|592866948|FG000|Overall Study|Lost to Follow-up|0|||
164137857|NCT00311402|592866949|FG001|Overall Study|Lost to Follow-up|3|||
164137858|NCT00311402|592866948|FG000|Overall Study|Withdrawal by Subject|17|||
164137859|NCT00311402|592866949|FG001|Overall Study|Withdrawal by Subject|18|||
164137860|NCT00311402|592866948|FG000|Overall Study|Lack of Efficacy|58|||
164137861|NCT00311402|592866949|FG001|Overall Study|Lack of Efficacy|42|||
164137862|NCT00311402|592866948|FG000|Overall Study|Protocol Violation|7|||
164137863|NCT00311402|592866949|FG001|Overall Study|Protocol Violation|6|||
164137864|NCT00311402|592866948|FG000|Overall Study|IRB's rejection etc.|10|||
164137865|NCT00311402|592866949|FG001|Overall Study|IRB's rejection etc.|3|||
164137866|NCT02640053|592866950|FG000|Overall Study|Withdrawal by Subject|2|||
164137867|NCT02640053|592866951|FG001|Overall Study|Withdrawal by Subject|1|||
164213533|NCT03086343|593147788|FG000|Period 2|Lost to Follow-up|6|||
164213534|NCT03086343|593147789|FG001|Period 2|Lost to Follow-up|11|||
164213535|NCT03086343|593147790|FG002|Period 2|Lost to Follow-up|1|||
164213536|NCT03086343|593147791|FG003|Period 2|Lost to Follow-up|0|||
164213537|NCT03086343|593147788|FG000|Period 2|COVID-19 Infection|5|||
164213538|NCT03086343|593147789|FG001|Period 2|COVID-19 Infection|0|||
164213539|NCT03086343|593147790|FG002|Period 2|COVID-19 Infection|0|||
164213540|NCT03086343|593147791|FG003|Period 2|COVID-19 Infection|0|||
164213541|NCT03086343|593147788|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
164213542|NCT03086343|593147789|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
164213543|NCT03086343|593147790|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
164213544|NCT03086343|593147791|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
164213545|NCT03086343|593147788|FG000|Period 2|Other, Not Specified|23|||
164213546|NCT03086343|593147789|FG001|Period 2|Other, Not Specified|22|||
164213547|NCT03086343|593147790|FG002|Period 2|Other, Not Specified|2|||
164213548|NCT03086343|593147791|FG003|Period 2|Other, Not Specified|4|||
164213549|NCT04900272|593147792|FG000|Overall Study|Lost to Follow-up|2|||
164213550|NCT04900272|593147792|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
164213551|NCT04900272|593147792|FG000|Overall Study|Withdrawal by Subject|1|||
164213552|NCT02447029|593147795|FG000|Overall Study|Withdrawal by Subject|3|||
164213553|NCT02447029|593147796|FG001|Overall Study|Withdrawal by Subject|2|||
164213554|NCT02299167|593147797|FG000|Overall Study|patients were excluded from the study|11|||
164213555|NCT03600428|593147798|FG000|Overall Study|Not eligible|0|||
164213556|NCT03600428|593147799|FG001|Overall Study|Not eligible|1|||
164213557|NCT03600428|593147798|FG000|Overall Study|Lost to Follow-up|5|||
164213558|NCT03600428|593147799|FG001|Overall Study|Lost to Follow-up|4|||
164213559|NCT00549328|593147801|FG000|Overall Study|Adverse Event|2|||
164213560|NCT00549328|593147801|FG000|Overall Study|Disease Progression|10|||
164213561|NCT00549328|593147801|FG000|Overall Study|Death|1|||
164213562|NCT00549328|593147801|FG000|Overall Study|Use of Prohibited Medication|1|||
164213563|NCT06420232|593147806|FG000|Overall Study|Withdrawal by Subject|3|||
164213564|NCT04868682|593147808|FG000|Post-treatment|Lost to Follow-up|1|||
164213565|NCT04868682|593147809|FG001|Post-treatment|Lost to Follow-up|1|||
164213566|NCT04868682|593147808|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
164213567|NCT04868682|593147809|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
164213568|NCT04868682|593147808|FG000|Six-month Assessment|Lost to Follow-up|1|||
164213569|NCT04868682|593147809|FG001|Six-month Assessment|Lost to Follow-up|0|||
164213570|NCT04868682|593147808|FG000|Six-month Assessment|Death|1|||
164213571|NCT04868682|593147809|FG001|Six-month Assessment|Death|0|||
164213572|NCT04868682|593147808|FG000|Six-month Assessment|Refused|0|||
164213573|NCT04868682|593147809|FG001|Six-month Assessment|Refused|1|||
164213574|NCT04868682|593147808|FG000|12-month Assessment|Lost to Follow-up|2|||
163876313|NCT04583423|591914837|FG003|Overall Study|Study Terminated by Sponsor|33|||
163876314|NCT04583423|591914834|FG000|Overall Study|Withdrawal by Subject|3|||
163876315|NCT04583423|591914835|FG001|Overall Study|Withdrawal by Subject|1|||
163876316|NCT04583423|591914836|FG002|Overall Study|Withdrawal by Subject|2|||
163876317|NCT04583423|591914837|FG003|Overall Study|Withdrawal by Subject|1|||
163876318|NCT03330795|591914838|FG000|Overall Study|Death|3|||
163876319|NCT03330795|591914838|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
163876320|NCT00393484|591914839|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
164213575|NCT04868682|593147809|FG001|12-month Assessment|Lost to Follow-up|1|||
164213576|NCT04868682|593147808|FG000|12-month Assessment|Death|0|||
164213577|NCT04868682|593147809|FG001|12-month Assessment|Death|1|||
164213578|NCT03880565|593147813|FG000|Overall Study|Withdrawal by Subject|1|||
164213579|NCT03880565|593147814|FG001|Overall Study|Withdrawal by Subject|0|||
164213580|NCT02202616|593147815|FG000|Overall Study|Screen failed|24|||
164213581|NCT02202616|593147815|FG000|Overall Study|Adverse Event|32|||
164213582|NCT02202616|593147815|FG000|Overall Study|Protocol deviation|18|||
164213583|NCT02202616|593147815|FG000|Overall Study|Patient withdrew consent|12|||
164213584|NCT02202616|593147815|FG000|Overall Study|Lost to Follow-up|6|||
164213585|NCT02202616|593147815|FG000|Overall Study|Administrative problems|6|||
164213586|NCT02202616|593147815|FG000|Overall Study|Abnormal test procedure result|1|||
164213587|NCT02202616|593147815|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164213588|NCT04327271|593147819|FG000|Overall Study|Death|1|||
164213589|NCT04327271|593147820|FG001|Overall Study|Death|0|||
164213590|NCT04327271|593147819|FG000|Overall Study|Withdrawal by Subject|1|||
164213591|NCT04327271|593147820|FG001|Overall Study|Withdrawal by Subject|0|||
164213592|NCT04327271|593147819|FG000|Overall Study|randomization error (data capture)|4|||
164213593|NCT04327271|593147820|FG001|Overall Study|randomization error (data capture)|3|||
164213594|NCT01044498|593147821|FG000|Overall Study|Withdrew consent|1|||
164213595|NCT01044498|593147822|FG001|Overall Study|Withdrew consent|1|||
164213596|NCT01044498|593147821|FG000|Overall Study|Adverse Event|1|||
164213597|NCT01044498|593147822|FG001|Overall Study|Adverse Event|1|||
164213598|NCT01044498|593147821|FG000|Overall Study|Other|1|||
164213599|NCT01044498|593147822|FG001|Overall Study|Other|0|||
164213600|NCT02903914|593147825|FG000|Overall Study|Adverse Event|0|||
164213601|NCT02903914|593147826|FG001|Overall Study|Adverse Event|0|||
164213602|NCT02903914|593147827|FG002|Overall Study|Adverse Event|1|||
164213603|NCT02903914|593147828|FG003|Overall Study|Adverse Event|0|||
164213604|NCT02903914|593147829|FG004|Overall Study|Adverse Event|0|||
164213605|NCT02903914|593147830|FG005|Overall Study|Adverse Event|0|||
164213606|NCT02903914|593147831|FG006|Overall Study|Adverse Event|2|||
164213607|NCT02903914|593147832|FG007|Overall Study|Adverse Event|0|||
164213608|NCT02903914|593147825|FG000|Overall Study|Withdrawal by Subject|3|||
164213609|NCT02903914|593147826|FG001|Overall Study|Withdrawal by Subject|1|||
164213610|NCT02903914|593147827|FG002|Overall Study|Withdrawal by Subject|28|||
164213611|NCT02903914|593147828|FG003|Overall Study|Withdrawal by Subject|0|||
164213612|NCT02903914|593147829|FG004|Overall Study|Withdrawal by Subject|1|||
164213613|NCT02903914|593147830|FG005|Overall Study|Withdrawal by Subject|2|||
164213614|NCT02903914|593147831|FG006|Overall Study|Withdrawal by Subject|12|||
164213615|NCT02903914|593147832|FG007|Overall Study|Withdrawal by Subject|0|||
164213616|NCT02903914|593147825|FG000|Overall Study|Progressive Disease|1|||
164213617|NCT02903914|593147826|FG001|Overall Study|Progressive Disease|0|||
164213618|NCT02903914|593147827|FG002|Overall Study|Progressive Disease|4|||
164213619|NCT02903914|593147828|FG003|Overall Study|Progressive Disease|0|||
164213620|NCT02903914|593147829|FG004|Overall Study|Progressive Disease|0|||
164213621|NCT02903914|593147830|FG005|Overall Study|Progressive Disease|0|||
164213622|NCT02903914|593147831|FG006|Overall Study|Progressive Disease|2|||
164213623|NCT02903914|593147832|FG007|Overall Study|Progressive Disease|0|||
164213624|NCT02903914|593147825|FG000|Overall Study|Death|0|||
164213625|NCT02903914|593147826|FG001|Overall Study|Death|0|||
164213626|NCT02903914|593147827|FG002|Overall Study|Death|9|||
164325725|NCT02241889|593567959|FG005|Overall Study|device issues|0|||
164325726|NCT02241889|593567954|FG000|Overall Study|Withdrawal by Subject|0|||
164325727|NCT02241889|593567955|FG001|Overall Study|Withdrawal by Subject|0|||
164325728|NCT02241889|593567956|FG002|Overall Study|Withdrawal by Subject|0|||
164325729|NCT02241889|593567957|FG003|Overall Study|Withdrawal by Subject|0|||
164325730|NCT02241889|593567958|FG004|Overall Study|Withdrawal by Subject|0|||
164325731|NCT02241889|593567959|FG005|Overall Study|Withdrawal by Subject|1|||
164325732|NCT00773838|593567960|FG000|Overall Study|Adverse Event|29|||
164325733|NCT00773838|593567960|FG000|Overall Study|Lost to Follow-up|1|||
164325734|NCT00773838|593567960|FG000|Overall Study|Physician Decision|8|||
164325735|NCT00773838|593567960|FG000|Overall Study|Progressive Disease|82|||
164325736|NCT00773838|593567960|FG000|Overall Study|Protocol Violation|2|||
164325737|NCT00773838|593567960|FG000|Overall Study|Withdrawal by Subject|21|||
164325738|NCT00459056|593567963|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
164325739|NCT00459056|593567964|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
164325740|NCT02522871|593567965|FG000|Overall Study|Protocol Violation|1|||
164325741|NCT02522871|593567966|FG001|Overall Study|Protocol Violation|4|||
164325742|NCT02522871|593567965|FG000|Overall Study|Treated without randomization|1|||
164325743|NCT02522871|593567966|FG001|Overall Study|Treated without randomization|0|||
164325744|NCT02522871|593567965|FG000|Overall Study|Death|9|||
164325745|NCT02522871|593567966|FG001|Overall Study|Death|9|||
164325746|NCT02522871|593567965|FG000|Overall Study|Died in operating room prior to transplant|0|||
164325747|NCT02522871|593567966|FG001|Overall Study|Died in operating room prior to transplant|1|||
164325748|NCT01715129|593567967|FG000|Overall Study|Adverse Event, fatal|1|||
164325749|NCT01715129|593567967|FG000|Overall Study|Lack of Efficacy|3|||
164325750|NCT01715129|593567967|FG000|Overall Study|Protocol Violation|1|||
164325751|NCT01715129|593567967|FG000|Overall Study|Consent Withdrawn|2|||
164325752|NCT01715129|593567967|FG000|Overall Study|Lost to Follow-up|1|||
164325753|NCT01715129|593567967|FG000|Overall Study|Other|1|||
164325754|NCT03149848|593567968|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
164325755|NCT03149848|593567968|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
164325756|NCT00378079|593567971|FG000|Overall Study|Lost to Follow-up|6|||
164325757|NCT00378079|593567972|FG001|Overall Study|Lost to Follow-up|1|||
164325758|NCT00378079|593567973|FG002|Overall Study|Lost to Follow-up|0|||
164325759|NCT02274038|593567974|FG000|Overall Study|Death|1|||
163876321|NCT00393484|591914840|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
163876322|NCT00393484|591914839|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
163876323|NCT00393484|591914840|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
163876324|NCT00393484|591914839|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
163876325|NCT00393484|591914840|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
164325760|NCT05458648|593567978|FG000|Overall Study|Physician Decision|1|||
164325761|NCT05458648|593567978|FG000|Overall Study|Patient presented in atrial flutter|1|||
164325762|NCT03610555|593567982|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
164325763|NCT03610555|593567983|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
164213627|NCT02903914|593147828|FG003|Overall Study|Death|0|||
164213628|NCT02903914|593147829|FG004|Overall Study|Death|1|||
164213629|NCT02903914|593147830|FG005|Overall Study|Death|3|||
164213630|NCT02903914|593147831|FG006|Overall Study|Death|24|||
164213631|NCT02903914|593147832|FG007|Overall Study|Death|2|||
164213632|NCT02903914|593147825|FG000|Overall Study|Lost to Follow-up|0|||
164213633|NCT02903914|593147826|FG001|Overall Study|Lost to Follow-up|1|||
164213634|NCT02903914|593147827|FG002|Overall Study|Lost to Follow-up|0|||
164213635|NCT02903914|593147828|FG003|Overall Study|Lost to Follow-up|0|||
164213636|NCT02903914|593147829|FG004|Overall Study|Lost to Follow-up|2|||
164213637|NCT02903914|593147830|FG005|Overall Study|Lost to Follow-up|0|||
164213638|NCT02903914|593147831|FG006|Overall Study|Lost to Follow-up|1|||
164213639|NCT02903914|593147832|FG007|Overall Study|Lost to Follow-up|0|||
164213640|NCT02903914|593147825|FG000|Overall Study|Physician Decision|0|||
164213641|NCT02903914|593147826|FG001|Overall Study|Physician Decision|0|||
164213642|NCT02903914|593147827|FG002|Overall Study|Physician Decision|1|||
164213643|NCT02903914|593147828|FG003|Overall Study|Physician Decision|0|||
164213644|NCT02903914|593147829|FG004|Overall Study|Physician Decision|0|||
164213645|NCT02903914|593147830|FG005|Overall Study|Physician Decision|0|||
164213646|NCT02903914|593147831|FG006|Overall Study|Physician Decision|1|||
164213647|NCT02903914|593147832|FG007|Overall Study|Physician Decision|0|||
164213648|NCT02903914|593147825|FG000|Overall Study|Symptomatic Deterioration|0|||
164213649|NCT02903914|593147826|FG001|Overall Study|Symptomatic Deterioration|0|||
164213650|NCT02903914|593147827|FG002|Overall Study|Symptomatic Deterioration|1|||
164213651|NCT02903914|593147828|FG003|Overall Study|Symptomatic Deterioration|0|||
164213652|NCT02903914|593147829|FG004|Overall Study|Symptomatic Deterioration|0|||
164213653|NCT02903914|593147830|FG005|Overall Study|Symptomatic Deterioration|0|||
164213654|NCT02903914|593147831|FG006|Overall Study|Symptomatic Deterioration|0|||
164213655|NCT02903914|593147832|FG007|Overall Study|Symptomatic Deterioration|0|||
164213656|NCT02903914|593147825|FG000|Overall Study|New Cancer Therapy|2|||
164213657|NCT02903914|593147826|FG001|Overall Study|New Cancer Therapy|2|||
164213658|NCT02903914|593147827|FG002|Overall Study|New Cancer Therapy|21|||
164213659|NCT02903914|593147828|FG003|Overall Study|New Cancer Therapy|4|||
164213660|NCT02903914|593147829|FG004|Overall Study|New Cancer Therapy|3|||
164213661|NCT02903914|593147830|FG005|Overall Study|New Cancer Therapy|6|||
164213662|NCT02903914|593147831|FG006|Overall Study|New Cancer Therapy|56|||
164213663|NCT02903914|593147832|FG007|Overall Study|New Cancer Therapy|3|||
164213664|NCT02903914|593147825|FG000|Overall Study|Didn't Return to Site|1|||
164213665|NCT02903914|593147826|FG001|Overall Study|Didn't Return to Site|0|||
164213666|NCT02903914|593147827|FG002|Overall Study|Didn't Return to Site|1|||
164213667|NCT02903914|593147828|FG003|Overall Study|Didn't Return to Site|1|||
164213668|NCT02903914|593147829|FG004|Overall Study|Didn't Return to Site|0|||
164213669|NCT02903914|593147830|FG005|Overall Study|Didn't Return to Site|0|||
164213670|NCT02903914|593147831|FG006|Overall Study|Didn't Return to Site|2|||
164213671|NCT02903914|593147832|FG007|Overall Study|Didn't Return to Site|0|||
164213672|NCT02903914|593147825|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
164213673|NCT02903914|593147826|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
164213674|NCT02903914|593147827|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
164213675|NCT02903914|593147828|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
164213676|NCT02903914|593147829|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
164213677|NCT02903914|593147830|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
164213678|NCT02903914|593147831|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
164213679|NCT02903914|593147832|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
164213680|NCT02903914|593147825|FG000|Overall Study|Follow-up Did Not Occur|0|||
164213681|NCT02903914|593147826|FG001|Overall Study|Follow-up Did Not Occur|1|||
164213682|NCT02903914|593147827|FG002|Overall Study|Follow-up Did Not Occur|1|||
164213683|NCT02903914|593147828|FG003|Overall Study|Follow-up Did Not Occur|0|||
164213684|NCT02903914|593147829|FG004|Overall Study|Follow-up Did Not Occur|2|||
164213685|NCT02903914|593147830|FG005|Overall Study|Follow-up Did Not Occur|0|||
164213686|NCT02903914|593147831|FG006|Overall Study|Follow-up Did Not Occur|8|||
164213687|NCT02903914|593147832|FG007|Overall Study|Follow-up Did Not Occur|0|||
164213688|NCT02903914|593147825|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
164213689|NCT02903914|593147826|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
164213690|NCT02903914|593147827|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
164213691|NCT02903914|593147828|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
164213692|NCT02903914|593147829|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
164213693|NCT02903914|593147830|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
164213694|NCT02903914|593147831|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
164213695|NCT02903914|593147832|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
164213696|NCT02903914|593147825|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213697|NCT02903914|593147826|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213698|NCT02903914|593147827|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
164325764|NCT03610555|593567984|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
164213699|NCT02903914|593147828|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213700|NCT02903914|593147829|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213701|NCT02903914|593147830|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
164213702|NCT02903914|593147831|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213703|NCT02903914|593147832|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
164213704|NCT02903914|593147825|FG000|Overall Study|Clinical Disease Progression|0|||
164213705|NCT02903914|593147826|FG001|Overall Study|Clinical Disease Progression|0|||
164213706|NCT02903914|593147827|FG002|Overall Study|Clinical Disease Progression|2|||
164213707|NCT02903914|593147828|FG003|Overall Study|Clinical Disease Progression|0|||
164213708|NCT02903914|593147829|FG004|Overall Study|Clinical Disease Progression|0|||
164213709|NCT02903914|593147830|FG005|Overall Study|Clinical Disease Progression|0|||
164213710|NCT02903914|593147831|FG006|Overall Study|Clinical Disease Progression|0|||
164213711|NCT02903914|593147832|FG007|Overall Study|Clinical Disease Progression|0|||
164213712|NCT02903914|593147825|FG000|Overall Study|Completed Follow-up Period|0|||
164213713|NCT02903914|593147826|FG001|Overall Study|Completed Follow-up Period|0|||
164213714|NCT02903914|593147827|FG002|Overall Study|Completed Follow-up Period|6|||
164213715|NCT02903914|593147828|FG003|Overall Study|Completed Follow-up Period|2|||
164213716|NCT02903914|593147829|FG004|Overall Study|Completed Follow-up Period|1|||
164213717|NCT02903914|593147830|FG005|Overall Study|Completed Follow-up Period|0|||
164213718|NCT02903914|593147831|FG006|Overall Study|Completed Follow-up Period|9|||
164213719|NCT02903914|593147832|FG007|Overall Study|Completed Follow-up Period|1|||
164213720|NCT02903914|593147825|FG000|Overall Study|Taken off Treatment per Protocol|0|||
164213721|NCT02903914|593147826|FG001|Overall Study|Taken off Treatment per Protocol|0|||
164213722|NCT02903914|593147827|FG002|Overall Study|Taken off Treatment per Protocol|0|||
164213723|NCT02903914|593147828|FG003|Overall Study|Taken off Treatment per Protocol|0|||
164213724|NCT02903914|593147829|FG004|Overall Study|Taken off Treatment per Protocol|0|||
164213725|NCT02903914|593147830|FG005|Overall Study|Taken off Treatment per Protocol|1|||
164213726|NCT02903914|593147831|FG006|Overall Study|Taken off Treatment per Protocol|0|||
164213727|NCT02903914|593147832|FG007|Overall Study|Taken off Treatment per Protocol|0|||
164213728|NCT02903914|593147825|FG000|Overall Study|Refused Further Treatment/Contact|0|||
164213729|NCT02903914|593147826|FG001|Overall Study|Refused Further Treatment/Contact|0|||
164213730|NCT02903914|593147827|FG002|Overall Study|Refused Further Treatment/Contact|0|||
164213731|NCT02903914|593147828|FG003|Overall Study|Refused Further Treatment/Contact|0|||
164213732|NCT02903914|593147829|FG004|Overall Study|Refused Further Treatment/Contact|0|||
164213733|NCT02903914|593147830|FG005|Overall Study|Refused Further Treatment/Contact|0|||
164213734|NCT02903914|593147831|FG006|Overall Study|Refused Further Treatment/Contact|1|||
164325765|NCT03610555|593567985|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
164325766|NCT01892722|593567986|FG000|Overall Study|Protocol deviation|0|||
164325767|NCT01892722|593567987|FG001|Overall Study|Protocol deviation|1|||
164325768|NCT01892722|593567986|FG000|Overall Study|Administrative problems|0|||
164213735|NCT02903914|593147832|FG007|Overall Study|Refused Further Treatment/Contact|0|||
164325769|NCT01892722|593567987|FG001|Overall Study|Administrative problems|1|||
164325770|NCT01892722|593567986|FG000|Overall Study|Patient/guardian decision|0|||
164325771|NCT01892722|593567987|FG001|Overall Study|Patient/guardian decision|2|||
164325772|NCT01892722|593567986|FG000|Overall Study|Physician Decision|1|||
164325773|NCT01892722|593567987|FG001|Overall Study|Physician Decision|2|||
164325774|NCT01892722|593567986|FG000|Overall Study|Adverse Event|3|||
164325775|NCT01892722|593567987|FG001|Overall Study|Adverse Event|2|||
164325776|NCT01892722|593567986|FG000|Overall Study|Lack of Efficacy|0|||
164325777|NCT01892722|593567987|FG001|Overall Study|Lack of Efficacy|7|||
164325778|NCT01892722|593567986|FG000|Overall Study|Withdrawal by Subject|3|||
164325779|NCT01892722|593567987|FG001|Overall Study|Withdrawal by Subject|5|||
164325780|NCT05217927|593567988|FG000|DBT Phase|Adverse Event|7|||
164325781|NCT05217927|593567989|FG001|DBT Phase|Adverse Event|2|||
164325782|NCT05217927|593567990|FG002|DBT Phase|Adverse Event|5|||
164325783|NCT05217927|593567988|FG000|DBT Phase|Lack of Efficacy|1|||
164325784|NCT05217927|593567989|FG001|DBT Phase|Lack of Efficacy|0|||
164325785|NCT05217927|593567990|FG002|DBT Phase|Lack of Efficacy|0|||
164325786|NCT05217927|593567988|FG000|DBT Phase|Lost to Follow-up|0|||
164325787|NCT05217927|593567989|FG001|DBT Phase|Lost to Follow-up|2|||
164325788|NCT05217927|593567990|FG002|DBT Phase|Lost to Follow-up|0|||
164325789|NCT05217927|593567988|FG000|DBT Phase|Non-compliance|1|||
164325790|NCT05217927|593567989|FG001|DBT Phase|Non-compliance|0|||
164325791|NCT05217927|593567990|FG002|DBT Phase|Non-compliance|0|||
164325792|NCT05217927|593567988|FG000|DBT Phase|Pregnancy|0|||
164325793|NCT05217927|593567989|FG001|DBT Phase|Pregnancy|0|||
163876326|NCT00393484|591914839|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
163876327|NCT00393484|591914840|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
164325794|NCT05217927|593567990|FG002|DBT Phase|Pregnancy|1|||
163876328|NCT00393484|591914839|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
163876329|NCT00393484|591914840|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
164213736|NCT02903914|593147825|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164325795|NCT05217927|593567988|FG000|DBT Phase|Protocol Violation|0|||
164325796|NCT05217927|593567989|FG001|DBT Phase|Protocol Violation|2|||
164325797|NCT05217927|593567990|FG002|DBT Phase|Protocol Violation|1|||
164325798|NCT05217927|593567988|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
164213737|NCT02903914|593147826|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213738|NCT02903914|593147827|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213739|NCT02903914|593147828|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164325799|NCT05217927|593567989|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
164325800|NCT05217927|593567990|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
164325801|NCT05217927|593567988|FG000|DBT Phase|Withdrawal of consent|8|||
164325802|NCT05217927|593567989|FG001|DBT Phase|Withdrawal of consent|5|||
164325803|NCT05217927|593567990|FG002|DBT Phase|Withdrawal of consent|7|||
164325804|NCT05217927|593567988|FG000|DBT Phase|Other|7|||
164325805|NCT05217927|593567989|FG001|DBT Phase|Other|3|||
164325806|NCT05217927|593567990|FG002|DBT Phase|Other|4|||
164325807|NCT05217927|593567988|FG000|DBT Phase|Randomized, not treated|2|||
164325808|NCT05217927|593567989|FG001|DBT Phase|Randomized, not treated|3|||
164325809|NCT05217927|593567990|FG002|DBT Phase|Randomized, not treated|2|||
164325810|NCT05217927|593567988|FG000|OLE Phase|Adverse Event|4|||
164325811|NCT05217927|593567989|FG001|OLE Phase|Adverse Event|1|||
164325812|NCT05217927|593567990|FG002|OLE Phase|Adverse Event|1|||
164325813|NCT05217927|593567988|FG000|OLE Phase|Extension phase eligibility failure|1|||
164325814|NCT05217927|593567989|FG001|OLE Phase|Extension phase eligibility failure|0|||
164325815|NCT05217927|593567990|FG002|OLE Phase|Extension phase eligibility failure|0|||
164325816|NCT05217927|593567988|FG000|OLE Phase|Lost to Follow-up|1|||
164325817|NCT05217927|593567989|FG001|OLE Phase|Lost to Follow-up|2|||
164325818|NCT05217927|593567990|FG002|OLE Phase|Lost to Follow-up|1|||
164325819|NCT05217927|593567988|FG000|OLE Phase|Non-compliance|0|||
164325820|NCT05217927|593567989|FG001|OLE Phase|Non-compliance|0|||
164325821|NCT05217927|593567990|FG002|OLE Phase|Non-compliance|1|||
164325822|NCT05217927|593567988|FG000|OLE Phase|Other|3|||
164325823|NCT05217927|593567989|FG001|OLE Phase|Other|5|||
164325824|NCT05217927|593567990|FG002|OLE Phase|Other|4|||
164325825|NCT05217927|593567988|FG000|OLE Phase|Withdrawal of consent|3|||
164325826|NCT05217927|593567989|FG001|OLE Phase|Withdrawal of consent|1|||
164325827|NCT05217927|593567990|FG002|OLE Phase|Withdrawal of consent|5|||
164325828|NCT00588952|593568957|FG000|Overall Study|Adverse Event|0|||
164325829|NCT00588952|593568958|FG001|Overall Study|Adverse Event|2|||
164325830|NCT00588952|593568957|FG000|Overall Study|Withdrawal by Subject|3|||
164325831|NCT00588952|593568958|FG001|Overall Study|Withdrawal by Subject|5|||
164325832|NCT03560739|593568960|FG000|Overall Study|Adverse Event|0|||
164325833|NCT03560739|593568961|FG001|Overall Study|Adverse Event|1|||
164325834|NCT03560739|593568962|FG002|Overall Study|Adverse Event|0|||
164325835|NCT03560739|593568963|FG003|Overall Study|Adverse Event|0|||
164325836|NCT01362595|593568964|FG000|Overall Study|Screen failure|10|||
164325837|NCT01362595|593568964|FG000|Overall Study|Withdrawal by Subject|2|||
164325838|NCT00959374|593568965|FG000|Overall Study|Withdrawal by Subject|2|||
164325839|NCT00959374|593568965|FG000|Overall Study|Lost to Follow-up|14|||
164325840|NCT00959374|593568965|FG000|Overall Study|Death|1|||
164325841|NCT00959374|593568965|FG000|Overall Study|Protocol Violation|1|||
164325842|NCT00959374|593568965|FG000|Overall Study|Implant Removed/Not Replaced|4|||
164325843|NCT00959374|593568965|FG000|Overall Study|Physician Decision|1|||
164325844|NCT02448680|593568966|FG000|Overall Study|Physician Decision|1|||
164325845|NCT02448680|593568967|FG001|Overall Study|Physician Decision|1|||
164325846|NCT02448680|593568966|FG000|Overall Study|Withdrawal by Subject|0|||
164325847|NCT02448680|593568967|FG001|Overall Study|Withdrawal by Subject|2|||
164325848|NCT01739400|593568968|FG000|Overall Study|Physician Decision|3|||
164325849|NCT01739400|593568969|FG001|Overall Study|Physician Decision|0|||
164325850|NCT01739400|593568968|FG000|Overall Study|Lost to Follow-up|2|||
164325851|NCT01739400|593568969|FG001|Overall Study|Lost to Follow-up|0|||
164325852|NCT01739400|593568968|FG000|Overall Study|Death|5|||
164325853|NCT01739400|593568969|FG001|Overall Study|Death|2|||
164325854|NCT01739400|593568968|FG000|Overall Study|Withdrawal by Subject|7|||
164325855|NCT01739400|593568969|FG001|Overall Study|Withdrawal by Subject|7|||
164325856|NCT01736657|593568970|FG000|Overall Study|insufficient vascular access|1|||
164325857|NCT03350984|593568971|FG000|Overall Study|Death|1|||
164325858|NCT03350984|593568972|FG001|Overall Study|Death|0|||
164325859|NCT03350984|593568971|FG000|Overall Study|Lost to Follow-up|5|||
164325860|NCT03350984|593568972|FG001|Overall Study|Lost to Follow-up|6|||
164325861|NCT03350984|593568971|FG000|Overall Study|Protocol Violation|1|||
164325862|NCT03350984|593568972|FG001|Overall Study|Protocol Violation|2|||
164325863|NCT03350984|593568971|FG000|Overall Study|Physician Decision|1|||
164325864|NCT03350984|593568972|FG001|Overall Study|Physician Decision|0|||
164325865|NCT00642473|593568981|FG000|Overall Study|Withdrawal by Subject|0|||
164325866|NCT00642473|593568982|FG001|Overall Study|Withdrawal by Subject|5|||
164325867|NCT00642473|593568981|FG000|Overall Study|Progression or death|2|||
164325868|NCT00642473|593568982|FG001|Overall Study|Progression or death|4|||
164325869|NCT00642473|593568981|FG000|Overall Study|Other|2|||
163980744|NCT01709149|592299648|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
164325870|NCT00642473|593568982|FG001|Overall Study|Other|2|||
164325871|NCT04533880|593568983|FG000|Overall Study|Lost to Follow-up|0|||
164325872|NCT04533880|593568984|FG001|Overall Study|Lost to Follow-up|1|||
164325873|NCT04533880|593568985|FG002|Overall Study|Lost to Follow-up|1|||
164325874|NCT02284178|593568987|FG000|Overall Study|Met exclusion criteria|49|||
164325875|NCT02284178|593568988|FG001|Overall Study|Met exclusion criteria|54|||
164325876|NCT01741012|593568989|FG000|Overall Study|Lost to Follow-up|1|||
164325877|NCT01741012|593568989|FG000|Overall Study|Withdrawal by Subject|2|||
164325878|NCT04123665|593568990|FG000|Overall Study|Withdrawal by Subject|7|||
164325879|NCT04123665|593568991|FG001|Overall Study|Withdrawal by Subject|0|||
164325880|NCT04123665|593568990|FG000|Overall Study|Lost to Follow-up|1|||
164325881|NCT04123665|593568991|FG001|Overall Study|Lost to Follow-up|0|||
164325882|NCT01711879|593568994|FG000|Overall Study|Death|1|||
164325883|NCT01711879|593568995|FG001|Overall Study|Death|0|||
164325884|NCT00958789|593568999|FG000|Overall Study|Death|5|||
164325885|NCT00958789|593568999|FG000|Overall Study|Lost to Follow-up|14|||
164325886|NCT00958789|593568999|FG000|Overall Study|Withdrawal by Subject|17|||
163876330|NCT00393484|591914839|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
163876331|NCT00393484|591914840|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
163876332|NCT00393484|591914839|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
163876333|NCT00393484|591914840|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
163876334|NCT00393484|591914839|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
163876335|NCT00393484|591914840|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
163876336|NCT00393484|591914839|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
163876337|NCT00393484|591914840|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
163876338|NCT00393484|591914839|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
163876339|NCT00393484|591914840|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
163876340|NCT01976312|591914851|FG000|Overall Study|Pregnancy|0|||
163876341|NCT01976312|591914852|FG001|Overall Study|Pregnancy|1|||
163876342|NCT01976312|591914851|FG000|Overall Study|Lost to Follow-up|2|||
163876343|NCT01976312|591914852|FG001|Overall Study|Lost to Follow-up|0|||
163876344|NCT01976312|591914851|FG000|Overall Study|Withdrawal by Subject|7|||
163876345|NCT01976312|591914852|FG001|Overall Study|Withdrawal by Subject|2|||
163876346|NCT01976312|591914851|FG000|Overall Study|Adverse Event|6|||
163876347|NCT01976312|591914852|FG001|Overall Study|Adverse Event|6|||
163876348|NCT01976312|591914851|FG000|Overall Study|Protocol Violation|2|||
163876349|NCT01976312|591914852|FG001|Overall Study|Protocol Violation|0|||
163876350|NCT02556138|591914853|FG000|Overall Study|Withdrawal by Subject|1|||
163876351|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
163876352|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
163876353|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
163876354|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
163876355|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
163876356|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
163876357|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
163876358|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
163876359|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
163876360|NCT03939312|591914854|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
164137868|NCT02640053|592866950|FG000|Overall Study|Adverse Event|1|||
164137869|NCT02640053|592866951|FG001|Overall Study|Adverse Event|1|||
164137870|NCT02640053|592866950|FG000|Overall Study|Alternative Therapy|1|||
164137871|NCT02640053|592866951|FG001|Overall Study|Alternative Therapy|1|||
164137872|NCT02640053|592866950|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
164137873|NCT02640053|592866951|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
164137874|NCT02754856|592866953|FG000|Overall Study|Withdrawal by Subject|1|||
164137875|NCT00530218|592866954|FG000|Overall Study|CMV Not Detected|13|||
164137876|NCT00530218|592866954|FG000|Overall Study|Death|12|||
164137877|NCT03477903|592866959|FG000|Overall Study|Study Terminated by Sponsor|1|||
164137878|NCT00407758|592866960|FG000|Overall Study|ineligible -improper prior treatment|1|||
164137879|NCT00750308|592866973|FG000|First Treatment|Adverse Event|0|||
164137880|NCT00750308|592866974|FG001|First Treatment|Adverse Event|1|||
164137881|NCT00750308|592866975|FG002|First Treatment|Adverse Event|0|||
164137882|NCT00750308|592866976|FG003|First Treatment|Adverse Event|0|||
164137883|NCT00750308|592866977|FG004|First Treatment|Adverse Event|0|||
164137884|NCT00750308|592866978|FG005|First Treatment|Adverse Event|0|||
164137885|NCT00750308|592866979|FG006|First Treatment|Adverse Event|0|||
164137886|NCT00750308|592866980|FG007|First Treatment|Adverse Event|0|||
164137887|NCT00750308|592866981|FG008|First Treatment|Adverse Event|0|||
164137888|NCT00750308|592866982|FG009|First Treatment|Adverse Event|0|||
164137889|NCT00750308|592866983|FG010|First Treatment|Adverse Event|1|||
164137890|NCT00750308|592866984|FG011|First Treatment|Adverse Event|1|||
164137891|NCT00750308|592866973|FG000|First Treatment|Withdrawal by Subject|0|||
164137892|NCT00750308|592866974|FG001|First Treatment|Withdrawal by Subject|0|||
164137893|NCT00750308|592866975|FG002|First Treatment|Withdrawal by Subject|0|||
164137894|NCT00750308|592866976|FG003|First Treatment|Withdrawal by Subject|1|||
164137895|NCT00750308|592866977|FG004|First Treatment|Withdrawal by Subject|0|||
164137896|NCT00750308|592866978|FG005|First Treatment|Withdrawal by Subject|0|||
164137897|NCT00750308|592866979|FG006|First Treatment|Withdrawal by Subject|0|||
164137898|NCT00750308|592866980|FG007|First Treatment|Withdrawal by Subject|1|||
164137899|NCT00750308|592866981|FG008|First Treatment|Withdrawal by Subject|0|||
164137900|NCT00750308|592866982|FG009|First Treatment|Withdrawal by Subject|0|||
164137901|NCT00750308|592866983|FG010|First Treatment|Withdrawal by Subject|0|||
164137902|NCT00750308|592866984|FG011|First Treatment|Withdrawal by Subject|0|||
164137903|NCT00750308|592866973|FG000|Second Treatment|Adverse Event|0|||
164137904|NCT00750308|592866974|FG001|Second Treatment|Adverse Event|0|||
164213740|NCT02903914|593147829|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213741|NCT02903914|593147830|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213742|NCT02903914|593147831|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
164213743|NCT02903914|593147832|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
164213744|NCT02406612|593147844|FG000|Overall Study|Screening Failure|3|||
164213745|NCT02406612|593147845|FG001|Overall Study|Screening Failure|0|||
164213746|NCT02406612|593147844|FG000|Overall Study|Intra-procedural Exclusion|1|||
164213747|NCT02406612|593147845|FG001|Overall Study|Intra-procedural Exclusion|3|||
164213748|NCT02406612|593147844|FG000|Overall Study|Guidewire Failure|0|||
164213749|NCT02406612|593147845|FG001|Overall Study|Guidewire Failure|1|||
164213750|NCT02830087|593147846|FG000|Overall Study|No study staff to follow-up patients|4|||
164213751|NCT02830087|593147847|FG001|Overall Study|No study staff to follow-up patients|4|||
164213752|NCT02830087|593147848|FG002|Overall Study|No study staff to follow-up patients|4|||
164213753|NCT02830087|593147849|FG003|Overall Study|No study staff to follow-up patients|3|||
164213754|NCT02830087|593147850|FG004|Overall Study|No study staff to follow-up patients|3|||
164213755|NCT02830087|593147851|FG005|Overall Study|No study staff to follow-up patients|3|||
164213756|NCT03483012|593147855|FG000|Overall Study|Lack of Efficacy|6|||
164213757|NCT02900976|593147856|FG000|Overall Study|Adverse Event|0|||
164213758|NCT02900976|593147857|FG001|Overall Study|Adverse Event|1|||
164213759|NCT02900976|593147856|FG000|Overall Study|Physician Decision|0|||
164213760|NCT02900976|593147857|FG001|Overall Study|Physician Decision|2|||
164213761|NCT02900976|593147856|FG000|Overall Study|Progressive disease|0|||
164213762|NCT02900976|593147857|FG001|Overall Study|Progressive disease|6|||
164213763|NCT03611946|593147860|FG000|Overall Study|Withdrawal by Subject|0|||
164213764|NCT03611946|593147861|FG001|Overall Study|Withdrawal by Subject|0|||
164213765|NCT03611946|593147862|FG002|Overall Study|Withdrawal by Subject|1|||
164213766|NCT03611946|593147863|FG003|Overall Study|Withdrawal by Subject|0|||
164213767|NCT05177094|593149265|FG000|Overall Study|Adverse Event|5|||
164213768|NCT05177094|593149266|FG001|Overall Study|Adverse Event|5|||
164213769|NCT05177094|593149265|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
164213770|NCT05177094|593149266|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
164213771|NCT05177094|593149265|FG000|Overall Study|Protocol Deviation|3|||
164213772|NCT05177094|593149266|FG001|Overall Study|Protocol Deviation|0|||
164213773|NCT05177094|593149265|FG000|Overall Study|Withdrawal by Subject|6|||
164213774|NCT05177094|593149266|FG001|Overall Study|Withdrawal by Subject|3|||
164213775|NCT05177094|593149265|FG000|Overall Study|Participant could not tolerate long study visits|1|||
164213776|NCT05177094|593149266|FG001|Overall Study|Participant could not tolerate long study visits|0|||
164213777|NCT02737618|593149267|FG000|Overall Study|Withdrawal by Subject|9|||
164213778|NCT03487445|593149273|FG000|Randomization|Not treated for administrative reasons|1|||
164213779|NCT03487445|593149274|FG001|Randomization|Not treated for administrative reasons|0|||
164213780|NCT01695746|593149279|FG000|Overall Study|Adverse Event|1|||
164213781|NCT01695746|593149279|FG000|Overall Study|Non-compliance by the participant|3|||
164213782|NCT01695746|593149279|FG000|Overall Study|Protocol Violation|5|||
164213783|NCT01695746|593149279|FG000|Overall Study|Participant not willing to participate|3|||
164213784|NCT04132050|593149287|FG000|Period I (Double-blind Period)|Adverse Event|3|||
164213785|NCT04132050|593149288|FG001|Period I (Double-blind Period)|Adverse Event|0|||
164213786|NCT04132050|593149287|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
164213787|NCT04132050|593149288|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
164213788|NCT04132050|593149287|FG000|R788 Treatment Period|Adverse Event|5|||
164213789|NCT04132050|593149288|FG001|R788 Treatment Period|Adverse Event|0|||
164213790|NCT04132050|593149287|FG000|R788 Treatment Period|Lack of Efficacy|5|||
164213791|NCT04132050|593149288|FG001|R788 Treatment Period|Lack of Efficacy|0|||
164213792|NCT04132050|593149287|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
164213793|NCT04132050|593149288|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
164213794|NCT03506477|593149289|FG000|Overall Study|Withdrawal by Subject|1|||
164213795|NCT03506477|593149290|FG001|Overall Study|Withdrawal by Subject|0|||
164213796|NCT03462680|593149291|FG000|Overall Study|Withdrawal by Subject|3|||
164213797|NCT03462680|593149292|FG001|Overall Study|Withdrawal by Subject|5|||
164213798|NCT02516241|593149293|FG000|Overall Study|Death|255|||
164213799|NCT02516241|593149294|FG001|Overall Study|Death|262|||
164213800|NCT02516241|593149295|FG002|Overall Study|Death|270|||
163876361|NCT03939312|591914854|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
163876362|NCT03939312|591914854|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
163876363|NCT01609218|591914856|FG000|Period 1|Adverse Event|3|||
164213801|NCT02516241|593149293|FG000|Overall Study|Lost to Follow-up|1|||
164213802|NCT02516241|593149294|FG001|Overall Study|Lost to Follow-up|1|||
164213803|NCT02516241|593149295|FG002|Overall Study|Lost to Follow-up|3|||
164213804|NCT02516241|593149293|FG000|Overall Study|Withdrawal by Subject|2|||
164213805|NCT02516241|593149294|FG001|Overall Study|Withdrawal by Subject|7|||
164213806|NCT02516241|593149295|FG002|Overall Study|Withdrawal by Subject|12|||
164213807|NCT02516241|593149293|FG000|Overall Study|participants ongoing at data cut-off|84|||
164213808|NCT02516241|593149294|FG001|Overall Study|participants ongoing at data cut-off|76|||
164213809|NCT02516241|593149295|FG002|Overall Study|participants ongoing at data cut-off|59|||
164213810|NCT00462462|593149297|FG000|Overall Study|Physician Decision|0|||
164213811|NCT00462462|593149298|FG001|Overall Study|Physician Decision|1|||
164213812|NCT01163617|593149299|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213813|NCT01163617|593149300|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
164213814|NCT01163617|593149301|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213815|NCT01163617|593149302|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213816|NCT01163617|593149303|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213817|NCT01163617|593149304|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213818|NCT01163617|593149305|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213819|NCT01163617|593149306|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
164213820|NCT01163617|593149299|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213821|NCT01163617|593149300|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
164213822|NCT01163617|593149301|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213823|NCT01163617|593149302|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213824|NCT01163617|593149303|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213825|NCT01163617|593149304|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213826|NCT01163617|593149305|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213827|NCT01163617|593149306|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
164213828|NCT01163617|593149299|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213829|NCT01163617|593149300|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213830|NCT01163617|593149301|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
164213831|NCT01163617|593149302|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213832|NCT01163617|593149303|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213833|NCT01163617|593149304|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213834|NCT01163617|593149305|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213835|NCT01163617|593149306|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
164213836|NCT02394756|593149307|FG000|Period 1|Lens Discomfort|0|||
164213837|NCT02394756|593149308|FG001|Period 1|Lens Discomfort|0|||
164213838|NCT02394756|593149309|FG002|Period 1|Lens Discomfort|0|||
164213839|NCT02394756|593149310|FG003|Period 1|Lens Discomfort|0|||
164213840|NCT02394756|593149311|FG004|Period 1|Lens Discomfort|0|||
164213841|NCT02394756|593149312|FG005|Period 1|Lens Discomfort|1|||
164213842|NCT02394756|593149307|FG000|Period 1|Withdrawal by Subject|0|||
164213843|NCT02394756|593149308|FG001|Period 1|Withdrawal by Subject|1|||
164213844|NCT02394756|593149309|FG002|Period 1|Withdrawal by Subject|1|||
164213845|NCT02394756|593149310|FG003|Period 1|Withdrawal by Subject|1|||
164213846|NCT02394756|593149311|FG004|Period 1|Withdrawal by Subject|0|||
164213847|NCT02394756|593149312|FG005|Period 1|Withdrawal by Subject|0|||
164213848|NCT02394756|593149307|FG000|Period 2|Unsatisfactory Visual Response|0|||
164213849|NCT02394756|593149308|FG001|Period 2|Unsatisfactory Visual Response|0|||
164213850|NCT02394756|593149309|FG002|Period 2|Unsatisfactory Visual Response|0|||
164213851|NCT02394756|593149310|FG003|Period 2|Unsatisfactory Visual Response|0|||
164213852|NCT02394756|593149311|FG004|Period 2|Unsatisfactory Visual Response|1|||
164213853|NCT02394756|593149312|FG005|Period 2|Unsatisfactory Visual Response|0|||
164213854|NCT03018938|593149313|FG000|Overall Study|Death|0|||
164213855|NCT03018938|593149314|FG001|Overall Study|Death|1|||
164213856|NCT03018938|593149313|FG000|Overall Study|Lost to Follow-up|21|||
164213857|NCT03018938|593149314|FG001|Overall Study|Lost to Follow-up|32|||
164213858|NCT03018938|593149313|FG000|Overall Study|Withdrawal by Subject|38|||
164213859|NCT03018938|593149314|FG001|Overall Study|Withdrawal by Subject|45|||
164213860|NCT03018938|593149313|FG000|Overall Study|Physician Decision|3|||
164213861|NCT03018938|593149314|FG001|Overall Study|Physician Decision|2|||
164213862|NCT03018938|593149313|FG000|Overall Study|Sponsor Decision|0|||
164213863|NCT03018938|593149314|FG001|Overall Study|Sponsor Decision|1|||
164213864|NCT03018938|593149313|FG000|Overall Study|Screen failure-After randomization|4|||
164213865|NCT03018938|593149314|FG001|Overall Study|Screen failure-After randomization|2|||
164213866|NCT03018938|593149313|FG000|Overall Study|Not recorded|0|||
164213867|NCT03018938|593149314|FG001|Overall Study|Not recorded|2|||
164213868|NCT00191100|593149315|FG000|Overall Study|Adverse Event|18|||
164213869|NCT00191100|593149316|FG001|Overall Study|Adverse Event|1|||
164213870|NCT00191100|593149315|FG000|Overall Study|Lost to Follow-up|2|||
164325887|NCT00958789|593568999|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
164213871|NCT00191100|593149316|FG001|Overall Study|Lost to Follow-up|0|||
164213872|NCT00191100|593149315|FG000|Overall Study|Patient Moved|0|||
164213873|NCT00191100|593149316|FG001|Overall Study|Patient Moved|1|||
164213874|NCT00191100|593149315|FG000|Overall Study|Withdrawal by Subject|9|||
164213875|NCT00191100|593149316|FG001|Overall Study|Withdrawal by Subject|3|||
164213876|NCT00191100|593149315|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
164213877|NCT00191100|593149316|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
164213878|NCT00191100|593149315|FG000|Overall Study|Clinical Relapse|2|||
164213879|NCT00191100|593149316|FG001|Overall Study|Clinical Relapse|1|||
164213880|NCT00191100|593149315|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
164213881|NCT00191100|593149316|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
164213882|NCT00191100|593149315|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
164213883|NCT00191100|593149316|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
164213884|NCT00191100|593149315|FG000|Overall Study|Physician Decision|3|||
164213885|NCT00191100|593149316|FG001|Overall Study|Physician Decision|1|||
164213886|NCT00191100|593149315|FG000|Overall Study|Death from Study Drug Toxicity|2|||
164213887|NCT00191100|593149316|FG001|Overall Study|Death from Study Drug Toxicity|0|||
164213888|NCT00191100|593149315|FG000|Overall Study|Protocol Violation|1|||
164213889|NCT00191100|593149316|FG001|Overall Study|Protocol Violation|1|||
164213890|NCT00191100|593149315|FG000|Overall Study|Death from Other Cause|1|||
164213891|NCT00191100|593149316|FG001|Overall Study|Death from Other Cause|0|||
164213892|NCT00191100|593149315|FG000|Overall Study|Reason Not Specified|0|||
164213893|NCT00191100|593149316|FG001|Overall Study|Reason Not Specified|1|||
164213894|NCT03069989|593149334|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
164213895|NCT03069989|593149335|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
164213896|NCT01127061|593150760|FG000|Overall Study|Lost to Follow-up|7|||
164213897|NCT01127061|593150761|FG001|Overall Study|Lost to Follow-up|10|||
164213898|NCT01127061|593150760|FG000|Overall Study|Physician Decision|3|||
164213899|NCT01127061|593150761|FG001|Overall Study|Physician Decision|3|||
164213900|NCT03921541|593150764|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
164213901|NCT03921541|593150765|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
164213902|NCT00003456|593150766|FG000|Overall Study|Not evaluable|8|||
164213903|NCT00420407|593150768|FG000|Overall Study|Lost to Follow-up|0|||
164213904|NCT00420407|593150769|FG001|Overall Study|Lost to Follow-up|3|||
164213905|NCT00420407|593150768|FG000|Overall Study|Physician Decision|2|||
164213906|NCT00420407|593150769|FG001|Overall Study|Physician Decision|1|||
164213907|NCT00420407|593150768|FG000|Overall Study|subject identified as detainee|1|||
164213908|NCT00420407|593150769|FG001|Overall Study|subject identified as detainee|0|||
164213909|NCT00420407|593150768|FG000|Overall Study|subject identified as Jehovah's witness|1|||
164213910|NCT00420407|593150769|FG001|Overall Study|subject identified as Jehovah's witness|0|||
164213911|NCT00420407|593150768|FG000|Overall Study|Withdrawal by Subject|0|||
164213912|NCT00420407|593150769|FG001|Overall Study|Withdrawal by Subject|2|||
164213913|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
164213914|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
164213915|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
164213916|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
164213917|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
164213918|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
164213919|NCT04633447|593150772|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
164213920|NCT04633447|593150773|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
164213921|NCT04633447|593150772|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
164213922|NCT04633447|593150773|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
164213923|NCT04633447|593150772|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
164213924|NCT04633447|593150773|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
164213925|NCT04333498|593150774|FG000|Overall Study|Lost to Follow-up|1|||
164213926|NCT04333498|593150775|FG001|Overall Study|Lost to Follow-up|0|||
164213927|NCT04333498|593150774|FG000|Overall Study|Lost to Follow-up|0|||
164213928|NCT04333498|593150775|FG001|Overall Study|Lost to Follow-up|1|||
164213929|NCT01565694|593150776|FG000|Dose-Titration Period|Adverse Event|4|||
164213930|NCT01565694|593150776|FG000|Dose-Titration Period|Protocol Violation|10|||
164213931|NCT01565694|593150776|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
164213932|NCT05399771|593150778|FG000|Overall Study|Physician Decision|3|||
164213933|NCT05399771|593150778|FG000|Overall Study|Adverse Event|1|||
164213934|NCT04766333|593150783|FG000|Overall Study|Lost to Follow-up|40|||
164213935|NCT04766333|593150784|FG001|Overall Study|Lost to Follow-up|826|||
164213936|NCT03234881|593150785|FG000|Overall Study|Lost to Follow-up|9|||
164213937|NCT03234881|593150786|FG001|Overall Study|Lost to Follow-up|3|||
164213938|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
164213939|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
164325888|NCT00958789|593568999|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
164325889|NCT00958789|593568999|FG000|Overall Study|Subject terminated|2|||
164213940|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
164325890|NCT00958789|593568999|FG000|Overall Study|Revision|7|||
164325891|NCT03183778|593569004|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
164213941|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
164213942|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
164213943|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
164213944|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213945|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213946|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213947|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213948|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
164213949|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
164213950|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213951|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213952|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213953|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213954|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
164213955|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
164213956|NCT00541229|593150787|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
164213957|NCT00541229|593150788|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
164213958|NCT00541229|593150789|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
164213959|NCT00541229|593150790|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
164213960|NCT00541229|593150791|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
164213961|NCT00541229|593150792|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
164213962|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
164213963|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
164213964|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
164213965|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
164213966|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
164213967|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
164213968|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
164213969|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
164213970|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
164213971|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
164213972|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
164213973|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
164213974|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213975|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213976|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213977|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213978|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
164213979|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
164213980|NCT00541229|593150787|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
164213981|NCT00541229|593150788|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
164213982|NCT00541229|593150789|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
164213983|NCT00541229|593150790|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
164213984|NCT00541229|593150791|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
164213985|NCT00541229|593150792|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
164213986|NCT00541229|593150787|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
164213987|NCT00541229|593150788|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
164213988|NCT00541229|593150789|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
164213989|NCT00541229|593150790|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
164213990|NCT00541229|593150791|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
164213991|NCT00541229|593150792|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
164213992|NCT00541229|593150787|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
164213993|NCT00541229|593150788|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213994|NCT00541229|593150789|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213995|NCT00541229|593150790|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213996|NCT00541229|593150791|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
164213997|NCT00541229|593150792|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
164213998|NCT00541229|593150787|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
164213999|NCT00541229|593150788|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214000|NCT00541229|593150789|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214001|NCT00541229|593150790|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214002|NCT00541229|593150791|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
164214003|NCT00541229|593150792|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
164325892|NCT01466179|593569005|FG000|Overall Study|Ongoing in core study|2|||
164325893|NCT01466179|593569005|FG000|Overall Study|Physician Decision|46|||
164325894|NCT01466179|593569005|FG000|Overall Study|Progressive disease|43|||
164214004|NCT00541229|593150787|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214005|NCT00541229|593150788|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214006|NCT00541229|593150789|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164325895|NCT01466179|593569005|FG000|Overall Study|Adverse Event|32|||
164325896|NCT01466179|593569005|FG000|Overall Study|Disease relapse|23|||
164214007|NCT00541229|593150790|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214008|NCT00541229|593150791|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
164214009|NCT00541229|593150792|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
164214010|NCT00541229|593150787|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
164214011|NCT00541229|593150788|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
164214012|NCT00541229|593150789|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
164214013|NCT00541229|593150790|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
164214014|NCT00541229|593150791|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
164214015|NCT00541229|593150792|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
164214016|NCT00541229|593150787|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
164214017|NCT00541229|593150788|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
164214018|NCT00541229|593150789|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
164214019|NCT00541229|593150790|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
164214020|NCT00541229|593150791|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
164214021|NCT00541229|593150792|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
164214022|NCT00541229|593150787|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214023|NCT00541229|593150788|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214024|NCT00541229|593150789|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214025|NCT00541229|593150790|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214026|NCT00541229|593150791|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
164214027|NCT00541229|593150792|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
164214028|NCT00541229|593150787|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214029|NCT00541229|593150788|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214030|NCT00541229|593150789|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
164214031|NCT00541229|593150790|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214032|NCT00541229|593150791|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214033|NCT00541229|593150792|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
164214034|NCT03807843|593150793|FG000|Overall Study|Lost to Follow-up|1|||
164214035|NCT03807843|593150794|FG001|Overall Study|Lost to Follow-up|0|||
164214036|NCT01312129|593150795|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
164214037|NCT01312129|593150796|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
164214038|NCT02397837|593150805|FG000|Overall Study|Withdrawal by Subject|6|||
164214039|NCT02397837|593150806|FG001|Overall Study|Withdrawal by Subject|5|||
164214040|NCT02397837|593150805|FG000|Overall Study|Physician Decision|1|||
164214041|NCT02397837|593150806|FG001|Overall Study|Physician Decision|1|||
164214042|NCT05276804|593150813|FG000|Overall Study|screen failure|23|||
164214043|NCT05276804|593150814|FG001|Overall Study|screen failure|0|||
164214044|NCT02827708|593150815|FG000|Overall Study|Lost to Follow-up|3|||
164214045|NCT02827708|593150816|FG001|Overall Study|Lost to Follow-up|1|||
164214046|NCT02827708|593150815|FG000|Overall Study|Withdrawal by Subject|1|||
164214047|NCT02827708|593150816|FG001|Overall Study|Withdrawal by Subject|2|||
164214048|NCT02827708|593150815|FG000|Overall Study|Death|1|||
164214049|NCT02827708|593150816|FG001|Overall Study|Death|2|||
164214050|NCT00407511|593150818|FG000|Overall Study|Adverse Event|9|||
164214051|NCT00407511|593150818|FG000|Overall Study|Lost to Follow-up|4|||
164214052|NCT00407511|593150818|FG000|Overall Study|Other|5|||
164214053|NCT00407511|593150818|FG000|Overall Study|Withdrawal by Subject|4|||
164214054|NCT05059080|593150821|FG000|Overall Study|Withdrawal by Subject|3|||
164214055|NCT05059080|593150821|FG000|Overall Study|Study Terminated by Sponsor|64|||
164214056|NCT00263562|593150822|FG000|Overall Study|Protocol Violation|3|||
164214057|NCT00263562|593150823|FG001|Overall Study|Protocol Violation|0|||
164214058|NCT01047501|593150824|FG000|Overall Study|Adverse Event|7|||
164214059|NCT01047501|593150825|FG001|Overall Study|Adverse Event|8|||
164214060|NCT01047501|593150826|FG002|Overall Study|Adverse Event|5|||
164214061|NCT01047501|593150824|FG000|Overall Study|Withdrew Consent|6|||
164214062|NCT01047501|593150825|FG001|Overall Study|Withdrew Consent|2|||
164214063|NCT01047501|593150826|FG002|Overall Study|Withdrew Consent|4|||
164214064|NCT01047501|593150824|FG000|Overall Study|Lost to Follow-up|0|||
164214065|NCT01047501|593150825|FG001|Overall Study|Lost to Follow-up|1|||
164214066|NCT01047501|593150826|FG002|Overall Study|Lost to Follow-up|1|||
164214067|NCT01047501|593150824|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
164214068|NCT01047501|593150825|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
164214069|NCT01047501|593150826|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
164214070|NCT01047501|593150824|FG000|Overall Study|Death|1|||
164214071|NCT01047501|593150825|FG001|Overall Study|Death|0|||
164214072|NCT01047501|593150826|FG002|Overall Study|Death|0|||
164214073|NCT01047501|593150824|FG000|Overall Study|Other discontinuation|1|||
164214074|NCT01047501|593150825|FG001|Overall Study|Other discontinuation|0|||
164214075|NCT01047501|593150826|FG002|Overall Study|Other discontinuation|1|||
164214076|NCT01047501|593150824|FG000|Overall Study|Investigator judgement|0|||
164214077|NCT01047501|593150825|FG001|Overall Study|Investigator judgement|0|||
164214078|NCT01047501|593150826|FG002|Overall Study|Investigator judgement|1|||
164214079|NCT04602000|593150827|FG000|Overall Study|Withdrawal by Subject|3|||
164214080|NCT04602000|593150828|FG001|Overall Study|Withdrawal by Subject|6|||
164214081|NCT04602000|593150829|FG002|Overall Study|Withdrawal by Subject|3|||
164214082|NCT04602000|593150830|FG003|Overall Study|Withdrawal by Subject|27|||
164214083|NCT04602000|593150831|FG004|Overall Study|Withdrawal by Subject|39|||
164214084|NCT04602000|593150827|FG000|Overall Study|Physician Decision|1|||
164214085|NCT04602000|593150828|FG001|Overall Study|Physician Decision|0|||
164214086|NCT04602000|593150829|FG002|Overall Study|Physician Decision|0|||
164214087|NCT04602000|593150830|FG003|Overall Study|Physician Decision|2|||
164214088|NCT04602000|593150831|FG004|Overall Study|Physician Decision|2|||
164214089|NCT04602000|593150827|FG000|Overall Study|Death|0|||
164214090|NCT04602000|593150828|FG001|Overall Study|Death|1|||
164214091|NCT04602000|593150829|FG002|Overall Study|Death|0|||
164214092|NCT04602000|593150830|FG003|Overall Study|Death|1|||
164214093|NCT04602000|593150831|FG004|Overall Study|Death|2|||
164214094|NCT04602000|593150827|FG000|Overall Study|Lost to Follow-up|0|||
164214095|NCT04602000|593150828|FG001|Overall Study|Lost to Follow-up|0|||
164214096|NCT04602000|593150829|FG002|Overall Study|Lost to Follow-up|0|||
164214097|NCT04602000|593150830|FG003|Overall Study|Lost to Follow-up|3|||
164214098|NCT04602000|593150831|FG004|Overall Study|Lost to Follow-up|4|||
164214099|NCT04602000|593150827|FG000|Overall Study|Other|4|||
164214100|NCT04602000|593150828|FG001|Overall Study|Other|1|||
164214101|NCT04602000|593150829|FG002|Overall Study|Other|2|||
164214102|NCT04602000|593150830|FG003|Overall Study|Other|5|||
164214103|NCT04602000|593150831|FG004|Overall Study|Other|4|||
164214104|NCT04602000|593150827|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214105|NCT04602000|593150828|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214106|NCT04602000|593150829|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
164214107|NCT04602000|593150830|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214108|NCT04602000|593150831|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
164214109|NCT00770484|593150838|FG000|Overall Study|Withdrawal by Subject|1|||
164214110|NCT00770484|593150839|FG001|Overall Study|Withdrawal by Subject|0|||
164214111|NCT00195429|593150840|FG000|Overall Study|Adverse Event|2|||
164214112|NCT00195429|593150841|FG001|Overall Study|Adverse Event|4|||
164214113|NCT00195429|593150840|FG000|Overall Study|Lack of Efficacy|2|||
164214114|NCT00195429|593150841|FG001|Overall Study|Lack of Efficacy|1|||
164214115|NCT00195429|593150840|FG000|Overall Study|Lost to Follow-up|1|||
164214116|NCT00195429|593150841|FG001|Overall Study|Lost to Follow-up|0|||
164214117|NCT00367458|593150842|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
164214118|NCT00367458|593150843|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
164214119|NCT05696847|593150847|FG000|Overall Study|Withdrawal by Subject|1|||
164214120|NCT05696847|593150848|FG001|Overall Study|Withdrawal by Subject|0|||
164214121|NCT05696847|593150849|FG002|Overall Study|Withdrawal by Subject|0|||
164214122|NCT05696847|593150850|FG003|Overall Study|Withdrawal by Subject|0|||
164214123|NCT05696847|593150851|FG004|Overall Study|Withdrawal by Subject|0|||
164214124|NCT05696847|593150852|FG005|Overall Study|Withdrawal by Subject|0|||
164325897|NCT01466179|593569005|FG000|Overall Study|Lack of Efficacy|14|||
164325898|NCT01466179|593569005|FG000|Overall Study|Death|7|||
164325899|NCT01466179|593569005|FG000|Overall Study|Withdrawal by Subject|7|||
164214125|NCT05696847|593150847|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164214126|NCT05696847|593150848|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164214127|NCT05696847|593150849|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164325900|NCT01466179|593569005|FG000|Overall Study|Protocol Violation|2|||
164325901|NCT01466179|593569005|FG000|Overall Study|Other|3|||
164325902|NCT03410823|593569006|FG000|Overall Study|Death|1|||
164325903|NCT03410823|593569006|FG000|Overall Study|Withdrawal by Subject|2|||
164325904|NCT03410823|593569006|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
164325905|NCT03707184|593569009|FG000|Overall Study|Withdrawal by Subject|2|||
164325906|NCT04704154|593569010|FG000|Overall Study|Adverse Event|3|||
164325907|NCT04704154|593569011|FG001|Overall Study|Adverse Event|2|||
164325908|NCT04704154|593569012|FG002|Overall Study|Adverse Event|4|||
164325909|NCT04704154|593569013|FG003|Overall Study|Adverse Event|2|||
164325910|NCT04704154|593569014|FG004|Overall Study|Adverse Event|3|||
164325911|NCT04704154|593569015|FG005|Overall Study|Adverse Event|0|||
164325912|NCT04704154|593569010|FG000|Overall Study|Death|3|||
164325913|NCT04704154|593569011|FG001|Overall Study|Death|0|||
163876364|NCT01609218|591914857|FG001|Period 1|Adverse Event|5|||
164214128|NCT05696847|593150850|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164214129|NCT05696847|593150851|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164214130|NCT05696847|593150852|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163876365|NCT01609218|591914856|FG000|Period 1|Sponsor Decision|0|||
163876366|NCT01609218|591914857|FG001|Period 1|Sponsor Decision|1|||
163876367|NCT01609218|591914856|FG000|Period 2|Adverse Event|1|||
164214131|NCT05696847|593150847|FG000|Overall Study|Adverse Event|0|||
164214132|NCT05696847|593150848|FG001|Overall Study|Adverse Event|0|||
164214133|NCT05696847|593150849|FG002|Overall Study|Adverse Event|0|||
164214134|NCT05696847|593150850|FG003|Overall Study|Adverse Event|0|||
164214135|NCT05696847|593150851|FG004|Overall Study|Adverse Event|0|||
164214136|NCT05696847|593150852|FG005|Overall Study|Adverse Event|1|||
164325914|NCT04704154|593569012|FG002|Overall Study|Death|0|||
164325915|NCT04704154|593569013|FG003|Overall Study|Death|0|||
164325916|NCT04704154|593569014|FG004|Overall Study|Death|3|||
164325917|NCT04704154|593569015|FG005|Overall Study|Death|0|||
164325918|NCT04704154|593569010|FG000|Overall Study|Physician Decision|1|||
163876368|NCT01609218|591914857|FG001|Period 2|Adverse Event|0|||
163876369|NCT02807779|591914858|FG000|Overall Study|Lost to Follow-up|1|||
163876370|NCT02807779|591914859|FG001|Overall Study|Lost to Follow-up|0|||
163876371|NCT02807779|591914860|FG002|Overall Study|Lost to Follow-up|0|||
163876372|NCT02807779|591914858|FG000|Overall Study|Physician Decision|2|||
163876373|NCT02807779|591914859|FG001|Overall Study|Physician Decision|0|||
163876374|NCT02807779|591914860|FG002|Overall Study|Physician Decision|1|||
163876375|NCT02807779|591914858|FG000|Overall Study|Death|1|||
163876376|NCT02807779|591914859|FG001|Overall Study|Death|1|||
163876377|NCT02807779|591914860|FG002|Overall Study|Death|0|||
163876378|NCT01216176|591916865|FG000|Overall Study|Adverse Event|0|||
163876379|NCT01216176|591916866|FG001|Overall Study|Adverse Event|8|||
163876380|NCT01216176|591916867|FG002|Overall Study|Adverse Event|0|||
163876381|NCT01216176|591916865|FG000|Overall Study|Physician Decision|0|||
163876382|NCT01216176|591916866|FG001|Overall Study|Physician Decision|0|||
163876383|NCT01216176|591916867|FG002|Overall Study|Physician Decision|1|||
163876384|NCT03725722|591916870|FG000|Overall Study|Lack of Efficacy|2|||
163980745|NCT01709149|592299649|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
163980746|NCT01709149|592299647|FG000|Open-label Lead-in Phase|Death|1|||
163980747|NCT01709149|592299648|FG001|Open-label Lead-in Phase|Death|0|||
163980748|NCT01709149|592299649|FG002|Open-label Lead-in Phase|Death|0|||
163876385|NCT03725722|591916871|FG001|Overall Study|Lack of Efficacy|1|||
163876386|NCT03725722|591916872|FG002|Overall Study|Lack of Efficacy|2|||
163876387|NCT03725722|591916873|FG003|Overall Study|Lack of Efficacy|0|||
163980749|NCT01709149|592299647|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
163980750|NCT01709149|592299648|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
163980751|NCT01709149|592299649|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
163980752|NCT01709149|592299647|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163980753|NCT01709149|592299648|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
163980754|NCT01709149|592299649|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
163980755|NCT01709149|592299647|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163980756|NCT01709149|592299648|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
163980757|NCT01709149|592299649|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
163980758|NCT01709149|592299647|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163980759|NCT01709149|592299648|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
163980760|NCT01709149|592299649|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
163980761|NCT01709149|592299647|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
163980762|NCT01709149|592299648|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
163980763|NCT01709149|592299649|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
163980764|NCT01709149|592299647|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
163980765|NCT01709149|592299648|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
163980766|NCT01709149|592299649|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
163980767|NCT01709149|592299647|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163980768|NCT01709149|592299648|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
163980769|NCT01709149|592299649|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163980770|NCT03509350|592299650|FG000|Overall Study|Withdrawal by Subject|0|||
163980771|NCT03509350|592299651|FG001|Overall Study|Withdrawal by Subject|2|||
163980772|NCT00763815|592299652|FG000|Overall Study|Adverse Event|14|||
163980773|NCT00763815|592299653|FG001|Overall Study|Adverse Event|29|||
163980774|NCT00763815|592299652|FG000|Overall Study|Lack of Efficacy|10|||
163980775|NCT00763815|592299653|FG001|Overall Study|Lack of Efficacy|11|||
163980776|NCT00763815|592299652|FG000|Overall Study|Poor Compliance to Protocol|6|||
163980777|NCT00763815|592299653|FG001|Overall Study|Poor Compliance to Protocol|6|||
163980778|NCT00763815|592299652|FG000|Overall Study|Lost to Follow-up|2|||
163980779|NCT00763815|592299653|FG001|Overall Study|Lost to Follow-up|4|||
163980780|NCT00763815|592299652|FG000|Overall Study|Early Termination|1|||
163980781|NCT00763815|592299653|FG001|Overall Study|Early Termination|0|||
163980782|NCT00763815|592299652|FG000|Overall Study|Familial and Personal Reasons|9|||
163980783|NCT00763815|592299653|FG001|Overall Study|Familial and Personal Reasons|16|||
163980784|NCT00763815|592299652|FG000|Overall Study|Physician Decision|1|||
163980785|NCT00763815|592299653|FG001|Overall Study|Physician Decision|0|||
163980786|NCT00763815|592299652|FG000|Overall Study|Withdrawal by Subject|7|||
163876388|NCT03725722|591916874|FG004|Overall Study|Lack of Efficacy|2|||
163876389|NCT03725722|591916870|FG000|Overall Study|Adverse Event|2|||
163876390|NCT03725722|591916871|FG001|Overall Study|Adverse Event|2|||
163876391|NCT03725722|591916872|FG002|Overall Study|Adverse Event|1|||
163876392|NCT03725722|591916873|FG003|Overall Study|Adverse Event|0|||
163876393|NCT03725722|591916874|FG004|Overall Study|Adverse Event|6|||
163876394|NCT03725722|591916870|FG000|Overall Study|Withdrawal by Subject|4|||
163876395|NCT03725722|591916871|FG001|Overall Study|Withdrawal by Subject|1|||
163876396|NCT03725722|591916872|FG002|Overall Study|Withdrawal by Subject|0|||
163876397|NCT03725722|591916873|FG003|Overall Study|Withdrawal by Subject|4|||
163876398|NCT03725722|591916874|FG004|Overall Study|Withdrawal by Subject|4|||
163876399|NCT03725722|591916870|FG000|Overall Study|Lost to Follow-up|3|||
163876400|NCT03725722|591916871|FG001|Overall Study|Lost to Follow-up|1|||
164214137|NCT05696847|593150847|FG000|Overall Study|Sponsor Decision|0|||
164214138|NCT05696847|593150848|FG001|Overall Study|Sponsor Decision|0|||
164214139|NCT05696847|593150849|FG002|Overall Study|Sponsor Decision|0|||
164214140|NCT05696847|593150850|FG003|Overall Study|Sponsor Decision|1|||
164214141|NCT05696847|593150851|FG004|Overall Study|Sponsor Decision|0|||
164214142|NCT05696847|593150852|FG005|Overall Study|Sponsor Decision|0|||
164214143|NCT01716156|593150853|FG000|Overall Study|Protocol Violation|1|||
164214144|NCT01716156|593150854|FG001|Overall Study|Protocol Violation|0|||
164214145|NCT01716156|593150855|FG002|Overall Study|Protocol Violation|0|||
164214146|NCT01716156|593150853|FG000|Overall Study|Withdrawal by Subject|0|||
164214147|NCT01716156|593150854|FG001|Overall Study|Withdrawal by Subject|1|||
164214148|NCT01716156|593150855|FG002|Overall Study|Withdrawal by Subject|2|||
164214149|NCT01716156|593150853|FG000|Overall Study|Lost to Follow-up|1|||
164214150|NCT01716156|593150854|FG001|Overall Study|Lost to Follow-up|0|||
164214151|NCT01716156|593150855|FG002|Overall Study|Lost to Follow-up|0|||
164214152|NCT05513950|593150858|FG000|Overall Study|Not treated due to technical reasons|0|||
164214153|NCT05513950|593150859|FG001|Overall Study|Not treated due to technical reasons|0|||
164214154|NCT05513950|593150860|FG002|Overall Study|Not treated due to technical reasons|1|||
164214155|NCT05513950|593150861|FG003|Overall Study|Not treated due to technical reasons|0|||
164214156|NCT05221866|593150862|FG000|Overall Study|Withdrawal by Subject|5|||
163980787|NCT00763815|592299653|FG001|Overall Study|Withdrawal by Subject|12|||
163980788|NCT00763815|592299652|FG000|Overall Study|Protocol Violation|2|||
163980789|NCT00763815|592299653|FG001|Overall Study|Protocol Violation|5|||
163980790|NCT00763815|592299652|FG000|Overall Study|Sponsor's Decision|0|||
163980791|NCT00763815|592299653|FG001|Overall Study|Sponsor's Decision|1|||
163980792|NCT04951037|592299654|FG000|Overall Study|Lost to Follow-up|16|||
163980793|NCT04951037|592299654|FG000|Overall Study|Withdrawal by Subject|5|||
163980794|NCT04951037|592299654|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
163980795|NCT05630937|592299655|FG000|Overall Study|Study terminated by sponsor|1|||
163980796|NCT05630937|592299656|FG001|Overall Study|Study terminated by sponsor|1|||
163980797|NCT05630937|592299657|FG002|Overall Study|Study terminated by sponsor|8|||
163980798|NCT05630937|592299658|FG003|Overall Study|Study terminated by sponsor|0|||
163980799|NCT05630937|592299655|FG000|Overall Study|Lost to Follow-up|0|||
163980800|NCT05630937|592299656|FG001|Overall Study|Lost to Follow-up|0|||
163980801|NCT05630937|592299657|FG002|Overall Study|Lost to Follow-up|1|||
163980802|NCT05630937|592299658|FG003|Overall Study|Lost to Follow-up|0|||
163980803|NCT05630937|592299655|FG000|Overall Study|Enrolled but not treated|0|||
163980804|NCT05630937|592299656|FG001|Overall Study|Enrolled but not treated|0|||
163980805|NCT05630937|592299657|FG002|Overall Study|Enrolled but not treated|0|||
163980806|NCT05630937|592299658|FG003|Overall Study|Enrolled but not treated|1|||
163980807|NCT03245450|592299659|FG000|Overall Study|Radiological disease progression|3|||
163980808|NCT03245450|592299660|FG001|Overall Study|Radiological disease progression|3|||
163980809|NCT03245450|592299661|FG002|Overall Study|Radiological disease progression|2|||
163980810|NCT03245450|592299662|FG003|Overall Study|Radiological disease progression|2|||
163980811|NCT03245450|592299663|FG004|Overall Study|Radiological disease progression|7|||
163980812|NCT03245450|592299664|FG005|Overall Study|Radiological disease progression|6|||
163980813|NCT03245450|592299665|FG006|Overall Study|Radiological disease progression|6|||
163980814|NCT03245450|592299659|FG000|Overall Study|Clinical disease progression|0|||
163980815|NCT03245450|592299660|FG001|Overall Study|Clinical disease progression|0|||
163980816|NCT03245450|592299661|FG002|Overall Study|Clinical disease progression|1|||
163980817|NCT03245450|592299662|FG003|Overall Study|Clinical disease progression|0|||
163980818|NCT03245450|592299663|FG004|Overall Study|Clinical disease progression|0|||
163980819|NCT03245450|592299664|FG005|Overall Study|Clinical disease progression|2|||
163980820|NCT03245450|592299665|FG006|Overall Study|Clinical disease progression|0|||
164214157|NCT05221866|593150863|FG001|Overall Study|Withdrawal by Subject|7|||
164325919|NCT04704154|593569011|FG001|Overall Study|Physician Decision|0|||
163980821|NCT03245450|592299659|FG000|Overall Study|Other|0|||
163980822|NCT03245450|592299660|FG001|Overall Study|Other|0|||
163980823|NCT03245450|592299661|FG002|Overall Study|Other|0|||
163980824|NCT03245450|592299662|FG003|Overall Study|Other|1|||
163980825|NCT03245450|592299663|FG004|Overall Study|Other|1|||
163980826|NCT03245450|592299664|FG005|Overall Study|Other|1|||
163980827|NCT03245450|592299665|FG006|Overall Study|Other|1|||
163980828|NCT03245450|592299659|FG000|Overall Study|Withdrawal by Subject|0|||
163980829|NCT03245450|592299660|FG001|Overall Study|Withdrawal by Subject|1|||
163980830|NCT03245450|592299661|FG002|Overall Study|Withdrawal by Subject|0|||
163980831|NCT03245450|592299662|FG003|Overall Study|Withdrawal by Subject|0|||
163980832|NCT03245450|592299663|FG004|Overall Study|Withdrawal by Subject|0|||
163980833|NCT03245450|592299664|FG005|Overall Study|Withdrawal by Subject|0|||
163980834|NCT03245450|592299665|FG006|Overall Study|Withdrawal by Subject|0|||
163980835|NCT03245450|592299659|FG000|Overall Study|Adverse Event|0|||
164214158|NCT05221866|593150864|FG002|Overall Study|Withdrawal by Subject|6|||
164214159|NCT05221866|593150865|FG003|Overall Study|Withdrawal by Subject|4|||
164214160|NCT05221866|593150862|FG000|Overall Study|Physician Decision|3|||
164214161|NCT05221866|593150863|FG001|Overall Study|Physician Decision|2|||
164214162|NCT05221866|593150864|FG002|Overall Study|Physician Decision|1|||
164214163|NCT05221866|593150865|FG003|Overall Study|Physician Decision|4|||
164214164|NCT05221866|593150862|FG000|Overall Study|Lost to Follow-up|12|||
164214165|NCT05221866|593150863|FG001|Overall Study|Lost to Follow-up|17|||
164214166|NCT05221866|593150864|FG002|Overall Study|Lost to Follow-up|14|||
164214167|NCT05221866|593150865|FG003|Overall Study|Lost to Follow-up|14|||
164214168|NCT05221866|593150862|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
164214169|NCT05221866|593150863|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
164214170|NCT05221866|593150864|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
164214171|NCT05221866|593150865|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
164214172|NCT05561140|593150866|FG000|Randomized Treatment Period|Adverse Event|1|||
164214173|NCT05561140|593150867|FG001|Randomized Treatment Period|Adverse Event|0|||
164214174|NCT05561140|593150866|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
164214175|NCT05561140|593150867|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
164214176|NCT05561140|593150866|FG000|Open Label Treatment Period|Adverse Event|6|||
164214177|NCT05561140|593150867|FG001|Open Label Treatment Period|Adverse Event|4|||
164214178|NCT05561140|593150866|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
164214179|NCT05561140|593150867|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
164214180|NCT05561140|593150866|FG000|Open Label Treatment Period|Physician Decision|0|||
164214181|NCT05561140|593150867|FG001|Open Label Treatment Period|Physician Decision|1|||
163876401|NCT03725722|591916872|FG002|Overall Study|Lost to Follow-up|2|||
164214182|NCT05561140|593150866|FG000|Open Label Treatment Period|Pregnancy|1|||
164214183|NCT05561140|593150867|FG001|Open Label Treatment Period|Pregnancy|0|||
163876402|NCT03725722|591916873|FG003|Overall Study|Lost to Follow-up|2|||
163876403|NCT03725722|591916874|FG004|Overall Study|Lost to Follow-up|1|||
163876404|NCT03725722|591916870|FG000|Overall Study|Personal reasons|0|||
163876405|NCT03725722|591916871|FG001|Overall Study|Personal reasons|0|||
163876406|NCT03725722|591916872|FG002|Overall Study|Personal reasons|1|||
163876407|NCT03725722|591916873|FG003|Overall Study|Personal reasons|0|||
163876408|NCT03725722|591916874|FG004|Overall Study|Personal reasons|1|||
163876409|NCT03725722|591916870|FG000|Overall Study|COVID-19 situation|0|||
163876410|NCT03725722|591916871|FG001|Overall Study|COVID-19 situation|1|||
163876411|NCT03725722|591916872|FG002|Overall Study|COVID-19 situation|0|||
163876412|NCT03725722|591916873|FG003|Overall Study|COVID-19 situation|0|||
163876413|NCT03725722|591916874|FG004|Overall Study|COVID-19 situation|0|||
163876414|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
163876415|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
163876416|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
164214184|NCT05561140|593150866|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
164214185|NCT05561140|593150867|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
164214186|NCT05561140|593150866|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
164214187|NCT05561140|593150867|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
164214188|NCT05561140|593150866|FG000|Open Label Treatment Period|Other|1|||
164214189|NCT05561140|593150867|FG001|Open Label Treatment Period|Other|0|||
164214190|NCT00221104|593150871|FG000|Overall Study|Adverse Event|1|||
164214191|NCT00221104|593150872|FG001|Overall Study|Adverse Event|0|||
164214192|NCT00221104|593150871|FG000|Overall Study|Physician Decision|1|||
164214193|NCT00221104|593150872|FG001|Overall Study|Physician Decision|0|||
164214194|NCT00221104|593150871|FG000|Overall Study|Protocol Violation|2|||
164214195|NCT00221104|593150872|FG001|Overall Study|Protocol Violation|0|||
164214196|NCT00221104|593150871|FG000|Overall Study|Withdrawal by Subject|42|||
164214197|NCT00221104|593150872|FG001|Overall Study|Withdrawal by Subject|29|||
164214198|NCT00221104|593150871|FG000|Overall Study|Others|37|||
164214199|NCT00221104|593150872|FG001|Overall Study|Others|47|||
164214200|NCT02989389|593150873|FG000|Period 1|Lost to Follow-up|0|||
164325920|NCT04704154|593569012|FG002|Overall Study|Physician Decision|1|||
163876417|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
163876418|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
163876419|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
163876420|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
163876421|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
163876422|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
163876423|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
163876424|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
163876425|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
163876426|NCT01600014|591916875|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
164214201|NCT02989389|593150874|FG001|Period 1|Lost to Follow-up|1|||
164214202|NCT02989389|593150875|FG002|Period 1|Lost to Follow-up|0|||
164214203|NCT02989389|593150876|FG003|Period 1|Lost to Follow-up|0|||
164214204|NCT02989389|593150877|FG004|Period 1|Lost to Follow-up|0|||
164214205|NCT02989389|593150878|FG005|Period 1|Lost to Follow-up|0|||
164214206|NCT02989389|593150879|FG006|Period 1|Lost to Follow-up|0|||
164325921|NCT04704154|593569013|FG003|Overall Study|Physician Decision|0|||
164214207|NCT02989389|593150880|FG007|Period 1|Lost to Follow-up|0|||
164214208|NCT02989389|593150881|FG008|Period 1|Lost to Follow-up|0|||
164214209|NCT02989389|593150882|FG009|Period 1|Lost to Follow-up|0|||
164214210|NCT02989389|593150873|FG000|Period 1|Physician Decision|0|||
164214211|NCT02989389|593150874|FG001|Period 1|Physician Decision|0|||
164214212|NCT02989389|593150875|FG002|Period 1|Physician Decision|0|||
164214213|NCT02989389|593150876|FG003|Period 1|Physician Decision|0|||
164214214|NCT02989389|593150877|FG004|Period 1|Physician Decision|0|||
164214215|NCT02989389|593150878|FG005|Period 1|Physician Decision|0|||
164214216|NCT02989389|593150879|FG006|Period 1|Physician Decision|0|||
164214217|NCT02989389|593150880|FG007|Period 1|Physician Decision|0|||
164214218|NCT02989389|593150881|FG008|Period 1|Physician Decision|1|||
164214219|NCT02989389|593150882|FG009|Period 1|Physician Decision|0|||
164214220|NCT01666652|593150883|FG000|Overall Study|Serious Adverse Event|0|||
164214221|NCT01666652|593150884|FG001|Overall Study|Serious Adverse Event|0|||
163980836|NCT03245450|592299660|FG001|Overall Study|Adverse Event|0|||
163980837|NCT03245450|592299661|FG002|Overall Study|Adverse Event|0|||
163980838|NCT03245450|592299662|FG003|Overall Study|Adverse Event|0|||
163980839|NCT03245450|592299663|FG004|Overall Study|Adverse Event|1|||
163980840|NCT03245450|592299664|FG005|Overall Study|Adverse Event|0|||
163980841|NCT03245450|592299665|FG006|Overall Study|Adverse Event|2|||
163980842|NCT02429414|592299666|FG000|Overall Study|Physician Decision|0|||
163980843|NCT02429414|592299667|FG001|Overall Study|Physician Decision|1|||
163980844|NCT01604265|592299672|FG000|Overall Study|Adverse Event|1|||
163980845|NCT01604265|592299673|FG001|Overall Study|Adverse Event|0|||
163980846|NCT01604265|592299672|FG000|Overall Study|Withdrawal by Subject|1|||
163980847|NCT01604265|592299673|FG001|Overall Study|Withdrawal by Subject|0|||
163980848|NCT01903837|592299674|FG000|Part A|Withdrawal by Subject|4|||
163980849|NCT01903837|592299675|FG001|Part A|Withdrawal by Subject|9|||
163980850|NCT01903837|592299676|FG002|Part A|Withdrawal by Subject|8|||
163980851|NCT01903837|592299677|FG003|Part A|Withdrawal by Subject|5|||
163980852|NCT01903837|592299674|FG000|Part A|Adverse Event|3|||
163980853|NCT01903837|592299675|FG001|Part A|Adverse Event|6|||
163980854|NCT01903837|592299676|FG002|Part A|Adverse Event|9|||
163980855|NCT01903837|592299677|FG003|Part A|Adverse Event|6|||
163980856|NCT01903837|592299674|FG000|Part A|Lost to Follow-up|9|||
163980857|NCT01903837|592299675|FG001|Part A|Lost to Follow-up|7|||
163980858|NCT01903837|592299676|FG002|Part A|Lost to Follow-up|7|||
163980859|NCT01903837|592299677|FG003|Part A|Lost to Follow-up|2|||
163980860|NCT01903837|592299674|FG000|Part A|Non-compliance with study drug|1|||
163980861|NCT01903837|592299675|FG001|Part A|Non-compliance with study drug|4|||
163980862|NCT01903837|592299676|FG002|Part A|Non-compliance with study drug|4|||
163980863|NCT01903837|592299677|FG003|Part A|Non-compliance with study drug|0|||
163980864|NCT01903837|592299674|FG000|Part A|Physician Decision|1|||
163980865|NCT01903837|592299675|FG001|Part A|Physician Decision|1|||
163980866|NCT01903837|592299676|FG002|Part A|Physician Decision|0|||
163980867|NCT01903837|592299677|FG003|Part A|Physician Decision|0|||
163980868|NCT01903837|592299674|FG000|Part A|Protocol Violation|1|||
163980869|NCT01903837|592299675|FG001|Part A|Protocol Violation|1|||
163980870|NCT01903837|592299676|FG002|Part A|Protocol Violation|0|||
163980871|NCT01903837|592299677|FG003|Part A|Protocol Violation|0|||
163980872|NCT01903837|592299674|FG000|Part B|Lost to Follow-up|0|||
163980873|NCT01903837|592299675|FG001|Part B|Lost to Follow-up|3|||
163980874|NCT01903837|592299676|FG002|Part B|Lost to Follow-up|3|||
163980875|NCT01903837|592299677|FG003|Part B|Lost to Follow-up|4|||
164214222|NCT01666652|593150885|FG002|Overall Study|Serious Adverse Event|0|||
163980876|NCT01903837|592299674|FG000|Part B|Withdrawal by Subject|1|||
163980877|NCT01903837|592299675|FG001|Part B|Withdrawal by Subject|2|||
163980878|NCT01903837|592299676|FG002|Part B|Withdrawal by Subject|0|||
163980879|NCT01903837|592299677|FG003|Part B|Withdrawal by Subject|3|||
164077705|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
163980880|NCT01903837|592299674|FG000|Part B|Adverse Event|3|||
163980881|NCT01903837|592299675|FG001|Part B|Adverse Event|0|||
163980882|NCT01903837|592299676|FG002|Part B|Adverse Event|2|||
163980883|NCT01903837|592299677|FG003|Part B|Adverse Event|0|||
163980884|NCT01903837|592299674|FG000|Part B|Non-compliance with study drug|2|||
163980885|NCT01903837|592299675|FG001|Part B|Non-compliance with study drug|0|||
163980886|NCT01903837|592299676|FG002|Part B|Non-compliance with study drug|0|||
163980887|NCT01903837|592299677|FG003|Part B|Non-compliance with study drug|1|||
163980888|NCT01903837|592299674|FG000|Part B|Incarceration|2|||
163980889|NCT01903837|592299675|FG001|Part B|Incarceration|0|||
163980890|NCT01903837|592299676|FG002|Part B|Incarceration|0|||
163980891|NCT01903837|592299677|FG003|Part B|Incarceration|1|||
164214223|NCT01666652|593150886|FG003|Overall Study|Serious Adverse Event|1|||
164214224|NCT01666652|593150887|FG004|Overall Study|Serious Adverse Event|0|||
164214225|NCT01666652|593150883|FG000|Overall Study|Withdrawal by Subject|0|||
163980892|NCT01903837|592299674|FG000|Part B|Physician Decision|1|||
163980893|NCT01903837|592299675|FG001|Part B|Physician Decision|0|||
164214226|NCT01666652|593150884|FG001|Overall Study|Withdrawal by Subject|0|||
164214227|NCT01666652|593150885|FG002|Overall Study|Withdrawal by Subject|0|||
164214228|NCT01666652|593150886|FG003|Overall Study|Withdrawal by Subject|0|||
164214229|NCT01666652|593150887|FG004|Overall Study|Withdrawal by Subject|1|||
164214230|NCT01666652|593150883|FG000|Overall Study|Moved from study area|1|||
164214231|NCT01666652|593150884|FG001|Overall Study|Moved from study area|0|||
164214232|NCT01666652|593150885|FG002|Overall Study|Moved from study area|0|||
164214233|NCT01666652|593150886|FG003|Overall Study|Moved from study area|2|||
164214234|NCT01666652|593150887|FG004|Overall Study|Moved from study area|0|||
164214235|NCT01666652|593150883|FG000|Overall Study|Lost to Follow-up|1|||
164214236|NCT01666652|593150884|FG001|Overall Study|Lost to Follow-up|1|||
164214237|NCT01666652|593150885|FG002|Overall Study|Lost to Follow-up|1|||
164214238|NCT01666652|593150886|FG003|Overall Study|Lost to Follow-up|1|||
164214239|NCT01666652|593150887|FG004|Overall Study|Lost to Follow-up|0|||
164214240|NCT00088153|593150888|FG000|Overall Study|Physician Decision|3|||
164214241|NCT00088153|593150889|FG001|Overall Study|Physician Decision|3|||
164214242|NCT00088153|593150888|FG000|Overall Study|Withdrawal by Subject|10|||
164214243|NCT00088153|593150889|FG001|Overall Study|Withdrawal by Subject|10|||
164214244|NCT00088153|593150888|FG000|Overall Study|Lost to Follow-up|11|||
164214245|NCT00088153|593150889|FG001|Overall Study|Lost to Follow-up|12|||
164214246|NCT01132755|593150890|FG000|Overall Study|Procedure not done due to medical reason|23|||
164214247|NCT01132755|593150890|FG000|Overall Study|Protocol Violation|15|||
164214248|NCT01132755|593150890|FG000|Overall Study|Withdrawal by Subject|4|||
164214249|NCT01757847|593150891|FG000|Overall Study|Withdrawal by Subject|3|||
164214250|NCT01757847|593150892|FG001|Overall Study|Withdrawal by Subject|4|||
164214251|NCT04057365|593150893|FG000|Overall Study|Withdrawal by Subject|2|||
164214252|NCT04057365|593150894|FG001|Overall Study|Withdrawal by Subject|0|||
164214253|NCT01063114|593150895|FG000|Overall Study|Lost to Follow-up|1|||
164214254|NCT04598828|593150898|FG000|Overall Study|Physician Decision|1|||
164214255|NCT04598828|593150899|FG001|Overall Study|Physician Decision|0|||
164214256|NCT04598828|593150898|FG000|Overall Study|Withdrawal by Subject|0|||
164214257|NCT04598828|593150899|FG001|Overall Study|Withdrawal by Subject|1|||
164214258|NCT04598828|593150898|FG000|Overall Study|Withdrawal by Subject|0|||
164214259|NCT04598828|593150899|FG001|Overall Study|Withdrawal by Subject|1|||
164214260|NCT02676973|593150900|FG000|Overall Study|Withdrawal by Subject|9|||
164214261|NCT02676973|593150901|FG001|Overall Study|Withdrawal by Subject|8|||
164214262|NCT02676973|593150902|FG002|Overall Study|Withdrawal by Subject|11|||
164214263|NCT02676973|593150900|FG000|Overall Study|Lost to Follow-up|8|||
164214264|NCT02676973|593150901|FG001|Overall Study|Lost to Follow-up|12|||
164214265|NCT02676973|593150902|FG002|Overall Study|Lost to Follow-up|8|||
164214266|NCT02676973|593150900|FG000|Overall Study|Death|2|||
164214267|NCT02676973|593150901|FG001|Overall Study|Death|1|||
163876427|NCT01600014|591916876|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
163876428|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
163876429|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
163876430|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
163876431|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
163876432|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
163876433|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
163876434|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
163876435|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
163876436|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
163876437|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
163876438|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
163876439|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
163876440|NCT01600014|591916875|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
163876441|NCT01600014|591916876|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
163876442|NCT01600014|591916875|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
163876443|NCT01600014|591916876|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
163876444|NCT01600014|591916875|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
163876445|NCT01600014|591916876|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
163876446|NCT01600014|591916875|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
164214268|NCT02676973|593150902|FG002|Overall Study|Death|5|||
164214269|NCT01078662|593150904|FG000|Overall Study|Death|41|||
164214270|NCT01078662|593150905|FG001|Overall Study|Death|103|||
164214271|NCT01078662|593150906|FG002|Overall Study|Death|18|||
164214272|NCT01078662|593150907|FG003|Overall Study|Death|5|||
164214273|NCT01078662|593150908|FG004|Overall Study|Death|8|||
164214274|NCT01078662|593150904|FG000|Overall Study|Patients reached data cut-off|12|||
164214275|NCT01078662|593150905|FG001|Overall Study|Patients reached data cut-off|53|||
163876447|NCT01600014|591916876|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
164214276|NCT01078662|593150906|FG002|Overall Study|Patients reached data cut-off|2|||
164214277|NCT01078662|593150907|FG003|Overall Study|Patients reached data cut-off|2|||
164214278|NCT01078662|593150908|FG004|Overall Study|Patients reached data cut-off|3|||
164214279|NCT01078662|593150904|FG000|Overall Study|Withdrawal by Subject|4|||
164214280|NCT01078662|593150905|FG001|Overall Study|Withdrawal by Subject|11|||
164214281|NCT01078662|593150906|FG002|Overall Study|Withdrawal by Subject|1|||
164214282|NCT01078662|593150907|FG003|Overall Study|Withdrawal by Subject|0|||
164214283|NCT01078662|593150908|FG004|Overall Study|Withdrawal by Subject|0|||
164214284|NCT01078662|593150904|FG000|Overall Study|Protocol Violation|0|||
164214285|NCT01078662|593150905|FG001|Overall Study|Protocol Violation|1|||
164214286|NCT01078662|593150906|FG002|Overall Study|Protocol Violation|0|||
164214287|NCT01078662|593150907|FG003|Overall Study|Protocol Violation|0|||
164214288|NCT01078662|593150908|FG004|Overall Study|Protocol Violation|0|||
164214289|NCT01078662|593150904|FG000|Overall Study|Lost to Follow-up|1|||
164214290|NCT01078662|593150905|FG001|Overall Study|Lost to Follow-up|0|||
164214291|NCT01078662|593150906|FG002|Overall Study|Lost to Follow-up|0|||
164214292|NCT01078662|593150907|FG003|Overall Study|Lost to Follow-up|0|||
164214293|NCT01078662|593150908|FG004|Overall Study|Lost to Follow-up|0|||
164214294|NCT02875080|593150913|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
164214295|NCT02875080|593150914|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
164214296|NCT02875080|593150915|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
164214297|NCT00182637|593151825|FG000|Overall Study|Adverse Event|2|||
164214298|NCT00182637|593151825|FG000|Overall Study|Disease Progression|1|||
164214299|NCT02068794|593151826|FG000|Overall Study|Withdrawal by Subject|0|||
164214300|NCT02068794|593151827|FG001|Overall Study|Withdrawal by Subject|1|||
164214301|NCT02068794|593151828|FG002|Overall Study|Withdrawal by Subject|2|||
164214302|NCT02068794|593151826|FG000|Overall Study|Early Progression|1|||
164214303|NCT02068794|593151827|FG001|Overall Study|Early Progression|0|||
164214304|NCT02068794|593151828|FG002|Overall Study|Early Progression|1|||
164214305|NCT02068794|593151826|FG000|Overall Study|Ineligible|0|||
164214306|NCT02068794|593151827|FG001|Overall Study|Ineligible|0|||
164214307|NCT02068794|593151828|FG002|Overall Study|Ineligible|1|||
164214308|NCT00898807|593151829|FG000|Overall Study|Withdrawal by Subject|5|||
164214309|NCT00898807|593151830|FG001|Overall Study|Withdrawal by Subject|3|||
164214310|NCT00898807|593151829|FG000|Overall Study|Family pressure to discontinue|2|||
164214311|NCT00898807|593151830|FG001|Overall Study|Family pressure to discontinue|2|||
164214312|NCT00898807|593151829|FG000|Overall Study|Lost to Follow-up|1|||
164214313|NCT00898807|593151830|FG001|Overall Study|Lost to Follow-up|3|||
164214314|NCT00898807|593151829|FG000|Overall Study|Death|0|||
164214315|NCT00898807|593151830|FG001|Overall Study|Death|1|||
164214316|NCT01482221|593151833|FG000|Overall Study|Lack of Efficacy|1|||
164214317|NCT01482221|593151834|FG001|Overall Study|Lack of Efficacy|0|||
164214318|NCT01482221|593151835|FG002|Overall Study|Lack of Efficacy|1|||
164214319|NCT01482221|593151833|FG000|Overall Study|Lost to Follow-up|3|||
164214320|NCT01482221|593151834|FG001|Overall Study|Lost to Follow-up|2|||
164214321|NCT01482221|593151835|FG002|Overall Study|Lost to Follow-up|1|||
164214322|NCT01482221|593151833|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
164214323|NCT01482221|593151834|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
164214324|NCT01482221|593151835|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
164214325|NCT01482221|593151833|FG000|Overall Study|Condition under Investigation Worsened|3|||
164214326|NCT01482221|593151834|FG001|Overall Study|Condition under Investigation Worsened|2|||
164214327|NCT01482221|593151835|FG002|Overall Study|Condition under Investigation Worsened|4|||
164214328|NCT01482221|593151833|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
164214329|NCT01482221|593151834|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
164214330|NCT01482221|593151835|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
164214331|NCT01482221|593151833|FG000|Overall Study|Adverse Event|1|||
164214332|NCT01482221|593151834|FG001|Overall Study|Adverse Event|7|||
164214333|NCT01482221|593151835|FG002|Overall Study|Adverse Event|3|||
164214334|NCT01482221|593151833|FG000|Overall Study|Withdrawal by Subject|10|||
164214335|NCT01482221|593151834|FG001|Overall Study|Withdrawal by Subject|7|||
164214336|NCT01482221|593151835|FG002|Overall Study|Withdrawal by Subject|12|||
164214337|NCT01482221|593151833|FG000|Overall Study|Incorrect randomization|0|||
164214338|NCT01482221|593151834|FG001|Overall Study|Incorrect randomization|1|||
164214339|NCT01482221|593151835|FG002|Overall Study|Incorrect randomization|0|||
164214340|NCT01482221|593151833|FG000|Overall Study|Physician Decision|0|||
164214341|NCT01482221|593151834|FG001|Overall Study|Physician Decision|1|||
164214342|NCT01482221|593151835|FG002|Overall Study|Physician Decision|0|||
164214343|NCT05607043|593151836|FG000|Overall Study|Lost to Follow-up|2|||
164214344|NCT05427916|593151840|FG000|Overall Study|Adverse Event|3|||
163876448|NCT03481660|591916880|FG000|Overall Study|Adverse Event|5|||
164214345|NCT05427916|593151841|FG001|Overall Study|Adverse Event|0|||
164214346|NCT05427916|593151840|FG000|Overall Study|Lack of Efficacy|6|||
164214347|NCT05427916|593151841|FG001|Overall Study|Lack of Efficacy|0|||
163876449|NCT03481660|591916881|FG001|Overall Study|Adverse Event|4|||
164214348|NCT05427916|593151840|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
164214349|NCT05427916|593151841|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
164214350|NCT01257542|593151844|FG000|Overall Study|Protocol Violation|3|||
164214351|NCT01257542|593151845|FG001|Overall Study|Protocol Violation|5|||
164214352|NCT01257542|593151844|FG000|Overall Study|Withdrawal by Subject|0|||
164214353|NCT01257542|593151845|FG001|Overall Study|Withdrawal by Subject|2|||
164214354|NCT00081458|593151846|FG000|Overall Study|Adverse Event|1|||
164214355|NCT00081458|593151847|FG001|Overall Study|Adverse Event|5|||
164214356|NCT00081458|593151848|FG002|Overall Study|Adverse Event|2|||
164214357|NCT00081458|593151846|FG000|Overall Study|Withdrawal by Subject|0|||
164214358|NCT00081458|593151847|FG001|Overall Study|Withdrawal by Subject|3|||
164214359|NCT00081458|593151848|FG002|Overall Study|Withdrawal by Subject|1|||
164214360|NCT00081458|593151846|FG000|Overall Study|Randomized but not dosed|0|||
164214361|NCT00081458|593151847|FG001|Overall Study|Randomized but not dosed|0|||
164214362|NCT00081458|593151848|FG002|Overall Study|Randomized but not dosed|1|||
164214363|NCT03097315|593151852|FG000|Overall Study|Withdrawal by Subject|1|||
164214364|NCT03384966|593151853|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
164214365|NCT03384966|593151854|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
164214366|NCT03384966|593151855|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
164214367|NCT03384966|593151853|FG000|Follow-up Period|Adverse Event|1|||
164214368|NCT03384966|593151854|FG001|Follow-up Period|Adverse Event|0|||
164214369|NCT03384966|593151855|FG002|Follow-up Period|Adverse Event|0|||
164214370|NCT04790201|593151856|FG000|Overall Study|Lost to Follow-up|0|||
164214371|NCT04790201|593151857|FG001|Overall Study|Lost to Follow-up|0|||
164214372|NCT04790201|593151858|FG002|Overall Study|Lost to Follow-up|2|||
164214373|NCT04790201|593151856|FG000|Overall Study|Death|0|||
164214374|NCT04790201|593151857|FG001|Overall Study|Death|1|||
164214375|NCT04790201|593151858|FG002|Overall Study|Death|0|||
164214376|NCT04790201|593151856|FG000|Overall Study|Protocol Violation|1|||
164214377|NCT04790201|593151857|FG001|Overall Study|Protocol Violation|0|||
164214378|NCT04790201|593151858|FG002|Overall Study|Protocol Violation|1|||
164214379|NCT01334515|593151859|FG000|Overall Study|Adverse Event|1|||
164214380|NCT01334515|593151860|FG001|Overall Study|Adverse Event|6|||
164214381|NCT01334515|593151859|FG000|Overall Study|Death|1|||
164214382|NCT01334515|593151860|FG001|Overall Study|Death|0|||
164214383|NCT01334515|593151859|FG000|Overall Study|Lack of Efficacy|8|||
164214384|NCT01334515|593151860|FG001|Overall Study|Lack of Efficacy|21|||
164214385|NCT01334515|593151859|FG000|Overall Study|Physician Decision|1|||
164214386|NCT01334515|593151860|FG001|Overall Study|Physician Decision|1|||
164214387|NCT01334515|593151859|FG000|Overall Study|Withdrawal by Subject|1|||
164214388|NCT01334515|593151860|FG001|Overall Study|Withdrawal by Subject|1|||
164214389|NCT03637374|593151861|FG000|Overall Study|Death|2|||
164214390|NCT03637374|593151862|FG001|Overall Study|Death|0|||
164214391|NCT00776997|593151863|FG000|Overall Study|Adverse Event|2|||
164214392|NCT02948400|593151864|FG000|Overall Study|Withdrawal by Subject|17|||
164214393|NCT02948400|593151865|FG001|Overall Study|Withdrawal by Subject|10|||
164214394|NCT02948400|593151864|FG000|Overall Study|failed to attend appointments|47|||
164214395|NCT02948400|593151865|FG001|Overall Study|failed to attend appointments|34|||
164214396|NCT02948400|593151864|FG000|Overall Study|COVID-related closure|6|||
164214397|NCT02948400|593151865|FG001|Overall Study|COVID-related closure|2|||
164214398|NCT02948400|593151864|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
164214399|NCT02948400|593151865|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
164214400|NCT02948400|593151864|FG000|Overall Study|motion sickness in virtual reality|2|||
164214401|NCT02948400|593151865|FG001|Overall Study|motion sickness in virtual reality|0|||
164214402|NCT03925220|593151866|FG000|Overall Study|Withdrawal by Subject|4|||
164214403|NCT03925220|593151867|FG001|Overall Study|Withdrawal by Subject|4|||
164214404|NCT03925220|593151868|FG002|Overall Study|Withdrawal by Subject|4|||
164214405|NCT03925220|593151869|FG003|Overall Study|Withdrawal by Subject|4|||
164214406|NCT03925220|593151866|FG000|Overall Study|Lost to Follow-up|40|||
164214407|NCT03925220|593151867|FG001|Overall Study|Lost to Follow-up|46|||
164214408|NCT03925220|593151868|FG002|Overall Study|Lost to Follow-up|37|||
164214409|NCT03925220|593151869|FG003|Overall Study|Lost to Follow-up|38|||
164214410|NCT05774977|593151870|FG000|Overall Study|Withdrawal by Subject|2|||
164214411|NCT00374868|593151871|FG000|Overall Study|Adverse Event|12|||
164214412|NCT00374868|593151871|FG000|Overall Study|Progressive Disease|7|||
164214413|NCT00374868|593151871|FG000|Overall Study|Physician Decision|13|||
164214414|NCT00374868|593151871|FG000|Overall Study|Lost to Follow-up|1|||
164214415|NCT00374868|593151871|FG000|Overall Study|Death|2|||
164214416|NCT00374868|593151871|FG000|Overall Study|Other - Not Specified|1|||
164214417|NCT04470427|593151872|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
164214418|NCT04470427|593151873|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
164214419|NCT04470427|593151874|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
164214420|NCT04470427|593151875|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
164214421|NCT04470427|593151876|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
164214422|NCT04470427|593151877|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
164214423|NCT04470427|593151872|FG000|Part B :Open-label|Other than specified|0|||
164214424|NCT04470427|593151873|FG001|Part B :Open-label|Other than specified|0|||
164214425|NCT04470427|593151874|FG002|Part B :Open-label|Other than specified|788|||
164214426|NCT04470427|593151875|FG003|Part B :Open-label|Other than specified|0|||
164214427|NCT04470427|593151876|FG004|Part B :Open-label|Other than specified|523|||
164214428|NCT04470427|593151877|FG005|Part B :Open-label|Other than specified|0|||
164214429|NCT04470427|593151872|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
164214430|NCT04470427|593151873|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
164214431|NCT04470427|593151874|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
163876450|NCT03481660|591916880|FG000|Overall Study|Death|13|||
163876451|NCT03481660|591916881|FG001|Overall Study|Death|9|||
163876452|NCT03481660|591916880|FG000|Overall Study|Lost to Follow-up|2|||
163876453|NCT03481660|591916881|FG001|Overall Study|Lost to Follow-up|2|||
163876454|NCT03481660|591916880|FG000|Overall Study|Physician Decision|2|||
163980894|NCT01903837|592299676|FG002|Part B|Physician Decision|0|||
163980895|NCT01903837|592299677|FG003|Part B|Physician Decision|2|||
163980896|NCT01903837|592299674|FG000|Part B|Lack of Efficacy|0|||
163980897|NCT01903837|592299675|FG001|Part B|Lack of Efficacy|1|||
163980898|NCT01903837|592299676|FG002|Part B|Lack of Efficacy|0|||
163980899|NCT01903837|592299677|FG003|Part B|Lack of Efficacy|0|||
163980900|NCT02706873|592299678|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
163980901|NCT02706873|592299679|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
163980902|NCT02706873|592299680|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
163980903|NCT02706873|592299681|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
163980904|NCT02706873|592299678|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
163980905|NCT02706873|592299679|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
163980906|NCT02706873|592299680|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
163980907|NCT02706873|592299681|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
163980908|NCT02706873|592299678|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
163980909|NCT02706873|592299679|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
163980910|NCT02706873|592299680|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
163980911|NCT02706873|592299681|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
163980912|NCT02706873|592299678|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
163980913|NCT02706873|592299679|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
163980914|NCT02706873|592299680|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
163980915|NCT02706873|592299681|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
163980916|NCT02706873|592299678|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
163980917|NCT02706873|592299679|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
163980918|NCT02706873|592299680|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
163980919|NCT02706873|592299681|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
163980920|NCT02706873|592299678|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
163980921|NCT02706873|592299679|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
163980922|NCT02706873|592299680|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
163980923|NCT02706873|592299681|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
163980924|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
163980925|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
163980926|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
163980927|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
163980928|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
163980929|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
163980930|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
163980931|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
163980932|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
163980933|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
163980934|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
163980935|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
163980936|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
163980937|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
163876455|NCT03481660|591916881|FG001|Overall Study|Physician Decision|3|||
163876456|NCT03481660|591916880|FG000|Overall Study|Withdrawal by Subject|14|||
163876457|NCT03481660|591916881|FG001|Overall Study|Withdrawal by Subject|7|||
163980938|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
163980939|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
163980940|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
163980941|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
163980942|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
163980943|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
163980944|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
163980945|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
163980946|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
163980947|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
163980948|NCT02706873|592299678|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
163980949|NCT02706873|592299679|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
163980950|NCT02706873|592299680|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
163980951|NCT02706873|592299681|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
163980952|NCT05098041|592299684|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
163980953|NCT00705939|592299685|FG000|Overall Study|Protocol Violation|0|||
163980954|NCT00705939|592299686|FG001|Overall Study|Protocol Violation|0|||
163980955|NCT00705939|592299687|FG002|Overall Study|Protocol Violation|1|||
163980956|NCT00705939|592299685|FG000|Overall Study|Withdrawal by Subject|0|||
163980957|NCT00705939|592299686|FG001|Overall Study|Withdrawal by Subject|1|||
163876458|NCT04278586|591916882|FG000|Overall Study|Withdrawal by Subject|13|||
163876459|NCT04278586|591916883|FG001|Overall Study|Withdrawal by Subject|6|||
163980958|NCT00705939|592299687|FG002|Overall Study|Withdrawal by Subject|3|||
163980959|NCT00705939|592299685|FG000|Overall Study|Physician Decision|0|||
163980960|NCT00705939|592299686|FG001|Overall Study|Physician Decision|1|||
163980961|NCT00705939|592299687|FG002|Overall Study|Physician Decision|0|||
163980962|NCT00618410|592299688|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
163980963|NCT00618410|592299689|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
163980964|NCT00464334|592299693|FG000|Overall Study|Adverse Event|0|||
163980965|NCT00464334|592299694|FG001|Overall Study|Adverse Event|0|||
163980966|NCT00464334|592299695|FG002|Overall Study|Adverse Event|0|||
163980967|NCT00464334|592299696|FG003|Overall Study|Adverse Event|1|||
163980968|NCT00464334|592299697|FG004|Overall Study|Adverse Event|1|||
163980969|NCT00464334|592299698|FG005|Overall Study|Adverse Event|1|||
164214432|NCT04470427|593151875|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
164214433|NCT04470427|593151876|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
164214434|NCT04470427|593151877|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
164214435|NCT04470427|593151872|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
164214436|NCT04470427|593151873|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
164214437|NCT04470427|593151874|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
164214438|NCT04470427|593151875|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
164214439|NCT04470427|593151876|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
164214440|NCT04470427|593151877|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
164214441|NCT01018979|593151878|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
164214442|NCT01018979|593151879|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
164214443|NCT01018979|593151878|FG000|Overall Study|Not received at least one dose|0|||
164214444|NCT01018979|593151879|FG001|Overall Study|Not received at least one dose|1|||
164214445|NCT02324153|593151882|FG000|Overall Study|Withdrawal by Subject|4|||
164214446|NCT02324153|593151883|FG001|Overall Study|Withdrawal by Subject|1|||
164214447|NCT02324153|593151882|FG000|Overall Study|Surgery postponed after randomization|3|||
164214448|NCT02324153|593151883|FG001|Overall Study|Surgery postponed after randomization|0|||
164214449|NCT02324153|593151882|FG000|Overall Study|Developed delirium preoperatively|1|||
164214450|NCT02324153|593151883|FG001|Overall Study|Developed delirium preoperatively|0|||
164214451|NCT01937299|593151884|FG000|Overall Study|Adverse Event|13|||
164214452|NCT01937299|593151885|FG001|Overall Study|Adverse Event|0|||
164214453|NCT01937299|593151884|FG000|Overall Study|Lack of Efficacy|0|||
164214454|NCT01937299|593151885|FG001|Overall Study|Lack of Efficacy|4|||
164214455|NCT01937299|593151884|FG000|Overall Study|Withdrawal by Subject|1|||
164214456|NCT01937299|593151885|FG001|Overall Study|Withdrawal by Subject|0|||
164214457|NCT01913353|593151886|FG000|Overall Study|Adverse Event|2|||
164214458|NCT01913353|593151887|FG001|Overall Study|Adverse Event|0|||
164214459|NCT01913353|593151886|FG000|Overall Study|Physician Decision|0|||
164214460|NCT01913353|593151887|FG001|Overall Study|Physician Decision|2|||
164214461|NCT01913353|593151886|FG000|Overall Study|Withdrawal by Subject|20|||
164214462|NCT01913353|593151887|FG001|Overall Study|Withdrawal by Subject|6|||
164214463|NCT01913353|593151886|FG000|Overall Study|multiple reasons|10|||
164214464|NCT01913353|593151887|FG001|Overall Study|multiple reasons|7|||
164214465|NCT00385840|593151888|FG000|Overall Study|Adverse Event|1|||
164214466|NCT00385840|593151889|FG001|Overall Study|Adverse Event|1|||
164214467|NCT00385840|593151888|FG000|Overall Study|Lost to Follow-up|3|||
164214468|NCT00385840|593151889|FG001|Overall Study|Lost to Follow-up|13|||
164214469|NCT00700635|593151890|FG000|Overall Study|Adverse Event|1|||
164214470|NCT00700635|593151891|FG001|Overall Study|Adverse Event|0|||
164214471|NCT00700635|593151892|FG002|Overall Study|Adverse Event|0|||
164214472|NCT00700635|593151890|FG000|Overall Study|Lost to Follow-up|1|||
164214473|NCT00700635|593151891|FG001|Overall Study|Lost to Follow-up|3|||
164214474|NCT00700635|593151892|FG002|Overall Study|Lost to Follow-up|0|||
164214475|NCT00700635|593151890|FG000|Overall Study|Protocol Violation|2|||
163980970|NCT00464334|592299699|FG006|Overall Study|Adverse Event|0|||
163980971|NCT00464334|592299700|FG007|Overall Study|Adverse Event|0|||
163980972|NCT00464334|592299701|FG008|Overall Study|Adverse Event|2|||
163980973|NCT00464334|592299702|FG009|Overall Study|Adverse Event|1|||
163980974|NCT00464334|592299703|FG010|Overall Study|Adverse Event|2|||
163980975|NCT00464334|592299693|FG000|Overall Study|Lack of Efficacy|0|||
163980976|NCT00464334|592299694|FG001|Overall Study|Lack of Efficacy|1|||
164214476|NCT00700635|593151891|FG001|Overall Study|Protocol Violation|2|||
164214477|NCT00700635|593151892|FG002|Overall Study|Protocol Violation|0|||
164214478|NCT00700635|593151890|FG000|Overall Study|Withdrawal by Subject|7|||
164214479|NCT00700635|593151891|FG001|Overall Study|Withdrawal by Subject|3|||
164214480|NCT00700635|593151892|FG002|Overall Study|Withdrawal by Subject|1|||
163980977|NCT00464334|592299695|FG002|Overall Study|Lack of Efficacy|0|||
163980978|NCT00464334|592299696|FG003|Overall Study|Lack of Efficacy|0|||
163980979|NCT00464334|592299697|FG004|Overall Study|Lack of Efficacy|0|||
163980980|NCT00464334|592299698|FG005|Overall Study|Lack of Efficacy|0|||
164214481|NCT01260948|593151893|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
164214482|NCT01260948|593151894|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
164214483|NCT01260948|593151893|FG000|Second Intervention|Emesis|0|||
164214484|NCT01260948|593151894|FG001|Second Intervention|Emesis|1|||
164214485|NCT03301714|593152864|FG000|Overall Study|Lost to Follow-up|10|||
163876460|NCT04278586|591916882|FG000|Overall Study|Lost to Follow-up|37|||
163876461|NCT04278586|591916883|FG001|Overall Study|Lost to Follow-up|24|||
163876462|NCT02791230|591916884|FG000|Overall Study|Adverse Event|10|||
163876463|NCT02791230|591916885|FG001|Overall Study|Adverse Event|9|||
163876464|NCT02791230|591916886|FG002|Overall Study|Adverse Event|66|||
163876465|NCT02791230|591916884|FG000|Overall Study|Death|38|||
164214486|NCT03301714|593152865|FG001|Overall Study|Lost to Follow-up|4|||
164214487|NCT03301714|593152866|FG002|Overall Study|Lost to Follow-up|4|||
164214488|NCT03301714|593152864|FG000|Overall Study|Did not receive allocated intervention|0|||
164214489|NCT03301714|593152865|FG001|Overall Study|Did not receive allocated intervention|2|||
164214490|NCT03301714|593152866|FG002|Overall Study|Did not receive allocated intervention|3|||
164214491|NCT03188185|593152867|FG000|Stage 1|Adverse Event|4|||
164214492|NCT03188185|593152868|FG001|Stage 1|Adverse Event|12|||
164214493|NCT03188185|593152869|FG002|Stage 1|Adverse Event|0|||
164214494|NCT03188185|593152870|FG003|Stage 1|Adverse Event|0|||
164214495|NCT03188185|593152867|FG000|Stage 1|Lack of Efficacy|0|||
164214496|NCT03188185|593152868|FG001|Stage 1|Lack of Efficacy|2|||
164214497|NCT03188185|593152869|FG002|Stage 1|Lack of Efficacy|0|||
164325922|NCT04704154|593569014|FG004|Overall Study|Physician Decision|2|||
164325923|NCT04704154|593569015|FG005|Overall Study|Physician Decision|0|||
164325924|NCT04704154|593569010|FG000|Overall Study|Participant Decision|1|||
164325925|NCT04704154|593569011|FG001|Overall Study|Participant Decision|1|||
164325926|NCT04704154|593569012|FG002|Overall Study|Participant Decision|0|||
164325927|NCT04704154|593569013|FG003|Overall Study|Participant Decision|0|||
164325928|NCT04704154|593569014|FG004|Overall Study|Participant Decision|0|||
164325929|NCT04704154|593569015|FG005|Overall Study|Participant Decision|0|||
164325930|NCT04704154|593569010|FG000|Overall Study|Progressive Disease|19|||
164325931|NCT04704154|593569011|FG001|Overall Study|Progressive Disease|17|||
164325932|NCT04704154|593569012|FG002|Overall Study|Progressive Disease|20|||
164325933|NCT04704154|593569013|FG003|Overall Study|Progressive Disease|18|||
164325934|NCT04704154|593569014|FG004|Overall Study|Progressive Disease|36|||
164325935|NCT04704154|593569015|FG005|Overall Study|Progressive Disease|30|||
164325936|NCT04704154|593569010|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
164325937|NCT04704154|593569011|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
164325938|NCT04704154|593569012|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
164325939|NCT04704154|593569013|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
164325940|NCT04704154|593569014|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
164325941|NCT04704154|593569015|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
164325942|NCT04704154|593569010|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
163876466|NCT02791230|591916885|FG001|Overall Study|Death|25|||
163876467|NCT02791230|591916886|FG002|Overall Study|Death|184|||
163876468|NCT02791230|591916884|FG000|Overall Study|Lack of Efficacy|1|||
163876469|NCT02791230|591916885|FG001|Overall Study|Lack of Efficacy|0|||
163876470|NCT02791230|591916886|FG002|Overall Study|Lack of Efficacy|3|||
163876471|NCT02791230|591916884|FG000|Overall Study|Lost to Follow-up|0|||
163876472|NCT02791230|591916885|FG001|Overall Study|Lost to Follow-up|0|||
163876473|NCT02791230|591916886|FG002|Overall Study|Lost to Follow-up|10|||
163876474|NCT02791230|591916884|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
163876475|NCT02791230|591916885|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
163876476|NCT02791230|591916886|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
163876477|NCT02791230|591916884|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
163876478|NCT02791230|591916885|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
163876479|NCT02791230|591916886|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
163876480|NCT02791230|591916884|FG000|Overall Study|Study sites terminated by sponsor|1|||
163876481|NCT02791230|591916885|FG001|Overall Study|Study sites terminated by sponsor|0|||
163876482|NCT02791230|591916886|FG002|Overall Study|Study sites terminated by sponsor|5|||
163876483|NCT02791230|591916884|FG000|Overall Study|Other|9|||
163876484|NCT02791230|591916885|FG001|Overall Study|Other|1|||
163876485|NCT02791230|591916886|FG002|Overall Study|Other|28|||
163876486|NCT02791230|591916884|FG000|Overall Study|Protocol Violation|0|||
163876487|NCT02791230|591916885|FG001|Overall Study|Protocol Violation|0|||
163876488|NCT02791230|591916886|FG002|Overall Study|Protocol Violation|4|||
163876489|NCT02791230|591916884|FG000|Overall Study|Withdrawal by Subject|24|||
163876490|NCT02791230|591916885|FG001|Overall Study|Withdrawal by Subject|13|||
163876491|NCT02791230|591916886|FG002|Overall Study|Withdrawal by Subject|172|||
163876492|NCT02791230|591916884|FG000|Overall Study|Enrolled but not treated|0|||
163876493|NCT02791230|591916885|FG001|Overall Study|Enrolled but not treated|0|||
163876494|NCT02791230|591916886|FG002|Overall Study|Enrolled but not treated|5|||
163876495|NCT05307978|591916897|FG000|Overall Study|Lost to Follow-up|0|||
163876496|NCT05307978|591916898|FG001|Overall Study|Lost to Follow-up|1|||
163876497|NCT05307978|591916899|FG002|Overall Study|Lost to Follow-up|0|||
164214498|NCT03188185|593152870|FG003|Stage 1|Lack of Efficacy|0|||
164214499|NCT03188185|593152867|FG000|Stage 1|Lost to Follow-up|6|||
164214500|NCT03188185|593152868|FG001|Stage 1|Lost to Follow-up|1|||
164214501|NCT03188185|593152869|FG002|Stage 1|Lost to Follow-up|0|||
164214502|NCT03188185|593152870|FG003|Stage 1|Lost to Follow-up|0|||
164214503|NCT03188185|593152867|FG000|Stage 1|Withdrawal by Subject|9|||
164214504|NCT03188185|593152868|FG001|Stage 1|Withdrawal by Subject|0|||
164214505|NCT03188185|593152869|FG002|Stage 1|Withdrawal by Subject|0|||
164214506|NCT03188185|593152870|FG003|Stage 1|Withdrawal by Subject|0|||
164214507|NCT03188185|593152867|FG000|Stage 1|Identified as a professional patient|0|||
164214508|NCT03188185|593152868|FG001|Stage 1|Identified as a professional patient|1|||
164214509|NCT03188185|593152869|FG002|Stage 1|Identified as a professional patient|0|||
164214510|NCT03188185|593152870|FG003|Stage 1|Identified as a professional patient|0|||
164214511|NCT03188185|593152867|FG000|Stage 2|Adverse Event|0|||
164214512|NCT03188185|593152868|FG001|Stage 2|Adverse Event|0|||
164214513|NCT03188185|593152869|FG002|Stage 2|Adverse Event|2|||
164214514|NCT03188185|593152870|FG003|Stage 2|Adverse Event|4|||
164214515|NCT03188185|593152867|FG000|Stage 2|Lack of Efficacy|0|||
164214516|NCT03188185|593152868|FG001|Stage 2|Lack of Efficacy|0|||
164214517|NCT03188185|593152869|FG002|Stage 2|Lack of Efficacy|3|||
164214518|NCT03188185|593152870|FG003|Stage 2|Lack of Efficacy|0|||
164214519|NCT03188185|593152867|FG000|Stage 2|Lost to Follow-up|0|||
164214520|NCT03188185|593152868|FG001|Stage 2|Lost to Follow-up|0|||
164214521|NCT03188185|593152869|FG002|Stage 2|Lost to Follow-up|1|||
164214522|NCT03188185|593152870|FG003|Stage 2|Lost to Follow-up|0|||
164214523|NCT03188185|593152867|FG000|Stage 2|Physician Decision|0|||
164214524|NCT03188185|593152868|FG001|Stage 2|Physician Decision|0|||
164214525|NCT03188185|593152869|FG002|Stage 2|Physician Decision|0|||
164214526|NCT03188185|593152870|FG003|Stage 2|Physician Decision|1|||
164214527|NCT03188185|593152867|FG000|Stage 2|Withdrawal by Subject|0|||
164214528|NCT03188185|593152868|FG001|Stage 2|Withdrawal by Subject|0|||
164214529|NCT03188185|593152869|FG002|Stage 2|Withdrawal by Subject|3|||
164214530|NCT03188185|593152870|FG003|Stage 2|Withdrawal by Subject|1|||
164214531|NCT02965456|593152871|FG000|Overall Study|Lost to Follow-up|40|||
164214532|NCT02965456|593152872|FG001|Overall Study|Lost to Follow-up|18|||
164214533|NCT02965456|593152871|FG000|Overall Study|Subject Request|22|||
164214534|NCT02965456|593152872|FG001|Overall Study|Subject Request|13|||
164214535|NCT02965456|593152871|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
164214536|NCT02965456|593152872|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
164214537|NCT02965456|593152871|FG000|Overall Study|Adverse Event|3|||
164214538|NCT02965456|593152872|FG001|Overall Study|Adverse Event|0|||
164214539|NCT02965456|593152871|FG000|Overall Study|Noncompliance with Study Drug|1|||
164214540|NCT02965456|593152872|FG001|Overall Study|Noncompliance with Study Drug|1|||
164214541|NCT02965456|593152871|FG000|Overall Study|Worsening Condition|0|||
164214542|NCT02965456|593152872|FG001|Overall Study|Worsening Condition|2|||
164325943|NCT04704154|593569011|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325944|NCT04704154|593569012|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
164325945|NCT04704154|593569013|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325946|NCT04704154|593569014|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325947|NCT04704154|593569015|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
164325948|NCT03220438|593569016|FG000|Overall Study|Lost to Follow-up|0|||
164325949|NCT03220438|593569017|FG001|Overall Study|Lost to Follow-up|0|||
164325950|NCT03220438|593569018|FG002|Overall Study|Lost to Follow-up|1|||
164325951|NCT03220438|593569019|FG003|Overall Study|Lost to Follow-up|0|||
164325952|NCT04062123|593569020|FG000|Overall Study|Withdrawal by Subject|0|||
164325953|NCT04062123|593569021|FG001|Overall Study|Withdrawal by Subject|1|||
164325954|NCT04062123|593569022|FG002|Overall Study|Withdrawal by Subject|0|||
164325955|NCT04190680|593569023|FG000|Overall Study|Not meeting criteria for data analysis|1|||
164325956|NCT04190680|593569024|FG001|Overall Study|Not meeting criteria for data analysis|15|||
164325957|NCT04190680|593569023|FG000|Overall Study|Administrative error|0|||
164325958|NCT04190680|593569024|FG001|Overall Study|Administrative error|18|||
164325959|NCT03780400|593569025|FG000|Overall Study|Lost to Follow-up|5|||
164325960|NCT03780400|593569025|FG000|Overall Study|Withdrawal by Subject|2|||
163980981|NCT00464334|592299699|FG006|Overall Study|Lack of Efficacy|0|||
164214543|NCT02965456|593152871|FG000|Overall Study|Lack of Efficacy|1|||
164214544|NCT02965456|593152872|FG001|Overall Study|Lack of Efficacy|0|||
164214545|NCT02965456|593152871|FG000|Overall Study|Physician Decision|0|||
164214546|NCT02965456|593152872|FG001|Overall Study|Physician Decision|1|||
164214547|NCT02965456|593152871|FG000|Overall Study|Pregnancy|1|||
163980982|NCT00464334|592299700|FG007|Overall Study|Lack of Efficacy|0|||
164214548|NCT02965456|593152872|FG001|Overall Study|Pregnancy|0|||
164214549|NCT02965456|593152871|FG000|Overall Study|Protocol Violation|0|||
164214550|NCT02965456|593152872|FG001|Overall Study|Protocol Violation|1|||
164214551|NCT02965456|593152871|FG000|Overall Study|Participant ran out of study drug|0|||
164214552|NCT02965456|593152872|FG001|Overall Study|Participant ran out of study drug|1|||
164214553|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
164214554|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
164214555|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
164214556|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Death|1|||
164214557|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Death|0|||
164214558|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Death|0|||
164214559|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
164214560|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
164214561|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
164214562|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
164214563|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
164214564|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
164214565|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
164214566|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
164214567|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
164214568|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
164214569|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
164214570|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
164214571|NCT05073315|593152873|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
164214572|NCT05073315|593152874|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
164214573|NCT05073315|593152875|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
164214574|NCT05073315|593152873|FG000|Period 2|Adverse Event|0|||
164214575|NCT05073315|593152874|FG001|Period 2|Adverse Event|3|||
164214576|NCT05073315|593152875|FG002|Period 2|Adverse Event|6|||
164214577|NCT05073315|593152873|FG000|Period 2|Lost to Follow-up|0|||
164214578|NCT05073315|593152874|FG001|Period 2|Lost to Follow-up|5|||
164214579|NCT05073315|593152875|FG002|Period 2|Lost to Follow-up|5|||
164214580|NCT05073315|593152873|FG000|Period 2|Withdrawal by Subject|0|||
164214581|NCT05073315|593152874|FG001|Period 2|Withdrawal by Subject|4|||
164214582|NCT05073315|593152875|FG002|Period 2|Withdrawal by Subject|9|||
164214583|NCT05073315|593152873|FG000|Period 2|Protocol Violation|0|||
164214584|NCT05073315|593152874|FG001|Period 2|Protocol Violation|0|||
164214585|NCT05073315|593152875|FG002|Period 2|Protocol Violation|1|||
164214586|NCT01529268|593152876|FG000|Overall Study|Lost to Follow-up|9|||
164214587|NCT01529268|593152877|FG001|Overall Study|Lost to Follow-up|3|||
164214588|NCT01529268|593152876|FG000|Overall Study|Moved|3|||
164214589|NCT01529268|593152877|FG001|Overall Study|Moved|0|||
164214590|NCT00303953|593152878|FG000|Overall Study|Ineligible|1|||
164214591|NCT00303953|593152878|FG000|Overall Study|Death|1|||
164214592|NCT00303953|593152878|FG000|Overall Study|Adverse Event|4|||
164214593|NCT00303953|593152878|FG000|Overall Study|Lack of Efficacy|12|||
164214594|NCT00303953|593152878|FG000|Overall Study|Physician Decision|1|||
164214595|NCT04465955|593152879|FG000|Overall Study|Withdrew consent|6|||
164214596|NCT04465955|593152880|FG001|Overall Study|Withdrew consent|10|||
164214597|NCT04465955|593152881|FG002|Overall Study|Withdrew consent|7|||
164214598|NCT04465955|593152879|FG000|Overall Study|Adverse Event|6|||
164214599|NCT04465955|593152880|FG001|Overall Study|Adverse Event|5|||
164214600|NCT04465955|593152881|FG002|Overall Study|Adverse Event|1|||
164214601|NCT04465955|593152879|FG000|Overall Study|Lost to Follow-up|2|||
164214602|NCT04465955|593152880|FG001|Overall Study|Lost to Follow-up|0|||
164214603|NCT04465955|593152881|FG002|Overall Study|Lost to Follow-up|3|||
164214604|NCT04465955|593152879|FG000|Overall Study|Other|1|||
164214605|NCT04465955|593152880|FG001|Overall Study|Other|1|||
164214606|NCT04465955|593152881|FG002|Overall Study|Other|3|||
164214607|NCT02393755|593152882|FG000|Overall Study|Withdrawal by Subject|0|||
164214608|NCT02393755|593152883|FG001|Overall Study|Withdrawal by Subject|3|||
164214609|NCT02393755|593152882|FG000|Overall Study|Adverse Event|0|||
164325961|NCT01850602|593569026|FG000|Overall Study|Adverse Event|7|||
164214610|NCT02393755|593152883|FG001|Overall Study|Adverse Event|2|||
164214611|NCT02393755|593152882|FG000|Overall Study|Physician Decision|0|||
164214612|NCT02393755|593152883|FG001|Overall Study|Physician Decision|2|||
164214613|NCT05324371|593152884|FG000|Overall Study|Withdrawal by Subject|1|||
164214614|NCT05324371|593152884|FG000|Overall Study|Death|1|||
164214615|NCT04822194|593152885|FG000|Overall Study|Withdrawal by Subject|5|||
164214616|NCT04822194|593152886|FG001|Overall Study|Withdrawal by Subject|4|||
164214617|NCT04822194|593152885|FG000|Overall Study|Technical issues with MR scanner|1|||
164214618|NCT04822194|593152886|FG001|Overall Study|Technical issues with MR scanner|0|||
164077706|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
164077707|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164214619|NCT04822194|593152885|FG000|Overall Study|Lost to Follow-up|5|||
164214620|NCT04822194|593152886|FG001|Overall Study|Lost to Follow-up|7|||
164214621|NCT05182125|593152887|FG000|Overall Study|Withdrawal by Subject|0|||
164214622|NCT05182125|593152888|FG001|Overall Study|Withdrawal by Subject|0|||
164214623|NCT05182125|593152889|FG002|Overall Study|Withdrawal by Subject|0|||
164214624|NCT05182125|593152890|FG003|Overall Study|Withdrawal by Subject|0|||
164214625|NCT05182125|593152891|FG004|Overall Study|Withdrawal by Subject|2|||
164214626|NCT05182125|593152892|FG005|Overall Study|Withdrawal by Subject|0|||
164214627|NCT05182125|593152887|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214628|NCT05182125|593152888|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214629|NCT05182125|593152889|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214630|NCT05182125|593152890|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
164325962|NCT01850602|593569027|FG001|Overall Study|Adverse Event|10|||
164214631|NCT05182125|593152891|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214632|NCT05182125|593152892|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
164214633|NCT05182125|593152887|FG000|Overall Study|Death|0|||
164214634|NCT05182125|593152888|FG001|Overall Study|Death|0|||
164214635|NCT05182125|593152889|FG002|Overall Study|Death|0|||
164214636|NCT05182125|593152890|FG003|Overall Study|Death|0|||
164214637|NCT05182125|593152891|FG004|Overall Study|Death|1|||
164214638|NCT05182125|593152892|FG005|Overall Study|Death|0|||
164214639|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
164214640|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
164214641|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164214642|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164214643|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
164214644|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
164214645|NCT02965833|593152896|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
164214646|NCT02965833|593152897|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
164214647|NCT02965833|593152896|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
164214648|NCT02965833|593152897|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
164214649|NCT03370302|593152899|FG000|Dose Escalation Phase|Other|0|||
164214650|NCT03370302|593152900|FG001|Dose Escalation Phase|Other|1|||
164214651|NCT03370302|593152901|FG002|Dose Escalation Phase|Other|1|||
164214652|NCT03370302|593152902|FG003|Dose Escalation Phase|Other|0|||
164214653|NCT03370302|593152903|FG004|Dose Escalation Phase|Other|0|||
164214654|NCT03370302|593152904|FG005|Dose Escalation Phase|Other|0|||
163980983|NCT00464334|592299701|FG008|Overall Study|Lack of Efficacy|0|||
163980984|NCT00464334|592299702|FG009|Overall Study|Lack of Efficacy|0|||
163980985|NCT00464334|592299703|FG010|Overall Study|Lack of Efficacy|0|||
163980986|NCT00464334|592299693|FG000|Overall Study|Lost to Follow-up|0|||
163980987|NCT00464334|592299694|FG001|Overall Study|Lost to Follow-up|0|||
163980988|NCT00464334|592299695|FG002|Overall Study|Lost to Follow-up|1|||
163980989|NCT00464334|592299696|FG003|Overall Study|Lost to Follow-up|0|||
163980990|NCT00464334|592299697|FG004|Overall Study|Lost to Follow-up|1|||
163980991|NCT00464334|592299698|FG005|Overall Study|Lost to Follow-up|0|||
163980992|NCT00464334|592299699|FG006|Overall Study|Lost to Follow-up|1|||
163980993|NCT00464334|592299700|FG007|Overall Study|Lost to Follow-up|0|||
163980994|NCT00464334|592299701|FG008|Overall Study|Lost to Follow-up|0|||
163980995|NCT00464334|592299702|FG009|Overall Study|Lost to Follow-up|0|||
163980996|NCT00464334|592299703|FG010|Overall Study|Lost to Follow-up|2|||
163980997|NCT00464334|592299693|FG000|Overall Study|Progressive Disease|0|||
163980998|NCT00464334|592299694|FG001|Overall Study|Progressive Disease|0|||
164214655|NCT03370302|593152899|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164214656|NCT03370302|593152900|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
164214657|NCT03370302|593152901|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
164214658|NCT03370302|593152902|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164214659|NCT03370302|593152903|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
164214660|NCT03370302|593152904|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
164214661|NCT03370302|593152899|FG000|Dose Escalation Phase|Adverse Event|1|||
164214662|NCT03370302|593152900|FG001|Dose Escalation Phase|Adverse Event|0|||
164214663|NCT03370302|593152901|FG002|Dose Escalation Phase|Adverse Event|2|||
164214664|NCT03370302|593152902|FG003|Dose Escalation Phase|Adverse Event|0|||
164214665|NCT03370302|593152903|FG004|Dose Escalation Phase|Adverse Event|0|||
164214666|NCT03370302|593152904|FG005|Dose Escalation Phase|Adverse Event|0|||
164214667|NCT03370302|593152899|FG000|Dose Escalation Phase|Progressive Disease|2|||
164214668|NCT03370302|593152900|FG001|Dose Escalation Phase|Progressive Disease|4|||
163980999|NCT00464334|592299695|FG002|Overall Study|Progressive Disease|0|||
163981000|NCT00464334|592299696|FG003|Overall Study|Progressive Disease|0|||
163981001|NCT00464334|592299697|FG004|Overall Study|Progressive Disease|0|||
163981002|NCT00464334|592299698|FG005|Overall Study|Progressive Disease|1|||
164214669|NCT03370302|593152901|FG002|Dose Escalation Phase|Progressive Disease|2|||
164214670|NCT03370302|593152902|FG003|Dose Escalation Phase|Progressive Disease|0|||
164214671|NCT03370302|593152903|FG004|Dose Escalation Phase|Progressive Disease|3|||
163981003|NCT00464334|592299699|FG006|Overall Study|Progressive Disease|0|||
163981004|NCT00464334|592299700|FG007|Overall Study|Progressive Disease|0|||
163981005|NCT00464334|592299701|FG008|Overall Study|Progressive Disease|1|||
163981006|NCT00464334|592299702|FG009|Overall Study|Progressive Disease|0|||
164214672|NCT03370302|593152904|FG005|Dose Escalation Phase|Progressive Disease|1|||
164214673|NCT03370302|593152899|FG000|Dose Expansion Phase|Progressive Disease|0|||
164214674|NCT03370302|593152900|FG001|Dose Expansion Phase|Progressive Disease|0|||
164214675|NCT03370302|593152901|FG002|Dose Expansion Phase|Progressive Disease|0|||
164214676|NCT03370302|593152902|FG003|Dose Expansion Phase|Progressive Disease|6|||
164214677|NCT03370302|593152903|FG004|Dose Expansion Phase|Progressive Disease|0|||
164214678|NCT03370302|593152904|FG005|Dose Expansion Phase|Progressive Disease|0|||
164214679|NCT00118287|593152905|FG000|Overall Study|Intracranial haemorrhage|1|||
164214680|NCT00118287|593152905|FG000|Overall Study|Muscle pain|1|||
163981007|NCT00464334|592299703|FG010|Overall Study|Progressive Disease|0|||
163981008|NCT00464334|592299693|FG000|Overall Study|Study Terminated by Sponsor|0|||
164325963|NCT01850602|593569026|FG000|Overall Study|Physician Decision|2|||
163981009|NCT00464334|592299694|FG001|Overall Study|Study Terminated by Sponsor|0|||
163981010|NCT00464334|592299695|FG002|Overall Study|Study Terminated by Sponsor|0|||
163981011|NCT00464334|592299696|FG003|Overall Study|Study Terminated by Sponsor|1|||
164214681|NCT04738487|593152906|FG000|Overall Study|Participant Ongoing in Study|298|||
164214682|NCT04738487|593152907|FG001|Overall Study|Participant Ongoing in Study|297|||
164214683|NCT04738487|593152906|FG000|Overall Study|Withdrawal by Subject|7|||
164214684|NCT04738487|593152907|FG001|Overall Study|Withdrawal by Subject|9|||
164214685|NCT04738487|593152906|FG000|Overall Study|Lost to Follow-up|2|||
164214686|NCT04738487|593152907|FG001|Overall Study|Lost to Follow-up|0|||
164214687|NCT04738487|593152906|FG000|Overall Study|Death|287|||
164214688|NCT04738487|593152907|FG001|Overall Study|Death|306|||
164214689|NCT03976375|593152908|FG000|Overall Study|Death|158|||
164214690|NCT03976375|593152909|FG001|Overall Study|Death|160|||
164214691|NCT03976375|593152910|FG002|Overall Study|Death|42|||
164214692|NCT03976375|593152908|FG000|Overall Study|Lost to Follow-up|2|||
164214693|NCT03976375|593152909|FG001|Overall Study|Lost to Follow-up|1|||
164214694|NCT03976375|593152910|FG002|Overall Study|Lost to Follow-up|1|||
164214695|NCT03976375|593152908|FG000|Overall Study|Withdrawal by Subject|5|||
164214696|NCT03976375|593152909|FG001|Overall Study|Withdrawal by Subject|9|||
163981012|NCT00464334|592299697|FG004|Overall Study|Study Terminated by Sponsor|0|||
163981013|NCT00464334|592299698|FG005|Overall Study|Study Terminated by Sponsor|0|||
163981014|NCT00464334|592299699|FG006|Overall Study|Study Terminated by Sponsor|0|||
164214697|NCT03976375|593152910|FG002|Overall Study|Withdrawal by Subject|4|||
164214698|NCT03976375|593152908|FG000|Overall Study|Sponsor decision|20|||
164214699|NCT03976375|593152909|FG001|Overall Study|Sponsor decision|19|||
164214700|NCT03976375|593152910|FG002|Overall Study|Sponsor decision|1|||
164214701|NCT04818112|593152911|FG000|Overall Study|Withdrawal by Subject|54|||
164214702|NCT04818112|593152912|FG001|Overall Study|Withdrawal by Subject|12|||
164214703|NCT04818112|593152911|FG000|Overall Study|Lost to Follow-up|38|||
164214704|NCT04818112|593152912|FG001|Overall Study|Lost to Follow-up|10|||
164214705|NCT03091439|593152913|FG000|Overall Study|Study Terminated by the Sponsor|1|||
164214706|NCT03091439|593152914|FG001|Overall Study|Study Terminated by the Sponsor|0|||
163876498|NCT05307978|591916900|FG003|Overall Study|Lost to Follow-up|4|||
163876499|NCT05307978|591916901|FG004|Overall Study|Lost to Follow-up|0|||
163876500|NCT05307978|591916902|FG005|Overall Study|Lost to Follow-up|0|||
163876501|NCT05307978|591916903|FG006|Overall Study|Lost to Follow-up|1|||
163876502|NCT05075408|591916904|FG000|Overall Study|Withdrawal by Subject|5|||
163876503|NCT05075408|591916905|FG001|Overall Study|Withdrawal by Subject|3|||
163876504|NCT05075408|591916906|FG002|Overall Study|Withdrawal by Subject|4|||
163876505|NCT05075408|591916904|FG000|Overall Study|Adverse Event|5|||
163876506|NCT05075408|591916905|FG001|Overall Study|Adverse Event|7|||
163876507|NCT05075408|591916906|FG002|Overall Study|Adverse Event|8|||
163876508|NCT05075408|591916904|FG000|Overall Study|Protocol Violation|0|||
163876509|NCT05075408|591916905|FG001|Overall Study|Protocol Violation|1|||
163876510|NCT05075408|591916906|FG002|Overall Study|Protocol Violation|0|||
163876511|NCT05075408|591916904|FG000|Overall Study|Lost to Follow-up|2|||
163876512|NCT05075408|591916905|FG001|Overall Study|Lost to Follow-up|1|||
163876513|NCT05075408|591916906|FG002|Overall Study|Lost to Follow-up|1|||
163876514|NCT05075408|591916904|FG000|Overall Study|Physician Decision|1|||
163876515|NCT05075408|591916905|FG001|Overall Study|Physician Decision|0|||
163876516|NCT05075408|591916906|FG002|Overall Study|Physician Decision|0|||
163876517|NCT05075408|591916904|FG000|Overall Study|Other-unspecified|3|||
163876518|NCT05075408|591916905|FG001|Overall Study|Other-unspecified|2|||
163876519|NCT05075408|591916906|FG002|Overall Study|Other-unspecified|0|||
163876520|NCT03651895|591916907|FG000|First Drug Assignment|Adverse Event|4|||
163876521|NCT03651895|591916908|FG001|First Drug Assignment|Adverse Event|5|||
163876522|NCT03651895|591916907|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
163876523|NCT03651895|591916908|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
163876524|NCT04855760|591916910|FG000|Overall Study|Adverse Event|21|||
163876525|NCT04855760|591916910|FG000|Overall Study|Withdrawal by Subject|116|||
163876526|NCT04855760|591916910|FG000|Overall Study|Lack of Efficacy|21|||
163876527|NCT04855760|591916910|FG000|Overall Study|Lost to Follow-up|49|||
163876528|NCT04855760|591916910|FG000|Overall Study|Protocol Violation|2|||
163876529|NCT04855760|591916910|FG000|Overall Study|Physician Decision|5|||
163876530|NCT04855760|591916910|FG000|Overall Study|Pregnancy|1|||
163876531|NCT04855760|591916910|FG000|Overall Study|Non-Compliance with Study Drug|11|||
163876532|NCT04855760|591916910|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
163876533|NCT04855760|591916910|FG000|Overall Study|Study Completed by Sponsor|202|||
163876534|NCT04855760|591916910|FG000|Overall Study|Other|13|||
163876535|NCT02879448|591916911|FG000|Overall Study|Death|251|||
163876536|NCT02879448|591916912|FG001|Overall Study|Death|263|||
163876537|NCT02879448|591916911|FG000|Overall Study|Lost to Follow-up|23|||
163876538|NCT02879448|591916912|FG001|Overall Study|Lost to Follow-up|28|||
163876539|NCT02879448|591916911|FG000|Overall Study|Withdrawal by Subject|42|||
163876540|NCT02879448|591916912|FG001|Overall Study|Withdrawal by Subject|79|||
163876541|NCT02879448|591916911|FG000|Overall Study|Other Reasons|8|||
163876542|NCT02879448|591916912|FG001|Overall Study|Other Reasons|12|||
163876543|NCT01718743|591916913|FG000|Overall Study|Physician Decision|7|||
163981015|NCT00464334|592299700|FG007|Overall Study|Study Terminated by Sponsor|0|||
163981016|NCT00464334|592299701|FG008|Overall Study|Study Terminated by Sponsor|0|||
163981017|NCT00464334|592299702|FG009|Overall Study|Study Terminated by Sponsor|0|||
163981018|NCT00464334|592299703|FG010|Overall Study|Study Terminated by Sponsor|0|||
163981019|NCT00464334|592299693|FG000|Overall Study|Withdrawal by Subject|1|||
163981020|NCT00464334|592299694|FG001|Overall Study|Withdrawal by Subject|7|||
163981021|NCT00464334|592299695|FG002|Overall Study|Withdrawal by Subject|4|||
164325964|NCT01850602|593569027|FG001|Overall Study|Physician Decision|1|||
164325965|NCT01850602|593569026|FG000|Overall Study|Withdrawal by Subject|2|||
163981022|NCT00464334|592299696|FG003|Overall Study|Withdrawal by Subject|2|||
164077708|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077709|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077710|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077711|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
164077712|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
164077713|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077714|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077715|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077716|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
164077717|NCT00950599|592650007|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
164077718|NCT00950599|592650008|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
164077719|NCT00950599|592650009|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
164077720|NCT00950599|592650010|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
164077721|NCT00950599|592650011|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
164077722|NCT00950599|592650012|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
164077723|NCT00950599|592650013|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
164077724|NCT00950599|592650014|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
164077725|NCT00950599|592650015|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
164077726|NCT00950599|592650016|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
164077727|NCT00950599|592650007|FG000|Follow-Up Period|Adverse Event|0|||
164077728|NCT00950599|592650008|FG001|Follow-Up Period|Adverse Event|0|||
164077729|NCT00950599|592650009|FG002|Follow-Up Period|Adverse Event|0|||
164077730|NCT00950599|592650010|FG003|Follow-Up Period|Adverse Event|0|||
164077731|NCT00950599|592650011|FG004|Follow-Up Period|Adverse Event|0|||
164077732|NCT00950599|592650012|FG005|Follow-Up Period|Adverse Event|0|||
164077733|NCT00950599|592650013|FG006|Follow-Up Period|Adverse Event|0|||
164077734|NCT00950599|592650014|FG007|Follow-Up Period|Adverse Event|0|||
164077735|NCT00950599|592650015|FG008|Follow-Up Period|Adverse Event|1|||
164077736|NCT00950599|592650016|FG009|Follow-Up Period|Adverse Event|0|||
164077737|NCT00950599|592650007|FG000|Follow-Up Period|Lack of Efficacy|0|||
164077738|NCT00950599|592650008|FG001|Follow-Up Period|Lack of Efficacy|0|||
164077739|NCT00950599|592650009|FG002|Follow-Up Period|Lack of Efficacy|0|||
164077740|NCT00950599|592650010|FG003|Follow-Up Period|Lack of Efficacy|0|||
164077741|NCT00950599|592650011|FG004|Follow-Up Period|Lack of Efficacy|0|||
164077742|NCT00950599|592650012|FG005|Follow-Up Period|Lack of Efficacy|0|||
164077743|NCT00950599|592650013|FG006|Follow-Up Period|Lack of Efficacy|0|||
164077744|NCT00950599|592650014|FG007|Follow-Up Period|Lack of Efficacy|0|||
164077745|NCT00950599|592650015|FG008|Follow-Up Period|Lack of Efficacy|3|||
164077746|NCT00950599|592650016|FG009|Follow-Up Period|Lack of Efficacy|0|||
164077747|NCT00950599|592650007|FG000|Follow-Up Period|Lost to Follow-up|0|||
164077748|NCT00950599|592650008|FG001|Follow-Up Period|Lost to Follow-up|0|||
164077749|NCT00950599|592650009|FG002|Follow-Up Period|Lost to Follow-up|0|||
164077750|NCT00950599|592650010|FG003|Follow-Up Period|Lost to Follow-up|0|||
164077751|NCT00950599|592650011|FG004|Follow-Up Period|Lost to Follow-up|0|||
164077752|NCT00950599|592650012|FG005|Follow-Up Period|Lost to Follow-up|0|||
164077753|NCT00950599|592650013|FG006|Follow-Up Period|Lost to Follow-up|0|||
164077754|NCT00950599|592650014|FG007|Follow-Up Period|Lost to Follow-up|0|||
164077755|NCT00950599|592650015|FG008|Follow-Up Period|Lost to Follow-up|5|||
164077756|NCT00950599|592650016|FG009|Follow-Up Period|Lost to Follow-up|1|||
164077757|NCT00950599|592650007|FG000|Follow-Up Period|Physician Decision|0|||
164077758|NCT00950599|592650008|FG001|Follow-Up Period|Physician Decision|0|||
164077759|NCT00950599|592650009|FG002|Follow-Up Period|Physician Decision|0|||
164077760|NCT00950599|592650010|FG003|Follow-Up Period|Physician Decision|0|||
164077761|NCT00950599|592650011|FG004|Follow-Up Period|Physician Decision|0|||
164077762|NCT00950599|592650012|FG005|Follow-Up Period|Physician Decision|0|||
164077763|NCT00950599|592650013|FG006|Follow-Up Period|Physician Decision|0|||
164077764|NCT00950599|592650014|FG007|Follow-Up Period|Physician Decision|0|||
164325966|NCT01850602|593569027|FG001|Overall Study|Withdrawal by Subject|4|||
164077765|NCT00950599|592650015|FG008|Follow-Up Period|Physician Decision|1|||
164077766|NCT00950599|592650016|FG009|Follow-Up Period|Physician Decision|0|||
164077767|NCT00950599|592650007|FG000|Follow-Up Period|Poor/Noncompliance|0|||
164325967|NCT01850602|593569026|FG000|Overall Study|Decrease in serum calcium|2|||
163981023|NCT00464334|592299697|FG004|Overall Study|Withdrawal by Subject|2|||
164214707|NCT03122106|593152915|FG000|Overall Study|Not enough tissue|1|||
164214708|NCT03122106|593152915|FG000|Overall Study|Disease progression during screening|2|||
164214709|NCT03122106|593152915|FG000|Overall Study|Poor RNA quality for vaccine|1|||
164214710|NCT04017962|593152916|FG000|Overall Study|Death|2|||
164214711|NCT04017962|593152917|FG001|Overall Study|Death|0|||
164214712|NCT04017962|593152916|FG000|Overall Study|Lost to Follow-up|2|||
164214713|NCT04017962|593152917|FG001|Overall Study|Lost to Follow-up|0|||
164214714|NCT04017962|593152916|FG000|Overall Study|Physician Decision|1|||
164214715|NCT04017962|593152917|FG001|Overall Study|Physician Decision|0|||
164214716|NCT04017962|593152916|FG000|Overall Study|Discontinued LTV|5|||
164214717|NCT04017962|593152917|FG001|Overall Study|Discontinued LTV|0|||
164214718|NCT05172570|593152918|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
164214719|NCT05172570|593152919|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
164214720|NCT05172570|593152920|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
164214721|NCT05172570|593152918|FG000|Overall Study|PI Decision due to equipment shortages|0|||
164214722|NCT05172570|593152919|FG001|Overall Study|PI Decision due to equipment shortages|0|||
164214723|NCT05172570|593152920|FG002|Overall Study|PI Decision due to equipment shortages|1|||
164214724|NCT00640289|593152921|FG000|Overall Study|Death|3|||
164325968|NCT01850602|593569027|FG001|Overall Study|Decrease in serum calcium|3|||
164325969|NCT01850602|593569026|FG000|Overall Study|Increase in serum ferritin|1|||
164325970|NCT01850602|593569027|FG001|Overall Study|Increase in serum ferritin|0|||
164325971|NCT00740051|593569030|FG000|Overall Study|Lack of Efficacy|2|||
164325972|NCT00740051|593569031|FG001|Overall Study|Lack of Efficacy|5|||
164325973|NCT00740051|593569030|FG000|Overall Study|Adverse Event|1|||
164325974|NCT00740051|593569031|FG001|Overall Study|Adverse Event|4|||
164325975|NCT00740051|593569030|FG000|Overall Study|Protocol Violation|2|||
164325976|NCT00740051|593569031|FG001|Overall Study|Protocol Violation|6|||
164325977|NCT00740051|593569030|FG000|Overall Study|Lost to Follow-up|3|||
164077768|NCT00950599|592650008|FG001|Follow-Up Period|Poor/Noncompliance|0|||
164077769|NCT00950599|592650009|FG002|Follow-Up Period|Poor/Noncompliance|0|||
164077770|NCT00950599|592650010|FG003|Follow-Up Period|Poor/Noncompliance|0|||
164077771|NCT00950599|592650011|FG004|Follow-Up Period|Poor/Noncompliance|0|||
164077772|NCT00950599|592650012|FG005|Follow-Up Period|Poor/Noncompliance|0|||
164077773|NCT00950599|592650013|FG006|Follow-Up Period|Poor/Noncompliance|0|||
164077774|NCT00950599|592650014|FG007|Follow-Up Period|Poor/Noncompliance|0|||
164077775|NCT00950599|592650015|FG008|Follow-Up Period|Poor/Noncompliance|1|||
164077776|NCT00950599|592650016|FG009|Follow-Up Period|Poor/Noncompliance|0|||
164077777|NCT00950599|592650007|FG000|Follow-Up Period|Subject withdrew Consent|0|||
164077778|NCT00950599|592650008|FG001|Follow-Up Period|Subject withdrew Consent|0|||
164077779|NCT00950599|592650009|FG002|Follow-Up Period|Subject withdrew Consent|0|||
164077780|NCT00950599|592650010|FG003|Follow-Up Period|Subject withdrew Consent|0|||
164077781|NCT00950599|592650011|FG004|Follow-Up Period|Subject withdrew Consent|0|||
164077782|NCT00950599|592650012|FG005|Follow-Up Period|Subject withdrew Consent|0|||
164077783|NCT00950599|592650013|FG006|Follow-Up Period|Subject withdrew Consent|0|||
164077784|NCT00950599|592650014|FG007|Follow-Up Period|Subject withdrew Consent|0|||
164077785|NCT00950599|592650015|FG008|Follow-Up Period|Subject withdrew Consent|2|||
164077786|NCT00950599|592650016|FG009|Follow-Up Period|Subject withdrew Consent|1|||
164077787|NCT00971204|592650017|FG000|Overall Study|Did not meet all criteria-not treated|14|||
164077788|NCT00971204|592650017|FG000|Overall Study|Lost to Follow-up|10|||
164077789|NCT02729194|592650018|FG000|Overall Study|Withdrawal by Subject|3|||
164077790|NCT01361607|592650021|FG000|Overall Study|Adverse Event|38|||
164077791|NCT01361607|592650022|FG001|Overall Study|Adverse Event|29|||
164077792|NCT01361607|592650021|FG000|Overall Study|Withdrawal by Subject|19|||
164077793|NCT01361607|592650022|FG001|Overall Study|Withdrawal by Subject|8|||
164077794|NCT01361607|592650021|FG000|Overall Study|Withdrawal by Investigator|5|||
164077795|NCT01361607|592650022|FG001|Overall Study|Withdrawal by Investigator|3|||
164077796|NCT01361607|592650021|FG000|Overall Study|Lost to Follow-up|1|||
164077797|NCT01361607|592650022|FG001|Overall Study|Lost to Follow-up|0|||
164077798|NCT01361607|592650021|FG000|Overall Study|Met Withdrawal Criteria|1|||
164077799|NCT01361607|592650022|FG001|Overall Study|Met Withdrawal Criteria|1|||
164077800|NCT02741271|592650033|FG000|Overall Study|Lost to Follow-up|2|||
164077801|NCT02741271|592650034|FG001|Overall Study|Lost to Follow-up|0|||
164077802|NCT02741271|592650033|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164077803|NCT02741271|592650034|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164077804|NCT00373685|592650035|FG000|Overall Study|Death|2|||
164077805|NCT00373685|592650036|FG001|Overall Study|Death|1|||
164077806|NCT00373685|592650035|FG000|Overall Study|Adverse Event|278|||
164077807|NCT00373685|592650036|FG001|Overall Study|Adverse Event|253|||
164077808|NCT00373685|592650035|FG000|Overall Study|Insufficient clinical response|169|||
164077809|NCT00373685|592650036|FG001|Overall Study|Insufficient clinical response|119|||
164325978|NCT00740051|593569031|FG001|Overall Study|Lost to Follow-up|8|||
164325979|NCT00740051|593569030|FG000|Overall Study|Withdrawal by Subject|6|||
164325980|NCT00740051|593569031|FG001|Overall Study|Withdrawal by Subject|8|||
164325981|NCT00740051|593569030|FG000|Overall Study|Other reason (not specified)|4|||
164077810|NCT00373685|592650035|FG000|Overall Study|Did not meet entrance criteria|167|||
164214725|NCT00640289|593152921|FG000|Overall Study|Withdrawal by Subject|1|||
164214726|NCT00640289|593152921|FG000|Overall Study|Lost to Follow-up|1|||
164214727|NCT00640289|593152921|FG000|Overall Study|Data collected under different amendment|2|||
164214728|NCT00640289|593152921|FG000|Overall Study|Transferred to another center|1|||
164214729|NCT00640289|593152921|FG000|Overall Study|Missing status|5|||
164214730|NCT03550209|593152923|FG000|Overall Study|Lost to Follow-up|1|||
164214731|NCT03550209|593152924|FG001|Overall Study|Lost to Follow-up|0|||
164214732|NCT03550209|593152925|FG002|Overall Study|Lost to Follow-up|1|||
164214733|NCT03550209|593152926|FG003|Overall Study|Lost to Follow-up|0|||
164214734|NCT03550209|593152923|FG000|Overall Study|Withdrawal by Subject|0|||
164214735|NCT03550209|593152924|FG001|Overall Study|Withdrawal by Subject|3|||
164214736|NCT03550209|593152925|FG002|Overall Study|Withdrawal by Subject|1|||
164214737|NCT03550209|593152926|FG003|Overall Study|Withdrawal by Subject|2|||
164214738|NCT03550209|593152923|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
164214739|NCT03550209|593152924|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
164214740|NCT03550209|593152925|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
164214741|NCT03550209|593152926|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
164214742|NCT00768053|593152927|FG000|Overall Study|Adverse Event|10|||
164214743|NCT00768053|593152927|FG000|Overall Study|Lost to Follow-up|1|||
164214744|NCT01202591|593152930|FG000|Overall Study|Adverse Event|2|||
164214745|NCT01202591|593152931|FG001|Overall Study|Adverse Event|1|||
164214746|NCT01202591|593152932|FG002|Overall Study|Adverse Event|4|||
164214747|NCT01202591|593152933|FG003|Overall Study|Adverse Event|4|||
164214748|NCT01202591|593152934|FG004|Overall Study|Adverse Event|0|||
164214749|NCT01202591|593152935|FG005|Overall Study|Adverse Event|0|||
164214750|NCT01202591|593152930|FG000|Overall Study|Other reason as per investigator|3|||
164214751|NCT01202591|593152931|FG001|Overall Study|Other reason as per investigator|4|||
164214752|NCT01202591|593152932|FG002|Overall Study|Other reason as per investigator|7|||
164214753|NCT01202591|593152933|FG003|Overall Study|Other reason as per investigator|3|||
164214754|NCT01202591|593152934|FG004|Overall Study|Other reason as per investigator|1|||
164214755|NCT01202591|593152935|FG005|Overall Study|Other reason as per investigator|3|||
164214756|NCT01202591|593152930|FG000|Overall Study|Withdrawal by Subject|0|||
164214757|NCT01202591|593152931|FG001|Overall Study|Withdrawal by Subject|0|||
164214758|NCT01202591|593152932|FG002|Overall Study|Withdrawal by Subject|0|||
164214759|NCT01202591|593152933|FG003|Overall Study|Withdrawal by Subject|0|||
164214760|NCT01202591|593152934|FG004|Overall Study|Withdrawal by Subject|2|||
164214761|NCT01202591|593152935|FG005|Overall Study|Withdrawal by Subject|1|||
164214762|NCT01202591|593152930|FG000|Overall Study|Objective Disease Progression|0|||
164214763|NCT01202591|593152931|FG001|Overall Study|Objective Disease Progression|0|||
164214764|NCT01202591|593152932|FG002|Overall Study|Objective Disease Progression|0|||
164214765|NCT01202591|593152933|FG003|Overall Study|Objective Disease Progression|0|||
164214766|NCT01202591|593152934|FG004|Overall Study|Objective Disease Progression|2|||
164214767|NCT01202591|593152935|FG005|Overall Study|Objective Disease Progression|0|||
164214768|NCT00632359|593152939|FG000|Overall Study|Withdrawal by Subject|2|||
164214769|NCT03599713|593152942|FG000|Overall Study|Death|38|||
164214770|NCT03599713|593152943|FG001|Overall Study|Death|3|||
164214771|NCT03599713|593152942|FG000|Overall Study|Withdrawal by Subject|17|||
164214772|NCT03599713|593152943|FG001|Overall Study|Withdrawal by Subject|0|||
164214773|NCT03599713|593152942|FG000|Overall Study|Lost to Follow-up|4|||
164214774|NCT03599713|593152943|FG001|Overall Study|Lost to Follow-up|0|||
164214775|NCT03599713|593152942|FG000|Overall Study|Discontinued Due to End of Study|42|||
164214776|NCT03599713|593152943|FG001|Overall Study|Discontinued Due to End of Study|3|||
164214777|NCT05578872|593152944|FG000|Overall Study|Withdrawal by Subject|2|||
164214778|NCT05578872|593152945|FG001|Overall Study|Withdrawal by Subject|1|||
164214779|NCT05578872|593152944|FG000|Overall Study|Adverse Event|1|||
164214780|NCT05578872|593152945|FG001|Overall Study|Adverse Event|1|||
164214781|NCT05578872|593152944|FG000|Overall Study|Physician Decision|1|||
164214782|NCT05578872|593152945|FG001|Overall Study|Physician Decision|2|||
164214783|NCT05578872|593152944|FG000|Overall Study|Progressive disease|10|||
164214784|NCT05578872|593152945|FG001|Overall Study|Progressive disease|9|||
164214785|NCT05578872|593152944|FG000|Overall Study|Sponsor decision|0|||
164214786|NCT05578872|593152945|FG001|Overall Study|Sponsor decision|1|||
164325982|NCT00740051|593569031|FG001|Overall Study|Other reason (not specified)|1|||
164325983|NCT03452527|593569032|FG000|Overall Study|Withdrawal by Subject|1|||
164214787|NCT05578872|593152944|FG000|Overall Study|Toxicity and Patient's decision|0|||
164214788|NCT05578872|593152945|FG001|Overall Study|Toxicity and Patient's decision|1|||
164214789|NCT05643794|593154260|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
164214790|NCT05643794|593154261|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164214791|NCT05643794|593154262|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
164214792|NCT05643794|593154260|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164214793|NCT05643794|593154261|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164214794|NCT05643794|593154262|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164214795|NCT05643794|593154260|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164325984|NCT03452527|593569033|FG001|Overall Study|Withdrawal by Subject|1|||
164214796|NCT05643794|593154261|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
164214797|NCT05643794|593154262|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164214798|NCT05643794|593154260|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164214799|NCT05643794|593154261|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164214800|NCT05643794|593154262|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164214801|NCT05643794|593154260|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
164214802|NCT05643794|593154261|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164214803|NCT05643794|593154262|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
164214804|NCT05643794|593154260|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
164214805|NCT05643794|593154261|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
164214806|NCT05643794|593154262|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
164214807|NCT04941898|593154263|FG000|Overall Study|Protocol Violation|1|||
164214808|NCT03641924|593154264|FG000|Overall Study|Withdrawal by Subject|26|||
164214809|NCT03641924|593154264|FG000|Overall Study|Lost to Follow-up|16|||
164214810|NCT03641924|593154264|FG000|Overall Study|Protocol Violation|10|||
164214811|NCT00587457|593154265|FG000|Overall Study|Adverse Event|1|||
164214812|NCT00587457|593154266|FG001|Overall Study|Adverse Event|2|||
164214813|NCT00587457|593154267|FG002|Overall Study|Adverse Event|1|||
164214814|NCT00587457|593154265|FG000|Overall Study|Disease progression|2|||
164214815|NCT00587457|593154266|FG001|Overall Study|Disease progression|0|||
164214816|NCT00587457|593154267|FG002|Overall Study|Disease progression|2|||
164214817|NCT00587457|593154265|FG000|Overall Study|Initiation of alternative therapy|0|||
164214818|NCT00587457|593154266|FG001|Overall Study|Initiation of alternative therapy|1|||
164214819|NCT00587457|593154267|FG002|Overall Study|Initiation of alternative therapy|0|||
164214820|NCT00587457|593154265|FG000|Overall Study|Undefined|0|||
164214821|NCT00587457|593154266|FG001|Overall Study|Undefined|0|||
164214822|NCT00587457|593154267|FG002|Overall Study|Undefined|1|||
164214823|NCT00587457|593154265|FG000|Overall Study|Development of neutralizing Abs|0|||
164214824|NCT00587457|593154266|FG001|Overall Study|Development of neutralizing Abs|0|||
164214825|NCT00587457|593154267|FG002|Overall Study|Development of neutralizing Abs|1|||
164214826|NCT01022580|593154268|FG000|Overall Study|Death|18|||
164214827|NCT01022580|593154269|FG001|Overall Study|Death|22|||
164214828|NCT03439839|593154270|FG000|Overall Study|Death|3|||
164214829|NCT03439839|593154271|FG001|Overall Study|Death|0|||
164214830|NCT03720847|593154272|FG000|Washout|Physician Decision|1|||
164214831|NCT03720847|593154273|FG001|Washout|Physician Decision|2|||
164214832|NCT01500096|593154274|FG000|Overall Study|Lost to Follow-up|1|||
164214833|NCT01500096|593154275|FG001|Overall Study|Lost to Follow-up|0|||
164214834|NCT01500096|593154276|FG002|Overall Study|Lost to Follow-up|0|||
164214835|NCT01500096|593154277|FG003|Overall Study|Lost to Follow-up|2|||
164214836|NCT03033901|593154281|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
164214837|NCT03033901|593154281|FG000|Overall Study|Refused PSG|23|||
164214838|NCT03033901|593154281|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
164214839|NCT03033901|593154281|FG000|Overall Study|Missing Oximetry Data|3|||
164214840|NCT00924651|593154284|FG000|Overall Study|Chemo started too soon|2|||
164214841|NCT00924651|593154285|FG001|Overall Study|Chemo started too soon|3|||
164214842|NCT00924651|593154284|FG000|Overall Study|No Reason|3|||
164077811|NCT00373685|592650036|FG001|Overall Study|Did not meet entrance criteria|184|||
164077812|NCT00373685|592650035|FG000|Overall Study|Lost to follow up|83|||
164077813|NCT00373685|592650036|FG001|Overall Study|Lost to follow up|103|||
164077814|NCT00373685|592650035|FG000|Overall Study|No longer willing to participate|337|||
164077815|NCT00373685|592650036|FG001|Overall Study|No longer willing to participate|352|||
164077816|NCT00373685|592650035|FG000|Overall Study|Other|149|||
164077817|NCT00373685|592650036|FG001|Overall Study|Other|146|||
164077818|NCT00373685|592650035|FG000|Overall Study|Protocol Violation|191|||
164077819|NCT00373685|592650036|FG001|Overall Study|Protocol Violation|182|||
164077820|NCT00373685|592650035|FG000|Overall Study|Final Status Unknown|12|||
164077821|NCT00373685|592650036|FG001|Overall Study|Final Status Unknown|4|||
164077822|NCT00373685|592650035|FG000|Overall Study|Randomized, not treated|51|||
164214843|NCT00924651|593154285|FG001|Overall Study|No Reason|7|||
164214844|NCT00924651|593154284|FG000|Overall Study|Overwhelmed|6|||
164214845|NCT00924651|593154285|FG001|Overall Study|Overwhelmed|6|||
164214846|NCT00924651|593154284|FG000|Overall Study|Noncompliant|1|||
164214847|NCT00924651|593154285|FG001|Overall Study|Noncompliant|4|||
164325985|NCT03452527|593569032|FG000|Overall Study|Study Terminated|2|||
164325986|NCT03452527|593569033|FG001|Overall Study|Study Terminated|3|||
164077823|NCT00373685|592650036|FG001|Overall Study|Randomized, not treated|77|||
164077824|NCT02570165|592650037|FG000|Overall Study|Adverse Event|1|||
164077825|NCT02570165|592650038|FG001|Overall Study|Adverse Event|0|||
164077826|NCT02570165|592650039|FG002|Overall Study|Adverse Event|2|||
164214848|NCT00924651|593154284|FG000|Overall Study|Medical|1|||
164214849|NCT00924651|593154285|FG001|Overall Study|Medical|3|||
164214850|NCT00924651|593154284|FG000|Overall Study|Changed Mind|10|||
164214851|NCT00924651|593154285|FG001|Overall Study|Changed Mind|1|||
164214852|NCT00924651|593154284|FG000|Overall Study|Incomplete Form|2|||
164325987|NCT01001299|593569034|FG000|Overall Study|Insufficient Therapeutic Response|20|||
164214853|NCT00924651|593154285|FG001|Overall Study|Incomplete Form|1|||
164214854|NCT00723944|593154286|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
164214855|NCT00723944|593154287|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
164214856|NCT00723944|593154286|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
164214857|NCT00723944|593154287|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
164214858|NCT00723944|593154286|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
164214859|NCT00723944|593154287|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
164214860|NCT00835978|593154288|FG000|Overall Study|Death|33|||
164214861|NCT00835978|593154289|FG001|Overall Study|Death|40|||
164214862|NCT00835978|593154290|FG002|Overall Study|Death|49|||
164214863|NCT00835978|593154291|FG003|Overall Study|Death|4|||
164214864|NCT00835978|593154288|FG000|Overall Study|Lost to Follow-up|3|||
164214865|NCT00835978|593154289|FG001|Overall Study|Lost to Follow-up|4|||
164214866|NCT00835978|593154290|FG002|Overall Study|Lost to Follow-up|2|||
164214867|NCT00835978|593154291|FG003|Overall Study|Lost to Follow-up|1|||
164214868|NCT00835978|593154288|FG000|Overall Study|Other|5|||
164214869|NCT00835978|593154289|FG001|Overall Study|Other|1|||
164214870|NCT00835978|593154290|FG002|Overall Study|Other|8|||
164214871|NCT00835978|593154291|FG003|Overall Study|Other|0|||
164214872|NCT00835978|593154288|FG000|Overall Study|Objective progression or relapse|2|||
164214873|NCT00835978|593154289|FG001|Overall Study|Objective progression or relapse|0|||
164214874|NCT00835978|593154290|FG002|Overall Study|Objective progression or relapse|1|||
164214875|NCT00835978|593154291|FG003|Overall Study|Objective progression or relapse|0|||
164214876|NCT00835978|593154288|FG000|Overall Study|Adverse Event|1|||
164214877|NCT00835978|593154289|FG001|Overall Study|Adverse Event|0|||
164214878|NCT00835978|593154290|FG002|Overall Study|Adverse Event|1|||
164214879|NCT00835978|593154291|FG003|Overall Study|Adverse Event|0|||
164214880|NCT00835978|593154288|FG000|Overall Study|Withdrawal by Subject|0|||
164214881|NCT00835978|593154289|FG001|Overall Study|Withdrawal by Subject|3|||
164214882|NCT00835978|593154290|FG002|Overall Study|Withdrawal by Subject|0|||
164214883|NCT00835978|593154291|FG003|Overall Study|Withdrawal by Subject|5|||
164214884|NCT00835978|593154288|FG000|Overall Study|Study terminated by sponsor|12|||
164214885|NCT00835978|593154289|FG001|Overall Study|Study terminated by sponsor|8|||
164214886|NCT00835978|593154290|FG002|Overall Study|Study terminated by sponsor|30|||
164214887|NCT00835978|593154291|FG003|Overall Study|Study terminated by sponsor|0|||
164214888|NCT02927145|593154292|FG000|Initial Recruitment|Withdrawal by Subject|0|||
164214889|NCT02927145|593154293|FG001|Initial Recruitment|Withdrawal by Subject|1|||
164214890|NCT02927145|593154294|FG002|Initial Recruitment|Withdrawal by Subject|1|||
164214891|NCT02927145|593154295|FG003|Initial Recruitment|Withdrawal by Subject|4|||
164214892|NCT02927145|593154296|FG004|Initial Recruitment|Withdrawal by Subject|1|||
164214893|NCT02927145|593154297|FG005|Initial Recruitment|Withdrawal by Subject|1|||
164214894|NCT02927145|593154298|FG006|Initial Recruitment|Withdrawal by Subject|0|||
164214895|NCT02927145|593154299|FG007|Initial Recruitment|Withdrawal by Subject|0|||
164214896|NCT02927145|593154300|FG008|Initial Recruitment|Withdrawal by Subject|2|||
164214897|NCT02927145|593154292|FG000|Initial Recruitment|Adverse Event|0|||
164214898|NCT02927145|593154293|FG001|Initial Recruitment|Adverse Event|0|||
164214899|NCT02927145|593154294|FG002|Initial Recruitment|Adverse Event|0|||
164214900|NCT02927145|593154295|FG003|Initial Recruitment|Adverse Event|0|||
164214901|NCT02927145|593154296|FG004|Initial Recruitment|Adverse Event|2|||
164214902|NCT02927145|593154297|FG005|Initial Recruitment|Adverse Event|0|||
164214903|NCT02927145|593154298|FG006|Initial Recruitment|Adverse Event|0|||
164214904|NCT02927145|593154299|FG007|Initial Recruitment|Adverse Event|0|||
164214905|NCT02927145|593154300|FG008|Initial Recruitment|Adverse Event|0|||
163981024|NCT00464334|592299698|FG005|Overall Study|Withdrawal by Subject|2|||
163981025|NCT00464334|592299699|FG006|Overall Study|Withdrawal by Subject|2|||
163981026|NCT00464334|592299700|FG007|Overall Study|Withdrawal by Subject|1|||
164214906|NCT02927145|593154292|FG000|Invitation for Additional Challenge|Pregnancy|0|||
164214907|NCT02927145|593154293|FG001|Invitation for Additional Challenge|Pregnancy|0|||
164214908|NCT02927145|593154294|FG002|Invitation for Additional Challenge|Pregnancy|0|||
164214909|NCT02927145|593154295|FG003|Invitation for Additional Challenge|Pregnancy|0|||
164214910|NCT02927145|593154296|FG004|Invitation for Additional Challenge|Pregnancy|0|||
164214911|NCT02927145|593154297|FG005|Invitation for Additional Challenge|Pregnancy|0|||
164214912|NCT02927145|593154298|FG006|Invitation for Additional Challenge|Pregnancy|1|||
164214913|NCT02927145|593154299|FG007|Invitation for Additional Challenge|Pregnancy|0|||
164214914|NCT02927145|593154300|FG008|Invitation for Additional Challenge|Pregnancy|0|||
164214915|NCT03298061|593154301|FG000|Overall Study|Adverse Event|3|||
164214916|NCT03298061|593154301|FG000|Overall Study|Lack of Efficacy|6|||
164214917|NCT03298061|593154301|FG000|Overall Study|Protocol Violation|1|||
164214918|NCT03298061|593154301|FG000|Overall Study|Physician Decision|7|||
164325988|NCT01001299|593569034|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
164214919|NCT03298061|593154301|FG000|Overall Study|Withdrawal by Subject|10|||
164325989|NCT01001299|593569034|FG000|Overall Study|Death|1|||
164214920|NCT02506036|593154303|FG000|First Intervention (4-6 Weeks)|Death|1|||
164214921|NCT02506036|593154304|FG001|First Intervention (4-6 Weeks)|Death|0|||
164214922|NCT02506036|593154303|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
164214923|NCT02506036|593154304|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
164325990|NCT01001299|593569034|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
164325991|NCT01001299|593569034|FG000|Overall Study|Withdrew Consent|1|||
164325992|NCT01565499|593569035|FG000|Overall Study|Physician Decision|1|||
164325993|NCT01565499|593569035|FG000|Overall Study|Adverse Event|5|||
164325994|NCT01565499|593569035|FG000|Overall Study|Withdrawal by Subject|2|||
164325995|NCT00476047|593569036|FG000|Overall Study|Lost to Follow-up|1|||
164325996|NCT02398227|593569038|FG000|Overall Study|Lost to Follow-up|21|||
164325997|NCT02398227|593569039|FG001|Overall Study|Lost to Follow-up|12|||
164325998|NCT02398227|593569038|FG000|Overall Study|Withdrawal by Subject|5|||
164325999|NCT02398227|593569039|FG001|Overall Study|Withdrawal by Subject|6|||
164326000|NCT02398227|593569038|FG000|Overall Study|Removed from treatment and dropped out|1|||
164326001|NCT02398227|593569039|FG001|Overall Study|Removed from treatment and dropped out|0|||
164326002|NCT02793622|593569040|FG000|Overall Study|Lost to Follow-up|31|||
164326003|NCT02793622|593569041|FG001|Overall Study|Lost to Follow-up|19|||
164326004|NCT02793622|593569040|FG000|Overall Study|Withdrawal by Subject|21|||
164326005|NCT02793622|593569041|FG001|Overall Study|Withdrawal by Subject|17|||
164326006|NCT02793622|593569040|FG000|Overall Study|Adverse Event|0|||
164326007|NCT02793622|593569041|FG001|Overall Study|Adverse Event|1|||
164326008|NCT02793622|593569040|FG000|Overall Study|Protocol Violation|1|||
164326009|NCT02793622|593569041|FG001|Overall Study|Protocol Violation|5|||
164326010|NCT04738318|593569042|FG000|Overall Study|Protocol Violation|1|||
164326011|NCT04738318|593569043|FG001|Overall Study|Protocol Violation|0|||
164326012|NCT00586664|593569048|FG000|Overall Study|Withdrawal by Subject|3|||
164326013|NCT00586664|593569049|FG001|Overall Study|Withdrawal by Subject|7|||
164326014|NCT00586664|593569050|FG002|Overall Study|Withdrawal by Subject|1|||
164326015|NCT00586664|593569048|FG000|Overall Study|Exclusion criteria met|2|||
164326016|NCT00586664|593569049|FG001|Overall Study|Exclusion criteria met|0|||
164326017|NCT00586664|593569050|FG002|Overall Study|Exclusion criteria met|0|||
164326018|NCT01585584|593569051|FG000|Overall Study|Lack of Efficacy|1|||
164326019|NCT01585584|593569051|FG000|Overall Study|Withdrawal by Subject|1|||
164326020|NCT01585584|593569051|FG000|Overall Study|Physician Decision|2|||
164326021|NCT01602666|593569055|FG000|Induction Chemotherapy|Death|2|||
164326022|NCT01602666|593569056|FG001|Induction Chemotherapy|Death|1|||
164326023|NCT01602666|593569055|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
164326024|NCT01602666|593569056|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
164326025|NCT01602666|593569055|FG000|Induction Chemotherapy|Physician Decision|12|||
164326026|NCT01602666|593569056|FG001|Induction Chemotherapy|Physician Decision|5|||
164326027|NCT01602666|593569055|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
164326028|NCT01602666|593569056|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
164326029|NCT01602666|593569055|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
164326030|NCT01602666|593569056|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
164326031|NCT01602666|593569055|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
164326032|NCT01602666|593569056|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
164326033|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
164326034|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
164326035|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
164326036|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
164326037|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
164326038|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
164326039|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
164326040|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
164326041|NCT01602666|593569055|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
164326042|NCT01602666|593569056|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
163876544|NCT01718743|591916913|FG000|Overall Study|Withdrawal by Subject|14|||
163876545|NCT01718743|591916913|FG000|Overall Study|Progressive Disease|22|||
163876546|NCT01718743|591916913|FG000|Overall Study|Toxicity|1|||
163876547|NCT01718743|591916913|FG000|Overall Study|Malignancy|1|||
163876548|NCT04868110|591916921|FG000|Overall Study|Withdrawal by Subject|3|||
163876549|NCT04868110|591916922|FG001|Overall Study|Withdrawal by Subject|4|||
163876550|NCT02553642|591916925|FG000|Overall Study|Withdrawal by Subject|0|||
163876551|NCT02553642|591916926|FG001|Overall Study|Withdrawal by Subject|3|||
163876552|NCT02553642|591916925|FG000|Overall Study|Physician Decision|0|||
163876553|NCT02553642|591916926|FG001|Overall Study|Physician Decision|1|||
163876554|NCT02553642|591916925|FG000|Overall Study|Additional cancer dx|0|||
163876555|NCT02553642|591916926|FG001|Overall Study|Additional cancer dx|1|||
163876556|NCT02553642|591916925|FG000|Overall Study|Never started treatment|0|||
163876557|NCT02553642|591916926|FG001|Overall Study|Never started treatment|1|||
164326043|NCT04369053|593570102|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
164326044|NCT04369053|593570102|FG000|Overall Study|Withdrawal by Subject|773|||
164326045|NCT04369053|593570102|FG000|Overall Study|Lost to Follow-up|182|||
163876558|NCT04424927|591916932|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
163876559|NCT04424927|591916933|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
163876560|NCT04424927|591916934|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
164214924|NCT02506036|593154303|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
164214925|NCT02506036|593154304|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
164214926|NCT01410604|593154306|FG000|Overall Study|Adverse Event|2|||
164214927|NCT01410604|593154307|FG001|Overall Study|Adverse Event|1|||
164214928|NCT01410604|593154306|FG000|Overall Study|Lost to Follow-up|1|||
164214929|NCT01410604|593154307|FG001|Overall Study|Lost to Follow-up|0|||
164214930|NCT01410604|593154306|FG000|Overall Study|Physician Decision|0|||
164214931|NCT01410604|593154307|FG001|Overall Study|Physician Decision|1|||
164214932|NCT02383173|593154312|FG000|Overall Study|Palliative Care Team withdrew|0|||
164214933|NCT02383173|593154313|FG001|Overall Study|Palliative Care Team withdrew|2|||
164214934|NCT00800540|593154317|FG000|Period One: 6 Weeks|Noncompliance|1|||
164214935|NCT00800540|593154318|FG001|Period One: 6 Weeks|Noncompliance|0|||
164214936|NCT00800540|593154317|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
164214937|NCT00800540|593154318|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
164214938|NCT00800540|593154317|FG000|Period 2: 6 Weeks|Adverse Event|0|||
164214939|NCT00800540|593154318|FG001|Period 2: 6 Weeks|Adverse Event|1|||
164214940|NCT00429299|593154319|FG000|Overall Study|Disease Progression|1|||
164214941|NCT00429299|593154320|FG001|Overall Study|Disease Progression|1|||
164214942|NCT00429299|593154321|FG002|Overall Study|Disease Progression|0|||
164214943|NCT00429299|593154319|FG000|Overall Study|Adverse Event|2|||
164214944|NCT00429299|593154320|FG001|Overall Study|Adverse Event|5|||
164214945|NCT00429299|593154321|FG002|Overall Study|Adverse Event|1|||
164214946|NCT00429299|593154319|FG000|Overall Study|Protocol Violation|1|||
164214947|NCT00429299|593154320|FG001|Overall Study|Protocol Violation|0|||
164214948|NCT00429299|593154321|FG002|Overall Study|Protocol Violation|0|||
164214949|NCT00429299|593154319|FG000|Overall Study|Withdrawal by Subject|0|||
164214950|NCT00429299|593154320|FG001|Overall Study|Withdrawal by Subject|1|||
164214951|NCT00429299|593154321|FG002|Overall Study|Withdrawal by Subject|3|||
164214952|NCT04871113|593154322|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214953|NCT04871113|593154323|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214954|NCT04871113|593154324|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214955|NCT04871113|593154325|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214956|NCT04871113|593154326|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214957|NCT04871113|593154327|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
164214958|NCT04871113|593154328|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214959|NCT04871113|593154329|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214960|NCT04871113|593154330|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214961|NCT04871113|593154331|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
164214962|NCT04871113|593154322|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214963|NCT04871113|593154323|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214964|NCT04871113|593154324|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214965|NCT04871113|593154325|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214966|NCT04871113|593154326|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214967|NCT04871113|593154327|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214968|NCT04871113|593154328|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
164214969|NCT04871113|593154329|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
164214970|NCT04871113|593154330|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214971|NCT04871113|593154331|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
164214972|NCT01239745|593154332|FG000|Overall Study|Study terminated by sponsor|45|||
164214973|NCT01239745|593154332|FG000|Overall Study|Adverse Event|1|||
164214974|NCT02143778|593154337|FG000|Overall Study|Withdrawal by Subject|2|||
164214975|NCT02143778|593154337|FG000|Overall Study|Device malfunction|1|||
164214976|NCT05630755|593154338|FG000|Overall Study|Lost to Follow-up|7|||
164214977|NCT05630755|593154339|FG001|Overall Study|Lost to Follow-up|0|||
164214978|NCT05630755|593154338|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
164214979|NCT05630755|593154339|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
164214980|NCT05630755|593154338|FG000|Overall Study|Withdrawal by Subject|9|||
164214981|NCT05630755|593154339|FG001|Overall Study|Withdrawal by Subject|3|||
164214982|NCT05630755|593154338|FG000|Overall Study|Participant moved away from trial site|0|||
164214983|NCT05630755|593154339|FG001|Overall Study|Participant moved away from trial site|1|||
164214984|NCT05630755|593154338|FG000|Overall Study|Status not Recorded|316|||
164214985|NCT05630755|593154339|FG001|Overall Study|Status not Recorded|161|||
164214986|NCT02969018|593154340|FG000|Overall Study|Adverse Event|2|||
164214987|NCT02969018|593154341|FG001|Overall Study|Adverse Event|4|||
164214988|NCT02969018|593154342|FG002|Overall Study|Adverse Event|1|||
164214989|NCT02969018|593154343|FG003|Overall Study|Adverse Event|2|||
164077827|NCT02570165|592650040|FG003|Overall Study|Adverse Event|0|||
164214990|NCT02969018|593154344|FG004|Overall Study|Adverse Event|0|||
164214991|NCT02969018|593154345|FG005|Overall Study|Adverse Event|1|||
164214992|NCT02969018|593154346|FG006|Overall Study|Adverse Event|2|||
164214993|NCT02969018|593154347|FG007|Overall Study|Adverse Event|0|||
164214994|NCT02969018|593154340|FG000|Overall Study|Lack of Efficacy|0|||
164214995|NCT02969018|593154341|FG001|Overall Study|Lack of Efficacy|1|||
164214996|NCT02969018|593154342|FG002|Overall Study|Lack of Efficacy|0|||
164214997|NCT02969018|593154343|FG003|Overall Study|Lack of Efficacy|0|||
164214998|NCT02969018|593154344|FG004|Overall Study|Lack of Efficacy|1|||
164214999|NCT02969018|593154345|FG005|Overall Study|Lack of Efficacy|1|||
164215000|NCT02969018|593154346|FG006|Overall Study|Lack of Efficacy|1|||
164215001|NCT02969018|593154347|FG007|Overall Study|Lack of Efficacy|1|||
164215002|NCT02969018|593154340|FG000|Overall Study|Lost to Follow-up|1|||
164215003|NCT02969018|593154341|FG001|Overall Study|Lost to Follow-up|2|||
164215004|NCT02969018|593154342|FG002|Overall Study|Lost to Follow-up|2|||
164215005|NCT02969018|593154343|FG003|Overall Study|Lost to Follow-up|0|||
164215006|NCT02969018|593154344|FG004|Overall Study|Lost to Follow-up|1|||
164215007|NCT02969018|593154345|FG005|Overall Study|Lost to Follow-up|1|||
164215008|NCT02969018|593154346|FG006|Overall Study|Lost to Follow-up|0|||
164215009|NCT02969018|593154347|FG007|Overall Study|Lost to Follow-up|1|||
164215010|NCT02969018|593154340|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215011|NCT02969018|593154341|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215012|NCT02969018|593154342|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215013|NCT02969018|593154343|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215014|NCT02969018|593154344|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215015|NCT02969018|593154345|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215016|NCT02969018|593154346|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
164215017|NCT02969018|593154347|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164215018|NCT02969018|593154340|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164215019|NCT02969018|593154341|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164215020|NCT02969018|593154342|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164215021|NCT02969018|593154343|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164215022|NCT02969018|593154344|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164215023|NCT02969018|593154345|FG005|Overall Study|Non-Compliance With Study Drug|0|||
164215024|NCT02969018|593154346|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164215025|NCT02969018|593154347|FG007|Overall Study|Non-Compliance With Study Drug|0|||
164215026|NCT02969018|593154340|FG000|Overall Study|Other|0|||
164215027|NCT02969018|593154341|FG001|Overall Study|Other|0|||
164215028|NCT02969018|593154342|FG002|Overall Study|Other|0|||
164215029|NCT02969018|593154343|FG003|Overall Study|Other|1|||
164215030|NCT02969018|593154344|FG004|Overall Study|Other|0|||
164215031|NCT02969018|593154345|FG005|Overall Study|Other|0|||
164215032|NCT02969018|593154346|FG006|Overall Study|Other|0|||
164215033|NCT02969018|593154347|FG007|Overall Study|Other|2|||
164215034|NCT02969018|593154340|FG000|Overall Study|Pregnancy|0|||
164215035|NCT02969018|593154341|FG001|Overall Study|Pregnancy|0|||
164215036|NCT02969018|593154342|FG002|Overall Study|Pregnancy|0|||
164215037|NCT02969018|593154343|FG003|Overall Study|Pregnancy|0|||
164215038|NCT02969018|593154344|FG004|Overall Study|Pregnancy|0|||
164215039|NCT02969018|593154345|FG005|Overall Study|Pregnancy|1|||
164215040|NCT02969018|593154346|FG006|Overall Study|Pregnancy|0|||
164215041|NCT02969018|593154347|FG007|Overall Study|Pregnancy|0|||
164215042|NCT02969018|593154340|FG000|Overall Study|Protocol Violation|0|||
164215043|NCT02969018|593154341|FG001|Overall Study|Protocol Violation|0|||
164215044|NCT02969018|593154342|FG002|Overall Study|Protocol Violation|1|||
164215045|NCT02969018|593154343|FG003|Overall Study|Protocol Violation|1|||
164215046|NCT02969018|593154344|FG004|Overall Study|Protocol Violation|0|||
164215047|NCT02969018|593154345|FG005|Overall Study|Protocol Violation|0|||
164215048|NCT02969018|593154346|FG006|Overall Study|Protocol Violation|0|||
164215049|NCT02969018|593154347|FG007|Overall Study|Protocol Violation|0|||
164215050|NCT02969018|593154340|FG000|Overall Study|Withdrawal by Subject|0|||
164215051|NCT02969018|593154341|FG001|Overall Study|Withdrawal by Subject|1|||
164215052|NCT02969018|593154342|FG002|Overall Study|Withdrawal by Subject|2|||
164215053|NCT02969018|593154343|FG003|Overall Study|Withdrawal by Subject|1|||
164326046|NCT04369053|593570102|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
164326047|NCT01394718|593570103|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
164215054|NCT02969018|593154344|FG004|Overall Study|Withdrawal by Subject|0|||
164215055|NCT02969018|593154345|FG005|Overall Study|Withdrawal by Subject|4|||
164215056|NCT02969018|593154346|FG006|Overall Study|Withdrawal by Subject|4|||
164215057|NCT02969018|593154347|FG007|Overall Study|Withdrawal by Subject|3|||
164215058|NCT01479530|593154353|FG000|Overall Study|Adverse Event|5|||
164326048|NCT01394718|593570104|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
164326049|NCT00472459|593570105|FG000|Overall Study|Adverse Event|13|||
164215059|NCT01479530|593154354|FG001|Overall Study|Adverse Event|6|||
164215060|NCT01479530|593154353|FG000|Overall Study|Lack of Efficacy|0|||
164215061|NCT01479530|593154354|FG001|Overall Study|Lack of Efficacy|1|||
164215062|NCT01479530|593154353|FG000|Overall Study|Protocol Violation|2|||
164215063|NCT01479530|593154354|FG001|Overall Study|Protocol Violation|3|||
164215064|NCT01479530|593154353|FG000|Overall Study|Withdrawal of Consent|3|||
164215065|NCT01479530|593154354|FG001|Overall Study|Withdrawal of Consent|2|||
164326050|NCT00472459|593570106|FG001|Overall Study|Adverse Event|13|||
164215066|NCT02836769|593154355|FG000|Overall Study|Lost to Follow-up|10|||
164215067|NCT02836769|593154355|FG000|Overall Study|Medical withdrawal|2|||
164215068|NCT02836769|593154355|FG000|Overall Study|Withdrawal by Subject|3|||
164215069|NCT04339972|593154356|FG000|Overall Study|Scheduling Issues|3|||
164215070|NCT04339972|593154357|FG001|Overall Study|Scheduling Issues|3|||
164215071|NCT04339972|593154356|FG000|Overall Study|dropout|1|||
164215072|NCT04339972|593154357|FG001|Overall Study|dropout|1|||
164215073|NCT04339972|593154356|FG000|Overall Study|Technical issues|1|||
164215074|NCT04339972|593154357|FG001|Overall Study|Technical issues|0|||
164215075|NCT04339972|593154356|FG000|Overall Study|Claustraphobia|0|||
164215076|NCT04339972|593154357|FG001|Overall Study|Claustraphobia|1|||
164215077|NCT00376506|593154359|FG000|Overall Study|Death|0|||
164215078|NCT00376506|593154360|FG001|Overall Study|Death|2|||
164215079|NCT00933166|593154362|FG000|Overall Study|Lost to Follow-up|4|||
164215080|NCT00933166|593154362|FG000|Overall Study|Lack of Efficacy|9|||
164215081|NCT00933166|593154362|FG000|Overall Study|Unavailable|4|||
164215082|NCT00933166|593154362|FG000|Overall Study|Withdrawal by Subject|1|||
164215083|NCT02403271|593154367|FG000|Period 1|Other varied reasons|1|||
164215084|NCT02403271|593154368|FG001|Period 1|Other varied reasons|0|||
164215085|NCT02403271|593154367|FG000|Period 2|Withdrawal by Subject|0|||
164215086|NCT02403271|593154368|FG001|Period 2|Withdrawal by Subject|14|||
164215087|NCT02403271|593154367|FG000|Period 2|Death|0|||
164215088|NCT02403271|593154368|FG001|Period 2|Death|84|||
164215089|NCT02403271|593154367|FG000|Period 2|Lost to Follow-up|0|||
164215090|NCT02403271|593154368|FG001|Period 2|Lost to Follow-up|2|||
164215091|NCT02403271|593154367|FG000|Period 2|Study Terminated by Sponsor|0|||
164215092|NCT02403271|593154368|FG001|Period 2|Study Terminated by Sponsor|14|||
164215093|NCT02403271|593154367|FG000|Period 2|Other varied reasons|0|||
164215094|NCT02403271|593154368|FG001|Period 2|Other varied reasons|10|||
164215095|NCT02112552|593154371|FG000|Overall Study|Withdrawal by Subject|1|||
164215096|NCT02112552|593154371|FG000|Overall Study|Adverse Event|1|||
164215097|NCT00774748|593154372|FG000|Overall Study|Lost to Follow-up|3|||
164215098|NCT03349515|593154376|FG000|Overall Study|Lack of Efficacy|2|||
164215099|NCT03349515|593154377|FG001|Overall Study|Lack of Efficacy|0|||
164215100|NCT03349515|593154376|FG000|Overall Study|Physician Decision|3|||
164215101|NCT03349515|593154377|FG001|Overall Study|Physician Decision|1|||
164215102|NCT02232698|593154382|FG000|Overall Study|Pregnancy|1|||
164215103|NCT02232698|593154383|FG001|Overall Study|Pregnancy|1|||
164215104|NCT02232698|593154382|FG000|Overall Study|Met exclusion criteria|1|||
164215105|NCT02232698|593154383|FG001|Overall Study|Met exclusion criteria|1|||
164215106|NCT02232698|593154382|FG000|Overall Study|Had device-associated symptoms|7|||
164215107|NCT02232698|593154383|FG001|Overall Study|Had device-associated symptoms|0|||
164215108|NCT02232698|593154382|FG000|Overall Study|Non-compliance with study device|1|||
164215109|NCT02232698|593154383|FG001|Overall Study|Non-compliance with study device|4|||
164215110|NCT02232698|593154382|FG000|Overall Study|Allocated to control group|0|||
164215111|NCT02232698|593154383|FG001|Overall Study|Allocated to control group|3|||
164215112|NCT02232698|593154382|FG000|Overall Study|Withdrawal by Subject|0|||
164215113|NCT02232698|593154383|FG001|Overall Study|Withdrawal by Subject|11|||
164215114|NCT00317369|593154385|FG000|Overall Study|Adverse Event|2|||
164215115|NCT00317369|593154386|FG001|Overall Study|Adverse Event|1|||
164215116|NCT00317369|593154387|FG002|Overall Study|Adverse Event|0|||
164215117|NCT00317369|593154385|FG000|Overall Study|Lack of Efficacy|0|||
164215118|NCT00317369|593154386|FG001|Overall Study|Lack of Efficacy|1|||
164215119|NCT00317369|593154387|FG002|Overall Study|Lack of Efficacy|1|||
164215120|NCT00317369|593154385|FG000|Overall Study|Withdrawal by Subject|0|||
164215121|NCT00317369|593154386|FG001|Overall Study|Withdrawal by Subject|0|||
164215122|NCT00317369|593154387|FG002|Overall Study|Withdrawal by Subject|1|||
164215123|NCT04069520|593154392|FG000|Overall Study|Lost to Follow-up|0|||
164215124|NCT04069520|593154393|FG001|Overall Study|Lost to Follow-up|2|||
164215125|NCT04069520|593154392|FG000|Overall Study|Withdrawal by Subject|0|||
164215126|NCT04069520|593154393|FG001|Overall Study|Withdrawal by Subject|1|||
164215127|NCT04069520|593154392|FG000|Overall Study|Prior Injury|1|||
164215128|NCT04069520|593154393|FG001|Overall Study|Prior Injury|0|||
163876561|NCT04424927|591916935|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
163876562|NCT04424927|591916936|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
163876563|NCT04424927|591916932|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
163876564|NCT04424927|591916933|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
163876565|NCT04424927|591916934|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
163876566|NCT04424927|591916935|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
163876567|NCT04424927|591916936|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
164215129|NCT04069520|593154392|FG000|Overall Study|Orthodontia|1|||
163876568|NCT04424927|591916932|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
163876569|NCT04424927|591916933|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164215130|NCT04069520|593154393|FG001|Overall Study|Orthodontia|0|||
164215131|NCT04069520|593154392|FG000|Overall Study|Cut from team|0|||
164215132|NCT04069520|593154393|FG001|Overall Study|Cut from team|2|||
164215133|NCT04615507|593154394|FG000|Period 1|Covid-19 exposure|2|||
164215134|NCT04615507|593154395|FG001|Period 1|Covid-19 exposure|1|||
164215135|NCT04615507|593154394|FG000|Period 2|Covid-19 exposure|0|||
164215136|NCT04615507|593154395|FG001|Period 2|Covid-19 exposure|1|||
164215137|NCT04615507|593154394|FG000|Period 2|Protocol Violation|1|||
164326051|NCT00472459|593570105|FG000|Overall Study|Withdrawal by Subject|5|||
164326052|NCT00472459|593570106|FG001|Overall Study|Withdrawal by Subject|5|||
164326053|NCT00472459|593570105|FG000|Overall Study|Protocol Violation|3|||
164326054|NCT00472459|593570106|FG001|Overall Study|Protocol Violation|3|||
164077828|NCT02570165|592650041|FG004|Overall Study|Adverse Event|0|||
164077829|NCT02570165|592650042|FG005|Overall Study|Adverse Event|0|||
164077830|NCT02570165|592650043|FG006|Overall Study|Adverse Event|0|||
164215138|NCT04615507|593154395|FG001|Period 2|Protocol Violation|0|||
164215139|NCT04615507|593154394|FG000|Period 2|Withdrawal by Subject|1|||
164215140|NCT04615507|593154395|FG001|Period 2|Withdrawal by Subject|0|||
164215141|NCT04615507|593154394|FG000|Period 2|Adverse Event|0|||
164215142|NCT04615507|593154395|FG001|Period 2|Adverse Event|1|||
164215143|NCT04615507|593154394|FG000|Period 3|Covid-19 exposure|0|||
164215144|NCT04615507|593154395|FG001|Period 3|Covid-19 exposure|1|||
164215145|NCT03407482|593154396|FG000|Overall Study|Adverse Event|12|||
164215146|NCT03407482|593154396|FG000|Overall Study|Disease Relapse|1|||
164215147|NCT03407482|593154396|FG000|Overall Study|Lost to Follow-up|1|||
164215148|NCT03407482|593154396|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164215149|NCT03407482|593154396|FG000|Overall Study|Pregnancy|2|||
164215150|NCT03407482|593154396|FG000|Overall Study|Protocol Violation|1|||
164215151|NCT03407482|593154396|FG000|Overall Study|Study Terminated By Sponsor|106|||
164215152|NCT03407482|593154396|FG000|Overall Study|Withdrawal by Subject|6|||
164215153|NCT03407482|593154396|FG000|Overall Study|Data Entry Error|1|||
164215154|NCT02207608|593154400|FG000|Overall Study|Adverse Event|1|||
164215155|NCT02207608|593154401|FG001|Overall Study|Adverse Event|0|||
164215156|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215157|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215158|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215159|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
164215160|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215161|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215162|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215163|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
164215164|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215165|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215166|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
164215167|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
164215168|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215169|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215170|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215171|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
164215172|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215173|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215174|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
164215175|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215176|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215177|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215178|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215179|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
164215180|NCT02850406|593154402|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
164215181|NCT02850406|593154403|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
164215182|NCT02850406|593154404|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
164215183|NCT02850406|593154405|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
164215184|NCT02850406|593154406|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
164215185|NCT02850406|593154407|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
164215186|NCT02850406|593154408|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
164215187|NCT02850406|593154409|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
164215188|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215189|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215190|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215191|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215192|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
164215193|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
164215194|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215195|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
164215196|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215197|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164077831|NCT02570165|592650037|FG000|Overall Study|Lack of Efficacy|0|||
164215198|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215199|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215200|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
164215201|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
164215202|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215203|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215204|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215205|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215206|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215207|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215208|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
164215209|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215210|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215211|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
164215212|NCT02850406|593154402|FG000|Part C (Up to 52 Weeks)|Other|0|||
164215213|NCT02850406|593154403|FG001|Part C (Up to 52 Weeks)|Other|0|||
164215214|NCT02850406|593154404|FG002|Part C (Up to 52 Weeks)|Other|0|||
164215215|NCT02850406|593154405|FG003|Part C (Up to 52 Weeks)|Other|0|||
164215216|NCT02850406|593154406|FG004|Part C (Up to 52 Weeks)|Other|1|||
164215217|NCT02850406|593154407|FG005|Part C (Up to 52 Weeks)|Other|3|||
164215218|NCT02850406|593154408|FG006|Part C (Up to 52 Weeks)|Other|0|||
164215219|NCT02850406|593154409|FG007|Part C (Up to 52 Weeks)|Other|0|||
164215220|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215221|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215222|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215223|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215224|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215225|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215226|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
164215227|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
164215228|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215229|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215230|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215231|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215232|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215233|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215234|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
164215235|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
164215236|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215237|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215238|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215239|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215240|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215241|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
164215242|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
164215243|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
164215244|NCT02850406|593154402|FG000|Part D (Up to 52 Weeks)|Other|0|||
164215245|NCT02850406|593154403|FG001|Part D (Up to 52 Weeks)|Other|0|||
164215246|NCT02850406|593154404|FG002|Part D (Up to 52 Weeks)|Other|0|||
164215247|NCT02850406|593154405|FG003|Part D (Up to 52 Weeks)|Other|0|||
164215248|NCT02850406|593154406|FG004|Part D (Up to 52 Weeks)|Other|0|||
164215249|NCT02850406|593154407|FG005|Part D (Up to 52 Weeks)|Other|0|||
164215250|NCT02850406|593154408|FG006|Part D (Up to 52 Weeks)|Other|0|||
164215251|NCT02850406|593154409|FG007|Part D (Up to 52 Weeks)|Other|1|||
164215252|NCT01653262|593155808|FG000|Overall Study|Lack of Efficacy|1|||
164215253|NCT01653262|593155808|FG000|Overall Study|SAE, non-fatal|1|||
164215254|NCT01653262|593155808|FG000|Overall Study|AE, non-serious non-fatal|1|||
164215255|NCT01112267|593155809|FG000|Overall Study|Adverse Event|24|||
164215256|NCT01112267|593155810|FG001|Overall Study|Adverse Event|6|||
164215257|NCT01112267|593155809|FG000|Overall Study|Withdrawal by Subject|3|||
164215258|NCT01112267|593155810|FG001|Overall Study|Withdrawal by Subject|5|||
164215259|NCT01112267|593155809|FG000|Overall Study|Protocol Violation|5|||
164215260|NCT01112267|593155810|FG001|Overall Study|Protocol Violation|3|||
164215261|NCT01112267|593155809|FG000|Overall Study|Participants not compliant|1|||
164215262|NCT01112267|593155810|FG001|Overall Study|Participants not compliant|2|||
164215263|NCT01112267|593155809|FG000|Overall Study|Participants not receive any study drug|1|||
164215264|NCT01112267|593155810|FG001|Overall Study|Participants not receive any study drug|2|||
164215265|NCT01373229|593155813|FG000|Overall Study|Death|3|||
164215266|NCT01373229|593155813|FG000|Overall Study|Physician Decision|3|||
163876570|NCT04424927|591916934|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164215267|NCT00726557|593155816|FG000|Overall Study|Screening failure|4|||
164215268|NCT00726557|593155816|FG000|Overall Study|No end of treatment documentation|37|||
164215269|NCT00726557|593155816|FG000|Overall Study|No follow-up documentation available|55|||
163876571|NCT04424927|591916935|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
164215270|NCT00726557|593155816|FG000|Overall Study|Treatment less than 3 months|17|||
164215271|NCT00726557|593155816|FG000|Overall Study|Inclusion criteria not met|15|||
164215272|NCT01946802|593155819|FG000|Overall Study|Death|1|||
164215273|NCT01946802|593155819|FG000|Overall Study|Withdrawal by Subject|2|||
164215274|NCT01946802|593155819|FG000|Overall Study|Combined septic shock|1|||
164215275|NCT01946802|593155819|FG000|Overall Study|Protocol Violation|1|||
164215276|NCT00153920|593155820|FG000|Overall Study|Adverse Event|9|||
164215277|NCT00153920|593155820|FG000|Overall Study|Progressive Disease|9|||
164077832|NCT02570165|592650038|FG001|Overall Study|Lack of Efficacy|1|||
164077833|NCT02570165|592650039|FG002|Overall Study|Lack of Efficacy|0|||
164077834|NCT02570165|592650040|FG003|Overall Study|Lack of Efficacy|0|||
164077835|NCT02570165|592650041|FG004|Overall Study|Lack of Efficacy|4|||
164077836|NCT02570165|592650042|FG005|Overall Study|Lack of Efficacy|0|||
164077837|NCT02570165|592650043|FG006|Overall Study|Lack of Efficacy|0|||
164077838|NCT02570165|592650037|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
164077839|NCT02570165|592650038|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
164077840|NCT02570165|592650039|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
164077841|NCT02570165|592650040|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
164077842|NCT02570165|592650041|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
164077843|NCT02570165|592650042|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
164077844|NCT02570165|592650043|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
164077845|NCT02570165|592650037|FG000|Overall Study|Lost to Follow-up|0|||
164077846|NCT02570165|592650038|FG001|Overall Study|Lost to Follow-up|0|||
164077847|NCT02570165|592650039|FG002|Overall Study|Lost to Follow-up|1|||
164077848|NCT02570165|592650040|FG003|Overall Study|Lost to Follow-up|1|||
164077849|NCT02570165|592650041|FG004|Overall Study|Lost to Follow-up|0|||
164077850|NCT02570165|592650042|FG005|Overall Study|Lost to Follow-up|0|||
164077851|NCT02570165|592650043|FG006|Overall Study|Lost to Follow-up|0|||
164077852|NCT02570165|592650037|FG000|Overall Study|Physician Decision|0|||
164077853|NCT02570165|592650038|FG001|Overall Study|Physician Decision|1|||
164077854|NCT02570165|592650039|FG002|Overall Study|Physician Decision|0|||
164077855|NCT02570165|592650040|FG003|Overall Study|Physician Decision|0|||
164077856|NCT02570165|592650041|FG004|Overall Study|Physician Decision|0|||
164077857|NCT02570165|592650042|FG005|Overall Study|Physician Decision|0|||
164077858|NCT02570165|592650043|FG006|Overall Study|Physician Decision|0|||
164077859|NCT02570165|592650037|FG000|Overall Study|Withdrawal by Subject|0|||
164077860|NCT02570165|592650038|FG001|Overall Study|Withdrawal by Subject|0|||
164077861|NCT02570165|592650039|FG002|Overall Study|Withdrawal by Subject|0|||
164077862|NCT02570165|592650040|FG003|Overall Study|Withdrawal by Subject|2|||
164077863|NCT02570165|592650041|FG004|Overall Study|Withdrawal by Subject|1|||
164077864|NCT02570165|592650042|FG005|Overall Study|Withdrawal by Subject|0|||
164077865|NCT02570165|592650043|FG006|Overall Study|Withdrawal by Subject|0|||
164077866|NCT02570165|592650037|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
164077867|NCT02570165|592650038|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
164077868|NCT02570165|592650039|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
164077869|NCT02570165|592650040|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
164077870|NCT02570165|592650041|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
164215278|NCT00153920|593155820|FG000|Overall Study|Physician Decision|3|||
164215279|NCT00153920|593155820|FG000|Overall Study|Lack of Response|3|||
164215280|NCT00153920|593155820|FG000|Overall Study|Death|2|||
164215281|NCT00153920|593155820|FG000|Overall Study|Withdrawal by Subject|1|||
164215282|NCT00153920|593155820|FG000|Overall Study|Non-Protocol Therapy|1|||
164215283|NCT00153920|593155820|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
164215284|NCT00153920|593155820|FG000|Overall Study|Progressive Disease before Trt|1|||
164215285|NCT02541903|593155821|FG000|Overall Study|Death|1|||
164215286|NCT00827242|593155822|FG000|Overall Study|Withdrawal by Subject|2|||
164215287|NCT00827242|593155823|FG001|Overall Study|Withdrawal by Subject|4|||
164215288|NCT00827242|593155822|FG000|Overall Study|Protocol Violation|1|||
164215289|NCT00827242|593155823|FG001|Overall Study|Protocol Violation|3|||
164215290|NCT00827242|593155822|FG000|Overall Study|Lost to Follow-up|0|||
164215291|NCT00827242|593155823|FG001|Overall Study|Lost to Follow-up|3|||
164215292|NCT00827242|593155822|FG000|Overall Study|Adverse Event Excluding Death|2|||
164215293|NCT00827242|593155823|FG001|Overall Study|Adverse Event Excluding Death|1|||
164215294|NCT00827242|593155822|FG000|Overall Study|Entry Criteria Not Met|4|||
164215295|NCT00827242|593155823|FG001|Overall Study|Entry Criteria Not Met|1|||
164215296|NCT00827242|593155822|FG000|Overall Study|Physician Decision|2|||
164215297|NCT00827242|593155823|FG001|Overall Study|Physician Decision|0|||
164215298|NCT00827242|593155822|FG000|Overall Study|Death|1|||
164215299|NCT00827242|593155823|FG001|Overall Study|Death|0|||
164215300|NCT00827242|593155822|FG000|Overall Study|Lack of Efficacy|1|||
164215301|NCT00827242|593155823|FG001|Overall Study|Lack of Efficacy|0|||
164215302|NCT05762679|593155824|FG000|Overall Study|Withdrawal by Subject|1|||
164215303|NCT05762679|593155824|FG000|Overall Study|No analyzable imaging data|1|||
164215304|NCT04795323|593155825|FG000|Overall Study|Did not interact with TARA|1|||
164215305|NCT04795323|593155826|FG001|Overall Study|Did not interact with TARA|0|||
164215306|NCT01944774|593155827|FG000|Overall Study|Withdrawal by Subject|2|||
164215307|NCT01944774|593155828|FG001|Overall Study|Withdrawal by Subject|3|||
164215308|NCT01944774|593155829|FG002|Overall Study|Withdrawal by Subject|3|||
164215309|NCT01944774|593155827|FG000|Overall Study|Adverse Event|3|||
164077871|NCT02570165|592650042|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
164215310|NCT01944774|593155828|FG001|Overall Study|Adverse Event|2|||
164215311|NCT01944774|593155829|FG002|Overall Study|Adverse Event|3|||
164215312|NCT01944774|593155827|FG000|Overall Study|Lack of Efficacy|1|||
164215313|NCT01944774|593155828|FG001|Overall Study|Lack of Efficacy|2|||
163876572|NCT04424927|591916936|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
163876573|NCT04424927|591916932|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
163876574|NCT04424927|591916933|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163876575|NCT04424927|591916934|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163876576|NCT04424927|591916935|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163876577|NCT04424927|591916936|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
163876578|NCT04424927|591916932|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
163876579|NCT04424927|591916933|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
163876580|NCT04424927|591916934|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
163876581|NCT04424927|591916935|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
163876582|NCT04424927|591916936|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
163876583|NCT04424927|591916932|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
163876584|NCT04424927|591916933|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
163876585|NCT04424927|591916934|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
163876586|NCT04424927|591916935|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
163876587|NCT04424927|591916936|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
163876588|NCT04424927|591916932|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
163876589|NCT04424927|591916933|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
163876590|NCT04424927|591916934|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
163876591|NCT04424927|591916935|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
163876592|NCT04424927|591916936|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
163876593|NCT04424927|591916932|FG000|Double-blind Period (24 Weeks)|Other|0|||
163876594|NCT04424927|591916933|FG001|Double-blind Period (24 Weeks)|Other|1|||
163876595|NCT04424927|591916934|FG002|Double-blind Period (24 Weeks)|Other|3|||
163876596|NCT04424927|591916935|FG003|Double-blind Period (24 Weeks)|Other|1|||
163876597|NCT04424927|591916936|FG004|Double-blind Period (24 Weeks)|Other|0|||
163876598|NCT02386553|591916942|FG000|Overall Study|Reason Not Specified|1|||
163876599|NCT02386553|591916943|FG001|Overall Study|Reason Not Specified|1|||
163876600|NCT02386553|591916942|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
163876601|NCT02386553|591916943|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
163876602|NCT04149002|591916954|FG000|Overall Study|Lost to Follow-up|1|||
163876603|NCT04149002|591916955|FG001|Overall Study|Lost to Follow-up|0|||
163876604|NCT04149002|591916954|FG000|Overall Study|Withdrawal by Subject|1|||
163876605|NCT04149002|591916955|FG001|Overall Study|Withdrawal by Subject|0|||
163981027|NCT00464334|592299701|FG008|Overall Study|Withdrawal by Subject|3|||
163981028|NCT00464334|592299702|FG009|Overall Study|Withdrawal by Subject|0|||
163981029|NCT00464334|592299703|FG010|Overall Study|Withdrawal by Subject|0|||
164077872|NCT02570165|592650043|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
164077873|NCT02570165|592650037|FG000|Overall Study|Withdrawal Request by GSK|0|||
164077874|NCT02570165|592650038|FG001|Overall Study|Withdrawal Request by GSK|0|||
164077875|NCT02570165|592650039|FG002|Overall Study|Withdrawal Request by GSK|2|||
164077876|NCT02570165|592650040|FG003|Overall Study|Withdrawal Request by GSK|0|||
164077877|NCT02570165|592650041|FG004|Overall Study|Withdrawal Request by GSK|0|||
164077878|NCT02570165|592650042|FG005|Overall Study|Withdrawal Request by GSK|0|||
164077879|NCT02570165|592650043|FG006|Overall Study|Withdrawal Request by GSK|0|||
164077880|NCT01953783|592650044|FG000|Overall Study|Progressive disease|2|||
164077881|NCT01789281|592650045|FG000|Overall Study|Disease progression|15|||
164077882|NCT01789281|592650046|FG001|Overall Study|Disease progression|4|||
164077883|NCT01789281|592650045|FG000|Overall Study|Adverse Event|5|||
164077884|NCT01789281|592650046|FG001|Overall Study|Adverse Event|5|||
163876606|NCT06061081|591916957|FG000|Overall Study|Withdrawal by Subject|1|||
163876607|NCT06061081|591916958|FG001|Overall Study|Withdrawal by Subject|0|||
163876608|NCT06061081|591916959|FG002|Overall Study|Withdrawal by Subject|0|||
163981030|NCT00797732|592299704|FG000|Overall Study|Withdrawal by Subject|3|||
163981031|NCT00797732|592299705|FG001|Overall Study|Withdrawal by Subject|3|||
163981032|NCT00797732|592299706|FG002|Overall Study|Withdrawal by Subject|0|||
163981033|NCT00797732|592299704|FG000|Overall Study|Lost to Follow-up|1|||
163981034|NCT00797732|592299705|FG001|Overall Study|Lost to Follow-up|0|||
163981035|NCT00797732|592299706|FG002|Overall Study|Lost to Follow-up|0|||
163981036|NCT00797732|592299704|FG000|Overall Study|Death|1|||
163981037|NCT00797732|592299705|FG001|Overall Study|Death|0|||
163981038|NCT00797732|592299706|FG002|Overall Study|Death|0|||
163981039|NCT00797732|592299704|FG000|Overall Study|Not meet inclusion criteria|0|||
163981040|NCT00797732|592299705|FG001|Overall Study|Not meet inclusion criteria|0|||
164077885|NCT01789281|592650045|FG000|Overall Study|Withdrawal by Subject|1|||
164077886|NCT01789281|592650046|FG001|Overall Study|Withdrawal by Subject|0|||
163876609|NCT06061081|591916960|FG003|Overall Study|Withdrawal by Subject|0|||
163981041|NCT00797732|592299706|FG002|Overall Study|Not meet inclusion criteria|7|||
163981042|NCT00797732|592299704|FG000|Overall Study|Excluded due to time constraints|0|||
163981043|NCT00797732|592299705|FG001|Overall Study|Excluded due to time constraints|0|||
164077887|NCT01789281|592650045|FG000|Overall Study|Lost to Follow-up|1|||
164077888|NCT01789281|592650046|FG001|Overall Study|Lost to Follow-up|0|||
164077889|NCT01789281|592650045|FG000|Overall Study|Administrative problems|0|||
164215314|NCT01944774|593155829|FG002|Overall Study|Lack of Efficacy|2|||
164215315|NCT01944774|593155827|FG000|Overall Study|Lost to Follow-up|0|||
164215316|NCT01944774|593155828|FG001|Overall Study|Lost to Follow-up|1|||
164215317|NCT01944774|593155829|FG002|Overall Study|Lost to Follow-up|0|||
164215318|NCT02503865|593155830|FG000|Overall Study|Moved out of area|1|||
164215319|NCT02503865|593155831|FG001|Overall Study|Moved out of area|8|||
164215320|NCT02503865|593155832|FG002|Overall Study|Moved out of area|0|||
164215321|NCT02503865|593155830|FG000|Overall Study|Refused treatment|4|||
164215322|NCT02503865|593155831|FG001|Overall Study|Refused treatment|39|||
164215323|NCT02503865|593155832|FG002|Overall Study|Refused treatment|2|||
164215324|NCT00021255|593155833|FG000|Overall Study|Death|1|||
164215325|NCT00021255|593155834|FG001|Overall Study|Death|0|||
164215326|NCT00021255|593155835|FG002|Overall Study|Death|2|||
164215327|NCT00021255|593155833|FG000|Overall Study|Breast cancer relapse|5|||
164215328|NCT00021255|593155834|FG001|Overall Study|Breast cancer relapse|18|||
164215329|NCT00021255|593155835|FG002|Overall Study|Breast cancer relapse|11|||
164215330|NCT00021255|593155833|FG000|Overall Study|Second primary malignancy|0|||
164215331|NCT00021255|593155834|FG001|Overall Study|Second primary malignancy|4|||
164215332|NCT00021255|593155835|FG002|Overall Study|Second primary malignancy|1|||
164215333|NCT00021255|593155833|FG000|Overall Study|Withdrawal by Subject|41|||
164215334|NCT00021255|593155834|FG001|Overall Study|Withdrawal by Subject|64|||
164215335|NCT00021255|593155835|FG002|Overall Study|Withdrawal by Subject|26|||
164215336|NCT00021255|593155833|FG000|Overall Study|Lost to Follow-up|0|||
164215337|NCT00021255|593155834|FG001|Overall Study|Lost to Follow-up|2|||
164215338|NCT00021255|593155835|FG002|Overall Study|Lost to Follow-up|3|||
164215339|NCT00021255|593155833|FG000|Overall Study|Cardiac toxicity|0|||
164215340|NCT00021255|593155834|FG001|Overall Study|Cardiac toxicity|61|||
164215341|NCT00021255|593155835|FG002|Overall Study|Cardiac toxicity|32|||
164215342|NCT00021255|593155833|FG000|Overall Study|Herceptin toxicity|0|||
164215343|NCT00021255|593155834|FG001|Overall Study|Herceptin toxicity|22|||
164215344|NCT00021255|593155835|FG002|Overall Study|Herceptin toxicity|6|||
164215345|NCT00021255|593155833|FG000|Overall Study|Adverse Event|46|||
164215346|NCT00021255|593155834|FG001|Overall Study|Adverse Event|30|||
163876610|NCT06061081|591916961|FG004|Overall Study|Withdrawal by Subject|0|||
163876611|NCT05782231|591916962|FG000|Overall Study|Withdrawal by Subject|1|||
163876612|NCT02252172|591916963|FG000|Overall Study|Lost to Follow-up|9|||
164215347|NCT00021255|593155835|FG002|Overall Study|Adverse Event|18|||
164215348|NCT00021255|593155833|FG000|Overall Study|Protocol Violation|0|||
164215349|NCT00021255|593155834|FG001|Overall Study|Protocol Violation|2|||
164215350|NCT00021255|593155835|FG002|Overall Study|Protocol Violation|0|||
164215351|NCT00021255|593155833|FG000|Overall Study|Other than specified above|0|||
164215352|NCT00021255|593155834|FG001|Overall Study|Other than specified above|38|||
164215353|NCT00021255|593155835|FG002|Overall Study|Other than specified above|19|||
164215354|NCT00021255|593155833|FG000|Overall Study|Missing|0|||
164215355|NCT00021255|593155834|FG001|Overall Study|Missing|27|||
164215356|NCT00021255|593155835|FG002|Overall Study|Missing|13|||
164215357|NCT00021255|593155833|FG000|Overall Study|Randomized but not treated|28|||
164215358|NCT00021255|593155834|FG001|Overall Study|Randomized but not treated|2|||
164215359|NCT00021255|593155835|FG002|Overall Study|Randomized but not treated|18|||
164215360|NCT00927082|593155836|FG000|Overall Study|Lost to Follow-up|9|||
164215361|NCT00927082|593155837|FG001|Overall Study|Lost to Follow-up|8|||
164215362|NCT00927082|593155838|FG002|Overall Study|Lost to Follow-up|12|||
164215363|NCT00927082|593155839|FG003|Overall Study|Lost to Follow-up|16|||
164215364|NCT00927082|593155836|FG000|Overall Study|Withdrawal by Subject|3|||
164215365|NCT00927082|593155837|FG001|Overall Study|Withdrawal by Subject|2|||
164215366|NCT00927082|593155838|FG002|Overall Study|Withdrawal by Subject|7|||
164215367|NCT00927082|593155839|FG003|Overall Study|Withdrawal by Subject|2|||
164215368|NCT00927082|593155836|FG000|Overall Study|Death|0|||
164215369|NCT00927082|593155837|FG001|Overall Study|Death|0|||
164215370|NCT00927082|593155838|FG002|Overall Study|Death|1|||
164215371|NCT00927082|593155839|FG003|Overall Study|Death|0|||
164215372|NCT00927082|593155836|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
164215373|NCT00927082|593155837|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
164215374|NCT00927082|593155838|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
164215375|NCT00927082|593155839|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
164215376|NCT02513563|593155842|FG000|Overall Study|Death|4|||
164215377|NCT02513563|593155842|FG000|Overall Study|Withdrawal by Subject|4|||
164215378|NCT02513563|593155842|FG000|Overall Study|Physician Decision|1|||
164215379|NCT01068912|593155843|FG000|Overall Study|Adverse Event|2|||
164215380|NCT01068912|593155844|FG001|Overall Study|Adverse Event|3|||
164215381|NCT01068912|593155845|FG002|Overall Study|Adverse Event|2|||
164215382|NCT01068912|593155843|FG000|Overall Study|Withdrawal by Subject|5|||
164215383|NCT01068912|593155844|FG001|Overall Study|Withdrawal by Subject|6|||
164215384|NCT01068912|593155845|FG002|Overall Study|Withdrawal by Subject|6|||
164215385|NCT01068912|593155843|FG000|Overall Study|Lost to Follow-up|3|||
164215386|NCT01068912|593155844|FG001|Overall Study|Lost to Follow-up|7|||
164215387|NCT01068912|593155845|FG002|Overall Study|Lost to Follow-up|3|||
164215388|NCT01068912|593155843|FG000|Overall Study|Protocol Violation|0|||
164215389|NCT01068912|593155844|FG001|Overall Study|Protocol Violation|2|||
164215390|NCT01068912|593155845|FG002|Overall Study|Protocol Violation|0|||
164215391|NCT01068912|593155843|FG000|Overall Study|aggravation influenza|1|||
164215392|NCT01068912|593155844|FG001|Overall Study|aggravation influenza|1|||
164215393|NCT01068912|593155845|FG002|Overall Study|aggravation influenza|1|||
164215394|NCT01068912|593155843|FG000|Overall Study|other underlying illness|0|||
164215395|NCT01068912|593155844|FG001|Overall Study|other underlying illness|3|||
164215396|NCT01068912|593155845|FG002|Overall Study|other underlying illness|3|||
164215397|NCT00825175|593155846|FG000|Overall Study|Withdrawal by Subject|0|||
164215398|NCT00825175|593155847|FG001|Overall Study|Withdrawal by Subject|5|||
164215399|NCT05128942|593155850|FG000|Overall Study|Withdrawal by Subject|1|||
164215400|NCT05128942|593155851|FG001|Overall Study|Withdrawal by Subject|0|||
164215401|NCT05128942|593155852|FG002|Overall Study|Withdrawal by Subject|1|||
164215402|NCT05128942|593155853|FG003|Overall Study|Withdrawal by Subject|0|||
164215403|NCT05128942|593155854|FG004|Overall Study|Withdrawal by Subject|0|||
164215404|NCT05128942|593155855|FG005|Overall Study|Withdrawal by Subject|0|||
164215405|NCT05128942|593155856|FG006|Overall Study|Withdrawal by Subject|0|||
164215406|NCT05128942|593155857|FG007|Overall Study|Withdrawal by Subject|0|||
164215407|NCT05128942|593155858|FG008|Overall Study|Withdrawal by Subject|0|||
164215408|NCT05128942|593155850|FG000|Overall Study|Other|2|||
164215409|NCT05128942|593155851|FG001|Overall Study|Other|0|||
164215410|NCT05128942|593155852|FG002|Overall Study|Other|2|||
164215411|NCT05128942|593155853|FG003|Overall Study|Other|0|||
164215412|NCT05128942|593155854|FG004|Overall Study|Other|0|||
164215413|NCT05128942|593155855|FG005|Overall Study|Other|0|||
164215414|NCT05128942|593155856|FG006|Overall Study|Other|0|||
164137905|NCT00750308|592866975|FG002|Second Treatment|Adverse Event|0|||
164137906|NCT00750308|592866976|FG003|Second Treatment|Adverse Event|0|||
164215415|NCT05128942|593155857|FG007|Overall Study|Other|0|||
164215416|NCT05128942|593155858|FG008|Overall Study|Other|0|||
164215417|NCT05128942|593155850|FG000|Overall Study|Termination by Sponsor|2|||
164215418|NCT05128942|593155851|FG001|Overall Study|Termination by Sponsor|6|||
164215419|NCT05128942|593155852|FG002|Overall Study|Termination by Sponsor|14|||
164215420|NCT05128942|593155853|FG003|Overall Study|Termination by Sponsor|2|||
164215421|NCT05128942|593155854|FG004|Overall Study|Termination by Sponsor|4|||
164215422|NCT05128942|593155855|FG005|Overall Study|Termination by Sponsor|8|||
164215423|NCT05128942|593155856|FG006|Overall Study|Termination by Sponsor|11|||
164215424|NCT05128942|593155857|FG007|Overall Study|Termination by Sponsor|6|||
164215425|NCT05128942|593155858|FG008|Overall Study|Termination by Sponsor|0|||
164215426|NCT05128942|593155850|FG000|Overall Study|Adverse Event|0|||
164215427|NCT05128942|593155851|FG001|Overall Study|Adverse Event|0|||
164215428|NCT05128942|593155852|FG002|Overall Study|Adverse Event|0|||
164215429|NCT05128942|593155853|FG003|Overall Study|Adverse Event|0|||
164215430|NCT05128942|593155854|FG004|Overall Study|Adverse Event|0|||
164215431|NCT05128942|593155855|FG005|Overall Study|Adverse Event|0|||
164215432|NCT05128942|593155856|FG006|Overall Study|Adverse Event|1|||
164215433|NCT05128942|593155857|FG007|Overall Study|Adverse Event|1|||
164215434|NCT05128942|593155858|FG008|Overall Study|Adverse Event|0|||
164215435|NCT05128942|593155850|FG000|Overall Study|Lost to Follow-up|0|||
164215436|NCT05128942|593155851|FG001|Overall Study|Lost to Follow-up|0|||
164215437|NCT05128942|593155852|FG002|Overall Study|Lost to Follow-up|0|||
164215438|NCT05128942|593155853|FG003|Overall Study|Lost to Follow-up|0|||
164215439|NCT05128942|593155854|FG004|Overall Study|Lost to Follow-up|1|||
163876613|NCT02252172|591916964|FG001|Overall Study|Lost to Follow-up|6|||
164137907|NCT00750308|592866977|FG004|Second Treatment|Adverse Event|0|||
164137908|NCT00750308|592866978|FG005|Second Treatment|Adverse Event|1|||
164137909|NCT00750308|592866979|FG006|Second Treatment|Adverse Event|0|||
164137910|NCT00750308|592866980|FG007|Second Treatment|Adverse Event|0|||
163876614|NCT02252172|591916963|FG000|Overall Study|Death|218|||
163876615|NCT02252172|591916964|FG001|Overall Study|Death|175|||
163876616|NCT02252172|591916963|FG000|Overall Study|Withdrawal by Subject|20|||
163876617|NCT02252172|591916964|FG001|Overall Study|Withdrawal by Subject|15|||
163876618|NCT02252172|591916963|FG000|Overall Study|Physician Decision|0|||
163876619|NCT02252172|591916964|FG001|Overall Study|Physician Decision|1|||
163876620|NCT02252172|591916963|FG000|Overall Study|End of data collection|122|||
164137911|NCT00750308|592866981|FG008|Second Treatment|Adverse Event|1|||
164137912|NCT00750308|592866982|FG009|Second Treatment|Adverse Event|0|||
164137913|NCT00750308|592866983|FG010|Second Treatment|Adverse Event|0|||
164137914|NCT00750308|592866984|FG011|Second Treatment|Adverse Event|0|||
164137915|NCT00750308|592866973|FG000|Second Treatment|Withdrawal by Subject|0|||
164137916|NCT00750308|592866974|FG001|Second Treatment|Withdrawal by Subject|0|||
164137917|NCT00750308|592866975|FG002|Second Treatment|Withdrawal by Subject|0|||
164137918|NCT00750308|592866976|FG003|Second Treatment|Withdrawal by Subject|0|||
164137919|NCT00750308|592866977|FG004|Second Treatment|Withdrawal by Subject|1|||
164137920|NCT00750308|592866978|FG005|Second Treatment|Withdrawal by Subject|0|||
164137921|NCT00750308|592866979|FG006|Second Treatment|Withdrawal by Subject|0|||
164137922|NCT00750308|592866980|FG007|Second Treatment|Withdrawal by Subject|0|||
164137923|NCT00750308|592866981|FG008|Second Treatment|Withdrawal by Subject|0|||
164137924|NCT00750308|592866982|FG009|Second Treatment|Withdrawal by Subject|0|||
164215440|NCT05128942|593155855|FG005|Overall Study|Lost to Follow-up|0|||
164215441|NCT05128942|593155856|FG006|Overall Study|Lost to Follow-up|0|||
164215442|NCT05128942|593155857|FG007|Overall Study|Lost to Follow-up|0|||
164215443|NCT05128942|593155858|FG008|Overall Study|Lost to Follow-up|0|||
164215444|NCT03998462|593155860|FG000|Overall Study|Withdrawal by Subject|10|||
164215445|NCT03998462|593155861|FG001|Overall Study|Withdrawal by Subject|4|||
164215446|NCT03998462|593155860|FG000|Overall Study|Lost to Follow-up|1|||
164215447|NCT03998462|593155861|FG001|Overall Study|Lost to Follow-up|0|||
164215448|NCT03998462|593155860|FG000|Overall Study|Technical Difficulties|1|||
164215449|NCT03998462|593155861|FG001|Overall Study|Technical Difficulties|2|||
164215450|NCT05710224|593155862|FG000|Overall Study|Death|1|||
164215451|NCT05710224|593155863|FG001|Overall Study|Death|0|||
164215452|NCT05710224|593155862|FG000|Overall Study|Lost to Follow-up|16|||
164215453|NCT05710224|593155863|FG001|Overall Study|Lost to Follow-up|7|||
164215454|NCT05710224|593155862|FG000|Overall Study|Withdrawal by Subject|4|||
164215455|NCT05710224|593155863|FG001|Overall Study|Withdrawal by Subject|6|||
164215456|NCT05710224|593155862|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164215457|NCT05710224|593155863|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164215458|NCT05710224|593155862|FG000|Overall Study|Participants Left The City|0|||
164215459|NCT05710224|593155863|FG001|Overall Study|Participants Left The City|2|||
164215460|NCT03369223|593155866|FG000|Overall Study|Lost to Follow-up|0|||
164215461|NCT03369223|593155867|FG001|Overall Study|Lost to Follow-up|0|||
164215462|NCT03369223|593155868|FG002|Overall Study|Lost to Follow-up|0|||
164215463|NCT03369223|593155869|FG003|Overall Study|Lost to Follow-up|0|||
164215464|NCT03369223|593155870|FG004|Overall Study|Lost to Follow-up|0|||
164215465|NCT03369223|593155871|FG005|Overall Study|Lost to Follow-up|0|||
164215466|NCT03369223|593155872|FG006|Overall Study|Lost to Follow-up|0|||
164215467|NCT03369223|593155873|FG007|Overall Study|Lost to Follow-up|0|||
164215468|NCT03369223|593155874|FG008|Overall Study|Lost to Follow-up|0|||
164215469|NCT03369223|593155875|FG009|Overall Study|Lost to Follow-up|0|||
164215470|NCT03369223|593155876|FG010|Overall Study|Lost to Follow-up|0|||
164215471|NCT03369223|593155877|FG011|Overall Study|Lost to Follow-up|0|||
164215472|NCT03369223|593155878|FG012|Overall Study|Lost to Follow-up|0|||
164215473|NCT03369223|593155879|FG013|Overall Study|Lost to Follow-up|0|||
164215474|NCT03369223|593155880|FG014|Overall Study|Lost to Follow-up|0|||
164215475|NCT03369223|593155881|FG015|Overall Study|Lost to Follow-up|0|||
164215476|NCT03369223|593155882|FG016|Overall Study|Lost to Follow-up|0|||
164215477|NCT03369223|593155883|FG017|Overall Study|Lost to Follow-up|0|||
164215478|NCT03369223|593155884|FG018|Overall Study|Lost to Follow-up|2|||
163876621|NCT02252172|591916964|FG001|Overall Study|End of data collection|170|||
163876622|NCT02252172|591916963|FG000|Overall Study|Site closure|0|||
163876623|NCT02252172|591916964|FG001|Overall Study|Site closure|1|||
163876624|NCT03830866|591916965|FG000|Overall Study|Death|90|||
163876625|NCT03830866|591916966|FG001|Overall Study|Death|111|||
163876626|NCT03830866|591916965|FG000|Overall Study|Lost to Follow-up|7|||
163876627|NCT03830866|591916966|FG001|Overall Study|Lost to Follow-up|7|||
163876628|NCT03830866|591916965|FG000|Overall Study|Withdrawal by Subject|19|||
163876629|NCT03830866|591916966|FG001|Overall Study|Withdrawal by Subject|16|||
163876630|NCT03830866|591916965|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
163876631|NCT03830866|591916966|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
163876632|NCT03830866|591916965|FG000|Overall Study|Other|1|||
163876633|NCT03830866|591916966|FG001|Overall Study|Other|1|||
163876634|NCT01426412|591916967|FG000|Overall Study|Withdrawal by Subject|1|||
163876635|NCT01426412|591916968|FG001|Overall Study|Withdrawal by Subject|0|||
163876636|NCT01426412|591916969|FG002|Overall Study|Withdrawal by Subject|0|||
163876637|NCT01426412|591916970|FG003|Overall Study|Withdrawal by Subject|0|||
163876638|NCT01426412|591916971|FG004|Overall Study|Withdrawal by Subject|1|||
163876639|NCT01426412|591916972|FG005|Overall Study|Withdrawal by Subject|0|||
163876640|NCT01426412|591916973|FG006|Overall Study|Withdrawal by Subject|0|||
163876641|NCT01426412|591916974|FG007|Overall Study|Withdrawal by Subject|3|||
163876642|NCT01426412|591916975|FG008|Overall Study|Withdrawal by Subject|1|||
163876643|NCT03014453|591916976|FG000|Overall Study|Lost to Follow-up|12|||
163876644|NCT03014453|591916976|FG000|Overall Study|Discontinued GER|3|||
163876645|NCT03014453|591916976|FG000|Overall Study|Excluded|19|||
163876646|NCT03014453|591916976|FG000|Overall Study|Refused to take part in|37|||
163876647|NCT00262301|591916979|FG000|Double-blind Phase|Lost to Follow-up|1|||
163876648|NCT00262301|591916980|FG001|Double-blind Phase|Lost to Follow-up|0|||
163876649|NCT00262301|591916981|FG002|Double-blind Phase|Lost to Follow-up|0|||
163876650|NCT00262301|591916979|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
164215479|NCT03369223|593155885|FG019|Overall Study|Lost to Follow-up|1|||
164215480|NCT03369223|593155866|FG000|Overall Study|Participant no longer meets study criteria|0|||
163876651|NCT00262301|591916980|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
163876652|NCT00262301|591916981|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
164077890|NCT01789281|592650046|FG001|Overall Study|Administrative problems|1|||
164215481|NCT03369223|593155867|FG001|Overall Study|Participant no longer meets study criteria|0|||
164215482|NCT03369223|593155868|FG002|Overall Study|Participant no longer meets study criteria|0|||
164215483|NCT03369223|593155869|FG003|Overall Study|Participant no longer meets study criteria|0|||
164215484|NCT03369223|593155870|FG004|Overall Study|Participant no longer meets study criteria|0|||
164215485|NCT03369223|593155871|FG005|Overall Study|Participant no longer meets study criteria|0|||
164215486|NCT03369223|593155872|FG006|Overall Study|Participant no longer meets study criteria|0|||
164215487|NCT03369223|593155873|FG007|Overall Study|Participant no longer meets study criteria|0|||
164215488|NCT03369223|593155874|FG008|Overall Study|Participant no longer meets study criteria|0|||
164215489|NCT03369223|593155875|FG009|Overall Study|Participant no longer meets study criteria|0|||
164215490|NCT03369223|593155876|FG010|Overall Study|Participant no longer meets study criteria|0|||
164215491|NCT03369223|593155877|FG011|Overall Study|Participant no longer meets study criteria|0|||
164215492|NCT03369223|593155878|FG012|Overall Study|Participant no longer meets study criteria|0|||
164215493|NCT03369223|593155879|FG013|Overall Study|Participant no longer meets study criteria|0|||
164215494|NCT03369223|593155880|FG014|Overall Study|Participant no longer meets study criteria|2|||
164215495|NCT03369223|593155881|FG015|Overall Study|Participant no longer meets study criteria|0|||
164215496|NCT03369223|593155882|FG016|Overall Study|Participant no longer meets study criteria|2|||
164215497|NCT03369223|593155883|FG017|Overall Study|Participant no longer meets study criteria|0|||
164215498|NCT03369223|593155884|FG018|Overall Study|Participant no longer meets study criteria|0|||
164215499|NCT03369223|593155885|FG019|Overall Study|Participant no longer meets study criteria|0|||
164215500|NCT03369223|593155866|FG000|Overall Study|Other reasons|0|||
164215501|NCT03369223|593155867|FG001|Overall Study|Other reasons|0|||
164215502|NCT03369223|593155868|FG002|Overall Study|Other reasons|0|||
164215503|NCT03369223|593155869|FG003|Overall Study|Other reasons|0|||
164215504|NCT03369223|593155870|FG004|Overall Study|Other reasons|0|||
163981044|NCT00797732|592299706|FG002|Overall Study|Excluded due to time constraints|24|||
163981045|NCT00797732|592299704|FG000|Overall Study|Refused to Participate|0|||
163981046|NCT00797732|592299705|FG001|Overall Study|Refused to Participate|0|||
163981047|NCT00797732|592299706|FG002|Overall Study|Refused to Participate|123|||
163981048|NCT03948178|592299707|FG000|Overall Study|Protocol Violation|1|||
163981049|NCT03948178|592299707|FG000|Overall Study|Lost to Follow-up|2|||
163981050|NCT03948178|592299707|FG000|Overall Study|Withdrawal by Subject|2|||
163981051|NCT03948178|592299707|FG000|Overall Study|Reason not known|2|||
163981052|NCT03948178|592299707|FG000|Overall Study|Personal reason|14|||
163981053|NCT03948178|592299707|FG000|Overall Study|Disease progression|30|||
163981054|NCT03948178|592299707|FG000|Overall Study|Adverse Event|12|||
163981055|NCT03948178|592299707|FG000|Overall Study|Sponsor terminated study|164|||
163981056|NCT01297270|592299708|FG000|Overall Study|Adverse Event|19|||
163981057|NCT01297270|592299709|FG001|Overall Study|Adverse Event|32|||
163981058|NCT01297270|592299710|FG002|Overall Study|Adverse Event|5|||
163981059|NCT01297270|592299708|FG000|Overall Study|Lack of Efficacy|15|||
163981060|NCT01297270|592299709|FG001|Overall Study|Lack of Efficacy|17|||
163981061|NCT01297270|592299710|FG002|Overall Study|Lack of Efficacy|15|||
163981062|NCT01297270|592299708|FG000|Overall Study|Lost to Follow-up|1|||
163981063|NCT01297270|592299709|FG001|Overall Study|Lost to Follow-up|2|||
163981064|NCT01297270|592299710|FG002|Overall Study|Lost to Follow-up|1|||
163981065|NCT01297270|592299708|FG000|Overall Study|Protocol Violation|0|||
163981066|NCT01297270|592299709|FG001|Overall Study|Protocol Violation|2|||
163981067|NCT01297270|592299710|FG002|Overall Study|Protocol Violation|0|||
163981068|NCT01297270|592299708|FG000|Overall Study|Withdrawal by Subject|7|||
163981069|NCT01297270|592299709|FG001|Overall Study|Withdrawal by Subject|15|||
163981070|NCT01297270|592299710|FG002|Overall Study|Withdrawal by Subject|7|||
163981071|NCT01297270|592299708|FG000|Overall Study|Other reason not defined above|3|||
163981072|NCT01297270|592299709|FG001|Overall Study|Other reason not defined above|3|||
163981073|NCT01297270|592299710|FG002|Overall Study|Other reason not defined above|1|||
163981074|NCT01297270|592299708|FG000|Overall Study|Not treated|0|||
163981075|NCT01297270|592299709|FG001|Overall Study|Not treated|1|||
163981076|NCT01297270|592299710|FG002|Overall Study|Not treated|0|||
163981077|NCT00401752|592299713|FG000|Overall Study|Adverse Event|2|||
163981078|NCT00401752|592299714|FG001|Overall Study|Adverse Event|5|||
164215505|NCT03369223|593155871|FG005|Overall Study|Other reasons|0|||
164215506|NCT03369223|593155872|FG006|Overall Study|Other reasons|0|||
164215507|NCT03369223|593155873|FG007|Overall Study|Other reasons|0|||
164215508|NCT03369223|593155874|FG008|Overall Study|Other reasons|0|||
164215509|NCT03369223|593155875|FG009|Overall Study|Other reasons|0|||
164215510|NCT03369223|593155876|FG010|Overall Study|Other reasons|0|||
164215511|NCT03369223|593155877|FG011|Overall Study|Other reasons|0|||
164215512|NCT03369223|593155878|FG012|Overall Study|Other reasons|0|||
164215513|NCT03369223|593155879|FG013|Overall Study|Other reasons|1|||
164215514|NCT03369223|593155880|FG014|Overall Study|Other reasons|2|||
164215515|NCT03369223|593155881|FG015|Overall Study|Other reasons|0|||
164215516|NCT03369223|593155882|FG016|Overall Study|Other reasons|1|||
163981079|NCT00401752|592299713|FG000|Overall Study|Withdrawal by Subject|2|||
163981080|NCT00401752|592299714|FG001|Overall Study|Withdrawal by Subject|6|||
164215517|NCT03369223|593155883|FG017|Overall Study|Other reasons|0|||
163981081|NCT00401752|592299713|FG000|Overall Study|Lost to Follow-up|1|||
163981082|NCT00401752|592299714|FG001|Overall Study|Lost to Follow-up|4|||
163981083|NCT00401752|592299713|FG000|Overall Study|Development of any exclusion criteria|4|||
163981084|NCT00401752|592299714|FG001|Overall Study|Development of any exclusion criteria|2|||
164215518|NCT03369223|593155884|FG018|Overall Study|Other reasons|0|||
163981085|NCT00401752|592299713|FG000|Overall Study|Physician Decision|1|||
163981086|NCT00401752|592299714|FG001|Overall Study|Physician Decision|1|||
163981087|NCT02432235|592299715|FG000|Overall Study|Death|1|||
163981088|NCT02432235|592299716|FG001|Overall Study|Death|1|||
163981089|NCT02432235|592299717|FG002|Overall Study|Death|2|||
163981090|NCT02432235|592299718|FG003|Overall Study|Death|2|||
163981091|NCT02432235|592299719|FG004|Overall Study|Death|1|||
163981092|NCT02432235|592299720|FG005|Overall Study|Death|3|||
163981093|NCT02432235|592299721|FG006|Overall Study|Death|11|||
163981094|NCT02432235|592299722|FG007|Overall Study|Death|15|||
163981095|NCT02432235|592299723|FG008|Overall Study|Death|15|||
163981096|NCT02432235|592299724|FG009|Overall Study|Death|3|||
163981097|NCT02432235|592299725|FG010|Overall Study|Death|1|||
163981098|NCT02432235|592299726|FG011|Overall Study|Death|0|||
163981099|NCT02432235|592299715|FG000|Overall Study|Withdrawal by Subject|0|||
163981100|NCT02432235|592299716|FG001|Overall Study|Withdrawal by Subject|1|||
163981101|NCT02432235|592299717|FG002|Overall Study|Withdrawal by Subject|0|||
163981102|NCT02432235|592299718|FG003|Overall Study|Withdrawal by Subject|0|||
163981103|NCT02432235|592299719|FG004|Overall Study|Withdrawal by Subject|0|||
163981104|NCT02432235|592299720|FG005|Overall Study|Withdrawal by Subject|2|||
163981105|NCT02432235|592299721|FG006|Overall Study|Withdrawal by Subject|5|||
163981106|NCT02432235|592299722|FG007|Overall Study|Withdrawal by Subject|3|||
163981107|NCT02432235|592299723|FG008|Overall Study|Withdrawal by Subject|1|||
163981108|NCT02432235|592299724|FG009|Overall Study|Withdrawal by Subject|0|||
163981109|NCT02432235|592299725|FG010|Overall Study|Withdrawal by Subject|0|||
163981110|NCT02432235|592299726|FG011|Overall Study|Withdrawal by Subject|0|||
163981111|NCT02432235|592299715|FG000|Overall Study|Lost to Follow-up|0|||
163981112|NCT02432235|592299716|FG001|Overall Study|Lost to Follow-up|0|||
163981113|NCT02432235|592299717|FG002|Overall Study|Lost to Follow-up|0|||
163981114|NCT02432235|592299718|FG003|Overall Study|Lost to Follow-up|0|||
163981115|NCT02432235|592299719|FG004|Overall Study|Lost to Follow-up|0|||
163981116|NCT02432235|592299720|FG005|Overall Study|Lost to Follow-up|1|||
163981117|NCT02432235|592299721|FG006|Overall Study|Lost to Follow-up|0|||
163981118|NCT02432235|592299722|FG007|Overall Study|Lost to Follow-up|0|||
163981119|NCT02432235|592299723|FG008|Overall Study|Lost to Follow-up|1|||
163981120|NCT02432235|592299724|FG009|Overall Study|Lost to Follow-up|0|||
163981121|NCT02432235|592299725|FG010|Overall Study|Lost to Follow-up|0|||
163981122|NCT02432235|592299726|FG011|Overall Study|Lost to Follow-up|0|||
163981123|NCT02432235|592299715|FG000|Overall Study|Miscellaneous|0|||
163981124|NCT02432235|592299716|FG001|Overall Study|Miscellaneous|0|||
163981125|NCT02432235|592299717|FG002|Overall Study|Miscellaneous|0|||
163981126|NCT02432235|592299718|FG003|Overall Study|Miscellaneous|0|||
163981127|NCT02432235|592299719|FG004|Overall Study|Miscellaneous|1|||
163981128|NCT02432235|592299720|FG005|Overall Study|Miscellaneous|6|||
163981129|NCT02432235|592299721|FG006|Overall Study|Miscellaneous|2|||
163981130|NCT02432235|592299722|FG007|Overall Study|Miscellaneous|2|||
163981131|NCT02432235|592299723|FG008|Overall Study|Miscellaneous|4|||
163981132|NCT02432235|592299724|FG009|Overall Study|Miscellaneous|0|||
163981133|NCT02432235|592299725|FG010|Overall Study|Miscellaneous|0|||
163981134|NCT02432235|592299726|FG011|Overall Study|Miscellaneous|1|||
163981135|NCT01895322|592299727|FG000|Overall Study|Adverse Event|1|||
163981136|NCT01895322|592299727|FG000|Overall Study|Withdrawal by Subject|2|||
163981137|NCT01895322|592299727|FG000|Overall Study|Protocol Violation|10|||
163981138|NCT01347554|592299733|FG000|Overall Study|Lack of Efficacy|7|||
163981139|NCT01347554|592299734|FG001|Overall Study|Lack of Efficacy|11|||
163981140|NCT02228590|592299740|FG000|Overall Study|Withdrawal by Subject|1|||
163981141|NCT02500121|592299741|FG000|Overall Study|Lost to Follow-up|0|||
163981142|NCT02500121|592299742|FG001|Overall Study|Lost to Follow-up|1|||
163981143|NCT02500121|592299741|FG000|Overall Study|Withdrawal by Subject|1|||
163981144|NCT02500121|592299742|FG001|Overall Study|Withdrawal by Subject|1|||
163981145|NCT02500121|592299741|FG000|Overall Study|Death|26|||
163981146|NCT02500121|592299742|FG001|Overall Study|Death|24|||
163981147|NCT02867995|592299746|FG000|Overall Study|Withdrawal by Subject|0|||
163981148|NCT02867995|592299747|FG001|Overall Study|Withdrawal by Subject|1|||
163981149|NCT02867995|592299746|FG000|Overall Study|Lost to Follow-up|0|||
163981150|NCT02867995|592299747|FG001|Overall Study|Lost to Follow-up|2|||
163981151|NCT01534533|592299748|FG000|Overall Study|Lost to Follow-up|3|||
163981152|NCT01534533|592299749|FG001|Overall Study|Lost to Follow-up|0|||
163981153|NCT01534533|592299750|FG002|Overall Study|Lost to Follow-up|4|||
163981154|NCT01534533|592299751|FG003|Overall Study|Lost to Follow-up|3|||
163981155|NCT01534533|592299748|FG000|Overall Study|Withdrawal by Subject|5|||
163981156|NCT01534533|592299749|FG001|Overall Study|Withdrawal by Subject|3|||
163981157|NCT01534533|592299750|FG002|Overall Study|Withdrawal by Subject|4|||
163981158|NCT01534533|592299751|FG003|Overall Study|Withdrawal by Subject|1|||
163981159|NCT03315871|592299752|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
163981160|NCT03315871|592299753|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
163981161|NCT03315871|592299754|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
164215519|NCT03369223|593155885|FG019|Overall Study|Other reasons|2|||
163981162|NCT03315871|592299752|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
163981163|NCT03315871|592299753|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
163981164|NCT03315871|592299754|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
163981165|NCT03315871|592299752|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
163981166|NCT03315871|592299753|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
164215520|NCT03369223|593155866|FG000|Overall Study|Death|0|||
164215521|NCT03369223|593155867|FG001|Overall Study|Death|0|||
164215522|NCT03369223|593155868|FG002|Overall Study|Death|0|||
164215523|NCT03369223|593155869|FG003|Overall Study|Death|0|||
164215524|NCT03369223|593155870|FG004|Overall Study|Death|0|||
164215525|NCT03369223|593155871|FG005|Overall Study|Death|0|||
164215526|NCT03369223|593155872|FG006|Overall Study|Death|0|||
164215527|NCT03369223|593155873|FG007|Overall Study|Death|0|||
164215528|NCT03369223|593155874|FG008|Overall Study|Death|0|||
164215529|NCT03369223|593155875|FG009|Overall Study|Death|0|||
164215530|NCT03369223|593155876|FG010|Overall Study|Death|0|||
164215531|NCT03369223|593155877|FG011|Overall Study|Death|0|||
164215532|NCT03369223|593155878|FG012|Overall Study|Death|0|||
164215533|NCT03369223|593155879|FG013|Overall Study|Death|1|||
164215534|NCT03369223|593155880|FG014|Overall Study|Death|0|||
164215535|NCT03369223|593155881|FG015|Overall Study|Death|0|||
164215536|NCT03369223|593155882|FG016|Overall Study|Death|0|||
164215537|NCT03369223|593155883|FG017|Overall Study|Death|0|||
164215538|NCT03369223|593155884|FG018|Overall Study|Death|1|||
164215539|NCT03369223|593155885|FG019|Overall Study|Death|0|||
164215540|NCT03369223|593155866|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164215541|NCT03369223|593155867|FG001|Overall Study|Adverse event unrelated to study drug|0|||
164215542|NCT03369223|593155868|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164215543|NCT03369223|593155869|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164215544|NCT03369223|593155870|FG004|Overall Study|Adverse event unrelated to study drug|0|||
164215545|NCT03369223|593155871|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164215546|NCT03369223|593155872|FG006|Overall Study|Adverse event unrelated to study drug|1|||
164215547|NCT03369223|593155873|FG007|Overall Study|Adverse event unrelated to study drug|0|||
164215548|NCT03369223|593155874|FG008|Overall Study|Adverse event unrelated to study drug|0|||
164215549|NCT03369223|593155875|FG009|Overall Study|Adverse event unrelated to study drug|1|||
163981167|NCT03315871|592299754|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
164215550|NCT03369223|593155876|FG010|Overall Study|Adverse event unrelated to study drug|0|||
164215551|NCT03369223|593155877|FG011|Overall Study|Adverse event unrelated to study drug|0|||
164215552|NCT03369223|593155878|FG012|Overall Study|Adverse event unrelated to study drug|0|||
164326055|NCT00472459|593570105|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
164326056|NCT00472459|593570106|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
164326057|NCT00472459|593570105|FG000|Overall Study|Lost to Follow-up|1|||
164326058|NCT00472459|593570106|FG001|Overall Study|Lost to Follow-up|1|||
164326059|NCT02395016|593570107|FG000|Overall Study|Adverse Event|4|||
164326060|NCT02395016|593570108|FG001|Overall Study|Adverse Event|3|||
164326061|NCT02395016|593570107|FG000|Overall Study|Withdrawal by Subject|9|||
164326062|NCT02395016|593570108|FG001|Overall Study|Withdrawal by Subject|6|||
164326063|NCT02395016|593570107|FG000|Overall Study|Protocol Violation|2|||
164326064|NCT02395016|593570108|FG001|Overall Study|Protocol Violation|3|||
164326065|NCT01547780|593570109|FG000|Baseline PET Scan|Physician Decision|1|||
164326066|NCT01547780|593570110|FG001|Baseline PET Scan|Physician Decision|0|||
164326067|NCT01547780|593570111|FG002|Baseline PET Scan|Physician Decision|1|||
164326068|NCT01547780|593570112|FG003|Baseline PET Scan|Physician Decision|0|||
164326069|NCT01547780|593570109|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
164326070|NCT01547780|593570110|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
164326071|NCT01547780|593570111|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
164326072|NCT01547780|593570112|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
164326073|NCT00814879|593570114|FG000|By Week 24|Cancer Diagnosis|1|||
164326074|NCT00814879|593570115|FG001|By Week 24|Cancer Diagnosis|0|||
164326075|NCT00814879|593570114|FG000|By Week 24|Incarceration|0|||
164326076|NCT00814879|593570115|FG001|By Week 24|Incarceration|1|||
164326077|NCT00814879|593570114|FG000|By Week 48|Lost to Follow-up|2|||
164326078|NCT00814879|593570115|FG001|By Week 48|Lost to Follow-up|2|||
163981168|NCT03315871|592299752|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
163981169|NCT03315871|592299753|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
164326079|NCT00814879|593570114|FG000|By Week 48|Death|0|||
164326080|NCT00814879|593570115|FG001|By Week 48|Death|1|||
164326081|NCT01461057|593570116|FG000|Overall Study|Death|10|||
163981170|NCT03315871|592299754|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
164215553|NCT03369223|593155879|FG013|Overall Study|Adverse event unrelated to study drug|4|||
164215554|NCT03369223|593155880|FG014|Overall Study|Adverse event unrelated to study drug|2|||
164215555|NCT03369223|593155881|FG015|Overall Study|Adverse event unrelated to study drug|0|||
164215556|NCT03369223|593155882|FG016|Overall Study|Adverse event unrelated to study drug|2|||
164215557|NCT03369223|593155883|FG017|Overall Study|Adverse event unrelated to study drug|1|||
164215558|NCT03369223|593155884|FG018|Overall Study|Adverse event unrelated to study drug|3|||
164326082|NCT01461057|593570117|FG001|Overall Study|Death|9|||
164326083|NCT01461057|593570116|FG000|Overall Study|Withdrawal by Subject|2|||
164077891|NCT01252238|592650047|FG000|Overall Study|Sponsor terminated study|4|||
164077892|NCT01252238|592650048|FG001|Overall Study|Sponsor terminated study|4|||
164077893|NCT01252238|592650049|FG002|Overall Study|Sponsor terminated study|4|||
164077894|NCT00411762|592650051|FG000|Overall Study|Withdrawal by Subject|5|||
164077895|NCT04428502|592650052|FG000|Overall Study|Did not meet entrance criteria|14|||
164077896|NCT02295280|592650054|FG000|Overall Study|Adverse Event|0|||
164077897|NCT02295280|592650055|FG001|Overall Study|Adverse Event|1|||
164077898|NCT02875067|592650056|FG000|Overall Study|Withdrawal by Subject|1|||
164077899|NCT02875067|592650056|FG000|Overall Study|Withdrawal by Termination of Study|5|||
164077900|NCT01430104|592650057|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
164077901|NCT02713243|592650059|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
164077902|NCT02713243|592650060|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
164077903|NCT02713243|592650059|FG000|Overall Study|Administrative problems|0|||
164077904|NCT02713243|592650060|FG001|Overall Study|Administrative problems|1|||
164077905|NCT02713243|592650059|FG000|Overall Study|Protocol deviation|0|||
164077906|NCT02713243|592650060|FG001|Overall Study|Protocol deviation|1|||
164077907|NCT03404206|592650068|FG000|Overall Study|Withdrawal by Subject|1|||
164077908|NCT03404206|592650069|FG001|Overall Study|Withdrawal by Subject|1|||
164077909|NCT03404206|592650070|FG002|Overall Study|Withdrawal by Subject|0|||
164077910|NCT03404206|592650068|FG000|Overall Study|Lost to Follow-up|3|||
164077911|NCT03404206|592650069|FG001|Overall Study|Lost to Follow-up|1|||
164077912|NCT03404206|592650070|FG002|Overall Study|Lost to Follow-up|0|||
164077913|NCT01133392|592650071|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
164077914|NCT01133392|592650072|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
164077915|NCT01133392|592650071|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
164077916|NCT01133392|592650072|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
164077917|NCT03751124|592650073|FG000|Overall Study|Adverse Event|4|||
164077918|NCT03751124|592650074|FG001|Overall Study|Adverse Event|3|||
164077919|NCT03751124|592650073|FG000|Overall Study|Protocol Deviation|0|||
164077920|NCT03751124|592650074|FG001|Overall Study|Protocol Deviation|1|||
164077921|NCT03751124|592650073|FG000|Overall Study|Lost to Follow-up|6|||
164077922|NCT03751124|592650074|FG001|Overall Study|Lost to Follow-up|4|||
164077923|NCT03751124|592650073|FG000|Overall Study|Withdrawal by Subject|6|||
164077924|NCT03751124|592650074|FG001|Overall Study|Withdrawal by Subject|8|||
164077925|NCT03751124|592650073|FG000|Overall Study|Lack of Efficacy|1|||
164077926|NCT03751124|592650074|FG001|Overall Study|Lack of Efficacy|1|||
164077927|NCT03751124|592650073|FG000|Overall Study|Pregnancy|0|||
164077928|NCT03751124|592650074|FG001|Overall Study|Pregnancy|1|||
164077929|NCT03751124|592650073|FG000|Overall Study|Other|9|||
164077930|NCT03751124|592650074|FG001|Overall Study|Other|9|||
164077931|NCT03751124|592650073|FG000|Overall Study|Participants who did not receive any study drug|0|||
164077932|NCT03751124|592650074|FG001|Overall Study|Participants who did not receive any study drug|1|||
164077933|NCT00555399|592650077|FG000|Overall Study|Withdrawal by Subject|0|||
164077934|NCT00555399|592650078|FG001|Overall Study|Withdrawal by Subject|0|||
164077935|NCT00555399|592650079|FG002|Overall Study|Withdrawal by Subject|1|||
164077936|NCT00555399|592650080|FG003|Overall Study|Withdrawal by Subject|0|||
164077937|NCT00555399|592650081|FG004|Overall Study|Withdrawal by Subject|0|||
164077938|NCT00555399|592650082|FG005|Overall Study|Withdrawal by Subject|0|||
164077939|NCT00555399|592650083|FG006|Overall Study|Withdrawal by Subject|0|||
164077940|NCT00555399|592650084|FG007|Overall Study|Withdrawal by Subject|0|||
164077941|NCT00555399|592650085|FG008|Overall Study|Withdrawal by Subject|0|||
164077942|NCT00555399|592650086|FG009|Overall Study|Withdrawal by Subject|0|||
164077943|NCT00555399|592650087|FG010|Overall Study|Withdrawal by Subject|0|||
164077944|NCT00555399|592650088|FG011|Overall Study|Withdrawal by Subject|1|||
164077945|NCT00555399|592650077|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
164077946|NCT00555399|592650078|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
164077947|NCT00555399|592650079|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
164077948|NCT00555399|592650080|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
164077949|NCT00555399|592650081|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
164077950|NCT00555399|592650082|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
164077951|NCT00555399|592650083|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
164077952|NCT00555399|592650084|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
164077953|NCT00555399|592650085|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
164077954|NCT00555399|592650086|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
164077955|NCT00555399|592650087|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
164326084|NCT01461057|593570117|FG001|Overall Study|Withdrawal by Subject|3|||
164077956|NCT00555399|592650088|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
164077957|NCT00860574|592651458|FG000|Overall Study|Death|2|||
164077958|NCT00860574|592651458|FG000|Overall Study|Relapse|1|||
164077959|NCT02496221|592651460|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
164077960|NCT02496221|592651461|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
164077961|NCT02496221|592651460|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
164077962|NCT02496221|592651461|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
164077963|NCT02496221|592651460|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
164077964|NCT02496221|592651461|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
164077965|NCT01335399|592651462|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
164077966|NCT01335399|592651463|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
164077967|NCT01335399|592651462|FG000|Pre-treatment Period|Participant request to discontinue|0|||
164077968|NCT01335399|592651463|FG001|Pre-treatment Period|Participant request to discontinue|1|||
164077969|NCT01335399|592651462|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
164077970|NCT01335399|592651463|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
164077971|NCT01335399|592651462|FG000|Pre-treatment Period|Consent withdrawal|3|||
164077972|NCT01335399|592651463|FG001|Pre-treatment Period|Consent withdrawal|0|||
164077973|NCT01335399|592651462|FG000|Treatment Period|Disease progression|117|||
164077974|NCT01335399|592651463|FG001|Treatment Period|Disease progression|145|||
164077975|NCT01335399|592651462|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
164077976|NCT01335399|592651463|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
164077977|NCT01335399|592651462|FG000|Treatment Period|Study drug toxicity|52|||
164077978|NCT01335399|592651463|FG001|Treatment Period|Study drug toxicity|64|||
164077979|NCT01335399|592651462|FG000|Treatment Period|Participant request to discontinue|30|||
164077980|NCT01335399|592651463|FG001|Treatment Period|Participant request to discontinue|22|||
164077981|NCT01335399|592651462|FG000|Treatment Period|Other reasons|30|||
164077982|NCT01335399|592651463|FG001|Treatment Period|Other reasons|30|||
164077983|NCT01335399|592651462|FG000|Treatment Period|Consent withdrawal|10|||
164077984|NCT01335399|592651463|FG001|Treatment Period|Consent withdrawal|7|||
164077985|NCT01335399|592651462|FG000|Treatment Period|Death|7|||
164077986|NCT01335399|592651463|FG001|Treatment Period|Death|6|||
164077987|NCT01335399|592651462|FG000|Treatment Period|Poor/Non-compliance|3|||
164077988|NCT01335399|592651463|FG001|Treatment Period|Poor/Non-compliance|4|||
164077989|NCT01335399|592651462|FG000|Treatment Period|Lost to Follow-up|2|||
164077990|NCT01335399|592651463|FG001|Treatment Period|Lost to Follow-up|2|||
164077991|NCT01335399|592651462|FG000|Treatment Period|Maximum clinical benefit|1|||
164077992|NCT01335399|592651463|FG001|Treatment Period|Maximum clinical benefit|1|||
164077993|NCT01335399|592651462|FG000|Treatment Period|No longer meet study criteria|1|||
164077994|NCT01335399|592651463|FG001|Treatment Period|No longer meet study criteria|1|||
164077995|NCT01335399|592651462|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
164077996|NCT01335399|592651463|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
164077997|NCT03262233|592651464|FG000|Overall Study|Withdrawal by Subject|12|||
164077998|NCT03262233|592651465|FG001|Overall Study|Withdrawal by Subject|8|||
164077999|NCT03262233|592651466|FG002|Overall Study|Withdrawal by Subject|21|||
164078000|NCT03262233|592651467|FG003|Overall Study|Withdrawal by Subject|13|||
164078001|NCT03262233|592651464|FG000|Overall Study|Declined due to shock|1|||
164078002|NCT03262233|592651465|FG001|Overall Study|Declined due to shock|2|||
164078003|NCT03262233|592651466|FG002|Overall Study|Declined due to shock|2|||
164078004|NCT03262233|592651467|FG003|Overall Study|Declined due to shock|3|||
164078005|NCT03262233|592651464|FG000|Overall Study|Protocol Violation|5|||
164078006|NCT03262233|592651465|FG001|Overall Study|Protocol Violation|10|||
164078007|NCT03262233|592651466|FG002|Overall Study|Protocol Violation|2|||
164078008|NCT03262233|592651467|FG003|Overall Study|Protocol Violation|13|||
164078009|NCT03262233|592651464|FG000|Overall Study|data collection artifact|0|||
164078010|NCT03262233|592651465|FG001|Overall Study|data collection artifact|1|||
164078011|NCT03262233|592651466|FG002|Overall Study|data collection artifact|0|||
164078012|NCT03262233|592651467|FG003|Overall Study|data collection artifact|0|||
164078013|NCT01120600|592651470|FG000|Overall Study|Adverse Event|7|||
164078014|NCT01120600|592651471|FG001|Overall Study|Adverse Event|7|||
164078015|NCT01120600|592651470|FG000|Overall Study|Excessive Bone Loss|0|||
164078016|NCT01120600|592651471|FG001|Overall Study|Excessive Bone Loss|4|||
164078017|NCT01120600|592651470|FG000|Overall Study|Lost to Follow-up|1|||
164078018|NCT01120600|592651471|FG001|Overall Study|Lost to Follow-up|3|||
164078019|NCT01120600|592651470|FG000|Overall Study|Physician Decision|1|||
164078020|NCT01120600|592651471|FG001|Overall Study|Physician Decision|3|||
164078021|NCT01120600|592651470|FG000|Overall Study|Protocol Violation|0|||
164078022|NCT01120600|592651471|FG001|Overall Study|Protocol Violation|4|||
164078023|NCT01120600|592651470|FG000|Overall Study|Withdrawal by Subject|10|||
164078024|NCT01120600|592651471|FG001|Overall Study|Withdrawal by Subject|11|||
164078025|NCT01165242|592651474|FG000|Overall Study|Unreachable Subjects|1|||
164078026|NCT01165242|592651475|FG001|Overall Study|Unreachable Subjects|0|||
164078027|NCT01165242|592651476|FG002|Overall Study|Unreachable Subjects|0|||
164078028|NCT01165242|592651474|FG000|Overall Study|Incarcerated Subjects|0|||
164078029|NCT01165242|592651475|FG001|Overall Study|Incarcerated Subjects|1|||
164078030|NCT01165242|592651476|FG002|Overall Study|Incarcerated Subjects|0|||
164078031|NCT01165242|592651474|FG000|Overall Study|Visit 2 Declined by Subject|0|||
164078032|NCT01165242|592651475|FG001|Overall Study|Visit 2 Declined by Subject|0|||
164078033|NCT01165242|592651476|FG002|Overall Study|Visit 2 Declined by Subject|1|||
164078034|NCT01165242|592651474|FG000|Overall Study|Withdrawal by Subject|0|||
164078035|NCT01165242|592651475|FG001|Overall Study|Withdrawal by Subject|2|||
164078036|NCT01165242|592651476|FG002|Overall Study|Withdrawal by Subject|2|||
163981171|NCT03315871|592299752|FG000|PROSTVAC + CV301|Progressive disease|0|||
163981172|NCT03315871|592299753|FG001|PROSTVAC + CV301|Progressive disease|0|||
163981173|NCT03315871|592299754|FG002|PROSTVAC + CV301|Progressive disease|1|||
164215559|NCT03369223|593155885|FG019|Overall Study|Adverse event unrelated to study drug|2|||
164215560|NCT03369223|593155866|FG000|Overall Study|Disease progression|6|||
164215561|NCT03369223|593155867|FG001|Overall Study|Disease progression|8|||
164215562|NCT03369223|593155868|FG002|Overall Study|Disease progression|5|||
164215563|NCT03369223|593155869|FG003|Overall Study|Disease progression|1|||
164215564|NCT03369223|593155870|FG004|Overall Study|Disease progression|9|||
164215565|NCT03369223|593155871|FG005|Overall Study|Disease progression|9|||
164215566|NCT03369223|593155872|FG006|Overall Study|Disease progression|4|||
164215567|NCT03369223|593155873|FG007|Overall Study|Disease progression|6|||
164215568|NCT03369223|593155874|FG008|Overall Study|Disease progression|10|||
164215569|NCT03369223|593155875|FG009|Overall Study|Disease progression|7|||
164215570|NCT03369223|593155876|FG010|Overall Study|Disease progression|4|||
164215571|NCT03369223|593155877|FG011|Overall Study|Disease progression|1|||
164215572|NCT03369223|593155878|FG012|Overall Study|Disease progression|1|||
164215573|NCT03369223|593155879|FG013|Overall Study|Disease progression|25|||
164215574|NCT03369223|593155880|FG014|Overall Study|Disease progression|22|||
164215575|NCT03369223|593155881|FG015|Overall Study|Disease progression|2|||
164215576|NCT03369223|593155882|FG016|Overall Study|Disease progression|10|||
164215577|NCT03369223|593155883|FG017|Overall Study|Disease progression|1|||
164215578|NCT03369223|593155884|FG018|Overall Study|Disease progression|18|||
164215579|NCT03369223|593155885|FG019|Overall Study|Disease progression|28|||
164215580|NCT03369223|593155866|FG000|Overall Study|Study drug toxicity|0|||
164215581|NCT03369223|593155867|FG001|Overall Study|Study drug toxicity|1|||
164215582|NCT03369223|593155868|FG002|Overall Study|Study drug toxicity|4|||
164215583|NCT03369223|593155869|FG003|Overall Study|Study drug toxicity|0|||
164215584|NCT03369223|593155870|FG004|Overall Study|Study drug toxicity|1|||
164215585|NCT03369223|593155871|FG005|Overall Study|Study drug toxicity|2|||
164215586|NCT03369223|593155872|FG006|Overall Study|Study drug toxicity|4|||
164215587|NCT03369223|593155873|FG007|Overall Study|Study drug toxicity|2|||
164215588|NCT03369223|593155874|FG008|Overall Study|Study drug toxicity|2|||
164215589|NCT03369223|593155875|FG009|Overall Study|Study drug toxicity|0|||
164215590|NCT03369223|593155876|FG010|Overall Study|Study drug toxicity|6|||
164215591|NCT03369223|593155877|FG011|Overall Study|Study drug toxicity|1|||
164215592|NCT03369223|593155878|FG012|Overall Study|Study drug toxicity|2|||
164215593|NCT03369223|593155879|FG013|Overall Study|Study drug toxicity|19|||
164215594|NCT03369223|593155880|FG014|Overall Study|Study drug toxicity|19|||
164215595|NCT03369223|593155881|FG015|Overall Study|Study drug toxicity|0|||
164215596|NCT03369223|593155882|FG016|Overall Study|Study drug toxicity|18|||
164215597|NCT03369223|593155883|FG017|Overall Study|Study drug toxicity|3|||
164215598|NCT03369223|593155884|FG018|Overall Study|Study drug toxicity|11|||
164215599|NCT03369223|593155885|FG019|Overall Study|Study drug toxicity|7|||
164215600|NCT03369223|593155866|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164215601|NCT03369223|593155867|FG001|Overall Study|Participant request to discontinue study treatment|1|||
164215602|NCT03369223|593155868|FG002|Overall Study|Participant request to discontinue study treatment|0|||
164215603|NCT03369223|593155869|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164215604|NCT03369223|593155870|FG004|Overall Study|Participant request to discontinue study treatment|1|||
164215605|NCT03369223|593155871|FG005|Overall Study|Participant request to discontinue study treatment|1|||
164215606|NCT03369223|593155872|FG006|Overall Study|Participant request to discontinue study treatment|1|||
164215607|NCT03369223|593155873|FG007|Overall Study|Participant request to discontinue study treatment|0|||
164215608|NCT03369223|593155874|FG008|Overall Study|Participant request to discontinue study treatment|0|||
164215609|NCT03369223|593155875|FG009|Overall Study|Participant request to discontinue study treatment|0|||
164215610|NCT03369223|593155876|FG010|Overall Study|Participant request to discontinue study treatment|0|||
164215611|NCT03369223|593155877|FG011|Overall Study|Participant request to discontinue study treatment|0|||
164215612|NCT03369223|593155878|FG012|Overall Study|Participant request to discontinue study treatment|0|||
164215613|NCT03369223|593155879|FG013|Overall Study|Participant request to discontinue study treatment|1|||
164215614|NCT03369223|593155880|FG014|Overall Study|Participant request to discontinue study treatment|1|||
164215615|NCT03369223|593155881|FG015|Overall Study|Participant request to discontinue study treatment|0|||
164215616|NCT03369223|593155882|FG016|Overall Study|Participant request to discontinue study treatment|0|||
164215617|NCT03369223|593155883|FG017|Overall Study|Participant request to discontinue study treatment|0|||
164215618|NCT03369223|593155884|FG018|Overall Study|Participant request to discontinue study treatment|1|||
164215619|NCT03369223|593155885|FG019|Overall Study|Participant request to discontinue study treatment|0|||
164326085|NCT01461057|593570116|FG000|Overall Study|Physician Decision|0|||
164326086|NCT01461057|593570117|FG001|Overall Study|Physician Decision|2|||
163981174|NCT03315871|592299752|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
164215620|NCT03369223|593155866|FG000|Overall Study|Participant withdrew consent|0|||
164215621|NCT03369223|593155867|FG001|Overall Study|Participant withdrew consent|1|||
164215622|NCT03369223|593155868|FG002|Overall Study|Participant withdrew consent|1|||
164215623|NCT03369223|593155869|FG003|Overall Study|Participant withdrew consent|0|||
164215624|NCT03369223|593155870|FG004|Overall Study|Participant withdrew consent|0|||
164326087|NCT01461057|593570116|FG000|Overall Study|Adverse Event|0|||
164215625|NCT03369223|593155871|FG005|Overall Study|Participant withdrew consent|0|||
164215626|NCT03369223|593155872|FG006|Overall Study|Participant withdrew consent|1|||
164215627|NCT03369223|593155873|FG007|Overall Study|Participant withdrew consent|1|||
164215628|NCT03369223|593155874|FG008|Overall Study|Participant withdrew consent|1|||
164215629|NCT03369223|593155875|FG009|Overall Study|Participant withdrew consent|0|||
164215630|NCT03369223|593155876|FG010|Overall Study|Participant withdrew consent|0|||
164215631|NCT03369223|593155877|FG011|Overall Study|Participant withdrew consent|1|||
164215632|NCT03369223|593155878|FG012|Overall Study|Participant withdrew consent|0|||
164215633|NCT03369223|593155879|FG013|Overall Study|Participant withdrew consent|0|||
164215634|NCT03369223|593155880|FG014|Overall Study|Participant withdrew consent|3|||
164215635|NCT03369223|593155881|FG015|Overall Study|Participant withdrew consent|0|||
164215636|NCT03369223|593155882|FG016|Overall Study|Participant withdrew consent|1|||
164215637|NCT03369223|593155883|FG017|Overall Study|Participant withdrew consent|0|||
164215638|NCT03369223|593155884|FG018|Overall Study|Participant withdrew consent|4|||
164215639|NCT03369223|593155885|FG019|Overall Study|Participant withdrew consent|2|||
164215640|NCT03369223|593155866|FG000|Overall Study|Randomized but not treated|0|||
164215641|NCT03369223|593155867|FG001|Overall Study|Randomized but not treated|0|||
164215642|NCT03369223|593155868|FG002|Overall Study|Randomized but not treated|0|||
164215643|NCT03369223|593155869|FG003|Overall Study|Randomized but not treated|0|||
164215644|NCT03369223|593155870|FG004|Overall Study|Randomized but not treated|0|||
164215645|NCT03369223|593155871|FG005|Overall Study|Randomized but not treated|0|||
164215646|NCT03369223|593155872|FG006|Overall Study|Randomized but not treated|0|||
164215647|NCT03369223|593155873|FG007|Overall Study|Randomized but not treated|0|||
164215648|NCT03369223|593155874|FG008|Overall Study|Randomized but not treated|0|||
164215649|NCT03369223|593155875|FG009|Overall Study|Randomized but not treated|0|||
164215650|NCT03369223|593155876|FG010|Overall Study|Randomized but not treated|0|||
164215651|NCT03369223|593155877|FG011|Overall Study|Randomized but not treated|0|||
164215652|NCT03369223|593155878|FG012|Overall Study|Randomized but not treated|0|||
164215653|NCT03369223|593155879|FG013|Overall Study|Randomized but not treated|1|||
164215654|NCT03369223|593155880|FG014|Overall Study|Randomized but not treated|1|||
164215655|NCT03369223|593155881|FG015|Overall Study|Randomized but not treated|0|||
164215656|NCT03369223|593155882|FG016|Overall Study|Randomized but not treated|0|||
164215657|NCT03369223|593155883|FG017|Overall Study|Randomized but not treated|0|||
164215658|NCT03369223|593155884|FG018|Overall Study|Randomized but not treated|0|||
164215659|NCT03369223|593155885|FG019|Overall Study|Randomized but not treated|0|||
164215660|NCT03010501|593155890|FG000|Study Week 1|Withdrawal by Subject|2|||
164215661|NCT03010501|593155891|FG001|Study Week 1|Withdrawal by Subject|1|||
164215662|NCT03010501|593155892|FG002|Study Week 1|Withdrawal by Subject|0|||
164215663|NCT03010501|593155893|FG003|Study Week 1|Withdrawal by Subject|2|||
164215664|NCT03010501|593155894|FG004|Study Week 1|Withdrawal by Subject|0|||
164215665|NCT03010501|593155895|FG005|Study Week 1|Withdrawal by Subject|0|||
164215666|NCT03010501|593155890|FG000|Study Week 3|Withdrawal by Subject|0|||
164215667|NCT03010501|593155891|FG001|Study Week 3|Withdrawal by Subject|0|||
164326088|NCT01461057|593570117|FG001|Overall Study|Adverse Event|1|||
164326089|NCT01461057|593570116|FG000|Overall Study|Progression of Disease|1|||
164326090|NCT01461057|593570117|FG001|Overall Study|Progression of Disease|0|||
164326091|NCT01461057|593570116|FG000|Overall Study|Study Terminated by Sponsor|2|||
164326092|NCT01461057|593570117|FG001|Overall Study|Study Terminated by Sponsor|0|||
164326093|NCT01288976|593570118|FG000|Overall Study|Withdrawal by Subject|58|||
164326094|NCT01288976|593570119|FG001|Overall Study|Withdrawal by Subject|12|||
164326095|NCT01288976|593570120|FG002|Overall Study|Withdrawal by Subject|9|||
164326096|NCT01288976|593570118|FG000|Overall Study|Death|98|||
164326097|NCT01288976|593570119|FG001|Overall Study|Death|6|||
164326098|NCT01288976|593570120|FG002|Overall Study|Death|4|||
164326099|NCT01288976|593570118|FG000|Overall Study|Data unavailable|22|||
164326100|NCT01288976|593570119|FG001|Overall Study|Data unavailable|9|||
164326101|NCT01288976|593570120|FG002|Overall Study|Data unavailable|7|||
164326102|NCT03228420|593570125|FG000|Overall Study|Lost to Follow-up|5|||
164326103|NCT03228420|593570126|FG001|Overall Study|Lost to Follow-up|3|||
164326104|NCT03228420|593570125|FG000|Overall Study|Withdrawal by Subject|10|||
164326105|NCT03228420|593570126|FG001|Overall Study|Withdrawal by Subject|0|||
164326106|NCT03228420|593570125|FG000|Overall Study|Adverse Event|5|||
163876653|NCT01017146|591916982|FG000|Overall Study|Adverse Event|11|||
163876654|NCT01017146|591916983|FG001|Overall Study|Adverse Event|1|||
163876655|NCT01017146|591916982|FG000|Overall Study|Lost to Follow-up|14|||
163876656|NCT01017146|591916983|FG001|Overall Study|Lost to Follow-up|14|||
164215668|NCT03010501|593155892|FG002|Study Week 3|Withdrawal by Subject|0|||
164215669|NCT03010501|593155893|FG003|Study Week 3|Withdrawal by Subject|1|||
164215670|NCT03010501|593155894|FG004|Study Week 3|Withdrawal by Subject|0|||
164215671|NCT03010501|593155895|FG005|Study Week 3|Withdrawal by Subject|0|||
164215672|NCT02347787|593155898|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
164215673|NCT02347787|593155899|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
164215674|NCT02347787|593155898|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
164215675|NCT02347787|593155899|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
164215676|NCT02347787|593155898|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
164326107|NCT03228420|593570126|FG001|Overall Study|Adverse Event|2|||
164326108|NCT01083173|593570127|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
164326109|NCT01083173|593570128|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
164326110|NCT01083173|593570127|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
164326111|NCT01083173|593570128|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
163981175|NCT03315871|592299753|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
163981176|NCT03315871|592299754|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
163981177|NCT00328627|592302643|FG000|Overall Study|Hyperglycemic Rescue|41|||
163981178|NCT00328627|592302644|FG001|Overall Study|Hyperglycemic Rescue|18|||
163981179|NCT00328627|592302645|FG002|Overall Study|Hyperglycemic Rescue|16|||
163981180|NCT00328627|592302646|FG003|Overall Study|Hyperglycemic Rescue|13|||
163981181|NCT00328627|592302647|FG004|Overall Study|Hyperglycemic Rescue|6|||
163981182|NCT00328627|592302648|FG005|Overall Study|Hyperglycemic Rescue|5|||
163981183|NCT00328627|592302649|FG006|Overall Study|Hyperglycemic Rescue|19|||
163981184|NCT00328627|592302650|FG007|Overall Study|Hyperglycemic Rescue|6|||
163981185|NCT00328627|592302651|FG008|Overall Study|Hyperglycemic Rescue|6|||
163981186|NCT00328627|592302652|FG009|Overall Study|Hyperglycemic Rescue|11|||
163981187|NCT00328627|592302653|FG010|Overall Study|Hyperglycemic Rescue|3|||
163981188|NCT00328627|592302654|FG011|Overall Study|Hyperglycemic Rescue|2|||
163981189|NCT00328627|592302643|FG000|Overall Study|Adverse Event|3|||
163981190|NCT00328627|592302644|FG001|Overall Study|Adverse Event|1|||
163981191|NCT00328627|592302645|FG002|Overall Study|Adverse Event|2|||
163981192|NCT00328627|592302646|FG003|Overall Study|Adverse Event|3|||
163981193|NCT00328627|592302647|FG004|Overall Study|Adverse Event|1|||
163981194|NCT00328627|592302648|FG005|Overall Study|Adverse Event|2|||
163981195|NCT00328627|592302649|FG006|Overall Study|Adverse Event|1|||
164078037|NCT01165242|592651474|FG000|Overall Study|Extended Holiday|0|||
164078038|NCT01165242|592651475|FG001|Overall Study|Extended Holiday|0|||
164078039|NCT01165242|592651476|FG002|Overall Study|Extended Holiday|1|||
164078040|NCT01165242|592651474|FG000|Overall Study|Lost to Follow-up|9|||
164078041|NCT01165242|592651475|FG001|Overall Study|Lost to Follow-up|7|||
164078042|NCT01165242|592651476|FG002|Overall Study|Lost to Follow-up|10|||
164078043|NCT03372083|592651477|FG000|Overall Study|Adverse Event|3|||
164078044|NCT03372083|592651477|FG000|Overall Study|Physician Decision|1|||
164078045|NCT03372083|592651477|FG000|Overall Study|Withdrawal by Subject|1|||
164078046|NCT01690520|592651480|FG000|Overall Study|Death|25|||
164078047|NCT01690520|592651481|FG001|Overall Study|Death|21|||
164078048|NCT01690520|592651480|FG000|Overall Study|Lost to Follow-up|2|||
164078049|NCT01690520|592651481|FG001|Overall Study|Lost to Follow-up|3|||
164078050|NCT01690520|592651480|FG000|Overall Study|Withdrawal by Subject|2|||
164078051|NCT01690520|592651481|FG001|Overall Study|Withdrawal by Subject|0|||
164078052|NCT01690520|592651480|FG000|Overall Study|Relapse|0|||
164078053|NCT01690520|592651481|FG001|Overall Study|Relapse|1|||
164078054|NCT01690520|592651480|FG000|Overall Study|Other|0|||
164078055|NCT01690520|592651481|FG001|Overall Study|Other|1|||
164078056|NCT01690520|592651480|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
164078057|NCT01690520|592651481|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
164078058|NCT01270841|592651482|FG000|Overall Study|Adverse Event|0|||
164078059|NCT01270841|592651483|FG001|Overall Study|Adverse Event|1|||
164078060|NCT01270841|592651484|FG002|Overall Study|Adverse Event|0|||
164078061|NCT01270841|592651485|FG003|Overall Study|Adverse Event|3|||
164078062|NCT01270841|592651482|FG000|Overall Study|Withdrawal by Subject|3|||
164078063|NCT01270841|592651483|FG001|Overall Study|Withdrawal by Subject|2|||
164078064|NCT01270841|592651484|FG002|Overall Study|Withdrawal by Subject|3|||
164078065|NCT01270841|592651485|FG003|Overall Study|Withdrawal by Subject|3|||
164078066|NCT01270841|592651482|FG000|Overall Study|Lost to Follow-up|3|||
164078067|NCT01270841|592651483|FG001|Overall Study|Lost to Follow-up|1|||
164078068|NCT01270841|592651484|FG002|Overall Study|Lost to Follow-up|4|||
164078069|NCT01270841|592651485|FG003|Overall Study|Lost to Follow-up|2|||
164078070|NCT01270841|592651482|FG000|Overall Study|Physician Decision|0|||
164078071|NCT01270841|592651483|FG001|Overall Study|Physician Decision|1|||
164078072|NCT01270841|592651484|FG002|Overall Study|Physician Decision|0|||
164078073|NCT01270841|592651485|FG003|Overall Study|Physician Decision|0|||
164078074|NCT01270841|592651482|FG000|Overall Study|Did not qualify|6|||
164078075|NCT01270841|592651483|FG001|Overall Study|Did not qualify|3|||
163981196|NCT00328627|592302650|FG007|Overall Study|Adverse Event|2|||
163981197|NCT00328627|592302651|FG008|Overall Study|Adverse Event|0|||
163981198|NCT00328627|592302652|FG009|Overall Study|Adverse Event|7|||
163981199|NCT00328627|592302653|FG010|Overall Study|Adverse Event|5|||
164078076|NCT01270841|592651484|FG002|Overall Study|Did not qualify|4|||
164078077|NCT01270841|592651485|FG003|Overall Study|Did not qualify|5|||
164078078|NCT01270841|592651482|FG000|Overall Study|Protocol Violation|1|||
164078079|NCT01270841|592651483|FG001|Overall Study|Protocol Violation|5|||
164078080|NCT01270841|592651484|FG002|Overall Study|Protocol Violation|0|||
164078081|NCT01270841|592651485|FG003|Overall Study|Protocol Violation|0|||
164078082|NCT01270841|592651482|FG000|Overall Study|Enrolled in error|0|||
164078083|NCT01270841|592651483|FG001|Overall Study|Enrolled in error|1|||
164215677|NCT02347787|593155899|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
164215678|NCT02347787|593155898|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
164215679|NCT02347787|593155899|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
164215680|NCT00544882|593155903|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
164215681|NCT00544882|593155904|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
164215682|NCT00544882|593155905|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
164215683|NCT00544882|593155903|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
164215684|NCT00544882|593155904|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
164215685|NCT00544882|593155905|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
164215686|NCT00544882|593155903|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
164215687|NCT00544882|593155904|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
164215688|NCT00544882|593155905|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
164215689|NCT00544882|593155903|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
164215690|NCT00544882|593155904|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
164215691|NCT00544882|593155905|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
164215692|NCT00544882|593155903|FG000|Cycle 3: Follow-up|Noncompliance|0|||
164215693|NCT00544882|593155904|FG001|Cycle 3: Follow-up|Noncompliance|1|||
164215694|NCT00544882|593155905|FG002|Cycle 3: Follow-up|Noncompliance|0|||
164215695|NCT00544882|593155903|FG000|Cycle 3: Follow-up|Pregnancy|0|||
164215696|NCT00544882|593155904|FG001|Cycle 3: Follow-up|Pregnancy|1|||
164215697|NCT00544882|593155905|FG002|Cycle 3: Follow-up|Pregnancy|0|||
164215698|NCT00308685|593155906|FG000|Overall Study|Lost to Follow-up|1|||
164215699|NCT00308685|593155907|FG001|Overall Study|Lost to Follow-up|0|||
164215700|NCT00308685|593155906|FG000|Overall Study|Need to administer prohibited medication|1|||
164215701|NCT00308685|593155907|FG001|Overall Study|Need to administer prohibited medication|2|||
164215702|NCT00308685|593155906|FG000|Overall Study|Other than specified|1|||
164215703|NCT00308685|593155907|FG001|Overall Study|Other than specified|3|||
164215704|NCT01121575|593155908|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
164215705|NCT01121575|593155909|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
164215706|NCT01121575|593155910|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
164215707|NCT01121575|593155911|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
164215708|NCT01121575|593155912|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
164215709|NCT01121575|593155913|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
164215710|NCT01121575|593155908|FG000|Overall Study|Unspecified Reasons|8|||
164215711|NCT01121575|593155909|FG001|Overall Study|Unspecified Reasons|6|||
164215712|NCT01121575|593155910|FG002|Overall Study|Unspecified Reasons|7|||
164215713|NCT01121575|593155911|FG003|Overall Study|Unspecified Reasons|5|||
164215714|NCT01121575|593155912|FG004|Overall Study|Unspecified Reasons|13|||
164215715|NCT01121575|593155913|FG005|Overall Study|Unspecified Reasons|10|||
164215716|NCT01121575|593155908|FG000|Overall Study|Death|6|||
164215717|NCT01121575|593155909|FG001|Overall Study|Death|0|||
164215718|NCT01121575|593155910|FG002|Overall Study|Death|0|||
164215719|NCT01121575|593155911|FG003|Overall Study|Death|1|||
164215720|NCT01121575|593155912|FG004|Overall Study|Death|7|||
164215721|NCT01121575|593155913|FG005|Overall Study|Death|1|||
164215722|NCT02583269|593155914|FG000|Overall Study|Patient hospitalized prior to start|1|||
164215723|NCT02583269|593155915|FG001|Overall Study|Patient hospitalized prior to start|0|||
164215724|NCT02583269|593155916|FG002|Overall Study|Patient hospitalized prior to start|0|||
164215725|NCT02583269|593155917|FG003|Overall Study|Patient hospitalized prior to start|0|||
164215726|NCT02583269|593155918|FG004|Overall Study|Patient hospitalized prior to start|0|||
164215727|NCT03244189|593155920|FG000|Overall Study|Death|0|||
164326112|NCT01083173|593570127|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
164326113|NCT01083173|593570128|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
164326114|NCT01083173|593570127|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
164326115|NCT01083173|593570128|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
164326116|NCT01083173|593570127|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
164326117|NCT01083173|593570128|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
164326118|NCT01083173|593570127|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
164326119|NCT01083173|593570128|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
164326120|NCT01083173|593570127|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
163876657|NCT01017146|591916982|FG000|Overall Study|Noncompliance with Study Product|1|||
163876658|NCT01017146|591916983|FG001|Overall Study|Noncompliance with Study Product|1|||
163876659|NCT01017146|591916982|FG000|Overall Study|Withdrawal by Subject|32|||
163876660|NCT01017146|591916983|FG001|Overall Study|Withdrawal by Subject|16|||
164215728|NCT03244189|593155921|FG001|Overall Study|Death|2|||
164215729|NCT03244189|593155920|FG000|Overall Study|Lost to Follow-up|92|||
164215730|NCT03244189|593155921|FG001|Overall Study|Lost to Follow-up|107|||
164215731|NCT03244189|593155920|FG000|Overall Study|Physician Decision|4|||
164215732|NCT03244189|593155921|FG001|Overall Study|Physician Decision|2|||
164215733|NCT03244189|593155920|FG000|Overall Study|Pregnancy|7|||
164215734|NCT03244189|593155921|FG001|Overall Study|Pregnancy|5|||
164215735|NCT03244189|593155920|FG000|Overall Study|Protocol Violation|0|||
164215736|NCT03244189|593155921|FG001|Overall Study|Protocol Violation|2|||
163876661|NCT01017146|591916982|FG000|Overall Study|Relocation|0|||
163876662|NCT01017146|591916983|FG001|Overall Study|Relocation|4|||
163876663|NCT01017146|591916982|FG000|Overall Study|Pregnancy|2|||
163876664|NCT01017146|591916983|FG001|Overall Study|Pregnancy|1|||
163876665|NCT01017146|591916982|FG000|Overall Study|Protocol Violation|2|||
163876666|NCT01017146|591916983|FG001|Overall Study|Protocol Violation|0|||
163876667|NCT01017146|591916982|FG000|Overall Study|Took Excluded Medication|2|||
163876668|NCT01017146|591916983|FG001|Overall Study|Took Excluded Medication|0|||
164078084|NCT01270841|592651484|FG002|Overall Study|Enrolled in error|0|||
164078085|NCT01270841|592651485|FG003|Overall Study|Enrolled in error|0|||
164078086|NCT01375010|592651486|FG000|Overall Study|Lost to Follow-up|8|||
164078087|NCT01375010|592651487|FG001|Overall Study|Lost to Follow-up|2|||
164078088|NCT01375010|592651486|FG000|Overall Study|Withdrawal by Subject|4|||
164078089|NCT01375010|592651487|FG001|Overall Study|Withdrawal by Subject|2|||
164078090|NCT02402933|592651488|FG000|Overall Study|Withdrawal by Subject|4|||
164078091|NCT02402933|592651488|FG000|Overall Study|Discontinued; Site Termination|10|||
164078092|NCT02544633|592651491|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
164078093|NCT02544633|592651492|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
164078094|NCT02544633|592651493|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
164078095|NCT02544633|592651494|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
164078096|NCT02544633|592651491|FG000|Treatment Period|Adverse Event|7|||
164078097|NCT02544633|592651492|FG001|Treatment Period|Adverse Event|4|||
164078098|NCT02544633|592651493|FG002|Treatment Period|Adverse Event|0|||
164078099|NCT02544633|592651494|FG003|Treatment Period|Adverse Event|5|||
164078100|NCT02544633|592651491|FG000|Treatment Period|Lack of Efficacy|17|||
164078101|NCT02544633|592651492|FG001|Treatment Period|Lack of Efficacy|11|||
164078102|NCT02544633|592651493|FG002|Treatment Period|Lack of Efficacy|5|||
164078103|NCT02544633|592651494|FG003|Treatment Period|Lack of Efficacy|5|||
164078104|NCT02544633|592651491|FG000|Treatment Period|Global Deterioration of Health|3|||
164078105|NCT02544633|592651492|FG001|Treatment Period|Global Deterioration of Health|3|||
164078106|NCT02544633|592651493|FG002|Treatment Period|Global Deterioration of Health|0|||
164078107|NCT02544633|592651494|FG003|Treatment Period|Global Deterioration of Health|1|||
164078108|NCT02544633|592651491|FG000|Treatment Period|Withdrawal by Subject|1|||
164078109|NCT02544633|592651492|FG001|Treatment Period|Withdrawal by Subject|0|||
164078110|NCT02544633|592651493|FG002|Treatment Period|Withdrawal by Subject|0|||
164078111|NCT02544633|592651494|FG003|Treatment Period|Withdrawal by Subject|0|||
164078112|NCT02544633|592651491|FG000|Treatment Period|Lost to Follow-up|0|||
164078113|NCT02544633|592651492|FG001|Treatment Period|Lost to Follow-up|1|||
164078114|NCT02544633|592651493|FG002|Treatment Period|Lost to Follow-up|0|||
164078115|NCT02544633|592651494|FG003|Treatment Period|Lost to Follow-up|0|||
164078116|NCT02544633|592651491|FG000|Treatment Period|Death|0|||
164078117|NCT02544633|592651492|FG001|Treatment Period|Death|0|||
164078118|NCT02544633|592651493|FG002|Treatment Period|Death|1|||
164078119|NCT02544633|592651494|FG003|Treatment Period|Death|0|||
164078120|NCT02544633|592651491|FG000|Treatment Period|Non-compliance|0|||
164078121|NCT02544633|592651492|FG001|Treatment Period|Non-compliance|0|||
164078122|NCT02544633|592651493|FG002|Treatment Period|Non-compliance|1|||
164078123|NCT02544633|592651494|FG003|Treatment Period|Non-compliance|0|||
164078124|NCT02544633|592651491|FG000|Treatment Period|Clinical Disease Progression|0|||
164078125|NCT02544633|592651492|FG001|Treatment Period|Clinical Disease Progression|0|||
164078126|NCT02544633|592651493|FG002|Treatment Period|Clinical Disease Progression|0|||
164078127|NCT02544633|592651494|FG003|Treatment Period|Clinical Disease Progression|1|||
164078128|NCT02544633|592651491|FG000|Survival Follow-up Period|Death|12|||
164078129|NCT02544633|592651492|FG001|Survival Follow-up Period|Death|14|||
164078130|NCT02544633|592651493|FG002|Survival Follow-up Period|Death|3|||
164078131|NCT02544633|592651494|FG003|Survival Follow-up Period|Death|9|||
164078132|NCT02544633|592651491|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
164078133|NCT02544633|592651492|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
164078134|NCT02544633|592651493|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
164078135|NCT02544633|592651494|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
163876669|NCT01017146|591916982|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163876670|NCT01017146|591916983|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
164078136|NCT02544633|592651491|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
164078137|NCT02544633|592651492|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
164078138|NCT02544633|592651493|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
164078139|NCT02544633|592651494|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
164078140|NCT02544633|592651491|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
164078141|NCT02544633|592651492|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
163876671|NCT01017146|591916982|FG000|Overall Study|Change in Work Situation|1|||
163876672|NCT01017146|591916983|FG001|Overall Study|Change in Work Situation|0|||
163876673|NCT00976495|591916994|FG000|Overall Study|Withdrawal by Subject|0|||
164078142|NCT02544633|592651493|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
164078143|NCT02544633|592651494|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
164078144|NCT02092961|592651495|FG000|Overall Study|Not reported|1|||
164078145|NCT02092961|592651496|FG001|Overall Study|Not reported|0|||
164078146|NCT02092961|592651497|FG002|Overall Study|Not reported|1|||
164215737|NCT03244189|593155920|FG000|Overall Study|Withdrawal by Subject|45|||
164215738|NCT03244189|593155921|FG001|Overall Study|Withdrawal by Subject|23|||
164215739|NCT03244189|593155920|FG000|Overall Study|Technical Problems|2|||
164215740|NCT03244189|593155921|FG001|Overall Study|Technical Problems|0|||
164215741|NCT06170827|593155922|FG000|Overall Study|Withdrawal by Subject|1|||
164215742|NCT06170827|593155923|FG001|Overall Study|Withdrawal by Subject|1|||
164215743|NCT03860584|593155931|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
164215744|NCT03860584|593155932|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
164215745|NCT03860584|593155931|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164215746|NCT03860584|593155932|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164215747|NCT03860584|593155931|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
164326121|NCT01083173|593570128|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
164326122|NCT01083173|593570127|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
163876674|NCT00976495|591916995|FG001|Overall Study|Withdrawal by Subject|1|||
163876675|NCT00976495|591916996|FG002|Overall Study|Withdrawal by Subject|0|||
163876676|NCT00001277|591916998|FG000|Overall Study|Adverse Event|0|||
163876677|NCT00001277|591916999|FG001|Overall Study|Adverse Event|0|||
163876678|NCT00001277|591917000|FG002|Overall Study|Adverse Event|1|||
163876679|NCT00001277|591916998|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
163876680|NCT00001277|591916999|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
163876681|NCT00001277|591917000|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
163876682|NCT02539225|591917004|FG000|Part A|Adverse Event|13|||
163876683|NCT02539225|591917005|FG001|Part A|Adverse Event|4|||
163876684|NCT02539225|591917004|FG000|Part A|Withdrawal by Subject|2|||
163876685|NCT02539225|591917005|FG001|Part A|Withdrawal by Subject|4|||
163876686|NCT02539225|591917004|FG000|Part A|Physician Decision|4|||
163876687|NCT02539225|591917005|FG001|Part A|Physician Decision|7|||
163876688|NCT02539225|591917004|FG000|Part A|Did Not Receive study Drug|1|||
163876689|NCT02539225|591917005|FG001|Part A|Did Not Receive study Drug|1|||
163876690|NCT02539225|591917004|FG000|Pre Treatment for Part B|Progressive disease|1|||
163876691|NCT02539225|591917005|FG001|Pre Treatment for Part B|Progressive disease|1|||
163876692|NCT02539225|591917004|FG000|Pre Treatment for Part B|Adverse Event|1|||
163876693|NCT02539225|591917005|FG001|Pre Treatment for Part B|Adverse Event|1|||
163876694|NCT02539225|591917004|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
163876695|NCT02539225|591917005|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
163876696|NCT02539225|591917004|FG000|Pre Treatment for Part B|Physician Decision|2|||
163876697|NCT02539225|591917005|FG001|Pre Treatment for Part B|Physician Decision|0|||
163876698|NCT02539225|591917004|FG000|Part B|Adverse Event|4|||
163876699|NCT02539225|591917005|FG001|Part B|Adverse Event|4|||
163876700|NCT02539225|591917004|FG000|Part B|Withdrawal by Subject|0|||
163876701|NCT02539225|591917005|FG001|Part B|Withdrawal by Subject|3|||
163876702|NCT02539225|591917004|FG000|Part B|Physician Decision|0|||
163876703|NCT02539225|591917005|FG001|Part B|Physician Decision|9|||
163876704|NCT03101371|591917008|FG000|Overall Study|Physician Decision|0|||
163876705|NCT03101371|591917009|FG001|Overall Study|Physician Decision|1|||
163876706|NCT03101371|591917008|FG000|Overall Study|Lost to Follow-up|1|||
163876707|NCT03101371|591917009|FG001|Overall Study|Lost to Follow-up|4|||
163876708|NCT03101371|591917008|FG000|Overall Study|Did not meet eligibility criteria|2|||
163876709|NCT03101371|591917009|FG001|Overall Study|Did not meet eligibility criteria|1|||
163876710|NCT01094184|591917013|FG000|Overall Study|Death|35|||
163876711|NCT01094184|591917014|FG001|Overall Study|Death|11|||
163876712|NCT02318134|591917015|FG000|Overall Study|Withdrawal by Subject|2|||
163876713|NCT02318134|591917016|FG001|Overall Study|Withdrawal by Subject|1|||
163876714|NCT03988842|591917017|FG000|Overall Study|Death|1|||
163876715|NCT04766034|591917018|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163876716|NCT04766034|591917019|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163876717|NCT04766034|591917020|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163876718|NCT04766034|591917021|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
163876719|NCT04766034|591917022|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
163876720|NCT04766034|591917018|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163876721|NCT04766034|591917019|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163876722|NCT04766034|591917020|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163876723|NCT04766034|591917021|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
163876724|NCT04766034|591917022|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
163876725|NCT04766034|591917018|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
163900154|NCT02397096|592005614|FG000|Study Extension 3|Availability of study medication locally|11|||
164215748|NCT03860584|593155932|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
164215749|NCT03860584|593155931|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
164215750|NCT03860584|593155932|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
164215751|NCT02369458|593155934|FG000|Overall Study|Determined to be not eligible|1|||
164215752|NCT02369458|593155935|FG001|Overall Study|Determined to be not eligible|0|||
164215753|NCT03853798|593155936|FG000|Overall Study|Death|0|||
164215754|NCT03853798|593155937|FG001|Overall Study|Death|0|||
164215755|NCT03853798|593155938|FG002|Overall Study|Death|0|||
164215756|NCT03853798|593155939|FG003|Overall Study|Death|0|||
164215757|NCT03853798|593155940|FG004|Overall Study|Death|0|||
164215758|NCT03853798|593155941|FG005|Overall Study|Death|1|||
164215759|NCT03853798|593155942|FG006|Overall Study|Death|0|||
164215760|NCT03853798|593155943|FG007|Overall Study|Death|0|||
164215761|NCT03853798|593155944|FG008|Overall Study|Death|0|||
164215762|NCT03853798|593155936|FG000|Overall Study|Adverse Event|0|||
164215763|NCT03853798|593155937|FG001|Overall Study|Adverse Event|0|||
164215764|NCT03853798|593155938|FG002|Overall Study|Adverse Event|2|||
164215765|NCT03853798|593155939|FG003|Overall Study|Adverse Event|0|||
164215766|NCT03853798|593155940|FG004|Overall Study|Adverse Event|0|||
164215767|NCT03853798|593155941|FG005|Overall Study|Adverse Event|0|||
164215768|NCT03853798|593155942|FG006|Overall Study|Adverse Event|0|||
164215769|NCT03853798|593155943|FG007|Overall Study|Adverse Event|0|||
164215770|NCT03853798|593155944|FG008|Overall Study|Adverse Event|0|||
164215771|NCT03853798|593155936|FG000|Overall Study|Withdrawal by Subject|0|||
164215772|NCT03853798|593155937|FG001|Overall Study|Withdrawal by Subject|1|||
164215773|NCT03853798|593155938|FG002|Overall Study|Withdrawal by Subject|4|||
164215774|NCT03853798|593155939|FG003|Overall Study|Withdrawal by Subject|0|||
164215775|NCT03853798|593155940|FG004|Overall Study|Withdrawal by Subject|0|||
164215776|NCT03853798|593155941|FG005|Overall Study|Withdrawal by Subject|5|||
164215777|NCT03853798|593155942|FG006|Overall Study|Withdrawal by Subject|0|||
164215778|NCT03853798|593155943|FG007|Overall Study|Withdrawal by Subject|0|||
164215779|NCT03853798|593155944|FG008|Overall Study|Withdrawal by Subject|4|||
164215780|NCT03853798|593155936|FG000|Overall Study|Physician Decision|1|||
164215781|NCT03853798|593155937|FG001|Overall Study|Physician Decision|0|||
164215782|NCT03853798|593155938|FG002|Overall Study|Physician Decision|0|||
164215783|NCT03853798|593155939|FG003|Overall Study|Physician Decision|0|||
164215784|NCT03853798|593155940|FG004|Overall Study|Physician Decision|0|||
164215785|NCT03853798|593155941|FG005|Overall Study|Physician Decision|0|||
164215786|NCT03853798|593155942|FG006|Overall Study|Physician Decision|0|||
164215787|NCT03853798|593155943|FG007|Overall Study|Physician Decision|0|||
164215788|NCT03853798|593155944|FG008|Overall Study|Physician Decision|1|||
164215789|NCT03853798|593155936|FG000|Overall Study|Lack of Efficacy|0|||
164215790|NCT03853798|593155937|FG001|Overall Study|Lack of Efficacy|0|||
164215791|NCT03853798|593155938|FG002|Overall Study|Lack of Efficacy|2|||
164215792|NCT03853798|593155939|FG003|Overall Study|Lack of Efficacy|0|||
164215793|NCT03853798|593155940|FG004|Overall Study|Lack of Efficacy|0|||
164215794|NCT03853798|593155941|FG005|Overall Study|Lack of Efficacy|0|||
164215795|NCT03853798|593155942|FG006|Overall Study|Lack of Efficacy|0|||
164215796|NCT03853798|593155943|FG007|Overall Study|Lack of Efficacy|0|||
164215797|NCT03853798|593155944|FG008|Overall Study|Lack of Efficacy|1|||
164215798|NCT03853798|593155936|FG000|Overall Study|Approved Drug Available for Indication|0|||
164215799|NCT03853798|593155937|FG001|Overall Study|Approved Drug Available for Indication|0|||
164326123|NCT01083173|593570128|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
164326124|NCT01083173|593570127|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
164326125|NCT01083173|593570128|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
164326126|NCT01083173|593570127|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
164326127|NCT01083173|593570128|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
164326128|NCT01083173|593570127|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
164326129|NCT01083173|593570128|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
164326130|NCT04626310|593570134|FG000|Overall Study|4-miss from treatment|6|||
164326131|NCT04626310|593570135|FG001|Overall Study|4-miss from treatment|5|||
164326132|NCT04626310|593570136|FG002|Overall Study|4-miss from treatment|5|||
164326133|NCT04626310|593570134|FG000|Overall Study|Withdrawal by Subject|1|||
164326134|NCT04626310|593570135|FG001|Overall Study|Withdrawal by Subject|0|||
164326135|NCT04626310|593570136|FG002|Overall Study|Withdrawal by Subject|3|||
164326136|NCT00740246|593570137|FG000|Overall Study|Received Blood Transfusion|0|||
164326137|NCT00740246|593570138|FG001|Overall Study|Received Blood Transfusion|1|||
163876726|NCT04766034|591917019|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
164215800|NCT03853798|593155938|FG002|Overall Study|Approved Drug Available for Indication|1|||
164215801|NCT03853798|593155939|FG003|Overall Study|Approved Drug Available for Indication|0|||
164215802|NCT03853798|593155940|FG004|Overall Study|Approved Drug Available for Indication|0|||
163876727|NCT04766034|591917020|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
164215803|NCT03853798|593155941|FG005|Overall Study|Approved Drug Available for Indication|1|||
164215804|NCT03853798|593155942|FG006|Overall Study|Approved Drug Available for Indication|0|||
164215805|NCT03853798|593155943|FG007|Overall Study|Approved Drug Available for Indication|0|||
164215806|NCT03853798|593155944|FG008|Overall Study|Approved Drug Available for Indication|0|||
164215807|NCT03853798|593155936|FG000|Overall Study|Other un-specified|0|||
163981200|NCT00328627|592302654|FG011|Overall Study|Adverse Event|4|||
163981201|NCT00328627|592302643|FG000|Overall Study|Protocol Violation|2|||
163981202|NCT00328627|592302644|FG001|Overall Study|Protocol Violation|2|||
163981203|NCT00328627|592302645|FG002|Overall Study|Protocol Violation|2|||
163981204|NCT00328627|592302646|FG003|Overall Study|Protocol Violation|8|||
163981205|NCT00328627|592302647|FG004|Overall Study|Protocol Violation|5|||
163981206|NCT00328627|592302648|FG005|Overall Study|Protocol Violation|5|||
163981207|NCT00328627|592302649|FG006|Overall Study|Protocol Violation|6|||
163981208|NCT00328627|592302650|FG007|Overall Study|Protocol Violation|2|||
163981209|NCT00328627|592302651|FG008|Overall Study|Protocol Violation|1|||
163981210|NCT00328627|592302652|FG009|Overall Study|Protocol Violation|4|||
163981211|NCT00328627|592302653|FG010|Overall Study|Protocol Violation|6|||
163981212|NCT00328627|592302654|FG011|Overall Study|Protocol Violation|2|||
163981213|NCT00328627|592302643|FG000|Overall Study|Lost to Follow-up|4|||
163981214|NCT00328627|592302644|FG001|Overall Study|Lost to Follow-up|2|||
163981215|NCT00328627|592302645|FG002|Overall Study|Lost to Follow-up|2|||
163981216|NCT00328627|592302646|FG003|Overall Study|Lost to Follow-up|4|||
163981217|NCT00328627|592302647|FG004|Overall Study|Lost to Follow-up|0|||
163981218|NCT00328627|592302648|FG005|Overall Study|Lost to Follow-up|2|||
163981219|NCT00328627|592302649|FG006|Overall Study|Lost to Follow-up|3|||
163981220|NCT00328627|592302650|FG007|Overall Study|Lost to Follow-up|0|||
163981221|NCT00328627|592302651|FG008|Overall Study|Lost to Follow-up|3|||
163981222|NCT00328627|592302652|FG009|Overall Study|Lost to Follow-up|2|||
163981223|NCT00328627|592302653|FG010|Overall Study|Lost to Follow-up|0|||
163981224|NCT00328627|592302654|FG011|Overall Study|Lost to Follow-up|1|||
163981225|NCT00328627|592302643|FG000|Overall Study|Withdrawal by Subject|5|||
163981226|NCT00328627|592302644|FG001|Overall Study|Withdrawal by Subject|4|||
164326138|NCT00740246|593570137|FG000|Overall Study|Adverse Event|1|||
164326139|NCT00740246|593570138|FG001|Overall Study|Adverse Event|2|||
163981227|NCT00328627|592302645|FG002|Overall Study|Withdrawal by Subject|5|||
163981228|NCT00328627|592302646|FG003|Overall Study|Withdrawal by Subject|6|||
163981229|NCT00328627|592302647|FG004|Overall Study|Withdrawal by Subject|2|||
163981230|NCT00328627|592302648|FG005|Overall Study|Withdrawal by Subject|5|||
163981231|NCT00328627|592302649|FG006|Overall Study|Withdrawal by Subject|4|||
163981232|NCT00328627|592302650|FG007|Overall Study|Withdrawal by Subject|4|||
163981233|NCT00328627|592302651|FG008|Overall Study|Withdrawal by Subject|4|||
163981234|NCT00328627|592302652|FG009|Overall Study|Withdrawal by Subject|5|||
163981235|NCT00328627|592302653|FG010|Overall Study|Withdrawal by Subject|2|||
163981236|NCT00328627|592302654|FG011|Overall Study|Withdrawal by Subject|7|||
163981237|NCT00328627|592302643|FG000|Overall Study|Pregnancy|0|||
163981238|NCT00328627|592302644|FG001|Overall Study|Pregnancy|1|||
163981239|NCT00328627|592302645|FG002|Overall Study|Pregnancy|0|||
163981240|NCT00328627|592302646|FG003|Overall Study|Pregnancy|0|||
163981241|NCT00328627|592302647|FG004|Overall Study|Pregnancy|0|||
163981242|NCT00328627|592302648|FG005|Overall Study|Pregnancy|0|||
163981243|NCT00328627|592302649|FG006|Overall Study|Pregnancy|0|||
163981244|NCT00328627|592302650|FG007|Overall Study|Pregnancy|0|||
163981245|NCT00328627|592302651|FG008|Overall Study|Pregnancy|0|||
163981246|NCT00328627|592302652|FG009|Overall Study|Pregnancy|0|||
163981247|NCT00328627|592302653|FG010|Overall Study|Pregnancy|0|||
163981248|NCT00328627|592302654|FG011|Overall Study|Pregnancy|0|||
163981249|NCT00328627|592302643|FG000|Overall Study|Physician Decision|4|||
163981250|NCT00328627|592302644|FG001|Overall Study|Physician Decision|3|||
163981251|NCT00328627|592302645|FG002|Overall Study|Physician Decision|1|||
163981252|NCT00328627|592302646|FG003|Overall Study|Physician Decision|2|||
164326140|NCT00740246|593570137|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
164326141|NCT00740246|593570138|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
164326142|NCT00740246|593570137|FG000|Overall Study|Lost to Follow-up|2|||
164326143|NCT00740246|593570138|FG001|Overall Study|Lost to Follow-up|2|||
164326144|NCT00740246|593570137|FG000|Overall Study|Withdrawal by Subject|4|||
164326145|NCT00740246|593570138|FG001|Overall Study|Withdrawal by Subject|3|||
163981253|NCT00328627|592302647|FG004|Overall Study|Physician Decision|1|||
163981254|NCT00328627|592302648|FG005|Overall Study|Physician Decision|1|||
163981255|NCT00328627|592302649|FG006|Overall Study|Physician Decision|1|||
163981256|NCT00328627|592302650|FG007|Overall Study|Physician Decision|0|||
163981257|NCT00328627|592302651|FG008|Overall Study|Physician Decision|3|||
163981258|NCT00328627|592302652|FG009|Overall Study|Physician Decision|2|||
163981259|NCT00328627|592302653|FG010|Overall Study|Physician Decision|1|||
163981260|NCT00328627|592302654|FG011|Overall Study|Physician Decision|0|||
163981261|NCT00328627|592302643|FG000|Overall Study|Other|0|||
164326146|NCT00740246|593570137|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
164326147|NCT00740246|593570138|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
164326148|NCT00740246|593570137|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
163981262|NCT00328627|592302644|FG001|Overall Study|Other|0|||
163981263|NCT00328627|592302645|FG002|Overall Study|Other|0|||
163981264|NCT00328627|592302646|FG003|Overall Study|Other|1|||
163981265|NCT00328627|592302647|FG004|Overall Study|Other|0|||
163981266|NCT00328627|592302648|FG005|Overall Study|Other|0|||
163981267|NCT00328627|592302649|FG006|Overall Study|Other|1|||
163981268|NCT00328627|592302650|FG007|Overall Study|Other|0|||
164215808|NCT03853798|593155937|FG001|Overall Study|Other un-specified|0|||
164215809|NCT03853798|593155938|FG002|Overall Study|Other un-specified|2|||
164215810|NCT03853798|593155939|FG003|Overall Study|Other un-specified|0|||
164215811|NCT03853798|593155940|FG004|Overall Study|Other un-specified|0|||
164215812|NCT03853798|593155941|FG005|Overall Study|Other un-specified|1|||
164215813|NCT03853798|593155942|FG006|Overall Study|Other un-specified|0|||
164215814|NCT03853798|593155943|FG007|Overall Study|Other un-specified|0|||
164215815|NCT03853798|593155944|FG008|Overall Study|Other un-specified|0|||
164215816|NCT02743494|593155945|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
164215817|NCT02743494|593155946|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
164215818|NCT02743494|593155945|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
164215819|NCT02743494|593155946|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
164215820|NCT02743494|593155945|FG000|Treatment Period|Disease recurrence|152|||
164215821|NCT02743494|593155946|FG001|Treatment Period|Disease recurrence|115|||
164215822|NCT02743494|593155945|FG000|Treatment Period|Study drug toxicity|56|||
164215823|NCT02743494|593155946|FG001|Treatment Period|Study drug toxicity|8|||
164215824|NCT02743494|593155945|FG000|Treatment Period|Death|1|||
164215825|NCT02743494|593155946|FG001|Treatment Period|Death|1|||
164215826|NCT02743494|593155945|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
164215827|NCT02743494|593155946|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
164215828|NCT02743494|593155945|FG000|Treatment Period|Participant request to discontinue treatment|31|||
164215829|NCT02743494|593155946|FG001|Treatment Period|Participant request to discontinue treatment|5|||
164215830|NCT02743494|593155945|FG000|Treatment Period|Participant withdrew consent|11|||
164215831|NCT02743494|593155946|FG001|Treatment Period|Participant withdrew consent|4|||
164215832|NCT02743494|593155945|FG000|Treatment Period|Lost to Follow-up|0|||
164215833|NCT02743494|593155946|FG001|Treatment Period|Lost to Follow-up|1|||
164215834|NCT02743494|593155945|FG000|Treatment Period|Poor/Non-compliance|2|||
164215835|NCT02743494|593155946|FG001|Treatment Period|Poor/Non-compliance|0|||
164215836|NCT02743494|593155945|FG000|Treatment Period|Other reasons|4|||
164215837|NCT02743494|593155946|FG001|Treatment Period|Other reasons|1|||
164215838|NCT04167670|593157244|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
164215839|NCT04167670|593157245|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
164215840|NCT04167670|593157246|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
164215841|NCT04167670|593157244|FG000|Overall Study|Significant protocol deviation|3|||
164215842|NCT04167670|593157245|FG001|Overall Study|Significant protocol deviation|1|||
164215843|NCT04167670|593157246|FG002|Overall Study|Significant protocol deviation|0|||
164215844|NCT04167670|593157244|FG000|Overall Study|Lost to Follow-up|0|||
164215845|NCT04167670|593157245|FG001|Overall Study|Lost to Follow-up|3|||
164215846|NCT04167670|593157246|FG002|Overall Study|Lost to Follow-up|3|||
164215847|NCT04167670|593157244|FG000|Overall Study|Voluntary Withdrawal|0|||
164215848|NCT04167670|593157245|FG001|Overall Study|Voluntary Withdrawal|1|||
164215849|NCT04167670|593157246|FG002|Overall Study|Voluntary Withdrawal|1|||
164215850|NCT04167670|593157244|FG000|Overall Study|Withdrawal of Consent|4|||
164215851|NCT04167670|593157245|FG001|Overall Study|Withdrawal of Consent|1|||
164215852|NCT04167670|593157246|FG002|Overall Study|Withdrawal of Consent|3|||
164215853|NCT04167670|593157244|FG000|Overall Study|Miscellaneous|7|||
164215854|NCT04167670|593157245|FG001|Overall Study|Miscellaneous|5|||
164215855|NCT04167670|593157246|FG002|Overall Study|Miscellaneous|3|||
164215856|NCT05399485|593157247|FG000|DBT Phase|Other|6|||
164215857|NCT05399485|593157248|FG001|DBT Phase|Other|5|||
164215858|NCT05399485|593157247|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
164215859|NCT05399485|593157248|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
164215860|NCT05399485|593157247|FG000|DBT Phase|Withdrawal by Subject|3|||
164215861|NCT05399485|593157248|FG001|DBT Phase|Withdrawal by Subject|2|||
164215862|NCT05399485|593157247|FG000|DBT Phase|Protocol Violation|2|||
164215863|NCT05399485|593157248|FG001|DBT Phase|Protocol Violation|1|||
164215864|NCT05399485|593157247|FG000|DBT Phase|Physician Decision|0|||
164215865|NCT05399485|593157248|FG001|DBT Phase|Physician Decision|1|||
164215866|NCT05399485|593157247|FG000|DBT Phase|Adverse Event|2|||
164215867|NCT05399485|593157248|FG001|DBT Phase|Adverse Event|1|||
164215868|NCT05399485|593157247|FG000|OLE Phase|Protocol deviation|1|||
164215869|NCT05399485|593157248|FG001|OLE Phase|Protocol deviation|0|||
164215870|NCT05399485|593157247|FG000|OLE Phase|Other|5|||
164215871|NCT05399485|593157248|FG001|OLE Phase|Other|5|||
164215872|NCT05399485|593157247|FG000|OLE Phase|Withdrawal by Subject|12|||
164215873|NCT05399485|593157248|FG001|OLE Phase|Withdrawal by Subject|7|||
164215874|NCT05399485|593157247|FG000|OLE Phase|Pregnancy|0|||
164215875|NCT05399485|593157248|FG001|OLE Phase|Pregnancy|2|||
164215876|NCT05399485|593157247|FG000|OLE Phase|Physician Decision|3|||
164215877|NCT05399485|593157248|FG001|OLE Phase|Physician Decision|0|||
164215878|NCT05399485|593157247|FG000|OLE Phase|Adverse Event|2|||
164215879|NCT05399485|593157248|FG001|OLE Phase|Adverse Event|2|||
164215880|NCT03554473|593157251|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
164215881|NCT03554473|593157252|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
164215882|NCT03554473|593157253|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
164215883|NCT03554473|593157251|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
164215884|NCT03554473|593157252|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
164215885|NCT03554473|593157253|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
164215886|NCT03554473|593157251|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
164215887|NCT03554473|593157252|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
164215888|NCT03554473|593157253|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
164215889|NCT01363076|593157254|FG000|Overall Study|Withdrawal by Subject|0|||
164215890|NCT01363076|593157255|FG001|Overall Study|Withdrawal by Subject|1|||
164215891|NCT02014103|593157256|FG000|Overall Study|Protocol Violation|7|||
164215892|NCT02014103|593157257|FG001|Overall Study|Protocol Violation|7|||
164215893|NCT02014103|593157256|FG000|Overall Study|Adverse Event|1|||
164215894|NCT02014103|593157257|FG001|Overall Study|Adverse Event|0|||
164215895|NCT02014103|593157256|FG000|Overall Study|Lost venous access|1|||
164215896|NCT02014103|593157257|FG001|Overall Study|Lost venous access|0|||
164215897|NCT02014103|593157256|FG000|Overall Study|Withdrawal by Subject|0|||
164215898|NCT02014103|593157257|FG001|Overall Study|Withdrawal by Subject|2|||
164215899|NCT04439175|593157258|FG000|Overall Study|Never started treatment|4|||
164215900|NCT04439175|593157258|FG000|Overall Study|Ineligible|5|||
164215901|NCT04439175|593157258|FG000|Overall Study|Adverse Event|6|||
164215902|NCT04439175|593157258|FG000|Overall Study|Death|4|||
164215903|NCT04439175|593157258|FG000|Overall Study|Disease progression|44|||
164215904|NCT04439175|593157258|FG000|Overall Study|Withdrawal by Subject|4|||
164215905|NCT04439175|593157258|FG000|Overall Study|Alternative Therapy|1|||
164215906|NCT04439175|593157258|FG000|Overall Study|Other|2|||
164215907|NCT05417113|593157261|FG000|Overall Study|Lost to Follow-up|2|||
164215908|NCT05417113|593157262|FG001|Overall Study|Lost to Follow-up|2|||
164215909|NCT01847209|593157263|FG000|Overall Study|Withdrawal by Subject|1|||
164215910|NCT01847209|593157263|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
164215911|NCT00729586|593157264|FG000|Overall Study|Ineligible|0|||
164215912|NCT00729586|593157265|FG001|Overall Study|Ineligible|1|||
164215913|NCT00729586|593157264|FG000|Overall Study|never treated|1|||
164215914|NCT00729586|593157265|FG001|Overall Study|never treated|0|||
164215915|NCT01631188|593157266|FG000|Overall Study|Physician Decision|75|||
164215916|NCT02513199|593157272|FG000|Treatment|Death|1|||
164215917|NCT02513199|593157272|FG000|Treatment|Lost to Follow-up|1|||
164215918|NCT02513199|593157272|FG000|Follow-Up|Death|11|||
164215919|NCT02582632|593157276|FG000|Overall Study|Other|1|||
164215920|NCT04307394|593157279|FG000|Overall Study|Lost to Follow-up|3|||
164215921|NCT04307394|593157279|FG000|Overall Study|Withdrawal by Subject|2|||
164215922|NCT02323334|593157280|FG000|Period 3|Lost to Follow-up|0|||
164215923|NCT02323334|593157281|FG001|Period 3|Lost to Follow-up|0|||
164215924|NCT02323334|593157282|FG002|Period 3|Lost to Follow-up|1|||
164215925|NCT02323334|593157283|FG003|Period 3|Lost to Follow-up|0|||
164215926|NCT02323334|593157284|FG004|Period 3|Lost to Follow-up|0|||
164215927|NCT02323334|593157285|FG005|Period 3|Lost to Follow-up|0|||
164215928|NCT02323334|593157286|FG006|Period 3|Lost to Follow-up|0|||
164215929|NCT02323334|593157287|FG007|Period 3|Lost to Follow-up|0|||
164215930|NCT02323334|593157288|FG008|Period 3|Lost to Follow-up|0|||
164215931|NCT02323334|593157289|FG009|Period 3|Lost to Follow-up|0|||
164215932|NCT02323334|593157290|FG010|Period 3|Lost to Follow-up|0|||
164215933|NCT02323334|593157291|FG011|Period 3|Lost to Follow-up|0|||
164215934|NCT02323334|593157292|FG012|Period 3|Lost to Follow-up|0|||
164215935|NCT02323334|593157293|FG013|Period 3|Lost to Follow-up|0|||
164215936|NCT02323334|593157294|FG014|Period 3|Lost to Follow-up|0|||
164215937|NCT02323334|593157295|FG015|Period 3|Lost to Follow-up|0|||
164215938|NCT02323334|593157296|FG016|Period 3|Lost to Follow-up|0|||
164215939|NCT02323334|593157280|FG000|Period 3|Withdrawal by Subject|1|||
164215940|NCT02323334|593157281|FG001|Period 3|Withdrawal by Subject|0|||
164215941|NCT02323334|593157282|FG002|Period 3|Withdrawal by Subject|0|||
164215942|NCT02323334|593157283|FG003|Period 3|Withdrawal by Subject|0|||
164215943|NCT02323334|593157284|FG004|Period 3|Withdrawal by Subject|0|||
164215944|NCT02323334|593157285|FG005|Period 3|Withdrawal by Subject|0|||
164215945|NCT02323334|593157286|FG006|Period 3|Withdrawal by Subject|0|||
164215946|NCT02323334|593157287|FG007|Period 3|Withdrawal by Subject|0|||
164215947|NCT02323334|593157288|FG008|Period 3|Withdrawal by Subject|0|||
164215948|NCT02323334|593157289|FG009|Period 3|Withdrawal by Subject|0|||
164215949|NCT02323334|593157290|FG010|Period 3|Withdrawal by Subject|0|||
164215950|NCT02323334|593157291|FG011|Period 3|Withdrawal by Subject|0|||
164215951|NCT02323334|593157292|FG012|Period 3|Withdrawal by Subject|0|||
164215952|NCT02323334|593157293|FG013|Period 3|Withdrawal by Subject|0|||
164215953|NCT02323334|593157294|FG014|Period 3|Withdrawal by Subject|0|||
164215954|NCT02323334|593157295|FG015|Period 3|Withdrawal by Subject|0|||
164215955|NCT02323334|593157296|FG016|Period 3|Withdrawal by Subject|0|||
164215956|NCT01617967|593157298|FG000|Overall Study|Protocol Violation|0|||
164215957|NCT01617967|593157299|FG001|Overall Study|Protocol Violation|0|||
163981269|NCT00328627|592302651|FG008|Overall Study|Other|0|||
164215958|NCT01617967|593157300|FG002|Overall Study|Protocol Violation|0|||
164215959|NCT01617967|593157301|FG003|Overall Study|Protocol Violation|1|||
164215960|NCT01617967|593157302|FG004|Overall Study|Protocol Violation|0|||
164215961|NCT01617967|593157303|FG005|Overall Study|Protocol Violation|0|||
164215962|NCT01617967|593157298|FG000|Overall Study|Withdrawal by Subject|0|||
164215963|NCT01617967|593157299|FG001|Overall Study|Withdrawal by Subject|0|||
164215964|NCT01617967|593157300|FG002|Overall Study|Withdrawal by Subject|0|||
164215965|NCT01617967|593157301|FG003|Overall Study|Withdrawal by Subject|0|||
164215966|NCT01617967|593157302|FG004|Overall Study|Withdrawal by Subject|0|||
164215967|NCT01617967|593157303|FG005|Overall Study|Withdrawal by Subject|1|||
164215968|NCT01617967|593157298|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
164215969|NCT01617967|593157299|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
164215970|NCT01617967|593157300|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
164215971|NCT01617967|593157301|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
164215972|NCT01617967|593157302|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
164215973|NCT01617967|593157303|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
164215974|NCT02453048|593157304|FG000|Overall Study|Only part of initial 6 mo. study|0|||
164215975|NCT02453048|593157305|FG001|Overall Study|Only part of initial 6 mo. study|0|||
164215976|NCT02453048|593157306|FG002|Overall Study|Only part of initial 6 mo. study|0|||
164215977|NCT02453048|593157307|FG003|Overall Study|Only part of initial 6 mo. study|0|||
164215978|NCT02453048|593157308|FG004|Overall Study|Only part of initial 6 mo. study|6|||
164215979|NCT02453048|593157304|FG000|Overall Study|Lost to Follow-up|0|||
164215980|NCT02453048|593157305|FG001|Overall Study|Lost to Follow-up|1|||
164215981|NCT02453048|593157306|FG002|Overall Study|Lost to Follow-up|2|||
164215982|NCT02453048|593157307|FG003|Overall Study|Lost to Follow-up|0|||
164215983|NCT02453048|593157308|FG004|Overall Study|Lost to Follow-up|0|||
164215984|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
164215985|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
164215986|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
164215987|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
164215988|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
164215989|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
164215990|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
164215991|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
164326149|NCT00740246|593570138|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
164326150|NCT00740246|593570137|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
164326151|NCT00740246|593570138|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
164326152|NCT00740246|593570137|FG000|Overall Study|Unable To Comply With Study Visits|2|||
164326153|NCT00740246|593570138|FG001|Overall Study|Unable To Comply With Study Visits|0|||
164326154|NCT00740246|593570137|FG000|Overall Study|Unable to Access Vein|0|||
164326155|NCT00740246|593570138|FG001|Overall Study|Unable to Access Vein|2|||
164326156|NCT00740246|593570137|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
164326157|NCT00740246|593570138|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
164326158|NCT01041495|593570139|FG000|Overall Study|Withdrawal by Subject|2|||
164326159|NCT01041495|593570140|FG001|Overall Study|Withdrawal by Subject|5|||
164326160|NCT01041495|593570139|FG000|Overall Study|Adverse Event|2|||
164326161|NCT01041495|593570140|FG001|Overall Study|Adverse Event|1|||
164326162|NCT01041495|593570139|FG000|Overall Study|Lost to Follow-up|0|||
164326163|NCT01041495|593570140|FG001|Overall Study|Lost to Follow-up|1|||
164326164|NCT03584373|593570141|FG000|Overall Study|Lost to Follow-up|7|||
164326165|NCT03584373|593570142|FG001|Overall Study|Lost to Follow-up|8|||
164326166|NCT00662532|593570144|FG000|Overall Study|Adverse Event|0|||
164326167|NCT00662532|593570145|FG001|Overall Study|Adverse Event|1|||
164326168|NCT00662532|593570144|FG000|Overall Study|Lost to Follow-up|0|||
163981270|NCT00328627|592302652|FG009|Overall Study|Other|1|||
163981271|NCT00328627|592302653|FG010|Overall Study|Other|1|||
164326169|NCT00662532|593570145|FG001|Overall Study|Lost to Follow-up|1|||
163981272|NCT00328627|592302654|FG011|Overall Study|Other|0|||
164215992|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
164215993|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
164215994|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
164215995|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
164215996|NCT00447278|593157310|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
164215997|NCT00447278|593157311|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
164215998|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
164326170|NCT01853618|593570149|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
164326171|NCT01853618|593570150|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
163981273|NCT00691483|592302656|FG000|Overall Study|Adverse Event|14|||
164215999|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
164216000|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
164216001|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
163981274|NCT00691483|592302657|FG001|Overall Study|Adverse Event|6|||
164216002|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
164216003|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
164216004|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
164216005|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
164216006|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
164216007|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
164216008|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
164216009|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
164216010|NCT00447278|593157310|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
164216011|NCT00447278|593157311|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
164216012|NCT03677401|593157312|FG000|Overall Study|Adverse Event|4|||
164216013|NCT03677401|593157313|FG001|Overall Study|Adverse Event|14|||
164216014|NCT03677401|593157312|FG000|Overall Study|Lack of Efficacy|3|||
164216015|NCT03677401|593157313|FG001|Overall Study|Lack of Efficacy|1|||
164216016|NCT03677401|593157312|FG000|Overall Study|Withdrawal by Subject|2|||
164216017|NCT03677401|593157313|FG001|Overall Study|Withdrawal by Subject|2|||
164216018|NCT03677401|593157312|FG000|Overall Study|Sponsor decision|0|||
164216019|NCT03677401|593157313|FG001|Overall Study|Sponsor decision|1|||
164216020|NCT03677401|593157312|FG000|Overall Study|Reason Unspecified|1|||
164216021|NCT03677401|593157313|FG001|Overall Study|Reason Unspecified|0|||
164216022|NCT06262607|593157314|FG000|Overall Study|Physician Decision|0|||
164216023|NCT06262607|593157315|FG001|Overall Study|Physician Decision|1|||
164216024|NCT06262607|593157314|FG000|Overall Study|Withdrawal by Subject|2|||
164216025|NCT06262607|593157315|FG001|Overall Study|Withdrawal by Subject|0|||
164216026|NCT00574951|593157316|FG000|Overall Study|Ineligible - improper prior treatment|1|||
164216027|NCT05161936|593157317|FG000|Overall Study|Study terminated by Sponsor|1|||
164216028|NCT05161936|593157318|FG001|Overall Study|Study terminated by Sponsor|0|||
164216029|NCT05161936|593157319|FG002|Overall Study|Study terminated by Sponsor|0|||
164216030|NCT05161936|593157317|FG000|Overall Study|Withdrawal by Subject|0|||
164216031|NCT05161936|593157318|FG001|Overall Study|Withdrawal by Subject|0|||
164216032|NCT05161936|593157319|FG002|Overall Study|Withdrawal by Subject|1|||
164216033|NCT04925934|593157335|FG000|Overall Study|Adverse Event|1|||
164216034|NCT04925934|593157336|FG001|Overall Study|Adverse Event|0|||
164216035|NCT04925934|593157337|FG002|Overall Study|Adverse Event|0|||
164216036|NCT04925934|593157335|FG000|Overall Study|Lost to Follow-up|2|||
164216037|NCT04925934|593157336|FG001|Overall Study|Lost to Follow-up|0|||
164326172|NCT01853618|593570151|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
164326173|NCT01853618|593570152|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
164326174|NCT01853618|593570153|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
164326175|NCT01853618|593570149|FG000|Overall Study|Progressive disease|1|||
164326176|NCT01853618|593570150|FG001|Overall Study|Progressive disease|1|||
164326177|NCT01853618|593570151|FG002|Overall Study|Progressive disease|1|||
164326178|NCT01853618|593570152|FG003|Overall Study|Progressive disease|1|||
164326179|NCT01853618|593570153|FG004|Overall Study|Progressive disease|2|||
164326180|NCT01853618|593570149|FG000|Overall Study|Physician Decision|0|||
164326181|NCT01853618|593570150|FG001|Overall Study|Physician Decision|1|||
164326182|NCT01853618|593570151|FG002|Overall Study|Physician Decision|1|||
164326183|NCT01853618|593570152|FG003|Overall Study|Physician Decision|0|||
164326184|NCT01853618|593570153|FG004|Overall Study|Physician Decision|0|||
164326185|NCT01853618|593570149|FG000|Overall Study|Refused further treatment|0|||
164326186|NCT01853618|593570150|FG001|Overall Study|Refused further treatment|0|||
164326187|NCT01853618|593570151|FG002|Overall Study|Refused further treatment|0|||
164326188|NCT01853618|593570152|FG003|Overall Study|Refused further treatment|0|||
164326189|NCT01853618|593570153|FG004|Overall Study|Refused further treatment|1|||
164326190|NCT01658813|593570154|FG000|Overall Study|Disease progression|3|||
164326191|NCT01092832|593570159|FG000|Overall Study|Other|1|||
164326192|NCT01092832|593570160|FG001|Overall Study|Other|0|||
164326193|NCT04777331|593570161|FG000|DBT Period|Death|2|||
164326194|NCT04777331|593570162|FG001|DBT Period|Death|1|||
164326195|NCT04777331|593570163|FG002|DBT Period|Death|0|||
164216038|NCT04925934|593157337|FG002|Overall Study|Lost to Follow-up|1|||
164326196|NCT04777331|593570161|FG000|DBT Period|Reason not Specified|1|||
164216039|NCT04925934|593157335|FG000|Overall Study|Death|0|||
164216040|NCT04925934|593157336|FG001|Overall Study|Death|1|||
164216041|NCT04925934|593157337|FG002|Overall Study|Death|0|||
164216042|NCT04925934|593157335|FG000|Overall Study|Withdrawal by Subject|8|||
164216043|NCT04925934|593157336|FG001|Overall Study|Withdrawal by Subject|5|||
164216044|NCT04925934|593157337|FG002|Overall Study|Withdrawal by Subject|9|||
164216045|NCT04925934|593157335|FG000|Overall Study|Other|2|||
164326197|NCT04777331|593570162|FG001|DBT Period|Reason not Specified|1|||
164326198|NCT04777331|593570163|FG002|DBT Period|Reason not Specified|0|||
164326199|NCT04777331|593570161|FG000|DBT Period|Physician Decision|4|||
164326200|NCT04777331|593570162|FG001|DBT Period|Physician Decision|0|||
164216046|NCT04925934|593157336|FG001|Overall Study|Other|2|||
164216047|NCT04925934|593157337|FG002|Overall Study|Other|2|||
164326201|NCT04777331|593570163|FG002|DBT Period|Physician Decision|0|||
164326202|NCT04777331|593570161|FG000|DBT Period|Withdrawal by Subject|12|||
163981275|NCT00691483|592302656|FG000|Overall Study|Lost to Follow-up|17|||
163981276|NCT00691483|592302657|FG001|Overall Study|Lost to Follow-up|10|||
163981277|NCT00691483|592302656|FG000|Overall Study|Withdrawal by Subject|24|||
163981278|NCT00691483|592302657|FG001|Overall Study|Withdrawal by Subject|7|||
163981279|NCT00691483|592302656|FG000|Overall Study|Other known cause|6|||
163981280|NCT00691483|592302657|FG001|Overall Study|Other known cause|1|||
163981281|NCT00691483|592302656|FG000|Overall Study|Randomized by not treated|7|||
163981282|NCT00691483|592302657|FG001|Overall Study|Randomized by not treated|1|||
163981283|NCT04623242|592302659|FG000|Overall Study|Withdrawal by Subject|7|||
163981284|NCT04623242|592302660|FG001|Overall Study|Withdrawal by Subject|12|||
163981285|NCT04623242|592302661|FG002|Overall Study|Withdrawal by Subject|5|||
163981286|NCT04623242|592302662|FG003|Overall Study|Withdrawal by Subject|7|||
163981287|NCT04623242|592302663|FG004|Overall Study|Withdrawal by Subject|0|||
163981288|NCT04623242|592302659|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
163981289|NCT04623242|592302660|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
163981290|NCT04623242|592302661|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
164216048|NCT04925934|593157335|FG000|Overall Study|Eastern European Conflict|7|||
164216049|NCT04925934|593157336|FG001|Overall Study|Eastern European Conflict|3|||
164216050|NCT04925934|593157337|FG002|Overall Study|Eastern European Conflict|2|||
164216051|NCT04425018|593157339|FG000|Overall Study|Withdrawal by Subject|1|||
164216052|NCT04425018|593157340|FG001|Overall Study|Withdrawal by Subject|2|||
164216053|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
164326203|NCT04777331|593570162|FG001|DBT Period|Withdrawal by Subject|11|||
164326204|NCT04777331|593570163|FG002|DBT Period|Withdrawal by Subject|0|||
164326205|NCT04777331|593570161|FG000|DBT Period|Randomized but not Treated|1|||
164326206|NCT04777331|593570162|FG001|DBT Period|Randomized but not Treated|3|||
164216054|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
164216055|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
164216056|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
164216057|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
164216058|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
164216059|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
164216060|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
164216061|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
164216062|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
164216063|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
164216064|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
164216065|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
164216066|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
164216067|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
164216068|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
164216069|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
164216070|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
164216071|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
164216072|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
164216073|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
164216074|NCT02337946|593157345|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
164216075|NCT02337946|593157346|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
164216076|NCT02337946|593157347|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
164216077|NCT02337946|593157345|FG000|In-between Period|Without Informed Consent|1|||
164216078|NCT02337946|593157346|FG001|In-between Period|Without Informed Consent|0|||
164216079|NCT02337946|593157347|FG002|In-between Period|Without Informed Consent|0|||
164216080|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
164216081|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
164216082|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
164216083|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
164216084|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
164216085|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
164216086|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
164216087|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
164216088|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
164326207|NCT04777331|593570163|FG002|DBT Period|Randomized but not Treated|0|||
164326208|NCT04777331|593570161|FG000|OLE Period|Ongoing in OLE|0|||
163981291|NCT04623242|592302662|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
164216089|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
163981292|NCT04623242|592302663|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
163981293|NCT04623242|592302659|FG000|Overall Study|Subject unblinded to mutation status|0|||
163981294|NCT04623242|592302660|FG001|Overall Study|Subject unblinded to mutation status|0|||
163981295|NCT04623242|592302661|FG002|Overall Study|Subject unblinded to mutation status|0|||
164216090|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
164216091|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
164216092|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
164216093|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
164216094|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
164216095|NCT02337946|593157345|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
164216096|NCT02337946|593157346|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
164216097|NCT02337946|593157347|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
164216098|NCT01327703|593157348|FG000|Second Treatment Period|Adverse Event|1|||
164216099|NCT01327703|593157349|FG001|Second Treatment Period|Adverse Event|1|||
164326209|NCT04777331|593570162|FG001|OLE Period|Ongoing in OLE|0|||
163981296|NCT04623242|592302662|FG003|Overall Study|Subject unblinded to mutation status|13|||
163981297|NCT04623242|592302663|FG004|Overall Study|Subject unblinded to mutation status|0|||
163981298|NCT02105454|592302666|FG000|Overall Study|Withdrawal by Subject|1|||
163981299|NCT05131204|592302667|FG000|Overall Study|Sponsor request|2|||
163981300|NCT05131204|592302668|FG001|Overall Study|Sponsor request|1|||
163981301|NCT02469090|592302670|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
163981302|NCT02469090|592302671|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
163981303|NCT02469090|592302672|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
163981304|NCT02469090|592302670|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
164326210|NCT04777331|593570163|FG002|OLE Period|Ongoing in OLE|534|||
164326211|NCT01401959|593570164|FG000|Enrolled|Withdrawal by Subject|1|||
164326212|NCT01401959|593570165|FG001|Enrolled|Withdrawal by Subject|0|||
164326213|NCT01401959|593570166|FG002|Enrolled|Withdrawal by Subject|0|||
164326214|NCT01401959|593570164|FG000|Treated|Disease Progression|2|||
164326215|NCT01401959|593570165|FG001|Treated|Disease Progression|2|||
164326216|NCT01401959|593570166|FG002|Treated|Disease Progression|1|||
164326217|NCT01401959|593570164|FG000|Treated|Adverse Event|4|||
164326218|NCT01401959|593570165|FG001|Treated|Adverse Event|3|||
164326219|NCT01401959|593570166|FG002|Treated|Adverse Event|2|||
164326220|NCT01401959|593570164|FG000|Treated|Withdrawal by Subject|1|||
164326221|NCT01401959|593570165|FG001|Treated|Withdrawal by Subject|2|||
164326222|NCT01401959|593570166|FG002|Treated|Withdrawal by Subject|2|||
164326223|NCT01401959|593570164|FG000|Treated|Protocol Violation|0|||
164326224|NCT01401959|593570165|FG001|Treated|Protocol Violation|1|||
164326225|NCT01401959|593570166|FG002|Treated|Protocol Violation|0|||
164326226|NCT00400153|593570167|FG000|Overall Study|AE due to study disease worsening|14|||
164326227|NCT00400153|593570168|FG001|Overall Study|AE due to study disease worsening|19|||
164326228|NCT00400153|593570169|FG002|Overall Study|AE due to study disease worsening|20|||
164326229|NCT00400153|593570167|FG000|Overall Study|AE due to other disease worsening|2|||
164326230|NCT00400153|593570168|FG001|Overall Study|AE due to other disease worsening|1|||
164326231|NCT00400153|593570169|FG002|Overall Study|AE due to other disease worsening|0|||
164326232|NCT00400153|593570167|FG000|Overall Study|AE due to other condition|3|||
164326233|NCT00400153|593570168|FG001|Overall Study|AE due to other condition|14|||
164326234|NCT00400153|593570169|FG002|Overall Study|AE due to other condition|15|||
164326235|NCT00400153|593570167|FG000|Overall Study|Protocol Violation|7|||
164326236|NCT00400153|593570168|FG001|Overall Study|Protocol Violation|4|||
164326237|NCT00400153|593570169|FG002|Overall Study|Protocol Violation|9|||
164326238|NCT00400153|593570167|FG000|Overall Study|Lost to Follow-up|2|||
164326239|NCT00400153|593570168|FG001|Overall Study|Lost to Follow-up|1|||
163981305|NCT02469090|592302671|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
163981306|NCT02469090|592302672|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
163981307|NCT02469090|592302670|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
163981308|NCT02469090|592302671|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
163981309|NCT02469090|592302672|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
164326240|NCT00400153|593570169|FG002|Overall Study|Lost to Follow-up|4|||
164326241|NCT00400153|593570167|FG000|Overall Study|Withdrawal by Subject|12|||
164326242|NCT00400153|593570168|FG001|Overall Study|Withdrawal by Subject|11|||
164326243|NCT00400153|593570169|FG002|Overall Study|Withdrawal by Subject|10|||
164326244|NCT00400153|593570167|FG000|Overall Study|Other reasons - not mentioned above|8|||
164326245|NCT00400153|593570168|FG001|Overall Study|Other reasons - not mentioned above|5|||
164326246|NCT00400153|593570169|FG002|Overall Study|Other reasons - not mentioned above|3|||
164326247|NCT01423604|593570170|FG000|Safety Run-In|Adverse Event|3|||
164326248|NCT01423604|593570171|FG001|Safety Run-In|Adverse Event|0|||
164326249|NCT01423604|593570170|FG000|Safety Run-In|Death|1|||
164326250|NCT01423604|593570171|FG001|Safety Run-In|Death|0|||
164326251|NCT01423604|593570170|FG000|Safety Run-In|Physician Decision|1|||
164326252|NCT01423604|593570171|FG001|Safety Run-In|Physician Decision|0|||
164326253|NCT01423604|593570170|FG000|Safety Run-In|Disease progression|3|||
164326254|NCT01423604|593570171|FG001|Safety Run-In|Disease progression|0|||
163981310|NCT02469090|592302670|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
163981311|NCT02469090|592302671|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
163981312|NCT02469090|592302672|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
164326255|NCT01423604|593570170|FG000|Safety Run-In|Patient decision|1|||
164326256|NCT01423604|593570171|FG001|Safety Run-In|Patient decision|0|||
164216100|NCT01327703|593157348|FG000|Second Treatment Period|Protocol Violation|0|||
164216101|NCT01327703|593157349|FG001|Second Treatment Period|Protocol Violation|1|||
164216102|NCT01131585|593157351|FG000|Overall Study|Adverse Event|0|||
164216103|NCT01131585|593157352|FG001|Overall Study|Adverse Event|2|||
164216104|NCT01131585|593157351|FG000|Overall Study|Abnormal laboratory value|1|||
164216105|NCT01131585|593157352|FG001|Overall Study|Abnormal laboratory value|0|||
164216106|NCT01131585|593157351|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164216107|NCT01131585|593157352|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164216108|NCT01131585|593157351|FG000|Overall Study|Protocol Violation|2|||
164216109|NCT01131585|593157352|FG001|Overall Study|Protocol Violation|1|||
164216110|NCT01131585|593157351|FG000|Overall Study|Withdrawal by Subject|3|||
164216111|NCT01131585|593157352|FG001|Overall Study|Withdrawal by Subject|3|||
164216112|NCT01131585|593157351|FG000|Overall Study|Lost to Follow-up|0|||
164216113|NCT01131585|593157352|FG001|Overall Study|Lost to Follow-up|1|||
164216114|NCT01131585|593157351|FG000|Overall Study|Administrative problems|1|||
164216115|NCT01131585|593157352|FG001|Overall Study|Administrative problems|1|||
164216116|NCT01131585|593157351|FG000|Overall Study|Study termination|78|||
164216117|NCT01131585|593157352|FG001|Overall Study|Study termination|32|||
164216118|NCT00812097|593157353|FG000|Overall Study|Death|3|||
164216119|NCT00812097|593157354|FG001|Overall Study|Death|10|||
164216120|NCT00812097|593157355|FG002|Overall Study|Death|3|||
164216121|NCT00812097|593157356|FG003|Overall Study|Death|3|||
164216122|NCT00812097|593157353|FG000|Overall Study|Withdrawal by Subject|14|||
164216123|NCT00812097|593157354|FG001|Overall Study|Withdrawal by Subject|12|||
164216124|NCT00812097|593157355|FG002|Overall Study|Withdrawal by Subject|8|||
164216125|NCT00812097|593157356|FG003|Overall Study|Withdrawal by Subject|2|||
164216126|NCT00812097|593157353|FG000|Overall Study|Lost to Follow-up|90|||
164216127|NCT00812097|593157354|FG001|Overall Study|Lost to Follow-up|14|||
164216128|NCT00812097|593157355|FG002|Overall Study|Lost to Follow-up|17|||
164216129|NCT00812097|593157356|FG003|Overall Study|Lost to Follow-up|5|||
164216130|NCT00812097|593157353|FG000|Overall Study|Explantation of study device(s)|27|||
164216131|NCT00812097|593157354|FG001|Overall Study|Explantation of study device(s)|29|||
164216132|NCT00812097|593157355|FG002|Overall Study|Explantation of study device(s)|14|||
164216133|NCT00812097|593157356|FG003|Overall Study|Explantation of study device(s)|20|||
164216134|NCT00812097|593157353|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
164216135|NCT00812097|593157354|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
164216136|NCT00812097|593157355|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
164216137|NCT00812097|593157356|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
164216138|NCT01786109|593157357|FG000|Overall Study|fail manometry barostat tube placement|1|||
164216139|NCT01786109|593157358|FG001|Overall Study|fail manometry barostat tube placement|0|||
164216140|NCT01786109|593157359|FG002|Overall Study|fail manometry barostat tube placement|0|||
164216141|NCT01786109|593157357|FG000|Overall Study|unrelated illness|0|||
164216142|NCT01786109|593157358|FG001|Overall Study|unrelated illness|0|||
164216143|NCT01786109|593157359|FG002|Overall Study|unrelated illness|1|||
164216144|NCT01786109|593157357|FG000|Overall Study|adverse effects colon preparation|0|||
164216145|NCT01786109|593157358|FG001|Overall Study|adverse effects colon preparation|0|||
164216146|NCT01786109|593157359|FG002|Overall Study|adverse effects colon preparation|1|||
164216147|NCT02949934|593157364|FG000|Natural Drinking Period|Adverse Event|1|||
164216148|NCT02949934|593157365|FG001|Natural Drinking Period|Adverse Event|0|||
164216149|NCT02949934|593157366|FG002|Natural Drinking Period|Adverse Event|0|||
164216150|NCT02949934|593157367|FG003|Natural Drinking Period|Adverse Event|1|||
164216151|NCT02949934|593157368|FG004|Natural Drinking Period|Adverse Event|0|||
164216152|NCT02949934|593157369|FG005|Natural Drinking Period|Adverse Event|0|||
164216153|NCT02949934|593157364|FG000|Natural Drinking Period|Lost to Follow-up|0|||
164216154|NCT02949934|593157365|FG001|Natural Drinking Period|Lost to Follow-up|0|||
164216155|NCT02949934|593157366|FG002|Natural Drinking Period|Lost to Follow-up|0|||
164216156|NCT02949934|593157367|FG003|Natural Drinking Period|Lost to Follow-up|0|||
164216157|NCT02949934|593157368|FG004|Natural Drinking Period|Lost to Follow-up|1|||
164216158|NCT02949934|593157369|FG005|Natural Drinking Period|Lost to Follow-up|0|||
164216159|NCT02949934|593157364|FG000|Neuroimaging|Protocol Violation|2|||
164216160|NCT02949934|593157365|FG001|Neuroimaging|Protocol Violation|0|||
164216161|NCT02949934|593157366|FG002|Neuroimaging|Protocol Violation|0|||
164216162|NCT02949934|593157367|FG003|Neuroimaging|Protocol Violation|0|||
164216163|NCT02949934|593157368|FG004|Neuroimaging|Protocol Violation|1|||
164326257|NCT01423604|593570170|FG000|Randomized|Adverse Event|4|||
164326258|NCT01423604|593570171|FG001|Randomized|Adverse Event|10|||
164216164|NCT02949934|593157369|FG005|Neuroimaging|Protocol Violation|0|||
164326259|NCT01423604|593570170|FG000|Randomized|Death|1|||
164326260|NCT01423604|593570171|FG001|Randomized|Death|0|||
164216165|NCT02949934|593157364|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
164216166|NCT02949934|593157365|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
164216167|NCT02949934|593157366|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
164216168|NCT02949934|593157367|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
164216169|NCT02949934|593157368|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
164216170|NCT02949934|593157369|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
164216171|NCT02949934|593157364|FG000|Neuroimaging|Not scanned|0|||
164216172|NCT02949934|593157365|FG001|Neuroimaging|Not scanned|0|||
164216173|NCT02949934|593157366|FG002|Neuroimaging|Not scanned|1|||
164216174|NCT02949934|593157367|FG003|Neuroimaging|Not scanned|0|||
164216175|NCT02949934|593157368|FG004|Neuroimaging|Not scanned|0|||
164216176|NCT02949934|593157369|FG005|Neuroimaging|Not scanned|2|||
164216177|NCT02949934|593157364|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
164216178|NCT02949934|593157365|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
164216179|NCT02949934|593157366|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
164216180|NCT02949934|593157367|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
164216181|NCT02949934|593157368|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
164216182|NCT02949934|593157369|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
164216183|NCT02949934|593157364|FG000|Bar Laboratory|Adverse Event|1|||
164216184|NCT02949934|593157365|FG001|Bar Laboratory|Adverse Event|0|||
164216185|NCT02949934|593157366|FG002|Bar Laboratory|Adverse Event|2|||
164216186|NCT02949934|593157367|FG003|Bar Laboratory|Adverse Event|0|||
164216187|NCT02949934|593157368|FG004|Bar Laboratory|Adverse Event|1|||
164216188|NCT02949934|593157369|FG005|Bar Laboratory|Adverse Event|0|||
164216189|NCT02949934|593157364|FG000|Bar Laboratory|Protocol Violation|0|||
164216190|NCT02949934|593157365|FG001|Bar Laboratory|Protocol Violation|0|||
164216191|NCT02949934|593157366|FG002|Bar Laboratory|Protocol Violation|0|||
164216192|NCT02949934|593157367|FG003|Bar Laboratory|Protocol Violation|1|||
164216193|NCT02949934|593157368|FG004|Bar Laboratory|Protocol Violation|0|||
164216194|NCT02949934|593157369|FG005|Bar Laboratory|Protocol Violation|0|||
164216195|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
164216196|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
164216197|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
164216198|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
164216199|NCT00849472|593157371|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
164216200|NCT00849472|593157371|FG000|Weekly Paclitaxel|Disease Progression|1|||
164216201|NCT00849472|593157371|FG000|Weekly Paclitaxel|Adverse Event|11|||
164216202|NCT00849472|593157371|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
164216203|NCT00849472|593157371|FG000|Weekly Paclitaxel|Physician Decision|3|||
164216204|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
164216205|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
163981313|NCT02469090|592302670|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
164216206|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
164216207|NCT00849472|593157371|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
164216208|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
164216209|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
164216210|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
164216211|NCT00849472|593157371|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
164216212|NCT05887401|593157374|FG000|Overall Study|Withdrawal by Subject|0|||
164216213|NCT05887401|593157375|FG001|Overall Study|Withdrawal by Subject|0|||
164216214|NCT05887401|593157376|FG002|Overall Study|Withdrawal by Subject|0|||
164216215|NCT05887401|593157377|FG003|Overall Study|Withdrawal by Subject|0|||
164216216|NCT05887401|593157378|FG004|Overall Study|Withdrawal by Subject|0|||
164216217|NCT05887401|593157379|FG005|Overall Study|Withdrawal by Subject|0|||
164216218|NCT05887401|593157380|FG006|Overall Study|Withdrawal by Subject|0|||
164216219|NCT05887401|593157381|FG007|Overall Study|Withdrawal by Subject|0|||
164216220|NCT05887401|593157382|FG008|Overall Study|Withdrawal by Subject|0|||
164216221|NCT05887401|593157383|FG009|Overall Study|Withdrawal by Subject|1|||
164216222|NCT05887401|593157384|FG010|Overall Study|Withdrawal by Subject|0|||
164216223|NCT05887401|593157385|FG011|Overall Study|Withdrawal by Subject|0|||
164216224|NCT05887401|593157386|FG012|Overall Study|Withdrawal by Subject|0|||
164216225|NCT05887401|593157387|FG013|Overall Study|Withdrawal by Subject|0|||
164216226|NCT05887401|593157388|FG014|Overall Study|Withdrawal by Subject|0|||
164216227|NCT05887401|593157389|FG015|Overall Study|Withdrawal by Subject|1|||
164216228|NCT05887401|593157374|FG000|Overall Study|Lost to Follow-up|0|||
164216229|NCT05887401|593157375|FG001|Overall Study|Lost to Follow-up|1|||
164216230|NCT05887401|593157376|FG002|Overall Study|Lost to Follow-up|1|||
164216231|NCT05887401|593157377|FG003|Overall Study|Lost to Follow-up|2|||
164216232|NCT05887401|593157378|FG004|Overall Study|Lost to Follow-up|0|||
164216233|NCT05887401|593157379|FG005|Overall Study|Lost to Follow-up|0|||
164216234|NCT05887401|593157380|FG006|Overall Study|Lost to Follow-up|0|||
163981314|NCT02469090|592302671|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
164216235|NCT05887401|593157381|FG007|Overall Study|Lost to Follow-up|0|||
164216236|NCT05887401|593157382|FG008|Overall Study|Lost to Follow-up|1|||
164216237|NCT05887401|593157383|FG009|Overall Study|Lost to Follow-up|1|||
164216238|NCT05887401|593157384|FG010|Overall Study|Lost to Follow-up|2|||
164216239|NCT05887401|593157385|FG011|Overall Study|Lost to Follow-up|1|||
164216240|NCT05887401|593157386|FG012|Overall Study|Lost to Follow-up|0|||
164216241|NCT05887401|593157387|FG013|Overall Study|Lost to Follow-up|0|||
164216242|NCT05887401|593157388|FG014|Overall Study|Lost to Follow-up|0|||
164216243|NCT05887401|593157389|FG015|Overall Study|Lost to Follow-up|0|||
164326261|NCT01423604|593570170|FG000|Randomized|Physician Decision|16|||
164326262|NCT01423604|593570171|FG001|Randomized|Physician Decision|13|||
164326263|NCT01423604|593570170|FG000|Randomized|Other - unspecified|37|||
164326264|NCT01423604|593570171|FG001|Randomized|Other - unspecified|31|||
164326265|NCT01423604|593570170|FG000|Randomized|Patient decision|5|||
164326266|NCT01423604|593570171|FG001|Randomized|Patient decision|9|||
164326267|NCT06785857|593570186|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
164326268|NCT06785857|593570187|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
164326269|NCT05952401|593570195|FG000|Overall Study|Lost to Follow-up|4|||
164326270|NCT05952401|593570196|FG001|Overall Study|Lost to Follow-up|1|||
164326271|NCT00543855|593571476|FG000|Overall Study|Adverse Event|3|||
164326272|NCT00543855|593571477|FG001|Overall Study|Adverse Event|1|||
164326273|NCT00543855|593571478|FG002|Overall Study|Adverse Event|3|||
164326274|NCT00543855|593571479|FG003|Overall Study|Adverse Event|4|||
164326275|NCT00543855|593571476|FG000|Overall Study|Lost to Follow-up|0|||
164326276|NCT00543855|593571477|FG001|Overall Study|Lost to Follow-up|0|||
164326277|NCT00543855|593571478|FG002|Overall Study|Lost to Follow-up|1|||
164326278|NCT00543855|593571479|FG003|Overall Study|Lost to Follow-up|0|||
164326279|NCT00543855|593571476|FG000|Overall Study|Withdrawal by Subject|0|||
164326280|NCT00543855|593571477|FG001|Overall Study|Withdrawal by Subject|1|||
164326281|NCT00543855|593571478|FG002|Overall Study|Withdrawal by Subject|2|||
164326282|NCT00543855|593571479|FG003|Overall Study|Withdrawal by Subject|0|||
164326283|NCT00543855|593571476|FG000|Overall Study|Protocol Violation|1|||
164326284|NCT00543855|593571477|FG001|Overall Study|Protocol Violation|0|||
164326285|NCT00543855|593571478|FG002|Overall Study|Protocol Violation|0|||
164326286|NCT00543855|593571479|FG003|Overall Study|Protocol Violation|0|||
164326287|NCT01994590|593571483|FG000|Overall Study|Adverse Event|1|||
164326288|NCT01994590|593571483|FG000|Overall Study|Trial Terminated|1|||
164326289|NCT00096954|593571487|FG000|Overall Study|Adverse Event|3|||
164326290|NCT00096954|593571488|FG001|Overall Study|Adverse Event|1|||
164326291|NCT00096954|593571487|FG000|Overall Study|Withdrawal by Subject|9|||
164326292|NCT00096954|593571488|FG001|Overall Study|Withdrawal by Subject|8|||
164326293|NCT00096954|593571487|FG000|Overall Study|Physician Decision|1|||
164326294|NCT00096954|593571488|FG001|Overall Study|Physician Decision|1|||
164326295|NCT00096954|593571487|FG000|Overall Study|Sponsors Decision|1|||
164326296|NCT00096954|593571488|FG001|Overall Study|Sponsors Decision|1|||
164326297|NCT00096954|593571487|FG000|Overall Study|Pregnancy|1|||
164326298|NCT00096954|593571488|FG001|Overall Study|Pregnancy|1|||
164326299|NCT00096954|593571487|FG000|Overall Study|Initiation of immunotherapy|1|||
164326300|NCT00096954|593571488|FG001|Overall Study|Initiation of immunotherapy|0|||
164326301|NCT00096954|593571487|FG000|Overall Study|Non-compliance|0|||
164326302|NCT00096954|593571488|FG001|Overall Study|Non-compliance|3|||
164216244|NCT04530526|593157390|FG000|Overall Study|Withdrawal by Subject|6|||
164216245|NCT05942040|593157391|FG000|Overall Study|No longer employed at study site.|0|||
164216246|NCT05942040|593157392|FG001|Overall Study|No longer employed at study site.|0|||
164216247|NCT05942040|593157393|FG002|Overall Study|No longer employed at study site.|3|||
164216248|NCT03442569|593157394|FG000|Overall Study|Subject was ineligible after enrollment|1|||
164216249|NCT06461455|593157395|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
164216250|NCT06461455|593157396|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
164216251|NCT06461455|593157395|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
164216252|NCT06461455|593157396|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
164216253|NCT06461455|593157395|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
164216254|NCT06461455|593157396|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
164216255|NCT06142383|593157397|FG000|Overall Study|Mis-randomized|0|||
164216256|NCT06142383|593157398|FG001|Overall Study|Mis-randomized|0|||
164216257|NCT06142383|593157399|FG002|Overall Study|Mis-randomized|1|||
164216258|NCT06142383|593157400|FG003|Overall Study|Mis-randomized|0|||
164216259|NCT06142383|593157401|FG004|Overall Study|Mis-randomized|0|||
164326303|NCT00096954|593571487|FG000|Overall Study|Lost to Follow-up|8|||
164326304|NCT00096954|593571488|FG001|Overall Study|Lost to Follow-up|5|||
164326305|NCT00719264|593571489|FG000|Overall Study|Adverse Event|41|||
164326306|NCT00719264|593571490|FG001|Overall Study|Adverse Event|49|||
164326307|NCT00719264|593571489|FG000|Overall Study|Death|13|||
164326308|NCT00719264|593571490|FG001|Overall Study|Death|10|||
164326309|NCT00719264|593571489|FG000|Overall Study|Administrative Problems|6|||
164326310|NCT00719264|593571490|FG001|Overall Study|Administrative Problems|4|||
164326311|NCT00719264|593571489|FG000|Overall Study|Lost to Follow-up|1|||
164326312|NCT00719264|593571490|FG001|Overall Study|Lost to Follow-up|1|||
164326313|NCT00719264|593571489|FG000|Overall Study|Withdrawal by Subject|12|||
164326314|NCT00719264|593571490|FG001|Overall Study|Withdrawal by Subject|7|||
164326315|NCT00719264|593571489|FG000|Overall Study|Protocol Deviation|1|||
164326316|NCT00719264|593571490|FG001|Overall Study|Protocol Deviation|3|||
164326317|NCT00719264|593571489|FG000|Overall Study|New Cancer Therapy|4|||
164326318|NCT00719264|593571490|FG001|Overall Study|New Cancer Therapy|2|||
164326319|NCT00719264|593571489|FG000|Overall Study|Disease Progression|104|||
164326320|NCT00719264|593571490|FG001|Overall Study|Disease Progression|107|||
164326321|NCT01277042|593571491|FG000|Overall Study|Adverse Event|4|||
164326322|NCT01277042|593571492|FG001|Overall Study|Adverse Event|3|||
164216260|NCT06142383|593157397|FG000|Overall Study|Adverse Event|0|||
164216261|NCT06142383|593157398|FG001|Overall Study|Adverse Event|1|||
164216262|NCT06142383|593157399|FG002|Overall Study|Adverse Event|1|||
164216263|NCT06142383|593157400|FG003|Overall Study|Adverse Event|0|||
164216264|NCT06142383|593157401|FG004|Overall Study|Adverse Event|0|||
164216265|NCT06142383|593157397|FG000|Overall Study|Death|0|||
164216266|NCT06142383|593157398|FG001|Overall Study|Death|1|||
164216267|NCT06142383|593157399|FG002|Overall Study|Death|3|||
164216268|NCT06142383|593157400|FG003|Overall Study|Death|0|||
164216269|NCT06142383|593157401|FG004|Overall Study|Death|1|||
164216270|NCT06142383|593157397|FG000|Overall Study|Study Terminated by Sponsor|20|||
164216271|NCT06142383|593157398|FG001|Overall Study|Study Terminated by Sponsor|17|||
164216272|NCT06142383|593157399|FG002|Overall Study|Study Terminated by Sponsor|33|||
164216273|NCT06142383|593157400|FG003|Overall Study|Study Terminated by Sponsor|0|||
164216274|NCT06142383|593157401|FG004|Overall Study|Study Terminated by Sponsor|21|||
164216275|NCT06142383|593157397|FG000|Overall Study|Subject Decision|0|||
164216276|NCT06142383|593157398|FG001|Overall Study|Subject Decision|1|||
164216277|NCT06142383|593157399|FG002|Overall Study|Subject Decision|2|||
164216278|NCT06142383|593157400|FG003|Overall Study|Subject Decision|0|||
164216279|NCT06142383|593157401|FG004|Overall Study|Subject Decision|0|||
164216280|NCT05800145|593157402|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
164216281|NCT05800145|593157403|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216282|NCT05800145|593157404|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216283|NCT05800145|593157405|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
164216284|NCT05800145|593157406|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216285|NCT05800145|593157407|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164216286|NCT05800145|593157402|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
164216287|NCT05800145|593157403|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216288|NCT05800145|593157404|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216289|NCT05800145|593157405|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
164216290|NCT05800145|593157406|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216291|NCT05800145|593157407|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
164216292|NCT05800145|593157402|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
164216293|NCT05800145|593157403|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
164216294|NCT05800145|593157404|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
164216295|NCT05800145|593157405|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
164216296|NCT05800145|593157406|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
164216297|NCT05800145|593157407|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
164216298|NCT04827446|593159067|FG000|Overall Study|Lost to Follow-up|1|||
164216299|NCT04827446|593159068|FG001|Overall Study|Lost to Follow-up|1|||
164216300|NCT04827446|593159067|FG000|Overall Study|Death|2|||
164216301|NCT04827446|593159068|FG001|Overall Study|Death|0|||
164216302|NCT04827446|593159067|FG000|Overall Study|Withdrawal by Subject|2|||
164216303|NCT04827446|593159068|FG001|Overall Study|Withdrawal by Subject|2|||
164216304|NCT04706403|593159069|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
164216305|NCT04706403|593159070|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
164216306|NCT04706403|593159071|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
164216307|NCT04706403|593159072|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
164216308|NCT04706403|593159073|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
164216309|NCT02642679|593159074|FG000|Overall Study|Withdrawal by Subject|1|||
164216310|NCT02642679|593159074|FG000|Overall Study|Physician Decision|1|||
164216311|NCT02642679|593159074|FG000|Overall Study|Physician Decision|1|||
164216312|NCT05206604|593159075|FG000|Overall Study|Non-compliance with study drug|0|||
164216313|NCT05206604|593159076|FG001|Overall Study|Non-compliance with study drug|0|||
164216314|NCT05206604|593159077|FG002|Overall Study|Non-compliance with study drug|0|||
164216315|NCT05206604|593159078|FG003|Overall Study|Non-compliance with study drug|0|||
164216316|NCT05206604|593159079|FG004|Overall Study|Non-compliance with study drug|0|||
164216317|NCT05206604|593159080|FG005|Overall Study|Non-compliance with study drug|1|||
164216318|NCT05206604|593159081|FG006|Overall Study|Non-compliance with study drug|0|||
164216319|NCT05206604|593159082|FG007|Overall Study|Non-compliance with study drug|0|||
164216320|NCT03735498|593159083|FG000|Overall Study|Withdrawal by Subject|3|||
164216321|NCT03735498|593159083|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
164216322|NCT00160615|593159085|FG000|Overall Study|Adverse Event|5|||
164216323|NCT00160615|593159086|FG001|Overall Study|Adverse Event|12|||
164216324|NCT00160615|593159085|FG000|Overall Study|Withdrawal by Subject|0|||
164216325|NCT00160615|593159086|FG001|Overall Study|Withdrawal by Subject|2|||
164216326|NCT00160615|593159085|FG000|Overall Study|Lack of Efficacy|11|||
164216327|NCT00160615|593159086|FG001|Overall Study|Lack of Efficacy|23|||
164216328|NCT00160615|593159085|FG000|Overall Study|Patient decision|1|||
164216329|NCT00160615|593159086|FG001|Overall Study|Patient decision|2|||
164216330|NCT00160615|593159085|FG000|Overall Study|Investigator decision|1|||
164216331|NCT00160615|593159086|FG001|Overall Study|Investigator decision|1|||
164216332|NCT00160615|593159085|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
164216333|NCT00160615|593159086|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
164216334|NCT00160615|593159085|FG000|Overall Study|Switch to surgical treatment|0|||
164216335|NCT00160615|593159086|FG001|Overall Study|Switch to surgical treatment|2|||
164216336|NCT00160615|593159085|FG000|Overall Study|Non-compliance was suspected|0|||
164216337|NCT00160615|593159086|FG001|Overall Study|Non-compliance was suspected|1|||
164216338|NCT00160615|593159085|FG000|Overall Study|Poor compliance|0|||
164216339|NCT00160615|593159086|FG001|Overall Study|Poor compliance|1|||
164216340|NCT05638737|593159087|FG000|Overall Study|Withdrawal by Subject|4|||
164216341|NCT05638737|593159088|FG001|Overall Study|Withdrawal by Subject|7|||
164216342|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216343|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
164216344|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216345|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216346|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216347|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
164216348|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
164216349|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216350|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216351|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216352|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216353|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
164216354|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
164216355|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216356|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216357|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216358|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216359|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
164216360|NCT03928704|593159093|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
164216361|NCT03928704|593159094|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
164216362|NCT03928704|593159095|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216363|NCT03928704|593159096|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216364|NCT03928704|593159097|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216365|NCT03928704|593159098|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
164216366|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216367|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216368|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
164216369|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216370|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216371|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
164216372|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216373|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216374|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
164216375|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216376|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216377|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
164216378|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
164216379|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
164216380|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
164216381|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
164216382|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
164216383|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
164216384|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216385|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216386|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
164216387|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216388|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216389|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
164216390|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216391|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216392|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216393|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164216394|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
164326323|NCT01277042|593571491|FG000|Overall Study|Lost to Follow-up|2|||
163876728|NCT04766034|591917021|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
163876729|NCT04766034|591917022|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
163876730|NCT04766034|591917018|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
163876731|NCT04766034|591917019|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
163876732|NCT04766034|591917020|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
163876733|NCT04766034|591917021|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
163876734|NCT04766034|591917022|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
163876735|NCT03398148|591918867|FG000|Substudy 1 Period 1|Adverse Event|5|||
163876736|NCT03398148|591918868|FG001|Substudy 1 Period 1|Adverse Event|2|||
163876737|NCT03398148|591918869|FG002|Substudy 1 Period 1|Adverse Event|2|||
163876738|NCT03398148|591918870|FG003|Substudy 1 Period 1|Adverse Event|0|||
163876739|NCT03398148|591918871|FG004|Substudy 1 Period 1|Adverse Event|8|||
164216395|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
164326324|NCT01277042|593571492|FG001|Overall Study|Lost to Follow-up|2|||
163876740|NCT03398148|591918872|FG005|Substudy 1 Period 1|Adverse Event|0|||
163876741|NCT03398148|591918873|FG006|Substudy 1 Period 1|Adverse Event|0|||
163876742|NCT03398148|591918874|FG007|Substudy 1 Period 1|Adverse Event|0|||
163876743|NCT03398148|591918875|FG008|Substudy 1 Period 1|Adverse Event|0|||
163876744|NCT03398148|591918876|FG009|Substudy 1 Period 1|Adverse Event|0|||
163876745|NCT03398148|591918877|FG010|Substudy 1 Period 1|Adverse Event|0|||
163876746|NCT03398148|591918878|FG011|Substudy 1 Period 1|Adverse Event|0|||
163876747|NCT03398148|591918879|FG012|Substudy 1 Period 1|Adverse Event|0|||
163876748|NCT03398148|591918880|FG013|Substudy 1 Period 1|Adverse Event|0|||
163876749|NCT03398148|591918881|FG014|Substudy 1 Period 1|Adverse Event|0|||
163876750|NCT03398148|591918867|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
163876751|NCT03398148|591918868|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
163876752|NCT03398148|591918869|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876753|NCT03398148|591918870|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
163876754|NCT03398148|591918871|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
163876755|NCT03398148|591918872|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876756|NCT03398148|591918873|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876757|NCT03398148|591918874|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876758|NCT03398148|591918875|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876759|NCT03398148|591918876|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876760|NCT03398148|591918877|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876761|NCT03398148|591918878|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876762|NCT03398148|591918879|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876763|NCT03398148|591918880|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876764|NCT03398148|591918881|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
163876765|NCT03398148|591918867|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
163876766|NCT03398148|591918868|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
163876767|NCT03398148|591918869|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
163876768|NCT03398148|591918870|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
163876769|NCT03398148|591918871|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
163876770|NCT03398148|591918872|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
163876771|NCT03398148|591918873|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
163876772|NCT03398148|591918874|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
163876773|NCT03398148|591918875|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
163876774|NCT03398148|591918876|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
163876775|NCT03398148|591918877|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
163876776|NCT03398148|591918878|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
163876777|NCT03398148|591918879|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
163876778|NCT03398148|591918880|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
163876779|NCT03398148|591918881|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
163876780|NCT03398148|591918867|FG000|Substudy 1 Period 1|Other|0|||
163876781|NCT03398148|591918868|FG001|Substudy 1 Period 1|Other|1|||
163876782|NCT03398148|591918869|FG002|Substudy 1 Period 1|Other|0|||
163876783|NCT03398148|591918870|FG003|Substudy 1 Period 1|Other|0|||
163876784|NCT03398148|591918871|FG004|Substudy 1 Period 1|Other|3|||
163876785|NCT03398148|591918872|FG005|Substudy 1 Period 1|Other|0|||
163876786|NCT03398148|591918873|FG006|Substudy 1 Period 1|Other|0|||
163876787|NCT03398148|591918874|FG007|Substudy 1 Period 1|Other|0|||
163876788|NCT03398148|591918875|FG008|Substudy 1 Period 1|Other|0|||
163876789|NCT03398148|591918876|FG009|Substudy 1 Period 1|Other|0|||
163876790|NCT03398148|591918877|FG010|Substudy 1 Period 1|Other|0|||
163876791|NCT03398148|591918878|FG011|Substudy 1 Period 1|Other|0|||
163876792|NCT03398148|591918879|FG012|Substudy 1 Period 1|Other|0|||
163876793|NCT03398148|591918880|FG013|Substudy 1 Period 1|Other|0|||
163876794|NCT03398148|591918881|FG014|Substudy 1 Period 1|Other|0|||
163876795|NCT03398148|591918867|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876796|NCT03398148|591918868|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876797|NCT03398148|591918869|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876798|NCT03398148|591918870|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
164216396|NCT03928704|593159093|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216397|NCT03928704|593159094|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216398|NCT03928704|593159095|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216399|NCT03928704|593159096|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216400|NCT03928704|593159097|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
164216401|NCT03928704|593159098|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
164216402|NCT00327171|593159101|FG000|Overall Study|Did not receive study medication|3|||
164216403|NCT00327171|593159102|FG001|Overall Study|Did not receive study medication|0|||
164216404|NCT00327171|593159101|FG000|Overall Study|Adverse Event|23|||
164216405|NCT00327171|593159102|FG001|Overall Study|Adverse Event|23|||
164216406|NCT00327171|593159101|FG000|Overall Study|Disease progression/lack of efficacy|68|||
164216407|NCT00327171|593159102|FG001|Overall Study|Disease progression/lack of efficacy|69|||
164216408|NCT00327171|593159101|FG000|Overall Study|Investigator/participant request|1|||
164216409|NCT00327171|593159102|FG001|Overall Study|Investigator/participant request|8|||
164216410|NCT00327171|593159101|FG000|Overall Study|Clinical progression|12|||
164216411|NCT00327171|593159102|FG001|Overall Study|Clinical progression|8|||
164216412|NCT00327171|593159101|FG000|Overall Study|Undisclosed history of ischemia|0|||
164216413|NCT00327171|593159102|FG001|Overall Study|Undisclosed history of ischemia|1|||
164216414|NCT00327171|593159101|FG000|Overall Study|Other|1|||
164216415|NCT00327171|593159102|FG001|Overall Study|Other|0|||
164216416|NCT01363440|593159103|FG000|Overall Study|Adverse Event|5|||
164216417|NCT01363440|593159104|FG001|Overall Study|Adverse Event|4|||
164216418|NCT01363440|593159105|FG002|Overall Study|Adverse Event|4|||
164216419|NCT01363440|593159103|FG000|Overall Study|Death|3|||
164216420|NCT01363440|593159104|FG001|Overall Study|Death|7|||
164216421|NCT01363440|593159105|FG002|Overall Study|Death|5|||
164216422|NCT01363440|593159103|FG000|Overall Study|Withdrawal by Subject|9|||
164216423|NCT01363440|593159104|FG001|Overall Study|Withdrawal by Subject|11|||
164216424|NCT01363440|593159105|FG002|Overall Study|Withdrawal by Subject|11|||
164216425|NCT01363440|593159103|FG000|Overall Study|Lost to Follow-up|2|||
164216426|NCT01363440|593159104|FG001|Overall Study|Lost to Follow-up|4|||
164216427|NCT01363440|593159105|FG002|Overall Study|Lost to Follow-up|5|||
164216428|NCT01363440|593159103|FG000|Overall Study|Other|4|||
164216429|NCT01363440|593159104|FG001|Overall Study|Other|5|||
164216430|NCT01363440|593159105|FG002|Overall Study|Other|2|||
164216431|NCT00992836|593159106|FG000|Overall Study|Lost to Follow-up|1|||
164216432|NCT00992836|593159106|FG000|Overall Study|Withdrawal by Subject|2|||
164216433|NCT00992836|593159106|FG000|Overall Study|Protocol Violation|2|||
164216434|NCT00266812|593159107|FG000|Overall Study|Disease Progression|9|||
164216435|NCT00266812|593159108|FG001|Overall Study|Disease Progression|3|||
164216436|NCT00266812|593159107|FG000|Overall Study|Death|5|||
164216437|NCT00266812|593159108|FG001|Overall Study|Death|4|||
164216438|NCT00266812|593159107|FG000|Overall Study|Adverse Event|3|||
164216439|NCT00266812|593159108|FG001|Overall Study|Adverse Event|1|||
164216440|NCT00266812|593159107|FG000|Overall Study|Protocol Violation|0|||
164216441|NCT00266812|593159108|FG001|Overall Study|Protocol Violation|1|||
164216442|NCT00266812|593159107|FG000|Overall Study|Withdrawal by Subject|0|||
164216443|NCT00266812|593159108|FG001|Overall Study|Withdrawal by Subject|2|||
164216444|NCT00266812|593159107|FG000|Overall Study|Discontinued before starting study drug|4|||
164216445|NCT00266812|593159108|FG001|Overall Study|Discontinued before starting study drug|0|||
164216446|NCT03695094|593159109|FG000|Overall Study|Adverse Event|1|||
164216447|NCT03695094|593159110|FG001|Overall Study|Adverse Event|1|||
164216448|NCT03695094|593159109|FG000|Overall Study|Withdrawal by Subject|1|||
164216449|NCT03695094|593159110|FG001|Overall Study|Withdrawal by Subject|0|||
164216450|NCT00530075|593159111|FG000|Overall Study|Adverse Event|1|||
164216451|NCT00530075|593159111|FG000|Overall Study|Death|1|||
164216452|NCT00530075|593159111|FG000|Overall Study|Lack of Efficacy|3|||
164216453|NCT00530075|593159111|FG000|Overall Study|Protocol Violation|1|||
164216454|NCT00530075|593159111|FG000|Overall Study|Withdrawal by Subject|1|||
164216455|NCT00416949|593159114|FG000|Overall Study|Patients refused to participate|5|||
164216456|NCT01166945|593159115|FG000|Randomized|diagnosed with Group A strep|4|||
164216457|NCT01166945|593159116|FG001|Randomized|diagnosed with Group A strep|4|||
164216458|NCT01166945|593159115|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
164216459|NCT01166945|593159116|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
164216460|NCT01166945|593159115|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
163876799|NCT03398148|591918871|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
164078147|NCT02092961|592651495|FG000|Overall Study|Study stopped|13|||
164216461|NCT01166945|593159116|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
164216462|NCT01166945|593159115|FG000|Day 30|Lost to Follow-up|4|||
164216463|NCT01166945|593159116|FG001|Day 30|Lost to Follow-up|3|||
164216464|NCT03520569|593159121|FG000|Overall Study|Withdrawal by Subject|1|||
164216465|NCT01178411|593159122|FG000|Overall Study|Adverse Event|5|||
164216466|NCT01178411|593159122|FG000|Overall Study|Withdrawal by Subject|4|||
164216467|NCT01178411|593159122|FG000|Overall Study|Protocol Violation|1|||
164216468|NCT01178411|593159122|FG000|Overall Study|Progressive disease per RECIST|32|||
164216469|NCT01178411|593159122|FG000|Overall Study|Progressive disease per clinician|9|||
164216470|NCT01178411|593159122|FG000|Overall Study|Physician Decision|6|||
164216471|NCT01178411|593159122|FG000|Overall Study|Death|1|||
164216472|NCT01178411|593159122|FG000|Overall Study|No reason provided|1|||
164216473|NCT01178411|593159122|FG000|Overall Study|Drug manufacturing ended|1|||
164216474|NCT00784927|593159123|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
164216475|NCT00784927|593159123|FG000|Overall Study|Protocol Violation|1|||
164216476|NCT00784927|593159123|FG000|Overall Study|Ineligible|1|||
164216477|NCT01471574|593159126|FG000|Treatment Period|Lack of Efficacy|12|||
164216478|NCT01471574|593159127|FG001|Treatment Period|Lack of Efficacy|4|||
164326325|NCT01277042|593571491|FG000|Overall Study|Withdrawal by Subject|2|||
164326326|NCT01277042|593571492|FG001|Overall Study|Withdrawal by Subject|0|||
164326327|NCT03581786|593571499|FG000|Overall Study|Death|67|||
164326328|NCT03581786|593571500|FG001|Overall Study|Death|47|||
164326329|NCT03581786|593571499|FG000|Overall Study|Withdrawal by Subject|2|||
164326330|NCT03581786|593571500|FG001|Overall Study|Withdrawal by Subject|5|||
164326331|NCT03581786|593571499|FG000|Overall Study|Lost to Follow-up|7|||
164326332|NCT03581786|593571500|FG001|Overall Study|Lost to Follow-up|4|||
164326333|NCT03581786|593571499|FG000|Overall Study|reason other than specified above|0|||
164326334|NCT03581786|593571500|FG001|Overall Study|reason other than specified above|1|||
164326335|NCT02469038|593571501|FG000|Overall Study|Physician Decision|4|||
164326336|NCT02469038|593571502|FG001|Overall Study|Physician Decision|5|||
164326337|NCT03435640|593571503|FG000|Overall Study|Withdrawal by Subject|0|||
164326338|NCT03435640|593571504|FG001|Overall Study|Withdrawal by Subject|1|||
164326339|NCT03435640|593571505|FG002|Overall Study|Withdrawal by Subject|0|||
164326340|NCT03435640|593571506|FG003|Overall Study|Withdrawal by Subject|2|||
164326341|NCT03435640|593571507|FG004|Overall Study|Withdrawal by Subject|0|||
164326342|NCT03435640|593571508|FG005|Overall Study|Withdrawal by Subject|0|||
164326343|NCT03435640|593571509|FG006|Overall Study|Withdrawal by Subject|3|||
164326344|NCT03435640|593571510|FG007|Overall Study|Withdrawal by Subject|0|||
164326345|NCT03435640|593571511|FG008|Overall Study|Withdrawal by Subject|0|||
164326346|NCT03435640|593571512|FG009|Overall Study|Withdrawal by Subject|2|||
164326347|NCT03435640|593571513|FG010|Overall Study|Withdrawal by Subject|3|||
164326348|NCT03435640|593571503|FG000|Overall Study|Lost to Follow-up|0|||
164326349|NCT03435640|593571504|FG001|Overall Study|Lost to Follow-up|0|||
164326350|NCT03435640|593571505|FG002|Overall Study|Lost to Follow-up|1|||
164326351|NCT03435640|593571506|FG003|Overall Study|Lost to Follow-up|0|||
164326352|NCT03435640|593571507|FG004|Overall Study|Lost to Follow-up|0|||
164326353|NCT03435640|593571508|FG005|Overall Study|Lost to Follow-up|0|||
164326354|NCT03435640|593571509|FG006|Overall Study|Lost to Follow-up|0|||
164326355|NCT03435640|593571510|FG007|Overall Study|Lost to Follow-up|0|||
164326356|NCT03435640|593571511|FG008|Overall Study|Lost to Follow-up|0|||
164326357|NCT03435640|593571512|FG009|Overall Study|Lost to Follow-up|0|||
164326358|NCT03435640|593571513|FG010|Overall Study|Lost to Follow-up|0|||
164326359|NCT01347307|593571514|FG000|Overall Study|Death|0|||
164326360|NCT01347307|593571515|FG001|Overall Study|Death|4|||
164326361|NCT01347307|593571514|FG000|Overall Study|Physician Decision|0|||
164326362|NCT01347307|593571515|FG001|Overall Study|Physician Decision|1|||
164326363|NCT01483690|593571516|FG000|Overall Study|Adverse Event|1|||
164326364|NCT01483690|593571517|FG001|Overall Study|Adverse Event|2|||
164326365|NCT01483690|593571516|FG000|Overall Study|clinical deterioration|1|||
164326366|NCT01483690|593571517|FG001|Overall Study|clinical deterioration|0|||
164326367|NCT01483690|593571516|FG000|Overall Study|Physician Decision|0|||
164326368|NCT01483690|593571517|FG001|Overall Study|Physician Decision|2|||
164326369|NCT01483690|593571516|FG000|Overall Study|exclusionary procedure|0|||
164326370|NCT01483690|593571517|FG001|Overall Study|exclusionary procedure|1|||
164326371|NCT02239224|593571518|FG000|Overall Study|Administrative|0|||
163876800|NCT03398148|591918872|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876801|NCT03398148|591918873|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876802|NCT03398148|591918874|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876803|NCT03398148|591918875|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876804|NCT03398148|591918876|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876805|NCT03398148|591918877|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876806|NCT03398148|591918878|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
164326372|NCT02239224|593571519|FG001|Overall Study|Administrative|0|||
164326373|NCT02239224|593571520|FG002|Overall Study|Administrative|3|||
164326374|NCT02239224|593571521|FG003|Overall Study|Administrative|1|||
164326375|NCT04565236|593571526|FG000|Overall Study|Patient/Guardian Decision|0|||
164326376|NCT04565236|593571527|FG001|Overall Study|Patient/Guardian Decision|0|||
163876807|NCT03398148|591918879|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
164326377|NCT04565236|593571528|FG002|Overall Study|Patient/Guardian Decision|1|||
164326378|NCT04565236|593571529|FG003|Overall Study|Patient/Guardian Decision|0|||
164326379|NCT00366340|593571530|FG000|Infant Series|Protocol Violation|3|||
164326380|NCT00366340|593571531|FG001|Infant Series|Protocol Violation|4|||
164326381|NCT00366340|593571530|FG000|Infant Series|Withdrawal by Subject|3|||
164326382|NCT00366340|593571531|FG001|Infant Series|Withdrawal by Subject|3|||
164326383|NCT00366340|593571530|FG000|Infant Series|Adverse Event|0|||
164216479|NCT01471574|593159128|FG002|Treatment Period|Lack of Efficacy|14|||
164216480|NCT01471574|593159129|FG003|Treatment Period|Lack of Efficacy|1|||
164216481|NCT01471574|593159126|FG000|Treatment Period|Adverse Event|7|||
164326384|NCT00366340|593571531|FG001|Infant Series|Adverse Event|2|||
164326385|NCT00366340|593571530|FG000|Infant Series|Lost to Follow-up|1|||
164326386|NCT00366340|593571531|FG001|Infant Series|Lost to Follow-up|1|||
164326387|NCT00366340|593571530|FG000|Infant Series|Failure to return|1|||
164326388|NCT00366340|593571531|FG001|Infant Series|Failure to return|0|||
164326389|NCT00366340|593571530|FG000|After the Infant Series|Parent/legal guardian request|1|||
164326390|NCT00366340|593571531|FG001|After the Infant Series|Parent/legal guardian request|1|||
164326391|NCT00366340|593571530|FG000|After the Infant Series|Failed to return|0|||
164326392|NCT00366340|593571531|FG001|After the Infant Series|Failed to return|1|||
164326393|NCT00366340|593571530|FG000|After the Infant Series|Protocol Violation|2|||
164326394|NCT00366340|593571531|FG001|After the Infant Series|Protocol Violation|2|||
164326395|NCT00366340|593571530|FG000|After the Infant Series|Adverse Event|0|||
164326396|NCT00366340|593571531|FG001|After the Infant Series|Adverse Event|1|||
164326397|NCT00366340|593571530|FG000|After the Infant Series|Lost to Follow-up|0|||
164326398|NCT00366340|593571531|FG001|After the Infant Series|Lost to Follow-up|1|||
164326399|NCT00366340|593571530|FG000|Toddler Dose|Failed to return|1|||
164326400|NCT00366340|593571531|FG001|Toddler Dose|Failed to return|0|||
164326401|NCT00366340|593571530|FG000|Toddler Dose|Parent/legal guardian request|0|||
164326402|NCT00366340|593571531|FG001|Toddler Dose|Parent/legal guardian request|1|||
164326403|NCT00367770|593571532|FG000|Overall Study|Adverse Event|1|||
164326404|NCT00367770|593571532|FG000|Overall Study|Withdrawal by Subject|1|||
164326405|NCT03282565|593571537|FG000|Overall Study|COVID-19 Research Shutdown|0|||
164326406|NCT03282565|593571538|FG001|Overall Study|COVID-19 Research Shutdown|2|||
164326407|NCT03282565|593571539|FG002|Overall Study|COVID-19 Research Shutdown|2|||
164326408|NCT02011893|593571541|FG000|Enrollment to Randomization|Adverse Event|2|||
164326409|NCT02011893|593571542|FG001|Enrollment to Randomization|Adverse Event|0|||
164326410|NCT02011893|593571543|FG002|Enrollment to Randomization|Adverse Event|0|||
164326411|NCT02011893|593571541|FG000|Enrollment to Randomization|Physician Decision|10|||
164326412|NCT02011893|593571542|FG001|Enrollment to Randomization|Physician Decision|0|||
164326413|NCT02011893|593571543|FG002|Enrollment to Randomization|Physician Decision|0|||
164326414|NCT02011893|593571541|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
164326415|NCT02011893|593571542|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
164326416|NCT02011893|593571543|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
164326417|NCT02011893|593571541|FG000|Enrollment to Randomization|Screening Failure|29|||
164326418|NCT02011893|593571542|FG001|Enrollment to Randomization|Screening Failure|0|||
164326419|NCT02011893|593571543|FG002|Enrollment to Randomization|Screening Failure|0|||
164326420|NCT02011893|593571541|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
164326421|NCT02011893|593571542|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
164326422|NCT02011893|593571543|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
164326423|NCT02011893|593571541|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
164326424|NCT02011893|593571542|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
164326425|NCT02011893|593571543|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
164326426|NCT02011893|593571541|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
164326427|NCT02011893|593571542|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
164326428|NCT02011893|593571543|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
164326429|NCT02011893|593571541|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
164326430|NCT02011893|593571542|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
164326431|NCT02011893|593571543|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
164326432|NCT02011893|593571541|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
164326433|NCT02011893|593571542|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
164326434|NCT02011893|593571543|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
164326435|NCT00991952|593571544|FG000|Overall Study|Adverse Event|0|||
164326436|NCT00991952|593571545|FG001|Overall Study|Adverse Event|1|||
164326437|NCT03116347|593571546|FG000|Overall Study|Withdrawal by Subject|1|||
164326438|NCT03116347|593571547|FG001|Overall Study|Withdrawal by Subject|2|||
164326439|NCT01255787|593571548|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
164326440|NCT01255787|593571549|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
164326441|NCT01255787|593571550|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
164326442|NCT01255787|593571551|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
164326443|NCT01255787|593571548|FG000|Overall Study|Major Protocol Deviation|1|||
164326444|NCT01255787|593571549|FG001|Overall Study|Major Protocol Deviation|1|||
164326445|NCT01255787|593571550|FG002|Overall Study|Major Protocol Deviation|0|||
164326446|NCT01255787|593571551|FG003|Overall Study|Major Protocol Deviation|4|||
164326447|NCT01255787|593571548|FG000|Overall Study|Lost to Follow-up|1|||
164326448|NCT01255787|593571549|FG001|Overall Study|Lost to Follow-up|2|||
164326449|NCT01255787|593571550|FG002|Overall Study|Lost to Follow-up|4|||
164326450|NCT01255787|593571551|FG003|Overall Study|Lost to Follow-up|2|||
164326451|NCT01255787|593571548|FG000|Overall Study|Withdrawal of Consent|3|||
164326452|NCT01255787|593571549|FG001|Overall Study|Withdrawal of Consent|9|||
164326453|NCT01255787|593571550|FG002|Overall Study|Withdrawal of Consent|3|||
164326454|NCT01255787|593571551|FG003|Overall Study|Withdrawal of Consent|4|||
164326455|NCT01255787|593571548|FG000|Overall Study|Pregnancy|0|||
163981315|NCT02469090|592302672|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
164326456|NCT01255787|593571549|FG001|Overall Study|Pregnancy|0|||
164326457|NCT01255787|593571550|FG002|Overall Study|Pregnancy|0|||
164326458|NCT01255787|593571551|FG003|Overall Study|Pregnancy|1|||
163981316|NCT02469090|592302670|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
163981317|NCT02469090|592302671|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
163981318|NCT02469090|592302672|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
163981319|NCT02469090|592302670|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
163981320|NCT02469090|592302671|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
164326459|NCT01255787|593571548|FG000|Overall Study|Lack of Efficacy|2|||
164326460|NCT01255787|593571549|FG001|Overall Study|Lack of Efficacy|2|||
164326461|NCT01255787|593571550|FG002|Overall Study|Lack of Efficacy|2|||
164326462|NCT01255787|593571551|FG003|Overall Study|Lack of Efficacy|2|||
164326463|NCT01255787|593571548|FG000|Overall Study|Noncompliance with Study Drug|3|||
164326464|NCT01255787|593571549|FG001|Overall Study|Noncompliance with Study Drug|1|||
164326465|NCT01255787|593571550|FG002|Overall Study|Noncompliance with Study Drug|0|||
164326466|NCT01255787|593571551|FG003|Overall Study|Noncompliance with Study Drug|0|||
164326467|NCT04966741|593571552|FG000|Overall Study|Lost to Follow-up|1|||
164326468|NCT04966741|593571553|FG001|Overall Study|Lost to Follow-up|0|||
164326469|NCT05764265|593571556|FG000|Overall Study|Adverse Event|1|||
164326470|NCT05764265|593571557|FG001|Overall Study|Adverse Event|0|||
164326471|NCT05764265|593571556|FG000|Overall Study|Physician Decision|1|||
164326472|NCT05764265|593571557|FG001|Overall Study|Physician Decision|8|||
164326473|NCT05764265|593571556|FG000|Overall Study|Study Terminated By Sponsor|20|||
164326474|NCT05764265|593571557|FG001|Overall Study|Study Terminated By Sponsor|0|||
164326475|NCT05764265|593571556|FG000|Overall Study|Participant Decision|1|||
164326476|NCT05764265|593571557|FG001|Overall Study|Participant Decision|0|||
164326477|NCT00509262|593571558|FG000|Overall Study|Adverse Event|16|||
164326478|NCT00509262|593571559|FG001|Overall Study|Adverse Event|18|||
164326479|NCT00509262|593571558|FG000|Overall Study|Other|2|||
164326480|NCT00509262|593571559|FG001|Overall Study|Other|2|||
164326481|NCT00509262|593571558|FG000|Overall Study|Lack of Efficacy|1|||
164326482|NCT00509262|593571559|FG001|Overall Study|Lack of Efficacy|0|||
164326483|NCT00509262|593571558|FG000|Overall Study|Lost to Follow-up|1|||
164326484|NCT00509262|593571559|FG001|Overall Study|Lost to Follow-up|6|||
164326485|NCT00509262|593571558|FG000|Overall Study|Physician Decision|1|||
164326486|NCT00509262|593571559|FG001|Overall Study|Physician Decision|3|||
164326487|NCT00509262|593571558|FG000|Overall Study|Protocol Violation|2|||
164326488|NCT00509262|593571559|FG001|Overall Study|Protocol Violation|2|||
164326489|NCT00509262|593571558|FG000|Overall Study|Withdrawal by Subject|24|||
164326490|NCT00509262|593571559|FG001|Overall Study|Withdrawal by Subject|11|||
164326491|NCT00725842|593571560|FG000|Overall Study|Lost to Follow-up|19|||
164326492|NCT00725842|593571560|FG000|Overall Study|Death|1|||
164326493|NCT00725842|593571560|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
164326494|NCT00725842|593571560|FG000|Overall Study|Consent date prior to study start date|5|||
164326495|NCT00725842|593571560|FG000|Overall Study|Inclusion criterion not met|1|||
164326496|NCT00725842|593571560|FG000|Overall Study|No Visit 1 data|1|||
164326497|NCT02009384|593571564|FG000|Overall Study|Death|2|||
164326498|NCT01075191|593571565|FG000|Overall Study|Death|1|||
164326499|NCT01075191|593571565|FG000|Overall Study|Intensification|3|||
164326500|NCT01075191|593571565|FG000|Overall Study|Co-morbidities|1|||
164326501|NCT01075191|593571565|FG000|Overall Study|Adverse Event|4|||
164326502|NCT01075191|593571565|FG000|Overall Study|Noncompliance|3|||
164326503|NCT01075191|593571565|FG000|Overall Study|Therapy Break|3|||
164326504|NCT01075191|593571565|FG000|Overall Study|Patient's Wish|2|||
164326505|NCT01075191|593571565|FG000|Overall Study|Unknown Reasons|1|||
164326506|NCT01244490|593571570|FG000|Overall Study|Lack of Efficacy|14|||
164326507|NCT01244490|593571571|FG001|Overall Study|Lack of Efficacy|5|||
164326508|NCT01244490|593571572|FG002|Overall Study|Lack of Efficacy|5|||
164326509|NCT01244490|593571570|FG000|Overall Study|Withdrawal by Subject|4|||
164326510|NCT01244490|593571571|FG001|Overall Study|Withdrawal by Subject|4|||
164326511|NCT01244490|593571572|FG002|Overall Study|Withdrawal by Subject|9|||
164326512|NCT01244490|593571570|FG000|Overall Study|Adverse Event|1|||
164326513|NCT01244490|593571571|FG001|Overall Study|Adverse Event|9|||
164326514|NCT01244490|593571572|FG002|Overall Study|Adverse Event|5|||
164326515|NCT01244490|593571570|FG000|Overall Study|Lost to Follow-up|0|||
164326516|NCT01244490|593571571|FG001|Overall Study|Lost to Follow-up|6|||
164326517|NCT01244490|593571572|FG002|Overall Study|Lost to Follow-up|3|||
164326518|NCT01244490|593571570|FG000|Overall Study|Other|0|||
164326519|NCT01244490|593571571|FG001|Overall Study|Other|0|||
164326520|NCT01244490|593571572|FG002|Overall Study|Other|1|||
164326521|NCT02414139|593571577|FG000|Treatment Period|Adverse Event|11|||
164326522|NCT02414139|593571578|FG001|Treatment Period|Adverse Event|6|||
164326523|NCT02414139|593571579|FG002|Treatment Period|Adverse Event|8|||
164326524|NCT02414139|593571580|FG003|Treatment Period|Adverse Event|5|||
164326525|NCT02414139|593571581|FG004|Treatment Period|Adverse Event|14|||
164326526|NCT02414139|593571582|FG005|Treatment Period|Adverse Event|3|||
164326527|NCT02414139|593571583|FG006|Treatment Period|Adverse Event|6|||
164326528|NCT02414139|593571584|FG007|Treatment Period|Adverse Event|1|||
164326529|NCT02414139|593571585|FG008|Treatment Period|Adverse Event|6|||
164326530|NCT02414139|593571586|FG009|Treatment Period|Adverse Event|8|||
164326531|NCT02414139|593571577|FG000|Treatment Period|Death|0|||
164326532|NCT02414139|593571578|FG001|Treatment Period|Death|0|||
164326533|NCT02414139|593571579|FG002|Treatment Period|Death|1|||
164326534|NCT02414139|593571580|FG003|Treatment Period|Death|1|||
164326535|NCT02414139|593571581|FG004|Treatment Period|Death|0|||
164326536|NCT02414139|593571582|FG005|Treatment Period|Death|0|||
164326537|NCT02414139|593571583|FG006|Treatment Period|Death|0|||
164326538|NCT02414139|593571584|FG007|Treatment Period|Death|0|||
164326539|NCT02414139|593571585|FG008|Treatment Period|Death|0|||
164326540|NCT02414139|593571586|FG009|Treatment Period|Death|1|||
164326541|NCT02414139|593571577|FG000|Treatment Period|Physician Decision|5|||
164326542|NCT02414139|593571578|FG001|Treatment Period|Physician Decision|4|||
164326543|NCT02414139|593571579|FG002|Treatment Period|Physician Decision|6|||
164326544|NCT02414139|593571580|FG003|Treatment Period|Physician Decision|1|||
164326545|NCT02414139|593571581|FG004|Treatment Period|Physician Decision|4|||
164326546|NCT02414139|593571582|FG005|Treatment Period|Physician Decision|0|||
164326547|NCT02414139|593571583|FG006|Treatment Period|Physician Decision|2|||
164326548|NCT02414139|593571584|FG007|Treatment Period|Physician Decision|0|||
164326549|NCT02414139|593571585|FG008|Treatment Period|Physician Decision|1|||
164326550|NCT02414139|593571586|FG009|Treatment Period|Physician Decision|4|||
164326551|NCT02414139|593571577|FG000|Treatment Period|Progressive disease|48|||
164326552|NCT02414139|593571578|FG001|Treatment Period|Progressive disease|31|||
164326553|NCT02414139|593571579|FG002|Treatment Period|Progressive disease|37|||
164326554|NCT02414139|593571580|FG003|Treatment Period|Progressive disease|21|||
164326555|NCT02414139|593571581|FG004|Treatment Period|Progressive disease|43|||
164326556|NCT02414139|593571582|FG005|Treatment Period|Progressive disease|12|||
164326557|NCT02414139|593571583|FG006|Treatment Period|Progressive disease|16|||
164326558|NCT02414139|593571584|FG007|Treatment Period|Progressive disease|2|||
164326559|NCT02414139|593571585|FG008|Treatment Period|Progressive disease|20|||
164326560|NCT02414139|593571586|FG009|Treatment Period|Progressive disease|14|||
164326561|NCT02414139|593571577|FG000|Treatment Period|Protocol deviation|0|||
164326562|NCT02414139|593571578|FG001|Treatment Period|Protocol deviation|0|||
164326563|NCT02414139|593571579|FG002|Treatment Period|Protocol deviation|1|||
164326564|NCT02414139|593571580|FG003|Treatment Period|Protocol deviation|0|||
164326565|NCT02414139|593571581|FG004|Treatment Period|Protocol deviation|0|||
164326566|NCT02414139|593571582|FG005|Treatment Period|Protocol deviation|0|||
164326567|NCT02414139|593571583|FG006|Treatment Period|Protocol deviation|0|||
164326568|NCT02414139|593571584|FG007|Treatment Period|Protocol deviation|0|||
164326569|NCT02414139|593571585|FG008|Treatment Period|Protocol deviation|0|||
164326570|NCT02414139|593571586|FG009|Treatment Period|Protocol deviation|0|||
164326571|NCT02414139|593571577|FG000|Treatment Period|Subject/Guardian decision|5|||
164326572|NCT02414139|593571578|FG001|Treatment Period|Subject/Guardian decision|1|||
164326573|NCT02414139|593571579|FG002|Treatment Period|Subject/Guardian decision|1|||
164326574|NCT02414139|593571580|FG003|Treatment Period|Subject/Guardian decision|2|||
164326575|NCT02414139|593571581|FG004|Treatment Period|Subject/Guardian decision|5|||
164326576|NCT02414139|593571582|FG005|Treatment Period|Subject/Guardian decision|0|||
164326577|NCT02414139|593571583|FG006|Treatment Period|Subject/Guardian decision|2|||
164326578|NCT02414139|593571584|FG007|Treatment Period|Subject/Guardian decision|0|||
164326579|NCT02414139|593571585|FG008|Treatment Period|Subject/Guardian decision|1|||
164326580|NCT02414139|593571586|FG009|Treatment Period|Subject/Guardian decision|1|||
164326581|NCT02414139|593571577|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326582|NCT02414139|593571578|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326583|NCT02414139|593571579|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326584|NCT02414139|593571580|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326585|NCT02414139|593571581|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
164326586|NCT02414139|593571582|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326587|NCT02414139|593571583|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
164326588|NCT02414139|593571584|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
164326589|NCT02414139|593571585|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
164326590|NCT02414139|593571586|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
164326591|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
164326592|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326593|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326594|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326595|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
164326596|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326597|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326598|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326599|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164326600|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164078148|NCT02092961|592651496|FG001|Overall Study|Study stopped|9|||
164216482|NCT01471574|593159127|FG001|Treatment Period|Adverse Event|3|||
164216483|NCT01471574|593159128|FG002|Treatment Period|Adverse Event|6|||
164216484|NCT01471574|593159129|FG003|Treatment Period|Adverse Event|1|||
164216485|NCT01471574|593159126|FG000|Treatment Period|Withdrawal by Subject|5|||
164216486|NCT01471574|593159127|FG001|Treatment Period|Withdrawal by Subject|1|||
164078149|NCT02092961|592651497|FG002|Overall Study|Study stopped|12|||
164078150|NCT02092961|592651495|FG000|Overall Study|Lack of therapeutic response|2|||
164078151|NCT02092961|592651496|FG001|Overall Study|Lack of therapeutic response|1|||
164078152|NCT02092961|592651497|FG002|Overall Study|Lack of therapeutic response|3|||
164078153|NCT02092961|592651495|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
164216487|NCT01471574|593159128|FG002|Treatment Period|Withdrawal by Subject|1|||
164216488|NCT01471574|593159129|FG003|Treatment Period|Withdrawal by Subject|0|||
164216489|NCT01471574|593159126|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
164216490|NCT01471574|593159127|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
164216491|NCT01471574|593159128|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
164216492|NCT01471574|593159129|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
164216493|NCT01471574|593159126|FG000|Treatment Period|Lost to Follow-up|1|||
164216494|NCT01471574|593159127|FG001|Treatment Period|Lost to Follow-up|2|||
164216495|NCT01471574|593159128|FG002|Treatment Period|Lost to Follow-up|2|||
164216496|NCT01471574|593159129|FG003|Treatment Period|Lost to Follow-up|0|||
164216497|NCT01471574|593159126|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
164216498|NCT01471574|593159127|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
164216499|NCT01471574|593159128|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
164216500|NCT01471574|593159129|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
164216501|NCT01471574|593159126|FG000|Treatment Period|Other|1|||
164216502|NCT01471574|593159127|FG001|Treatment Period|Other|0|||
164216503|NCT01471574|593159128|FG002|Treatment Period|Other|0|||
164216504|NCT01471574|593159129|FG003|Treatment Period|Other|0|||
164216505|NCT01471574|593159126|FG000|Follow-up Period|Withdrawal by Subject|3|||
164216506|NCT01471574|593159127|FG001|Follow-up Period|Withdrawal by Subject|0|||
164216507|NCT01471574|593159128|FG002|Follow-up Period|Withdrawal by Subject|3|||
164216508|NCT01471574|593159129|FG003|Follow-up Period|Withdrawal by Subject|1|||
164216509|NCT01471574|593159126|FG000|Follow-up Period|Lost to Follow-up|4|||
164216510|NCT01471574|593159127|FG001|Follow-up Period|Lost to Follow-up|1|||
164216511|NCT01471574|593159128|FG002|Follow-up Period|Lost to Follow-up|3|||
164216512|NCT01471574|593159129|FG003|Follow-up Period|Lost to Follow-up|2|||
164216513|NCT01471574|593159126|FG000|Follow-up Period|Death|0|||
164216514|NCT01471574|593159127|FG001|Follow-up Period|Death|0|||
164216515|NCT01471574|593159128|FG002|Follow-up Period|Death|1|||
164216516|NCT01471574|593159129|FG003|Follow-up Period|Death|0|||
164216517|NCT01471574|593159126|FG000|Follow-up Period|Follow-up no longer required|0|||
164216518|NCT01471574|593159127|FG001|Follow-up Period|Follow-up no longer required|1|||
164216519|NCT01471574|593159128|FG002|Follow-up Period|Follow-up no longer required|0|||
164216520|NCT01471574|593159129|FG003|Follow-up Period|Follow-up no longer required|0|||
164216521|NCT01795937|593159130|FG000|Overall Study|Withdrawal by Subject|1|||
164216522|NCT01795937|593159131|FG001|Overall Study|Withdrawal by Subject|0|||
164216523|NCT01795937|593159132|FG002|Overall Study|Withdrawal by Subject|0|||
164216524|NCT01795937|593159130|FG000|Overall Study|Physician Decision|0|||
164216525|NCT01795937|593159131|FG001|Overall Study|Physician Decision|1|||
164216526|NCT01795937|593159132|FG002|Overall Study|Physician Decision|0|||
164216527|NCT01137812|593159133|FG000|Overall Study|Adverse Event|21|||
164216528|NCT01137812|593159134|FG001|Overall Study|Adverse Event|14|||
164216529|NCT01137812|593159133|FG000|Overall Study|Lost to Follow-up|6|||
164216530|NCT01137812|593159134|FG001|Overall Study|Lost to Follow-up|8|||
164216531|NCT01137812|593159133|FG000|Overall Study|Physician Decision|25|||
164216532|NCT01137812|593159134|FG001|Overall Study|Physician Decision|17|||
164216533|NCT01137812|593159133|FG000|Overall Study|Protocol Violation|5|||
164216534|NCT01137812|593159134|FG001|Overall Study|Protocol Violation|4|||
164216535|NCT01137812|593159133|FG000|Overall Study|Withdrawal by Subject|5|||
164216536|NCT01137812|593159134|FG001|Overall Study|Withdrawal by Subject|13|||
164216537|NCT01137812|593159133|FG000|Overall Study|Death|2|||
164216538|NCT01137812|593159134|FG001|Overall Study|Death|0|||
164216539|NCT01137812|593159133|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
164216540|NCT01137812|593159134|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
164216541|NCT01137812|593159133|FG000|Overall Study|Other|19|||
164216542|NCT01137812|593159134|FG001|Overall Study|Other|27|||
164216543|NCT03927157|593159138|FG000|Overall Study|Adverse Event|1|||
164216544|NCT03927157|593159139|FG001|Overall Study|Adverse Event|3|||
164216545|NCT03927157|593159138|FG000|Overall Study|Protocol Violation|1|||
164216546|NCT03927157|593159139|FG001|Overall Study|Protocol Violation|2|||
164216547|NCT03927157|593159138|FG000|Overall Study|Withdrawal by Subject|8|||
164216548|NCT03927157|593159139|FG001|Overall Study|Withdrawal by Subject|21|||
164216549|NCT03927157|593159138|FG000|Overall Study|Due to COVID-19 pandemic|5|||
164216550|NCT03927157|593159139|FG001|Overall Study|Due to COVID-19 pandemic|2|||
164216551|NCT03927157|593159138|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
164216552|NCT03927157|593159139|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
164326601|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Death|0|||
164326602|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Death|1|||
164326603|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Death|0|||
164326604|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Death|0|||
164326605|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Death|1|||
164326606|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Death|0|||
164326607|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Death|0|||
164326608|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Death|0|||
164326609|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Death|0|||
164326610|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Death|1|||
164326611|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
164326612|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326613|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326614|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326615|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326616|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326617|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326618|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326619|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326620|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164326621|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
164326622|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164326623|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
164326624|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164326625|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
164326626|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164326627|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164326628|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164326629|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164326630|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164326631|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
164326632|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
164326633|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
164326634|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
164326635|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
164326636|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
164326637|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
164326638|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
164326639|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164326640|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164326641|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326642|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
164326643|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326644|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326645|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326646|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326647|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326648|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
164326649|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
163876808|NCT03398148|591918880|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876809|NCT03398148|591918881|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
163876810|NCT03398148|591918867|FG000|Substudy 1 Period 2|Adverse Event|0|||
163876811|NCT03398148|591918868|FG001|Substudy 1 Period 2|Adverse Event|0|||
163876812|NCT03398148|591918869|FG002|Substudy 1 Period 2|Adverse Event|0|||
163876813|NCT03398148|591918870|FG003|Substudy 1 Period 2|Adverse Event|0|||
163876814|NCT03398148|591918871|FG004|Substudy 1 Period 2|Adverse Event|0|||
163876815|NCT03398148|591918872|FG005|Substudy 1 Period 2|Adverse Event|2|||
163876816|NCT03398148|591918873|FG006|Substudy 1 Period 2|Adverse Event|4|||
163876817|NCT03398148|591918874|FG007|Substudy 1 Period 2|Adverse Event|0|||
163876818|NCT03398148|591918875|FG008|Substudy 1 Period 2|Adverse Event|0|||
163876819|NCT03398148|591918876|FG009|Substudy 1 Period 2|Adverse Event|0|||
163876820|NCT03398148|591918877|FG010|Substudy 1 Period 2|Adverse Event|0|||
163876821|NCT03398148|591918878|FG011|Substudy 1 Period 2|Adverse Event|0|||
163876822|NCT03398148|591918879|FG012|Substudy 1 Period 2|Adverse Event|0|||
163981321|NCT02469090|592302672|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
163981322|NCT02469090|592302670|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
163876823|NCT03398148|591918880|FG013|Substudy 1 Period 2|Adverse Event|0|||
163876824|NCT03398148|591918881|FG014|Substudy 1 Period 2|Adverse Event|0|||
163876825|NCT03398148|591918867|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
164216553|NCT03927157|593159138|FG000|Overall Study|Other than above|0|||
164216554|NCT03927157|593159139|FG001|Overall Study|Other than above|1|||
164216555|NCT02965716|593159140|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164216556|NCT02965716|593159141|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
164216557|NCT02965716|593159140|FG000|Overall Study|Progression/Relapse|8|||
164216558|NCT02965716|593159141|FG001|Overall Study|Progression/Relapse|16|||
164216559|NCT02965716|593159140|FG000|Overall Study|Death|1|||
164216560|NCT02965716|593159141|FG001|Overall Study|Death|0|||
164216561|NCT02965716|593159140|FG000|Overall Study|Not Protocol Specified|1|||
164216562|NCT02965716|593159141|FG001|Overall Study|Not Protocol Specified|3|||
164216563|NCT02265744|593159144|FG000|Overall Study|Poor/Non-compliance|1|||
164216564|NCT02265744|593159145|FG001|Overall Study|Poor/Non-compliance|1|||
164216565|NCT02265744|593159146|FG002|Overall Study|Poor/Non-compliance|0|||
164216566|NCT02265744|593159147|FG003|Overall Study|Poor/Non-compliance|0|||
164216567|NCT02265744|593159148|FG004|Overall Study|Poor/Non-compliance|2|||
164216568|NCT02265744|593159144|FG000|Overall Study|Lost to Follow-up|0|||
164216569|NCT02265744|593159145|FG001|Overall Study|Lost to Follow-up|0|||
164216570|NCT02265744|593159146|FG002|Overall Study|Lost to Follow-up|0|||
164216571|NCT02265744|593159147|FG003|Overall Study|Lost to Follow-up|1|||
164216572|NCT02265744|593159148|FG004|Overall Study|Lost to Follow-up|0|||
164216573|NCT02265744|593159144|FG000|Overall Study|Death|0|||
164216574|NCT02265744|593159145|FG001|Overall Study|Death|0|||
164216575|NCT02265744|593159146|FG002|Overall Study|Death|0|||
164216576|NCT02265744|593159147|FG003|Overall Study|Death|2|||
164216577|NCT02265744|593159148|FG004|Overall Study|Death|0|||
164216578|NCT02265744|593159144|FG000|Overall Study|Withdrawal by Subject|2|||
164216579|NCT02265744|593159145|FG001|Overall Study|Withdrawal by Subject|0|||
164216580|NCT02265744|593159146|FG002|Overall Study|Withdrawal by Subject|0|||
164216581|NCT02265744|593159147|FG003|Overall Study|Withdrawal by Subject|2|||
164216582|NCT02265744|593159148|FG004|Overall Study|Withdrawal by Subject|0|||
164216583|NCT02265744|593159144|FG000|Overall Study|Participant request to discontinue|2|||
164216584|NCT02265744|593159145|FG001|Overall Study|Participant request to discontinue|2|||
164216585|NCT02265744|593159146|FG002|Overall Study|Participant request to discontinue|2|||
164216586|NCT02265744|593159147|FG003|Overall Study|Participant request to discontinue|0|||
164216587|NCT02265744|593159148|FG004|Overall Study|Participant request to discontinue|0|||
164216588|NCT02265744|593159144|FG000|Overall Study|Adverse Event|8|||
164216589|NCT02265744|593159145|FG001|Overall Study|Adverse Event|4|||
164216590|NCT02265744|593159146|FG002|Overall Study|Adverse Event|9|||
164216591|NCT02265744|593159147|FG003|Overall Study|Adverse Event|8|||
164216592|NCT02265744|593159148|FG004|Overall Study|Adverse Event|2|||
164216593|NCT02265744|593159144|FG000|Overall Study|Lack of Efficacy|2|||
164216594|NCT02265744|593159145|FG001|Overall Study|Lack of Efficacy|4|||
164216595|NCT02265744|593159146|FG002|Overall Study|Lack of Efficacy|3|||
164216596|NCT02265744|593159147|FG003|Overall Study|Lack of Efficacy|4|||
164216597|NCT02265744|593159148|FG004|Overall Study|Lack of Efficacy|5|||
164216598|NCT02265744|593159144|FG000|Overall Study|Reason not provided by Investigator|1|||
164216599|NCT02265744|593159145|FG001|Overall Study|Reason not provided by Investigator|0|||
164216600|NCT02265744|593159146|FG002|Overall Study|Reason not provided by Investigator|0|||
164216601|NCT02265744|593159147|FG003|Overall Study|Reason not provided by Investigator|2|||
164216602|NCT02265744|593159148|FG004|Overall Study|Reason not provided by Investigator|0|||
164216603|NCT02265744|593159144|FG000|Overall Study|Administrative reason by sponsor|3|||
164216604|NCT02265744|593159145|FG001|Overall Study|Administrative reason by sponsor|2|||
164216605|NCT02265744|593159146|FG002|Overall Study|Administrative reason by sponsor|2|||
164216606|NCT02265744|593159147|FG003|Overall Study|Administrative reason by sponsor|3|||
164216607|NCT02265744|593159148|FG004|Overall Study|Administrative reason by sponsor|3|||
164216608|NCT02265744|593159144|FG000|Overall Study|Subject no longer meets study criteria|0|||
164216609|NCT02265744|593159145|FG001|Overall Study|Subject no longer meets study criteria|0|||
164216610|NCT02265744|593159146|FG002|Overall Study|Subject no longer meets study criteria|0|||
164216611|NCT02265744|593159147|FG003|Overall Study|Subject no longer meets study criteria|0|||
164216612|NCT02265744|593159148|FG004|Overall Study|Subject no longer meets study criteria|1|||
164326650|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
164326651|NCT02414139|593571577|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
164326652|NCT02414139|593571578|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164326653|NCT02414139|593571579|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
164326654|NCT02414139|593571580|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164216613|NCT02265744|593159144|FG000|Overall Study|Pregnancy|1|||
164216614|NCT02265744|593159145|FG001|Overall Study|Pregnancy|2|||
164216615|NCT02265744|593159146|FG002|Overall Study|Pregnancy|1|||
164216616|NCT02265744|593159147|FG003|Overall Study|Pregnancy|1|||
164216617|NCT02265744|593159148|FG004|Overall Study|Pregnancy|0|||
164216618|NCT00923702|593159149|FG000|Overall Study|Ongoing enrollment|0|||
164216619|NCT00923702|593159150|FG001|Overall Study|Ongoing enrollment|0|||
164216620|NCT00923702|593159151|FG002|Overall Study|Ongoing enrollment|0|||
164216621|NCT00923702|593159152|FG003|Overall Study|Ongoing enrollment|0|||
164216622|NCT00923702|593159153|FG004|Overall Study|Ongoing enrollment|354|||
164216623|NCT05950906|593159157|FG000|Overall Study|Adverse Event|0|||
164326655|NCT02414139|593571581|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164326656|NCT02414139|593571582|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164326657|NCT02414139|593571583|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164326658|NCT02414139|593571584|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164326659|NCT02414139|593571585|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164326660|NCT02414139|593571586|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164326661|NCT01226121|593571587|FG000|Overall Study|Lost to Follow-up|2|||
164326662|NCT01226121|593571588|FG001|Overall Study|Lost to Follow-up|0|||
164326663|NCT01226121|593571589|FG002|Overall Study|Lost to Follow-up|1|||
164326664|NCT03324581|593571590|FG000|Overall Study|Adverse Event|18|||
164326665|NCT03324581|593571591|FG001|Overall Study|Adverse Event|11|||
164326666|NCT03324581|593571592|FG002|Overall Study|Adverse Event|7|||
164326667|NCT03324581|593571590|FG000|Overall Study|Lack of Efficacy|0|||
164326668|NCT03324581|593571591|FG001|Overall Study|Lack of Efficacy|1|||
164326669|NCT03324581|593571592|FG002|Overall Study|Lack of Efficacy|0|||
164326670|NCT03324581|593571590|FG000|Overall Study|Lost to Follow-up|5|||
164326671|NCT03324581|593571591|FG001|Overall Study|Lost to Follow-up|3|||
164326672|NCT03324581|593571592|FG002|Overall Study|Lost to Follow-up|6|||
164326673|NCT03324581|593571590|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
164326674|NCT03324581|593571591|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
164326675|NCT03324581|593571592|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
163876826|NCT03398148|591918868|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876827|NCT03398148|591918869|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876828|NCT03398148|591918870|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876829|NCT03398148|591918871|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876830|NCT03398148|591918872|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876831|NCT03398148|591918873|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
163876832|NCT03398148|591918874|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
163876833|NCT03398148|591918875|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876834|NCT03398148|591918876|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876835|NCT03398148|591918877|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876836|NCT03398148|591918878|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876837|NCT03398148|591918879|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876838|NCT03398148|591918880|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876839|NCT03398148|591918881|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
163876840|NCT03398148|591918867|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
163876841|NCT03398148|591918868|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
163876842|NCT03398148|591918869|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
163876843|NCT03398148|591918870|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
163876844|NCT03398148|591918871|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
163876845|NCT03398148|591918872|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
163876846|NCT03398148|591918873|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
163876847|NCT03398148|591918874|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
163876848|NCT03398148|591918875|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
163876849|NCT03398148|591918876|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
163876850|NCT03398148|591918877|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
163876851|NCT03398148|591918878|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
163876852|NCT03398148|591918879|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
163876853|NCT03398148|591918880|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
163876854|NCT03398148|591918881|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
163876855|NCT03398148|591918867|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876856|NCT03398148|591918868|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876857|NCT03398148|591918869|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876858|NCT03398148|591918870|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876859|NCT03398148|591918871|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876860|NCT03398148|591918872|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876861|NCT03398148|591918873|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
163876862|NCT03398148|591918874|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876863|NCT03398148|591918875|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876864|NCT03398148|591918876|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876865|NCT03398148|591918877|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876866|NCT03398148|591918878|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876867|NCT03398148|591918879|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876868|NCT03398148|591918880|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164326676|NCT03324581|593571590|FG000|Overall Study|Physician Decision|0|||
163876869|NCT03398148|591918881|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876870|NCT03398148|591918867|FG000|Substudy 1 Period 2|Other|0|||
163876871|NCT03398148|591918868|FG001|Substudy 1 Period 2|Other|0|||
164326677|NCT03324581|593571591|FG001|Overall Study|Physician Decision|1|||
163876872|NCT03398148|591918869|FG002|Substudy 1 Period 2|Other|0|||
163876873|NCT03398148|591918870|FG003|Substudy 1 Period 2|Other|0|||
163876874|NCT03398148|591918871|FG004|Substudy 1 Period 2|Other|0|||
164216624|NCT05950906|593159158|FG001|Overall Study|Adverse Event|0|||
164216625|NCT05950906|593159159|FG002|Overall Study|Adverse Event|0|||
164216626|NCT05950906|593159160|FG003|Overall Study|Adverse Event|0|||
164216627|NCT05950906|593159161|FG004|Overall Study|Adverse Event|0|||
164216628|NCT05950906|593159162|FG005|Overall Study|Adverse Event|0|||
164216629|NCT05950906|593159163|FG006|Overall Study|Adverse Event|0|||
164216630|NCT05950906|593159164|FG007|Overall Study|Adverse Event|0|||
164216631|NCT05950906|593159165|FG008|Overall Study|Adverse Event|0|||
164216632|NCT05950906|593159166|FG009|Overall Study|Adverse Event|0|||
164216633|NCT05950906|593159167|FG010|Overall Study|Adverse Event|0|||
164216634|NCT05950906|593159168|FG011|Overall Study|Adverse Event|0|||
164216635|NCT05950906|593159169|FG012|Overall Study|Adverse Event|1|||
164216636|NCT05950906|593159170|FG013|Overall Study|Adverse Event|0|||
164216637|NCT05950906|593159157|FG000|Overall Study|Physician Decision|0|||
164216638|NCT05950906|593159158|FG001|Overall Study|Physician Decision|0|||
164216639|NCT05950906|593159159|FG002|Overall Study|Physician Decision|0|||
164216640|NCT05950906|593159160|FG003|Overall Study|Physician Decision|0|||
164216641|NCT05950906|593159161|FG004|Overall Study|Physician Decision|0|||
164216642|NCT05950906|593159162|FG005|Overall Study|Physician Decision|0|||
164216643|NCT05950906|593159163|FG006|Overall Study|Physician Decision|0|||
164216644|NCT05950906|593159164|FG007|Overall Study|Physician Decision|0|||
164216645|NCT05950906|593159165|FG008|Overall Study|Physician Decision|0|||
164216646|NCT05950906|593159166|FG009|Overall Study|Physician Decision|0|||
164216647|NCT05950906|593159167|FG010|Overall Study|Physician Decision|0|||
164216648|NCT05950906|593159168|FG011|Overall Study|Physician Decision|0|||
164216649|NCT05950906|593159169|FG012|Overall Study|Physician Decision|1|||
164216650|NCT05950906|593159170|FG013|Overall Study|Physician Decision|0|||
164216651|NCT02448043|593159171|FG000|Overall Study|Withdrawal by Subject|2|||
164216652|NCT02448043|593159172|FG001|Overall Study|Withdrawal by Subject|2|||
164216653|NCT02448043|593159171|FG000|Overall Study|Protocol Violation|1|||
164216654|NCT02448043|593159172|FG001|Overall Study|Protocol Violation|2|||
164216655|NCT03325439|593159175|FG000|Overall Study|Ineligibility|3|||
164216656|NCT02315625|593159178|FG000|First Intervention|Disease Progression|1|||
164216657|NCT02315625|593159179|FG001|First Intervention|Disease Progression|0|||
164216658|NCT02315625|593159178|FG000|Second Intervention|Physician Decision|2|||
164216659|NCT02315625|593159179|FG001|Second Intervention|Physician Decision|1|||
164216660|NCT02315625|593159178|FG000|Second Intervention|Study closure|1|||
164216661|NCT02315625|593159179|FG001|Second Intervention|Study closure|0|||
164216662|NCT02315625|593159178|FG000|Second Intervention|Disease Progression|1|||
164216663|NCT02315625|593159179|FG001|Second Intervention|Disease Progression|0|||
164216664|NCT06132386|593159182|FG000|Overall Study|ineligble laboratory|1|||
164216665|NCT06132386|593159183|FG001|Overall Study|ineligble laboratory|0|||
164216666|NCT06132386|593159184|FG002|Overall Study|ineligble laboratory|0|||
164216667|NCT06132386|593159185|FG003|Overall Study|ineligble laboratory|0|||
164216668|NCT06132386|593159186|FG004|Overall Study|ineligble laboratory|1|||
164216669|NCT06132386|593159187|FG005|Overall Study|ineligble laboratory|0|||
164216670|NCT06132386|593159182|FG000|Overall Study|ineligible vital signs|0|||
164216671|NCT06132386|593159183|FG001|Overall Study|ineligible vital signs|1|||
164216672|NCT06132386|593159184|FG002|Overall Study|ineligible vital signs|0|||
164216673|NCT06132386|593159185|FG003|Overall Study|ineligible vital signs|0|||
164326678|NCT03324581|593571592|FG002|Overall Study|Physician Decision|2|||
164216674|NCT06132386|593159186|FG004|Overall Study|ineligible vital signs|0|||
164216675|NCT06132386|593159187|FG005|Overall Study|ineligible vital signs|0|||
164216676|NCT03514017|593159192|FG000|Overall Study|Death|1|||
164216677|NCT03514017|593159192|FG000|Overall Study|Adverse Event|1|||
164216678|NCT03971422|593160422|FG000|Overall Study|Lost to Follow-up|0|||
164216679|NCT03971422|593160423|FG001|Overall Study|Lost to Follow-up|1|||
164216680|NCT03971422|593160424|FG002|Overall Study|Lost to Follow-up|0|||
164216681|NCT03971422|593160422|FG000|Overall Study|Lack of Efficacy|5|||
164216682|NCT03971422|593160423|FG001|Overall Study|Lack of Efficacy|1|||
164216683|NCT03971422|593160424|FG002|Overall Study|Lack of Efficacy|1|||
164216684|NCT03971422|593160422|FG000|Overall Study|Adverse event, not fatal|2|||
164216685|NCT03971422|593160423|FG001|Overall Study|Adverse event, not fatal|2|||
164216686|NCT03971422|593160424|FG002|Overall Study|Adverse event, not fatal|5|||
164216687|NCT03971422|593160422|FG000|Overall Study|Worsening of MG Symptoms|1|||
164216688|NCT03971422|593160423|FG001|Overall Study|Worsening of MG Symptoms|4|||
164216689|NCT03971422|593160424|FG002|Overall Study|Worsening of MG Symptoms|2|||
164216690|NCT03971422|593160422|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
163876875|NCT03398148|591918872|FG005|Substudy 1 Period 2|Other|0|||
164216691|NCT03971422|593160423|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
164216692|NCT03971422|593160424|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
164216693|NCT03971422|593160422|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
164216694|NCT03971422|593160423|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
164216695|NCT03971422|593160424|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
164216696|NCT03971422|593160422|FG000|Overall Study|Due to COVID-19 pandemic|0|||
164216697|NCT03971422|593160423|FG001|Overall Study|Due to COVID-19 pandemic|1|||
164216698|NCT03971422|593160424|FG002|Overall Study|Due to COVID-19 pandemic|1|||
164216699|NCT04575324|593160427|FG000|Overall Study|Lost to Follow-up|29|||
164216700|NCT04575324|593160428|FG001|Overall Study|Lost to Follow-up|25|||
164216701|NCT04575324|593160427|FG000|Overall Study|Death|1|||
164216702|NCT04575324|593160428|FG001|Overall Study|Death|2|||
164216703|NCT04575324|593160427|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
164216704|NCT04575324|593160428|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
164216705|NCT01105130|593160429|FG000|Overall Study|Withdrawal by Subject|4|||
164216706|NCT01105130|593160430|FG001|Overall Study|Withdrawal by Subject|6|||
164216707|NCT01105130|593160431|FG002|Overall Study|Withdrawal by Subject|2|||
164216708|NCT01105130|593160429|FG000|Overall Study|Never Started|2|||
164216709|NCT01105130|593160430|FG001|Overall Study|Never Started|2|||
164216710|NCT01105130|593160431|FG002|Overall Study|Never Started|4|||
164216711|NCT01105130|593160429|FG000|Overall Study|Toxicity|1|||
164216712|NCT01105130|593160430|FG001|Overall Study|Toxicity|3|||
164216713|NCT01105130|593160431|FG002|Overall Study|Toxicity|2|||
164216714|NCT01105130|593160429|FG000|Overall Study|Multiple Reasons|3|||
164216715|NCT01105130|593160430|FG001|Overall Study|Multiple Reasons|0|||
164216716|NCT01105130|593160431|FG002|Overall Study|Multiple Reasons|2|||
164216717|NCT01028053|593160439|FG000|Overall Study|Screen Failure|113|||
164216718|NCT01028053|593160439|FG000|Overall Study|Patient Request|11|||
164216719|NCT01028053|593160439|FG000|Overall Study|Protocol Violation|1|||
164216720|NCT01028053|593160439|FG000|Overall Study|Physician Decision|2|||
164216721|NCT01028053|593160439|FG000|Overall Study|Technical Problem|1|||
164216722|NCT01028053|593160439|FG000|Overall Study|Terminated by Sponsor|1|||
164216723|NCT01028053|593160439|FG000|Overall Study|Various reasons|4|||
164216724|NCT01177410|593160440|FG000|Overall Study|Adverse Event|0|||
164216725|NCT01177410|593160441|FG001|Overall Study|Adverse Event|2|||
164216726|NCT01177410|593160442|FG002|Overall Study|Adverse Event|2|||
164216727|NCT01177410|593160440|FG000|Overall Study|Withdrawal by Subject|1|||
164216728|NCT01177410|593160441|FG001|Overall Study|Withdrawal by Subject|4|||
164216729|NCT01177410|593160442|FG002|Overall Study|Withdrawal by Subject|3|||
164216730|NCT01177410|593160440|FG000|Overall Study|Lost to Follow-up|0|||
164216731|NCT01177410|593160441|FG001|Overall Study|Lost to Follow-up|1|||
164216732|NCT01177410|593160442|FG002|Overall Study|Lost to Follow-up|0|||
164216733|NCT00471354|593160443|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
164216734|NCT00471354|593160443|FG000|Overall Study|Adverse Event|13|||
164216735|NCT00471354|593160443|FG000|Overall Study|Protocol Violation|12|||
164216736|NCT00471354|593160443|FG000|Overall Study|Withdrawal by Subject|1|||
164216737|NCT00471354|593160443|FG000|Overall Study|Physician Decision|4|||
164216738|NCT00471354|593160443|FG000|Overall Study|Sponsor Decision|1|||
164216739|NCT00471354|593160443|FG000|Overall Study|Lost to Follow-up|3|||
164216740|NCT00471354|593160443|FG000|Overall Study|Lack of Efficacy|5|||
164216741|NCT00471354|593160443|FG000|Overall Study|Patient/Caregiver Decision|12|||
164216742|NCT01336972|593160444|FG000|Overall Study|Adverse Event|1|||
164216743|NCT01336972|593160445|FG001|Overall Study|Adverse Event|1|||
164216744|NCT01336972|593160446|FG002|Overall Study|Adverse Event|0|||
164216745|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
164216746|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
164216747|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
164216748|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
164216749|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
164326679|NCT03324581|593571590|FG000|Overall Study|Protocol Deviation|8|||
164326680|NCT03324581|593571591|FG001|Overall Study|Protocol Deviation|9|||
164326681|NCT03324581|593571592|FG002|Overall Study|Protocol Deviation|4|||
164326682|NCT03324581|593571590|FG000|Overall Study|Withdrawal by Subject|6|||
164326683|NCT03324581|593571591|FG001|Overall Study|Withdrawal by Subject|8|||
164326684|NCT03324581|593571592|FG002|Overall Study|Withdrawal by Subject|6|||
164326685|NCT03324581|593571590|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
164326686|NCT03324581|593571591|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
164326687|NCT03324581|593571592|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
164326688|NCT04473482|593571593|FG000|Overall Study|Death|0|||
164326689|NCT04473482|593571594|FG001|Overall Study|Death|3|||
164326690|NCT04473482|593571593|FG000|Overall Study|Lost to Follow-up|9|||
164326691|NCT04473482|593571594|FG001|Overall Study|Lost to Follow-up|7|||
164326692|NCT04473482|593571593|FG000|Overall Study|Withdrawal by Subject|2|||
163981323|NCT02469090|592302671|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
164216750|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
164326693|NCT04473482|593571594|FG001|Overall Study|Withdrawal by Subject|1|||
164216751|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
164326694|NCT00266864|593571596|FG000|Overall Study|Lost to Follow-up|4|||
164326695|NCT00266864|593571597|FG001|Overall Study|Lost to Follow-up|1|||
164326696|NCT00266864|593571596|FG000|Overall Study|Withdrawal by Subject|1|||
164216752|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
164216753|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
164216754|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
164216755|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
164216756|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
164326697|NCT00266864|593571597|FG001|Overall Study|Withdrawal by Subject|1|||
164326698|NCT00727532|593571598|FG000|Overall Study|Adverse Event|1|||
164216757|NCT03446573|593160450|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
164216758|NCT03446573|593160451|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
164216759|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
164216760|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
164216761|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
164216762|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
164216763|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
164216764|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
164216765|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
164216766|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
164216767|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
164216768|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
164216769|NCT03446573|593160450|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
164216770|NCT03446573|593160451|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
164216771|NCT02639559|593160452|FG000|Overall Study|Mobilization failure|0|||
164216772|NCT02639559|593160453|FG001|Overall Study|Mobilization failure|3|||
164216773|NCT02639559|593160452|FG000|Overall Study|Issues with vascular acess|1|||
164216774|NCT02639559|593160453|FG001|Overall Study|Issues with vascular acess|0|||
164216775|NCT02691663|593160460|FG000|Overall Study|Screen failure after baseline|2|||
164216776|NCT02691663|593160461|FG001|Overall Study|Screen failure after baseline|2|||
164216777|NCT02691663|593160460|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
164216778|NCT02691663|593160461|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
164216779|NCT02691663|593160460|FG000|Overall Study|Withdrawn after Follow up 2|1|||
164216780|NCT02691663|593160461|FG001|Overall Study|Withdrawn after Follow up 2|1|||
164216781|NCT02691663|593160460|FG000|Overall Study|Lost to Follow-up|3|||
164216782|NCT02691663|593160461|FG001|Overall Study|Lost to Follow-up|2|||
164216783|NCT03142750|593160462|FG000|Overall Study|Lost to Follow-up|4|||
164216784|NCT03142750|593160463|FG001|Overall Study|Lost to Follow-up|1|||
164216785|NCT00303628|593160468|FG000|Overall Study|Disease progression|0|||
164216786|NCT00303628|593160469|FG001|Overall Study|Disease progression|1|||
164216787|NCT00303628|593160468|FG000|Overall Study|Adverse Event|26|||
164216788|NCT00303628|593160469|FG001|Overall Study|Adverse Event|36|||
164216789|NCT00303628|593160468|FG000|Overall Study|Death|0|||
164216790|NCT00303628|593160469|FG001|Overall Study|Death|1|||
164216791|NCT00303628|593160468|FG000|Overall Study|Withdrawal by Subject|11|||
164216792|NCT00303628|593160469|FG001|Overall Study|Withdrawal by Subject|20|||
164216793|NCT00303628|593160468|FG000|Overall Study|Alternative therapy|2|||
164216794|NCT00303628|593160469|FG001|Overall Study|Alternative therapy|0|||
164216795|NCT00303628|593160468|FG000|Overall Study|Other complicating disease|0|||
164216796|NCT00303628|593160469|FG001|Overall Study|Other complicating disease|1|||
164216797|NCT00303628|593160468|FG000|Overall Study|Not start protocol therapy|3|||
164216798|NCT00303628|593160469|FG001|Overall Study|Not start protocol therapy|5|||
164216799|NCT00303628|593160468|FG000|Overall Study|Other|8|||
164216800|NCT00303628|593160469|FG001|Overall Study|Other|9|||
164326699|NCT00727532|593571598|FG000|Overall Study|Withdrawal by Subject|1|||
164326700|NCT00829933|593571599|FG000|Overall Study|Adverse Event|2|||
164326701|NCT00829933|593571600|FG001|Overall Study|Adverse Event|3|||
164326702|NCT00829933|593571601|FG002|Overall Study|Adverse Event|2|||
164216801|NCT03158688|593160470|FG000|Overall Study|Withdrawal by Subject|14|||
164326703|NCT00829933|593571602|FG003|Overall Study|Adverse Event|1|||
164326704|NCT00829933|593571599|FG000|Overall Study|Death|0|||
164326705|NCT00829933|593571600|FG001|Overall Study|Death|0|||
164326706|NCT00829933|593571601|FG002|Overall Study|Death|1|||
164326707|NCT00829933|593571602|FG003|Overall Study|Death|1|||
164326708|NCT00829933|593571599|FG000|Overall Study|Lack of Efficacy|0|||
164326709|NCT00829933|593571600|FG001|Overall Study|Lack of Efficacy|1|||
164326710|NCT00829933|593571601|FG002|Overall Study|Lack of Efficacy|0|||
164216802|NCT03158688|593160471|FG001|Overall Study|Withdrawal by Subject|28|||
164216803|NCT03158688|593160470|FG000|Overall Study|Decision by sponsor|13|||
164216804|NCT03158688|593160471|FG001|Overall Study|Decision by sponsor|37|||
164326711|NCT00829933|593571602|FG003|Overall Study|Lack of Efficacy|0|||
164326712|NCT00829933|593571599|FG000|Overall Study|Physician Decision|5|||
164326713|NCT00829933|593571600|FG001|Overall Study|Physician Decision|7|||
164326714|NCT00829933|593571601|FG002|Overall Study|Physician Decision|8|||
164216805|NCT03158688|593160470|FG000|Overall Study|Lost to Follow-up|4|||
164216806|NCT03158688|593160471|FG001|Overall Study|Lost to Follow-up|3|||
164216807|NCT03158688|593160470|FG000|Overall Study|Death|74|||
164326715|NCT00829933|593571602|FG003|Overall Study|Physician Decision|1|||
164326716|NCT00829933|593571599|FG000|Overall Study|Pregnancy|0|||
163981324|NCT02469090|592302672|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
164216808|NCT03158688|593160471|FG001|Overall Study|Death|142|||
164216809|NCT00471107|593160472|FG000|Overall Study|Technical problems/data loss|3|||
164326717|NCT00829933|593571600|FG001|Overall Study|Pregnancy|0|||
164326718|NCT00829933|593571601|FG002|Overall Study|Pregnancy|0|||
164216810|NCT00471107|593160473|FG001|Overall Study|Technical problems/data loss|1|||
164216811|NCT00471107|593160474|FG002|Overall Study|Technical problems/data loss|3|||
164216812|NCT02942407|593160475|FG000|Overall Study|Lost to Follow-up|3|||
164216813|NCT02942407|593160476|FG001|Overall Study|Lost to Follow-up|2|||
164216814|NCT02942407|593160475|FG000|Overall Study|Withdrawal by Subject|7|||
164216815|NCT02942407|593160476|FG001|Overall Study|Withdrawal by Subject|9|||
164216816|NCT02942407|593160475|FG000|Overall Study|Death|16|||
164216817|NCT02942407|593160476|FG001|Overall Study|Death|13|||
164216818|NCT05887908|593160477|FG000|Overall Study|Adverse Event|6|||
164216819|NCT05887908|593160478|FG001|Overall Study|Adverse Event|1|||
164216820|NCT05887908|593160479|FG002|Overall Study|Adverse Event|1|||
164216821|NCT05887908|593160477|FG000|Overall Study|Physician Decision|4|||
164216822|NCT05887908|593160478|FG001|Overall Study|Physician Decision|1|||
164216823|NCT05887908|593160479|FG002|Overall Study|Physician Decision|0|||
164216824|NCT05887908|593160477|FG000|Overall Study|Withdrawal by Subject|3|||
164216825|NCT05887908|593160478|FG001|Overall Study|Withdrawal by Subject|2|||
164216826|NCT05887908|593160479|FG002|Overall Study|Withdrawal by Subject|3|||
164216827|NCT05887908|593160477|FG000|Overall Study|Ineligibility after the start of the study|4|||
164216828|NCT05887908|593160478|FG001|Overall Study|Ineligibility after the start of the study|1|||
164216829|NCT05887908|593160479|FG002|Overall Study|Ineligibility after the start of the study|0|||
164216830|NCT05887908|593160477|FG000|Overall Study|Subject non-compliance|4|||
164216831|NCT05887908|593160478|FG001|Overall Study|Subject non-compliance|0|||
164216832|NCT05887908|593160479|FG002|Overall Study|Subject non-compliance|4|||
164216833|NCT05887908|593160477|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
164216834|NCT05887908|593160478|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
164216835|NCT05887908|593160479|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
164216836|NCT05887908|593160477|FG000|Overall Study|Pregnancy|0|||
164216837|NCT05887908|593160478|FG001|Overall Study|Pregnancy|1|||
164216838|NCT05887908|593160479|FG002|Overall Study|Pregnancy|0|||
164216839|NCT05887908|593160477|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
164216840|NCT05887908|593160478|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
164216841|NCT05887908|593160479|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
164216842|NCT05887908|593160477|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
164216843|NCT05887908|593160478|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
164216844|NCT05887908|593160479|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
164216845|NCT05887908|593160477|FG000|Overall Study|Other Reason|3|||
164216846|NCT05887908|593160478|FG001|Overall Study|Other Reason|3|||
164216847|NCT05887908|593160479|FG002|Overall Study|Other Reason|3|||
164216848|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
164326719|NCT00829933|593571602|FG003|Overall Study|Pregnancy|2|||
164326720|NCT00829933|593571599|FG000|Overall Study|Protocol Violation|2|||
164326721|NCT00829933|593571600|FG001|Overall Study|Protocol Violation|1|||
164326722|NCT00829933|593571601|FG002|Overall Study|Protocol Violation|0|||
164326723|NCT00829933|593571602|FG003|Overall Study|Protocol Violation|0|||
164326724|NCT00829933|593571599|FG000|Overall Study|withdrew before treatment started|5|||
164326725|NCT00829933|593571600|FG001|Overall Study|withdrew before treatment started|1|||
164326726|NCT00829933|593571601|FG002|Overall Study|withdrew before treatment started|2|||
164326727|NCT00829933|593571602|FG003|Overall Study|withdrew before treatment started|9|||
164326728|NCT03687970|593571606|FG000|Overall Study|visit scheduling conflicts|2|||
164326729|NCT03687970|593571607|FG001|Overall Study|visit scheduling conflicts|0|||
164326730|NCT00686998|593571608|FG000|Overall Study|Adverse Event|3|||
164326731|NCT00686998|593571609|FG001|Overall Study|Adverse Event|2|||
164326732|NCT00686998|593571610|FG002|Overall Study|Adverse Event|1|||
164326733|NCT00686998|593571608|FG000|Overall Study|Withdrawal by Subject|2|||
164326734|NCT00686998|593571609|FG001|Overall Study|Withdrawal by Subject|1|||
164326735|NCT00686998|593571610|FG002|Overall Study|Withdrawal by Subject|2|||
164326736|NCT00686998|593571608|FG000|Overall Study|Lack of Efficacy|7|||
164326737|NCT00686998|593571609|FG001|Overall Study|Lack of Efficacy|5|||
164326738|NCT00686998|593571610|FG002|Overall Study|Lack of Efficacy|0|||
164326739|NCT00686998|593571608|FG000|Overall Study|Other|0|||
164326740|NCT00686998|593571609|FG001|Overall Study|Other|0|||
164326741|NCT00686998|593571610|FG002|Overall Study|Other|1|||
164326742|NCT00686998|593571608|FG000|Overall Study|Safety Reasons|1|||
164326743|NCT00686998|593571609|FG001|Overall Study|Safety Reasons|0|||
164326744|NCT00686998|593571610|FG002|Overall Study|Safety Reasons|0|||
164326745|NCT06374394|593571614|FG000|Overall Study|Adverse Event|0|||
163876876|NCT03398148|591918873|FG006|Substudy 1 Period 2|Other|1|||
164216849|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
164216850|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
164216851|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
164216852|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
164326746|NCT06374394|593571615|FG001|Overall Study|Adverse Event|2|||
164326747|NCT06374394|593571614|FG000|Overall Study|Lost to Follow-up|6|||
164326748|NCT06374394|593571615|FG001|Overall Study|Lost to Follow-up|9|||
164326749|NCT06374394|593571614|FG000|Overall Study|Withdrawal by Subject|1|||
164216853|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
164216854|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
164216855|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
164216856|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
164216857|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
164216858|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
164216859|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
164216860|NCT03928743|593160483|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
164216861|NCT03928743|593160484|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
164216862|NCT03928743|593160485|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
164216863|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
164216864|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
164216865|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
164216866|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
164216867|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
164216868|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
164216869|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
164216870|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
164216871|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
164216872|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
164216873|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
164216874|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
164216875|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
164216876|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
164216877|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
164216878|NCT03928743|593160483|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
164216879|NCT03928743|593160484|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
164216880|NCT03928743|593160485|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
164216881|NCT04828486|593160488|FG000|Overall Study|Adverse Event|2|||
164216882|NCT04828486|593160488|FG000|Overall Study|Death|1|||
164216883|NCT04828486|593160488|FG000|Overall Study|Disease Progression|8|||
164216884|NCT04828486|593160488|FG000|Overall Study|Other Complicating Disease|1|||
164216885|NCT04828486|593160488|FG000|Overall Study|Withdrawal by Subject|1|||
164216886|NCT06204887|593160489|FG000|Overall Study|Lost to Follow-up|3|||
164216887|NCT06204887|593160490|FG001|Overall Study|Lost to Follow-up|4|||
164216888|NCT06204887|593160491|FG002|Overall Study|Lost to Follow-up|1|||
164216889|NCT06204887|593160492|FG003|Overall Study|Lost to Follow-up|6|||
164216890|NCT02762604|593160496|FG000|Overall Study|Lost to Follow-up|2|||
164216891|NCT02762604|593160497|FG001|Overall Study|Lost to Follow-up|7|||
164216892|NCT02762604|593160496|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
164216893|NCT02762604|593160497|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
164216894|NCT03833167|593160498|FG000|Overall Study|Withdrawal by Subject|4|||
164216895|NCT03833167|593160499|FG001|Overall Study|Withdrawal by Subject|6|||
164216896|NCT03833167|593160498|FG000|Overall Study|Ongoing|186|||
164216897|NCT03833167|593160499|FG001|Overall Study|Ongoing|194|||
164216898|NCT03833167|593160498|FG000|Overall Study|Lost to Follow-up|1|||
164216899|NCT03833167|593160499|FG001|Overall Study|Lost to Follow-up|1|||
164326750|NCT06374394|593571615|FG001|Overall Study|Withdrawal by Subject|7|||
164326751|NCT06374394|593571614|FG000|Overall Study|Other|1|||
164326752|NCT06374394|593571615|FG001|Overall Study|Other|0|||
164326753|NCT00356122|593571616|FG000|TREATMENT|Lack of Efficacy|26|||
164326754|NCT00356122|593571616|FG000|TREATMENT|Adverse Event|10|||
163876877|NCT03398148|591918874|FG007|Substudy 1 Period 2|Other|0|||
163876878|NCT03398148|591918875|FG008|Substudy 1 Period 2|Other|0|||
163876879|NCT03398148|591918876|FG009|Substudy 1 Period 2|Other|0|||
163876880|NCT03398148|591918877|FG010|Substudy 1 Period 2|Other|0|||
163876881|NCT03398148|591918878|FG011|Substudy 1 Period 2|Other|0|||
163876882|NCT03398148|591918879|FG012|Substudy 1 Period 2|Other|0|||
163876883|NCT03398148|591918880|FG013|Substudy 1 Period 2|Other|0|||
163876884|NCT03398148|591918881|FG014|Substudy 1 Period 2|Other|0|||
163876885|NCT03398148|591918867|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
164326755|NCT00356122|593571616|FG000|TREATMENT|Subject's request|4|||
163876886|NCT03398148|591918868|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876887|NCT03398148|591918869|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
164216900|NCT03833167|593160498|FG000|Overall Study|Physician Decision|0|||
164216901|NCT03833167|593160499|FG001|Overall Study|Physician Decision|2|||
164216902|NCT03833167|593160498|FG000|Overall Study|Death|34|||
164216903|NCT03833167|593160499|FG001|Overall Study|Death|22|||
164326756|NCT00356122|593571616|FG000|TREATMENT|Other|4|||
163876888|NCT03398148|591918870|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876889|NCT03398148|591918871|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
164216904|NCT02227199|593160502|FG000|Overall Study|Physician Decision|0|||
164216905|NCT02227199|593160503|FG001|Overall Study|Physician Decision|0|||
164216906|NCT02227199|593160504|FG002|Overall Study|Physician Decision|1|||
164216907|NCT02227199|593160502|FG000|Overall Study|Adverse Event|0|||
164216908|NCT02227199|593160503|FG001|Overall Study|Adverse Event|0|||
164216909|NCT02227199|593160504|FG002|Overall Study|Adverse Event|3|||
164216910|NCT03003962|593160505|FG000|Overall Study|Withdrawal by Subject|5|||
164216911|NCT03003962|593160506|FG001|Overall Study|Withdrawal by Subject|17|||
164216912|NCT03003962|593160505|FG000|Overall Study|Death|274|||
164216913|NCT03003962|593160506|FG001|Overall Study|Death|277|||
164216914|NCT03003962|593160505|FG000|Overall Study|Participants ongoing at DCO|55|||
164216915|NCT03003962|593160506|FG001|Overall Study|Participants ongoing at DCO|40|||
164216916|NCT05179603|593160507|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164216917|NCT05179603|593160507|FG000|Overall Study|Withdrawal by Subject|1|||
164216918|NCT05179603|593160507|FG000|Overall Study|Progressive disease|4|||
164216919|NCT05179603|593160507|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
164216920|NCT05937373|593160508|FG000|Overall Study|Out of Window|2|||
164216921|NCT05937373|593160509|FG001|Overall Study|Out of Window|0|||
164216922|NCT05937373|593160508|FG000|Overall Study|Device fell off prior to date of surgery|0|||
164216923|NCT05937373|593160509|FG001|Overall Study|Device fell off prior to date of surgery|2|||
164216924|NCT06061952|593160510|FG000|Overall Study|Withdrawal by Subject|1|||
164216925|NCT06061952|593160511|FG001|Overall Study|Withdrawal by Subject|2|||
164216926|NCT06061952|593160510|FG000|Overall Study|Lost to Follow-up|2|||
164216927|NCT06061952|593160511|FG001|Overall Study|Lost to Follow-up|2|||
164216928|NCT01405911|593160512|FG000|Overall Study|Pre-treatment lab AE|0|||
164216929|NCT01405911|593160513|FG001|Overall Study|Pre-treatment lab AE|1|||
164216930|NCT01405911|593160514|FG002|Overall Study|Pre-treatment lab AE|0|||
164216931|NCT01405911|593160512|FG000|Overall Study|Lost to Follow-up|0|||
164216932|NCT01405911|593160513|FG001|Overall Study|Lost to Follow-up|1|||
164216933|NCT01405911|593160514|FG002|Overall Study|Lost to Follow-up|0|||
164216934|NCT01405911|593160512|FG000|Overall Study|Protocol Violation|1|||
164216935|NCT01405911|593160513|FG001|Overall Study|Protocol Violation|0|||
164216936|NCT01405911|593160514|FG002|Overall Study|Protocol Violation|0|||
164216937|NCT01405911|593160512|FG000|Overall Study|Withdrawal by Subject|3|||
164216938|NCT01405911|593160513|FG001|Overall Study|Withdrawal by Subject|1|||
164216939|NCT01405911|593160514|FG002|Overall Study|Withdrawal by Subject|1|||
164216940|NCT01685437|593160516|FG000|Overall Study|Withdrawal by Subject|22|||
164216941|NCT01685437|593160516|FG000|Overall Study|Lost to Follow-up|3|||
164216942|NCT01685437|593160516|FG000|Overall Study|Adverse Event|1|||
164216943|NCT01685437|593160516|FG000|Overall Study|Protocol Violation|4|||
164216944|NCT01685437|593160516|FG000|Overall Study|Unable to make visits due to work|1|||
164216945|NCT03770455|593160523|FG000|Overall Study|Screen failures|3|||
164216946|NCT04937387|593160524|FG000|Overall Study|Adverse Event|1|||
163876890|NCT03398148|591918872|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876891|NCT03398148|591918873|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
163876892|NCT03398148|591918874|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876893|NCT03398148|591918875|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876894|NCT03398148|591918876|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876895|NCT03398148|591918877|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876896|NCT03398148|591918878|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876897|NCT03398148|591918879|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876898|NCT03398148|591918880|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876899|NCT03398148|591918881|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
163876900|NCT03398148|591918867|FG000|Substudy 2 Period 1|Adverse Event|0|||
163876901|NCT03398148|591918868|FG001|Substudy 2 Period 1|Adverse Event|0|||
163876902|NCT03398148|591918869|FG002|Substudy 2 Period 1|Adverse Event|0|||
163876903|NCT03398148|591918870|FG003|Substudy 2 Period 1|Adverse Event|0|||
163876904|NCT03398148|591918871|FG004|Substudy 2 Period 1|Adverse Event|0|||
163876905|NCT03398148|591918872|FG005|Substudy 2 Period 1|Adverse Event|0|||
163876906|NCT03398148|591918873|FG006|Substudy 2 Period 1|Adverse Event|0|||
163876907|NCT03398148|591918874|FG007|Substudy 2 Period 1|Adverse Event|0|||
163876908|NCT03398148|591918875|FG008|Substudy 2 Period 1|Adverse Event|0|||
164216947|NCT04937387|593160525|FG001|Overall Study|Adverse Event|0|||
164216948|NCT04937387|593160526|FG002|Overall Study|Adverse Event|2|||
164216949|NCT04937387|593160527|FG003|Overall Study|Adverse Event|0|||
164216950|NCT04937387|593160524|FG000|Overall Study|Lack of Efficacy|1|||
163876909|NCT03398148|591918876|FG009|Substudy 2 Period 1|Adverse Event|12|||
163876910|NCT03398148|591918877|FG010|Substudy 2 Period 1|Adverse Event|2|||
164216951|NCT04937387|593160525|FG001|Overall Study|Lack of Efficacy|0|||
163876911|NCT03398148|591918878|FG011|Substudy 2 Period 1|Adverse Event|0|||
164216952|NCT04937387|593160526|FG002|Overall Study|Lack of Efficacy|0|||
164216953|NCT04937387|593160527|FG003|Overall Study|Lack of Efficacy|1|||
164216954|NCT04937387|593160524|FG000|Overall Study|Withdrawal by Subject|1|||
164216955|NCT04937387|593160525|FG001|Overall Study|Withdrawal by Subject|0|||
164216956|NCT04937387|593160526|FG002|Overall Study|Withdrawal by Subject|1|||
164216957|NCT04937387|593160527|FG003|Overall Study|Withdrawal by Subject|1|||
164216958|NCT04937387|593160524|FG000|Overall Study|Randomized in error|0|||
164078154|NCT02092961|592651496|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
164078155|NCT02092961|592651497|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
164078156|NCT02092961|592651495|FG000|Overall Study|Adverse Event|2|||
164216959|NCT04937387|593160525|FG001|Overall Study|Randomized in error|0|||
163876912|NCT03398148|591918879|FG012|Substudy 2 Period 1|Adverse Event|0|||
163876913|NCT03398148|591918880|FG013|Substudy 2 Period 1|Adverse Event|0|||
163876914|NCT03398148|591918881|FG014|Substudy 2 Period 1|Adverse Event|0|||
163876915|NCT03398148|591918867|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876916|NCT03398148|591918868|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876917|NCT03398148|591918869|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876918|NCT03398148|591918870|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876919|NCT03398148|591918871|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876920|NCT03398148|591918872|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876921|NCT03398148|591918873|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876922|NCT03398148|591918874|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876923|NCT03398148|591918875|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876924|NCT03398148|591918876|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
163876925|NCT03398148|591918877|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
163876926|NCT03398148|591918878|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876927|NCT03398148|591918879|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876928|NCT03398148|591918880|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876929|NCT03398148|591918881|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
163876930|NCT03398148|591918867|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
163876931|NCT03398148|591918868|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
163876932|NCT03398148|591918869|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
163876933|NCT03398148|591918870|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
163876934|NCT03398148|591918871|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
163876935|NCT03398148|591918872|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
163876936|NCT03398148|591918873|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
163981325|NCT01485627|592302673|FG000|Overall Study|Patient withdrew|6|||
163981326|NCT01485627|592302674|FG001|Overall Study|Patient withdrew|5|||
163981327|NCT01485627|592302673|FG000|Overall Study|Patient died|3|||
163981328|NCT01485627|592302674|FG001|Overall Study|Patient died|1|||
163981329|NCT01485627|592302673|FG000|Overall Study|Patient lost to followup|0|||
163981330|NCT01485627|592302674|FG001|Overall Study|Patient lost to followup|1|||
163981331|NCT01485627|592302673|FG000|Overall Study|Caregiver withdrew|3|||
163981332|NCT01485627|592302674|FG001|Overall Study|Caregiver withdrew|3|||
163981333|NCT01485627|592302673|FG000|Overall Study|Caregiver lost to follow up|11|||
163981334|NCT01485627|592302674|FG001|Overall Study|Caregiver lost to follow up|12|||
163981335|NCT01485627|592302673|FG000|Overall Study|Caregiver died|1|||
163981336|NCT01485627|592302674|FG001|Overall Study|Caregiver died|0|||
163981337|NCT01485627|592302673|FG000|Overall Study|caregiver was not bereaved|42|||
163981338|NCT01485627|592302674|FG001|Overall Study|caregiver was not bereaved|35|||
163981339|NCT01425203|592302675|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
163981340|NCT01425203|592302676|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
163981341|NCT01425203|592302677|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
163981342|NCT01425203|592302675|FG000|Treatment Phase|Failure at futility timepoint|8|||
163981343|NCT01425203|592302676|FG001|Treatment Phase|Failure at futility timepoint|27|||
163981344|NCT01425203|592302677|FG002|Treatment Phase|Failure at futility timepoint|0|||
163981345|NCT01425203|592302675|FG000|Treatment Phase|Other virologic failure criteria|5|||
163981346|NCT01425203|592302676|FG001|Treatment Phase|Other virologic failure criteria|3|||
163981347|NCT01425203|592302677|FG002|Treatment Phase|Other virologic failure criteria|0|||
163981348|NCT01425203|592302675|FG000|Treatment Phase|Unidentified reasons|11|||
163981349|NCT01425203|592302676|FG001|Treatment Phase|Unidentified reasons|5|||
163981350|NCT01425203|592302677|FG002|Treatment Phase|Unidentified reasons|0|||
163981351|NCT01425203|592302675|FG000|Treatment Phase|Did not receive treatment|0|||
163981352|NCT01425203|592302676|FG001|Treatment Phase|Did not receive treatment|1|||
163981353|NCT01425203|592302677|FG002|Treatment Phase|Did not receive treatment|0|||
163981354|NCT01425203|592302675|FG000|Crossover Phase|Failure at futility timepoint|0|||
163981355|NCT01425203|592302676|FG001|Crossover Phase|Failure at futility timepoint|0|||
163981356|NCT01425203|592302677|FG002|Crossover Phase|Failure at futility timepoint|3|||
163981357|NCT01425203|592302675|FG000|Crossover Phase|Other virologic failure criteria|0|||
163981358|NCT01425203|592302676|FG001|Crossover Phase|Other virologic failure criteria|0|||
163981359|NCT01425203|592302677|FG002|Crossover Phase|Other virologic failure criteria|3|||
163981360|NCT00290433|592302680|FG000|Overall Study|Disease Progression|13|||
163981361|NCT00290433|592302680|FG000|Overall Study|Adverse Event|14|||
163981362|NCT00290433|592302680|FG000|Overall Study|Withdrawal by Subject|1|||
163981363|NCT00290433|592302680|FG000|Overall Study|Non-Compliance|1|||
163981364|NCT00290433|592302680|FG000|Overall Study|Congestive Heart Failure|1|||
164216960|NCT04937387|593160526|FG002|Overall Study|Randomized in error|0|||
163876937|NCT03398148|591918874|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
163876938|NCT03398148|591918875|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
163981365|NCT00290433|592302680|FG000|Overall Study|Transplant in CR|5|||
163981366|NCT00290433|592302680|FG000|Overall Study|Unrelated Infection/Death|1|||
163981367|NCT02275338|592302687|FG000|Overall Study|Adverse Event|15|||
164216961|NCT04937387|593160527|FG003|Overall Study|Randomized in error|1|||
164216962|NCT01039675|593160528|FG000|Overall Study|Adverse Event|0|||
164216963|NCT01039675|593160529|FG001|Overall Study|Adverse Event|2|||
164216964|NCT01039675|593160528|FG000|Overall Study|Lack of Efficacy|0|||
164216965|NCT01039675|593160529|FG001|Overall Study|Lack of Efficacy|2|||
164216966|NCT01039675|593160528|FG000|Overall Study|Withdrawal by Subject|0|||
164216967|NCT01039675|593160529|FG001|Overall Study|Withdrawal by Subject|1|||
164216968|NCT01039675|593160528|FG000|Overall Study|Lost to Follow-up|0|||
164216969|NCT01039675|593160529|FG001|Overall Study|Lost to Follow-up|1|||
164216970|NCT01039675|593160528|FG000|Overall Study|Physician Decision|0|||
164216971|NCT01039675|593160529|FG001|Overall Study|Physician Decision|1|||
164216972|NCT00567580|593162011|FG000|Overall Study|Protocol Violation|28|||
164216973|NCT00567580|593162012|FG001|Overall Study|Protocol Violation|24|||
164216974|NCT00567580|593162013|FG002|Overall Study|Protocol Violation|24|||
164216975|NCT01658878|593162014|FG000|Treatment Period|Disease Progression|1|||
164216976|NCT01658878|593162015|FG001|Treatment Period|Disease Progression|3|||
164216977|NCT01658878|593162016|FG002|Treatment Period|Disease Progression|2|||
164216978|NCT01658878|593162017|FG003|Treatment Period|Disease Progression|1|||
164216979|NCT01658878|593162018|FG004|Treatment Period|Disease Progression|13|||
164216980|NCT01658878|593162019|FG005|Treatment Period|Disease Progression|3|||
164216981|NCT01658878|593162020|FG006|Treatment Period|Disease Progression|4|||
164216982|NCT01658878|593162021|FG007|Treatment Period|Disease Progression|3|||
164216983|NCT01658878|593162022|FG008|Treatment Period|Disease Progression|5|||
164216984|NCT01658878|593162023|FG009|Treatment Period|Disease Progression|3|||
164216985|NCT01658878|593162024|FG010|Treatment Period|Disease Progression|3|||
164216986|NCT01658878|593162025|FG011|Treatment Period|Disease Progression|4|||
164216987|NCT01658878|593162026|FG012|Treatment Period|Disease Progression|43|||
164216988|NCT01658878|593162027|FG013|Treatment Period|Disease Progression|48|||
164216989|NCT01658878|593162028|FG014|Treatment Period|Disease Progression|33|||
164216990|NCT01658878|593162029|FG015|Treatment Period|Disease Progression|46|||
164216991|NCT01658878|593162030|FG016|Treatment Period|Disease Progression|41|||
164216992|NCT01658878|593162031|FG017|Treatment Period|Disease Progression|42|||
164216993|NCT01658878|593162032|FG018|Treatment Period|Disease Progression|28|||
164216994|NCT01658878|593162033|FG019|Treatment Period|Disease Progression|37|||
164216995|NCT01658878|593162034|FG020|Treatment Period|Disease Progression|37|||
164216996|NCT01658878|593162035|FG021|Treatment Period|Disease Progression|39|||
164216997|NCT01658878|593162036|FG022|Treatment Period|Disease Progression|27|||
164216998|NCT01658878|593162037|FG023|Treatment Period|Disease Progression|19|||
164216999|NCT01658878|593162014|FG000|Treatment Period|Study Drug Toxicity|0|||
164217000|NCT01658878|593162015|FG001|Treatment Period|Study Drug Toxicity|0|||
164217001|NCT01658878|593162016|FG002|Treatment Period|Study Drug Toxicity|0|||
164217002|NCT01658878|593162017|FG003|Treatment Period|Study Drug Toxicity|1|||
164217003|NCT01658878|593162018|FG004|Treatment Period|Study Drug Toxicity|0|||
164217004|NCT01658878|593162019|FG005|Treatment Period|Study Drug Toxicity|0|||
164217005|NCT01658878|593162020|FG006|Treatment Period|Study Drug Toxicity|0|||
164217006|NCT01658878|593162021|FG007|Treatment Period|Study Drug Toxicity|0|||
164217007|NCT01658878|593162022|FG008|Treatment Period|Study Drug Toxicity|0|||
164217008|NCT01658878|593162023|FG009|Treatment Period|Study Drug Toxicity|0|||
164217009|NCT01658878|593162024|FG010|Treatment Period|Study Drug Toxicity|0|||
164217010|NCT01658878|593162025|FG011|Treatment Period|Study Drug Toxicity|0|||
164217011|NCT01658878|593162026|FG012|Treatment Period|Study Drug Toxicity|7|||
164217012|NCT01658878|593162027|FG013|Treatment Period|Study Drug Toxicity|1|||
164217013|NCT01658878|593162028|FG014|Treatment Period|Study Drug Toxicity|5|||
164217014|NCT01658878|593162029|FG015|Treatment Period|Study Drug Toxicity|0|||
164217015|NCT01658878|593162030|FG016|Treatment Period|Study Drug Toxicity|5|||
164217016|NCT01658878|593162031|FG017|Treatment Period|Study Drug Toxicity|10|||
164217017|NCT01658878|593162032|FG018|Treatment Period|Study Drug Toxicity|12|||
164217018|NCT01658878|593162033|FG019|Treatment Period|Study Drug Toxicity|4|||
164217019|NCT01658878|593162034|FG020|Treatment Period|Study Drug Toxicity|2|||
163876939|NCT03398148|591918876|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
163876940|NCT03398148|591918877|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
163876941|NCT03398148|591918878|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
163876942|NCT03398148|591918879|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
163876943|NCT03398148|591918880|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
163876944|NCT03398148|591918881|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
163876945|NCT03398148|591918867|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164217020|NCT01658878|593162035|FG021|Treatment Period|Study Drug Toxicity|3|||
164217021|NCT01658878|593162036|FG022|Treatment Period|Study Drug Toxicity|2|||
164217022|NCT01658878|593162037|FG023|Treatment Period|Study Drug Toxicity|6|||
164217023|NCT01658878|593162014|FG000|Treatment Period|Maximum Clinical Benefit|0|||
164217024|NCT01658878|593162015|FG001|Treatment Period|Maximum Clinical Benefit|0|||
164217025|NCT01658878|593162016|FG002|Treatment Period|Maximum Clinical Benefit|1|||
164217026|NCT01658878|593162017|FG003|Treatment Period|Maximum Clinical Benefit|0|||
164217027|NCT01658878|593162018|FG004|Treatment Period|Maximum Clinical Benefit|0|||
164217028|NCT01658878|593162019|FG005|Treatment Period|Maximum Clinical Benefit|0|||
164217029|NCT01658878|593162020|FG006|Treatment Period|Maximum Clinical Benefit|0|||
164217030|NCT01658878|593162021|FG007|Treatment Period|Maximum Clinical Benefit|0|||
164217031|NCT01658878|593162022|FG008|Treatment Period|Maximum Clinical Benefit|0|||
164217032|NCT01658878|593162023|FG009|Treatment Period|Maximum Clinical Benefit|0|||
164217033|NCT01658878|593162024|FG010|Treatment Period|Maximum Clinical Benefit|0|||
164217034|NCT01658878|593162025|FG011|Treatment Period|Maximum Clinical Benefit|0|||
164217035|NCT01658878|593162026|FG012|Treatment Period|Maximum Clinical Benefit|0|||
164217036|NCT01658878|593162027|FG013|Treatment Period|Maximum Clinical Benefit|0|||
164217037|NCT01658878|593162028|FG014|Treatment Period|Maximum Clinical Benefit|0|||
164217038|NCT01658878|593162029|FG015|Treatment Period|Maximum Clinical Benefit|0|||
164217039|NCT01658878|593162030|FG016|Treatment Period|Maximum Clinical Benefit|0|||
164217040|NCT01658878|593162031|FG017|Treatment Period|Maximum Clinical Benefit|0|||
164217041|NCT01658878|593162032|FG018|Treatment Period|Maximum Clinical Benefit|1|||
164217042|NCT01658878|593162033|FG019|Treatment Period|Maximum Clinical Benefit|1|||
164217043|NCT01658878|593162034|FG020|Treatment Period|Maximum Clinical Benefit|0|||
164217044|NCT01658878|593162035|FG021|Treatment Period|Maximum Clinical Benefit|0|||
164217045|NCT01658878|593162036|FG022|Treatment Period|Maximum Clinical Benefit|0|||
164217046|NCT01658878|593162037|FG023|Treatment Period|Maximum Clinical Benefit|0|||
164217047|NCT01658878|593162014|FG000|Treatment Period|Other Reasons|0|||
164217048|NCT01658878|593162015|FG001|Treatment Period|Other Reasons|0|||
164217049|NCT01658878|593162016|FG002|Treatment Period|Other Reasons|0|||
164217050|NCT01658878|593162017|FG003|Treatment Period|Other Reasons|1|||
164217051|NCT01658878|593162018|FG004|Treatment Period|Other Reasons|0|||
164217052|NCT01658878|593162019|FG005|Treatment Period|Other Reasons|0|||
164217053|NCT01658878|593162020|FG006|Treatment Period|Other Reasons|0|||
164217054|NCT01658878|593162021|FG007|Treatment Period|Other Reasons|0|||
164217055|NCT01658878|593162022|FG008|Treatment Period|Other Reasons|0|||
164217056|NCT01658878|593162023|FG009|Treatment Period|Other Reasons|0|||
164217057|NCT01658878|593162024|FG010|Treatment Period|Other Reasons|0|||
164217058|NCT01658878|593162025|FG011|Treatment Period|Other Reasons|0|||
164217059|NCT01658878|593162026|FG012|Treatment Period|Other Reasons|2|||
164217060|NCT01658878|593162027|FG013|Treatment Period|Other Reasons|0|||
164217061|NCT01658878|593162028|FG014|Treatment Period|Other Reasons|0|||
164217062|NCT01658878|593162029|FG015|Treatment Period|Other Reasons|2|||
164217063|NCT01658878|593162030|FG016|Treatment Period|Other Reasons|1|||
164217064|NCT01658878|593162031|FG017|Treatment Period|Other Reasons|1|||
164217065|NCT01658878|593162032|FG018|Treatment Period|Other Reasons|3|||
164217066|NCT01658878|593162033|FG019|Treatment Period|Other Reasons|1|||
164217067|NCT01658878|593162034|FG020|Treatment Period|Other Reasons|4|||
164217068|NCT01658878|593162035|FG021|Treatment Period|Other Reasons|0|||
164217069|NCT01658878|593162036|FG022|Treatment Period|Other Reasons|0|||
164217070|NCT01658878|593162037|FG023|Treatment Period|Other Reasons|4|||
164217071|NCT01658878|593162014|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217072|NCT01658878|593162015|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217073|NCT01658878|593162016|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217074|NCT01658878|593162017|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217075|NCT01658878|593162018|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217076|NCT01658878|593162019|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217077|NCT01658878|593162020|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217078|NCT01658878|593162021|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217079|NCT01658878|593162022|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217080|NCT01658878|593162023|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217081|NCT01658878|593162024|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217082|NCT01658878|593162025|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217083|NCT01658878|593162026|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217084|NCT01658878|593162027|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217085|NCT01658878|593162028|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
164217086|NCT01658878|593162029|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217087|NCT01658878|593162030|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217088|NCT01658878|593162031|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
164217089|NCT01658878|593162032|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217090|NCT01658878|593162033|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217091|NCT01658878|593162034|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217092|NCT01658878|593162035|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217093|NCT01658878|593162036|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217094|NCT01658878|593162037|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164217095|NCT01658878|593162014|FG000|Treatment Period|Poor/Non-compliance|0|||
164217096|NCT01658878|593162015|FG001|Treatment Period|Poor/Non-compliance|0|||
164217097|NCT01658878|593162016|FG002|Treatment Period|Poor/Non-compliance|0|||
164217098|NCT01658878|593162017|FG003|Treatment Period|Poor/Non-compliance|0|||
164217099|NCT01658878|593162018|FG004|Treatment Period|Poor/Non-compliance|0|||
163981368|NCT02275338|592302687|FG000|Overall Study|Lack of Efficacy|3|||
164217100|NCT01658878|593162019|FG005|Treatment Period|Poor/Non-compliance|0|||
164217101|NCT01658878|593162020|FG006|Treatment Period|Poor/Non-compliance|0|||
164217102|NCT01658878|593162021|FG007|Treatment Period|Poor/Non-compliance|0|||
164217103|NCT01658878|593162022|FG008|Treatment Period|Poor/Non-compliance|0|||
164217104|NCT01658878|593162023|FG009|Treatment Period|Poor/Non-compliance|0|||
164217105|NCT01658878|593162024|FG010|Treatment Period|Poor/Non-compliance|0|||
164217106|NCT01658878|593162025|FG011|Treatment Period|Poor/Non-compliance|0|||
164217107|NCT01658878|593162026|FG012|Treatment Period|Poor/Non-compliance|0|||
164217108|NCT01658878|593162027|FG013|Treatment Period|Poor/Non-compliance|0|||
164217109|NCT01658878|593162028|FG014|Treatment Period|Poor/Non-compliance|0|||
164217110|NCT01658878|593162029|FG015|Treatment Period|Poor/Non-compliance|1|||
164217111|NCT01658878|593162030|FG016|Treatment Period|Poor/Non-compliance|0|||
164217112|NCT01658878|593162031|FG017|Treatment Period|Poor/Non-compliance|0|||
164217113|NCT01658878|593162032|FG018|Treatment Period|Poor/Non-compliance|0|||
164217114|NCT01658878|593162033|FG019|Treatment Period|Poor/Non-compliance|0|||
164217115|NCT01658878|593162034|FG020|Treatment Period|Poor/Non-compliance|0|||
164217116|NCT01658878|593162035|FG021|Treatment Period|Poor/Non-compliance|0|||
163876946|NCT03398148|591918868|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876947|NCT03398148|591918869|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876948|NCT03398148|591918870|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164217117|NCT01658878|593162036|FG022|Treatment Period|Poor/Non-compliance|0|||
164217118|NCT01658878|593162037|FG023|Treatment Period|Poor/Non-compliance|0|||
164217119|NCT01658878|593162014|FG000|Treatment Period|Participant Withdrew Consent|0|||
164217120|NCT01658878|593162015|FG001|Treatment Period|Participant Withdrew Consent|0|||
164217121|NCT01658878|593162016|FG002|Treatment Period|Participant Withdrew Consent|0|||
164217122|NCT01658878|593162017|FG003|Treatment Period|Participant Withdrew Consent|0|||
164217123|NCT01658878|593162018|FG004|Treatment Period|Participant Withdrew Consent|0|||
164217124|NCT01658878|593162019|FG005|Treatment Period|Participant Withdrew Consent|0|||
164217125|NCT01658878|593162020|FG006|Treatment Period|Participant Withdrew Consent|0|||
164217126|NCT01658878|593162021|FG007|Treatment Period|Participant Withdrew Consent|0|||
164217127|NCT01658878|593162022|FG008|Treatment Period|Participant Withdrew Consent|0|||
164217128|NCT01658878|593162023|FG009|Treatment Period|Participant Withdrew Consent|0|||
164217129|NCT01658878|593162024|FG010|Treatment Period|Participant Withdrew Consent|0|||
164217130|NCT01658878|593162025|FG011|Treatment Period|Participant Withdrew Consent|0|||
164217131|NCT01658878|593162026|FG012|Treatment Period|Participant Withdrew Consent|1|||
164217132|NCT01658878|593162027|FG013|Treatment Period|Participant Withdrew Consent|0|||
164217133|NCT01658878|593162028|FG014|Treatment Period|Participant Withdrew Consent|2|||
164217134|NCT01658878|593162029|FG015|Treatment Period|Participant Withdrew Consent|0|||
164217135|NCT01658878|593162030|FG016|Treatment Period|Participant Withdrew Consent|0|||
164217136|NCT01658878|593162031|FG017|Treatment Period|Participant Withdrew Consent|2|||
164217137|NCT01658878|593162032|FG018|Treatment Period|Participant Withdrew Consent|1|||
164217138|NCT01658878|593162033|FG019|Treatment Period|Participant Withdrew Consent|2|||
164217139|NCT01658878|593162034|FG020|Treatment Period|Participant Withdrew Consent|1|||
164217140|NCT01658878|593162035|FG021|Treatment Period|Participant Withdrew Consent|0|||
164217141|NCT01658878|593162036|FG022|Treatment Period|Participant Withdrew Consent|2|||
164217142|NCT01658878|593162037|FG023|Treatment Period|Participant Withdrew Consent|2|||
164217143|NCT01658878|593162014|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217144|NCT01658878|593162015|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217145|NCT01658878|593162016|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217146|NCT01658878|593162017|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217147|NCT01658878|593162018|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217148|NCT01658878|593162019|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217149|NCT01658878|593162020|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217150|NCT01658878|593162021|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217151|NCT01658878|593162022|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217152|NCT01658878|593162023|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217153|NCT01658878|593162024|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217154|NCT01658878|593162025|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217155|NCT01658878|593162026|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164217156|NCT01658878|593162027|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
164217157|NCT01658878|593162028|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
164217158|NCT01658878|593162029|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164217159|NCT01658878|593162030|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217160|NCT01658878|593162031|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
163876949|NCT03398148|591918871|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876950|NCT03398148|591918872|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164217161|NCT01658878|593162032|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164299699|NCT00283296|593472900|FG000|Overall Study|in-home trial not completed|5|||
163981369|NCT02275338|592302687|FG000|Overall Study|Withdrawal by Subject|4|||
163981370|NCT02275338|592302687|FG000|Overall Study|Disease progression (death)|1|||
164217162|NCT01658878|593162033|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217163|NCT01658878|593162034|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217164|NCT01658878|593162035|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
164217165|NCT01658878|593162036|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
164217166|NCT01658878|593162037|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
164217167|NCT01658878|593162014|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
164217168|NCT01658878|593162015|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
164217169|NCT01658878|593162016|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
164217170|NCT01658878|593162017|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
164217171|NCT01658878|593162018|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
164217172|NCT01658878|593162019|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
164217173|NCT01658878|593162020|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
164217174|NCT01658878|593162021|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
164217175|NCT01658878|593162022|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
164217176|NCT01658878|593162023|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
164217177|NCT01658878|593162024|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
164217178|NCT01658878|593162025|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
164217179|NCT01658878|593162026|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
164217180|NCT01658878|593162027|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
164217181|NCT01658878|593162028|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
164217182|NCT01658878|593162029|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
164217183|NCT01658878|593162030|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
164217184|NCT01658878|593162031|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
164217185|NCT01658878|593162032|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
164217186|NCT01658878|593162033|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
164217187|NCT01658878|593162034|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
164217188|NCT01658878|593162035|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
164217189|NCT01658878|593162036|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
164217190|NCT01658878|593162037|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
164217191|NCT01658878|593162014|FG000|Treatment Period|Death|0|||
164217192|NCT01658878|593162015|FG001|Treatment Period|Death|0|||
164217193|NCT01658878|593162016|FG002|Treatment Period|Death|0|||
164217194|NCT01658878|593162017|FG003|Treatment Period|Death|0|||
164217195|NCT01658878|593162018|FG004|Treatment Period|Death|0|||
164217196|NCT01658878|593162019|FG005|Treatment Period|Death|0|||
164217197|NCT01658878|593162020|FG006|Treatment Period|Death|0|||
164217198|NCT01658878|593162021|FG007|Treatment Period|Death|0|||
164217199|NCT01658878|593162022|FG008|Treatment Period|Death|0|||
164217200|NCT01658878|593162023|FG009|Treatment Period|Death|0|||
164217201|NCT01658878|593162024|FG010|Treatment Period|Death|0|||
164217202|NCT01658878|593162025|FG011|Treatment Period|Death|0|||
164217203|NCT01658878|593162026|FG012|Treatment Period|Death|1|||
164217204|NCT01658878|593162027|FG013|Treatment Period|Death|0|||
164217205|NCT01658878|593162028|FG014|Treatment Period|Death|0|||
164217206|NCT01658878|593162029|FG015|Treatment Period|Death|0|||
164217207|NCT01658878|593162030|FG016|Treatment Period|Death|1|||
164217208|NCT01658878|593162031|FG017|Treatment Period|Death|1|||
164217209|NCT01658878|593162032|FG018|Treatment Period|Death|0|||
164217210|NCT01658878|593162033|FG019|Treatment Period|Death|0|||
164217211|NCT01658878|593162034|FG020|Treatment Period|Death|0|||
164217212|NCT01658878|593162035|FG021|Treatment Period|Death|2|||
164217213|NCT01658878|593162036|FG022|Treatment Period|Death|0|||
164217214|NCT01658878|593162037|FG023|Treatment Period|Death|0|||
164217215|NCT01658878|593162014|FG000|Treatment Period|Adverse Event|0|||
164217216|NCT01658878|593162015|FG001|Treatment Period|Adverse Event|0|||
164217217|NCT01658878|593162016|FG002|Treatment Period|Adverse Event|0|||
164217218|NCT01658878|593162017|FG003|Treatment Period|Adverse Event|0|||
164217219|NCT01658878|593162018|FG004|Treatment Period|Adverse Event|0|||
164217220|NCT01658878|593162019|FG005|Treatment Period|Adverse Event|0|||
164217221|NCT01658878|593162020|FG006|Treatment Period|Adverse Event|0|||
164217222|NCT01658878|593162021|FG007|Treatment Period|Adverse Event|0|||
164217223|NCT01658878|593162022|FG008|Treatment Period|Adverse Event|0|||
164217224|NCT01658878|593162023|FG009|Treatment Period|Adverse Event|0|||
164217225|NCT01658878|593162024|FG010|Treatment Period|Adverse Event|0|||
164217226|NCT01658878|593162025|FG011|Treatment Period|Adverse Event|0|||
164217227|NCT01658878|593162026|FG012|Treatment Period|Adverse Event|0|||
164217228|NCT01658878|593162027|FG013|Treatment Period|Adverse Event|0|||
164217229|NCT01658878|593162028|FG014|Treatment Period|Adverse Event|0|||
164217230|NCT01658878|593162029|FG015|Treatment Period|Adverse Event|0|||
163981371|NCT02275338|592302687|FG000|Overall Study|Ineligible to start Phase 2|4|||
163981372|NCT02275338|592302687|FG000|Overall Study|Reason not specified|5|||
164217231|NCT01658878|593162030|FG016|Treatment Period|Adverse Event|10|||
164217232|NCT01658878|593162031|FG017|Treatment Period|Adverse Event|3|||
164217233|NCT01658878|593162032|FG018|Treatment Period|Adverse Event|3|||
164217234|NCT01658878|593162033|FG019|Treatment Period|Adverse Event|2|||
164217235|NCT01658878|593162034|FG020|Treatment Period|Adverse Event|3|||
164217236|NCT01658878|593162035|FG021|Treatment Period|Adverse Event|3|||
164217237|NCT01658878|593162036|FG022|Treatment Period|Adverse Event|4|||
164217238|NCT01658878|593162037|FG023|Treatment Period|Adverse Event|3|||
164217239|NCT01658878|593162014|FG000|Treatment Period|Lost to Follow-up|0|||
164217240|NCT01658878|593162015|FG001|Treatment Period|Lost to Follow-up|0|||
164217241|NCT01658878|593162016|FG002|Treatment Period|Lost to Follow-up|0|||
164217242|NCT01658878|593162017|FG003|Treatment Period|Lost to Follow-up|0|||
164217243|NCT01658878|593162018|FG004|Treatment Period|Lost to Follow-up|0|||
164217244|NCT01658878|593162019|FG005|Treatment Period|Lost to Follow-up|0|||
164217245|NCT01658878|593162020|FG006|Treatment Period|Lost to Follow-up|0|||
164217246|NCT01658878|593162021|FG007|Treatment Period|Lost to Follow-up|0|||
164217247|NCT01658878|593162022|FG008|Treatment Period|Lost to Follow-up|0|||
164217248|NCT01658878|593162023|FG009|Treatment Period|Lost to Follow-up|0|||
164217249|NCT01658878|593162024|FG010|Treatment Period|Lost to Follow-up|0|||
164217250|NCT01658878|593162025|FG011|Treatment Period|Lost to Follow-up|0|||
164217251|NCT01658878|593162026|FG012|Treatment Period|Lost to Follow-up|0|||
164217252|NCT01658878|593162027|FG013|Treatment Period|Lost to Follow-up|0|||
164217253|NCT01658878|593162028|FG014|Treatment Period|Lost to Follow-up|0|||
164217254|NCT01658878|593162029|FG015|Treatment Period|Lost to Follow-up|0|||
164217255|NCT01658878|593162030|FG016|Treatment Period|Lost to Follow-up|1|||
164217256|NCT01658878|593162031|FG017|Treatment Period|Lost to Follow-up|0|||
164217257|NCT01658878|593162032|FG018|Treatment Period|Lost to Follow-up|1|||
164217258|NCT01658878|593162033|FG019|Treatment Period|Lost to Follow-up|1|||
164217259|NCT01658878|593162034|FG020|Treatment Period|Lost to Follow-up|0|||
164217260|NCT01658878|593162035|FG021|Treatment Period|Lost to Follow-up|0|||
164217261|NCT01658878|593162036|FG022|Treatment Period|Lost to Follow-up|1|||
164217262|NCT01658878|593162037|FG023|Treatment Period|Lost to Follow-up|0|||
164217263|NCT00134719|593162039|FG000|Primary Vaccination Phase|Adverse Event|4|||
164217264|NCT00134719|593162040|FG001|Primary Vaccination Phase|Adverse Event|0|||
164217265|NCT00134719|593162041|FG002|Primary Vaccination Phase|Adverse Event|0|||
164217266|NCT00134719|593162039|FG000|Primary Vaccination Phase|Protocol Violation|1|||
164217267|NCT00134719|593162040|FG001|Primary Vaccination Phase|Protocol Violation|0|||
164217268|NCT00134719|593162041|FG002|Primary Vaccination Phase|Protocol Violation|0|||
164217269|NCT00134719|593162039|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
164217270|NCT00134719|593162040|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
164217271|NCT00134719|593162041|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
164217272|NCT00134719|593162039|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
164217273|NCT00134719|593162040|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
164217274|NCT00134719|593162041|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
164217275|NCT00134719|593162039|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
164217276|NCT00134719|593162040|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
164217277|NCT00134719|593162041|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
164217278|NCT00134719|593162039|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
164217279|NCT00134719|593162040|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
164217280|NCT00134719|593162041|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
164217281|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217282|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
164217283|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
164217284|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217285|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217286|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217287|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
164217288|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
164217289|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217290|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
164217291|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217292|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217293|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217294|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
164217295|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217296|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217297|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
164326757|NCT00356122|593571616|FG000|TREATMENT|Did not receive study medication|1|||
164217298|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217299|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217300|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217301|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
164217302|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
164217303|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217304|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217305|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217306|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217307|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217308|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
164217309|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217310|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217311|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
164217312|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217313|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217314|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217315|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
164217316|NCT01807520|593162042|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
164217317|NCT01807520|593162043|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217318|NCT01807520|593162044|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217319|NCT01807520|593162045|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217320|NCT01807520|593162046|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217321|NCT01807520|593162047|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217322|NCT01807520|593162048|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
164217323|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
164217324|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
164217325|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217326|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217327|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
164217328|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217329|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
164217330|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217331|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217332|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217333|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
164217334|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217335|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217336|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
164217337|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
164217338|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217339|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217340|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217341|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217342|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217343|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
164217344|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217345|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
164217346|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217347|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217348|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217349|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217350|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
164217351|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
164217352|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217353|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217354|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
164217355|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217356|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217357|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
164217358|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
164217359|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
164217360|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217361|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217362|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
164217363|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217364|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
164217365|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
164217366|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
164217367|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217368|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
164217369|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217370|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217371|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
164217372|NCT01807520|593162042|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
164217373|NCT01807520|593162043|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
164217374|NCT01807520|593162044|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
164217375|NCT01807520|593162045|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
164217376|NCT01807520|593162046|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
164217377|NCT01807520|593162047|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
164217378|NCT01807520|593162048|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
164217379|NCT01807520|593162042|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217380|NCT01807520|593162043|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217381|NCT01807520|593162044|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217382|NCT01807520|593162045|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217383|NCT01807520|593162046|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217384|NCT01807520|593162047|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
164217385|NCT01807520|593162048|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
164217386|NCT01807520|593162042|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217387|NCT01807520|593162043|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
163876951|NCT03398148|591918873|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876952|NCT03398148|591918874|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164217388|NCT01807520|593162044|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217389|NCT01807520|593162045|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217390|NCT01807520|593162046|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217391|NCT01807520|593162047|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
164217392|NCT01807520|593162048|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
164217393|NCT01807520|593162042|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217394|NCT01807520|593162043|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217395|NCT01807520|593162044|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217396|NCT01807520|593162045|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217397|NCT01807520|593162046|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
164217398|NCT01807520|593162047|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
164217399|NCT01807520|593162048|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
164217400|NCT00620035|593162051|FG000|Overall Study|Adverse Event|106|||
164217401|NCT00620035|593162051|FG000|Overall Study|Withdrawal of Informed Consent|1|||
164217402|NCT00620035|593162051|FG000|Overall Study|Other Reason|38|||
164217403|NCT03600350|593162053|FG000|Overall Study|Death|1|||
164217404|NCT03600350|593162053|FG000|Overall Study|On Follow Up|18|||
164217405|NCT02400736|593162054|FG000|Overall Study|Lost to Follow-up|6|||
164217406|NCT02400736|593162055|FG001|Overall Study|Lost to Follow-up|6|||
164217407|NCT02400736|593162054|FG000|Overall Study|Withdrawal by Subject|2|||
164217408|NCT02400736|593162055|FG001|Overall Study|Withdrawal by Subject|1|||
164326758|NCT00356122|593571616|FG000|FOLLOW-UP|Death|37|||
164326759|NCT00356122|593571616|FG000|FOLLOW-UP|Lost to Follow-up|2|||
164326760|NCT00356122|593571616|FG000|FOLLOW-UP|Other|2|||
164326761|NCT00636987|593572546|FG000|Overall Study|Death|44|||
164326762|NCT00636987|593572546|FG000|Overall Study|Explanted|13|||
164326763|NCT00636987|593572546|FG000|Overall Study|Lost to Follow-up|63|||
164326764|NCT00636987|593572546|FG000|Overall Study|5 year visit window not complete|69|||
164326765|NCT03954041|593572552|FG000|Overall Study|Lost to Follow-up|3|||
164326766|NCT03954041|593572553|FG001|Overall Study|Lost to Follow-up|3|||
164326767|NCT03954041|593572554|FG002|Overall Study|Lost to Follow-up|6|||
164326768|NCT03954041|593572552|FG000|Overall Study|Death|4|||
164326769|NCT03954041|593572553|FG001|Overall Study|Death|0|||
164326770|NCT03954041|593572554|FG002|Overall Study|Death|1|||
164326771|NCT03954041|593572552|FG000|Overall Study|Death by neurologic criteria|0|||
164326772|NCT03954041|593572553|FG001|Overall Study|Death by neurologic criteria|0|||
164326773|NCT03954041|593572554|FG002|Overall Study|Death by neurologic criteria|1|||
164326774|NCT03954041|593572552|FG000|Overall Study|Reason not specified|7|||
163876953|NCT03398148|591918875|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876954|NCT03398148|591918876|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876955|NCT03398148|591918877|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
163876956|NCT03398148|591918878|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164078157|NCT02092961|592651496|FG001|Overall Study|Adverse Event|4|||
164217409|NCT02400736|593162054|FG000|Overall Study|Moved from the area|3|||
164217410|NCT02400736|593162055|FG001|Overall Study|Moved from the area|1|||
164217411|NCT01771913|593162056|FG000|Overall Study|Withdrawal by Subject|1|||
164217412|NCT01771913|593162057|FG001|Overall Study|Withdrawal by Subject|0|||
164326775|NCT03954041|593572553|FG001|Overall Study|Reason not specified|4|||
163876957|NCT03398148|591918879|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
164217413|NCT04621760|593162058|FG000|Overall Study|Lost to Follow-up|2|||
164217414|NCT04621760|593162059|FG001|Overall Study|Lost to Follow-up|4|||
164217415|NCT04621760|593162058|FG000|Overall Study|Withdrawal by Subject|1|||
164326776|NCT03954041|593572554|FG002|Overall Study|Reason not specified|2|||
164326777|NCT03954041|593572552|FG000|Overall Study|Withdrew prior to dosing|4|||
164326778|NCT03954041|593572553|FG001|Overall Study|Withdrew prior to dosing|2|||
164326779|NCT03954041|593572554|FG002|Overall Study|Withdrew prior to dosing|0|||
164326780|NCT00442468|593572562|FG000|Overall Study|Adverse Event|4|||
164326781|NCT00442468|593572562|FG000|Overall Study|Withdrawal by Subject|91|||
164326782|NCT00442468|593572562|FG000|Overall Study|Did not complete all study procedures|88|||
164326783|NCT00589784|593572563|FG000|Overall Study|Withdrawal by Subject|0|||
164326784|NCT00589784|593572564|FG001|Overall Study|Withdrawal by Subject|6|||
164326785|NCT00589784|593572563|FG000|Overall Study|Patient inevaluable|1|||
164326786|NCT00589784|593572564|FG001|Overall Study|Patient inevaluable|0|||
164326787|NCT00589784|593572563|FG000|Overall Study|Adverse Event|0|||
164326788|NCT00589784|593572564|FG001|Overall Study|Adverse Event|4|||
164326789|NCT00287079|593572566|FG000|Overall Study|Qualifying relapse|12|||
164326790|NCT00287079|593572567|FG001|Overall Study|Qualifying relapse|1|||
164326791|NCT00287079|593572566|FG000|Overall Study|Non-qualifying relapse|1|||
164326792|NCT00287079|593572567|FG001|Overall Study|Non-qualifying relapse|0|||
164326793|NCT00287079|593572566|FG000|Overall Study|Adverse Event|5|||
164326794|NCT00287079|593572567|FG001|Overall Study|Adverse Event|0|||
164326795|NCT00287079|593572566|FG000|Overall Study|Protocol Violation|1|||
164326796|NCT00287079|593572567|FG001|Overall Study|Protocol Violation|0|||
164326797|NCT00287079|593572566|FG000|Overall Study|Other|3|||
164217416|NCT04621760|593162059|FG001|Overall Study|Withdrawal by Subject|0|||
164217417|NCT02029443|593162060|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
164217418|NCT02029443|593162061|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
164217419|NCT02029443|593162062|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
164217420|NCT02029443|593162063|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
164217421|NCT02029443|593162064|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
164217422|NCT02029443|593162060|FG000|Overall Study|Death|13|||
164217423|NCT02029443|593162061|FG001|Overall Study|Death|2|||
164217424|NCT02029443|593162062|FG002|Overall Study|Death|2|||
164326798|NCT00287079|593572567|FG001|Overall Study|Other|0|||
164326799|NCT02953509|593572572|FG000|Overall Study|Death|1|||
164326800|NCT02953509|593572573|FG001|Overall Study|Death|3|||
164326801|NCT02953509|593572574|FG002|Overall Study|Death|3|||
164326802|NCT02953509|593572575|FG003|Overall Study|Death|4|||
164326803|NCT02953509|593572576|FG004|Overall Study|Death|12|||
164326804|NCT02953509|593572577|FG005|Overall Study|Death|3|||
164326805|NCT02953509|593572578|FG006|Overall Study|Death|25|||
164326806|NCT02953509|593572579|FG007|Overall Study|Death|10|||
164326807|NCT02953509|593572580|FG008|Overall Study|Death|21|||
164326808|NCT02953509|593572581|FG009|Overall Study|Death|20|||
164326809|NCT02953509|593572572|FG000|Overall Study|Reason Not Specified|0|||
164326810|NCT02953509|593572573|FG001|Overall Study|Reason Not Specified|2|||
164326811|NCT02953509|593572574|FG002|Overall Study|Reason Not Specified|8|||
164326812|NCT02953509|593572575|FG003|Overall Study|Reason Not Specified|2|||
164326813|NCT02953509|593572576|FG004|Overall Study|Reason Not Specified|11|||
164326814|NCT02953509|593572577|FG005|Overall Study|Reason Not Specified|4|||
164326815|NCT02953509|593572578|FG006|Overall Study|Reason Not Specified|12|||
164326816|NCT02953509|593572579|FG007|Overall Study|Reason Not Specified|2|||
164326817|NCT02953509|593572580|FG008|Overall Study|Reason Not Specified|7|||
164326818|NCT02953509|593572581|FG009|Overall Study|Reason Not Specified|2|||
164326819|NCT02953509|593572572|FG000|Overall Study|Consent Withdrawn|1|||
164326820|NCT02953509|593572573|FG001|Overall Study|Consent Withdrawn|1|||
164326821|NCT02953509|593572574|FG002|Overall Study|Consent Withdrawn|2|||
164326822|NCT02953509|593572575|FG003|Overall Study|Consent Withdrawn|1|||
164326823|NCT02953509|593572576|FG004|Overall Study|Consent Withdrawn|3|||
164326824|NCT02953509|593572577|FG005|Overall Study|Consent Withdrawn|0|||
164326825|NCT02953509|593572578|FG006|Overall Study|Consent Withdrawn|4|||
164326826|NCT02953509|593572579|FG007|Overall Study|Consent Withdrawn|1|||
164326827|NCT02953509|593572580|FG008|Overall Study|Consent Withdrawn|1|||
164326828|NCT02953509|593572581|FG009|Overall Study|Consent Withdrawn|4|||
164326829|NCT02953509|593572572|FG000|Overall Study|Lost to Follow-up|0|||
164326830|NCT02953509|593572573|FG001|Overall Study|Lost to Follow-up|0|||
164326831|NCT02953509|593572574|FG002|Overall Study|Lost to Follow-up|0|||
164326832|NCT02953509|593572575|FG003|Overall Study|Lost to Follow-up|0|||
164326833|NCT02953509|593572576|FG004|Overall Study|Lost to Follow-up|0|||
164326834|NCT02953509|593572577|FG005|Overall Study|Lost to Follow-up|0|||
164326835|NCT02953509|593572578|FG006|Overall Study|Lost to Follow-up|1|||
164326836|NCT02953509|593572579|FG007|Overall Study|Lost to Follow-up|1|||
164326837|NCT02953509|593572580|FG008|Overall Study|Lost to Follow-up|1|||
164326838|NCT02953509|593572581|FG009|Overall Study|Lost to Follow-up|1|||
164217425|NCT02029443|593162063|FG003|Overall Study|Death|11|||
164078158|NCT02092961|592651497|FG002|Overall Study|Adverse Event|0|||
164217426|NCT02029443|593162064|FG004|Overall Study|Death|2|||
164326839|NCT02953509|593572572|FG000|Overall Study|Study terminated by sponsor|1|||
164326840|NCT02953509|593572573|FG001|Overall Study|Study terminated by sponsor|0|||
164326841|NCT02953509|593572574|FG002|Overall Study|Study terminated by sponsor|0|||
164326842|NCT02953509|593572575|FG003|Overall Study|Study terminated by sponsor|0|||
164326843|NCT02953509|593572576|FG004|Overall Study|Study terminated by sponsor|0|||
164326844|NCT02953509|593572577|FG005|Overall Study|Study terminated by sponsor|0|||
164217427|NCT02029443|593162060|FG000|Overall Study|Lost to Follow-up|1|||
164217428|NCT02029443|593162061|FG001|Overall Study|Lost to Follow-up|0|||
164217429|NCT02029443|593162062|FG002|Overall Study|Lost to Follow-up|1|||
164217430|NCT02029443|593162063|FG003|Overall Study|Lost to Follow-up|1|||
164217431|NCT02029443|593162064|FG004|Overall Study|Lost to Follow-up|0|||
164217432|NCT02029443|593162060|FG000|Overall Study|Started other anti-cancer therapy|17|||
164217433|NCT02029443|593162061|FG001|Overall Study|Started other anti-cancer therapy|4|||
164217434|NCT02029443|593162062|FG002|Overall Study|Started other anti-cancer therapy|7|||
164217435|NCT02029443|593162063|FG003|Overall Study|Started other anti-cancer therapy|9|||
164326845|NCT02953509|593572578|FG006|Overall Study|Study terminated by sponsor|1|||
164326846|NCT02953509|593572579|FG007|Overall Study|Study terminated by sponsor|0|||
164326847|NCT02953509|593572580|FG008|Overall Study|Study terminated by sponsor|1|||
164326848|NCT02953509|593572581|FG009|Overall Study|Study terminated by sponsor|1|||
164326849|NCT02325791|593572586|FG000|Overall Study|Adverse Event|0|||
164326850|NCT02325791|593572587|FG001|Overall Study|Adverse Event|1|||
164326851|NCT02325791|593572588|FG002|Overall Study|Adverse Event|1|||
164326852|NCT02325791|593572589|FG003|Overall Study|Adverse Event|0|||
164326853|NCT02325791|593572586|FG000|Overall Study|Death|0|||
164326854|NCT02325791|593572587|FG001|Overall Study|Death|3|||
164326855|NCT02325791|593572588|FG002|Overall Study|Death|0|||
164326856|NCT02325791|593572589|FG003|Overall Study|Death|1|||
164326857|NCT02325791|593572586|FG000|Overall Study|Lost to Follow-up|0|||
164326858|NCT02325791|593572587|FG001|Overall Study|Lost to Follow-up|15|||
164326859|NCT02325791|593572588|FG002|Overall Study|Lost to Follow-up|14|||
164326860|NCT02325791|593572589|FG003|Overall Study|Lost to Follow-up|9|||
164326861|NCT02325791|593572586|FG000|Overall Study|Physician Decision|0|||
164326862|NCT02325791|593572587|FG001|Overall Study|Physician Decision|1|||
164326863|NCT02325791|593572588|FG002|Overall Study|Physician Decision|1|||
164326864|NCT02325791|593572589|FG003|Overall Study|Physician Decision|0|||
164326865|NCT02325791|593572586|FG000|Overall Study|Protocol Violation|0|||
164326866|NCT02325791|593572587|FG001|Overall Study|Protocol Violation|0|||
164326867|NCT02325791|593572588|FG002|Overall Study|Protocol Violation|1|||
164326868|NCT02325791|593572589|FG003|Overall Study|Protocol Violation|0|||
164326869|NCT02325791|593572586|FG000|Overall Study|Withdrawal by Subject|0|||
164326870|NCT02325791|593572587|FG001|Overall Study|Withdrawal by Subject|5|||
164326871|NCT02325791|593572588|FG002|Overall Study|Withdrawal by Subject|8|||
164326872|NCT02325791|593572589|FG003|Overall Study|Withdrawal by Subject|16|||
164326873|NCT00722371|593572590|FG000|Overall Study|Adverse Event|6|||
164326874|NCT00722371|593572591|FG001|Overall Study|Adverse Event|13|||
164326875|NCT00722371|593572592|FG002|Overall Study|Adverse Event|9|||
164326876|NCT00722371|593572593|FG003|Overall Study|Adverse Event|10|||
164326877|NCT00722371|593572594|FG004|Overall Study|Adverse Event|6|||
164326878|NCT00722371|593572595|FG005|Overall Study|Adverse Event|8|||
164326879|NCT00722371|593572596|FG006|Overall Study|Adverse Event|4|||
164326880|NCT00722371|593572590|FG000|Overall Study|Contraindication|0|||
164326881|NCT00722371|593572591|FG001|Overall Study|Contraindication|0|||
164326882|NCT00722371|593572592|FG002|Overall Study|Contraindication|1|||
164326883|NCT00722371|593572593|FG003|Overall Study|Contraindication|0|||
164326884|NCT00722371|593572594|FG004|Overall Study|Contraindication|0|||
164326885|NCT00722371|593572595|FG005|Overall Study|Contraindication|0|||
164326886|NCT00722371|593572596|FG006|Overall Study|Contraindication|0|||
164326887|NCT00722371|593572590|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
164326888|NCT00722371|593572591|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
164326889|NCT00722371|593572592|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
164326890|NCT00722371|593572593|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
164326891|NCT00722371|593572594|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
163981373|NCT02275338|592302687|FG000|Overall Study|Does not meet entry criteria|1|||
163981374|NCT03603496|592302692|FG000|Overall Study|Death|19|||
163981375|NCT03603496|592302693|FG001|Overall Study|Death|24|||
163981376|NCT03603496|592302692|FG000|Overall Study|Lost to Follow-up|141|||
163981377|NCT03603496|592302693|FG001|Overall Study|Lost to Follow-up|141|||
163981378|NCT03603496|592302692|FG000|Overall Study|Withdrawal by Subject|26|||
163981379|NCT03603496|592302693|FG001|Overall Study|Withdrawal by Subject|20|||
163981380|NCT00004259|592302696|FG000|Overall Study|Protocol Violation|1|||
163981381|NCT00004259|592302697|FG001|Overall Study|Protocol Violation|2|||
163981382|NCT00004259|592302698|FG002|Overall Study|Protocol Violation|0|||
163981383|NCT00004259|592302699|FG003|Overall Study|Protocol Violation|0|||
163981384|NCT00004259|592302696|FG000|Overall Study|Withdrawal by Subject|0|||
163981385|NCT00004259|592302697|FG001|Overall Study|Withdrawal by Subject|2|||
163981386|NCT00004259|592302698|FG002|Overall Study|Withdrawal by Subject|0|||
163981387|NCT00004259|592302699|FG003|Overall Study|Withdrawal by Subject|0|||
163981388|NCT03594227|592302700|FG000|Overall Study|Adverse Event|2|||
163981389|NCT03594227|592302701|FG001|Overall Study|Adverse Event|1|||
163981390|NCT03594227|592302702|FG002|Overall Study|Adverse Event|0|||
164217436|NCT02029443|593162064|FG004|Overall Study|Started other anti-cancer therapy|3|||
164326892|NCT00722371|593572595|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
164326893|NCT00722371|593572596|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
164326894|NCT00722371|593572590|FG000|Overall Study|Excluded medication|0|||
164217437|NCT02029443|593162060|FG000|Overall Study|Withdrawal by Subject|3|||
164217438|NCT02029443|593162061|FG001|Overall Study|Withdrawal by Subject|1|||
164217439|NCT02029443|593162062|FG002|Overall Study|Withdrawal by Subject|1|||
164217440|NCT02029443|593162063|FG003|Overall Study|Withdrawal by Subject|1|||
164217441|NCT02029443|593162064|FG004|Overall Study|Withdrawal by Subject|0|||
164326895|NCT00722371|593572591|FG001|Overall Study|Excluded medication|1|||
164326896|NCT00722371|593572592|FG002|Overall Study|Excluded medication|1|||
164326897|NCT00722371|593572593|FG003|Overall Study|Excluded medication|0|||
164326898|NCT00722371|593572594|FG004|Overall Study|Excluded medication|0|||
164326899|NCT00722371|593572595|FG005|Overall Study|Excluded medication|0|||
164326900|NCT00722371|593572596|FG006|Overall Study|Excluded medication|1|||
164326901|NCT00722371|593572590|FG000|Overall Study|Hyperglycemia|2|||
164326902|NCT00722371|593572591|FG001|Overall Study|Hyperglycemia|6|||
164326903|NCT00722371|593572592|FG002|Overall Study|Hyperglycemia|4|||
164326904|NCT00722371|593572593|FG003|Overall Study|Hyperglycemia|2|||
164326905|NCT00722371|593572594|FG004|Overall Study|Hyperglycemia|5|||
164217442|NCT02029443|593162060|FG000|Overall Study|Other|6|||
164217443|NCT02029443|593162061|FG001|Overall Study|Other|6|||
164217444|NCT02029443|593162062|FG002|Overall Study|Other|4|||
164217445|NCT02029443|593162063|FG003|Overall Study|Other|2|||
164217446|NCT02029443|593162064|FG004|Overall Study|Other|0|||
164217447|NCT00366535|593162065|FG000|First Phase: 12 Weeks|Adverse Event|1|||
164217448|NCT00366535|593162066|FG001|First Phase: 12 Weeks|Adverse Event|3|||
164217449|NCT00366535|593162065|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
164217450|NCT00366535|593162066|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
164217451|NCT00366535|593162065|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
164217452|NCT00366535|593162066|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
164217453|NCT00366535|593162065|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
164217454|NCT00366535|593162066|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
164217455|NCT06042855|593162071|FG000|Overall Study|No Receipt of Study Drug|48|||
164217456|NCT06042855|593162072|FG001|Overall Study|No Receipt of Study Drug|57|||
164217457|NCT06042855|593162071|FG000|Overall Study|Administratively Withdrawn|59|||
164217458|NCT06042855|593162072|FG001|Overall Study|Administratively Withdrawn|59|||
164217459|NCT01428128|593162077|FG000|Overall Study|Withdrawal by Subject|4|||
164217460|NCT01428128|593162077|FG000|Overall Study|Screen failure by p53|10|||
164217461|NCT01428128|593162077|FG000|Overall Study|Received Neulasta in one cycle|2|||
164217462|NCT01428128|593162077|FG000|Overall Study|Adverse Event|1|||
164217463|NCT06100250|593162079|FG000|Overall Study|Lost to Follow-up|5|||
164217464|NCT05259033|593162081|FG000|Overall Study|Withdrawal by Subject|10|||
164217465|NCT05259033|593162082|FG001|Overall Study|Withdrawal by Subject|5|||
164217466|NCT05259033|593162081|FG000|Overall Study|Lost to Follow-up|1|||
164217467|NCT05259033|593162082|FG001|Overall Study|Lost to Follow-up|0|||
164217468|NCT05259033|593162081|FG000|Overall Study|Death|2|||
164217469|NCT05259033|593162082|FG001|Overall Study|Death|0|||
164217470|NCT05537571|593162083|FG000|Overall Study|Withdrawal by Subject|1|||
164217471|NCT05537571|593162084|FG001|Overall Study|Withdrawal by Subject|1|||
164217472|NCT05537571|593162085|FG002|Overall Study|Withdrawal by Subject|0|||
164217473|NCT05537571|593162086|FG003|Overall Study|Withdrawal by Subject|0|||
164217474|NCT05537571|593162087|FG004|Overall Study|Withdrawal by Subject|0|||
164217475|NCT05537571|593162083|FG000|Overall Study|Adverse Event|2|||
164217476|NCT05537571|593162084|FG001|Overall Study|Adverse Event|0|||
164217477|NCT05537571|593162085|FG002|Overall Study|Adverse Event|0|||
164217478|NCT05537571|593162086|FG003|Overall Study|Adverse Event|0|||
164217479|NCT05537571|593162087|FG004|Overall Study|Adverse Event|0|||
164217480|NCT05537571|593162083|FG000|Overall Study|Hepatitis A screening result|2|||
164217481|NCT05537571|593162084|FG001|Overall Study|Hepatitis A screening result|0|||
164217482|NCT05537571|593162085|FG002|Overall Study|Hepatitis A screening result|0|||
164217483|NCT05537571|593162086|FG003|Overall Study|Hepatitis A screening result|0|||
164217484|NCT05537571|593162087|FG004|Overall Study|Hepatitis A screening result|0|||
164217485|NCT05537571|593162083|FG000|Overall Study|Lost to Follow-up|0|||
164217486|NCT05537571|593162084|FG001|Overall Study|Lost to Follow-up|0|||
164217487|NCT05537571|593162085|FG002|Overall Study|Lost to Follow-up|1|||
164217488|NCT05537571|593162086|FG003|Overall Study|Lost to Follow-up|0|||
164217489|NCT05537571|593162087|FG004|Overall Study|Lost to Follow-up|1|||
164217490|NCT06375655|593162088|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
164217491|NCT06375655|593162089|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
164217492|NCT00283959|593162091|FG000|Extension Period|Low Compliance|1|||
164217493|NCT05865886|593162092|FG000|Overall Study|Serious adverse event|0|||
164217494|NCT05865886|593162093|FG001|Overall Study|Serious adverse event|1|||
164217495|NCT06394323|593162094|FG000|Overall Study|Death|0|||
164217496|NCT06394323|593162095|FG001|Overall Study|Death|1|||
164217497|NCT06394323|593162096|FG002|Overall Study|Death|0|||
164217498|NCT06394323|593162097|FG003|Overall Study|Death|0|||
164217499|NCT06394323|593162094|FG000|Overall Study|Physician Decision|0|||
164217500|NCT06394323|593162095|FG001|Overall Study|Physician Decision|2|||
164217501|NCT06394323|593162096|FG002|Overall Study|Physician Decision|0|||
164217502|NCT06394323|593162097|FG003|Overall Study|Physician Decision|0|||
164217503|NCT06394323|593162094|FG000|Overall Study|Withdrawal by Subject|4|||
163981391|NCT03594227|592302703|FG003|Overall Study|Adverse Event|2|||
163981392|NCT03594227|592302700|FG000|Overall Study|Lost to Follow-up|1|||
163981393|NCT03594227|592302701|FG001|Overall Study|Lost to Follow-up|1|||
163981394|NCT03594227|592302702|FG002|Overall Study|Lost to Follow-up|1|||
163981395|NCT03594227|592302703|FG003|Overall Study|Lost to Follow-up|0|||
163981396|NCT03594227|592302700|FG000|Overall Study|Withdrawal by Subject|1|||
163981397|NCT03594227|592302701|FG001|Overall Study|Withdrawal by Subject|1|||
163981398|NCT03594227|592302702|FG002|Overall Study|Withdrawal by Subject|1|||
163981399|NCT03594227|592302703|FG003|Overall Study|Withdrawal by Subject|1|||
163981400|NCT03594227|592302700|FG000|Overall Study|Pregnancy|0|||
163981401|NCT03594227|592302701|FG001|Overall Study|Pregnancy|1|||
163981402|NCT03594227|592302702|FG002|Overall Study|Pregnancy|0|||
163981403|NCT03594227|592302703|FG003|Overall Study|Pregnancy|0|||
163981404|NCT03594227|592302700|FG000|Overall Study|Sponsor Decision|0|||
163981405|NCT03594227|592302701|FG001|Overall Study|Sponsor Decision|0|||
163981406|NCT03594227|592302702|FG002|Overall Study|Sponsor Decision|0|||
163981407|NCT03594227|592302703|FG003|Overall Study|Sponsor Decision|1|||
163981408|NCT03594227|592302700|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
163981409|NCT03594227|592302701|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
163981410|NCT03594227|592302702|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
163981411|NCT03594227|592302703|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
163981412|NCT00109707|592302709|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
163981413|NCT00109707|592302710|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
163981414|NCT00109707|592302711|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
163981415|NCT00109707|592302709|FG000|Overall Study|Abnormal laboratory values|1|||
163981416|NCT00109707|592302710|FG001|Overall Study|Abnormal laboratory values|0|||
163981417|NCT00109707|592302711|FG002|Overall Study|Abnormal laboratory values|0|||
163981418|NCT00109707|592302709|FG000|Overall Study|Administrative problems|2|||
163981419|NCT00109707|592302710|FG001|Overall Study|Administrative problems|0|||
163981420|NCT00109707|592302711|FG002|Overall Study|Administrative problems|1|||
163981421|NCT00109707|592302709|FG000|Overall Study|Adverse Event|10|||
163981422|NCT00109707|592302710|FG001|Overall Study|Adverse Event|2|||
163981423|NCT00109707|592302711|FG002|Overall Study|Adverse Event|3|||
164326906|NCT00722371|593572595|FG005|Overall Study|Hyperglycemia|1|||
164326907|NCT00722371|593572596|FG006|Overall Study|Hyperglycemia|1|||
164326908|NCT00722371|593572590|FG000|Overall Study|Hypoglycemia|1|||
164326909|NCT00722371|593572591|FG001|Overall Study|Hypoglycemia|0|||
164326910|NCT00722371|593572592|FG002|Overall Study|Hypoglycemia|0|||
164326911|NCT00722371|593572593|FG003|Overall Study|Hypoglycemia|0|||
164326912|NCT00722371|593572594|FG004|Overall Study|Hypoglycemia|0|||
164326913|NCT00722371|593572595|FG005|Overall Study|Hypoglycemia|0|||
164326914|NCT00722371|593572596|FG006|Overall Study|Hypoglycemia|0|||
164326915|NCT00722371|593572590|FG000|Overall Study|Lack of Efficacy|4|||
164326916|NCT00722371|593572591|FG001|Overall Study|Lack of Efficacy|6|||
164326917|NCT00722371|593572592|FG002|Overall Study|Lack of Efficacy|6|||
164326918|NCT00722371|593572593|FG003|Overall Study|Lack of Efficacy|6|||
164326919|NCT00722371|593572594|FG004|Overall Study|Lack of Efficacy|2|||
164326920|NCT00722371|593572595|FG005|Overall Study|Lack of Efficacy|3|||
164326921|NCT00722371|593572596|FG006|Overall Study|Lack of Efficacy|0|||
164326922|NCT00722371|593572590|FG000|Overall Study|Lost to Follow-up|11|||
164326923|NCT00722371|593572591|FG001|Overall Study|Lost to Follow-up|14|||
164326924|NCT00722371|593572592|FG002|Overall Study|Lost to Follow-up|21|||
164326925|NCT00722371|593572593|FG003|Overall Study|Lost to Follow-up|13|||
164326926|NCT00722371|593572594|FG004|Overall Study|Lost to Follow-up|8|||
164326927|NCT00722371|593572595|FG005|Overall Study|Lost to Follow-up|16|||
163981424|NCT00109707|592302709|FG000|Overall Study|Death|4|||
163981425|NCT00109707|592302710|FG001|Overall Study|Death|0|||
163981426|NCT00109707|592302711|FG002|Overall Study|Death|0|||
164078159|NCT01623830|592651500|FG000|Overall Study|Withdrawal by Subject|6|||
164326928|NCT00722371|593572596|FG006|Overall Study|Lost to Follow-up|13|||
164326929|NCT00722371|593572590|FG000|Overall Study|Physician Decision|5|||
164326930|NCT00722371|593572591|FG001|Overall Study|Physician Decision|2|||
164326931|NCT00722371|593572592|FG002|Overall Study|Physician Decision|2|||
164326932|NCT00722371|593572593|FG003|Overall Study|Physician Decision|5|||
164326933|NCT00722371|593572594|FG004|Overall Study|Physician Decision|2|||
164326934|NCT00722371|593572595|FG005|Overall Study|Physician Decision|3|||
164326935|NCT00722371|593572596|FG006|Overall Study|Physician Decision|4|||
164078160|NCT01623830|592651501|FG001|Overall Study|Withdrawal by Subject|7|||
164326936|NCT00722371|593572590|FG000|Overall Study|Pregnancy|1|||
164326937|NCT00722371|593572591|FG001|Overall Study|Pregnancy|1|||
163981427|NCT00109707|592302709|FG000|Overall Study|Disease progression|12|||
164078161|NCT01623830|592651500|FG000|Overall Study|Exclusion from Study|1|||
164326938|NCT00722371|593572592|FG002|Overall Study|Pregnancy|0|||
164326939|NCT00722371|593572593|FG003|Overall Study|Pregnancy|0|||
163981428|NCT00109707|592302710|FG001|Overall Study|Disease progression|4|||
163981429|NCT00109707|592302711|FG002|Overall Study|Disease progression|3|||
163981430|NCT00109707|592302709|FG000|Overall Study|Lost to Follow-up|3|||
163981431|NCT00109707|592302710|FG001|Overall Study|Lost to Follow-up|0|||
164326940|NCT00722371|593572594|FG004|Overall Study|Pregnancy|0|||
164217504|NCT06394323|593162095|FG001|Overall Study|Withdrawal by Subject|4|||
164217505|NCT06394323|593162096|FG002|Overall Study|Withdrawal by Subject|0|||
164217506|NCT06394323|593162097|FG003|Overall Study|Withdrawal by Subject|0|||
164217507|NCT01778985|593162982|FG000|Overall Study|Lost to Follow-up|1|||
164217508|NCT01778985|593162983|FG001|Overall Study|Lost to Follow-up|0|||
164217509|NCT01778985|593162982|FG000|Overall Study|Physician Decision|2|||
164217510|NCT01778985|593162983|FG001|Overall Study|Physician Decision|2|||
164217511|NCT01778985|593162982|FG000|Overall Study|Protocol Violation|4|||
164217512|NCT01778985|593162983|FG001|Overall Study|Protocol Violation|1|||
164217513|NCT01002105|593162984|FG000|Overall Study|Lost to Follow-up|10|||
164217514|NCT01002105|593162985|FG001|Overall Study|Lost to Follow-up|16|||
164217515|NCT01002105|593162984|FG000|Overall Study|non compliance|5|||
164326941|NCT00722371|593572595|FG005|Overall Study|Pregnancy|1|||
164326942|NCT00722371|593572596|FG006|Overall Study|Pregnancy|0|||
164326943|NCT00722371|593572590|FG000|Overall Study|Protocol Violation|6|||
164326944|NCT00722371|593572591|FG001|Overall Study|Protocol Violation|1|||
164326945|NCT00722371|593572592|FG002|Overall Study|Protocol Violation|0|||
164326946|NCT00722371|593572593|FG003|Overall Study|Protocol Violation|1|||
164326947|NCT00722371|593572594|FG004|Overall Study|Protocol Violation|4|||
164326948|NCT00722371|593572595|FG005|Overall Study|Protocol Violation|2|||
164326949|NCT00722371|593572596|FG006|Overall Study|Protocol Violation|1|||
164326950|NCT00722371|593572590|FG000|Overall Study|Withdrawal by Subject|18|||
164326951|NCT00722371|593572591|FG001|Overall Study|Withdrawal by Subject|27|||
164326952|NCT00722371|593572592|FG002|Overall Study|Withdrawal by Subject|19|||
164326953|NCT00722371|593572593|FG003|Overall Study|Withdrawal by Subject|23|||
164326954|NCT00722371|593572594|FG004|Overall Study|Withdrawal by Subject|19|||
164326955|NCT00722371|593572595|FG005|Overall Study|Withdrawal by Subject|18|||
164326956|NCT00722371|593572596|FG006|Overall Study|Withdrawal by Subject|26|||
164326957|NCT00718237|593572597|FG000|Overall Study|Adverse Event|1|||
164326958|NCT00718237|593572598|FG001|Overall Study|Adverse Event|3|||
164326959|NCT00718237|593572597|FG000|Overall Study|Lost to Follow-up|2|||
164326960|NCT00718237|593572598|FG001|Overall Study|Lost to Follow-up|2|||
164326961|NCT00718237|593572597|FG000|Overall Study|Physician Decision|1|||
164326962|NCT00718237|593572598|FG001|Overall Study|Physician Decision|0|||
164326963|NCT00718237|593572597|FG000|Overall Study|Withdrawal by Subject|9|||
164326964|NCT00718237|593572598|FG001|Overall Study|Withdrawal by Subject|10|||
164326965|NCT00555425|593572599|FG000|Overall Study|Missed Medication > 1 wk|34|||
164326966|NCT00555425|593572600|FG001|Overall Study|Missed Medication > 1 wk|15|||
164326967|NCT00555425|593572599|FG000|Overall Study|Missed 3 physician management visits|1|||
164326968|NCT00555425|593572600|FG001|Overall Study|Missed 3 physician management visits|0|||
164326969|NCT00555425|593572599|FG000|Overall Study|Met criteria for protective transfer|16|||
164326970|NCT00555425|593572600|FG001|Overall Study|Met criteria for protective transfer|3|||
164326971|NCT00555425|593572599|FG000|Overall Study|Became pregnant and transferred care|0|||
164326972|NCT00555425|593572600|FG001|Overall Study|Became pregnant and transferred care|1|||
164326973|NCT01185834|593572601|FG000|Overall Study|Lost to Follow-up|2|||
164326974|NCT01185834|593572601|FG000|Overall Study|Discomfort|4|||
164326975|NCT01185834|593572601|FG000|Overall Study|Biomicroscopy|4|||
164326976|NCT01185834|593572601|FG000|Overall Study|Time/Job Conflict|2|||
164326977|NCT01185834|593572601|FG000|Overall Study|Early exit - Site error|2|||
164326978|NCT02694718|593572603|FG000|Overall Study|Death|1|||
164326979|NCT02694718|593572603|FG000|Overall Study|Withdrawal by Subject|1|||
164326980|NCT00322153|593572605|FG000|Overall Study|Adverse Event|21|||
164326981|NCT00322153|593572606|FG001|Overall Study|Adverse Event|34|||
164326982|NCT00322153|593572605|FG000|Overall Study|Protocol Violation|6|||
164326983|NCT00322153|593572606|FG001|Overall Study|Protocol Violation|14|||
164326984|NCT00322153|593572605|FG000|Overall Study|Withdrawal by Subject|18|||
164326985|NCT00322153|593572606|FG001|Overall Study|Withdrawal by Subject|10|||
164326986|NCT00322153|593572605|FG000|Overall Study|Lack of Efficacy|8|||
164326987|NCT00322153|593572606|FG001|Overall Study|Lack of Efficacy|3|||
163876958|NCT03398148|591918880|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876959|NCT03398148|591918881|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
163876960|NCT03398148|591918867|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164326988|NCT00322153|593572605|FG000|Overall Study|Lost to Follow-up|5|||
164326989|NCT00322153|593572606|FG001|Overall Study|Lost to Follow-up|4|||
164326990|NCT00322153|593572605|FG000|Overall Study|Withdrawn for other reasons|5|||
164326991|NCT00322153|593572606|FG001|Overall Study|Withdrawn for other reasons|4|||
163876961|NCT03398148|591918868|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164326992|NCT03523000|593572608|FG000|Overall Study|Withdrawal by Subject|3|||
164326993|NCT03523000|593572609|FG001|Overall Study|Withdrawal by Subject|0|||
164326994|NCT03523000|593572608|FG000|Overall Study|Unsuccessful trial|2|||
164217516|NCT01002105|593162985|FG001|Overall Study|non compliance|3|||
164217517|NCT01002105|593162984|FG000|Overall Study|condition worsened|4|||
164217518|NCT01002105|593162985|FG001|Overall Study|condition worsened|2|||
164217519|NCT00552058|593162986|FG000|Overall Study|Adverse Event|8|||
164326995|NCT03523000|593572609|FG001|Overall Study|Unsuccessful trial|0|||
164326996|NCT00772070|593572610|FG000|Overall Study|Lost to Follow-up|0|||
164326997|NCT00772070|593572611|FG001|Overall Study|Lost to Follow-up|8|||
164326998|NCT00772070|593572610|FG000|Overall Study|Withdrawal by Subject|0|||
163981432|NCT00109707|592302711|FG002|Overall Study|Lost to Follow-up|0|||
163981433|NCT00109707|592302709|FG000|Overall Study|Protocol Violation|1|||
163981434|NCT00109707|592302710|FG001|Overall Study|Protocol Violation|0|||
163981435|NCT00109707|592302711|FG002|Overall Study|Protocol Violation|0|||
163981436|NCT00109707|592302709|FG000|Overall Study|Patient withdrew consent|6|||
163981437|NCT00109707|592302710|FG001|Overall Study|Patient withdrew consent|1|||
163981438|NCT00109707|592302711|FG002|Overall Study|Patient withdrew consent|0|||
163981439|NCT02111993|592302716|FG000|Overall Study|Physician Decision|5|||
163981440|NCT02111993|592302717|FG001|Overall Study|Physician Decision|4|||
163981441|NCT01400451|592302730|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
163981442|NCT01400451|592302731|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
163981443|NCT01400451|592302732|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
163981444|NCT01400451|592302730|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
163981445|NCT01400451|592302731|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
163981446|NCT01400451|592302732|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
163981447|NCT01400451|592302730|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
163981448|NCT01400451|592302731|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
164217520|NCT00552058|593162987|FG001|Overall Study|Adverse Event|7|||
164217521|NCT00552058|593162986|FG000|Overall Study|Lack of Efficacy|1|||
164217522|NCT00552058|593162987|FG001|Overall Study|Lack of Efficacy|5|||
164217523|NCT00552058|593162986|FG000|Overall Study|Lost to Follow-up|1|||
164217524|NCT00552058|593162987|FG001|Overall Study|Lost to Follow-up|0|||
164217525|NCT00552058|593162986|FG000|Overall Study|Withdrawal by Subject|4|||
164217526|NCT00552058|593162987|FG001|Overall Study|Withdrawal by Subject|4|||
164217527|NCT00552058|593162986|FG000|Overall Study|Other: Protocol Violation|0|||
164217528|NCT00552058|593162987|FG001|Overall Study|Other: Protocol Violation|1|||
164217529|NCT00552058|593162986|FG000|Overall Study|Other: Non Compliance|1|||
164217530|NCT00552058|593162987|FG001|Overall Study|Other: Non Compliance|2|||
164217531|NCT00552058|593162986|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
164217532|NCT00552058|593162987|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
164217533|NCT00552058|593162986|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
164217534|NCT00552058|593162987|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
164217535|NCT00552058|593162986|FG000|Overall Study|Other: Positive Stool Result|0|||
164217536|NCT00552058|593162987|FG001|Overall Study|Other: Positive Stool Result|1|||
164217537|NCT00552058|593162986|FG000|Overall Study|Other: Randomized in error|0|||
164217538|NCT00552058|593162987|FG001|Overall Study|Other: Randomized in error|1|||
164217539|NCT00552058|593162986|FG000|Overall Study|Other: Sponsors Decision|0|||
164217540|NCT00552058|593162987|FG001|Overall Study|Other: Sponsors Decision|1|||
164217541|NCT00552058|593162986|FG000|Overall Study|Other: Early Roll Over|1|||
164217542|NCT00552058|593162987|FG001|Overall Study|Other: Early Roll Over|0|||
164217543|NCT05788328|593162988|FG000|Treatment Period 4 (5 Days)|Other|1|||
164217544|NCT05788328|593162988|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
164217545|NCT00845182|593162989|FG000|Overall Study|Lost to Follow-up|3|||
164217546|NCT00845182|593162990|FG001|Overall Study|Lost to Follow-up|3|||
164217547|NCT00845182|593162991|FG002|Overall Study|Lost to Follow-up|4|||
164217548|NCT00845182|593162989|FG000|Overall Study|Adverse Event|0|||
164217549|NCT00845182|593162990|FG001|Overall Study|Adverse Event|1|||
164217550|NCT00845182|593162991|FG002|Overall Study|Adverse Event|1|||
164217551|NCT00845182|593162989|FG000|Overall Study|Physician Decision|0|||
164217552|NCT00845182|593162990|FG001|Overall Study|Physician Decision|0|||
164217553|NCT00845182|593162991|FG002|Overall Study|Physician Decision|1|||
164217554|NCT01875237|593162992|FG000|Overall Study|GVDH before DLI|1|||
164217555|NCT01875237|593162993|FG001|Overall Study|GVDH before DLI|0|||
164217556|NCT01875237|593162992|FG000|Overall Study|DLI cells could not be produced|1|||
164217557|NCT01875237|593162993|FG001|Overall Study|DLI cells could not be produced|0|||
164217558|NCT05558410|593162994|FG000|Overall Study|Adverse Event|1|||
164217559|NCT05558410|593162995|FG001|Overall Study|Adverse Event|2|||
164217560|NCT05558410|593162996|FG002|Overall Study|Adverse Event|0|||
164217561|NCT05558410|593162994|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
164217562|NCT05558410|593162995|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164217563|NCT05558410|593162996|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
164217564|NCT05558410|593162994|FG000|Overall Study|Lost to Follow-up|10|||
164217565|NCT05558410|593162995|FG001|Overall Study|Lost to Follow-up|17|||
164217566|NCT05558410|593162996|FG002|Overall Study|Lost to Follow-up|19|||
163981449|NCT01400451|592302732|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
163981450|NCT01400451|592302730|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
164217567|NCT05558410|593162994|FG000|Overall Study|Death|1|||
164217568|NCT05558410|593162995|FG001|Overall Study|Death|0|||
164217569|NCT05558410|593162996|FG002|Overall Study|Death|0|||
164217570|NCT05558410|593162994|FG000|Overall Study|Other non-compliance|0|||
164217571|NCT05558410|593162995|FG001|Overall Study|Other non-compliance|1|||
164217572|NCT05558410|593162996|FG002|Overall Study|Other non-compliance|2|||
164217573|NCT05558410|593162994|FG000|Overall Study|Sponsor Decision|1|||
164217574|NCT05558410|593162995|FG001|Overall Study|Sponsor Decision|0|||
164217575|NCT05558410|593162996|FG002|Overall Study|Sponsor Decision|0|||
164217576|NCT05558410|593162994|FG000|Overall Study|Other|1|||
164217577|NCT05558410|593162995|FG001|Overall Study|Other|0|||
164217578|NCT05558410|593162996|FG002|Overall Study|Other|1|||
164326999|NCT00772070|593572611|FG001|Overall Study|Withdrawal by Subject|2|||
164327000|NCT00772070|593572610|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
164327001|NCT00772070|593572611|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
164327002|NCT03993379|593572616|FG000|Overall Study|The study was terminated early due to business decision.|0|||
164327003|NCT03993379|593572617|FG001|Overall Study|The study was terminated early due to business decision.|2|||
164327004|NCT03993379|593572618|FG002|Overall Study|The study was terminated early due to business decision.|0|||
164327005|NCT03993379|593572619|FG003|Overall Study|The study was terminated early due to business decision.|0|||
164327006|NCT03993379|593572616|FG000|Overall Study|Withdrawal by Subject|0|||
164327007|NCT03993379|593572617|FG001|Overall Study|Withdrawal by Subject|1|||
164327008|NCT03993379|593572618|FG002|Overall Study|Withdrawal by Subject|0|||
164327009|NCT03993379|593572619|FG003|Overall Study|Withdrawal by Subject|0|||
164327010|NCT02380690|593572620|FG000|Overall Study|Lost to Follow-up|14|||
164327011|NCT02380690|593572621|FG001|Overall Study|Lost to Follow-up|4|||
164327012|NCT02380690|593572620|FG000|Overall Study|Withdrawal by Subject|20|||
164327013|NCT02380690|593572621|FG001|Overall Study|Withdrawal by Subject|8|||
164327014|NCT02361346|593572622|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327015|NCT02361346|593572623|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327016|NCT02361346|593572624|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327017|NCT02361346|593572625|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
164327018|NCT02361346|593572626|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327019|NCT02361346|593572627|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327020|NCT02361346|593572628|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327021|NCT02361346|593572629|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327022|NCT02361346|593572630|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
164327023|NCT02361346|593572622|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327024|NCT02361346|593572623|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164217579|NCT05141357|593162997|FG000|Overall Study|Adverse Event|3|||
164217580|NCT05141357|593162997|FG000|Overall Study|Lack of Efficacy|2|||
164217581|NCT01028560|593162998|FG000|Overall Study|Lack of Efficacy|3|||
164217582|NCT01028560|593162999|FG001|Overall Study|Lack of Efficacy|6|||
164327025|NCT02361346|593572624|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327026|NCT02361346|593572625|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327027|NCT02361346|593572626|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
164327028|NCT02361346|593572627|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327029|NCT02361346|593572628|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327030|NCT02361346|593572629|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327031|NCT02361346|593572630|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
164327032|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
164327033|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
164327034|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
164327035|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
164327036|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
164327037|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
164327038|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
164327039|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
164327040|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
164327041|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327042|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327043|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327044|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327045|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
163981451|NCT01400451|592302731|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
163981452|NCT01400451|592302732|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
164217583|NCT01028560|593162998|FG000|Overall Study|Withdrawal by Subject|7|||
164217584|NCT01028560|593162999|FG001|Overall Study|Withdrawal by Subject|12|||
164217585|NCT01960842|593163002|FG000|Overall Study|Adverse Event|1|||
164217586|NCT01960842|593163002|FG000|Overall Study|Withdrawal by Subject|2|||
164217587|NCT02441114|593163004|FG000|Washout2|Withdrawal by Subject|4|||
164217588|NCT05278065|593163005|FG000|Overall Study|Withdrawal by Subject|1|||
164217589|NCT05278065|593163006|FG001|Overall Study|Withdrawal by Subject|0|||
164217590|NCT02070991|593163011|FG000|Overall Study|Death|2|||
164217591|NCT02070991|593163012|FG001|Overall Study|Death|0|||
164217592|NCT02070991|593163011|FG000|Overall Study|Withdrawal by Subject|1|||
164217593|NCT02070991|593163012|FG001|Overall Study|Withdrawal by Subject|0|||
164217594|NCT04999020|593163013|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
164217595|NCT04999020|593163014|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
164217596|NCT04999020|593163015|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
164217597|NCT04999020|593163016|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
164217598|NCT04999020|593163013|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
164217599|NCT04999020|593163014|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
164217600|NCT04999020|593163015|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
164217601|NCT04999020|593163016|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
164217602|NCT04999020|593163013|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
164217603|NCT04999020|593163014|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
164217604|NCT04999020|593163015|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
164217605|NCT04999020|593163016|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
164217606|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164217607|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164217608|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
164217609|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
164217610|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164217611|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
164217612|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
164217613|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
164217614|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
164217615|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
164217616|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
164217617|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
164217618|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164217619|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164217620|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
164217621|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
164217622|NCT04999020|593163013|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
164217623|NCT04999020|593163014|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
164327046|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327047|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327048|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
164327049|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
164327050|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327051|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327052|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327053|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327054|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327055|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327056|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327057|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
164327058|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
164327059|NCT02361346|593572622|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327060|NCT02361346|593572623|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327061|NCT02361346|593572624|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327062|NCT02361346|593572625|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327063|NCT02361346|593572626|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327064|NCT02361346|593572627|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327065|NCT02361346|593572628|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327066|NCT02361346|593572629|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
164327067|NCT02361346|593572630|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
164327068|NCT02483429|593572634|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
164327069|NCT02483429|593572635|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
164327070|NCT03576274|593572636|FG000|Overall Study|Lost to Follow-up|3|||
164327071|NCT03576274|593572637|FG001|Overall Study|Lost to Follow-up|2|||
164327072|NCT03576274|593572638|FG002|Overall Study|Lost to Follow-up|3|||
164327073|NCT03576274|593572639|FG003|Overall Study|Lost to Follow-up|1|||
164327074|NCT03576274|593572640|FG004|Overall Study|Lost to Follow-up|3|||
164327075|NCT03576274|593572636|FG000|Overall Study|Withdrawal by Subject|5|||
164327076|NCT03576274|593572637|FG001|Overall Study|Withdrawal by Subject|3|||
164327077|NCT03576274|593572638|FG002|Overall Study|Withdrawal by Subject|2|||
164327078|NCT03576274|593572639|FG003|Overall Study|Withdrawal by Subject|8|||
164327079|NCT03576274|593572640|FG004|Overall Study|Withdrawal by Subject|6|||
164327080|NCT04854642|593574140|FG000|Overall Study|Adverse Event|1|||
163876962|NCT03398148|591918869|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876963|NCT03398148|591918870|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876964|NCT03398148|591918871|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876965|NCT03398148|591918872|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876966|NCT03398148|591918873|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876967|NCT03398148|591918874|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
164217624|NCT04999020|593163015|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
163981453|NCT01400451|592302730|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
163981454|NCT01400451|592302731|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
163981455|NCT01400451|592302732|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
163981456|NCT01505634|592302734|FG000|Overall Study|Withdrawal by Subject|2|||
163981457|NCT01505634|592302735|FG001|Overall Study|Withdrawal by Subject|5|||
164217625|NCT04999020|593163016|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
164217626|NCT03123588|593163017|FG000|Overall Study|Study Terminated by Sponsor|2|||
164217627|NCT03123588|593163018|FG001|Overall Study|Study Terminated by Sponsor|5|||
164217628|NCT03123588|593163017|FG000|Overall Study|Withdrawal by Subject|1|||
164217629|NCT03123588|593163018|FG001|Overall Study|Withdrawal by Subject|0|||
164217630|NCT03123588|593163017|FG000|Overall Study|Adverse Event|1|||
164217631|NCT03123588|593163018|FG001|Overall Study|Adverse Event|0|||
164217632|NCT03123588|593163017|FG000|Overall Study|Physician Decision|2|||
164217633|NCT03123588|593163018|FG001|Overall Study|Physician Decision|1|||
164217634|NCT04740567|593163019|FG000|Overall Study|Death|31|||
164217635|NCT04740567|593163020|FG001|Overall Study|Death|43|||
164217636|NCT04740567|593163019|FG000|Overall Study|Lost to Follow-up|2|||
164217637|NCT04740567|593163020|FG001|Overall Study|Lost to Follow-up|11|||
164217638|NCT04740567|593163019|FG000|Overall Study|Patient declined to participate|13|||
164217639|NCT04740567|593163020|FG001|Overall Study|Patient declined to participate|26|||
164217640|NCT04740567|593163019|FG000|Overall Study|Patient was physically incapable|1|||
164217641|NCT04740567|593163020|FG001|Overall Study|Patient was physically incapable|3|||
164217642|NCT04740567|593163019|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
164217643|NCT04740567|593163020|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
164217644|NCT02063724|593163021|FG000|Overall Study|Disease progression|1|||
164217645|NCT02697422|593163022|FG000|Overall Study|Declined exit survey|9|||
164217646|NCT02697422|593163023|FG001|Overall Study|Declined exit survey|2|||
164217647|NCT02697422|593163022|FG000|Overall Study|Lost to Follow-up|13|||
164217648|NCT02697422|593163023|FG001|Overall Study|Lost to Follow-up|8|||
164217649|NCT02697422|593163022|FG000|Overall Study|Death|2|||
164217650|NCT02697422|593163023|FG001|Overall Study|Death|1|||
164217651|NCT02697422|593163022|FG000|Overall Study|Withdrawal by Subject|0|||
164217652|NCT02697422|593163023|FG001|Overall Study|Withdrawal by Subject|1|||
164217653|NCT02697422|593163022|FG000|Overall Study|Physician Decision|1|||
164217654|NCT02697422|593163023|FG001|Overall Study|Physician Decision|1|||
164217655|NCT02697422|593163022|FG000|Overall Study|Exit survey data lost|1|||
164217656|NCT02697422|593163023|FG001|Overall Study|Exit survey data lost|0|||
164217657|NCT02068599|593163025|FG000|Overall Study|Adverse Event|4|||
164217658|NCT02068599|593163026|FG001|Overall Study|Adverse Event|1|||
164217659|NCT02068599|593163027|FG002|Overall Study|Adverse Event|1|||
164217660|NCT02068599|593163025|FG000|Overall Study|Withdrawal by Subject|2|||
164217661|NCT02068599|593163026|FG001|Overall Study|Withdrawal by Subject|7|||
164217662|NCT02068599|593163027|FG002|Overall Study|Withdrawal by Subject|5|||
164217663|NCT02068599|593163025|FG000|Overall Study|Protocol Violation|4|||
164217664|NCT02068599|593163026|FG001|Overall Study|Protocol Violation|2|||
164217665|NCT02068599|593163027|FG002|Overall Study|Protocol Violation|3|||
164217666|NCT02068599|593163025|FG000|Overall Study|Lost to Follow-up|1|||
164217667|NCT02068599|593163026|FG001|Overall Study|Lost to Follow-up|0|||
164217668|NCT02068599|593163027|FG002|Overall Study|Lost to Follow-up|0|||
164217669|NCT02068599|593163025|FG000|Overall Study|Lack of Efficacy|0|||
164217670|NCT02068599|593163026|FG001|Overall Study|Lack of Efficacy|0|||
164217671|NCT02068599|593163027|FG002|Overall Study|Lack of Efficacy|3|||
164217672|NCT02068599|593163025|FG000|Overall Study|Noncompliance|0|||
164217673|NCT02068599|593163026|FG001|Overall Study|Noncompliance|0|||
164217674|NCT02068599|593163027|FG002|Overall Study|Noncompliance|1|||
164217675|NCT03019588|593163028|FG000|Overall Study|Death|44|||
164217676|NCT03019588|593163029|FG001|Overall Study|Death|46|||
164217677|NCT03019588|593163028|FG000|Overall Study|Study terminated by Sponsor|3|||
164217678|NCT03019588|593163029|FG001|Overall Study|Study terminated by Sponsor|1|||
164217679|NCT02958527|593163030|FG000|Overall Study|Not collected CRFs|12|||
164217680|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
164217681|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
164217682|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Death|28|||
164217683|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Death|29|||
164217684|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
163981458|NCT01505634|592302736|FG002|Overall Study|Withdrawal by Subject|1|||
163981459|NCT01505634|592302734|FG000|Overall Study|Physician Decision|1|||
164217685|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
164217686|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Other|30|||
164217687|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Other|20|||
164217688|NCT00699751|593163033|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
164217689|NCT00699751|593163034|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
164217690|NCT00699751|593163033|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
164217691|NCT00699751|593163034|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
164217692|NCT00699751|593163033|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
164327081|NCT04854642|593574141|FG001|Overall Study|Adverse Event|2|||
164327082|NCT04854642|593574140|FG000|Overall Study|Withdrawal by Subject|0|||
164327083|NCT04854642|593574141|FG001|Overall Study|Withdrawal by Subject|1|||
164327084|NCT02294773|593574143|FG000|Overall Study|Withdrawal by Subject|0|||
164327085|NCT02294773|593574144|FG001|Overall Study|Withdrawal by Subject|2|||
164327086|NCT01865084|593574145|FG000|Double Blind Period (DB)|Adverse Event|2|||
164327087|NCT01865084|593574146|FG001|Double Blind Period (DB)|Adverse Event|2|||
164327088|NCT01865084|593574147|FG002|Double Blind Period (DB)|Adverse Event|1|||
164327089|NCT01865084|593574145|FG000|Double Blind Period (DB)|Protocol Violation|0|||
164327090|NCT01865084|593574146|FG001|Double Blind Period (DB)|Protocol Violation|0|||
164327091|NCT01865084|593574147|FG002|Double Blind Period (DB)|Protocol Violation|1|||
164327092|NCT01865084|593574145|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
164327093|NCT01865084|593574146|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
164327094|NCT01865084|593574147|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
164327095|NCT01865084|593574145|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
164327096|NCT01865084|593574146|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
164327097|NCT01865084|593574147|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
164327098|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
164327099|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
164327100|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
164327101|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
164327102|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
164327103|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
164327104|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
164327105|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
164327106|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
164327107|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
164327108|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
164327109|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
164327110|NCT01865084|593574145|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
164327111|NCT01865084|593574146|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
164327112|NCT01865084|593574147|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
164327113|NCT03442764|593574148|FG000|Overall Study|Adverse Event|1|||
164327114|NCT03442764|593574149|FG001|Overall Study|Adverse Event|0|||
164327115|NCT03442764|593574150|FG002|Overall Study|Adverse Event|0|||
164327116|NCT01801072|593574151|FG000|Overall Study|Lost to Follow-up|17|||
164327117|NCT01801072|593574152|FG001|Overall Study|Lost to Follow-up|14|||
164327118|NCT01801072|593574151|FG000|Overall Study|Physician Decision|2|||
164327119|NCT01801072|593574152|FG001|Overall Study|Physician Decision|3|||
164327120|NCT01801072|593574151|FG000|Overall Study|Withdrawal by Subject|1|||
164327121|NCT01801072|593574152|FG001|Overall Study|Withdrawal by Subject|0|||
164327122|NCT01801072|593574151|FG000|Overall Study|Protocol Violation|2|||
164327123|NCT01801072|593574152|FG001|Overall Study|Protocol Violation|0|||
164327124|NCT01801072|593574151|FG000|Overall Study|Death|7|||
164327125|NCT01801072|593574152|FG001|Overall Study|Death|8|||
164217693|NCT00699751|593163034|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
164217694|NCT00699751|593163033|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
164217695|NCT00699751|593163034|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
164217696|NCT01947933|593163035|FG000|Overall Study|Withdrawal by Subject|0|||
164217697|NCT01947933|593163036|FG001|Overall Study|Withdrawal by Subject|0|||
164217698|NCT01947933|593163037|FG002|Overall Study|Withdrawal by Subject|1|||
164217699|NCT01947933|593163038|FG003|Overall Study|Withdrawal by Subject|0|||
164327126|NCT03693170|593574153|FG000|Overall Study|Disease Progression|48|||
164327127|NCT03693170|593574153|FG000|Overall Study|Adverse Event|16|||
164327128|NCT03693170|593574153|FG000|Overall Study|Physician Decision|6|||
164327129|NCT03693170|593574153|FG000|Overall Study|Protocol Violation|2|||
164217700|NCT01947933|593163039|FG004|Overall Study|Withdrawal by Subject|0|||
164217701|NCT01947933|593163040|FG005|Overall Study|Withdrawal by Subject|0|||
164217702|NCT01947933|593163041|FG006|Overall Study|Withdrawal by Subject|0|||
164217703|NCT01947933|593163042|FG007|Overall Study|Withdrawal by Subject|0|||
164217704|NCT01947933|593163043|FG008|Overall Study|Withdrawal by Subject|0|||
164327130|NCT03693170|593574153|FG000|Overall Study|Death|1|||
164327131|NCT03693170|593574153|FG000|Overall Study|Non compliance with study drug|1|||
164327132|NCT03693170|593574153|FG000|Overall Study|Withdrawal by Subject|1|||
164327133|NCT04444895|593574154|FG000|Overall Study|Adverse Event|2|||
164327134|NCT04444895|593574154|FG000|Overall Study|Lost to Follow-up|2|||
164327135|NCT04444895|593574154|FG000|Overall Study|Withdrawal by Subject|5|||
164327136|NCT03034200|593574155|FG000|Overall Study|Disease progression|8|||
164327137|NCT03034200|593574156|FG001|Overall Study|Disease progression|10|||
164327138|NCT03034200|593574157|FG002|Overall Study|Disease progression|4|||
164217705|NCT01947933|593163035|FG000|Overall Study|Lost to Follow-up|0|||
164327139|NCT03034200|593574155|FG000|Overall Study|Physician Decision|2|||
164327140|NCT03034200|593574156|FG001|Overall Study|Physician Decision|0|||
164217706|NCT01947933|593163036|FG001|Overall Study|Lost to Follow-up|0|||
164217707|NCT01947933|593163037|FG002|Overall Study|Lost to Follow-up|0|||
164217708|NCT01947933|593163038|FG003|Overall Study|Lost to Follow-up|0|||
164217709|NCT01947933|593163039|FG004|Overall Study|Lost to Follow-up|0|||
164217710|NCT01947933|593163040|FG005|Overall Study|Lost to Follow-up|0|||
164217711|NCT01947933|593163041|FG006|Overall Study|Lost to Follow-up|0|||
164217712|NCT01947933|593163042|FG007|Overall Study|Lost to Follow-up|0|||
164217713|NCT01947933|593163043|FG008|Overall Study|Lost to Follow-up|1|||
164217714|NCT00294398|593163044|FG000|Overall Study|Lost to Follow-up|21|||
164217715|NCT00294398|593163045|FG001|Overall Study|Lost to Follow-up|26|||
164217716|NCT02939781|593163048|FG000|Overall Study|Protocol Violation|8|||
164217717|NCT02939781|593163048|FG000|Overall Study|Withdrawal by Subject|1|||
164217718|NCT04337021|593163053|FG000|Overall Study|Lost to Follow-up|54|||
164217719|NCT04337021|593163054|FG001|Overall Study|Lost to Follow-up|66|||
164217720|NCT02593864|593163056|FG000|Overall Study|Withdrawal by Subject|3|||
164217721|NCT02593864|593163056|FG000|Overall Study|Lost to Follow-up|3|||
164327141|NCT03034200|593574157|FG002|Overall Study|Physician Decision|3|||
164327142|NCT03034200|593574155|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
164327143|NCT03034200|593574156|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
164327144|NCT03034200|593574157|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
164217722|NCT06991803|593163060|FG000|Overall Study|Lost to Follow-up|0|||
164217723|NCT06991803|593163061|FG001|Overall Study|Lost to Follow-up|4|||
164327145|NCT03034200|593574155|FG000|Overall Study|Adjuvant Therapy|0|||
164327146|NCT03034200|593574156|FG001|Overall Study|Adjuvant Therapy|0|||
164327147|NCT03034200|593574157|FG002|Overall Study|Adjuvant Therapy|1|||
164327148|NCT00510874|593574158|FG000|Overall Study|Withdrawal by Subject|1|||
164327149|NCT00510874|593574159|FG001|Overall Study|Withdrawal by Subject|1|||
164327150|NCT00510874|593574160|FG002|Overall Study|Withdrawal by Subject|0|||
164327151|NCT00510874|593574161|FG003|Overall Study|Withdrawal by Subject|0|||
164327152|NCT00510874|593574162|FG004|Overall Study|Withdrawal by Subject|3|||
164327153|NCT00510874|593574163|FG005|Overall Study|Withdrawal by Subject|0|||
164327154|NCT00510874|593574164|FG006|Overall Study|Withdrawal by Subject|0|||
164327155|NCT00510874|593574158|FG000|Overall Study|Lost to Follow-up|2|||
164327156|NCT00510874|593574159|FG001|Overall Study|Lost to Follow-up|3|||
164327157|NCT00510874|593574160|FG002|Overall Study|Lost to Follow-up|1|||
164327158|NCT00510874|593574161|FG003|Overall Study|Lost to Follow-up|3|||
164327159|NCT00510874|593574162|FG004|Overall Study|Lost to Follow-up|4|||
164327160|NCT00510874|593574163|FG005|Overall Study|Lost to Follow-up|0|||
164327161|NCT00510874|593574164|FG006|Overall Study|Lost to Follow-up|1|||
164327162|NCT01251146|593574165|FG000|Overall Study|Lost to Follow-up|3|||
164327163|NCT01251146|593574166|FG001|Overall Study|Lost to Follow-up|10|||
164327164|NCT00053365|593574168|FG000|Overall Study|Incorrect cell type|1|||
164327165|NCT00053365|593574168|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
164327166|NCT00053365|593574168|FG000|Overall Study|Never treated|4|||
164327167|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
164327168|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
164327169|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
164327170|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
164327171|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
164327172|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
164327173|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
164327174|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
164327175|NCT03347188|593574178|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
164327176|NCT03347188|593574179|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
164327177|NCT03347188|593574178|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
164327178|NCT03347188|593574179|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
164327179|NCT03347188|593574178|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
164327180|NCT03347188|593574179|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
164327181|NCT03347188|593574178|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
164327182|NCT03347188|593574179|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
164327183|NCT03139604|593574180|FG000|Overall Study|Other|7|||
164327184|NCT03139604|593574181|FG001|Overall Study|Other|3|||
164327185|NCT03139604|593574180|FG000|Overall Study|Withdrawal by Subject|16|||
164327186|NCT03139604|593574181|FG001|Overall Study|Withdrawal by Subject|17|||
164327187|NCT03139604|593574180|FG000|Overall Study|Physician Decision|1|||
164327188|NCT03139604|593574181|FG001|Overall Study|Physician Decision|2|||
164327189|NCT03139604|593574180|FG000|Overall Study|Lost to Follow-up|3|||
164327190|NCT03139604|593574181|FG001|Overall Study|Lost to Follow-up|1|||
164217724|NCT06991803|593163062|FG002|Overall Study|Lost to Follow-up|0|||
164217725|NCT06991803|593163063|FG003|Overall Study|Lost to Follow-up|3|||
164217726|NCT06991803|593163064|FG004|Overall Study|Lost to Follow-up|2|||
164217727|NCT06991803|593163065|FG005|Overall Study|Lost to Follow-up|5|||
164217728|NCT02564978|593163071|FG000|Overall Study|Adverse Event|8|||
164217729|NCT02564978|593163071|FG000|Overall Study|Death|1|||
164217730|NCT02564978|593163071|FG000|Overall Study|Lost to Follow-up|1|||
164327191|NCT03139604|593574180|FG000|Overall Study|Death|65|||
164327192|NCT03139604|593574181|FG001|Overall Study|Death|67|||
164327193|NCT03139604|593574180|FG000|Overall Study|Study Terminated by Sponsor|122|||
164327194|NCT03139604|593574181|FG001|Overall Study|Study Terminated by Sponsor|127|||
164327195|NCT03139604|593574180|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
164327196|NCT03139604|593574181|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
164327197|NCT04148911|593574182|FG000|Overall Study|Death|104|||
164327198|NCT04148911|593574182|FG000|Overall Study|Lost to Follow-up|5|||
164327199|NCT04148911|593574182|FG000|Overall Study|Withdrawal by Subject|17|||
164327200|NCT04148911|593574182|FG000|Overall Study|Study Ended by Sponsor|56|||
164327201|NCT00521001|593574185|FG000|Overall Study|Ineligible|1|||
164327202|NCT00470184|593574186|FG000|Overall Study|Not Treated(became ineligible)|4|||
164327203|NCT00470184|593574186|FG000|Overall Study|Not treated (other)|1|||
164327204|NCT00470184|593574186|FG000|Overall Study|disease Progression|4|||
164327205|NCT00470184|593574186|FG000|Overall Study|Adverse Event|3|||
164327206|NCT00470184|593574186|FG000|Overall Study|Withdrawal by Subject|4|||
164327207|NCT00470184|593574186|FG000|Overall Study|other|5|||
164327208|NCT00470184|593574186|FG000|Overall Study|recurrence|1|||
164327209|NCT03190369|593574190|FG000|Overall Study|Poor compliance to protocol|0|||
164327210|NCT03190369|593574191|FG001|Overall Study|Poor compliance to protocol|1|||
164327211|NCT03190369|593574190|FG000|Overall Study|Withdraw before treatment|1|||
164327212|NCT03190369|593574191|FG001|Overall Study|Withdraw before treatment|5|||
164327213|NCT03190369|593574190|FG000|Overall Study|Randomized but not treated|0|||
164327214|NCT03190369|593574191|FG001|Overall Study|Randomized but not treated|2|||
164327215|NCT01606254|593574194|FG000|Overall Study|Withdrawal by Subject|1|||
164327216|NCT01606254|593574195|FG001|Overall Study|Withdrawal by Subject|3|||
164327217|NCT01606254|593574196|FG002|Overall Study|Withdrawal by Subject|0|||
164327218|NCT01606254|593574197|FG003|Overall Study|Withdrawal by Subject|2|||
164327219|NCT01606254|593574194|FG000|Overall Study|Adverse Event|1|||
164327220|NCT01606254|593574195|FG001|Overall Study|Adverse Event|1|||
164327221|NCT01606254|593574196|FG002|Overall Study|Adverse Event|0|||
164327222|NCT01606254|593574197|FG003|Overall Study|Adverse Event|1|||
164327223|NCT04543409|593574198|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164327224|NCT04543409|593574199|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164327225|NCT04543409|593574198|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
164327226|NCT04543409|593574199|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
164327227|NCT04543409|593574198|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
164327228|NCT04543409|593574199|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
164327229|NCT04543409|593574198|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
164327230|NCT04543409|593574199|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
164327231|NCT04543409|593574198|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
164327232|NCT04543409|593574199|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
164327233|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
164327234|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
164327235|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
164327236|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
164327237|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
164327238|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
164327239|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
164327240|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
164327241|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
164327242|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
164327243|NCT04543409|593574198|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
164327244|NCT04543409|593574199|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
164327245|NCT01052844|593574200|FG000|Overall Study|Adverse Event|0|||
164327246|NCT01052844|593574201|FG001|Overall Study|Adverse Event|1|||
164327247|NCT02093026|593574202|FG000|Overall Study|Adverse Event|26|||
164327248|NCT02093026|593574202|FG000|Overall Study|Death|10|||
164327249|NCT02093026|593574202|FG000|Overall Study|Other|157|||
164327250|NCT02195011|593574211|FG000|Overall Study|Adverse Event|4|||
164327251|NCT02195011|593574212|FG001|Overall Study|Adverse Event|0|||
164327252|NCT02195011|593574211|FG000|Overall Study|Progressive Disease|18|||
164327253|NCT02195011|593574212|FG001|Overall Study|Progressive Disease|1|||
164327254|NCT02195011|593574211|FG000|Overall Study|Withdrawal by Subject|3|||
164327255|NCT02195011|593574212|FG001|Overall Study|Withdrawal by Subject|0|||
164327256|NCT00174291|593574214|FG000|Overall Study|Lost to Follow-up|1|||
164078162|NCT01623830|592651501|FG001|Overall Study|Exclusion from Study|2|||
164327257|NCT00174291|593574215|FG001|Overall Study|Lost to Follow-up|1|||
164327258|NCT00174291|593574214|FG000|Overall Study|Protocol Violation|0|||
164327259|NCT00174291|593574215|FG001|Overall Study|Protocol Violation|2|||
164327260|NCT00174291|593574214|FG000|Overall Study|Study terminated by sponsor|1|||
164327261|NCT00174291|593574215|FG001|Overall Study|Study terminated by sponsor|0|||
163876968|NCT03398148|591918875|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876969|NCT03398148|591918876|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876970|NCT03398148|591918877|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
163876971|NCT03398148|591918878|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876972|NCT03398148|591918879|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876973|NCT03398148|591918880|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876974|NCT03398148|591918881|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
163876975|NCT03398148|591918867|FG000|Substudy 2 Period 1|Other|0|||
163876976|NCT03398148|591918868|FG001|Substudy 2 Period 1|Other|0|||
163876977|NCT03398148|591918869|FG002|Substudy 2 Period 1|Other|0|||
163876978|NCT03398148|591918870|FG003|Substudy 2 Period 1|Other|0|||
163876979|NCT03398148|591918871|FG004|Substudy 2 Period 1|Other|0|||
163876980|NCT03398148|591918872|FG005|Substudy 2 Period 1|Other|0|||
163876981|NCT03398148|591918873|FG006|Substudy 2 Period 1|Other|0|||
163876982|NCT03398148|591918874|FG007|Substudy 2 Period 1|Other|0|||
163876983|NCT03398148|591918875|FG008|Substudy 2 Period 1|Other|0|||
163876984|NCT03398148|591918876|FG009|Substudy 2 Period 1|Other|4|||
163876985|NCT03398148|591918877|FG010|Substudy 2 Period 1|Other|4|||
164217731|NCT02564978|593163071|FG000|Overall Study|Withdrawal by Subject|15|||
164217732|NCT02564978|593163071|FG000|Overall Study|Early Study Closure|2|||
164217733|NCT02564978|593163071|FG000|Overall Study|Other Reason|5|||
164299700|NCT03558737|593472901|FG000|Overall Study|Death|1|||
164299701|NCT03558737|593472902|FG001|Overall Study|Death|1|||
164299702|NCT01294553|593472903|FG000|Overall Study|Duplicated Participants|1|||
164299703|NCT01294553|593472903|FG000|Overall Study|Protocol Violation|268|||
164299704|NCT01217229|593472904|FG000|Overall Study|Adverse Event|1|||
164327262|NCT00174291|593574214|FG000|Overall Study|Withdrawal by Subject|3|||
164327263|NCT00174291|593574215|FG001|Overall Study|Withdrawal by Subject|3|||
164327264|NCT01466595|593574216|FG000|Overall Study|Withdrawal by Subject|0|||
164327265|NCT01466595|593574217|FG001|Overall Study|Withdrawal by Subject|1|||
164327266|NCT00450112|593574220|FG000|Overall Study|Other Treatment Required|5|||
164327267|NCT00450112|593574221|FG001|Overall Study|Other Treatment Required|1|||
164327268|NCT00450112|593574220|FG000|Overall Study|Withdrawal by Subject|4|||
164327269|NCT00450112|593574221|FG001|Overall Study|Withdrawal by Subject|1|||
164327270|NCT00450112|593574220|FG000|Overall Study|Lost to Follow-up|2|||
164327271|NCT00450112|593574221|FG001|Overall Study|Lost to Follow-up|1|||
164327272|NCT00450112|593574220|FG000|Overall Study|Others|2|||
164327273|NCT00450112|593574221|FG001|Overall Study|Others|3|||
164327274|NCT03418571|593574222|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
164327275|NCT03418571|593574223|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
164327276|NCT00559754|593574224|FG000|Overall Study|Disease progression|1|||
164327277|NCT00559754|593574224|FG000|Overall Study|Adverse Event|5|||
164327278|NCT00559754|593574224|FG000|Overall Study|Protocol Violation|1|||
164327279|NCT00559754|593574224|FG000|Overall Study|Investigator criteria|2|||
164327280|NCT00559754|593574224|FG000|Overall Study|Withdrawal by Subject|2|||
164327281|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
164327282|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
164327283|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
164327284|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
164327285|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
164327286|NCT00586326|593574225|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
164327287|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
164327288|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
164327289|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
164327290|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
164327291|NCT00586326|593574225|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
164327292|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
164327293|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
164327294|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
164327295|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
164327296|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
164327297|NCT00586326|593574225|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
164327298|NCT01439347|593574226|FG000|Overall Study|Death|10|||
164327299|NCT01439347|593574227|FG001|Overall Study|Death|9|||
164327300|NCT01439347|593574226|FG000|Overall Study|Withdrawal by Subject|0|||
164327301|NCT01439347|593574227|FG001|Overall Study|Withdrawal by Subject|1|||
163876986|NCT03398148|591918878|FG011|Substudy 2 Period 1|Other|0|||
164327302|NCT01439347|593574226|FG000|Overall Study|Physician Decision|1|||
163876987|NCT03398148|591918879|FG012|Substudy 2 Period 1|Other|0|||
163876988|NCT03398148|591918880|FG013|Substudy 2 Period 1|Other|0|||
164299705|NCT01217229|593472904|FG000|Overall Study|Disease progression, deterioration|2|||
164299706|NCT01217229|593472904|FG000|Overall Study|Disease progression, Cheson criteria|14|||
164299707|NCT01217229|593472904|FG000|Overall Study|Protocol Violation|1|||
164327303|NCT01439347|593574227|FG001|Overall Study|Physician Decision|0|||
163876989|NCT03398148|591918881|FG014|Substudy 2 Period 1|Other|0|||
164327304|NCT01439347|593574226|FG000|Overall Study|Sponsor Terminated Study|2|||
164327305|NCT01439347|593574227|FG001|Overall Study|Sponsor Terminated Study|3|||
164327306|NCT03595774|593574228|FG000|Overall Study|Adverse Event|1|||
164327307|NCT03595774|593574229|FG001|Overall Study|Adverse Event|0|||
164327308|NCT03595774|593574230|FG002|Overall Study|Adverse Event|1|||
164327309|NCT03595774|593574231|FG003|Overall Study|Adverse Event|0|||
164327310|NCT03595774|593574228|FG000|Overall Study|screen failure|0|||
164327311|NCT03595774|593574229|FG001|Overall Study|screen failure|1|||
164327312|NCT03595774|593574230|FG002|Overall Study|screen failure|0|||
164327313|NCT03595774|593574231|FG003|Overall Study|screen failure|1|||
164327314|NCT03882008|593574232|FG000|Overall Study|Withdrawal by Subject|1|||
164327315|NCT03882008|593574232|FG000|Overall Study|Lost to Follow-up|1|||
164327316|NCT03519386|593574237|FG000|Overall Study|Withdrawal by Subject|4|||
164327317|NCT03519386|593574238|FG001|Overall Study|Withdrawal by Subject|1|||
164327318|NCT03519386|593574239|FG002|Overall Study|Withdrawal by Subject|2|||
164327319|NCT03519386|593574237|FG000|Overall Study|Physician Decision|1|||
164327320|NCT03519386|593574238|FG001|Overall Study|Physician Decision|1|||
164327321|NCT03519386|593574239|FG002|Overall Study|Physician Decision|1|||
164327322|NCT03519386|593574237|FG000|Overall Study|Lost to Follow-up|0|||
164327323|NCT03519386|593574238|FG001|Overall Study|Lost to Follow-up|1|||
164327324|NCT03519386|593574239|FG002|Overall Study|Lost to Follow-up|1|||
164327325|NCT03519386|593574237|FG000|Overall Study|Death|1|||
164327326|NCT03519386|593574238|FG001|Overall Study|Death|0|||
164327327|NCT03519386|593574239|FG002|Overall Study|Death|4|||
164327328|NCT03519386|593574237|FG000|Overall Study|Adverse Event|2|||
164327329|NCT03519386|593574238|FG001|Overall Study|Adverse Event|1|||
164327330|NCT03519386|593574239|FG002|Overall Study|Adverse Event|2|||
164327331|NCT03519386|593574237|FG000|Overall Study|Explanted|2|||
164327332|NCT03519386|593574238|FG001|Overall Study|Explanted|1|||
164327333|NCT03519386|593574239|FG002|Overall Study|Explanted|0|||
164327334|NCT03519386|593574237|FG000|Overall Study|Ongoing in study|190|||
164327335|NCT03519386|593574238|FG001|Overall Study|Ongoing in study|192|||
164327336|NCT03519386|593574239|FG002|Overall Study|Ongoing in study|183|||
164327337|NCT01582854|593574241|FG000|Overall Study|Death|8|||
164327338|NCT01582854|593574242|FG001|Overall Study|Death|5|||
164327339|NCT01582854|593574241|FG000|Overall Study|Adverse Event|2|||
164327340|NCT01582854|593574242|FG001|Overall Study|Adverse Event|3|||
164327341|NCT01582854|593574241|FG000|Overall Study|Withdrawal by Participant|8|||
164327342|NCT01582854|593574242|FG001|Overall Study|Withdrawal by Participant|11|||
164327343|NCT01582854|593574241|FG000|Overall Study|Lost to Follow-up|1|||
164327344|NCT01582854|593574242|FG001|Overall Study|Lost to Follow-up|2|||
164327345|NCT01582854|593574241|FG000|Overall Study|Physician Decision|0|||
164327346|NCT01582854|593574242|FG001|Overall Study|Physician Decision|1|||
164327347|NCT01582854|593574241|FG000|Overall Study|Recurrent Stroke|13|||
164327348|NCT01582854|593574242|FG001|Overall Study|Recurrent Stroke|8|||
164327349|NCT01582854|593574241|FG000|Overall Study|Disallowed Concomitant Medication|3|||
164327350|NCT01582854|593574242|FG001|Overall Study|Disallowed Concomitant Medication|2|||
163981460|NCT01505634|592302735|FG001|Overall Study|Physician Decision|1|||
163981461|NCT01505634|592302736|FG002|Overall Study|Physician Decision|0|||
163981462|NCT01505634|592302734|FG000|Overall Study|Adverse Event|1|||
163981463|NCT01505634|592302735|FG001|Overall Study|Adverse Event|0|||
163981464|NCT01505634|592302736|FG002|Overall Study|Adverse Event|0|||
164327351|NCT01582854|593574241|FG000|Overall Study|Carotid or Neurosurgery|0|||
164327352|NCT01582854|593574242|FG001|Overall Study|Carotid or Neurosurgery|1|||
164327353|NCT01582854|593574241|FG000|Overall Study|General Anaesthesia|0|||
164327354|NCT01582854|593574242|FG001|Overall Study|General Anaesthesia|1|||
164327355|NCT01582854|593574241|FG000|Overall Study|Other Miscellaneous Reason|1|||
164327356|NCT01582854|593574242|FG001|Overall Study|Other Miscellaneous Reason|0|||
164327357|NCT03101267|593574243|FG000|Primary Study Period|Withdrawal by Subject|1|||
164327358|NCT03101267|593574244|FG001|Primary Study Period|Withdrawal by Subject|2|||
164327359|NCT03101267|593574245|FG002|Primary Study Period|Withdrawal by Subject|3|||
164327360|NCT03101267|593574243|FG000|Primary Study Period|Miscellaneous|2|||
164327361|NCT03101267|593574244|FG001|Primary Study Period|Miscellaneous|0|||
164327362|NCT03101267|593574245|FG002|Primary Study Period|Miscellaneous|0|||
164327363|NCT04068896|593574246|FG000|Overall Study|Adverse Event|2|||
164327364|NCT04068896|593574247|FG001|Overall Study|Adverse Event|0|||
164327365|NCT04068896|593574248|FG002|Overall Study|Adverse Event|1|||
164327366|NCT04068896|593574249|FG003|Overall Study|Adverse Event|0|||
164327367|NCT04068896|593574250|FG004|Overall Study|Adverse Event|0|||
163981465|NCT01505634|592302734|FG000|Overall Study|Insufficient supply of drug at site|1|||
163981466|NCT01505634|592302735|FG001|Overall Study|Insufficient supply of drug at site|0|||
164327368|NCT04068896|593574251|FG005|Overall Study|Adverse Event|0|||
164327369|NCT04068896|593574246|FG000|Overall Study|Death|3|||
164327370|NCT04068896|593574247|FG001|Overall Study|Death|1|||
164327371|NCT04068896|593574248|FG002|Overall Study|Death|3|||
164327372|NCT04068896|593574249|FG003|Overall Study|Death|19|||
164327373|NCT04068896|593574250|FG004|Overall Study|Death|17|||
164327374|NCT04068896|593574251|FG005|Overall Study|Death|0|||
164327375|NCT04068896|593574246|FG000|Overall Study|Physician Decision|0|||
164327376|NCT04068896|593574247|FG001|Overall Study|Physician Decision|0|||
164078163|NCT02468557|592651502|FG000|Overall Study|Adverse Event|1|||
164327377|NCT04068896|593574248|FG002|Overall Study|Physician Decision|0|||
164327378|NCT04068896|593574249|FG003|Overall Study|Physician Decision|1|||
164327379|NCT04068896|593574250|FG004|Overall Study|Physician Decision|0|||
164327380|NCT04068896|593574251|FG005|Overall Study|Physician Decision|0|||
164327381|NCT04068896|593574246|FG000|Overall Study|progressive disease|3|||
164327382|NCT04068896|593574247|FG001|Overall Study|progressive disease|5|||
164327383|NCT04068896|593574248|FG002|Overall Study|progressive disease|3|||
164327384|NCT04068896|593574249|FG003|Overall Study|progressive disease|2|||
164327385|NCT04068896|593574250|FG004|Overall Study|progressive disease|1|||
164327386|NCT04068896|593574251|FG005|Overall Study|progressive disease|2|||
164327387|NCT04068896|593574246|FG000|Overall Study|Study terminated by sponsor|0|||
164327388|NCT04068896|593574247|FG001|Overall Study|Study terminated by sponsor|0|||
164327389|NCT04068896|593574248|FG002|Overall Study|Study terminated by sponsor|1|||
164327390|NCT04068896|593574249|FG003|Overall Study|Study terminated by sponsor|2|||
164327391|NCT04068896|593574250|FG004|Overall Study|Study terminated by sponsor|1|||
164327392|NCT04068896|593574251|FG005|Overall Study|Study terminated by sponsor|4|||
164327393|NCT04068896|593574246|FG000|Overall Study|Protocol Violation|0|||
164327394|NCT04068896|593574247|FG001|Overall Study|Protocol Violation|0|||
164327395|NCT04068896|593574248|FG002|Overall Study|Protocol Violation|0|||
164327396|NCT04068896|593574249|FG003|Overall Study|Protocol Violation|1|||
164327397|NCT04068896|593574250|FG004|Overall Study|Protocol Violation|0|||
164327398|NCT04068896|593574251|FG005|Overall Study|Protocol Violation|0|||
164327399|NCT04068896|593574246|FG000|Overall Study|Withdrawal by Subject|0|||
164327400|NCT04068896|593574247|FG001|Overall Study|Withdrawal by Subject|3|||
164327401|NCT04068896|593574248|FG002|Overall Study|Withdrawal by Subject|0|||
164327402|NCT04068896|593574249|FG003|Overall Study|Withdrawal by Subject|2|||
164327403|NCT04068896|593574250|FG004|Overall Study|Withdrawal by Subject|1|||
164327404|NCT04068896|593574251|FG005|Overall Study|Withdrawal by Subject|0|||
164327405|NCT04068896|593574246|FG000|Overall Study|Symptomatic deterioration|2|||
164327406|NCT04068896|593574247|FG001|Overall Study|Symptomatic deterioration|0|||
164327407|NCT04068896|593574248|FG002|Overall Study|Symptomatic deterioration|0|||
164327408|NCT04068896|593574249|FG003|Overall Study|Symptomatic deterioration|0|||
164327409|NCT04068896|593574250|FG004|Overall Study|Symptomatic deterioration|0|||
164327410|NCT04068896|593574251|FG005|Overall Study|Symptomatic deterioration|0|||
164327411|NCT00484185|593574252|FG000|Overall Study|Lost to Follow-up|44|||
164327412|NCT00484185|593574252|FG000|Overall Study|Other|20|||
164327413|NCT00484185|593574252|FG000|Overall Study|Randomized but not treated|5|||
164327414|NCT00484185|593574252|FG000|Overall Study|Death|2|||
164327415|NCT01222403|593574253|FG000|Overall Study|Inappropriate enrollment|0|||
164327416|NCT01222403|593574254|FG001|Overall Study|Inappropriate enrollment|2|||
164327417|NCT02068768|593574256|FG000|Overall Study|Lost to Follow-up|5|||
164327418|NCT02068768|593574256|FG000|Overall Study|Early Termination by Sponsor|2|||
164327419|NCT00913692|593574257|FG000|Screening (4 Months)|Physician Decision|3|||
164327420|NCT00913692|593574257|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
164327421|NCT00913692|593574257|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
164327422|NCT02290431|593574259|FG000|Overall Study|Adverse Event|20|||
164327423|NCT02290431|593574259|FG000|Overall Study|Progressive disease|4|||
164327424|NCT02290431|593574259|FG000|Overall Study|Study terminated by Sponsor|1|||
164327425|NCT02290431|593574259|FG000|Overall Study|Physician Decision|2|||
164327426|NCT00321893|593574260|FG000|Overall Study|Non-Compliance/Refusal|16|||
164327427|NCT00321893|593574261|FG001|Overall Study|Non-Compliance/Refusal|10|||
164327428|NCT00321893|593574260|FG000|Overall Study|Lost to Follow-up|2|||
164327429|NCT00321893|593574261|FG001|Overall Study|Lost to Follow-up|1|||
164327430|NCT00321893|593574260|FG000|Overall Study|Adverse Event|6|||
164327431|NCT00321893|593574261|FG001|Overall Study|Adverse Event|3|||
164327432|NCT03455764|593574262|FG000|Overall Study|Adverse Event|1|||
164327433|NCT03455764|593574263|FG001|Overall Study|Adverse Event|0|||
164327434|NCT03455764|593574264|FG002|Overall Study|Adverse Event|0|||
164327435|NCT03455764|593574265|FG003|Overall Study|Adverse Event|0|||
164327436|NCT03455764|593574266|FG004|Overall Study|Adverse Event|0|||
164327437|NCT03455764|593574262|FG000|Overall Study|Disease Progression|4|||
164327438|NCT03455764|593574263|FG001|Overall Study|Disease Progression|0|||
163876990|NCT03398148|591918867|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876991|NCT03398148|591918868|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876992|NCT03398148|591918869|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876993|NCT03398148|591918870|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876994|NCT03398148|591918871|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876995|NCT03398148|591918872|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876996|NCT03398148|591918873|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876997|NCT03398148|591918874|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876998|NCT03398148|591918875|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
163876999|NCT03398148|591918876|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
163877000|NCT03398148|591918877|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
164327439|NCT03455764|593574264|FG002|Overall Study|Disease Progression|0|||
164327440|NCT03455764|593574265|FG003|Overall Study|Disease Progression|0|||
164327441|NCT03455764|593574266|FG004|Overall Study|Disease Progression|0|||
164217734|NCT03787212|593165044|FG000|Period 1|Study Termination|2|||
164217735|NCT03787212|593165045|FG001|Period 1|Study Termination|2|||
164217736|NCT02316613|593165048|FG000|Overall Study|Death|63|||
164217737|NCT02316613|593165048|FG000|Overall Study|Lost to Follow-up|9|||
164217738|NCT02316613|593165048|FG000|Overall Study|Lymphoma transformation|2|||
164217739|NCT02316613|593165048|FG000|Overall Study|Participant moved/changed medical team|11|||
164217740|NCT02316613|593165048|FG000|Overall Study|No data and duplicate cases|5|||
164217741|NCT02316613|593165048|FG000|Overall Study|Did not met selection criteria|14|||
164217742|NCT02545127|593165049|FG000|Overall Study|Lost to Follow-up|1|||
164217743|NCT02545127|593165050|FG001|Overall Study|Lost to Follow-up|0|||
164217744|NCT03309605|593165053|FG000|Overall Study|Adverse Event|0|||
164217745|NCT03309605|593165054|FG001|Overall Study|Adverse Event|0|||
164217746|NCT03309605|593165055|FG002|Overall Study|Adverse Event|0|||
164217747|NCT03309605|593165056|FG003|Overall Study|Adverse Event|1|||
164217748|NCT03309605|593165057|FG004|Overall Study|Adverse Event|0|||
164217749|NCT03309605|593165058|FG005|Overall Study|Adverse Event|0|||
164217750|NCT03309605|593165059|FG006|Overall Study|Adverse Event|2|||
164217751|NCT03309605|593165060|FG007|Overall Study|Adverse Event|1|||
164217752|NCT03309605|593165053|FG000|Overall Study|Withdrawal by Subject|0|||
164217753|NCT03309605|593165054|FG001|Overall Study|Withdrawal by Subject|0|||
164217754|NCT03309605|593165055|FG002|Overall Study|Withdrawal by Subject|0|||
164217755|NCT03309605|593165056|FG003|Overall Study|Withdrawal by Subject|0|||
164217756|NCT03309605|593165057|FG004|Overall Study|Withdrawal by Subject|1|||
164327442|NCT03455764|593574262|FG000|Overall Study|On Treatment|1|||
164327443|NCT03455764|593574263|FG001|Overall Study|On Treatment|0|||
164327444|NCT03455764|593574264|FG002|Overall Study|On Treatment|0|||
164327445|NCT03455764|593574265|FG003|Overall Study|On Treatment|0|||
164327446|NCT03455764|593574266|FG004|Overall Study|On Treatment|0|||
164327447|NCT02125604|593574269|FG000|Overall Study|Other|4|||
164327448|NCT02125604|593574269|FG000|Overall Study|Investigator Decision|1|||
164327449|NCT02125604|593574269|FG000|Overall Study|Lost to Follow-up|2|||
164327450|NCT02125604|593574269|FG000|Overall Study|Consent Withdrawn|4|||
164327451|NCT02125604|593574269|FG000|Overall Study|Adverse Event|20|||
164327452|NCT00782795|593574272|FG000|Overall Study|Withdrawal by Subject|1|||
164327453|NCT00782795|593574273|FG001|Overall Study|Withdrawal by Subject|2|||
164327454|NCT01683019|593576008|FG000|Overall Study|Withdrawal by Subject|2|||
164327455|NCT01683019|593576009|FG001|Overall Study|Withdrawal by Subject|1|||
164327456|NCT01683019|593576010|FG002|Overall Study|Withdrawal by Subject|4|||
164327457|NCT03437512|593576011|FG000|Randomized|Withdrawal by Subject|0|||
164327458|NCT03437512|593576012|FG001|Randomized|Withdrawal by Subject|2|||
164327459|NCT03437512|593576011|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
164327460|NCT03437512|593576012|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
164327461|NCT00301821|593576013|FG000|Overall Study|Ineligible|25|||
164327462|NCT00301821|593576013|FG000|Overall Study|Cancel|1|||
164327463|NCT03332771|593576014|FG000|Overall Study|Adverse Event|6|||
164327464|NCT03332771|593576015|FG001|Overall Study|Adverse Event|4|||
164327465|NCT03332771|593576016|FG002|Overall Study|Adverse Event|1|||
164327466|NCT03332771|593576017|FG003|Overall Study|Adverse Event|3|||
164078164|NCT02468557|592651502|FG000|Overall Study|Death|1|||
164078165|NCT02468557|592651502|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
164078166|NCT02468557|592651502|FG000|Overall Study|All Enrolled but Never Dosed|4|||
164078167|NCT01605461|592651503|FG000|Overall Study|Lost to Follow-up|3|||
164078168|NCT01605461|592651503|FG000|Overall Study|Withdrawal by Subject|1|||
164078169|NCT02024698|592651504|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
164078170|NCT02024698|592651505|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
164078171|NCT03322462|592651506|FG000|Overall Study|Technical difficulties|2|||
164078172|NCT03322462|592651506|FG000|Overall Study|Other|1|||
164078173|NCT00515073|592651511|FG000|Overall Study|Withdrawal by Subject|1|||
164078174|NCT00515073|592651511|FG000|Overall Study|Physician Decision|1|||
164217757|NCT03309605|593165058|FG005|Overall Study|Withdrawal by Subject|0|||
164217758|NCT03309605|593165059|FG006|Overall Study|Withdrawal by Subject|1|||
164217759|NCT03309605|593165060|FG007|Overall Study|Withdrawal by Subject|1|||
164217760|NCT02082483|593165061|FG000|Overall Study|Lost to Follow-up|1|||
164217761|NCT02082483|593165062|FG001|Overall Study|Lost to Follow-up|1|||
164217762|NCT02082483|593165061|FG000|Overall Study|Withdrawal by Subject|2|||
164217763|NCT02082483|593165062|FG001|Overall Study|Withdrawal by Subject|1|||
164327467|NCT03332771|593576014|FG000|Overall Study|Poor Compliance to Protocol|0|||
164327468|NCT03332771|593576015|FG001|Overall Study|Poor Compliance to Protocol|1|||
164327469|NCT03332771|593576016|FG002|Overall Study|Poor Compliance to Protocol|0|||
164327470|NCT03332771|593576017|FG003|Overall Study|Poor Compliance to Protocol|1|||
164327471|NCT03332771|593576014|FG000|Overall Study|Lost to Follow-up|2|||
164327472|NCT03332771|593576015|FG001|Overall Study|Lost to Follow-up|2|||
164327473|NCT03332771|593576016|FG002|Overall Study|Lost to Follow-up|1|||
164078175|NCT02764489|592651512|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
164078176|NCT02764489|592651513|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
164217764|NCT02082483|593165061|FG000|Overall Study|Physician Decision|1|||
164217765|NCT02082483|593165062|FG001|Overall Study|Physician Decision|1|||
164217766|NCT02082483|593165061|FG000|Overall Study|Death|2|||
164217767|NCT02082483|593165062|FG001|Overall Study|Death|3|||
164217768|NCT00422461|593165063|FG000|Overall Study|Adverse Event|1|||
164217769|NCT00422461|593165064|FG001|Overall Study|Adverse Event|2|||
164217770|NCT00422461|593165065|FG002|Overall Study|Adverse Event|1|||
164217771|NCT00422461|593165066|FG003|Overall Study|Adverse Event|1|||
164217772|NCT00422461|593165063|FG000|Overall Study|Other|0|||
164217773|NCT00422461|593165064|FG001|Overall Study|Other|0|||
164217774|NCT00422461|593165065|FG002|Overall Study|Other|0|||
164217775|NCT00422461|593165066|FG003|Overall Study|Other|2|||
164217776|NCT00422461|593165063|FG000|Overall Study|Participants no longer willing to participate in study|1|||
164217777|NCT00422461|593165064|FG001|Overall Study|Participants no longer willing to participate in study|0|||
164217778|NCT00422461|593165065|FG002|Overall Study|Participants no longer willing to participate in study|0|||
164217779|NCT00422461|593165066|FG003|Overall Study|Participants no longer willing to participate in study|0|||
164217780|NCT00422461|593165063|FG000|Overall Study|Randomized but not treated|1|||
164217781|NCT00422461|593165064|FG001|Overall Study|Randomized but not treated|1|||
164217782|NCT00422461|593165065|FG002|Overall Study|Randomized but not treated|0|||
164217783|NCT00422461|593165066|FG003|Overall Study|Randomized but not treated|0|||
164217784|NCT02181621|593165067|FG000|Overall Study|Adverse Event|1|||
164327474|NCT03332771|593576017|FG003|Overall Study|Lost to Follow-up|2|||
164327475|NCT03332771|593576014|FG000|Overall Study|At the Participant's own request|20|||
164327476|NCT03332771|593576015|FG001|Overall Study|At the Participant's own request|26|||
164327477|NCT03332771|593576016|FG002|Overall Study|At the Participant's own request|14|||
164327478|NCT03332771|593576017|FG003|Overall Study|At the Participant's own request|23|||
164327479|NCT03332771|593576014|FG000|Overall Study|Reason Not Specified|6|||
164327480|NCT03332771|593576015|FG001|Overall Study|Reason Not Specified|18|||
164327481|NCT03332771|593576016|FG002|Overall Study|Reason Not Specified|16|||
164327482|NCT03332771|593576017|FG003|Overall Study|Reason Not Specified|19|||
164327483|NCT00737464|593576020|FG000|Overall Study|Adverse Event|1|||
164327484|NCT00737464|593576020|FG000|Overall Study|Death|6|||
164327485|NCT00737464|593576020|FG000|Overall Study|Other - Failure to Return|1|||
164217785|NCT02181621|593165068|FG001|Overall Study|Adverse Event|0|||
164217786|NCT02181621|593165067|FG000|Overall Study|Previously Enrolled|0|||
164217787|NCT02181621|593165068|FG001|Overall Study|Previously Enrolled|1|||
164217788|NCT02181621|593165067|FG000|Overall Study|Enrollment Hold|1|||
164217789|NCT02181621|593165068|FG001|Overall Study|Enrollment Hold|1|||
164217790|NCT00145327|593165069|FG000|Overall Study|Withdrawal by Subject|77|||
164217791|NCT00145327|593165070|FG001|Overall Study|Withdrawal by Subject|72|||
164217792|NCT00145327|593165071|FG002|Overall Study|Withdrawal by Subject|164|||
164217793|NCT00145327|593165069|FG000|Overall Study|Death|26|||
164327486|NCT00737464|593576020|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
164327487|NCT00737464|593576020|FG000|Overall Study|Other reasons|4|||
164327488|NCT02423109|593576021|FG000|Lens 1|Adverse Event|1|||
164327489|NCT02423109|593576022|FG001|Lens 1|Adverse Event|0|||
164327490|NCT04177355|593576024|FG000|Overall Study|Lost to Follow-up|0|||
164327491|NCT04177355|593576025|FG001|Overall Study|Lost to Follow-up|2|||
164327492|NCT04177355|593576026|FG002|Overall Study|Lost to Follow-up|0|||
164327493|NCT04177355|593576027|FG003|Overall Study|Lost to Follow-up|1|||
164327494|NCT04177355|593576028|FG004|Overall Study|Lost to Follow-up|2|||
164327495|NCT04177355|593576029|FG005|Overall Study|Lost to Follow-up|0|||
164327496|NCT04177355|593576030|FG006|Overall Study|Lost to Follow-up|1|||
164327497|NCT04177355|593576031|FG007|Overall Study|Lost to Follow-up|0|||
164327498|NCT04177355|593576032|FG008|Overall Study|Lost to Follow-up|0|||
164327499|NCT04177355|593576033|FG009|Overall Study|Lost to Follow-up|0|||
164327500|NCT04177355|593576034|FG010|Overall Study|Lost to Follow-up|0|||
164327501|NCT04177355|593576024|FG000|Overall Study|Withdrawal by Subject|0|||
164327502|NCT04177355|593576025|FG001|Overall Study|Withdrawal by Subject|0|||
164078177|NCT02764489|592651512|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
164078178|NCT02764489|592651513|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
164327503|NCT04177355|593576026|FG002|Overall Study|Withdrawal by Subject|0|||
164327504|NCT04177355|593576027|FG003|Overall Study|Withdrawal by Subject|1|||
164327505|NCT04177355|593576028|FG004|Overall Study|Withdrawal by Subject|1|||
164327506|NCT04177355|593576029|FG005|Overall Study|Withdrawal by Subject|0|||
164217794|NCT00145327|593165070|FG001|Overall Study|Death|18|||
164217795|NCT00145327|593165071|FG002|Overall Study|Death|30|||
164217796|NCT00145327|593165069|FG000|Overall Study|Adverse Event|14|||
164327507|NCT04177355|593576030|FG006|Overall Study|Withdrawal by Subject|0|||
164327508|NCT04177355|593576031|FG007|Overall Study|Withdrawal by Subject|0|||
164217797|NCT00145327|593165070|FG001|Overall Study|Adverse Event|11|||
164217798|NCT00145327|593165071|FG002|Overall Study|Adverse Event|22|||
164217799|NCT00145327|593165069|FG000|Overall Study|Lost to Follow-up|9|||
164327509|NCT04177355|593576032|FG008|Overall Study|Withdrawal by Subject|1|||
164327510|NCT04177355|593576033|FG009|Overall Study|Withdrawal by Subject|0|||
164217800|NCT00145327|593165070|FG001|Overall Study|Lost to Follow-up|14|||
164217801|NCT00145327|593165071|FG002|Overall Study|Lost to Follow-up|14|||
164327511|NCT04177355|593576034|FG010|Overall Study|Withdrawal by Subject|0|||
164327512|NCT02742246|593576035|FG000|Overall Study|Never initiated treatment|5|||
164327513|NCT02742246|593576036|FG001|Overall Study|Never initiated treatment|3|||
164327514|NCT02742246|593576037|FG002|Overall Study|Never initiated treatment|1|||
164327515|NCT02742246|593576035|FG000|Overall Study|dropped out during treatment|7|||
164327516|NCT02742246|593576036|FG001|Overall Study|dropped out during treatment|13|||
164327517|NCT02742246|593576037|FG002|Overall Study|dropped out during treatment|10|||
164327518|NCT02742246|593576035|FG000|Overall Study|Death|1|||
164327519|NCT02742246|593576036|FG001|Overall Study|Death|0|||
164327520|NCT02742246|593576037|FG002|Overall Study|Death|0|||
164327521|NCT03489551|593576038|FG000|Overall Study|Withdrawal by Subject|2|||
164327522|NCT00054717|593576039|FG000|Overall Study|Randomized but not treated|2|||
164327523|NCT00054717|593576040|FG001|Overall Study|Randomized but not treated|8|||
164327524|NCT00054717|593576039|FG000|Overall Study|Adverse Event|70|||
164327525|NCT00054717|593576040|FG001|Overall Study|Adverse Event|22|||
164327526|NCT00054717|593576039|FG000|Overall Study|Protocol Violation|18|||
164327527|NCT00054717|593576040|FG001|Overall Study|Protocol Violation|19|||
164327528|NCT00054717|593576039|FG000|Overall Study|Lost to Follow-up|23|||
164327529|NCT00054717|593576040|FG001|Overall Study|Lost to Follow-up|13|||
164078179|NCT02764489|592651512|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
164078180|NCT02764489|592651513|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
164078181|NCT02764489|592651512|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
164078182|NCT02764489|592651513|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
164078183|NCT01625845|592651514|FG000|Overall Study|Adverse Event|1|||
164078184|NCT01625845|592651515|FG001|Overall Study|Adverse Event|2|||
164078185|NCT01625845|592651514|FG000|Overall Study|Lost to Follow-up|2|||
164078186|NCT01625845|592651515|FG001|Overall Study|Lost to Follow-up|1|||
164078187|NCT01625845|592651514|FG000|Overall Study|Withdrawal by Subject|2|||
164078188|NCT01625845|592651515|FG001|Overall Study|Withdrawal by Subject|0|||
164078189|NCT02853929|592651516|FG000|Overall Study|Lost to Follow-up|3|||
164078190|NCT02853929|592651517|FG001|Overall Study|Lost to Follow-up|0|||
164078191|NCT02853929|592651516|FG000|Overall Study|Withdrawal by Subject|1|||
164078192|NCT02853929|592651517|FG001|Overall Study|Withdrawal by Subject|0|||
164078193|NCT02853929|592651516|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
164078194|NCT02853929|592651517|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
164078195|NCT01294592|592651518|FG000|Overall Study|Adverse Event|28|||
164078196|NCT01294592|592651519|FG001|Overall Study|Adverse Event|13|||
164078197|NCT01294592|592651518|FG000|Overall Study|Lack of Efficacy|7|||
164078198|NCT01294592|592651519|FG001|Overall Study|Lack of Efficacy|5|||
164078199|NCT01294592|592651518|FG000|Overall Study|Protocol Violation|1|||
164078200|NCT01294592|592651519|FG001|Overall Study|Protocol Violation|7|||
164078201|NCT01294592|592651518|FG000|Overall Study|Lost to Follow-up|7|||
164078202|NCT01294592|592651519|FG001|Overall Study|Lost to Follow-up|9|||
164078203|NCT01294592|592651518|FG000|Overall Study|Physician Decision|6|||
164078204|NCT01294592|592651519|FG001|Overall Study|Physician Decision|11|||
164078205|NCT01294592|592651518|FG000|Overall Study|Withdrawal by Subject|28|||
164078206|NCT01294592|592651519|FG001|Overall Study|Withdrawal by Subject|28|||
164078207|NCT00623623|592651520|FG000|Overall Study|Previous enrolment into this study|1|||
164078208|NCT00623623|592651521|FG001|Overall Study|Previous enrolment into this study|1|||
164078209|NCT00693784|592651522|FG000|Overall Study|Lost to Follow-up|2|||
164078210|NCT00693784|592651522|FG000|Overall Study|Withdrawal by Subject|2|||
164078211|NCT02265952|592651523|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
164078212|NCT02265952|592651524|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
164078213|NCT02265952|592651523|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
164078214|NCT02265952|592651524|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
164078215|NCT00326885|592651527|FG000|Overall Study|Adverse Event|1|||
164078216|NCT00326885|592651527|FG000|Overall Study|Withdrawal by Subject|3|||
164078217|NCT00326885|592651527|FG000|Overall Study|Physician Decision|1|||
164078218|NCT00326885|592651527|FG000|Overall Study|Hospice withdrew consent|2|||
164078219|NCT01759381|592651532|FG000|Overall Study|Death|1|||
164078220|NCT01759381|592651533|FG001|Overall Study|Death|0|||
164078221|NCT00738673|592651535|FG000|Overall Study|Adverse Event|1|||
164327530|NCT00054717|593576039|FG000|Overall Study|Withdrawal by Subject|32|||
164327531|NCT00054717|593576040|FG001|Overall Study|Withdrawal by Subject|20|||
164327532|NCT00054717|593576039|FG000|Overall Study|Other reason not defined above|117|||
164327533|NCT00054717|593576040|FG001|Overall Study|Other reason not defined above|217|||
164327534|NCT01082640|593576049|FG000|Overall Study|Adverse Event|9|||
164327535|NCT01082640|593576050|FG001|Overall Study|Adverse Event|5|||
164327536|NCT01082640|593576051|FG002|Overall Study|Adverse Event|3|||
164078222|NCT00738673|592651536|FG001|Overall Study|Adverse Event|0|||
164078223|NCT00738673|592651535|FG000|Overall Study|Lack of Efficacy|19|||
164078224|NCT00738673|592651536|FG001|Overall Study|Lack of Efficacy|8|||
164078225|NCT00738673|592651535|FG000|Overall Study|Protocol Violation|1|||
164078226|NCT00738673|592651536|FG001|Overall Study|Protocol Violation|2|||
164078227|NCT00738673|592651535|FG000|Overall Study|Withdrawal by Subject|3|||
164078228|NCT00738673|592651536|FG001|Overall Study|Withdrawal by Subject|1|||
164078229|NCT02736227|592651537|FG000|Overall Study|Withdrawal by Subject|0|||
164078230|NCT02736227|592651538|FG001|Overall Study|Withdrawal by Subject|0|||
164327537|NCT01082640|593576049|FG000|Overall Study|Withdrawal by Subject|3|||
164327538|NCT01082640|593576050|FG001|Overall Study|Withdrawal by Subject|3|||
164327539|NCT01082640|593576051|FG002|Overall Study|Withdrawal by Subject|2|||
164327540|NCT01082640|593576049|FG000|Overall Study|Major protocol deviation|3|||
164327541|NCT01082640|593576050|FG001|Overall Study|Major protocol deviation|3|||
164327542|NCT01082640|593576051|FG002|Overall Study|Major protocol deviation|0|||
164327543|NCT01082640|593576049|FG000|Overall Study|Lost to Follow-up|0|||
164327544|NCT01082640|593576050|FG001|Overall Study|Lost to Follow-up|3|||
164327545|NCT01082640|593576051|FG002|Overall Study|Lost to Follow-up|0|||
164327546|NCT01082640|593576049|FG000|Overall Study|Other|2|||
164217802|NCT00145327|593165069|FG000|Overall Study|Administrative problems|12|||
164217803|NCT00145327|593165070|FG001|Overall Study|Administrative problems|9|||
164217804|NCT00145327|593165071|FG002|Overall Study|Administrative problems|13|||
164217805|NCT00145327|593165069|FG000|Overall Study|Protocol Violation|2|||
164217806|NCT00145327|593165070|FG001|Overall Study|Protocol Violation|0|||
164217807|NCT00145327|593165071|FG002|Overall Study|Protocol Violation|2|||
164217808|NCT00145327|593165069|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164217809|NCT00145327|593165070|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164217810|NCT00145327|593165071|FG002|Overall Study|Abnormal laboratory value(s)|2|||
164217811|NCT00145327|593165069|FG000|Overall Study|Missing - not stated|1|||
164217812|NCT00145327|593165070|FG001|Overall Study|Missing - not stated|0|||
164217813|NCT00145327|593165071|FG002|Overall Study|Missing - not stated|1|||
164217814|NCT00960856|593165073|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164217815|NCT00960856|593165074|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
164217816|NCT00960856|593165075|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
164217817|NCT00960856|593165076|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
164217818|NCT00960856|593165073|FG000|Washout Period of 7 Days|Adverse Event|0|||
164217819|NCT00960856|593165074|FG001|Washout Period of 7 Days|Adverse Event|0|||
164217820|NCT00960856|593165075|FG002|Washout Period of 7 Days|Adverse Event|1|||
164217821|NCT00960856|593165076|FG003|Washout Period of 7 Days|Adverse Event|0|||
164217822|NCT04027946|593165077|FG000|Overall Study|Screen failures|3|||
164217823|NCT05938010|593165079|FG000|Overall Study|Lost to Follow-up|2|||
164217824|NCT00985192|593165080|FG000|Overall Study|Withdrawal by Subject|1|||
164217825|NCT00985192|593165080|FG000|Overall Study|Disease Progression|1|||
164217826|NCT00985192|593165080|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
164217827|NCT01454063|593165081|FG000|Randomized|Adverse Event|1|||
164217828|NCT01454063|593165082|FG001|Randomized|Adverse Event|1|||
164217829|NCT01454063|593165081|FG000|Randomized|Protocol Violation|0|||
164217830|NCT01454063|593165082|FG001|Randomized|Protocol Violation|1|||
164217831|NCT01562444|593165086|FG000|Overall Study|Did not meet entry criteria|2|||
164217832|NCT01562444|593165087|FG001|Overall Study|Did not meet entry criteria|0|||
164217833|NCT01562444|593165088|FG002|Overall Study|Did not meet entry criteria|3|||
164217834|NCT01562444|593165086|FG000|Overall Study|Did not comply with blood draw schedule|1|||
164217835|NCT01562444|593165087|FG001|Overall Study|Did not comply with blood draw schedule|0|||
164217836|NCT01562444|593165088|FG002|Overall Study|Did not comply with blood draw schedule|1|||
164217837|NCT01562444|593165086|FG000|Overall Study|Unavailable serological results|0|||
164217838|NCT01562444|593165087|FG001|Overall Study|Unavailable serological results|2|||
164217839|NCT01562444|593165088|FG002|Overall Study|Unavailable serological results|2|||
164217840|NCT01562444|593165086|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
164217841|NCT01562444|593165087|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
164217842|NCT01562444|593165088|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
164217843|NCT01562444|593165086|FG000|Overall Study|Protocol forbidden medication|1|||
164217844|NCT01562444|593165087|FG001|Overall Study|Protocol forbidden medication|0|||
164217845|NCT01562444|593165088|FG002|Overall Study|Protocol forbidden medication|0|||
164217846|NCT03055195|593165093|FG000|Overall Study|Lack of Efficacy|1|||
164217847|NCT03055195|593165094|FG001|Overall Study|Lack of Efficacy|0|||
164078231|NCT02736227|592651539|FG002|Overall Study|Withdrawal by Subject|1|||
164078232|NCT02736227|592651537|FG000|Overall Study|Physician Decision|0|||
164078233|NCT02736227|592651538|FG001|Overall Study|Physician Decision|0|||
164078234|NCT02736227|592651539|FG002|Overall Study|Physician Decision|5|||
164078235|NCT02736227|592651537|FG000|Overall Study|Non Compliant|0|||
164327547|NCT01082640|593576050|FG001|Overall Study|Other|1|||
164217848|NCT03055195|593165093|FG000|Overall Study|Withdrawal by Subject|6|||
164217849|NCT03055195|593165094|FG001|Overall Study|Withdrawal by Subject|7|||
164078236|NCT02736227|592651538|FG001|Overall Study|Non Compliant|0|||
164217850|NCT03055195|593165093|FG000|Overall Study|Study Terminated by Sponsor|2|||
164217851|NCT03055195|593165094|FG001|Overall Study|Study Terminated by Sponsor|6|||
164217852|NCT03055195|593165093|FG000|Overall Study|Protocol Violation|2|||
164217853|NCT03055195|593165094|FG001|Overall Study|Protocol Violation|1|||
164078237|NCT02736227|592651539|FG002|Overall Study|Non Compliant|2|||
164217854|NCT03055195|593165093|FG000|Overall Study|Physician Decision|1|||
164217855|NCT03055195|593165094|FG001|Overall Study|Physician Decision|0|||
164327548|NCT01082640|593576051|FG002|Overall Study|Other|3|||
164078238|NCT00068237|592651540|FG000|Overall Study|Ineligible|3|||
164217856|NCT00790933|593165098|FG000|Overall Study|Adverse Event|94|||
164217857|NCT00790933|593165099|FG001|Overall Study|Adverse Event|119|||
164217858|NCT00790933|593165100|FG002|Overall Study|Adverse Event|65|||
164217859|NCT00790933|593165101|FG003|Overall Study|Adverse Event|5|||
164217860|NCT00790933|593165102|FG004|Overall Study|Adverse Event|69|||
164217861|NCT00790933|593165098|FG000|Overall Study|Protocol Violation(s)|8|||
164217862|NCT00790933|593165099|FG001|Overall Study|Protocol Violation(s)|18|||
164217863|NCT00790933|593165100|FG002|Overall Study|Protocol Violation(s)|7|||
164217864|NCT00790933|593165101|FG003|Overall Study|Protocol Violation(s)|0|||
164217865|NCT00790933|593165102|FG004|Overall Study|Protocol Violation(s)|12|||
164217866|NCT00790933|593165098|FG000|Overall Study|Lack of Efficacy|192|||
164217867|NCT00790933|593165099|FG001|Overall Study|Lack of Efficacy|176|||
164217868|NCT00790933|593165100|FG002|Overall Study|Lack of Efficacy|130|||
164217869|NCT00790933|593165101|FG003|Overall Study|Lack of Efficacy|1|||
164217870|NCT00790933|593165102|FG004|Overall Study|Lack of Efficacy|121|||
164217871|NCT00790933|593165098|FG000|Overall Study|Study Terminated by Sponsor|0|||
164217872|NCT00790933|593165099|FG001|Overall Study|Study Terminated by Sponsor|0|||
164217873|NCT00790933|593165100|FG002|Overall Study|Study Terminated by Sponsor|1|||
164217874|NCT00790933|593165101|FG003|Overall Study|Study Terminated by Sponsor|0|||
164217875|NCT00790933|593165102|FG004|Overall Study|Study Terminated by Sponsor|0|||
164217876|NCT00790933|593165098|FG000|Overall Study|Withdrawal by Subject|123|||
164217877|NCT00790933|593165099|FG001|Overall Study|Withdrawal by Subject|120|||
164217878|NCT00790933|593165100|FG002|Overall Study|Withdrawal by Subject|52|||
164217879|NCT00790933|593165101|FG003|Overall Study|Withdrawal by Subject|6|||
164217880|NCT00790933|593165102|FG004|Overall Study|Withdrawal by Subject|50|||
164217881|NCT00790933|593165098|FG000|Overall Study|Lost to Follow-up|13|||
164217882|NCT00790933|593165099|FG001|Overall Study|Lost to Follow-up|31|||
164217883|NCT00790933|593165100|FG002|Overall Study|Lost to Follow-up|10|||
164217884|NCT00790933|593165101|FG003|Overall Study|Lost to Follow-up|1|||
164217885|NCT00790933|593165102|FG004|Overall Study|Lost to Follow-up|15|||
164217886|NCT00790933|593165098|FG000|Overall Study|Reason Not Specified|8|||
164217887|NCT00790933|593165099|FG001|Overall Study|Reason Not Specified|16|||
164217888|NCT00790933|593165100|FG002|Overall Study|Reason Not Specified|4|||
164217889|NCT00790933|593165101|FG003|Overall Study|Reason Not Specified|1|||
164217890|NCT00790933|593165102|FG004|Overall Study|Reason Not Specified|9|||
164217891|NCT00245570|593165104|FG000|Washout Between Periods III and IV|Adverse Event|0|||
164217892|NCT00245570|593165105|FG001|Washout Between Periods III and IV|Adverse Event|1|||
164217893|NCT00245570|593165106|FG002|Washout Between Periods III and IV|Adverse Event|0|||
164217894|NCT00245570|593165107|FG003|Washout Between Periods III and IV|Adverse Event|0|||
164217895|NCT00245570|593165108|FG004|Washout Between Periods III and IV|Adverse Event|0|||
164217896|NCT00245570|593165109|FG005|Washout Between Periods III and IV|Adverse Event|0|||
164217897|NCT00866320|593165119|FG000|Overall Study|Withdrawal by Subject|4|||
164217898|NCT00866320|593165119|FG000|Overall Study|Death|2|||
164217899|NCT00896233|593165120|FG000|Overall Study|Claustrophobia during MRI|1|||
164217900|NCT05507450|593165121|FG000|Overall Study|Death|0|||
164217901|NCT05507450|593165122|FG001|Overall Study|Death|0|||
164217902|NCT05507450|593165123|FG002|Overall Study|Death|1|||
164217903|NCT05507450|593165124|FG003|Overall Study|Death|0|||
164217904|NCT05507450|593165121|FG000|Overall Study|Lost to Follow-up|22|||
164217905|NCT05507450|593165122|FG001|Overall Study|Lost to Follow-up|20|||
164217906|NCT05507450|593165123|FG002|Overall Study|Lost to Follow-up|20|||
164217907|NCT05507450|593165124|FG003|Overall Study|Lost to Follow-up|7|||
164217908|NCT05507450|593165121|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164217909|NCT05507450|593165122|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164217910|NCT05507450|593165123|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164217911|NCT05507450|593165124|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164217912|NCT05507450|593165121|FG000|Overall Study|Withdrawal by Subject|4|||
164217913|NCT05507450|593165122|FG001|Overall Study|Withdrawal by Subject|11|||
164217914|NCT05507450|593165123|FG002|Overall Study|Withdrawal by Subject|7|||
164217915|NCT05507450|593165124|FG003|Overall Study|Withdrawal by Subject|3|||
164327549|NCT03823378|593576053|FG000|Overall Study|Adverse Event|2|||
164327550|NCT03823378|593576054|FG001|Overall Study|Adverse Event|2|||
164327551|NCT03823378|593576055|FG002|Overall Study|Adverse Event|0|||
163981467|NCT01505634|592302736|FG002|Overall Study|Insufficient supply of drug at site|0|||
164217916|NCT05507450|593165121|FG000|Overall Study|Participant left the country|0|||
164217917|NCT05507450|593165122|FG001|Overall Study|Participant left the country|0|||
164217918|NCT05507450|593165123|FG002|Overall Study|Participant left the country|1|||
163981468|NCT01505634|592302734|FG000|Overall Study|Protocol Violation|2|||
164217919|NCT05507450|593165124|FG003|Overall Study|Participant left the country|0|||
164217920|NCT05436288|593165125|FG000|Overall Study|Lost to Follow-up|1|||
164217921|NCT05436288|593165125|FG000|Overall Study|Adverse Event|1|||
164327552|NCT03823378|593576056|FG003|Overall Study|Adverse Event|0|||
164327553|NCT03823378|593576057|FG004|Overall Study|Adverse Event|0|||
163981469|NCT01505634|592302735|FG001|Overall Study|Protocol Violation|0|||
164217922|NCT03767894|593165131|FG000|Overall Study|Withdrawal by Subject|1|||
164217923|NCT00387127|593165132|FG000|Overall Study|Lost to Follow-up|0|||
164217924|NCT00387127|593165133|FG001|Overall Study|Lost to Follow-up|4|||
164217925|NCT00387127|593165132|FG000|Overall Study|Death|16|||
164217926|NCT00387127|593165133|FG001|Overall Study|Death|16|||
164217927|NCT00387127|593165132|FG000|Overall Study|Physician Decision|0|||
164217928|NCT00387127|593165133|FG001|Overall Study|Physician Decision|1|||
164217929|NCT00387127|593165132|FG000|Overall Study|Withdrawal by Subject|3|||
164217930|NCT00387127|593165133|FG001|Overall Study|Withdrawal by Subject|2|||
164217931|NCT00387127|593165132|FG000|Overall Study|Required by Protocol Amendment #4|12|||
164217932|NCT00387127|593165133|FG001|Overall Study|Required by Protocol Amendment #4|10|||
164217933|NCT00387127|593165132|FG000|Overall Study|Serious Adverse Event|1|||
164217934|NCT00387127|593165133|FG001|Overall Study|Serious Adverse Event|1|||
164217935|NCT00387127|593165132|FG000|Overall Study|Sponsor Unblinded|1|||
164217936|NCT00387127|593165133|FG001|Overall Study|Sponsor Unblinded|0|||
164217937|NCT04149353|593165137|FG000|Overall Study|Study terminated|1|||
164217938|NCT01871727|593165138|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
164217939|NCT01871727|593165139|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
164217940|NCT01871727|593165140|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
164217941|NCT01871727|593165141|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
164217942|NCT01871727|593165142|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
164217943|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
164217944|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
164217945|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
164217946|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
164217947|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
164217948|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217949|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217950|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217951|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
164217952|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
164217953|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217954|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217955|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217956|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
164217957|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
164217958|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217959|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217960|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217961|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
164217962|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
164217963|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217964|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217965|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217966|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
164217967|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
164217968|NCT01871727|593165138|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217969|NCT01871727|593165139|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217970|NCT01871727|593165140|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217971|NCT01871727|593165141|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
164217972|NCT01871727|593165142|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
164217973|NCT01263028|593165143|FG000|Overall Study|Withdrawal by Subject|1|||
164217974|NCT01263028|593165143|FG000|Overall Study|Adverse Event|1|||
164217975|NCT01263028|593165143|FG000|Overall Study|Study terminated due to low enrollment.|4|||
164217976|NCT06038643|593165144|FG000|Overall Study|Withdrawal by Subject|9|||
164217977|NCT06038643|593165145|FG001|Overall Study|Withdrawal by Subject|4|||
164217978|NCT06038643|593165144|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
164217979|NCT06038643|593165145|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
164217980|NCT03573882|593165146|FG000|Overall Study|Study Terminated by Sponsor|22|||
164217981|NCT03573882|593165147|FG001|Overall Study|Study Terminated by Sponsor|17|||
164217982|NCT03573882|593165148|FG002|Overall Study|Study Terminated by Sponsor|18|||
164217983|NCT03573882|593165146|FG000|Overall Study|Withdrawal by Subject|6|||
164217984|NCT03573882|593165147|FG001|Overall Study|Withdrawal by Subject|11|||
164217985|NCT03573882|593165148|FG002|Overall Study|Withdrawal by Subject|7|||
164217986|NCT03573882|593165146|FG000|Overall Study|Adverse Event|7|||
164217987|NCT03573882|593165147|FG001|Overall Study|Adverse Event|5|||
164217988|NCT03573882|593165148|FG002|Overall Study|Adverse Event|6|||
164217989|NCT03573882|593165146|FG000|Overall Study|Lost to Follow-up|2|||
164217990|NCT03573882|593165147|FG001|Overall Study|Lost to Follow-up|5|||
164217991|NCT03573882|593165148|FG002|Overall Study|Lost to Follow-up|3|||
164217992|NCT03573882|593165146|FG000|Overall Study|Physician Decision|4|||
164217993|NCT03573882|593165147|FG001|Overall Study|Physician Decision|3|||
164217994|NCT03573882|593165148|FG002|Overall Study|Physician Decision|2|||
164217995|NCT03573882|593165146|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
164217996|NCT03573882|593165147|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
164217997|NCT03573882|593165148|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
164217998|NCT03573882|593165146|FG000|Overall Study|Pregnancy|1|||
164217999|NCT03573882|593165147|FG001|Overall Study|Pregnancy|2|||
164218000|NCT03573882|593165148|FG002|Overall Study|Pregnancy|0|||
164218001|NCT03573882|593165146|FG000|Overall Study|Other|4|||
164218002|NCT03573882|593165147|FG001|Overall Study|Other|2|||
164218003|NCT03573882|593165148|FG002|Overall Study|Other|2|||
164218004|NCT02691572|593165149|FG000|Overall Study|Withdrawal by Subject|1|||
164218005|NCT02691572|593165150|FG001|Overall Study|Withdrawal by Subject|0|||
164218006|NCT02691572|593165149|FG000|Overall Study|Protocol Violation|0|||
164218007|NCT02691572|593165150|FG001|Overall Study|Protocol Violation|1|||
164218008|NCT00250718|593165151|FG000|Overall Study|Death|1|||
164218009|NCT00250718|593165151|FG000|Overall Study|Adverse Event|1|||
164218010|NCT00250718|593165151|FG000|Overall Study|Withdrawal by Subject|1|||
164218011|NCT04439123|593165152|FG000|Overall Study|Adverse Event|11|||
164218012|NCT04439123|593165152|FG000|Overall Study|Death|1|||
164218013|NCT04439123|593165152|FG000|Overall Study|Disease progression|19|||
164218014|NCT04439123|593165152|FG000|Overall Study|Withdrawal by Subject|2|||
164218015|NCT04439123|593165152|FG000|Overall Study|Still on treatment|2|||
164218016|NCT00424008|593165153|FG000|Overall Study|Adverse Event|8|||
164218017|NCT00424008|593165154|FG001|Overall Study|Adverse Event|6|||
164218018|NCT00424008|593165153|FG000|Overall Study|Lack of Efficacy|40|||
164218019|NCT00424008|593165154|FG001|Overall Study|Lack of Efficacy|34|||
164218020|NCT00424008|593165153|FG000|Overall Study|Lost to Follow-up|1|||
164218021|NCT00424008|593165154|FG001|Overall Study|Lost to Follow-up|2|||
164218022|NCT00424008|593165153|FG000|Overall Study|Withdrawal by Subject|5|||
164218023|NCT00424008|593165154|FG001|Overall Study|Withdrawal by Subject|8|||
164218024|NCT00424008|593165153|FG000|Overall Study|Noncompliance with protocol|13|||
164218025|NCT00424008|593165154|FG001|Overall Study|Noncompliance with protocol|7|||
164218026|NCT00424008|593165153|FG000|Overall Study|Did not meet protocol eligibility|16|||
164218027|NCT00424008|593165154|FG001|Overall Study|Did not meet protocol eligibility|21|||
164218028|NCT00424008|593165153|FG000|Overall Study|Administrative|266|||
164218029|NCT00424008|593165154|FG001|Overall Study|Administrative|257|||
164218030|NCT02530242|593165160|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
164218031|NCT02530242|593165161|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
164218032|NCT02665455|593165164|FG000|Overall Study|Withdrawal by Subject|6|||
164218033|NCT02665455|593165164|FG000|Overall Study|Lost to Follow-up|1|||
164218034|NCT02665455|593165164|FG000|Overall Study|Adverse Event|1|||
164218035|NCT02665455|593165164|FG000|Overall Study|Protocol Violation|1|||
164218036|NCT01671059|593165168|FG000|Overall Study|Adverse Event|4|||
164218037|NCT01671059|593165168|FG000|Overall Study|Lack of Efficacy|1|||
164218038|NCT04971837|593166647|FG000|Overall Study|Long Term Illness|1|||
164218039|NCT04971837|593166647|FG000|Overall Study|BMI too low|9|||
164218040|NCT04971837|593166647|FG000|Overall Study|geographic location|1|||
164218041|NCT04971837|593166647|FG000|Overall Study|Discontinued scheduling conflict|1|||
164218042|NCT03166631|593166648|FG000|Overall Study|Progressive disease|2|||
164218043|NCT03166631|593166649|FG001|Overall Study|Progressive disease|1|||
164218044|NCT03166631|593166650|FG002|Overall Study|Progressive disease|3|||
164218045|NCT03166631|593166651|FG003|Overall Study|Progressive disease|4|||
164218046|NCT03166631|593166652|FG004|Overall Study|Progressive disease|2|||
164218047|NCT03166631|593166653|FG005|Overall Study|Progressive disease|2|||
164218048|NCT03166631|593166654|FG006|Overall Study|Progressive disease|5|||
164218049|NCT03166631|593166655|FG007|Overall Study|Progressive disease|6|||
164218050|NCT03166631|593166656|FG008|Overall Study|Progressive disease|11|||
164218051|NCT03166631|593166657|FG009|Overall Study|Progressive disease|5|||
164218052|NCT03166631|593166658|FG010|Overall Study|Progressive disease|7|||
164218053|NCT03166631|593166648|FG000|Overall Study|Physician Decision|0|||
164218054|NCT03166631|593166649|FG001|Overall Study|Physician Decision|0|||
164218055|NCT03166631|593166650|FG002|Overall Study|Physician Decision|0|||
164218056|NCT03166631|593166651|FG003|Overall Study|Physician Decision|0|||
164218057|NCT03166631|593166652|FG004|Overall Study|Physician Decision|0|||
164218058|NCT03166631|593166653|FG005|Overall Study|Physician Decision|0|||
164218059|NCT03166631|593166654|FG006|Overall Study|Physician Decision|1|||
164218060|NCT03166631|593166655|FG007|Overall Study|Physician Decision|0|||
164218061|NCT03166631|593166656|FG008|Overall Study|Physician Decision|1|||
164218062|NCT03166631|593166657|FG009|Overall Study|Physician Decision|0|||
164218063|NCT03166631|593166658|FG010|Overall Study|Physician Decision|1|||
164218064|NCT03166631|593166648|FG000|Overall Study|Death|0|||
164218065|NCT03166631|593166649|FG001|Overall Study|Death|0|||
164218066|NCT03166631|593166650|FG002|Overall Study|Death|0|||
164218067|NCT03166631|593166651|FG003|Overall Study|Death|0|||
164218068|NCT03166631|593166652|FG004|Overall Study|Death|1|||
164218069|NCT03166631|593166653|FG005|Overall Study|Death|0|||
164218070|NCT03166631|593166654|FG006|Overall Study|Death|1|||
164218071|NCT03166631|593166655|FG007|Overall Study|Death|0|||
164218072|NCT03166631|593166656|FG008|Overall Study|Death|0|||
164218073|NCT03166631|593166657|FG009|Overall Study|Death|0|||
164218074|NCT03166631|593166658|FG010|Overall Study|Death|0|||
164218075|NCT03166631|593166648|FG000|Overall Study|Adverse Event|1|||
164218076|NCT03166631|593166649|FG001|Overall Study|Adverse Event|0|||
164218077|NCT03166631|593166650|FG002|Overall Study|Adverse Event|0|||
164218078|NCT03166631|593166651|FG003|Overall Study|Adverse Event|0|||
164218079|NCT03166631|593166652|FG004|Overall Study|Adverse Event|0|||
164218080|NCT03166631|593166653|FG005|Overall Study|Adverse Event|1|||
164218081|NCT03166631|593166654|FG006|Overall Study|Adverse Event|1|||
164218082|NCT03166631|593166655|FG007|Overall Study|Adverse Event|0|||
164218083|NCT03166631|593166656|FG008|Overall Study|Adverse Event|1|||
164218084|NCT03166631|593166657|FG009|Overall Study|Adverse Event|2|||
164218085|NCT03166631|593166658|FG010|Overall Study|Adverse Event|1|||
164218086|NCT03166631|593166648|FG000|Overall Study|Withdrawal by Subject|0|||
164218087|NCT03166631|593166649|FG001|Overall Study|Withdrawal by Subject|0|||
164218088|NCT03166631|593166650|FG002|Overall Study|Withdrawal by Subject|0|||
164218089|NCT03166631|593166651|FG003|Overall Study|Withdrawal by Subject|0|||
164218090|NCT03166631|593166652|FG004|Overall Study|Withdrawal by Subject|0|||
164218091|NCT03166631|593166653|FG005|Overall Study|Withdrawal by Subject|0|||
164218092|NCT03166631|593166654|FG006|Overall Study|Withdrawal by Subject|0|||
164218093|NCT03166631|593166655|FG007|Overall Study|Withdrawal by Subject|0|||
164218094|NCT03166631|593166656|FG008|Overall Study|Withdrawal by Subject|1|||
164218095|NCT03166631|593166657|FG009|Overall Study|Withdrawal by Subject|1|||
164218096|NCT03166631|593166658|FG010|Overall Study|Withdrawal by Subject|0|||
164218097|NCT03022630|593166659|FG000|Overall Study|Death|9|||
164218098|NCT03022630|593166660|FG001|Overall Study|Death|7|||
164218099|NCT03022630|593166659|FG000|Overall Study|Withdrawal by Subject|0|||
164218100|NCT03022630|593166660|FG001|Overall Study|Withdrawal by Subject|5|||
164218101|NCT00382070|593166661|FG000|Overall Study|No follow up data mapped to Other|17|||
164218102|NCT00382070|593166662|FG001|Overall Study|No follow up data mapped to Other|19|||
164218103|NCT00382070|593166661|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
164218104|NCT00382070|593166662|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
164218105|NCT00382070|593166661|FG000|Overall Study|No clinical assessment|9|||
164218106|NCT00382070|593166662|FG001|Overall Study|No clinical assessment|11|||
164218107|NCT04289298|593166663|FG000|Overall Study|Lost to Follow-up|5|||
164218108|NCT04289298|593166664|FG001|Overall Study|Lost to Follow-up|0|||
164218109|NCT04289298|593166663|FG000|Overall Study|Withdrawal by Subject|2|||
164218110|NCT04289298|593166664|FG001|Overall Study|Withdrawal by Subject|0|||
164218111|NCT01734928|593166665|FG000|Randomization|Physician Decision|0|||
164218112|NCT01734928|593166666|FG001|Randomization|Physician Decision|1|||
164218113|NCT01734928|593166665|FG000|Randomization|clinical progression|0|||
164218114|NCT01734928|593166666|FG001|Randomization|clinical progression|1|||
164218115|NCT01734928|593166665|FG000|Randomization|progressive disease|0|||
164218116|NCT01734928|593166666|FG001|Randomization|progressive disease|2|||
164218117|NCT01734928|593166665|FG000|Randomization|Withdrew informed consent|0|||
164218118|NCT01734928|593166666|FG001|Randomization|Withdrew informed consent|4|||
164218119|NCT01734928|593166665|FG000|Randomization|Death|1|||
164218120|NCT01734928|593166666|FG001|Randomization|Death|0|||
164218121|NCT01734928|593166665|FG000|Randomization|Randomization error|1|||
164218122|NCT01734928|593166666|FG001|Randomization|Randomization error|0|||
164218123|NCT01734928|593166665|FG000|Randomization|Lost to Follow-up|1|||
164218124|NCT01734928|593166666|FG001|Randomization|Lost to Follow-up|0|||
164218125|NCT01734928|593166665|FG000|Treatment Period|Lost to Follow-up|0|||
164078239|NCT00068237|592651540|FG000|Overall Study|No protocol treatment received|2|||
164078240|NCT05288673|592651541|FG000|Overall Study|Consent withdrawn by subject|0|||
164078241|NCT05288673|592651542|FG001|Overall Study|Consent withdrawn by subject|0|||
164078242|NCT05288673|592651543|FG002|Overall Study|Consent withdrawn by subject|1|||
164218126|NCT01734928|593166666|FG001|Treatment Period|Lost to Follow-up|2|||
164218127|NCT01734928|593166665|FG000|Treatment Period|Progressive Disease|167|||
164218128|NCT01734928|593166666|FG001|Treatment Period|Progressive Disease|165|||
164218129|NCT01734928|593166665|FG000|Treatment Period|Adverse Event|39|||
164218130|NCT01734928|593166666|FG001|Treatment Period|Adverse Event|52|||
164218131|NCT01734928|593166665|FG000|Treatment Period|Withdrawal of Consent|25|||
164078243|NCT03056352|592651544|FG000|Overall Study|Lost to Follow-up|1|||
164078244|NCT00571922|592651545|FG000|Overall Study|Completion unknown|36|||
164078245|NCT00571922|592651546|FG001|Overall Study|Completion unknown|36|||
164078246|NCT02971605|592651547|FG000|Overall Study|Withdrawal by Subject|1|||
164078247|NCT01154153|592651550|FG000|Overall Study|Poor compliance to protocol|2|||
164078248|NCT01154153|592651551|FG001|Overall Study|Poor compliance to protocol|0|||
164218132|NCT01734928|593166666|FG001|Treatment Period|Withdrawal of Consent|22|||
164218133|NCT01734928|593166665|FG000|Treatment Period|Death|20|||
164218134|NCT01734928|593166666|FG001|Treatment Period|Death|9|||
164218135|NCT01734928|593166665|FG000|Treatment Period|Other Reasons|27|||
164078249|NCT01154153|592651550|FG000|Overall Study|Unable to use labs|2|||
164078250|NCT01154153|592651551|FG001|Overall Study|Unable to use labs|3|||
164078251|NCT01154153|592651550|FG000|Overall Study|Withdrew consent|1|||
164078252|NCT01154153|592651551|FG001|Overall Study|Withdrew consent|0|||
164218136|NCT01734928|593166666|FG001|Treatment Period|Other Reasons|19|||
164218137|NCT01734928|593166665|FG000|Treatment Period|Pregnancy|0|||
164218138|NCT01734928|593166666|FG001|Treatment Period|Pregnancy|1|||
164218139|NCT00504231|593166667|FG000|Overall Study|Discrepant chart documentation re route|0|||
164218140|NCT00504231|593166668|FG001|Overall Study|Discrepant chart documentation re route|0|||
164218141|NCT00504231|593166669|FG002|Overall Study|Discrepant chart documentation re route|1|||
164218142|NCT00504231|593166670|FG003|Overall Study|Discrepant chart documentation re route|0|||
164218143|NCT01629563|593166671|FG000|Overall Study|Adverse Event|16|||
164218144|NCT01629563|593166672|FG001|Overall Study|Adverse Event|16|||
164218145|NCT01629563|593166671|FG000|Overall Study|Death|2|||
164218146|NCT01629563|593166672|FG001|Overall Study|Death|0|||
164327554|NCT03823378|593576058|FG005|Overall Study|Adverse Event|0|||
164327555|NCT03823378|593576053|FG000|Overall Study|Lost to Follow-up|0|||
164327556|NCT03823378|593576054|FG001|Overall Study|Lost to Follow-up|1|||
164327557|NCT03823378|593576055|FG002|Overall Study|Lost to Follow-up|0|||
164327558|NCT03823378|593576056|FG003|Overall Study|Lost to Follow-up|0|||
164327559|NCT03823378|593576057|FG004|Overall Study|Lost to Follow-up|1|||
164327560|NCT03823378|593576058|FG005|Overall Study|Lost to Follow-up|0|||
164327561|NCT03823378|593576053|FG000|Overall Study|Withdrawal by Subject|0|||
164327562|NCT03823378|593576054|FG001|Overall Study|Withdrawal by Subject|1|||
164327563|NCT03823378|593576055|FG002|Overall Study|Withdrawal by Subject|4|||
164327564|NCT03823378|593576056|FG003|Overall Study|Withdrawal by Subject|2|||
164327565|NCT03823378|593576057|FG004|Overall Study|Withdrawal by Subject|0|||
164327566|NCT03823378|593576058|FG005|Overall Study|Withdrawal by Subject|1|||
164327567|NCT03823378|593576053|FG000|Overall Study|Other, not specified|19|||
164327568|NCT03823378|593576054|FG001|Overall Study|Other, not specified|12|||
164327569|NCT03823378|593576055|FG002|Overall Study|Other, not specified|6|||
164327570|NCT03823378|593576056|FG003|Overall Study|Other, not specified|8|||
164327571|NCT03823378|593576057|FG004|Overall Study|Other, not specified|17|||
164327572|NCT03823378|593576058|FG005|Overall Study|Other, not specified|7|||
164327573|NCT01289782|593576059|FG000|Overall Study|Lost to Follow-up|14|||
164327574|NCT01289782|593576060|FG001|Overall Study|Lost to Follow-up|7|||
164327575|NCT01289782|593576059|FG000|Overall Study|Protocol Violation|1|||
164327576|NCT01289782|593576060|FG001|Overall Study|Protocol Violation|1|||
164327577|NCT01289782|593576059|FG000|Overall Study|Withdrawal by Subject|8|||
164327578|NCT01289782|593576060|FG001|Overall Study|Withdrawal by Subject|2|||
164327579|NCT01289782|593576059|FG000|Overall Study|Sponsor's Decision|1|||
164327580|NCT01289782|593576060|FG001|Overall Study|Sponsor's Decision|0|||
164327581|NCT01289782|593576059|FG000|Overall Study|Reason not specified|1|||
164327582|NCT01289782|593576060|FG001|Overall Study|Reason not specified|2|||
164327583|NCT01264016|593576066|FG000|Overall Study|Withdrawal by Subject|1|||
164327584|NCT01264016|593576066|FG000|Overall Study|Felt faint at sight of blood|1|||
164327585|NCT01056380|593576067|FG000|Overall Study|Lost to Follow-up|2|||
164327586|NCT01056380|593576068|FG001|Overall Study|Lost to Follow-up|3|||
164327587|NCT01629706|593576069|FG000|Phase 1 PureVision|Screen Failure|4|||
163877001|NCT03398148|591918878|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
163877002|NCT03398148|591918879|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
163877003|NCT03398148|591918880|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
164218147|NCT01629563|593166671|FG000|Overall Study|Lack of Efficacy|2|||
164218148|NCT01629563|593166672|FG001|Overall Study|Lack of Efficacy|3|||
164218149|NCT01629563|593166671|FG000|Overall Study|Lost to Follow-up|1|||
164218150|NCT01629563|593166672|FG001|Overall Study|Lost to Follow-up|0|||
164218151|NCT01629563|593166671|FG000|Overall Study|Pregnancy|1|||
164218152|NCT01629563|593166672|FG001|Overall Study|Pregnancy|2|||
164218153|NCT01629563|593166671|FG000|Overall Study|Protocol Violation|0|||
164218154|NCT01629563|593166672|FG001|Overall Study|Protocol Violation|1|||
164218155|NCT01629563|593166671|FG000|Overall Study|Withdrawal by Subject|27|||
164218156|NCT01629563|593166672|FG001|Overall Study|Withdrawal by Subject|20|||
164218157|NCT01629563|593166671|FG000|Overall Study|surgery|0|||
164327588|NCT01629706|593576069|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
164327589|NCT01629706|593576069|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
164327590|NCT01629706|593576069|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
164327591|NCT01629706|593576069|FG000|Phase 2 Habitual|Screen Failure|6|||
164327592|NCT01629706|593576069|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
164327593|NCT01629706|593576069|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
164327594|NCT01629706|593576069|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
163877004|NCT03398148|591918881|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
163877005|NCT03398148|591918867|FG000|Substudy 2 Period 2|Adverse Event|0|||
163877006|NCT03398148|591918868|FG001|Substudy 2 Period 2|Adverse Event|0|||
163877007|NCT03398148|591918869|FG002|Substudy 2 Period 2|Adverse Event|0|||
163877008|NCT03398148|591918870|FG003|Substudy 2 Period 2|Adverse Event|0|||
163877009|NCT03398148|591918871|FG004|Substudy 2 Period 2|Adverse Event|0|||
163877010|NCT03398148|591918872|FG005|Substudy 2 Period 2|Adverse Event|0|||
163877011|NCT03398148|591918873|FG006|Substudy 2 Period 2|Adverse Event|0|||
163877012|NCT03398148|591918874|FG007|Substudy 2 Period 2|Adverse Event|0|||
163877013|NCT03398148|591918875|FG008|Substudy 2 Period 2|Adverse Event|0|||
163877014|NCT03398148|591918876|FG009|Substudy 2 Period 2|Adverse Event|0|||
163877015|NCT03398148|591918877|FG010|Substudy 2 Period 2|Adverse Event|0|||
163877016|NCT03398148|591918878|FG011|Substudy 2 Period 2|Adverse Event|0|||
164218158|NCT01629563|593166672|FG001|Overall Study|surgery|3|||
164218159|NCT01629563|593166671|FG000|Overall Study|Lack of return of menses|12|||
164218160|NCT01629563|593166672|FG001|Overall Study|Lack of return of menses|7|||
164218161|NCT01629563|593166671|FG000|Overall Study|Protocol Violation|0|||
164218162|NCT01629563|593166672|FG001|Overall Study|Protocol Violation|1|||
164327595|NCT01629706|593576069|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
164327596|NCT00048061|593576070|FG000|Overall Study|Adverse Event|41|||
164327597|NCT00048061|593576071|FG001|Overall Study|Adverse Event|32|||
164327598|NCT00048061|593576072|FG002|Overall Study|Adverse Event|44|||
164327599|NCT00048061|593576073|FG003|Overall Study|Adverse Event|37|||
164327600|NCT00048061|593576070|FG000|Overall Study|Lost to Follow-up|3|||
164327601|NCT00048061|593576071|FG001|Overall Study|Lost to Follow-up|2|||
164327602|NCT00048061|593576072|FG002|Overall Study|Lost to Follow-up|4|||
164327603|NCT00048061|593576073|FG003|Overall Study|Lost to Follow-up|5|||
164327604|NCT00048061|593576070|FG000|Overall Study|Withdrawal by Subject|20|||
164327605|NCT00048061|593576071|FG001|Overall Study|Withdrawal by Subject|29|||
164327606|NCT00048061|593576072|FG002|Overall Study|Withdrawal by Subject|29|||
164078253|NCT00964223|592651552|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
164078254|NCT03439293|592651553|FG000|Overall Study|Death|22|||
164078255|NCT03439293|592651553|FG000|Overall Study|Withdrawal by Subject|8|||
164078256|NCT03439293|592651553|FG000|Overall Study|Lost to Follow-up|2|||
164078257|NCT03439293|592651553|FG000|Overall Study|Reason Not Specified|28|||
164078258|NCT03439293|592651553|FG000|Overall Study|Missing|1|||
164078259|NCT05478603|592651556|FG000|Overall Study|Withdrawal by Subject|0|||
164078260|NCT05478603|592651557|FG001|Overall Study|Withdrawal by Subject|1|||
164078261|NCT05478603|592651558|FG002|Overall Study|Withdrawal by Subject|0|||
164078262|NCT05478603|592651559|FG003|Overall Study|Withdrawal by Subject|0|||
164078263|NCT03634488|592651562|FG000|Overall Study|Death|1|||
164327607|NCT00048061|593576073|FG003|Overall Study|Withdrawal by Subject|32|||
164327608|NCT00048061|593576070|FG000|Overall Study|Did not follow-up|5|||
164327609|NCT00048061|593576071|FG001|Overall Study|Did not follow-up|5|||
164327610|NCT00048061|593576072|FG002|Overall Study|Did not follow-up|4|||
164327611|NCT00048061|593576073|FG003|Overall Study|Did not follow-up|5|||
164327612|NCT00048061|593576070|FG000|Overall Study|Early improvement|6|||
164327613|NCT00048061|593576071|FG001|Overall Study|Early improvement|5|||
164327614|NCT00048061|593576072|FG002|Overall Study|Early improvement|3|||
164327615|NCT00048061|593576073|FG003|Overall Study|Early improvement|0|||
164327616|NCT03583073|593576074|FG000|Overall Study|Lost to Follow-up|8|||
164327617|NCT03583073|593576075|FG001|Overall Study|Lost to Follow-up|12|||
164327618|NCT01262352|593576080|FG000|Period 1|Illness after randomization|1|||
164327619|NCT01262352|593576081|FG001|Period 1|Illness after randomization|0|||
164327620|NCT01262352|593576080|FG000|Washout|Adverse Event|1|||
164327621|NCT01262352|593576081|FG001|Washout|Adverse Event|1|||
164327622|NCT01262352|593576080|FG000|Washout|Extended Washout|0|||
164327623|NCT01262352|593576081|FG001|Washout|Extended Washout|1|||
164327624|NCT01298193|593576082|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
164327625|NCT01298193|593576082|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
164327626|NCT01298193|593576082|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
164327627|NCT01298193|593576082|FG000|Efficacy Phase (Second Cycle)|Death|1|||
164327628|NCT01975831|593576083|FG000|Overall Study|Adverse Event|1|||
164327629|NCT01975831|593576084|FG001|Overall Study|Adverse Event|2|||
164327630|NCT01975831|593576085|FG002|Overall Study|Adverse Event|2|||
164327631|NCT01975831|593576086|FG003|Overall Study|Adverse Event|0|||
164327632|NCT01975831|593576087|FG004|Overall Study|Adverse Event|1|||
164327633|NCT01975831|593576088|FG005|Overall Study|Adverse Event|1|||
164327634|NCT01975831|593576089|FG006|Overall Study|Adverse Event|3|||
164327635|NCT01975831|593576090|FG007|Overall Study|Adverse Event|4|||
164327636|NCT01975831|593576091|FG008|Overall Study|Adverse Event|1|||
164327637|NCT01975831|593576083|FG000|Overall Study|Death|1|||
164078264|NCT03634488|592651563|FG001|Overall Study|Death|0|||
164078265|NCT03634488|592651564|FG002|Overall Study|Death|0|||
164138000|NCT02582866|592866996|FG000|Overall Study|Pregnancy|2|||
164327638|NCT01975831|593576084|FG001|Overall Study|Death|1|||
164327639|NCT01975831|593576085|FG002|Overall Study|Death|0|||
164327640|NCT01975831|593576086|FG003|Overall Study|Death|0|||
164327641|NCT01975831|593576087|FG004|Overall Study|Death|1|||
164327642|NCT01975831|593576088|FG005|Overall Study|Death|0|||
164327643|NCT01975831|593576089|FG006|Overall Study|Death|1|||
164327644|NCT01975831|593576090|FG007|Overall Study|Death|0|||
164327645|NCT01975831|593576091|FG008|Overall Study|Death|0|||
164327646|NCT01975831|593576083|FG000|Overall Study|Progressive Disease|1|||
164327647|NCT01975831|593576084|FG001|Overall Study|Progressive Disease|3|||
164327648|NCT01975831|593576085|FG002|Overall Study|Progressive Disease|2|||
164327649|NCT01975831|593576086|FG003|Overall Study|Progressive Disease|4|||
164327650|NCT01975831|593576087|FG004|Overall Study|Progressive Disease|13|||
164327651|NCT01975831|593576088|FG005|Overall Study|Progressive Disease|9|||
164327652|NCT01975831|593576089|FG006|Overall Study|Progressive Disease|10|||
164327653|NCT01975831|593576090|FG007|Overall Study|Progressive Disease|8|||
164327654|NCT01975831|593576091|FG008|Overall Study|Progressive Disease|10|||
164327655|NCT01975831|593576083|FG000|Overall Study|Withdrawal by Subject|0|||
164327656|NCT01975831|593576084|FG001|Overall Study|Withdrawal by Subject|3|||
164327657|NCT01975831|593576085|FG002|Overall Study|Withdrawal by Subject|0|||
164327658|NCT01975831|593576086|FG003|Overall Study|Withdrawal by Subject|0|||
164327659|NCT01975831|593576087|FG004|Overall Study|Withdrawal by Subject|3|||
164327660|NCT01975831|593576088|FG005|Overall Study|Withdrawal by Subject|1|||
164218163|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
164218164|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Adverse Event|1|||
164218165|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
164218166|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Physician Decision|1|||
164218167|NCT00088881|593166674|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
164218168|NCT00088881|593166674|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
164218169|NCT00088881|593166674|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
164218170|NCT02370394|593166682|FG000|Overall Study|Lost to Follow-up|2|||
164218171|NCT02370394|593166683|FG001|Overall Study|Lost to Follow-up|1|||
164218172|NCT02370394|593166682|FG000|Overall Study|Withdrawal by Subject|0|||
164218173|NCT02370394|593166683|FG001|Overall Study|Withdrawal by Subject|1|||
164218174|NCT00456612|593166685|FG000|Overall Study|Withdrawal by Subject|3|||
164218175|NCT00720083|593166689|FG000|Overall Study|Ineligible|1|||
164218176|NCT00720083|593166690|FG001|Overall Study|Ineligible|2|||
164218177|NCT00894647|593166691|FG000|Overall Study|Adverse Event|5|||
164218178|NCT00894647|593166692|FG001|Overall Study|Adverse Event|4|||
164218179|NCT00894647|593166691|FG000|Overall Study|Withdrawal by Subject|4|||
164218180|NCT00894647|593166692|FG001|Overall Study|Withdrawal by Subject|4|||
164218181|NCT00894647|593166691|FG000|Overall Study|Lost to Follow-up|0|||
164218182|NCT00894647|593166692|FG001|Overall Study|Lost to Follow-up|2|||
164218183|NCT00894647|593166691|FG000|Overall Study|Non-compliance with study procedures|0|||
164218184|NCT00894647|593166692|FG001|Overall Study|Non-compliance with study procedures|2|||
164218185|NCT00894647|593166691|FG000|Overall Study|Other, not due to AE|1|||
164218186|NCT00894647|593166692|FG001|Overall Study|Other, not due to AE|2|||
164218187|NCT01913470|593166698|FG000|Overall Study|Lost to Follow-up|0|||
164218188|NCT01913470|593166699|FG001|Overall Study|Lost to Follow-up|1|||
164218189|NCT01913470|593166698|FG000|Overall Study|Physician Decision|0|||
164218190|NCT01913470|593166699|FG001|Overall Study|Physician Decision|1|||
164218191|NCT01913470|593166698|FG000|Overall Study|Withdrawal by Subject|0|||
164218192|NCT01913470|593166699|FG001|Overall Study|Withdrawal by Subject|1|||
164218193|NCT01524705|593166700|FG000|Overall Study|Adverse Event|2|||
164218194|NCT01524705|593166701|FG001|Overall Study|Adverse Event|0|||
164218195|NCT01524705|593166700|FG000|Overall Study|Death|1|||
164218196|NCT01524705|593166701|FG001|Overall Study|Death|0|||
164218197|NCT01524705|593166700|FG000|Overall Study|Lost to Follow-up|0|||
164218198|NCT01524705|593166701|FG001|Overall Study|Lost to Follow-up|1|||
164218199|NCT01524705|593166700|FG000|Overall Study|Withdrawal by Subject|0|||
164218200|NCT01524705|593166701|FG001|Overall Study|Withdrawal by Subject|1|||
164218201|NCT01524705|593166700|FG000|Overall Study|Pancreatic Cancer|0|||
164218202|NCT01524705|593166701|FG001|Overall Study|Pancreatic Cancer|1|||
164218203|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
164218204|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
164218205|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
164218206|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
164218207|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
164218208|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
164218209|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
164218210|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
164218211|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
164218212|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
164218213|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
164078266|NCT03634488|592651562|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
164078267|NCT03634488|592651563|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
164078268|NCT03634488|592651564|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
164078269|NCT00869089|592651565|FG000|Overall Study|Lost to Follow-up|1|||
164078270|NCT00869089|592651565|FG000|Overall Study|Withdrawal by Subject|1|||
164078271|NCT00869089|592651565|FG000|Overall Study|Screen Fail|1|||
164078272|NCT01169844|592651573|FG000|Overall Study|Adverse Event|0|||
164078273|NCT01169844|592651574|FG001|Overall Study|Adverse Event|1|||
164078274|NCT01169844|592651573|FG000|Overall Study|Patient withdrew consent|4|||
164218214|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
164218215|NCT02573467|593166710|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
164327661|NCT01975831|593576089|FG006|Overall Study|Withdrawal by Subject|1|||
164078275|NCT01169844|592651574|FG001|Overall Study|Patient withdrew consent|0|||
164218216|NCT02573467|593166711|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
164218217|NCT02573467|593166712|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
164218218|NCT02573467|593166713|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
164218219|NCT02573467|593166710|FG000|Post-treatment Follow up Epoch|Death|1|||
164218220|NCT02573467|593166711|FG001|Post-treatment Follow up Epoch|Death|1|||
164218221|NCT02573467|593166712|FG002|Post-treatment Follow up Epoch|Death|0|||
164218222|NCT02573467|593166713|FG003|Post-treatment Follow up Epoch|Death|1|||
164218223|NCT02573467|593166710|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
164218224|NCT02573467|593166711|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
163877017|NCT03398148|591918879|FG012|Substudy 2 Period 2|Adverse Event|0|||
163877018|NCT03398148|591918880|FG013|Substudy 2 Period 2|Adverse Event|1|||
163877019|NCT03398148|591918881|FG014|Substudy 2 Period 2|Adverse Event|3|||
163877020|NCT03398148|591918867|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
163877021|NCT03398148|591918868|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
163877022|NCT03398148|591918869|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
163877023|NCT03398148|591918870|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
163877024|NCT03398148|591918871|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
163877025|NCT03398148|591918872|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
163877026|NCT03398148|591918873|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
164078276|NCT01169844|592651573|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164078277|NCT01169844|592651574|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164078278|NCT00435825|592651578|FG000|Overall Study|Abnormality of Laboratory Test|0|||
164078279|NCT00435825|592651579|FG001|Overall Study|Abnormality of Laboratory Test|1|||
164078280|NCT00435825|592651580|FG002|Overall Study|Abnormality of Laboratory Test|0|||
164078281|NCT00435825|592651581|FG003|Overall Study|Abnormality of Laboratory Test|0|||
164078282|NCT00435825|592651578|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164078283|NCT00435825|592651579|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164078284|NCT00435825|592651580|FG002|Overall Study|Insufficient Therapeutic Response|0|||
164078285|NCT00435825|592651581|FG003|Overall Study|Insufficient Therapeutic Response|3|||
164078286|NCT00435825|592651578|FG000|Overall Study|Other Protocol Violation|1|||
164078287|NCT00435825|592651579|FG001|Overall Study|Other Protocol Violation|0|||
164078288|NCT00435825|592651580|FG002|Overall Study|Other Protocol Violation|0|||
164078289|NCT00435825|592651581|FG003|Overall Study|Other Protocol Violation|0|||
164078290|NCT00435825|592651578|FG000|Overall Study|Refused treatment|2|||
164078291|NCT00435825|592651579|FG001|Overall Study|Refused treatment|0|||
164078292|NCT00435825|592651580|FG002|Overall Study|Refused treatment|0|||
164078293|NCT00435825|592651581|FG003|Overall Study|Refused treatment|5|||
164078294|NCT00435825|592651578|FG000|Overall Study|Failure to return|5|||
164078295|NCT00435825|592651579|FG001|Overall Study|Failure to return|0|||
164078296|NCT00435825|592651580|FG002|Overall Study|Failure to return|4|||
164078297|NCT00435825|592651581|FG003|Overall Study|Failure to return|0|||
164078298|NCT00435825|592651578|FG000|Overall Study|Did not receive study drug|1|||
164078299|NCT00435825|592651579|FG001|Overall Study|Did not receive study drug|0|||
164078300|NCT00435825|592651580|FG002|Overall Study|Did not receive study drug|2|||
164218225|NCT02573467|593166712|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
164218226|NCT02573467|593166713|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
164218227|NCT02573467|593166710|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
164218228|NCT02573467|593166711|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
164218229|NCT02573467|593166712|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
164218230|NCT02573467|593166713|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
164218231|NCT00103506|593166715|FG000|Overall Study|Study closed by sponsor|34|||
164218232|NCT00103506|593166716|FG001|Overall Study|Study closed by sponsor|37|||
164218233|NCT00103506|593166715|FG000|Overall Study|Death|257|||
164218234|NCT00103506|593166716|FG001|Overall Study|Death|253|||
164218235|NCT00103506|593166715|FG000|Overall Study|Lost to Follow-up|13|||
164218236|NCT00103506|593166716|FG001|Overall Study|Lost to Follow-up|13|||
164218237|NCT00103506|593166715|FG000|Overall Study|Withdrawal by Subject|18|||
164218238|NCT00103506|593166716|FG001|Overall Study|Withdrawal by Subject|21|||
164218239|NCT00710970|593166719|FG000|Overall Study|Never took drug|3|||
164218240|NCT02153827|593166720|FG000|Overall Study|Lost to Follow-up|3|||
164218241|NCT02153827|593166721|FG001|Overall Study|Lost to Follow-up|9|||
164218242|NCT04233580|593166726|FG000|Overall Study|Adverse Event|3|||
164218243|NCT04233580|593166727|FG001|Overall Study|Adverse Event|3|||
164218244|NCT04233580|593166726|FG000|Overall Study|Withdrawal by Subject|2|||
164218245|NCT04233580|593166727|FG001|Overall Study|Withdrawal by Subject|1|||
164218246|NCT00625378|593166728|FG000|Overall Study|Adverse Event|22|||
163877027|NCT03398148|591918874|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
163877028|NCT03398148|591918875|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
163877029|NCT03398148|591918876|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
163877030|NCT03398148|591918877|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
164078301|NCT00435825|592651581|FG003|Overall Study|Did not receive study drug|0|||
164078302|NCT00435825|592651578|FG000|Overall Study|Did not enter follow-up|0|||
164078303|NCT00435825|592651579|FG001|Overall Study|Did not enter follow-up|4|||
164078304|NCT00435825|592651580|FG002|Overall Study|Did not enter follow-up|1|||
164078305|NCT00435825|592651581|FG003|Overall Study|Did not enter follow-up|3|||
164078306|NCT00435825|592651578|FG000|Overall Study|Did not complete full follow-up period|6|||
164078307|NCT00435825|592651579|FG001|Overall Study|Did not complete full follow-up period|6|||
164078308|NCT00435825|592651580|FG002|Overall Study|Did not complete full follow-up period|4|||
164078309|NCT00435825|592651581|FG003|Overall Study|Did not complete full follow-up period|5|||
164218247|NCT00625378|593166729|FG001|Overall Study|Adverse Event|0|||
164218248|NCT00625378|593166728|FG000|Overall Study|Withdrawal by Subject|16|||
164218249|NCT00625378|593166729|FG001|Overall Study|Withdrawal by Subject|0|||
164218250|NCT00625378|593166728|FG000|Overall Study|Death|38|||
164218251|NCT00625378|593166729|FG001|Overall Study|Death|0|||
164218252|NCT00625378|593166728|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
164218253|NCT00625378|593166729|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
164218254|NCT00625378|593166728|FG000|Overall Study|Lost to Follow-up|17|||
164218255|NCT00625378|593166729|FG001|Overall Study|Lost to Follow-up|0|||
164218256|NCT00625378|593166728|FG000|Overall Study|Non-compliant with study medication|3|||
164218257|NCT00625378|593166729|FG001|Overall Study|Non-compliant with study medication|0|||
164218258|NCT00625378|593166728|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
164218259|NCT00625378|593166729|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
164218260|NCT00625378|593166728|FG000|Overall Study|Medical decision|1|||
164218261|NCT00625378|593166729|FG001|Overall Study|Medical decision|0|||
164218262|NCT00625378|593166728|FG000|Overall Study|Multiple toxicities|1|||
164218263|NCT00625378|593166729|FG001|Overall Study|Multiple toxicities|0|||
164218264|NCT00625378|593166728|FG000|Overall Study|New cancer|1|||
164218265|NCT00625378|593166729|FG001|Overall Study|New cancer|0|||
164218266|NCT00625378|593166728|FG000|Overall Study|PTA program|2|||
164218267|NCT00625378|593166729|FG001|Overall Study|PTA program|0|||
164218268|NCT00625378|593166728|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
164218269|NCT00625378|593166729|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
164218270|NCT00625378|593166728|FG000|Overall Study|Sponsor decision|1|||
164218271|NCT00625378|593166729|FG001|Overall Study|Sponsor decision|0|||
164218272|NCT00625378|593166728|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
164218273|NCT00625378|593166729|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
164218274|NCT00625378|593166728|FG000|Overall Study|Switch to commercial drug|6|||
164218275|NCT00625378|593166729|FG001|Overall Study|Switch to commercial drug|1|||
164218276|NCT00625378|593166728|FG000|Overall Study|Missing|2|||
164218277|NCT00625378|593166729|FG001|Overall Study|Missing|0|||
164218278|NCT00625378|593166728|FG000|Overall Study|End of treatment not available|2|||
164218279|NCT00625378|593166729|FG001|Overall Study|End of treatment not available|0|||
164218280|NCT00625378|593166728|FG000|Overall Study|Never treated|2|||
164218281|NCT00625378|593166729|FG001|Overall Study|Never treated|0|||
164218282|NCT01371565|593166730|FG000|Overall Study|Withdrawal by Subject|1|||
164218283|NCT01371565|593166730|FG000|Overall Study|Death|1|||
164218284|NCT01371565|593166730|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
164218285|NCT02565186|593166731|FG000|Overall Study|Adverse Event|113|||
164218286|NCT02565186|593166732|FG001|Overall Study|Adverse Event|148|||
164218287|NCT02565186|593166731|FG000|Overall Study|Lost to Follow-up|102|||
164218288|NCT02565186|593166732|FG001|Overall Study|Lost to Follow-up|93|||
164218289|NCT02565186|593166731|FG000|Overall Study|Non-Compliance|57|||
164218290|NCT02565186|593166732|FG001|Overall Study|Non-Compliance|55|||
164218291|NCT02565186|593166731|FG000|Overall Study|Withdrawal by Subject|229|||
164218292|NCT02565186|593166732|FG001|Overall Study|Withdrawal by Subject|214|||
164218293|NCT02565186|593166731|FG000|Overall Study|Physician Decision|18|||
164218294|NCT02565186|593166732|FG001|Overall Study|Physician Decision|16|||
164218295|NCT02565186|593166731|FG000|Overall Study|Sponsor Request|5|||
164218296|NCT02565186|593166732|FG001|Overall Study|Sponsor Request|9|||
164218297|NCT02565186|593166731|FG000|Overall Study|Missing|1|||
164218298|NCT02565186|593166732|FG001|Overall Study|Missing|0|||
164218299|NCT02565186|593166731|FG000|Overall Study|Did Not Receive Study Drug|55|||
164218300|NCT02565186|593166732|FG001|Overall Study|Did Not Receive Study Drug|86|||
164218301|NCT00617903|593166733|FG000|Overall Study|Withdrawal by Subject|2|||
164218302|NCT00617903|593166734|FG001|Overall Study|Withdrawal by Subject|3|||
164218303|NCT00617903|593166733|FG000|Overall Study|Lost to Follow-up|1|||
164218304|NCT00617903|593166734|FG001|Overall Study|Lost to Follow-up|1|||
164218305|NCT00617903|593166733|FG000|Overall Study|Lack of Efficacy|0|||
164218306|NCT00617903|593166734|FG001|Overall Study|Lack of Efficacy|1|||
164218307|NCT00617903|593166733|FG000|Overall Study|Adverse Event|0|||
164078310|NCT05003167|592651582|FG000|Overall Study|Withdrawal by Subject|1|||
164078311|NCT01010230|592651583|FG000|Overall Study|Withdrawal by Subject|6|||
164078312|NCT01010230|592651584|FG001|Overall Study|Withdrawal by Subject|5|||
164078313|NCT01010230|592651583|FG000|Overall Study|Lost to Follow-up|4|||
164078314|NCT01010230|592651584|FG001|Overall Study|Lost to Follow-up|2|||
164327662|NCT01975831|593576090|FG007|Overall Study|Withdrawal by Subject|0|||
164078315|NCT00530439|592651585|FG000|Overall Study|GDM|9|||
164327663|NCT01975831|593576091|FG008|Overall Study|Withdrawal by Subject|0|||
164218308|NCT00617903|593166734|FG001|Overall Study|Adverse Event|1|||
164218309|NCT00617903|593166733|FG000|Overall Study|noncompliance|0|||
164327664|NCT01975831|593576083|FG000|Overall Study|Physician Decision|0|||
164218310|NCT00617903|593166734|FG001|Overall Study|noncompliance|1|||
164218311|NCT04676646|593166735|FG000|Open-label Run-in Phase|Adverse Event|3|||
164218312|NCT04676646|593166736|FG001|Open-label Run-in Phase|Adverse Event|0|||
164218313|NCT04676646|593166737|FG002|Open-label Run-in Phase|Adverse Event|0|||
164218314|NCT04676646|593166735|FG000|Open-label Run-in Phase|Death|3|||
164327665|NCT01975831|593576084|FG001|Overall Study|Physician Decision|0|||
164078316|NCT00530439|592651586|FG001|Overall Study|GDM|3|||
164078317|NCT00530439|592651585|FG000|Overall Study|Withdraw|18|||
164078318|NCT00530439|592651586|FG001|Overall Study|Withdraw|14|||
164218315|NCT04676646|593166736|FG001|Open-label Run-in Phase|Death|0|||
164218316|NCT04676646|593166737|FG002|Open-label Run-in Phase|Death|0|||
164327666|NCT01975831|593576085|FG002|Overall Study|Physician Decision|0|||
164327667|NCT01975831|593576086|FG003|Overall Study|Physician Decision|0|||
164327668|NCT01975831|593576087|FG004|Overall Study|Physician Decision|0|||
164327669|NCT01975831|593576088|FG005|Overall Study|Physician Decision|1|||
164327670|NCT01975831|593576089|FG006|Overall Study|Physician Decision|0|||
164327671|NCT01975831|593576090|FG007|Overall Study|Physician Decision|1|||
164327672|NCT01975831|593576091|FG008|Overall Study|Physician Decision|0|||
164327673|NCT01975831|593576083|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
164327674|NCT01975831|593576084|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
164327675|NCT01975831|593576085|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
164327676|NCT01975831|593576086|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
164327677|NCT01975831|593576087|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
164327678|NCT01975831|593576088|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
164327679|NCT01975831|593576089|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
164327680|NCT01975831|593576090|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
164078319|NCT00530439|592651585|FG000|Overall Study|Missed abortion|1|||
164078320|NCT00530439|592651586|FG001|Overall Study|Missed abortion|4|||
164078321|NCT00530439|592651585|FG000|Overall Study|Misclassification|2|||
164327681|NCT01975831|593576091|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
164327682|NCT01975831|593576083|FG000|Overall Study|Entered Hospice|0|||
164327683|NCT01975831|593576084|FG001|Overall Study|Entered Hospice|0|||
164327684|NCT01975831|593576085|FG002|Overall Study|Entered Hospice|0|||
164327685|NCT01975831|593576086|FG003|Overall Study|Entered Hospice|0|||
164327686|NCT01975831|593576087|FG004|Overall Study|Entered Hospice|0|||
164327687|NCT01975831|593576088|FG005|Overall Study|Entered Hospice|1|||
164327688|NCT01975831|593576089|FG006|Overall Study|Entered Hospice|0|||
164327689|NCT01975831|593576090|FG007|Overall Study|Entered Hospice|0|||
164327690|NCT01975831|593576091|FG008|Overall Study|Entered Hospice|0|||
164327691|NCT01975831|593576083|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327692|NCT01975831|593576084|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327693|NCT01975831|593576085|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327694|NCT01975831|593576086|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327695|NCT01975831|593576087|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327696|NCT01975831|593576088|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327697|NCT01975831|593576089|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
164327698|NCT01975831|593576090|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
164327699|NCT01975831|593576091|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
164327700|NCT02925793|593576092|FG000|Overall Study|Adverse Event|3|||
164327701|NCT02925793|593576093|FG001|Overall Study|Adverse Event|3|||
164327702|NCT02925793|593576094|FG002|Overall Study|Adverse Event|6|||
164327703|NCT02925793|593576092|FG000|Overall Study|Withdrawal by Subject|16|||
164327704|NCT02925793|593576093|FG001|Overall Study|Withdrawal by Subject|15|||
164327705|NCT02925793|593576094|FG002|Overall Study|Withdrawal by Subject|13|||
164327706|NCT02925793|593576092|FG000|Overall Study|Investigator Discretion|0|||
164327707|NCT02925793|593576093|FG001|Overall Study|Investigator Discretion|1|||
164327708|NCT02925793|593576094|FG002|Overall Study|Investigator Discretion|1|||
164327709|NCT02925793|593576092|FG000|Overall Study|Lost to Follow-up|2|||
164327710|NCT02925793|593576093|FG001|Overall Study|Lost to Follow-up|3|||
164327711|NCT02925793|593576094|FG002|Overall Study|Lost to Follow-up|1|||
164078322|NCT00530439|592651586|FG001|Overall Study|Misclassification|0|||
164078323|NCT00530439|592651585|FG000|Overall Study|Twin pregnancy|0|||
164078324|NCT00530439|592651586|FG001|Overall Study|Twin pregnancy|2|||
164078325|NCT00530439|592651585|FG000|Overall Study|Severe malformation/abortion|0|||
164078326|NCT00530439|592651586|FG001|Overall Study|Severe malformation/abortion|3|||
164078327|NCT02367781|592651589|FG000|Overall Study|Withdrawal by Subject|20|||
164078328|NCT02367781|592651590|FG001|Overall Study|Withdrawal by Subject|13|||
164078329|NCT02367781|592651589|FG000|Overall Study|Protocol Violation|0|||
164078330|NCT02367781|592651590|FG001|Overall Study|Protocol Violation|1|||
164078331|NCT02367781|592651589|FG000|Overall Study|Physician Decision|7|||
164327712|NCT02925793|593576092|FG000|Overall Study|Lack of Efficacy|2|||
164327713|NCT02925793|593576093|FG001|Overall Study|Lack of Efficacy|6|||
164327714|NCT02925793|593576094|FG002|Overall Study|Lack of Efficacy|4|||
164327715|NCT02925793|593576092|FG000|Overall Study|Other:|2|||
164327716|NCT02925793|593576093|FG001|Overall Study|Other:|1|||
164327717|NCT02925793|593576094|FG002|Overall Study|Other:|3|||
164327718|NCT00393042|593576097|FG000|First Intervention|Withdrawal by Subject|1|||
164327719|NCT00393042|593576098|FG001|First Intervention|Withdrawal by Subject|2|||
164327720|NCT00393042|593576097|FG000|First Intervention|Lost to Follow-up|3|||
164327721|NCT00393042|593576098|FG001|First Intervention|Lost to Follow-up|3|||
164327722|NCT00393042|593576097|FG000|First Intervention|Protocol Violation|1|||
164078332|NCT02367781|592651590|FG001|Overall Study|Physician Decision|0|||
164078333|NCT02367781|592651589|FG000|Overall Study|Randomized in Error|5|||
164078334|NCT02367781|592651590|FG001|Overall Study|Randomized in Error|4|||
164327723|NCT00393042|593576098|FG001|First Intervention|Protocol Violation|0|||
164327724|NCT00393042|593576097|FG000|First Intervention|Adverse Event|0|||
164327725|NCT00393042|593576098|FG001|First Intervention|Adverse Event|1|||
164327726|NCT00393042|593576097|FG000|Second Intervetion|Adverse Event|0|||
164327727|NCT00393042|593576098|FG001|Second Intervetion|Adverse Event|3|||
164327728|NCT00393042|593576097|FG000|Second Intervetion|Withdrawal by Subject|0|||
164327729|NCT00393042|593576098|FG001|Second Intervetion|Withdrawal by Subject|2|||
164327730|NCT00393042|593576097|FG000|Second Intervetion|Lack of Efficacy|1|||
164327731|NCT00393042|593576098|FG001|Second Intervetion|Lack of Efficacy|0|||
164327732|NCT00393042|593576097|FG000|Second Intervetion|Lost to Follow-up|0|||
164327733|NCT00393042|593576098|FG001|Second Intervetion|Lost to Follow-up|2|||
164327734|NCT00393042|593576097|FG000|Second Intervetion|Protocol Violation|1|||
164327735|NCT00393042|593576098|FG001|Second Intervetion|Protocol Violation|1|||
164327736|NCT03475875|593576099|FG000|Period 1|Lost to Follow-up|1|||
164327737|NCT03475875|593576100|FG001|Period 1|Lost to Follow-up|0|||
164327738|NCT03475875|593576099|FG000|Period 1|Adverse Event|2|||
164327739|NCT03475875|593576100|FG001|Period 1|Adverse Event|1|||
164327740|NCT03475875|593576099|FG000|Period 2|Adverse Event|3|||
164327741|NCT03475875|593576100|FG001|Period 2|Adverse Event|0|||
164327742|NCT03475875|593576099|FG000|Period 2|Protocol Violation|0|||
164327743|NCT03475875|593576100|FG001|Period 2|Protocol Violation|1|||
164327744|NCT02045303|593576104|FG000|Overall Study|Protocol Violation|2|||
164327745|NCT02045303|593576105|FG001|Overall Study|Protocol Violation|1|||
164327746|NCT02045303|593576106|FG002|Overall Study|Protocol Violation|0|||
164327747|NCT02045303|593576104|FG000|Overall Study|Withdrawal by Subject|0|||
164327748|NCT02045303|593576105|FG001|Overall Study|Withdrawal by Subject|2|||
164327749|NCT02045303|593576106|FG002|Overall Study|Withdrawal by Subject|0|||
164327750|NCT01642407|593576107|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
164327751|NCT01642407|593576107|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
164327752|NCT01642407|593576107|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
163981470|NCT01505634|592302736|FG002|Overall Study|Protocol Violation|0|||
163981471|NCT01505634|592302734|FG000|Overall Study|Lost to Follow-up|1|||
163981472|NCT01505634|592302735|FG001|Overall Study|Lost to Follow-up|4|||
163981473|NCT01505634|592302736|FG002|Overall Study|Lost to Follow-up|4|||
163981474|NCT01505634|592302734|FG000|Overall Study|Death|1|||
163981475|NCT01505634|592302735|FG001|Overall Study|Death|0|||
163981476|NCT01505634|592302736|FG002|Overall Study|Death|0|||
163981477|NCT01505634|592302734|FG000|Overall Study|In a conflict zone|0|||
163981478|NCT01505634|592302735|FG001|Overall Study|In a conflict zone|0|||
163981479|NCT01505634|592302736|FG002|Overall Study|In a conflict zone|1|||
163981480|NCT00960843|592302737|FG000|Overall Study|Lost to Follow-up|2|||
163981481|NCT00960843|592302738|FG001|Overall Study|Lost to Follow-up|0|||
163981482|NCT00960843|592302737|FG000|Overall Study|Protocol Violation|0|||
163981483|NCT00960843|592302738|FG001|Overall Study|Protocol Violation|4|||
163981484|NCT00960843|592302737|FG000|Overall Study|Repeated needle dislodgment|0|||
163981485|NCT00960843|592302738|FG001|Overall Study|Repeated needle dislodgment|1|||
163981486|NCT01967537|592302739|FG000|Overall Study|Withdrawal by Subject|52|||
163981487|NCT01967537|592302739|FG000|Overall Study|Refuse treatment|2|||
163981488|NCT01967537|592302739|FG000|Overall Study|Lost to Follow-up|6|||
163981489|NCT00254501|592302742|FG000|Overall Study|Lost to Follow-up|1|||
163981490|NCT00254501|592302743|FG001|Overall Study|Lost to Follow-up|1|||
164078335|NCT02367781|592651589|FG000|Overall Study|Non-Compliance|1|||
164327753|NCT00256282|593576108|FG000|Overall Study|Disease progression, relapse during acti|12|||
164327754|NCT00256282|593576108|FG000|Overall Study|Adverse Event|3|||
164327755|NCT00256282|593576108|FG000|Overall Study|Physician Decision|1|||
164327756|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
164327757|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
164327758|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
164327759|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
164327760|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
164327761|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
164327762|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
164327763|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
164327764|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
164327765|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
164327766|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
164327767|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
164327768|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
163981491|NCT00317109|592302744|FG000|Overall Study|Withdrawal by Subject|2|||
163981492|NCT00317109|592302745|FG001|Overall Study|Withdrawal by Subject|0|||
163981493|NCT00317109|592302744|FG000|Overall Study|Migated/moved from study area|1|||
163981494|NCT00317109|592302745|FG001|Overall Study|Migated/moved from study area|0|||
164078336|NCT02367781|592651590|FG001|Overall Study|Non-Compliance|0|||
163981495|NCT01508702|592302749|FG000|Overall Study|Adverse Event|7|||
163981496|NCT01508702|592302750|FG001|Overall Study|Adverse Event|3|||
163981497|NCT01508702|592302749|FG000|Overall Study|Gout flare|2|||
163981498|NCT01508702|592302750|FG001|Overall Study|Gout flare|0|||
163981499|NCT01508702|592302749|FG000|Overall Study|Protocol Violation|2|||
164078337|NCT02367781|592651589|FG000|Overall Study|Lost to Follow-up|1|||
164078338|NCT02367781|592651590|FG001|Overall Study|Lost to Follow-up|2|||
164078339|NCT02367781|592651589|FG000|Overall Study|Death|330|||
164078340|NCT02367781|592651590|FG001|Overall Study|Death|176|||
164078341|NCT02367781|592651589|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
164078342|NCT02367781|592651590|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
164078343|NCT02367781|592651589|FG000|Overall Study|Prolonged Hospitalization|1|||
164078344|NCT02367781|592651590|FG001|Overall Study|Prolonged Hospitalization|0|||
164078345|NCT02367781|592651589|FG000|Overall Study|Death Prior First Dose|1|||
164078346|NCT02367781|592651590|FG001|Overall Study|Death Prior First Dose|0|||
164078347|NCT02367781|592651589|FG000|Overall Study|Administrative-Change Facility|1|||
164078348|NCT02367781|592651590|FG001|Overall Study|Administrative-Change Facility|0|||
164078349|NCT02367781|592651589|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
164218317|NCT04676646|593166735|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
164218318|NCT04676646|593166736|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
164218319|NCT04676646|593166737|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
164218320|NCT04676646|593166735|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
164218321|NCT04676646|593166736|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
164218322|NCT04676646|593166737|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
164218323|NCT04676646|593166735|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
164218324|NCT04676646|593166736|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
164218325|NCT04676646|593166737|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
164218326|NCT04676646|593166735|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
164218327|NCT04676646|593166736|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
164218328|NCT04676646|593166737|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
164218329|NCT04676646|593166735|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
164218330|NCT04676646|593166736|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
164218331|NCT04676646|593166737|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
164138001|NCT02582866|592866996|FG000|Overall Study|Sponsor decision|1|||
164138002|NCT02582866|592866996|FG000|Overall Study|Withdrawal due to personal reasons|1|||
164138003|NCT03567382|592866997|FG000|Overall Study|Lost to Follow-up|1|||
164138004|NCT03567382|592866998|FG001|Overall Study|Lost to Follow-up|21|||
164138005|NCT03567382|592866999|FG002|Overall Study|Lost to Follow-up|1|||
164138006|NCT03567382|592867000|FG003|Overall Study|Lost to Follow-up|21|||
164138007|NCT03567382|592866997|FG000|Overall Study|Withdrawal by Subject|2|||
164138008|NCT03567382|592866998|FG001|Overall Study|Withdrawal by Subject|14|||
164138009|NCT03567382|592866999|FG002|Overall Study|Withdrawal by Subject|1|||
164138010|NCT03567382|592867000|FG003|Overall Study|Withdrawal by Subject|12|||
164138011|NCT03246646|592867005|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
164138012|NCT03246646|592867006|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
164138013|NCT03246646|592867005|FG000|Overall Study|Withdrawal by Subject|3|||
164138014|NCT03246646|592867006|FG001|Overall Study|Withdrawal by Subject|0|||
164138015|NCT03246646|592867005|FG000|Overall Study|Lost to Follow-up|7|||
164138016|NCT03246646|592867006|FG001|Overall Study|Lost to Follow-up|0|||
164138017|NCT00758680|592867009|FG000|Overall Study|Adverse Event|0|||
164138018|NCT00758680|592867010|FG001|Overall Study|Adverse Event|0|||
164138019|NCT00758680|592867011|FG002|Overall Study|Adverse Event|0|||
164138020|NCT00758680|592867012|FG003|Overall Study|Adverse Event|0|||
164138021|NCT00758680|592867013|FG004|Overall Study|Adverse Event|0|||
164138022|NCT00758680|592867014|FG005|Overall Study|Adverse Event|0|||
164138023|NCT00758680|592867015|FG006|Overall Study|Adverse Event|0|||
164138024|NCT00758680|592867016|FG007|Overall Study|Adverse Event|1|||
164138025|NCT00758680|592867017|FG008|Overall Study|Adverse Event|0|||
164138026|NCT00758680|592867018|FG009|Overall Study|Adverse Event|1|||
164138027|NCT00758680|592867009|FG000|Overall Study|Laboratory Adverse Event|0|||
164138028|NCT00758680|592867010|FG001|Overall Study|Laboratory Adverse Event|0|||
164138029|NCT00758680|592867011|FG002|Overall Study|Laboratory Adverse Event|0|||
164138030|NCT00758680|592867012|FG003|Overall Study|Laboratory Adverse Event|0|||
164138031|NCT00758680|592867013|FG004|Overall Study|Laboratory Adverse Event|0|||
164138032|NCT00758680|592867014|FG005|Overall Study|Laboratory Adverse Event|0|||
164138033|NCT00758680|592867015|FG006|Overall Study|Laboratory Adverse Event|0|||
164138034|NCT00758680|592867016|FG007|Overall Study|Laboratory Adverse Event|0|||
164138035|NCT00758680|592867017|FG008|Overall Study|Laboratory Adverse Event|1|||
164138036|NCT00758680|592867018|FG009|Overall Study|Laboratory Adverse Event|0|||
164138037|NCT00758680|592867009|FG000|Overall Study|Withdrawal by Subject|0|||
164138038|NCT00758680|592867010|FG001|Overall Study|Withdrawal by Subject|0|||
164138039|NCT00758680|592867011|FG002|Overall Study|Withdrawal by Subject|0|||
164138040|NCT00758680|592867012|FG003|Overall Study|Withdrawal by Subject|0|||
164138041|NCT00758680|592867013|FG004|Overall Study|Withdrawal by Subject|0|||
164138042|NCT00758680|592867014|FG005|Overall Study|Withdrawal by Subject|0|||
164138043|NCT00758680|592867015|FG006|Overall Study|Withdrawal by Subject|1|||
164218332|NCT04676646|593166735|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
164218333|NCT04676646|593166736|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
164218334|NCT04676646|593166737|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
164218335|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
163877031|NCT03398148|591918878|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
163877032|NCT03398148|591918879|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
163877033|NCT03398148|591918880|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
163877034|NCT03398148|591918881|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
163877035|NCT03398148|591918867|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877036|NCT03398148|591918868|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877037|NCT03398148|591918869|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877038|NCT03398148|591918870|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877039|NCT03398148|591918871|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877040|NCT03398148|591918872|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877041|NCT03398148|591918873|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877042|NCT03398148|591918874|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877043|NCT03398148|591918875|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877044|NCT03398148|591918876|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877045|NCT03398148|591918877|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877046|NCT03398148|591918878|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
163877047|NCT03398148|591918879|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
163877048|NCT03398148|591918880|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
163877049|NCT03398148|591918881|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
163877050|NCT03398148|591918867|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
163877051|NCT03398148|591918868|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
163877052|NCT03398148|591918869|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
163877053|NCT03398148|591918870|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
163877054|NCT03398148|591918871|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
163877055|NCT03398148|591918872|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
163877056|NCT03398148|591918873|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
163877057|NCT03398148|591918874|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
163877058|NCT03398148|591918875|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
163877059|NCT03398148|591918876|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
163877060|NCT03398148|591918877|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
163877061|NCT03398148|591918878|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
163877062|NCT03398148|591918879|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
163877063|NCT03398148|591918880|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
163877064|NCT03398148|591918881|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
163877065|NCT03398148|591918867|FG000|Substudy 2 Period 2|Other|0|||
163877066|NCT03398148|591918868|FG001|Substudy 2 Period 2|Other|0|||
163877067|NCT03398148|591918869|FG002|Substudy 2 Period 2|Other|0|||
163877068|NCT03398148|591918870|FG003|Substudy 2 Period 2|Other|0|||
163877069|NCT03398148|591918871|FG004|Substudy 2 Period 2|Other|0|||
163877070|NCT03398148|591918872|FG005|Substudy 2 Period 2|Other|0|||
163877071|NCT03398148|591918873|FG006|Substudy 2 Period 2|Other|0|||
163877072|NCT03398148|591918874|FG007|Substudy 2 Period 2|Other|0|||
163877073|NCT03398148|591918875|FG008|Substudy 2 Period 2|Other|0|||
163877074|NCT03398148|591918876|FG009|Substudy 2 Period 2|Other|0|||
163877075|NCT03398148|591918877|FG010|Substudy 2 Period 2|Other|0|||
163877076|NCT03398148|591918878|FG011|Substudy 2 Period 2|Other|0|||
163877077|NCT03398148|591918879|FG012|Substudy 2 Period 2|Other|0|||
163877078|NCT03398148|591918880|FG013|Substudy 2 Period 2|Other|1|||
163877079|NCT03398148|591918881|FG014|Substudy 2 Period 2|Other|1|||
163877080|NCT03398148|591918867|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877081|NCT03398148|591918868|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877082|NCT03398148|591918869|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877083|NCT03398148|591918870|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877084|NCT03398148|591918871|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877085|NCT03398148|591918872|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877086|NCT03398148|591918873|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877087|NCT03398148|591918874|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877088|NCT03398148|591918875|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
164218336|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
163877089|NCT03398148|591918876|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877090|NCT03398148|591918877|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877091|NCT03398148|591918878|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877092|NCT03398148|591918879|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
163877093|NCT03398148|591918880|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
163877094|NCT03398148|591918881|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
163877095|NCT01259401|591918882|FG000|4-month Follow-up|Death|0|||
164218337|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
164218338|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Death|0|||
163877096|NCT01259401|591918883|FG001|4-month Follow-up|Death|1|||
163877097|NCT01259401|591918882|FG000|4-month Follow-up|Lost to Follow-up|0|||
163877098|NCT01259401|591918883|FG001|4-month Follow-up|Lost to Follow-up|1|||
163877099|NCT00212355|591918884|FG000|Overall Study|Adverse Event|1|||
163877100|NCT00212355|591918884|FG000|Overall Study|Withdrawal by Subject|1|||
163877101|NCT00212355|591918884|FG000|Overall Study|A change of address|1|||
163877102|NCT00186992|591918887|FG000|Overall Study|Withdrawal by Subject|5|||
163877103|NCT00186992|591918887|FG000|Overall Study|Physician's discretion|13|||
163877104|NCT00186992|591918887|FG000|Overall Study|PI Discretion|4|||
163877105|NCT00186992|591918887|FG000|Overall Study|Ineligible|2|||
163877106|NCT00186992|591918887|FG000|Overall Study|Lost to Follow-up|2|||
163877107|NCT00186992|591918887|FG000|Overall Study|Still on Study|9|||
163877108|NCT05644002|591918890|FG000|Overall Study|Lost to Follow-up|1|||
163877109|NCT05644002|591918891|FG001|Overall Study|Lost to Follow-up|2|||
163877110|NCT05644002|591918890|FG000|Overall Study|Withdrawal by Subject|0|||
163877111|NCT05644002|591918891|FG001|Overall Study|Withdrawal by Subject|1|||
163877112|NCT05756075|591918896|FG000|Overall Study|Withdrawal by Subject|16|||
163877113|NCT05756075|591918897|FG001|Overall Study|Withdrawal by Subject|9|||
163877114|NCT03821844|591918898|FG000|Overall Study|Death|37|||
163877115|NCT03821844|591918899|FG001|Overall Study|Death|31|||
163877116|NCT03821844|591918898|FG000|Overall Study|Discharged|10|||
163877117|NCT03821844|591918899|FG001|Overall Study|Discharged|14|||
163877118|NCT03821844|591918898|FG000|Overall Study|Not present in facility at followup|2|||
163877119|NCT03821844|591918899|FG001|Overall Study|Not present in facility at followup|3|||
163877120|NCT03416023|591918900|FG000|Overall Study|Exclusion criteria failure|1|||
163877121|NCT03416023|591918900|FG000|Overall Study|Withdrawal by Subject|6|||
163877122|NCT03416023|591918900|FG000|Overall Study|Explanted|7|||
163877123|NCT03416023|591918900|FG000|Overall Study|Physician Decision|1|||
163877124|NCT03416023|591918900|FG000|Overall Study|Lost to Follow-up|1|||
163877125|NCT03416023|591918900|FG000|Overall Study|Death|1|||
163877126|NCT02837510|591918901|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
163877127|NCT02837510|591918902|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
163877128|NCT02837510|591918901|FG000|Washout (2 Weeks)|Adverse Event|0|||
163877129|NCT02837510|591918902|FG001|Washout (2 Weeks)|Adverse Event|1|||
163877130|NCT02837510|591918901|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
163877131|NCT02837510|591918902|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
163877132|NCT02837510|591918901|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
163877133|NCT02837510|591918902|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
163877134|NCT02837510|591918901|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
163877135|NCT02837510|591918902|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
163877136|NCT02837510|591918901|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
163877137|NCT02837510|591918902|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
163877138|NCT05419505|591918904|FG000|Overall Study|Adverse Event|0|||
163877139|NCT05419505|591918905|FG001|Overall Study|Adverse Event|0|||
163877140|NCT05419505|591918906|FG002|Overall Study|Adverse Event|0|||
163877141|NCT05419505|591918907|FG003|Overall Study|Adverse Event|1|||
163877142|NCT05419505|591918908|FG004|Overall Study|Adverse Event|0|||
163877143|NCT05419505|591918909|FG005|Overall Study|Adverse Event|0|||
163877144|NCT05419505|591918910|FG006|Overall Study|Adverse Event|0|||
163877145|NCT05419505|591918911|FG007|Overall Study|Adverse Event|0|||
163877146|NCT05419505|591918904|FG000|Overall Study|Withdrawal by Subject|1|||
163877147|NCT05419505|591918905|FG001|Overall Study|Withdrawal by Subject|2|||
163877148|NCT05419505|591918906|FG002|Overall Study|Withdrawal by Subject|0|||
163877149|NCT05419505|591918907|FG003|Overall Study|Withdrawal by Subject|0|||
163877150|NCT05419505|591918908|FG004|Overall Study|Withdrawal by Subject|0|||
163877151|NCT05419505|591918909|FG005|Overall Study|Withdrawal by Subject|0|||
163877152|NCT05419505|591918910|FG006|Overall Study|Withdrawal by Subject|1|||
163877153|NCT05419505|591918911|FG007|Overall Study|Withdrawal by Subject|0|||
163877154|NCT05419505|591918904|FG000|Overall Study|Lost to Follow-up|2|||
163877155|NCT05419505|591918905|FG001|Overall Study|Lost to Follow-up|1|||
164078350|NCT02367781|592651590|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
164218339|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Death|1|||
164218340|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Death|2|||
164218341|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
164218342|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
164218343|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
163877156|NCT05419505|591918906|FG002|Overall Study|Lost to Follow-up|0|||
163877157|NCT05419505|591918907|FG003|Overall Study|Lost to Follow-up|0|||
163877158|NCT05419505|591918908|FG004|Overall Study|Lost to Follow-up|1|||
163877159|NCT05419505|591918909|FG005|Overall Study|Lost to Follow-up|2|||
163877160|NCT05419505|591918910|FG006|Overall Study|Lost to Follow-up|0|||
163877161|NCT05419505|591918911|FG007|Overall Study|Lost to Follow-up|1|||
163877162|NCT02780388|591918914|FG000|Overall Study|Lost to Follow-up|0|||
163877163|NCT02780388|591918915|FG001|Overall Study|Lost to Follow-up|1|||
163877164|NCT02780388|591918916|FG002|Overall Study|Lost to Follow-up|0|||
163877165|NCT02780388|591918917|FG003|Overall Study|Lost to Follow-up|0|||
163877166|NCT02780388|591918918|FG004|Overall Study|Lost to Follow-up|0|||
163877167|NCT02780388|591918914|FG000|Overall Study|Withdrawal by Subject|1|||
163877168|NCT02780388|591918915|FG001|Overall Study|Withdrawal by Subject|1|||
163877169|NCT02780388|591918916|FG002|Overall Study|Withdrawal by Subject|0|||
164327769|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
164327770|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
164327771|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
164327772|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
164327773|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
164327774|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
164327775|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
164327776|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
164327777|NCT02431247|593576109|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
164327778|NCT02431247|593576110|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
164327779|NCT02431247|593576111|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
164327780|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
164327781|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
164327782|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
164327783|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
164327784|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
164327785|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
164327786|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
164327787|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
164327788|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
164327789|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
164327790|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
164327791|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
164327792|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
164327793|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
164327794|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
164327795|NCT02431247|593576109|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
164327796|NCT02431247|593576110|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
164327797|NCT02431247|593576111|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
164327798|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
164327799|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
164327800|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Other|2|||
164327801|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Other|2|||
164327802|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Personal reasons|2|||
164327803|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Personal reasons|2|||
164327804|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
164327805|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
164327806|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
164327807|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
164327808|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
164327809|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
164327810|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
164327811|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
164327812|NCT00667446|593576112|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
164327813|NCT00667446|593576113|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
164327814|NCT00667446|593576112|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
164327815|NCT00667446|593576113|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
164327816|NCT03631355|593576114|FG000|Overall Study|Lost to Follow-up|1|||
164327817|NCT03631355|593576115|FG001|Overall Study|Lost to Follow-up|2|||
164327818|NCT02810340|593576116|FG000|Overall Study|Withdrawal by Subject|1|||
164327819|NCT02810340|593576117|FG001|Overall Study|Withdrawal by Subject|0|||
164327820|NCT02810340|593576118|FG002|Overall Study|Withdrawal by Subject|0|||
164327821|NCT02810340|593576116|FG000|Overall Study|Incarceration|0|||
164327822|NCT02810340|593576117|FG001|Overall Study|Incarceration|1|||
164327823|NCT02810340|593576118|FG002|Overall Study|Incarceration|0|||
164327824|NCT02810340|593576116|FG000|Overall Study|Lost to Follow-up|0|||
164327825|NCT02810340|593576117|FG001|Overall Study|Lost to Follow-up|0|||
164078351|NCT02367781|592651589|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
164078352|NCT02367781|592651590|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
164078353|NCT02367781|592651589|FG000|Overall Study|Study Terminated by Sponsor|3|||
164078354|NCT02367781|592651590|FG001|Overall Study|Study Terminated by Sponsor|1|||
164078355|NCT02367781|592651589|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
164078356|NCT02367781|592651590|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
164078357|NCT02367781|592651589|FG000|Overall Study|Sponsor Decision|2|||
164078358|NCT02367781|592651590|FG001|Overall Study|Sponsor Decision|0|||
164078359|NCT02367781|592651589|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
164078360|NCT02367781|592651590|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
164078361|NCT00343642|592653694|FG000|Overall Study|Lost to Follow-up|0|||
163877170|NCT02780388|591918917|FG003|Overall Study|Withdrawal by Subject|0|||
163877171|NCT02780388|591918918|FG004|Overall Study|Withdrawal by Subject|0|||
163877172|NCT03857620|591918920|FG000|Overall Study|Death|4|||
163877173|NCT03857620|591918921|FG001|Overall Study|Death|5|||
163877174|NCT03857620|591918922|FG002|Overall Study|Death|7|||
163877175|NCT03857620|591918920|FG000|Overall Study|Lost to Follow-up|2|||
163877176|NCT03857620|591918921|FG001|Overall Study|Lost to Follow-up|5|||
163877177|NCT03857620|591918922|FG002|Overall Study|Lost to Follow-up|3|||
163877178|NCT03857620|591918920|FG000|Overall Study|Disease progression or relapse after study registration|1|||
163877179|NCT03857620|591918921|FG001|Overall Study|Disease progression or relapse after study registration|5|||
163877180|NCT03857620|591918922|FG002|Overall Study|Disease progression or relapse after study registration|1|||
163877181|NCT03857620|591918920|FG000|Overall Study|Ineligible|5|||
163877182|NCT03857620|591918921|FG001|Overall Study|Ineligible|0|||
163877183|NCT03857620|591918922|FG002|Overall Study|Ineligible|2|||
163877184|NCT03857620|591918920|FG000|Overall Study|No malignancy|1|||
163877185|NCT03857620|591918921|FG001|Overall Study|No malignancy|0|||
164218344|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
164218345|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
164218346|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
164218347|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
164218348|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
164218349|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
164218350|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
164218351|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
164327826|NCT02810340|593576118|FG002|Overall Study|Lost to Follow-up|1|||
164327827|NCT03945175|593576119|FG000|Overall Study|Did not meet inclusion criteria|31|||
164327828|NCT03945175|593576119|FG000|Overall Study|Withdrew consent|2|||
164327829|NCT03945175|593576119|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
164327830|NCT03945175|593576119|FG000|Overall Study|Early termination during Mydayis treatment|1|||
164327831|NCT01306877|593576127|FG000|Overall Study|Lost to Follow-up|3|||
164327832|NCT01306877|593576128|FG001|Overall Study|Lost to Follow-up|3|||
164327833|NCT01306877|593576127|FG000|Overall Study|Physician Decision|0|||
164327834|NCT01306877|593576128|FG001|Overall Study|Physician Decision|1|||
164327835|NCT01307020|593576134|FG000|Overall Study|Lost to Follow-up|0|||
164327836|NCT01307020|593576135|FG001|Overall Study|Lost to Follow-up|0|||
164327837|NCT01307020|593576136|FG002|Overall Study|Lost to Follow-up|1|||
164327838|NCT01307020|593576137|FG003|Overall Study|Lost to Follow-up|1|||
164327839|NCT01307020|593576138|FG004|Overall Study|Lost to Follow-up|0|||
164327840|NCT01307020|593576139|FG005|Overall Study|Lost to Follow-up|0|||
164327841|NCT01307020|593576140|FG006|Overall Study|Lost to Follow-up|1|||
164327842|NCT01307020|593576141|FG007|Overall Study|Lost to Follow-up|0|||
164327843|NCT01307020|593576142|FG008|Overall Study|Lost to Follow-up|0|||
164327844|NCT01307020|593576143|FG009|Overall Study|Lost to Follow-up|0|||
164327845|NCT01307020|593576134|FG000|Overall Study|Electronic data capture failure|0|||
164327846|NCT01307020|593576135|FG001|Overall Study|Electronic data capture failure|1|||
164327847|NCT01307020|593576136|FG002|Overall Study|Electronic data capture failure|0|||
164327848|NCT01307020|593576137|FG003|Overall Study|Electronic data capture failure|0|||
164327849|NCT01307020|593576138|FG004|Overall Study|Electronic data capture failure|0|||
164327850|NCT01307020|593576139|FG005|Overall Study|Electronic data capture failure|0|||
164327851|NCT01307020|593576140|FG006|Overall Study|Electronic data capture failure|0|||
164327852|NCT01307020|593576141|FG007|Overall Study|Electronic data capture failure|0|||
163877186|NCT03857620|591918922|FG002|Overall Study|No malignancy|1|||
163877187|NCT03857620|591918920|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
164218352|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
164218353|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
164218354|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
164218355|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
164218356|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
164218357|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
164218358|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
164218359|NCT04676646|593166735|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
164218360|NCT04676646|593166736|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
164218361|NCT04676646|593166737|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
164327853|NCT01307020|593576142|FG008|Overall Study|Electronic data capture failure|0|||
163877188|NCT03857620|591918921|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
163877189|NCT03857620|591918922|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
163877190|NCT03857620|591918920|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
163877191|NCT03857620|591918921|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
163877192|NCT03857620|591918922|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
163877193|NCT03857620|591918920|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
163877194|NCT03857620|591918921|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
163877195|NCT03857620|591918922|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
163877196|NCT03857620|591918920|FG000|Overall Study|Surgery not performed, patient decision|0|||
163877197|NCT03857620|591918921|FG001|Overall Study|Surgery not performed, patient decision|3|||
163877198|NCT03857620|591918922|FG002|Overall Study|Surgery not performed, patient decision|1|||
163877199|NCT03857620|591918920|FG000|Overall Study|Surgery not performed, other reason|3|||
163877200|NCT03857620|591918921|FG001|Overall Study|Surgery not performed, other reason|1|||
163877201|NCT03857620|591918922|FG002|Overall Study|Surgery not performed, other reason|4|||
163981500|NCT01508702|592302750|FG001|Overall Study|Protocol Violation|1|||
163981501|NCT01508702|592302749|FG000|Overall Study|Lost to Follow-up|1|||
164218362|NCT05156125|593166738|FG000|Overall Study|Lack of Efficacy|1|||
164218363|NCT05156125|593166739|FG001|Overall Study|Lack of Efficacy|1|||
164218364|NCT05156125|593166740|FG002|Overall Study|Lack of Efficacy|1|||
164218365|NCT05156125|593166738|FG000|Overall Study|Physician Decision|0|||
164218366|NCT05156125|593166739|FG001|Overall Study|Physician Decision|0|||
164218367|NCT05156125|593166740|FG002|Overall Study|Physician Decision|1|||
164218368|NCT05156125|593166738|FG000|Overall Study|Non-compliance|0|||
164218369|NCT05156125|593166739|FG001|Overall Study|Non-compliance|1|||
164218370|NCT05156125|593166740|FG002|Overall Study|Non-compliance|1|||
164218371|NCT05156125|593166738|FG000|Overall Study|Withdrawal by Subject|0|||
164218372|NCT05156125|593166739|FG001|Overall Study|Withdrawal by Subject|0|||
164218373|NCT05156125|593166740|FG002|Overall Study|Withdrawal by Subject|1|||
164218374|NCT05156125|593166738|FG000|Overall Study|Adverse Event|2|||
164218375|NCT05156125|593166739|FG001|Overall Study|Adverse Event|1|||
164218376|NCT05156125|593166740|FG002|Overall Study|Adverse Event|0|||
164218377|NCT02609633|593166743|FG000|Overall Study|Consent Withdrawn|0|||
164218378|NCT02609633|593166744|FG001|Overall Study|Consent Withdrawn|1|||
164218379|NCT02609633|593166743|FG000|Overall Study|Protocol Deviation|1|||
164218380|NCT02609633|593166744|FG001|Overall Study|Protocol Deviation|0|||
164218381|NCT02609633|593166743|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
164218382|NCT02609633|593166744|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
164218383|NCT02609633|593166743|FG000|Overall Study|Reason not Specified|2|||
164218384|NCT02609633|593166744|FG001|Overall Study|Reason not Specified|1|||
164218385|NCT03670628|593166747|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
164218386|NCT03670628|593166748|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
164218387|NCT03670628|593166747|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
164218388|NCT03670628|593166748|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
164218389|NCT00997126|593166752|FG000|Overall Study|Physician Decision|7|||
164218390|NCT00997126|593166753|FG001|Overall Study|Physician Decision|11|||
164218391|NCT02287025|593166754|FG000|Overall Study|Not treated|2|||
164218392|NCT02287025|593166755|FG001|Overall Study|Not treated|0|||
164218393|NCT02287025|593166754|FG000|Overall Study|Progression of disease|3|||
164218394|NCT02287025|593166755|FG001|Overall Study|Progression of disease|2|||
164218395|NCT02287025|593166754|FG000|Overall Study|Adverse Event|2|||
164218396|NCT02287025|593166755|FG001|Overall Study|Adverse Event|4|||
164218397|NCT02287025|593166754|FG000|Overall Study|Withdrawal by Subject|2|||
164218398|NCT02287025|593166755|FG001|Overall Study|Withdrawal by Subject|2|||
164218399|NCT02287025|593166754|FG000|Overall Study|Screening failed|1|||
164218400|NCT02287025|593166755|FG001|Overall Study|Screening failed|1|||
164218401|NCT00899847|593166756|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
164218402|NCT01769443|593166757|FG000|Overall Study|Study closure|1|||
164218403|NCT01769443|593166758|FG001|Overall Study|Study closure|0|||
164218404|NCT04996264|593166759|FG000|Overall Study|Lost to Follow-up|0|||
164218405|NCT04996264|593166760|FG001|Overall Study|Lost to Follow-up|1|||
164218406|NCT04996264|593166759|FG000|Overall Study|Withdrawal by Subject|4|||
164218407|NCT04996264|593166760|FG001|Overall Study|Withdrawal by Subject|3|||
164327854|NCT01307020|593576143|FG009|Overall Study|Electronic data capture failure|0|||
164327855|NCT02359851|593576144|FG000|Overall Study|Death|1|||
163981502|NCT01508702|592302750|FG001|Overall Study|Lost to Follow-up|2|||
164218408|NCT04996264|593166759|FG000|Overall Study|1 left AMA|0|||
164218409|NCT04996264|593166760|FG001|Overall Study|1 left AMA|1|||
164218410|NCT04996264|593166759|FG000|Overall Study|Subject changed hospitals|0|||
164218411|NCT04996264|593166760|FG001|Overall Study|Subject changed hospitals|1|||
164218412|NCT04996264|593166759|FG000|Overall Study|unable to complete due to work|0|||
164218413|NCT04996264|593166760|FG001|Overall Study|unable to complete due to work|1|||
164218414|NCT00685698|593166761|FG000|Overall Study|Withdrawal by Subject|1|||
164218415|NCT00685698|593166761|FG000|Overall Study|Protocol Violation|6|||
164218416|NCT00685698|593166761|FG000|Overall Study|Adverse Event|3|||
164218417|NCT00685698|593166761|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
164218418|NCT00685698|593166761|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
164218419|NCT00685698|593166761|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
164218420|NCT02583477|593166762|FG000|Overall Study|Adverse Event|0|||
164218421|NCT02583477|593166763|FG001|Overall Study|Adverse Event|2|||
164218422|NCT02583477|593166762|FG000|Overall Study|Death|1|||
164218423|NCT02583477|593166763|FG001|Overall Study|Death|16|||
163877202|NCT03857620|591918920|FG000|Overall Study|Worsening performance status after surgery performed|0|||
163877203|NCT03857620|591918921|FG001|Overall Study|Worsening performance status after surgery performed|1|||
163877204|NCT03857620|591918922|FG002|Overall Study|Worsening performance status after surgery performed|1|||
163877205|NCT04118452|591918923|FG000|Overall Study|Lost to Follow-up|5|||
163877206|NCT04118452|591918924|FG001|Overall Study|Lost to Follow-up|5|||
163877207|NCT04118452|591918923|FG000|Overall Study|Withdrawal by Subject|17|||
163877208|NCT04118452|591918924|FG001|Overall Study|Withdrawal by Subject|17|||
163877209|NCT04586920|591918925|FG000|Overall Study|Lost to Follow-up|0|||
163877210|NCT04586920|591918926|FG001|Overall Study|Lost to Follow-up|0|||
163877211|NCT04586920|591918927|FG002|Overall Study|Lost to Follow-up|0|||
163877212|NCT04586920|591918928|FG003|Overall Study|Lost to Follow-up|0|||
163877213|NCT04586920|591918929|FG004|Overall Study|Lost to Follow-up|0|||
163877214|NCT04586920|591918930|FG005|Overall Study|Lost to Follow-up|0|||
163877215|NCT04586920|591918931|FG006|Overall Study|Lost to Follow-up|1|||
163877216|NCT04586920|591918932|FG007|Overall Study|Lost to Follow-up|1|||
163877217|NCT04586920|591918933|FG008|Overall Study|Lost to Follow-up|0|||
163877218|NCT04586920|591918934|FG009|Overall Study|Lost to Follow-up|1|||
163877219|NCT04586920|591918935|FG010|Overall Study|Lost to Follow-up|0|||
163877220|NCT04586920|591918936|FG011|Overall Study|Lost to Follow-up|0|||
163877221|NCT04586920|591918937|FG012|Overall Study|Lost to Follow-up|0|||
163877222|NCT04586920|591918938|FG013|Overall Study|Lost to Follow-up|1|||
163877223|NCT04586920|591918939|FG014|Overall Study|Lost to Follow-up|0|||
163877224|NCT04586920|591918940|FG015|Overall Study|Lost to Follow-up|0|||
163877225|NCT04586920|591918941|FG016|Overall Study|Lost to Follow-up|0|||
163877226|NCT04586920|591918942|FG017|Overall Study|Lost to Follow-up|0|||
163877227|NCT04586920|591918925|FG000|Overall Study|Withdrawal by Subject|0|||
163877228|NCT04586920|591918926|FG001|Overall Study|Withdrawal by Subject|0|||
163877229|NCT04586920|591918927|FG002|Overall Study|Withdrawal by Subject|0|||
163877230|NCT04586920|591918928|FG003|Overall Study|Withdrawal by Subject|0|||
163877231|NCT04586920|591918929|FG004|Overall Study|Withdrawal by Subject|0|||
163877232|NCT04586920|591918930|FG005|Overall Study|Withdrawal by Subject|0|||
163877233|NCT04586920|591918931|FG006|Overall Study|Withdrawal by Subject|0|||
163877234|NCT04586920|591918932|FG007|Overall Study|Withdrawal by Subject|1|||
163877235|NCT04586920|591918933|FG008|Overall Study|Withdrawal by Subject|0|||
163877236|NCT04586920|591918934|FG009|Overall Study|Withdrawal by Subject|1|||
163877237|NCT04586920|591918935|FG010|Overall Study|Withdrawal by Subject|0|||
163877238|NCT04586920|591918936|FG011|Overall Study|Withdrawal by Subject|1|||
163877239|NCT04586920|591918937|FG012|Overall Study|Withdrawal by Subject|0|||
163877240|NCT04586920|591918938|FG013|Overall Study|Withdrawal by Subject|0|||
163877241|NCT04586920|591918939|FG014|Overall Study|Withdrawal by Subject|0|||
163877242|NCT04586920|591918940|FG015|Overall Study|Withdrawal by Subject|0|||
163877243|NCT04586920|591918941|FG016|Overall Study|Withdrawal by Subject|0|||
163877244|NCT04586920|591918942|FG017|Overall Study|Withdrawal by Subject|0|||
163877245|NCT00894543|591918949|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
163877246|NCT00894543|591918950|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
163877247|NCT00894543|591918949|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
163877248|NCT00894543|591918950|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
163877249|NCT03446157|591918951|FG000|Overall Study|Death|11|||
163877250|NCT03446157|591918952|FG001|Overall Study|Death|9|||
163877251|NCT03446157|591918951|FG000|Overall Study|Lost to Follow-up|0|||
163877252|NCT03446157|591918952|FG001|Overall Study|Lost to Follow-up|1|||
163877253|NCT03446157|591918951|FG000|Overall Study|Withdrawal by Subject|2|||
163877254|NCT03446157|591918952|FG001|Overall Study|Withdrawal by Subject|1|||
163877255|NCT05384730|591918961|FG000|Overall Study|Adverse Event|1|||
163877256|NCT05384730|591918962|FG001|Overall Study|Adverse Event|0|||
163877257|NCT05384730|591918961|FG000|Overall Study|Lack of social support|2|||
163877258|NCT05384730|591918962|FG001|Overall Study|Lack of social support|0|||
163877259|NCT05384730|591918961|FG000|Overall Study|Hospital readmission|2|||
163877260|NCT05384730|591918962|FG001|Overall Study|Hospital readmission|0|||
163877261|NCT05384730|591918961|FG000|Overall Study|Disease progression|5|||
163877262|NCT05384730|591918962|FG001|Overall Study|Disease progression|0|||
163877263|NCT05384730|591918961|FG000|Overall Study|Overwhelmed with College commitments|0|||
164218424|NCT02583477|593166762|FG000|Overall Study|Study terminated|2|||
164218425|NCT02583477|593166763|FG001|Overall Study|Study terminated|2|||
164218426|NCT00567112|593166765|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
163877264|NCT05384730|591918962|FG001|Overall Study|Overwhelmed with College commitments|2|||
163877265|NCT00411151|591918963|FG000|Overall Study|Death|38|||
163877266|NCT00411151|591918963|FG000|Overall Study|Withdrawal by Subject|2|||
163877267|NCT00411151|591918963|FG000|Overall Study|Lost to Follow-up|2|||
163877268|NCT00411151|591918963|FG000|Overall Study|Protocol Violation|1|||
164078362|NCT00343642|592653695|FG001|Overall Study|Lost to Follow-up|1|||
164078363|NCT00343642|592653696|FG002|Overall Study|Lost to Follow-up|0|||
164078364|NCT00343642|592653694|FG000|Overall Study|Pregnancy|1|||
164078365|NCT00343642|592653695|FG001|Overall Study|Pregnancy|0|||
164078366|NCT00343642|592653696|FG002|Overall Study|Pregnancy|2|||
164078367|NCT00343642|592653694|FG000|Overall Study|Withdrawal by Subject|2|||
164078368|NCT00343642|592653695|FG001|Overall Study|Withdrawal by Subject|3|||
164078369|NCT00343642|592653696|FG002|Overall Study|Withdrawal by Subject|4|||
164078370|NCT00343642|592653694|FG000|Overall Study|Adverse Event|0|||
164078371|NCT00343642|592653695|FG001|Overall Study|Adverse Event|0|||
164078372|NCT00343642|592653696|FG002|Overall Study|Adverse Event|1|||
164078373|NCT00343642|592653694|FG000|Overall Study|Flare up|6|||
164078374|NCT00343642|592653695|FG001|Overall Study|Flare up|4|||
164078375|NCT00343642|592653696|FG002|Overall Study|Flare up|0|||
164078376|NCT01393990|592653699|FG000|Overall Study|Adverse Event|0|||
164078377|NCT01393990|592653700|FG001|Overall Study|Adverse Event|0|||
164078378|NCT01393990|592653701|FG002|Overall Study|Adverse Event|0|||
164078379|NCT01393990|592653702|FG003|Overall Study|Adverse Event|0|||
164078380|NCT01393990|592653703|FG004|Overall Study|Adverse Event|0|||
164078381|NCT01393990|592653704|FG005|Overall Study|Adverse Event|0|||
164078382|NCT01393990|592653705|FG006|Overall Study|Adverse Event|0|||
164078383|NCT01393990|592653706|FG007|Overall Study|Adverse Event|0|||
164078384|NCT01393990|592653707|FG008|Overall Study|Adverse Event|0|||
164078385|NCT01393990|592653708|FG009|Overall Study|Adverse Event|0|||
164078386|NCT01393990|592653709|FG010|Overall Study|Adverse Event|0|||
164078387|NCT01393990|592653710|FG011|Overall Study|Adverse Event|0|||
164078388|NCT01393990|592653711|FG012|Overall Study|Adverse Event|0|||
164078389|NCT01393990|592653712|FG013|Overall Study|Adverse Event|0|||
164078390|NCT01393990|592653713|FG014|Overall Study|Adverse Event|1|||
164078391|NCT01393990|592653714|FG015|Overall Study|Adverse Event|1|||
164078392|NCT01393990|592653715|FG016|Overall Study|Adverse Event|0|||
164078393|NCT01393990|592653716|FG017|Overall Study|Adverse Event|0|||
163877269|NCT00411151|591918963|FG000|Overall Study|Trial prematurely closed|4|||
163877270|NCT01619410|591918967|FG000|Overall Study|Lost to Follow-up|7|||
163877271|NCT01619410|591918968|FG001|Overall Study|Lost to Follow-up|4|||
163877272|NCT04452318|591918973|FG000|Overall Study|Physician Decision|1|||
163877273|NCT04452318|591918974|FG001|Overall Study|Physician Decision|2|||
163877274|NCT04452318|591918975|FG002|Overall Study|Physician Decision|0|||
163877275|NCT04452318|591918976|FG003|Overall Study|Physician Decision|2|||
164218427|NCT00567112|593166766|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
164218428|NCT00567112|593166767|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
163877276|NCT04452318|591918977|FG004|Overall Study|Physician Decision|0|||
163877277|NCT04452318|591918978|FG005|Overall Study|Physician Decision|2|||
163877278|NCT04452318|591918979|FG006|Overall Study|Physician Decision|5|||
163877279|NCT04452318|591918973|FG000|Overall Study|Death|2|||
163877280|NCT04452318|591918974|FG001|Overall Study|Death|3|||
163877281|NCT04452318|591918975|FG002|Overall Study|Death|0|||
164078394|NCT01393990|592653699|FG000|Overall Study|Progressive Disease|1|||
164078395|NCT01393990|592653700|FG001|Overall Study|Progressive Disease|0|||
164078396|NCT01393990|592653701|FG002|Overall Study|Progressive Disease|0|||
164078397|NCT01393990|592653702|FG003|Overall Study|Progressive Disease|1|||
164078398|NCT01393990|592653703|FG004|Overall Study|Progressive Disease|1|||
164078399|NCT01393990|592653704|FG005|Overall Study|Progressive Disease|1|||
164078400|NCT01393990|592653705|FG006|Overall Study|Progressive Disease|1|||
164078401|NCT01393990|592653706|FG007|Overall Study|Progressive Disease|1|||
164218429|NCT00567112|593166765|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
164218430|NCT00567112|593166766|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
164218431|NCT00567112|593166767|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
164218432|NCT00567112|593166765|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
164218433|NCT00567112|593166766|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
164218434|NCT00567112|593166767|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
164218435|NCT03753542|593166768|FG000|Overall Study|Lost to Follow-up|9|||
164218436|NCT03753542|593166769|FG001|Overall Study|Lost to Follow-up|14|||
164218437|NCT00002874|593166770|FG000|Overall Study|Withdrawal by Subject|1|||
163877282|NCT04452318|591918976|FG003|Overall Study|Death|0|||
163877283|NCT04452318|591918977|FG004|Overall Study|Death|0|||
163877284|NCT04452318|591918978|FG005|Overall Study|Death|0|||
164078402|NCT01393990|592653707|FG008|Overall Study|Progressive Disease|3|||
164218438|NCT00002874|593166771|FG001|Overall Study|Withdrawal by Subject|1|||
164218439|NCT00002874|593166770|FG000|Overall Study|Protocol Violation|44|||
163877285|NCT04452318|591918979|FG006|Overall Study|Death|0|||
163877286|NCT04452318|591918973|FG000|Overall Study|Lost to Follow-up|38|||
163877287|NCT04452318|591918974|FG001|Overall Study|Lost to Follow-up|28|||
163877288|NCT04452318|591918975|FG002|Overall Study|Lost to Follow-up|0|||
163877289|NCT04452318|591918976|FG003|Overall Study|Lost to Follow-up|3|||
164078403|NCT01393990|592653708|FG009|Overall Study|Progressive Disease|1|||
164078404|NCT01393990|592653709|FG010|Overall Study|Progressive Disease|0|||
164078405|NCT01393990|592653710|FG011|Overall Study|Progressive Disease|0|||
164078406|NCT01393990|592653711|FG012|Overall Study|Progressive Disease|0|||
164078407|NCT01393990|592653712|FG013|Overall Study|Progressive Disease|1|||
163877290|NCT04452318|591918977|FG004|Overall Study|Lost to Follow-up|3|||
163877291|NCT04452318|591918978|FG005|Overall Study|Lost to Follow-up|2|||
163877292|NCT04452318|591918979|FG006|Overall Study|Lost to Follow-up|1|||
163877293|NCT04452318|591918973|FG000|Overall Study|Withdrawal by Subject|46|||
163877294|NCT04452318|591918974|FG001|Overall Study|Withdrawal by Subject|40|||
163877295|NCT04452318|591918975|FG002|Overall Study|Withdrawal by Subject|0|||
163877296|NCT04452318|591918976|FG003|Overall Study|Withdrawal by Subject|18|||
163877297|NCT04452318|591918977|FG004|Overall Study|Withdrawal by Subject|6|||
163877298|NCT04452318|591918978|FG005|Overall Study|Withdrawal by Subject|8|||
163877299|NCT04452318|591918979|FG006|Overall Study|Withdrawal by Subject|6|||
164078408|NCT01393990|592653713|FG014|Overall Study|Progressive Disease|6|||
164078409|NCT01393990|592653714|FG015|Overall Study|Progressive Disease|1|||
164078410|NCT01393990|592653715|FG016|Overall Study|Progressive Disease|0|||
164078411|NCT01393990|592653716|FG017|Overall Study|Progressive Disease|0|||
164078412|NCT01393990|592653699|FG000|Overall Study|Death|0|||
164078413|NCT01393990|592653700|FG001|Overall Study|Death|0|||
164078414|NCT01393990|592653701|FG002|Overall Study|Death|0|||
164078415|NCT01393990|592653702|FG003|Overall Study|Death|0|||
164078416|NCT01393990|592653703|FG004|Overall Study|Death|1|||
164218440|NCT00002874|593166771|FG001|Overall Study|Protocol Violation|34|||
164218441|NCT02114684|593166779|FG000|Overall Study|Death|6|||
164218442|NCT02114684|593166780|FG001|Overall Study|Death|4|||
164218443|NCT02114684|593166779|FG000|Overall Study|Lost to Follow-up|1|||
164218444|NCT02114684|593166780|FG001|Overall Study|Lost to Follow-up|2|||
164218445|NCT02114684|593166779|FG000|Overall Study|Withdrawal by Subject|1|||
164218446|NCT02114684|593166780|FG001|Overall Study|Withdrawal by Subject|2|||
164218447|NCT02114684|593166779|FG000|Overall Study|Relocation|3|||
164218448|NCT02114684|593166780|FG001|Overall Study|Relocation|1|||
164218449|NCT02114684|593166779|FG000|Overall Study|Rifampicin resistant on culture|0|||
164218450|NCT02114684|593166780|FG001|Overall Study|Rifampicin resistant on culture|1|||
164218451|NCT02114684|593166779|FG000|Overall Study|Patient Incarcerated|1|||
164218452|NCT02114684|593166780|FG001|Overall Study|Patient Incarcerated|0|||
164218453|NCT04625972|593166781|FG000|Overall Study|Death|3|||
164218454|NCT04625972|593166782|FG001|Overall Study|Death|2|||
164218455|NCT04625972|593166781|FG000|Overall Study|Lost to Follow-up|82|||
164218456|NCT04625972|593166782|FG001|Overall Study|Lost to Follow-up|38|||
164218457|NCT04625972|593166781|FG000|Overall Study|Physician Decision|2|||
164218458|NCT04625972|593166782|FG001|Overall Study|Physician Decision|0|||
164218459|NCT04625972|593166781|FG000|Overall Study|Protocol Violation|0|||
164218460|NCT04625972|593166782|FG001|Overall Study|Protocol Violation|1|||
164218461|NCT04625972|593166781|FG000|Overall Study|Withdrawal by Subject|37|||
164218462|NCT04625972|593166782|FG001|Overall Study|Withdrawal by Subject|24|||
164218463|NCT04625972|593166781|FG000|Overall Study|Not specified elsewhere|8|||
164218464|NCT04625972|593166782|FG001|Overall Study|Not specified elsewhere|6|||
164218465|NCT05591755|593166783|FG000|Overall Study|Screen Failure|1|||
164218466|NCT05591755|593166784|FG001|Overall Study|Screen Failure|0|||
164218467|NCT05591755|593166785|FG002|Overall Study|Screen Failure|0|||
164218468|NCT05591755|593166786|FG003|Overall Study|Screen Failure|0|||
164218469|NCT05591755|593166783|FG000|Overall Study|Protocol Violation|0|||
164218470|NCT05591755|593166784|FG001|Overall Study|Protocol Violation|0|||
164218471|NCT05591755|593166785|FG002|Overall Study|Protocol Violation|2|||
164218472|NCT05591755|593166786|FG003|Overall Study|Protocol Violation|0|||
164218473|NCT05591755|593166783|FG000|Overall Study|Withdrawal by Subject|0|||
164218474|NCT05591755|593166784|FG001|Overall Study|Withdrawal by Subject|1|||
164218475|NCT05591755|593166785|FG002|Overall Study|Withdrawal by Subject|0|||
164218476|NCT05591755|593166786|FG003|Overall Study|Withdrawal by Subject|0|||
164218477|NCT03828383|593166792|FG000|Overall Study|Lost to Follow-up|3|||
164218478|NCT03828383|593166793|FG001|Overall Study|Lost to Follow-up|2|||
164218479|NCT03828383|593166792|FG000|Overall Study|Withdrawal by Subject|4|||
164218480|NCT03828383|593166793|FG001|Overall Study|Withdrawal by Subject|5|||
164218481|NCT00504309|593166794|FG000|Overall Study|Death|0|||
164218482|NCT00504309|593166795|FG001|Overall Study|Death|0|||
164218483|NCT00504309|593166796|FG002|Overall Study|Death|0|||
164218484|NCT00504309|593166797|FG003|Overall Study|Death|0|||
163877300|NCT03771352|591918980|FG000|Overall Study|Screen failure|2|||
163877301|NCT03771352|591918980|FG000|Overall Study|Withdrawal by Subject|2|||
164078417|NCT01393990|592653704|FG005|Overall Study|Death|0|||
164078418|NCT01393990|592653705|FG006|Overall Study|Death|0|||
164078419|NCT01393990|592653706|FG007|Overall Study|Death|0|||
164218485|NCT00504309|593166798|FG004|Overall Study|Death|1|||
164218486|NCT00504309|593166799|FG005|Overall Study|Death|0|||
164218487|NCT00504309|593166794|FG000|Overall Study|Withdrawal by Subject|0|||
164218488|NCT00504309|593166795|FG001|Overall Study|Withdrawal by Subject|0|||
164218489|NCT00504309|593166796|FG002|Overall Study|Withdrawal by Subject|1|||
164218490|NCT00504309|593166797|FG003|Overall Study|Withdrawal by Subject|0|||
164218491|NCT00504309|593166798|FG004|Overall Study|Withdrawal by Subject|0|||
164218492|NCT00504309|593166799|FG005|Overall Study|Withdrawal by Subject|0|||
164218493|NCT03345095|593166801|FG000|Overall Study|Lack of Efficacy|184|||
164218494|NCT03345095|593166802|FG001|Overall Study|Lack of Efficacy|156|||
164218495|NCT03345095|593166801|FG000|Overall Study|Adverse Event|36|||
163877302|NCT03380390|591918985|FG000|Overall Study|Adverse Event|3|||
163877303|NCT05494788|591918988|FG000|Initial Treatment Period|Adverse Event|2|||
163877304|NCT05494788|591918988|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
163877305|NCT05494788|591918988|FG000|Extension Period|Adverse Event|1|||
163877306|NCT05494788|591918988|FG000|Extension Period|Withdrawal by Subject|1|||
163877307|NCT01771731|591918989|FG000|Overall Study|Physician Decision|1|||
163877308|NCT01771731|591918990|FG001|Overall Study|Physician Decision|0|||
163877309|NCT01771731|591918989|FG000|Overall Study|Protocol Violation|0|||
164078420|NCT01393990|592653707|FG008|Overall Study|Death|0|||
164078421|NCT01393990|592653708|FG009|Overall Study|Death|0|||
164078422|NCT01393990|592653709|FG010|Overall Study|Death|0|||
164078423|NCT01393990|592653710|FG011|Overall Study|Death|0|||
164078424|NCT01393990|592653711|FG012|Overall Study|Death|0|||
164078425|NCT01393990|592653712|FG013|Overall Study|Death|1|||
164078426|NCT01393990|592653713|FG014|Overall Study|Death|1|||
164078427|NCT01393990|592653714|FG015|Overall Study|Death|0|||
164078428|NCT01393990|592653715|FG016|Overall Study|Death|0|||
164078429|NCT01393990|592653716|FG017|Overall Study|Death|0|||
164078430|NCT01393990|592653699|FG000|Overall Study|Withdrawal by Subject|0|||
164078431|NCT01393990|592653700|FG001|Overall Study|Withdrawal by Subject|0|||
164078432|NCT01393990|592653701|FG002|Overall Study|Withdrawal by Subject|0|||
164078433|NCT01393990|592653702|FG003|Overall Study|Withdrawal by Subject|0|||
164078434|NCT01393990|592653703|FG004|Overall Study|Withdrawal by Subject|0|||
164078435|NCT01393990|592653704|FG005|Overall Study|Withdrawal by Subject|0|||
164218496|NCT03345095|593166802|FG001|Overall Study|Adverse Event|118|||
164218497|NCT03345095|593166801|FG000|Overall Study|Withdrawal by Subject|22|||
164218498|NCT03345095|593166802|FG001|Overall Study|Withdrawal by Subject|59|||
164218499|NCT03345095|593166801|FG000|Overall Study|Physician Decision|3|||
164218500|NCT03345095|593166802|FG001|Overall Study|Physician Decision|18|||
164078436|NCT01393990|592653705|FG006|Overall Study|Withdrawal by Subject|0|||
164078437|NCT01393990|592653706|FG007|Overall Study|Withdrawal by Subject|0|||
164078438|NCT01393990|592653707|FG008|Overall Study|Withdrawal by Subject|0|||
164078439|NCT01393990|592653708|FG009|Overall Study|Withdrawal by Subject|0|||
164078440|NCT01393990|592653709|FG010|Overall Study|Withdrawal by Subject|0|||
164078441|NCT01393990|592653710|FG011|Overall Study|Withdrawal by Subject|0|||
164078442|NCT01393990|592653711|FG012|Overall Study|Withdrawal by Subject|0|||
164078443|NCT01393990|592653712|FG013|Overall Study|Withdrawal by Subject|0|||
164078444|NCT01393990|592653713|FG014|Overall Study|Withdrawal by Subject|1|||
164078445|NCT01393990|592653714|FG015|Overall Study|Withdrawal by Subject|1|||
164078446|NCT01393990|592653715|FG016|Overall Study|Withdrawal by Subject|0|||
164218501|NCT03345095|593166801|FG000|Overall Study|Death|2|||
164218502|NCT03345095|593166802|FG001|Overall Study|Death|4|||
164218503|NCT03345095|593166801|FG000|Overall Study|Other reasons|2|||
164218504|NCT03345095|593166802|FG001|Overall Study|Other reasons|11|||
164218505|NCT03345095|593166801|FG000|Overall Study|Protocol Violation|0|||
164218506|NCT03345095|593166802|FG001|Overall Study|Protocol Violation|1|||
164218507|NCT00983957|593166806|FG000|Overall Study|Adverse Event|1|||
164218508|NCT00983957|593166806|FG000|Overall Study|Personal Reasons|1|||
164218509|NCT00884949|593168345|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
164327856|NCT02359851|593576144|FG000|Overall Study|Disease progression|1|||
164327857|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
164327858|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
164078447|NCT01393990|592653716|FG017|Overall Study|Withdrawal by Subject|0|||
164218510|NCT00884949|593168345|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
164218511|NCT01108796|593168348|FG000|Overall Study|Adverse Event|0|||
164218512|NCT01108796|593168349|FG001|Overall Study|Adverse Event|1|||
164218513|NCT01108796|593168348|FG000|Overall Study|Lost to Follow-up|7|||
164218514|NCT01108796|593168349|FG001|Overall Study|Lost to Follow-up|6|||
164218515|NCT01129284|593168362|FG000|Overall Study|Adverse Event|2|||
164218516|NCT01129284|593168363|FG001|Overall Study|Adverse Event|0|||
164218517|NCT01129284|593168364|FG002|Overall Study|Adverse Event|1|||
164218518|NCT03197935|593168370|FG000|Overall Study|Death due to any cause|26|||
164218519|NCT03197935|593168371|FG001|Overall Study|Death due to any cause|15|||
164218520|NCT03197935|593168370|FG000|Overall Study|Lost to Follow-up|3|||
164218521|NCT03197935|593168371|FG001|Overall Study|Lost to Follow-up|5|||
164218522|NCT03197935|593168370|FG000|Overall Study|Physician Decision|2|||
164218523|NCT03197935|593168371|FG001|Overall Study|Physician Decision|1|||
164218524|NCT03197935|593168370|FG000|Overall Study|Withdrawal by Subject|16|||
164218525|NCT03197935|593168371|FG001|Overall Study|Withdrawal by Subject|8|||
164327859|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
164078448|NCT00331630|592653726|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
164078449|NCT00331630|592653726|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
164078450|NCT00331630|592653726|FG000|Follow up for 5 Years|Death|5|||
163877310|NCT01771731|591918990|FG001|Overall Study|Protocol Violation|1|||
163877311|NCT01771731|591918989|FG000|Overall Study|Adverse event: Pain Crisis|1|||
164078451|NCT00331630|592653726|FG000|Follow up for 5 Years|Data collection was stopped|24|||
164078452|NCT01133821|592653728|FG000|Overall Study|Lost to Follow-up|8|||
164218526|NCT03315689|593168377|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
164327860|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
164327861|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
164327862|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
164327863|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
164327864|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
164327865|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
164327866|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
164327867|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
164327868|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
164327869|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
164327870|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
164327871|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
164327872|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
164327873|NCT00491556|593576145|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
164327874|NCT00491556|593576146|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
164327875|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
164327876|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
164327877|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
164327878|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
164327879|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
164327880|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
164327881|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
164327882|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
164327883|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
164327884|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
164327885|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
164327886|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
164327887|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
164327888|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
164327889|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
164327890|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
164327891|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
164327892|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
164327893|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
164327894|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
164327895|NCT00491556|593576145|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
164327896|NCT00491556|593576146|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
164327897|NCT04480424|593576147|FG000|Overall Study|Withdrawal by Subject|0|||
164327898|NCT04480424|593576148|FG001|Overall Study|Withdrawal by Subject|2|||
164327899|NCT04480424|593576147|FG000|Overall Study|Lost to Follow-up|3|||
164327900|NCT04480424|593576148|FG001|Overall Study|Lost to Follow-up|3|||
164327901|NCT04480424|593576147|FG000|Overall Study|Death|14|||
164327902|NCT04480424|593576148|FG001|Overall Study|Death|16|||
164327903|NCT04480424|593576147|FG000|Overall Study|Reason not Specified|5|||
163981503|NCT01508702|592302749|FG000|Overall Study|Withdrawal by Subject|11|||
163981504|NCT01508702|592302750|FG001|Overall Study|Withdrawal by Subject|7|||
163981505|NCT04472429|592302751|FG000|Randomized Period|Ongoing|90|||
163981506|NCT04472429|592302752|FG001|Randomized Period|Ongoing|40|||
163981507|NCT04472429|592302753|FG002|Randomized Period|Ongoing|0|||
163981508|NCT04472429|592302751|FG000|Randomized Period|Death|52|||
163981509|NCT04472429|592302752|FG001|Randomized Period|Death|37|||
163981510|NCT04472429|592302753|FG002|Randomized Period|Death|0|||
163981511|NCT04472429|592302751|FG000|Randomized Period|Lost to Follow-up|4|||
163981512|NCT04472429|592302752|FG001|Randomized Period|Lost to Follow-up|0|||
163981513|NCT04472429|592302753|FG002|Randomized Period|Lost to Follow-up|0|||
163981514|NCT04472429|592302751|FG000|Randomized Period|Physician Decision|1|||
163981515|NCT04472429|592302752|FG001|Randomized Period|Physician Decision|2|||
163981516|NCT04472429|592302753|FG002|Randomized Period|Physician Decision|0|||
163981517|NCT04472429|592302751|FG000|Randomized Period|Withdrawal by Subject|6|||
163981518|NCT04472429|592302752|FG001|Randomized Period|Withdrawal by Subject|5|||
163981519|NCT04472429|592302753|FG002|Randomized Period|Withdrawal by Subject|0|||
163981520|NCT04472429|592302751|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
163981521|NCT04472429|592302752|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
164327904|NCT04480424|593576148|FG001|Overall Study|Reason not Specified|5|||
164327905|NCT00993044|593576149|FG000|Irinotecan 50 mg|Physician Decision|1|||
164327906|NCT00734747|593576150|FG000|SRS Procedure|No staples placed|3|||
163981522|NCT04472429|592302753|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
163981523|NCT04472429|592302751|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
163981524|NCT04472429|592302752|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
163877312|NCT01771731|591918990|FG001|Overall Study|Adverse event: Pain Crisis|1|||
164078453|NCT01133821|592653729|FG001|Overall Study|Lost to Follow-up|11|||
163877313|NCT00087139|591918991|FG000|Overall Study|Adverse Event|18|||
163877314|NCT00087139|591918992|FG001|Overall Study|Adverse Event|17|||
163877315|NCT00087139|591918993|FG002|Overall Study|Adverse Event|13|||
163877316|NCT00087139|591918991|FG000|Overall Study|Death|2|||
163877317|NCT00087139|591918992|FG001|Overall Study|Death|1|||
163877318|NCT00087139|591918993|FG002|Overall Study|Death|0|||
163877319|NCT00087139|591918991|FG000|Overall Study|Withdrawal by Subject|3|||
163877320|NCT00087139|591918992|FG001|Overall Study|Withdrawal by Subject|2|||
163877321|NCT00087139|591918993|FG002|Overall Study|Withdrawal by Subject|2|||
163877322|NCT00087139|591918991|FG000|Overall Study|Physician Decision|1|||
163877323|NCT00087139|591918992|FG001|Overall Study|Physician Decision|1|||
163877324|NCT00087139|591918993|FG002|Overall Study|Physician Decision|1|||
163877325|NCT00087139|591918991|FG000|Overall Study|Disease progression|9|||
163877326|NCT00087139|591918992|FG001|Overall Study|Disease progression|19|||
163877327|NCT00087139|591918993|FG002|Overall Study|Disease progression|12|||
163877328|NCT00087139|591918991|FG000|Overall Study|Ineligible|4|||
163877329|NCT00087139|591918992|FG001|Overall Study|Ineligible|7|||
163877330|NCT00087139|591918993|FG002|Overall Study|Ineligible|4|||
163877331|NCT00087139|591918991|FG000|Overall Study|Symptomatic deterioration|1|||
163877332|NCT00087139|591918992|FG001|Overall Study|Symptomatic deterioration|1|||
163877333|NCT00087139|591918993|FG002|Overall Study|Symptomatic deterioration|3|||
163877334|NCT00087139|591918991|FG000|Overall Study|Use of coumadin|1|||
163877335|NCT00087139|591918992|FG001|Overall Study|Use of coumadin|0|||
163877336|NCT00087139|591918993|FG002|Overall Study|Use of coumadin|0|||
163877337|NCT00087139|591918991|FG000|Overall Study|Response achieved|0|||
163877338|NCT00087139|591918992|FG001|Overall Study|Response achieved|1|||
163877339|NCT00087139|591918993|FG002|Overall Study|Response achieved|0|||
163877340|NCT00087139|591918991|FG000|Overall Study|Extradural disease|0|||
163877341|NCT00087139|591918992|FG001|Overall Study|Extradural disease|0|||
163877342|NCT00087139|591918993|FG002|Overall Study|Extradural disease|1|||
163877343|NCT00073749|591918994|FG000|Overall Study|Disease Progression|2|||
163877344|NCT00073749|591918995|FG001|Overall Study|Disease Progression|0|||
163877345|NCT00073749|591918996|FG002|Overall Study|Disease Progression|3|||
163877346|NCT00073749|591918997|FG003|Overall Study|Disease Progression|2|||
163877347|NCT00073749|591918998|FG004|Overall Study|Disease Progression|3|||
163877348|NCT00073749|591918999|FG005|Overall Study|Disease Progression|1|||
163877349|NCT00073749|591919000|FG006|Overall Study|Disease Progression|3|||
163877350|NCT00073749|591918994|FG000|Overall Study|Death|0|||
163877351|NCT00073749|591918995|FG001|Overall Study|Death|1|||
163877352|NCT00073749|591918996|FG002|Overall Study|Death|1|||
163877353|NCT00073749|591918997|FG003|Overall Study|Death|0|||
163877354|NCT00073749|591918998|FG004|Overall Study|Death|0|||
163877355|NCT00073749|591918999|FG005|Overall Study|Death|0|||
163877356|NCT00073749|591919000|FG006|Overall Study|Death|29|||
163877357|NCT00073749|591918994|FG000|Overall Study|Adverse Event|0|||
163877358|NCT00073749|591918995|FG001|Overall Study|Adverse Event|3|||
163877359|NCT00073749|591918996|FG002|Overall Study|Adverse Event|6|||
163877360|NCT00073749|591918997|FG003|Overall Study|Adverse Event|4|||
163877361|NCT00073749|591918998|FG004|Overall Study|Adverse Event|2|||
163877362|NCT00073749|591918999|FG005|Overall Study|Adverse Event|1|||
163877363|NCT00073749|591919000|FG006|Overall Study|Adverse Event|0|||
163981525|NCT04472429|592302753|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
163981526|NCT04472429|592302751|FG000|Open-label Monotherapy Period|Ongoing|0|||
163981527|NCT04472429|592302752|FG001|Open-label Monotherapy Period|Ongoing|0|||
163981528|NCT04472429|592302753|FG002|Open-label Monotherapy Period|Ongoing|32|||
163981529|NCT04472429|592302751|FG000|Open-label Monotherapy Period|Death|0|||
163981530|NCT04472429|592302752|FG001|Open-label Monotherapy Period|Death|0|||
163981531|NCT04472429|592302753|FG002|Open-label Monotherapy Period|Death|35|||
163981532|NCT04472429|592302751|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
163981533|NCT04472429|592302752|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
163981534|NCT04472429|592302753|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
163981535|NCT01180660|592302754|FG000|Overall Study|Changed to open surgery|1|||
163981536|NCT01180660|592302755|FG001|Overall Study|Changed to open surgery|0|||
164078454|NCT01133821|592653728|FG000|Overall Study|Withdrawal by Subject|8|||
164327907|NCT00734747|593576150|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
163877364|NCT00073749|591918994|FG000|Overall Study|Physician Decision|0|||
163877365|NCT00073749|591918995|FG001|Overall Study|Physician Decision|0|||
163877366|NCT00073749|591918996|FG002|Overall Study|Physician Decision|1|||
163877367|NCT00073749|591918997|FG003|Overall Study|Physician Decision|0|||
163877368|NCT00073749|591918998|FG004|Overall Study|Physician Decision|0|||
163877369|NCT00073749|591918999|FG005|Overall Study|Physician Decision|2|||
163877370|NCT00073749|591919000|FG006|Overall Study|Physician Decision|0|||
163877371|NCT00073749|591918994|FG000|Overall Study|Withdrawal by Subject|0|||
163877372|NCT00073749|591918995|FG001|Overall Study|Withdrawal by Subject|1|||
163877373|NCT00073749|591918996|FG002|Overall Study|Withdrawal by Subject|0|||
163877374|NCT00073749|591918997|FG003|Overall Study|Withdrawal by Subject|0|||
163981537|NCT00250835|592302756|FG000|Overall Study|Withdrawal by Subject|1|||
163981538|NCT03461757|592302757|FG000|Overall Study|Adverse Event|1|||
164327908|NCT01897714|593577804|FG000|Phase I (Dose Escalation)|Disease progression|3|||
164327909|NCT01897714|593577805|FG001|Phase I (Dose Escalation)|Disease progression|5|||
164327910|NCT01897714|593577806|FG002|Phase I (Dose Escalation)|Disease progression|1|||
164327911|NCT01897714|593577807|FG003|Phase I (Dose Escalation)|Disease progression|3|||
164327912|NCT01897714|593577808|FG004|Phase I (Dose Escalation)|Disease progression|0|||
164327913|NCT01897714|593577809|FG005|Phase I (Dose Escalation)|Disease progression|0|||
164327914|NCT01897714|593577804|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
164327915|NCT01897714|593577805|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
164327916|NCT01897714|593577806|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
164327917|NCT01897714|593577807|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
164327918|NCT01897714|593577808|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
164327919|NCT01897714|593577809|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
164327920|NCT01897714|593577804|FG000|Phase I (Dose Escalation)|Other|0|||
164327921|NCT01897714|593577805|FG001|Phase I (Dose Escalation)|Other|1|||
164327922|NCT01897714|593577806|FG002|Phase I (Dose Escalation)|Other|0|||
164327923|NCT01897714|593577807|FG003|Phase I (Dose Escalation)|Other|0|||
164327924|NCT01897714|593577808|FG004|Phase I (Dose Escalation)|Other|0|||
164327925|NCT01897714|593577809|FG005|Phase I (Dose Escalation)|Other|0|||
164327926|NCT01897714|593577804|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
164078455|NCT01133821|592653729|FG001|Overall Study|Withdrawal by Subject|3|||
164078456|NCT01133821|592653728|FG000|Overall Study|preferred other treatment|1|||
164078457|NCT01133821|592653729|FG001|Overall Study|preferred other treatment|1|||
164078458|NCT01133821|592653728|FG000|Overall Study|Protocol Violation|0|||
164078459|NCT01133821|592653729|FG001|Overall Study|Protocol Violation|1|||
164078460|NCT01133821|592653728|FG000|Overall Study|Refused participation|1|||
164078461|NCT01133821|592653729|FG001|Overall Study|Refused participation|3|||
164078462|NCT01859390|592653732|FG000|Overall Study|Insufficient Sputum Collected|1|||
164078463|NCT01859390|592653733|FG001|Overall Study|Insufficient Sputum Collected|3|||
164078464|NCT01859390|592653732|FG000|Overall Study|Sample Missing Collection Date|0|||
164078465|NCT01859390|592653733|FG001|Overall Study|Sample Missing Collection Date|1|||
164078466|NCT01859390|592653732|FG000|Overall Study|Tube Cracked|0|||
164078467|NCT01859390|592653733|FG001|Overall Study|Tube Cracked|2|||
164078468|NCT01859390|592653732|FG000|Overall Study|Shipment Error|0|||
164078469|NCT01859390|592653733|FG001|Overall Study|Shipment Error|1|||
164078470|NCT02451670|592653734|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
164078471|NCT02451670|592653735|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
164078472|NCT00463866|592653739|FG000|Overall Study|Adverse Event|70|||
164078473|NCT00463866|592653740|FG001|Overall Study|Adverse Event|93|||
164078474|NCT00463866|592653739|FG000|Overall Study|Withdrawal by Subject|81|||
164078475|NCT00463866|592653740|FG001|Overall Study|Withdrawal by Subject|79|||
164078476|NCT00463866|592653739|FG000|Overall Study|Lost to Follow-up|46|||
164078477|NCT00463866|592653740|FG001|Overall Study|Lost to Follow-up|55|||
164078478|NCT00463866|592653739|FG000|Overall Study|Incorrect Enrolment|64|||
164078479|NCT00463866|592653740|FG001|Overall Study|Incorrect Enrolment|66|||
164078480|NCT00463866|592653739|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
164078481|NCT00463866|592653740|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
164078482|NCT00463866|592653739|FG000|Overall Study|Safety Reason|1|||
164078483|NCT00463866|592653740|FG001|Overall Study|Safety Reason|3|||
164078484|NCT00463866|592653739|FG000|Overall Study|Mis-Randomization of subject|0|||
164078485|NCT00463866|592653740|FG001|Overall Study|Mis-Randomization of subject|1|||
164078486|NCT00463866|592653739|FG000|Overall Study|Other|22|||
164078487|NCT00463866|592653740|FG001|Overall Study|Other|22|||
164078488|NCT01084005|592653741|FG000|Overall Study|Adverse Event|1|||
164078489|NCT01084005|592653742|FG001|Overall Study|Adverse Event|8|||
164078490|NCT01084005|592653741|FG000|Overall Study|Protocol Violation|3|||
164078491|NCT01084005|592653742|FG001|Overall Study|Protocol Violation|7|||
164078492|NCT01084005|592653741|FG000|Overall Study|Withdrawal by Subject|1|||
164078493|NCT01084005|592653742|FG001|Overall Study|Withdrawal by Subject|1|||
164078494|NCT02480010|592653747|FG000|Overall Study|Adverse Event|3|||
164078495|NCT02480010|592653748|FG001|Overall Study|Adverse Event|1|||
164078496|NCT02480010|592653747|FG000|Overall Study|Death|1|||
164078497|NCT02480010|592653748|FG001|Overall Study|Death|0|||
164078498|NCT02480010|592653747|FG000|Overall Study|Insufficient therapeutic response|31|||
164078499|NCT02480010|592653748|FG001|Overall Study|Insufficient therapeutic response|29|||
164078500|NCT02480010|592653747|FG000|Overall Study|Refused Treatment|0|||
164078501|NCT02480010|592653748|FG001|Overall Study|Refused Treatment|3|||
164327927|NCT01897714|593577805|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
164078502|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
164078503|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164078504|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164078505|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164327928|NCT01897714|593577806|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
164327929|NCT01897714|593577807|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
164327930|NCT01897714|593577808|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
164327931|NCT01897714|593577809|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
163877375|NCT00073749|591918998|FG004|Overall Study|Withdrawal by Subject|1|||
163877376|NCT00073749|591918999|FG005|Overall Study|Withdrawal by Subject|0|||
163877377|NCT00073749|591919000|FG006|Overall Study|Withdrawal by Subject|2|||
163877378|NCT00073749|591918994|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
163877379|NCT00073749|591918995|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
163877380|NCT00073749|591918996|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
163877381|NCT00073749|591918997|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
163877382|NCT00073749|591918998|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
163877383|NCT00073749|591918999|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
163877384|NCT00073749|591919000|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
163877385|NCT00073749|591918994|FG000|Overall Study|Lost to Follow-up|0|||
163877386|NCT00073749|591918995|FG001|Overall Study|Lost to Follow-up|0|||
163877387|NCT00073749|591918996|FG002|Overall Study|Lost to Follow-up|0|||
163877388|NCT00073749|591918997|FG003|Overall Study|Lost to Follow-up|0|||
163877389|NCT00073749|591918998|FG004|Overall Study|Lost to Follow-up|0|||
163877390|NCT00073749|591918999|FG005|Overall Study|Lost to Follow-up|0|||
163877391|NCT00073749|591919000|FG006|Overall Study|Lost to Follow-up|2|||
163877392|NCT00073749|591918994|FG000|Overall Study|Other|0|||
163877393|NCT00073749|591918995|FG001|Overall Study|Other|0|||
163877394|NCT00073749|591918996|FG002|Overall Study|Other|0|||
163877395|NCT00073749|591918997|FG003|Overall Study|Other|0|||
163877396|NCT00073749|591918998|FG004|Overall Study|Other|0|||
163877397|NCT00073749|591918999|FG005|Overall Study|Other|2|||
163877398|NCT00073749|591919000|FG006|Overall Study|Other|0|||
163877399|NCT02272816|591919001|FG000|Overall Study|Adverse Event|1|||
163877400|NCT04154384|591919008|FG000|Overall Study|Lost to Follow-up|24|||
163877401|NCT04154384|591919009|FG001|Overall Study|Lost to Follow-up|33|||
163877402|NCT04154384|591919010|FG002|Overall Study|Lost to Follow-up|0|||
163877403|NCT04154384|591919008|FG000|Overall Study|Withdrawal by Subject|7|||
163877404|NCT04154384|591919009|FG001|Overall Study|Withdrawal by Subject|18|||
163877405|NCT04154384|591919010|FG002|Overall Study|Withdrawal by Subject|0|||
163877406|NCT04154384|591919008|FG000|Overall Study|Missing outcome data|1|||
163877407|NCT04154384|591919009|FG001|Overall Study|Missing outcome data|0|||
163877408|NCT04154384|591919010|FG002|Overall Study|Missing outcome data|0|||
163877409|NCT04095104|591919011|FG000|Overall Study|Withdrawal by Subject|0|||
163877410|NCT04095104|591919012|FG001|Overall Study|Withdrawal by Subject|1|||
163877411|NCT01136876|591919013|FG000|Overall Study|Lost to Follow-up|0|||
163877412|NCT01136876|591919014|FG001|Overall Study|Lost to Follow-up|1|||
163877413|NCT01136876|591919013|FG000|Overall Study|Physician Decision|3|||
163877414|NCT01136876|591919014|FG001|Overall Study|Physician Decision|5|||
163877415|NCT01136876|591919013|FG000|Overall Study|Missing NGAL measurement|2|||
163877416|NCT01136876|591919014|FG001|Overall Study|Missing NGAL measurement|5|||
163877417|NCT04732338|591919017|FG000|Overall Study|Lost to Follow-up|3|||
163877418|NCT04732338|591919018|FG001|Overall Study|Lost to Follow-up|3|||
163877419|NCT00065260|591919019|FG000|Overall Study|Death|0|||
163877420|NCT00065260|591919020|FG001|Overall Study|Death|1|||
163877421|NCT04484935|591919021|FG000|Overall Study|Other|0|||
163877422|NCT04484935|591919022|FG001|Overall Study|Other|1|||
163877423|NCT04484935|591919021|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163877424|NCT04484935|591919022|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163877425|NCT04484935|591919021|FG000|Overall Study|Lost to Follow-up|1|||
163877426|NCT04484935|591919022|FG001|Overall Study|Lost to Follow-up|0|||
163877427|NCT04484935|591919021|FG000|Overall Study|Death|2|||
163877428|NCT04484935|591919022|FG001|Overall Study|Death|1|||
163877429|NCT03750968|591919023|FG000|Overall Study|Adverse Event|2|||
163877430|NCT03750968|591919024|FG001|Overall Study|Adverse Event|0|||
163877431|NCT03750968|591919023|FG000|Overall Study|Lost to Follow-up|1|||
163877432|NCT03750968|591919024|FG001|Overall Study|Lost to Follow-up|3|||
163877433|NCT00088413|591919027|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
163877434|NCT00088413|591919028|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
163877435|NCT00088413|591919029|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
163877436|NCT00088413|591919030|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
163877437|NCT00088413|591919027|FG000|Overall Study|Adverse Events/Side Effects|0|||
163877438|NCT00088413|591919028|FG001|Overall Study|Adverse Events/Side Effects|1|||
163877439|NCT00088413|591919029|FG002|Overall Study|Adverse Events/Side Effects|1|||
163877440|NCT00088413|591919030|FG003|Overall Study|Adverse Events/Side Effects|0|||
163877441|NCT00088413|591919027|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
163877442|NCT00088413|591919028|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
163877443|NCT00088413|591919029|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
163877444|NCT00088413|591919030|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
163877445|NCT00088413|591919027|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
163877446|NCT00088413|591919028|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
164138122|NCT00805467|592868374|FG002|Overall Study|Death|7|||
163877447|NCT00088413|591919029|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
163877448|NCT00088413|591919030|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
163877449|NCT00088413|591919027|FG000|Overall Study|Death|0|||
164138123|NCT00805467|592868375|FG003|Overall Study|Death|5|||
164327932|NCT01897714|593577804|FG000|Phase II (MTD)|Lost to Follow-up|0|||
164327933|NCT01897714|593577805|FG001|Phase II (MTD)|Lost to Follow-up|0|||
164327934|NCT01897714|593577806|FG002|Phase II (MTD)|Lost to Follow-up|0|||
164327935|NCT01897714|593577807|FG003|Phase II (MTD)|Lost to Follow-up|0|||
164327936|NCT01897714|593577808|FG004|Phase II (MTD)|Lost to Follow-up|1|||
164327937|NCT01897714|593577809|FG005|Phase II (MTD)|Lost to Follow-up|0|||
164327938|NCT01897714|593577804|FG000|Phase II (MTD)|Death|0|||
164327939|NCT01897714|593577805|FG001|Phase II (MTD)|Death|0|||
164327940|NCT01897714|593577806|FG002|Phase II (MTD)|Death|0|||
164327941|NCT01897714|593577807|FG003|Phase II (MTD)|Death|0|||
164327942|NCT01897714|593577808|FG004|Phase II (MTD)|Death|25|||
164327943|NCT01897714|593577809|FG005|Phase II (MTD)|Death|10|||
164327944|NCT01897714|593577804|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
164327945|NCT01897714|593577805|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
164327946|NCT01897714|593577806|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
164327947|NCT01897714|593577807|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
164327948|NCT01897714|593577808|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
164327949|NCT01897714|593577809|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
164327950|NCT01897714|593577804|FG000|Phase II (MTD)|Other|0|||
164327951|NCT01897714|593577805|FG001|Phase II (MTD)|Other|0|||
164327952|NCT01897714|593577806|FG002|Phase II (MTD)|Other|0|||
164327953|NCT01897714|593577807|FG003|Phase II (MTD)|Other|0|||
164327954|NCT01897714|593577808|FG004|Phase II (MTD)|Other|3|||
164327955|NCT01897714|593577809|FG005|Phase II (MTD)|Other|0|||
164327956|NCT05828095|593577818|FG000|Overall Study|Lost to Follow-up|1|||
164327957|NCT05828095|593577819|FG001|Overall Study|Lost to Follow-up|0|||
164327958|NCT05828095|593577818|FG000|Overall Study|Reactogenicity symptom|0|||
164327959|NCT05828095|593577819|FG001|Overall Study|Reactogenicity symptom|1|||
164327960|NCT03206073|593577820|FG000|Overall Study|Participant Noncompliance|0|||
164327961|NCT03206073|593577821|FG001|Overall Study|Participant Noncompliance|1|||
164327962|NCT03206073|593577822|FG002|Overall Study|Participant Noncompliance|0|||
164327963|NCT03206073|593577823|FG003|Overall Study|Participant Noncompliance|0|||
164078506|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164078507|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164078508|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
164078509|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
164327964|NCT03206073|593577820|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
164327965|NCT03206073|593577821|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
164327966|NCT03206073|593577822|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
164327967|NCT03206073|593577823|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
164327968|NCT03206073|593577820|FG000|Overall Study|Death|0|||
164327969|NCT03206073|593577821|FG001|Overall Study|Death|0|||
164327970|NCT03206073|593577822|FG002|Overall Study|Death|1|||
164327971|NCT03206073|593577823|FG003|Overall Study|Death|0|||
164327972|NCT03206073|593577820|FG000|Overall Study|Taken off active treatment|0|||
164327973|NCT03206073|593577821|FG001|Overall Study|Taken off active treatment|0|||
164327974|NCT03206073|593577822|FG002|Overall Study|Taken off active treatment|3|||
164327975|NCT03206073|593577823|FG003|Overall Study|Taken off active treatment|0|||
164327976|NCT05523323|593577824|FG000|Overall Study|Death|26|||
164327977|NCT05523323|593577825|FG001|Overall Study|Death|21|||
164327978|NCT05523323|593577824|FG000|Overall Study|Ongoing participants|35|||
164327979|NCT05523323|593577825|FG001|Overall Study|Ongoing participants|30|||
164327980|NCT02428608|593577830|FG000|Overall Study|Pregnancy|2|||
163877450|NCT00088413|591919028|FG001|Overall Study|Death|1|||
163877451|NCT00088413|591919029|FG002|Overall Study|Death|0|||
163877452|NCT00088413|591919030|FG003|Overall Study|Death|0|||
163877453|NCT00088413|591919027|FG000|Overall Study|Progressive disease|9|||
163877454|NCT00088413|591919028|FG001|Overall Study|Progressive disease|11|||
163877455|NCT00088413|591919029|FG002|Overall Study|Progressive disease|8|||
163877456|NCT00088413|591919030|FG003|Overall Study|Progressive disease|14|||
163877457|NCT00088413|591919027|FG000|Overall Study|Other|0|||
163877458|NCT00088413|591919028|FG001|Overall Study|Other|1|||
163877459|NCT00088413|591919029|FG002|Overall Study|Other|0|||
163877460|NCT00088413|591919030|FG003|Overall Study|Other|0|||
163877461|NCT00088413|591919027|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
163877462|NCT00088413|591919028|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
164138124|NCT00805467|592868372|FG000|Overall Study|Physician Decision|0|||
164327981|NCT02428608|593577830|FG000|Overall Study|Lost to Follow-up|37|||
163877463|NCT00088413|591919029|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
163877464|NCT00088413|591919030|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
163877465|NCT02759016|591919031|FG000|Overall Study|Not treated with BI 836826|1|||
164327982|NCT02428608|593577830|FG000|Overall Study|Withdrawal by Subject|2|||
164327983|NCT02428608|593577830|FG000|Overall Study|scheduling conflicts|15|||
164327984|NCT02428608|593577830|FG000|Overall Study|moved away|10|||
164327985|NCT02428608|593577830|FG000|Overall Study|Death|1|||
164327986|NCT02428608|593577830|FG000|Overall Study|various|16|||
164327987|NCT03868124|593577831|FG000|Overall Study|Withdrawal by Subject|4|||
164078510|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164078511|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164078512|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164078513|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164078514|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164078515|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
164078516|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
164078517|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
164078518|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
164078519|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
164078520|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
164078521|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
164078522|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
164078523|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
164078524|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164078525|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164078526|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164078527|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164078528|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164078529|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
164078530|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
164078531|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164078532|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164078533|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164078534|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164078535|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164078536|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
164078537|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
164078538|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
164078539|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
164078540|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
164078541|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
164078542|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
164078543|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
164078544|NCT00606684|592653749|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
164078545|NCT00606684|592653750|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164078546|NCT00606684|592653751|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164078547|NCT00606684|592653752|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164078548|NCT00606684|592653753|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164078549|NCT00606684|592653754|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164078550|NCT00606684|592653755|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
164078551|NCT00606684|592653749|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164078552|NCT00606684|592653750|FG001|Double-Blind Treatment Period|Adverse Event|3|||
164078553|NCT00606684|592653751|FG002|Double-Blind Treatment Period|Adverse Event|2|||
164078554|NCT00606684|592653752|FG003|Double-Blind Treatment Period|Adverse Event|4|||
164078555|NCT00606684|592653753|FG004|Double-Blind Treatment Period|Adverse Event|2|||
164078556|NCT00606684|592653754|FG005|Double-Blind Treatment Period|Adverse Event|0|||
163877466|NCT02759016|591919032|FG001|Overall Study|Not treated with BI 836826|0|||
163877467|NCT02759016|591919031|FG000|Overall Study|Progressive disease|1|||
163877468|NCT02759016|591919032|FG001|Overall Study|Progressive disease|0|||
163877469|NCT02759016|591919031|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
163877470|NCT02759016|591919032|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
163877471|NCT02759016|591919031|FG000|Overall Study|Other not defined above|2|||
163877472|NCT02759016|591919032|FG001|Overall Study|Other not defined above|1|||
163877473|NCT02891915|591919041|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
163877474|NCT02891915|591919042|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
163877475|NCT02891915|591919041|FG000|Overall Study|Withdrawal by Subject|3|||
163877476|NCT02891915|591919042|FG001|Overall Study|Withdrawal by Subject|3|||
163877477|NCT02891915|591919041|FG000|Overall Study|Became Ineligible After Enrollment|2|||
163877478|NCT02891915|591919042|FG001|Overall Study|Became Ineligible After Enrollment|1|||
163877479|NCT02891915|591919041|FG000|Overall Study|Lost to Follow-up|1|||
163877480|NCT02891915|591919042|FG001|Overall Study|Lost to Follow-up|4|||
163877481|NCT02891915|591919041|FG000|Overall Study|Physician Decision|1|||
163877482|NCT02891915|591919042|FG001|Overall Study|Physician Decision|0|||
163877483|NCT04048382|591919043|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
163877484|NCT04048382|591919044|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
163877485|NCT04048382|591919043|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
164078557|NCT00606684|592653755|FG006|Double-Blind Treatment Period|Adverse Event|1|||
164078558|NCT00606684|592653749|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164078559|NCT00606684|592653750|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
164078560|NCT00606684|592653751|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
164078561|NCT00606684|592653752|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
164078562|NCT00606684|592653753|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
164078563|NCT00606684|592653754|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
164078564|NCT00606684|592653755|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
164078565|NCT00606684|592653749|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164078566|NCT00606684|592653750|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
164078567|NCT00606684|592653751|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
164078568|NCT00606684|592653752|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
164078569|NCT00606684|592653753|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
164078570|NCT00606684|592653754|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
164078571|NCT00606684|592653755|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
164078572|NCT00606684|592653749|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
164078573|NCT00606684|592653750|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
164078574|NCT00606684|592653751|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
164078575|NCT00606684|592653752|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
164078576|NCT00606684|592653753|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
164078577|NCT00606684|592653754|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
164078578|NCT00606684|592653755|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
164078579|NCT00606684|592653749|FG000|Double-Blind Treatment Period|Physician Decision|0|||
164078580|NCT00606684|592653750|FG001|Double-Blind Treatment Period|Physician Decision|5|||
164078581|NCT00606684|592653751|FG002|Double-Blind Treatment Period|Physician Decision|1|||
164078582|NCT00606684|592653752|FG003|Double-Blind Treatment Period|Physician Decision|0|||
164078583|NCT00606684|592653753|FG004|Double-Blind Treatment Period|Physician Decision|3|||
164078584|NCT00606684|592653754|FG005|Double-Blind Treatment Period|Physician Decision|1|||
164078585|NCT00606684|592653755|FG006|Double-Blind Treatment Period|Physician Decision|2|||
164078586|NCT00606684|592653749|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164078587|NCT00606684|592653750|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164078588|NCT00606684|592653751|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164078589|NCT00606684|592653752|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164078590|NCT00606684|592653753|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164078591|NCT00606684|592653754|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164078592|NCT00606684|592653755|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164078593|NCT03568500|592653756|FG000|Overall Study|Lost to Follow-up|1|||
164078594|NCT03568500|592653757|FG001|Overall Study|Lost to Follow-up|1|||
164078595|NCT03568500|592653758|FG002|Overall Study|Lost to Follow-up|2|||
164078596|NCT03568500|592653756|FG000|Overall Study|Adverse Event|1|||
164078597|NCT03568500|592653757|FG001|Overall Study|Adverse Event|1|||
164078598|NCT03568500|592653758|FG002|Overall Study|Adverse Event|2|||
164078599|NCT03568500|592653756|FG000|Overall Study|Physician Decision|1|||
164078600|NCT03568500|592653757|FG001|Overall Study|Physician Decision|0|||
164078601|NCT03568500|592653758|FG002|Overall Study|Physician Decision|0|||
164078602|NCT03568500|592653756|FG000|Overall Study|Withdrawal by Subject|4|||
164078603|NCT03568500|592653757|FG001|Overall Study|Withdrawal by Subject|2|||
164078604|NCT03568500|592653758|FG002|Overall Study|Withdrawal by Subject|0|||
164078605|NCT03568500|592653756|FG000|Overall Study|Technical Problems|2|||
164078606|NCT03568500|592653757|FG001|Overall Study|Technical Problems|1|||
164078607|NCT03568500|592653758|FG002|Overall Study|Technical Problems|0|||
164078608|NCT03568500|592653756|FG000|Overall Study|Participant Noncompliance|1|||
164078609|NCT03568500|592653757|FG001|Overall Study|Participant Noncompliance|1|||
164078610|NCT03568500|592653758|FG002|Overall Study|Participant Noncompliance|0|||
164078611|NCT03377556|592653774|FG000|Overall Study|Adverse Event|5|||
164078612|NCT03377556|592653774|FG000|Overall Study|Refusal unrelated to adverse events|1|||
164078613|NCT03377556|592653774|FG000|Overall Study|Progression/relapse|38|||
164078614|NCT03377556|592653774|FG000|Overall Study|Death|3|||
164078615|NCT00910858|592653775|FG000|Pharmacokinetic Phase|Adverse Event|1|||
164078616|NCT00910858|592653776|FG001|Pharmacokinetic Phase|Adverse Event|0|||
164078617|NCT00910858|592653777|FG002|Pharmacokinetic Phase|Adverse Event|0|||
164078618|NCT00910858|592653775|FG000|Monotherapy Phase|Adverse Event|3|||
164078619|NCT00910858|592653776|FG001|Monotherapy Phase|Adverse Event|2|||
164078620|NCT00910858|592653777|FG002|Monotherapy Phase|Adverse Event|0|||
164078621|NCT00910858|592653775|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
164078622|NCT00910858|592653776|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
164078623|NCT00910858|592653777|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
164078624|NCT00910858|592653775|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
164078625|NCT00910858|592653776|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
164078626|NCT00910858|592653777|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
164078627|NCT00910858|592653775|FG000|Monotherapy Phase|Protocol Violation|1|||
164078628|NCT00910858|592653776|FG001|Monotherapy Phase|Protocol Violation|0|||
163877486|NCT04048382|591919044|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
163877487|NCT04048382|591919043|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
163877488|NCT04048382|591919044|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
163877489|NCT02119650|591919049|FG000|Overall Study|Adverse Event|3|||
163877490|NCT02119650|591919050|FG001|Overall Study|Adverse Event|4|||
163877491|NCT02119650|591919049|FG000|Overall Study|Subject decision|2|||
163877492|NCT02119650|591919050|FG001|Overall Study|Subject decision|3|||
163877493|NCT02119650|591919049|FG000|Overall Study|Disease progression|11|||
163877494|NCT02119650|591919050|FG001|Overall Study|Disease progression|14|||
163877495|NCT02119650|591919049|FG000|Overall Study|Death|5|||
163877496|NCT02119650|591919050|FG001|Overall Study|Death|1|||
163877497|NCT02119650|591919049|FG000|Overall Study|Noncompliance with study treatment|1|||
163877498|NCT02119650|591919050|FG001|Overall Study|Noncompliance with study treatment|1|||
163877499|NCT02119650|591919049|FG000|Overall Study|Study terminated by the sponsor|1|||
163877500|NCT02119650|591919050|FG001|Overall Study|Study terminated by the sponsor|0|||
163877501|NCT02119650|591919049|FG000|Overall Study|Physician Decision|0|||
163877502|NCT02119650|591919050|FG001|Overall Study|Physician Decision|2|||
163877503|NCT02119650|591919049|FG000|Overall Study|Multiple reasons for termination|2|||
163877504|NCT02119650|591919050|FG001|Overall Study|Multiple reasons for termination|1|||
163877505|NCT03481816|591919051|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
163877506|NCT03481816|591919052|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
163877507|NCT03481816|591919051|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
163877508|NCT03481816|591919052|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
163877509|NCT03481816|591919051|FG000|Dose Expansion|Withdrawal by Subject|0|||
163877510|NCT03481816|591919052|FG001|Dose Expansion|Withdrawal by Subject|2|||
163877511|NCT03481816|591919051|FG000|Dose Expansion|Physician Decision|0|||
163877512|NCT03481816|591919052|FG001|Dose Expansion|Physician Decision|5|||
163877513|NCT02269475|591919053|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
163877514|NCT02269475|591919054|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
163877515|NCT02269475|591919053|FG000|Overall Study|Withdrawal by Subject|0|||
163877516|NCT02269475|591919054|FG001|Overall Study|Withdrawal by Subject|1|||
163877517|NCT02730871|591919055|FG000|Overall Study|Adverse Event|6|||
163981539|NCT03461757|592302758|FG001|Overall Study|Adverse Event|0|||
163981540|NCT03461757|592302757|FG000|Overall Study|Lost to Follow-up|13|||
163981541|NCT03461757|592302758|FG001|Overall Study|Lost to Follow-up|7|||
163981542|NCT03461757|592302757|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
163981543|NCT03461757|592302758|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
163981544|NCT03461757|592302757|FG000|Overall Study|Non-compliance with study treatment|0|||
163981545|NCT03461757|592302758|FG001|Overall Study|Non-compliance with study treatment|1|||
163981546|NCT03461757|592302757|FG000|Overall Study|Pregnancy|2|||
163981547|NCT03461757|592302758|FG001|Overall Study|Pregnancy|0|||
163981548|NCT03461757|592302757|FG000|Overall Study|Protocol Violation|1|||
163981549|NCT03461757|592302758|FG001|Overall Study|Protocol Violation|1|||
163981550|NCT03461757|592302757|FG000|Overall Study|Withdrawal by Subject|7|||
163981551|NCT03461757|592302758|FG001|Overall Study|Withdrawal by Subject|7|||
163981552|NCT03461757|592302757|FG000|Overall Study|Other Reasons|1|||
163981553|NCT03461757|592302758|FG001|Overall Study|Other Reasons|4|||
163981554|NCT02425826|592302759|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
163981555|NCT02425826|592302760|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
163981556|NCT02425826|592302761|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
163981557|NCT02425826|592302759|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
163981558|NCT02425826|592302760|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
163981559|NCT02425826|592302761|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
163981560|NCT02425826|592302759|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
163981561|NCT02425826|592302760|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
163981562|NCT02425826|592302761|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
163981563|NCT02425826|592302759|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
163981564|NCT02425826|592302760|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
163877518|NCT02730871|591919056|FG001|Overall Study|Adverse Event|0|||
163877519|NCT05368558|591919057|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
163877520|NCT05368558|591919058|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
163877521|NCT05368558|591919059|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
163877522|NCT05368558|591919060|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877523|NCT05368558|591919061|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877524|NCT05368558|591919062|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877525|NCT05368558|591919063|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877526|NCT05368558|591919064|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877527|NCT05368558|591919065|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877528|NCT05368558|591919066|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877529|NCT05368558|591919067|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877530|NCT05368558|591919068|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
163877531|NCT05368558|591919057|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
164327988|NCT03868124|593577832|FG001|Overall Study|Withdrawal by Subject|0|||
164327989|NCT03868124|593577833|FG002|Overall Study|Withdrawal by Subject|1|||
164327990|NCT03868124|593577831|FG000|Overall Study|Physician Decision|1|||
164327991|NCT03868124|593577832|FG001|Overall Study|Physician Decision|0|||
164327992|NCT03868124|593577833|FG002|Overall Study|Physician Decision|1|||
164327993|NCT03868124|593577831|FG000|Overall Study|Lost to Follow-up|1|||
164327994|NCT03868124|593577832|FG001|Overall Study|Lost to Follow-up|1|||
164327995|NCT03868124|593577833|FG002|Overall Study|Lost to Follow-up|2|||
164327996|NCT03868124|593577831|FG000|Overall Study|Death|1|||
164327997|NCT03868124|593577832|FG001|Overall Study|Death|1|||
164327998|NCT03868124|593577833|FG002|Overall Study|Death|2|||
164327999|NCT03868124|593577831|FG000|Overall Study|Adverse Event|0|||
164328000|NCT03868124|593577832|FG001|Overall Study|Adverse Event|0|||
164328001|NCT03868124|593577833|FG002|Overall Study|Adverse Event|3|||
164328002|NCT03868124|593577831|FG000|Overall Study|Explanted|2|||
164328003|NCT03868124|593577832|FG001|Overall Study|Explanted|1|||
164328004|NCT03868124|593577833|FG002|Overall Study|Explanted|0|||
164328005|NCT03868124|593577831|FG000|Overall Study|Ongoing in study|176|||
164328006|NCT03868124|593577832|FG001|Overall Study|Ongoing in study|180|||
164328007|NCT03868124|593577833|FG002|Overall Study|Ongoing in study|183|||
164328008|NCT00397943|593577834|FG000|Overall Study|Unspecified reasons|12|||
164328009|NCT00397943|593577835|FG001|Overall Study|Unspecified reasons|9|||
164328010|NCT00397943|593577836|FG002|Overall Study|Unspecified reasons|0|||
164328011|NCT00397943|593577837|FG003|Overall Study|Unspecified reasons|0|||
164328012|NCT00397943|593577838|FG004|Overall Study|Unspecified reasons|0|||
164328013|NCT05007717|593577839|FG000|Overall Study|Death|3|||
164328014|NCT05007717|593577840|FG001|Overall Study|Death|2|||
164328015|NCT01117051|593577841|FG000|Overall Study|Withdrawal by Subject|5|||
164328016|NCT01117051|593577842|FG001|Overall Study|Withdrawal by Subject|3|||
164328017|NCT01117051|593577841|FG000|Overall Study|Adverse Event|4|||
164328018|NCT01117051|593577842|FG001|Overall Study|Adverse Event|3|||
164328019|NCT01117051|593577841|FG000|Overall Study|Lost to Follow-up|0|||
164328020|NCT01117051|593577842|FG001|Overall Study|Lost to Follow-up|1|||
164328021|NCT01117051|593577841|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
164328022|NCT01117051|593577842|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
164328023|NCT01117051|593577841|FG000|Overall Study|Sponsor's decision|3|||
164328024|NCT01117051|593577842|FG001|Overall Study|Sponsor's decision|1|||
164328025|NCT01117051|593577841|FG000|Overall Study|Surgical procedure|0|||
164328026|NCT01117051|593577842|FG001|Overall Study|Surgical procedure|1|||
164328027|NCT01117051|593577841|FG000|Overall Study|Randomized by mistake|0|||
164328028|NCT01117051|593577842|FG001|Overall Study|Randomized by mistake|1|||
164328029|NCT01117051|593577841|FG000|Overall Study|Convenience issue|1|||
164328030|NCT01117051|593577842|FG001|Overall Study|Convenience issue|0|||
164328031|NCT00206076|593577844|FG000|Overall Study|Physician Decision|2|||
164328032|NCT00206076|593577845|FG001|Overall Study|Physician Decision|0|||
164328033|NCT00206076|593577844|FG000|Overall Study|Withdrawal by Subject|1|||
164328034|NCT00206076|593577845|FG001|Overall Study|Withdrawal by Subject|1|||
164328035|NCT00427960|593577846|FG000|Overall Study|Adverse Event|2|||
164328036|NCT00427960|593577847|FG001|Overall Study|Adverse Event|0|||
164328037|NCT00427960|593577846|FG000|Overall Study|Withdrawal by Subject|0|||
164328038|NCT00427960|593577847|FG001|Overall Study|Withdrawal by Subject|3|||
164328039|NCT00427960|593577846|FG000|Overall Study|Other|0|||
164328040|NCT00427960|593577847|FG001|Overall Study|Other|1|||
164328041|NCT01142128|593577848|FG000|Overall Study|Physician Decision|1|||
164328042|NCT01142128|593577848|FG000|Overall Study|Lost to Follow-up|1|||
164328043|NCT01142128|593577848|FG000|Overall Study|Withdrawal by Subject|2|||
164328044|NCT03355664|593577849|FG000|Overall Study|Adverse Event|1|||
164328045|NCT03355664|593577850|FG001|Overall Study|Adverse Event|2|||
164328046|NCT03355664|593577849|FG000|Overall Study|Lost to Follow-up|11|||
164328047|NCT03355664|593577850|FG001|Overall Study|Lost to Follow-up|7|||
164328048|NCT03355664|593577849|FG000|Overall Study|Protocol Violation|1|||
164328049|NCT03355664|593577850|FG001|Overall Study|Protocol Violation|2|||
164328050|NCT03355664|593577849|FG000|Overall Study|Withdrawal by Subject|2|||
164328051|NCT03355664|593577850|FG001|Overall Study|Withdrawal by Subject|1|||
164328052|NCT02821910|593577854|FG000|Overall Study|Withdrawal by Subject|0|||
164328053|NCT02821910|593577855|FG001|Overall Study|Withdrawal by Subject|0|||
164328054|NCT02821910|593577856|FG002|Overall Study|Withdrawal by Subject|1|||
164328055|NCT02821910|593577857|FG003|Overall Study|Withdrawal by Subject|0|||
164328056|NCT02821910|593577858|FG004|Overall Study|Withdrawal by Subject|0|||
164328057|NCT02821910|593577859|FG005|Overall Study|Withdrawal by Subject|1|||
164328058|NCT02821910|593577854|FG000|Overall Study|Other than specified|1|||
164328059|NCT02821910|593577855|FG001|Overall Study|Other than specified|0|||
164328060|NCT02821910|593577856|FG002|Overall Study|Other than specified|1|||
164328061|NCT02821910|593577857|FG003|Overall Study|Other than specified|0|||
164328062|NCT02821910|593577858|FG004|Overall Study|Other than specified|0|||
164328063|NCT02821910|593577859|FG005|Overall Study|Other than specified|0|||
164328064|NCT00423670|593577860|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
164328065|NCT00423670|593577861|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
164138125|NCT00805467|592868373|FG001|Overall Study|Physician Decision|1|||
164328066|NCT00423670|593577862|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328067|NCT00423670|593577863|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328068|NCT00423670|593577864|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328069|NCT00423670|593577865|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328070|NCT00423670|593577866|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328071|NCT00423670|593577867|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
164328072|NCT00423670|593577860|FG000|Treatment Period|Adverse Event|8|||
164328073|NCT00423670|593577861|FG001|Treatment Period|Adverse Event|12|||
164328074|NCT00423670|593577862|FG002|Treatment Period|Adverse Event|15|||
164328075|NCT00423670|593577863|FG003|Treatment Period|Adverse Event|20|||
164328076|NCT00423670|593577864|FG004|Treatment Period|Adverse Event|9|||
164328077|NCT00423670|593577865|FG005|Treatment Period|Adverse Event|4|||
164328078|NCT00423670|593577866|FG006|Treatment Period|Adverse Event|7|||
164328079|NCT00423670|593577867|FG007|Treatment Period|Adverse Event|2|||
164328080|NCT00423670|593577860|FG000|Treatment Period|Protocol-defined clinical event|0|||
164328081|NCT00423670|593577861|FG001|Treatment Period|Protocol-defined clinical event|7|||
164328082|NCT00423670|593577862|FG002|Treatment Period|Protocol-defined clinical event|4|||
164328083|NCT00423670|593577863|FG003|Treatment Period|Protocol-defined clinical event|12|||
164328084|NCT00423670|593577864|FG004|Treatment Period|Protocol-defined clinical event|5|||
164328085|NCT00423670|593577865|FG005|Treatment Period|Protocol-defined clinical event|4|||
164328086|NCT00423670|593577866|FG006|Treatment Period|Protocol-defined clinical event|16|||
164328087|NCT00423670|593577867|FG007|Treatment Period|Protocol-defined clinical event|15|||
164328088|NCT00423670|593577860|FG000|Treatment Period|Lost to Follow-up|2|||
164328089|NCT00423670|593577861|FG001|Treatment Period|Lost to Follow-up|1|||
164328090|NCT00423670|593577862|FG002|Treatment Period|Lost to Follow-up|3|||
164328091|NCT00423670|593577863|FG003|Treatment Period|Lost to Follow-up|1|||
164328092|NCT00423670|593577864|FG004|Treatment Period|Lost to Follow-up|6|||
164328093|NCT00423670|593577865|FG005|Treatment Period|Lost to Follow-up|0|||
164328094|NCT00423670|593577866|FG006|Treatment Period|Lost to Follow-up|3|||
164328095|NCT00423670|593577867|FG007|Treatment Period|Lost to Follow-up|1|||
164328096|NCT00423670|593577860|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
164328097|NCT00423670|593577861|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
164328098|NCT00423670|593577862|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
164328099|NCT00423670|593577863|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
164328100|NCT00423670|593577864|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
164328101|NCT00423670|593577865|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
164328102|NCT00423670|593577866|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
164328103|NCT00423670|593577867|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
164328104|NCT00423670|593577860|FG000|Treatment Period|Investigator decision|0|||
164328105|NCT00423670|593577861|FG001|Treatment Period|Investigator decision|0|||
164328106|NCT00423670|593577862|FG002|Treatment Period|Investigator decision|0|||
164328107|NCT00423670|593577863|FG003|Treatment Period|Investigator decision|0|||
164328108|NCT00423670|593577864|FG004|Treatment Period|Investigator decision|0|||
164328109|NCT00423670|593577865|FG005|Treatment Period|Investigator decision|0|||
164328110|NCT00423670|593577866|FG006|Treatment Period|Investigator decision|0|||
164328111|NCT00423670|593577867|FG007|Treatment Period|Investigator decision|1|||
164328112|NCT00423670|593577860|FG000|Treatment Period|Non-compliance with protocol|3|||
164328113|NCT00423670|593577861|FG001|Treatment Period|Non-compliance with protocol|1|||
164328114|NCT00423670|593577862|FG002|Treatment Period|Non-compliance with protocol|1|||
164328115|NCT00423670|593577863|FG003|Treatment Period|Non-compliance with protocol|3|||
164328116|NCT00423670|593577864|FG004|Treatment Period|Non-compliance with protocol|2|||
164328117|NCT00423670|593577865|FG005|Treatment Period|Non-compliance with protocol|0|||
164328118|NCT00423670|593577866|FG006|Treatment Period|Non-compliance with protocol|2|||
164328119|NCT00423670|593577867|FG007|Treatment Period|Non-compliance with protocol|2|||
164328120|NCT00423670|593577860|FG000|Follow-up Period|Lost to Follow-up|0|||
164328121|NCT00423670|593577861|FG001|Follow-up Period|Lost to Follow-up|12|||
164328122|NCT00423670|593577862|FG002|Follow-up Period|Lost to Follow-up|8|||
164328123|NCT00423670|593577863|FG003|Follow-up Period|Lost to Follow-up|3|||
164328124|NCT00423670|593577864|FG004|Follow-up Period|Lost to Follow-up|1|||
164328125|NCT00423670|593577865|FG005|Follow-up Period|Lost to Follow-up|0|||
164328126|NCT00423670|593577866|FG006|Follow-up Period|Lost to Follow-up|5|||
164328127|NCT00423670|593577867|FG007|Follow-up Period|Lost to Follow-up|0|||
164328128|NCT00423670|593577860|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328129|NCT00423670|593577861|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
164328130|NCT00423670|593577862|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
164328131|NCT00423670|593577863|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328132|NCT00423670|593577864|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328133|NCT00423670|593577865|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
164078629|NCT00910858|592653777|FG002|Monotherapy Phase|Protocol Violation|0|||
164328134|NCT00423670|593577866|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328135|NCT00423670|593577867|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
164328136|NCT00423670|593577860|FG000|Follow-up Period|Non-compliance with protocol|2|||
164328137|NCT00423670|593577861|FG001|Follow-up Period|Non-compliance with protocol|0|||
164328138|NCT00423670|593577862|FG002|Follow-up Period|Non-compliance with protocol|1|||
164328139|NCT00423670|593577863|FG003|Follow-up Period|Non-compliance with protocol|1|||
164328140|NCT00423670|593577864|FG004|Follow-up Period|Non-compliance with protocol|0|||
164328141|NCT00423670|593577865|FG005|Follow-up Period|Non-compliance with protocol|0|||
164328142|NCT00423670|593577866|FG006|Follow-up Period|Non-compliance with protocol|3|||
164328143|NCT00423670|593577867|FG007|Follow-up Period|Non-compliance with protocol|2|||
164328144|NCT00900601|593577868|FG000|Overall Study|Physician Decision|1|||
164328145|NCT02131532|593577869|FG000|Overall Study|Withdrawal by Subject|1|||
164328146|NCT02131532|593577869|FG000|Overall Study|Physician Decision|1|||
164328147|NCT02131532|593577869|FG000|Overall Study|Other health conditions|2|||
164328148|NCT01856023|593577870|FG000|Overall Study|Death|1|||
164328149|NCT01856023|593577871|FG001|Overall Study|Death|2|||
164328150|NCT01856023|593577870|FG000|Overall Study|Adverse Event|2|||
164328151|NCT01856023|593577871|FG001|Overall Study|Adverse Event|1|||
164328152|NCT01856023|593577870|FG000|Overall Study|Lack of Efficacy|5|||
164328153|NCT01856023|593577871|FG001|Overall Study|Lack of Efficacy|5|||
164328154|NCT01856023|593577870|FG000|Overall Study|non compliance, study closure|1|||
163981565|NCT02425826|592302761|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
163981566|NCT02425826|592302759|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
163981567|NCT02425826|592302760|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
163981568|NCT02425826|592302761|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
163981569|NCT02425826|592302759|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
163981570|NCT02425826|592302760|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
164328155|NCT01856023|593577871|FG001|Overall Study|non compliance, study closure|3|||
164328156|NCT01856023|593577870|FG000|Overall Study|Withdrawal by Subject|1|||
164328157|NCT01856023|593577871|FG001|Overall Study|Withdrawal by Subject|1|||
164328158|NCT00829283|593577872|FG000|Overall Study|Lost to Follow-up|7|||
164328159|NCT00829283|593577873|FG001|Overall Study|Lost to Follow-up|25|||
164328160|NCT00424255|593577874|FG000|Overall Study|Death|115|||
164328161|NCT00424255|593577875|FG001|Overall Study|Death|111|||
164328162|NCT00424255|593577874|FG000|Overall Study|Lost to Follow-up|26|||
164328163|NCT00424255|593577875|FG001|Overall Study|Lost to Follow-up|20|||
164328164|NCT00424255|593577874|FG000|Overall Study|Protocol Violation|0|||
164328165|NCT00424255|593577875|FG001|Overall Study|Protocol Violation|1|||
164328166|NCT00424255|593577874|FG000|Overall Study|Withdrawal by Subject|34|||
164328167|NCT00424255|593577875|FG001|Overall Study|Withdrawal by Subject|38|||
164328168|NCT00424255|593577874|FG000|Overall Study|Physician Decision|3|||
164328169|NCT00424255|593577875|FG001|Overall Study|Physician Decision|7|||
164328170|NCT00424255|593577874|FG000|Overall Study|Cognitive Disturbance|1|||
164328171|NCT00424255|593577875|FG001|Overall Study|Cognitive Disturbance|0|||
164328172|NCT00424255|593577874|FG000|Overall Study|Non-compliance by Participants|1|||
164328173|NCT00424255|593577875|FG001|Overall Study|Non-compliance by Participants|0|||
164328174|NCT00424255|593577874|FG000|Overall Study|Fatigue|1|||
164328175|NCT00424255|593577875|FG001|Overall Study|Fatigue|0|||
164328176|NCT00424255|593577874|FG000|Overall Study|Disease Progression|0|||
163981571|NCT02425826|592302761|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
163981572|NCT02425826|592302759|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
163981573|NCT02425826|592302760|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
163981574|NCT02425826|592302761|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
163981575|NCT02425826|592302759|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
164218527|NCT03315689|593168378|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
164218528|NCT03315689|593168377|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
164218529|NCT03315689|593168378|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
164218530|NCT03315689|593168377|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
164218531|NCT03315689|593168378|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
164218532|NCT00864513|593168379|FG000|Overall Study|Withdrawal by Subject|3|||
164218533|NCT00762788|593168380|FG000|Overall Study|Lost to Follow-up|26|||
164218534|NCT00762788|593168381|FG001|Overall Study|Lost to Follow-up|37|||
164218535|NCT00762788|593168382|FG002|Overall Study|Lost to Follow-up|21|||
164218536|NCT00762788|593168383|FG003|Overall Study|Lost to Follow-up|26|||
164218537|NCT00762788|593168384|FG004|Overall Study|Lost to Follow-up|13|||
164218538|NCT00762788|593168385|FG005|Overall Study|Lost to Follow-up|21|||
164218539|NCT03073109|593168386|FG000|Overall Study|Adverse Event|0|||
164218540|NCT03073109|593168387|FG001|Overall Study|Adverse Event|1|||
164218541|NCT03073109|593168386|FG000|Overall Study|Other|2|||
164328177|NCT00424255|593577875|FG001|Overall Study|Disease Progression|2|||
164328178|NCT00424255|593577874|FG000|Overall Study|Sponsor Terminated Study|161|||
164328179|NCT00424255|593577875|FG001|Overall Study|Sponsor Terminated Study|167|||
164218542|NCT03073109|593168387|FG001|Overall Study|Other|0|||
164218543|NCT03073109|593168386|FG000|Overall Study|Lost to Follow-up|8|||
164328180|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
164328181|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
164328182|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
164328183|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
164078630|NCT00910858|592653775|FG000|Monotherapy Phase|Other|3|||
164078631|NCT00910858|592653776|FG001|Monotherapy Phase|Other|4|||
164078632|NCT00910858|592653777|FG002|Monotherapy Phase|Other|2|||
164078633|NCT00910858|592653775|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
164078634|NCT00910858|592653776|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
164078635|NCT00910858|592653777|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
164078636|NCT00910858|592653775|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
164078637|NCT00910858|592653776|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
164078638|NCT00910858|592653777|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
164078639|NCT00910858|592653775|FG000|Combined Treatment Phase|Protocol Violation|1|||
164078640|NCT00910858|592653776|FG001|Combined Treatment Phase|Protocol Violation|0|||
164078641|NCT00910858|592653777|FG002|Combined Treatment Phase|Protocol Violation|0|||
164078642|NCT00910858|592653775|FG000|Combined Treatment Phase|Other|0|||
164078643|NCT00910858|592653776|FG001|Combined Treatment Phase|Other|2|||
164078644|NCT00910858|592653777|FG002|Combined Treatment Phase|Other|1|||
164078645|NCT00827827|592653779|FG000|Overall Study|Lost to Follow-up|3|||
164078646|NCT00827827|592653780|FG001|Overall Study|Lost to Follow-up|0|||
164078647|NCT00827827|592653779|FG000|Overall Study|Fall at home- hospitalization|1|||
164078648|NCT00827827|592653780|FG001|Overall Study|Fall at home- hospitalization|0|||
164078649|NCT00827827|592653779|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
164078650|NCT00827827|592653780|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
164078651|NCT00827827|592653779|FG000|Overall Study|Gout|1|||
164078652|NCT00827827|592653780|FG001|Overall Study|Gout|0|||
164078653|NCT00827827|592653779|FG000|Overall Study|Transportation issues|1|||
164078654|NCT00827827|592653780|FG001|Overall Study|Transportation issues|0|||
164078655|NCT00827827|592653779|FG000|Overall Study|Burned with water at home|1|||
164078656|NCT00827827|592653780|FG001|Overall Study|Burned with water at home|0|||
164078657|NCT01907737|592653792|FG000|Overall Study|Withdrawal by Subject|1|||
164078658|NCT01165684|592653793|FG000|Overall Study|Adverse Event|1|||
164078659|NCT01165684|592653794|FG001|Overall Study|Adverse Event|1|||
164078660|NCT01165684|592653793|FG000|Overall Study|Lack of Efficacy|2|||
164078661|NCT01165684|592653794|FG001|Overall Study|Lack of Efficacy|1|||
164078662|NCT01165684|592653793|FG000|Overall Study|Protocol Violation|7|||
164078663|NCT01165684|592653794|FG001|Overall Study|Protocol Violation|15|||
164078664|NCT01165684|592653793|FG000|Overall Study|Withdrawal Criteria|2|||
164218544|NCT03073109|593168387|FG001|Overall Study|Lost to Follow-up|1|||
164218545|NCT00421733|593168388|FG000|Overall Study|Adverse Event|4|||
164218546|NCT00421733|593168389|FG001|Overall Study|Adverse Event|9|||
164218547|NCT00421733|593168390|FG002|Overall Study|Adverse Event|2|||
164218548|NCT00421733|593168388|FG000|Overall Study|Lost to Follow-up|1|||
164218549|NCT00421733|593168389|FG001|Overall Study|Lost to Follow-up|2|||
164218550|NCT00421733|593168390|FG002|Overall Study|Lost to Follow-up|4|||
164218551|NCT00421733|593168388|FG000|Overall Study|Withdrawal by Subject|1|||
164218552|NCT00421733|593168389|FG001|Overall Study|Withdrawal by Subject|2|||
164218553|NCT00421733|593168390|FG002|Overall Study|Withdrawal by Subject|7|||
164218554|NCT00421733|593168388|FG000|Overall Study|Death|0|||
164218555|NCT00421733|593168389|FG001|Overall Study|Death|3|||
164218556|NCT00421733|593168390|FG002|Overall Study|Death|0|||
164218557|NCT00421733|593168388|FG000|Overall Study|Required dialysis|1|||
164218558|NCT00421733|593168389|FG001|Overall Study|Required dialysis|0|||
164218559|NCT00421733|593168390|FG002|Overall Study|Required dialysis|0|||
164218560|NCT00421733|593168388|FG000|Overall Study|Administrative|2|||
164218561|NCT00421733|593168389|FG001|Overall Study|Administrative|0|||
164218562|NCT00421733|593168390|FG002|Overall Study|Administrative|0|||
164218563|NCT00421733|593168388|FG000|Overall Study|Did not satisfy entry criteria|1|||
164218564|NCT00421733|593168389|FG001|Overall Study|Did not satisfy entry criteria|3|||
164218565|NCT00421733|593168390|FG002|Overall Study|Did not satisfy entry criteria|2|||
164218566|NCT00421733|593168388|FG000|Overall Study|Sponsor request|1|||
164218567|NCT00421733|593168389|FG001|Overall Study|Sponsor request|0|||
164218568|NCT00421733|593168390|FG002|Overall Study|Sponsor request|3|||
164218569|NCT00421733|593168388|FG000|Overall Study|Protocol deviation|4|||
164218570|NCT00421733|593168389|FG001|Overall Study|Protocol deviation|7|||
164218571|NCT00421733|593168390|FG002|Overall Study|Protocol deviation|2|||
164218572|NCT00120250|593168391|FG000|Overall Study|Lost to Follow-up|1|||
164218573|NCT00120250|593168392|FG001|Overall Study|Lost to Follow-up|1|||
164218574|NCT00120250|593168391|FG000|Overall Study|Protocol Violation|0|||
164218575|NCT00120250|593168392|FG001|Overall Study|Protocol Violation|1|||
164218576|NCT01967277|593168393|FG000|Overall Study|Lost to Follow-up|1|||
164218577|NCT01967277|593168394|FG001|Overall Study|Lost to Follow-up|2|||
164218578|NCT01967277|593168393|FG000|Overall Study|Unrelated illness|0|||
164218579|NCT01967277|593168394|FG001|Overall Study|Unrelated illness|1|||
164218580|NCT01829165|593168395|FG000|Overall Study|Did not complete intervention|2|||
164078665|NCT01165684|592653794|FG001|Overall Study|Withdrawal Criteria|13|||
164078666|NCT01165684|592653793|FG000|Overall Study|Unclassified|16|||
164078667|NCT01165684|592653794|FG001|Overall Study|Unclassified|22|||
164078668|NCT01886300|592653815|FG000|Overall Study|Trial terminated by sponsor|16|||
164218581|NCT01829165|593168396|FG001|Overall Study|Did not complete intervention|0|||
164218582|NCT00397930|593168399|FG000|Overall Study|Personal reasons|14|||
164218583|NCT00397930|593168400|FG001|Overall Study|Personal reasons|8|||
164218584|NCT00397930|593168399|FG000|Overall Study|Other medical|9|||
164218585|NCT00397930|593168400|FG001|Overall Study|Other medical|4|||
164218586|NCT00397930|593168399|FG000|Overall Study|Unknown reasons|9|||
164218587|NCT00397930|593168400|FG001|Overall Study|Unknown reasons|14|||
164218588|NCT00397930|593168399|FG000|Overall Study|Noncompliant|3|||
164218589|NCT00397930|593168400|FG001|Overall Study|Noncompliant|2|||
164218590|NCT00397930|593168399|FG000|Overall Study|Too time-consuming|2|||
164218591|NCT00397930|593168400|FG001|Overall Study|Too time-consuming|9|||
164218592|NCT00397930|593168399|FG000|Overall Study|Started own yoga program|1|||
164218593|NCT00397930|593168400|FG001|Overall Study|Started own yoga program|1|||
164218594|NCT00397930|593168399|FG000|Overall Study|Did not want to be in control group|0|||
164218595|NCT00397930|593168400|FG001|Overall Study|Did not want to be in control group|1|||
163981576|NCT02425826|592302760|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
163981577|NCT02425826|592302761|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
163981578|NCT02425826|592302759|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
163981579|NCT02425826|592302760|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
163981580|NCT02425826|592302761|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
163981581|NCT02425826|592302759|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
163981582|NCT02425826|592302760|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
163981583|NCT02425826|592302761|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
163981584|NCT03861559|592302762|FG000|Overall Study|Adverse Event|0|||
163981585|NCT03861559|592302763|FG001|Overall Study|Adverse Event|2|||
163981586|NCT03861559|592302762|FG000|Overall Study|Treatment failure|0|||
163981587|NCT03861559|592302763|FG001|Overall Study|Treatment failure|2|||
163981588|NCT03861559|592302762|FG000|Overall Study|Noncompliance|1|||
163981589|NCT03861559|592302763|FG001|Overall Study|Noncompliance|1|||
163981590|NCT03861559|592302762|FG000|Overall Study|Did not meet eligibility requirements|1|||
163981591|NCT03861559|592302763|FG001|Overall Study|Did not meet eligibility requirements|0|||
163981592|NCT00879697|592302766|FG000|Overall Study|Physician Decision|2|||
163981593|NCT00879697|592302767|FG001|Overall Study|Physician Decision|2|||
163981594|NCT01836783|592302771|FG000|Overall Study|Withdrawal by Subject|0|||
163981595|NCT01836783|592302772|FG001|Overall Study|Withdrawal by Subject|2|||
163981596|NCT04942925|592302775|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
163981597|NCT04942925|592302776|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
163981598|NCT04942925|592302775|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
163981599|NCT04942925|592302776|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
163981600|NCT02124564|592302780|FG000|Treatment Period|Adverse Event|2|||
163981601|NCT02124564|592302780|FG000|Treatment Period|Lack of Efficacy|3|||
163981602|NCT02124564|592302780|FG000|Treatment Period|Withdrawal by Subject|2|||
163981603|NCT01100437|592302781|FG000|Titration/Stabilization|Adverse Event|0|||
163981604|NCT01100437|592302782|FG001|Titration/Stabilization|Adverse Event|0|||
163981605|NCT01100437|592302783|FG002|Titration/Stabilization|Adverse Event|4|||
163981606|NCT01100437|592302781|FG000|Titration/Stabilization|Non-compliance|0|||
163981607|NCT01100437|592302782|FG001|Titration/Stabilization|Non-compliance|0|||
163981608|NCT01100437|592302783|FG002|Titration/Stabilization|Non-compliance|1|||
163981609|NCT01100437|592302781|FG000|Titration/Stabilization|Sponsor canceled study|0|||
163981610|NCT01100437|592302782|FG001|Titration/Stabilization|Sponsor canceled study|0|||
163981611|NCT01100437|592302783|FG002|Titration/Stabilization|Sponsor canceled study|1|||
163981612|NCT01100437|592302781|FG000|Maintenance|Withdrawal by Subject|0|||
163981613|NCT01100437|592302782|FG001|Maintenance|Withdrawal by Subject|0|||
163981614|NCT01100437|592302783|FG002|Maintenance|Withdrawal by Subject|1|||
163981615|NCT01100437|592302781|FG000|Maintenance|Sponsor termination of study|0|||
163981616|NCT01100437|592302782|FG001|Maintenance|Sponsor termination of study|0|||
163981617|NCT01100437|592302783|FG002|Maintenance|Sponsor termination of study|1|||
163981618|NCT04489888|592302784|FG000|Overall Study|Death|75|||
163981619|NCT04489888|592302784|FG000|Overall Study|Sponsor Decision|26|||
163981620|NCT03829657|592302794|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
163981621|NCT03829657|592302795|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
163981622|NCT03829657|592302796|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
163981623|NCT03829657|592302797|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
163981624|NCT03829657|592302798|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
163981625|NCT03829657|592302794|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
163981626|NCT03829657|592302795|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163981627|NCT03829657|592302796|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163981628|NCT03829657|592302797|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163981629|NCT03829657|592302798|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
163981630|NCT03829657|592302794|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
163981631|NCT03829657|592302795|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
163981632|NCT03829657|592302796|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
164218596|NCT00397930|593168399|FG000|Overall Study|Withdrawal by Subject|0|||
164218597|NCT00397930|593168400|FG001|Overall Study|Withdrawal by Subject|8|||
164328184|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
164328185|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
164328186|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
164328187|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
164328188|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
164328189|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
164328190|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
164328191|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
164328192|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
164328193|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
164328194|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
164328195|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
164328196|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
164328197|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
164328198|NCT00591578|593577877|FG000|Double-Blind Treatment Phase|Other|4|||
164328199|NCT00591578|593577878|FG001|Double-Blind Treatment Phase|Other|9|||
164328200|NCT00591578|593577879|FG002|Double-Blind Treatment Phase|Other|4|||
164328201|NCT00591578|593577877|FG000|Open-Label Extension Phase|Adverse Event|3|||
164328202|NCT00591578|593577878|FG001|Open-Label Extension Phase|Adverse Event|5|||
164328203|NCT00591578|593577879|FG002|Open-Label Extension Phase|Adverse Event|0|||
164328204|NCT00591578|593577877|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
164328205|NCT00591578|593577878|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
164328206|NCT00591578|593577879|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164328207|NCT00591578|593577877|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
164328208|NCT00591578|593577878|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
164328209|NCT00591578|593577879|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
164328210|NCT00591578|593577877|FG000|Open-Label Extension Phase|Other|1|||
164328211|NCT00591578|593577878|FG001|Open-Label Extension Phase|Other|0|||
164328212|NCT00591578|593577879|FG002|Open-Label Extension Phase|Other|0|||
164328213|NCT00870233|593577882|FG000|Overall Study|Withdrawal by Subject|18|||
164328214|NCT00870233|593577882|FG000|Overall Study|Did not undergo laparotomy|3|||
164328215|NCT00870233|593577882|FG000|Overall Study|Incompatible internet browser|2|||
164328216|NCT00870233|593577882|FG000|Overall Study|Death|1|||
164328217|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
164328218|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
164328219|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
164328220|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
164328221|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
164328222|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
164328223|NCT01369485|593577883|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
164328224|NCT01369485|593577884|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
164328225|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
164328226|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
164328227|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
164328228|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
164328229|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
164328230|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
164328231|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
164328232|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
164328233|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
164328234|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
164328235|NCT01369485|593577883|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
164328236|NCT01369485|593577884|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
164328237|NCT02942576|593577885|FG000|Overall Study|Adverse Event|28|||
164328238|NCT02942576|593577886|FG001|Overall Study|Adverse Event|6|||
164328239|NCT02942576|593577885|FG000|Overall Study|Withdrawal by Subject|7|||
164328240|NCT02942576|593577886|FG001|Overall Study|Withdrawal by Subject|5|||
164328241|NCT02942576|593577885|FG000|Overall Study|Physician Decision|1|||
164328242|NCT02942576|593577886|FG001|Overall Study|Physician Decision|4|||
164078669|NCT00901628|592653816|FG000|Overall Study|disconnection of catheter|4|||
164078670|NCT00901628|592653817|FG001|Overall Study|disconnection of catheter|8|||
164078671|NCT00901628|592653816|FG000|Overall Study|disconnection of drain|0|||
164078672|NCT00901628|592653817|FG001|Overall Study|disconnection of drain|1|||
164078673|NCT00901628|592653816|FG000|Overall Study|peroneal nerve palsy|0|||
164078674|NCT00901628|592653817|FG001|Overall Study|peroneal nerve palsy|1|||
164078675|NCT00608205|592653818|FG000|Overall Study|Adverse Event|3|||
164078676|NCT00608205|592653819|FG001|Overall Study|Adverse Event|2|||
164328243|NCT02942576|593577885|FG000|Overall Study|Other|10|||
164328244|NCT02942576|593577886|FG001|Overall Study|Other|8|||
164328245|NCT00769483|593577887|FG000|Overall Study|Withdrawal by Subject|0|||
164078677|NCT00608205|592653818|FG000|Overall Study|Patient non-compliant|0|||
164328246|NCT00769483|593577888|FG001|Overall Study|Withdrawal by Subject|1|||
164328247|NCT00769483|593577889|FG002|Overall Study|Withdrawal by Subject|0|||
164328248|NCT00769483|593577890|FG003|Overall Study|Withdrawal by Subject|0|||
164328249|NCT00769483|593577891|FG004|Overall Study|Withdrawal by Subject|1|||
164328250|NCT00769483|593577892|FG005|Overall Study|Withdrawal by Subject|0|||
164328251|NCT00006389|593577893|FG000|Overall Study|Adverse Event|1|||
164328252|NCT01285960|593577900|FG000|Overall Study|Withdrawal by Subject|2|||
164328253|NCT01285960|593577900|FG000|Overall Study|Lost to Follow-up|2|||
164328254|NCT01285960|593577900|FG000|Overall Study|2 subjects received less 10 sonications|2|||
164328255|NCT01309308|593577901|FG000|Overall Study|Lost to Follow-up|6|||
164328256|NCT01309308|593577902|FG001|Overall Study|Lost to Follow-up|4|||
164328257|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Adverse Event|1|||
164328258|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Adverse Event|0|||
164328259|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Adverse Event|0|||
164328260|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Adverse Event|0|||
164328261|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Adverse Event|0|||
164328262|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164078678|NCT00608205|592653819|FG001|Overall Study|Patient non-compliant|1|||
164078679|NCT02008721|592653820|FG000|Overall Study|Withdrawal by Subject|5|||
164328263|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
164328264|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328265|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328266|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
164328267|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
164328268|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
164328269|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
164328270|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
164328271|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
164328272|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328273|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
164328274|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328275|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328276|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
164328277|NCT00473746|593577903|FG000|Period 1 (Phase 1)|Reason not specified|0|||
164328278|NCT00473746|593577904|FG001|Period 1 (Phase 1)|Reason not specified|1|||
164328279|NCT00473746|593577905|FG002|Period 1 (Phase 1)|Reason not specified|0|||
164328280|NCT00473746|593577906|FG003|Period 1 (Phase 1)|Reason not specified|0|||
164328281|NCT00473746|593577907|FG004|Period 1 (Phase 1)|Reason not specified|0|||
164328282|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Adverse Event|0|||
164328283|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Adverse Event|0|||
164328284|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Adverse Event|0|||
164328285|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Adverse Event|0|||
164328286|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Adverse Event|3|||
164328287|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Death|0|||
164328288|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Death|0|||
164328289|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Death|0|||
164328290|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Death|0|||
164328291|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Death|1|||
164328292|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
164328293|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
164328294|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
164328295|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
164328296|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
164328297|NCT00473746|593577903|FG000|Period 2 (Phase 2)|Reason not specified|0|||
164328298|NCT00473746|593577904|FG001|Period 2 (Phase 2)|Reason not specified|0|||
164328299|NCT00473746|593577905|FG002|Period 2 (Phase 2)|Reason not specified|0|||
164328300|NCT00473746|593577906|FG003|Period 2 (Phase 2)|Reason not specified|0|||
164328301|NCT00473746|593577907|FG004|Period 2 (Phase 2)|Reason not specified|3|||
164328302|NCT01017575|593577910|FG000|Overall Study|Lack of Efficacy|0|||
164078680|NCT02008721|592653821|FG001|Overall Study|Withdrawal by Subject|1|||
164328303|NCT01017575|593577911|FG001|Overall Study|Lack of Efficacy|1|||
164328304|NCT01017575|593577912|FG002|Overall Study|Lack of Efficacy|0|||
164328305|NCT01017575|593577913|FG003|Overall Study|Lack of Efficacy|1|||
164328306|NCT01017575|593577914|FG004|Overall Study|Lack of Efficacy|1|||
164328307|NCT01017575|593577910|FG000|Overall Study|Adverse Event|0|||
164328308|NCT01017575|593577911|FG001|Overall Study|Adverse Event|1|||
164328309|NCT01017575|593577912|FG002|Overall Study|Adverse Event|0|||
164328310|NCT01017575|593577913|FG003|Overall Study|Adverse Event|0|||
164328311|NCT01017575|593577914|FG004|Overall Study|Adverse Event|2|||
164328312|NCT01017575|593577910|FG000|Overall Study|Withdrawal by Subject|1|||
164328313|NCT01017575|593577911|FG001|Overall Study|Withdrawal by Subject|0|||
164328314|NCT01017575|593577912|FG002|Overall Study|Withdrawal by Subject|0|||
164328315|NCT01017575|593577913|FG003|Overall Study|Withdrawal by Subject|0|||
164328316|NCT01017575|593577914|FG004|Overall Study|Withdrawal by Subject|0|||
164328317|NCT01962922|593577915|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
164328318|NCT01962922|593577916|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
164328319|NCT01962922|593577915|FG000|PK Portion Day 7|non-compliance|1|||
163877532|NCT05368558|591919058|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877533|NCT05368558|591919059|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877534|NCT05368558|591919060|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
163877535|NCT05368558|591919061|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877536|NCT05368558|591919062|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
163877537|NCT05368558|591919063|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877538|NCT05368558|591919064|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877539|NCT05368558|591919065|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877540|NCT05368558|591919066|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877541|NCT05368558|591919067|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877542|NCT05368558|591919068|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
163877543|NCT05368558|591919057|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877544|NCT05368558|591919058|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877545|NCT05368558|591919059|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877546|NCT05368558|591919060|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
163877547|NCT05368558|591919061|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877548|NCT05368558|591919062|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877549|NCT05368558|591919063|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877550|NCT05368558|591919064|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877551|NCT05368558|591919065|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877552|NCT05368558|591919066|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877553|NCT05368558|591919067|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877554|NCT05368558|591919068|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
163877555|NCT05368558|591919057|FG000|Blinded Extension Period (BEP)|other|0|||
163877556|NCT05368558|591919058|FG001|Blinded Extension Period (BEP)|other|0|||
163877557|NCT05368558|591919059|FG002|Blinded Extension Period (BEP)|other|0|||
163877558|NCT05368558|591919060|FG003|Blinded Extension Period (BEP)|other|0|||
163877559|NCT05368558|591919061|FG004|Blinded Extension Period (BEP)|other|0|||
163877560|NCT05368558|591919062|FG005|Blinded Extension Period (BEP)|other|1|||
163877561|NCT05368558|591919063|FG006|Blinded Extension Period (BEP)|other|0|||
163877562|NCT05368558|591919064|FG007|Blinded Extension Period (BEP)|other|0|||
163877563|NCT05368558|591919065|FG008|Blinded Extension Period (BEP)|other|0|||
163877564|NCT05368558|591919066|FG009|Blinded Extension Period (BEP)|other|0|||
163877565|NCT05368558|591919067|FG010|Blinded Extension Period (BEP)|other|0|||
163877566|NCT05368558|591919068|FG011|Blinded Extension Period (BEP)|other|0|||
163877567|NCT01303445|591919069|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
163981633|NCT03829657|592302797|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
163981634|NCT03829657|592302798|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
163981635|NCT03829657|592302794|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
163981636|NCT03829657|592302795|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
163981637|NCT03829657|592302796|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
163981638|NCT03829657|592302797|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163981639|NCT03829657|592302798|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
163981640|NCT03829657|592302794|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
163981641|NCT03829657|592302795|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
163981642|NCT03829657|592302796|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
163981643|NCT03829657|592302797|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
163981644|NCT03829657|592302798|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
163981645|NCT03829657|592302794|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
163981646|NCT03829657|592302795|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
163981647|NCT03829657|592302796|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
163981648|NCT03829657|592302797|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
163981649|NCT03829657|592302798|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
163981650|NCT03829657|592302794|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163981651|NCT03829657|592302795|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163981652|NCT03829657|592302796|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163981653|NCT03829657|592302797|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
163981654|NCT03829657|592302798|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
163981655|NCT03829657|592302794|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
163981656|NCT03829657|592302795|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
163981657|NCT03829657|592302796|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
163981658|NCT03829657|592302797|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
163981659|NCT03829657|592302798|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
163981660|NCT03829657|592302794|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
164218598|NCT00397930|593168399|FG000|Overall Study|Missing data|0|||
164218599|NCT00397930|593168400|FG001|Overall Study|Missing data|4|||
164328320|NCT01962922|593577916|FG001|PK Portion Day 7|non-compliance|0|||
164328321|NCT01962922|593577915|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
164328322|NCT01962922|593577916|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
164328323|NCT01962922|593577915|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
164328324|NCT01962922|593577916|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
164328325|NCT00976573|593577924|FG000|Overall Study|Ineligible|0|||
164328326|NCT00976573|593577925|FG001|Overall Study|Ineligible|1|||
164328327|NCT00976573|593577924|FG000|Overall Study|Cancel prior to receiving treatment|4|||
164328328|NCT00976573|593577925|FG001|Overall Study|Cancel prior to receiving treatment|2|||
164328329|NCT02730208|593577926|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164328330|NCT02730208|593577927|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
164328331|NCT00995865|593577932|FG000|Overall Study|Protocol Violation|2|||
164078681|NCT02008721|592653820|FG000|Overall Study|Death|4|||
164078682|NCT02008721|592653821|FG001|Overall Study|Death|2|||
164078683|NCT02008721|592653820|FG000|Overall Study|Adverse Event|3|||
164078684|NCT02008721|592653821|FG001|Overall Study|Adverse Event|5|||
164078685|NCT02008721|592653820|FG000|Overall Study|Protocol Violation|3|||
164078686|NCT02008721|592653821|FG001|Overall Study|Protocol Violation|2|||
164078687|NCT00295854|592653824|FG000|Overall Study|Adverse Event|7|||
164218600|NCT01158404|593168401|FG000|Overall Study|Withdrawal by Subject|0|||
164218601|NCT01158404|593168402|FG001|Overall Study|Withdrawal by Subject|1|||
164218602|NCT01158404|593168403|FG002|Overall Study|Withdrawal by Subject|0|||
164218603|NCT01158404|593168404|FG003|Overall Study|Withdrawal by Subject|0|||
164218604|NCT01158404|593168405|FG004|Overall Study|Withdrawal by Subject|3|||
164218605|NCT01158404|593168406|FG005|Overall Study|Withdrawal by Subject|1|||
164218606|NCT01158404|593168407|FG006|Overall Study|Withdrawal by Subject|0|||
164218607|NCT01158404|593168408|FG007|Overall Study|Withdrawal by Subject|1|||
164218608|NCT01158404|593168401|FG000|Overall Study|Physician Decision|0|||
164218609|NCT01158404|593168402|FG001|Overall Study|Physician Decision|0|||
164218610|NCT01158404|593168403|FG002|Overall Study|Physician Decision|0|||
164218611|NCT01158404|593168404|FG003|Overall Study|Physician Decision|0|||
164218612|NCT01158404|593168405|FG004|Overall Study|Physician Decision|0|||
164218613|NCT01158404|593168406|FG005|Overall Study|Physician Decision|0|||
164218614|NCT01158404|593168407|FG006|Overall Study|Physician Decision|0|||
164218615|NCT01158404|593168408|FG007|Overall Study|Physician Decision|1|||
164218616|NCT01158404|593168401|FG000|Overall Study|Progressive Disease|0|||
164218617|NCT01158404|593168402|FG001|Overall Study|Progressive Disease|0|||
164218618|NCT01158404|593168403|FG002|Overall Study|Progressive Disease|0|||
164218619|NCT01158404|593168404|FG003|Overall Study|Progressive Disease|0|||
164218620|NCT01158404|593168405|FG004|Overall Study|Progressive Disease|0|||
164218621|NCT01158404|593168406|FG005|Overall Study|Progressive Disease|0|||
164218622|NCT01158404|593168407|FG006|Overall Study|Progressive Disease|1|||
164218623|NCT01158404|593168408|FG007|Overall Study|Progressive Disease|0|||
164218624|NCT02056288|593168409|FG000|In-Hospital Data|Surgery cancelled|1|||
164218625|NCT02056288|593168410|FG001|In-Hospital Data|Surgery cancelled|0|||
164218626|NCT02056288|593168409|FG000|In-Hospital Data|Protocol Violation|3|||
164218627|NCT02056288|593168410|FG001|In-Hospital Data|Protocol Violation|0|||
164218628|NCT02056288|593168409|FG000|In-Hospital Data|Physician Decision|1|||
164218629|NCT02056288|593168410|FG001|In-Hospital Data|Physician Decision|0|||
164218630|NCT02056288|593168409|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
164218631|NCT02056288|593168410|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
164218632|NCT02384460|593168413|FG000|Overall Study|Protocol Violation|0|||
164218633|NCT02384460|593168414|FG001|Overall Study|Protocol Violation|1|||
164218634|NCT02384460|593168413|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
164218635|NCT02384460|593168414|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
164218636|NCT02384460|593168413|FG000|Overall Study|Adverse Event|5|||
164218637|NCT02384460|593168414|FG001|Overall Study|Adverse Event|2|||
164218638|NCT02384460|593168413|FG000|Overall Study|Withdrawal by Subject|0|||
164218639|NCT02384460|593168414|FG001|Overall Study|Withdrawal by Subject|3|||
164218640|NCT02384460|593168413|FG000|Overall Study|Elective medical treatment|1|||
164218641|NCT02384460|593168414|FG001|Overall Study|Elective medical treatment|0|||
164218642|NCT02384460|593168413|FG000|Overall Study|Non-compliance|1|||
164218643|NCT02384460|593168414|FG001|Overall Study|Non-compliance|0|||
164218644|NCT02400580|593168415|FG000|Overall Study|Withdrawal by Subject|1|||
164218645|NCT02400580|593168416|FG001|Overall Study|Withdrawal by Subject|1|||
164218646|NCT02400580|593168415|FG000|Overall Study|Adverse Event|1|||
164218647|NCT02400580|593168416|FG001|Overall Study|Adverse Event|0|||
164218648|NCT00965094|593168419|FG000|Overall Study|Adverse Event|5|||
164218649|NCT00965094|593168420|FG001|Overall Study|Adverse Event|0|||
164218650|NCT00965094|593168419|FG000|Overall Study|Lost to Follow-up|0|||
164218651|NCT00965094|593168420|FG001|Overall Study|Lost to Follow-up|1|||
164218652|NCT01060111|593168421|FG000|Overall Study|Adverse Event|9|||
164328332|NCT00995865|593577933|FG001|Overall Study|Protocol Violation|0|||
164328333|NCT00995865|593577934|FG002|Overall Study|Protocol Violation|0|||
164078688|NCT00295854|592653825|FG001|Overall Study|Adverse Event|7|||
164078689|NCT00295854|592653826|FG002|Overall Study|Adverse Event|6|||
164078690|NCT00295854|592653824|FG000|Overall Study|Protocol Violation|1|||
164078691|NCT00295854|592653825|FG001|Overall Study|Protocol Violation|1|||
164078692|NCT00295854|592653826|FG002|Overall Study|Protocol Violation|1|||
164078693|NCT00295854|592653824|FG000|Overall Study|Lost to Follow-up|2|||
164078694|NCT00295854|592653825|FG001|Overall Study|Lost to Follow-up|0|||
164078695|NCT00295854|592653826|FG002|Overall Study|Lost to Follow-up|1|||
164078696|NCT00295854|592653824|FG000|Overall Study|Withdrawal by Subject|3|||
164078697|NCT00295854|592653825|FG001|Overall Study|Withdrawal by Subject|7|||
164078698|NCT00295854|592653826|FG002|Overall Study|Withdrawal by Subject|4|||
164078699|NCT00295854|592653824|FG000|Overall Study|did not continue to meet criteria|1|||
164078700|NCT00295854|592653825|FG001|Overall Study|did not continue to meet criteria|1|||
164078701|NCT00295854|592653826|FG002|Overall Study|did not continue to meet criteria|2|||
164078702|NCT00295854|592653824|FG000|Overall Study|required a prohibited medication|1|||
164078703|NCT00295854|592653825|FG001|Overall Study|required a prohibited medication|0|||
164078704|NCT00295854|592653826|FG002|Overall Study|required a prohibited medication|0|||
164078705|NCT00295854|592653824|FG000|Overall Study|Other|3|||
164078706|NCT00295854|592653825|FG001|Overall Study|Other|5|||
164078707|NCT00295854|592653826|FG002|Overall Study|Other|1|||
164078708|NCT01967888|592653830|FG000|Overall Study|Lost to Follow-up|6|||
164078709|NCT01967888|592653831|FG001|Overall Study|Lost to Follow-up|4|||
164078710|NCT01967888|592653830|FG000|Overall Study|Withdrawal by Subject|1|||
164078711|NCT01967888|592653831|FG001|Overall Study|Withdrawal by Subject|1|||
164078712|NCT01967888|592653830|FG000|Overall Study|Did Not Have Transplant|1|||
164078713|NCT01967888|592653831|FG001|Overall Study|Did Not Have Transplant|0|||
164078714|NCT01967888|592653830|FG000|Overall Study|Research visit not done, data recorded|1|||
164078715|NCT01967888|592653831|FG001|Overall Study|Research visit not done, data recorded|0|||
164078716|NCT01967888|592653830|FG000|Overall Study|Subject excluded after randomization|1|||
164078717|NCT01967888|592653831|FG001|Overall Study|Subject excluded after randomization|0|||
164078718|NCT01967888|592653830|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
164078719|NCT01967888|592653831|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
163877568|NCT01303445|591919070|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
163877569|NCT01303445|591919069|FG000|Second Intervention (7 Days)|Adverse Event|0|||
163877570|NCT01303445|591919070|FG001|Second Intervention (7 Days)|Adverse Event|2|||
163877571|NCT01303445|591919069|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
163877572|NCT01303445|591919070|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
163877573|NCT01303445|591919069|FG000|Washout (14 Days)|Protocol Violation|1|||
163877574|NCT01303445|591919070|FG001|Washout (14 Days)|Protocol Violation|0|||
163877575|NCT01303445|591919069|FG000|Washout (14 Days)|Lost to Follow-up|0|||
163877576|NCT01303445|591919070|FG001|Washout (14 Days)|Lost to Follow-up|2|||
163877577|NCT01303445|591919069|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
163877578|NCT01303445|591919070|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
163877579|NCT01303445|591919069|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
163877580|NCT01303445|591919070|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
163877581|NCT05094141|591919074|FG000|Overall Study|Death|0|||
163877582|NCT05094141|591919075|FG001|Overall Study|Death|0|||
163877583|NCT05094141|591919076|FG002|Overall Study|Death|1|||
163877584|NCT05094141|591919074|FG000|Overall Study|Withdrawal by Subject|0|||
163877585|NCT05094141|591919075|FG001|Overall Study|Withdrawal by Subject|0|||
163877586|NCT05094141|591919076|FG002|Overall Study|Withdrawal by Subject|1|||
163877587|NCT05094141|591919074|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
163877588|NCT05094141|591919075|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
163877589|NCT05094141|591919076|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
163877590|NCT05094141|591919074|FG000|Overall Study|Did not participate in randomization|0|||
163877591|NCT05094141|591919075|FG001|Overall Study|Did not participate in randomization|0|||
163877592|NCT05094141|591919076|FG002|Overall Study|Did not participate in randomization|33|||
163877593|NCT05134337|591921056|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
163877594|NCT05134337|591921057|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
163877595|NCT04923347|591921058|FG000|Overall Study|Withdrawal by Subject|14|||
163877596|NCT03683069|591921062|FG000|Overall Study|see limitations|12|||
163877597|NCT03683069|591921063|FG001|Overall Study|see limitations|13|||
163877598|NCT02605837|591921065|FG000|Overall Study|Adverse Event|3|||
163877599|NCT02605837|591921066|FG001|Overall Study|Adverse Event|1|||
163877600|NCT02605837|591921065|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163877601|NCT02605837|591921066|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164218653|NCT01060111|593168422|FG001|Overall Study|Adverse Event|5|||
163877602|NCT02605837|591921065|FG000|Overall Study|Withdrawal by Subject|8|||
163877603|NCT02605837|591921066|FG001|Overall Study|Withdrawal by Subject|8|||
163877604|NCT02605837|591921065|FG000|Overall Study|Physician Decision|0|||
163877605|NCT02605837|591921066|FG001|Overall Study|Physician Decision|1|||
163877606|NCT05104697|591921067|FG000|Overall Study|Withdrawal by Subject|0|||
164078720|NCT01967888|592653830|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
164078721|NCT01967888|592653831|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
164078722|NCT03175120|592653835|FG000|Overall Study|Adverse Event|2|||
164078723|NCT03175120|592653836|FG001|Overall Study|Adverse Event|2|||
164078724|NCT03175120|592653835|FG000|Overall Study|Protocol Violation|5|||
164078725|NCT03175120|592653836|FG001|Overall Study|Protocol Violation|2|||
164078726|NCT03175120|592653835|FG000|Overall Study|Lost to Follow-up|1|||
164078727|NCT03175120|592653836|FG001|Overall Study|Lost to Follow-up|0|||
164078728|NCT03175120|592653835|FG000|Overall Study|Withdrawal by Subject|2|||
164078729|NCT03175120|592653836|FG001|Overall Study|Withdrawal by Subject|5|||
164078730|NCT03175120|592653835|FG000|Overall Study|Other|2|||
164078731|NCT03175120|592653836|FG001|Overall Study|Other|3|||
164078732|NCT04120194|592653837|FG000|Overall Study|Lost to Follow-up|11|||
164078733|NCT04120194|592653838|FG001|Overall Study|Lost to Follow-up|8|||
164218654|NCT01060111|593168423|FG002|Overall Study|Adverse Event|18|||
164218655|NCT01060111|593168421|FG000|Overall Study|Lack of Efficacy|2|||
164218656|NCT01060111|593168422|FG001|Overall Study|Lack of Efficacy|1|||
163877607|NCT05104697|591921068|FG001|Overall Study|Withdrawal by Subject|1|||
164078734|NCT04120194|592653837|FG000|Overall Study|Adverse Event|4|||
163877608|NCT03845465|591921069|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
163877609|NCT03845465|591921070|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
163877610|NCT03845465|591921069|FG000|6-month Data Collection|Withdrawal by Subject|0|||
163877611|NCT03845465|591921070|FG001|6-month Data Collection|Withdrawal by Subject|2|||
163877612|NCT03845465|591921069|FG000|12-month Data Collection|Withdrawal by Subject|0|||
163877613|NCT03845465|591921070|FG001|12-month Data Collection|Withdrawal by Subject|2|||
163877614|NCT03913195|591921071|FG000|Overall Study|Adverse Event|0|||
163877615|NCT03913195|591921072|FG001|Overall Study|Adverse Event|0|||
163877616|NCT03913195|591921073|FG002|Overall Study|Adverse Event|1|||
163877617|NCT03913195|591921074|FG003|Overall Study|Adverse Event|1|||
163877618|NCT03913195|591921075|FG004|Overall Study|Adverse Event|0|||
163877619|NCT03913195|591921071|FG000|Overall Study|Withdrawal by Subject|0|||
163877620|NCT03913195|591921072|FG001|Overall Study|Withdrawal by Subject|0|||
163877621|NCT03913195|591921073|FG002|Overall Study|Withdrawal by Subject|1|||
163877622|NCT03913195|591921074|FG003|Overall Study|Withdrawal by Subject|0|||
163877623|NCT03913195|591921075|FG004|Overall Study|Withdrawal by Subject|1|||
163877624|NCT03913195|591921071|FG000|Overall Study|non adherence to study|0|||
163877625|NCT03913195|591921072|FG001|Overall Study|non adherence to study|0|||
163877626|NCT03913195|591921073|FG002|Overall Study|non adherence to study|1|||
163877627|NCT03913195|591921074|FG003|Overall Study|non adherence to study|0|||
163877628|NCT03913195|591921075|FG004|Overall Study|non adherence to study|0|||
163877629|NCT03899961|591921076|FG000|Overall Study|-delivery prior to|2|||
163877630|NCT03899961|591921077|FG001|Overall Study|-delivery prior to|7|||
163877631|NCT03899961|591921076|FG000|Overall Study|req general anesth|1|||
163877632|NCT03899961|591921077|FG001|Overall Study|req general anesth|2|||
163877633|NCT03899961|591921076|FG000|Overall Study|capacity|5|||
163877634|NCT03899961|591921077|FG001|Overall Study|capacity|6|||
163877635|NCT03899961|591921076|FG000|Overall Study|Withdrawal by Subject|1|||
163877636|NCT03899961|591921077|FG001|Overall Study|Withdrawal by Subject|1|||
163877637|NCT05107401|591921078|FG000|Overall Study|Lost to Follow-up|13|||
163877638|NCT05107401|591921079|FG001|Overall Study|Lost to Follow-up|12|||
163877639|NCT02349412|591921080|FG000|Overall Study|Withdrawal by Subject|7|||
163877640|NCT02349412|591921081|FG001|Overall Study|Withdrawal by Subject|7|||
163877641|NCT04093362|591921086|FG000|Overall Study|Study Termination|1|||
163877642|NCT04093362|591921087|FG001|Overall Study|Study Termination|1|||
163877643|NCT04093362|591921086|FG000|Overall Study|Withdrawal of Consent|1|||
163877644|NCT04093362|591921087|FG001|Overall Study|Withdrawal of Consent|0|||
163877645|NCT04093362|591921086|FG000|Overall Study|Death|1|||
163877646|NCT04093362|591921087|FG001|Overall Study|Death|3|||
163877647|NCT04093362|591921086|FG000|Overall Study|Reason not Specified|1|||
163877648|NCT04093362|591921087|FG001|Overall Study|Reason not Specified|2|||
163877649|NCT03055377|591921099|FG000|Treatment Phase|Lost to Follow-up|28|||
163877650|NCT03055377|591921100|FG001|Treatment Phase|Lost to Follow-up|24|||
163877651|NCT03055377|591921099|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
163877652|NCT03055377|591921100|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
163877653|NCT05952076|591921101|FG000|Overall Study|Death|1|||
163877654|NCT05952076|591921102|FG001|Overall Study|Death|1|||
163877655|NCT05952076|591921101|FG000|Overall Study|Lost to Follow-up|0|||
163877656|NCT05952076|591921102|FG001|Overall Study|Lost to Follow-up|1|||
163877657|NCT04143061|591921103|FG000|Overall Study|Protocol Deviation|0|||
163877658|NCT04143061|591921104|FG001|Overall Study|Protocol Deviation|0|||
163877659|NCT04143061|591921105|FG002|Overall Study|Protocol Deviation|0|||
164218657|NCT01060111|593168423|FG002|Overall Study|Lack of Efficacy|0|||
163877660|NCT04143061|591921106|FG003|Overall Study|Protocol Deviation|0|||
163877661|NCT04143061|591921107|FG004|Overall Study|Protocol Deviation|0|||
163877662|NCT04143061|591921108|FG005|Overall Study|Protocol Deviation|0|||
163877663|NCT04143061|591921109|FG006|Overall Study|Protocol Deviation|5|||
164078735|NCT04120194|592653838|FG001|Overall Study|Adverse Event|5|||
164078736|NCT04120194|592653837|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
164078737|NCT04120194|592653838|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
164078738|NCT04120194|592653837|FG000|Overall Study|Miscellaneous|4|||
164328334|NCT00995865|593577932|FG000|Overall Study|Lost to Follow-up|0|||
164328335|NCT00995865|593577933|FG001|Overall Study|Lost to Follow-up|0|||
164328336|NCT00995865|593577934|FG002|Overall Study|Lost to Follow-up|1|||
164328337|NCT02021656|593577940|FG000|Overall Study|Adverse Event|1|||
164328338|NCT02021656|593577940|FG000|Overall Study|Lack of Efficacy|2|||
164328339|NCT02021656|593577940|FG000|Overall Study|Lost to Follow-up|1|||
164328340|NCT02021656|593577940|FG000|Overall Study|Withdrew Consent|2|||
164328341|NCT00596362|593577950|FG000|Overall Study|Progressive Disease|1|||
164328342|NCT00817479|593577951|FG000|Overall Study|Physician Decision|1|||
164218658|NCT01060111|593168421|FG000|Overall Study|Inappropriate participant|5|||
164218659|NCT01060111|593168422|FG001|Overall Study|Inappropriate participant|4|||
164218660|NCT01060111|593168423|FG002|Overall Study|Inappropriate participant|5|||
164218661|NCT01060111|593168421|FG000|Overall Study|Participants' evasion for hospital visit|0|||
164218662|NCT01060111|593168422|FG001|Overall Study|Participants' evasion for hospital visit|3|||
164218663|NCT01060111|593168423|FG002|Overall Study|Participants' evasion for hospital visit|2|||
164218664|NCT01060111|593168421|FG000|Overall Study|Participants' non-cooperation|8|||
164218665|NCT01060111|593168422|FG001|Overall Study|Participants' non-cooperation|6|||
164328343|NCT00817479|593577952|FG001|Overall Study|Physician Decision|1|||
164328344|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328345|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328346|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328347|NCT05985980|593577955|FG000|Overall Study|Withdrawal by Subject|1|||
164328348|NCT00523367|593577956|FG000|Overall Study|19 screen failures|19|||
164328349|NCT00523367|593577956|FG000|Overall Study|4 Withdrawn by PI|4|||
164328350|NCT02793128|593577957|FG000|Overall Study|Death|4|||
164328351|NCT02793128|593577957|FG000|Overall Study|Withdrawal by Subject|2|||
164328352|NCT02793128|593577957|FG000|Overall Study|Physician Decision|1|||
164328353|NCT02793128|593577957|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
164328354|NCT02793128|593577957|FG000|Overall Study|Patient elected nephroureterectomy|1|||
164328355|NCT00055471|593577961|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
164328356|NCT00055471|593577962|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
164328357|NCT00055471|593577963|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
164328358|NCT00055471|593577961|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
164328359|NCT00055471|593577962|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
164328360|NCT00055471|593577963|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
164328361|NCT00055471|593577961|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
164328362|NCT00055471|593577962|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
164328363|NCT00055471|593577963|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
164328364|NCT01854944|593577964|FG000|Overall Study|Withdrawal by Subject|0|||
164328365|NCT01854944|593577965|FG001|Overall Study|Withdrawal by Subject|0|||
164328366|NCT01854944|593577966|FG002|Overall Study|Withdrawal by Subject|1|||
164328367|NCT00282347|593577969|FG000|Treatment Period|Death|2|||
164328368|NCT00282347|593577970|FG001|Treatment Period|Death|0|||
164328369|NCT00282347|593577969|FG000|Treatment Period|Lost to Follow-up|2|||
164328370|NCT00282347|593577970|FG001|Treatment Period|Lost to Follow-up|5|||
164328371|NCT00282347|593577969|FG000|Treatment Period|Withdrawal by Subject|1|||
164328372|NCT00282347|593577970|FG001|Treatment Period|Withdrawal by Subject|3|||
164328373|NCT00282347|593577969|FG000|Treatment Period|Physician Decision|0|||
164328374|NCT00282347|593577970|FG001|Treatment Period|Physician Decision|1|||
164328375|NCT00282347|593577969|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
164328376|NCT00282347|593577970|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
164328377|NCT00282347|593577969|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
164328378|NCT00282347|593577970|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
164328379|NCT00282347|593577969|FG000|Safety Follow-up Period|Physician Decision|1|||
164328380|NCT00282347|593577970|FG001|Safety Follow-up Period|Physician Decision|1|||
164328381|NCT00282347|593577969|FG000|Safety Follow-up Period|Protocol Deviation|0|||
164328382|NCT00282347|593577970|FG001|Safety Follow-up Period|Protocol Deviation|2|||
164078739|NCT04120194|592653838|FG001|Overall Study|Miscellaneous|5|||
164078740|NCT02622074|592653839|FG000|Overall Study|Death|4|||
164078741|NCT02622074|592653840|FG001|Overall Study|Death|0|||
164218666|NCT01060111|593168423|FG002|Overall Study|Participants' non-cooperation|6|||
164218667|NCT01060111|593168421|FG000|Overall Study|Adverse event and insufficient effect|0|||
164218668|NCT01060111|593168422|FG001|Overall Study|Adverse event and insufficient effect|1|||
164328383|NCT00282347|593577969|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
164328384|NCT00282347|593577970|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
164328385|NCT00282347|593577969|FG000|B Cell Follow-up Period|Physician Decision|1|||
164078742|NCT02622074|592653841|FG002|Overall Study|Death|0|||
163877664|NCT04143061|591921110|FG007|Overall Study|Protocol Deviation|5|||
164218669|NCT01060111|593168423|FG002|Overall Study|Adverse event and insufficient effect|0|||
164328386|NCT00282347|593577970|FG001|B Cell Follow-up Period|Physician Decision|0|||
164328387|NCT00282347|593577969|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
164078743|NCT02622074|592653842|FG003|Overall Study|Death|1|||
164078744|NCT02622074|592653843|FG004|Overall Study|Death|1|||
163877665|NCT04143061|591921103|FG000|Overall Study|Withdrawal by Subject|2|||
163877666|NCT04143061|591921104|FG001|Overall Study|Withdrawal by Subject|0|||
163877667|NCT04143061|591921105|FG002|Overall Study|Withdrawal by Subject|0|||
163877668|NCT04143061|591921106|FG003|Overall Study|Withdrawal by Subject|0|||
163877669|NCT04143061|591921107|FG004|Overall Study|Withdrawal by Subject|0|||
163877670|NCT04143061|591921108|FG005|Overall Study|Withdrawal by Subject|1|||
163877671|NCT04143061|591921109|FG006|Overall Study|Withdrawal by Subject|0|||
163877672|NCT04143061|591921110|FG007|Overall Study|Withdrawal by Subject|0|||
163877673|NCT04143061|591921103|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163877674|NCT04143061|591921104|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163877675|NCT04143061|591921105|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163981661|NCT03829657|592302795|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
163981662|NCT03829657|592302796|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
163981663|NCT03829657|592302797|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
163981664|NCT03829657|592302798|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
163981665|NCT03829657|592302794|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163981666|NCT03829657|592302795|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163981667|NCT03829657|592302796|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163981668|NCT03829657|592302797|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
163981669|NCT03829657|592302798|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
163981670|NCT03368170|592304448|FG000|Overall Study|Adverse Event|2|||
163981671|NCT03368170|592304449|FG001|Overall Study|Adverse Event|1|||
163981672|NCT03445000|592304452|FG000|Overall Study|Disease progression|8|||
163981673|NCT03445000|592304452|FG000|Overall Study|Adverse Event|3|||
163981674|NCT03445000|592304452|FG000|Overall Study|Death|2|||
163981675|NCT03445000|592304452|FG000|Overall Study|Physician Decision|1|||
163981676|NCT02605642|592304453|FG000|Overall Study|Other|11|||
163981677|NCT02605642|592304454|FG001|Overall Study|Other|1|||
163981678|NCT02605642|592304453|FG000|Overall Study|Participant non-compliance|2|||
163981679|NCT02605642|592304454|FG001|Overall Study|Participant non-compliance|4|||
163981680|NCT02605642|592304453|FG000|Overall Study|Physician Decision|10|||
163981681|NCT02605642|592304454|FG001|Overall Study|Physician Decision|0|||
163981682|NCT02605642|592304453|FG000|Overall Study|Lost to Follow-up|12|||
163981683|NCT02605642|592304454|FG001|Overall Study|Lost to Follow-up|1|||
163981684|NCT02605642|592304453|FG000|Overall Study|Adverse Event|14|||
163981685|NCT02605642|592304454|FG001|Overall Study|Adverse Event|2|||
163981686|NCT02605642|592304453|FG000|Overall Study|Withdrawal by Subject|23|||
163981687|NCT02605642|592304454|FG001|Overall Study|Withdrawal by Subject|2|||
163981688|NCT02605642|592304453|FG000|Overall Study|Lack of response|24|||
163981689|NCT02605642|592304454|FG001|Overall Study|Lack of response|11|||
163981690|NCT02111564|592304457|FG000|Overall Study|Death|109|||
163981691|NCT02111564|592304458|FG001|Overall Study|Death|120|||
163981692|NCT02111564|592304457|FG000|Overall Study|Lost to Follow-up|2|||
163981693|NCT02111564|592304458|FG001|Overall Study|Lost to Follow-up|3|||
163981694|NCT02111564|592304457|FG000|Overall Study|Withdrawal by Subject|20|||
163981695|NCT02111564|592304458|FG001|Overall Study|Withdrawal by Subject|20|||
163981696|NCT00687362|592304459|FG000|Overall Study|Protocol Violation|2|||
163981697|NCT00687362|592304459|FG000|Overall Study|Withdrawal by Subject|1|||
163981698|NCT03704194|592304469|FG000|Overall Study|Withdrawal by Subject|0|||
163981699|NCT03704194|592304470|FG001|Overall Study|Withdrawal by Subject|1|||
163981700|NCT00925015|592304471|FG000|Overall Study|Adverse Event|1|||
163981701|NCT00925015|592304472|FG001|Overall Study|Adverse Event|2|||
163981702|NCT00925015|592304473|FG002|Overall Study|Adverse Event|1|||
163981703|NCT00925015|592304471|FG000|Overall Study|Physician Decision|0|||
163981704|NCT00925015|592304472|FG001|Overall Study|Physician Decision|1|||
163981705|NCT00925015|592304473|FG002|Overall Study|Physician Decision|0|||
163981706|NCT00925015|592304471|FG000|Overall Study|Progressive Disease|7|||
163981707|NCT00925015|592304472|FG001|Overall Study|Progressive Disease|3|||
163981708|NCT00925015|592304473|FG002|Overall Study|Progressive Disease|4|||
163981709|NCT00925015|592304471|FG000|Overall Study|Withdrawal by Subject|0|||
163981710|NCT00925015|592304472|FG001|Overall Study|Withdrawal by Subject|0|||
163981711|NCT00925015|592304473|FG002|Overall Study|Withdrawal by Subject|1|||
163981712|NCT04986202|592304476|FG000|Overall Study|Death|10|||
163981713|NCT04986202|592304477|FG001|Overall Study|Death|3|||
163981714|NCT04986202|592304478|FG002|Overall Study|Death|10|||
163981715|NCT04986202|592304476|FG000|Overall Study|Physician Decision|3|||
163981716|NCT04986202|592304477|FG001|Overall Study|Physician Decision|1|||
163981717|NCT04986202|592304478|FG002|Overall Study|Physician Decision|2|||
163981718|NCT04986202|592304476|FG000|Overall Study|Withdrawal by Subject|4|||
163981719|NCT04986202|592304477|FG001|Overall Study|Withdrawal by Subject|2|||
163981720|NCT04986202|592304478|FG002|Overall Study|Withdrawal by Subject|4|||
163981721|NCT03806127|592304484|FG000|Overall Study|Withdrawal by Subject|4|||
163981722|NCT03806127|592304485|FG001|Overall Study|Withdrawal by Subject|5|||
163981723|NCT03806127|592304484|FG000|Overall Study|Protocol Violation|3|||
163981724|NCT03806127|592304485|FG001|Overall Study|Protocol Violation|1|||
163981725|NCT03806127|592304484|FG000|Overall Study|Adverse Event|3|||
163981726|NCT03806127|592304485|FG001|Overall Study|Adverse Event|0|||
164078745|NCT02622074|592653844|FG005|Overall Study|Death|0|||
164078746|NCT02622074|592653839|FG000|Overall Study|Withdrawal by Subject|0|||
164078747|NCT02622074|592653840|FG001|Overall Study|Withdrawal by Subject|1|||
164078748|NCT02622074|592653841|FG002|Overall Study|Withdrawal by Subject|0|||
164078749|NCT02622074|592653842|FG003|Overall Study|Withdrawal by Subject|0|||
164078750|NCT02622074|592653843|FG004|Overall Study|Withdrawal by Subject|0|||
164078751|NCT02622074|592653844|FG005|Overall Study|Withdrawal by Subject|0|||
164078752|NCT02114931|592653845|FG000|Overall Study|Withdrawal by Subject|15|||
164078753|NCT02114931|592653846|FG001|Overall Study|Withdrawal by Subject|18|||
164078754|NCT02114931|592653845|FG000|Overall Study|Adverse Event|4|||
164078755|NCT02114931|592653846|FG001|Overall Study|Adverse Event|6|||
164078756|NCT02114931|592653845|FG000|Overall Study|Lost to Follow-up|3|||
164078757|NCT02114931|592653846|FG001|Overall Study|Lost to Follow-up|3|||
164078758|NCT02114931|592653845|FG000|Overall Study|Physician Decision|1|||
164078759|NCT02114931|592653846|FG001|Overall Study|Physician Decision|2|||
164078760|NCT02114931|592653845|FG000|Overall Study|Other|2|||
164078761|NCT02114931|592653846|FG001|Overall Study|Other|1|||
164078762|NCT03565211|592653850|FG000|Overall Study|Withdrawal by Subject|2|||
164078763|NCT03565211|592653850|FG000|Overall Study|Lost to Follow-up|1|||
164078764|NCT03565211|592653850|FG000|Overall Study|Adverse Event|44|||
164078765|NCT03565211|592653850|FG000|Overall Study|Personal issues|1|||
164078766|NCT00986154|592653851|FG000|Overall Study|Death|136|||
164078767|NCT00986154|592653852|FG001|Overall Study|Death|127|||
164078768|NCT00986154|592653851|FG000|Overall Study|Lost to Follow-up|7|||
164078769|NCT00986154|592653852|FG001|Overall Study|Lost to Follow-up|4|||
164078770|NCT00986154|592653851|FG000|Overall Study|Withdrawal by Subject|32|||
164218670|NCT01060111|593168421|FG000|Overall Study|Participants' non-cooperation|1|||
164218671|NCT01060111|593168422|FG001|Overall Study|Participants' non-cooperation|0|||
164218672|NCT01060111|593168423|FG002|Overall Study|Participants' non-cooperation|0|||
164218673|NCT01060111|593168421|FG000|Overall Study|Other|2|||
164218674|NCT01060111|593168422|FG001|Overall Study|Other|3|||
164218675|NCT01060111|593168423|FG002|Overall Study|Other|4|||
164218676|NCT01433978|593168424|FG000|Core Study|Adverse Event, Non-Fatal|0|||
164218677|NCT01433978|593168425|FG001|Core Study|Adverse Event, Non-Fatal|1|||
164218678|NCT01433978|593168426|FG002|Core Study|Adverse Event, Non-Fatal|0|||
164218679|NCT01433978|593168424|FG000|Core Study|Lack of Efficacy|5|||
164218680|NCT01433978|593168425|FG001|Core Study|Lack of Efficacy|1|||
164218681|NCT01433978|593168426|FG002|Core Study|Lack of Efficacy|0|||
164218682|NCT01433978|593168424|FG000|Core Study|Study Terminated by Sponsor|6|||
164218683|NCT01433978|593168425|FG001|Core Study|Study Terminated by Sponsor|9|||
164218684|NCT01433978|593168426|FG002|Core Study|Study Terminated by Sponsor|0|||
164218685|NCT01433978|593168424|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
164218686|NCT01433978|593168425|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
164218687|NCT01433978|593168426|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
164218688|NCT01433978|593168424|FG000|Extension Phase|Lack of Efficacy|0|||
164218689|NCT01433978|593168425|FG001|Extension Phase|Lack of Efficacy|0|||
164218690|NCT01433978|593168426|FG002|Extension Phase|Lack of Efficacy|1|||
164218691|NCT01433978|593168424|FG000|Extension Phase|Study Terminated by Sponsor|0|||
164218692|NCT01433978|593168425|FG001|Extension Phase|Study Terminated by Sponsor|0|||
164218693|NCT01433978|593168426|FG002|Extension Phase|Study Terminated by Sponsor|4|||
164218694|NCT01773889|593168429|FG000|Overall Study|lack of funding|2|||
164218695|NCT02301429|593168430|FG000|Overall Study|not acceptable vascular anatomy|3|||
164218696|NCT03954938|593168431|FG000|Overall Study|Withdrawal by Subject|2|||
164218697|NCT03954938|593168431|FG000|Overall Study|Adverse Event|1|||
164218698|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
164218699|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
164218700|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
164218701|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
164218702|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
164218703|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
164218704|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
164218705|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
164218706|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
164218707|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
164078771|NCT00986154|592653852|FG001|Overall Study|Withdrawal by Subject|33|||
164078772|NCT00986154|592653851|FG000|Overall Study|investigator/subject decide not continue|6|||
164078773|NCT00986154|592653852|FG001|Overall Study|investigator/subject decide not continue|3|||
164218708|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
164218709|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
164218710|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
164218711|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
164218712|NCT00976391|593168433|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
164218713|NCT00976391|593168434|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
164078774|NCT00986154|592653851|FG000|Overall Study|never received study drug|25|||
164078775|NCT00986154|592653852|FG001|Overall Study|never received study drug|27|||
164078776|NCT00267007|592653853|FG000|Overall Study|Withdrawal by Subject|6|||
164078777|NCT00267007|592653854|FG001|Overall Study|Withdrawal by Subject|0|||
164078778|NCT00267007|592653853|FG000|Overall Study|Lost to Follow-up|1|||
164078779|NCT00267007|592653854|FG001|Overall Study|Lost to Follow-up|0|||
164078780|NCT00267007|592653853|FG000|Overall Study|Non-compliance|0|||
164078781|NCT00267007|592653854|FG001|Overall Study|Non-compliance|1|||
164078782|NCT00267007|592653853|FG000|Overall Study|Adverse Event|1|||
164078783|NCT00267007|592653854|FG001|Overall Study|Adverse Event|0|||
164078784|NCT01205529|592653856|FG000|Overall Study|Procedure Cancelled|4|||
164078785|NCT01205529|592653856|FG000|Overall Study|Withdrawal by Subject|2|||
164078786|NCT01205529|592653856|FG000|Overall Study|Physician Decision|4|||
164078787|NCT01205529|592653856|FG000|Overall Study|Unstable post op|15|||
164078788|NCT01205529|592653856|FG000|Overall Study|No longer met criteria|30|||
164078789|NCT03840135|592653857|FG000|Overall Study|Protocol Violation|6|||
164078790|NCT03840135|592653858|FG001|Overall Study|Protocol Violation|1|||
164078791|NCT03840135|592653857|FG000|Overall Study|Withdrawal by Subject|1|||
164078792|NCT03840135|592653858|FG001|Overall Study|Withdrawal by Subject|0|||
164078793|NCT04133519|592653859|FG000|Overall Study|Withdrawal by Subject|5|||
164078794|NCT04133519|592653860|FG001|Overall Study|Withdrawal by Subject|4|||
164078795|NCT04133519|592653859|FG000|Overall Study|Protocol Violation|0|||
164078796|NCT04133519|592653860|FG001|Overall Study|Protocol Violation|1|||
164078797|NCT04133519|592653859|FG000|Overall Study|Never started treatment|1|||
164078798|NCT04133519|592653860|FG001|Overall Study|Never started treatment|1|||
164078799|NCT00323609|592653861|FG000|Overall Study|Death|16|||
164078800|NCT00323609|592653862|FG001|Overall Study|Death|21|||
164078801|NCT00323609|592653863|FG002|Overall Study|Death|0|||
164078802|NCT00323609|592653864|FG003|Overall Study|Death|0|||
164078803|NCT00323609|592653861|FG000|Overall Study|Lost to Follow-up|9|||
164078804|NCT00323609|592653862|FG001|Overall Study|Lost to Follow-up|10|||
164078805|NCT00323609|592653863|FG002|Overall Study|Lost to Follow-up|0|||
164078806|NCT00323609|592653864|FG003|Overall Study|Lost to Follow-up|0|||
164328388|NCT00282347|593577970|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
164328389|NCT02101112|593577971|FG000|Overall Study|Adverse Event|0|||
164328390|NCT02101112|593577972|FG001|Overall Study|Adverse Event|0|||
164328391|NCT02101112|593577973|FG002|Overall Study|Adverse Event|1|||
164328392|NCT02101112|593577974|FG003|Overall Study|Adverse Event|0|||
164328393|NCT02101112|593577975|FG004|Overall Study|Adverse Event|0|||
164328394|NCT02101112|593577976|FG005|Overall Study|Adverse Event|0|||
164328395|NCT02101112|593577971|FG000|Overall Study|Withdrawal by Subject|0|||
164328396|NCT02101112|593577972|FG001|Overall Study|Withdrawal by Subject|0|||
164328397|NCT02101112|593577973|FG002|Overall Study|Withdrawal by Subject|0|||
164328398|NCT02101112|593577974|FG003|Overall Study|Withdrawal by Subject|0|||
164328399|NCT02101112|593577975|FG004|Overall Study|Withdrawal by Subject|1|||
164328400|NCT02101112|593577976|FG005|Overall Study|Withdrawal by Subject|0|||
164328401|NCT04340063|593577977|FG000|Overall Study|Withdrawal by Subject|1|||
164328402|NCT04340063|593577978|FG001|Overall Study|Withdrawal by Subject|2|||
164328403|NCT04340063|593577977|FG000|Overall Study|Lost to Follow-up|3|||
164328404|NCT04340063|593577978|FG001|Overall Study|Lost to Follow-up|1|||
164328405|NCT04340063|593577977|FG000|Overall Study|Protocol Violation|0|||
164328406|NCT04340063|593577978|FG001|Overall Study|Protocol Violation|1|||
164328407|NCT00920829|593579482|FG000|Allocation|No post randomization data|3|||
164328408|NCT00920829|593579483|FG001|Allocation|No post randomization data|1|||
164328409|NCT00920829|593579484|FG002|Allocation|No post randomization data|0|||
164328410|NCT00920829|593579485|FG003|Allocation|No post randomization data|2|||
164328411|NCT00920829|593579482|FG000|Available for Analysis|Withdrawal by Subject|6|||
164328412|NCT00920829|593579483|FG001|Available for Analysis|Withdrawal by Subject|6|||
164328413|NCT00920829|593579484|FG002|Available for Analysis|Withdrawal by Subject|6|||
164328414|NCT00920829|593579485|FG003|Available for Analysis|Withdrawal by Subject|10|||
164328415|NCT00920829|593579482|FG000|Available for Analysis|Required Medical Treatment|0|||
164328416|NCT00920829|593579483|FG001|Available for Analysis|Required Medical Treatment|1|||
164328417|NCT00920829|593579484|FG002|Available for Analysis|Required Medical Treatment|2|||
164328418|NCT00920829|593579485|FG003|Available for Analysis|Required Medical Treatment|0|||
164328419|NCT00920829|593579482|FG000|Available for Analysis|Adverse Event|1|||
164078807|NCT00323609|592653861|FG000|Overall Study|Physician Decision|2|||
164078808|NCT00323609|592653862|FG001|Overall Study|Physician Decision|0|||
164078809|NCT00323609|592653863|FG002|Overall Study|Physician Decision|0|||
164078810|NCT00323609|592653864|FG003|Overall Study|Physician Decision|1|||
164078811|NCT00323609|592653861|FG000|Overall Study|Withdrawal by Subject|11|||
164328420|NCT00920829|593579483|FG001|Available for Analysis|Adverse Event|2|||
164328421|NCT00920829|593579484|FG002|Available for Analysis|Adverse Event|1|||
164328422|NCT00920829|593579485|FG003|Available for Analysis|Adverse Event|0|||
164328423|NCT00920829|593579482|FG000|Available for Analysis|Death|1|||
164328424|NCT00920829|593579483|FG001|Available for Analysis|Death|0|||
164328425|NCT00920829|593579484|FG002|Available for Analysis|Death|0|||
164328426|NCT00920829|593579485|FG003|Available for Analysis|Death|0|||
164078812|NCT00323609|592653862|FG001|Overall Study|Withdrawal by Subject|23|||
164078813|NCT00323609|592653863|FG002|Overall Study|Withdrawal by Subject|4|||
164078814|NCT00323609|592653864|FG003|Overall Study|Withdrawal by Subject|4|||
164328427|NCT00920829|593579482|FG000|Available for Analysis|Protocol Violation|0|||
164218714|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
164218715|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
164218716|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
164218717|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
164218718|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
164218719|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
164218720|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
164218721|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
164218722|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
164218723|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
164218724|NCT00976391|593168433|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
164218725|NCT00976391|593168434|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
164218726|NCT04270760|593168435|FG000|Overall Study|Withdrawal by Subject|0|||
164218727|NCT04270760|593168436|FG001|Overall Study|Withdrawal by Subject|1|||
164218728|NCT04270760|593168437|FG002|Overall Study|Withdrawal by Subject|3|||
164218729|NCT04270760|593168438|FG003|Overall Study|Withdrawal by Subject|0|||
164218730|NCT04270760|593168439|FG004|Overall Study|Withdrawal by Subject|0|||
164218731|NCT04270760|593168435|FG000|Overall Study|Lost to Follow-up|1|||
164218732|NCT04270760|593168436|FG001|Overall Study|Lost to Follow-up|2|||
164218733|NCT04270760|593168437|FG002|Overall Study|Lost to Follow-up|1|||
164218734|NCT04270760|593168438|FG003|Overall Study|Lost to Follow-up|0|||
164218735|NCT04270760|593168439|FG004|Overall Study|Lost to Follow-up|0|||
164218736|NCT04270760|593168435|FG000|Overall Study|Death|0|||
164218737|NCT04270760|593168436|FG001|Overall Study|Death|0|||
164218738|NCT04270760|593168437|FG002|Overall Study|Death|0|||
164218739|NCT04270760|593168438|FG003|Overall Study|Death|0|||
164218740|NCT04270760|593168439|FG004|Overall Study|Death|1|||
164218741|NCT00887588|593168440|FG000|Core Period|Death|1|||
164218742|NCT00887588|593168441|FG001|Core Period|Death|1|||
164218743|NCT00887588|593168440|FG000|Core Period|Lost to Follow-up|3|||
164218744|NCT00887588|593168441|FG001|Core Period|Lost to Follow-up|1|||
164218745|NCT00887588|593168440|FG000|Core Period|Withdrawal by Subject|6|||
164218746|NCT00887588|593168441|FG001|Core Period|Withdrawal by Subject|8|||
164218747|NCT00887588|593168440|FG000|Core Period|Adverse Event|9|||
164218748|NCT00887588|593168441|FG001|Core Period|Adverse Event|11|||
164218749|NCT00887588|593168440|FG000|Extension Period|Adverse Event|4|||
164218750|NCT00887588|593168441|FG001|Extension Period|Adverse Event|4|||
164218751|NCT00887588|593168440|FG000|Extension Period|Death|0|||
164218752|NCT00887588|593168441|FG001|Extension Period|Death|1|||
164218753|NCT00887588|593168440|FG000|Extension Period|Protocol deviation|1|||
164218754|NCT00887588|593168441|FG001|Extension Period|Protocol deviation|0|||
164218755|NCT00887588|593168440|FG000|Extension Period|Lost to Follow-up|1|||
164218756|NCT00887588|593168441|FG001|Extension Period|Lost to Follow-up|0|||
164218757|NCT04180696|593168450|FG000|Overall Study|Death|5|||
164218758|NCT04180696|593168451|FG001|Overall Study|Death|6|||
164218759|NCT04180696|593168450|FG000|Overall Study|Lost to Follow-up|1|||
164218760|NCT04180696|593168451|FG001|Overall Study|Lost to Follow-up|0|||
164218761|NCT04180696|593168450|FG000|Overall Study|Withdrawal by Subject|0|||
164218762|NCT04180696|593168451|FG001|Overall Study|Withdrawal by Subject|1|||
164218763|NCT04210375|593168455|FG000|Overall Study|Death|0|||
164218764|NCT04210375|593168456|FG001|Overall Study|Death|1|||
164218765|NCT04210375|593168457|FG002|Overall Study|Death|0|||
164218766|NCT04210375|593168458|FG003|Overall Study|Death|0|||
163877676|NCT04143061|591921106|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163877677|NCT04143061|591921107|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
163877678|NCT04143061|591921108|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
163877679|NCT04143061|591921109|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
163877680|NCT04143061|591921110|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
163877681|NCT04905407|591921111|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
163877682|NCT04905407|591921112|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
163877683|NCT04905407|591921113|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
163877684|NCT04905407|591921114|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
163877685|NCT04905407|591921111|FG000|Part 1 and Part 2|Death|7|||
164078815|NCT00323609|592653861|FG000|Overall Study|Other non-VCF-related medical condition|3|||
164218767|NCT05752487|593168461|FG000|Overall Study|Enrolled, not treated|9|||
164218768|NCT05752487|593168461|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
164218769|NCT05752487|593168461|FG000|Overall Study|Withdrawal by Subject|2|||
164218770|NCT04124965|593168463|FG000|Overall Study|Adverse event, non-fatal|3|||
164218771|NCT04124965|593168464|FG001|Overall Study|Adverse event, non-fatal|1|||
164218772|NCT04124965|593168463|FG000|Overall Study|Withdrawal by Subject|1|||
164218773|NCT04124965|593168464|FG001|Overall Study|Withdrawal by Subject|1|||
164218774|NCT04124965|593168463|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
164218775|NCT04124965|593168464|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
164218776|NCT04124965|593168463|FG000|Overall Study|Pregnancy|1|||
164218777|NCT04124965|593168464|FG001|Overall Study|Pregnancy|0|||
163877686|NCT04905407|591921112|FG001|Part 1 and Part 2|Death|7|||
163877687|NCT04905407|591921113|FG002|Part 1 and Part 2|Death|7|||
164218778|NCT04124965|593168463|FG000|Overall Study|Sponsor and participant decision|0|||
164078816|NCT00323609|592653862|FG001|Overall Study|Other non-VCF-related medical condition|2|||
164078817|NCT00323609|592653863|FG002|Overall Study|Other non-VCF-related medical condition|0|||
164078818|NCT00323609|592653864|FG003|Overall Study|Other non-VCF-related medical condition|0|||
164078819|NCT00323609|592653861|FG000|Overall Study|Sponsor discontinued trial|29|||
164078820|NCT00323609|592653862|FG001|Overall Study|Sponsor discontinued trial|29|||
164078821|NCT00323609|592653863|FG002|Overall Study|Sponsor discontinued trial|0|||
164078822|NCT00323609|592653864|FG003|Overall Study|Sponsor discontinued trial|0|||
164078823|NCT00323609|592653861|FG000|Overall Study|Unrelenting or severe back pain|1|||
164078824|NCT00323609|592653862|FG001|Overall Study|Unrelenting or severe back pain|1|||
164078825|NCT00323609|592653863|FG002|Overall Study|Unrelenting or severe back pain|0|||
164078826|NCT00323609|592653864|FG003|Overall Study|Unrelenting or severe back pain|0|||
164078827|NCT00323609|592653861|FG000|Overall Study|Logistical withdrawal|9|||
164078828|NCT00323609|592653862|FG001|Overall Study|Logistical withdrawal|5|||
164218779|NCT04124965|593168464|FG001|Overall Study|Sponsor and participant decision|1|||
164218780|NCT04124965|593168463|FG000|Overall Study|Personal surgery|0|||
164218781|NCT04124965|593168464|FG001|Overall Study|Personal surgery|1|||
164218782|NCT04124965|593168463|FG000|Overall Study|Physician Decision|0|||
164218783|NCT04124965|593168464|FG001|Overall Study|Physician Decision|1|||
164218784|NCT02405962|593168465|FG000|Overall Study|Lost to Follow-up|1|||
164218785|NCT02405962|593168466|FG001|Overall Study|Lost to Follow-up|4|||
164218786|NCT02405962|593168465|FG000|Overall Study|A participant has moved to another place|0|||
164218787|NCT02405962|593168466|FG001|Overall Study|A participant has moved to another place|1|||
164218788|NCT01214720|593168469|FG000|Overall Study|Alive and still on treatment|34|||
164218789|NCT01214720|593168470|FG001|Overall Study|Alive and still on treatment|18|||
164218790|NCT01214720|593168469|FG000|Overall Study|Alive and in follow-up|45|||
164218791|NCT01214720|593168470|FG001|Overall Study|Alive and in follow-up|48|||
164218792|NCT01214720|593168469|FG000|Overall Study|Lost to Follow-up|6|||
164218793|NCT01214720|593168470|FG001|Overall Study|Lost to Follow-up|2|||
164218794|NCT01980888|593168471|FG000|Overall Study|Study Terminated by Sponsor|116|||
164218795|NCT01980888|593168472|FG001|Overall Study|Study Terminated by Sponsor|122|||
164218796|NCT01980888|593168471|FG000|Overall Study|Withdrew Consent|17|||
164218797|NCT01980888|593168472|FG001|Overall Study|Withdrew Consent|6|||
164218798|NCT01980888|593168471|FG000|Overall Study|Investigator's Discretion|8|||
164218799|NCT01980888|593168472|FG001|Overall Study|Investigator's Discretion|3|||
164218800|NCT01980888|593168471|FG000|Overall Study|Non-Compliance with Study Drug|3|||
164218801|NCT01980888|593168472|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164218802|NCT00433290|593168473|FG000|Overall Study|Adverse Event|24|||
164218803|NCT00433290|593168474|FG001|Overall Study|Adverse Event|7|||
164218804|NCT00433290|593168473|FG000|Overall Study|Lack of Efficacy|1|||
164218805|NCT00433290|593168474|FG001|Overall Study|Lack of Efficacy|5|||
164218806|NCT00433290|593168473|FG000|Overall Study|Withdrawal by Subject|4|||
164218807|NCT00433290|593168474|FG001|Overall Study|Withdrawal by Subject|2|||
164218808|NCT00433290|593168473|FG000|Overall Study|Protocol Violation|3|||
164218809|NCT00433290|593168474|FG001|Overall Study|Protocol Violation|2|||
164218810|NCT00433290|593168473|FG000|Overall Study|Physician Decision|2|||
164218811|NCT00433290|593168474|FG001|Overall Study|Physician Decision|0|||
164218812|NCT00433290|593168473|FG000|Overall Study|Entry Criteria Not Met|0|||
164218813|NCT00433290|593168474|FG001|Overall Study|Entry Criteria Not Met|1|||
164218814|NCT00433290|593168473|FG000|Overall Study|Lost to Follow-up|1|||
164218815|NCT00433290|593168474|FG001|Overall Study|Lost to Follow-up|0|||
164218816|NCT01397747|593168479|FG000|Overall Study|Multitarget DNA test excluded|689|||
164218817|NCT01397747|593168479|FG000|Overall Study|Colonoscopy excluded|304|||
164218818|NCT01397747|593168479|FG000|Overall Study|FIT excluded|34|||
164218819|NCT00086307|593168480|FG000|Overall Study|Lack of Efficacy|1|||
164328428|NCT00920829|593579483|FG001|Available for Analysis|Protocol Violation|0|||
163877688|NCT04905407|591921114|FG003|Part 1 and Part 2|Death|0|||
163877689|NCT04905407|591921111|FG000|Part 1 and Part 2|Other than specified|0|||
163877690|NCT04905407|591921112|FG001|Part 1 and Part 2|Other than specified|0|||
163877691|NCT04905407|591921113|FG002|Part 1 and Part 2|Other than specified|1|||
163877692|NCT04905407|591921114|FG003|Part 1 and Part 2|Other than specified|0|||
163877693|NCT04905407|591921111|FG000|Part 3|Death|0|||
163877694|NCT04905407|591921112|FG001|Part 3|Death|0|||
163877695|NCT04905407|591921113|FG002|Part 3|Death|0|||
163877696|NCT04905407|591921114|FG003|Part 3|Death|2|||
163877697|NCT00150813|591921117|FG000|Overall Study|Adverse Event|1|||
163877698|NCT00150813|591921117|FG000|Overall Study|Lack of Efficacy|1|||
163877699|NCT00150813|591921117|FG000|Overall Study|Lost to Follow-up|5|||
163877700|NCT00150813|591921117|FG000|Overall Study|Withdrawal by Subject|5|||
163877701|NCT00150813|591921117|FG000|Overall Study|Remission|3|||
163877702|NCT00150813|591921117|FG000|Overall Study|Planned pregancy|1|||
163877703|NCT00150813|591921117|FG000|Overall Study|Switch to commercially available LEV|2|||
163877704|NCT04048681|591921120|FG000|Overall Study|family emergency|0|||
163877705|NCT04048681|591921121|FG001|Overall Study|family emergency|0|||
163877706|NCT04048681|591921122|FG002|Overall Study|family emergency|0|||
164078829|NCT00323609|592653863|FG002|Overall Study|Logistical withdrawal|0|||
163877707|NCT04048681|591921123|FG003|Overall Study|family emergency|1|||
163877708|NCT04048681|591921124|FG004|Overall Study|family emergency|0|||
163981727|NCT03806127|592304484|FG000|Overall Study|Unable to Complete Procedures|0|||
163981728|NCT03806127|592304485|FG001|Overall Study|Unable to Complete Procedures|1|||
163981729|NCT03806127|592304484|FG000|Overall Study|Pregnancy|0|||
163981730|NCT03806127|592304485|FG001|Overall Study|Pregnancy|1|||
163981731|NCT03806127|592304484|FG000|Overall Study|Lost to Follow-up|5|||
163981732|NCT03806127|592304485|FG001|Overall Study|Lost to Follow-up|1|||
163981733|NCT03806127|592304484|FG000|Overall Study|Physician Decision|1|||
163981734|NCT03806127|592304485|FG001|Overall Study|Physician Decision|1|||
163981735|NCT03806127|592304484|FG000|Overall Study|Could Not Come Due to Covid|1|||
163981736|NCT03806127|592304485|FG001|Overall Study|Could Not Come Due to Covid|0|||
163981737|NCT03806127|592304484|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
163981738|NCT03806127|592304485|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
164138126|NCT00805467|592868374|FG002|Overall Study|Physician Decision|2|||
163877709|NCT00448669|591921130|FG000|Overall Study|Lost to Follow-up|52|||
163877710|NCT00448669|591921131|FG001|Overall Study|Lost to Follow-up|63|||
163877711|NCT00448669|591921130|FG000|Overall Study|Withdrawal by Subject|90|||
163877712|NCT00448669|591921131|FG001|Overall Study|Withdrawal by Subject|74|||
163877713|NCT00448669|591921130|FG000|Overall Study|Relocated|49|||
163877714|NCT00448669|591921131|FG001|Overall Study|Relocated|36|||
163877715|NCT00448669|591921130|FG000|Overall Study|Were withdrawn by investigator|10|||
163877716|NCT00448669|591921131|FG001|Overall Study|Were withdrawn by investigator|6|||
163877717|NCT00448669|591921130|FG000|Overall Study|Death|2|||
163877718|NCT00448669|591921131|FG001|Overall Study|Death|4|||
163877719|NCT00448669|591921130|FG000|Overall Study|Had other reasons|5|||
163877720|NCT00448669|591921131|FG001|Overall Study|Had other reasons|6|||
163877721|NCT00448669|591921130|FG000|Overall Study|HIV-infected at enrollment|1|||
163877722|NCT00448669|591921131|FG001|Overall Study|HIV-infected at enrollment|2|||
163877723|NCT00448669|591921130|FG000|Overall Study|Never started drug|9|||
163877724|NCT00448669|591921131|FG001|Overall Study|Never started drug|7|||
163877725|NCT04287985|591921132|FG000|Overall Study|Adverse Event|1|||
163877726|NCT04287985|591921133|FG001|Overall Study|Adverse Event|0|||
163877727|NCT04287985|591921134|FG002|Overall Study|Adverse Event|0|||
163877728|NCT04287985|591921135|FG003|Overall Study|Adverse Event|0|||
163877729|NCT04287985|591921132|FG000|Overall Study|Protocol Violation|0|||
163877730|NCT04287985|591921133|FG001|Overall Study|Protocol Violation|1|||
163877731|NCT04287985|591921134|FG002|Overall Study|Protocol Violation|0|||
163877732|NCT04287985|591921135|FG003|Overall Study|Protocol Violation|0|||
163877733|NCT04287985|591921132|FG000|Overall Study|Physician Decision|0|||
163877734|NCT04287985|591921133|FG001|Overall Study|Physician Decision|0|||
163877735|NCT04287985|591921134|FG002|Overall Study|Physician Decision|0|||
163877736|NCT04287985|591921135|FG003|Overall Study|Physician Decision|1|||
163877737|NCT04287985|591921132|FG000|Overall Study|Withdrawal by Subject|2|||
163877738|NCT04287985|591921133|FG001|Overall Study|Withdrawal by Subject|1|||
163877739|NCT04287985|591921134|FG002|Overall Study|Withdrawal by Subject|1|||
163877740|NCT04287985|591921135|FG003|Overall Study|Withdrawal by Subject|2|||
163877741|NCT02638337|591921136|FG000|Overall Study|Adverse Event|6|||
163877742|NCT02638337|591921137|FG001|Overall Study|Adverse Event|10|||
163877743|NCT02638337|591921136|FG000|Overall Study|Protocol Violation|3|||
163877744|NCT02638337|591921137|FG001|Overall Study|Protocol Violation|0|||
163877745|NCT02638337|591921136|FG000|Overall Study|Withdrawal by Subject|13|||
163877746|NCT02638337|591921137|FG001|Overall Study|Withdrawal by Subject|16|||
163877747|NCT02638337|591921136|FG000|Overall Study|Lost to Follow-up|7|||
163877748|NCT02638337|591921137|FG001|Overall Study|Lost to Follow-up|7|||
163877749|NCT02638337|591921136|FG000|Overall Study|Other - Miscellaneous|4|||
163877750|NCT02638337|591921137|FG001|Overall Study|Other - Miscellaneous|3|||
163877751|NCT01340066|591921138|FG000|Placebo Run in Period|Screen Failures|27|||
163877752|NCT01340066|591921139|FG001|Placebo Run in Period|Screen Failures|0|||
163877753|NCT01340066|591921140|FG002|Placebo Run in Period|Screen Failures|0|||
163877754|NCT01340066|591921138|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
163877755|NCT01340066|591921139|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
163877756|NCT01340066|591921140|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
163877757|NCT01340066|591921138|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
163877758|NCT01340066|591921139|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
163877759|NCT01340066|591921140|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
163877760|NCT01340066|591921138|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
163877761|NCT01340066|591921139|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
163877762|NCT01340066|591921140|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
163877763|NCT02789020|591921141|FG000|Overall Study|Withdrawal by Subject|6|||
163981739|NCT03806127|592304484|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
163981740|NCT03806127|592304485|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
163981741|NCT03806127|592304484|FG000|Overall Study|Covid 19 Restrictions|2|||
163877764|NCT02789020|591921142|FG001|Overall Study|Withdrawal by Subject|5|||
163877765|NCT05512962|591921145|FG000|Overall Study|Withdrawal by Subject|1|||
164138127|NCT00805467|592868375|FG003|Overall Study|Physician Decision|6|||
164138128|NCT00805467|592868372|FG000|Overall Study|Not reported|0|||
164138129|NCT00805467|592868373|FG001|Overall Study|Not reported|0|||
163981742|NCT03806127|592304485|FG001|Overall Study|Covid 19 Restrictions|0|||
163981743|NCT03806127|592304484|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
163981744|NCT03806127|592304485|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
163981745|NCT03806127|592304484|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
163981746|NCT03806127|592304485|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
163981747|NCT03823391|592304491|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
163981748|NCT03823391|592304492|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
163981749|NCT03823391|592304491|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
163981750|NCT03823391|592304492|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
163981751|NCT05882318|592304498|FG000|Overall Study|Withdrawal by Subject|1|||
163981752|NCT05882318|592304499|FG001|Overall Study|Withdrawal by Subject|0|||
163981753|NCT05882318|592304498|FG000|Overall Study|Protocol Violation|0|||
163981754|NCT05882318|592304499|FG001|Overall Study|Protocol Violation|1|||
163981755|NCT05030311|592304500|FG000|Overall Study|Technical problems|0|||
163981756|NCT05030311|592304501|FG001|Overall Study|Technical problems|1|||
163981757|NCT05030311|592304500|FG000|Overall Study|Withdrawal by Subject|31|||
163981758|NCT05030311|592304501|FG001|Overall Study|Withdrawal by Subject|17|||
163981759|NCT05030311|592304500|FG000|Overall Study|Adverse Event|13|||
163981760|NCT05030311|592304501|FG001|Overall Study|Adverse Event|5|||
163981761|NCT05030311|592304500|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163981762|NCT05030311|592304501|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163981763|NCT05030311|592304500|FG000|Overall Study|Physician Decision|5|||
163981764|NCT05030311|592304501|FG001|Overall Study|Physician Decision|2|||
163981765|NCT05030311|592304500|FG000|Overall Study|Lost to Follow-up|5|||
163981766|NCT05030311|592304501|FG001|Overall Study|Lost to Follow-up|1|||
163981767|NCT05030311|592304500|FG000|Overall Study|Protocol Violation|4|||
163981768|NCT05030311|592304501|FG001|Overall Study|Protocol Violation|4|||
163981769|NCT03042468|592304502|FG000|Overall Study|Death|0|||
163981770|NCT03042468|592304503|FG001|Overall Study|Death|1|||
163981771|NCT03042468|592304504|FG002|Overall Study|Death|1|||
163981772|NCT03042468|592304505|FG003|Overall Study|Death|0|||
163981773|NCT03042468|592304506|FG004|Overall Study|Death|0|||
163981774|NCT03042468|592304507|FG005|Overall Study|Death|0|||
163981775|NCT03042468|592304502|FG000|Overall Study|Withdrawal by Subject|0|||
163981776|NCT03042468|592304503|FG001|Overall Study|Withdrawal by Subject|0|||
163981777|NCT03042468|592304504|FG002|Overall Study|Withdrawal by Subject|0|||
163981778|NCT03042468|592304505|FG003|Overall Study|Withdrawal by Subject|0|||
163981779|NCT03042468|592304506|FG004|Overall Study|Withdrawal by Subject|0|||
163981780|NCT03042468|592304507|FG005|Overall Study|Withdrawal by Subject|1|||
163981781|NCT03042468|592304502|FG000|Overall Study|Lost to Follow-up|0|||
163981782|NCT03042468|592304503|FG001|Overall Study|Lost to Follow-up|0|||
163981783|NCT03042468|592304504|FG002|Overall Study|Lost to Follow-up|0|||
163981784|NCT03042468|592304505|FG003|Overall Study|Lost to Follow-up|0|||
163981785|NCT03042468|592304506|FG004|Overall Study|Lost to Follow-up|1|||
163981786|NCT03042468|592304507|FG005|Overall Study|Lost to Follow-up|1|||
163981787|NCT02264990|592304508|FG000|Overall Study|Death|255|||
163981788|NCT02264990|592304509|FG001|Overall Study|Death|250|||
163981789|NCT02264990|592304508|FG000|Overall Study|Withdrawal by Subject|4|||
163981790|NCT02264990|592304509|FG001|Overall Study|Withdrawal by Subject|5|||
163981791|NCT02264990|592304508|FG000|Overall Study|Lost to Follow-up|1|||
163981792|NCT02264990|592304509|FG001|Overall Study|Lost to Follow-up|3|||
163981793|NCT02264990|592304508|FG000|Overall Study|Other|0|||
163981794|NCT02264990|592304509|FG001|Overall Study|Other|1|||
163981795|NCT03031301|592304511|FG000|Overall Study|Protocol Violation|4|||
163981796|NCT03031301|592304512|FG001|Overall Study|Protocol Violation|8|||
163981797|NCT03031301|592304511|FG000|Overall Study|Withdrawal by Subject|7|||
163981798|NCT03031301|592304512|FG001|Overall Study|Withdrawal by Subject|4|||
163981799|NCT03031301|592304511|FG000|Overall Study|Lost to Follow-up|4|||
163981800|NCT03031301|592304512|FG001|Overall Study|Lost to Follow-up|12|||
163981801|NCT03031301|592304511|FG000|Overall Study|Noncompliance|1|||
163981802|NCT03031301|592304512|FG001|Overall Study|Noncompliance|3|||
163981803|NCT03031301|592304511|FG000|Overall Study|Technical issue|1|||
163981804|NCT03031301|592304512|FG001|Overall Study|Technical issue|1|||
163981805|NCT03031301|592304511|FG000|Overall Study|Adverse Event|1|||
163981806|NCT03031301|592304512|FG001|Overall Study|Adverse Event|0|||
163981807|NCT00267748|592304513|FG000|Non-randomized Period|Progressive disease|10|||
163981808|NCT00267748|592304514|FG001|Non-randomized Period|Progressive disease|0|||
163981809|NCT00267748|592304515|FG002|Non-randomized Period|Progressive disease|0|||
163981810|NCT00267748|592304513|FG000|Non-randomized Period|Adverse Event|8|||
163981811|NCT00267748|592304514|FG001|Non-randomized Period|Adverse Event|0|||
163981812|NCT00267748|592304515|FG002|Non-randomized Period|Adverse Event|0|||
163981813|NCT00267748|592304513|FG000|Non-randomized Period|Death|1|||
163981814|NCT00267748|592304514|FG001|Non-randomized Period|Death|0|||
163981815|NCT00267748|592304515|FG002|Non-randomized Period|Death|0|||
163981816|NCT00267748|592304513|FG000|Non-randomized Period|Participant not willing to participate|1|||
163981817|NCT00267748|592304514|FG001|Non-randomized Period|Participant not willing to participate|0|||
163981818|NCT00267748|592304515|FG002|Non-randomized Period|Participant not willing to participate|0|||
163981819|NCT00267748|592304513|FG000|Non-randomized Period|Other|3|||
163981820|NCT00267748|592304514|FG001|Non-randomized Period|Other|0|||
163981821|NCT00267748|592304515|FG002|Non-randomized Period|Other|0|||
163981822|NCT00267748|592304513|FG000|Randomized Period|Death|0|||
163981823|NCT00267748|592304514|FG001|Randomized Period|Death|2|||
163981824|NCT00267748|592304515|FG002|Randomized Period|Death|3|||
163981825|NCT00267748|592304513|FG000|Randomized Period|Adverse Event|0|||
163981826|NCT00267748|592304514|FG001|Randomized Period|Adverse Event|23|||
163981827|NCT00267748|592304515|FG002|Randomized Period|Adverse Event|25|||
163981828|NCT00267748|592304513|FG000|Randomized Period|Global deterioration of health status|0|||
163981829|NCT00267748|592304514|FG001|Randomized Period|Global deterioration of health status|6|||
163981830|NCT00267748|592304515|FG002|Randomized Period|Global deterioration of health status|7|||
163981831|NCT00267748|592304513|FG000|Randomized Period|Lost to Follow-up|0|||
163981832|NCT00267748|592304514|FG001|Randomized Period|Lost to Follow-up|1|||
163981833|NCT00267748|592304515|FG002|Randomized Period|Lost to Follow-up|0|||
163981834|NCT00267748|592304513|FG000|Randomized Period|Objective progression or relapse|0|||
163981835|NCT00267748|592304514|FG001|Randomized Period|Objective progression or relapse|77|||
163981836|NCT00267748|592304515|FG002|Randomized Period|Objective progression or relapse|86|||
163981837|NCT00267748|592304513|FG000|Randomized Period|Withdrawal by Subject|0|||
163981838|NCT00267748|592304514|FG001|Randomized Period|Withdrawal by Subject|9|||
163981839|NCT00267748|592304515|FG002|Randomized Period|Withdrawal by Subject|2|||
163981840|NCT00267748|592304513|FG000|Randomized Period|Other|0|||
163981841|NCT00267748|592304514|FG001|Randomized Period|Other|9|||
163981842|NCT00267748|592304515|FG002|Randomized Period|Other|6|||
163981843|NCT00267748|592304513|FG000|Randomized Period|randomized but not treated|0|||
163981844|NCT00267748|592304514|FG001|Randomized Period|randomized but not treated|0|||
163981845|NCT00267748|592304515|FG002|Randomized Period|randomized but not treated|3|||
163981846|NCT01294800|592304516|FG000|Overall Study|Adverse Event|7|||
163981847|NCT01294800|592304517|FG001|Overall Study|Adverse Event|6|||
163981848|NCT01294800|592304518|FG002|Overall Study|Adverse Event|12|||
163981849|NCT01294800|592304519|FG003|Overall Study|Adverse Event|5|||
163981850|NCT01294800|592304516|FG000|Overall Study|Subject Withdrew Consent|2|||
163981851|NCT01294800|592304517|FG001|Overall Study|Subject Withdrew Consent|2|||
163981852|NCT01294800|592304518|FG002|Overall Study|Subject Withdrew Consent|2|||
163981853|NCT01294800|592304519|FG003|Overall Study|Subject Withdrew Consent|11|||
163981854|NCT01294800|592304516|FG000|Overall Study|Lost to Follow-up|0|||
163981855|NCT01294800|592304517|FG001|Overall Study|Lost to Follow-up|0|||
163981856|NCT01294800|592304518|FG002|Overall Study|Lost to Follow-up|1|||
163981857|NCT01294800|592304519|FG003|Overall Study|Lost to Follow-up|0|||
163981858|NCT01294800|592304516|FG000|Overall Study|Non-compliance With Protocol|0|||
163981859|NCT01294800|592304517|FG001|Overall Study|Non-compliance With Protocol|1|||
163981860|NCT01294800|592304518|FG002|Overall Study|Non-compliance With Protocol|1|||
163981861|NCT01294800|592304519|FG003|Overall Study|Non-compliance With Protocol|0|||
163981862|NCT01294800|592304516|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
163981863|NCT01294800|592304517|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
163981864|NCT01294800|592304518|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
163981865|NCT01294800|592304519|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
163981866|NCT01662895|592304521|FG000|Overall Study|Lost to Follow-up|0|||
163981867|NCT01662895|592304522|FG001|Overall Study|Lost to Follow-up|1|||
163981868|NCT00493038|592304523|FG000|Treatment|Adverse Event|8|||
163981869|NCT00493038|592304524|FG001|Treatment|Adverse Event|4|||
163981870|NCT00493038|592304523|FG000|Treatment|Lost to Follow-up|5|||
163981871|NCT00493038|592304524|FG001|Treatment|Lost to Follow-up|3|||
163981872|NCT00493038|592304523|FG000|Treatment|Withdrawal by Subject|11|||
163981873|NCT00493038|592304524|FG001|Treatment|Withdrawal by Subject|12|||
163981874|NCT00493038|592304523|FG000|Treatment|Other|0|||
163981875|NCT00493038|592304524|FG001|Treatment|Other|1|||
163981876|NCT00493038|592304523|FG000|Follow-up|Lost to Follow-up|1|||
163981877|NCT00493038|592304524|FG001|Follow-up|Lost to Follow-up|0|||
163981878|NCT01100944|592304525|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
164078830|NCT00323609|592653864|FG003|Overall Study|Logistical withdrawal|1|||
164078831|NCT00323609|592653861|FG000|Overall Study|Other reason|11|||
163981879|NCT01100944|592304526|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
163981880|NCT01100944|592304527|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
164078832|NCT00323609|592653862|FG001|Overall Study|Other reason|8|||
164078833|NCT00323609|592653863|FG002|Overall Study|Other reason|4|||
163981881|NCT01100944|592304525|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
163981882|NCT01100944|592304526|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
163981883|NCT01100944|592304527|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
163981884|NCT01100944|592304525|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
163981885|NCT01100944|592304526|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
163981886|NCT01100944|592304527|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
163981887|NCT01100944|592304525|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
164078834|NCT00323609|592653864|FG003|Overall Study|Other reason|9|||
164078835|NCT01684722|592653870|FG000|Overall Study|Lost to Follow-up|78|||
163877766|NCT05512962|591921146|FG001|Overall Study|Withdrawal by Subject|0|||
163877767|NCT00136435|591921147|FG000|Overall Study|Ineligible|8|||
163877768|NCT00136435|591921147|FG000|Overall Study|Induction Death|1|||
163877769|NCT00136435|591921147|FG000|Overall Study|Induction Failure|10|||
163877770|NCT00136435|591921147|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
163877771|NCT00136435|591921147|FG000|Overall Study|Withdrawal by Subject|3|||
163877772|NCT00136435|591921147|FG000|Overall Study|Adverse Event|19|||
163877773|NCT00136435|591921147|FG000|Overall Study|Relapse|4|||
163877774|NCT00136435|591921147|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
163877775|NCT00390299|591921152|FG000|Overall Study|Cancellation|1|||
163981888|NCT01100944|592304526|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
163981889|NCT01100944|592304527|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
163981890|NCT01665807|592304528|FG000|Overall Study|Withdrawal by Subject|2|||
163981891|NCT01665807|592304529|FG001|Overall Study|Withdrawal by Subject|0|||
163981892|NCT01665807|592304530|FG002|Overall Study|Withdrawal by Subject|1|||
163981893|NCT01618214|592304531|FG000|Overall Study|Adverse Event|3|||
163981894|NCT01618214|592304532|FG001|Overall Study|Adverse Event|1|||
163981895|NCT01618214|592304531|FG000|Overall Study|Lack of Efficacy|1|||
163981896|NCT01618214|592304532|FG001|Overall Study|Lack of Efficacy|1|||
163981897|NCT01618214|592304531|FG000|Overall Study|Protocol Violation|1|||
163981898|NCT01618214|592304532|FG001|Overall Study|Protocol Violation|4|||
163981899|NCT01618214|592304531|FG000|Overall Study|Withdrawal Criteria|1|||
163981900|NCT01618214|592304532|FG001|Overall Study|Withdrawal Criteria|2|||
163981901|NCT01618214|592304531|FG000|Overall Study|Unclassified|4|||
163981902|NCT01618214|592304532|FG001|Overall Study|Unclassified|5|||
163981903|NCT00623428|592304535|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
163981904|NCT00623428|592304536|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
163981905|NCT00623428|592304535|FG000|Treatment Period|Death|0|||
163981906|NCT00623428|592304536|FG001|Treatment Period|Death|1|||
163981907|NCT00623428|592304535|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
163981908|NCT00623428|592304536|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
163981909|NCT00623428|592304535|FG000|Treatment Period|Insufficient therapeutic response|0|||
163981910|NCT00623428|592304536|FG001|Treatment Period|Insufficient therapeutic response|2|||
163981911|NCT00623428|592304535|FG000|Treatment Period|Other|0|||
164078836|NCT01684722|592653871|FG001|Overall Study|Lost to Follow-up|56|||
164078837|NCT01684722|592653872|FG002|Overall Study|Lost to Follow-up|75|||
164078838|NCT01684722|592653873|FG003|Overall Study|Lost to Follow-up|89|||
164078839|NCT01684722|592653870|FG000|Overall Study|Death|19|||
164078840|NCT01684722|592653871|FG001|Overall Study|Death|21|||
163877776|NCT00390299|591921153|FG001|Overall Study|Cancellation|0|||
163877777|NCT00390299|591921154|FG002|Overall Study|Cancellation|0|||
163877778|NCT00390299|591921155|FG003|Overall Study|Cancellation|0|||
163877779|NCT00390299|591921156|FG004|Overall Study|Cancellation|0|||
163877780|NCT02965846|591921158|FG000|Overall Study|Lost to Follow-up|1|||
163877781|NCT02965846|591921159|FG001|Overall Study|Lost to Follow-up|0|||
163877782|NCT02965846|591921160|FG002|Overall Study|Lost to Follow-up|0|||
163877783|NCT02965846|591921158|FG000|Overall Study|Withdrawal by Subject|0|||
163877784|NCT02965846|591921159|FG001|Overall Study|Withdrawal by Subject|1|||
163877785|NCT02965846|591921160|FG002|Overall Study|Withdrawal by Subject|0|||
163877786|NCT02965846|591921158|FG000|Overall Study|Study Terminated By Sponsor|4|||
163877787|NCT02965846|591921159|FG001|Overall Study|Study Terminated By Sponsor|4|||
163877788|NCT02965846|591921160|FG002|Overall Study|Study Terminated By Sponsor|0|||
163877789|NCT02965846|591921158|FG000|Overall Study|Participants not randomized|0|||
163877790|NCT02965846|591921159|FG001|Overall Study|Participants not randomized|0|||
163877791|NCT02965846|591921160|FG002|Overall Study|Participants not randomized|33|||
163877792|NCT00539734|591921161|FG000|Overall Study|Protocol Violation|1|||
163877793|NCT02794480|591921162|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
163877794|NCT02794480|591921163|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
163877795|NCT02794480|591921164|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
163877796|NCT02794480|591921165|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
163877797|NCT02794480|591921162|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
163877798|NCT02794480|591921163|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
163877799|NCT02794480|591921164|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
163981912|NCT00623428|592304536|FG001|Treatment Period|Other|1|||
163981913|NCT00623428|592304535|FG000|Treatment Period|Withdrawal by Subject|0|||
163981914|NCT00623428|592304536|FG001|Treatment Period|Withdrawal by Subject|1|||
163981915|NCT00623428|592304535|FG000|Follow-up Period|Relapse post-treatment|11|||
163981916|NCT00623428|592304536|FG001|Follow-up Period|Relapse post-treatment|3|||
163877800|NCT02794480|591921165|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
163877801|NCT02794480|591921162|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163877802|NCT02794480|591921163|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163877803|NCT02794480|591921164|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163877804|NCT02794480|591921165|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
163981917|NCT00623428|592304535|FG000|Follow-up Period|Failure to return|10|||
164078841|NCT01684722|592653872|FG002|Overall Study|Death|19|||
163981918|NCT00623428|592304536|FG001|Follow-up Period|Failure to return|2|||
163981919|NCT00623428|592304535|FG000|Follow-up Period|Patient withdrew consent|5|||
163981920|NCT00623428|592304536|FG001|Follow-up Period|Patient withdrew consent|4|||
163981921|NCT00623428|592304535|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
163981922|NCT00623428|592304536|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
163981923|NCT00623428|592304535|FG000|Follow-up Period|Did not cooperate|0|||
163981924|NCT00623428|592304536|FG001|Follow-up Period|Did not cooperate|3|||
163981925|NCT00623428|592304535|FG000|Follow-up Period|Reason not specified|1|||
163981926|NCT00623428|592304536|FG001|Follow-up Period|Reason not specified|1|||
163981927|NCT00623428|592304535|FG000|Follow-up Period|Death|0|||
163981928|NCT00623428|592304536|FG001|Follow-up Period|Death|1|||
163981929|NCT02937818|592304537|FG000|Overall Study|Participants decision|2|||
163981930|NCT02937818|592304538|FG001|Overall Study|Participants decision|1|||
163981931|NCT02937818|592304539|FG002|Overall Study|Participants decision|1|||
163877805|NCT02794480|591921162|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163877806|NCT02794480|591921163|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
163877807|NCT02794480|591921164|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163877808|NCT02794480|591921165|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163877809|NCT02794480|591921162|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
163877810|NCT02794480|591921163|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163877811|NCT02794480|591921164|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163877812|NCT02794480|591921165|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
163877813|NCT01070069|591921166|FG000|Overall Study|Death|1|||
163877814|NCT01070069|591921167|FG001|Overall Study|Death|0|||
163877815|NCT01070069|591921168|FG002|Overall Study|Death|2|||
163877816|NCT01070069|591921169|FG003|Overall Study|Death|0|||
163877817|NCT01070069|591921170|FG004|Overall Study|Death|1|||
163877818|NCT01070069|591921166|FG000|Overall Study|Withdrawal by Subject|1|||
163877819|NCT01070069|591921167|FG001|Overall Study|Withdrawal by Subject|1|||
163877820|NCT01070069|591921168|FG002|Overall Study|Withdrawal by Subject|4|||
163877821|NCT01070069|591921169|FG003|Overall Study|Withdrawal by Subject|0|||
163877822|NCT01070069|591921170|FG004|Overall Study|Withdrawal by Subject|0|||
163877823|NCT01070069|591921166|FG000|Overall Study|Lost to Follow-up|4|||
163877824|NCT01070069|591921167|FG001|Overall Study|Lost to Follow-up|1|||
163877825|NCT01070069|591921168|FG002|Overall Study|Lost to Follow-up|0|||
163877826|NCT01070069|591921169|FG003|Overall Study|Lost to Follow-up|0|||
163877827|NCT01070069|591921170|FG004|Overall Study|Lost to Follow-up|3|||
163877828|NCT03101930|591921171|FG000|Overall Study|Withdrawal by Subject|2|||
163877829|NCT03101930|591921172|FG001|Overall Study|Withdrawal by Subject|1|||
163877830|NCT03101930|591921173|FG002|Overall Study|Withdrawal by Subject|2|||
163877831|NCT02814838|591921174|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
163877832|NCT02814838|591921175|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
163877833|NCT02814838|591921174|FG000|Overall Study|Consent withdrawal|1|||
163877834|NCT02814838|591921175|FG001|Overall Study|Consent withdrawal|1|||
163877835|NCT01747486|591921176|FG000|Stage 1|Physician Decision|3|||
163877836|NCT01747486|591921177|FG001|Stage 1|Physician Decision|0|||
163877837|NCT01747486|591921176|FG000|Stage 1|Withdrawal by Subject|4|||
163877838|NCT01747486|591921177|FG001|Stage 1|Withdrawal by Subject|3|||
163877839|NCT01747486|591921176|FG000|Stage 1|Disease progression|4|||
163877840|NCT01747486|591921177|FG001|Stage 1|Disease progression|9|||
163877841|NCT01747486|591921176|FG000|Stage 1|Death|1|||
163877842|NCT01747486|591921177|FG001|Stage 1|Death|1|||
163877843|NCT01747486|591921176|FG000|Stage 2|Physician Decision|2|||
163877844|NCT01747486|591921177|FG001|Stage 2|Physician Decision|0|||
163877845|NCT01747486|591921176|FG000|Stage 2|Withdrawal by Subject|1|||
163877846|NCT01747486|591921177|FG001|Stage 2|Withdrawal by Subject|0|||
163877847|NCT01747486|591921176|FG000|Stage 2|New Cancer Therapy|3|||
163877848|NCT01747486|591921177|FG001|Stage 2|New Cancer Therapy|0|||
163877849|NCT01747486|591921176|FG000|Stage 2|Disease Progression|3|||
163877850|NCT01747486|591921177|FG001|Stage 2|Disease Progression|0|||
163877851|NCT00632749|591921178|FG000|Overall Study|Progressive disease|3|||
163877852|NCT00632749|591921179|FG001|Overall Study|Progressive disease|2|||
163981932|NCT02937818|592304540|FG003|Overall Study|Participants decision|1|||
163877853|NCT00632749|591921180|FG002|Overall Study|Progressive disease|2|||
163877854|NCT00632749|591921181|FG003|Overall Study|Progressive disease|2|||
163877855|NCT00632749|591921182|FG004|Overall Study|Progressive disease|4|||
163877856|NCT00632749|591921183|FG005|Overall Study|Progressive disease|4|||
163877857|NCT00632749|591921184|FG006|Overall Study|Progressive disease|3|||
163877858|NCT00632749|591921185|FG007|Overall Study|Progressive disease|2|||
163877859|NCT00632749|591921186|FG008|Overall Study|Progressive disease|3|||
163877860|NCT00632749|591921187|FG009|Overall Study|Progressive disease|2|||
163877861|NCT00632749|591921188|FG010|Overall Study|Progressive disease|4|||
163877862|NCT00632749|591921189|FG011|Overall Study|Progressive disease|3|||
163877863|NCT00632749|591921190|FG012|Overall Study|Progressive disease|2|||
163877864|NCT00632749|591921191|FG013|Overall Study|Progressive disease|4|||
163877865|NCT00632749|591921178|FG000|Overall Study|Other Adverse event|1|||
163877866|NCT00632749|591921179|FG001|Overall Study|Other Adverse event|1|||
163877867|NCT00632749|591921180|FG002|Overall Study|Other Adverse event|1|||
163877868|NCT00632749|591921181|FG003|Overall Study|Other Adverse event|1|||
163877869|NCT00632749|591921182|FG004|Overall Study|Other Adverse event|2|||
163877870|NCT00632749|591921183|FG005|Overall Study|Other Adverse event|4|||
163877871|NCT00632749|591921184|FG006|Overall Study|Other Adverse event|1|||
163877872|NCT00632749|591921185|FG007|Overall Study|Other Adverse event|2|||
163877873|NCT00632749|591921186|FG008|Overall Study|Other Adverse event|2|||
163877874|NCT00632749|591921187|FG009|Overall Study|Other Adverse event|0|||
163877875|NCT00632749|591921188|FG010|Overall Study|Other Adverse event|1|||
163877876|NCT00632749|591921189|FG011|Overall Study|Other Adverse event|0|||
163877877|NCT00632749|591921190|FG012|Overall Study|Other Adverse event|1|||
163877878|NCT00632749|591921191|FG013|Overall Study|Other Adverse event|0|||
163877879|NCT00632749|591921178|FG000|Overall Study|Refuse to continue medication|0|||
163877880|NCT00632749|591921179|FG001|Overall Study|Refuse to continue medication|0|||
163877881|NCT00632749|591921180|FG002|Overall Study|Refuse to continue medication|0|||
163877882|NCT00632749|591921181|FG003|Overall Study|Refuse to continue medication|1|||
163877883|NCT00632749|591921182|FG004|Overall Study|Refuse to continue medication|0|||
163877884|NCT00632749|591921183|FG005|Overall Study|Refuse to continue medication|0|||
163877885|NCT00632749|591921184|FG006|Overall Study|Refuse to continue medication|0|||
163877886|NCT00632749|591921185|FG007|Overall Study|Refuse to continue medication|0|||
163877887|NCT00632749|591921186|FG008|Overall Study|Refuse to continue medication|0|||
163877888|NCT00632749|591921187|FG009|Overall Study|Refuse to continue medication|1|||
163877889|NCT00632749|591921188|FG010|Overall Study|Refuse to continue medication|0|||
163877890|NCT00632749|591921189|FG011|Overall Study|Refuse to continue medication|0|||
163877891|NCT00632749|591921190|FG012|Overall Study|Refuse to continue medication|0|||
163877892|NCT00632749|591921191|FG013|Overall Study|Refuse to continue medication|0|||
163877893|NCT00632749|591921178|FG000|Overall Study|Reason other than those specified above|0|||
163877894|NCT00632749|591921179|FG001|Overall Study|Reason other than those specified above|2|||
163877895|NCT00632749|591921180|FG002|Overall Study|Reason other than those specified above|0|||
163877896|NCT00632749|591921181|FG003|Overall Study|Reason other than those specified above|0|||
163877897|NCT00632749|591921182|FG004|Overall Study|Reason other than those specified above|1|||
163877898|NCT00632749|591921183|FG005|Overall Study|Reason other than those specified above|0|||
163877899|NCT00632749|591921184|FG006|Overall Study|Reason other than those specified above|1|||
163877900|NCT00632749|591921185|FG007|Overall Study|Reason other than those specified above|0|||
163877901|NCT00632749|591921186|FG008|Overall Study|Reason other than those specified above|0|||
163877902|NCT00632749|591921187|FG009|Overall Study|Reason other than those specified above|0|||
163877903|NCT00632749|591921188|FG010|Overall Study|Reason other than those specified above|2|||
163877904|NCT00632749|591921189|FG011|Overall Study|Reason other than those specified above|1|||
163877905|NCT00632749|591921190|FG012|Overall Study|Reason other than those specified above|0|||
163877906|NCT00632749|591921191|FG013|Overall Study|Reason other than those specified above|2|||
163877907|NCT00611559|591921192|FG000|Overall Study|Lost to Follow-up|0|||
163877908|NCT00611559|591921193|FG001|Overall Study|Lost to Follow-up|1|||
163877909|NCT00611559|591921194|FG002|Overall Study|Lost to Follow-up|0|||
163877910|NCT00611559|591921192|FG000|Overall Study|Protocol Violation|1|||
163877911|NCT00611559|591921193|FG001|Overall Study|Protocol Violation|0|||
163877912|NCT00611559|591921194|FG002|Overall Study|Protocol Violation|1|||
163877913|NCT00879333|591921195|FG000|Overall Study|Adverse Event|94|||
163877914|NCT00879333|591921196|FG001|Overall Study|Adverse Event|34|||
163877915|NCT00879333|591921195|FG000|Overall Study|Abnormal Laboratory Value|1|||
163877916|NCT00879333|591921196|FG001|Overall Study|Abnormal Laboratory Value|0|||
163877917|NCT00879333|591921195|FG000|Overall Study|Withdrawal by Subject|20|||
163877918|NCT00879333|591921196|FG001|Overall Study|Withdrawal by Subject|7|||
163877919|NCT00879333|591921195|FG000|Overall Study|Lost to Follow-up|2|||
163877920|NCT00879333|591921196|FG001|Overall Study|Lost to Follow-up|1|||
163877921|NCT00879333|591921195|FG000|Overall Study|Administrative Problems|2|||
163877922|NCT00879333|591921196|FG001|Overall Study|Administrative Problems|0|||
163877923|NCT00879333|591921195|FG000|Overall Study|Death|16|||
163877924|NCT00879333|591921196|FG001|Overall Study|Death|5|||
163877925|NCT00879333|591921195|FG000|Overall Study|Disease Progression|292|||
163877926|NCT00879333|591921196|FG001|Overall Study|Disease Progression|169|||
163877927|NCT00879333|591921195|FG000|Overall Study|Protocol Violation|1|||
163981933|NCT02937818|592304537|FG000|Overall Study|Adverse Event|2|||
163981934|NCT02937818|592304538|FG001|Overall Study|Adverse Event|4|||
163981935|NCT02937818|592304539|FG002|Overall Study|Adverse Event|1|||
163981936|NCT02937818|592304540|FG003|Overall Study|Adverse Event|1|||
163877928|NCT00879333|591921196|FG001|Overall Study|Protocol Violation|1|||
163877929|NCT05321069|591921199|FG000|Overall Study|Adverse Event|52|||
163877930|NCT05321069|591921200|FG001|Overall Study|Adverse Event|52|||
163877931|NCT05321069|591921201|FG002|Overall Study|Adverse Event|64|||
163877932|NCT05321069|591921199|FG000|Overall Study|Protocol Violation|1|||
163877933|NCT05321069|591921200|FG001|Overall Study|Protocol Violation|1|||
163877934|NCT05321069|591921201|FG002|Overall Study|Protocol Violation|0|||
163877935|NCT05321069|591921199|FG000|Overall Study|Withdrawal by Subject|23|||
163877936|NCT05321069|591921200|FG001|Overall Study|Withdrawal by Subject|18|||
163877937|NCT05321069|591921201|FG002|Overall Study|Withdrawal by Subject|12|||
164078842|NCT01684722|592653873|FG003|Overall Study|Death|21|||
164218820|NCT00086307|593168481|FG001|Overall Study|Lack of Efficacy|1|||
164218821|NCT00086307|593168482|FG002|Overall Study|Lack of Efficacy|2|||
164218822|NCT00086307|593168480|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
163877938|NCT05321069|591921199|FG000|Overall Study|Lost to Follow-up|1|||
163877939|NCT05321069|591921200|FG001|Overall Study|Lost to Follow-up|0|||
163877940|NCT05321069|591921201|FG002|Overall Study|Lost to Follow-up|1|||
163877941|NCT05321069|591921199|FG000|Overall Study|No reason stated by the participants|23|||
163877942|NCT05321069|591921200|FG001|Overall Study|No reason stated by the participants|22|||
163877943|NCT05321069|591921201|FG002|Overall Study|No reason stated by the participants|16|||
163877944|NCT05321069|591921199|FG000|Overall Study|Lack of Efficacy|1|||
163877945|NCT05321069|591921200|FG001|Overall Study|Lack of Efficacy|1|||
163877946|NCT05321069|591921201|FG002|Overall Study|Lack of Efficacy|0|||
163877947|NCT05048186|591921204|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
163877948|NCT05048186|591921205|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
163877949|NCT05048186|591921204|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
163877950|NCT05048186|591921205|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
163877951|NCT02412748|591921206|FG000|Overall Study|Lost to Follow-up|38|||
163877952|NCT02412748|591921207|FG001|Overall Study|Lost to Follow-up|39|||
163877953|NCT04218266|591921210|FG000|Overall Study|Death|1|||
163877954|NCT04218266|591921211|FG001|Overall Study|Death|2|||
163877955|NCT04218266|591921212|FG002|Overall Study|Death|3|||
163877956|NCT04218266|591921210|FG000|Overall Study|Adverse Event|13|||
163877957|NCT04218266|591921211|FG001|Overall Study|Adverse Event|14|||
163877958|NCT04218266|591921212|FG002|Overall Study|Adverse Event|11|||
163877959|NCT04218266|591921210|FG000|Overall Study|Other|7|||
163877960|NCT04218266|591921211|FG001|Overall Study|Other|5|||
163877961|NCT04218266|591921212|FG002|Overall Study|Other|14|||
163877962|NCT04218266|591921210|FG000|Overall Study|Physician Decision|1|||
163877963|NCT04218266|591921211|FG001|Overall Study|Physician Decision|3|||
163877964|NCT04218266|591921212|FG002|Overall Study|Physician Decision|2|||
163877965|NCT04218266|591921210|FG000|Overall Study|Non-compliance with study drug|0|||
163877966|NCT04218266|591921211|FG001|Overall Study|Non-compliance with study drug|0|||
163877967|NCT04218266|591921212|FG002|Overall Study|Non-compliance with study drug|1|||
163877968|NCT04218266|591921210|FG000|Overall Study|Withdrawal by Subject|1|||
163877969|NCT04218266|591921211|FG001|Overall Study|Withdrawal by Subject|3|||
163877970|NCT04218266|591921212|FG002|Overall Study|Withdrawal by Subject|1|||
163877971|NCT04218266|591921210|FG000|Overall Study|Study drug never administered|2|||
163877972|NCT04218266|591921211|FG001|Overall Study|Study drug never administered|0|||
163877973|NCT04218266|591921212|FG002|Overall Study|Study drug never administered|0|||
163877974|NCT04820686|591921217|FG000|Overall Study|Withdrawal by Subject|5|||
163877975|NCT04820686|591921218|FG001|Overall Study|Withdrawal by Subject|2|||
163877976|NCT04820686|591921219|FG002|Overall Study|Withdrawal by Subject|3|||
163877977|NCT04820686|591921217|FG000|Overall Study|Study Termination|25|||
163877978|NCT04820686|591921218|FG001|Overall Study|Study Termination|13|||
163877979|NCT04820686|591921219|FG002|Overall Study|Study Termination|14|||
163877980|NCT04820686|591921217|FG000|Overall Study|Adverse Event|0|||
163877981|NCT04820686|591921218|FG001|Overall Study|Adverse Event|1|||
163877982|NCT04820686|591921219|FG002|Overall Study|Adverse Event|0|||
163877983|NCT01424670|591921220|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
163877984|NCT01424670|591921221|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
163877985|NCT01424670|591921220|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
163877986|NCT01424670|591921221|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
163877987|NCT01424670|591921220|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
163877988|NCT01424670|591921221|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
163877989|NCT01424670|591921220|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
163877990|NCT01424670|591921221|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
163877991|NCT01424670|591921220|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
163877992|NCT01424670|591921221|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
163877993|NCT01424670|591921220|FG000|Continuation Period|Adverse Event|13|||
163877994|NCT01424670|591921221|FG001|Continuation Period|Adverse Event|5|||
163877995|NCT01424670|591921220|FG000|Continuation Period|Lost to Follow-up|2|||
163877996|NCT01424670|591921221|FG001|Continuation Period|Lost to Follow-up|0|||
163877997|NCT01424670|591921220|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
163877998|NCT01424670|591921221|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
163877999|NCT01424670|591921220|FG000|Continuation Period|Physician Decision|5|||
163878000|NCT01424670|591921221|FG001|Continuation Period|Physician Decision|4|||
163878001|NCT01424670|591921220|FG000|Continuation Period|Withdrawal by Subject|13|||
163878002|NCT01424670|591921221|FG001|Continuation Period|Withdrawal by Subject|4|||
163878003|NCT00761189|591921222|FG000|Overall Study|Adverse Event|42|||
163878004|NCT00761189|591921222|FG000|Overall Study|Lack of Efficacy|45|||
163878005|NCT00761189|591921222|FG000|Overall Study|Lost to Follow-up|36|||
163878006|NCT00761189|591921222|FG000|Overall Study|Withdrawal by Subject|49|||
163878007|NCT00761189|591921222|FG000|Overall Study|Other|13|||
164078843|NCT01664494|592653874|FG000|Overall Study|Withdrawal by Subject|27|||
163981937|NCT02937818|592304537|FG000|Overall Study|Disease progression|17|||
163981938|NCT02937818|592304538|FG001|Overall Study|Disease progression|15|||
163981939|NCT02937818|592304539|FG002|Overall Study|Disease progression|7|||
163981940|NCT02937818|592304540|FG003|Overall Study|Disease progression|19|||
163981941|NCT02937818|592304537|FG000|Overall Study|Condition under investigation worsened|0|||
163981942|NCT02937818|592304538|FG001|Overall Study|Condition under investigation worsened|0|||
163981943|NCT02937818|592304539|FG002|Overall Study|Condition under investigation worsened|1|||
163981944|NCT02937818|592304540|FG003|Overall Study|Condition under investigation worsened|0|||
163981945|NCT01692301|592304541|FG000|Overall Study|Adverse Event|15|||
164078844|NCT01664494|592653874|FG000|Overall Study|Death|18|||
164078845|NCT01664494|592653874|FG000|Overall Study|Other|49|||
164078846|NCT01664494|592653874|FG000|Overall Study|Lost to Follow-up|99|||
164218823|NCT00086307|593168481|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
164218824|NCT00086307|593168482|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
164078847|NCT00219557|592653875|FG000|Phase 1|Lack of Efficacy|3|||
164078848|NCT00219557|592653876|FG001|Phase 1|Lack of Efficacy|0|||
164078849|NCT00219557|592653877|FG002|Phase 1|Lack of Efficacy|0|||
164078850|NCT00219557|592653875|FG000|Phase 1|Adverse Event|2|||
164078851|NCT00219557|592653876|FG001|Phase 1|Adverse Event|0|||
164078852|NCT00219557|592653877|FG002|Phase 1|Adverse Event|0|||
164078853|NCT00219557|592653875|FG000|Phase 1|Withdrawal by Subject|1|||
164078854|NCT00219557|592653876|FG001|Phase 1|Withdrawal by Subject|0|||
164078855|NCT00219557|592653877|FG002|Phase 1|Withdrawal by Subject|0|||
164078856|NCT00219557|592653875|FG000|Phase 1|Started chemotherapy at other institute|1|||
164078857|NCT00219557|592653876|FG001|Phase 1|Started chemotherapy at other institute|0|||
164078858|NCT00219557|592653877|FG002|Phase 1|Started chemotherapy at other institute|0|||
164078859|NCT00219557|592653875|FG000|Phase 2|Lack of Efficacy|0|||
164078860|NCT00219557|592653876|FG001|Phase 2|Lack of Efficacy|21|||
164078861|NCT00219557|592653877|FG002|Phase 2|Lack of Efficacy|15|||
164078862|NCT00219557|592653875|FG000|Phase 2|Adverse Event|0|||
164078863|NCT00219557|592653876|FG001|Phase 2|Adverse Event|22|||
164078864|NCT00219557|592653877|FG002|Phase 2|Adverse Event|2|||
164078865|NCT00219557|592653875|FG000|Phase 2|Death|0|||
164078866|NCT00219557|592653876|FG001|Phase 2|Death|8|||
164078867|NCT00219557|592653877|FG002|Phase 2|Death|2|||
164078868|NCT00219557|592653875|FG000|Phase 2|Other|0|||
164078869|NCT00219557|592653876|FG001|Phase 2|Other|8|||
164078870|NCT00219557|592653877|FG002|Phase 2|Other|6|||
164078871|NCT00219557|592653875|FG000|Phase 2|Withdrawal by Subject|0|||
164078872|NCT00219557|592653876|FG001|Phase 2|Withdrawal by Subject|9|||
164078873|NCT00219557|592653877|FG002|Phase 2|Withdrawal by Subject|5|||
164078874|NCT00219557|592653875|FG000|Phase 2|Treatment not received|0|||
164078875|NCT00219557|592653876|FG001|Phase 2|Treatment not received|1|||
164078876|NCT00219557|592653877|FG002|Phase 2|Treatment not received|3|||
164078877|NCT03063632|592653878|FG000|Overall Study|Death|4|||
164078878|NCT03063632|592653879|FG001|Overall Study|Death|6|||
164078879|NCT03063632|592653878|FG000|Overall Study|Lost to Follow-up|0|||
164078880|NCT03063632|592653879|FG001|Overall Study|Lost to Follow-up|1|||
164078881|NCT03063632|592653878|FG000|Overall Study|Withdrawal by Subject|0|||
164078882|NCT03063632|592653879|FG001|Overall Study|Withdrawal by Subject|2|||
164078883|NCT03063632|592653878|FG000|Overall Study|Physician Decision|2|||
164078884|NCT03063632|592653879|FG001|Overall Study|Physician Decision|0|||
164078885|NCT03063632|592653878|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
164078886|NCT03063632|592653879|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
164078887|NCT01612156|592653880|FG000|Overall Study|Protocol Violation|2|||
164078888|NCT01612156|592653881|FG001|Overall Study|Protocol Violation|0|||
164078889|NCT00410410|592653882|FG000|Induction Period (IP)|Death|1|||
164078890|NCT00410410|592653883|FG001|Induction Period (IP)|Death|0|||
164078891|NCT00410410|592653884|FG002|Induction Period (IP)|Death|0|||
164078892|NCT00410410|592653885|FG003|Induction Period (IP)|Death|0|||
164078893|NCT00410410|592653886|FG004|Induction Period (IP)|Death|0|||
164078894|NCT00410410|592653887|FG005|Induction Period (IP)|Death|0|||
164078895|NCT00410410|592653888|FG006|Induction Period (IP)|Death|0|||
164078896|NCT00410410|592653889|FG007|Induction Period (IP)|Death|0|||
164078897|NCT00410410|592653890|FG008|Induction Period (IP)|Death|0|||
164078898|NCT00410410|592653882|FG000|Induction Period (IP)|Adverse Event|3|||
164218825|NCT00086307|593168480|FG000|Overall Study|Nausea and headaches|0|||
164218826|NCT00086307|593168481|FG001|Overall Study|Nausea and headaches|0|||
164218827|NCT00086307|593168482|FG002|Overall Study|Nausea and headaches|1|||
164078899|NCT00410410|592653883|FG001|Induction Period (IP)|Adverse Event|4|||
164078900|NCT00410410|592653884|FG002|Induction Period (IP)|Adverse Event|2|||
164078901|NCT00410410|592653885|FG003|Induction Period (IP)|Adverse Event|4|||
164078902|NCT00410410|592653886|FG004|Induction Period (IP)|Adverse Event|1|||
164078903|NCT00410410|592653887|FG005|Induction Period (IP)|Adverse Event|0|||
164078904|NCT00410410|592653888|FG006|Induction Period (IP)|Adverse Event|0|||
164078905|NCT00410410|592653889|FG007|Induction Period (IP)|Adverse Event|0|||
164078906|NCT00410410|592653890|FG008|Induction Period (IP)|Adverse Event|0|||
164078907|NCT00410410|592653882|FG000|Induction Period (IP)|Lack of Efficacy|26|||
163981946|NCT01692301|592304542|FG001|Overall Study|Adverse Event|12|||
163981947|NCT01692301|592304541|FG000|Overall Study|Death|1|||
163981948|NCT01692301|592304542|FG001|Overall Study|Death|2|||
163981949|NCT01692301|592304541|FG000|Overall Study|Lack of Efficacy|0|||
163981950|NCT01692301|592304542|FG001|Overall Study|Lack of Efficacy|5|||
163981951|NCT01692301|592304541|FG000|Overall Study|Non-compliance with study treatment|1|||
163981952|NCT01692301|592304542|FG001|Overall Study|Non-compliance with study treatment|2|||
163981953|NCT01692301|592304541|FG000|Overall Study|Protocol deviation|9|||
163981954|NCT01692301|592304542|FG001|Overall Study|Protocol deviation|2|||
163981955|NCT01692301|592304541|FG000|Overall Study|Patient/guardian decision|16|||
163981956|NCT01692301|592304542|FG001|Overall Study|Patient/guardian decision|15|||
163981957|NCT01692301|592304541|FG000|Overall Study|Technical problems|0|||
163981958|NCT01692301|592304542|FG001|Overall Study|Technical problems|1|||
163981959|NCT01692301|592304541|FG000|Overall Study|Physician Decision|2|||
163981960|NCT01692301|592304542|FG001|Overall Study|Physician Decision|2|||
163981961|NCT01692301|592304541|FG000|Overall Study|Lost to Follow-up|1|||
164328429|NCT00920829|593579484|FG002|Available for Analysis|Protocol Violation|1|||
164328430|NCT00920829|593579485|FG003|Available for Analysis|Protocol Violation|0|||
164328431|NCT00920829|593579482|FG000|Available for Analysis|Required more treatment|0|||
164328432|NCT00920829|593579483|FG001|Available for Analysis|Required more treatment|2|||
164328433|NCT00920829|593579484|FG002|Available for Analysis|Required more treatment|0|||
164328434|NCT00920829|593579485|FG003|Available for Analysis|Required more treatment|1|||
164328435|NCT03875118|593579486|FG000|Overall Study|Withdrawal by Subject|4|||
164328436|NCT03875118|593579487|FG001|Overall Study|Withdrawal by Subject|4|||
164328437|NCT02237911|593579488|FG000|Overall Study|Withdrawal by Subject|4|||
163981962|NCT01692301|592304542|FG001|Overall Study|Lost to Follow-up|1|||
163981963|NCT01142726|592304543|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
163981964|NCT01142726|592304544|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
163981965|NCT01142726|592304545|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
163981966|NCT01142726|592304543|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
163981967|NCT01142726|592304544|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
163981968|NCT01142726|592304545|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
163981969|NCT01142726|592304543|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
163981970|NCT01142726|592304544|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
163981971|NCT01142726|592304545|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
163981972|NCT01142726|592304543|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
163981973|NCT01142726|592304544|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
163981974|NCT01142726|592304545|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
163981975|NCT01142726|592304543|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
163981976|NCT01142726|592304544|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
163981977|NCT01142726|592304545|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
163981978|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
163981979|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
163981980|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
163981981|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
163981982|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
163981983|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
163981984|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
163981985|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
163981986|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
163981987|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
163981988|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
163981989|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
163981990|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
163981991|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
163981992|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
164078908|NCT00410410|592653883|FG001|Induction Period (IP)|Lack of Efficacy|24|||
163981993|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
163981994|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
163981995|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
163981996|NCT01142726|592304543|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
163981997|NCT01142726|592304544|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
163981998|NCT01142726|592304545|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
163981999|NCT01142726|592304543|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
163982000|NCT01142726|592304544|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
163982001|NCT01142726|592304545|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
164078909|NCT00410410|592653884|FG002|Induction Period (IP)|Lack of Efficacy|8|||
164138130|NCT00805467|592868374|FG002|Overall Study|Not reported|3|||
164328438|NCT02237911|593579489|FG001|Overall Study|Withdrawal by Subject|7|||
163878008|NCT01494922|591921223|FG000|Overall Study|Adverse Event|1|||
163878009|NCT04377308|591921224|FG000|Overall Study|Withdrawal by Subject|0|||
163878010|NCT04377308|591921225|FG001|Overall Study|Withdrawal by Subject|1|||
163878011|NCT00709098|591921229|FG000|Double-blind Period|Withdrawal of consent|3|||
163878012|NCT00709098|591921230|FG001|Double-blind Period|Withdrawal of consent|3|||
163878013|NCT00709098|591921231|FG002|Double-blind Period|Withdrawal of consent|0|||
163878014|NCT00709098|591921229|FG000|Double-blind Period|Administrative reason|1|||
163878015|NCT00709098|591921230|FG001|Double-blind Period|Administrative reason|3|||
163878016|NCT00709098|591921231|FG002|Double-blind Period|Administrative reason|0|||
163878017|NCT00709098|591921229|FG000|Double-blind Period|Death|1|||
163878018|NCT00709098|591921230|FG001|Double-blind Period|Death|1|||
163878019|NCT00709098|591921231|FG002|Double-blind Period|Death|0|||
163878020|NCT00709098|591921229|FG000|Double-blind Period|Lost to Follow-up|1|||
163878021|NCT00709098|591921230|FG001|Double-blind Period|Lost to Follow-up|1|||
163878022|NCT00709098|591921231|FG002|Double-blind Period|Lost to Follow-up|0|||
163878023|NCT00709098|591921229|FG000|Open-label Period|Withdrawal of consent|0|||
163878024|NCT00709098|591921230|FG001|Open-label Period|Withdrawal of consent|0|||
163878025|NCT00709098|591921231|FG002|Open-label Period|Withdrawal of consent|7|||
163878026|NCT00709098|591921229|FG000|Open-label Period|Administrative reason|0|||
163878027|NCT00709098|591921230|FG001|Open-label Period|Administrative reason|0|||
163878028|NCT00709098|591921231|FG002|Open-label Period|Administrative reason|5|||
163878029|NCT00709098|591921229|FG000|Open-label Period|Death|0|||
163878030|NCT00709098|591921230|FG001|Open-label Period|Death|0|||
163878031|NCT00709098|591921231|FG002|Open-label Period|Death|1|||
163878032|NCT00709098|591921229|FG000|Open-label Period|Lost to Follow-up|0|||
163878033|NCT00709098|591921230|FG001|Open-label Period|Lost to Follow-up|0|||
163878034|NCT00709098|591921231|FG002|Open-label Period|Lost to Follow-up|1|||
163878035|NCT01037985|591921232|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
163878036|NCT01037985|591921233|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
163878037|NCT01037985|591921232|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
163878038|NCT01037985|591921233|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
163878039|NCT01037985|591921232|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
163878040|NCT01037985|591921233|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
163878041|NCT01037985|591921232|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
163878042|NCT01037985|591921233|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
163878043|NCT00774852|591921237|FG000|Overall Study|Adverse Event|9|||
163878044|NCT00774852|591921238|FG001|Overall Study|Adverse Event|6|||
163878045|NCT00774852|591921237|FG000|Overall Study|Death|2|||
163878046|NCT00774852|591921238|FG001|Overall Study|Death|1|||
163878047|NCT00774852|591921237|FG000|Overall Study|Lack of Efficacy|3|||
163878048|NCT00774852|591921238|FG001|Overall Study|Lack of Efficacy|7|||
163878049|NCT00774852|591921237|FG000|Overall Study|Lost to Follow-up|9|||
163878050|NCT00774852|591921238|FG001|Overall Study|Lost to Follow-up|5|||
163878051|NCT00774852|591921237|FG000|Overall Study|Physician Decision|2|||
163878052|NCT00774852|591921238|FG001|Overall Study|Physician Decision|6|||
163878053|NCT00774852|591921237|FG000|Overall Study|Pregnancy|1|||
163878054|NCT00774852|591921238|FG001|Overall Study|Pregnancy|2|||
163878055|NCT00774852|591921237|FG000|Overall Study|Withdrawal by Subject|2|||
163878056|NCT00774852|591921238|FG001|Overall Study|Withdrawal by Subject|2|||
163878057|NCT00774852|591921237|FG000|Overall Study|Non-responder|15|||
163878058|NCT00774852|591921238|FG001|Overall Study|Non-responder|11|||
163878059|NCT00774852|591921237|FG000|Overall Study|Subject non-compliance|0|||
163878060|NCT00774852|591921238|FG001|Overall Study|Subject non-compliance|1|||
163878061|NCT00774852|591921237|FG000|Overall Study|Protocol Violation|1|||
163878062|NCT00774852|591921238|FG001|Overall Study|Protocol Violation|0|||
163878063|NCT00774852|591921237|FG000|Overall Study|Subject received prohibited medication|1|||
163878064|NCT00774852|591921238|FG001|Overall Study|Subject received prohibited medication|0|||
163878065|NCT04428112|591921239|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
163878066|NCT04428112|591921240|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
163878067|NCT04428112|591921239|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
163878068|NCT04428112|591921240|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
163878069|NCT04428112|591921239|FG000|Overall Study|Withdrawal by Subject|9|||
163878070|NCT04428112|591921240|FG001|Overall Study|Withdrawal by Subject|4|||
163878071|NCT04428112|591921239|FG000|Overall Study|Lost to Follow-up|27|||
163878072|NCT04428112|591921240|FG001|Overall Study|Lost to Follow-up|7|||
163878073|NCT04402294|591921243|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
163878074|NCT04402294|591921244|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
163878075|NCT04402294|591921243|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
163878076|NCT04402294|591921244|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
163878077|NCT04459416|591922702|FG000|Overall Study|Lost to Follow-up|2|||
163878078|NCT04459416|591922703|FG001|Overall Study|Lost to Follow-up|0|||
163878079|NCT04459416|591922702|FG000|Overall Study|Withdrawal by Subject|8|||
163982002|NCT01142726|592304543|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
163982003|NCT01142726|592304544|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
163982004|NCT01142726|592304545|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
163982005|NCT01142726|592304543|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
163982006|NCT01142726|592304544|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
163982007|NCT01142726|592304545|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
163982008|NCT01142726|592304543|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
163982009|NCT01142726|592304544|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
163982010|NCT01142726|592304545|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
163982011|NCT01568593|592304546|FG000|Overall Study|Lack of Efficacy|4|||
163982012|NCT01568593|592304547|FG001|Overall Study|Lack of Efficacy|1|||
163982013|NCT01568593|592304546|FG000|Overall Study|Adverse Event|3|||
163982014|NCT01568593|592304547|FG001|Overall Study|Adverse Event|2|||
163982015|NCT02109484|592304548|FG000|Overall Study|Lost to Follow-up|0|||
163982016|NCT02109484|592304549|FG001|Overall Study|Lost to Follow-up|0|||
163982017|NCT02109484|592304550|FG002|Overall Study|Lost to Follow-up|0|||
163982018|NCT02109484|592304551|FG003|Overall Study|Lost to Follow-up|1|||
163982019|NCT02109484|592304552|FG004|Overall Study|Lost to Follow-up|1|||
163982020|NCT02109484|592304553|FG005|Overall Study|Lost to Follow-up|0|||
163982021|NCT02109484|592304554|FG006|Overall Study|Lost to Follow-up|1|||
163982022|NCT02109484|592304555|FG007|Overall Study|Lost to Follow-up|0|||
163982023|NCT02109484|592304548|FG000|Overall Study|Withdrawal by Subject|0|||
163982024|NCT02109484|592304549|FG001|Overall Study|Withdrawal by Subject|0|||
163982025|NCT02109484|592304550|FG002|Overall Study|Withdrawal by Subject|0|||
163982026|NCT02109484|592304551|FG003|Overall Study|Withdrawal by Subject|0|||
163982027|NCT02109484|592304552|FG004|Overall Study|Withdrawal by Subject|1|||
163982028|NCT02109484|592304553|FG005|Overall Study|Withdrawal by Subject|1|||
163982029|NCT02109484|592304554|FG006|Overall Study|Withdrawal by Subject|1|||
163982030|NCT02109484|592304555|FG007|Overall Study|Withdrawal by Subject|0|||
163982031|NCT02109484|592304548|FG000|Overall Study|Physician Decision|0|||
163982032|NCT02109484|592304549|FG001|Overall Study|Physician Decision|0|||
163982033|NCT02109484|592304550|FG002|Overall Study|Physician Decision|0|||
163982034|NCT02109484|592304551|FG003|Overall Study|Physician Decision|0|||
163982035|NCT02109484|592304552|FG004|Overall Study|Physician Decision|2|||
163982036|NCT02109484|592304553|FG005|Overall Study|Physician Decision|0|||
163982037|NCT02109484|592304554|FG006|Overall Study|Physician Decision|0|||
163982038|NCT02109484|592304555|FG007|Overall Study|Physician Decision|0|||
163982039|NCT02109484|592304548|FG000|Overall Study|Death|0|||
163982040|NCT02109484|592304549|FG001|Overall Study|Death|0|||
163982041|NCT02109484|592304550|FG002|Overall Study|Death|0|||
163982042|NCT02109484|592304551|FG003|Overall Study|Death|0|||
163982043|NCT02109484|592304552|FG004|Overall Study|Death|0|||
163982044|NCT02109484|592304553|FG005|Overall Study|Death|0|||
163982045|NCT02109484|592304554|FG006|Overall Study|Death|0|||
163982046|NCT02109484|592304555|FG007|Overall Study|Death|2|||
163982047|NCT02109484|592304548|FG000|Overall Study|Moved away from study area|0|||
163982048|NCT02109484|592304549|FG001|Overall Study|Moved away from study area|0|||
163982049|NCT02109484|592304550|FG002|Overall Study|Moved away from study area|0|||
163982050|NCT02109484|592304551|FG003|Overall Study|Moved away from study area|0|||
163982051|NCT02109484|592304552|FG004|Overall Study|Moved away from study area|0|||
163982052|NCT02109484|592304553|FG005|Overall Study|Moved away from study area|0|||
163982053|NCT02109484|592304554|FG006|Overall Study|Moved away from study area|1|||
163982054|NCT02109484|592304555|FG007|Overall Study|Moved away from study area|1|||
163982055|NCT00796315|592304556|FG000|Overall Study|Protocol Violation|0|||
163982056|NCT00796315|592304557|FG001|Overall Study|Protocol Violation|1|||
163982057|NCT00796315|592304558|FG002|Overall Study|Protocol Violation|0|||
163982058|NCT00574275|592304559|FG000|Overall Study|Randomized but not treated|2|||
163982059|NCT00574275|592304560|FG001|Overall Study|Randomized but not treated|3|||
163982060|NCT00574275|592304559|FG000|Overall Study|Adverse Event|32|||
163982061|NCT00574275|592304560|FG001|Overall Study|Adverse Event|76|||
163982062|NCT00574275|592304559|FG000|Overall Study|Disease progression|160|||
163982063|NCT00574275|592304560|FG001|Overall Study|Disease progression|146|||
163982064|NCT00574275|592304559|FG000|Overall Study|Lost to Follow-up|2|||
163982065|NCT00574275|592304560|FG001|Overall Study|Lost to Follow-up|1|||
163982066|NCT00574275|592304559|FG000|Overall Study|Study stopped based on DMC decision|62|||
163982067|NCT00574275|592304560|FG001|Overall Study|Study stopped based on DMC decision|23|||
163982068|NCT00574275|592304559|FG000|Overall Study|Withdrawal by Subject|15|||
163982069|NCT00574275|592304560|FG001|Overall Study|Withdrawal by Subject|17|||
163982070|NCT00574275|592304559|FG000|Overall Study|Error calculating tumor measurement|1|||
163982071|NCT00574275|592304560|FG001|Overall Study|Error calculating tumor measurement|0|||
163982072|NCT00574275|592304559|FG000|Overall Study|Physician Decision|1|||
163982073|NCT00574275|592304560|FG001|Overall Study|Physician Decision|1|||
163982074|NCT00574275|592304559|FG000|Overall Study|Protocol Violation|0|||
163982075|NCT00574275|592304560|FG001|Overall Study|Protocol Violation|1|||
163982076|NCT00574275|592304559|FG000|Overall Study|Patient and Investigator decision|0|||
163982077|NCT00574275|592304560|FG001|Overall Study|Patient and Investigator decision|1|||
163982078|NCT00574275|592304559|FG000|Overall Study|Insurance change|0|||
164078910|NCT00410410|592653885|FG003|Induction Period (IP)|Lack of Efficacy|8|||
164078911|NCT00410410|592653886|FG004|Induction Period (IP)|Lack of Efficacy|7|||
164078912|NCT00410410|592653887|FG005|Induction Period (IP)|Lack of Efficacy|7|||
164328439|NCT02237911|593579490|FG002|Overall Study|Withdrawal by Subject|2|||
164328440|NCT02237911|593579488|FG000|Overall Study|Lost to Follow-up|3|||
164328441|NCT02237911|593579489|FG001|Overall Study|Lost to Follow-up|1|||
164328442|NCT02237911|593579490|FG002|Overall Study|Lost to Follow-up|1|||
164328443|NCT00721123|593579491|FG000|Overall Study|Adverse Event|96|||
164328444|NCT00721123|593579491|FG000|Overall Study|Death|10|||
164328445|NCT00721123|593579491|FG000|Overall Study|Insufficient Therapeutic Response|21|||
164328446|NCT00721123|593579491|FG000|Overall Study|Protocol Violation|1|||
164328447|NCT00721123|593579491|FG000|Overall Study|Refused Treatment|41|||
164328448|NCT00721123|593579491|FG000|Overall Study|Failure to Return|9|||
164328449|NCT00721123|593579491|FG000|Overall Study|Withdrawal by Subject|5|||
164328450|NCT03468985|593579492|FG000|Overall Study|Adverse Event|0|||
164328451|NCT03468985|593579493|FG001|Overall Study|Adverse Event|2|||
164328452|NCT03468985|593579494|FG002|Overall Study|Adverse Event|0|||
164328453|NCT03468985|593579495|FG003|Overall Study|Adverse Event|0|||
164328454|NCT03468985|593579492|FG000|Overall Study|Withdrawal by Subject|0|||
164328455|NCT03468985|593579493|FG001|Overall Study|Withdrawal by Subject|0|||
164328456|NCT03468985|593579494|FG002|Overall Study|Withdrawal by Subject|0|||
164328457|NCT03468985|593579495|FG003|Overall Study|Withdrawal by Subject|1|||
164328458|NCT03981822|593579496|FG000|Overall Study|Lost to Follow-up|0|||
164328459|NCT03981822|593579497|FG001|Overall Study|Lost to Follow-up|1|||
164328460|NCT03981822|593579498|FG002|Overall Study|Lost to Follow-up|1|||
164328461|NCT03981822|593579499|FG003|Overall Study|Lost to Follow-up|0|||
164328462|NCT03981822|593579500|FG004|Overall Study|Lost to Follow-up|6|||
164328463|NCT03981822|593579501|FG005|Overall Study|Lost to Follow-up|4|||
164328464|NCT03981822|593579502|FG006|Overall Study|Lost to Follow-up|4|||
164328465|NCT03981822|593579503|FG007|Overall Study|Lost to Follow-up|2|||
164328466|NCT03981822|593579496|FG000|Overall Study|Withdrawal by Subject|0|||
164328467|NCT03981822|593579497|FG001|Overall Study|Withdrawal by Subject|1|||
163878080|NCT04459416|591922703|FG001|Overall Study|Withdrawal by Subject|10|||
163878081|NCT04459416|591922702|FG000|Overall Study|Disease progression|0|||
163878082|NCT04459416|591922703|FG001|Overall Study|Disease progression|3|||
163878083|NCT04924062|591922704|FG000|Overall Study|Death|49|||
163878084|NCT04924062|591922705|FG001|Overall Study|Death|63|||
163878085|NCT04924062|591922704|FG000|Overall Study|Participant On-going|26|||
163878086|NCT04924062|591922705|FG001|Overall Study|Participant On-going|20|||
163878087|NCT05478525|591922708|FG000|Overall Study|Withdrawal by Subject|0|||
163878088|NCT05478525|591922709|FG001|Overall Study|Withdrawal by Subject|1|||
163878089|NCT05478525|591922710|FG002|Overall Study|Withdrawal by Subject|2|||
163878090|NCT05478525|591922711|FG003|Overall Study|Withdrawal by Subject|0|||
163878091|NCT05478525|591922708|FG000|Overall Study|COVID-19 Infection|2|||
163878092|NCT05478525|591922709|FG001|Overall Study|COVID-19 Infection|0|||
163878093|NCT05478525|591922710|FG002|Overall Study|COVID-19 Infection|1|||
163878094|NCT05478525|591922711|FG003|Overall Study|COVID-19 Infection|1|||
163878095|NCT01649271|591922712|FG000|Overall Study|Progressive disease|4|||
163878096|NCT01649271|591922713|FG001|Overall Study|Progressive disease|5|||
163878097|NCT01649271|591922712|FG000|Overall Study|Other Adverse Event|0|||
163878098|NCT01649271|591922713|FG001|Overall Study|Other Adverse Event|2|||
163878099|NCT01649271|591922712|FG000|Overall Study|Withdrawal by Subject|1|||
163878100|NCT01649271|591922713|FG001|Overall Study|Withdrawal by Subject|0|||
163878101|NCT01649271|591922712|FG000|Overall Study|Other than stated above|1|||
163878102|NCT01649271|591922713|FG001|Overall Study|Other than stated above|0|||
163878103|NCT01991977|591922714|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
163878104|NCT01991977|591922714|FG000|Overall Study|Withdrew after start of treatment|5|||
163878105|NCT04038957|591922716|FG000|Overall Study|Withdrawal by Subject|1|||
163878106|NCT04038957|591922716|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
163878107|NCT05656911|591922721|FG000|Treatment Phase|Physician Decision|2|||
163878108|NCT05656911|591922722|FG001|Treatment Phase|Physician Decision|0|||
163878109|NCT05656911|591922721|FG000|Treatment Phase|Lack of Efficacy|6|||
163878110|NCT05656911|591922722|FG001|Treatment Phase|Lack of Efficacy|3|||
163878111|NCT05656911|591922721|FG000|Treatment Phase|Subject Decision|4|||
163878112|NCT05656911|591922722|FG001|Treatment Phase|Subject Decision|2|||
163878113|NCT05656911|591922721|FG000|Treatment Phase|Other Reasons|1|||
163878114|NCT05656911|591922722|FG001|Treatment Phase|Other Reasons|0|||
163878115|NCT05656911|591922721|FG000|Treatment Phase|Adverse Event|3|||
163878116|NCT05656911|591922722|FG001|Treatment Phase|Adverse Event|1|||
163878117|NCT05656911|591922721|FG000|Follow-up Phase|Subject Decision|0|||
163878118|NCT05656911|591922722|FG001|Follow-up Phase|Subject Decision|1|||
163878119|NCT05656911|591922721|FG000|Follow-up Phase|Missing|1|||
163878120|NCT05656911|591922722|FG001|Follow-up Phase|Missing|0|||
163878121|NCT03547908|591922723|FG000|Blinded Phase|Lost to Follow-up|3|||
164328468|NCT03981822|593579498|FG002|Overall Study|Withdrawal by Subject|0|||
164328469|NCT03981822|593579499|FG003|Overall Study|Withdrawal by Subject|0|||
164328470|NCT03981822|593579500|FG004|Overall Study|Withdrawal by Subject|0|||
164328471|NCT03981822|593579501|FG005|Overall Study|Withdrawal by Subject|1|||
164328472|NCT03981822|593579502|FG006|Overall Study|Withdrawal by Subject|0|||
164328473|NCT03981822|593579503|FG007|Overall Study|Withdrawal by Subject|2|||
164328474|NCT03981822|593579496|FG000|Overall Study|COVID-19 Related|0|||
164328475|NCT03981822|593579497|FG001|Overall Study|COVID-19 Related|0|||
164328476|NCT03981822|593579498|FG002|Overall Study|COVID-19 Related|0|||
164328477|NCT03981822|593579499|FG003|Overall Study|COVID-19 Related|0|||
164328478|NCT03981822|593579500|FG004|Overall Study|COVID-19 Related|2|||
164328479|NCT03981822|593579501|FG005|Overall Study|COVID-19 Related|1|||
164328480|NCT03981822|593579502|FG006|Overall Study|COVID-19 Related|2|||
164328481|NCT03981822|593579503|FG007|Overall Study|COVID-19 Related|1|||
164328482|NCT04521777|593579505|FG000|Overall Study|Death|2|||
164328483|NCT04521777|593579505|FG000|Overall Study|Withdrawal by Subject|2|||
164328484|NCT01143207|593579509|FG000|Overall Study|Lost to Follow-up|2|||
164328485|NCT03416374|593579512|FG000|Between Treatment Period I and II|Other|0|||
164328486|NCT03416374|593579513|FG001|Between Treatment Period I and II|Other|9|||
164328487|NCT03416374|593579512|FG000|Treatment Period II|Lack of Efficacy|3|||
164328488|NCT03416374|593579513|FG001|Treatment Period II|Lack of Efficacy|11|||
164328489|NCT03416374|593579512|FG000|Treatment Period II|Adverse Event|1|||
164328490|NCT03416374|593579513|FG001|Treatment Period II|Adverse Event|4|||
164328491|NCT03416374|593579512|FG000|Treatment Period II|Death|0|||
164328492|NCT03416374|593579513|FG001|Treatment Period II|Death|1|||
164328493|NCT03416374|593579512|FG000|Treatment Period II|Other|0|||
164328494|NCT03416374|593579513|FG001|Treatment Period II|Other|2|||
164328495|NCT03463031|593579514|FG000|Overall Study|Withdrawal by Subject|4|||
164328496|NCT03463031|593579515|FG001|Overall Study|Withdrawal by Subject|2|||
164328497|NCT03463031|593579514|FG000|Overall Study|Investigator/Sponsor Decision|0|||
164328498|NCT03463031|593579515|FG001|Overall Study|Investigator/Sponsor Decision|1|||
164328499|NCT03463031|593579514|FG000|Overall Study|Lost to Follow-up|1|||
164328500|NCT03463031|593579515|FG001|Overall Study|Lost to Follow-up|1|||
164328501|NCT03463031|593579514|FG000|Overall Study|Adverse Event|4|||
164328502|NCT03463031|593579515|FG001|Overall Study|Adverse Event|1|||
164328503|NCT03463031|593579514|FG000|Overall Study|Use of prohibited medication by subject|1|||
164328504|NCT03463031|593579515|FG001|Overall Study|Use of prohibited medication by subject|0|||
164328505|NCT01241240|593579516|FG000|Overall Study|Adverse Event|5|||
164328506|NCT01241240|593579517|FG001|Overall Study|Adverse Event|4|||
164328507|NCT01241240|593579516|FG000|Overall Study|Lost to Follow-up|2|||
164328508|NCT01241240|593579517|FG001|Overall Study|Lost to Follow-up|4|||
164328509|NCT01241240|593579516|FG000|Overall Study|Personal Reasons|1|||
164328510|NCT01241240|593579517|FG001|Overall Study|Personal Reasons|1|||
164328511|NCT01025154|593579518|FG000|Overall Study|Lost to Follow-up|1|||
164328512|NCT01025154|593579518|FG000|Overall Study|Withdrawal by Subject|1|||
164328513|NCT02376829|593579525|FG000|Overall Study|Withdrawal by Subject|27|||
164328514|NCT02376829|593579526|FG001|Overall Study|Withdrawal by Subject|44|||
164328515|NCT00057954|593579527|FG000|Overall Study|Death|1|||
164328516|NCT00057954|593579527|FG000|Overall Study|Disease progression|1|||
164328517|NCT01251744|593579528|FG000|Overall Study|Lost to Follow-up|1|||
164328518|NCT01251744|593579529|FG001|Overall Study|Lost to Follow-up|0|||
164328519|NCT02147184|593579530|FG000|Overall Study|Lost to Follow-up|28|||
164328520|NCT02147184|593579531|FG001|Overall Study|Lost to Follow-up|15|||
164328521|NCT02147184|593579530|FG000|Overall Study|Study Burden|11|||
163878122|NCT03547908|591922724|FG001|Blinded Phase|Lost to Follow-up|3|||
163878123|NCT03547908|591922725|FG002|Blinded Phase|Lost to Follow-up|0|||
163878124|NCT03547908|591922726|FG003|Blinded Phase|Lost to Follow-up|0|||
163878125|NCT03547908|591922723|FG000|Blinded Phase|Withdrew Consent|2|||
163878126|NCT03547908|591922724|FG001|Blinded Phase|Withdrew Consent|3|||
163878127|NCT03547908|591922725|FG002|Blinded Phase|Withdrew Consent|0|||
163878128|NCT03547908|591922726|FG003|Blinded Phase|Withdrew Consent|0|||
163878129|NCT03547908|591922723|FG000|Blinded Phase|Investigator's Discretion|2|||
163878130|NCT03547908|591922724|FG001|Blinded Phase|Investigator's Discretion|1|||
163878131|NCT03547908|591922725|FG002|Blinded Phase|Investigator's Discretion|0|||
163878132|NCT03547908|591922726|FG003|Blinded Phase|Investigator's Discretion|0|||
163878133|NCT03547908|591922723|FG000|Blinded Phase|Death|2|||
163878134|NCT03547908|591922724|FG001|Blinded Phase|Death|0|||
163878135|NCT03547908|591922725|FG002|Blinded Phase|Death|0|||
163878136|NCT03547908|591922726|FG003|Blinded Phase|Death|0|||
163878137|NCT03547908|591922723|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
163878138|NCT03547908|591922724|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
163878139|NCT03547908|591922725|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
163878140|NCT03547908|591922726|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
163878141|NCT03547908|591922723|FG000|Blinded Phase|Adverse Event|1|||
164328522|NCT02147184|593579531|FG001|Overall Study|Study Burden|7|||
164328523|NCT02147184|593579530|FG000|Overall Study|Pregnancy|6|||
164328524|NCT02147184|593579531|FG001|Overall Study|Pregnancy|0|||
164328525|NCT02147184|593579530|FG000|Overall Study|Moved out of state|3|||
164328526|NCT02147184|593579531|FG001|Overall Study|Moved out of state|3|||
164328527|NCT02147184|593579530|FG000|Overall Study|Physician Decision|0|||
163878142|NCT03547908|591922724|FG001|Blinded Phase|Adverse Event|0|||
164328528|NCT02147184|593579531|FG001|Overall Study|Physician Decision|2|||
164328529|NCT02147184|593579530|FG000|Overall Study|Other|1|||
164328530|NCT02147184|593579531|FG001|Overall Study|Other|0|||
163982079|NCT00574275|592304560|FG001|Overall Study|Insurance change|1|||
163982080|NCT00574275|592304559|FG000|Overall Study|Operation for curative intent|0|||
163982081|NCT00574275|592304560|FG001|Overall Study|Operation for curative intent|1|||
163982082|NCT00889265|592304563|FG000|Overall Study|Adverse Event|1|||
163982083|NCT00889265|592304563|FG000|Overall Study|Lost to Follow-up|5|||
163982084|NCT00889265|592304563|FG000|Overall Study|Protocol Violation|1|||
163982085|NCT03028870|592304564|FG000|Overall Study|Adverse Event|7|||
163982086|NCT03028870|592304565|FG001|Overall Study|Adverse Event|4|||
163982087|NCT03028870|592304566|FG002|Overall Study|Adverse Event|3|||
163982088|NCT03028870|592304567|FG003|Overall Study|Adverse Event|3|||
163982089|NCT03028870|592304564|FG000|Overall Study|Withdrawal by Subject|1|||
163982090|NCT03028870|592304565|FG001|Overall Study|Withdrawal by Subject|1|||
163982091|NCT03028870|592304566|FG002|Overall Study|Withdrawal by Subject|1|||
163982092|NCT03028870|592304567|FG003|Overall Study|Withdrawal by Subject|2|||
163982093|NCT03028870|592304564|FG000|Overall Study|Lost to Follow-up|1|||
163982094|NCT03028870|592304565|FG001|Overall Study|Lost to Follow-up|0|||
163982095|NCT03028870|592304566|FG002|Overall Study|Lost to Follow-up|0|||
163982096|NCT03028870|592304567|FG003|Overall Study|Lost to Follow-up|0|||
163982097|NCT03028870|592304564|FG000|Overall Study|Lack of Efficacy|3|||
163982098|NCT03028870|592304565|FG001|Overall Study|Lack of Efficacy|0|||
163982099|NCT03028870|592304566|FG002|Overall Study|Lack of Efficacy|0|||
163982100|NCT03028870|592304567|FG003|Overall Study|Lack of Efficacy|0|||
163982101|NCT03028870|592304564|FG000|Overall Study|Administrative|5|||
163982102|NCT03028870|592304565|FG001|Overall Study|Administrative|5|||
163982103|NCT03028870|592304566|FG002|Overall Study|Administrative|12|||
163982104|NCT03028870|592304567|FG003|Overall Study|Administrative|4|||
163982105|NCT01294579|592304570|FG000|Overall Study|Disease progression|12|||
163982106|NCT01294579|592304570|FG000|Overall Study|Adverse Event|11|||
163982107|NCT01294579|592304570|FG000|Overall Study|Study closed/terminated|3|||
163982108|NCT01294579|592304570|FG000|Overall Study|Lost to Follow-up|1|||
163982109|NCT01294579|592304570|FG000|Overall Study|Physician Decision|3|||
163982110|NCT01294579|592304570|FG000|Overall Study|Withdrawal by Subject|5|||
163982111|NCT02788747|592304571|FG000|Overall Study|Adverse Event|1|||
163982112|NCT02788747|592304572|FG001|Overall Study|Adverse Event|0|||
164218828|NCT00086307|593168480|FG000|Overall Study|Constipation and sleepiness|0|||
164218829|NCT00086307|593168481|FG001|Overall Study|Constipation and sleepiness|0|||
164218830|NCT00086307|593168482|FG002|Overall Study|Constipation and sleepiness|1|||
164218831|NCT00086307|593168480|FG000|Overall Study|Suicidal ideation|0|||
164218832|NCT00086307|593168481|FG001|Overall Study|Suicidal ideation|0|||
164218833|NCT00086307|593168482|FG002|Overall Study|Suicidal ideation|1|||
164218834|NCT00086307|593168480|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
164218835|NCT00086307|593168481|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
163878143|NCT03547908|591922725|FG002|Blinded Phase|Adverse Event|0|||
163878144|NCT03547908|591922726|FG003|Blinded Phase|Adverse Event|0|||
163878145|NCT03547908|591922723|FG000|Blinded Phase|Randomized But Never Treated|1|||
163878146|NCT03547908|591922724|FG001|Blinded Phase|Randomized But Never Treated|0|||
163878147|NCT03547908|591922725|FG002|Blinded Phase|Randomized But Never Treated|0|||
163878148|NCT03547908|591922726|FG003|Blinded Phase|Randomized But Never Treated|0|||
163878149|NCT03547908|591922723|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
163878150|NCT03547908|591922724|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
163878151|NCT03547908|591922725|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
163878152|NCT03547908|591922726|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
163878153|NCT03547908|591922723|FG000|Open-label Extension Phase|Death|0|||
163878154|NCT03547908|591922724|FG001|Open-label Extension Phase|Death|0|||
163878155|NCT03547908|591922725|FG002|Open-label Extension Phase|Death|1|||
163878156|NCT03547908|591922726|FG003|Open-label Extension Phase|Death|0|||
163878157|NCT04059354|591922733|FG000|Overall Study|COVID-19 pandemic|3|||
163878158|NCT00567398|591922734|FG000|Overall Study|Adverse Event|6|||
163878159|NCT00567398|591922735|FG001|Overall Study|Adverse Event|14|||
163878160|NCT00567398|591922734|FG000|Overall Study|Physician Decision|0|||
163878161|NCT00567398|591922735|FG001|Overall Study|Physician Decision|4|||
163878162|NCT00567398|591922734|FG000|Overall Study|Withdrawal by Subject|0|||
163878163|NCT00567398|591922735|FG001|Overall Study|Withdrawal by Subject|2|||
163878164|NCT00567398|591922734|FG000|Overall Study|Renal Transplantation|0|||
163878165|NCT00567398|591922735|FG001|Overall Study|Renal Transplantation|3|||
163878166|NCT00567398|591922734|FG000|Overall Study|Other|1|||
163878167|NCT00567398|591922735|FG001|Overall Study|Other|0|||
163878168|NCT03517553|591922736|FG000|Overall Study|Withdrawal by Subject|2|||
163878169|NCT03271151|591922737|FG000|Overall Study|Lost to Follow-up|1|||
163878170|NCT03271151|591922738|FG001|Overall Study|Lost to Follow-up|3|||
163878171|NCT03271151|591922737|FG000|Overall Study|Withdrawal by Subject|1|||
163878172|NCT03271151|591922738|FG001|Overall Study|Withdrawal by Subject|0|||
163878173|NCT02201108|591922739|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
163878174|NCT02201108|591922740|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
163878175|NCT02201108|591922741|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
163878176|NCT02201108|591922739|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
163878177|NCT02201108|591922740|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
163878178|NCT02201108|591922741|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
163878179|NCT02201108|591922739|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
163878180|NCT02201108|591922740|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
163878181|NCT02201108|591922741|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
163878182|NCT02201108|591922739|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
163878183|NCT02201108|591922740|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
163878184|NCT02201108|591922741|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
163878185|NCT02201108|591922739|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
163878186|NCT02201108|591922740|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
163878187|NCT02201108|591922741|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
163878188|NCT02201108|591922739|FG000|Open Label Period (up to Week 192)|Other reason|4|||
163878189|NCT02201108|591922740|FG001|Open Label Period (up to Week 192)|Other reason|7|||
163878190|NCT02201108|591922741|FG002|Open Label Period (up to Week 192)|Other reason|0|||
163878191|NCT02201108|591922739|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
163878192|NCT02201108|591922740|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
163878193|NCT02201108|591922741|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
163878194|NCT02201108|591922739|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
163878195|NCT02201108|591922740|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
163878196|NCT02201108|591922741|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
163878197|NCT02201108|591922739|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
163878198|NCT02201108|591922740|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
163878199|NCT02201108|591922741|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
163878200|NCT05387447|591922742|FG000|Overall Study|Participants changed their minds about study participation.|3|||
163878201|NCT05387447|591922743|FG001|Overall Study|Participants changed their minds about study participation.|5|||
163878202|NCT01673984|591922744|FG000|Overall Study|Adverse Event|1|||
163878203|NCT01673984|591922745|FG001|Overall Study|Adverse Event|0|||
163878204|NCT01673984|591922744|FG000|Overall Study|Study termination|9|||
163878205|NCT01673984|591922745|FG001|Overall Study|Study termination|6|||
163878206|NCT05919082|591922748|FG000|Overall Study|Adverse Event|3|||
163878207|NCT05919082|591922749|FG001|Overall Study|Adverse Event|0|||
163878208|NCT05919082|591922748|FG000|Overall Study|Lost to Follow-up|0|||
163878209|NCT05919082|591922749|FG001|Overall Study|Lost to Follow-up|1|||
163878210|NCT05919082|591922748|FG000|Overall Study|Withdrawal by Subject|8|||
163878211|NCT05919082|591922749|FG001|Overall Study|Withdrawal by Subject|9|||
163878212|NCT05919082|591922748|FG000|Overall Study|Lack of Efficacy|0|||
163878213|NCT05919082|591922749|FG001|Overall Study|Lack of Efficacy|1|||
163878214|NCT05919082|591922748|FG000|Overall Study|Investigator Decision|1|||
163878215|NCT05919082|591922749|FG001|Overall Study|Investigator Decision|0|||
163878216|NCT02287311|591922753|FG000|Cohort 1: Dose Level 1|Death|2|||
163878217|NCT02287311|591922754|FG001|Cohort 1: Dose Level 1|Death|0|||
163878218|NCT02287311|591922755|FG002|Cohort 1: Dose Level 1|Death|0|||
163878219|NCT02287311|591922756|FG003|Cohort 1: Dose Level 1|Death|3|||
163878220|NCT02287311|591922757|FG004|Cohort 1: Dose Level 1|Death|0|||
163878221|NCT02287311|591922758|FG005|Cohort 1: Dose Level 1|Death|0|||
163878222|NCT02287311|591922759|FG006|Cohort 1: Dose Level 1|Death|1|||
163878223|NCT02287311|591922760|FG007|Cohort 1: Dose Level 1|Death|0|||
163982113|NCT02788747|592304573|FG002|Overall Study|Adverse Event|0|||
163982114|NCT00562354|592304576|FG000|Overall Study|Physician Decision|0|||
163982115|NCT00562354|592304577|FG001|Overall Study|Physician Decision|1|||
163982116|NCT00562354|592304576|FG000|Overall Study|Lost to Follow-up|0|||
163982117|NCT00562354|592304577|FG001|Overall Study|Lost to Follow-up|1|||
163982118|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
163982119|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
163982120|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
163982121|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
163982122|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
163982123|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
163982124|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
163982125|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
163982126|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
163982127|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
163982128|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
163982129|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
163982130|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
163982131|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
163878224|NCT02287311|591922761|FG008|Cohort 1: Dose Level 1|Death|0|||
163982132|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
163982133|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
163982134|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
164138131|NCT00805467|592868375|FG003|Overall Study|Not reported|7|||
164328531|NCT02117414|593579532|FG000|Overall Study|Death|5|||
164328532|NCT02117414|593579533|FG001|Overall Study|Death|2|||
164328533|NCT02117414|593579532|FG000|Overall Study|Withdrawal by Subject|10|||
164328534|NCT02117414|593579533|FG001|Overall Study|Withdrawal by Subject|4|||
164328535|NCT02663687|593579535|FG000|Overall Study|Adverse Event|1|||
164328536|NCT02663687|593579536|FG001|Overall Study|Adverse Event|0|||
164328537|NCT02663687|593579537|FG002|Overall Study|Adverse Event|0|||
164328538|NCT02663687|593579538|FG003|Overall Study|Adverse Event|0|||
164328539|NCT02663687|593579539|FG004|Overall Study|Adverse Event|0|||
164328540|NCT02663687|593579535|FG000|Overall Study|Other|1|||
164328541|NCT02663687|593579536|FG001|Overall Study|Other|0|||
164328542|NCT02663687|593579537|FG002|Overall Study|Other|1|||
164328543|NCT02663687|593579538|FG003|Overall Study|Other|0|||
164328544|NCT02663687|593579539|FG004|Overall Study|Other|0|||
164328545|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
164328546|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
164328547|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
164328548|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
164328549|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
164328550|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
164328551|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
164328552|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
164328553|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
164328554|NCT00417482|593579540|FG000|Phase B 1st 16 Weeks|Death|1|||
164328555|NCT00417482|593579541|FG001|Phase B 1st 16 Weeks|Death|0|||
164328556|NCT00417482|593579542|FG002|Phase B 1st 16 Weeks|Death|0|||
164328557|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
164328558|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
164328559|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
164328560|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
164328561|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
164328562|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
164328563|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
164328564|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
164328565|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
164328566|NCT00417482|593579540|FG000|Phase B 2nd 16 Weeks|Death|1|||
163982135|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
164218836|NCT00086307|593168482|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
164218837|NCT00086307|593168480|FG000|Overall Study|Withdrawal by Subject|0|||
164218838|NCT00086307|593168481|FG001|Overall Study|Withdrawal by Subject|0|||
164218839|NCT00086307|593168482|FG002|Overall Study|Withdrawal by Subject|2|||
164218840|NCT03158311|593168485|FG000|Overall Study|Subject/Guardian Decision|10|||
164218841|NCT03158311|593168486|FG001|Overall Study|Subject/Guardian Decision|6|||
164218842|NCT03158311|593168487|FG002|Overall Study|Subject/Guardian Decision|11|||
164218843|NCT03158311|593168485|FG000|Overall Study|Adverse Event|5|||
164218844|NCT03158311|593168486|FG001|Overall Study|Adverse Event|3|||
164218845|NCT03158311|593168487|FG002|Overall Study|Adverse Event|3|||
164218846|NCT03158311|593168485|FG000|Overall Study|Techinical Problems|3|||
164218847|NCT03158311|593168486|FG001|Overall Study|Techinical Problems|1|||
164218848|NCT03158311|593168487|FG002|Overall Study|Techinical Problems|5|||
164218849|NCT03158311|593168485|FG000|Overall Study|Physician Decision|2|||
164218850|NCT03158311|593168486|FG001|Overall Study|Physician Decision|3|||
164218851|NCT03158311|593168487|FG002|Overall Study|Physician Decision|7|||
164218852|NCT03158311|593168485|FG000|Overall Study|Lost to Follow-up|1|||
164218853|NCT03158311|593168486|FG001|Overall Study|Lost to Follow-up|1|||
164218854|NCT03158311|593168487|FG002|Overall Study|Lost to Follow-up|1|||
164218855|NCT03158311|593168485|FG000|Overall Study|Sponsor decision|1|||
164218856|NCT03158311|593168486|FG001|Overall Study|Sponsor decision|0|||
164218857|NCT03158311|593168487|FG002|Overall Study|Sponsor decision|0|||
164218858|NCT03158311|593168485|FG000|Overall Study|Pregnancy|0|||
164218859|NCT03158311|593168486|FG001|Overall Study|Pregnancy|2|||
164218860|NCT03158311|593168487|FG002|Overall Study|Pregnancy|0|||
164218861|NCT03158311|593168485|FG000|Overall Study|Randomized in error|0|||
164218862|NCT03158311|593168486|FG001|Overall Study|Randomized in error|0|||
164218863|NCT03158311|593168487|FG002|Overall Study|Randomized in error|1|||
164328567|NCT00417482|593579541|FG001|Phase B 2nd 16 Weeks|Death|1|||
164328568|NCT00417482|593579542|FG002|Phase B 2nd 16 Weeks|Death|0|||
164328569|NCT01323946|593579543|FG000|Overall Study|Lost to Follow-up|0|||
164328570|NCT01323946|593579544|FG001|Overall Study|Lost to Follow-up|1|||
164328571|NCT01323946|593579545|FG002|Overall Study|Lost to Follow-up|0|||
164218864|NCT01018953|593168488|FG000|Overall Study|Adverse Event|2|||
164218865|NCT01018953|593168488|FG000|Overall Study|Withdrawal by Subject|1|||
164218866|NCT01018953|593168488|FG000|Overall Study|Study termination by sponsor|5|||
164218867|NCT00724503|593168489|FG000|Overall Study|Lost to Follow-up|4|||
164218868|NCT00724503|593168490|FG001|Overall Study|Lost to Follow-up|8|||
164218869|NCT00724503|593168489|FG000|Overall Study|Withdrawal by Subject|11|||
164328572|NCT01323946|593579543|FG000|Overall Study|Parents refused the last blood draw|1|||
164328573|NCT01323946|593579544|FG001|Overall Study|Parents refused the last blood draw|0|||
164078913|NCT00410410|592653888|FG006|Induction Period (IP)|Lack of Efficacy|0|||
164078914|NCT00410410|592653889|FG007|Induction Period (IP)|Lack of Efficacy|0|||
164078915|NCT00410410|592653890|FG008|Induction Period (IP)|Lack of Efficacy|0|||
164078916|NCT00410410|592653882|FG000|Induction Period (IP)|Lost to Follow-up|2|||
164078917|NCT00410410|592653883|FG001|Induction Period (IP)|Lost to Follow-up|2|||
164078918|NCT00410410|592653884|FG002|Induction Period (IP)|Lost to Follow-up|2|||
164078919|NCT00410410|592653885|FG003|Induction Period (IP)|Lost to Follow-up|3|||
164078920|NCT00410410|592653886|FG004|Induction Period (IP)|Lost to Follow-up|0|||
164078921|NCT00410410|592653887|FG005|Induction Period (IP)|Lost to Follow-up|1|||
164078922|NCT00410410|592653888|FG006|Induction Period (IP)|Lost to Follow-up|0|||
164078923|NCT00410410|592653889|FG007|Induction Period (IP)|Lost to Follow-up|0|||
164078924|NCT00410410|592653890|FG008|Induction Period (IP)|Lost to Follow-up|0|||
164078925|NCT00410410|592653882|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
164078926|NCT00410410|592653883|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
164078927|NCT00410410|592653884|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
164078928|NCT00410410|592653885|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
164078929|NCT00410410|592653886|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
164078930|NCT00410410|592653887|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
164078931|NCT00410410|592653888|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
164078932|NCT00410410|592653889|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
164078933|NCT00410410|592653890|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
164078934|NCT00410410|592653882|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078935|NCT00410410|592653883|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078936|NCT00410410|592653884|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
164078937|NCT00410410|592653885|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078938|NCT00410410|592653886|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078939|NCT00410410|592653887|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078940|NCT00410410|592653888|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078941|NCT00410410|592653889|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078942|NCT00410410|592653890|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
164078943|NCT00410410|592653882|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078944|NCT00410410|592653883|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078945|NCT00410410|592653884|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078946|NCT00410410|592653885|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078947|NCT00410410|592653886|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
164078948|NCT00410410|592653887|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
164078949|NCT00410410|592653888|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078950|NCT00410410|592653889|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078951|NCT00410410|592653890|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
164078952|NCT00410410|592653882|FG000|Induction Period (IP)|Other|0|||
164078953|NCT00410410|592653883|FG001|Induction Period (IP)|Other|0|||
164078954|NCT00410410|592653884|FG002|Induction Period (IP)|Other|1|||
164078955|NCT00410410|592653885|FG003|Induction Period (IP)|Other|0|||
164078956|NCT00410410|592653886|FG004|Induction Period (IP)|Other|0|||
164078957|NCT00410410|592653887|FG005|Induction Period (IP)|Other|0|||
164078958|NCT00410410|592653888|FG006|Induction Period (IP)|Other|0|||
164078959|NCT00410410|592653889|FG007|Induction Period (IP)|Other|0|||
164328574|NCT01323946|593579545|FG002|Overall Study|Parents refused the last blood draw|0|||
164328575|NCT01323946|593579543|FG000|Overall Study|Withdrawal by Subject|2|||
163982136|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
163982137|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
164328576|NCT01323946|593579544|FG001|Overall Study|Withdrawal by Subject|2|||
164328577|NCT01323946|593579545|FG002|Overall Study|Withdrawal by Subject|0|||
164328578|NCT03189381|593579547|FG000|Overall Study|Death|1|||
164328579|NCT03189381|593579548|FG001|Overall Study|Death|0|||
164328580|NCT00251004|593579549|FG000|Overall Study|Withdrawal by Subject|23|||
163982138|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
163982139|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
163982140|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
163982141|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
163982142|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
163982143|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
163982144|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
164328581|NCT00251004|593579550|FG001|Overall Study|Withdrawal by Subject|16|||
163982145|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
164328582|NCT00251004|593579551|FG002|Overall Study|Withdrawal by Subject|14|||
163982146|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
164328583|NCT00251004|593579549|FG000|Overall Study|Death|9|||
164328584|NCT00251004|593579550|FG001|Overall Study|Death|10|||
164218870|NCT00724503|593168490|FG001|Overall Study|Withdrawal by Subject|23|||
164218871|NCT00724503|593168489|FG000|Overall Study|Death|190|||
164218872|NCT00724503|593168490|FG001|Overall Study|Death|182|||
164218873|NCT00724503|593168489|FG000|Overall Study|Adverse Event|1|||
164218874|NCT00724503|593168490|FG001|Overall Study|Adverse Event|0|||
164218875|NCT00724503|593168489|FG000|Overall Study|Not otherwise specified|4|||
164218876|NCT00724503|593168490|FG001|Overall Study|Not otherwise specified|7|||
164218877|NCT01184118|593168491|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
164218878|NCT01184118|593168491|FG000|Overall Study|No physiologic confirmation of asthma|8|||
164218879|NCT01184118|593168491|FG000|Overall Study|FEV1 <60% predicted|2|||
164218880|NCT01184118|593168491|FG000|Overall Study|Exclusionary medical condition|2|||
164218881|NCT01184118|593168491|FG000|Overall Study|Withdrawal by Subject|5|||
164218882|NCT01186419|593168492|FG000|Overall Study|Withdrawal by Subject|5|||
164218883|NCT01186419|593168493|FG001|Overall Study|Withdrawal by Subject|3|||
164218884|NCT01186419|593168492|FG000|Overall Study|Adverse Event|1|||
164218885|NCT01186419|593168493|FG001|Overall Study|Adverse Event|2|||
164218886|NCT01186419|593168492|FG000|Overall Study|Physician Decision|0|||
164218887|NCT01186419|593168493|FG001|Overall Study|Physician Decision|3|||
164218888|NCT01186419|593168492|FG000|Overall Study|Other|1|||
164218889|NCT01186419|593168493|FG001|Overall Study|Other|1|||
164218890|NCT01560416|593168502|FG000|Randomized Phase|Crossover Participants|7|||
164218891|NCT01560416|593168503|FG001|Randomized Phase|Crossover Participants|0|||
164218892|NCT01033071|593168504|FG000|Overall Study|Adverse Event|28|||
164218893|NCT01033071|593168505|FG001|Overall Study|Adverse Event|51|||
164218894|NCT01033071|593168506|FG002|Overall Study|Adverse Event|26|||
164218895|NCT01033071|593168504|FG000|Overall Study|Protocol Violation|0|||
164218896|NCT01033071|593168505|FG001|Overall Study|Protocol Violation|2|||
164218897|NCT01033071|593168506|FG002|Overall Study|Protocol Violation|1|||
164218898|NCT01033071|593168504|FG000|Overall Study|Lost to Follow-up|4|||
164218899|NCT01033071|593168505|FG001|Overall Study|Lost to Follow-up|5|||
164218900|NCT01033071|593168506|FG002|Overall Study|Lost to Follow-up|5|||
164218901|NCT01033071|593168504|FG000|Overall Study|Withdrawal by Subject|17|||
164218902|NCT01033071|593168505|FG001|Overall Study|Withdrawal by Subject|14|||
164218903|NCT01033071|593168506|FG002|Overall Study|Withdrawal by Subject|11|||
164218904|NCT01033071|593168504|FG000|Overall Study|Lack of Efficacy|0|||
164218905|NCT01033071|593168505|FG001|Overall Study|Lack of Efficacy|1|||
164218906|NCT01033071|593168506|FG002|Overall Study|Lack of Efficacy|1|||
164218907|NCT01033071|593168504|FG000|Overall Study|Other|6|||
164218908|NCT01033071|593168505|FG001|Overall Study|Other|4|||
164218909|NCT01033071|593168506|FG002|Overall Study|Other|3|||
164218910|NCT04073407|593168509|FG000|Part 1|Withdrawal by Subject|1|||
164218911|NCT04073407|593168510|FG001|Part 1|Withdrawal by Subject|0|||
164218912|NCT04073407|593168509|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
164218913|NCT04073407|593168510|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
164218914|NCT04073407|593168509|FG000|Part 2|Withdrawal by Subject|0|||
164218915|NCT04073407|593168510|FG001|Part 2|Withdrawal by Subject|1|||
164218916|NCT03684057|593169905|FG000|Overall Study|Withdrawal by Subject|4|||
164218917|NCT03684057|593169906|FG001|Overall Study|Withdrawal by Subject|5|||
164218918|NCT00758043|593169907|FG000|Overall Study|Adverse Event|1|||
164218919|NCT00758043|593169908|FG001|Overall Study|Adverse Event|20|||
164218920|NCT00758043|593169909|FG002|Overall Study|Adverse Event|12|||
164218921|NCT00758043|593169910|FG003|Overall Study|Adverse Event|62|||
164218922|NCT00758043|593169907|FG000|Overall Study|Lack of Efficacy|0|||
164218923|NCT00758043|593169908|FG001|Overall Study|Lack of Efficacy|6|||
164218924|NCT00758043|593169909|FG002|Overall Study|Lack of Efficacy|18|||
164218925|NCT00758043|593169910|FG003|Overall Study|Lack of Efficacy|12|||
164218926|NCT00758043|593169907|FG000|Overall Study|Refused Further Treatment|0|||
164218927|NCT00758043|593169908|FG001|Overall Study|Refused Further Treatment|11|||
164218928|NCT00758043|593169909|FG002|Overall Study|Refused Further Treatment|5|||
164218929|NCT00758043|593169910|FG003|Overall Study|Refused Further Treatment|8|||
164218930|NCT00758043|593169907|FG000|Overall Study|Lost to Follow-up|0|||
164218931|NCT00758043|593169908|FG001|Overall Study|Lost to Follow-up|2|||
164218932|NCT00758043|593169909|FG002|Overall Study|Lost to Follow-up|2|||
163878225|NCT02287311|591922753|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163878226|NCT02287311|591922754|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164218933|NCT00758043|593169910|FG003|Overall Study|Lost to Follow-up|5|||
164218934|NCT00758043|593169907|FG000|Overall Study|Withdrawal by Subject|0|||
164218935|NCT00758043|593169908|FG001|Overall Study|Withdrawal by Subject|1|||
164218936|NCT00758043|593169909|FG002|Overall Study|Withdrawal by Subject|1|||
164218937|NCT00758043|593169910|FG003|Overall Study|Withdrawal by Subject|4|||
164218938|NCT00758043|593169907|FG000|Overall Study|Required Prohibited Medication|0|||
164218939|NCT00758043|593169908|FG001|Overall Study|Required Prohibited Medication|0|||
164218940|NCT00758043|593169909|FG002|Overall Study|Required Prohibited Medication|1|||
164218941|NCT00758043|593169910|FG003|Overall Study|Required Prohibited Medication|3|||
164218942|NCT00758043|593169907|FG000|Overall Study|Non-Compliant With study Drug|0|||
164218943|NCT00758043|593169908|FG001|Overall Study|Non-Compliant With study Drug|0|||
163878227|NCT02287311|591922755|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163878228|NCT02287311|591922756|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
163878229|NCT02287311|591922757|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
164328585|NCT00251004|593579551|FG002|Overall Study|Death|8|||
164328586|NCT00251004|593579549|FG000|Overall Study|Lost to Follow-up|1|||
164328587|NCT00251004|593579550|FG001|Overall Study|Lost to Follow-up|2|||
164328588|NCT00251004|593579551|FG002|Overall Study|Lost to Follow-up|1|||
164328589|NCT00251004|593579549|FG000|Overall Study|Graft Loss|12|||
164328590|NCT00251004|593579550|FG001|Overall Study|Graft Loss|13|||
164328591|NCT00251004|593579551|FG002|Overall Study|Graft Loss|8|||
164328592|NCT00887744|593579552|FG000|Overall Study|Adverse Event|3|||
164328593|NCT00887744|593579552|FG000|Overall Study|Death|1|||
164328594|NCT00887744|593579552|FG000|Overall Study|Lost to Follow-up|3|||
164328595|NCT00887744|593579552|FG000|Overall Study|Withdrawal by Subject|18|||
164328596|NCT00887744|593579552|FG000|Overall Study|Various reasons|9|||
164328597|NCT01569464|593579553|FG000|Overall Study|Adverse Event|4|||
164328598|NCT01569464|593579554|FG001|Overall Study|Adverse Event|0|||
164328599|NCT01569464|593579553|FG000|Overall Study|Lack of Efficacy|1|||
164328600|NCT01569464|593579554|FG001|Overall Study|Lack of Efficacy|0|||
164328601|NCT01569464|593579553|FG000|Overall Study|Protocol Violation|1|||
164328602|NCT01569464|593579554|FG001|Overall Study|Protocol Violation|0|||
164328603|NCT01569464|593579553|FG000|Overall Study|Lost to Follow-up|2|||
164328604|NCT01569464|593579554|FG001|Overall Study|Lost to Follow-up|3|||
164328605|NCT01569464|593579553|FG000|Overall Study|Withdrawal by Subject|1|||
164328606|NCT01569464|593579554|FG001|Overall Study|Withdrawal by Subject|1|||
164328607|NCT01569464|593579553|FG000|Overall Study|Other|1|||
164328608|NCT01569464|593579554|FG001|Overall Study|Other|1|||
164328609|NCT04025710|593579560|FG000|Overall Study|Death|3|||
164328610|NCT04025710|593579560|FG000|Overall Study|Lost to Follow-up|5|||
164328611|NCT04025710|593579560|FG000|Overall Study|Withdrawal by Subject|1|||
164328612|NCT04025710|593579560|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
164328613|NCT04025710|593579560|FG000|Overall Study|Drop-out according to protocol|34|||
164328614|NCT01343901|593579563|FG000|Overall Study|Death|85|||
164328615|NCT01343901|593579563|FG000|Overall Study|Physician Decision|4|||
163878230|NCT02287311|591922758|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163878231|NCT02287311|591922759|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
163878232|NCT02287311|591922760|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163878233|NCT02287311|591922761|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
163982147|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
163982148|NCT00784654|592304578|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
163982149|NCT00784654|592304579|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
163982150|NCT00784654|592304580|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
163982151|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
163982152|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
163982153|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
163982154|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
163982155|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
163982156|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
163982157|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163982158|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
163982159|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
163982160|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
163982161|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
163982162|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
163982163|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Adverse Event|0|||
163982164|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Adverse Event|1|||
163982165|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Adverse Event|1|||
163982166|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
164078960|NCT00410410|592653890|FG008|Induction Period (IP)|Other|0|||
163878234|NCT02287311|591922753|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
163878235|NCT02287311|591922754|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
163878236|NCT02287311|591922755|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
163878237|NCT02287311|591922756|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
163878238|NCT02287311|591922757|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
163878239|NCT02287311|591922758|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
163982167|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
163982168|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
163982169|NCT00784654|592304578|FG000|Randomized Withdrawal Period|Family reasons|0|||
163982170|NCT00784654|592304579|FG001|Randomized Withdrawal Period|Family reasons|0|||
164328616|NCT01343901|593579563|FG000|Overall Study|Lost to Follow-up|12|||
164328617|NCT01343901|593579563|FG000|Overall Study|Management by another medical team|11|||
164328618|NCT01343901|593579563|FG000|Overall Study|Participant decision|1|||
164328619|NCT01562873|593579564|FG000|Overall Study|Disease Progression per RECIST|10|||
164328620|NCT01562873|593579565|FG001|Overall Study|Disease Progression per RECIST|0|||
164328621|NCT01562873|593579564|FG000|Overall Study|Adverse Event|1|||
164218944|NCT00758043|593169909|FG002|Overall Study|Non-Compliant With study Drug|0|||
164218945|NCT00758043|593169910|FG003|Overall Study|Non-Compliant With study Drug|1|||
164218946|NCT00758043|593169907|FG000|Overall Study|Other Reasons|0|||
164218947|NCT00758043|593169908|FG001|Overall Study|Other Reasons|1|||
164218948|NCT00758043|593169909|FG002|Overall Study|Other Reasons|0|||
164218949|NCT00758043|593169910|FG003|Overall Study|Other Reasons|5|||
164218950|NCT03422718|593169914|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
164218951|NCT03422718|593169915|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
164218952|NCT03422718|593169916|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
164218953|NCT03422718|593169917|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
164218954|NCT03422718|593169918|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
164218955|NCT03422718|593169919|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
164218956|NCT03422718|593169920|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
164218957|NCT03422718|593169921|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
164218958|NCT03422718|593169914|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
164218959|NCT03422718|593169915|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
164218960|NCT03422718|593169916|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
164218961|NCT03422718|593169917|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
164218962|NCT03422718|593169918|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
164218963|NCT03422718|593169919|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
164218964|NCT03422718|593169920|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
164218965|NCT03422718|593169921|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
164218966|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
164218967|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
164218968|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
164218969|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
164218970|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
164218971|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
164218972|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
164218973|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
164218974|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218975|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
164218976|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218977|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218978|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
164218979|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
164328622|NCT01562873|593579565|FG001|Overall Study|Adverse Event|0|||
164328623|NCT01562873|593579564|FG000|Overall Study|Clinical Disease Progression|9|||
164328624|NCT01562873|593579565|FG001|Overall Study|Clinical Disease Progression|0|||
164328625|NCT01562873|593579564|FG000|Overall Study|Clinical PD and adverse event|1|||
164328626|NCT01562873|593579565|FG001|Overall Study|Clinical PD and adverse event|0|||
164328627|NCT05308290|593579569|FG000|Overall Study|Death|1|||
163878240|NCT02287311|591922759|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
163878241|NCT02287311|591922760|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
163878242|NCT02287311|591922761|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
163878243|NCT02287311|591922753|FG000|Cohort 2: Dose Level 2|Death|0|||
163878244|NCT02287311|591922754|FG001|Cohort 2: Dose Level 2|Death|2|||
163878245|NCT02287311|591922755|FG002|Cohort 2: Dose Level 2|Death|0|||
163878246|NCT02287311|591922756|FG003|Cohort 2: Dose Level 2|Death|0|||
163878247|NCT02287311|591922757|FG004|Cohort 2: Dose Level 2|Death|2|||
163878248|NCT02287311|591922758|FG005|Cohort 2: Dose Level 2|Death|0|||
163878249|NCT02287311|591922759|FG006|Cohort 2: Dose Level 2|Death|0|||
163878250|NCT02287311|591922760|FG007|Cohort 2: Dose Level 2|Death|2|||
163878251|NCT02287311|591922761|FG008|Cohort 2: Dose Level 2|Death|0|||
163878252|NCT02287311|591922753|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878253|NCT02287311|591922754|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878254|NCT02287311|591922755|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878255|NCT02287311|591922756|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878256|NCT02287311|591922757|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
163878257|NCT02287311|591922758|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878258|NCT02287311|591922759|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878259|NCT02287311|591922760|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878260|NCT02287311|591922761|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
163878261|NCT02287311|591922753|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
163878262|NCT02287311|591922754|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
164218980|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
164218981|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
163878263|NCT02287311|591922755|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
163878264|NCT02287311|591922756|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
164078961|NCT00410410|592653882|FG000|Maintenance Period (MP)|Death|0|||
164078962|NCT00410410|592653883|FG001|Maintenance Period (MP)|Death|0|||
164078963|NCT00410410|592653884|FG002|Maintenance Period (MP)|Death|0|||
164078964|NCT00410410|592653885|FG003|Maintenance Period (MP)|Death|0|||
164078965|NCT00410410|592653886|FG004|Maintenance Period (MP)|Death|0|||
164078966|NCT00410410|592653887|FG005|Maintenance Period (MP)|Death|0|||
164078967|NCT00410410|592653888|FG006|Maintenance Period (MP)|Death|1|||
164078968|NCT00410410|592653889|FG007|Maintenance Period (MP)|Death|0|||
164078969|NCT00410410|592653890|FG008|Maintenance Period (MP)|Death|0|||
164078970|NCT00410410|592653882|FG000|Maintenance Period (MP)|Adverse Event|0|||
164078971|NCT00410410|592653883|FG001|Maintenance Period (MP)|Adverse Event|0|||
164078972|NCT00410410|592653884|FG002|Maintenance Period (MP)|Adverse Event|0|||
164078973|NCT00410410|592653885|FG003|Maintenance Period (MP)|Adverse Event|0|||
164078974|NCT00410410|592653886|FG004|Maintenance Period (MP)|Adverse Event|0|||
164078975|NCT00410410|592653887|FG005|Maintenance Period (MP)|Adverse Event|0|||
164078976|NCT00410410|592653888|FG006|Maintenance Period (MP)|Adverse Event|1|||
164078977|NCT00410410|592653889|FG007|Maintenance Period (MP)|Adverse Event|3|||
164078978|NCT00410410|592653890|FG008|Maintenance Period (MP)|Adverse Event|0|||
164078979|NCT00410410|592653882|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
164078980|NCT00410410|592653883|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
164078981|NCT00410410|592653884|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
164078982|NCT00410410|592653885|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
164078983|NCT00410410|592653886|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
164078984|NCT00410410|592653887|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
164078985|NCT00410410|592653888|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
164078986|NCT00410410|592653889|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
164078987|NCT00410410|592653890|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
164078988|NCT00410410|592653882|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
164078989|NCT00410410|592653883|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
164078990|NCT00410410|592653884|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
164078991|NCT00410410|592653885|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
164078992|NCT00410410|592653886|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
164078993|NCT00410410|592653887|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
164078994|NCT00410410|592653888|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
164078995|NCT00410410|592653889|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
164078996|NCT00410410|592653890|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
164078997|NCT00410410|592653882|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
164078998|NCT00410410|592653883|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
164078999|NCT00410410|592653884|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
164079000|NCT00410410|592653885|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
164079001|NCT00410410|592653886|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
164079002|NCT00410410|592653887|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
164079003|NCT00410410|592653888|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
164079004|NCT00410410|592653889|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
164079005|NCT00410410|592653890|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
164079006|NCT00410410|592653882|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164079007|NCT00410410|592653883|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164328628|NCT05308290|593579570|FG001|Overall Study|Death|0|||
164328629|NCT05308290|593579569|FG000|Overall Study|Lost to Follow-up|2|||
164328630|NCT05308290|593579570|FG001|Overall Study|Lost to Follow-up|1|||
164328631|NCT05308290|593579569|FG000|Overall Study|still in study followup|0|||
164328632|NCT05308290|593579570|FG001|Overall Study|still in study followup|1|||
164328633|NCT02117427|593579571|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
164328634|NCT02117427|593579572|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
164328635|NCT02117427|593579573|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
164328636|NCT02117427|593579571|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
164328637|NCT02117427|593579572|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
164328638|NCT02117427|593579573|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
164328639|NCT02117427|593579571|FG000|Overall Study|Physician Decision|0|||
164328640|NCT02117427|593579572|FG001|Overall Study|Physician Decision|2|||
164328641|NCT02117427|593579573|FG002|Overall Study|Physician Decision|0|||
164328642|NCT02117427|593579571|FG000|Overall Study|No longer meets inclusion criteria|0|||
164328643|NCT02117427|593579572|FG001|Overall Study|No longer meets inclusion criteria|1|||
164328644|NCT02117427|593579573|FG002|Overall Study|No longer meets inclusion criteria|0|||
164328645|NCT02117427|593579571|FG000|Overall Study|Death|0|||
164328646|NCT02117427|593579572|FG001|Overall Study|Death|1|||
164328647|NCT02117427|593579573|FG002|Overall Study|Death|0|||
164328648|NCT00410202|593579574|FG000|On-Treatment|Continuing treatment|69|||
164328649|NCT00410202|593579575|FG001|On-Treatment|Continuing treatment|71|||
164328650|NCT00410202|593579576|FG002|On-Treatment|Continuing treatment|66|||
164328651|NCT00410202|593579574|FG000|On-Treatment|Adverse Event|1|||
164079008|NCT00410410|592653884|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164079009|NCT00410410|592653885|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164079010|NCT00410410|592653886|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164328652|NCT00410202|593579575|FG001|On-Treatment|Adverse Event|3|||
164218982|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
164218983|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
164218984|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
164218985|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
164218986|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
164218987|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
164218988|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
164218989|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
164218990|NCT03422718|593169914|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
164218991|NCT03422718|593169915|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
164218992|NCT03422718|593169916|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
164218993|NCT03422718|593169917|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
164218994|NCT03422718|593169918|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
164218995|NCT03422718|593169919|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
164218996|NCT03422718|593169920|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
164218997|NCT03422718|593169921|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
164218998|NCT00669331|593169924|FG000|Randomisation to First Dose|Adverse Event|1|||
164218999|NCT00669331|593169925|FG001|Randomisation to First Dose|Adverse Event|0|||
164219000|NCT00669331|593169924|FG000|Randomisation to First Dose|Protocol Violation|1|||
164219001|NCT00669331|593169925|FG001|Randomisation to First Dose|Protocol Violation|0|||
164219002|NCT00669331|593169924|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
164219003|NCT00669331|593169925|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
164219004|NCT00669331|593169924|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
164219005|NCT00669331|593169925|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
164219006|NCT00669331|593169924|FG000|Randomisation to First Dose|Death|1|||
164219007|NCT00669331|593169925|FG001|Randomisation to First Dose|Death|0|||
164219008|NCT00669331|593169924|FG000|Randomisation to First Dose|Sponsor decision|0|||
164219009|NCT00669331|593169925|FG001|Randomisation to First Dose|Sponsor decision|1|||
164219010|NCT00669331|593169924|FG000|Randomisation to First Dose|Randomised in error|3|||
164219011|NCT00669331|593169925|FG001|Randomisation to First Dose|Randomised in error|10|||
164219012|NCT00669331|593169924|FG000|Blinded Treatment Period|Adverse Event|16|||
164219013|NCT00669331|593169925|FG001|Blinded Treatment Period|Adverse Event|10|||
164219014|NCT00669331|593169924|FG000|Blinded Treatment Period|Protocol Violation|1|||
164219015|NCT00669331|593169925|FG001|Blinded Treatment Period|Protocol Violation|1|||
164219016|NCT00669331|593169924|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
164079011|NCT00410410|592653887|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
163878265|NCT02287311|591922757|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
163878266|NCT02287311|591922758|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
163878267|NCT02287311|591922759|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
163878268|NCT02287311|591922760|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
164079012|NCT00410410|592653888|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
164079013|NCT00410410|592653889|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
164079014|NCT00410410|592653890|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
164079015|NCT00410410|592653882|FG000|Open-Label Period (OL)|Death|0|||
164079016|NCT00410410|592653883|FG001|Open-Label Period (OL)|Death|0|||
164079017|NCT00410410|592653884|FG002|Open-Label Period (OL)|Death|0|||
164079018|NCT00410410|592653885|FG003|Open-Label Period (OL)|Death|0|||
164079019|NCT00410410|592653886|FG004|Open-Label Period (OL)|Death|0|||
164079020|NCT00410410|592653887|FG005|Open-Label Period (OL)|Death|0|||
164079021|NCT00410410|592653888|FG006|Open-Label Period (OL)|Death|0|||
164079022|NCT00410410|592653889|FG007|Open-Label Period (OL)|Death|0|||
164079023|NCT00410410|592653890|FG008|Open-Label Period (OL)|Death|1|||
164079024|NCT00410410|592653882|FG000|Open-Label Period (OL)|Adverse Event|0|||
164079025|NCT00410410|592653883|FG001|Open-Label Period (OL)|Adverse Event|0|||
164079026|NCT00410410|592653884|FG002|Open-Label Period (OL)|Adverse Event|0|||
164079027|NCT00410410|592653885|FG003|Open-Label Period (OL)|Adverse Event|0|||
164079028|NCT00410410|592653886|FG004|Open-Label Period (OL)|Adverse Event|0|||
164219017|NCT00669331|593169925|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
164219018|NCT00669331|593169924|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
163878269|NCT02287311|591922761|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
163878270|NCT02287311|591922753|FG000|Cohort 3: Dose Level 3|Death|0|||
163878271|NCT02287311|591922754|FG001|Cohort 3: Dose Level 3|Death|0|||
163878272|NCT02287311|591922755|FG002|Cohort 3: Dose Level 3|Death|4|||
163878273|NCT02287311|591922756|FG003|Cohort 3: Dose Level 3|Death|0|||
163878274|NCT02287311|591922757|FG004|Cohort 3: Dose Level 3|Death|0|||
163878275|NCT02287311|591922758|FG005|Cohort 3: Dose Level 3|Death|4|||
164079029|NCT00410410|592653887|FG005|Open-Label Period (OL)|Adverse Event|0|||
164219019|NCT00669331|593169925|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
164219020|NCT00669331|593169924|FG000|Blinded Treatment Period|Death|0|||
163878276|NCT02287311|591922759|FG006|Cohort 3: Dose Level 3|Death|0|||
163878277|NCT02287311|591922760|FG007|Cohort 3: Dose Level 3|Death|0|||
163878278|NCT02287311|591922761|FG008|Cohort 3: Dose Level 3|Death|2|||
163878279|NCT02287311|591922753|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
164219021|NCT00669331|593169925|FG001|Blinded Treatment Period|Death|2|||
164219022|NCT00669331|593169924|FG000|Blinded Treatment Period|Physician Decision|3|||
164219023|NCT00669331|593169925|FG001|Blinded Treatment Period|Physician Decision|3|||
164219024|NCT00669331|593169924|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
164219025|NCT00669331|593169925|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
164219026|NCT03387046|593169926|FG000|Overall Study|Adverse Event|1|||
164219027|NCT03387046|593169927|FG001|Overall Study|Adverse Event|1|||
164219028|NCT00509600|593169928|FG000|Overall Study|Adverse Event|1|||
164219029|NCT00986232|593169929|FG000|Overall Study|Adverse Event|1|||
164219030|NCT00986232|593169930|FG001|Overall Study|Adverse Event|2|||
164219031|NCT00986232|593169931|FG002|Overall Study|Adverse Event|3|||
164219032|NCT00986232|593169932|FG003|Overall Study|Adverse Event|0|||
164219033|NCT00986232|593169929|FG000|Overall Study|Lost to Follow-up|19|||
164219034|NCT00986232|593169930|FG001|Overall Study|Lost to Follow-up|12|||
164219035|NCT00986232|593169931|FG002|Overall Study|Lost to Follow-up|12|||
164219036|NCT00986232|593169932|FG003|Overall Study|Lost to Follow-up|7|||
164219037|NCT00986232|593169929|FG000|Overall Study|Protocol Violation|2|||
164219038|NCT00986232|593169930|FG001|Overall Study|Protocol Violation|3|||
164219039|NCT00986232|593169931|FG002|Overall Study|Protocol Violation|0|||
164219040|NCT00986232|593169932|FG003|Overall Study|Protocol Violation|1|||
164219041|NCT00986232|593169929|FG000|Overall Study|Withdrawal by Subject|13|||
164219042|NCT00986232|593169930|FG001|Overall Study|Withdrawal by Subject|16|||
164219043|NCT00986232|593169931|FG002|Overall Study|Withdrawal by Subject|12|||
164219044|NCT00986232|593169932|FG003|Overall Study|Withdrawal by Subject|3|||
164219045|NCT00986232|593169929|FG000|Overall Study|Missed one or more bleeds|13|||
164219046|NCT00986232|593169930|FG001|Overall Study|Missed one or more bleeds|10|||
164219047|NCT00986232|593169931|FG002|Overall Study|Missed one or more bleeds|6|||
164219048|NCT00986232|593169932|FG003|Overall Study|Missed one or more bleeds|7|||
164219049|NCT00986232|593169929|FG000|Overall Study|Incomplete safety follow-up|3|||
164219050|NCT00986232|593169930|FG001|Overall Study|Incomplete safety follow-up|7|||
164219051|NCT00986232|593169931|FG002|Overall Study|Incomplete safety follow-up|2|||
164219052|NCT00986232|593169932|FG003|Overall Study|Incomplete safety follow-up|2|||
164219053|NCT02568423|593169933|FG000|Overall Study|Lost to Follow-up|0|||
164219054|NCT02568423|593169934|FG001|Overall Study|Lost to Follow-up|2|||
164219055|NCT02568423|593169935|FG002|Overall Study|Lost to Follow-up|0|||
164219056|NCT02568423|593169936|FG003|Overall Study|Lost to Follow-up|0|||
164328653|NCT00410202|593579576|FG002|On-Treatment|Adverse Event|2|||
164328654|NCT00410202|593579574|FG000|On-Treatment|Death|1|||
164328655|NCT00410202|593579575|FG001|On-Treatment|Death|0|||
164328656|NCT00410202|593579576|FG002|On-Treatment|Death|0|||
164328657|NCT00410202|593579574|FG000|On-Treatment|Lost to Follow-up|1|||
164328658|NCT00410202|593579575|FG001|On-Treatment|Lost to Follow-up|0|||
164328659|NCT00410202|593579576|FG002|On-Treatment|Lost to Follow-up|1|||
164328660|NCT00410202|593579574|FG000|On-Treatment|Lack of Efficacy|1|||
164328661|NCT00410202|593579575|FG001|On-Treatment|Lack of Efficacy|4|||
164328662|NCT00410202|593579576|FG002|On-Treatment|Lack of Efficacy|0|||
164328663|NCT00410202|593579574|FG000|On-Treatment|Withdrawal by Subject|2|||
164328664|NCT00410202|593579575|FG001|On-Treatment|Withdrawal by Subject|1|||
164328665|NCT00410202|593579576|FG002|On-Treatment|Withdrawal by Subject|1|||
164328666|NCT00410202|593579574|FG000|On-Treatment|Other Reason|0|||
164328667|NCT00410202|593579575|FG001|On-Treatment|Other Reason|0|||
164328668|NCT00410202|593579576|FG002|On-Treatment|Other Reason|1|||
164328669|NCT00410202|593579574|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
164328670|NCT00410202|593579575|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
164328671|NCT00410202|593579576|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
164328672|NCT00410202|593579574|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
164328673|NCT00410202|593579575|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
164328674|NCT00410202|593579576|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
164328675|NCT00410202|593579574|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
164328676|NCT00410202|593579575|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
164219057|NCT02568423|593169937|FG004|Overall Study|Lost to Follow-up|0|||
164219058|NCT02568423|593169938|FG005|Overall Study|Lost to Follow-up|0|||
164219059|NCT02568423|593169939|FG006|Overall Study|Lost to Follow-up|0|||
164328677|NCT00410202|593579576|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
164328678|NCT01178073|593579579|FG000|Overall Study|Adverse Event|34|||
164219060|NCT02568423|593169940|FG007|Overall Study|Lost to Follow-up|0|||
164328679|NCT01178073|593579580|FG001|Overall Study|Adverse Event|27|||
164328680|NCT01178073|593579581|FG002|Overall Study|Adverse Event|24|||
164219061|NCT02568423|593169933|FG000|Overall Study|Physician Decision|0|||
164219062|NCT02568423|593169934|FG001|Overall Study|Physician Decision|0|||
164219063|NCT02568423|593169935|FG002|Overall Study|Physician Decision|0|||
164219064|NCT02568423|593169936|FG003|Overall Study|Physician Decision|0|||
164328681|NCT01178073|593579579|FG000|Overall Study|Protocol Violation|1|||
164219065|NCT02568423|593169937|FG004|Overall Study|Physician Decision|0|||
164219066|NCT02568423|593169938|FG005|Overall Study|Physician Decision|1|||
164219067|NCT02568423|593169939|FG006|Overall Study|Physician Decision|0|||
164219068|NCT02568423|593169940|FG007|Overall Study|Physician Decision|0|||
163982171|NCT00784654|592304580|FG002|Randomized Withdrawal Period|Family reasons|1|||
163982172|NCT01014689|592304596|FG000|Overall Study|Lack of Efficacy|0|||
163982173|NCT01014689|592304597|FG001|Overall Study|Lack of Efficacy|1|||
163982174|NCT01014689|592304596|FG000|Overall Study|Adverse Event|3|||
163982175|NCT01014689|592304597|FG001|Overall Study|Adverse Event|0|||
163982176|NCT01014689|592304596|FG000|Overall Study|Withdrawal by Subject|5|||
163982177|NCT01014689|592304597|FG001|Overall Study|Withdrawal by Subject|4|||
164219069|NCT03794544|593169941|FG000|Overall Study|Withdrawal by Subject|1|||
164219070|NCT03794544|593169942|FG001|Overall Study|Withdrawal by Subject|1|||
164219071|NCT03794544|593169943|FG002|Overall Study|Withdrawal by Subject|0|||
164219072|NCT03794544|593169944|FG003|Overall Study|Withdrawal by Subject|0|||
164219073|NCT03794544|593169941|FG000|Overall Study|Death|0|||
164219074|NCT03794544|593169942|FG001|Overall Study|Death|0|||
164219075|NCT03794544|593169943|FG002|Overall Study|Death|0|||
164219076|NCT03794544|593169944|FG003|Overall Study|Death|1|||
164219077|NCT03794544|593169941|FG000|Overall Study|Lost to Follow-up|0|||
164219078|NCT03794544|593169942|FG001|Overall Study|Lost to Follow-up|1|||
164219079|NCT03794544|593169943|FG002|Overall Study|Lost to Follow-up|1|||
164219080|NCT03794544|593169944|FG003|Overall Study|Lost to Follow-up|0|||
164219081|NCT03794544|593169941|FG000|Overall Study|Other|0|||
164219082|NCT03794544|593169942|FG001|Overall Study|Other|1|||
164219083|NCT03794544|593169943|FG002|Overall Study|Other|0|||
164219084|NCT03794544|593169944|FG003|Overall Study|Other|0|||
164219085|NCT00585585|593169952|FG000|Overall Study|Adverse Event|1|||
164219086|NCT01964560|593169955|FG000|Overall Study|Adverse Event|23|||
164219087|NCT01964560|593169955|FG000|Overall Study|Lack of Efficacy|46|||
164219088|NCT01964560|593169955|FG000|Overall Study|Protocol deviation|2|||
164219089|NCT01964560|593169955|FG000|Overall Study|Lost to Follow-up|4|||
164219090|NCT01964560|593169955|FG000|Overall Study|Withdrawal by Subject|64|||
164219091|NCT01964560|593169955|FG000|Overall Study|Surgery-hemispherotomy|1|||
164219092|NCT01964560|593169955|FG000|Overall Study|Surgery|1|||
164219093|NCT01964560|593169955|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
164219094|NCT01964560|593169955|FG000|Overall Study|Patient and Investigator choice|1|||
164219095|NCT01964560|593169955|FG000|Overall Study|Patient was prescribed CBD|1|||
164219096|NCT01964560|593169955|FG000|Overall Study|Participant moved to another country|1|||
164219097|NCT02217982|593169969|FG000|Overall Study|Trial discontinued|1|||
164219098|NCT02217982|593169970|FG001|Overall Study|Trial discontinued|0|||
164219099|NCT02217982|593169969|FG000|Overall Study|Adverse Event|0|||
164219100|NCT02217982|593169970|FG001|Overall Study|Adverse Event|1|||
164219101|NCT01755637|593169971|FG000|Period 1|Adverse Event|0|||
164219102|NCT01755637|593169972|FG001|Period 1|Adverse Event|1|||
164219103|NCT03338023|593169975|FG000|Overall Study|Withdrawal by Subject|3|||
164219104|NCT03338023|593169976|FG001|Overall Study|Withdrawal by Subject|4|||
164219105|NCT03338023|593169975|FG000|Overall Study|Protocol Violation|3|||
164219106|NCT03338023|593169976|FG001|Overall Study|Protocol Violation|3|||
164219107|NCT03338023|593169975|FG000|Overall Study|Lost to Follow-up|2|||
164219108|NCT03338023|593169976|FG001|Overall Study|Lost to Follow-up|1|||
164219109|NCT03338023|593169975|FG000|Overall Study|Physician Decision|1|||
164219110|NCT03338023|593169976|FG001|Overall Study|Physician Decision|2|||
164219111|NCT02030418|593169980|FG000|Overall Study|Death|78|||
164219112|NCT02030418|593169980|FG000|Overall Study|Missed 12-Month Visit|9|||
164219113|NCT02030418|593169980|FG000|Overall Study|Withdrawn|57|||
164219114|NCT00724893|593169981|FG000|Overall Study|Adverse Event|76|||
164219115|NCT00724893|593169982|FG001|Overall Study|Adverse Event|142|||
164219116|NCT00724893|593169981|FG000|Overall Study|Withdrawal by Subject|0|||
164219117|NCT00724893|593169982|FG001|Overall Study|Withdrawal by Subject|1|||
164219118|NCT00724893|593169981|FG000|Overall Study|Lack of virologic response|94|||
164219119|NCT00724893|593169982|FG001|Overall Study|Lack of virologic response|202|||
164219120|NCT00724893|593169981|FG000|Overall Study|Reason not specified|193|||
164219121|NCT00724893|593169982|FG001|Overall Study|Reason not specified|7|||
164219122|NCT00724893|593169981|FG000|Overall Study|Patient choice|0|||
164219123|NCT00724893|593169982|FG001|Overall Study|Patient choice|26|||
164219124|NCT00724893|593169981|FG000|Overall Study|Geographic reasons|0|||
164219125|NCT00724893|593169982|FG001|Overall Study|Geographic reasons|11|||
163982178|NCT01014689|592304596|FG000|Overall Study|Protocol Violation|1|||
164219126|NCT00724893|593169981|FG000|Overall Study|Incarceration|0|||
164219127|NCT00724893|593169982|FG001|Overall Study|Incarceration|9|||
164079030|NCT00410410|592653888|FG006|Open-Label Period (OL)|Adverse Event|0|||
164219128|NCT00724893|593169981|FG000|Overall Study|Substance abuse|0|||
164219129|NCT00724893|593169982|FG001|Overall Study|Substance abuse|3|||
164219130|NCT00724893|593169981|FG000|Overall Study|Financial reasons|0|||
164219131|NCT00724893|593169982|FG001|Overall Study|Financial reasons|2|||
164219132|NCT00724893|593169981|FG000|Overall Study|Assigned shorter treatment|0|||
164219133|NCT00724893|593169982|FG001|Overall Study|Assigned shorter treatment|2|||
164219134|NCT00724893|593169981|FG000|Overall Study|Lost to Follow-up|0|||
164219135|NCT00724893|593169982|FG001|Overall Study|Lost to Follow-up|52|||
164219136|NCT00724893|593169981|FG000|Overall Study|Unknown, missing data|1|||
164219137|NCT00724893|593169982|FG001|Overall Study|Unknown, missing data|1|||
164219138|NCT01279200|593169985|FG000|Overall Study|Withdrawal by Subject|1|||
164219139|NCT01279200|593169986|FG001|Overall Study|Withdrawal by Subject|3|||
164219140|NCT01279200|593169985|FG000|Overall Study|Patient withdrawal due to high cost|0|||
164219141|NCT01279200|593169986|FG001|Overall Study|Patient withdrawal due to high cost|1|||
164219142|NCT01279200|593169985|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
164219143|NCT01279200|593169986|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
164219144|NCT01279200|593169985|FG000|Overall Study|ultrasound screening failure|0|||
164219145|NCT01279200|593169986|FG001|Overall Study|ultrasound screening failure|1|||
164219146|NCT01279200|593169985|FG000|Overall Study|Lost to Follow-up|0|||
164219147|NCT01279200|593169986|FG001|Overall Study|Lost to Follow-up|1|||
164219148|NCT01279200|593169985|FG000|Overall Study|Adverse Event|1|||
164219149|NCT01279200|593169986|FG001|Overall Study|Adverse Event|0|||
164219150|NCT01399099|593169987|FG000|Overall Study|Lost to Follow-up|14|||
164219151|NCT01399099|593169987|FG000|Overall Study|Physician Decision|1|||
164219152|NCT01399099|593169987|FG000|Overall Study|Protocol Violation|1|||
164328682|NCT01178073|593579580|FG001|Overall Study|Protocol Violation|1|||
164328683|NCT01178073|593579581|FG002|Overall Study|Protocol Violation|1|||
164328684|NCT01178073|593579579|FG000|Overall Study|Lost to Follow-up|2|||
164328685|NCT01178073|593579580|FG001|Overall Study|Lost to Follow-up|0|||
164328686|NCT01178073|593579581|FG002|Overall Study|Lost to Follow-up|3|||
164328687|NCT01178073|593579579|FG000|Overall Study|Physician Decision|14|||
164328688|NCT01178073|593579580|FG001|Overall Study|Physician Decision|10|||
164328689|NCT01178073|593579581|FG002|Overall Study|Physician Decision|10|||
164328690|NCT01178073|593579579|FG000|Overall Study|Withdrawal by Subject|10|||
164328691|NCT01178073|593579580|FG001|Overall Study|Withdrawal by Subject|6|||
164328692|NCT01178073|593579581|FG002|Overall Study|Withdrawal by Subject|8|||
164328693|NCT01178073|593579579|FG000|Overall Study|Missing Completion Status|1|||
164328694|NCT01178073|593579580|FG001|Overall Study|Missing Completion Status|0|||
164328695|NCT01178073|593579581|FG002|Overall Study|Missing Completion Status|0|||
164328696|NCT01674634|593579582|FG000|Overall Study|Withdrawal by Subject|3|||
164328697|NCT01674634|593579582|FG000|Overall Study|Lost to Follow-up|3|||
164328698|NCT00937391|593579583|FG000|Stage 2|Withdrawal by Subject|1|||
164328699|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
164328700|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
164328701|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
164328702|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
164328703|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
164328704|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
164328705|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
164328706|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
164328707|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
164328708|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
164328709|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
164328710|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
164328711|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
164328712|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
164328713|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
164328714|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
164328715|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
164328716|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
164328717|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
164328718|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
164328719|NCT01226043|593579593|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
164328720|NCT01226043|593579594|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
164328721|NCT01226043|593579595|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
164328722|NCT01226043|593579596|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
164328723|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Adverse Event|0|||
164328724|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Adverse Event|0|||
164328725|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Adverse Event|1|||
164328726|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Adverse Event|1|||
164328727|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
164328728|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
164328729|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
164328730|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
164219153|NCT01399099|593169987|FG000|Overall Study|Skin Irritation|13|||
164219154|NCT01399099|593169987|FG000|Overall Study|Infection|1|||
164328731|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
164219155|NCT01399099|593169987|FG000|Overall Study|Miscellaneous|4|||
164219156|NCT01179516|593169988|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
164328732|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
163982179|NCT01014689|592304597|FG001|Overall Study|Protocol Violation|1|||
164219157|NCT01179516|593169989|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
164328733|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
164219158|NCT01179516|593169990|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
164219159|NCT01179516|593169988|FG000|Overall Study|Lack of Efficacy|4|||
164219160|NCT01179516|593169989|FG001|Overall Study|Lack of Efficacy|2|||
164219161|NCT01179516|593169990|FG002|Overall Study|Lack of Efficacy|0|||
164219162|NCT01179516|593169988|FG000|Overall Study|Noncompliance with Study Drug|2|||
164219163|NCT01179516|593169989|FG001|Overall Study|Noncompliance with Study Drug|0|||
164219164|NCT01179516|593169990|FG002|Overall Study|Noncompliance with Study Drug|1|||
164219165|NCT01179516|593169988|FG000|Overall Study|Protocol Deviations|4|||
164219166|NCT01179516|593169989|FG001|Overall Study|Protocol Deviations|3|||
164219167|NCT01179516|593169990|FG002|Overall Study|Protocol Deviations|3|||
164219168|NCT01179516|593169988|FG000|Overall Study|Withdrawal of Consent|2|||
164219169|NCT01179516|593169989|FG001|Overall Study|Withdrawal of Consent|6|||
164219170|NCT01179516|593169990|FG002|Overall Study|Withdrawal of Consent|10|||
164219171|NCT01179516|593169988|FG000|Overall Study|Lost to Follow-up|7|||
164219172|NCT01179516|593169989|FG001|Overall Study|Lost to Follow-up|7|||
164219173|NCT01179516|593169990|FG002|Overall Study|Lost to Follow-up|3|||
164219174|NCT01179516|593169988|FG000|Overall Study|Other|2|||
164219175|NCT01179516|593169989|FG001|Overall Study|Other|0|||
164219176|NCT01179516|593169990|FG002|Overall Study|Other|2|||
164219177|NCT01668537|593169991|FG000|Overall Study|Request to Discontinue Prematurely|1|||
164219178|NCT01668537|593169992|FG001|Overall Study|Request to Discontinue Prematurely|1|||
164219179|NCT01668537|593169991|FG000|Overall Study|Subject unwilling/unable to comply|5|||
164219180|NCT01668537|593169992|FG001|Overall Study|Subject unwilling/unable to comply|0|||
164219181|NCT01668537|593169991|FG000|Overall Study|Reason Precludes Participation|1|||
164219182|NCT01668537|593169992|FG001|Overall Study|Reason Precludes Participation|0|||
164219183|NCT01668537|593169991|FG000|Overall Study|Lost to Follow-up|13|||
164219184|NCT01668537|593169992|FG001|Overall Study|Lost to Follow-up|6|||
164219185|NCT01668537|593169991|FG000|Overall Study|Other|2|||
164219186|NCT01668537|593169992|FG001|Overall Study|Other|3|||
164219187|NCT01149538|593169993|FG000|Overall Study|Lost to Follow-up|0|||
164219188|NCT01149538|593169994|FG001|Overall Study|Lost to Follow-up|1|||
164219189|NCT01149538|593169993|FG000|Overall Study|Withdrawal by Subject|5|||
164219190|NCT01149538|593169994|FG001|Overall Study|Withdrawal by Subject|3|||
164079031|NCT00410410|592653889|FG007|Open-Label Period (OL)|Adverse Event|0|||
164079032|NCT00410410|592653890|FG008|Open-Label Period (OL)|Adverse Event|10|||
164079033|NCT00410410|592653882|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
164079034|NCT00410410|592653883|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
164079035|NCT00410410|592653884|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
164079036|NCT00410410|592653885|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
164079037|NCT00410410|592653886|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
164079038|NCT00410410|592653887|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
164079039|NCT00410410|592653888|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
164079040|NCT00410410|592653889|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
164079041|NCT00410410|592653890|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
164079042|NCT00410410|592653882|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
164079043|NCT00410410|592653883|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
164079044|NCT00410410|592653884|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
164079045|NCT00410410|592653885|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
164079046|NCT00410410|592653886|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
164079047|NCT00410410|592653887|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
164079048|NCT00410410|592653888|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
164079049|NCT00410410|592653889|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
164079050|NCT00410410|592653890|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
164079051|NCT00410410|592653882|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079052|NCT00410410|592653883|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079053|NCT00410410|592653884|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079054|NCT00410410|592653885|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079055|NCT00410410|592653886|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079056|NCT00410410|592653887|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079057|NCT00410410|592653888|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079058|NCT00410410|592653889|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
164079059|NCT00410410|592653890|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
164079060|NCT00410410|592653882|FG000|Open-Label Period (OL)|Pregnancy|0|||
164079061|NCT00410410|592653883|FG001|Open-Label Period (OL)|Pregnancy|0|||
164079062|NCT00410410|592653884|FG002|Open-Label Period (OL)|Pregnancy|0|||
164079063|NCT00410410|592653885|FG003|Open-Label Period (OL)|Pregnancy|0|||
164079064|NCT00410410|592653886|FG004|Open-Label Period (OL)|Pregnancy|0|||
164219191|NCT03412890|593169997|FG000|Overall Study|Adverse Event|5|||
164219192|NCT03412890|593169998|FG001|Overall Study|Adverse Event|5|||
164219193|NCT03412890|593169999|FG002|Overall Study|Adverse Event|9|||
164219194|NCT03412890|593169997|FG000|Overall Study|Protocol deviation|2|||
164219195|NCT03412890|593169998|FG001|Overall Study|Protocol deviation|1|||
164219196|NCT03412890|593169999|FG002|Overall Study|Protocol deviation|2|||
164219197|NCT03412890|593169997|FG000|Overall Study|Lost to Follow-up|7|||
164219198|NCT03412890|593169998|FG001|Overall Study|Lost to Follow-up|10|||
164219199|NCT03412890|593169999|FG002|Overall Study|Lost to Follow-up|10|||
164219200|NCT03412890|593169997|FG000|Overall Study|Withdrawal by Subject|9|||
164219201|NCT03412890|593169998|FG001|Overall Study|Withdrawal by Subject|12|||
164219202|NCT03412890|593169999|FG002|Overall Study|Withdrawal by Subject|11|||
164219203|NCT03412890|593169997|FG000|Overall Study|Lack of Efficacy|2|||
164219204|NCT03412890|593169998|FG001|Overall Study|Lack of Efficacy|7|||
164219205|NCT03412890|593169999|FG002|Overall Study|Lack of Efficacy|5|||
164219206|NCT03412890|593169997|FG000|Overall Study|Other|5|||
164219207|NCT03412890|593169998|FG001|Overall Study|Other|6|||
164219208|NCT03412890|593169999|FG002|Overall Study|Other|5|||
164219209|NCT03412890|593169997|FG000|Overall Study|Participants who did not receive any study drug|0|||
164219210|NCT03412890|593169998|FG001|Overall Study|Participants who did not receive any study drug|1|||
164219211|NCT03412890|593169999|FG002|Overall Study|Participants who did not receive any study drug|0|||
164219212|NCT02336503|593170000|FG000|Overall Study|Lost to Follow-up|0|||
164219213|NCT02336503|593170001|FG001|Overall Study|Lost to Follow-up|3|||
164219214|NCT02336503|593170002|FG002|Overall Study|Lost to Follow-up|0|||
164219215|NCT02336503|593170003|FG003|Overall Study|Lost to Follow-up|2|||
164219216|NCT02336503|593170000|FG000|Overall Study|Withdrawal by Subject|2|||
164219217|NCT02336503|593170001|FG001|Overall Study|Withdrawal by Subject|0|||
164219218|NCT02336503|593170002|FG002|Overall Study|Withdrawal by Subject|0|||
164219219|NCT02336503|593170003|FG003|Overall Study|Withdrawal by Subject|4|||
164219220|NCT02336503|593170000|FG000|Overall Study|Adverse Event|0|||
164219221|NCT02336503|593170001|FG001|Overall Study|Adverse Event|0|||
164219222|NCT02336503|593170002|FG002|Overall Study|Adverse Event|1|||
164328734|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
164328735|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
164328736|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
163878280|NCT02287311|591922754|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163878281|NCT02287311|591922755|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
163878282|NCT02287311|591922756|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163878283|NCT02287311|591922757|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163878284|NCT02287311|591922758|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
163878285|NCT02287311|591922759|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163878286|NCT02287311|591922760|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163878287|NCT02287311|591922761|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
163878288|NCT02287311|591922753|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878289|NCT02287311|591922754|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878290|NCT02287311|591922755|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878291|NCT02287311|591922756|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878292|NCT02287311|591922757|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878293|NCT02287311|591922758|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
163878294|NCT02287311|591922759|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878295|NCT02287311|591922760|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
163878296|NCT02287311|591922761|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
163878297|NCT03896516|591922762|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
163878298|NCT03896516|591922763|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
163878299|NCT03896516|591922762|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
163878300|NCT03896516|591922763|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
163878301|NCT03896516|591922762|FG000|Washout Period|Physician Decision|3|||
163878302|NCT03896516|591922763|FG001|Washout Period|Physician Decision|1|||
163878303|NCT03896516|591922762|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
163878304|NCT03896516|591922763|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
163878305|NCT05461131|591922764|FG000|Overall Study|Lost to Follow-up|0|||
163878306|NCT05461131|591922765|FG001|Overall Study|Lost to Follow-up|2|||
163878307|NCT04437433|591922775|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
163878308|NCT04437433|591922776|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
163878309|NCT04437433|591922775|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
163878310|NCT04437433|591922776|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
163878311|NCT04437433|591922775|FG000|Overall Study|Adverse Event|9|||
163878312|NCT04437433|591922776|FG001|Overall Study|Adverse Event|0|||
163878313|NCT04437433|591922775|FG000|Overall Study|Lack of Efficacy|4|||
163878314|NCT04437433|591922776|FG001|Overall Study|Lack of Efficacy|0|||
163878315|NCT04437433|591922775|FG000|Overall Study|Withdrawal by Subject|4|||
164219223|NCT02336503|593170003|FG003|Overall Study|Adverse Event|0|||
164219224|NCT01436500|593170004|FG000|Overall Study|Death|1|||
164219225|NCT01436500|593170005|FG001|Overall Study|Death|0|||
164219226|NCT01436500|593170006|FG002|Overall Study|Death|0|||
164219227|NCT01436500|593170007|FG003|Overall Study|Death|0|||
164219228|NCT01436500|593170008|FG004|Overall Study|Death|0|||
164219229|NCT01436500|593170004|FG000|Overall Study|Adverse Event|0|||
163878316|NCT04437433|591922776|FG001|Overall Study|Withdrawal by Subject|1|||
163878317|NCT04437433|591922775|FG000|Overall Study|Protocol Deviation|0|||
164219230|NCT01436500|593170005|FG001|Overall Study|Adverse Event|2|||
164219231|NCT01436500|593170006|FG002|Overall Study|Adverse Event|2|||
164219232|NCT01436500|593170007|FG003|Overall Study|Adverse Event|0|||
164219233|NCT01436500|593170008|FG004|Overall Study|Adverse Event|1|||
163878318|NCT04437433|591922776|FG001|Overall Study|Protocol Deviation|1|||
163878319|NCT04437433|591922775|FG000|Overall Study|Other, not specified|0|||
163878320|NCT04437433|591922776|FG001|Overall Study|Other, not specified|1|||
163878321|NCT04579250|591922778|FG000|Overall Study|Withdrawal by Subject|1|||
163878322|NCT04579250|591922779|FG001|Overall Study|Withdrawal by Subject|1|||
163878323|NCT04579250|591922780|FG002|Overall Study|Withdrawal by Subject|0|||
163878324|NCT04579250|591922778|FG000|Overall Study|Lost to Follow-up|1|||
163878325|NCT04579250|591922779|FG001|Overall Study|Lost to Follow-up|1|||
163878326|NCT04579250|591922780|FG002|Overall Study|Lost to Follow-up|0|||
163878327|NCT04579250|591922778|FG000|Overall Study|Moved from area|0|||
163878328|NCT04579250|591922779|FG001|Overall Study|Moved from area|1|||
163878329|NCT04579250|591922780|FG002|Overall Study|Moved from area|2|||
163878330|NCT02919449|591922781|FG000|Overall Study|Withdrawal by Subject|1|||
163878331|NCT02919449|591922781|FG000|Overall Study|Investigator decision|1|||
163878332|NCT04711135|591922785|FG000|Overall Study|Physician Decision|0|||
163878333|NCT04711135|591922786|FG001|Overall Study|Physician Decision|1|||
163878334|NCT04711135|591922785|FG000|Overall Study|Ongoing treatment|0|||
163878335|NCT04711135|591922786|FG001|Overall Study|Ongoing treatment|1|||
163878336|NCT03578536|591922789|FG000|Overall Study|Lost to Follow-up|1|||
163878337|NCT02538900|591922792|FG000|Overall Study|Death|2|||
163878338|NCT02538900|591922793|FG001|Overall Study|Death|2|||
163878339|NCT02538900|591922794|FG002|Overall Study|Death|2|||
163878340|NCT02538900|591922792|FG000|Overall Study|Withdrawal by Subject|18|||
163878341|NCT02538900|591922793|FG001|Overall Study|Withdrawal by Subject|16|||
163878342|NCT02538900|591922794|FG002|Overall Study|Withdrawal by Subject|15|||
164219234|NCT01436500|593170004|FG000|Overall Study|Withdrawal by Subject|0|||
164219235|NCT01436500|593170005|FG001|Overall Study|Withdrawal by Subject|0|||
164219236|NCT01436500|593170006|FG002|Overall Study|Withdrawal by Subject|2|||
164219237|NCT01436500|593170007|FG003|Overall Study|Withdrawal by Subject|0|||
164219238|NCT01436500|593170008|FG004|Overall Study|Withdrawal by Subject|2|||
164219239|NCT01436500|593170004|FG000|Overall Study|Physician Decision|0|||
163878343|NCT03732820|591922795|FG000|Overall Study|Death|168|||
163878344|NCT03732820|591922796|FG001|Overall Study|Death|203|||
163878345|NCT03732820|591922795|FG000|Overall Study|Other|2|||
163878346|NCT03732820|591922796|FG001|Overall Study|Other|2|||
163878347|NCT03732820|591922795|FG000|Overall Study|Failure to meet randomisation criteria|1|||
163878348|NCT03732820|591922796|FG001|Overall Study|Failure to meet randomisation criteria|1|||
163878349|NCT03732820|591922795|FG000|Overall Study|Patient decision|14|||
163878350|NCT03732820|591922796|FG001|Overall Study|Patient decision|10|||
163878351|NCT03732820|591922795|FG000|Overall Study|Screen failure|0|||
163878352|NCT03732820|591922796|FG001|Overall Study|Screen failure|1|||
163878353|NCT03732820|591922795|FG000|Overall Study|Patients ongoing study at data cut off|210|||
163878354|NCT03732820|591922796|FG001|Overall Study|Patients ongoing study at data cut off|178|||
163878355|NCT03732820|591922795|FG000|Overall Study|Lost to Follow-up|4|||
163878356|NCT03732820|591922796|FG001|Overall Study|Lost to Follow-up|2|||
163878357|NCT02374307|591922799|FG000|3-months Follow-up|Lost to Follow-up|1|||
163878358|NCT02374307|591922800|FG001|3-months Follow-up|Lost to Follow-up|2|||
163878359|NCT02374307|591922799|FG000|3-months Follow-up|Withdrawal by Subject|1|||
163878360|NCT02374307|591922800|FG001|3-months Follow-up|Withdrawal by Subject|4|||
163878361|NCT02374307|591922799|FG000|3-months Follow-up|Death|1|||
163878362|NCT02374307|591922800|FG001|3-months Follow-up|Death|2|||
164219240|NCT01436500|593170005|FG001|Overall Study|Physician Decision|0|||
164219241|NCT01436500|593170006|FG002|Overall Study|Physician Decision|1|||
164219242|NCT01436500|593170007|FG003|Overall Study|Physician Decision|0|||
164219243|NCT01436500|593170008|FG004|Overall Study|Physician Decision|0|||
164219244|NCT01436500|593170004|FG000|Overall Study|liver transplant|1|||
164219245|NCT01436500|593170005|FG001|Overall Study|liver transplant|0|||
164219246|NCT01436500|593170006|FG002|Overall Study|liver transplant|0|||
164219247|NCT01436500|593170007|FG003|Overall Study|liver transplant|0|||
164219248|NCT01436500|593170008|FG004|Overall Study|liver transplant|0|||
164219249|NCT01436500|593170004|FG000|Overall Study|initiation of dialysis|0|||
164219250|NCT01436500|593170005|FG001|Overall Study|initiation of dialysis|0|||
164219251|NCT01436500|593170006|FG002|Overall Study|initiation of dialysis|0|||
164219252|NCT01436500|593170007|FG003|Overall Study|initiation of dialysis|0|||
164219253|NCT01436500|593170008|FG004|Overall Study|initiation of dialysis|1|||
164219254|NCT01436500|593170004|FG000|Overall Study|discontinued study drug|1|||
164219255|NCT01436500|593170005|FG001|Overall Study|discontinued study drug|0|||
164219256|NCT01436500|593170006|FG002|Overall Study|discontinued study drug|0|||
164219257|NCT01436500|593170007|FG003|Overall Study|discontinued study drug|0|||
164219258|NCT01436500|593170008|FG004|Overall Study|discontinued study drug|0|||
164219259|NCT01436500|593170004|FG000|Overall Study|Other|0|||
164219260|NCT01436500|593170005|FG001|Overall Study|Other|1|||
164219261|NCT01436500|593170006|FG002|Overall Study|Other|0|||
164219262|NCT01436500|593170007|FG003|Overall Study|Other|1|||
164219263|NCT01436500|593170008|FG004|Overall Study|Other|0|||
164219264|NCT02021318|593170012|FG000|Overall Study|Adverse Event|2|||
164219265|NCT02021318|593170013|FG001|Overall Study|Adverse Event|1|||
164219266|NCT02021318|593170012|FG000|Overall Study|Death|33|||
164219267|NCT02021318|593170013|FG001|Overall Study|Death|34|||
164079065|NCT00410410|592653887|FG005|Open-Label Period (OL)|Pregnancy|0|||
164079066|NCT00410410|592653888|FG006|Open-Label Period (OL)|Pregnancy|0|||
164079067|NCT00410410|592653889|FG007|Open-Label Period (OL)|Pregnancy|0|||
164079068|NCT00410410|592653890|FG008|Open-Label Period (OL)|Pregnancy|1|||
164079069|NCT00410410|592653882|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079070|NCT00410410|592653883|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079071|NCT00410410|592653884|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079072|NCT00410410|592653885|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079073|NCT00410410|592653886|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079074|NCT00410410|592653887|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079075|NCT00410410|592653888|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079076|NCT00410410|592653889|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
164079077|NCT00410410|592653890|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
164079078|NCT00410410|592653882|FG000|Open-Label Period (OL)|Other|0|||
164079079|NCT00410410|592653883|FG001|Open-Label Period (OL)|Other|0|||
164079080|NCT00410410|592653884|FG002|Open-Label Period (OL)|Other|0|||
164079081|NCT00410410|592653885|FG003|Open-Label Period (OL)|Other|0|||
164079082|NCT00410410|592653886|FG004|Open-Label Period (OL)|Other|0|||
164079083|NCT00410410|592653887|FG005|Open-Label Period (OL)|Other|0|||
164079084|NCT00410410|592653888|FG006|Open-Label Period (OL)|Other|0|||
164079085|NCT00410410|592653889|FG007|Open-Label Period (OL)|Other|0|||
164079086|NCT00410410|592653890|FG008|Open-Label Period (OL)|Other|7|||
164079087|NCT01783496|592653891|FG000|Overall Study|Lost to Follow-up|0|||
164079088|NCT01783496|592653892|FG001|Overall Study|Lost to Follow-up|0|||
164079089|NCT01783496|592653893|FG002|Overall Study|Lost to Follow-up|0|||
164079090|NCT01783496|592653894|FG003|Overall Study|Lost to Follow-up|2|||
164079091|NCT01783496|592653895|FG004|Overall Study|Lost to Follow-up|0|||
164079092|NCT01783496|592653896|FG005|Overall Study|Lost to Follow-up|1|||
164079093|NCT01783496|592653891|FG000|Overall Study|Withdrawal by Subject|1|||
164079094|NCT01783496|592653892|FG001|Overall Study|Withdrawal by Subject|0|||
164079095|NCT01783496|592653893|FG002|Overall Study|Withdrawal by Subject|0|||
164079096|NCT01783496|592653894|FG003|Overall Study|Withdrawal by Subject|0|||
164079097|NCT01783496|592653895|FG004|Overall Study|Withdrawal by Subject|0|||
164219268|NCT02021318|593170012|FG000|Overall Study|Lost to Follow-up|3|||
164219269|NCT02021318|593170013|FG001|Overall Study|Lost to Follow-up|3|||
164219270|NCT02021318|593170012|FG000|Overall Study|Progressive Disease|0|||
164219271|NCT02021318|593170013|FG001|Overall Study|Progressive Disease|1|||
164219272|NCT02021318|593170012|FG000|Overall Study|Withdrawal by Subject|30|||
164219273|NCT02021318|593170013|FG001|Overall Study|Withdrawal by Subject|18|||
164219274|NCT02021318|593170012|FG000|Overall Study|Physician Decision|3|||
164219275|NCT02021318|593170013|FG001|Overall Study|Physician Decision|3|||
164219276|NCT02021318|593170012|FG000|Overall Study|Miscellaneous|2|||
164219277|NCT02021318|593170013|FG001|Overall Study|Miscellaneous|3|||
164219278|NCT01068249|593170014|FG000|Overall Study|Death|1|||
164219279|NCT01068249|593170014|FG000|Overall Study|Withdrawal by Subject|3|||
164219280|NCT01740427|593170015|FG000|Overall Study|Objective Progression or Relapse|286|||
164219281|NCT01740427|593170016|FG001|Overall Study|Objective Progression or Relapse|172|||
164219282|NCT01740427|593170015|FG000|Overall Study|Adverse Event|32|||
164219283|NCT01740427|593170016|FG001|Overall Study|Adverse Event|9|||
164219284|NCT01740427|593170015|FG000|Overall Study|Global Deterioration of Health Status|28|||
164219285|NCT01740427|593170016|FG001|Overall Study|Global Deterioration of Health Status|12|||
164219286|NCT01740427|593170015|FG000|Overall Study|Participant Refused Continued Treatment|27|||
164219287|NCT01740427|593170016|FG001|Overall Study|Participant Refused Continued Treatment|15|||
164219288|NCT01740427|593170015|FG000|Overall Study|Unspecified reasons|52|||
164219289|NCT01740427|593170016|FG001|Overall Study|Unspecified reasons|8|||
163982180|NCT01014689|592304596|FG000|Overall Study|Lost to Follow-up|3|||
163982181|NCT01014689|592304597|FG001|Overall Study|Lost to Follow-up|7|||
163982182|NCT01014689|592304596|FG000|Overall Study|Pregnancy|1|||
163982183|NCT01014689|592304597|FG001|Overall Study|Pregnancy|0|||
163982184|NCT04418076|592304599|FG000|Overall Study|Death|1|||
163982185|NCT04418076|592304600|FG001|Overall Study|Death|0|||
163982186|NCT04418076|592304601|FG002|Overall Study|Death|0|||
163982187|NCT04418076|592304602|FG003|Overall Study|Death|0|||
163982188|NCT04418076|592304599|FG000|Overall Study|Lost to Follow-up|2|||
163982189|NCT04418076|592304600|FG001|Overall Study|Lost to Follow-up|5|||
163982190|NCT04418076|592304601|FG002|Overall Study|Lost to Follow-up|1|||
163982191|NCT04418076|592304602|FG003|Overall Study|Lost to Follow-up|2|||
163982192|NCT04418076|592304599|FG000|Overall Study|Withdrawal by Subject|1|||
163982193|NCT04418076|592304600|FG001|Overall Study|Withdrawal by Subject|0|||
163982194|NCT04418076|592304601|FG002|Overall Study|Withdrawal by Subject|1|||
163982195|NCT04418076|592304602|FG003|Overall Study|Withdrawal by Subject|1|||
163982196|NCT04418076|592304599|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
163982197|NCT04418076|592304600|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
163982198|NCT04418076|592304601|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
163982199|NCT04418076|592304602|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
164219290|NCT01740427|593170015|FG000|Overall Study|Death|10|||
164219291|NCT01740427|593170016|FG001|Overall Study|Death|3|||
164219292|NCT01740427|593170015|FG000|Overall Study|Protocol Violation|5|||
164219293|NCT01740427|593170016|FG001|Overall Study|Protocol Violation|3|||
164219294|NCT01740427|593170015|FG000|Overall Study|Lost to Follow-up|3|||
164219295|NCT01740427|593170016|FG001|Overall Study|Lost to Follow-up|0|||
164219296|NCT01740427|593170015|FG000|Overall Study|Site Terminated by Sponsor|1|||
164219297|NCT01740427|593170016|FG001|Overall Study|Site Terminated by Sponsor|0|||
164219298|NCT02184156|593170019|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
164219299|NCT02184156|593170020|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
164219300|NCT02184156|593170019|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
164219301|NCT02184156|593170020|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
164219302|NCT00165698|593170022|FG000|Overall Study|Adverse Event|2|||
164219303|NCT00165698|593170023|FG001|Overall Study|Adverse Event|10|||
164219304|NCT00165698|593170022|FG000|Overall Study|Lost to Follow-up|2|||
164219305|NCT00165698|593170023|FG001|Overall Study|Lost to Follow-up|2|||
164219306|NCT00165698|593170022|FG000|Overall Study|Withdrawal by Subject|2|||
164219307|NCT00165698|593170023|FG001|Overall Study|Withdrawal by Subject|1|||
164219308|NCT00165698|593170022|FG000|Overall Study|Protocol Violation|1|||
164219309|NCT00165698|593170023|FG001|Overall Study|Protocol Violation|0|||
164219310|NCT00165698|593170022|FG000|Overall Study|Not Taken/Lost the medicine|1|||
164079098|NCT01783496|592653896|FG005|Overall Study|Withdrawal by Subject|0|||
164079099|NCT01023269|592653897|FG000|Overall Study|early termination of the study|2|||
164079100|NCT01023269|592653898|FG001|Overall Study|early termination of the study|0|||
164079101|NCT00106028|592653899|FG000|Overall Study|Adverse Event|3|||
164079102|NCT00106028|592653900|FG001|Overall Study|Adverse Event|2|||
164079103|NCT00106028|592653899|FG000|Overall Study|Protocol Violation|1|||
164079104|NCT00106028|592653900|FG001|Overall Study|Protocol Violation|1|||
164079105|NCT00106028|592653899|FG000|Overall Study|Withdrawal by Subject|2|||
164079106|NCT00106028|592653900|FG001|Overall Study|Withdrawal by Subject|8|||
164079107|NCT00106028|592653899|FG000|Overall Study|Lost to Follow-up|0|||
164079108|NCT00106028|592653900|FG001|Overall Study|Lost to Follow-up|1|||
164079109|NCT00947011|592653901|FG000|Overall Study|Study was terminated,PI left institution|12|||
164079110|NCT05266456|592653904|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
164079111|NCT05266456|592653905|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
164079112|NCT05266456|592653906|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
164079113|NCT05266456|592653907|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
164079114|NCT05266456|592653904|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
164079115|NCT05266456|592653905|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
164079116|NCT05266456|592653906|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
164079117|NCT05266456|592653907|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
164079118|NCT05266456|592653904|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
164079119|NCT05266456|592653905|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
163878363|NCT02374307|591922799|FG000|3-months Follow-up|Missed first follow-up|5|||
163878364|NCT02374307|591922800|FG001|3-months Follow-up|Missed first follow-up|1|||
164079120|NCT05266456|592653906|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
164079121|NCT05266456|592653907|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
164079122|NCT05266456|592653904|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
164079123|NCT05266456|592653905|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
164079124|NCT05266456|592653906|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
164079125|NCT05266456|592653907|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
164079126|NCT05266456|592653904|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
164079127|NCT05266456|592653905|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
164079128|NCT05266456|592653906|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
164079129|NCT05266456|592653907|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
164219311|NCT00165698|593170023|FG001|Overall Study|Not Taken/Lost the medicine|2|||
164219312|NCT01483651|593170024|FG000|Overall Study|Withdrawal by Subject|0|||
164219313|NCT01483651|593170025|FG001|Overall Study|Withdrawal by Subject|1|||
163878365|NCT02374307|591922799|FG000|6-months Follow-up|Lost to Follow-up|1|||
163878366|NCT02374307|591922800|FG001|6-months Follow-up|Lost to Follow-up|2|||
163878367|NCT02374307|591922799|FG000|6-months Follow-up|Death|2|||
163878368|NCT02374307|591922800|FG001|6-months Follow-up|Death|1|||
163878369|NCT02374307|591922799|FG000|6-months Follow-up|Withdrawal by Subject|0|||
163878370|NCT02374307|591922800|FG001|6-months Follow-up|Withdrawal by Subject|3|||
163878371|NCT01989455|591922801|FG000|Overall Study|Adverse Event|0|||
163878372|NCT01989455|591922802|FG001|Overall Study|Adverse Event|1|||
163878373|NCT01989455|591922803|FG002|Overall Study|Adverse Event|0|||
164079130|NCT02746705|592653914|FG000|Overall Study|Physician Decision|1|||
164079131|NCT02746705|592653915|FG001|Overall Study|Physician Decision|1|||
164079132|NCT02746705|592653914|FG000|Overall Study|Lost to Follow-up|1|||
164079133|NCT02746705|592653915|FG001|Overall Study|Lost to Follow-up|0|||
164079134|NCT02746705|592653914|FG000|Overall Study|outlier scores deemed not valid|0|||
163878374|NCT01989455|591922804|FG003|Overall Study|Adverse Event|0|||
163878375|NCT01989455|591922805|FG004|Overall Study|Adverse Event|0|||
164219314|NCT01483651|593170026|FG002|Overall Study|Withdrawal by Subject|1|||
163982200|NCT01344876|592304604|FG000|Overall Study|Adverse Event|0|||
163982201|NCT01344876|592304605|FG001|Overall Study|Adverse Event|0|||
163982202|NCT01344876|592304606|FG002|Overall Study|Adverse Event|0|||
163982203|NCT01344876|592304607|FG003|Overall Study|Adverse Event|0|||
163982204|NCT01344876|592304608|FG004|Overall Study|Adverse Event|1|||
163982205|NCT01344876|592304604|FG000|Overall Study|Withdrawal by Subject|0|||
163982206|NCT01344876|592304605|FG001|Overall Study|Withdrawal by Subject|0|||
163982207|NCT01344876|592304606|FG002|Overall Study|Withdrawal by Subject|1|||
163982208|NCT01344876|592304607|FG003|Overall Study|Withdrawal by Subject|0|||
163982209|NCT01344876|592304608|FG004|Overall Study|Withdrawal by Subject|0|||
163982210|NCT01344876|592304604|FG000|Overall Study|Definite progression of primary disease|1|||
163982211|NCT01344876|592304605|FG001|Overall Study|Definite progression of primary disease|0|||
163982212|NCT01344876|592304606|FG002|Overall Study|Definite progression of primary disease|0|||
163982213|NCT01344876|592304607|FG003|Overall Study|Definite progression of primary disease|3|||
163982214|NCT01344876|592304608|FG004|Overall Study|Definite progression of primary disease|0|||
163982215|NCT05107765|592304609|FG000|Overall Study|Lost to Follow-up|4|||
163982216|NCT05107765|592304610|FG001|Overall Study|Lost to Follow-up|1|||
164219315|NCT01483651|593170027|FG003|Overall Study|Withdrawal by Subject|0|||
164219316|NCT01483651|593170028|FG004|Overall Study|Withdrawal by Subject|0|||
164219317|NCT01483651|593170029|FG005|Overall Study|Withdrawal by Subject|1|||
164219318|NCT02547935|593170030|FG000|Overall Study|Other|0|||
164219319|NCT02547935|593170031|FG001|Overall Study|Other|1|||
164219320|NCT02547935|593170032|FG002|Overall Study|Other|0|||
164219321|NCT02547935|593170030|FG000|Overall Study|Withdrawal by Subject|2|||
164219322|NCT02547935|593170031|FG001|Overall Study|Withdrawal by Subject|3|||
164219323|NCT02547935|593170032|FG002|Overall Study|Withdrawal by Subject|4|||
164219324|NCT02547935|593170030|FG000|Overall Study|Screen Failure|2|||
164219325|NCT02547935|593170031|FG001|Overall Study|Screen Failure|0|||
164219326|NCT02547935|593170032|FG002|Overall Study|Screen Failure|0|||
164219327|NCT02547935|593170030|FG000|Overall Study|Physician Decision|0|||
164219328|NCT02547935|593170031|FG001|Overall Study|Physician Decision|1|||
164219329|NCT02547935|593170032|FG002|Overall Study|Physician Decision|0|||
164219330|NCT02547935|593170030|FG000|Overall Study|Lost to Follow-up|0|||
164219331|NCT02547935|593170031|FG001|Overall Study|Lost to Follow-up|2|||
164219332|NCT02547935|593170032|FG002|Overall Study|Lost to Follow-up|1|||
164219333|NCT02547935|593170030|FG000|Overall Study|Death|1|||
164219334|NCT02547935|593170031|FG001|Overall Study|Death|1|||
164219335|NCT02547935|593170032|FG002|Overall Study|Death|0|||
164219336|NCT01937117|593170037|FG000|Overall Study|Disease Progression|7|||
164219337|NCT01937117|593170037|FG000|Overall Study|Physician Decision|4|||
164219338|NCT01937117|593170037|FG000|Overall Study|Adverse Event|2|||
164219339|NCT01695772|593170044|FG000|Overall Study|Withdrawal by Subject|18|||
164219340|NCT01695772|593170044|FG000|Overall Study|Progressive Disease|8|||
164219341|NCT01695772|593170044|FG000|Overall Study|Investigator Decision|5|||
164219342|NCT01695772|593170044|FG000|Overall Study|Lost to Follow-up|4|||
164219343|NCT01695772|593170044|FG000|Overall Study|Protocol Violation|2|||
164219344|NCT01695772|593170044|FG000|Overall Study|Unspecified Reason|1|||
164219345|NCT01567085|593171732|FG000|Overall Study|Death|6|||
164219346|NCT01567085|593171732|FG000|Overall Study|Adverse Event|6|||
164219347|NCT01567085|593171732|FG000|Overall Study|Lost to Follow-up|3|||
164219348|NCT01567085|593171732|FG000|Overall Study|Graft loss|2|||
164219349|NCT01567085|593171732|FG000|Overall Study|Renal transplantectomy|1|||
164219350|NCT01567085|593171732|FG000|Overall Study|Returned to chronic dialysis|1|||
164219351|NCT01567085|593171732|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
164219352|NCT04193176|593171733|FG000|Overall Study|Withdrawal by Subject|6|||
164219353|NCT04193176|593171734|FG001|Overall Study|Withdrawal by Subject|10|||
164219354|NCT00944645|593171739|FG000|Period 2|Adverse Event|1|||
164219355|NCT00944645|593171740|FG001|Period 2|Adverse Event|0|||
164219356|NCT00944645|593171739|FG000|Period 2|Lost to Follow-up|0|||
164219357|NCT00944645|593171740|FG001|Period 2|Lost to Follow-up|3|||
164219358|NCT00944645|593171739|FG000|Period 2|Withdrawal by Subject|7|||
164219359|NCT00944645|593171740|FG001|Period 2|Withdrawal by Subject|6|||
164219360|NCT03537729|593171744|FG000|Overall Study|Death|2|||
164219361|NCT03537729|593171745|FG001|Overall Study|Death|2|||
164219362|NCT03537729|593171746|FG002|Overall Study|Death|7|||
164219363|NCT03537729|593171744|FG000|Overall Study|Withdrawal by Subject|3|||
164219364|NCT03537729|593171745|FG001|Overall Study|Withdrawal by Subject|3|||
164219365|NCT03537729|593171746|FG002|Overall Study|Withdrawal by Subject|0|||
164219366|NCT03537729|593171744|FG000|Overall Study|Subject Moved|8|||
164219367|NCT03537729|593171745|FG001|Overall Study|Subject Moved|5|||
163982217|NCT05107765|592304609|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
163982218|NCT05107765|592304610|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
163982219|NCT05107765|592304609|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
164219368|NCT03537729|593171746|FG002|Overall Study|Subject Moved|4|||
164219369|NCT03537729|593171744|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
164219370|NCT03537729|593171745|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
164219371|NCT03537729|593171746|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
164219372|NCT03537729|593171744|FG000|Overall Study|COVID-19 Site Restrictions|11|||
164219373|NCT03537729|593171745|FG001|Overall Study|COVID-19 Site Restrictions|15|||
164219374|NCT03537729|593171746|FG002|Overall Study|COVID-19 Site Restrictions|18|||
164219375|NCT03537729|593171744|FG000|Overall Study|Decline in Health|5|||
164219376|NCT03537729|593171745|FG001|Overall Study|Decline in Health|9|||
164219377|NCT03537729|593171746|FG002|Overall Study|Decline in Health|4|||
164219378|NCT03537729|593171744|FG000|Overall Study|Determined Ineligible|0|||
164219379|NCT03537729|593171745|FG001|Overall Study|Determined Ineligible|0|||
164219380|NCT03537729|593171746|FG002|Overall Study|Determined Ineligible|1|||
164219381|NCT00284934|593171749|FG000|Overall Study|Adverse Event|1|||
164219382|NCT00284934|593171750|FG001|Overall Study|Adverse Event|2|||
164219383|NCT00284934|593171749|FG000|Overall Study|Other reasons|3|||
164219384|NCT00284934|593171750|FG001|Overall Study|Other reasons|1|||
164219385|NCT01783015|593171756|FG000|Blinded Treatment|Adverse Event|0|||
164219386|NCT01783015|593171757|FG001|Blinded Treatment|Adverse Event|1|||
164219387|NCT01783015|593171758|FG002|Blinded Treatment|Adverse Event|0|||
164219388|NCT01783015|593171756|FG000|Blinded Treatment|Protocol Violation|0|||
164219389|NCT01783015|593171757|FG001|Blinded Treatment|Protocol Violation|1|||
164219390|NCT01783015|593171758|FG002|Blinded Treatment|Protocol Violation|0|||
164219391|NCT01783015|593171756|FG000|Blinded Treatment|Withdrawal by Subject|0|||
164219392|NCT01783015|593171757|FG001|Blinded Treatment|Withdrawal by Subject|1|||
164219393|NCT01783015|593171758|FG002|Blinded Treatment|Withdrawal by Subject|0|||
164219394|NCT01783015|593171756|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
164219395|NCT01783015|593171757|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
164219396|NCT01783015|593171758|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
164219397|NCT01783015|593171756|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
164219398|NCT01783015|593171757|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
164219399|NCT01783015|593171758|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
164219400|NCT01348698|593171759|FG000|Overall Study|Does not meet lesion size criteria|1|||
164219401|NCT01348698|593171759|FG000|Overall Study|Death|3|||
164219402|NCT01348698|593171759|FG000|Overall Study|PI decision to close study|68|||
164219403|NCT02502383|593171762|FG000|Overall Study|Lost to Follow-up|130|||
164219404|NCT02502383|593171763|FG001|Overall Study|Lost to Follow-up|131|||
164219405|NCT02502383|593171762|FG000|Overall Study|Withdrawal by Subject|31|||
164219406|NCT02502383|593171763|FG001|Overall Study|Withdrawal by Subject|24|||
164219407|NCT01428713|593171764|FG000|Overall Study|Non-compliance|2|||
164219408|NCT01428713|593171765|FG001|Overall Study|Non-compliance|2|||
164219409|NCT01428713|593171764|FG000|Overall Study|Withdrawal by Subject|1|||
164219410|NCT01428713|593171765|FG001|Overall Study|Withdrawal by Subject|1|||
164219411|NCT01428713|593171764|FG000|Overall Study|Adverse Event|0|||
164219412|NCT01428713|593171765|FG001|Overall Study|Adverse Event|2|||
164219413|NCT00875667|593171766|FG000|Overall Study|Adverse Event|29|||
164219414|NCT00875667|593171767|FG001|Overall Study|Adverse Event|10|||
164219415|NCT00875667|593171766|FG000|Overall Study|Withdrawal by Subject|17|||
164219416|NCT00875667|593171767|FG001|Overall Study|Withdrawal by Subject|5|||
164219417|NCT00875667|593171766|FG000|Overall Study|Death|7|||
164219418|NCT00875667|593171767|FG001|Overall Study|Death|2|||
164219419|NCT00875667|593171766|FG000|Overall Study|Protocol Violation|2|||
164219420|NCT00875667|593171767|FG001|Overall Study|Protocol Violation|0|||
164219421|NCT00875667|593171766|FG000|Overall Study|Disease Progression|100|||
164219422|NCT00875667|593171767|FG001|Overall Study|Disease Progression|49|||
164219423|NCT00875667|593171766|FG000|Overall Study|Miscellaneous|12|||
163878376|NCT01989455|591922801|FG000|Overall Study|Withdrawal by Subject|0|||
163878377|NCT01989455|591922802|FG001|Overall Study|Withdrawal by Subject|1|||
163878378|NCT01989455|591922803|FG002|Overall Study|Withdrawal by Subject|0|||
164219424|NCT00875667|593171767|FG001|Overall Study|Miscellaneous|6|||
164219425|NCT00875667|593171766|FG000|Overall Study|Randomized but no Study Drug Given|3|||
164219426|NCT00875667|593171767|FG001|Overall Study|Randomized but no Study Drug Given|1|||
164219427|NCT01441414|593171780|FG000|Overall Study|Participant died|9|||
164219428|NCT01441414|593171780|FG000|Overall Study|Other reasons|3|||
164219429|NCT01441414|593171780|FG000|Overall Study|Study terminated by sponsor|2|||
164219430|NCT01441414|593171780|FG000|Overall Study|Subject refused further follow-up|1|||
164219431|NCT03791060|593171781|FG000|Overall Study|Withdrawal by Subject|1|||
164219432|NCT01011283|593171782|FG000|Overall Study|Adverse Event|4|||
164219433|NCT01011283|593171783|FG001|Overall Study|Adverse Event|2|||
164219434|NCT01011283|593171782|FG000|Overall Study|Progressive Disease|0|||
164219435|NCT01011283|593171783|FG001|Overall Study|Progressive Disease|2|||
164219436|NCT01011283|593171782|FG000|Overall Study|Terminated by Sponsor|5|||
164219437|NCT01011283|593171783|FG001|Overall Study|Terminated by Sponsor|5|||
164219438|NCT01011283|593171782|FG000|Overall Study|Other|2|||
164219439|NCT01011283|593171783|FG001|Overall Study|Other|2|||
164219440|NCT01717859|593171784|FG000|Overall Study|Adverse Event|5|||
164219441|NCT01717859|593171784|FG000|Overall Study|Moved out of state|1|||
164219442|NCT01717859|593171784|FG000|Overall Study|Patient concerned about mental health|1|||
164219443|NCT01717859|593171784|FG000|Overall Study|Lost to Follow-up|1|||
164219444|NCT01717859|593171784|FG000|Overall Study|Withdrawal by Subject|2|||
164219445|NCT01814332|593171785|FG000|Overall Study|Adverse Event|8|||
164219446|NCT01814332|593171786|FG001|Overall Study|Adverse Event|3|||
164079135|NCT02746705|592653915|FG001|Overall Study|outlier scores deemed not valid|1|||
164079136|NCT00479401|592653916|FG000|Overall Study|Adverse Event|24|||
163878379|NCT01989455|591922804|FG003|Overall Study|Withdrawal by Subject|0|||
163878380|NCT01989455|591922805|FG004|Overall Study|Withdrawal by Subject|0|||
163878381|NCT01989455|591922801|FG000|Overall Study|Technical problems with infusion|0|||
163878382|NCT01989455|591922802|FG001|Overall Study|Technical problems with infusion|0|||
163878383|NCT01989455|591922803|FG002|Overall Study|Technical problems with infusion|1|||
163878384|NCT01989455|591922804|FG003|Overall Study|Technical problems with infusion|0|||
163878385|NCT01989455|591922805|FG004|Overall Study|Technical problems with infusion|1|||
163878386|NCT00632203|591922806|FG000|Overall Study|Did not start study treatment|1|||
163878387|NCT00632203|591922807|FG001|Overall Study|Did not start study treatment|0|||
163878388|NCT00999167|591922808|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
163878389|NCT00999167|591922809|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
163878390|NCT00999167|591922810|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
163878391|NCT00999167|591922808|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
163878392|NCT00999167|591922809|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
163878393|NCT00999167|591922810|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
163878394|NCT00999167|591922808|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
163878395|NCT00999167|591922809|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
163878396|NCT00999167|591922810|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
163878397|NCT00999167|591922808|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
163878398|NCT00999167|591922809|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
163878399|NCT00999167|591922810|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
163878400|NCT00999167|591922808|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
163878401|NCT00999167|591922809|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
163878402|NCT00999167|591922810|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
163878403|NCT00999167|591922808|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
163878404|NCT00999167|591922809|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
163878405|NCT00999167|591922810|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
163878406|NCT00999167|591922808|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
163878407|NCT00999167|591922809|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
163878408|NCT00999167|591922810|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
163878409|NCT00999167|591922808|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
163878410|NCT00999167|591922809|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
163878411|NCT00999167|591922810|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
163878412|NCT04238247|591922811|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
163878413|NCT04238247|591922812|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
163878414|NCT04238247|591922813|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
163878415|NCT04238247|591922814|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
163878416|NCT04238247|591922811|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
163878417|NCT04238247|591922812|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
163878418|NCT04238247|591922813|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
163878419|NCT04238247|591922814|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
163878420|NCT04238247|591922811|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
163878421|NCT04238247|591922812|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
163878422|NCT04238247|591922813|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
163878423|NCT04238247|591922814|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
163878424|NCT04238247|591922811|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
163878425|NCT04238247|591922812|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
163878426|NCT04238247|591922813|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
163878427|NCT04238247|591922814|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
163878428|NCT04950127|591922815|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
163878429|NCT04950127|591922816|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
163878430|NCT04950127|591922817|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
163878431|NCT04950127|591922818|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
163878432|NCT04950127|591922819|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
163878433|NCT04950127|591922820|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
163878434|NCT04950127|591922815|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
163878435|NCT04950127|591922816|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
163878436|NCT04950127|591922817|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
163878437|NCT04950127|591922818|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
163878438|NCT04950127|591922819|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
163878439|NCT04950127|591922820|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
163878440|NCT04950127|591922815|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
163878441|NCT04950127|591922816|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
163878442|NCT04950127|591922817|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
164079137|NCT00479401|592653917|FG001|Overall Study|Adverse Event|20|||
164219447|NCT01814332|593171785|FG000|Overall Study|Withdrawal by Subject|3|||
164219448|NCT01814332|593171786|FG001|Overall Study|Withdrawal by Subject|8|||
164219449|NCT01814332|593171785|FG000|Overall Study|Protocol Violation|0|||
164219450|NCT01814332|593171786|FG001|Overall Study|Protocol Violation|4|||
164219451|NCT01814332|593171785|FG000|Overall Study|Lost to Follow-up|5|||
164219452|NCT01814332|593171786|FG001|Overall Study|Lost to Follow-up|1|||
164219453|NCT04389671|593171787|FG000|Overall Study|Death|7|||
164219454|NCT05987540|593171788|FG000|Overall Study|Withdrawal by Subject|2|||
164219455|NCT05987540|593171788|FG000|Overall Study|Death|1|||
164219456|NCT05987540|593171788|FG000|Overall Study|Study Termination|1|||
164219457|NCT05987540|593171788|FG000|Overall Study|Adverse Event|2|||
164219458|NCT00122187|593171789|FG000|Overall Study|Withdrew because of resource limitations|2|||
164219459|NCT00122187|593171790|FG001|Overall Study|Withdrew because of resource limitations|2|||
164219460|NCT01290731|593171794|FG000|Overall Study|Withdrawal by Subject|1|||
164219461|NCT02181738|593171800|FG000|Overall Study|Participant Withdrew Consent|2|||
164219462|NCT02181738|593171801|FG001|Overall Study|Participant Withdrew Consent|1|||
164219463|NCT02181738|593171802|FG002|Overall Study|Participant Withdrew Consent|1|||
164219464|NCT02181738|593171803|FG003|Overall Study|Participant Withdrew Consent|1|||
164219465|NCT02181738|593171800|FG000|Overall Study|Lost to Follow-up|1|||
164219466|NCT02181738|593171801|FG001|Overall Study|Lost to Follow-up|2|||
164219467|NCT02181738|593171802|FG002|Overall Study|Lost to Follow-up|1|||
164219468|NCT02181738|593171803|FG003|Overall Study|Lost to Follow-up|1|||
164219469|NCT02181738|593171800|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
164219470|NCT02181738|593171801|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
164219471|NCT02181738|593171802|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
164219472|NCT02181738|593171803|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
164219473|NCT02181738|593171800|FG000|Overall Study|Poor/Non-Compliance|1|||
164219474|NCT02181738|593171801|FG001|Overall Study|Poor/Non-Compliance|0|||
164219475|NCT02181738|593171802|FG002|Overall Study|Poor/Non-Compliance|2|||
164219476|NCT02181738|593171803|FG003|Overall Study|Poor/Non-Compliance|1|||
164219477|NCT02181738|593171800|FG000|Overall Study|Disease Progression|28|||
164219478|NCT02181738|593171801|FG001|Overall Study|Disease Progression|35|||
164219479|NCT02181738|593171802|FG002|Overall Study|Disease Progression|40|||
164219480|NCT02181738|593171803|FG003|Overall Study|Disease Progression|0|||
164219481|NCT02181738|593171800|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
164219482|NCT02181738|593171801|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
163982220|NCT05107765|592304610|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
163982221|NCT00562588|592304611|FG000|Overall Study|Adverse Event|40|||
163982222|NCT00562588|592304612|FG001|Overall Study|Adverse Event|58|||
163982223|NCT00562588|592304611|FG000|Overall Study|Protocol Violation|30|||
164219483|NCT02181738|593171802|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
164219484|NCT02181738|593171803|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
164219485|NCT02181738|593171800|FG000|Overall Study|Study Drug Toxicity|6|||
164219486|NCT02181738|593171801|FG001|Overall Study|Study Drug Toxicity|11|||
164219487|NCT02181738|593171802|FG002|Overall Study|Study Drug Toxicity|8|||
164219488|NCT02181738|593171803|FG003|Overall Study|Study Drug Toxicity|1|||
164219489|NCT02181738|593171800|FG000|Overall Study|Other Reasons|14|||
164219490|NCT02181738|593171801|FG001|Overall Study|Other Reasons|16|||
164219491|NCT02181738|593171802|FG002|Overall Study|Other Reasons|28|||
164219492|NCT02181738|593171803|FG003|Overall Study|Other Reasons|0|||
164219493|NCT02181738|593171800|FG000|Overall Study|Maximum Clinical Benefit|3|||
164219494|NCT02181738|593171801|FG001|Overall Study|Maximum Clinical Benefit|0|||
164219495|NCT02181738|593171802|FG002|Overall Study|Maximum Clinical Benefit|1|||
164219496|NCT02181738|593171803|FG003|Overall Study|Maximum Clinical Benefit|0|||
164219497|NCT02181738|593171800|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164219498|NCT02181738|593171801|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164219499|NCT02181738|593171802|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164219500|NCT02181738|593171803|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
164219501|NCT00888849|593171808|FG000|Overall Study|Death|4|||
164219502|NCT00888849|593171809|FG001|Overall Study|Death|7|||
164219503|NCT00888849|593171808|FG000|Overall Study|Lost to Follow-up|1|||
164219504|NCT00888849|593171809|FG001|Overall Study|Lost to Follow-up|2|||
164219505|NCT05064800|593171810|FG000|Period 3|Withdrawal by Subject|0|||
164219506|NCT05064800|593171811|FG001|Period 3|Withdrawal by Subject|0|||
164219507|NCT05064800|593171812|FG002|Period 3|Withdrawal by Subject|0|||
164219508|NCT05064800|593171813|FG003|Period 3|Withdrawal by Subject|0|||
164219509|NCT05064800|593171814|FG004|Period 3|Withdrawal by Subject|1|||
164219510|NCT05064800|593171815|FG005|Period 3|Withdrawal by Subject|0|||
164219511|NCT00629239|593171816|FG000|Overall Study|Adverse Event|7|||
164219512|NCT00629239|593171817|FG001|Overall Study|Adverse Event|4|||
164219513|NCT00629239|593171816|FG000|Overall Study|Physician Decision|1|||
164219514|NCT00629239|593171817|FG001|Overall Study|Physician Decision|0|||
164219515|NCT01851369|593171820|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219516|NCT01851369|593171821|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219517|NCT01851369|593171822|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219518|NCT01851369|593171823|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219519|NCT01851369|593171824|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219520|NCT01851369|593171825|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
164219521|NCT01851369|593171826|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219522|NCT01851369|593171827|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219523|NCT01851369|593171828|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219524|NCT01851369|593171829|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219525|NCT01851369|593171830|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219526|NCT01851369|593171831|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219527|NCT01851369|593171832|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
164219528|NCT00183391|593171833|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
164219529|NCT00183391|593171834|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
164219530|NCT00183391|593171833|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
164219531|NCT00183391|593171834|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
164219532|NCT00395512|593171835|FG000|Overall Study|Adverse Event|3|||
164219533|NCT00395512|593171836|FG001|Overall Study|Adverse Event|8|||
164219534|NCT00395512|593171837|FG002|Overall Study|Adverse Event|6|||
164219535|NCT00395512|593171838|FG003|Overall Study|Adverse Event|6|||
164219536|NCT00395512|593171835|FG000|Overall Study|Protocol Violation|2|||
164219537|NCT00395512|593171836|FG001|Overall Study|Protocol Violation|3|||
164219538|NCT00395512|593171837|FG002|Overall Study|Protocol Violation|6|||
164219539|NCT00395512|593171838|FG003|Overall Study|Protocol Violation|7|||
164219540|NCT00395512|593171835|FG000|Overall Study|Lost to Follow-up|2|||
164219541|NCT00395512|593171836|FG001|Overall Study|Lost to Follow-up|6|||
164219542|NCT00395512|593171837|FG002|Overall Study|Lost to Follow-up|5|||
164219543|NCT00395512|593171838|FG003|Overall Study|Lost to Follow-up|5|||
164219544|NCT00395512|593171835|FG000|Overall Study|Withdrawal by Subject|6|||
164219545|NCT00395512|593171836|FG001|Overall Study|Withdrawal by Subject|5|||
164219546|NCT00395512|593171837|FG002|Overall Study|Withdrawal by Subject|5|||
164219547|NCT00395512|593171838|FG003|Overall Study|Withdrawal by Subject|12|||
164219548|NCT00395512|593171835|FG000|Overall Study|Physician Decision|6|||
164219549|NCT00395512|593171836|FG001|Overall Study|Physician Decision|4|||
164219550|NCT00395512|593171837|FG002|Overall Study|Physician Decision|2|||
164219551|NCT00395512|593171838|FG003|Overall Study|Physician Decision|2|||
164219552|NCT00395512|593171835|FG000|Overall Study|Other|1|||
164219553|NCT00395512|593171836|FG001|Overall Study|Other|1|||
164219554|NCT00395512|593171837|FG002|Overall Study|Other|0|||
164219555|NCT00395512|593171838|FG003|Overall Study|Other|0|||
164219556|NCT00395512|593171835|FG000|Overall Study|Hyperglycemic Rescue|18|||
164219557|NCT00395512|593171836|FG001|Overall Study|Hyperglycemic Rescue|10|||
164219558|NCT00395512|593171837|FG002|Overall Study|Hyperglycemic Rescue|4|||
164219559|NCT00395512|593171838|FG003|Overall Study|Hyperglycemic Rescue|6|||
164219560|NCT01936974|593171839|FG000|Overall Study|Physician Decision|2|||
164219561|NCT01936974|593171840|FG001|Overall Study|Physician Decision|5|||
164219562|NCT04584554|593171841|FG000|Overall Study|Withdrawal by Subject|2|||
164219563|NCT04584554|593171842|FG001|Overall Study|Withdrawal by Subject|2|||
164219564|NCT00063999|593171843|FG000|Overall Study|Withdrawal by Subject|1|||
164219565|NCT00063999|593171844|FG001|Overall Study|Withdrawal by Subject|0|||
164219566|NCT00063999|593171843|FG000|Overall Study|Ineligible|44|||
164219567|NCT00063999|593171844|FG001|Overall Study|Ineligible|24|||
164219568|NCT02497755|593171847|FG000|Overall Study|Protocol Violation|1|||
164219569|NCT02497755|593171848|FG001|Overall Study|Protocol Violation|0|||
164219570|NCT03983109|593171859|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
164219571|NCT03983109|593171860|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
164219572|NCT05085405|593171861|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219573|NCT05085405|593171862|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219574|NCT05085405|593171863|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
164219575|NCT05085405|593171864|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
164219576|NCT05085405|593171865|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219577|NCT05085405|593171866|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
164219578|NCT05085405|593171861|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219579|NCT05085405|593171862|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219580|NCT05085405|593171863|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219581|NCT05085405|593171864|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
164219582|NCT05085405|593171865|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219583|NCT05085405|593171866|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
164219584|NCT01860404|593171867|FG000|Overall Study|Lost to Follow-up|3|||
164219585|NCT01860404|593171868|FG001|Overall Study|Lost to Follow-up|4|||
164219586|NCT01860404|593171869|FG002|Overall Study|Lost to Follow-up|1|||
164219587|NCT01860404|593171870|FG003|Overall Study|Lost to Follow-up|6|||
164219588|NCT01860404|593171871|FG004|Overall Study|Lost to Follow-up|4|||
164219589|NCT01860404|593171867|FG000|Overall Study|Withdrawal by Subject|0|||
164219590|NCT01860404|593171868|FG001|Overall Study|Withdrawal by Subject|0|||
164219591|NCT01860404|593171869|FG002|Overall Study|Withdrawal by Subject|4|||
164219592|NCT01860404|593171870|FG003|Overall Study|Withdrawal by Subject|0|||
164219593|NCT01860404|593171871|FG004|Overall Study|Withdrawal by Subject|0|||
164219594|NCT01928771|593171881|FG000|Overall Study|Adverse Event|6|||
164219595|NCT01928771|593171882|FG001|Overall Study|Adverse Event|5|||
164219596|NCT01928771|593171883|FG002|Overall Study|Adverse Event|1|||
164219597|NCT01928771|593171881|FG000|Overall Study|Death|2|||
164219598|NCT01928771|593171882|FG001|Overall Study|Death|2|||
164219599|NCT01928771|593171883|FG002|Overall Study|Death|2|||
164328737|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
164328738|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
164328739|NCT01226043|593579593|FG000|6-week Re-randomization Phase|Physician Decision|0|||
164328740|NCT01226043|593579594|FG001|6-week Re-randomization Phase|Physician Decision|0|||
164328741|NCT01226043|593579595|FG002|6-week Re-randomization Phase|Physician Decision|3|||
164328742|NCT01226043|593579596|FG003|6-week Re-randomization Phase|Physician Decision|2|||
164328743|NCT01226043|593579593|FG000|6-week Re-randomization Phase|completed in error|0|||
164328744|NCT01226043|593579594|FG001|6-week Re-randomization Phase|completed in error|0|||
164328745|NCT01226043|593579595|FG002|6-week Re-randomization Phase|completed in error|0|||
164328746|NCT01226043|593579596|FG003|6-week Re-randomization Phase|completed in error|1|||
164328747|NCT01226043|593579593|FG000|30-week Observational Phase|Adverse Event|0|||
164328748|NCT01226043|593579594|FG001|30-week Observational Phase|Adverse Event|0|||
164328749|NCT01226043|593579595|FG002|30-week Observational Phase|Adverse Event|1|||
164328750|NCT01226043|593579596|FG003|30-week Observational Phase|Adverse Event|1|||
164328751|NCT01226043|593579593|FG000|30-week Observational Phase|Protocol Violation|0|||
164328752|NCT01226043|593579594|FG001|30-week Observational Phase|Protocol Violation|0|||
164328753|NCT01226043|593579595|FG002|30-week Observational Phase|Protocol Violation|0|||
164328754|NCT01226043|593579596|FG003|30-week Observational Phase|Protocol Violation|1|||
164328755|NCT01226043|593579593|FG000|30-week Observational Phase|Lost to Follow-up|0|||
164328756|NCT01226043|593579594|FG001|30-week Observational Phase|Lost to Follow-up|0|||
164328757|NCT01226043|593579595|FG002|30-week Observational Phase|Lost to Follow-up|2|||
164328758|NCT01226043|593579596|FG003|30-week Observational Phase|Lost to Follow-up|2|||
164328759|NCT01226043|593579593|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
164328760|NCT01226043|593579594|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
164328761|NCT01226043|593579595|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
164328762|NCT01226043|593579596|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
164328763|NCT01226043|593579593|FG000|30-week Observational Phase|Physician Decision|0|||
164328764|NCT01226043|593579594|FG001|30-week Observational Phase|Physician Decision|0|||
164328765|NCT01226043|593579595|FG002|30-week Observational Phase|Physician Decision|2|||
164079138|NCT00479401|592653918|FG002|Overall Study|Adverse Event|4|||
164079139|NCT00479401|592653916|FG000|Overall Study|Lack of Efficacy|2|||
164328766|NCT01226043|593579596|FG003|30-week Observational Phase|Physician Decision|2|||
164328767|NCT00510952|593579604|FG000|Overall Study|Adverse Event|1|||
164328768|NCT00510952|593579605|FG001|Overall Study|Adverse Event|0|||
164328769|NCT00510952|593579604|FG000|Overall Study|Entry Criteria Not Met|3|||
164328770|NCT00510952|593579605|FG001|Overall Study|Entry Criteria Not Met|1|||
164328771|NCT00510952|593579604|FG000|Overall Study|Lost to Follow-up|5|||
164328772|NCT00510952|593579605|FG001|Overall Study|Lost to Follow-up|3|||
164328773|NCT00510952|593579604|FG000|Overall Study|Physician Decision|1|||
164328774|NCT00510952|593579605|FG001|Overall Study|Physician Decision|1|||
164328775|NCT00510952|593579604|FG000|Overall Study|Protocol Violation|7|||
164328776|NCT00510952|593579605|FG001|Overall Study|Protocol Violation|4|||
164328777|NCT00510952|593579604|FG000|Overall Study|Sponsor Decision|1|||
164328778|NCT00510952|593579605|FG001|Overall Study|Sponsor Decision|0|||
164328779|NCT00510952|593579604|FG000|Overall Study|Withdrawal by Subject|6|||
164328780|NCT00510952|593579605|FG001|Overall Study|Withdrawal by Subject|7|||
164328781|NCT00510952|593579604|FG000|Overall Study|Did Not Receive Study Drug|2|||
164328782|NCT00510952|593579605|FG001|Overall Study|Did Not Receive Study Drug|0|||
164328783|NCT02782923|593579606|FG000|Overall Study|Lost to Follow-up|15|||
164328784|NCT02418156|593579607|FG000|Overall Study|Lost to Follow-up|12|||
164219600|NCT01928771|593171881|FG000|Overall Study|Lost to Follow-up|5|||
164219601|NCT01928771|593171882|FG001|Overall Study|Lost to Follow-up|6|||
164328785|NCT02418156|593579607|FG000|Overall Study|Death|2|||
164328786|NCT02418156|593579607|FG000|Overall Study|Physician Decision|1|||
164328787|NCT02418156|593579607|FG000|Overall Study|Withdrawal by Subject|1|||
164328788|NCT02418156|593579607|FG000|Overall Study|Subject refused to return|1|||
164079140|NCT00479401|592653917|FG001|Overall Study|Lack of Efficacy|2|||
164079141|NCT00479401|592653918|FG002|Overall Study|Lack of Efficacy|4|||
164219602|NCT01928771|593171883|FG002|Overall Study|Lost to Follow-up|3|||
164328789|NCT05063318|593579615|FG000|Overall Study|Progressive disease|2|||
164328790|NCT05063318|593579616|FG001|Overall Study|Progressive disease|0|||
164328791|NCT05063318|593579617|FG002|Overall Study|Progressive disease|3|||
164328792|NCT05063318|593579615|FG000|Overall Study|Compassionate use|1|||
164219603|NCT01928771|593171881|FG000|Overall Study|Withdrawal by Subject|20|||
164219604|NCT01928771|593171882|FG001|Overall Study|Withdrawal by Subject|15|||
164219605|NCT01928771|593171883|FG002|Overall Study|Withdrawal by Subject|17|||
164219606|NCT01928771|593171881|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
164219607|NCT01928771|593171882|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
164219608|NCT01928771|593171883|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
164219609|NCT01928771|593171881|FG000|Overall Study|Other Reasons|9|||
164219610|NCT01928771|593171882|FG001|Overall Study|Other Reasons|9|||
164219611|NCT01928771|593171883|FG002|Overall Study|Other Reasons|14|||
164219612|NCT01928771|593171881|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
164219613|NCT01928771|593171882|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164219614|NCT01928771|593171883|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
164219615|NCT01030900|593171884|FG000|Overall Study|Not treated due to congestive heart failure|1|||
164219616|NCT01030900|593171884|FG000|Overall Study|Not treated due to rapid disease|1|||
164219617|NCT00441896|593171885|FG000|Overall Study|Withdrawal by Subject|0|||
164219618|NCT00441896|593171886|FG001|Overall Study|Withdrawal by Subject|0|||
164219619|NCT00441896|593171887|FG002|Overall Study|Withdrawal by Subject|0|||
164219620|NCT00441896|593171888|FG003|Overall Study|Withdrawal by Subject|1|||
164219621|NCT00441896|593171889|FG004|Overall Study|Withdrawal by Subject|0|||
164219622|NCT00441896|593171890|FG005|Overall Study|Withdrawal by Subject|0|||
164219623|NCT00441896|593171891|FG006|Overall Study|Withdrawal by Subject|0|||
164219624|NCT00441896|593171892|FG007|Overall Study|Withdrawal by Subject|0|||
164219625|NCT00441896|593171893|FG008|Overall Study|Withdrawal by Subject|0|||
164219626|NCT00441896|593171894|FG009|Overall Study|Withdrawal by Subject|0|||
164219627|NCT00441896|593171885|FG000|Overall Study|Other|0|||
164219628|NCT00441896|593171886|FG001|Overall Study|Other|0|||
164219629|NCT00441896|593171887|FG002|Overall Study|Other|0|||
164219630|NCT00441896|593171888|FG003|Overall Study|Other|0|||
164219631|NCT00441896|593171889|FG004|Overall Study|Other|1|||
164219632|NCT00441896|593171890|FG005|Overall Study|Other|0|||
164219633|NCT00441896|593171891|FG006|Overall Study|Other|0|||
164219634|NCT00441896|593171892|FG007|Overall Study|Other|0|||
164219635|NCT00441896|593171893|FG008|Overall Study|Other|0|||
164219636|NCT00441896|593171894|FG009|Overall Study|Other|0|||
164219637|NCT01301092|593171895|FG000|Overall Study|Lost to Follow-up|0|||
164219638|NCT01301092|593171896|FG001|Overall Study|Lost to Follow-up|0|||
164219639|NCT01301092|593171897|FG002|Overall Study|Lost to Follow-up|1|||
164219640|NCT03334175|593171898|FG000|Overall Study|Lost to Follow-up|0|||
164219641|NCT03334175|593171899|FG001|Overall Study|Lost to Follow-up|1|||
164219642|NCT00004859|593171904|FG000|Overall Study|Lack of Efficacy|43|||
164219643|NCT00004859|593171905|FG001|Overall Study|Lack of Efficacy|113|||
164079142|NCT00479401|592653916|FG000|Overall Study|Protocol Violation|2|||
164079143|NCT00479401|592653917|FG001|Overall Study|Protocol Violation|1|||
164079144|NCT00479401|592653918|FG002|Overall Study|Protocol Violation|1|||
164079145|NCT00479401|592653916|FG000|Overall Study|Lost to Follow-up|1|||
164328793|NCT05063318|593579616|FG001|Overall Study|Compassionate use|3|||
164328794|NCT05063318|593579617|FG002|Overall Study|Compassionate use|3|||
164328795|NCT05063318|593579615|FG000|Overall Study|Adverse Event|0|||
164328796|NCT05063318|593579616|FG001|Overall Study|Adverse Event|1|||
164079146|NCT00479401|592653917|FG001|Overall Study|Lost to Follow-up|1|||
164219644|NCT00004859|593171904|FG000|Overall Study|Adverse Event|31|||
164219645|NCT00004859|593171905|FG001|Overall Study|Adverse Event|93|||
164219646|NCT00004859|593171904|FG000|Overall Study|Death|5|||
164328797|NCT05063318|593579617|FG002|Overall Study|Adverse Event|0|||
164328798|NCT05063318|593579615|FG000|Overall Study|Withdrawal by Subject|0|||
164079147|NCT00479401|592653918|FG002|Overall Study|Lost to Follow-up|1|||
164079148|NCT00479401|592653916|FG000|Overall Study|Withdrawal by Subject|16|||
164079149|NCT00479401|592653917|FG001|Overall Study|Withdrawal by Subject|10|||
164079150|NCT00479401|592653918|FG002|Overall Study|Withdrawal by Subject|2|||
164079151|NCT00479401|592653916|FG000|Overall Study|Exclusion criteria, relocation|4|||
164079152|NCT00479401|592653917|FG001|Overall Study|Exclusion criteria, relocation|3|||
164079153|NCT00479401|592653918|FG002|Overall Study|Exclusion criteria, relocation|0|||
164079154|NCT00928252|592655581|FG000|Overall Study|Physician Decision|3|||
164219647|NCT00004859|593171905|FG001|Overall Study|Death|5|||
164219648|NCT00004859|593171904|FG000|Overall Study|Withdrawal by Subject|7|||
164219649|NCT00004859|593171905|FG001|Overall Study|Withdrawal by Subject|33|||
164219650|NCT00004859|593171904|FG000|Overall Study|Protocol Violation|2|||
164219651|NCT00004859|593171905|FG001|Overall Study|Protocol Violation|2|||
164328799|NCT05063318|593579616|FG001|Overall Study|Withdrawal by Subject|1|||
164328800|NCT05063318|593579617|FG002|Overall Study|Withdrawal by Subject|0|||
164079155|NCT02257632|592655582|FG000|Overall Study|Withdrawal by Subject|0|||
164079156|NCT02257632|592655583|FG001|Overall Study|Withdrawal by Subject|1|||
164079157|NCT02257632|592655582|FG000|Overall Study|Adverse Event|1|||
164219652|NCT00004859|593171904|FG000|Overall Study|other disease|0|||
164219653|NCT00004859|593171905|FG001|Overall Study|other disease|3|||
164079158|NCT02257632|592655583|FG001|Overall Study|Adverse Event|2|||
164219654|NCT00004859|593171904|FG000|Overall Study|error|3|||
164219655|NCT00004859|593171905|FG001|Overall Study|error|1|||
164328801|NCT03287635|593579618|FG000|Overall Study|Lost to Follow-up|5|||
163878443|NCT04950127|591922818|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163878444|NCT04950127|591922819|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163878445|NCT04950127|591922820|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
163878446|NCT04950127|591922815|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163878447|NCT04950127|591922816|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163878448|NCT04950127|591922817|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163878449|NCT04950127|591922818|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163878450|NCT04950127|591922819|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
163878451|NCT04950127|591922820|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
163878452|NCT04950127|591922815|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
163878453|NCT04950127|591922816|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
163878454|NCT04950127|591922817|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
163878455|NCT04950127|591922818|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
163878456|NCT04950127|591922819|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
163878457|NCT04950127|591922820|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
163878458|NCT01711632|591922821|FG000|Overall Study|Adverse Event|4|||
163878459|NCT01711632|591922821|FG000|Overall Study|Death|3|||
163878460|NCT01711632|591922821|FG000|Overall Study|Lost to Follow-up|3|||
163878461|NCT01711632|591922821|FG000|Overall Study|Withdrawal by Subject|4|||
163878462|NCT01711632|591922821|FG000|Overall Study|Progressive disease|2|||
163878463|NCT01711632|591922821|FG000|Overall Study|No follow up required in re-treatment|3|||
163878464|NCT01711632|591922821|FG000|Overall Study|No follow up required in re-treatment|3|||
163878465|NCT04315181|591922822|FG000|Overall Study|Non-responsive to drug conditions.|1|||
163878466|NCT01948661|591922823|FG000|Overall Study|Withdrawal by Subject|2|||
163878467|NCT01948661|591922824|FG001|Overall Study|Withdrawal by Subject|4|||
163878468|NCT03517969|591922825|FG000|Overall Study|Never started protocol treatment|3|||
163878469|NCT03517969|591922826|FG001|Overall Study|Never started protocol treatment|5|||
163878470|NCT03517969|591922825|FG000|Overall Study|Disease progression|11|||
163878471|NCT03517969|591922826|FG001|Overall Study|Disease progression|16|||
163878472|NCT03517969|591922825|FG000|Overall Study|PSA progression|8|||
163878473|NCT03517969|591922826|FG001|Overall Study|PSA progression|1|||
163878474|NCT03517969|591922825|FG000|Overall Study|Clinical progression|4|||
163878475|NCT03517969|591922826|FG001|Overall Study|Clinical progression|2|||
163878476|NCT03517969|591922825|FG000|Overall Study|Adverse Event|5|||
163878477|NCT03517969|591922826|FG001|Overall Study|Adverse Event|4|||
163878478|NCT03517969|591922825|FG000|Overall Study|Intercurrent illness|1|||
163878479|NCT03517969|591922826|FG001|Overall Study|Intercurrent illness|2|||
163878480|NCT03517969|591922825|FG000|Overall Study|Death|1|||
163878481|NCT03517969|591922826|FG001|Overall Study|Death|1|||
163878482|NCT03517969|591922825|FG000|Overall Study|Withdrawal by Subject|1|||
163878483|NCT03517969|591922826|FG001|Overall Study|Withdrawal by Subject|2|||
163878484|NCT03517969|591922825|FG000|Overall Study|Physician Decision|1|||
163878485|NCT03517969|591922826|FG001|Overall Study|Physician Decision|1|||
163878486|NCT03517969|591922825|FG000|Overall Study|No clinical benefit|1|||
163878487|NCT03517969|591922826|FG001|Overall Study|No clinical benefit|0|||
163878488|NCT03517969|591922825|FG000|Overall Study|Delayed treatment for dental treatment|1|||
163878489|NCT03517969|591922826|FG001|Overall Study|Delayed treatment for dental treatment|0|||
163878490|NCT03517969|591922825|FG000|Overall Study|Difficult to maintain appointment|0|||
163878491|NCT03517969|591922826|FG001|Overall Study|Difficult to maintain appointment|1|||
163878492|NCT03517969|591922825|FG000|Overall Study|Protocol Violation|0|||
163878493|NCT03517969|591922826|FG001|Overall Study|Protocol Violation|1|||
163878494|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Adverse Event|4|||
163878495|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Adverse Event|1|||
163878496|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
163878497|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
163878498|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
163878499|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
163878500|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
163982224|NCT00562588|592304612|FG001|Overall Study|Protocol Violation|26|||
163982225|NCT00562588|592304611|FG000|Overall Study|Lost to Follow-up|12|||
163982226|NCT00562588|592304612|FG001|Overall Study|Lost to Follow-up|4|||
163982227|NCT00562588|592304611|FG000|Overall Study|Withdrawal by Subject|10|||
164219656|NCT00004859|593171904|FG000|Overall Study|missing data|14|||
164219657|NCT00004859|593171905|FG001|Overall Study|missing data|11|||
164219658|NCT00004859|593171904|FG000|Overall Study|Other|13|||
164219659|NCT00004859|593171905|FG001|Overall Study|Other|21|||
164219660|NCT03882801|593173507|FG000|Period 1|Adverse Event|0|||
164219661|NCT03882801|593173508|FG001|Period 1|Adverse Event|1|||
164219662|NCT03882801|593173507|FG000|Period 1|Non-compliance with study drug|1|||
164219663|NCT03882801|593173508|FG001|Period 1|Non-compliance with study drug|1|||
164219664|NCT03882801|593173507|FG000|Period 1|Never treated with study drug|1|||
164219665|NCT03882801|593173508|FG001|Period 1|Never treated with study drug|0|||
164219666|NCT03882801|593173507|FG000|Washout Period|Physician Decision|0|||
164219667|NCT03882801|593173508|FG001|Washout Period|Physician Decision|1|||
164219668|NCT03882801|593173507|FG000|Period 2|Non-compliance with study drug|0|||
164219669|NCT03882801|593173508|FG001|Period 2|Non-compliance with study drug|1|||
164219670|NCT03548415|593173511|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164219671|NCT03548415|593173512|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164219672|NCT03548415|593173513|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
164219673|NCT03548415|593173514|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
164219674|NCT03548415|593173515|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
164219675|NCT04605588|593173516|FG000|Overall Study|Withdrawal by Subject|1|||
164219676|NCT04605588|593173517|FG001|Overall Study|Withdrawal by Subject|0|||
164219677|NCT01230814|593173518|FG000|Overall Study|Lost to Follow-up|11|||
164219678|NCT01230814|593173519|FG001|Overall Study|Lost to Follow-up|3|||
164219679|NCT01230814|593173518|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
164219680|NCT01230814|593173519|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
164219681|NCT01297244|593173520|FG000|Overall Study|Progressive disease|22|||
164219682|NCT01297244|593173521|FG001|Overall Study|Progressive disease|3|||
164219683|NCT01297244|593173520|FG000|Overall Study|Adverse Event|9|||
164219684|NCT01297244|593173521|FG001|Overall Study|Adverse Event|1|||
164219685|NCT01297244|593173520|FG000|Overall Study|Death|1|||
164219686|NCT01297244|593173521|FG001|Overall Study|Death|1|||
164219687|NCT01297244|593173520|FG000|Overall Study|Clinical progression|1|||
164219688|NCT01297244|593173521|FG001|Overall Study|Clinical progression|1|||
164219689|NCT01297244|593173520|FG000|Overall Study|Withdrawal by Subject|2|||
164219690|NCT01297244|593173521|FG001|Overall Study|Withdrawal by Subject|0|||
164219691|NCT02595749|593173522|FG000|Overall Study|Withdrawal by Subject|12|||
164219692|NCT02595749|593173523|FG001|Overall Study|Withdrawal by Subject|7|||
164219693|NCT01803737|593173524|FG000|Overall Study|Lack of Time|1|||
164219694|NCT01803737|593173525|FG001|Overall Study|Lack of Time|0|||
164219695|NCT01803737|593173524|FG000|Overall Study|Medical Reason|0|||
164219696|NCT01803737|593173525|FG001|Overall Study|Medical Reason|1|||
164219697|NCT01803737|593173524|FG000|Overall Study|Lost to Follow-up|0|||
164219698|NCT01803737|593173525|FG001|Overall Study|Lost to Follow-up|2|||
164219699|NCT00504556|593173531|FG000|Overall Study|Adverse Event|11|||
164219700|NCT00504556|593173532|FG001|Overall Study|Adverse Event|11|||
164219701|NCT00504556|593173533|FG002|Overall Study|Adverse Event|14|||
164219702|NCT00504556|593173534|FG003|Overall Study|Adverse Event|13|||
164219703|NCT00504556|593173535|FG004|Overall Study|Adverse Event|5|||
164219704|NCT00504556|593173531|FG000|Overall Study|Death|3|||
164219705|NCT00504556|593173532|FG001|Overall Study|Death|3|||
164219706|NCT00504556|593173533|FG002|Overall Study|Death|1|||
164219707|NCT00504556|593173534|FG003|Overall Study|Death|0|||
164219708|NCT00504556|593173535|FG004|Overall Study|Death|2|||
164219709|NCT00504556|593173531|FG000|Overall Study|Protocol Violation|1|||
164219710|NCT00504556|593173532|FG001|Overall Study|Protocol Violation|3|||
164219711|NCT00504556|593173533|FG002|Overall Study|Protocol Violation|2|||
164219712|NCT00504556|593173534|FG003|Overall Study|Protocol Violation|1|||
164219713|NCT00504556|593173535|FG004|Overall Study|Protocol Violation|2|||
164219714|NCT00504556|593173531|FG000|Overall Study|Lost to Follow-up|0|||
164219715|NCT00504556|593173532|FG001|Overall Study|Lost to Follow-up|0|||
164219716|NCT00504556|593173533|FG002|Overall Study|Lost to Follow-up|1|||
164328802|NCT03287635|593579618|FG000|Overall Study|Withdrawal by Subject|1|||
164328803|NCT03287635|593579618|FG000|Overall Study|Physician Decision|1|||
164328804|NCT02247531|593581180|FG000|Overall Study|Adverse Event|3|||
164328805|NCT02247531|593581181|FG001|Overall Study|Adverse Event|4|||
164328806|NCT02247531|593581182|FG002|Overall Study|Adverse Event|9|||
164328807|NCT02247531|593581180|FG000|Overall Study|Death|8|||
164328808|NCT02247531|593581181|FG001|Overall Study|Death|9|||
164328809|NCT02247531|593581182|FG002|Overall Study|Death|5|||
164328810|NCT02247531|593581180|FG000|Overall Study|Lost to Follow-up|1|||
164328811|NCT02247531|593581181|FG001|Overall Study|Lost to Follow-up|8|||
164219717|NCT00504556|593173534|FG003|Overall Study|Lost to Follow-up|1|||
164219718|NCT00504556|593173535|FG004|Overall Study|Lost to Follow-up|1|||
164219719|NCT00504556|593173531|FG000|Overall Study|Withdrawal by Subject|16|||
164219720|NCT00504556|593173532|FG001|Overall Study|Withdrawal by Subject|16|||
164219721|NCT00504556|593173533|FG002|Overall Study|Withdrawal by Subject|7|||
164328812|NCT02247531|593581182|FG002|Overall Study|Lost to Follow-up|3|||
164328813|NCT02247531|593581180|FG000|Overall Study|Non-compliance|2|||
164219722|NCT00504556|593173534|FG003|Overall Study|Withdrawal by Subject|8|||
164219723|NCT00504556|593173535|FG004|Overall Study|Withdrawal by Subject|12|||
164219724|NCT00504556|593173531|FG000|Overall Study|administrative reasons|0|||
164219725|NCT00504556|593173532|FG001|Overall Study|administrative reasons|2|||
164219726|NCT00504556|593173533|FG002|Overall Study|administrative reasons|2|||
164219727|NCT00504556|593173534|FG003|Overall Study|administrative reasons|1|||
164219728|NCT00504556|593173535|FG004|Overall Study|administrative reasons|2|||
164219729|NCT00504556|593173531|FG000|Overall Study|did not meet entry criteria|2|||
164219730|NCT00504556|593173532|FG001|Overall Study|did not meet entry criteria|0|||
164219731|NCT00504556|593173533|FG002|Overall Study|did not meet entry criteria|1|||
164219732|NCT00504556|593173534|FG003|Overall Study|did not meet entry criteria|1|||
164219733|NCT00504556|593173535|FG004|Overall Study|did not meet entry criteria|0|||
164219734|NCT00504556|593173531|FG000|Overall Study|data monitor committee decision|0|||
164219735|NCT00504556|593173532|FG001|Overall Study|data monitor committee decision|0|||
164219736|NCT00504556|593173533|FG002|Overall Study|data monitor committee decision|0|||
164219737|NCT00504556|593173534|FG003|Overall Study|data monitor committee decision|100|||
164219738|NCT00504556|593173535|FG004|Overall Study|data monitor committee decision|0|||
164219739|NCT00504556|593173531|FG000|Overall Study|Other|2|||
164219740|NCT00504556|593173532|FG001|Overall Study|Other|2|||
164219741|NCT00504556|593173533|FG002|Overall Study|Other|2|||
164219742|NCT00504556|593173534|FG003|Overall Study|Other|3|||
164219743|NCT00504556|593173535|FG004|Overall Study|Other|0|||
164219744|NCT00504556|593173531|FG000|Overall Study|not in safety analysis set|0|||
164219745|NCT00504556|593173532|FG001|Overall Study|not in safety analysis set|1|||
164219746|NCT00504556|593173533|FG002|Overall Study|not in safety analysis set|1|||
164219747|NCT00504556|593173534|FG003|Overall Study|not in safety analysis set|0|||
164219748|NCT00504556|593173535|FG004|Overall Study|not in safety analysis set|1|||
164219749|NCT03558672|593173536|FG000|Overall Study|Study Early Termination|10|||
164219750|NCT03607695|593173537|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
164219751|NCT03607695|593173537|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
164219752|NCT01027416|593173538|FG000|Overall Study|Withdrawal by Subject|0|||
164219753|NCT01027416|593173539|FG001|Overall Study|Withdrawal by Subject|1|||
164219754|NCT01027416|593173538|FG000|Overall Study|Physician Decision|1|||
164219755|NCT01027416|593173539|FG001|Overall Study|Physician Decision|4|||
164219756|NCT02741193|593173540|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
164219757|NCT02741193|593173540|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
164219758|NCT00676052|593173544|FG000|Overall Study|Adverse Event|0|||
164219759|NCT00676052|593173545|FG001|Overall Study|Adverse Event|1|||
164219760|NCT00676052|593173546|FG002|Overall Study|Adverse Event|1|||
164219761|NCT00676052|593173547|FG003|Overall Study|Adverse Event|2|||
164219762|NCT00676052|593173548|FG004|Overall Study|Adverse Event|2|||
164219763|NCT00676052|593173549|FG005|Overall Study|Adverse Event|2|||
164219764|NCT00676052|593173544|FG000|Overall Study|Lack of Efficacy|2|||
164219765|NCT00676052|593173545|FG001|Overall Study|Lack of Efficacy|2|||
164219766|NCT00676052|593173546|FG002|Overall Study|Lack of Efficacy|1|||
164219767|NCT00676052|593173547|FG003|Overall Study|Lack of Efficacy|1|||
164219768|NCT00676052|593173548|FG004|Overall Study|Lack of Efficacy|2|||
164219769|NCT00676052|593173549|FG005|Overall Study|Lack of Efficacy|1|||
164219770|NCT00676052|593173544|FG000|Overall Study|Protocol Violation|5|||
164219771|NCT00676052|593173545|FG001|Overall Study|Protocol Violation|3|||
164219772|NCT00676052|593173546|FG002|Overall Study|Protocol Violation|2|||
164219773|NCT00676052|593173547|FG003|Overall Study|Protocol Violation|2|||
164219774|NCT00676052|593173548|FG004|Overall Study|Protocol Violation|1|||
163878501|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
163878502|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
164219775|NCT00676052|593173549|FG005|Overall Study|Protocol Violation|2|||
164219776|NCT00676052|593173544|FG000|Overall Study|Lost to Follow-up|0|||
164219777|NCT00676052|593173545|FG001|Overall Study|Lost to Follow-up|0|||
164219778|NCT00676052|593173546|FG002|Overall Study|Lost to Follow-up|0|||
164219779|NCT00676052|593173547|FG003|Overall Study|Lost to Follow-up|0|||
164219780|NCT00676052|593173548|FG004|Overall Study|Lost to Follow-up|1|||
164219781|NCT00676052|593173549|FG005|Overall Study|Lost to Follow-up|0|||
164219782|NCT00676052|593173544|FG000|Overall Study|Physician Decision|1|||
164219783|NCT00676052|593173545|FG001|Overall Study|Physician Decision|1|||
164219784|NCT00676052|593173546|FG002|Overall Study|Physician Decision|1|||
164219785|NCT00676052|593173547|FG003|Overall Study|Physician Decision|0|||
164219786|NCT00676052|593173548|FG004|Overall Study|Physician Decision|0|||
164219787|NCT00676052|593173549|FG005|Overall Study|Physician Decision|1|||
164219788|NCT00676052|593173544|FG000|Overall Study|Withdrawal by Subject|1|||
164219789|NCT00676052|593173545|FG001|Overall Study|Withdrawal by Subject|0|||
164219790|NCT00676052|593173546|FG002|Overall Study|Withdrawal by Subject|1|||
164219791|NCT00676052|593173547|FG003|Overall Study|Withdrawal by Subject|0|||
164219792|NCT00676052|593173548|FG004|Overall Study|Withdrawal by Subject|0|||
164219793|NCT00676052|593173549|FG005|Overall Study|Withdrawal by Subject|0|||
164219794|NCT02365064|593173561|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
164219795|NCT02365064|593173562|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
164219796|NCT02365064|593173561|FG000|Overall Study|Withdrawal by Subject|6|||
164219797|NCT02365064|593173562|FG001|Overall Study|Withdrawal by Subject|9|||
164219798|NCT02365064|593173561|FG000|Overall Study|Treatment intolerance|2|||
164219799|NCT02365064|593173562|FG001|Overall Study|Treatment intolerance|4|||
164219800|NCT00500110|593173571|FG000|Overall Study|Withdrawal by Subject|3|||
164219801|NCT00605657|593173572|FG000|Overall Study|Adverse Event|1|||
164219802|NCT00605657|593173572|FG000|Overall Study|Protocol Violation|1|||
164219803|NCT00662038|593173575|FG000|Overall Study|Reason not specified|3|||
164219804|NCT00662038|593173575|FG000|Overall Study|Withdrawn consent|22|||
164219805|NCT00662038|593173575|FG000|Overall Study|Withdrawal by Subject|83|||
164219806|NCT00662038|593173575|FG000|Overall Study|Sponsor decision|1|||
164219807|NCT00662038|593173575|FG000|Overall Study|Physician Decision|19|||
164219808|NCT00662038|593173575|FG000|Overall Study|Lung transplantation|44|||
164219809|NCT00662038|593173575|FG000|Overall Study|Lost to Follow-up|1|||
164219810|NCT00662038|593173575|FG000|Overall Study|Death|95|||
164219811|NCT00662038|593173575|FG000|Overall Study|Adverse Event|358|||
164219812|NCT00662038|593173575|FG000|Overall Study|Continued treatment|5|||
164219813|NCT00397046|593173576|FG000|Overall Study|Disease Progression|3|||
164219814|NCT00397046|593173577|FG001|Overall Study|Disease Progression|3|||
164219815|NCT00397046|593173578|FG002|Overall Study|Disease Progression|10|||
164219816|NCT00397046|593173579|FG003|Overall Study|Disease Progression|5|||
164079159|NCT00720798|592655587|FG000|Overall Study|Adverse Event|304|||
164219817|NCT01975285|593173581|FG000|Overall Study|Failed Block and follow up|2|||
164219818|NCT01975285|593173582|FG001|Overall Study|Failed Block and follow up|2|||
164219819|NCT04535362|593173583|FG000|Overall Study|Lost to Follow-up|3|||
164219820|NCT04535362|593173584|FG001|Overall Study|Lost to Follow-up|1|||
164219821|NCT02018887|593173590|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
164219822|NCT02018887|593173591|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219823|NCT02018887|593173592|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219824|NCT02018887|593173593|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219825|NCT02018887|593173594|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164328814|NCT02247531|593581181|FG001|Overall Study|Non-compliance|2|||
164328815|NCT02247531|593581182|FG002|Overall Study|Non-compliance|0|||
164328816|NCT02247531|593581180|FG000|Overall Study|Withdrawal by Subject|26|||
164328817|NCT02247531|593581181|FG001|Overall Study|Withdrawal by Subject|31|||
164328818|NCT02247531|593581182|FG002|Overall Study|Withdrawal by Subject|25|||
164328819|NCT02247531|593581180|FG000|Overall Study|Study Terminated by Sponsor|64|||
164328820|NCT02247531|593581181|FG001|Overall Study|Study Terminated by Sponsor|66|||
164328821|NCT02247531|593581182|FG002|Overall Study|Study Terminated by Sponsor|62|||
164328822|NCT02247531|593581180|FG000|Overall Study|Physician Decision|0|||
164328823|NCT02247531|593581181|FG001|Overall Study|Physician Decision|2|||
164328824|NCT02247531|593581182|FG002|Overall Study|Physician Decision|2|||
164328825|NCT02247531|593581180|FG000|Overall Study|Unspecified Reason|2|||
164328826|NCT02247531|593581181|FG001|Overall Study|Unspecified Reason|3|||
164328827|NCT02247531|593581182|FG002|Overall Study|Unspecified Reason|4|||
164328828|NCT04879225|593581185|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
164328829|NCT04879225|593581185|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
164328830|NCT01751802|593581191|FG000|Overall Study|Adverse Event|4|||
164328831|NCT01751802|593581192|FG001|Overall Study|Adverse Event|2|||
164328832|NCT00608543|593581193|FG000|Overall Study|Adverse Event|4|||
164328833|NCT01869725|593581194|FG000|Overall Study|ineligible after registration|1|||
164328834|NCT01869725|593581194|FG000|Overall Study|Death|1|||
164328835|NCT01869725|593581194|FG000|Overall Study|Lost to Follow-up|2|||
164328836|NCT01068652|593581197|FG000|Overall Study|Adverse Event|4|||
164328837|NCT01068652|593581198|FG001|Overall Study|Adverse Event|0|||
164328838|NCT01068652|593581197|FG000|Overall Study|Lack of Efficacy|0|||
164328839|NCT01068652|593581198|FG001|Overall Study|Lack of Efficacy|2|||
164328840|NCT01068652|593581197|FG000|Overall Study|Lost to Follow-up|2|||
164328841|NCT01068652|593581198|FG001|Overall Study|Lost to Follow-up|1|||
164328842|NCT01068652|593581197|FG000|Overall Study|Protocol Violation|3|||
164219826|NCT02018887|593173595|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219827|NCT02018887|593173596|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219828|NCT02018887|593173597|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219829|NCT02018887|593173598|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219830|NCT02018887|593173599|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219831|NCT02018887|593173600|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
164219832|NCT02018887|593173590|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219833|NCT02018887|593173591|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219834|NCT02018887|593173592|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219835|NCT02018887|593173593|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219836|NCT02018887|593173594|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
164219837|NCT02018887|593173595|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219838|NCT02018887|593173596|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
164219839|NCT02018887|593173597|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
164219840|NCT02018887|593173598|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219841|NCT02018887|593173599|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219842|NCT02018887|593173600|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
164219843|NCT02018887|593173590|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
164219844|NCT02018887|593173591|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
164219845|NCT02018887|593173592|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
164219846|NCT02018887|593173593|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
164219847|NCT02018887|593173594|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
164219848|NCT02018887|593173595|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
164219849|NCT02018887|593173596|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
164219850|NCT02018887|593173597|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
164219851|NCT02018887|593173598|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
164219852|NCT02018887|593173599|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
164219853|NCT02018887|593173600|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
164219854|NCT02018887|593173590|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
164219855|NCT02018887|593173591|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
164219856|NCT02018887|593173592|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
164219857|NCT02018887|593173593|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
164219858|NCT02018887|593173594|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
164219859|NCT02018887|593173595|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
164219860|NCT02018887|593173596|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
164219861|NCT02018887|593173597|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
164219862|NCT02018887|593173598|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
164219863|NCT02018887|593173599|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
164219864|NCT02018887|593173600|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
164219865|NCT04053452|593173601|FG000|Overall Study|Withdrawal by Subject|1|||
164219866|NCT04053452|593173602|FG001|Overall Study|Withdrawal by Subject|0|||
164219867|NCT04053452|593173601|FG000|Overall Study|Time restraint due to inpatient needs|1|||
164219868|NCT04053452|593173602|FG001|Overall Study|Time restraint due to inpatient needs|2|||
164219869|NCT01421134|593173603|FG000|Overall Study|Adverse Event|3|||
164219870|NCT01421134|593173604|FG001|Overall Study|Adverse Event|5|||
164219871|NCT01421134|593173603|FG000|Overall Study|Lack of Efficacy|2|||
164219872|NCT01421134|593173604|FG001|Overall Study|Lack of Efficacy|4|||
164219873|NCT01421134|593173603|FG000|Overall Study|Protocol Violation|0|||
164219874|NCT01421134|593173604|FG001|Overall Study|Protocol Violation|3|||
164219875|NCT01421134|593173603|FG000|Overall Study|Withdrawal by Subject|1|||
164219876|NCT01421134|593173604|FG001|Overall Study|Withdrawal by Subject|1|||
164219877|NCT01421134|593173603|FG000|Overall Study|Administrative|0|||
164219878|NCT01421134|593173604|FG001|Overall Study|Administrative|1|||
164219879|NCT01421134|593173603|FG000|Overall Study|Lost to Follow-up|1|||
164219880|NCT01421134|593173604|FG001|Overall Study|Lost to Follow-up|1|||
164079160|NCT00720798|592655587|FG000|Overall Study|Death|39|||
164079161|NCT00720798|592655587|FG000|Overall Study|Insufficient Therapeutic Response|129|||
164079162|NCT00720798|592655587|FG000|Overall Study|Protocol Violation|4|||
164079163|NCT00720798|592655587|FG000|Overall Study|Refused Treatment|151|||
164079164|NCT00720798|592655587|FG000|Overall Study|Failure to Return|46|||
164079165|NCT00720798|592655587|FG000|Overall Study|Reason not Specified|83|||
164079166|NCT02806232|592655590|FG000|Overall Study|Lost to Follow-up|1|||
164079167|NCT02806232|592655591|FG001|Overall Study|Lost to Follow-up|2|||
164219881|NCT02959892|593173605|FG000|Overall Study|PET tracer synthesis failure|1|||
164219882|NCT02959892|593173606|FG001|Overall Study|PET tracer synthesis failure|0|||
164219883|NCT02959892|593173605|FG000|Overall Study|Study termination|0|||
164219884|NCT02959892|593173606|FG001|Overall Study|Study termination|1|||
164219885|NCT02061592|593173610|FG000|Period 1|Withdrawal by Subject|1|||
164219886|NCT02061592|593173611|FG001|Period 1|Withdrawal by Subject|0|||
164219887|NCT02061592|593173610|FG000|Period 1|Protocol Violation|1|||
164219888|NCT02061592|593173611|FG001|Period 1|Protocol Violation|0|||
164219889|NCT02061592|593173610|FG000|Period 2|Lost to Follow-up|0|||
164219890|NCT02061592|593173611|FG001|Period 2|Lost to Follow-up|1|||
164219891|NCT04433975|593173612|FG000|1-month Follow Up|Withdrawal by Subject|1|||
164079168|NCT02806232|592655592|FG002|Overall Study|Lost to Follow-up|1|||
164079169|NCT02806232|592655593|FG003|Overall Study|Lost to Follow-up|0|||
164079170|NCT02806232|592655594|FG004|Overall Study|Lost to Follow-up|0|||
164079171|NCT02806232|592655595|FG005|Overall Study|Lost to Follow-up|1|||
164079172|NCT02806232|592655596|FG006|Overall Study|Lost to Follow-up|0|||
164079173|NCT02806232|592655597|FG007|Overall Study|Lost to Follow-up|0|||
164079174|NCT02806232|592655598|FG008|Overall Study|Lost to Follow-up|0|||
164328843|NCT01068652|593581198|FG001|Overall Study|Protocol Violation|6|||
164328844|NCT01068652|593581197|FG000|Overall Study|Withdrawal criteria|1|||
164328845|NCT01068652|593581198|FG001|Overall Study|Withdrawal criteria|2|||
164328846|NCT01068652|593581197|FG000|Overall Study|Patient was not eligible|1|||
164328847|NCT01068652|593581198|FG001|Overall Study|Patient was not eligible|0|||
164328848|NCT01068652|593581197|FG000|Overall Study|Unclassified|7|||
164328849|NCT01068652|593581198|FG001|Overall Study|Unclassified|4|||
164328850|NCT00214500|593581199|FG000|Treatment Period|Adverse Event|1|||
164328851|NCT00214500|593581199|FG000|Extension Period|Withdrawal by Subject|2|||
164328852|NCT03170232|593581200|FG000|Overall Study|Adverse Event|0|||
164328853|NCT03170232|593581201|FG001|Overall Study|Adverse Event|1|||
164328854|NCT03170232|593581200|FG000|Overall Study|Protocol Violation|0|||
164328855|NCT03170232|593581201|FG001|Overall Study|Protocol Violation|1|||
164328856|NCT03170232|593581200|FG000|Overall Study|Lack of Efficacy|0|||
164328857|NCT03170232|593581201|FG001|Overall Study|Lack of Efficacy|1|||
164328858|NCT03170232|593581200|FG000|Overall Study|Study closed/terminated|26|||
164328859|NCT03170232|593581201|FG001|Overall Study|Study closed/terminated|23|||
164328860|NCT03170232|593581200|FG000|Overall Study|Lost to Follow-up|1|||
164328861|NCT03170232|593581201|FG001|Overall Study|Lost to Follow-up|0|||
164328862|NCT03170232|593581200|FG000|Overall Study|Withdrawal by Subject|0|||
164328863|NCT03170232|593581201|FG001|Overall Study|Withdrawal by Subject|1|||
164328864|NCT00147251|593581202|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
164328865|NCT00147251|593581203|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
164328866|NCT02537574|593581204|FG000|Overall Study|Adverse Event|1|||
164328867|NCT02537574|593581205|FG001|Overall Study|Adverse Event|3|||
164328868|NCT02537574|593581206|FG002|Overall Study|Adverse Event|2|||
164328869|NCT02537574|593581204|FG000|Overall Study|Lost to Follow-up|40|||
164328870|NCT02537574|593581205|FG001|Overall Study|Lost to Follow-up|51|||
164328871|NCT02537574|593581206|FG002|Overall Study|Lost to Follow-up|55|||
164328872|NCT02537574|593581204|FG000|Overall Study|Noncompliance with study drug|0|||
164328873|NCT02537574|593581205|FG001|Overall Study|Noncompliance with study drug|1|||
164328874|NCT02537574|593581206|FG002|Overall Study|Noncompliance with study drug|1|||
164328875|NCT02537574|593581204|FG000|Overall Study|Physician Decision|2|||
164328876|NCT02537574|593581205|FG001|Overall Study|Physician Decision|0|||
164328877|NCT02537574|593581206|FG002|Overall Study|Physician Decision|0|||
164328878|NCT02537574|593581204|FG000|Overall Study|Protocol Violation|4|||
164328879|NCT02537574|593581205|FG001|Overall Study|Protocol Violation|2|||
164328880|NCT02537574|593581206|FG002|Overall Study|Protocol Violation|3|||
164328881|NCT02537574|593581204|FG000|Overall Study|Withdrawal by Subject|37|||
164328882|NCT02537574|593581205|FG001|Overall Study|Withdrawal by Subject|27|||
164328883|NCT02537574|593581206|FG002|Overall Study|Withdrawal by Subject|29|||
164328884|NCT02537574|593581204|FG000|Overall Study|Lack of Efficacy|14|||
164328885|NCT02537574|593581205|FG001|Overall Study|Lack of Efficacy|16|||
164328886|NCT02537574|593581206|FG002|Overall Study|Lack of Efficacy|15|||
164328887|NCT02537574|593581204|FG000|Overall Study|Duplicate Patient|1|||
164328888|NCT02537574|593581205|FG001|Overall Study|Duplicate Patient|0|||
164328889|NCT02537574|593581206|FG002|Overall Study|Duplicate Patient|0|||
164328890|NCT02537574|593581204|FG000|Overall Study|Patient not Stable|0|||
164328891|NCT02537574|593581205|FG001|Overall Study|Patient not Stable|1|||
164328892|NCT02537574|593581206|FG002|Overall Study|Patient not Stable|0|||
164328893|NCT02537574|593581204|FG000|Overall Study|Incarceration|0|||
164328894|NCT02537574|593581205|FG001|Overall Study|Incarceration|1|||
164328895|NCT02537574|593581206|FG002|Overall Study|Incarceration|0|||
164328896|NCT02537574|593581204|FG000|Overall Study|Failed Naloxone Challenge|0|||
164328897|NCT02537574|593581205|FG001|Overall Study|Failed Naloxone Challenge|1|||
164328898|NCT02537574|593581206|FG002|Overall Study|Failed Naloxone Challenge|0|||
164328899|NCT02537574|593581204|FG000|Overall Study|Transportation Issues|0|||
164328900|NCT02537574|593581205|FG001|Overall Study|Transportation Issues|0|||
164328901|NCT02537574|593581206|FG002|Overall Study|Transportation Issues|1|||
164328902|NCT02537574|593581204|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
164079175|NCT02806232|592655590|FG000|Overall Study|Withdrawal by Subject|0|||
164328903|NCT02537574|593581205|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
164328904|NCT02537574|593581206|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
164328905|NCT02537574|593581204|FG000|Overall Study|Noncompliance with Protocol|0|||
164328906|NCT02537574|593581205|FG001|Overall Study|Noncompliance with Protocol|0|||
164328907|NCT02537574|593581206|FG002|Overall Study|Noncompliance with Protocol|1|||
164328908|NCT01151098|593581207|FG000|Overall Study|Adverse Event|82|||
164328909|NCT01151098|593581207|FG000|Overall Study|Lost to Follow-up|6|||
164328910|NCT01151098|593581207|FG000|Overall Study|Lack of Efficacy|15|||
164328911|NCT01151098|593581207|FG000|Overall Study|Protocol Violation|1|||
164328912|NCT01151098|593581207|FG000|Overall Study|Miscellaneous|13|||
164219892|NCT04433975|593173613|FG001|1-month Follow Up|Withdrawal by Subject|1|||
164219893|NCT04433975|593173612|FG000|1-month Follow Up|Lost to Follow-up|21|||
164219894|NCT04433975|593173613|FG001|1-month Follow Up|Lost to Follow-up|25|||
164219895|NCT04433975|593173612|FG000|3-month Follow Up|Lost to Follow-up|20|||
164219896|NCT04433975|593173613|FG001|3-month Follow Up|Lost to Follow-up|24|||
164219897|NCT04433975|593173612|FG000|3-month Follow Up|Death|1|||
164219898|NCT04433975|593173613|FG001|3-month Follow Up|Death|0|||
164219899|NCT04433975|593173612|FG000|3-month Follow Up|Withdrawal by Subject|2|||
164219900|NCT04433975|593173613|FG001|3-month Follow Up|Withdrawal by Subject|0|||
164219901|NCT04433975|593173612|FG000|6-month Follow Up|Lost to Follow-up|23|||
164219902|NCT04433975|593173613|FG001|6-month Follow Up|Lost to Follow-up|28|||
164219903|NCT04433975|593173612|FG000|6-month Follow Up|Withdrawal by Subject|1|||
164219904|NCT04433975|593173613|FG001|6-month Follow Up|Withdrawal by Subject|1|||
164219905|NCT04433975|593173612|FG000|9-month Follow Up|Lost to Follow-up|27|||
164219906|NCT04433975|593173613|FG001|9-month Follow Up|Lost to Follow-up|36|||
164219907|NCT04433975|593173612|FG000|9-month Follow Up|Death|0|||
164219908|NCT04433975|593173613|FG001|9-month Follow Up|Death|1|||
164219909|NCT04433975|593173612|FG000|12-month Follow Up|Lost to Follow-up|27|||
164219910|NCT04433975|593173613|FG001|12-month Follow Up|Lost to Follow-up|31|||
164219911|NCT04882215|593173614|FG000|Overall Study|Withdrawal by Subject|5|||
164219912|NCT04882215|593173615|FG001|Overall Study|Withdrawal by Subject|0|||
164219913|NCT06083493|593173616|FG000|Overall Study|Technical issues with the interventional device|2|||
164219914|NCT06083493|593173617|FG001|Overall Study|Technical issues with the interventional device|2|||
164219915|NCT06083493|593173616|FG000|Overall Study|Performed incorrect visual task|1|||
164219916|NCT06083493|593173617|FG001|Overall Study|Performed incorrect visual task|0|||
164219917|NCT06083493|593173616|FG000|Overall Study|Insufficient baseline performance|0|||
164219918|NCT06083493|593173617|FG001|Overall Study|Insufficient baseline performance|1|||
164219919|NCT04392635|593173620|FG000|Overall Study|Lost to Follow-up|0|||
164219920|NCT04392635|593173621|FG001|Overall Study|Lost to Follow-up|1|||
164219921|NCT00114777|593173633|FG000|Randomization to Month 36|Death|10|||
164219922|NCT00114777|593173634|FG001|Randomization to Month 36|Death|4|||
164219923|NCT00114777|593173635|FG002|Randomization to Month 36|Death|3|||
164219924|NCT00114777|593173633|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
164219925|NCT00114777|593173634|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
164219926|NCT00114777|593173635|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
164219927|NCT00114777|593173633|FG000|Randomization to Month 36|Lack of Efficacy|19|||
164219928|NCT00114777|593173634|FG001|Randomization to Month 36|Lack of Efficacy|15|||
164219929|NCT00114777|593173635|FG002|Randomization to Month 36|Lack of Efficacy|17|||
164219930|NCT00114777|593173633|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
164219931|NCT00114777|593173634|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
164219932|NCT00114777|593173635|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
164219933|NCT00114777|593173633|FG000|Randomization to Month 36|Adverse Event|34|||
164219934|NCT00114777|593173634|FG001|Randomization to Month 36|Adverse Event|35|||
164219935|NCT00114777|593173635|FG002|Randomization to Month 36|Adverse Event|44|||
164219936|NCT00114777|593173633|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
164219937|NCT00114777|593173634|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
164219938|NCT00114777|593173635|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
164219939|NCT00114777|593173633|FG000|Randomization to Month 36|Other|9|||
164219940|NCT00114777|593173634|FG001|Randomization to Month 36|Other|3|||
164219941|NCT00114777|593173635|FG002|Randomization to Month 36|Other|12|||
164219942|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Death|8|||
164219943|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Death|13|||
164219944|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Death|7|||
164219945|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
163878503|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
163878504|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Other|6|||
163878505|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Other|1|||
163878506|NCT03271489|591922827|FG000|Double-Blind (DB) Period|Missing|1|||
163878507|NCT03271489|591922828|FG001|Double-Blind (DB) Period|Missing|0|||
163878508|NCT03271489|591922827|FG000|Open-Label (OL) Period|Adverse Event|2|||
163878509|NCT03271489|591922828|FG001|Open-Label (OL) Period|Adverse Event|0|||
163878510|NCT03271489|591922827|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
163878511|NCT03271489|591922828|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
163878512|NCT03271489|591922827|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
163878513|NCT03271489|591922828|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
163878514|NCT03271489|591922827|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
163878515|NCT03271489|591922828|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
163878516|NCT03271489|591922827|FG000|Open-Label (OL) Period|No Specified|2|||
163878517|NCT03271489|591922828|FG001|Open-Label (OL) Period|No Specified|2|||
163878518|NCT03271489|591922827|FG000|Open-Label (OL) Period|Missing|2|||
164219946|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
164219947|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
164219948|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
164219949|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
164219950|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
164219951|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
164219952|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
164219953|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
164219954|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
164219955|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
164219956|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
164219957|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
164219958|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
164219959|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
164219960|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
164219961|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
164219962|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
164219963|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
164219964|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
164219965|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
164219966|NCT00114777|593173633|FG000|Long-Term Extension to Month 84|Other|2|||
164219967|NCT00114777|593173634|FG001|Long-Term Extension to Month 84|Other|0|||
164219968|NCT00114777|593173635|FG002|Long-Term Extension to Month 84|Other|2|||
164219969|NCT01181128|593173636|FG000|Overall Study|Withdrawal by Subject|2|||
164219970|NCT01181128|593173637|FG001|Overall Study|Withdrawal by Subject|2|||
164219971|NCT01181128|593173638|FG002|Overall Study|Withdrawal by Subject|0|||
164219972|NCT01181128|593173636|FG000|Overall Study|Death|1|||
164219973|NCT01181128|593173637|FG001|Overall Study|Death|0|||
164219974|NCT01181128|593173638|FG002|Overall Study|Death|0|||
164219975|NCT01181128|593173636|FG000|Overall Study|Physician Decision|2|||
164219976|NCT01181128|593173637|FG001|Overall Study|Physician Decision|0|||
164219977|NCT01181128|593173638|FG002|Overall Study|Physician Decision|0|||
164219978|NCT01181128|593173636|FG000|Overall Study|Adverse Event|0|||
164219979|NCT01181128|593173637|FG001|Overall Study|Adverse Event|2|||
164219980|NCT01181128|593173638|FG002|Overall Study|Adverse Event|0|||
164219981|NCT01181128|593173636|FG000|Overall Study|Other|1|||
164219982|NCT01181128|593173637|FG001|Overall Study|Other|1|||
164219983|NCT01181128|593173638|FG002|Overall Study|Other|1|||
164219984|NCT04477486|593173641|FG000|Overall Study|Death|2|||
164219985|NCT04477486|593173641|FG000|Overall Study|Ongoing at Time of Analysis|11|||
164219986|NCT02460380|593173644|FG000|Overall Study|Withdrawal by Subject|10|||
164219987|NCT02460380|593173645|FG001|Overall Study|Withdrawal by Subject|5|||
164219988|NCT00514917|593173656|FG000|Overall Study|Death|4|||
164219989|NCT00514917|593173657|FG001|Overall Study|Death|10|||
164219990|NCT00514917|593173656|FG000|Overall Study|Protocol Violation|1|||
164219991|NCT00514917|593173657|FG001|Overall Study|Protocol Violation|0|||
164219992|NCT00514917|593173656|FG000|Overall Study|Lost to Follow-up|4|||
164219993|NCT00514917|593173657|FG001|Overall Study|Lost to Follow-up|3|||
164219994|NCT00514917|593173656|FG000|Overall Study|Withdrawal by Subject|18|||
164219995|NCT00514917|593173657|FG001|Overall Study|Withdrawal by Subject|16|||
164219996|NCT00514917|593173656|FG000|Overall Study|Discontinued due to study closure|88|||
164219997|NCT00514917|593173657|FG001|Overall Study|Discontinued due to study closure|81|||
164219998|NCT00514917|593173656|FG000|Overall Study|Undefined|11|||
164219999|NCT00514917|593173657|FG001|Overall Study|Undefined|5|||
164220000|NCT02280499|593173658|FG000|Overall Study|Death|14|||
164220001|NCT02280499|593173658|FG000|Overall Study|Lost to Follow-up|42|||
164220002|NCT02280499|593173658|FG000|Overall Study|Adverse Event|5|||
164220003|NCT04560309|593173665|FG000|Overall Study|Meet drop out criteria|1|||
164220004|NCT04560309|593173666|FG001|Overall Study|Meet drop out criteria|1|||
164220005|NCT00356421|593173668|FG000|Overall Study|Lack of Efficacy|3|||
164220006|NCT00356421|593173669|FG001|Overall Study|Lack of Efficacy|0|||
164220007|NCT00356421|593173668|FG000|Overall Study|Withdrawal by Subject|9|||
164220008|NCT00356421|593173669|FG001|Overall Study|Withdrawal by Subject|2|||
164220009|NCT00356421|593173668|FG000|Overall Study|Related to study drug|15|||
163982228|NCT00562588|592304612|FG001|Overall Study|Withdrawal by Subject|9|||
163982229|NCT00562588|592304611|FG000|Overall Study|Other|0|||
164220010|NCT00356421|593173669|FG001|Overall Study|Related to study drug|12|||
164220011|NCT00356421|593173668|FG000|Overall Study|Not related to study drug|5|||
164220012|NCT00356421|593173669|FG001|Overall Study|Not related to study drug|3|||
164220013|NCT04689009|593173670|FG000|Overall Study|Adverse Event|1|||
164220014|NCT04689009|593173671|FG001|Overall Study|Adverse Event|0|||
164220015|NCT04689009|593173670|FG000|Overall Study|Lost to Follow-up|1|||
164220016|NCT04689009|593173671|FG001|Overall Study|Lost to Follow-up|2|||
164220017|NCT04689009|593173670|FG000|Overall Study|Withdrawal by Subject|4|||
164220018|NCT04689009|593173671|FG001|Overall Study|Withdrawal by Subject|3|||
164220019|NCT04689009|593173670|FG000|Overall Study|Protocol Violation|1|||
164220020|NCT04689009|593173671|FG001|Overall Study|Protocol Violation|0|||
164220021|NCT02187055|593173672|FG000|Overall Study|Lack of Efficacy|10|||
164220022|NCT02187055|593173673|FG001|Overall Study|Lack of Efficacy|3|||
164220023|NCT02187055|593173674|FG002|Overall Study|Lack of Efficacy|7|||
164220024|NCT02187055|593173672|FG000|Overall Study|Lost to Follow-up|2|||
164220025|NCT02187055|593173673|FG001|Overall Study|Lost to Follow-up|7|||
164220026|NCT02187055|593173674|FG002|Overall Study|Lost to Follow-up|3|||
164220027|NCT02187055|593173672|FG000|Overall Study|No longer meets eligibility criteria|0|||
163878519|NCT03271489|591922828|FG001|Open-Label (OL) Period|Missing|0|||
163982230|NCT00562588|592304612|FG001|Overall Study|Other|2|||
163982231|NCT03047980|592306440|FG000|Overall Study|Adverse Event|1|||
163982232|NCT02164981|592306441|FG000|Started|Withdrawal by Subject|2|||
163982233|NCT02164981|592306442|FG001|Started|Withdrawal by Subject|1|||
163982234|NCT02164981|592306443|FG002|Started|Withdrawal by Subject|0|||
163982235|NCT02164981|592306441|FG000|Started|Protocol Violation|2|||
163982236|NCT02164981|592306442|FG001|Started|Protocol Violation|0|||
163982237|NCT02164981|592306443|FG002|Started|Protocol Violation|0|||
163982238|NCT02164981|592306441|FG000|Started|Adverse Event|1|||
163982239|NCT02164981|592306442|FG001|Started|Adverse Event|2|||
163982240|NCT02164981|592306443|FG002|Started|Adverse Event|0|||
164220028|NCT02187055|593173673|FG001|Overall Study|No longer meets eligibility criteria|2|||
163878520|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
163878521|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
163878522|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
163878523|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
163878524|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
163878525|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
163878526|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
163878527|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
163878528|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
163878529|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
163878530|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
163878531|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
163878532|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
163878533|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
163878534|NCT03271489|591922827|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
163878535|NCT03271489|591922828|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
163878536|NCT02860130|591922829|FG000|Overall Study|Adverse Event|2|||
163878537|NCT02860130|591922830|FG001|Overall Study|Adverse Event|3|||
163878538|NCT02860130|591922829|FG000|Overall Study|Protocol Violation|1|||
163878539|NCT02860130|591922830|FG001|Overall Study|Protocol Violation|1|||
163878540|NCT02860130|591922829|FG000|Overall Study|Withdrawal by Subject|0|||
163878541|NCT02860130|591922830|FG001|Overall Study|Withdrawal by Subject|2|||
163878542|NCT02860130|591922829|FG000|Overall Study|Physician Decision|2|||
163878543|NCT02860130|591922830|FG001|Overall Study|Physician Decision|2|||
163878544|NCT02860130|591922829|FG000|Overall Study|Other|2|||
163878545|NCT02860130|591922830|FG001|Overall Study|Other|1|||
163878546|NCT02886286|591922831|FG000|Overall Study|pump motor stall|0|||
163878547|NCT02886286|591922832|FG001|Overall Study|pump motor stall|1|||
163878548|NCT01127373|591922833|FG000|Overall Study|Not Treated|3|||
163878549|NCT01127373|591922833|FG000|Overall Study|Lost to Follow-up|7|||
163878550|NCT01127373|591922833|FG000|Overall Study|Withdrawal by Subject|1|||
163878551|NCT01127373|591922833|FG000|Overall Study|Disease progression|1|||
163878552|NCT00522951|591922836|FG000|Period 1|body motion|0|||
163878553|NCT00522951|591922837|FG001|Period 1|body motion|1|||
163878554|NCT00522951|591922836|FG000|Washout Period|Adverse Event|0|||
163878555|NCT00522951|591922837|FG001|Washout Period|Adverse Event|1|||
163878556|NCT00522951|591922836|FG000|Washout Period|Death|0|||
163878557|NCT00522951|591922837|FG001|Washout Period|Death|1|||
163878558|NCT00522951|591922836|FG000|Period 2|Withdrawal by Subject|1|||
163878559|NCT00522951|591922837|FG001|Period 2|Withdrawal by Subject|0|||
163878560|NCT00522951|591922836|FG000|Period 2|residual contrast medium|1|||
163878561|NCT00522951|591922837|FG001|Period 2|residual contrast medium|1|||
163878562|NCT02140645|591922841|FG000|Overall Study|Not linked|5489|||
164220029|NCT02187055|593173674|FG002|Overall Study|No longer meets eligibility criteria|0|||
164220030|NCT02187055|593173672|FG000|Overall Study|No longer willing to participate|6|||
164220031|NCT02187055|593173673|FG001|Overall Study|No longer willing to participate|8|||
164220032|NCT02187055|593173674|FG002|Overall Study|No longer willing to participate|10|||
164220033|NCT02187055|593173672|FG000|Overall Study|Other|5|||
164220034|NCT02187055|593173673|FG001|Overall Study|Other|6|||
164220035|NCT02187055|593173674|FG002|Overall Study|Other|3|||
164220036|NCT02187055|593173672|FG000|Overall Study|Protocol Violation|9|||
164220037|NCT02187055|593173673|FG001|Overall Study|Protocol Violation|9|||
164220038|NCT02187055|593173674|FG002|Overall Study|Protocol Violation|4|||
164220039|NCT02187055|593173672|FG000|Overall Study|Pregnancy|3|||
164220040|NCT02187055|593173673|FG001|Overall Study|Pregnancy|1|||
164220041|NCT02187055|593173674|FG002|Overall Study|Pregnancy|0|||
164220042|NCT02187055|593173672|FG000|Overall Study|Withdrawal by Subject|11|||
164220043|NCT02187055|593173673|FG001|Overall Study|Withdrawal by Subject|11|||
164220044|NCT02187055|593173674|FG002|Overall Study|Withdrawal by Subject|11|||
164220045|NCT02187055|593173672|FG000|Overall Study|Adverse Event|21|||
164220046|NCT02187055|593173673|FG001|Overall Study|Adverse Event|26|||
164220047|NCT02187055|593173674|FG002|Overall Study|Adverse Event|36|||
164220048|NCT02187055|593173672|FG000|Overall Study|Death|2|||
164220049|NCT02187055|593173673|FG001|Overall Study|Death|0|||
164220050|NCT02187055|593173674|FG002|Overall Study|Death|0|||
164220051|NCT00985790|593173677|FG000|Overall Study|Withdrawal by Subject|1|||
164220052|NCT00985790|593173678|FG001|Overall Study|Withdrawal by Subject|1|||
164220053|NCT00985790|593173677|FG000|Overall Study|Lost to Follow-up|6|||
164220054|NCT00985790|593173678|FG001|Overall Study|Lost to Follow-up|7|||
164220055|NCT03462563|593173682|FG000|Overall Study|Death|1|||
164220056|NCT03462563|593173683|FG001|Overall Study|Death|1|||
164220057|NCT03462563|593173682|FG000|Overall Study|Termination of study|2|||
164220058|NCT03462563|593173683|FG001|Overall Study|Termination of study|1|||
164220059|NCT03462563|593173682|FG000|Overall Study|Adverse Event|1|||
164220060|NCT03462563|593173683|FG001|Overall Study|Adverse Event|3|||
164220061|NCT03462563|593173682|FG000|Overall Study|Unspecified reason|10|||
164220062|NCT03462563|593173683|FG001|Overall Study|Unspecified reason|12|||
164220063|NCT03462563|593173682|FG000|Overall Study|Physician Decision|1|||
164220064|NCT03462563|593173683|FG001|Overall Study|Physician Decision|0|||
164220065|NCT05089357|593173684|FG000|Overall Study|Withdrawal by Subject|23|||
164220066|NCT05089357|593173684|FG000|Overall Study|Lost to Follow-up|6|||
164220067|NCT05089357|593173684|FG000|Overall Study|Medical reason|1|||
164220068|NCT05089357|593173684|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
164220069|NCT05089357|593173684|FG000|Overall Study|Pregnancy|2|||
164220070|NCT00689052|593173685|FG000|Overall Study|Adverse Event|4|||
164220071|NCT00689052|593173686|FG001|Overall Study|Adverse Event|6|||
164220072|NCT00689052|593173685|FG000|Overall Study|Protocol Violation|1|||
164220073|NCT00689052|593173686|FG001|Overall Study|Protocol Violation|0|||
164220074|NCT00689052|593173685|FG000|Overall Study|Lost to Follow-up|2|||
164220075|NCT00689052|593173686|FG001|Overall Study|Lost to Follow-up|0|||
164220076|NCT00689052|593173685|FG000|Overall Study|Withdrawal by Subject|2|||
164220077|NCT00689052|593173686|FG001|Overall Study|Withdrawal by Subject|0|||
164220078|NCT00689052|593173685|FG000|Overall Study|Early termination of the trial|22|||
164220079|NCT00689052|593173686|FG001|Overall Study|Early termination of the trial|24|||
164220080|NCT03020888|593173687|FG000|Overall Study|Physician Decision|4|||
164220081|NCT03020888|593173687|FG000|Overall Study|Withdrawal by Subject|6|||
164220082|NCT03020888|593173687|FG000|Overall Study|Insurance coverage|2|||
164220083|NCT03020888|593173687|FG000|Overall Study|Lost to Follow-up|1|||
164220084|NCT01407367|593173688|FG000|Overall Study|Death|24|||
164220085|NCT01407367|593173689|FG001|Overall Study|Death|32|||
164220086|NCT01407367|593173688|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
164220087|NCT01407367|593173689|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
164220088|NCT01407367|593173688|FG000|Overall Study|Withdrawal by Subject|4|||
164220089|NCT01407367|593173689|FG001|Overall Study|Withdrawal by Subject|15|||
164220090|NCT01407367|593173688|FG000|Overall Study|Lost to Follow-up|0|||
164220091|NCT01407367|593173689|FG001|Overall Study|Lost to Follow-up|2|||
164220092|NCT01793129|593175450|FG000|Overall Study|Lost to Follow-up|3|||
164220093|NCT01793129|593175451|FG001|Overall Study|Lost to Follow-up|7|||
164220094|NCT01793129|593175450|FG000|Overall Study|Withdrawal by Subject|0|||
164220095|NCT01793129|593175451|FG001|Overall Study|Withdrawal by Subject|2|||
163878563|NCT02140645|591922842|FG001|Overall Study|Not linked|61654|||
164220096|NCT02469961|593175460|FG000|Overall Study|Physician Decision|4|||
164220097|NCT02469961|593175461|FG001|Overall Study|Physician Decision|1|||
164220098|NCT00454142|593175462|FG000|Overall Study|Withdrawal by Subject|1|||
164220099|NCT00520572|593175463|FG000|Overall Study|Adverse Event|9|||
164220100|NCT00520572|593175464|FG001|Overall Study|Adverse Event|3|||
164220101|NCT00520572|593175465|FG002|Overall Study|Adverse Event|6|||
164220102|NCT00520572|593175466|FG003|Overall Study|Adverse Event|9|||
164220103|NCT00520572|593175467|FG004|Overall Study|Adverse Event|7|||
164220104|NCT00520572|593175468|FG005|Overall Study|Adverse Event|2|||
163878564|NCT02140645|591922843|FG002|Overall Study|Not linked|4236|||
164079176|NCT02806232|592655591|FG001|Overall Study|Withdrawal by Subject|2|||
164079177|NCT02806232|592655592|FG002|Overall Study|Withdrawal by Subject|0|||
164079178|NCT02806232|592655593|FG003|Overall Study|Withdrawal by Subject|0|||
164079179|NCT02806232|592655594|FG004|Overall Study|Withdrawal by Subject|2|||
164079180|NCT02806232|592655595|FG005|Overall Study|Withdrawal by Subject|1|||
164079181|NCT02806232|592655596|FG006|Overall Study|Withdrawal by Subject|0|||
164220105|NCT00520572|593175463|FG000|Overall Study|Withdrawal by Subject|0|||
164220106|NCT00520572|593175464|FG001|Overall Study|Withdrawal by Subject|9|||
164220107|NCT00520572|593175465|FG002|Overall Study|Withdrawal by Subject|5|||
164220108|NCT00520572|593175466|FG003|Overall Study|Withdrawal by Subject|2|||
164220109|NCT00520572|593175467|FG004|Overall Study|Withdrawal by Subject|2|||
164220110|NCT00520572|593175468|FG005|Overall Study|Withdrawal by Subject|0|||
164220111|NCT00520572|593175463|FG000|Overall Study|Protocol Violation|0|||
164220112|NCT00520572|593175464|FG001|Overall Study|Protocol Violation|0|||
164220113|NCT00520572|593175465|FG002|Overall Study|Protocol Violation|1|||
164220114|NCT00520572|593175466|FG003|Overall Study|Protocol Violation|0|||
164220115|NCT00520572|593175467|FG004|Overall Study|Protocol Violation|0|||
164220116|NCT00520572|593175468|FG005|Overall Study|Protocol Violation|0|||
164220117|NCT00520572|593175463|FG000|Overall Study|Lack of Efficacy|1|||
164220118|NCT00520572|593175464|FG001|Overall Study|Lack of Efficacy|1|||
164220119|NCT00520572|593175465|FG002|Overall Study|Lack of Efficacy|1|||
164220120|NCT00520572|593175466|FG003|Overall Study|Lack of Efficacy|2|||
164220121|NCT00520572|593175467|FG004|Overall Study|Lack of Efficacy|1|||
164220122|NCT00520572|593175468|FG005|Overall Study|Lack of Efficacy|0|||
164220123|NCT00520572|593175463|FG000|Overall Study|Lost to Follow-up|0|||
164220124|NCT00520572|593175464|FG001|Overall Study|Lost to Follow-up|0|||
164220125|NCT00520572|593175465|FG002|Overall Study|Lost to Follow-up|0|||
164220126|NCT00520572|593175466|FG003|Overall Study|Lost to Follow-up|0|||
164220127|NCT00520572|593175467|FG004|Overall Study|Lost to Follow-up|1|||
164220128|NCT00520572|593175468|FG005|Overall Study|Lost to Follow-up|0|||
164220129|NCT00520572|593175463|FG000|Overall Study|Incorrect enrollment|1|||
164220130|NCT00520572|593175464|FG001|Overall Study|Incorrect enrollment|0|||
164220131|NCT00520572|593175465|FG002|Overall Study|Incorrect enrollment|1|||
164220132|NCT00520572|593175466|FG003|Overall Study|Incorrect enrollment|0|||
164220133|NCT00520572|593175467|FG004|Overall Study|Incorrect enrollment|1|||
164220134|NCT00520572|593175468|FG005|Overall Study|Incorrect enrollment|0|||
164220135|NCT00520572|593175463|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220136|NCT00520572|593175464|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
164220137|NCT00520572|593175465|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220138|NCT00520572|593175466|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220139|NCT00520572|593175467|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220140|NCT00520572|593175468|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
164220141|NCT00520572|593175463|FG000|Overall Study|Long break in taking Medication|0|||
164220142|NCT00520572|593175464|FG001|Overall Study|Long break in taking Medication|0|||
164220143|NCT00520572|593175465|FG002|Overall Study|Long break in taking Medication|0|||
164220144|NCT00520572|593175466|FG003|Overall Study|Long break in taking Medication|1|||
164220145|NCT00520572|593175467|FG004|Overall Study|Long break in taking Medication|0|||
164220146|NCT00520572|593175468|FG005|Overall Study|Long break in taking Medication|0|||
164220147|NCT00520572|593175463|FG000|Overall Study|Did not receive Treatment|1|||
164220148|NCT00520572|593175464|FG001|Overall Study|Did not receive Treatment|0|||
164220149|NCT00520572|593175465|FG002|Overall Study|Did not receive Treatment|1|||
164220150|NCT00520572|593175466|FG003|Overall Study|Did not receive Treatment|0|||
164220151|NCT00520572|593175467|FG004|Overall Study|Did not receive Treatment|0|||
164328913|NCT00107952|593581208|FG000|Overall Study|Death|75|||
164328914|NCT00107952|593581209|FG001|Overall Study|Death|61|||
164328915|NCT00107952|593581208|FG000|Overall Study|Lost to Follow-up|0|||
164328916|NCT00107952|593581209|FG001|Overall Study|Lost to Follow-up|3|||
164328917|NCT00107952|593581208|FG000|Overall Study|Withdrawal by Subject|9|||
164328918|NCT00107952|593581209|FG001|Overall Study|Withdrawal by Subject|6|||
164328919|NCT00107952|593581208|FG000|Overall Study|Other|2|||
164328920|NCT00107952|593581209|FG001|Overall Study|Other|5|||
164328921|NCT00107952|593581208|FG000|Overall Study|Never received study treatment|9|||
164328922|NCT00107952|593581209|FG001|Overall Study|Never received study treatment|6|||
164328923|NCT03533686|593581210|FG000|Overall Study|Withdrawal by Subject|1|||
164328924|NCT03533686|593581211|FG001|Overall Study|Withdrawal by Subject|0|||
164328925|NCT03533686|593581212|FG002|Overall Study|Withdrawal by Subject|0|||
164328926|NCT03533686|593581213|FG003|Overall Study|Withdrawal by Subject|3|||
164328927|NCT03533686|593581214|FG004|Overall Study|Withdrawal by Subject|5|||
164328928|NCT03533686|593581215|FG005|Overall Study|Withdrawal by Subject|1|||
164328929|NCT03533686|593581210|FG000|Overall Study|Lost to Follow-up|0|||
164220152|NCT00520572|593175468|FG005|Overall Study|Did not receive Treatment|0|||
164220153|NCT01748552|593175473|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
164220154|NCT01748552|593175474|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
164220155|NCT01748552|593175475|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
164220156|NCT01748552|593175476|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
164220157|NCT01748552|593175477|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
164220158|NCT01748552|593175478|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
164220159|NCT01748552|593175479|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
164220160|NCT01748552|593175480|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
164220161|NCT01748552|593175481|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
164220162|NCT01748552|593175482|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
164220163|NCT01748552|593175483|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
164220164|NCT01748552|593175484|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
164220165|NCT01748552|593175473|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220166|NCT01748552|593175474|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220167|NCT01748552|593175475|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220168|NCT01748552|593175476|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220169|NCT01748552|593175477|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220170|NCT01748552|593175478|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220171|NCT01748552|593175479|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
164220172|NCT01748552|593175480|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
164220173|NCT01748552|593175481|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
164220174|NCT01748552|593175482|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220175|NCT01748552|593175483|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220176|NCT01748552|593175484|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
164220177|NCT01386645|593175485|FG000|Overall Study|Physician Decision|0|||
164220178|NCT01386645|593175486|FG001|Overall Study|Physician Decision|0|||
164220179|NCT01386645|593175487|FG002|Overall Study|Physician Decision|1|||
164220180|NCT01386645|593175485|FG000|Overall Study|Withdrawal by Subject|0|||
164220181|NCT01386645|593175486|FG001|Overall Study|Withdrawal by Subject|1|||
164220182|NCT01386645|593175487|FG002|Overall Study|Withdrawal by Subject|1|||
164220183|NCT02930941|593175488|FG000|Overall Study|Lost to Follow-up|1|||
164220184|NCT02930941|593175489|FG001|Overall Study|Lost to Follow-up|2|||
164220185|NCT00289978|593175490|FG000|Overall Study|Withdrawal by Subject|31|||
164220186|NCT00289978|593175491|FG001|Overall Study|Withdrawal by Subject|17|||
164220187|NCT00289978|593175492|FG002|Overall Study|Withdrawal by Subject|28|||
164220188|NCT00289978|593175490|FG000|Overall Study|Adverse Event|22|||
164220189|NCT00289978|593175491|FG001|Overall Study|Adverse Event|13|||
164220190|NCT00289978|593175492|FG002|Overall Study|Adverse Event|18|||
164220191|NCT00289978|593175490|FG000|Overall Study|Lack of Efficacy|13|||
164220192|NCT00289978|593175491|FG001|Overall Study|Lack of Efficacy|6|||
164220193|NCT00289978|593175492|FG002|Overall Study|Lack of Efficacy|25|||
164220194|NCT00289978|593175490|FG000|Overall Study|Abnormal laboratory value(s)|20|||
164220195|NCT00289978|593175491|FG001|Overall Study|Abnormal laboratory value(s)|9|||
164220196|NCT00289978|593175492|FG002|Overall Study|Abnormal laboratory value(s)|1|||
164220197|NCT00289978|593175490|FG000|Overall Study|Lost to Follow-up|3|||
164220198|NCT00289978|593175491|FG001|Overall Study|Lost to Follow-up|5|||
164220199|NCT00289978|593175492|FG002|Overall Study|Lost to Follow-up|7|||
164220200|NCT00289978|593175490|FG000|Overall Study|Protocol Violation|5|||
164220201|NCT00289978|593175491|FG001|Overall Study|Protocol Violation|5|||
164220202|NCT00289978|593175492|FG002|Overall Study|Protocol Violation|4|||
164220203|NCT00289978|593175490|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164220204|NCT00289978|593175491|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164220205|NCT00289978|593175492|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164220206|NCT00289978|593175490|FG000|Overall Study|Death|1|||
164220207|NCT00289978|593175491|FG001|Overall Study|Death|0|||
164220208|NCT00289978|593175492|FG002|Overall Study|Death|2|||
164220209|NCT00903344|593175493|FG000|Overall Study|Pregnancy|2|||
164220210|NCT00903344|593175494|FG001|Overall Study|Pregnancy|3|||
164220211|NCT00903344|593175493|FG000|Overall Study|Lost to Follow-up|3|||
164328930|NCT03533686|593581211|FG001|Overall Study|Lost to Follow-up|1|||
164328931|NCT03533686|593581212|FG002|Overall Study|Lost to Follow-up|0|||
164328932|NCT03533686|593581213|FG003|Overall Study|Lost to Follow-up|0|||
164328933|NCT03533686|593581214|FG004|Overall Study|Lost to Follow-up|2|||
164328934|NCT03533686|593581215|FG005|Overall Study|Lost to Follow-up|0|||
164328935|NCT03533686|593581210|FG000|Overall Study|Screen Failure|0|||
164328936|NCT03533686|593581211|FG001|Overall Study|Screen Failure|0|||
164328937|NCT03533686|593581212|FG002|Overall Study|Screen Failure|0|||
164328938|NCT03533686|593581213|FG003|Overall Study|Screen Failure|2|||
164220212|NCT00903344|593175494|FG001|Overall Study|Lost to Follow-up|0|||
164328939|NCT03533686|593581214|FG004|Overall Study|Screen Failure|0|||
164328940|NCT03533686|593581215|FG005|Overall Study|Screen Failure|0|||
164220213|NCT00585169|593175495|FG000|Overall Study|Withdrawal by Subject|1|||
164220214|NCT00527748|593175508|FG000|Overall Study|Other|3|||
164220215|NCT03055221|593175509|FG000|Overall Study|Adverse Event|2|||
164220216|NCT03055221|593175509|FG000|Overall Study|Withdrawal by Subject|4|||
164220217|NCT03055221|593175509|FG000|Overall Study|Death|6|||
164220218|NCT03055221|593175509|FG000|Overall Study|Physician Decision|1|||
164220219|NCT03055221|593175509|FG000|Overall Study|Study terminated by Sponsor|3|||
164220220|NCT03055221|593175509|FG000|Overall Study|Lost to Follow-up|4|||
164220221|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
164220222|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
164220223|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
164220224|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
164220225|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
164220226|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
164220227|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
164220228|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
164220229|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
164220230|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
164220231|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
164220232|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
164220233|NCT01243424|593175510|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
164220234|NCT01243424|593175511|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
164220235|NCT01243424|593175510|FG000|Discontinuation From Treatment|Not treated|5|||
164220236|NCT01243424|593175511|FG001|Discontinuation From Treatment|Not treated|4|||
164220237|NCT01243424|593175510|FG000|Discontinuation From Treatment|Adverse Event|457|||
164220238|NCT01243424|593175511|FG001|Discontinuation From Treatment|Adverse Event|523|||
164220239|NCT01243424|593175510|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
164220240|NCT01243424|593175511|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
164220241|NCT01243424|593175510|FG000|Discontinuation From Treatment|Protocol Violation|46|||
164220242|NCT01243424|593175511|FG001|Discontinuation From Treatment|Protocol Violation|47|||
164220243|NCT01243424|593175510|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
164220244|NCT01243424|593175511|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
164220245|NCT01243424|593175510|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
164220246|NCT01243424|593175511|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
164220247|NCT01243424|593175510|FG000|Discontinuation From Treatment|Other than listed above|230|||
164220248|NCT01243424|593175511|FG001|Discontinuation From Treatment|Other than listed above|211|||
164220249|NCT01093885|593175512|FG000|Overall Study|Adverse Event|4|||
164220250|NCT01093885|593175512|FG000|Overall Study|Lost to Follow-up|1|||
164220251|NCT00710554|593175513|FG000|Overall Study|Adverse Event|24|||
164220252|NCT00710554|593175514|FG001|Overall Study|Adverse Event|7|||
164220253|NCT00710554|593175513|FG000|Overall Study|Withdrawal by Subject|7|||
164220254|NCT00710554|593175514|FG001|Overall Study|Withdrawal by Subject|3|||
164220255|NCT00710554|593175513|FG000|Overall Study|Lost to Follow-up|7|||
164220256|NCT00710554|593175514|FG001|Overall Study|Lost to Follow-up|1|||
164220257|NCT00710554|593175513|FG000|Overall Study|Lack of Efficacy|11|||
164220258|NCT00710554|593175514|FG001|Overall Study|Lack of Efficacy|12|||
164220259|NCT00710554|593175513|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
164220260|NCT00710554|593175514|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
164220261|NCT04621786|593175515|FG000|Overall Study|Lost to Follow-up|9|||
164220262|NCT04621786|593175515|FG000|Overall Study|Protocol Violation|3|||
164220263|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
164220264|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
164220265|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
164220266|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
164220267|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
164220268|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
164220269|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
164220270|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
164079182|NCT02806232|592655597|FG007|Overall Study|Withdrawal by Subject|0|||
164079183|NCT02806232|592655598|FG008|Overall Study|Withdrawal by Subject|0|||
164079184|NCT00434161|592655599|FG000|Overall Study|Adverse Event|5|||
164220271|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
164220272|NCT00292370|593175520|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
164220273|NCT00292370|593175521|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
164079185|NCT00434161|592655600|FG001|Overall Study|Adverse Event|1|||
164220274|NCT00292370|593175522|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
164220275|NCT00292370|593175520|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
164220276|NCT00292370|593175521|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
164220277|NCT00292370|593175522|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
164220278|NCT00292370|593175520|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
164220279|NCT00292370|593175521|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
164220280|NCT00292370|593175522|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
164220281|NCT01301001|593175523|FG000|First Intervention|Lost to Follow-up|4|||
164220282|NCT01301001|593175524|FG001|First Intervention|Lost to Follow-up|4|||
164220283|NCT01301001|593175523|FG000|First Intervention|Withdrawal by Subject|1|||
164220284|NCT01301001|593175524|FG001|First Intervention|Withdrawal by Subject|4|||
164220285|NCT01301001|593175523|FG000|First Intervention|Adverse Event|5|||
164220286|NCT01301001|593175524|FG001|First Intervention|Adverse Event|0|||
164220287|NCT01301001|593175523|FG000|First Intervention|Protocol Violation|0|||
164220288|NCT01301001|593175524|FG001|First Intervention|Protocol Violation|1|||
164220289|NCT01301001|593175523|FG000|Second Intervention|Adverse Event|2|||
164220290|NCT01301001|593175524|FG001|Second Intervention|Adverse Event|0|||
164220291|NCT01301001|593175523|FG000|Second Intervention|Withdrawal by Subject|2|||
164220292|NCT01301001|593175524|FG001|Second Intervention|Withdrawal by Subject|0|||
164220293|NCT01560988|593175525|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
164220294|NCT01560988|593175526|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
164220295|NCT01560988|593175525|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
164220296|NCT01560988|593175526|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
164220297|NCT01560988|593175525|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
164220298|NCT01560988|593175526|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
164220299|NCT01346709|593175527|FG000|Overall Study|Protocol Violation|35|||
164220300|NCT01346709|593175527|FG000|Overall Study|Lost to Follow-up|31|||
164220301|NCT01346709|593175527|FG000|Overall Study|Missing data in candidate risk factor|285|||
164220302|NCT04821245|593175528|FG000|Overall Study|Withdrawal by Subject|3|||
164220303|NCT04821245|593175528|FG000|Overall Study|Physician Decision|1|||
164220304|NCT04821245|593175528|FG000|Overall Study|Protocol Violation|5|||
164220305|NCT01840163|593175529|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
164220306|NCT01840163|593175530|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
164220307|NCT01840163|593175529|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
164220308|NCT01840163|593175530|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
164220309|NCT01840163|593175529|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
164220310|NCT01840163|593175530|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
164220311|NCT02421510|593175534|FG000|Overall Study|Other|4|||
164220312|NCT02421510|593175535|FG001|Overall Study|Other|2|||
164220313|NCT02421510|593175536|FG002|Overall Study|Other|3|||
164220314|NCT02421510|593175534|FG000|Overall Study|Protocol Violation|1|||
164220315|NCT02421510|593175535|FG001|Overall Study|Protocol Violation|2|||
164220316|NCT02421510|593175536|FG002|Overall Study|Protocol Violation|0|||
164220317|NCT02421510|593175534|FG000|Overall Study|Death|1|||
163878565|NCT02140645|591922844|FG003|Overall Study|Not linked|13833|||
163878566|NCT02140645|591922845|FG004|Overall Study|Not linked|3286|||
163878567|NCT02140645|591922846|FG005|Overall Study|Not linked|70896|||
163878568|NCT05450458|591922847|FG000|Overall Study|Lost to Follow-up|4|||
163878569|NCT01101451|591922849|FG000|Overall Study|Eligible and never treated|0|||
163878570|NCT01101451|591922850|FG001|Overall Study|Eligible and never treated|5|||
163878571|NCT01101451|591922849|FG000|Overall Study|Ineligible and treated|12|||
163878572|NCT01101451|591922850|FG001|Overall Study|Ineligible and treated|8|||
163878573|NCT01101451|591922849|FG000|Overall Study|Ineligible and never treated|2|||
163878574|NCT01101451|591922850|FG001|Overall Study|Ineligible and never treated|2|||
163878575|NCT01044303|591922852|FG000|Overall Study|Lost to Follow-up|2|||
163878576|NCT01227265|591922853|FG000|Overall Study|Did Not Receive Treatment|1|||
163878577|NCT01227265|591922854|FG001|Overall Study|Did Not Receive Treatment|2|||
163878578|NCT01227265|591922855|FG002|Overall Study|Did Not Receive Treatment|0|||
163878579|NCT01227265|591922853|FG000|Overall Study|Administrative|1|||
163878580|NCT01227265|591922854|FG001|Overall Study|Administrative|0|||
163878581|NCT01227265|591922855|FG002|Overall Study|Administrative|2|||
163878582|NCT01227265|591922853|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164220318|NCT02421510|593175535|FG001|Overall Study|Death|0|||
164220319|NCT02421510|593175536|FG002|Overall Study|Death|0|||
164220320|NCT02421510|593175534|FG000|Overall Study|Noncompliance with study drug|1|||
163878583|NCT01227265|591922854|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
164220321|NCT02421510|593175535|FG001|Overall Study|Noncompliance with study drug|0|||
164220322|NCT02421510|593175536|FG002|Overall Study|Noncompliance with study drug|0|||
163878584|NCT01227265|591922855|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
163878585|NCT01227265|591922853|FG000|Overall Study|Protocol Violation|2|||
163878586|NCT01227265|591922854|FG001|Overall Study|Protocol Violation|1|||
163878587|NCT01227265|591922855|FG002|Overall Study|Protocol Violation|0|||
163878588|NCT01227265|591922853|FG000|Overall Study|Withdrawal by Subject|7|||
163878589|NCT01227265|591922854|FG001|Overall Study|Withdrawal by Subject|7|||
164220323|NCT02421510|593175534|FG000|Overall Study|Physician Decision|1|||
164220324|NCT02421510|593175535|FG001|Overall Study|Physician Decision|1|||
164220325|NCT02421510|593175536|FG002|Overall Study|Physician Decision|3|||
164220326|NCT02421510|593175534|FG000|Overall Study|Adverse Event|9|||
164220327|NCT02421510|593175535|FG001|Overall Study|Adverse Event|10|||
164220328|NCT02421510|593175536|FG002|Overall Study|Adverse Event|18|||
164220329|NCT02421510|593175534|FG000|Overall Study|Pregnancy|1|||
164220330|NCT02421510|593175535|FG001|Overall Study|Pregnancy|1|||
164220331|NCT02421510|593175536|FG002|Overall Study|Pregnancy|0|||
164220332|NCT02421510|593175534|FG000|Overall Study|Withdrawal by Subject|14|||
164220333|NCT02421510|593175535|FG001|Overall Study|Withdrawal by Subject|18|||
164220334|NCT02421510|593175536|FG002|Overall Study|Withdrawal by Subject|12|||
164220335|NCT02421510|593175534|FG000|Overall Study|Lost to Follow-up|1|||
164220336|NCT02421510|593175535|FG001|Overall Study|Lost to Follow-up|1|||
164220337|NCT02421510|593175536|FG002|Overall Study|Lost to Follow-up|0|||
164220338|NCT01058005|593175539|FG000|Overall Study|Adverse Event|0|||
164220339|NCT01058005|593175540|FG001|Overall Study|Adverse Event|2|||
164220340|NCT01058005|593175541|FG002|Overall Study|Adverse Event|1|||
164220341|NCT01058005|593175539|FG000|Overall Study|Physician Decision|2|||
164220342|NCT01058005|593175540|FG001|Overall Study|Physician Decision|2|||
164220343|NCT01058005|593175541|FG002|Overall Study|Physician Decision|0|||
164220344|NCT01058005|593175539|FG000|Overall Study|Withdrawal by Subject|4|||
164220345|NCT01058005|593175540|FG001|Overall Study|Withdrawal by Subject|5|||
164220346|NCT01058005|593175541|FG002|Overall Study|Withdrawal by Subject|11|||
164220347|NCT01058005|593175539|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
164220348|NCT01058005|593175540|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
164220349|NCT01058005|593175541|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
164220350|NCT01058005|593175539|FG000|Overall Study|Reason Missing|5|||
164079186|NCT00434161|592655601|FG002|Overall Study|Adverse Event|4|||
164079187|NCT00434161|592655599|FG000|Overall Study|Lost to Follow-up|0|||
164079188|NCT00434161|592655600|FG001|Overall Study|Lost to Follow-up|1|||
164079189|NCT00434161|592655601|FG002|Overall Study|Lost to Follow-up|0|||
164079190|NCT00434161|592655599|FG000|Overall Study|Death|1|||
164079191|NCT00434161|592655600|FG001|Overall Study|Death|0|||
164079192|NCT00434161|592655601|FG002|Overall Study|Death|1|||
164079193|NCT00434161|592655599|FG000|Overall Study|Non-Compliance|1|||
164079194|NCT00434161|592655600|FG001|Overall Study|Non-Compliance|1|||
164079195|NCT00434161|592655601|FG002|Overall Study|Non-Compliance|0|||
164079196|NCT00434161|592655599|FG000|Overall Study|Withdrawal by Subject|2|||
164079197|NCT00434161|592655600|FG001|Overall Study|Withdrawal by Subject|0|||
164079198|NCT00434161|592655601|FG002|Overall Study|Withdrawal by Subject|3|||
164220351|NCT01058005|593175540|FG001|Overall Study|Reason Missing|3|||
163982241|NCT02164981|592306441|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
163982242|NCT02164981|592306442|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
163982243|NCT02164981|592306443|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
163982244|NCT02164981|592306441|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
163982245|NCT02164981|592306442|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
163982246|NCT02164981|592306443|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
163982247|NCT02164981|592306441|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
163982248|NCT02164981|592306442|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
163982249|NCT02164981|592306443|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
164220352|NCT01058005|593175541|FG002|Overall Study|Reason Missing|1|||
164220353|NCT01698008|593175542|FG000|Overall Study|Withdrawal by Subject|1|||
164220354|NCT01698008|593175543|FG001|Overall Study|Withdrawal by Subject|2|||
164220355|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|No Data|249|||
164220356|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|No Data|66|||
164220357|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|No Data|2|||
164220358|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|Other|33|||
164220359|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|Other|20|||
164220360|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|Other|0|||
164220361|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
164220362|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
164220363|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
164220364|NCT01623752|593175547|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
164220365|NCT01623752|593175548|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
164220366|NCT01623752|593175549|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
164220367|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
164220368|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
164220369|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
164220370|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|Other|5|||
164328941|NCT02632838|593581216|FG000|Overall Study|Withdrawal by Subject|3|||
164079199|NCT00434161|592655599|FG000|Overall Study|Logistical error study assessments|1|||
164079200|NCT00434161|592655600|FG001|Overall Study|Logistical error study assessments|0|||
164079201|NCT00434161|592655601|FG002|Overall Study|Logistical error study assessments|3|||
163982250|NCT01761266|592306449|FG000|Overall Study|Death|415|||
164220371|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|Other|1|||
164220372|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|Other|0|||
164220373|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|No Data|43|||
164220374|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|No Data|11|||
164220375|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|No Data|0|||
164220376|NCT01623752|593175547|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
164328942|NCT02632838|593581217|FG001|Overall Study|Withdrawal by Subject|0|||
164220377|NCT01623752|593175548|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
164220378|NCT01623752|593175549|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
164220379|NCT00981175|593175550|FG000|Primary Dose Vaccination|Adverse Event|1|||
164220380|NCT00981175|593175551|FG001|Primary Dose Vaccination|Adverse Event|0|||
164220381|NCT00981175|593175550|FG000|Primary Dose Vaccination|Protocol Violation|0|||
164220382|NCT00981175|593175551|FG001|Primary Dose Vaccination|Protocol Violation|1|||
164220383|NCT00981175|593175550|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
164220384|NCT00981175|593175551|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
164220385|NCT00981175|593175550|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
164220386|NCT00981175|593175551|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
164220387|NCT02619812|593175552|FG000|Overall Study|Withdrawal by Subject|0|||
164220388|NCT02619812|593175553|FG001|Overall Study|Withdrawal by Subject|0|||
164220389|NCT02619812|593175554|FG002|Overall Study|Withdrawal by Subject|1|||
164220390|NCT02619812|593175555|FG003|Overall Study|Withdrawal by Subject|2|||
164220391|NCT04865978|593175569|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
164220392|NCT04865978|593175570|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
164220393|NCT04263532|593175571|FG000|Overall Study|Withdrawal by Subject|2|||
164220394|NCT04263532|593175572|FG001|Overall Study|Withdrawal by Subject|0|||
164220395|NCT04098302|593175573|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
164220396|NCT04098302|593175574|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
164328943|NCT02632838|593581216|FG000|Overall Study|Lost to Follow-up|0|||
164328944|NCT02632838|593581217|FG001|Overall Study|Lost to Follow-up|2|||
164328945|NCT03370289|593581224|FG000|Overall Study|Screen Failure|1|||
164328946|NCT03370289|593581224|FG000|Overall Study|Sample Size Sufficient|4|||
164328947|NCT02140775|593581226|FG000|Overall Study|Withdrawal by Subject|30|||
164328948|NCT02140775|593581227|FG001|Overall Study|Withdrawal by Subject|7|||
164328949|NCT00938964|593581229|FG000|Overall Study|Death|3|||
164328950|NCT00938964|593581230|FG001|Overall Study|Death|3|||
164328951|NCT00938964|593581229|FG000|Overall Study|Lost to Follow-up|2|||
164328952|NCT00938964|593581230|FG001|Overall Study|Lost to Follow-up|3|||
164328953|NCT00938964|593581229|FG000|Overall Study|Withdrawal by Subject|22|||
164328954|NCT00938964|593581230|FG001|Overall Study|Withdrawal by Subject|18|||
164328955|NCT00938964|593581229|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
164328956|NCT00938964|593581230|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
164328957|NCT01858636|593581231|FG000|Overall Study|No Device Deployment Attempted|24|||
164328958|NCT01858636|593581231|FG000|Overall Study|Physician Decision|1|||
164328959|NCT01858636|593581231|FG000|Overall Study|Death|1|||
164328960|NCT01858636|593581231|FG000|Overall Study|Lost to Follow-up|1|||
164328961|NCT01858636|593581231|FG000|Overall Study|Withdrawal by Subject|1|||
164328962|NCT01227564|593581235|FG000|Overall Study|No Longer Willing to Participate|4|||
164328963|NCT01227564|593581236|FG001|Overall Study|No Longer Willing to Participate|2|||
164328964|NCT01227564|593581237|FG002|Overall Study|No Longer Willing to Participate|5|||
164328965|NCT01227564|593581235|FG000|Overall Study|Participant moved to another town|0|||
164328966|NCT01227564|593581236|FG001|Overall Study|Participant moved to another town|0|||
164328967|NCT01227564|593581237|FG002|Overall Study|Participant moved to another town|1|||
164328968|NCT00999921|593581253|FG000|Overall Study|Lost to Follow-up|10|||
164328969|NCT00999921|593581254|FG001|Overall Study|Lost to Follow-up|19|||
164328970|NCT04650854|593581255|FG000|Overall Study|Adverse Event|1|||
164328971|NCT04650854|593581256|FG001|Overall Study|Adverse Event|12|||
164328972|NCT04650854|593581257|FG002|Overall Study|Adverse Event|14|||
164328973|NCT04650854|593581255|FG000|Overall Study|Lack of Efficacy|1|||
164328974|NCT04650854|593581256|FG001|Overall Study|Lack of Efficacy|3|||
164328975|NCT04650854|593581257|FG002|Overall Study|Lack of Efficacy|6|||
164328976|NCT04650854|593581255|FG000|Overall Study|Lost to Follow-up|1|||
164328977|NCT04650854|593581256|FG001|Overall Study|Lost to Follow-up|1|||
164328978|NCT04650854|593581257|FG002|Overall Study|Lost to Follow-up|0|||
164328979|NCT04650854|593581255|FG000|Overall Study|Withdrawal by Subject|2|||
164328980|NCT04650854|593581256|FG001|Overall Study|Withdrawal by Subject|17|||
164328981|NCT04650854|593581257|FG002|Overall Study|Withdrawal by Subject|9|||
164328982|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
164328983|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
164328984|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
164328985|NCT04650854|593581255|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
164328986|NCT04650854|593581256|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
164328987|NCT04650854|593581257|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
164220397|NCT04098302|593175575|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
164220398|NCT04098302|593175576|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
164328988|NCT04650854|593581255|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
164328989|NCT04650854|593581256|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
164328990|NCT04650854|593581257|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
164220399|NCT04098302|593175573|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
164328991|NCT04650854|593581255|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
163982251|NCT01761266|592306450|FG001|Overall Study|Death|402|||
163982252|NCT01761266|592306449|FG000|Overall Study|Lost to Follow-up|8|||
163982253|NCT01761266|592306450|FG001|Overall Study|Lost to Follow-up|12|||
163982254|NCT01761266|592306449|FG000|Overall Study|Withdrawal by Subject|14|||
163982255|NCT01761266|592306450|FG001|Overall Study|Withdrawal by Subject|10|||
163982256|NCT01761266|592306449|FG000|Overall Study|Sponsor Decision|41|||
163982257|NCT01761266|592306450|FG001|Overall Study|Sponsor Decision|52|||
163982258|NCT01662440|592306451|FG000|Overall Study|Adverse Event|1|||
163982259|NCT01662440|592306452|FG001|Overall Study|Adverse Event|0|||
163982260|NCT01662440|592306453|FG002|Overall Study|Adverse Event|0|||
163982261|NCT01662440|592306454|FG003|Overall Study|Adverse Event|1|||
163982262|NCT01662440|592306451|FG000|Overall Study|Death|0|||
163982263|NCT01662440|592306452|FG001|Overall Study|Death|1|||
163878590|NCT01227265|591922855|FG002|Overall Study|Withdrawal by Subject|3|||
163878591|NCT01227265|591922853|FG000|Overall Study|Lost to Follow-up|2|||
163878592|NCT01227265|591922854|FG001|Overall Study|Lost to Follow-up|0|||
163878593|NCT01227265|591922855|FG002|Overall Study|Lost to Follow-up|3|||
163878594|NCT01227265|591922853|FG000|Overall Study|Adverse Event|6|||
163878595|NCT01227265|591922854|FG001|Overall Study|Adverse Event|10|||
163878596|NCT01227265|591922855|FG002|Overall Study|Adverse Event|5|||
163878597|NCT02910713|591922856|FG000|Overall Study|Protocol Violation|2|||
163878598|NCT02910713|591922856|FG000|Overall Study|Subject Choice|4|||
163878599|NCT02910713|591922856|FG000|Overall Study|Received One Application|10|||
163878600|NCT02910713|591922856|FG000|Overall Study|Received Neither Application|18|||
163878601|NCT02910713|591922856|FG000|Overall Study|Enrollment cap|7|||
163878602|NCT02910713|591922856|FG000|Overall Study|Investigator Discretion|1|||
163878603|NCT03744312|591925112|FG000|Overall Study|Withdrawal by Subject|0|||
163878604|NCT03744312|591925113|FG001|Overall Study|Withdrawal by Subject|1|||
163878605|NCT03744312|591925112|FG000|Overall Study|Screen fail|0|||
163878606|NCT03744312|591925113|FG001|Overall Study|Screen fail|1|||
163878607|NCT03152786|591925114|FG000|Overall Study|Withdrawal by Subject|2|||
163878608|NCT03152786|591925115|FG001|Overall Study|Withdrawal by Subject|1|||
163878609|NCT00979576|591925121|FG000|Combination Treatment Phase|Progressive disease|3|||
163878610|NCT00979576|591925122|FG001|Combination Treatment Phase|Progressive disease|1|||
163878611|NCT00979576|591925123|FG002|Combination Treatment Phase|Progressive disease|5|||
163878612|NCT00979576|591925121|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
163878613|NCT00979576|591925122|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
163878614|NCT00979576|591925123|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
163878615|NCT00979576|591925121|FG000|Combination Treatment Phase|Adverse Event|0|||
163878616|NCT00979576|591925122|FG001|Combination Treatment Phase|Adverse Event|2|||
163878617|NCT00979576|591925123|FG002|Combination Treatment Phase|Adverse Event|2|||
163878618|NCT00979576|591925121|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
163878619|NCT00979576|591925122|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
163878620|NCT00979576|591925123|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
163878621|NCT05338086|591925124|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
163878622|NCT05338086|591925125|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163878623|NCT05338086|591925126|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163878624|NCT05338086|591925127|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163878625|NCT05338086|591925128|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
163878626|NCT05338086|591925124|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
163878627|NCT05338086|591925125|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
163878628|NCT05338086|591925126|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
163878629|NCT05338086|591925127|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
163878630|NCT05338086|591925128|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
163878631|NCT05338086|591925124|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
163878632|NCT05338086|591925125|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
163878633|NCT05338086|591925126|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
163878634|NCT05338086|591925127|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
163878635|NCT05338086|591925128|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
163878636|NCT05338086|591925124|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
163878637|NCT05338086|591925125|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163878638|NCT05338086|591925126|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163878639|NCT05338086|591925127|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163878640|NCT05338086|591925128|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
163878641|NCT05338086|591925124|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
163878642|NCT05338086|591925125|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
163878643|NCT05338086|591925126|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
163878644|NCT05338086|591925127|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
163878645|NCT05338086|591925128|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
163878646|NCT05338086|591925124|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
163878647|NCT05338086|591925125|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
163878648|NCT05338086|591925126|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
163878649|NCT05338086|591925127|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
163878650|NCT05338086|591925128|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
163878651|NCT05338086|591925124|FG000|Transition Period (M12 to M18)|Death|0|||
163878652|NCT05338086|591925125|FG001|Transition Period (M12 to M18)|Death|0|||
163878653|NCT05338086|591925126|FG002|Transition Period (M12 to M18)|Death|1|||
163878654|NCT05338086|591925127|FG003|Transition Period (M12 to M18)|Death|0|||
164220400|NCT04098302|593175574|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
164220401|NCT04098302|593175575|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
163878655|NCT05338086|591925128|FG004|Transition Period (M12 to M18)|Death|0|||
163878656|NCT05338086|591925124|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
163878657|NCT05338086|591925125|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
163878658|NCT05338086|591925126|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
163878659|NCT05338086|591925127|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
164220402|NCT04098302|593175576|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
164220403|NCT04098302|593175573|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
164220404|NCT04098302|593175574|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
164220405|NCT04098302|593175575|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
164220406|NCT04098302|593175576|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
164220407|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
164220408|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
164220409|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
164220410|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
164220411|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
164220412|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
164220413|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
164220414|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
164220415|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
164220416|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
164220417|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
164220418|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
164220419|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
164220420|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
164220421|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
164220422|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
164220423|NCT04098302|593175573|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
164220424|NCT04098302|593175574|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
164220425|NCT04098302|593175575|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
164220426|NCT04098302|593175576|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
164220427|NCT05061706|593175577|FG000|Overall Study|Adverse Event|29|||
164220428|NCT05061706|593175578|FG001|Overall Study|Adverse Event|1|||
164220429|NCT05061706|593175577|FG000|Overall Study|Lack of Efficacy|0|||
164220430|NCT05061706|593175578|FG001|Overall Study|Lack of Efficacy|1|||
164220431|NCT05061706|593175577|FG000|Overall Study|Lost to Follow-up|2|||
164220432|NCT05061706|593175578|FG001|Overall Study|Lost to Follow-up|2|||
164220433|NCT05061706|593175577|FG000|Overall Study|Protocol Violation|3|||
163878660|NCT05338086|591925128|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
163878661|NCT05338086|591925124|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
163878662|NCT05338086|591925125|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
163878663|NCT05338086|591925126|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
164220434|NCT05061706|593175578|FG001|Overall Study|Protocol Violation|1|||
164220435|NCT05061706|593175577|FG000|Overall Study|Withdrawal by Subject|3|||
164220436|NCT05061706|593175578|FG001|Overall Study|Withdrawal by Subject|9|||
164220437|NCT00191152|593175579|FG000|Initial Treatment|Adverse Event|43|||
164220438|NCT00191152|593175580|FG001|Initial Treatment|Adverse Event|67|||
164220439|NCT00191152|593175579|FG000|Initial Treatment|Physician Decision|40|||
164220440|NCT00191152|593175580|FG001|Initial Treatment|Physician Decision|31|||
164220441|NCT00191152|593175579|FG000|Initial Treatment|Withdrawal by Subject|40|||
164220442|NCT00191152|593175580|FG001|Initial Treatment|Withdrawal by Subject|28|||
164220443|NCT00191152|593175579|FG000|Initial Treatment|Lost to Follow-up|0|||
164220444|NCT00191152|593175580|FG001|Initial Treatment|Lost to Follow-up|6|||
164220445|NCT00191152|593175579|FG000|Initial Treatment|Other|18|||
164220446|NCT00191152|593175580|FG001|Initial Treatment|Other|21|||
164220447|NCT00191152|593175579|FG000|Crossover Treatment|Adverse Event|8|||
164220448|NCT00191152|593175580|FG001|Crossover Treatment|Adverse Event|8|||
164220449|NCT00191152|593175579|FG000|Crossover Treatment|Physician Decision|7|||
164220450|NCT00191152|593175580|FG001|Crossover Treatment|Physician Decision|7|||
164220451|NCT00191152|593175579|FG000|Crossover Treatment|Withdrawal by Subject|6|||
164220452|NCT00191152|593175580|FG001|Crossover Treatment|Withdrawal by Subject|9|||
164220453|NCT00191152|593175579|FG000|Crossover Treatment|Lost to Follow-up|2|||
164220454|NCT00191152|593175580|FG001|Crossover Treatment|Lost to Follow-up|1|||
164220455|NCT00191152|593175579|FG000|Crossover Treatment|Other|4|||
164220456|NCT00191152|593175580|FG001|Crossover Treatment|Other|3|||
164220457|NCT01543503|593175581|FG000|Overall Study|Lost to Follow-up|32|||
164220458|NCT01543503|593175582|FG001|Overall Study|Lost to Follow-up|36|||
164220459|NCT01543503|593175581|FG000|Overall Study|Adverse Event|9|||
164220460|NCT01543503|593175582|FG001|Overall Study|Adverse Event|13|||
164220461|NCT01543503|593175581|FG000|Overall Study|Lack of Efficacy|4|||
164220462|NCT01543503|593175582|FG001|Overall Study|Lack of Efficacy|16|||
164220463|NCT01543503|593175581|FG000|Overall Study|Participant withdrew informed consent|8|||
164220464|NCT01543503|593175582|FG001|Overall Study|Participant withdrew informed consent|10|||
164220465|NCT01543503|593175581|FG000|Overall Study|Change of jobs|0|||
164220466|NCT01543503|593175582|FG001|Overall Study|Change of jobs|1|||
164220467|NCT01543503|593175581|FG000|Overall Study|Intolerance to the biologic treatment|0|||
164220468|NCT01543503|593175582|FG001|Overall Study|Intolerance to the biologic treatment|1|||
164220469|NCT01543503|593175581|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
164220470|NCT01543503|593175582|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
164220471|NCT01543503|593175581|FG000|Overall Study|Participant did not complete last visit|0|||
164220472|NCT01543503|593175582|FG001|Overall Study|Participant did not complete last visit|2|||
164220473|NCT01543503|593175581|FG000|Overall Study|Refused to continue treatment|7|||
164220474|NCT01543503|593175582|FG001|Overall Study|Refused to continue treatment|0|||
164220475|NCT01543503|593175581|FG000|Overall Study|Incorrect medication received|1|||
164220476|NCT01543503|593175582|FG001|Overall Study|Incorrect medication received|0|||
164220477|NCT01543503|593175581|FG000|Overall Study|Participant moved to another city|2|||
164220478|NCT01543503|593175582|FG001|Overall Study|Participant moved to another city|0|||
164220479|NCT01543503|593175581|FG000|Overall Study|Participant will not return for visits|0|||
164220480|NCT01543503|593175582|FG001|Overall Study|Participant will not return for visits|2|||
164220481|NCT01543503|593175581|FG000|Overall Study|Participant transferred to another city|1|||
164220482|NCT01543503|593175582|FG001|Overall Study|Participant transferred to another city|0|||
164220483|NCT01543503|593175581|FG000|Overall Study|Participant moved to Scotland|1|||
164220484|NCT01543503|593175582|FG001|Overall Study|Participant moved to Scotland|0|||
164220485|NCT01543503|593175581|FG000|Overall Study|Participant decision to stop treatment|1|||
164220486|NCT01543503|593175582|FG001|Overall Study|Participant decision to stop treatment|0|||
164220487|NCT01543503|593175581|FG000|Overall Study|Investigator did not wish to participate|1|||
164220488|NCT01543503|593175582|FG001|Overall Study|Investigator did not wish to participate|1|||
164220489|NCT01543503|593175581|FG000|Overall Study|Participant recruited after closing date|0|||
164220490|NCT01543503|593175582|FG001|Overall Study|Participant recruited after closing date|1|||
164220491|NCT01543503|593175581|FG000|Overall Study|Site stopped participation|5|||
164220492|NCT01543503|593175582|FG001|Overall Study|Site stopped participation|1|||
164220493|NCT01543503|593175581|FG000|Overall Study|Participant did not attend a visit|1|||
163878664|NCT05338086|591925127|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
163878665|NCT05338086|591925128|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
163878666|NCT05338086|591925124|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
163982264|NCT01662440|592306453|FG002|Overall Study|Death|0|||
164220494|NCT01543503|593175582|FG001|Overall Study|Participant did not attend a visit|0|||
164220495|NCT01543503|593175581|FG000|Overall Study|Moved to other rheumatologic site|0|||
164220496|NCT01543503|593175582|FG001|Overall Study|Moved to other rheumatologic site|1|||
164220497|NCT01543503|593175581|FG000|Overall Study|Participant consented to another study|0|||
164220498|NCT01543503|593175582|FG001|Overall Study|Participant consented to another study|2|||
164220499|NCT01543503|593175581|FG000|Overall Study|Participant went to United States|1|||
164220500|NCT01543503|593175582|FG001|Overall Study|Participant went to United States|0|||
164220501|NCT01543503|593175581|FG000|Overall Study|Screen failure|1|||
164220502|NCT01543503|593175582|FG001|Overall Study|Screen failure|0|||
164220503|NCT01986751|593175583|FG000|Overall Study|improperly consented|10|||
164220504|NCT01986751|593175584|FG001|Overall Study|improperly consented|2|||
164220505|NCT00052715|593175590|FG000|Overall Study|wrong histology|1|||
164220506|NCT01078545|593175591|FG000|Overall Study|Lost to Follow-up|13|||
164220507|NCT01078545|593175591|FG000|Overall Study|Physician Decision|6|||
164220508|NCT01078545|593175591|FG000|Overall Study|Withdrawal by Subject|3|||
164220509|NCT01078545|593175591|FG000|Overall Study|Death|3|||
164220510|NCT01078545|593175591|FG000|Overall Study|Participant moved to another physician|1|||
164220511|NCT01774370|593175594|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
164220512|NCT01774370|593175594|FG000|Overall Study|Administered prior to the contract date|4|||
164220513|NCT01774370|593175594|FG000|Overall Study|Subjects of contraindications|34|||
164220514|NCT01774370|593175594|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
164220515|NCT01774370|593175594|FG000|Overall Study|Follow-up failure|34|||
164220516|NCT04243837|593175597|FG000|Overall Study|Adverse Event|2|||
164220517|NCT04243837|593175598|FG001|Overall Study|Adverse Event|1|||
164220518|NCT04243837|593175597|FG000|Overall Study|Withdrawal by Subject|4|||
164220519|NCT04243837|593175598|FG001|Overall Study|Withdrawal by Subject|2|||
164220520|NCT04243837|593175597|FG000|Overall Study|Covid-19 lock down|1|||
164220521|NCT04243837|593175598|FG001|Overall Study|Covid-19 lock down|0|||
164220522|NCT04243837|593175597|FG000|Overall Study|Study Terminated by Sponsor|11|||
164220523|NCT04243837|593175598|FG001|Overall Study|Study Terminated by Sponsor|12|||
164220524|NCT03501277|593175602|FG000|Intervention Period 1 (4 Days)|Other|0|||
164220525|NCT03501277|593175603|FG001|Intervention Period 1 (4 Days)|Other|0|||
164220526|NCT03501277|593175604|FG002|Intervention Period 1 (4 Days)|Other|1|||
164220527|NCT03501277|593175605|FG003|Intervention Period 1 (4 Days)|Other|0|||
164220528|NCT03501277|593175602|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
164220529|NCT03501277|593175603|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
164220530|NCT03501277|593175604|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
164220531|NCT03501277|593175605|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
164220532|NCT03501277|593175602|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
164220533|NCT03501277|593175603|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
164220534|NCT03501277|593175604|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
164220535|NCT03501277|593175605|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
164220536|NCT03501277|593175602|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
164220537|NCT03501277|593175603|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
164220538|NCT03501277|593175604|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
164220539|NCT03501277|593175605|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
164220540|NCT01489358|593175607|FG000|Overall Study|Lost to Follow-up|0|||
164220541|NCT01489358|593175608|FG001|Overall Study|Lost to Follow-up|0|||
164220542|NCT01489358|593175609|FG002|Overall Study|Lost to Follow-up|2|||
164220543|NCT01873833|593175610|FG000|Overall Study|Withdrawal by Subject|1|||
164220544|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Adverse Event|14|||
164220545|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Adverse Event|27|||
164220546|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Adverse Event|60|||
164220547|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Adverse Event|0|||
164220548|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Adverse Event|0|||
164220549|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Pregnancy|0|||
164220550|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Pregnancy|7|||
164220551|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Pregnancy|9|||
164220552|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Pregnancy|0|||
164220553|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Pregnancy|0|||
164220554|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
163878667|NCT05338086|591925125|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
163878668|NCT05338086|591925126|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
163878669|NCT05338086|591925127|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
163878670|NCT05338086|591925128|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
163878671|NCT03424811|591925133|FG000|Overall Study|Lost to Follow-up|9|||
163878672|NCT03424811|591925134|FG001|Overall Study|Lost to Follow-up|0|||
163878673|NCT02597946|591925137|FG000|Overall Study|Withdrawal by Subject|1|||
163878674|NCT02597946|591925137|FG000|Overall Study|Progressive disease|16|||
163878675|NCT02597946|591925137|FG000|Overall Study|Other than above|1|||
163982265|NCT01662440|592306454|FG003|Overall Study|Death|0|||
163982266|NCT01662440|592306451|FG000|Overall Study|Lost to Follow-up|2|||
163982267|NCT01662440|592306452|FG001|Overall Study|Lost to Follow-up|2|||
163982268|NCT01662440|592306453|FG002|Overall Study|Lost to Follow-up|4|||
163982269|NCT01662440|592306454|FG003|Overall Study|Lost to Follow-up|1|||
163982270|NCT01662440|592306451|FG000|Overall Study|Subject moved to another country.|0|||
163982271|NCT01662440|592306452|FG001|Overall Study|Subject moved to another country.|1|||
164220555|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
163982272|NCT01662440|592306453|FG002|Overall Study|Subject moved to another country.|0|||
164220556|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
164079202|NCT03342898|592655602|FG000|Overall Study|Adverse Event|3|||
164220557|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
164220558|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
164220559|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
163878676|NCT04823611|591925144|FG000|Overall Study|Adverse Event|2|||
163878677|NCT04823611|591925145|FG001|Overall Study|Adverse Event|0|||
163878678|NCT04823611|591925146|FG002|Overall Study|Adverse Event|1|||
163878679|NCT04823611|591925147|FG003|Overall Study|Adverse Event|0|||
163878680|NCT04823611|591925148|FG004|Overall Study|Adverse Event|0|||
163878681|NCT04823611|591925149|FG005|Overall Study|Adverse Event|0|||
163878682|NCT04823611|591925150|FG006|Overall Study|Adverse Event|0|||
163878683|NCT05038566|591925151|FG000|Overall Study|Technical Difficulties with the Device|0|||
163878684|NCT05038566|591925152|FG001|Overall Study|Technical Difficulties with the Device|1|||
163878685|NCT04850807|591925161|FG000|Overall Study|Death|50|||
163878686|NCT04850807|591925162|FG001|Overall Study|Death|55|||
163878687|NCT04850807|591925161|FG000|Overall Study|Discharged|17|||
163878688|NCT04850807|591925162|FG001|Overall Study|Discharged|13|||
163878689|NCT04850807|591925161|FG000|Overall Study|Incomplete baseline data|3|||
163878690|NCT04850807|591925162|FG001|Overall Study|Incomplete baseline data|2|||
163878691|NCT03739996|591925163|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
163878692|NCT03739996|591925163|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
163878693|NCT03739996|591925163|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
163878694|NCT03739996|591925163|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
163878695|NCT03739996|591925163|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
163878696|NCT03739996|591925163|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
163878697|NCT03739996|591925163|FG000|Step 3 (SOC ART)|Death|1|||
163878698|NCT03739996|591925163|FG000|Step 3 (SOC ART)|Participant moved|1|||
163878699|NCT05141903|591925164|FG000|Overall Study|Withdrawal by Subject|0|||
163878700|NCT05141903|591925165|FG001|Overall Study|Withdrawal by Subject|1|||
163878701|NCT05141903|591925166|FG002|Overall Study|Withdrawal by Subject|1|||
163878702|NCT05141903|591925167|FG003|Overall Study|Withdrawal by Subject|0|||
163878703|NCT05141903|591925168|FG004|Overall Study|Withdrawal by Subject|0|||
163878704|NCT05141903|591925164|FG000|Overall Study|Other|1|||
163878705|NCT05141903|591925165|FG001|Overall Study|Other|1|||
163878706|NCT05141903|591925166|FG002|Overall Study|Other|0|||
163878707|NCT05141903|591925167|FG003|Overall Study|Other|0|||
163878708|NCT05141903|591925168|FG004|Overall Study|Other|0|||
163878709|NCT04178733|591925170|FG000|Overall Study|Investigator Decision|0|||
163878710|NCT04178733|591925171|FG001|Overall Study|Investigator Decision|0|||
163878711|NCT04178733|591925172|FG002|Overall Study|Investigator Decision|0|||
163878712|NCT04178733|591925173|FG003|Overall Study|Investigator Decision|1|||
163878713|NCT04178733|591925174|FG004|Overall Study|Investigator Decision|2|||
163878714|NCT03655132|591925179|FG000|Overall Study|Lost to Follow-up|2|||
163878715|NCT03655132|591925180|FG001|Overall Study|Lost to Follow-up|1|||
163878716|NCT03655132|591925179|FG000|Overall Study|Withdrawal by Subject|0|||
163878717|NCT03655132|591925180|FG001|Overall Study|Withdrawal by Subject|1|||
163878718|NCT03655132|591925179|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
163878719|NCT03655132|591925180|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
163878720|NCT02651324|591925182|FG000|Overall Study|drug not administered, due dispensing issue|1|||
163878721|NCT02651324|591925183|FG001|Overall Study|drug not administered, due dispensing issue|0|||
163878722|NCT05439603|591925184|FG000|Overall Study|met withdrawal criteria|2|||
163878723|NCT04549168|591925190|FG000|Randomization Phase|Adverse Event|0|||
163878724|NCT04549168|591925191|FG001|Randomization Phase|Adverse Event|0|||
163878725|NCT04549168|591925192|FG002|Randomization Phase|Adverse Event|1|||
163878726|NCT04549168|591925190|FG000|Randomization Phase|Other|0|||
163878727|NCT04549168|591925191|FG001|Randomization Phase|Other|2|||
163878728|NCT04549168|591925192|FG002|Randomization Phase|Other|0|||
163878729|NCT04549168|591925190|FG000|Randomization Phase|Withdrawal by Subject|0|||
163878730|NCT04549168|591925191|FG001|Randomization Phase|Withdrawal by Subject|2|||
163878731|NCT04549168|591925192|FG002|Randomization Phase|Withdrawal by Subject|1|||
163878732|NCT04737772|591925197|FG000|Phase 2 Study|Lost to Follow-up|15|||
163878733|NCT04737772|591925198|FG001|Phase 2 Study|Lost to Follow-up|15|||
163878734|NCT04737772|591925197|FG000|Phase 2 Study|Withdrawal by Subject|0|||
163878735|NCT04737772|591925198|FG001|Phase 2 Study|Withdrawal by Subject|1|||
163878736|NCT04737772|591925197|FG000|Phase 2 Study|Did not take any coaching calls|4|||
163878737|NCT04737772|591925198|FG001|Phase 2 Study|Did not take any coaching calls|0|||
163878738|NCT04737772|591925197|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
163982273|NCT01662440|592306454|FG003|Overall Study|Subject moved to another country.|0|||
163878739|NCT04737772|591925198|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
163878740|NCT04737772|591925197|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
163878741|NCT04737772|591925198|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
163878742|NCT02549339|591925199|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
163878743|NCT02549339|591925200|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
163878744|NCT02549339|591925199|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
163878745|NCT02549339|591925200|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
163878746|NCT02549339|591925199|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
163878747|NCT02549339|591925200|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
163982274|NCT01662440|592306451|FG000|Overall Study|Protocol Violation|1|||
164220560|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
164220561|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
164220562|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
164220563|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
164220564|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Death|1|||
164220565|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Death|2|||
164220566|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Death|2|||
164220567|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Death|0|||
164220568|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Death|0|||
164220569|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
164220570|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
164220571|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
164220572|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
164220573|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
164220574|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
164220575|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
164220576|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
164220577|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
164220578|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
164220579|NCT00098293|593175612|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
164220580|NCT00098293|593175613|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220581|NCT00098293|593175614|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220582|NCT00098293|593175615|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220583|NCT00098293|593175616|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
164220584|NCT00098293|593175612|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220585|NCT00098293|593175613|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220586|NCT00098293|593175614|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
164220587|NCT00098293|593175615|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220588|NCT00098293|593175616|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
164220589|NCT00098293|593175612|FG000|Open-label (OL) Phase|Adverse Event|0|||
164220590|NCT00098293|593175613|FG001|Open-label (OL) Phase|Adverse Event|3|||
164220591|NCT00098293|593175614|FG002|Open-label (OL) Phase|Adverse Event|7|||
164220592|NCT00098293|593175615|FG003|Open-label (OL) Phase|Adverse Event|6|||
164220593|NCT00098293|593175616|FG004|Open-label (OL) Phase|Adverse Event|0|||
164220594|NCT00098293|593175612|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
164220595|NCT00098293|593175613|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
164220596|NCT00098293|593175614|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
164220597|NCT00098293|593175615|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
164220598|NCT00098293|593175616|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
164220599|NCT00098293|593175612|FG000|Open-label (OL) Phase|Pregnancy|0|||
164220600|NCT00098293|593175613|FG001|Open-label (OL) Phase|Pregnancy|1|||
164220601|NCT00098293|593175614|FG002|Open-label (OL) Phase|Pregnancy|0|||
164220602|NCT00098293|593175615|FG003|Open-label (OL) Phase|Pregnancy|3|||
164220603|NCT00098293|593175616|FG004|Open-label (OL) Phase|Pregnancy|0|||
164220604|NCT00098293|593175612|FG000|Open-label (OL) Phase|Protocol Violation|0|||
164220605|NCT00098293|593175613|FG001|Open-label (OL) Phase|Protocol Violation|6|||
164220606|NCT00098293|593175614|FG002|Open-label (OL) Phase|Protocol Violation|13|||
164220607|NCT00098293|593175615|FG003|Open-label (OL) Phase|Protocol Violation|16|||
164220608|NCT00098293|593175616|FG004|Open-label (OL) Phase|Protocol Violation|0|||
164220609|NCT00098293|593175612|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
164220610|NCT00098293|593175613|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
164220611|NCT00098293|593175614|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
164220612|NCT00098293|593175615|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
164220613|NCT00098293|593175616|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
164220614|NCT00098293|593175612|FG000|Open-label (OL) Phase|Death|0|||
164220615|NCT00098293|593175613|FG001|Open-label (OL) Phase|Death|2|||
164220616|NCT00098293|593175614|FG002|Open-label (OL) Phase|Death|3|||
164220617|NCT00098293|593175615|FG003|Open-label (OL) Phase|Death|0|||
163878748|NCT02549339|591925199|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
164220618|NCT00098293|593175616|FG004|Open-label (OL) Phase|Death|0|||
164220619|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Death|0|||
164220620|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Death|0|||
164220621|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Death|0|||
163878749|NCT02549339|591925200|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
164220622|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Death|0|||
164220623|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Death|1|||
163878750|NCT02549339|591925199|FG000|12-month Follow-up|Lack of Efficacy|0|||
163878751|NCT02549339|591925200|FG001|12-month Follow-up|Lack of Efficacy|2|||
163878752|NCT02549339|591925199|FG000|12-month Follow-up|Withdrawal by Subject|8|||
163878753|NCT02549339|591925200|FG001|12-month Follow-up|Withdrawal by Subject|3|||
164220624|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220625|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220626|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220627|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
164220628|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
164220629|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220630|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220631|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220632|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
164220633|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
164220634|NCT00098293|593175612|FG000|Supplemental Phase (SP)|Other|0|||
164220635|NCT00098293|593175613|FG001|Supplemental Phase (SP)|Other|0|||
164079203|NCT03342898|592655603|FG001|Overall Study|Adverse Event|1|||
164079204|NCT03342898|592655604|FG002|Overall Study|Adverse Event|0|||
164079205|NCT03342898|592655602|FG000|Overall Study|Lost to Follow-up|44|||
164079206|NCT03342898|592655603|FG001|Overall Study|Lost to Follow-up|40|||
164079207|NCT03342898|592655604|FG002|Overall Study|Lost to Follow-up|42|||
164079208|NCT03342898|592655602|FG000|Overall Study|Withdrawal of Consent|5|||
164079209|NCT03342898|592655603|FG001|Overall Study|Withdrawal of Consent|9|||
164079210|NCT03342898|592655604|FG002|Overall Study|Withdrawal of Consent|11|||
164079211|NCT03342898|592655602|FG000|Overall Study|Death|0|||
164079212|NCT03342898|592655603|FG001|Overall Study|Death|1|||
164079213|NCT03342898|592655604|FG002|Overall Study|Death|1|||
164079214|NCT03342898|592655602|FG000|Overall Study|Reason not Specified|2|||
164079215|NCT03342898|592655603|FG001|Overall Study|Reason not Specified|2|||
164079216|NCT03342898|592655604|FG002|Overall Study|Reason not Specified|0|||
164079217|NCT03997448|592655605|FG000|Study Treatment|Disease Progression|1|||
164079218|NCT03997448|592655605|FG000|Study Treatment|Symptomatic Deterioration|1|||
164079219|NCT03997448|592655605|FG000|Follow up|Death|2|||
164079220|NCT03997448|592655605|FG000|Follow up|study terminated|1|||
164079221|NCT01312779|592655606|FG000|Overall Study|Withdrawal by Subject|2|||
164079222|NCT01312779|592655606|FG000|Overall Study|Death|3|||
164079223|NCT01312779|592655606|FG000|Overall Study|Not Implanted with Device|27|||
164079224|NCT01621490|592655607|FG000|Overall Study|Subject no longer meets study criteria|0|||
164079225|NCT01621490|592655608|FG001|Overall Study|Subject no longer meets study criteria|0|||
164079226|NCT01621490|592655609|FG002|Overall Study|Subject no longer meets study criteria|0|||
164079227|NCT01621490|592655610|FG003|Overall Study|Subject no longer meets study criteria|0|||
164079228|NCT01621490|592655611|FG004|Overall Study|Subject no longer meets study criteria|1|||
164079229|NCT01621490|592655612|FG005|Overall Study|Subject no longer meets study criteria|0|||
164079230|NCT01621490|592655613|FG006|Overall Study|Subject no longer meets study criteria|0|||
164079231|NCT01621490|592655614|FG007|Overall Study|Subject no longer meets study criteria|0|||
164079232|NCT01621490|592655615|FG008|Overall Study|Subject no longer meets study criteria|0|||
164079233|NCT01621490|592655616|FG009|Overall Study|Subject no longer meets study criteria|0|||
163878754|NCT02549339|591925199|FG000|12-month Follow-up|Lost to Follow-up|1|||
163878755|NCT02549339|591925200|FG001|12-month Follow-up|Lost to Follow-up|3|||
164079234|NCT01621490|592655617|FG010|Overall Study|Subject no longer meets study criteria|0|||
164079235|NCT01621490|592655607|FG000|Overall Study|Maximum clinical benefit|3|||
164079236|NCT01621490|592655608|FG001|Overall Study|Maximum clinical benefit|2|||
164079237|NCT01621490|592655609|FG002|Overall Study|Maximum clinical benefit|0|||
164079238|NCT01621490|592655610|FG003|Overall Study|Maximum clinical benefit|0|||
164079239|NCT01621490|592655611|FG004|Overall Study|Maximum clinical benefit|0|||
164079240|NCT01621490|592655612|FG005|Overall Study|Maximum clinical benefit|0|||
164220636|NCT00098293|593175614|FG002|Supplemental Phase (SP)|Other|0|||
164328992|NCT04650854|593581256|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
164079241|NCT01621490|592655613|FG006|Overall Study|Maximum clinical benefit|1|||
164079242|NCT01621490|592655614|FG007|Overall Study|Maximum clinical benefit|2|||
164079243|NCT01621490|592655615|FG008|Overall Study|Maximum clinical benefit|2|||
164079244|NCT01621490|592655616|FG009|Overall Study|Maximum clinical benefit|0|||
164079245|NCT01621490|592655617|FG010|Overall Study|Maximum clinical benefit|0|||
164079246|NCT01621490|592655607|FG000|Overall Study|Withdrawal by Subject|1|||
164079247|NCT01621490|592655608|FG001|Overall Study|Withdrawal by Subject|0|||
164079248|NCT01621490|592655609|FG002|Overall Study|Withdrawal by Subject|0|||
164079249|NCT01621490|592655610|FG003|Overall Study|Withdrawal by Subject|0|||
164079250|NCT01621490|592655611|FG004|Overall Study|Withdrawal by Subject|0|||
164079251|NCT01621490|592655612|FG005|Overall Study|Withdrawal by Subject|1|||
164079252|NCT01621490|592655613|FG006|Overall Study|Withdrawal by Subject|0|||
164079253|NCT01621490|592655614|FG007|Overall Study|Withdrawal by Subject|0|||
164079254|NCT01621490|592655615|FG008|Overall Study|Withdrawal by Subject|0|||
164079255|NCT01621490|592655616|FG009|Overall Study|Withdrawal by Subject|0|||
164079256|NCT01621490|592655617|FG010|Overall Study|Withdrawal by Subject|0|||
164079257|NCT01621490|592655607|FG000|Overall Study|Subject request to discontinue study|1|||
164220637|NCT00098293|593175615|FG003|Supplemental Phase (SP)|Other|0|||
164079258|NCT01621490|592655608|FG001|Overall Study|Subject request to discontinue study|3|||
164079259|NCT01621490|592655609|FG002|Overall Study|Subject request to discontinue study|1|||
164079260|NCT01621490|592655610|FG003|Overall Study|Subject request to discontinue study|1|||
164079261|NCT01621490|592655611|FG004|Overall Study|Subject request to discontinue study|0|||
164220638|NCT00098293|593175616|FG004|Supplemental Phase (SP)|Other|22|||
164328993|NCT04650854|593581257|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
164220639|NCT01968785|593175617|FG000|Overall Study|Withdrawal by Subject|1|||
164220640|NCT01968785|593175618|FG001|Overall Study|Withdrawal by Subject|0|||
164220641|NCT01666314|593175626|FG000|Overall Study|Adverse Event|3|||
164220642|NCT01666314|593175627|FG001|Overall Study|Adverse Event|13|||
164220643|NCT01666314|593175628|FG002|Overall Study|Adverse Event|7|||
164220644|NCT01666314|593175629|FG003|Overall Study|Adverse Event|7|||
164220645|NCT01666314|593175626|FG000|Overall Study|Progressive Disease|11|||
164220646|NCT01666314|593175627|FG001|Overall Study|Progressive Disease|9|||
164220647|NCT01666314|593175628|FG002|Overall Study|Progressive Disease|19|||
164220648|NCT01666314|593175629|FG003|Overall Study|Progressive Disease|20|||
164220649|NCT01666314|593175626|FG000|Overall Study|Symptomatic Deterioration|1|||
164220650|NCT01666314|593175627|FG001|Overall Study|Symptomatic Deterioration|0|||
164220651|NCT01666314|593175628|FG002|Overall Study|Symptomatic Deterioration|2|||
164220652|NCT01666314|593175629|FG003|Overall Study|Symptomatic Deterioration|0|||
164220653|NCT01666314|593175626|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
164220654|NCT01666314|593175627|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
164220655|NCT01666314|593175628|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
164220656|NCT01666314|593175629|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
164220657|NCT01666314|593175626|FG000|Overall Study|Withdrawal by Subject|1|||
164220658|NCT01666314|593175627|FG001|Overall Study|Withdrawal by Subject|1|||
164220659|NCT01666314|593175628|FG002|Overall Study|Withdrawal by Subject|2|||
164220660|NCT01666314|593175629|FG003|Overall Study|Withdrawal by Subject|3|||
164220661|NCT01666314|593175626|FG000|Overall Study|Reason not Specified|10|||
164220662|NCT01666314|593175627|FG001|Overall Study|Reason not Specified|7|||
164220663|NCT01666314|593175628|FG002|Overall Study|Reason not Specified|5|||
164220664|NCT01666314|593175629|FG003|Overall Study|Reason not Specified|5|||
164220665|NCT04739709|593175630|FG000|Overall Study|Physician Decision|1|||
164220666|NCT04739709|593175631|FG001|Overall Study|Physician Decision|0|||
164220667|NCT01452347|593175634|FG000|Overall Study|Adverse Event|2|||
164220668|NCT01452347|593175635|FG001|Overall Study|Adverse Event|1|||
164220669|NCT01452347|593175634|FG000|Overall Study|Non compliance protocol|2|||
164220670|NCT01452347|593175635|FG001|Overall Study|Non compliance protocol|0|||
164220671|NCT01452347|593175634|FG000|Overall Study|Lost to Follow-up|2|||
164220672|NCT01452347|593175635|FG001|Overall Study|Lost to Follow-up|0|||
164220673|NCT01452347|593175634|FG000|Overall Study|Withdrawal by Subject|3|||
164220674|NCT01452347|593175635|FG001|Overall Study|Withdrawal by Subject|3|||
164220675|NCT01452347|593175634|FG000|Overall Study|Not treated|6|||
164220676|NCT01452347|593175635|FG001|Overall Study|Not treated|3|||
164220677|NCT01452347|593175634|FG000|Overall Study|Other reason not defined above|2|||
164220678|NCT01452347|593175635|FG001|Overall Study|Other reason not defined above|0|||
164220679|NCT05762744|593175636|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
164220680|NCT05762744|593175637|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
164220681|NCT05762744|593175636|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
164220682|NCT05762744|593175637|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
164220683|NCT02724644|593177687|FG000|Overall Study|Adverse Event|7|||
164220684|NCT02724644|593177688|FG001|Overall Study|Adverse Event|1|||
164220685|NCT02724644|593177687|FG000|Overall Study|Lost to Follow-up|6|||
164220686|NCT02724644|593177688|FG001|Overall Study|Lost to Follow-up|2|||
164220687|NCT02724644|593177687|FG000|Overall Study|Withdrawal by Subject|7|||
164220688|NCT02724644|593177688|FG001|Overall Study|Withdrawal by Subject|1|||
164220689|NCT02724644|593177687|FG000|Overall Study|Administrative|1|||
164220690|NCT02724644|593177688|FG001|Overall Study|Administrative|0|||
164220691|NCT01882829|593177689|FG000|Overall Study|Adverse Event|4|||
164220692|NCT01882829|593177689|FG000|Overall Study|Protocol Violation|1|||
164220693|NCT01882829|593177689|FG000|Overall Study|Withdrawal by Subject|1|||
164220694|NCT03312114|593177690|FG000|Overall Study|All the five enrolled dropped out of the|5|||
164220695|NCT01245751|593177698|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
164220696|NCT01245751|593177699|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
164220697|NCT01245751|593177700|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
164220698|NCT01245751|593177701|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
164220699|NCT01245751|593177698|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
164220700|NCT01245751|593177699|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
164220701|NCT01245751|593177700|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
164220702|NCT01245751|593177701|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
164220703|NCT01245751|593177698|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
164220704|NCT01245751|593177699|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
164220705|NCT01245751|593177700|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
164220706|NCT01245751|593177701|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
164220707|NCT02391584|593177707|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
164220708|NCT02391584|593177708|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
164220709|NCT02391584|593177707|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
164220710|NCT02391584|593177708|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
164220711|NCT02391584|593177707|FG000|3 Month|Lost to Follow-up|1|||
164220712|NCT02391584|593177708|FG001|3 Month|Lost to Follow-up|0|||
164220713|NCT02391584|593177707|FG000|6 Month|Withdrawal by Subject|1|||
164220714|NCT02391584|593177708|FG001|6 Month|Withdrawal by Subject|0|||
164220715|NCT02391584|593177707|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
164220716|NCT02391584|593177708|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
164220717|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
164220718|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
164220719|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
164220720|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
164220721|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
164220722|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
164220723|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
164220724|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220725|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220726|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
164220727|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
164220728|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
164220729|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Other|6|||
164220730|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Other|3|||
164220731|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Other|0|||
164220732|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
164220733|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164220734|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164220735|NCT03636269|593177709|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
164220736|NCT03636269|593177710|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
164220737|NCT03636269|593177711|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
164220738|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Adverse Event|0|||
164220739|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Adverse Event|0|||
164220740|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Adverse Event|21|||
164220741|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
164220742|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
164220743|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
164220744|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220745|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
164220746|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
164220747|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
164220748|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
164220749|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
164220750|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Administrative|0|||
164220751|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Administrative|0|||
164220752|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Administrative|36|||
164220753|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Other|0|||
164220754|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Other|0|||
164220755|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Other|9|||
164220756|NCT03636269|593177709|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
164220757|NCT03636269|593177710|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
164220758|NCT03636269|593177711|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
164220759|NCT02852434|593177727|FG000|Overall Study|Withdrawal by Subject|0|||
164220760|NCT02852434|593177728|FG001|Overall Study|Withdrawal by Subject|1|||
163982275|NCT01662440|592306452|FG001|Overall Study|Protocol Violation|0|||
164220761|NCT02852434|593177727|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
164220762|NCT02852434|593177728|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
164220763|NCT03188705|593177731|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
164220764|NCT03188705|593177731|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
164220765|NCT03774810|593177732|FG000|Phase 1|Lack of Efficacy|21|||
164220766|NCT03774810|593177733|FG001|Phase 1|Lack of Efficacy|0|||
164220767|NCT03774810|593177734|FG002|Phase 1|Lack of Efficacy|0|||
163982276|NCT01662440|592306453|FG002|Overall Study|Protocol Violation|0|||
164220768|NCT03774810|593177735|FG003|Phase 1|Lack of Efficacy|0|||
164220769|NCT03774810|593177736|FG004|Phase 1|Lack of Efficacy|0|||
164220770|NCT03774810|593177732|FG000|Phase 1|Withdrawal by Subject|9|||
164220771|NCT03774810|593177733|FG001|Phase 1|Withdrawal by Subject|0|||
164220772|NCT03774810|593177734|FG002|Phase 1|Withdrawal by Subject|0|||
164220773|NCT03774810|593177735|FG003|Phase 1|Withdrawal by Subject|0|||
164220774|NCT03774810|593177736|FG004|Phase 1|Withdrawal by Subject|0|||
164220775|NCT03774810|593177732|FG000|Phase 1|Lost to Follow-up|2|||
164220776|NCT03774810|593177733|FG001|Phase 1|Lost to Follow-up|0|||
164220777|NCT03774810|593177734|FG002|Phase 1|Lost to Follow-up|0|||
164220778|NCT03774810|593177735|FG003|Phase 1|Lost to Follow-up|0|||
164220779|NCT03774810|593177736|FG004|Phase 1|Lost to Follow-up|0|||
164220780|NCT03774810|593177732|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
164220781|NCT03774810|593177733|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
164220782|NCT03774810|593177734|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
164220783|NCT03774810|593177735|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
164220784|NCT03774810|593177736|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
164220785|NCT03774810|593177732|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
164220786|NCT03774810|593177733|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
164220787|NCT03774810|593177734|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
164220788|NCT03774810|593177735|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
164220789|NCT03774810|593177736|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
164220790|NCT03774810|593177732|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220791|NCT03774810|593177733|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
164220792|NCT03774810|593177734|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220793|NCT03774810|593177735|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220794|NCT03774810|593177736|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
164220795|NCT03774810|593177732|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
164220796|NCT03774810|593177733|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
164220797|NCT03774810|593177734|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
164220798|NCT03774810|593177735|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
164220799|NCT03774810|593177736|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
164220800|NCT03774810|593177732|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
164220801|NCT03774810|593177733|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
163878756|NCT02549339|591925199|FG000|12-month Follow-up|Other|0|||
163878757|NCT02549339|591925200|FG001|12-month Follow-up|Other|3|||
163878758|NCT05415410|591925201|FG000|Overall Study|Death|3|||
163878759|NCT05415410|591925202|FG001|Overall Study|Death|6|||
163878760|NCT05415410|591925203|FG002|Overall Study|Death|1|||
163878761|NCT05415410|591925201|FG000|Overall Study|Trial Terminated by Sponsor|1|||
163878762|NCT05415410|591925202|FG001|Overall Study|Trial Terminated by Sponsor|5|||
163878763|NCT05415410|591925203|FG002|Overall Study|Trial Terminated by Sponsor|0|||
163878764|NCT05415410|591925201|FG000|Overall Study|Adverse Event|2|||
163878765|NCT05415410|591925202|FG001|Overall Study|Adverse Event|1|||
163878766|NCT05415410|591925203|FG002|Overall Study|Adverse Event|0|||
163878767|NCT05415410|591925201|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
163878768|NCT05415410|591925202|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
163878769|NCT05415410|591925203|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
163878770|NCT05415410|591925201|FG000|Overall Study|Withdrawal by Subject|1|||
163878771|NCT05415410|591925202|FG001|Overall Study|Withdrawal by Subject|0|||
163878772|NCT05415410|591925203|FG002|Overall Study|Withdrawal by Subject|0|||
163878773|NCT05415410|591925201|FG000|Overall Study|Pregnancy|5|||
163878774|NCT05415410|591925202|FG001|Overall Study|Pregnancy|2|||
163878775|NCT05415410|591925203|FG002|Overall Study|Pregnancy|0|||
163878776|NCT02365766|591925204|FG000|Overall Study|Withdrawal by Subject|0|||
163878777|NCT02365766|591925205|FG001|Overall Study|Withdrawal by Subject|0|||
163878778|NCT02365766|591925206|FG002|Overall Study|Withdrawal by Subject|1|||
163878779|NCT02365766|591925204|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163878780|NCT02365766|591925205|FG001|Overall Study|Eligibility Criteria Not Met|0|||
163878781|NCT02365766|591925206|FG002|Overall Study|Eligibility Criteria Not Met|1|||
163878782|NCT02724956|591925211|FG000|Overall Study|Physician Decision|1|||
163878783|NCT02724956|591925212|FG001|Overall Study|Physician Decision|0|||
163878784|NCT02724956|591925211|FG000|Overall Study|Lack of Efficacy|0|||
163878785|NCT02724956|591925212|FG001|Overall Study|Lack of Efficacy|1|||
163878786|NCT02724956|591925211|FG000|Overall Study|Withdrawal by Subject|0|||
163878787|NCT02724956|591925212|FG001|Overall Study|Withdrawal by Subject|1|||
163878788|NCT04600752|591925218|FG000|Overall Study|Physician Decision|0|||
164220802|NCT03774810|593177734|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
164220803|NCT03774810|593177735|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
163878789|NCT04600752|591925219|FG001|Overall Study|Physician Decision|0|||
163878790|NCT04600752|591925220|FG002|Overall Study|Physician Decision|1|||
163878791|NCT04600752|591925218|FG000|Overall Study|Adverse Event|0|||
163878792|NCT04600752|591925219|FG001|Overall Study|Adverse Event|1|||
163878793|NCT04600752|591925220|FG002|Overall Study|Adverse Event|0|||
164220804|NCT03774810|593177736|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
164220805|NCT03774810|593177732|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
164220806|NCT03774810|593177733|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
164220807|NCT03774810|593177734|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
164220808|NCT03774810|593177735|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
164220809|NCT03774810|593177736|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
164220810|NCT01145222|593177739|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
164220811|NCT01145222|593177740|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
164220812|NCT01145222|593177741|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
164220813|NCT01145222|593177742|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
164220814|NCT01145222|593177739|FG000|Overall Study|Poor bowel preparation|0|||
164220815|NCT01145222|593177740|FG001|Overall Study|Poor bowel preparation|0|||
164220816|NCT01145222|593177741|FG002|Overall Study|Poor bowel preparation|0|||
164220817|NCT01145222|593177742|FG003|Overall Study|Poor bowel preparation|1|||
164328994|NCT04650854|593581255|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
164328995|NCT04650854|593581256|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
164328996|NCT04650854|593581257|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
164328997|NCT04650854|593581255|FG000|Overall Study|Use of Rescue Medication|0|||
164328998|NCT04650854|593581256|FG001|Overall Study|Use of Rescue Medication|0|||
164328999|NCT04650854|593581257|FG002|Overall Study|Use of Rescue Medication|1|||
164329000|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Sponsor|0|||
164329001|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Sponsor|0|||
164329002|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Sponsor|2|||
164329003|NCT04650854|593581255|FG000|Overall Study|Rescue Medication|0|||
164329004|NCT04650854|593581256|FG001|Overall Study|Rescue Medication|0|||
164329005|NCT04650854|593581257|FG002|Overall Study|Rescue Medication|1|||
164329006|NCT04650854|593581255|FG000|Overall Study|Participant Want to Start a Family|0|||
164329007|NCT04650854|593581256|FG001|Overall Study|Participant Want to Start a Family|0|||
164329008|NCT04650854|593581257|FG002|Overall Study|Participant Want to Start a Family|1|||
164329009|NCT04650854|593581255|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
164329010|NCT04650854|593581256|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
164329011|NCT04650854|593581257|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
164329012|NCT04650854|593581255|FG000|Overall Study|Participant Screened For MG0020|0|||
164329013|NCT04650854|593581256|FG001|Overall Study|Participant Screened For MG0020|2|||
164329014|NCT04650854|593581257|FG002|Overall Study|Participant Screened For MG0020|3|||
164329015|NCT04650854|593581255|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
164329016|NCT04650854|593581256|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
164329017|NCT04650854|593581257|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
164329018|NCT04650854|593581255|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
164329019|NCT04650854|593581256|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
164329020|NCT04650854|593581257|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
164329021|NCT04650854|593581255|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
164329022|NCT04650854|593581256|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
164329023|NCT04650854|593581257|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
164329024|NCT04650854|593581255|FG000|Overall Study|End Of Study|0|||
164329025|NCT04650854|593581256|FG001|Overall Study|End Of Study|2|||
163878794|NCT04600752|591925218|FG000|Overall Study|Withdrawal by Subject|2|||
163878795|NCT04600752|591925219|FG001|Overall Study|Withdrawal by Subject|1|||
163878796|NCT04600752|591925220|FG002|Overall Study|Withdrawal by Subject|0|||
163878797|NCT04600752|591925218|FG000|Overall Study|Lack of Efficacy|1|||
163878798|NCT04600752|591925219|FG001|Overall Study|Lack of Efficacy|0|||
163878799|NCT04600752|591925220|FG002|Overall Study|Lack of Efficacy|0|||
163878800|NCT04436107|591925221|FG000|Overall Study|Sponsor Ended Study|2|||
163878801|NCT04436107|591925222|FG001|Overall Study|Sponsor Ended Study|4|||
163878802|NCT04436107|591925223|FG002|Overall Study|Sponsor Ended Study|8|||
163878803|NCT04436107|591925224|FG003|Overall Study|Sponsor Ended Study|20|||
163878804|NCT04436107|591925221|FG000|Overall Study|Death|3|||
163878805|NCT04436107|591925222|FG001|Overall Study|Death|5|||
163878806|NCT04436107|591925223|FG002|Overall Study|Death|3|||
163878807|NCT04436107|591925224|FG003|Overall Study|Death|18|||
163878808|NCT04436107|591925221|FG000|Overall Study|Withdrawal by Subject|1|||
163878809|NCT04436107|591925222|FG001|Overall Study|Withdrawal by Subject|1|||
163878810|NCT04436107|591925223|FG002|Overall Study|Withdrawal by Subject|0|||
163878811|NCT04436107|591925224|FG003|Overall Study|Withdrawal by Subject|1|||
163982277|NCT01662440|592306454|FG003|Overall Study|Protocol Violation|0|||
163982278|NCT01662440|592306451|FG000|Overall Study|Withdrawal by Subject|5|||
164329026|NCT04650854|593581257|FG002|Overall Study|End Of Study|1|||
163878812|NCT00604669|591925233|FG000|Overall Study|lack of information in chart|7|||
163878813|NCT00274469|591925239|FG000|Overall Study|Death|63|||
163878814|NCT00274469|591925240|FG001|Overall Study|Death|74|||
163878815|NCT00274469|591925239|FG000|Overall Study|Did not consent to OS follow-up|16|||
163878816|NCT00274469|591925240|FG001|Overall Study|Did not consent to OS follow-up|19|||
163982279|NCT01662440|592306452|FG001|Overall Study|Withdrawal by Subject|2|||
163982280|NCT01662440|592306453|FG002|Overall Study|Withdrawal by Subject|2|||
163878817|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
163878818|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
163878819|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
163878820|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
163878821|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
163878822|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
163878823|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
163878824|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
163878825|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
163878826|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
163878827|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
163878828|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
163878829|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
163878830|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
163878831|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
163878832|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
163878833|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
163878834|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
164079262|NCT01621490|592655612|FG005|Overall Study|Subject request to discontinue study|2|||
164079263|NCT01621490|592655613|FG006|Overall Study|Subject request to discontinue study|1|||
163878835|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
163878836|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
163878837|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
163878838|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
164079264|NCT01621490|592655614|FG007|Overall Study|Subject request to discontinue study|0|||
164079265|NCT01621490|592655615|FG008|Overall Study|Subject request to discontinue study|1|||
164079266|NCT01621490|592655616|FG009|Overall Study|Subject request to discontinue study|0|||
164079267|NCT01621490|592655617|FG010|Overall Study|Subject request to discontinue study|0|||
164079268|NCT01621490|592655607|FG000|Overall Study|Adverse event unrelated to study drug|1|||
164079269|NCT01621490|592655608|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164079270|NCT01621490|592655609|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164079271|NCT01621490|592655610|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164079272|NCT01621490|592655611|FG004|Overall Study|Adverse event unrelated to study drug|0|||
164079273|NCT01621490|592655612|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164079274|NCT01621490|592655613|FG006|Overall Study|Adverse event unrelated to study drug|0|||
164079275|NCT01621490|592655614|FG007|Overall Study|Adverse event unrelated to study drug|2|||
164079276|NCT01621490|592655615|FG008|Overall Study|Adverse event unrelated to study drug|0|||
164079277|NCT01621490|592655616|FG009|Overall Study|Adverse event unrelated to study drug|0|||
164079278|NCT01621490|592655617|FG010|Overall Study|Adverse event unrelated to study drug|0|||
164079279|NCT01621490|592655607|FG000|Overall Study|Disease progression|27|||
164079280|NCT01621490|592655608|FG001|Overall Study|Disease progression|28|||
164079281|NCT01621490|592655609|FG002|Overall Study|Disease progression|1|||
164079282|NCT01621490|592655610|FG003|Overall Study|Disease progression|5|||
164079283|NCT01621490|592655611|FG004|Overall Study|Disease progression|3|||
164079284|NCT01621490|592655612|FG005|Overall Study|Disease progression|8|||
164079285|NCT01621490|592655613|FG006|Overall Study|Disease progression|7|||
164079286|NCT01621490|592655614|FG007|Overall Study|Disease progression|1|||
164079287|NCT01621490|592655615|FG008|Overall Study|Disease progression|4|||
164079288|NCT01621490|592655616|FG009|Overall Study|Disease progression|1|||
164079289|NCT01621490|592655617|FG010|Overall Study|Disease progression|1|||
164079290|NCT01621490|592655607|FG000|Overall Study|Study drug toxicity|1|||
164079291|NCT01621490|592655608|FG001|Overall Study|Study drug toxicity|4|||
164079292|NCT01621490|592655609|FG002|Overall Study|Study drug toxicity|5|||
164079293|NCT01621490|592655610|FG003|Overall Study|Study drug toxicity|3|||
164079294|NCT01621490|592655611|FG004|Overall Study|Study drug toxicity|1|||
164079295|NCT01621490|592655612|FG005|Overall Study|Study drug toxicity|10|||
164079296|NCT01621490|592655613|FG006|Overall Study|Study drug toxicity|1|||
164079297|NCT01621490|592655614|FG007|Overall Study|Study drug toxicity|4|||
164079298|NCT01621490|592655615|FG008|Overall Study|Study drug toxicity|1|||
164079299|NCT01621490|592655616|FG009|Overall Study|Study drug toxicity|0|||
164079300|NCT01621490|592655617|FG010|Overall Study|Study drug toxicity|0|||
164079301|NCT01621490|592655607|FG000|Overall Study|Death|0|||
164079302|NCT01621490|592655608|FG001|Overall Study|Death|0|||
163878839|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
164079303|NCT01621490|592655609|FG002|Overall Study|Death|0|||
164079304|NCT01621490|592655610|FG003|Overall Study|Death|0|||
164079305|NCT01621490|592655611|FG004|Overall Study|Death|0|||
164079306|NCT01621490|592655612|FG005|Overall Study|Death|0|||
164079307|NCT01621490|592655613|FG006|Overall Study|Death|0|||
164079308|NCT01621490|592655614|FG007|Overall Study|Death|0|||
164079309|NCT01621490|592655615|FG008|Overall Study|Death|1|||
164079310|NCT01621490|592655616|FG009|Overall Study|Death|0|||
164220818|NCT00927186|593177743|FG000|12 Months Primary Study|Adverse Event|5|||
164220819|NCT00927186|593177744|FG001|12 Months Primary Study|Adverse Event|2|||
164220820|NCT00927186|593177743|FG000|12 Months Primary Study|Lost to Follow-up|1|||
164220821|NCT00927186|593177744|FG001|12 Months Primary Study|Lost to Follow-up|0|||
164220822|NCT00927186|593177743|FG000|12 Months Primary Study|Protocol Violation|0|||
164220823|NCT00927186|593177744|FG001|12 Months Primary Study|Protocol Violation|1|||
164220824|NCT00927186|593177743|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
164220825|NCT00927186|593177744|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
164220826|NCT00604383|593177745|FG000|Overall Study|Withdrawal by Subject|33|||
164220827|NCT00604383|593177746|FG001|Overall Study|Withdrawal by Subject|31|||
164220828|NCT00604383|593177745|FG000|Overall Study|Lost to Follow-up|24|||
164220829|NCT00604383|593177746|FG001|Overall Study|Lost to Follow-up|19|||
164220830|NCT00604383|593177745|FG000|Overall Study|Death|14|||
164220831|NCT00604383|593177746|FG001|Overall Study|Death|22|||
164220832|NCT00604383|593177745|FG000|Overall Study|Adverse Event|16|||
164220833|NCT00604383|593177746|FG001|Overall Study|Adverse Event|9|||
164220834|NCT00604383|593177745|FG000|Overall Study|Physician Decision|0|||
164220835|NCT00604383|593177746|FG001|Overall Study|Physician Decision|3|||
164220836|NCT04985682|593177748|FG000|Overall Study|Withdrawal by Subject|1|||
164220837|NCT03016403|593177751|FG000|Baseline|Death|5|||
164220838|NCT03016403|593177752|FG001|Baseline|Death|8|||
164220839|NCT03016403|593177753|FG002|Baseline|Death|1|||
164220840|NCT03016403|593177754|FG003|Baseline|Death|0|||
164220841|NCT03016403|593177751|FG000|Baseline|Withdrawal by Subject|2|||
164220842|NCT03016403|593177752|FG001|Baseline|Withdrawal by Subject|8|||
164220843|NCT03016403|593177753|FG002|Baseline|Withdrawal by Subject|4|||
164220844|NCT03016403|593177754|FG003|Baseline|Withdrawal by Subject|10|||
164220845|NCT03016403|593177751|FG000|Baseline|Lost to Follow-up|9|||
164220846|NCT03016403|593177752|FG001|Baseline|Lost to Follow-up|11|||
164220847|NCT03016403|593177753|FG002|Baseline|Lost to Follow-up|6|||
164220848|NCT03016403|593177754|FG003|Baseline|Lost to Follow-up|24|||
164220849|NCT03016403|593177751|FG000|6-week Follow-up|Death|1|||
164220850|NCT03016403|593177752|FG001|6-week Follow-up|Death|4|||
164220851|NCT03016403|593177753|FG002|6-week Follow-up|Death|0|||
164220852|NCT03016403|593177754|FG003|6-week Follow-up|Death|0|||
164220853|NCT03016403|593177751|FG000|6-week Follow-up|Lost to Follow-up|2|||
164220854|NCT03016403|593177752|FG001|6-week Follow-up|Lost to Follow-up|7|||
164220855|NCT03016403|593177753|FG002|6-week Follow-up|Lost to Follow-up|4|||
164220856|NCT03016403|593177754|FG003|6-week Follow-up|Lost to Follow-up|8|||
164220857|NCT03016403|593177751|FG000|6-week Follow-up|Withdrawal by Subject|0|||
164220858|NCT03016403|593177752|FG001|6-week Follow-up|Withdrawal by Subject|2|||
164220859|NCT03016403|593177753|FG002|6-week Follow-up|Withdrawal by Subject|0|||
164220860|NCT03016403|593177754|FG003|6-week Follow-up|Withdrawal by Subject|1|||
164220861|NCT03016403|593177751|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
164220862|NCT03016403|593177752|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
164220863|NCT03016403|593177753|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
164220864|NCT03016403|593177754|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
164220865|NCT03016403|593177751|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
164220866|NCT03016403|593177752|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
164220867|NCT03016403|593177753|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
164220868|NCT03016403|593177754|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
164220869|NCT03016403|593177751|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
164220870|NCT03016403|593177752|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
164220871|NCT03016403|593177753|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
164220872|NCT03016403|593177754|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
164220873|NCT00799864|593177755|FG000|Overall Study|Participant reached a virologic endpoint|9|||
164220874|NCT00799864|593177756|FG001|Overall Study|Participant reached a virologic endpoint|2|||
164220875|NCT00799864|593177757|FG002|Overall Study|Participant reached a virologic endpoint|2|||
164220876|NCT00799864|593177758|FG003|Overall Study|Participant reached a virologic endpoint|0|||
163878840|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
163878841|NCT03338816|591925246|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
163878842|NCT03338816|591925247|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
163878843|NCT03338816|591925248|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
163878844|NCT03338816|591925249|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
163878845|NCT04999592|591925250|FG000|Overall Study|Withdrawal by Subject|1|||
163878846|NCT04999592|591925251|FG001|Overall Study|Withdrawal by Subject|0|||
164079311|NCT01621490|592655617|FG010|Overall Study|Death|0|||
164079312|NCT01621490|592655607|FG000|Overall Study|Other reasons|7|||
164220877|NCT00799864|593177759|FG004|Overall Study|Participant reached a virologic endpoint|0|||
164220878|NCT00799864|593177755|FG000|Overall Study|Other|2|||
164220879|NCT00799864|593177756|FG001|Overall Study|Other|1|||
164220880|NCT00799864|593177757|FG002|Overall Study|Other|0|||
164220881|NCT00799864|593177758|FG003|Overall Study|Other|0|||
164220882|NCT00799864|593177759|FG004|Overall Study|Other|0|||
164220883|NCT00576407|593177760|FG000|Overall Study|Death|7|||
164220884|NCT00576407|593177760|FG000|Overall Study|Physician Decision|1|||
164220885|NCT00621322|593177761|FG000|Overall Study|Lost to Follow-up|0|||
164220886|NCT00621322|593177762|FG001|Overall Study|Lost to Follow-up|0|||
164220887|NCT00621322|593177763|FG002|Overall Study|Lost to Follow-up|0|||
164220888|NCT00621322|593177764|FG003|Overall Study|Lost to Follow-up|0|||
164220889|NCT00621322|593177765|FG004|Overall Study|Lost to Follow-up|1|||
164220890|NCT00621322|593177766|FG005|Overall Study|Lost to Follow-up|0|||
164220891|NCT00621322|593177761|FG000|Overall Study|Physician Decision|0|||
164220892|NCT00621322|593177762|FG001|Overall Study|Physician Decision|0|||
164220893|NCT00621322|593177763|FG002|Overall Study|Physician Decision|1|||
164220894|NCT00621322|593177764|FG003|Overall Study|Physician Decision|1|||
164220895|NCT00621322|593177765|FG004|Overall Study|Physician Decision|0|||
164220896|NCT00621322|593177766|FG005|Overall Study|Physician Decision|0|||
164220897|NCT00621322|593177761|FG000|Overall Study|Withdrawal by Subject|0|||
164220898|NCT00621322|593177762|FG001|Overall Study|Withdrawal by Subject|0|||
164220899|NCT00621322|593177763|FG002|Overall Study|Withdrawal by Subject|0|||
164220900|NCT00621322|593177764|FG003|Overall Study|Withdrawal by Subject|1|||
164220901|NCT00621322|593177765|FG004|Overall Study|Withdrawal by Subject|0|||
164220902|NCT00621322|593177766|FG005|Overall Study|Withdrawal by Subject|2|||
164220903|NCT00621322|593177761|FG000|Overall Study|Migrated/moved from study area|1|||
164220904|NCT00621322|593177762|FG001|Overall Study|Migrated/moved from study area|0|||
164220905|NCT00621322|593177763|FG002|Overall Study|Migrated/moved from study area|1|||
164220906|NCT00621322|593177764|FG003|Overall Study|Migrated/moved from study area|1|||
164220907|NCT00621322|593177765|FG004|Overall Study|Migrated/moved from study area|0|||
164220908|NCT00621322|593177766|FG005|Overall Study|Migrated/moved from study area|2|||
164220909|NCT00225758|593177767|FG000|Overall Study|Adverse Event|4|||
164220910|NCT04641975|593177768|FG000|Overall Study|Protocol Violation|1|||
164220911|NCT04641975|593177769|FG001|Overall Study|Protocol Violation|2|||
164220912|NCT04641975|593177770|FG002|Overall Study|Protocol Violation|0|||
164220913|NCT04641975|593177771|FG003|Overall Study|Protocol Violation|0|||
164220914|NCT04641975|593177768|FG000|Overall Study|Adverse Event|0|||
164220915|NCT04641975|593177769|FG001|Overall Study|Adverse Event|0|||
164220916|NCT04641975|593177770|FG002|Overall Study|Adverse Event|1|||
164220917|NCT04641975|593177771|FG003|Overall Study|Adverse Event|1|||
164220918|NCT04641975|593177768|FG000|Overall Study|Withdrawal by Subject|1|||
164220919|NCT04641975|593177769|FG001|Overall Study|Withdrawal by Subject|0|||
164220920|NCT04641975|593177770|FG002|Overall Study|Withdrawal by Subject|0|||
164220921|NCT04641975|593177771|FG003|Overall Study|Withdrawal by Subject|0|||
164220922|NCT05587998|593177777|FG000|Overall Study|Withdrawal by Subject|1|||
164220923|NCT05587998|593177778|FG001|Overall Study|Withdrawal by Subject|1|||
164220924|NCT05587998|593177777|FG000|Overall Study|Not treated|3|||
164220925|NCT05587998|593177778|FG001|Overall Study|Not treated|1|||
164220926|NCT05587998|593177777|FG000|Overall Study|Non-compliance with study procedures|0|||
164220927|NCT05587998|593177778|FG001|Overall Study|Non-compliance with study procedures|1|||
164220928|NCT03528577|593177781|FG000|Sequence 1|Failed Spirometry|1|||
164220929|NCT03528577|593177781|FG000|Sequence 1|Restricted medication|1|||
164220930|NCT03528577|593177781|FG000|Sequence 2|Adverse Event|1|||
164220931|NCT03528577|593177781|FG000|Sequence 2|Withdrawal by Subject|1|||
164220932|NCT03528577|593177781|FG000|Sequence 2|Failed Spirometry|1|||
164220933|NCT03528577|593177781|FG000|Sequence 3|Failed Spirometry|1|||
164220934|NCT03528577|593177781|FG000|Sequence 4|Failed Spirometry|2|||
164220935|NCT03528577|593177781|FG000|Sequence 4|Adverse Event|1|||
164220936|NCT00601107|593177782|FG000|Overall Study|Adverse Event|0|||
164220937|NCT00601107|593177783|FG001|Overall Study|Adverse Event|1|||
164220938|NCT00601107|593177784|FG002|Overall Study|Adverse Event|3|||
164220939|NCT00601107|593177785|FG003|Overall Study|Adverse Event|0|||
164220940|NCT00601107|593177782|FG000|Overall Study|Withdrawal by Subject|5|||
164220941|NCT00601107|593177783|FG001|Overall Study|Withdrawal by Subject|4|||
164220942|NCT00601107|593177784|FG002|Overall Study|Withdrawal by Subject|7|||
164220943|NCT00601107|593177785|FG003|Overall Study|Withdrawal by Subject|4|||
164220944|NCT00601107|593177782|FG000|Overall Study|Lost to Follow-up|3|||
164329027|NCT04650854|593581255|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
164329028|NCT04650854|593581256|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
163878847|NCT02671435|591925252|FG000|Overall Study|Death|1|||
164079313|NCT01621490|592655608|FG001|Overall Study|Other reasons|6|||
164220945|NCT00601107|593177783|FG001|Overall Study|Lost to Follow-up|3|||
164220946|NCT00601107|593177784|FG002|Overall Study|Lost to Follow-up|0|||
164220947|NCT00601107|593177785|FG003|Overall Study|Lost to Follow-up|3|||
164220948|NCT00601107|593177782|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
164220949|NCT00601107|593177783|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
164220950|NCT00601107|593177784|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
164220951|NCT00601107|593177785|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
164220952|NCT00601107|593177782|FG000|Overall Study|Worsening of Psoriasis|4|||
164220953|NCT00601107|593177783|FG001|Overall Study|Worsening of Psoriasis|1|||
164220954|NCT00601107|593177784|FG002|Overall Study|Worsening of Psoriasis|1|||
164220955|NCT00601107|593177785|FG003|Overall Study|Worsening of Psoriasis|4|||
164220956|NCT00601107|593177782|FG000|Overall Study|Undefined|1|||
163878848|NCT02671435|591925253|FG001|Overall Study|Death|3|||
163878849|NCT02671435|591925254|FG002|Overall Study|Death|0|||
163878850|NCT02671435|591925255|FG003|Overall Study|Death|16|||
163878851|NCT02671435|591925256|FG004|Overall Study|Death|14|||
163878852|NCT02671435|591925257|FG005|Overall Study|Death|29|||
163878853|NCT02671435|591925258|FG006|Overall Study|Death|34|||
163878854|NCT02671435|591925259|FG007|Overall Study|Death|28|||
163878855|NCT02671435|591925260|FG008|Overall Study|Death|19|||
163878856|NCT02671435|591925261|FG009|Overall Study|Death|10|||
163878857|NCT02671435|591925262|FG010|Overall Study|Death|8|||
163878858|NCT02671435|591925263|FG011|Overall Study|Death|29|||
163878859|NCT02671435|591925264|FG012|Overall Study|Death|29|||
163878860|NCT02671435|591925265|FG013|Overall Study|Death|29|||
163878861|NCT02671435|591925266|FG014|Overall Study|Death|27|||
163878862|NCT02671435|591925252|FG000|Overall Study|Lost to Follow-up|0|||
163878863|NCT02671435|591925253|FG001|Overall Study|Lost to Follow-up|0|||
163878864|NCT02671435|591925254|FG002|Overall Study|Lost to Follow-up|1|||
163878865|NCT02671435|591925255|FG003|Overall Study|Lost to Follow-up|0|||
163878866|NCT02671435|591925256|FG004|Overall Study|Lost to Follow-up|1|||
163878867|NCT02671435|591925257|FG005|Overall Study|Lost to Follow-up|1|||
163878868|NCT02671435|591925258|FG006|Overall Study|Lost to Follow-up|2|||
163878869|NCT02671435|591925259|FG007|Overall Study|Lost to Follow-up|2|||
163878870|NCT02671435|591925260|FG008|Overall Study|Lost to Follow-up|0|||
163878871|NCT02671435|591925261|FG009|Overall Study|Lost to Follow-up|2|||
163878872|NCT02671435|591925262|FG010|Overall Study|Lost to Follow-up|0|||
163878873|NCT02671435|591925263|FG011|Overall Study|Lost to Follow-up|3|||
163878874|NCT02671435|591925264|FG012|Overall Study|Lost to Follow-up|3|||
163878875|NCT02671435|591925265|FG013|Overall Study|Lost to Follow-up|2|||
163878876|NCT02671435|591925266|FG014|Overall Study|Lost to Follow-up|0|||
163878877|NCT02671435|591925252|FG000|Overall Study|Withdrawal by Subject|2|||
163878878|NCT02671435|591925253|FG001|Overall Study|Withdrawal by Subject|0|||
163878879|NCT02671435|591925254|FG002|Overall Study|Withdrawal by Subject|2|||
163878880|NCT02671435|591925255|FG003|Overall Study|Withdrawal by Subject|2|||
163878881|NCT02671435|591925256|FG004|Overall Study|Withdrawal by Subject|2|||
163878882|NCT02671435|591925257|FG005|Overall Study|Withdrawal by Subject|7|||
163878883|NCT02671435|591925258|FG006|Overall Study|Withdrawal by Subject|2|||
163878884|NCT02671435|591925259|FG007|Overall Study|Withdrawal by Subject|7|||
163878885|NCT02671435|591925260|FG008|Overall Study|Withdrawal by Subject|1|||
163878886|NCT02671435|591925261|FG009|Overall Study|Withdrawal by Subject|1|||
163878887|NCT02671435|591925262|FG010|Overall Study|Withdrawal by Subject|2|||
163878888|NCT02671435|591925263|FG011|Overall Study|Withdrawal by Subject|4|||
163878889|NCT02671435|591925264|FG012|Overall Study|Withdrawal by Subject|4|||
163878890|NCT02671435|591925265|FG013|Overall Study|Withdrawal by Subject|4|||
163878891|NCT02671435|591925266|FG014|Overall Study|Withdrawal by Subject|2|||
163878892|NCT02671435|591925252|FG000|Overall Study|Un-specified|0|||
163878893|NCT02671435|591925253|FG001|Overall Study|Un-specified|0|||
163878894|NCT02671435|591925254|FG002|Overall Study|Un-specified|0|||
163878895|NCT02671435|591925255|FG003|Overall Study|Un-specified|0|||
163878896|NCT02671435|591925256|FG004|Overall Study|Un-specified|1|||
163878897|NCT02671435|591925257|FG005|Overall Study|Un-specified|3|||
163878898|NCT02671435|591925258|FG006|Overall Study|Un-specified|2|||
163878899|NCT02671435|591925259|FG007|Overall Study|Un-specified|3|||
163878900|NCT02671435|591925260|FG008|Overall Study|Un-specified|0|||
163878901|NCT02671435|591925261|FG009|Overall Study|Un-specified|5|||
163878902|NCT02671435|591925262|FG010|Overall Study|Un-specified|8|||
163878903|NCT02671435|591925263|FG011|Overall Study|Un-specified|4|||
163878904|NCT02671435|591925264|FG012|Overall Study|Un-specified|5|||
163878905|NCT02671435|591925265|FG013|Overall Study|Un-specified|9|||
163878906|NCT02671435|591925266|FG014|Overall Study|Un-specified|8|||
163878907|NCT04128319|591925269|FG000|Overall Study|Death|3|||
163878908|NCT00976937|591925270|FG000|Overall Study|Adverse Event|4|||
163878909|NCT00976937|591925271|FG001|Overall Study|Adverse Event|5|||
163878910|NCT00976937|591925270|FG000|Overall Study|Lost to Follow-up|2|||
163878911|NCT00976937|591925271|FG001|Overall Study|Lost to Follow-up|1|||
163878912|NCT00976937|591925270|FG000|Overall Study|Withdrawal by Subject|5|||
164079314|NCT01621490|592655609|FG002|Overall Study|Other reasons|4|||
164329029|NCT04650854|593581257|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
164329030|NCT04650854|593581255|FG000|Overall Study|Participant Received Rescue Medication|0|||
164329031|NCT04650854|593581256|FG001|Overall Study|Participant Received Rescue Medication|1|||
164329032|NCT04650854|593581257|FG002|Overall Study|Participant Received Rescue Medication|0|||
164329033|NCT04650854|593581255|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
164329034|NCT04650854|593581256|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
164329035|NCT04650854|593581257|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
163878913|NCT00976937|591925271|FG001|Overall Study|Withdrawal by Subject|3|||
163878914|NCT00976937|591925270|FG000|Overall Study|Poor compliance to protocol|3|||
163878915|NCT00976937|591925271|FG001|Overall Study|Poor compliance to protocol|0|||
163878916|NCT00976937|591925270|FG000|Overall Study|Personal and Familial Reason|2|||
163878917|NCT00976937|591925271|FG001|Overall Study|Personal and Familial Reason|2|||
164220957|NCT00601107|593177783|FG001|Overall Study|Undefined|0|||
164220958|NCT00601107|593177784|FG002|Overall Study|Undefined|1|||
164220959|NCT00601107|593177785|FG003|Overall Study|Undefined|0|||
164220960|NCT03892915|593177786|FG000|Overall Study|Lost to Follow-up|6|||
164220961|NCT03892915|593177787|FG001|Overall Study|Lost to Follow-up|12|||
164220962|NCT03892915|593177786|FG000|Overall Study|Death|0|||
164220963|NCT03892915|593177787|FG001|Overall Study|Death|2|||
164220964|NCT03892915|593177786|FG000|Overall Study|Withdrawal by Subject|1|||
164220965|NCT03892915|593177787|FG001|Overall Study|Withdrawal by Subject|1|||
164220966|NCT03892915|593177786|FG000|Overall Study|unsuccessful delivery|13|||
164220967|NCT03892915|593177787|FG001|Overall Study|unsuccessful delivery|18|||
164220968|NCT03364686|593177788|FG000|Overall Study|Physician Decision|2|||
164220969|NCT01520714|593177789|FG000|Overall Study|Protocol Violation|0|||
164220970|NCT01520714|593177790|FG001|Overall Study|Protocol Violation|3|||
164220971|NCT01520714|593177789|FG000|Overall Study|Adverse Event|0|||
164220972|NCT01520714|593177790|FG001|Overall Study|Adverse Event|2|||
164220973|NCT01520714|593177789|FG000|Overall Study|Lack of Efficacy|0|||
164220974|NCT01520714|593177790|FG001|Overall Study|Lack of Efficacy|1|||
164220975|NCT01478087|593177799|FG000|Overall Study|due to sponsor closing study|1|||
164220976|NCT03518203|593177802|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
164220977|NCT03518203|593177802|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
164220978|NCT04146909|593177804|FG000|Overall Study|Withdrawal by Subject|3|||
164220979|NCT04146909|593177804|FG000|Overall Study|Did not qualify after consented|1|||
164220980|NCT00345592|593177805|FG000|Overall Study|Death|14|||
164220981|NCT00345592|593177806|FG001|Overall Study|Death|16|||
164220982|NCT00345592|593177805|FG000|Overall Study|Withdrawal by Subject|11|||
164220983|NCT00345592|593177806|FG001|Overall Study|Withdrawal by Subject|8|||
164220984|NCT03336866|593177821|FG000|Overall Study|Lost to Follow-up|2|||
164220985|NCT03336866|593177822|FG001|Overall Study|Lost to Follow-up|0|||
164220986|NCT03336866|593177823|FG002|Overall Study|Lost to Follow-up|3|||
164220987|NCT03336866|593177821|FG000|Overall Study|Withdrawal by Subject|1|||
164220988|NCT03336866|593177822|FG001|Overall Study|Withdrawal by Subject|1|||
164220989|NCT03336866|593177823|FG002|Overall Study|Withdrawal by Subject|0|||
164220990|NCT03336866|593177821|FG000|Overall Study|Noncompliance with clinic house rules|0|||
164220991|NCT03336866|593177822|FG001|Overall Study|Noncompliance with clinic house rules|0|||
164220992|NCT03336866|593177823|FG002|Overall Study|Noncompliance with clinic house rules|1|||
164220993|NCT00032487|593177824|FG000|Overall Study|Withdrawal by Subject|67|||
164220994|NCT00032487|593177825|FG001|Overall Study|Withdrawal by Subject|43|||
164220995|NCT00032487|593177824|FG000|Overall Study|Adverse Event|3|||
164220996|NCT00032487|593177825|FG001|Overall Study|Adverse Event|7|||
164220997|NCT00032487|593177824|FG000|Overall Study|Lost to Follow-up|57|||
164220998|NCT00032487|593177825|FG001|Overall Study|Lost to Follow-up|58|||
164220999|NCT00032487|593177824|FG000|Overall Study|Had other reason|12|||
164221000|NCT00032487|593177825|FG001|Overall Study|Had other reason|12|||
164221001|NCT04796207|593177826|FG000|Overall Study|Lost to Follow-up|7|||
164221002|NCT04796207|593177827|FG001|Overall Study|Lost to Follow-up|2|||
164221003|NCT01860989|593177828|FG000|Overall Study|Unsatisfactory therapeutic|5|||
164221004|NCT00421993|593177833|FG000|Overall Study|Withdrawal by Subject|22|||
164221005|NCT00421993|593177834|FG001|Overall Study|Withdrawal by Subject|23|||
164221006|NCT00421993|593177835|FG002|Overall Study|Withdrawal by Subject|23|||
164221007|NCT00421993|593177836|FG003|Overall Study|Withdrawal by Subject|24|||
164221008|NCT00421993|593177833|FG000|Overall Study|Lost to Follow-up|18|||
164221009|NCT00421993|593177834|FG001|Overall Study|Lost to Follow-up|19|||
164221010|NCT00421993|593177835|FG002|Overall Study|Lost to Follow-up|22|||
164221011|NCT00421993|593177836|FG003|Overall Study|Lost to Follow-up|20|||
164079315|NCT01621490|592655610|FG003|Overall Study|Other reasons|1|||
164079316|NCT01621490|592655611|FG004|Overall Study|Other reasons|1|||
164079317|NCT01621490|592655612|FG005|Overall Study|Other reasons|3|||
164079318|NCT01621490|592655613|FG006|Overall Study|Other reasons|1|||
163878918|NCT04442126|591925276|FG000|Overall Study|Withdrawal by Subject|0|||
163878919|NCT04442126|591925277|FG001|Overall Study|Withdrawal by Subject|0|||
163878920|NCT04442126|591925278|FG002|Overall Study|Withdrawal by Subject|0|||
164079319|NCT01621490|592655614|FG007|Overall Study|Other reasons|1|||
164221012|NCT00421993|593177833|FG000|Overall Study|Adverse Event|11|||
164221013|NCT00421993|593177834|FG001|Overall Study|Adverse Event|1|||
164221014|NCT00421993|593177835|FG002|Overall Study|Adverse Event|6|||
164221015|NCT00421993|593177836|FG003|Overall Study|Adverse Event|4|||
164221016|NCT00421993|593177833|FG000|Overall Study|Protocol Violation|2|||
163878921|NCT04442126|591925279|FG003|Overall Study|Withdrawal by Subject|2|||
163878922|NCT04442126|591925280|FG004|Overall Study|Withdrawal by Subject|1|||
164221017|NCT00421993|593177834|FG001|Overall Study|Protocol Violation|2|||
164221018|NCT00421993|593177835|FG002|Overall Study|Protocol Violation|0|||
164221019|NCT00421993|593177836|FG003|Overall Study|Protocol Violation|1|||
164221020|NCT00421993|593177833|FG000|Overall Study|Lack of Efficacy|0|||
164221021|NCT00421993|593177834|FG001|Overall Study|Lack of Efficacy|3|||
164221022|NCT00421993|593177835|FG002|Overall Study|Lack of Efficacy|0|||
164221023|NCT00421993|593177836|FG003|Overall Study|Lack of Efficacy|5|||
164221024|NCT00421993|593177833|FG000|Overall Study|Pregnancy|0|||
164079320|NCT01621490|592655615|FG008|Overall Study|Other reasons|1|||
164079321|NCT01621490|592655616|FG009|Overall Study|Other reasons|0|||
164079322|NCT01621490|592655617|FG010|Overall Study|Other reasons|0|||
164079323|NCT00506753|592655618|FG000|Overall Study|Lost to Follow-up|21|||
164079324|NCT00506753|592655619|FG001|Overall Study|Lost to Follow-up|15|||
164079325|NCT00461500|592655620|FG000|Overall Study|Adverse Event|1|||
164079326|NCT00461500|592655621|FG001|Overall Study|Adverse Event|0|||
164079327|NCT00461500|592655620|FG000|Overall Study|Lack of Efficacy|0|||
164079328|NCT00461500|592655621|FG001|Overall Study|Lack of Efficacy|1|||
164079329|NCT00461500|592655620|FG000|Overall Study|Expired Drug Treatment|1|||
164079330|NCT00461500|592655621|FG001|Overall Study|Expired Drug Treatment|1|||
164079331|NCT00461500|592655620|FG000|Overall Study|Study Stopped|1|||
164079332|NCT00461500|592655621|FG001|Overall Study|Study Stopped|2|||
164079333|NCT00461500|592655620|FG000|Overall Study|Drug Treatment Misuse|1|||
164079334|NCT00461500|592655621|FG001|Overall Study|Drug Treatment Misuse|0|||
164079335|NCT00461500|592655620|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
164079336|NCT00461500|592655621|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
164079337|NCT00461500|592655620|FG000|Overall Study|Lost to Follow-up|2|||
164079338|NCT00461500|592655621|FG001|Overall Study|Lost to Follow-up|2|||
164079339|NCT01267266|592655627|FG000|Enrollment Phase|Withdrawal by Subject|2|||
164079340|NCT01267266|592655628|FG001|Enrollment Phase|Withdrawal by Subject|0|||
164079341|NCT01267266|592655627|FG000|Lead-in Phase|Lack of Efficacy|20|||
164079342|NCT01267266|592655628|FG001|Lead-in Phase|Lack of Efficacy|0|||
164079343|NCT01267266|592655627|FG000|Lead-in Phase|Adverse Event|2|||
164079344|NCT01267266|592655628|FG001|Lead-in Phase|Adverse Event|0|||
164079345|NCT01267266|592655627|FG000|Lead-in Phase|Withdrawal by Subject|1|||
164079346|NCT01267266|592655628|FG001|Lead-in Phase|Withdrawal by Subject|0|||
164079347|NCT01335477|592655630|FG000|Overall Study|Adverse Event|30|||
164079348|NCT01335477|592655631|FG001|Overall Study|Adverse Event|42|||
164079349|NCT01335477|592655630|FG000|Overall Study|Non compliant with protocol|0|||
164079350|NCT01335477|592655631|FG001|Overall Study|Non compliant with protocol|2|||
164079351|NCT01335477|592655630|FG000|Overall Study|Lost to Follow-up|1|||
164079352|NCT01335477|592655631|FG001|Overall Study|Lost to Follow-up|2|||
164079353|NCT01335477|592655630|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
164079354|NCT01335477|592655631|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
164079355|NCT01335477|592655630|FG000|Overall Study|Not treated|1|||
164079356|NCT01335477|592655631|FG001|Overall Study|Not treated|2|||
164079357|NCT01335477|592655630|FG000|Overall Study|Reason other than those stated above|2|||
164079358|NCT01335477|592655631|FG001|Overall Study|Reason other than those stated above|2|||
164079359|NCT03549130|592655633|FG000|Overall Study|Adverse Event|0|||
164079360|NCT03549130|592655634|FG001|Overall Study|Adverse Event|1|||
164079361|NCT03549130|592655633|FG000|Overall Study|Lost to Follow-up|0|||
164079362|NCT03549130|592655634|FG001|Overall Study|Lost to Follow-up|1|||
164079363|NCT01078623|592655635|FG000|Treatment Period 1|Adverse Event|1|||
164079364|NCT01078623|592655636|FG001|Treatment Period 1|Adverse Event|1|||
164079365|NCT01078623|592655637|FG002|Treatment Period 1|Adverse Event|1|||
164079366|NCT01078623|592655638|FG003|Treatment Period 1|Adverse Event|0|||
164079367|NCT01078623|592655639|FG004|Treatment Period 1|Adverse Event|0|||
164079368|NCT01078623|592655640|FG005|Treatment Period 1|Adverse Event|0|||
164079369|NCT01078623|592655641|FG006|Treatment Period 1|Adverse Event|1|||
164079370|NCT01078623|592655642|FG007|Treatment Period 1|Adverse Event|0|||
164079371|NCT01078623|592655643|FG008|Treatment Period 1|Adverse Event|1|||
164079372|NCT01078623|592655644|FG009|Treatment Period 1|Adverse Event|1|||
164079373|NCT01078623|592655645|FG010|Treatment Period 1|Adverse Event|0|||
164079374|NCT01078623|592655646|FG011|Treatment Period 1|Adverse Event|0|||
164079375|NCT01078623|592655647|FG012|Treatment Period 1|Adverse Event|0|||
164079376|NCT01078623|592655648|FG013|Treatment Period 1|Adverse Event|0|||
164079377|NCT01078623|592655649|FG014|Treatment Period 1|Adverse Event|0|||
164079378|NCT01078623|592655650|FG015|Treatment Period 1|Adverse Event|0|||
164079379|NCT01078623|592655651|FG016|Treatment Period 1|Adverse Event|0|||
164079380|NCT01078623|592655652|FG017|Treatment Period 1|Adverse Event|0|||
164079381|NCT01078623|592655653|FG018|Treatment Period 1|Adverse Event|0|||
164079382|NCT01078623|592655654|FG019|Treatment Period 1|Adverse Event|0|||
164079383|NCT01078623|592655635|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164079384|NCT01078623|592655636|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164079385|NCT01078623|592655637|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164079386|NCT01078623|592655638|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164079387|NCT01078623|592655639|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164079388|NCT01078623|592655640|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164079389|NCT01078623|592655641|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164079390|NCT01078623|592655642|FG007|Treatment Period 1|Withdrawal by Subject|1|||
164079391|NCT01078623|592655643|FG008|Treatment Period 1|Withdrawal by Subject|0|||
164079392|NCT01078623|592655644|FG009|Treatment Period 1|Withdrawal by Subject|0|||
164079393|NCT01078623|592655645|FG010|Treatment Period 1|Withdrawal by Subject|1|||
164079394|NCT01078623|592655646|FG011|Treatment Period 1|Withdrawal by Subject|0|||
164079395|NCT01078623|592655647|FG012|Treatment Period 1|Withdrawal by Subject|0|||
164079396|NCT01078623|592655648|FG013|Treatment Period 1|Withdrawal by Subject|0|||
164079397|NCT01078623|592655649|FG014|Treatment Period 1|Withdrawal by Subject|0|||
164221025|NCT00421993|593177834|FG001|Overall Study|Pregnancy|1|||
164221026|NCT00421993|593177835|FG002|Overall Study|Pregnancy|1|||
164221027|NCT00421993|593177836|FG003|Overall Study|Pregnancy|2|||
164221028|NCT00421993|593177833|FG000|Overall Study|Subject transportation issues|0|||
164221029|NCT00421993|593177834|FG001|Overall Study|Subject transportation issues|0|||
164221030|NCT00421993|593177835|FG002|Overall Study|Subject transportation issues|0|||
164221031|NCT00421993|593177836|FG003|Overall Study|Subject transportation issues|1|||
164221032|NCT01751685|593177837|FG000|6-mo Followup|Missed study visit|1|||
164221033|NCT01751685|593177838|FG001|6-mo Followup|Missed study visit|0|||
164221034|NCT01751685|593177837|FG000|6-mo Followup|Withdrawal by Subject|2|||
164221035|NCT01751685|593177838|FG001|6-mo Followup|Withdrawal by Subject|2|||
164221036|NCT01751685|593177837|FG000|6-mo Followup|Lost to Follow-up|0|||
164221037|NCT01751685|593177838|FG001|6-mo Followup|Lost to Follow-up|1|||
164221038|NCT01751685|593177837|FG000|12-mo Followup|Lost to Follow-up|5|||
164221039|NCT01751685|593177838|FG001|12-mo Followup|Lost to Follow-up|0|||
164221040|NCT01107457|593177840|FG000|Part A|Adverse Event|1|||
164221041|NCT01107457|593177841|FG001|Part A|Adverse Event|2|||
164221042|NCT01107457|593177842|FG002|Part A|Adverse Event|1|||
164221043|NCT01107457|593177843|FG003|Part A|Adverse Event|0|||
164221044|NCT01107457|593177844|FG004|Part A|Adverse Event|0|||
164221045|NCT01107457|593177845|FG005|Part A|Adverse Event|0|||
164221046|NCT01107457|593177840|FG000|Part A|Withdrawal by Subject|3|||
164221047|NCT01107457|593177841|FG001|Part A|Withdrawal by Subject|3|||
164221048|NCT01107457|593177842|FG002|Part A|Withdrawal by Subject|0|||
164221049|NCT01107457|593177843|FG003|Part A|Withdrawal by Subject|3|||
164221050|NCT01107457|593177844|FG004|Part A|Withdrawal by Subject|1|||
164221051|NCT01107457|593177845|FG005|Part A|Withdrawal by Subject|0|||
164221052|NCT01107457|593177840|FG000|Part A|Lost to Follow-up|0|||
164221053|NCT01107457|593177841|FG001|Part A|Lost to Follow-up|1|||
164221054|NCT01107457|593177842|FG002|Part A|Lost to Follow-up|0|||
164221055|NCT01107457|593177843|FG003|Part A|Lost to Follow-up|0|||
164221056|NCT01107457|593177844|FG004|Part A|Lost to Follow-up|0|||
164221057|NCT01107457|593177845|FG005|Part A|Lost to Follow-up|0|||
164221058|NCT01107457|593177840|FG000|Part A|Lack of Efficacy|1|||
164221059|NCT01107457|593177841|FG001|Part A|Lack of Efficacy|0|||
164221060|NCT01107457|593177842|FG002|Part A|Lack of Efficacy|0|||
164221061|NCT01107457|593177843|FG003|Part A|Lack of Efficacy|0|||
164221062|NCT01107457|593177844|FG004|Part A|Lack of Efficacy|0|||
164221063|NCT01107457|593177845|FG005|Part A|Lack of Efficacy|0|||
164221064|NCT01107457|593177840|FG000|Part A|Protocol Violation|0|||
164221065|NCT01107457|593177841|FG001|Part A|Protocol Violation|1|||
164221066|NCT01107457|593177842|FG002|Part A|Protocol Violation|0|||
164221067|NCT01107457|593177843|FG003|Part A|Protocol Violation|0|||
164221068|NCT01107457|593177844|FG004|Part A|Protocol Violation|0|||
164221069|NCT01107457|593177845|FG005|Part A|Protocol Violation|0|||
164221070|NCT01107457|593177840|FG000|Part B and C|Adverse Event|0|||
164221071|NCT01107457|593177841|FG001|Part B and C|Adverse Event|0|||
163878923|NCT04442126|591925281|FG005|Overall Study|Withdrawal by Subject|0|||
163878924|NCT04442126|591925282|FG006|Overall Study|Withdrawal by Subject|1|||
163878925|NCT04442126|591925283|FG007|Overall Study|Withdrawal by Subject|1|||
163878926|NCT04442126|591925284|FG008|Overall Study|Withdrawal by Subject|3|||
163878927|NCT04442126|591925276|FG000|Overall Study|Death|1|||
163878928|NCT04442126|591925277|FG001|Overall Study|Death|0|||
163878929|NCT04442126|591925278|FG002|Overall Study|Death|0|||
163878930|NCT04442126|591925279|FG003|Overall Study|Death|1|||
163878931|NCT04442126|591925280|FG004|Overall Study|Death|2|||
163878932|NCT04442126|591925281|FG005|Overall Study|Death|2|||
163878933|NCT04442126|591925282|FG006|Overall Study|Death|4|||
164221072|NCT01107457|593177842|FG002|Part B and C|Adverse Event|0|||
164221073|NCT01107457|593177843|FG003|Part B and C|Adverse Event|0|||
164221074|NCT01107457|593177844|FG004|Part B and C|Adverse Event|0|||
163878934|NCT04442126|591925283|FG007|Overall Study|Death|1|||
163878935|NCT04442126|591925284|FG008|Overall Study|Death|5|||
163878936|NCT04442126|591925276|FG000|Overall Study|Study Terminated by Sponsor|0|||
164221075|NCT01107457|593177845|FG005|Part B and C|Adverse Event|12|||
164221076|NCT01107457|593177840|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221077|NCT01107457|593177841|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221078|NCT01107457|593177842|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
163878937|NCT04442126|591925277|FG001|Overall Study|Study Terminated by Sponsor|0|||
163878938|NCT04442126|591925278|FG002|Overall Study|Study Terminated by Sponsor|0|||
163878939|NCT04442126|591925279|FG003|Overall Study|Study Terminated by Sponsor|0|||
164221079|NCT01107457|593177843|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221080|NCT01107457|593177844|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
164221081|NCT01107457|593177845|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
164221082|NCT01107457|593177840|FG000|Part B and C|Physician Decision|0|||
164221083|NCT01107457|593177841|FG001|Part B and C|Physician Decision|0|||
164221084|NCT01107457|593177842|FG002|Part B and C|Physician Decision|0|||
164221085|NCT01107457|593177843|FG003|Part B and C|Physician Decision|0|||
164221086|NCT01107457|593177844|FG004|Part B and C|Physician Decision|0|||
164221087|NCT01107457|593177845|FG005|Part B and C|Physician Decision|3|||
164221088|NCT01107457|593177840|FG000|Part B and C|Lack of Efficacy|0|||
164221089|NCT01107457|593177841|FG001|Part B and C|Lack of Efficacy|0|||
164221090|NCT01107457|593177842|FG002|Part B and C|Lack of Efficacy|0|||
164221091|NCT01107457|593177843|FG003|Part B and C|Lack of Efficacy|0|||
164221092|NCT01107457|593177844|FG004|Part B and C|Lack of Efficacy|0|||
164221093|NCT01107457|593177845|FG005|Part B and C|Lack of Efficacy|7|||
164221094|NCT01107457|593177840|FG000|Part B and C|Lost to Follow-up|0|||
164221095|NCT01107457|593177841|FG001|Part B and C|Lost to Follow-up|0|||
164221096|NCT01107457|593177842|FG002|Part B and C|Lost to Follow-up|0|||
164221097|NCT01107457|593177843|FG003|Part B and C|Lost to Follow-up|0|||
164221098|NCT01107457|593177844|FG004|Part B and C|Lost to Follow-up|0|||
164221099|NCT01107457|593177845|FG005|Part B and C|Lost to Follow-up|10|||
164221100|NCT01107457|593177840|FG000|Part B and C|Protocol Violation|0|||
164221101|NCT01107457|593177841|FG001|Part B and C|Protocol Violation|0|||
164221102|NCT01107457|593177842|FG002|Part B and C|Protocol Violation|0|||
164221103|NCT01107457|593177843|FG003|Part B and C|Protocol Violation|0|||
164221104|NCT01107457|593177844|FG004|Part B and C|Protocol Violation|0|||
164221105|NCT01107457|593177845|FG005|Part B and C|Protocol Violation|1|||
164221106|NCT01107457|593177840|FG000|Part B and C|Sponsor Decision|0|||
164221107|NCT01107457|593177841|FG001|Part B and C|Sponsor Decision|0|||
164221108|NCT01107457|593177842|FG002|Part B and C|Sponsor Decision|0|||
164221109|NCT01107457|593177843|FG003|Part B and C|Sponsor Decision|0|||
164221110|NCT01107457|593177844|FG004|Part B and C|Sponsor Decision|0|||
164221111|NCT01107457|593177845|FG005|Part B and C|Sponsor Decision|66|||
164221112|NCT01107457|593177840|FG000|Part B and C|Withdrawal by Subject|0|||
164221113|NCT01107457|593177841|FG001|Part B and C|Withdrawal by Subject|0|||
164221114|NCT01107457|593177842|FG002|Part B and C|Withdrawal by Subject|0|||
164221115|NCT01107457|593177843|FG003|Part B and C|Withdrawal by Subject|0|||
164221116|NCT01107457|593177844|FG004|Part B and C|Withdrawal by Subject|0|||
164221117|NCT01107457|593177845|FG005|Part B and C|Withdrawal by Subject|16|||
164221118|NCT01107457|593177840|FG000|Part B and C|Clinical Relapse|0|||
164221119|NCT01107457|593177841|FG001|Part B and C|Clinical Relapse|0|||
164221120|NCT01107457|593177842|FG002|Part B and C|Clinical Relapse|0|||
164221121|NCT01107457|593177843|FG003|Part B and C|Clinical Relapse|0|||
164221122|NCT01107457|593177844|FG004|Part B and C|Clinical Relapse|0|||
164221123|NCT01107457|593177845|FG005|Part B and C|Clinical Relapse|4|||
164221124|NCT03601052|593177846|FG000|Overall Study|Lost to Follow-up|2|||
164221125|NCT01727154|593177850|FG000|Overall Study|Death|17|||
164221126|NCT01727154|593177850|FG000|Overall Study|Withdrawal by Subject|14|||
164221127|NCT01727154|593177850|FG000|Overall Study|Subject Withdrew Consent|18|||
164221128|NCT01727154|593177850|FG000|Overall Study|Study Terminated|6|||
164221129|NCT01727154|593177850|FG000|Overall Study|No Discontinuation Documentation|4|||
164221130|NCT00003474|593177851|FG000|Overall Study|Not Evaluable|14|||
164221131|NCT01198548|593177853|FG000|Overall Study|Disease Progression|9|||
164221132|NCT01198548|593177853|FG000|Overall Study|Administrative Decision|1|||
164221133|NCT02186171|593177855|FG000|Overall Study|Withdrawal by Subject|1|||
164221134|NCT02186171|593177856|FG001|Overall Study|Withdrawal by Subject|9|||
164221135|NCT02186171|593177855|FG000|Overall Study|Lost to Follow-up|2|||
164221136|NCT02186171|593177856|FG001|Overall Study|Lost to Follow-up|2|||
164221137|NCT02186171|593177855|FG000|Overall Study|Death|1|||
164221138|NCT02186171|593177856|FG001|Overall Study|Death|2|||
164221139|NCT02186171|593177855|FG000|Overall Study|Protocol-specified Criteria|0|||
164221140|NCT02186171|593177856|FG001|Overall Study|Protocol-specified Criteria|2|||
164221141|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
164221142|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
164221143|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
164221144|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Physician Decision|2|||
164221145|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Physician Decision|4|||
164221146|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Physician Decision|0|||
164221147|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
164221148|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
163878940|NCT04442126|591925280|FG004|Overall Study|Study Terminated by Sponsor|0|||
163878941|NCT04442126|591925281|FG005|Overall Study|Study Terminated by Sponsor|1|||
163878942|NCT04442126|591925282|FG006|Overall Study|Study Terminated by Sponsor|4|||
163878943|NCT04442126|591925283|FG007|Overall Study|Study Terminated by Sponsor|2|||
163878944|NCT04442126|591925284|FG008|Overall Study|Study Terminated by Sponsor|10|||
164221149|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
164221150|NCT01245062|593177857|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
164221151|NCT01245062|593177858|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
164221152|NCT01245062|593177859|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
164221153|NCT01245062|593177857|FG000|Cross-over Phase|Lost to Follow-up|0|||
164329036|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
163878945|NCT04442126|591925276|FG000|Overall Study|Lost to Follow-up|0|||
163878946|NCT04442126|591925277|FG001|Overall Study|Lost to Follow-up|0|||
163878947|NCT04442126|591925278|FG002|Overall Study|Lost to Follow-up|0|||
163878948|NCT04442126|591925279|FG003|Overall Study|Lost to Follow-up|0|||
164221154|NCT01245062|593177858|FG001|Cross-over Phase|Lost to Follow-up|0|||
164221155|NCT01245062|593177859|FG002|Cross-over Phase|Lost to Follow-up|1|||
163878949|NCT04442126|591925280|FG004|Overall Study|Lost to Follow-up|0|||
163878950|NCT04442126|591925281|FG005|Overall Study|Lost to Follow-up|0|||
163878951|NCT04442126|591925282|FG006|Overall Study|Lost to Follow-up|0|||
164079398|NCT01078623|592655650|FG015|Treatment Period 1|Withdrawal by Subject|0|||
164079399|NCT01078623|592655651|FG016|Treatment Period 1|Withdrawal by Subject|0|||
164079400|NCT01078623|592655652|FG017|Treatment Period 1|Withdrawal by Subject|0|||
164079401|NCT01078623|592655653|FG018|Treatment Period 1|Withdrawal by Subject|0|||
164079402|NCT01078623|592655654|FG019|Treatment Period 1|Withdrawal by Subject|0|||
164079403|NCT01078623|592655635|FG000|Treatment Period 1|Protocol Violation|0|||
164079404|NCT01078623|592655636|FG001|Treatment Period 1|Protocol Violation|0|||
164079405|NCT01078623|592655637|FG002|Treatment Period 1|Protocol Violation|0|||
164079406|NCT01078623|592655638|FG003|Treatment Period 1|Protocol Violation|0|||
164079407|NCT01078623|592655639|FG004|Treatment Period 1|Protocol Violation|0|||
164079408|NCT01078623|592655640|FG005|Treatment Period 1|Protocol Violation|1|||
164079409|NCT01078623|592655641|FG006|Treatment Period 1|Protocol Violation|0|||
164079410|NCT01078623|592655642|FG007|Treatment Period 1|Protocol Violation|0|||
164079411|NCT01078623|592655643|FG008|Treatment Period 1|Protocol Violation|0|||
164079412|NCT01078623|592655644|FG009|Treatment Period 1|Protocol Violation|0|||
164079413|NCT01078623|592655645|FG010|Treatment Period 1|Protocol Violation|0|||
164079414|NCT01078623|592655646|FG011|Treatment Period 1|Protocol Violation|0|||
164079415|NCT01078623|592655647|FG012|Treatment Period 1|Protocol Violation|0|||
164079416|NCT01078623|592655648|FG013|Treatment Period 1|Protocol Violation|0|||
164079417|NCT01078623|592655649|FG014|Treatment Period 1|Protocol Violation|0|||
164079418|NCT01078623|592655650|FG015|Treatment Period 1|Protocol Violation|0|||
164079419|NCT01078623|592655651|FG016|Treatment Period 1|Protocol Violation|0|||
164079420|NCT01078623|592655652|FG017|Treatment Period 1|Protocol Violation|0|||
164079421|NCT01078623|592655653|FG018|Treatment Period 1|Protocol Violation|0|||
164079422|NCT01078623|592655654|FG019|Treatment Period 1|Protocol Violation|0|||
164079423|NCT01078623|592655635|FG000|Treatment Period 2|Adverse Event|0|||
164079424|NCT01078623|592655636|FG001|Treatment Period 2|Adverse Event|0|||
164079425|NCT01078623|592655637|FG002|Treatment Period 2|Adverse Event|0|||
164079426|NCT01078623|592655638|FG003|Treatment Period 2|Adverse Event|0|||
164079427|NCT01078623|592655639|FG004|Treatment Period 2|Adverse Event|0|||
164079428|NCT01078623|592655640|FG005|Treatment Period 2|Adverse Event|0|||
164079429|NCT01078623|592655641|FG006|Treatment Period 2|Adverse Event|1|||
164079430|NCT01078623|592655642|FG007|Treatment Period 2|Adverse Event|0|||
164079431|NCT01078623|592655643|FG008|Treatment Period 2|Adverse Event|0|||
164079432|NCT01078623|592655644|FG009|Treatment Period 2|Adverse Event|0|||
164079433|NCT01078623|592655645|FG010|Treatment Period 2|Adverse Event|0|||
164079434|NCT01078623|592655646|FG011|Treatment Period 2|Adverse Event|0|||
164079435|NCT01078623|592655647|FG012|Treatment Period 2|Adverse Event|0|||
164079436|NCT01078623|592655648|FG013|Treatment Period 2|Adverse Event|0|||
164079437|NCT01078623|592655649|FG014|Treatment Period 2|Adverse Event|0|||
164079438|NCT01078623|592655650|FG015|Treatment Period 2|Adverse Event|0|||
164079439|NCT01078623|592655651|FG016|Treatment Period 2|Adverse Event|0|||
164079440|NCT01078623|592655652|FG017|Treatment Period 2|Adverse Event|0|||
164079441|NCT01078623|592655653|FG018|Treatment Period 2|Adverse Event|1|||
164079442|NCT01078623|592655654|FG019|Treatment Period 2|Adverse Event|0|||
164079443|NCT01078623|592655635|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164079444|NCT01078623|592655636|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164079445|NCT01078623|592655637|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164079446|NCT01078623|592655638|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164079447|NCT01078623|592655639|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164079448|NCT01078623|592655640|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164079449|NCT01078623|592655641|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164079450|NCT01078623|592655642|FG007|Treatment Period 2|Withdrawal by Subject|0|||
164079451|NCT01078623|592655643|FG008|Treatment Period 2|Withdrawal by Subject|0|||
164079452|NCT01078623|592655644|FG009|Treatment Period 2|Withdrawal by Subject|0|||
164079453|NCT01078623|592655645|FG010|Treatment Period 2|Withdrawal by Subject|0|||
164079454|NCT01078623|592655646|FG011|Treatment Period 2|Withdrawal by Subject|0|||
164079455|NCT01078623|592655647|FG012|Treatment Period 2|Withdrawal by Subject|0|||
164079456|NCT01078623|592655648|FG013|Treatment Period 2|Withdrawal by Subject|0|||
164079457|NCT01078623|592655649|FG014|Treatment Period 2|Withdrawal by Subject|0|||
164079458|NCT01078623|592655650|FG015|Treatment Period 2|Withdrawal by Subject|0|||
164079459|NCT01078623|592655651|FG016|Treatment Period 2|Withdrawal by Subject|0|||
164079460|NCT01078623|592655652|FG017|Treatment Period 2|Withdrawal by Subject|0|||
164079461|NCT01078623|592655653|FG018|Treatment Period 2|Withdrawal by Subject|0|||
164079462|NCT01078623|592655654|FG019|Treatment Period 2|Withdrawal by Subject|0|||
164079463|NCT01078623|592655635|FG000|Treatment Period 3|Adverse Event|0|||
164079464|NCT01078623|592655636|FG001|Treatment Period 3|Adverse Event|0|||
164079465|NCT01078623|592655637|FG002|Treatment Period 3|Adverse Event|0|||
164079466|NCT01078623|592655638|FG003|Treatment Period 3|Adverse Event|0|||
164079467|NCT01078623|592655639|FG004|Treatment Period 3|Adverse Event|1|||
164079468|NCT01078623|592655640|FG005|Treatment Period 3|Adverse Event|0|||
164079469|NCT01078623|592655641|FG006|Treatment Period 3|Adverse Event|0|||
164079470|NCT01078623|592655642|FG007|Treatment Period 3|Adverse Event|0|||
163878952|NCT04442126|591925283|FG007|Overall Study|Lost to Follow-up|1|||
164079471|NCT01078623|592655643|FG008|Treatment Period 3|Adverse Event|0|||
164329037|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
164329038|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
164329039|NCT04650854|593581255|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
164329040|NCT04650854|593581256|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
164329041|NCT04650854|593581257|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
164329042|NCT04650854|593581255|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
164329043|NCT04650854|593581256|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
164329044|NCT04650854|593581257|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
164329045|NCT04650854|593581255|FG000|Overall Study|Enrollment Cup|0|||
164329046|NCT04650854|593581256|FG001|Overall Study|Enrollment Cup|0|||
164329047|NCT04650854|593581257|FG002|Overall Study|Enrollment Cup|1|||
164329048|NCT00704808|593581272|FG000|Overall Study|Discontinued prior to starting treatment|14|||
164329049|NCT00704808|593581272|FG000|Overall Study|Death|7|||
164329050|NCT00704808|593581272|FG000|Overall Study|Tumor progression|80|||
164329051|NCT00704808|593581272|FG000|Overall Study|Patient's decision|11|||
164329052|NCT00704808|593581272|FG000|Overall Study|Early therapy discontinuation|16|||
164329053|NCT00704808|593581272|FG000|Overall Study|Adverse Event|1|||
164079472|NCT01078623|592655644|FG009|Treatment Period 3|Adverse Event|0|||
164079473|NCT01078623|592655645|FG010|Treatment Period 3|Adverse Event|0|||
164079474|NCT01078623|592655646|FG011|Treatment Period 3|Adverse Event|0|||
164079475|NCT01078623|592655647|FG012|Treatment Period 3|Adverse Event|0|||
164079476|NCT01078623|592655648|FG013|Treatment Period 3|Adverse Event|1|||
164079477|NCT01078623|592655649|FG014|Treatment Period 3|Adverse Event|0|||
164079478|NCT01078623|592655650|FG015|Treatment Period 3|Adverse Event|0|||
164079479|NCT01078623|592655651|FG016|Treatment Period 3|Adverse Event|0|||
164079480|NCT01078623|592655652|FG017|Treatment Period 3|Adverse Event|0|||
164079481|NCT01078623|592655653|FG018|Treatment Period 3|Adverse Event|0|||
164079482|NCT01078623|592655654|FG019|Treatment Period 3|Adverse Event|0|||
164079483|NCT01078623|592655635|FG000|Treatment Period 4|Adverse Event|0|||
164079484|NCT01078623|592655636|FG001|Treatment Period 4|Adverse Event|0|||
164079485|NCT01078623|592655637|FG002|Treatment Period 4|Adverse Event|1|||
164079486|NCT01078623|592655638|FG003|Treatment Period 4|Adverse Event|0|||
164079487|NCT01078623|592655639|FG004|Treatment Period 4|Adverse Event|0|||
164329054|NCT00704808|593581272|FG000|Overall Study|Lost to Follow-up|1|||
164329055|NCT00704808|593581272|FG000|Overall Study|Treatment change|1|||
164329056|NCT01982331|593581281|FG000|Received Vaccination 2|Adverse Event|1|||
164329057|NCT01982331|593581282|FG001|Received Vaccination 2|Adverse Event|2|||
164329058|NCT01982331|593581281|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
164329059|NCT01982331|593581282|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
164329060|NCT01982331|593581281|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
164329061|NCT01982331|593581282|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
164329062|NCT03500679|593581283|FG000|Overall Study|Lost to Follow-up|6|||
164079488|NCT01078623|592655640|FG005|Treatment Period 4|Adverse Event|0|||
164079489|NCT01078623|592655641|FG006|Treatment Period 4|Adverse Event|0|||
164079490|NCT01078623|592655642|FG007|Treatment Period 4|Adverse Event|0|||
164079491|NCT01078623|592655643|FG008|Treatment Period 4|Adverse Event|0|||
164079492|NCT01078623|592655644|FG009|Treatment Period 4|Adverse Event|0|||
164079493|NCT01078623|592655645|FG010|Treatment Period 4|Adverse Event|0|||
164079494|NCT01078623|592655646|FG011|Treatment Period 4|Adverse Event|0|||
164221156|NCT01245062|593177857|FG000|Cross-over Phase|Physician Decision|0|||
164221157|NCT01245062|593177858|FG001|Cross-over Phase|Physician Decision|0|||
164221158|NCT01245062|593177859|FG002|Cross-over Phase|Physician Decision|1|||
164221159|NCT01245062|593177857|FG000|Cross-over Phase|Withdrew Consent|0|||
164221160|NCT01245062|593177858|FG001|Cross-over Phase|Withdrew Consent|0|||
164221161|NCT01245062|593177859|FG002|Cross-over Phase|Withdrew Consent|4|||
164221162|NCT01245062|593177857|FG000|Cross-over Phase|Study closed/ terminated|0|||
164221163|NCT01245062|593177858|FG001|Cross-over Phase|Study closed/ terminated|0|||
164221164|NCT01245062|593177859|FG002|Cross-over Phase|Study closed/ terminated|11|||
164221165|NCT02015104|593177861|FG000|Overall Study|Withdrew consent after first dose drug|1|||
164221166|NCT02015104|593177862|FG001|Overall Study|Withdrew consent after first dose drug|0|||
164221167|NCT02015104|593177861|FG000|Overall Study|Withdrew consent prior to treatment|0|||
164221168|NCT02015104|593177862|FG001|Overall Study|Withdrew consent prior to treatment|1|||
164221169|NCT06025695|593177863|FG000|Overall Study|Adverse Event|5|||
164221170|NCT06025695|593177864|FG001|Overall Study|Adverse Event|6|||
164221171|NCT06025695|593177863|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
164221172|NCT06025695|593177864|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
164221173|NCT06025695|593177863|FG000|Overall Study|Other|23|||
164221174|NCT06025695|593177864|FG001|Overall Study|Other|19|||
164221175|NCT06025695|593177863|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
164221176|NCT06025695|593177864|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
164221177|NCT03011372|593177865|FG000|Overall Study|Death|16|||
164221178|NCT03011372|593177865|FG000|Overall Study|Lost to Follow-up|2|||
164221179|NCT03011372|593177865|FG000|Overall Study|Sponsor Decision|17|||
164221180|NCT03011372|593177865|FG000|Overall Study|Withdrawal by Subject|7|||
164221181|NCT03011372|593177865|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
164221182|NCT03011372|593177865|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
164221183|NCT03011372|593177865|FG000|Overall Study|Sponsor's Decision|2|||
164221184|NCT03572218|593177866|FG000|Overall Study|Lost to Follow-up|3|||
164221185|NCT03572218|593177867|FG001|Overall Study|Lost to Follow-up|2|||
164221186|NCT03572218|593177866|FG000|Overall Study|No longer available for study visits|2|||
164221187|NCT03572218|593177867|FG001|Overall Study|No longer available for study visits|1|||
164221188|NCT03572218|593177866|FG000|Overall Study|No longer interested|1|||
164221189|NCT03572218|593177867|FG001|Overall Study|No longer interested|2|||
164221190|NCT01350973|593177871|FG000|Overall Study|Adverse Event|4|||
164221191|NCT01350973|593177872|FG001|Overall Study|Adverse Event|7|||
164221192|NCT01350973|593177873|FG002|Overall Study|Adverse Event|7|||
164221193|NCT01350973|593177871|FG000|Overall Study|Voluntary Withdrawal|2|||
164221194|NCT01350973|593177872|FG001|Overall Study|Voluntary Withdrawal|1|||
164221195|NCT01350973|593177873|FG002|Overall Study|Voluntary Withdrawal|1|||
164221196|NCT00853047|593177874|FG000|Core Phase|Participant Request|0|||
164221197|NCT00853047|593177875|FG001|Core Phase|Participant Request|0|||
164221198|NCT00853047|593177876|FG002|Core Phase|Participant Request|0|||
164221199|NCT00853047|593177877|FG003|Core Phase|Participant Request|1|||
164221200|NCT00853047|593177878|FG004|Core Phase|Participant Request|0|||
164221201|NCT00853047|593177879|FG005|Core Phase|Participant Request|0|||
164221202|NCT00853047|593177874|FG000|Open-Label Extension Phase|Participant Request|0|||
164221203|NCT00853047|593177875|FG001|Open-Label Extension Phase|Participant Request|0|||
164221204|NCT00853047|593177876|FG002|Open-Label Extension Phase|Participant Request|0|||
164221205|NCT00853047|593177877|FG003|Open-Label Extension Phase|Participant Request|0|||
164221206|NCT00853047|593177878|FG004|Open-Label Extension Phase|Participant Request|0|||
164221207|NCT00853047|593177879|FG005|Open-Label Extension Phase|Participant Request|7|||
164221208|NCT00853047|593177874|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164221209|NCT00853047|593177875|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164221210|NCT00853047|593177876|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164221211|NCT00853047|593177877|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
164221212|NCT00853047|593177878|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
164221213|NCT00853047|593177879|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
164221214|NCT00853047|593177874|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221215|NCT00853047|593177875|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221216|NCT00853047|593177876|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164079495|NCT01078623|592655647|FG012|Treatment Period 4|Adverse Event|0|||
164079496|NCT01078623|592655648|FG013|Treatment Period 4|Adverse Event|0|||
164079497|NCT01078623|592655649|FG014|Treatment Period 4|Adverse Event|0|||
164221217|NCT00853047|593177877|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221218|NCT00853047|593177878|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
164221219|NCT00853047|593177879|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
164221220|NCT00853047|593177874|FG000|Open-Label Extension Phase|Investigator Decision|0|||
164221221|NCT00853047|593177875|FG001|Open-Label Extension Phase|Investigator Decision|0|||
164221222|NCT00853047|593177876|FG002|Open-Label Extension Phase|Investigator Decision|0|||
164221223|NCT00853047|593177877|FG003|Open-Label Extension Phase|Investigator Decision|0|||
164221224|NCT00853047|593177878|FG004|Open-Label Extension Phase|Investigator Decision|0|||
164221225|NCT00853047|593177879|FG005|Open-Label Extension Phase|Investigator Decision|1|||
163878953|NCT04442126|591925284|FG008|Overall Study|Lost to Follow-up|2|||
163878954|NCT04442126|591925276|FG000|Overall Study|Progressive Disease|0|||
163878955|NCT04442126|591925277|FG001|Overall Study|Progressive Disease|1|||
163878956|NCT04442126|591925278|FG002|Overall Study|Progressive Disease|3|||
163878957|NCT04442126|591925279|FG003|Overall Study|Progressive Disease|0|||
163878958|NCT04442126|591925280|FG004|Overall Study|Progressive Disease|3|||
163878959|NCT04442126|591925281|FG005|Overall Study|Progressive Disease|0|||
163878960|NCT04442126|591925282|FG006|Overall Study|Progressive Disease|0|||
163878961|NCT04442126|591925283|FG007|Overall Study|Progressive Disease|0|||
163878962|NCT04442126|591925284|FG008|Overall Study|Progressive Disease|0|||
163878963|NCT04442126|591925276|FG000|Overall Study|Other|0|||
163878964|NCT04442126|591925277|FG001|Overall Study|Other|0|||
163878965|NCT04442126|591925278|FG002|Overall Study|Other|0|||
163878966|NCT04442126|591925279|FG003|Overall Study|Other|0|||
163878967|NCT04442126|591925280|FG004|Overall Study|Other|0|||
163878968|NCT04442126|591925281|FG005|Overall Study|Other|0|||
163878969|NCT04442126|591925282|FG006|Overall Study|Other|0|||
163878970|NCT04442126|591925283|FG007|Overall Study|Other|0|||
163878971|NCT04442126|591925284|FG008|Overall Study|Other|1|||
163878972|NCT06450405|591925285|FG000|Overall Study|Study funding terminated.|0|||
163878973|NCT06450405|591925286|FG001|Overall Study|Study funding terminated.|2|||
163878974|NCT03767517|591925287|FG000|Overall Study|Lost to Follow-up|16|||
163878975|NCT03767517|591925288|FG001|Overall Study|Lost to Follow-up|10|||
163878976|NCT03767517|591925287|FG000|Overall Study|Death|2|||
163878977|NCT03767517|591925288|FG001|Overall Study|Death|3|||
163878978|NCT04994509|591925290|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
163878979|NCT04994509|591925291|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
163878980|NCT04994509|591925292|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
163878981|NCT04994509|591925290|FG000|Overall Study|Withdrew Consent|73|||
163878982|NCT04994509|591925291|FG001|Overall Study|Withdrew Consent|72|||
163878983|NCT04994509|591925292|FG002|Overall Study|Withdrew Consent|46|||
163878984|NCT04994509|591925290|FG000|Overall Study|Lost to Follow-up|39|||
163878985|NCT04994509|591925291|FG001|Overall Study|Lost to Follow-up|36|||
163878986|NCT04994509|591925292|FG002|Overall Study|Lost to Follow-up|26|||
163878987|NCT04994509|591925290|FG000|Overall Study|HIV-1 Infection|4|||
163878988|NCT04994509|591925291|FG001|Overall Study|HIV-1 Infection|20|||
163878989|NCT04994509|591925292|FG002|Overall Study|HIV-1 Infection|12|||
163878990|NCT04994509|591925290|FG000|Overall Study|Investigator's Discretion|9|||
163878991|NCT04994509|591925291|FG001|Overall Study|Investigator's Discretion|8|||
163878992|NCT04994509|591925292|FG002|Overall Study|Investigator's Discretion|11|||
163878993|NCT04994509|591925290|FG000|Overall Study|Randomized but Never Treated|10|||
163878994|NCT04994509|591925291|FG001|Overall Study|Randomized but Never Treated|10|||
163878995|NCT04994509|591925292|FG002|Overall Study|Randomized but Never Treated|3|||
163878996|NCT04994509|591925290|FG000|Overall Study|Pregnancy|5|||
163878997|NCT04994509|591925291|FG001|Overall Study|Pregnancy|5|||
163878998|NCT04994509|591925292|FG002|Overall Study|Pregnancy|0|||
163878999|NCT04994509|591925290|FG000|Overall Study|Death|0|||
163879000|NCT04994509|591925291|FG001|Overall Study|Death|5|||
163879001|NCT04994509|591925292|FG002|Overall Study|Death|0|||
163879002|NCT04994509|591925290|FG000|Overall Study|Adverse Event|2|||
163879003|NCT04994509|591925291|FG001|Overall Study|Adverse Event|1|||
163879004|NCT04994509|591925292|FG002|Overall Study|Adverse Event|0|||
163879005|NCT04994509|591925290|FG000|Overall Study|Non-compliance With Study Drug|1|||
163879006|NCT04994509|591925291|FG001|Overall Study|Non-compliance With Study Drug|1|||
163879007|NCT04994509|591925292|FG002|Overall Study|Non-compliance With Study Drug|1|||
163879008|NCT04994509|591925290|FG000|Overall Study|Withdrew Assent|3|||
163879009|NCT04994509|591925291|FG001|Overall Study|Withdrew Assent|0|||
163879010|NCT04994509|591925292|FG002|Overall Study|Withdrew Assent|0|||
163879011|NCT04994509|591925290|FG000|Overall Study|Protocol Violation|1|||
163879012|NCT04994509|591925291|FG001|Overall Study|Protocol Violation|0|||
163879013|NCT04994509|591925292|FG002|Overall Study|Protocol Violation|0|||
163879014|NCT02396199|591926617|FG000|Overall Study|Lost to Follow-up|1|||
163879015|NCT02396199|591926617|FG000|Overall Study|Death|4|||
163879016|NCT06066541|591926629|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
163879017|NCT06066541|591926630|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
163879018|NCT06066541|591926631|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
163879019|NCT06066541|591926632|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
163879020|NCT06066541|591926633|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
163879021|NCT06066541|591926634|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
164221226|NCT00853047|593177874|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
164221227|NCT00853047|593177875|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
163879022|NCT06066541|591926635|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
163879023|NCT06066541|591926629|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
164079498|NCT01078623|592655650|FG015|Treatment Period 4|Adverse Event|0|||
164079499|NCT01078623|592655651|FG016|Treatment Period 4|Adverse Event|0|||
164079500|NCT01078623|592655652|FG017|Treatment Period 4|Adverse Event|0|||
164079501|NCT01078623|592655653|FG018|Treatment Period 4|Adverse Event|0|||
164079502|NCT01078623|592655654|FG019|Treatment Period 4|Adverse Event|0|||
164079503|NCT01078623|592655635|FG000|Treatment Period 4|Withdrawal by Subject|0|||
164079504|NCT01078623|592655636|FG001|Treatment Period 4|Withdrawal by Subject|0|||
164079505|NCT01078623|592655637|FG002|Treatment Period 4|Withdrawal by Subject|0|||
164079506|NCT01078623|592655638|FG003|Treatment Period 4|Withdrawal by Subject|0|||
164079507|NCT01078623|592655639|FG004|Treatment Period 4|Withdrawal by Subject|0|||
164079508|NCT01078623|592655640|FG005|Treatment Period 4|Withdrawal by Subject|0|||
164079509|NCT01078623|592655641|FG006|Treatment Period 4|Withdrawal by Subject|0|||
164079510|NCT01078623|592655642|FG007|Treatment Period 4|Withdrawal by Subject|0|||
164079511|NCT01078623|592655643|FG008|Treatment Period 4|Withdrawal by Subject|0|||
164079512|NCT01078623|592655644|FG009|Treatment Period 4|Withdrawal by Subject|0|||
164079513|NCT01078623|592655645|FG010|Treatment Period 4|Withdrawal by Subject|0|||
164079514|NCT01078623|592655646|FG011|Treatment Period 4|Withdrawal by Subject|0|||
164079515|NCT01078623|592655647|FG012|Treatment Period 4|Withdrawal by Subject|0|||
164079516|NCT01078623|592655648|FG013|Treatment Period 4|Withdrawal by Subject|0|||
164079517|NCT01078623|592655649|FG014|Treatment Period 4|Withdrawal by Subject|0|||
164079518|NCT01078623|592655650|FG015|Treatment Period 4|Withdrawal by Subject|1|||
164079519|NCT01078623|592655651|FG016|Treatment Period 4|Withdrawal by Subject|0|||
164079520|NCT01078623|592655652|FG017|Treatment Period 4|Withdrawal by Subject|0|||
164079521|NCT01078623|592655653|FG018|Treatment Period 4|Withdrawal by Subject|0|||
164079522|NCT01078623|592655654|FG019|Treatment Period 4|Withdrawal by Subject|0|||
164079523|NCT00447603|592655672|FG000|Screening|Withdrawal by Subject|1|||
164079524|NCT00447603|592655673|FG001|Screening|Withdrawal by Subject|0|||
164079525|NCT00447603|592655674|FG002|Screening|Withdrawal by Subject|0|||
164079526|NCT00447603|592655672|FG000|Screening|Protocol Violation|1|||
164079527|NCT00447603|592655673|FG001|Screening|Protocol Violation|0|||
164079528|NCT00447603|592655674|FG002|Screening|Protocol Violation|0|||
164079529|NCT00447603|592655672|FG000|Screening|Screen Failure|4|||
164079530|NCT00447603|592655673|FG001|Screening|Screen Failure|0|||
164079531|NCT00447603|592655674|FG002|Screening|Screen Failure|0|||
164079532|NCT00447603|592655672|FG000|Screening|Study Terminated by Sponsor|15|||
164079533|NCT00447603|592655673|FG001|Screening|Study Terminated by Sponsor|0|||
164079534|NCT00447603|592655674|FG002|Screening|Study Terminated by Sponsor|0|||
164079535|NCT00447603|592655672|FG000|Filter Period|Adverse Event|0|||
164079536|NCT00447603|592655673|FG001|Filter Period|Adverse Event|0|||
164079537|NCT00447603|592655674|FG002|Filter Period|Adverse Event|1|||
164079538|NCT00447603|592655672|FG000|Filter Period|Screen Failure|0|||
164079539|NCT00447603|592655673|FG001|Filter Period|Screen Failure|3|||
164079540|NCT00447603|592655674|FG002|Filter Period|Screen Failure|4|||
164079541|NCT00447603|592655672|FG000|Filter Period|Study terminated by Sponsor|0|||
164079542|NCT00447603|592655673|FG001|Filter Period|Study terminated by Sponsor|1|||
164079543|NCT00447603|592655674|FG002|Filter Period|Study terminated by Sponsor|10|||
164079544|NCT01797120|592655677|FG000|Overall Study|Disesae progression|37|||
164079545|NCT01797120|592655678|FG001|Overall Study|Disesae progression|49|||
164079546|NCT01797120|592655677|FG000|Overall Study|Adverse Event|13|||
164079547|NCT01797120|592655678|FG001|Overall Study|Adverse Event|5|||
164079548|NCT01797120|592655677|FG000|Overall Study|Withdrawal by Subject|6|||
164079549|NCT01797120|592655678|FG001|Overall Study|Withdrawal by Subject|6|||
164079550|NCT01797120|592655677|FG000|Overall Study|Symptomatic progression|2|||
164079551|NCT01797120|592655678|FG001|Overall Study|Symptomatic progression|1|||
164079552|NCT01797120|592655677|FG000|Overall Study|Non-compliance|1|||
164079553|NCT01797120|592655678|FG001|Overall Study|Non-compliance|0|||
164079554|NCT01797120|592655677|FG000|Overall Study|Physician Decision|3|||
164079555|NCT01797120|592655678|FG001|Overall Study|Physician Decision|0|||
164079556|NCT01797120|592655677|FG000|Overall Study|still on treatment|2|||
164079557|NCT01797120|592655678|FG001|Overall Study|still on treatment|4|||
164079558|NCT01797120|592655677|FG000|Overall Study|never start protocol therapy|2|||
164079559|NCT01797120|592655678|FG001|Overall Study|never start protocol therapy|0|||
164221228|NCT00853047|593177876|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
164221229|NCT00853047|593177877|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
164221230|NCT00853047|593177878|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
164221231|NCT00853047|593177879|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
164221232|NCT02638493|593177880|FG000|Overall Study|Inability to provide semen samples|2|||
164221233|NCT02638493|593177881|FG001|Overall Study|Inability to provide semen samples|0|||
164221234|NCT02638493|593177882|FG002|Overall Study|Inability to provide semen samples|0|||
164221235|NCT01569763|593179929|FG000|Overall Study|Lack of Efficacy|2|||
164221236|NCT01569763|593179930|FG001|Overall Study|Lack of Efficacy|7|||
164221237|NCT01569763|593179929|FG000|Overall Study|Adverse Event|1|||
164221238|NCT01569763|593179930|FG001|Overall Study|Adverse Event|0|||
164221239|NCT01926509|593179931|FG000|Overall Study|vital sign met discontinuation criteria|1|||
164221240|NCT01926509|593179932|FG001|Overall Study|vital sign met discontinuation criteria|0|||
164221241|NCT01926509|593179933|FG002|Overall Study|vital sign met discontinuation criteria|0|||
164221242|NCT01926509|593179934|FG003|Overall Study|vital sign met discontinuation criteria|0|||
164221243|NCT02730169|593179935|FG000|Overall Study|Protocol Violation|1|||
164221244|NCT02730169|593179936|FG001|Overall Study|Protocol Violation|0|||
164221245|NCT02730169|593179937|FG002|Overall Study|Protocol Violation|0|||
164221246|NCT02730169|593179938|FG003|Overall Study|Protocol Violation|1|||
164221247|NCT02730169|593179935|FG000|Overall Study|Adverse Event|2|||
164221248|NCT02730169|593179936|FG001|Overall Study|Adverse Event|3|||
164221249|NCT02730169|593179937|FG002|Overall Study|Adverse Event|3|||
164221250|NCT02730169|593179938|FG003|Overall Study|Adverse Event|0|||
164221251|NCT02730169|593179935|FG000|Overall Study|Adverse Event of Special Interest|0|||
164221252|NCT02730169|593179936|FG001|Overall Study|Adverse Event of Special Interest|1|||
164221253|NCT02730169|593179937|FG002|Overall Study|Adverse Event of Special Interest|2|||
164221254|NCT02730169|593179938|FG003|Overall Study|Adverse Event of Special Interest|0|||
164221255|NCT02730169|593179935|FG000|Overall Study|Withdrawal by Subject|6|||
164221256|NCT02730169|593179936|FG001|Overall Study|Withdrawal by Subject|11|||
164221257|NCT02730169|593179937|FG002|Overall Study|Withdrawal by Subject|6|||
164221258|NCT02730169|593179938|FG003|Overall Study|Withdrawal by Subject|8|||
164221259|NCT02730169|593179935|FG000|Overall Study|Lost to Follow-up|5|||
164221260|NCT02730169|593179936|FG001|Overall Study|Lost to Follow-up|6|||
164221261|NCT02730169|593179937|FG002|Overall Study|Lost to Follow-up|5|||
164221262|NCT02730169|593179938|FG003|Overall Study|Lost to Follow-up|6|||
164221263|NCT02730169|593179935|FG000|Overall Study|Other|0|||
164221264|NCT02730169|593179936|FG001|Overall Study|Other|0|||
164221265|NCT02730169|593179937|FG002|Overall Study|Other|1|||
164221266|NCT02730169|593179938|FG003|Overall Study|Other|1|||
164221267|NCT03004183|593179939|FG000|Overall Study|Adverse Event|7|||
164221268|NCT03004183|593179939|FG000|Overall Study|Lost to Follow-up|1|||
164221269|NCT03004183|593179939|FG000|Overall Study|Physician Decision|40|||
164221270|NCT03004183|593179939|FG000|Overall Study|Withdrawal by Subject|1|||
164221271|NCT03004183|593179939|FG000|Overall Study|COVID-19|1|||
164221272|NCT02698787|593179943|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
164221273|NCT02698787|593179944|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
164221274|NCT02533674|593179950|FG000|Dose Level I|Progressive disease|1|||
164221275|NCT02533674|593179951|FG001|Dose Level I|Progressive disease|0|||
164221276|NCT02533674|593179952|FG002|Dose Level I|Progressive disease|0|||
164221277|NCT02533674|593179953|FG003|Dose Level I|Progressive disease|0|||
164221278|NCT02533674|593179954|FG004|Dose Level I|Progressive disease|0|||
163879024|NCT06066541|591926630|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
163879025|NCT06066541|591926631|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
163879026|NCT06066541|591926632|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
164079560|NCT05751629|592655696|FG000|Overall Study|Withdrawal by Subject|6|||
164079561|NCT05751629|592655696|FG000|Overall Study|Death|25|||
164079562|NCT05751629|592655696|FG000|Overall Study|Study Site Closed|9|||
164221279|NCT02533674|593179955|FG005|Dose Level I|Progressive disease|0|||
164221280|NCT02533674|593179956|FG006|Dose Level I|Progressive disease|0|||
163879027|NCT06066541|591926633|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
164079563|NCT05751629|592655696|FG000|Overall Study|Physician Decision|1|||
164079564|NCT01909466|592655698|FG000|Overall Study|Lost to Follow-up|5|||
164079565|NCT01909466|592655699|FG001|Overall Study|Lost to Follow-up|7|||
164221281|NCT02533674|593179957|FG007|Dose Level I|Progressive disease|0|||
164221282|NCT02533674|593179950|FG000|Dose Level I|Withdrawal by Subject|1|||
164221283|NCT02533674|593179951|FG001|Dose Level I|Withdrawal by Subject|0|||
164221284|NCT02533674|593179952|FG002|Dose Level I|Withdrawal by Subject|0|||
164221285|NCT02533674|593179953|FG003|Dose Level I|Withdrawal by Subject|0|||
164221286|NCT02533674|593179954|FG004|Dose Level I|Withdrawal by Subject|0|||
164221287|NCT02533674|593179955|FG005|Dose Level I|Withdrawal by Subject|0|||
164221288|NCT02533674|593179956|FG006|Dose Level I|Withdrawal by Subject|0|||
164221289|NCT02533674|593179957|FG007|Dose Level I|Withdrawal by Subject|0|||
164221290|NCT02533674|593179950|FG000|Dose Level I|Physician Decision|1|||
164221291|NCT02533674|593179951|FG001|Dose Level I|Physician Decision|0|||
164221292|NCT02533674|593179952|FG002|Dose Level I|Physician Decision|0|||
164221293|NCT02533674|593179953|FG003|Dose Level I|Physician Decision|0|||
164221294|NCT02533674|593179954|FG004|Dose Level I|Physician Decision|0|||
164221295|NCT02533674|593179955|FG005|Dose Level I|Physician Decision|0|||
164221296|NCT02533674|593179956|FG006|Dose Level I|Physician Decision|0|||
164221297|NCT02533674|593179957|FG007|Dose Level I|Physician Decision|0|||
164221298|NCT02533674|593179950|FG000|Dose Level I|Death|1|||
164221299|NCT02533674|593179951|FG001|Dose Level I|Death|0|||
164221300|NCT02533674|593179952|FG002|Dose Level I|Death|0|||
164221301|NCT02533674|593179953|FG003|Dose Level I|Death|0|||
164221302|NCT02533674|593179954|FG004|Dose Level I|Death|0|||
164221303|NCT02533674|593179955|FG005|Dose Level I|Death|0|||
164221304|NCT02533674|593179956|FG006|Dose Level I|Death|0|||
164221305|NCT02533674|593179957|FG007|Dose Level I|Death|0|||
164221306|NCT02533674|593179950|FG000|Dose Level I|Never Treated|1|||
164221307|NCT02533674|593179951|FG001|Dose Level I|Never Treated|0|||
164221308|NCT02533674|593179952|FG002|Dose Level I|Never Treated|0|||
164221309|NCT02533674|593179953|FG003|Dose Level I|Never Treated|0|||
164221310|NCT02533674|593179954|FG004|Dose Level I|Never Treated|0|||
164221311|NCT02533674|593179955|FG005|Dose Level I|Never Treated|0|||
164221312|NCT02533674|593179956|FG006|Dose Level I|Never Treated|0|||
164221313|NCT02533674|593179957|FG007|Dose Level I|Never Treated|0|||
164221314|NCT02533674|593179950|FG000|Dose Level II|Progressive disease|0|||
164221315|NCT02533674|593179951|FG001|Dose Level II|Progressive disease|3|||
164221316|NCT02533674|593179952|FG002|Dose Level II|Progressive disease|0|||
164221317|NCT02533674|593179953|FG003|Dose Level II|Progressive disease|0|||
164221318|NCT02533674|593179954|FG004|Dose Level II|Progressive disease|0|||
164221319|NCT02533674|593179955|FG005|Dose Level II|Progressive disease|0|||
164221320|NCT02533674|593179956|FG006|Dose Level II|Progressive disease|0|||
164221321|NCT02533674|593179957|FG007|Dose Level II|Progressive disease|0|||
164221322|NCT02533674|593179950|FG000|Dose Level II|Withdrawal by Subject|0|||
164221323|NCT02533674|593179951|FG001|Dose Level II|Withdrawal by Subject|1|||
164221324|NCT02533674|593179952|FG002|Dose Level II|Withdrawal by Subject|0|||
164221325|NCT02533674|593179953|FG003|Dose Level II|Withdrawal by Subject|0|||
164221326|NCT02533674|593179954|FG004|Dose Level II|Withdrawal by Subject|0|||
164221327|NCT02533674|593179955|FG005|Dose Level II|Withdrawal by Subject|0|||
164221328|NCT02533674|593179956|FG006|Dose Level II|Withdrawal by Subject|0|||
164221329|NCT02533674|593179957|FG007|Dose Level II|Withdrawal by Subject|0|||
164221330|NCT02533674|593179950|FG000|Dose Level II|Treatment-related AE|0|||
164221331|NCT02533674|593179951|FG001|Dose Level II|Treatment-related AE|1|||
164221332|NCT02533674|593179952|FG002|Dose Level II|Treatment-related AE|0|||
164221333|NCT02533674|593179953|FG003|Dose Level II|Treatment-related AE|0|||
164221334|NCT02533674|593179954|FG004|Dose Level II|Treatment-related AE|0|||
164221335|NCT02533674|593179955|FG005|Dose Level II|Treatment-related AE|0|||
164221336|NCT02533674|593179956|FG006|Dose Level II|Treatment-related AE|0|||
164221337|NCT02533674|593179957|FG007|Dose Level II|Treatment-related AE|0|||
164221338|NCT02533674|593179950|FG000|Dose Level II|Physician Decision|0|||
164221339|NCT02533674|593179951|FG001|Dose Level II|Physician Decision|1|||
164221340|NCT02533674|593179952|FG002|Dose Level II|Physician Decision|0|||
164079566|NCT01909466|592655698|FG000|Overall Study|Adverse Event|3|||
164079567|NCT01909466|592655699|FG001|Overall Study|Adverse Event|4|||
164079568|NCT01909466|592655698|FG000|Overall Study|Met Withdrawal Criteria|0|||
164079569|NCT01909466|592655699|FG001|Overall Study|Met Withdrawal Criteria|3|||
164079570|NCT01909466|592655698|FG000|Overall Study|Physician Decision|2|||
164079571|NCT01909466|592655699|FG001|Overall Study|Physician Decision|0|||
164221341|NCT02533674|593179953|FG003|Dose Level II|Physician Decision|0|||
164221342|NCT02533674|593179954|FG004|Dose Level II|Physician Decision|0|||
164221343|NCT02533674|593179955|FG005|Dose Level II|Physician Decision|0|||
164079572|NCT01909466|592655698|FG000|Overall Study|Withdrawal by Subject|11|||
164221344|NCT02533674|593179956|FG006|Dose Level II|Physician Decision|0|||
164221345|NCT02533674|593179957|FG007|Dose Level II|Physician Decision|0|||
164221346|NCT02533674|593179950|FG000|Dose Level II|Non-treatment-related AE|0|||
164221347|NCT02533674|593179951|FG001|Dose Level II|Non-treatment-related AE|1|||
164221348|NCT02533674|593179952|FG002|Dose Level II|Non-treatment-related AE|0|||
164221349|NCT02533674|593179953|FG003|Dose Level II|Non-treatment-related AE|0|||
163982281|NCT01662440|592306454|FG003|Overall Study|Withdrawal by Subject|2|||
163982282|NCT00112905|592306455|FG000|Overall Study|Adverse Event|4|||
163982283|NCT00112905|592306455|FG000|Overall Study|Death|1|||
163982284|NCT00112905|592306455|FG000|Overall Study|Ineligibility|5|||
163982285|NCT00112905|592306455|FG000|Overall Study|Alternative treatment|1|||
163982286|NCT00112905|592306455|FG000|Overall Study|performance status was deteiorating|1|||
163982287|NCT01765673|592306456|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
163982288|NCT02600507|592306457|FG000|Overall Study|Adverse Event|3|||
163982289|NCT02600507|592306458|FG001|Overall Study|Adverse Event|15|||
163982290|NCT02600507|592306459|FG002|Overall Study|Adverse Event|5|||
163982291|NCT02600507|592306457|FG000|Overall Study|Lack of Efficacy|3|||
163982292|NCT02600507|592306458|FG001|Overall Study|Lack of Efficacy|8|||
163982293|NCT02600507|592306459|FG002|Overall Study|Lack of Efficacy|5|||
163982294|NCT02600507|592306457|FG000|Overall Study|Lost to Follow-up|3|||
163982295|NCT02600507|592306458|FG001|Overall Study|Lost to Follow-up|5|||
163982296|NCT02600507|592306459|FG002|Overall Study|Lost to Follow-up|2|||
163982297|NCT02600507|592306457|FG000|Overall Study|Protocol Violation|12|||
163982298|NCT02600507|592306458|FG001|Overall Study|Protocol Violation|4|||
163982299|NCT02600507|592306459|FG002|Overall Study|Protocol Violation|4|||
163982300|NCT02600507|592306457|FG000|Overall Study|Physician Decision|1|||
163982301|NCT02600507|592306458|FG001|Overall Study|Physician Decision|0|||
163982302|NCT02600507|592306459|FG002|Overall Study|Physician Decision|1|||
163982303|NCT02600507|592306457|FG000|Overall Study|Withdrawal by Subject|7|||
163982304|NCT02600507|592306458|FG001|Overall Study|Withdrawal by Subject|11|||
163982305|NCT02600507|592306459|FG002|Overall Study|Withdrawal by Subject|7|||
163982306|NCT02600507|592306457|FG000|Overall Study|Other|0|||
163982307|NCT02600507|592306458|FG001|Overall Study|Other|1|||
163982308|NCT02600507|592306459|FG002|Overall Study|Other|1|||
163982309|NCT04541004|592306462|FG000|Overall Study|Adverse Event|2|||
163982310|NCT05048719|592306463|FG000|Overall Study|Withdrawal by Subject|2|||
163982311|NCT05048719|592306464|FG001|Overall Study|Withdrawal by Subject|1|||
163982312|NCT05048719|592306465|FG002|Overall Study|Withdrawal by Subject|3|||
163982313|NCT05048719|592306466|FG003|Overall Study|Withdrawal by Subject|1|||
163982314|NCT05048719|592306467|FG004|Overall Study|Withdrawal by Subject|0|||
163982315|NCT05048719|592306468|FG005|Overall Study|Withdrawal by Subject|2|||
163982316|NCT05048719|592306469|FG006|Overall Study|Withdrawal by Subject|1|||
163982317|NCT05048719|592306470|FG007|Overall Study|Withdrawal by Subject|1|||
163982318|NCT05048719|592306471|FG008|Overall Study|Withdrawal by Subject|0|||
163982319|NCT05048719|592306463|FG000|Overall Study|Death|1|||
163982320|NCT05048719|592306464|FG001|Overall Study|Death|0|||
163982321|NCT05048719|592306465|FG002|Overall Study|Death|0|||
163982322|NCT05048719|592306466|FG003|Overall Study|Death|0|||
163982323|NCT05048719|592306467|FG004|Overall Study|Death|0|||
163982324|NCT05048719|592306468|FG005|Overall Study|Death|0|||
163982325|NCT05048719|592306469|FG006|Overall Study|Death|0|||
163982326|NCT05048719|592306470|FG007|Overall Study|Death|0|||
163982327|NCT05048719|592306471|FG008|Overall Study|Death|0|||
163982328|NCT05048719|592306463|FG000|Overall Study|Adverse Event|0|||
163982329|NCT05048719|592306464|FG001|Overall Study|Adverse Event|1|||
163982330|NCT05048719|592306465|FG002|Overall Study|Adverse Event|2|||
163982331|NCT05048719|592306466|FG003|Overall Study|Adverse Event|0|||
163982332|NCT05048719|592306467|FG004|Overall Study|Adverse Event|1|||
163982333|NCT05048719|592306468|FG005|Overall Study|Adverse Event|0|||
163982334|NCT05048719|592306469|FG006|Overall Study|Adverse Event|0|||
163982335|NCT05048719|592306470|FG007|Overall Study|Adverse Event|0|||
163982336|NCT05048719|592306471|FG008|Overall Study|Adverse Event|0|||
163982337|NCT05048719|592306463|FG000|Overall Study|Lost to Follow-up|0|||
163982338|NCT05048719|592306464|FG001|Overall Study|Lost to Follow-up|0|||
163982339|NCT05048719|592306465|FG002|Overall Study|Lost to Follow-up|1|||
163982340|NCT05048719|592306466|FG003|Overall Study|Lost to Follow-up|3|||
163982341|NCT05048719|592306467|FG004|Overall Study|Lost to Follow-up|1|||
163982342|NCT05048719|592306468|FG005|Overall Study|Lost to Follow-up|1|||
163982343|NCT05048719|592306469|FG006|Overall Study|Lost to Follow-up|1|||
164221350|NCT02533674|593179954|FG004|Dose Level II|Non-treatment-related AE|0|||
163982344|NCT05048719|592306470|FG007|Overall Study|Lost to Follow-up|1|||
163982345|NCT05048719|592306471|FG008|Overall Study|Lost to Follow-up|0|||
163982346|NCT05048719|592306463|FG000|Overall Study|Physician Decision|0|||
163982347|NCT05048719|592306464|FG001|Overall Study|Physician Decision|0|||
163982348|NCT05048719|592306465|FG002|Overall Study|Physician Decision|0|||
163982349|NCT05048719|592306466|FG003|Overall Study|Physician Decision|0|||
163982350|NCT05048719|592306467|FG004|Overall Study|Physician Decision|0|||
163982351|NCT05048719|592306468|FG005|Overall Study|Physician Decision|0|||
163982352|NCT05048719|592306469|FG006|Overall Study|Physician Decision|0|||
163982353|NCT05048719|592306470|FG007|Overall Study|Physician Decision|1|||
163879028|NCT06066541|591926634|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
163879029|NCT06066541|591926635|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
163879030|NCT04533022|591926636|FG000|Overall Study|Withdrawal by Subject|15|||
163879031|NCT04533022|591926636|FG000|Overall Study|Adverse Event|6|||
163879032|NCT04533022|591926636|FG000|Overall Study|Death|1|||
163879033|NCT04533022|591926636|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
163879034|NCT04533022|591926636|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
163879035|NCT02163447|591926637|FG000|Overall Study|Withdrawal by Subject|2|||
163879036|NCT02163447|591926638|FG001|Overall Study|Withdrawal by Subject|0|||
163879037|NCT02163447|591926639|FG002|Overall Study|Withdrawal by Subject|1|||
163879038|NCT02163447|591926637|FG000|Overall Study|Lost to Follow-up|1|||
163879039|NCT02163447|591926638|FG001|Overall Study|Lost to Follow-up|3|||
163879040|NCT02163447|591926639|FG002|Overall Study|Lost to Follow-up|0|||
163879041|NCT02163447|591926637|FG000|Overall Study|Moved out of study area|2|||
163879042|NCT02163447|591926638|FG001|Overall Study|Moved out of study area|3|||
163879043|NCT02163447|591926639|FG002|Overall Study|Moved out of study area|2|||
163879044|NCT02163447|591926637|FG000|Overall Study|Became HIV infected at time of delivery|1|||
163879045|NCT02163447|591926638|FG001|Overall Study|Became HIV infected at time of delivery|0|||
163879046|NCT02163447|591926639|FG002|Overall Study|Became HIV infected at time of delivery|0|||
163879047|NCT03897686|591926640|FG000|Overall Study|Protocol Violation|1|||
163879048|NCT03897686|591926641|FG001|Overall Study|Protocol Violation|1|||
163879049|NCT03897686|591926640|FG000|Overall Study|Withdrawal by Subject|1|||
163879050|NCT03897686|591926641|FG001|Overall Study|Withdrawal by Subject|1|||
163879051|NCT05415436|591926642|FG000|Overall Study|Surgeon cancelled procedure|1|||
163879052|NCT05415436|591926643|FG001|Overall Study|Surgeon cancelled procedure|0|||
163982354|NCT05048719|592306471|FG008|Overall Study|Physician Decision|1|||
163982355|NCT05048719|592306463|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
163879053|NCT05415436|591926642|FG000|Overall Study|Death|1|||
163879054|NCT05415436|591926643|FG001|Overall Study|Death|0|||
163982356|NCT05048719|592306464|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982357|NCT05048719|592306465|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982358|NCT05048719|592306466|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982359|NCT05048719|592306467|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982360|NCT05048719|592306468|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982361|NCT05048719|592306469|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982362|NCT05048719|592306470|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982363|NCT05048719|592306471|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
163982364|NCT05048719|592306463|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982365|NCT05048719|592306464|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
163982366|NCT05048719|592306465|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982367|NCT05048719|592306466|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982368|NCT05048719|592306467|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982369|NCT05048719|592306468|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982370|NCT05048719|592306469|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982371|NCT05048719|592306470|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982372|NCT05048719|592306471|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
163982373|NCT05048719|592306463|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982374|NCT05048719|592306464|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
163982375|NCT05048719|592306465|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982376|NCT05048719|592306466|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982377|NCT05048719|592306467|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982378|NCT05048719|592306468|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982379|NCT05048719|592306469|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982380|NCT05048719|592306470|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982381|NCT05048719|592306471|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
163982382|NCT05048719|592306463|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163982383|NCT05048719|592306464|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163982384|NCT05048719|592306465|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163982385|NCT05048719|592306466|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
163982386|NCT05048719|592306467|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164138287|NCT00715624|592868456|FG000|Overall Study|Lost to Follow-up|1|||
164138288|NCT00715624|592868457|FG001|Overall Study|Lost to Follow-up|2|||
164138289|NCT00715624|592868456|FG000|Overall Study|Protocol Violation|1|||
164138290|NCT00715624|592868457|FG001|Overall Study|Protocol Violation|0|||
164221351|NCT02533674|593179955|FG005|Dose Level II|Non-treatment-related AE|0|||
164221352|NCT02533674|593179956|FG006|Dose Level II|Non-treatment-related AE|0|||
164221353|NCT02533674|593179957|FG007|Dose Level II|Non-treatment-related AE|0|||
164221354|NCT02533674|593179950|FG000|Dose Level III|Progressive disease|0|||
164221355|NCT02533674|593179951|FG001|Dose Level III|Progressive disease|0|||
164221356|NCT02533674|593179952|FG002|Dose Level III|Progressive disease|2|||
164221357|NCT02533674|593179953|FG003|Dose Level III|Progressive disease|0|||
164221358|NCT02533674|593179954|FG004|Dose Level III|Progressive disease|0|||
164221359|NCT02533674|593179955|FG005|Dose Level III|Progressive disease|0|||
164221360|NCT02533674|593179956|FG006|Dose Level III|Progressive disease|0|||
164221361|NCT02533674|593179957|FG007|Dose Level III|Progressive disease|0|||
164221362|NCT02533674|593179950|FG000|Dose Level III|Withdrawal by Subject|0|||
164221363|NCT02533674|593179951|FG001|Dose Level III|Withdrawal by Subject|0|||
164221364|NCT02533674|593179952|FG002|Dose Level III|Withdrawal by Subject|1|||
164221365|NCT02533674|593179953|FG003|Dose Level III|Withdrawal by Subject|0|||
164221366|NCT02533674|593179954|FG004|Dose Level III|Withdrawal by Subject|0|||
164221367|NCT02533674|593179955|FG005|Dose Level III|Withdrawal by Subject|0|||
164221368|NCT02533674|593179956|FG006|Dose Level III|Withdrawal by Subject|0|||
164221369|NCT02533674|593179957|FG007|Dose Level III|Withdrawal by Subject|0|||
164221370|NCT02533674|593179950|FG000|Dose Level III|Treatment-related AE|0|||
164221371|NCT02533674|593179951|FG001|Dose Level III|Treatment-related AE|0|||
164221372|NCT02533674|593179952|FG002|Dose Level III|Treatment-related AE|1|||
164221373|NCT02533674|593179953|FG003|Dose Level III|Treatment-related AE|0|||
164221374|NCT02533674|593179954|FG004|Dose Level III|Treatment-related AE|0|||
164221375|NCT02533674|593179955|FG005|Dose Level III|Treatment-related AE|0|||
164221376|NCT02533674|593179956|FG006|Dose Level III|Treatment-related AE|0|||
164221377|NCT02533674|593179957|FG007|Dose Level III|Treatment-related AE|0|||
164221378|NCT02533674|593179950|FG000|Dose Level IV|Progressive disease|0|||
164221379|NCT02533674|593179951|FG001|Dose Level IV|Progressive disease|0|||
164221380|NCT02533674|593179952|FG002|Dose Level IV|Progressive disease|0|||
164221381|NCT02533674|593179953|FG003|Dose Level IV|Progressive disease|3|||
164221382|NCT02533674|593179954|FG004|Dose Level IV|Progressive disease|0|||
164221383|NCT02533674|593179955|FG005|Dose Level IV|Progressive disease|0|||
164221384|NCT02533674|593179956|FG006|Dose Level IV|Progressive disease|0|||
164221385|NCT02533674|593179957|FG007|Dose Level IV|Progressive disease|0|||
164221386|NCT02533674|593179950|FG000|Dose Level IV|Withdrawal by Subject|0|||
164221387|NCT02533674|593179951|FG001|Dose Level IV|Withdrawal by Subject|0|||
164221388|NCT02533674|593179952|FG002|Dose Level IV|Withdrawal by Subject|0|||
164221389|NCT02533674|593179953|FG003|Dose Level IV|Withdrawal by Subject|1|||
164221390|NCT02533674|593179954|FG004|Dose Level IV|Withdrawal by Subject|0|||
164221391|NCT02533674|593179955|FG005|Dose Level IV|Withdrawal by Subject|0|||
164221392|NCT02533674|593179956|FG006|Dose Level IV|Withdrawal by Subject|0|||
164221393|NCT02533674|593179957|FG007|Dose Level IV|Withdrawal by Subject|0|||
164221394|NCT02533674|593179950|FG000|Dose Level IV|Physician Decision|0|||
164221395|NCT02533674|593179951|FG001|Dose Level IV|Physician Decision|0|||
164221396|NCT02533674|593179952|FG002|Dose Level IV|Physician Decision|0|||
164221397|NCT02533674|593179953|FG003|Dose Level IV|Physician Decision|1|||
164221398|NCT02533674|593179954|FG004|Dose Level IV|Physician Decision|0|||
164221399|NCT02533674|593179955|FG005|Dose Level IV|Physician Decision|0|||
164221400|NCT02533674|593179956|FG006|Dose Level IV|Physician Decision|0|||
164221401|NCT02533674|593179957|FG007|Dose Level IV|Physician Decision|0|||
164221402|NCT02533674|593179950|FG000|Dose Level V|Progressive disease|0|||
164221403|NCT02533674|593179951|FG001|Dose Level V|Progressive disease|0|||
164221404|NCT02533674|593179952|FG002|Dose Level V|Progressive disease|0|||
164221405|NCT02533674|593179953|FG003|Dose Level V|Progressive disease|0|||
164221406|NCT02533674|593179954|FG004|Dose Level V|Progressive disease|3|||
164221407|NCT02533674|593179955|FG005|Dose Level V|Progressive disease|0|||
164221408|NCT02533674|593179956|FG006|Dose Level V|Progressive disease|0|||
164221409|NCT02533674|593179957|FG007|Dose Level V|Progressive disease|0|||
164221410|NCT02533674|593179950|FG000|Dose Level V|Withdrawal by Subject|0|||
164329063|NCT03500679|593581284|FG001|Overall Study|Lost to Follow-up|3|||
164329064|NCT03500679|593581283|FG000|Overall Study|Withdrawal by Subject|3|||
164329065|NCT03500679|593581284|FG001|Overall Study|Withdrawal by Subject|0|||
164329066|NCT00744471|593581286|FG000|Overall Study|Randomized but not treated|1|||
164221411|NCT02533674|593179951|FG001|Dose Level V|Withdrawal by Subject|0|||
164221412|NCT02533674|593179952|FG002|Dose Level V|Withdrawal by Subject|0|||
164221413|NCT02533674|593179953|FG003|Dose Level V|Withdrawal by Subject|0|||
164221414|NCT02533674|593179954|FG004|Dose Level V|Withdrawal by Subject|1|||
164329067|NCT00744471|593581287|FG001|Overall Study|Randomized but not treated|1|||
164221415|NCT02533674|593179955|FG005|Dose Level V|Withdrawal by Subject|0|||
164221416|NCT02533674|593179956|FG006|Dose Level V|Withdrawal by Subject|0|||
164221417|NCT02533674|593179957|FG007|Dose Level V|Withdrawal by Subject|0|||
164221418|NCT02533674|593179950|FG000|Dose Level V|Physician Decision|0|||
164221419|NCT02533674|593179951|FG001|Dose Level V|Physician Decision|0|||
164221420|NCT02533674|593179952|FG002|Dose Level V|Physician Decision|0|||
164221421|NCT02533674|593179953|FG003|Dose Level V|Physician Decision|0|||
164221422|NCT02533674|593179954|FG004|Dose Level V|Physician Decision|1|||
164221423|NCT02533674|593179955|FG005|Dose Level V|Physician Decision|0|||
164221424|NCT02533674|593179956|FG006|Dose Level V|Physician Decision|0|||
164221425|NCT02533674|593179957|FG007|Dose Level V|Physician Decision|0|||
164221426|NCT02533674|593179950|FG000|Dose Level VI|Progressive disease|0|||
164221427|NCT02533674|593179951|FG001|Dose Level VI|Progressive disease|0|||
164221428|NCT02533674|593179952|FG002|Dose Level VI|Progressive disease|0|||
164221429|NCT02533674|593179953|FG003|Dose Level VI|Progressive disease|0|||
164221430|NCT02533674|593179954|FG004|Dose Level VI|Progressive disease|0|||
164221431|NCT02533674|593179955|FG005|Dose Level VI|Progressive disease|7|||
164221432|NCT02533674|593179956|FG006|Dose Level VI|Progressive disease|0|||
164221433|NCT02533674|593179957|FG007|Dose Level VI|Progressive disease|0|||
164221434|NCT02533674|593179950|FG000|Dose Level VI|Withdrawal by Subject|0|||
164221435|NCT02533674|593179951|FG001|Dose Level VI|Withdrawal by Subject|0|||
164221436|NCT02533674|593179952|FG002|Dose Level VI|Withdrawal by Subject|0|||
164221437|NCT02533674|593179953|FG003|Dose Level VI|Withdrawal by Subject|0|||
164221438|NCT02533674|593179954|FG004|Dose Level VI|Withdrawal by Subject|0|||
164221439|NCT02533674|593179955|FG005|Dose Level VI|Withdrawal by Subject|1|||
164221440|NCT02533674|593179956|FG006|Dose Level VI|Withdrawal by Subject|0|||
164221441|NCT02533674|593179957|FG007|Dose Level VI|Withdrawal by Subject|0|||
164221442|NCT02533674|593179950|FG000|Dose Level VI|Treatment-related AE|0|||
164221443|NCT02533674|593179951|FG001|Dose Level VI|Treatment-related AE|0|||
164221444|NCT02533674|593179952|FG002|Dose Level VI|Treatment-related AE|0|||
164221445|NCT02533674|593179953|FG003|Dose Level VI|Treatment-related AE|0|||
164221446|NCT02533674|593179954|FG004|Dose Level VI|Treatment-related AE|0|||
164221447|NCT02533674|593179955|FG005|Dose Level VI|Treatment-related AE|1|||
164221448|NCT02533674|593179956|FG006|Dose Level VI|Treatment-related AE|0|||
164221449|NCT02533674|593179957|FG007|Dose Level VI|Treatment-related AE|0|||
164221450|NCT02533674|593179950|FG000|Dose Level VII|Progressive disease|0|||
164221451|NCT02533674|593179951|FG001|Dose Level VII|Progressive disease|0|||
164221452|NCT02533674|593179952|FG002|Dose Level VII|Progressive disease|0|||
164221453|NCT02533674|593179953|FG003|Dose Level VII|Progressive disease|0|||
164221454|NCT02533674|593179954|FG004|Dose Level VII|Progressive disease|0|||
164221455|NCT02533674|593179955|FG005|Dose Level VII|Progressive disease|0|||
164221456|NCT02533674|593179956|FG006|Dose Level VII|Progressive disease|10|||
164221457|NCT02533674|593179957|FG007|Dose Level VII|Progressive disease|0|||
164221458|NCT02533674|593179950|FG000|Dose Level VII|Withdrawal by Subject|0|||
164221459|NCT02533674|593179951|FG001|Dose Level VII|Withdrawal by Subject|0|||
164221460|NCT02533674|593179952|FG002|Dose Level VII|Withdrawal by Subject|0|||
164221461|NCT02533674|593179953|FG003|Dose Level VII|Withdrawal by Subject|0|||
164221462|NCT02533674|593179954|FG004|Dose Level VII|Withdrawal by Subject|0|||
164221463|NCT02533674|593179955|FG005|Dose Level VII|Withdrawal by Subject|0|||
164221464|NCT02533674|593179956|FG006|Dose Level VII|Withdrawal by Subject|3|||
164221465|NCT02533674|593179957|FG007|Dose Level VII|Withdrawal by Subject|0|||
164221466|NCT02533674|593179950|FG000|Dose Level VII|Treatment-related AE|0|||
164221467|NCT02533674|593179951|FG001|Dose Level VII|Treatment-related AE|0|||
164221468|NCT02533674|593179952|FG002|Dose Level VII|Treatment-related AE|0|||
164221469|NCT02533674|593179953|FG003|Dose Level VII|Treatment-related AE|0|||
164221470|NCT02533674|593179954|FG004|Dose Level VII|Treatment-related AE|0|||
164221471|NCT02533674|593179955|FG005|Dose Level VII|Treatment-related AE|0|||
164221472|NCT02533674|593179956|FG006|Dose Level VII|Treatment-related AE|1|||
164221473|NCT02533674|593179957|FG007|Dose Level VII|Treatment-related AE|0|||
164221474|NCT02533674|593179950|FG000|Dose Level VII|Death|0|||
164221475|NCT02533674|593179951|FG001|Dose Level VII|Death|0|||
164221476|NCT02533674|593179952|FG002|Dose Level VII|Death|0|||
164221477|NCT02533674|593179953|FG003|Dose Level VII|Death|0|||
164221478|NCT02533674|593179954|FG004|Dose Level VII|Death|0|||
164221479|NCT02533674|593179955|FG005|Dose Level VII|Death|0|||
164221480|NCT02533674|593179956|FG006|Dose Level VII|Death|2|||
164221481|NCT02533674|593179957|FG007|Dose Level VII|Death|0|||
164221482|NCT02533674|593179950|FG000|Dose Level VIII|Progressive disease|0|||
164221483|NCT02533674|593179951|FG001|Dose Level VIII|Progressive disease|0|||
164221484|NCT02533674|593179952|FG002|Dose Level VIII|Progressive disease|0|||
164221485|NCT02533674|593179953|FG003|Dose Level VIII|Progressive disease|0|||
164221486|NCT02533674|593179954|FG004|Dose Level VIII|Progressive disease|0|||
164221487|NCT02533674|593179955|FG005|Dose Level VIII|Progressive disease|0|||
164221488|NCT02533674|593179956|FG006|Dose Level VIII|Progressive disease|0|||
164221489|NCT02533674|593179957|FG007|Dose Level VIII|Progressive disease|3|||
164221490|NCT02533674|593179950|FG000|Dose Level VIII|Withdrawal by Subject|0|||
164221491|NCT02533674|593179951|FG001|Dose Level VIII|Withdrawal by Subject|0|||
164221492|NCT02533674|593179952|FG002|Dose Level VIII|Withdrawal by Subject|0|||
164221493|NCT02533674|593179953|FG003|Dose Level VIII|Withdrawal by Subject|0|||
164221494|NCT02533674|593179954|FG004|Dose Level VIII|Withdrawal by Subject|0|||
164221495|NCT02533674|593179955|FG005|Dose Level VIII|Withdrawal by Subject|0|||
164221496|NCT02533674|593179956|FG006|Dose Level VIII|Withdrawal by Subject|0|||
164221497|NCT02533674|593179957|FG007|Dose Level VIII|Withdrawal by Subject|1|||
164221498|NCT02533674|593179950|FG000|Dose Level VIII|Treatment-related AE|0|||
164221499|NCT02533674|593179951|FG001|Dose Level VIII|Treatment-related AE|0|||
164221500|NCT02533674|593179952|FG002|Dose Level VIII|Treatment-related AE|0|||
164221501|NCT02533674|593179953|FG003|Dose Level VIII|Treatment-related AE|0|||
164221502|NCT02533674|593179954|FG004|Dose Level VIII|Treatment-related AE|0|||
164221503|NCT02533674|593179955|FG005|Dose Level VIII|Treatment-related AE|0|||
164221504|NCT02533674|593179956|FG006|Dose Level VIII|Treatment-related AE|0|||
164221505|NCT02533674|593179957|FG007|Dose Level VIII|Treatment-related AE|1|||
164221506|NCT02533674|593179950|FG000|Dose Level VIII|Never treated|0|||
164221507|NCT02533674|593179951|FG001|Dose Level VIII|Never treated|0|||
164221508|NCT02533674|593179952|FG002|Dose Level VIII|Never treated|0|||
164221509|NCT02533674|593179953|FG003|Dose Level VIII|Never treated|0|||
164221510|NCT02533674|593179954|FG004|Dose Level VIII|Never treated|0|||
164221511|NCT02533674|593179955|FG005|Dose Level VIII|Never treated|0|||
164221512|NCT02533674|593179956|FG006|Dose Level VIII|Never treated|0|||
164221513|NCT02533674|593179957|FG007|Dose Level VIII|Never treated|1|||
164221514|NCT01160744|593179961|FG000|Overall Study|Withdrawal by Subject|11|||
164221515|NCT01160744|593179962|FG001|Overall Study|Withdrawal by Subject|5|||
164221516|NCT01160744|593179963|FG002|Overall Study|Withdrawal by Subject|6|||
164221517|NCT01160744|593179964|FG003|Overall Study|Withdrawal by Subject|4|||
164221518|NCT01160744|593179961|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
164221519|NCT01160744|593179962|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
164221520|NCT01160744|593179963|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
164221521|NCT01160744|593179964|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
164221522|NCT01502072|593179966|FG000|Overall Study|Withdrawal by Subject|1|||
164221523|NCT01502072|593179967|FG001|Overall Study|Withdrawal by Subject|0|||
164221524|NCT01502072|593179968|FG002|Overall Study|Withdrawal by Subject|0|||
163879055|NCT05386355|591926654|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163879056|NCT05386355|591926655|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
164079573|NCT01909466|592655699|FG001|Overall Study|Withdrawal by Subject|9|||
164079574|NCT01909466|592655698|FG000|Overall Study|Lack of Efficacy|1|||
164079575|NCT01909466|592655699|FG001|Overall Study|Lack of Efficacy|0|||
164079576|NCT00772577|592655702|FG000|Overall Study|Adverse Event|6|||
164079577|NCT00772577|592655703|FG001|Overall Study|Adverse Event|3|||
164079578|NCT00772577|592655702|FG000|Overall Study|Abnormal laboratory values|0|||
164079579|NCT00772577|592655703|FG001|Overall Study|Abnormal laboratory values|1|||
164079580|NCT00772577|592655702|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164079581|NCT00772577|592655703|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164079582|NCT00772577|592655702|FG000|Overall Study|Patient withdrew consent|8|||
164079583|NCT00772577|592655703|FG001|Overall Study|Patient withdrew consent|5|||
164079584|NCT00772577|592655702|FG000|Overall Study|Lost to Follow-up|4|||
164079585|NCT00772577|592655703|FG001|Overall Study|Lost to Follow-up|3|||
164079586|NCT00772577|592655702|FG000|Overall Study|Administrative problems|2|||
164079587|NCT00772577|592655703|FG001|Overall Study|Administrative problems|1|||
164079588|NCT00772577|592655702|FG000|Overall Study|Protocol Deviation|3|||
164079589|NCT00772577|592655703|FG001|Overall Study|Protocol Deviation|2|||
164079590|NCT00672620|592655704|FG000|Overall Study|Adverse Event|7|||
164079591|NCT00672620|592655705|FG001|Overall Study|Adverse Event|7|||
164079592|NCT00672620|592655706|FG002|Overall Study|Adverse Event|12|||
164079593|NCT00672620|592655707|FG003|Overall Study|Adverse Event|17|||
164079594|NCT00672620|592655704|FG000|Overall Study|Lack of Efficacy|1|||
164079595|NCT00672620|592655705|FG001|Overall Study|Lack of Efficacy|2|||
164079596|NCT00672620|592655706|FG002|Overall Study|Lack of Efficacy|2|||
164079597|NCT00672620|592655707|FG003|Overall Study|Lack of Efficacy|0|||
164079598|NCT00672620|592655704|FG000|Overall Study|Noncompliance with Study Drug|3|||
164079599|NCT00672620|592655705|FG001|Overall Study|Noncompliance with Study Drug|4|||
164079600|NCT00672620|592655706|FG002|Overall Study|Noncompliance with Study Drug|0|||
164079601|NCT00672620|592655707|FG003|Overall Study|Noncompliance with Study Drug|2|||
164079602|NCT00672620|592655704|FG000|Overall Study|Protocol Deviations|5|||
164079603|NCT00672620|592655705|FG001|Overall Study|Protocol Deviations|7|||
164079604|NCT00672620|592655706|FG002|Overall Study|Protocol Deviations|2|||
164079605|NCT00672620|592655707|FG003|Overall Study|Protocol Deviations|5|||
164079606|NCT00672620|592655704|FG000|Overall Study|Withdrawal of Consent|6|||
164079607|NCT00672620|592655705|FG001|Overall Study|Withdrawal of Consent|12|||
164079608|NCT00672620|592655706|FG002|Overall Study|Withdrawal of Consent|5|||
164079609|NCT00672620|592655707|FG003|Overall Study|Withdrawal of Consent|6|||
164079610|NCT00672620|592655704|FG000|Overall Study|Lost to Follow-up|8|||
164079611|NCT00672620|592655705|FG001|Overall Study|Lost to Follow-up|19|||
164079612|NCT00672620|592655706|FG002|Overall Study|Lost to Follow-up|8|||
164079613|NCT00672620|592655707|FG003|Overall Study|Lost to Follow-up|11|||
164221525|NCT01502072|593179966|FG000|Overall Study|Death|0|||
164221526|NCT01502072|593179967|FG001|Overall Study|Death|1|||
164221527|NCT01502072|593179968|FG002|Overall Study|Death|0|||
164221528|NCT02773537|593179976|FG000|Overall Study|Lost to Follow-up|0|||
164221529|NCT02773537|593179977|FG001|Overall Study|Lost to Follow-up|1|||
164221530|NCT02773537|593179978|FG002|Overall Study|Lost to Follow-up|4|||
164079614|NCT00672620|592655704|FG000|Overall Study|Reason not Specified|3|||
164079615|NCT00672620|592655705|FG001|Overall Study|Reason not Specified|3|||
164079616|NCT00672620|592655706|FG002|Overall Study|Reason not Specified|2|||
164079617|NCT00672620|592655707|FG003|Overall Study|Reason not Specified|1|||
164079618|NCT02965820|592655708|FG000|Period 2, Second 30 Days|Adverse Event|1|||
164079619|NCT02965820|592655709|FG001|Period 2, Second 30 Days|Adverse Event|1|||
164079620|NCT04272775|592655715|FG000|Overall Study|Study Terminated by Sponsor|1|||
164079621|NCT04272775|592655716|FG001|Overall Study|Study Terminated by Sponsor|0|||
164079622|NCT04272775|592655715|FG000|Overall Study|Protocol Violation|0|||
164079623|NCT04272775|592655716|FG001|Overall Study|Protocol Violation|1|||
164079624|NCT04272775|592655715|FG000|Overall Study|Symptomatic Deterioration|1|||
164079625|NCT04272775|592655716|FG001|Overall Study|Symptomatic Deterioration|1|||
164079626|NCT04272775|592655715|FG000|Overall Study|Withdrawal by Subject|1|||
164079627|NCT04272775|592655716|FG001|Overall Study|Withdrawal by Subject|2|||
164079628|NCT04272775|592655715|FG000|Overall Study|Adverse Event|1|||
164079629|NCT04272775|592655716|FG001|Overall Study|Adverse Event|2|||
164079630|NCT04272775|592655715|FG000|Overall Study|Progressive Disease|3|||
164079631|NCT04272775|592655716|FG001|Overall Study|Progressive Disease|1|||
164079632|NCT02063698|592655722|FG000|Overall Study|did not complete booklet for days 2-8|1|||
164079633|NCT02063698|592655723|FG001|Overall Study|did not complete booklet for days 2-8|2|||
163879057|NCT05386355|591926656|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163879058|NCT05386355|591926657|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
163879059|NCT03157167|591926660|FG000|Overall Study|Withdrawal by Subject|1|||
163879060|NCT03157167|591926661|FG001|Overall Study|Withdrawal by Subject|0|||
163879061|NCT03157167|591926662|FG002|Overall Study|Withdrawal by Subject|0|||
163879062|NCT03263026|591926665|FG000|Overall Study|Withdrawal by Subject|1|||
164079634|NCT01092702|592655724|FG000|Overall Study|Withdrawal by Subject|7|||
164079635|NCT01092702|592655724|FG000|Overall Study|Lost to Follow-up|2|||
164079636|NCT00449930|592655725|FG000|Overall Study|Adverse Event|9|||
164079637|NCT00449930|592655726|FG001|Overall Study|Adverse Event|19|||
164079638|NCT00449930|592655725|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
164079639|NCT00449930|592655726|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
164079640|NCT00449930|592655725|FG000|Overall Study|Lack of Efficacy|10|||
164079641|NCT00449930|592655726|FG001|Overall Study|Lack of Efficacy|1|||
164079642|NCT00449930|592655725|FG000|Overall Study|Lost to Follow-up|9|||
164079643|NCT00449930|592655726|FG001|Overall Study|Lost to Follow-up|14|||
164079644|NCT00449930|592655725|FG000|Overall Study|Physician Decision|1|||
164079645|NCT00449930|592655726|FG001|Overall Study|Physician Decision|2|||
164079646|NCT00449930|592655725|FG000|Overall Study|Protocol Violation|14|||
164079647|NCT00449930|592655726|FG001|Overall Study|Protocol Violation|15|||
164079648|NCT00449930|592655725|FG000|Overall Study|Withdrawal by Subject|16|||
164079649|NCT00449930|592655726|FG001|Overall Study|Withdrawal by Subject|23|||
164079650|NCT00449930|592655725|FG000|Overall Study|Glycemic discontinuation criteria|1|||
164079651|NCT00449930|592655726|FG001|Overall Study|Glycemic discontinuation criteria|1|||
164079652|NCT00575328|592655728|FG000|Overall Study|Adverse Event|1|||
164079653|NCT00575328|592655729|FG001|Overall Study|Adverse Event|1|||
164079654|NCT00575328|592655728|FG000|Overall Study|Lost to Follow-up|2|||
164079655|NCT00575328|592655729|FG001|Overall Study|Lost to Follow-up|1|||
164079656|NCT02124746|592655730|FG000|Overall Study|Adverse Event|2|||
164079657|NCT02124746|592655731|FG001|Overall Study|Adverse Event|1|||
164079658|NCT02124746|592655732|FG002|Overall Study|Adverse Event|2|||
164079659|NCT02124746|592655730|FG000|Overall Study|Death|2|||
164079660|NCT02124746|592655731|FG001|Overall Study|Death|1|||
164079661|NCT02124746|592655732|FG002|Overall Study|Death|3|||
164079662|NCT02124746|592655730|FG000|Overall Study|Lack of Efficacy|3|||
164079663|NCT02124746|592655731|FG001|Overall Study|Lack of Efficacy|2|||
164079664|NCT02124746|592655732|FG002|Overall Study|Lack of Efficacy|2|||
164079665|NCT02124746|592655730|FG000|Overall Study|Physician Decision|6|||
164079666|NCT02124746|592655731|FG001|Overall Study|Physician Decision|4|||
164079667|NCT02124746|592655732|FG002|Overall Study|Physician Decision|5|||
164079668|NCT02124746|592655730|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164079669|NCT02124746|592655731|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164079670|NCT02124746|592655732|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164079671|NCT02124746|592655730|FG000|Overall Study|Withdrawal by Subject|3|||
164079672|NCT02124746|592655731|FG001|Overall Study|Withdrawal by Subject|3|||
164079673|NCT02124746|592655732|FG002|Overall Study|Withdrawal by Subject|0|||
164221531|NCT01908699|593179985|FG000|Overall Study|Adverse Event|8|||
164079674|NCT02124746|592655730|FG000|Overall Study|Study Terminated by Sponsor|0|||
164079675|NCT02124746|592655731|FG001|Overall Study|Study Terminated by Sponsor|0|||
164079676|NCT02124746|592655732|FG002|Overall Study|Study Terminated by Sponsor|6|||
164079677|NCT02124746|592655730|FG000|Overall Study|Disease Progression|3|||
164079678|NCT02124746|592655731|FG001|Overall Study|Disease Progression|6|||
164079679|NCT02124746|592655732|FG002|Overall Study|Disease Progression|4|||
164079680|NCT01722266|592655733|FG000|Overall Study|Withdrawal by Subject|1|||
164079681|NCT01722266|592655734|FG001|Overall Study|Withdrawal by Subject|2|||
164079682|NCT01722266|592655735|FG002|Overall Study|Withdrawal by Subject|0|||
164079683|NCT01722266|592655736|FG003|Overall Study|Withdrawal by Subject|0|||
164079684|NCT01722266|592655733|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
164221532|NCT01908699|593179986|FG001|Overall Study|Adverse Event|12|||
164221533|NCT01908699|593179985|FG000|Overall Study|Lack of Efficacy|2|||
164221534|NCT01908699|593179986|FG001|Overall Study|Lack of Efficacy|2|||
164221535|NCT01908699|593179985|FG000|Overall Study|Lost to Follow-up|2|||
164221536|NCT01908699|593179986|FG001|Overall Study|Lost to Follow-up|4|||
164221537|NCT01908699|593179985|FG000|Overall Study|Physician Decision|8|||
164221538|NCT01908699|593179986|FG001|Overall Study|Physician Decision|8|||
164221539|NCT01908699|593179985|FG000|Overall Study|Withdrawal by Subject|15|||
164221540|NCT01908699|593179986|FG001|Overall Study|Withdrawal by Subject|10|||
164221541|NCT01908699|593179985|FG000|Overall Study|Pregnancy|0|||
164221542|NCT01908699|593179986|FG001|Overall Study|Pregnancy|1|||
164221543|NCT01908699|593179985|FG000|Overall Study|Randomized in Error|1|||
164221544|NCT01908699|593179986|FG001|Overall Study|Randomized in Error|0|||
164221545|NCT01908699|593179985|FG000|Overall Study|Death|9|||
164221546|NCT01908699|593179986|FG001|Overall Study|Death|12|||
164221547|NCT01908699|593179985|FG000|Overall Study|Progressive Disease|30|||
164221548|NCT01908699|593179986|FG001|Overall Study|Progressive Disease|29|||
164221549|NCT01697501|593179987|FG000|Overall Study|Protocol Violation|2|||
164221550|NCT02242903|593179988|FG000|Overall Study|Withdrawal by Subject|1|||
164221551|NCT02242903|593179989|FG001|Overall Study|Withdrawal by Subject|0|||
164221552|NCT02242903|593179990|FG002|Overall Study|Withdrawal by Subject|0|||
164221553|NCT02242903|593179991|FG003|Overall Study|Withdrawal by Subject|0|||
164221554|NCT02242903|593179992|FG004|Overall Study|Withdrawal by Subject|0|||
164221555|NCT02242903|593179993|FG005|Overall Study|Withdrawal by Subject|0|||
164221556|NCT02242903|593179994|FG006|Overall Study|Withdrawal by Subject|0|||
164221557|NCT02105012|593179995|FG000|Overall Study|Withdrawal by Subject|11|||
164221558|NCT02105012|593179995|FG000|Overall Study|Protocol Specified Criteria|9|||
164221559|NCT02105012|593179995|FG000|Overall Study|Lost to Follow-up|4|||
164221560|NCT02105012|593179995|FG000|Overall Study|Protocol Violation|4|||
164221561|NCT02105012|593179995|FG000|Overall Study|Physician Decision|3|||
164221562|NCT02105012|593179995|FG000|Overall Study|Adverse Event|1|||
164221563|NCT02105012|593179995|FG000|Overall Study|Lack of Efficacy|1|||
164221564|NCT00493285|593179996|FG000|Overall Study|Lost to Follow-up|0|||
164221565|NCT00493285|593179997|FG001|Overall Study|Lost to Follow-up|0|||
164221566|NCT00493285|593179998|FG002|Overall Study|Lost to Follow-up|0|||
164221567|NCT00493285|593179999|FG003|Overall Study|Lost to Follow-up|0|||
164221568|NCT00493285|593180000|FG004|Overall Study|Lost to Follow-up|1|||
164221569|NCT00493285|593180001|FG005|Overall Study|Lost to Follow-up|0|||
164221570|NCT03021005|593180002|FG000|Overall Study|Lost to Follow-up|39|||
164221571|NCT03021005|593180003|FG001|Overall Study|Lost to Follow-up|26|||
164221572|NCT03994120|593180010|FG000|Overall Study|Lost to Follow-up|3|||
164221573|NCT03994120|593180011|FG001|Overall Study|Lost to Follow-up|1|||
164221574|NCT00215553|593180012|FG000|Overall Study|Adverse Event|0|||
164221575|NCT00215553|593180013|FG001|Overall Study|Adverse Event|1|||
164221576|NCT00215553|593180014|FG002|Overall Study|Adverse Event|2|||
164221577|NCT00215553|593180015|FG003|Overall Study|Adverse Event|1|||
164221578|NCT00215553|593180016|FG004|Overall Study|Adverse Event|2|||
164221579|NCT00215553|593180017|FG005|Overall Study|Adverse Event|6|||
164221580|NCT00215553|593180018|FG006|Overall Study|Adverse Event|0|||
164221581|NCT01111292|593180019|FG000|Treatment|Physician Decision|1|||
164221582|NCT01111292|593180020|FG001|Treatment|Physician Decision|1|||
164221583|NCT01429623|593180021|FG000|Overall Study|Death|1|||
164221584|NCT01429623|593180022|FG001|Overall Study|Death|0|||
164221585|NCT01429623|593180021|FG000|Overall Study|Adverse Event|7|||
164221586|NCT01429623|593180022|FG001|Overall Study|Adverse Event|14|||
164221587|NCT01429623|593180021|FG000|Overall Study|Withdrawal by Subject|19|||
164221588|NCT01429623|593180022|FG001|Overall Study|Withdrawal by Subject|13|||
164221589|NCT01429623|593180021|FG000|Overall Study|Physician Decision|2|||
164221590|NCT01429623|593180022|FG001|Overall Study|Physician Decision|3|||
164221591|NCT01429623|593180021|FG000|Overall Study|Protocol Violation|3|||
164221592|NCT01429623|593180022|FG001|Overall Study|Protocol Violation|2|||
164221593|NCT01429623|593180021|FG000|Overall Study|Assorted|1|||
164221594|NCT01429623|593180022|FG001|Overall Study|Assorted|2|||
164221595|NCT01429623|593180021|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
164221596|NCT01429623|593180022|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
164221597|NCT01429623|593180021|FG000|Overall Study|No post baseline data|4|||
164221598|NCT01429623|593180022|FG001|Overall Study|No post baseline data|4|||
164221599|NCT03156621|593180023|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
164221600|NCT03156621|593180024|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
164221601|NCT03156621|593180023|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164221602|NCT03156621|593180024|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
164221603|NCT01259024|593180026|FG000|Overall Study|Physician Decision|1|||
164221604|NCT01657500|593180027|FG000|Overall Study|set impropperly matched|3|||
164221605|NCT01657500|593180028|FG001|Overall Study|set impropperly matched|3|||
164221606|NCT01657500|593180027|FG000|Overall Study|Lost to Follow-up|2|||
164221607|NCT01657500|593180028|FG001|Overall Study|Lost to Follow-up|2|||
164221608|NCT00756444|593180029|FG000|Overall Study|Adverse Event|1|||
164221609|NCT00756444|593180030|FG001|Overall Study|Adverse Event|1|||
164221610|NCT00756444|593180029|FG000|Overall Study|Withdrawal by Subject|6|||
164329068|NCT00744471|593581288|FG002|Overall Study|Randomized but not treated|4|||
164329069|NCT00744471|593581289|FG003|Overall Study|Randomized but not treated|0|||
164329070|NCT00744471|593581286|FG000|Overall Study|Death|0|||
164329071|NCT00744471|593581287|FG001|Overall Study|Death|0|||
164329072|NCT00744471|593581288|FG002|Overall Study|Death|0|||
164329073|NCT00744471|593581289|FG003|Overall Study|Death|1|||
164329074|NCT00744471|593581286|FG000|Overall Study|Adverse Event|6|||
164329075|NCT00744471|593581287|FG001|Overall Study|Adverse Event|7|||
164329076|NCT00744471|593581288|FG002|Overall Study|Adverse Event|5|||
164329077|NCT00744471|593581289|FG003|Overall Study|Adverse Event|9|||
164329078|NCT00744471|593581286|FG000|Overall Study|Withdrawal by Subject|9|||
164329079|NCT00744471|593581287|FG001|Overall Study|Withdrawal by Subject|9|||
164329080|NCT00744471|593581288|FG002|Overall Study|Withdrawal by Subject|15|||
164329081|NCT00744471|593581289|FG003|Overall Study|Withdrawal by Subject|12|||
164329082|NCT00744471|593581286|FG000|Overall Study|Protocol Violation|1|||
164329083|NCT00744471|593581287|FG001|Overall Study|Protocol Violation|4|||
164329084|NCT00744471|593581288|FG002|Overall Study|Protocol Violation|1|||
164329085|NCT00744471|593581289|FG003|Overall Study|Protocol Violation|2|||
164329086|NCT00744471|593581286|FG000|Overall Study|Entered extension study|41|||
164329087|NCT00744471|593581287|FG001|Overall Study|Entered extension study|84|||
164329088|NCT00744471|593581288|FG002|Overall Study|Entered extension study|100|||
164329089|NCT00744471|593581289|FG003|Overall Study|Entered extension study|91|||
164329090|NCT00744471|593581286|FG000|Overall Study|Other|2|||
164329091|NCT00744471|593581287|FG001|Overall Study|Other|3|||
164329092|NCT00744471|593581288|FG002|Overall Study|Other|6|||
164329093|NCT00744471|593581289|FG003|Overall Study|Other|2|||
164329094|NCT00744471|593581286|FG000|Overall Study|Lack of Efficacy|83|||
164329095|NCT00744471|593581287|FG001|Overall Study|Lack of Efficacy|37|||
164329096|NCT00744471|593581288|FG002|Overall Study|Lack of Efficacy|19|||
164329097|NCT00744471|593581289|FG003|Overall Study|Lack of Efficacy|31|||
164329098|NCT00744471|593581286|FG000|Overall Study|Lost to Follow-up|0|||
164329099|NCT00744471|593581287|FG001|Overall Study|Lost to Follow-up|0|||
164329100|NCT00744471|593581288|FG002|Overall Study|Lost to Follow-up|2|||
164329101|NCT00744471|593581289|FG003|Overall Study|Lost to Follow-up|0|||
164329102|NCT04706416|593581292|FG000|Overall Study|Lost to Follow-up|2|||
164329103|NCT04706416|593581293|FG001|Overall Study|Lost to Follow-up|0|||
164329104|NCT01280955|593581294|FG000|Overall Study|Death|2|||
164329105|NCT01280955|593581294|FG000|Overall Study|Withdrawal by Subject|1|||
164329106|NCT01484054|593581295|FG000|Period 1|Withdrawal by Subject|0|||
164329107|NCT01484054|593581296|FG001|Period 1|Withdrawal by Subject|1|||
164329108|NCT05281601|593581299|FG000|Overall Study|Physician Decision|2|||
164329109|NCT05281601|593581300|FG001|Overall Study|Physician Decision|0|||
164329110|NCT05281601|593581299|FG000|Overall Study|Lost to Follow-up|2|||
164329111|NCT05281601|593581300|FG001|Overall Study|Lost to Follow-up|0|||
164329112|NCT05281601|593581299|FG000|Overall Study|Death|1|||
164329113|NCT05281601|593581300|FG001|Overall Study|Death|0|||
164329114|NCT05281601|593581299|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164329115|NCT05281601|593581300|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164329116|NCT00901927|593581303|FG000|Overall Study|Lack of Efficacy|1|||
164329117|NCT00901927|593581303|FG000|Overall Study|Protocol Violation|3|||
164329118|NCT00901927|593581303|FG000|Overall Study|Withdrawal by Subject|2|||
164329119|NCT03119701|593581316|FG000|6-day Dosing|Death|4|||
164329120|NCT03119701|593581317|FG001|6-day Dosing|Death|1|||
164329121|NCT03119701|593581316|FG000|6-day Dosing|Adverse Event|3|||
164329122|NCT03119701|593581317|FG001|6-day Dosing|Adverse Event|0|||
164329123|NCT03119701|593581316|FG000|6-day Dosing|Physician Decision|0|||
164138445|NCT00724048|592868525|FG002|Overall Study|Lost to Follow-up|0|||
164138446|NCT00724048|592868526|FG003|Overall Study|Lost to Follow-up|0|||
164138447|NCT00724048|592868523|FG000|Overall Study|Withdrawal by Subject|1|||
164138448|NCT00724048|592868524|FG001|Overall Study|Withdrawal by Subject|2|||
164138449|NCT00724048|592868525|FG002|Overall Study|Withdrawal by Subject|1|||
164138450|NCT00724048|592868526|FG003|Overall Study|Withdrawal by Subject|2|||
164138451|NCT00724048|592868523|FG000|Overall Study|Investigator decision|0|||
164138452|NCT00724048|592868524|FG001|Overall Study|Investigator decision|0|||
164138453|NCT00724048|592868525|FG002|Overall Study|Investigator decision|1|||
164138454|NCT00724048|592868526|FG003|Overall Study|Investigator decision|0|||
164138455|NCT00724048|592868523|FG000|Overall Study|Did not tolerate study drug|0|||
164138456|NCT00724048|592868524|FG001|Overall Study|Did not tolerate study drug|0|||
164138457|NCT00724048|592868525|FG002|Overall Study|Did not tolerate study drug|0|||
164138458|NCT00724048|592868526|FG003|Overall Study|Did not tolerate study drug|1|||
164138459|NCT00724048|592868523|FG000|Overall Study|Other than specified|1|||
164138460|NCT00724048|592868524|FG001|Overall Study|Other than specified|1|||
164138461|NCT00724048|592868525|FG002|Overall Study|Other than specified|0|||
164138462|NCT00724048|592868526|FG003|Overall Study|Other than specified|0|||
164138463|NCT04874155|592868527|FG000|Overall Study|Lost to Follow-up|1|||
164138464|NCT04874155|592868528|FG001|Overall Study|Lost to Follow-up|1|||
164138465|NCT04874155|592868527|FG000|Overall Study|Withdrawal by Subject|2|||
164138466|NCT04874155|592868528|FG001|Overall Study|Withdrawal by Subject|2|||
164138467|NCT06281171|592868531|FG000|Timepoint 2|Lost to Follow-up|6|||
164221611|NCT00756444|593180030|FG001|Overall Study|Withdrawal by Subject|8|||
164221612|NCT00756444|593180029|FG000|Overall Study|Lost to Follow-up|0|||
164221613|NCT00756444|593180030|FG001|Overall Study|Lost to Follow-up|1|||
164221614|NCT00756444|593180029|FG000|Overall Study|Death|5|||
164221615|NCT00756444|593180030|FG001|Overall Study|Death|4|||
164221616|NCT00756444|593180029|FG000|Overall Study|Disease Progression|2|||
164221617|NCT00756444|593180030|FG001|Overall Study|Disease Progression|7|||
164221618|NCT00756444|593180029|FG000|Overall Study|Ineligibility Determined|1|||
164221619|NCT00756444|593180030|FG001|Overall Study|Ineligibility Determined|0|||
164221620|NCT01530997|593180031|FG000|Overall Study|Physician Decision|1|||
164221621|NCT01530997|593180031|FG000|Overall Study|Withdrawal by Subject|1|||
164221622|NCT02318277|593180033|FG000|Overall Study|Physician Decision|0|||
164221623|NCT02318277|593180034|FG001|Overall Study|Physician Decision|0|||
164221624|NCT02318277|593180035|FG002|Overall Study|Physician Decision|0|||
164221625|NCT02318277|593180036|FG003|Overall Study|Physician Decision|0|||
164221626|NCT02318277|593180037|FG004|Overall Study|Physician Decision|0|||
164221627|NCT02318277|593180038|FG005|Overall Study|Physician Decision|0|||
164221628|NCT02318277|593180039|FG006|Overall Study|Physician Decision|0|||
164221629|NCT02318277|593180040|FG007|Overall Study|Physician Decision|1|||
164221630|NCT02318277|593180033|FG000|Overall Study|Other|0|||
164221631|NCT02318277|593180034|FG001|Overall Study|Other|0|||
164221632|NCT02318277|593180035|FG002|Overall Study|Other|0|||
164221633|NCT02318277|593180036|FG003|Overall Study|Other|0|||
164221634|NCT02318277|593180037|FG004|Overall Study|Other|0|||
164221635|NCT02318277|593180038|FG005|Overall Study|Other|0|||
164221636|NCT02318277|593180039|FG006|Overall Study|Other|1|||
164221637|NCT02318277|593180040|FG007|Overall Study|Other|0|||
164221638|NCT02318277|593180033|FG000|Overall Study|Withdrawal by Subject|0|||
164221639|NCT02318277|593180034|FG001|Overall Study|Withdrawal by Subject|0|||
164221640|NCT02318277|593180035|FG002|Overall Study|Withdrawal by Subject|1|||
164221641|NCT02318277|593180036|FG003|Overall Study|Withdrawal by Subject|0|||
164221642|NCT02318277|593180037|FG004|Overall Study|Withdrawal by Subject|1|||
164221643|NCT02318277|593180038|FG005|Overall Study|Withdrawal by Subject|1|||
164221644|NCT02318277|593180039|FG006|Overall Study|Withdrawal by Subject|6|||
164221645|NCT02318277|593180040|FG007|Overall Study|Withdrawal by Subject|14|||
164221646|NCT02318277|593180033|FG000|Overall Study|Participant trial terminated by sponsor|0|||
164221647|NCT02318277|593180034|FG001|Overall Study|Participant trial terminated by sponsor|0|||
164221648|NCT02318277|593180035|FG002|Overall Study|Participant trial terminated by sponsor|1|||
164221649|NCT02318277|593180036|FG003|Overall Study|Participant trial terminated by sponsor|0|||
164221650|NCT02318277|593180037|FG004|Overall Study|Participant trial terminated by sponsor|1|||
164221651|NCT02318277|593180038|FG005|Overall Study|Participant trial terminated by sponsor|2|||
164221652|NCT02318277|593180039|FG006|Overall Study|Participant trial terminated by sponsor|5|||
164221653|NCT02318277|593180040|FG007|Overall Study|Participant trial terminated by sponsor|16|||
164221654|NCT02318277|593180033|FG000|Overall Study|Lost to Follow-up|1|||
164221655|NCT02318277|593180034|FG001|Overall Study|Lost to Follow-up|0|||
164221656|NCT02318277|593180035|FG002|Overall Study|Lost to Follow-up|1|||
164221657|NCT02318277|593180036|FG003|Overall Study|Lost to Follow-up|0|||
164221658|NCT02318277|593180037|FG004|Overall Study|Lost to Follow-up|0|||
164221659|NCT02318277|593180038|FG005|Overall Study|Lost to Follow-up|0|||
164221660|NCT02318277|593180039|FG006|Overall Study|Lost to Follow-up|3|||
164221661|NCT02318277|593180040|FG007|Overall Study|Lost to Follow-up|4|||
164221662|NCT02318277|593180033|FG000|Overall Study|Death|5|||
164221663|NCT02318277|593180034|FG001|Overall Study|Death|3|||
164221664|NCT02318277|593180035|FG002|Overall Study|Death|1|||
164221665|NCT02318277|593180036|FG003|Overall Study|Death|4|||
164221666|NCT02318277|593180037|FG004|Overall Study|Death|6|||
164221667|NCT02318277|593180038|FG005|Overall Study|Death|5|||
164221668|NCT02318277|593180039|FG006|Overall Study|Death|34|||
164221669|NCT02318277|593180040|FG007|Overall Study|Death|58|||
164221670|NCT02318277|593180033|FG000|Overall Study|Transitioned to Hospice|0|||
164221671|NCT02318277|593180034|FG001|Overall Study|Transitioned to Hospice|0|||
163879063|NCT03263026|591926666|FG001|Overall Study|Withdrawal by Subject|0|||
164329124|NCT03119701|593581317|FG001|6-day Dosing|Physician Decision|1|||
163879064|NCT03263026|591926665|FG000|Overall Study|Death|1|||
163879065|NCT03263026|591926666|FG001|Overall Study|Death|0|||
164221672|NCT02318277|593180035|FG002|Overall Study|Transitioned to Hospice|0|||
164221673|NCT02318277|593180036|FG003|Overall Study|Transitioned to Hospice|0|||
164329125|NCT03119701|593581316|FG000|6-day Dosing|Withdrawal by Subject|0|||
164221674|NCT02318277|593180037|FG004|Overall Study|Transitioned to Hospice|0|||
164221675|NCT02318277|593180038|FG005|Overall Study|Transitioned to Hospice|1|||
164221676|NCT02318277|593180039|FG006|Overall Study|Transitioned to Hospice|0|||
164329126|NCT03119701|593581317|FG001|6-day Dosing|Withdrawal by Subject|1|||
164221677|NCT02318277|593180040|FG007|Overall Study|Transitioned to Hospice|0|||
164221678|NCT03566550|593180042|FG000|Overall Study|Withdrawal by Subject|0|||
164221679|NCT03566550|593180043|FG001|Overall Study|Withdrawal by Subject|1|||
164221680|NCT02829957|593180046|FG000|Overall Study|Lost to Follow-up|2|||
164329127|NCT03119701|593581316|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
164221681|NCT02829957|593180047|FG001|Overall Study|Lost to Follow-up|1|||
164221682|NCT03511066|593180048|FG000|Overall Study|Withdrawal by Subject|1|||
164221683|NCT03511066|593180049|FG001|Overall Study|Withdrawal by Subject|2|||
164221684|NCT03511066|593180050|FG002|Overall Study|Withdrawal by Subject|3|||
164221685|NCT03511066|593180048|FG000|Overall Study|Lost to Follow-up|2|||
164221686|NCT03511066|593180049|FG001|Overall Study|Lost to Follow-up|3|||
164221687|NCT03511066|593180050|FG002|Overall Study|Lost to Follow-up|0|||
164221688|NCT03113136|593180055|FG000|Overall Study|Lost to Follow-up|22|||
164221689|NCT03113136|593180056|FG001|Overall Study|Lost to Follow-up|47|||
164221690|NCT03113136|593180057|FG002|Overall Study|Lost to Follow-up|54|||
164221691|NCT03113136|593180055|FG000|Overall Study|Withdrawal by Subject|4|||
164221692|NCT03113136|593180056|FG001|Overall Study|Withdrawal by Subject|13|||
164221693|NCT03113136|593180057|FG002|Overall Study|Withdrawal by Subject|14|||
164221694|NCT03113136|593180055|FG000|Overall Study|Ineligible|0|||
164221695|NCT03113136|593180056|FG001|Overall Study|Ineligible|2|||
164221696|NCT03113136|593180057|FG002|Overall Study|Ineligible|1|||
164221697|NCT03113136|593180055|FG000|Overall Study|Study Team Decision|1|||
164221698|NCT03113136|593180056|FG001|Overall Study|Study Team Decision|4|||
164221699|NCT03113136|593180057|FG002|Overall Study|Study Team Decision|0|||
164221700|NCT02675452|593180059|FG000|Overall Study|Sponsor decision|0|||
164221701|NCT02675452|593180060|FG001|Overall Study|Sponsor decision|0|||
164221702|NCT02675452|593180061|FG002|Overall Study|Sponsor decision|0|||
164221703|NCT02675452|593180062|FG003|Overall Study|Sponsor decision|0|||
164221704|NCT02675452|593180063|FG004|Overall Study|Sponsor decision|0|||
164221705|NCT02675452|593180064|FG005|Overall Study|Sponsor decision|0|||
164221706|NCT02675452|593180065|FG006|Overall Study|Sponsor decision|0|||
164221707|NCT02675452|593180066|FG007|Overall Study|Sponsor decision|0|||
164221708|NCT02675452|593180067|FG008|Overall Study|Sponsor decision|0|||
164221709|NCT02675452|593180068|FG009|Overall Study|Sponsor decision|1|||
164221710|NCT02675452|593180069|FG010|Overall Study|Sponsor decision|0|||
164221711|NCT02675452|593180070|FG011|Overall Study|Sponsor decision|0|||
164221712|NCT02675452|593180071|FG012|Overall Study|Sponsor decision|0|||
164221713|NCT02675452|593180072|FG013|Overall Study|Sponsor decision|2|||
164221714|NCT02675452|593180073|FG014|Overall Study|Sponsor decision|1|||
164221715|NCT02675452|593180074|FG015|Overall Study|Sponsor decision|0|||
164221716|NCT02675452|593180075|FG016|Overall Study|Sponsor decision|1|||
164221717|NCT02675452|593180076|FG017|Overall Study|Sponsor decision|0|||
164221718|NCT02675452|593180077|FG018|Overall Study|Sponsor decision|0|||
164221719|NCT02675452|593180078|FG019|Overall Study|Sponsor decision|0|||
164221720|NCT02675452|593180079|FG020|Overall Study|Sponsor decision|0|||
164221721|NCT02675452|593180080|FG021|Overall Study|Sponsor decision|0|||
164221722|NCT02675452|593180081|FG022|Overall Study|Sponsor decision|0|||
164221723|NCT02675452|593180082|FG023|Overall Study|Sponsor decision|0|||
164221724|NCT02675452|593180083|FG024|Overall Study|Sponsor decision|0|||
164221725|NCT02675452|593180084|FG025|Overall Study|Sponsor decision|0|||
164221726|NCT02675452|593180085|FG026|Overall Study|Sponsor decision|2|||
164221727|NCT02675452|593180086|FG027|Overall Study|Sponsor decision|0|||
164221728|NCT02675452|593180087|FG028|Overall Study|Sponsor decision|0|||
164221729|NCT02675452|593180059|FG000|Overall Study|Withdrawal by Subject|0|||
164221730|NCT02675452|593180060|FG001|Overall Study|Withdrawal by Subject|0|||
164221731|NCT02675452|593180061|FG002|Overall Study|Withdrawal by Subject|0|||
164221732|NCT02675452|593180062|FG003|Overall Study|Withdrawal by Subject|0|||
164221733|NCT02675452|593180063|FG004|Overall Study|Withdrawal by Subject|0|||
164221734|NCT02675452|593180064|FG005|Overall Study|Withdrawal by Subject|0|||
164221735|NCT02675452|593180065|FG006|Overall Study|Withdrawal by Subject|0|||
164221736|NCT02675452|593180066|FG007|Overall Study|Withdrawal by Subject|0|||
164221737|NCT02675452|593180067|FG008|Overall Study|Withdrawal by Subject|0|||
164221738|NCT02675452|593180068|FG009|Overall Study|Withdrawal by Subject|1|||
164221739|NCT02675452|593180069|FG010|Overall Study|Withdrawal by Subject|0|||
163982387|NCT05048719|592306468|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
164006620|NCT00847613|592391042|FG001|Overall Study|Ongoing at cut-off date|265|||
164221740|NCT02675452|593180070|FG011|Overall Study|Withdrawal by Subject|1|||
164221741|NCT02675452|593180071|FG012|Overall Study|Withdrawal by Subject|0|||
164221742|NCT02675452|593180072|FG013|Overall Study|Withdrawal by Subject|1|||
164221743|NCT02675452|593180073|FG014|Overall Study|Withdrawal by Subject|1|||
164221744|NCT02675452|593180074|FG015|Overall Study|Withdrawal by Subject|0|||
164221745|NCT02675452|593180075|FG016|Overall Study|Withdrawal by Subject|2|||
164221746|NCT02675452|593180076|FG017|Overall Study|Withdrawal by Subject|0|||
164221747|NCT02675452|593180077|FG018|Overall Study|Withdrawal by Subject|0|||
164221748|NCT02675452|593180078|FG019|Overall Study|Withdrawal by Subject|0|||
164221749|NCT02675452|593180079|FG020|Overall Study|Withdrawal by Subject|0|||
164221750|NCT02675452|593180080|FG021|Overall Study|Withdrawal by Subject|0|||
164221751|NCT02675452|593180081|FG022|Overall Study|Withdrawal by Subject|3|||
164221752|NCT02675452|593180082|FG023|Overall Study|Withdrawal by Subject|0|||
164221753|NCT02675452|593180083|FG024|Overall Study|Withdrawal by Subject|1|||
164221754|NCT02675452|593180084|FG025|Overall Study|Withdrawal by Subject|0|||
164221755|NCT02675452|593180085|FG026|Overall Study|Withdrawal by Subject|1|||
164221756|NCT02675452|593180086|FG027|Overall Study|Withdrawal by Subject|3|||
164221757|NCT02675452|593180087|FG028|Overall Study|Withdrawal by Subject|4|||
164221758|NCT02675452|593180059|FG000|Overall Study|Death|0|||
164221759|NCT02675452|593180060|FG001|Overall Study|Death|0|||
164221760|NCT02675452|593180061|FG002|Overall Study|Death|1|||
164221761|NCT02675452|593180062|FG003|Overall Study|Death|0|||
164221762|NCT02675452|593180063|FG004|Overall Study|Death|0|||
164221763|NCT02675452|593180064|FG005|Overall Study|Death|1|||
164221764|NCT02675452|593180065|FG006|Overall Study|Death|0|||
164221765|NCT02675452|593180066|FG007|Overall Study|Death|0|||
164221766|NCT02675452|593180067|FG008|Overall Study|Death|1|||
164221767|NCT02675452|593180068|FG009|Overall Study|Death|0|||
164221768|NCT02675452|593180069|FG010|Overall Study|Death|0|||
164221769|NCT02675452|593180070|FG011|Overall Study|Death|0|||
164221770|NCT02675452|593180071|FG012|Overall Study|Death|1|||
164221771|NCT02675452|593180072|FG013|Overall Study|Death|0|||
164221772|NCT02675452|593180073|FG014|Overall Study|Death|0|||
164221773|NCT02675452|593180074|FG015|Overall Study|Death|2|||
164221774|NCT02675452|593180075|FG016|Overall Study|Death|0|||
164221775|NCT02675452|593180076|FG017|Overall Study|Death|0|||
164221776|NCT02675452|593180077|FG018|Overall Study|Death|4|||
164221777|NCT02675452|593180078|FG019|Overall Study|Death|3|||
164221778|NCT02675452|593180079|FG020|Overall Study|Death|3|||
164221779|NCT02675452|593180080|FG021|Overall Study|Death|3|||
164221780|NCT02675452|593180081|FG022|Overall Study|Death|7|||
164221781|NCT02675452|593180082|FG023|Overall Study|Death|5|||
164221782|NCT02675452|593180083|FG024|Overall Study|Death|3|||
164221783|NCT02675452|593180084|FG025|Overall Study|Death|4|||
164221784|NCT02675452|593180085|FG026|Overall Study|Death|7|||
164221785|NCT02675452|593180086|FG027|Overall Study|Death|6|||
164221786|NCT02675452|593180087|FG028|Overall Study|Death|9|||
164221787|NCT02675452|593180059|FG000|Overall Study|Lost to Follow-up|0|||
164221788|NCT02675452|593180060|FG001|Overall Study|Lost to Follow-up|1|||
164221789|NCT02675452|593180061|FG002|Overall Study|Lost to Follow-up|0|||
164221790|NCT02675452|593180062|FG003|Overall Study|Lost to Follow-up|0|||
164221791|NCT02675452|593180063|FG004|Overall Study|Lost to Follow-up|0|||
164221792|NCT02675452|593180064|FG005|Overall Study|Lost to Follow-up|0|||
164221793|NCT02675452|593180065|FG006|Overall Study|Lost to Follow-up|0|||
164221794|NCT02675452|593180066|FG007|Overall Study|Lost to Follow-up|0|||
164221795|NCT02675452|593180067|FG008|Overall Study|Lost to Follow-up|0|||
164221796|NCT02675452|593180068|FG009|Overall Study|Lost to Follow-up|0|||
164221797|NCT02675452|593180069|FG010|Overall Study|Lost to Follow-up|0|||
164221798|NCT02675452|593180070|FG011|Overall Study|Lost to Follow-up|0|||
164221799|NCT02675452|593180071|FG012|Overall Study|Lost to Follow-up|1|||
163879066|NCT03263026|591926665|FG000|Overall Study|Other/ Various|41|||
163879067|NCT03263026|591926666|FG001|Overall Study|Other/ Various|29|||
163879068|NCT03775109|591926668|FG000|Overall Study|Adverse Event|1|||
163879069|NCT03775109|591926669|FG001|Overall Study|Adverse Event|0|||
163879070|NCT03775109|591926668|FG000|Overall Study|COVID-19 outbreak|2|||
163879071|NCT03775109|591926669|FG001|Overall Study|COVID-19 outbreak|0|||
163879072|NCT03775109|591926668|FG000|Overall Study|Lost to Follow-up|0|||
163879073|NCT03775109|591926669|FG001|Overall Study|Lost to Follow-up|2|||
164221800|NCT02675452|593180072|FG013|Overall Study|Lost to Follow-up|0|||
164221801|NCT02675452|593180073|FG014|Overall Study|Lost to Follow-up|0|||
164221802|NCT02675452|593180074|FG015|Overall Study|Lost to Follow-up|0|||
164221803|NCT02675452|593180075|FG016|Overall Study|Lost to Follow-up|0|||
164221804|NCT02675452|593180076|FG017|Overall Study|Lost to Follow-up|0|||
164221805|NCT02675452|593180077|FG018|Overall Study|Lost to Follow-up|0|||
164221806|NCT02675452|593180078|FG019|Overall Study|Lost to Follow-up|0|||
164221807|NCT02675452|593180079|FG020|Overall Study|Lost to Follow-up|0|||
163879074|NCT03775109|591926668|FG000|Overall Study|Withdrawal by Subject|1|||
164221808|NCT02675452|593180080|FG021|Overall Study|Lost to Follow-up|0|||
164221809|NCT02675452|593180081|FG022|Overall Study|Lost to Follow-up|0|||
164221810|NCT02675452|593180082|FG023|Overall Study|Lost to Follow-up|0|||
164221811|NCT02675452|593180083|FG024|Overall Study|Lost to Follow-up|0|||
164221812|NCT02675452|593180084|FG025|Overall Study|Lost to Follow-up|0|||
164221813|NCT02675452|593180085|FG026|Overall Study|Lost to Follow-up|1|||
164221814|NCT02675452|593180086|FG027|Overall Study|Lost to Follow-up|0|||
163879075|NCT03775109|591926669|FG001|Overall Study|Withdrawal by Subject|1|||
163879076|NCT03775109|591926668|FG000|Overall Study|Death|0|||
164221815|NCT02675452|593180087|FG028|Overall Study|Lost to Follow-up|0|||
164221816|NCT02675452|593180059|FG000|Overall Study|Other|0|||
164221817|NCT02675452|593180060|FG001|Overall Study|Other|0|||
164221818|NCT02675452|593180061|FG002|Overall Study|Other|0|||
164221819|NCT02675452|593180062|FG003|Overall Study|Other|0|||
164221820|NCT02675452|593180063|FG004|Overall Study|Other|0|||
164221821|NCT02675452|593180064|FG005|Overall Study|Other|0|||
164079685|NCT01722266|592655734|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
164079686|NCT01722266|592655735|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
164079687|NCT01722266|592655736|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
164079688|NCT01722266|592655733|FG000|Overall Study|Dropped out due to Nausea|0|||
164079689|NCT01722266|592655734|FG001|Overall Study|Dropped out due to Nausea|0|||
164079690|NCT01722266|592655735|FG002|Overall Study|Dropped out due to Nausea|2|||
164079691|NCT01722266|592655736|FG003|Overall Study|Dropped out due to Nausea|0|||
164079692|NCT00124449|592655741|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
164079693|NCT00124449|592655742|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
164079694|NCT00124449|592655741|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
164079695|NCT00124449|592655742|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
164079696|NCT00124449|592655741|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
164079697|NCT00124449|592655742|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
164079698|NCT00124449|592655741|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
164079699|NCT00124449|592655742|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
164079700|NCT00124449|592655741|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
164079701|NCT00124449|592655742|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
164079702|NCT00124449|592655741|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
164079703|NCT00124449|592655742|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
164079704|NCT00124449|592655741|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
164079705|NCT00124449|592655742|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
164079706|NCT00124449|592655741|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
164079707|NCT00124449|592655742|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
164079708|NCT00124449|592655741|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
164079709|NCT00124449|592655742|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
164079710|NCT00124449|592655741|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
164079711|NCT00124449|592655742|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
164079712|NCT00124449|592655741|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
164079713|NCT00124449|592655742|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
164079714|NCT00124449|592655741|FG000|18-Month Untreated Observation Period|Relocated|1|||
164079715|NCT00124449|592655742|FG001|18-Month Untreated Observation Period|Relocated|0|||
164079716|NCT03811249|592655743|FG000|Overall Study|Withdrawal by Subject|44|||
164079717|NCT03811249|592655743|FG000|Overall Study|Missed Visit|24|||
164079718|NCT01504867|592655747|FG000|Overall Study|Inclusion criteria not met|2|||
164079719|NCT01504867|592655748|FG001|Overall Study|Inclusion criteria not met|2|||
164079720|NCT01504867|592655747|FG000|Overall Study|Consent revoked|5|||
164079721|NCT01504867|592655748|FG001|Overall Study|Consent revoked|1|||
164079722|NCT03124381|592655754|FG000|Overall Study|Lost to Follow-up|1|||
164079723|NCT03124381|592655755|FG001|Overall Study|Lost to Follow-up|1|||
164079724|NCT03124381|592655754|FG000|Overall Study|Withdrawal by Subject|6|||
164079725|NCT03124381|592655755|FG001|Overall Study|Withdrawal by Subject|3|||
164079726|NCT03124381|592655754|FG000|Overall Study|Protocol Violation|0|||
164079727|NCT03124381|592655755|FG001|Overall Study|Protocol Violation|1|||
164079728|NCT03124381|592655754|FG000|Overall Study|Adverse Event|1|||
164079729|NCT03124381|592655755|FG001|Overall Study|Adverse Event|1|||
164079730|NCT03124381|592655754|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
164079731|NCT03124381|592655755|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
164079732|NCT02473510|592655758|FG000|Overall Study|Lost to Follow-up|1|||
164079733|NCT02473510|592655759|FG001|Overall Study|Lost to Follow-up|2|||
164079734|NCT00990093|592655760|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
164079735|NCT00990093|592655761|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
164079736|NCT00990093|592655760|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
164079737|NCT00990093|592655761|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
164079738|NCT00990093|592655760|FG000|Test Period 1 (1-14 Days)|Other|1|||
164079739|NCT00990093|592655761|FG001|Test Period 1 (1-14 Days)|Other|0|||
164079740|NCT00990093|592655760|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
164079741|NCT00990093|592655761|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
164079742|NCT00990093|592655760|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
164079743|NCT00990093|592655761|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
164079744|NCT00990093|592655760|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
164079745|NCT00990093|592655761|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
164079746|NCT00990093|592655760|FG000|Test Period 2 (15-28 Days)|Other|0|||
164221822|NCT02675452|593180065|FG006|Overall Study|Other|0|||
164079747|NCT00990093|592655761|FG001|Test Period 2 (15-28 Days)|Other|1|||
164079748|NCT00378482|592655766|FG000|Overall Study|Lost to Follow-up|1|||
164221823|NCT02675452|593180066|FG007|Overall Study|Other|0|||
164079749|NCT00378482|592655766|FG000|Overall Study|Lack of Efficacy|8|||
164079750|NCT00378482|592655766|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
164079751|NCT00378482|592655766|FG000|Overall Study|Withdrawal by Subject|4|||
164079752|NCT00378482|592655766|FG000|Overall Study|Adverse Event|9|||
164079753|NCT03185949|592655767|FG000|ITT Analysis|Withdrawal by Subject|4|||
164221824|NCT02675452|593180067|FG008|Overall Study|Other|0|||
164221825|NCT02675452|593180068|FG009|Overall Study|Other|0|||
164221826|NCT02675452|593180069|FG010|Overall Study|Other|0|||
164221827|NCT02675452|593180070|FG011|Overall Study|Other|0|||
164221828|NCT02675452|593180071|FG012|Overall Study|Other|0|||
164221829|NCT02675452|593180072|FG013|Overall Study|Other|0|||
164221830|NCT02675452|593180073|FG014|Overall Study|Other|0|||
164221831|NCT02675452|593180074|FG015|Overall Study|Other|0|||
164221832|NCT02675452|593180075|FG016|Overall Study|Other|0|||
164221833|NCT02675452|593180076|FG017|Overall Study|Other|0|||
164221834|NCT02675452|593180077|FG018|Overall Study|Other|0|||
164221835|NCT02675452|593180078|FG019|Overall Study|Other|0|||
164221836|NCT02675452|593180079|FG020|Overall Study|Other|0|||
164221837|NCT02675452|593180080|FG021|Overall Study|Other|0|||
164221838|NCT02675452|593180081|FG022|Overall Study|Other|0|||
164221839|NCT02675452|593180082|FG023|Overall Study|Other|0|||
164221840|NCT02675452|593180083|FG024|Overall Study|Other|0|||
164221841|NCT02675452|593180084|FG025|Overall Study|Other|0|||
164221842|NCT02675452|593180085|FG026|Overall Study|Other|1|||
164221843|NCT02675452|593180086|FG027|Overall Study|Other|0|||
164221844|NCT02675452|593180087|FG028|Overall Study|Other|0|||
164221845|NCT03467945|593180088|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164221846|NCT03467945|593180089|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164221847|NCT03467945|593180090|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164221848|NCT03467945|593180091|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164221849|NCT03467945|593180088|FG000|Treatment Period 3|Withdrawal by Subject|1|||
164221850|NCT03467945|593180089|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164221851|NCT03467945|593180090|FG002|Treatment Period 3|Withdrawal by Subject|2|||
164221852|NCT03467945|593180091|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164221853|NCT00977561|593180092|FG000|Overall Study|Death|3|||
164221854|NCT00977561|593180093|FG001|Overall Study|Death|2|||
164221855|NCT00977561|593180092|FG000|Overall Study|Study terminated|0|||
164221856|NCT00977561|593180093|FG001|Overall Study|Study terminated|2|||
164221857|NCT00977561|593180092|FG000|Overall Study|Other|2|||
164221858|NCT00977561|593180093|FG001|Overall Study|Other|0|||
164221859|NCT02218268|593180094|FG000|24 Hour Washout|Physician Decision|11|||
164221860|NCT02218268|593180095|FG001|24 Hour Washout|Physician Decision|9|||
164221861|NCT03651336|593180096|FG000|Overall Study|Withdrawal by Subject|4|||
164221862|NCT01341990|593180097|FG000|Overall Study|Adverse Event|0|||
164221863|NCT01341990|593180098|FG001|Overall Study|Adverse Event|1|||
164221864|NCT01341990|593180097|FG000|Overall Study|Torn Study Lens|1|||
164221865|NCT01341990|593180098|FG001|Overall Study|Torn Study Lens|0|||
164221866|NCT01341990|593180097|FG000|Overall Study|Withdrawal by Subject|2|||
164221867|NCT01341990|593180098|FG001|Overall Study|Withdrawal by Subject|0|||
164221868|NCT01125748|593180100|FG000|Overall Study|Adverse Event|0|||
164221869|NCT01125748|593180101|FG001|Overall Study|Adverse Event|2|||
164221870|NCT01125748|593180100|FG000|Overall Study|Lost to Follow-up|0|||
164221871|NCT01125748|593180101|FG001|Overall Study|Lost to Follow-up|1|||
164221872|NCT01125748|593180100|FG000|Overall Study|Physician Decision|8|||
164221873|NCT01125748|593180101|FG001|Overall Study|Physician Decision|7|||
164221874|NCT01125748|593180100|FG000|Overall Study|Patient Decision to Withdraw|2|||
164221875|NCT01125748|593180101|FG001|Overall Study|Patient Decision to Withdraw|4|||
164221876|NCT01028391|593180102|FG000|Overall Study|Adverse Event|4|||
164221877|NCT01028391|593180103|FG001|Overall Study|Adverse Event|0|||
164079754|NCT03185949|592655768|FG001|ITT Analysis|Withdrawal by Subject|3|||
164079755|NCT03185949|592655767|FG000|PP Analysis|Protocol Violation|2|||
164079756|NCT03185949|592655768|FG001|PP Analysis|Protocol Violation|2|||
164221878|NCT01028391|593180102|FG000|Overall Study|Lack of Efficacy|0|||
164221879|NCT01028391|593180103|FG001|Overall Study|Lack of Efficacy|2|||
164221880|NCT01028391|593180102|FG000|Overall Study|Lost to Follow-up|3|||
164221881|NCT01028391|593180103|FG001|Overall Study|Lost to Follow-up|4|||
164221882|NCT01028391|593180102|FG000|Overall Study|Physician Decision|0|||
164221883|NCT01028391|593180103|FG001|Overall Study|Physician Decision|1|||
164221884|NCT01028391|593180102|FG000|Overall Study|Withdrawal by Subject|6|||
164221885|NCT01028391|593180103|FG001|Overall Study|Withdrawal by Subject|3|||
164221886|NCT01028391|593180102|FG000|Overall Study|Needed excluded medication|1|||
164221887|NCT01028391|593180103|FG001|Overall Study|Needed excluded medication|1|||
164221888|NCT00694161|593180104|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
164079757|NCT03185949|592655767|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
164221889|NCT00694161|593180104|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
164221890|NCT00694161|593180104|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
164221891|NCT00837330|593180105|FG000|Overall Study|Lost to Follow-up|1|||
164221892|NCT00837330|593180106|FG001|Overall Study|Lost to Follow-up|3|||
164221893|NCT01227395|593180107|FG000|Overall Study|Protocol Violation|0|||
164221894|NCT01227395|593180108|FG001|Overall Study|Protocol Violation|1|||
164221895|NCT02774278|593180109|FG000|Overall Study|Lack of Efficacy|199|||
164221896|NCT02774278|593180109|FG000|Overall Study|Death|29|||
164221897|NCT02774278|593180109|FG000|Overall Study|Adverse event/intercurrent illness|16|||
164221898|NCT02774278|593180109|FG000|Overall Study|Refused treatment/did not cooperate|9|||
164221899|NCT02774278|593180109|FG000|Overall Study|Administrative reasons|6|||
164221900|NCT02774278|593180109|FG000|Overall Study|Withdrawal by Subject|3|||
164221901|NCT02774278|593180109|FG000|Overall Study|Protocol Violation|2|||
164221902|NCT00694122|593180112|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
164221903|NCT00694122|593180113|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
164221904|NCT00694122|593180112|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
164221905|NCT00694122|593180113|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
164221906|NCT00694122|593180112|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
164221907|NCT00694122|593180113|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
164221908|NCT00105508|593180114|FG000|Overall Study|Prephase Dropout|1|||
164221909|NCT00105508|593180115|FG001|Overall Study|Prephase Dropout|0|||
164221910|NCT00105508|593180114|FG000|Overall Study|Adverse Event|16|||
164221911|NCT00105508|593180115|FG001|Overall Study|Adverse Event|19|||
164221912|NCT00105508|593180114|FG000|Overall Study|Insufficient Efficacy|1|||
164221913|NCT00105508|593180115|FG001|Overall Study|Insufficient Efficacy|0|||
164221914|NCT00105508|593180114|FG000|Overall Study|Withdrawal by Subject|10|||
164221915|NCT00105508|593180115|FG001|Overall Study|Withdrawal by Subject|6|||
164221916|NCT00105508|593180114|FG000|Overall Study|Lost to Follow-up|3|||
164221917|NCT00105508|593180115|FG001|Overall Study|Lost to Follow-up|0|||
164221918|NCT00105508|593180114|FG000|Overall Study|Protocol Violation|1|||
164221919|NCT00105508|593180115|FG001|Overall Study|Protocol Violation|2|||
164221920|NCT00105508|593180114|FG000|Overall Study|Other|8|||
164221921|NCT00105508|593180115|FG001|Overall Study|Other|9|||
164221922|NCT00683384|593180116|FG000|Overall Study|Death|1|||
164221923|NCT00683384|593180116|FG000|Overall Study|Adverse Event|1|||
164221924|NCT03632720|593180120|FG000|Overall Study|Adverse Event|2|||
164221925|NCT03632720|593180121|FG001|Overall Study|Adverse Event|0|||
164221926|NCT03632720|593180122|FG002|Overall Study|Adverse Event|0|||
164221927|NCT03632720|593180120|FG000|Overall Study|Lost to Follow-up|0|||
164221928|NCT03632720|593180121|FG001|Overall Study|Lost to Follow-up|1|||
164221929|NCT03632720|593180122|FG002|Overall Study|Lost to Follow-up|0|||
164221930|NCT03632720|593180120|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
164221931|NCT03632720|593180121|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
164221932|NCT03632720|593180122|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
164221933|NCT03632720|593180120|FG000|Overall Study|Screen failure|0|||
164221934|NCT03632720|593180121|FG001|Overall Study|Screen failure|1|||
164221935|NCT03632720|593180122|FG002|Overall Study|Screen failure|0|||
164221936|NCT01049828|593180125|FG000|Overall Study|Claustrophibia and Frustration|2|||
164221937|NCT00290238|593180126|FG000|Overall Study|Study terminated|27|||
164221938|NCT00290238|593180127|FG001|Overall Study|Study terminated|27|||
164221939|NCT00290238|593180126|FG000|Overall Study|Lost to Follow-up|0|||
164221940|NCT00290238|593180127|FG001|Overall Study|Lost to Follow-up|1|||
164221941|NCT00290238|593180126|FG000|Overall Study|Withdrawal by Subject|15|||
164221942|NCT00290238|593180127|FG001|Overall Study|Withdrawal by Subject|13|||
164221943|NCT01179399|593180128|FG000|Overall Study|Adverse Event|1|||
164221944|NCT01179399|593180128|FG000|Overall Study|Lack of Efficacy|30|||
164221945|NCT01179399|593180128|FG000|Overall Study|Withdrawal by Subject|1|||
164221946|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164221947|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
164221948|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164221949|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
164221950|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
164221951|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164221952|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
164221953|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
164221954|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
164221955|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
163879077|NCT03775109|591926669|FG001|Overall Study|Death|1|||
164079758|NCT03185949|592655768|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
164079759|NCT02482805|592657693|FG000|Overall Study|Lost to Follow-up|4|||
164079760|NCT02482805|592657694|FG001|Overall Study|Lost to Follow-up|4|||
164079761|NCT02482805|592657695|FG002|Overall Study|Lost to Follow-up|0|||
164079762|NCT01806597|592657696|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
164079763|NCT01806597|592657697|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
164079764|NCT01806597|592657698|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
164079765|NCT01806597|592657699|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
164079766|NCT01806597|592657700|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
164079767|NCT01806597|592657701|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
164079768|NCT01806597|592657696|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
164079769|NCT01806597|592657697|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164079770|NCT01806597|592657698|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164079771|NCT01806597|592657699|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164079772|NCT01806597|592657700|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
164079773|NCT01806597|592657701|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
164079774|NCT01806597|592657696|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164079775|NCT01806597|592657697|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
164079776|NCT01806597|592657698|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164079777|NCT01806597|592657699|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164079778|NCT01806597|592657700|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164079779|NCT01806597|592657701|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
164079780|NCT01806597|592657696|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
164079781|NCT01806597|592657697|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
164079782|NCT01806597|592657698|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
164079783|NCT01806597|592657699|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
164079784|NCT01806597|592657700|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
164079785|NCT01806597|592657701|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
164079786|NCT01806597|592657696|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164079787|NCT01806597|592657697|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
164079788|NCT01806597|592657698|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164079789|NCT01806597|592657699|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164079790|NCT01806597|592657700|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164079791|NCT01806597|592657701|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
164079792|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
164079793|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
164079794|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
164079795|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
164079796|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
164079797|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
164079798|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
164079799|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
164079800|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
164079801|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
164079802|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
164079803|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
164079804|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
164079805|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164079806|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164079807|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
163879078|NCT03775109|591926668|FG000|Overall Study|Lack of Efficacy|1|||
163879079|NCT03775109|591926669|FG001|Overall Study|Lack of Efficacy|0|||
163879080|NCT05691452|591926673|FG000|Overall Study|Withdrawal by Subject|1|||
163879081|NCT05691452|591926674|FG001|Overall Study|Withdrawal by Subject|1|||
163879082|NCT05691452|591926675|FG002|Overall Study|Withdrawal by Subject|0|||
163879083|NCT05691452|591926673|FG000|Overall Study|Physician Decision|1|||
163879084|NCT05691452|591926674|FG001|Overall Study|Physician Decision|0|||
163879085|NCT05691452|591926675|FG002|Overall Study|Physician Decision|0|||
164079808|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164079809|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
164079810|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
163879086|NCT05691452|591926673|FG000|Overall Study|Lost to Follow-up|0|||
163879087|NCT05691452|591926674|FG001|Overall Study|Lost to Follow-up|0|||
163879088|NCT05691452|591926675|FG002|Overall Study|Lost to Follow-up|1|||
163879089|NCT05691452|591926673|FG000|Overall Study|Adverse Event|0|||
163879090|NCT05691452|591926674|FG001|Overall Study|Adverse Event|0|||
164079811|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
164079812|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
164079813|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
163982388|NCT05048719|592306469|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163982389|NCT05048719|592306470|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163982390|NCT05048719|592306471|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
163982391|NCT05048719|592306463|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982392|NCT05048719|592306464|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982393|NCT05048719|592306465|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982394|NCT05048719|592306466|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982395|NCT05048719|592306467|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982396|NCT05048719|592306468|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
163982397|NCT05048719|592306469|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982398|NCT05048719|592306470|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982399|NCT05048719|592306471|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
163982400|NCT00605085|592306472|FG000|Overall Study|Withdrawal by Subject|8|||
163982401|NCT00605085|592306473|FG001|Overall Study|Withdrawal by Subject|5|||
163982402|NCT00605085|592306472|FG000|Overall Study|Adverse Event|9|||
163982403|NCT00605085|592306473|FG001|Overall Study|Adverse Event|5|||
163982404|NCT00605085|592306472|FG000|Overall Study|Pregnancy|2|||
163982405|NCT00605085|592306473|FG001|Overall Study|Pregnancy|0|||
163982406|NCT00605085|592306472|FG000|Overall Study|Protocol Violation|3|||
163982407|NCT00605085|592306473|FG001|Overall Study|Protocol Violation|2|||
163982408|NCT00605085|592306472|FG000|Overall Study|Lost to Follow-up|10|||
163982409|NCT00605085|592306473|FG001|Overall Study|Lost to Follow-up|5|||
163982410|NCT00605085|592306472|FG000|Overall Study|administrative reasons|18|||
163982411|NCT00605085|592306473|FG001|Overall Study|administrative reasons|8|||
163982412|NCT03257267|592306474|FG000|Overall Study|Adverse Event|17|||
163982413|NCT03257267|592306475|FG001|Overall Study|Adverse Event|7|||
163982414|NCT03257267|592306474|FG000|Overall Study|Death|96|||
163982415|NCT03257267|592306475|FG001|Overall Study|Death|98|||
163982416|NCT03257267|592306474|FG000|Overall Study|Lost to Follow-up|2|||
163982417|NCT03257267|592306475|FG001|Overall Study|Lost to Follow-up|2|||
163982418|NCT03257267|592306474|FG000|Overall Study|Non-compliance with Study Drug|0|||
163982419|NCT03257267|592306475|FG001|Overall Study|Non-compliance with Study Drug|2|||
163982420|NCT03257267|592306474|FG000|Overall Study|Participant Decision|35|||
163982421|NCT03257267|592306475|FG001|Overall Study|Participant Decision|43|||
163982422|NCT03257267|592306474|FG000|Overall Study|Sponsor Decision|1|||
163982423|NCT03257267|592306475|FG001|Overall Study|Sponsor Decision|0|||
163982424|NCT03257267|592306474|FG000|Overall Study|Physician Decision|1|||
163982425|NCT03257267|592306475|FG001|Overall Study|Physician Decision|3|||
163982426|NCT03257267|592306474|FG000|Overall Study|Disease Progression|109|||
163982427|NCT03257267|592306475|FG001|Overall Study|Disease Progression|121|||
163982428|NCT03257267|592306474|FG000|Overall Study|Withdrawal by Subject|8|||
163982429|NCT03257267|592306475|FG001|Overall Study|Withdrawal by Subject|26|||
163982430|NCT03257267|592306474|FG000|Overall Study|Other|0|||
163982431|NCT03257267|592306475|FG001|Overall Study|Other|2|||
163879091|NCT05691452|591926675|FG002|Overall Study|Adverse Event|1|||
163879092|NCT01938547|591926678|FG000|Overall Study|Physician Decision|1|||
163879093|NCT05320432|591926683|FG000|Overall Study|Withdrawal by Subject|0|||
163879094|NCT05320432|591926684|FG001|Overall Study|Withdrawal by Subject|2|||
163879095|NCT01894061|591926688|FG000|Overall Study|Screen failure|1|||
163879096|NCT01894061|591926688|FG000|Overall Study|Withdrawal by Subject|1|||
163879097|NCT02728076|591926689|FG000|Overall Study|Physician Decision|4|||
163879098|NCT05054374|591926690|FG000|Overall Study|Withdrawal by Subject|1|||
163879099|NCT05054374|591926691|FG001|Overall Study|Withdrawal by Subject|0|||
163879100|NCT05054374|591926692|FG002|Overall Study|Withdrawal by Subject|0|||
163879101|NCT05054374|591926693|FG003|Overall Study|Withdrawal by Subject|0|||
163879102|NCT05054374|591926690|FG000|Overall Study|Progressive Disease|5|||
163879103|NCT05054374|591926691|FG001|Overall Study|Progressive Disease|0|||
163879104|NCT05054374|591926692|FG002|Overall Study|Progressive Disease|0|||
163879105|NCT05054374|591926693|FG003|Overall Study|Progressive Disease|0|||
163879106|NCT04791709|591926694|FG000|Overall Study|Withdrawal by Subject|3|||
163879107|NCT01532388|591926695|FG000|3-month Follow-up|Lost to Follow-up|68|||
163879108|NCT01532388|591926696|FG001|3-month Follow-up|Lost to Follow-up|68|||
163879109|NCT01532388|591926695|FG000|6-month Follow-up|Lost to Follow-up|74|||
163879110|NCT01532388|591926696|FG001|6-month Follow-up|Lost to Follow-up|66|||
163879111|NCT01532388|591926695|FG000|12-month Follow-up|Lost to Follow-up|69|||
163879112|NCT01532388|591926696|FG001|12-month Follow-up|Lost to Follow-up|67|||
163879113|NCT03385629|591926697|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
163879114|NCT03385629|591926698|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
163879115|NCT03385629|591926697|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
163879116|NCT03385629|591926698|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
163879117|NCT03385629|591926697|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
163879118|NCT03385629|591926698|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
164221956|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
164221957|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
164221958|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
164221959|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164221960|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164221961|NCT03738215|593180129|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
164221962|NCT03738215|593180130|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
164221963|NCT03738215|593180131|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
164221964|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
164221965|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
164221966|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
164221967|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
164221968|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
164221969|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
164221970|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
164221971|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
164221972|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
164221973|NCT03738215|593180129|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
164221974|NCT03738215|593180130|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
164221975|NCT03738215|593180131|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
164221976|NCT00394472|593181716|FG000|Overall Study|Protocol Violation|1|||
164221977|NCT00394472|593181717|FG001|Overall Study|Protocol Violation|3|||
164221978|NCT00394472|593181716|FG000|Overall Study|incorrect enrolment|4|||
164221979|NCT00394472|593181717|FG001|Overall Study|incorrect enrolment|2|||
164221980|NCT00394472|593181716|FG000|Overall Study|Adverse Event|4|||
164221981|NCT00394472|593181717|FG001|Overall Study|Adverse Event|2|||
164079814|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
163982432|NCT01982292|592306476|FG000|Overall Study|Adverse Event|2|||
163982433|NCT01982292|592306477|FG001|Overall Study|Adverse Event|0|||
163982434|NCT01982292|592306476|FG000|Overall Study|Death|1|||
163982435|NCT01982292|592306477|FG001|Overall Study|Death|0|||
163982436|NCT01982292|592306476|FG000|Overall Study|Lost to Follow-up|2|||
163982437|NCT01982292|592306477|FG001|Overall Study|Lost to Follow-up|0|||
163982438|NCT01982292|592306476|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
163982439|NCT01982292|592306477|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
163982440|NCT01982292|592306476|FG000|Overall Study|Protocol Deviation|1|||
163982441|NCT01982292|592306477|FG001|Overall Study|Protocol Deviation|0|||
163982442|NCT01982292|592306476|FG000|Overall Study|Patient/Guardian Decision|3|||
163982443|NCT01982292|592306477|FG001|Overall Study|Patient/Guardian Decision|1|||
163982444|NCT01982292|592306476|FG000|Overall Study|Technical Problems|2|||
163982445|NCT01982292|592306477|FG001|Overall Study|Technical Problems|0|||
163982446|NCT03409744|592306478|FG000|Overall Study|Death|2|||
163982447|NCT03409744|592306478|FG000|Overall Study|Physician Decision|5|||
163982448|NCT03409744|592306478|FG000|Overall Study|Pregnancy|1|||
163982449|NCT03409744|592306478|FG000|Overall Study|Lost to Follow-up|1|||
163982450|NCT03409744|592306478|FG000|Overall Study|Protocol Violation|1|||
163982451|NCT04872101|592306479|FG000|Overall Study|Withdrawal by Subject|10|||
163982452|NCT04872101|592306480|FG001|Overall Study|Withdrawal by Subject|16|||
164079815|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
164079816|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
164079817|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164221982|NCT00394472|593181716|FG000|Overall Study|Withdrawal by Subject|0|||
164221983|NCT00394472|593181717|FG001|Overall Study|Withdrawal by Subject|2|||
164221984|NCT00394472|593181716|FG000|Overall Study|Physician Decision|0|||
164221985|NCT00394472|593181717|FG001|Overall Study|Physician Decision|1|||
164221986|NCT00394472|593181716|FG000|Overall Study|Lost to Follow-up|0|||
163879119|NCT04431726|591926704|FG000|Overall Study|Ongoing in the Study|55|||
163879120|NCT01095796|591926705|FG000|Overall Study|Randomized but Not Treated|5|||
163879121|NCT01095796|591926706|FG001|Overall Study|Randomized but Not Treated|2|||
163879122|NCT01095796|591926705|FG000|Overall Study|Adverse Event|9|||
163879123|NCT01095796|591926706|FG001|Overall Study|Adverse Event|19|||
163879124|NCT01095796|591926705|FG000|Overall Study|Death|3|||
163879125|NCT01095796|591926706|FG001|Overall Study|Death|2|||
163879126|NCT01095796|591926705|FG000|Overall Study|Pregnancy|2|||
163879127|NCT01095796|591926706|FG001|Overall Study|Pregnancy|0|||
163879128|NCT01095796|591926705|FG000|Overall Study|Lack of Efficacy|5|||
163879129|NCT01095796|591926706|FG001|Overall Study|Lack of Efficacy|3|||
163982453|NCT04872101|592306479|FG000|Overall Study|Lack of Efficacy|6|||
163982454|NCT04872101|592306480|FG001|Overall Study|Lack of Efficacy|14|||
163982455|NCT04872101|592306479|FG000|Overall Study|Adverse Event|1|||
163982456|NCT04872101|592306480|FG001|Overall Study|Adverse Event|6|||
163982457|NCT04872101|592306479|FG000|Overall Study|Lost to Follow-up|2|||
163982458|NCT04872101|592306480|FG001|Overall Study|Lost to Follow-up|1|||
163982459|NCT04872101|592306479|FG000|Overall Study|Pregnancy|2|||
163879130|NCT01095796|591926705|FG000|Overall Study|Investigator's Discretion|7|||
163879131|NCT01095796|591926706|FG001|Overall Study|Investigator's Discretion|2|||
163879132|NCT01095796|591926705|FG000|Overall Study|Withdrew Consent|16|||
163879133|NCT01095796|591926706|FG001|Overall Study|Withdrew Consent|22|||
163879134|NCT01095796|591926705|FG000|Overall Study|Lost to Follow-up|27|||
163879135|NCT01095796|591926706|FG001|Overall Study|Lost to Follow-up|29|||
163879136|NCT01095796|591926705|FG000|Overall Study|Participant Noncompliance|5|||
163879137|NCT01095796|591926706|FG001|Overall Study|Participant Noncompliance|10|||
163879138|NCT01095796|591926705|FG000|Overall Study|Protocol Violation|1|||
163879139|NCT01095796|591926706|FG001|Overall Study|Protocol Violation|0|||
163879140|NCT01095796|591926705|FG000|Overall Study|Participant Transferred to Another Study|215|||
163879141|NCT01095796|591926706|FG001|Overall Study|Participant Transferred to Another Study|200|||
163879142|NCT05480943|591926711|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
163879143|NCT05480943|591926711|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
163879144|NCT05480943|591926711|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
163879145|NCT05480943|591926711|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
163879146|NCT03069313|591926712|FG000|Overall Study|Adverse Event|5|||
163879147|NCT03912831|591926713|FG000|Overall Study|Death|1|||
163879148|NCT03912831|591926714|FG001|Overall Study|Death|1|||
163879149|NCT03912831|591926715|FG002|Overall Study|Death|1|||
163879150|NCT03912831|591926716|FG003|Overall Study|Death|1|||
163879151|NCT03912831|591926717|FG004|Overall Study|Death|1|||
163879152|NCT03912831|591926718|FG005|Overall Study|Death|1|||
163879153|NCT03912831|591926713|FG000|Overall Study|Reason not Specified|0|||
163879154|NCT03912831|591926714|FG001|Overall Study|Reason not Specified|0|||
163879155|NCT03912831|591926715|FG002|Overall Study|Reason not Specified|0|||
163879156|NCT03912831|591926716|FG003|Overall Study|Reason not Specified|0|||
163879157|NCT03912831|591926717|FG004|Overall Study|Reason not Specified|1|||
163879158|NCT03912831|591926718|FG005|Overall Study|Reason not Specified|0|||
163879159|NCT03912831|591926713|FG000|Overall Study|Withdrawal by Participant|0|||
163879160|NCT03912831|591926714|FG001|Overall Study|Withdrawal by Participant|0|||
163879161|NCT03912831|591926715|FG002|Overall Study|Withdrawal by Participant|0|||
163879162|NCT03912831|591926716|FG003|Overall Study|Withdrawal by Participant|0|||
163879163|NCT03912831|591926717|FG004|Overall Study|Withdrawal by Participant|1|||
163879164|NCT03912831|591926718|FG005|Overall Study|Withdrawal by Participant|0|||
163879165|NCT04623775|591926720|FG000|Randomization|No Longer Meets Study Criteria|2|||
163879166|NCT04623775|591926721|FG001|Randomization|No Longer Meets Study Criteria|1|||
163879167|NCT04623775|591926722|FG002|Randomization|No Longer Meets Study Criteria|0|||
163879168|NCT04623775|591926723|FG003|Randomization|No Longer Meets Study Criteria|0|||
163879169|NCT04623775|591926720|FG000|Randomization|Withdrew Consent|0|||
163879170|NCT04623775|591926721|FG001|Randomization|Withdrew Consent|0|||
163879171|NCT04623775|591926722|FG002|Randomization|Withdrew Consent|0|||
163879172|NCT04623775|591926723|FG003|Randomization|Withdrew Consent|1|||
163879173|NCT04623775|591926720|FG000|Randomization|Other Reasons|0|||
163879174|NCT04623775|591926721|FG001|Randomization|Other Reasons|0|||
163879175|NCT04623775|591926722|FG002|Randomization|Other Reasons|0|||
163879176|NCT04623775|591926723|FG003|Randomization|Other Reasons|1|||
163879177|NCT04623775|591926720|FG000|Treatment Period|participant withdrew consent|4|||
163879178|NCT04623775|591926721|FG001|Treatment Period|participant withdrew consent|0|||
163879179|NCT04623775|591926722|FG002|Treatment Period|participant withdrew consent|1|||
163879180|NCT04623775|591926723|FG003|Treatment Period|participant withdrew consent|2|||
163879181|NCT04623775|591926720|FG000|Treatment Period|Death|3|||
163879182|NCT04623775|591926721|FG001|Treatment Period|Death|1|||
163879183|NCT04623775|591926722|FG002|Treatment Period|Death|4|||
163879184|NCT04623775|591926723|FG003|Treatment Period|Death|2|||
163879185|NCT04623775|591926720|FG000|Treatment Period|Lost to Follow-up|0|||
163879186|NCT04623775|591926721|FG001|Treatment Period|Lost to Follow-up|2|||
163879187|NCT04623775|591926722|FG002|Treatment Period|Lost to Follow-up|0|||
163879188|NCT04623775|591926723|FG003|Treatment Period|Lost to Follow-up|0|||
163879189|NCT04623775|591926720|FG000|Treatment Period|poor/non compliance|0|||
163879190|NCT04623775|591926721|FG001|Treatment Period|poor/non compliance|0|||
163879191|NCT04623775|591926722|FG002|Treatment Period|poor/non compliance|1|||
163879192|NCT04623775|591926723|FG003|Treatment Period|poor/non compliance|0|||
163879193|NCT04623775|591926720|FG000|Treatment Period|participant no longer meets study criteria|0|||
163879194|NCT04623775|591926721|FG001|Treatment Period|participant no longer meets study criteria|1|||
163879195|NCT04623775|591926722|FG002|Treatment Period|participant no longer meets study criteria|0|||
163879196|NCT04623775|591926723|FG003|Treatment Period|participant no longer meets study criteria|0|||
163879197|NCT04623775|591926720|FG000|Treatment Period|administrative reasons by sponsor|3|||
163879198|NCT04623775|591926721|FG001|Treatment Period|administrative reasons by sponsor|2|||
163879199|NCT04623775|591926722|FG002|Treatment Period|administrative reasons by sponsor|0|||
163879200|NCT04623775|591926723|FG003|Treatment Period|administrative reasons by sponsor|0|||
163879201|NCT04623775|591926720|FG000|Treatment Period|other reasons|2|||
163879202|NCT04623775|591926721|FG001|Treatment Period|other reasons|0|||
163879203|NCT04623775|591926722|FG002|Treatment Period|other reasons|1|||
163879204|NCT04623775|591926723|FG003|Treatment Period|other reasons|1|||
163982460|NCT04872101|592306480|FG001|Overall Study|Pregnancy|0|||
163982461|NCT04872101|592306479|FG000|Overall Study|Prohibited Medication|1|||
163982462|NCT04872101|592306480|FG001|Overall Study|Prohibited Medication|0|||
163982463|NCT04872101|592306479|FG000|Overall Study|Not dosed|1|||
163982464|NCT04872101|592306480|FG001|Overall Study|Not dosed|0|||
163982465|NCT05804877|592306481|FG000|Overall Study|Lost to Follow-up|1|||
163982466|NCT05804877|592306482|FG001|Overall Study|Lost to Follow-up|3|||
164221987|NCT00394472|593181717|FG001|Overall Study|Lost to Follow-up|1|||
164221988|NCT03211858|593181718|FG000|Overall Study|Adverse Event|8|||
164221989|NCT03211858|593181719|FG001|Overall Study|Adverse Event|6|||
164221990|NCT03211858|593181718|FG000|Overall Study|Lack of Efficacy|0|||
164221991|NCT03211858|593181719|FG001|Overall Study|Lack of Efficacy|4|||
164221992|NCT03211858|593181718|FG000|Overall Study|Poor compliance to protocol|6|||
164221993|NCT03211858|593181719|FG001|Overall Study|Poor compliance to protocol|2|||
164221994|NCT03211858|593181718|FG000|Overall Study|Non-serious Hypoglycemia|1|||
164221995|NCT03211858|593181719|FG001|Overall Study|Non-serious Hypoglycemia|0|||
164221996|NCT03211858|593181718|FG000|Overall Study|Other than specified above|22|||
164221997|NCT03211858|593181719|FG001|Overall Study|Other than specified above|21|||
164221998|NCT00004228|593181720|FG000|Overall Study|Adverse Event|0|||
164221999|NCT00004228|593181721|FG001|Overall Study|Adverse Event|1|||
164222000|NCT00004228|593181722|FG002|Overall Study|Adverse Event|0|||
163982467|NCT05804877|592306481|FG000|Overall Study|Withdrawal by Subject|1|||
163982468|NCT05804877|592306482|FG001|Overall Study|Withdrawal by Subject|0|||
163982469|NCT05804877|592306481|FG000|Overall Study|Withdrawal by Subject|1|||
163982470|NCT05804877|592306482|FG001|Overall Study|Withdrawal by Subject|0|||
163982471|NCT00879229|592306483|FG000|Overall Study|Study terminated by Sponsor|13|||
163982472|NCT00879229|592306484|FG001|Overall Study|Study terminated by Sponsor|12|||
163982473|NCT00879229|592306483|FG000|Overall Study|Death|4|||
163982474|NCT00879229|592306484|FG001|Overall Study|Death|2|||
163982475|NCT00879229|592306483|FG000|Overall Study|Adverse Event|2|||
163982476|NCT00879229|592306484|FG001|Overall Study|Adverse Event|0|||
163982477|NCT00879229|592306483|FG000|Overall Study|Withdrawal by Subject|1|||
163982478|NCT00879229|592306484|FG001|Overall Study|Withdrawal by Subject|0|||
163982479|NCT00879229|592306483|FG000|Overall Study|Clinical status did not improve|1|||
163982480|NCT00879229|592306484|FG001|Overall Study|Clinical status did not improve|0|||
163982481|NCT00879229|592306483|FG000|Overall Study|Other|1|||
163982482|NCT00879229|592306484|FG001|Overall Study|Other|0|||
163982483|NCT00264004|592306485|FG000|Overall Study|Adverse Event|2|||
163982484|NCT00264004|592306486|FG001|Overall Study|Adverse Event|3|||
163982485|NCT00264004|592306487|FG002|Overall Study|Adverse Event|6|||
163982486|NCT00264004|592306488|FG003|Overall Study|Adverse Event|4|||
163982487|NCT00264004|592306485|FG000|Overall Study|Withdrawal by Subject|0|||
163982488|NCT00264004|592306486|FG001|Overall Study|Withdrawal by Subject|1|||
163982489|NCT00264004|592306487|FG002|Overall Study|Withdrawal by Subject|2|||
163982490|NCT00264004|592306488|FG003|Overall Study|Withdrawal by Subject|2|||
163982491|NCT00264004|592306485|FG000|Overall Study|Other|2|||
163982492|NCT00264004|592306486|FG001|Overall Study|Other|2|||
163982493|NCT00264004|592306487|FG002|Overall Study|Other|0|||
163982494|NCT00264004|592306488|FG003|Overall Study|Other|3|||
163982495|NCT00264004|592306485|FG000|Overall Study|Development study specific disc. crit.|1|||
163982496|NCT00264004|592306486|FG001|Overall Study|Development study specific disc. crit.|0|||
163982497|NCT00264004|592306487|FG002|Overall Study|Development study specific disc. crit.|1|||
163982498|NCT00264004|592306488|FG003|Overall Study|Development study specific disc. crit.|0|||
163982499|NCT00264004|592306485|FG000|Overall Study|Cond. under inv. worsened|9|||
163982500|NCT00264004|592306486|FG001|Overall Study|Cond. under inv. worsened|5|||
163982501|NCT00264004|592306487|FG002|Overall Study|Cond. under inv. worsened|3|||
163982502|NCT00264004|592306488|FG003|Overall Study|Cond. under inv. worsened|4|||
163982503|NCT00264004|592306485|FG000|Overall Study|Not treated|3|||
163982504|NCT00264004|592306486|FG001|Overall Study|Not treated|0|||
163982505|NCT00264004|592306487|FG002|Overall Study|Not treated|2|||
163982506|NCT00264004|592306488|FG003|Overall Study|Not treated|2|||
163982507|NCT02475681|592306489|FG000|Overall Study|Death|16|||
164222001|NCT00004228|593181723|FG003|Overall Study|Adverse Event|0|||
164222002|NCT00004228|593181724|FG004|Overall Study|Adverse Event|1|||
163982508|NCT02475681|592306490|FG001|Overall Study|Death|6|||
163982509|NCT02475681|592306491|FG002|Overall Study|Death|9|||
163982510|NCT02475681|592306489|FG000|Overall Study|Physician Decision|0|||
163982511|NCT02475681|592306490|FG001|Overall Study|Physician Decision|3|||
163982512|NCT02475681|592306491|FG002|Overall Study|Physician Decision|1|||
163982513|NCT02475681|592306489|FG000|Overall Study|Withdrawal by Subject|12|||
163982514|NCT02475681|592306490|FG001|Overall Study|Withdrawal by Subject|6|||
163982515|NCT02475681|592306491|FG002|Overall Study|Withdrawal by Subject|9|||
163982516|NCT02475681|592306489|FG000|Overall Study|Lost to Follow-up|2|||
163982517|NCT02475681|592306490|FG001|Overall Study|Lost to Follow-up|1|||
163982518|NCT02475681|592306491|FG002|Overall Study|Lost to Follow-up|3|||
163982519|NCT02475681|592306489|FG000|Overall Study|Ongoing in Study|0|||
163982520|NCT02475681|592306490|FG001|Overall Study|Ongoing in Study|163|||
163982521|NCT02475681|592306491|FG002|Overall Study|Ongoing in Study|157|||
163982522|NCT02475681|592306489|FG000|Overall Study|Reasons other than above listed|2|||
163982523|NCT02475681|592306490|FG001|Overall Study|Reasons other than above listed|0|||
163982524|NCT02475681|592306491|FG002|Overall Study|Reasons other than above listed|0|||
163982525|NCT01262365|592306498|FG000|Overall Study|Lack of Efficacy|35|||
163982526|NCT01262365|592306499|FG001|Overall Study|Lack of Efficacy|30|||
163982527|NCT01262365|592306500|FG002|Overall Study|Lack of Efficacy|47|||
163982528|NCT01262365|592306498|FG000|Overall Study|Protocol Violation|3|||
163982529|NCT01262365|592306499|FG001|Overall Study|Protocol Violation|1|||
163982530|NCT01262365|592306500|FG002|Overall Study|Protocol Violation|1|||
163982531|NCT01262365|592306498|FG000|Overall Study|Lost to Follow-up|3|||
163982532|NCT01262365|592306499|FG001|Overall Study|Lost to Follow-up|7|||
163982533|NCT01262365|592306500|FG002|Overall Study|Lost to Follow-up|6|||
163982534|NCT01262365|592306498|FG000|Overall Study|Withdrawal by Subject|17|||
163982535|NCT01262365|592306499|FG001|Overall Study|Withdrawal by Subject|22|||
163982536|NCT01262365|592306500|FG002|Overall Study|Withdrawal by Subject|22|||
163982537|NCT01262365|592306498|FG000|Overall Study|Death|1|||
163982538|NCT01262365|592306499|FG001|Overall Study|Death|2|||
163982539|NCT01262365|592306500|FG002|Overall Study|Death|1|||
163982540|NCT01262365|592306498|FG000|Overall Study|Adverse Event|26|||
163982541|NCT01262365|592306499|FG001|Overall Study|Adverse Event|16|||
163982542|NCT01262365|592306500|FG002|Overall Study|Adverse Event|11|||
163982543|NCT01262365|592306498|FG000|Overall Study|sponsor decision|1|||
163982544|NCT01262365|592306499|FG001|Overall Study|sponsor decision|1|||
163982545|NCT01262365|592306500|FG002|Overall Study|sponsor decision|0|||
164079818|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
163982546|NCT01262365|592306498|FG000|Overall Study|Randomization error|1|||
163982547|NCT01262365|592306499|FG001|Overall Study|Randomization error|0|||
163982548|NCT01262365|592306500|FG002|Overall Study|Randomization error|2|||
163982549|NCT01262365|592306498|FG000|Overall Study|Non-compliance|1|||
163982550|NCT01262365|592306499|FG001|Overall Study|Non-compliance|0|||
163982551|NCT01262365|592306500|FG002|Overall Study|Non-compliance|2|||
164079819|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164079820|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164079821|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
164138468|NCT06281171|592868532|FG001|Timepoint 2|Lost to Follow-up|4|||
164329128|NCT03119701|593581317|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
163879205|NCT04623775|591926720|FG000|Treatment Period|disease progression|40|||
163879206|NCT04623775|591926721|FG001|Treatment Period|disease progression|35|||
163879207|NCT04623775|591926722|FG002|Treatment Period|disease progression|63|||
163879208|NCT04623775|591926723|FG003|Treatment Period|disease progression|63|||
163879209|NCT04623775|591926720|FG000|Treatment Period|study drug toxicity|12|||
163879210|NCT04623775|591926721|FG001|Treatment Period|study drug toxicity|15|||
163879211|NCT04623775|591926722|FG002|Treatment Period|study drug toxicity|13|||
163879212|NCT04623775|591926723|FG003|Treatment Period|study drug toxicity|12|||
163879213|NCT04623775|591926720|FG000|Treatment Period|AE unrelated to study drug|4|||
163879214|NCT04623775|591926721|FG001|Treatment Period|AE unrelated to study drug|9|||
163879215|NCT04623775|591926722|FG002|Treatment Period|AE unrelated to study drug|12|||
163879216|NCT04623775|591926723|FG003|Treatment Period|AE unrelated to study drug|9|||
163879217|NCT04623775|591926720|FG000|Treatment Period|participant request to discontinue treatment|0|||
163879218|NCT04623775|591926721|FG001|Treatment Period|participant request to discontinue treatment|2|||
163879219|NCT04623775|591926722|FG002|Treatment Period|participant request to discontinue treatment|2|||
163879220|NCT04623775|591926723|FG003|Treatment Period|participant request to discontinue treatment|0|||
163879221|NCT06024174|591926724|FG000|Overall Study|Other Reasons|1|||
163879222|NCT06024174|591926724|FG000|Overall Study|Study terminated by Sponsor|4|||
163879223|NCT02525692|591928062|FG000|Overall Study|Withdrawal by Subject|1|||
163879224|NCT02525692|591928063|FG001|Overall Study|Withdrawal by Subject|1|||
163879225|NCT02525692|591928064|FG002|Overall Study|Withdrawal by Subject|0|||
163879226|NCT02525692|591928065|FG003|Overall Study|Withdrawal by Subject|5|||
163879227|NCT02525692|591928066|FG004|Overall Study|Withdrawal by Subject|0|||
163879228|NCT02525692|591928067|FG005|Overall Study|Withdrawal by Subject|1|||
163879229|NCT02525692|591928062|FG000|Overall Study|Death|16|||
163879230|NCT02525692|591928063|FG001|Overall Study|Death|18|||
163879231|NCT02525692|591928064|FG002|Overall Study|Death|7|||
163879232|NCT02525692|591928065|FG003|Overall Study|Death|20|||
163879233|NCT02525692|591928066|FG004|Overall Study|Death|3|||
163982552|NCT01262365|592306498|FG000|Overall Study|Suspected pregnancy|1|||
163982553|NCT01262365|592306499|FG001|Overall Study|Suspected pregnancy|0|||
163982554|NCT01262365|592306500|FG002|Overall Study|Suspected pregnancy|0|||
163982555|NCT01262365|592306498|FG000|Overall Study|Patient pregnant|1|||
163982556|NCT01262365|592306499|FG001|Overall Study|Patient pregnant|0|||
163982557|NCT01262365|592306500|FG002|Overall Study|Patient pregnant|1|||
164329129|NCT00406718|593581323|FG000|Overall Study|Withdrawal by Subject|2|||
163879234|NCT02525692|591928067|FG005|Overall Study|Death|6|||
163879235|NCT02525692|591928062|FG000|Overall Study|Lost to Follow-up|0|||
163879236|NCT02525692|591928063|FG001|Overall Study|Lost to Follow-up|0|||
163879237|NCT02525692|591928064|FG002|Overall Study|Lost to Follow-up|1|||
164079822|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164079823|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
164079824|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164079825|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
164079826|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164079827|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
164079828|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
164079829|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
164138469|NCT06281171|592868531|FG000|Timepoint 3|Lost to Follow-up|0|||
164138470|NCT06281171|592868532|FG001|Timepoint 3|Lost to Follow-up|5|||
164138471|NCT03258853|592868534|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
164138472|NCT03258853|592868535|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
164138473|NCT04730349|592868537|FG000|Overall Study|Participant withdrew consent|1|||
164138474|NCT04730349|592868538|FG001|Overall Study|Participant withdrew consent|0|||
164138475|NCT04730349|592868537|FG000|Overall Study|Disease progression|6|||
164138476|NCT04730349|592868538|FG001|Overall Study|Disease progression|4|||
164138477|NCT04730349|592868537|FG000|Overall Study|Study drug toxicity|0|||
164138478|NCT04730349|592868538|FG001|Overall Study|Study drug toxicity|1|||
164138479|NCT00638027|592868539|FG000|Overall Study|Adverse Event|0|||
164138480|NCT00638027|592868540|FG001|Overall Study|Adverse Event|2|||
164138481|NCT03395405|592870079|FG000|Overall Study|Death|0|||
163879238|NCT02525692|591928065|FG003|Overall Study|Lost to Follow-up|5|||
163879239|NCT02525692|591928066|FG004|Overall Study|Lost to Follow-up|0|||
163879240|NCT02525692|591928067|FG005|Overall Study|Lost to Follow-up|0|||
163879241|NCT04112316|591928068|FG000|First Period (8 Weeks)|Protocol Violation|1|||
163879242|NCT04112316|591928069|FG001|First Period (8 Weeks)|Protocol Violation|0|||
163879243|NCT04112316|591928068|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
163879244|NCT04112316|591928069|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
163879245|NCT04247542|591928072|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
163879246|NCT04247542|591928073|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
163879247|NCT04247542|591928074|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
163879248|NCT04247542|591928072|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
163879249|NCT04247542|591928073|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
163879250|NCT04247542|591928074|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
163879251|NCT03438188|591928075|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
163879252|NCT03438188|591928076|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
163879253|NCT03438188|591928077|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
163879254|NCT03438188|591928075|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
163879255|NCT03438188|591928076|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
163879256|NCT03438188|591928077|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
163879257|NCT03438188|591928075|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
163879258|NCT03438188|591928076|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
163879259|NCT03438188|591928077|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
163879260|NCT03438188|591928075|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
163879261|NCT03438188|591928076|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
163879262|NCT03438188|591928077|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
163879263|NCT03438188|591928075|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
163879264|NCT03438188|591928076|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
163879265|NCT03438188|591928077|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
163879266|NCT05058391|591928078|FG000|Overall Study|Adverse Event|1|||
163879267|NCT03833245|591928083|FG000|Overall Study|Death|0|||
163879268|NCT03833245|591928084|FG001|Overall Study|Death|1|||
163879269|NCT03347383|591928085|FG000|Overall Study|Death|39|||
163879270|NCT03347383|591928085|FG000|Overall Study|Withdrawal by Subject|3|||
163879271|NCT03347383|591928085|FG000|Overall Study|Lost to Follow-up|9|||
163879272|NCT04842643|591928087|FG000|Overall Study|Physician Decision|1|||
163879273|NCT04842643|591928087|FG000|Overall Study|Other|1|||
163879274|NCT03484702|591928088|FG000|Treatment Period|Death|3|||
163879275|NCT03484702|591928089|FG001|Treatment Period|Death|1|||
163879276|NCT03484702|591928090|FG002|Treatment Period|Death|0|||
163879277|NCT03484702|591928091|FG003|Treatment Period|Death|0|||
163879278|NCT03484702|591928092|FG004|Treatment Period|Death|0|||
163879279|NCT03484702|591928093|FG005|Treatment Period|Death|0|||
163879280|NCT03484702|591928088|FG000|Treatment Period|Adverse Event|1|||
163879281|NCT03484702|591928089|FG001|Treatment Period|Adverse Event|0|||
163879282|NCT03484702|591928090|FG002|Treatment Period|Adverse Event|0|||
163879283|NCT03484702|591928091|FG003|Treatment Period|Adverse Event|0|||
163879284|NCT03484702|591928092|FG004|Treatment Period|Adverse Event|0|||
163982558|NCT01262365|592306498|FG000|Overall Study|Toxicity related to study drug|0|||
163982559|NCT01262365|592306499|FG001|Overall Study|Toxicity related to study drug|1|||
163982560|NCT01262365|592306500|FG002|Overall Study|Toxicity related to study drug|0|||
163982561|NCT01262365|592306498|FG000|Overall Study|Cannot tolerate the protocol|0|||
163982562|NCT01262365|592306499|FG001|Overall Study|Cannot tolerate the protocol|1|||
164138482|NCT03395405|592870080|FG001|Overall Study|Death|2|||
164138483|NCT03395405|592870079|FG000|Overall Study|Lost to Follow-up|0|||
164138484|NCT03395405|592870080|FG001|Overall Study|Lost to Follow-up|1|||
164138485|NCT03395405|592870079|FG000|Overall Study|Protocol Violation|0|||
164138486|NCT03395405|592870080|FG001|Overall Study|Protocol Violation|1|||
164138487|NCT03395405|592870079|FG000|Overall Study|Withdrawal by Subject|3|||
164138488|NCT03395405|592870080|FG001|Overall Study|Withdrawal by Subject|1|||
164138489|NCT03395405|592870079|FG000|Overall Study|COVID-19 Pandemic|1|||
164138490|NCT03395405|592870080|FG001|Overall Study|COVID-19 Pandemic|0|||
164138491|NCT00660907|592870088|FG000|Overall Study|Incorrect Enrollment|1|||
164138492|NCT00660907|592870089|FG001|Overall Study|Incorrect Enrollment|1|||
164138493|NCT00660907|592870088|FG000|Overall Study|Adverse Event|33|||
164138494|NCT00660907|592870089|FG001|Overall Study|Adverse Event|19|||
164138495|NCT00660907|592870088|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
164138496|NCT00660907|592870089|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
164138497|NCT00660907|592870088|FG000|Overall Study|Withdrawal by Subject|23|||
164138498|NCT00660907|592870089|FG001|Overall Study|Withdrawal by Subject|32|||
164138499|NCT00660907|592870088|FG000|Overall Study|Lost to Follow-up|3|||
164138500|NCT00660907|592870089|FG001|Overall Study|Lost to Follow-up|3|||
164138501|NCT00660907|592870088|FG000|Overall Study|Poor/Non-Compliance|5|||
164138502|NCT00660907|592870089|FG001|Overall Study|Poor/Non-Compliance|1|||
164138503|NCT00660907|592870088|FG000|Overall Study|Safety|1|||
164138504|NCT00660907|592870089|FG001|Overall Study|Safety|0|||
164138505|NCT00660907|592870088|FG000|Overall Study|Death|1|||
164138506|NCT00660907|592870089|FG001|Overall Study|Death|3|||
164138507|NCT00660907|592870088|FG000|Overall Study|Various|11|||
164138508|NCT00660907|592870089|FG001|Overall Study|Various|8|||
164138509|NCT04975191|592870090|FG000|Overall Study|Protocol Violation|1|||
164138510|NCT04975191|592870091|FG001|Overall Study|Protocol Violation|2|||
164138511|NCT04975191|592870092|FG002|Overall Study|Protocol Violation|2|||
164138512|NCT04975191|592870093|FG003|Overall Study|Protocol Violation|2|||
164138513|NCT04975191|592870090|FG000|Overall Study|Lost to Follow-up|13|||
164138514|NCT04975191|592870091|FG001|Overall Study|Lost to Follow-up|3|||
164138515|NCT04975191|592870092|FG002|Overall Study|Lost to Follow-up|8|||
164138516|NCT04975191|592870093|FG003|Overall Study|Lost to Follow-up|8|||
164138517|NCT00478244|592870099|FG000|Overall Study|Did not receive transplant|1|||
164138518|NCT02152605|592870105|FG000|Overall Study|Adverse Event|6|||
164138519|NCT02152605|592870106|FG001|Overall Study|Adverse Event|8|||
164138520|NCT02152605|592870105|FG000|Overall Study|Lack of Efficacy|7|||
164138521|NCT02152605|592870106|FG001|Overall Study|Lack of Efficacy|4|||
164138522|NCT02152605|592870105|FG000|Overall Study|Protocol deviation|1|||
164138523|NCT02152605|592870106|FG001|Overall Study|Protocol deviation|4|||
164138524|NCT02152605|592870105|FG000|Overall Study|Lost to Follow-up|1|||
164138525|NCT02152605|592870106|FG001|Overall Study|Lost to Follow-up|0|||
164138526|NCT02152605|592870105|FG000|Overall Study|Withdrew consent|4|||
164138527|NCT02152605|592870106|FG001|Overall Study|Withdrew consent|2|||
164138528|NCT00537303|592870113|FG000|Overall Study|Adverse Event|1|||
164138529|NCT00537303|592870114|FG001|Overall Study|Adverse Event|4|||
164138530|NCT00537303|592870113|FG000|Overall Study|Lack of Efficacy|6|||
164138531|NCT00537303|592870114|FG001|Overall Study|Lack of Efficacy|7|||
164138532|NCT00537303|592870113|FG000|Overall Study|Protocol Violation|8|||
164138533|NCT00537303|592870114|FG001|Overall Study|Protocol Violation|4|||
164138534|NCT00537303|592870113|FG000|Overall Study|Withdrawal criteria|3|||
164138535|NCT00537303|592870114|FG001|Overall Study|Withdrawal criteria|3|||
164138536|NCT00537303|592870113|FG000|Overall Study|Unclassified|8|||
164138537|NCT00537303|592870114|FG001|Overall Study|Unclassified|7|||
164138538|NCT01473524|592870119|FG000|DB Phase|Adverse Event|4|||
164138539|NCT01473524|592870120|FG001|DB Phase|Adverse Event|8|||
164138540|NCT01473524|592870121|FG002|DB Phase|Adverse Event|2|||
164138541|NCT01473524|592870122|FG003|DB Phase|Adverse Event|0|||
164138542|NCT01473524|592870123|FG004|DB Phase|Adverse Event|0|||
164138543|NCT01473524|592870124|FG005|DB Phase|Adverse Event|0|||
164138544|NCT01473524|592870119|FG000|DB Phase|Death|1|||
164138545|NCT01473524|592870120|FG001|DB Phase|Death|0|||
164138546|NCT01473524|592870121|FG002|DB Phase|Death|0|||
164138547|NCT01473524|592870122|FG003|DB Phase|Death|0|||
164138548|NCT01473524|592870123|FG004|DB Phase|Death|0|||
164138549|NCT01473524|592870124|FG005|DB Phase|Death|0|||
164138550|NCT01473524|592870119|FG000|DB Phase|Withdrawal by Subject|2|||
164138551|NCT01473524|592870120|FG001|DB Phase|Withdrawal by Subject|1|||
164138552|NCT01473524|592870121|FG002|DB Phase|Withdrawal by Subject|1|||
164138553|NCT01473524|592870122|FG003|DB Phase|Withdrawal by Subject|0|||
164138554|NCT01473524|592870123|FG004|DB Phase|Withdrawal by Subject|0|||
164222003|NCT00004228|593181725|FG005|Overall Study|Adverse Event|0|||
164222004|NCT00004228|593181726|FG006|Overall Study|Adverse Event|0|||
164222005|NCT00004228|593181720|FG000|Overall Study|Death|0|||
164222006|NCT00004228|593181721|FG001|Overall Study|Death|1|||
164222007|NCT00004228|593181722|FG002|Overall Study|Death|2|||
164222008|NCT00004228|593181723|FG003|Overall Study|Death|0|||
164222009|NCT00004228|593181724|FG004|Overall Study|Death|1|||
164222010|NCT00004228|593181725|FG005|Overall Study|Death|0|||
164222011|NCT00004228|593181726|FG006|Overall Study|Death|0|||
164222012|NCT00004228|593181720|FG000|Overall Study|Lack of Efficacy|1|||
164222013|NCT00004228|593181721|FG001|Overall Study|Lack of Efficacy|6|||
164222014|NCT00004228|593181722|FG002|Overall Study|Lack of Efficacy|5|||
164222015|NCT00004228|593181723|FG003|Overall Study|Lack of Efficacy|3|||
164222016|NCT00004228|593181724|FG004|Overall Study|Lack of Efficacy|9|||
164222017|NCT00004228|593181725|FG005|Overall Study|Lack of Efficacy|8|||
164222018|NCT00004228|593181726|FG006|Overall Study|Lack of Efficacy|4|||
164222019|NCT00004228|593181720|FG000|Overall Study|Lost to Follow-up|0|||
164222020|NCT00004228|593181721|FG001|Overall Study|Lost to Follow-up|0|||
164222021|NCT00004228|593181722|FG002|Overall Study|Lost to Follow-up|1|||
164222022|NCT00004228|593181723|FG003|Overall Study|Lost to Follow-up|0|||
164222023|NCT00004228|593181724|FG004|Overall Study|Lost to Follow-up|0|||
164222024|NCT00004228|593181725|FG005|Overall Study|Lost to Follow-up|0|||
164222025|NCT00004228|593181726|FG006|Overall Study|Lost to Follow-up|0|||
164222026|NCT00004228|593181720|FG000|Overall Study|Physician Decision|1|||
164222027|NCT00004228|593181721|FG001|Overall Study|Physician Decision|0|||
164222028|NCT00004228|593181722|FG002|Overall Study|Physician Decision|3|||
164222029|NCT00004228|593181723|FG003|Overall Study|Physician Decision|2|||
164222030|NCT00004228|593181724|FG004|Overall Study|Physician Decision|1|||
164222031|NCT00004228|593181725|FG005|Overall Study|Physician Decision|1|||
164222032|NCT00004228|593181726|FG006|Overall Study|Physician Decision|1|||
164222033|NCT00004228|593181720|FG000|Overall Study|Protocol Violation|0|||
164222034|NCT00004228|593181721|FG001|Overall Study|Protocol Violation|5|||
164222035|NCT00004228|593181722|FG002|Overall Study|Protocol Violation|2|||
164222036|NCT00004228|593181723|FG003|Overall Study|Protocol Violation|1|||
164222037|NCT00004228|593181724|FG004|Overall Study|Protocol Violation|1|||
164222038|NCT00004228|593181725|FG005|Overall Study|Protocol Violation|2|||
164222039|NCT00004228|593181726|FG006|Overall Study|Protocol Violation|0|||
164222040|NCT00004228|593181720|FG000|Overall Study|Withdrawal by Subject|3|||
164222041|NCT00004228|593181721|FG001|Overall Study|Withdrawal by Subject|0|||
164222042|NCT00004228|593181722|FG002|Overall Study|Withdrawal by Subject|1|||
164222043|NCT00004228|593181723|FG003|Overall Study|Withdrawal by Subject|0|||
164222044|NCT00004228|593181724|FG004|Overall Study|Withdrawal by Subject|2|||
164222045|NCT00004228|593181725|FG005|Overall Study|Withdrawal by Subject|1|||
164222046|NCT00004228|593181726|FG006|Overall Study|Withdrawal by Subject|2|||
164222047|NCT00004228|593181720|FG000|Overall Study|Other|0|||
164222048|NCT00004228|593181721|FG001|Overall Study|Other|0|||
164222049|NCT00004228|593181722|FG002|Overall Study|Other|1|||
164222050|NCT00004228|593181723|FG003|Overall Study|Other|0|||
164222051|NCT00004228|593181724|FG004|Overall Study|Other|0|||
164222052|NCT00004228|593181725|FG005|Overall Study|Other|0|||
164222053|NCT00004228|593181726|FG006|Overall Study|Other|0|||
164222054|NCT00004228|593181720|FG000|Overall Study|ineligible|4|||
164222055|NCT00004228|593181721|FG001|Overall Study|ineligible|2|||
164222056|NCT00004228|593181722|FG002|Overall Study|ineligible|4|||
164222057|NCT00004228|593181723|FG003|Overall Study|ineligible|1|||
164222058|NCT00004228|593181724|FG004|Overall Study|ineligible|1|||
164222059|NCT00004228|593181725|FG005|Overall Study|ineligible|2|||
164222060|NCT00004228|593181726|FG006|Overall Study|ineligible|5|||
164329130|NCT00406718|593581324|FG001|Overall Study|Withdrawal by Subject|9|||
164329131|NCT00406718|593581325|FG002|Overall Study|Withdrawal by Subject|4|||
164329132|NCT00406718|593581323|FG000|Overall Study|Lost to Follow-up|2|||
164079830|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
164079831|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
164079832|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
164079833|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
164079834|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
164222061|NCT01529112|593181727|FG000|Overall Study|Adverse Event|2|||
164222062|NCT01529112|593181728|FG001|Overall Study|Adverse Event|0|||
164222063|NCT01529112|593181727|FG000|Overall Study|Death|59|||
164222064|NCT01529112|593181728|FG001|Overall Study|Death|38|||
164222065|NCT01529112|593181727|FG000|Overall Study|Protocol Violation|1|||
164222066|NCT01529112|593181728|FG001|Overall Study|Protocol Violation|0|||
164222067|NCT01529112|593181727|FG000|Overall Study|Withdrawal by Subject|7|||
164222068|NCT01529112|593181728|FG001|Overall Study|Withdrawal by Subject|3|||
164222069|NCT00107614|593181729|FG000|Overall Study|Physician Decision|10|||
164222070|NCT00107614|593181729|FG000|Overall Study|Death|2|||
164222071|NCT01013870|593181730|FG000|Overall Study|Lost to Follow-up|1|||
164222072|NCT01013870|593181731|FG001|Overall Study|Lost to Follow-up|3|||
164222073|NCT02457546|593181733|FG000|Overall Study|Other reasons|4|||
164222074|NCT02457546|593181734|FG001|Overall Study|Other reasons|1|||
164222075|NCT02457546|593181733|FG000|Overall Study|Refused to complete study/procedures|1|||
164222076|NCT02457546|593181734|FG001|Overall Study|Refused to complete study/procedures|1|||
164222077|NCT02457546|593181733|FG000|Overall Study|Lost to Follow-up|4|||
164222078|NCT02457546|593181734|FG001|Overall Study|Lost to Follow-up|1|||
164222079|NCT02457546|593181733|FG000|Overall Study|Adverse Event|0|||
164222080|NCT02457546|593181734|FG001|Overall Study|Adverse Event|1|||
164222081|NCT00779909|593181738|FG000|Overall Study|Lost to Follow-up|1|||
164222082|NCT00779909|593181739|FG001|Overall Study|Lost to Follow-up|0|||
164222083|NCT00779909|593181740|FG002|Overall Study|Lost to Follow-up|0|||
164222084|NCT00779909|593181741|FG003|Overall Study|Lost to Follow-up|1|||
164222085|NCT00779909|593181738|FG000|Overall Study|Withdrawal by Subject|0|||
164222086|NCT00779909|593181739|FG001|Overall Study|Withdrawal by Subject|1|||
164222087|NCT00779909|593181740|FG002|Overall Study|Withdrawal by Subject|0|||
164222088|NCT00779909|593181741|FG003|Overall Study|Withdrawal by Subject|0|||
164222089|NCT01174459|593181745|FG000|Overall Study|case report form (CRF) not collected|5|||
164222090|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
164222091|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
164222092|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
164222093|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
164222094|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
164222095|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
164222096|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
164222097|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
164222098|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
164222099|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
164222100|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
164222101|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
164222102|NCT00290758|593181746|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
164222103|NCT00290758|593181747|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
164222104|NCT00290758|593181746|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
164222105|NCT00290758|593181747|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
164222106|NCT00474968|593181749|FG000|Overall Study|Withdrawal by Subject|8|||
164222107|NCT00474968|593181750|FG001|Overall Study|Withdrawal by Subject|7|||
164222108|NCT00474968|593181749|FG000|Overall Study|Protocol Violation|9|||
164222109|NCT00474968|593181750|FG001|Overall Study|Protocol Violation|8|||
164222110|NCT00474968|593181749|FG000|Overall Study|Sample not collected|1|||
164222111|NCT00474968|593181750|FG001|Overall Study|Sample not collected|1|||
164222112|NCT04914000|593181751|FG000|Overall Study|Lost to Follow-up|8|||
164222113|NCT04914000|593181751|FG000|Overall Study|Withdrawal by Subject|1|||
164079835|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
164079836|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
164079837|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
164079838|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
164079839|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
164079840|NCT01806597|592657696|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
164079841|NCT01806597|592657697|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164079842|NCT01806597|592657698|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164222114|NCT01096186|593181753|FG000|Overall Study|Adverse Event|16|||
163982563|NCT01262365|592306500|FG002|Overall Study|Cannot tolerate the protocol|0|||
163982564|NCT01262365|592306498|FG000|Overall Study|Patient unavailable|0|||
163982565|NCT01262365|592306499|FG001|Overall Study|Patient unavailable|0|||
163982566|NCT01262365|592306500|FG002|Overall Study|Patient unavailable|1|||
163982567|NCT00494091|592306501|FG000|Overall Study|Death|5|||
163982568|NCT00494091|592306502|FG001|Overall Study|Death|54|||
164222115|NCT01096186|593181753|FG000|Overall Study|Death|4|||
164222116|NCT01096186|593181753|FG000|Overall Study|Lack of Efficacy|4|||
164222117|NCT01096186|593181753|FG000|Overall Study|Lost to Follow-up|2|||
163982569|NCT00494091|592306501|FG000|Overall Study|Lost to Follow-up|0|||
164222118|NCT01096186|593181753|FG000|Overall Study|Withdrawal by Subject|22|||
163982570|NCT00494091|592306502|FG001|Overall Study|Lost to Follow-up|4|||
163982571|NCT00494091|592306501|FG000|Overall Study|Other|1|||
163982572|NCT00494091|592306502|FG001|Overall Study|Other|11|||
164222119|NCT01096186|593181753|FG000|Overall Study|Physician Decision|1|||
164222120|NCT01096186|593181753|FG000|Overall Study|Noncompliance with study drug|1|||
164222121|NCT00079781|593181754|FG000|Pre-implant Period|Withdrawal by Subject|2|||
164222122|NCT00079781|593181755|FG001|Pre-implant Period|Withdrawal by Subject|0|||
164222123|NCT00079781|593181756|FG002|Pre-implant Period|Withdrawal by Subject|0|||
164222124|NCT00079781|593181754|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
164222125|NCT00079781|593181755|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
164222126|NCT00079781|593181756|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
163982573|NCT00494091|592306501|FG000|Overall Study|Withdrawal by Subject|0|||
163982574|NCT00494091|592306502|FG001|Overall Study|Withdrawal by Subject|7|||
164222127|NCT00079781|593181754|FG000|Follow-up Period|Withdrawal by Subject|3|||
164222128|NCT00079781|593181755|FG001|Follow-up Period|Withdrawal by Subject|0|||
164222129|NCT00079781|593181756|FG002|Follow-up Period|Withdrawal by Subject|1|||
164222130|NCT00079781|593181754|FG000|Follow-up Period|Lost to Follow-up|1|||
164222131|NCT00079781|593181755|FG001|Follow-up Period|Lost to Follow-up|0|||
164222132|NCT00079781|593181756|FG002|Follow-up Period|Lost to Follow-up|0|||
164222133|NCT00079781|593181754|FG000|Follow-up Period|Death|0|||
164222134|NCT00079781|593181755|FG001|Follow-up Period|Death|0|||
164222135|NCT00079781|593181756|FG002|Follow-up Period|Death|1|||
164222136|NCT00564070|593181757|FG000|Overall Study|Lost to Follow-up|9|||
164222137|NCT00564070|593181758|FG001|Overall Study|Lost to Follow-up|7|||
164222138|NCT00564070|593181757|FG000|Overall Study|Worsening depression, referred to care|3|||
164222139|NCT00564070|593181758|FG001|Overall Study|Worsening depression, referred to care|0|||
164222140|NCT03142334|593181759|FG000|Overall Study|Death|18|||
164222141|NCT03142334|593181760|FG001|Overall Study|Death|33|||
164222142|NCT03142334|593181759|FG000|Overall Study|Withdrawal by Subject|15|||
164222143|NCT03142334|593181760|FG001|Overall Study|Withdrawal by Subject|11|||
164222144|NCT03142334|593181759|FG000|Overall Study|Ongoing on trial follow up|463|||
164222145|NCT03142334|593181760|FG001|Overall Study|Ongoing on trial follow up|454|||
164222146|NCT01217047|593181761|FG000|Overall Study|Lost to Follow-up|0|||
164222147|NCT01217047|593181762|FG001|Overall Study|Lost to Follow-up|1|||
164222148|NCT01217047|593181763|FG002|Overall Study|Lost to Follow-up|0|||
164222149|NCT03835117|593181764|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
164222150|NCT03835117|593181765|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
164222151|NCT03225989|593181769|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
164222152|NCT03225989|593181770|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
164222153|NCT03225989|593181771|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
164222154|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
164222155|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
164222156|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
164222157|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
164222158|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
164222159|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
164222160|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
164222161|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
164222162|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
164222163|NCT03225989|593181769|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
164222164|NCT03225989|593181770|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
164222165|NCT03225989|593181771|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
164222166|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
164222167|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
164222168|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
164222169|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
164222170|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
164222171|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
164222172|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
164222173|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
164222174|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
164222175|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
164222176|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
164222177|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
164222178|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
164222179|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
164222180|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
163879285|NCT03484702|591928093|FG005|Treatment Period|Adverse Event|0|||
163879286|NCT03484702|591928088|FG000|Treatment Period|Participant Withdrew from Study|0|||
163879287|NCT03484702|591928089|FG001|Treatment Period|Participant Withdrew from Study|1|||
163879288|NCT03484702|591928090|FG002|Treatment Period|Participant Withdrew from Study|0|||
163879289|NCT03484702|591928091|FG003|Treatment Period|Participant Withdrew from Study|0|||
163879290|NCT03484702|591928092|FG004|Treatment Period|Participant Withdrew from Study|0|||
163879291|NCT03484702|591928093|FG005|Treatment Period|Participant Withdrew from Study|0|||
163879292|NCT03484702|591928088|FG000|Treatment Period|Physician Decision|0|||
163879293|NCT03484702|591928089|FG001|Treatment Period|Physician Decision|1|||
163879294|NCT03484702|591928090|FG002|Treatment Period|Physician Decision|0|||
163879295|NCT03484702|591928091|FG003|Treatment Period|Physician Decision|0|||
163982575|NCT00527605|592306506|FG000|Overall Study|Adverse Event|3|||
164222181|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
163879296|NCT03484702|591928092|FG004|Treatment Period|Physician Decision|0|||
163879297|NCT03484702|591928093|FG005|Treatment Period|Physician Decision|1|||
163879298|NCT02840474|591928094|FG000|Overall Study|Lost to Follow-up|1|||
164222182|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
164222183|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
164222184|NCT03225989|593181769|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
164222185|NCT03225989|593181770|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
164222186|NCT03225989|593181771|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
164222187|NCT03093870|593181775|FG000|Overall Study|Withdrawal by Subject|2|||
164222188|NCT03093870|593181776|FG001|Overall Study|Withdrawal by Subject|6|||
164222189|NCT03093870|593181777|FG002|Overall Study|Withdrawal by Subject|5|||
164222190|NCT03093870|593181775|FG000|Overall Study|Death|1|||
164222191|NCT03093870|593181776|FG001|Overall Study|Death|35|||
164222192|NCT03093870|593181777|FG002|Overall Study|Death|35|||
164222193|NCT03093870|593181775|FG000|Overall Study|Radiographic disease progression|10|||
164222194|NCT03093870|593181776|FG001|Overall Study|Radiographic disease progression|0|||
164222195|NCT03093870|593181777|FG002|Overall Study|Radiographic disease progression|0|||
164222196|NCT03093870|593181775|FG000|Overall Study|Clinical disease progression|1|||
164222197|NCT03093870|593181776|FG001|Overall Study|Clinical disease progression|0|||
164222198|NCT03093870|593181777|FG002|Overall Study|Clinical disease progression|0|||
164222199|NCT03093870|593181775|FG000|Overall Study|Physician Decision|2|||
164222200|NCT03093870|593181776|FG001|Overall Study|Physician Decision|0|||
164222201|NCT03093870|593181777|FG002|Overall Study|Physician Decision|0|||
164222202|NCT03093870|593181775|FG000|Overall Study|Adverse Event|7|||
164222203|NCT03093870|593181776|FG001|Overall Study|Adverse Event|0|||
164222204|NCT03093870|593181777|FG002|Overall Study|Adverse Event|0|||
164222205|NCT03093870|593181775|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
164222206|NCT03093870|593181776|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
164222207|NCT03093870|593181777|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
164222208|NCT03093870|593181775|FG000|Overall Study|Lost to Follow-up|0|||
164222209|NCT03093870|593181776|FG001|Overall Study|Lost to Follow-up|0|||
164222210|NCT03093870|593181777|FG002|Overall Study|Lost to Follow-up|1|||
164222211|NCT02006654|593181778|FG000|Overall Study|Withdrawal before treatment|4|||
164222212|NCT02006654|593181779|FG001|Overall Study|Withdrawal before treatment|2|||
164222213|NCT02006654|593181778|FG000|Overall Study|Adverse Event|16|||
164222214|NCT02006654|593181779|FG001|Overall Study|Adverse Event|17|||
164222215|NCT02006654|593181778|FG000|Overall Study|Death|1|||
164222216|NCT02006654|593181779|FG001|Overall Study|Death|0|||
164222217|NCT02006654|593181778|FG000|Overall Study|Withdrawal by Subject|14|||
164222218|NCT02006654|593181779|FG001|Overall Study|Withdrawal by Subject|12|||
164222219|NCT02006654|593181778|FG000|Overall Study|Protocol Violation|5|||
164222220|NCT02006654|593181779|FG001|Overall Study|Protocol Violation|8|||
164222221|NCT02006654|593181778|FG000|Overall Study|Lost to Follow-up|1|||
164222222|NCT02006654|593181779|FG001|Overall Study|Lost to Follow-up|0|||
164222223|NCT02006654|593181778|FG000|Overall Study|patient's will|2|||
164222224|NCT02006654|593181779|FG001|Overall Study|patient's will|1|||
164222225|NCT02006654|593181778|FG000|Overall Study|insufficient compliance|1|||
164222226|NCT02006654|593181779|FG001|Overall Study|insufficient compliance|0|||
164222227|NCT02006654|593181778|FG000|Overall Study|worsening cognitive condition|0|||
164222228|NCT02006654|593181779|FG001|Overall Study|worsening cognitive condition|1|||
164222229|NCT02006654|593181778|FG000|Overall Study|faecal incontinence|0|||
164222230|NCT02006654|593181779|FG001|Overall Study|faecal incontinence|1|||
164222231|NCT02006654|593181778|FG000|Overall Study|mood disorder|0|||
164222232|NCT02006654|593181779|FG001|Overall Study|mood disorder|1|||
164222233|NCT02006654|593181778|FG000|Overall Study|disallowed medication|1|||
164222234|NCT02006654|593181779|FG001|Overall Study|disallowed medication|0|||
164222235|NCT02006654|593181778|FG000|Overall Study|moving out of state|0|||
164222236|NCT02006654|593181779|FG001|Overall Study|moving out of state|1|||
164222237|NCT04193527|593181780|FG000|Overall Study|Other|1|||
163879299|NCT02840474|591928095|FG001|Overall Study|Lost to Follow-up|0|||
163879300|NCT04638998|591928100|FG000|Overall Study|Withdrawal by Subject|1|||
163879301|NCT04638998|591928101|FG001|Overall Study|Withdrawal by Subject|3|||
163879302|NCT03713086|591928104|FG000|Overall Study|Withdrawal by Subject|0|||
163879303|NCT03713086|591928105|FG001|Overall Study|Withdrawal by Subject|2|||
163879304|NCT03713086|591928106|FG002|Overall Study|Withdrawal by Subject|1|||
163879305|NCT03713086|591928107|FG003|Overall Study|Withdrawal by Subject|0|||
163879306|NCT03713086|591928104|FG000|Overall Study|Lost to Follow-up|0|||
164222238|NCT04193527|593181781|FG001|Overall Study|Other|1|||
164222239|NCT04193527|593181782|FG002|Overall Study|Other|0|||
164222240|NCT03808909|593181783|FG000|Overall Study|Lost to Follow-up|3|||
163879307|NCT03713086|591928105|FG001|Overall Study|Lost to Follow-up|1|||
164222241|NCT03808909|593181784|FG001|Overall Study|Lost to Follow-up|0|||
164222242|NCT01608308|593181785|FG000|Overall Study|pretreatment medical and billing reasons|0|||
164222243|NCT01608308|593181786|FG001|Overall Study|pretreatment medical and billing reasons|2|||
164222244|NCT02362412|593181791|FG000|Treatment Period III|Lost to Follow-up|0|||
164222245|NCT02362412|593181792|FG001|Treatment Period III|Lost to Follow-up|1|||
164222246|NCT00545948|593181794|FG000|Overall Study|Not Treated|1|||
164222247|NCT00545948|593181795|FG001|Overall Study|Not Treated|1|||
164222248|NCT00545948|593181796|FG002|Overall Study|Not Treated|7|||
164222249|NCT04595370|593181797|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
164222250|NCT04595370|593181798|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222251|NCT04595370|593181799|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222252|NCT04595370|593181800|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222253|NCT04595370|593181801|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222254|NCT04595370|593181802|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
164222255|NCT04595370|593181797|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222256|NCT04595370|593181798|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222257|NCT04595370|593181799|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
164222258|NCT04595370|593181800|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222259|NCT04595370|593181801|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222260|NCT04595370|593181802|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
164222261|NCT04595370|593181797|FG000|Overall Study|Adverse Event|0|||
164222262|NCT04595370|593181798|FG001|Overall Study|Adverse Event|4|||
164222263|NCT04595370|593181799|FG002|Overall Study|Adverse Event|3|||
164222264|NCT04595370|593181800|FG003|Overall Study|Adverse Event|1|||
164222265|NCT04595370|593181801|FG004|Overall Study|Adverse Event|1|||
164222266|NCT04595370|593181802|FG005|Overall Study|Adverse Event|1|||
164222267|NCT04595370|593181797|FG000|Overall Study|Withdrawal of Consent|1|||
164222268|NCT04595370|593181798|FG001|Overall Study|Withdrawal of Consent|1|||
164222269|NCT04595370|593181799|FG002|Overall Study|Withdrawal of Consent|1|||
164222270|NCT04595370|593181800|FG003|Overall Study|Withdrawal of Consent|0|||
164222271|NCT04595370|593181801|FG004|Overall Study|Withdrawal of Consent|0|||
164222272|NCT04595370|593181802|FG005|Overall Study|Withdrawal of Consent|0|||
164222273|NCT04595370|593181797|FG000|Overall Study|Death|0|||
164222274|NCT04595370|593181798|FG001|Overall Study|Death|1|||
164222275|NCT04595370|593181799|FG002|Overall Study|Death|0|||
164222276|NCT04595370|593181800|FG003|Overall Study|Death|0|||
164222277|NCT04595370|593181801|FG004|Overall Study|Death|1|||
164222278|NCT04595370|593181802|FG005|Overall Study|Death|0|||
164222279|NCT04595370|593181797|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222280|NCT04595370|593181798|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222281|NCT04595370|593181799|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164222282|NCT04595370|593181800|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222283|NCT04595370|593181801|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222284|NCT04595370|593181802|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164222285|NCT04595370|593181797|FG000|Overall Study|Withdrawal by Subject|0|||
164222286|NCT04595370|593181798|FG001|Overall Study|Withdrawal by Subject|0|||
164222287|NCT04595370|593181799|FG002|Overall Study|Withdrawal by Subject|1|||
164222288|NCT04595370|593181800|FG003|Overall Study|Withdrawal by Subject|0|||
164222289|NCT04595370|593181801|FG004|Overall Study|Withdrawal by Subject|2|||
164222290|NCT04595370|593181802|FG005|Overall Study|Withdrawal by Subject|0|||
164222291|NCT04595370|593181797|FG000|Overall Study|Lost to Follow-up|0|||
164222292|NCT04595370|593181798|FG001|Overall Study|Lost to Follow-up|0|||
164222293|NCT04595370|593181799|FG002|Overall Study|Lost to Follow-up|0|||
164222294|NCT04595370|593181800|FG003|Overall Study|Lost to Follow-up|0|||
164222295|NCT04595370|593181801|FG004|Overall Study|Lost to Follow-up|1|||
164222296|NCT04595370|593181802|FG005|Overall Study|Lost to Follow-up|0|||
164222297|NCT04595370|593181797|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
164222298|NCT04595370|593181798|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
164222299|NCT04595370|593181799|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
164222300|NCT04595370|593181800|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
164222301|NCT04595370|593181801|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
164222302|NCT04595370|593181802|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
164222303|NCT03520387|593181803|FG000|Pre-Randomization|Withdrawal by Subject|1|||
164222304|NCT03520387|593181804|FG001|Pre-Randomization|Withdrawal by Subject|0|||
164222305|NCT03520387|593181805|FG002|Pre-Randomization|Withdrawal by Subject|0|||
164222306|NCT03520387|593181806|FG003|Pre-Randomization|Withdrawal by Subject|0|||
164222307|NCT03520387|593181807|FG004|Pre-Randomization|Withdrawal by Subject|0|||
164222308|NCT03520387|593181803|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
164222309|NCT03520387|593181804|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222310|NCT03520387|593181805|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222311|NCT03520387|593181806|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222312|NCT03520387|593181807|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
164222313|NCT00541775|593181808|FG000|Overall Study|Adverse Event|3|||
164222314|NCT00541775|593181809|FG001|Overall Study|Adverse Event|2|||
164222315|NCT00541775|593181810|FG002|Overall Study|Adverse Event|1|||
164222316|NCT00541775|593181808|FG000|Overall Study|Lack of Efficacy|0|||
163982576|NCT00527605|592306507|FG001|Overall Study|Adverse Event|0|||
163982577|NCT00527605|592306506|FG000|Overall Study|Withdrawal by Subject|3|||
163982578|NCT00527605|592306507|FG001|Overall Study|Withdrawal by Subject|7|||
163982579|NCT00527605|592306506|FG000|Overall Study|Lost to Follow-up|6|||
163982580|NCT00527605|592306507|FG001|Overall Study|Lost to Follow-up|2|||
163982581|NCT00527605|592306506|FG000|Overall Study|Protocol Violation|1|||
163982582|NCT00527605|592306507|FG001|Overall Study|Protocol Violation|2|||
163982583|NCT04312009|592306513|FG000|Overall Study|Withdrawal by Subject|2|||
163982584|NCT04312009|592306514|FG001|Overall Study|Withdrawal by Subject|1|||
163982585|NCT01363986|592306515|FG000|Overall Study|Disease progression|1|||
163982586|NCT02354703|592306525|FG000|Overall Study|Withdrawal by Subject|1|||
163982587|NCT02354703|592306526|FG001|Overall Study|Withdrawal by Subject|1|||
163982588|NCT02354703|592306527|FG002|Overall Study|Withdrawal by Subject|1|||
164222317|NCT00541775|593181809|FG001|Overall Study|Lack of Efficacy|0|||
163982589|NCT02354703|592306528|FG003|Overall Study|Withdrawal by Subject|1|||
163982590|NCT02354703|592306525|FG000|Overall Study|Lost to Follow-up|2|||
163982591|NCT02354703|592306526|FG001|Overall Study|Lost to Follow-up|7|||
163982592|NCT02354703|592306527|FG002|Overall Study|Lost to Follow-up|9|||
163982593|NCT02354703|592306528|FG003|Overall Study|Lost to Follow-up|2|||
163982594|NCT02354703|592306525|FG000|Overall Study|Adverse Event|0|||
163982595|NCT02354703|592306526|FG001|Overall Study|Adverse Event|0|||
163982596|NCT02354703|592306527|FG002|Overall Study|Adverse Event|1|||
163982597|NCT02354703|592306528|FG003|Overall Study|Adverse Event|0|||
163982598|NCT00699348|592306530|FG000|Overall Study|Death|6|||
163982599|NCT00699348|592306530|FG000|Overall Study|Adverse Event|15|||
163982600|NCT00699348|592306530|FG000|Overall Study|Withdrawal by Subject|11|||
163982601|NCT00699348|592306530|FG000|Overall Study|Protocol Violation|10|||
163982602|NCT00699348|592306530|FG000|Overall Study|Lack of Efficacy|8|||
163982603|NCT00699348|592306530|FG000|Overall Study|Failure to return|1|||
163982604|NCT00699348|592306530|FG000|Overall Study|Blood transfusion|24|||
163982605|NCT00699348|592306530|FG000|Overall Study|Renal transplantation|10|||
163982606|NCT00699348|592306530|FG000|Overall Study|Other|5|||
163982607|NCT00122135|592306531|FG000|Overall Study|Withdrawal by Subject|3|||
163982608|NCT00122135|592306532|FG001|Overall Study|Withdrawal by Subject|0|||
163982609|NCT03269344|592306533|FG000|Overall Study|Protocol Violation|4|||
163982610|NCT03269344|592306534|FG001|Overall Study|Protocol Violation|3|||
163982611|NCT04478708|592306537|FG000|Overall Study|Lost to Follow-up|0|||
164222318|NCT00541775|593181810|FG002|Overall Study|Lack of Efficacy|3|||
164222319|NCT00541775|593181808|FG000|Overall Study|Lost to Follow-up|0|||
164222320|NCT00541775|593181809|FG001|Overall Study|Lost to Follow-up|0|||
164222321|NCT00541775|593181810|FG002|Overall Study|Lost to Follow-up|2|||
164222322|NCT00541775|593181808|FG000|Overall Study|Protocol Violation|1|||
164222323|NCT00541775|593181809|FG001|Overall Study|Protocol Violation|0|||
164222324|NCT00541775|593181810|FG002|Overall Study|Protocol Violation|0|||
164222325|NCT00541775|593181808|FG000|Overall Study|Withdrawal by Subject and Other|5|||
164222326|NCT00541775|593181809|FG001|Overall Study|Withdrawal by Subject and Other|0|||
164222327|NCT00541775|593181810|FG002|Overall Study|Withdrawal by Subject and Other|2|||
164222328|NCT01945242|593181811|FG000|Overall Study|Physician Decision|3|||
164222329|NCT01945242|593181812|FG001|Overall Study|Physician Decision|3|||
164222330|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Death|0|||
164222331|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Death|2|||
164222332|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Death|2|||
164222333|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Death|0|||
164222334|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
163982612|NCT04478708|592306538|FG001|Overall Study|Lost to Follow-up|0|||
163982613|NCT04478708|592306539|FG002|Overall Study|Lost to Follow-up|0|||
163982614|NCT04478708|592306540|FG003|Overall Study|Lost to Follow-up|0|||
163982615|NCT04478708|592306541|FG004|Overall Study|Lost to Follow-up|0|||
163982616|NCT04478708|592306542|FG005|Overall Study|Lost to Follow-up|0|||
163982617|NCT04478708|592306543|FG006|Overall Study|Lost to Follow-up|0|||
163982618|NCT04478708|592306544|FG007|Overall Study|Lost to Follow-up|0|||
163982619|NCT04478708|592306545|FG008|Overall Study|Lost to Follow-up|1|||
163982620|NCT04478708|592306546|FG009|Overall Study|Lost to Follow-up|1|||
163982621|NCT04478708|592306547|FG010|Overall Study|Lost to Follow-up|1|||
163982622|NCT04478708|592306548|FG011|Overall Study|Lost to Follow-up|2|||
163982623|NCT04478708|592306549|FG012|Overall Study|Lost to Follow-up|1|||
164222335|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
164222336|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
164222337|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
164222338|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
164222339|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
163982624|NCT04478708|592306550|FG013|Overall Study|Lost to Follow-up|0|||
163982625|NCT04478708|592306551|FG014|Overall Study|Lost to Follow-up|0|||
163982626|NCT04478708|592306552|FG015|Overall Study|Lost to Follow-up|0|||
163982627|NCT04478708|592306553|FG016|Overall Study|Lost to Follow-up|0|||
163982628|NCT04478708|592306537|FG000|Overall Study|Withdrawal of consent from study|0|||
163982629|NCT04478708|592306538|FG001|Overall Study|Withdrawal of consent from study|1|||
163982630|NCT04478708|592306539|FG002|Overall Study|Withdrawal of consent from study|2|||
164222340|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
164222341|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
164222342|NCT04913675|593181814|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
164222343|NCT04913675|593181815|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
164222344|NCT04913675|593181816|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
164222345|NCT04913675|593181817|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
164222346|NCT04913675|593181814|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
164222347|NCT04913675|593181815|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
164222348|NCT04913675|593181816|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
164222349|NCT04913675|593181817|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
164222350|NCT01541254|593181821|FG000|Overall Study|Withdrawal by Subject|1|||
164222351|NCT01541254|593181821|FG000|Overall Study|excluded - metal allergy|1|||
164222352|NCT01541254|593181821|FG000|Overall Study|enrolled after study closed|1|||
164222353|NCT01541254|593181821|FG000|Overall Study|GI bleed prior to procedure|1|||
164222354|NCT01541254|593181821|FG000|Overall Study|stent not required|1|||
164222355|NCT01541254|593181821|FG000|Overall Study|alternate stent used|1|||
164222356|NCT05660538|593181822|FG000|Overall Study|Adverse Event|0|||
164222357|NCT05660538|593181823|FG001|Overall Study|Adverse Event|0|||
164222358|NCT05660538|593181824|FG002|Overall Study|Adverse Event|1|||
164222359|NCT05660538|593181825|FG003|Overall Study|Adverse Event|0|||
164222360|NCT05660538|593181822|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164222361|NCT05660538|593181823|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
164222362|NCT05660538|593181824|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
164222363|NCT05660538|593181825|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
164222364|NCT05660538|593181822|FG000|Overall Study|Lost to Follow-up|0|||
164222365|NCT05660538|593181823|FG001|Overall Study|Lost to Follow-up|0|||
164222366|NCT05660538|593181824|FG002|Overall Study|Lost to Follow-up|1|||
164222367|NCT05660538|593181825|FG003|Overall Study|Lost to Follow-up|1|||
164222368|NCT05660538|593181822|FG000|Overall Study|Death|0|||
164222369|NCT05660538|593181823|FG001|Overall Study|Death|0|||
164222370|NCT05660538|593181824|FG002|Overall Study|Death|1|||
164222371|NCT05660538|593181825|FG003|Overall Study|Death|0|||
164222372|NCT05660538|593181822|FG000|Overall Study|Physician Decision|0|||
164222373|NCT05660538|593181823|FG001|Overall Study|Physician Decision|0|||
164222374|NCT05660538|593181824|FG002|Overall Study|Physician Decision|0|||
164222375|NCT05660538|593181825|FG003|Overall Study|Physician Decision|1|||
164222376|NCT05660538|593181822|FG000|Overall Study|Sponsor Decision|1|||
164222377|NCT05660538|593181823|FG001|Overall Study|Sponsor Decision|0|||
164222378|NCT05660538|593181824|FG002|Overall Study|Sponsor Decision|0|||
164222379|NCT05660538|593181825|FG003|Overall Study|Sponsor Decision|0|||
164222380|NCT05660538|593181822|FG000|Overall Study|Other|1|||
164222381|NCT05660538|593181823|FG001|Overall Study|Other|0|||
164222382|NCT05660538|593181824|FG002|Overall Study|Other|0|||
164222383|NCT05660538|593181825|FG003|Overall Study|Other|1|||
164222384|NCT05660538|593181822|FG000|Overall Study|Randomized but did not receive study drug|1|||
164222385|NCT05660538|593181823|FG001|Overall Study|Randomized but did not receive study drug|0|||
164222386|NCT05660538|593181824|FG002|Overall Study|Randomized but did not receive study drug|0|||
164222387|NCT05660538|593181825|FG003|Overall Study|Randomized but did not receive study drug|1|||
163879308|NCT03713086|591928106|FG002|Overall Study|Lost to Follow-up|0|||
163879309|NCT03713086|591928107|FG003|Overall Study|Lost to Follow-up|1|||
164222388|NCT05660538|593181822|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
164222389|NCT05660538|593181823|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
164222390|NCT05660538|593181824|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
164222391|NCT05660538|593181825|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
164222392|NCT04648241|593181826|FG000|Overall Study|Lost to Follow-up|1|||
164079843|NCT01806597|592657699|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164079844|NCT01806597|592657700|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164079845|NCT01806597|592657701|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
164079846|NCT01806597|592657696|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164079847|NCT01806597|592657697|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164222393|NCT04648241|593181827|FG001|Overall Study|Lost to Follow-up|0|||
164222394|NCT02489045|593181830|FG000|Overall Study|unable to collect usable data|53|||
164222395|NCT02489045|593181830|FG000|Follow-up|Lost to Follow-up|10|||
163879310|NCT05374837|591928109|FG000|Overall Study|Lost to Follow-up|17|||
164079848|NCT01806597|592657698|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164079849|NCT01806597|592657699|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164079850|NCT01806597|592657700|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
164079851|NCT01806597|592657701|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
164079852|NCT01806597|592657696|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164079853|NCT01806597|592657697|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164222396|NCT00120874|593181835|FG000|Overall Study|Death|0|||
164222397|NCT00120874|593181836|FG001|Overall Study|Death|1|||
164222398|NCT01108055|593181837|FG000|Overall Study|Ineligible|11|||
164222399|NCT01108055|593181837|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
164222400|NCT03339453|593181844|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
164222401|NCT03339453|593181845|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
164222402|NCT01348490|593181847|FG000|Overall Study|Death|1|||
164222403|NCT01348490|593181847|FG000|Overall Study|Adverse Event|3|||
164222404|NCT01348490|593181847|FG000|Overall Study|Consent withdrawn|7|||
164222405|NCT01348490|593181847|FG000|Overall Study|Disease progression|3|||
164222406|NCT01348490|593181847|FG000|Overall Study|Lost to Follow-up|1|||
164222407|NCT01348490|593181847|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
164222408|NCT01348490|593181847|FG000|Overall Study|Other Unspecified|8|||
164222409|NCT00300495|593181848|FG000|Overall Study|Protocol Violation|4|||
164222410|NCT00300495|593181849|FG001|Overall Study|Protocol Violation|1|||
164222411|NCT03834883|593181858|FG000|Second Treatment|Withdrawal by Subject|1|||
164222412|NCT03834883|593181859|FG001|Second Treatment|Withdrawal by Subject|0|||
164222413|NCT03834883|593181860|FG002|Second Treatment|Withdrawal by Subject|0|||
164222414|NCT03834883|593181861|FG003|Second Treatment|Withdrawal by Subject|0|||
164222415|NCT03834883|593181858|FG000|Second Treatment|COVID-19 pandemic|1|||
164222416|NCT03834883|593181859|FG001|Second Treatment|COVID-19 pandemic|0|||
164222417|NCT03834883|593181860|FG002|Second Treatment|COVID-19 pandemic|1|||
164222418|NCT03834883|593181861|FG003|Second Treatment|COVID-19 pandemic|1|||
164222419|NCT02487199|593181863|FG000|Overall Study|Withdrew Consent|0|||
164222420|NCT02487199|593181864|FG001|Overall Study|Withdrew Consent|1|||
164222421|NCT00286455|593181865|FG000|Overall Study|Hyperglycemia rescue|19|||
164222422|NCT00286455|593181866|FG001|Overall Study|Hyperglycemia rescue|13|||
164222423|NCT00286455|593181867|FG002|Overall Study|Hyperglycemia rescue|10|||
164222424|NCT00286455|593181865|FG000|Overall Study|Adverse Event|1|||
164222425|NCT00286455|593181866|FG001|Overall Study|Adverse Event|3|||
164222426|NCT00286455|593181867|FG002|Overall Study|Adverse Event|2|||
164222427|NCT00286455|593181865|FG000|Overall Study|Lost to Follow-up|0|||
164222428|NCT00286455|593181866|FG001|Overall Study|Lost to Follow-up|3|||
164222429|NCT00286455|593181867|FG002|Overall Study|Lost to Follow-up|3|||
164222430|NCT00286455|593181865|FG000|Overall Study|Physician Decision|3|||
164222431|NCT00286455|593181866|FG001|Overall Study|Physician Decision|0|||
164222432|NCT00286455|593181867|FG002|Overall Study|Physician Decision|2|||
164222433|NCT00286455|593181865|FG000|Overall Study|Protocol Violation|1|||
164222434|NCT00286455|593181866|FG001|Overall Study|Protocol Violation|1|||
164222435|NCT00286455|593181867|FG002|Overall Study|Protocol Violation|0|||
164222436|NCT00286455|593181865|FG000|Overall Study|Participant Non-compliance|1|||
164222437|NCT00286455|593181866|FG001|Overall Study|Participant Non-compliance|0|||
164222438|NCT00286455|593181867|FG002|Overall Study|Participant Non-compliance|0|||
164222439|NCT00286455|593181865|FG000|Overall Study|Withdrawal by Subject|0|||
164222440|NCT00286455|593181866|FG001|Overall Study|Withdrawal by Subject|8|||
164222441|NCT00286455|593181867|FG002|Overall Study|Withdrawal by Subject|7|||
164222442|NCT01213251|593184552|FG000|Overall Study|Death|2|||
164222443|NCT01213251|593184553|FG001|Overall Study|Death|1|||
164222444|NCT01213251|593184554|FG002|Overall Study|Death|2|||
164222445|NCT01213251|593184552|FG000|Overall Study|Exit|3|||
164222446|NCT01213251|593184553|FG001|Overall Study|Exit|2|||
164222447|NCT01213251|593184554|FG002|Overall Study|Exit|8|||
164222448|NCT01213251|593184552|FG000|Overall Study|Protocol Violation|1|||
164222449|NCT01213251|593184553|FG001|Overall Study|Protocol Violation|1|||
164222450|NCT01213251|593184554|FG002|Overall Study|Protocol Violation|0|||
164222451|NCT01213251|593184552|FG000|Overall Study|Missed 18-Month Follow-up|0|||
164222452|NCT01213251|593184553|FG001|Overall Study|Missed 18-Month Follow-up|0|||
164222453|NCT01213251|593184554|FG002|Overall Study|Missed 18-Month Follow-up|1|||
164222454|NCT02933151|593184555|FG000|Overall Study|Lost to Follow-up|19|||
164222455|NCT02933151|593184556|FG001|Overall Study|Lost to Follow-up|18|||
163879311|NCT05374837|591928110|FG001|Overall Study|Lost to Follow-up|18|||
164222456|NCT02933151|593184555|FG000|Overall Study|Death|1732|||
164222457|NCT02933151|593184556|FG001|Overall Study|Death|1827|||
164222458|NCT02933151|593184555|FG000|Overall Study|Transplant|210|||
164222459|NCT02933151|593184556|FG001|Overall Study|Transplant|278|||
164222460|NCT02933151|593184555|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
164222461|NCT02933151|593184556|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
164222462|NCT02933151|593184555|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
164222463|NCT02933151|593184556|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
164222464|NCT02933151|593184555|FG000|Overall Study|Recovered Kidney Function|47|||
164222465|NCT02933151|593184556|FG001|Overall Study|Recovered Kidney Function|29|||
164222466|NCT00862277|593184559|FG000|Overall Study|Protocol Violation|1|||
164222467|NCT00862277|593184560|FG001|Overall Study|Protocol Violation|2|||
164222468|NCT00862277|593184561|FG002|Overall Study|Protocol Violation|5|||
163879312|NCT05406921|591928113|FG000|Overall Study|Withdrawal by Subject|25|||
163879313|NCT05406921|591928114|FG001|Overall Study|Withdrawal by Subject|0|||
163879314|NCT05406921|591928115|FG002|Overall Study|Withdrawal by Subject|25|||
164222469|NCT02168439|593184562|FG000|Overall Study|Protocol Violation|0|||
164222470|NCT02168439|593184563|FG001|Overall Study|Protocol Violation|2|||
164222471|NCT02004275|593184564|FG000|Phase 1|Ineligible|0|||
164222472|NCT02004275|593184565|FG001|Phase 1|Ineligible|0|||
164222473|NCT02004275|593184566|FG002|Phase 1|Ineligible|0|||
164222474|NCT02004275|593184567|FG003|Phase 1|Ineligible|1|||
164222475|NCT02004275|593184568|FG004|Phase 1|Ineligible|1|||
164222476|NCT02004275|593184569|FG005|Phase 1|Ineligible|0|||
164222477|NCT02004275|593184564|FG000|Phase 1|Protocol Violation|0|||
164222478|NCT02004275|593184565|FG001|Phase 1|Protocol Violation|0|||
164222479|NCT02004275|593184566|FG002|Phase 1|Protocol Violation|0|||
164222480|NCT02004275|593184567|FG003|Phase 1|Protocol Violation|1|||
164222481|NCT02004275|593184568|FG004|Phase 1|Protocol Violation|0|||
164222482|NCT02004275|593184569|FG005|Phase 1|Protocol Violation|5|||
164222483|NCT02004275|593184564|FG000|Phase 2 Part 1|Ineligible|6|||
164222484|NCT02004275|593184565|FG001|Phase 2 Part 1|Ineligible|9|||
164222485|NCT02004275|593184566|FG002|Phase 2 Part 1|Ineligible|0|||
164222486|NCT02004275|593184567|FG003|Phase 2 Part 1|Ineligible|0|||
164222487|NCT02004275|593184568|FG004|Phase 2 Part 1|Ineligible|0|||
164222488|NCT02004275|593184569|FG005|Phase 2 Part 1|Ineligible|0|||
164222489|NCT02004275|593184564|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
164222490|NCT02004275|593184565|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
164222491|NCT02004275|593184566|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
164222492|NCT02004275|593184567|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
164222493|NCT02004275|593184568|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
164222494|NCT02004275|593184569|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
164222495|NCT04432298|593184572|FG000|Overall Study|Other than specified|1|||
164222496|NCT04432298|593184573|FG001|Overall Study|Other than specified|0|||
164222497|NCT04432298|593184572|FG000|Overall Study|Lost to Follow-up|0|||
164222498|NCT04432298|593184573|FG001|Overall Study|Lost to Follow-up|1|||
164222499|NCT04432298|593184572|FG000|Overall Study|Death|3|||
164222500|NCT04432298|593184573|FG001|Overall Study|Death|2|||
164222501|NCT04432298|593184572|FG000|Overall Study|Withdrawal by Subject|2|||
164222502|NCT04432298|593184573|FG001|Overall Study|Withdrawal by Subject|0|||
164222503|NCT01423084|593184576|FG000|Overall Study|Adverse Event|0|||
164222504|NCT01423084|593184577|FG001|Overall Study|Adverse Event|1|||
164222505|NCT01423084|593184576|FG000|Overall Study|Withdrawal by Subject|2|||
163982631|NCT04478708|592306540|FG003|Overall Study|Withdrawal of consent from study|0|||
163982632|NCT04478708|592306541|FG004|Overall Study|Withdrawal of consent from study|1|||
163982633|NCT04478708|592306542|FG005|Overall Study|Withdrawal of consent from study|1|||
163982634|NCT04478708|592306543|FG006|Overall Study|Withdrawal of consent from study|1|||
163982635|NCT04478708|592306544|FG007|Overall Study|Withdrawal of consent from study|0|||
163982636|NCT04478708|592306545|FG008|Overall Study|Withdrawal of consent from study|0|||
163982637|NCT04478708|592306546|FG009|Overall Study|Withdrawal of consent from study|0|||
163982638|NCT04478708|592306547|FG010|Overall Study|Withdrawal of consent from study|4|||
163982639|NCT04478708|592306548|FG011|Overall Study|Withdrawal of consent from study|3|||
163982640|NCT04478708|592306549|FG012|Overall Study|Withdrawal of consent from study|0|||
163982641|NCT04478708|592306550|FG013|Overall Study|Withdrawal of consent from study|0|||
163982642|NCT04478708|592306551|FG014|Overall Study|Withdrawal of consent from study|1|||
163982643|NCT04478708|592306552|FG015|Overall Study|Withdrawal of consent from study|0|||
163982644|NCT04478708|592306553|FG016|Overall Study|Withdrawal of consent from study|4|||
163982645|NCT01869114|592306554|FG000|Overall Study|Death|19|||
163982646|NCT01869114|592306555|FG001|Overall Study|Death|18|||
163982647|NCT01869114|592306556|FG002|Overall Study|Death|8|||
163982648|NCT01869114|592306554|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
163982649|NCT01869114|592306555|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
163982650|NCT01869114|592306556|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
163982651|NCT01869114|592306554|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
163982652|NCT01869114|592306555|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
163982653|NCT01869114|592306556|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
163982654|NCT01869114|592306554|FG000|Overall Study|Withdrawal by Subject|0|||
163982655|NCT01869114|592306555|FG001|Overall Study|Withdrawal by Subject|3|||
163982656|NCT01869114|592306556|FG002|Overall Study|Withdrawal by Subject|0|||
163982657|NCT01869114|592306554|FG000|Overall Study|Disease Progression|0|||
164222506|NCT01423084|593184577|FG001|Overall Study|Withdrawal by Subject|3|||
164222507|NCT01682603|593184581|FG000|Overall Study|Lost to Follow-up|3|||
164222508|NCT02462057|593184582|FG000|Overall Study|Left Vitality|32|||
164222509|NCT02462057|593184583|FG001|Overall Study|Left Vitality|27|||
164222510|NCT02462057|593184584|FG002|Overall Study|Left Vitality|23|||
164222511|NCT02462057|593184585|FG003|Overall Study|Left Vitality|35|||
163982658|NCT01869114|592306555|FG001|Overall Study|Disease Progression|1|||
163982659|NCT01869114|592306556|FG002|Overall Study|Disease Progression|0|||
163982660|NCT00179309|592306557|FG000|Treatment|Toxicity|2|||
164222512|NCT02462057|593184586|FG004|Overall Study|Left Vitality|33|||
163982661|NCT00179309|592306558|FG001|Treatment|Toxicity|3|||
163982662|NCT00179309|592306557|FG000|Treatment|Withdrawal by Subject|1|||
163982663|NCT00179309|592306558|FG001|Treatment|Withdrawal by Subject|2|||
164222513|NCT02462057|593184582|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
164222514|NCT02462057|593184583|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
164222515|NCT02462057|593184584|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
164222516|NCT02462057|593184585|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
164222517|NCT02462057|593184586|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
164222518|NCT01791205|593184587|FG000|Phase II|Lack of Efficacy|6|||
164222519|NCT01791205|593184588|FG001|Phase II|Lack of Efficacy|0|||
164222520|NCT01791205|593184587|FG000|Phase II|Adverse Event|2|||
164222521|NCT01791205|593184588|FG001|Phase II|Adverse Event|0|||
164222522|NCT01791205|593184587|FG000|Phase II|Safety|1|||
164222523|NCT01791205|593184588|FG001|Phase II|Safety|0|||
164222524|NCT01791205|593184587|FG000|Phase II|Lost to Follow-up|1|||
164222525|NCT01791205|593184588|FG001|Phase II|Lost to Follow-up|0|||
164222526|NCT01791205|593184587|FG000|Phase II|Remission of disease|1|||
164222527|NCT01791205|593184588|FG001|Phase II|Remission of disease|0|||
164222528|NCT01791205|593184587|FG000|Phase II|Physician's decision|1|||
164222529|NCT01791205|593184588|FG001|Phase II|Physician's decision|0|||
164222530|NCT05345405|593184589|FG000|Overall Study|Withdrawal by Subject|2|||
164222531|NCT05345405|593184590|FG001|Overall Study|Withdrawal by Subject|0|||
164222532|NCT05345405|593184591|FG002|Overall Study|Withdrawal by Subject|0|||
164222533|NCT05345405|593184589|FG000|Overall Study|Did not meet eligibility criteria|0|||
164222534|NCT05345405|593184590|FG001|Overall Study|Did not meet eligibility criteria|2|||
164222535|NCT05345405|593184591|FG002|Overall Study|Did not meet eligibility criteria|0|||
164222536|NCT05345405|593184589|FG000|Overall Study|Lost to Follow-up|0|||
164222537|NCT05345405|593184590|FG001|Overall Study|Lost to Follow-up|0|||
164222538|NCT05345405|593184591|FG002|Overall Study|Lost to Follow-up|1|||
164222539|NCT01896986|593184592|FG000|Overall Study|samples lost|14|||
164222540|NCT01896986|593184593|FG001|Overall Study|samples lost|23|||
164222541|NCT01750281|593184594|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
164222542|NCT01750281|593184595|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
164222543|NCT01750281|593184596|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
164222544|NCT01750281|593184594|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
164222545|NCT01750281|593184595|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
164222546|NCT01750281|593184596|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
164222547|NCT01750281|593184594|FG000|Overall Study|Did not receive treatment|0|||
164222548|NCT01750281|593184595|FG001|Overall Study|Did not receive treatment|1|||
164222549|NCT01750281|593184596|FG002|Overall Study|Did not receive treatment|0|||
164222550|NCT04189588|593184597|FG000|Overall Study|Death|0|||
164222551|NCT04189588|593184598|FG001|Overall Study|Death|1|||
164222552|NCT04189588|593184597|FG000|Overall Study|Lost to Follow-up|0|||
164222553|NCT04189588|593184598|FG001|Overall Study|Lost to Follow-up|1|||
164222554|NCT01658735|593184602|FG000|Overall Study|Lack of Efficacy|1|||
164222555|NCT01658735|593184603|FG001|Overall Study|Lack of Efficacy|0|||
164222556|NCT01658735|593184604|FG002|Overall Study|Lack of Efficacy|1|||
164222557|NCT01658735|593184602|FG000|Overall Study|Lost to Follow-up|1|||
164222558|NCT01658735|593184603|FG001|Overall Study|Lost to Follow-up|1|||
164222559|NCT01658735|593184604|FG002|Overall Study|Lost to Follow-up|0|||
164222560|NCT01658735|593184602|FG000|Overall Study|Protocol Violation|0|||
164222561|NCT01658735|593184603|FG001|Overall Study|Protocol Violation|1|||
164222562|NCT01658735|593184604|FG002|Overall Study|Protocol Violation|0|||
164222563|NCT01658735|593184602|FG000|Overall Study|Withdrawal by Subject|3|||
164222564|NCT01658735|593184603|FG001|Overall Study|Withdrawal by Subject|5|||
164222565|NCT01658735|593184604|FG002|Overall Study|Withdrawal by Subject|3|||
164222566|NCT03757715|593184605|FG000|Overall Study|Lost to Follow-up|4|||
164222567|NCT03757715|593184606|FG001|Overall Study|Lost to Follow-up|9|||
164222568|NCT03757715|593184605|FG000|Overall Study|Withdrawal by Subject|1|||
164222569|NCT03757715|593184606|FG001|Overall Study|Withdrawal by Subject|1|||
164222570|NCT00281580|593184607|FG000|Overall Study|Adverse Event|2|||
164222571|NCT00281580|593184608|FG001|Overall Study|Adverse Event|0|||
164222572|NCT00281580|593184609|FG002|Overall Study|Adverse Event|2|||
164222573|NCT00281580|593184610|FG003|Overall Study|Adverse Event|4|||
164222574|NCT00281580|593184611|FG004|Overall Study|Adverse Event|1|||
164222575|NCT00281580|593184612|FG005|Overall Study|Adverse Event|0|||
164222576|NCT00281580|593184613|FG006|Overall Study|Adverse Event|1|||
164222577|NCT00281580|593184614|FG007|Overall Study|Adverse Event|0|||
163879315|NCT05406921|591928113|FG000|Overall Study|Protocol Violation|0|||
164222578|NCT00281580|593184615|FG008|Overall Study|Adverse Event|1|||
164222579|NCT00281580|593184616|FG009|Overall Study|Adverse Event|6|||
163879316|NCT05406921|591928114|FG001|Overall Study|Protocol Violation|12|||
163879317|NCT05406921|591928115|FG002|Overall Study|Protocol Violation|0|||
163879318|NCT04831281|591928118|FG000|Overall Study|Adverse Event|1|||
163879319|NCT04831281|591928119|FG001|Overall Study|Adverse Event|0|||
163879320|NCT04831281|591928120|FG002|Overall Study|Adverse Event|3|||
163879321|NCT04831281|591928118|FG000|Overall Study|Withdrawal by Subject|0|||
163879322|NCT04831281|591928119|FG001|Overall Study|Withdrawal by Subject|1|||
163879323|NCT04831281|591928120|FG002|Overall Study|Withdrawal by Subject|2|||
163879324|NCT04831281|591928118|FG000|Overall Study|Undetermined|1|||
163879325|NCT04831281|591928119|FG001|Overall Study|Undetermined|1|||
164222580|NCT00281580|593184617|FG010|Overall Study|Adverse Event|0|||
164222581|NCT00281580|593184618|FG011|Overall Study|Adverse Event|5|||
164222582|NCT00281580|593184619|FG012|Overall Study|Adverse Event|8|||
164222583|NCT00281580|593184620|FG013|Overall Study|Adverse Event|2|||
164222584|NCT00281580|593184621|FG014|Overall Study|Adverse Event|3|||
164222585|NCT00281580|593184622|FG015|Overall Study|Adverse Event|3|||
164222586|NCT00281580|593184607|FG000|Overall Study|Protocol Violation|0|||
164222587|NCT00281580|593184608|FG001|Overall Study|Protocol Violation|0|||
164222588|NCT00281580|593184609|FG002|Overall Study|Protocol Violation|1|||
164222589|NCT00281580|593184610|FG003|Overall Study|Protocol Violation|1|||
163879326|NCT04831281|591928120|FG002|Overall Study|Undetermined|0|||
163879327|NCT02249949|591928121|FG000|Overall Study|Cancelled prior to treatment|2|||
163879328|NCT02097420|591928124|FG000|Overall Study|Death|6|||
163879329|NCT02097420|591928124|FG000|Overall Study|Valve explanted|13|||
163879330|NCT02097420|591928124|FG000|Overall Study|Other Reason|1|||
163879331|NCT05059262|591928125|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
163879332|NCT05059262|591928126|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
163879333|NCT05059262|591928125|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
163879334|NCT05059262|591928126|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
163879335|NCT05059262|591928125|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
163879336|NCT05059262|591928126|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
163879337|NCT05059262|591928125|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
163879338|NCT05059262|591928126|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
163879339|NCT05059262|591928125|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
163879340|NCT05059262|591928126|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
163879341|NCT05059262|591928125|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
163879342|NCT05059262|591928126|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
163879343|NCT05059262|591928125|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
163879344|NCT05059262|591928126|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
163879345|NCT05059262|591928125|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
163879346|NCT05059262|591928126|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
163879347|NCT05059262|591928125|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
163879348|NCT05059262|591928126|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
163879349|NCT02312960|591928127|FG000|Overall Study|Death|24|||
163879350|NCT02312960|591928128|FG001|Overall Study|Death|32|||
163879351|NCT02312960|591928129|FG002|Overall Study|Death|25|||
163879352|NCT02312960|591928130|FG003|Overall Study|Death|11|||
163879353|NCT02312960|591928131|FG004|Overall Study|Death|5|||
163879354|NCT02312960|591928132|FG005|Overall Study|Death|5|||
163879355|NCT02312960|591928133|FG006|Overall Study|Death|8|||
163879356|NCT02312960|591928134|FG007|Overall Study|Death|5|||
163879357|NCT02312960|591928135|FG008|Overall Study|Death|7|||
163879358|NCT02312960|591928136|FG009|Overall Study|Death|3|||
163879359|NCT02312960|591928137|FG010|Overall Study|Death|3|||
163879360|NCT02312960|591928138|FG011|Overall Study|Death|1|||
163879361|NCT02312960|591928139|FG012|Overall Study|Death|25|||
163879362|NCT02312960|591928140|FG013|Overall Study|Death|19|||
163879363|NCT02312960|591928127|FG000|Overall Study|Missing|0|||
163879364|NCT02312960|591928128|FG001|Overall Study|Missing|0|||
163879365|NCT02312960|591928129|FG002|Overall Study|Missing|2|||
163879366|NCT02312960|591928130|FG003|Overall Study|Missing|0|||
163879367|NCT02312960|591928131|FG004|Overall Study|Missing|0|||
163879368|NCT02312960|591928132|FG005|Overall Study|Missing|0|||
163879369|NCT02312960|591928133|FG006|Overall Study|Missing|0|||
163879370|NCT02312960|591928134|FG007|Overall Study|Missing|0|||
163879371|NCT02312960|591928135|FG008|Overall Study|Missing|0|||
163879372|NCT02312960|591928136|FG009|Overall Study|Missing|0|||
163879373|NCT02312960|591928137|FG010|Overall Study|Missing|0|||
163879374|NCT02312960|591928138|FG011|Overall Study|Missing|0|||
163879375|NCT02312960|591928139|FG012|Overall Study|Missing|0|||
163879376|NCT02312960|591928140|FG013|Overall Study|Missing|0|||
163879377|NCT02312960|591928127|FG000|Overall Study|Lost to Follow-up|0|||
163879378|NCT02312960|591928128|FG001|Overall Study|Lost to Follow-up|0|||
163879379|NCT02312960|591928129|FG002|Overall Study|Lost to Follow-up|1|||
163879380|NCT02312960|591928130|FG003|Overall Study|Lost to Follow-up|0|||
163879381|NCT02312960|591928131|FG004|Overall Study|Lost to Follow-up|0|||
163879382|NCT02312960|591928132|FG005|Overall Study|Lost to Follow-up|0|||
163879383|NCT02312960|591928133|FG006|Overall Study|Lost to Follow-up|1|||
164222590|NCT00281580|593184611|FG004|Overall Study|Protocol Violation|0|||
163879384|NCT02312960|591928134|FG007|Overall Study|Lost to Follow-up|1|||
163879385|NCT02312960|591928135|FG008|Overall Study|Lost to Follow-up|0|||
163879386|NCT02312960|591928136|FG009|Overall Study|Lost to Follow-up|1|||
163879387|NCT02312960|591928137|FG010|Overall Study|Lost to Follow-up|0|||
163879388|NCT02312960|591928138|FG011|Overall Study|Lost to Follow-up|0|||
163879389|NCT02312960|591928139|FG012|Overall Study|Lost to Follow-up|1|||
163879390|NCT02312960|591928140|FG013|Overall Study|Lost to Follow-up|0|||
163879391|NCT02312960|591928127|FG000|Overall Study|Withdrawal by Subject|1|||
163879392|NCT02312960|591928128|FG001|Overall Study|Withdrawal by Subject|2|||
163879393|NCT02312960|591928129|FG002|Overall Study|Withdrawal by Subject|0|||
163879394|NCT02312960|591928130|FG003|Overall Study|Withdrawal by Subject|0|||
164222591|NCT00281580|593184612|FG005|Overall Study|Protocol Violation|0|||
164079854|NCT01806597|592657698|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164079855|NCT01806597|592657699|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164079856|NCT01806597|592657700|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
164079857|NCT01806597|592657701|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
164079858|NCT01806597|592657696|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164079859|NCT01806597|592657697|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164079860|NCT01806597|592657698|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164079861|NCT01806597|592657699|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
163879395|NCT02312960|591928131|FG004|Overall Study|Withdrawal by Subject|1|||
163879396|NCT02312960|591928132|FG005|Overall Study|Withdrawal by Subject|0|||
163879397|NCT02312960|591928133|FG006|Overall Study|Withdrawal by Subject|1|||
163879398|NCT02312960|591928134|FG007|Overall Study|Withdrawal by Subject|2|||
163879399|NCT02312960|591928135|FG008|Overall Study|Withdrawal by Subject|2|||
163879400|NCT02312960|591928136|FG009|Overall Study|Withdrawal by Subject|3|||
163879401|NCT02312960|591928137|FG010|Overall Study|Withdrawal by Subject|0|||
163879402|NCT02312960|591928138|FG011|Overall Study|Withdrawal by Subject|0|||
163879403|NCT02312960|591928139|FG012|Overall Study|Withdrawal by Subject|2|||
163879404|NCT02312960|591928140|FG013|Overall Study|Withdrawal by Subject|0|||
163879405|NCT05691309|591928157|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
163879406|NCT05691309|591928157|FG000|Overall Study|vancomycin levels not evaluable|2|||
163879407|NCT03131648|591928158|FG000|Initial Treatment Period|Not dosed|2|||
163879408|NCT03131648|591928159|FG001|Initial Treatment Period|Not dosed|2|||
163879409|NCT03131648|591928160|FG002|Initial Treatment Period|Not dosed|0|||
163879410|NCT03131648|591928161|FG003|Initial Treatment Period|Not dosed|0|||
163879411|NCT03131648|591928162|FG004|Initial Treatment Period|Not dosed|0|||
163879412|NCT03131648|591928163|FG005|Initial Treatment Period|Not dosed|0|||
163879413|NCT03131648|591928164|FG006|Initial Treatment Period|Not dosed|0|||
163879414|NCT03131648|591928165|FG007|Initial Treatment Period|Not dosed|0|||
163879415|NCT03131648|591928158|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
163879416|NCT03131648|591928159|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
163879417|NCT03131648|591928160|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163879418|NCT03131648|591928161|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163879419|NCT03131648|591928162|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163879420|NCT03131648|591928163|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163879421|NCT03131648|591928164|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163879422|NCT03131648|591928165|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163879423|NCT03131648|591928158|FG000|Open-label Treatment|Discontinued IMP|0|||
163879424|NCT03131648|591928159|FG001|Open-label Treatment|Discontinued IMP|0|||
163879425|NCT03131648|591928160|FG002|Open-label Treatment|Discontinued IMP|0|||
163879426|NCT03131648|591928161|FG003|Open-label Treatment|Discontinued IMP|0|||
163879427|NCT03131648|591928162|FG004|Open-label Treatment|Discontinued IMP|0|||
163879428|NCT03131648|591928163|FG005|Open-label Treatment|Discontinued IMP|0|||
163879429|NCT03131648|591928164|FG006|Open-label Treatment|Discontinued IMP|112|||
163879430|NCT03131648|591928165|FG007|Open-label Treatment|Discontinued IMP|0|||
163879431|NCT03131648|591928158|FG000|Open-label Treatment|Completed Week 50|0|||
163879432|NCT03131648|591928159|FG001|Open-label Treatment|Completed Week 50|0|||
163879433|NCT03131648|591928160|FG002|Open-label Treatment|Completed Week 50|0|||
163879434|NCT03131648|591928161|FG003|Open-label Treatment|Completed Week 50|0|||
163879435|NCT03131648|591928162|FG004|Open-label Treatment|Completed Week 50|0|||
163879436|NCT03131648|591928163|FG005|Open-label Treatment|Completed Week 50|0|||
163879437|NCT03131648|591928164|FG006|Open-label Treatment|Completed Week 50|6|||
163879438|NCT03131648|591928165|FG007|Open-label Treatment|Completed Week 50|0|||
163879439|NCT03131648|591928158|FG000|Maintenance Treatment Period|Not dosed|0|||
163879440|NCT03131648|591928159|FG001|Maintenance Treatment Period|Not dosed|0|||
163879441|NCT03131648|591928160|FG002|Maintenance Treatment Period|Not dosed|3|||
163879442|NCT03131648|591928161|FG003|Maintenance Treatment Period|Not dosed|2|||
163879443|NCT03131648|591928162|FG004|Maintenance Treatment Period|Not dosed|1|||
163879444|NCT03131648|591928163|FG005|Maintenance Treatment Period|Not dosed|0|||
163879445|NCT03131648|591928164|FG006|Maintenance Treatment Period|Not dosed|0|||
163879446|NCT03131648|591928165|FG007|Maintenance Treatment Period|Not dosed|0|||
163879447|NCT03131648|591928158|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
163879448|NCT03131648|591928159|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
163879449|NCT03131648|591928160|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
163879450|NCT03131648|591928161|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
163879451|NCT03131648|591928162|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
163879452|NCT03131648|591928163|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
163879453|NCT03131648|591928164|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
163879454|NCT03131648|591928165|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
163879455|NCT03131648|591928158|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163879456|NCT03131648|591928159|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163879457|NCT03131648|591928160|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
164222592|NCT00281580|593184613|FG006|Overall Study|Protocol Violation|1|||
164222593|NCT00281580|593184614|FG007|Overall Study|Protocol Violation|0|||
164222594|NCT00281580|593184615|FG008|Overall Study|Protocol Violation|2|||
164222595|NCT00281580|593184616|FG009|Overall Study|Protocol Violation|0|||
164222596|NCT00281580|593184617|FG010|Overall Study|Protocol Violation|1|||
164222597|NCT00281580|593184618|FG011|Overall Study|Protocol Violation|2|||
164222598|NCT00281580|593184619|FG012|Overall Study|Protocol Violation|0|||
164222599|NCT00281580|593184620|FG013|Overall Study|Protocol Violation|1|||
164222600|NCT00281580|593184621|FG014|Overall Study|Protocol Violation|1|||
164222601|NCT00281580|593184622|FG015|Overall Study|Protocol Violation|3|||
164222602|NCT00281580|593184607|FG000|Overall Study|Withdrawal by Subject|3|||
164079862|NCT01806597|592657700|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
164138555|NCT01473524|592870124|FG005|DB Phase|Withdrawal by Subject|0|||
163879458|NCT03131648|591928161|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
163879459|NCT03131648|591928162|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
163879460|NCT03131648|591928163|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
163879461|NCT03131648|591928164|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163879462|NCT03131648|591928165|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163879463|NCT03131648|591928158|FG000|Maintenance Treatment Period|Completed Week 50|0|||
163879464|NCT03131648|591928159|FG001|Maintenance Treatment Period|Completed Week 50|0|||
164138556|NCT01473524|592870119|FG000|LTSE Phase|Withdrawal by Subject|0|||
164138557|NCT01473524|592870120|FG001|LTSE Phase|Withdrawal by Subject|0|||
164138558|NCT01473524|592870121|FG002|LTSE Phase|Withdrawal by Subject|0|||
164138559|NCT01473524|592870122|FG003|LTSE Phase|Withdrawal by Subject|3|||
164138560|NCT01473524|592870123|FG004|LTSE Phase|Withdrawal by Subject|3|||
164138561|NCT01473524|592870124|FG005|LTSE Phase|Withdrawal by Subject|6|||
164138562|NCT01473524|592870119|FG000|LTSE Phase|Death|0|||
164138563|NCT01473524|592870120|FG001|LTSE Phase|Death|0|||
164138564|NCT01473524|592870121|FG002|LTSE Phase|Death|0|||
164138565|NCT01473524|592870122|FG003|LTSE Phase|Death|0|||
164138566|NCT01473524|592870123|FG004|LTSE Phase|Death|1|||
164138567|NCT01473524|592870124|FG005|LTSE Phase|Death|0|||
164138568|NCT01473524|592870119|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
164138569|NCT01473524|592870120|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
164138570|NCT01473524|592870121|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
164138571|NCT01473524|592870122|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
164138572|NCT01473524|592870123|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
164138573|NCT01473524|592870124|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
164138574|NCT01473524|592870119|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
164138575|NCT01473524|592870120|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
164138576|NCT01473524|592870121|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
164138577|NCT01473524|592870122|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
164138578|NCT01473524|592870123|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
164138579|NCT01473524|592870124|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
164138580|NCT01473524|592870119|FG000|LTSE Phase|Lost to Follow-up|0|||
164138581|NCT01473524|592870120|FG001|LTSE Phase|Lost to Follow-up|0|||
164138582|NCT01473524|592870121|FG002|LTSE Phase|Lost to Follow-up|0|||
164138583|NCT01473524|592870122|FG003|LTSE Phase|Lost to Follow-up|1|||
164138584|NCT01473524|592870123|FG004|LTSE Phase|Lost to Follow-up|3|||
164138585|NCT01473524|592870124|FG005|LTSE Phase|Lost to Follow-up|2|||
164138586|NCT01473524|592870119|FG000|LTSE Phase|Principal Investigator Decision|0|||
164138587|NCT01473524|592870120|FG001|LTSE Phase|Principal Investigator Decision|0|||
164138588|NCT01473524|592870121|FG002|LTSE Phase|Principal Investigator Decision|0|||
164138589|NCT01473524|592870122|FG003|LTSE Phase|Principal Investigator Decision|1|||
164138590|NCT01473524|592870123|FG004|LTSE Phase|Principal Investigator Decision|1|||
164138591|NCT01473524|592870124|FG005|LTSE Phase|Principal Investigator Decision|3|||
164138592|NCT01473524|592870119|FG000|LTSE Phase|Liver Transplantation|0|||
164138593|NCT01473524|592870120|FG001|LTSE Phase|Liver Transplantation|0|||
164138594|NCT01473524|592870121|FG002|LTSE Phase|Liver Transplantation|0|||
164138595|NCT01473524|592870122|FG003|LTSE Phase|Liver Transplantation|0|||
164138596|NCT01473524|592870123|FG004|LTSE Phase|Liver Transplantation|0|||
164138597|NCT01473524|592870124|FG005|LTSE Phase|Liver Transplantation|1|||
164138598|NCT01473524|592870119|FG000|LTSE Phase|Pregnancy|0|||
164138599|NCT01473524|592870120|FG001|LTSE Phase|Pregnancy|0|||
164138600|NCT01473524|592870121|FG002|LTSE Phase|Pregnancy|0|||
164138601|NCT01473524|592870122|FG003|LTSE Phase|Pregnancy|1|||
164138602|NCT01473524|592870123|FG004|LTSE Phase|Pregnancy|0|||
164138603|NCT01473524|592870124|FG005|LTSE Phase|Pregnancy|0|||
164138604|NCT01473524|592870119|FG000|LTSE Phase|Protocol Violation|0|||
164138605|NCT01473524|592870120|FG001|LTSE Phase|Protocol Violation|0|||
164138606|NCT01473524|592870121|FG002|LTSE Phase|Protocol Violation|0|||
164138607|NCT01473524|592870122|FG003|LTSE Phase|Protocol Violation|0|||
164138608|NCT01473524|592870123|FG004|LTSE Phase|Protocol Violation|0|||
164138609|NCT01473524|592870124|FG005|LTSE Phase|Protocol Violation|1|||
164138610|NCT01544179|592870125|FG000|Overall Study|Death|50|||
163879465|NCT03131648|591928160|FG002|Maintenance Treatment Period|Completed Week 50|0|||
163879466|NCT03131648|591928161|FG003|Maintenance Treatment Period|Completed Week 50|0|||
163879467|NCT03131648|591928162|FG004|Maintenance Treatment Period|Completed Week 50|1|||
163879468|NCT03131648|591928163|FG005|Maintenance Treatment Period|Completed Week 50|0|||
163879469|NCT03131648|591928164|FG006|Maintenance Treatment Period|Completed Week 50|0|||
163879470|NCT03131648|591928165|FG007|Maintenance Treatment Period|Completed Week 50|0|||
163879471|NCT03131648|591928158|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879472|NCT03131648|591928159|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879473|NCT03131648|591928160|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879474|NCT03131648|591928161|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879475|NCT03131648|591928162|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879476|NCT03131648|591928163|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879477|NCT03131648|591928164|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
163879478|NCT03131648|591928165|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
163879479|NCT01707030|591928166|FG000|Overall Study|Death|1|||
163879480|NCT01707030|591928167|FG001|Overall Study|Death|1|||
163879481|NCT01707030|591928166|FG000|Overall Study|Withdrawal by Subject|2|||
163879482|NCT01707030|591928167|FG001|Overall Study|Withdrawal by Subject|3|||
163879483|NCT01707030|591928166|FG000|Overall Study|Lost to Follow-up|8|||
163879484|NCT01707030|591928167|FG001|Overall Study|Lost to Follow-up|13|||
163879485|NCT02724878|591928168|FG000|Overall Study|Still on Active Therapy|15|||
163879486|NCT02724878|591928168|FG000|Overall Study|Disease Progression|31|||
163879487|NCT02724878|591928168|FG000|Overall Study|Toxicity|5|||
163879488|NCT02724878|591928168|FG000|Overall Study|Death|1|||
163879489|NCT02724878|591928168|FG000|Overall Study|Withdrawal by Subject|4|||
163879490|NCT02724878|591928168|FG000|Overall Study|Lost to Follow-up|2|||
163879491|NCT02724878|591928168|FG000|Overall Study|Protocol Violation|1|||
163879492|NCT02724878|591928168|FG000|Overall Study|Ineligible for Study Drug|5|||
163879493|NCT02724878|591928168|FG000|Overall Study|not started|1|||
163879494|NCT04263311|591928170|FG000|Overall Study|Lost to Follow-up|1|||
163879495|NCT04263311|591928171|FG001|Overall Study|Lost to Follow-up|2|||
163879496|NCT04263311|591928172|FG002|Overall Study|Lost to Follow-up|0|||
163879497|NCT04263311|591928170|FG000|Overall Study|Health Issues|1|||
163879498|NCT04263311|591928171|FG001|Overall Study|Health Issues|0|||
163879499|NCT04263311|591928172|FG002|Overall Study|Health Issues|0|||
163879500|NCT04263311|591928170|FG000|Overall Study|Left the country|1|||
163879501|NCT04263311|591928171|FG001|Overall Study|Left the country|0|||
163879502|NCT04263311|591928172|FG002|Overall Study|Left the country|0|||
163879503|NCT04263311|591928170|FG000|Overall Study|Unable to maintain time commitment|1|||
163879504|NCT04263311|591928171|FG001|Overall Study|Unable to maintain time commitment|0|||
163879505|NCT04263311|591928172|FG002|Overall Study|Unable to maintain time commitment|0|||
163879506|NCT04263311|591928170|FG000|Overall Study|No longer interested|1|||
163879507|NCT04263311|591928171|FG001|Overall Study|No longer interested|0|||
163879508|NCT04263311|591928172|FG002|Overall Study|No longer interested|0|||
163879509|NCT04263311|591928170|FG000|Overall Study|Ineligible post consent|0|||
163879510|NCT04263311|591928171|FG001|Overall Study|Ineligible post consent|0|||
163879511|NCT04263311|591928172|FG002|Overall Study|Ineligible post consent|5|||
163879512|NCT04838613|591928173|FG000|Overall Study|Withdrawal by Subject|3|||
163879513|NCT04838613|591928174|FG001|Overall Study|Withdrawal by Subject|6|||
163879514|NCT04838613|591928173|FG000|Overall Study|Protocol Deviation|3|||
163879515|NCT04838613|591928174|FG001|Overall Study|Protocol Deviation|2|||
163879516|NCT04838613|591928173|FG000|Overall Study|Technical Problems|0|||
163879517|NCT04838613|591928174|FG001|Overall Study|Technical Problems|5|||
163879518|NCT04838613|591928173|FG000|Overall Study|Physician Decision|2|||
163879519|NCT04838613|591928174|FG001|Overall Study|Physician Decision|0|||
164079863|NCT01806597|592657701|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
164079864|NCT01806597|592657696|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164079865|NCT01806597|592657697|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164079866|NCT01806597|592657698|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164079867|NCT01806597|592657699|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164079868|NCT01806597|592657700|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
164079869|NCT01806597|592657701|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
164079870|NCT01806597|592657696|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164079871|NCT01806597|592657697|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164079872|NCT01806597|592657698|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164138611|NCT01544179|592870126|FG001|Overall Study|Death|37|||
163879520|NCT04757610|591928175|FG000|Overall Study|Adverse Event|13|||
163879521|NCT04757610|591928176|FG001|Overall Study|Adverse Event|10|||
163879522|NCT04757610|591928177|FG002|Overall Study|Adverse Event|5|||
163879523|NCT04757610|591928175|FG000|Overall Study|Death|5|||
163879524|NCT04757610|591928176|FG001|Overall Study|Death|13|||
163879525|NCT04757610|591928177|FG002|Overall Study|Death|8|||
163879526|NCT04757610|591928175|FG000|Overall Study|Lack of Efficacy|1|||
163879527|NCT04757610|591928176|FG001|Overall Study|Lack of Efficacy|2|||
163879528|NCT04757610|591928177|FG002|Overall Study|Lack of Efficacy|3|||
164222603|NCT00281580|593184608|FG001|Overall Study|Withdrawal by Subject|0|||
164222604|NCT00281580|593184609|FG002|Overall Study|Withdrawal by Subject|1|||
164222605|NCT00281580|593184610|FG003|Overall Study|Withdrawal by Subject|1|||
164222606|NCT00281580|593184611|FG004|Overall Study|Withdrawal by Subject|1|||
164222607|NCT00281580|593184612|FG005|Overall Study|Withdrawal by Subject|2|||
164222608|NCT00281580|593184613|FG006|Overall Study|Withdrawal by Subject|2|||
164222609|NCT00281580|593184614|FG007|Overall Study|Withdrawal by Subject|0|||
164222610|NCT00281580|593184615|FG008|Overall Study|Withdrawal by Subject|1|||
164222611|NCT00281580|593184616|FG009|Overall Study|Withdrawal by Subject|4|||
164222612|NCT00281580|593184617|FG010|Overall Study|Withdrawal by Subject|1|||
164222613|NCT00281580|593184618|FG011|Overall Study|Withdrawal by Subject|1|||
164222614|NCT00281580|593184619|FG012|Overall Study|Withdrawal by Subject|2|||
164222615|NCT00281580|593184620|FG013|Overall Study|Withdrawal by Subject|2|||
164222616|NCT00281580|593184621|FG014|Overall Study|Withdrawal by Subject|1|||
164222617|NCT00281580|593184622|FG015|Overall Study|Withdrawal by Subject|5|||
164222618|NCT00281580|593184607|FG000|Overall Study|Lack of Efficacy|2|||
164222619|NCT00281580|593184608|FG001|Overall Study|Lack of Efficacy|1|||
164222620|NCT00281580|593184609|FG002|Overall Study|Lack of Efficacy|1|||
164222621|NCT00281580|593184610|FG003|Overall Study|Lack of Efficacy|6|||
164222622|NCT00281580|593184611|FG004|Overall Study|Lack of Efficacy|2|||
164222623|NCT00281580|593184612|FG005|Overall Study|Lack of Efficacy|0|||
164222624|NCT00281580|593184613|FG006|Overall Study|Lack of Efficacy|0|||
164222625|NCT00281580|593184614|FG007|Overall Study|Lack of Efficacy|0|||
164222626|NCT00281580|593184615|FG008|Overall Study|Lack of Efficacy|0|||
164222627|NCT00281580|593184616|FG009|Overall Study|Lack of Efficacy|0|||
164222628|NCT00281580|593184617|FG010|Overall Study|Lack of Efficacy|0|||
164222629|NCT00281580|593184618|FG011|Overall Study|Lack of Efficacy|1|||
164222630|NCT00281580|593184619|FG012|Overall Study|Lack of Efficacy|0|||
164222631|NCT00281580|593184620|FG013|Overall Study|Lack of Efficacy|2|||
164222632|NCT00281580|593184621|FG014|Overall Study|Lack of Efficacy|1|||
164222633|NCT00281580|593184622|FG015|Overall Study|Lack of Efficacy|0|||
164222634|NCT00281580|593184607|FG000|Overall Study|Lost to Follow-up|0|||
164222635|NCT00281580|593184608|FG001|Overall Study|Lost to Follow-up|0|||
164222636|NCT00281580|593184609|FG002|Overall Study|Lost to Follow-up|0|||
164222637|NCT00281580|593184610|FG003|Overall Study|Lost to Follow-up|3|||
164222638|NCT00281580|593184611|FG004|Overall Study|Lost to Follow-up|0|||
164222639|NCT00281580|593184612|FG005|Overall Study|Lost to Follow-up|1|||
164222640|NCT00281580|593184613|FG006|Overall Study|Lost to Follow-up|0|||
164222641|NCT00281580|593184614|FG007|Overall Study|Lost to Follow-up|1|||
164222642|NCT00281580|593184615|FG008|Overall Study|Lost to Follow-up|2|||
164222643|NCT00281580|593184616|FG009|Overall Study|Lost to Follow-up|1|||
164222644|NCT00281580|593184617|FG010|Overall Study|Lost to Follow-up|1|||
164222645|NCT00281580|593184618|FG011|Overall Study|Lost to Follow-up|0|||
164222646|NCT00281580|593184619|FG012|Overall Study|Lost to Follow-up|1|||
164222647|NCT00281580|593184620|FG013|Overall Study|Lost to Follow-up|0|||
163982664|NCT00179309|592306557|FG000|Treatment|Allergy|1|||
163982665|NCT00179309|592306558|FG001|Treatment|Allergy|0|||
163982666|NCT01289015|592306560|FG000|Overall Study|Protocol Violation|12|||
163982667|NCT01289015|592306561|FG001|Overall Study|Protocol Violation|9|||
163982668|NCT01289015|592306560|FG000|Overall Study|Adverse Event|3|||
163982669|NCT01289015|592306561|FG001|Overall Study|Adverse Event|0|||
163982670|NCT01289015|592306560|FG000|Overall Study|Lost to Follow-up|33|||
163982671|NCT01289015|592306561|FG001|Overall Study|Lost to Follow-up|17|||
163982672|NCT01289015|592306560|FG000|Overall Study|Withdrawal by Subject|17|||
163982673|NCT01289015|592306561|FG001|Overall Study|Withdrawal by Subject|8|||
163982674|NCT01289015|592306560|FG000|Overall Study|Disease progression|1|||
163982675|NCT01289015|592306561|FG001|Overall Study|Disease progression|0|||
163982676|NCT01289015|592306560|FG000|Overall Study|Negative baseline culture and others|33|||
163982677|NCT01289015|592306561|FG001|Overall Study|Negative baseline culture and others|20|||
163982678|NCT05980299|592306564|FG000|Overall Study|Death|28|||
163982679|NCT05980299|592306565|FG001|Overall Study|Death|0|||
163982680|NCT05980299|592306564|FG000|Overall Study|Discharged from Nursing Home|9|||
163982681|NCT05980299|592306565|FG001|Overall Study|Discharged from Nursing Home|0|||
163982682|NCT05980299|592306564|FG000|Overall Study|Lost to Follow-up|0|||
163982683|NCT05980299|592306565|FG001|Overall Study|Lost to Follow-up|10|||
163982684|NCT05048342|592306573|FG000|Overall Study|Adverse Event|1|||
163982685|NCT05048342|592306573|FG000|Overall Study|Subject decision|2|||
163982686|NCT01441063|592306574|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
163982687|NCT01441063|592306574|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
163982688|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
163982689|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
163982690|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
164222648|NCT00281580|593184621|FG014|Overall Study|Lost to Follow-up|0|||
164222649|NCT00281580|593184622|FG015|Overall Study|Lost to Follow-up|0|||
164222650|NCT00281580|593184607|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
164222651|NCT00281580|593184608|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
164222652|NCT00281580|593184609|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
164329133|NCT00406718|593581324|FG001|Overall Study|Lost to Follow-up|5|||
164079873|NCT01806597|592657699|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164079874|NCT01806597|592657700|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
164079875|NCT01806597|592657701|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
164079876|NCT01144663|592657702|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
164079877|NCT01144663|592657703|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
164079878|NCT01144663|592657704|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
164079879|NCT01144663|592657705|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
164079880|NCT01144663|592657702|FG000|Primary Vaccination Phase|Adverse Event|1|||
164079881|NCT01144663|592657703|FG001|Primary Vaccination Phase|Adverse Event|0|||
164079882|NCT01144663|592657704|FG002|Primary Vaccination Phase|Adverse Event|0|||
164079883|NCT01144663|592657705|FG003|Primary Vaccination Phase|Adverse Event|1|||
164079884|NCT01144663|592657702|FG000|Primary Vaccination Phase|Protocol Violation|2|||
164079885|NCT01144663|592657703|FG001|Primary Vaccination Phase|Protocol Violation|0|||
164079886|NCT01144663|592657704|FG002|Primary Vaccination Phase|Protocol Violation|1|||
164079887|NCT01144663|592657705|FG003|Primary Vaccination Phase|Protocol Violation|0|||
164079888|NCT01144663|592657702|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
164079889|NCT01144663|592657703|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
164079890|NCT01144663|592657704|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
164079891|NCT01144663|592657705|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
164079892|NCT01144663|592657702|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
164079893|NCT01144663|592657703|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
164079894|NCT01144663|592657704|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
164079895|NCT01144663|592657705|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
164079896|NCT01144663|592657702|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
164079897|NCT01144663|592657703|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
164079898|NCT01144663|592657704|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
164079899|NCT01144663|592657705|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
164079900|NCT01144663|592657702|FG000|Primary Vaccination Phase|Other|0|||
164079901|NCT01144663|592657703|FG001|Primary Vaccination Phase|Other|1|||
164079902|NCT01144663|592657704|FG002|Primary Vaccination Phase|Other|0|||
164079903|NCT01144663|592657705|FG003|Primary Vaccination Phase|Other|2|||
164079904|NCT01144663|592657702|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
164079905|NCT01144663|592657703|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
164079906|NCT01144663|592657704|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
164079907|NCT01144663|592657705|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
164079908|NCT01144663|592657702|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
164138612|NCT01544179|592870125|FG000|Overall Study|Lost to Follow-up|0|||
164138613|NCT01544179|592870126|FG001|Overall Study|Lost to Follow-up|1|||
164138614|NCT01544179|592870125|FG000|Overall Study|Adverse Event|0|||
164138615|NCT01544179|592870126|FG001|Overall Study|Adverse Event|1|||
164138616|NCT01544179|592870125|FG000|Overall Study|Withdrawal by Subject|12|||
164138617|NCT01544179|592870126|FG001|Overall Study|Withdrawal by Subject|7|||
164138618|NCT01544179|592870125|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
164138619|NCT01544179|592870126|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164138620|NCT01635283|592870129|FG000|Overall Study|Tumor Progression|3|||
164138621|NCT01635283|592870129|FG000|Overall Study|Lost to Follow-up|1|||
164138622|NCT01438996|592870132|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
164138623|NCT01438996|592870133|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
164138624|NCT01438996|592870134|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
164138625|NCT04516759|592870135|FG000|Overall Study|Withdrawal by Subject|1|||
164138626|NCT04516759|592870136|FG001|Overall Study|Withdrawal by Subject|1|||
164138627|NCT04516759|592870135|FG000|Overall Study|Other|0|||
164138628|NCT04516759|592870136|FG001|Overall Study|Other|1|||
164138629|NCT02246114|592870137|FG000|Overall Study|miscarriage|1|||
164138630|NCT02246114|592870138|FG001|Overall Study|miscarriage|0|||
164138631|NCT00229723|592870146|FG000|Concomitant Phase|Adverse Event|4|||
164138632|NCT00229723|592870147|FG001|Concomitant Phase|Adverse Event|2|||
164138633|NCT00229723|592870148|FG002|Concomitant Phase|Adverse Event|5|||
164138634|NCT00229723|592870149|FG003|Concomitant Phase|Adverse Event|2|||
164138635|NCT00229723|592870150|FG004|Concomitant Phase|Adverse Event|0|||
164138636|NCT00229723|592870151|FG005|Concomitant Phase|Adverse Event|1|||
164138637|NCT00229723|592870152|FG006|Concomitant Phase|Adverse Event|2|||
164138638|NCT00229723|592870146|FG000|Concomitant Phase|Objective disease progression|0|||
164138639|NCT00229723|592870147|FG001|Concomitant Phase|Objective disease progression|0|||
164138640|NCT00229723|592870148|FG002|Concomitant Phase|Objective disease progression|0|||
164138641|NCT00229723|592870149|FG003|Concomitant Phase|Objective disease progression|0|||
164138642|NCT00229723|592870150|FG004|Concomitant Phase|Objective disease progression|0|||
164138643|NCT00229723|592870151|FG005|Concomitant Phase|Objective disease progression|0|||
164138644|NCT00229723|592870152|FG006|Concomitant Phase|Objective disease progression|0|||
164138645|NCT00229723|592870146|FG000|Concomitant Phase|Clinical progression|0|||
164138646|NCT00229723|592870147|FG001|Concomitant Phase|Clinical progression|0|||
164138647|NCT00229723|592870148|FG002|Concomitant Phase|Clinical progression|0|||
164222653|NCT00281580|593184610|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
164222654|NCT00281580|593184611|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
164222655|NCT00281580|593184612|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
164222656|NCT00281580|593184613|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
164222657|NCT00281580|593184614|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
164222658|NCT00281580|593184615|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
164222659|NCT00281580|593184616|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
164222660|NCT00281580|593184617|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
164222661|NCT00281580|593184618|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
164222662|NCT00281580|593184619|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
164222663|NCT00281580|593184620|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
164222664|NCT00281580|593184621|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
164222665|NCT00281580|593184622|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
164222666|NCT03302936|593184624|FG000|Overall Study|Protocol Violation|3|||
164222667|NCT03302936|593184625|FG001|Overall Study|Protocol Violation|4|||
164222668|NCT01379937|593184626|FG000|Overall Study|Protocol Violation|0|||
164222669|NCT01379937|593184627|FG001|Overall Study|Protocol Violation|0|||
164222670|NCT01379937|593184628|FG002|Overall Study|Protocol Violation|0|||
164222671|NCT01379937|593184629|FG003|Overall Study|Protocol Violation|1|||
164222672|NCT01379937|593184626|FG000|Overall Study|Consent withdrawal|0|||
164222673|NCT01379937|593184627|FG001|Overall Study|Consent withdrawal|1|||
164222674|NCT01379937|593184628|FG002|Overall Study|Consent withdrawal|0|||
164222675|NCT01379937|593184629|FG003|Overall Study|Consent withdrawal|0|||
164222676|NCT01379937|593184626|FG000|Overall Study|Lost to Follow-up|1|||
164222677|NCT01379937|593184627|FG001|Overall Study|Lost to Follow-up|2|||
163879529|NCT04757610|591928175|FG000|Overall Study|Lost to Follow-up|7|||
163879530|NCT04757610|591928176|FG001|Overall Study|Lost to Follow-up|2|||
163879531|NCT04757610|591928177|FG002|Overall Study|Lost to Follow-up|7|||
164222678|NCT01379937|593184628|FG002|Overall Study|Lost to Follow-up|2|||
164222679|NCT01379937|593184629|FG003|Overall Study|Lost to Follow-up|0|||
164222680|NCT01122680|593184630|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
164222681|NCT01122680|593184631|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
164222682|NCT01122680|593184632|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
164222683|NCT01122680|593184633|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
164222684|NCT01122680|593184630|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
164222685|NCT01122680|593184631|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
164222686|NCT01122680|593184632|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
164222687|NCT01122680|593184633|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
164222688|NCT01122680|593184630|FG000|Period 1 (4 Weeks)|Other|1|||
164222689|NCT01122680|593184631|FG001|Period 1 (4 Weeks)|Other|1|||
164222690|NCT01122680|593184632|FG002|Period 1 (4 Weeks)|Other|0|||
164222691|NCT01122680|593184633|FG003|Period 1 (4 Weeks)|Other|0|||
164222692|NCT01122680|593184630|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
164222693|NCT01122680|593184631|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
164222694|NCT01122680|593184632|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
164222695|NCT01122680|593184633|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
164222696|NCT01122680|593184630|FG000|Period 2 (4 Weeks)|Other|1|||
164222697|NCT01122680|593184631|FG001|Period 2 (4 Weeks)|Other|0|||
164222698|NCT01122680|593184632|FG002|Period 2 (4 Weeks)|Other|0|||
164222699|NCT01122680|593184633|FG003|Period 2 (4 Weeks)|Other|0|||
164222700|NCT01122680|593184630|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
164222701|NCT01122680|593184631|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
164222702|NCT01122680|593184632|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
164222703|NCT01122680|593184633|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
164222704|NCT01122680|593184630|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164222705|NCT01122680|593184631|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
164222706|NCT01122680|593184632|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164222707|NCT01122680|593184633|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164222708|NCT02264821|593184636|FG000|Overall Study|Protocol Violation|1|||
164222709|NCT02264821|593184637|FG001|Overall Study|Protocol Violation|3|||
164222710|NCT02264821|593184638|FG002|Overall Study|Protocol Violation|6|||
164222711|NCT02067156|593184641|FG000|Overall Study|Lost to Follow-up|4|||
164222712|NCT01853280|593184642|FG000|Overall Study|Lack of Efficacy|2|||
164222713|NCT01853280|593184643|FG001|Overall Study|Lack of Efficacy|2|||
164222714|NCT01853280|593184642|FG000|Overall Study|Lost to Follow-up|0|||
164222715|NCT01853280|593184643|FG001|Overall Study|Lost to Follow-up|1|||
164222716|NCT01853280|593184642|FG000|Overall Study|Physician Decision|0|||
164222717|NCT01853280|593184643|FG001|Overall Study|Physician Decision|1|||
164222718|NCT01853280|593184642|FG000|Overall Study|Withdrawal by Subject|0|||
164222719|NCT01853280|593184643|FG001|Overall Study|Withdrawal by Subject|1|||
164222720|NCT01853280|593184642|FG000|Overall Study|Ineligible|0|||
164222721|NCT01853280|593184643|FG001|Overall Study|Ineligible|1|||
163879532|NCT04757610|591928175|FG000|Overall Study|Physician Decision|4|||
164222722|NCT01655069|593184644|FG000|Overall Study|Physician Decision|0|||
164222723|NCT01655069|593184645|FG001|Overall Study|Physician Decision|0|||
164222724|NCT01655069|593184646|FG002|Overall Study|Physician Decision|0|||
164222725|NCT01655069|593184647|FG003|Overall Study|Physician Decision|1|||
164222726|NCT01655069|593184644|FG000|Overall Study|Adverse Event|6|||
164222727|NCT01655069|593184645|FG001|Overall Study|Adverse Event|7|||
164222728|NCT01655069|593184646|FG002|Overall Study|Adverse Event|2|||
164222729|NCT01655069|593184647|FG003|Overall Study|Adverse Event|3|||
164222730|NCT01655069|593184644|FG000|Overall Study|Lack of Efficacy|0|||
164222731|NCT01655069|593184645|FG001|Overall Study|Lack of Efficacy|1|||
164222732|NCT01655069|593184646|FG002|Overall Study|Lack of Efficacy|0|||
164222733|NCT01655069|593184647|FG003|Overall Study|Lack of Efficacy|0|||
164222734|NCT01655069|593184644|FG000|Overall Study|No Treatment Needed|0|||
164222735|NCT01655069|593184645|FG001|Overall Study|No Treatment Needed|1|||
164222736|NCT01655069|593184646|FG002|Overall Study|No Treatment Needed|0|||
164222737|NCT01655069|593184647|FG003|Overall Study|No Treatment Needed|0|||
164222738|NCT01655069|593184644|FG000|Overall Study|Withdrawal by Subject|2|||
164222739|NCT01655069|593184645|FG001|Overall Study|Withdrawal by Subject|3|||
164222740|NCT01655069|593184646|FG002|Overall Study|Withdrawal by Subject|0|||
164222741|NCT01655069|593184647|FG003|Overall Study|Withdrawal by Subject|0|||
164222742|NCT00104884|593184648|FG000|Overall Study|Disease progression|4|||
164222743|NCT03473301|593184649|FG000|Overall Study|Protocol Violation|4|||
164222744|NCT03473301|593184650|FG001|Overall Study|Protocol Violation|0|||
164222745|NCT03473301|593184651|FG002|Overall Study|Protocol Violation|0|||
164222746|NCT03473301|593184649|FG000|Overall Study|Withdrawal by Subject|0|||
164222747|NCT03473301|593184650|FG001|Overall Study|Withdrawal by Subject|1|||
164222748|NCT03473301|593184651|FG002|Overall Study|Withdrawal by Subject|0|||
164222749|NCT03473301|593184649|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
164222750|NCT03473301|593184650|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
164222751|NCT03473301|593184651|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
164222752|NCT05529173|593184652|FG000|Overall Study|Physician Decision|3|||
164222753|NCT05529173|593184653|FG001|Overall Study|Physician Decision|6|||
164222754|NCT05529173|593184652|FG000|Overall Study|Sample shipment delay more than one day|4|||
164222755|NCT05529173|593184653|FG001|Overall Study|Sample shipment delay more than one day|0|||
164222756|NCT00835042|593184656|FG000|First Intervention|Withdrawal by Subject|3|||
164222757|NCT00835042|593184657|FG001|First Intervention|Withdrawal by Subject|0|||
164222758|NCT00835042|593184656|FG000|First Intervention|Adverse Event|1|||
164222759|NCT00835042|593184657|FG001|First Intervention|Adverse Event|2|||
164222760|NCT00835042|593184656|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
164222761|NCT00835042|593184657|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
164222762|NCT03760081|593184658|FG000|Overall Study|Miscellaneous|0|||
164222763|NCT03760081|593184659|FG001|Overall Study|Miscellaneous|1|||
164222764|NCT03760081|593184658|FG000|Overall Study|Progressive Disease|5|||
164222765|NCT03760081|593184659|FG001|Overall Study|Progressive Disease|10|||
164222766|NCT03760081|593184658|FG000|Overall Study|Death|1|||
164222767|NCT03760081|593184659|FG001|Overall Study|Death|1|||
164222768|NCT04034056|593184660|FG000|Overall Study|Withdrawal by Subject|2|||
164222769|NCT04034056|593184660|FG000|Overall Study|Reason Not Specified|13|||
164222770|NCT04034056|593184660|FG000|Overall Study|Adverse Event|56|||
164222771|NCT04135352|593184662|FG000|Overall Study|Not treated-randomization error|0|||
164222772|NCT04135352|593184663|FG001|Overall Study|Not treated-randomization error|0|||
164222773|NCT04135352|593184664|FG002|Overall Study|Not treated-randomization error|1|||
164222774|NCT04135352|593184665|FG003|Overall Study|Not treated-randomization error|0|||
164222775|NCT04135352|593184666|FG004|Overall Study|Not treated-randomization error|0|||
164222776|NCT04135352|593184667|FG005|Overall Study|Not treated-randomization error|0|||
164222777|NCT04135352|593184668|FG006|Overall Study|Not treated-randomization error|0|||
164222778|NCT04135352|593184669|FG007|Overall Study|Not treated-randomization error|0|||
164222779|NCT04135352|593184662|FG000|Overall Study|Withdrawal by Subject|0|||
164222780|NCT04135352|593184663|FG001|Overall Study|Withdrawal by Subject|0|||
164222781|NCT04135352|593184664|FG002|Overall Study|Withdrawal by Subject|2|||
164222782|NCT04135352|593184665|FG003|Overall Study|Withdrawal by Subject|0|||
164222783|NCT04135352|593184666|FG004|Overall Study|Withdrawal by Subject|0|||
164222784|NCT04135352|593184667|FG005|Overall Study|Withdrawal by Subject|0|||
164222785|NCT04135352|593184668|FG006|Overall Study|Withdrawal by Subject|0|||
164222786|NCT04135352|593184669|FG007|Overall Study|Withdrawal by Subject|0|||
164222787|NCT04135352|593184662|FG000|Overall Study|Sponsor Decision|0|||
164222788|NCT04135352|593184663|FG001|Overall Study|Sponsor Decision|0|||
164222789|NCT04135352|593184664|FG002|Overall Study|Sponsor Decision|2|||
164222790|NCT04135352|593184665|FG003|Overall Study|Sponsor Decision|5|||
164222791|NCT04135352|593184666|FG004|Overall Study|Sponsor Decision|1|||
164222792|NCT04135352|593184667|FG005|Overall Study|Sponsor Decision|4|||
164222793|NCT04135352|593184668|FG006|Overall Study|Sponsor Decision|0|||
164222794|NCT04135352|593184669|FG007|Overall Study|Sponsor Decision|0|||
164222795|NCT04135352|593184662|FG000|Overall Study|Physician Decision|0|||
164222796|NCT04135352|593184663|FG001|Overall Study|Physician Decision|0|||
164222797|NCT04135352|593184664|FG002|Overall Study|Physician Decision|1|||
164222798|NCT04135352|593184665|FG003|Overall Study|Physician Decision|0|||
164222799|NCT04135352|593184666|FG004|Overall Study|Physician Decision|1|||
164222800|NCT04135352|593184667|FG005|Overall Study|Physician Decision|0|||
164222801|NCT04135352|593184668|FG006|Overall Study|Physician Decision|0|||
164222802|NCT04135352|593184669|FG007|Overall Study|Physician Decision|0|||
164222803|NCT04135352|593184662|FG000|Overall Study|Death|3|||
164222804|NCT04135352|593184663|FG001|Overall Study|Death|4|||
164222805|NCT04135352|593184664|FG002|Overall Study|Death|7|||
164222806|NCT04135352|593184665|FG003|Overall Study|Death|0|||
164222807|NCT04135352|593184666|FG004|Overall Study|Death|3|||
164222808|NCT04135352|593184667|FG005|Overall Study|Death|1|||
164222809|NCT04135352|593184668|FG006|Overall Study|Death|0|||
164222810|NCT04135352|593184669|FG007|Overall Study|Death|0|||
164222811|NCT02453191|593184670|FG000|Overall Study|Withdrawal by Subject|1|||
164222812|NCT02571244|593184671|FG000|Overall Study|Lost to Follow-up|0|||
164222813|NCT02571244|593184672|FG001|Overall Study|Lost to Follow-up|1|||
164222814|NCT02571244|593184671|FG000|Overall Study|Unable to reach out post discharge|3|||
164222815|NCT02571244|593184672|FG001|Overall Study|Unable to reach out post discharge|0|||
164222816|NCT01696214|593184675|FG000|Overall Study|Lost to Follow-up|1|||
164222817|NCT01696214|593184676|FG001|Overall Study|Lost to Follow-up|0|||
164222818|NCT01696214|593184677|FG002|Overall Study|Lost to Follow-up|0|||
164222819|NCT01696214|593184678|FG003|Overall Study|Lost to Follow-up|0|||
164222820|NCT02134028|593184679|FG000|Overall Study|Lack of Efficacy|1|||
164222821|NCT02134028|593184680|FG001|Overall Study|Lack of Efficacy|0|||
164222822|NCT02134028|593184681|FG002|Overall Study|Lack of Efficacy|3|||
164222823|NCT02134028|593184682|FG003|Overall Study|Lack of Efficacy|2|||
164222824|NCT02134028|593184683|FG004|Overall Study|Lack of Efficacy|1|||
164222825|NCT02134028|593184684|FG005|Overall Study|Lack of Efficacy|2|||
164222826|NCT02134028|593184685|FG006|Overall Study|Lack of Efficacy|1|||
164222827|NCT02134028|593184686|FG007|Overall Study|Lack of Efficacy|0|||
164222828|NCT02134028|593184679|FG000|Overall Study|Poor compliance to protocol|1|||
164222829|NCT02134028|593184680|FG001|Overall Study|Poor compliance to protocol|1|||
164222830|NCT02134028|593184681|FG002|Overall Study|Poor compliance to protocol|3|||
164222831|NCT02134028|593184682|FG003|Overall Study|Poor compliance to protocol|7|||
164222832|NCT02134028|593184683|FG004|Overall Study|Poor compliance to protocol|1|||
164222833|NCT02134028|593184684|FG005|Overall Study|Poor compliance to protocol|1|||
164222834|NCT02134028|593184685|FG006|Overall Study|Poor compliance to protocol|0|||
164222835|NCT02134028|593184686|FG007|Overall Study|Poor compliance to protocol|0|||
164222836|NCT02134028|593184679|FG000|Overall Study|Other unspecified|4|||
164222837|NCT02134028|593184680|FG001|Overall Study|Other unspecified|22|||
164222838|NCT02134028|593184681|FG002|Overall Study|Other unspecified|33|||
164222839|NCT02134028|593184682|FG003|Overall Study|Other unspecified|64|||
164222840|NCT02134028|593184683|FG004|Overall Study|Other unspecified|8|||
164222841|NCT02134028|593184684|FG005|Overall Study|Other unspecified|6|||
164222842|NCT02134028|593184685|FG006|Overall Study|Other unspecified|2|||
164222843|NCT02134028|593184686|FG007|Overall Study|Other unspecified|1|||
164222844|NCT02134028|593184679|FG000|Overall Study|Adverse Event|3|||
164222845|NCT02134028|593184680|FG001|Overall Study|Adverse Event|19|||
164222846|NCT02134028|593184681|FG002|Overall Study|Adverse Event|13|||
164222847|NCT02134028|593184682|FG003|Overall Study|Adverse Event|32|||
164222848|NCT02134028|593184683|FG004|Overall Study|Adverse Event|4|||
164222849|NCT02134028|593184684|FG005|Overall Study|Adverse Event|5|||
164222850|NCT02134028|593184685|FG006|Overall Study|Adverse Event|1|||
164222851|NCT02134028|593184686|FG007|Overall Study|Adverse Event|2|||
164222852|NCT01210443|593184687|FG000|Overall Study|Study terminated by sponsor|2|||
164222853|NCT02807181|593184690|FG000|Overall Study|Death|28|||
164222854|NCT02807181|593184691|FG001|Overall Study|Death|24|||
164222855|NCT02807181|593184690|FG000|Overall Study|Withdrawal by Subject|1|||
164222856|NCT02807181|593184691|FG001|Overall Study|Withdrawal by Subject|1|||
164222857|NCT02807181|593184690|FG000|Overall Study|Lost to Follow-up|0|||
164222858|NCT02807181|593184691|FG001|Overall Study|Lost to Follow-up|2|||
164222859|NCT02807181|593184690|FG000|Overall Study|Subject decision|1|||
164222860|NCT02807181|593184691|FG001|Overall Study|Subject decision|0|||
164222861|NCT02807181|593184690|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
163982691|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
163982692|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
163982693|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
163982694|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
163982695|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
163982696|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
163982697|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
163982698|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
163982699|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
163982700|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
163982701|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
164222862|NCT02807181|593184691|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
164222863|NCT02807181|593184690|FG000|Overall Study|In Study|3|||
164222864|NCT02807181|593184691|FG001|Overall Study|In Study|3|||
164222865|NCT02807181|593184690|FG000|Overall Study|Post Progression|3|||
164222866|NCT02807181|593184691|FG001|Overall Study|Post Progression|2|||
164222867|NCT01309100|593184694|FG000|Overall Study|Protocol Violation|1|||
164222868|NCT01309100|593184694|FG000|Overall Study|Positive Slit lamp finding|1|||
164222869|NCT03722030|593184695|FG000|Overall Study|Withdrawal by Subject|1|||
164222870|NCT03722030|593184696|FG001|Overall Study|Withdrawal by Subject|0|||
164222871|NCT01663987|593184698|FG000|Overall Study|Adverse Event|7|||
164222872|NCT01663987|593184699|FG001|Overall Study|Adverse Event|2|||
164222873|NCT01663987|593184698|FG000|Overall Study|Lost to Follow-up|1|||
164222874|NCT01663987|593184699|FG001|Overall Study|Lost to Follow-up|1|||
164222875|NCT01663987|593184698|FG000|Overall Study|Withdrawal by Subject|2|||
164222876|NCT01663987|593184699|FG001|Overall Study|Withdrawal by Subject|3|||
164222877|NCT01663987|593184698|FG000|Overall Study|Other reason not defined above|3|||
164222878|NCT01663987|593184699|FG001|Overall Study|Other reason not defined above|0|||
164222879|NCT00468546|593184701|FG000|Week 24 Analysis|Lack of Efficacy|83|||
164222880|NCT00468546|593184702|FG001|Week 24 Analysis|Lack of Efficacy|37|||
164222881|NCT00468546|593184701|FG000|Week 24 Analysis|Refused treatment|5|||
164222882|NCT00468546|593184702|FG001|Week 24 Analysis|Refused treatment|5|||
164222883|NCT00468546|593184701|FG000|Week 24 Analysis|Adverse Event|1|||
164222884|NCT00468546|593184702|FG001|Week 24 Analysis|Adverse Event|8|||
164222885|NCT00468546|593184701|FG000|Week 24 Analysis|Failure to return|3|||
164222886|NCT00468546|593184702|FG001|Week 24 Analysis|Failure to return|4|||
164222887|NCT00468546|593184701|FG000|Week 24 Analysis|Rescue therapy|2|||
164222888|NCT00468546|593184702|FG001|Week 24 Analysis|Rescue therapy|0|||
164222889|NCT00468546|593184701|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
164222890|NCT00468546|593184702|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
164222891|NCT00468546|593184701|FG000|Week 24 Analysis|Due to clinical hold|1|||
164222892|NCT00468546|593184702|FG001|Week 24 Analysis|Due to clinical hold|0|||
164222893|NCT00468546|593184701|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
164222894|NCT00468546|593184702|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
164222895|NCT00468546|593184701|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
164222896|NCT00468546|593184702|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
164222897|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
164222898|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
164222899|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Death|1|||
164222900|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Death|0|||
164222901|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
164222902|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
164222903|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
164222904|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
164222905|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
164222906|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
164222907|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
164222908|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
164222909|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
164222910|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
164222911|NCT00468546|593184701|FG000|Week 24 to Week 104 Analysis|Other|17|||
164222912|NCT00468546|593184702|FG001|Week 24 to Week 104 Analysis|Other|14|||
164222913|NCT04000724|593184705|FG000|Overall Study|Withdrawal by Subject|5|||
164222914|NCT04000724|593184706|FG001|Overall Study|Withdrawal by Subject|3|||
164222915|NCT04000724|593184707|FG002|Overall Study|Withdrawal by Subject|4|||
164222916|NCT04000724|593184705|FG000|Overall Study|Lost to Follow-up|11|||
164222917|NCT04000724|593184706|FG001|Overall Study|Lost to Follow-up|7|||
164222918|NCT04000724|593184707|FG002|Overall Study|Lost to Follow-up|13|||
164222919|NCT00455455|593184708|FG000|Washout|Withdrawal by Subject|0|||
164222920|NCT00455455|593184709|FG001|Washout|Withdrawal by Subject|1|||
164222921|NCT00455455|593184708|FG000|Washout|Withdrawal by Subject|1|||
164222922|NCT00455455|593184709|FG001|Washout|Withdrawal by Subject|0|||
164222923|NCT00472641|593184710|FG000|Overall Study|Lack of Efficacy|3|||
164222924|NCT00472641|593184710|FG000|Overall Study|Adverse Event|3|||
164222925|NCT00472641|593184710|FG000|Overall Study|Lost to Follow-up|1|||
164222926|NCT00676689|593184713|FG000|Overall Study|Screen Failure|2|||
164222927|NCT00676689|593184713|FG000|Overall Study|Death|2|||
164222928|NCT00676689|593184713|FG000|Overall Study|Lost to Follow-up|4|||
164222929|NCT00676689|593184713|FG000|Overall Study|Physician Decision|1|||
164222930|NCT00676689|593184713|FG000|Overall Study|Withdrawal by Subject|3|||
164222931|NCT00676689|593184713|FG000|Overall Study|Continuing FU|49|||
164222932|NCT01827943|593184714|FG000|Overall Study|Protocol Violation|8|||
164222933|NCT01827943|593184714|FG000|Overall Study|Never treated because of an rapid progression|1|||
164222934|NCT00501085|593184715|FG000|Overall Study|Lost to Follow-up|195|||
164222935|NCT00501085|593184715|FG000|Overall Study|Withdrawal by Subject|34|||
164222936|NCT00501085|593184715|FG000|Overall Study|Subject Decision|1|||
164222937|NCT00501085|593184715|FG000|Overall Study|Revision Surgery|7|||
164222938|NCT00501085|593184715|FG000|Overall Study|Explantation Surgery|26|||
164222939|NCT00501085|593184715|FG000|Overall Study|Adverse Event|4|||
164222940|NCT00501085|593184715|FG000|Overall Study|Non-Compliance|24|||
164222941|NCT00501085|593184715|FG000|Overall Study|Study closed by sponsor|109|||
164222942|NCT00501085|593184715|FG000|Overall Study|Other loss to follow-up|32|||
164222943|NCT01487161|593184716|FG000|Overall Study|Adverse Event|1|||
164222944|NCT01487161|593184717|FG001|Overall Study|Adverse Event|0|||
164222945|NCT01487161|593184718|FG002|Overall Study|Adverse Event|0|||
164222946|NCT01487161|593184719|FG003|Overall Study|Adverse Event|0|||
164222947|NCT01487161|593184716|FG000|Overall Study|Withdrawal by Subject|1|||
164222948|NCT01487161|593184717|FG001|Overall Study|Withdrawal by Subject|1|||
164222949|NCT01487161|593184718|FG002|Overall Study|Withdrawal by Subject|1|||
164222950|NCT01487161|593184719|FG003|Overall Study|Withdrawal by Subject|2|||
164222951|NCT01487161|593184716|FG000|Overall Study|missing data|0|||
164222952|NCT01487161|593184717|FG001|Overall Study|missing data|1|||
164222953|NCT01487161|593184718|FG002|Overall Study|missing data|0|||
164222954|NCT01487161|593184719|FG003|Overall Study|missing data|0|||
164222955|NCT01084135|593184720|FG000|20 Week|Physician Decision|0|||
164222956|NCT01084135|593184721|FG001|20 Week|Physician Decision|1|||
164222957|NCT00663351|593184722|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
164222958|NCT00663351|593184723|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
164222959|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
164222960|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
164222961|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
164222962|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
164222963|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
164222964|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
164222965|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
164222966|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
164222967|NCT00663351|593184722|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
164222968|NCT00663351|593184723|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
164222969|NCT02366130|593184724|FG000|Overall Study|Withdrawal by Subject|3|||
164222970|NCT02366130|593184724|FG000|Overall Study|Ineligible|6|||
164222971|NCT01065766|593184725|FG000|Overall Study|Assessed before the contracted date|1|||
164222972|NCT01065766|593184725|FG000|Overall Study|Contraindication to administration|6|||
164222973|NCT01065766|593184725|FG000|Overall Study|Violated dosage/administration|25|||
164222974|NCT04518410|593184729|FG000|Overall Study|Lost to Follow-up|1|||
164222975|NCT04518410|593184730|FG001|Overall Study|Lost to Follow-up|1|||
164222976|NCT04518410|593184731|FG002|Overall Study|Lost to Follow-up|8|||
164222977|NCT04518410|593184732|FG003|Overall Study|Lost to Follow-up|5|||
164222978|NCT04518410|593184733|FG004|Overall Study|Lost to Follow-up|92|||
164222979|NCT04518410|593184734|FG005|Overall Study|Lost to Follow-up|25|||
164222980|NCT04518410|593184735|FG006|Overall Study|Lost to Follow-up|25|||
164222981|NCT04518410|593184736|FG007|Overall Study|Lost to Follow-up|3|||
164222982|NCT04518410|593184737|FG008|Overall Study|Lost to Follow-up|2|||
164222983|NCT04518410|593184738|FG009|Overall Study|Lost to Follow-up|13|||
164222984|NCT04518410|593184739|FG010|Overall Study|Lost to Follow-up|9|||
164222985|NCT04518410|593184740|FG011|Overall Study|Lost to Follow-up|13|||
164222986|NCT04518410|593184741|FG012|Overall Study|Lost to Follow-up|9|||
164222987|NCT04518410|593184742|FG013|Overall Study|Lost to Follow-up|13|||
164222988|NCT04518410|593184743|FG014|Overall Study|Lost to Follow-up|8|||
164222989|NCT04518410|593184744|FG015|Overall Study|Lost to Follow-up|10|||
164222990|NCT04518410|593184745|FG016|Overall Study|Lost to Follow-up|6|||
164222991|NCT04518410|593184746|FG017|Overall Study|Lost to Follow-up|13|||
164222992|NCT04518410|593184747|FG018|Overall Study|Lost to Follow-up|21|||
164222993|NCT04518410|593184748|FG019|Overall Study|Lost to Follow-up|6|||
164222994|NCT04518410|593184749|FG020|Overall Study|Lost to Follow-up|7|||
164222995|NCT04518410|593184750|FG021|Overall Study|Lost to Follow-up|21|||
164222996|NCT04518410|593184751|FG022|Overall Study|Lost to Follow-up|1|||
164222997|NCT04518410|593184752|FG023|Overall Study|Lost to Follow-up|7|||
164222998|NCT04518410|593184753|FG024|Overall Study|Lost to Follow-up|6|||
164222999|NCT04518410|593184729|FG000|Overall Study|Withdrawal by Subject|1|||
164223000|NCT04518410|593184730|FG001|Overall Study|Withdrawal by Subject|2|||
164223001|NCT04518410|593184731|FG002|Overall Study|Withdrawal by Subject|2|||
164223002|NCT04518410|593184732|FG003|Overall Study|Withdrawal by Subject|3|||
164223003|NCT04518410|593184733|FG004|Overall Study|Withdrawal by Subject|20|||
164223004|NCT04518410|593184734|FG005|Overall Study|Withdrawal by Subject|20|||
164223005|NCT04518410|593184735|FG006|Overall Study|Withdrawal by Subject|25|||
164223006|NCT04518410|593184736|FG007|Overall Study|Withdrawal by Subject|6|||
164223007|NCT04518410|593184737|FG008|Overall Study|Withdrawal by Subject|1|||
164223008|NCT04518410|593184738|FG009|Overall Study|Withdrawal by Subject|12|||
164223009|NCT04518410|593184739|FG010|Overall Study|Withdrawal by Subject|5|||
164223010|NCT04518410|593184740|FG011|Overall Study|Withdrawal by Subject|7|||
164223011|NCT04518410|593184741|FG012|Overall Study|Withdrawal by Subject|2|||
164223012|NCT04518410|593184742|FG013|Overall Study|Withdrawal by Subject|13|||
164223013|NCT04518410|593184743|FG014|Overall Study|Withdrawal by Subject|4|||
164223014|NCT04518410|593184744|FG015|Overall Study|Withdrawal by Subject|9|||
164223015|NCT04518410|593184745|FG016|Overall Study|Withdrawal by Subject|0|||
164223016|NCT04518410|593184746|FG017|Overall Study|Withdrawal by Subject|15|||
164223017|NCT04518410|593184747|FG018|Overall Study|Withdrawal by Subject|12|||
164223018|NCT04518410|593184748|FG019|Overall Study|Withdrawal by Subject|9|||
164223019|NCT04518410|593184749|FG020|Overall Study|Withdrawal by Subject|14|||
164223020|NCT04518410|593184750|FG021|Overall Study|Withdrawal by Subject|3|||
164223021|NCT04518410|593184751|FG022|Overall Study|Withdrawal by Subject|2|||
164223022|NCT04518410|593184752|FG023|Overall Study|Withdrawal by Subject|9|||
164223023|NCT04518410|593184753|FG024|Overall Study|Withdrawal by Subject|8|||
164223024|NCT04518410|593184729|FG000|Overall Study|Other|1|||
164223025|NCT04518410|593184730|FG001|Overall Study|Other|0|||
164223026|NCT04518410|593184731|FG002|Overall Study|Other|0|||
164223027|NCT04518410|593184732|FG003|Overall Study|Other|1|||
164223028|NCT04518410|593184733|FG004|Overall Study|Other|6|||
164223029|NCT04518410|593184734|FG005|Overall Study|Other|6|||
164223030|NCT04518410|593184735|FG006|Overall Study|Other|5|||
164223031|NCT04518410|593184736|FG007|Overall Study|Other|2|||
164223032|NCT04518410|593184737|FG008|Overall Study|Other|0|||
164223033|NCT04518410|593184738|FG009|Overall Study|Other|1|||
164223034|NCT04518410|593184739|FG010|Overall Study|Other|0|||
164223035|NCT04518410|593184740|FG011|Overall Study|Other|2|||
164223036|NCT04518410|593184741|FG012|Overall Study|Other|0|||
164223037|NCT04518410|593184742|FG013|Overall Study|Other|0|||
164223038|NCT04518410|593184743|FG014|Overall Study|Other|0|||
164223039|NCT04518410|593184744|FG015|Overall Study|Other|3|||
164223040|NCT04518410|593184745|FG016|Overall Study|Other|1|||
164223041|NCT04518410|593184746|FG017|Overall Study|Other|1|||
164223042|NCT04518410|593184747|FG018|Overall Study|Other|1|||
164223043|NCT04518410|593184748|FG019|Overall Study|Other|0|||
164223044|NCT04518410|593184749|FG020|Overall Study|Other|1|||
164223045|NCT04518410|593184750|FG021|Overall Study|Other|0|||
164223046|NCT04518410|593184751|FG022|Overall Study|Other|1|||
164223047|NCT04518410|593184752|FG023|Overall Study|Other|2|||
164223048|NCT04518410|593184753|FG024|Overall Study|Other|2|||
164223049|NCT04518410|593184729|FG000|Overall Study|Protocol Violation|0|||
164223050|NCT04518410|593184730|FG001|Overall Study|Protocol Violation|0|||
164223051|NCT04518410|593184731|FG002|Overall Study|Protocol Violation|0|||
164223052|NCT04518410|593184732|FG003|Overall Study|Protocol Violation|2|||
164223053|NCT04518410|593184733|FG004|Overall Study|Protocol Violation|17|||
164223054|NCT04518410|593184734|FG005|Overall Study|Protocol Violation|1|||
164223055|NCT04518410|593184735|FG006|Overall Study|Protocol Violation|2|||
164223056|NCT04518410|593184736|FG007|Overall Study|Protocol Violation|1|||
164223057|NCT04518410|593184737|FG008|Overall Study|Protocol Violation|0|||
164223058|NCT04518410|593184738|FG009|Overall Study|Protocol Violation|0|||
164223059|NCT04518410|593184739|FG010|Overall Study|Protocol Violation|0|||
164223060|NCT04518410|593184740|FG011|Overall Study|Protocol Violation|0|||
164223061|NCT04518410|593184741|FG012|Overall Study|Protocol Violation|0|||
164223062|NCT04518410|593184742|FG013|Overall Study|Protocol Violation|0|||
164223063|NCT04518410|593184743|FG014|Overall Study|Protocol Violation|0|||
164223064|NCT04518410|593184744|FG015|Overall Study|Protocol Violation|0|||
164223065|NCT04518410|593184745|FG016|Overall Study|Protocol Violation|1|||
164223066|NCT04518410|593184746|FG017|Overall Study|Protocol Violation|1|||
164223067|NCT04518410|593184747|FG018|Overall Study|Protocol Violation|0|||
164223068|NCT04518410|593184748|FG019|Overall Study|Protocol Violation|0|||
164223069|NCT04518410|593184749|FG020|Overall Study|Protocol Violation|1|||
164223070|NCT04518410|593184750|FG021|Overall Study|Protocol Violation|2|||
164223071|NCT04518410|593184751|FG022|Overall Study|Protocol Violation|0|||
164223072|NCT04518410|593184752|FG023|Overall Study|Protocol Violation|3|||
164223073|NCT04518410|593184753|FG024|Overall Study|Protocol Violation|0|||
164223074|NCT04518410|593184729|FG000|Overall Study|Death|0|||
164223075|NCT04518410|593184730|FG001|Overall Study|Death|0|||
163879533|NCT04757610|591928176|FG001|Overall Study|Physician Decision|1|||
163879534|NCT04757610|591928177|FG002|Overall Study|Physician Decision|2|||
163879535|NCT04757610|591928175|FG000|Overall Study|Withdrawal by Subject|26|||
163879536|NCT04757610|591928176|FG001|Overall Study|Withdrawal by Subject|25|||
164223076|NCT04518410|593184731|FG002|Overall Study|Death|0|||
163879537|NCT04757610|591928177|FG002|Overall Study|Withdrawal by Subject|25|||
163879538|NCT04757610|591928175|FG000|Overall Study|Study Terminated by Sponsor|105|||
163879539|NCT04757610|591928176|FG001|Overall Study|Study Terminated by Sponsor|105|||
164223077|NCT04518410|593184732|FG003|Overall Study|Death|0|||
163879540|NCT04757610|591928177|FG002|Overall Study|Study Terminated by Sponsor|110|||
163879541|NCT04757610|591928175|FG000|Overall Study|Randomized in Error|1|||
163879542|NCT04757610|591928176|FG001|Overall Study|Randomized in Error|0|||
164223078|NCT04518410|593184733|FG004|Overall Study|Death|12|||
164223079|NCT04518410|593184734|FG005|Overall Study|Death|2|||
164223080|NCT04518410|593184735|FG006|Overall Study|Death|11|||
164223081|NCT04518410|593184736|FG007|Overall Study|Death|0|||
164223082|NCT04518410|593184737|FG008|Overall Study|Death|1|||
164223083|NCT04518410|593184738|FG009|Overall Study|Death|0|||
164223084|NCT04518410|593184739|FG010|Overall Study|Death|0|||
164223085|NCT04518410|593184740|FG011|Overall Study|Death|0|||
164223086|NCT04518410|593184741|FG012|Overall Study|Death|0|||
164223087|NCT04518410|593184742|FG013|Overall Study|Death|1|||
164223088|NCT04518410|593184743|FG014|Overall Study|Death|1|||
164223089|NCT04518410|593184744|FG015|Overall Study|Death|0|||
164223090|NCT04518410|593184745|FG016|Overall Study|Death|0|||
164223091|NCT04518410|593184746|FG017|Overall Study|Death|1|||
164223092|NCT04518410|593184747|FG018|Overall Study|Death|4|||
164223093|NCT04518410|593184748|FG019|Overall Study|Death|4|||
164223094|NCT04518410|593184749|FG020|Overall Study|Death|1|||
164223095|NCT04518410|593184750|FG021|Overall Study|Death|0|||
164223096|NCT04518410|593184751|FG022|Overall Study|Death|0|||
164223097|NCT04518410|593184752|FG023|Overall Study|Death|0|||
164223098|NCT04518410|593184753|FG024|Overall Study|Death|0|||
164223099|NCT04518410|593184729|FG000|Overall Study|Requirement to start alternative therapy|0|||
164223100|NCT04518410|593184730|FG001|Overall Study|Requirement to start alternative therapy|0|||
164223101|NCT04518410|593184731|FG002|Overall Study|Requirement to start alternative therapy|1|||
164223102|NCT04518410|593184732|FG003|Overall Study|Requirement to start alternative therapy|0|||
164223103|NCT04518410|593184733|FG004|Overall Study|Requirement to start alternative therapy|0|||
164223104|NCT04518410|593184734|FG005|Overall Study|Requirement to start alternative therapy|0|||
164223105|NCT04518410|593184735|FG006|Overall Study|Requirement to start alternative therapy|0|||
164223106|NCT04518410|593184736|FG007|Overall Study|Requirement to start alternative therapy|0|||
164223107|NCT04518410|593184737|FG008|Overall Study|Requirement to start alternative therapy|0|||
164223108|NCT04518410|593184738|FG009|Overall Study|Requirement to start alternative therapy|0|||
164223109|NCT04518410|593184739|FG010|Overall Study|Requirement to start alternative therapy|0|||
164223110|NCT04518410|593184740|FG011|Overall Study|Requirement to start alternative therapy|0|||
164223111|NCT04518410|593184741|FG012|Overall Study|Requirement to start alternative therapy|0|||
164223112|NCT04518410|593184742|FG013|Overall Study|Requirement to start alternative therapy|0|||
164223113|NCT04518410|593184743|FG014|Overall Study|Requirement to start alternative therapy|0|||
164223114|NCT04518410|593184744|FG015|Overall Study|Requirement to start alternative therapy|0|||
164079909|NCT01144663|592657703|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
164079910|NCT01144663|592657704|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
164079911|NCT01144663|592657705|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
164079912|NCT01144663|592657702|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
164079913|NCT01144663|592657703|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
164138723|NCT00229723|592870147|FG001|Maintenance Phase|Other|4|||
164138724|NCT00229723|592870148|FG002|Maintenance Phase|Other|1|||
164138725|NCT00229723|592870149|FG003|Maintenance Phase|Other|2|||
164138726|NCT00229723|592870150|FG004|Maintenance Phase|Other|3|||
164138727|NCT00229723|592870151|FG005|Maintenance Phase|Other|3|||
164138728|NCT00229723|592870152|FG006|Maintenance Phase|Other|1|||
164138729|NCT01338870|592870154|FG000|Overall Study|Lost to Follow-up|0|||
164138730|NCT01338870|592870155|FG001|Overall Study|Lost to Follow-up|0|||
164138731|NCT01338870|592870156|FG002|Overall Study|Lost to Follow-up|1|||
164138732|NCT01338870|592870157|FG003|Overall Study|Lost to Follow-up|0|||
164138733|NCT01338870|592870158|FG004|Overall Study|Lost to Follow-up|1|||
164138734|NCT01338870|592870159|FG005|Overall Study|Lost to Follow-up|0|||
164138735|NCT01338870|592870154|FG000|Overall Study|Withdrawal by Subject|2|||
164138736|NCT01338870|592870155|FG001|Overall Study|Withdrawal by Subject|3|||
164138737|NCT01338870|592870156|FG002|Overall Study|Withdrawal by Subject|4|||
164138738|NCT01338870|592870157|FG003|Overall Study|Withdrawal by Subject|0|||
164138739|NCT01338870|592870158|FG004|Overall Study|Withdrawal by Subject|0|||
164138740|NCT01338870|592870159|FG005|Overall Study|Withdrawal by Subject|2|||
164138741|NCT01338870|592870154|FG000|Overall Study|Other|3|||
164138742|NCT01338870|592870155|FG001|Overall Study|Other|3|||
164138743|NCT01338870|592870156|FG002|Overall Study|Other|3|||
164138744|NCT01338870|592870157|FG003|Overall Study|Other|2|||
164138745|NCT01338870|592870158|FG004|Overall Study|Other|0|||
164138746|NCT01338870|592870159|FG005|Overall Study|Other|2|||
164138747|NCT01338870|592870154|FG000|Overall Study|Protocol Violation|0|||
164138748|NCT01338870|592870155|FG001|Overall Study|Protocol Violation|2|||
164138749|NCT01338870|592870156|FG002|Overall Study|Protocol Violation|2|||
164138750|NCT01338870|592870157|FG003|Overall Study|Protocol Violation|2|||
164138751|NCT01338870|592870158|FG004|Overall Study|Protocol Violation|1|||
164138752|NCT01338870|592870159|FG005|Overall Study|Protocol Violation|1|||
164138753|NCT01338870|592870154|FG000|Overall Study|Adverse Event|4|||
164138754|NCT01338870|592870155|FG001|Overall Study|Adverse Event|4|||
164138755|NCT01338870|592870156|FG002|Overall Study|Adverse Event|1|||
164138756|NCT01338870|592870157|FG003|Overall Study|Adverse Event|5|||
164138757|NCT01338870|592870158|FG004|Overall Study|Adverse Event|4|||
164138758|NCT01338870|592870159|FG005|Overall Study|Adverse Event|1|||
164138759|NCT03201445|592870161|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
164138760|NCT03201445|592870162|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
164138761|NCT03201445|592870161|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
164138762|NCT03201445|592870162|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
164138763|NCT03201445|592870161|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
164138764|NCT03201445|592870162|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
164138765|NCT03201445|592870161|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
164138766|NCT03201445|592870162|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
164138767|NCT03201445|592870161|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
164138768|NCT03201445|592870162|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
164223115|NCT04518410|593184745|FG016|Overall Study|Requirement to start alternative therapy|0|||
164223116|NCT04518410|593184746|FG017|Overall Study|Requirement to start alternative therapy|0|||
164223117|NCT04518410|593184747|FG018|Overall Study|Requirement to start alternative therapy|0|||
164223118|NCT04518410|593184748|FG019|Overall Study|Requirement to start alternative therapy|0|||
164223119|NCT04518410|593184749|FG020|Overall Study|Requirement to start alternative therapy|0|||
164223120|NCT04518410|593184750|FG021|Overall Study|Requirement to start alternative therapy|0|||
164223121|NCT04518410|593184751|FG022|Overall Study|Requirement to start alternative therapy|0|||
164223122|NCT04518410|593184752|FG023|Overall Study|Requirement to start alternative therapy|0|||
164223123|NCT04518410|593184753|FG024|Overall Study|Requirement to start alternative therapy|0|||
164223124|NCT04518410|593184729|FG000|Overall Study|Randomized but not treated|0|||
164223125|NCT04518410|593184730|FG001|Overall Study|Randomized but not treated|0|||
164223126|NCT04518410|593184731|FG002|Overall Study|Randomized but not treated|0|||
164223127|NCT04518410|593184732|FG003|Overall Study|Randomized but not treated|2|||
164223128|NCT04518410|593184733|FG004|Overall Study|Randomized but not treated|6|||
164223129|NCT04518410|593184734|FG005|Overall Study|Randomized but not treated|4|||
164223130|NCT04518410|593184735|FG006|Overall Study|Randomized but not treated|3|||
164223131|NCT04518410|593184736|FG007|Overall Study|Randomized but not treated|3|||
164223132|NCT04518410|593184737|FG008|Overall Study|Randomized but not treated|0|||
164223133|NCT04518410|593184738|FG009|Overall Study|Randomized but not treated|4|||
164223134|NCT04518410|593184739|FG010|Overall Study|Randomized but not treated|0|||
164223135|NCT04518410|593184740|FG011|Overall Study|Randomized but not treated|0|||
164223136|NCT04518410|593184741|FG012|Overall Study|Randomized but not treated|1|||
164223137|NCT04518410|593184742|FG013|Overall Study|Randomized but not treated|3|||
164223138|NCT04518410|593184743|FG014|Overall Study|Randomized but not treated|3|||
164223139|NCT04518410|593184744|FG015|Overall Study|Randomized but not treated|3|||
164223140|NCT04518410|593184745|FG016|Overall Study|Randomized but not treated|4|||
164223141|NCT04518410|593184746|FG017|Overall Study|Randomized but not treated|5|||
164223142|NCT04518410|593184747|FG018|Overall Study|Randomized but not treated|4|||
164223143|NCT04518410|593184748|FG019|Overall Study|Randomized but not treated|0|||
164223144|NCT04518410|593184749|FG020|Overall Study|Randomized but not treated|0|||
164223145|NCT04518410|593184750|FG021|Overall Study|Randomized but not treated|5|||
164223146|NCT04518410|593184751|FG022|Overall Study|Randomized but not treated|0|||
164223147|NCT04518410|593184752|FG023|Overall Study|Randomized but not treated|3|||
164223148|NCT04518410|593184753|FG024|Overall Study|Randomized but not treated|1|||
164223149|NCT04518410|593184729|FG000|Overall Study|Screen Fail but Randomized|0|||
164223150|NCT04518410|593184730|FG001|Overall Study|Screen Fail but Randomized|0|||
164223151|NCT04518410|593184731|FG002|Overall Study|Screen Fail but Randomized|0|||
164223152|NCT04518410|593184732|FG003|Overall Study|Screen Fail but Randomized|0|||
164223153|NCT04518410|593184733|FG004|Overall Study|Screen Fail but Randomized|2|||
164223154|NCT04518410|593184734|FG005|Overall Study|Screen Fail but Randomized|0|||
164223155|NCT04518410|593184735|FG006|Overall Study|Screen Fail but Randomized|0|||
164223156|NCT04518410|593184736|FG007|Overall Study|Screen Fail but Randomized|0|||
164223157|NCT04518410|593184737|FG008|Overall Study|Screen Fail but Randomized|0|||
164223158|NCT04518410|593184738|FG009|Overall Study|Screen Fail but Randomized|0|||
164223159|NCT04518410|593184739|FG010|Overall Study|Screen Fail but Randomized|0|||
164223160|NCT04518410|593184740|FG011|Overall Study|Screen Fail but Randomized|0|||
164223161|NCT04518410|593184741|FG012|Overall Study|Screen Fail but Randomized|0|||
164223162|NCT04518410|593184742|FG013|Overall Study|Screen Fail but Randomized|0|||
164223163|NCT04518410|593184743|FG014|Overall Study|Screen Fail but Randomized|0|||
164223164|NCT04518410|593184744|FG015|Overall Study|Screen Fail but Randomized|0|||
164223165|NCT04518410|593184745|FG016|Overall Study|Screen Fail but Randomized|0|||
164223166|NCT04518410|593184746|FG017|Overall Study|Screen Fail but Randomized|0|||
164223167|NCT04518410|593184747|FG018|Overall Study|Screen Fail but Randomized|0|||
164223168|NCT04518410|593184748|FG019|Overall Study|Screen Fail but Randomized|0|||
164223169|NCT04518410|593184749|FG020|Overall Study|Screen Fail but Randomized|0|||
164223170|NCT04518410|593184750|FG021|Overall Study|Screen Fail but Randomized|0|||
164223171|NCT04518410|593184751|FG022|Overall Study|Screen Fail but Randomized|0|||
164223172|NCT04518410|593184752|FG023|Overall Study|Screen Fail but Randomized|0|||
164223173|NCT04518410|593184753|FG024|Overall Study|Screen Fail but Randomized|0|||
164223174|NCT04518410|593184729|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223175|NCT04518410|593184730|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223176|NCT04518410|593184731|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223177|NCT04518410|593184732|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223178|NCT04518410|593184733|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
164223179|NCT04518410|593184734|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
163879543|NCT04757610|591928177|FG002|Overall Study|Randomized in Error|0|||
164223180|NCT04518410|593184735|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
164223181|NCT04518410|593184736|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164329134|NCT00406718|593581325|FG002|Overall Study|Lost to Follow-up|4|||
164223182|NCT04518410|593184737|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
164223183|NCT04518410|593184738|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
164223184|NCT04518410|593184739|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164223185|NCT04518410|593184740|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223186|NCT04518410|593184741|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223187|NCT04518410|593184742|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164223188|NCT04518410|593184743|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
164223189|NCT04518410|593184744|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
164223190|NCT04518410|593184745|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
164223191|NCT04518410|593184746|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
164223192|NCT04518410|593184747|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
164223193|NCT04518410|593184748|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
164223194|NCT04518410|593184749|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
164223195|NCT04518410|593184750|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
164223196|NCT04518410|593184751|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
164223197|NCT04518410|593184752|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
164223198|NCT04518410|593184753|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
164223199|NCT04518410|593184729|FG000|Overall Study|Dual Enrolled Subject|0|||
164223200|NCT04518410|593184730|FG001|Overall Study|Dual Enrolled Subject|0|||
164223201|NCT04518410|593184731|FG002|Overall Study|Dual Enrolled Subject|0|||
164223202|NCT04518410|593184732|FG003|Overall Study|Dual Enrolled Subject|0|||
164223203|NCT04518410|593184733|FG004|Overall Study|Dual Enrolled Subject|0|||
164223204|NCT04518410|593184734|FG005|Overall Study|Dual Enrolled Subject|0|||
164223205|NCT04518410|593184735|FG006|Overall Study|Dual Enrolled Subject|0|||
164223206|NCT04518410|593184736|FG007|Overall Study|Dual Enrolled Subject|0|||
164223207|NCT04518410|593184737|FG008|Overall Study|Dual Enrolled Subject|0|||
164223208|NCT04518410|593184738|FG009|Overall Study|Dual Enrolled Subject|0|||
164223209|NCT04518410|593184739|FG010|Overall Study|Dual Enrolled Subject|0|||
164223210|NCT04518410|593184740|FG011|Overall Study|Dual Enrolled Subject|0|||
164223211|NCT04518410|593184741|FG012|Overall Study|Dual Enrolled Subject|0|||
164223212|NCT04518410|593184742|FG013|Overall Study|Dual Enrolled Subject|0|||
164223213|NCT04518410|593184743|FG014|Overall Study|Dual Enrolled Subject|0|||
164223214|NCT04518410|593184744|FG015|Overall Study|Dual Enrolled Subject|0|||
164223215|NCT04518410|593184745|FG016|Overall Study|Dual Enrolled Subject|0|||
164223216|NCT04518410|593184746|FG017|Overall Study|Dual Enrolled Subject|1|||
164223217|NCT04518410|593184747|FG018|Overall Study|Dual Enrolled Subject|0|||
164223218|NCT04518410|593184748|FG019|Overall Study|Dual Enrolled Subject|0|||
164223219|NCT04518410|593184749|FG020|Overall Study|Dual Enrolled Subject|0|||
164223220|NCT04518410|593184750|FG021|Overall Study|Dual Enrolled Subject|0|||
164223221|NCT04518410|593184751|FG022|Overall Study|Dual Enrolled Subject|0|||
164223222|NCT04518410|593184752|FG023|Overall Study|Dual Enrolled Subject|0|||
164223223|NCT04518410|593184753|FG024|Overall Study|Dual Enrolled Subject|0|||
164223224|NCT05737745|593184754|FG000|Overall Study|Withdrawal by Subject|0|||
164223225|NCT05737745|593184755|FG001|Overall Study|Withdrawal by Subject|6|||
164223226|NCT05737745|593184756|FG002|Overall Study|Withdrawal by Subject|1|||
164223227|NCT02569242|593184757|FG000|Overall Study|Death|1|||
164223228|NCT02569242|593184758|FG001|Overall Study|Death|0|||
164223229|NCT02569242|593184757|FG000|Overall Study|Withdrawal by Subject|0|||
164223230|NCT02569242|593184758|FG001|Overall Study|Withdrawal by Subject|1|||
164223231|NCT02057666|593184759|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
164079914|NCT01144663|592657704|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
164079915|NCT01144663|592657705|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
164079916|NCT01144663|592657702|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
164079917|NCT01144663|592657703|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
164079918|NCT01144663|592657704|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
164079919|NCT01144663|592657705|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
164079920|NCT01144663|592657702|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
164079921|NCT01144663|592657703|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
164079922|NCT01144663|592657704|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
164079923|NCT01144663|592657705|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
164079924|NCT01144663|592657702|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
164223232|NCT02057666|593184760|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
164223233|NCT02057666|593184759|FG000|Double Blind Treatment Period|Poor tolerability|7|||
164223234|NCT02057666|593184760|FG001|Double Blind Treatment Period|Poor tolerability|2|||
164223235|NCT02057666|593184759|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
164223236|NCT02057666|593184760|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
164223237|NCT02057666|593184759|FG000|Double Blind Treatment Period|Physician Decision|1|||
163879544|NCT00951379|591928181|FG000|Overall Study|Adverse Event|4|||
163879545|NCT00951379|591928182|FG001|Overall Study|Adverse Event|1|||
163879546|NCT00951379|591928181|FG000|Overall Study|Withdrawal by Subject|1|||
163879547|NCT00951379|591928182|FG001|Overall Study|Withdrawal by Subject|0|||
163879548|NCT00951379|591928181|FG000|Overall Study|Noncompliance|1|||
163879549|NCT00951379|591928182|FG001|Overall Study|Noncompliance|0|||
163879550|NCT00951379|591928181|FG000|Overall Study|Disease Progression|0|||
163879551|NCT00951379|591928182|FG001|Overall Study|Disease Progression|1|||
163879552|NCT03432858|591928183|FG000|Overall Study|Protocol Violation|2|||
163879553|NCT03432858|591928184|FG001|Overall Study|Protocol Violation|1|||
163879554|NCT03432858|591928185|FG002|Overall Study|Protocol Violation|9|||
163879555|NCT03432858|591928183|FG000|Overall Study|Withdrawal by Subject|0|||
163879556|NCT03432858|591928184|FG001|Overall Study|Withdrawal by Subject|1|||
163879557|NCT03432858|591928185|FG002|Overall Study|Withdrawal by Subject|1|||
163879558|NCT03432858|591928183|FG000|Overall Study|Procedure canceled/rescheduled|0|||
163879559|NCT03432858|591928184|FG001|Overall Study|Procedure canceled/rescheduled|9|||
164223238|NCT02057666|593184760|FG001|Double Blind Treatment Period|Physician Decision|0|||
164223239|NCT02057666|593184759|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
163879560|NCT03432858|591928185|FG002|Overall Study|Procedure canceled/rescheduled|6|||
163879561|NCT03432858|591928183|FG000|Overall Study|Required postop mobilization with splinting|0|||
163879562|NCT03432858|591928184|FG001|Overall Study|Required postop mobilization with splinting|0|||
163982702|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
163982703|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
163982704|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
163982705|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
163982706|NCT04418765|592306575|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
163982707|NCT04418765|592306576|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
163982708|NCT04418765|592306577|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
164223240|NCT02057666|593184760|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
164223241|NCT02057666|593184759|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
164223242|NCT02057666|593184760|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
164223243|NCT02057666|593184759|FG000|Double Blind Treatment Period|Sponsor's request|70|||
164223244|NCT02057666|593184760|FG001|Double Blind Treatment Period|Sponsor's request|34|||
164223245|NCT02057666|593184759|FG000|Open-Label Treatment Period|Poor tolerability|0|||
163982709|NCT04418765|592306575|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
163982710|NCT04418765|592306576|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
164223246|NCT02057666|593184760|FG001|Open-Label Treatment Period|Poor tolerability|1|||
164223247|NCT02057666|593184759|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
164223248|NCT02057666|593184760|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
164223249|NCT02057666|593184759|FG000|Open-Label Treatment Period|Sponsor's request|0|||
164223250|NCT02057666|593184760|FG001|Open-Label Treatment Period|Sponsor's request|4|||
164223251|NCT05661734|593184761|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
163982711|NCT04418765|592306577|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
164223252|NCT05661734|593184761|FG000|Overall Study|Lost to Follow-up|13|||
164223253|NCT05661734|593184761|FG000|Overall Study|Enrolled but not dosed|2|||
163982712|NCT04418765|592306575|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
163982713|NCT04418765|592306576|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
163982714|NCT04418765|592306577|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
164223254|NCT03259308|593184762|FG000|Overall Study|Adverse Event|5|||
164223255|NCT03259308|593184763|FG001|Overall Study|Adverse Event|4|||
164223256|NCT03259308|593184764|FG002|Overall Study|Adverse Event|1|||
164223257|NCT03259308|593184762|FG000|Overall Study|Withdrawal by Subject|2|||
164223258|NCT03259308|593184763|FG001|Overall Study|Withdrawal by Subject|1|||
164223259|NCT03259308|593184764|FG002|Overall Study|Withdrawal by Subject|3|||
164223260|NCT03259308|593184762|FG000|Overall Study|Lost to Follow-up|0|||
164223261|NCT03259308|593184763|FG001|Overall Study|Lost to Follow-up|0|||
163982715|NCT04418765|592306575|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
164223262|NCT03259308|593184764|FG002|Overall Study|Lost to Follow-up|1|||
164223263|NCT03259308|593184762|FG000|Overall Study|Pregnancy|0|||
164223264|NCT03259308|593184763|FG001|Overall Study|Pregnancy|0|||
163879563|NCT03432858|591928185|FG002|Overall Study|Required postop mobilization with splinting|1|||
163982716|NCT04418765|592306576|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
164223265|NCT03259308|593184764|FG002|Overall Study|Pregnancy|1|||
163879564|NCT03580369|591928189|FG000|Overall Study|No treatment due to mis-randomization|1|||
163879565|NCT03580369|591928190|FG001|Overall Study|No treatment due to mis-randomization|0|||
164223266|NCT03259308|593184762|FG000|Overall Study|Protocol Deviation|0|||
164223267|NCT03259308|593184763|FG001|Overall Study|Protocol Deviation|3|||
164223268|NCT03259308|593184764|FG002|Overall Study|Protocol Deviation|0|||
164223269|NCT03259308|593184762|FG000|Overall Study|Lack of Efficacy|0|||
164223270|NCT03259308|593184763|FG001|Overall Study|Lack of Efficacy|0|||
164223271|NCT03259308|593184764|FG002|Overall Study|Lack of Efficacy|1|||
164223272|NCT01251965|593186483|FG000|Overall Study|Participant/physician decision|1|||
164223273|NCT01251965|593186484|FG001|Overall Study|Participant/physician decision|2|||
164223274|NCT01251965|593186485|FG002|Overall Study|Participant/physician decision|0|||
164223275|NCT01251965|593186483|FG000|Overall Study|Death|0|||
164223276|NCT01251965|593186484|FG001|Overall Study|Death|0|||
164223277|NCT01251965|593186485|FG002|Overall Study|Death|11|||
164223278|NCT01027754|593186486|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
164223279|NCT01027754|593186487|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
164223280|NCT01027754|593186486|FG000|Overall Study|Withdrawal by Subject|0|||
164223281|NCT01027754|593186487|FG001|Overall Study|Withdrawal by Subject|5|||
164223282|NCT02529488|593186488|FG000|Overall Study|Adverse Event|1|||
164223283|NCT02529488|593186488|FG000|Overall Study|Death|3|||
164223284|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
164223285|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223286|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223287|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223288|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223289|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
164223290|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
164223291|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
164223292|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223293|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
164223294|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223295|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223296|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223297|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
164223298|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
164223299|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223300|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223301|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223302|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223303|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223304|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
164223305|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
164223306|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223307|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223308|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223309|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223310|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
163879566|NCT03580369|591928191|FG002|Overall Study|No treatment due to mis-randomization|0|||
163879567|NCT03580369|591928192|FG003|Overall Study|No treatment due to mis-randomization|0|||
163879568|NCT03580369|591928193|FG004|Overall Study|No treatment due to mis-randomization|3|||
163879569|NCT03580369|591928194|FG005|Overall Study|No treatment due to mis-randomization|0|||
163879570|NCT03580369|591928195|FG006|Overall Study|No treatment due to mis-randomization|0|||
163879571|NCT03580369|591928196|FG007|Overall Study|No treatment due to mis-randomization|0|||
163879572|NCT03580369|591928189|FG000|Overall Study|Reason unknown|0|||
163879573|NCT03580369|591928190|FG001|Overall Study|Reason unknown|0|||
163879574|NCT03580369|591928191|FG002|Overall Study|Reason unknown|1|||
163879575|NCT03580369|591928192|FG003|Overall Study|Reason unknown|0|||
163879576|NCT03580369|591928193|FG004|Overall Study|Reason unknown|0|||
163879577|NCT03580369|591928194|FG005|Overall Study|Reason unknown|0|||
163879578|NCT03580369|591928195|FG006|Overall Study|Reason unknown|0|||
163879579|NCT03580369|591928196|FG007|Overall Study|Reason unknown|0|||
163879580|NCT03580369|591928189|FG000|Overall Study|Technical problems|0|||
163879581|NCT03580369|591928190|FG001|Overall Study|Technical problems|0|||
163879582|NCT03580369|591928191|FG002|Overall Study|Technical problems|0|||
163879583|NCT03580369|591928192|FG003|Overall Study|Technical problems|0|||
163879584|NCT03580369|591928193|FG004|Overall Study|Technical problems|1|||
164223311|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
164223312|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
163879585|NCT03580369|591928194|FG005|Overall Study|Technical problems|0|||
163879586|NCT03580369|591928195|FG006|Overall Study|Technical problems|2|||
163879587|NCT03580369|591928196|FG007|Overall Study|Technical problems|0|||
163879588|NCT03580369|591928189|FG000|Overall Study|Pregnancy|2|||
163879589|NCT03580369|591928190|FG001|Overall Study|Pregnancy|0|||
163879590|NCT03580369|591928191|FG002|Overall Study|Pregnancy|3|||
163879591|NCT03580369|591928192|FG003|Overall Study|Pregnancy|0|||
163879592|NCT03580369|591928193|FG004|Overall Study|Pregnancy|2|||
163879593|NCT03580369|591928194|FG005|Overall Study|Pregnancy|0|||
163879594|NCT03580369|591928195|FG006|Overall Study|Pregnancy|0|||
163879595|NCT03580369|591928196|FG007|Overall Study|Pregnancy|0|||
163879596|NCT03580369|591928189|FG000|Overall Study|Lost to Follow-up|2|||
163879597|NCT03580369|591928190|FG001|Overall Study|Lost to Follow-up|0|||
164138769|NCT03201445|592870161|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
163879598|NCT03580369|591928191|FG002|Overall Study|Lost to Follow-up|2|||
163879599|NCT03580369|591928192|FG003|Overall Study|Lost to Follow-up|0|||
163879600|NCT03580369|591928193|FG004|Overall Study|Lost to Follow-up|3|||
163879601|NCT03580369|591928194|FG005|Overall Study|Lost to Follow-up|0|||
164138770|NCT03201445|592870162|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
164138771|NCT03201445|592870161|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
164138772|NCT03201445|592870162|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
164138773|NCT03201445|592870161|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
164138774|NCT03201445|592870162|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
164138775|NCT03201445|592870161|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
164138776|NCT03201445|592870162|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
164138777|NCT03201445|592870161|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
164138778|NCT03201445|592870162|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
164138779|NCT03201445|592870161|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
164138780|NCT03201445|592870162|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
164138781|NCT03201445|592870161|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
164138782|NCT03201445|592870162|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
164138783|NCT03201445|592870161|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
164138784|NCT03201445|592870162|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
164138785|NCT03201445|592870161|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
164138786|NCT03201445|592870162|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
164138787|NCT03201445|592870161|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
164138788|NCT03201445|592870162|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
164138789|NCT03201445|592870161|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
164138790|NCT03201445|592870162|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
164138791|NCT03201445|592870161|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
164138792|NCT03201445|592870162|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
164138793|NCT03201445|592870161|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
164138794|NCT03201445|592870162|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
164138795|NCT03201445|592870161|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
164138796|NCT03201445|592870162|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
164138797|NCT03201445|592870161|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
164138798|NCT03201445|592870162|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
164138799|NCT03201445|592870161|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
164138800|NCT03201445|592870162|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
164138801|NCT01228019|592870163|FG000|Overall Study|Dose Violation|70|||
164138802|NCT01228019|592870163|FG000|Overall Study|Duplicate enrollment|1|||
164138803|NCT01228019|592870163|FG000|Overall Study|Missing pre-treatment data|72|||
164138804|NCT01228019|592870163|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
164138805|NCT01228019|592870163|FG000|Overall Study|Violation of Entry Criterion|9|||
164138806|NCT01268501|592870164|FG000|Overall Study|Lost to Follow-up|1|||
164138807|NCT01268501|592870164|FG000|Overall Study|Withdrawal by Subject|3|||
164138808|NCT01268501|592870164|FG000|Overall Study|Unacceptable Subjective Vision|3|||
164138809|NCT01268501|592870164|FG000|Overall Study|Handling Difficulties|2|||
164138810|NCT00474266|592870167|FG000|Overall Study|Withdrawal by Subject|7|||
164138811|NCT00474266|592870168|FG001|Overall Study|Withdrawal by Subject|20|||
164138812|NCT00474266|592870169|FG002|Overall Study|Withdrawal by Subject|4|||
164138813|NCT00474266|592870170|FG003|Overall Study|Withdrawal by Subject|7|||
164138814|NCT02774642|592870171|FG000|Overall Study|Lost to Follow-up|9|||
164138815|NCT02774642|592870172|FG001|Overall Study|Lost to Follow-up|7|||
164138816|NCT02329847|592870173|FG000|Overall Study|Death|4|||
164138817|NCT02329847|592870174|FG001|Overall Study|Death|4|||
164138818|NCT02329847|592870175|FG002|Overall Study|Death|22|||
164138819|NCT02329847|592870176|FG003|Overall Study|Death|12|||
164138820|NCT02329847|592870177|FG004|Overall Study|Death|20|||
164138821|NCT02329847|592870178|FG005|Overall Study|Death|13|||
164138822|NCT02329847|592870173|FG000|Overall Study|Lost to Follow-up|0|||
164138823|NCT02329847|592870174|FG001|Overall Study|Lost to Follow-up|0|||
164223313|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
164223314|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223315|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223316|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223317|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223318|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
164223319|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223320|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223321|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223322|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223323|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
164223324|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
164223325|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
164223326|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223327|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
164223328|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
164223329|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223330|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223331|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
164223332|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
164223333|NCT01557244|593186495|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
164223334|NCT01557244|593186496|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223335|NCT01557244|593186497|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
164223336|NCT01557244|593186498|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223337|NCT01557244|593186499|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223338|NCT01557244|593186500|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223339|NCT01557244|593186501|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
164223340|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
164223341|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
164223342|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223343|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223344|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223345|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
164223346|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
164223347|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
164223348|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
164223349|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223350|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223351|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
163879602|NCT03580369|591928195|FG006|Overall Study|Lost to Follow-up|1|||
163879603|NCT03580369|591928196|FG007|Overall Study|Lost to Follow-up|0|||
164079925|NCT01144663|592657703|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
164079926|NCT01144663|592657704|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
164079927|NCT01144663|592657705|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
164079928|NCT01473758|592657709|FG000|Cycle 1|Adverse Event|10|||
164079929|NCT01473758|592657710|FG001|Cycle 1|Adverse Event|2|||
164079930|NCT01473758|592657711|FG002|Cycle 1|Adverse Event|0|||
164079931|NCT01473758|592657712|FG003|Cycle 1|Adverse Event|0|||
164079932|NCT01473758|592657709|FG000|Cycle 1|Withdrawal by Subject|1|||
164079933|NCT01473758|592657710|FG001|Cycle 1|Withdrawal by Subject|1|||
164079934|NCT01473758|592657711|FG002|Cycle 1|Withdrawal by Subject|0|||
164079935|NCT01473758|592657712|FG003|Cycle 1|Withdrawal by Subject|0|||
164079936|NCT01473758|592657709|FG000|Cycle 2|Adverse Event|0|||
164079937|NCT01473758|592657710|FG001|Cycle 2|Adverse Event|0|||
164079938|NCT01473758|592657711|FG002|Cycle 2|Adverse Event|5|||
164079939|NCT01473758|592657712|FG003|Cycle 2|Adverse Event|0|||
164079940|NCT02763579|592657713|FG000|Global Period|Death|167|||
164079941|NCT02763579|592657714|FG001|Global Period|Death|151|||
164079942|NCT02763579|592657715|FG002|Global Period|Death|0|||
164079943|NCT02763579|592657716|FG003|Global Period|Death|0|||
164223352|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164223353|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
164079944|NCT02763579|592657713|FG000|Global Period|Lost to Follow-up|2|||
164079945|NCT02763579|592657714|FG001|Global Period|Lost to Follow-up|4|||
164079946|NCT02763579|592657715|FG002|Global Period|Lost to Follow-up|0|||
164079947|NCT02763579|592657716|FG003|Global Period|Lost to Follow-up|0|||
164223354|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223355|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223356|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223357|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
164223358|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223359|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223360|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
164223361|NCT01557244|593186495|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
164223362|NCT01557244|593186496|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
164223363|NCT01557244|593186497|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223364|NCT01557244|593186498|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223365|NCT01557244|593186499|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223366|NCT01557244|593186500|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223367|NCT01557244|593186501|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
164223368|NCT01313676|593186502|FG000|Overall Study|Adverse Event|395|||
164223369|NCT01313676|593186503|FG001|Overall Study|Adverse Event|365|||
164223370|NCT01313676|593186504|FG002|Overall Study|Adverse Event|372|||
164223371|NCT01313676|593186505|FG003|Overall Study|Adverse Event|333|||
164223372|NCT01313676|593186502|FG000|Overall Study|Lack of Efficacy|98|||
164223373|NCT01313676|593186503|FG001|Overall Study|Lack of Efficacy|90|||
164223374|NCT01313676|593186504|FG002|Overall Study|Lack of Efficacy|65|||
164223375|NCT01313676|593186505|FG003|Overall Study|Lack of Efficacy|46|||
164223376|NCT01313676|593186502|FG000|Overall Study|Protocol Violation|37|||
164223377|NCT01313676|593186503|FG001|Overall Study|Protocol Violation|44|||
164223378|NCT01313676|593186504|FG002|Overall Study|Protocol Violation|46|||
164223379|NCT01313676|593186505|FG003|Overall Study|Protocol Violation|44|||
164223380|NCT01313676|593186502|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
164223381|NCT01313676|593186503|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
164223382|NCT01313676|593186504|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
164223383|NCT01313676|593186505|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
164223384|NCT01313676|593186502|FG000|Overall Study|Study Closed/terminated|7|||
164223385|NCT01313676|593186503|FG001|Overall Study|Study Closed/terminated|6|||
164223386|NCT01313676|593186504|FG002|Overall Study|Study Closed/terminated|9|||
164223387|NCT01313676|593186505|FG003|Overall Study|Study Closed/terminated|9|||
164223388|NCT01313676|593186502|FG000|Overall Study|Lost to Follow-up|0|||
164223389|NCT01313676|593186503|FG001|Overall Study|Lost to Follow-up|0|||
164223390|NCT01313676|593186504|FG002|Overall Study|Lost to Follow-up|1|||
164223391|NCT01313676|593186505|FG003|Overall Study|Lost to Follow-up|0|||
164223392|NCT01313676|593186502|FG000|Overall Study|Physician Decision|53|||
164223393|NCT01313676|593186503|FG001|Overall Study|Physician Decision|64|||
164223394|NCT01313676|593186504|FG002|Overall Study|Physician Decision|62|||
164223395|NCT01313676|593186505|FG003|Overall Study|Physician Decision|48|||
164223396|NCT01313676|593186502|FG000|Overall Study|Decision by Participant or Proxy|643|||
164223397|NCT01313676|593186503|FG001|Overall Study|Decision by Participant or Proxy|527|||
164223398|NCT01313676|593186504|FG002|Overall Study|Decision by Participant or Proxy|515|||
164223399|NCT01313676|593186505|FG003|Overall Study|Decision by Participant or Proxy|492|||
164223400|NCT01313676|593186502|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
164223401|NCT01313676|593186503|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
164223402|NCT01313676|593186504|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
164223403|NCT01313676|593186505|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
164223404|NCT01313676|593186502|FG000|Overall Study|Investigator Site Closed|12|||
164223405|NCT01313676|593186503|FG001|Overall Study|Investigator Site Closed|11|||
164223406|NCT01313676|593186504|FG002|Overall Study|Investigator Site Closed|15|||
164223407|NCT01313676|593186505|FG003|Overall Study|Investigator Site Closed|10|||
164223408|NCT01313676|593186502|FG000|Overall Study|Missing|1|||
164223409|NCT01313676|593186503|FG001|Overall Study|Missing|1|||
164223410|NCT01313676|593186504|FG002|Overall Study|Missing|1|||
164223411|NCT01313676|593186505|FG003|Overall Study|Missing|0|||
164223412|NCT01654250|593186506|FG000|Overall Study|Lost to Follow-up|1|||
163879604|NCT03580369|591928189|FG000|Overall Study|Physician Decision|4|||
163879605|NCT03580369|591928190|FG001|Overall Study|Physician Decision|0|||
163879606|NCT03580369|591928191|FG002|Overall Study|Physician Decision|4|||
163879607|NCT03580369|591928192|FG003|Overall Study|Physician Decision|1|||
164223413|NCT01654250|593186507|FG001|Overall Study|Lost to Follow-up|0|||
164223414|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
164223415|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
164223416|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
164223417|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
164223418|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
164223419|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
164223420|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
164223421|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
164223422|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
164223423|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
164223424|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
164223425|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
164223426|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
164223427|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
164223428|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
164223429|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
164223430|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
164223431|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
164223432|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
164223433|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
164223434|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
164223435|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
164223436|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
164223437|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
164223438|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
164223439|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
164223440|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
164223441|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
164223442|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
164223443|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
164223444|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
164223445|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
164223446|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
164223447|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
164223448|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
164223449|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
164223450|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
164223451|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
164223452|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
164223453|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
164223454|NCT02596893|593186508|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
164223455|NCT02596893|593186509|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
164223456|NCT02596893|593186510|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
164223457|NCT02596893|593186511|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
164223458|NCT03280615|593186512|FG000|Overall Study|Lost to Follow-up|1|||
164223459|NCT03280615|593186513|FG001|Overall Study|Lost to Follow-up|2|||
164223460|NCT03280615|593186512|FG000|Overall Study|Adverse Event|1|||
164223461|NCT03280615|593186513|FG001|Overall Study|Adverse Event|1|||
164223462|NCT03280615|593186512|FG000|Overall Study|Withdrawal by Subject|2|||
164223463|NCT03280615|593186513|FG001|Overall Study|Withdrawal by Subject|2|||
164223464|NCT00090402|593186514|FG000|Overall Study|Death|1|||
164223465|NCT00090402|593186515|FG001|Overall Study|Death|1|||
164223466|NCT00090402|593186516|FG002|Overall Study|Death|0|||
164223467|NCT00090402|593186514|FG000|Overall Study|subject moved|0|||
164223468|NCT00090402|593186515|FG001|Overall Study|subject moved|1|||
164223469|NCT00090402|593186516|FG002|Overall Study|subject moved|0|||
163879608|NCT03580369|591928193|FG004|Overall Study|Physician Decision|1|||
163879609|NCT03580369|591928194|FG005|Overall Study|Physician Decision|0|||
163879610|NCT03580369|591928195|FG006|Overall Study|Physician Decision|0|||
163879611|NCT03580369|591928196|FG007|Overall Study|Physician Decision|0|||
163879612|NCT03580369|591928189|FG000|Overall Study|Lack of Efficacy|3|||
163879613|NCT03580369|591928190|FG001|Overall Study|Lack of Efficacy|0|||
163879614|NCT03580369|591928191|FG002|Overall Study|Lack of Efficacy|7|||
163879615|NCT03580369|591928192|FG003|Overall Study|Lack of Efficacy|0|||
163879616|NCT03580369|591928193|FG004|Overall Study|Lack of Efficacy|2|||
163879617|NCT03580369|591928194|FG005|Overall Study|Lack of Efficacy|0|||
163879618|NCT03580369|591928195|FG006|Overall Study|Lack of Efficacy|3|||
163879619|NCT03580369|591928196|FG007|Overall Study|Lack of Efficacy|0|||
163879620|NCT03580369|591928189|FG000|Overall Study|Protocol Violation|6|||
163879621|NCT03580369|591928190|FG001|Overall Study|Protocol Violation|0|||
163879622|NCT03580369|591928191|FG002|Overall Study|Protocol Violation|6|||
163879623|NCT03580369|591928192|FG003|Overall Study|Protocol Violation|1|||
163879624|NCT03580369|591928193|FG004|Overall Study|Protocol Violation|8|||
163879625|NCT03580369|591928194|FG005|Overall Study|Protocol Violation|2|||
163879626|NCT03580369|591928195|FG006|Overall Study|Protocol Violation|1|||
163879627|NCT03580369|591928196|FG007|Overall Study|Protocol Violation|0|||
164223470|NCT00090402|593186514|FG000|Overall Study|stopped taking study medication|1|||
164223471|NCT00090402|593186515|FG001|Overall Study|stopped taking study medication|0|||
164223472|NCT00090402|593186516|FG002|Overall Study|stopped taking study medication|1|||
164223473|NCT01530256|593186517|FG000|Overall Study|Death|2|||
164223474|NCT02123511|593186522|FG000|Overall Study|Cancelled treatment|1|||
164223475|NCT02123511|593186523|FG001|Overall Study|Cancelled treatment|0|||
164223476|NCT02123511|593186522|FG000|Overall Study|Incomplete data|1|||
164223477|NCT02123511|593186523|FG001|Overall Study|Incomplete data|3|||
164223478|NCT02123511|593186522|FG000|Overall Study|Ineligible|0|||
164223479|NCT02123511|593186523|FG001|Overall Study|Ineligible|1|||
164223480|NCT02180672|593186524|FG000|Overall Study|Lost to Follow-up|5|||
164223481|NCT02180672|593186525|FG001|Overall Study|Lost to Follow-up|7|||
164223482|NCT01133977|593186526|FG000|Overall Study|Adverse Event|0|||
164223483|NCT01133977|593186527|FG001|Overall Study|Adverse Event|0|||
164223484|NCT01133977|593186528|FG002|Overall Study|Adverse Event|1|||
164223485|NCT01133977|593186529|FG003|Overall Study|Adverse Event|0|||
164223486|NCT01133977|593186530|FG004|Overall Study|Adverse Event|0|||
164223487|NCT01133977|593186526|FG000|Overall Study|Death|1|||
164223488|NCT01133977|593186527|FG001|Overall Study|Death|1|||
164223489|NCT01133977|593186528|FG002|Overall Study|Death|1|||
164223490|NCT01133977|593186529|FG003|Overall Study|Death|7|||
164223491|NCT01133977|593186530|FG004|Overall Study|Death|3|||
164223492|NCT01133977|593186526|FG000|Overall Study|Started a New Line of Therapy|2|||
164223493|NCT01133977|593186527|FG001|Overall Study|Started a New Line of Therapy|6|||
164223494|NCT01133977|593186528|FG002|Overall Study|Started a New Line of Therapy|4|||
164223495|NCT01133977|593186529|FG003|Overall Study|Started a New Line of Therapy|25|||
164223496|NCT01133977|593186530|FG004|Overall Study|Started a New Line of Therapy|33|||
164223497|NCT01133977|593186526|FG000|Overall Study|Lost to Follow-up|0|||
164223498|NCT01133977|593186527|FG001|Overall Study|Lost to Follow-up|0|||
164223499|NCT01133977|593186528|FG002|Overall Study|Lost to Follow-up|0|||
164223500|NCT01133977|593186529|FG003|Overall Study|Lost to Follow-up|2|||
164223501|NCT01133977|593186530|FG004|Overall Study|Lost to Follow-up|1|||
164223502|NCT01133977|593186526|FG000|Overall Study|Withdrawal by Subject|0|||
164223503|NCT01133977|593186527|FG001|Overall Study|Withdrawal by Subject|0|||
164223504|NCT01133977|593186528|FG002|Overall Study|Withdrawal by Subject|0|||
164223505|NCT01133977|593186529|FG003|Overall Study|Withdrawal by Subject|5|||
164223506|NCT01133977|593186530|FG004|Overall Study|Withdrawal by Subject|1|||
164223507|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
164223508|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
164223509|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
164223510|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
164223511|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
164223512|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
164223513|NCT02662582|593186546|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164223514|NCT02662582|593186547|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164223515|NCT00609973|593186549|FG000|Overall Study|Adverse Event|2|||
164223516|NCT00609973|593186550|FG001|Overall Study|Adverse Event|1|||
164223517|NCT00609973|593186549|FG000|Overall Study|Protocol Violation|4|||
164223518|NCT00609973|593186550|FG001|Overall Study|Protocol Violation|3|||
164223519|NCT00609973|593186549|FG000|Overall Study|Lost to Follow-up|2|||
164223520|NCT00609973|593186550|FG001|Overall Study|Lost to Follow-up|1|||
164223521|NCT00609973|593186549|FG000|Overall Study|Withdrawal by Subject|0|||
164223522|NCT00609973|593186550|FG001|Overall Study|Withdrawal by Subject|1|||
164223523|NCT01392495|593186553|FG000|Overall Study|Death|3|||
164223524|NCT01392495|593186553|FG000|Overall Study|Administrative problems|8|||
164223525|NCT01392495|593186553|FG000|Overall Study|Withdrawal by Subject|2|||
164223526|NCT01392495|593186553|FG000|Overall Study|Adverse Event|3|||
164223527|NCT00806026|593186554|FG000|Overall Study|Death|0|||
164223528|NCT00806026|593186555|FG001|Overall Study|Death|0|||
164223529|NCT00806026|593186556|FG002|Overall Study|Death|0|||
164223530|NCT00806026|593186557|FG003|Overall Study|Death|1|||
164223531|NCT00806026|593186558|FG004|Overall Study|Death|0|||
164223532|NCT00806026|593186559|FG005|Overall Study|Death|0|||
164223533|NCT00806026|593186554|FG000|Overall Study|Did not meet entrance criteria|4|||
164223534|NCT00806026|593186555|FG001|Overall Study|Did not meet entrance criteria|1|||
164223535|NCT00806026|593186556|FG002|Overall Study|Did not meet entrance criteria|2|||
164223536|NCT00806026|593186557|FG003|Overall Study|Did not meet entrance criteria|1|||
164223537|NCT00806026|593186558|FG004|Overall Study|Did not meet entrance criteria|0|||
164223538|NCT00806026|593186559|FG005|Overall Study|Did not meet entrance criteria|0|||
164223539|NCT00806026|593186554|FG000|Overall Study|Lack of Efficacy|5|||
164223540|NCT00806026|593186555|FG001|Overall Study|Lack of Efficacy|18|||
164223541|NCT00806026|593186556|FG002|Overall Study|Lack of Efficacy|13|||
164223542|NCT00806026|593186557|FG003|Overall Study|Lack of Efficacy|4|||
164223543|NCT00806026|593186558|FG004|Overall Study|Lack of Efficacy|8|||
164223544|NCT00806026|593186559|FG005|Overall Study|Lack of Efficacy|7|||
164223545|NCT00806026|593186554|FG000|Overall Study|Lost to Follow-up|8|||
164223546|NCT00806026|593186555|FG001|Overall Study|Lost to Follow-up|15|||
164223547|NCT00806026|593186556|FG002|Overall Study|Lost to Follow-up|8|||
164223548|NCT00806026|593186557|FG003|Overall Study|Lost to Follow-up|2|||
164223549|NCT00806026|593186558|FG004|Overall Study|Lost to Follow-up|6|||
164223550|NCT00806026|593186559|FG005|Overall Study|Lost to Follow-up|6|||
164223551|NCT00806026|593186554|FG000|Overall Study|Withdrawal by Subject|14|||
164223552|NCT00806026|593186555|FG001|Overall Study|Withdrawal by Subject|17|||
164223553|NCT00806026|593186556|FG002|Overall Study|Withdrawal by Subject|9|||
164223554|NCT00806026|593186557|FG003|Overall Study|Withdrawal by Subject|2|||
164223555|NCT00806026|593186558|FG004|Overall Study|Withdrawal by Subject|5|||
164223556|NCT00806026|593186559|FG005|Overall Study|Withdrawal by Subject|3|||
164223557|NCT00806026|593186554|FG000|Overall Study|Other|3|||
164223558|NCT00806026|593186555|FG001|Overall Study|Other|6|||
164223559|NCT00806026|593186556|FG002|Overall Study|Other|8|||
164223560|NCT00806026|593186557|FG003|Overall Study|Other|2|||
164223561|NCT00806026|593186558|FG004|Overall Study|Other|0|||
164223562|NCT00806026|593186559|FG005|Overall Study|Other|4|||
164223563|NCT00806026|593186554|FG000|Overall Study|Protocol Violation|6|||
164223564|NCT00806026|593186555|FG001|Overall Study|Protocol Violation|9|||
164223565|NCT00806026|593186556|FG002|Overall Study|Protocol Violation|9|||
164223566|NCT00806026|593186557|FG003|Overall Study|Protocol Violation|0|||
164223567|NCT00806026|593186558|FG004|Overall Study|Protocol Violation|2|||
164223568|NCT00806026|593186559|FG005|Overall Study|Protocol Violation|3|||
164223569|NCT00806026|593186554|FG000|Overall Study|Adverse Event|52|||
164223570|NCT00806026|593186555|FG001|Overall Study|Adverse Event|35|||
164223571|NCT00806026|593186556|FG002|Overall Study|Adverse Event|44|||
164223572|NCT00806026|593186557|FG003|Overall Study|Adverse Event|17|||
164223573|NCT00806026|593186558|FG004|Overall Study|Adverse Event|9|||
164223574|NCT00806026|593186559|FG005|Overall Study|Adverse Event|9|||
164223575|NCT01452789|593186564|FG000|Overall Study|Withdrawal by Subject|3|||
164223576|NCT01452789|593186565|FG001|Overall Study|Withdrawal by Subject|2|||
164223577|NCT01927861|593186573|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
164223578|NCT01927861|593186574|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
164223579|NCT01927861|593186573|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
164223580|NCT01927861|593186574|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
164223581|NCT00987935|593186575|FG000|Overall Study|Progressive disease|3|||
164223582|NCT00987935|593186576|FG001|Overall Study|Progressive disease|2|||
164223583|NCT00987935|593186577|FG002|Overall Study|Progressive disease|3|||
164223584|NCT00987935|593186578|FG003|Overall Study|Progressive disease|2|||
164223585|NCT00987935|593186579|FG004|Overall Study|Progressive disease|5|||
164223586|NCT00987935|593186580|FG005|Overall Study|Progressive disease|3|||
164223587|NCT00987935|593186581|FG006|Overall Study|Progressive disease|9|||
164223588|NCT00987935|593186582|FG007|Overall Study|Progressive disease|48|||
164223589|NCT00987935|593186583|FG008|Overall Study|Progressive disease|23|||
164223590|NCT00987935|593186575|FG000|Overall Study|Adverse Event|0|||
164223591|NCT00987935|593186576|FG001|Overall Study|Adverse Event|1|||
164223592|NCT00987935|593186577|FG002|Overall Study|Adverse Event|0|||
164223593|NCT00987935|593186578|FG003|Overall Study|Adverse Event|1|||
164223594|NCT00987935|593186579|FG004|Overall Study|Adverse Event|1|||
164223595|NCT00987935|593186580|FG005|Overall Study|Adverse Event|0|||
164223596|NCT00987935|593186581|FG006|Overall Study|Adverse Event|2|||
164223597|NCT00987935|593186582|FG007|Overall Study|Adverse Event|10|||
164223598|NCT00987935|593186583|FG008|Overall Study|Adverse Event|6|||
164223599|NCT00987935|593186575|FG000|Overall Study|Refused to continue taking trial med.|1|||
164223600|NCT00987935|593186576|FG001|Overall Study|Refused to continue taking trial med.|0|||
164223601|NCT00987935|593186577|FG002|Overall Study|Refused to continue taking trial med.|0|||
164223602|NCT00987935|593186578|FG003|Overall Study|Refused to continue taking trial med.|0|||
164223603|NCT00987935|593186579|FG004|Overall Study|Refused to continue taking trial med.|1|||
164223604|NCT00987935|593186580|FG005|Overall Study|Refused to continue taking trial med.|0|||
164223605|NCT00987935|593186581|FG006|Overall Study|Refused to continue taking trial med.|4|||
164223606|NCT00987935|593186582|FG007|Overall Study|Refused to continue taking trial med.|4|||
164223607|NCT00987935|593186583|FG008|Overall Study|Refused to continue taking trial med.|2|||
164223608|NCT00987935|593186575|FG000|Overall Study|Reason other than those specified above|0|||
164223609|NCT00987935|593186576|FG001|Overall Study|Reason other than those specified above|0|||
164223610|NCT00987935|593186577|FG002|Overall Study|Reason other than those specified above|0|||
164223611|NCT00987935|593186578|FG003|Overall Study|Reason other than those specified above|0|||
164223612|NCT00987935|593186579|FG004|Overall Study|Reason other than those specified above|0|||
164223613|NCT00987935|593186580|FG005|Overall Study|Reason other than those specified above|0|||
164223614|NCT00987935|593186581|FG006|Overall Study|Reason other than those specified above|0|||
164223615|NCT00987935|593186582|FG007|Overall Study|Reason other than those specified above|0|||
164223616|NCT00987935|593186583|FG008|Overall Study|Reason other than those specified above|1|||
164223617|NCT01089543|593186584|FG000|Overall Study|Withdrawal by Subject|2|||
164223618|NCT01089543|593186585|FG001|Overall Study|Withdrawal by Subject|3|||
164223619|NCT01089543|593186586|FG002|Overall Study|Withdrawal by Subject|3|||
164223620|NCT01089543|593186587|FG003|Overall Study|Withdrawal by Subject|1|||
164223621|NCT01089543|593186584|FG000|Overall Study|Physician Decision|1|||
164223622|NCT01089543|593186585|FG001|Overall Study|Physician Decision|0|||
164223623|NCT01089543|593186586|FG002|Overall Study|Physician Decision|0|||
164223624|NCT01089543|593186587|FG003|Overall Study|Physician Decision|1|||
164223625|NCT01089543|593186584|FG000|Overall Study|Adverse Event|0|||
164223626|NCT01089543|593186585|FG001|Overall Study|Adverse Event|1|||
163982717|NCT04418765|592306577|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
163982718|NCT04418765|592306575|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
163982719|NCT04418765|592306576|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
163982720|NCT04418765|592306577|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
163982721|NCT04418765|592306575|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
163982722|NCT04418765|592306576|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
163982723|NCT04418765|592306577|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
163982724|NCT04418765|592306575|FG000|Extension Period (48 Weeks)|Other than specified|0|||
163982725|NCT04418765|592306576|FG001|Extension Period (48 Weeks)|Other than specified|5|||
164223627|NCT01089543|593186586|FG002|Overall Study|Adverse Event|0|||
163879628|NCT03580369|591928189|FG000|Overall Study|Adverse Event|7|||
163879629|NCT03580369|591928190|FG001|Overall Study|Adverse Event|0|||
163879630|NCT03580369|591928191|FG002|Overall Study|Adverse Event|14|||
163879631|NCT03580369|591928192|FG003|Overall Study|Adverse Event|1|||
163879632|NCT03580369|591928193|FG004|Overall Study|Adverse Event|6|||
163879633|NCT03580369|591928194|FG005|Overall Study|Adverse Event|0|||
163879634|NCT03580369|591928195|FG006|Overall Study|Adverse Event|1|||
163879635|NCT03580369|591928196|FG007|Overall Study|Adverse Event|0|||
163879636|NCT03580369|591928189|FG000|Overall Study|Withdrawal by Subject|19|||
163879637|NCT03580369|591928190|FG001|Overall Study|Withdrawal by Subject|0|||
163879638|NCT03580369|591928191|FG002|Overall Study|Withdrawal by Subject|17|||
163879639|NCT03580369|591928192|FG003|Overall Study|Withdrawal by Subject|0|||
163879640|NCT03580369|591928193|FG004|Overall Study|Withdrawal by Subject|16|||
163879641|NCT03580369|591928194|FG005|Overall Study|Withdrawal by Subject|1|||
163879642|NCT03580369|591928195|FG006|Overall Study|Withdrawal by Subject|7|||
163879643|NCT03580369|591928196|FG007|Overall Study|Withdrawal by Subject|0|||
163879644|NCT05239039|591928200|FG000|Overall Study|Withdrawal by Subject|0|||
163879645|NCT05239039|591928201|FG001|Overall Study|Withdrawal by Subject|1|||
163879646|NCT03690206|591928202|FG000|Overall Study|Withdrawal by Subject|2|||
163879647|NCT03690206|591928203|FG001|Overall Study|Withdrawal by Subject|0|||
163879648|NCT03690206|591928204|FG002|Overall Study|Withdrawal by Subject|0|||
163879649|NCT03690206|591928202|FG000|Overall Study|ICF withdrawal|2|||
163879650|NCT03690206|591928203|FG001|Overall Study|ICF withdrawal|0|||
163879651|NCT03690206|591928204|FG002|Overall Study|ICF withdrawal|0|||
163879652|NCT03819686|591929543|FG000|Overall Study|Lost to Follow-up|2|||
163879653|NCT03819686|591929544|FG001|Overall Study|Lost to Follow-up|3|||
163879654|NCT06143670|591929545|FG000|Overall Study|Lost to Follow-up|0|||
163879655|NCT06143670|591929546|FG001|Overall Study|Lost to Follow-up|1|||
163879656|NCT06143670|591929545|FG000|Overall Study|Withdrawal by Subject|3|||
163879657|NCT06143670|591929546|FG001|Overall Study|Withdrawal by Subject|0|||
163879658|NCT03625882|591929549|FG000|Overall Study|Protocol Violation|3|||
163879659|NCT00739648|591929553|FG000|Overall Study|Adverse Event|3|||
163879660|NCT00739648|591929554|FG001|Overall Study|Adverse Event|15|||
163879661|NCT00739648|591929553|FG000|Overall Study|Withdrawal by Subject|13|||
163879662|NCT00739648|591929554|FG001|Overall Study|Withdrawal by Subject|25|||
163879663|NCT00739648|591929553|FG000|Overall Study|Lost to Follow-up|4|||
163879664|NCT00739648|591929554|FG001|Overall Study|Lost to Follow-up|7|||
163879665|NCT00739648|591929553|FG000|Overall Study|Death|2|||
163879666|NCT00739648|591929554|FG001|Overall Study|Death|0|||
163879667|NCT00739648|591929553|FG000|Overall Study|Do not know|4|||
163879668|NCT00739648|591929554|FG001|Overall Study|Do not know|6|||
163879669|NCT05110495|591929555|FG000|Overall Study|Lost to Follow-up|1|||
163879670|NCT05110495|591929555|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
163879671|NCT04173663|591929556|FG000|Overall Study|Withdrawal by Subject|1|||
163879672|NCT04173663|591929557|FG001|Overall Study|Withdrawal by Subject|6|||
163879673|NCT04173663|591929556|FG000|Overall Study|Lost to Follow-up|17|||
163879674|NCT04173663|591929557|FG001|Overall Study|Lost to Follow-up|24|||
163879675|NCT04716634|591929562|FG000|Overall Study|Death|24|||
163879676|NCT04716634|591929563|FG001|Overall Study|Death|24|||
163879677|NCT04716634|591929564|FG002|Overall Study|Death|8|||
163879678|NCT04716634|591929562|FG000|Overall Study|Closed by Sponsor|4|||
163879679|NCT04716634|591929563|FG001|Overall Study|Closed by Sponsor|4|||
163879680|NCT04716634|591929564|FG002|Overall Study|Closed by Sponsor|5|||
163879681|NCT04716634|591929562|FG000|Overall Study|Lost to Follow-up|1|||
163879682|NCT04716634|591929563|FG001|Overall Study|Lost to Follow-up|0|||
163879683|NCT04716634|591929564|FG002|Overall Study|Lost to Follow-up|1|||
163879684|NCT04716634|591929562|FG000|Overall Study|Withdrawal by Subject|0|||
163879685|NCT04716634|591929563|FG001|Overall Study|Withdrawal by Subject|0|||
163879686|NCT04716634|591929564|FG002|Overall Study|Withdrawal by Subject|1|||
163879687|NCT04833777|591929565|FG000|Overall Study|Lost to Follow-up|1|||
163879688|NCT04833777|591929566|FG001|Overall Study|Lost to Follow-up|0|||
163879689|NCT03089398|591929574|FG000|Overall Study|Death|4|||
163879690|NCT03089398|591929575|FG001|Overall Study|Death|9|||
163879691|NCT03089398|591929574|FG000|Overall Study|Lost to Follow-up|21|||
163879692|NCT03089398|591929575|FG001|Overall Study|Lost to Follow-up|30|||
163879693|NCT03089398|591929574|FG000|Overall Study|Withdrawal by Subject|2|||
163879694|NCT03089398|591929575|FG001|Overall Study|Withdrawal by Subject|2|||
164223628|NCT01089543|593186587|FG003|Overall Study|Adverse Event|0|||
164223629|NCT00754559|593186589|FG000|Overall Study|Adverse Event|15|||
164223630|NCT00754559|593186589|FG000|Overall Study|Protocol Violation|11|||
164223631|NCT00754559|593186589|FG000|Overall Study|Lack of Efficacy|10|||
164223632|NCT00754559|593186589|FG000|Overall Study|Lost to Follow-up|2|||
164223633|NCT00754559|593186589|FG000|Overall Study|Administrative reason|1|||
164223634|NCT00754559|593186589|FG000|Overall Study|Other|5|||
164223635|NCT00754559|593186589|FG000|Overall Study|Withdrawal by Subject|3|||
164223636|NCT01248468|593186590|FG000|Overall Study|Administrative problem|1|||
164223637|NCT01248468|593186591|FG001|Overall Study|Administrative problem|0|||
164223638|NCT01248468|593186592|FG002|Overall Study|Administrative problem|0|||
164223639|NCT01248468|593186590|FG000|Overall Study|Lost to Follow-up|9|||
164223640|NCT01248468|593186591|FG001|Overall Study|Lost to Follow-up|12|||
164223641|NCT01248468|593186592|FG002|Overall Study|Lost to Follow-up|4|||
164223642|NCT01248468|593186590|FG000|Overall Study|Pregnancy|1|||
164223643|NCT01248468|593186591|FG001|Overall Study|Pregnancy|0|||
164223644|NCT01248468|593186592|FG002|Overall Study|Pregnancy|0|||
164223645|NCT01248468|593186590|FG000|Overall Study|Withdrawal by Subject|4|||
164223646|NCT01248468|593186591|FG001|Overall Study|Withdrawal by Subject|2|||
164223647|NCT01248468|593186592|FG002|Overall Study|Withdrawal by Subject|0|||
164223648|NCT01370538|593186593|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
164223649|NCT01370538|593186594|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
164223650|NCT01370538|593186593|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164223651|NCT01370538|593186594|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164223652|NCT01370538|593186593|FG000|Overall Study|Adverse Event|1|||
164223653|NCT01370538|593186594|FG001|Overall Study|Adverse Event|0|||
164223654|NCT01370538|593186593|FG000|Overall Study|Protocol Violation|8|||
164223655|NCT01370538|593186594|FG001|Overall Study|Protocol Violation|5|||
164223656|NCT01370538|593186593|FG000|Overall Study|Development of study specific withdrawal|1|||
164223657|NCT01370538|593186594|FG001|Overall Study|Development of study specific withdrawal|1|||
164223658|NCT01370538|593186593|FG000|Overall Study|Lost to follow up|6|||
164223659|NCT01370538|593186594|FG001|Overall Study|Lost to follow up|10|||
164223660|NCT00728182|593186595|FG000|Overall Study|Adverse Event|1|||
164223661|NCT00728182|593186596|FG001|Overall Study|Adverse Event|0|||
164223662|NCT00728182|593186595|FG000|Overall Study|Lost to Follow-up|2|||
164223663|NCT00728182|593186596|FG001|Overall Study|Lost to Follow-up|0|||
164223664|NCT00728182|593186595|FG000|Overall Study|Death|0|||
164223665|NCT00728182|593186596|FG001|Overall Study|Death|2|||
164223666|NCT00728182|593186595|FG000|Overall Study|Protocol Noncompliance|0|||
164223667|NCT00728182|593186596|FG001|Overall Study|Protocol Noncompliance|1|||
164223668|NCT01898091|593186599|FG000|Overall Study|Lost to Follow-up|1|||
164223669|NCT01898091|593186600|FG001|Overall Study|Lost to Follow-up|1|||
164223670|NCT01898091|593186599|FG000|Overall Study|Withdrawal by Subject|1|||
164223671|NCT01898091|593186600|FG001|Overall Study|Withdrawal by Subject|5|||
164223672|NCT00309244|593186601|FG000|Overall Study|Adverse Event|29|||
164223673|NCT00309244|593186602|FG001|Overall Study|Adverse Event|12|||
164223674|NCT00309244|593186601|FG000|Overall Study|Lost to Follow-up|6|||
164223675|NCT00309244|593186602|FG001|Overall Study|Lost to Follow-up|22|||
164223676|NCT00309244|593186601|FG000|Overall Study|Physician Decision|5|||
164223677|NCT00309244|593186602|FG001|Overall Study|Physician Decision|8|||
164223678|NCT00309244|593186601|FG000|Overall Study|Protocol Violation|6|||
164223679|NCT00309244|593186602|FG001|Overall Study|Protocol Violation|3|||
164223680|NCT00309244|593186601|FG000|Overall Study|Withdrawal by Subject|50|||
164223681|NCT00309244|593186602|FG001|Overall Study|Withdrawal by Subject|32|||
164223682|NCT00309244|593186601|FG000|Overall Study|Various|7|||
164223683|NCT00309244|593186602|FG001|Overall Study|Various|7|||
163879695|NCT04820855|591929580|FG000|Overall Study|Lost to Follow-up|6|||
163879696|NCT04820855|591929581|FG001|Overall Study|Lost to Follow-up|9|||
163879697|NCT04838262|591929582|FG000|Overall Study|Withdrawal by Subject|9|||
163879698|NCT04838262|591929583|FG001|Overall Study|Withdrawal by Subject|4|||
163879699|NCT02927769|591929584|FG000|Induction Phase|Study drug toxicity|1|||
163879700|NCT02927769|591929585|FG001|Induction Phase|Study drug toxicity|1|||
163879701|NCT02927769|591929584|FG000|Induction Phase|Disease progression|0|||
163879702|NCT02927769|591929585|FG001|Induction Phase|Disease progression|1|||
163879703|NCT02927769|591929584|FG000|Intensification Phase|Study drug toxicity|1|||
163879704|NCT02927769|591929585|FG001|Intensification Phase|Study drug toxicity|0|||
163879705|NCT05524233|591929590|FG000|Overall Study|Lost to Follow-up|2|||
163879706|NCT05524233|591929590|FG000|Overall Study|Adverse Event|2|||
163879707|NCT05524233|591929590|FG000|Overall Study|Withdrawal by Subject|1|||
163879708|NCT02307565|591929592|FG000|Overall Study|Adverse Event|3|||
163879709|NCT02307565|591929593|FG001|Overall Study|Adverse Event|2|||
163982726|NCT04418765|592306577|FG002|Extension Period (48 Weeks)|Other than specified|2|||
163982727|NCT03345472|592306582|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
164223684|NCT00309244|593186601|FG000|Overall Study|Randomized but not dosed|11|||
164223685|NCT00309244|593186602|FG001|Overall Study|Randomized but not dosed|12|||
164223686|NCT00309244|593186601|FG000|Overall Study|Death|4|||
164223687|NCT00309244|593186602|FG001|Overall Study|Death|1|||
164223688|NCT01905267|593186603|FG000|Overall Study|Physician Decision|2|||
164223689|NCT01905267|593186604|FG001|Overall Study|Physician Decision|2|||
164223690|NCT03438656|593186605|FG000|Overall Study|Lost to Follow-up|2|||
164223691|NCT03335566|593186606|FG000|Overall Study|Adverse Event|0|||
164223692|NCT03335566|593186607|FG001|Overall Study|Adverse Event|1|||
164223693|NCT03335566|593186606|FG000|Overall Study|Lost to Follow-up|1|||
164223694|NCT03335566|593186607|FG001|Overall Study|Lost to Follow-up|0|||
164223695|NCT03335566|593186606|FG000|Overall Study|Technical Problems|1|||
164223696|NCT03335566|593186607|FG001|Overall Study|Technical Problems|0|||
164223697|NCT03335566|593186606|FG000|Overall Study|Protocol Violation|1|||
164223698|NCT03335566|593186607|FG001|Overall Study|Protocol Violation|0|||
164223699|NCT03335566|593186606|FG000|Overall Study|Other than specified above|1|||
164223700|NCT03335566|593186607|FG001|Overall Study|Other than specified above|2|||
164223701|NCT04223687|593186608|FG000|Overall Study|Missing primary outcome|1|||
164223702|NCT04223687|593186609|FG001|Overall Study|Missing primary outcome|0|||
164223703|NCT02945046|593186611|FG000|Overall Study|Adverse Event|1|||
164223704|NCT02945046|593186612|FG001|Overall Study|Adverse Event|0|||
164223705|NCT02945046|593186613|FG002|Overall Study|Adverse Event|2|||
164223706|NCT02945046|593186611|FG000|Overall Study|Withdrawal by Subject|3|||
164223707|NCT02945046|593186612|FG001|Overall Study|Withdrawal by Subject|3|||
164223708|NCT02945046|593186613|FG002|Overall Study|Withdrawal by Subject|3|||
164223709|NCT02945046|593186611|FG000|Overall Study|Protocol Violation|2|||
164223710|NCT02945046|593186612|FG001|Overall Study|Protocol Violation|3|||
164223711|NCT02945046|593186613|FG002|Overall Study|Protocol Violation|2|||
164223712|NCT02945046|593186611|FG000|Overall Study|Lost to Follow-up|1|||
164223713|NCT02945046|593186612|FG001|Overall Study|Lost to Follow-up|1|||
164223714|NCT02945046|593186613|FG002|Overall Study|Lost to Follow-up|0|||
164223715|NCT02945046|593186611|FG000|Overall Study|Lack of Efficacy|1|||
164223716|NCT02945046|593186612|FG001|Overall Study|Lack of Efficacy|2|||
164223717|NCT02945046|593186613|FG002|Overall Study|Lack of Efficacy|1|||
164223718|NCT02945046|593186611|FG000|Overall Study|Other than specified|5|||
164223719|NCT02945046|593186612|FG001|Overall Study|Other than specified|4|||
164223720|NCT02945046|593186613|FG002|Overall Study|Other than specified|7|||
164223721|NCT00362609|593186621|FG000|Overall Study|Withdrawal by Subject|0|||
164223722|NCT00362609|593186622|FG001|Overall Study|Withdrawal by Subject|1|||
164223723|NCT00362609|593186621|FG000|Overall Study|Protocol Violation|0|||
164223724|NCT00362609|593186622|FG001|Overall Study|Protocol Violation|1|||
164223725|NCT02205359|593186623|FG000|Overall Study|Death|293|||
164223726|NCT02205359|593186624|FG001|Overall Study|Death|327|||
164223727|NCT02205359|593186623|FG000|Overall Study|Lost to Follow-up|182|||
164223728|NCT02205359|593186624|FG001|Overall Study|Lost to Follow-up|162|||
164223729|NCT02205359|593186623|FG000|Overall Study|Physician Decision|51|||
164223730|NCT02205359|593186624|FG001|Overall Study|Physician Decision|53|||
164223731|NCT02205359|593186623|FG000|Overall Study|Withdrawal by Subject|167|||
164223732|NCT02205359|593186624|FG001|Overall Study|Withdrawal by Subject|169|||
164223733|NCT00236197|593186625|FG000|Overall Study|Withdrawal by Subject|3|||
164223734|NCT00236197|593186626|FG001|Overall Study|Withdrawal by Subject|2|||
164223735|NCT00236197|593186625|FG000|Overall Study|Lost to Follow-up|1|||
164223736|NCT00236197|593186626|FG001|Overall Study|Lost to Follow-up|5|||
164223737|NCT00236197|593186625|FG000|Overall Study|Protocol Violation|0|||
164223738|NCT00236197|593186626|FG001|Overall Study|Protocol Violation|3|||
164223739|NCT00236197|593186625|FG000|Overall Study|Medication non-compliance|1|||
164223740|NCT00236197|593186626|FG001|Overall Study|Medication non-compliance|2|||
164223741|NCT00236197|593186625|FG000|Overall Study|Other|0|||
164329135|NCT01888003|593581328|FG000|Overall Study|Study Terminated|5|||
163982728|NCT03345472|592306582|FG000|Implant to 3 Months|Physician Decision|1|||
163982729|NCT03345472|592306582|FG000|Implant to 3 Months|Adverse Event|1|||
163982730|NCT03345472|592306582|FG000|3 Months to 12 Months|Physician Decision|3|||
163982731|NCT03345472|592306582|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
163982732|NCT03345472|592306582|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
163982733|NCT03345472|592306582|FG000|3 Months to 12 Months|Adverse Event|1|||
163982734|NCT03345472|592306582|FG000|3 Months to 12 Months|Death|1|||
163982735|NCT01926782|592306583|FG000|Overall Study|Participant moved|2|||
163982736|NCT01926782|592306584|FG001|Overall Study|Participant moved|0|||
163982737|NCT01926782|592306585|FG002|Overall Study|Participant moved|1|||
163982738|NCT01926782|592306586|FG003|Overall Study|Participant moved|1|||
163982739|NCT01926782|592306587|FG004|Overall Study|Participant moved|0|||
163982740|NCT01926782|592306588|FG005|Overall Study|Participant moved|3|||
164223742|NCT00236197|593186626|FG001|Overall Study|Other|2|||
164223743|NCT00480025|593186627|FG000|Overall Study|Protocol Violation|12|||
164223744|NCT00480025|593186628|FG001|Overall Study|Protocol Violation|7|||
164223745|NCT00480025|593186627|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
164223746|NCT00480025|593186628|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
164223747|NCT00480025|593186627|FG000|Overall Study|Disease Progression / Recurrence|449|||
164223748|NCT00480025|593186628|FG001|Overall Study|Disease Progression / Recurrence|224|||
164223749|NCT00480025|593186627|FG000|Overall Study|Adverse Event|44|||
164223750|NCT00480025|593186628|FG001|Overall Study|Adverse Event|12|||
164223751|NCT00480025|593186627|FG000|Overall Study|Other|70|||
164223752|NCT00480025|593186628|FG001|Overall Study|Other|29|||
164223753|NCT00480025|593186627|FG000|Overall Study|SAE including intercurrent illness|76|||
164079948|NCT02763579|592657713|FG000|Global Period|Physician Decision|0|||
164079949|NCT02763579|592657714|FG001|Global Period|Physician Decision|2|||
164079950|NCT02763579|592657715|FG002|Global Period|Physician Decision|0|||
164079951|NCT02763579|592657716|FG003|Global Period|Physician Decision|0|||
164079952|NCT02763579|592657713|FG000|Global Period|Study Terminated By Sponsor|21|||
164079953|NCT02763579|592657714|FG001|Global Period|Study Terminated By Sponsor|26|||
164079954|NCT02763579|592657715|FG002|Global Period|Study Terminated By Sponsor|0|||
164079955|NCT02763579|592657716|FG003|Global Period|Study Terminated By Sponsor|0|||
164079956|NCT02763579|592657713|FG000|Global Period|Withdrawal by Subject|12|||
164079957|NCT02763579|592657714|FG001|Global Period|Withdrawal by Subject|18|||
164079958|NCT02763579|592657715|FG002|Global Period|Withdrawal by Subject|0|||
164079959|NCT02763579|592657716|FG003|Global Period|Withdrawal by Subject|0|||
163879710|NCT02307565|591929592|FG000|Overall Study|Withdrawal by Subject|2|||
163879711|NCT02307565|591929593|FG001|Overall Study|Withdrawal by Subject|2|||
164079960|NCT02763579|592657713|FG000|China Period|Death|0|||
164079961|NCT02763579|592657714|FG001|China Period|Death|0|||
163879712|NCT00650104|591929594|FG000|Overall Study|Adverse Event|17|||
163879713|NCT00650104|591929594|FG000|Overall Study|Death|2|||
163879714|NCT00650104|591929594|FG000|Overall Study|Withdrawal by Subject|11|||
163879715|NCT00650104|591929594|FG000|Overall Study|Physician Decision|7|||
163879716|NCT00650104|591929594|FG000|Overall Study|Lost to Follow-up|1|||
163879717|NCT00650104|591929594|FG000|Overall Study|Non-compliance|2|||
163879718|NCT00650104|591929594|FG000|Overall Study|Sponsor Terminated Dosing|1|||
163879719|NCT03436745|591929595|FG000|Overall Study|Ineligible|0|||
163879720|NCT03436745|591929596|FG001|Overall Study|Ineligible|0|||
163879721|NCT03436745|591929597|FG002|Overall Study|Ineligible|1|||
163879722|NCT00792636|591929600|FG000|Overall Study|Protocol Violation|17|||
163879723|NCT00792636|591929601|FG001|Overall Study|Protocol Violation|23|||
163879724|NCT00792636|591929602|FG002|Overall Study|Protocol Violation|20|||
163879725|NCT00792636|591929600|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
163879726|NCT00792636|591929601|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
163879727|NCT00792636|591929602|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
163879728|NCT00792636|591929600|FG000|Overall Study|Lost to Follow-up|13|||
163879729|NCT00792636|591929601|FG001|Overall Study|Lost to Follow-up|19|||
163879730|NCT00792636|591929602|FG002|Overall Study|Lost to Follow-up|14|||
163879731|NCT00792636|591929600|FG000|Overall Study|Withdrew Consent|10|||
163879732|NCT00792636|591929601|FG001|Overall Study|Withdrew Consent|13|||
163879733|NCT00792636|591929602|FG002|Overall Study|Withdrew Consent|9|||
163879734|NCT00792636|591929600|FG000|Overall Study|Lack of Efficacy|3|||
163879735|NCT00792636|591929601|FG001|Overall Study|Lack of Efficacy|4|||
163879736|NCT00792636|591929602|FG002|Overall Study|Lack of Efficacy|13|||
163879737|NCT00792636|591929600|FG000|Overall Study|Adverse Event|4|||
163879738|NCT00792636|591929601|FG001|Overall Study|Adverse Event|2|||
163879739|NCT00792636|591929602|FG002|Overall Study|Adverse Event|3|||
163879740|NCT00792636|591929600|FG000|Overall Study|Investigator Discretion|2|||
163879741|NCT00792636|591929601|FG001|Overall Study|Investigator Discretion|0|||
163879742|NCT00792636|591929602|FG002|Overall Study|Investigator Discretion|2|||
163879743|NCT01772472|591929609|FG000|Overall Study|Death|126|||
163879744|NCT01772472|591929610|FG001|Overall Study|Death|94|||
163879745|NCT01772472|591929609|FG000|Overall Study|Lost to Follow-up|51|||
163879746|NCT01772472|591929610|FG001|Overall Study|Lost to Follow-up|50|||
163879747|NCT01772472|591929609|FG000|Overall Study|Other|9|||
163879748|NCT01772472|591929610|FG001|Overall Study|Other|7|||
163879749|NCT01772472|591929609|FG000|Overall Study|Physician Decision|1|||
163879750|NCT01772472|591929610|FG001|Overall Study|Physician Decision|7|||
163879751|NCT01772472|591929609|FG000|Overall Study|Withdrawal by Subject|115|||
163879752|NCT01772472|591929610|FG001|Overall Study|Withdrawal by Subject|90|||
163879753|NCT01772472|591929609|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
163879754|NCT01772472|591929610|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
163879755|NCT02697136|591929611|FG000|Overall Study|Adverse Event|3|||
163879756|NCT02697136|591929612|FG001|Overall Study|Adverse Event|0|||
163879757|NCT04391894|591929616|FG000|Overall Study|Adverse Event|1|||
163879758|NCT04391894|591929617|FG001|Overall Study|Adverse Event|1|||
163879759|NCT04391894|591929618|FG002|Overall Study|Adverse Event|1|||
164079962|NCT02763579|592657715|FG002|China Period|Death|46|||
164079963|NCT02763579|592657716|FG003|China Period|Death|48|||
164079964|NCT02763579|592657713|FG000|China Period|Lost to Follow-up|0|||
163879760|NCT04391894|591929619|FG003|Overall Study|Adverse Event|1|||
163879761|NCT04391894|591929620|FG004|Overall Study|Adverse Event|1|||
163879762|NCT04391894|591929616|FG000|Overall Study|Lost to Follow-up|1|||
163879763|NCT04391894|591929617|FG001|Overall Study|Lost to Follow-up|0|||
164079965|NCT02763579|592657714|FG001|China Period|Lost to Follow-up|0|||
164079966|NCT02763579|592657715|FG002|China Period|Lost to Follow-up|1|||
163879764|NCT04391894|591929618|FG002|Overall Study|Lost to Follow-up|0|||
163879765|NCT04391894|591929619|FG003|Overall Study|Lost to Follow-up|0|||
163879766|NCT04391894|591929620|FG004|Overall Study|Lost to Follow-up|0|||
163879767|NCT04391894|591929616|FG000|Overall Study|Protocol Violation|0|||
163879768|NCT04391894|591929617|FG001|Overall Study|Protocol Violation|0|||
163879769|NCT04391894|591929618|FG002|Overall Study|Protocol Violation|0|||
163879770|NCT04391894|591929619|FG003|Overall Study|Protocol Violation|1|||
164223754|NCT00480025|593186628|FG001|Overall Study|SAE including intercurrent illness|42|||
164223755|NCT06868667|593186634|FG000|Overall Study|Death|0|||
164223756|NCT06868667|593186635|FG001|Overall Study|Death|4|||
164223757|NCT06868667|593186634|FG000|Overall Study|Lost to Follow-up|0|||
164223758|NCT06868667|593186635|FG001|Overall Study|Lost to Follow-up|1|||
164223759|NCT06868667|593186634|FG000|Overall Study|Withdrawal by Subject|1|||
164223760|NCT06868667|593186635|FG001|Overall Study|Withdrawal by Subject|0|||
164223761|NCT06868667|593186634|FG000|Overall Study|Ongoing|9|||
164223762|NCT06868667|593186635|FG001|Overall Study|Ongoing|9|||
164223763|NCT01699685|593188444|FG000|Period 1|Adverse Event|1|||
164223764|NCT01699685|593188445|FG001|Period 1|Adverse Event|1|||
164223765|NCT01699685|593188444|FG000|Period 1|Medical or ethical, noncompliance|2|||
164223766|NCT01699685|593188445|FG001|Period 1|Medical or ethical, noncompliance|0|||
164223767|NCT01699685|593188444|FG000|Period 1|Other|0|||
164223768|NCT01699685|593188445|FG001|Period 1|Other|1|||
164223769|NCT01699685|593188444|FG000|Period 1|Patient request|0|||
164223770|NCT01699685|593188445|FG001|Period 1|Patient request|1|||
164223771|NCT01699685|593188444|FG000|Period 2|Lost to Follow-up|1|||
164223772|NCT01699685|593188445|FG001|Period 2|Lost to Follow-up|0|||
164223773|NCT02821000|593188446|FG000|Overall Study|Death|89|||
164223774|NCT02821000|593188446|FG000|Overall Study|Sponsor Decision|12|||
164223775|NCT02821000|593188446|FG000|Overall Study|Withdrawal by Subject|2|||
164223776|NCT00326495|593188447|FG000|Overall Study|Switched to alternative treatment|1|||
164223777|NCT00326495|593188447|FG000|Overall Study|Disease progression before treatment|1|||
164223778|NCT00326495|593188447|FG000|Overall Study|Refused further treatment|2|||
164223779|NCT00326495|593188447|FG000|Overall Study|Subject off study before assessment|1|||
164223780|NCT05058456|593188448|FG000|Overall Study|Death|1|||
164223781|NCT05058456|593188448|FG000|Overall Study|End of Study data not yet due for release|34|||
164223782|NCT03931785|593188449|FG000|Overall Study|Lost to Follow-up|4|||
164223783|NCT03931785|593188450|FG001|Overall Study|Lost to Follow-up|1|||
164223784|NCT03931785|593188451|FG002|Overall Study|Lost to Follow-up|4|||
164223785|NCT03931785|593188452|FG003|Overall Study|Lost to Follow-up|3|||
164223786|NCT03931785|593188449|FG000|Overall Study|Adverse Event|1|||
164223787|NCT03931785|593188450|FG001|Overall Study|Adverse Event|0|||
164223788|NCT03931785|593188451|FG002|Overall Study|Adverse Event|3|||
164223789|NCT03931785|593188452|FG003|Overall Study|Adverse Event|4|||
164223790|NCT03931785|593188449|FG000|Overall Study|Protocol Violation|0|||
164223791|NCT03931785|593188450|FG001|Overall Study|Protocol Violation|1|||
164223792|NCT03931785|593188451|FG002|Overall Study|Protocol Violation|0|||
164223793|NCT03931785|593188452|FG003|Overall Study|Protocol Violation|0|||
164223794|NCT03931785|593188449|FG000|Overall Study|Noncompliance With Study drug|0|||
164223795|NCT03931785|593188450|FG001|Overall Study|Noncompliance With Study drug|1|||
164079967|NCT02763579|592657716|FG003|China Period|Lost to Follow-up|1|||
164079968|NCT02763579|592657713|FG000|China Period|Physician Decision|0|||
164079969|NCT02763579|592657714|FG001|China Period|Physician Decision|0|||
164079970|NCT02763579|592657715|FG002|China Period|Physician Decision|0|||
164079971|NCT02763579|592657716|FG003|China Period|Physician Decision|1|||
164079972|NCT02763579|592657713|FG000|China Period|Study Terminated By Sponsor|0|||
164079973|NCT02763579|592657714|FG001|China Period|Study Terminated By Sponsor|0|||
164079974|NCT02763579|592657715|FG002|China Period|Study Terminated By Sponsor|3|||
164079975|NCT02763579|592657716|FG003|China Period|Study Terminated By Sponsor|4|||
164079976|NCT02763579|592657713|FG000|China Period|Withdrawal by Subject|0|||
164079977|NCT02763579|592657714|FG001|China Period|Withdrawal by Subject|0|||
164079978|NCT02763579|592657715|FG002|China Period|Withdrawal by Subject|3|||
164079979|NCT02763579|592657716|FG003|China Period|Withdrawal by Subject|3|||
164079980|NCT01003886|592657720|FG000|Overall Study|Lack of Efficacy|5|||
164079981|NCT01003886|592657720|FG000|Overall Study|Lost to Follow-up|169|||
164079982|NCT01003886|592657720|FG000|Overall Study|Withdrawal by Subject|39|||
164079983|NCT01003886|592657720|FG000|Overall Study|Other|14|||
164079984|NCT01003886|592657720|FG000|Overall Study|Adverse Event|3|||
164079985|NCT00909727|592657721|FG000|Overall Study|Adverse Event|1|||
164079986|NCT00909727|592657722|FG001|Overall Study|Adverse Event|0|||
164079987|NCT00909727|592657721|FG000|Overall Study|Wrong Genotype|1|||
164079988|NCT00909727|592657722|FG001|Overall Study|Wrong Genotype|0|||
164079989|NCT00909727|592657721|FG000|Overall Study|Withdrawal of Consent|1|||
164079990|NCT00909727|592657722|FG001|Overall Study|Withdrawal of Consent|0|||
164079991|NCT00909727|592657721|FG000|Overall Study|Prohibited Medication|1|||
164079992|NCT00909727|592657722|FG001|Overall Study|Prohibited Medication|0|||
164079993|NCT01567306|592657726|FG000|Overall Study|Protocol Violation|2|||
164079994|NCT01567306|592657727|FG001|Overall Study|Protocol Violation|2|||
164223796|NCT03931785|593188451|FG002|Overall Study|Noncompliance With Study drug|0|||
164223797|NCT03931785|593188452|FG003|Overall Study|Noncompliance With Study drug|0|||
164223798|NCT03931785|593188449|FG000|Overall Study|Other Not specified|0|||
164223799|NCT03931785|593188450|FG001|Overall Study|Other Not specified|2|||
164223800|NCT03931785|593188451|FG002|Overall Study|Other Not specified|2|||
163879771|NCT04391894|591929620|FG004|Overall Study|Protocol Violation|0|||
164079995|NCT01567306|592657728|FG002|Overall Study|Protocol Violation|0|||
164223801|NCT03931785|593188452|FG003|Overall Study|Other Not specified|2|||
164223802|NCT03931785|593188449|FG000|Overall Study|Withdrawal by Subject|0|||
164223803|NCT03931785|593188450|FG001|Overall Study|Withdrawal by Subject|2|||
164223804|NCT03931785|593188451|FG002|Overall Study|Withdrawal by Subject|4|||
164223805|NCT03931785|593188452|FG003|Overall Study|Withdrawal by Subject|1|||
164223806|NCT03931785|593188449|FG000|Overall Study|Pregnancy|0|||
164223807|NCT03931785|593188450|FG001|Overall Study|Pregnancy|0|||
164223808|NCT03931785|593188451|FG002|Overall Study|Pregnancy|0|||
164223809|NCT03931785|593188452|FG003|Overall Study|Pregnancy|1|||
164223810|NCT01897896|593188459|FG000|Overall Study|Death|1|||
164223811|NCT01897896|593188460|FG001|Overall Study|Death|0|||
164223812|NCT01897896|593188459|FG000|Overall Study|Adverse Event|11|||
164223813|NCT01897896|593188460|FG001|Overall Study|Adverse Event|1|||
164223814|NCT01897896|593188459|FG000|Overall Study|Lost to Follow-up|1|||
164223815|NCT01897896|593188460|FG001|Overall Study|Lost to Follow-up|0|||
164223816|NCT01897896|593188459|FG000|Overall Study|Non-compliance with study drug dosing|1|||
164223817|NCT01897896|593188460|FG001|Overall Study|Non-compliance with study drug dosing|1|||
164223818|NCT01897896|593188459|FG000|Overall Study|Withdrawal by Subject|7|||
164223819|NCT01897896|593188460|FG001|Overall Study|Withdrawal by Subject|1|||
164223820|NCT01897896|593188459|FG000|Overall Study|Require drug that interfere with study|1|||
164223821|NCT01897896|593188460|FG001|Overall Study|Require drug that interfere with study|4|||
164223822|NCT01897896|593188459|FG000|Overall Study|Protocol Violation|1|||
164223823|NCT01897896|593188460|FG001|Overall Study|Protocol Violation|1|||
164223824|NCT01897896|593188459|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
164223825|NCT01897896|593188460|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
164223826|NCT01897896|593188459|FG000|Overall Study|Caregiver can no longer participate|0|||
164223827|NCT01897896|593188460|FG001|Overall Study|Caregiver can no longer participate|2|||
164223828|NCT01897896|593188459|FG000|Overall Study|Other than specified|2|||
164223829|NCT01897896|593188460|FG001|Overall Study|Other than specified|1|||
164223830|NCT02451007|593188470|FG000|Overall Study|Withdrawal by Subject|4|||
164223831|NCT02451007|593188470|FG000|Overall Study|Adverse Event|1|||
164223832|NCT02451007|593188470|FG000|Overall Study|Disease Progression|2|||
164223833|NCT01716559|593188471|FG000|Overall Study|Adverse Event|11|||
164223834|NCT01716559|593188471|FG000|Overall Study|Death|21|||
164223835|NCT01716559|593188471|FG000|Overall Study|Withdrawal by Subject|4|||
164223836|NCT01716559|593188471|FG000|Overall Study|Other withdrawal reason|75|||
164223837|NCT00348374|593188472|FG000|Overall Study|Adverse Event|1|||
164223838|NCT00348374|593188473|FG001|Overall Study|Adverse Event|4|||
164223839|NCT00348374|593188472|FG000|Overall Study|Lost to Follow-up|1|||
164223840|NCT00348374|593188473|FG001|Overall Study|Lost to Follow-up|3|||
164223841|NCT00348374|593188472|FG000|Overall Study|Withdrawal by Subject|5|||
164223842|NCT00348374|593188473|FG001|Overall Study|Withdrawal by Subject|5|||
164223843|NCT00348374|593188472|FG000|Overall Study|Other|11|||
164223844|NCT00348374|593188473|FG001|Overall Study|Other|12|||
164223845|NCT00348374|593188472|FG000|Overall Study|ongoing at date of cutoff|1|||
164223846|NCT00348374|593188473|FG001|Overall Study|ongoing at date of cutoff|1|||
164223847|NCT00348374|593188472|FG000|Overall Study|randomized but did not receive treatment|0|||
164223848|NCT00348374|593188473|FG001|Overall Study|randomized but did not receive treatment|7|||
164223849|NCT00458705|593188481|FG000|Overall Study|Adverse Event|4|||
164223850|NCT00458705|593188481|FG000|Overall Study|Not Treated|1|||
164223851|NCT03574389|593188485|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
164223852|NCT03574389|593188486|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
164223853|NCT03574389|593188487|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
164223854|NCT03574389|593188488|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
164223855|NCT03574389|593188489|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
164223856|NCT03574389|593188490|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
164223857|NCT03574389|593188491|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
164223858|NCT03574389|593188485|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
164223859|NCT03574389|593188486|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
163879772|NCT04391894|591929616|FG000|Overall Study|Withdrawal by Subject|2|||
163879773|NCT04391894|591929617|FG001|Overall Study|Withdrawal by Subject|0|||
163879774|NCT04391894|591929618|FG002|Overall Study|Withdrawal by Subject|3|||
163879775|NCT04391894|591929619|FG003|Overall Study|Withdrawal by Subject|0|||
163879776|NCT04391894|591929620|FG004|Overall Study|Withdrawal by Subject|1|||
163879777|NCT04391894|591929616|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
163879778|NCT04391894|591929617|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
163982741|NCT01926782|592306583|FG000|Overall Study|Physician Decision|0|||
164223860|NCT03574389|593188487|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
164223861|NCT03574389|593188488|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
164223862|NCT03574389|593188489|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
164223863|NCT03574389|593188490|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
164223864|NCT03574389|593188491|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
164223865|NCT03574389|593188485|FG000|Vaccination Period|Other|6|||
164223866|NCT03574389|593188486|FG001|Vaccination Period|Other|0|||
164223867|NCT03574389|593188487|FG002|Vaccination Period|Other|0|||
164223868|NCT03574389|593188488|FG003|Vaccination Period|Other|0|||
163879779|NCT04391894|591929618|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
163879780|NCT04391894|591929619|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
163879781|NCT04391894|591929620|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
164223869|NCT03574389|593188489|FG004|Vaccination Period|Other|0|||
164223870|NCT03574389|593188490|FG005|Vaccination Period|Other|0|||
164223871|NCT03574389|593188491|FG006|Vaccination Period|Other|0|||
164223872|NCT03574389|593188485|FG000|Vaccination Period|Adverse Event|0|||
164223873|NCT03574389|593188486|FG001|Vaccination Period|Adverse Event|1|||
164223874|NCT03574389|593188487|FG002|Vaccination Period|Adverse Event|0|||
164223875|NCT03574389|593188488|FG003|Vaccination Period|Adverse Event|0|||
164223876|NCT03574389|593188489|FG004|Vaccination Period|Adverse Event|0|||
164223877|NCT03574389|593188490|FG005|Vaccination Period|Adverse Event|0|||
164223878|NCT03574389|593188491|FG006|Vaccination Period|Adverse Event|0|||
164223879|NCT03574389|593188485|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
164223880|NCT03574389|593188486|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
164223881|NCT03574389|593188487|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
164223882|NCT03574389|593188488|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
164223883|NCT03574389|593188489|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
164223884|NCT03574389|593188490|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
164223885|NCT03574389|593188491|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
164223886|NCT00378560|593188492|FG000|Overall Study|Adverse Event|1|||
164223887|NCT00378560|593188493|FG001|Overall Study|Adverse Event|0|||
164223888|NCT00378560|593188492|FG000|Overall Study|Lost to Follow-up|24|||
164223889|NCT00378560|593188493|FG001|Overall Study|Lost to Follow-up|29|||
164223890|NCT00378560|593188492|FG000|Overall Study|Protocol Violation|2|||
164223891|NCT00378560|593188493|FG001|Overall Study|Protocol Violation|0|||
164223892|NCT00378560|593188492|FG000|Overall Study|Withdrawal by Subject|17|||
164223893|NCT00378560|593188493|FG001|Overall Study|Withdrawal by Subject|21|||
164223894|NCT00378560|593188492|FG000|Overall Study|Moved|4|||
164223895|NCT00378560|593188493|FG001|Overall Study|Moved|3|||
164223896|NCT00378560|593188492|FG000|Overall Study|Pregnancy|7|||
164223897|NCT00378560|593188493|FG001|Overall Study|Pregnancy|5|||
164223898|NCT00378560|593188492|FG000|Overall Study|Laboratory test values abnormal|1|||
164223899|NCT00378560|593188493|FG001|Overall Study|Laboratory test values abnormal|0|||
164223900|NCT02070380|593188496|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
164223901|NCT02070380|593188497|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
164223902|NCT02070380|593188498|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
164223903|NCT02070380|593188499|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
164223904|NCT02070380|593188496|FG000|Second Injection|Image sets missing or technically inadeq|0|||
164223905|NCT02070380|593188497|FG001|Second Injection|Image sets missing or technically inadeq|1|||
164223906|NCT02070380|593188498|FG002|Second Injection|Image sets missing or technically inadeq|0|||
164223907|NCT02070380|593188499|FG003|Second Injection|Image sets missing or technically inadeq|0|||
164223908|NCT02070380|593188496|FG000|Second Injection|Protocol Violation|0|||
164223909|NCT02070380|593188497|FG001|Second Injection|Protocol Violation|1|||
164223910|NCT02070380|593188498|FG002|Second Injection|Protocol Violation|1|||
164223911|NCT02070380|593188499|FG003|Second Injection|Protocol Violation|5|||
164223912|NCT00337194|593188510|FG000|Overall Study|Adverse Event|5|||
164223913|NCT00337194|593188511|FG001|Overall Study|Adverse Event|1|||
164223914|NCT00337194|593188510|FG000|Overall Study|Death|2|||
164223915|NCT00337194|593188511|FG001|Overall Study|Death|0|||
163879782|NCT02323321|591929624|FG000|Overall Study|Re-Transplant|1|||
163879783|NCT02323321|591929624|FG000|Overall Study|Death|12|||
163879784|NCT00446225|591929625|FG000|Overall Study|Protocol Violation|1|||
163879785|NCT00446225|591929626|FG001|Overall Study|Protocol Violation|0|||
163879786|NCT05633407|591929627|FG000|Overall Study|Physician Decision|2|||
163879787|NCT05633407|591929628|FG001|Overall Study|Physician Decision|0|||
163879788|NCT05633407|591929627|FG000|Overall Study|Adverse Event|1|||
163879789|NCT05633407|591929628|FG001|Overall Study|Adverse Event|0|||
163879790|NCT05633407|591929627|FG000|Overall Study|Withdrawal by Subject|1|||
163879791|NCT05633407|591929628|FG001|Overall Study|Withdrawal by Subject|0|||
163879792|NCT05633407|591929627|FG000|Overall Study|Other|1|||
164223916|NCT00337194|593188510|FG000|Overall Study|Withdrawal by Subject|1|||
164223917|NCT00337194|593188511|FG001|Overall Study|Withdrawal by Subject|0|||
164223918|NCT00337194|593188510|FG000|Overall Study|Disease progression|1|||
164223919|NCT00337194|593188511|FG001|Overall Study|Disease progression|2|||
164223920|NCT00337194|593188510|FG000|Overall Study|Subsequent non-protocol therapy|3|||
164223921|NCT00337194|593188511|FG001|Overall Study|Subsequent non-protocol therapy|1|||
164223922|NCT00159874|593188516|FG000|Overall Study|Adverse Event|2|||
164223923|NCT00159874|593188517|FG001|Overall Study|Adverse Event|2|||
164223924|NCT00159874|593188518|FG002|Overall Study|Adverse Event|5|||
164223925|NCT00159874|593188519|FG003|Overall Study|Adverse Event|1|||
164223926|NCT00159874|593188520|FG004|Overall Study|Adverse Event|1|||
164223927|NCT00159874|593188521|FG005|Overall Study|Adverse Event|2|||
164223928|NCT00159874|593188522|FG006|Overall Study|Adverse Event|0|||
163879793|NCT05633407|591929628|FG001|Overall Study|Other|1|||
163879794|NCT02500758|591929631|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
163879795|NCT02500758|591929632|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
164223929|NCT00159874|593188516|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
164223930|NCT00159874|593188517|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
164223931|NCT00159874|593188518|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
164223932|NCT00159874|593188519|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
164223933|NCT00159874|593188520|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
164223934|NCT00159874|593188521|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
164223935|NCT00159874|593188522|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
164223936|NCT00159874|593188516|FG000|Overall Study|Lack of Efficacy|2|||
164223937|NCT00159874|593188517|FG001|Overall Study|Lack of Efficacy|0|||
164223938|NCT00159874|593188518|FG002|Overall Study|Lack of Efficacy|1|||
164223939|NCT00159874|593188519|FG003|Overall Study|Lack of Efficacy|1|||
164223940|NCT00159874|593188520|FG004|Overall Study|Lack of Efficacy|0|||
164223941|NCT00159874|593188521|FG005|Overall Study|Lack of Efficacy|3|||
164223942|NCT00159874|593188522|FG006|Overall Study|Lack of Efficacy|0|||
164223943|NCT00159874|593188516|FG000|Overall Study|Lost to Follow-up|1|||
164223944|NCT00159874|593188517|FG001|Overall Study|Lost to Follow-up|0|||
164223945|NCT00159874|593188518|FG002|Overall Study|Lost to Follow-up|3|||
164223946|NCT00159874|593188519|FG003|Overall Study|Lost to Follow-up|0|||
164223947|NCT00159874|593188520|FG004|Overall Study|Lost to Follow-up|1|||
164223948|NCT00159874|593188521|FG005|Overall Study|Lost to Follow-up|2|||
164223949|NCT00159874|593188522|FG006|Overall Study|Lost to Follow-up|1|||
164223950|NCT00159874|593188516|FG000|Overall Study|Other|8|||
164223951|NCT00159874|593188517|FG001|Overall Study|Other|8|||
164223952|NCT00159874|593188518|FG002|Overall Study|Other|8|||
164223953|NCT00159874|593188519|FG003|Overall Study|Other|0|||
164223954|NCT00159874|593188520|FG004|Overall Study|Other|2|||
164223955|NCT00159874|593188521|FG005|Overall Study|Other|1|||
164223956|NCT00159874|593188522|FG006|Overall Study|Other|3|||
164223957|NCT00159874|593188516|FG000|Overall Study|Protocol Violation|0|||
164223958|NCT00159874|593188517|FG001|Overall Study|Protocol Violation|5|||
164223959|NCT00159874|593188518|FG002|Overall Study|Protocol Violation|2|||
164223960|NCT00159874|593188519|FG003|Overall Study|Protocol Violation|0|||
164223961|NCT00159874|593188520|FG004|Overall Study|Protocol Violation|0|||
164223962|NCT00159874|593188521|FG005|Overall Study|Protocol Violation|0|||
164223963|NCT00159874|593188522|FG006|Overall Study|Protocol Violation|0|||
164223964|NCT00159874|593188516|FG000|Overall Study|Death|3|||
164223965|NCT00159874|593188517|FG001|Overall Study|Death|8|||
164223966|NCT00159874|593188518|FG002|Overall Study|Death|15|||
164223967|NCT00159874|593188519|FG003|Overall Study|Death|0|||
164223968|NCT00159874|593188520|FG004|Overall Study|Death|1|||
164223969|NCT00159874|593188521|FG005|Overall Study|Death|2|||
164223970|NCT00159874|593188522|FG006|Overall Study|Death|0|||
164223971|NCT00159874|593188516|FG000|Overall Study|Withdrawal by Subject|2|||
164223972|NCT00159874|593188517|FG001|Overall Study|Withdrawal by Subject|6|||
164223973|NCT00159874|593188518|FG002|Overall Study|Withdrawal by Subject|8|||
164223974|NCT00159874|593188519|FG003|Overall Study|Withdrawal by Subject|4|||
164223975|NCT00159874|593188520|FG004|Overall Study|Withdrawal by Subject|3|||
164223976|NCT00159874|593188521|FG005|Overall Study|Withdrawal by Subject|2|||
164223977|NCT00159874|593188522|FG006|Overall Study|Withdrawal by Subject|1|||
164223978|NCT00159874|593188516|FG000|Overall Study|Pregnancy|1|||
164223979|NCT00159874|593188517|FG001|Overall Study|Pregnancy|1|||
164223980|NCT00159874|593188518|FG002|Overall Study|Pregnancy|0|||
164223981|NCT00159874|593188519|FG003|Overall Study|Pregnancy|0|||
164223982|NCT00159874|593188520|FG004|Overall Study|Pregnancy|0|||
164223983|NCT00159874|593188521|FG005|Overall Study|Pregnancy|0|||
164223984|NCT00159874|593188522|FG006|Overall Study|Pregnancy|0|||
164223985|NCT01104870|593188523|FG000|Overall Study|Adverse Event|1|||
164223986|NCT01104870|593188524|FG001|Overall Study|Adverse Event|1|||
164329136|NCT01888003|593581329|FG001|Overall Study|Study Terminated|6|||
163982742|NCT01926782|592306584|FG001|Overall Study|Physician Decision|2|||
163982743|NCT01926782|592306585|FG002|Overall Study|Physician Decision|1|||
163982744|NCT01926782|592306586|FG003|Overall Study|Physician Decision|1|||
163982745|NCT01926782|592306587|FG004|Overall Study|Physician Decision|0|||
163982746|NCT01926782|592306588|FG005|Overall Study|Physician Decision|0|||
163982747|NCT01926782|592306583|FG000|Overall Study|Other than specified|2|||
163982748|NCT01926782|592306584|FG001|Overall Study|Other than specified|3|||
163982749|NCT01926782|592306585|FG002|Overall Study|Other than specified|5|||
163982750|NCT01926782|592306586|FG003|Overall Study|Other than specified|12|||
163982751|NCT01926782|592306587|FG004|Overall Study|Other than specified|4|||
163982752|NCT01926782|592306588|FG005|Overall Study|Other than specified|11|||
164223987|NCT01104870|593188525|FG002|Overall Study|Adverse Event|0|||
164223988|NCT01104870|593188523|FG000|Overall Study|Death|0|||
164223989|NCT01104870|593188524|FG001|Overall Study|Death|0|||
164223990|NCT01104870|593188525|FG002|Overall Study|Death|1|||
164223991|NCT01104870|593188523|FG000|Overall Study|Withdrawal by Subject|0|||
164223992|NCT01104870|593188524|FG001|Overall Study|Withdrawal by Subject|0|||
164223993|NCT01104870|593188525|FG002|Overall Study|Withdrawal by Subject|1|||
164223994|NCT05463705|593188528|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
163982753|NCT01926782|592306583|FG000|Overall Study|Adverse Event|13|||
163982754|NCT01926782|592306584|FG001|Overall Study|Adverse Event|4|||
164223995|NCT05463705|593188529|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
164223996|NCT05463705|593188530|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
164223997|NCT05463705|593188531|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
164223998|NCT05463705|593188532|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
164223999|NCT05463705|593188533|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
164224000|NCT02771145|593188534|FG000|Overall Study|Adverse Event|3|||
164224001|NCT02771145|593188534|FG000|Overall Study|Lost to Follow-up|1|||
164224002|NCT00276380|593188535|FG000|Overall Study|Adverse Event|5|||
164224003|NCT00276380|593188536|FG001|Overall Study|Adverse Event|3|||
164224004|NCT00276380|593188535|FG000|Overall Study|Lost to Follow-up|1|||
164224005|NCT00276380|593188536|FG001|Overall Study|Lost to Follow-up|1|||
164224006|NCT00276380|593188535|FG000|Overall Study|Withdrawal by Subject|3|||
164224007|NCT00276380|593188536|FG001|Overall Study|Withdrawal by Subject|6|||
164224008|NCT00276380|593188535|FG000|Overall Study|Death|5|||
164224009|NCT00276380|593188536|FG001|Overall Study|Death|3|||
164224010|NCT00276380|593188535|FG000|Overall Study|Abnormal aPPT Levels|0|||
164224011|NCT00276380|593188536|FG001|Overall Study|Abnormal aPPT Levels|1|||
164224012|NCT03596983|593188537|FG000|Overall Study|Withdrawal by Subject|3|||
164224013|NCT03071965|593188538|FG000|Overall Study|Adverse Event|0|||
164224014|NCT03071965|593188539|FG001|Overall Study|Adverse Event|0|||
164224015|NCT03071965|593188540|FG002|Overall Study|Adverse Event|1|||
164224016|NCT03071965|593188541|FG003|Overall Study|Adverse Event|0|||
164224017|NCT03071965|593188538|FG000|Overall Study|Death|0|||
164224018|NCT03071965|593188539|FG001|Overall Study|Death|0|||
164224019|NCT03071965|593188540|FG002|Overall Study|Death|1|||
164224020|NCT03071965|593188541|FG003|Overall Study|Death|1|||
164224021|NCT03071965|593188538|FG000|Overall Study|COVID-19|0|||
164224022|NCT03071965|593188539|FG001|Overall Study|COVID-19|1|||
164224023|NCT03071965|593188540|FG002|Overall Study|COVID-19|0|||
164224024|NCT03071965|593188541|FG003|Overall Study|COVID-19|1|||
164224025|NCT03071965|593188538|FG000|Overall Study|Other Health Reason|0|||
164224026|NCT03071965|593188539|FG001|Overall Study|Other Health Reason|0|||
164224027|NCT03071965|593188540|FG002|Overall Study|Other Health Reason|0|||
164224028|NCT03071965|593188541|FG003|Overall Study|Other Health Reason|1|||
164224029|NCT02346370|593188542|FG000|Overall Study|Not treated|1|||
164224030|NCT02346370|593188543|FG001|Overall Study|Not treated|0|||
164224031|NCT02346370|593188544|FG002|Overall Study|Not treated|0|||
164224032|NCT02346370|593188542|FG000|Overall Study|Withdrawal of consent|1|||
163879796|NCT02500758|591929631|FG000|Washout (1 Week)|Lost to Follow-up|2|||
163879797|NCT02500758|591929632|FG001|Washout (1 Week)|Lost to Follow-up|2|||
163879798|NCT02500758|591929631|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
164079996|NCT01567306|592657729|FG003|Overall Study|Protocol Violation|3|||
164079997|NCT01567306|592657730|FG004|Overall Study|Protocol Violation|1|||
163879799|NCT02500758|591929632|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
163879800|NCT02500758|591929631|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
163879801|NCT02500758|591929632|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
163879802|NCT02500758|591929631|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
163879803|NCT02500758|591929632|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
163879804|NCT00220740|591929633|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
163879805|NCT00220740|591929634|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
163879806|NCT00220740|591929633|FG000|Efficacy Period|Adverse Event|1|||
163879807|NCT00220740|591929634|FG001|Efficacy Period|Adverse Event|1|||
164079998|NCT01567306|592657731|FG005|Overall Study|Protocol Violation|1|||
164079999|NCT01567306|592657726|FG000|Overall Study|Change site living|1|||
164080000|NCT01567306|592657727|FG001|Overall Study|Change site living|0|||
164080001|NCT01567306|592657728|FG002|Overall Study|Change site living|0|||
163879808|NCT00220740|591929633|FG000|Efficacy Period|Withdrawal by Subject|1|||
163879809|NCT00220740|591929634|FG001|Efficacy Period|Withdrawal by Subject|0|||
163879810|NCT00220740|591929633|FG000|Efficacy Period|Protocol Violation|1|||
164080002|NCT01567306|592657729|FG003|Overall Study|Change site living|0|||
164224033|NCT02346370|593188543|FG001|Overall Study|Withdrawal of consent|0|||
164224034|NCT02346370|593188544|FG002|Overall Study|Withdrawal of consent|0|||
164224035|NCT02346370|593188542|FG000|Overall Study|Death|1|||
164224036|NCT02346370|593188543|FG001|Overall Study|Death|3|||
164224037|NCT02346370|593188544|FG002|Overall Study|Death|1|||
164224038|NCT02346370|593188542|FG000|Overall Study|Sponsor discontinued study|5|||
164224039|NCT02346370|593188543|FG001|Overall Study|Sponsor discontinued study|0|||
164224040|NCT02346370|593188544|FG002|Overall Study|Sponsor discontinued study|2|||
164224041|NCT02346370|593188542|FG000|Overall Study|Radiologic progression|0|||
164224042|NCT02346370|593188543|FG001|Overall Study|Radiologic progression|0|||
164224043|NCT02346370|593188544|FG002|Overall Study|Radiologic progression|1|||
164224044|NCT02346370|593188542|FG000|Overall Study|Physician Decision|0|||
164080003|NCT01567306|592657730|FG004|Overall Study|Change site living|0|||
164080004|NCT01567306|592657731|FG005|Overall Study|Change site living|0|||
164080005|NCT01567306|592657726|FG000|Overall Study|Adverse Event|0|||
164224045|NCT02346370|593188543|FG001|Overall Study|Physician Decision|1|||
164224046|NCT02346370|593188544|FG002|Overall Study|Physician Decision|0|||
163982755|NCT01926782|592306585|FG002|Overall Study|Adverse Event|17|||
163982756|NCT01926782|592306586|FG003|Overall Study|Adverse Event|4|||
163982757|NCT01926782|592306587|FG004|Overall Study|Adverse Event|3|||
163982758|NCT01926782|592306588|FG005|Overall Study|Adverse Event|14|||
163982759|NCT01926782|592306583|FG000|Overall Study|Poor compliance to protocol|5|||
163982760|NCT01926782|592306584|FG001|Overall Study|Poor compliance to protocol|3|||
163982761|NCT01926782|592306585|FG002|Overall Study|Poor compliance to protocol|8|||
163982762|NCT01926782|592306586|FG003|Overall Study|Poor compliance to protocol|0|||
163982763|NCT01926782|592306587|FG004|Overall Study|Poor compliance to protocol|1|||
163982764|NCT01926782|592306588|FG005|Overall Study|Poor compliance to protocol|6|||
163982765|NCT01926782|592306583|FG000|Overall Study|Randomized and not treated|0|||
163982766|NCT01926782|592306584|FG001|Overall Study|Randomized and not treated|0|||
163982767|NCT01926782|592306585|FG002|Overall Study|Randomized and not treated|0|||
163982768|NCT01926782|592306586|FG003|Overall Study|Randomized and not treated|1|||
163982769|NCT01926782|592306587|FG004|Overall Study|Randomized and not treated|0|||
164224047|NCT03654326|593188545|FG000|Overall Study|Withdrawal by Subject|5|||
164224048|NCT03654326|593188546|FG001|Overall Study|Withdrawal by Subject|3|||
164224049|NCT03654326|593188545|FG000|Overall Study|Physician Decision|0|||
164224050|NCT03654326|593188546|FG001|Overall Study|Physician Decision|1|||
164224051|NCT03654326|593188545|FG000|Overall Study|Unable to adhere to study schedule|0|||
164224052|NCT03654326|593188546|FG001|Overall Study|Unable to adhere to study schedule|1|||
163982770|NCT01926782|592306588|FG005|Overall Study|Randomized and not treated|0|||
163982771|NCT01926782|592306583|FG000|Overall Study|Withdrawal by Subject|6|||
163982772|NCT01926782|592306584|FG001|Overall Study|Withdrawal by Subject|1|||
163982773|NCT01926782|592306585|FG002|Overall Study|Withdrawal by Subject|8|||
163982774|NCT01926782|592306586|FG003|Overall Study|Withdrawal by Subject|1|||
163982775|NCT01926782|592306587|FG004|Overall Study|Withdrawal by Subject|0|||
163982776|NCT01926782|592306588|FG005|Overall Study|Withdrawal by Subject|5|||
163982777|NCT01926782|592306583|FG000|Overall Study|Related to study drug administration|0|||
163982778|NCT01926782|592306584|FG001|Overall Study|Related to study drug administration|0|||
164224053|NCT03654326|593188545|FG000|Overall Study|Lost to Follow-up|1|||
164224054|NCT03654326|593188546|FG001|Overall Study|Lost to Follow-up|1|||
163982779|NCT01926782|592306585|FG002|Overall Study|Related to study drug administration|0|||
163982780|NCT01926782|592306586|FG003|Overall Study|Related to study drug administration|0|||
163982781|NCT01926782|592306587|FG004|Overall Study|Related to study drug administration|0|||
163982782|NCT01926782|592306588|FG005|Overall Study|Related to study drug administration|2|||
163982783|NCT04607733|592306591|FG000|Overall Study|Lost to Follow-up|1|||
163982784|NCT04607733|592306592|FG001|Overall Study|Lost to Follow-up|0|||
163982785|NCT04607733|592306593|FG002|Overall Study|Lost to Follow-up|0|||
163982786|NCT04607733|592306594|FG003|Overall Study|Lost to Follow-up|1|||
163982787|NCT04607733|592306595|FG004|Overall Study|Lost to Follow-up|1|||
163982788|NCT04607733|592306596|FG005|Overall Study|Lost to Follow-up|0|||
163982789|NCT04607733|592306591|FG000|Overall Study|Withdrawal by Subject|0|||
163982790|NCT04607733|592306592|FG001|Overall Study|Withdrawal by Subject|0|||
163982791|NCT04607733|592306593|FG002|Overall Study|Withdrawal by Subject|0|||
163982792|NCT04607733|592306594|FG003|Overall Study|Withdrawal by Subject|0|||
163982793|NCT04607733|592306595|FG004|Overall Study|Withdrawal by Subject|1|||
163982794|NCT04607733|592306596|FG005|Overall Study|Withdrawal by Subject|0|||
163982795|NCT01639833|592306622|FG000|Overall Study|Death|4|||
163982796|NCT01639833|592306623|FG001|Overall Study|Death|2|||
163982797|NCT01639833|592306622|FG000|Overall Study|Withdrawal by Subject|2|||
163982798|NCT01639833|592306623|FG001|Overall Study|Withdrawal by Subject|2|||
163982799|NCT03504397|592306624|FG000|Overall Study|Progressive Disease|151|||
163982800|NCT03504397|592306625|FG001|Overall Study|Progressive Disease|199|||
163982801|NCT03504397|592306624|FG000|Overall Study|Withdrawal by Subject|29|||
164224055|NCT01362270|593188551|FG000|Overall Study|Withdrawal by Subject|1|||
164224056|NCT01362270|593188552|FG001|Overall Study|Withdrawal by Subject|0|||
164224057|NCT01362270|593188551|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
164224058|NCT01362270|593188552|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
164224059|NCT01362270|593188551|FG000|Overall Study|Met excl. criteria before 1st session|1|||
164224060|NCT01362270|593188552|FG001|Overall Study|Met excl. criteria before 1st session|1|||
164224061|NCT01691482|593188553|FG000|Treatment Period 2|Adverse Event|0|||
164224062|NCT01691482|593188554|FG001|Treatment Period 2|Adverse Event|1|||
164224063|NCT01691482|593188553|FG000|Treatment Period 2|Protocol Violation|1|||
164224064|NCT01691482|593188554|FG001|Treatment Period 2|Protocol Violation|1|||
164224065|NCT01953354|593188555|FG000|Overall Study|Withdrawal by Subject|0|||
163982802|NCT03504397|592306625|FG001|Overall Study|Withdrawal by Subject|17|||
163982803|NCT03504397|592306624|FG000|Overall Study|Lost to Follow-up|1|||
164224066|NCT01953354|593188556|FG001|Overall Study|Withdrawal by Subject|1|||
164224067|NCT01953354|593188555|FG000|Overall Study|Decision of Sponsor|0|||
164224068|NCT01953354|593188556|FG001|Overall Study|Decision of Sponsor|1|||
164224069|NCT01953354|593188555|FG000|Overall Study|Disease Exacerbation|1|||
164224070|NCT01953354|593188556|FG001|Overall Study|Disease Exacerbation|0|||
163982804|NCT03504397|592306625|FG001|Overall Study|Lost to Follow-up|0|||
163982805|NCT03504397|592306624|FG000|Overall Study|Death|14|||
163982806|NCT03504397|592306625|FG001|Overall Study|Death|16|||
164224071|NCT00819832|593188557|FG000|Overall Study|Sponsor Termination of Study|3|||
164224072|NCT00819832|593188558|FG001|Overall Study|Sponsor Termination of Study|0|||
164224073|NCT00819832|593188559|FG002|Overall Study|Sponsor Termination of Study|0|||
164224074|NCT00819832|593188560|FG003|Overall Study|Sponsor Termination of Study|0|||
164224075|NCT00819832|593188561|FG004|Overall Study|Sponsor Termination of Study|0|||
164224076|NCT00819832|593188562|FG005|Overall Study|Sponsor Termination of Study|0|||
164224077|NCT01063881|593188563|FG000|Overall Study|Adverse Event|12|||
164224078|NCT01063881|593188564|FG001|Overall Study|Adverse Event|2|||
164224079|NCT01063881|593188565|FG002|Overall Study|Adverse Event|0|||
164224080|NCT01063881|593188563|FG000|Overall Study|Lost to Follow-up|13|||
163879811|NCT00220740|591929634|FG001|Efficacy Period|Protocol Violation|0|||
163879812|NCT00220740|591929633|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
163879813|NCT00220740|591929634|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
163879814|NCT01057433|591929635|FG000|Overall Study|Adverse Event|1|||
163879815|NCT04854096|591929638|FG000|Overall Study|Adverse Event|1|||
163879816|NCT04854096|591929639|FG001|Overall Study|Adverse Event|0|||
163879817|NCT04854096|591929638|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
163879818|NCT04854096|591929639|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
163879819|NCT04854096|591929638|FG000|Overall Study|Withdrawal by Subject|1|||
163879820|NCT04854096|591929639|FG001|Overall Study|Withdrawal by Subject|0|||
163879821|NCT04854096|591929638|FG000|Overall Study|Other reasons|1|||
163879822|NCT04854096|591929639|FG001|Overall Study|Other reasons|0|||
163879823|NCT00593489|591929641|FG000|Allocation|did not attend workshop; allocation not|2|||
163879824|NCT00593489|591929642|FG001|Allocation|did not attend workshop; allocation not|1|||
163879825|NCT03930342|591929645|FG000|Overall Study|Lost to Follow-up|70|||
163879826|NCT03930342|591929646|FG001|Overall Study|Lost to Follow-up|77|||
163879827|NCT02742519|591929647|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
163879828|NCT02742519|591929648|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
163879829|NCT02742519|591929649|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
163879830|NCT02742519|591929647|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
163879831|NCT02742519|591929648|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
163879832|NCT02742519|591929649|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
163879833|NCT02742519|591929647|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
163879834|NCT02742519|591929648|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
163879835|NCT02742519|591929649|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
163879836|NCT01011946|591929651|FG000|Overall Study|Transferred to another hospital|2|||
163879837|NCT01011946|591929651|FG000|Overall Study|No pathological lab value|1|||
163879838|NCT03527160|591929653|FG000|Overall Study|No urine collected|13|||
163879839|NCT03527160|591929653|FG000|Overall Study|No clinical serum creatinine collected|6|||
163879840|NCT03527160|591929653|FG000|Overall Study|Did not meet inclusion|2|||
163879841|NCT01721291|591929655|FG000|Overall Study|Withdrawal by Subject|1|||
163879842|NCT01721291|591929656|FG001|Overall Study|Withdrawal by Subject|0|||
163879843|NCT01721291|591929655|FG000|Overall Study|did not like the treatment|1|||
163879844|NCT01721291|591929656|FG001|Overall Study|did not like the treatment|0|||
163879845|NCT01091168|591929657|FG000|Overall Study|Progressive disease|250|||
163879846|NCT01091168|591929658|FG001|Overall Study|Progressive disease|234|||
163879847|NCT01091168|591929657|FG000|Overall Study|Adverse Event|21|||
163879848|NCT01091168|591929658|FG001|Overall Study|Adverse Event|24|||
163879849|NCT01091168|591929657|FG000|Overall Study|Lost to Follow-up|0|||
163879850|NCT01091168|591929658|FG001|Overall Study|Lost to Follow-up|1|||
163879851|NCT01091168|591929657|FG000|Overall Study|Physician, patient's decision, other|27|||
163879852|NCT01091168|591929658|FG001|Overall Study|Physician, patient's decision, other|37|||
163879853|NCT03978637|591929659|FG000|Overall Study|Death|0|||
163879854|NCT03978637|591929660|FG001|Overall Study|Death|2|||
163879855|NCT03978637|591929661|FG002|Overall Study|Death|2|||
163879856|NCT03978637|591929662|FG003|Overall Study|Death|0|||
163879857|NCT03978637|591929659|FG000|Overall Study|Withdrawal by Subject|0|||
163879858|NCT03978637|591929660|FG001|Overall Study|Withdrawal by Subject|0|||
163879859|NCT03978637|591929661|FG002|Overall Study|Withdrawal by Subject|1|||
163879860|NCT03978637|591929662|FG003|Overall Study|Withdrawal by Subject|0|||
163879861|NCT03978637|591929659|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
163879862|NCT03978637|591929660|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
163879863|NCT03978637|591929661|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
163879864|NCT03978637|591929662|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
163879865|NCT01959698|591929663|FG000|Overall Study|Adverse Event|0|||
163879866|NCT01959698|591929664|FG001|Overall Study|Adverse Event|0|||
163879867|NCT01959698|591929665|FG002|Overall Study|Adverse Event|0|||
163879868|NCT01959698|591929666|FG003|Overall Study|Adverse Event|0|||
163879869|NCT01959698|591929667|FG004|Overall Study|Adverse Event|0|||
163879870|NCT01959698|591929668|FG005|Overall Study|Adverse Event|0|||
163879871|NCT01959698|591929669|FG006|Overall Study|Adverse Event|1|||
163879872|NCT01959698|591929663|FG000|Overall Study|Physician Decision|1|||
163879873|NCT01959698|591929664|FG001|Overall Study|Physician Decision|0|||
164224081|NCT01063881|593188564|FG001|Overall Study|Lost to Follow-up|7|||
164224082|NCT01063881|593188565|FG002|Overall Study|Lost to Follow-up|1|||
164224083|NCT01063881|593188563|FG000|Overall Study|Withdrawal by Subject|25|||
164224084|NCT01063881|593188564|FG001|Overall Study|Withdrawal by Subject|1|||
164224085|NCT01063881|593188565|FG002|Overall Study|Withdrawal by Subject|0|||
164224086|NCT01063881|593188563|FG000|Overall Study|Reason for not completed not specified|5|||
164224087|NCT01063881|593188564|FG001|Overall Study|Reason for not completed not specified|1|||
164224088|NCT01063881|593188565|FG002|Overall Study|Reason for not completed not specified|0|||
164224089|NCT00066170|593188566|FG000|Overall Study|Adverse Event|2|||
164224090|NCT00066170|593188567|FG001|Overall Study|Adverse Event|4|||
164224091|NCT00066170|593188568|FG002|Overall Study|Adverse Event|1|||
164224092|NCT00066170|593188569|FG003|Overall Study|Adverse Event|7|||
164224093|NCT00066170|593188566|FG000|Overall Study|Serious Adverse Event|0|||
164224094|NCT00066170|593188567|FG001|Overall Study|Serious Adverse Event|0|||
164224095|NCT00066170|593188568|FG002|Overall Study|Serious Adverse Event|1|||
164224096|NCT00066170|593188569|FG003|Overall Study|Serious Adverse Event|1|||
164224097|NCT00066170|593188566|FG000|Overall Study|Lost to Follow-up|0|||
164224098|NCT00066170|593188567|FG001|Overall Study|Lost to Follow-up|1|||
164224099|NCT00066170|593188568|FG002|Overall Study|Lost to Follow-up|0|||
164224100|NCT00066170|593188569|FG003|Overall Study|Lost to Follow-up|0|||
164224101|NCT00066170|593188566|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
164224102|NCT00066170|593188567|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
164224103|NCT00066170|593188568|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
164224104|NCT00066170|593188569|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
164224105|NCT00066170|593188566|FG000|Overall Study|Protocol Violation|3|||
164080006|NCT01567306|592657727|FG001|Overall Study|Adverse Event|0|||
164080007|NCT01567306|592657728|FG002|Overall Study|Adverse Event|0|||
164080008|NCT01567306|592657729|FG003|Overall Study|Adverse Event|2|||
164080009|NCT01567306|592657730|FG004|Overall Study|Adverse Event|4|||
164080010|NCT01567306|592657731|FG005|Overall Study|Adverse Event|1|||
164080011|NCT01567306|592657726|FG000|Overall Study|Lost to Follow-up|0|||
164080012|NCT01567306|592657727|FG001|Overall Study|Lost to Follow-up|0|||
164080013|NCT01567306|592657728|FG002|Overall Study|Lost to Follow-up|0|||
164080014|NCT01567306|592657729|FG003|Overall Study|Lost to Follow-up|0|||
164080015|NCT01567306|592657730|FG004|Overall Study|Lost to Follow-up|2|||
164080016|NCT01567306|592657731|FG005|Overall Study|Lost to Follow-up|0|||
164080017|NCT01567306|592657726|FG000|Overall Study|Withdrawal by Subject|0|||
164080018|NCT01567306|592657727|FG001|Overall Study|Withdrawal by Subject|0|||
164080019|NCT01567306|592657728|FG002|Overall Study|Withdrawal by Subject|0|||
164080020|NCT01567306|592657729|FG003|Overall Study|Withdrawal by Subject|0|||
164080021|NCT01567306|592657730|FG004|Overall Study|Withdrawal by Subject|0|||
164080022|NCT01567306|592657731|FG005|Overall Study|Withdrawal by Subject|1|||
164080023|NCT00829413|592657734|FG000|Overall Study|No study drug admimnistered|13|||
164080024|NCT00829413|592657734|FG000|Overall Study|Training Patients|67|||
164080025|NCT00829413|592657734|FG000|Overall Study|No truth standard procedure available|9|||
164080026|NCT00829413|592657734|FG000|Overall Study|Technically inadequate truth standard|2|||
164080027|NCT00829413|592657734|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
164080028|NCT00294723|592657735|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
164080029|NCT00294723|592657736|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
164080030|NCT00294723|592657737|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
164080031|NCT00294723|592657735|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
164080032|NCT00294723|592657736|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
164080033|NCT00294723|592657737|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
164080034|NCT00294723|592657735|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
164080035|NCT00294723|592657736|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
164080036|NCT00294723|592657737|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
164080037|NCT00294723|592657735|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
164080038|NCT00294723|592657736|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
164080039|NCT00294723|592657737|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
164224106|NCT00066170|593188567|FG001|Overall Study|Protocol Violation|0|||
164224107|NCT00066170|593188568|FG002|Overall Study|Protocol Violation|0|||
164224108|NCT00066170|593188569|FG003|Overall Study|Protocol Violation|0|||
164224109|NCT00066170|593188566|FG000|Overall Study|Other|1|||
164080040|NCT00294723|592657735|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
164080041|NCT00294723|592657736|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
164080042|NCT00294723|592657737|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
164080043|NCT00294723|592657735|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
164080044|NCT00294723|592657736|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
164080045|NCT00294723|592657737|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
164080046|NCT00294723|592657735|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
164224110|NCT00066170|593188567|FG001|Overall Study|Other|5|||
164224111|NCT00066170|593188568|FG002|Overall Study|Other|2|||
164224112|NCT00066170|593188569|FG003|Overall Study|Other|0|||
164224113|NCT01370642|593188572|FG000|Overall Study|Adverse Event|2|||
164224114|NCT01370642|593188573|FG001|Overall Study|Adverse Event|1|||
163982807|NCT03504397|592306624|FG000|Overall Study|Adverse Event|40|||
163982808|NCT03504397|592306625|FG001|Overall Study|Adverse Event|14|||
163982809|NCT03504397|592306624|FG000|Overall Study|miscellaneous|17|||
163982810|NCT03504397|592306625|FG001|Overall Study|miscellaneous|15|||
163982811|NCT03504397|592306624|FG000|Overall Study|Protocol deviation|1|||
163982812|NCT03504397|592306625|FG001|Overall Study|Protocol deviation|0|||
163982813|NCT03504397|592306624|FG000|Overall Study|Participants who did not take the study drug|4|||
163982814|NCT03504397|592306625|FG001|Overall Study|Participants who did not take the study drug|4|||
163982815|NCT00070941|592306626|FG000|Overall Study|Adverse Event|10|||
163982816|NCT00070941|592306627|FG001|Overall Study|Adverse Event|8|||
163982817|NCT00070941|592306628|FG002|Overall Study|Adverse Event|4|||
163982818|NCT01888640|592306629|FG000|Overall Study|Lost to Follow-up|1|||
163982819|NCT01888640|592306630|FG001|Overall Study|Lost to Follow-up|2|||
163982820|NCT01888640|592306631|FG002|Overall Study|Lost to Follow-up|0|||
163982821|NCT01888640|592306629|FG000|Overall Study|Withdrawal by Subject|15|||
163982822|NCT01888640|592306630|FG001|Overall Study|Withdrawal by Subject|11|||
163982823|NCT01888640|592306631|FG002|Overall Study|Withdrawal by Subject|4|||
163982824|NCT01888640|592306629|FG000|Overall Study|Minimum dose not met|10|||
163982825|NCT01888640|592306630|FG001|Overall Study|Minimum dose not met|16|||
163982826|NCT01888640|592306631|FG002|Overall Study|Minimum dose not met|0|||
164224115|NCT01370642|593188574|FG002|Overall Study|Adverse Event|1|||
164224116|NCT01370642|593188572|FG000|Overall Study|Detectable HCV RNA|0|||
164224117|NCT01370642|593188573|FG001|Overall Study|Detectable HCV RNA|0|||
164224118|NCT01370642|593188574|FG002|Overall Study|Detectable HCV RNA|22|||
164224119|NCT01370642|593188572|FG000|Overall Study|Lost to Follow-up|0|||
164224120|NCT01370642|593188573|FG001|Overall Study|Lost to Follow-up|0|||
164224121|NCT01370642|593188574|FG002|Overall Study|Lost to Follow-up|1|||
164224122|NCT01370642|593188572|FG000|Overall Study|Physician Decision|4|||
164224123|NCT01370642|593188573|FG001|Overall Study|Physician Decision|1|||
164224124|NCT01370642|593188574|FG002|Overall Study|Physician Decision|2|||
163982827|NCT01888640|592306629|FG000|Overall Study|Given wrong unit (placebo)|1|||
163982828|NCT01888640|592306630|FG001|Overall Study|Given wrong unit (placebo)|0|||
163982829|NCT01888640|592306631|FG002|Overall Study|Given wrong unit (placebo)|0|||
163982830|NCT01888640|592306629|FG000|Overall Study|Excluded for prior TENS|0|||
163982831|NCT01888640|592306630|FG001|Overall Study|Excluded for prior TENS|1|||
163982832|NCT01888640|592306631|FG002|Overall Study|Excluded for prior TENS|0|||
163982833|NCT01888640|592306629|FG000|Overall Study|Researcher Termination of Participant|0|||
163982834|NCT01888640|592306630|FG001|Overall Study|Researcher Termination of Participant|1|||
163982835|NCT01888640|592306631|FG002|Overall Study|Researcher Termination of Participant|1|||
163982836|NCT02199080|592306632|FG000|Overall Study|Protocol Violation|12|||
163982837|NCT02443883|592306633|FG000|Overall Study|Adverse Event|0|||
163982838|NCT02443883|592306634|FG001|Overall Study|Adverse Event|1|||
163982839|NCT02443883|592306635|FG002|Overall Study|Adverse Event|0|||
163982840|NCT02443883|592306636|FG003|Overall Study|Adverse Event|0|||
163982841|NCT02443883|592306633|FG000|Overall Study|Lost to Follow-up|3|||
163982842|NCT02443883|592306634|FG001|Overall Study|Lost to Follow-up|2|||
163982843|NCT02443883|592306635|FG002|Overall Study|Lost to Follow-up|1|||
163982844|NCT02443883|592306636|FG003|Overall Study|Lost to Follow-up|0|||
163982845|NCT02443883|592306633|FG000|Overall Study|Physician Decision|1|||
163982846|NCT02443883|592306634|FG001|Overall Study|Physician Decision|1|||
163982847|NCT02443883|592306635|FG002|Overall Study|Physician Decision|0|||
163982848|NCT02443883|592306636|FG003|Overall Study|Physician Decision|3|||
163982849|NCT02443883|592306633|FG000|Overall Study|Withdrawal by Subject|1|||
164080047|NCT00294723|592657736|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
163982850|NCT02443883|592306634|FG001|Overall Study|Withdrawal by Subject|0|||
163982851|NCT02443883|592306635|FG002|Overall Study|Withdrawal by Subject|0|||
163982852|NCT02443883|592306636|FG003|Overall Study|Withdrawal by Subject|2|||
163982853|NCT02443883|592306633|FG000|Overall Study|Randomized, but never treated|1|||
163982854|NCT02443883|592306634|FG001|Overall Study|Randomized, but never treated|0|||
163982855|NCT02443883|592306635|FG002|Overall Study|Randomized, but never treated|0|||
163982856|NCT02443883|592306636|FG003|Overall Study|Randomized, but never treated|0|||
163982857|NCT01277549|592306637|FG000|Overall Study|Failed to meet eligibility criteria|13|||
163982858|NCT01277549|592306638|FG001|Overall Study|Failed to meet eligibility criteria|9|||
163982859|NCT01277549|592306637|FG000|Overall Study|Withdrawal by Subject|1|||
164080048|NCT00294723|592657737|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
164224125|NCT01370642|593188572|FG000|Overall Study|Withdrawal by Subject|2|||
163982860|NCT01277549|592306638|FG001|Overall Study|Withdrawal by Subject|3|||
163982861|NCT01277549|592306637|FG000|Overall Study|Protocol Violation|10|||
163982862|NCT01277549|592306638|FG001|Overall Study|Protocol Violation|1|||
164080049|NCT00294723|592657735|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
164224126|NCT01370642|593188573|FG001|Overall Study|Withdrawal by Subject|4|||
164224127|NCT01370642|593188574|FG002|Overall Study|Withdrawal by Subject|3|||
163982863|NCT01277549|592306637|FG000|Overall Study|Physician Decision|2|||
163982864|NCT01277549|592306638|FG001|Overall Study|Physician Decision|1|||
163982865|NCT00999908|592306639|FG000|Treatment Period 1|Subject withdrew consent|2|||
163982866|NCT00999908|592306640|FG001|Treatment Period 1|Subject withdrew consent|0|||
164224128|NCT01796470|593188575|FG000|Overall Study|Adverse Event|4|||
164224129|NCT01796470|593188576|FG001|Overall Study|Adverse Event|2|||
164224130|NCT01796470|593188577|FG002|Overall Study|Adverse Event|2|||
164224131|NCT01796470|593188578|FG003|Overall Study|Adverse Event|1|||
164224132|NCT01796470|593188579|FG004|Overall Study|Adverse Event|3|||
164224133|NCT01796470|593188575|FG000|Overall Study|Death|2|||
164224134|NCT01796470|593188576|FG001|Overall Study|Death|0|||
164224135|NCT01796470|593188577|FG002|Overall Study|Death|0|||
164224136|NCT01796470|593188578|FG003|Overall Study|Death|0|||
164224137|NCT01796470|593188579|FG004|Overall Study|Death|1|||
164224138|NCT01796470|593188575|FG000|Overall Study|Initiated New Therapy|9|||
164224139|NCT01796470|593188576|FG001|Overall Study|Initiated New Therapy|0|||
164224140|NCT01796470|593188577|FG002|Overall Study|Initiated New Therapy|0|||
164224141|NCT01796470|593188578|FG003|Overall Study|Initiated New Therapy|0|||
164224142|NCT01796470|593188579|FG004|Overall Study|Initiated New Therapy|2|||
164224143|NCT01796470|593188575|FG000|Overall Study|Lost to Follow-up|0|||
164224144|NCT01796470|593188576|FG001|Overall Study|Lost to Follow-up|1|||
164224145|NCT01796470|593188577|FG002|Overall Study|Lost to Follow-up|0|||
164224146|NCT01796470|593188578|FG003|Overall Study|Lost to Follow-up|0|||
164224147|NCT01796470|593188579|FG004|Overall Study|Lost to Follow-up|0|||
164224148|NCT01796470|593188575|FG000|Overall Study|Physician Decision|5|||
164224149|NCT01796470|593188576|FG001|Overall Study|Physician Decision|4|||
164224150|NCT01796470|593188577|FG002|Overall Study|Physician Decision|1|||
164224151|NCT01796470|593188578|FG003|Overall Study|Physician Decision|0|||
163879874|NCT01959698|591929665|FG002|Overall Study|Physician Decision|1|||
163879875|NCT01959698|591929666|FG003|Overall Study|Physician Decision|2|||
163879876|NCT01959698|591929667|FG004|Overall Study|Physician Decision|0|||
163879877|NCT01959698|591929668|FG005|Overall Study|Physician Decision|3|||
163879878|NCT01959698|591929669|FG006|Overall Study|Physician Decision|3|||
163879879|NCT05792423|591929670|FG000|Overall Study|Withdrawal by Subject|2|||
163879880|NCT03747484|591931118|FG000|Overall Study|Lack of Efficacy|0|||
163879881|NCT03747484|591931119|FG001|Overall Study|Lack of Efficacy|1|||
164080050|NCT00294723|592657736|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
164224152|NCT01796470|593188579|FG004|Overall Study|Physician Decision|1|||
164224153|NCT01796470|593188575|FG000|Overall Study|Progressive Disease|7|||
164224154|NCT01796470|593188576|FG001|Overall Study|Progressive Disease|7|||
164224155|NCT01796470|593188577|FG002|Overall Study|Progressive Disease|3|||
164224156|NCT01796470|593188578|FG003|Overall Study|Progressive Disease|2|||
163879882|NCT03747484|591931120|FG002|Overall Study|Lack of Efficacy|1|||
163879883|NCT03747484|591931121|FG003|Overall Study|Lack of Efficacy|2|||
163879884|NCT03747484|591931122|FG004|Overall Study|Lack of Efficacy|2|||
163879885|NCT05418296|591931128|FG000|Overall Study|Withdrawal by Subject|4|||
163879886|NCT05418296|591931129|FG001|Overall Study|Withdrawal by Subject|1|||
163879887|NCT03101904|591931130|FG000|Wash Out (10 Days)|Adverse Event|1|||
163879888|NCT03101904|591931131|FG001|Wash Out (10 Days)|Adverse Event|0|||
163879889|NCT03101904|591931130|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
163879890|NCT03101904|591931131|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
163879891|NCT04538417|591931132|FG000|Overall Study|Withdrawal by Subject|2|||
163879892|NCT04703322|591931134|FG000|Overall Study|Ongoing|8|||
163879893|NCT04703322|591931134|FG000|Overall Study|Withdrawal by Subject|1|||
163879894|NCT01180634|591931135|FG000|Overall Study|Adverse Event|4|||
163879895|NCT01180634|591931136|FG001|Overall Study|Adverse Event|1|||
163879896|NCT01180634|591931135|FG000|Overall Study|Miscellaneous|2|||
163879897|NCT01180634|591931136|FG001|Overall Study|Miscellaneous|0|||
163879898|NCT01180634|591931135|FG000|Overall Study|Withdrawal by Subject|4|||
163879899|NCT01180634|591931136|FG001|Overall Study|Withdrawal by Subject|0|||
163879900|NCT04419168|591931137|FG000|Overall Study|Protocol Violation|1|||
163879901|NCT04419168|591931138|FG001|Overall Study|Protocol Violation|1|||
163879902|NCT04419168|591931137|FG000|Overall Study|Lost to Follow-up|7|||
163879903|NCT04419168|591931138|FG001|Overall Study|Lost to Follow-up|7|||
163879904|NCT04419168|591931137|FG000|Overall Study|Missed 6-month Visit|48|||
163879905|NCT04419168|591931138|FG001|Overall Study|Missed 6-month Visit|45|||
163879906|NCT05009251|591931142|FG000|Overall Study|Protocol Violation|100|||
163879907|NCT05009251|591931143|FG001|Overall Study|Protocol Violation|105|||
163879908|NCT05009251|591931144|FG002|Overall Study|Protocol Violation|119|||
163879909|NCT05009251|591931145|FG003|Overall Study|Protocol Violation|120|||
163879910|NCT05009251|591931146|FG004|Overall Study|Protocol Violation|119|||
163879911|NCT05009251|591931142|FG000|Overall Study|Death|25|||
163879912|NCT05009251|591931143|FG001|Overall Study|Death|22|||
163879913|NCT05009251|591931144|FG002|Overall Study|Death|24|||
163879914|NCT05009251|591931145|FG003|Overall Study|Death|19|||
163879915|NCT05009251|591931146|FG004|Overall Study|Death|15|||
163879916|NCT02662062|591931151|FG000|Overall Study|Withdrawal by Subject|1|||
163879917|NCT00676715|591931152|FG000|Treatment Period (TP)|Adverse Event|0|||
163879918|NCT00676715|591931153|FG001|Treatment Period (TP)|Adverse Event|3|||
163879919|NCT00676715|591931154|FG002|Treatment Period (TP)|Adverse Event|2|||
163879920|NCT00676715|591931155|FG003|Treatment Period (TP)|Adverse Event|2|||
163879921|NCT00676715|591931152|FG000|Treatment Period (TP)|Death|0|||
163879922|NCT00676715|591931153|FG001|Treatment Period (TP)|Death|0|||
164224157|NCT01796470|593188579|FG004|Overall Study|Progressive Disease|0|||
164224158|NCT01796470|593188575|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
164224159|NCT01796470|593188576|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
164224160|NCT01796470|593188577|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
164224161|NCT01796470|593188578|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
164224162|NCT01796470|593188579|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
164224163|NCT01796470|593188575|FG000|Overall Study|Withdrawal by Subject|7|||
164224164|NCT01796470|593188576|FG001|Overall Study|Withdrawal by Subject|0|||
164224165|NCT01796470|593188577|FG002|Overall Study|Withdrawal by Subject|0|||
163879923|NCT00676715|591931154|FG002|Treatment Period (TP)|Death|1|||
163879924|NCT00676715|591931155|FG003|Treatment Period (TP)|Death|0|||
163879925|NCT00676715|591931152|FG000|Treatment Period (TP)|Failure to return|1|||
163879926|NCT00676715|591931153|FG001|Treatment Period (TP)|Failure to return|0|||
163879927|NCT00676715|591931154|FG002|Treatment Period (TP)|Failure to return|0|||
163879928|NCT00676715|591931155|FG003|Treatment Period (TP)|Failure to return|0|||
163879929|NCT00676715|591931152|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
163879930|NCT00676715|591931153|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
163879931|NCT00676715|591931154|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
163879932|NCT00676715|591931155|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
163879933|NCT00676715|591931152|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
163879934|NCT00676715|591931153|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
163879935|NCT00676715|591931154|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
163982867|NCT00999908|592306641|FG002|Treatment Period 1|Subject withdrew consent|0|||
163982868|NCT00999908|592306639|FG000|Treatment Period 2|Protocol Violation|1|||
163982869|NCT00999908|592306640|FG001|Treatment Period 2|Protocol Violation|0|||
163982870|NCT00999908|592306641|FG002|Treatment Period 2|Protocol Violation|0|||
163982871|NCT01097863|592306644|FG000|Overall Study|Discomfort|1|||
163982872|NCT01097863|592306645|FG001|Overall Study|Discomfort|0|||
163982873|NCT01097863|592306646|FG002|Overall Study|Discomfort|1|||
163982874|NCT01097863|592306644|FG000|Overall Study|Did not return for final visit|0|||
163982875|NCT01097863|592306645|FG001|Overall Study|Did not return for final visit|0|||
163982876|NCT01097863|592306646|FG002|Overall Study|Did not return for final visit|1|||
163982877|NCT00419380|592306647|FG000|Overall Study|Lack of Efficacy|1|||
163982878|NCT00419380|592306648|FG001|Overall Study|Lack of Efficacy|7|||
163982879|NCT00419380|592306647|FG000|Overall Study|Physician Decision|0|||
163982880|NCT00419380|592306648|FG001|Overall Study|Physician Decision|1|||
163982881|NCT00419380|592306647|FG000|Overall Study|Lost to Follow-up|0|||
163982882|NCT00419380|592306648|FG001|Overall Study|Lost to Follow-up|1|||
163982883|NCT00419380|592306647|FG000|Overall Study|Withdrawal by Subject|0|||
163982884|NCT00419380|592306648|FG001|Overall Study|Withdrawal by Subject|1|||
163982885|NCT03099707|592306649|FG000|Overall Study|Withdrawal by Subject|0|||
163982886|NCT03099707|592306650|FG001|Overall Study|Withdrawal by Subject|3|||
163982887|NCT03099707|592306649|FG000|Overall Study|Lost to Follow-up|0|||
163982888|NCT03099707|592306650|FG001|Overall Study|Lost to Follow-up|1|||
163982889|NCT03167073|592306651|FG000|Overall Study|Stillbirth|1|||
163982890|NCT03167073|592306652|FG001|Overall Study|Stillbirth|0|||
163982891|NCT01079182|592306660|FG000|Overall Study|Lost to Follow-up|1634|||
163982892|NCT01079182|592306660|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
163982893|NCT01079182|592306660|FG000|Overall Study|Lack of Efficacy|514|||
163982894|NCT01079182|592306660|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
163982895|NCT01079182|592306660|FG000|Overall Study|Reasons not Evaluated|271|||
163982896|NCT01026831|592306661|FG000|Overall Study|Adverse Event|4|||
163982897|NCT01026831|592306662|FG001|Overall Study|Adverse Event|3|||
163982898|NCT01026831|592306661|FG000|Overall Study|Lost to Follow-up|2|||
163982899|NCT01026831|592306662|FG001|Overall Study|Lost to Follow-up|0|||
163982900|NCT01026831|592306661|FG000|Overall Study|Physician Decision|1|||
163982901|NCT01026831|592306662|FG001|Overall Study|Physician Decision|1|||
163982902|NCT01026831|592306661|FG000|Overall Study|Protocol Violation|0|||
163982903|NCT01026831|592306662|FG001|Overall Study|Protocol Violation|2|||
163982904|NCT01026831|592306661|FG000|Overall Study|Withdrawal by Subject|7|||
163982905|NCT01026831|592306662|FG001|Overall Study|Withdrawal by Subject|5|||
163982906|NCT01430455|592306666|FG000|Overall Study|Withdrawal by Subject|1|||
163982907|NCT01430455|592306666|FG000|Overall Study|Switched to follow-up phase|1|||
163982908|NCT05061719|592306667|FG000|Overall Study|Adverse Event|60|||
163982909|NCT05061719|592306667|FG000|Overall Study|Death|1|||
163982910|NCT05061719|592306667|FG000|Overall Study|Lack of Efficacy|7|||
163982911|NCT05061719|592306667|FG000|Overall Study|Lost to Follow-up|5|||
163982912|NCT05061719|592306667|FG000|Overall Study|Pregnancy|1|||
163982913|NCT05061719|592306667|FG000|Overall Study|Protocol Violation|8|||
163982914|NCT05061719|592306667|FG000|Overall Study|Withdrawal by Subject|41|||
164224166|NCT01796470|593188578|FG003|Overall Study|Withdrawal by Subject|0|||
163982915|NCT05061719|592306667|FG000|Overall Study|Site Closure|2|||
163982916|NCT01652287|592308336|FG000|Overall Study|Withdrawal by Subject|2|||
163982917|NCT01652287|592308337|FG001|Overall Study|Withdrawal by Subject|0|||
163982918|NCT01592760|592308338|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
163982919|NCT01592760|592308339|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
163982920|NCT01592760|592308340|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
163982921|NCT01637142|592308343|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
163982922|NCT00984204|592308345|FG000|Overall Study|Death|1|||
163982923|NCT00984204|592308345|FG000|Overall Study|Lost to Follow-up|4|||
163982924|NCT00984204|592308345|FG000|Overall Study|Lack of Efficacy|10|||
163982925|NCT00559507|592308346|FG000|Overall Study|Not treated, patient ineligible|3|||
163982926|NCT04681170|592308347|FG000|Stratified Enrolment & run-in|Death|1|||
163982927|NCT04681170|592308348|FG001|Stratified Enrolment & run-in|Death|0|||
163982928|NCT04681170|592308347|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
163982929|NCT04681170|592308348|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
163982930|NCT04681170|592308347|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
163982931|NCT04681170|592308348|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
163982932|NCT04681170|592308347|FG000|Open Label Efficacy Phase|Adverse Event|0|||
163982933|NCT04681170|592308348|FG001|Open Label Efficacy Phase|Adverse Event|2|||
163982934|NCT04681170|592308347|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
163982935|NCT04681170|592308348|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
163982936|NCT04681170|592308347|FG000|Open Label Safety Phase|AEs and none compliance|0|||
163982937|NCT04681170|592308348|FG001|Open Label Safety Phase|AEs and none compliance|1|||
163982938|NCT01407926|592308353|FG000|Overall Study|Lost to Follow-up|55|||
163982939|NCT02468648|592308354|FG000|Overall Study|Death|1|||
163982940|NCT02118792|592308355|FG000|Overall Study|Withdrawal by Subject|6|||
163982941|NCT02118792|592308356|FG001|Overall Study|Withdrawal by Subject|3|||
163982942|NCT02118792|592308355|FG000|Overall Study|Lost to Follow-up|4|||
163982943|NCT02118792|592308356|FG001|Overall Study|Lost to Follow-up|4|||
163982944|NCT02118792|592308355|FG000|Overall Study|Adverse Event|5|||
163982945|NCT02118792|592308356|FG001|Overall Study|Adverse Event|4|||
163982946|NCT02118792|592308355|FG000|Overall Study|Withdrawal by parent/guardian|14|||
163982947|NCT02118792|592308356|FG001|Overall Study|Withdrawal by parent/guardian|20|||
163982948|NCT02118792|592308355|FG000|Overall Study|Other|1|||
163982949|NCT02118792|592308356|FG001|Overall Study|Other|6|||
163982950|NCT02118792|592308355|FG000|Overall Study|Randomised but not treated|1|||
163982951|NCT02118792|592308356|FG001|Overall Study|Randomised but not treated|0|||
163982952|NCT04232696|592308358|FG000|Overall Study|Implant attempted but not completed|5|||
163982953|NCT04232696|592308359|FG001|Overall Study|Implant attempted but not completed|2|||
163982954|NCT04232696|592308358|FG000|Overall Study|Not satisfied with therapy outcome|0|||
163982955|NCT04232696|592308359|FG001|Overall Study|Not satisfied with therapy outcome|8|||
163982956|NCT04232696|592308358|FG000|Overall Study|Adverse Event|0|||
163982957|NCT04232696|592308359|FG001|Overall Study|Adverse Event|3|||
163982958|NCT04232696|592308358|FG000|Overall Study|Withdrawal by Subject|0|||
163982959|NCT04232696|592308359|FG001|Overall Study|Withdrawal by Subject|3|||
163982960|NCT04232696|592308358|FG000|Overall Study|Missed Visit|0|||
163982961|NCT04232696|592308359|FG001|Overall Study|Missed Visit|2|||
164224167|NCT01796470|593188579|FG004|Overall Study|Withdrawal by Subject|1|||
164224168|NCT00147537|593188580|FG000|Phase 1b|Death|0|||
164224169|NCT00147537|593188581|FG001|Phase 1b|Death|1|||
164224170|NCT00147537|593188582|FG002|Phase 1b|Death|2|||
164224171|NCT00147537|593188583|FG003|Phase 1b|Death|1|||
164224172|NCT00147537|593188584|FG004|Phase 1b|Death|2|||
164224173|NCT00147537|593188585|FG005|Phase 1b|Death|2|||
164224174|NCT00147537|593188586|FG006|Phase 1b|Death|1|||
164224175|NCT00147537|593188587|FG007|Phase 1b|Death|3|||
164224176|NCT00147537|593188588|FG008|Phase 1b|Death|9|||
164224177|NCT00147537|593188589|FG009|Phase 1b|Death|0|||
164224178|NCT00147537|593188590|FG010|Phase 1b|Death|0|||
164224179|NCT00147537|593188580|FG000|Phase 1b|Lost to Follow-up|2|||
164224180|NCT00147537|593188581|FG001|Phase 1b|Lost to Follow-up|1|||
164224181|NCT00147537|593188582|FG002|Phase 1b|Lost to Follow-up|0|||
164224182|NCT00147537|593188583|FG003|Phase 1b|Lost to Follow-up|0|||
164224183|NCT00147537|593188584|FG004|Phase 1b|Lost to Follow-up|0|||
164224184|NCT00147537|593188585|FG005|Phase 1b|Lost to Follow-up|0|||
164224185|NCT00147537|593188586|FG006|Phase 1b|Lost to Follow-up|2|||
164224186|NCT00147537|593188587|FG007|Phase 1b|Lost to Follow-up|0|||
164224187|NCT00147537|593188588|FG008|Phase 1b|Lost to Follow-up|1|||
164224188|NCT00147537|593188589|FG009|Phase 1b|Lost to Follow-up|0|||
164224189|NCT00147537|593188590|FG010|Phase 1b|Lost to Follow-up|0|||
164224190|NCT00147537|593188580|FG000|Phase 1b|Other|0|||
164224191|NCT00147537|593188581|FG001|Phase 1b|Other|0|||
164080051|NCT00294723|592657737|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
164224192|NCT00147537|593188582|FG002|Phase 1b|Other|2|||
164224193|NCT00147537|593188583|FG003|Phase 1b|Other|1|||
164224194|NCT00147537|593188584|FG004|Phase 1b|Other|1|||
164224195|NCT00147537|593188585|FG005|Phase 1b|Other|1|||
163982962|NCT04232696|592308358|FG000|Overall Study|Other reason|0|||
163982963|NCT04232696|592308359|FG001|Overall Study|Other reason|1|||
163982964|NCT00488982|592308360|FG000|Course 1|Physician Decision|0|||
163982965|NCT00488982|592308361|FG001|Course 1|Physician Decision|2|||
163982966|NCT00488982|592308362|FG002|Course 1|Physician Decision|4|||
164224196|NCT00147537|593188586|FG006|Phase 1b|Other|14|||
164224197|NCT00147537|593188587|FG007|Phase 1b|Other|4|||
164224198|NCT00147537|593188588|FG008|Phase 1b|Other|4|||
164224199|NCT00147537|593188589|FG009|Phase 1b|Other|0|||
163982967|NCT00488982|592308360|FG000|Course 1|Withdrawal by Subject|0|||
163982968|NCT00488982|592308361|FG001|Course 1|Withdrawal by Subject|8|||
163982969|NCT00488982|592308362|FG002|Course 1|Withdrawal by Subject|2|||
163982970|NCT00488982|592308360|FG000|Course 1|nonprotocol therapy|0|||
163982971|NCT00488982|592308361|FG001|Course 1|nonprotocol therapy|2|||
163982972|NCT00488982|592308362|FG002|Course 1|nonprotocol therapy|2|||
163982973|NCT00488982|592308360|FG000|Course 1|Adverse Event|0|||
163982974|NCT00488982|592308361|FG001|Course 1|Adverse Event|0|||
163982975|NCT00488982|592308362|FG002|Course 1|Adverse Event|6|||
163982976|NCT01368835|592308363|FG000|Overall Study|Inclusion criteria/photography quality|22|||
163982977|NCT01368835|592308363|FG000|Overall Study|Lost to Follow-up|11|||
163982978|NCT01678144|592308364|FG000|Stage 1: MAR Classic|Adverse Event|1|||
163982979|NCT02754726|592308365|FG000|Overall Study|Progressive Disease by RECIST|13|||
163982980|NCT02754726|592308365|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
163982981|NCT02754726|592308365|FG000|Overall Study|Clinical Disease Progression|5|||
163982982|NCT02754726|592308365|FG000|Overall Study|Adverse Event|3|||
163982983|NCT02754726|592308365|FG000|Overall Study|Withdrawal by Subject|1|||
163982984|NCT02754726|592308365|FG000|Overall Study|Tolerability|1|||
163982985|NCT05289830|592308374|FG000|Overall Study|Lost to Follow-up|1|||
163982986|NCT05289830|592308375|FG001|Overall Study|Lost to Follow-up|1|||
163982987|NCT05289830|592308374|FG000|Overall Study|Physician Decision|0|||
163982988|NCT05289830|592308375|FG001|Overall Study|Physician Decision|1|||
163982989|NCT01046825|592308376|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163982990|NCT01046825|592308377|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
163982991|NCT01046825|592308378|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163982992|NCT01046825|592308379|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163982993|NCT01046825|592308380|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
163982994|NCT01046825|592308376|FG000|Overall Study|Physician Decision|0|||
163982995|NCT01046825|592308377|FG001|Overall Study|Physician Decision|1|||
163982996|NCT01046825|592308378|FG002|Overall Study|Physician Decision|2|||
163982997|NCT01046825|592308379|FG003|Overall Study|Physician Decision|0|||
164080052|NCT00294723|592657735|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
164080053|NCT00294723|592657736|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
164080054|NCT00294723|592657737|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
164080055|NCT00294723|592657735|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
164080056|NCT00294723|592657736|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
164080057|NCT00294723|592657737|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
164080058|NCT00294723|592657735|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
164080059|NCT00294723|592657736|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
164080060|NCT00294723|592657737|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
164080061|NCT00294723|592657735|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
164080062|NCT00294723|592657736|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
164080063|NCT00294723|592657737|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
164080064|NCT00891774|592657742|FG000|Overall Study|Lost to Follow-up|5|||
164080065|NCT00891774|592657742|FG000|Overall Study|Illness (Self/Mother)|3|||
164080066|NCT00891774|592657742|FG000|Overall Study|Withdrawal by Subject|2|||
164080067|NCT00891774|592657742|FG000|Overall Study|Protocol Violation|4|||
164080068|NCT03255031|592657747|FG000|Overall Study|Adverse Event|5|||
164080069|NCT03255031|592657748|FG001|Overall Study|Adverse Event|3|||
164080070|NCT03255031|592657747|FG000|Overall Study|Physician Decision|2|||
164080071|NCT03255031|592657748|FG001|Overall Study|Physician Decision|1|||
164080072|NCT03255031|592657747|FG000|Overall Study|Withdrawal by Subject|9|||
164080073|NCT03255031|592657748|FG001|Overall Study|Withdrawal by Subject|3|||
164080074|NCT01809314|592657749|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
164080075|NCT01809314|592657749|FG000|Overall Study|Adverse Event|6|||
164080076|NCT01809314|592657749|FG000|Overall Study|Insufficient Therapeutic Response|14|||
163982998|NCT01046825|592308380|FG004|Overall Study|Physician Decision|0|||
163982999|NCT01046825|592308376|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163983000|NCT01046825|592308377|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163983001|NCT01046825|592308378|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
163983002|NCT01046825|592308379|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163983003|NCT01046825|592308380|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
163983004|NCT01046825|592308376|FG000|Overall Study|Found to be ineligible|0|||
163983005|NCT01046825|592308377|FG001|Overall Study|Found to be ineligible|1|||
163983006|NCT01046825|592308378|FG002|Overall Study|Found to be ineligible|0|||
163983007|NCT01046825|592308379|FG003|Overall Study|Found to be ineligible|0|||
163983008|NCT01046825|592308380|FG004|Overall Study|Found to be ineligible|0|||
163983009|NCT01046825|592308376|FG000|Overall Study|Death|0|||
163983010|NCT01046825|592308377|FG001|Overall Study|Death|0|||
163983011|NCT01046825|592308378|FG002|Overall Study|Death|0|||
164080077|NCT01809314|592657749|FG000|Overall Study|Lost to Follow-up|724|||
164080078|NCT00863057|592657752|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
164224200|NCT00147537|593188590|FG010|Phase 1b|Other|0|||
164224201|NCT00147537|593188580|FG000|Phase 1b|Withdrawal by Subject|0|||
163879936|NCT00676715|591931155|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
163879937|NCT00676715|591931152|FG000|Treatment Period (TP)|Withdrew consent|3|||
163879938|NCT00676715|591931153|FG001|Treatment Period (TP)|Withdrew consent|3|||
163879939|NCT00676715|591931154|FG002|Treatment Period (TP)|Withdrew consent|3|||
163879940|NCT00676715|591931155|FG003|Treatment Period (TP)|Withdrew consent|3|||
163879941|NCT00676715|591931152|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
163879942|NCT00676715|591931153|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
163879943|NCT00676715|591931154|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
163879944|NCT00676715|591931155|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
163879945|NCT00676715|591931152|FG000|Treatment Period (TP)|Administrative|0|||
163879946|NCT00676715|591931153|FG001|Treatment Period (TP)|Administrative|0|||
163879947|NCT00676715|591931154|FG002|Treatment Period (TP)|Administrative|0|||
163879948|NCT00676715|591931155|FG003|Treatment Period (TP)|Administrative|1|||
163879949|NCT00676715|591931152|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
163879950|NCT00676715|591931153|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
163879951|NCT00676715|591931154|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
163879952|NCT00676715|591931155|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
163879953|NCT00676715|591931152|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
163879954|NCT00676715|591931153|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
163879955|NCT00676715|591931154|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
163879956|NCT00676715|591931155|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
163879957|NCT00676715|591931152|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
163879958|NCT00676715|591931153|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
163879959|NCT00676715|591931154|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
163879960|NCT00676715|591931155|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
163879961|NCT00676715|591931152|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
163879962|NCT00676715|591931153|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
163879963|NCT00676715|591931154|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
163879964|NCT00676715|591931155|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
163879965|NCT00676715|591931152|FG000|Treatment-free Period (TFP)|Death|1|||
163879966|NCT00676715|591931153|FG001|Treatment-free Period (TFP)|Death|1|||
163879967|NCT00676715|591931154|FG002|Treatment-free Period (TFP)|Death|1|||
163879968|NCT00676715|591931155|FG003|Treatment-free Period (TFP)|Death|0|||
163879969|NCT00676715|591931152|FG000|Open Label Extension (OLE)|Reason not provided|3|||
163879970|NCT00676715|591931153|FG001|Open Label Extension (OLE)|Reason not provided|4|||
163879971|NCT00676715|591931154|FG002|Open Label Extension (OLE)|Reason not provided|1|||
163879972|NCT00676715|591931155|FG003|Open Label Extension (OLE)|Reason not provided|4|||
163879973|NCT00676715|591931152|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
163879974|NCT00676715|591931153|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
163879975|NCT00676715|591931154|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
163879976|NCT00676715|591931155|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
163879977|NCT00676715|591931152|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
163879978|NCT00676715|591931153|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
163879979|NCT00676715|591931154|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
163879980|NCT00676715|591931155|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
163879981|NCT00676715|591931152|FG000|Open Label Extension (OLE)|Adverse Event|0|||
163879982|NCT00676715|591931153|FG001|Open Label Extension (OLE)|Adverse Event|3|||
163879983|NCT00676715|591931154|FG002|Open Label Extension (OLE)|Adverse Event|1|||
163879984|NCT00676715|591931155|FG003|Open Label Extension (OLE)|Adverse Event|0|||
163879985|NCT00676715|591931152|FG000|Open Label Extension (OLE)|Death|2|||
163879986|NCT00676715|591931153|FG001|Open Label Extension (OLE)|Death|0|||
163879987|NCT00676715|591931154|FG002|Open Label Extension (OLE)|Death|2|||
163879988|NCT00676715|591931155|FG003|Open Label Extension (OLE)|Death|2|||
163879989|NCT05249439|591931157|FG000|Overall Study|Withdrawal by Subject|2|||
163879990|NCT05249439|591931158|FG001|Overall Study|Withdrawal by Subject|5|||
163879991|NCT05249439|591931157|FG000|Overall Study|Physician Decision|3|||
163879992|NCT05249439|591931158|FG001|Overall Study|Physician Decision|1|||
163879993|NCT00616967|591931159|FG000|Overall Study|Withdrawal by Subject|0|||
163879994|NCT00616967|591931160|FG001|Overall Study|Withdrawal by Subject|0|||
163879995|NCT00616967|591931161|FG002|Overall Study|Withdrawal by Subject|1|||
163879996|NCT02910583|591931162|FG000|Overall Study|Death|7|||
163879997|NCT02910583|591931163|FG001|Overall Study|Death|3|||
163879998|NCT02910583|591931162|FG000|Overall Study|Lost to Follow-up|1|||
163879999|NCT02910583|591931163|FG001|Overall Study|Lost to Follow-up|0|||
163880000|NCT02910583|591931162|FG000|Overall Study|Withdrawal by Subject|12|||
164224202|NCT00147537|593188581|FG001|Phase 1b|Withdrawal by Subject|0|||
163880001|NCT02910583|591931163|FG001|Overall Study|Withdrawal by Subject|8|||
163880002|NCT02910583|591931162|FG000|Overall Study|Other, Not Specified|6|||
163880003|NCT02910583|591931163|FG001|Overall Study|Other, Not Specified|3|||
163880004|NCT01331005|591931165|FG000|Overall Study|Lost to Follow-up|2|||
163880005|NCT01331005|591931166|FG001|Overall Study|Lost to Follow-up|1|||
163880006|NCT01331005|591931165|FG000|Overall Study|Withdrawal by Subject|2|||
164224203|NCT00147537|593188582|FG002|Phase 1b|Withdrawal by Subject|0|||
163880007|NCT01331005|591931166|FG001|Overall Study|Withdrawal by Subject|3|||
163880008|NCT03161379|591931178|FG000|Overall Study|Withdrawal by Subject|4|||
163880009|NCT03161379|591931178|FG000|Overall Study|disease progression during chemotherapy|5|||
163880010|NCT03161379|591931178|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
163880011|NCT03161379|591931178|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
163880012|NCT05021640|591931179|FG000|Overall Study|Lost to Follow-up|0|||
163880013|NCT05021640|591931180|FG001|Overall Study|Lost to Follow-up|0|||
163880014|NCT05021640|591931181|FG002|Overall Study|Lost to Follow-up|0|||
163880015|NCT05021640|591931182|FG003|Overall Study|Lost to Follow-up|0|||
163880016|NCT05021640|591931183|FG004|Overall Study|Lost to Follow-up|1|||
163880017|NCT03779204|591931185|FG000|Overall Study|Lost to Follow-up|2|||
163880018|NCT03779204|591931186|FG001|Overall Study|Lost to Follow-up|0|||
163880019|NCT03315754|591931187|FG000|Overall Study|COVID-19 complications leading to death|1|||
163880020|NCT03315754|591931187|FG000|Overall Study|insurance coverage issue|1|||
163880021|NCT02954341|591931188|FG000|Overall Study|Attempted Implant unsuccessful|5|||
163880022|NCT02954341|591931188|FG000|Overall Study|Death|90|||
163880023|NCT02954341|591931188|FG000|Overall Study|Withdrawal by Subject|4|||
163880024|NCT02954341|591931188|FG000|Overall Study|Physician Decision|13|||
163880025|NCT02954341|591931188|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
163880026|NCT02954341|591931188|FG000|Overall Study|Not implanted due to physician's decision|1|||
163880027|NCT02954341|591931188|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
163880028|NCT05227209|591931189|FG000|Overall Study|Adverse Event|11|||
163880029|NCT05227209|591931189|FG000|Overall Study|Lost to Follow-up|1|||
163880030|NCT05227209|591931189|FG000|Overall Study|Withdrawal by Subject|7|||
163880031|NCT05227209|591931189|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
163880032|NCT05633953|591931190|FG000|Overall Study|Adverse Event|7|||
163880033|NCT05633953|591931190|FG000|Overall Study|Death|30|||
163880034|NCT05633953|591931190|FG000|Overall Study|Lost to Follow-up|1|||
163880035|NCT05633953|591931190|FG000|Overall Study|Osilodrostat discontinued|4|||
163880036|NCT05633953|591931190|FG000|Overall Study|Physician Decision|1|||
163880037|NCT05633953|591931190|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
163880038|NCT05633953|591931190|FG000|Overall Study|Progressive disease|2|||
163880039|NCT04245501|591931192|FG000|Overall Study|Adverse Event|2|||
163880040|NCT04245501|591931193|FG001|Overall Study|Adverse Event|0|||
163880041|NCT04245501|591931192|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
163880042|NCT04245501|591931193|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
163880043|NCT05337748|591931199|FG000|Overall Study|Withdrawal by Subject|1|||
163880044|NCT05337748|591931200|FG001|Overall Study|Withdrawal by Subject|0|||
163880045|NCT05337748|591931199|FG000|Overall Study|Death|1|||
163880046|NCT05337748|591931200|FG001|Overall Study|Death|0|||
163880047|NCT02506959|591931201|FG000|Overall Study|Physician Decision|2|||
163880048|NCT02506959|591931202|FG001|Overall Study|Physician Decision|1|||
163880049|NCT04541706|591931204|FG000|Overall Study|Withdrawal by Subject|3|||
163880050|NCT04541706|591931204|FG000|Overall Study|Progressive disease|33|||
163880051|NCT04541706|591931204|FG000|Overall Study|Physician Decision|1|||
163880052|NCT04541706|591931204|FG000|Overall Study|Lost to Follow-up|2|||
163880053|NCT04541706|591931204|FG000|Overall Study|Death|5|||
163880054|NCT04541706|591931204|FG000|Overall Study|Adverse Event|1|||
163880055|NCT04812535|591931209|FG000|Overall Study|Withdrawal by Subject|0|||
163880056|NCT04812535|591931210|FG001|Overall Study|Withdrawal by Subject|0|||
163880057|NCT04812535|591931211|FG002|Overall Study|Withdrawal by Subject|0|||
163880058|NCT04812535|591931212|FG003|Overall Study|Withdrawal by Subject|1|||
163880059|NCT04812535|591931209|FG000|Overall Study|Death|7|||
163880060|NCT04812535|591931210|FG001|Overall Study|Death|2|||
163880061|NCT04812535|591931211|FG002|Overall Study|Death|4|||
163880062|NCT04812535|591931212|FG003|Overall Study|Death|1|||
163880063|NCT04812535|591931209|FG000|Overall Study|Due to premature study termination by sponsor|2|||
163880064|NCT04812535|591931210|FG001|Overall Study|Due to premature study termination by sponsor|0|||
163880065|NCT04812535|591931211|FG002|Overall Study|Due to premature study termination by sponsor|1|||
163880066|NCT04812535|591931212|FG003|Overall Study|Due to premature study termination by sponsor|3|||
163880067|NCT04401800|591931213|FG000|Overall Study|Death|17|||
163880068|NCT04401800|591931213|FG000|Overall Study|Lost to Follow-up|5|||
164224204|NCT00147537|593188583|FG003|Phase 1b|Withdrawal by Subject|0|||
164224205|NCT00147537|593188584|FG004|Phase 1b|Withdrawal by Subject|0|||
164224206|NCT00147537|593188585|FG005|Phase 1b|Withdrawal by Subject|0|||
163880069|NCT04401800|591931213|FG000|Overall Study|Withdrawal by Subject|4|||
163880070|NCT04927065|591931214|FG000|First Booster|Adverse Event|1|||
163880071|NCT04927065|591931215|FG001|First Booster|Adverse Event|0|||
164224207|NCT00147537|593188586|FG006|Phase 1b|Withdrawal by Subject|0|||
164224208|NCT00147537|593188587|FG007|Phase 1b|Withdrawal by Subject|0|||
163880072|NCT04927065|591931216|FG002|First Booster|Adverse Event|0|||
163880073|NCT04927065|591931217|FG003|First Booster|Adverse Event|0|||
163880074|NCT04927065|591931218|FG004|First Booster|Adverse Event|0|||
163880075|NCT04927065|591931219|FG005|First Booster|Adverse Event|0|||
163880076|NCT04927065|591931220|FG006|First Booster|Adverse Event|0|||
164224209|NCT00147537|593188588|FG008|Phase 1b|Withdrawal by Subject|2|||
164224210|NCT00147537|593188589|FG009|Phase 1b|Withdrawal by Subject|0|||
163880077|NCT04927065|591931221|FG007|First Booster|Adverse Event|1|||
163880078|NCT04927065|591931222|FG008|First Booster|Adverse Event|0|||
163880079|NCT04927065|591931223|FG009|First Booster|Adverse Event|0|||
163880080|NCT04927065|591931224|FG010|First Booster|Adverse Event|0|||
163880081|NCT04927065|591931225|FG011|First Booster|Adverse Event|0|||
163880082|NCT04927065|591931226|FG012|First Booster|Adverse Event|0|||
163880083|NCT04927065|591931227|FG013|First Booster|Adverse Event|0|||
163880084|NCT04927065|591931228|FG014|First Booster|Adverse Event|0|||
163880085|NCT04927065|591931229|FG015|First Booster|Adverse Event|0|||
163880086|NCT04927065|591931214|FG000|First Booster|Death|1|||
163880087|NCT04927065|591931215|FG001|First Booster|Death|0|||
163880088|NCT04927065|591931216|FG002|First Booster|Death|0|||
163880089|NCT04927065|591931217|FG003|First Booster|Death|1|||
163880090|NCT04927065|591931218|FG004|First Booster|Death|0|||
163880091|NCT04927065|591931219|FG005|First Booster|Death|1|||
163880092|NCT04927065|591931220|FG006|First Booster|Death|0|||
163880093|NCT04927065|591931221|FG007|First Booster|Death|0|||
163880094|NCT04927065|591931222|FG008|First Booster|Death|0|||
163880095|NCT04927065|591931223|FG009|First Booster|Death|0|||
163880096|NCT04927065|591931224|FG010|First Booster|Death|0|||
163880097|NCT04927065|591931225|FG011|First Booster|Death|0|||
163880098|NCT04927065|591931226|FG012|First Booster|Death|0|||
163880099|NCT04927065|591931227|FG013|First Booster|Death|0|||
163880100|NCT04927065|591931228|FG014|First Booster|Death|0|||
163880101|NCT04927065|591931229|FG015|First Booster|Death|0|||
163880102|NCT04927065|591931214|FG000|First Booster|Lost to Follow-up|8|||
163880103|NCT04927065|591931215|FG001|First Booster|Lost to Follow-up|20|||
163880104|NCT04927065|591931216|FG002|First Booster|Lost to Follow-up|0|||
163880105|NCT04927065|591931217|FG003|First Booster|Lost to Follow-up|11|||
163880106|NCT04927065|591931218|FG004|First Booster|Lost to Follow-up|43|||
163880107|NCT04927065|591931219|FG005|First Booster|Lost to Follow-up|30|||
163880108|NCT04927065|591931220|FG006|First Booster|Lost to Follow-up|28|||
163880109|NCT04927065|591931221|FG007|First Booster|Lost to Follow-up|23|||
163880110|NCT04927065|591931222|FG008|First Booster|Lost to Follow-up|4|||
163880111|NCT04927065|591931223|FG009|First Booster|Lost to Follow-up|15|||
163880112|NCT04927065|591931224|FG010|First Booster|Lost to Follow-up|0|||
163880113|NCT04927065|591931225|FG011|First Booster|Lost to Follow-up|0|||
163880114|NCT04927065|591931226|FG012|First Booster|Lost to Follow-up|0|||
163880115|NCT04927065|591931227|FG013|First Booster|Lost to Follow-up|0|||
163880116|NCT04927065|591931228|FG014|First Booster|Lost to Follow-up|0|||
163880117|NCT04927065|591931229|FG015|First Booster|Lost to Follow-up|0|||
163880118|NCT04927065|591931214|FG000|First Booster|Physician Decision|1|||
163880119|NCT04927065|591931215|FG001|First Booster|Physician Decision|0|||
163880120|NCT04927065|591931216|FG002|First Booster|Physician Decision|0|||
163880121|NCT04927065|591931217|FG003|First Booster|Physician Decision|3|||
163880122|NCT04927065|591931218|FG004|First Booster|Physician Decision|1|||
163880123|NCT04927065|591931219|FG005|First Booster|Physician Decision|1|||
163880124|NCT04927065|591931220|FG006|First Booster|Physician Decision|0|||
163880125|NCT04927065|591931221|FG007|First Booster|Physician Decision|3|||
163880126|NCT04927065|591931222|FG008|First Booster|Physician Decision|0|||
163880127|NCT04927065|591931223|FG009|First Booster|Physician Decision|0|||
163880128|NCT04927065|591931224|FG010|First Booster|Physician Decision|0|||
163880129|NCT04927065|591931225|FG011|First Booster|Physician Decision|0|||
163880130|NCT04927065|591931226|FG012|First Booster|Physician Decision|0|||
163880131|NCT04927065|591931227|FG013|First Booster|Physician Decision|0|||
163880132|NCT04927065|591931228|FG014|First Booster|Physician Decision|0|||
163880133|NCT04927065|591931229|FG015|First Booster|Physician Decision|0|||
163880134|NCT04927065|591931214|FG000|First Booster|Protocol Violation|4|||
163880135|NCT04927065|591931215|FG001|First Booster|Protocol Violation|4|||
163880136|NCT04927065|591931216|FG002|First Booster|Protocol Violation|0|||
163880137|NCT04927065|591931217|FG003|First Booster|Protocol Violation|3|||
163880138|NCT04927065|591931218|FG004|First Booster|Protocol Violation|0|||
163880139|NCT04927065|591931219|FG005|First Booster|Protocol Violation|0|||
163880140|NCT04927065|591931220|FG006|First Booster|Protocol Violation|0|||
163880141|NCT04927065|591931221|FG007|First Booster|Protocol Violation|2|||
163880142|NCT04927065|591931222|FG008|First Booster|Protocol Violation|0|||
163880143|NCT04927065|591931223|FG009|First Booster|Protocol Violation|0|||
163880144|NCT04927065|591931224|FG010|First Booster|Protocol Violation|0|||
163880145|NCT04927065|591931225|FG011|First Booster|Protocol Violation|0|||
164224211|NCT00147537|593188590|FG010|Phase 1b|Withdrawal by Subject|0|||
163880146|NCT04927065|591931226|FG012|First Booster|Protocol Violation|0|||
163880147|NCT04927065|591931227|FG013|First Booster|Protocol Violation|0|||
163880148|NCT04927065|591931228|FG014|First Booster|Protocol Violation|0|||
163880149|NCT04927065|591931229|FG015|First Booster|Protocol Violation|0|||
163880150|NCT04927065|591931214|FG000|First Booster|Withdrawal by Subject|8|||
163880151|NCT04927065|591931215|FG001|First Booster|Withdrawal by Subject|23|||
163880152|NCT04927065|591931216|FG002|First Booster|Withdrawal by Subject|0|||
163880153|NCT04927065|591931217|FG003|First Booster|Withdrawal by Subject|19|||
163880154|NCT04927065|591931218|FG004|First Booster|Withdrawal by Subject|20|||
163880155|NCT04927065|591931219|FG005|First Booster|Withdrawal by Subject|15|||
163880156|NCT04927065|591931220|FG006|First Booster|Withdrawal by Subject|6|||
163983012|NCT01046825|592308379|FG003|Overall Study|Death|1|||
163983013|NCT01046825|592308380|FG004|Overall Study|Death|0|||
163983014|NCT01046825|592308376|FG000|Overall Study|Did not submit biology samples|0|||
163983015|NCT01046825|592308377|FG001|Overall Study|Did not submit biology samples|0|||
163983016|NCT01046825|592308378|FG002|Overall Study|Did not submit biology samples|0|||
163983017|NCT01046825|592308379|FG003|Overall Study|Did not submit biology samples|0|||
163983018|NCT01046825|592308380|FG004|Overall Study|Did not submit biology samples|13|||
163983019|NCT02872311|592308384|FG000|Overall Study|Death|2|||
163983020|NCT02872311|592308385|FG001|Overall Study|Death|0|||
163983021|NCT02872311|592308386|FG002|Overall Study|Death|0|||
163983022|NCT02872311|592308387|FG003|Overall Study|Death|0|||
163983023|NCT02872311|592308388|FG004|Overall Study|Death|0|||
163983024|NCT02872311|592308384|FG000|Overall Study|Lost to Follow-up|2|||
163983025|NCT02872311|592308385|FG001|Overall Study|Lost to Follow-up|0|||
163983026|NCT02872311|592308386|FG002|Overall Study|Lost to Follow-up|0|||
163983027|NCT02872311|592308387|FG003|Overall Study|Lost to Follow-up|0|||
163983028|NCT02872311|592308388|FG004|Overall Study|Lost to Follow-up|0|||
163983029|NCT02872311|592308384|FG000|Overall Study|Protocol Violation|0|||
163983030|NCT02872311|592308385|FG001|Overall Study|Protocol Violation|2|||
163983031|NCT02872311|592308386|FG002|Overall Study|Protocol Violation|1|||
163983032|NCT02872311|592308387|FG003|Overall Study|Protocol Violation|0|||
163983033|NCT02872311|592308388|FG004|Overall Study|Protocol Violation|0|||
163983034|NCT05617911|592308389|FG000|Overall Study|Withdrawal by Subject|1|||
163983035|NCT05617911|592308390|FG001|Overall Study|Withdrawal by Subject|0|||
163983036|NCT03557359|592308391|FG000|Dose 1: 240 mg|Adverse Event|1|||
163983037|NCT03557359|592308392|FG001|Dose 1: 240 mg|Adverse Event|0|||
163983038|NCT04868903|592308393|FG000|Overall Study|Adverse Event|0|||
163983039|NCT04868903|592308394|FG001|Overall Study|Adverse Event|0|||
163983040|NCT04868903|592308395|FG002|Overall Study|Adverse Event|0|||
163983041|NCT04868903|592308396|FG003|Overall Study|Adverse Event|1|||
163983042|NCT04868903|592308393|FG000|Overall Study|Withdrawal by Subject|29|||
163983043|NCT04868903|592308394|FG001|Overall Study|Withdrawal by Subject|44|||
163983044|NCT04868903|592308395|FG002|Overall Study|Withdrawal by Subject|17|||
163983045|NCT04868903|592308396|FG003|Overall Study|Withdrawal by Subject|12|||
163983046|NCT04868903|592308393|FG000|Overall Study|Hyperparathyroidism|3|||
163983047|NCT04868903|592308394|FG001|Overall Study|Hyperparathyroidism|5|||
163983048|NCT04868903|592308395|FG002|Overall Study|Hyperparathyroidism|2|||
163983049|NCT04868903|592308396|FG003|Overall Study|Hyperparathyroidism|3|||
163983050|NCT03975647|592308397|FG000|Overall Study|Death|71|||
163983051|NCT03975647|592308398|FG001|Overall Study|Death|63|||
163983052|NCT03975647|592308397|FG000|Overall Study|Lost to Follow-up|2|||
163983053|NCT03975647|592308398|FG001|Overall Study|Lost to Follow-up|2|||
163983054|NCT03975647|592308397|FG000|Overall Study|Subject withdrawal of consent|7|||
163983055|NCT03975647|592308398|FG001|Overall Study|Subject withdrawal of consent|11|||
163983056|NCT03735667|592308399|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
163983057|NCT03735667|592308400|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
163983058|NCT03735667|592308401|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
163983059|NCT03735667|592308399|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
163983060|NCT03735667|592308400|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
164080079|NCT00863057|592657753|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
164080080|NCT00863057|592657754|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
164080081|NCT00863057|592657755|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
164080082|NCT00863057|592657752|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
164080083|NCT00863057|592657753|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
164080084|NCT00863057|592657754|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
164080085|NCT00863057|592657755|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
164080086|NCT00863057|592657752|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
164080087|NCT00863057|592657753|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
164080088|NCT00863057|592657754|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
164080089|NCT00863057|592657755|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
163983061|NCT03735667|592308401|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
163983062|NCT03735667|592308399|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
163983063|NCT03735667|592308400|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
163983064|NCT03735667|592308401|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
163983065|NCT03735667|592308399|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
163983066|NCT03735667|592308400|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
163983067|NCT03735667|592308401|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
163983068|NCT03735667|592308399|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
163983069|NCT03735667|592308400|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
163983070|NCT03735667|592308401|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
163983071|NCT03735667|592308399|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
163983072|NCT03735667|592308400|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
163983073|NCT03735667|592308401|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
163983074|NCT03735667|592308399|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
164080090|NCT00863057|592657752|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
163983075|NCT03735667|592308400|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
163983076|NCT03735667|592308401|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
163983077|NCT03735667|592308399|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
163983078|NCT03735667|592308400|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
163983079|NCT03735667|592308401|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
163983080|NCT03735667|592308399|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
163983081|NCT03735667|592308400|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
163983082|NCT03735667|592308401|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
163983083|NCT03735667|592308399|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
163983084|NCT03735667|592308400|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
163983085|NCT03735667|592308401|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
163983086|NCT03735667|592308399|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
163983087|NCT03735667|592308400|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
163983088|NCT03735667|592308401|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
163983089|NCT03735667|592308399|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
163983090|NCT03735667|592308400|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
163983091|NCT03735667|592308401|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
163983092|NCT03092726|592308402|FG000|Overall Study|Adverse Event|3|||
163983093|NCT03092726|592308403|FG001|Overall Study|Adverse Event|10|||
163983094|NCT03092726|592308402|FG000|Overall Study|Lack of Efficacy|0|||
163983095|NCT03092726|592308403|FG001|Overall Study|Lack of Efficacy|1|||
163983096|NCT03092726|592308402|FG000|Overall Study|Lost to Follow-up|1|||
163983097|NCT03092726|592308403|FG001|Overall Study|Lost to Follow-up|0|||
163983098|NCT03092726|592308402|FG000|Overall Study|Withdrawal by Subject|5|||
163983099|NCT03092726|592308403|FG001|Overall Study|Withdrawal by Subject|3|||
163983100|NCT02296242|592308411|FG000|Overall Study|Death|1|||
163983101|NCT02296242|592308412|FG001|Overall Study|Death|1|||
163983102|NCT02296242|592308413|FG002|Overall Study|Death|1|||
163983103|NCT02296242|592308414|FG003|Overall Study|Death|1|||
163983104|NCT02296242|592308415|FG004|Overall Study|Death|1|||
163983105|NCT02296242|592308411|FG000|Overall Study|Withdrawal by Subject|0|||
163983106|NCT02296242|592308412|FG001|Overall Study|Withdrawal by Subject|0|||
163983107|NCT02296242|592308413|FG002|Overall Study|Withdrawal by Subject|1|||
163983108|NCT02296242|592308414|FG003|Overall Study|Withdrawal by Subject|1|||
163983109|NCT02296242|592308415|FG004|Overall Study|Withdrawal by Subject|3|||
163983110|NCT02296242|592308411|FG000|Overall Study|Disease Progression|1|||
163983111|NCT02296242|592308412|FG001|Overall Study|Disease Progression|3|||
163983112|NCT02296242|592308413|FG002|Overall Study|Disease Progression|2|||
163983113|NCT02296242|592308414|FG003|Overall Study|Disease Progression|8|||
163983114|NCT02296242|592308415|FG004|Overall Study|Disease Progression|11|||
163983115|NCT02296242|592308411|FG000|Overall Study|Unacceptable Toxicity|0|||
163983116|NCT02296242|592308412|FG001|Overall Study|Unacceptable Toxicity|0|||
163983117|NCT02296242|592308413|FG002|Overall Study|Unacceptable Toxicity|0|||
164080091|NCT00863057|592657753|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
164080092|NCT00863057|592657754|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
164080093|NCT00863057|592657755|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
164080094|NCT02087046|592657759|FG000|Overall Study|Adverse Event|4|||
164080095|NCT02087046|592657759|FG000|Overall Study|Death|1|||
164080096|NCT02087046|592657759|FG000|Overall Study|Lost to Follow-up|3|||
164080097|NCT02087046|592657759|FG000|Overall Study|Withdrawal by Subject|2|||
164080098|NCT02087046|592657759|FG000|Overall Study|Physician Decision|1|||
164080099|NCT02444533|592657760|FG000|Overall Study|Not able to complete forms|0|||
164080100|NCT02444533|592657761|FG001|Overall Study|Not able to complete forms|2|||
164080101|NCT02444533|592657760|FG000|Overall Study|Only gave post-procedure complications|2|||
164080102|NCT02444533|592657761|FG001|Overall Study|Only gave post-procedure complications|2|||
164080103|NCT02974114|592657764|FG000|Overall Study|Other (Not specified)|0|||
164080104|NCT02974114|592657765|FG001|Overall Study|Other (Not specified)|1|||
164080105|NCT02974114|592657766|FG002|Overall Study|Other (Not specified)|2|||
164080106|NCT00545233|592657769|FG000|Overall Study|Adverse Event|10|||
163983118|NCT02296242|592308414|FG003|Overall Study|Unacceptable Toxicity|0|||
163983119|NCT02296242|592308415|FG004|Overall Study|Unacceptable Toxicity|1|||
163983120|NCT02296242|592308411|FG000|Overall Study|Patient Condition Changed|0|||
163983121|NCT02296242|592308412|FG001|Overall Study|Patient Condition Changed|0|||
163983122|NCT02296242|592308413|FG002|Overall Study|Patient Condition Changed|2|||
163983123|NCT02296242|592308414|FG003|Overall Study|Patient Condition Changed|0|||
163983124|NCT02296242|592308415|FG004|Overall Study|Patient Condition Changed|1|||
163983125|NCT02296242|592308411|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
163983126|NCT02296242|592308412|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
163983127|NCT02296242|592308413|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
164080107|NCT00545233|592657770|FG001|Overall Study|Adverse Event|5|||
164080108|NCT00545233|592657769|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
164080109|NCT00545233|592657770|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164080110|NCT00545233|592657769|FG000|Overall Study|Protocol Violation|2|||
164080111|NCT00545233|592657770|FG001|Overall Study|Protocol Violation|0|||
163983128|NCT02296242|592308414|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
163983129|NCT02296242|592308415|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
163983130|NCT02296242|592308411|FG000|Overall Study|Lost to Follow-up|1|||
163983131|NCT02296242|592308412|FG001|Overall Study|Lost to Follow-up|0|||
163983132|NCT02296242|592308413|FG002|Overall Study|Lost to Follow-up|0|||
163983133|NCT02296242|592308414|FG003|Overall Study|Lost to Follow-up|0|||
163983134|NCT02296242|592308415|FG004|Overall Study|Lost to Follow-up|0|||
163983135|NCT02296242|592308411|FG000|Overall Study|Need for Hydroxyurea|2|||
163983136|NCT02296242|592308412|FG001|Overall Study|Need for Hydroxyurea|0|||
163983137|NCT02296242|592308413|FG002|Overall Study|Need for Hydroxyurea|0|||
163983138|NCT02296242|592308414|FG003|Overall Study|Need for Hydroxyurea|0|||
163983139|NCT02296242|592308415|FG004|Overall Study|Need for Hydroxyurea|0|||
163983140|NCT02296242|592308411|FG000|Overall Study|Screened for Other Protocol|0|||
163983141|NCT02296242|592308412|FG001|Overall Study|Screened for Other Protocol|1|||
163983142|NCT02296242|592308413|FG002|Overall Study|Screened for Other Protocol|0|||
163983143|NCT02296242|592308414|FG003|Overall Study|Screened for Other Protocol|0|||
163983144|NCT02296242|592308415|FG004|Overall Study|Screened for Other Protocol|0|||
163983145|NCT02296242|592308411|FG000|Overall Study|Physician Decision|0|||
163983146|NCT02296242|592308412|FG001|Overall Study|Physician Decision|1|||
163983147|NCT02296242|592308413|FG002|Overall Study|Physician Decision|0|||
163983148|NCT02296242|592308414|FG003|Overall Study|Physician Decision|1|||
163983149|NCT02296242|592308415|FG004|Overall Study|Physician Decision|0|||
163983150|NCT02296242|592308411|FG000|Overall Study|Alternative Treatment|0|||
163983151|NCT02296242|592308412|FG001|Overall Study|Alternative Treatment|0|||
163983152|NCT02296242|592308413|FG002|Overall Study|Alternative Treatment|0|||
163983153|NCT02296242|592308414|FG003|Overall Study|Alternative Treatment|1|||
163983154|NCT02296242|592308415|FG004|Overall Study|Alternative Treatment|0|||
163983155|NCT02296242|592308411|FG000|Overall Study|Adverse Event|0|||
163983156|NCT02296242|592308412|FG001|Overall Study|Adverse Event|0|||
163983157|NCT02296242|592308413|FG002|Overall Study|Adverse Event|0|||
163983158|NCT02296242|592308414|FG003|Overall Study|Adverse Event|1|||
163983159|NCT02296242|592308415|FG004|Overall Study|Adverse Event|0|||
163983160|NCT02296242|592308411|FG000|Overall Study|Lack of Efficacy|0|||
163983161|NCT02296242|592308412|FG001|Overall Study|Lack of Efficacy|0|||
163983162|NCT02296242|592308413|FG002|Overall Study|Lack of Efficacy|0|||
163983163|NCT02296242|592308414|FG003|Overall Study|Lack of Efficacy|0|||
163983164|NCT02296242|592308415|FG004|Overall Study|Lack of Efficacy|3|||
163983165|NCT01290692|592308421|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
163983166|NCT02780648|592308422|FG000|Overall Study|Disease Progression|1|||
163983167|NCT02780648|592308423|FG001|Overall Study|Disease Progression|0|||
163983168|NCT01110200|592308432|FG000|Overall Study|Adverse Event|28|||
163983169|NCT01110200|592308433|FG001|Overall Study|Adverse Event|28|||
163983170|NCT01110200|592308432|FG000|Overall Study|Withdrawal by Subject|25|||
163983171|NCT01110200|592308433|FG001|Overall Study|Withdrawal by Subject|32|||
163983172|NCT01110200|592308432|FG000|Overall Study|Lack of Efficacy|16|||
163983173|NCT01110200|592308433|FG001|Overall Study|Lack of Efficacy|25|||
163983174|NCT01110200|592308432|FG000|Overall Study|Protocol Violation|14|||
163983175|NCT01110200|592308433|FG001|Overall Study|Protocol Violation|12|||
163983176|NCT01110200|592308432|FG000|Overall Study|Physician Decision|13|||
163983177|NCT01110200|592308433|FG001|Overall Study|Physician Decision|17|||
163983178|NCT01110200|592308432|FG000|Overall Study|Lost to Follow-up|10|||
163983179|NCT01110200|592308433|FG001|Overall Study|Lost to Follow-up|7|||
163983180|NCT00903175|592308434|FG000|Period 1 - First Line|Adverse Event|36|||
164224212|NCT00147537|593188580|FG000|Phase 1b|Randomized but not treated|0|||
164224213|NCT00147537|593188581|FG001|Phase 1b|Randomized but not treated|0|||
164224214|NCT00147537|593188582|FG002|Phase 1b|Randomized but not treated|0|||
164224215|NCT00147537|593188583|FG003|Phase 1b|Randomized but not treated|0|||
164224216|NCT00147537|593188584|FG004|Phase 1b|Randomized but not treated|0|||
164224217|NCT00147537|593188585|FG005|Phase 1b|Randomized but not treated|0|||
164224218|NCT00147537|593188586|FG006|Phase 1b|Randomized but not treated|1|||
164224219|NCT00147537|593188587|FG007|Phase 1b|Randomized but not treated|0|||
164329137|NCT01888003|593581330|FG002|Overall Study|Study Terminated|40|||
163983181|NCT00903175|592308435|FG001|Period 1 - First Line|Adverse Event|50|||
163983182|NCT00903175|592308434|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
163983183|NCT00903175|592308435|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
163983184|NCT00903175|592308434|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
163983185|NCT00903175|592308435|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
163983186|NCT00903175|592308434|FG000|Period 1 - First Line|Protocol Violation|3|||
163983187|NCT00903175|592308435|FG001|Period 1 - First Line|Protocol Violation|3|||
163983188|NCT00903175|592308434|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
163983189|NCT00903175|592308435|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
163983190|NCT00903175|592308434|FG000|Period 1 - First Line|Administrative problems|12|||
163983191|NCT00903175|592308435|FG001|Period 1 - First Line|Administrative problems|13|||
163983192|NCT00903175|592308434|FG000|Period 1 - First Line|Death|17|||
163983193|NCT00903175|592308435|FG001|Period 1 - First Line|Death|10|||
163983194|NCT00903175|592308434|FG000|Period 2 - Second Line|Missing|1|||
164329138|NCT03187756|593581331|FG000|Overall Study|Termination of study|4|||
164224220|NCT00147537|593188588|FG008|Phase 1b|Randomized but not treated|1|||
164224221|NCT00147537|593188589|FG009|Phase 1b|Randomized but not treated|0|||
164224222|NCT00147537|593188590|FG010|Phase 1b|Randomized but not treated|0|||
164224223|NCT00147537|593188580|FG000|Phase 2|Death|0|||
164224224|NCT00147537|593188581|FG001|Phase 2|Death|0|||
164224225|NCT00147537|593188582|FG002|Phase 2|Death|0|||
164224226|NCT00147537|593188583|FG003|Phase 2|Death|0|||
164224227|NCT00147537|593188584|FG004|Phase 2|Death|0|||
164224228|NCT00147537|593188585|FG005|Phase 2|Death|0|||
164224229|NCT00147537|593188586|FG006|Phase 2|Death|0|||
164224230|NCT00147537|593188587|FG007|Phase 2|Death|0|||
164224231|NCT00147537|593188588|FG008|Phase 2|Death|0|||
164224232|NCT00147537|593188589|FG009|Phase 2|Death|85|||
164224233|NCT00147537|593188590|FG010|Phase 2|Death|31|||
164224234|NCT00147537|593188580|FG000|Phase 2|Lost to Follow-up|0|||
164224235|NCT00147537|593188581|FG001|Phase 2|Lost to Follow-up|0|||
164224236|NCT00147537|593188582|FG002|Phase 2|Lost to Follow-up|0|||
164224237|NCT00147537|593188583|FG003|Phase 2|Lost to Follow-up|0|||
164224238|NCT00147537|593188584|FG004|Phase 2|Lost to Follow-up|0|||
164224239|NCT00147537|593188585|FG005|Phase 2|Lost to Follow-up|0|||
164224240|NCT00147537|593188586|FG006|Phase 2|Lost to Follow-up|0|||
164224241|NCT00147537|593188587|FG007|Phase 2|Lost to Follow-up|0|||
163880157|NCT04927065|591931221|FG007|First Booster|Withdrawal by Subject|24|||
163880158|NCT04927065|591931222|FG008|First Booster|Withdrawal by Subject|0|||
163880159|NCT04927065|591931223|FG009|First Booster|Withdrawal by Subject|4|||
163880160|NCT04927065|591931224|FG010|First Booster|Withdrawal by Subject|0|||
163880161|NCT04927065|591931225|FG011|First Booster|Withdrawal by Subject|0|||
163880162|NCT04927065|591931226|FG012|First Booster|Withdrawal by Subject|0|||
164224242|NCT00147537|593188588|FG008|Phase 2|Lost to Follow-up|0|||
164224243|NCT00147537|593188589|FG009|Phase 2|Lost to Follow-up|12|||
163880163|NCT04927065|591931227|FG013|First Booster|Withdrawal by Subject|0|||
163880164|NCT04927065|591931228|FG014|First Booster|Withdrawal by Subject|0|||
163880165|NCT04927065|591931229|FG015|First Booster|Withdrawal by Subject|0|||
163880166|NCT04927065|591931214|FG000|First Booster|Other Than Specified|1|||
163880167|NCT04927065|591931215|FG001|First Booster|Other Than Specified|1|||
163880168|NCT04927065|591931216|FG002|First Booster|Other Than Specified|0|||
163880169|NCT04927065|591931217|FG003|First Booster|Other Than Specified|1|||
163880170|NCT04927065|591931218|FG004|First Booster|Other Than Specified|2|||
163880171|NCT04927065|591931219|FG005|First Booster|Other Than Specified|3|||
163880172|NCT04927065|591931220|FG006|First Booster|Other Than Specified|2|||
163880173|NCT04927065|591931221|FG007|First Booster|Other Than Specified|6|||
163880174|NCT04927065|591931222|FG008|First Booster|Other Than Specified|0|||
163880175|NCT04927065|591931223|FG009|First Booster|Other Than Specified|4|||
163880176|NCT04927065|591931224|FG010|First Booster|Other Than Specified|0|||
163880177|NCT04927065|591931225|FG011|First Booster|Other Than Specified|0|||
163880178|NCT04927065|591931226|FG012|First Booster|Other Than Specified|0|||
163880179|NCT04927065|591931227|FG013|First Booster|Other Than Specified|0|||
163880180|NCT04927065|591931228|FG014|First Booster|Other Than Specified|0|||
163880181|NCT04927065|591931229|FG015|First Booster|Other Than Specified|0|||
163880182|NCT04927065|591931214|FG000|Second Booster|Death|0|||
163880183|NCT04927065|591931215|FG001|Second Booster|Death|0|||
163880184|NCT04927065|591931216|FG002|Second Booster|Death|0|||
163880185|NCT04927065|591931217|FG003|Second Booster|Death|0|||
164224244|NCT00147537|593188590|FG010|Phase 2|Lost to Follow-up|4|||
164224245|NCT00147537|593188580|FG000|Phase 2|Other|0|||
164224246|NCT00147537|593188581|FG001|Phase 2|Other|0|||
164224247|NCT00147537|593188582|FG002|Phase 2|Other|0|||
164224248|NCT00147537|593188583|FG003|Phase 2|Other|0|||
164224249|NCT00147537|593188584|FG004|Phase 2|Other|0|||
164224250|NCT00147537|593188585|FG005|Phase 2|Other|0|||
164224251|NCT00147537|593188586|FG006|Phase 2|Other|0|||
164224252|NCT00147537|593188587|FG007|Phase 2|Other|0|||
164224253|NCT00147537|593188588|FG008|Phase 2|Other|0|||
164224254|NCT00147537|593188589|FG009|Phase 2|Other|47|||
164224255|NCT00147537|593188590|FG010|Phase 2|Other|12|||
164224256|NCT00147537|593188580|FG000|Phase 2|Withdrawal by Subject|0|||
164224257|NCT00147537|593188581|FG001|Phase 2|Withdrawal by Subject|0|||
164224258|NCT00147537|593188582|FG002|Phase 2|Withdrawal by Subject|0|||
163880186|NCT04927065|591931218|FG004|Second Booster|Death|0|||
163880187|NCT04927065|591931219|FG005|Second Booster|Death|0|||
163880188|NCT04927065|591931220|FG006|Second Booster|Death|0|||
163880189|NCT04927065|591931221|FG007|Second Booster|Death|0|||
163880190|NCT04927065|591931222|FG008|Second Booster|Death|0|||
163880191|NCT04927065|591931223|FG009|Second Booster|Death|0|||
163880192|NCT04927065|591931224|FG010|Second Booster|Death|2|||
164224259|NCT00147537|593188583|FG003|Phase 2|Withdrawal by Subject|0|||
164224260|NCT00147537|593188584|FG004|Phase 2|Withdrawal by Subject|0|||
164224261|NCT00147537|593188585|FG005|Phase 2|Withdrawal by Subject|0|||
164224262|NCT00147537|593188586|FG006|Phase 2|Withdrawal by Subject|0|||
164224263|NCT00147537|593188587|FG007|Phase 2|Withdrawal by Subject|0|||
164224264|NCT00147537|593188588|FG008|Phase 2|Withdrawal by Subject|0|||
164224265|NCT00147537|593188589|FG009|Phase 2|Withdrawal by Subject|16|||
164224266|NCT00147537|593188590|FG010|Phase 2|Withdrawal by Subject|4|||
164224267|NCT00147537|593188580|FG000|Phase 2|Randomized but not treated|0|||
164224268|NCT00147537|593188581|FG001|Phase 2|Randomized but not treated|0|||
164224269|NCT00147537|593188582|FG002|Phase 2|Randomized but not treated|0|||
164224270|NCT00147537|593188583|FG003|Phase 2|Randomized but not treated|0|||
164224271|NCT00147537|593188584|FG004|Phase 2|Randomized but not treated|0|||
164224272|NCT00147537|593188585|FG005|Phase 2|Randomized but not treated|0|||
164224273|NCT00147537|593188586|FG006|Phase 2|Randomized but not treated|0|||
164224274|NCT00147537|593188587|FG007|Phase 2|Randomized but not treated|0|||
164224275|NCT00147537|593188588|FG008|Phase 2|Randomized but not treated|0|||
164224276|NCT00147537|593188589|FG009|Phase 2|Randomized but not treated|1|||
164224277|NCT00147537|593188590|FG010|Phase 2|Randomized but not treated|1|||
164224278|NCT02191397|593188591|FG000|Overall Study|Adverse Event|28|||
164224279|NCT02191397|593188592|FG001|Overall Study|Adverse Event|17|||
164224280|NCT02191397|593188591|FG000|Overall Study|Lack of Efficacy|10|||
164224281|NCT02191397|593188592|FG001|Overall Study|Lack of Efficacy|5|||
164224282|NCT02191397|593188591|FG000|Overall Study|Protocol Violation|0|||
163880193|NCT04927065|591931225|FG011|Second Booster|Death|0|||
163880194|NCT04927065|591931226|FG012|Second Booster|Death|2|||
163880195|NCT04927065|591931227|FG013|Second Booster|Death|2|||
163880196|NCT04927065|591931228|FG014|Second Booster|Death|0|||
163880197|NCT04927065|591931229|FG015|Second Booster|Death|0|||
163880198|NCT04927065|591931214|FG000|Second Booster|Lost to Follow-up|0|||
163880199|NCT04927065|591931215|FG001|Second Booster|Lost to Follow-up|0|||
163880200|NCT04927065|591931216|FG002|Second Booster|Lost to Follow-up|3|||
163880201|NCT04927065|591931217|FG003|Second Booster|Lost to Follow-up|0|||
163880202|NCT04927065|591931218|FG004|Second Booster|Lost to Follow-up|0|||
163880203|NCT04927065|591931219|FG005|Second Booster|Lost to Follow-up|0|||
163880204|NCT04927065|591931220|FG006|Second Booster|Lost to Follow-up|0|||
163880205|NCT04927065|591931221|FG007|Second Booster|Lost to Follow-up|0|||
163880206|NCT04927065|591931222|FG008|Second Booster|Lost to Follow-up|0|||
163880207|NCT04927065|591931223|FG009|Second Booster|Lost to Follow-up|0|||
163880208|NCT04927065|591931224|FG010|Second Booster|Lost to Follow-up|14|||
163880209|NCT04927065|591931225|FG011|Second Booster|Lost to Follow-up|10|||
163880210|NCT04927065|591931226|FG012|Second Booster|Lost to Follow-up|13|||
163880211|NCT04927065|591931227|FG013|Second Booster|Lost to Follow-up|16|||
163880212|NCT04927065|591931228|FG014|Second Booster|Lost to Follow-up|0|||
163880213|NCT04927065|591931229|FG015|Second Booster|Lost to Follow-up|0|||
163880214|NCT04927065|591931214|FG000|Second Booster|Physician Decision|0|||
163880215|NCT04927065|591931215|FG001|Second Booster|Physician Decision|0|||
163880216|NCT04927065|591931216|FG002|Second Booster|Physician Decision|0|||
163880217|NCT04927065|591931217|FG003|Second Booster|Physician Decision|0|||
163880218|NCT04927065|591931218|FG004|Second Booster|Physician Decision|0|||
163880219|NCT04927065|591931219|FG005|Second Booster|Physician Decision|0|||
163880220|NCT04927065|591931220|FG006|Second Booster|Physician Decision|0|||
163880221|NCT04927065|591931221|FG007|Second Booster|Physician Decision|0|||
163880222|NCT04927065|591931222|FG008|Second Booster|Physician Decision|0|||
163880223|NCT04927065|591931223|FG009|Second Booster|Physician Decision|0|||
163880224|NCT04927065|591931224|FG010|Second Booster|Physician Decision|0|||
163880225|NCT04927065|591931225|FG011|Second Booster|Physician Decision|3|||
163880226|NCT04927065|591931226|FG012|Second Booster|Physician Decision|0|||
163880227|NCT04927065|591931227|FG013|Second Booster|Physician Decision|1|||
163880228|NCT04927065|591931228|FG014|Second Booster|Physician Decision|0|||
163880229|NCT04927065|591931229|FG015|Second Booster|Physician Decision|0|||
163880230|NCT04927065|591931214|FG000|Second Booster|Withdrawal by Subject|0|||
163880231|NCT04927065|591931215|FG001|Second Booster|Withdrawal by Subject|0|||
163880232|NCT04927065|591931216|FG002|Second Booster|Withdrawal by Subject|4|||
163880233|NCT04927065|591931217|FG003|Second Booster|Withdrawal by Subject|0|||
163880234|NCT04927065|591931218|FG004|Second Booster|Withdrawal by Subject|0|||
163880235|NCT04927065|591931219|FG005|Second Booster|Withdrawal by Subject|0|||
163880236|NCT04927065|591931220|FG006|Second Booster|Withdrawal by Subject|0|||
163880237|NCT04927065|591931221|FG007|Second Booster|Withdrawal by Subject|0|||
163880238|NCT04927065|591931222|FG008|Second Booster|Withdrawal by Subject|0|||
163880239|NCT04927065|591931223|FG009|Second Booster|Withdrawal by Subject|0|||
163880240|NCT04927065|591931224|FG010|Second Booster|Withdrawal by Subject|3|||
163880241|NCT04927065|591931225|FG011|Second Booster|Withdrawal by Subject|16|||
163880242|NCT04927065|591931226|FG012|Second Booster|Withdrawal by Subject|13|||
163880243|NCT04927065|591931227|FG013|Second Booster|Withdrawal by Subject|9|||
163880244|NCT04927065|591931228|FG014|Second Booster|Withdrawal by Subject|0|||
163880245|NCT04927065|591931229|FG015|Second Booster|Withdrawal by Subject|0|||
163880246|NCT04927065|591931214|FG000|Second Booster|Other Than Specified|0|||
163880247|NCT04927065|591931215|FG001|Second Booster|Other Than Specified|0|||
163880248|NCT04927065|591931216|FG002|Second Booster|Other Than Specified|0|||
163880249|NCT04927065|591931217|FG003|Second Booster|Other Than Specified|0|||
163880250|NCT04927065|591931218|FG004|Second Booster|Other Than Specified|0|||
163880251|NCT04927065|591931219|FG005|Second Booster|Other Than Specified|0|||
163880252|NCT04927065|591931220|FG006|Second Booster|Other Than Specified|0|||
163880253|NCT04927065|591931221|FG007|Second Booster|Other Than Specified|0|||
164224283|NCT02191397|593188592|FG001|Overall Study|Protocol Violation|3|||
164224284|NCT02191397|593188591|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
164329139|NCT00323869|593581334|FG000|Overall Study|Death|1|||
163983195|NCT00903175|592308435|FG001|Period 2 - Second Line|Missing|0|||
163983196|NCT00903175|592308434|FG000|Period 2 - Second Line|Adverse Event|16|||
163983197|NCT00903175|592308435|FG001|Period 2 - Second Line|Adverse Event|20|||
163983198|NCT00903175|592308434|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
163983199|NCT00903175|592308435|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
163983200|NCT00903175|592308434|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
163983201|NCT00903175|592308435|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
163983202|NCT00903175|592308434|FG000|Period 2 - Second Line|Administrative problems|19|||
163983203|NCT00903175|592308435|FG001|Period 2 - Second Line|Administrative problems|9|||
163983204|NCT00903175|592308434|FG000|Period 2 - Second Line|Death|5|||
163983205|NCT00903175|592308435|FG001|Period 2 - Second Line|Death|2|||
163983206|NCT03074474|592308438|FG000|Overall Study|Lost to Follow-up|10|||
163983207|NCT03074474|592308438|FG000|Overall Study|Withdrawal by Subject|10|||
163983208|NCT03074474|592308438|FG000|Overall Study|Death|4|||
163983209|NCT03074474|592308438|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
163983210|NCT00371865|592308441|FG000|Overall Study|Lack of Efficacy|0|||
163983211|NCT00371865|592308442|FG001|Overall Study|Lack of Efficacy|2|||
163983212|NCT00371865|592308441|FG000|Overall Study|Protocol Violation|3|||
163983213|NCT00371865|592308442|FG001|Overall Study|Protocol Violation|2|||
163983214|NCT00371865|592308441|FG000|Overall Study|Withdrawal by Subject|12|||
163983215|NCT00371865|592308442|FG001|Overall Study|Withdrawal by Subject|10|||
163983216|NCT05073458|592308449|FG000|24-week Double-blind Period|Adverse Event|1|||
163983217|NCT05073458|592308450|FG001|24-week Double-blind Period|Adverse Event|0|||
163983218|NCT05073458|592308449|FG000|24-week Double-blind Period|Physician Decision|1|||
163983219|NCT05073458|592308450|FG001|24-week Double-blind Period|Physician Decision|0|||
163983220|NCT05073458|592308449|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
163983221|NCT05073458|592308450|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
163983222|NCT05073458|592308449|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
163983223|NCT05073458|592308450|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
163983224|NCT05073458|592308449|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
163983225|NCT05073458|592308450|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
163983226|NCT05073458|592308449|FG000|24-week Open-label Period|Adverse Event|1|||
163983227|NCT05073458|592308450|FG001|24-week Open-label Period|Adverse Event|2|||
163983228|NCT05913232|592308458|FG000|Overall Study|Adverse Event|0|||
163983229|NCT05913232|592308459|FG001|Overall Study|Adverse Event|2|||
163983230|NCT05913232|592308460|FG002|Overall Study|Adverse Event|1|||
163983231|NCT05913232|592308461|FG003|Overall Study|Adverse Event|1|||
163983232|NCT05103332|592308462|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983233|NCT05103332|592308463|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
163983234|NCT05103332|592308464|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
163983235|NCT05103332|592308465|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983236|NCT05103332|592308466|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983237|NCT05103332|592308467|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
163983238|NCT05103332|592308468|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983239|NCT05103332|592308469|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983240|NCT05103332|592308470|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983241|NCT05103332|592308471|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983242|NCT05103332|592308472|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983243|NCT05103332|592308473|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983244|NCT05103332|592308474|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983245|NCT05103332|592308475|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983246|NCT05103332|592308476|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983247|NCT05103332|592308477|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983248|NCT05103332|592308478|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983249|NCT05103332|592308479|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983250|NCT05103332|592308462|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983251|NCT05103332|592308463|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
163983252|NCT05103332|592308464|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983253|NCT05103332|592308465|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
163983254|NCT05103332|592308466|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983255|NCT05103332|592308467|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983256|NCT05103332|592308468|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983257|NCT05103332|592308469|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983258|NCT05103332|592308470|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983259|NCT05103332|592308471|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983260|NCT05103332|592308472|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983261|NCT05103332|592308473|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983262|NCT05103332|592308474|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983263|NCT05103332|592308475|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983264|NCT05103332|592308476|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983265|NCT05103332|592308477|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983266|NCT05103332|592308478|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983267|NCT05103332|592308479|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
163983268|NCT05103332|592308462|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
163983269|NCT05103332|592308463|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163983270|NCT05103332|592308464|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
163880254|NCT04927065|591931222|FG008|Second Booster|Other Than Specified|0|||
163880255|NCT04927065|591931223|FG009|Second Booster|Other Than Specified|0|||
163880256|NCT04927065|591931224|FG010|Second Booster|Other Than Specified|1|||
163880257|NCT04927065|591931225|FG011|Second Booster|Other Than Specified|1|||
163880258|NCT04927065|591931226|FG012|Second Booster|Other Than Specified|4|||
163880259|NCT04927065|591931227|FG013|Second Booster|Other Than Specified|0|||
163880260|NCT04927065|591931228|FG014|Second Booster|Other Than Specified|0|||
163880261|NCT04927065|591931229|FG015|Second Booster|Other Than Specified|0|||
163880262|NCT04927065|591931214|FG000|Third Booster|Lost to Follow-up|0|||
163880263|NCT04927065|591931215|FG001|Third Booster|Lost to Follow-up|0|||
163880264|NCT04927065|591931216|FG002|Third Booster|Lost to Follow-up|0|||
163880265|NCT04927065|591931217|FG003|Third Booster|Lost to Follow-up|0|||
163880266|NCT04927065|591931218|FG004|Third Booster|Lost to Follow-up|0|||
163880267|NCT04927065|591931219|FG005|Third Booster|Lost to Follow-up|0|||
163880268|NCT04927065|591931220|FG006|Third Booster|Lost to Follow-up|0|||
163880269|NCT04927065|591931221|FG007|Third Booster|Lost to Follow-up|0|||
163880270|NCT04927065|591931222|FG008|Third Booster|Lost to Follow-up|0|||
163880271|NCT04927065|591931223|FG009|Third Booster|Lost to Follow-up|0|||
163880272|NCT04927065|591931224|FG010|Third Booster|Lost to Follow-up|0|||
163880273|NCT04927065|591931225|FG011|Third Booster|Lost to Follow-up|0|||
163880274|NCT04927065|591931226|FG012|Third Booster|Lost to Follow-up|0|||
163880275|NCT04927065|591931227|FG013|Third Booster|Lost to Follow-up|0|||
163880276|NCT04927065|591931228|FG014|Third Booster|Lost to Follow-up|0|||
163880277|NCT04927065|591931229|FG015|Third Booster|Lost to Follow-up|1|||
163880278|NCT04927065|591931214|FG000|Third Booster|Withdrawal by Subject|0|||
163880279|NCT04927065|591931215|FG001|Third Booster|Withdrawal by Subject|0|||
163880280|NCT04927065|591931216|FG002|Third Booster|Withdrawal by Subject|0|||
163880281|NCT04927065|591931217|FG003|Third Booster|Withdrawal by Subject|0|||
163880282|NCT04927065|591931218|FG004|Third Booster|Withdrawal by Subject|0|||
163880283|NCT04927065|591931219|FG005|Third Booster|Withdrawal by Subject|0|||
163880284|NCT04927065|591931220|FG006|Third Booster|Withdrawal by Subject|0|||
163880285|NCT04927065|591931221|FG007|Third Booster|Withdrawal by Subject|0|||
163880286|NCT04927065|591931222|FG008|Third Booster|Withdrawal by Subject|0|||
163880287|NCT04927065|591931223|FG009|Third Booster|Withdrawal by Subject|0|||
163880288|NCT04927065|591931224|FG010|Third Booster|Withdrawal by Subject|0|||
163880289|NCT04927065|591931225|FG011|Third Booster|Withdrawal by Subject|0|||
163983271|NCT05103332|592308465|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163983272|NCT05103332|592308466|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163983273|NCT05103332|592308467|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
163983274|NCT05103332|592308468|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983275|NCT05103332|592308469|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983276|NCT05103332|592308470|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983277|NCT05103332|592308471|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983278|NCT05103332|592308472|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983279|NCT05103332|592308473|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983280|NCT05103332|592308474|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983281|NCT05103332|592308475|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983282|NCT05103332|592308476|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983283|NCT05103332|592308477|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983284|NCT05103332|592308478|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983285|NCT05103332|592308479|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983286|NCT05103332|592308462|FG000|DB Period (6 Months=168 Days)|Other|0|||
163983287|NCT05103332|592308463|FG001|DB Period (6 Months=168 Days)|Other|0|||
163983288|NCT05103332|592308464|FG002|DB Period (6 Months=168 Days)|Other|0|||
163983289|NCT05103332|592308465|FG003|DB Period (6 Months=168 Days)|Other|1|||
163983290|NCT05103332|592308466|FG004|DB Period (6 Months=168 Days)|Other|0|||
163983291|NCT05103332|592308467|FG005|DB Period (6 Months=168 Days)|Other|0|||
163983292|NCT05103332|592308468|FG006|DB Period (6 Months=168 Days)|Other|0|||
163983293|NCT05103332|592308469|FG007|DB Period (6 Months=168 Days)|Other|0|||
163983294|NCT05103332|592308470|FG008|DB Period (6 Months=168 Days)|Other|0|||
163983295|NCT05103332|592308471|FG009|DB Period (6 Months=168 Days)|Other|0|||
163880290|NCT04927065|591931226|FG012|Third Booster|Withdrawal by Subject|0|||
163880291|NCT04927065|591931227|FG013|Third Booster|Withdrawal by Subject|0|||
163880292|NCT04927065|591931228|FG014|Third Booster|Withdrawal by Subject|0|||
163880293|NCT04927065|591931229|FG015|Third Booster|Withdrawal by Subject|1|||
163983296|NCT05103332|592308472|FG010|DB Period (6 Months=168 Days)|Other|0|||
163983297|NCT05103332|592308473|FG011|DB Period (6 Months=168 Days)|Other|0|||
163983298|NCT05103332|592308474|FG012|DB Period (6 Months=168 Days)|Other|0|||
163983299|NCT05103332|592308475|FG013|DB Period (6 Months=168 Days)|Other|0|||
163983300|NCT05103332|592308476|FG014|DB Period (6 Months=168 Days)|Other|0|||
163983301|NCT05103332|592308477|FG015|DB Period (6 Months=168 Days)|Other|0|||
163983302|NCT05103332|592308478|FG016|DB Period (6 Months=168 Days)|Other|0|||
163983303|NCT05103332|592308479|FG017|DB Period (6 Months=168 Days)|Other|0|||
163983304|NCT05103332|592308462|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983305|NCT05103332|592308463|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983306|NCT05103332|592308464|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983307|NCT05103332|592308465|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983308|NCT05103332|592308466|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983309|NCT05103332|592308467|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983310|NCT05103332|592308468|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983311|NCT05103332|592308469|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983312|NCT05103332|592308470|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983313|NCT05103332|592308471|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983314|NCT05103332|592308472|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
163983315|NCT05103332|592308473|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983316|NCT05103332|592308474|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983317|NCT05103332|592308475|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983318|NCT05103332|592308476|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983319|NCT05103332|592308477|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983320|NCT05103332|592308478|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983321|NCT05103332|592308479|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
163983322|NCT05103332|592308462|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983323|NCT05103332|592308463|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983324|NCT05103332|592308464|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983325|NCT05103332|592308465|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983326|NCT05103332|592308466|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983327|NCT05103332|592308467|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983328|NCT05103332|592308468|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983329|NCT05103332|592308469|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983330|NCT05103332|592308470|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
163983331|NCT05103332|592308471|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983332|NCT05103332|592308472|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983333|NCT05103332|592308473|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983334|NCT05103332|592308474|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983335|NCT05103332|592308475|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983336|NCT05103332|592308476|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983337|NCT05103332|592308477|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983338|NCT05103332|592308478|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983339|NCT05103332|592308479|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
163983340|NCT05103332|592308462|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983341|NCT05103332|592308463|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983342|NCT05103332|592308464|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983343|NCT05103332|592308465|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983344|NCT05103332|592308466|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983345|NCT05103332|592308467|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983346|NCT05103332|592308468|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983347|NCT05103332|592308469|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983348|NCT05103332|592308470|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983349|NCT05103332|592308471|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983350|NCT05103332|592308472|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983351|NCT05103332|592308473|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
163983352|NCT05103332|592308474|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983353|NCT05103332|592308475|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983354|NCT05103332|592308476|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983355|NCT05103332|592308477|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983356|NCT05103332|592308478|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983357|NCT05103332|592308479|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
163983358|NCT05103332|592308462|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983359|NCT05103332|592308463|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983360|NCT05103332|592308464|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983361|NCT05103332|592308465|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983362|NCT05103332|592308466|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983363|NCT05103332|592308467|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983364|NCT05103332|592308468|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
164224285|NCT02191397|593188592|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
164224286|NCT02191397|593188591|FG000|Overall Study|Lost to Follow-up|10|||
164080112|NCT00545233|592657769|FG000|Overall Study|Refused Treatment|9|||
164080113|NCT00545233|592657770|FG001|Overall Study|Refused Treatment|7|||
164224287|NCT02191397|593188592|FG001|Overall Study|Lost to Follow-up|11|||
164224288|NCT02191397|593188591|FG000|Overall Study|Physician Decision|8|||
164224289|NCT02191397|593188592|FG001|Overall Study|Physician Decision|3|||
164080114|NCT00545233|592657769|FG000|Overall Study|Failure to Return|4|||
164080115|NCT00545233|592657770|FG001|Overall Study|Failure to Return|6|||
164080116|NCT00545233|592657769|FG000|Overall Study|Insufficient response|14|||
164080117|NCT00545233|592657770|FG001|Overall Study|Insufficient response|15|||
164224290|NCT02191397|593188591|FG000|Overall Study|Withdrawal by Subject|22|||
164224291|NCT02191397|593188592|FG001|Overall Study|Withdrawal by Subject|27|||
164224292|NCT03888482|593188596|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
164224293|NCT03888482|593188597|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
164224294|NCT03888482|593188596|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
164224295|NCT03888482|593188597|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
164224296|NCT02294019|593188598|FG000|Overall Study|Adverse Event|2|||
164224297|NCT02294019|593188598|FG000|Overall Study|Protocol Violation|68|||
164224298|NCT02294019|593188598|FG000|Overall Study|Lost to Follow-up|31|||
164224299|NCT02294019|593188598|FG000|Overall Study|Other|1|||
164224300|NCT02294019|593188598|FG000|Overall Study|Withdrawal by Subject|1|||
164224301|NCT01189227|593188600|FG000|Overall Study|Study terminated due to low accrual|6|||
164224302|NCT01189227|593188601|FG001|Overall Study|Study terminated due to low accrual|3|||
164224303|NCT04818086|593188602|FG000|Overall Study|Physician Decision|1|||
164224304|NCT04818086|593188603|FG001|Overall Study|Physician Decision|0|||
164224305|NCT04818086|593188602|FG000|Overall Study|Withdrawal by Subject|0|||
164224306|NCT04818086|593188603|FG001|Overall Study|Withdrawal by Subject|1|||
164224307|NCT04128228|593188605|FG000|Overall Study|Withdrawal by Subject|3|||
164224308|NCT04128228|593188606|FG001|Overall Study|Withdrawal by Subject|3|||
163880294|NCT04021602|591931236|FG000|Overall Study|Lost to Follow-up|3|||
163880295|NCT04021602|591931237|FG001|Overall Study|Lost to Follow-up|3|||
163880296|NCT04021602|591931238|FG002|Overall Study|Lost to Follow-up|1|||
163880297|NCT04021602|591931236|FG000|Overall Study|Adverse Event|1|||
163880298|NCT04021602|591931237|FG001|Overall Study|Adverse Event|0|||
163880299|NCT04021602|591931238|FG002|Overall Study|Adverse Event|1|||
163880300|NCT02689284|591931239|FG000|Overall Study|Adverse Event|1|||
163880301|NCT02689284|591931240|FG001|Overall Study|Adverse Event|8|||
163880302|NCT02689284|591931239|FG000|Overall Study|Death|0|||
163880303|NCT02689284|591931240|FG001|Overall Study|Death|1|||
163880304|NCT02689284|591931239|FG000|Overall Study|Physician Decision|1|||
163880305|NCT02689284|591931240|FG001|Overall Study|Physician Decision|2|||
163880306|NCT02689284|591931239|FG000|Overall Study|Withdrawal by Subject|0|||
163880307|NCT02689284|591931240|FG001|Overall Study|Withdrawal by Subject|1|||
163880308|NCT02689284|591931239|FG000|Overall Study|progression of cancer|1|||
163880309|NCT02689284|591931240|FG001|Overall Study|progression of cancer|72|||
163880310|NCT02689284|591931239|FG000|Overall Study|decreased heart function|0|||
163880311|NCT02689284|591931240|FG001|Overall Study|decreased heart function|1|||
163880312|NCT02689284|591931239|FG000|Overall Study|concern for anemia|0|||
163880313|NCT02689284|591931240|FG001|Overall Study|concern for anemia|1|||
163880314|NCT02689284|591931239|FG000|Overall Study|no measurable cancer for evaluation|0|||
163880315|NCT02689284|591931240|FG001|Overall Study|no measurable cancer for evaluation|1|||
163880316|NCT05592418|591931241|FG000|Overall Study|Adverse Event|1|||
163880317|NCT05592418|591931242|FG001|Overall Study|Adverse Event|0|||
163880318|NCT05592418|591931241|FG000|Overall Study|Lost to Follow-up|1|||
163880319|NCT05592418|591931242|FG001|Overall Study|Lost to Follow-up|3|||
163880320|NCT05592418|591931241|FG000|Overall Study|Withdrawal by Subject|2|||
163880321|NCT05592418|591931242|FG001|Overall Study|Withdrawal by Subject|7|||
163880322|NCT05481320|591931244|FG000|Overall Study|Withdrawal by Subject|1|||
163880323|NCT05481320|591931245|FG001|Overall Study|Withdrawal by Subject|1|||
163880324|NCT05481320|591931244|FG000|Overall Study|Care recipent passed away|0|||
163880325|NCT05481320|591931245|FG001|Overall Study|Care recipent passed away|1|||
163880326|NCT05481320|591931244|FG000|Overall Study|Out-of-window assessment|0|||
163880327|NCT05481320|591931245|FG001|Overall Study|Out-of-window assessment|1|||
163880328|NCT05481320|591931244|FG000|Overall Study|No longer a primary caregiver|3|||
163880329|NCT05481320|591931245|FG001|Overall Study|No longer a primary caregiver|0|||
163880330|NCT05481320|591931244|FG000|Overall Study|Unable to contact|1|||
163880331|NCT05481320|591931245|FG001|Overall Study|Unable to contact|0|||
163880332|NCT02923180|591931246|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
163880333|NCT02923180|591931246|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
163880334|NCT05198310|591931247|FG000|Overall Study|Lost to Follow-up|0|||
163880335|NCT05198310|591931248|FG001|Overall Study|Lost to Follow-up|1|||
163880336|NCT05198310|591931249|FG002|Overall Study|Lost to Follow-up|0|||
163880337|NCT05198310|591931250|FG003|Overall Study|Lost to Follow-up|0|||
163880338|NCT05198310|591931251|FG004|Overall Study|Lost to Follow-up|0|||
163880339|NCT05198310|591931252|FG005|Overall Study|Lost to Follow-up|0|||
164224309|NCT04128228|593188607|FG002|Overall Study|Withdrawal by Subject|0|||
164224310|NCT04128228|593188608|FG003|Overall Study|Withdrawal by Subject|0|||
164224311|NCT04128228|593188605|FG000|Overall Study|noncompliance|2|||
164224312|NCT04128228|593188606|FG001|Overall Study|noncompliance|2|||
164224313|NCT04128228|593188607|FG002|Overall Study|noncompliance|0|||
164224314|NCT04128228|593188608|FG003|Overall Study|noncompliance|0|||
164224315|NCT01016015|593188609|FG000|Overall Study|Not Treated|3|||
164224316|NCT01016015|593188609|FG000|Overall Study|Withdrawal by Subject|1|||
164224317|NCT01016015|593188609|FG000|Overall Study|Adverse Event|15|||
164224318|NCT01117350|593188613|FG000|Comparative Period|Not Treated|5|||
164224319|NCT01117350|593188614|FG001|Comparative Period|Not Treated|8|||
164224320|NCT01117350|593188613|FG000|Comparative Period|Adverse Event|6|||
164224321|NCT01117350|593188614|FG001|Comparative Period|Adverse Event|33|||
164224322|NCT01117350|593188613|FG000|Comparative Period|Lost to Follow-up|11|||
164224323|NCT01117350|593188614|FG001|Comparative Period|Lost to Follow-up|7|||
164224324|NCT01117350|593188613|FG000|Comparative Period|Withdrawal by Subject|9|||
164224325|NCT01117350|593188614|FG001|Comparative Period|Withdrawal by Subject|13|||
164224326|NCT01117350|593188613|FG000|Comparative Period|Protocol Violation|8|||
164224327|NCT01117350|593188614|FG001|Comparative Period|Protocol Violation|12|||
164224328|NCT01117350|593188613|FG000|Comparative Period|Lack of Efficacy|1|||
164224329|NCT01117350|593188614|FG001|Comparative Period|Lack of Efficacy|0|||
164224330|NCT01117350|593188613|FG000|Comparative Period|Physician Decision|0|||
163880340|NCT05198310|591931253|FG006|Overall Study|Lost to Follow-up|0|||
163880341|NCT05198310|591931254|FG007|Overall Study|Lost to Follow-up|0|||
163880342|NCT05198310|591931247|FG000|Overall Study|Withdrawal by Subject|0|||
163880343|NCT05198310|591931248|FG001|Overall Study|Withdrawal by Subject|0|||
163880344|NCT05198310|591931249|FG002|Overall Study|Withdrawal by Subject|0|||
163880345|NCT05198310|591931250|FG003|Overall Study|Withdrawal by Subject|2|||
163880346|NCT05198310|591931251|FG004|Overall Study|Withdrawal by Subject|0|||
163880347|NCT05198310|591931252|FG005|Overall Study|Withdrawal by Subject|2|||
163880348|NCT05198310|591931253|FG006|Overall Study|Withdrawal by Subject|1|||
163880349|NCT05198310|591931254|FG007|Overall Study|Withdrawal by Subject|3|||
163880350|NCT04116736|591931255|FG000|Overall Study|Withdrew consent during study|3|||
163880351|NCT04116736|591931256|FG001|Overall Study|Withdrew consent during study|1|||
163880352|NCT04116736|591931255|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
163880353|NCT04116736|591931256|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
163880354|NCT04116736|591931255|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
163880355|NCT04116736|591931256|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
163880356|NCT04116736|591931255|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
163880357|NCT04116736|591931256|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
163880358|NCT04116736|591931255|FG000|Overall Study|Subject was enrolled in error|2|||
163880359|NCT04116736|591931256|FG001|Overall Study|Subject was enrolled in error|0|||
163880360|NCT04116736|591931255|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
163880361|NCT04116736|591931256|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
163880362|NCT04116736|591931255|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
163880363|NCT04116736|591931256|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
163880364|NCT04116736|591931255|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
163880365|NCT04116736|591931256|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
163880366|NCT01872078|591931264|FG000|Overall Study|Adverse Event|0|||
163880367|NCT01872078|591931265|FG001|Overall Study|Adverse Event|0|||
163880368|NCT01872078|591931266|FG002|Overall Study|Adverse Event|1|||
163880369|NCT01872078|591931267|FG003|Overall Study|Adverse Event|0|||
163880370|NCT01872078|591931264|FG000|Overall Study|Dose administration non-compliance|0|||
163880371|NCT01872078|591931265|FG001|Overall Study|Dose administration non-compliance|0|||
163880372|NCT01872078|591931266|FG002|Overall Study|Dose administration non-compliance|0|||
163880373|NCT01872078|591931267|FG003|Overall Study|Dose administration non-compliance|1|||
163880374|NCT01872078|591931264|FG000|Overall Study|Protocol Violation|0|||
163880375|NCT01872078|591931265|FG001|Overall Study|Protocol Violation|0|||
163880376|NCT01872078|591931266|FG002|Overall Study|Protocol Violation|1|||
163880377|NCT01872078|591931267|FG003|Overall Study|Protocol Violation|0|||
163880378|NCT01872078|591931264|FG000|Overall Study|Withdrawal by Subject|0|||
163880379|NCT01872078|591931265|FG001|Overall Study|Withdrawal by Subject|0|||
163880380|NCT01872078|591931266|FG002|Overall Study|Withdrawal by Subject|1|||
163983365|NCT05103332|592308469|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
163983366|NCT05103332|592308470|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983367|NCT05103332|592308471|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
164224331|NCT01117350|593188614|FG001|Comparative Period|Physician Decision|1|||
164224332|NCT01117350|593188613|FG000|Comparative Period|Move to another city/country|2|||
164224333|NCT01117350|593188614|FG001|Comparative Period|Move to another city/country|1|||
164224334|NCT01117350|593188613|FG000|Extension Period|Not included in extension, not treated|0|||
164224335|NCT01117350|593188614|FG001|Extension Period|Not included in extension, not treated|50|||
164224336|NCT01117350|593188613|FG000|Extension Period|Adverse Event|0|||
164224337|NCT01117350|593188614|FG001|Extension Period|Adverse Event|2|||
164224338|NCT01117350|593188613|FG000|Extension Period|Protocol Violation|0|||
164224339|NCT01117350|593188614|FG001|Extension Period|Protocol Violation|2|||
164224340|NCT01117350|593188613|FG000|Extension Period|Lost to Follow-up|0|||
164224341|NCT01117350|593188614|FG001|Extension Period|Lost to Follow-up|2|||
164224342|NCT01117350|593188613|FG000|Extension Period|Withdrawal by Subject|0|||
164224343|NCT01117350|593188614|FG001|Extension Period|Withdrawal by Subject|3|||
164080118|NCT00545233|592657769|FG000|Overall Study|Physician Decision|2|||
164080119|NCT00545233|592657770|FG001|Overall Study|Physician Decision|1|||
164080120|NCT06371079|592657771|FG000|Overall Study|Missing data|88|||
164080121|NCT06371079|592657772|FG001|Overall Study|Missing data|247|||
164080122|NCT01238211|592657773|FG000|Overall Study|Continues active treatment|31|||
164080123|NCT01238211|592657773|FG000|Overall Study|Adverse Event|7|||
164080124|NCT01238211|592657773|FG000|Overall Study|Death|4|||
164224344|NCT01117350|593188613|FG000|Extension Period|Lack of Efficacy|0|||
164080125|NCT01238211|592657773|FG000|Overall Study|Relapse/Progression|2|||
164080126|NCT01238211|592657773|FG000|Overall Study|Withdrawal by Subject|7|||
164080127|NCT01238211|592657773|FG000|Overall Study|Non-protocol treatment|4|||
164080128|NCT01238211|592657773|FG000|Overall Study|Investigator/Patient Decision|3|||
164080129|NCT02868281|592657774|FG000|Overall Study|Adverse Event|2|||
164080130|NCT02868281|592657775|FG001|Overall Study|Adverse Event|2|||
164080131|NCT02868281|592657774|FG000|Overall Study|Protocol Violation|13|||
164080132|NCT02868281|592657775|FG001|Overall Study|Protocol Violation|10|||
164080133|NCT02868281|592657774|FG000|Overall Study|Lost to Follow-up|3|||
164080134|NCT02868281|592657775|FG001|Overall Study|Lost to Follow-up|6|||
164080135|NCT02868281|592657774|FG000|Overall Study|Withdrawal by Subject|11|||
164080136|NCT02868281|592657775|FG001|Overall Study|Withdrawal by Subject|15|||
164080137|NCT02868281|592657774|FG000|Overall Study|Physician Decision|2|||
163880381|NCT01872078|591931267|FG003|Overall Study|Withdrawal by Subject|0|||
164080138|NCT02868281|592657775|FG001|Overall Study|Physician Decision|0|||
164080139|NCT02868281|592657774|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
164080140|NCT02868281|592657775|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
164080141|NCT02868281|592657774|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
164224345|NCT01117350|593188614|FG001|Extension Period|Lack of Efficacy|2|||
163880382|NCT01872078|591931264|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
163880383|NCT01872078|591931265|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
163880384|NCT01872078|591931266|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
163880385|NCT01872078|591931267|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
163880386|NCT00753090|591933338|FG000|Overall Study|Withdrawal by Subject|10|||
163880387|NCT00753090|591933339|FG001|Overall Study|Withdrawal by Subject|10|||
163880388|NCT00753090|591933338|FG000|Overall Study|Death|17|||
163880389|NCT00753090|591933339|FG001|Overall Study|Death|6|||
163880390|NCT00753090|591933338|FG000|Overall Study|Study Prosthesis Removed|12|||
163880391|NCT00753090|591933339|FG001|Overall Study|Study Prosthesis Removed|3|||
163880392|NCT00753090|591933338|FG000|Overall Study|Lost to Follow-up|2|||
163880393|NCT00753090|591933339|FG001|Overall Study|Lost to Follow-up|2|||
163880394|NCT00753090|591933338|FG000|Overall Study|Other|127|||
163880395|NCT00753090|591933339|FG001|Overall Study|Other|75|||
163880396|NCT04052516|591933341|FG000|Overall Study|Withdrawal by Subject|4|||
163880397|NCT04052516|591933342|FG001|Overall Study|Withdrawal by Subject|5|||
163880398|NCT04052516|591933343|FG002|Overall Study|Withdrawal by Subject|6|||
163880399|NCT04052516|591933341|FG000|Overall Study|Adverse Event|3|||
163880400|NCT04052516|591933342|FG001|Overall Study|Adverse Event|2|||
163880401|NCT04052516|591933343|FG002|Overall Study|Adverse Event|8|||
163880402|NCT04052516|591933341|FG000|Overall Study|Lost to Follow-up|2|||
163880403|NCT04052516|591933342|FG001|Overall Study|Lost to Follow-up|5|||
163880404|NCT04052516|591933343|FG002|Overall Study|Lost to Follow-up|3|||
163880405|NCT04052516|591933341|FG000|Overall Study|Protocol Violation|1|||
163880406|NCT04052516|591933342|FG001|Overall Study|Protocol Violation|1|||
163880407|NCT04052516|591933343|FG002|Overall Study|Protocol Violation|0|||
163880408|NCT04052516|591933341|FG000|Overall Study|Death|1|||
163880409|NCT04052516|591933342|FG001|Overall Study|Death|0|||
163880410|NCT04052516|591933343|FG002|Overall Study|Death|0|||
163880411|NCT04052516|591933341|FG000|Overall Study|Physician Decision|0|||
163880412|NCT04052516|591933342|FG001|Overall Study|Physician Decision|1|||
163880413|NCT04052516|591933343|FG002|Overall Study|Physician Decision|0|||
163880414|NCT04052516|591933341|FG000|Overall Study|Pregnancy|1|||
163880415|NCT04052516|591933342|FG001|Overall Study|Pregnancy|0|||
163880416|NCT04052516|591933343|FG002|Overall Study|Pregnancy|0|||
164080142|NCT02868281|592657775|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
164080143|NCT02868281|592657774|FG000|Overall Study|Long journey/moving away|1|||
163880417|NCT04052516|591933341|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
163880418|NCT04052516|591933342|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
164080144|NCT02868281|592657775|FG001|Overall Study|Long journey/moving away|1|||
164224346|NCT01117350|593188613|FG000|Extension Period|Inclusion criteria not respected|0|||
164224347|NCT01117350|593188614|FG001|Extension Period|Inclusion criteria not respected|1|||
164224348|NCT01117350|593188613|FG000|Extension Period|Prohibited medication|0|||
163983368|NCT05103332|592308472|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
163983369|NCT05103332|592308473|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
163983370|NCT05103332|592308474|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983371|NCT05103332|592308475|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983372|NCT05103332|592308476|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983373|NCT05103332|592308477|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983374|NCT05103332|592308478|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983375|NCT05103332|592308479|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
163983376|NCT05103332|592308462|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983377|NCT05103332|592308463|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983378|NCT05103332|592308464|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983379|NCT05103332|592308465|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983380|NCT05103332|592308466|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983381|NCT05103332|592308467|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983382|NCT05103332|592308468|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983383|NCT05103332|592308469|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983384|NCT05103332|592308470|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983385|NCT05103332|592308471|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983386|NCT05103332|592308472|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983387|NCT05103332|592308473|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
163983388|NCT05103332|592308474|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
163983389|NCT05103332|592308475|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
163983390|NCT05103332|592308476|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
163983391|NCT05103332|592308477|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
163983392|NCT05103332|592308478|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
163983393|NCT05103332|592308479|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
163983394|NCT05103332|592308462|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983395|NCT05103332|592308463|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983396|NCT05103332|592308464|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983397|NCT05103332|592308465|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983398|NCT05103332|592308466|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983399|NCT05103332|592308467|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983400|NCT05103332|592308468|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983401|NCT05103332|592308469|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983402|NCT05103332|592308470|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983403|NCT05103332|592308471|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983404|NCT05103332|592308472|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983405|NCT05103332|592308473|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983406|NCT05103332|592308474|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983407|NCT05103332|592308475|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983408|NCT05103332|592308476|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983409|NCT05103332|592308477|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983410|NCT05103332|592308478|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
163983411|NCT05103332|592308479|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
163983412|NCT05103332|592308462|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983413|NCT05103332|592308463|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983414|NCT05103332|592308464|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983415|NCT05103332|592308465|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983416|NCT05103332|592308466|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983417|NCT05103332|592308467|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983418|NCT05103332|592308468|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983419|NCT05103332|592308469|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983420|NCT05103332|592308470|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983421|NCT05103332|592308471|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983422|NCT05103332|592308472|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983423|NCT05103332|592308473|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
163983424|NCT05103332|592308474|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
163983425|NCT05103332|592308475|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
163983426|NCT05103332|592308476|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
163983427|NCT05103332|592308477|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
163983428|NCT05103332|592308478|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
163983429|NCT05103332|592308479|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
163983430|NCT05103332|592308462|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
164080145|NCT01335464|592657776|FG000|Overall Study|Adverse Event|15|||
164080146|NCT01335464|592657777|FG001|Overall Study|Adverse Event|25|||
163983431|NCT05103332|592308463|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983432|NCT05103332|592308464|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983433|NCT05103332|592308465|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983434|NCT05103332|592308466|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983435|NCT05103332|592308467|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983436|NCT05103332|592308468|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983437|NCT05103332|592308469|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983438|NCT05103332|592308470|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983439|NCT05103332|592308471|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983440|NCT05103332|592308472|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983441|NCT05103332|592308473|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983442|NCT05103332|592308474|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983443|NCT05103332|592308475|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983444|NCT05103332|592308476|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
163983445|NCT05103332|592308477|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
163983446|NCT05103332|592308478|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
163983447|NCT05103332|592308479|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
163983448|NCT05103332|592308462|FG000|SFU Period (6 Months=168 Days)|Death|0|||
163983449|NCT05103332|592308463|FG001|SFU Period (6 Months=168 Days)|Death|0|||
163983450|NCT05103332|592308464|FG002|SFU Period (6 Months=168 Days)|Death|0|||
163983451|NCT05103332|592308465|FG003|SFU Period (6 Months=168 Days)|Death|0|||
163983452|NCT05103332|592308466|FG004|SFU Period (6 Months=168 Days)|Death|0|||
163983453|NCT05103332|592308467|FG005|SFU Period (6 Months=168 Days)|Death|0|||
163983454|NCT05103332|592308468|FG006|SFU Period (6 Months=168 Days)|Death|0|||
163983455|NCT05103332|592308469|FG007|SFU Period (6 Months=168 Days)|Death|0|||
163983456|NCT05103332|592308470|FG008|SFU Period (6 Months=168 Days)|Death|0|||
163983457|NCT05103332|592308471|FG009|SFU Period (6 Months=168 Days)|Death|0|||
163983458|NCT05103332|592308472|FG010|SFU Period (6 Months=168 Days)|Death|0|||
163983459|NCT05103332|592308473|FG011|SFU Period (6 Months=168 Days)|Death|0|||
163983460|NCT05103332|592308474|FG012|SFU Period (6 Months=168 Days)|Death|0|||
163983461|NCT05103332|592308475|FG013|SFU Period (6 Months=168 Days)|Death|0|||
163983462|NCT05103332|592308476|FG014|SFU Period (6 Months=168 Days)|Death|1|||
163983463|NCT05103332|592308477|FG015|SFU Period (6 Months=168 Days)|Death|0|||
163983464|NCT05103332|592308478|FG016|SFU Period (6 Months=168 Days)|Death|0|||
163983465|NCT05103332|592308479|FG017|SFU Period (6 Months=168 Days)|Death|1|||
163983466|NCT04428476|592308480|FG000|Overall Study|Withdrawal by Subject|1|||
163983467|NCT04428476|592308480|FG000|Overall Study|Still on treatment|12|||
163983468|NCT02043548|592308481|FG000|Overall Study|Lack of Efficacy|1|||
163983469|NCT02043548|592308482|FG001|Overall Study|Lack of Efficacy|0|||
163983470|NCT02043548|592308481|FG000|Overall Study|Adverse Event|0|||
163983471|NCT02043548|592308482|FG001|Overall Study|Adverse Event|1|||
163983472|NCT01425008|592308483|FG000|Dose Escalation Phase|Progressive Disease|2|||
163983473|NCT01425008|592308484|FG001|Dose Escalation Phase|Progressive Disease|3|||
163983474|NCT01425008|592308485|FG002|Dose Escalation Phase|Progressive Disease|2|||
163983475|NCT01425008|592308486|FG003|Dose Escalation Phase|Progressive Disease|3|||
163983476|NCT01425008|592308487|FG004|Dose Escalation Phase|Progressive Disease|5|||
163983477|NCT01425008|592308488|FG005|Dose Escalation Phase|Progressive Disease|4|||
163983478|NCT01425008|592308489|FG006|Dose Escalation Phase|Progressive Disease|0|||
163983479|NCT01425008|592308490|FG007|Dose Escalation Phase|Progressive Disease|2|||
163983480|NCT01425008|592308491|FG008|Dose Escalation Phase|Progressive Disease|6|||
163983481|NCT01425008|592308492|FG009|Dose Escalation Phase|Progressive Disease|2|||
163983482|NCT01425008|592308493|FG010|Dose Escalation Phase|Progressive Disease|0|||
163983483|NCT01425008|592308494|FG011|Dose Escalation Phase|Progressive Disease|0|||
163983484|NCT01425008|592308495|FG012|Dose Escalation Phase|Progressive Disease|0|||
163983485|NCT01425008|592308496|FG013|Dose Escalation Phase|Progressive Disease|0|||
163983486|NCT01425008|592308497|FG014|Dose Escalation Phase|Progressive Disease|0|||
163983487|NCT01425008|592308498|FG015|Dose Escalation Phase|Progressive Disease|0|||
163983488|NCT01425008|592308499|FG016|Dose Escalation Phase|Progressive Disease|0|||
163983489|NCT01425008|592308500|FG017|Dose Escalation Phase|Progressive Disease|0|||
163983490|NCT01425008|592308501|FG018|Dose Escalation Phase|Progressive Disease|0|||
163983491|NCT01425008|592308483|FG000|Dose Escalation Phase|Adverse Event|2|||
164080147|NCT01335464|592657776|FG000|Overall Study|Non compliant with protocol|2|||
163983492|NCT01425008|592308484|FG001|Dose Escalation Phase|Adverse Event|0|||
163983493|NCT01425008|592308485|FG002|Dose Escalation Phase|Adverse Event|0|||
163983494|NCT01425008|592308486|FG003|Dose Escalation Phase|Adverse Event|0|||
164080148|NCT01335464|592657777|FG001|Overall Study|Non compliant with protocol|0|||
163983495|NCT01425008|592308487|FG004|Dose Escalation Phase|Adverse Event|0|||
163983496|NCT01425008|592308488|FG005|Dose Escalation Phase|Adverse Event|2|||
163983497|NCT01425008|592308489|FG006|Dose Escalation Phase|Adverse Event|0|||
163983498|NCT01425008|592308490|FG007|Dose Escalation Phase|Adverse Event|0|||
163983499|NCT01425008|592308491|FG008|Dose Escalation Phase|Adverse Event|2|||
164080149|NCT01335464|592657776|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
164080150|NCT01335464|592657777|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
163983500|NCT01425008|592308492|FG009|Dose Escalation Phase|Adverse Event|0|||
163983501|NCT01425008|592308493|FG010|Dose Escalation Phase|Adverse Event|0|||
163983502|NCT01425008|592308494|FG011|Dose Escalation Phase|Adverse Event|0|||
163983503|NCT01425008|592308495|FG012|Dose Escalation Phase|Adverse Event|0|||
163983504|NCT01425008|592308496|FG013|Dose Escalation Phase|Adverse Event|0|||
163983505|NCT01425008|592308497|FG014|Dose Escalation Phase|Adverse Event|0|||
163983506|NCT01425008|592308498|FG015|Dose Escalation Phase|Adverse Event|0|||
163983507|NCT01425008|592308499|FG016|Dose Escalation Phase|Adverse Event|0|||
163983508|NCT01425008|592308500|FG017|Dose Escalation Phase|Adverse Event|0|||
163983509|NCT01425008|592308501|FG018|Dose Escalation Phase|Adverse Event|0|||
163983510|NCT01425008|592308483|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983511|NCT01425008|592308484|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983512|NCT01425008|592308485|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983513|NCT01425008|592308486|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983514|NCT01425008|592308487|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163983515|NCT01425008|592308488|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983516|NCT01425008|592308489|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
163983517|NCT01425008|592308490|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163983518|NCT01425008|592308491|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
163983519|NCT01425008|592308492|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983520|NCT01425008|592308493|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983521|NCT01425008|592308494|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983522|NCT01425008|592308495|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983523|NCT01425008|592308496|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983524|NCT01425008|592308497|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983525|NCT01425008|592308498|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983526|NCT01425008|592308499|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983527|NCT01425008|592308500|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983528|NCT01425008|592308501|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
163983529|NCT01425008|592308483|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
163983530|NCT01425008|592308484|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
163983531|NCT01425008|592308485|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
163983532|NCT01425008|592308486|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164080151|NCT01335464|592657776|FG000|Overall Study|Not treated|2|||
164224349|NCT01117350|593188614|FG001|Extension Period|Prohibited medication|1|||
164224350|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
164224351|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
164224352|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
164224353|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Adverse Event|5|||
164224354|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Adverse Event|1|||
163880419|NCT04052516|591933343|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
163880420|NCT04052516|591933341|FG000|Overall Study|Reason not recorded|0|||
163880421|NCT04052516|591933342|FG001|Overall Study|Reason not recorded|1|||
163880422|NCT04052516|591933343|FG002|Overall Study|Reason not recorded|0|||
163880423|NCT04521478|591933346|FG000|Overall Study|Protocol Violation|2|||
163880424|NCT04521478|591933347|FG001|Overall Study|Protocol Violation|0|||
163880425|NCT04521478|591933348|FG002|Overall Study|Protocol Violation|1|||
163880426|NCT04521478|591933349|FG003|Overall Study|Protocol Violation|0|||
163880427|NCT04521478|591933350|FG004|Overall Study|Protocol Violation|0|||
163880428|NCT04521478|591933351|FG005|Overall Study|Protocol Violation|0|||
163880429|NCT04521478|591933346|FG000|Overall Study|Technical Problems|0|||
163880430|NCT04521478|591933347|FG001|Overall Study|Technical Problems|0|||
163880431|NCT04521478|591933348|FG002|Overall Study|Technical Problems|0|||
163880432|NCT04521478|591933349|FG003|Overall Study|Technical Problems|1|||
163880433|NCT04521478|591933350|FG004|Overall Study|Technical Problems|0|||
163880434|NCT04521478|591933351|FG005|Overall Study|Technical Problems|0|||
163880435|NCT04521478|591933346|FG000|Overall Study|Burden of Study Procedures|1|||
163880436|NCT04521478|591933347|FG001|Overall Study|Burden of Study Procedures|0|||
163880437|NCT04521478|591933348|FG002|Overall Study|Burden of Study Procedures|0|||
163880438|NCT04521478|591933349|FG003|Overall Study|Burden of Study Procedures|1|||
163880439|NCT04521478|591933350|FG004|Overall Study|Burden of Study Procedures|0|||
163880440|NCT04521478|591933351|FG005|Overall Study|Burden of Study Procedures|1|||
163880441|NCT04521478|591933346|FG000|Overall Study|Lack of Efficacy|0|||
163880442|NCT04521478|591933347|FG001|Overall Study|Lack of Efficacy|0|||
163880443|NCT04521478|591933348|FG002|Overall Study|Lack of Efficacy|0|||
163880444|NCT04521478|591933349|FG003|Overall Study|Lack of Efficacy|0|||
163880445|NCT04521478|591933350|FG004|Overall Study|Lack of Efficacy|1|||
163880446|NCT04521478|591933351|FG005|Overall Study|Lack of Efficacy|1|||
164224355|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Adverse Event|0|||
163880447|NCT04521478|591933346|FG000|Overall Study|Adverse Event|7|||
163880448|NCT04521478|591933347|FG001|Overall Study|Adverse Event|0|||
163880449|NCT04521478|591933348|FG002|Overall Study|Adverse Event|2|||
163880450|NCT04521478|591933349|FG003|Overall Study|Adverse Event|1|||
163880451|NCT04521478|591933350|FG004|Overall Study|Adverse Event|2|||
163983533|NCT01425008|592308487|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
163983534|NCT01425008|592308488|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
163983535|NCT01425008|592308489|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
163983536|NCT01425008|592308490|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
163983537|NCT01425008|592308491|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
163983538|NCT01425008|592308492|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
163983539|NCT01425008|592308493|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
163983540|NCT01425008|592308494|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
163983541|NCT01425008|592308495|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
164080152|NCT01335464|592657777|FG001|Overall Study|Not treated|0|||
164080153|NCT01335464|592657776|FG000|Overall Study|Reason other than those stated above|1|||
163880452|NCT04521478|591933351|FG005|Overall Study|Adverse Event|7|||
163983542|NCT01425008|592308496|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
163983543|NCT01425008|592308497|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
163983544|NCT01425008|592308498|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
163983545|NCT01425008|592308499|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
163983546|NCT01425008|592308500|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
163983547|NCT01425008|592308501|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
163983548|NCT01425008|592308483|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983549|NCT01425008|592308484|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983550|NCT01425008|592308485|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
163983551|NCT01425008|592308486|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983552|NCT01425008|592308487|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983553|NCT01425008|592308488|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983554|NCT01425008|592308489|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983555|NCT01425008|592308490|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983556|NCT01425008|592308491|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
163983557|NCT01425008|592308492|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
163983558|NCT01425008|592308493|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983559|NCT01425008|592308494|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983560|NCT01425008|592308495|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983561|NCT01425008|592308496|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983562|NCT01425008|592308497|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983563|NCT01425008|592308498|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983564|NCT01425008|592308499|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983565|NCT01425008|592308500|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
164080154|NCT01335464|592657777|FG001|Overall Study|Reason other than those stated above|1|||
164080155|NCT02533999|592657781|FG000|Overall Study|Lost to Follow-up|3|||
164080156|NCT02533999|592657782|FG001|Overall Study|Lost to Follow-up|5|||
164080157|NCT02533999|592657781|FG000|Overall Study|Protocol Violation|3|||
164080158|NCT02533999|592657782|FG001|Overall Study|Protocol Violation|0|||
164080159|NCT02533999|592657781|FG000|Overall Study|Adverse Event|0|||
164080160|NCT02533999|592657782|FG001|Overall Study|Adverse Event|1|||
164080161|NCT02533999|592657781|FG000|Overall Study|Randomized but intervention not received|0|||
164080162|NCT02533999|592657782|FG001|Overall Study|Randomized but intervention not received|1|||
164080163|NCT03210259|592657783|FG000|12-Week Run-in Period|Adverse Event|1|||
164080164|NCT03210259|592657784|FG001|12-Week Run-in Period|Adverse Event|0|||
164080165|NCT03210259|592657785|FG002|12-Week Run-in Period|Adverse Event|0|||
164080166|NCT03210259|592657783|FG000|12-Week Run-in Period|Death|1|||
163880453|NCT04521478|591933346|FG000|Overall Study|No Reason Available|0|||
163880454|NCT04521478|591933347|FG001|Overall Study|No Reason Available|2|||
163880455|NCT04521478|591933348|FG002|Overall Study|No Reason Available|0|||
163880456|NCT04521478|591933349|FG003|Overall Study|No Reason Available|0|||
163880457|NCT04521478|591933350|FG004|Overall Study|No Reason Available|1|||
163880458|NCT04521478|591933351|FG005|Overall Study|No Reason Available|0|||
163880459|NCT04521478|591933346|FG000|Overall Study|Other than listed|3|||
163880460|NCT04521478|591933347|FG001|Overall Study|Other than listed|3|||
163880461|NCT04521478|591933348|FG002|Overall Study|Other than listed|3|||
163880462|NCT04521478|591933349|FG003|Overall Study|Other than listed|2|||
163880463|NCT04521478|591933350|FG004|Overall Study|Other than listed|3|||
163880464|NCT04521478|591933351|FG005|Overall Study|Other than listed|3|||
163880465|NCT04521478|591933346|FG000|Overall Study|Not treated|0|||
163880466|NCT04521478|591933347|FG001|Overall Study|Not treated|0|||
163880467|NCT04521478|591933348|FG002|Overall Study|Not treated|0|||
163983566|NCT01425008|592308501|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
163983567|NCT01425008|592308483|FG000|Dose Escalation Phase|Other|0|||
163983568|NCT01425008|592308484|FG001|Dose Escalation Phase|Other|0|||
164080167|NCT03210259|592657784|FG001|12-Week Run-in Period|Death|0|||
164080168|NCT03210259|592657785|FG002|12-Week Run-in Period|Death|0|||
163880468|NCT04521478|591933349|FG003|Overall Study|Not treated|0|||
163880469|NCT04521478|591933350|FG004|Overall Study|Not treated|0|||
163880470|NCT04521478|591933351|FG005|Overall Study|Not treated|1|||
164080169|NCT03210259|592657783|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
164080170|NCT03210259|592657784|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
164080171|NCT03210259|592657785|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
163983569|NCT01425008|592308485|FG002|Dose Escalation Phase|Other|0|||
163983570|NCT01425008|592308486|FG003|Dose Escalation Phase|Other|0|||
163983571|NCT01425008|592308487|FG004|Dose Escalation Phase|Other|0|||
163983572|NCT01425008|592308488|FG005|Dose Escalation Phase|Other|0|||
163983573|NCT01425008|592308489|FG006|Dose Escalation Phase|Other|0|||
163983574|NCT01425008|592308490|FG007|Dose Escalation Phase|Other|0|||
163983575|NCT01425008|592308491|FG008|Dose Escalation Phase|Other|1|||
163983576|NCT01425008|592308492|FG009|Dose Escalation Phase|Other|0|||
163983577|NCT01425008|592308493|FG010|Dose Escalation Phase|Other|0|||
163983578|NCT01425008|592308494|FG011|Dose Escalation Phase|Other|0|||
163983579|NCT01425008|592308495|FG012|Dose Escalation Phase|Other|0|||
163983580|NCT01425008|592308496|FG013|Dose Escalation Phase|Other|0|||
163983581|NCT01425008|592308497|FG014|Dose Escalation Phase|Other|0|||
163983582|NCT01425008|592308498|FG015|Dose Escalation Phase|Other|0|||
163983583|NCT01425008|592308499|FG016|Dose Escalation Phase|Other|0|||
163983584|NCT01425008|592308500|FG017|Dose Escalation Phase|Other|0|||
163983585|NCT01425008|592308501|FG018|Dose Escalation Phase|Other|0|||
163983586|NCT01425008|592308483|FG000|Dose Expansion Phase|Progressive Disease|0|||
163983587|NCT01425008|592308484|FG001|Dose Expansion Phase|Progressive Disease|0|||
163983588|NCT01425008|592308485|FG002|Dose Expansion Phase|Progressive Disease|0|||
163983589|NCT01425008|592308486|FG003|Dose Expansion Phase|Progressive Disease|0|||
163983590|NCT01425008|592308487|FG004|Dose Expansion Phase|Progressive Disease|0|||
163983591|NCT01425008|592308488|FG005|Dose Expansion Phase|Progressive Disease|0|||
163983592|NCT01425008|592308489|FG006|Dose Expansion Phase|Progressive Disease|0|||
163983593|NCT01425008|592308490|FG007|Dose Expansion Phase|Progressive Disease|0|||
163983594|NCT01425008|592308491|FG008|Dose Expansion Phase|Progressive Disease|0|||
163983595|NCT01425008|592308492|FG009|Dose Expansion Phase|Progressive Disease|0|||
163983596|NCT01425008|592308493|FG010|Dose Expansion Phase|Progressive Disease|10|||
163983597|NCT01425008|592308494|FG011|Dose Expansion Phase|Progressive Disease|4|||
163983598|NCT01425008|592308495|FG012|Dose Expansion Phase|Progressive Disease|12|||
163983599|NCT01425008|592308496|FG013|Dose Expansion Phase|Progressive Disease|1|||
163983600|NCT01425008|592308497|FG014|Dose Expansion Phase|Progressive Disease|5|||
163983601|NCT01425008|592308498|FG015|Dose Expansion Phase|Progressive Disease|8|||
163983602|NCT01425008|592308499|FG016|Dose Expansion Phase|Progressive Disease|9|||
163983603|NCT01425008|592308500|FG017|Dose Expansion Phase|Progressive Disease|2|||
163983604|NCT01425008|592308501|FG018|Dose Expansion Phase|Progressive Disease|10|||
163983605|NCT01425008|592308483|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
163983606|NCT01425008|592308484|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
163983607|NCT01425008|592308485|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
163983608|NCT01425008|592308486|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
163983609|NCT01425008|592308487|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
163983610|NCT01425008|592308488|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
163983611|NCT01425008|592308489|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
163983612|NCT01425008|592308490|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
163983613|NCT01425008|592308491|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
163983614|NCT01425008|592308492|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
163983615|NCT01425008|592308493|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
163983616|NCT01425008|592308494|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
163983617|NCT01425008|592308495|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
163983618|NCT01425008|592308496|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
163983619|NCT01425008|592308497|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
163983620|NCT01425008|592308498|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
163983621|NCT01425008|592308499|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
163983622|NCT01425008|592308500|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
163983623|NCT01425008|592308501|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
163983624|NCT01425008|592308483|FG000|Dose Expansion Phase|Other|0|||
163983625|NCT01425008|592308484|FG001|Dose Expansion Phase|Other|0|||
163983626|NCT01425008|592308485|FG002|Dose Expansion Phase|Other|0|||
163983627|NCT01425008|592308486|FG003|Dose Expansion Phase|Other|0|||
163983628|NCT01425008|592308487|FG004|Dose Expansion Phase|Other|0|||
163983629|NCT01425008|592308488|FG005|Dose Expansion Phase|Other|0|||
163983630|NCT01425008|592308489|FG006|Dose Expansion Phase|Other|0|||
163983631|NCT01425008|592308490|FG007|Dose Expansion Phase|Other|0|||
163983632|NCT01425008|592308491|FG008|Dose Expansion Phase|Other|0|||
163983633|NCT01425008|592308492|FG009|Dose Expansion Phase|Other|0|||
163983634|NCT01425008|592308493|FG010|Dose Expansion Phase|Other|0|||
163983635|NCT01425008|592308494|FG011|Dose Expansion Phase|Other|0|||
163983636|NCT01425008|592308495|FG012|Dose Expansion Phase|Other|1|||
163983637|NCT01425008|592308496|FG013|Dose Expansion Phase|Other|0|||
163983638|NCT01425008|592308497|FG014|Dose Expansion Phase|Other|0|||
163983639|NCT01425008|592308498|FG015|Dose Expansion Phase|Other|0|||
163983640|NCT01425008|592308499|FG016|Dose Expansion Phase|Other|2|||
163983641|NCT01425008|592308500|FG017|Dose Expansion Phase|Other|0|||
163983642|NCT01425008|592308501|FG018|Dose Expansion Phase|Other|4|||
163983643|NCT01425008|592308483|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983644|NCT01425008|592308484|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983645|NCT01425008|592308485|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983646|NCT01425008|592308486|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983647|NCT01425008|592308487|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983648|NCT01425008|592308488|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983649|NCT01425008|592308489|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983650|NCT01425008|592308490|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983651|NCT01425008|592308491|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983652|NCT01425008|592308492|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983653|NCT01425008|592308493|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
163983654|NCT01425008|592308494|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
163983655|NCT01425008|592308495|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983656|NCT01425008|592308496|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983657|NCT01425008|592308497|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983658|NCT01425008|592308498|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
163983659|NCT01425008|592308499|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
163983660|NCT01425008|592308500|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
163983661|NCT01425008|592308501|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
163983662|NCT01425008|592308483|FG000|Dose Expansion Phase|Adverse Event|0|||
163983663|NCT01425008|592308484|FG001|Dose Expansion Phase|Adverse Event|0|||
163983664|NCT01425008|592308485|FG002|Dose Expansion Phase|Adverse Event|0|||
163983665|NCT01425008|592308486|FG003|Dose Expansion Phase|Adverse Event|0|||
163983666|NCT01425008|592308487|FG004|Dose Expansion Phase|Adverse Event|0|||
163983667|NCT01425008|592308488|FG005|Dose Expansion Phase|Adverse Event|0|||
163983668|NCT01425008|592308489|FG006|Dose Expansion Phase|Adverse Event|0|||
163983669|NCT01425008|592308490|FG007|Dose Expansion Phase|Adverse Event|0|||
163983670|NCT01425008|592308491|FG008|Dose Expansion Phase|Adverse Event|0|||
163983671|NCT01425008|592308492|FG009|Dose Expansion Phase|Adverse Event|0|||
163983672|NCT01425008|592308493|FG010|Dose Expansion Phase|Adverse Event|2|||
163983673|NCT01425008|592308494|FG011|Dose Expansion Phase|Adverse Event|3|||
163983674|NCT01425008|592308495|FG012|Dose Expansion Phase|Adverse Event|3|||
163983675|NCT01425008|592308496|FG013|Dose Expansion Phase|Adverse Event|0|||
163983676|NCT01425008|592308497|FG014|Dose Expansion Phase|Adverse Event|1|||
163983677|NCT01425008|592308498|FG015|Dose Expansion Phase|Adverse Event|1|||
163983678|NCT01425008|592308499|FG016|Dose Expansion Phase|Adverse Event|5|||
163983679|NCT01425008|592308500|FG017|Dose Expansion Phase|Adverse Event|0|||
163983680|NCT01425008|592308501|FG018|Dose Expansion Phase|Adverse Event|3|||
163983681|NCT01425008|592308483|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
163983682|NCT01425008|592308484|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
163983683|NCT01425008|592308485|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
164224356|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
163983684|NCT01425008|592308486|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
163983685|NCT01425008|592308487|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
163983686|NCT01425008|592308488|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
163983687|NCT01425008|592308489|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
163983688|NCT01425008|592308490|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
163983689|NCT01425008|592308491|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
163983690|NCT01425008|592308492|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
163983691|NCT01425008|592308493|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
163983692|NCT01425008|592308494|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
163983693|NCT01425008|592308495|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
163983694|NCT01425008|592308496|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
163983695|NCT01425008|592308497|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
163983696|NCT01425008|592308498|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
164224357|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
164224358|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
164224359|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Death|8|||
164224360|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Death|24|||
164224361|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Death|0|||
163983697|NCT01425008|592308499|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
163983698|NCT01425008|592308500|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
164224362|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
164224363|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
164224364|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
163983699|NCT01425008|592308501|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
163983700|NCT01425008|592308483|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983701|NCT01425008|592308484|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983702|NCT01425008|592308485|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983703|NCT01425008|592308486|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983704|NCT01425008|592308487|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164080172|NCT03210259|592657783|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
164080173|NCT03210259|592657784|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
164224365|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
164224366|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
163983705|NCT01425008|592308488|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983706|NCT01425008|592308489|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983707|NCT01425008|592308490|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983708|NCT01425008|592308491|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983709|NCT01425008|592308492|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983710|NCT01425008|592308493|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983711|NCT01425008|592308494|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983712|NCT01425008|592308495|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983713|NCT01425008|592308496|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983714|NCT01425008|592308497|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983715|NCT01425008|592308498|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983716|NCT01425008|592308499|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983717|NCT01425008|592308500|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
163983718|NCT01425008|592308501|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
163983719|NCT04179175|592310094|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
163983720|NCT04179175|592310095|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
163983721|NCT04179175|592310096|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
163983722|NCT04179175|592310097|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
163983723|NCT04179175|592310098|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
163983724|NCT04179175|592310099|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
163983725|NCT04179175|592310094|FG000|Overall Study|Adverse Event|5|||
163983726|NCT04179175|592310095|FG001|Overall Study|Adverse Event|3|||
163983727|NCT04179175|592310096|FG002|Overall Study|Adverse Event|3|||
163983728|NCT04179175|592310097|FG003|Overall Study|Adverse Event|4|||
163983729|NCT04179175|592310098|FG004|Overall Study|Adverse Event|6|||
163983730|NCT04179175|592310099|FG005|Overall Study|Adverse Event|6|||
163983731|NCT04179175|592310094|FG000|Overall Study|Lack of Efficacy|5|||
163983732|NCT04179175|592310095|FG001|Overall Study|Lack of Efficacy|1|||
163983733|NCT04179175|592310096|FG002|Overall Study|Lack of Efficacy|3|||
163983734|NCT04179175|592310097|FG003|Overall Study|Lack of Efficacy|2|||
163983735|NCT04179175|592310098|FG004|Overall Study|Lack of Efficacy|18|||
163983736|NCT04179175|592310099|FG005|Overall Study|Lack of Efficacy|7|||
163983737|NCT04179175|592310094|FG000|Overall Study|Lost to Follow-up|5|||
163983738|NCT04179175|592310095|FG001|Overall Study|Lost to Follow-up|3|||
163983739|NCT04179175|592310096|FG002|Overall Study|Lost to Follow-up|2|||
163983740|NCT04179175|592310097|FG003|Overall Study|Lost to Follow-up|2|||
163983741|NCT04179175|592310098|FG004|Overall Study|Lost to Follow-up|4|||
163983742|NCT04179175|592310099|FG005|Overall Study|Lost to Follow-up|5|||
163983743|NCT04179175|592310094|FG000|Overall Study|Physician Decision|2|||
163983744|NCT04179175|592310095|FG001|Overall Study|Physician Decision|0|||
163983745|NCT04179175|592310096|FG002|Overall Study|Physician Decision|2|||
163983746|NCT04179175|592310097|FG003|Overall Study|Physician Decision|3|||
163983747|NCT04179175|592310098|FG004|Overall Study|Physician Decision|1|||
163983748|NCT04179175|592310099|FG005|Overall Study|Physician Decision|1|||
163983749|NCT04179175|592310094|FG000|Overall Study|Pregnancy|3|||
163983750|NCT04179175|592310095|FG001|Overall Study|Pregnancy|0|||
163983751|NCT04179175|592310096|FG002|Overall Study|Pregnancy|3|||
163983752|NCT04179175|592310097|FG003|Overall Study|Pregnancy|0|||
163983753|NCT04179175|592310098|FG004|Overall Study|Pregnancy|1|||
163983754|NCT04179175|592310099|FG005|Overall Study|Pregnancy|2|||
163983755|NCT04179175|592310094|FG000|Overall Study|Withdrawal by Subject|22|||
163983756|NCT04179175|592310095|FG001|Overall Study|Withdrawal by Subject|10|||
163983757|NCT04179175|592310096|FG002|Overall Study|Withdrawal by Subject|12|||
163983758|NCT04179175|592310097|FG003|Overall Study|Withdrawal by Subject|8|||
163983759|NCT04179175|592310098|FG004|Overall Study|Withdrawal by Subject|23|||
163983760|NCT04179175|592310099|FG005|Overall Study|Withdrawal by Subject|31|||
163983761|NCT04179175|592310094|FG000|Overall Study|Technical problems|0|||
163983762|NCT04179175|592310095|FG001|Overall Study|Technical problems|0|||
163983763|NCT04179175|592310096|FG002|Overall Study|Technical problems|1|||
163983764|NCT04179175|592310097|FG003|Overall Study|Technical problems|1|||
163983765|NCT04179175|592310098|FG004|Overall Study|Technical problems|0|||
163983766|NCT04179175|592310099|FG005|Overall Study|Technical problems|0|||
163983767|NCT03215030|592310104|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
163983768|NCT03215030|592310105|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
163983769|NCT03215030|592310106|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983770|NCT03215030|592310107|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
163983771|NCT03215030|592310108|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983772|NCT03215030|592310109|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983773|NCT03215030|592310110|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983774|NCT03215030|592310111|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983775|NCT03215030|592310112|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983776|NCT03215030|592310113|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983777|NCT03215030|592310114|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983778|NCT03215030|592310115|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
163983779|NCT03215030|592310104|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163983780|NCT03215030|592310105|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983781|NCT03215030|592310106|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983782|NCT03215030|592310107|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163983783|NCT03215030|592310108|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983784|NCT03215030|592310109|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983785|NCT03215030|592310110|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983786|NCT03215030|592310111|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983787|NCT03215030|592310112|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983788|NCT03215030|592310113|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983789|NCT03215030|592310114|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163983790|NCT03215030|592310115|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164224367|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
164224368|NCT02931539|593188615|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
164224369|NCT02931539|593188616|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
164224370|NCT02931539|593188617|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
164224371|NCT02931539|593188615|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
164224372|NCT02931539|593188616|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
164224373|NCT02931539|593188617|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
164224374|NCT06097273|593188620|FG000|Overall Study|Death|2|||
164224375|NCT06097273|593188621|FG001|Overall Study|Death|1|||
164224376|NCT06097273|593188622|FG002|Overall Study|Death|2|||
164224377|NCT06097273|593188623|FG003|Overall Study|Death|2|||
164224378|NCT06097273|593188620|FG000|Overall Study|Lost to Follow-up|27|||
164224379|NCT06097273|593188621|FG001|Overall Study|Lost to Follow-up|18|||
164224380|NCT06097273|593188622|FG002|Overall Study|Lost to Follow-up|36|||
164224381|NCT06097273|593188623|FG003|Overall Study|Lost to Follow-up|31|||
164224382|NCT06097273|593188620|FG000|Overall Study|Physician Decision|0|||
164224383|NCT06097273|593188621|FG001|Overall Study|Physician Decision|1|||
164224384|NCT06097273|593188622|FG002|Overall Study|Physician Decision|0|||
164224385|NCT06097273|593188623|FG003|Overall Study|Physician Decision|3|||
164224386|NCT06097273|593188620|FG000|Overall Study|Protocol Violation|1|||
164224387|NCT06097273|593188621|FG001|Overall Study|Protocol Violation|1|||
164224388|NCT06097273|593188622|FG002|Overall Study|Protocol Violation|2|||
164224389|NCT06097273|593188623|FG003|Overall Study|Protocol Violation|1|||
164224390|NCT06097273|593188620|FG000|Overall Study|Withdrawal by Subject|14|||
163983791|NCT03215030|592310104|FG000|Part 1: Dose Escalation|Death|15|||
163983792|NCT03215030|592310105|FG001|Part 1: Dose Escalation|Death|6|||
163983793|NCT03215030|592310106|FG002|Part 1: Dose Escalation|Death|6|||
163983794|NCT03215030|592310107|FG003|Part 1: Dose Escalation|Death|8|||
163983795|NCT03215030|592310108|FG004|Part 1: Dose Escalation|Death|0|||
163983796|NCT03215030|592310109|FG005|Part 1: Dose Escalation|Death|0|||
163983797|NCT03215030|592310110|FG006|Part 1: Dose Escalation|Death|0|||
163983798|NCT03215030|592310111|FG007|Part 1: Dose Escalation|Death|0|||
163983799|NCT03215030|592310112|FG008|Part 1: Dose Escalation|Death|0|||
163983800|NCT03215030|592310113|FG009|Part 1: Dose Escalation|Death|0|||
163983801|NCT03215030|592310114|FG010|Part 1: Dose Escalation|Death|0|||
163983802|NCT03215030|592310115|FG011|Part 1: Dose Escalation|Death|0|||
163983803|NCT03215030|592310104|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
163983804|NCT03215030|592310105|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
163983805|NCT03215030|592310106|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
163983806|NCT03215030|592310107|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
163983807|NCT03215030|592310108|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
163983808|NCT03215030|592310109|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
163983809|NCT03215030|592310110|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
163983810|NCT03215030|592310111|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
163983811|NCT03215030|592310112|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
163983812|NCT03215030|592310113|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
163983813|NCT03215030|592310114|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
164224391|NCT06097273|593188621|FG001|Overall Study|Withdrawal by Subject|11|||
164224392|NCT06097273|593188622|FG002|Overall Study|Withdrawal by Subject|14|||
164224393|NCT06097273|593188623|FG003|Overall Study|Withdrawal by Subject|15|||
163983814|NCT03215030|592310115|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
164224394|NCT06097273|593188620|FG000|Overall Study|Other Than Specified|7|||
163983815|NCT03215030|592310104|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983816|NCT03215030|592310105|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983817|NCT03215030|592310106|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983818|NCT03215030|592310107|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164080174|NCT03210259|592657785|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
163983819|NCT03215030|592310108|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164224395|NCT06097273|593188621|FG001|Overall Study|Other Than Specified|3|||
164224396|NCT06097273|593188622|FG002|Overall Study|Other Than Specified|11|||
164224397|NCT06097273|593188623|FG003|Overall Study|Other Than Specified|6|||
164224398|NCT03681093|593190233|FG000|Overall Study|Subject decision|0|||
164224399|NCT03681093|593190234|FG001|Overall Study|Subject decision|2|||
164224400|NCT03681093|593190235|FG002|Overall Study|Subject decision|1|||
164224401|NCT00368849|593190239|FG000|Overall Study|Withdrawal by Subject|0|||
164224402|NCT00368849|593190240|FG001|Overall Study|Withdrawal by Subject|1|||
164224403|NCT00368849|593190239|FG000|Overall Study|Physician Decision|0|||
164224404|NCT00368849|593190240|FG001|Overall Study|Physician Decision|1|||
164224405|NCT01902303|593190241|FG000|Overall Study|Adverse Event|0|||
164224406|NCT01902303|593190242|FG001|Overall Study|Adverse Event|1|||
164224407|NCT01902303|593190241|FG000|Overall Study|Lost to Follow-up|0|||
164224408|NCT01902303|593190242|FG001|Overall Study|Lost to Follow-up|1|||
164224409|NCT01902303|593190241|FG000|Overall Study|Protocol Violation|2|||
164224410|NCT01902303|593190242|FG001|Overall Study|Protocol Violation|2|||
164224411|NCT01902303|593190241|FG000|Overall Study|subject lost investigational product|0|||
164224412|NCT01902303|593190242|FG001|Overall Study|subject lost investigational product|1|||
164224413|NCT01902303|593190241|FG000|Overall Study|Did not develop a cold sore|21|||
164224414|NCT01902303|593190242|FG001|Overall Study|Did not develop a cold sore|19|||
164224415|NCT03635996|593190243|FG000|Overall Study|Study terminated by Sponsor|94|||
164224416|NCT03635996|593190243|FG000|Overall Study|Withdrawal by Subject|20|||
164224417|NCT03635996|593190243|FG000|Overall Study|Ablation|26|||
164224418|NCT03635996|593190243|FG000|Overall Study|Adverse Event|7|||
164224419|NCT03635996|593190243|FG000|Overall Study|Physician Decision|3|||
164224420|NCT03635996|593190243|FG000|Overall Study|Prohibited medication|5|||
164224421|NCT03635996|593190243|FG000|Overall Study|Did not meet eligibility criteria|5|||
164224422|NCT03635996|593190243|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
164224423|NCT03635996|593190243|FG000|Overall Study|Protocol Violation|1|||
164224424|NCT03635996|593190243|FG000|Overall Study|Lost to Follow-up|1|||
164224425|NCT04359680|593190244|FG000|Overall Study|Withdrawal by Subject|29|||
164224426|NCT04359680|593190245|FG001|Overall Study|Withdrawal by Subject|24|||
164224427|NCT04359680|593190244|FG000|Overall Study|Adverse Event|6|||
164224428|NCT04359680|593190245|FG001|Overall Study|Adverse Event|2|||
164224429|NCT04359680|593190244|FG000|Overall Study|Lost to Follow-up|56|||
164224430|NCT04359680|593190245|FG001|Overall Study|Lost to Follow-up|59|||
164224431|NCT04359680|593190244|FG000|Overall Study|Protocol Violation|3|||
164224432|NCT04359680|593190245|FG001|Overall Study|Protocol Violation|5|||
164224433|NCT04359680|593190244|FG000|Overall Study|Physician Decision|1|||
164224434|NCT04359680|593190245|FG001|Overall Study|Physician Decision|1|||
164224435|NCT04359680|593190244|FG000|Overall Study|Sponsor Decision|0|||
164224436|NCT04359680|593190245|FG001|Overall Study|Sponsor Decision|1|||
164224437|NCT02802865|593190246|FG000|Overall Study|Pregnancy|1|||
164224438|NCT02802865|593190247|FG001|Overall Study|Pregnancy|1|||
164224439|NCT02802865|593190246|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
164224440|NCT02802865|593190247|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
163983820|NCT03215030|592310109|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983821|NCT03215030|592310110|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983822|NCT03215030|592310111|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
163983823|NCT03215030|592310112|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
164080175|NCT03210259|592657783|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
164080176|NCT03210259|592657784|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
164080177|NCT03210259|592657785|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
164080178|NCT03210259|592657783|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
164080179|NCT03210259|592657784|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
164080180|NCT03210259|592657785|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
164080181|NCT03210259|592657783|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
163983824|NCT03215030|592310113|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983825|NCT03215030|592310114|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983826|NCT03215030|592310115|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
163983827|NCT03215030|592310104|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983828|NCT03215030|592310105|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983829|NCT03215030|592310106|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983830|NCT03215030|592310107|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983831|NCT03215030|592310108|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163983832|NCT03215030|592310109|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163983833|NCT03215030|592310110|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
163983834|NCT03215030|592310111|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
164080182|NCT03210259|592657784|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
164224441|NCT01862029|593190248|FG000|Overall Study|Physician Decision|1|||
164224442|NCT01832038|593190249|FG000|Overall Study|Death|5|||
164224443|NCT01832038|593190249|FG000|Overall Study|Adverse Event|50|||
164224444|NCT01832038|593190249|FG000|Overall Study|Lack of Efficacy|81|||
164224445|NCT01832038|593190249|FG000|Overall Study|Protocol Violation|7|||
164224446|NCT01832038|593190249|FG000|Overall Study|Lost to Follow-up|10|||
164224447|NCT01832038|593190249|FG000|Overall Study|Withdrawal by Subject|49|||
164224448|NCT01832038|593190249|FG000|Overall Study|Visit non-compliance|2|||
164224449|NCT01832038|593190249|FG000|Overall Study|Subject refused to return visit|2|||
164224450|NCT01832038|593190249|FG000|Overall Study|Not convenient to come back to site|2|||
164224451|NCT01832038|593190249|FG000|Overall Study|Participant was asked to quit|5|||
164224452|NCT01832038|593190249|FG000|Overall Study|Back home|1|||
164224453|NCT01832038|593190249|FG000|Overall Study|Pregnancy|1|||
164224454|NCT01832038|593190249|FG000|Overall Study|Low compliance|3|||
164224455|NCT01832038|593190249|FG000|Overall Study|Prohibit procedure|2|||
164224456|NCT01832038|593190249|FG000|Overall Study|Not possible to visit the hospital|1|||
164224457|NCT01832038|593190249|FG000|Overall Study|Changes of implementation system|3|||
164224458|NCT01832038|593190249|FG000|Overall Study|Plan to pregnancy|7|||
164224459|NCT01832038|593190249|FG000|Overall Study|Bad mood and has suicidal thought|1|||
164224460|NCT01832038|593190249|FG000|Overall Study|Prohibited concomitant medication|1|||
164224461|NCT01832038|593190249|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
164224462|NCT01832038|593190249|FG000|Overall Study|Subject considered the efficacy was poor|1|||
164224463|NCT03810365|593190250|FG000|Overall Study|Lost to Follow-up|2|||
164224464|NCT03810365|593190251|FG001|Overall Study|Lost to Follow-up|2|||
164224465|NCT03810365|593190250|FG000|Overall Study|Withdrawal by Subject|4|||
164224466|NCT03810365|593190251|FG001|Overall Study|Withdrawal by Subject|5|||
164224467|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
164224468|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
164224469|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
164224470|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
164224471|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
164224472|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
164224473|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
164224474|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
164224475|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
164224476|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
163880471|NCT05062265|591933355|FG000|Overall Study|Withdrawal by Subject|1|||
164080183|NCT03210259|592657785|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
164080184|NCT03210259|592657783|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
164080185|NCT03210259|592657784|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
164080186|NCT03210259|592657785|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
164080187|NCT03210259|592657783|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
164080188|NCT03210259|592657784|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
164080189|NCT03210259|592657785|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
164080190|NCT03210259|592657783|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
164080191|NCT03210259|592657784|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
164080192|NCT03210259|592657785|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
164080193|NCT03210259|592657783|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
164080194|NCT03210259|592657784|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
164080195|NCT03210259|592657785|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
164080196|NCT03940586|592657789|FG000|Overall Study|Death|3|||
164224477|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
164224478|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
163880472|NCT05062265|591933356|FG001|Overall Study|Withdrawal by Subject|0|||
163880473|NCT06311084|591933360|FG000|Overall Study|Lost to Follow-up|14|||
163880474|NCT04725240|591933361|FG000|Overall Study|Adverse Event|2|||
163880475|NCT03393975|591933367|FG000|Urgent Treatment Period|Physician Decision|0|||
163880476|NCT03393975|591933368|FG001|Urgent Treatment Period|Physician Decision|0|||
163880477|NCT03393975|591933369|FG002|Urgent Treatment Period|Physician Decision|0|||
163880478|NCT03393975|591933370|FG003|Urgent Treatment Period|Physician Decision|1|||
163880479|NCT03393975|591933367|FG000|Prophylaxis Period 1|Reason not Specified|0|||
163880480|NCT03393975|591933368|FG001|Prophylaxis Period 1|Reason not Specified|1|||
163880481|NCT03393975|591933369|FG002|Prophylaxis Period 1|Reason not Specified|0|||
163880482|NCT03393975|591933370|FG003|Prophylaxis Period 1|Reason not Specified|0|||
163880483|NCT03393975|591933367|FG000|Prophylaxis Period 2|Reason not Specified|0|||
163880484|NCT03393975|591933368|FG001|Prophylaxis Period 2|Reason not Specified|1|||
163880485|NCT03393975|591933369|FG002|Prophylaxis Period 2|Reason not Specified|0|||
163880486|NCT03393975|591933370|FG003|Prophylaxis Period 2|Reason not Specified|0|||
163880487|NCT02592330|591933371|FG000|Overall Study|Withdrawal by Subject|1|||
163880488|NCT02592330|591933372|FG001|Overall Study|Withdrawal by Subject|0|||
163880489|NCT02592330|591933371|FG000|Overall Study|Failed Biopsy|1|||
163880490|NCT02592330|591933372|FG001|Overall Study|Failed Biopsy|0|||
163880491|NCT03090152|591933373|FG000|Overall Study|Withdrawal by Subject|0|||
163880492|NCT03090152|591933374|FG001|Overall Study|Withdrawal by Subject|2|||
163880493|NCT03090152|591933375|FG002|Overall Study|Withdrawal by Subject|1|||
163880494|NCT03090152|591933373|FG000|Overall Study|Surgery Canceled|1|||
163880495|NCT03090152|591933374|FG001|Overall Study|Surgery Canceled|0|||
163880496|NCT03090152|591933375|FG002|Overall Study|Surgery Canceled|0|||
163880497|NCT03090152|591933373|FG000|Overall Study|Epidural catheter could not be placed|0|||
163880498|NCT03090152|591933374|FG001|Overall Study|Epidural catheter could not be placed|2|||
163880499|NCT03090152|591933375|FG002|Overall Study|Epidural catheter could not be placed|0|||
163880500|NCT03958955|591933376|FG000|Overall Study|Adverse Event|1|||
164080197|NCT03940586|592657790|FG001|Overall Study|Death|2|||
164080198|NCT03940586|592657791|FG002|Overall Study|Death|0|||
164224479|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
164224480|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
164224481|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
164224482|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
164224483|NCT01755156|593190252|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
164224484|NCT01755156|593190253|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
164224485|NCT01755156|593190252|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
164224486|NCT01755156|593190253|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
164224487|NCT01755156|593190252|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
164224488|NCT01755156|593190253|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
164224489|NCT03048019|593190254|FG000|Overall Study|Adverse Event|1|||
164224490|NCT03048019|593190255|FG001|Overall Study|Adverse Event|0|||
164224491|NCT01730729|593190256|FG000|Overall Study|Adverse Event|1|||
164224492|NCT01730729|593190256|FG000|Overall Study|Death|1|||
164224493|NCT01730729|593190256|FG000|Overall Study|Progressive Disease|12|||
164224494|NCT00382863|593190257|FG000|Overall Study|Death|9|||
164224495|NCT00382863|593190258|FG001|Overall Study|Death|9|||
164224496|NCT00382863|593190257|FG000|Overall Study|Lost to Follow-up|1|||
164224497|NCT00382863|593190258|FG001|Overall Study|Lost to Follow-up|2|||
164224498|NCT00382863|593190257|FG000|Overall Study|Withdrawal by Subject|5|||
164224499|NCT00382863|593190258|FG001|Overall Study|Withdrawal by Subject|25|||
164224500|NCT01292473|593190261|FG000|Overall Study|Adverse Event|1|||
164224501|NCT01292473|593190262|FG001|Overall Study|Adverse Event|0|||
164224502|NCT01292473|593190263|FG002|Overall Study|Adverse Event|1|||
164224503|NCT01292473|593190264|FG003|Overall Study|Adverse Event|1|||
164224504|NCT01292473|593190261|FG000|Overall Study|Lost to Follow-up|1|||
164224505|NCT01292473|593190262|FG001|Overall Study|Lost to Follow-up|1|||
164224506|NCT01292473|593190263|FG002|Overall Study|Lost to Follow-up|2|||
164224507|NCT01292473|593190264|FG003|Overall Study|Lost to Follow-up|2|||
164224508|NCT01292473|593190261|FG000|Overall Study|Withdrawal by Subject|3|||
164224509|NCT01292473|593190262|FG001|Overall Study|Withdrawal by Subject|4|||
164224510|NCT01292473|593190263|FG002|Overall Study|Withdrawal by Subject|3|||
164224511|NCT01292473|593190264|FG003|Overall Study|Withdrawal by Subject|3|||
164224512|NCT01292473|593190261|FG000|Overall Study|Physician Decision|0|||
164224513|NCT01292473|593190262|FG001|Overall Study|Physician Decision|1|||
164224514|NCT01292473|593190263|FG002|Overall Study|Physician Decision|0|||
164224515|NCT01292473|593190264|FG003|Overall Study|Physician Decision|0|||
164224516|NCT01292473|593190261|FG000|Overall Study|Disease Progression|0|||
164224517|NCT01292473|593190262|FG001|Overall Study|Disease Progression|1|||
164224518|NCT01292473|593190263|FG002|Overall Study|Disease Progression|3|||
164224519|NCT01292473|593190264|FG003|Overall Study|Disease Progression|6|||
164224520|NCT00203242|593190265|FG000|Overall Study|Lost to Follow-up|1|||
164224521|NCT00449787|593190266|FG000|Overall Study|Lost to Follow-up|10|||
164224522|NCT00449787|593190267|FG001|Overall Study|Lost to Follow-up|8|||
164224523|NCT00449787|593190266|FG000|Overall Study|Did not require medication|95|||
164224524|NCT00449787|593190267|FG001|Overall Study|Did not require medication|92|||
164224525|NCT02094885|593190273|FG000|Overall Study|Death|1|||
164224526|NCT02094885|593190274|FG001|Overall Study|Death|5|||
164224527|NCT02094885|593190273|FG000|Overall Study|Withdrawn due to age|1|||
164224528|NCT02094885|593190274|FG001|Overall Study|Withdrawn due to age|0|||
164224529|NCT01061710|593190275|FG000|Overall Study|Protocol Violation|14|||
164224530|NCT01903720|593190276|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
164224531|NCT01903720|593190276|FG000|Overall Study|Adverse Event|1|||
164224532|NCT01903720|593190276|FG000|Overall Study|Rescinding of informed consent|2|||
164224533|NCT01903720|593190276|FG000|Overall Study|Lost to Follow-up|2|||
164224534|NCT01903720|593190276|FG000|Overall Study|Treatment with alternative drug|1|||
164224535|NCT00552279|593190285|FG000|Overall Study|Adverse Event|0|||
164224536|NCT00552279|593190286|FG001|Overall Study|Adverse Event|1|||
164224537|NCT00552279|593190285|FG000|Overall Study|Withdrawal by Subject|12|||
164224538|NCT00552279|593190286|FG001|Overall Study|Withdrawal by Subject|1|||
164224539|NCT00552279|593190285|FG000|Overall Study|Lost to Follow-up|1|||
164224540|NCT00552279|593190286|FG001|Overall Study|Lost to Follow-up|0|||
164224541|NCT00552279|593190285|FG000|Overall Study|Other|1|||
164224542|NCT00552279|593190286|FG001|Overall Study|Other|1|||
164224543|NCT02150863|593190287|FG000|Overall Study|Lost to Follow-up|0|||
164224544|NCT02150863|593190288|FG001|Overall Study|Lost to Follow-up|1|||
164224545|NCT02150863|593190289|FG002|Overall Study|Lost to Follow-up|0|||
164224546|NCT04829214|593190290|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
164224547|NCT04829214|593190291|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
164224548|NCT04829214|593190290|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
163880501|NCT04673929|591933377|FG000|Overall Study|Death|73|||
163880502|NCT04673929|591933377|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
164224549|NCT04829214|593190291|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
164224550|NCT05287685|593190292|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
164224551|NCT05287685|593190293|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
164224552|NCT05287685|593190292|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
164224553|NCT05287685|593190293|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
164224554|NCT06399471|593190294|FG000|Overall Study|Withdrawal by Subject|1|||
164224555|NCT04008069|593190295|FG000|Open-Label Period|Adverse Event|1|||
164224556|NCT04008069|593190296|FG001|Open-Label Period|Adverse Event|0|||
164224557|NCT04008069|593190297|FG002|Open-Label Period|Adverse Event|0|||
164224558|NCT04008069|593190295|FG000|Open-Label Period|Lack of Efficacy|4|||
164224559|NCT04008069|593190296|FG001|Open-Label Period|Lack of Efficacy|0|||
164224560|NCT04008069|593190297|FG002|Open-Label Period|Lack of Efficacy|0|||
164224561|NCT04008069|593190295|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
164224562|NCT04008069|593190296|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
164224563|NCT04008069|593190297|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
164224564|NCT04008069|593190295|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
164224565|NCT04008069|593190296|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
164224566|NCT04008069|593190297|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
164224567|NCT00511199|593190298|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
164224568|NCT00511199|593190299|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
164224569|NCT00511199|593190298|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
164224570|NCT00511199|593190299|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
164224571|NCT00511199|593190298|FG000|Overall Study|Withdrawal of Informed Consent|19|||
164224572|NCT00511199|593190299|FG001|Overall Study|Withdrawal of Informed Consent|4|||
164224573|NCT00511199|593190298|FG000|Overall Study|Pregnancy|6|||
164224574|NCT00511199|593190299|FG001|Overall Study|Pregnancy|3|||
164224575|NCT00511199|593190298|FG000|Overall Study|Pregnancy Wish|16|||
164224576|NCT00511199|593190299|FG001|Overall Study|Pregnancy Wish|8|||
164224577|NCT00511199|593190298|FG000|Overall Study|Lost to Follow-up|40|||
164224578|NCT00511199|593190299|FG001|Overall Study|Lost to Follow-up|17|||
164224579|NCT00511199|593190298|FG000|Overall Study|Other Reason|78|||
164224580|NCT00511199|593190299|FG001|Overall Study|Other Reason|37|||
164224581|NCT01570192|593190305|FG000|Overall Study|no qualifying organism|6|||
164224582|NCT01570192|593190306|FG001|Overall Study|no qualifying organism|12|||
164224583|NCT01570192|593190305|FG000|Overall Study|changed to palliative care|1|||
164224584|NCT01570192|593190306|FG001|Overall Study|changed to palliative care|0|||
164224585|NCT01570192|593190305|FG000|Overall Study|Physician Decision|0|||
164224586|NCT01570192|593190306|FG001|Overall Study|Physician Decision|1|||
164224587|NCT02965976|593190307|FG000|Overall Study|Withdrawal by Subject|2|||
164224588|NCT02965976|593190308|FG001|Overall Study|Withdrawal by Subject|0|||
164224589|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
164224590|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
164224591|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
164224592|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
164224593|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
164224594|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
164224595|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
164224596|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
164224597|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
164224598|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
164224599|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
164224600|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
164224601|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
164224602|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
164224603|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
164224604|NCT00407030|593190309|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
164224605|NCT00407030|593190310|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
164224606|NCT00407030|593190311|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
164224607|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
163983835|NCT03215030|592310112|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983836|NCT03215030|592310113|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983837|NCT03215030|592310114|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983838|NCT03215030|592310115|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163983839|NCT03215030|592310104|FG000|Part 2: Dose Expansion|Death|0|||
163983840|NCT03215030|592310105|FG001|Part 2: Dose Expansion|Death|0|||
163983841|NCT03215030|592310106|FG002|Part 2: Dose Expansion|Death|0|||
163983842|NCT03215030|592310107|FG003|Part 2: Dose Expansion|Death|0|||
163983843|NCT03215030|592310108|FG004|Part 2: Dose Expansion|Death|3|||
163983844|NCT03215030|592310109|FG005|Part 2: Dose Expansion|Death|1|||
163983845|NCT03215030|592310110|FG006|Part 2: Dose Expansion|Death|5|||
164080199|NCT03940586|592657789|FG000|Overall Study|Physician Decision|1|||
164080200|NCT03940586|592657790|FG001|Overall Study|Physician Decision|0|||
164080201|NCT03940586|592657791|FG002|Overall Study|Physician Decision|1|||
164080202|NCT03940586|592657789|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
164224608|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
164224609|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
164224610|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
164224611|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
163880503|NCT02807636|591933381|FG000|Overall Study|Lost to Follow-up|10|||
163983846|NCT03215030|592310111|FG007|Part 2: Dose Expansion|Death|4|||
163983847|NCT03215030|592310112|FG008|Part 2: Dose Expansion|Death|0|||
163983848|NCT03215030|592310113|FG009|Part 2: Dose Expansion|Death|0|||
163983849|NCT03215030|592310114|FG010|Part 2: Dose Expansion|Death|0|||
163983850|NCT03215030|592310115|FG011|Part 2: Dose Expansion|Death|0|||
163983851|NCT03215030|592310104|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
163983852|NCT03215030|592310105|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
163983853|NCT03215030|592310106|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
164080203|NCT03940586|592657790|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
164080204|NCT03940586|592657791|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
164080205|NCT03940586|592657789|FG000|Overall Study|Not Treated|0|||
164080206|NCT03940586|592657790|FG001|Overall Study|Not Treated|2|||
164080207|NCT03940586|592657791|FG002|Overall Study|Not Treated|0|||
164080208|NCT04304950|592657792|FG000|Overall Study|Lost to Follow-up|1|||
164080209|NCT04304950|592657793|FG001|Overall Study|Lost to Follow-up|1|||
164080210|NCT02006147|592657794|FG000|Overall Study|Protocol Violation|1|||
164080211|NCT02006147|592657795|FG001|Overall Study|Protocol Violation|1|||
164080212|NCT02006147|592657796|FG002|Overall Study|Protocol Violation|0|||
164080213|NCT02006147|592657797|FG003|Overall Study|Protocol Violation|0|||
164080214|NCT02006147|592657794|FG000|Overall Study|Withdrawal by Subject|0|||
164080215|NCT02006147|592657795|FG001|Overall Study|Withdrawal by Subject|1|||
164329140|NCT03172910|593583232|FG000|Overall Study|Adverse Event|0|||
163880504|NCT02807636|591933382|FG001|Overall Study|Lost to Follow-up|13|||
163880505|NCT02807636|591933383|FG002|Overall Study|Lost to Follow-up|6|||
163880506|NCT02807636|591933381|FG000|Overall Study|Protocol Deviation|1|||
163880507|NCT02807636|591933382|FG001|Overall Study|Protocol Deviation|0|||
163880508|NCT02807636|591933383|FG002|Overall Study|Protocol Deviation|0|||
163880509|NCT02807636|591933381|FG000|Overall Study|Symptomatic Deterioration|0|||
163880510|NCT02807636|591933382|FG001|Overall Study|Symptomatic Deterioration|1|||
163880511|NCT02807636|591933383|FG002|Overall Study|Symptomatic Deterioration|0|||
163880512|NCT02807636|591933381|FG000|Overall Study|Withdrawal by Subject|39|||
163880513|NCT02807636|591933382|FG001|Overall Study|Withdrawal by Subject|28|||
163880514|NCT02807636|591933383|FG002|Overall Study|Withdrawal by Subject|24|||
163880515|NCT02807636|591933381|FG000|Overall Study|Death|303|||
163880516|NCT02807636|591933382|FG001|Overall Study|Death|332|||
163880517|NCT02807636|591933383|FG002|Overall Study|Death|272|||
163880518|NCT02807636|591933381|FG000|Overall Study|Study Terminated By Sponsor|47|||
163880519|NCT02807636|591933382|FG001|Overall Study|Study Terminated By Sponsor|76|||
163880520|NCT02807636|591933383|FG002|Overall Study|Study Terminated By Sponsor|60|||
163880521|NCT02807636|591933381|FG000|Overall Study|Physician Decision|0|||
163880522|NCT02807636|591933382|FG001|Overall Study|Physician Decision|1|||
163880523|NCT02807636|591933383|FG002|Overall Study|Physician Decision|0|||
163880524|NCT05082909|591933384|FG000|Overall Study|Protocol Violation|0|||
163880525|NCT05082909|591933385|FG001|Overall Study|Protocol Violation|0|||
163880526|NCT05082909|591933386|FG002|Overall Study|Protocol Violation|1|||
163880527|NCT05082909|591933387|FG003|Overall Study|Protocol Violation|0|||
163880528|NCT05082909|591933388|FG004|Overall Study|Protocol Violation|0|||
163880529|NCT05082909|591933389|FG005|Overall Study|Protocol Violation|0|||
163880530|NCT04088630|591933390|FG000|Overall Study|Lost to Follow-up|3|||
163880531|NCT04088630|591933391|FG001|Overall Study|Lost to Follow-up|2|||
163880532|NCT04088630|591933392|FG002|Overall Study|Lost to Follow-up|6|||
163880533|NCT04088630|591933390|FG000|Overall Study|Death|3|||
163880534|NCT04088630|591933391|FG001|Overall Study|Death|1|||
163880535|NCT04088630|591933392|FG002|Overall Study|Death|1|||
163880536|NCT04088630|591933390|FG000|Overall Study|Physician Decision|0|||
163880537|NCT04088630|591933391|FG001|Overall Study|Physician Decision|1|||
163880538|NCT04088630|591933392|FG002|Overall Study|Physician Decision|1|||
163880539|NCT03526861|591933409|FG000|Initial Treatment Period|Not dosed|1|||
163880540|NCT03526861|591933410|FG001|Initial Treatment Period|Not dosed|1|||
163880541|NCT03526861|591933411|FG002|Initial Treatment Period|Not dosed|1|||
163880542|NCT03526861|591933412|FG003|Initial Treatment Period|Not dosed|0|||
163880543|NCT03526861|591933413|FG004|Initial Treatment Period|Not dosed|0|||
163880544|NCT03526861|591933414|FG005|Initial Treatment Period|Not dosed|0|||
163880545|NCT03526861|591933415|FG006|Initial Treatment Period|Not dosed|0|||
163880546|NCT03526861|591933416|FG007|Initial Treatment Period|Not dosed|0|||
163880547|NCT03526861|591933417|FG008|Initial Treatment Period|Not dosed|0|||
163880548|NCT03526861|591933409|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
163880549|NCT03526861|591933410|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
163880550|NCT03526861|591933411|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
163880551|NCT03526861|591933412|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
164080216|NCT02006147|592657796|FG002|Overall Study|Withdrawal by Subject|0|||
164080217|NCT02006147|592657797|FG003|Overall Study|Withdrawal by Subject|0|||
164080218|NCT02006147|592657794|FG000|Overall Study|Withdrawal by Sponsor|1|||
164080219|NCT02006147|592657795|FG001|Overall Study|Withdrawal by Sponsor|0|||
163983854|NCT03215030|592310107|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
163983855|NCT03215030|592310108|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
163983856|NCT03215030|592310109|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
163983857|NCT03215030|592310110|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
163983858|NCT03215030|592310111|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
163983859|NCT03215030|592310112|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
163983860|NCT03215030|592310113|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
163983861|NCT03215030|592310114|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
163983862|NCT03215030|592310115|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
163983863|NCT03215030|592310104|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
163983864|NCT03215030|592310105|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
163983865|NCT03215030|592310106|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
163983866|NCT03215030|592310107|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
163983867|NCT03215030|592310108|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
163983868|NCT03215030|592310109|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
163983869|NCT03215030|592310110|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
163983870|NCT03215030|592310111|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
163983871|NCT03215030|592310112|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
163983872|NCT03215030|592310113|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
163983873|NCT03215030|592310114|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
163983874|NCT03215030|592310115|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
163983875|NCT03215030|592310104|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983876|NCT03215030|592310105|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983877|NCT03215030|592310106|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983878|NCT03215030|592310107|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983879|NCT03215030|592310108|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983880|NCT03215030|592310109|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983881|NCT03215030|592310110|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983882|NCT03215030|592310111|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983883|NCT03215030|592310112|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
163983884|NCT03215030|592310113|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
163983885|NCT03215030|592310114|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983886|NCT03215030|592310115|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
163983887|NCT03215030|592310104|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983888|NCT03215030|592310105|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983889|NCT03215030|592310106|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983890|NCT03215030|592310107|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983891|NCT03215030|592310108|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983892|NCT03215030|592310109|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983893|NCT03215030|592310110|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983894|NCT03215030|592310111|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983895|NCT03215030|592310112|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
163983896|NCT03215030|592310113|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
163983897|NCT03215030|592310114|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983898|NCT03215030|592310115|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
163983899|NCT03215030|592310104|FG000|Part 3: Dose Extension|Death|0|||
163983900|NCT03215030|592310105|FG001|Part 3: Dose Extension|Death|0|||
163983901|NCT03215030|592310106|FG002|Part 3: Dose Extension|Death|0|||
163983902|NCT03215030|592310107|FG003|Part 3: Dose Extension|Death|0|||
163983903|NCT03215030|592310108|FG004|Part 3: Dose Extension|Death|0|||
163983904|NCT03215030|592310109|FG005|Part 3: Dose Extension|Death|0|||
163880552|NCT03526861|591933413|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880553|NCT03526861|591933414|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880554|NCT03526861|591933415|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880555|NCT03526861|591933416|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880556|NCT03526861|591933417|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880557|NCT03526861|591933409|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
163880558|NCT03526861|591933410|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
163880559|NCT03526861|591933411|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
163880560|NCT03526861|591933412|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163880561|NCT03526861|591933413|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163880562|NCT03526861|591933414|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163880563|NCT03526861|591933415|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163880564|NCT03526861|591933416|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163983905|NCT03215030|592310110|FG006|Part 3: Dose Extension|Death|0|||
163983906|NCT03215030|592310111|FG007|Part 3: Dose Extension|Death|0|||
163983907|NCT03215030|592310112|FG008|Part 3: Dose Extension|Death|19|||
163983908|NCT03215030|592310113|FG009|Part 3: Dose Extension|Death|20|||
163983909|NCT03215030|592310114|FG010|Part 3: Dose Extension|Death|0|||
163983910|NCT03215030|592310115|FG011|Part 3: Dose Extension|Death|0|||
163983911|NCT03215030|592310104|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
163983912|NCT03215030|592310105|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
163983913|NCT03215030|592310106|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
163983914|NCT03215030|592310107|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
163983915|NCT03215030|592310108|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
163983916|NCT03215030|592310109|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
163983917|NCT03215030|592310110|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
163983918|NCT03215030|592310111|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
163983919|NCT03215030|592310112|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
163983920|NCT03215030|592310113|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
163983921|NCT03215030|592310114|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
163983922|NCT03215030|592310115|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
163983923|NCT03215030|592310104|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983924|NCT03215030|592310105|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983925|NCT03215030|592310106|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983926|NCT03215030|592310107|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983927|NCT03215030|592310108|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983928|NCT03215030|592310109|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983929|NCT03215030|592310110|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983930|NCT03215030|592310111|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983931|NCT03215030|592310112|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983932|NCT03215030|592310113|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
163983933|NCT03215030|592310114|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
164080220|NCT02006147|592657796|FG002|Overall Study|Withdrawal by Sponsor|0|||
163983934|NCT03215030|592310115|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
163983935|NCT01745146|592310116|FG000|Overall Study|Withdrawal by Subject|1|||
163983936|NCT01745146|592310117|FG001|Overall Study|Withdrawal by Subject|3|||
163983937|NCT01745146|592310116|FG000|Overall Study|Lost to Follow-up|2|||
163983938|NCT01745146|592310117|FG001|Overall Study|Lost to Follow-up|0|||
163983939|NCT00130832|592310118|FG000|Overall Study|Adverse Event|1|||
163983940|NCT00130832|592310119|FG001|Overall Study|Adverse Event|1|||
163983941|NCT00130832|592310118|FG000|Overall Study|Lost to Follow-up|1|||
163983942|NCT00130832|592310119|FG001|Overall Study|Lost to Follow-up|2|||
163983943|NCT00130832|592310118|FG000|Overall Study|Protocol Violation|6|||
163983944|NCT00130832|592310119|FG001|Overall Study|Protocol Violation|8|||
163983945|NCT00130832|592310118|FG000|Overall Study|Withdrawal by Subject|6|||
163983946|NCT00130832|592310119|FG001|Overall Study|Withdrawal by Subject|1|||
163983947|NCT00130832|592310118|FG000|Overall Study|Moved|2|||
163983948|NCT00130832|592310119|FG001|Overall Study|Moved|2|||
163983949|NCT00130832|592310118|FG000|Overall Study|Other|0|||
163983950|NCT00130832|592310119|FG001|Overall Study|Other|3|||
163983951|NCT02770326|592310121|FG000|Overall Study|Death|3|||
163983952|NCT02770326|592310121|FG000|Overall Study|Lost to Follow-up|1|||
163983953|NCT01885000|592310122|FG000|Overall Study|Adverse Event|1|||
163983954|NCT01885000|592310123|FG001|Overall Study|Adverse Event|0|||
163983955|NCT01885000|592310122|FG000|Overall Study|Withdrawal by Subject|1|||
163983956|NCT01885000|592310123|FG001|Overall Study|Withdrawal by Subject|1|||
163983957|NCT01885000|592310122|FG000|Overall Study|Protocol Violation|0|||
163983958|NCT01885000|592310123|FG001|Overall Study|Protocol Violation|1|||
163983959|NCT02792842|592310124|FG000|Overall Study|Adverse Event|4|||
163983960|NCT02792842|592310125|FG001|Overall Study|Adverse Event|2|||
163983961|NCT02792842|592310126|FG002|Overall Study|Adverse Event|3|||
163983962|NCT02792842|592310124|FG000|Overall Study|Withdrawal by Subject|0|||
163983963|NCT02792842|592310125|FG001|Overall Study|Withdrawal by Subject|1|||
163983964|NCT02792842|592310126|FG002|Overall Study|Withdrawal by Subject|2|||
163983965|NCT02792842|592310124|FG000|Overall Study|Lost to Follow-up|0|||
163983966|NCT02792842|592310125|FG001|Overall Study|Lost to Follow-up|0|||
163983967|NCT02792842|592310126|FG002|Overall Study|Lost to Follow-up|1|||
163983968|NCT02792842|592310124|FG000|Overall Study|Schedule delay|0|||
163983969|NCT02792842|592310125|FG001|Overall Study|Schedule delay|1|||
163983970|NCT02792842|592310126|FG002|Overall Study|Schedule delay|1|||
163983971|NCT02363686|592310129|FG000|Overall Study|Withdrawal by Subject|22|||
163983972|NCT02363686|592310129|FG000|Overall Study|incomplete FEES examinations|13|||
163983973|NCT00577993|592310136|FG000|Overall Study|Adverse Event|1|||
163983974|NCT00577993|592310137|FG001|Overall Study|Adverse Event|0|||
163983975|NCT00577993|592310138|FG002|Overall Study|Adverse Event|0|||
163983976|NCT00577993|592310136|FG000|Overall Study|Death|0|||
163983977|NCT00577993|592310137|FG001|Overall Study|Death|1|||
163983978|NCT00577993|592310138|FG002|Overall Study|Death|1|||
163983979|NCT00577993|592310136|FG000|Overall Study|Lack of Efficacy|0|||
163983980|NCT00577993|592310137|FG001|Overall Study|Lack of Efficacy|1|||
163983981|NCT00577993|592310138|FG002|Overall Study|Lack of Efficacy|0|||
163983982|NCT00577993|592310136|FG000|Overall Study|Protocol Violation|2|||
163983983|NCT00577993|592310137|FG001|Overall Study|Protocol Violation|3|||
164080221|NCT02006147|592657797|FG003|Overall Study|Withdrawal by Sponsor|0|||
164080222|NCT03182686|592657802|FG000|Overall Study|Lost to Follow-up|2|||
164080223|NCT03182686|592657803|FG001|Overall Study|Lost to Follow-up|0|||
164080224|NCT03182686|592657802|FG000|Overall Study|Adverse Event|2|||
164080225|NCT03182686|592657803|FG001|Overall Study|Adverse Event|0|||
164080226|NCT03182686|592657802|FG000|Overall Study|Withdrawal by Subject|3|||
164080227|NCT03182686|592657803|FG001|Overall Study|Withdrawal by Subject|0|||
164080228|NCT01154127|592657804|FG000|Period 1 (21 Days)|Adverse Event|3|||
164080229|NCT01154127|592657805|FG001|Period 1 (21 Days)|Adverse Event|4|||
164080230|NCT01154127|592657804|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
164080231|NCT01154127|592657805|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
164080232|NCT01154127|592657804|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
164080233|NCT01154127|592657805|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
164080234|NCT01154127|592657804|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
164080235|NCT01154127|592657805|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
164080236|NCT01154127|592657804|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
164080237|NCT01154127|592657805|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
164080238|NCT01697449|592657806|FG000|Overall Study|Disease progression|47|||
164080239|NCT01697449|592657806|FG000|Overall Study|Adverse Event|7|||
164080240|NCT01697449|592657806|FG000|Overall Study|Lost to Follow-up|5|||
164080241|NCT01697449|592657806|FG000|Overall Study|Withdrawal by Subject|2|||
164080242|NCT01697449|592657806|FG000|Overall Study|Physician Decision|1|||
164080243|NCT01697449|592657806|FG000|Overall Study|Death|2|||
164080244|NCT01697449|592657806|FG000|Overall Study|Other|1|||
164080245|NCT01697449|592657806|FG000|Overall Study|Missing|25|||
164080246|NCT01337050|592657807|FG000|Overall Study|Death|0|||
163880565|NCT03526861|591933417|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
163880566|NCT03526861|591933409|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880567|NCT03526861|591933410|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880568|NCT03526861|591933411|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880569|NCT03526861|591933412|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
163880570|NCT03526861|591933413|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
163880571|NCT03526861|591933414|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880572|NCT03526861|591933415|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
163880573|NCT03526861|591933416|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880574|NCT03526861|591933417|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880575|NCT03526861|591933409|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163880576|NCT03526861|591933410|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163880577|NCT03526861|591933411|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163880578|NCT03526861|591933412|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
163880579|NCT03526861|591933413|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
163880580|NCT03526861|591933414|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
163880581|NCT03526861|591933415|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
163880582|NCT03526861|591933416|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
163880583|NCT03526861|591933417|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
163880584|NCT03526861|591933409|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880585|NCT03526861|591933410|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880586|NCT03526861|591933411|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880587|NCT03526861|591933412|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
163880588|NCT03526861|591933413|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880589|NCT03526861|591933414|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880590|NCT03526861|591933415|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880591|NCT03526861|591933416|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880592|NCT03526861|591933417|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880593|NCT03526861|591933409|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880594|NCT03526861|591933410|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880595|NCT03526861|591933411|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880596|NCT03526861|591933412|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
164080247|NCT01337050|592657808|FG001|Overall Study|Death|0|||
164080248|NCT01337050|592657809|FG002|Overall Study|Death|4|||
164080249|NCT01337050|592657807|FG000|Overall Study|Other|4|||
164080250|NCT01337050|592657808|FG001|Overall Study|Other|6|||
164080251|NCT01337050|592657809|FG002|Overall Study|Other|8|||
164080252|NCT01337050|592657807|FG000|Overall Study|Participants refused further follow-up|0|||
164080253|NCT01337050|592657808|FG001|Overall Study|Participants refused further follow-up|7|||
164080254|NCT01337050|592657809|FG002|Overall Study|Participants refused further follow-up|7|||
163983984|NCT00577993|592310138|FG002|Overall Study|Protocol Violation|0|||
163983985|NCT00577993|592310136|FG000|Overall Study|Withdrawal by Subject|1|||
163983986|NCT00577993|592310137|FG001|Overall Study|Withdrawal by Subject|0|||
163983987|NCT00577993|592310138|FG002|Overall Study|Withdrawal by Subject|2|||
164080255|NCT00003102|592657810|FG000|Overall Study|Physician Decision|1|||
164080256|NCT00003102|592657811|FG001|Overall Study|Physician Decision|1|||
163983988|NCT00577993|592310136|FG000|Overall Study|Conversion|2|||
163983989|NCT00577993|592310137|FG001|Overall Study|Conversion|5|||
163983990|NCT00577993|592310138|FG002|Overall Study|Conversion|0|||
163983991|NCT00577993|592310136|FG000|Overall Study|Uninsured|1|||
164080257|NCT00003102|592657812|FG002|Overall Study|Physician Decision|0|||
164080258|NCT00003102|592657810|FG000|Overall Study|Progressive Disease|0|||
163983992|NCT00577993|592310137|FG001|Overall Study|Uninsured|0|||
163983993|NCT00577993|592310138|FG002|Overall Study|Uninsured|0|||
163983994|NCT02217566|592310139|FG000|Overall Study|Lost to Follow-up|2|||
163983995|NCT02217566|592310139|FG000|Overall Study|Death|3|||
163983996|NCT02217566|592310139|FG000|Overall Study|Early study termination|6|||
163983997|NCT02064387|592310144|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
164080259|NCT00003102|592657811|FG001|Overall Study|Progressive Disease|1|||
164080260|NCT00003102|592657812|FG002|Overall Study|Progressive Disease|0|||
164080261|NCT00003102|592657810|FG000|Overall Study|Adverse Event|0|||
164080262|NCT00003102|592657811|FG001|Overall Study|Adverse Event|1|||
164080263|NCT00003102|592657812|FG002|Overall Study|Adverse Event|1|||
164080264|NCT00003102|592657810|FG000|Overall Study|Death|0|||
164080265|NCT00003102|592657811|FG001|Overall Study|Death|0|||
164080266|NCT00003102|592657812|FG002|Overall Study|Death|1|||
164080267|NCT05037409|592657813|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
164080268|NCT05037409|592657814|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
164080269|NCT05037409|592657815|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
164080270|NCT01559818|592657818|FG000|Overall Study|Physician Decision|1|||
164080271|NCT01559818|592657818|FG000|Overall Study|Pregnancy|1|||
164080272|NCT01559818|592657818|FG000|Overall Study|Study terminated by Sponsor|4|||
164080273|NCT01559818|592657818|FG000|Overall Study|Withdrawal by Subject|1|||
164080274|NCT01512979|592657820|FG000|Overall Study|Adverse Event|2|||
164080275|NCT01512979|592657821|FG001|Overall Study|Adverse Event|2|||
164080276|NCT01512979|592657820|FG000|Overall Study|Protocol Violation|1|||
164080277|NCT01512979|592657821|FG001|Overall Study|Protocol Violation|4|||
164080278|NCT01512979|592657820|FG000|Overall Study|Lost to Follow-up|2|||
164080279|NCT01512979|592657821|FG001|Overall Study|Lost to Follow-up|5|||
164080280|NCT01512979|592657820|FG000|Overall Study|Withdrawal by Subject|1|||
164080281|NCT01512979|592657821|FG001|Overall Study|Withdrawal by Subject|2|||
164080282|NCT01512979|592657820|FG000|Overall Study|Reason other than stated above|13|||
164080283|NCT01512979|592657821|FG001|Overall Study|Reason other than stated above|9|||
164080284|NCT00529568|592657822|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
164080285|NCT00529568|592657823|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
164080286|NCT00529568|592657824|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
164080287|NCT00529568|592657822|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
164080288|NCT00529568|592657823|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
164080289|NCT00529568|592657824|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
164080290|NCT00529568|592657822|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
164080291|NCT00529568|592657823|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
164080292|NCT00529568|592657824|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
164080293|NCT00529568|592657822|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
164080294|NCT00529568|592657823|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
163983998|NCT02064387|592310145|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163983999|NCT02064387|592310146|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984000|NCT02064387|592310147|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984001|NCT02064387|592310148|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984002|NCT02064387|592310149|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984003|NCT02064387|592310150|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984004|NCT02064387|592310151|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
163984005|NCT02064387|592310152|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984006|NCT02064387|592310153|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
163984007|NCT02064387|592310154|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984008|NCT02064387|592310155|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
163984009|NCT02064387|592310144|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
164080295|NCT00529568|592657824|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
164080296|NCT00529568|592657822|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
164080297|NCT00529568|592657823|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
164138824|NCT02329847|592870175|FG002|Overall Study|Lost to Follow-up|2|||
163984010|NCT02064387|592310145|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984011|NCT02064387|592310146|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984012|NCT02064387|592310147|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984013|NCT02064387|592310148|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984014|NCT02064387|592310149|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984015|NCT02064387|592310150|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984016|NCT02064387|592310151|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
163984017|NCT02064387|592310152|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984018|NCT02064387|592310153|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984019|NCT02064387|592310154|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984020|NCT02064387|592310155|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
163984021|NCT02064387|592310144|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984022|NCT02064387|592310145|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984023|NCT02064387|592310146|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984024|NCT02064387|592310147|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984025|NCT02064387|592310148|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984026|NCT02064387|592310149|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984027|NCT02064387|592310150|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984028|NCT02064387|592310151|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984029|NCT02064387|592310152|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
163984030|NCT02064387|592310153|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984031|NCT02064387|592310154|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984032|NCT02064387|592310155|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
163984033|NCT02064387|592310144|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
163984034|NCT02064387|592310145|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
163984035|NCT02064387|592310146|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
163984036|NCT02064387|592310147|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
163984037|NCT02064387|592310148|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
163984038|NCT02064387|592310149|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
163984039|NCT02064387|592310150|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
163984040|NCT02064387|592310151|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
163984041|NCT02064387|592310152|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
163984042|NCT02064387|592310153|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
163984043|NCT02064387|592310154|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
163984044|NCT02064387|592310155|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
163984045|NCT02064387|592310144|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984046|NCT02064387|592310145|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984047|NCT02064387|592310146|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984048|NCT02064387|592310147|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984049|NCT02064387|592310148|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984050|NCT02064387|592310149|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984051|NCT02064387|592310150|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984052|NCT02064387|592310151|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984053|NCT02064387|592310152|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984054|NCT02064387|592310153|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984055|NCT02064387|592310154|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
163984056|NCT02064387|592310155|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
163984057|NCT02436876|592310159|FG000|Overall Study|Lost to Follow-up|0|||
163984058|NCT02436876|592310160|FG001|Overall Study|Lost to Follow-up|1|||
163984059|NCT02436876|592310161|FG002|Overall Study|Lost to Follow-up|1|||
163984060|NCT02436876|592310162|FG003|Overall Study|Lost to Follow-up|1|||
163984061|NCT02436876|592310159|FG000|Overall Study|Withdrawal by Subject|1|||
163984062|NCT02436876|592310160|FG001|Overall Study|Withdrawal by Subject|0|||
163984063|NCT02436876|592310161|FG002|Overall Study|Withdrawal by Subject|0|||
163984064|NCT02436876|592310162|FG003|Overall Study|Withdrawal by Subject|1|||
164080298|NCT00529568|592657824|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
164080299|NCT00529568|592657822|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
164080300|NCT00529568|592657823|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
164080301|NCT00529568|592657824|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
164080302|NCT00529568|592657822|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
164080303|NCT00529568|592657823|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
163984065|NCT02436876|592310159|FG000|Overall Study|Physician Decision|0|||
163984066|NCT02436876|592310160|FG001|Overall Study|Physician Decision|2|||
163984067|NCT02436876|592310161|FG002|Overall Study|Physician Decision|1|||
163984068|NCT02436876|592310162|FG003|Overall Study|Physician Decision|0|||
164080304|NCT00529568|592657824|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
164080305|NCT00529568|592657822|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
164080306|NCT00529568|592657823|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
164080307|NCT00529568|592657824|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
164080308|NCT00529568|592657822|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
164080309|NCT00529568|592657823|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
164080310|NCT00529568|592657824|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
164080311|NCT00529568|592657822|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
164080312|NCT00529568|592657823|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
164080313|NCT00529568|592657824|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
164080314|NCT00529568|592657822|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
164080315|NCT00529568|592657823|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
164080316|NCT00529568|592657824|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
164080317|NCT04049552|592657825|FG000|Overall Study|Lost to Follow-up|1|||
164080318|NCT00738920|592657827|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
164080319|NCT00738920|592657828|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
164080320|NCT00738920|592657829|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
164080321|NCT00738920|592657827|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
164080322|NCT00738920|592657828|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
164080323|NCT00738920|592657829|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
164080324|NCT00738920|592657827|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
164080325|NCT00738920|592657828|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
164080326|NCT00738920|592657829|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
164080327|NCT00738920|592657827|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
164080328|NCT00738920|592657828|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
164080329|NCT00738920|592657829|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
164080330|NCT00738920|592657827|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
164080331|NCT00738920|592657828|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
164080332|NCT00738920|592657829|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
164080333|NCT00738920|592657827|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
164080334|NCT00738920|592657828|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
164080335|NCT00738920|592657829|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
164080336|NCT00738920|592657827|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
164080337|NCT00738920|592657828|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
164080338|NCT00738920|592657829|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
164080339|NCT00738920|592657827|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
164080340|NCT00738920|592657828|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
164080341|NCT00738920|592657829|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
164080342|NCT00738920|592657827|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
164080343|NCT00738920|592657828|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
164080344|NCT00738920|592657829|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
164080345|NCT00738920|592657827|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
164080346|NCT00738920|592657828|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
164080347|NCT00738920|592657829|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
164080348|NCT04147611|592657833|FG000|Overall Study|Physician Decision|0|||
164080349|NCT04147611|592657834|FG001|Overall Study|Physician Decision|1|||
164080350|NCT01123980|592657839|FG000|Overall Study|Adverse Event|1|||
164080351|NCT01123980|592657840|FG001|Overall Study|Adverse Event|1|||
164080352|NCT01123980|592657839|FG000|Overall Study|Lack of Efficacy|1|||
164080353|NCT01123980|592657840|FG001|Overall Study|Lack of Efficacy|0|||
164080354|NCT01123980|592657839|FG000|Overall Study|Physician Decision|0|||
164080355|NCT01123980|592657840|FG001|Overall Study|Physician Decision|1|||
164080356|NCT01123980|592657839|FG000|Overall Study|Lost to Follow-up|0|||
164080357|NCT01123980|592657840|FG001|Overall Study|Lost to Follow-up|6|||
164080358|NCT01123980|592657839|FG000|Overall Study|Protocol Violation|6|||
164080359|NCT01123980|592657840|FG001|Overall Study|Protocol Violation|6|||
164080360|NCT01123980|592657839|FG000|Overall Study|Withdrawal by Subject|5|||
164080361|NCT01123980|592657840|FG001|Overall Study|Withdrawal by Subject|3|||
164080362|NCT01123980|592657839|FG000|Overall Study|Unclassified|6|||
164080363|NCT01123980|592657840|FG001|Overall Study|Unclassified|7|||
164080364|NCT04385199|592657841|FG000|Overall Study|Withdrawal by Subject|1|||
164080365|NCT04385199|592657842|FG001|Overall Study|Withdrawal by Subject|0|||
164080366|NCT02557672|592657843|FG000|Overall Study|Withdrawal by Subject|4|||
164080367|NCT02557672|592657844|FG001|Overall Study|Withdrawal by Subject|2|||
164080368|NCT03705169|592657845|FG000|Overall Study|Lost to Follow-up|0|||
164080369|NCT03705169|592657846|FG001|Overall Study|Lost to Follow-up|0|||
164080370|NCT03705169|592657847|FG002|Overall Study|Lost to Follow-up|0|||
164080371|NCT03705169|592657848|FG003|Overall Study|Lost to Follow-up|2|||
164080372|NCT03705169|592657849|FG004|Overall Study|Lost to Follow-up|0|||
164080373|NCT03705169|592657850|FG005|Overall Study|Lost to Follow-up|2|||
164080374|NCT03705169|592657851|FG006|Overall Study|Lost to Follow-up|1|||
163984069|NCT02436876|592310159|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
163984070|NCT02436876|592310160|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
163984071|NCT02436876|592310161|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
163984072|NCT02436876|592310162|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
163984073|NCT00075504|592310163|FG000|Overall Study|Withdrawal by Subject|9|||
163984074|NCT00075504|592310164|FG001|Overall Study|Withdrawal by Subject|7|||
163984075|NCT03127384|592310169|FG000|Overall Study|Lost to Follow-up|4|||
163984076|NCT03127384|592310169|FG000|Overall Study|Subject request|2|||
163984077|NCT00689871|592310170|FG000|Overall Study|Lost to Follow-up|123|||
163984078|NCT00689871|592310171|FG001|Overall Study|Lost to Follow-up|13|||
163984079|NCT00689871|592310172|FG002|Overall Study|Lost to Follow-up|37|||
163984080|NCT00689871|592310173|FG003|Overall Study|Lost to Follow-up|1|||
163984081|NCT00689871|592310170|FG000|Overall Study|Explanted of All Study Devices|36|||
163984082|NCT00689871|592310171|FG001|Overall Study|Explanted of All Study Devices|25|||
163984083|NCT00689871|592310172|FG002|Overall Study|Explanted of All Study Devices|29|||
163984084|NCT00689871|592310173|FG003|Overall Study|Explanted of All Study Devices|3|||
163984085|NCT00689871|592310170|FG000|Overall Study|Withdrawal by Subject|13|||
163984086|NCT00689871|592310171|FG001|Overall Study|Withdrawal by Subject|3|||
163984087|NCT00689871|592310172|FG002|Overall Study|Withdrawal by Subject|4|||
163984088|NCT00689871|592310173|FG003|Overall Study|Withdrawal by Subject|1|||
163984089|NCT00689871|592310170|FG000|Overall Study|Death|1|||
163984090|NCT00689871|592310171|FG001|Overall Study|Death|10|||
163984091|NCT00689871|592310172|FG002|Overall Study|Death|2|||
163984092|NCT00689871|592310173|FG003|Overall Study|Death|2|||
163984093|NCT00689871|592310170|FG000|Overall Study|Physician Decision|2|||
163984094|NCT00689871|592310171|FG001|Overall Study|Physician Decision|1|||
163984095|NCT00689871|592310172|FG002|Overall Study|Physician Decision|1|||
163984096|NCT00689871|592310173|FG003|Overall Study|Physician Decision|0|||
163984097|NCT00137111|592310191|FG000|Total Therapy|Death|35|||
163984098|NCT00137111|592310192|FG001|Total Therapy|Death|0|||
163984099|NCT00137111|592310193|FG002|Total Therapy|Death|0|||
163984100|NCT00137111|592310194|FG003|Total Therapy|Death|0|||
163984101|NCT00137111|592310191|FG000|Total Therapy|Non Compliance|5|||
163984102|NCT00137111|592310192|FG001|Total Therapy|Non Compliance|0|||
163984103|NCT00137111|592310193|FG002|Total Therapy|Non Compliance|0|||
163984104|NCT00137111|592310194|FG003|Total Therapy|Non Compliance|0|||
163984105|NCT04417894|592310195|FG000|Overall Study|Lost to Follow-up|3|||
163984106|NCT04417894|592310196|FG001|Overall Study|Lost to Follow-up|0|||
163984107|NCT04417894|592310195|FG000|Overall Study|Withdrawal by Subject|7|||
163984108|NCT04417894|592310196|FG001|Overall Study|Withdrawal by Subject|6|||
163984109|NCT04417894|592310195|FG000|Overall Study|Lack of Efficacy|3|||
163984110|NCT04417894|592310196|FG001|Overall Study|Lack of Efficacy|1|||
163984111|NCT00262873|592310197|FG000|Overall Study|Adverse Event|3|||
163984112|NCT00262873|592310197|FG000|Overall Study|Withdrawal by Subject|5|||
164080375|NCT03705169|592657852|FG007|Overall Study|Lost to Follow-up|0|||
164080376|NCT03705169|592657853|FG008|Overall Study|Lost to Follow-up|0|||
164080377|NCT03705169|592657854|FG009|Overall Study|Lost to Follow-up|1|||
164080378|NCT03705169|592657845|FG000|Overall Study|Adverse Event|0|||
164080379|NCT03705169|592657846|FG001|Overall Study|Adverse Event|0|||
164080380|NCT03705169|592657847|FG002|Overall Study|Adverse Event|0|||
164080381|NCT03705169|592657848|FG003|Overall Study|Adverse Event|1|||
164080382|NCT03705169|592657849|FG004|Overall Study|Adverse Event|0|||
164080383|NCT03705169|592657850|FG005|Overall Study|Adverse Event|0|||
164080384|NCT03705169|592657851|FG006|Overall Study|Adverse Event|0|||
164080385|NCT03705169|592657852|FG007|Overall Study|Adverse Event|0|||
164080386|NCT03705169|592657853|FG008|Overall Study|Adverse Event|0|||
164080387|NCT03705169|592657854|FG009|Overall Study|Adverse Event|0|||
164080388|NCT03705169|592657845|FG000|Overall Study|Site Closure|0|||
164080389|NCT03705169|592657846|FG001|Overall Study|Site Closure|0|||
164080390|NCT03705169|592657847|FG002|Overall Study|Site Closure|0|||
164080391|NCT03705169|592657848|FG003|Overall Study|Site Closure|1|||
164080392|NCT03705169|592657849|FG004|Overall Study|Site Closure|0|||
164080393|NCT03705169|592657850|FG005|Overall Study|Site Closure|0|||
164080394|NCT03705169|592657851|FG006|Overall Study|Site Closure|0|||
164080395|NCT03705169|592657852|FG007|Overall Study|Site Closure|0|||
164080396|NCT03705169|592657853|FG008|Overall Study|Site Closure|0|||
164080397|NCT03705169|592657854|FG009|Overall Study|Site Closure|0|||
163984113|NCT00844753|592310198|FG000|Overall Study|Lack of Efficacy|1|||
163984114|NCT00844753|592310199|FG001|Overall Study|Lack of Efficacy|0|||
163984115|NCT00844753|592310200|FG002|Overall Study|Lack of Efficacy|2|||
163984116|NCT00844753|592310201|FG003|Overall Study|Lack of Efficacy|2|||
163984117|NCT00844753|592310198|FG000|Overall Study|Adverse Event|3|||
163984118|NCT00844753|592310199|FG001|Overall Study|Adverse Event|2|||
163984119|NCT00844753|592310200|FG002|Overall Study|Adverse Event|5|||
163984120|NCT00844753|592310201|FG003|Overall Study|Adverse Event|5|||
163984121|NCT00844753|592310198|FG000|Overall Study|Lost to Follow-up|1|||
163984122|NCT00844753|592310199|FG001|Overall Study|Lost to Follow-up|1|||
163984123|NCT00844753|592310200|FG002|Overall Study|Lost to Follow-up|0|||
163984124|NCT00844753|592310201|FG003|Overall Study|Lost to Follow-up|1|||
163984125|NCT00844753|592310198|FG000|Overall Study|could not swallow medication|2|||
163984126|NCT00844753|592310199|FG001|Overall Study|could not swallow medication|0|||
163984127|NCT00844753|592310200|FG002|Overall Study|could not swallow medication|0|||
163984128|NCT00844753|592310201|FG003|Overall Study|could not swallow medication|0|||
163984129|NCT00844753|592310198|FG000|Overall Study|Withdrawal by Subject|1|||
163984130|NCT00844753|592310199|FG001|Overall Study|Withdrawal by Subject|0|||
163984131|NCT00844753|592310200|FG002|Overall Study|Withdrawal by Subject|0|||
163984132|NCT00844753|592310201|FG003|Overall Study|Withdrawal by Subject|3|||
163984133|NCT02508194|592310204|FG000|Overall Study|Death|5|||
163984134|NCT02508194|592310205|FG001|Overall Study|Death|3|||
163984135|NCT02508194|592310204|FG000|Overall Study|Lost to Follow-up|25|||
163984136|NCT02508194|592310205|FG001|Overall Study|Lost to Follow-up|18|||
163984137|NCT02508194|592310204|FG000|Overall Study|Withdrawal by Subject|20|||
163984138|NCT02508194|592310205|FG001|Overall Study|Withdrawal by Subject|18|||
163984139|NCT02508194|592310204|FG000|Overall Study|Error in Randomization|1|||
163984140|NCT02508194|592310205|FG001|Overall Study|Error in Randomization|3|||
163984141|NCT02508194|592310204|FG000|Overall Study|Principal Investigator Decision|1|||
163984142|NCT02508194|592310205|FG001|Overall Study|Principal Investigator Decision|2|||
163984143|NCT03892746|592310207|FG000|Overall Study|Withdrawal by Subject|2|||
163984144|NCT03892746|592310208|FG001|Overall Study|Withdrawal by Subject|1|||
163984145|NCT03892746|592310207|FG000|Overall Study|Lost to Follow-up|2|||
163984146|NCT03892746|592310208|FG001|Overall Study|Lost to Follow-up|0|||
163984147|NCT03977467|592310209|FG000|Overall Study|Disease Progression|1|||
163984148|NCT03977467|592310210|FG001|Overall Study|Disease Progression|1|||
163984149|NCT03977467|592310211|FG002|Overall Study|Disease Progression|30|||
163984150|NCT03977467|592310212|FG003|Overall Study|Disease Progression|0|||
163984151|NCT03977467|592310209|FG000|Overall Study|Adverse Event|0|||
163984152|NCT03977467|592310210|FG001|Overall Study|Adverse Event|1|||
163984153|NCT03977467|592310211|FG002|Overall Study|Adverse Event|0|||
163984154|NCT03977467|592310212|FG003|Overall Study|Adverse Event|0|||
163984155|NCT03977467|592310209|FG000|Overall Study|Death|0|||
163984156|NCT03977467|592310210|FG001|Overall Study|Death|0|||
163984157|NCT03977467|592310211|FG002|Overall Study|Death|3|||
163984158|NCT03977467|592310212|FG003|Overall Study|Death|0|||
163984159|NCT03977467|592310209|FG000|Overall Study|Lack of Efficacy|0|||
163984160|NCT03977467|592310210|FG001|Overall Study|Lack of Efficacy|0|||
163984161|NCT03977467|592310211|FG002|Overall Study|Lack of Efficacy|1|||
163984162|NCT03977467|592310212|FG003|Overall Study|Lack of Efficacy|0|||
163984163|NCT03977467|592310209|FG000|Overall Study|Withdrawal by Subject|2|||
163984164|NCT03977467|592310210|FG001|Overall Study|Withdrawal by Subject|1|||
163984165|NCT03977467|592310211|FG002|Overall Study|Withdrawal by Subject|4|||
163984166|NCT03977467|592310212|FG003|Overall Study|Withdrawal by Subject|0|||
163984167|NCT03977467|592310209|FG000|Overall Study|Study Terminated|1|||
163984168|NCT03977467|592310210|FG001|Overall Study|Study Terminated|0|||
163984169|NCT03977467|592310211|FG002|Overall Study|Study Terminated|0|||
163984170|NCT03977467|592310212|FG003|Overall Study|Study Terminated|1|||
163984171|NCT02289950|592310217|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
163984172|NCT02289950|592310218|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
163984173|NCT02289950|592310217|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
163984174|NCT02289950|592310218|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
163984175|NCT02289950|592310217|FG000|Overall Study|Lost to Follow-up|1|||
163984176|NCT02289950|592310218|FG001|Overall Study|Lost to Follow-up|0|||
163984177|NCT02289950|592310217|FG000|Overall Study|Physician Decision|9|||
163984178|NCT02289950|592310218|FG001|Overall Study|Physician Decision|3|||
163984179|NCT02289950|592310217|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
163984180|NCT02289950|592310218|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
163984181|NCT02289950|592310217|FG000|Overall Study|Withdrawal by Subject|1|||
163984182|NCT02289950|592310218|FG001|Overall Study|Withdrawal by Subject|3|||
163984183|NCT02289950|592310217|FG000|Overall Study|Test article held for greater than 28 days|0|||
163984184|NCT02289950|592310218|FG001|Overall Study|Test article held for greater than 28 days|1|||
163984185|NCT02289950|592310217|FG000|Overall Study|Adverse Event|11|||
163984186|NCT02289950|592310218|FG001|Overall Study|Adverse Event|3|||
163984187|NCT02289950|592310217|FG000|Overall Study|Death|1|||
163984188|NCT02289950|592310218|FG001|Overall Study|Death|1|||
163984189|NCT02289950|592310217|FG000|Overall Study|Other|5|||
163984190|NCT02289950|592310218|FG001|Overall Study|Other|2|||
163984191|NCT02289950|592310217|FG000|Overall Study|Not Treated|2|||
163984192|NCT02289950|592310218|FG001|Overall Study|Not Treated|1|||
163984193|NCT01471782|592310219|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
163984194|NCT01471782|592310220|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
163984195|NCT01471782|592310221|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
163984196|NCT01471782|592310222|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
163984197|NCT01471782|592310223|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
163984198|NCT01471782|592310224|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
163984199|NCT01471782|592310219|FG000|Overall Study|Lack of Efficacy|1|||
163984200|NCT01471782|592310220|FG001|Overall Study|Lack of Efficacy|2|||
163984201|NCT01471782|592310221|FG002|Overall Study|Lack of Efficacy|1|||
163984202|NCT01471782|592310222|FG003|Overall Study|Lack of Efficacy|1|||
163984203|NCT01471782|592310223|FG004|Overall Study|Lack of Efficacy|5|||
163984204|NCT01471782|592310224|FG005|Overall Study|Lack of Efficacy|18|||
163984205|NCT01471782|592310219|FG000|Overall Study|Adverse Event|1|||
163984206|NCT01471782|592310220|FG001|Overall Study|Adverse Event|1|||
163984207|NCT01471782|592310221|FG002|Overall Study|Adverse Event|2|||
163984208|NCT01471782|592310222|FG003|Overall Study|Adverse Event|2|||
163984209|NCT01471782|592310223|FG004|Overall Study|Adverse Event|3|||
163984210|NCT01471782|592310224|FG005|Overall Study|Adverse Event|1|||
163984211|NCT01471782|592310219|FG000|Overall Study|Other|0|||
163984212|NCT01471782|592310220|FG001|Overall Study|Other|0|||
163984213|NCT01471782|592310221|FG002|Overall Study|Other|1|||
163984214|NCT01471782|592310222|FG003|Overall Study|Other|1|||
163984215|NCT01471782|592310223|FG004|Overall Study|Other|6|||
163984216|NCT01471782|592310224|FG005|Overall Study|Other|5|||
163984217|NCT01471782|592310219|FG000|Overall Study|Change of Chemotherapy|1|||
163984218|NCT01471782|592310220|FG001|Overall Study|Change of Chemotherapy|1|||
163984219|NCT01471782|592310221|FG002|Overall Study|Change of Chemotherapy|0|||
163984220|NCT01471782|592310222|FG003|Overall Study|Change of Chemotherapy|0|||
163984221|NCT01471782|592310223|FG004|Overall Study|Change of Chemotherapy|1|||
163984222|NCT01471782|592310224|FG005|Overall Study|Change of Chemotherapy|4|||
163984223|NCT01471782|592310219|FG000|Overall Study|Disease Relapse|0|||
163984224|NCT01471782|592310220|FG001|Overall Study|Disease Relapse|0|||
163984225|NCT01471782|592310221|FG002|Overall Study|Disease Relapse|0|||
163984226|NCT01471782|592310222|FG003|Overall Study|Disease Relapse|1|||
163984227|NCT01471782|592310223|FG004|Overall Study|Disease Relapse|2|||
163984228|NCT01471782|592310224|FG005|Overall Study|Disease Relapse|1|||
163984229|NCT01471782|592310219|FG000|Overall Study|Physician Decision|0|||
163984230|NCT01471782|592310220|FG001|Overall Study|Physician Decision|0|||
164080398|NCT03705169|592657845|FG000|Overall Study|Did not receive study treatment|0|||
164080399|NCT03705169|592657846|FG001|Overall Study|Did not receive study treatment|0|||
164080400|NCT03705169|592657847|FG002|Overall Study|Did not receive study treatment|0|||
163984231|NCT01471782|592310221|FG002|Overall Study|Physician Decision|0|||
164080401|NCT03705169|592657848|FG003|Overall Study|Did not receive study treatment|1|||
164080402|NCT03705169|592657849|FG004|Overall Study|Did not receive study treatment|0|||
164080403|NCT03705169|592657850|FG005|Overall Study|Did not receive study treatment|0|||
164080404|NCT03705169|592657851|FG006|Overall Study|Did not receive study treatment|0|||
164080405|NCT03705169|592657852|FG007|Overall Study|Did not receive study treatment|0|||
164080406|NCT03705169|592657853|FG008|Overall Study|Did not receive study treatment|0|||
164080407|NCT03705169|592657854|FG009|Overall Study|Did not receive study treatment|0|||
163984232|NCT01471782|592310222|FG003|Overall Study|Physician Decision|0|||
163984233|NCT01471782|592310223|FG004|Overall Study|Physician Decision|3|||
163984234|NCT01471782|592310224|FG005|Overall Study|Physician Decision|8|||
163984235|NCT01471782|592310219|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163984236|NCT01471782|592310220|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163984237|NCT01471782|592310221|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163984238|NCT01471782|592310222|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163984239|NCT01471782|592310223|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
163984240|NCT01471782|592310224|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163984241|NCT01471782|592310219|FG000|Overall Study|Death|0|||
163984242|NCT01471782|592310220|FG001|Overall Study|Death|0|||
163984243|NCT01471782|592310221|FG002|Overall Study|Death|0|||
163984244|NCT01471782|592310222|FG003|Overall Study|Death|0|||
163984245|NCT01471782|592310223|FG004|Overall Study|Death|0|||
163984246|NCT01471782|592310224|FG005|Overall Study|Death|1|||
163984247|NCT00936208|592310225|FG000|Overall Study|Protocol Violation|37|||
163984248|NCT00936208|592310226|FG001|Overall Study|Protocol Violation|22|||
163984249|NCT04428424|592310227|FG000|Overall Study|Does not meet entrance criteria|132|||
163984250|NCT04428424|592310227|FG000|Overall Study|Lost to Follow-up|115|||
163984251|NCT03359759|592310228|FG000|Overall Study|Death|3|||
163984252|NCT03359759|592310228|FG000|Overall Study|Lost to Follow-up|2|||
163984253|NCT04818593|592310229|FG000|Overall Study|Low Oocyte Yield|8|||
163984254|NCT04818593|592310230|FG001|Overall Study|Low Oocyte Yield|8|||
163984255|NCT04818593|592310229|FG000|Overall Study|Not ICSI Insemination|7|||
163984256|NCT04818593|592310230|FG001|Overall Study|Not ICSI Insemination|7|||
163984257|NCT04818593|592310229|FG000|Overall Study|Poor Sperm Quality|2|||
163984258|NCT04818593|592310230|FG001|Overall Study|Poor Sperm Quality|2|||
163984259|NCT04818593|592310229|FG000|Overall Study|Withdrawal by Subject|2|||
163984260|NCT04818593|592310230|FG001|Overall Study|Withdrawal by Subject|2|||
163984261|NCT04818593|592310229|FG000|Overall Study|Conversion to IUI due to low response|1|||
164080408|NCT03705169|592657845|FG000|Overall Study|Concerns about study visit compliance|0|||
164080409|NCT03705169|592657846|FG001|Overall Study|Concerns about study visit compliance|0|||
163984262|NCT04818593|592310230|FG001|Overall Study|Conversion to IUI due to low response|1|||
163984263|NCT03809611|592310231|FG000|Overall Study|Withdrawal by Subject|1|||
163984264|NCT03809611|592310232|FG001|Overall Study|Withdrawal by Subject|1|||
163984265|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
163984266|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
163984267|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
163984268|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
163984269|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
163984270|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
163984271|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
163984272|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
163984273|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
163984274|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
163984275|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
163984276|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
163984277|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
163984278|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
163984279|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
163984280|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
163984281|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
163984282|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
163984283|NCT02600494|592310233|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
163984284|NCT02600494|592310234|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
163984285|NCT02600494|592310235|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
163984286|NCT02600494|592310233|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
163984287|NCT02600494|592310234|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
163984288|NCT02600494|592310235|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
163984289|NCT02600494|592310233|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
163984290|NCT02600494|592310234|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
163984291|NCT02600494|592310235|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
163984292|NCT02600494|592310233|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
163984293|NCT02600494|592310234|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
163984294|NCT02600494|592310235|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
163984295|NCT02600494|592310233|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
163984296|NCT02600494|592310234|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
163984297|NCT02600494|592310235|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
163984298|NCT02600494|592310233|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
163984299|NCT02600494|592310234|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
163984300|NCT02600494|592310235|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
163984301|NCT02600494|592310233|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
163984302|NCT02600494|592310234|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
163984303|NCT02600494|592310235|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
163984304|NCT03124563|592310237|FG000|Overall Study|Lost to Follow-up|1|||
163984305|NCT03124563|592310238|FG001|Overall Study|Lost to Follow-up|1|||
163984306|NCT03124563|592310237|FG000|Overall Study|Withdrawal by Subject|1|||
163984307|NCT03124563|592310238|FG001|Overall Study|Withdrawal by Subject|1|||
163984308|NCT04745689|592310241|FG000|Overall Study|Death|9|||
163984309|NCT04745689|592310242|FG001|Overall Study|Death|6|||
163984310|NCT04745689|592310241|FG000|Overall Study|Lost to Follow-up|1|||
163984311|NCT04745689|592310242|FG001|Overall Study|Lost to Follow-up|0|||
163984312|NCT04745689|592310241|FG000|Overall Study|Withdrawal by Subject|2|||
163984313|NCT04745689|592310242|FG001|Overall Study|Withdrawal by Subject|0|||
163984314|NCT04745689|592310241|FG000|Overall Study|Study terminated by sponsor|10|||
163984315|NCT04745689|592310242|FG001|Overall Study|Study terminated by sponsor|3|||
163984316|NCT04316585|592312320|FG000|Overall Study|Adverse Event|2|||
163984317|NCT04316585|592312321|FG001|Overall Study|Adverse Event|1|||
163984318|NCT04316585|592312320|FG000|Overall Study|Lost to Follow-up|1|||
163984319|NCT04316585|592312321|FG001|Overall Study|Lost to Follow-up|0|||
163984320|NCT04316585|592312320|FG000|Overall Study|Withdrawal by Subject|2|||
163984321|NCT04316585|592312321|FG001|Overall Study|Withdrawal by Subject|3|||
163984322|NCT04316585|592312320|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
163984323|NCT04316585|592312321|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
163984324|NCT04316585|592312320|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
163984325|NCT04316585|592312321|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
163984326|NCT03118297|592312322|FG000|Overall Study|Lost to Follow-up|0|||
163984327|NCT03118297|592312323|FG001|Overall Study|Lost to Follow-up|2|||
163984328|NCT01121393|592312324|FG000|Overall Study|Progressive disease|201|||
163984329|NCT01121393|592312325|FG001|Overall Study|Progressive disease|20|||
163984330|NCT01121393|592312324|FG000|Overall Study|Other Adverse events|24|||
163984331|NCT01121393|592312325|FG001|Overall Study|Other Adverse events|45|||
163984332|NCT01121393|592312324|FG000|Overall Study|Non-compliant with protocol|0|||
163984333|NCT01121393|592312325|FG001|Overall Study|Non-compliant with protocol|3|||
163984334|NCT01121393|592312324|FG000|Overall Study|Lost to Follow-up|1|||
163984335|NCT01121393|592312325|FG001|Overall Study|Lost to Follow-up|0|||
163984336|NCT01121393|592312324|FG000|Overall Study|Refused cont. medication|7|||
163984337|NCT01121393|592312325|FG001|Overall Study|Refused cont. medication|7|||
163984338|NCT01121393|592312324|FG000|Overall Study|Not treated|3|||
163984339|NCT01121393|592312325|FG001|Overall Study|Not treated|9|||
163984340|NCT01121393|592312324|FG000|Overall Study|Other than listed|6|||
163984341|NCT01121393|592312325|FG001|Overall Study|Other than listed|0|||
163984342|NCT00608985|592312332|FG000|Overall Study|Adverse Event|2|||
163984343|NCT00608985|592312333|FG001|Overall Study|Adverse Event|7|||
163984344|NCT00608985|592312334|FG002|Overall Study|Adverse Event|4|||
163984345|NCT00608985|592312335|FG003|Overall Study|Adverse Event|6|||
163984346|NCT00608985|592312332|FG000|Overall Study|Administrative/Other|7|||
163984347|NCT00608985|592312333|FG001|Overall Study|Administrative/Other|4|||
163984348|NCT00608985|592312334|FG002|Overall Study|Administrative/Other|1|||
163984349|NCT00608985|592312335|FG003|Overall Study|Administrative/Other|2|||
163984350|NCT00608985|592312332|FG000|Overall Study|Withdrawal of Consent|5|||
163984351|NCT00608985|592312333|FG001|Overall Study|Withdrawal of Consent|1|||
163984352|NCT00608985|592312334|FG002|Overall Study|Withdrawal of Consent|1|||
163984353|NCT00608985|592312335|FG003|Overall Study|Withdrawal of Consent|1|||
163984354|NCT00608985|592312332|FG000|Overall Study|Lost to Follow-up|2|||
163984355|NCT00608985|592312333|FG001|Overall Study|Lost to Follow-up|1|||
163984356|NCT00608985|592312334|FG002|Overall Study|Lost to Follow-up|0|||
163984357|NCT00608985|592312335|FG003|Overall Study|Lost to Follow-up|0|||
163984358|NCT00661271|592312336|FG000|Overall Study|Lost to Follow-up|28|||
163984359|NCT00661271|592312337|FG001|Overall Study|Lost to Follow-up|25|||
163984360|NCT00953758|592312338|FG000|Overall Study|Death|2|||
163984361|NCT00953758|592312339|FG001|Overall Study|Death|0|||
163984362|NCT00953758|592312340|FG002|Overall Study|Death|1|||
163984363|NCT00953758|592312341|FG003|Overall Study|Death|1|||
163984364|NCT00953758|592312342|FG004|Overall Study|Death|1|||
163984365|NCT00953758|592312343|FG005|Overall Study|Death|1|||
163984366|NCT00953758|592312344|FG006|Overall Study|Death|1|||
163984367|NCT00953758|592312345|FG007|Overall Study|Death|3|||
163984368|NCT00953758|592312346|FG008|Overall Study|Death|1|||
163984369|NCT00953758|592312347|FG009|Overall Study|Death|0|||
163984370|NCT00953758|592312338|FG000|Overall Study|Participant refused further follow-up|0|||
163984371|NCT00953758|592312339|FG001|Overall Study|Participant refused further follow-up|0|||
163984372|NCT00953758|592312340|FG002|Overall Study|Participant refused further follow-up|1|||
163984373|NCT00953758|592312341|FG003|Overall Study|Participant refused further follow-up|0|||
163984374|NCT00953758|592312342|FG004|Overall Study|Participant refused further follow-up|3|||
163984375|NCT00953758|592312343|FG005|Overall Study|Participant refused further follow-up|0|||
163984376|NCT00953758|592312344|FG006|Overall Study|Participant refused further follow-up|0|||
163984377|NCT00953758|592312345|FG007|Overall Study|Participant refused further follow-up|0|||
163984378|NCT00953758|592312346|FG008|Overall Study|Participant refused further follow-up|1|||
163984379|NCT00953758|592312347|FG009|Overall Study|Participant refused further follow-up|0|||
163984380|NCT00953758|592312338|FG000|Overall Study|Lost to Follow-up|0|||
163984381|NCT00953758|592312339|FG001|Overall Study|Lost to Follow-up|0|||
163984382|NCT00953758|592312340|FG002|Overall Study|Lost to Follow-up|0|||
163984383|NCT00953758|592312341|FG003|Overall Study|Lost to Follow-up|1|||
163984384|NCT00953758|592312342|FG004|Overall Study|Lost to Follow-up|0|||
163984385|NCT00953758|592312343|FG005|Overall Study|Lost to Follow-up|0|||
163984386|NCT00953758|592312344|FG006|Overall Study|Lost to Follow-up|0|||
163984387|NCT00953758|592312345|FG007|Overall Study|Lost to Follow-up|1|||
163984388|NCT00953758|592312346|FG008|Overall Study|Lost to Follow-up|0|||
163984389|NCT00953758|592312347|FG009|Overall Study|Lost to Follow-up|1|||
163984390|NCT00953758|592312338|FG000|Overall Study|Physician Decision|0|||
163984391|NCT00953758|592312339|FG001|Overall Study|Physician Decision|0|||
163984392|NCT00953758|592312340|FG002|Overall Study|Physician Decision|0|||
163984393|NCT00953758|592312341|FG003|Overall Study|Physician Decision|0|||
163984394|NCT00953758|592312342|FG004|Overall Study|Physician Decision|1|||
163984395|NCT00953758|592312343|FG005|Overall Study|Physician Decision|0|||
163984396|NCT00953758|592312344|FG006|Overall Study|Physician Decision|0|||
163984397|NCT00953758|592312345|FG007|Overall Study|Physician Decision|0|||
163984398|NCT00953758|592312346|FG008|Overall Study|Physician Decision|0|||
163984399|NCT00953758|592312347|FG009|Overall Study|Physician Decision|0|||
163984400|NCT00953758|592312338|FG000|Overall Study|Disease progression|0|||
163984401|NCT00953758|592312339|FG001|Overall Study|Disease progression|0|||
163984402|NCT00953758|592312340|FG002|Overall Study|Disease progression|0|||
163984403|NCT00953758|592312341|FG003|Overall Study|Disease progression|0|||
163984404|NCT00953758|592312342|FG004|Overall Study|Disease progression|1|||
163984405|NCT00953758|592312343|FG005|Overall Study|Disease progression|0|||
163984406|NCT00953758|592312344|FG006|Overall Study|Disease progression|0|||
163984407|NCT00953758|592312345|FG007|Overall Study|Disease progression|0|||
163984408|NCT00953758|592312346|FG008|Overall Study|Disease progression|0|||
163984409|NCT00953758|592312347|FG009|Overall Study|Disease progression|0|||
163984410|NCT00953758|592312338|FG000|Overall Study|Participant went for transplant|0|||
163984411|NCT00953758|592312339|FG001|Overall Study|Participant went for transplant|0|||
163984412|NCT00953758|592312340|FG002|Overall Study|Participant went for transplant|0|||
163984413|NCT00953758|592312341|FG003|Overall Study|Participant went for transplant|0|||
163984414|NCT00953758|592312342|FG004|Overall Study|Participant went for transplant|0|||
163984415|NCT00953758|592312343|FG005|Overall Study|Participant went for transplant|0|||
163984416|NCT00953758|592312344|FG006|Overall Study|Participant went for transplant|0|||
163984417|NCT00953758|592312345|FG007|Overall Study|Participant went for transplant|0|||
163984418|NCT00953758|592312346|FG008|Overall Study|Participant went for transplant|1|||
163984419|NCT00953758|592312347|FG009|Overall Study|Participant went for transplant|0|||
163984420|NCT00706030|592312349|FG000|Overall Study|Disease Progression|4|||
163984421|NCT00706030|592312350|FG001|Overall Study|Disease Progression|6|||
163984422|NCT00706030|592312351|FG002|Overall Study|Disease Progression|46|||
163984423|NCT00706030|592312352|FG003|Overall Study|Disease Progression|12|||
163984424|NCT00706030|592312349|FG000|Overall Study|Adverse Event|1|||
163984425|NCT00706030|592312350|FG001|Overall Study|Adverse Event|0|||
163984426|NCT00706030|592312351|FG002|Overall Study|Adverse Event|4|||
163984427|NCT00706030|592312352|FG003|Overall Study|Adverse Event|2|||
163984428|NCT00706030|592312349|FG000|Overall Study|Withdrawal by Subject|1|||
163984429|NCT00706030|592312350|FG001|Overall Study|Withdrawal by Subject|0|||
163984430|NCT00706030|592312351|FG002|Overall Study|Withdrawal by Subject|2|||
163984431|NCT00706030|592312352|FG003|Overall Study|Withdrawal by Subject|0|||
163984432|NCT00706030|592312349|FG000|Overall Study|Physician Decision|0|||
163984433|NCT00706030|592312350|FG001|Overall Study|Physician Decision|0|||
163984434|NCT00706030|592312351|FG002|Overall Study|Physician Decision|2|||
163984435|NCT00706030|592312352|FG003|Overall Study|Physician Decision|0|||
163984436|NCT00706030|592312349|FG000|Overall Study|Not recorded|0|||
163984437|NCT00706030|592312350|FG001|Overall Study|Not recorded|0|||
163984438|NCT00706030|592312351|FG002|Overall Study|Not recorded|2|||
163984439|NCT00706030|592312352|FG003|Overall Study|Not recorded|0|||
163984440|NCT00706030|592312349|FG000|Overall Study|Protocol Violation|0|||
163984441|NCT00706030|592312350|FG001|Overall Study|Protocol Violation|0|||
163984442|NCT00706030|592312351|FG002|Overall Study|Protocol Violation|1|||
163984443|NCT00706030|592312352|FG003|Overall Study|Protocol Violation|1|||
163984444|NCT00706030|592312349|FG000|Overall Study|Failed to return|0|||
163984445|NCT00706030|592312350|FG001|Overall Study|Failed to return|0|||
163984446|NCT00706030|592312351|FG002|Overall Study|Failed to return|1|||
163984447|NCT00706030|592312352|FG003|Overall Study|Failed to return|0|||
163984448|NCT00706030|592312349|FG000|Overall Study|Symptomatic Deterioration|0|||
163984449|NCT00706030|592312350|FG001|Overall Study|Symptomatic Deterioration|0|||
163984450|NCT00706030|592312351|FG002|Overall Study|Symptomatic Deterioration|1|||
163984451|NCT00706030|592312352|FG003|Overall Study|Symptomatic Deterioration|0|||
163984452|NCT00706030|592312349|FG000|Overall Study|No treatment received|0|||
163984453|NCT00706030|592312350|FG001|Overall Study|No treatment received|0|||
163984454|NCT00706030|592312351|FG002|Overall Study|No treatment received|0|||
163984455|NCT00706030|592312352|FG003|Overall Study|No treatment received|1|||
163984456|NCT00706030|592312349|FG000|Overall Study|Death|0|||
163984457|NCT00706030|592312350|FG001|Overall Study|Death|0|||
163984458|NCT00706030|592312351|FG002|Overall Study|Death|1|||
163984459|NCT00706030|592312352|FG003|Overall Study|Death|0|||
163984460|NCT05779072|592312353|FG000|Overall Study|Lost to Follow-up|0|||
163984461|NCT05779072|592312354|FG001|Overall Study|Lost to Follow-up|1|||
163984462|NCT05779072|592312353|FG000|Overall Study|Withdrawal by Subject|1|||
163984463|NCT05779072|592312354|FG001|Overall Study|Withdrawal by Subject|5|||
163880597|NCT03526861|591933413|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880598|NCT03526861|591933414|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880599|NCT03526861|591933415|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880600|NCT03526861|591933416|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
163880601|NCT03526861|591933417|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
163880602|NCT03526861|591933409|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880603|NCT03526861|591933410|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880604|NCT03526861|591933411|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880605|NCT03526861|591933412|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880606|NCT03526861|591933413|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880607|NCT03526861|591933414|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163984464|NCT03870555|592312355|FG000|Period 3 (2 Days)|Adverse Event|1|||
163984465|NCT03870555|592312356|FG001|Period 3 (2 Days)|Adverse Event|0|||
163984466|NCT03870555|592312357|FG002|Period 3 (2 Days)|Adverse Event|0|||
163984467|NCT00293579|592312358|FG000|Overall Study|Withdrawal by Subject|1|||
163984468|NCT03215771|592312359|FG000|Overall Study|Withdrawal by Subject|2|||
163984469|NCT03215771|592312359|FG000|Overall Study|Physician Decision|1|||
163984470|NCT02703311|592312360|FG000|Overall Study|Death|5|||
163984471|NCT02703311|592312360|FG000|Overall Study|Withdrawal by Subject|3|||
163984472|NCT00343889|592312361|FG000|Overall Study|Lost to Follow-up|2|||
164080410|NCT03705169|592657847|FG002|Overall Study|Concerns about study visit compliance|0|||
163984473|NCT00343889|592312362|FG001|Overall Study|Lost to Follow-up|0|||
164080411|NCT03705169|592657848|FG003|Overall Study|Concerns about study visit compliance|1|||
164080412|NCT03705169|592657849|FG004|Overall Study|Concerns about study visit compliance|0|||
164080413|NCT03705169|592657850|FG005|Overall Study|Concerns about study visit compliance|0|||
164080414|NCT03705169|592657851|FG006|Overall Study|Concerns about study visit compliance|0|||
164080415|NCT03705169|592657852|FG007|Overall Study|Concerns about study visit compliance|0|||
164080416|NCT03705169|592657853|FG008|Overall Study|Concerns about study visit compliance|0|||
164080417|NCT03705169|592657854|FG009|Overall Study|Concerns about study visit compliance|0|||
164080418|NCT00458302|592659484|FG000|Overall Study|Adverse Event|4|||
164080419|NCT00458302|592659485|FG001|Overall Study|Adverse Event|14|||
164080420|NCT00458302|592659484|FG000|Overall Study|Pregnancy|2|||
164080421|NCT00458302|592659485|FG001|Overall Study|Pregnancy|1|||
164080422|NCT00458302|592659484|FG000|Overall Study|Protocol Violation|0|||
164080423|NCT00458302|592659485|FG001|Overall Study|Protocol Violation|2|||
164080424|NCT00458302|592659484|FG000|Overall Study|Withdrawal by Subject|6|||
164080425|NCT00458302|592659485|FG001|Overall Study|Withdrawal by Subject|4|||
164080426|NCT00458302|592659484|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
164080427|NCT00458302|592659485|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
164080428|NCT00458302|592659484|FG000|Overall Study|Study Termination By Sponsor|1|||
164080429|NCT00458302|592659485|FG001|Overall Study|Study Termination By Sponsor|0|||
164080430|NCT00458302|592659484|FG000|Overall Study|Lost to Follow-up|2|||
164080431|NCT00458302|592659485|FG001|Overall Study|Lost to Follow-up|0|||
164080432|NCT00458302|592659484|FG000|Overall Study|Other|4|||
164080433|NCT00458302|592659485|FG001|Overall Study|Other|2|||
164080434|NCT01513551|592659488|FG000|Overall Study|Death|0|||
164080435|NCT01513551|592659489|FG001|Overall Study|Death|1|||
164080436|NCT01513551|592659490|FG002|Overall Study|Death|0|||
163984474|NCT00343889|592312361|FG000|Overall Study|Withdrawal by Subject|0|||
163984475|NCT00343889|592312362|FG001|Overall Study|Withdrawal by Subject|1|||
163984476|NCT00343889|592312361|FG000|Overall Study|Protocol Violation|1|||
163984477|NCT00343889|592312362|FG001|Overall Study|Protocol Violation|0|||
163984478|NCT00088374|592312363|FG000|Overall Study|patient did not receive any 17AAG|1|||
163984479|NCT00088374|592312363|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
163984480|NCT00852995|592312364|FG000|Overall Study|Adverse Event|1|||
163984481|NCT00852995|592312365|FG001|Overall Study|Adverse Event|0|||
164080437|NCT01513551|592659488|FG000|Overall Study|Lost to Follow-up|3|||
164080438|NCT01513551|592659489|FG001|Overall Study|Lost to Follow-up|5|||
164080439|NCT01513551|592659490|FG002|Overall Study|Lost to Follow-up|2|||
164080440|NCT01513551|592659488|FG000|Overall Study|Withdrawal by Subject|1|||
164080441|NCT01513551|592659489|FG001|Overall Study|Withdrawal by Subject|0|||
164080442|NCT01513551|592659490|FG002|Overall Study|Withdrawal by Subject|2|||
164080443|NCT01513551|592659488|FG000|Overall Study|Randomized but not vaccinated|0|||
164080444|NCT01513551|592659489|FG001|Overall Study|Randomized but not vaccinated|0|||
164080445|NCT01513551|592659490|FG002|Overall Study|Randomized but not vaccinated|1|||
164080446|NCT01706198|592659493|FG000|Overall Study|Adverse Event|12|||
164080447|NCT01706198|592659494|FG001|Overall Study|Adverse Event|15|||
164080448|NCT01706198|592659493|FG000|Overall Study|Protocol Violation|7|||
164080449|NCT01706198|592659494|FG001|Overall Study|Protocol Violation|5|||
164080450|NCT01706198|592659493|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
164080451|NCT01706198|592659494|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
164080452|NCT01706198|592659493|FG000|Overall Study|Lost to Follow-up|97|||
164080453|NCT01706198|592659494|FG001|Overall Study|Lost to Follow-up|93|||
164080454|NCT01706198|592659493|FG000|Overall Study|Physician Decision|23|||
164080455|NCT01706198|592659494|FG001|Overall Study|Physician Decision|37|||
164080456|NCT01706198|592659493|FG000|Overall Study|Withdrawal by Subject|23|||
164080457|NCT01706198|592659494|FG001|Overall Study|Withdrawal by Subject|31|||
164080458|NCT00549198|592659495|FG000|Overall Study|Adverse Event|28|||
164080459|NCT00549198|592659496|FG001|Overall Study|Adverse Event|26|||
164080460|NCT00549198|592659495|FG000|Overall Study|Insufficient Viral Load Response|4|||
164080461|NCT00549198|592659496|FG001|Overall Study|Insufficient Viral Load Response|2|||
164080462|NCT00549198|592659495|FG000|Overall Study|Protocol-defined Virological Failure|7|||
164080463|NCT00549198|592659496|FG001|Overall Study|Protocol-defined Virological Failure|0|||
164080464|NCT00549198|592659495|FG000|Overall Study|Non-compliance|2|||
164080465|NCT00549198|592659496|FG001|Overall Study|Non-compliance|4|||
163984482|NCT00852995|592312366|FG002|Overall Study|Adverse Event|4|||
163984483|NCT00852995|592312367|FG003|Overall Study|Adverse Event|0|||
163984484|NCT00852995|592312368|FG004|Overall Study|Adverse Event|0|||
163984485|NCT00852995|592312364|FG000|Overall Study|Lost to Follow-up|0|||
164080466|NCT00549198|592659495|FG000|Overall Study|Lost to Follow-up|7|||
163984486|NCT00852995|592312365|FG001|Overall Study|Lost to Follow-up|1|||
164080467|NCT00549198|592659496|FG001|Overall Study|Lost to Follow-up|8|||
164080468|NCT00549198|592659495|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
164080469|NCT00549198|592659496|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
164080470|NCT00549198|592659495|FG000|Overall Study|Protocol Violation|7|||
164080471|NCT00549198|592659496|FG001|Overall Study|Protocol Violation|2|||
164080472|NCT00549198|592659495|FG000|Overall Study|Investigator Decision|4|||
163984487|NCT00852995|592312366|FG002|Overall Study|Lost to Follow-up|1|||
163984488|NCT00852995|592312367|FG003|Overall Study|Lost to Follow-up|0|||
163984489|NCT00852995|592312368|FG004|Overall Study|Lost to Follow-up|0|||
163984490|NCT00852995|592312364|FG000|Overall Study|Withdrawal by Subject|4|||
163984491|NCT00852995|592312365|FG001|Overall Study|Withdrawal by Subject|0|||
163984492|NCT00852995|592312366|FG002|Overall Study|Withdrawal by Subject|0|||
163984493|NCT00852995|592312367|FG003|Overall Study|Withdrawal by Subject|1|||
163984494|NCT00852995|592312368|FG004|Overall Study|Withdrawal by Subject|2|||
163984495|NCT00852995|592312364|FG000|Overall Study|Non-Compliance|0|||
163984496|NCT00852995|592312365|FG001|Overall Study|Non-Compliance|0|||
163984497|NCT00852995|592312366|FG002|Overall Study|Non-Compliance|0|||
163984498|NCT00852995|592312367|FG003|Overall Study|Non-Compliance|2|||
163984499|NCT00852995|592312368|FG004|Overall Study|Non-Compliance|0|||
163984500|NCT00852995|592312364|FG000|Overall Study|Progressive Disease|1|||
163984501|NCT00852995|592312365|FG001|Overall Study|Progressive Disease|0|||
163984502|NCT00852995|592312366|FG002|Overall Study|Progressive Disease|0|||
163984503|NCT00852995|592312367|FG003|Overall Study|Progressive Disease|2|||
163984504|NCT00852995|592312368|FG004|Overall Study|Progressive Disease|1|||
163984505|NCT00852995|592312364|FG000|Overall Study|Physician Decision|1|||
163984506|NCT00852995|592312365|FG001|Overall Study|Physician Decision|0|||
163984507|NCT00852995|592312366|FG002|Overall Study|Physician Decision|0|||
163984508|NCT00852995|592312367|FG003|Overall Study|Physician Decision|0|||
163984509|NCT00852995|592312368|FG004|Overall Study|Physician Decision|0|||
163984510|NCT00852995|592312364|FG000|Overall Study|Protocol Violation|0|||
163984511|NCT00852995|592312365|FG001|Overall Study|Protocol Violation|0|||
163984512|NCT00852995|592312366|FG002|Overall Study|Protocol Violation|0|||
163984513|NCT00852995|592312367|FG003|Overall Study|Protocol Violation|0|||
163984514|NCT00852995|592312368|FG004|Overall Study|Protocol Violation|1|||
163984515|NCT00852995|592312364|FG000|Overall Study|Moved Out of Area|1|||
163984516|NCT00852995|592312365|FG001|Overall Study|Moved Out of Area|0|||
163984517|NCT00852995|592312366|FG002|Overall Study|Moved Out of Area|0|||
163984518|NCT00852995|592312367|FG003|Overall Study|Moved Out of Area|0|||
163984519|NCT00852995|592312368|FG004|Overall Study|Moved Out of Area|0|||
163984520|NCT00866307|592312370|FG000|Induction|Adverse Event|5|||
163984521|NCT00866307|592312371|FG001|Induction|Adverse Event|0|||
163984522|NCT00866307|592312372|FG002|Induction|Adverse Event|0|||
163984523|NCT00866307|592312370|FG000|Induction|Death|2|||
163984524|NCT00866307|592312371|FG001|Induction|Death|0|||
163984525|NCT00866307|592312372|FG002|Induction|Death|0|||
163984526|NCT00866307|592312370|FG000|Induction|Physician Decision|5|||
163984527|NCT00866307|592312371|FG001|Induction|Physician Decision|0|||
163984528|NCT00866307|592312372|FG002|Induction|Physician Decision|0|||
163984529|NCT00866307|592312370|FG000|Induction|Progressive Disease|1|||
163984530|NCT00866307|592312371|FG001|Induction|Progressive Disease|0|||
163984531|NCT00866307|592312372|FG002|Induction|Progressive Disease|0|||
163984532|NCT00866307|592312370|FG000|Induction|Identification of Patients with Day 29 M|3|||
163984533|NCT00866307|592312371|FG001|Induction|Identification of Patients with Day 29 M|0|||
163984534|NCT00866307|592312372|FG002|Induction|Identification of Patients with Day 29 M|0|||
163984535|NCT00866307|592312370|FG000|Induction|Inadequate cytognetic samples th|1|||
163984536|NCT00866307|592312371|FG001|Induction|Inadequate cytognetic samples th|0|||
163984537|NCT00866307|592312372|FG002|Induction|Inadequate cytognetic samples th|0|||
163984538|NCT00866307|592312370|FG000|Induction|Improper post-induction consent|2|||
163984539|NCT00866307|592312371|FG001|Induction|Improper post-induction consent|0|||
163984540|NCT00866307|592312372|FG002|Induction|Improper post-induction consent|0|||
163984541|NCT00866307|592312370|FG000|Induction|Study was closed at the time|1|||
163984542|NCT00866307|592312371|FG001|Induction|Study was closed at the time|0|||
163984543|NCT00866307|592312372|FG002|Induction|Study was closed at the time|0|||
163984544|NCT00866307|592312370|FG000|Consolidation/Maintenance|Adverse Event|0|||
163984545|NCT00866307|592312371|FG001|Consolidation/Maintenance|Adverse Event|0|||
163984546|NCT00866307|592312372|FG002|Consolidation/Maintenance|Adverse Event|8|||
163984547|NCT00866307|592312370|FG000|Consolidation/Maintenance|Death|0|||
163984548|NCT00866307|592312371|FG001|Consolidation/Maintenance|Death|0|||
163984549|NCT00866307|592312372|FG002|Consolidation/Maintenance|Death|1|||
163984550|NCT00866307|592312370|FG000|Consolidation/Maintenance|Physician Decision|0|||
163984551|NCT00866307|592312371|FG001|Consolidation/Maintenance|Physician Decision|3|||
163984552|NCT00866307|592312372|FG002|Consolidation/Maintenance|Physician Decision|2|||
163984553|NCT00866307|592312370|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
163984554|NCT00866307|592312371|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
163984555|NCT00866307|592312372|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
163984556|NCT00866307|592312370|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
163984557|NCT00866307|592312371|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
163984558|NCT00866307|592312372|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
163984559|NCT00866307|592312370|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
163984560|NCT00866307|592312371|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
163984561|NCT00866307|592312372|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
163984562|NCT00866307|592312370|FG000|Consolidation/Maintenance|Therapy error|0|||
163984563|NCT00866307|592312371|FG001|Consolidation/Maintenance|Therapy error|1|||
163984564|NCT00866307|592312372|FG002|Consolidation/Maintenance|Therapy error|0|||
163984565|NCT00866307|592312370|FG000|Consolidation/Maintenance|Non-compliance|0|||
163984566|NCT00866307|592312371|FG001|Consolidation/Maintenance|Non-compliance|0|||
163984567|NCT00866307|592312372|FG002|Consolidation/Maintenance|Non-compliance|1|||
163984568|NCT00866307|592312370|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
163984569|NCT00866307|592312371|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
163984570|NCT00866307|592312372|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
163984571|NCT02573155|592312375|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
163984572|NCT02573155|592312376|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
163984573|NCT02573155|592312375|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
163984574|NCT02573155|592312376|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
163984575|NCT02573155|592312375|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
163984576|NCT02573155|592312376|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
163984577|NCT02573155|592312375|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
163984578|NCT02573155|592312376|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
163984579|NCT02573155|592312375|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
163984580|NCT02573155|592312376|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
163984581|NCT02573155|592312375|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
163984582|NCT02573155|592312376|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
163984583|NCT02573155|592312375|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
163984584|NCT02573155|592312376|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
163984585|NCT02573155|592312375|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
163984586|NCT02573155|592312376|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
163984587|NCT01681433|592312377|FG000|Overall Study|Lack of Efficacy|23|||
163984588|NCT01681433|592312378|FG001|Overall Study|Lack of Efficacy|23|||
163984589|NCT01681433|592312377|FG000|Overall Study|Withdrawal by Subject|5|||
163984590|NCT01681433|592312378|FG001|Overall Study|Withdrawal by Subject|5|||
163984591|NCT01681433|592312377|FG000|Overall Study|Protocol Violation|2|||
163984592|NCT01681433|592312378|FG001|Overall Study|Protocol Violation|0|||
163984593|NCT01681433|592312377|FG000|Overall Study|Adverse Event|2|||
163984594|NCT01681433|592312378|FG001|Overall Study|Adverse Event|4|||
163984595|NCT01681433|592312377|FG000|Overall Study|Lost to Follow-up|0|||
163984596|NCT01681433|592312378|FG001|Overall Study|Lost to Follow-up|1|||
163984597|NCT00903929|592312379|FG000|Overall Study|Withdrawal by Subject|0|||
163984598|NCT00903929|592312380|FG001|Overall Study|Withdrawal by Subject|0|||
163984599|NCT00903929|592312381|FG002|Overall Study|Withdrawal by Subject|1|||
163984600|NCT00903929|592312382|FG003|Overall Study|Withdrawal by Subject|2|||
163984601|NCT00903929|592312379|FG000|Overall Study|Adverse Event|0|||
163984602|NCT00903929|592312380|FG001|Overall Study|Adverse Event|0|||
163984603|NCT00903929|592312381|FG002|Overall Study|Adverse Event|0|||
163984604|NCT00903929|592312382|FG003|Overall Study|Adverse Event|1|||
163984605|NCT00626093|592312386|FG000|Overall Study|Lost to Follow-up|5|||
163984606|NCT00626093|592312386|FG000|Overall Study|Death|1|||
163984607|NCT00626093|592312386|FG000|Overall Study|Physician Decision|4|||
163984608|NCT00626093|592312386|FG000|Overall Study|Withdrawal by Subject|6|||
163984609|NCT00626093|592312386|FG000|Overall Study|Protocol Violation|1|||
163984610|NCT00626093|592312386|FG000|Overall Study|One of the required devices not implante|6|||
163984611|NCT00511355|592312387|FG000|Overall Study|Adverse Event|4|||
163984612|NCT00511355|592312388|FG001|Overall Study|Adverse Event|4|||
163984613|NCT00511355|592312387|FG000|Overall Study|Pregnancy Wish|1|||
163984614|NCT00511355|592312388|FG001|Overall Study|Pregnancy Wish|0|||
163984615|NCT00511355|592312387|FG000|Overall Study|Lost to Follow-up|2|||
163984616|NCT00511355|592312388|FG001|Overall Study|Lost to Follow-up|1|||
163984617|NCT00511355|592312387|FG000|Overall Study|Other Reason|0|||
163984618|NCT00511355|592312388|FG001|Overall Study|Other Reason|1|||
163984619|NCT00511355|592312387|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
163984620|NCT00511355|592312388|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
163984621|NCT00511355|592312387|FG000|Overall Study|Withdrawal of informed consent|0|||
163984622|NCT00511355|592312388|FG001|Overall Study|Withdrawal of informed consent|1|||
163984623|NCT00511355|592312387|FG000|Overall Study|Other reason pre-treatment|0|||
163984624|NCT00511355|592312388|FG001|Overall Study|Other reason pre-treatment|1|||
163984625|NCT01632566|592312389|FG000|Overall Study|Withdrawal by Subject|0|||
163984626|NCT01632566|592312390|FG001|Overall Study|Withdrawal by Subject|1|||
164080473|NCT00549198|592659496|FG001|Overall Study|Investigator Decision|3|||
164080474|NCT00549198|592659495|FG000|Overall Study|Withdrawal by Subject|7|||
164080475|NCT00549198|592659496|FG001|Overall Study|Withdrawal by Subject|7|||
164080476|NCT00549198|592659495|FG000|Overall Study|Disease Progression|1|||
163984627|NCT01632566|592312391|FG002|Overall Study|Withdrawal by Subject|0|||
163984628|NCT01632566|592312392|FG003|Overall Study|Withdrawal by Subject|0|||
163984629|NCT01632566|592312393|FG004|Overall Study|Withdrawal by Subject|0|||
163984630|NCT01632566|592312389|FG000|Overall Study|Sponsor Decision|0|||
163984631|NCT01632566|592312390|FG001|Overall Study|Sponsor Decision|2|||
164080477|NCT00549198|592659496|FG001|Overall Study|Disease Progression|0|||
163984632|NCT01632566|592312391|FG002|Overall Study|Sponsor Decision|9|||
163984633|NCT01632566|592312392|FG003|Overall Study|Sponsor Decision|2|||
163984634|NCT01632566|592312393|FG004|Overall Study|Sponsor Decision|2|||
163984635|NCT00454805|592312394|FG000|Overall Study|Withdrawal by Subject|9|||
163984636|NCT00454805|592312395|FG001|Overall Study|Withdrawal by Subject|2|||
163984637|NCT00454805|592312394|FG000|Overall Study|Death|0|||
163984638|NCT00454805|592312395|FG001|Overall Study|Death|2|||
163984639|NCT00454805|592312394|FG000|Overall Study|Disease progression|16|||
163984640|NCT00454805|592312395|FG001|Overall Study|Disease progression|19|||
163984641|NCT00454805|592312394|FG000|Overall Study|In order to begin radiotherapy|1|||
163984642|NCT00454805|592312395|FG001|Overall Study|In order to begin radiotherapy|0|||
163984643|NCT00217087|592312396|FG000|Overall Study|decided to have esophagectomy|1|||
163984644|NCT00217087|592312397|FG001|Overall Study|decided to have esophagectomy|2|||
163984645|NCT00217087|592312396|FG000|Overall Study|completed less than 12 months return|10|||
163984646|NCT00217087|592312397|FG001|Overall Study|completed less than 12 months return|18|||
163984647|NCT03208231|592312402|FG000|Overall Study|Death|1|||
163984648|NCT03208231|592312403|FG001|Overall Study|Death|2|||
163984649|NCT03208231|592312402|FG000|Overall Study|Moved and unable to get to clinic|1|||
163984650|NCT03208231|592312403|FG001|Overall Study|Moved and unable to get to clinic|0|||
163984651|NCT03208231|592312402|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
163984652|NCT03208231|592312403|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
163984653|NCT03205995|592312404|FG000|Overall Study|Adverse Event|1|||
163984654|NCT03205995|592312404|FG000|Overall Study|Death|1|||
163984655|NCT03205995|592312404|FG000|Overall Study|Physician Decision|2|||
163984656|NCT03205995|592312404|FG000|Overall Study|Protocol Violation|2|||
163984657|NCT04947800|592312407|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
163984658|NCT04947800|592312408|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
163984659|NCT04947800|592312409|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
163984660|NCT02158091|592312410|FG000|Overall Study|DLT|2|||
163984661|NCT02158091|592312411|FG001|Overall Study|DLT|1|||
163984662|NCT02158091|592312412|FG002|Overall Study|DLT|0|||
163984663|NCT01328951|592312413|FG000|Overall Study|Disease Progression|17|||
163984664|NCT01328951|592312414|FG001|Overall Study|Disease Progression|14|||
163984665|NCT01328951|592312413|FG000|Overall Study|Adverse Event|2|||
163984666|NCT01328951|592312414|FG001|Overall Study|Adverse Event|0|||
163984667|NCT01328951|592312413|FG000|Overall Study|Death|243|||
163984668|NCT01328951|592312414|FG001|Overall Study|Death|258|||
163984669|NCT01328951|592312413|FG000|Overall Study|Lost to Follow-up|6|||
163984670|NCT01328951|592312414|FG001|Overall Study|Lost to Follow-up|7|||
163984671|NCT01328951|592312413|FG000|Overall Study|Withdrawal by Subject|6|||
163984672|NCT01328951|592312414|FG001|Overall Study|Withdrawal by Subject|6|||
163984673|NCT01328951|592312413|FG000|Overall Study|Study Closed by the Sponsor|36|||
163984674|NCT01328951|592312414|FG001|Overall Study|Study Closed by the Sponsor|31|||
163984675|NCT01328951|592312413|FG000|Overall Study|Other|11|||
163984676|NCT01328951|592312414|FG001|Overall Study|Other|6|||
164080478|NCT00549198|592659495|FG000|Overall Study|Participant Moved|2|||
164080479|NCT00549198|592659496|FG001|Overall Study|Participant Moved|0|||
164080480|NCT00549198|592659495|FG000|Overall Study|Participant not able to perform Week 96|1|||
164080481|NCT00549198|592659496|FG001|Overall Study|Participant not able to perform Week 96|0|||
164080482|NCT00549198|592659495|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
164080483|NCT00549198|592659496|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
164080484|NCT00549198|592659495|FG000|Overall Study|Prohibited Medication|1|||
164080485|NCT00549198|592659496|FG001|Overall Study|Prohibited Medication|2|||
164080486|NCT00549198|592659495|FG000|Overall Study|Participant planning pregnancy|1|||
164080487|NCT00549198|592659496|FG001|Overall Study|Participant planning pregnancy|0|||
164080488|NCT00549198|592659495|FG000|Overall Study|Participant overweight, no scan possible|1|||
164080489|NCT00549198|592659496|FG001|Overall Study|Participant overweight, no scan possible|0|||
164080490|NCT00549198|592659495|FG000|Overall Study|No scan facilities|0|||
164080491|NCT00549198|592659496|FG001|Overall Study|No scan facilities|2|||
164080492|NCT00549198|592659495|FG000|Overall Study|Pregnancy|0|||
164080493|NCT00549198|592659496|FG001|Overall Study|Pregnancy|3|||
164080494|NCT00549198|592659495|FG000|Overall Study|Not Exposed to Study Drug|3|||
164080495|NCT00549198|592659496|FG001|Overall Study|Not Exposed to Study Drug|4|||
164080496|NCT01764854|592659506|FG000|Overall Study|Adverse Event|0|||
164080497|NCT01764854|592659507|FG001|Overall Study|Adverse Event|0|||
164080498|NCT01764854|592659508|FG002|Overall Study|Adverse Event|2|||
164080499|NCT01764854|592659509|FG003|Overall Study|Adverse Event|0|||
164080500|NCT01764854|592659506|FG000|Overall Study|Withdrawal by Subject|0|||
164080501|NCT01764854|592659507|FG001|Overall Study|Withdrawal by Subject|0|||
163984677|NCT01627899|592312417|FG000|Overall Study|Study terminated early by sponsor.|5|||
163984678|NCT01358864|592312424|FG000|Overall Study|Adverse Event|0|||
163984679|NCT01358864|592312425|FG001|Overall Study|Adverse Event|6|||
163984680|NCT01358864|592312426|FG002|Overall Study|Adverse Event|9|||
163984681|NCT01358864|592312427|FG003|Overall Study|Adverse Event|0|||
163984682|NCT01358864|592312428|FG004|Overall Study|Adverse Event|4|||
164080502|NCT01764854|592659508|FG002|Overall Study|Withdrawal by Subject|1|||
164080503|NCT01764854|592659509|FG003|Overall Study|Withdrawal by Subject|0|||
164080504|NCT01764854|592659506|FG000|Overall Study|relocation|0|||
164080505|NCT01764854|592659507|FG001|Overall Study|relocation|0|||
164080506|NCT01764854|592659508|FG002|Overall Study|relocation|2|||
163984683|NCT01358864|592312429|FG005|Overall Study|Adverse Event|8|||
163984684|NCT01358864|592312430|FG006|Overall Study|Adverse Event|12|||
163984685|NCT01358864|592312431|FG007|Overall Study|Adverse Event|7|||
163984686|NCT01358864|592312424|FG000|Overall Study|Lack of Efficacy|26|||
163984687|NCT01358864|592312425|FG001|Overall Study|Lack of Efficacy|3|||
163984688|NCT01358864|592312426|FG002|Overall Study|Lack of Efficacy|4|||
163984689|NCT01358864|592312427|FG003|Overall Study|Lack of Efficacy|19|||
163984690|NCT01358864|592312428|FG004|Overall Study|Lack of Efficacy|7|||
163984691|NCT01358864|592312429|FG005|Overall Study|Lack of Efficacy|4|||
163984692|NCT01358864|592312430|FG006|Overall Study|Lack of Efficacy|49|||
163984693|NCT01358864|592312431|FG007|Overall Study|Lack of Efficacy|44|||
163984694|NCT01358864|592312424|FG000|Overall Study|Lost to Follow-up|0|||
163984695|NCT01358864|592312425|FG001|Overall Study|Lost to Follow-up|0|||
163984696|NCT01358864|592312426|FG002|Overall Study|Lost to Follow-up|1|||
163984697|NCT01358864|592312427|FG003|Overall Study|Lost to Follow-up|0|||
163984698|NCT01358864|592312428|FG004|Overall Study|Lost to Follow-up|0|||
163984699|NCT01358864|592312429|FG005|Overall Study|Lost to Follow-up|0|||
163984700|NCT01358864|592312430|FG006|Overall Study|Lost to Follow-up|0|||
163984701|NCT01358864|592312431|FG007|Overall Study|Lost to Follow-up|1|||
163984702|NCT01358864|592312424|FG000|Overall Study|Withdrawal by Subject|3|||
163984703|NCT01358864|592312425|FG001|Overall Study|Withdrawal by Subject|4|||
163984704|NCT01358864|592312426|FG002|Overall Study|Withdrawal by Subject|2|||
163984705|NCT01358864|592312427|FG003|Overall Study|Withdrawal by Subject|0|||
163984706|NCT01358864|592312428|FG004|Overall Study|Withdrawal by Subject|0|||
163984707|NCT01358864|592312429|FG005|Overall Study|Withdrawal by Subject|1|||
163984708|NCT01358864|592312430|FG006|Overall Study|Withdrawal by Subject|1|||
163984709|NCT01358864|592312431|FG007|Overall Study|Withdrawal by Subject|3|||
163984710|NCT01358864|592312424|FG000|Overall Study|Other reason not defined above|2|||
163984711|NCT01358864|592312425|FG001|Overall Study|Other reason not defined above|0|||
163984712|NCT01358864|592312426|FG002|Overall Study|Other reason not defined above|0|||
163984713|NCT01358864|592312427|FG003|Overall Study|Other reason not defined above|0|||
163984714|NCT01358864|592312428|FG004|Overall Study|Other reason not defined above|0|||
163984715|NCT01358864|592312429|FG005|Overall Study|Other reason not defined above|0|||
163984716|NCT01358864|592312430|FG006|Overall Study|Other reason not defined above|2|||
163984717|NCT01358864|592312431|FG007|Overall Study|Other reason not defined above|0|||
164080507|NCT01764854|592659509|FG003|Overall Study|relocation|0|||
164080508|NCT01764854|592659506|FG000|Overall Study|Protocol Violation|0|||
164080509|NCT01764854|592659507|FG001|Overall Study|Protocol Violation|0|||
163880608|NCT03526861|591933415|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880609|NCT03526861|591933416|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
163880610|NCT03526861|591933417|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
163880611|NCT03526861|591933409|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880612|NCT03526861|591933410|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880613|NCT03526861|591933411|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880614|NCT03526861|591933412|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880615|NCT03526861|591933413|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880616|NCT03526861|591933414|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880617|NCT03526861|591933415|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880618|NCT03526861|591933416|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
163880619|NCT03526861|591933417|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
163880620|NCT04089371|591933420|FG000|Overall Study|Withdrawal by Subject|0|||
163880621|NCT04089371|591933421|FG001|Overall Study|Withdrawal by Subject|1|||
163880622|NCT04089371|591933420|FG000|Overall Study|Study terminated early|0|||
163880623|NCT04089371|591933421|FG001|Overall Study|Study terminated early|9|||
163880624|NCT03453619|591933422|FG000|Core Study (Part A)|Physician Decision|0|||
163880625|NCT03453619|591933423|FG001|Core Study (Part A)|Physician Decision|0|||
163880626|NCT03453619|591933424|FG002|Core Study (Part A)|Physician Decision|2|||
163880627|NCT03453619|591933425|FG003|Core Study (Part A)|Physician Decision|0|||
163880628|NCT03453619|591933422|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
163984718|NCT01358864|592312424|FG000|Overall Study|Not treated|0|||
163984719|NCT01358864|592312425|FG001|Overall Study|Not treated|0|||
163984720|NCT01358864|592312426|FG002|Overall Study|Not treated|0|||
163984721|NCT01358864|592312427|FG003|Overall Study|Not treated|0|||
164080510|NCT01764854|592659508|FG002|Overall Study|Protocol Violation|1|||
164329141|NCT03172910|593583233|FG001|Overall Study|Adverse Event|0|||
164329142|NCT03172910|593583234|FG002|Overall Study|Adverse Event|0|||
163880629|NCT03453619|591933423|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
163880630|NCT03453619|591933424|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
163880631|NCT03453619|591933425|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
163880632|NCT03453619|591933422|FG000|Core Study (Part A)|Other|0|||
163880633|NCT03453619|591933423|FG001|Core Study (Part A)|Other|1|||
163880634|NCT03453619|591933424|FG002|Core Study (Part A)|Other|0|||
163880635|NCT03453619|591933425|FG003|Core Study (Part A)|Other|0|||
163880636|NCT03453619|591933422|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
163880637|NCT03453619|591933423|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
163880638|NCT03453619|591933424|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
163880639|NCT03453619|591933425|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
163880640|NCT03453619|591933422|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
163880641|NCT03453619|591933423|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
163880642|NCT03453619|591933424|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
163880643|NCT03453619|591933425|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
163880644|NCT03453619|591933422|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
163880645|NCT03453619|591933423|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
163880646|NCT03453619|591933424|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
163880647|NCT03453619|591933425|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
163880648|NCT03453619|591933422|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
163880649|NCT03453619|591933423|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
163880650|NCT03453619|591933424|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
163880651|NCT03453619|591933425|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
163880652|NCT04237298|591933426|FG000|Overall Study|Lost to Follow-up|4|||
163880653|NCT04237298|591933427|FG001|Overall Study|Lost to Follow-up|5|||
163880654|NCT04556656|591933431|FG000|Overall Study|Withdrawal by Subject|14|||
163880655|NCT04556656|591933432|FG001|Overall Study|Withdrawal by Subject|12|||
163880656|NCT04556656|591933431|FG000|Overall Study|Physician Decision|1|||
163880657|NCT04556656|591933432|FG001|Overall Study|Physician Decision|0|||
163880658|NCT04556656|591933431|FG000|Overall Study|Adverse Event|4|||
163880659|NCT04556656|591933432|FG001|Overall Study|Adverse Event|7|||
163880660|NCT04556656|591933431|FG000|Overall Study|Death|4|||
163880661|NCT04556656|591933432|FG001|Overall Study|Death|0|||
163880662|NCT04556656|591933431|FG000|Overall Study|Lost to Follow-up|3|||
163880663|NCT04556656|591933432|FG001|Overall Study|Lost to Follow-up|2|||
163880664|NCT04556656|591933431|FG000|Overall Study|Not further specified|2|||
163880665|NCT04556656|591933432|FG001|Overall Study|Not further specified|1|||
163880666|NCT05536440|591933433|FG000|Overall Study|Adverse Event|0|||
163880667|NCT05536440|591933434|FG001|Overall Study|Adverse Event|0|||
163880668|NCT05536440|591933435|FG002|Overall Study|Adverse Event|0|||
163880669|NCT05536440|591933436|FG003|Overall Study|Adverse Event|0|||
163880670|NCT05536440|591933437|FG004|Overall Study|Adverse Event|0|||
163880671|NCT05536440|591933438|FG005|Overall Study|Adverse Event|0|||
163880672|NCT05536440|591933439|FG006|Overall Study|Adverse Event|0|||
163880673|NCT05536440|591933440|FG007|Overall Study|Adverse Event|0|||
163880674|NCT05536440|591933441|FG008|Overall Study|Adverse Event|1|||
163880675|NCT01566695|591933442|FG000|Overall Study|Lack of Efficacy|1|||
163880676|NCT01566695|591933443|FG001|Overall Study|Lack of Efficacy|0|||
163880677|NCT01566695|591933442|FG000|Overall Study|Adverse Event|3|||
163880678|NCT01566695|591933443|FG001|Overall Study|Adverse Event|0|||
163880679|NCT01566695|591933442|FG000|Overall Study|Death|79|||
163880680|NCT01566695|591933443|FG001|Overall Study|Death|86|||
163880681|NCT01566695|591933442|FG000|Overall Study|Withdrawal by Subject|13|||
163880682|NCT01566695|591933443|FG001|Overall Study|Withdrawal by Subject|12|||
163880683|NCT01566695|591933442|FG000|Overall Study|Lost to Follow-up|0|||
163880684|NCT01566695|591933443|FG001|Overall Study|Lost to Follow-up|3|||
163880685|NCT01566695|591933442|FG000|Overall Study|Other reasons|11|||
163880686|NCT01566695|591933443|FG001|Overall Study|Other reasons|8|||
163880687|NCT01416831|591933445|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
163880688|NCT01416831|591933446|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
163880689|NCT05470400|591933447|FG000|Overall Study|Lost to Follow-up|0|||
163880690|NCT05470400|591933448|FG001|Overall Study|Lost to Follow-up|0|||
163880691|NCT05470400|591933449|FG002|Overall Study|Lost to Follow-up|0|||
163880692|NCT05470400|591933450|FG003|Overall Study|Lost to Follow-up|0|||
163880693|NCT05470400|591933451|FG004|Overall Study|Lost to Follow-up|0|||
163880694|NCT05470400|591933452|FG005|Overall Study|Lost to Follow-up|0|||
163880695|NCT05470400|591933453|FG006|Overall Study|Lost to Follow-up|0|||
163880696|NCT05470400|591933454|FG007|Overall Study|Lost to Follow-up|1|||
163880697|NCT05470400|591933447|FG000|Overall Study|Withdrawal by Subject|1|||
163880698|NCT05470400|591933448|FG001|Overall Study|Withdrawal by Subject|0|||
163880699|NCT05470400|591933449|FG002|Overall Study|Withdrawal by Subject|0|||
163880700|NCT05470400|591933450|FG003|Overall Study|Withdrawal by Subject|0|||
163880701|NCT05470400|591933451|FG004|Overall Study|Withdrawal by Subject|0|||
163880702|NCT05470400|591933452|FG005|Overall Study|Withdrawal by Subject|1|||
163880703|NCT05470400|591933453|FG006|Overall Study|Withdrawal by Subject|0|||
163984722|NCT01358864|592312428|FG004|Overall Study|Not treated|0|||
163984723|NCT01358864|592312429|FG005|Overall Study|Not treated|0|||
163984724|NCT01358864|592312430|FG006|Overall Study|Not treated|1|||
163984725|NCT01358864|592312431|FG007|Overall Study|Not treated|0|||
163984726|NCT04042103|592312432|FG000|Overall Study|Lost to Follow-up|1|||
163984727|NCT04042103|592312432|FG000|Overall Study|Withdrawal by Subject|1|||
163984728|NCT04209855|592312433|FG000|Overall Study|Death|161|||
163984729|NCT04209855|592312434|FG001|Overall Study|Death|177|||
163984730|NCT04209855|592312433|FG000|Overall Study|PI Discretion|1|||
163984731|NCT04209855|592312434|FG001|Overall Study|PI Discretion|1|||
163984732|NCT04209855|592312433|FG000|Overall Study|Lost to Follow-up|5|||
163984733|NCT04209855|592312434|FG001|Overall Study|Lost to Follow-up|2|||
163984734|NCT04209855|592312433|FG000|Overall Study|Withdrew consent|10|||
163984735|NCT04209855|592312434|FG001|Overall Study|Withdrew consent|24|||
163984736|NCT04209855|592312433|FG000|Overall Study|Sponsor decision|44|||
163984737|NCT04209855|592312434|FG001|Overall Study|Sponsor decision|18|||
163984738|NCT04209855|592312433|FG000|Overall Study|Other than specified|6|||
163984739|NCT04209855|592312434|FG001|Overall Study|Other than specified|4|||
163984740|NCT00271817|592312436|FG000|Part 1|Adverse Event|68|||
163984741|NCT00271817|592312437|FG001|Part 1|Adverse Event|25|||
163984742|NCT00271817|592312438|FG002|Part 1|Adverse Event|156|||
163984743|NCT00271817|592312436|FG000|Part 1|Lost to Follow-up|6|||
163984744|NCT00271817|592312437|FG001|Part 1|Lost to Follow-up|8|||
163984745|NCT00271817|592312438|FG002|Part 1|Lost to Follow-up|24|||
163984746|NCT00271817|592312436|FG000|Part 1|Protocol Violation|5|||
163984747|NCT00271817|592312437|FG001|Part 1|Protocol Violation|4|||
163984748|NCT00271817|592312438|FG002|Part 1|Protocol Violation|7|||
163984749|NCT00271817|592312436|FG000|Part 1|Patient Moved|3|||
163984750|NCT00271817|592312437|FG001|Part 1|Patient Moved|1|||
163984751|NCT00271817|592312438|FG002|Part 1|Patient Moved|5|||
163984752|NCT00271817|592312436|FG000|Part 1|Withdrawal by Subject|23|||
163984753|NCT00271817|592312437|FG001|Part 1|Withdrawal by Subject|17|||
163984754|NCT00271817|592312438|FG002|Part 1|Withdrawal by Subject|45|||
163984755|NCT00271817|592312436|FG000|Part 1|LDL < 50 mg/dL|1|||
163984756|NCT00271817|592312437|FG001|Part 1|LDL < 50 mg/dL|4|||
163984757|NCT00271817|592312438|FG002|Part 1|LDL < 50 mg/dL|48|||
163984758|NCT00271817|592312436|FG000|Part 2|Adverse Event|0|||
163984759|NCT00271817|592312437|FG001|Part 2|Adverse Event|17|||
163984760|NCT00271817|592312438|FG002|Part 2|Adverse Event|33|||
163984761|NCT00271817|592312436|FG000|Part 2|Lack of Efficacy|0|||
163984762|NCT00271817|592312437|FG001|Part 2|Lack of Efficacy|1|||
163984763|NCT00271817|592312438|FG002|Part 2|Lack of Efficacy|6|||
163984764|NCT00271817|592312436|FG000|Part 2|Lost to Follow-up|0|||
163984765|NCT00271817|592312437|FG001|Part 2|Lost to Follow-up|6|||
164329143|NCT03172910|593583235|FG003|Overall Study|Adverse Event|0|||
163984766|NCT00271817|592312438|FG002|Part 2|Lost to Follow-up|18|||
163984767|NCT00271817|592312436|FG000|Part 2|Protocol Violation|0|||
163984768|NCT00271817|592312437|FG001|Part 2|Protocol Violation|3|||
163984769|NCT00271817|592312438|FG002|Part 2|Protocol Violation|5|||
163984770|NCT00271817|592312436|FG000|Part 2|Patient Moved|0|||
163984771|NCT00271817|592312437|FG001|Part 2|Patient Moved|0|||
163984772|NCT00271817|592312438|FG002|Part 2|Patient Moved|5|||
163984773|NCT00271817|592312436|FG000|Part 2|Withdrawal by Subject|0|||
163984774|NCT00271817|592312437|FG001|Part 2|Withdrawal by Subject|2|||
163984775|NCT00271817|592312438|FG002|Part 2|Withdrawal by Subject|13|||
163984776|NCT00271817|592312436|FG000|Part 2|LDL < 50 mg/dL|0|||
163984777|NCT00271817|592312437|FG001|Part 2|LDL < 50 mg/dL|3|||
163984778|NCT00271817|592312438|FG002|Part 2|LDL < 50 mg/dL|4|||
163984779|NCT00264238|592312442|FG000|Overall Study|Protocol Violation|1|||
163984780|NCT00861744|592312443|FG000|Overall Study|Adverse Event|0|||
163984781|NCT00861744|592312444|FG001|Overall Study|Adverse Event|0|||
163984782|NCT00861744|592312445|FG002|Overall Study|Adverse Event|0|||
163984783|NCT00861744|592312446|FG003|Overall Study|Adverse Event|1|||
163984784|NCT00861744|592312443|FG000|Overall Study|Lost to Follow-up|7|||
163984785|NCT00861744|592312444|FG001|Overall Study|Lost to Follow-up|19|||
163984786|NCT00861744|592312445|FG002|Overall Study|Lost to Follow-up|17|||
163984787|NCT00861744|592312446|FG003|Overall Study|Lost to Follow-up|12|||
163984788|NCT00861744|592312443|FG000|Overall Study|Withdrawal by Subject|10|||
163984789|NCT00861744|592312444|FG001|Overall Study|Withdrawal by Subject|6|||
163984790|NCT00861744|592312445|FG002|Overall Study|Withdrawal by Subject|6|||
163984791|NCT00861744|592312446|FG003|Overall Study|Withdrawal by Subject|19|||
163984792|NCT00861744|592312443|FG000|Overall Study|Protocol Violation|0|||
163984793|NCT00861744|592312444|FG001|Overall Study|Protocol Violation|1|||
163984794|NCT00861744|592312445|FG002|Overall Study|Protocol Violation|0|||
163984795|NCT00861744|592312446|FG003|Overall Study|Protocol Violation|0|||
163984796|NCT00861744|592312443|FG000|Overall Study|Migration from study area|0|||
164329144|NCT03172910|593583236|FG004|Overall Study|Adverse Event|1|||
163984797|NCT00861744|592312444|FG001|Overall Study|Migration from study area|3|||
163984798|NCT00861744|592312445|FG002|Overall Study|Migration from study area|1|||
163984799|NCT00861744|592312446|FG003|Overall Study|Migration from study area|0|||
163984800|NCT00861744|592312443|FG000|Overall Study|Blood draws|0|||
163984801|NCT00861744|592312444|FG001|Overall Study|Blood draws|0|||
163984802|NCT00861744|592312445|FG002|Overall Study|Blood draws|0|||
164329145|NCT01397201|593583237|FG000|Overall Study|Not treated|0|||
163984803|NCT00861744|592312446|FG003|Overall Study|Blood draws|1|||
163984804|NCT01411085|592312447|FG000|Overall Study|Physician Decision|1|||
163984805|NCT01411085|592312447|FG000|Overall Study|Protocol Violation|1|||
163984806|NCT01411085|592312447|FG000|Overall Study|Adverse Event|1|||
163984807|NCT05568888|592312448|FG000|Overall Study|Physician Decision|1|||
163984808|NCT05568888|592312449|FG001|Overall Study|Physician Decision|0|||
163984809|NCT05568888|592312448|FG000|Overall Study|Protocol Deviation|2|||
163984810|NCT05568888|592312449|FG001|Overall Study|Protocol Deviation|1|||
163984811|NCT05568888|592312448|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
163984812|NCT05568888|592312449|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
163984813|NCT05568888|592312448|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
163984814|NCT05568888|592312449|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
163984815|NCT05568888|592312448|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
163984816|NCT05568888|592312449|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
163984817|NCT01564862|592312450|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
163984818|NCT01564862|592312451|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
163984819|NCT01564862|592312452|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
163984820|NCT01564862|592312450|FG000|Overall Study|Major Protocol Deviation|3|||
163984821|NCT01564862|592312451|FG001|Overall Study|Major Protocol Deviation|3|||
163984822|NCT01564862|592312452|FG002|Overall Study|Major Protocol Deviation|4|||
163984823|NCT01564862|592312450|FG000|Overall Study|Lost to Follow-up|10|||
163984824|NCT01564862|592312451|FG001|Overall Study|Lost to Follow-up|8|||
163984825|NCT01564862|592312452|FG002|Overall Study|Lost to Follow-up|6|||
163984826|NCT01564862|592312450|FG000|Overall Study|Voluntary Withdrawal|9|||
163984827|NCT01564862|592312451|FG001|Overall Study|Voluntary Withdrawal|6|||
163984828|NCT01564862|592312452|FG002|Overall Study|Voluntary Withdrawal|8|||
163984829|NCT01564862|592312450|FG000|Overall Study|Lack of Efficacy|1|||
163984830|NCT01564862|592312451|FG001|Overall Study|Lack of Efficacy|5|||
163984831|NCT01564862|592312452|FG002|Overall Study|Lack of Efficacy|6|||
163984832|NCT01564862|592312450|FG000|Overall Study|Other reason(s)|1|||
163984833|NCT01564862|592312451|FG001|Overall Study|Other reason(s)|0|||
163984834|NCT01564862|592312452|FG002|Overall Study|Other reason(s)|0|||
163984835|NCT02193074|592312455|FG000|Overall Study|Withdrawal by Subject|1|||
163984836|NCT02193074|592312456|FG001|Overall Study|Withdrawal by Subject|2|||
163984837|NCT02193074|592312455|FG000|Overall Study|Adverse Event|16|||
163984838|NCT02193074|592312456|FG001|Overall Study|Adverse Event|13|||
163984839|NCT01844986|592312457|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
163984840|NCT01844986|592312458|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
163984841|NCT01844986|592312457|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
163984842|NCT01844986|592312458|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
163984843|NCT01844986|592312457|FG000|Overall Study (Global Cohort)|Death|55|||
163984844|NCT01844986|592312458|FG001|Overall Study (Global Cohort)|Death|26|||
163984845|NCT01844986|592312457|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
163984846|NCT01844986|592312458|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
163984847|NCT01844986|592312457|FG000|Overall Study (China Cohort)|Death|10|||
163984848|NCT01844986|592312458|FG001|Overall Study (China Cohort)|Death|6|||
163984849|NCT04381650|592312461|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984850|NCT04381650|592312462|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984851|NCT04381650|592312463|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984852|NCT04381650|592312464|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
163880704|NCT05470400|591933454|FG007|Overall Study|Withdrawal by Subject|2|||
163880705|NCT05956002|591933455|FG000|Treatment Period 3|Adverse Event|0|||
163880706|NCT05956002|591933456|FG001|Treatment Period 3|Adverse Event|0|||
163880707|NCT05956002|591933457|FG002|Treatment Period 3|Adverse Event|1|||
163880708|NCT05956002|591933458|FG003|Treatment Period 3|Adverse Event|0|||
163880709|NCT04784559|591933459|FG000|Overall Study|Withdrawal by Subject|3|||
163880710|NCT04784559|591933460|FG001|Overall Study|Withdrawal by Subject|2|||
163880711|NCT04784559|591933461|FG002|Overall Study|Withdrawal by Subject|1|||
163880712|NCT04784559|591933459|FG000|Overall Study|Death|2|||
163880713|NCT04784559|591933460|FG001|Overall Study|Death|1|||
163984853|NCT04381650|592312465|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984854|NCT04381650|592312466|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984855|NCT04381650|592312467|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984856|NCT04381650|592312468|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984857|NCT04381650|592312469|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984858|NCT04381650|592312470|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984859|NCT04381650|592312471|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
163984860|NCT04381650|592312461|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984861|NCT04381650|592312462|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163880714|NCT04784559|591933461|FG002|Overall Study|Death|2|||
163880715|NCT04784559|591933459|FG000|Overall Study|Lost to Follow-up|0|||
163880716|NCT04784559|591933460|FG001|Overall Study|Lost to Follow-up|0|||
163880717|NCT04784559|591933461|FG002|Overall Study|Lost to Follow-up|2|||
163984862|NCT04381650|592312463|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984863|NCT04381650|592312464|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
163984864|NCT04381650|592312465|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984865|NCT04381650|592312466|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984866|NCT04381650|592312467|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984867|NCT04381650|592312468|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984868|NCT04381650|592312469|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984869|NCT04381650|592312470|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984870|NCT04381650|592312471|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
163984871|NCT04381650|592312461|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
163984872|NCT04381650|592312462|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
163984873|NCT04381650|592312463|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
163984874|NCT04381650|592312464|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
163984875|NCT04381650|592312465|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984876|NCT04381650|592312466|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984877|NCT04381650|592312467|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984878|NCT04381650|592312468|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984879|NCT04381650|592312469|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984880|NCT04381650|592312470|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984881|NCT04381650|592312471|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
163984882|NCT04381650|592312461|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984883|NCT04381650|592312462|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984884|NCT04381650|592312463|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
163984885|NCT04381650|592312464|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
163984886|NCT04381650|592312465|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984887|NCT04381650|592312466|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984888|NCT04381650|592312467|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984889|NCT04381650|592312468|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984890|NCT04381650|592312469|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984891|NCT04381650|592312470|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984892|NCT04381650|592312471|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
163984893|NCT04381650|592312461|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984894|NCT04381650|592312462|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
163984895|NCT04381650|592312463|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
163984896|NCT04381650|592312464|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
163984897|NCT04381650|592312465|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984898|NCT04381650|592312466|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984899|NCT04381650|592312467|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984900|NCT04381650|592312468|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984901|NCT04381650|592312469|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984902|NCT04381650|592312470|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984903|NCT04381650|592312471|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
163984904|NCT04381650|592312461|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984905|NCT04381650|592312462|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984906|NCT04381650|592312463|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984907|NCT04381650|592312464|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984908|NCT04381650|592312465|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
164080511|NCT01764854|592659509|FG003|Overall Study|Protocol Violation|2|||
164080512|NCT03273387|592659510|FG000|Overall Study|Death|2|||
164080513|NCT03273387|592659511|FG001|Overall Study|Death|2|||
164080514|NCT03273387|592659510|FG000|Overall Study|Withdrawal by Subject|1|||
164080515|NCT03273387|592659511|FG001|Overall Study|Withdrawal by Subject|1|||
164080516|NCT02668783|592659512|FG000|Overall Study|Pregnancy|0|||
164080517|NCT02668783|592659513|FG001|Overall Study|Pregnancy|1|||
164080518|NCT02668783|592659512|FG000|Overall Study|Protocol Violation|2|||
164080519|NCT02668783|592659513|FG001|Overall Study|Protocol Violation|1|||
164080520|NCT02668783|592659512|FG000|Overall Study|Study terminated by sponsor|9|||
164080521|NCT02668783|592659513|FG001|Overall Study|Study terminated by sponsor|10|||
164080522|NCT02668783|592659512|FG000|Overall Study|Subject moved|1|||
163984909|NCT04381650|592312466|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
164080523|NCT02668783|592659513|FG001|Overall Study|Subject moved|0|||
164080524|NCT02668783|592659512|FG000|Overall Study|Withdrawal by Subject|1|||
164080525|NCT02668783|592659513|FG001|Overall Study|Withdrawal by Subject|0|||
164080526|NCT04480463|592659514|FG000|Overall Study|Death|0|||
164080527|NCT04480463|592659515|FG001|Overall Study|Death|1|||
163984910|NCT04381650|592312467|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984911|NCT04381650|592312468|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984912|NCT04381650|592312469|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
164080528|NCT04480463|592659514|FG000|Overall Study|Adverse Event|6|||
164080529|NCT04480463|592659515|FG001|Overall Study|Adverse Event|8|||
164080530|NCT04480463|592659514|FG000|Overall Study|Lost to Follow-up|3|||
164080531|NCT04480463|592659515|FG001|Overall Study|Lost to Follow-up|2|||
164080532|NCT04480463|592659514|FG000|Overall Study|Physician Decision|2|||
163984913|NCT04381650|592312470|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
163984914|NCT04381650|592312471|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
163984915|NCT04381650|592312461|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984916|NCT04381650|592312462|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984917|NCT04381650|592312463|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984918|NCT04381650|592312464|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984919|NCT04381650|592312465|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984920|NCT04381650|592312466|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984921|NCT04381650|592312467|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984922|NCT04381650|592312468|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163984923|NCT04381650|592312469|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163984924|NCT04381650|592312470|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163984925|NCT04381650|592312471|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163984926|NCT04381650|592312461|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163984927|NCT04381650|592312462|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163984928|NCT04381650|592312463|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163984929|NCT04381650|592312464|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163984930|NCT04381650|592312465|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
163984931|NCT04381650|592312466|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
163984932|NCT04381650|592312467|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
163984933|NCT04381650|592312468|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
163984934|NCT04381650|592312469|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
163984935|NCT04381650|592312470|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
163984936|NCT04381650|592312471|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
163984937|NCT04381650|592312461|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163984938|NCT04381650|592312462|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163984939|NCT04381650|592312463|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163984940|NCT04381650|592312464|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
163984941|NCT04381650|592312465|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
163984942|NCT04381650|592312466|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
163984943|NCT04381650|592312467|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
163984944|NCT04381650|592312468|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
163984945|NCT04381650|592312469|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
163984946|NCT04381650|592312470|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
163984947|NCT04381650|592312471|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
163984948|NCT04381650|592312461|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984949|NCT04381650|592312462|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984950|NCT04381650|592312463|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984951|NCT04381650|592312464|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984952|NCT04381650|592312465|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984953|NCT04381650|592312466|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984954|NCT04381650|592312467|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984955|NCT04381650|592312468|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
163984956|NCT04381650|592312469|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984957|NCT04381650|592312470|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984958|NCT04381650|592312471|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
163984959|NCT05416138|592314154|FG000|Overall Study|Withdrawal by Subject|2|||
163984960|NCT05416138|592314155|FG001|Overall Study|Withdrawal by Subject|1|||
163984961|NCT04705051|592314156|FG000|Overall Study|Enrolled but not treated|1|||
163984962|NCT04705051|592314156|FG000|Overall Study|Study terminated by sponsor|23|||
163984963|NCT03686397|592314157|FG000|Overall Study|Lack of Efficacy|3|||
163984964|NCT03686397|592314158|FG001|Overall Study|Lack of Efficacy|5|||
163984965|NCT03686397|592314157|FG000|Overall Study|Adverse Event|0|||
163984966|NCT03686397|592314158|FG001|Overall Study|Adverse Event|1|||
163984967|NCT03686397|592314157|FG000|Overall Study|Protocol Violation|0|||
163984968|NCT03686397|592314158|FG001|Overall Study|Protocol Violation|1|||
163984969|NCT03686397|592314157|FG000|Overall Study|Withdrawal by Subject|0|||
163984970|NCT03686397|592314158|FG001|Overall Study|Withdrawal by Subject|1|||
163984971|NCT03686397|592314157|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
163984972|NCT03686397|592314158|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
163984973|NCT00542997|592314161|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
163984974|NCT00542997|592314161|FG000|Wash in / Wash Out Period|Adverse Event|3|||
163984975|NCT00542997|592314161|FG000|Efficacy Period|Adverse Event|3|||
163984976|NCT00598975|592314162|FG000|Overall Study|Adverse Event|1|||
163984977|NCT00598975|592314163|FG001|Overall Study|Adverse Event|1|||
163984978|NCT00598975|592314162|FG000|Overall Study|Brain metastases|1|||
163984979|NCT00598975|592314163|FG001|Overall Study|Brain metastases|0|||
163984980|NCT00598975|592314162|FG000|Overall Study|Withdrawal by Subject|1|||
163984981|NCT00598975|592314163|FG001|Overall Study|Withdrawal by Subject|1|||
163984982|NCT00598975|592314162|FG000|Overall Study|Withdrawal of consent|0|||
163984983|NCT00598975|592314163|FG001|Overall Study|Withdrawal of consent|1|||
163984984|NCT00598975|592314162|FG000|Overall Study|Disease progression|8|||
163984985|NCT00598975|592314163|FG001|Overall Study|Disease progression|3|||
163984986|NCT00598975|592314162|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
163984987|NCT00598975|592314163|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
163984988|NCT01178138|592314166|FG000|Overall Study|Lost to Follow-up|8|||
163984989|NCT01178138|592314166|FG000|Overall Study|Withdrawal by Subject|7|||
163984990|NCT01178138|592314166|FG000|Overall Study|Physician Decision|8|||
163984991|NCT03160560|592314167|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
163984992|NCT03160560|592314168|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163984993|NCT03160560|592314169|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163984994|NCT03160560|592314170|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163984995|NCT03160560|592314167|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
163984996|NCT03160560|592314168|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163984997|NCT03160560|592314169|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163984998|NCT03160560|592314170|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
163984999|NCT00403260|592314171|FG000|Overall Study|Adverse Event|5|||
163985000|NCT00403260|592314172|FG001|Overall Study|Adverse Event|4|||
163985001|NCT00403260|592314171|FG000|Overall Study|Withdrawal by Subject|5|||
163985002|NCT00403260|592314172|FG001|Overall Study|Withdrawal by Subject|6|||
163985003|NCT00403260|592314171|FG000|Overall Study|Lost to Follow-up|49|||
163985004|NCT00403260|592314172|FG001|Overall Study|Lost to Follow-up|25|||
163985005|NCT00403260|592314171|FG000|Overall Study|Re-appearance of P. falciparum|34|||
163985006|NCT00403260|592314172|FG001|Overall Study|Re-appearance of P. falciparum|25|||
163985007|NCT00403260|592314171|FG000|Overall Study|P. vivax infection|26|||
163985008|NCT00403260|592314172|FG001|Overall Study|P. vivax infection|4|||
163985009|NCT00403260|592314171|FG000|Overall Study|Mixed infection with P. vivax|2|||
163985010|NCT00403260|592314172|FG001|Overall Study|Mixed infection with P. vivax|0|||
163985011|NCT00403260|592314171|FG000|Overall Study|Mixed infection with P. falciparum|1|||
163985012|NCT00403260|592314172|FG001|Overall Study|Mixed infection with P. falciparum|0|||
163985013|NCT00403260|592314171|FG000|Overall Study|P. vivax infection at screening|1|||
163985014|NCT00403260|592314172|FG001|Overall Study|P. vivax infection at screening|0|||
163985015|NCT00403260|592314171|FG000|Overall Study|P. ovale infection|1|||
163985016|NCT00403260|592314172|FG001|Overall Study|P. ovale infection|0|||
163985017|NCT00403260|592314171|FG000|Overall Study|Gametocyte re-appearance|1|||
163985018|NCT00403260|592314172|FG001|Overall Study|Gametocyte re-appearance|1|||
163985019|NCT00403260|592314171|FG000|Overall Study|Withdrawn from study accidentally|0|||
163985020|NCT00403260|592314172|FG001|Overall Study|Withdrawn from study accidentally|1|||
163985021|NCT01241708|592314179|FG000|Overall Study|Withdrawal by Subject|6|||
163985022|NCT01241708|592314179|FG000|Overall Study|Screen Failure|6|||
163985023|NCT01241708|592314179|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
163985024|NCT01241708|592314179|FG000|Overall Study|Lost to Follow-up|5|||
163985025|NCT04137887|592314182|FG000|Overall Study|Death|102|||
163985026|NCT04137887|592314183|FG001|Overall Study|Death|92|||
163985027|NCT04137887|592314182|FG000|Overall Study|Withdrawal by Subject|2|||
163985028|NCT04137887|592314183|FG001|Overall Study|Withdrawal by Subject|3|||
163985029|NCT04137887|592314182|FG000|Overall Study|Randomized but not treated|0|||
163985030|NCT04137887|592314183|FG001|Overall Study|Randomized but not treated|1|||
163985031|NCT01790503|592314186|FG000|Overall Study|Adverse Event|1|||
163985032|NCT01790503|592314187|FG001|Overall Study|Adverse Event|0|||
163985033|NCT01790503|592314188|FG002|Overall Study|Adverse Event|0|||
163985034|NCT01790503|592314189|FG003|Overall Study|Adverse Event|0|||
163985035|NCT01790503|592314190|FG004|Overall Study|Adverse Event|0|||
164080533|NCT04480463|592659515|FG001|Overall Study|Physician Decision|5|||
164080534|NCT04480463|592659514|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
164080535|NCT04480463|592659515|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
164080536|NCT04480463|592659514|FG000|Overall Study|Protocol Violation|2|||
164080537|NCT04480463|592659515|FG001|Overall Study|Protocol Violation|1|||
164080538|NCT04480463|592659514|FG000|Overall Study|Withdrawal by Subject|6|||
164080539|NCT04480463|592659515|FG001|Overall Study|Withdrawal by Subject|7|||
164080540|NCT04480463|592659514|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
164080541|NCT04480463|592659515|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
164138825|NCT02329847|592870176|FG003|Overall Study|Lost to Follow-up|3|||
164329146|NCT01397201|593583238|FG001|Overall Study|Not treated|0|||
163880718|NCT04784559|591933459|FG000|Overall Study|Participant worsened, PI decision|1|||
163880719|NCT04784559|591933460|FG001|Overall Study|Participant worsened, PI decision|0|||
163880720|NCT04784559|591933461|FG002|Overall Study|Participant worsened, PI decision|0|||
163880721|NCT04784559|591933459|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
163880722|NCT04784559|591933460|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
163880723|NCT04784559|591933461|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
163880724|NCT04784559|591933459|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
163880725|NCT04784559|591933460|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
163985036|NCT01790503|592314191|FG005|Overall Study|Adverse Event|2|||
163985037|NCT01790503|592314192|FG006|Overall Study|Adverse Event|0|||
163985038|NCT01790503|592314193|FG007|Overall Study|Adverse Event|0|||
163985039|NCT01790503|592314194|FG008|Overall Study|Adverse Event|2|||
163985040|NCT01790503|592314195|FG009|Overall Study|Adverse Event|4|||
163985041|NCT01790503|592314196|FG010|Overall Study|Adverse Event|7|||
163985042|NCT01790503|592314186|FG000|Overall Study|Withdrawal by Subject|0|||
163985043|NCT01790503|592314187|FG001|Overall Study|Withdrawal by Subject|0|||
163985044|NCT01790503|592314188|FG002|Overall Study|Withdrawal by Subject|1|||
163985045|NCT01790503|592314189|FG003|Overall Study|Withdrawal by Subject|1|||
163985046|NCT01790503|592314190|FG004|Overall Study|Withdrawal by Subject|1|||
163985047|NCT01790503|592314191|FG005|Overall Study|Withdrawal by Subject|2|||
163985048|NCT01790503|592314192|FG006|Overall Study|Withdrawal by Subject|1|||
163985049|NCT01790503|592314193|FG007|Overall Study|Withdrawal by Subject|0|||
163985050|NCT01790503|592314194|FG008|Overall Study|Withdrawal by Subject|0|||
163985051|NCT01790503|592314195|FG009|Overall Study|Withdrawal by Subject|0|||
163985052|NCT01790503|592314196|FG010|Overall Study|Withdrawal by Subject|1|||
163985053|NCT01790503|592314186|FG000|Overall Study|Disease progression|2|||
163985054|NCT01790503|592314187|FG001|Overall Study|Disease progression|1|||
163985055|NCT01790503|592314188|FG002|Overall Study|Disease progression|0|||
163985056|NCT01790503|592314189|FG003|Overall Study|Disease progression|1|||
163985057|NCT01790503|592314190|FG004|Overall Study|Disease progression|2|||
163985058|NCT01790503|592314191|FG005|Overall Study|Disease progression|1|||
163985059|NCT01790503|592314192|FG006|Overall Study|Disease progression|0|||
163985060|NCT01790503|592314193|FG007|Overall Study|Disease progression|1|||
163985061|NCT01790503|592314194|FG008|Overall Study|Disease progression|0|||
163985062|NCT01790503|592314195|FG009|Overall Study|Disease progression|17|||
163985063|NCT01790503|592314196|FG010|Overall Study|Disease progression|7|||
163985064|NCT01790503|592314186|FG000|Overall Study|Protocol Violation|0|||
163985065|NCT01790503|592314187|FG001|Overall Study|Protocol Violation|0|||
163985066|NCT01790503|592314188|FG002|Overall Study|Protocol Violation|0|||
163985067|NCT01790503|592314189|FG003|Overall Study|Protocol Violation|0|||
163985068|NCT01790503|592314190|FG004|Overall Study|Protocol Violation|0|||
163985069|NCT01790503|592314191|FG005|Overall Study|Protocol Violation|0|||
163985070|NCT01790503|592314192|FG006|Overall Study|Protocol Violation|0|||
163985071|NCT01790503|592314193|FG007|Overall Study|Protocol Violation|0|||
163985072|NCT01790503|592314194|FG008|Overall Study|Protocol Violation|0|||
163985073|NCT01790503|592314195|FG009|Overall Study|Protocol Violation|1|||
163985074|NCT01790503|592314196|FG010|Overall Study|Protocol Violation|0|||
163985075|NCT01790503|592314186|FG000|Overall Study|Physician Decision|0|||
163985076|NCT01790503|592314187|FG001|Overall Study|Physician Decision|0|||
163985077|NCT01790503|592314188|FG002|Overall Study|Physician Decision|0|||
163985078|NCT01790503|592314189|FG003|Overall Study|Physician Decision|0|||
163985079|NCT01790503|592314190|FG004|Overall Study|Physician Decision|0|||
163985080|NCT01790503|592314191|FG005|Overall Study|Physician Decision|0|||
163985081|NCT01790503|592314192|FG006|Overall Study|Physician Decision|0|||
163985082|NCT01790503|592314193|FG007|Overall Study|Physician Decision|0|||
163985083|NCT01790503|592314194|FG008|Overall Study|Physician Decision|0|||
163985084|NCT01790503|592314195|FG009|Overall Study|Physician Decision|1|||
163985085|NCT01790503|592314196|FG010|Overall Study|Physician Decision|1|||
163985086|NCT01790503|592314186|FG000|Overall Study|Death|0|||
163985087|NCT01790503|592314187|FG001|Overall Study|Death|0|||
163985088|NCT01790503|592314188|FG002|Overall Study|Death|0|||
163985089|NCT01790503|592314189|FG003|Overall Study|Death|0|||
163985090|NCT01790503|592314190|FG004|Overall Study|Death|0|||
163985091|NCT01790503|592314191|FG005|Overall Study|Death|0|||
163985092|NCT01790503|592314192|FG006|Overall Study|Death|0|||
163985093|NCT01790503|592314193|FG007|Overall Study|Death|0|||
163985094|NCT01790503|592314194|FG008|Overall Study|Death|0|||
163985095|NCT01790503|592314195|FG009|Overall Study|Death|1|||
163985096|NCT01790503|592314196|FG010|Overall Study|Death|0|||
163985097|NCT01790503|592314186|FG000|Overall Study|Non Compliance|0|||
163985098|NCT01790503|592314187|FG001|Overall Study|Non Compliance|0|||
163985099|NCT01790503|592314188|FG002|Overall Study|Non Compliance|0|||
163985100|NCT01790503|592314189|FG003|Overall Study|Non Compliance|0|||
163985101|NCT01790503|592314190|FG004|Overall Study|Non Compliance|1|||
163985102|NCT01790503|592314191|FG005|Overall Study|Non Compliance|0|||
163985103|NCT01790503|592314192|FG006|Overall Study|Non Compliance|0|||
163985104|NCT01790503|592314193|FG007|Overall Study|Non Compliance|0|||
163985105|NCT01790503|592314194|FG008|Overall Study|Non Compliance|0|||
163985106|NCT01790503|592314195|FG009|Overall Study|Non Compliance|0|||
163985107|NCT01790503|592314196|FG010|Overall Study|Non Compliance|0|||
163985108|NCT01790503|592314186|FG000|Overall Study|Other|0|||
163985109|NCT01790503|592314187|FG001|Overall Study|Other|0|||
163985110|NCT01790503|592314188|FG002|Overall Study|Other|0|||
163985111|NCT01790503|592314189|FG003|Overall Study|Other|0|||
163985112|NCT01790503|592314190|FG004|Overall Study|Other|1|||
163985113|NCT01790503|592314191|FG005|Overall Study|Other|0|||
163985114|NCT01790503|592314192|FG006|Overall Study|Other|0|||
163985115|NCT01790503|592314193|FG007|Overall Study|Other|0|||
163985116|NCT01790503|592314194|FG008|Overall Study|Other|1|||
163985117|NCT01790503|592314195|FG009|Overall Study|Other|2|||
163985118|NCT01790503|592314196|FG010|Overall Study|Other|0|||
163985119|NCT04183335|592314197|FG000|Overall Study|Adverse Event|1|||
163985120|NCT04183335|592314198|FG001|Overall Study|Adverse Event|0|||
163985121|NCT04183335|592314197|FG000|Overall Study|Withdrawal by Subject|12|||
163985122|NCT04183335|592314198|FG001|Overall Study|Withdrawal by Subject|3|||
163985123|NCT00049673|592314199|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
163985124|NCT00049673|592314200|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
163985125|NCT01535729|592314201|FG000|Overall Study|Withdrawal by Subject|2|||
163985126|NCT01535729|592314201|FG000|Overall Study|Disease progression|230|||
163985127|NCT01535729|592314201|FG000|Overall Study|Discontinued treatment|25|||
163985128|NCT01535729|592314201|FG000|Overall Study|Lost to Follow-up|8|||
163985129|NCT01535729|592314201|FG000|Overall Study|Death|52|||
163985130|NCT01535729|592314201|FG000|Overall Study|Other|19|||
163985131|NCT01535729|592314201|FG000|Overall Study|Did not sign informed consent|1|||
163985132|NCT01535729|592314201|FG000|Overall Study|No previous chemotherapy|33|||
163985133|NCT01535729|592314201|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
163985134|NCT01535729|592314201|FG000|Overall Study|Protocol Violation|11|||
163985135|NCT01535729|592314201|FG000|Overall Study|Screening failure|1|||
163985136|NCT01535729|592314201|FG000|Overall Study|Not treated|9|||
163985137|NCT01535729|592314201|FG000|Overall Study|No participant record available|5|||
163985138|NCT03733392|592314204|FG000|Overall Study|Withdrawal by Subject|11|||
163985139|NCT03733392|592314205|FG001|Overall Study|Withdrawal by Subject|1|||
163985140|NCT03733392|592314204|FG000|Overall Study|Death|1|||
163985141|NCT03733392|592314205|FG001|Overall Study|Death|0|||
163985142|NCT03733392|592314204|FG000|Overall Study|Lost to Follow-up|5|||
163985143|NCT03733392|592314205|FG001|Overall Study|Lost to Follow-up|0|||
163985144|NCT03733392|592314204|FG000|Overall Study|Protocol Violation|0|||
163985145|NCT03733392|592314205|FG001|Overall Study|Protocol Violation|1|||
163985146|NCT03733392|592314204|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
163985147|NCT03733392|592314205|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
163985148|NCT03733392|592314204|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
163985149|NCT03733392|592314205|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
163985150|NCT03733392|592314204|FG000|Overall Study|Patient Non-Compliance|2|||
163985151|NCT03733392|592314205|FG001|Overall Study|Patient Non-Compliance|1|||
163985152|NCT03733392|592314204|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
163985153|NCT03733392|592314205|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
163985154|NCT03733392|592314204|FG000|Overall Study|Withdrawal prior to procedure|5|||
163985155|NCT03733392|592314205|FG001|Overall Study|Withdrawal prior to procedure|2|||
163985156|NCT02740478|592314206|FG000|Overall Study|Withdrawal by Subject|1|||
163985157|NCT01934140|592314213|FG000|Persistence Phase (Year 6-10)|Other|24|||
163985158|NCT01934140|592314214|FG001|Persistence Phase (Year 6-10)|Other|6|||
163985159|NCT01934140|592314213|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
163985160|NCT01934140|592314214|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
163985161|NCT01934140|592314213|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
163985162|NCT01934140|592314214|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
163985163|NCT01934140|592314213|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
163985164|NCT01934140|592314214|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
163985165|NCT01934140|592314213|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
163985166|NCT01934140|592314214|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
163985167|NCT01934140|592314213|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
163985168|NCT01934140|592314214|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
163985169|NCT01934140|592314213|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
163985170|NCT01934140|592314214|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
163985171|NCT01934140|592314213|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
163985172|NCT01934140|592314214|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
163985173|NCT01461044|592314218|FG000|Overall Study|Death|58|||
163985174|NCT01461044|592314219|FG001|Overall Study|Death|35|||
163880726|NCT04784559|591933461|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
163880727|NCT04784559|591933459|FG000|Overall Study|Did not meet all inclusion criteria|0|||
163880728|NCT04784559|591933460|FG001|Overall Study|Did not meet all inclusion criteria|1|||
163880729|NCT04784559|591933461|FG002|Overall Study|Did not meet all inclusion criteria|0|||
163880730|NCT04784559|591933459|FG000|Overall Study|The participant was transferred to IRCU|0|||
163880731|NCT04784559|591933460|FG001|Overall Study|The participant was transferred to IRCU|1|||
163880732|NCT04784559|591933461|FG002|Overall Study|The participant was transferred to IRCU|0|||
163880733|NCT04784559|591933459|FG000|Overall Study|SAE|0|||
163985175|NCT01461044|592314218|FG000|Overall Study|Lost to Follow-up|12|||
163985176|NCT01461044|592314219|FG001|Overall Study|Lost to Follow-up|5|||
163985177|NCT00618748|592314220|FG000|Overall Study|Adverse Event|4|||
163985178|NCT00618748|592314221|FG001|Overall Study|Adverse Event|3|||
163880734|NCT04784559|591933460|FG001|Overall Study|SAE|1|||
163880735|NCT04784559|591933461|FG002|Overall Study|SAE|0|||
163880736|NCT04784559|591933459|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
163880737|NCT04784559|591933460|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
163880738|NCT04784559|591933461|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
163880739|NCT05323084|591933462|FG000|Period 2 - Washout|Lost to Follow-up|0|||
163880740|NCT05323084|591933463|FG001|Period 2 - Washout|Lost to Follow-up|1|||
163880741|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
163880742|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
163880743|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
163880744|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880745|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880746|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880747|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880748|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880749|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880750|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880751|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880752|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880753|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
163880754|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
163880755|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
163880756|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880757|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880758|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880759|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880760|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880761|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880762|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880763|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880764|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880765|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880766|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
163880767|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
163880768|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
163880769|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880770|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880771|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880772|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880773|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880774|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880775|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880776|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880777|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880778|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880779|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
163880780|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
163880781|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
163880782|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880783|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880784|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880785|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880786|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880787|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880788|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880789|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880790|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880791|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880792|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
163880793|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
163880794|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
163880795|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
163880796|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880797|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880798|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880799|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163985179|NCT00618748|592314222|FG002|Overall Study|Adverse Event|8|||
163985180|NCT00618748|592314220|FG000|Overall Study|Physician Decision|3|||
163985181|NCT00618748|592314221|FG001|Overall Study|Physician Decision|1|||
163985182|NCT00618748|592314222|FG002|Overall Study|Physician Decision|1|||
163985183|NCT00618748|592314220|FG000|Overall Study|Withdrawal by Subject|4|||
163985184|NCT00618748|592314221|FG001|Overall Study|Withdrawal by Subject|1|||
163985185|NCT00618748|592314222|FG002|Overall Study|Withdrawal by Subject|5|||
163985186|NCT00200850|592314223|FG000|Overall Study|relocation|1|||
163985187|NCT00200850|592314224|FG001|Overall Study|relocation|0|||
163985188|NCT00200850|592314225|FG002|Overall Study|relocation|1|||
163985189|NCT00200850|592314223|FG000|Overall Study|too busy|1|||
163985190|NCT00200850|592314224|FG001|Overall Study|too busy|0|||
163985191|NCT00200850|592314225|FG002|Overall Study|too busy|0|||
163985192|NCT00200850|592314223|FG000|Overall Study|Pregnancy|0|||
163985193|NCT00200850|592314224|FG001|Overall Study|Pregnancy|0|||
163985194|NCT00200850|592314225|FG002|Overall Study|Pregnancy|1|||
163985195|NCT00200850|592314223|FG000|Overall Study|Poor adherence|0|||
163985196|NCT00200850|592314224|FG001|Overall Study|Poor adherence|0|||
163985197|NCT00200850|592314225|FG002|Overall Study|Poor adherence|1|||
163985198|NCT00200850|592314223|FG000|Overall Study|optic neuritis|0|||
163985199|NCT00200850|592314224|FG001|Overall Study|optic neuritis|0|||
163985200|NCT00200850|592314225|FG002|Overall Study|optic neuritis|1|||
163985201|NCT00200850|592314223|FG000|Overall Study|Adverse Event|1|||
163985202|NCT00200850|592314224|FG001|Overall Study|Adverse Event|1|||
163985203|NCT00200850|592314225|FG002|Overall Study|Adverse Event|2|||
163985204|NCT02814565|592314231|FG000|Overall Study|Lack of Efficacy|0|||
163985205|NCT02814565|592314232|FG001|Overall Study|Lack of Efficacy|1|||
163985206|NCT02814565|592314231|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
163985207|NCT02814565|592314232|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
163985208|NCT01414257|592314233|FG000|Overall Study|No Visit After First Day of Treatment|12|||
163985209|NCT01414257|592314233|FG000|Overall Study|Protocol Violation|10|||
163985210|NCT01978093|592314234|FG000|Overall Study|Death|1|||
163985211|NCT01978093|592314235|FG001|Overall Study|Death|0|||
163985212|NCT01978093|592314234|FG000|Overall Study|Adverse Event|0|||
163985213|NCT01978093|592314235|FG001|Overall Study|Adverse Event|5|||
163985214|NCT01978093|592314234|FG000|Overall Study|Protocol Violation|8|||
163985215|NCT01978093|592314235|FG001|Overall Study|Protocol Violation|2|||
163985216|NCT01978093|592314234|FG000|Overall Study|Withdrawal by Subject|29|||
163985217|NCT01978093|592314235|FG001|Overall Study|Withdrawal by Subject|25|||
163985218|NCT01978093|592314234|FG000|Overall Study|Lost to Follow-up|11|||
163985219|NCT01978093|592314235|FG001|Overall Study|Lost to Follow-up|15|||
163985220|NCT01978093|592314234|FG000|Overall Study|Migrated/moved from study area|11|||
163985221|NCT01978093|592314235|FG001|Overall Study|Migrated/moved from study area|13|||
163985222|NCT01978093|592314234|FG000|Overall Study|Loss of kaiser coverage|4|||
163985223|NCT01978093|592314235|FG001|Overall Study|Loss of kaiser coverage|10|||
163985224|NCT01978093|592314234|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
163985225|NCT01978093|592314235|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
163985226|NCT01978093|592314234|FG000|Overall Study|Mother lost custody of child|0|||
163985227|NCT01978093|592314235|FG001|Overall Study|Mother lost custody of child|1|||
163985228|NCT01978093|592314234|FG000|Overall Study|Child was in care of grandmother|0|||
163985229|NCT01978093|592314235|FG001|Overall Study|Child was in care of grandmother|1|||
163985230|NCT01978093|592314234|FG000|Overall Study|N/A for vaccine administration|0|||
163985231|NCT01978093|592314235|FG001|Overall Study|N/A for vaccine administration|1|||
163985232|NCT03033745|592314243|FG000|Overall Study|Protocol Violation|0|||
163985233|NCT03033745|592314244|FG001|Overall Study|Protocol Violation|0|||
163985234|NCT03033745|592314245|FG002|Overall Study|Protocol Violation|1|||
163985235|NCT03033745|592314243|FG000|Overall Study|Adverse Event|1|||
163985236|NCT03033745|592314244|FG001|Overall Study|Adverse Event|0|||
163985237|NCT03033745|592314245|FG002|Overall Study|Adverse Event|1|||
163985238|NCT03033745|592314243|FG000|Overall Study|Withdrawal by Subject|0|||
163985239|NCT03033745|592314244|FG001|Overall Study|Withdrawal by Subject|1|||
163985240|NCT03033745|592314245|FG002|Overall Study|Withdrawal by Subject|0|||
163985241|NCT03728309|592314249|FG000|Overall Study|Randomized but not Treated|0|||
163985242|NCT03728309|592314250|FG001|Overall Study|Randomized but not Treated|1|||
163985243|NCT03728309|592314249|FG000|Overall Study|Adverse Event|0|||
163985244|NCT03728309|592314250|FG001|Overall Study|Adverse Event|1|||
163985245|NCT03728309|592314249|FG000|Overall Study|Withdrawal by Subject|2|||
163985246|NCT03728309|592314250|FG001|Overall Study|Withdrawal by Subject|8|||
163985247|NCT03728309|592314249|FG000|Overall Study|Lost to Follow-up|9|||
163985248|NCT03728309|592314250|FG001|Overall Study|Lost to Follow-up|10|||
163985249|NCT03728309|592314249|FG000|Overall Study|Protocol Deviation|0|||
163985250|NCT03728309|592314250|FG001|Overall Study|Protocol Deviation|1|||
163985251|NCT03728309|592314249|FG000|Overall Study|Due to COVID|1|||
163985252|NCT03728309|592314250|FG001|Overall Study|Due to COVID|3|||
163985253|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
163985254|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
164138826|NCT02329847|592870177|FG004|Overall Study|Lost to Follow-up|0|||
163985255|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
163985256|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
163985257|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163985258|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163985259|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
163985260|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163985261|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
163985262|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163985263|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163985264|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163985265|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
163985266|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
163985267|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
163985268|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
164080542|NCT04480463|592659514|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
164080543|NCT04480463|592659515|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
163985269|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
163985270|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
163985271|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
163985272|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
164080544|NCT04480463|592659514|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
164080545|NCT04480463|592659515|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
164080546|NCT04480463|592659514|FG000|Overall Study|Other|6|||
164080547|NCT04480463|592659515|FG001|Overall Study|Other|4|||
164080548|NCT01399723|592659516|FG000|Overall Study|Lost to Follow-up|0|||
164080549|NCT01399723|592659517|FG001|Overall Study|Lost to Follow-up|1|||
164080550|NCT00673361|592659518|FG000|Overall Study|Screen Failure|2|||
164080551|NCT01769378|592659524|FG000|Overall Study|Adverse Event|10|||
164080552|NCT01769378|592659525|FG001|Overall Study|Adverse Event|0|||
164080553|NCT01769378|592659524|FG000|Overall Study|Entry criteria not met|1|||
164080554|NCT01769378|592659525|FG001|Overall Study|Entry criteria not met|0|||
164080555|NCT01769378|592659524|FG000|Overall Study|Protocol Violation|1|||
164080556|NCT01769378|592659525|FG001|Overall Study|Protocol Violation|1|||
164080557|NCT01769378|592659524|FG000|Overall Study|Withdrawal by Subject|10|||
164080558|NCT01769378|592659525|FG001|Overall Study|Withdrawal by Subject|3|||
164080559|NCT01769378|592659524|FG000|Overall Study|Sponsor Decision|1|||
164080560|NCT01769378|592659525|FG001|Overall Study|Sponsor Decision|0|||
164080561|NCT01769378|592659524|FG000|Overall Study|Lost to Follow-up|2|||
164080562|NCT01769378|592659525|FG001|Overall Study|Lost to Follow-up|0|||
164080563|NCT01958281|592659526|FG000|Overall Study|Lack of Efficacy|5|||
164080564|NCT01958281|592659527|FG001|Overall Study|Lack of Efficacy|2|||
164080565|NCT01958281|592659528|FG002|Overall Study|Lack of Efficacy|0|||
164080566|NCT01958281|592659526|FG000|Overall Study|Adverse Event|0|||
164080567|NCT01958281|592659527|FG001|Overall Study|Adverse Event|2|||
164080568|NCT01958281|592659528|FG002|Overall Study|Adverse Event|0|||
164080569|NCT01958281|592659526|FG000|Overall Study|Withdrew Consent|1|||
164080570|NCT01958281|592659527|FG001|Overall Study|Withdrew Consent|0|||
164080571|NCT01958281|592659528|FG002|Overall Study|Withdrew Consent|0|||
164080572|NCT03038113|592659529|FG000|Overall Study|Withdrawal by Subject|0|||
164080573|NCT03038113|592659530|FG001|Overall Study|Withdrawal by Subject|0|||
164080574|NCT03038113|592659531|FG002|Overall Study|Withdrawal by Subject|1|||
164080575|NCT03038113|592659532|FG003|Overall Study|Withdrawal by Subject|0|||
164080576|NCT03038113|592659533|FG004|Overall Study|Withdrawal by Subject|0|||
164080577|NCT03038113|592659534|FG005|Overall Study|Withdrawal by Subject|0|||
164080578|NCT03038113|592659535|FG006|Overall Study|Withdrawal by Subject|0|||
164080579|NCT03038113|592659536|FG007|Overall Study|Withdrawal by Subject|0|||
164080580|NCT03038113|592659537|FG008|Overall Study|Withdrawal by Subject|0|||
164080581|NCT03038113|592659538|FG009|Overall Study|Withdrawal by Subject|0|||
164080582|NCT03038113|592659539|FG010|Overall Study|Withdrawal by Subject|0|||
164080583|NCT03038113|592659540|FG011|Overall Study|Withdrawal by Subject|0|||
164080584|NCT03038113|592659541|FG012|Overall Study|Withdrawal by Subject|0|||
164080585|NCT03038113|592659542|FG013|Overall Study|Withdrawal by Subject|1|||
164080586|NCT03038113|592659529|FG000|Overall Study|Lost to Follow-up|0|||
164080587|NCT03038113|592659530|FG001|Overall Study|Lost to Follow-up|0|||
164080588|NCT03038113|592659531|FG002|Overall Study|Lost to Follow-up|0|||
164080589|NCT03038113|592659532|FG003|Overall Study|Lost to Follow-up|0|||
163985273|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
164080590|NCT03038113|592659533|FG004|Overall Study|Lost to Follow-up|0|||
164080591|NCT03038113|592659534|FG005|Overall Study|Lost to Follow-up|0|||
164080592|NCT03038113|592659535|FG006|Overall Study|Lost to Follow-up|1|||
164080593|NCT03038113|592659536|FG007|Overall Study|Lost to Follow-up|0|||
164080594|NCT03038113|592659537|FG008|Overall Study|Lost to Follow-up|0|||
164080595|NCT03038113|592659538|FG009|Overall Study|Lost to Follow-up|0|||
163985274|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163985275|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163985276|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
163985277|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
163985278|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163985279|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163985280|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163985281|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163985282|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
163985283|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163985284|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
163985285|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
164080596|NCT03038113|592659539|FG010|Overall Study|Lost to Follow-up|0|||
164080597|NCT03038113|592659540|FG011|Overall Study|Lost to Follow-up|0|||
163985286|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163985287|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163985288|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
163985289|NCT03403205|592314251|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
163985290|NCT03403205|592314252|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
163985291|NCT03403205|592314253|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
163985292|NCT03403205|592314254|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
163985293|NCT03403205|592314255|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
163985294|NCT03403205|592314256|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
163985295|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
163985296|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
163985297|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
163985298|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
163985299|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
163985300|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
163985301|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
163985302|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
163985303|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
163985304|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
163985305|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
163985306|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
163985307|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Death|1|||
163985308|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Death|0|||
163985309|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Death|0|||
163985310|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Death|0|||
163985311|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Death|0|||
163985312|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Death|0|||
163985313|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
163985314|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163985315|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163985316|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163985317|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163985318|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
163985319|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
163985320|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
163985321|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
163985322|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
163985323|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
163985324|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
163985325|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
163985326|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163985327|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163985328|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163985329|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163985330|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
163985331|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
163985332|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
163985333|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
163985334|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
163985335|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
164080598|NCT03038113|592659541|FG012|Overall Study|Lost to Follow-up|0|||
164080599|NCT03038113|592659542|FG013|Overall Study|Lost to Follow-up|0|||
164080600|NCT02784106|592659543|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
164138827|NCT02329847|592870178|FG005|Overall Study|Lost to Follow-up|1|||
164080601|NCT02784106|592659544|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
163880800|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880801|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880802|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880803|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880804|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880805|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
163880806|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
163880807|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
163880808|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
163880809|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880810|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880811|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880812|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880813|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880814|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880815|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880816|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880817|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880818|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
163880819|NCT01261312|591933464|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
163880820|NCT01261312|591933465|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880821|NCT01261312|591933466|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
163880822|NCT01261312|591933467|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880823|NCT01261312|591933468|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880824|NCT01261312|591933469|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880825|NCT01261312|591933470|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880826|NCT01261312|591933471|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880827|NCT01261312|591933472|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880828|NCT01261312|591933473|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880829|NCT01261312|591933474|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880830|NCT01261312|591933475|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880831|NCT01261312|591933476|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
163880832|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880833|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880834|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880835|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
163880836|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
163880837|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
163880838|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880839|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880840|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880841|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880842|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880843|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880844|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
163880845|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880846|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880847|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880848|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880849|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
163880850|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
163880851|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880852|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880853|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880854|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880855|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880856|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880857|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
163880858|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880859|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880860|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880861|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
164224612|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
164224613|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
163985336|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
163985337|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
163985338|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
163985339|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
163985340|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
163985341|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
163985342|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
163985343|NCT03403205|592314251|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
163985344|NCT03403205|592314252|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
163985345|NCT03403205|592314253|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
163985346|NCT03403205|592314254|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
163985347|NCT03403205|592314255|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
163985348|NCT03403205|592314256|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
163985349|NCT03847610|592314257|FG000|Overall Study|Withdrawal by Subject|1|||
163985350|NCT02004873|592314258|FG000|Overall Study|Implant unsuccessful|6|||
163985351|NCT02004873|592314258|FG000|Overall Study|Awaiting 6-month visit|390|||
163985352|NCT02004873|592314258|FG000|Overall Study|Missed 6-month visit|4|||
163985353|NCT02004873|592314258|FG000|Overall Study|Death|23|||
163985354|NCT02004873|592314258|FG000|Overall Study|Withdrawal by Subject|1|||
163985355|NCT01445769|592314260|FG000|Overall Study|Consent Withdrawn|2|||
163985356|NCT01445769|592314260|FG000|Overall Study|Disease Progression|1|||
163985357|NCT01445769|592314260|FG000|Overall Study|Lost to Follow-up|5|||
163985358|NCT01276236|592314261|FG000|Overall Study|Lack of Efficacy|2|||
163985359|NCT01276236|592314261|FG000|Overall Study|Withdrawal by Subject|4|||
163985360|NCT00044512|592314262|FG000|Follow Up|Lost to Follow-up|2|||
163985361|NCT02799069|592314263|FG000|Overall Study|Adverse Event|0|||
163985362|NCT02799069|592314264|FG001|Overall Study|Adverse Event|2|||
163985363|NCT02799069|592314265|FG002|Overall Study|Adverse Event|2|||
163985364|NCT02799069|592314263|FG000|Overall Study|Lack of Efficacy|2|||
163985365|NCT02799069|592314264|FG001|Overall Study|Lack of Efficacy|0|||
163985366|NCT02799069|592314265|FG002|Overall Study|Lack of Efficacy|0|||
163985367|NCT02799069|592314263|FG000|Overall Study|Lost to Follow-up|1|||
163985368|NCT02799069|592314264|FG001|Overall Study|Lost to Follow-up|1|||
163985369|NCT02799069|592314265|FG002|Overall Study|Lost to Follow-up|0|||
163985370|NCT02799069|592314263|FG000|Overall Study|Withdrawal by Subject|4|||
163985371|NCT02799069|592314264|FG001|Overall Study|Withdrawal by Subject|4|||
163985372|NCT02799069|592314265|FG002|Overall Study|Withdrawal by Subject|3|||
163985373|NCT02799069|592314263|FG000|Overall Study|Protocol Violation|1|||
163985374|NCT02799069|592314264|FG001|Overall Study|Protocol Violation|0|||
163985375|NCT02799069|592314265|FG002|Overall Study|Protocol Violation|2|||
163985376|NCT03440814|592314270|FG000|Overall Study|Adverse Event|2|||
163985377|NCT03440814|592314271|FG001|Overall Study|Adverse Event|1|||
163985378|NCT03440814|592314270|FG000|Overall Study|Lost to Follow-up|2|||
163985379|NCT03440814|592314271|FG001|Overall Study|Lost to Follow-up|0|||
163985380|NCT03440814|592314270|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
163985381|NCT03440814|592314271|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
163985382|NCT02695628|592314272|FG000|Overall Study|Withdrawal by Subject|1|||
163985383|NCT02678390|592314273|FG000|AE (1 Day)|Withdrawal by Subject|0|||
163985384|NCT02678390|592314274|FG001|AE (1 Day)|Withdrawal by Subject|1|||
163985385|NCT03499028|592314275|FG000|Overall Study|Lost to Follow-up|12|||
163985386|NCT03499028|592314276|FG001|Overall Study|Lost to Follow-up|9|||
163985387|NCT03499028|592314275|FG000|Overall Study|Withdrawal by Subject|5|||
163985388|NCT03499028|592314276|FG001|Overall Study|Withdrawal by Subject|8|||
163985389|NCT03499028|592314275|FG000|Overall Study|Unplanned SNF discharge|5|||
163985390|NCT03499028|592314276|FG001|Overall Study|Unplanned SNF discharge|8|||
163985391|NCT01437397|592314277|FG000|Overall Study|Lost to Follow-up|9|||
163985392|NCT01437397|592314278|FG001|Overall Study|Lost to Follow-up|4|||
163985393|NCT01437397|592314279|FG002|Overall Study|Lost to Follow-up|2|||
163985394|NCT01437397|592314280|FG003|Overall Study|Lost to Follow-up|4|||
163985395|NCT01437397|592314281|FG004|Overall Study|Lost to Follow-up|5|||
163985396|NCT01437397|592314277|FG000|Overall Study|Withdrawal by Subject|11|||
163985397|NCT01437397|592314278|FG001|Overall Study|Withdrawal by Subject|12|||
163985398|NCT01437397|592314279|FG002|Overall Study|Withdrawal by Subject|24|||
163985399|NCT01437397|592314280|FG003|Overall Study|Withdrawal by Subject|11|||
163985400|NCT01437397|592314281|FG004|Overall Study|Withdrawal by Subject|22|||
163985401|NCT01437397|592314277|FG000|Overall Study|Protocol Violation|10|||
163985402|NCT01437397|592314278|FG001|Overall Study|Protocol Violation|12|||
163985403|NCT01437397|592314279|FG002|Overall Study|Protocol Violation|13|||
163985404|NCT01437397|592314280|FG003|Overall Study|Protocol Violation|21|||
163985405|NCT01437397|592314281|FG004|Overall Study|Protocol Violation|19|||
163985406|NCT01437397|592314277|FG000|Overall Study|Lack of Efficacy|5|||
163985407|NCT01437397|592314278|FG001|Overall Study|Lack of Efficacy|4|||
163985408|NCT01437397|592314279|FG002|Overall Study|Lack of Efficacy|8|||
163985409|NCT01437397|592314280|FG003|Overall Study|Lack of Efficacy|10|||
164224614|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
164224615|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
164224616|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
164224617|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
164224618|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
164224619|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
164224620|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
164224621|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
164224622|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
164224623|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
163880862|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
163880863|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
163880864|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880865|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880866|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880867|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880868|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880869|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880870|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
163880871|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880872|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880873|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880874|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
163880875|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
163880876|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
163880877|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880878|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880879|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880880|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880881|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880882|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880883|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
163880884|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880885|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880886|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880887|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880888|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880889|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
163880890|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880891|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880892|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880893|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880894|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880895|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880896|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
163880897|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880898|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880899|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880900|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
163880901|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
163880902|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
163880903|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880904|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880905|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880906|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880907|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880908|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880909|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
163880910|NCT01261312|591933464|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880911|NCT01261312|591933465|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880912|NCT01261312|591933466|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880913|NCT01261312|591933467|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
163880914|NCT01261312|591933468|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
163880915|NCT01261312|591933469|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
163880916|NCT01261312|591933470|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880917|NCT01261312|591933471|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880918|NCT01261312|591933472|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880919|NCT01261312|591933473|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880920|NCT01261312|591933474|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
164329147|NCT01397201|593583239|FG002|Overall Study|Not treated|1|||
164080602|NCT02784106|592659545|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164080603|NCT02784106|592659546|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164138828|NCT02329847|592870173|FG000|Overall Study|Physician Decision|0|||
163985410|NCT01437397|592314281|FG004|Overall Study|Lack of Efficacy|20|||
163985411|NCT01437397|592314277|FG000|Overall Study|Adverse Event|21|||
163985412|NCT01437397|592314278|FG001|Overall Study|Adverse Event|22|||
163985413|NCT01437397|592314279|FG002|Overall Study|Adverse Event|16|||
163985414|NCT01437397|592314280|FG003|Overall Study|Adverse Event|14|||
163985415|NCT01437397|592314281|FG004|Overall Study|Adverse Event|21|||
163985416|NCT01437397|592314277|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
163985417|NCT01437397|592314278|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
163985418|NCT01437397|592314279|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
163985419|NCT01437397|592314280|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
163985420|NCT01437397|592314281|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
163985421|NCT04518462|592314287|FG000|Overall Study|Withdrawal by Subject|0|||
163985422|NCT04518462|592314288|FG001|Overall Study|Withdrawal by Subject|0|||
163985423|NCT04518462|592314289|FG002|Overall Study|Withdrawal by Subject|1|||
163985424|NCT04518462|592314287|FG000|Overall Study|Physician Decision|1|||
163985425|NCT04518462|592314288|FG001|Overall Study|Physician Decision|1|||
163985426|NCT04518462|592314289|FG002|Overall Study|Physician Decision|0|||
163985427|NCT01003210|592314290|FG000|Overall Study|Lost to Follow-up|1|||
163985428|NCT01003210|592314291|FG001|Overall Study|Lost to Follow-up|3|||
163985429|NCT05036083|592314301|FG000|Overall Study|Physician Decision|1|||
163985430|NCT05036083|592314301|FG000|Overall Study|Withdrawal by Subject|1|||
163985431|NCT05036083|592314301|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
163985432|NCT05036083|592314301|FG000|Overall Study|IV not sustainable|1|||
163985433|NCT02396589|592314302|FG000|Intervention|Lost to Follow-up|1|||
163985434|NCT02396589|592314303|FG001|Intervention|Lost to Follow-up|0|||
163985435|NCT02396589|592314302|FG000|6 Month Follow-up|change in health status|0|||
163985436|NCT02396589|592314303|FG001|6 Month Follow-up|change in health status|1|||
163985437|NCT02396589|592314302|FG000|9 Month Follow-up|Death|0|||
164138829|NCT02329847|592870174|FG001|Overall Study|Physician Decision|0|||
164138830|NCT02329847|592870175|FG002|Overall Study|Physician Decision|0|||
164138831|NCT02329847|592870176|FG003|Overall Study|Physician Decision|0|||
164138832|NCT02329847|592870177|FG004|Overall Study|Physician Decision|1|||
164138833|NCT02329847|592870178|FG005|Overall Study|Physician Decision|0|||
164138834|NCT02329847|592870173|FG000|Overall Study|Withdrawal by Subject|2|||
164138835|NCT02329847|592870174|FG001|Overall Study|Withdrawal by Subject|1|||
164138836|NCT02329847|592870175|FG002|Overall Study|Withdrawal by Subject|5|||
164138837|NCT02329847|592870176|FG003|Overall Study|Withdrawal by Subject|7|||
164138838|NCT02329847|592870177|FG004|Overall Study|Withdrawal by Subject|8|||
164138839|NCT02329847|592870178|FG005|Overall Study|Withdrawal by Subject|3|||
164138840|NCT02329847|592870173|FG000|Overall Study|Other|1|||
164138841|NCT02329847|592870174|FG001|Overall Study|Other|2|||
164138842|NCT02329847|592870175|FG002|Overall Study|Other|6|||
164138843|NCT02329847|592870176|FG003|Overall Study|Other|13|||
164138844|NCT02329847|592870177|FG004|Overall Study|Other|10|||
164138845|NCT02329847|592870178|FG005|Overall Study|Other|3|||
164138846|NCT05330468|592870179|FG000|Overall Study|Death|6|||
164138847|NCT05330468|592870179|FG000|Overall Study|Withdrawal by Subject|4|||
164138848|NCT05330468|592870179|FG000|Overall Study|Lost to Follow-up|4|||
164138849|NCT02828241|592870182|FG000|Overall Study|Adverse Event|7|||
164138850|NCT02828241|592870183|FG001|Overall Study|Adverse Event|2|||
164138851|NCT02828241|592870182|FG000|Overall Study|Protocol Violation|1|||
164138852|NCT02828241|592870183|FG001|Overall Study|Protocol Violation|0|||
164138853|NCT04572893|592870184|FG000|Part A|Adverse Event|1|||
164138854|NCT04572893|592870185|FG001|Part A|Adverse Event|0|||
164138855|NCT04572893|592870186|FG002|Part A|Adverse Event|0|||
164138856|NCT04572893|592870187|FG003|Part A|Adverse Event|0|||
164138857|NCT04572893|592870188|FG004|Part A|Adverse Event|0|||
164138858|NCT04572893|592870189|FG005|Part A|Adverse Event|0|||
164138859|NCT04572893|592870190|FG006|Part A|Adverse Event|0|||
164138860|NCT04572893|592870184|FG000|Part B|Withdrawal by Subject|0|||
164138861|NCT04572893|592870185|FG001|Part B|Withdrawal by Subject|0|||
164138862|NCT04572893|592870186|FG002|Part B|Withdrawal by Subject|0|||
164138863|NCT04572893|592870187|FG003|Part B|Withdrawal by Subject|0|||
164138864|NCT04572893|592870188|FG004|Part B|Withdrawal by Subject|0|||
164138865|NCT04572893|592870189|FG005|Part B|Withdrawal by Subject|1|||
164138866|NCT04572893|592870190|FG006|Part B|Withdrawal by Subject|0|||
164138867|NCT04572893|592870184|FG000|Part B|Study terminated by sponsor|0|||
164138868|NCT04572893|592870185|FG001|Part B|Study terminated by sponsor|0|||
164138869|NCT04572893|592870186|FG002|Part B|Study terminated by sponsor|0|||
164138870|NCT04572893|592870187|FG003|Part B|Study terminated by sponsor|0|||
164138871|NCT04572893|592870188|FG004|Part B|Study terminated by sponsor|7|||
164138872|NCT04572893|592870189|FG005|Part B|Study terminated by sponsor|5|||
164138873|NCT04572893|592870190|FG006|Part B|Study terminated by sponsor|3|||
164138874|NCT04572893|592870184|FG000|Part B|Lost to Follow-up|0|||
164224624|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
164224625|NCT00407030|593190309|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
164224626|NCT00407030|593190310|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
164224627|NCT00407030|593190311|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
164224628|NCT01340170|593190312|FG000|Overall Study|Lost to Follow-up|2|||
164224629|NCT01340170|593190313|FG001|Overall Study|Lost to Follow-up|4|||
164224630|NCT01340170|593190314|FG002|Overall Study|Lost to Follow-up|0|||
164224631|NCT01340170|593190312|FG000|Overall Study|Implant failure|1|||
164224632|NCT01340170|593190313|FG001|Overall Study|Implant failure|3|||
163880921|NCT01261312|591933475|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880922|NCT01261312|591933476|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
163880923|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880924|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880925|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880926|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880927|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880928|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880929|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
163880930|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
163880931|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
163880932|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880933|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880934|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880935|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
163880936|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880937|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880938|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880939|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880940|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880941|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880942|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880943|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
163880944|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
163880945|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880946|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880947|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880948|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
163880949|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880950|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880951|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880952|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880953|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880954|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163985438|NCT02396589|592314303|FG001|9 Month Follow-up|Death|1|||
163985439|NCT02396589|592314302|FG000|12 Month Follow up|Lost to Follow-up|0|||
163985440|NCT02396589|592314303|FG001|12 Month Follow up|Lost to Follow-up|2|||
163985441|NCT05593016|592316155|FG000|Overall Study|Death|1|||
163985442|NCT05593016|592316156|FG001|Overall Study|Death|1|||
163985443|NCT05593016|592316157|FG002|Overall Study|Death|1|||
163985444|NCT05593016|592316158|FG003|Overall Study|Death|0|||
163985445|NCT05593016|592316159|FG004|Overall Study|Death|0|||
163985446|NCT05593016|592316155|FG000|Overall Study|Lost to Follow-up|1|||
163985447|NCT05593016|592316156|FG001|Overall Study|Lost to Follow-up|1|||
163985448|NCT05593016|592316157|FG002|Overall Study|Lost to Follow-up|1|||
163985449|NCT05593016|592316158|FG003|Overall Study|Lost to Follow-up|2|||
163985450|NCT05593016|592316159|FG004|Overall Study|Lost to Follow-up|0|||
163985451|NCT02615990|592316163|FG000|Overall Study|study terminated|1|||
163985452|NCT02615990|592316164|FG001|Overall Study|study terminated|1|||
163985453|NCT00808444|592316165|FG000|Overall Study|Withdrawal by Subject|1|||
163985454|NCT00808444|592316166|FG001|Overall Study|Withdrawal by Subject|0|||
163985455|NCT00808444|592316165|FG000|Overall Study|Lost to Follow-up|0|||
163985456|NCT00808444|592316166|FG001|Overall Study|Lost to Follow-up|1|||
163985457|NCT04401267|592316167|FG000|Overall Study|Death|0|||
163985458|NCT04401267|592316168|FG001|Overall Study|Death|1|||
163985459|NCT04401267|592316167|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
163880955|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
163880956|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
163985460|NCT04401267|592316168|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
163985461|NCT04401267|592316167|FG000|Overall Study|Found to be Ineligible|1|||
163985462|NCT04401267|592316168|FG001|Overall Study|Found to be Ineligible|0|||
163985463|NCT01449708|592316178|FG000|Overall Study|Protocol Violation|0|||
163985464|NCT01449708|592316179|FG001|Overall Study|Protocol Violation|1|||
163985465|NCT01449708|592316178|FG000|Overall Study|surgical complication|1|||
164080604|NCT02784106|592659543|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
164080605|NCT02784106|592659544|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164080606|NCT02784106|592659545|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164080607|NCT02784106|592659546|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164080608|NCT02784106|592659543|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
164080609|NCT02784106|592659544|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
164080610|NCT02784106|592659545|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
164080611|NCT02784106|592659546|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
164080612|NCT02784106|592659543|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
164080613|NCT02784106|592659544|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164080614|NCT02784106|592659545|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164080615|NCT02784106|592659546|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164080616|NCT02784106|592659543|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
164080617|NCT02784106|592659544|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
164080618|NCT02784106|592659545|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
164080619|NCT02784106|592659546|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
164080620|NCT02784106|592659543|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
164080621|NCT02784106|592659544|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
164080622|NCT02784106|592659545|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
164080623|NCT02784106|592659546|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
164080624|NCT02927847|592659547|FG000|Overall Study|Lost to Follow-up|1|||
164080625|NCT02927847|592659548|FG001|Overall Study|Lost to Follow-up|0|||
164080626|NCT02927847|592659547|FG000|Overall Study|Withdrawal by Subject|4|||
164080627|NCT02927847|592659548|FG001|Overall Study|Withdrawal by Subject|2|||
164080628|NCT02927847|592659547|FG000|Overall Study|PI withdrawn due to missed visits|1|||
164080629|NCT02927847|592659548|FG001|Overall Study|PI withdrawn due to missed visits|1|||
164080630|NCT00553540|592659549|FG000|Overall Study|discharged after first visit|2|||
164080631|NCT00553540|592659550|FG001|Overall Study|discharged after first visit|5|||
164080632|NCT01755858|592659553|FG000|Overall Study|Adverse Event|1|||
164080633|NCT01755858|592659554|FG001|Overall Study|Adverse Event|1|||
164080634|NCT03882047|592659555|FG000|Overall Study|Adverse Event|0|||
164080635|NCT03882047|592659556|FG001|Overall Study|Adverse Event|2|||
164080636|NCT03882047|592659557|FG002|Overall Study|Adverse Event|2|||
164080637|NCT03882047|592659555|FG000|Overall Study|Treatment Failure|3|||
164080638|NCT03882047|592659556|FG001|Overall Study|Treatment Failure|3|||
164080639|NCT03882047|592659557|FG002|Overall Study|Treatment Failure|12|||
164080640|NCT03882047|592659555|FG000|Overall Study|Lost to Follow-up|0|||
164080641|NCT03882047|592659556|FG001|Overall Study|Lost to Follow-up|1|||
164080642|NCT03882047|592659557|FG002|Overall Study|Lost to Follow-up|0|||
164080643|NCT03882047|592659555|FG000|Overall Study|Did Not Wish to Continue|1|||
164080644|NCT03882047|592659556|FG001|Overall Study|Did Not Wish to Continue|4|||
164080645|NCT03882047|592659557|FG002|Overall Study|Did Not Wish to Continue|1|||
164080646|NCT03882047|592659555|FG000|Overall Study|Noncompliance With Protocol|2|||
164080647|NCT03882047|592659556|FG001|Overall Study|Noncompliance With Protocol|0|||
164080648|NCT03882047|592659557|FG002|Overall Study|Noncompliance With Protocol|0|||
164080649|NCT03882047|592659555|FG000|Overall Study|Did Not Meet Eligibility|0|||
164080650|NCT03882047|592659556|FG001|Overall Study|Did Not Meet Eligibility|0|||
164080651|NCT03882047|592659557|FG002|Overall Study|Did Not Meet Eligibility|1|||
164080652|NCT00175019|592659559|FG000|Overall Study|Adverse Event|54|||
164080653|NCT00175019|592659560|FG001|Overall Study|Adverse Event|22|||
164080654|NCT00175019|592659561|FG002|Overall Study|Adverse Event|2|||
164080655|NCT00175019|592659559|FG000|Overall Study|Protocol Violation|6|||
164080656|NCT00175019|592659560|FG001|Overall Study|Protocol Violation|3|||
164080657|NCT00175019|592659561|FG002|Overall Study|Protocol Violation|3|||
164080658|NCT00175019|592659559|FG000|Overall Study|Lost to Follow-up|42|||
164080659|NCT00175019|592659560|FG001|Overall Study|Lost to Follow-up|39|||
164080660|NCT00175019|592659561|FG002|Overall Study|Lost to Follow-up|9|||
164080661|NCT00175019|592659559|FG000|Overall Study|Did not continue under Amendment 4|1|||
164080662|NCT00175019|592659560|FG001|Overall Study|Did not continue under Amendment 4|1|||
164080663|NCT00175019|592659561|FG002|Overall Study|Did not continue under Amendment 4|2|||
164080664|NCT00175019|592659559|FG000|Overall Study|Personal Reason(s)|39|||
164080665|NCT00175019|592659560|FG001|Overall Study|Personal Reason(s)|31|||
164080666|NCT00175019|592659561|FG002|Overall Study|Personal Reason(s)|8|||
164080667|NCT00175019|592659559|FG000|Overall Study|Therapeutic Failure|10|||
164080668|NCT00175019|592659560|FG001|Overall Study|Therapeutic Failure|38|||
164080669|NCT00175019|592659561|FG002|Overall Study|Therapeutic Failure|22|||
164080670|NCT00175019|592659559|FG000|Overall Study|Gout Flare|2|||
164080671|NCT00175019|592659560|FG001|Overall Study|Gout Flare|3|||
164080672|NCT00175019|592659561|FG002|Overall Study|Gout Flare|0|||
164080673|NCT00175019|592659559|FG000|Overall Study|Reason Not Specified|40|||
164080674|NCT00175019|592659560|FG001|Overall Study|Reason Not Specified|34|||
164080675|NCT00175019|592659561|FG002|Overall Study|Reason Not Specified|11|||
164080676|NCT00475852|592659565|FG000|Overall Study|Death|444|||
164080677|NCT00475852|592659566|FG001|Overall Study|Death|456|||
164138875|NCT04572893|592870185|FG001|Part B|Lost to Follow-up|0|||
164224633|NCT01340170|593190314|FG002|Overall Study|Implant failure|0|||
164224634|NCT03878602|593190315|FG000|Overall Study|cord blood donation|7|||
164224635|NCT03878602|593190316|FG001|Overall Study|cord blood donation|1|||
164224636|NCT03878602|593190315|FG000|Overall Study|incomplete data collection|2|||
164080678|NCT00475852|592659565|FG000|Overall Study|Withdrawal by Subject|19|||
164080679|NCT00475852|592659566|FG001|Overall Study|Withdrawal by Subject|24|||
164080680|NCT00475852|592659565|FG000|Overall Study|Lost to Follow-up|54|||
164080681|NCT00475852|592659566|FG001|Overall Study|Lost to Follow-up|68|||
164080682|NCT00297479|592659567|FG000|Overall Study|Lost to Follow-up|37|||
164080683|NCT00297479|592659568|FG001|Overall Study|Lost to Follow-up|54|||
164080684|NCT00297479|592659569|FG002|Overall Study|Lost to Follow-up|51|||
164080685|NCT03263819|592659570|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
164080686|NCT03263819|592659571|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
164080687|NCT00686920|592659576|FG000|Overall Study|Death|45|||
164080688|NCT00686920|592659577|FG001|Overall Study|Death|14|||
164080689|NCT00686920|592659576|FG000|Overall Study|Liver Transplant|23|||
164224637|NCT03878602|593190316|FG001|Overall Study|incomplete data collection|0|||
164224638|NCT00736476|593190317|FG000|Overall Study|Adverse Event|1|||
164224639|NCT00736476|593190318|FG001|Overall Study|Adverse Event|0|||
164224640|NCT02633527|593190319|FG000|Overall Study|Failed to meet eligibility|0|||
164224641|NCT02633527|593190320|FG001|Overall Study|Failed to meet eligibility|1|||
164224642|NCT02633527|593190321|FG002|Overall Study|Failed to meet eligibility|1|||
164224643|NCT02633527|593190322|FG003|Overall Study|Failed to meet eligibility|0|||
164224644|NCT02633527|593190323|FG004|Overall Study|Failed to meet eligibility|1|||
164224645|NCT02633527|593190319|FG000|Overall Study|Adverse Event|0|||
164224646|NCT02633527|593190320|FG001|Overall Study|Adverse Event|4|||
164224647|NCT02633527|593190321|FG002|Overall Study|Adverse Event|3|||
164224648|NCT02633527|593190322|FG003|Overall Study|Adverse Event|1|||
164224649|NCT02633527|593190323|FG004|Overall Study|Adverse Event|5|||
164224650|NCT02633527|593190319|FG000|Overall Study|Lost to Follow-up|1|||
164224651|NCT02633527|593190320|FG001|Overall Study|Lost to Follow-up|2|||
164224652|NCT02633527|593190321|FG002|Overall Study|Lost to Follow-up|5|||
164224653|NCT02633527|593190322|FG003|Overall Study|Lost to Follow-up|5|||
164224654|NCT02633527|593190323|FG004|Overall Study|Lost to Follow-up|4|||
164224655|NCT02633527|593190319|FG000|Overall Study|Withdrawal by Subject|0|||
164224656|NCT02633527|593190320|FG001|Overall Study|Withdrawal by Subject|3|||
164224657|NCT02633527|593190321|FG002|Overall Study|Withdrawal by Subject|5|||
164224658|NCT02633527|593190322|FG003|Overall Study|Withdrawal by Subject|4|||
164224659|NCT02633527|593190323|FG004|Overall Study|Withdrawal by Subject|4|||
164224660|NCT02633527|593190319|FG000|Overall Study|Protocol Violation|0|||
164224661|NCT02633527|593190320|FG001|Overall Study|Protocol Violation|1|||
164224662|NCT02633527|593190321|FG002|Overall Study|Protocol Violation|1|||
164224663|NCT02633527|593190322|FG003|Overall Study|Protocol Violation|1|||
164224664|NCT02633527|593190323|FG004|Overall Study|Protocol Violation|1|||
164224665|NCT02633527|593190319|FG000|Overall Study|Physician Decision|0|||
164224666|NCT02633527|593190320|FG001|Overall Study|Physician Decision|0|||
164224667|NCT02633527|593190321|FG002|Overall Study|Physician Decision|0|||
164224668|NCT02633527|593190322|FG003|Overall Study|Physician Decision|0|||
164224669|NCT02633527|593190323|FG004|Overall Study|Physician Decision|1|||
164224670|NCT02633527|593190319|FG000|Overall Study|Administrative reason|1|||
164224671|NCT02633527|593190320|FG001|Overall Study|Administrative reason|0|||
164224672|NCT02633527|593190321|FG002|Overall Study|Administrative reason|0|||
164224673|NCT02633527|593190322|FG003|Overall Study|Administrative reason|1|||
164224674|NCT02633527|593190323|FG004|Overall Study|Administrative reason|0|||
164224675|NCT02633527|593190319|FG000|Overall Study|Multiple reasons|1|||
164224676|NCT02633527|593190320|FG001|Overall Study|Multiple reasons|0|||
164224677|NCT02633527|593190321|FG002|Overall Study|Multiple reasons|2|||
164224678|NCT02633527|593190322|FG003|Overall Study|Multiple reasons|2|||
164224679|NCT02633527|593190323|FG004|Overall Study|Multiple reasons|1|||
164224680|NCT00452530|593190324|FG000|Overall Study|Death|1|||
164224681|NCT00452530|593190325|FG001|Overall Study|Death|0|||
164224682|NCT00452530|593190324|FG000|Overall Study|Adverse Event|40|||
164224683|NCT00452530|593190325|FG001|Overall Study|Adverse Event|44|||
164224684|NCT00452530|593190324|FG000|Overall Study|Withdrawal by Subject|68|||
164224685|NCT00452530|593190325|FG001|Overall Study|Withdrawal by Subject|57|||
164224686|NCT00452530|593190324|FG000|Overall Study|Lost to Follow-up|1|||
164224687|NCT00452530|593190325|FG001|Overall Study|Lost to Follow-up|0|||
164224688|NCT00452530|593190324|FG000|Overall Study|Poor compliance/noncompliance|1|||
163880957|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
164080690|NCT00686920|592659577|FG001|Overall Study|Liver Transplant|8|||
164080691|NCT00686920|592659576|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
164224689|NCT00452530|593190325|FG001|Overall Study|Poor compliance/noncompliance|2|||
164224690|NCT00452530|593190324|FG000|Overall Study|No longer met study criteria|18|||
164224691|NCT00452530|593190325|FG001|Overall Study|No longer met study criteria|22|||
164224692|NCT00452530|593190324|FG000|Overall Study|Other|7|||
164224693|NCT00452530|593190325|FG001|Overall Study|Other|11|||
164224694|NCT06091956|593190326|FG000|Overall Study|Withdrawal by Subject|1|||
164224695|NCT06091956|593190326|FG000|Overall Study|Complicating Disease|1|||
164224696|NCT02176525|593190329|FG000|Overall Study|Adverse Event|0|||
164224697|NCT02176525|593190330|FG001|Overall Study|Adverse Event|0|||
164224698|NCT02176525|593190331|FG002|Overall Study|Adverse Event|0|||
164224699|NCT02176525|593190332|FG003|Overall Study|Adverse Event|1|||
164224700|NCT02176525|593190333|FG004|Overall Study|Adverse Event|1|||
164224701|NCT02176525|593190334|FG005|Overall Study|Adverse Event|0|||
164224702|NCT02176525|593190335|FG006|Overall Study|Adverse Event|1|||
164224703|NCT02176525|593190336|FG007|Overall Study|Adverse Event|0|||
164224704|NCT02176525|593190329|FG000|Overall Study|not treated|1|||
164224705|NCT02176525|593190330|FG001|Overall Study|not treated|0|||
163880958|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880959|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880960|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880961|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
163880962|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
163880963|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
163880964|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
163880965|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
163880966|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
163880967|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
163880968|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
163880969|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
163880970|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
163880971|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
163880972|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
163880973|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
163880974|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
163880975|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880976|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880977|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880978|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880979|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880980|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880981|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
163880982|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
163880983|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
163880984|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880985|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880986|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880987|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
163880988|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880989|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880990|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880991|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880992|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880993|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880994|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
163880995|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
163880996|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
163880997|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880998|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163880999|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163881000|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
163881001|NCT01261312|591933464|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881002|NCT01261312|591933465|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881003|NCT01261312|591933466|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881004|NCT01261312|591933467|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881005|NCT01261312|591933468|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881006|NCT01261312|591933469|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881007|NCT01261312|591933470|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
163881008|NCT01261312|591933471|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
163881009|NCT01261312|591933472|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
163881010|NCT01261312|591933473|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
164224706|NCT02176525|593190331|FG002|Overall Study|not treated|0|||
164224707|NCT02176525|593190332|FG003|Overall Study|not treated|0|||
164224708|NCT02176525|593190333|FG004|Overall Study|not treated|0|||
164224709|NCT02176525|593190334|FG005|Overall Study|not treated|1|||
164224710|NCT02176525|593190335|FG006|Overall Study|not treated|0|||
164080692|NCT00686920|592659577|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
164080693|NCT00686920|592659576|FG000|Overall Study|Withdrawal by Subject|23|||
164080694|NCT00686920|592659577|FG001|Overall Study|Withdrawal by Subject|5|||
164080695|NCT00686920|592659576|FG000|Overall Study|Protocol Violation|2|||
163985466|NCT01449708|592316179|FG001|Overall Study|surgical complication|2|||
163985467|NCT01449708|592316178|FG000|Overall Study|respiratory failure|1|||
163985468|NCT01449708|592316179|FG001|Overall Study|respiratory failure|0|||
163985469|NCT02889796|592316180|FG000|Overall Study|Withdrew Consent|18|||
163985470|NCT02889796|592316181|FG001|Overall Study|Withdrew Consent|29|||
163985471|NCT02889796|592316182|FG002|Overall Study|Withdrew Consent|20|||
164080696|NCT00686920|592659577|FG001|Overall Study|Protocol Violation|1|||
164080697|NCT00686920|592659576|FG000|Overall Study|Adverse Event|10|||
164080698|NCT00686920|592659577|FG001|Overall Study|Adverse Event|2|||
164080699|NCT00686920|592659576|FG000|Overall Study|Personal Reason|0|||
164080700|NCT00686920|592659577|FG001|Overall Study|Personal Reason|1|||
164080701|NCT00686920|592659576|FG000|Overall Study|Lost to Follow-up|15|||
164080702|NCT00686920|592659577|FG001|Overall Study|Lost to Follow-up|3|||
164080703|NCT00686920|592659576|FG000|Overall Study|Moved to Another State|1|||
164080704|NCT00686920|592659577|FG001|Overall Study|Moved to Another State|0|||
164080705|NCT00686920|592659576|FG000|Overall Study|Transferred to Nursing Home|1|||
163985472|NCT02889796|592316183|FG003|Overall Study|Withdrew Consent|1|||
163985473|NCT02889796|592316184|FG004|Overall Study|Withdrew Consent|2|||
164080706|NCT00686920|592659577|FG001|Overall Study|Transferred to Nursing Home|0|||
164080707|NCT00686920|592659576|FG000|Overall Study|Noncompliance|9|||
163985474|NCT02889796|592316185|FG005|Overall Study|Withdrew Consent|35|||
163985475|NCT02889796|592316180|FG000|Overall Study|Investigator's Discretion|10|||
164080708|NCT00686920|592659577|FG001|Overall Study|Noncompliance|0|||
164080709|NCT00686920|592659576|FG000|Overall Study|Principal Investigator Decision|2|||
164138876|NCT04572893|592870186|FG002|Part B|Lost to Follow-up|0|||
164138877|NCT04572893|592870187|FG003|Part B|Lost to Follow-up|0|||
164138878|NCT04572893|592870188|FG004|Part B|Lost to Follow-up|0|||
164138879|NCT04572893|592870189|FG005|Part B|Lost to Follow-up|0|||
164138880|NCT04572893|592870190|FG006|Part B|Lost to Follow-up|1|||
164138881|NCT04572893|592870184|FG000|Part B|Adverse Event|0|||
164138882|NCT04572893|592870185|FG001|Part B|Adverse Event|0|||
164138883|NCT04572893|592870186|FG002|Part B|Adverse Event|0|||
164138884|NCT04572893|592870187|FG003|Part B|Adverse Event|0|||
164138885|NCT04572893|592870188|FG004|Part B|Adverse Event|1|||
164138886|NCT04572893|592870189|FG005|Part B|Adverse Event|1|||
164138887|NCT04572893|592870190|FG006|Part B|Adverse Event|0|||
164138888|NCT00477295|592870198|FG000|Overall Study|Adverse Event|31|||
164138889|NCT00477295|592870199|FG001|Overall Study|Adverse Event|35|||
164138890|NCT00477295|592870198|FG000|Overall Study|Withdrawal by Subject|35|||
164138891|NCT00477295|592870199|FG001|Overall Study|Withdrawal by Subject|24|||
164138892|NCT00477295|592870198|FG000|Overall Study|Lack of Efficacy|23|||
164138893|NCT00477295|592870199|FG001|Overall Study|Lack of Efficacy|23|||
164138894|NCT00477295|592870198|FG000|Overall Study|Protocol Violation|3|||
164138895|NCT00477295|592870199|FG001|Overall Study|Protocol Violation|8|||
164138896|NCT00477295|592870198|FG000|Overall Study|Physician Decision|4|||
164138897|NCT00477295|592870199|FG001|Overall Study|Physician Decision|5|||
164138898|NCT00477295|592870198|FG000|Overall Study|Lost to Follow-up|21|||
164138899|NCT00477295|592870199|FG001|Overall Study|Lost to Follow-up|11|||
164138900|NCT00477295|592870198|FG000|Overall Study|Other|4|||
164138901|NCT00477295|592870199|FG001|Overall Study|Other|3|||
164138902|NCT03276780|592870202|FG000|Overall Study|Withdrawal by Subject|5|||
164138903|NCT03276780|592870203|FG001|Overall Study|Withdrawal by Subject|3|||
164138904|NCT03276780|592870202|FG000|Overall Study|Lost to Follow-up|3|||
164138905|NCT03276780|592870203|FG001|Overall Study|Lost to Follow-up|5|||
164138906|NCT03276780|592870202|FG000|Overall Study|Moved out of state|1|||
164138907|NCT03276780|592870203|FG001|Overall Study|Moved out of state|1|||
164138908|NCT03276780|592870202|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
164138909|NCT03276780|592870203|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
164138910|NCT03276780|592870202|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
164138911|NCT03276780|592870203|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
164138912|NCT00510289|592870204|FG000|Overall Study|Withdrawal by Subject|7|||
164138913|NCT00510289|592870204|FG000|Overall Study|Refused bone marrow biopsy|2|||
164138914|NCT00510289|592870204|FG000|Overall Study|Lost to Follow-up|1|||
164138915|NCT00510289|592870204|FG000|Overall Study|Progressed prior to starting drug|2|||
164138916|NCT03835221|592870205|FG000|Methafilcon A|Withdrawal by Subject|1|||
164138917|NCT00861198|592870206|FG000|Overall Study|SpyGlass Failed|5|||
164138918|NCT02288182|592870207|FG000|Overall Study|Adverse Event|0|||
164138919|NCT02288182|592870208|FG001|Overall Study|Adverse Event|1|||
164138920|NCT02288182|592870207|FG000|Overall Study|Lost to Follow-up|0|||
164138921|NCT02288182|592870208|FG001|Overall Study|Lost to Follow-up|1|||
164138922|NCT04619992|592870213|FG000|Overall Study|Withdrawal by Subject|1|||
164138923|NCT04619992|592870214|FG001|Overall Study|Withdrawal by Subject|0|||
164138924|NCT01197755|592870215|FG000|Overall Study|Adverse Event|8|||
164224711|NCT02176525|593190336|FG007|Overall Study|not treated|0|||
164224712|NCT02100644|593190339|FG000|LTG Escalation Phase|Adverse Event|9|||
164224713|NCT02100644|593190340|FG001|LTG Escalation Phase|Adverse Event|0|||
164224714|NCT02100644|593190341|FG002|LTG Escalation Phase|Adverse Event|0|||
164224715|NCT02100644|593190339|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
164224716|NCT02100644|593190340|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
164224717|NCT02100644|593190341|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
164224718|NCT02100644|593190339|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
164224719|NCT02100644|593190340|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
164224720|NCT02100644|593190341|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
164224721|NCT03163264|593190349|FG000|Overall Study|Withdrawal by Subject|13|||
164224722|NCT03163264|593190350|FG001|Overall Study|Withdrawal by Subject|3|||
164224723|NCT03163264|593190351|FG002|Overall Study|Withdrawal by Subject|4|||
164224724|NCT03163264|593190352|FG003|Overall Study|Withdrawal by Subject|2|||
164224725|NCT03163264|593190349|FG000|Overall Study|Lost to Follow-up|17|||
164224726|NCT03163264|593190350|FG001|Overall Study|Lost to Follow-up|20|||
164224727|NCT03163264|593190351|FG002|Overall Study|Lost to Follow-up|0|||
164224728|NCT03163264|593190352|FG003|Overall Study|Lost to Follow-up|0|||
164224729|NCT03163264|593190349|FG000|Overall Study|Death|0|||
164224730|NCT03163264|593190350|FG001|Overall Study|Death|2|||
164224731|NCT03163264|593190351|FG002|Overall Study|Death|0|||
164224732|NCT03163264|593190352|FG003|Overall Study|Death|0|||
164224733|NCT03679884|593190353|FG000|Overall Study|Other|12|||
164224734|NCT03679884|593190354|FG001|Overall Study|Other|12|||
164224735|NCT03679884|593190355|FG002|Overall Study|Other|12|||
164224736|NCT03679884|593190356|FG003|Overall Study|Other|7|||
164224737|NCT03679884|593190357|FG004|Overall Study|Other|8|||
164224738|NCT03679884|593190353|FG000|Overall Study|Lack of Efficacy|15|||
164224739|NCT03679884|593190354|FG001|Overall Study|Lack of Efficacy|29|||
164224740|NCT03679884|593190355|FG002|Overall Study|Lack of Efficacy|13|||
164224741|NCT03679884|593190356|FG003|Overall Study|Lack of Efficacy|29|||
164224742|NCT03679884|593190357|FG004|Overall Study|Lack of Efficacy|10|||
164080710|NCT00686920|592659577|FG001|Overall Study|Principal Investigator Decision|0|||
164080711|NCT00814658|592659581|FG000|Overall Study|Lost to Follow-up|0|||
164080712|NCT00814658|592659582|FG001|Overall Study|Lost to Follow-up|1|||
164080713|NCT00814658|592659581|FG000|Overall Study|Physician Decision|1|||
164080714|NCT00814658|592659582|FG001|Overall Study|Physician Decision|0|||
164080715|NCT00814658|592659581|FG000|Overall Study|Adverse Event|3|||
164080716|NCT00814658|592659582|FG001|Overall Study|Adverse Event|3|||
164080717|NCT01141283|592659583|FG000|Overall Study|Adverse Event|56|||
164080718|NCT01141283|592659583|FG000|Overall Study|Lost to Follow-up|4|||
164080719|NCT01141283|592659583|FG000|Overall Study|Withdrawal by Subject|14|||
164080720|NCT01141283|592659583|FG000|Overall Study|Administrative|4|||
164080721|NCT01141283|592659583|FG000|Overall Study|Lack of Efficacy|10|||
164080722|NCT01208402|592659585|FG000|Overall Study|Withdrawal by Subject|1|||
164080723|NCT01208402|592659586|FG001|Overall Study|Withdrawal by Subject|0|||
164080724|NCT01571635|592659588|FG000|Overall Study|Adverse Event|3|||
164080725|NCT01571635|592659589|FG001|Overall Study|Adverse Event|0|||
164080726|NCT01571635|592659590|FG002|Overall Study|Adverse Event|2|||
164080727|NCT01571635|592659591|FG003|Overall Study|Adverse Event|3|||
164080728|NCT01571635|592659592|FG004|Overall Study|Adverse Event|5|||
164080729|NCT01571635|592659588|FG000|Overall Study|Other reasons|2|||
164080730|NCT01571635|592659589|FG001|Overall Study|Other reasons|1|||
164080731|NCT01571635|592659590|FG002|Overall Study|Other reasons|2|||
164080732|NCT01571635|592659591|FG003|Overall Study|Other reasons|2|||
164080733|NCT01571635|592659592|FG004|Overall Study|Other reasons|1|||
164080734|NCT01571635|592659588|FG000|Overall Study|Study terminated by sponsor|0|||
164080735|NCT01571635|592659589|FG001|Overall Study|Study terminated by sponsor|4|||
164080736|NCT01571635|592659590|FG002|Overall Study|Study terminated by sponsor|1|||
164080737|NCT01571635|592659591|FG003|Overall Study|Study terminated by sponsor|3|||
164080738|NCT01571635|592659592|FG004|Overall Study|Study terminated by sponsor|1|||
164080739|NCT01571635|592659588|FG000|Overall Study|Withdrew consent|1|||
164224743|NCT03679884|593190353|FG000|Overall Study|Death|1|||
164080740|NCT01571635|592659589|FG001|Overall Study|Withdrew consent|1|||
164224744|NCT03679884|593190354|FG001|Overall Study|Death|0|||
164224745|NCT03679884|593190355|FG002|Overall Study|Death|0|||
164224746|NCT03679884|593190356|FG003|Overall Study|Death|0|||
164224747|NCT03679884|593190357|FG004|Overall Study|Death|0|||
164224748|NCT03679884|593190353|FG000|Overall Study|Adverse Event|2|||
164224749|NCT03679884|593190354|FG001|Overall Study|Adverse Event|10|||
164224750|NCT03679884|593190355|FG002|Overall Study|Adverse Event|9|||
164080741|NCT01571635|592659590|FG002|Overall Study|Withdrew consent|2|||
164080742|NCT01571635|592659591|FG003|Overall Study|Withdrew consent|3|||
164080743|NCT01571635|592659592|FG004|Overall Study|Withdrew consent|0|||
164224751|NCT03679884|593190356|FG003|Overall Study|Adverse Event|6|||
164224752|NCT03679884|593190357|FG004|Overall Study|Adverse Event|6|||
164080744|NCT01571635|592659588|FG000|Overall Study|Lack of Efficacy|0|||
164224753|NCT03679884|593190353|FG000|Overall Study|Withdrawal by Subject|12|||
164224754|NCT03679884|593190354|FG001|Overall Study|Withdrawal by Subject|23|||
164224755|NCT03679884|593190355|FG002|Overall Study|Withdrawal by Subject|8|||
164224756|NCT03679884|593190356|FG003|Overall Study|Withdrawal by Subject|8|||
164224757|NCT03679884|593190357|FG004|Overall Study|Withdrawal by Subject|9|||
164224758|NCT03679884|593190353|FG000|Overall Study|Lost to Follow-up|1|||
164224759|NCT03679884|593190354|FG001|Overall Study|Lost to Follow-up|4|||
164224760|NCT03679884|593190355|FG002|Overall Study|Lost to Follow-up|2|||
164080745|NCT01571635|592659589|FG001|Overall Study|Lack of Efficacy|2|||
164080746|NCT01571635|592659590|FG002|Overall Study|Lack of Efficacy|0|||
164080747|NCT01571635|592659591|FG003|Overall Study|Lack of Efficacy|1|||
164080748|NCT01571635|592659592|FG004|Overall Study|Lack of Efficacy|2|||
163985476|NCT02889796|592316181|FG001|Overall Study|Investigator's Discretion|9|||
163985477|NCT02889796|592316182|FG002|Overall Study|Investigator's Discretion|10|||
163985478|NCT02889796|592316183|FG003|Overall Study|Investigator's Discretion|3|||
163985479|NCT02889796|592316184|FG004|Overall Study|Investigator's Discretion|0|||
163985480|NCT02889796|592316185|FG005|Overall Study|Investigator's Discretion|15|||
163985481|NCT02889796|592316180|FG000|Overall Study|Adverse Event|17|||
163985482|NCT02889796|592316181|FG001|Overall Study|Adverse Event|8|||
163985483|NCT02889796|592316182|FG002|Overall Study|Adverse Event|8|||
163985484|NCT02889796|592316183|FG003|Overall Study|Adverse Event|4|||
163985485|NCT02889796|592316184|FG004|Overall Study|Adverse Event|1|||
163985486|NCT02889796|592316185|FG005|Overall Study|Adverse Event|7|||
163985487|NCT02889796|592316180|FG000|Overall Study|Lost to Follow-up|5|||
163985488|NCT02889796|592316181|FG001|Overall Study|Lost to Follow-up|7|||
163985489|NCT02889796|592316182|FG002|Overall Study|Lost to Follow-up|2|||
163985490|NCT02889796|592316183|FG003|Overall Study|Lost to Follow-up|0|||
163985491|NCT02889796|592316184|FG004|Overall Study|Lost to Follow-up|2|||
163985492|NCT02889796|592316185|FG005|Overall Study|Lost to Follow-up|6|||
163985493|NCT02889796|592316180|FG000|Overall Study|Protocol Violation|0|||
163985494|NCT02889796|592316181|FG001|Overall Study|Protocol Violation|1|||
164224761|NCT03679884|593190356|FG003|Overall Study|Lost to Follow-up|0|||
164224762|NCT03679884|593190357|FG004|Overall Study|Lost to Follow-up|3|||
163985495|NCT02889796|592316182|FG002|Overall Study|Protocol Violation|3|||
164080749|NCT05017493|592659598|FG000|Overall Study|Withdrawal by Subject|26|||
164080750|NCT05017493|592659599|FG001|Overall Study|Withdrawal by Subject|0|||
164080751|NCT05017493|592659598|FG000|Overall Study|Physician Decision|15|||
164080752|NCT05017493|592659599|FG001|Overall Study|Physician Decision|0|||
164080753|NCT05017493|592659598|FG000|Overall Study|Protocol Violation|81|||
164080754|NCT05017493|592659599|FG001|Overall Study|Protocol Violation|0|||
164080755|NCT00345683|592659602|FG000|Overall Study|Lost to Follow-up|19|||
164080756|NCT00345683|592659603|FG001|Overall Study|Lost to Follow-up|7|||
164080757|NCT00345683|592659602|FG000|Overall Study|Other|6|||
164080758|NCT00345683|592659603|FG001|Overall Study|Other|2|||
164080759|NCT00096486|592659604|FG000|Overall Study|Withdrawal by Subject|0|||
164080760|NCT00096486|592659605|FG001|Overall Study|Withdrawal by Subject|0|||
164080761|NCT00096486|592659606|FG002|Overall Study|Withdrawal by Subject|1|||
164080762|NCT00096486|592659607|FG003|Overall Study|Withdrawal by Subject|1|||
164080763|NCT00096486|592659604|FG000|Overall Study|Not Treated|0|||
164080764|NCT00096486|592659605|FG001|Overall Study|Not Treated|0|||
164080765|NCT00096486|592659606|FG002|Overall Study|Not Treated|1|||
164080766|NCT00096486|592659607|FG003|Overall Study|Not Treated|1|||
164080767|NCT04071626|592659608|FG000|Overall Study|Withdrawal by Subject|1|||
164080768|NCT04071626|592659609|FG001|Overall Study|Withdrawal by Subject|1|||
164080769|NCT04071626|592659608|FG000|Overall Study|Protocol Violation|0|||
164080770|NCT04071626|592659609|FG001|Overall Study|Protocol Violation|1|||
164080771|NCT00125359|592659610|FG000|Overall Study|Death|4|||
164080772|NCT00125359|592659610|FG000|Overall Study|Adverse Event|5|||
164080773|NCT00125359|592659610|FG000|Overall Study|Physician Decision|14|||
164080774|NCT01201356|592659611|FG000|Overall Study|Adverse Event|170|||
163985496|NCT02889796|592316183|FG003|Overall Study|Protocol Violation|0|||
163985497|NCT02889796|592316184|FG004|Overall Study|Protocol Violation|0|||
163985498|NCT02889796|592316185|FG005|Overall Study|Protocol Violation|4|||
163985499|NCT02889796|592316180|FG000|Overall Study|Non-compliance With Study Drug|0|||
163985500|NCT02889796|592316181|FG001|Overall Study|Non-compliance With Study Drug|2|||
163985501|NCT02889796|592316182|FG002|Overall Study|Non-compliance With Study Drug|0|||
164224763|NCT01026038|593190358|FG000|Overall Study|Lost to Follow-up|1|||
164224764|NCT01026038|593190359|FG001|Overall Study|Lost to Follow-up|1|||
164080775|NCT01201356|592659611|FG000|Overall Study|Abnormal laboratory value(s)|51|||
164080776|NCT01201356|592659611|FG000|Overall Study|Abnormal test procedure result(s)|3|||
164080777|NCT01201356|592659611|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
164080778|NCT01201356|592659611|FG000|Overall Study|Condition no longer requires study drug|12|||
164080779|NCT01201356|592659611|FG000|Overall Study|Withdrawal by Subject|144|||
164080780|NCT01201356|592659611|FG000|Overall Study|Lost to Follow-up|50|||
164224765|NCT01026038|593190360|FG002|Overall Study|Lost to Follow-up|0|||
164224766|NCT02792257|593190368|FG000|Overall Study|Lost to Follow-up|3|||
163985502|NCT02889796|592316183|FG003|Overall Study|Non-compliance With Study Drug|0|||
163985503|NCT02889796|592316184|FG004|Overall Study|Non-compliance With Study Drug|1|||
163985504|NCT02889796|592316185|FG005|Overall Study|Non-compliance With Study Drug|2|||
163985505|NCT02889796|592316180|FG000|Overall Study|Death|1|||
163985506|NCT02889796|592316181|FG001|Overall Study|Death|1|||
163985507|NCT02889796|592316182|FG002|Overall Study|Death|0|||
164224767|NCT02792257|593190369|FG001|Overall Study|Lost to Follow-up|4|||
164224768|NCT02792257|593190368|FG000|Overall Study|Allergy|0|||
164224769|NCT02792257|593190369|FG001|Overall Study|Allergy|1|||
164224770|NCT02792257|593190368|FG000|Overall Study|Protocol Violation|2|||
164224771|NCT02792257|593190369|FG001|Overall Study|Protocol Violation|0|||
164224772|NCT02792257|593190368|FG000|Overall Study|Excessive Agitation|0|||
164224773|NCT02792257|593190369|FG001|Overall Study|Excessive Agitation|1|||
164224774|NCT02792257|593190368|FG000|Overall Study|Not Feeling Well|0|||
164224775|NCT02792257|593190369|FG001|Overall Study|Not Feeling Well|1|||
164224776|NCT03760666|593190371|FG000|Overall Study|Adverse Event|2|||
164224777|NCT03760666|593190372|FG001|Overall Study|Adverse Event|4|||
164224778|NCT03760666|593190373|FG002|Overall Study|Adverse Event|1|||
164224779|NCT03760666|593190371|FG000|Overall Study|AML Disease Progression|3|||
164224780|NCT03760666|593190372|FG001|Overall Study|AML Disease Progression|3|||
164224781|NCT03760666|593190373|FG002|Overall Study|AML Disease Progression|0|||
164224782|NCT03760666|593190371|FG000|Overall Study|Physician Decision|0|||
164224783|NCT03760666|593190372|FG001|Overall Study|Physician Decision|3|||
164224784|NCT03760666|593190373|FG002|Overall Study|Physician Decision|0|||
164224785|NCT03760666|593190371|FG000|Overall Study|Withdrawal by Subject|0|||
164224786|NCT03760666|593190372|FG001|Overall Study|Withdrawal by Subject|1|||
164224787|NCT03760666|593190373|FG002|Overall Study|Withdrawal by Subject|0|||
164224788|NCT01800058|593190379|FG000|Overall Study|Lost to Follow-up|1|||
164224789|NCT01064622|593190380|FG000|Randomized Phase II|Withdrawal by Subject|2|||
164224790|NCT01064622|593190381|FG001|Randomized Phase II|Withdrawal by Subject|2|||
164224791|NCT01064622|593190380|FG000|Randomized Phase II|Protocol Violation|0|||
164224792|NCT01064622|593190381|FG001|Randomized Phase II|Protocol Violation|1|||
164224793|NCT02946996|593190384|FG000|Overall Study|non-evaluable|3|||
164224794|NCT02946996|593190385|FG001|Overall Study|non-evaluable|6|||
164224795|NCT02946996|593190386|FG002|Overall Study|non-evaluable|5|||
164224796|NCT00176254|593190387|FG000|Overall Study|Lost to Follow-up|1|||
163985508|NCT02889796|592316183|FG003|Overall Study|Death|1|||
163985509|NCT02889796|592316184|FG004|Overall Study|Death|0|||
163985510|NCT02889796|592316185|FG005|Overall Study|Death|1|||
163985511|NCT02889796|592316180|FG000|Overall Study|Pregnancy|0|||
163985512|NCT02889796|592316181|FG001|Overall Study|Pregnancy|1|||
163985513|NCT02889796|592316182|FG002|Overall Study|Pregnancy|1|||
163985514|NCT02889796|592316183|FG003|Overall Study|Pregnancy|0|||
163985515|NCT02889796|592316184|FG004|Overall Study|Pregnancy|0|||
163985516|NCT02889796|592316185|FG005|Overall Study|Pregnancy|0|||
163985517|NCT02889796|592316180|FG000|Overall Study|Randomized but not Dosed|2|||
163985518|NCT02889796|592316181|FG001|Overall Study|Randomized but not Dosed|0|||
163985519|NCT02889796|592316182|FG002|Overall Study|Randomized but not Dosed|0|||
163985520|NCT02889796|592316183|FG003|Overall Study|Randomized but not Dosed|0|||
163985521|NCT02889796|592316184|FG004|Overall Study|Randomized but not Dosed|0|||
163985522|NCT02889796|592316185|FG005|Overall Study|Randomized but not Dosed|2|||
163985523|NCT04294459|592316186|FG000|Overall Study|Adverse Event|0|||
163985524|NCT04294459|592316187|FG001|Overall Study|Adverse Event|1|||
163985525|NCT02787863|592316188|FG000|Overall Study|Death|1|||
163985526|NCT02787863|592316189|FG001|Overall Study|Death|0|||
163985527|NCT02787863|592316190|FG002|Overall Study|Death|1|||
163985528|NCT02787863|592316191|FG003|Overall Study|Death|0|||
163985529|NCT02787863|592316192|FG004|Overall Study|Death|0|||
163985530|NCT02787863|592316193|FG005|Overall Study|Death|0|||
163985531|NCT02787863|592316194|FG006|Overall Study|Death|0|||
163985532|NCT02787863|592316195|FG007|Overall Study|Death|0|||
163985533|NCT02787863|592316188|FG000|Overall Study|Withdrawal by Subject|0|||
163985534|NCT02787863|592316189|FG001|Overall Study|Withdrawal by Subject|1|||
163985535|NCT02787863|592316190|FG002|Overall Study|Withdrawal by Subject|1|||
163985536|NCT02787863|592316191|FG003|Overall Study|Withdrawal by Subject|0|||
163985537|NCT02787863|592316192|FG004|Overall Study|Withdrawal by Subject|0|||
163985538|NCT02787863|592316193|FG005|Overall Study|Withdrawal by Subject|0|||
163985539|NCT02787863|592316194|FG006|Overall Study|Withdrawal by Subject|0|||
163985540|NCT02787863|592316195|FG007|Overall Study|Withdrawal by Subject|0|||
163985541|NCT02479802|592316196|FG000|Overall Study|Lost to Follow-up|1|||
163985542|NCT02479802|592316196|FG000|Overall Study|Adverse Event|1|||
163985543|NCT02421887|592316197|FG000|Overall Study|Lost to Follow-up|5|||
163985544|NCT02421887|592316198|FG001|Overall Study|Lost to Follow-up|0|||
163985545|NCT02421887|592316197|FG000|Overall Study|Withdrawal by Subject|8|||
163985546|NCT02421887|592316198|FG001|Overall Study|Withdrawal by Subject|5|||
163985547|NCT02421887|592316197|FG000|Overall Study|Physician Decision|2|||
163985548|NCT02421887|592316198|FG001|Overall Study|Physician Decision|4|||
163985549|NCT02421887|592316197|FG000|Overall Study|Adverse Event|2|||
163985550|NCT02421887|592316198|FG001|Overall Study|Adverse Event|0|||
163985551|NCT01882907|592316199|FG000|Overall Study|Adverse Event|3|||
163985552|NCT01882907|592316200|FG001|Overall Study|Adverse Event|1|||
163985553|NCT01882907|592316199|FG000|Overall Study|Lack of Efficacy|0|||
163985554|NCT01882907|592316200|FG001|Overall Study|Lack of Efficacy|3|||
164224797|NCT05330429|593190390|FG000|Overall Study|Study Terminated by Sponsor|4|||
163985555|NCT01882907|592316199|FG000|Overall Study|Lost to Follow-up|1|||
163985556|NCT01882907|592316200|FG001|Overall Study|Lost to Follow-up|4|||
164329148|NCT01397201|593583240|FG003|Overall Study|Not treated|0|||
164224798|NCT05330429|593190391|FG001|Overall Study|Study Terminated by Sponsor|33|||
164224799|NCT05330429|593190392|FG002|Overall Study|Study Terminated by Sponsor|12|||
164224800|NCT05330429|593190390|FG000|Overall Study|Death|5|||
164224801|NCT05330429|593190391|FG001|Overall Study|Death|2|||
164224802|NCT05330429|593190392|FG002|Overall Study|Death|4|||
164224803|NCT05330429|593190390|FG000|Overall Study|Withdrew Consent|0|||
164224804|NCT05330429|593190391|FG001|Overall Study|Withdrew Consent|5|||
164224805|NCT05330429|593190392|FG002|Overall Study|Withdrew Consent|4|||
164224806|NCT05330429|593190390|FG000|Overall Study|Investigator's Discretion|0|||
164224807|NCT05330429|593190391|FG001|Overall Study|Investigator's Discretion|1|||
164224808|NCT05330429|593190392|FG002|Overall Study|Investigator's Discretion|3|||
164224809|NCT05330429|593190390|FG000|Overall Study|Subject Decision|1|||
164224810|NCT05330429|593190391|FG001|Overall Study|Subject Decision|2|||
164224811|NCT05330429|593190392|FG002|Overall Study|Subject Decision|0|||
164224812|NCT05330429|593190390|FG000|Overall Study|Lost to Follow-up|0|||
164224813|NCT05330429|593190391|FG001|Overall Study|Lost to Follow-up|1|||
164224814|NCT05330429|593190392|FG002|Overall Study|Lost to Follow-up|0|||
164224815|NCT02568254|593190396|FG000|Period 2|Adverse Event|0|||
164224816|NCT02568254|593190397|FG001|Period 2|Adverse Event|0|||
164224817|NCT02568254|593190398|FG002|Period 2|Adverse Event|1|||
164224818|NCT02568254|593190399|FG003|Period 2|Adverse Event|0|||
164224819|NCT02568254|593190400|FG004|Period 2|Adverse Event|0|||
164224820|NCT02568254|593190401|FG005|Period 2|Adverse Event|0|||
164224821|NCT02568254|593190396|FG000|Period 3|Unstatisfactory Lens fitting|0|||
164224822|NCT02568254|593190397|FG001|Period 3|Unstatisfactory Lens fitting|0|||
164224823|NCT02568254|593190398|FG002|Period 3|Unstatisfactory Lens fitting|0|||
164224824|NCT02568254|593190399|FG003|Period 3|Unstatisfactory Lens fitting|0|||
164224825|NCT02568254|593190400|FG004|Period 3|Unstatisfactory Lens fitting|1|||
164224826|NCT02568254|593190401|FG005|Period 3|Unstatisfactory Lens fitting|0|||
164224827|NCT02113878|593192128|FG000|Overall Study|Adverse Event|1|||
164224828|NCT02113878|593192129|FG001|Overall Study|Adverse Event|0|||
164224829|NCT02113878|593192128|FG000|Overall Study|Withdrawal by Subject|1|||
164224830|NCT02113878|593192129|FG001|Overall Study|Withdrawal by Subject|0|||
163881011|NCT01261312|591933474|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881012|NCT01261312|591933475|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881013|NCT01261312|591933476|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
163881014|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881015|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881016|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881017|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881018|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881019|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881020|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881021|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881022|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
163881023|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
163881024|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
163881025|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
163881026|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
163881027|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881028|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881029|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881030|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881031|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881032|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881033|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881034|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881035|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881036|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
163881037|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
163881038|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
163881039|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
163881040|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163881041|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163985557|NCT01882907|592316199|FG000|Overall Study|Protocol Violation|10|||
163881042|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163881043|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163881044|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163985558|NCT01882907|592316200|FG001|Overall Study|Protocol Violation|14|||
163985559|NCT01882907|592316199|FG000|Overall Study|Withdrawal by Subject|0|||
164224831|NCT02113878|593192128|FG000|Overall Study|patient non-compliance|1|||
164329149|NCT01397201|593583241|FG004|Overall Study|Not treated|0|||
164080781|NCT01201356|592659611|FG000|Overall Study|administrative problems|74|||
164080782|NCT01201356|592659611|FG000|Overall Study|Death|16|||
164080783|NCT01201356|592659611|FG000|Overall Study|Protocol Violation|12|||
164080784|NCT00585039|592659612|FG000|Overall Study|medication spilled|2|||
164080785|NCT00585039|592659613|FG001|Overall Study|medication spilled|0|||
164080786|NCT02173301|592659614|FG000|Overall Study|Adverse Event|7|||
164080787|NCT02173301|592659615|FG001|Overall Study|Adverse Event|8|||
164080788|NCT02173301|592659616|FG002|Overall Study|Adverse Event|13|||
164080789|NCT02173301|592659617|FG003|Overall Study|Adverse Event|5|||
164080790|NCT02173301|592659614|FG000|Overall Study|Withdrawal by Subject|8|||
164080791|NCT02173301|592659615|FG001|Overall Study|Withdrawal by Subject|10|||
164080792|NCT02173301|592659616|FG002|Overall Study|Withdrawal by Subject|4|||
164080793|NCT02173301|592659617|FG003|Overall Study|Withdrawal by Subject|8|||
164080794|NCT02173301|592659614|FG000|Overall Study|Lost to Follow-up|4|||
164080795|NCT02173301|592659615|FG001|Overall Study|Lost to Follow-up|4|||
164080796|NCT02173301|592659616|FG002|Overall Study|Lost to Follow-up|2|||
164080797|NCT02173301|592659617|FG003|Overall Study|Lost to Follow-up|2|||
164080798|NCT02173301|592659614|FG000|Overall Study|Protocol Violation|0|||
164080799|NCT02173301|592659615|FG001|Overall Study|Protocol Violation|1|||
164080800|NCT02173301|592659616|FG002|Overall Study|Protocol Violation|0|||
164080801|NCT02173301|592659617|FG003|Overall Study|Protocol Violation|0|||
164080802|NCT02173301|592659614|FG000|Overall Study|Physician Decision|0|||
164080803|NCT02173301|592659615|FG001|Overall Study|Physician Decision|0|||
164080804|NCT02173301|592659616|FG002|Overall Study|Physician Decision|1|||
164080805|NCT02173301|592659617|FG003|Overall Study|Physician Decision|0|||
164080806|NCT02173301|592659614|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
164080807|NCT02173301|592659615|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
164080808|NCT02173301|592659616|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
164080809|NCT02173301|592659617|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
164080810|NCT01585831|592659618|FG000|Overall Study|Physician Decision|0|||
164080811|NCT01585831|592659619|FG001|Overall Study|Physician Decision|1|||
164080812|NCT01585831|592659618|FG000|Overall Study|Withdrawal by Subject|2|||
164080813|NCT01585831|592659619|FG001|Overall Study|Withdrawal by Subject|1|||
164080814|NCT01225991|592659620|FG000|Overall Study|Withdrawal by Subject|6|||
164080815|NCT04079842|592659621|FG000|Overall Study|Request of subject|2|||
164080816|NCT04079842|592659621|FG000|Overall Study|Unable to draw Arterial samples|1|||
164080817|NCT02904200|592659622|FG000|Overall Study|Withdrawal by Subject|1|||
164080818|NCT02904200|592659623|FG001|Overall Study|Withdrawal by Subject|0|||
164080819|NCT02133352|592659624|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
164080820|NCT04444752|592659625|FG000|Overall Study|Adverse Event|1|||
164080821|NCT04444752|592659626|FG001|Overall Study|Adverse Event|0|||
164080822|NCT04444752|592659627|FG002|Overall Study|Adverse Event|0|||
164080823|NCT04444752|592659628|FG003|Overall Study|Adverse Event|2|||
164080824|NCT04444752|592659625|FG000|Overall Study|Lost to Follow-up|2|||
164080825|NCT04444752|592659626|FG001|Overall Study|Lost to Follow-up|6|||
164080826|NCT04444752|592659627|FG002|Overall Study|Lost to Follow-up|2|||
164080827|NCT04444752|592659628|FG003|Overall Study|Lost to Follow-up|5|||
164080828|NCT04444752|592659625|FG000|Overall Study|Physician Decision|0|||
164080829|NCT04444752|592659626|FG001|Overall Study|Physician Decision|0|||
164080830|NCT04444752|592659627|FG002|Overall Study|Physician Decision|0|||
164080831|NCT04444752|592659628|FG003|Overall Study|Physician Decision|2|||
164080832|NCT04444752|592659625|FG000|Overall Study|Pregnancy|0|||
164080833|NCT04444752|592659626|FG001|Overall Study|Pregnancy|0|||
164080834|NCT04444752|592659627|FG002|Overall Study|Pregnancy|0|||
164080835|NCT04444752|592659628|FG003|Overall Study|Pregnancy|1|||
164080836|NCT04444752|592659625|FG000|Overall Study|Withdrawal by Subject|6|||
164080837|NCT04444752|592659626|FG001|Overall Study|Withdrawal by Subject|5|||
164080838|NCT04444752|592659627|FG002|Overall Study|Withdrawal by Subject|3|||
164080839|NCT04444752|592659628|FG003|Overall Study|Withdrawal by Subject|4|||
164080840|NCT04444752|592659625|FG000|Overall Study|Protocol Violation|1|||
164080841|NCT04444752|592659626|FG001|Overall Study|Protocol Violation|1|||
164080842|NCT04444752|592659627|FG002|Overall Study|Protocol Violation|0|||
164080843|NCT04444752|592659628|FG003|Overall Study|Protocol Violation|0|||
164080844|NCT04444752|592659625|FG000|Overall Study|Patient moving out of town|1|||
164080845|NCT04444752|592659626|FG001|Overall Study|Patient moving out of town|0|||
164080846|NCT04444752|592659627|FG002|Overall Study|Patient moving out of town|0|||
164080847|NCT04444752|592659628|FG003|Overall Study|Patient moving out of town|1|||
164080848|NCT04444752|592659625|FG000|Overall Study|Lack of Efficacy|0|||
164080849|NCT04444752|592659626|FG001|Overall Study|Lack of Efficacy|0|||
164224832|NCT02113878|593192129|FG001|Overall Study|patient non-compliance|0|||
164080850|NCT04444752|592659627|FG002|Overall Study|Lack of Efficacy|0|||
164224833|NCT03142451|593192130|FG000|Overall Study|Adverse Event|5|||
164080851|NCT04444752|592659628|FG003|Overall Study|Lack of Efficacy|1|||
164080852|NCT04444752|592659625|FG000|Overall Study|Death|0|||
164080853|NCT04444752|592659626|FG001|Overall Study|Death|0|||
164080854|NCT04444752|592659627|FG002|Overall Study|Death|1|||
164080855|NCT04444752|592659628|FG003|Overall Study|Death|0|||
164080856|NCT00579254|592659629|FG000|Overall Study|Lost to Follow-up|39|||
164080857|NCT00579254|592659629|FG000|Overall Study|Discontinued when study terminated|73|||
164080858|NCT02038634|592661514|FG000|Overall Study|Lost to Follow-up|0|||
164080859|NCT02038634|592661515|FG001|Overall Study|Lost to Follow-up|1|||
164080860|NCT03572933|592661517|FG000|Overall Study|Adverse Event|4|||
164080861|NCT03572933|592661518|FG001|Overall Study|Adverse Event|1|||
164080862|NCT03572933|592661517|FG000|Overall Study|Withdrawal by Subject|0|||
164224834|NCT03142451|593192131|FG001|Overall Study|Adverse Event|2|||
164224835|NCT03142451|593192130|FG000|Overall Study|Lost to Follow-up|25|||
164224836|NCT03142451|593192131|FG001|Overall Study|Lost to Follow-up|8|||
164224837|NCT03142451|593192130|FG000|Overall Study|Participant request|24|||
164224838|NCT03142451|593192131|FG001|Overall Study|Participant request|12|||
164224839|NCT03142451|593192130|FG000|Overall Study|Protocol Violation|3|||
164224840|NCT03142451|593192131|FG001|Overall Study|Protocol Violation|1|||
164224841|NCT03142451|593192130|FG000|Overall Study|Other|1|||
164224842|NCT03142451|593192131|FG001|Overall Study|Other|1|||
164224843|NCT02144337|593192132|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
164224844|NCT02144337|593192133|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
164224845|NCT02144337|593192132|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
164224846|NCT02144337|593192133|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
164224847|NCT02144337|593192132|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
164224848|NCT02144337|593192133|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
164224849|NCT02144337|593192132|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
163881045|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163881046|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163881047|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
163881048|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
164080863|NCT03572933|592661518|FG001|Overall Study|Withdrawal by Subject|1|||
164080864|NCT01381900|592661519|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
164080865|NCT01381900|592661520|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
164080866|NCT01381900|592661521|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
164080867|NCT01381900|592661519|FG000|Overall Study|Adverse Event|4|||
164080868|NCT01381900|592661520|FG001|Overall Study|Adverse Event|6|||
164080869|NCT01381900|592661521|FG002|Overall Study|Adverse Event|7|||
164080870|NCT01381900|592661519|FG000|Overall Study|Noncompliance with study drug|0|||
164080871|NCT01381900|592661520|FG001|Overall Study|Noncompliance with study drug|0|||
164080872|NCT01381900|592661521|FG002|Overall Study|Noncompliance with study drug|1|||
164080873|NCT01381900|592661519|FG000|Overall Study|Physician Decision|0|||
164080874|NCT01381900|592661520|FG001|Overall Study|Physician Decision|1|||
164080875|NCT01381900|592661521|FG002|Overall Study|Physician Decision|1|||
164080876|NCT01381900|592661519|FG000|Overall Study|Protocol Violation|0|||
164080877|NCT01381900|592661520|FG001|Overall Study|Protocol Violation|1|||
164080878|NCT01381900|592661521|FG002|Overall Study|Protocol Violation|1|||
164080879|NCT01381900|592661519|FG000|Overall Study|Withdrawal by Subject|0|||
164080880|NCT01381900|592661520|FG001|Overall Study|Withdrawal by Subject|0|||
164080881|NCT01381900|592661521|FG002|Overall Study|Withdrawal by Subject|1|||
164080882|NCT01381900|592661519|FG000|Overall Study|Early withdraw|3|||
164080883|NCT01381900|592661520|FG001|Overall Study|Early withdraw|1|||
164080884|NCT01381900|592661521|FG002|Overall Study|Early withdraw|1|||
164080885|NCT01772368|592661522|FG000|Overall Study|Adverse Event|1|||
164080886|NCT01772368|592661522|FG000|Overall Study|Withdrawal by Subject|3|||
164080887|NCT01772368|592661522|FG000|Overall Study|Protocol Violation|2|||
164080888|NCT01772368|592661522|FG000|Overall Study|Other|1|||
164224850|NCT02144337|593192133|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
163881049|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
163881050|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
163881051|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
163881052|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
163881053|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881054|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881055|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881056|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881057|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881058|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881059|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881060|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881061|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
163881062|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
164080889|NCT00112489|592661526|FG000|Overall Study|Refused further treatment|8|||
164080890|NCT00112489|592661526|FG000|Overall Study|Adverse Event|12|||
164080891|NCT00112489|592661526|FG000|Overall Study|Death|2|||
164080892|NCT00112489|592661526|FG000|Overall Study|Other, Not Specified|9|||
164080893|NCT00112489|592661526|FG000|Overall Study|Patient never treated|2|||
164080894|NCT00112489|592661526|FG000|Overall Study|Ineligible|7|||
164080895|NCT02891200|592661531|FG000|Overall Study|Lost to Follow-up|31|||
164080896|NCT02891200|592661532|FG001|Overall Study|Lost to Follow-up|36|||
164080897|NCT02891200|592661531|FG000|Overall Study|Death|10|||
164080898|NCT02891200|592661532|FG001|Overall Study|Death|9|||
164080899|NCT02891200|592661531|FG000|Overall Study|Withdrawal by Subject|1|||
164080900|NCT02891200|592661532|FG001|Overall Study|Withdrawal by Subject|4|||
163881063|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
164080901|NCT02231710|592661533|FG000|Overall Study|Physician Decision|1|||
164080902|NCT01339910|592661534|FG000|Overall Study|Withdrawal by Subject|1|||
164080903|NCT01339910|592661535|FG001|Overall Study|Withdrawal by Subject|0|||
164080904|NCT01339910|592661534|FG000|Overall Study|Physician Decision|1|||
164080905|NCT01339910|592661535|FG001|Overall Study|Physician Decision|0|||
164080906|NCT01339910|592661534|FG000|Overall Study|Disease relapse|1|||
164080907|NCT01339910|592661535|FG001|Overall Study|Disease relapse|4|||
164080908|NCT02322879|592661536|FG000|First Intervention|Physician Decision|1|||
164080909|NCT02322879|592661537|FG001|First Intervention|Physician Decision|0|||
164080910|NCT00124020|592661544|FG000|Overall Study|Death|67|||
164080911|NCT00124020|592661545|FG001|Overall Study|Death|71|||
164080912|NCT00124020|592661544|FG000|Overall Study|Withdrawal by Subject|13|||
164080913|NCT00124020|592661545|FG001|Overall Study|Withdrawal by Subject|11|||
164080914|NCT00124020|592661544|FG000|Overall Study|Lost to Follow-up|5|||
164080915|NCT00124020|592661545|FG001|Overall Study|Lost to Follow-up|8|||
164080916|NCT00124020|592661544|FG000|Overall Study|Other|1|||
164080917|NCT00124020|592661545|FG001|Overall Study|Other|1|||
164080918|NCT00124020|592661544|FG000|Overall Study|Transfer to another hospital|2|||
164080919|NCT00124020|592661545|FG001|Overall Study|Transfer to another hospital|0|||
164080920|NCT01799590|592661546|FG000|Overall Study|Adverse Event|13|||
164080921|NCT01799590|592661547|FG001|Overall Study|Adverse Event|7|||
164080922|NCT01799590|592661548|FG002|Overall Study|Adverse Event|5|||
164080923|NCT01799590|592661546|FG000|Overall Study|Pregnancy|2|||
164080924|NCT01799590|592661547|FG001|Overall Study|Pregnancy|0|||
164080925|NCT01799590|592661548|FG002|Overall Study|Pregnancy|0|||
164080926|NCT01799590|592661546|FG000|Overall Study|Lack of Efficacy|3|||
164080927|NCT01799590|592661547|FG001|Overall Study|Lack of Efficacy|1|||
164080928|NCT01799590|592661548|FG002|Overall Study|Lack of Efficacy|3|||
164080929|NCT01799590|592661546|FG000|Overall Study|Participants convenience|4|||
164080930|NCT01799590|592661547|FG001|Overall Study|Participants convenience|4|||
164080931|NCT01799590|592661548|FG002|Overall Study|Participants convenience|2|||
164080932|NCT01799590|592661546|FG000|Overall Study|Aggravation of complications|0|||
164080933|NCT01799590|592661547|FG001|Overall Study|Aggravation of complications|1|||
164080934|NCT01799590|592661548|FG002|Overall Study|Aggravation of complications|1|||
164080935|NCT01799590|592661546|FG000|Overall Study|Using drugs with restricted days of use|0|||
164080936|NCT01799590|592661547|FG001|Overall Study|Using drugs with restricted days of use|3|||
164080937|NCT01799590|592661548|FG002|Overall Study|Using drugs with restricted days of use|2|||
164080938|NCT01799590|592661546|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
164080939|NCT01799590|592661547|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
164080940|NCT01799590|592661548|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
164080941|NCT01799590|592661546|FG000|Overall Study|Other|3|||
164080942|NCT01799590|592661547|FG001|Overall Study|Other|0|||
164080943|NCT01799590|592661548|FG002|Overall Study|Other|1|||
163881064|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
163881065|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
163881066|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881067|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881068|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881069|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881070|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881071|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881072|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881073|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881074|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
163881075|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
163881076|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
164080944|NCT00752791|592661549|FG000|Overall Study|Adverse Event|7|||
164080945|NCT00752791|592661549|FG000|Overall Study|Withdrawal by Subject|1|||
163881077|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
164080946|NCT00752791|592661549|FG000|Overall Study|Physician Decision|1|||
164080947|NCT00752791|592661549|FG000|Overall Study|Death|1|||
164080948|NCT00752791|592661549|FG000|Overall Study|Renal transplant|3|||
164080949|NCT00752791|592661549|FG000|Overall Study|Switched to hemodialysis|2|||
164080950|NCT00752791|592661549|FG000|Overall Study|Protocol deviation|1|||
164080951|NCT01977092|592661552|FG000|Overall Study|Death|3|||
164080952|NCT01977092|592661553|FG001|Overall Study|Death|4|||
164080953|NCT01977092|592661552|FG000|Overall Study|Lost to Follow-up|23|||
164080954|NCT01977092|592661553|FG001|Overall Study|Lost to Follow-up|14|||
164080955|NCT01977092|592661552|FG000|Overall Study|Withdrawal by Subject|2|||
164080956|NCT01977092|592661553|FG001|Overall Study|Withdrawal by Subject|1|||
164080957|NCT01977092|592661552|FG000|Overall Study|In prison|3|||
164080958|NCT01977092|592661553|FG001|Overall Study|In prison|11|||
164080959|NCT01155583|592661557|FG000|Phase I|Screen failure - did not start treatment|0|||
164080960|NCT01155583|592661558|FG001|Phase I|Screen failure - did not start treatment|0|||
164080961|NCT01155583|592661559|FG002|Phase I|Screen failure - did not start treatment|0|||
164080962|NCT01155583|592661560|FG003|Phase I|Screen failure - did not start treatment|0|||
164080963|NCT01155583|592661561|FG004|Phase I|Screen failure - did not start treatment|1|||
164080964|NCT01155583|592661562|FG005|Phase I|Screen failure - did not start treatment|0|||
164080965|NCT01155583|592661563|FG006|Phase I|Screen failure - did not start treatment|0|||
164080966|NCT01155583|592661564|FG007|Phase I|Screen failure - did not start treatment|2|||
164080967|NCT01155583|592661565|FG008|Phase I|Screen failure - did not start treatment|0|||
164080968|NCT01155583|592661557|FG000|Phase I|Withdrawal by Subject|0|||
164080969|NCT01155583|592661558|FG001|Phase I|Withdrawal by Subject|0|||
164080970|NCT01155583|592661559|FG002|Phase I|Withdrawal by Subject|0|||
164080971|NCT01155583|592661560|FG003|Phase I|Withdrawal by Subject|0|||
164080972|NCT01155583|592661561|FG004|Phase I|Withdrawal by Subject|0|||
164224851|NCT02144337|593192132|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
163881078|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
163881079|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881080|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881081|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881082|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881083|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881084|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881085|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881086|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881087|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
163881088|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
163881089|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
163881090|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
163881091|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
163881092|NCT01261312|591933464|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881093|NCT01261312|591933465|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881094|NCT01261312|591933466|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881095|NCT01261312|591933467|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881096|NCT01261312|591933468|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881097|NCT01261312|591933469|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881098|NCT01261312|591933470|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881099|NCT01261312|591933471|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881100|NCT01261312|591933472|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
163881101|NCT01261312|591933473|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
163881102|NCT01261312|591933474|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
163881103|NCT01261312|591933475|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
163881104|NCT01261312|591933476|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
163881105|NCT04294225|591933477|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
163881106|NCT04294225|591933477|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
163881107|NCT04294225|591933477|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
163881108|NCT04294225|591933477|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
163881109|NCT04294225|591933477|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
163881110|NCT03336333|591933484|FG000|Overall Study|Remained on study at time of data cut-off|202|||
163881111|NCT03336333|591933485|FG001|Overall Study|Remained on study at time of data cut-off|219|||
163881112|NCT03336333|591933486|FG002|Overall Study|Remained on study at time of data cut-off|102|||
163881113|NCT03336333|591933484|FG000|Overall Study|Death|14|||
163881114|NCT03336333|591933485|FG001|Overall Study|Death|16|||
163881115|NCT03336333|591933486|FG002|Overall Study|Death|8|||
163881116|NCT03336333|591933484|FG000|Overall Study|Withdrawal by Subject|16|||
163881117|NCT03336333|591933485|FG001|Overall Study|Withdrawal by Subject|5|||
163881118|NCT03336333|591933486|FG002|Overall Study|Withdrawal by Subject|1|||
163881119|NCT03336333|591933484|FG000|Overall Study|Physician Decision|5|||
163881120|NCT03336333|591933485|FG001|Overall Study|Physician Decision|1|||
163881121|NCT03336333|591933486|FG002|Overall Study|Physician Decision|0|||
163881122|NCT03336333|591933484|FG000|Overall Study|Lost to Follow-up|1|||
163881123|NCT03336333|591933485|FG001|Overall Study|Lost to Follow-up|0|||
163881124|NCT03336333|591933486|FG002|Overall Study|Lost to Follow-up|0|||
164080973|NCT01155583|592661562|FG005|Phase I|Withdrawal by Subject|0|||
164080974|NCT01155583|592661563|FG006|Phase I|Withdrawal by Subject|0|||
164224852|NCT02144337|593192133|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
164080975|NCT01155583|592661564|FG007|Phase I|Withdrawal by Subject|1|||
164080976|NCT01155583|592661565|FG008|Phase I|Withdrawal by Subject|0|||
164080977|NCT00886483|592661572|FG000|Overall Study|Lost to Follow-up|0|||
164080978|NCT00886483|592661573|FG001|Overall Study|Lost to Follow-up|1|||
164080979|NCT00886483|592661572|FG000|Overall Study|Pursue medications|1|||
164080980|NCT00886483|592661573|FG001|Overall Study|Pursue medications|2|||
164080981|NCT00886483|592661572|FG000|Overall Study|Distance to center, poor grades|1|||
164080982|NCT00886483|592661573|FG001|Overall Study|Distance to center, poor grades|0|||
164080983|NCT01001169|592661574|FG000|Overall Study|Withdrawal by Subject|2|||
164080984|NCT01001169|592661575|FG001|Overall Study|Withdrawal by Subject|1|||
164080985|NCT00602030|592661576|FG000|Lead-in Phase|Disease Progression|2|||
164080986|NCT00602030|592661577|FG001|Lead-in Phase|Disease Progression|3|||
164080987|NCT00602030|592661578|FG002|Lead-in Phase|Disease Progression|0|||
164080988|NCT00602030|592661579|FG003|Lead-in Phase|Disease Progression|0|||
164080989|NCT00602030|592661580|FG004|Lead-in Phase|Disease Progression|0|||
164080990|NCT00602030|592661576|FG000|Lead-in Phase|Adverse Event|0|||
164080991|NCT00602030|592661577|FG001|Lead-in Phase|Adverse Event|2|||
164080992|NCT00602030|592661578|FG002|Lead-in Phase|Adverse Event|0|||
164080993|NCT00602030|592661579|FG003|Lead-in Phase|Adverse Event|0|||
164080994|NCT00602030|592661580|FG004|Lead-in Phase|Adverse Event|0|||
164080995|NCT00602030|592661576|FG000|Double-blind Phase|Disease progression|0|||
164080996|NCT00602030|592661577|FG001|Double-blind Phase|Disease progression|0|||
164080997|NCT00602030|592661578|FG002|Double-blind Phase|Disease progression|33|||
164080998|NCT00602030|592661579|FG003|Double-blind Phase|Disease progression|30|||
164080999|NCT00602030|592661580|FG004|Double-blind Phase|Disease progression|0|||
164081000|NCT00602030|592661576|FG000|Double-blind Phase|Adverse Event|0|||
164081001|NCT00602030|592661577|FG001|Double-blind Phase|Adverse Event|0|||
164081002|NCT00602030|592661578|FG002|Double-blind Phase|Adverse Event|9|||
163881125|NCT03846505|591933494|FG000|Treatment Phase|Withdrawal by Subject|9|||
163881126|NCT03846505|591933495|FG001|Treatment Phase|Withdrawal by Subject|11|||
163881127|NCT03846505|591933494|FG000|Treatment Phase|Lost to Follow-up|6|||
163881128|NCT03846505|591933495|FG001|Treatment Phase|Lost to Follow-up|2|||
163881129|NCT03846505|591933494|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
163881130|NCT03846505|591933495|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
163881131|NCT03846505|591933494|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
163881132|NCT03846505|591933495|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
163881133|NCT03665597|591933496|FG000|Period 1|Adverse Event|1|||
163881134|NCT03665597|591933497|FG001|Period 1|Adverse Event|0|||
163881135|NCT03665597|591933498|FG002|Period 1|Adverse Event|0|||
163881136|NCT03665597|591933499|FG003|Period 1|Adverse Event|1|||
163881137|NCT03665597|591933500|FG004|Period 1|Adverse Event|0|||
163881138|NCT03665597|591933501|FG005|Period 1|Adverse Event|0|||
163881139|NCT03665597|591933502|FG006|Period 1|Adverse Event|0|||
163881140|NCT03665597|591933496|FG000|Period 1|Screen Failure|0|||
163881141|NCT03665597|591933497|FG001|Period 1|Screen Failure|0|||
163881142|NCT03665597|591933498|FG002|Period 1|Screen Failure|0|||
164081003|NCT00602030|592661579|FG003|Double-blind Phase|Adverse Event|18|||
164081004|NCT00602030|592661580|FG004|Double-blind Phase|Adverse Event|0|||
164224853|NCT05333965|593192134|FG000|First Intervention|Adverse Event|0|||
164224854|NCT05333965|593192135|FG001|First Intervention|Adverse Event|1|||
164224855|NCT05333965|593192134|FG000|First Intervention|Withdrawal by Subject|0|||
164224856|NCT05333965|593192135|FG001|First Intervention|Withdrawal by Subject|1|||
164224857|NCT00871000|593192138|FG000|Overall Study|Withdrawal by Subject|1|||
164224858|NCT00871000|593192139|FG001|Overall Study|Withdrawal by Subject|0|||
164224859|NCT01052428|593192140|FG000|Overall Study|Death|1|||
164224860|NCT01052428|593192141|FG001|Overall Study|Death|0|||
164224861|NCT01052428|593192140|FG000|Overall Study|Withdrawal by Subject|0|||
164224862|NCT01052428|593192141|FG001|Overall Study|Withdrawal by Subject|1|||
164224863|NCT03400787|593192142|FG000|Overall Study|Lost to Follow-up|1|||
164224864|NCT03400787|593192143|FG001|Overall Study|Lost to Follow-up|0|||
164224865|NCT03400787|593192142|FG000|Overall Study|Death|1|||
164224866|NCT03400787|593192143|FG001|Overall Study|Death|0|||
164224867|NCT03400787|593192142|FG000|Overall Study|Protocol Violation|0|||
164224868|NCT03400787|593192143|FG001|Overall Study|Protocol Violation|2|||
164224869|NCT03400787|593192142|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
164224870|NCT03400787|593192143|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
163881143|NCT03665597|591933499|FG003|Period 1|Screen Failure|1|||
163881144|NCT03665597|591933500|FG004|Period 1|Screen Failure|0|||
164224871|NCT02402907|593192146|FG000|Overall Study|Delivered vaginally|9|||
163881145|NCT03665597|591933501|FG005|Period 1|Screen Failure|0|||
164081005|NCT00602030|592661576|FG000|Double-blind Phase|Consent withdrawal|0|||
164081006|NCT00602030|592661577|FG001|Double-blind Phase|Consent withdrawal|0|||
164081007|NCT00602030|592661578|FG002|Double-blind Phase|Consent withdrawal|4|||
164081008|NCT00602030|592661579|FG003|Double-blind Phase|Consent withdrawal|3|||
164081009|NCT00602030|592661580|FG004|Double-blind Phase|Consent withdrawal|0|||
164224872|NCT02402907|593192147|FG001|Overall Study|Delivered vaginally|3|||
163881146|NCT03665597|591933502|FG006|Period 1|Screen Failure|0|||
163881147|NCT03665597|591933496|FG000|Period 1|Death|0|||
164081010|NCT00602030|592661576|FG000|Double-blind Phase|Death|0|||
164081011|NCT00602030|592661577|FG001|Double-blind Phase|Death|0|||
164081012|NCT00602030|592661578|FG002|Double-blind Phase|Death|3|||
164081013|NCT00602030|592661579|FG003|Double-blind Phase|Death|3|||
164081014|NCT00602030|592661580|FG004|Double-blind Phase|Death|0|||
164081015|NCT00602030|592661576|FG000|Double-blind Phase|Administrative decision|0|||
164081016|NCT00602030|592661577|FG001|Double-blind Phase|Administrative decision|0|||
164081017|NCT00602030|592661578|FG002|Double-blind Phase|Administrative decision|0|||
164081018|NCT00602030|592661579|FG003|Double-blind Phase|Administrative decision|2|||
164081019|NCT00602030|592661580|FG004|Double-blind Phase|Administrative decision|0|||
164081020|NCT00602030|592661576|FG000|Double-blind Phase|Ineligibility|0|||
164081021|NCT00602030|592661577|FG001|Double-blind Phase|Ineligibility|0|||
164081022|NCT00602030|592661578|FG002|Double-blind Phase|Ineligibility|0|||
164081023|NCT00602030|592661579|FG003|Double-blind Phase|Ineligibility|1|||
164081024|NCT00602030|592661580|FG004|Double-blind Phase|Ineligibility|0|||
164081025|NCT00602030|592661576|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
164081026|NCT00602030|592661577|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
164081027|NCT00602030|592661578|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
164081028|NCT00602030|592661579|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
164081029|NCT00602030|592661580|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
164081030|NCT00602030|592661576|FG000|Double-blind Phase|Reason not specified|0|||
164081031|NCT00602030|592661577|FG001|Double-blind Phase|Reason not specified|0|||
164081032|NCT00602030|592661578|FG002|Double-blind Phase|Reason not specified|4|||
164081033|NCT00602030|592661579|FG003|Double-blind Phase|Reason not specified|2|||
164081034|NCT00602030|592661580|FG004|Double-blind Phase|Reason not specified|0|||
164081035|NCT00602030|592661576|FG000|Crossover Phase|Disease Progression|0|||
164081036|NCT00602030|592661577|FG001|Crossover Phase|Disease Progression|0|||
164081037|NCT00602030|592661578|FG002|Crossover Phase|Disease Progression|0|||
164081038|NCT00602030|592661579|FG003|Crossover Phase|Disease Progression|0|||
164081039|NCT00602030|592661580|FG004|Crossover Phase|Disease Progression|11|||
164081040|NCT00602030|592661576|FG000|Crossover Phase|Adverse Event|0|||
164081041|NCT00602030|592661577|FG001|Crossover Phase|Adverse Event|0|||
164081042|NCT00602030|592661578|FG002|Crossover Phase|Adverse Event|0|||
164081043|NCT00602030|592661579|FG003|Crossover Phase|Adverse Event|0|||
164081044|NCT00602030|592661580|FG004|Crossover Phase|Adverse Event|3|||
164081045|NCT00602030|592661576|FG000|Crossover Phase|Consent withdrawal|0|||
164081046|NCT00602030|592661577|FG001|Crossover Phase|Consent withdrawal|0|||
164081047|NCT00602030|592661578|FG002|Crossover Phase|Consent withdrawal|0|||
164081048|NCT00602030|592661579|FG003|Crossover Phase|Consent withdrawal|0|||
164081049|NCT00602030|592661580|FG004|Crossover Phase|Consent withdrawal|2|||
164081050|NCT01138150|592661581|FG000|Overall Study|blood unable to be processed|0|||
164081051|NCT01138150|592661582|FG001|Overall Study|blood unable to be processed|1|||
164081052|NCT01138150|592661581|FG000|Overall Study|Physician Decision|1|||
164081053|NCT01138150|592661582|FG001|Overall Study|Physician Decision|0|||
164081054|NCT01580020|592661583|FG000|Overall Study|Lack of Efficacy|0|||
164081055|NCT01580020|592661584|FG001|Overall Study|Lack of Efficacy|5|||
164081056|NCT01580020|592661585|FG002|Overall Study|Lack of Efficacy|0|||
164081057|NCT01580020|592661586|FG003|Overall Study|Lack of Efficacy|1|||
164081058|NCT01580020|592661583|FG000|Overall Study|Withdrawal by Subject|0|||
164081059|NCT01580020|592661584|FG001|Overall Study|Withdrawal by Subject|1|||
164081060|NCT01580020|592661585|FG002|Overall Study|Withdrawal by Subject|1|||
164081061|NCT01580020|592661586|FG003|Overall Study|Withdrawal by Subject|0|||
164081062|NCT01580020|592661583|FG000|Overall Study|Adverse Event|1|||
164081063|NCT01580020|592661584|FG001|Overall Study|Adverse Event|1|||
164081064|NCT01580020|592661585|FG002|Overall Study|Adverse Event|1|||
164081065|NCT01580020|592661586|FG003|Overall Study|Adverse Event|1|||
164081066|NCT01580020|592661583|FG000|Overall Study|Administrative Problems|0|||
164081067|NCT01580020|592661584|FG001|Overall Study|Administrative Problems|0|||
164081068|NCT01580020|592661585|FG002|Overall Study|Administrative Problems|1|||
164081069|NCT01580020|592661586|FG003|Overall Study|Administrative Problems|0|||
164081070|NCT01580020|592661583|FG000|Overall Study|Lost to Follow-up|0|||
164081071|NCT01580020|592661584|FG001|Overall Study|Lost to Follow-up|0|||
164081072|NCT01580020|592661585|FG002|Overall Study|Lost to Follow-up|1|||
164081073|NCT01580020|592661586|FG003|Overall Study|Lost to Follow-up|0|||
164081074|NCT01724359|592661587|FG000|Overall Study|Adverse Event|10|||
164081075|NCT01724359|592661587|FG000|Overall Study|Death|1|||
164081076|NCT01724359|592661587|FG000|Overall Study|Other|20|||
164081077|NCT02151461|592661594|FG000|Overall Study|Adverse Event|5|||
164081078|NCT02151461|592661595|FG001|Overall Study|Adverse Event|1|||
164081079|NCT02151461|592661596|FG002|Overall Study|Adverse Event|0|||
164081080|NCT02151461|592661597|FG003|Overall Study|Adverse Event|2|||
164081081|NCT02151461|592661594|FG000|Overall Study|Lost to Follow-up|0|||
164224873|NCT02402907|593192146|FG000|Overall Study|Delivered outside of Sinai|1|||
164081082|NCT02151461|592661595|FG001|Overall Study|Lost to Follow-up|0|||
164081083|NCT02151461|592661596|FG002|Overall Study|Lost to Follow-up|1|||
164081084|NCT02151461|592661597|FG003|Overall Study|Lost to Follow-up|1|||
164224874|NCT02402907|593192147|FG001|Overall Study|Delivered outside of Sinai|1|||
164081085|NCT02151461|592661594|FG000|Overall Study|Withdrawal by Subject|1|||
164081086|NCT02151461|592661595|FG001|Overall Study|Withdrawal by Subject|0|||
164081087|NCT02151461|592661596|FG002|Overall Study|Withdrawal by Subject|1|||
164081088|NCT02151461|592661597|FG003|Overall Study|Withdrawal by Subject|1|||
164081089|NCT02151461|592661594|FG000|Overall Study|Treatment discontinuation|0|||
164081090|NCT02151461|592661595|FG001|Overall Study|Treatment discontinuation|0|||
164081091|NCT02151461|592661596|FG002|Overall Study|Treatment discontinuation|1|||
164081092|NCT02151461|592661597|FG003|Overall Study|Treatment discontinuation|0|||
164081093|NCT02168270|592661598|FG000|Overall Study|Lack of Efficacy|4|||
164081094|NCT00252187|592661599|FG000|Overall Study|Adverse Event|3|||
164081095|NCT00252187|592661600|FG001|Overall Study|Adverse Event|1|||
164081096|NCT00252187|592661599|FG000|Overall Study|Withdrawal by Subject|1|||
164081097|NCT00252187|592661600|FG001|Overall Study|Withdrawal by Subject|0|||
164081098|NCT00593333|592661601|FG000|Overall Study|Lost to Follow-up|10|||
164081099|NCT00593333|592661602|FG001|Overall Study|Lost to Follow-up|11|||
164081100|NCT01738581|592661603|FG000|Overall Study|Lost to Follow-up|1|||
164081101|NCT01738581|592661604|FG001|Overall Study|Lost to Follow-up|0|||
164081102|NCT02191579|592661611|FG000|Treatment 1|Multiple Reasons Specified|27|||
164081103|NCT02191579|592661612|FG001|Treatment 1|Multiple Reasons Specified|58|||
164081104|NCT02191579|592661611|FG000|Treatment 2|Multiple Reasons Specified|0|||
164081105|NCT02191579|592661612|FG001|Treatment 2|Multiple Reasons Specified|25|||
164081106|NCT02862535|592661613|FG000|Overall Study|Death|7|||
164081107|NCT02862535|592661614|FG001|Overall Study|Death|3|||
164081108|NCT02862535|592661615|FG002|Overall Study|Death|2|||
164081109|NCT02862535|592661616|FG003|Overall Study|Death|5|||
164081110|NCT02862535|592661613|FG000|Overall Study|Study Terminated by Sponsor|1|||
164081111|NCT02862535|592661614|FG001|Overall Study|Study Terminated by Sponsor|3|||
164081112|NCT02862535|592661615|FG002|Overall Study|Study Terminated by Sponsor|8|||
164081113|NCT02862535|592661616|FG003|Overall Study|Study Terminated by Sponsor|5|||
164081114|NCT02862535|592661613|FG000|Overall Study|Enrolled, not Treated|1|||
164081115|NCT02862535|592661614|FG001|Overall Study|Enrolled, not Treated|0|||
164081116|NCT02862535|592661615|FG002|Overall Study|Enrolled, not Treated|0|||
164081117|NCT02862535|592661616|FG003|Overall Study|Enrolled, not Treated|1|||
164081118|NCT02280356|592661617|FG000|Overall Study|Not Treated|2|||
164081119|NCT02280356|592661617|FG000|Overall Study|Withdrawal by Subject|1|||
164081120|NCT02280356|592661617|FG000|Overall Study|Not evaluable|2|||
164081121|NCT01086215|592661621|FG000|Overall Study|Death|14|||
164081122|NCT01086215|592661622|FG001|Overall Study|Death|8|||
164081123|NCT01086215|592661623|FG002|Overall Study|Death|8|||
164081124|NCT01086215|592661624|FG003|Overall Study|Death|1|||
164081125|NCT01086215|592661621|FG000|Overall Study|Lost to Follow-up|22|||
164081126|NCT01086215|592661622|FG001|Overall Study|Lost to Follow-up|39|||
164081127|NCT01086215|592661623|FG002|Overall Study|Lost to Follow-up|18|||
164081128|NCT01086215|592661624|FG003|Overall Study|Lost to Follow-up|2|||
164081129|NCT01965652|592661625|FG000|Overall Study|Adverse Event|40|||
164081130|NCT01965652|592661626|FG001|Overall Study|Adverse Event|37|||
164081131|NCT01965652|592661625|FG000|Overall Study|Withdrawal by Subject|62|||
164081132|NCT01965652|592661626|FG001|Overall Study|Withdrawal by Subject|69|||
164081133|NCT01965652|592661625|FG000|Overall Study|Lost to Follow-up|53|||
164081134|NCT01965652|592661626|FG001|Overall Study|Lost to Follow-up|40|||
164081135|NCT01965652|592661625|FG000|Overall Study|Protocol Violation|34|||
164081136|NCT01965652|592661626|FG001|Overall Study|Protocol Violation|38|||
164081137|NCT01965652|592661625|FG000|Overall Study|Death|3|||
164081138|NCT01965652|592661626|FG001|Overall Study|Death|4|||
164081139|NCT01965652|592661625|FG000|Overall Study|Other - Miscellaneous|18|||
164081140|NCT01965652|592661626|FG001|Overall Study|Other - Miscellaneous|21|||
164081141|NCT01965652|592661625|FG000|Overall Study|Pregnancy|0|||
164081142|NCT01965652|592661626|FG001|Overall Study|Pregnancy|1|||
164081143|NCT01121900|592661631|FG000|First Intervention Period|Adverse Event|1|||
164081144|NCT01121900|592661632|FG001|First Intervention Period|Adverse Event|1|||
164081145|NCT01121900|592661631|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164081146|NCT01121900|592661632|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164081147|NCT03493698|592661633|FG000|Treatment Period C|Adverse Event|1|||
164081148|NCT03493698|592661633|FG000|Treatment Period C|Withdrawal by Subject|1|||
164081149|NCT00408876|592661634|FG000|Overall Study|Adverse Event|9|||
164081150|NCT00408876|592661635|FG001|Overall Study|Adverse Event|17|||
164081151|NCT00408876|592661636|FG002|Overall Study|Adverse Event|27|||
164081152|NCT00408876|592661637|FG003|Overall Study|Adverse Event|10|||
164081153|NCT00408876|592661634|FG000|Overall Study|Withdrawal by Subject|3|||
164081154|NCT00408876|592661635|FG001|Overall Study|Withdrawal by Subject|6|||
164081155|NCT00408876|592661636|FG002|Overall Study|Withdrawal by Subject|6|||
164081156|NCT00408876|592661637|FG003|Overall Study|Withdrawal by Subject|14|||
164081157|NCT00408876|592661634|FG000|Overall Study|Lack of Efficacy|2|||
164081158|NCT00408876|592661635|FG001|Overall Study|Lack of Efficacy|4|||
164081159|NCT00408876|592661636|FG002|Overall Study|Lack of Efficacy|5|||
164081160|NCT00408876|592661637|FG003|Overall Study|Lack of Efficacy|6|||
164081161|NCT00408876|592661634|FG000|Overall Study|Lost to Follow-up|1|||
164081162|NCT00408876|592661635|FG001|Overall Study|Lost to Follow-up|6|||
164081163|NCT00408876|592661636|FG002|Overall Study|Lost to Follow-up|5|||
164081164|NCT00408876|592661637|FG003|Overall Study|Lost to Follow-up|2|||
164081165|NCT00408876|592661634|FG000|Overall Study|Protocol Violation|0|||
164081166|NCT00408876|592661635|FG001|Overall Study|Protocol Violation|3|||
164081167|NCT00408876|592661636|FG002|Overall Study|Protocol Violation|4|||
164081168|NCT00408876|592661637|FG003|Overall Study|Protocol Violation|3|||
164081169|NCT00408876|592661634|FG000|Overall Study|Physician Decision|1|||
164081170|NCT00408876|592661635|FG001|Overall Study|Physician Decision|0|||
164081171|NCT00408876|592661636|FG002|Overall Study|Physician Decision|3|||
164081172|NCT00408876|592661637|FG003|Overall Study|Physician Decision|0|||
164081173|NCT00291330|592661638|FG000|Overall Study|Adverse Event|47|||
164081174|NCT00291330|592661639|FG001|Overall Study|Adverse Event|40|||
164081175|NCT00291330|592661638|FG000|Overall Study|Protocol Violation|13|||
164081176|NCT00291330|592661639|FG001|Overall Study|Protocol Violation|20|||
164081177|NCT00291330|592661638|FG000|Overall Study|Lost to Follow-up|16|||
164081178|NCT00291330|592661639|FG001|Overall Study|Lost to Follow-up|11|||
164081179|NCT00291330|592661638|FG000|Overall Study|Withdrawal by Subject|22|||
164081180|NCT00291330|592661639|FG001|Overall Study|Withdrawal by Subject|25|||
164081181|NCT00291330|592661638|FG000|Overall Study|Other|3|||
164081182|NCT00291330|592661639|FG001|Overall Study|Other|1|||
164081183|NCT00566709|592661640|FG000|Overall Study|Protocol Violation|5|||
164081184|NCT00566709|592661641|FG001|Overall Study|Protocol Violation|0|||
164081185|NCT03443869|592661642|FG000|Overall Study|Death|3|||
164081186|NCT03443869|592661643|FG001|Overall Study|Death|3|||
164081187|NCT03443869|592661642|FG000|Overall Study|Withdrawal by Subject|34|||
164081188|NCT03443869|592661643|FG001|Overall Study|Withdrawal by Subject|22|||
164081189|NCT03443869|592661642|FG000|Overall Study|Lost to Follow-up|1|||
164081190|NCT03443869|592661643|FG001|Overall Study|Lost to Follow-up|2|||
164081191|NCT03443869|592661642|FG000|Overall Study|Physician Decision|3|||
164081192|NCT03443869|592661643|FG001|Overall Study|Physician Decision|3|||
164081193|NCT03443869|592661642|FG000|Overall Study|Other|4|||
164081194|NCT03443869|592661643|FG001|Overall Study|Other|4|||
164081195|NCT02390219|592661644|FG000|Overall Study|Death|1|||
164081196|NCT02390219|592661644|FG000|Overall Study|Physician Decision|1|||
164081197|NCT02390219|592661644|FG000|Overall Study|Adverse Event|6|||
164081198|NCT02390219|592661644|FG000|Overall Study|Withdrawal by Subject|1|||
164081199|NCT02390219|592661644|FG000|Overall Study|Lost to Follow-up|2|||
164081200|NCT02390219|592661644|FG000|Overall Study|Other|2|||
164081201|NCT00299728|592661645|FG000|Overall Study|Lost to Follow-up|0|||
164081202|NCT00299728|592661646|FG001|Overall Study|Lost to Follow-up|1|||
164081203|NCT00299728|592661645|FG000|Overall Study|Withdrawal by Subject|0|||
164081204|NCT00299728|592661646|FG001|Overall Study|Withdrawal by Subject|1|||
164081205|NCT00299728|592661645|FG000|Overall Study|Progressive disease|0|||
164081206|NCT00299728|592661646|FG001|Overall Study|Progressive disease|1|||
164081207|NCT00931385|592661650|FG000|Overall Study|Adverse Event|2|||
164081208|NCT00931385|592661651|FG001|Overall Study|Adverse Event|1|||
164081209|NCT00931385|592661652|FG002|Overall Study|Adverse Event|0|||
164081210|NCT00931385|592661653|FG003|Overall Study|Adverse Event|3|||
164081211|NCT00931385|592661650|FG000|Overall Study|Protocol Violation|0|||
164081212|NCT00931385|592661651|FG001|Overall Study|Protocol Violation|0|||
164081213|NCT00931385|592661652|FG002|Overall Study|Protocol Violation|1|||
164081214|NCT00931385|592661653|FG003|Overall Study|Protocol Violation|0|||
164081215|NCT00931385|592661650|FG000|Overall Study|Withdrawal by Subject|0|||
164081216|NCT00931385|592661651|FG001|Overall Study|Withdrawal by Subject|1|||
164081217|NCT00931385|592661652|FG002|Overall Study|Withdrawal by Subject|0|||
164081218|NCT00931385|592661653|FG003|Overall Study|Withdrawal by Subject|1|||
164081219|NCT00931385|592661650|FG000|Overall Study|Lost to Follow-up|0|||
164081220|NCT00931385|592661651|FG001|Overall Study|Lost to Follow-up|0|||
164081221|NCT00931385|592661652|FG002|Overall Study|Lost to Follow-up|0|||
164081222|NCT00931385|592661653|FG003|Overall Study|Lost to Follow-up|1|||
164081223|NCT02230085|592661656|FG000|Overall Study|Physician Decision|1|||
164081224|NCT02230085|592661656|FG000|Overall Study|Withdrawal by Subject|3|||
164081225|NCT00580983|592661657|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
164081226|NCT01360632|592661658|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
164081227|NCT01360632|592661659|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
164081228|NCT01360632|592661660|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
164081229|NCT01360632|592661661|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
164081230|NCT01360632|592661662|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
164081231|NCT01360632|592661658|FG000|Phase A (8 Weeks)|Adverse Event|60|||
164081232|NCT01360632|592661659|FG001|Phase A (8 Weeks)|Adverse Event|0|||
164081233|NCT01360632|592661660|FG002|Phase A (8 Weeks)|Adverse Event|0|||
164081234|NCT01360632|592661661|FG003|Phase A (8 Weeks)|Adverse Event|0|||
164081235|NCT01360632|592661662|FG004|Phase A (8 Weeks)|Adverse Event|0|||
164081236|NCT01360632|592661658|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
164081237|NCT01360632|592661659|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164081238|NCT01360632|592661660|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164081239|NCT01360632|592661661|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164081240|NCT01360632|592661662|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
164081241|NCT01360632|592661658|FG000|Phase A (8 Weeks)|Physician Decision|10|||
164081242|NCT01360632|592661659|FG001|Phase A (8 Weeks)|Physician Decision|0|||
164081243|NCT01360632|592661660|FG002|Phase A (8 Weeks)|Physician Decision|0|||
164081244|NCT01360632|592661661|FG003|Phase A (8 Weeks)|Physician Decision|0|||
164081245|NCT01360632|592661662|FG004|Phase A (8 Weeks)|Physician Decision|0|||
164081246|NCT01360632|592661658|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
164081247|NCT01360632|592661659|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164081248|NCT01360632|592661660|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164081249|NCT01360632|592661661|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164081250|NCT01360632|592661662|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
164081251|NCT01360632|592661658|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
164081252|NCT01360632|592661659|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
164081253|NCT01360632|592661660|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
164081254|NCT01360632|592661661|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
164081255|NCT01360632|592661662|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
164081256|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
164081257|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
164081258|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
164081259|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
164081260|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
164081261|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Adverse Event|0|||
164081262|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Adverse Event|3|||
164081263|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Adverse Event|9|||
164081264|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Adverse Event|3|||
164081265|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Adverse Event|0|||
164081266|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164081267|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164081268|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
164081269|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
164081270|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
164081271|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Physician Decision|0|||
164081272|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Physician Decision|0|||
164081273|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Physician Decision|0|||
164081274|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Physician Decision|1|||
164081275|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Physician Decision|0|||
164081276|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
164081277|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
164081278|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
164081279|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
164081280|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
164081281|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
164081282|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
164081283|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
164081284|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
164081285|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
164081286|NCT01360632|592661658|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
164081287|NCT01360632|592661659|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
164081288|NCT01360632|592661660|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
164081289|NCT01360632|592661661|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
164081290|NCT01360632|592661662|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
164081291|NCT01360632|592661658|FG000|Phase A+|Lost to Follow-up|0|||
164081292|NCT01360632|592661659|FG001|Phase A+|Lost to Follow-up|0|||
164081293|NCT01360632|592661660|FG002|Phase A+|Lost to Follow-up|0|||
164081294|NCT01360632|592661661|FG003|Phase A+|Lost to Follow-up|0|||
164081295|NCT01360632|592661662|FG004|Phase A+|Lost to Follow-up|2|||
164081296|NCT01360632|592661658|FG000|Phase A+|Adverse Event|0|||
164081297|NCT01360632|592661659|FG001|Phase A+|Adverse Event|0|||
164081298|NCT01360632|592661660|FG002|Phase A+|Adverse Event|0|||
164081299|NCT01360632|592661661|FG003|Phase A+|Adverse Event|0|||
164081300|NCT01360632|592661662|FG004|Phase A+|Adverse Event|2|||
164081301|NCT01360632|592661658|FG000|Phase A+|Met Withdrawal Criteria|0|||
164081302|NCT01360632|592661659|FG001|Phase A+|Met Withdrawal Criteria|0|||
164081303|NCT01360632|592661660|FG002|Phase A+|Met Withdrawal Criteria|0|||
164081304|NCT01360632|592661661|FG003|Phase A+|Met Withdrawal Criteria|0|||
164224875|NCT02402907|593192146|FG000|Overall Study|Lost to follow up after C-Section|10|||
164224876|NCT02402907|593192147|FG001|Overall Study|Lost to follow up after C-Section|23|||
164081305|NCT01360632|592661662|FG004|Phase A+|Met Withdrawal Criteria|7|||
164081306|NCT01360632|592661658|FG000|Phase A+|Physician Decision|0|||
164081307|NCT01360632|592661659|FG001|Phase A+|Physician Decision|0|||
164081308|NCT01360632|592661660|FG002|Phase A+|Physician Decision|0|||
164081309|NCT01360632|592661661|FG003|Phase A+|Physician Decision|0|||
164081310|NCT01360632|592661662|FG004|Phase A+|Physician Decision|3|||
164081311|NCT01360632|592661658|FG000|Phase A+|Withdrawal by Subject|0|||
164081312|NCT01360632|592661659|FG001|Phase A+|Withdrawal by Subject|0|||
164081313|NCT01360632|592661660|FG002|Phase A+|Withdrawal by Subject|0|||
164081314|NCT01360632|592661661|FG003|Phase A+|Withdrawal by Subject|0|||
164081315|NCT01360632|592661662|FG004|Phase A+|Withdrawal by Subject|8|||
164081316|NCT01360632|592661658|FG000|Phase A+|Protocol Deviation|0|||
164081317|NCT01360632|592661659|FG001|Phase A+|Protocol Deviation|0|||
164081318|NCT01360632|592661660|FG002|Phase A+|Protocol Deviation|0|||
164081319|NCT01360632|592661661|FG003|Phase A+|Protocol Deviation|0|||
164081320|NCT01360632|592661662|FG004|Phase A+|Protocol Deviation|3|||
163881148|NCT03665597|591933497|FG001|Period 1|Death|0|||
163881149|NCT03665597|591933498|FG002|Period 1|Death|0|||
163881150|NCT03665597|591933499|FG003|Period 1|Death|0|||
163881151|NCT03665597|591933500|FG004|Period 1|Death|0|||
163881152|NCT03665597|591933501|FG005|Period 1|Death|0|||
163881153|NCT03665597|591933502|FG006|Period 1|Death|45|||
163881154|NCT03665597|591933496|FG000|Period 1|Withdrawal by Subject|0|||
163881155|NCT03665597|591933497|FG001|Period 1|Withdrawal by Subject|0|||
163881156|NCT03665597|591933498|FG002|Period 1|Withdrawal by Subject|0|||
163881157|NCT03665597|591933499|FG003|Period 1|Withdrawal by Subject|0|||
163881158|NCT03665597|591933500|FG004|Period 1|Withdrawal by Subject|0|||
163881159|NCT03665597|591933501|FG005|Period 1|Withdrawal by Subject|0|||
163881160|NCT03665597|591933502|FG006|Period 1|Withdrawal by Subject|5|||
163881161|NCT03665597|591933496|FG000|Period 2|Adverse Event|0|||
163881162|NCT03665597|591933497|FG001|Period 2|Adverse Event|0|||
163881163|NCT03665597|591933498|FG002|Period 2|Adverse Event|0|||
163881164|NCT03665597|591933499|FG003|Period 2|Adverse Event|0|||
163881165|NCT03665597|591933500|FG004|Period 2|Adverse Event|0|||
163881166|NCT03665597|591933501|FG005|Period 2|Adverse Event|1|||
163881167|NCT03665597|591933502|FG006|Period 2|Adverse Event|0|||
163881168|NCT03665597|591933496|FG000|Period 3|Adverse Event|0|||
163881169|NCT03665597|591933497|FG001|Period 3|Adverse Event|1|||
163881170|NCT03665597|591933498|FG002|Period 3|Adverse Event|0|||
163881171|NCT03665597|591933499|FG003|Period 3|Adverse Event|0|||
163881172|NCT03665597|591933500|FG004|Period 3|Adverse Event|0|||
163881173|NCT03665597|591933501|FG005|Period 3|Adverse Event|0|||
163881174|NCT03665597|591933502|FG006|Period 3|Adverse Event|0|||
163881175|NCT03665597|591933496|FG000|Period 3|Death|0|||
163881176|NCT03665597|591933497|FG001|Period 3|Death|0|||
163881177|NCT03665597|591933498|FG002|Period 3|Death|0|||
163881178|NCT03665597|591933499|FG003|Period 3|Death|0|||
163881179|NCT03665597|591933500|FG004|Period 3|Death|1|||
163881180|NCT03665597|591933501|FG005|Period 3|Death|0|||
163881181|NCT03665597|591933502|FG006|Period 3|Death|0|||
163881182|NCT03665597|591933496|FG000|Period 4|Adverse Event|2|||
163881183|NCT03665597|591933497|FG001|Period 4|Adverse Event|2|||
163881184|NCT03665597|591933498|FG002|Period 4|Adverse Event|2|||
163881185|NCT03665597|591933499|FG003|Period 4|Adverse Event|2|||
163881186|NCT03665597|591933500|FG004|Period 4|Adverse Event|1|||
163881187|NCT03665597|591933501|FG005|Period 4|Adverse Event|0|||
163881188|NCT03665597|591933502|FG006|Period 4|Adverse Event|0|||
163881189|NCT03665597|591933496|FG000|Period 4|Death|0|||
163881190|NCT03665597|591933497|FG001|Period 4|Death|0|||
163881191|NCT03665597|591933498|FG002|Period 4|Death|2|||
163881192|NCT03665597|591933499|FG003|Period 4|Death|0|||
163881193|NCT03665597|591933500|FG004|Period 4|Death|0|||
163881194|NCT03665597|591933501|FG005|Period 4|Death|0|||
163881195|NCT03665597|591933502|FG006|Period 4|Death|0|||
163881196|NCT03665597|591933496|FG000|Period 4|Physician Decision|1|||
163881197|NCT03665597|591933497|FG001|Period 4|Physician Decision|2|||
163881198|NCT03665597|591933498|FG002|Period 4|Physician Decision|0|||
163881199|NCT03665597|591933499|FG003|Period 4|Physician Decision|0|||
163881200|NCT03665597|591933500|FG004|Period 4|Physician Decision|0|||
163881201|NCT03665597|591933501|FG005|Period 4|Physician Decision|0|||
163881202|NCT03665597|591933502|FG006|Period 4|Physician Decision|0|||
163881203|NCT05516147|591933503|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
163881204|NCT04450342|591933505|FG000|Overall Study|Adverse Event|1|||
163881205|NCT04450342|591933506|FG001|Overall Study|Adverse Event|1|||
163881206|NCT04450342|591933507|FG002|Overall Study|Adverse Event|0|||
163881207|NCT04450342|591933505|FG000|Overall Study|Device not used|1|||
163881208|NCT04450342|591933506|FG001|Overall Study|Device not used|0|||
163881209|NCT04450342|591933507|FG002|Overall Study|Device not used|0|||
163881210|NCT04450342|591933505|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
163881211|NCT04450342|591933506|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
163881212|NCT04450342|591933507|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
163881213|NCT04450342|591933505|FG000|Overall Study|Physician Decision|1|||
163881214|NCT04450342|591933506|FG001|Overall Study|Physician Decision|0|||
163881215|NCT04450342|591933507|FG002|Overall Study|Physician Decision|1|||
163881216|NCT04450342|591933505|FG000|Overall Study|Protocol Deviation|0|||
163881217|NCT04450342|591933506|FG001|Overall Study|Protocol Deviation|1|||
163881218|NCT04450342|591933507|FG002|Overall Study|Protocol Deviation|0|||
163881219|NCT04450342|591933505|FG000|Overall Study|Reoperation|1|||
163881220|NCT04450342|591933506|FG001|Overall Study|Reoperation|1|||
163881221|NCT04450342|591933507|FG002|Overall Study|Reoperation|0|||
163881222|NCT04450342|591933505|FG000|Overall Study|Screen Failures|0|||
163881223|NCT04450342|591933506|FG001|Overall Study|Screen Failures|0|||
163881224|NCT04450342|591933507|FG002|Overall Study|Screen Failures|2|||
163881225|NCT04450342|591933505|FG000|Overall Study|Site Terminated by Sponsor|1|||
163881226|NCT04450342|591933506|FG001|Overall Study|Site Terminated by Sponsor|1|||
163881227|NCT04450342|591933507|FG002|Overall Study|Site Terminated by Sponsor|1|||
163881228|NCT04450342|591933505|FG000|Overall Study|Study Terminated by Sponsor|31|||
163881229|NCT04450342|591933506|FG001|Overall Study|Study Terminated by Sponsor|29|||
163881230|NCT04450342|591933507|FG002|Overall Study|Study Terminated by Sponsor|6|||
163881231|NCT04450342|591933505|FG000|Overall Study|Withdrawal by Subject|0|||
164081321|NCT00811070|592661663|FG000|Overall Study|Death|0|||
164081322|NCT00811070|592661664|FG001|Overall Study|Death|0|||
164081323|NCT00811070|592661665|FG002|Overall Study|Death|0|||
164081324|NCT00811070|592661666|FG003|Overall Study|Death|2|||
164081325|NCT00811070|592661667|FG004|Overall Study|Death|5|||
164081326|NCT00811070|592661668|FG005|Overall Study|Death|0|||
164081327|NCT00811070|592661663|FG000|Overall Study|Other|1|||
164081328|NCT00811070|592661664|FG001|Overall Study|Other|0|||
164081329|NCT00811070|592661665|FG002|Overall Study|Other|0|||
164081330|NCT00811070|592661666|FG003|Overall Study|Other|0|||
164081331|NCT00811070|592661667|FG004|Overall Study|Other|0|||
164081332|NCT00811070|592661668|FG005|Overall Study|Other|0|||
164081333|NCT00811070|592661663|FG000|Overall Study|Withdrawal by Subject|0|||
164081334|NCT00811070|592661664|FG001|Overall Study|Withdrawal by Subject|1|||
164081335|NCT00811070|592661665|FG002|Overall Study|Withdrawal by Subject|0|||
164081336|NCT00811070|592661666|FG003|Overall Study|Withdrawal by Subject|0|||
164081337|NCT00811070|592661667|FG004|Overall Study|Withdrawal by Subject|0|||
164081338|NCT00811070|592661668|FG005|Overall Study|Withdrawal by Subject|0|||
164081339|NCT00811070|592661663|FG000|Overall Study|Physician Decision|0|||
164081340|NCT00811070|592661664|FG001|Overall Study|Physician Decision|0|||
164081341|NCT00811070|592661665|FG002|Overall Study|Physician Decision|0|||
164081342|NCT00811070|592661666|FG003|Overall Study|Physician Decision|0|||
164081343|NCT00811070|592661667|FG004|Overall Study|Physician Decision|0|||
164081344|NCT00811070|592661668|FG005|Overall Study|Physician Decision|1|||
164081345|NCT00665626|592661671|FG000|Overall Study|Lack of Efficacy|8|||
164081346|NCT00665626|592661672|FG001|Overall Study|Lack of Efficacy|5|||
164081347|NCT00665626|592661671|FG000|Overall Study|Lost to Follow-up|0|||
164081348|NCT00665626|592661672|FG001|Overall Study|Lost to Follow-up|2|||
164081349|NCT00665626|592661671|FG000|Overall Study|Withdrawal by Subject|0|||
164081350|NCT00665626|592661672|FG001|Overall Study|Withdrawal by Subject|1|||
164081351|NCT00665626|592661671|FG000|Overall Study|Protocol Violation|0|||
164081352|NCT00665626|592661672|FG001|Overall Study|Protocol Violation|2|||
164081353|NCT00665626|592661671|FG000|Overall Study|Adverse Event|1|||
164081354|NCT00665626|592661672|FG001|Overall Study|Adverse Event|9|||
164081355|NCT00665626|592661671|FG000|Overall Study|Due to exclusion criteria|0|||
164081356|NCT00665626|592661672|FG001|Overall Study|Due to exclusion criteria|1|||
164081357|NCT00665626|592661671|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
164081358|NCT00665626|592661672|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
164081359|NCT00665626|592661671|FG000|Overall Study|Unably to comply with dosing regimen|0|||
164081360|NCT00665626|592661672|FG001|Overall Study|Unably to comply with dosing regimen|1|||
164081361|NCT00665626|592661671|FG000|Overall Study|Death|1|||
164081362|NCT00665626|592661672|FG001|Overall Study|Death|0|||
164081363|NCT02046369|592661673|FG000|Overall Study|Adverse Event|3|||
164081364|NCT02046369|592661674|FG001|Overall Study|Adverse Event|3|||
164081365|NCT02046369|592661673|FG000|Overall Study|Lack of Efficacy|3|||
164081366|NCT02046369|592661674|FG001|Overall Study|Lack of Efficacy|3|||
164081367|NCT02046369|592661673|FG000|Overall Study|Lost to Follow-up|3|||
164081368|NCT02046369|592661674|FG001|Overall Study|Lost to Follow-up|3|||
164081369|NCT02046369|592661673|FG000|Overall Study|Protocol Violation|1|||
164081370|NCT02046369|592661674|FG001|Overall Study|Protocol Violation|2|||
164081371|NCT02046369|592661673|FG000|Overall Study|Withdrawal by Subject|3|||
164081372|NCT02046369|592661674|FG001|Overall Study|Withdrawal by Subject|6|||
164081373|NCT02046369|592661673|FG000|Overall Study|never received study drug|0|||
164081374|NCT02046369|592661674|FG001|Overall Study|never received study drug|1|||
164081375|NCT02046369|592661673|FG000|Overall Study|non compliance|1|||
164081376|NCT02046369|592661674|FG001|Overall Study|non compliance|0|||
164081377|NCT03120520|592661675|FG000|Overall Study|Lost to Follow-up|1|||
164081378|NCT03120520|592661676|FG001|Overall Study|Lost to Follow-up|1|||
164081379|NCT03120520|592661677|FG002|Overall Study|Lost to Follow-up|1|||
164081380|NCT03120520|592661678|FG003|Overall Study|Lost to Follow-up|1|||
164081381|NCT03120520|592661675|FG000|Overall Study|Withdrawal by Subject|3|||
164081382|NCT03120520|592661676|FG001|Overall Study|Withdrawal by Subject|2|||
164081383|NCT03120520|592661677|FG002|Overall Study|Withdrawal by Subject|3|||
164081384|NCT03120520|592661678|FG003|Overall Study|Withdrawal by Subject|2|||
164081385|NCT03120520|592661675|FG000|Overall Study|Other|0|||
164081386|NCT03120520|592661676|FG001|Overall Study|Other|1|||
164081387|NCT03120520|592661677|FG002|Overall Study|Other|0|||
164081388|NCT03120520|592661678|FG003|Overall Study|Other|0|||
164081389|NCT04345471|592661680|FG000|Overall Study|Adverse Event|8|||
164081390|NCT04345471|592661681|FG001|Overall Study|Adverse Event|5|||
164081391|NCT04345471|592661682|FG002|Overall Study|Adverse Event|6|||
164081392|NCT04345471|592661680|FG000|Overall Study|Lack of Efficacy|1|||
164081393|NCT04345471|592661681|FG001|Overall Study|Lack of Efficacy|1|||
164081394|NCT04345471|592661682|FG002|Overall Study|Lack of Efficacy|0|||
164081395|NCT04345471|592661680|FG000|Overall Study|Protocol Violation|0|||
164081396|NCT04345471|592661681|FG001|Overall Study|Protocol Violation|1|||
164081397|NCT04345471|592661682|FG002|Overall Study|Protocol Violation|2|||
164081398|NCT04345471|592661680|FG000|Overall Study|Withdrawal by Subject|10|||
164081399|NCT04345471|592661681|FG001|Overall Study|Withdrawal by Subject|5|||
164081400|NCT04345471|592661682|FG002|Overall Study|Withdrawal by Subject|10|||
163985560|NCT01882907|592316200|FG001|Overall Study|Withdrawal by Subject|6|||
163985561|NCT03124784|592316205|FG000|Overall Study|Adverse Event|1|||
163985562|NCT03124784|592316205|FG000|Overall Study|Computer/Equip Malfunction|1|||
163985563|NCT02162732|592316206|FG000|Overall Study|Biopsy not performed.|18|||
163985564|NCT01784965|592316207|FG000|Overall Study|Withdrawal by Subject|6|||
163985565|NCT01784965|592316208|FG001|Overall Study|Withdrawal by Subject|3|||
163985566|NCT01784965|592316207|FG000|Overall Study|Adverse Event|0|||
163985567|NCT01784965|592316208|FG001|Overall Study|Adverse Event|8|||
163985568|NCT03757988|592316211|FG000|Overall Study|Withdrawal by Subject|1|||
163985569|NCT02450487|592316214|FG000|Overall Study|Lost to Follow-up|3|||
163985570|NCT04269395|592316215|FG000|Overall Study|Lost to Follow-up|1|||
163985571|NCT04269395|592316216|FG001|Overall Study|Lost to Follow-up|0|||
163985572|NCT04269395|592316215|FG000|Overall Study|Study terminated by Sponsor|13|||
163985573|NCT04269395|592316216|FG001|Overall Study|Study terminated by Sponsor|10|||
163985574|NCT05587296|592316217|FG000|Overall Study|Adverse Event|15|||
163985575|NCT05587296|592316218|FG001|Overall Study|Adverse Event|7|||
163985576|NCT05587296|592316217|FG000|Overall Study|Lack of Efficacy|2|||
163985577|NCT05587296|592316218|FG001|Overall Study|Lack of Efficacy|0|||
163985578|NCT05587296|592316217|FG000|Overall Study|Lost to Follow-up|1|||
163985579|NCT05587296|592316218|FG001|Overall Study|Lost to Follow-up|0|||
163985580|NCT05587296|592316217|FG000|Overall Study|Withdrawal by Subject|14|||
163985581|NCT05587296|592316218|FG001|Overall Study|Withdrawal by Subject|4|||
163985582|NCT05587296|592316217|FG000|Overall Study|miscellaneous|3|||
163985583|NCT05587296|592316218|FG001|Overall Study|miscellaneous|6|||
163985584|NCT05587296|592316217|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
163985585|NCT05587296|592316218|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
163985586|NCT02847624|592316221|FG000|Overall Study|Lost to Follow-up|28|||
163985587|NCT02847624|592316221|FG000|Overall Study|Protocol Violation|98|||
163985588|NCT02847624|592316221|FG000|Overall Study|Case report failures|4|||
163985589|NCT04735653|592316222|FG000|Overall Study|Lost to Follow-up|17|||
163985590|NCT04735653|592316223|FG001|Overall Study|Lost to Follow-up|7|||
163985591|NCT04735653|592316222|FG000|Overall Study|Withdrawal by Subject|8|||
163985592|NCT04735653|592316223|FG001|Overall Study|Withdrawal by Subject|2|||
163985593|NCT04735653|592316222|FG000|Overall Study|Death|0|||
163985594|NCT04735653|592316223|FG001|Overall Study|Death|2|||
163985595|NCT04735653|592316222|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
163985596|NCT04735653|592316223|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
163985597|NCT04161495|592316229|FG000|Overall Study|Withdrawal by Subject|3|||
163985598|NCT04161495|592316230|FG001|Overall Study|Withdrawal by Subject|0|||
163985599|NCT04161495|592316229|FG000|Overall Study|Protocol Violation|1|||
163985600|NCT04161495|592316230|FG001|Overall Study|Protocol Violation|0|||
163985601|NCT04161495|592316229|FG000|Overall Study|Prohibited concomitant medication|3|||
163985602|NCT04161495|592316230|FG001|Overall Study|Prohibited concomitant medication|0|||
163985603|NCT04161495|592316229|FG000|Overall Study|Adverse Event|1|||
163985604|NCT04161495|592316230|FG001|Overall Study|Adverse Event|0|||
163985605|NCT04161495|592316229|FG000|Overall Study|Other - Unspecified|1|||
163985606|NCT04161495|592316230|FG001|Overall Study|Other - Unspecified|0|||
163985607|NCT04161495|592316229|FG000|Overall Study|Death|0|||
163985608|NCT04161495|592316230|FG001|Overall Study|Death|1|||
163985609|NCT00252057|592316233|FG000|Overall Study|Withdrawal by Subject|2|||
163985610|NCT00252057|592316234|FG001|Overall Study|Withdrawal by Subject|5|||
163985611|NCT00252057|592316233|FG000|Overall Study|Death|1|||
163985612|NCT00252057|592316234|FG001|Overall Study|Death|2|||
163985613|NCT00252057|592316233|FG000|Overall Study|Participant previously enrolled|0|||
163985614|NCT00252057|592316234|FG001|Overall Study|Participant previously enrolled|1|||
163985615|NCT02926209|592316235|FG000|Study Cohort|Poor Bowel Preparation|1|||
163985616|NCT02926209|592316236|FG001|Study Cohort|Poor Bowel Preparation|0|||
163985617|NCT00429858|592316237|FG000|Overall Study|Withdrawal by Subject|1|||
163985618|NCT00429858|592316237|FG000|Overall Study|Study Termination|1|||
163985619|NCT01587079|592316238|FG000|Overall Study|Protocol-specified criteria|9|||
163985620|NCT01587079|592316238|FG000|Overall Study|Protocol Violation|5|||
163985621|NCT01587079|592316238|FG000|Overall Study|Lost to Follow-up|2|||
163985622|NCT01587079|592316238|FG000|Overall Study|Physician Decision|2|||
163985623|NCT01587079|592316238|FG000|Overall Study|Withdrawal by Subject|7|||
163985624|NCT01587079|592316238|FG000|Overall Study|Adverse Event|14|||
163985625|NCT01764633|592316239|FG000|Overall Study|Withdrawal by Subject|105|||
163985626|NCT01764633|592316240|FG001|Overall Study|Withdrawal by Subject|88|||
163985627|NCT01764633|592316239|FG000|Overall Study|Lost to Follow-up|13|||
163985628|NCT01764633|592316240|FG001|Overall Study|Lost to Follow-up|5|||
163985629|NCT02268058|592316241|FG000|Overall Study|Protocol Violation|1|||
163985630|NCT02268058|592316242|FG001|Overall Study|Protocol Violation|0|||
163985631|NCT02268058|592316243|FG002|Overall Study|Protocol Violation|0|||
163985632|NCT02268058|592316244|FG003|Overall Study|Protocol Violation|0|||
163985633|NCT04142983|592316245|FG000|Overall Study|Lost to Follow-up|73|||
163985634|NCT04142983|592316245|FG000|Overall Study|Withdrawal by Subject|10|||
163985635|NCT04142983|592316245|FG000|Overall Study|Physician Decision|1|||
163985636|NCT04142983|592316245|FG000|Overall Study|Adverse Event|1|||
164081401|NCT01025193|592661683|FG000|Overall Study|Protocol Violation|1|||
164081402|NCT01025193|592661683|FG000|Overall Study|Adverse Event|3|||
164081403|NCT02378506|592661688|FG000|Overall Study|Lack of Efficacy|3|||
164081404|NCT02378506|592661688|FG000|Overall Study|Withdrawal by Subject|4|||
164081405|NCT02378506|592661688|FG000|Overall Study|Protocol Violation|2|||
164081406|NCT02378506|592661688|FG000|Overall Study|Death|1|||
164081407|NCT02378506|592661688|FG000|Overall Study|Adverse Event|14|||
164081408|NCT02378506|592661688|FG000|Overall Study|Randomized But Not Treated|1|||
164081409|NCT00433381|592663215|FG000|Overall Study|Ineligible / no protocol treatment|3|||
164081410|NCT00433381|592663216|FG001|Overall Study|Ineligible / no protocol treatment|3|||
164081411|NCT01387282|592663217|FG000|Overall Study|Death|47|||
164081412|NCT01387282|592663218|FG001|Overall Study|Death|16|||
164081413|NCT01387282|592663217|FG000|Overall Study|Other|5|||
164081414|NCT01387282|592663218|FG001|Overall Study|Other|1|||
164081415|NCT01387282|592663217|FG000|Overall Study|Unrelated AE|6|||
164081416|NCT01387282|592663218|FG001|Overall Study|Unrelated AE|4|||
164081417|NCT01387282|592663217|FG000|Overall Study|Withdrawal by patient|33|||
164081418|NCT01387282|592663218|FG001|Overall Study|Withdrawal by patient|23|||
164081419|NCT01387282|592663217|FG000|Overall Study|Study drug-related AE|2|||
164081420|NCT01387282|592663218|FG001|Overall Study|Study drug-related AE|2|||
164081421|NCT01387282|592663217|FG000|Overall Study|Lost to Follow-up|4|||
164081422|NCT01387282|592663218|FG001|Overall Study|Lost to Follow-up|1|||
164081423|NCT04582266|592663219|FG000|Overall Study|Lost to Follow-up|7|||
164081424|NCT04582266|592663220|FG001|Overall Study|Lost to Follow-up|5|||
164081425|NCT04582266|592663219|FG000|Overall Study|Withdrawal by Subject|1|||
164081426|NCT04582266|592663220|FG001|Overall Study|Withdrawal by Subject|0|||
164081427|NCT04582266|592663219|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
164081428|NCT04582266|592663220|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
164081429|NCT01034137|592663228|FG000|Overall Study|Adverse Event|9|||
164081430|NCT01034137|592663229|FG001|Overall Study|Adverse Event|10|||
164081431|NCT01034137|592663230|FG002|Overall Study|Adverse Event|8|||
164081432|NCT01034137|592663228|FG000|Overall Study|Withdrawal by Subject|4|||
164081433|NCT01034137|592663229|FG001|Overall Study|Withdrawal by Subject|3|||
164081434|NCT01034137|592663230|FG002|Overall Study|Withdrawal by Subject|3|||
164081435|NCT01034137|592663228|FG000|Overall Study|Lack of Efficacy|9|||
164081436|NCT01034137|592663229|FG001|Overall Study|Lack of Efficacy|4|||
164081437|NCT01034137|592663230|FG002|Overall Study|Lack of Efficacy|13|||
164081438|NCT01034137|592663228|FG000|Overall Study|Protocol Violation|2|||
164081439|NCT01034137|592663229|FG001|Overall Study|Protocol Violation|2|||
164081440|NCT01034137|592663230|FG002|Overall Study|Protocol Violation|1|||
163881232|NCT04450342|591933506|FG001|Overall Study|Withdrawal by Subject|1|||
163881233|NCT04450342|591933507|FG002|Overall Study|Withdrawal by Subject|2|||
163881234|NCT02874534|591933508|FG000|Overall Study|Withdrawal by Subject|5|||
163881235|NCT02874534|591933509|FG001|Overall Study|Withdrawal by Subject|8|||
163881236|NCT02874534|591933508|FG000|Overall Study|Lost to Follow-up|2|||
163881237|NCT02874534|591933509|FG001|Overall Study|Lost to Follow-up|2|||
163881238|NCT02874534|591933508|FG000|Overall Study|Ongoing in study|1|||
163881239|NCT02874534|591933509|FG001|Overall Study|Ongoing in study|1|||
163881240|NCT03941860|591933513|FG000|Overall Study|Withdrawal by Subject|0|||
163881241|NCT03941860|591933514|FG001|Overall Study|Withdrawal by Subject|1|||
163881242|NCT04093752|591933515|FG000|Overall Study|Adverse Event|7|||
163881243|NCT04093752|591933516|FG001|Overall Study|Adverse Event|19|||
163881244|NCT04093752|591933517|FG002|Overall Study|Adverse Event|18|||
163881245|NCT04093752|591933518|FG003|Overall Study|Adverse Event|4|||
163881246|NCT04093752|591933515|FG000|Overall Study|Withdrawal by Subject|6|||
163881247|NCT04093752|591933516|FG001|Overall Study|Withdrawal by Subject|6|||
163881248|NCT04093752|591933517|FG002|Overall Study|Withdrawal by Subject|8|||
163881249|NCT04093752|591933518|FG003|Overall Study|Withdrawal by Subject|20|||
163881250|NCT04093752|591933515|FG000|Overall Study|Lost to Follow-up|2|||
163881251|NCT04093752|591933516|FG001|Overall Study|Lost to Follow-up|1|||
163881252|NCT04093752|591933517|FG002|Overall Study|Lost to Follow-up|1|||
164081441|NCT01034137|592663228|FG000|Overall Study|Refused treatment or did not cooperate|2|||
164081442|NCT01034137|592663229|FG001|Overall Study|Refused treatment or did not cooperate|0|||
164081443|NCT01034137|592663230|FG002|Overall Study|Refused treatment or did not cooperate|1|||
164081444|NCT01034137|592663228|FG000|Overall Study|Administrative or other|2|||
164081445|NCT01034137|592663229|FG001|Overall Study|Administrative or other|3|||
164081446|NCT01034137|592663230|FG002|Overall Study|Administrative or other|4|||
164081447|NCT01466686|592663231|FG000|Overall Study|Withdrawal by Subject|1|||
164329150|NCT01397201|593583237|FG000|Overall Study|Not yet defined|3|||
163881253|NCT04093752|591933518|FG003|Overall Study|Lost to Follow-up|1|||
163881254|NCT04093752|591933515|FG000|Overall Study|Death|0|||
163881255|NCT04093752|591933516|FG001|Overall Study|Death|0|||
164081448|NCT02049359|592663232|FG000|Overall Study|Lost to Follow-up|26|||
164081449|NCT02049359|592663233|FG001|Overall Study|Lost to Follow-up|19|||
164081450|NCT00658320|592663234|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
163881256|NCT04093752|591933517|FG002|Overall Study|Death|1|||
163881257|NCT04093752|591933518|FG003|Overall Study|Death|2|||
164081451|NCT00658320|592663235|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
164081452|NCT00658320|592663234|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
164081453|NCT00658320|592663235|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
164081454|NCT00658320|592663234|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
164081455|NCT00658320|592663235|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
164081456|NCT00658320|592663234|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
164081457|NCT00658320|592663235|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
164081458|NCT01405950|592663236|FG000|Overall Study|Withdrawal by Subject|1|||
164081459|NCT01405950|592663237|FG001|Overall Study|Withdrawal by Subject|0|||
164081460|NCT01405950|592663238|FG002|Overall Study|Withdrawal by Subject|0|||
164081461|NCT01405950|592663239|FG003|Overall Study|Withdrawal by Subject|0|||
164081462|NCT02410252|592663241|FG000|Overall Study|Withdrawal by Subject|4|||
164081463|NCT02410252|592663241|FG000|Overall Study|Physician Decision|2|||
164081464|NCT01007916|592663245|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
164081465|NCT01007916|592663246|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
164081466|NCT01007916|592663245|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
164081467|NCT01007916|592663246|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
164081468|NCT00387712|592663249|FG000|Overall Study|Physician Decision|6|||
164081469|NCT00387712|592663250|FG001|Overall Study|Physician Decision|4|||
164081470|NCT00387712|592663249|FG000|Overall Study|Lost to Follow-up|17|||
164081471|NCT00387712|592663250|FG001|Overall Study|Lost to Follow-up|20|||
164081472|NCT00387712|592663249|FG000|Overall Study|Withdrawal by Subject|6|||
164081473|NCT00387712|592663250|FG001|Overall Study|Withdrawal by Subject|12|||
164081474|NCT04467697|592663267|FG000|Overall Study|Adverse Event|2|||
164081475|NCT04467697|592663267|FG000|Overall Study|Lost to Follow-up|6|||
164081476|NCT04467697|592663267|FG000|Overall Study|Withdrawal by Subject|9|||
164081477|NCT04467697|592663267|FG000|Overall Study|Protocol Violation|3|||
164081478|NCT00268346|592663268|FG000|Overall Study|Adverse Event|0|||
164081479|NCT00268346|592663269|FG001|Overall Study|Adverse Event|1|||
164081480|NCT00268346|592663268|FG000|Overall Study|Death|0|||
164081481|NCT00268346|592663269|FG001|Overall Study|Death|1|||
164081482|NCT00268346|592663268|FG000|Overall Study|Withdrawal by Subject|0|||
164081483|NCT00268346|592663269|FG001|Overall Study|Withdrawal by Subject|1|||
164081484|NCT02043366|592663272|FG000|Overall Study|Lost to Follow-up|2|||
164081485|NCT02043366|592663273|FG001|Overall Study|Lost to Follow-up|2|||
164081486|NCT02043366|592663274|FG002|Overall Study|Lost to Follow-up|2|||
164081487|NCT02043366|592663275|FG003|Overall Study|Lost to Follow-up|2|||
164081488|NCT02043366|592663276|FG004|Overall Study|Lost to Follow-up|2|||
164081489|NCT02043366|592663277|FG005|Overall Study|Lost to Follow-up|2|||
164081490|NCT01489956|592663278|FG000|Overall Study|Lost to Follow-up|1|||
164081491|NCT01489956|592663279|FG001|Overall Study|Lost to Follow-up|0|||
164224877|NCT02595437|593192149|FG000|Triferic Via IV|Withdrawal by Subject|1|||
164224878|NCT02837952|593192151|FG000|Overall Study|Adverse Event|0|||
164224879|NCT02837952|593192152|FG001|Overall Study|Adverse Event|1|||
164224880|NCT02837952|593192151|FG000|Overall Study|Withdrawal by Subject|4|||
164224881|NCT02837952|593192152|FG001|Overall Study|Withdrawal by Subject|5|||
164224882|NCT02837952|593192151|FG000|Overall Study|Medication Error|1|||
164224883|NCT02837952|593192152|FG001|Overall Study|Medication Error|0|||
164224884|NCT03439072|593192155|FG000|Overall Study|Withdrawal by Subject|2|||
164224885|NCT03439072|593192156|FG001|Overall Study|Withdrawal by Subject|3|||
164224886|NCT03439072|593192155|FG000|Overall Study|Physician Decision|0|||
164224887|NCT03439072|593192156|FG001|Overall Study|Physician Decision|1|||
164224888|NCT02003898|593192157|FG000|Overall Study|Death|3|||
164224889|NCT02003898|593192157|FG000|Overall Study|Lost to Follow-up|12|||
164224890|NCT02003898|593192157|FG000|Overall Study|Withdrawal by Subject|52|||
164224891|NCT01651208|593192158|FG000|Overall Study|Lost to Follow-up|14|||
163881258|NCT04093752|591933515|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
163881259|NCT04093752|591933516|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
163881260|NCT04093752|591933517|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
163881261|NCT04093752|591933518|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
163881262|NCT04093752|591933515|FG000|Overall Study|Covid 19|0|||
163881263|NCT04093752|591933516|FG001|Overall Study|Covid 19|0|||
163881264|NCT04093752|591933517|FG002|Overall Study|Covid 19|0|||
163881265|NCT04093752|591933518|FG003|Overall Study|Covid 19|1|||
163881266|NCT04093752|591933515|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
163881267|NCT04093752|591933516|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
163881268|NCT04093752|591933517|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
163881269|NCT04093752|591933518|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
163881270|NCT04093752|591933515|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
163881271|NCT04093752|591933516|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
163881272|NCT04093752|591933517|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
163881273|NCT04093752|591933518|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
163881274|NCT04093752|591933515|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
164224892|NCT01651208|593192159|FG001|Overall Study|Lost to Follow-up|16|||
164329151|NCT01397201|593583238|FG001|Overall Study|Not yet defined|6|||
164329152|NCT01397201|593583239|FG002|Overall Study|Not yet defined|5|||
164329153|NCT01397201|593583240|FG003|Overall Study|Not yet defined|5|||
164329154|NCT01397201|593583241|FG004|Overall Study|Not yet defined|4|||
164329155|NCT01397201|593583237|FG000|Overall Study|Adverse Event|2|||
164329156|NCT01397201|593583238|FG001|Overall Study|Adverse Event|0|||
164329157|NCT01397201|593583239|FG002|Overall Study|Adverse Event|0|||
164329158|NCT01397201|593583240|FG003|Overall Study|Adverse Event|0|||
163881275|NCT04093752|591933516|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
163881276|NCT04093752|591933517|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
163881277|NCT04093752|591933518|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
163881278|NCT04774237|591933525|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
163881279|NCT04774237|591933526|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
163881280|NCT04774237|591933527|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
163881281|NCT04774237|591933528|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
163881282|NCT04774237|591933529|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
163881283|NCT04774237|591933530|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
163881284|NCT02630823|591935472|FG000|Overall Study|Withdrawal by Subject|1|||
163881285|NCT02630823|591935472|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
163881286|NCT02682316|591935485|FG000|Overall Study|Benign Final Pathology|27|||
163881287|NCT02682316|591935486|FG001|Overall Study|Benign Final Pathology|26|||
163881288|NCT02682316|591935485|FG000|Overall Study|Reoperation before 30 days|7|||
163881289|NCT02682316|591935486|FG001|Overall Study|Reoperation before 30 days|6|||
163881290|NCT02682316|591935485|FG000|Overall Study|Ineligible|1|||
163881291|NCT02682316|591935486|FG001|Overall Study|Ineligible|0|||
163881292|NCT02682316|591935485|FG000|Overall Study|Death|1|||
163881293|NCT02682316|591935486|FG001|Overall Study|Death|0|||
163881294|NCT02682316|591935485|FG000|Overall Study|Lost to Follow-up|7|||
163881295|NCT02682316|591935486|FG001|Overall Study|Lost to Follow-up|3|||
163881296|NCT04083235|591935510|FG000|Overall Study|Death|252|||
163881297|NCT04083235|591935511|FG001|Overall Study|Death|277|||
163881298|NCT04083235|591935510|FG000|Overall Study|Withdrawal by Subject|13|||
163881299|NCT04083235|591935511|FG001|Overall Study|Withdrawal by Subject|17|||
163881300|NCT04083235|591935510|FG000|Overall Study|Lost to Follow-up|1|||
163881301|NCT04083235|591935511|FG001|Overall Study|Lost to Follow-up|1|||
163881302|NCT04083235|591935510|FG000|Overall Study|Does not meet entry criteria|1|||
163881303|NCT04083235|591935511|FG001|Overall Study|Does not meet entry criteria|0|||
163881304|NCT04083235|591935510|FG000|Overall Study|Did not receive treatment|13|||
163881305|NCT04083235|591935511|FG001|Overall Study|Did not receive treatment|8|||
163881306|NCT04083235|591935510|FG000|Overall Study|Ongoing at the time of DCO|44|||
163881307|NCT04083235|591935511|FG001|Overall Study|Ongoing at the time of DCO|7|||
163881308|NCT03016169|591935512|FG000|Overall Study|Lost to Follow-up|4|||
163881309|NCT03016169|591935512|FG000|Overall Study|Death|54|||
163881310|NCT03016169|591935512|FG000|Overall Study|Device Explant|11|||
163881311|NCT03016169|591935512|FG000|Overall Study|Withdrawal by Subject|19|||
163881312|NCT03016169|591935512|FG000|Overall Study|Other Reasons|1|||
163881313|NCT04060355|591935513|FG000|Overall Study|Lost to Follow-up|41|||
163881314|NCT01140880|591935514|FG000|Overall Study|Death|0|||
163881315|NCT01140880|591935515|FG001|Overall Study|Death|1|||
163881316|NCT01140880|591935514|FG000|Overall Study|Withdrawal by Subject|6|||
163881317|NCT01140880|591935515|FG001|Overall Study|Withdrawal by Subject|3|||
163881318|NCT01140880|591935514|FG000|Overall Study|Lost to Follow-up|8|||
163881319|NCT01140880|591935515|FG001|Overall Study|Lost to Follow-up|10|||
163881320|NCT01140880|591935514|FG000|Overall Study|Protocol Violation|0|||
163881321|NCT01140880|591935515|FG001|Overall Study|Protocol Violation|30|||
163881322|NCT04421378|591935520|FG000|Overall Study|Adverse Event|2|||
163881323|NCT04421378|591935521|FG001|Overall Study|Adverse Event|7|||
163881324|NCT04421378|591935522|FG002|Overall Study|Adverse Event|0|||
163881325|NCT04421378|591935523|FG003|Overall Study|Adverse Event|1|||
163881326|NCT04421378|591935524|FG004|Overall Study|Adverse Event|0|||
163881327|NCT04421378|591935520|FG000|Overall Study|Physician Decision|1|||
163881328|NCT04421378|591935521|FG001|Overall Study|Physician Decision|2|||
163881329|NCT04421378|591935522|FG002|Overall Study|Physician Decision|0|||
163881330|NCT04421378|591935523|FG003|Overall Study|Physician Decision|0|||
163881331|NCT04421378|591935524|FG004|Overall Study|Physician Decision|0|||
163881332|NCT04421378|591935520|FG000|Overall Study|Progressive Disease|16|||
163881333|NCT04421378|591935521|FG001|Overall Study|Progressive Disease|4|||
163881334|NCT04421378|591935522|FG002|Overall Study|Progressive Disease|18|||
163881335|NCT04421378|591935523|FG003|Overall Study|Progressive Disease|11|||
163881336|NCT04421378|591935524|FG004|Overall Study|Progressive Disease|3|||
163881337|NCT04421378|591935520|FG000|Overall Study|Study Terminated by Sponsor|0|||
163881338|NCT04421378|591935521|FG001|Overall Study|Study Terminated by Sponsor|1|||
163881339|NCT04421378|591935522|FG002|Overall Study|Study Terminated by Sponsor|1|||
163881340|NCT04421378|591935523|FG003|Overall Study|Study Terminated by Sponsor|0|||
163881341|NCT04421378|591935524|FG004|Overall Study|Study Terminated by Sponsor|0|||
163881342|NCT04421378|591935520|FG000|Overall Study|Withdrawal by Subject|3|||
163881343|NCT04421378|591935521|FG001|Overall Study|Withdrawal by Subject|1|||
164329159|NCT01397201|593583241|FG004|Overall Study|Adverse Event|0|||
163985637|NCT04142983|592316245|FG000|Overall Study|No longer eligible|4|||
163985638|NCT04142983|592316245|FG000|Overall Study|Screen Failure|10|||
163985639|NCT04781816|592316246|FG000|Overall Study|Adverse Event|0|||
163985640|NCT04781816|592316247|FG001|Overall Study|Adverse Event|1|||
163985641|NCT04781816|592316246|FG000|Overall Study|Withdrawal by Subject|1|||
163985642|NCT04781816|592316247|FG001|Overall Study|Withdrawal by Subject|1|||
163985643|NCT04781816|592316246|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
163985644|NCT04781816|592316247|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
163985645|NCT04372927|592316252|FG000|Overall Study|Death|1|||
163985646|NCT01847885|592316256|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
163985647|NCT01847885|592316257|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
163985648|NCT01847885|592316258|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
163985649|NCT01847885|592316256|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
163985650|NCT01847885|592316257|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
163985651|NCT01847885|592316258|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
163985652|NCT01847885|592316256|FG000|Initial Enrollment (Consented)|Screen failure|39|||
163985653|NCT01847885|592316257|FG001|Initial Enrollment (Consented)|Screen failure|0|||
163985654|NCT01847885|592316258|FG002|Initial Enrollment (Consented)|Screen failure|0|||
163985655|NCT01847885|592316256|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
163985656|NCT01847885|592316257|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
163985657|NCT01847885|592316258|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
163985658|NCT01847885|592316256|FG000|Randomization|Protocol Violation|0|||
163985659|NCT01847885|592316257|FG001|Randomization|Protocol Violation|1|||
163985660|NCT01847885|592316258|FG002|Randomization|Protocol Violation|0|||
163985661|NCT01847885|592316256|FG000|Randomization|Withdrawal by Subject|0|||
164224893|NCT00986102|593192176|FG000|Overall Study|Lost to Follow-up|0|||
164224894|NCT00986102|593192177|FG001|Overall Study|Lost to Follow-up|1|||
164224895|NCT00986102|593192178|FG002|Overall Study|Lost to Follow-up|0|||
164224896|NCT00986102|593192179|FG003|Overall Study|Lost to Follow-up|1|||
164224897|NCT00986102|593192176|FG000|Overall Study|Withdrawal by Subject|1|||
164224898|NCT00986102|593192177|FG001|Overall Study|Withdrawal by Subject|1|||
164224899|NCT00986102|593192178|FG002|Overall Study|Withdrawal by Subject|0|||
164224900|NCT00986102|593192179|FG003|Overall Study|Withdrawal by Subject|0|||
164224901|NCT02314247|593192180|FG000|Overall Study|Adverse Event|2|||
164224902|NCT02314247|593192181|FG001|Overall Study|Adverse Event|1|||
164224903|NCT02314247|593192182|FG002|Overall Study|Adverse Event|0|||
164224904|NCT02314247|593192180|FG000|Overall Study|Withdrawal by Subject|1|||
164224905|NCT02314247|593192181|FG001|Overall Study|Withdrawal by Subject|3|||
164224906|NCT02314247|593192182|FG002|Overall Study|Withdrawal by Subject|1|||
164224907|NCT02314247|593192180|FG000|Overall Study|Progression of Disease|6|||
164224908|NCT02314247|593192181|FG001|Overall Study|Progression of Disease|2|||
164224909|NCT02314247|593192182|FG002|Overall Study|Progression of Disease|0|||
164224910|NCT01260311|593192188|FG000|Overall Study|Adverse Event|11|||
164224911|NCT01260311|593192188|FG000|Overall Study|Lack of Efficacy|4|||
164224912|NCT01260311|593192188|FG000|Overall Study|Lost to Follow-up|25|||
164224913|NCT01260311|593192188|FG000|Overall Study|Withdrawal by Subject|6|||
164224914|NCT01260311|593192188|FG000|Overall Study|Financial Constraints|77|||
164224915|NCT01260311|593192188|FG000|Overall Study|Gone to Province|2|||
164224916|NCT01260311|593192188|FG000|Overall Study|Medication Stopped|1|||
164224917|NCT01260311|593192188|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
164224918|NCT00478140|593192189|FG000|Overall Study|Clinical Disease Progression|1|||
164224919|NCT00425854|593192192|FG000|Overall Study|Progressive Disease|19|||
164224920|NCT00425854|593192193|FG001|Overall Study|Progressive Disease|12|||
164224921|NCT00425854|593192192|FG000|Overall Study|Dose reduction toxicity AE|8|||
164224922|NCT00425854|593192193|FG001|Overall Study|Dose reduction toxicity AE|7|||
164224923|NCT00425854|593192192|FG000|Overall Study|Other Adverse Event|2|||
164224924|NCT00425854|593192193|FG001|Overall Study|Other Adverse Event|2|||
164224925|NCT01630811|593192194|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
164224926|NCT01630811|593192195|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164224927|NCT01725308|593192198|FG000|Treatment Period I|Did Not Receive Drug|1|||
164224928|NCT01725308|593192199|FG001|Treatment Period I|Did Not Receive Drug|0|||
164224929|NCT01725308|593192200|FG002|Treatment Period I|Did Not Receive Drug|0|||
164224930|NCT01725308|593192198|FG000|Treatment Period I|Adverse Event|5|||
164224931|NCT01725308|593192199|FG001|Treatment Period I|Adverse Event|4|||
164224932|NCT01725308|593192200|FG002|Treatment Period I|Adverse Event|21|||
164224933|NCT01725308|593192198|FG000|Treatment Period I|Insufficient Response|7|||
164224934|NCT01725308|593192199|FG001|Treatment Period I|Insufficient Response|0|||
164224935|NCT01725308|593192200|FG002|Treatment Period I|Insufficient Response|5|||
164224936|NCT01725308|593192198|FG000|Treatment Period I|Worsening of the Target Disease|8|||
164224937|NCT01725308|593192199|FG001|Treatment Period I|Worsening of the Target Disease|0|||
164224938|NCT01725308|593192200|FG002|Treatment Period I|Worsening of the Target Disease|2|||
164224939|NCT01725308|593192198|FG000|Treatment Period I|Changes in the Episodes|3|||
163985662|NCT01847885|592316257|FG001|Randomization|Withdrawal by Subject|0|||
163985663|NCT01847885|592316258|FG002|Randomization|Withdrawal by Subject|2|||
164329160|NCT01229397|593583247|FG000|Overall Study|Withdrawal by Subject|3|||
164329161|NCT01229397|593583248|FG001|Overall Study|Withdrawal by Subject|3|||
164329162|NCT01229397|593583247|FG000|Overall Study|Lost to Follow-up|7|||
164329163|NCT01229397|593583248|FG001|Overall Study|Lost to Follow-up|6|||
164329164|NCT01229397|593583247|FG000|Overall Study|Migrated/moved from study area|1|||
164329165|NCT01229397|593583248|FG001|Overall Study|Migrated/moved from study area|0|||
164329166|NCT01810432|593583251|FG000|Washout|Protocol Violation|0|||
164329167|NCT01810432|593583252|FG001|Washout|Protocol Violation|1|||
164329168|NCT01810432|593583251|FG000|Washout|Adverse Event|1|||
164329169|NCT01810432|593583252|FG001|Washout|Adverse Event|0|||
164329170|NCT01810432|593583251|FG000|Period 2|Withdrawal by Subject|2|||
164329171|NCT01810432|593583252|FG001|Period 2|Withdrawal by Subject|1|||
164329172|NCT01810432|593583251|FG000|Period 2|Physician Decision|1|||
164329173|NCT01810432|593583252|FG001|Period 2|Physician Decision|0|||
164329174|NCT01810432|593583251|FG000|Period 2|Lost to Follow-up|1|||
164329175|NCT01810432|593583252|FG001|Period 2|Lost to Follow-up|1|||
164329176|NCT03343067|593583255|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
164329177|NCT03343067|593583256|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
164329178|NCT03343067|593583257|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
164329179|NCT00542451|593583258|FG000|Overall Study|Adverse Event|31|||
164329180|NCT00542451|593583258|FG000|Overall Study|Withdrawal by Subject|30|||
164329181|NCT00542451|593583258|FG000|Overall Study|Physician Decision|4|||
164329182|NCT00542451|593583258|FG000|Overall Study|Recurrent disease|1|||
164329183|NCT00542451|593583258|FG000|Overall Study|unknown reason|1|||
164329184|NCT00542451|593583258|FG000|Overall Study|Death|2|||
164329185|NCT00542451|593583258|FG000|Overall Study|Lost to Follow-up|10|||
164329186|NCT00116168|593583261|FG000|Overall Study|Lost to Follow-up|6|||
164329187|NCT00116168|593583262|FG001|Overall Study|Lost to Follow-up|5|||
164329188|NCT00116168|593583263|FG002|Overall Study|Lost to Follow-up|0|||
164329189|NCT00116168|593583264|FG003|Overall Study|Lost to Follow-up|0|||
164329190|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
164329191|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
164329192|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
164329193|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
164329194|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164329195|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
164329196|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164329197|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
164329198|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
164329199|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
164329200|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
164329201|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
164329202|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
164329203|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
164329204|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
164329205|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
164329206|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Program Termination|3|||
164329207|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Program Termination|0|||
164329208|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Program Termination|1|||
164329209|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Program Termination|1|||
164329210|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
164329211|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
164329212|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
164329213|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
164329214|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
164329215|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
164329216|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
164329217|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
164329218|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
164329219|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
164329220|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
164329221|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
164329222|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
164329223|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
164329224|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
164329225|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
164329226|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
164329227|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
164329228|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
164329229|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
164329230|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
164329231|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
164329232|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
164329233|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
164329234|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
164329235|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
164329236|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
164329237|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
164329238|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
164329239|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
164329240|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
164329241|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
164329242|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
164329243|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
164329244|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
164329245|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
164329246|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
164329247|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
164329248|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
164329249|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
164329250|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
164329251|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
164329252|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
164329253|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
164329254|NCT03739840|593583265|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
164329255|NCT03739840|593583266|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
164329256|NCT03739840|593583267|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
164329257|NCT03739840|593583268|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
164329258|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
164329259|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
164329260|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
164329261|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
164329262|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
164329263|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
164329264|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
164329265|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
164329266|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
164329267|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
164329268|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
164329269|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
164329270|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
164329271|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
164329272|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
164329273|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
164329274|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
164329275|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
164329276|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
164329277|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
164329278|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
164329279|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
164329280|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
164329281|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
164329282|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
164329283|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
164329284|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
164329285|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
164329286|NCT03739840|593583265|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
164329287|NCT03739840|593583266|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
164329288|NCT03739840|593583267|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
164329289|NCT03739840|593583268|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
164329290|NCT05153473|593583269|FG000|Overall Study|Death|46|||
163881344|NCT04421378|591935522|FG002|Overall Study|Withdrawal by Subject|0|||
163881345|NCT04421378|591935523|FG003|Overall Study|Withdrawal by Subject|2|||
163881346|NCT04421378|591935524|FG004|Overall Study|Withdrawal by Subject|0|||
163881347|NCT04421378|591935520|FG000|Overall Study|Other|1|||
163881348|NCT04421378|591935521|FG001|Overall Study|Other|0|||
163881349|NCT04421378|591935522|FG002|Overall Study|Other|0|||
163881350|NCT04421378|591935523|FG003|Overall Study|Other|0|||
164329291|NCT05153473|593583269|FG000|Overall Study|Lost to Follow-up|3|||
164081492|NCT01489956|592663280|FG002|Overall Study|Lost to Follow-up|0|||
164224940|NCT01725308|593192199|FG001|Treatment Period I|Changes in the Episodes|0|||
164329292|NCT02788474|593583270|FG000|Double Blind Treatment Period|Not treated|1|||
164329293|NCT02788474|593583271|FG001|Double Blind Treatment Period|Not treated|0|||
164329294|NCT02788474|593583270|FG000|Double Blind Treatment Period|Patient's refusal|3|||
164329295|NCT02788474|593583271|FG001|Double Blind Treatment Period|Patient's refusal|0|||
164081493|NCT01489956|592663278|FG000|Overall Study|Withdrawal by Subject|0|||
164081494|NCT01489956|592663279|FG001|Overall Study|Withdrawal by Subject|0|||
164081495|NCT01489956|592663280|FG002|Overall Study|Withdrawal by Subject|1|||
164081496|NCT00723554|592663282|FG000|Overall Study|Adverse Event|12|||
164081497|NCT00723554|592663282|FG000|Overall Study|Investigator's judgement|5|||
164081498|NCT00723554|592663282|FG000|Overall Study|Inhaled medication other than iloprost|4|||
164081499|NCT00723554|592663282|FG000|Overall Study|Withdrawal of consent|3|||
164081500|NCT00723554|592663282|FG000|Overall Study|Other|3|||
164081501|NCT00723554|592663282|FG000|Overall Study|Lost to Follow-up|1|||
164081502|NCT00723554|592663282|FG000|Overall Study|Non-compliance|1|||
164081503|NCT01405820|592663283|FG000|Randomized Treatment Period|Adverse Event|3|||
164081504|NCT01405820|592663284|FG001|Randomized Treatment Period|Adverse Event|3|||
164081505|NCT01405820|592663285|FG002|Randomized Treatment Period|Adverse Event|3|||
164081506|NCT01405820|592663286|FG003|Randomized Treatment Period|Adverse Event|0|||
164081507|NCT01405820|592663287|FG004|Randomized Treatment Period|Adverse Event|2|||
164081508|NCT01405820|592663288|FG005|Randomized Treatment Period|Adverse Event|1|||
164081509|NCT01405820|592663283|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
164081510|NCT01405820|592663284|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
164081511|NCT01405820|592663285|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
164081512|NCT01405820|592663286|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
164081513|NCT01405820|592663287|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
164081514|NCT01405820|592663288|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
164081515|NCT01405820|592663283|FG000|Randomized Treatment Period|Other|2|||
164081516|NCT01405820|592663284|FG001|Randomized Treatment Period|Other|2|||
164081517|NCT01405820|592663285|FG002|Randomized Treatment Period|Other|1|||
164081518|NCT01405820|592663286|FG003|Randomized Treatment Period|Other|1|||
164224941|NCT01725308|593192200|FG002|Treatment Period I|Changes in the Episodes|2|||
164224942|NCT01725308|593192198|FG000|Treatment Period I|Withdrawal of Consent|12|||
164224943|NCT01725308|593192199|FG001|Treatment Period I|Withdrawal of Consent|7|||
164224944|NCT01725308|593192200|FG002|Treatment Period I|Withdrawal of Consent|5|||
164224945|NCT01725308|593192198|FG000|Treatment Period I|Lost to Follow-up|3|||
164224946|NCT01725308|593192199|FG001|Treatment Period I|Lost to Follow-up|2|||
164224947|NCT01725308|593192200|FG002|Treatment Period I|Lost to Follow-up|2|||
164224948|NCT01725308|593192198|FG000|Treatment Period I|Protocol Deviations|3|||
164224949|NCT01725308|593192199|FG001|Treatment Period I|Protocol Deviations|1|||
164224950|NCT01725308|593192200|FG002|Treatment Period I|Protocol Deviations|1|||
164224951|NCT01725308|593192198|FG000|Treatment Period I|Miscellaneous|2|||
164224952|NCT01725308|593192199|FG001|Treatment Period I|Miscellaneous|0|||
164224953|NCT01725308|593192200|FG002|Treatment Period I|Miscellaneous|3|||
164224954|NCT01725308|593192198|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
164224955|NCT01725308|593192199|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
164224956|NCT01725308|593192200|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
164224957|NCT01725308|593192198|FG000|Treatment Period II|Did Not Receive Drug|4|||
164224958|NCT01725308|593192199|FG001|Treatment Period II|Did Not Receive Drug|0|||
164224959|NCT01725308|593192200|FG002|Treatment Period II|Did Not Receive Drug|0|||
164224960|NCT01725308|593192198|FG000|Treatment Period II|Adverse Event|13|||
164224961|NCT01725308|593192199|FG001|Treatment Period II|Adverse Event|8|||
164224962|NCT01725308|593192200|FG002|Treatment Period II|Adverse Event|20|||
164224963|NCT01725308|593192198|FG000|Treatment Period II|Insufficient Response|2|||
164224964|NCT01725308|593192199|FG001|Treatment Period II|Insufficient Response|4|||
164224965|NCT01725308|593192200|FG002|Treatment Period II|Insufficient Response|6|||
164224966|NCT01725308|593192198|FG000|Treatment Period II|Worsening of the Target Disease|1|||
164224967|NCT01725308|593192199|FG001|Treatment Period II|Worsening of the Target Disease|4|||
164224968|NCT01725308|593192200|FG002|Treatment Period II|Worsening of the Target Disease|2|||
164224969|NCT01725308|593192198|FG000|Treatment Period II|Changes in the Episodes|1|||
164224970|NCT01725308|593192199|FG001|Treatment Period II|Changes in the Episodes|0|||
164224971|NCT01725308|593192200|FG002|Treatment Period II|Changes in the Episodes|5|||
164224972|NCT01725308|593192198|FG000|Treatment Period II|Withdrawal of Consent|28|||
164224973|NCT01725308|593192199|FG001|Treatment Period II|Withdrawal of Consent|2|||
164224974|NCT01725308|593192200|FG002|Treatment Period II|Withdrawal of Consent|16|||
164224975|NCT01725308|593192198|FG000|Treatment Period II|Lost to Follow-up|1|||
164224976|NCT01725308|593192199|FG001|Treatment Period II|Lost to Follow-up|5|||
164224977|NCT01725308|593192200|FG002|Treatment Period II|Lost to Follow-up|3|||
164224978|NCT01725308|593192198|FG000|Treatment Period II|Protocol Deviations|0|||
164224979|NCT01725308|593192199|FG001|Treatment Period II|Protocol Deviations|0|||
163881351|NCT04421378|591935524|FG004|Overall Study|Other|0|||
164081519|NCT01405820|592663287|FG004|Randomized Treatment Period|Other|0|||
163985664|NCT01847885|592316256|FG000|Randomization|Screen Failure|0|||
163985665|NCT01847885|592316257|FG001|Randomization|Screen Failure|3|||
163985666|NCT01847885|592316258|FG002|Randomization|Screen Failure|0|||
163985667|NCT05130463|592316263|FG000|Overall Study|Unspecified reasons|2|||
163985668|NCT05130463|592316263|FG000|Overall Study|off-label indication dose|435|||
163985669|NCT03652662|592316265|FG000|Overall Study|Withdrawal by Subject|2|||
163985670|NCT03652662|592316266|FG001|Overall Study|Withdrawal by Subject|1|||
163985671|NCT03652662|592316265|FG000|Overall Study|Lost to Follow-up|1|||
163985672|NCT03652662|592316266|FG001|Overall Study|Lost to Follow-up|0|||
163985673|NCT00487539|592316267|FG000|Overall Study|Adverse Event|3|||
163985674|NCT00487539|592316268|FG001|Overall Study|Adverse Event|2|||
163985675|NCT00487539|592316269|FG002|Overall Study|Adverse Event|1|||
163985676|NCT00487539|592316270|FG003|Overall Study|Adverse Event|1|||
163985677|NCT00487539|592316267|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163985678|NCT00487539|592316268|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163985679|NCT00487539|592316269|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
163985680|NCT00487539|592316270|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
163985681|NCT00487539|592316267|FG000|Overall Study|Other|3|||
163985682|NCT00487539|592316268|FG001|Overall Study|Other|1|||
163985683|NCT00487539|592316269|FG002|Overall Study|Other|2|||
163985684|NCT00487539|592316270|FG003|Overall Study|Other|2|||
163985685|NCT02751502|592316271|FG000|Overall Study|Lack of funding|4|||
163985686|NCT02925156|592316272|FG000|Overall Study|Lost to Follow-up|27|||
163985687|NCT02925156|592316273|FG001|Overall Study|Lost to Follow-up|53|||
163985688|NCT02925156|592316274|FG002|Overall Study|Lost to Follow-up|51|||
164224980|NCT01725308|593192200|FG002|Treatment Period II|Protocol Deviations|1|||
164224981|NCT01725308|593192198|FG000|Treatment Period II|Miscellaneous|5|||
164224982|NCT01725308|593192199|FG001|Treatment Period II|Miscellaneous|3|||
164224983|NCT01725308|593192200|FG002|Treatment Period II|Miscellaneous|7|||
164224984|NCT05652140|593192202|FG000|Overall Study|Lost to Follow-up|7|||
164224985|NCT05652140|593192203|FG001|Overall Study|Lost to Follow-up|16|||
164224986|NCT05652140|593192204|FG002|Overall Study|Lost to Follow-up|22|||
164224987|NCT05652140|593192205|FG003|Overall Study|Lost to Follow-up|31|||
164224988|NCT06048705|593192209|FG000|Overall Study|Physician Decision|1|||
164224989|NCT06048705|593192210|FG001|Overall Study|Physician Decision|0|||
164224990|NCT06048705|593192211|FG002|Overall Study|Physician Decision|0|||
164224991|NCT06048705|593192209|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
164224992|NCT06048705|593192210|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
164224993|NCT06048705|593192211|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
164224994|NCT06048705|593192209|FG000|Overall Study|Death prior to lymphodepletion|0|||
164224995|NCT06048705|593192210|FG001|Overall Study|Death prior to lymphodepletion|0|||
164224996|NCT06048705|593192211|FG002|Overall Study|Death prior to lymphodepletion|1|||
164224997|NCT02614066|593192212|FG000|Overall Study|Death|6|||
164224998|NCT02614066|593192213|FG001|Overall Study|Death|14|||
164224999|NCT02614066|593192214|FG002|Overall Study|Death|11|||
164225000|NCT02614066|593192215|FG003|Overall Study|Death|29|||
164225001|NCT02614066|593192212|FG000|Overall Study|Full consent withdrawn|0|||
164225002|NCT02614066|593192213|FG001|Overall Study|Full consent withdrawn|1|||
164225003|NCT02614066|593192214|FG002|Overall Study|Full consent withdrawn|0|||
164225004|NCT02614066|593192215|FG003|Overall Study|Full consent withdrawn|8|||
164225005|NCT02614066|593192212|FG000|Overall Study|Lost to Follow-up|0|||
164225006|NCT02614066|593192213|FG001|Overall Study|Lost to Follow-up|2|||
164225007|NCT02614066|593192214|FG002|Overall Study|Lost to Follow-up|2|||
164225008|NCT02614066|593192215|FG003|Overall Study|Lost to Follow-up|2|||
164225009|NCT02614066|593192212|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
164225010|NCT02614066|593192213|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
164225011|NCT02614066|593192214|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
164225012|NCT02614066|593192215|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
164225013|NCT02614066|593192212|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
164225014|NCT02614066|593192213|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
164225015|NCT02614066|593192214|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
164225016|NCT02614066|593192215|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
164225017|NCT02614066|593192212|FG000|Overall Study|Reason not specified|0|||
164225018|NCT02614066|593192213|FG001|Overall Study|Reason not specified|2|||
164225019|NCT02614066|593192214|FG002|Overall Study|Reason not specified|1|||
164225020|NCT02614066|593192215|FG003|Overall Study|Reason not specified|1|||
164225021|NCT04565756|593192216|FG000|Overall Study|Withdrawal by Subject|0|||
164225022|NCT04565756|593192217|FG001|Overall Study|Withdrawal by Subject|0|||
164225023|NCT04565756|593192218|FG002|Overall Study|Withdrawal by Subject|0|||
164225024|NCT04565756|593192219|FG003|Overall Study|Withdrawal by Subject|0|||
164225025|NCT04565756|593192220|FG004|Overall Study|Withdrawal by Subject|1|||
163985689|NCT02925156|592316275|FG003|Overall Study|Lost to Follow-up|59|||
163985690|NCT02925156|592316276|FG004|Overall Study|Lost to Follow-up|89|||
163985691|NCT02925156|592316277|FG005|Overall Study|Lost to Follow-up|107|||
163985692|NCT02925156|592316278|FG006|Overall Study|Lost to Follow-up|34|||
163985693|NCT02925156|592316279|FG007|Overall Study|Lost to Follow-up|36|||
164329296|NCT02788474|593583270|FG000|Double Blind Treatment Period|Adverse Event|6|||
164329297|NCT02788474|593583271|FG001|Double Blind Treatment Period|Adverse Event|4|||
164329298|NCT02788474|593583270|FG000|Open Label Treatment Period|Adverse Event|29|||
164329299|NCT02788474|593583271|FG001|Open Label Treatment Period|Adverse Event|9|||
164329300|NCT02788474|593583270|FG000|Open Label Treatment Period|Other than reason specified|1|||
164329301|NCT02788474|593583271|FG001|Open Label Treatment Period|Other than reason specified|0|||
164329302|NCT02788474|593583270|FG000|Open Label Treatment Period|Patient's refusal|1|||
164329303|NCT02788474|593583271|FG001|Open Label Treatment Period|Patient's refusal|3|||
164329304|NCT02788474|593583270|FG000|Open Label Treatment Period|Non-compliance|1|||
164329305|NCT02788474|593583271|FG001|Open Label Treatment Period|Non-compliance|0|||
164329306|NCT03555435|593583272|FG000|Overall Study|Lost to Follow-up|17|||
164329307|NCT03555435|593583273|FG001|Overall Study|Lost to Follow-up|19|||
164329308|NCT03555435|593583274|FG002|Overall Study|Lost to Follow-up|8|||
164329309|NCT01243671|593583280|FG000|Overall Study|Adverse Event|3|||
164329310|NCT01243671|593583280|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
164329311|NCT01243671|593583280|FG000|Overall Study|Other|1|||
164329312|NCT02962765|593583281|FG000|Overall Study|Protocol Violation|9|||
164329313|NCT02962765|593583281|FG000|Overall Study|Withdrawal by Subject|3|||
164329314|NCT02962765|593583281|FG000|Overall Study|Lost to Follow-up|1|||
164329315|NCT02962765|593583281|FG000|Overall Study|Death|1|||
164329316|NCT02962765|593583281|FG000|Overall Study|Limited access to study medication|3|||
164329317|NCT00245583|593583285|FG000|Overall Study|Lost to Follow-up|1|||
164329318|NCT00245583|593583286|FG001|Overall Study|Lost to Follow-up|5|||
164329319|NCT00245583|593583285|FG000|Overall Study|Adverse Event|2|||
164329320|NCT00245583|593583286|FG001|Overall Study|Adverse Event|1|||
164329321|NCT00245583|593583285|FG000|Overall Study|Lack of Efficacy|1|||
164329322|NCT00245583|593583286|FG001|Overall Study|Lack of Efficacy|0|||
164329323|NCT00245583|593583285|FG000|Overall Study|Withdrawal by Subject|2|||
164329324|NCT00245583|593583286|FG001|Overall Study|Withdrawal by Subject|3|||
164329325|NCT01309893|593583287|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
164329326|NCT01309893|593583288|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
164329327|NCT01309893|593583287|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
164329328|NCT01309893|593583288|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
164329329|NCT02017171|593583289|FG000|Overall Study|Death|10|||
164329330|NCT02017171|593583290|FG001|Overall Study|Death|4|||
164329331|NCT02017171|593583289|FG000|Overall Study|Withdrawal by Subject|23|||
164329332|NCT02017171|593583290|FG001|Overall Study|Withdrawal by Subject|17|||
164329333|NCT02017171|593583289|FG000|Overall Study|Lost to Follow-up|21|||
164329334|NCT02017171|593583290|FG001|Overall Study|Lost to Follow-up|20|||
164329335|NCT02017171|593583289|FG000|Overall Study|ESKD|6|||
164329336|NCT02017171|593583290|FG001|Overall Study|ESKD|2|||
164329337|NCT02017171|593583289|FG000|Overall Study|Miscellaneous|2|||
163881352|NCT04258709|591935525|FG000|Overall Study|Lost to Follow-up|10|||
163881353|NCT04258709|591935526|FG001|Overall Study|Lost to Follow-up|4|||
163881354|NCT04258709|591935525|FG000|Overall Study|Withdrawal by Subject|1|||
163881355|NCT04258709|591935526|FG001|Overall Study|Withdrawal by Subject|0|||
163881356|NCT04258709|591935525|FG000|Overall Study|Fetal demise|0|||
163881357|NCT04258709|591935526|FG001|Overall Study|Fetal demise|1|||
163881358|NCT04258709|591935525|FG000|Overall Study|Protocol Violation|1|||
163881359|NCT04258709|591935526|FG001|Overall Study|Protocol Violation|1|||
163881360|NCT03175029|591935527|FG000|Overall Study|Withdrawal by Subject|2|||
163881361|NCT03175029|591935528|FG001|Overall Study|Withdrawal by Subject|1|||
163881362|NCT03175029|591935527|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
163881363|NCT03175029|591935528|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
163881364|NCT02729311|591935534|FG000|Overall Study|Withdrawal by Subject|8|||
163881365|NCT02729311|591935535|FG001|Overall Study|Withdrawal by Subject|2|||
163881366|NCT05324124|591935536|FG000|Period 1|Withdrawal by Subject|1|||
163881367|NCT05324124|591935537|FG001|Period 1|Withdrawal by Subject|0|||
163881368|NCT05324124|591935536|FG000|Period 1|Physician Decision|0|||
163881369|NCT05324124|591935537|FG001|Period 1|Physician Decision|1|||
163881370|NCT05034952|591935538|FG000|Overall Study|Adverse Event|1|||
163881371|NCT05034952|591935539|FG001|Overall Study|Adverse Event|0|||
164329338|NCT02017171|593583290|FG001|Overall Study|Miscellaneous|3|||
164329339|NCT02220998|593583291|FG000|Overall Study|Randomized but Never Treated|1|||
164329340|NCT02220998|593583292|FG001|Overall Study|Randomized but Never Treated|2|||
164329341|NCT02220998|593583291|FG000|Overall Study|Death|2|||
163881372|NCT05034952|591935540|FG002|Overall Study|Adverse Event|0|||
163881373|NCT05034952|591935541|FG003|Overall Study|Adverse Event|0|||
163881374|NCT05034952|591935538|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164329342|NCT02220998|593583292|FG001|Overall Study|Death|0|||
164329343|NCT02220998|593583291|FG000|Overall Study|Lack of Efficacy|0|||
164329344|NCT02220998|593583292|FG001|Overall Study|Lack of Efficacy|5|||
164329345|NCT02220998|593583291|FG000|Overall Study|Lost to Follow-up|4|||
164329346|NCT02220998|593583292|FG001|Overall Study|Lost to Follow-up|4|||
164329347|NCT00873860|593583293|FG000|Overall Study|Lost to Follow-up|1|||
163881375|NCT05034952|591935539|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164225026|NCT04565756|593192221|FG005|Overall Study|Withdrawal by Subject|0|||
164225027|NCT04565756|593192216|FG000|Overall Study|Protocol Violation|0|||
164225028|NCT04565756|593192217|FG001|Overall Study|Protocol Violation|0|||
164225029|NCT04565756|593192218|FG002|Overall Study|Protocol Violation|0|||
164225030|NCT04565756|593192219|FG003|Overall Study|Protocol Violation|0|||
164225031|NCT04565756|593192220|FG004|Overall Study|Protocol Violation|0|||
164225032|NCT04565756|593192221|FG005|Overall Study|Protocol Violation|1|||
164329348|NCT00873860|593583294|FG001|Overall Study|Lost to Follow-up|0|||
164329349|NCT00873860|593583295|FG002|Overall Study|Lost to Follow-up|0|||
164329350|NCT00873860|593583296|FG003|Overall Study|Lost to Follow-up|1|||
164329351|NCT00873860|593583293|FG000|Overall Study|Withdrawal by Subject|1|||
164329352|NCT00873860|593583294|FG001|Overall Study|Withdrawal by Subject|0|||
164329353|NCT00873860|593583295|FG002|Overall Study|Withdrawal by Subject|2|||
164329354|NCT00873860|593583296|FG003|Overall Study|Withdrawal by Subject|0|||
164329355|NCT00873860|593583293|FG000|Overall Study|Death|1|||
164329356|NCT00873860|593583294|FG001|Overall Study|Death|0|||
164329357|NCT00873860|593583295|FG002|Overall Study|Death|0|||
164329358|NCT00873860|593583296|FG003|Overall Study|Death|0|||
164329359|NCT00873860|593583293|FG000|Overall Study|Other|1|||
164329360|NCT00873860|593583294|FG001|Overall Study|Other|0|||
164329361|NCT00873860|593583295|FG002|Overall Study|Other|1|||
164329362|NCT00873860|593583296|FG003|Overall Study|Other|0|||
164329363|NCT01484938|593583297|FG000|Overall Study|Adverse Event|2|||
164329364|NCT01484938|593583297|FG000|Overall Study|Lost to Follow-up|1|||
164329365|NCT01484938|593583297|FG000|Overall Study|Noncompliance|1|||
164329366|NCT01172275|593583302|FG000|Overall Study|Lost to Follow-up|1|||
164329367|NCT01172275|593583303|FG001|Overall Study|Lost to Follow-up|0|||
164329368|NCT01172275|593583302|FG000|Overall Study|Protocol Violation|1|||
164329369|NCT01172275|593583303|FG001|Overall Study|Protocol Violation|0|||
164329370|NCT02862600|593583304|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
164329371|NCT02862600|593583304|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
164329372|NCT02862600|593583304|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
164329373|NCT02862600|593583304|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
164329374|NCT00194675|593583305|FG000|Overall Study|Lost to Follow-up|1|||
164329375|NCT00194675|593583306|FG001|Overall Study|Lost to Follow-up|1|||
164329376|NCT00194675|593583305|FG000|Overall Study|lack of interest|1|||
164329377|NCT00194675|593583306|FG001|Overall Study|lack of interest|1|||
164329378|NCT00194675|593583305|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
164329379|NCT00194675|593583306|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
164329380|NCT00194675|593583305|FG000|Overall Study|Protocol Violation|1|||
164329381|NCT00194675|593583306|FG001|Overall Study|Protocol Violation|0|||
164329382|NCT00194675|593583305|FG000|Overall Study|Death|1|||
164329383|NCT00194675|593583306|FG001|Overall Study|Death|0|||
164329384|NCT00667420|593583311|FG000|Overall Study|Adverse Event|2|||
164329385|NCT00667420|593583311|FG000|Overall Study|Lack of Efficacy|5|||
164329386|NCT00667420|593583311|FG000|Overall Study|Physician Decision|1|||
164329387|NCT00667420|593583311|FG000|Overall Study|Withdrawal by Subject|2|||
164329388|NCT04437368|593583312|FG000|Overall Study|Death|3|||
164329389|NCT04437368|593583313|FG001|Overall Study|Death|0|||
164329390|NCT04437368|593583314|FG002|Overall Study|Death|2|||
164329391|NCT04437368|593583312|FG000|Overall Study|Study terminated by sponsor|16|||
164329392|NCT04437368|593583313|FG001|Overall Study|Study terminated by sponsor|1|||
164329393|NCT04437368|593583314|FG002|Overall Study|Study terminated by sponsor|25|||
164329394|NCT04437368|593583312|FG000|Overall Study|Withdrawal by Subject|4|||
164329395|NCT04437368|593583313|FG001|Overall Study|Withdrawal by Subject|0|||
164329396|NCT04437368|593583314|FG002|Overall Study|Withdrawal by Subject|3|||
164329397|NCT04437368|593583312|FG000|Overall Study|Sponsor instructions|23|||
163881376|NCT05034952|591935540|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
163881377|NCT05034952|591935541|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
163881378|NCT05034952|591935538|FG000|Overall Study|Lost to Follow-up|1|||
163881379|NCT05034952|591935539|FG001|Overall Study|Lost to Follow-up|4|||
163881380|NCT05034952|591935540|FG002|Overall Study|Lost to Follow-up|3|||
163881381|NCT05034952|591935541|FG003|Overall Study|Lost to Follow-up|3|||
163881382|NCT05034952|591935538|FG000|Overall Study|Other|0|||
163881383|NCT05034952|591935539|FG001|Overall Study|Other|0|||
163881384|NCT05034952|591935540|FG002|Overall Study|Other|0|||
164225033|NCT00968968|593192226|FG000|Overall Study|Study closed/terminated|10|||
164225034|NCT00968968|593192227|FG001|Overall Study|Study closed/terminated|10|||
164225035|NCT00968968|593192226|FG000|Overall Study|Protocol defined stopping criteria|3|||
164329398|NCT04437368|593583313|FG001|Overall Study|Sponsor instructions|0|||
164329399|NCT04437368|593583314|FG002|Overall Study|Sponsor instructions|0|||
164329400|NCT00095628|593583315|FG000|Overall Study|Disease progression prior to treatment|1|||
164225036|NCT00968968|593192227|FG001|Overall Study|Protocol defined stopping criteria|1|||
164329401|NCT04271280|593583316|FG000|Overall Study|Lost to Follow-up|300|||
164329402|NCT04271280|593583316|FG000|Overall Study|Death|153|||
164329403|NCT04271280|593583316|FG000|Overall Study|Withdrawal of consent by patient|59|||
164329404|NCT04271280|593583316|FG000|Overall Study|Other|51|||
164329405|NCT04271280|593583316|FG000|Overall Study|No end of study information|42|||
164329406|NCT00495131|593583317|FG000|Overall Study|Adverse Event|6|||
163985694|NCT02925156|592316280|FG008|Overall Study|Lost to Follow-up|73|||
163985695|NCT02925156|592316281|FG009|Overall Study|Lost to Follow-up|34|||
163985696|NCT01844895|592316282|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
163985697|NCT01844895|592316282|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
163985698|NCT01844895|592316282|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
163985699|NCT01844895|592316282|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
164329407|NCT00495131|593583318|FG001|Overall Study|Adverse Event|2|||
164329408|NCT00495131|593583317|FG000|Overall Study|Lack of Efficacy|0|||
164329409|NCT00495131|593583318|FG001|Overall Study|Lack of Efficacy|2|||
164329410|NCT00495131|593583317|FG000|Overall Study|Lost to Follow-up|0|||
164329411|NCT00495131|593583318|FG001|Overall Study|Lost to Follow-up|2|||
164329412|NCT00495131|593583317|FG000|Overall Study|Withdrawal by Subject|1|||
164329413|NCT00495131|593583318|FG001|Overall Study|Withdrawal by Subject|0|||
164329414|NCT03224546|593583319|FG000|Overall Study|Lost to Follow-up|9|||
164329415|NCT03224546|593583320|FG001|Overall Study|Lost to Follow-up|8|||
164329416|NCT03224546|593583321|FG002|Overall Study|Lost to Follow-up|3|||
164329417|NCT03224546|593583319|FG000|Overall Study|Withdrawal by Subject|7|||
164329418|NCT03224546|593583320|FG001|Overall Study|Withdrawal by Subject|14|||
164329419|NCT03224546|593583321|FG002|Overall Study|Withdrawal by Subject|12|||
164329420|NCT01539317|593583324|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
164329421|NCT01539317|593583325|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
164329422|NCT04223232|593583326|FG000|Overall Study|Withdrawal by Subject|1|||
164329423|NCT00364130|593583327|FG000|Intervention Period|Lost to Follow-up|4|||
164329424|NCT00364130|593583328|FG001|Intervention Period|Lost to Follow-up|3|||
164329425|NCT00364130|593583327|FG000|Intervention Period|Pregnancy|1|||
164329426|NCT00364130|593583328|FG001|Intervention Period|Pregnancy|0|||
164329427|NCT00364130|593583327|FG000|Intervention Period|Withdrawal by Subject|4|||
164329428|NCT00364130|593583328|FG001|Intervention Period|Withdrawal by Subject|5|||
164329429|NCT00364130|593583327|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
164329430|NCT00364130|593583328|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
164329431|NCT00586846|593583336|FG000|Overall Study|Physician Decision|1|||
164329432|NCT00586846|593583336|FG000|Overall Study|Death|1|||
164329433|NCT00586846|593583336|FG000|Overall Study|Evaluable for Toxicity Only|4|||
164329434|NCT01702571|593583345|FG000|Overall Study|Death|1067|||
164329435|NCT01702571|593583346|FG001|Overall Study|Death|76|||
164329436|NCT01702571|593583345|FG000|Overall Study|Lost to Follow-up|144|||
164329437|NCT01702571|593583346|FG001|Overall Study|Lost to Follow-up|10|||
164329438|NCT01702571|593583345|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
164329439|NCT01702571|593583346|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
164329440|NCT01702571|593583345|FG000|Overall Study|Investigator Decision|5|||
164329441|NCT01702571|593583346|FG001|Overall Study|Investigator Decision|0|||
164329442|NCT01702571|593583345|FG000|Overall Study|Not Classifiable|1|||
164329443|NCT01702571|593583346|FG001|Overall Study|Not Classifiable|0|||
164329444|NCT01702571|593583345|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
164329445|NCT01702571|593583346|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
164329446|NCT01702571|593583345|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
164329447|NCT01702571|593583346|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
164329448|NCT01702571|593583345|FG000|Overall Study|Progressive Disease|3|||
164329449|NCT01702571|593583346|FG001|Overall Study|Progressive Disease|0|||
164329450|NCT01702571|593583345|FG000|Overall Study|Protocol Violation|2|||
164329451|NCT01702571|593583346|FG001|Overall Study|Protocol Violation|0|||
164329452|NCT01702571|593583345|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
164329453|NCT01702571|593583346|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
164329454|NCT01702571|593583345|FG000|Overall Study|Termination By Sponsor|4|||
164329455|NCT01702571|593583346|FG001|Overall Study|Termination By Sponsor|0|||
164329456|NCT01702571|593583345|FG000|Overall Study|Withdrawal by Subject|177|||
164329457|NCT01702571|593583346|FG001|Overall Study|Withdrawal by Subject|29|||
164329458|NCT03004443|593583347|FG000|Overall Study|Pregnancy|0|||
164329459|NCT03004443|593583348|FG001|Overall Study|Pregnancy|1|||
164329460|NCT00828854|593583349|FG000|Overall Study|Disease Progression|17|||
164329461|NCT00828854|593583349|FG000|Overall Study|Adverse Event|9|||
164329462|NCT00828854|593583349|FG000|Overall Study|Reason not Specified|1|||
164329463|NCT04221230|593583350|FG000|Overall Study|Lost to Follow-up|12|||
164329464|NCT04221230|593583351|FG001|Overall Study|Lost to Follow-up|12|||
164329465|NCT04221230|593583350|FG000|Overall Study|Protocol Violation|2|||
164329466|NCT04221230|593583351|FG001|Overall Study|Protocol Violation|2|||
164329467|NCT04221230|593583350|FG000|Overall Study|Adverse Event|0|||
164329468|NCT04221230|593583351|FG001|Overall Study|Adverse Event|8|||
164329469|NCT04221230|593583350|FG000|Overall Study|Physician Decision|1|||
164329470|NCT04221230|593583351|FG001|Overall Study|Physician Decision|0|||
164329471|NCT04221230|593583350|FG000|Overall Study|Withdrawal by Subject|13|||
163985700|NCT01844895|592316282|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
164329472|NCT04221230|593583351|FG001|Overall Study|Withdrawal by Subject|11|||
164329473|NCT04221230|593583350|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164329474|NCT04221230|593583351|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163985701|NCT01844895|592316282|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
164329475|NCT04221230|593583350|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164329476|NCT04221230|593583351|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164329477|NCT04221230|593583350|FG000|Overall Study|Pregnancy|0|||
164329478|NCT04221230|593583351|FG001|Overall Study|Pregnancy|1|||
164329479|NCT04221230|593583350|FG000|Overall Study|Other|1|||
164329480|NCT04221230|593583351|FG001|Overall Study|Other|2|||
164329481|NCT00915356|593583352|FG000|Overall Study|Withdrawal by Subject|1|||
164329482|NCT00915356|593583353|FG001|Overall Study|Withdrawal by Subject|0|||
164329483|NCT00915356|593583354|FG002|Overall Study|Withdrawal by Subject|0|||
164329484|NCT00915356|593583355|FG003|Overall Study|Withdrawal by Subject|0|||
164329485|NCT00915356|593583356|FG004|Overall Study|Withdrawal by Subject|0|||
164329486|NCT00191646|593583358|FG000|Overall Study|Toxicity|26|||
164329487|NCT00191646|593583359|FG001|Overall Study|Toxicity|37|||
164329488|NCT00191646|593583358|FG000|Overall Study|Disease Progression|5|||
164329489|NCT00191646|593583359|FG001|Overall Study|Disease Progression|6|||
164329490|NCT00191646|593583358|FG000|Overall Study|Physician Decision|20|||
164329491|NCT00191646|593583359|FG001|Overall Study|Physician Decision|11|||
164329492|NCT00191646|593583358|FG000|Overall Study|Withdrawal by Subject|58|||
164329493|NCT00191646|593583359|FG001|Overall Study|Withdrawal by Subject|39|||
164329494|NCT00191646|593583358|FG000|Overall Study|Protocol Violation|5|||
164329495|NCT00191646|593583359|FG001|Overall Study|Protocol Violation|7|||
164329496|NCT00191646|593583358|FG000|Overall Study|Death|6|||
164329497|NCT00191646|593583359|FG001|Overall Study|Death|8|||
164329498|NCT00191646|593583358|FG000|Overall Study|Other|33|||
164329499|NCT00191646|593583359|FG001|Overall Study|Other|34|||
164329500|NCT00191646|593583358|FG000|Overall Study|Missing Data|18|||
164329501|NCT00191646|593583359|FG001|Overall Study|Missing Data|11|||
164329502|NCT05211284|593583367|FG000|Overall Study|Study Terminated|3|||
164329503|NCT05211284|593583368|FG001|Overall Study|Study Terminated|1|||
164329504|NCT04090957|593583373|FG000|Overall Study|Lost to Follow-up|22|||
164329505|NCT04090957|593583374|FG001|Overall Study|Lost to Follow-up|25|||
164329506|NCT04090957|593583375|FG002|Overall Study|Lost to Follow-up|25|||
164329507|NCT04090957|593583376|FG003|Overall Study|Lost to Follow-up|36|||
164329508|NCT04090957|593583373|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
164329509|NCT04090957|593583374|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
164329510|NCT04090957|593583375|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
164329511|NCT04090957|593583376|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
164329512|NCT04090957|593583373|FG000|Overall Study|Adverse Event|19|||
164329513|NCT04090957|593583374|FG001|Overall Study|Adverse Event|25|||
164329514|NCT04090957|593583375|FG002|Overall Study|Adverse Event|8|||
164329515|NCT04090957|593583376|FG003|Overall Study|Adverse Event|104|||
164329516|NCT04090957|593583373|FG000|Overall Study|Other|10|||
164329517|NCT04090957|593583374|FG001|Overall Study|Other|6|||
164329518|NCT04090957|593583375|FG002|Overall Study|Other|5|||
164329519|NCT04090957|593583376|FG003|Overall Study|Other|12|||
164329520|NCT04090957|593583373|FG000|Overall Study|Serious Adverse Event|7|||
164329521|NCT04090957|593583374|FG001|Overall Study|Serious Adverse Event|11|||
164329522|NCT04090957|593583375|FG002|Overall Study|Serious Adverse Event|1|||
164329523|NCT04090957|593583376|FG003|Overall Study|Serious Adverse Event|32|||
164329524|NCT04090957|593583373|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
164329525|NCT04090957|593583374|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
164329526|NCT04090957|593583375|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
164329527|NCT04090957|593583376|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
164329528|NCT04090957|593583373|FG000|Overall Study|Lack of Efficacy|1|||
164329529|NCT04090957|593583374|FG001|Overall Study|Lack of Efficacy|1|||
164329530|NCT04090957|593583375|FG002|Overall Study|Lack of Efficacy|9|||
164329531|NCT04090957|593583376|FG003|Overall Study|Lack of Efficacy|0|||
164329532|NCT04090957|593583373|FG000|Overall Study|Protocol Violation|3|||
164329533|NCT04090957|593583374|FG001|Overall Study|Protocol Violation|5|||
164329534|NCT04090957|593583375|FG002|Overall Study|Protocol Violation|2|||
164329535|NCT04090957|593583376|FG003|Overall Study|Protocol Violation|1|||
164329536|NCT04090957|593583373|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
164329537|NCT04090957|593583374|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
164329538|NCT04090957|593583375|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
164329539|NCT04090957|593583376|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
164329540|NCT04090957|593583373|FG000|Overall Study|COVID-19|2|||
164329541|NCT04090957|593583374|FG001|Overall Study|COVID-19|2|||
163881385|NCT05034952|591935541|FG003|Overall Study|Other|1|||
164329542|NCT04090957|593583375|FG002|Overall Study|COVID-19|3|||
164329543|NCT04090957|593583376|FG003|Overall Study|COVID-19|7|||
164329544|NCT04090957|593583373|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
164329545|NCT04090957|593583374|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
164329546|NCT04090957|593583375|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
164329547|NCT04090957|593583376|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
164329548|NCT04090957|593583373|FG000|Overall Study|Physician Decision|2|||
163881386|NCT02287610|591935542|FG000|Overall Study|Lost to Follow-up|3|||
163881387|NCT02287610|591935542|FG000|Overall Study|Withdrawal by Subject|8|||
164329549|NCT04090957|593583374|FG001|Overall Study|Physician Decision|1|||
164329550|NCT04090957|593583375|FG002|Overall Study|Physician Decision|1|||
164329551|NCT04090957|593583376|FG003|Overall Study|Physician Decision|5|||
164329552|NCT04090957|593583373|FG000|Overall Study|Sponsor Decision|1|||
164329553|NCT04090957|593583374|FG001|Overall Study|Sponsor Decision|1|||
164329554|NCT04090957|593583375|FG002|Overall Study|Sponsor Decision|1|||
164329555|NCT04090957|593583376|FG003|Overall Study|Sponsor Decision|3|||
164329556|NCT04090957|593583373|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
164329557|NCT04090957|593583374|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
164329558|NCT04090957|593583375|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
164329559|NCT04090957|593583376|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
164329560|NCT04090957|593583373|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
164329561|NCT04090957|593583374|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
164329562|NCT04090957|593583375|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
164329563|NCT04090957|593583376|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
164329564|NCT04090957|593583373|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
164329565|NCT04090957|593583374|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
164329566|NCT04090957|593583375|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
164329567|NCT04090957|593583376|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
164329568|NCT04090957|593583373|FG000|Overall Study|Death|1|||
164329569|NCT04090957|593583374|FG001|Overall Study|Death|0|||
164329570|NCT04090957|593583375|FG002|Overall Study|Death|0|||
164329571|NCT04090957|593583376|FG003|Overall Study|Death|0|||
164329572|NCT04090957|593583373|FG000|Overall Study|No Treatment Administered|2|||
164329573|NCT04090957|593583374|FG001|Overall Study|No Treatment Administered|1|||
164329574|NCT04090957|593583375|FG002|Overall Study|No Treatment Administered|2|||
164329575|NCT04090957|593583376|FG003|Overall Study|No Treatment Administered|1|||
164329576|NCT01909453|593583377|FG000|Overall Study|Ongoing|118|||
164329577|NCT01909453|593583378|FG001|Overall Study|Ongoing|103|||
164329578|NCT01909453|593583379|FG002|Overall Study|Ongoing|83|||
164329579|NCT01909453|593583380|FG003|Overall Study|Ongoing|164|||
164329580|NCT01909453|593583381|FG004|Overall Study|Ongoing|50|||
164329581|NCT01909453|593583377|FG000|Overall Study|Death|69|||
164329582|NCT01909453|593583378|FG001|Overall Study|Death|74|||
164329583|NCT01909453|593583379|FG002|Overall Study|Death|88|||
164329584|NCT01909453|593583380|FG003|Overall Study|Death|86|||
164329585|NCT01909453|593583381|FG004|Overall Study|Death|29|||
164329586|NCT01909453|593583377|FG000|Overall Study|Lost to Follow-up|3|||
164329587|NCT01909453|593583378|FG001|Overall Study|Lost to Follow-up|4|||
164329588|NCT01909453|593583379|FG002|Overall Study|Lost to Follow-up|4|||
164329589|NCT01909453|593583380|FG003|Overall Study|Lost to Follow-up|3|||
164329590|NCT01909453|593583381|FG004|Overall Study|Lost to Follow-up|3|||
164329591|NCT01909453|593583377|FG000|Overall Study|Withdrawal by Subject|2|||
164329592|NCT01909453|593583378|FG001|Overall Study|Withdrawal by Subject|13|||
164329593|NCT01909453|593583379|FG002|Overall Study|Withdrawal by Subject|16|||
164329594|NCT01909453|593583380|FG003|Overall Study|Withdrawal by Subject|5|||
164329595|NCT01909453|593583381|FG004|Overall Study|Withdrawal by Subject|4|||
164329596|NCT00122278|593584733|FG000|Overall Study|Lost to Follow-up|2|||
164329597|NCT00122278|593584734|FG001|Overall Study|Lost to Follow-up|0|||
164329598|NCT01002482|593584735|FG000|Overall Study|Withdrawal by Subject|14|||
164329599|NCT01002482|593584736|FG001|Overall Study|Withdrawal by Subject|21|||
164329600|NCT01002482|593584735|FG000|Overall Study|Included twice|1|||
164329601|NCT01002482|593584736|FG001|Overall Study|Included twice|0|||
164329602|NCT02598960|593584740|FG000|Treatment Period|Disease Progression|4|||
164329603|NCT02598960|593584741|FG001|Treatment Period|Disease Progression|4|||
164329604|NCT02598960|593584742|FG002|Treatment Period|Disease Progression|4|||
164329605|NCT02598960|593584743|FG003|Treatment Period|Disease Progression|6|||
164329606|NCT02598960|593584744|FG004|Treatment Period|Disease Progression|8|||
164329607|NCT02598960|593584745|FG005|Treatment Period|Disease Progression|2|||
164329608|NCT02598960|593584746|FG006|Treatment Period|Disease Progression|2|||
164329609|NCT02598960|593584747|FG007|Treatment Period|Disease Progression|3|||
164329610|NCT02598960|593584748|FG008|Treatment Period|Disease Progression|7|||
164329611|NCT02598960|593584749|FG009|Treatment Period|Disease Progression|9|||
164329612|NCT02598960|593584750|FG010|Treatment Period|Disease Progression|7|||
164329613|NCT02598960|593584751|FG011|Treatment Period|Disease Progression|143|||
164329614|NCT02598960|593584752|FG012|Treatment Period|Disease Progression|23|||
163881388|NCT02287610|591935542|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
163881389|NCT04950660|591935543|FG000|Overall Study|Protocol Violation|4|||
164329615|NCT02598960|593584740|FG000|Treatment Period|Study drug toxicity|0|||
164329616|NCT02598960|593584741|FG001|Treatment Period|Study drug toxicity|0|||
164329617|NCT02598960|593584742|FG002|Treatment Period|Study drug toxicity|0|||
164329618|NCT02598960|593584743|FG003|Treatment Period|Study drug toxicity|0|||
164329619|NCT02598960|593584744|FG004|Treatment Period|Study drug toxicity|0|||
163881390|NCT04950660|591935544|FG001|Overall Study|Protocol Violation|2|||
164081520|NCT01405820|592663288|FG005|Randomized Treatment Period|Other|0|||
164225037|NCT00968968|593192226|FG000|Overall Study|Withdrawal by Subject|2|||
164225038|NCT00968968|593192227|FG001|Overall Study|Withdrawal by Subject|0|||
164225039|NCT00968968|593192226|FG000|Overall Study|Physician Decision|1|||
164225040|NCT00968968|593192227|FG001|Overall Study|Physician Decision|2|||
164225041|NCT00968968|593192226|FG000|Overall Study|Lost to Follow-up|0|||
164329620|NCT02598960|593584745|FG005|Treatment Period|Study drug toxicity|0|||
164329621|NCT02598960|593584746|FG006|Treatment Period|Study drug toxicity|0|||
164329622|NCT02598960|593584747|FG007|Treatment Period|Study drug toxicity|0|||
164329623|NCT02598960|593584748|FG008|Treatment Period|Study drug toxicity|0|||
164329624|NCT02598960|593584749|FG009|Treatment Period|Study drug toxicity|1|||
164329625|NCT02598960|593584750|FG010|Treatment Period|Study drug toxicity|0|||
164329626|NCT02598960|593584751|FG011|Treatment Period|Study drug toxicity|3|||
164329627|NCT02598960|593584752|FG012|Treatment Period|Study drug toxicity|0|||
164329628|NCT02598960|593584740|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
164329629|NCT02598960|593584741|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
164329630|NCT02598960|593584742|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
164329631|NCT02598960|593584743|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
164329632|NCT02598960|593584744|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
164329633|NCT02598960|593584745|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
164329634|NCT02598960|593584746|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
164329635|NCT02598960|593584747|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
164329636|NCT02598960|593584748|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
164329637|NCT02598960|593584749|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
164329638|NCT02598960|593584750|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
164329639|NCT02598960|593584751|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
164329640|NCT02598960|593584752|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
164329641|NCT02598960|593584740|FG000|Treatment Period|participant request to discontinue|0|||
164329642|NCT02598960|593584741|FG001|Treatment Period|participant request to discontinue|1|||
164329643|NCT02598960|593584742|FG002|Treatment Period|participant request to discontinue|0|||
164329644|NCT02598960|593584743|FG003|Treatment Period|participant request to discontinue|0|||
164329645|NCT02598960|593584744|FG004|Treatment Period|participant request to discontinue|1|||
164329646|NCT02598960|593584745|FG005|Treatment Period|participant request to discontinue|0|||
164329647|NCT02598960|593584746|FG006|Treatment Period|participant request to discontinue|0|||
164329648|NCT02598960|593584747|FG007|Treatment Period|participant request to discontinue|0|||
164329649|NCT02598960|593584748|FG008|Treatment Period|participant request to discontinue|0|||
164329650|NCT02598960|593584749|FG009|Treatment Period|participant request to discontinue|0|||
164329651|NCT02598960|593584750|FG010|Treatment Period|participant request to discontinue|1|||
164329652|NCT02598960|593584751|FG011|Treatment Period|participant request to discontinue|4|||
164329653|NCT02598960|593584752|FG012|Treatment Period|participant request to discontinue|0|||
164329654|NCT02598960|593584740|FG000|Treatment Period|participant withdrew consent|0|||
164329655|NCT02598960|593584741|FG001|Treatment Period|participant withdrew consent|0|||
164329656|NCT02598960|593584742|FG002|Treatment Period|participant withdrew consent|0|||
164329657|NCT02598960|593584743|FG003|Treatment Period|participant withdrew consent|0|||
164329658|NCT02598960|593584744|FG004|Treatment Period|participant withdrew consent|0|||
164329659|NCT02598960|593584745|FG005|Treatment Period|participant withdrew consent|0|||
164225042|NCT00968968|593192227|FG001|Overall Study|Lost to Follow-up|1|||
164225043|NCT04401293|593192228|FG000|Overall Study|Withdrawal by Subject|1|||
164225044|NCT04401293|593192229|FG001|Overall Study|Withdrawal by Subject|3|||
164225045|NCT01783938|593192235|FG000|Overall Study|Disease Progression|18|||
164225046|NCT01783938|593192236|FG001|Overall Study|Disease Progression|41|||
164225047|NCT01783938|593192235|FG000|Overall Study|Study Drug Toxicity|27|||
164225048|NCT01783938|593192236|FG001|Overall Study|Study Drug Toxicity|14|||
164225049|NCT01783938|593192235|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
164225050|NCT01783938|593192236|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
164225051|NCT01783938|593192235|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
164225052|NCT01783938|593192236|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
164225053|NCT01783938|593192235|FG000|Overall Study|Participant Withdrew Consent|2|||
164225054|NCT01783938|593192236|FG001|Overall Study|Participant Withdrew Consent|0|||
164225055|NCT01783938|593192235|FG000|Overall Study|Maximum Clinical Benefit|1|||
164225056|NCT01783938|593192236|FG001|Overall Study|Maximum Clinical Benefit|0|||
164329660|NCT02598960|593584746|FG006|Treatment Period|participant withdrew consent|0|||
164329661|NCT02598960|593584747|FG007|Treatment Period|participant withdrew consent|0|||
164329662|NCT02598960|593584748|FG008|Treatment Period|participant withdrew consent|0|||
164329663|NCT02598960|593584749|FG009|Treatment Period|participant withdrew consent|0|||
164225057|NCT01783938|593192235|FG000|Overall Study|Other Reasons|3|||
164225058|NCT01783938|593192236|FG001|Overall Study|Other Reasons|1|||
164225059|NCT00930176|593192238|FG000|Overall Study|Death|1|||
164225060|NCT01712074|593192243|FG000|Placebo Run-in Period|Adverse Event|2|||
164225061|NCT01712074|593192244|FG001|Placebo Run-in Period|Adverse Event|0|||
164225062|NCT01712074|593192245|FG002|Placebo Run-in Period|Adverse Event|0|||
164329664|NCT02598960|593584750|FG010|Treatment Period|participant withdrew consent|0|||
164329665|NCT02598960|593584751|FG011|Treatment Period|participant withdrew consent|3|||
164329666|NCT02598960|593584752|FG012|Treatment Period|participant withdrew consent|0|||
164329667|NCT02598960|593584740|FG000|Treatment Period|No longer meets study criteria|0|||
164329668|NCT02598960|593584741|FG001|Treatment Period|No longer meets study criteria|0|||
164329669|NCT02598960|593584742|FG002|Treatment Period|No longer meets study criteria|0|||
164329670|NCT02598960|593584743|FG003|Treatment Period|No longer meets study criteria|0|||
164329671|NCT02598960|593584744|FG004|Treatment Period|No longer meets study criteria|0|||
164329672|NCT02598960|593584745|FG005|Treatment Period|No longer meets study criteria|0|||
164329673|NCT02598960|593584746|FG006|Treatment Period|No longer meets study criteria|0|||
164329674|NCT02598960|593584747|FG007|Treatment Period|No longer meets study criteria|0|||
164329675|NCT02598960|593584748|FG008|Treatment Period|No longer meets study criteria|0|||
164329676|NCT02598960|593584749|FG009|Treatment Period|No longer meets study criteria|0|||
164329677|NCT02598960|593584750|FG010|Treatment Period|No longer meets study criteria|0|||
164329678|NCT02598960|593584751|FG011|Treatment Period|No longer meets study criteria|1|||
164329679|NCT02598960|593584752|FG012|Treatment Period|No longer meets study criteria|0|||
164329680|NCT02598960|593584740|FG000|Treatment Period|Other Reasons|0|||
164329681|NCT02598960|593584741|FG001|Treatment Period|Other Reasons|0|||
164329682|NCT02598960|593584742|FG002|Treatment Period|Other Reasons|0|||
164329683|NCT02598960|593584743|FG003|Treatment Period|Other Reasons|0|||
164329684|NCT02598960|593584744|FG004|Treatment Period|Other Reasons|0|||
164329685|NCT02598960|593584745|FG005|Treatment Period|Other Reasons|0|||
164329686|NCT02598960|593584746|FG006|Treatment Period|Other Reasons|0|||
164329687|NCT02598960|593584747|FG007|Treatment Period|Other Reasons|0|||
164329688|NCT02598960|593584748|FG008|Treatment Period|Other Reasons|0|||
164329689|NCT02598960|593584749|FG009|Treatment Period|Other Reasons|0|||
164329690|NCT02598960|593584750|FG010|Treatment Period|Other Reasons|0|||
164329691|NCT02598960|593584751|FG011|Treatment Period|Other Reasons|0|||
164329692|NCT02598960|593584752|FG012|Treatment Period|Other Reasons|1|||
164329693|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|Death|1|||
164329694|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|Death|0|||
164329695|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|Death|0|||
164329696|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|Death|0|||
164329697|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|Death|0|||
164329698|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|Death|0|||
164329699|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|Death|0|||
164329700|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|Death|0|||
164329701|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|Death|0|||
164329702|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|Death|1|||
164329703|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|Death|0|||
164329704|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|Death|11|||
164329705|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|Death|2|||
164329706|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329707|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329708|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329709|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329710|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329711|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329712|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329713|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329714|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329715|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329716|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329717|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
164329718|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
164329719|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
164329720|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
164329721|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
164329722|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
164329723|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
164329724|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
164329725|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
163881391|NCT04950660|591935543|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
164329726|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
164329727|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
163881392|NCT04950660|591935544|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
164329728|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
163881393|NCT04950660|591935543|FG000|Overall Study|Withdrawal by Subject|0|||
164329729|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
164329730|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
164329731|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
164329732|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329733|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329734|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329735|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329736|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329737|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329738|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329739|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329740|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329741|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329742|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329743|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
164329744|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
164329745|NCT02598960|593584740|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
164329746|NCT02598960|593584741|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
164329747|NCT02598960|593584742|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
164329748|NCT02598960|593584743|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
164329749|NCT02598960|593584744|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
164329750|NCT02598960|593584745|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
164329751|NCT02598960|593584746|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
164329752|NCT02598960|593584747|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
164329753|NCT02598960|593584748|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
164329754|NCT02598960|593584749|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
164329755|NCT02598960|593584750|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
164329756|NCT02598960|593584751|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
164329757|NCT02598960|593584752|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
164329758|NCT00398411|593584753|FG000|Overall Study|Death|0|||
164329759|NCT00398411|593584754|FG001|Overall Study|Death|1|||
164329760|NCT00401531|593584755|FG000|Overall Study|Adverse Event|2|||
164329761|NCT00401531|593584756|FG001|Overall Study|Adverse Event|0|||
164329762|NCT00401531|593584755|FG000|Overall Study|Protocol Violation|3|||
164329763|NCT00401531|593584756|FG001|Overall Study|Protocol Violation|7|||
164329764|NCT00401531|593584755|FG000|Overall Study|Lost to Follow-up|1|||
164329765|NCT00401531|593584756|FG001|Overall Study|Lost to Follow-up|1|||
164329766|NCT00401531|593584755|FG000|Overall Study|Withdrawal by Subject|3|||
164329767|NCT00401531|593584756|FG001|Overall Study|Withdrawal by Subject|2|||
164329768|NCT01614600|593584761|FG000|Overall Study|Unacceptable fit|1|||
164329769|NCT01614600|593584761|FG000|Overall Study|Discomfort|1|||
164329770|NCT01614600|593584761|FG000|Overall Study|Unable to remove lens at the end of day|1|||
164329771|NCT01614600|593584761|FG000|Overall Study|Protocol deviation|1|||
164329772|NCT03403374|593584762|FG000|Overall Study|Lost to Follow-up|1|||
164329773|NCT00736957|593584768|FG000|Overall Study|Adverse Event|43|||
164329774|NCT00736957|593584768|FG000|Overall Study|Withdrawal by Subject|49|||
164329775|NCT00736957|593584768|FG000|Overall Study|violation of eligibility criteria|2|||
164329776|NCT00736957|593584768|FG000|Overall Study|did not attend hospital appointments|1|||
164329777|NCT00736957|593584768|FG000|Overall Study|not eligible for Treatment Period I|22|||
164329778|NCT00736957|593584768|FG000|Overall Study|Physician Decision|5|||
164329779|NCT02395666|593584769|FG000|Overall Study|Physician Decision|3|||
164329780|NCT02395666|593584770|FG001|Overall Study|Physician Decision|0|||
164329781|NCT02395666|593584769|FG000|Overall Study|Lost to Follow-up|1|||
164329782|NCT02395666|593584770|FG001|Overall Study|Lost to Follow-up|0|||
164329783|NCT02395666|593584769|FG000|Overall Study|Withdrawal by Subject|2|||
164329784|NCT02395666|593584770|FG001|Overall Study|Withdrawal by Subject|1|||
164329785|NCT03646643|593584771|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
164329786|NCT03646643|593584772|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
164329787|NCT03646643|593584771|FG000|Overall Study|Lost to Follow-up|0|||
164329788|NCT03646643|593584772|FG001|Overall Study|Lost to Follow-up|1|||
164329789|NCT02806973|593584773|FG000|Period 1|Withdrawal by Subject|0|||
164329790|NCT02806973|593584774|FG001|Period 1|Withdrawal by Subject|2|||
164329791|NCT02806973|593584775|FG002|Period 1|Withdrawal by Subject|1|||
164329792|NCT02806973|593584776|FG003|Period 1|Withdrawal by Subject|1|||
164329793|NCT02806973|593584773|FG000|Period 1|Adverse Event|0|||
164329794|NCT02806973|593584774|FG001|Period 1|Adverse Event|0|||
164329795|NCT02806973|593584775|FG002|Period 1|Adverse Event|0|||
164329796|NCT02806973|593584776|FG003|Period 1|Adverse Event|1|||
163985702|NCT01844895|592316282|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
164329797|NCT02806973|593584773|FG000|Period 3|Withdrawal by Subject|0|||
164329798|NCT02806973|593584774|FG001|Period 3|Withdrawal by Subject|0|||
164329799|NCT02806973|593584775|FG002|Period 3|Withdrawal by Subject|0|||
164329800|NCT02806973|593584776|FG003|Period 3|Withdrawal by Subject|3|||
164329801|NCT02806973|593584773|FG000|Period 3|Adverse Event|0|||
164329802|NCT02806973|593584774|FG001|Period 3|Adverse Event|0|||
164329803|NCT02806973|593584775|FG002|Period 3|Adverse Event|1|||
164329804|NCT02806973|593584776|FG003|Period 3|Adverse Event|0|||
164329805|NCT04209426|593584779|FG000|Overall Study|Lost to Follow-up|3|||
164329806|NCT04209426|593584780|FG001|Overall Study|Lost to Follow-up|2|||
164329807|NCT04060862|593584781|FG000|Overall Study|Symptomatic Deterioration|1|||
164329808|NCT04060862|593584781|FG000|Overall Study|Un-specified|6|||
164329809|NCT04060862|593584781|FG000|Overall Study|Progressive disease|12|||
164329810|NCT04060862|593584781|FG000|Overall Study|Physician Decision|1|||
164329811|NCT01031381|593584786|FG000|Overall Study|Physician Decision|3|||
164329812|NCT01031381|593584786|FG000|Overall Study|Withdrawal by Subject|6|||
164329813|NCT02694523|593584787|FG000|Part A|Adverse Event|7|||
164329814|NCT02694523|593584788|FG001|Part A|Adverse Event|3|||
164329815|NCT02694523|593584789|FG002|Part A|Adverse Event|0|||
164329816|NCT02694523|593584790|FG003|Part A|Adverse Event|0|||
164329817|NCT02694523|593584791|FG004|Part A|Adverse Event|0|||
164329818|NCT02694523|593584792|FG005|Part A|Adverse Event|0|||
164329819|NCT02694523|593584793|FG006|Part A|Adverse Event|0|||
164225063|NCT01712074|593192243|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
164225064|NCT01712074|593192244|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
164225065|NCT01712074|593192245|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
164225066|NCT01712074|593192243|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
164225067|NCT01712074|593192244|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
164225068|NCT01712074|593192245|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
164225069|NCT01712074|593192243|FG000|Placebo Run-in Period|Other|1|||
164225070|NCT01712074|593192244|FG001|Placebo Run-in Period|Other|0|||
164225071|NCT01712074|593192245|FG002|Placebo Run-in Period|Other|0|||
164225072|NCT01712074|593192243|FG000|Placebo Run-in Period|No longer willing to participate|1|||
164225073|NCT01712074|593192244|FG001|Placebo Run-in Period|No longer willing to participate|0|||
164225074|NCT01712074|593192245|FG002|Placebo Run-in Period|No longer willing to participate|0|||
164225075|NCT01712074|593192243|FG000|Double Blind Period|Adverse Event|0|||
164225076|NCT01712074|593192244|FG001|Double Blind Period|Adverse Event|2|||
164225077|NCT01712074|593192245|FG002|Double Blind Period|Adverse Event|1|||
164225078|NCT01712074|593192243|FG000|Double Blind Period|No longer willing to participate|0|||
164225079|NCT01712074|593192244|FG001|Double Blind Period|No longer willing to participate|2|||
164225080|NCT01712074|593192245|FG002|Double Blind Period|No longer willing to participate|4|||
164225081|NCT01712074|593192243|FG000|Double Blind Period|Death|0|||
164225082|NCT01712074|593192244|FG001|Double Blind Period|Death|1|||
164225083|NCT01712074|593192245|FG002|Double Blind Period|Death|0|||
164225084|NCT01712074|593192243|FG000|Double Blind Period|Lost to Follow-up|0|||
164225085|NCT01712074|593192244|FG001|Double Blind Period|Lost to Follow-up|2|||
164225086|NCT01712074|593192245|FG002|Double Blind Period|Lost to Follow-up|1|||
164225087|NCT01712074|593192243|FG000|Double Blind Period|Other|0|||
164225088|NCT01712074|593192244|FG001|Double Blind Period|Other|4|||
164225089|NCT01712074|593192245|FG002|Double Blind Period|Other|1|||
164225090|NCT01712074|593192243|FG000|Double Blind Period|Protocol Violation|0|||
164225091|NCT01712074|593192244|FG001|Double Blind Period|Protocol Violation|0|||
164225092|NCT01712074|593192245|FG002|Double Blind Period|Protocol Violation|1|||
164225093|NCT01712074|593192243|FG000|Double Blind Period|No longer met eligibility criteria|0|||
164225094|NCT01712074|593192244|FG001|Double Blind Period|No longer met eligibility criteria|3|||
164225095|NCT01712074|593192245|FG002|Double Blind Period|No longer met eligibility criteria|0|||
164225096|NCT03478787|593192246|FG000|Overall Study|Adverse Event|5|||
164329820|NCT02694523|593584787|FG000|Part A|Protocol Violation|1|||
164329821|NCT02694523|593584788|FG001|Part A|Protocol Violation|0|||
164225097|NCT03478787|593192247|FG001|Overall Study|Adverse Event|1|||
164225098|NCT03478787|593192246|FG000|Overall Study|Protocol Violation|3|||
164225099|NCT03478787|593192247|FG001|Overall Study|Protocol Violation|0|||
164225100|NCT03478787|593192246|FG000|Overall Study|Lack of Efficacy|7|||
164225101|NCT03478787|593192247|FG001|Overall Study|Lack of Efficacy|1|||
164225102|NCT03478787|593192246|FG000|Overall Study|Lost to Follow-up|9|||
164225103|NCT03478787|593192247|FG001|Overall Study|Lost to Follow-up|5|||
164225104|NCT03478787|593192246|FG000|Overall Study|Withdrawal by Subject|2|||
164329822|NCT02694523|593584789|FG002|Part A|Protocol Violation|0|||
164329823|NCT02694523|593584790|FG003|Part A|Protocol Violation|0|||
164329824|NCT02694523|593584791|FG004|Part A|Protocol Violation|0|||
164225105|NCT03478787|593192247|FG001|Overall Study|Withdrawal by Subject|6|||
164329825|NCT02694523|593584792|FG005|Part A|Protocol Violation|0|||
164329826|NCT02694523|593584793|FG006|Part A|Protocol Violation|0|||
164225106|NCT03478787|593192246|FG000|Overall Study|Other, Not Specified|3|||
164225107|NCT03478787|593192247|FG001|Overall Study|Other, Not Specified|0|||
164225108|NCT02413346|593192248|FG000|Overall Study|Adverse Event|6|||
164225109|NCT02413346|593192249|FG001|Overall Study|Adverse Event|6|||
164329827|NCT02694523|593584787|FG000|Part A|Lost to Follow-up|1|||
164329828|NCT02694523|593584788|FG001|Part A|Lost to Follow-up|2|||
163881394|NCT04950660|591935544|FG001|Overall Study|Withdrawal by Subject|1|||
163881395|NCT04950660|591935543|FG000|Overall Study|Hypotension|1|||
163881396|NCT04950660|591935544|FG001|Overall Study|Hypotension|0|||
163881397|NCT04783935|591935547|FG000|Overall Study|Withdrawal by Subject|6|||
163881398|NCT04783935|591935547|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
163881399|NCT04783935|591935547|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
163881400|NCT04783935|591935547|FG000|Overall Study|Lost to Follow-up|3|||
163881401|NCT04783935|591935547|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
163881402|NCT05273749|591935550|FG000|Overall Study|Adverse Event|14|||
163881403|NCT05273749|591935551|FG001|Overall Study|Adverse Event|8|||
164225110|NCT02413346|593192248|FG000|Overall Study|Withdrawal by Subject|30|||
164225111|NCT02413346|593192249|FG001|Overall Study|Withdrawal by Subject|40|||
164225112|NCT02413346|593192248|FG000|Overall Study|Lost to Follow-up|17|||
164225113|NCT02413346|593192249|FG001|Overall Study|Lost to Follow-up|21|||
164225114|NCT02413346|593192248|FG000|Overall Study|Protocol Violation|2|||
164225115|NCT02413346|593192249|FG001|Overall Study|Protocol Violation|0|||
164225116|NCT02413346|593192248|FG000|Overall Study|Other Miscellaneous Reasons|4|||
164225117|NCT02413346|593192249|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164225118|NCT02766478|593192254|FG000|Overall Study|Withdrawal by Subject|1|||
164225119|NCT02766478|593192255|FG001|Overall Study|Withdrawal by Subject|1|||
164225120|NCT05626686|593192256|FG000|Overall Study|Protocol Violation|3|||
164225121|NCT05626686|593192256|FG000|Overall Study|Withdrawal by Subject|3|||
164225122|NCT00682435|593192257|FG000|Overall Study|Insufficient data|5|||
164225123|NCT00682435|593192257|FG000|Overall Study|Erroneously enrolled twice|2|||
164225124|NCT00089583|593192258|FG000|Overall Study|Adverse Event|0|||
164225125|NCT00089583|593192259|FG001|Overall Study|Adverse Event|3|||
164225126|NCT00089583|593192258|FG000|Overall Study|Insufficient Viral Load Response|5|||
164225127|NCT00089583|593192259|FG001|Overall Study|Insufficient Viral Load Response|5|||
164225128|NCT00089583|593192258|FG000|Overall Study|Withdrawal by Subject|0|||
164225129|NCT00089583|593192259|FG001|Overall Study|Withdrawal by Subject|4|||
164225130|NCT00089583|593192258|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
164225131|NCT00089583|593192259|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
164225132|NCT00089583|593192258|FG000|Overall Study|Participant Refused Study Medication|0|||
164225133|NCT00089583|593192259|FG001|Overall Study|Participant Refused Study Medication|2|||
164225134|NCT00089583|593192258|FG000|Overall Study|Non-Compliance|0|||
164225135|NCT00089583|593192259|FG001|Overall Study|Non-Compliance|4|||
164225136|NCT00089583|593192258|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
164225137|NCT00089583|593192259|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
164225138|NCT00089583|593192258|FG000|Overall Study|Participant Management Criteria Met|0|||
164225139|NCT00089583|593192259|FG001|Overall Study|Participant Management Criteria Met|1|||
164225140|NCT00089583|593192258|FG000|Overall Study|Reason Not Provided|0|||
164225141|NCT00089583|593192259|FG001|Overall Study|Reason Not Provided|1|||
164225142|NCT00089583|593192258|FG000|Overall Study|Protocol Violation|0|||
164225143|NCT00089583|593192259|FG001|Overall Study|Protocol Violation|3|||
164225144|NCT00089583|593192258|FG000|Overall Study|Principal Investigator Decision|0|||
164225145|NCT00089583|593192259|FG001|Overall Study|Principal Investigator Decision|10|||
164225146|NCT00089583|593192258|FG000|Overall Study|Start of Disallowed Medication|0|||
164225147|NCT00089583|593192259|FG001|Overall Study|Start of Disallowed Medication|1|||
164225148|NCT00089583|593192258|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
164225149|NCT00089583|593192259|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
164225150|NCT00089583|593192258|FG000|Overall Study|Participant Incarcerated|0|||
164225151|NCT00089583|593192259|FG001|Overall Study|Participant Incarcerated|1|||
164225152|NCT03289741|593192260|FG000|Overall Study|Adverse Event|1|||
164225153|NCT03289741|593192261|FG001|Overall Study|Adverse Event|1|||
164225154|NCT03289741|593192260|FG000|Overall Study|Physician Decision|2|||
164225155|NCT03289741|593192261|FG001|Overall Study|Physician Decision|2|||
164225156|NCT03289741|593192260|FG000|Overall Study|Withdrawal by Subject|1|||
164225157|NCT03289741|593192261|FG001|Overall Study|Withdrawal by Subject|0|||
164225158|NCT00992394|593192265|FG000|Overall Study|Lack of Efficacy|6|||
164225159|NCT00992394|593192266|FG001|Overall Study|Lack of Efficacy|3|||
164225160|NCT00992394|593192265|FG000|Overall Study|Adverse Event|4|||
164225161|NCT00992394|593192266|FG001|Overall Study|Adverse Event|5|||
164225162|NCT00992394|593192265|FG000|Overall Study|Withdrawal by Subject|8|||
164225163|NCT00992394|593192266|FG001|Overall Study|Withdrawal by Subject|2|||
164225164|NCT00992394|593192265|FG000|Overall Study|Physician Decision|1|||
164225165|NCT00992394|593192266|FG001|Overall Study|Physician Decision|0|||
164225166|NCT00992394|593192265|FG000|Overall Study|Protocol Violation|2|||
164225167|NCT00992394|593192266|FG001|Overall Study|Protocol Violation|4|||
164225168|NCT00992394|593192265|FG000|Overall Study|Lost to Follow-up|2|||
164225169|NCT00992394|593192266|FG001|Overall Study|Lost to Follow-up|0|||
164225170|NCT00992394|593192265|FG000|Overall Study|Other event|1|||
164225171|NCT00992394|593192266|FG001|Overall Study|Other event|0|||
164225172|NCT01245049|593192267|FG000|Overall Study|Migrated/moved from study area|0|||
164225173|NCT01245049|593192268|FG001|Overall Study|Migrated/moved from study area|1|||
164225174|NCT01245049|593192267|FG000|Overall Study|Withdrawal by Subject|0|||
164225175|NCT01245049|593192268|FG001|Overall Study|Withdrawal by Subject|1|||
164329829|NCT02694523|593584789|FG002|Part A|Lost to Follow-up|0|||
164329830|NCT02694523|593584790|FG003|Part A|Lost to Follow-up|0|||
164329831|NCT02694523|593584791|FG004|Part A|Lost to Follow-up|0|||
164329832|NCT02694523|593584792|FG005|Part A|Lost to Follow-up|0|||
163881404|NCT05273749|591935550|FG000|Overall Study|Lack of Efficacy|2|||
163881405|NCT05273749|591935551|FG001|Overall Study|Lack of Efficacy|8|||
163881406|NCT05273749|591935550|FG000|Overall Study|Physician Decision|0|||
163881407|NCT05273749|591935551|FG001|Overall Study|Physician Decision|2|||
163881408|NCT05273749|591935550|FG000|Overall Study|Withdrawal by Subject|14|||
163881409|NCT05273749|591935551|FG001|Overall Study|Withdrawal by Subject|16|||
163881410|NCT05273749|591935550|FG000|Overall Study|Lost to Follow-up|10|||
163881411|NCT05273749|591935551|FG001|Overall Study|Lost to Follow-up|10|||
163881412|NCT05273749|591935550|FG000|Overall Study|Pregnancy|1|||
163881413|NCT05273749|591935551|FG001|Overall Study|Pregnancy|0|||
163881414|NCT05273749|591935550|FG000|Overall Study|Non-Compliance|3|||
163881415|NCT05273749|591935551|FG001|Overall Study|Non-Compliance|2|||
163881416|NCT05273749|591935550|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
163881417|NCT05273749|591935551|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
163881418|NCT04382898|591935552|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
163881419|NCT04382898|591935553|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
163881420|NCT04382898|591935554|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
163881421|NCT04382898|591935555|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
163881422|NCT04382898|591935556|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
163881423|NCT04382898|591935552|FG000|Part 1: Dose Titration|Death|6|||
163881424|NCT04382898|591935553|FG001|Part 1: Dose Titration|Death|0|||
163881425|NCT04382898|591935554|FG002|Part 1: Dose Titration|Death|0|||
163881426|NCT04382898|591935555|FG003|Part 1: Dose Titration|Death|0|||
163881427|NCT04382898|591935556|FG004|Part 1: Dose Titration|Death|0|||
163881428|NCT04382898|591935552|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163881429|NCT04382898|591935553|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163881430|NCT04382898|591935554|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
163881431|NCT04382898|591935555|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163881432|NCT04382898|591935556|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
163881433|NCT04382898|591935552|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
163881434|NCT04382898|591935553|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
163881435|NCT04382898|591935554|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
163881436|NCT04382898|591935555|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
163881437|NCT04382898|591935556|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
163881438|NCT04382898|591935552|FG000|Part 2: Dose Expansion|Death|0|||
163881439|NCT04382898|591935553|FG001|Part 2: Dose Expansion|Death|17|||
163881440|NCT04382898|591935554|FG002|Part 2: Dose Expansion|Death|13|||
163881441|NCT04382898|591935555|FG003|Part 2: Dose Expansion|Death|1|||
163881442|NCT04382898|591935556|FG004|Part 2: Dose Expansion|Death|0|||
163881443|NCT04382898|591935552|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
163881444|NCT04382898|591935553|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
163881445|NCT04382898|591935554|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
163881446|NCT04382898|591935555|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
163881447|NCT04382898|591935556|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
163881448|NCT04382898|591935552|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
163881449|NCT04382898|591935553|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
163881450|NCT04382898|591935554|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
163881451|NCT04382898|591935555|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
163881452|NCT04382898|591935556|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
163881453|NCT04382898|591935552|FG000|Part 2: Dose Expansion|Other|0|||
163881454|NCT04382898|591935553|FG001|Part 2: Dose Expansion|Other|0|||
163881455|NCT04382898|591935554|FG002|Part 2: Dose Expansion|Other|1|||
163881456|NCT04382898|591935555|FG003|Part 2: Dose Expansion|Other|0|||
163881457|NCT04382898|591935556|FG004|Part 2: Dose Expansion|Other|0|||
163881458|NCT05229120|591935557|FG000|Overall Study|Withdrawal by Subject|8|||
163881459|NCT03932682|591935560|FG000|Overall Study|Death|1|||
163881460|NCT03932682|591935561|FG001|Overall Study|Death|2|||
163881461|NCT03932682|591935560|FG000|Overall Study|Withdrawal by Subject|37|||
163881462|NCT03932682|591935561|FG001|Overall Study|Withdrawal by Subject|45|||
163881463|NCT03932682|591935560|FG000|Overall Study|Lost to Follow-up|19|||
163881464|NCT03932682|591935561|FG001|Overall Study|Lost to Follow-up|25|||
163881465|NCT03932682|591935560|FG000|Overall Study|Protocol Violation|0|||
163985703|NCT01318109|592316283|FG000|Overall Study|Adverse Event|0|||
163985704|NCT01318109|592316284|FG001|Overall Study|Adverse Event|2|||
163881466|NCT03932682|591935561|FG001|Overall Study|Protocol Violation|2|||
163985705|NCT01318109|592316285|FG002|Overall Study|Adverse Event|0|||
163881467|NCT03932682|591935560|FG000|Overall Study|Other|9|||
163881468|NCT03932682|591935561|FG001|Overall Study|Other|23|||
163881469|NCT04321031|591935562|FG000|Overall Study|Adverse Event|0|||
163881470|NCT04321031|591935563|FG001|Overall Study|Adverse Event|2|||
163881471|NCT04321031|591935564|FG002|Overall Study|Adverse Event|2|||
164329833|NCT02694523|593584793|FG006|Part A|Lost to Follow-up|0|||
164225176|NCT01245049|593192267|FG000|Overall Study|Lost to Follow-up|1|||
164225177|NCT01245049|593192268|FG001|Overall Study|Lost to Follow-up|2|||
164225178|NCT00450749|593192269|FG000|Overall Study|Withdrawal by Subject|0|||
164225179|NCT00450749|593192270|FG001|Overall Study|Withdrawal by Subject|0|||
164225180|NCT00450749|593192271|FG002|Overall Study|Withdrawal by Subject|2|||
164225181|NCT00450749|593192269|FG000|Overall Study|Noncompliant|0|||
164225182|NCT00450749|593192270|FG001|Overall Study|Noncompliant|1|||
164225183|NCT00450749|593192271|FG002|Overall Study|Noncompliant|0|||
164225184|NCT02151604|593192272|FG000|Overall Study|Lost to Follow-up|3|||
164225185|NCT02151604|593192272|FG000|Overall Study|Withdrawal by Subject|2|||
164225186|NCT02151604|593192272|FG000|Overall Study|Physician Decision|3|||
163881472|NCT04321031|591935565|FG003|Overall Study|Adverse Event|2|||
163881473|NCT04321031|591935566|FG004|Overall Study|Adverse Event|2|||
163881474|NCT04321031|591935567|FG005|Overall Study|Adverse Event|2|||
163881475|NCT04321031|591935568|FG006|Overall Study|Adverse Event|0|||
163881476|NCT04321031|591935562|FG000|Overall Study|Lost to Follow-up|0|||
164225187|NCT02151604|593192272|FG000|Overall Study|Death|1|||
164225188|NCT00537082|593192274|FG000|Overall Study|Adverse Event|6|||
164225189|NCT00537082|593192275|FG001|Overall Study|Adverse Event|6|||
163881477|NCT04321031|591935563|FG001|Overall Study|Lost to Follow-up|0|||
163881478|NCT04321031|591935564|FG002|Overall Study|Lost to Follow-up|0|||
163881479|NCT04321031|591935565|FG003|Overall Study|Lost to Follow-up|1|||
163881480|NCT04321031|591935566|FG004|Overall Study|Lost to Follow-up|0|||
164225190|NCT00537082|593192276|FG002|Overall Study|Adverse Event|3|||
164225191|NCT00537082|593192274|FG000|Overall Study|Protocol Violation|0|||
164225192|NCT00537082|593192275|FG001|Overall Study|Protocol Violation|2|||
164225193|NCT00537082|593192276|FG002|Overall Study|Protocol Violation|1|||
164225194|NCT00537082|593192274|FG000|Overall Study|Lack of Efficacy|0|||
164225195|NCT00537082|593192275|FG001|Overall Study|Lack of Efficacy|0|||
164225196|NCT00537082|593192276|FG002|Overall Study|Lack of Efficacy|2|||
164225197|NCT00537082|593192274|FG000|Overall Study|Withdrawal by Subject|0|||
164225198|NCT00537082|593192275|FG001|Overall Study|Withdrawal by Subject|1|||
164225199|NCT00537082|593192276|FG002|Overall Study|Withdrawal by Subject|0|||
164225200|NCT00537082|593192274|FG000|Overall Study|Discontinued before initiating treatment|3|||
164225201|NCT00537082|593192275|FG001|Overall Study|Discontinued before initiating treatment|0|||
164225202|NCT00537082|593192276|FG002|Overall Study|Discontinued before initiating treatment|0|||
164225203|NCT04495478|593192277|FG000|Overall Study|Withdrawal by Subject|0|||
164225204|NCT04495478|593192278|FG001|Overall Study|Withdrawal by Subject|0|||
164225205|NCT04495478|593192279|FG002|Overall Study|Withdrawal by Subject|0|||
164225206|NCT04495478|593192280|FG003|Overall Study|Withdrawal by Subject|1|||
164225207|NCT04495478|593192281|FG004|Overall Study|Withdrawal by Subject|0|||
164225208|NCT04495478|593192282|FG005|Overall Study|Withdrawal by Subject|0|||
164225209|NCT04495478|593192283|FG006|Overall Study|Withdrawal by Subject|0|||
164225210|NCT04495478|593192277|FG000|Overall Study|Physician Decision|0|||
164225211|NCT04495478|593192278|FG001|Overall Study|Physician Decision|1|||
164225212|NCT04495478|593192279|FG002|Overall Study|Physician Decision|0|||
164225213|NCT04495478|593192280|FG003|Overall Study|Physician Decision|0|||
164225214|NCT04495478|593192281|FG004|Overall Study|Physician Decision|1|||
164225215|NCT04495478|593192282|FG005|Overall Study|Physician Decision|0|||
164225216|NCT04495478|593192283|FG006|Overall Study|Physician Decision|0|||
164225217|NCT00655746|593192284|FG000|Overall Study|Withdrawal by Subject|1|||
164225218|NCT00561821|593192285|FG000|Overall Study|Not treated|0|||
164225219|NCT00561821|593192286|FG001|Overall Study|Not treated|0|||
164225220|NCT00561821|593192287|FG002|Overall Study|Not treated|1|||
164225221|NCT00561821|593192288|FG003|Overall Study|Not treated|0|||
164225222|NCT00561821|593192285|FG000|Overall Study|Withdrawal by Subject|0|||
164225223|NCT00561821|593192286|FG001|Overall Study|Withdrawal by Subject|1|||
164225224|NCT00561821|593192287|FG002|Overall Study|Withdrawal by Subject|0|||
164225225|NCT00561821|593192288|FG003|Overall Study|Withdrawal by Subject|2|||
164225226|NCT00561821|593192285|FG000|Overall Study|Reasons not related to trial|2|||
164225227|NCT00561821|593192286|FG001|Overall Study|Reasons not related to trial|1|||
164225228|NCT00561821|593192287|FG002|Overall Study|Reasons not related to trial|0|||
164225229|NCT00561821|593192288|FG003|Overall Study|Reasons not related to trial|0|||
164225230|NCT00561821|593192285|FG000|Overall Study|Other (reason not specified)|1|||
164225231|NCT00561821|593192286|FG001|Overall Study|Other (reason not specified)|1|||
163881481|NCT04321031|591935567|FG005|Overall Study|Lost to Follow-up|2|||
163881482|NCT04321031|591935568|FG006|Overall Study|Lost to Follow-up|1|||
164225232|NCT00561821|593192287|FG002|Overall Study|Other (reason not specified)|0|||
164225233|NCT00561821|593192288|FG003|Overall Study|Other (reason not specified)|0|||
164225234|NCT00561821|593192285|FG000|Overall Study|Adverse Event|2|||
164225235|NCT00561821|593192286|FG001|Overall Study|Adverse Event|3|||
164225236|NCT00561821|593192287|FG002|Overall Study|Adverse Event|1|||
164225237|NCT00561821|593192288|FG003|Overall Study|Adverse Event|1|||
164225238|NCT03178942|593192289|FG000|Overall Study|Withdrawal by Subject|2|||
164225239|NCT03178942|593192290|FG001|Overall Study|Withdrawal by Subject|0|||
164225240|NCT03178942|593192289|FG000|Overall Study|Lost to Follow-up|1|||
164225241|NCT03178942|593192290|FG001|Overall Study|Lost to Follow-up|2|||
164225242|NCT01197300|593193950|FG000|Overall Study|Lost to Follow-up|0|||
163985706|NCT01318109|592316283|FG000|Overall Study|Withdrawal by Subject|1|||
163985707|NCT01318109|592316284|FG001|Overall Study|Withdrawal by Subject|0|||
163985708|NCT01318109|592316285|FG002|Overall Study|Withdrawal by Subject|0|||
163985709|NCT01318109|592316283|FG000|Overall Study|Schedule Conflict|0|||
163985710|NCT01318109|592316284|FG001|Overall Study|Schedule Conflict|1|||
163985711|NCT01318109|592316285|FG002|Overall Study|Schedule Conflict|0|||
163985712|NCT04982250|592316293|FG000|Overall Study|Lost to Follow-up|0|||
163985713|NCT04982250|592316294|FG001|Overall Study|Lost to Follow-up|26|||
163985714|NCT04982250|592316295|FG002|Overall Study|Lost to Follow-up|0|||
163985715|NCT04982250|592316296|FG003|Overall Study|Lost to Follow-up|0|||
163985716|NCT04982250|592316297|FG004|Overall Study|Lost to Follow-up|72|||
163985717|NCT04982250|592316298|FG005|Overall Study|Lost to Follow-up|69|||
163985718|NCT04982250|592316293|FG000|Overall Study|Not Eligible to Enroll|0|||
163985719|NCT04982250|592316294|FG001|Overall Study|Not Eligible to Enroll|0|||
163985720|NCT04982250|592316295|FG002|Overall Study|Not Eligible to Enroll|0|||
163985721|NCT04982250|592316296|FG003|Overall Study|Not Eligible to Enroll|0|||
163985722|NCT04982250|592316297|FG004|Overall Study|Not Eligible to Enroll|10|||
163985723|NCT04982250|592316298|FG005|Overall Study|Not Eligible to Enroll|7|||
163985724|NCT02926950|592316306|FG000|Overall Study|Adverse Event|4|||
163985725|NCT02926950|592316307|FG001|Overall Study|Adverse Event|6|||
163985726|NCT02926950|592316306|FG000|Overall Study|At the participant's own request|21|||
163985727|NCT02926950|592316307|FG001|Overall Study|At the participant's own request|25|||
163985728|NCT02926950|592316306|FG000|Overall Study|Reason not Specified|17|||
163985729|NCT02926950|592316307|FG001|Overall Study|Reason not Specified|9|||
163985730|NCT02926950|592316306|FG000|Overall Study|Lost to Follow-up|7|||
163985731|NCT02926950|592316307|FG001|Overall Study|Lost to Follow-up|8|||
163985732|NCT02028455|592316310|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163985733|NCT02028455|592316311|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163985734|NCT02028455|592316312|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163985735|NCT02028455|592316313|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163985736|NCT02028455|592316314|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163985737|NCT02028455|592316315|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
163985738|NCT02028455|592316316|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
163985739|NCT02028455|592316317|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
163985740|NCT02028455|592316310|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
163985741|NCT02028455|592316311|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
163985742|NCT02028455|592316312|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
163985743|NCT02028455|592316313|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
163985744|NCT02028455|592316314|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
163985745|NCT02028455|592316315|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
163985746|NCT02028455|592316316|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
163985747|NCT02028455|592316317|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
163985748|NCT02028455|592316310|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163985749|NCT02028455|592316311|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163985750|NCT02028455|592316312|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163985751|NCT02028455|592316313|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163985752|NCT02028455|592316314|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163985753|NCT02028455|592316315|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
163985754|NCT02028455|592316316|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
163985755|NCT02028455|592316317|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
163985756|NCT02028455|592316310|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163985757|NCT02028455|592316311|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163985758|NCT02028455|592316312|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
163985759|NCT02028455|592316313|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
163985760|NCT02028455|592316314|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163985761|NCT02028455|592316315|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
163985762|NCT02028455|592316316|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
163985763|NCT02028455|592316317|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
163985764|NCT07099521|592316318|FG000|Overall Study|Incompeleted stimulus program|1|||
163985765|NCT07099521|592316319|FG001|Overall Study|Incompeleted stimulus program|0|||
163985766|NCT07099521|592316318|FG000|Overall Study|Non-social anxiety symtpoms|0|||
163985767|NCT07099521|592316319|FG001|Overall Study|Non-social anxiety symtpoms|1|||
163985768|NCT07099521|592316318|FG000|Overall Study|Extreme values|2|||
163985769|NCT07099521|592316319|FG001|Overall Study|Extreme values|4|||
163985770|NCT02392429|592317850|FG000|Screening|Screen failure|15|||
163985771|NCT02392429|592317850|FG000|Enrolled Participants|Ineligible due to disease|3|||
163985772|NCT02392429|592317850|FG000|Enrolled Participants|Withdrawal by Subject|4|||
164225243|NCT01197300|593193951|FG001|Overall Study|Lost to Follow-up|1|||
164225244|NCT01197300|593193950|FG000|Overall Study|Protocol Violation|0|||
164225245|NCT01197300|593193951|FG001|Overall Study|Protocol Violation|1|||
164225246|NCT03443401|593193960|FG000|Overall Study|Lost to Follow-up|13|||
164225247|NCT03443401|593193960|FG000|Overall Study|Influential outlier|1|||
164225248|NCT02363283|593193961|FG000|Overall Study|Withdrawal by Subject|1|||
164225249|NCT02363283|593193961|FG000|Overall Study|Not eligible due to transaminitis|1|||
164225250|NCT00530257|593193967|FG000|Overall Study|Lost to Follow-up|1|||
164225251|NCT04110145|593193971|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225252|NCT04110145|593193972|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225253|NCT04110145|593193973|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225254|NCT04110145|593193974|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
164225255|NCT04110145|593193975|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
164225256|NCT05401409|593193976|FG000|Overall Study|Lost to Follow-up|1|||
164225257|NCT05401409|593193977|FG001|Overall Study|Lost to Follow-up|0|||
164225258|NCT02562040|593193978|FG000|Overall Study|Lost to Follow-up|20|||
164225259|NCT02562040|593193979|FG001|Overall Study|Lost to Follow-up|28|||
163985773|NCT02392429|592317850|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
163985774|NCT02392429|592317850|FG000|Evaluable|Death|5|||
163985775|NCT02392429|592317850|FG000|Evaluable|Withdrawal by Subject|1|||
163985776|NCT02392429|592317850|FG000|Evaluable|Adverse Event|1|||
164225260|NCT02562040|593193978|FG000|Overall Study|Withdrawal by Subject|8|||
164225261|NCT02562040|593193979|FG001|Overall Study|Withdrawal by Subject|7|||
164225262|NCT02562040|593193978|FG000|Overall Study|Adverse Event|1|||
164225263|NCT02562040|593193979|FG001|Overall Study|Adverse Event|0|||
164225264|NCT02255279|593193981|FG000|Overall Study|Lost to Follow-up|2|||
164225265|NCT02255279|593193982|FG001|Overall Study|Lost to Follow-up|2|||
164225266|NCT02255279|593193981|FG000|Overall Study|Protocol Violation|0|||
164225267|NCT02255279|593193982|FG001|Overall Study|Protocol Violation|1|||
164225268|NCT02255279|593193981|FG000|Overall Study|Withdrawal by Subject|3|||
164225269|NCT02255279|593193982|FG001|Overall Study|Withdrawal by Subject|6|||
164225270|NCT00432991|593193987|FG000|Overall Study|Protocol Violation|7|||
164225271|NCT00432991|593193988|FG001|Overall Study|Protocol Violation|12|||
164225272|NCT00363467|593193989|FG000|Overall Study|Physician Decision|1|||
164225273|NCT03160573|593193992|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
164225274|NCT03160573|593193993|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
164225275|NCT03160573|593193994|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
164225276|NCT03160573|593193995|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
164225277|NCT02715856|593194020|FG000|Overall Study|Software Issues|12|||
164225278|NCT02715856|593194021|FG001|Overall Study|Software Issues|7|||
164225279|NCT02715856|593194020|FG000|Overall Study|Death|6|||
164225280|NCT02715856|593194021|FG001|Overall Study|Death|5|||
164225281|NCT02715856|593194020|FG000|Overall Study|Non- Compliant|0|||
164225282|NCT02715856|593194021|FG001|Overall Study|Non- Compliant|40|||
164225283|NCT00128492|593194022|FG000|Overall Study|AE unrelated to study|2|||
164225284|NCT00128492|593194023|FG001|Overall Study|AE unrelated to study|9|||
164225285|NCT00128492|593194022|FG000|Overall Study|Study drug intolerance (AE)|2|||
164225286|NCT00128492|593194023|FG001|Overall Study|Study drug intolerance (AE)|8|||
164225287|NCT00128492|593194022|FG000|Overall Study|AE related to study|1|||
164225288|NCT00128492|593194023|FG001|Overall Study|AE related to study|4|||
164225289|NCT00128492|593194022|FG000|Overall Study|Death|1|||
164225290|NCT00128492|593194023|FG001|Overall Study|Death|0|||
164225291|NCT00128492|593194022|FG000|Overall Study|Lost to Follow-up|1|||
164225292|NCT00128492|593194023|FG001|Overall Study|Lost to Follow-up|5|||
164225293|NCT00128492|593194022|FG000|Overall Study|Noncompliance|0|||
164225294|NCT00128492|593194023|FG001|Overall Study|Noncompliance|5|||
164225295|NCT00128492|593194022|FG000|Overall Study|Personal or administrative|10|||
164225296|NCT00128492|593194023|FG001|Overall Study|Personal or administrative|22|||
164225297|NCT00128492|593194022|FG000|Overall Study|Withdrawal by Subject|3|||
164225298|NCT00128492|593194023|FG001|Overall Study|Withdrawal by Subject|5|||
164225299|NCT00128492|593194022|FG000|Overall Study|Pregnancy|0|||
163985777|NCT02392429|592317850|FG000|Evaluable|remission bone marrow biopsy|3|||
164225300|NCT00128492|593194023|FG001|Overall Study|Pregnancy|1|||
164225301|NCT03436420|593194024|FG000|Overall Study|Lack of Efficacy|3|||
164225302|NCT00756314|593194025|FG000|Overall Study|Lost to Follow-up|2|||
164225303|NCT00756314|593194026|FG001|Overall Study|Lost to Follow-up|59|||
164225304|NCT02605967|593194027|FG000|Overall Study|subject / guardian decision|1|||
164225305|NCT02605967|593194028|FG001|Overall Study|subject / guardian decision|2|||
164225306|NCT02605967|593194027|FG000|Overall Study|Physician Decision|10|||
164225307|NCT02605967|593194028|FG001|Overall Study|Physician Decision|1|||
164225308|NCT02605967|593194027|FG000|Overall Study|Death|4|||
164225309|NCT02605967|593194028|FG001|Overall Study|Death|2|||
164225310|NCT02605967|593194027|FG000|Overall Study|Adverse Event|1|||
164225311|NCT02605967|593194028|FG001|Overall Study|Adverse Event|0|||
164225312|NCT02605967|593194027|FG000|Overall Study|progressive disease|66|||
164225313|NCT02605967|593194028|FG001|Overall Study|progressive disease|35|||
164225314|NCT03627468|593194029|FG000|Overall Study|Adverse Event|5|||
164225315|NCT03627468|593194030|FG001|Overall Study|Adverse Event|33|||
164225316|NCT03627468|593194029|FG000|Overall Study|Withdrawal by Subject|13|||
164225317|NCT03627468|593194030|FG001|Overall Study|Withdrawal by Subject|23|||
164225318|NCT03627468|593194029|FG000|Overall Study|Physician Decision|1|||
164225319|NCT03627468|593194030|FG001|Overall Study|Physician Decision|0|||
164225320|NCT03627468|593194029|FG000|Overall Study|Protocol Violation|0|||
163985778|NCT03266016|592317851|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
163985779|NCT03266016|592317852|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
164225321|NCT03627468|593194030|FG001|Overall Study|Protocol Violation|2|||
164225322|NCT03627468|593194029|FG000|Overall Study|Lost to Follow-up|10|||
163985780|NCT03266016|592317853|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
163985781|NCT03266016|592317854|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
163985782|NCT03266016|592317851|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
163985783|NCT03266016|592317852|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
163985784|NCT03266016|592317853|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
163985785|NCT03266016|592317854|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
163985786|NCT00768898|592317855|FG000|Overall Study|Unrelated injury|1|||
163985787|NCT00768898|592317855|FG000|Overall Study|Headache|1|||
163985788|NCT01777763|592317858|FG000|Overall Study|Adverse Event|2|||
163985789|NCT01777763|592317859|FG001|Overall Study|Adverse Event|32|||
163985790|NCT01777763|592317858|FG000|Overall Study|Protocol Violation|1|||
163985791|NCT01777763|592317859|FG001|Overall Study|Protocol Violation|7|||
163985792|NCT01777763|592317858|FG000|Overall Study|Withdrawal by Subject|0|||
163985793|NCT01777763|592317859|FG001|Overall Study|Withdrawal by Subject|2|||
163985794|NCT01777763|592317858|FG000|Overall Study|Treatment Failure|1|||
163985795|NCT01777763|592317859|FG001|Overall Study|Treatment Failure|6|||
163985796|NCT02787850|592317864|FG000|Overall Study|Withdrawal by Subject|0|||
163985797|NCT02787850|592317865|FG001|Overall Study|Withdrawal by Subject|1|||
163985798|NCT03718143|592317866|FG000|Overall Study|Death|1|||
163985799|NCT03718143|592317867|FG001|Overall Study|Death|0|||
163985800|NCT03718143|592317868|FG002|Overall Study|Death|0|||
163985801|NCT03718143|592317866|FG000|Overall Study|Progression of Disease|1|||
163985802|NCT03718143|592317867|FG001|Overall Study|Progression of Disease|0|||
163985803|NCT03718143|592317868|FG002|Overall Study|Progression of Disease|0|||
163985804|NCT03718143|592317866|FG000|Overall Study|Withdrawal of Informed Consent|1|||
163985805|NCT03718143|592317867|FG001|Overall Study|Withdrawal of Informed Consent|2|||
163985806|NCT03718143|592317868|FG002|Overall Study|Withdrawal of Informed Consent|1|||
163985807|NCT01191697|592317871|FG000|Overall Study|Death|1|||
163985808|NCT01191697|592317871|FG000|Overall Study|Physician Decision|2|||
163985809|NCT01191697|592317871|FG000|Overall Study|Pursue chemoradiation|2|||
163985810|NCT01191697|592317871|FG000|Overall Study|Break from chemotherapy|2|||
163985811|NCT01191697|592317871|FG000|Overall Study|Withdrawal by Subject|1|||
163985812|NCT01191697|592317871|FG000|Overall Study|Surveillance|1|||
163985813|NCT01191697|592317871|FG000|Overall Study|Adverse Event|2|||
163985814|NCT01191697|592317871|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
163985815|NCT01191697|592317871|FG000|Overall Study|Not completed but analyzed|25|||
163985816|NCT05702515|592317874|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
163985817|NCT01396005|592317875|FG000|Overall Study|Withdrawal by Subject|0|||
163985818|NCT01396005|592317876|FG001|Overall Study|Withdrawal by Subject|1|||
163985819|NCT01396005|592317875|FG000|Overall Study|Non-compliance with protocol|0|||
163985820|NCT01396005|592317876|FG001|Overall Study|Non-compliance with protocol|1|||
163985821|NCT01789970|592317881|FG000|Open-label Titration Period|Adverse Event|68|||
163985822|NCT01789970|592317882|FG001|Open-label Titration Period|Adverse Event|0|||
163985823|NCT01789970|592317883|FG002|Open-label Titration Period|Adverse Event|0|||
163985824|NCT01789970|592317881|FG000|Open-label Titration Period|Lack of Efficacy|31|||
164225323|NCT03627468|593194030|FG001|Overall Study|Lost to Follow-up|16|||
164225324|NCT03627468|593194029|FG000|Overall Study|Death|1|||
164225325|NCT03627468|593194030|FG001|Overall Study|Death|0|||
164225326|NCT03627468|593194029|FG000|Overall Study|Pregnancy|1|||
164225327|NCT03627468|593194030|FG001|Overall Study|Pregnancy|1|||
164225328|NCT03627468|593194029|FG000|Overall Study|Lack of Efficacy|0|||
163985825|NCT01789970|592317882|FG001|Open-label Titration Period|Lack of Efficacy|0|||
163985826|NCT01789970|592317883|FG002|Open-label Titration Period|Lack of Efficacy|0|||
163985827|NCT01789970|592317881|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
163985828|NCT01789970|592317882|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
163985829|NCT01789970|592317883|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
163985830|NCT01789970|592317881|FG000|Open-label Titration Period|Protocol Violation|18|||
164225329|NCT03627468|593194030|FG001|Overall Study|Lack of Efficacy|2|||
163985831|NCT01789970|592317882|FG001|Open-label Titration Period|Protocol Violation|0|||
163985832|NCT01789970|592317883|FG002|Open-label Titration Period|Protocol Violation|0|||
163985833|NCT01789970|592317881|FG000|Open-label Titration Period|Lost to Follow-up|5|||
163985834|NCT01789970|592317882|FG001|Open-label Titration Period|Lost to Follow-up|0|||
164225330|NCT03627468|593194029|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
164225331|NCT03627468|593194030|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
164225332|NCT01475825|593194034|FG000|Overall Study|Adverse Event|41|||
164225333|NCT01475825|593194035|FG001|Overall Study|Adverse Event|15|||
164225334|NCT01475825|593194036|FG002|Overall Study|Adverse Event|27|||
164225335|NCT01475825|593194037|FG003|Overall Study|Adverse Event|11|||
164225336|NCT01475825|593194034|FG000|Overall Study|Death|1|||
164225337|NCT01475825|593194035|FG001|Overall Study|Death|0|||
164225338|NCT01475825|593194036|FG002|Overall Study|Death|1|||
164225339|NCT01475825|593194037|FG003|Overall Study|Death|0|||
164225340|NCT01475825|593194034|FG000|Overall Study|Lack of Efficacy|0|||
164225341|NCT01475825|593194035|FG001|Overall Study|Lack of Efficacy|0|||
164225342|NCT01475825|593194036|FG002|Overall Study|Lack of Efficacy|1|||
164225343|NCT01475825|593194037|FG003|Overall Study|Lack of Efficacy|0|||
164225344|NCT01475825|593194034|FG000|Overall Study|Lost to Follow-up|0|||
164225345|NCT01475825|593194035|FG001|Overall Study|Lost to Follow-up|0|||
163881483|NCT04321031|591935562|FG000|Overall Study|Withdrawal by Subject|2|||
163881484|NCT04321031|591935563|FG001|Overall Study|Withdrawal by Subject|2|||
163881485|NCT04321031|591935564|FG002|Overall Study|Withdrawal by Subject|1|||
163881486|NCT04321031|591935565|FG003|Overall Study|Withdrawal by Subject|3|||
163881487|NCT04321031|591935566|FG004|Overall Study|Withdrawal by Subject|1|||
163881488|NCT04321031|591935567|FG005|Overall Study|Withdrawal by Subject|0|||
163881489|NCT04321031|591935568|FG006|Overall Study|Withdrawal by Subject|1|||
163881490|NCT04321031|591935562|FG000|Overall Study|Non-compliance with study drug|0|||
163881491|NCT04321031|591935563|FG001|Overall Study|Non-compliance with study drug|0|||
163881492|NCT04321031|591935564|FG002|Overall Study|Non-compliance with study drug|0|||
163881493|NCT04321031|591935565|FG003|Overall Study|Non-compliance with study drug|0|||
163881494|NCT04321031|591935566|FG004|Overall Study|Non-compliance with study drug|0|||
163881495|NCT04321031|591935567|FG005|Overall Study|Non-compliance with study drug|1|||
163881496|NCT04321031|591935568|FG006|Overall Study|Non-compliance with study drug|0|||
163881497|NCT04321031|591935562|FG000|Overall Study|Other|0|||
163881498|NCT04321031|591935563|FG001|Overall Study|Other|0|||
163881499|NCT04321031|591935564|FG002|Overall Study|Other|0|||
163881500|NCT04321031|591935565|FG003|Overall Study|Other|1|||
163881501|NCT04321031|591935566|FG004|Overall Study|Other|0|||
163881502|NCT04321031|591935567|FG005|Overall Study|Other|0|||
163881503|NCT04321031|591935568|FG006|Overall Study|Other|0|||
163881504|NCT05687916|591935573|FG000|Overall Study|Adverse Event|1|||
163881505|NCT05687916|591935574|FG001|Overall Study|Adverse Event|2|||
163881506|NCT05687916|591935575|FG002|Overall Study|Adverse Event|0|||
163881507|NCT05687916|591935573|FG000|Overall Study|Withdrawal by Subject|1|||
163881508|NCT05687916|591935574|FG001|Overall Study|Withdrawal by Subject|0|||
163881509|NCT05687916|591935575|FG002|Overall Study|Withdrawal by Subject|1|||
163881510|NCT05687916|591935573|FG000|Overall Study|Protocol Violation|0|||
163881511|NCT05687916|591935574|FG001|Overall Study|Protocol Violation|2|||
163881512|NCT05687916|591935575|FG002|Overall Study|Protocol Violation|1|||
163881513|NCT05687916|591935573|FG000|Overall Study|Reason not Specified|1|||
163881514|NCT05687916|591935574|FG001|Overall Study|Reason not Specified|0|||
163881515|NCT05687916|591935575|FG002|Overall Study|Reason not Specified|0|||
163881516|NCT00931710|591935576|FG000|Overall Study|Adverse Event|16|||
163881517|NCT00931710|591935577|FG001|Overall Study|Adverse Event|10|||
163881518|NCT00931710|591935576|FG000|Overall Study|Abnormal test procedure results|2|||
163881519|NCT00931710|591935577|FG001|Overall Study|Abnormal test procedure results|0|||
163881520|NCT00931710|591935576|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
163881521|NCT00931710|591935577|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
163881522|NCT00931710|591935576|FG000|Overall Study|Patient withdrew consent|4|||
163881523|NCT00931710|591935577|FG001|Overall Study|Patient withdrew consent|9|||
163881524|NCT00931710|591935576|FG000|Overall Study|Lost to Follow-up|6|||
163881525|NCT00931710|591935577|FG001|Overall Study|Lost to Follow-up|5|||
163881526|NCT00931710|591935576|FG000|Overall Study|Protocol deviation|1|||
163881527|NCT00931710|591935577|FG001|Overall Study|Protocol deviation|2|||
163881528|NCT03338790|591935578|FG000|Overall Study|Disease Progression|65|||
163881529|NCT03338790|591935579|FG001|Overall Study|Disease Progression|43|||
163881530|NCT03338790|591935580|FG002|Overall Study|Disease Progression|50|||
163881531|NCT03338790|591935581|FG003|Overall Study|Disease Progression|37|||
163881532|NCT03338790|591935578|FG000|Overall Study|Study Drug Toxicity|9|||
163881533|NCT03338790|591935579|FG001|Overall Study|Study Drug Toxicity|8|||
163881534|NCT03338790|591935580|FG002|Overall Study|Study Drug Toxicity|15|||
163881535|NCT03338790|591935581|FG003|Overall Study|Study Drug Toxicity|0|||
163881536|NCT03338790|591935578|FG000|Overall Study|Death|1|||
163881537|NCT03338790|591935579|FG001|Overall Study|Death|1|||
163881538|NCT03338790|591935580|FG002|Overall Study|Death|1|||
163881539|NCT03338790|591935581|FG003|Overall Study|Death|0|||
163881540|NCT03338790|591935578|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
163881541|NCT03338790|591935579|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
163881542|NCT03338790|591935580|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
163881543|NCT03338790|591935581|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
163881544|NCT03338790|591935578|FG000|Overall Study|Participant request to discontinue study treatment|3|||
164225346|NCT01475825|593194036|FG002|Overall Study|Lost to Follow-up|3|||
164225347|NCT01475825|593194037|FG003|Overall Study|Lost to Follow-up|1|||
164225348|NCT01475825|593194034|FG000|Overall Study|Non-compliance with Study Drug|1|||
164225349|NCT01475825|593194035|FG001|Overall Study|Non-compliance with Study Drug|2|||
163881545|NCT03338790|591935579|FG001|Overall Study|Participant request to discontinue study treatment|3|||
163881546|NCT03338790|591935580|FG002|Overall Study|Participant request to discontinue study treatment|2|||
163881547|NCT03338790|591935581|FG003|Overall Study|Participant request to discontinue study treatment|1|||
163881548|NCT03338790|591935578|FG000|Overall Study|Poor/non-compliance|0|||
163881549|NCT03338790|591935579|FG001|Overall Study|Poor/non-compliance|1|||
163881550|NCT03338790|591935580|FG002|Overall Study|Poor/non-compliance|0|||
163881551|NCT03338790|591935581|FG003|Overall Study|Poor/non-compliance|0|||
163881552|NCT03338790|591935578|FG000|Overall Study|Participant withdrew consent|1|||
163881553|NCT03338790|591935579|FG001|Overall Study|Participant withdrew consent|0|||
163881554|NCT03338790|591935580|FG002|Overall Study|Participant withdrew consent|1|||
163881555|NCT03338790|591935581|FG003|Overall Study|Participant withdrew consent|1|||
163881556|NCT03338790|591935578|FG000|Overall Study|Other reasons|0|||
163881557|NCT03338790|591935579|FG001|Overall Study|Other reasons|5|||
163881558|NCT03338790|591935580|FG002|Overall Study|Other reasons|0|||
163881559|NCT03338790|591935581|FG003|Overall Study|Other reasons|2|||
163881560|NCT03338790|591935578|FG000|Overall Study|Not reported|0|||
163881561|NCT03338790|591935579|FG001|Overall Study|Not reported|0|||
163881562|NCT03338790|591935580|FG002|Overall Study|Not reported|1|||
163881563|NCT03338790|591935581|FG003|Overall Study|Not reported|0|||
163881564|NCT03338790|591935578|FG000|Overall Study|Completed treatment period|1|||
163881565|NCT03338790|591935579|FG001|Overall Study|Completed treatment period|2|||
163881566|NCT03338790|591935580|FG002|Overall Study|Completed treatment period|0|||
163881567|NCT03338790|591935581|FG003|Overall Study|Completed treatment period|0|||
163881568|NCT04588298|591935585|FG000|Overall Study|Adverse Event|0|||
163881569|NCT04588298|591935586|FG001|Overall Study|Adverse Event|0|||
163881570|NCT04588298|591935587|FG002|Overall Study|Adverse Event|1|||
163881571|NCT04588298|591935588|FG003|Overall Study|Adverse Event|0|||
163881572|NCT04588298|591935589|FG004|Overall Study|Adverse Event|2|||
163881573|NCT04588298|591935585|FG000|Overall Study|Withdrawal by Subject|1|||
163881574|NCT04588298|591935586|FG001|Overall Study|Withdrawal by Subject|0|||
163881575|NCT04588298|591935587|FG002|Overall Study|Withdrawal by Subject|0|||
163881576|NCT04588298|591935588|FG003|Overall Study|Withdrawal by Subject|1|||
163881577|NCT04588298|591935589|FG004|Overall Study|Withdrawal by Subject|0|||
163881578|NCT03892616|591935590|FG000|Washout Period 2|Met discontinuation criterion|0|||
163881579|NCT03892616|591935591|FG001|Washout Period 2|Met discontinuation criterion|0|||
163881580|NCT03892616|591935592|FG002|Washout Period 2|Met discontinuation criterion|0|||
163881581|NCT03892616|591935593|FG003|Washout Period 2|Met discontinuation criterion|0|||
163881582|NCT03892616|591935594|FG004|Washout Period 2|Met discontinuation criterion|0|||
163881583|NCT03892616|591935595|FG005|Washout Period 2|Met discontinuation criterion|0|||
163881584|NCT03892616|591935596|FG006|Washout Period 2|Met discontinuation criterion|0|||
163881585|NCT03892616|591935597|FG007|Washout Period 2|Met discontinuation criterion|0|||
163881586|NCT03892616|591935598|FG008|Washout Period 2|Met discontinuation criterion|1|||
163881587|NCT03892616|591935599|FG009|Washout Period 2|Met discontinuation criterion|0|||
163881588|NCT03892616|591935600|FG010|Washout Period 2|Met discontinuation criterion|0|||
163881589|NCT03892616|591935601|FG011|Washout Period 2|Met discontinuation criterion|0|||
163881590|NCT03924986|591935602|FG000|Overall Study|Death|57|||
163881591|NCT03924986|591935603|FG001|Overall Study|Death|66|||
163881592|NCT03924986|591935602|FG000|Overall Study|Study Concluded by Sponsor|51|||
163881593|NCT03924986|591935603|FG001|Overall Study|Study Concluded by Sponsor|41|||
163881594|NCT03924986|591935602|FG000|Overall Study|Withdrawal by Subject|15|||
163881595|NCT03924986|591935603|FG001|Overall Study|Withdrawal by Subject|20|||
163881596|NCT03924986|591935602|FG000|Overall Study|Lost to Follow-up|7|||
163881597|NCT03924986|591935603|FG001|Overall Study|Lost to Follow-up|5|||
163881598|NCT03924986|591935602|FG000|Overall Study|Miscellaneous|1|||
163881599|NCT03924986|591935603|FG001|Overall Study|Miscellaneous|0|||
163881600|NCT02907099|591935609|FG000|Overall Study|Adverse Event|1|||
163881601|NCT02907099|591935609|FG000|Overall Study|Withdrawal by Subject|2|||
163881602|NCT02907099|591935609|FG000|Overall Study|Screen Fail|2|||
163881603|NCT05569252|591935610|FG000|Overall Study|Adverse event (central vision loss)|1|||
163881604|NCT05569252|591935611|FG001|Overall Study|Adverse event (central vision loss)|0|||
164138925|NCT01197755|592870216|FG001|Overall Study|Adverse Event|10|||
164138926|NCT01197755|592870217|FG002|Overall Study|Adverse Event|10|||
164138927|NCT01197755|592870215|FG000|Overall Study|Study-specific discontinuation criteria|2|||
164138928|NCT01197755|592870216|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164138929|NCT01197755|592870217|FG002|Overall Study|Study-specific discontinuation criteria|0|||
164138930|NCT01197755|592870215|FG000|Overall Study|Entered the long-term extension study|18|||
164138931|NCT01197755|592870216|FG001|Overall Study|Entered the long-term extension study|21|||
164138932|NCT01197755|592870217|FG002|Overall Study|Entered the long-term extension study|35|||
164138933|NCT01197755|592870215|FG000|Overall Study|Lack of therapeutic response|0|||
164138934|NCT01197755|592870216|FG001|Overall Study|Lack of therapeutic response|7|||
164138935|NCT01197755|592870217|FG002|Overall Study|Lack of therapeutic response|4|||
164138936|NCT01197755|592870215|FG000|Overall Study|Severe non-compliance to the protocol|2|||
164138937|NCT01197755|592870216|FG001|Overall Study|Severe non-compliance to the protocol|1|||
163985835|NCT01789970|592317883|FG002|Open-label Titration Period|Lost to Follow-up|0|||
163985836|NCT01789970|592317881|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
163985837|NCT01789970|592317882|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
163985838|NCT01789970|592317883|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
163985839|NCT01789970|592317881|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
163985840|NCT01789970|592317882|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
163985841|NCT01789970|592317883|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
163985842|NCT01789970|592317881|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
163985843|NCT01789970|592317882|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
163985844|NCT01789970|592317883|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
163985845|NCT01789970|592317881|FG000|Open-label Titration Period|Pregnancy|2|||
163985846|NCT01789970|592317882|FG001|Open-label Titration Period|Pregnancy|0|||
163985847|NCT01789970|592317883|FG002|Open-label Titration Period|Pregnancy|0|||
163985848|NCT01789970|592317881|FG000|Open-label Titration Period|Other|76|||
163985849|NCT01789970|592317882|FG001|Open-label Titration Period|Other|0|||
163985850|NCT01789970|592317883|FG002|Open-label Titration Period|Other|0|||
163985851|NCT01789970|592317881|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
163985852|NCT01789970|592317882|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
163985853|NCT01789970|592317883|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
163985854|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
163985855|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
163985856|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
163985857|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
163985858|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
163985859|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
163985860|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
163985861|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
163985862|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
163985863|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163985864|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
163985865|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
163985866|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
163985867|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
163985868|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
163985869|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
163985870|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
163985871|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
163985872|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
163985873|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
163985874|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
163985875|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
163985876|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
163985877|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
163985878|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
163985879|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
164225350|NCT01475825|593194036|FG002|Overall Study|Non-compliance with Study Drug|4|||
164225351|NCT01475825|593194037|FG003|Overall Study|Non-compliance with Study Drug|0|||
164225352|NCT01475825|593194034|FG000|Overall Study|Other: Not available|0|||
164225353|NCT01475825|593194035|FG001|Overall Study|Other: Not available|0|||
164225354|NCT01475825|593194036|FG002|Overall Study|Other: Not available|2|||
164225355|NCT01475825|593194037|FG003|Overall Study|Other: Not available|0|||
164081521|NCT01405820|592663283|FG000|Randomized Treatment Period|Physician Decision|0|||
164081522|NCT01405820|592663284|FG001|Randomized Treatment Period|Physician Decision|2|||
164225356|NCT01475825|593194034|FG000|Overall Study|Protocol Violation|1|||
163985880|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
163985881|NCT01789970|592317881|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
163985882|NCT01789970|592317882|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
163985883|NCT01789970|592317883|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
163985884|NCT02475655|592317884|FG000|Overall Study|Lost to Follow-up|0|||
163985885|NCT02475655|592317885|FG001|Overall Study|Lost to Follow-up|1|||
163985886|NCT00643994|592317886|FG000|Overall Study|Death|24|||
163985887|NCT00643994|592317886|FG000|Overall Study|Lost to Follow-up|72|||
163985888|NCT00662792|592317891|FG000|Period 1|Personal Reasons|0|||
164081523|NCT01405820|592663285|FG002|Randomized Treatment Period|Physician Decision|1|||
164225357|NCT01475825|593194035|FG001|Overall Study|Protocol Violation|0|||
164225358|NCT01475825|593194036|FG002|Overall Study|Protocol Violation|0|||
164225359|NCT01475825|593194037|FG003|Overall Study|Protocol Violation|0|||
163881605|NCT05569252|591935612|FG002|Overall Study|Adverse event (central vision loss)|0|||
163881606|NCT05569252|591935613|FG003|Overall Study|Adverse event (central vision loss)|0|||
163881607|NCT02949362|591935614|FG000|Retrospective Period|Inform consent not signed by participant|4|||
163881608|NCT02949362|591935615|FG001|Retrospective Period|Inform consent not signed by participant|1|||
163881609|NCT02949362|591935616|FG002|Retrospective Period|Inform consent not signed by participant|0|||
163881610|NCT02949362|591935617|FG003|Retrospective Period|Inform consent not signed by participant|0|||
163881611|NCT02949362|591935614|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
163881612|NCT02949362|591935615|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
163881613|NCT02949362|591935616|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
163881614|NCT02949362|591935617|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
163881615|NCT02949362|591935614|FG000|Prospective Period|Other|0|||
163881616|NCT02949362|591935615|FG001|Prospective Period|Other|0|||
163881617|NCT02949362|591935616|FG002|Prospective Period|Other|0|||
163881618|NCT02949362|591935617|FG003|Prospective Period|Other|4|||
163881619|NCT05268302|591935618|FG000|Overall Study|Death|0|||
163881620|NCT05268302|591935619|FG001|Overall Study|Death|1|||
163881621|NCT02811679|591935620|FG000|Overall Study|Adverse Event|1|||
163881622|NCT02811679|591935620|FG000|Overall Study|Lack of Efficacy|6|||
163881623|NCT02811679|591935620|FG000|Overall Study|Early study closure due to slow accrual|3|||
163881624|NCT05319860|591935624|FG000|Overall Study|Death|1|||
163881625|NCT05319860|591935625|FG001|Overall Study|Death|1|||
163881626|NCT05319860|591935624|FG000|Overall Study|Lost to Follow-up|3|||
163881627|NCT05319860|591935625|FG001|Overall Study|Lost to Follow-up|1|||
163881628|NCT05319860|591935624|FG000|Overall Study|Withdrawal by Subject|1|||
163881629|NCT05319860|591935625|FG001|Overall Study|Withdrawal by Subject|7|||
163881630|NCT04314895|591935626|FG000|Overall Study|Lost to Follow-up|1|||
163881631|NCT04314895|591935626|FG000|Overall Study|Death|10|||
163881632|NCT04314895|591935626|FG000|Overall Study|Physician Decision|2|||
163881633|NCT03361748|591935627|FG000|Overall Study|Death|77|||
163881634|NCT03361748|591935627|FG000|Overall Study|Lost to Follow-up|4|||
163881635|NCT03361748|591935627|FG000|Overall Study|Withdrawal by Subject|20|||
163881636|NCT01084707|591935628|FG000|Overall Study|Withdrawal by Subject|6|||
163881637|NCT00901901|591935629|FG000|Treatment Period|Adverse Event|120|||
163881638|NCT00901901|591935630|FG001|Treatment Period|Adverse Event|128|||
163881639|NCT00901901|591935629|FG000|Treatment Period|Withdrawal by Subject|26|||
163881640|NCT00901901|591935630|FG001|Treatment Period|Withdrawal by Subject|24|||
163881641|NCT00901901|591935629|FG000|Treatment Period|Physician Decision|2|||
163881642|NCT00901901|591935630|FG001|Treatment Period|Physician Decision|2|||
163881643|NCT00901901|591935629|FG000|Treatment Period|Lost to Follow-up|3|||
163881644|NCT00901901|591935630|FG001|Treatment Period|Lost to Follow-up|5|||
163881645|NCT00901901|591935629|FG000|Treatment Period|Noncompliance with study medication|4|||
163881646|NCT00901901|591935630|FG001|Treatment Period|Noncompliance with study medication|1|||
163881647|NCT00901901|591935629|FG000|Treatment Period|Missing|1|||
163881648|NCT00901901|591935630|FG001|Treatment Period|Missing|0|||
163881649|NCT00901901|591935629|FG000|Treatment Period|Never treated|0|||
163881650|NCT00901901|591935630|FG001|Treatment Period|Never treated|3|||
163881651|NCT00901901|591935629|FG000|Treatment Period|Protocol driven decision point|0|||
163881652|NCT00901901|591935630|FG001|Treatment Period|Protocol driven decision point|2|||
163881653|NCT00901901|591935629|FG000|Treatment Period|Study terminated by sponsor|2|||
163881654|NCT00901901|591935630|FG001|Treatment Period|Study terminated by sponsor|0|||
163881655|NCT00901901|591935629|FG000|Treatment Period|Protocol Violation|5|||
163881656|NCT00901901|591935630|FG001|Treatment Period|Protocol Violation|9|||
163881657|NCT00901901|591935629|FG000|Treatment Period|Switch to commercial drug|1|||
163881658|NCT00901901|591935630|FG001|Treatment Period|Switch to commercial drug|1|||
163881659|NCT00901901|591935629|FG000|Treatment Period|Transfer to treatment continuation study|5|||
163881660|NCT00901901|591935630|FG001|Treatment Period|Transfer to treatment continuation study|2|||
163881661|NCT00901901|591935629|FG000|Follow-up Period|Death|181|||
163881662|NCT00901901|591935630|FG001|Follow-up Period|Death|208|||
163881663|NCT00901901|591935629|FG000|Follow-up Period|Protocol driven decision point|47|||
164225360|NCT01475825|593194034|FG000|Overall Study|Physician Decision|0|||
164225361|NCT01475825|593194035|FG001|Overall Study|Physician Decision|1|||
164225362|NCT01475825|593194036|FG002|Overall Study|Physician Decision|0|||
164225363|NCT01475825|593194037|FG003|Overall Study|Physician Decision|0|||
164225364|NCT01475825|593194034|FG000|Overall Study|Withdrawal by Subject|8|||
164225365|NCT01475825|593194035|FG001|Overall Study|Withdrawal by Subject|3|||
164225366|NCT01475825|593194036|FG002|Overall Study|Withdrawal by Subject|11|||
164225367|NCT01475825|593194037|FG003|Overall Study|Withdrawal by Subject|7|||
164225368|NCT01475825|593194034|FG000|Overall Study|Did not enter OLC|15|||
163881664|NCT00901901|591935630|FG001|Follow-up Period|Protocol driven decision point|36|||
163881665|NCT00901901|591935629|FG000|Follow-up Period|Withdrawal by Subject|6|||
163881666|NCT00901901|591935630|FG001|Follow-up Period|Withdrawal by Subject|9|||
163881667|NCT00901901|591935629|FG000|Follow-up Period|Lost to Follow-up|12|||
164225369|NCT01475825|593194035|FG001|Overall Study|Did not enter OLC|11|||
164225370|NCT01475825|593194036|FG002|Overall Study|Did not enter OLC|15|||
164225371|NCT01475825|593194037|FG003|Overall Study|Did not enter OLC|11|||
164081524|NCT01405820|592663286|FG003|Randomized Treatment Period|Physician Decision|0|||
164081525|NCT01405820|592663287|FG004|Randomized Treatment Period|Physician Decision|0|||
164081526|NCT01405820|592663288|FG005|Randomized Treatment Period|Physician Decision|0|||
164081527|NCT01405820|592663283|FG000|Randomized Treatment Period|Rescue|0|||
164081528|NCT01405820|592663284|FG001|Randomized Treatment Period|Rescue|1|||
164081529|NCT01405820|592663285|FG002|Randomized Treatment Period|Rescue|13|||
164081530|NCT01405820|592663286|FG003|Randomized Treatment Period|Rescue|10|||
164081531|NCT01405820|592663287|FG004|Randomized Treatment Period|Rescue|8|||
164081532|NCT01405820|592663288|FG005|Randomized Treatment Period|Rescue|8|||
164081533|NCT01405820|592663283|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
164081534|NCT01405820|592663284|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
164081535|NCT01405820|592663285|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
164081536|NCT01405820|592663286|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
163881668|NCT00901901|591935630|FG001|Follow-up Period|Lost to Follow-up|8|||
163881669|NCT00901901|591935629|FG000|Follow-up Period|Missing|94|||
163881670|NCT00901901|591935630|FG001|Follow-up Period|Missing|80|||
163881671|NCT02187003|591937159|FG000|Overall Study|Adverse Event|2|||
163881672|NCT02187003|591937160|FG001|Overall Study|Adverse Event|0|||
163881673|NCT02187003|591937159|FG000|Overall Study|Lost to Follow-up|14|||
163881674|NCT02187003|591937160|FG001|Overall Study|Lost to Follow-up|10|||
163881675|NCT02187003|591937159|FG000|Overall Study|Withdrawal by Subject|3|||
163881676|NCT02187003|591937160|FG001|Overall Study|Withdrawal by Subject|7|||
163881677|NCT02187003|591937159|FG000|Overall Study|Protocol Violation|2|||
163881678|NCT02187003|591937160|FG001|Overall Study|Protocol Violation|4|||
163881679|NCT02187003|591937159|FG000|Overall Study|Other|5|||
163881680|NCT02187003|591937160|FG001|Overall Study|Other|5|||
163881681|NCT02187003|591937159|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163881682|NCT02187003|591937160|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
163881683|NCT03648840|591937163|FG000|First IV Infusion Session|Adverse Event|0|||
163881684|NCT03648840|591937164|FG001|First IV Infusion Session|Adverse Event|2|||
163881685|NCT03648840|591937163|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
163881686|NCT03648840|591937164|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
163881687|NCT03648840|591937163|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
163881688|NCT03648840|591937164|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
163881689|NCT03648840|591937163|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
163881690|NCT03648840|591937164|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
163881691|NCT05382936|591937165|FG000|Overall Study|Progressive Disease|3|||
163881692|NCT05382936|591937166|FG001|Overall Study|Progressive Disease|5|||
163881693|NCT05382936|591937167|FG002|Overall Study|Progressive Disease|2|||
163881694|NCT05382936|591937168|FG003|Overall Study|Progressive Disease|5|||
163881695|NCT05382936|591937165|FG000|Overall Study|Adverse Event|0|||
163881696|NCT05382936|591937166|FG001|Overall Study|Adverse Event|1|||
163881697|NCT05382936|591937167|FG002|Overall Study|Adverse Event|1|||
163881698|NCT05382936|591937168|FG003|Overall Study|Adverse Event|0|||
163881699|NCT05382936|591937165|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
163881700|NCT05382936|591937166|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
163881701|NCT05382936|591937167|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
163881702|NCT05382936|591937168|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
163881703|NCT05382936|591937165|FG000|Overall Study|Withdrawal by Subject|0|||
163881704|NCT05382936|591937166|FG001|Overall Study|Withdrawal by Subject|0|||
163881705|NCT05382936|591937167|FG002|Overall Study|Withdrawal by Subject|1|||
163881706|NCT05382936|591937168|FG003|Overall Study|Withdrawal by Subject|1|||
163881707|NCT05063994|591937169|FG000|Cortef Run-In|Withdrawal of Consent|1|||
163881708|NCT05063994|591937170|FG001|Cortef Run-In|Withdrawal of Consent|0|||
163881709|NCT05063994|591937171|FG002|Cortef Run-In|Withdrawal of Consent|0|||
163881710|NCT05063994|591937169|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
163881711|NCT05063994|591937170|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
163881712|NCT05063994|591937171|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
163881713|NCT05063994|591937169|FG000|Treatment|Physician Decision|0|||
163881714|NCT05063994|591937170|FG001|Treatment|Physician Decision|0|||
163881715|NCT05063994|591937171|FG002|Treatment|Physician Decision|1|||
163881716|NCT05063994|591937169|FG000|Treatment|Withdrawal by Subject|0|||
163881717|NCT05063994|591937170|FG001|Treatment|Withdrawal by Subject|0|||
163881718|NCT05063994|591937171|FG002|Treatment|Withdrawal by Subject|1|||
163881719|NCT05063994|591937169|FG000|Treatment|Withdrawal of Consent|0|||
163881720|NCT05063994|591937170|FG001|Treatment|Withdrawal of Consent|0|||
163881721|NCT05063994|591937171|FG002|Treatment|Withdrawal of Consent|1|||
163881722|NCT04630262|591937172|FG000|Overall Study|Intraoperative Screen Failure|5|||
163881723|NCT04630262|591937172|FG000|Overall Study|Study terminated prematurely|71|||
163881724|NCT04630262|591937172|FG000|Overall Study|Withdrawal by Subject|2|||
163881725|NCT04630262|591937172|FG000|Overall Study|Physician Decision|2|||
164081537|NCT01405820|592663287|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
163881726|NCT01195831|591937173|FG000|Overall Study|Lost to Follow-up|2|||
163985889|NCT00662792|592317892|FG001|Period 1|Personal Reasons|0|||
163985890|NCT00662792|592317893|FG002|Period 1|Personal Reasons|1|||
163985891|NCT00662792|592317894|FG003|Period 1|Personal Reasons|0|||
163985892|NCT00662792|592317891|FG000|Period 1|Refused continuing medication|0|||
163985893|NCT00662792|592317892|FG001|Period 1|Refused continuing medication|1|||
163985894|NCT00662792|592317893|FG002|Period 1|Refused continuing medication|1|||
163985895|NCT00662792|592317894|FG003|Period 1|Refused continuing medication|0|||
163985896|NCT00662792|592317891|FG000|Period 1|Lost to Follow-up|1|||
163985897|NCT00662792|592317892|FG001|Period 1|Lost to Follow-up|0|||
163985898|NCT00662792|592317893|FG002|Period 1|Lost to Follow-up|0|||
163985899|NCT00662792|592317894|FG003|Period 1|Lost to Follow-up|0|||
163985900|NCT00662792|592317891|FG000|Period 1|Other adverse event (AE)|0|||
163985901|NCT00662792|592317892|FG001|Period 1|Other adverse event (AE)|2|||
163985902|NCT00662792|592317893|FG002|Period 1|Other adverse event (AE)|0|||
163985903|NCT00662792|592317894|FG003|Period 1|Other adverse event (AE)|0|||
163985904|NCT00662792|592317891|FG000|Period 1|Worsening of disease under study (AE)|1|||
163985905|NCT00662792|592317892|FG001|Period 1|Worsening of disease under study (AE)|3|||
163985906|NCT00662792|592317893|FG002|Period 1|Worsening of disease under study (AE)|2|||
163985907|NCT00662792|592317894|FG003|Period 1|Worsening of disease under study (AE)|0|||
163985908|NCT00662792|592317891|FG000|Period 1|Not treated|0|||
163985909|NCT00662792|592317892|FG001|Period 1|Not treated|1|||
163985910|NCT00662792|592317893|FG002|Period 1|Not treated|0|||
163985911|NCT00662792|592317894|FG003|Period 1|Not treated|0|||
163985912|NCT00662792|592317891|FG000|Period 2|Worsening of disease under study|1|||
163985913|NCT00662792|592317892|FG001|Period 2|Worsening of disease under study|0|||
163985914|NCT00662792|592317893|FG002|Period 2|Worsening of disease under study|0|||
163985915|NCT00662792|592317894|FG003|Period 2|Worsening of disease under study|3|||
163985916|NCT00662792|592317891|FG000|Period 3|Refused continuing medication|1|||
163985917|NCT00662792|592317892|FG001|Period 3|Refused continuing medication|0|||
163985918|NCT00662792|592317893|FG002|Period 3|Refused continuing medication|1|||
163985919|NCT00662792|592317894|FG003|Period 3|Refused continuing medication|0|||
163985920|NCT00662792|592317891|FG000|Period 3|Other adverse event (AE)|0|||
164329834|NCT02694523|593584787|FG000|Part A|Withdrawal by Subject|3|||
164329835|NCT02694523|593584788|FG001|Part A|Withdrawal by Subject|1|||
164329836|NCT02694523|593584789|FG002|Part A|Withdrawal by Subject|0|||
164329837|NCT02694523|593584790|FG003|Part A|Withdrawal by Subject|0|||
164329838|NCT02694523|593584791|FG004|Part A|Withdrawal by Subject|0|||
164329839|NCT02694523|593584792|FG005|Part A|Withdrawal by Subject|0|||
164329840|NCT02694523|593584793|FG006|Part A|Withdrawal by Subject|0|||
164329841|NCT02694523|593584787|FG000|Part A|Other|1|||
164329842|NCT02694523|593584788|FG001|Part A|Other|1|||
164329843|NCT02694523|593584789|FG002|Part A|Other|0|||
164329844|NCT02694523|593584790|FG003|Part A|Other|0|||
163985921|NCT00662792|592317892|FG001|Period 3|Other adverse event (AE)|0|||
163985922|NCT00662792|592317893|FG002|Period 3|Other adverse event (AE)|1|||
163985923|NCT00662792|592317894|FG003|Period 3|Other adverse event (AE)|1|||
163985924|NCT00662792|592317891|FG000|Period 4|Refused continuing medication|0|||
163985925|NCT00662792|592317892|FG001|Period 4|Refused continuing medication|1|||
163985926|NCT00662792|592317893|FG002|Period 4|Refused continuing medication|0|||
163985927|NCT00662792|592317894|FG003|Period 4|Refused continuing medication|0|||
163985928|NCT00662792|592317891|FG000|Period 4|Other adverse event (AE)|1|||
163985929|NCT00662792|592317892|FG001|Period 4|Other adverse event (AE)|0|||
163985930|NCT00662792|592317893|FG002|Period 4|Other adverse event (AE)|0|||
163985931|NCT00662792|592317894|FG003|Period 4|Other adverse event (AE)|0|||
163985932|NCT00662792|592317891|FG000|Period 4|Worsening of disease under study (AE)|0|||
163985933|NCT00662792|592317892|FG001|Period 4|Worsening of disease under study (AE)|0|||
163985934|NCT00662792|592317893|FG002|Period 4|Worsening of disease under study (AE)|0|||
164081538|NCT01405820|592663288|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
164081539|NCT01405820|592663283|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
164081540|NCT01405820|592663284|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
164081541|NCT01405820|592663285|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
164081542|NCT01405820|592663286|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
164081543|NCT01405820|592663287|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
164081544|NCT01405820|592663288|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
164081545|NCT01405820|592663283|FG000|Randomized Treatment Period|Death|0|||
164329845|NCT02694523|593584791|FG004|Part A|Other|0|||
164329846|NCT02694523|593584792|FG005|Part A|Other|0|||
164329847|NCT02694523|593584793|FG006|Part A|Other|0|||
164329848|NCT02694523|593584787|FG000|Part B|Adverse Event|0|||
164329849|NCT02694523|593584788|FG001|Part B|Adverse Event|0|||
163985935|NCT00662792|592317894|FG003|Period 4|Worsening of disease under study (AE)|1|||
163985936|NCT02499029|592317895|FG000|Overall Study|Lost to Follow-up|2|||
163985937|NCT02499029|592317896|FG001|Overall Study|Lost to Follow-up|2|||
163985938|NCT02499029|592317895|FG000|Overall Study|Physician Decision|2|||
163985939|NCT02499029|592317896|FG001|Overall Study|Physician Decision|1|||
163985940|NCT02499029|592317895|FG000|Overall Study|Death|1|||
164329850|NCT02694523|593584789|FG002|Part B|Adverse Event|7|||
163985941|NCT02499029|592317896|FG001|Overall Study|Death|0|||
164329851|NCT02694523|593584790|FG003|Part B|Adverse Event|1|||
164329852|NCT02694523|593584791|FG004|Part B|Adverse Event|1|||
164081546|NCT01405820|592663284|FG001|Randomized Treatment Period|Death|0|||
164081547|NCT01405820|592663285|FG002|Randomized Treatment Period|Death|0|||
164081548|NCT01405820|592663286|FG003|Randomized Treatment Period|Death|1|||
164329853|NCT02694523|593584792|FG005|Part B|Adverse Event|2|||
164081549|NCT01405820|592663287|FG004|Randomized Treatment Period|Death|0|||
164081550|NCT01405820|592663288|FG005|Randomized Treatment Period|Death|0|||
164081551|NCT01405820|592663283|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164081552|NCT01405820|592663284|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164081553|NCT01405820|592663285|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164081554|NCT01405820|592663286|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
164081555|NCT01405820|592663287|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164081556|NCT01405820|592663288|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
164081557|NCT01405820|592663283|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
164081558|NCT01405820|592663284|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
164081559|NCT01405820|592663285|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
164081560|NCT01405820|592663286|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
164081561|NCT01405820|592663287|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
164081562|NCT01405820|592663288|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
164081563|NCT01405820|592663283|FG000|Open-Label Treatment Period|Other|1|||
164081564|NCT01405820|592663284|FG001|Open-Label Treatment Period|Other|1|||
164081565|NCT01405820|592663285|FG002|Open-Label Treatment Period|Other|1|||
164081566|NCT01405820|592663286|FG003|Open-Label Treatment Period|Other|1|||
164081567|NCT01405820|592663287|FG004|Open-Label Treatment Period|Other|1|||
164329854|NCT02694523|593584793|FG006|Part B|Adverse Event|0|||
164329855|NCT02694523|593584787|FG000|Part B|Protocol Violation|0|||
163881727|NCT01195831|591937174|FG001|Overall Study|Lost to Follow-up|4|||
163881728|NCT01195831|591937173|FG000|Overall Study|Withdrawal by Subject|2|||
163881729|NCT01195831|591937174|FG001|Overall Study|Withdrawal by Subject|2|||
163881730|NCT01195831|591937173|FG000|Overall Study|Adverse Event|4|||
163881731|NCT01195831|591937174|FG001|Overall Study|Adverse Event|2|||
163881732|NCT01195831|591937173|FG000|Overall Study|Protocol Violation|0|||
163881733|NCT01195831|591937174|FG001|Overall Study|Protocol Violation|2|||
163881734|NCT03692676|591937175|FG000|Overall Study|exclude patients with prior use|4424|||
163881735|NCT03692676|591937176|FG001|Overall Study|exclude patients with prior use|24726|||
163881736|NCT03692676|591937177|FG002|Overall Study|exclude patients with prior use|0|||
163881737|NCT03692676|591937178|FG003|Overall Study|exclude patients with prior use|0|||
163881738|NCT03692676|591937175|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
163881739|NCT03692676|591937176|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
163881740|NCT03692676|591937177|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
163881741|NCT03692676|591937178|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
163881742|NCT03692676|591937175|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
163881743|NCT03692676|591937176|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
163881744|NCT03692676|591937177|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
163881745|NCT03692676|591937178|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
163881746|NCT03692676|591937175|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
163881747|NCT03692676|591937176|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
163881748|NCT03692676|591937177|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
163881749|NCT03692676|591937178|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
163881750|NCT03692676|591937175|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
163881751|NCT03692676|591937176|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
163881752|NCT03692676|591937177|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
163881753|NCT03692676|591937178|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
163881754|NCT03692676|591937175|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
163881755|NCT03692676|591937176|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
163881756|NCT03692676|591937177|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
163881757|NCT03692676|591937178|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
163881758|NCT03692676|591937175|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
163881759|NCT03692676|591937176|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
163881760|NCT03692676|591937177|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
163881761|NCT03692676|591937178|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
163881762|NCT03692676|591937175|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
163881763|NCT03692676|591937176|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
164081568|NCT01405820|592663288|FG005|Open-Label Treatment Period|Other|1|||
164081569|NCT01405820|592663283|FG000|Open-Label Treatment Period|Physician Decision|0|||
164081570|NCT01405820|592663284|FG001|Open-Label Treatment Period|Physician Decision|0|||
164329856|NCT02694523|593584788|FG001|Part B|Protocol Violation|0|||
164329857|NCT02694523|593584789|FG002|Part B|Protocol Violation|1|||
163985942|NCT01999582|592317897|FG000|Overall Study|Withdrawal by Subject|0|||
163985943|NCT01999582|592317898|FG001|Overall Study|Withdrawal by Subject|0|||
163985944|NCT01999582|592317899|FG002|Overall Study|Withdrawal by Subject|0|||
163985945|NCT01999582|592317900|FG003|Overall Study|Withdrawal by Subject|1|||
163985946|NCT01999582|592317901|FG004|Overall Study|Withdrawal by Subject|0|||
163985947|NCT01999582|592317902|FG005|Overall Study|Withdrawal by Subject|0|||
163985948|NCT01999582|592317897|FG000|Overall Study|Adverse Event|0|||
163985949|NCT01999582|592317898|FG001|Overall Study|Adverse Event|0|||
163985950|NCT01999582|592317899|FG002|Overall Study|Adverse Event|3|||
163985951|NCT01999582|592317900|FG003|Overall Study|Adverse Event|0|||
163985952|NCT01999582|592317901|FG004|Overall Study|Adverse Event|1|||
163985953|NCT01999582|592317902|FG005|Overall Study|Adverse Event|0|||
163985954|NCT01999582|592317897|FG000|Overall Study|Other Reasons|1|||
163985955|NCT01999582|592317898|FG001|Overall Study|Other Reasons|0|||
163985956|NCT01999582|592317899|FG002|Overall Study|Other Reasons|3|||
163985957|NCT01999582|592317900|FG003|Overall Study|Other Reasons|1|||
163985958|NCT01999582|592317901|FG004|Overall Study|Other Reasons|1|||
163985959|NCT01999582|592317902|FG005|Overall Study|Other Reasons|2|||
163985960|NCT01999582|592317897|FG000|Overall Study|Protocol Violation|1|||
163985961|NCT01999582|592317898|FG001|Overall Study|Protocol Violation|0|||
163985962|NCT01999582|592317899|FG002|Overall Study|Protocol Violation|0|||
163985963|NCT01999582|592317900|FG003|Overall Study|Protocol Violation|0|||
163985964|NCT01999582|592317901|FG004|Overall Study|Protocol Violation|0|||
163985965|NCT01999582|592317902|FG005|Overall Study|Protocol Violation|1|||
163985966|NCT01999582|592317897|FG000|Overall Study|Lack of Efficacy|1|||
163985967|NCT01999582|592317898|FG001|Overall Study|Lack of Efficacy|3|||
163985968|NCT01999582|592317899|FG002|Overall Study|Lack of Efficacy|0|||
163985969|NCT01999582|592317900|FG003|Overall Study|Lack of Efficacy|1|||
163985970|NCT01999582|592317901|FG004|Overall Study|Lack of Efficacy|0|||
163985971|NCT01999582|592317902|FG005|Overall Study|Lack of Efficacy|0|||
163985972|NCT02347176|592317903|FG000|Overall Study|Lost to Follow-up|2|||
163985973|NCT02347176|592317904|FG001|Overall Study|Lost to Follow-up|3|||
163985974|NCT02347176|592317905|FG002|Overall Study|Lost to Follow-up|1|||
163985975|NCT02347176|592317906|FG003|Overall Study|Lost to Follow-up|1|||
163985976|NCT02347176|592317903|FG000|Overall Study|Withdrawal by Subject|9|||
163985977|NCT02347176|592317904|FG001|Overall Study|Withdrawal by Subject|5|||
163985978|NCT02347176|592317905|FG002|Overall Study|Withdrawal by Subject|5|||
163985979|NCT02347176|592317906|FG003|Overall Study|Withdrawal by Subject|3|||
163985980|NCT02347176|592317903|FG000|Overall Study|Other|1|||
163985981|NCT02347176|592317904|FG001|Overall Study|Other|2|||
163985982|NCT02347176|592317905|FG002|Overall Study|Other|2|||
163985983|NCT02347176|592317906|FG003|Overall Study|Other|0|||
163985984|NCT00411554|592317909|FG000|Overall Study|Adverse Event|2|||
163985985|NCT00411554|592317910|FG001|Overall Study|Adverse Event|4|||
163985986|NCT00411554|592317909|FG000|Overall Study|Lack of Efficacy|2|||
163985987|NCT00411554|592317910|FG001|Overall Study|Lack of Efficacy|5|||
164329858|NCT02694523|593584790|FG003|Part B|Protocol Violation|0|||
163985988|NCT00411554|592317909|FG000|Overall Study|Withdrawal by Subject|3|||
163985989|NCT00411554|592317910|FG001|Overall Study|Withdrawal by Subject|0|||
163985990|NCT00411554|592317909|FG000|Overall Study|Patient Moved|1|||
163985991|NCT00411554|592317910|FG001|Overall Study|Patient Moved|0|||
163985992|NCT02462473|592317913|FG000|Overall Study|Death|1|||
163985993|NCT02462473|592317913|FG000|Overall Study|Other|3|||
163985994|NCT01536860|592317915|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
163985995|NCT01536860|592317916|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
163985996|NCT01536860|592317917|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
163985997|NCT01707693|592317918|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
163985998|NCT01707693|592317919|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
163985999|NCT01707693|592317918|FG000|Overall Study Allocation|Protocol Violation|4|||
163986000|NCT01707693|592317919|FG001|Overall Study Allocation|Protocol Violation|3|||
163986001|NCT01707693|592317918|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
163986002|NCT01707693|592317919|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
163986003|NCT01707693|592317918|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
163986004|NCT01707693|592317919|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
163986005|NCT00927095|592317923|FG000|Overall Study|Adverse Event|3|||
163986006|NCT00927095|592317924|FG001|Overall Study|Adverse Event|1|||
164329859|NCT02694523|593584791|FG004|Part B|Protocol Violation|0|||
164329860|NCT02694523|593584792|FG005|Part B|Protocol Violation|0|||
163986007|NCT00927095|592317925|FG002|Overall Study|Adverse Event|0|||
163986008|NCT00927095|592317923|FG000|Overall Study|Withdrawal by Subject|2|||
163986009|NCT00927095|592317924|FG001|Overall Study|Withdrawal by Subject|1|||
163986010|NCT00927095|592317925|FG002|Overall Study|Withdrawal by Subject|1|||
163986011|NCT00927095|592317923|FG000|Overall Study|Physician Decision|1|||
163986012|NCT00927095|592317924|FG001|Overall Study|Physician Decision|2|||
163986013|NCT00927095|592317925|FG002|Overall Study|Physician Decision|1|||
163986014|NCT01543087|592317932|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
163986015|NCT01543087|592317933|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
163986016|NCT01543087|592317934|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
163986017|NCT01543087|592317935|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
163986018|NCT01543087|592317936|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
163986019|NCT01543087|592317937|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
163986020|NCT01543087|592317932|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
163986021|NCT01543087|592317933|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
163986022|NCT01543087|592317934|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
163986023|NCT01543087|592317935|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
163986024|NCT01543087|592317936|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
163986025|NCT01543087|592317937|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
163986026|NCT01543087|592317932|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
163986027|NCT01543087|592317933|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
163986028|NCT01543087|592317934|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
163986029|NCT01543087|592317935|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
163986030|NCT01543087|592317936|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
163986031|NCT01543087|592317937|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
163986032|NCT01543087|592317932|FG000|Stage 1 (48 Months)|Other than specified|5|||
163986033|NCT01543087|592317933|FG001|Stage 1 (48 Months)|Other than specified|0|||
163986034|NCT01543087|592317934|FG002|Stage 1 (48 Months)|Other than specified|9|||
163986035|NCT01543087|592317935|FG003|Stage 1 (48 Months)|Other than specified|0|||
163986036|NCT01543087|592317936|FG004|Stage 1 (48 Months)|Other than specified|0|||
163986037|NCT01543087|592317937|FG005|Stage 1 (48 Months)|Other than specified|0|||
163986038|NCT01543087|592317932|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
163986039|NCT01543087|592317933|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
163986040|NCT01543087|592317934|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
164225372|NCT04157738|593194038|FG000|Overall Study|Moved out of state|0|||
164225373|NCT04157738|593194039|FG001|Overall Study|Moved out of state|2|||
164225374|NCT04157738|593194038|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
164225375|NCT04157738|593194039|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
164225376|NCT02244957|593194040|FG000|Overall Study|Lack of Efficacy|1|||
164225377|NCT02244957|593194041|FG001|Overall Study|Lack of Efficacy|0|||
164225378|NCT01725282|593194043|FG000|Overall Study|Adverse Event|1|||
164225379|NCT01725282|593194044|FG001|Overall Study|Adverse Event|3|||
164225380|NCT01725282|593194045|FG002|Overall Study|Adverse Event|6|||
164225381|NCT01725282|593194046|FG003|Overall Study|Adverse Event|4|||
164225382|NCT01725282|593194043|FG000|Overall Study|Exacerbation of Target Disease|1|||
164225383|NCT01725282|593194044|FG001|Overall Study|Exacerbation of Target Disease|0|||
164225384|NCT01725282|593194045|FG002|Overall Study|Exacerbation of Target Disease|0|||
164225385|NCT01725282|593194046|FG003|Overall Study|Exacerbation of Target Disease|1|||
163986041|NCT01543087|592317935|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
163986042|NCT01543087|592317936|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
163986043|NCT01543087|592317937|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
163986044|NCT01543087|592317932|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163986045|NCT01543087|592317933|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
163986046|NCT01543087|592317934|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163986047|NCT01543087|592317935|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
164225386|NCT01725282|593194043|FG000|Overall Study|Met Exclusion Criteria|0|||
164225387|NCT01725282|593194044|FG001|Overall Study|Met Exclusion Criteria|0|||
164225388|NCT01725282|593194045|FG002|Overall Study|Met Exclusion Criteria|1|||
164225389|NCT01725282|593194046|FG003|Overall Study|Met Exclusion Criteria|0|||
164225390|NCT01725282|593194043|FG000|Overall Study|Study Site Withdrawal|0|||
164225391|NCT01725282|593194044|FG001|Overall Study|Study Site Withdrawal|1|||
163986048|NCT01543087|592317936|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
163986049|NCT01543087|592317937|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
163986050|NCT01543087|592317932|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
163986051|NCT01543087|592317933|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
163986052|NCT01543087|592317934|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
163986053|NCT01543087|592317935|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
164225392|NCT01725282|593194045|FG002|Overall Study|Study Site Withdrawal|0|||
164225393|NCT01725282|593194046|FG003|Overall Study|Study Site Withdrawal|0|||
164225394|NCT01725282|593194043|FG000|Overall Study|Withdrawal by Subject|0|||
163986054|NCT01543087|592317936|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
163986055|NCT01543087|592317937|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
163986056|NCT00143455|592317938|FG000|Cohort 1|Adverse Event|8|||
163986057|NCT00143455|592317939|FG001|Cohort 1|Adverse Event|4|||
163986058|NCT00143455|592317940|FG002|Cohort 1|Adverse Event|0|||
163986059|NCT00143455|592317941|FG003|Cohort 1|Adverse Event|0|||
164225395|NCT01725282|593194044|FG001|Overall Study|Withdrawal by Subject|0|||
164225396|NCT01725282|593194045|FG002|Overall Study|Withdrawal by Subject|1|||
164225397|NCT01725282|593194046|FG003|Overall Study|Withdrawal by Subject|1|||
164329861|NCT02694523|593584793|FG006|Part B|Protocol Violation|0|||
164225398|NCT01725282|593194043|FG000|Overall Study|Lack of Efficacy|0|||
164225399|NCT01725282|593194044|FG001|Overall Study|Lack of Efficacy|1|||
164329862|NCT02694523|593584787|FG000|Part B|Lost to Follow-up|0|||
164329863|NCT02694523|593584788|FG001|Part B|Lost to Follow-up|0|||
163986060|NCT00143455|592317938|FG000|Cohort 1|Death|5|||
163986061|NCT00143455|592317939|FG001|Cohort 1|Death|2|||
163986062|NCT00143455|592317940|FG002|Cohort 1|Death|0|||
163986063|NCT00143455|592317941|FG003|Cohort 1|Death|0|||
163986064|NCT00143455|592317938|FG000|Cohort 1|Progressive Disease|0|||
163986065|NCT00143455|592317939|FG001|Cohort 1|Progressive Disease|6|||
163986066|NCT00143455|592317940|FG002|Cohort 1|Progressive Disease|0|||
163986067|NCT00143455|592317941|FG003|Cohort 1|Progressive Disease|0|||
163986068|NCT00143455|592317938|FG000|Cohort 1|Withdrawal by Subject|1|||
163986069|NCT00143455|592317939|FG001|Cohort 1|Withdrawal by Subject|4|||
163986070|NCT00143455|592317940|FG002|Cohort 1|Withdrawal by Subject|0|||
163986071|NCT00143455|592317941|FG003|Cohort 1|Withdrawal by Subject|0|||
163986072|NCT00143455|592317938|FG000|Cohort 1|Randomized But Not Treated|0|||
163986073|NCT00143455|592317939|FG001|Cohort 1|Randomized But Not Treated|1|||
163986074|NCT00143455|592317940|FG002|Cohort 1|Randomized But Not Treated|0|||
163986075|NCT00143455|592317941|FG003|Cohort 1|Randomized But Not Treated|0|||
163986076|NCT00143455|592317938|FG000|Cohort 2|Adverse Event|0|||
163986077|NCT00143455|592317939|FG001|Cohort 2|Adverse Event|0|||
163986078|NCT00143455|592317940|FG002|Cohort 2|Adverse Event|42|||
163986079|NCT00143455|592317941|FG003|Cohort 2|Adverse Event|30|||
163986080|NCT00143455|592317938|FG000|Cohort 2|No Longer Required Study Treatment|0|||
163986081|NCT00143455|592317939|FG001|Cohort 2|No Longer Required Study Treatment|0|||
163986082|NCT00143455|592317940|FG002|Cohort 2|No Longer Required Study Treatment|1|||
163986083|NCT00143455|592317941|FG003|Cohort 2|No Longer Required Study Treatment|0|||
163986084|NCT00143455|592317938|FG000|Cohort 2|Protocol Violation|0|||
163986085|NCT00143455|592317939|FG001|Cohort 2|Protocol Violation|0|||
163986086|NCT00143455|592317940|FG002|Cohort 2|Protocol Violation|1|||
163986087|NCT00143455|592317941|FG003|Cohort 2|Protocol Violation|1|||
163986088|NCT00143455|592317938|FG000|Cohort 2|Lost to Follow-up|0|||
163986089|NCT00143455|592317939|FG001|Cohort 2|Lost to Follow-up|0|||
163986090|NCT00143455|592317940|FG002|Cohort 2|Lost to Follow-up|1|||
163986091|NCT00143455|592317941|FG003|Cohort 2|Lost to Follow-up|4|||
163986092|NCT00143455|592317938|FG000|Cohort 2|Death|0|||
163986093|NCT00143455|592317939|FG001|Cohort 2|Death|0|||
163986094|NCT00143455|592317940|FG002|Cohort 2|Death|20|||
163986095|NCT00143455|592317941|FG003|Cohort 2|Death|12|||
163986096|NCT00143455|592317938|FG000|Cohort 2|Progressive Disease|0|||
163986097|NCT00143455|592317939|FG001|Cohort 2|Progressive Disease|0|||
163986098|NCT00143455|592317940|FG002|Cohort 2|Progressive Disease|20|||
163986099|NCT00143455|592317941|FG003|Cohort 2|Progressive Disease|27|||
164081571|NCT01405820|592663285|FG002|Open-Label Treatment Period|Physician Decision|1|||
164081572|NCT01405820|592663286|FG003|Open-Label Treatment Period|Physician Decision|2|||
164081573|NCT01405820|592663287|FG004|Open-Label Treatment Period|Physician Decision|1|||
164081574|NCT01405820|592663288|FG005|Open-Label Treatment Period|Physician Decision|0|||
164081575|NCT01405820|592663283|FG000|Open-Label Treatment Period|Adverse Event|0|||
164081576|NCT01405820|592663284|FG001|Open-Label Treatment Period|Adverse Event|0|||
164081577|NCT01405820|592663285|FG002|Open-Label Treatment Period|Adverse Event|0|||
164081578|NCT01405820|592663286|FG003|Open-Label Treatment Period|Adverse Event|1|||
164081579|NCT01405820|592663287|FG004|Open-Label Treatment Period|Adverse Event|0|||
164081580|NCT01405820|592663288|FG005|Open-Label Treatment Period|Adverse Event|0|||
164081581|NCT03222141|592663291|FG000|Overall Study|Death|15|||
164081582|NCT03222141|592663291|FG000|Overall Study|Lost to Follow-up|3|||
164081583|NCT00827359|592663294|FG000|Overall Study|Progressive Diseas|19|||
164081584|NCT00827359|592663294|FG000|Overall Study|Unacceptable Toxicity|5|||
164081585|NCT00827359|592663294|FG000|Overall Study|Ineligible|1|||
164081586|NCT02436135|592663295|FG000|Overall Study|Progressive Disease|3|||
164081587|NCT02436135|592663296|FG001|Overall Study|Progressive Disease|1|||
164081588|NCT02436135|592663295|FG000|Overall Study|Investigator Discretion|1|||
164081589|NCT02436135|592663296|FG001|Overall Study|Investigator Discretion|2|||
164081590|NCT02436135|592663295|FG000|Overall Study|Adverse Event|1|||
164081591|NCT02436135|592663296|FG001|Overall Study|Adverse Event|0|||
164081592|NCT02436135|592663295|FG000|Overall Study|Withdrawal by Participant|1|||
164081593|NCT02436135|592663296|FG001|Overall Study|Withdrawal by Participant|0|||
164081594|NCT02436135|592663295|FG000|Overall Study|Study Terminated By Sponsor|0|||
164081595|NCT02436135|592663296|FG001|Overall Study|Study Terminated By Sponsor|1|||
163986100|NCT00143455|592317938|FG000|Cohort 2|Withdrawal by Subject|0|||
163986101|NCT00143455|592317939|FG001|Cohort 2|Withdrawal by Subject|0|||
163986102|NCT00143455|592317940|FG002|Cohort 2|Withdrawal by Subject|13|||
163986103|NCT00143455|592317941|FG003|Cohort 2|Withdrawal by Subject|12|||
163986104|NCT00143455|592317938|FG000|Cohort 2|Other|0|||
163986105|NCT00143455|592317939|FG001|Cohort 2|Other|0|||
163986106|NCT00143455|592317940|FG002|Cohort 2|Other|7|||
163986107|NCT00143455|592317941|FG003|Cohort 2|Other|6|||
163986108|NCT00143455|592317938|FG000|Cohort 2|Randomized But Not Treated|0|||
163986109|NCT00143455|592317939|FG001|Cohort 2|Randomized But Not Treated|0|||
163986110|NCT00143455|592317940|FG002|Cohort 2|Randomized But Not Treated|1|||
163986111|NCT00143455|592317941|FG003|Cohort 2|Randomized But Not Treated|1|||
163986112|NCT02682901|592317942|FG000|Overall Study|Adverse Event|10|||
163986113|NCT02682901|592317943|FG001|Overall Study|Adverse Event|3|||
163986114|NCT02682901|592317942|FG000|Overall Study|Lack of Efficacy|0|||
164081596|NCT00415532|592663299|FG000|Treatment Period|Adverse Event|2|||
164225400|NCT01725282|593194045|FG002|Overall Study|Lack of Efficacy|0|||
164225401|NCT01725282|593194046|FG003|Overall Study|Lack of Efficacy|1|||
164225402|NCT05071027|593194047|FG000|Overall Study|Lost to Follow-up|1|||
164225403|NCT05071027|593194048|FG001|Overall Study|Lost to Follow-up|4|||
164225404|NCT04576481|593194049|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
164225405|NCT04576481|593194050|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
164225406|NCT04576481|593194051|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
164225407|NCT04576481|593194052|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
164225408|NCT05463952|593194056|FG000|Treatment|Progressive disease|4|||
164225409|NCT05463952|593194056|FG000|Treatment|Ongoing|2|||
164225410|NCT02739828|593194058|FG000|Overall Study|Adverse Event|1|||
164225411|NCT02739828|593194058|FG000|Overall Study|Lost to Follow-up|4|||
164225412|NCT00489359|593194061|FG000|Overall Study|Death|0|||
164225413|NCT00489359|593194062|FG001|Overall Study|Death|2|||
164225414|NCT00489359|593194061|FG000|Overall Study|Progressive Disease|5|||
164225415|NCT00489359|593194062|FG001|Overall Study|Progressive Disease|6|||
164225416|NCT00489359|593194061|FG000|Overall Study|Lost to Follow-up|1|||
164225417|NCT00489359|593194062|FG001|Overall Study|Lost to Follow-up|0|||
164225418|NCT00489359|593194061|FG000|Overall Study|Withdrawal by Subject|1|||
163881764|NCT03692676|591937177|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
163881765|NCT03692676|591937178|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
163881766|NCT03692676|591937175|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
163881767|NCT03692676|591937176|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
163881768|NCT03692676|591937177|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
163881769|NCT03692676|591937178|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
163881770|NCT03692676|591937175|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
163881771|NCT03692676|591937176|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
163881772|NCT03692676|591937177|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
163881773|NCT03692676|591937178|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
163881774|NCT03692676|591937175|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
163881775|NCT03692676|591937176|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
163881776|NCT03692676|591937177|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
163881777|NCT03692676|591937178|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
163881778|NCT03692676|591937175|FG000|Overall Study|Other|0|||
163881779|NCT03692676|591937176|FG001|Overall Study|Other|805|||
163881780|NCT03692676|591937177|FG002|Overall Study|Other|758|||
163881781|NCT03692676|591937178|FG003|Overall Study|Other|277|||
163881782|NCT03692676|591937175|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
163881783|NCT03692676|591937176|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
163881784|NCT03692676|591937177|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
163881785|NCT03692676|591937178|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
163881786|NCT03692611|591937179|FG000|Overall Study|Found to be ineligible postrandomization|3|||
163881787|NCT03692611|591937180|FG001|Overall Study|Found to be ineligible postrandomization|0|||
163881788|NCT03988634|591937182|FG000|Double-Blind|Adverse Event|4|||
163881789|NCT03988634|591937183|FG001|Double-Blind|Adverse Event|0|||
163881790|NCT03988634|591937184|FG002|Double-Blind|Adverse Event|0|||
163881791|NCT03988634|591937182|FG000|Double-Blind|Death|18|||
163881792|NCT03988634|591937183|FG001|Double-Blind|Death|26|||
163881793|NCT03988634|591937184|FG002|Double-Blind|Death|0|||
163881794|NCT03988634|591937182|FG000|Double-Blind|Lost to Follow-up|6|||
163881795|NCT03988634|591937183|FG001|Double-Blind|Lost to Follow-up|7|||
163881796|NCT03988634|591937184|FG002|Double-Blind|Lost to Follow-up|0|||
163881797|NCT03988634|591937182|FG000|Double-Blind|Physician Decision|9|||
163881798|NCT03988634|591937183|FG001|Double-Blind|Physician Decision|5|||
163881799|NCT03988634|591937184|FG002|Double-Blind|Physician Decision|0|||
163881800|NCT03988634|591937182|FG000|Double-Blind|Subject decision|24|||
163881801|NCT03988634|591937183|FG001|Double-Blind|Subject decision|13|||
163881802|NCT03988634|591937184|FG002|Double-Blind|Subject decision|0|||
163881803|NCT03988634|591937182|FG000|Open-Label|Adverse Event|0|||
163881804|NCT03988634|591937183|FG001|Open-Label|Adverse Event|0|||
163881805|NCT03988634|591937184|FG002|Open-Label|Adverse Event|7|||
163881806|NCT03988634|591937182|FG000|Open-Label|Physician Decision|0|||
163881807|NCT03988634|591937183|FG001|Open-Label|Physician Decision|0|||
163881808|NCT03988634|591937184|FG002|Open-Label|Physician Decision|1|||
163881809|NCT03988634|591937182|FG000|Open-Label|Technical problems|0|||
163881810|NCT03988634|591937183|FG001|Open-Label|Technical problems|0|||
163881811|NCT03988634|591937184|FG002|Open-Label|Technical problems|1|||
163881812|NCT02995434|591937185|FG000|Overall Study|Adverse Event|1|||
163881813|NCT02995434|591937186|FG001|Overall Study|Adverse Event|0|||
163881814|NCT02995434|591937185|FG000|Overall Study|Withdrawal by Subject|6|||
164225419|NCT00489359|593194062|FG001|Overall Study|Withdrawal by Subject|5|||
164225420|NCT00489359|593194061|FG000|Overall Study|Adverse Event|0|||
164225421|NCT00489359|593194062|FG001|Overall Study|Adverse Event|16|||
164225422|NCT03180138|593194063|FG000|Overall Study|Mobile-phone could not be verified|2|||
164225423|NCT03180138|593194064|FG001|Overall Study|Mobile-phone could not be verified|13|||
164225424|NCT03180138|593194065|FG002|Overall Study|Mobile-phone could not be verified|15|||
164225425|NCT03180138|593194063|FG000|Overall Study|No prior immunization records|17|||
163986115|NCT02682901|592317943|FG001|Overall Study|Lack of Efficacy|1|||
163986116|NCT00720109|592317958|FG000|Induction Period|Did not meet eligibility criteria|3|||
163986117|NCT00720109|592317959|FG001|Induction Period|Did not meet eligibility criteria|0|||
163986118|NCT00720109|592317960|FG002|Induction Period|Did not meet eligibility criteria|0|||
163986119|NCT00720109|592317958|FG000|Induction Period|Bone Marrow Transplant|2|||
163986120|NCT00720109|592317959|FG001|Induction Period|Bone Marrow Transplant|0|||
163986121|NCT00720109|592317960|FG002|Induction Period|Bone Marrow Transplant|0|||
163986122|NCT00720109|592317958|FG000|Induction Period|Physician Decision|1|||
163986123|NCT00720109|592317959|FG001|Induction Period|Physician Decision|0|||
163986124|NCT00720109|592317960|FG002|Induction Period|Physician Decision|0|||
163986125|NCT00720109|592317958|FG000|Risk Stratification Period|Adverse Event|0|||
163986126|NCT00720109|592317959|FG001|Risk Stratification Period|Adverse Event|1|||
163986127|NCT00720109|592317960|FG002|Risk Stratification Period|Adverse Event|0|||
163986128|NCT00720109|592317958|FG000|Risk Stratification Period|Physician Decision|0|||
163986129|NCT00720109|592317959|FG001|Risk Stratification Period|Physician Decision|2|||
163986130|NCT00720109|592317960|FG002|Risk Stratification Period|Physician Decision|1|||
163986131|NCT00720109|592317958|FG000|Risk Stratification Period|Bone marrow transplant|0|||
163986132|NCT00720109|592317959|FG001|Risk Stratification Period|Bone marrow transplant|9|||
163986133|NCT00720109|592317960|FG002|Risk Stratification Period|Bone marrow transplant|7|||
163986134|NCT00720109|592317958|FG000|Risk Stratification Period|Disease progression or relapse|0|||
163986135|NCT00720109|592317959|FG001|Risk Stratification Period|Disease progression or relapse|2|||
163986136|NCT00720109|592317960|FG002|Risk Stratification Period|Disease progression or relapse|0|||
163986137|NCT00720109|592317958|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
163986138|NCT00720109|592317959|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
163986139|NCT00720109|592317960|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
163986140|NCT02665286|592317961|FG000|Overall Study|Lost to Follow-up|3|||
163986141|NCT02665286|592317962|FG001|Overall Study|Lost to Follow-up|2|||
163986142|NCT02665286|592317963|FG002|Overall Study|Lost to Follow-up|1|||
163986143|NCT00915343|592317964|FG000|Part B - Open Label Period|Treatment switch|0|||
163986144|NCT00915343|592317965|FG001|Part B - Open Label Period|Treatment switch|0|||
163986145|NCT00915343|592317966|FG002|Part B - Open Label Period|Treatment switch|1|||
163986146|NCT00915343|592317964|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
163986147|NCT00915343|592317965|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
163986148|NCT00915343|592317966|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
163986149|NCT04153188|592317976|FG000|Overall Study|Lost to Follow-up|1|||
163986150|NCT04153188|592317977|FG001|Overall Study|Lost to Follow-up|1|||
163986151|NCT04153188|592317976|FG000|Overall Study|Withdrawal by Subject|2|||
163986152|NCT04153188|592317977|FG001|Overall Study|Withdrawal by Subject|0|||
163986153|NCT04153188|592317976|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
163986154|NCT04153188|592317977|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
163986155|NCT01489527|592317978|FG000|Overall Study|Pregnancy|9|||
163986156|NCT01489527|592317979|FG001|Overall Study|Pregnancy|14|||
163986157|NCT01489527|592317978|FG000|Overall Study|Participant moved|6|||
163986158|NCT01489527|592317979|FG001|Overall Study|Participant moved|7|||
163986159|NCT01489527|592317978|FG000|Overall Study|Withdrawal by Subject|0|||
163986160|NCT01489527|592317979|FG001|Overall Study|Withdrawal by Subject|4|||
163986161|NCT01489527|592317978|FG000|Overall Study|Lost to Follow-up|5|||
163986162|NCT01489527|592317979|FG001|Overall Study|Lost to Follow-up|1|||
163986163|NCT01489527|592317978|FG000|Overall Study|Procedures|1|||
163986164|NCT01489527|592317979|FG001|Overall Study|Procedures|0|||
163986165|NCT01489527|592317978|FG000|Overall Study|Not compliant|1|||
163986166|NCT01489527|592317979|FG001|Overall Study|Not compliant|0|||
163986167|NCT04899232|592317980|FG000|Screening Period|Physician Decision|1|||
163986168|NCT04899232|592317981|FG001|Screening Period|Physician Decision|0|||
163986169|NCT04899232|592317982|FG002|Screening Period|Physician Decision|0|||
163986170|NCT04899232|592317980|FG000|Screening Period|Withdrawal by Subject|1|||
163986171|NCT04899232|592317981|FG001|Screening Period|Withdrawal by Subject|0|||
163986172|NCT04899232|592317982|FG002|Screening Period|Withdrawal by Subject|0|||
163986173|NCT04899232|592317980|FG000|Screening Period|Participant discharged before receiving intervention|3|||
164225426|NCT03180138|593194064|FG001|Overall Study|No prior immunization records|0|||
164329864|NCT02694523|593584789|FG002|Part B|Lost to Follow-up|2|||
163986174|NCT04899232|592317981|FG001|Screening Period|Participant discharged before receiving intervention|0|||
163986175|NCT04899232|592317982|FG002|Screening Period|Participant discharged before receiving intervention|0|||
163986176|NCT00700271|592317983|FG000|Overall Study|Adverse Event|4|||
163986177|NCT00700271|592317984|FG001|Overall Study|Adverse Event|6|||
163986178|NCT00700271|592317983|FG000|Overall Study|Protocol Violation|1|||
163986179|NCT00700271|592317984|FG001|Overall Study|Protocol Violation|0|||
163986180|NCT00700271|592317983|FG000|Overall Study|Administrative Reasons|1|||
163986181|NCT00700271|592317984|FG001|Overall Study|Administrative Reasons|0|||
163986182|NCT00700271|592317983|FG000|Overall Study|Withdrawal by Subject|6|||
163986183|NCT00700271|592317984|FG001|Overall Study|Withdrawal by Subject|4|||
163986184|NCT00700271|592317983|FG000|Overall Study|Lost to Follow-up|2|||
163986185|NCT00700271|592317984|FG001|Overall Study|Lost to Follow-up|2|||
163986186|NCT02406781|592317985|FG000|Overall Study|Protocol Violation|2|||
163986187|NCT02406781|592317986|FG001|Overall Study|Protocol Violation|2|||
163986188|NCT02406781|592317987|FG002|Overall Study|Protocol Violation|2|||
163986189|NCT02406781|592317988|FG003|Overall Study|Protocol Violation|2|||
163986190|NCT02406781|592317989|FG004|Overall Study|Protocol Violation|1|||
163986191|NCT02406781|592317990|FG005|Overall Study|Protocol Violation|5|||
163986192|NCT02406781|592317991|FG006|Overall Study|Protocol Violation|3|||
163986193|NCT02553460|592317992|FG000|Overall Study|Death|3|||
163986194|NCT02553460|592317992|FG000|Overall Study|Withdrawal by Subject|1|||
163986195|NCT02553460|592317992|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
163986196|NCT02553460|592317992|FG000|Overall Study|Relapse or Transplant|14|||
163986197|NCT02553460|592317992|FG000|Overall Study|No response to treatment|2|||
163986198|NCT02553460|592317992|FG000|Overall Study|CAR T cells|2|||
163986199|NCT00482014|592320089|FG000|Overall Study|Withdrawal by Subject|1|||
163986200|NCT00482014|592320090|FG001|Overall Study|Withdrawal by Subject|2|||
163986201|NCT00482014|592320091|FG002|Overall Study|Withdrawal by Subject|3|||
163986202|NCT00482014|592320092|FG003|Overall Study|Withdrawal by Subject|4|||
163986203|NCT00482014|592320089|FG000|Overall Study|Adverse Event|3|||
163986204|NCT00482014|592320090|FG001|Overall Study|Adverse Event|0|||
163986205|NCT00482014|592320091|FG002|Overall Study|Adverse Event|2|||
163986206|NCT00482014|592320092|FG003|Overall Study|Adverse Event|8|||
163986207|NCT00482014|592320089|FG000|Overall Study|Death|1|||
163986208|NCT00482014|592320090|FG001|Overall Study|Death|2|||
163986209|NCT00482014|592320091|FG002|Overall Study|Death|1|||
163986210|NCT00482014|592320092|FG003|Overall Study|Death|4|||
163986211|NCT00482014|592320089|FG000|Overall Study|Lack of Efficacy|1|||
163986212|NCT00482014|592320090|FG001|Overall Study|Lack of Efficacy|0|||
163986213|NCT00482014|592320091|FG002|Overall Study|Lack of Efficacy|4|||
163986214|NCT00482014|592320092|FG003|Overall Study|Lack of Efficacy|6|||
163986215|NCT00482014|592320089|FG000|Overall Study|Sponsor Decision|1|||
163986216|NCT00482014|592320090|FG001|Overall Study|Sponsor Decision|2|||
163986217|NCT00482014|592320091|FG002|Overall Study|Sponsor Decision|1|||
163986218|NCT00482014|592320092|FG003|Overall Study|Sponsor Decision|1|||
163986219|NCT01284114|592320095|FG000|Overall Study|viral infection|1|||
163986220|NCT01284114|592320095|FG000|Overall Study|From the results of ALLTITUDE study|1|||
163986221|NCT01284114|592320095|FG000|Overall Study|Symptomatic hypotension|1|||
163986222|NCT01284114|592320095|FG000|Overall Study|dizziness|1|||
163986223|NCT00544869|592320096|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
163986224|NCT00544869|592320097|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
163986225|NCT00544869|592320098|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
163986226|NCT00544869|592320096|FG000|Overall Study|Adverse Event|6|||
163986227|NCT00544869|592320097|FG001|Overall Study|Adverse Event|1|||
163986228|NCT00544869|592320098|FG002|Overall Study|Adverse Event|0|||
163986229|NCT00544869|592320096|FG000|Overall Study|Lack of Efficacy|1|||
163986230|NCT00544869|592320097|FG001|Overall Study|Lack of Efficacy|1|||
163986231|NCT00544869|592320098|FG002|Overall Study|Lack of Efficacy|0|||
163986232|NCT00544869|592320096|FG000|Overall Study|Physician Decision|2|||
163986233|NCT00544869|592320097|FG001|Overall Study|Physician Decision|0|||
163986234|NCT00544869|592320098|FG002|Overall Study|Physician Decision|0|||
163986235|NCT02322710|592320099|FG000|Overall Study|No efficacy assessment post-baseline|0|||
163986236|NCT02322710|592320100|FG001|Overall Study|No efficacy assessment post-baseline|1|||
163986237|NCT02322710|592320099|FG000|Overall Study|Protocol Violation|20|||
163986238|NCT02322710|592320100|FG001|Overall Study|Protocol Violation|25|||
163986239|NCT04161131|592320101|FG000|Overall Study|Ineligible|2|||
163986240|NCT04161131|592320101|FG000|Overall Study|Lost to Follow-up|4|||
163986241|NCT05064059|592320102|FG000|Overall Study|Death|199|||
163986242|NCT05064059|592320103|FG001|Overall Study|Death|196|||
163986243|NCT05064059|592320102|FG000|Overall Study|Physician Decision|4|||
163986244|NCT05064059|592320103|FG001|Overall Study|Physician Decision|2|||
163986245|NCT05064059|592320102|FG000|Overall Study|Sponsor Decision|14|||
163986246|NCT05064059|592320103|FG001|Overall Study|Sponsor Decision|11|||
163986247|NCT05064059|592320102|FG000|Overall Study|Withdrawal by Subject|4|||
163986248|NCT05064059|592320103|FG001|Overall Study|Withdrawal by Subject|11|||
163986249|NCT03905863|592320104|FG000|Overall Study|Adverse Event|2|||
163986250|NCT03905863|592320105|FG001|Overall Study|Adverse Event|4|||
163986251|NCT03905863|592320104|FG000|Overall Study|Withdrawal by Subject|2|||
163986252|NCT03905863|592320105|FG001|Overall Study|Withdrawal by Subject|2|||
163986253|NCT03905863|592320104|FG000|Overall Study|Physician Decision|0|||
163986254|NCT03905863|592320105|FG001|Overall Study|Physician Decision|3|||
163986255|NCT03905863|592320104|FG000|Overall Study|Lost to Follow-up|1|||
163986256|NCT03905863|592320105|FG001|Overall Study|Lost to Follow-up|0|||
163986257|NCT03905863|592320104|FG000|Overall Study|Protocol Violation|0|||
163986258|NCT03905863|592320105|FG001|Overall Study|Protocol Violation|2|||
163986259|NCT03905863|592320104|FG000|Overall Study|Death|0|||
163986260|NCT03905863|592320105|FG001|Overall Study|Death|1|||
163986261|NCT02944448|592320106|FG000|Overall Study|Adverse Event|37|||
163986262|NCT02944448|592320107|FG001|Overall Study|Adverse Event|6|||
163986263|NCT02944448|592320106|FG000|Overall Study|Lack of Efficacy|8|||
163986264|NCT02944448|592320107|FG001|Overall Study|Lack of Efficacy|5|||
163986265|NCT02944448|592320106|FG000|Overall Study|Lost to Follow-up|3|||
163986266|NCT02944448|592320107|FG001|Overall Study|Lost to Follow-up|1|||
163986267|NCT02944448|592320106|FG000|Overall Study|Protocol Violation|25|||
163986268|NCT02944448|592320107|FG001|Overall Study|Protocol Violation|7|||
163986269|NCT02944448|592320106|FG000|Overall Study|Withdrawal by Subject|14|||
163986270|NCT02944448|592320107|FG001|Overall Study|Withdrawal by Subject|4|||
163986271|NCT02944448|592320106|FG000|Overall Study|Sponsor did not supply drug in time|0|||
163986272|NCT02944448|592320107|FG001|Overall Study|Sponsor did not supply drug in time|1|||
163986273|NCT02944448|592320106|FG000|Overall Study|Noncompliant with dosing|1|||
163986274|NCT02944448|592320107|FG001|Overall Study|Noncompliant with dosing|0|||
164329865|NCT02694523|593584790|FG003|Part B|Lost to Follow-up|3|||
164329866|NCT02694523|593584791|FG004|Part B|Lost to Follow-up|2|||
164329867|NCT02694523|593584792|FG005|Part B|Lost to Follow-up|0|||
164329868|NCT02694523|593584793|FG006|Part B|Lost to Follow-up|1|||
164329869|NCT02694523|593584787|FG000|Part B|Withdrawal by Subject|0|||
164329870|NCT02694523|593584788|FG001|Part B|Withdrawal by Subject|0|||
164329871|NCT02694523|593584789|FG002|Part B|Withdrawal by Subject|9|||
164329872|NCT02694523|593584790|FG003|Part B|Withdrawal by Subject|0|||
164329873|NCT02694523|593584791|FG004|Part B|Withdrawal by Subject|1|||
164329874|NCT02694523|593584792|FG005|Part B|Withdrawal by Subject|3|||
164329875|NCT02694523|593584793|FG006|Part B|Withdrawal by Subject|0|||
164329876|NCT02694523|593584787|FG000|Part B|Other|0|||
164329877|NCT02694523|593584788|FG001|Part B|Other|0|||
164329878|NCT02694523|593584789|FG002|Part B|Other|1|||
164329879|NCT02694523|593584790|FG003|Part B|Other|0|||
164329880|NCT02694523|593584791|FG004|Part B|Other|0|||
164329881|NCT02694523|593584792|FG005|Part B|Other|0|||
164329882|NCT02694523|593584793|FG006|Part B|Other|1|||
164329883|NCT01058265|593584794|FG000|Overall Study|Lost to Follow-up|11|||
164329884|NCT01058265|593584795|FG001|Overall Study|Lost to Follow-up|12|||
164329885|NCT02169284|593584796|FG000|Overall Study|Physician Decision|0|||
164329886|NCT02169284|593584797|FG001|Overall Study|Physician Decision|1|||
164329887|NCT01367119|593584798|FG000|Overall Study|Adverse Event|1|||
164329888|NCT01367119|593584799|FG001|Overall Study|Adverse Event|0|||
164329889|NCT01367119|593584798|FG000|Overall Study|Withdrawal by Subject|1|||
164329890|NCT01367119|593584799|FG001|Overall Study|Withdrawal by Subject|1|||
164329891|NCT02964507|593584802|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329892|NCT02964507|593584803|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
164329893|NCT02964507|593584804|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329894|NCT02964507|593584805|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329895|NCT02964507|593584806|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
164329896|NCT02964507|593584807|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329897|NCT02964507|593584808|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329898|NCT02964507|593584809|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
164329899|NCT02964507|593584802|FG000|Overall Study|Study terminated by Sponsor|9|||
164329900|NCT02964507|593584803|FG001|Overall Study|Study terminated by Sponsor|1|||
164329901|NCT02964507|593584804|FG002|Overall Study|Study terminated by Sponsor|9|||
164329902|NCT02964507|593584805|FG003|Overall Study|Study terminated by Sponsor|3|||
163986275|NCT02944448|592320106|FG000|Overall Study|Abnormal laboratory values|1|||
163986276|NCT02944448|592320107|FG001|Overall Study|Abnormal laboratory values|0|||
163986277|NCT00804687|592320111|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
163986278|NCT00804687|592320112|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
163986279|NCT00804687|592320113|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
163986280|NCT00804687|592320114|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
163986281|NCT00804687|592320115|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
163986282|NCT00804687|592320116|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
163986283|NCT00804687|592320111|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
163986284|NCT00804687|592320112|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
163986285|NCT00804687|592320113|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
163986286|NCT00804687|592320114|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
163986287|NCT00804687|592320115|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
163986288|NCT00804687|592320116|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
163986289|NCT00804687|592320111|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
163986290|NCT00804687|592320112|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
163986291|NCT00804687|592320113|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
163986292|NCT00804687|592320114|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
163986293|NCT00804687|592320115|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
164329903|NCT02964507|593584806|FG004|Overall Study|Study terminated by Sponsor|3|||
163986294|NCT00804687|592320116|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
163986295|NCT00804687|592320111|FG000|Period 5: Treatment Period|Positive drug test|1|||
163986296|NCT00804687|592320112|FG001|Period 5: Treatment Period|Positive drug test|0|||
163986297|NCT00804687|592320113|FG002|Period 5: Treatment Period|Positive drug test|0|||
163986298|NCT00804687|592320114|FG003|Period 5: Treatment Period|Positive drug test|0|||
163986299|NCT00804687|592320115|FG004|Period 5: Treatment Period|Positive drug test|0|||
163986300|NCT00804687|592320116|FG005|Period 5: Treatment Period|Positive drug test|0|||
163986301|NCT00805740|592320122|FG000|Overall Study|Death|7|||
163986302|NCT00805740|592320123|FG001|Overall Study|Death|4|||
163986303|NCT00805740|592320122|FG000|Overall Study|Withdrawal by Subject|1|||
163986304|NCT00805740|592320123|FG001|Overall Study|Withdrawal by Subject|0|||
163986305|NCT00805740|592320122|FG000|Overall Study|Lost to Follow-up|1|||
163986306|NCT00805740|592320123|FG001|Overall Study|Lost to Follow-up|0|||
163986307|NCT00805740|592320122|FG000|Overall Study|Randomized, but not treated|2|||
163986308|NCT00805740|592320123|FG001|Overall Study|Randomized, but not treated|0|||
163986309|NCT05227690|592320128|FG000|Overall Study|Adverse Event|5|||
163986310|NCT05227690|592320129|FG001|Overall Study|Adverse Event|6|||
163986311|NCT05227690|592320130|FG002|Overall Study|Adverse Event|10|||
163986312|NCT05227690|592320128|FG000|Overall Study|Lack of Efficacy|2|||
163986313|NCT05227690|592320129|FG001|Overall Study|Lack of Efficacy|4|||
163986314|NCT05227690|592320130|FG002|Overall Study|Lack of Efficacy|1|||
163986315|NCT05227690|592320128|FG000|Overall Study|Physician Decision|6|||
163986316|NCT05227690|592320129|FG001|Overall Study|Physician Decision|0|||
163986317|NCT05227690|592320130|FG002|Overall Study|Physician Decision|4|||
163986318|NCT05227690|592320128|FG000|Overall Study|Withdrawal of consent|28|||
163986319|NCT05227690|592320129|FG001|Overall Study|Withdrawal of consent|27|||
163986320|NCT05227690|592320130|FG002|Overall Study|Withdrawal of consent|21|||
163986321|NCT05227690|592320128|FG000|Overall Study|Other, not specified|2|||
163986322|NCT05227690|592320129|FG001|Overall Study|Other, not specified|2|||
163986323|NCT05227690|592320130|FG002|Overall Study|Other, not specified|1|||
163986324|NCT00975156|592320131|FG000|Overall Study|Protocol Violation|0|||
163986325|NCT00975156|592320132|FG001|Overall Study|Protocol Violation|1|||
163986326|NCT02634580|592320133|FG000|Double-blind Treatment Period|Subject Request|1|||
163986327|NCT02634580|592320134|FG001|Double-blind Treatment Period|Subject Request|0|||
163986328|NCT02634580|592320135|FG002|Double-blind Treatment Period|Subject Request|1|||
163986329|NCT02634580|592320136|FG003|Double-blind Treatment Period|Subject Request|1|||
163986330|NCT02634580|592320133|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
163986331|NCT02634580|592320134|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
163986332|NCT02634580|592320135|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
163986333|NCT02634580|592320136|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
163986334|NCT00424827|592320142|FG000|Overall Study|Adverse Event|1|||
163986335|NCT02397473|592320145|FG000|Treatment Phase|Adverse Event|1|||
163986336|NCT02397473|592320146|FG001|Treatment Phase|Adverse Event|2|||
163986337|NCT02397473|592320145|FG000|Treatment Phase|Lack of Efficacy|8|||
163986338|NCT02397473|592320146|FG001|Treatment Phase|Lack of Efficacy|1|||
163986339|NCT02397473|592320145|FG000|Treatment Phase|Lost to Follow-up|1|||
163986340|NCT02397473|592320146|FG001|Treatment Phase|Lost to Follow-up|0|||
163986341|NCT02397473|592320145|FG000|Treatment Phase|Withdrawal by Subject|2|||
163986342|NCT02397473|592320146|FG001|Treatment Phase|Withdrawal by Subject|1|||
163986343|NCT02397473|592320145|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
163986344|NCT02397473|592320146|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
163986345|NCT02397473|592320145|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
163986346|NCT02397473|592320146|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
163986347|NCT02397473|592320145|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
163986348|NCT02397473|592320146|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
163986349|NCT02397473|592320145|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
163986350|NCT02397473|592320146|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
163986351|NCT02397473|592320145|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
163986352|NCT02397473|592320146|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
163986353|NCT01467492|592320147|FG000|Overall Study|Withdrawal by Subject|6|||
163986354|NCT01467492|592320148|FG001|Overall Study|Withdrawal by Subject|4|||
163986355|NCT01467492|592320147|FG000|Overall Study|Study Terminated by Sponsor|6|||
163986356|NCT01467492|592320148|FG001|Overall Study|Study Terminated by Sponsor|4|||
163986357|NCT01467492|592320147|FG000|Overall Study|Adverse Event|4|||
163986358|NCT01467492|592320148|FG001|Overall Study|Adverse Event|3|||
163986359|NCT01467492|592320147|FG000|Overall Study|Lost to Follow-up|3|||
163986360|NCT01467492|592320148|FG001|Overall Study|Lost to Follow-up|2|||
163986361|NCT01467492|592320147|FG000|Overall Study|Undefined|2|||
163986362|NCT01467492|592320148|FG001|Overall Study|Undefined|0|||
163986363|NCT01467492|592320147|FG000|Overall Study|Enrolled But Not Treated|1|||
163986364|NCT01467492|592320148|FG001|Overall Study|Enrolled But Not Treated|0|||
163986365|NCT00491179|592320149|FG000|Overall Study|Adverse Event|5|||
163986366|NCT00491179|592320150|FG001|Overall Study|Adverse Event|1|||
163986367|NCT00491179|592320149|FG000|Overall Study|Withdrawal by Subject|2|||
163986368|NCT00491179|592320150|FG001|Overall Study|Withdrawal by Subject|1|||
164081597|NCT00415532|592663300|FG001|Treatment Period|Adverse Event|3|||
163881815|NCT02995434|591937186|FG001|Overall Study|Withdrawal by Subject|3|||
163881816|NCT04150718|591937192|FG000|Overall Study|Withdrawal by Subject|2|||
163881817|NCT04150718|591937193|FG001|Overall Study|Withdrawal by Subject|7|||
163881818|NCT04150718|591937194|FG002|Overall Study|Withdrawal by Subject|1|||
163881819|NCT04150718|591937192|FG000|Overall Study|Lost to Follow-up|1|||
163881820|NCT04150718|591937193|FG001|Overall Study|Lost to Follow-up|2|||
163881821|NCT04150718|591937194|FG002|Overall Study|Lost to Follow-up|0|||
163881822|NCT04150718|591937192|FG000|Overall Study|Ineligible|1|||
163881823|NCT04150718|591937193|FG001|Overall Study|Ineligible|0|||
163881824|NCT04150718|591937194|FG002|Overall Study|Ineligible|10|||
163881825|NCT03047928|591937195|FG000|Overall Study|Adverse Event|0|||
163881826|NCT03047928|591937196|FG001|Overall Study|Adverse Event|2|||
163881827|NCT03047928|591937197|FG002|Overall Study|Adverse Event|0|||
163881828|NCT03047928|591937195|FG000|Overall Study|Protocol Violation|0|||
163881829|NCT03047928|591937196|FG001|Overall Study|Protocol Violation|1|||
163881830|NCT03047928|591937197|FG002|Overall Study|Protocol Violation|0|||
163881831|NCT03047928|591937195|FG000|Overall Study|included in another protocol|0|||
163881832|NCT03047928|591937196|FG001|Overall Study|included in another protocol|1|||
163881833|NCT03047928|591937197|FG002|Overall Study|included in another protocol|0|||
163881834|NCT02437318|591937198|FG000|Overall Study|Progressive disease|207|||
163881835|NCT02437318|591937199|FG001|Overall Study|Progressive disease|240|||
163881836|NCT02437318|591937198|FG000|Overall Study|Subject/guardian decision|24|||
163881837|NCT02437318|591937199|FG001|Overall Study|Subject/guardian decision|11|||
163881838|NCT02437318|591937198|FG000|Overall Study|Physician Decision|29|||
163881839|NCT02437318|591937199|FG001|Overall Study|Physician Decision|22|||
163881840|NCT02437318|591937198|FG000|Overall Study|Adverse Event|14|||
163881841|NCT02437318|591937199|FG001|Overall Study|Adverse Event|4|||
163881842|NCT02437318|591937198|FG000|Overall Study|Death|4|||
163881843|NCT02437318|591937199|FG001|Overall Study|Death|4|||
163881844|NCT02437318|591937198|FG000|Overall Study|Protocol deviation|5|||
163881845|NCT02437318|591937199|FG001|Overall Study|Protocol deviation|7|||
163881846|NCT02437318|591937198|FG000|Overall Study|Sponsor decision|1|||
163881847|NCT02437318|591937199|FG001|Overall Study|Sponsor decision|0|||
163881848|NCT06074523|591937201|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
163881849|NCT06074523|591937201|FG000|Overall Study|Withdrawal by Subject|1|||
163881850|NCT03406871|591937209|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
163881851|NCT03406871|591937210|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
163881852|NCT03406871|591937211|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
163881853|NCT03406871|591937209|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
163881854|NCT03406871|591937210|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
163881855|NCT03406871|591937211|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
163881856|NCT03406871|591937209|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
163881857|NCT03406871|591937210|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
163881858|NCT03406871|591937211|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
163881859|NCT03406871|591937209|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
163881860|NCT03406871|591937210|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
163881861|NCT03406871|591937211|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
163881862|NCT03406871|591937209|FG000|Expansion Cohort(Final Analysis)|Death|0|||
163881863|NCT03406871|591937210|FG001|Expansion Cohort(Final Analysis)|Death|1|||
163881864|NCT03406871|591937211|FG002|Expansion Cohort(Final Analysis)|Death|0|||
163881865|NCT03406871|591937209|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
163881866|NCT03406871|591937210|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
163881867|NCT03406871|591937211|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
163881868|NCT02281955|591937216|FG000|Overall Study|Death|1|||
163881869|NCT04177823|591937217|FG000|Overall Study|Physician Decision|1|||
163881870|NCT04177823|591937217|FG000|Overall Study|Withdrawal by Subject|1|||
163881871|NCT03683719|591937218|FG000|Overall Study|Lack of Efficacy|1|||
163881872|NCT03683719|591937219|FG001|Overall Study|Lack of Efficacy|3|||
163881873|NCT03683719|591937220|FG002|Overall Study|Lack of Efficacy|4|||
163881874|NCT03683719|591937221|FG003|Overall Study|Lack of Efficacy|0|||
163881875|NCT03683719|591937222|FG004|Overall Study|Lack of Efficacy|4|||
163881876|NCT03683719|591937218|FG000|Overall Study|Adverse Event|6|||
163881877|NCT03683719|591937219|FG001|Overall Study|Adverse Event|6|||
163881878|NCT03683719|591937220|FG002|Overall Study|Adverse Event|0|||
163881879|NCT03683719|591937221|FG003|Overall Study|Adverse Event|1|||
163881880|NCT03683719|591937222|FG004|Overall Study|Adverse Event|3|||
163881881|NCT03683719|591937218|FG000|Overall Study|Withdrawal by Subject|4|||
163881882|NCT03683719|591937219|FG001|Overall Study|Withdrawal by Subject|4|||
163881883|NCT03683719|591937220|FG002|Overall Study|Withdrawal by Subject|3|||
163881884|NCT03683719|591937221|FG003|Overall Study|Withdrawal by Subject|5|||
163881885|NCT03683719|591937222|FG004|Overall Study|Withdrawal by Subject|5|||
163881886|NCT03683719|591937218|FG000|Overall Study|Lost to Follow-up|1|||
163881887|NCT03683719|591937219|FG001|Overall Study|Lost to Follow-up|0|||
163881888|NCT03683719|591937220|FG002|Overall Study|Lost to Follow-up|0|||
163881889|NCT03683719|591937221|FG003|Overall Study|Lost to Follow-up|1|||
163986369|NCT02009878|592320152|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
163986370|NCT02009878|592320153|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
163986371|NCT02009878|592320154|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
163986372|NCT01790048|592320156|FG000|Overall Study|Incorrect Age|9|||
163986373|NCT01790048|592320157|FG001|Overall Study|Incorrect Age|14|||
163986374|NCT01790048|592320156|FG000|Overall Study|data entry error|0|||
163986375|NCT01790048|592320157|FG001|Overall Study|data entry error|1|||
163986376|NCT01790048|592320156|FG000|Overall Study|Other|0|||
163986377|NCT01790048|592320157|FG001|Overall Study|Other|2|||
163986378|NCT01790048|592320156|FG000|Overall Study|SAM at Enrollment|2|||
163986379|NCT01790048|592320157|FG001|Overall Study|SAM at Enrollment|0|||
163986380|NCT01790048|592320156|FG000|Overall Study|Measurement error|1|||
163986381|NCT01790048|592320157|FG001|Overall Study|Measurement error|0|||
163986382|NCT01491178|592320160|FG000|Overall Study|Adverse Event|1016|||
163986383|NCT01491178|592320160|FG000|Overall Study|Improvement of NVAF|210|||
163986384|NCT01491178|592320160|FG000|Overall Study|To conduct invasive treatment|59|||
163986385|NCT01491178|592320160|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
163986386|NCT01491178|592320160|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
163986387|NCT01491178|592320160|FG000|Overall Study|To take a contraindication|20|||
163986388|NCT01491178|592320160|FG000|Overall Study|Other than specified above|657|||
163986389|NCT05689047|592320163|FG000|Overall Study|Lost to Follow-up|0|||
163986390|NCT05689047|592320164|FG001|Overall Study|Lost to Follow-up|1|||
163986391|NCT05689047|592320163|FG000|Overall Study|Protocol Deviation|1|||
163986392|NCT05689047|592320164|FG001|Overall Study|Protocol Deviation|0|||
163986393|NCT01604512|592320165|FG000|Overall Study|Withdrawal by Subject|3|||
163986394|NCT01604512|592320165|FG000|Overall Study|Not treated|4|||
163986395|NCT03132636|592320166|FG000|Overall Study|Adverse Event|1|||
163986396|NCT03132636|592320167|FG001|Overall Study|Adverse Event|2|||
163986397|NCT03132636|592320166|FG000|Overall Study|Death|4|||
163986398|NCT03132636|592320167|FG001|Overall Study|Death|7|||
163986399|NCT03132636|592320166|FG000|Overall Study|Lost to Follow-up|3|||
163986400|NCT03132636|592320167|FG001|Overall Study|Lost to Follow-up|2|||
163986401|NCT03132636|592320166|FG000|Overall Study|Non compliance with protocol by participant|1|||
163986402|NCT03132636|592320167|FG001|Overall Study|Non compliance with protocol by participant|1|||
163986403|NCT03132636|592320166|FG000|Overall Study|Subject decision|1|||
163986404|NCT03132636|592320167|FG001|Overall Study|Subject decision|9|||
163986405|NCT03132636|592320166|FG000|Overall Study|Sponsor decision|0|||
163986406|NCT03132636|592320167|FG001|Overall Study|Sponsor decision|1|||
163986407|NCT03132636|592320166|FG000|Overall Study|Physician Decision|1|||
163986408|NCT03132636|592320167|FG001|Overall Study|Physician Decision|0|||
163986409|NCT03132636|592320166|FG000|Overall Study|Progressive disease|33|||
163986410|NCT03132636|592320167|FG001|Overall Study|Progressive disease|36|||
163986411|NCT03132636|592320166|FG000|Overall Study|Withdrawal of consent|2|||
163986412|NCT03132636|592320167|FG001|Overall Study|Withdrawal of consent|5|||
163986413|NCT03132636|592320166|FG000|Overall Study|Did not re-consent|1|||
164225427|NCT03180138|593194065|FG002|Overall Study|No prior immunization records|6|||
164225428|NCT03180138|593194063|FG000|Overall Study|Found to be >24 mon after randomization|3|||
164225429|NCT03180138|593194064|FG001|Overall Study|Found to be >24 mon after randomization|0|||
163986414|NCT03132636|592320167|FG001|Overall Study|Did not re-consent|0|||
163986415|NCT03132636|592320166|FG000|Overall Study|Lost insurance coverage|1|||
163986416|NCT03132636|592320167|FG001|Overall Study|Lost insurance coverage|0|||
163986417|NCT03132636|592320166|FG000|Overall Study|Related to radiological outcomes|0|||
164081598|NCT00415532|592663299|FG000|Treatment Period|Death|2|||
164081599|NCT00415532|592663300|FG001|Treatment Period|Death|1|||
164081600|NCT00415532|592663299|FG000|Treatment Period|Lost to Follow-up|1|||
164081601|NCT00415532|592663300|FG001|Treatment Period|Lost to Follow-up|1|||
164081602|NCT00415532|592663299|FG000|Treatment Period|Protocol Violation|1|||
164081603|NCT00415532|592663300|FG001|Treatment Period|Protocol Violation|0|||
164081604|NCT00415532|592663299|FG000|Treatment Period|Withdrawal by Subject|6|||
164081605|NCT00415532|592663300|FG001|Treatment Period|Withdrawal by Subject|6|||
164081606|NCT00415532|592663299|FG000|Treatment Period|Other|2|||
164081607|NCT00415532|592663300|FG001|Treatment Period|Other|2|||
164081608|NCT00415532|592663299|FG000|Treatment Period|Ineligibility determined|1|||
164081609|NCT00415532|592663300|FG001|Treatment Period|Ineligibility determined|1|||
164081610|NCT00415532|592663299|FG000|Treatment Period|Noncompliance|1|||
164081611|NCT00415532|592663300|FG001|Treatment Period|Noncompliance|1|||
164081612|NCT00415532|592663299|FG000|Treatment Period|Requirement for alternative therapy|1|||
164081613|NCT00415532|592663300|FG001|Treatment Period|Requirement for alternative therapy|0|||
164225430|NCT03180138|593194065|FG002|Overall Study|Found to be >24 mon after randomization|3|||
163986418|NCT03132636|592320167|FG001|Overall Study|Related to radiological outcomes|1|||
163986419|NCT03132636|592320166|FG000|Overall Study|Unable to come to site for continued visits|0|||
163986420|NCT03132636|592320167|FG001|Overall Study|Unable to come to site for continued visits|1|||
163986421|NCT01415752|592320170|FG000|Induction (Step 1)|Ineligible|4|||
163986422|NCT01415752|592320171|FG001|Induction (Step 1)|Ineligible|3|||
164225431|NCT04191733|593194067|FG000|Overall Study|Withdrawn due to study closure|13|||
164081614|NCT00415532|592663299|FG000|Safety Follow Up Period|Adverse Event|1|||
164081615|NCT00415532|592663300|FG001|Safety Follow Up Period|Adverse Event|3|||
164329904|NCT02964507|593584807|FG005|Overall Study|Study terminated by Sponsor|2|||
164329905|NCT02964507|593584808|FG006|Overall Study|Study terminated by Sponsor|0|||
164329906|NCT02964507|593584809|FG007|Overall Study|Study terminated by Sponsor|0|||
164329907|NCT02964507|593584802|FG000|Overall Study|Other|3|||
164329908|NCT02964507|593584803|FG001|Overall Study|Other|0|||
164329909|NCT02964507|593584804|FG002|Overall Study|Other|0|||
164329910|NCT02964507|593584805|FG003|Overall Study|Other|0|||
164329911|NCT02964507|593584806|FG004|Overall Study|Other|1|||
164329912|NCT02964507|593584807|FG005|Overall Study|Other|0|||
164329913|NCT02964507|593584808|FG006|Overall Study|Other|0|||
164329914|NCT02964507|593584809|FG007|Overall Study|Other|0|||
164329915|NCT02964507|593584802|FG000|Overall Study|Death|11|||
164329916|NCT02964507|593584803|FG001|Overall Study|Death|9|||
164329917|NCT02964507|593584804|FG002|Overall Study|Death|12|||
164329918|NCT02964507|593584805|FG003|Overall Study|Death|2|||
164329919|NCT02964507|593584806|FG004|Overall Study|Death|10|||
164329920|NCT02964507|593584807|FG005|Overall Study|Death|5|||
164329921|NCT02964507|593584808|FG006|Overall Study|Death|0|||
164329922|NCT02964507|593584809|FG007|Overall Study|Death|0|||
164329923|NCT02964507|593584802|FG000|Overall Study|Withdrawal by Subject|1|||
164329924|NCT02964507|593584803|FG001|Overall Study|Withdrawal by Subject|0|||
164329925|NCT02964507|593584804|FG002|Overall Study|Withdrawal by Subject|1|||
164329926|NCT02964507|593584805|FG003|Overall Study|Withdrawal by Subject|1|||
164329927|NCT02964507|593584806|FG004|Overall Study|Withdrawal by Subject|0|||
164329928|NCT02964507|593584807|FG005|Overall Study|Withdrawal by Subject|1|||
164329929|NCT02964507|593584808|FG006|Overall Study|Withdrawal by Subject|0|||
164329930|NCT02964507|593584809|FG007|Overall Study|Withdrawal by Subject|0|||
164329931|NCT02964507|593584802|FG000|Overall Study|Physician Decision|2|||
164329932|NCT02964507|593584803|FG001|Overall Study|Physician Decision|0|||
164329933|NCT02964507|593584804|FG002|Overall Study|Physician Decision|3|||
164329934|NCT02964507|593584805|FG003|Overall Study|Physician Decision|0|||
164329935|NCT02964507|593584806|FG004|Overall Study|Physician Decision|1|||
164329936|NCT02964507|593584807|FG005|Overall Study|Physician Decision|0|||
163881890|NCT03683719|591937222|FG004|Overall Study|Lost to Follow-up|1|||
163881891|NCT03683719|591937218|FG000|Overall Study|Other personal reasons|0|||
163881892|NCT03683719|591937219|FG001|Overall Study|Other personal reasons|0|||
163881893|NCT03683719|591937220|FG002|Overall Study|Other personal reasons|1|||
163881894|NCT03683719|591937221|FG003|Overall Study|Other personal reasons|0|||
163881895|NCT03683719|591937222|FG004|Overall Study|Other personal reasons|1|||
163881896|NCT00601900|591937224|FG000|Overall Study|Withdrawal by Subject|0|||
163881897|NCT00601900|591937225|FG001|Overall Study|Withdrawal by Subject|3|||
163881898|NCT03699709|591937226|FG000|Overall Study|Death|1|||
163881899|NCT03699709|591937227|FG001|Overall Study|Death|2|||
163881900|NCT03699709|591937226|FG000|Overall Study|Lost to Follow-up|10|||
163881901|NCT03699709|591937227|FG001|Overall Study|Lost to Follow-up|3|||
163881902|NCT03699709|591937226|FG000|Overall Study|Withdrawal by Subject|5|||
163881903|NCT03699709|591937227|FG001|Overall Study|Withdrawal by Subject|0|||
163881904|NCT03699709|591937226|FG000|Overall Study|incarcerated|1|||
163881905|NCT03699709|591937227|FG001|Overall Study|incarcerated|0|||
163881906|NCT03699709|591937226|FG000|Overall Study|scheduled, but no show|0|||
163881907|NCT03699709|591937227|FG001|Overall Study|scheduled, but no show|1|||
163881908|NCT03519581|591937228|FG000|Overall Study|Lost to Follow-up|3|||
163881909|NCT03519581|591937229|FG001|Overall Study|Lost to Follow-up|2|||
163881910|NCT03519581|591937228|FG000|Overall Study|Adverse Event|5|||
163881911|NCT03519581|591937229|FG001|Overall Study|Adverse Event|2|||
163881912|NCT03519581|591937228|FG000|Overall Study|Withdrawal by Subject|2|||
163881913|NCT03519581|591937229|FG001|Overall Study|Withdrawal by Subject|0|||
163881914|NCT03519581|591937228|FG000|Overall Study|Change to insurance|2|||
163881915|NCT03519581|591937229|FG001|Overall Study|Change to insurance|1|||
163881916|NCT03519581|591937228|FG000|Overall Study|Other|2|||
163881917|NCT03519581|591937229|FG001|Overall Study|Other|4|||
163881918|NCT05371652|591937231|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
163881919|NCT05371652|591937231|FG000|Overall Study|Withdrawal by Subject|12|||
163881920|NCT05371652|591937231|FG000|Overall Study|Adverse Event|1|||
163881921|NCT05371652|591937231|FG000|Overall Study|Other|11|||
163881922|NCT04410042|591937232|FG000|Overall Study|Not Eligible|1|||
163881923|NCT04410042|591937233|FG001|Overall Study|Not Eligible|1|||
164225432|NCT04191733|593194068|FG001|Overall Study|Withdrawn due to study closure|14|||
164225433|NCT04191733|593194067|FG000|Overall Study|Withdrawal by Subject|2|||
164225434|NCT04191733|593194068|FG001|Overall Study|Withdrawal by Subject|4|||
164225435|NCT04191733|593194067|FG000|Overall Study|Physician Decision|1|||
164225436|NCT04191733|593194068|FG001|Overall Study|Physician Decision|1|||
164225437|NCT04191733|593194067|FG000|Overall Study|Lost to Follow-up|5|||
164225438|NCT04191733|593194068|FG001|Overall Study|Lost to Follow-up|6|||
164225439|NCT04191733|593194067|FG000|Overall Study|Death|0|||
164225440|NCT04191733|593194068|FG001|Overall Study|Death|1|||
164225441|NCT01903733|593194071|FG000|Overall Study|Death|23|||
164329937|NCT02964507|593584808|FG006|Overall Study|Physician Decision|0|||
164329938|NCT02964507|593584809|FG007|Overall Study|Physician Decision|0|||
164329939|NCT04341662|593584810|FG000|Overall Study|Did not have source-verified blood loss data|423|||
163986423|NCT01415752|592320172|FG002|Induction (Step 1)|Ineligible|4|||
163986424|NCT01415752|592320173|FG003|Induction (Step 1)|Ineligible|4|||
163986425|NCT01415752|592320170|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
163986426|NCT01415752|592320171|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
163986427|NCT01415752|592320172|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
163986428|NCT01415752|592320173|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
163986429|NCT01415752|592320170|FG000|Maintenance (Step 2)|Adverse Event|3|||
163986430|NCT01415752|592320171|FG001|Maintenance (Step 2)|Adverse Event|4|||
163986431|NCT01415752|592320172|FG002|Maintenance (Step 2)|Adverse Event|9|||
163986432|NCT01415752|592320173|FG003|Maintenance (Step 2)|Adverse Event|6|||
163986433|NCT01415752|592320170|FG000|Maintenance (Step 2)|Death|1|||
163986434|NCT01415752|592320171|FG001|Maintenance (Step 2)|Death|1|||
163986435|NCT01415752|592320172|FG002|Maintenance (Step 2)|Death|2|||
163986436|NCT01415752|592320173|FG003|Maintenance (Step 2)|Death|0|||
163986437|NCT01415752|592320170|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
163986438|NCT01415752|592320171|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
163986439|NCT01415752|592320172|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
163986440|NCT01415752|592320173|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
163986441|NCT01415752|592320170|FG000|Maintenance (Step 2)|Alternative therapy|0|||
163986442|NCT01415752|592320171|FG001|Maintenance (Step 2)|Alternative therapy|1|||
163986443|NCT01415752|592320172|FG002|Maintenance (Step 2)|Alternative therapy|0|||
163986444|NCT01415752|592320173|FG003|Maintenance (Step 2)|Alternative therapy|0|||
163986445|NCT01415752|592320170|FG000|Maintenance (Step 2)|Other reasons|3|||
163986446|NCT01415752|592320171|FG001|Maintenance (Step 2)|Other reasons|6|||
163986447|NCT01415752|592320172|FG002|Maintenance (Step 2)|Other reasons|4|||
163986448|NCT01415752|592320173|FG003|Maintenance (Step 2)|Other reasons|6|||
163986449|NCT01415752|592320170|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
163986450|NCT01415752|592320171|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
163986451|NCT01415752|592320172|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
163986452|NCT01415752|592320173|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
163986453|NCT01415752|592320170|FG000|Maintenance (Step 2)|ineligible|1|||
163986454|NCT01415752|592320171|FG001|Maintenance (Step 2)|ineligible|1|||
163986455|NCT01415752|592320172|FG002|Maintenance (Step 2)|ineligible|1|||
163986456|NCT01415752|592320173|FG003|Maintenance (Step 2)|ineligible|0|||
163986457|NCT01415752|592320170|FG000|Maintenance (Step 2)|Missing|4|||
163986458|NCT01415752|592320171|FG001|Maintenance (Step 2)|Missing|1|||
163986459|NCT01415752|592320172|FG002|Maintenance (Step 2)|Missing|4|||
163986460|NCT01415752|592320173|FG003|Maintenance (Step 2)|Missing|3|||
163986461|NCT03083886|592320174|FG000|Overall Study|Withdrawal by Subject|51|||
163986462|NCT03083886|592320175|FG001|Overall Study|Withdrawal by Subject|73|||
163986463|NCT03083886|592320176|FG002|Overall Study|Withdrawal by Subject|104|||
163986464|NCT03083886|592320174|FG000|Overall Study|Missing Baseline data|43|||
163986465|NCT03083886|592320175|FG001|Overall Study|Missing Baseline data|42|||
163986466|NCT03083886|592320176|FG002|Overall Study|Missing Baseline data|31|||
163986467|NCT03083886|592320174|FG000|Overall Study|Investigator terminated|1|||
163986468|NCT03083886|592320175|FG001|Overall Study|Investigator terminated|6|||
163986469|NCT03083886|592320176|FG002|Overall Study|Investigator terminated|3|||
163986470|NCT01391507|592320177|FG000|Overall Study|Death|0|||
163986471|NCT01391507|592320178|FG001|Overall Study|Death|0|||
163986472|NCT01391507|592320179|FG002|Overall Study|Death|0|||
163986473|NCT01391507|592320180|FG003|Overall Study|Death|1|||
163986474|NCT01391507|592320177|FG000|Overall Study|Adverse Event|1|||
163986475|NCT01391507|592320178|FG001|Overall Study|Adverse Event|1|||
163986476|NCT01391507|592320179|FG002|Overall Study|Adverse Event|2|||
163986477|NCT01391507|592320180|FG003|Overall Study|Adverse Event|2|||
163986478|NCT01391507|592320177|FG000|Overall Study|Withdrawal by Subject|1|||
163986479|NCT01391507|592320178|FG001|Overall Study|Withdrawal by Subject|2|||
163986480|NCT01391507|592320179|FG002|Overall Study|Withdrawal by Subject|1|||
163986481|NCT01391507|592320180|FG003|Overall Study|Withdrawal by Subject|1|||
163986482|NCT01391507|592320177|FG000|Overall Study|Lack of Efficacy|0|||
163986483|NCT01391507|592320178|FG001|Overall Study|Lack of Efficacy|0|||
163986484|NCT01391507|592320179|FG002|Overall Study|Lack of Efficacy|0|||
163986485|NCT01391507|592320180|FG003|Overall Study|Lack of Efficacy|1|||
163986486|NCT01391507|592320177|FG000|Overall Study|Protocol Violation|2|||
163986487|NCT01391507|592320178|FG001|Overall Study|Protocol Violation|1|||
163986488|NCT01391507|592320179|FG002|Overall Study|Protocol Violation|1|||
164225442|NCT01903733|593194072|FG001|Overall Study|Death|54|||
164225443|NCT01903733|593194073|FG002|Overall Study|Death|30|||
163986489|NCT01391507|592320180|FG003|Overall Study|Protocol Violation|2|||
163986490|NCT01453855|592320181|FG000|Overall Study|Adverse Event|3|||
163986491|NCT01453855|592320182|FG001|Overall Study|Adverse Event|4|||
163986492|NCT01453855|592320181|FG000|Overall Study|Lost to Follow-up|2|||
163986493|NCT01453855|592320182|FG001|Overall Study|Lost to Follow-up|1|||
163986494|NCT01453855|592320181|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
163986495|NCT01453855|592320182|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
163986496|NCT01453855|592320181|FG000|Overall Study|Noncompliance|1|||
163986497|NCT01453855|592320182|FG001|Overall Study|Noncompliance|0|||
164225444|NCT01903733|593194074|FG003|Overall Study|Death|98|||
164081616|NCT00415532|592663299|FG000|Safety Follow Up Period|Death|3|||
164081617|NCT00415532|592663300|FG001|Safety Follow Up Period|Death|0|||
164081618|NCT00415532|592663299|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
164081619|NCT00415532|592663300|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
164081620|NCT00415532|592663299|FG000|Safety Follow Up Period|Other|1|||
164081621|NCT00415532|592663300|FG001|Safety Follow Up Period|Other|4|||
164081622|NCT00415532|592663299|FG000|Safety Follow Up Period|Ineligibility determined|1|||
164081623|NCT00415532|592663300|FG001|Safety Follow Up Period|Ineligibility determined|1|||
164081624|NCT00415532|592663299|FG000|Safety Follow Up Period|Noncompliance|1|||
164081625|NCT00415532|592663300|FG001|Safety Follow Up Period|Noncompliance|0|||
164081626|NCT00415532|592663299|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
164081627|NCT00415532|592663300|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
164081628|NCT01698320|592663301|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
164081629|NCT01698320|592663302|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
164081630|NCT01698320|592663303|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
164081631|NCT01698320|592663301|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
164081632|NCT01698320|592663302|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
164081633|NCT01698320|592663303|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
164081634|NCT01698320|592663301|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
164081635|NCT01698320|592663302|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
164081636|NCT01698320|592663303|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
164225445|NCT01903733|593194071|FG000|Overall Study|Participant refused further follow-up|35|||
164225446|NCT01903733|593194072|FG001|Overall Study|Participant refused further follow-up|38|||
164225447|NCT01903733|593194073|FG002|Overall Study|Participant refused further follow-up|13|||
164225448|NCT01903733|593194074|FG003|Overall Study|Participant refused further follow-up|9|||
164225449|NCT01903733|593194071|FG000|Overall Study|Lost to Follow-up|18|||
164225450|NCT01903733|593194072|FG001|Overall Study|Lost to Follow-up|19|||
163881938|NCT04322643|591937243|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
163881939|NCT05486078|591937246|FG000|Overall Study|4 drop out and one withdrawn|5|||
163881940|NCT03302494|591937247|FG000|Overall Study|Other|7|||
163881941|NCT03302494|591937248|FG001|Overall Study|Other|4|||
163881942|NCT03302494|591937249|FG002|Overall Study|Other|6|||
163881943|NCT03302494|591937247|FG000|Overall Study|Withdrawal by Subject|10|||
163881944|NCT03302494|591937248|FG001|Overall Study|Withdrawal by Subject|2|||
163881945|NCT03302494|591937249|FG002|Overall Study|Withdrawal by Subject|9|||
163881946|NCT03302494|591937247|FG000|Overall Study|Study Terminated by Sponsor|32|||
163881947|NCT03302494|591937248|FG001|Overall Study|Study Terminated by Sponsor|29|||
163881948|NCT03302494|591937249|FG002|Overall Study|Study Terminated by Sponsor|30|||
163881949|NCT03302494|591937247|FG000|Overall Study|Physician Decision|1|||
163881950|NCT03302494|591937248|FG001|Overall Study|Physician Decision|0|||
163881951|NCT03302494|591937249|FG002|Overall Study|Physician Decision|1|||
163881952|NCT03302494|591937247|FG000|Overall Study|Lost to Follow-up|1|||
163881953|NCT03302494|591937248|FG001|Overall Study|Lost to Follow-up|3|||
163881954|NCT03302494|591937249|FG002|Overall Study|Lost to Follow-up|3|||
163881955|NCT03302494|591937247|FG000|Overall Study|Death|13|||
163881956|NCT03302494|591937248|FG001|Overall Study|Death|11|||
163881957|NCT03302494|591937249|FG002|Overall Study|Death|4|||
163881958|NCT03302494|591937247|FG000|Overall Study|Adverse Event|1|||
163881959|NCT03302494|591937248|FG001|Overall Study|Adverse Event|2|||
163881960|NCT03302494|591937249|FG002|Overall Study|Adverse Event|0|||
163881961|NCT03302494|591937247|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
163881962|NCT03302494|591937248|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
163881963|NCT03302494|591937249|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
163881964|NCT05134233|591937250|FG000|Overall Study|Pregnancy|1|||
163881965|NCT05134233|591937250|FG000|Overall Study|MEP value too low|2|||
163881966|NCT05134233|591937250|FG000|Overall Study|Lost to Follow-up|1|||
163881967|NCT03978871|591937251|FG000|Overall Study|Lost to Follow-up|11|||
163881968|NCT03978871|591937252|FG001|Overall Study|Lost to Follow-up|12|||
163881969|NCT05710107|591937253|FG000|Overall Study|Withdrawal by Subject|1|||
163881970|NCT05710107|591937254|FG001|Overall Study|Withdrawal by Subject|1|||
163881971|NCT05710107|591937253|FG000|Overall Study|Lost to Follow-up|8|||
163881972|NCT05710107|591937254|FG001|Overall Study|Lost to Follow-up|9|||
163881973|NCT05710107|591937253|FG000|Overall Study|Unable to place assigned block|2|||
163881974|NCT05710107|591937254|FG001|Overall Study|Unable to place assigned block|0|||
163881975|NCT05710107|591937253|FG000|Overall Study|Withdrawn by study team|0|||
163881976|NCT05710107|591937254|FG001|Overall Study|Withdrawn by study team|1|||
163881977|NCT04166773|591937255|FG000|Overall Study|Adverse Event|2|||
163881978|NCT04166773|591937256|FG001|Overall Study|Adverse Event|0|||
163881979|NCT04166773|591937257|FG002|Overall Study|Adverse Event|2|||
163881980|NCT04166773|591937258|FG003|Overall Study|Adverse Event|1|||
163881981|NCT04166773|591937255|FG000|Overall Study|Lost to Follow-up|4|||
163881982|NCT04166773|591937256|FG001|Overall Study|Lost to Follow-up|2|||
164329940|NCT04341662|593584811|FG001|Overall Study|Did not have source-verified blood loss data|514|||
164329941|NCT02675231|593584812|FG000|Overall Study|Withdrawal by Subject|2|||
164329942|NCT02675231|593584813|FG001|Overall Study|Withdrawal by Subject|4|||
164329943|NCT02675231|593584814|FG002|Overall Study|Withdrawal by Subject|2|||
164329944|NCT02675231|593584812|FG000|Overall Study|Lost to Follow-up|3|||
164329945|NCT02675231|593584813|FG001|Overall Study|Lost to Follow-up|4|||
164329946|NCT02675231|593584814|FG002|Overall Study|Lost to Follow-up|3|||
164329947|NCT00064298|593584815|FG000|Overall Study|Withdrawal by Subject|2|||
164329948|NCT00064298|593584816|FG001|Overall Study|Withdrawal by Subject|1|||
164329949|NCT00064298|593584815|FG000|Overall Study|Lost to Follow-up|2|||
164329950|NCT00064298|593584816|FG001|Overall Study|Lost to Follow-up|2|||
164329951|NCT00064298|593584815|FG000|Overall Study|Death|0|||
164329952|NCT00064298|593584816|FG001|Overall Study|Death|1|||
164329953|NCT00064298|593584815|FG000|Overall Study|Disease Progression|2|||
164329954|NCT00064298|593584816|FG001|Overall Study|Disease Progression|1|||
164329955|NCT03309046|593584817|FG000|Overall Study|Withdrawal by Subject|4|||
164329956|NCT03309046|593584818|FG001|Overall Study|Withdrawal by Subject|17|||
164329957|NCT02764190|593584819|FG000|Overall Study|Lost to Follow-up|17|||
164329958|NCT02764190|593584820|FG001|Overall Study|Lost to Follow-up|13|||
164329959|NCT00591266|593584821|FG000|Overall Study|Adverse Event|2|||
164329960|NCT00591266|593584822|FG001|Overall Study|Adverse Event|2|||
164329961|NCT00591266|593584823|FG002|Overall Study|Adverse Event|3|||
164329962|NCT00591266|593584821|FG000|Overall Study|Lost to Follow-up|0|||
164329963|NCT00591266|593584822|FG001|Overall Study|Lost to Follow-up|1|||
164329964|NCT00591266|593584823|FG002|Overall Study|Lost to Follow-up|0|||
164329965|NCT00591266|593584821|FG000|Overall Study|Protocol Violation|0|||
164329966|NCT00591266|593584822|FG001|Overall Study|Protocol Violation|0|||
164329967|NCT00591266|593584823|FG002|Overall Study|Protocol Violation|1|||
164329968|NCT00591266|593584821|FG000|Overall Study|Withdrawal by Subject|6|||
164329969|NCT00591266|593584822|FG001|Overall Study|Withdrawal by Subject|2|||
164329970|NCT00591266|593584823|FG002|Overall Study|Withdrawal by Subject|5|||
164329971|NCT00591266|593584821|FG000|Overall Study|Lack of Efficacy|0|||
164329972|NCT00591266|593584822|FG001|Overall Study|Lack of Efficacy|2|||
164329973|NCT00591266|593584823|FG002|Overall Study|Lack of Efficacy|0|||
164329974|NCT00591266|593584821|FG000|Overall Study|Other|1|||
164329975|NCT00591266|593584822|FG001|Overall Study|Other|4|||
164329976|NCT00591266|593584823|FG002|Overall Study|Other|5|||
164329977|NCT03488927|593584824|FG000|Overall Study|Withdrawal by Subject|44|||
164329978|NCT03488927|593584825|FG001|Overall Study|Withdrawal by Subject|118|||
164329979|NCT03488927|593584826|FG002|Overall Study|Withdrawal by Subject|217|||
164329980|NCT03497676|593584827|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
164329981|NCT03497676|593584828|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
164329982|NCT03497676|593584829|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
164329983|NCT03497676|593584830|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
164329984|NCT03497676|593584827|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
164329985|NCT03497676|593584828|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
164329986|NCT03497676|593584829|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
164329987|NCT03497676|593584830|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
164329988|NCT03497676|593584827|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
164329989|NCT03497676|593584828|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
164329990|NCT03497676|593584829|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
164329991|NCT03497676|593584830|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
164329992|NCT03497676|593584827|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
164329993|NCT03497676|593584828|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
164329994|NCT03497676|593584829|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
164329995|NCT03497676|593584830|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
164329996|NCT03497676|593584827|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
164329997|NCT03497676|593584828|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
164329998|NCT03497676|593584829|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
163881983|NCT04166773|591937257|FG002|Overall Study|Lost to Follow-up|1|||
163881984|NCT04166773|591937258|FG003|Overall Study|Lost to Follow-up|3|||
163881985|NCT04166773|591937255|FG000|Overall Study|Physician Decision|0|||
163881986|NCT04166773|591937256|FG001|Overall Study|Physician Decision|0|||
163881987|NCT04166773|591937257|FG002|Overall Study|Physician Decision|0|||
163881988|NCT04166773|591937258|FG003|Overall Study|Physician Decision|1|||
163881989|NCT04166773|591937255|FG000|Overall Study|Withdrawal by Subject|1|||
163881990|NCT04166773|591937256|FG001|Overall Study|Withdrawal by Subject|1|||
163881991|NCT04166773|591937257|FG002|Overall Study|Withdrawal by Subject|2|||
163881992|NCT04166773|591937258|FG003|Overall Study|Withdrawal by Subject|5|||
163881993|NCT04072822|591937259|FG000|Treatment|Adverse Event|9|||
163881994|NCT04072822|591937260|FG001|Treatment|Adverse Event|5|||
163881995|NCT04072822|591937259|FG000|Treatment|Met Stopping Criteria|13|||
163881996|NCT04072822|591937260|FG001|Treatment|Met Stopping Criteria|24|||
163881997|NCT04072822|591937259|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
164329999|NCT03497676|593584830|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
164330000|NCT03497676|593584827|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
164330001|NCT03497676|593584828|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
164330002|NCT03497676|593584829|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
164330003|NCT03497676|593584830|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
164330004|NCT03497676|593584827|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
164330005|NCT03497676|593584828|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
164330006|NCT03497676|593584829|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
164225451|NCT01903733|593194073|FG002|Overall Study|Lost to Follow-up|6|||
164225452|NCT01903733|593194074|FG003|Overall Study|Lost to Follow-up|9|||
164225453|NCT01903733|593194071|FG000|Overall Study|Other|10|||
164225454|NCT01903733|593194072|FG001|Overall Study|Other|15|||
164225455|NCT01903733|593194073|FG002|Overall Study|Other|12|||
164225456|NCT01903733|593194074|FG003|Overall Study|Other|3|||
164330007|NCT03497676|593584830|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
164330008|NCT03497676|593584827|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
164330009|NCT03497676|593584828|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
164330010|NCT03497676|593584829|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
164330011|NCT03497676|593584830|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
164330012|NCT00880165|593584833|FG000|Overall Study|Withdrawal by Subject|27|||
164330013|NCT00880165|593584834|FG001|Overall Study|Withdrawal by Subject|23|||
164330014|NCT00880165|593584833|FG000|Overall Study|Not diagnosed with OSA|14|||
164330015|NCT00880165|593584834|FG001|Overall Study|Not diagnosed with OSA|8|||
164330016|NCT00880165|593584833|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
164330017|NCT00880165|593584834|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
164330018|NCT00880165|593584833|FG000|Overall Study|Lost to follow|9|||
164330019|NCT00880165|593584834|FG001|Overall Study|Lost to follow|15|||
164330020|NCT00395538|593584835|FG000|Overall Study|Did not re-consent to revised protocol|1|||
164330021|NCT00395538|593584836|FG001|Overall Study|Did not re-consent to revised protocol|10|||
164330022|NCT00395538|593584837|FG002|Overall Study|Did not re-consent to revised protocol|0|||
164330023|NCT00395538|593584835|FG000|Overall Study|FDA partial hold on PTH|0|||
164330024|NCT00395538|593584836|FG001|Overall Study|FDA partial hold on PTH|0|||
164330025|NCT00395538|593584837|FG002|Overall Study|FDA partial hold on PTH|11|||
164330026|NCT00395538|593584835|FG000|Overall Study|Failed screening|0|||
164330027|NCT00395538|593584836|FG001|Overall Study|Failed screening|0|||
163986498|NCT01453855|592320181|FG000|Overall Study|Inadequate Control of IOP|1|||
164330028|NCT00395538|593584837|FG002|Overall Study|Failed screening|4|||
164330029|NCT00395538|593584835|FG000|Overall Study|Switch to Natpara|0|||
164330030|NCT00395538|593584836|FG001|Overall Study|Switch to Natpara|0|||
164330031|NCT00395538|593584837|FG002|Overall Study|Switch to Natpara|3|||
164330032|NCT00395538|593584835|FG000|Overall Study|Adverse Event|1|||
164330033|NCT00395538|593584836|FG001|Overall Study|Adverse Event|0|||
164330034|NCT00395538|593584837|FG002|Overall Study|Adverse Event|2|||
164330035|NCT00395538|593584835|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
164330036|NCT00395538|593584836|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
164330037|NCT00395538|593584837|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
164330038|NCT00395538|593584835|FG000|Overall Study|Non-compliance with study protocol|0|||
164330039|NCT00395538|593584836|FG001|Overall Study|Non-compliance with study protocol|1|||
164330040|NCT00395538|593584837|FG002|Overall Study|Non-compliance with study protocol|0|||
163986499|NCT01453855|592320182|FG001|Overall Study|Inadequate Control of IOP|5|||
163986500|NCT01453855|592320181|FG000|Overall Study|Other|0|||
163986501|NCT01453855|592320182|FG001|Overall Study|Other|1|||
163986502|NCT01562548|592320185|FG000|Overall Study|Lost to Follow-up|0|||
163986503|NCT01562548|592320186|FG001|Overall Study|Lost to Follow-up|0|||
164225457|NCT01903733|593194071|FG000|Overall Study|Missing|2|||
164225458|NCT01903733|593194072|FG001|Overall Study|Missing|0|||
164225459|NCT01903733|593194073|FG002|Overall Study|Missing|0|||
164225460|NCT01903733|593194074|FG003|Overall Study|Missing|0|||
164225461|NCT01903733|593194071|FG000|Overall Study|Investigator request|18|||
164225462|NCT01903733|593194072|FG001|Overall Study|Investigator request|0|||
164225463|NCT01903733|593194073|FG002|Overall Study|Investigator request|0|||
164225464|NCT01903733|593194074|FG003|Overall Study|Investigator request|0|||
164225465|NCT02202577|593194075|FG000|Overall Study|Lost to Follow-up|6|||
164225466|NCT02202577|593194076|FG001|Overall Study|Lost to Follow-up|16|||
164225467|NCT02202577|593194075|FG000|Overall Study|Protocol Violation|7|||
164225468|NCT02202577|593194076|FG001|Overall Study|Protocol Violation|3|||
163986504|NCT01562548|592320187|FG002|Overall Study|Lost to Follow-up|1|||
163986505|NCT01562548|592320188|FG003|Overall Study|Lost to Follow-up|0|||
164225469|NCT01714063|593194077|FG000|Overall Study|Equipment malfunction|2|||
163986506|NCT01285908|592320189|FG000|Baseline Measurement|unable to insert catheter|1|||
163986507|NCT01285908|592320190|FG001|Baseline Measurement|unable to insert catheter|0|||
164225470|NCT01646216|593194078|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
164225471|NCT01646216|593194079|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
164225472|NCT01646216|593194078|FG000|Overall Study|Did not complete training|0|||
164330041|NCT00395538|593584835|FG000|Overall Study|PTH resistance|0|||
164330042|NCT00395538|593584836|FG001|Overall Study|PTH resistance|0|||
164330043|NCT00395538|593584837|FG002|Overall Study|PTH resistance|1|||
164330044|NCT00395538|593584835|FG000|Overall Study|Pregnancy|1|||
164330045|NCT00395538|593584836|FG001|Overall Study|Pregnancy|0|||
164330046|NCT00395538|593584837|FG002|Overall Study|Pregnancy|0|||
164330047|NCT00395538|593584835|FG000|Overall Study|Partial recovery of parathyroid function|0|||
164330048|NCT00395538|593584836|FG001|Overall Study|Partial recovery of parathyroid function|0|||
164330049|NCT00395538|593584837|FG002|Overall Study|Partial recovery of parathyroid function|1|||
164330050|NCT00395538|593584835|FG000|Overall Study|Participant elected to discontinue|0|||
164330051|NCT00395538|593584836|FG001|Overall Study|Participant elected to discontinue|0|||
164330052|NCT00395538|593584837|FG002|Overall Study|Participant elected to discontinue|1|||
164330053|NCT01074047|593584838|FG000|Treatment Phase|Adverse Event|89|||
164330054|NCT01074047|593584839|FG001|Treatment Phase|Adverse Event|66|||
164330055|NCT01074047|593584838|FG000|Treatment Phase|Disease Progression|16|||
164330056|NCT01074047|593584839|FG001|Treatment Phase|Disease Progression|21|||
164330057|NCT01074047|593584838|FG000|Treatment Phase|Withdrawal by Subject|27|||
164330058|NCT01074047|593584839|FG001|Treatment Phase|Withdrawal by Subject|48|||
164330059|NCT01074047|593584838|FG000|Treatment Phase|Death|53|||
164330060|NCT01074047|593584839|FG001|Treatment Phase|Death|58|||
164330061|NCT01074047|593584838|FG000|Treatment Phase|Lost to Follow-up|0|||
164330062|NCT01074047|593584839|FG001|Treatment Phase|Lost to Follow-up|1|||
164330063|NCT01074047|593584838|FG000|Treatment Phase|Protocol Violation|0|||
164330064|NCT01074047|593584839|FG001|Treatment Phase|Protocol Violation|1|||
164330065|NCT01074047|593584838|FG000|Treatment Phase|Miscellaneous|32|||
164330066|NCT01074047|593584839|FG001|Treatment Phase|Miscellaneous|39|||
164330067|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
164330068|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
164330069|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
164330070|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
164330071|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Death|116|||
164330072|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Death|124|||
164330073|NCT01074047|593584838|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
164330074|NCT01074047|593584839|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
164330075|NCT01074047|593584838|FG000|Extension Phase|Physician Decision|1|||
164330076|NCT01074047|593584839|FG001|Extension Phase|Physician Decision|0|||
164330077|NCT01074047|593584838|FG000|Extension Phase|Adverse Event|5|||
164330078|NCT01074047|593584839|FG001|Extension Phase|Adverse Event|0|||
164330079|NCT01074047|593584838|FG000|Extension Phase|Disease Progression|9|||
164330080|NCT01074047|593584839|FG001|Extension Phase|Disease Progression|0|||
164330081|NCT01074047|593584838|FG000|Extension Phase|Withdrawal by Subject|2|||
164330082|NCT01074047|593584839|FG001|Extension Phase|Withdrawal by Subject|0|||
164330083|NCT01074047|593584838|FG000|Extension Phase|Death|5|||
164330084|NCT01074047|593584839|FG001|Extension Phase|Death|0|||
164330085|NCT02211638|593584840|FG000|Overall Study|Case Report Forms Uncollected|291|||
164330086|NCT02211638|593584840|FG000|Overall Study|Protocol Violation|692|||
164330087|NCT05140382|593584842|FG000|Overall Study|Death|3|||
164330088|NCT05140382|593584843|FG001|Overall Study|Death|0|||
164330089|NCT05140382|593584844|FG002|Overall Study|Death|0|||
164330090|NCT05140382|593584842|FG000|Overall Study|Investigator decision|1|||
164330091|NCT05140382|593584843|FG001|Overall Study|Investigator decision|0|||
164330092|NCT05140382|593584844|FG002|Overall Study|Investigator decision|0|||
164330093|NCT05140382|593584842|FG000|Overall Study|Other|4|||
164330094|NCT05140382|593584843|FG001|Overall Study|Other|0|||
164225473|NCT01646216|593194079|FG001|Overall Study|Did not complete training|2|||
164225474|NCT01646216|593194078|FG000|Overall Study|Investigator decision|1|||
164225475|NCT01646216|593194079|FG001|Overall Study|Investigator decision|1|||
164225476|NCT03721107|593194080|FG000|Overall Study|Adverse Event|1|||
164225477|NCT03721107|593194081|FG001|Overall Study|Adverse Event|1|||
164225478|NCT03721107|593194082|FG002|Overall Study|Adverse Event|6|||
164225479|NCT03721107|593194083|FG003|Overall Study|Adverse Event|5|||
164225480|NCT03721107|593194080|FG000|Overall Study|Lost to Follow-up|2|||
164225481|NCT03721107|593194081|FG001|Overall Study|Lost to Follow-up|0|||
164225482|NCT03721107|593194082|FG002|Overall Study|Lost to Follow-up|3|||
164225483|NCT03721107|593194083|FG003|Overall Study|Lost to Follow-up|0|||
164330095|NCT05140382|593584844|FG002|Overall Study|Other|1|||
164330096|NCT05140382|593584842|FG000|Overall Study|Progressive disease|20|||
164330097|NCT05140382|593584843|FG001|Overall Study|Progressive disease|1|||
164225484|NCT03721107|593194080|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
164225485|NCT03721107|593194081|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
164330098|NCT05140382|593584844|FG002|Overall Study|Progressive disease|12|||
164330099|NCT05140382|593584842|FG000|Overall Study|Subjective disease progression|2|||
164330100|NCT05140382|593584843|FG001|Overall Study|Subjective disease progression|1|||
164330101|NCT05140382|593584844|FG002|Overall Study|Subjective disease progression|0|||
164330102|NCT05140382|593584842|FG000|Overall Study|Unknown at data cut-off|0|||
164330103|NCT05140382|593584843|FG001|Overall Study|Unknown at data cut-off|0|||
164330104|NCT05140382|593584844|FG002|Overall Study|Unknown at data cut-off|1|||
164330105|NCT05140382|593584842|FG000|Overall Study|Withdrawal by Subject|1|||
164330106|NCT05140382|593584843|FG001|Overall Study|Withdrawal by Subject|0|||
164330107|NCT05140382|593584844|FG002|Overall Study|Withdrawal by Subject|4|||
164330108|NCT05140382|593584842|FG000|Overall Study|Withdrawal of consent|0|||
164330109|NCT05140382|593584843|FG001|Overall Study|Withdrawal of consent|0|||
164330110|NCT05140382|593584844|FG002|Overall Study|Withdrawal of consent|1|||
164330111|NCT05419908|593584845|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
164330112|NCT05419908|593584846|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
164330113|NCT05419908|593584845|FG000|Overall Study|Serious Adverse Event|0|||
164330114|NCT05419908|593584846|FG001|Overall Study|Serious Adverse Event|2|||
164330115|NCT05419908|593584845|FG000|Overall Study|Withdrawal by Subject|2|||
164330116|NCT05419908|593584846|FG001|Overall Study|Withdrawal by Subject|0|||
164330117|NCT05419908|593584845|FG000|Overall Study|Miscellaneous|1|||
164330118|NCT05419908|593584846|FG001|Overall Study|Miscellaneous|1|||
164330119|NCT01659658|593586604|FG000|Overall Study|Withdrawal by Patient|18|||
164330120|NCT01659658|593586605|FG001|Overall Study|Withdrawal by Patient|4|||
164330121|NCT01659658|593586606|FG002|Overall Study|Withdrawal by Patient|2|||
164330122|NCT01659658|593586607|FG003|Overall Study|Withdrawal by Patient|0|||
164330123|NCT01659658|593586608|FG004|Overall Study|Withdrawal by Patient|11|||
164330124|NCT01659658|593586604|FG000|Overall Study|Study Terminated by Sponsor|9|||
164330125|NCT01659658|593586605|FG001|Overall Study|Study Terminated by Sponsor|7|||
164330126|NCT01659658|593586606|FG002|Overall Study|Study Terminated by Sponsor|0|||
164330127|NCT01659658|593586607|FG003|Overall Study|Study Terminated by Sponsor|1|||
164330128|NCT01659658|593586608|FG004|Overall Study|Study Terminated by Sponsor|4|||
164330129|NCT01659658|593586604|FG000|Overall Study|Reason not Specified|61|||
164330130|NCT01659658|593586605|FG001|Overall Study|Reason not Specified|15|||
164330131|NCT01659658|593586606|FG002|Overall Study|Reason not Specified|8|||
164330132|NCT01659658|593586607|FG003|Overall Study|Reason not Specified|1|||
164330133|NCT01659658|593586608|FG004|Overall Study|Reason not Specified|34|||
164330134|NCT01659658|593586604|FG000|Overall Study|Lost to Follow-up|2|||
164330135|NCT01659658|593586605|FG001|Overall Study|Lost to Follow-up|0|||
164330136|NCT01659658|593586606|FG002|Overall Study|Lost to Follow-up|0|||
164330137|NCT01659658|593586607|FG003|Overall Study|Lost to Follow-up|0|||
164330138|NCT01659658|593586608|FG004|Overall Study|Lost to Follow-up|0|||
164330139|NCT01927341|593586609|FG000|Phase 1b|Lost to Follow-up|1|||
164330140|NCT01927341|593586610|FG001|Phase 1b|Lost to Follow-up|0|||
164330141|NCT01927341|593586611|FG002|Phase 1b|Lost to Follow-up|0|||
164330142|NCT01927341|593586612|FG003|Phase 1b|Lost to Follow-up|0|||
164330143|NCT01927341|593586613|FG004|Phase 1b|Lost to Follow-up|0|||
164330144|NCT01927341|593586609|FG000|Phase 1b|Death|2|||
164330145|NCT01927341|593586610|FG001|Phase 1b|Death|0|||
164330146|NCT01927341|593586611|FG002|Phase 1b|Death|0|||
164330147|NCT01927341|593586612|FG003|Phase 1b|Death|0|||
164330148|NCT01927341|593586613|FG004|Phase 1b|Death|0|||
164330149|NCT01927341|593586609|FG000|Phase 1b|Follow-up completed|7|||
164330150|NCT01927341|593586610|FG001|Phase 1b|Follow-up completed|0|||
164330151|NCT01927341|593586611|FG002|Phase 1b|Follow-up completed|0|||
164330152|NCT01927341|593586612|FG003|Phase 1b|Follow-up completed|0|||
164330153|NCT01927341|593586613|FG004|Phase 1b|Follow-up completed|0|||
164330154|NCT01927341|593586609|FG000|Phase 2|Lost to Follow-up|0|||
164330155|NCT01927341|593586610|FG001|Phase 2|Lost to Follow-up|1|||
164330156|NCT01927341|593586611|FG002|Phase 2|Lost to Follow-up|0|||
164330157|NCT01927341|593586612|FG003|Phase 2|Lost to Follow-up|0|||
164330158|NCT01927341|593586613|FG004|Phase 2|Lost to Follow-up|0|||
164330159|NCT01927341|593586609|FG000|Phase 2|Participant withdrew consent|0|||
164330160|NCT01927341|593586610|FG001|Phase 2|Participant withdrew consent|2|||
164330161|NCT01927341|593586611|FG002|Phase 2|Participant withdrew consent|1|||
164330162|NCT01927341|593586612|FG003|Phase 2|Participant withdrew consent|2|||
164330163|NCT01927341|593586613|FG004|Phase 2|Participant withdrew consent|3|||
164330164|NCT01927341|593586609|FG000|Phase 2|Death|0|||
164081637|NCT01698320|592663301|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
164081638|NCT01698320|592663302|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
164081639|NCT01698320|592663303|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
164081640|NCT01698320|592663301|FG000|12-Week Double-Blind Period|Adverse Event|0|||
164081641|NCT01698320|592663302|FG001|12-Week Double-Blind Period|Adverse Event|1|||
164330165|NCT01927341|593586610|FG001|Phase 2|Death|4|||
164330166|NCT01927341|593586611|FG002|Phase 2|Death|0|||
164330167|NCT01927341|593586612|FG003|Phase 2|Death|3|||
164330168|NCT01927341|593586613|FG004|Phase 2|Death|2|||
164330169|NCT01927341|593586609|FG000|Phase 2|New cancer therapy|0|||
164330170|NCT01927341|593586610|FG001|Phase 2|New cancer therapy|1|||
164330171|NCT01927341|593586611|FG002|Phase 2|New cancer therapy|0|||
164330172|NCT01927341|593586612|FG003|Phase 2|New cancer therapy|4|||
164330173|NCT01927341|593586613|FG004|Phase 2|New cancer therapy|1|||
164330174|NCT01927341|593586609|FG000|Phase 2|Disease progression|0|||
164330175|NCT01927341|593586610|FG001|Phase 2|Disease progression|1|||
164330176|NCT01927341|593586611|FG002|Phase 2|Disease progression|1|||
164330177|NCT01927341|593586612|FG003|Phase 2|Disease progression|1|||
164081642|NCT01698320|592663303|FG002|12-Week Double-Blind Period|Adverse Event|1|||
164225486|NCT03721107|593194082|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
164225487|NCT03721107|593194083|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
164225488|NCT03721107|593194080|FG000|Overall Study|Physician Decision|0|||
164225489|NCT03721107|593194081|FG001|Overall Study|Physician Decision|1|||
164225490|NCT03721107|593194082|FG002|Overall Study|Physician Decision|0|||
164225491|NCT03721107|593194083|FG003|Overall Study|Physician Decision|0|||
164225492|NCT03721107|593194080|FG000|Overall Study|Pregnancy|0|||
164225493|NCT03721107|593194081|FG001|Overall Study|Pregnancy|0|||
164225494|NCT03721107|593194082|FG002|Overall Study|Pregnancy|1|||
164225495|NCT03721107|593194083|FG003|Overall Study|Pregnancy|0|||
164225496|NCT03721107|593194080|FG000|Overall Study|Withdrawal by Subject|1|||
164225497|NCT03721107|593194081|FG001|Overall Study|Withdrawal by Subject|1|||
164225498|NCT03721107|593194082|FG002|Overall Study|Withdrawal by Subject|5|||
164225499|NCT03721107|593194083|FG003|Overall Study|Withdrawal by Subject|5|||
164225500|NCT03721107|593194080|FG000|Overall Study|Other|1|||
164225501|NCT03721107|593194081|FG001|Overall Study|Other|0|||
164225502|NCT03721107|593194082|FG002|Overall Study|Other|0|||
164225503|NCT03721107|593194083|FG003|Overall Study|Other|1|||
164225504|NCT02369159|593194086|FG000|Overall Study|Adverse Event|0|||
164225505|NCT02369159|593194087|FG001|Overall Study|Adverse Event|1|||
164225506|NCT02369159|593194086|FG000|Overall Study|Lost to Follow-up|1|||
164225507|NCT02369159|593194087|FG001|Overall Study|Lost to Follow-up|1|||
164225508|NCT02369159|593194086|FG000|Overall Study|Withdrawal by Subject|7|||
164225509|NCT02369159|593194087|FG001|Overall Study|Withdrawal by Subject|0|||
164225510|NCT00563316|593194090|FG000|Overall Study|Adverse Event|2|||
164225511|NCT00563316|593194090|FG000|Overall Study|Physician Decision|1|||
164225512|NCT00563316|593194090|FG000|Overall Study|Lost to Follow-up|2|||
164225513|NCT00563316|593194090|FG000|Overall Study|Death|1|||
163881998|NCT04072822|591937260|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
163881999|NCT04072822|591937259|FG000|Treatment|Withdrawal by Subject|0|||
163882000|NCT04072822|591937260|FG001|Treatment|Withdrawal by Subject|2|||
163882001|NCT04072822|591937259|FG000|Treatment|Death|0|||
163882002|NCT04072822|591937260|FG001|Treatment|Death|2|||
163882003|NCT04072822|591937259|FG000|Treatment|Lost to Follow-up|11|||
163882004|NCT04072822|591937260|FG001|Treatment|Lost to Follow-up|3|||
163882005|NCT04072822|591937259|FG000|Treatment|Physician Decision|1|||
163882006|NCT04072822|591937260|FG001|Treatment|Physician Decision|0|||
163882007|NCT04072822|591937259|FG000|Treatment|Other|7|||
163882008|NCT04072822|591937260|FG001|Treatment|Other|9|||
163882009|NCT04072822|591937259|FG000|Follow-up|Withdrawal by Subject|1|||
163882010|NCT04072822|591937260|FG001|Follow-up|Withdrawal by Subject|0|||
163882011|NCT04072822|591937259|FG000|Follow-up|Lost to Follow-up|5|||
163882012|NCT04072822|591937260|FG001|Follow-up|Lost to Follow-up|4|||
163882013|NCT03033576|591937261|FG000|Overall Study|Ineligible|1|||
163882014|NCT03033576|591937262|FG001|Overall Study|Ineligible|1|||
163882015|NCT03033576|591937261|FG000|Overall Study|Adverse Event|4|||
163882016|NCT03033576|591937262|FG001|Overall Study|Adverse Event|20|||
163882017|NCT03033576|591937261|FG000|Overall Study|Progression/relapse|9|||
163882018|NCT03033576|591937262|FG001|Overall Study|Progression/relapse|36|||
163882019|NCT03033576|591937261|FG000|Overall Study|Death|1|||
163882020|NCT03033576|591937262|FG001|Overall Study|Death|1|||
163882021|NCT03033576|591937261|FG000|Overall Study|Patient refusal|1|||
163882022|NCT03033576|591937262|FG001|Overall Study|Patient refusal|6|||
163882023|NCT03033576|591937261|FG000|Overall Study|Other, unspecified reasons|0|||
163882024|NCT03033576|591937262|FG001|Overall Study|Other, unspecified reasons|4|||
163882025|NCT03033576|591937261|FG000|Overall Study|Currently on protocol therapy|0|||
163882026|NCT03033576|591937262|FG001|Overall Study|Currently on protocol therapy|2|||
163882027|NCT03719443|591937263|FG000|Overall Study|Lost to Follow-up|0|||
163882028|NCT03719443|591937264|FG001|Overall Study|Lost to Follow-up|0|||
163882029|NCT03719443|591937265|FG002|Overall Study|Lost to Follow-up|1|||
163882030|NCT03719443|591937266|FG003|Overall Study|Lost to Follow-up|0|||
163882031|NCT03719443|591937267|FG004|Overall Study|Lost to Follow-up|1|||
163986508|NCT01285908|592320191|FG002|Baseline Measurement|unable to insert catheter|0|||
163986509|NCT01285908|592320189|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
163986510|NCT01285908|592320190|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
163986511|NCT01285908|592320191|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
163986512|NCT01285908|592320189|FG000|Baseline Measurement|unable to tolerate procedure|1|||
163986513|NCT01285908|592320190|FG001|Baseline Measurement|unable to tolerate procedure|0|||
163986514|NCT01285908|592320191|FG002|Baseline Measurement|unable to tolerate procedure|0|||
163986515|NCT03655756|592320192|FG000|Overall Study|Death|1|||
163986516|NCT03529773|592320193|FG000|Overall Study|Adverse Event|0|||
163986517|NCT03529773|592320194|FG001|Overall Study|Adverse Event|0|||
163986518|NCT03529773|592320195|FG002|Overall Study|Adverse Event|0|||
163986519|NCT03529773|592320196|FG003|Overall Study|Adverse Event|0|||
163986520|NCT03529773|592320197|FG004|Overall Study|Adverse Event|0|||
163986521|NCT03529773|592320198|FG005|Overall Study|Adverse Event|0|||
163986522|NCT03529773|592320199|FG006|Overall Study|Adverse Event|0|||
163986523|NCT03529773|592320200|FG007|Overall Study|Adverse Event|0|||
163986524|NCT03529773|592320201|FG008|Overall Study|Adverse Event|0|||
163986525|NCT03529773|592320202|FG009|Overall Study|Adverse Event|0|||
164330178|NCT01927341|593586613|FG004|Phase 2|Disease progression|0|||
164330179|NCT01927341|593586609|FG000|Phase 2|Follow-up completed|0|||
164330180|NCT01927341|593586610|FG001|Phase 2|Follow-up completed|6|||
164330181|NCT01927341|593586611|FG002|Phase 2|Follow-up completed|3|||
164330182|NCT01927341|593586612|FG003|Phase 2|Follow-up completed|5|||
164330183|NCT01927341|593586613|FG004|Phase 2|Follow-up completed|2|||
164330184|NCT00674973|593586614|FG000|Overall Study|Insufficient Therapeutic Response|77|||
164330185|NCT00674973|593586615|FG001|Overall Study|Insufficient Therapeutic Response|72|||
164330186|NCT00674973|593586614|FG000|Overall Study|Refused Treatment|1|||
164330187|NCT00674973|593586615|FG001|Overall Study|Refused Treatment|5|||
164330188|NCT00674973|593586614|FG000|Overall Study|Failure to Return|1|||
164330189|NCT00674973|593586615|FG001|Overall Study|Failure to Return|0|||
164330190|NCT00674973|593586614|FG000|Overall Study|Adverse Event|2|||
164330191|NCT00674973|593586615|FG001|Overall Study|Adverse Event|9|||
164330192|NCT00674973|593586614|FG000|Overall Study|Death|19|||
164330193|NCT00674973|593586615|FG001|Overall Study|Death|15|||
164330194|NCT00674973|593586614|FG000|Overall Study|Protocol Violation|0|||
164330195|NCT00674973|593586615|FG001|Overall Study|Protocol Violation|1|||
164330196|NCT00451451|593586616|FG000|Overall Study|Adverse Event|11|||
164330197|NCT00451451|593586617|FG001|Overall Study|Adverse Event|21|||
164330198|NCT00451451|593586618|FG002|Overall Study|Adverse Event|26|||
164330199|NCT00451451|593586619|FG003|Overall Study|Adverse Event|10|||
164330200|NCT00451451|593586616|FG000|Overall Study|Lost to Follow-up|11|||
164330201|NCT00451451|593586617|FG001|Overall Study|Lost to Follow-up|9|||
164330202|NCT00451451|593586618|FG002|Overall Study|Lost to Follow-up|8|||
164330203|NCT00451451|593586619|FG003|Overall Study|Lost to Follow-up|11|||
163986526|NCT03529773|592320203|FG010|Overall Study|Adverse Event|0|||
163986527|NCT03529773|592320204|FG011|Overall Study|Adverse Event|0|||
163986528|NCT03529773|592320205|FG012|Overall Study|Adverse Event|0|||
163986529|NCT03529773|592320206|FG013|Overall Study|Adverse Event|0|||
164330204|NCT00451451|593586616|FG000|Overall Study|Consent Withdrawn|14|||
164330205|NCT00451451|593586617|FG001|Overall Study|Consent Withdrawn|9|||
164330206|NCT00451451|593586618|FG002|Overall Study|Consent Withdrawn|17|||
164330207|NCT00451451|593586619|FG003|Overall Study|Consent Withdrawn|17|||
164330208|NCT00451451|593586616|FG000|Overall Study|Investigator Decision|6|||
164330209|NCT00451451|593586617|FG001|Overall Study|Investigator Decision|2|||
164330210|NCT00451451|593586618|FG002|Overall Study|Investigator Decision|1|||
164330211|NCT00451451|593586619|FG003|Overall Study|Investigator Decision|2|||
164330212|NCT00451451|593586616|FG000|Overall Study|Subject Non-Compliance|8|||
164330213|NCT00451451|593586617|FG001|Overall Study|Subject Non-Compliance|4|||
164330214|NCT00451451|593586618|FG002|Overall Study|Subject Non-Compliance|3|||
164330215|NCT00451451|593586619|FG003|Overall Study|Subject Non-Compliance|3|||
164330216|NCT00451451|593586616|FG000|Overall Study|Death|1|||
164330217|NCT00451451|593586617|FG001|Overall Study|Death|0|||
164330218|NCT00451451|593586618|FG002|Overall Study|Death|0|||
164330219|NCT00451451|593586619|FG003|Overall Study|Death|1|||
163986530|NCT03529773|592320207|FG014|Overall Study|Adverse Event|0|||
163986531|NCT03529773|592320208|FG015|Overall Study|Adverse Event|0|||
163986532|NCT03529773|592320209|FG016|Overall Study|Adverse Event|0|||
163986533|NCT03529773|592320210|FG017|Overall Study|Adverse Event|0|||
164330220|NCT00451451|593586616|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
164330221|NCT00451451|593586617|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
164330222|NCT00451451|593586618|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
164330223|NCT00451451|593586619|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
163882032|NCT03719443|591937268|FG005|Overall Study|Lost to Follow-up|0|||
163882033|NCT03719443|591937269|FG006|Overall Study|Lost to Follow-up|1|||
163882034|NCT03719443|591937263|FG000|Overall Study|Withdrawal by Subject|0|||
163882035|NCT03719443|591937264|FG001|Overall Study|Withdrawal by Subject|0|||
163882036|NCT03719443|591937265|FG002|Overall Study|Withdrawal by Subject|1|||
163882037|NCT03719443|591937266|FG003|Overall Study|Withdrawal by Subject|0|||
163882038|NCT03719443|591937267|FG004|Overall Study|Withdrawal by Subject|0|||
163882039|NCT03719443|591937268|FG005|Overall Study|Withdrawal by Subject|0|||
163882040|NCT03719443|591937269|FG006|Overall Study|Withdrawal by Subject|0|||
163882041|NCT01214616|591937274|FG000|Overall Study|Progressive disease|2|||
163882042|NCT01214616|591937275|FG001|Overall Study|Progressive disease|2|||
163882043|NCT01214616|591937276|FG002|Overall Study|Progressive disease|2|||
163882044|NCT01214616|591937277|FG003|Overall Study|Progressive disease|4|||
163882045|NCT01214616|591937274|FG000|Overall Study|Dose limiting toxicity|0|||
164330224|NCT00084838|593586622|FG000|Overall Study|Death|1|||
164330225|NCT00084838|593586622|FG000|Overall Study|Adverse Event|2|||
164330226|NCT00084838|593586622|FG000|Overall Study|Withdrawal by Subject|1|||
164330227|NCT00084838|593586622|FG000|Overall Study|Progressive Disease|4|||
164330228|NCT00084838|593586622|FG000|Overall Study|Pt Non-Compliance|1|||
164330229|NCT00084838|593586622|FG000|Overall Study|Ineligible|4|||
164330230|NCT00518687|593586623|FG000|Overall Study|Adverse Event|201|||
164330231|NCT00518687|593586624|FG001|Overall Study|Adverse Event|177|||
164330232|NCT00518687|593586623|FG000|Overall Study|Lost to Follow-up|144|||
164330233|NCT00518687|593586624|FG001|Overall Study|Lost to Follow-up|155|||
164330234|NCT00518687|593586623|FG000|Overall Study|Physician Decision|42|||
164330235|NCT00518687|593586624|FG001|Overall Study|Physician Decision|48|||
164330236|NCT00518687|593586623|FG000|Overall Study|Progressive disease|2|||
164330237|NCT00518687|593586624|FG001|Overall Study|Progressive disease|2|||
164330238|NCT00518687|593586623|FG000|Overall Study|Protocol Violation|8|||
164330239|NCT00518687|593586624|FG001|Overall Study|Protocol Violation|10|||
164330240|NCT00518687|593586623|FG000|Overall Study|Study terminated by sponsor|930|||
164330241|NCT00518687|593586624|FG001|Overall Study|Study terminated by sponsor|918|||
164330242|NCT00518687|593586623|FG000|Overall Study|Withdrawal by Subject|110|||
164330243|NCT00518687|593586624|FG001|Overall Study|Withdrawal by Subject|110|||
164330244|NCT01442038|593586627|FG000|Overall Study|Death|35|||
164330245|NCT01442038|593586628|FG001|Overall Study|Death|29|||
164330246|NCT01442038|593586627|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
164330247|NCT01442038|593586628|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
164330248|NCT01442038|593586627|FG000|Overall Study|Participant Withdrew Consent|137|||
164330249|NCT01442038|593586628|FG001|Overall Study|Participant Withdrew Consent|102|||
164330250|NCT01442038|593586627|FG000|Overall Study|Lost to Follow-up|37|||
164330251|NCT01442038|593586628|FG001|Overall Study|Lost to Follow-up|51|||
164330252|NCT01442038|593586627|FG000|Overall Study|Adverse Event|26|||
164330253|NCT01442038|593586628|FG001|Overall Study|Adverse Event|15|||
164330254|NCT01442038|593586627|FG000|Overall Study|Protocol Deviation|9|||
164330255|NCT01442038|593586628|FG001|Overall Study|Protocol Deviation|20|||
164330256|NCT01442038|593586627|FG000|Overall Study|Investigator's Discretion|13|||
164330257|NCT01442038|593586628|FG001|Overall Study|Investigator's Discretion|16|||
164330258|NCT01442038|593586627|FG000|Overall Study|Study Terminated By Sponsor|2|||
164330259|NCT01442038|593586628|FG001|Overall Study|Study Terminated By Sponsor|3|||
164330260|NCT00089284|593586629|FG000|Overall Study|Adverse event before starting treatment|0|||
164330261|NCT00089284|593586630|FG001|Overall Study|Adverse event before starting treatment|0|||
164330262|NCT00089284|593586631|FG002|Overall Study|Adverse event before starting treatment|0|||
164330263|NCT00089284|593586632|FG003|Overall Study|Adverse event before starting treatment|0|||
164330264|NCT00089284|593586633|FG004|Overall Study|Adverse event before starting treatment|0|||
164330265|NCT00089284|593586634|FG005|Overall Study|Adverse event before starting treatment|0|||
164330266|NCT00089284|593586635|FG006|Overall Study|Adverse event before starting treatment|1|||
164330267|NCT00137631|593586636|FG000|Overall Study|Lost to Follow-up|37|||
164330268|NCT00137631|593586637|FG001|Overall Study|Lost to Follow-up|41|||
164330269|NCT02611960|593586638|FG000|Overall Study|Adverse Event|7|||
164330270|NCT02611960|593586639|FG001|Overall Study|Adverse Event|8|||
164330271|NCT02611960|593586638|FG000|Overall Study|Death|98|||
164330272|NCT02611960|593586639|FG001|Overall Study|Death|92|||
164330273|NCT02611960|593586638|FG000|Overall Study|Withdrawal by Subject|1|||
164330274|NCT02611960|593586639|FG001|Overall Study|Withdrawal by Subject|5|||
164330275|NCT02611960|593586638|FG000|Overall Study|Sponsor Decision|11|||
164330276|NCT02611960|593586639|FG001|Overall Study|Sponsor Decision|11|||
164330277|NCT01092507|593586640|FG000|Overall Study|Withdrawal by Subject|2|||
164330278|NCT01092507|593586641|FG001|Overall Study|Withdrawal by Subject|0|||
164330279|NCT00085709|593586653|FG000|Overall Study|Adverse Event|8|||
164330280|NCT00085709|593586654|FG001|Overall Study|Adverse Event|0|||
164330281|NCT00085709|593586653|FG000|Overall Study|Death|8|||
164330282|NCT00085709|593586654|FG001|Overall Study|Death|2|||
164330283|NCT00085709|593586653|FG000|Overall Study|Refusal unrelated to adverse events|1|||
164330284|NCT00085709|593586654|FG001|Overall Study|Refusal unrelated to adverse events|2|||
164330285|NCT00085709|593586653|FG000|Overall Study|Progression|3|||
164330286|NCT00085709|593586654|FG001|Overall Study|Progression|4|||
164330287|NCT00085709|593586653|FG000|Overall Study|Not protocol specified|12|||
164330288|NCT00085709|593586654|FG001|Overall Study|Not protocol specified|22|||
164330289|NCT00085709|593586653|FG000|Overall Study|Not eligible|19|||
164330290|NCT00085709|593586654|FG001|Overall Study|Not eligible|19|||
164330291|NCT00085709|593586653|FG000|Overall Study|Withdrawal by Subject|2|||
164330292|NCT00085709|593586654|FG001|Overall Study|Withdrawal by Subject|1|||
164330293|NCT04131556|593586655|FG000|Overall Study|Adverse Event|1|||
164330294|NCT04131556|593586655|FG000|Overall Study|Withdrawal by Subject|1|||
164330295|NCT01229371|593586656|FG000|Overall Study|Withdrawal by Subject|0|||
164330296|NCT01229371|593586657|FG001|Overall Study|Withdrawal by Subject|1|||
164330297|NCT01229371|593586658|FG002|Overall Study|Withdrawal by Subject|0|||
164330298|NCT01229371|593586659|FG003|Overall Study|Withdrawal by Subject|0|||
164330299|NCT04622735|593586660|FG000|Overall Study|Lost to Follow-up|1|||
164330300|NCT04622735|593586661|FG001|Overall Study|Lost to Follow-up|2|||
164330301|NCT04622735|593586662|FG002|Overall Study|Lost to Follow-up|1|||
164330302|NCT04622735|593586660|FG000|Overall Study|Adverse Event|0|||
164330303|NCT04622735|593586661|FG001|Overall Study|Adverse Event|0|||
164330304|NCT04622735|593586662|FG002|Overall Study|Adverse Event|1|||
164081643|NCT01698320|592663301|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
164330305|NCT04622735|593586660|FG000|Overall Study|Protocol Violation|1|||
164330306|NCT04622735|593586661|FG001|Overall Study|Protocol Violation|0|||
164330307|NCT04622735|593586662|FG002|Overall Study|Protocol Violation|0|||
164330308|NCT05314478|593586663|FG000|Overall Study|Physician Decision|1|||
164330309|NCT00145600|593586668|FG000|Overall Study|Death|1|||
164330310|NCT00145600|593586669|FG001|Overall Study|Death|2|||
163986534|NCT03529773|592320211|FG018|Overall Study|Adverse Event|0|||
163986535|NCT03529773|592320212|FG019|Overall Study|Adverse Event|0|||
163986536|NCT03529773|592320213|FG020|Overall Study|Adverse Event|0|||
163986537|NCT03529773|592320214|FG021|Overall Study|Adverse Event|0|||
163986538|NCT03529773|592320215|FG022|Overall Study|Adverse Event|0|||
163986539|NCT03529773|592320216|FG023|Overall Study|Adverse Event|0|||
163986540|NCT03529773|592320217|FG024|Overall Study|Adverse Event|0|||
163986541|NCT03529773|592320218|FG025|Overall Study|Adverse Event|0|||
163986542|NCT03529773|592320219|FG026|Overall Study|Adverse Event|0|||
163986543|NCT03529773|592320220|FG027|Overall Study|Adverse Event|0|||
163986544|NCT03529773|592320221|FG028|Overall Study|Adverse Event|0|||
163986545|NCT03529773|592320222|FG029|Overall Study|Adverse Event|0|||
163986546|NCT03529773|592320223|FG030|Overall Study|Adverse Event|1|||
163986547|NCT03529773|592320224|FG031|Overall Study|Adverse Event|0|||
163986548|NCT03529773|592320225|FG032|Overall Study|Adverse Event|0|||
164225514|NCT00563316|593194090|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
164225515|NCT00563316|593194090|FG000|Overall Study|Other|1|||
164225516|NCT02991859|593194094|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225517|NCT02991859|593194095|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
164225518|NCT02991859|593194096|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225519|NCT02991859|593194097|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225520|NCT02991859|593194098|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
164225521|NCT02991859|593194099|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225522|NCT02991859|593194100|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225523|NCT02991859|593194101|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225524|NCT02991859|593194102|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225525|NCT02991859|593194103|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225526|NCT02991859|593194104|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225527|NCT02991859|593194105|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225528|NCT02991859|593194106|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225529|NCT02991859|593194107|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225530|NCT02991859|593194108|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225531|NCT02991859|593194109|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225532|NCT02991859|593194110|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
164225533|NCT02991859|593194094|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225534|NCT02991859|593194095|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225535|NCT02991859|593194096|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225536|NCT02991859|593194097|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225537|NCT02991859|593194098|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225538|NCT02991859|593194099|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225539|NCT02991859|593194100|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225540|NCT02991859|593194101|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225541|NCT02991859|593194102|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225542|NCT02991859|593194103|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225543|NCT02991859|593194104|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225544|NCT02991859|593194105|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225545|NCT02991859|593194106|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
164225546|NCT02991859|593194107|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
164225547|NCT02991859|593194108|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225548|NCT02991859|593194109|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225549|NCT02991859|593194110|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
164225550|NCT02991859|593194094|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225551|NCT02991859|593194095|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225552|NCT02991859|593194096|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225553|NCT02991859|593194097|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225554|NCT02991859|593194098|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225555|NCT02991859|593194099|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
164225556|NCT02991859|593194100|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225557|NCT02991859|593194101|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225558|NCT02991859|593194102|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225559|NCT02991859|593194103|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225560|NCT02991859|593194104|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225561|NCT02991859|593194105|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164330311|NCT00145600|593586670|FG002|Overall Study|Death|2|||
163986549|NCT03529773|592320226|FG033|Overall Study|Adverse Event|0|||
163986550|NCT03529773|592320227|FG034|Overall Study|Adverse Event|0|||
163986551|NCT03529773|592320228|FG035|Overall Study|Adverse Event|1|||
163986552|NCT03529773|592320229|FG036|Overall Study|Adverse Event|0|||
164225562|NCT02991859|593194106|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225563|NCT02991859|593194107|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225564|NCT02991859|593194108|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225565|NCT02991859|593194109|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225566|NCT02991859|593194110|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
164225567|NCT02991859|593194094|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225568|NCT02991859|593194095|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225569|NCT02991859|593194096|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225570|NCT02991859|593194097|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164330312|NCT00145600|593586671|FG003|Overall Study|Death|6|||
164330313|NCT00145600|593586668|FG000|Overall Study|Ineligible|3|||
163986553|NCT03529773|592320230|FG037|Overall Study|Adverse Event|0|||
163986554|NCT03529773|592320231|FG038|Overall Study|Adverse Event|1|||
163986555|NCT03529773|592320232|FG039|Overall Study|Adverse Event|1|||
163986556|NCT03529773|592320193|FG000|Overall Study|Death|0|||
163986557|NCT03529773|592320194|FG001|Overall Study|Death|0|||
164330314|NCT00145600|593586669|FG001|Overall Study|Ineligible|0|||
164330315|NCT00145600|593586670|FG002|Overall Study|Ineligible|1|||
164330316|NCT00145600|593586671|FG003|Overall Study|Ineligible|5|||
164330317|NCT00145600|593586668|FG000|Overall Study|Lost to Follow-up|2|||
164330318|NCT00145600|593586669|FG001|Overall Study|Lost to Follow-up|6|||
164330319|NCT00145600|593586670|FG002|Overall Study|Lost to Follow-up|2|||
164330320|NCT00145600|593586671|FG003|Overall Study|Lost to Follow-up|4|||
164330321|NCT00145600|593586668|FG000|Overall Study|Noncompliance|1|||
164330322|NCT00145600|593586669|FG001|Overall Study|Noncompliance|0|||
164330323|NCT00145600|593586670|FG002|Overall Study|Noncompliance|0|||
164330324|NCT00145600|593586671|FG003|Overall Study|Noncompliance|0|||
164330325|NCT00145600|593586668|FG000|Overall Study|Withdrawal by Subject|1|||
164330326|NCT00145600|593586669|FG001|Overall Study|Withdrawal by Subject|2|||
164330327|NCT00145600|593586670|FG002|Overall Study|Withdrawal by Subject|0|||
164330328|NCT00145600|593586671|FG003|Overall Study|Withdrawal by Subject|1|||
164330329|NCT00736879|593586675|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
164330330|NCT00736879|593586676|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164330331|NCT00736879|593586677|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164330332|NCT00736879|593586678|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
164330333|NCT00736879|593586675|FG000|Double Blind Treatment Period|Adverse Event|0|||
164330334|NCT00736879|593586676|FG001|Double Blind Treatment Period|Adverse Event|1|||
164330335|NCT00736879|593586677|FG002|Double Blind Treatment Period|Adverse Event|1|||
164330336|NCT00736879|593586678|FG003|Double Blind Treatment Period|Adverse Event|0|||
164330337|NCT00736879|593586675|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
164330338|NCT00736879|593586676|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
164330339|NCT00736879|593586677|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
164330340|NCT00736879|593586678|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
164330341|NCT00736879|593586675|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164330342|NCT00736879|593586676|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164330343|NCT00736879|593586677|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
164330344|NCT00736879|593586678|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
164330345|NCT00736879|593586675|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
164330346|NCT00736879|593586676|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
164330347|NCT00736879|593586677|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
164330348|NCT00736879|593586678|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
164330349|NCT00736879|593586675|FG000|Double Blind Treatment Period|No longer met criteria|0|||
164330350|NCT00736879|593586676|FG001|Double Blind Treatment Period|No longer met criteria|1|||
164330351|NCT00736879|593586677|FG002|Double Blind Treatment Period|No longer met criteria|0|||
164330352|NCT00736879|593586678|FG003|Double Blind Treatment Period|No longer met criteria|0|||
164330353|NCT00736879|593586675|FG000|Double Blind Treatment Period|non-specified|0|||
164330354|NCT00736879|593586676|FG001|Double Blind Treatment Period|non-specified|1|||
164330355|NCT00736879|593586677|FG002|Double Blind Treatment Period|non-specified|0|||
164330356|NCT00736879|593586678|FG003|Double Blind Treatment Period|non-specified|0|||
164330357|NCT00736879|593586675|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
163986558|NCT03529773|592320195|FG002|Overall Study|Death|0|||
163986559|NCT03529773|592320196|FG003|Overall Study|Death|0|||
163986560|NCT03529773|592320197|FG004|Overall Study|Death|0|||
164330358|NCT00736879|593586676|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
163986561|NCT03529773|592320198|FG005|Overall Study|Death|0|||
163986562|NCT03529773|592320199|FG006|Overall Study|Death|0|||
163986563|NCT03529773|592320200|FG007|Overall Study|Death|0|||
163986564|NCT03529773|592320201|FG008|Overall Study|Death|0|||
163986565|NCT03529773|592320202|FG009|Overall Study|Death|0|||
163986566|NCT03529773|592320203|FG010|Overall Study|Death|0|||
163986567|NCT03529773|592320204|FG011|Overall Study|Death|0|||
163986568|NCT03529773|592320205|FG012|Overall Study|Death|1|||
163986569|NCT03529773|592320206|FG013|Overall Study|Death|0|||
163986570|NCT03529773|592320207|FG014|Overall Study|Death|0|||
164225571|NCT02991859|593194098|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
163986571|NCT03529773|592320208|FG015|Overall Study|Death|0|||
163986572|NCT03529773|592320209|FG016|Overall Study|Death|0|||
163986573|NCT03529773|592320210|FG017|Overall Study|Death|0|||
163986574|NCT03529773|592320211|FG018|Overall Study|Death|0|||
163986575|NCT03529773|592320212|FG019|Overall Study|Death|1|||
163986576|NCT03529773|592320213|FG020|Overall Study|Death|0|||
164330359|NCT00736879|593586677|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
164330360|NCT00736879|593586678|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
164330361|NCT00736879|593586675|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
164330362|NCT00736879|593586676|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
164330363|NCT00736879|593586677|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
164330364|NCT00736879|593586678|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
164330365|NCT03583164|593586685|FG000|Overall Study|Death in Main Phase|35|||
164330366|NCT03583164|593586685|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
164330367|NCT03583164|593586685|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
164330368|NCT03583164|593586685|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
164330369|NCT03583164|593586685|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
164330370|NCT03583164|593586685|FG000|Overall Study|Physician decision in Main Phase|1|||
164330371|NCT03583164|593586685|FG000|Overall Study|Physician decision in Extended Phase|2|||
164330372|NCT03583164|593586685|FG000|Overall Study|Death in Extended Phase|13|||
164330373|NCT03583164|593586685|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
164330374|NCT03583164|593586685|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
164330375|NCT03583164|593586685|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
164330376|NCT03583164|593586685|FG000|Overall Study|Treatment failure in Main Phase|2|||
164330377|NCT03583164|593586685|FG000|Overall Study|Treatment failure in Extended Phase|4|||
164330378|NCT03583164|593586685|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
164330379|NCT03583164|593586685|FG000|Overall Study|Other not specified reason in Main Phase|2|||
164330380|NCT02869438|593586693|FG000|Overall Study|Lost to Follow-up|1|||
164330381|NCT02869438|593586694|FG001|Overall Study|Lost to Follow-up|0|||
164330382|NCT02869438|593586693|FG000|Overall Study|Adverse Event|1|||
164330383|NCT02869438|593586694|FG001|Overall Study|Adverse Event|0|||
164330384|NCT02869438|593586693|FG000|Overall Study|Withdrawal by Subject|1|||
164330385|NCT02869438|593586694|FG001|Overall Study|Withdrawal by Subject|2|||
164330386|NCT00573248|593586701|FG000|Overall Study|scheduling conflicts|15|||
164330387|NCT00573248|593586702|FG001|Overall Study|scheduling conflicts|11|||
164330388|NCT05323656|593586703|FG000|Overall Study|Still On-Treatment|6|||
164330389|NCT05323656|593586704|FG001|Overall Study|Still On-Treatment|6|||
164330390|NCT05323656|593586703|FG000|Overall Study|Progressive Disease|15|||
164330391|NCT05323656|593586704|FG001|Overall Study|Progressive Disease|14|||
164330392|NCT05323656|593586703|FG000|Overall Study|Adverse Event|2|||
164330393|NCT05323656|593586704|FG001|Overall Study|Adverse Event|3|||
164330394|NCT05323656|593586703|FG000|Overall Study|Death|1|||
164330395|NCT05323656|593586704|FG001|Overall Study|Death|2|||
164330396|NCT05323656|593586703|FG000|Overall Study|Withdrawal by Subject|1|||
164330397|NCT05323656|593586704|FG001|Overall Study|Withdrawal by Subject|0|||
164330398|NCT05323656|593586703|FG000|Overall Study|Clinical disease progression|0|||
164330399|NCT05323656|593586704|FG001|Overall Study|Clinical disease progression|1|||
164330400|NCT05323656|593586703|FG000|Overall Study|Patient and Investigator decision|1|||
164330401|NCT05323656|593586704|FG001|Overall Study|Patient and Investigator decision|0|||
164330402|NCT05323656|593586703|FG000|Overall Study|Physician Decision|0|||
164330403|NCT05323656|593586704|FG001|Overall Study|Physician Decision|1|||
164330404|NCT03880461|593586705|FG000|Overall Study|Determined ineligible after enrollment|45|||
164330405|NCT03880461|593586706|FG001|Overall Study|Determined ineligible after enrollment|44|||
164330406|NCT03880461|593586705|FG000|Overall Study|No weight measurement after enrollment|24|||
164330407|NCT03880461|593586706|FG001|Overall Study|No weight measurement after enrollment|17|||
164330408|NCT03953183|593586708|FG000|Overall Study|Physician Decision|0|||
164330409|NCT03953183|593586709|FG001|Overall Study|Physician Decision|1|||
164330410|NCT03953183|593586708|FG000|Overall Study|Withdrawal by Subject|0|||
164330411|NCT03953183|593586709|FG001|Overall Study|Withdrawal by Subject|1|||
164330412|NCT01115803|593586723|FG000|Overall Study|Withdrawal by Subject|0|||
164330413|NCT01115803|593586724|FG001|Overall Study|Withdrawal by Subject|0|||
164330414|NCT01115803|593586725|FG002|Overall Study|Withdrawal by Subject|0|||
164330415|NCT01115803|593586726|FG003|Overall Study|Withdrawal by Subject|0|||
164330416|NCT01115803|593586727|FG004|Overall Study|Withdrawal by Subject|0|||
164330417|NCT01115803|593586728|FG005|Overall Study|Withdrawal by Subject|0|||
163986577|NCT03529773|592320214|FG021|Overall Study|Death|0|||
163986578|NCT03529773|592320215|FG022|Overall Study|Death|1|||
163986579|NCT03529773|592320216|FG023|Overall Study|Death|0|||
163986580|NCT03529773|592320217|FG024|Overall Study|Death|0|||
163986581|NCT03529773|592320218|FG025|Overall Study|Death|0|||
163986582|NCT03529773|592320219|FG026|Overall Study|Death|0|||
163986583|NCT03529773|592320220|FG027|Overall Study|Death|0|||
164330418|NCT01115803|593586729|FG006|Overall Study|Withdrawal by Subject|1|||
164330419|NCT01115803|593586723|FG000|Overall Study|Lost to Follow-up|0|||
164330420|NCT01115803|593586724|FG001|Overall Study|Lost to Follow-up|0|||
163882046|NCT01214616|591937275|FG001|Overall Study|Dose limiting toxicity|2|||
163882047|NCT01214616|591937276|FG002|Overall Study|Dose limiting toxicity|0|||
163882048|NCT01214616|591937277|FG003|Overall Study|Dose limiting toxicity|0|||
163882049|NCT01214616|591937274|FG000|Overall Study|Other adverse events|0|||
163882050|NCT01214616|591937275|FG001|Overall Study|Other adverse events|1|||
164081644|NCT01698320|592663302|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
164330421|NCT01115803|593586725|FG002|Overall Study|Lost to Follow-up|1|||
164330422|NCT01115803|593586726|FG003|Overall Study|Lost to Follow-up|0|||
164330423|NCT01115803|593586727|FG004|Overall Study|Lost to Follow-up|0|||
164330424|NCT01115803|593586728|FG005|Overall Study|Lost to Follow-up|0|||
164330425|NCT01115803|593586729|FG006|Overall Study|Lost to Follow-up|0|||
164330426|NCT01115803|593586723|FG000|Overall Study|Progressive Disease during Cycle1|0|||
164330427|NCT01115803|593586724|FG001|Overall Study|Progressive Disease during Cycle1|0|||
164330428|NCT01115803|593586725|FG002|Overall Study|Progressive Disease during Cycle1|0|||
164330429|NCT01115803|593586726|FG003|Overall Study|Progressive Disease during Cycle1|0|||
164330430|NCT01115803|593586727|FG004|Overall Study|Progressive Disease during Cycle1|0|||
164330431|NCT01115803|593586728|FG005|Overall Study|Progressive Disease during Cycle1|0|||
164330432|NCT01115803|593586729|FG006|Overall Study|Progressive Disease during Cycle1|1|||
164330433|NCT03063203|593586730|FG000|Overall Study|Chose alternative therapy|3|||
164330434|NCT03063203|593586730|FG000|Overall Study|Death|2|||
164330435|NCT03063203|593586730|FG000|Overall Study|Disease progression|4|||
164330436|NCT03063203|593586730|FG000|Overall Study|Physician Decision|5|||
164330437|NCT04718103|593586731|FG000|Overall Study|Adverse Event|1|||
164330438|NCT04718103|593586732|FG001|Overall Study|Adverse Event|1|||
164330439|NCT04718103|593586731|FG000|Overall Study|Lack of Efficacy|4|||
164081645|NCT01698320|592663303|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
164081646|NCT01698320|592663301|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
164081647|NCT01698320|592663302|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
164081648|NCT01698320|592663303|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
164081649|NCT01698320|592663301|FG000|12-Week Double-Blind Period|Pregnancy|0|||
164081650|NCT01698320|592663302|FG001|12-Week Double-Blind Period|Pregnancy|1|||
164081651|NCT01698320|592663303|FG002|12-Week Double-Blind Period|Pregnancy|1|||
164081652|NCT01698320|592663301|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
164081653|NCT01698320|592663302|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
164081654|NCT01698320|592663303|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
164081655|NCT01698320|592663301|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
164081656|NCT01698320|592663302|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
164081657|NCT01698320|592663303|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
164081658|NCT01698320|592663301|FG000|40-Week Open-Label Period|Adverse Event|0|||
164081659|NCT01698320|592663302|FG001|40-Week Open-Label Period|Adverse Event|3|||
164081660|NCT01698320|592663303|FG002|40-Week Open-Label Period|Adverse Event|2|||
164081661|NCT01698320|592663301|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
164081662|NCT01698320|592663302|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
164081663|NCT01698320|592663303|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
164081664|NCT01698320|592663301|FG000|40-Week Open-Label Period|Pregnancy|0|||
164081665|NCT01698320|592663302|FG001|40-Week Open-Label Period|Pregnancy|2|||
164081666|NCT01698320|592663303|FG002|40-Week Open-Label Period|Pregnancy|1|||
164081667|NCT01698320|592663301|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
164081668|NCT01698320|592663302|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
164081669|NCT01698320|592663303|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
164081670|NCT01698320|592663301|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
164081671|NCT01698320|592663302|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
164081672|NCT01698320|592663303|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
164081673|NCT01107535|592663304|FG000|Overall Study|Death|5|||
164081674|NCT03567057|592663305|FG000|Overall Study|Adverse Event|56|||
164081675|NCT03567057|592663306|FG001|Overall Study|Adverse Event|53|||
164081676|NCT03567057|592663307|FG002|Overall Study|Adverse Event|28|||
164330440|NCT04718103|593586732|FG001|Overall Study|Lack of Efficacy|1|||
164330441|NCT04718103|593586731|FG000|Overall Study|Lost to Follow-up|2|||
164330442|NCT04718103|593586732|FG001|Overall Study|Lost to Follow-up|2|||
164330443|NCT04718103|593586731|FG000|Overall Study|Physician Decision|2|||
164330444|NCT04718103|593586732|FG001|Overall Study|Physician Decision|0|||
164330445|NCT04718103|593586731|FG000|Overall Study|Pregnancy|0|||
164330446|NCT04718103|593586732|FG001|Overall Study|Pregnancy|1|||
164330447|NCT04718103|593586731|FG000|Overall Study|Withdrawal by Subject|10|||
164330448|NCT04718103|593586732|FG001|Overall Study|Withdrawal by Subject|6|||
164330449|NCT04718103|593586731|FG000|Overall Study|Randomized, not treated|4|||
164330450|NCT04718103|593586732|FG001|Overall Study|Randomized, not treated|1|||
164081677|NCT03567057|592663305|FG000|Overall Study|Withdrawal by Subject|22|||
164081678|NCT03567057|592663306|FG001|Overall Study|Withdrawal by Subject|24|||
164081679|NCT03567057|592663307|FG002|Overall Study|Withdrawal by Subject|13|||
164081680|NCT03567057|592663305|FG000|Overall Study|Lost to Follow-up|3|||
163986584|NCT03529773|592320221|FG028|Overall Study|Death|0|||
163986585|NCT03529773|592320222|FG029|Overall Study|Death|0|||
163986586|NCT03529773|592320223|FG030|Overall Study|Death|0|||
163986587|NCT03529773|592320224|FG031|Overall Study|Death|0|||
164330451|NCT04718103|593586731|FG000|Overall Study|GCP violations|7|||
164330452|NCT04718103|593586732|FG001|Overall Study|GCP violations|5|||
164330453|NCT02273739|593586733|FG000|Overall Study|Progression of Disease|3|||
164330454|NCT02273739|593586734|FG001|Overall Study|Progression of Disease|4|||
164330455|NCT02273739|593586735|FG002|Overall Study|Progression of Disease|5|||
164330456|NCT02273739|593586736|FG003|Overall Study|Progression of Disease|2|||
164330457|NCT02273739|593586733|FG000|Overall Study|Death|0|||
164330458|NCT02273739|593586734|FG001|Overall Study|Death|0|||
164330459|NCT02273739|593586735|FG002|Overall Study|Death|0|||
164330460|NCT02273739|593586736|FG003|Overall Study|Death|2|||
164330461|NCT02273739|593586733|FG000|Overall Study|Adverse Event|0|||
164330462|NCT02273739|593586734|FG001|Overall Study|Adverse Event|0|||
164330463|NCT02273739|593586735|FG002|Overall Study|Adverse Event|0|||
164330464|NCT02273739|593586736|FG003|Overall Study|Adverse Event|1|||
164330465|NCT02273739|593586733|FG000|Overall Study|Withdrawal by Subject|0|||
164330466|NCT02273739|593586734|FG001|Overall Study|Withdrawal by Subject|0|||
164330467|NCT02273739|593586735|FG002|Overall Study|Withdrawal by Subject|2|||
164330468|NCT02273739|593586736|FG003|Overall Study|Withdrawal by Subject|1|||
164330469|NCT02273739|593586733|FG000|Overall Study|Physician Decision|0|||
164330470|NCT02273739|593586734|FG001|Overall Study|Physician Decision|0|||
164330471|NCT02273739|593586735|FG002|Overall Study|Physician Decision|0|||
164330472|NCT02273739|593586736|FG003|Overall Study|Physician Decision|1|||
164330473|NCT02280473|593586738|FG000|Overall Study|Adverse Event|1|||
164330474|NCT02280473|593586739|FG001|Overall Study|Adverse Event|1|||
164330475|NCT02280473|593586738|FG000|Overall Study|Lack of Efficacy|0|||
164330476|NCT02280473|593586739|FG001|Overall Study|Lack of Efficacy|1|||
164330477|NCT02280473|593586738|FG000|Overall Study|Lost to Follow-up|0|||
164330478|NCT02280473|593586739|FG001|Overall Study|Lost to Follow-up|1|||
164330479|NCT02393690|593586740|FG000|Overall Study|Ineligible|0|||
164330480|NCT02393690|593586741|FG001|Overall Study|Ineligible|1|||
164330481|NCT05298306|593586742|FG000|Overall Study|Physician Decision|0|||
164330482|NCT05298306|593586743|FG001|Overall Study|Physician Decision|0|||
164330483|NCT05298306|593586744|FG002|Overall Study|Physician Decision|0|||
164330484|NCT05298306|593586745|FG003|Overall Study|Physician Decision|1|||
164330485|NCT05298306|593586746|FG004|Overall Study|Physician Decision|0|||
164330486|NCT05298306|593586747|FG005|Overall Study|Physician Decision|0|||
164330487|NCT05080660|593586749|FG000|Overall Study|Adverse Event|4|||
164330488|NCT05080660|593586750|FG001|Overall Study|Adverse Event|0|||
164330489|NCT05080660|593586749|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
164330490|NCT05080660|593586750|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
164330491|NCT05080660|593586749|FG000|Overall Study|Physician Decision|1|||
164330492|NCT05080660|593586750|FG001|Overall Study|Physician Decision|0|||
164330493|NCT05080660|593586749|FG000|Overall Study|Protocol Deviation|2|||
164330494|NCT05080660|593586750|FG001|Overall Study|Protocol Deviation|0|||
164330495|NCT05080660|593586749|FG000|Overall Study|Withdrawal by Subject|5|||
164330496|NCT05080660|593586750|FG001|Overall Study|Withdrawal by Subject|2|||
164330497|NCT00237185|593586751|FG000|Core|Adverse Event|3|||
164330498|NCT00237185|593586752|FG001|Core|Adverse Event|4|||
164330499|NCT00237185|593586751|FG000|Core|Abnormal laboratory value|0|||
164330500|NCT00237185|593586752|FG001|Core|Abnormal laboratory value|4|||
164330501|NCT00237185|593586751|FG000|Core|Abnormal test procedure results|1|||
164330502|NCT00237185|593586752|FG001|Core|Abnormal test procedure results|0|||
164330503|NCT00237185|593586751|FG000|Core|Lack of Efficacy|30|||
164330504|NCT00237185|593586752|FG001|Core|Lack of Efficacy|23|||
164330505|NCT00237185|593586751|FG000|Core|Protocol Violation|1|||
164330506|NCT00237185|593586752|FG001|Core|Protocol Violation|1|||
164330507|NCT00237185|593586751|FG000|Core|Withdrawal by Subject|4|||
164330508|NCT00237185|593586752|FG001|Core|Withdrawal by Subject|4|||
164330509|NCT00237185|593586751|FG000|Core|Administrative problems|0|||
164330510|NCT00237185|593586752|FG001|Core|Administrative problems|1|||
164330511|NCT00237185|593586751|FG000|Core|Death|4|||
164330512|NCT00237185|593586752|FG001|Core|Death|0|||
164330513|NCT00237185|593586751|FG000|Core|Determined ineligible post randomization|1|||
164330514|NCT00237185|593586752|FG001|Core|Determined ineligible post randomization|0|||
164330515|NCT00237185|593586751|FG000|Extension|Adverse Event|1|||
164330516|NCT00237185|593586752|FG001|Extension|Adverse Event|0|||
163986588|NCT03529773|592320225|FG032|Overall Study|Death|0|||
164330517|NCT00237185|593586751|FG000|Extension|Abnormal laboratory value|0|||
163986589|NCT03529773|592320226|FG033|Overall Study|Death|1|||
163986590|NCT03529773|592320227|FG034|Overall Study|Death|1|||
164330518|NCT00237185|593586752|FG001|Extension|Abnormal laboratory value|1|||
164330519|NCT00237185|593586751|FG000|Extension|Lack of Efficacy|9|||
164330520|NCT00237185|593586752|FG001|Extension|Lack of Efficacy|14|||
164330521|NCT00237185|593586751|FG000|Extension|Condition no longer required study drug|0|||
164330522|NCT00237185|593586752|FG001|Extension|Condition no longer required study drug|1|||
164330523|NCT00237185|593586751|FG000|Extension|Withdrawal by Subject|3|||
164330524|NCT00237185|593586752|FG001|Extension|Withdrawal by Subject|2|||
163986591|NCT03529773|592320228|FG035|Overall Study|Death|0|||
163986592|NCT03529773|592320229|FG036|Overall Study|Death|1|||
163986593|NCT03529773|592320230|FG037|Overall Study|Death|0|||
163986594|NCT03529773|592320231|FG038|Overall Study|Death|0|||
163986595|NCT03529773|592320232|FG039|Overall Study|Death|0|||
163986596|NCT03529773|592320193|FG000|Overall Study|Lost to Follow-up|0|||
163986597|NCT03529773|592320194|FG001|Overall Study|Lost to Follow-up|0|||
163986598|NCT03529773|592320195|FG002|Overall Study|Lost to Follow-up|1|||
163986599|NCT03529773|592320196|FG003|Overall Study|Lost to Follow-up|0|||
163986600|NCT03529773|592320197|FG004|Overall Study|Lost to Follow-up|1|||
163986601|NCT03529773|592320198|FG005|Overall Study|Lost to Follow-up|1|||
163986602|NCT03529773|592320199|FG006|Overall Study|Lost to Follow-up|0|||
163986603|NCT03529773|592320200|FG007|Overall Study|Lost to Follow-up|0|||
163986604|NCT03529773|592320201|FG008|Overall Study|Lost to Follow-up|0|||
163986605|NCT03529773|592320202|FG009|Overall Study|Lost to Follow-up|0|||
163986606|NCT03529773|592320203|FG010|Overall Study|Lost to Follow-up|0|||
163986607|NCT03529773|592320204|FG011|Overall Study|Lost to Follow-up|0|||
163986608|NCT03529773|592320205|FG012|Overall Study|Lost to Follow-up|0|||
163986609|NCT03529773|592320206|FG013|Overall Study|Lost to Follow-up|1|||
163986610|NCT03529773|592320207|FG014|Overall Study|Lost to Follow-up|4|||
163986611|NCT03529773|592320208|FG015|Overall Study|Lost to Follow-up|1|||
163986612|NCT03529773|592320209|FG016|Overall Study|Lost to Follow-up|1|||
163986613|NCT03529773|592320210|FG017|Overall Study|Lost to Follow-up|0|||
163986614|NCT03529773|592320211|FG018|Overall Study|Lost to Follow-up|1|||
163986615|NCT03529773|592320212|FG019|Overall Study|Lost to Follow-up|1|||
163986616|NCT03529773|592320213|FG020|Overall Study|Lost to Follow-up|2|||
163986617|NCT03529773|592320214|FG021|Overall Study|Lost to Follow-up|4|||
163986618|NCT03529773|592320215|FG022|Overall Study|Lost to Follow-up|3|||
163986619|NCT03529773|592320216|FG023|Overall Study|Lost to Follow-up|4|||
163986620|NCT03529773|592320217|FG024|Overall Study|Lost to Follow-up|3|||
163986621|NCT03529773|592320218|FG025|Overall Study|Lost to Follow-up|5|||
163986622|NCT03529773|592320219|FG026|Overall Study|Lost to Follow-up|5|||
163986623|NCT03529773|592320220|FG027|Overall Study|Lost to Follow-up|0|||
163986624|NCT03529773|592320221|FG028|Overall Study|Lost to Follow-up|0|||
163986625|NCT03529773|592320222|FG029|Overall Study|Lost to Follow-up|0|||
163986626|NCT03529773|592320223|FG030|Overall Study|Lost to Follow-up|1|||
163986627|NCT03529773|592320224|FG031|Overall Study|Lost to Follow-up|0|||
163986628|NCT03529773|592320225|FG032|Overall Study|Lost to Follow-up|0|||
163986629|NCT03529773|592320226|FG033|Overall Study|Lost to Follow-up|1|||
163882051|NCT01214616|591937276|FG002|Overall Study|Other adverse events|1|||
163882052|NCT01214616|591937277|FG003|Overall Study|Other adverse events|1|||
163882053|NCT01214616|591937274|FG000|Overall Study|Withdrawal by Subject|1|||
163882054|NCT01214616|591937275|FG001|Overall Study|Withdrawal by Subject|0|||
163882055|NCT01214616|591937276|FG002|Overall Study|Withdrawal by Subject|0|||
163882056|NCT01214616|591937277|FG003|Overall Study|Withdrawal by Subject|1|||
163882057|NCT03447470|591937278|FG000|Overall Study|Death|0|||
163882058|NCT03447470|591937279|FG001|Overall Study|Death|1|||
163882059|NCT03447470|591937280|FG002|Overall Study|Death|3|||
163882060|NCT03447470|591937281|FG003|Overall Study|Death|0|||
163882061|NCT03447470|591937282|FG004|Overall Study|Death|1|||
163882062|NCT03447470|591937283|FG005|Overall Study|Death|0|||
163882063|NCT03447470|591937284|FG006|Overall Study|Death|3|||
163882064|NCT03447470|591937285|FG007|Overall Study|Death|3|||
163882065|NCT03447470|591937286|FG008|Overall Study|Death|1|||
163882066|NCT03447470|591937278|FG000|Overall Study|Withdrawal by Subject|1|||
163882067|NCT03447470|591937279|FG001|Overall Study|Withdrawal by Subject|0|||
163882068|NCT03447470|591937280|FG002|Overall Study|Withdrawal by Subject|0|||
163882069|NCT03447470|591937281|FG003|Overall Study|Withdrawal by Subject|0|||
163882070|NCT03447470|591937282|FG004|Overall Study|Withdrawal by Subject|1|||
163882071|NCT03447470|591937283|FG005|Overall Study|Withdrawal by Subject|0|||
163882072|NCT03447470|591937284|FG006|Overall Study|Withdrawal by Subject|1|||
163882073|NCT03447470|591937285|FG007|Overall Study|Withdrawal by Subject|1|||
163882074|NCT03447470|591937286|FG008|Overall Study|Withdrawal by Subject|3|||
163882075|NCT03447470|591937278|FG000|Overall Study|Treatment discontinued|3|||
163882076|NCT03447470|591937279|FG001|Overall Study|Treatment discontinued|2|||
163882077|NCT03447470|591937280|FG002|Overall Study|Treatment discontinued|4|||
163882078|NCT03447470|591937281|FG003|Overall Study|Treatment discontinued|6|||
163986630|NCT03529773|592320227|FG034|Overall Study|Lost to Follow-up|1|||
163986631|NCT03529773|592320228|FG035|Overall Study|Lost to Follow-up|0|||
163986632|NCT03529773|592320229|FG036|Overall Study|Lost to Follow-up|0|||
163986633|NCT03529773|592320230|FG037|Overall Study|Lost to Follow-up|3|||
163986634|NCT03529773|592320231|FG038|Overall Study|Lost to Follow-up|1|||
163986635|NCT03529773|592320232|FG039|Overall Study|Lost to Follow-up|1|||
163986636|NCT03529773|592320193|FG000|Overall Study|No longer meets eligibility criteria|0|||
163986637|NCT03529773|592320194|FG001|Overall Study|No longer meets eligibility criteria|0|||
163986638|NCT03529773|592320195|FG002|Overall Study|No longer meets eligibility criteria|0|||
163986639|NCT03529773|592320196|FG003|Overall Study|No longer meets eligibility criteria|0|||
163986640|NCT03529773|592320197|FG004|Overall Study|No longer meets eligibility criteria|0|||
163882079|NCT03447470|591937282|FG004|Overall Study|Treatment discontinued|2|||
164081681|NCT03567057|592663306|FG001|Overall Study|Lost to Follow-up|5|||
163986641|NCT03529773|592320198|FG005|Overall Study|No longer meets eligibility criteria|0|||
163986642|NCT03529773|592320199|FG006|Overall Study|No longer meets eligibility criteria|0|||
163986643|NCT03529773|592320200|FG007|Overall Study|No longer meets eligibility criteria|0|||
163986644|NCT03529773|592320201|FG008|Overall Study|No longer meets eligibility criteria|0|||
163986645|NCT03529773|592320202|FG009|Overall Study|No longer meets eligibility criteria|0|||
163986646|NCT03529773|592320203|FG010|Overall Study|No longer meets eligibility criteria|0|||
163986647|NCT03529773|592320204|FG011|Overall Study|No longer meets eligibility criteria|0|||
163986648|NCT03529773|592320205|FG012|Overall Study|No longer meets eligibility criteria|0|||
163986649|NCT03529773|592320206|FG013|Overall Study|No longer meets eligibility criteria|0|||
163986650|NCT03529773|592320207|FG014|Overall Study|No longer meets eligibility criteria|0|||
163986651|NCT03529773|592320208|FG015|Overall Study|No longer meets eligibility criteria|0|||
163986652|NCT03529773|592320209|FG016|Overall Study|No longer meets eligibility criteria|0|||
163986653|NCT03529773|592320210|FG017|Overall Study|No longer meets eligibility criteria|0|||
163986654|NCT03529773|592320211|FG018|Overall Study|No longer meets eligibility criteria|0|||
163986655|NCT03529773|592320212|FG019|Overall Study|No longer meets eligibility criteria|0|||
163986656|NCT03529773|592320213|FG020|Overall Study|No longer meets eligibility criteria|0|||
163986657|NCT03529773|592320214|FG021|Overall Study|No longer meets eligibility criteria|0|||
164081682|NCT03567057|592663307|FG002|Overall Study|Lost to Follow-up|2|||
164081683|NCT03567057|592663305|FG000|Overall Study|COVID-19 pandemic|4|||
164081684|NCT03567057|592663306|FG001|Overall Study|COVID-19 pandemic|3|||
164081685|NCT03567057|592663307|FG002|Overall Study|COVID-19 pandemic|0|||
164081686|NCT03567057|592663305|FG000|Overall Study|Non-compliance with study drug|4|||
164081687|NCT03567057|592663306|FG001|Overall Study|Non-compliance with study drug|2|||
164081688|NCT03567057|592663307|FG002|Overall Study|Non-compliance with study drug|0|||
164081689|NCT03567057|592663305|FG000|Overall Study|Lack of Efficacy|3|||
164081690|NCT03567057|592663306|FG001|Overall Study|Lack of Efficacy|0|||
163986658|NCT03529773|592320215|FG022|Overall Study|No longer meets eligibility criteria|1|||
163986659|NCT03529773|592320216|FG023|Overall Study|No longer meets eligibility criteria|0|||
163986660|NCT03529773|592320217|FG024|Overall Study|No longer meets eligibility criteria|0|||
163986661|NCT03529773|592320218|FG025|Overall Study|No longer meets eligibility criteria|0|||
163986662|NCT03529773|592320219|FG026|Overall Study|No longer meets eligibility criteria|0|||
163986663|NCT03529773|592320220|FG027|Overall Study|No longer meets eligibility criteria|0|||
163986664|NCT03529773|592320221|FG028|Overall Study|No longer meets eligibility criteria|0|||
163986665|NCT03529773|592320222|FG029|Overall Study|No longer meets eligibility criteria|0|||
163986666|NCT03529773|592320223|FG030|Overall Study|No longer meets eligibility criteria|0|||
163986667|NCT03529773|592320224|FG031|Overall Study|No longer meets eligibility criteria|0|||
163986668|NCT03529773|592320225|FG032|Overall Study|No longer meets eligibility criteria|0|||
163986669|NCT03529773|592320226|FG033|Overall Study|No longer meets eligibility criteria|0|||
163986670|NCT03529773|592320227|FG034|Overall Study|No longer meets eligibility criteria|0|||
163986671|NCT03529773|592320228|FG035|Overall Study|No longer meets eligibility criteria|0|||
163986672|NCT03529773|592320229|FG036|Overall Study|No longer meets eligibility criteria|0|||
163986673|NCT03529773|592320230|FG037|Overall Study|No longer meets eligibility criteria|0|||
163986674|NCT03529773|592320231|FG038|Overall Study|No longer meets eligibility criteria|1|||
163986675|NCT03529773|592320232|FG039|Overall Study|No longer meets eligibility criteria|0|||
163986676|NCT03529773|592320193|FG000|Overall Study|Other|0|||
163986677|NCT03529773|592320194|FG001|Overall Study|Other|0|||
163986678|NCT03529773|592320195|FG002|Overall Study|Other|0|||
163986679|NCT03529773|592320196|FG003|Overall Study|Other|0|||
163986680|NCT03529773|592320197|FG004|Overall Study|Other|0|||
163986681|NCT03529773|592320198|FG005|Overall Study|Other|0|||
163986682|NCT03529773|592320199|FG006|Overall Study|Other|0|||
163986683|NCT03529773|592320200|FG007|Overall Study|Other|0|||
163986684|NCT03529773|592320201|FG008|Overall Study|Other|0|||
163986685|NCT03529773|592320202|FG009|Overall Study|Other|0|||
163986686|NCT03529773|592320203|FG010|Overall Study|Other|0|||
163986687|NCT03529773|592320204|FG011|Overall Study|Other|0|||
163986688|NCT03529773|592320205|FG012|Overall Study|Other|1|||
164081691|NCT03567057|592663307|FG002|Overall Study|Lack of Efficacy|1|||
163986689|NCT03529773|592320206|FG013|Overall Study|Other|0|||
163986690|NCT03529773|592320207|FG014|Overall Study|Other|2|||
163986691|NCT03529773|592320208|FG015|Overall Study|Other|0|||
163986692|NCT03529773|592320209|FG016|Overall Study|Other|0|||
163986693|NCT03529773|592320210|FG017|Overall Study|Other|3|||
163986694|NCT03529773|592320211|FG018|Overall Study|Other|0|||
163986695|NCT03529773|592320212|FG019|Overall Study|Other|0|||
163986696|NCT03529773|592320213|FG020|Overall Study|Other|1|||
163986697|NCT03529773|592320214|FG021|Overall Study|Other|0|||
163986698|NCT03529773|592320215|FG022|Overall Study|Other|1|||
163986699|NCT03529773|592320216|FG023|Overall Study|Other|0|||
163986700|NCT03529773|592320217|FG024|Overall Study|Other|3|||
163986701|NCT03529773|592320218|FG025|Overall Study|Other|2|||
164081692|NCT03567057|592663305|FG000|Overall Study|Death|1|||
164081693|NCT03567057|592663306|FG001|Overall Study|Death|0|||
164081694|NCT03567057|592663307|FG002|Overall Study|Death|0|||
164081695|NCT03567057|592663305|FG000|Overall Study|Physician Decision|1|||
164330525|NCT00237185|593586751|FG000|Extension|Lost to Follow-up|1|||
164330526|NCT00237185|593586752|FG001|Extension|Lost to Follow-up|0|||
164330527|NCT00237185|593586751|FG000|Extension|Administrative problems|1|||
164330528|NCT00237185|593586752|FG001|Extension|Administrative problems|0|||
164330529|NCT00237185|593586751|FG000|Extension|Death|1|||
164330530|NCT00237185|593586752|FG001|Extension|Death|1|||
164330531|NCT02204007|593586753|FG000|Overall Study|Surgery Canceled|1|||
164330532|NCT02204007|593586754|FG001|Overall Study|Surgery Canceled|1|||
164330533|NCT03194490|593586755|FG000|Overall Study|Lost to Follow-up|1|||
164330534|NCT03194490|593586756|FG001|Overall Study|Lost to Follow-up|3|||
164330535|NCT03194490|593586755|FG000|Overall Study|participant developed specific neck pain|1|||
164330536|NCT03194490|593586756|FG001|Overall Study|participant developed specific neck pain|0|||
164330537|NCT03911843|593586757|FG000|Overall Study|Adverse Event|2|||
164330538|NCT03911843|593586758|FG001|Overall Study|Adverse Event|0|||
164330539|NCT03911843|593586757|FG000|Overall Study|Protocol Violation|2|||
164330540|NCT03911843|593586758|FG001|Overall Study|Protocol Violation|0|||
164330541|NCT03911843|593586757|FG000|Overall Study|Lost to Follow-up|0|||
164330542|NCT03911843|593586758|FG001|Overall Study|Lost to Follow-up|1|||
164330543|NCT02059005|593586761|FG000|Overall Study|Death|1|||
164330544|NCT02059005|593586762|FG001|Overall Study|Death|3|||
164330545|NCT02059005|593586761|FG000|Overall Study|Lost to Follow-up|19|||
164330546|NCT02059005|593586762|FG001|Overall Study|Lost to Follow-up|19|||
164330547|NCT02059005|593586761|FG000|Overall Study|Incarceration|0|||
164330548|NCT02059005|593586762|FG001|Overall Study|Incarceration|1|||
164330549|NCT02059005|593586761|FG000|Overall Study|Inpatient|0|||
164330550|NCT02059005|593586762|FG001|Overall Study|Inpatient|1|||
164330551|NCT02750943|593586765|FG000|Overall Study|Lost to Follow-up|1|||
164330552|NCT02750943|593586766|FG001|Overall Study|Lost to Follow-up|2|||
164330553|NCT02750943|593586765|FG000|Overall Study|Withdrawal by Subject|5|||
164330554|NCT02750943|593586766|FG001|Overall Study|Withdrawal by Subject|7|||
164330555|NCT00171054|593586767|FG000|Overall Study|Protocol Violation|1|||
164330556|NCT00171054|593586768|FG001|Overall Study|Protocol Violation|2|||
164330557|NCT00171054|593586767|FG000|Overall Study|Patient withdrew consent|1|||
164330558|NCT00171054|593586768|FG001|Overall Study|Patient withdrew consent|0|||
164330559|NCT00171054|593586767|FG000|Overall Study|Lost to Follow-up|0|||
164330560|NCT00171054|593586768|FG001|Overall Study|Lost to Follow-up|1|||
164330561|NCT00171054|593586767|FG000|Overall Study|Adverse Event|8|||
164330562|NCT00171054|593586768|FG001|Overall Study|Adverse Event|8|||
163882080|NCT03447470|591937283|FG005|Overall Study|Treatment discontinued|1|||
163882081|NCT03447470|591937284|FG006|Overall Study|Treatment discontinued|2|||
163882082|NCT03447470|591937285|FG007|Overall Study|Treatment discontinued|4|||
163882083|NCT03447470|591937286|FG008|Overall Study|Treatment discontinued|3|||
163882084|NCT01361711|591937290|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
163882085|NCT01361711|591937290|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
163882086|NCT01361711|591937290|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
163882087|NCT01361711|591937290|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
163882088|NCT01361711|591937290|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
163882089|NCT01361711|591937290|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
163882090|NCT01361711|591937290|FG000|Completed Week 18 of Treatment|Other|9|||
163882091|NCT01361711|591937290|FG000|10 Year Follow-up|Still in follow-up|22|||
163882092|NCT01361711|591937290|FG000|10 Year Follow-up|Death|7|||
163882093|NCT01361711|591937290|FG000|10 Year Follow-up|Developed new cancer|1|||
163882094|NCT01361711|591937290|FG000|10 Year Follow-up|Lost to Follow-up|2|||
163882095|NCT01361711|591937290|FG000|10 Year Follow-up|New treatment started|6|||
163882096|NCT01361711|591937290|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
163882097|NCT01361711|591937290|FG000|10 Year Follow-up|Progressive Disease|1|||
163882098|NCT02596126|591937291|FG000|Overall Study|Lost to Follow-up|12|||
163882099|NCT02596126|591937292|FG001|Overall Study|Lost to Follow-up|21|||
163882100|NCT02596126|591937291|FG000|Overall Study|Protocol Violation|7|||
163882101|NCT02596126|591937292|FG001|Overall Study|Protocol Violation|9|||
163882102|NCT02471638|591937295|FG000|Overall Study|Early Term Withdrawal|10|||
163882103|NCT05113966|591939254|FG000|Overall Study|Death|21|||
163882104|NCT05113966|591939254|FG000|Overall Study|Study Terminated by Sponsor|9|||
163882105|NCT04490915|591939255|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
163882106|NCT04490915|591939256|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
163882107|NCT04490915|591939255|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163882108|NCT04490915|591939256|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163882109|NCT04490915|591939255|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163882110|NCT04490915|591939256|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
163882111|NCT04490915|591939255|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
164330563|NCT00171054|593586767|FG000|Overall Study|Condition no longer required study drug|0|||
164330564|NCT00171054|593586768|FG001|Overall Study|Condition no longer required study drug|1|||
164330565|NCT04597918|593586769|FG000|Overall Study|Withdrawal by Subject|6|||
164330566|NCT04597918|593586769|FG000|Overall Study|Lost to Follow-up|3|||
164330567|NCT04597918|593586769|FG000|Overall Study|Death|1|||
164330568|NCT04382755|593586778|FG000|Overall Study|Withdrawal by Subject|1|||
164330569|NCT04382755|593586779|FG001|Overall Study|Withdrawal by Subject|0|||
164330570|NCT04382755|593586778|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
164330571|NCT04382755|593586779|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
164330572|NCT04382755|593586778|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
164330573|NCT04382755|593586779|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
164330574|NCT04041700|593586784|FG000|Overall Study|Pregnancy|1|||
164330575|NCT04041700|593586784|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
164330576|NCT03120624|593586785|FG000|Overall Study|Withdrawal by Subject|0|||
164330577|NCT03120624|593586786|FG001|Overall Study|Withdrawal by Subject|1|||
164330578|NCT03120624|593586787|FG002|Overall Study|Withdrawal by Subject|0|||
164330579|NCT03120624|593586788|FG003|Overall Study|Withdrawal by Subject|0|||
164330580|NCT03120624|593586789|FG004|Overall Study|Withdrawal by Subject|0|||
164330581|NCT03120624|593586790|FG005|Overall Study|Withdrawal by Subject|0|||
164330582|NCT03120624|593586791|FG006|Overall Study|Withdrawal by Subject|0|||
164330583|NCT03120624|593586792|FG007|Overall Study|Withdrawal by Subject|0|||
164330584|NCT01104701|593588227|FG000|Overall Study|Withdrawal by Subject|0|||
164330585|NCT01104701|593588228|FG001|Overall Study|Withdrawal by Subject|1|||
164330586|NCT01104701|593588229|FG002|Overall Study|Withdrawal by Subject|2|||
164330587|NCT01104701|593588230|FG003|Overall Study|Withdrawal by Subject|1|||
164330588|NCT01104701|593588227|FG000|Overall Study|Adverse Event|0|||
164330589|NCT01104701|593588228|FG001|Overall Study|Adverse Event|0|||
164330590|NCT01104701|593588229|FG002|Overall Study|Adverse Event|0|||
163986702|NCT03529773|592320219|FG026|Overall Study|Other|2|||
163986703|NCT03529773|592320220|FG027|Overall Study|Other|0|||
163986704|NCT03529773|592320221|FG028|Overall Study|Other|0|||
163986705|NCT03529773|592320222|FG029|Overall Study|Other|0|||
163986706|NCT03529773|592320223|FG030|Overall Study|Other|0|||
163986707|NCT03529773|592320224|FG031|Overall Study|Other|0|||
163986708|NCT03529773|592320225|FG032|Overall Study|Other|0|||
163986709|NCT03529773|592320226|FG033|Overall Study|Other|0|||
163986710|NCT03529773|592320227|FG034|Overall Study|Other|1|||
163986711|NCT03529773|592320228|FG035|Overall Study|Other|1|||
163986712|NCT03529773|592320229|FG036|Overall Study|Other|0|||
163986713|NCT03529773|592320230|FG037|Overall Study|Other|0|||
163986714|NCT03529773|592320231|FG038|Overall Study|Other|0|||
163986715|NCT03529773|592320232|FG039|Overall Study|Other|0|||
164081696|NCT03567057|592663306|FG001|Overall Study|Physician Decision|0|||
164081697|NCT03567057|592663307|FG002|Overall Study|Physician Decision|0|||
164330591|NCT01104701|593588230|FG003|Overall Study|Adverse Event|1|||
164330592|NCT01104701|593588227|FG000|Overall Study|Physician Decision|0|||
164330593|NCT01104701|593588228|FG001|Overall Study|Physician Decision|2|||
164330594|NCT01104701|593588229|FG002|Overall Study|Physician Decision|0|||
164330595|NCT01104701|593588230|FG003|Overall Study|Physician Decision|0|||
164330596|NCT00891462|593588231|FG000|Overall Study|Withdrawal by Subject|9|||
164330597|NCT00891462|593588232|FG001|Overall Study|Withdrawal by Subject|6|||
164330598|NCT00891462|593588233|FG002|Overall Study|Withdrawal by Subject|7|||
164330599|NCT00891462|593588231|FG000|Overall Study|Adverse Event|7|||
164330600|NCT00891462|593588232|FG001|Overall Study|Adverse Event|8|||
164330601|NCT00891462|593588233|FG002|Overall Study|Adverse Event|7|||
164330602|NCT00891462|593588231|FG000|Overall Study|Lack of Efficacy|10|||
164330603|NCT00891462|593588232|FG001|Overall Study|Lack of Efficacy|5|||
164330604|NCT00891462|593588233|FG002|Overall Study|Lack of Efficacy|1|||
164081698|NCT03567057|592663305|FG000|Overall Study|Unstable medical condition|1|||
164081699|NCT03567057|592663306|FG001|Overall Study|Unstable medical condition|0|||
164081700|NCT03567057|592663307|FG002|Overall Study|Unstable medical condition|0|||
164081701|NCT03567057|592663305|FG000|Overall Study|Medical history event|0|||
164081702|NCT03567057|592663306|FG001|Overall Study|Medical history event|0|||
164081703|NCT03567057|592663307|FG002|Overall Study|Medical history event|1|||
164081704|NCT03567057|592663305|FG000|Overall Study|Other|0|||
164330605|NCT00891462|593588231|FG000|Overall Study|COPD exacerbation|7|||
164330606|NCT00891462|593588232|FG001|Overall Study|COPD exacerbation|4|||
164330607|NCT00891462|593588233|FG002|Overall Study|COPD exacerbation|1|||
164330608|NCT00891462|593588231|FG000|Overall Study|Other Reason|2|||
164330609|NCT00891462|593588232|FG001|Overall Study|Other Reason|5|||
164330610|NCT00891462|593588233|FG002|Overall Study|Other Reason|3|||
164330611|NCT00891462|593588231|FG000|Overall Study|Protocol Violation|2|||
164330612|NCT00891462|593588232|FG001|Overall Study|Protocol Violation|1|||
164330613|NCT00891462|593588233|FG002|Overall Study|Protocol Violation|3|||
164330614|NCT00891462|593588231|FG000|Overall Study|Inclusion/exclusion criteria|0|||
163986716|NCT03529773|592320193|FG000|Overall Study|Physician Decision|0|||
163986717|NCT03529773|592320194|FG001|Overall Study|Physician Decision|0|||
163986718|NCT03529773|592320195|FG002|Overall Study|Physician Decision|0|||
163986719|NCT03529773|592320196|FG003|Overall Study|Physician Decision|0|||
163986720|NCT03529773|592320197|FG004|Overall Study|Physician Decision|0|||
163986721|NCT03529773|592320198|FG005|Overall Study|Physician Decision|0|||
163986722|NCT03529773|592320199|FG006|Overall Study|Physician Decision|0|||
164081705|NCT03567057|592663306|FG001|Overall Study|Other|0|||
164330615|NCT00891462|593588232|FG001|Overall Study|Inclusion/exclusion criteria|2|||
164330616|NCT00891462|593588233|FG002|Overall Study|Inclusion/exclusion criteria|2|||
164330617|NCT00891462|593588231|FG000|Overall Study|Lost to Follow-up|0|||
163882112|NCT04490915|591939256|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
163882113|NCT04490915|591939255|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
163882114|NCT04490915|591939256|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
163882115|NCT04490915|591939255|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
163882116|NCT04490915|591939256|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
163882117|NCT04490915|591939255|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
163882118|NCT04490915|591939256|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
163882119|NCT00667251|591939258|FG000|Overall Study|Disease progression|232|||
163882120|NCT00667251|591939259|FG001|Overall Study|Disease progression|203|||
163882121|NCT00667251|591939258|FG000|Overall Study|Toxicity|44|||
163882122|NCT00667251|591939259|FG001|Overall Study|Toxicity|23|||
163882123|NCT00667251|591939258|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
163882124|NCT00667251|591939259|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
163882125|NCT00667251|591939258|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
163882126|NCT00667251|591939259|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
163882127|NCT00667251|591939258|FG000|Overall Study|Symptomatic progression|8|||
163882128|NCT00667251|591939259|FG001|Overall Study|Symptomatic progression|4|||
163882129|NCT00667251|591939258|FG000|Overall Study|Death|6|||
163882130|NCT00667251|591939259|FG001|Overall Study|Death|11|||
163882131|NCT00667251|591939258|FG000|Overall Study|Intercurrent illness|5|||
163882132|NCT00667251|591939259|FG001|Overall Study|Intercurrent illness|6|||
163882133|NCT00667251|591939258|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
163882134|NCT00667251|591939259|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
163882135|NCT00667251|591939258|FG000|Overall Study|Randomized not Treated|4|||
163882136|NCT00667251|591939259|FG001|Overall Study|Randomized not Treated|1|||
163882137|NCT03376321|591939260|FG000|Overall Study|Other|5|||
163882138|NCT03376321|591939261|FG001|Overall Study|Other|1|||
163882139|NCT03376321|591939260|FG000|Overall Study|Withdrawal by Subject|8|||
163882140|NCT03376321|591939261|FG001|Overall Study|Withdrawal by Subject|14|||
163882141|NCT03376321|591939260|FG000|Overall Study|Lost to Follow-up|1|||
163882142|NCT03376321|591939261|FG001|Overall Study|Lost to Follow-up|7|||
163882143|NCT03376321|591939260|FG000|Overall Study|Death|4|||
163882144|NCT03376321|591939261|FG001|Overall Study|Death|0|||
163882145|NCT03376321|591939260|FG000|Overall Study|Randomized, not treated|5|||
163882146|NCT03376321|591939261|FG001|Overall Study|Randomized, not treated|3|||
163882147|NCT01426425|591939262|FG000|Overall Study|Exited prior to EP study|22|||
163882148|NCT01426425|591939262|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
163882149|NCT01426425|591939262|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
163882150|NCT03281291|591939268|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
163882151|NCT03281291|591939269|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
163882152|NCT03281291|591939270|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
163882153|NCT03281291|591939271|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
163882154|NCT03281291|591939272|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
163882155|NCT03281291|591939268|FG000|Overall Study|Protocol Deviation|2|||
163882156|NCT03281291|591939269|FG001|Overall Study|Protocol Deviation|0|||
163882157|NCT03281291|591939270|FG002|Overall Study|Protocol Deviation|1|||
163882158|NCT03281291|591939271|FG003|Overall Study|Protocol Deviation|2|||
163882159|NCT03281291|591939272|FG004|Overall Study|Protocol Deviation|1|||
163882160|NCT03281291|591939268|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
163882161|NCT03281291|591939269|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
163882162|NCT03281291|591939270|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
163882163|NCT03281291|591939271|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
163882164|NCT03281291|591939272|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
163882165|NCT03281291|591939268|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
163882166|NCT03281291|591939269|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
163882167|NCT03281291|591939270|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
163882168|NCT03281291|591939271|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
163882169|NCT03281291|591939272|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
163882170|NCT03281291|591939268|FG000|Overall Study|Lost to Follow-up|10|||
163882171|NCT03281291|591939269|FG001|Overall Study|Lost to Follow-up|10|||
163882172|NCT03281291|591939270|FG002|Overall Study|Lost to Follow-up|4|||
163882173|NCT03281291|591939271|FG003|Overall Study|Lost to Follow-up|6|||
163882174|NCT03281291|591939272|FG004|Overall Study|Lost to Follow-up|10|||
163882175|NCT03281291|591939268|FG000|Overall Study|Other|0|||
163882176|NCT03281291|591939269|FG001|Overall Study|Other|2|||
163882177|NCT03281291|591939270|FG002|Overall Study|Other|0|||
163882178|NCT03281291|591939271|FG003|Overall Study|Other|2|||
163882179|NCT03281291|591939272|FG004|Overall Study|Other|1|||
164330618|NCT00891462|593588232|FG001|Overall Study|Lost to Follow-up|2|||
164330619|NCT00891462|593588233|FG002|Overall Study|Lost to Follow-up|0|||
163882180|NCT00512070|591939273|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
164330620|NCT00423722|593588234|FG000|Overall Study|Death|4|||
164330621|NCT00423722|593588235|FG001|Overall Study|Death|4|||
164330622|NCT00423722|593588234|FG000|Overall Study|Declined to participate|2|||
164330623|NCT00423722|593588235|FG001|Overall Study|Declined to participate|3|||
164330624|NCT00423722|593588234|FG000|Overall Study|Unable to complete questionnaires|4|||
164330625|NCT00423722|593588235|FG001|Overall Study|Unable to complete questionnaires|4|||
164330626|NCT00423722|593588234|FG000|Overall Study|Withdrawal by Subject|4|||
164330627|NCT00423722|593588235|FG001|Overall Study|Withdrawal by Subject|2|||
164330628|NCT00215683|593588236|FG000|Overall Study|Adverse Event|15|||
164330629|NCT00215683|593588237|FG001|Overall Study|Adverse Event|16|||
164330630|NCT00215683|593588238|FG002|Overall Study|Adverse Event|15|||
164330631|NCT00215683|593588236|FG000|Overall Study|Lack of Efficacy|5|||
164225572|NCT02991859|593194099|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225573|NCT02991859|593194100|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164330632|NCT00215683|593588237|FG001|Overall Study|Lack of Efficacy|1|||
164330633|NCT00215683|593588238|FG002|Overall Study|Lack of Efficacy|2|||
164330634|NCT00215683|593588236|FG000|Overall Study|Lost to Follow-up|0|||
164330635|NCT00215683|593588237|FG001|Overall Study|Lost to Follow-up|2|||
164225574|NCT02991859|593194101|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225575|NCT02991859|593194102|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225576|NCT02991859|593194103|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
164225577|NCT02991859|593194104|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164330636|NCT00215683|593588238|FG002|Overall Study|Lost to Follow-up|1|||
163882181|NCT00512070|591939274|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
164225578|NCT02991859|593194105|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225579|NCT02991859|593194106|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225580|NCT02991859|593194107|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225581|NCT02991859|593194108|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225582|NCT02991859|593194109|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225583|NCT02991859|593194110|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
164225584|NCT02991859|593194094|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225585|NCT02991859|593194095|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225586|NCT02991859|593194096|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225587|NCT02991859|593194097|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225588|NCT02991859|593194098|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225589|NCT02991859|593194099|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225590|NCT02991859|593194100|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225591|NCT02991859|593194101|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225592|NCT02991859|593194102|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
164225593|NCT02991859|593194103|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225594|NCT02991859|593194104|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225595|NCT02991859|593194105|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225596|NCT02991859|593194106|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225597|NCT02991859|593194107|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225598|NCT02991859|593194108|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225599|NCT02991859|593194109|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225600|NCT02991859|593194110|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
164225601|NCT01514422|593194118|FG000|Overall Study|Lost to Follow-up|1|||
164225602|NCT03511209|593194119|FG000|Overall Study|Withdrawal by Subject|2|||
164225603|NCT03511209|593194120|FG001|Overall Study|Withdrawal by Subject|4|||
164225604|NCT03511209|593194119|FG000|Overall Study|Death|1|||
164225605|NCT03511209|593194120|FG001|Overall Study|Death|0|||
164225606|NCT03511209|593194119|FG000|Overall Study|Lost to Follow-up|0|||
164225607|NCT03511209|593194120|FG001|Overall Study|Lost to Follow-up|2|||
163882182|NCT00512070|591939275|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
163882183|NCT00512070|591939273|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
163882184|NCT00512070|591939274|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
163882185|NCT00512070|591939275|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
163882186|NCT04956861|591939276|FG000|Overall Study|Withdrawal by Subject|4|||
163882187|NCT04956861|591939277|FG001|Overall Study|Withdrawal by Subject|4|||
163882188|NCT04956861|591939278|FG002|Overall Study|Withdrawal by Subject|2|||
163986723|NCT03529773|592320200|FG007|Overall Study|Physician Decision|0|||
164225608|NCT00562861|593194121|FG000|Overall Study|Adverse Event|1|||
164225609|NCT00562861|593194122|FG001|Overall Study|Adverse Event|1|||
164225610|NCT00562861|593194121|FG000|Overall Study|Lack of Efficacy|5|||
164330637|NCT00215683|593588236|FG000|Overall Study|Withdrawal by Subject|9|||
164330638|NCT00215683|593588237|FG001|Overall Study|Withdrawal by Subject|4|||
164330639|NCT00215683|593588238|FG002|Overall Study|Withdrawal by Subject|13|||
164225611|NCT00562861|593194122|FG001|Overall Study|Lack of Efficacy|5|||
164225612|NCT00562861|593194121|FG000|Overall Study|noncompliance, moved|7|||
163882189|NCT04956861|591939276|FG000|Overall Study|Physician Decision|4|||
164225613|NCT00562861|593194122|FG001|Overall Study|noncompliance, moved|2|||
164225614|NCT00562861|593194121|FG000|Overall Study|Lost to Follow-up|7|||
164225615|NCT00562861|593194122|FG001|Overall Study|Lost to Follow-up|3|||
164225616|NCT00655356|593194123|FG000|Overall Study|Withdrawal by Subject|3|||
164225617|NCT00655356|593194124|FG001|Overall Study|Withdrawal by Subject|4|||
164225618|NCT00655356|593194123|FG000|Overall Study|Sponsor Request|10|||
164225619|NCT00655356|593194124|FG001|Overall Study|Sponsor Request|4|||
164225620|NCT00655356|593194123|FG000|Overall Study|Adverse Event|1|||
164225621|NCT00655356|593194124|FG001|Overall Study|Adverse Event|1|||
164225622|NCT00655356|593194123|FG000|Overall Study|Protocol Violation|2|||
164225623|NCT00655356|593194124|FG001|Overall Study|Protocol Violation|1|||
164330640|NCT00215683|593588236|FG000|Overall Study|Physician Decision|0|||
164330641|NCT00215683|593588237|FG001|Overall Study|Physician Decision|0|||
164330642|NCT00215683|593588238|FG002|Overall Study|Physician Decision|1|||
164330643|NCT00215683|593588236|FG000|Overall Study|Difficult to attend visits|0|||
164330644|NCT00215683|593588237|FG001|Overall Study|Difficult to attend visits|1|||
164330645|NCT00215683|593588238|FG002|Overall Study|Difficult to attend visits|0|||
164330646|NCT00215683|593588236|FG000|Overall Study|No study drug available|0|||
164330647|NCT00215683|593588237|FG001|Overall Study|No study drug available|1|||
164330648|NCT00215683|593588238|FG002|Overall Study|No study drug available|0|||
164330649|NCT00215683|593588236|FG000|Overall Study|Intermittent therapy required|0|||
164330650|NCT00215683|593588237|FG001|Overall Study|Intermittent therapy required|1|||
164330651|NCT00215683|593588238|FG002|Overall Study|Intermittent therapy required|0|||
164330652|NCT02437513|593588240|FG000|Overall Study|Withdrawal by Subject|2|||
164330653|NCT00595465|593588241|FG000|Overall Study|Adverse Event|4|||
164330654|NCT00595465|593588242|FG001|Overall Study|Adverse Event|3|||
164330655|NCT00595465|593588243|FG002|Overall Study|Adverse Event|3|||
164330656|NCT00595465|593588241|FG000|Overall Study|Pregnancy|0|||
164330657|NCT00595465|593588242|FG001|Overall Study|Pregnancy|0|||
164330658|NCT00595465|593588243|FG002|Overall Study|Pregnancy|1|||
164330659|NCT00595465|593588241|FG000|Overall Study|Protocol Violation|2|||
164330660|NCT00595465|593588242|FG001|Overall Study|Protocol Violation|1|||
164330661|NCT00595465|593588243|FG002|Overall Study|Protocol Violation|0|||
164330662|NCT00595465|593588241|FG000|Overall Study|Lost to Follow-up|0|||
164330663|NCT00595465|593588242|FG001|Overall Study|Lost to Follow-up|0|||
164330664|NCT00595465|593588243|FG002|Overall Study|Lost to Follow-up|2|||
164330665|NCT00595465|593588241|FG000|Overall Study|administrative reason|0|||
164330666|NCT00595465|593588242|FG001|Overall Study|administrative reason|0|||
164330667|NCT00595465|593588243|FG002|Overall Study|administrative reason|1|||
164330668|NCT00107783|593588244|FG000|Overall Study|Adverse Event|0|||
164330669|NCT00107783|593588245|FG001|Overall Study|Adverse Event|2|||
164330670|NCT00107783|593588244|FG000|Overall Study|Death|0|||
164330671|NCT00107783|593588245|FG001|Overall Study|Death|1|||
163882190|NCT04956861|591939277|FG001|Overall Study|Physician Decision|5|||
164225624|NCT00655356|593194123|FG000|Overall Study|Other Reason|1|||
164225625|NCT00655356|593194124|FG001|Overall Study|Other Reason|0|||
164225626|NCT01093573|593194129|FG000|Overall Study|Physician Decision|0|||
164225627|NCT01093573|593194130|FG001|Overall Study|Physician Decision|0|||
164225628|NCT01093573|593194131|FG002|Overall Study|Physician Decision|1|||
164225629|NCT01093573|593194129|FG000|Overall Study|Insurance Denied|0|||
164225630|NCT01093573|593194130|FG001|Overall Study|Insurance Denied|0|||
164225631|NCT01093573|593194131|FG002|Overall Study|Insurance Denied|1|||
164225632|NCT01623154|593194132|FG000|Overall Study|Did not drink Pranactin Citric|4|||
164225633|NCT01412983|593194133|FG000|1st Period|Ineligible|0|||
164225634|NCT01412983|593194134|FG001|1st Period|Ineligible|1|||
164225635|NCT01412983|593194133|FG000|1st Period|Positive slit lamp finding|0|||
164225636|NCT01412983|593194134|FG001|1st Period|Positive slit lamp finding|1|||
164225637|NCT01412983|593194133|FG000|1st Period|Unacceptable lens movement|0|||
164225638|NCT01412983|593194134|FG001|1st Period|Unacceptable lens movement|1|||
164225639|NCT01412983|593194133|FG000|1st Period|Inability to maintain wear|0|||
164225640|NCT01412983|593194134|FG001|1st Period|Inability to maintain wear|1|||
164330672|NCT00107783|593588244|FG000|Overall Study|Withdrawal by Subject|2|||
164330673|NCT00107783|593588245|FG001|Overall Study|Withdrawal by Subject|0|||
163882191|NCT04956861|591939278|FG002|Overall Study|Physician Decision|1|||
163882192|NCT00961571|591939279|FG000|Overall Study|Physician Decision|39|||
163882193|NCT02900924|591939283|FG000|Overall Study|Death|52|||
163882194|NCT02900924|591939283|FG000|Overall Study|Lost to Follow-up|4|||
163882195|NCT02900924|591939283|FG000|Overall Study|Withdrawal by Subject|20|||
164225641|NCT04349098|593194135|FG000|Overall Study|Death|16|||
164330674|NCT00107783|593588244|FG000|Overall Study|Second hip replacement|1|||
164330675|NCT00107783|593588245|FG001|Overall Study|Second hip replacement|1|||
164330676|NCT01298531|593588246|FG000|Overall Study|Lack of Efficacy|0|||
163882196|NCT02900924|591939283|FG000|Overall Study|Missed Visit|33|||
163986724|NCT03529773|592320201|FG008|Overall Study|Physician Decision|0|||
164225642|NCT04349098|593194136|FG001|Overall Study|Death|8|||
164225643|NCT04349098|593194135|FG000|Overall Study|Lost to Follow-up|11|||
164225644|NCT04349098|593194136|FG001|Overall Study|Lost to Follow-up|8|||
164330677|NCT01298531|593588247|FG001|Overall Study|Lack of Efficacy|1|||
164330678|NCT01298531|593588246|FG000|Overall Study|Lost to Follow-up|2|||
164225645|NCT04349098|593194135|FG000|Overall Study|Withdrawal by Subject|8|||
164225646|NCT04349098|593194136|FG001|Overall Study|Withdrawal by Subject|5|||
164225647|NCT04349098|593194135|FG000|Overall Study|Other|3|||
164225648|NCT04349098|593194136|FG001|Overall Study|Other|5|||
164225649|NCT00800384|593194137|FG000|Overall Study|Withdrawal by Subject|24|||
164225650|NCT00800384|593194138|FG001|Overall Study|Withdrawal by Subject|17|||
164225651|NCT00800384|593194137|FG000|Overall Study|Lost to Follow-up|17|||
164225652|NCT00800384|593194138|FG001|Overall Study|Lost to Follow-up|26|||
164225653|NCT04280783|593196134|FG000|Overall Study|Family issues unrelated to the study.|1|||
164225654|NCT04280783|593196135|FG001|Overall Study|Family issues unrelated to the study.|0|||
164225655|NCT04280783|593196134|FG000|Overall Study|Withdrawal by Subject|0|||
164225656|NCT04280783|593196135|FG001|Overall Study|Withdrawal by Subject|1|||
164225657|NCT01394185|593196136|FG000|Overall Study|Withdrawal by Subject|2|||
164225658|NCT01394185|593196137|FG001|Overall Study|Withdrawal by Subject|0|||
164081706|NCT03567057|592663307|FG002|Overall Study|Other|1|||
164081707|NCT01271933|592663308|FG000|Single-Blind Phase|Lack of Efficacy|37|||
164081708|NCT01271933|592663309|FG001|Single-Blind Phase|Lack of Efficacy|0|||
164081709|NCT01271933|592663310|FG002|Single-Blind Phase|Lack of Efficacy|0|||
164081710|NCT01271933|592663308|FG000|Single-Blind Phase|Lost to Follow-up|10|||
164081711|NCT01271933|592663309|FG001|Single-Blind Phase|Lost to Follow-up|0|||
164081712|NCT01271933|592663310|FG002|Single-Blind Phase|Lost to Follow-up|0|||
164081713|NCT01271933|592663308|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
164081714|NCT01271933|592663309|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
163882197|NCT03143153|591939284|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
163882198|NCT03143153|591939285|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
163882199|NCT03143153|591939286|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
163882200|NCT03143153|591939284|FG000|Pre-Treatment|Participant withdrew consent|0|||
163882201|NCT03143153|591939285|FG001|Pre-Treatment|Participant withdrew consent|1|||
163882202|NCT03143153|591939286|FG002|Pre-Treatment|Participant withdrew consent|12|||
163882203|NCT03143153|591939284|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
163882204|NCT03143153|591939285|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
163882205|NCT03143153|591939286|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
163882206|NCT03143153|591939284|FG000|Pre-Treatment|Other Reasons|1|||
163882207|NCT03143153|591939285|FG001|Pre-Treatment|Other Reasons|2|||
163882208|NCT03143153|591939286|FG002|Pre-Treatment|Other Reasons|1|||
163882209|NCT03143153|591939284|FG000|Pre-Treatment|Disease Progression|1|||
163882210|NCT03143153|591939285|FG001|Pre-Treatment|Disease Progression|1|||
163882211|NCT03143153|591939286|FG002|Pre-Treatment|Disease Progression|2|||
163882212|NCT03143153|591939284|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
163882213|NCT03143153|591939285|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
163882214|NCT03143153|591939286|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
163882215|NCT03143153|591939284|FG000|Treatment|Disease progression|174|||
163882216|NCT03143153|591939285|FG001|Treatment|Disease progression|184|||
163882217|NCT03143153|591939286|FG002|Treatment|Disease progression|193|||
163882218|NCT03143153|591939284|FG000|Treatment|Study drug toxicity|59|||
163882219|NCT03143153|591939285|FG001|Treatment|Study drug toxicity|33|||
163882220|NCT03143153|591939286|FG002|Treatment|Study drug toxicity|40|||
163882221|NCT03143153|591939284|FG000|Treatment|Death|5|||
163882222|NCT03143153|591939285|FG001|Treatment|Death|3|||
163882223|NCT03143153|591939286|FG002|Treatment|Death|4|||
164081715|NCT01271933|592663310|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
164081716|NCT01271933|592663308|FG000|Single-Blind Phase|Protocol Violation|3|||
164081717|NCT01271933|592663309|FG001|Single-Blind Phase|Protocol Violation|0|||
164081718|NCT01271933|592663310|FG002|Single-Blind Phase|Protocol Violation|0|||
164225659|NCT01394185|593196138|FG002|Overall Study|Withdrawal by Subject|0|||
164225660|NCT01394185|593196139|FG003|Overall Study|Withdrawal by Subject|0|||
164330679|NCT01298531|593588247|FG001|Overall Study|Lost to Follow-up|0|||
164330680|NCT01298531|593588246|FG000|Overall Study|Protocol Violation|1|||
164330681|NCT01298531|593588247|FG001|Overall Study|Protocol Violation|1|||
164330682|NCT01298531|593588246|FG000|Overall Study|Adverse Event|4|||
164330683|NCT01298531|593588247|FG001|Overall Study|Adverse Event|3|||
164330684|NCT01298531|593588246|FG000|Overall Study|Does not meet entrance criteria|0|||
163882224|NCT03143153|591939284|FG000|Treatment|Adverse event unrelated to study drug|19|||
163882225|NCT03143153|591939285|FG001|Treatment|Adverse event unrelated to study drug|28|||
163882226|NCT03143153|591939286|FG002|Treatment|Adverse event unrelated to study drug|12|||
163882227|NCT03143153|591939284|FG000|Treatment|Participant request to discontinue study treatment|13|||
164225661|NCT01394185|593196140|FG004|Overall Study|Withdrawal by Subject|1|||
164225662|NCT01394185|593196141|FG005|Overall Study|Withdrawal by Subject|0|||
164225663|NCT01394185|593196136|FG000|Overall Study|Change in protocol|3|||
164081719|NCT01271933|592663308|FG000|Single-Blind Phase|Adverse Event|52|||
164225664|NCT01394185|593196137|FG001|Overall Study|Change in protocol|0|||
164330685|NCT01298531|593588247|FG001|Overall Study|Does not meet entrance criteria|1|||
164330686|NCT01298531|593588246|FG000|Overall Study|Other|2|||
164330687|NCT01298531|593588247|FG001|Overall Study|Other|1|||
164081720|NCT01271933|592663309|FG001|Single-Blind Phase|Adverse Event|0|||
164081721|NCT01271933|592663310|FG002|Single-Blind Phase|Adverse Event|0|||
164225665|NCT01394185|593196138|FG002|Overall Study|Change in protocol|0|||
163882228|NCT03143153|591939285|FG001|Treatment|Participant request to discontinue study treatment|15|||
163882229|NCT03143153|591939286|FG002|Treatment|Participant request to discontinue study treatment|20|||
163882230|NCT03143153|591939284|FG000|Treatment|Participant withdrew consent|3|||
163882231|NCT03143153|591939285|FG001|Treatment|Participant withdrew consent|4|||
163882232|NCT03143153|591939286|FG002|Treatment|Participant withdrew consent|12|||
163882233|NCT03143153|591939284|FG000|Treatment|Pregnancy|1|||
163882234|NCT03143153|591939285|FG001|Treatment|Pregnancy|0|||
163882235|NCT03143153|591939286|FG002|Treatment|Pregnancy|0|||
163882236|NCT03143153|591939284|FG000|Treatment|Maximum clinical benefit|1|||
163882237|NCT03143153|591939285|FG001|Treatment|Maximum clinical benefit|3|||
163882238|NCT03143153|591939286|FG002|Treatment|Maximum clinical benefit|4|||
163882239|NCT03143153|591939284|FG000|Treatment|Completed treatment as per Protocol|13|||
163882240|NCT03143153|591939285|FG001|Treatment|Completed treatment as per Protocol|8|||
163882241|NCT03143153|591939286|FG002|Treatment|Completed treatment as per Protocol|0|||
163882242|NCT03143153|591939284|FG000|Treatment|Other reasons|12|||
163882243|NCT03143153|591939285|FG001|Treatment|Other reasons|7|||
163882244|NCT03143153|591939286|FG002|Treatment|Other reasons|15|||
163882245|NCT03143153|591939284|FG000|Treatment|Not reported|1|||
163882246|NCT03143153|591939285|FG001|Treatment|Not reported|0|||
163882247|NCT03143153|591939286|FG002|Treatment|Not reported|0|||
163882248|NCT02736409|591939292|FG000|Overall Study|Withdrawal by Subject|4|||
163882249|NCT02736409|591939293|FG001|Overall Study|Withdrawal by Subject|2|||
163882250|NCT02736409|591939294|FG002|Overall Study|Withdrawal by Subject|17|||
163882251|NCT02736409|591939295|FG003|Overall Study|Withdrawal by Subject|3|||
163882252|NCT02736409|591939292|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163882253|NCT02736409|591939293|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163882254|NCT02736409|591939294|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163882255|NCT02736409|591939295|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163882256|NCT02736409|591939292|FG000|Overall Study|Adverse Event|0|||
163882257|NCT02736409|591939293|FG001|Overall Study|Adverse Event|1|||
163882258|NCT02736409|591939294|FG002|Overall Study|Adverse Event|5|||
163882259|NCT02736409|591939295|FG003|Overall Study|Adverse Event|4|||
163882260|NCT02736409|591939292|FG000|Overall Study|Other|0|||
163882261|NCT02736409|591939293|FG001|Overall Study|Other|0|||
163882262|NCT02736409|591939294|FG002|Overall Study|Other|1|||
163882263|NCT02736409|591939295|FG003|Overall Study|Other|1|||
163882264|NCT02736409|591939292|FG000|Overall Study|Pregnancy|0|||
163882265|NCT02736409|591939293|FG001|Overall Study|Pregnancy|0|||
163882266|NCT02736409|591939294|FG002|Overall Study|Pregnancy|1|||
163882267|NCT02736409|591939295|FG003|Overall Study|Pregnancy|0|||
163882268|NCT02736409|591939292|FG000|Overall Study|Lost to Follow-up|0|||
163882269|NCT02736409|591939293|FG001|Overall Study|Lost to Follow-up|0|||
163882270|NCT02736409|591939294|FG002|Overall Study|Lost to Follow-up|2|||
163882271|NCT02736409|591939295|FG003|Overall Study|Lost to Follow-up|1|||
163882272|NCT02736409|591939292|FG000|Overall Study|Physician Decision|0|||
163882273|NCT02736409|591939293|FG001|Overall Study|Physician Decision|0|||
163882274|NCT02736409|591939294|FG002|Overall Study|Physician Decision|0|||
163882275|NCT02736409|591939295|FG003|Overall Study|Physician Decision|2|||
163882276|NCT01415154|591939296|FG000|Overall Study|Lack of Efficacy|4|||
163882277|NCT01415154|591939297|FG001|Overall Study|Lack of Efficacy|5|||
163882278|NCT01415154|591939296|FG000|Overall Study|Withdrawal by Subject|7|||
163882279|NCT01415154|591939297|FG001|Overall Study|Withdrawal by Subject|8|||
163882280|NCT01415154|591939296|FG000|Overall Study|Lost to Follow-up|1|||
163882281|NCT01415154|591939297|FG001|Overall Study|Lost to Follow-up|4|||
163882282|NCT01415154|591939296|FG000|Overall Study|Protocol Violation|0|||
163882283|NCT01415154|591939297|FG001|Overall Study|Protocol Violation|1|||
163882284|NCT01415154|591939296|FG000|Overall Study|Satisfactory Response|0|||
163882285|NCT01415154|591939297|FG001|Overall Study|Satisfactory Response|1|||
163882286|NCT01415154|591939296|FG000|Overall Study|Adverse Event|1|||
163882287|NCT01415154|591939297|FG001|Overall Study|Adverse Event|1|||
163882288|NCT04382404|591939318|FG000|Overall Study|Adverse Event|1|||
163882289|NCT04382404|591939318|FG000|Overall Study|Lost to Follow-up|2|||
164225666|NCT01394185|593196139|FG003|Overall Study|Change in protocol|0|||
164225667|NCT01394185|593196140|FG004|Overall Study|Change in protocol|3|||
163882290|NCT01580488|591939322|FG000|Overall Study|Withdrawal by Subject|1|||
163882291|NCT03792256|591939324|FG000|Overall Study|Death|0|||
163882292|NCT03792256|591939325|FG001|Overall Study|Death|1|||
163882293|NCT03792256|591939324|FG000|Overall Study|Lack of Efficacy|0|||
164225668|NCT01394185|593196141|FG005|Overall Study|Change in protocol|0|||
163882294|NCT03792256|591939325|FG001|Overall Study|Lack of Efficacy|1|||
163882295|NCT03792256|591939324|FG000|Overall Study|Withdrawal by Subject|0|||
163882296|NCT03792256|591939325|FG001|Overall Study|Withdrawal by Subject|1|||
163882297|NCT04562649|591939330|FG000|Overall Study|Withdrawal by Subject|11|||
163882298|NCT04562649|591939331|FG001|Overall Study|Withdrawal by Subject|8|||
163882299|NCT04562649|591939330|FG000|Overall Study|Lost to Follow-up|26|||
163882300|NCT04562649|591939331|FG001|Overall Study|Lost to Follow-up|20|||
163882301|NCT05368103|591939332|FG000|Overall Study|Withdrawal by Subject|4|||
164225669|NCT01394185|593196136|FG000|Overall Study|Protocol Violation|1|||
163986725|NCT03529773|592320202|FG009|Overall Study|Physician Decision|0|||
163986726|NCT03529773|592320203|FG010|Overall Study|Physician Decision|0|||
163986727|NCT03529773|592320204|FG011|Overall Study|Physician Decision|0|||
163986728|NCT03529773|592320205|FG012|Overall Study|Physician Decision|0|||
163986729|NCT03529773|592320206|FG013|Overall Study|Physician Decision|0|||
163986730|NCT03529773|592320207|FG014|Overall Study|Physician Decision|0|||
163986731|NCT03529773|592320208|FG015|Overall Study|Physician Decision|0|||
163986732|NCT03529773|592320209|FG016|Overall Study|Physician Decision|0|||
163986733|NCT03529773|592320210|FG017|Overall Study|Physician Decision|0|||
163986734|NCT03529773|592320211|FG018|Overall Study|Physician Decision|0|||
163986735|NCT03529773|592320212|FG019|Overall Study|Physician Decision|1|||
163986736|NCT03529773|592320213|FG020|Overall Study|Physician Decision|1|||
163986737|NCT03529773|592320214|FG021|Overall Study|Physician Decision|0|||
163986738|NCT03529773|592320215|FG022|Overall Study|Physician Decision|0|||
163986739|NCT03529773|592320216|FG023|Overall Study|Physician Decision|0|||
163986740|NCT03529773|592320217|FG024|Overall Study|Physician Decision|0|||
163986741|NCT03529773|592320218|FG025|Overall Study|Physician Decision|0|||
164225670|NCT01394185|593196137|FG001|Overall Study|Protocol Violation|0|||
164225671|NCT01394185|593196138|FG002|Overall Study|Protocol Violation|0|||
164225672|NCT01394185|593196139|FG003|Overall Study|Protocol Violation|1|||
164225673|NCT01394185|593196140|FG004|Overall Study|Protocol Violation|0|||
164225674|NCT01394185|593196141|FG005|Overall Study|Protocol Violation|1|||
164225675|NCT02254460|593196142|FG000|Overall Study|Adverse Event|1|||
164225676|NCT02254460|593196143|FG001|Overall Study|Adverse Event|0|||
164225677|NCT01050218|593196144|FG000|Overall Study|Adverse Event|37|||
164225678|NCT01050218|593196144|FG000|Overall Study|Lack of Efficacy|8|||
164225679|NCT01050218|593196144|FG000|Overall Study|Protocol Violation|3|||
164225680|NCT01050218|593196144|FG000|Overall Study|Withdrawal by Subject|18|||
164225681|NCT01050218|593196144|FG000|Overall Study|Discontinued by sponsor|18|||
164225682|NCT01050218|593196144|FG000|Overall Study|Compliance|2|||
164225683|NCT01050218|593196144|FG000|Overall Study|Failed to return|7|||
164225684|NCT01050218|593196144|FG000|Overall Study|Serious Adverse Event|1|||
164225685|NCT01050218|593196144|FG000|Overall Study|Family emergency|1|||
164225686|NCT02336555|593196145|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
164225687|NCT02336555|593196146|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
164225688|NCT02336555|593196145|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
164225689|NCT02336555|593196146|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
164225690|NCT02336555|593196145|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
164225691|NCT02336555|593196146|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
164225692|NCT01959919|593196147|FG000|Overall Study|Did not meet the eligibility criteria|2|||
164225693|NCT01537432|593196149|FG000|Overall Study|Lost to Follow-up|3|||
164225694|NCT01537432|593196150|FG001|Overall Study|Lost to Follow-up|1|||
164225695|NCT01537432|593196149|FG000|Overall Study|Withdrawal by Subject|0|||
164225696|NCT01537432|593196150|FG001|Overall Study|Withdrawal by Subject|1|||
164225697|NCT01537432|593196149|FG000|Overall Study|Administrative problems|1|||
164225698|NCT01537432|593196150|FG001|Overall Study|Administrative problems|0|||
164225699|NCT01537432|593196149|FG000|Overall Study|Adverse Event|1|||
164225700|NCT01537432|593196150|FG001|Overall Study|Adverse Event|0|||
164225701|NCT01537432|593196149|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164225702|NCT01537432|593196150|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164225703|NCT03682367|593196153|FG000|Overall Study|Protocol Violation|2|||
164225704|NCT03682367|593196154|FG001|Overall Study|Protocol Violation|1|||
164225705|NCT03682367|593196153|FG000|Overall Study|Closed Study Early|0|||
164225706|NCT03682367|593196154|FG001|Overall Study|Closed Study Early|3|||
164225707|NCT05166902|593196155|FG000|First Intervention|Lost to Follow-up|0|||
164225708|NCT05166902|593196156|FG001|First Intervention|Lost to Follow-up|1|||
164225709|NCT01550965|593196165|FG000|Overall Study|Adverse Event|26|||
164225710|NCT01550965|593196165|FG000|Overall Study|Withdrawal by Subject|10|||
164225711|NCT01550965|593196165|FG000|Overall Study|Lost to Follow-up|2|||
164225712|NCT01550965|593196165|FG000|Overall Study|Lack of Efficacy|59|||
163986742|NCT03529773|592320219|FG026|Overall Study|Physician Decision|0|||
163986743|NCT03529773|592320220|FG027|Overall Study|Physician Decision|0|||
163986744|NCT03529773|592320221|FG028|Overall Study|Physician Decision|0|||
164225713|NCT01550965|593196165|FG000|Overall Study|Other|13|||
164225714|NCT00160563|593196168|FG000|Overall Study|Adverse Event|1|||
164225715|NCT00160563|593196169|FG001|Overall Study|Adverse Event|1|||
164225716|NCT00160563|593196170|FG002|Overall Study|Adverse Event|1|||
164225717|NCT00160563|593196168|FG000|Overall Study|Lost to Follow-up|1|||
164225718|NCT00160563|593196169|FG001|Overall Study|Lost to Follow-up|1|||
164225719|NCT00160563|593196170|FG002|Overall Study|Lost to Follow-up|2|||
164225720|NCT00160563|593196168|FG000|Overall Study|Protocol Violation|0|||
163986745|NCT03529773|592320222|FG029|Overall Study|Physician Decision|0|||
163986746|NCT03529773|592320223|FG030|Overall Study|Physician Decision|0|||
163986747|NCT03529773|592320224|FG031|Overall Study|Physician Decision|0|||
163986748|NCT03529773|592320225|FG032|Overall Study|Physician Decision|0|||
164330688|NCT00422097|593588248|FG000|Dose Level 2|Still on treatment|0|||
164330689|NCT00422097|593588249|FG001|Dose Level 2|Still on treatment|1|||
164330690|NCT00422097|593588250|FG002|Dose Level 2|Still on treatment|0|||
164225721|NCT00160563|593196169|FG001|Overall Study|Protocol Violation|0|||
164225722|NCT00160563|593196170|FG002|Overall Study|Protocol Violation|3|||
164225723|NCT00160563|593196168|FG000|Overall Study|Withdrawal by Subject|1|||
164225724|NCT00160563|593196169|FG001|Overall Study|Withdrawal by Subject|2|||
164225725|NCT00160563|593196170|FG002|Overall Study|Withdrawal by Subject|3|||
164225726|NCT00160563|593196168|FG000|Overall Study|Other (listed in the study report)|48|||
164225727|NCT00160563|593196169|FG001|Overall Study|Other (listed in the study report)|40|||
164225728|NCT00160563|593196170|FG002|Overall Study|Other (listed in the study report)|81|||
164225729|NCT00160563|593196168|FG000|Overall Study|Missing reason|0|||
164225730|NCT00160563|593196169|FG001|Overall Study|Missing reason|1|||
164225731|NCT00160563|593196170|FG002|Overall Study|Missing reason|0|||
164225732|NCT00309946|593196171|FG000|Overall Study|Withdrawal by Subject|1|||
164225733|NCT01347086|593196175|FG000|Overall Study|failed screening visit|0|||
164225734|NCT01347086|593196176|FG001|Overall Study|failed screening visit|0|||
164225735|NCT01347086|593196177|FG002|Overall Study|failed screening visit|1|||
164225736|NCT01347086|593196178|FG003|Overall Study|failed screening visit|0|||
164225737|NCT01347086|593196179|FG004|Overall Study|failed screening visit|0|||
164225738|NCT01347086|593196180|FG005|Overall Study|failed screening visit|0|||
164225739|NCT01347086|593196181|FG006|Overall Study|failed screening visit|1|||
164225740|NCT01347086|593196182|FG007|Overall Study|failed screening visit|1|||
164225741|NCT01347086|593196183|FG008|Overall Study|failed screening visit|0|||
164225742|NCT01347086|593196184|FG009|Overall Study|failed screening visit|1|||
164225743|NCT03111108|593196186|FG000|Overall Study|Death|0|||
164330691|NCT00422097|593588251|FG003|Dose Level 2|Still on treatment|0|||
164330692|NCT00422097|593588252|FG004|Dose Level 2|Still on treatment|0|||
164330693|NCT00422097|593588253|FG005|Dose Level 2|Still on treatment|0|||
164330694|NCT00422097|593588254|FG006|Dose Level 2|Still on treatment|0|||
164330695|NCT00422097|593588255|FG007|Dose Level 2|Still on treatment|0|||
164330696|NCT02360995|593588256|FG000|Overall Study|Lost to Follow-up|2|||
164330697|NCT02360995|593588257|FG001|Overall Study|Lost to Follow-up|0|||
164330698|NCT02360995|593588258|FG002|Overall Study|Lost to Follow-up|2|||
164330699|NCT02360995|593588256|FG000|Overall Study|Withdrawal by Subject|0|||
164330700|NCT02360995|593588257|FG001|Overall Study|Withdrawal by Subject|1|||
164330701|NCT02360995|593588258|FG002|Overall Study|Withdrawal by Subject|0|||
164330702|NCT02476422|593588259|FG000|Overall Study|Subject/guardian decision|0|||
164330703|NCT02476422|593588260|FG001|Overall Study|Subject/guardian decision|1|||
164330704|NCT03960554|593588266|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
164330705|NCT03960554|593588267|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
164330706|NCT02545075|593588268|FG000|Randomization|Lost to Follow-up|0|||
164330707|NCT02545075|593588269|FG001|Randomization|Lost to Follow-up|1|||
164330708|NCT02545075|593588268|FG000|Randomization|Withdrawal by Subject|0|||
164330709|NCT02545075|593588269|FG001|Randomization|Withdrawal by Subject|6|||
164330710|NCT02545075|593588268|FG000|Treatment|Disease progression|71|||
164330711|NCT02545075|593588269|FG001|Treatment|Disease progression|32|||
164330712|NCT02545075|593588268|FG000|Treatment|Participant dicontinued study treatment|7|||
163882302|NCT05368103|591939332|FG000|Overall Study|Lost to Follow-up|1|||
164081722|NCT01271933|592663308|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
164225744|NCT03111108|593196187|FG001|Overall Study|Death|1|||
164225745|NCT03111108|593196186|FG000|Overall Study|Withdrawal by Subject|1|||
164225746|NCT03111108|593196187|FG001|Overall Study|Withdrawal by Subject|0|||
164225747|NCT01514357|593196188|FG000|Overall Study|Screen failure|2|||
164225748|NCT01514357|593196189|FG001|Overall Study|Screen failure|0|||
164330713|NCT02545075|593588269|FG001|Treatment|Participant dicontinued study treatment|9|||
164330714|NCT02545075|593588268|FG000|Treatment|Withdrawal by Subject|1|||
164330715|NCT02545075|593588269|FG001|Treatment|Withdrawal by Subject|0|||
164330716|NCT02545075|593588268|FG000|Treatment|Adverse event not related to study drug|1|||
164330717|NCT02545075|593588269|FG001|Treatment|Adverse event not related to study drug|0|||
164330718|NCT02545075|593588268|FG000|Treatment|Death|1|||
163882303|NCT05368103|591939332|FG000|Overall Study|Lack of Efficacy|3|||
163882304|NCT05784662|591939338|FG000|Overall Study|Lost to Follow-up|21|||
163882305|NCT05784662|591939339|FG001|Overall Study|Lost to Follow-up|17|||
163882306|NCT02913872|591939347|FG000|Overall Study|Withdrawal by Subject|1|||
163882307|NCT04739956|591939350|FG000|Overall Study|Withdrawal by Subject|1|||
163882308|NCT04739956|591939351|FG001|Overall Study|Withdrawal by Subject|1|||
163882309|NCT03920111|591939352|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
163882310|NCT03920111|591939353|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
163882311|NCT03920111|591939354|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
163882312|NCT05177848|591939357|FG000|Overall Study|Lost to Follow-up|1|||
163882313|NCT05177848|591939358|FG001|Overall Study|Lost to Follow-up|4|||
163882314|NCT05177848|591939357|FG000|Overall Study|Discontinued|2|||
163882315|NCT05177848|591939358|FG001|Overall Study|Discontinued|1|||
163882316|NCT06414213|591939359|FG000|Overall Study|Lost to Follow-up|1|||
163882317|NCT06414213|591939360|FG001|Overall Study|Lost to Follow-up|1|||
163882318|NCT06414213|591939361|FG002|Overall Study|Lost to Follow-up|3|||
163882319|NCT03110315|591939362|FG000|Overall Study|Withdrawal by Subject|1|||
163882320|NCT03110315|591939363|FG001|Overall Study|Withdrawal by Subject|0|||
163882321|NCT05256706|591939367|FG000|Overall Study|Lost to Follow-up|9|||
163882322|NCT05256706|591939368|FG001|Overall Study|Lost to Follow-up|3|||
163882323|NCT05256706|591939367|FG000|Overall Study|Withdrawal by Subject|7|||
163882324|NCT05256706|591939368|FG001|Overall Study|Withdrawal by Subject|11|||
163882325|NCT05256706|591939367|FG000|Overall Study|Screen Failures|3|||
164225749|NCT01514357|593196188|FG000|Overall Study|Withdrawal by Subject|2|||
164225750|NCT01514357|593196189|FG001|Overall Study|Withdrawal by Subject|0|||
163882326|NCT05256706|591939368|FG001|Overall Study|Screen Failures|0|||
163882327|NCT03720795|591939370|FG000|Phase 1|Lost to Follow-up|4|||
163882328|NCT03720795|591939370|FG000|Phase 1|Withdrawal by Subject|6|||
163882329|NCT03720795|591939370|FG000|Phase 1|Protocol Violation|1|||
163882330|NCT03720795|591939370|FG000|Phase 1|Other|1|||
163882331|NCT03720795|591939370|FG000|Phase 2|Lost to Follow-up|5|||
163882332|NCT03720795|591939370|FG000|Phase 2|Withdrawal by Subject|10|||
163882333|NCT03720795|591939370|FG000|Phase 2|Protocol Violation|2|||
163882334|NCT03720795|591939370|FG000|3 Month Follow Up|Lost to Follow-up|2|||
163882335|NCT01573442|591939373|FG000|Overall Study|Cancels|9|||
163882336|NCT01573442|591939374|FG001|Overall Study|Cancels|10|||
163882337|NCT04763265|591939380|FG000|Overall Study|Adverse Event|1|||
163882338|NCT04763265|591939381|FG001|Overall Study|Adverse Event|0|||
163882339|NCT04763265|591939380|FG000|Overall Study|Lost to Follow-up|2|||
163882340|NCT04763265|591939381|FG001|Overall Study|Lost to Follow-up|4|||
163882341|NCT04763265|591939380|FG000|Overall Study|Withdrawal by Subject|0|||
163882342|NCT04763265|591939381|FG001|Overall Study|Withdrawal by Subject|1|||
163882343|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Other|0|||
163882344|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Other|0|||
163882345|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Other|0|||
163882346|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Other|0|||
163882347|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Other|0|||
163882348|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Other|0|||
163882349|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Other|0|||
163882350|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Other|0|||
163882351|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Other|0|||
163882352|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Other|0|||
163882353|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Other|1|||
163882354|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Other|1|||
163882355|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Other|1|||
163882356|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Other|0|||
163882357|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Other|3|||
163882358|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Other|1|||
163882359|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Other|1|||
163882360|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Other|0|||
163882361|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882362|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882363|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882364|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882365|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882366|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
164225751|NCT04691115|593196190|FG000|Overall Study|Withdrawal by Subject|0|||
164225752|NCT04691115|593196191|FG001|Overall Study|Withdrawal by Subject|0|||
164225753|NCT04691115|593196192|FG002|Overall Study|Withdrawal by Subject|0|||
164225754|NCT04691115|593196193|FG003|Overall Study|Withdrawal by Subject|0|||
164225755|NCT04691115|593196194|FG004|Overall Study|Withdrawal by Subject|0|||
164225756|NCT04691115|593196195|FG005|Overall Study|Withdrawal by Subject|1|||
164225757|NCT04691115|593196196|FG006|Overall Study|Withdrawal by Subject|0|||
164225758|NCT04691115|593196197|FG007|Overall Study|Withdrawal by Subject|0|||
164225759|NCT04691115|593196198|FG008|Overall Study|Withdrawal by Subject|0|||
164225760|NCT04691115|593196199|FG009|Overall Study|Withdrawal by Subject|0|||
163882367|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
163882368|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
164225761|NCT04691115|593196200|FG010|Overall Study|Withdrawal by Subject|0|||
164225762|NCT04691115|593196201|FG011|Overall Study|Withdrawal by Subject|0|||
164225763|NCT04691115|593196202|FG012|Overall Study|Withdrawal by Subject|0|||
164225764|NCT04691115|593196203|FG013|Overall Study|Withdrawal by Subject|0|||
164225765|NCT00830336|593196207|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
164225766|NCT00830336|593196208|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
164225767|NCT00867334|593196209|FG000|Overall Study|Withdrawal by Subject|0|||
164225768|NCT00867334|593196210|FG001|Overall Study|Withdrawal by Subject|1|||
163882369|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
163882370|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882371|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882372|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882373|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
163882374|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882375|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882376|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882377|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882378|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
163882379|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882380|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882381|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882382|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882383|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882384|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882385|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882386|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
163882387|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882388|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882389|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882390|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882391|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882392|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882393|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882394|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882395|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882396|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
163882397|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882398|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882399|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882400|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882401|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882402|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882403|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882404|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882405|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882406|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
163882407|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882408|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882409|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882410|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882411|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882412|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882413|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882414|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
163882415|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Death|0|||
163882416|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Death|0|||
163882417|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Death|0|||
163882418|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Death|0|||
163882419|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Death|0|||
163882420|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Death|0|||
163882421|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Death|0|||
163882422|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Death|0|||
163882423|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Death|0|||
163882424|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Death|1|||
163986749|NCT03529773|592320226|FG033|Overall Study|Physician Decision|0|||
164225769|NCT00867334|593196209|FG000|Overall Study|Withdrawal by Subject|1|||
163882425|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Death|0|||
163882426|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Death|1|||
163882427|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Death|0|||
164225770|NCT00867334|593196210|FG001|Overall Study|Withdrawal by Subject|0|||
164225771|NCT00867334|593196209|FG000|Overall Study|Withdrawal by Subject|1|||
164225772|NCT00867334|593196210|FG001|Overall Study|Withdrawal by Subject|0|||
164225773|NCT01148771|593196211|FG000|Washout Period|Withdrawal by Subject|0|||
164225774|NCT01148771|593196212|FG001|Washout Period|Withdrawal by Subject|1|||
164225775|NCT01437189|593196217|FG000|Overall Study|Adverse Event|3|||
164225776|NCT01437189|593196217|FG000|Overall Study|Lack of Efficacy|4|||
164225777|NCT01437189|593196217|FG000|Overall Study|Withdrawal by Subject|8|||
164330719|NCT02545075|593588269|FG001|Treatment|Death|0|||
164330720|NCT02545075|593588268|FG000|Treatment|Participant drug toxicity|1|||
164330721|NCT02545075|593588269|FG001|Treatment|Participant drug toxicity|0|||
164330722|NCT02545075|593588268|FG000|Treatment|Completed treatment|40|||
164330723|NCT02545075|593588269|FG001|Treatment|Completed treatment|12|||
164225778|NCT00347269|593196218|FG000|Overall Study|Lost to Follow-up|74|||
164330724|NCT00735254|593588274|FG000|Overall Study|Protocol Violation|1|||
164330725|NCT00735254|593588275|FG001|Overall Study|Protocol Violation|1|||
164330726|NCT00735254|593588276|FG002|Overall Study|Protocol Violation|1|||
164330727|NCT00735254|593588277|FG003|Overall Study|Protocol Violation|0|||
164330728|NCT06400979|593588278|FG000|Overall Study|Lost to Follow-up|29|||
164330729|NCT06400979|593588278|FG000|Overall Study|Withdrawal by Subject|1|||
164330730|NCT00925990|593588283|FG000|Overall Study|Adverse Event|1|||
164330731|NCT00925990|593588284|FG001|Overall Study|Adverse Event|3|||
164330732|NCT00925990|593588283|FG000|Overall Study|Withdrawal by Subject|2|||
164330733|NCT00925990|593588284|FG001|Overall Study|Withdrawal by Subject|2|||
164330734|NCT00925990|593588283|FG000|Overall Study|Lost to Follow-up|1|||
164330735|NCT00925990|593588284|FG001|Overall Study|Lost to Follow-up|3|||
164330736|NCT00925990|593588283|FG000|Overall Study|Physician Decision|1|||
164330737|NCT00925990|593588284|FG001|Overall Study|Physician Decision|1|||
164330738|NCT00925990|593588283|FG000|Overall Study|moved out of state, missed medication|0|||
164330739|NCT00925990|593588284|FG001|Overall Study|moved out of state, missed medication|2|||
164330740|NCT00750880|593588288|FG000|Overall Study|Adverse Event|76|||
164330741|NCT00750880|593588288|FG000|Overall Study|Death|4|||
164330742|NCT00750880|593588288|FG000|Overall Study|Lack of Efficacy|46|||
164225779|NCT00347269|593196219|FG001|Overall Study|Lost to Follow-up|65|||
164225780|NCT00347269|593196218|FG000|Overall Study|Withdrawal by Subject|18|||
164225781|NCT00347269|593196219|FG001|Overall Study|Withdrawal by Subject|38|||
164225782|NCT00347269|593196218|FG000|Overall Study|Death|2|||
164225783|NCT00347269|593196219|FG001|Overall Study|Death|3|||
164225784|NCT00835549|593196220|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
164225785|NCT00835549|593196221|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164225786|NCT03268499|593196222|FG000|Overall Study|Withdrawal by Subject|2|||
164225787|NCT03268499|593196223|FG001|Overall Study|Withdrawal by Subject|1|||
164225788|NCT04064567|593196228|FG000|Overall Study|Lost to Follow-up|23|||
164225789|NCT04064567|593196229|FG001|Overall Study|Lost to Follow-up|22|||
164225790|NCT04064567|593196228|FG000|Overall Study|Withdrawal by Subject|0|||
164225791|NCT04064567|593196229|FG001|Overall Study|Withdrawal by Subject|1|||
164225792|NCT04064567|593196228|FG000|Overall Study|Reincarcerated|7|||
164225793|NCT04064567|593196229|FG001|Overall Study|Reincarcerated|10|||
164225794|NCT04064567|593196228|FG000|Overall Study|Moved out of U.S.|0|||
164225795|NCT04064567|593196229|FG001|Overall Study|Moved out of U.S.|1|||
164225796|NCT03464461|593196232|FG000|Overall Study|exclusionary medication given ,|1|||
164330743|NCT00750880|593588288|FG000|Overall Study|Lost to Follow-up|10|||
164330744|NCT00750880|593588288|FG000|Overall Study|Protocol Violation|15|||
164330745|NCT00750880|593588288|FG000|Overall Study|Withdrawal by Subject|33|||
164330746|NCT00750880|593588288|FG000|Overall Study|Physician Decision|20|||
164330747|NCT00750880|593588288|FG000|Overall Study|Administrative|11|||
164330748|NCT00249288|593588294|FG000|Overall Study|Lost to Follow-up|3|||
164330749|NCT00249288|593588295|FG001|Overall Study|Lost to Follow-up|3|||
164330750|NCT00249288|593588294|FG000|Overall Study|Withdrawal by Subject|2|||
164330751|NCT00249288|593588295|FG001|Overall Study|Withdrawal by Subject|2|||
164225797|NCT03464461|593196233|FG001|Overall Study|exclusionary medication given ,|2|||
164225798|NCT03464461|593196234|FG002|Overall Study|exclusionary medication given ,|0|||
164225799|NCT03464461|593196232|FG000|Overall Study|Physician Decision|0|||
164225800|NCT03464461|593196233|FG001|Overall Study|Physician Decision|1|||
164225801|NCT03464461|593196234|FG002|Overall Study|Physician Decision|0|||
164225802|NCT05524948|593196235|FG000|Overall Study|Withdrawal by Subject|1|||
164225803|NCT05524948|593196236|FG001|Overall Study|Withdrawal by Subject|0|||
164225804|NCT05524948|593196235|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
164225805|NCT05524948|593196236|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
164225806|NCT03460704|593196239|FG000|Overall Study|Withdrawal by Subject|11|||
164330752|NCT03091777|593588296|FG000|Overall Study|Pregnancy|2|||
164330753|NCT03091777|593588297|FG001|Overall Study|Pregnancy|1|||
164225807|NCT03460704|593196240|FG001|Overall Study|Withdrawal by Subject|14|||
164225808|NCT03460704|593196239|FG000|Overall Study|Study terminated by the Sponsor|29|||
164225809|NCT03460704|593196240|FG001|Overall Study|Study terminated by the Sponsor|19|||
164330754|NCT03091777|593588298|FG002|Overall Study|Pregnancy|0|||
164330755|NCT03091777|593588296|FG000|Overall Study|Adverse Event|2|||
164330756|NCT03091777|593588297|FG001|Overall Study|Adverse Event|1|||
164330757|NCT03091777|593588298|FG002|Overall Study|Adverse Event|4|||
164330758|NCT03091777|593588296|FG000|Overall Study|Withdrawal by Subject|4|||
164225810|NCT03460704|593196239|FG000|Overall Study|Adverse Event|10|||
164225811|NCT03460704|593196240|FG001|Overall Study|Adverse Event|5|||
164225812|NCT03460704|593196239|FG000|Overall Study|Death|3|||
164225813|NCT03460704|593196240|FG001|Overall Study|Death|2|||
164225814|NCT03460704|593196239|FG000|Overall Study|Non-Compliance with Study Drug|3|||
164225815|NCT03460704|593196240|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164225816|NCT03460704|593196239|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164225817|NCT03460704|593196240|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
164225818|NCT03460704|593196239|FG000|Overall Study|Other|2|||
164225819|NCT03460704|593196240|FG001|Overall Study|Other|1|||
164225820|NCT02913326|593196241|FG000|Overall Study|Reason not listed|0|||
164225821|NCT02913326|593196242|FG001|Overall Study|Reason not listed|1|||
164225822|NCT02913326|593196241|FG000|Overall Study|Lost to Follow-up|0|||
164225823|NCT02913326|593196242|FG001|Overall Study|Lost to Follow-up|1|||
164225824|NCT02913326|593196241|FG000|Overall Study|Adverse Event|1|||
164225825|NCT02913326|593196242|FG001|Overall Study|Adverse Event|0|||
164225826|NCT01767857|593196243|FG000|Overall Study|Adverse Event|27|||
164225827|NCT01767857|593196244|FG001|Overall Study|Adverse Event|7|||
164225828|NCT01767857|593196243|FG000|Overall Study|Death|28|||
164225829|NCT01767857|593196244|FG001|Overall Study|Death|13|||
164225830|NCT01767857|593196243|FG000|Overall Study|Lack of Efficacy|299|||
164225831|NCT01767857|593196244|FG001|Overall Study|Lack of Efficacy|151|||
164225832|NCT01767857|593196243|FG000|Overall Study|Lost to Follow-up|1|||
164225833|NCT01767857|593196244|FG001|Overall Study|Lost to Follow-up|1|||
164225834|NCT01767857|593196243|FG000|Overall Study|Withdrawal by Subject|38|||
164225835|NCT01767857|593196244|FG001|Overall Study|Withdrawal by Subject|18|||
164225836|NCT01767857|593196243|FG000|Overall Study|Physician Decision|17|||
164225837|NCT01767857|593196244|FG001|Overall Study|Physician Decision|10|||
164225838|NCT01767857|593196243|FG000|Overall Study|Protocol Terminated|1|||
164225839|NCT01767857|593196244|FG001|Overall Study|Protocol Terminated|0|||
164225840|NCT01767857|593196243|FG000|Overall Study|Randomized But Never Treated|19|||
164225841|NCT01767857|593196244|FG001|Overall Study|Randomized But Never Treated|13|||
164225842|NCT01421459|593196245|FG000|Overall Study|Adverse Event|6|||
164225843|NCT01421459|593196246|FG001|Overall Study|Adverse Event|10|||
164225844|NCT01421459|593196245|FG000|Overall Study|Death|1|||
164225845|NCT01421459|593196246|FG001|Overall Study|Death|1|||
164225846|NCT01421459|593196245|FG000|Overall Study|Lack of Efficacy|1|||
164225847|NCT01421459|593196246|FG001|Overall Study|Lack of Efficacy|2|||
164225848|NCT01421459|593196245|FG000|Overall Study|Lost to Follow-up|8|||
164225849|NCT01421459|593196246|FG001|Overall Study|Lost to Follow-up|9|||
164225850|NCT01421459|593196245|FG000|Overall Study|Physician Decision|9|||
164225851|NCT01421459|593196246|FG001|Overall Study|Physician Decision|9|||
164225852|NCT01421459|593196245|FG000|Overall Study|Protocol Violation|8|||
164225853|NCT01421459|593196246|FG001|Overall Study|Protocol Violation|5|||
164225854|NCT01421459|593196245|FG000|Overall Study|Withdrawal by Subject|12|||
164225855|NCT01421459|593196246|FG001|Overall Study|Withdrawal by Subject|16|||
164330759|NCT03091777|593588297|FG001|Overall Study|Withdrawal by Subject|2|||
164330760|NCT03091777|593588298|FG002|Overall Study|Withdrawal by Subject|6|||
164330761|NCT03091777|593588296|FG000|Overall Study|Protocol Violation|2|||
164330762|NCT03091777|593588297|FG001|Overall Study|Protocol Violation|1|||
164330763|NCT03091777|593588298|FG002|Overall Study|Protocol Violation|1|||
164330764|NCT03091777|593588296|FG000|Overall Study|Lost to Follow-up|12|||
164330765|NCT03091777|593588297|FG001|Overall Study|Lost to Follow-up|14|||
164225856|NCT02899754|593196247|FG000|Overall Study|Lost to Follow-up|7|||
164225857|NCT02899754|593196248|FG001|Overall Study|Lost to Follow-up|9|||
164225858|NCT04818229|593196249|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
164225859|NCT04818229|593196250|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
164225860|NCT04818229|593196251|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
164225861|NCT04818229|593196249|FG000|Overall Study|Adverse Event|3|||
164225862|NCT04818229|593196250|FG001|Overall Study|Adverse Event|1|||
164225863|NCT04818229|593196251|FG002|Overall Study|Adverse Event|1|||
164225864|NCT04818229|593196249|FG000|Overall Study|Withdrawal by Subject|0|||
164225865|NCT04818229|593196250|FG001|Overall Study|Withdrawal by Subject|0|||
164225866|NCT04818229|593196251|FG002|Overall Study|Withdrawal by Subject|2|||
164225867|NCT04818229|593196249|FG000|Overall Study|Lost to Follow-up|0|||
164225868|NCT04818229|593196250|FG001|Overall Study|Lost to Follow-up|0|||
164225869|NCT04818229|593196251|FG002|Overall Study|Lost to Follow-up|1|||
164225870|NCT04082364|593196252|FG000|Overall Study|Death|23|||
164225871|NCT04082364|593196253|FG001|Overall Study|Death|1|||
164330766|NCT03091777|593588298|FG002|Overall Study|Lost to Follow-up|7|||
164330767|NCT03091777|593588296|FG000|Overall Study|Lack of Efficacy|0|||
164225872|NCT04082364|593196254|FG002|Overall Study|Death|1|||
164225873|NCT04082364|593196255|FG003|Overall Study|Death|2|||
164330768|NCT03091777|593588297|FG001|Overall Study|Lack of Efficacy|0|||
164330769|NCT03091777|593588298|FG002|Overall Study|Lack of Efficacy|5|||
164225874|NCT04082364|593196256|FG004|Overall Study|Death|1|||
164330770|NCT03091777|593588296|FG000|Overall Study|Noncompliance with study drug|2|||
163882428|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Death|1|||
164225875|NCT04082364|593196252|FG000|Overall Study|Lost to Follow-up|1|||
164225876|NCT04082364|593196253|FG001|Overall Study|Lost to Follow-up|0|||
164225877|NCT04082364|593196254|FG002|Overall Study|Lost to Follow-up|0|||
164225878|NCT04082364|593196255|FG003|Overall Study|Lost to Follow-up|0|||
164225879|NCT04082364|593196256|FG004|Overall Study|Lost to Follow-up|1|||
164225880|NCT04082364|593196252|FG000|Overall Study|Physician Decision|1|||
164225881|NCT04082364|593196253|FG001|Overall Study|Physician Decision|1|||
164225882|NCT04082364|593196254|FG002|Overall Study|Physician Decision|0|||
164225883|NCT04082364|593196255|FG003|Overall Study|Physician Decision|2|||
164225884|NCT04082364|593196256|FG004|Overall Study|Physician Decision|1|||
164225885|NCT04082364|593196252|FG000|Overall Study|Withdrawal by Subject|1|||
164225886|NCT04082364|593196253|FG001|Overall Study|Withdrawal by Subject|1|||
164225887|NCT04082364|593196254|FG002|Overall Study|Withdrawal by Subject|0|||
164225888|NCT04082364|593196255|FG003|Overall Study|Withdrawal by Subject|0|||
164225889|NCT04082364|593196256|FG004|Overall Study|Withdrawal by Subject|1|||
164225890|NCT04082364|593196252|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
164225891|NCT04082364|593196253|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
164225892|NCT04082364|593196254|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
164225893|NCT04082364|593196255|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
164225894|NCT04082364|593196256|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
164225895|NCT04082364|593196252|FG000|Overall Study|Disease progression|0|||
164225896|NCT04082364|593196253|FG001|Overall Study|Disease progression|0|||
164225897|NCT04082364|593196254|FG002|Overall Study|Disease progression|0|||
164225898|NCT04082364|593196255|FG003|Overall Study|Disease progression|1|||
164225899|NCT04082364|593196256|FG004|Overall Study|Disease progression|0|||
164225900|NCT03186378|593196257|FG000|Overall Study|Lost to Follow-up|1|||
164225901|NCT03186378|593196258|FG001|Overall Study|Lost to Follow-up|0|||
164225902|NCT03247673|593196262|FG000|Overall Study|Withdrawal by Subject|1|||
164225903|NCT03247673|593196263|FG001|Overall Study|Withdrawal by Subject|0|||
164225904|NCT03247673|593196264|FG002|Overall Study|Withdrawal by Subject|3|||
164225905|NCT03247673|593196262|FG000|Overall Study|Lost to Follow-up|0|||
164225906|NCT03247673|593196263|FG001|Overall Study|Lost to Follow-up|0|||
164225907|NCT03247673|593196264|FG002|Overall Study|Lost to Follow-up|1|||
164225908|NCT02971137|593196269|FG000|Overall Study|Lost to Follow-up|44|||
164225909|NCT02971137|593196270|FG001|Overall Study|Lost to Follow-up|56|||
164225910|NCT02757963|593196271|FG000|Overall Study|Adverse Event|3|||
164225911|NCT02757963|593196271|FG000|Overall Study|Reached Stopping Criteria|1054|||
164225912|NCT02757963|593196271|FG000|Overall Study|Lost to Follow-up|5|||
164225913|NCT02757963|593196271|FG000|Overall Study|Physician Decision|1|||
164225914|NCT02757963|593196271|FG000|Overall Study|Withdrawal by Subject|34|||
164225915|NCT00215657|593196272|FG000|Overall Study|Adverse Event|5|||
164225916|NCT00215657|593196273|FG001|Overall Study|Adverse Event|1|||
164225917|NCT00215657|593196274|FG002|Overall Study|Adverse Event|3|||
164225918|NCT00215657|593196275|FG003|Overall Study|Adverse Event|0|||
164225919|NCT00215657|593196276|FG004|Overall Study|Adverse Event|3|||
164225920|NCT00215657|593196277|FG005|Overall Study|Adverse Event|1|||
164225921|NCT00215657|593196278|FG006|Overall Study|Adverse Event|0|||
164225922|NCT00215657|593196279|FG007|Overall Study|Adverse Event|3|||
164225923|NCT00215657|593196272|FG000|Overall Study|Withdrawal by Subject|6|||
164225924|NCT00215657|593196273|FG001|Overall Study|Withdrawal by Subject|3|||
164225925|NCT00215657|593196274|FG002|Overall Study|Withdrawal by Subject|3|||
164225926|NCT00215657|593196275|FG003|Overall Study|Withdrawal by Subject|1|||
164225927|NCT00215657|593196276|FG004|Overall Study|Withdrawal by Subject|6|||
164225928|NCT00215657|593196277|FG005|Overall Study|Withdrawal by Subject|1|||
164225929|NCT00215657|593196278|FG006|Overall Study|Withdrawal by Subject|10|||
164225930|NCT00215657|593196279|FG007|Overall Study|Withdrawal by Subject|3|||
164225931|NCT00215657|593196272|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
164225932|NCT00215657|593196273|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
164225933|NCT00215657|593196274|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
164225934|NCT00215657|593196275|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
164225935|NCT00215657|593196276|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
164225936|NCT00215657|593196277|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
164225937|NCT00215657|593196278|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
164225938|NCT00215657|593196279|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
164225939|NCT00215657|593196272|FG000|Overall Study|Insufficient testosterone response|5|||
164225940|NCT00215657|593196273|FG001|Overall Study|Insufficient testosterone response|4|||
164225941|NCT00215657|593196274|FG002|Overall Study|Insufficient testosterone response|1|||
164225942|NCT00215657|593196275|FG003|Overall Study|Insufficient testosterone response|12|||
164081723|NCT01271933|592663309|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
164225943|NCT00215657|593196276|FG004|Overall Study|Insufficient testosterone response|8|||
164225944|NCT00215657|593196277|FG005|Overall Study|Insufficient testosterone response|12|||
164225945|NCT00215657|593196278|FG006|Overall Study|Insufficient testosterone response|4|||
164225946|NCT00215657|593196279|FG007|Overall Study|Insufficient testosterone response|7|||
164225947|NCT00215657|593196272|FG000|Overall Study|Other|3|||
164225948|NCT00215657|593196273|FG001|Overall Study|Other|1|||
164225949|NCT00215657|593196274|FG002|Overall Study|Other|2|||
164225950|NCT00215657|593196275|FG003|Overall Study|Other|3|||
164225951|NCT00215657|593196276|FG004|Overall Study|Other|5|||
164225952|NCT00215657|593196277|FG005|Overall Study|Other|4|||
164225953|NCT00215657|593196278|FG006|Overall Study|Other|6|||
164225954|NCT00215657|593196279|FG007|Overall Study|Other|1|||
164225955|NCT04755231|593196280|FG000|Overall Study|Lost to Follow-up|5|||
164225956|NCT04755231|593196280|FG000|Overall Study|Withdrawal by Subject|5|||
164225957|NCT03769467|593196281|FG000|Overall Study|Adverse Event|1|||
164225958|NCT03769467|593196282|FG001|Overall Study|Adverse Event|1|||
164225959|NCT03769467|593196283|FG002|Overall Study|Adverse Event|0|||
164225960|NCT03769467|593196281|FG000|Overall Study|Death|3|||
164225961|NCT03769467|593196282|FG001|Overall Study|Death|3|||
164225962|NCT03769467|593196283|FG002|Overall Study|Death|0|||
164225963|NCT03769467|593196281|FG000|Overall Study|Study Terminated By Sponsor|2|||
164225964|NCT03769467|593196282|FG001|Overall Study|Study Terminated By Sponsor|1|||
164225965|NCT03769467|593196283|FG002|Overall Study|Study Terminated By Sponsor|0|||
164225966|NCT03769467|593196281|FG000|Overall Study|Withdrawal by Subject|0|||
164225967|NCT03769467|593196282|FG001|Overall Study|Withdrawal by Subject|1|||
164225968|NCT03769467|593196283|FG002|Overall Study|Withdrawal by Subject|0|||
164225969|NCT04754399|593196284|FG000|Overall Study|Adverse Event|5|||
164225970|NCT04754399|593196284|FG000|Overall Study|Withdrawal by Subject|6|||
164225971|NCT05259722|593196287|FG000|Overall Study|Adverse Event|2|||
164225972|NCT05259722|593196288|FG001|Overall Study|Adverse Event|24|||
164225973|NCT05259722|593196287|FG000|Overall Study|Lost to Follow-up|5|||
164225974|NCT05259722|593196288|FG001|Overall Study|Lost to Follow-up|1|||
164225975|NCT05259722|593196287|FG000|Overall Study|Lack of Efficacy|8|||
164225976|NCT05259722|593196288|FG001|Overall Study|Lack of Efficacy|26|||
164225977|NCT05259722|593196287|FG000|Overall Study|Withdrawal by Subject|15|||
164225978|NCT05259722|593196288|FG001|Overall Study|Withdrawal by Subject|33|||
164225979|NCT05259722|593196287|FG000|Overall Study|Various reasons|3|||
164225980|NCT05259722|593196288|FG001|Overall Study|Various reasons|9|||
164225981|NCT05259722|593196287|FG000|Overall Study|Not exposed to IMP|1|||
164225982|NCT05259722|593196288|FG001|Overall Study|Not exposed to IMP|12|||
164225983|NCT05259722|593196287|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
164330771|NCT03091777|593588297|FG001|Overall Study|Noncompliance with study drug|3|||
164330772|NCT03091777|593588298|FG002|Overall Study|Noncompliance with study drug|1|||
164330773|NCT03091777|593588296|FG000|Overall Study|Physician Decision|1|||
164330774|NCT03091777|593588297|FG001|Overall Study|Physician Decision|0|||
164330775|NCT03091777|593588298|FG002|Overall Study|Physician Decision|1|||
164225984|NCT05259722|593196288|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
164330776|NCT03091777|593588296|FG000|Overall Study|Abnormal Laboratory Value|7|||
164330777|NCT03091777|593588297|FG001|Overall Study|Abnormal Laboratory Value|11|||
164330778|NCT03091777|593588298|FG002|Overall Study|Abnormal Laboratory Value|12|||
164330779|NCT02536833|593588299|FG000|Overall Study|Discontinued Before Treatment|0|||
164330780|NCT02536833|593588300|FG001|Overall Study|Discontinued Before Treatment|0|||
164330781|NCT02536833|593588301|FG002|Overall Study|Discontinued Before Treatment|1|||
164330782|NCT02536833|593588302|FG003|Overall Study|Discontinued Before Treatment|2|||
164330783|NCT02536833|593588299|FG000|Overall Study|Adverse Event|1|||
164330784|NCT02536833|593588300|FG001|Overall Study|Adverse Event|3|||
164330785|NCT02536833|593588301|FG002|Overall Study|Adverse Event|4|||
164330786|NCT02536833|593588302|FG003|Overall Study|Adverse Event|1|||
164330787|NCT02536833|593588299|FG000|Overall Study|Lost to Follow-up|2|||
164330788|NCT02536833|593588300|FG001|Overall Study|Lost to Follow-up|1|||
164330789|NCT02536833|593588301|FG002|Overall Study|Lost to Follow-up|2|||
163882429|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Death|0|||
164225985|NCT01887600|593196289|FG000|Overall Study|Death|39|||
164225986|NCT01887600|593196290|FG001|Overall Study|Death|16|||
164225987|NCT01887600|593196289|FG000|Overall Study|Lack of Efficacy|3|||
164225988|NCT01887600|593196290|FG001|Overall Study|Lack of Efficacy|26|||
164225989|NCT01887600|593196289|FG000|Overall Study|Lost to Follow-up|5|||
164225990|NCT01887600|593196290|FG001|Overall Study|Lost to Follow-up|1|||
164225991|NCT01887600|593196289|FG000|Overall Study|Physician Decision|7|||
163882430|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Death|0|||
163882431|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Death|2|||
163882432|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Death|0|||
164225992|NCT01887600|593196290|FG001|Overall Study|Physician Decision|8|||
163882433|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
163882434|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
164225993|NCT01887600|593196289|FG000|Overall Study|Protocol Deviation|3|||
164225994|NCT01887600|593196290|FG001|Overall Study|Protocol Deviation|0|||
164330790|NCT02536833|593588302|FG003|Overall Study|Lost to Follow-up|2|||
164225995|NCT01887600|593196289|FG000|Overall Study|Withdrawal by Subject|58|||
164225996|NCT01887600|593196290|FG001|Overall Study|Withdrawal by Subject|52|||
164225997|NCT01887600|593196289|FG000|Overall Study|Adverse Event|21|||
164330791|NCT02536833|593588299|FG000|Overall Study|Physician Decision|0|||
164330792|NCT02536833|593588300|FG001|Overall Study|Physician Decision|0|||
164330793|NCT02536833|593588301|FG002|Overall Study|Physician Decision|0|||
164330794|NCT02536833|593588302|FG003|Overall Study|Physician Decision|1|||
164330795|NCT02536833|593588299|FG000|Overall Study|Site Terminated by Sponsor|2|||
164330796|NCT02536833|593588300|FG001|Overall Study|Site Terminated by Sponsor|2|||
164225998|NCT01887600|593196290|FG001|Overall Study|Adverse Event|9|||
164225999|NCT01887600|593196289|FG000|Overall Study|Non-compliance with study drug|3|||
164226000|NCT01887600|593196290|FG001|Overall Study|Non-compliance with study drug|0|||
164226001|NCT01887600|593196289|FG000|Overall Study|Miscellaneous|6|||
164226002|NCT01887600|593196290|FG001|Overall Study|Miscellaneous|2|||
164226003|NCT01887600|593196289|FG000|Overall Study|Progressive Disease|1|||
164226004|NCT01887600|593196290|FG001|Overall Study|Progressive Disease|0|||
164226005|NCT00962650|593196291|FG000|Overall Study|Transgastric DP was not completed|2|||
164226006|NCT03688139|593196292|FG000|Overall Study|Lost to Follow-up|2|||
164226007|NCT03688139|593196293|FG001|Overall Study|Lost to Follow-up|0|||
164226008|NCT03688139|593196292|FG000|Overall Study|Physician Decision|0|||
164226009|NCT03688139|593196293|FG001|Overall Study|Physician Decision|1|||
164226010|NCT03688139|593196292|FG000|Overall Study|Withdrawal by Subject|2|||
164226011|NCT03688139|593196293|FG001|Overall Study|Withdrawal by Subject|3|||
164226012|NCT00231465|593196294|FG000|Overall Study|Completed only one cycle|1|||
164226013|NCT00231465|593196294|FG000|Overall Study|Did not have follow up CT scans|1|||
164226014|NCT00127933|593196297|FG000|Overall Study|Randomized but not dosed|1|||
164226015|NCT00127933|593196298|FG001|Overall Study|Randomized but not dosed|0|||
164226016|NCT00498485|593196299|FG000|Overall Study|Adverse Event|1|||
164226017|NCT00498485|593196300|FG001|Overall Study|Adverse Event|5|||
164226018|NCT03072875|593196301|FG000|Overall Study|Lost to Follow-up|1|||
164226019|NCT01943825|593196302|FG000|Overall Study|Lost to Follow-up|9|||
164226020|NCT01943825|593196303|FG001|Overall Study|Lost to Follow-up|3|||
164226021|NCT01943825|593196304|FG002|Overall Study|Lost to Follow-up|12|||
164226022|NCT01943825|593196305|FG003|Overall Study|Lost to Follow-up|8|||
164226023|NCT01943825|593196302|FG000|Overall Study|Withdrawal by Subject|1|||
164226024|NCT01943825|593196303|FG001|Overall Study|Withdrawal by Subject|0|||
164226025|NCT01943825|593196304|FG002|Overall Study|Withdrawal by Subject|3|||
164226026|NCT01943825|593196305|FG003|Overall Study|Withdrawal by Subject|2|||
164226027|NCT01943825|593196302|FG000|Overall Study|Other than specified above|0|||
164226028|NCT01943825|593196303|FG001|Overall Study|Other than specified above|1|||
164226029|NCT01943825|593196304|FG002|Overall Study|Other than specified above|0|||
164226030|NCT01943825|593196305|FG003|Overall Study|Other than specified above|1|||
164226031|NCT00452400|593196306|FG000|Overall Study|Adverse Event|1|||
164226032|NCT00452400|593196307|FG001|Overall Study|Adverse Event|1|||
164226033|NCT00452400|593196308|FG002|Overall Study|Adverse Event|5|||
164226034|NCT00452400|593196309|FG003|Overall Study|Adverse Event|0|||
164226035|NCT00452400|593196310|FG004|Overall Study|Adverse Event|2|||
164226036|NCT00452400|593196306|FG000|Overall Study|Protocol Violation|0|||
164226037|NCT00452400|593196307|FG001|Overall Study|Protocol Violation|0|||
164226038|NCT00452400|593196308|FG002|Overall Study|Protocol Violation|1|||
164226039|NCT00452400|593196309|FG003|Overall Study|Protocol Violation|0|||
164226040|NCT00452400|593196310|FG004|Overall Study|Protocol Violation|0|||
163882435|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
163882436|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
163882437|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
163882438|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
163882439|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
163882440|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
163882441|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
163882442|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
163882443|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
163882444|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
163882445|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
163882446|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
163882447|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
163882448|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
163882449|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
163882450|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
163882451|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Adverse Event|0|||
163882452|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Adverse Event|0|||
163882453|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Adverse Event|0|||
163882454|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Adverse Event|0|||
163882455|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Adverse Event|0|||
163882456|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Adverse Event|0|||
164226041|NCT00452400|593196306|FG000|Overall Study|Lost to Follow-up|1|||
163882457|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Adverse Event|2|||
163986750|NCT03529773|592320227|FG034|Overall Study|Physician Decision|0|||
163986751|NCT03529773|592320228|FG035|Overall Study|Physician Decision|0|||
163986752|NCT03529773|592320229|FG036|Overall Study|Physician Decision|0|||
164226042|NCT00452400|593196307|FG001|Overall Study|Lost to Follow-up|0|||
164226043|NCT00452400|593196308|FG002|Overall Study|Lost to Follow-up|0|||
163882458|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Adverse Event|0|||
163882459|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Adverse Event|0|||
163882460|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Adverse Event|0|||
164226044|NCT00452400|593196309|FG003|Overall Study|Lost to Follow-up|0|||
164226045|NCT00452400|593196310|FG004|Overall Study|Lost to Follow-up|0|||
164226046|NCT00452400|593196306|FG000|Overall Study|Withdrawal by Subject|1|||
164226047|NCT00452400|593196307|FG001|Overall Study|Withdrawal by Subject|0|||
164226048|NCT00452400|593196308|FG002|Overall Study|Withdrawal by Subject|1|||
164226049|NCT00452400|593196309|FG003|Overall Study|Withdrawal by Subject|0|||
164226050|NCT00452400|593196310|FG004|Overall Study|Withdrawal by Subject|0|||
164226051|NCT00452400|593196306|FG000|Overall Study|Lack of Efficacy|2|||
164226052|NCT00452400|593196307|FG001|Overall Study|Lack of Efficacy|0|||
164226053|NCT00452400|593196308|FG002|Overall Study|Lack of Efficacy|0|||
164226054|NCT00452400|593196309|FG003|Overall Study|Lack of Efficacy|0|||
164226055|NCT00452400|593196310|FG004|Overall Study|Lack of Efficacy|0|||
164226056|NCT00452400|593196306|FG000|Overall Study|Other reasons not listed above|0|||
164226057|NCT00452400|593196307|FG001|Overall Study|Other reasons not listed above|0|||
164226058|NCT00452400|593196308|FG002|Overall Study|Other reasons not listed above|0|||
164226059|NCT00452400|593196309|FG003|Overall Study|Other reasons not listed above|1|||
164226060|NCT00452400|593196310|FG004|Overall Study|Other reasons not listed above|1|||
164226061|NCT03378635|593196315|FG000|Overall Study|Adverse Event|1|||
164226062|NCT03378635|593196316|FG001|Overall Study|Adverse Event|0|||
164226063|NCT03378635|593196317|FG002|Overall Study|Adverse Event|0|||
164226064|NCT03378635|593196315|FG000|Overall Study|Withdrawal by Subject|1|||
164226065|NCT03378635|593196316|FG001|Overall Study|Withdrawal by Subject|0|||
164226066|NCT03378635|593196317|FG002|Overall Study|Withdrawal by Subject|0|||
164226067|NCT01472835|593196320|FG000|Overall Study|Lost to Follow-up|2|||
164226068|NCT01472835|593196321|FG001|Overall Study|Lost to Follow-up|0|||
164226069|NCT01835431|593196338|FG000|Overall Study|Adverse Event|1|||
164226070|NCT01835431|593196339|FG001|Overall Study|Adverse Event|0|||
164226071|NCT01835431|593196338|FG000|Overall Study|other|0|||
164226072|NCT01835431|593196339|FG001|Overall Study|other|2|||
164226073|NCT01835431|593196338|FG000|Overall Study|Withdrawal by Subject|6|||
164226074|NCT01835431|593196339|FG001|Overall Study|Withdrawal by Subject|10|||
164226075|NCT01835431|593196338|FG000|Overall Study|Protocol Violation|1|||
164226076|NCT01835431|593196339|FG001|Overall Study|Protocol Violation|0|||
164226077|NCT01316900|593196340|FG000|Overall Study|Adverse Event|10|||
164226078|NCT01316900|593196341|FG001|Overall Study|Adverse Event|10|||
164226079|NCT01316900|593196342|FG002|Overall Study|Adverse Event|15|||
164226080|NCT01316900|593196343|FG003|Overall Study|Adverse Event|9|||
164226081|NCT01316900|593196340|FG000|Overall Study|Lack of Efficacy|17|||
164226082|NCT01316900|593196341|FG001|Overall Study|Lack of Efficacy|9|||
164226083|NCT01316900|593196342|FG002|Overall Study|Lack of Efficacy|5|||
164226084|NCT01316900|593196343|FG003|Overall Study|Lack of Efficacy|7|||
164226085|NCT01316900|593196340|FG000|Overall Study|Protocol Violation|7|||
164226086|NCT01316900|593196341|FG001|Overall Study|Protocol Violation|1|||
164226087|NCT01316900|593196342|FG002|Overall Study|Protocol Violation|4|||
164226088|NCT01316900|593196343|FG003|Overall Study|Protocol Violation|0|||
164226089|NCT01316900|593196340|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
164226090|NCT01316900|593196341|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
164226091|NCT01316900|593196342|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
164226092|NCT01316900|593196343|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
164226093|NCT01316900|593196340|FG000|Overall Study|Lost to Follow-up|1|||
164226094|NCT01316900|593196341|FG001|Overall Study|Lost to Follow-up|0|||
164226095|NCT01316900|593196342|FG002|Overall Study|Lost to Follow-up|1|||
164226096|NCT01316900|593196343|FG003|Overall Study|Lost to Follow-up|1|||
164226097|NCT01316900|593196340|FG000|Overall Study|Withdrawal by Subject|7|||
164226098|NCT01316900|593196341|FG001|Overall Study|Withdrawal by Subject|8|||
164226099|NCT01316900|593196342|FG002|Overall Study|Withdrawal by Subject|6|||
164226100|NCT01316900|593196343|FG003|Overall Study|Withdrawal by Subject|9|||
164226101|NCT01684033|593196344|FG000|Period 1, First 30 Days|Adverse Event|1|||
164226102|NCT01684033|593196345|FG001|Period 1, First 30 Days|Adverse Event|1|||
164226103|NCT01684033|593196344|FG000|Period 1, First 30 Days|Noncompliance|1|||
164226104|NCT01684033|593196345|FG001|Period 1, First 30 Days|Noncompliance|0|||
164226105|NCT01684033|593196344|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
164330797|NCT02536833|593588301|FG002|Overall Study|Site Terminated by Sponsor|2|||
164330798|NCT02536833|593588302|FG003|Overall Study|Site Terminated by Sponsor|2|||
164330799|NCT02536833|593588299|FG000|Overall Study|Subject Non-Compliance|0|||
164330800|NCT02536833|593588300|FG001|Overall Study|Subject Non-Compliance|1|||
164330801|NCT02536833|593588301|FG002|Overall Study|Subject Non-Compliance|1|||
164226106|NCT01684033|593196345|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
164226107|NCT01684033|593196344|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
164226108|NCT01684033|593196345|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
164226109|NCT01684033|593196344|FG000|Period 2, Second 30 Days|Adverse Event|1|||
164226110|NCT01684033|593196345|FG001|Period 2, Second 30 Days|Adverse Event|0|||
164226111|NCT05346640|593196346|FG000|Overall Study|Lack of Efficacy|2|||
164226112|NCT05346640|593196346|FG000|Overall Study|Lost to Follow-up|14|||
164226113|NCT05346640|593196346|FG000|Overall Study|Protocol Violation|4|||
164226114|NCT05346640|593196346|FG000|Overall Study|Withdrawal by Subject|2|||
164330802|NCT02536833|593588302|FG003|Overall Study|Subject Non-Compliance|0|||
164330803|NCT02536833|593588299|FG000|Overall Study|Withdrawal by Subject|4|||
164330804|NCT02536833|593588300|FG001|Overall Study|Withdrawal by Subject|3|||
164226115|NCT05346640|593196346|FG000|Overall Study|Physiological Complications|3|||
164226116|NCT05346640|593196346|FG000|Overall Study|Other Reason|3|||
164226117|NCT03726879|593196347|FG000|Overall Study|Death|11|||
164226118|NCT03726879|593196348|FG001|Overall Study|Death|13|||
164226119|NCT03726879|593196347|FG000|Overall Study|Physician Decision|0|||
164226120|NCT03726879|593196348|FG001|Overall Study|Physician Decision|2|||
164226121|NCT03726879|593196347|FG000|Overall Study|Protocol Violation|0|||
164226122|NCT03726879|593196348|FG001|Overall Study|Protocol Violation|1|||
164226123|NCT03726879|593196347|FG000|Overall Study|Withdrawal by Subject|5|||
164226124|NCT03726879|593196348|FG001|Overall Study|Withdrawal by Subject|6|||
164226125|NCT03726879|593196347|FG000|Overall Study|TSH result is unstable|0|||
164226126|NCT03726879|593196348|FG001|Overall Study|TSH result is unstable|1|||
164226127|NCT03726879|593196347|FG000|Overall Study|Disease relapse|1|||
164226128|NCT03726879|593196348|FG001|Overall Study|Disease relapse|0|||
164226129|NCT03726879|593196347|FG000|Overall Study|Lost to Follow-up|3|||
164226130|NCT03726879|593196348|FG001|Overall Study|Lost to Follow-up|0|||
164226131|NCT02496156|593196349|FG000|Overall Study|Lost to Follow-up|5|||
164226132|NCT02496156|593196350|FG001|Overall Study|Lost to Follow-up|0|||
164226133|NCT02496156|593196349|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
164226134|NCT02496156|593196350|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
164226135|NCT00507507|593196351|FG000|Treatment Period|Lost to Follow-up|0|||
164226136|NCT00507507|593196352|FG001|Treatment Period|Lost to Follow-up|2|||
164226137|NCT00507507|593196351|FG000|Treatment Period|Physician Decision|4|||
164226138|NCT00507507|593196352|FG001|Treatment Period|Physician Decision|1|||
164226139|NCT00507507|593196351|FG000|Treatment Period|Protocol Violation|1|||
164226140|NCT00507507|593196352|FG001|Treatment Period|Protocol Violation|2|||
164226141|NCT00507507|593196351|FG000|Treatment Period|Adverse Event|1|||
164226142|NCT00507507|593196352|FG001|Treatment Period|Adverse Event|1|||
164226143|NCT00507507|593196351|FG000|Treatment Period|Withdrawal by Subject|46|||
164226144|NCT00507507|593196352|FG001|Treatment Period|Withdrawal by Subject|47|||
164226145|NCT00507507|593196351|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
164226146|NCT00507507|593196352|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
164330805|NCT02536833|593588301|FG002|Overall Study|Withdrawal by Subject|5|||
164330806|NCT02536833|593588302|FG003|Overall Study|Withdrawal by Subject|11|||
164081724|NCT01271933|592663310|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
164081725|NCT01271933|592663308|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
164330807|NCT00089674|593588303|FG000|Overall Study|Physician Decision|4|||
164081726|NCT01271933|592663309|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
164081727|NCT01271933|592663310|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
164081728|NCT01271933|592663308|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
164081729|NCT01271933|592663309|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
164081730|NCT01271933|592663310|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
164081731|NCT01271933|592663308|FG000|Double-Blind Phase|Randomized but not treated|0|||
164081732|NCT01271933|592663309|FG001|Double-Blind Phase|Randomized but not treated|0|||
164081733|NCT01271933|592663310|FG002|Double-Blind Phase|Randomized but not treated|1|||
164226147|NCT00507507|593196351|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
164226148|NCT00507507|593196352|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
164226149|NCT00507507|593196351|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
164226150|NCT00507507|593196352|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
164226151|NCT02371889|593198384|FG000|Overall Study|Adverse medication effect|11|||
164226152|NCT02371889|593198385|FG001|Overall Study|Adverse medication effect|2|||
164226153|NCT02371889|593198384|FG000|Overall Study|Lost to Follow-up|6|||
164226154|NCT02371889|593198385|FG001|Overall Study|Lost to Follow-up|5|||
164226155|NCT02371889|593198384|FG000|Overall Study|Personal time constraints|2|||
164226156|NCT02371889|593198385|FG001|Overall Study|Personal time constraints|4|||
164226157|NCT02371889|593198384|FG000|Overall Study|Lack of Efficacy|0|||
164226158|NCT02371889|593198385|FG001|Overall Study|Lack of Efficacy|2|||
163882461|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Adverse Event|1|||
164330808|NCT00089674|593588304|FG001|Overall Study|Physician Decision|2|||
163882462|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Adverse Event|2|||
163882463|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Adverse Event|0|||
163882464|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Adverse Event|1|||
163882465|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Adverse Event|0|||
163882466|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Adverse Event|0|||
163882467|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Adverse Event|1|||
163882468|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Adverse Event|0|||
163882469|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
163882470|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
163882471|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
163882472|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
164226159|NCT02371889|593198384|FG000|Overall Study|Relapse|0|||
164226160|NCT02371889|593198385|FG001|Overall Study|Relapse|1|||
164226161|NCT05130281|593198386|FG000|Overall Study|Withdrawal by Subject|0|||
164226162|NCT05130281|593198387|FG001|Overall Study|Withdrawal by Subject|0|||
164226163|NCT05130281|593198388|FG002|Overall Study|Withdrawal by Subject|1|||
164226164|NCT06844812|593198389|FG000|Overall Study|Lost to Follow-up|5|||
164226165|NCT06844812|593198389|FG000|Overall Study|stigmatization concerns|2|||
164226166|NCT06844812|593198389|FG000|Overall Study|medication refusal|2|||
164226167|NCT06844812|593198389|FG000|Overall Study|concerns about possible side effects|2|||
164226168|NCT06844812|593198389|FG000|Overall Study|wanting to seek another specialist opinion|2|||
164226169|NCT06844812|593198389|FG000|Overall Study|side effects (dizziness)|1|||
164226170|NCT05520333|593198393|FG000|Overall Study|Lost to Follow-up|3|||
164226171|NCT05520333|593198394|FG001|Overall Study|Lost to Follow-up|6|||
164226172|NCT02410200|593198397|FG000|Overall Study|Adverse Event|2|||
163882473|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
163882474|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
164081734|NCT01271933|592663308|FG000|Double-Blind Phase|Lack of Efficacy|0|||
164226173|NCT05069415|593198398|FG000|Overall Study|Withdrawal by Subject|2|||
164226174|NCT05069415|593198399|FG001|Overall Study|Withdrawal by Subject|0|||
164226175|NCT05069415|593198398|FG000|Overall Study|Adverse Event|2|||
164226176|NCT05069415|593198399|FG001|Overall Study|Adverse Event|0|||
164226177|NCT00101400|593198402|FG000|Survival Follow-Up|Alive|7|||
164226178|NCT03701074|593198403|FG000|Overall Study|Physician Decision|1|||
164226179|NCT03701074|593198404|FG001|Overall Study|Physician Decision|0|||
164226180|NCT01661595|593198410|FG000|Phase 1: Week 0-4|Adverse Event|1|||
164226181|NCT01661595|593198411|FG001|Phase 1: Week 0-4|Adverse Event|0|||
164226182|NCT01661595|593198412|FG002|Phase 1: Week 0-4|Adverse Event|0|||
164226183|NCT01661595|593198413|FG003|Phase 1: Week 0-4|Adverse Event|0|||
164226184|NCT01661595|593198410|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
164226185|NCT01661595|593198411|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
164226186|NCT01661595|593198412|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
164226187|NCT01661595|593198413|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
164226188|NCT01500135|593198414|FG000|Overall Study|Withdrawal of Consent|4|||
164226189|NCT01500135|593198415|FG001|Overall Study|Withdrawal of Consent|0|||
164226190|NCT01500135|593198414|FG000|Overall Study|Lost to Follow-up|6|||
164226191|NCT01500135|593198415|FG001|Overall Study|Lost to Follow-up|4|||
164226192|NCT01500135|593198414|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
164226193|NCT01500135|593198415|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
164226194|NCT01500135|593198414|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
164226195|NCT01500135|593198415|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
164226196|NCT01500135|593198414|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
164226197|NCT01500135|593198415|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
164226198|NCT01500135|593198414|FG000|Overall Study|Participant was a Safety Concern|1|||
164226199|NCT01500135|593198415|FG001|Overall Study|Participant was a Safety Concern|0|||
164226200|NCT01500135|593198414|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
164226201|NCT01500135|593198415|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
164226202|NCT00661687|593198416|FG000|Overall Study|Study related symptoms and complaints|5|||
164081735|NCT01271933|592663309|FG001|Double-Blind Phase|Lack of Efficacy|6|||
164081736|NCT01271933|592663310|FG002|Double-Blind Phase|Lack of Efficacy|9|||
164081737|NCT01271933|592663308|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164081738|NCT01271933|592663309|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164081739|NCT01271933|592663310|FG002|Double-Blind Phase|Lost to Follow-up|1|||
164081740|NCT01271933|592663308|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164081741|NCT01271933|592663309|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
164081742|NCT01271933|592663310|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
164226203|NCT00661687|593198416|FG000|Overall Study|Positive slit lamp findings|4|||
164226204|NCT00661687|593198416|FG000|Overall Study|Inability to maintain wearing schedule|3|||
164226205|NCT00661687|593198416|FG000|Overall Study|Physician Decision|1|||
164226206|NCT00661687|593198416|FG000|Overall Study|Adverse Event|2|||
164226207|NCT00912509|593198417|FG000|Overall Study|Lost to Follow-up|1|||
164226208|NCT00912509|593198418|FG001|Overall Study|Lost to Follow-up|0|||
164226209|NCT00912509|593198417|FG000|Overall Study|Lack of Efficacy|4|||
164226210|NCT00912509|593198418|FG001|Overall Study|Lack of Efficacy|3|||
164226211|NCT05538728|593198419|FG000|Overall Study|Withdrawal by Subject|1|||
164226212|NCT05538728|593198420|FG001|Overall Study|Withdrawal by Subject|1|||
164226213|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Adverse Event|2|||
164226214|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Adverse Event|0|||
164226215|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Physician Decision|0|||
164226216|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Physician Decision|1|||
164226217|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
164226218|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
164226219|NCT01362530|593198422|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
164226220|NCT01362530|593198423|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
164226221|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
164226222|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
164081743|NCT01271933|592663308|FG000|Double-Blind Phase|Adverse Event|0|||
164226223|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
164226224|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
164226225|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
164226226|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
164226227|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
164226228|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
164226229|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
164226230|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
164226231|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
164226232|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
164226233|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
164226234|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
164226235|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
164226236|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
164226237|NCT01362530|593198422|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
164226238|NCT01362530|593198423|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
164226239|NCT01034657|593198424|FG000|Core Phase|Withdrawal by Subject|1|||
164226240|NCT01034657|593198425|FG001|Core Phase|Withdrawal by Subject|0|||
164226241|NCT01034657|593198426|FG002|Core Phase|Withdrawal by Subject|0|||
164226242|NCT01034657|593198424|FG000|Core Phase|Lack of Efficacy|2|||
164226243|NCT01034657|593198425|FG001|Core Phase|Lack of Efficacy|0|||
164226244|NCT01034657|593198426|FG002|Core Phase|Lack of Efficacy|0|||
164226245|NCT01034657|593198424|FG000|Core Phase|Abnormal laboratory value|1|||
164226246|NCT01034657|593198425|FG001|Core Phase|Abnormal laboratory value|0|||
164226247|NCT01034657|593198426|FG002|Core Phase|Abnormal laboratory value|0|||
164226248|NCT01034657|593198424|FG000|Core Phase|Adverse Event|8|||
164226249|NCT01034657|593198425|FG001|Core Phase|Adverse Event|0|||
164226250|NCT01034657|593198426|FG002|Core Phase|Adverse Event|0|||
164226251|NCT01034657|593198424|FG000|Core Phase|Protocol Violation|2|||
164226252|NCT01034657|593198425|FG001|Core Phase|Protocol Violation|0|||
164226253|NCT01034657|593198426|FG002|Core Phase|Protocol Violation|0|||
164226254|NCT01034657|593198424|FG000|Randomized Phase|Withdrawal by Subject|0|||
164226255|NCT01034657|593198425|FG001|Randomized Phase|Withdrawal by Subject|2|||
164226256|NCT01034657|593198426|FG002|Randomized Phase|Withdrawal by Subject|0|||
164226257|NCT01034657|593198424|FG000|Randomized Phase|Lack of Efficacy|5|||
164226258|NCT01034657|593198425|FG001|Randomized Phase|Lack of Efficacy|1|||
164226259|NCT01034657|593198426|FG002|Randomized Phase|Lack of Efficacy|0|||
164226260|NCT01034657|593198424|FG000|Randomized Phase|Abnormal laboratory value|0|||
164226261|NCT01034657|593198425|FG001|Randomized Phase|Abnormal laboratory value|1|||
164226262|NCT01034657|593198426|FG002|Randomized Phase|Abnormal laboratory value|0|||
164226263|NCT01034657|593198424|FG000|Randomized Phase|Adverse Event|0|||
164226264|NCT01034657|593198425|FG001|Randomized Phase|Adverse Event|2|||
164226265|NCT01034657|593198426|FG002|Randomized Phase|Adverse Event|1|||
164226266|NCT01517178|593198427|FG000|Period 1|Adverse Event|1|||
164226267|NCT01517178|593198428|FG001|Period 1|Adverse Event|2|||
164226268|NCT01517178|593198427|FG000|Period 1|Lack of Efficacy|0|||
164226269|NCT01517178|593198428|FG001|Period 1|Lack of Efficacy|1|||
164226270|NCT01517178|593198427|FG000|Period 1|E.g. study termination|3|||
164226271|NCT01517178|593198428|FG001|Period 1|E.g. study termination|1|||
164226272|NCT01517178|593198427|FG000|Period 1|Withdrawal by Subject|0|||
164226273|NCT01517178|593198428|FG001|Period 1|Withdrawal by Subject|1|||
164226274|NCT01517178|593198427|FG000|Period 2|Adverse Event|1|||
164226275|NCT01517178|593198428|FG001|Period 2|Adverse Event|0|||
164226276|NCT01517178|593198427|FG000|Period 2|Withdrawal by Subject|3|||
164226277|NCT01517178|593198428|FG001|Period 2|Withdrawal by Subject|0|||
164226278|NCT01517178|593198427|FG000|Period 2|E.g. study termination|2|||
164226279|NCT01517178|593198428|FG001|Period 2|E.g. study termination|2|||
164226280|NCT01557569|593198429|FG000|Overall Study|Adverse Event|2|||
164226281|NCT01557569|593198430|FG001|Overall Study|Adverse Event|0|||
164226282|NCT01557569|593198429|FG000|Overall Study|high blood pressure|0|||
164226283|NCT01557569|593198430|FG001|Overall Study|high blood pressure|1|||
164226284|NCT01557569|593198429|FG000|Overall Study|Withdrawal by Subject|3|||
164226285|NCT01557569|593198430|FG001|Overall Study|Withdrawal by Subject|5|||
164226286|NCT01557569|593198429|FG000|Overall Study|noncompliance with rules of residential|0|||
164226287|NCT01557569|593198430|FG001|Overall Study|noncompliance with rules of residential|1|||
164330809|NCT00089674|593588303|FG000|Overall Study|Adverse Event|23|||
164330810|NCT00089674|593588304|FG001|Overall Study|Adverse Event|29|||
164226288|NCT01772693|593198431|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
164226289|NCT01772693|593198432|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
164226290|NCT01772693|593198431|FG000|Overall Study|Withdrawal by Subject|2|||
164226291|NCT01772693|593198432|FG001|Overall Study|Withdrawal by Subject|0|||
164226292|NCT01772693|593198431|FG000|Overall Study|Alternative Treatment|2|||
164226293|NCT01772693|593198432|FG001|Overall Study|Alternative Treatment|0|||
164226294|NCT01633112|593198435|FG000|Overall Study|Lack of Efficacy|1|||
164226295|NCT01633112|593198436|FG001|Overall Study|Lack of Efficacy|6|||
164226296|NCT01633112|593198437|FG002|Overall Study|Lack of Efficacy|13|||
164226297|NCT01633112|593198435|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164226298|NCT01633112|593198436|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164226299|NCT01633112|593198437|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164226300|NCT01633112|593198435|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164226301|NCT01633112|593198436|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164226302|NCT01633112|593198437|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164226303|NCT01633112|593198435|FG000|Overall Study|Administrative problems|1|||
164226304|NCT01633112|593198436|FG001|Overall Study|Administrative problems|2|||
164226305|NCT01633112|593198437|FG002|Overall Study|Administrative problems|5|||
164226306|NCT01633112|593198435|FG000|Overall Study|Adverse Event|16|||
164226307|NCT01633112|593198436|FG001|Overall Study|Adverse Event|18|||
164226308|NCT01633112|593198437|FG002|Overall Study|Adverse Event|20|||
164226309|NCT01633112|593198435|FG000|Overall Study|Lost to Follow-up|7|||
164226310|NCT01633112|593198436|FG001|Overall Study|Lost to Follow-up|19|||
164226311|NCT01633112|593198437|FG002|Overall Study|Lost to Follow-up|6|||
164226312|NCT01633112|593198435|FG000|Overall Study|Protocol Violation|4|||
164226313|NCT01633112|593198436|FG001|Overall Study|Protocol Violation|0|||
164226314|NCT01633112|593198437|FG002|Overall Study|Protocol Violation|2|||
164226315|NCT01633112|593198435|FG000|Overall Study|Subject no longer requires study drug|0|||
164226316|NCT01633112|593198436|FG001|Overall Study|Subject no longer requires study drug|0|||
164226317|NCT01633112|593198437|FG002|Overall Study|Subject no longer requires study drug|1|||
164226318|NCT01633112|593198435|FG000|Overall Study|Withdrawal by Subject|20|||
164226319|NCT01633112|593198436|FG001|Overall Study|Withdrawal by Subject|12|||
164226320|NCT01633112|593198437|FG002|Overall Study|Withdrawal by Subject|41|||
164226321|NCT01633112|593198435|FG000|Overall Study|missing Study Completion CRF|1|||
164226322|NCT01633112|593198436|FG001|Overall Study|missing Study Completion CRF|1|||
164226323|NCT01633112|593198437|FG002|Overall Study|missing Study Completion CRF|4|||
164226324|NCT01225952|593198439|FG000|Overall Study|Lost to Follow-up|1|||
164226325|NCT01225952|593198440|FG001|Overall Study|Lost to Follow-up|0|||
164226326|NCT01225952|593198441|FG002|Overall Study|Lost to Follow-up|0|||
164226327|NCT01225952|593198439|FG000|Overall Study|Study Eye Explanted|0|||
164226328|NCT01225952|593198440|FG001|Overall Study|Study Eye Explanted|0|||
164226329|NCT01225952|593198441|FG002|Overall Study|Study Eye Explanted|1|||
164226330|NCT01225952|593198439|FG000|Overall Study|Withdrawal by Subject|4|||
164226331|NCT01225952|593198440|FG001|Overall Study|Withdrawal by Subject|4|||
164226332|NCT01225952|593198441|FG002|Overall Study|Withdrawal by Subject|5|||
164226333|NCT01225952|593198439|FG000|Overall Study|Surgical complications|1|||
164226334|NCT01225952|593198440|FG001|Overall Study|Surgical complications|0|||
164226335|NCT01225952|593198441|FG002|Overall Study|Surgical complications|0|||
164330811|NCT00089674|593588303|FG000|Overall Study|Withdrawal by Subject|143|||
164330812|NCT00089674|593588304|FG001|Overall Study|Withdrawal by Subject|127|||
164330813|NCT00089674|593588303|FG000|Overall Study|Death|43|||
164330814|NCT00089674|593588304|FG001|Overall Study|Death|43|||
164330815|NCT00089674|593588303|FG000|Overall Study|Disease progression|21|||
164330816|NCT00089674|593588304|FG001|Overall Study|Disease progression|23|||
164330817|NCT00089674|593588303|FG000|Overall Study|Ineligibility determined|8|||
164330818|NCT00089674|593588304|FG001|Overall Study|Ineligibility determined|10|||
164330819|NCT00089674|593588303|FG000|Overall Study|Lost to Follow-up|21|||
164226336|NCT00889005|593198442|FG000|Overall Study|Lost to Follow-up|4|||
164226337|NCT00889005|593198443|FG001|Overall Study|Lost to Follow-up|2|||
164226338|NCT00889005|593198442|FG000|Overall Study|Withdrawal by Subject|4|||
164330820|NCT00089674|593588304|FG001|Overall Study|Lost to Follow-up|17|||
164330821|NCT00089674|593588303|FG000|Overall Study|Noncompliance|7|||
164330822|NCT00089674|593588304|FG001|Overall Study|Noncompliance|3|||
164330823|NCT00089674|593588303|FG000|Overall Study|Other|5|||
164226339|NCT00889005|593198443|FG001|Overall Study|Withdrawal by Subject|0|||
164226340|NCT02872142|593198447|FG000|Overall Study|Adverse Event|2|||
164226341|NCT02872142|593198447|FG000|Overall Study|Death|1|||
164226342|NCT02872142|593198447|FG000|Overall Study|Participant Decision|3|||
164226343|NCT05122143|593198448|FG000|Overall Study|Adverse Event|1|||
164330824|NCT00089674|593588304|FG001|Overall Study|Other|9|||
164330825|NCT00089674|593588303|FG000|Overall Study|Requirement for alternative therapy|14|||
164330826|NCT00089674|593588304|FG001|Overall Study|Requirement for alternative therapy|4|||
164330827|NCT01437878|593588305|FG000|Overall Study|Withdrawal by Subject|1|||
164330828|NCT01437878|593588306|FG001|Overall Study|Withdrawal by Subject|0|||
164330829|NCT01476644|593588313|FG000|Overall Study|Death|5|||
164226344|NCT05122143|593198449|FG001|Overall Study|Adverse Event|0|||
164330830|NCT01476644|593588313|FG000|Overall Study|moved to another state|2|||
163882475|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
164226345|NCT05122143|593198450|FG002|Overall Study|Adverse Event|0|||
164226346|NCT05122143|593198451|FG003|Overall Study|Adverse Event|0|||
164226347|NCT05122143|593198452|FG004|Overall Study|Adverse Event|1|||
164330831|NCT01476644|593588313|FG000|Overall Study|Lost to Follow-up|19|||
164330832|NCT01476644|593588313|FG000|Overall Study|Withdrawal by Subject|13|||
164330833|NCT01462227|593588315|FG000|Second Assignment|Lost to Follow-up|1|||
164226348|NCT05122143|593198453|FG005|Overall Study|Adverse Event|0|||
164226349|NCT05122143|593198448|FG000|Overall Study|Protocol non-compliance|0|||
164330834|NCT01462227|593588316|FG001|Second Assignment|Lost to Follow-up|0|||
164330835|NCT01462227|593588317|FG002|Second Assignment|Lost to Follow-up|0|||
164226350|NCT05122143|593198449|FG001|Overall Study|Protocol non-compliance|0|||
164226351|NCT05122143|593198450|FG002|Overall Study|Protocol non-compliance|1|||
164226352|NCT05122143|593198451|FG003|Overall Study|Protocol non-compliance|0|||
164226353|NCT05122143|593198452|FG004|Overall Study|Protocol non-compliance|0|||
164226354|NCT05122143|593198453|FG005|Overall Study|Protocol non-compliance|0|||
164226355|NCT05122143|593198448|FG000|Overall Study|Covid contact|0|||
164226356|NCT05122143|593198449|FG001|Overall Study|Covid contact|0|||
164226357|NCT05122143|593198450|FG002|Overall Study|Covid contact|0|||
164226358|NCT05122143|593198451|FG003|Overall Study|Covid contact|0|||
164226359|NCT05122143|593198452|FG004|Overall Study|Covid contact|1|||
164226360|NCT05122143|593198453|FG005|Overall Study|Covid contact|0|||
164226361|NCT00692237|593198456|FG000|Overall Study|Withdrawal by Subject|1|||
164226362|NCT00692237|593198457|FG001|Overall Study|Withdrawal by Subject|3|||
164226363|NCT00692237|593198456|FG000|Overall Study|Adverse Event|0|||
164226364|NCT00692237|593198457|FG001|Overall Study|Adverse Event|1|||
164226365|NCT00395447|593198460|FG000|Overall Study|Death|37|||
164226366|NCT00395447|593198461|FG001|Overall Study|Death|32|||
164226367|NCT00395447|593198460|FG000|Overall Study|Lost to Follow-up|52|||
164226368|NCT00395447|593198461|FG001|Overall Study|Lost to Follow-up|43|||
164226369|NCT00395447|593198460|FG000|Overall Study|Withdrawal by Subject|24|||
164226370|NCT00395447|593198461|FG001|Overall Study|Withdrawal by Subject|19|||
164226371|NCT00395447|593198460|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
164226372|NCT00395447|593198461|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
164226373|NCT03766906|593198462|FG000|Overall Study|Withdrawal by Subject|6|||
164226374|NCT02624687|593198463|FG000|Overall Study|Withdrawal by Subject|1|||
164226375|NCT02624687|593198464|FG001|Overall Study|Withdrawal by Subject|1|||
164226376|NCT02624687|593198463|FG000|Overall Study|medical leave from work|0|||
164226377|NCT02624687|593198464|FG001|Overall Study|medical leave from work|1|||
164226378|NCT00836901|593198467|FG000|First Intervention|Withdrawal by Subject|1|||
164226379|NCT00836901|593198468|FG001|First Intervention|Withdrawal by Subject|0|||
164226380|NCT01047540|593198469|FG000|Overall Study|Protocol Violation|1|||
164226381|NCT01047540|593198470|FG001|Overall Study|Protocol Violation|0|||
164226382|NCT01047540|593198471|FG002|Overall Study|Protocol Violation|0|||
164226383|NCT01047540|593198472|FG003|Overall Study|Protocol Violation|0|||
164226384|NCT01047540|593198473|FG004|Overall Study|Protocol Violation|0|||
164226385|NCT01047540|593198469|FG000|Overall Study|Lost to Follow-up|1|||
164226386|NCT01047540|593198470|FG001|Overall Study|Lost to Follow-up|0|||
164226387|NCT01047540|593198471|FG002|Overall Study|Lost to Follow-up|0|||
164226388|NCT01047540|593198472|FG003|Overall Study|Lost to Follow-up|0|||
164226389|NCT01047540|593198473|FG004|Overall Study|Lost to Follow-up|0|||
164226390|NCT01047540|593198469|FG000|Overall Study|Withdrawal by Subject|1|||
164226391|NCT01047540|593198470|FG001|Overall Study|Withdrawal by Subject|0|||
164226392|NCT01047540|593198471|FG002|Overall Study|Withdrawal by Subject|3|||
164226393|NCT01047540|593198472|FG003|Overall Study|Withdrawal by Subject|0|||
164226394|NCT01047540|593198473|FG004|Overall Study|Withdrawal by Subject|1|||
164226395|NCT01047540|593198469|FG000|Overall Study|Pregnancy|1|||
164226396|NCT01047540|593198470|FG001|Overall Study|Pregnancy|0|||
164226397|NCT01047540|593198471|FG002|Overall Study|Pregnancy|0|||
164226398|NCT01047540|593198472|FG003|Overall Study|Pregnancy|0|||
164226399|NCT01047540|593198473|FG004|Overall Study|Pregnancy|0|||
164226400|NCT01047540|593198469|FG000|Overall Study|Adverse Event|1|||
164226401|NCT01047540|593198470|FG001|Overall Study|Adverse Event|0|||
164226402|NCT01047540|593198471|FG002|Overall Study|Adverse Event|0|||
164226403|NCT01047540|593198472|FG003|Overall Study|Adverse Event|0|||
164226404|NCT01047540|593198473|FG004|Overall Study|Adverse Event|0|||
164226405|NCT03032484|593198479|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
164226406|NCT03032484|593198480|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
164226407|NCT03032484|593198479|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
164226408|NCT03032484|593198480|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
164226409|NCT01689649|593198481|FG000|Overall Study|Lack of Efficacy|3|||
164226410|NCT01689649|593198481|FG000|Overall Study|Non-compliance|11|||
164226411|NCT01689649|593198481|FG000|Overall Study|Protocol Violation|3|||
164226412|NCT01689649|593198481|FG000|Overall Study|Lost to Follow-up|5|||
164226413|NCT04893811|593198482|FG000|Vaccination Phase|Death|1|||
163882476|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
163882477|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
164226414|NCT04893811|593198483|FG001|Vaccination Phase|Death|0|||
164226415|NCT04893811|593198482|FG000|Vaccination Phase|Lost to Follow-up|1|||
164226416|NCT04893811|593198483|FG001|Vaccination Phase|Lost to Follow-up|1|||
163882478|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
164226417|NCT04893811|593198482|FG000|Vaccination Phase|Protocol Violation|2|||
164226418|NCT04893811|593198483|FG001|Vaccination Phase|Protocol Violation|0|||
164226419|NCT04893811|593198482|FG000|Vaccination Phase|Withdrawal by Subject|2|||
164226420|NCT04893811|593198483|FG001|Vaccination Phase|Withdrawal by Subject|1|||
164226421|NCT04893811|593198482|FG000|Vaccination Phase|Other|0|||
164226422|NCT04893811|593198483|FG001|Vaccination Phase|Other|1|||
164226423|NCT04893811|593198482|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
164226424|NCT04893811|593198483|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
164226425|NCT04893811|593198482|FG000|Follow-up Phase|Lost to Follow-up|0|||
164226426|NCT04893811|593198483|FG001|Follow-up Phase|Lost to Follow-up|1|||
164226427|NCT00595075|593198490|FG000|Overall Study|Withdrawal by Subject|1|||
164226428|NCT00595075|593198491|FG001|Overall Study|Withdrawal by Subject|0|||
164226429|NCT05261490|593198493|FG000|Overall Study|Other|1|||
164226430|NCT05261490|593198494|FG001|Overall Study|Other|0|||
164226431|NCT05261490|593198495|FG002|Overall Study|Other|0|||
164226432|NCT05261490|593198493|FG000|Overall Study|Study Terminated by Sponsor|1|||
164226433|NCT05261490|593198494|FG001|Overall Study|Study Terminated by Sponsor|1|||
164226434|NCT05261490|593198495|FG002|Overall Study|Study Terminated by Sponsor|4|||
164226435|NCT05261490|593198493|FG000|Overall Study|Death|1|||
164226436|NCT05261490|593198494|FG001|Overall Study|Death|2|||
164226437|NCT05261490|593198495|FG002|Overall Study|Death|0|||
164226438|NCT01335685|593198499|FG000|Overall Study|Study Terminated by Sponsor|2|||
164226439|NCT01335685|593198500|FG001|Overall Study|Study Terminated by Sponsor|1|||
164226440|NCT01335685|593198501|FG002|Overall Study|Study Terminated by Sponsor|1|||
164226441|NCT01335685|593198502|FG003|Overall Study|Study Terminated by Sponsor|10|||
164226442|NCT01335685|593198503|FG004|Overall Study|Study Terminated by Sponsor|0|||
164226443|NCT01335685|593198504|FG005|Overall Study|Study Terminated by Sponsor|4|||
164226444|NCT01335685|593198505|FG006|Overall Study|Study Terminated by Sponsor|2|||
164226445|NCT01335685|593198506|FG007|Overall Study|Study Terminated by Sponsor|3|||
164226446|NCT01335685|593198499|FG000|Overall Study|Withdrawal by Subject|1|||
164226447|NCT01335685|593198500|FG001|Overall Study|Withdrawal by Subject|0|||
164226448|NCT01335685|593198501|FG002|Overall Study|Withdrawal by Subject|0|||
164226449|NCT01335685|593198502|FG003|Overall Study|Withdrawal by Subject|1|||
164226450|NCT01335685|593198503|FG004|Overall Study|Withdrawal by Subject|0|||
164226451|NCT01335685|593198504|FG005|Overall Study|Withdrawal by Subject|0|||
164226452|NCT01335685|593198505|FG006|Overall Study|Withdrawal by Subject|0|||
164226453|NCT01335685|593198506|FG007|Overall Study|Withdrawal by Subject|0|||
164226454|NCT01335685|593198499|FG000|Overall Study|Reason not Specified|0|||
164226455|NCT01335685|593198500|FG001|Overall Study|Reason not Specified|0|||
164226456|NCT01335685|593198501|FG002|Overall Study|Reason not Specified|1|||
164226457|NCT01335685|593198502|FG003|Overall Study|Reason not Specified|0|||
164226458|NCT01335685|593198503|FG004|Overall Study|Reason not Specified|0|||
164330836|NCT01462227|593588318|FG003|Second Assignment|Lost to Follow-up|0|||
164330837|NCT01462227|593588315|FG000|Second Assignment|Protocol Violation|0|||
164330838|NCT01462227|593588316|FG001|Second Assignment|Protocol Violation|1|||
164330839|NCT01462227|593588317|FG002|Second Assignment|Protocol Violation|1|||
164330840|NCT01462227|593588318|FG003|Second Assignment|Protocol Violation|0|||
164330841|NCT00586066|593588321|FG000|Overall Study|Lost to Follow-up|6|||
164330842|NCT00586066|593588322|FG001|Overall Study|Lost to Follow-up|3|||
164330843|NCT00586066|593588321|FG000|Overall Study|Lack of Efficacy|5|||
164330844|NCT00586066|593588322|FG001|Overall Study|Lack of Efficacy|3|||
164330845|NCT00586066|593588321|FG000|Overall Study|Adverse Event|2|||
164330846|NCT00586066|593588322|FG001|Overall Study|Adverse Event|2|||
164330847|NCT00586066|593588321|FG000|Overall Study|Physician Decision|1|||
164330848|NCT00586066|593588322|FG001|Overall Study|Physician Decision|0|||
164330849|NCT00586066|593588321|FG000|Overall Study|Withdrawal of consent|4|||
164330850|NCT00586066|593588322|FG001|Overall Study|Withdrawal of consent|2|||
164330851|NCT00144027|593588323|FG000|Overall Study|Lost to Follow-up|1|||
163882479|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
163882480|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
163882481|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
163882482|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
163882483|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
163882484|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
163882485|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
163882486|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
163882487|NCT03269136|591939388|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882488|NCT03269136|591939389|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882489|NCT03269136|591939390|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164226459|NCT01335685|593198504|FG005|Overall Study|Reason not Specified|1|||
164226460|NCT01335685|593198505|FG006|Overall Study|Reason not Specified|0|||
164226461|NCT01335685|593198506|FG007|Overall Study|Reason not Specified|0|||
164226462|NCT02554474|593198507|FG000|Overall Study|Protocol Violation|1|||
164226463|NCT02554474|593198508|FG001|Overall Study|Protocol Violation|1|||
164226464|NCT02554474|593198507|FG000|Overall Study|Health issue not related to the study|1|||
164330852|NCT00144027|593588324|FG001|Overall Study|Lost to Follow-up|3|||
163882490|NCT03269136|591939391|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882491|NCT03269136|591939392|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164226465|NCT02554474|593198508|FG001|Overall Study|Health issue not related to the study|0|||
164330853|NCT00144027|593588323|FG000|Overall Study|Withdrawal by Subject|2|||
164330854|NCT00144027|593588324|FG001|Overall Study|Withdrawal by Subject|2|||
164330855|NCT00144027|593588323|FG000|Overall Study|did not complete baseline assessment|0|||
164226466|NCT02554474|593198507|FG000|Overall Study|Withdrawal by Subject|1|||
164226467|NCT02554474|593198508|FG001|Overall Study|Withdrawal by Subject|1|||
164226468|NCT03211832|593198511|FG000|Overall Study|No longer with agency|32|||
164226469|NCT03211832|593198512|FG001|Overall Study|No longer with agency|49|||
164226470|NCT03211832|593198513|FG002|Overall Study|No longer with agency|30|||
164226471|NCT03211832|593198511|FG000|Overall Study|Declined survey|3|||
164226472|NCT03211832|593198512|FG001|Overall Study|Declined survey|3|||
164226473|NCT03211832|593198513|FG002|Overall Study|Declined survey|2|||
164226474|NCT03211832|593198511|FG000|Overall Study|Not available during data collection|1|||
164226475|NCT03211832|593198512|FG001|Overall Study|Not available during data collection|0|||
164226476|NCT03211832|593198513|FG002|Overall Study|Not available during data collection|2|||
164226477|NCT03777020|593198517|FG000|Overall Study|Withdrawal by Subject|4|||
164226478|NCT03777020|593198518|FG001|Overall Study|Withdrawal by Subject|4|||
164226479|NCT03777020|593198517|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
164226480|NCT03777020|593198518|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
164226481|NCT01422382|593198519|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
164226482|NCT00967499|593198520|FG000|Overall Study|Adverse Event|0|||
164226483|NCT00967499|593198521|FG001|Overall Study|Adverse Event|1|||
164226484|NCT00967499|593198520|FG000|Overall Study|Protocol Violation|1|||
164226485|NCT00967499|593198521|FG001|Overall Study|Protocol Violation|0|||
164226486|NCT00967499|593198520|FG000|Overall Study|Sponsor Decision|1|||
163882492|NCT03269136|591939393|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882493|NCT03269136|591939394|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164226487|NCT00967499|593198521|FG001|Overall Study|Sponsor Decision|0|||
164226488|NCT00967499|593198520|FG000|Overall Study|Randomized but not treated|63|||
164226489|NCT00967499|593198521|FG001|Overall Study|Randomized but not treated|59|||
164226490|NCT00420056|593198528|FG000|Overall Study|Objective progression or relapse|17|||
164226491|NCT03111732|593198532|FG000|Overall Study|Enrolled in different study|1|||
164226492|NCT03111732|593198532|FG000|Overall Study|Progressive disease|3|||
164226493|NCT03111732|593198532|FG000|Overall Study|Withdrawal by Subject|1|||
164226494|NCT00289900|593198536|FG000|Overall Study|Adverse Event|28|||
164226495|NCT00289900|593198537|FG001|Overall Study|Adverse Event|40|||
164226496|NCT00289900|593198538|FG002|Overall Study|Adverse Event|13|||
164226497|NCT00289900|593198539|FG003|Overall Study|Adverse Event|19|||
164226498|NCT00289900|593198540|FG004|Overall Study|Adverse Event|20|||
164226499|NCT00289900|593198541|FG005|Overall Study|Adverse Event|33|||
164226500|NCT00289900|593198536|FG000|Overall Study|Lost to Follow-up|7|||
164226501|NCT00289900|593198537|FG001|Overall Study|Lost to Follow-up|7|||
164226502|NCT00289900|593198538|FG002|Overall Study|Lost to Follow-up|8|||
164226503|NCT00289900|593198539|FG003|Overall Study|Lost to Follow-up|8|||
164226504|NCT00289900|593198540|FG004|Overall Study|Lost to Follow-up|4|||
164226505|NCT00289900|593198541|FG005|Overall Study|Lost to Follow-up|8|||
164226506|NCT00289900|593198536|FG000|Overall Study|Participant had flushing|18|||
164226507|NCT00289900|593198537|FG001|Overall Study|Participant had flushing|42|||
164226508|NCT00289900|593198538|FG002|Overall Study|Participant had flushing|1|||
164226509|NCT00289900|593198539|FG003|Overall Study|Participant had flushing|2|||
164226510|NCT00289900|593198540|FG004|Overall Study|Participant had flushing|0|||
164226511|NCT00289900|593198541|FG005|Overall Study|Participant had flushing|4|||
164226512|NCT00289900|593198536|FG000|Overall Study|Other|0|||
164226513|NCT00289900|593198537|FG001|Overall Study|Other|0|||
164226514|NCT00289900|593198538|FG002|Overall Study|Other|0|||
164226515|NCT00289900|593198539|FG003|Overall Study|Other|5|||
164226516|NCT00289900|593198540|FG004|Overall Study|Other|1|||
164226517|NCT00289900|593198541|FG005|Overall Study|Other|0|||
164330856|NCT00144027|593588324|FG001|Overall Study|did not complete baseline assessment|6|||
164330857|NCT00910988|593588325|FG000|Overall Study|Lost to Follow-up|2|||
164330858|NCT00910988|593588326|FG001|Overall Study|Lost to Follow-up|4|||
164330859|NCT00910988|593588327|FG002|Overall Study|Lost to Follow-up|3|||
164330860|NCT00910988|593588328|FG003|Overall Study|Lost to Follow-up|0|||
164330861|NCT01977937|593588329|FG000|Overall Study|Withdrawal by Subject|2|||
164330862|NCT01977937|593588330|FG001|Overall Study|Withdrawal by Subject|1|||
164330863|NCT01977937|593588329|FG000|Overall Study|Adverse Event|1|||
163882494|NCT03269136|591939395|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164226518|NCT00289900|593198536|FG000|Overall Study|Participant moved|1|||
164226519|NCT00289900|593198537|FG001|Overall Study|Participant moved|0|||
164226520|NCT00289900|593198538|FG002|Overall Study|Participant moved|0|||
164226521|NCT00289900|593198539|FG003|Overall Study|Participant moved|1|||
164226522|NCT00289900|593198540|FG004|Overall Study|Participant moved|1|||
164226523|NCT00289900|593198541|FG005|Overall Study|Participant moved|1|||
164226524|NCT00289900|593198536|FG000|Overall Study|Withdrawal by Subject|10|||
164226525|NCT00289900|593198537|FG001|Overall Study|Withdrawal by Subject|21|||
163882495|NCT03269136|591939396|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882496|NCT03269136|591939397|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164226526|NCT00289900|593198538|FG002|Overall Study|Withdrawal by Subject|8|||
164226527|NCT00289900|593198539|FG003|Overall Study|Withdrawal by Subject|18|||
164330864|NCT01977937|593588330|FG001|Overall Study|Adverse Event|0|||
164330865|NCT01977937|593588329|FG000|Overall Study|Physician Decision|0|||
164226528|NCT00289900|593198540|FG004|Overall Study|Withdrawal by Subject|12|||
164226529|NCT00289900|593198541|FG005|Overall Study|Withdrawal by Subject|11|||
164226530|NCT00289900|593198536|FG000|Overall Study|Protocol Violation|3|||
164226531|NCT00289900|593198537|FG001|Overall Study|Protocol Violation|9|||
164226532|NCT00289900|593198538|FG002|Overall Study|Protocol Violation|2|||
164226533|NCT00289900|593198539|FG003|Overall Study|Protocol Violation|6|||
164226534|NCT00289900|593198540|FG004|Overall Study|Protocol Violation|7|||
164226535|NCT00289900|593198541|FG005|Overall Study|Protocol Violation|4|||
164226536|NCT00289900|593198536|FG000|Overall Study|site terminated|1|||
164226537|NCT00289900|593198537|FG001|Overall Study|site terminated|0|||
164226538|NCT00289900|593198538|FG002|Overall Study|site terminated|1|||
164226539|NCT00289900|593198539|FG003|Overall Study|site terminated|0|||
164226540|NCT00289900|593198540|FG004|Overall Study|site terminated|0|||
164226541|NCT00289900|593198541|FG005|Overall Study|site terminated|0|||
164226542|NCT00289900|593198536|FG000|Overall Study|Not treated|0|||
164226543|NCT00289900|593198537|FG001|Overall Study|Not treated|1|||
164226544|NCT00289900|593198538|FG002|Overall Study|Not treated|0|||
164226545|NCT00289900|593198539|FG003|Overall Study|Not treated|0|||
164226546|NCT00289900|593198540|FG004|Overall Study|Not treated|0|||
164226547|NCT00289900|593198541|FG005|Overall Study|Not treated|0|||
164226548|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
164226549|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
164226550|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
164226551|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
164226552|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
164226553|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
164226554|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
164226555|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164226556|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
164226557|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
164226558|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
164226559|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
164226560|NCT01703221|593198542|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164226561|NCT01703221|593198543|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164226562|NCT01703221|593198544|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
164226563|NCT01703221|593198542|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
164226564|NCT01703221|593198543|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
164226565|NCT01703221|593198544|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
164226566|NCT01703221|593198542|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
164226567|NCT01703221|593198543|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
164226568|NCT01703221|593198544|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
164226569|NCT01703221|593198542|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
164226570|NCT01703221|593198543|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
164226571|NCT01703221|593198544|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
164226572|NCT01152385|593198545|FG000|Overall Study|Withdrawal by Subject|3|||
164226573|NCT01152385|593198546|FG001|Overall Study|Withdrawal by Subject|1|||
164226574|NCT01152385|593198547|FG002|Overall Study|Withdrawal by Subject|1|||
164226575|NCT01152385|593198548|FG003|Overall Study|Withdrawal by Subject|1|||
164226576|NCT01152385|593198545|FG000|Overall Study|Protocol Violation|0|||
164226577|NCT01152385|593198546|FG001|Overall Study|Protocol Violation|0|||
164226578|NCT01152385|593198547|FG002|Overall Study|Protocol Violation|0|||
164226579|NCT01152385|593198548|FG003|Overall Study|Protocol Violation|1|||
164226580|NCT01152385|593198545|FG000|Overall Study|Adverse Event|1|||
164226581|NCT01152385|593198546|FG001|Overall Study|Adverse Event|1|||
164226582|NCT01152385|593198547|FG002|Overall Study|Adverse Event|0|||
164226583|NCT01152385|593198548|FG003|Overall Study|Adverse Event|0|||
164226584|NCT01152385|593198545|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164226585|NCT01152385|593198546|FG001|Overall Study|Study-specific withdrawal criteria|1|||
164226586|NCT01152385|593198547|FG002|Overall Study|Study-specific withdrawal criteria|2|||
164226587|NCT01152385|593198548|FG003|Overall Study|Study-specific withdrawal criteria|0|||
164226588|NCT01152385|593198545|FG000|Overall Study|Other|4|||
164226589|NCT01152385|593198546|FG001|Overall Study|Other|3|||
164226590|NCT01152385|593198547|FG002|Overall Study|Other|2|||
164226591|NCT01152385|593198548|FG003|Overall Study|Other|3|||
164226592|NCT03249558|593198549|FG000|Overall Study|Lost to Follow-up|2|||
164226593|NCT03249558|593198550|FG001|Overall Study|Lost to Follow-up|1|||
164226594|NCT03249558|593198551|FG002|Overall Study|Lost to Follow-up|4|||
163986753|NCT03529773|592320230|FG037|Overall Study|Physician Decision|0|||
164226595|NCT03249558|593198549|FG000|Overall Study|Physician Decision|1|||
164226596|NCT03249558|593198550|FG001|Overall Study|Physician Decision|0|||
164226597|NCT03249558|593198551|FG002|Overall Study|Physician Decision|0|||
164226598|NCT03249558|593198549|FG000|Overall Study|Withdrawal by Subject|6|||
164226599|NCT03249558|593198550|FG001|Overall Study|Withdrawal by Subject|5|||
164226600|NCT03249558|593198551|FG002|Overall Study|Withdrawal by Subject|7|||
164226601|NCT03249558|593198549|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
164226602|NCT03249558|593198550|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
164226603|NCT03249558|593198551|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
164226604|NCT03249558|593198549|FG000|Overall Study|Protocol Violation|1|||
164226605|NCT03249558|593198550|FG001|Overall Study|Protocol Violation|1|||
164226606|NCT03249558|593198551|FG002|Overall Study|Protocol Violation|2|||
164226607|NCT02656173|593198552|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
164226608|NCT02656173|593198553|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
164226609|NCT02656173|593198552|FG000|Overall Study|Adverse Event|7|||
164226610|NCT02656173|593198553|FG001|Overall Study|Adverse Event|5|||
164226611|NCT02656173|593198552|FG000|Overall Study|Withdrawal by Subject|1|||
164226612|NCT02656173|593198553|FG001|Overall Study|Withdrawal by Subject|3|||
164226613|NCT02656173|593198552|FG000|Overall Study|Protocol Violation|0|||
164226614|NCT02656173|593198553|FG001|Overall Study|Protocol Violation|1|||
164226615|NCT02656173|593198552|FG000|Overall Study|Miscellaneous|2|||
164226616|NCT02656173|593198553|FG001|Overall Study|Miscellaneous|0|||
164226617|NCT03927846|593198557|FG000|Overall Study|Lost to Follow-up|10|||
164226618|NCT03927846|593198558|FG001|Overall Study|Lost to Follow-up|11|||
164226619|NCT03449147|593198559|FG000|52-week Treatment Period|Death|0|||
164226620|NCT03449147|593198560|FG001|52-week Treatment Period|Death|1|||
164226621|NCT03449147|593198561|FG002|52-week Treatment Period|Death|0|||
164226622|NCT03449147|593198559|FG000|52-week Treatment Period|Lost to Follow-up|6|||
164226623|NCT03449147|593198560|FG001|52-week Treatment Period|Lost to Follow-up|2|||
164226624|NCT03449147|593198561|FG002|52-week Treatment Period|Lost to Follow-up|5|||
164226625|NCT03449147|593198559|FG000|52-week Treatment Period|Other|0|||
164226626|NCT03449147|593198560|FG001|52-week Treatment Period|Other|1|||
164226627|NCT03449147|593198561|FG002|52-week Treatment Period|Other|2|||
164226628|NCT03449147|593198559|FG000|52-week Treatment Period|Physician Decision|1|||
164226629|NCT03449147|593198560|FG001|52-week Treatment Period|Physician Decision|0|||
164226630|NCT03449147|593198561|FG002|52-week Treatment Period|Physician Decision|3|||
164226631|NCT03449147|593198559|FG000|52-week Treatment Period|Screen Failure|1|||
164226632|NCT03449147|593198560|FG001|52-week Treatment Period|Screen Failure|2|||
164226633|NCT03449147|593198561|FG002|52-week Treatment Period|Screen Failure|0|||
164226634|NCT03449147|593198559|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
164226635|NCT03449147|593198560|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
164226636|NCT03449147|593198561|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
164226637|NCT03449147|593198559|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
164226638|NCT03449147|593198560|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
164226639|NCT03449147|593198561|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
164226640|NCT03449147|593198559|FG000|12-Week Off-Treatment Durability Period|Other|0|||
164226641|NCT03449147|593198560|FG001|12-Week Off-Treatment Durability Period|Other|1|||
164226642|NCT03449147|593198561|FG002|12-Week Off-Treatment Durability Period|Other|0|||
164226643|NCT00954538|593198562|FG000|Part III|Withdrawal by Subject|0|||
164226644|NCT00954538|593198563|FG001|Part III|Withdrawal by Subject|0|||
164226645|NCT00954538|593198564|FG002|Part III|Withdrawal by Subject|0|||
164226646|NCT00954538|593198565|FG003|Part III|Withdrawal by Subject|0|||
164226647|NCT00954538|593198566|FG004|Part III|Withdrawal by Subject|1|||
164226648|NCT00954538|593198567|FG005|Part III|Withdrawal by Subject|0|||
164226649|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Death|2|||
164226650|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
164226651|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
164226652|NCT00974233|593198572|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
164226653|NCT00974233|593198572|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
164226654|NCT00974233|593198572|FG000|Maintenance Lenalidomide|Adverse Event|8|||
164226655|NCT01657942|593198573|FG000|Overall Study|Alternative Treatment|7|||
163882497|NCT03269136|591939398|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164226656|NCT01657942|593198573|FG000|Overall Study|Lost to Follow-up|1|||
164226657|NCT03061214|593198576|FG000|Overall Study|Withdrawal by Subject|21|||
164226658|NCT03061214|593198577|FG001|Overall Study|Withdrawal by Subject|26|||
164226659|NCT03061214|593198578|FG002|Overall Study|Withdrawal by Subject|9|||
164226660|NCT03061214|593198576|FG000|Overall Study|Lost to Follow-up|3|||
164226661|NCT03061214|593198577|FG001|Overall Study|Lost to Follow-up|1|||
164226662|NCT03061214|593198578|FG002|Overall Study|Lost to Follow-up|1|||
164226663|NCT03061214|593198576|FG000|Overall Study|Death|1|||
164226664|NCT03061214|593198577|FG001|Overall Study|Death|1|||
164226665|NCT03061214|593198578|FG002|Overall Study|Death|0|||
164226666|NCT02904265|593199919|FG000|Overall Study|Physician Decision|1|||
164226667|NCT02904265|593199920|FG001|Overall Study|Physician Decision|2|||
164226668|NCT00185614|593199925|FG000|Inter-treatment Period|Physician Decision|1|||
164226669|NCT00185614|593199925|FG000|Inter-treatment Period|Relapse|2|||
164226670|NCT00185614|593199925|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
164226671|NCT00993473|593199929|FG000|Overall Study|Adverse Event|0|||
164226672|NCT00993473|593199930|FG001|Overall Study|Adverse Event|2|||
164226673|NCT00993473|593199929|FG000|Overall Study|Protocol Violation|1|||
164226674|NCT00993473|593199930|FG001|Overall Study|Protocol Violation|2|||
164226675|NCT00993473|593199929|FG000|Overall Study|Lost to Follow-up|1|||
164226676|NCT00993473|593199930|FG001|Overall Study|Lost to Follow-up|0|||
164226677|NCT00993473|593199929|FG000|Overall Study|Withdrawal by Subject|1|||
164226678|NCT00993473|593199930|FG001|Overall Study|Withdrawal by Subject|5|||
164226679|NCT00993473|593199929|FG000|Overall Study|Technical problem with CGM device|0|||
164226680|NCT00993473|593199930|FG001|Overall Study|Technical problem with CGM device|1|||
164226681|NCT00993473|593199929|FG000|Overall Study|Family event|1|||
164226682|NCT00993473|593199930|FG001|Overall Study|Family event|0|||
164226683|NCT00770679|593199941|FG000|Overall Study|Lost to Follow-up|3|||
164226684|NCT00770679|593199941|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
164226685|NCT01998477|593199942|FG000|Overall Study|Lost to Follow-up|4|||
164226686|NCT01998477|593199943|FG001|Overall Study|Lost to Follow-up|5|||
164226687|NCT01998477|593199942|FG000|Overall Study|Withdrawal by Subject|6|||
164226688|NCT01998477|593199943|FG001|Overall Study|Withdrawal by Subject|0|||
164226689|NCT00129974|593199944|FG000|Overall Study|Other|1|||
164226690|NCT00113373|593199949|FG000|Overall Study|Ineligible: wrong primary|1|||
164226691|NCT00113373|593199949|FG000|Overall Study|Ineligible: second primary|1|||
164226692|NCT00113373|593199949|FG000|Overall Study|Never Treated|1|||
164226693|NCT02395627|593199950|FG000|Overall Study|Withdrawal by Subject|0|||
164226694|NCT02395627|593199951|FG001|Overall Study|Withdrawal by Subject|2|||
164226695|NCT02395627|593199952|FG002|Overall Study|Withdrawal by Subject|0|||
164226696|NCT02395627|593199950|FG000|Overall Study|Did not receive pembrolizumab|3|||
164226697|NCT02395627|593199951|FG001|Overall Study|Did not receive pembrolizumab|1|||
164226698|NCT02395627|593199952|FG002|Overall Study|Did not receive pembrolizumab|0|||
164226699|NCT03253627|593199953|FG000|Overall Study|Lost to Follow-up|1|||
164226700|NCT03253627|593199954|FG001|Overall Study|Lost to Follow-up|2|||
164226701|NCT03253627|593199953|FG000|Overall Study|Withdrawal by Subject|0|||
164226702|NCT03253627|593199954|FG001|Overall Study|Withdrawal by Subject|2|||
164226703|NCT03253627|593199953|FG000|Overall Study|Inability to complete MRI|1|||
164226704|NCT03253627|593199954|FG001|Overall Study|Inability to complete MRI|0|||
164226705|NCT00979407|593199961|FG000|Overall Study|Withdrawal by Subject|3|||
164226706|NCT00979407|593199962|FG001|Overall Study|Withdrawal by Subject|4|||
164226707|NCT00979407|593199961|FG000|Overall Study|Lost to Follow-up|3|||
164226708|NCT00979407|593199962|FG001|Overall Study|Lost to Follow-up|3|||
164226709|NCT00855166|593199963|FG000|Overall Study|Adverse Event|0|||
164226710|NCT00855166|593199964|FG001|Overall Study|Adverse Event|2|||
164226711|NCT00855166|593199963|FG000|Overall Study|Death|0|||
164226712|NCT00855166|593199964|FG001|Overall Study|Death|1|||
164226713|NCT00855166|593199963|FG000|Overall Study|Withdrawal by Subject|1|||
164226714|NCT00855166|593199964|FG001|Overall Study|Withdrawal by Subject|4|||
164226715|NCT00855166|593199963|FG000|Overall Study|Poor/non-compliance|2|||
164226716|NCT00855166|593199964|FG001|Overall Study|Poor/non-compliance|0|||
164226717|NCT00855166|593199963|FG000|Overall Study|Administrative reasons by sponsor|1|||
164226718|NCT00855166|593199964|FG001|Overall Study|Administrative reasons by sponsor|0|||
164226719|NCT00855166|593199963|FG000|Overall Study|Subject no longer meets study criteria|1|||
164226720|NCT00855166|593199964|FG001|Overall Study|Subject no longer meets study criteria|1|||
164226721|NCT00489476|593199965|FG000|Overall Study|Lost to Follow-up|0|||
164226722|NCT00489476|593199966|FG001|Overall Study|Lost to Follow-up|1|||
164226723|NCT00489476|593199967|FG002|Overall Study|Lost to Follow-up|0|||
164226724|NCT00489476|593199968|FG003|Overall Study|Lost to Follow-up|0|||
164226725|NCT04003389|593199971|FG000|Overall Study|Adverse Event|27|||
164226726|NCT04003389|593199972|FG001|Overall Study|Adverse Event|34|||
164226727|NCT04003389|593199973|FG002|Overall Study|Adverse Event|28|||
164226728|NCT04003389|593199971|FG000|Overall Study|Lost to Follow-up|39|||
164330866|NCT01977937|593588330|FG001|Overall Study|Physician Decision|1|||
164330867|NCT02819518|593588333|FG000|Overall Study|Death|9|||
164330868|NCT02819518|593588334|FG001|Overall Study|Death|12|||
164330869|NCT02819518|593588335|FG002|Overall Study|Death|9|||
164330870|NCT02819518|593588336|FG003|Overall Study|Death|475|||
164330871|NCT02819518|593588337|FG004|Overall Study|Death|244|||
164330872|NCT02819518|593588333|FG000|Overall Study|Withdrawal by Subject|0|||
164330873|NCT02819518|593588334|FG001|Overall Study|Withdrawal by Subject|0|||
164330874|NCT02819518|593588335|FG002|Overall Study|Withdrawal by Subject|0|||
164330875|NCT02819518|593588336|FG003|Overall Study|Withdrawal by Subject|25|||
164330876|NCT02819518|593588337|FG004|Overall Study|Withdrawal by Subject|8|||
164330877|NCT02819518|593588333|FG000|Overall Study|Lost to Follow-up|0|||
164330878|NCT02819518|593588334|FG001|Overall Study|Lost to Follow-up|0|||
163986754|NCT03529773|592320231|FG038|Overall Study|Physician Decision|0|||
164226729|NCT04003389|593199972|FG001|Overall Study|Lost to Follow-up|30|||
164226730|NCT04003389|593199973|FG002|Overall Study|Lost to Follow-up|33|||
164226731|NCT04003389|593199971|FG000|Overall Study|Protocol Violation|1|||
164226732|NCT04003389|593199972|FG001|Overall Study|Protocol Violation|6|||
164226733|NCT04003389|593199973|FG002|Overall Study|Protocol Violation|5|||
164330879|NCT02819518|593588335|FG002|Overall Study|Lost to Follow-up|0|||
164330880|NCT02819518|593588336|FG003|Overall Study|Lost to Follow-up|0|||
164226734|NCT04003389|593199971|FG000|Overall Study|Withdrawal by Subject|119|||
164226735|NCT04003389|593199972|FG001|Overall Study|Withdrawal by Subject|79|||
164330881|NCT02819518|593588337|FG004|Overall Study|Lost to Follow-up|1|||
164330882|NCT02819518|593588333|FG000|Overall Study|Sponsor Decision|1|||
164226736|NCT04003389|593199973|FG002|Overall Study|Withdrawal by Subject|85|||
164226737|NCT04003389|593199971|FG000|Overall Study|Miscellaneous|14|||
164226738|NCT04003389|593199972|FG001|Overall Study|Miscellaneous|11|||
164226739|NCT04003389|593199973|FG002|Overall Study|Miscellaneous|14|||
164226740|NCT04003389|593199971|FG000|Overall Study|Participant did not receive study drug|1|||
164226741|NCT04003389|593199972|FG001|Overall Study|Participant did not receive study drug|0|||
164226742|NCT04003389|593199973|FG002|Overall Study|Participant did not receive study drug|0|||
164226743|NCT02514746|593199978|FG000|Overall Study|Chronically Ill|1|||
164226744|NCT02514746|593199979|FG001|Overall Study|Chronically Ill|2|||
164226745|NCT02514746|593199978|FG000|Overall Study|Physician Decision|4|||
164226746|NCT02514746|593199979|FG001|Overall Study|Physician Decision|2|||
164226747|NCT02514746|593199978|FG000|Overall Study|Withdrawal by Subject|12|||
164226748|NCT02514746|593199979|FG001|Overall Study|Withdrawal by Subject|10|||
164226749|NCT02514746|593199978|FG000|Overall Study|Other|5|||
164226750|NCT02514746|593199979|FG001|Overall Study|Other|1|||
164226751|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
164226752|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
164226753|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
164226754|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
164226755|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
164226756|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
164226757|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
164226758|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
164226759|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
164226760|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
164226761|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
164226762|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
164226763|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
164226764|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
164226765|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
164226766|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
164226767|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
164226768|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
164226769|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
164226770|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
164226771|NCT04003142|593199980|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
164226772|NCT04003142|593199981|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
164226773|NCT04003142|593199982|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
164226774|NCT04003142|593199983|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
164226775|NCT04003142|593199984|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
164226776|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
164226777|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
164226778|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
164226779|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
164226780|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
164226781|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Death|0|||
164226782|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Death|0|||
164226783|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Death|0|||
164226784|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Death|0|||
164226785|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Death|1|||
164226786|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
164226787|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
164226788|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
164226789|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
164226790|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
164226791|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226792|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226793|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
164226794|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226795|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
164226796|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
164226797|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
164226798|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
164226799|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
164226800|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
164226801|NCT04003142|593199980|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
164226802|NCT04003142|593199981|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
164226803|NCT04003142|593199982|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
164226804|NCT04003142|593199983|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
164226805|NCT04003142|593199984|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
164226806|NCT04806373|593199985|FG000|Overall Study|Withdrawal by Subject|1|||
164226807|NCT04806373|593199986|FG001|Overall Study|Withdrawal by Subject|1|||
164226808|NCT03382873|593199987|FG000|Overall Study|Lost to Follow-up|9|||
164226809|NCT03382873|593199988|FG001|Overall Study|Lost to Follow-up|10|||
164226810|NCT03382873|593199987|FG000|Overall Study|Withdrawal by Subject|6|||
164226811|NCT03382873|593199988|FG001|Overall Study|Withdrawal by Subject|11|||
164226812|NCT03382873|593199987|FG000|Overall Study|Visit not completed due to pandemic|16|||
164226813|NCT03382873|593199988|FG001|Overall Study|Visit not completed due to pandemic|41|||
164226814|NCT01450631|593199989|FG000|Overall Study|Lost to Follow-up|2|||
164226815|NCT01450631|593199990|FG001|Overall Study|Lost to Follow-up|4|||
164226816|NCT01450631|593199989|FG000|Overall Study|Withdrawal by Subject|1|||
164226817|NCT01450631|593199990|FG001|Overall Study|Withdrawal by Subject|0|||
164226818|NCT03624036|593199999|FG000|Overall Study|Death|2|||
164226819|NCT03624036|593200000|FG001|Overall Study|Death|3|||
164226820|NCT03624036|593200001|FG002|Overall Study|Death|0|||
164226821|NCT03624036|593200002|FG003|Overall Study|Death|1|||
164226822|NCT03624036|593199999|FG000|Overall Study|Withdrawal by Subject|1|||
164226823|NCT03624036|593200000|FG001|Overall Study|Withdrawal by Subject|0|||
164226824|NCT03624036|593200001|FG002|Overall Study|Withdrawal by Subject|1|||
164226825|NCT03624036|593200002|FG003|Overall Study|Withdrawal by Subject|0|||
164226826|NCT03624036|593199999|FG000|Overall Study|Enrolled but Never Treated|1|||
164226827|NCT03624036|593200000|FG001|Overall Study|Enrolled but Never Treated|0|||
164226828|NCT03624036|593200001|FG002|Overall Study|Enrolled but Never Treated|0|||
164226829|NCT03624036|593200002|FG003|Overall Study|Enrolled but Never Treated|0|||
164226830|NCT03624036|593199999|FG000|Overall Study|Reason not Specified|3|||
164226831|NCT03624036|593200000|FG001|Overall Study|Reason not Specified|0|||
164226832|NCT03624036|593200001|FG002|Overall Study|Reason not Specified|2|||
164226833|NCT03624036|593200002|FG003|Overall Study|Reason not Specified|2|||
164226834|NCT01185366|593200008|FG000|First Line Therapy|Insurance Coverage Denied|1|||
164226835|NCT01185366|593200009|FG001|First Line Therapy|Insurance Coverage Denied|1|||
164226836|NCT01185366|593200008|FG000|First Line Therapy|Withdrawal by Subject|1|||
164226837|NCT01185366|593200009|FG001|First Line Therapy|Withdrawal by Subject|0|||
164226838|NCT01185366|593200008|FG000|First Line Therapy|Lack of Metastatic Site|1|||
164226839|NCT01185366|593200009|FG001|First Line Therapy|Lack of Metastatic Site|0|||
164226840|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
164226841|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
164226842|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
164226843|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
164226844|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
164226845|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
164226846|NCT01185366|593200008|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
164226847|NCT01185366|593200009|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
164226848|NCT01390584|593200014|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
164226849|NCT01390584|593200015|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
164226850|NCT01390584|593200016|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
164226851|NCT00025233|593200017|FG000|Overall Study|Ineligible: wrong cell type|1|||
164226852|NCT00025233|593200017|FG000|Overall Study|Ineligible: wrong primary|1|||
164226853|NCT00025233|593200017|FG000|Overall Study|Ineligible: improper prior treatment|1|||
164226854|NCT00025233|593200017|FG000|Overall Study|Never treated|1|||
164226855|NCT00401830|593200018|FG000|Overall Study|Adverse Event|10|||
164226856|NCT00401830|593200019|FG001|Overall Study|Adverse Event|18|||
164226857|NCT00401830|593200018|FG000|Overall Study|Lack of Efficacy|11|||
164226858|NCT00401830|593200019|FG001|Overall Study|Lack of Efficacy|5|||
164226859|NCT00401830|593200018|FG000|Overall Study|Withdrawal by Subject|4|||
164226860|NCT00401830|593200019|FG001|Overall Study|Withdrawal by Subject|3|||
164226861|NCT00401830|593200018|FG000|Overall Study|Protocol Violation|3|||
164226862|NCT00401830|593200019|FG001|Overall Study|Protocol Violation|3|||
164226863|NCT00401830|593200018|FG000|Overall Study|Non-compliance with drug study|1|||
164226864|NCT00401830|593200019|FG001|Overall Study|Non-compliance with drug study|0|||
164226865|NCT00401830|593200018|FG000|Overall Study|Lost to Follow-up|1|||
164226866|NCT00401830|593200019|FG001|Overall Study|Lost to Follow-up|3|||
164226867|NCT00401830|593200018|FG000|Overall Study|Other: Personal / Family problems|1|||
164226868|NCT00401830|593200019|FG001|Overall Study|Other: Personal / Family problems|0|||
164226869|NCT01720602|593200020|FG000|Overall Study|Adverse Event|3|||
164226870|NCT01720602|593200020|FG000|Overall Study|Progressive disease on therapy|2|||
164226871|NCT02539394|593200021|FG000|Overall Study|Protocol Violation|1|||
164226872|NCT02539394|593200022|FG001|Overall Study|Protocol Violation|3|||
164226873|NCT02539394|593200021|FG000|Overall Study|Lost to Follow-up|1|||
164226874|NCT02539394|593200022|FG001|Overall Study|Lost to Follow-up|2|||
164226875|NCT02539394|593200021|FG000|Overall Study|Incomplete dataset|6|||
164226876|NCT02539394|593200022|FG001|Overall Study|Incomplete dataset|6|||
164226877|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
164226878|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
164226879|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
164226880|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164226881|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164226882|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
164226883|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Other|2|||
164226884|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Other|1|||
164226885|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Other|1|||
164226886|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
164226887|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
164226888|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
164226889|NCT02691494|593200025|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164226890|NCT02691494|593200026|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
164226891|NCT02691494|593200027|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
164226892|NCT04634331|593200028|FG000|Overall Study|Withdrawal by Subject|2|||
164226893|NCT04634331|593200029|FG001|Overall Study|Withdrawal by Subject|2|||
164226894|NCT00461812|593200034|FG000|Overall Study|study terminated|10|||
164226895|NCT02916433|593200035|FG000|Overall Study|Withdrawal by Subject|1|||
164226896|NCT02916433|593200036|FG001|Overall Study|Withdrawal by Subject|0|||
164226897|NCT02916433|593200035|FG000|Overall Study|Physician Decision|1|||
164226898|NCT02916433|593200036|FG001|Overall Study|Physician Decision|0|||
164226899|NCT01694771|593200037|FG000|Overall Study|Adverse Event|18|||
164226900|NCT01694771|593200038|FG001|Overall Study|Adverse Event|16|||
164226901|NCT01694771|593200037|FG000|Overall Study|Lack of Efficacy|1|||
164226902|NCT01694771|593200038|FG001|Overall Study|Lack of Efficacy|0|||
164226903|NCT01694771|593200037|FG000|Overall Study|Non compliance protocol|7|||
164226904|NCT01694771|593200038|FG001|Overall Study|Non compliance protocol|6|||
164226905|NCT01694771|593200037|FG000|Overall Study|Lost to Follow-up|2|||
164226906|NCT01694771|593200038|FG001|Overall Study|Lost to Follow-up|3|||
164226907|NCT01694771|593200037|FG000|Overall Study|Consent withdrawn|7|||
164226908|NCT01694771|593200038|FG001|Overall Study|Consent withdrawn|9|||
164226909|NCT01694771|593200037|FG000|Overall Study|Other reasons|5|||
164226910|NCT01694771|593200038|FG001|Overall Study|Other reasons|6|||
164226911|NCT00890097|593200039|FG000|Overall Study|Adverse Event|21|||
164226912|NCT00890097|593200040|FG001|Overall Study|Adverse Event|32|||
164226913|NCT00890097|593200041|FG002|Overall Study|Adverse Event|28|||
164226914|NCT00890097|593200039|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
164226915|NCT00890097|593200040|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
164226916|NCT00890097|593200041|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
164226917|NCT00890097|593200039|FG000|Overall Study|Withdrew Consent|9|||
164226918|NCT00890097|593200040|FG001|Overall Study|Withdrew Consent|6|||
164226919|NCT00890097|593200041|FG002|Overall Study|Withdrew Consent|9|||
164226920|NCT00890097|593200039|FG000|Overall Study|Lost to Follow-up|5|||
164226921|NCT00890097|593200040|FG001|Overall Study|Lost to Follow-up|5|||
164226922|NCT00890097|593200041|FG002|Overall Study|Lost to Follow-up|5|||
164226923|NCT00890097|593200039|FG000|Overall Study|Noncompliance|0|||
164226924|NCT00890097|593200040|FG001|Overall Study|Noncompliance|4|||
164226925|NCT00890097|593200041|FG002|Overall Study|Noncompliance|4|||
164226926|NCT00890097|593200039|FG000|Overall Study|Sponsor Decision|7|||
164226927|NCT00890097|593200040|FG001|Overall Study|Sponsor Decision|11|||
164226928|NCT00890097|593200041|FG002|Overall Study|Sponsor Decision|7|||
164226929|NCT00890097|593200039|FG000|Overall Study|Did not attend final visit|2|||
164226930|NCT00890097|593200040|FG001|Overall Study|Did not attend final visit|3|||
164226931|NCT00890097|593200041|FG002|Overall Study|Did not attend final visit|0|||
164226932|NCT00890097|593200039|FG000|Overall Study|Subject Decision|3|||
164226933|NCT00890097|593200040|FG001|Overall Study|Subject Decision|2|||
164226934|NCT00890097|593200041|FG002|Overall Study|Subject Decision|6|||
164226935|NCT00890097|593200039|FG000|Overall Study|Randomization Error|2|||
164226936|NCT00890097|593200040|FG001|Overall Study|Randomization Error|0|||
164226937|NCT00890097|593200041|FG002|Overall Study|Randomization Error|0|||
164226938|NCT00890097|593200039|FG000|Overall Study|Failed inclusion criteria|3|||
164226939|NCT00890097|593200040|FG001|Overall Study|Failed inclusion criteria|4|||
164226940|NCT00890097|593200041|FG002|Overall Study|Failed inclusion criteria|0|||
164226941|NCT00890097|593200039|FG000|Overall Study|Transportation|0|||
164226942|NCT00890097|593200040|FG001|Overall Study|Transportation|2|||
164226943|NCT00890097|593200041|FG002|Overall Study|Transportation|0|||
164226944|NCT00890097|593200039|FG000|Overall Study|Subject Moved|0|||
164226945|NCT00890097|593200040|FG001|Overall Study|Subject Moved|4|||
164330883|NCT02819518|593588334|FG001|Overall Study|Sponsor Decision|1|||
164226946|NCT00890097|593200041|FG002|Overall Study|Subject Moved|0|||
164226947|NCT00890097|593200039|FG000|Overall Study|Protocol Deviation|1|||
163986755|NCT03529773|592320232|FG039|Overall Study|Physician Decision|0|||
164330884|NCT02819518|593588335|FG002|Overall Study|Sponsor Decision|0|||
164330885|NCT02819518|593588336|FG003|Overall Study|Sponsor Decision|34|||
164226948|NCT00890097|593200040|FG001|Overall Study|Protocol Deviation|1|||
164226949|NCT00890097|593200041|FG002|Overall Study|Protocol Deviation|1|||
164226950|NCT03878069|593200048|FG000|Overall Study|Death|0|||
164226951|NCT03878069|593200049|FG001|Overall Study|Death|1|||
164226952|NCT03878069|593200050|FG002|Overall Study|Death|0|||
164226953|NCT00834587|593200051|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164226954|NCT00834587|593200052|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164226955|NCT02536339|593200054|FG000|Overall Study|Death|20|||
164330886|NCT02819518|593588337|FG004|Overall Study|Sponsor Decision|17|||
164226956|NCT02536339|593200054|FG000|Overall Study|Withdrawal by Subject|3|||
164226957|NCT02536339|593200054|FG000|Overall Study|Lost to Follow-up|2|||
164226958|NCT02536339|593200054|FG000|Overall Study|Treatment discontinued|2|||
164226959|NCT02536339|593200054|FG000|Overall Study|Physician Decision|1|||
164226960|NCT01691092|593200055|FG000|Overall Study|Lost to Follow-up|10|||
164226961|NCT01691092|593200055|FG000|Overall Study|Physician Decision|4|||
164226962|NCT01691092|593200055|FG000|Overall Study|Withdrawal by Subject|3|||
164226963|NCT01691092|593200055|FG000|Overall Study|non-compliance|3|||
164226964|NCT01691092|593200055|FG000|Overall Study|used for different study|2|||
164226965|NCT01691092|593200055|FG000|Overall Study|screen fail|19|||
163882498|NCT03269136|591939399|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882499|NCT03269136|591939400|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164226966|NCT03727022|593201305|FG000|Phase A|Lost to Follow-up|2|||
164226967|NCT03727022|593201306|FG001|Phase A|Lost to Follow-up|3|||
164226968|NCT03727022|593201305|FG000|Phase A|Withdrawal by Subject|10|||
164226969|NCT03727022|593201306|FG001|Phase A|Withdrawal by Subject|9|||
164226970|NCT03727022|593201305|FG000|Phase B|Lost to Follow-up|0|||
164226971|NCT03727022|593201306|FG001|Phase B|Lost to Follow-up|1|||
164226972|NCT03727022|593201305|FG000|Phase B|Subject Non-Compliance|1|||
164226973|NCT03727022|593201306|FG001|Phase B|Subject Non-Compliance|0|||
164226974|NCT03727022|593201305|FG000|Phase B|Withdrawal by Subject|3|||
164226975|NCT03727022|593201306|FG001|Phase B|Withdrawal by Subject|3|||
164226976|NCT03727022|593201305|FG000|Phase B|Site Closure|4|||
164226977|NCT03727022|593201306|FG001|Phase B|Site Closure|0|||
164226978|NCT05550818|593201307|FG000|Overall Study|Protocol Violation|1|||
164226979|NCT05550818|593201308|FG001|Overall Study|Protocol Violation|1|||
164226980|NCT05550818|593201307|FG000|Overall Study|Withdrawal by Subject|2|||
164226981|NCT05550818|593201308|FG001|Overall Study|Withdrawal by Subject|1|||
164226982|NCT00581100|593201309|FG000|Overall Study|Death|1|||
164226983|NCT00581100|593201310|FG001|Overall Study|Death|0|||
164226984|NCT00581100|593201309|FG000|Overall Study|Adverse Event|2|||
164226985|NCT00581100|593201310|FG001|Overall Study|Adverse Event|1|||
164226986|NCT00581100|593201309|FG000|Overall Study|Withdrawal by Subject|1|||
164226987|NCT00581100|593201310|FG001|Overall Study|Withdrawal by Subject|4|||
164226988|NCT00581100|593201309|FG000|Overall Study|Other|3|||
164226989|NCT00581100|593201310|FG001|Overall Study|Other|0|||
164226990|NCT00590317|593201311|FG000|Overall Study|Lack of Efficacy|1|||
164226991|NCT00590317|593201312|FG001|Overall Study|Lack of Efficacy|5|||
164226992|NCT03031912|593201313|FG000|Overall Study|Lost to Follow-up|1|||
164226993|NCT03031912|593201314|FG001|Overall Study|Lost to Follow-up|1|||
164226994|NCT03031912|593201315|FG002|Overall Study|Lost to Follow-up|0|||
164226995|NCT03031912|593201316|FG003|Overall Study|Lost to Follow-up|1|||
164226996|NCT03031912|593201317|FG004|Overall Study|Lost to Follow-up|0|||
164226997|NCT03031912|593201318|FG005|Overall Study|Lost to Follow-up|0|||
164226998|NCT03031912|593201319|FG006|Overall Study|Lost to Follow-up|0|||
164226999|NCT03031912|593201320|FG007|Overall Study|Lost to Follow-up|0|||
164227000|NCT03031912|593201321|FG008|Overall Study|Lost to Follow-up|0|||
164227001|NCT03031912|593201322|FG009|Overall Study|Lost to Follow-up|0|||
164227002|NCT04097743|593201325|FG000|Overall Study|Non-compliance of the study instruction.|1|||
164227003|NCT04097743|593201326|FG001|Overall Study|Non-compliance of the study instruction.|0|||
164227004|NCT05562934|593201337|FG000|Overall Study|Adverse Event|0|||
164227005|NCT05562934|593201338|FG001|Overall Study|Adverse Event|2|||
164227006|NCT05562934|593201339|FG002|Overall Study|Adverse Event|0|||
164227007|NCT05562934|593201340|FG003|Overall Study|Adverse Event|0|||
164227008|NCT05562934|593201341|FG004|Overall Study|Adverse Event|2|||
164227009|NCT05562934|593201337|FG000|Overall Study|Lost to Follow-up|0|||
164227010|NCT05562934|593201338|FG001|Overall Study|Lost to Follow-up|0|||
164227011|NCT05562934|593201339|FG002|Overall Study|Lost to Follow-up|0|||
164227012|NCT05562934|593201340|FG003|Overall Study|Lost to Follow-up|0|||
164227013|NCT05562934|593201341|FG004|Overall Study|Lost to Follow-up|1|||
164227014|NCT05562934|593201337|FG000|Overall Study|Protocol Violation|0|||
164227015|NCT05562934|593201338|FG001|Overall Study|Protocol Violation|0|||
164227016|NCT05562934|593201339|FG002|Overall Study|Protocol Violation|0|||
164227017|NCT05562934|593201340|FG003|Overall Study|Protocol Violation|1|||
164330887|NCT02819518|593588333|FG000|Overall Study|Transferred to extension study|1|||
164330888|NCT02819518|593588334|FG001|Overall Study|Transferred to extension study|1|||
164227018|NCT05562934|593201341|FG004|Overall Study|Protocol Violation|1|||
164227019|NCT05562934|593201337|FG000|Overall Study|Withdrawal by Subject|0|||
164227020|NCT05562934|593201338|FG001|Overall Study|Withdrawal by Subject|0|||
164227021|NCT05562934|593201339|FG002|Overall Study|Withdrawal by Subject|1|||
164227022|NCT05562934|593201340|FG003|Overall Study|Withdrawal by Subject|1|||
164227023|NCT05562934|593201341|FG004|Overall Study|Withdrawal by Subject|0|||
164227024|NCT05365217|593201342|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164227025|NCT05365217|593201343|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164227026|NCT03997383|593201344|FG000|Double-blind Treatment Period|Adverse Event|4|||
164227027|NCT03997383|593201345|FG001|Double-blind Treatment Period|Adverse Event|3|||
164227028|NCT03997383|593201344|FG000|Double-blind Treatment Period|Death|4|||
164227029|NCT03997383|593201345|FG001|Double-blind Treatment Period|Death|4|||
164330889|NCT02819518|593588335|FG002|Overall Study|Transferred to extension study|1|||
164227030|NCT03997383|593201344|FG000|Double-blind Treatment Period|Physician Decision|2|||
164227031|NCT03997383|593201345|FG001|Double-blind Treatment Period|Physician Decision|0|||
164227032|NCT03997383|593201344|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
164227033|NCT03997383|593201345|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
164227034|NCT03997383|593201344|FG000|Open-label Extension Period|Ongoing|148|||
164227035|NCT03997383|593201345|FG001|Open-label Extension Period|Ongoing|151|||
164227036|NCT03997383|593201344|FG000|Open-label Extension Period|Adverse Event|4|||
164227037|NCT03997383|593201345|FG001|Open-label Extension Period|Adverse Event|1|||
164227038|NCT03997383|593201344|FG000|Open-label Extension Period|Death|8|||
164227039|NCT03997383|593201345|FG001|Open-label Extension Period|Death|9|||
164227040|NCT03997383|593201344|FG000|Open-label Extension Period|Physician Decision|1|||
164227041|NCT03997383|593201345|FG001|Open-label Extension Period|Physician Decision|1|||
164227042|NCT03997383|593201344|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
164227043|NCT03997383|593201345|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
164227044|NCT03997383|593201344|FG000|Open-label Extension Period|Reason Not Specified|2|||
164227045|NCT03997383|593201345|FG001|Open-label Extension Period|Reason Not Specified|0|||
164227046|NCT00069953|593201348|FG000|Overall Study|Protocol Violation|2|||
164227047|NCT02940223|593201349|FG000|Overall Study|Failed Requirement|2|||
164227048|NCT02940223|593201350|FG001|Overall Study|Failed Requirement|0|||
164227049|NCT05528510|593201352|FG000|Overall Study|Death|1|||
164227050|NCT05528510|593201353|FG001|Overall Study|Death|0|||
164227051|NCT05528510|593201354|FG002|Overall Study|Death|0|||
164227052|NCT05528510|593201352|FG000|Overall Study|Lost to Follow-up|1|||
164227053|NCT05528510|593201353|FG001|Overall Study|Lost to Follow-up|0|||
164227054|NCT05528510|593201354|FG002|Overall Study|Lost to Follow-up|0|||
164227055|NCT05528510|593201352|FG000|Overall Study|Withdrawal by Subject|4|||
164227056|NCT05528510|593201353|FG001|Overall Study|Withdrawal by Subject|1|||
164227057|NCT05528510|593201354|FG002|Overall Study|Withdrawal by Subject|3|||
164227058|NCT05528510|593201352|FG000|Overall Study|Other|2|||
164227059|NCT05528510|593201353|FG001|Overall Study|Other|2|||
164227060|NCT05528510|593201354|FG002|Overall Study|Other|1|||
164227061|NCT01856478|593201357|FG000|Overall Study|Not treated|0|||
164227062|NCT01856478|593201358|FG001|Overall Study|Not treated|8|||
164227063|NCT01856478|593201357|FG000|Overall Study|Progressive disease per RECIST|146|||
164227064|NCT01856478|593201358|FG001|Overall Study|Progressive disease per RECIST|49|||
164227065|NCT01856478|593201357|FG000|Overall Study|Worsening of underlying cancer|6|||
164227066|NCT01856478|593201358|FG001|Overall Study|Worsening of underlying cancer|2|||
164227067|NCT01856478|593201357|FG000|Overall Study|Adverse events|57|||
164227068|NCT01856478|593201358|FG001|Overall Study|Adverse events|30|||
164227069|NCT01856478|593201357|FG000|Overall Study|Non-compliant with protocol|1|||
164227070|NCT01856478|593201358|FG001|Overall Study|Non-compliant with protocol|1|||
164227071|NCT01856478|593201357|FG000|Overall Study|Lost to Follow-up|1|||
164227072|NCT01856478|593201358|FG001|Overall Study|Lost to Follow-up|1|||
164227073|NCT01856478|593201357|FG000|Overall Study|Refused to continue trial medication|13|||
164227074|NCT01856478|593201358|FG001|Overall Study|Refused to continue trial medication|11|||
164227075|NCT01856478|593201357|FG000|Overall Study|Other reason than listed|4|||
164227076|NCT01856478|593201358|FG001|Overall Study|Other reason than listed|10|||
164227077|NCT05032820|593201359|FG000|Overall Study|Lost to Follow-up|1|||
164227078|NCT05032820|593201359|FG000|Overall Study|Withdrawal by Subject|1|||
164227079|NCT04108208|593201360|FG000|Overall Study|Withdrawal by Subject|2|||
164227080|NCT04108208|593201361|FG001|Overall Study|Withdrawal by Subject|6|||
164227081|NCT04108208|593201360|FG000|Overall Study|other-ongoing|20|||
164227082|NCT04108208|593201361|FG001|Overall Study|other-ongoing|40|||
164227083|NCT04108208|593201360|FG000|Overall Study|Death|1|||
164227084|NCT04108208|593201361|FG001|Overall Study|Death|4|||
164227085|NCT04108208|593201360|FG000|Overall Study|Lost to Follow-up|2|||
164227086|NCT04108208|593201361|FG001|Overall Study|Lost to Follow-up|0|||
164227087|NCT04936308|593201362|FG000|Overall Study|Death|0|||
164227088|NCT04936308|593201363|FG001|Overall Study|Death|0|||
164227089|NCT04936308|593201364|FG002|Overall Study|Death|1|||
164227090|NCT04936308|593201362|FG000|Overall Study|Withdrawal by Subject|6|||
164227091|NCT04936308|593201363|FG001|Overall Study|Withdrawal by Subject|3|||
164227092|NCT04936308|593201364|FG002|Overall Study|Withdrawal by Subject|0|||
164227093|NCT04936308|593201362|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
164227094|NCT04936308|593201363|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
164227095|NCT04936308|593201364|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
164227096|NCT04936308|593201362|FG000|Overall Study|Completed protocol-required follow-up|1|||
164227097|NCT04936308|593201363|FG001|Overall Study|Completed protocol-required follow-up|2|||
164227098|NCT04936308|593201364|FG002|Overall Study|Completed protocol-required follow-up|2|||
164227099|NCT04936308|593201362|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
164227100|NCT04936308|593201363|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
164227101|NCT04936308|593201364|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
164227102|NCT04936308|593201362|FG000|Overall Study|Other|3|||
164227103|NCT04936308|593201363|FG001|Overall Study|Other|0|||
164227104|NCT04936308|593201364|FG002|Overall Study|Other|2|||
164227105|NCT04770272|593201365|FG000|Overall Study|Death|1|||
164227106|NCT04770272|593201366|FG001|Overall Study|Death|0|||
164227107|NCT04770272|593201365|FG000|Overall Study|Withdrawal by Subject|11|||
164227108|NCT04770272|593201366|FG001|Overall Study|Withdrawal by Subject|12|||
164227109|NCT04770272|593201365|FG000|Overall Study|Protocol Violation|0|||
164227110|NCT04770272|593201366|FG001|Overall Study|Protocol Violation|2|||
164227111|NCT04770272|593201365|FG000|Overall Study|Adverse Event|23|||
164227112|NCT04770272|593201366|FG001|Overall Study|Adverse Event|21|||
164227113|NCT04770272|593201365|FG000|Overall Study|Physician Decision|7|||
164227114|NCT04770272|593201366|FG001|Overall Study|Physician Decision|3|||
164227115|NCT04770272|593201365|FG000|Overall Study|Disease progression|4|||
164227116|NCT04770272|593201366|FG001|Overall Study|Disease progression|8|||
164227117|NCT04770272|593201365|FG000|Overall Study|Switched to other therapy.|0|||
164227118|NCT04770272|593201366|FG001|Overall Study|Switched to other therapy.|2|||
164227119|NCT02363946|593201367|FG000|Overall Study|Lost to Follow-up|0|||
164227120|NCT02363946|593201368|FG001|Overall Study|Lost to Follow-up|0|||
164227121|NCT02363946|593201369|FG002|Overall Study|Lost to Follow-up|0|||
164227122|NCT02363946|593201370|FG003|Overall Study|Lost to Follow-up|0|||
164227123|NCT02363946|593201371|FG004|Overall Study|Lost to Follow-up|0|||
164227124|NCT02363946|593201372|FG005|Overall Study|Lost to Follow-up|0|||
164227125|NCT02363946|593201373|FG006|Overall Study|Lost to Follow-up|0|||
164227126|NCT02363946|593201374|FG007|Overall Study|Lost to Follow-up|1|||
164227127|NCT02363946|593201375|FG008|Overall Study|Lost to Follow-up|0|||
164227128|NCT02363946|593201376|FG009|Overall Study|Lost to Follow-up|0|||
164227129|NCT02363946|593201377|FG010|Overall Study|Lost to Follow-up|0|||
164227130|NCT02363946|593201378|FG011|Overall Study|Lost to Follow-up|0|||
164227131|NCT02363946|593201379|FG012|Overall Study|Lost to Follow-up|0|||
164227132|NCT03769116|593201382|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
164227133|NCT03769116|593201383|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
164227134|NCT03769116|593201382|FG000|Part 3 - Open Label|Physician Decision|1|||
164227135|NCT03769116|593201383|FG001|Part 3 - Open Label|Physician Decision|0|||
164227136|NCT03769116|593201382|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
164227137|NCT03769116|593201383|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
164227138|NCT03030261|593201385|FG000|Overall Study|Still receiving continuation therapy|5|||
164227139|NCT01615029|593201386|FG000|Overall Study|Adverse Event|1|||
164227140|NCT01615029|593201387|FG001|Overall Study|Adverse Event|0|||
164227141|NCT01615029|593201388|FG002|Overall Study|Adverse Event|3|||
164227142|NCT01615029|593201389|FG003|Overall Study|Adverse Event|0|||
164227143|NCT01615029|593201390|FG004|Overall Study|Adverse Event|4|||
164227144|NCT01615029|593201386|FG000|Overall Study|Progressive disease|1|||
164227145|NCT01615029|593201387|FG001|Overall Study|Progressive disease|1|||
164227146|NCT01615029|593201388|FG002|Overall Study|Progressive disease|1|||
164227147|NCT01615029|593201389|FG003|Overall Study|Progressive disease|1|||
164227148|NCT01615029|593201390|FG004|Overall Study|Progressive disease|10|||
164227149|NCT01615029|593201386|FG000|Overall Study|Physician Decision|0|||
164227150|NCT01615029|593201387|FG001|Overall Study|Physician Decision|0|||
164227151|NCT01615029|593201388|FG002|Overall Study|Physician Decision|0|||
164227152|NCT01615029|593201389|FG003|Overall Study|Physician Decision|0|||
164227153|NCT01615029|593201390|FG004|Overall Study|Physician Decision|2|||
164227154|NCT04903093|593201391|FG000|Overall Study|Withdrawal by Subject|0|||
164227155|NCT04903093|593201392|FG001|Overall Study|Withdrawal by Subject|0|||
164227156|NCT04903093|593201393|FG002|Overall Study|Withdrawal by Subject|0|||
164227157|NCT04903093|593201394|FG003|Overall Study|Withdrawal by Subject|1|||
164227158|NCT04903093|593201395|FG004|Overall Study|Withdrawal by Subject|0|||
164227159|NCT04903093|593201396|FG005|Overall Study|Withdrawal by Subject|0|||
164227160|NCT01539525|593201406|FG000|Overall Study|Lost to Follow-up|19|||
164227161|NCT01539525|593201407|FG001|Overall Study|Lost to Follow-up|12|||
164227162|NCT01539525|593201408|FG002|Overall Study|Lost to Follow-up|11|||
164227163|NCT01539525|593201406|FG000|Overall Study|Withdrawal by Subject|0|||
164227164|NCT01539525|593201407|FG001|Overall Study|Withdrawal by Subject|3|||
164227165|NCT01539525|593201408|FG002|Overall Study|Withdrawal by Subject|2|||
164227166|NCT01539525|593201406|FG000|Overall Study|Protocol Violation|1|||
164227167|NCT01539525|593201407|FG001|Overall Study|Protocol Violation|1|||
164227168|NCT01539525|593201408|FG002|Overall Study|Protocol Violation|4|||
164227169|NCT02268851|593201409|FG000|Overall Study|Death|0|||
164330890|NCT02819518|593588336|FG003|Overall Study|Transferred to extension study|32|||
164227170|NCT02268851|593201410|FG001|Overall Study|Death|0|||
164227171|NCT02268851|593201411|FG002|Overall Study|Death|0|||
164227172|NCT02268851|593201412|FG003|Overall Study|Death|1|||
164227173|NCT02268851|593201413|FG004|Overall Study|Death|2|||
164330891|NCT02819518|593588337|FG004|Overall Study|Transferred to extension study|11|||
164227174|NCT02268851|593201414|FG005|Overall Study|Death|1|||
164227175|NCT02268851|593201409|FG000|Overall Study|Adverse Event|0|||
164227176|NCT02268851|593201410|FG001|Overall Study|Adverse Event|0|||
164227177|NCT02268851|593201411|FG002|Overall Study|Adverse Event|0|||
164227178|NCT02268851|593201412|FG003|Overall Study|Adverse Event|0|||
164227179|NCT02268851|593201413|FG004|Overall Study|Adverse Event|2|||
164227180|NCT02268851|593201414|FG005|Overall Study|Adverse Event|2|||
164330892|NCT02766465|593588338|FG000|Overall Study|Withdrawal by Subject|0|||
164227181|NCT02268851|593201409|FG000|Overall Study|Withdrawal by Subject|0|||
164227182|NCT02268851|593201410|FG001|Overall Study|Withdrawal by Subject|0|||
164227183|NCT02268851|593201411|FG002|Overall Study|Withdrawal by Subject|0|||
164227184|NCT02268851|593201412|FG003|Overall Study|Withdrawal by Subject|2|||
164227185|NCT02268851|593201413|FG004|Overall Study|Withdrawal by Subject|0|||
164227186|NCT02268851|593201414|FG005|Overall Study|Withdrawal by Subject|1|||
164227187|NCT02268851|593201409|FG000|Overall Study|Progressive Disease|1|||
164227188|NCT02268851|593201410|FG001|Overall Study|Progressive Disease|3|||
164227189|NCT02268851|593201411|FG002|Overall Study|Progressive Disease|0|||
164227190|NCT02268851|593201412|FG003|Overall Study|Progressive Disease|0|||
164227191|NCT02268851|593201413|FG004|Overall Study|Progressive Disease|1|||
164227192|NCT02268851|593201414|FG005|Overall Study|Progressive Disease|4|||
164227193|NCT02268851|593201409|FG000|Overall Study|Physician Decision|0|||
164227194|NCT02268851|593201410|FG001|Overall Study|Physician Decision|0|||
164227195|NCT02268851|593201411|FG002|Overall Study|Physician Decision|1|||
164227196|NCT02268851|593201412|FG003|Overall Study|Physician Decision|0|||
164227197|NCT02268851|593201413|FG004|Overall Study|Physician Decision|0|||
164227198|NCT02268851|593201414|FG005|Overall Study|Physician Decision|1|||
164227199|NCT02268851|593201409|FG000|Overall Study|Patient Compliance|0|||
164227200|NCT02268851|593201410|FG001|Overall Study|Patient Compliance|0|||
164227201|NCT02268851|593201411|FG002|Overall Study|Patient Compliance|0|||
164227202|NCT02268851|593201412|FG003|Overall Study|Patient Compliance|0|||
164227203|NCT02268851|593201413|FG004|Overall Study|Patient Compliance|1|||
164227204|NCT02268851|593201414|FG005|Overall Study|Patient Compliance|1|||
164227205|NCT02268851|593201409|FG000|Overall Study|Co-Morbid Condition|0|||
164227206|NCT02268851|593201410|FG001|Overall Study|Co-Morbid Condition|0|||
164227207|NCT02268851|593201411|FG002|Overall Study|Co-Morbid Condition|0|||
164227208|NCT02268851|593201412|FG003|Overall Study|Co-Morbid Condition|0|||
164227209|NCT02268851|593201413|FG004|Overall Study|Co-Morbid Condition|1|||
164227210|NCT02268851|593201414|FG005|Overall Study|Co-Morbid Condition|1|||
164227211|NCT03425188|593201416|FG000|Overall Study|Withdrawal by Subject|1|||
164227212|NCT02184442|593201417|FG000|Overall Study|Death|61|||
164227213|NCT02184442|593201418|FG001|Overall Study|Death|65|||
164227214|NCT02184442|593201417|FG000|Overall Study|Withdrawal by Subject|3|||
164227215|NCT02184442|593201418|FG001|Overall Study|Withdrawal by Subject|11|||
164227216|NCT00787800|593201419|FG000|Overall Study|Withdrawal by Subject|3|||
164227217|NCT00787800|593201420|FG001|Overall Study|Withdrawal by Subject|5|||
164227218|NCT00787800|593201419|FG000|Overall Study|Death|0|||
164227219|NCT00787800|593201420|FG001|Overall Study|Death|2|||
164227220|NCT03810495|593201421|FG000|Overall Study|Lost to Follow-up|2|||
164227221|NCT03810495|593201421|FG000|Overall Study|Withdrawal by Subject|1|||
164227222|NCT01905683|593201424|FG000|Overall Study|Protocol Violation|1|||
164227223|NCT01905683|593201424|FG000|Overall Study|Re-injection criteria not met; others|13|||
164227224|NCT01905683|593201424|FG000|Overall Study|Physician Decision|1|||
164227225|NCT01905683|593201424|FG000|Overall Study|Lack of Efficacy|8|||
164227226|NCT01905683|593201424|FG000|Overall Study|Withdrawal by Subject|20|||
164227227|NCT01905683|593201424|FG000|Overall Study|Adverse Event|4|||
164227228|NCT01905683|593201424|FG000|Overall Study|Lost to Follow-up|4|||
164227229|NCT02037984|593201427|FG000|Overall Study|Lack of Efficacy|0|||
164227230|NCT02037984|593201428|FG001|Overall Study|Lack of Efficacy|0|||
164227231|NCT02037984|593201429|FG002|Overall Study|Lack of Efficacy|3|||
164227232|NCT02037984|593201430|FG003|Overall Study|Lack of Efficacy|10|||
164227233|NCT02037984|593201431|FG004|Overall Study|Lack of Efficacy|2|||
164227234|NCT02037984|593201432|FG005|Overall Study|Lack of Efficacy|2|||
164227235|NCT02037984|593201433|FG006|Overall Study|Lack of Efficacy|4|||
164227236|NCT02037984|593201434|FG007|Overall Study|Lack of Efficacy|3|||
164227237|NCT02037984|593201427|FG000|Overall Study|Lost to Follow-up|1|||
164227238|NCT02037984|593201428|FG001|Overall Study|Lost to Follow-up|0|||
164227239|NCT02037984|593201429|FG002|Overall Study|Lost to Follow-up|3|||
164227240|NCT02037984|593201430|FG003|Overall Study|Lost to Follow-up|5|||
164227241|NCT02037984|593201431|FG004|Overall Study|Lost to Follow-up|2|||
164227242|NCT02037984|593201432|FG005|Overall Study|Lost to Follow-up|2|||
164227243|NCT02037984|593201433|FG006|Overall Study|Lost to Follow-up|2|||
164227244|NCT02037984|593201434|FG007|Overall Study|Lost to Follow-up|4|||
164227245|NCT02037984|593201427|FG000|Overall Study|Physician Decision|0|||
164227246|NCT02037984|593201428|FG001|Overall Study|Physician Decision|0|||
164227247|NCT02037984|593201429|FG002|Overall Study|Physician Decision|0|||
164227248|NCT02037984|593201430|FG003|Overall Study|Physician Decision|0|||
164227249|NCT02037984|593201431|FG004|Overall Study|Physician Decision|0|||
164227250|NCT02037984|593201432|FG005|Overall Study|Physician Decision|0|||
164227251|NCT02037984|593201433|FG006|Overall Study|Physician Decision|1|||
164227252|NCT02037984|593201434|FG007|Overall Study|Physician Decision|0|||
164227253|NCT02037984|593201427|FG000|Overall Study|Protocol Violation|0|||
164227254|NCT02037984|593201428|FG001|Overall Study|Protocol Violation|0|||
164227255|NCT02037984|593201429|FG002|Overall Study|Protocol Violation|0|||
164227256|NCT02037984|593201430|FG003|Overall Study|Protocol Violation|0|||
164227257|NCT02037984|593201431|FG004|Overall Study|Protocol Violation|0|||
164227258|NCT02037984|593201432|FG005|Overall Study|Protocol Violation|1|||
164227259|NCT02037984|593201433|FG006|Overall Study|Protocol Violation|2|||
164227260|NCT02037984|593201434|FG007|Overall Study|Protocol Violation|0|||
164227261|NCT02037984|593201427|FG000|Overall Study|Technical Problems|0|||
164227262|NCT02037984|593201428|FG001|Overall Study|Technical Problems|0|||
164227263|NCT02037984|593201429|FG002|Overall Study|Technical Problems|3|||
164227264|NCT02037984|593201430|FG003|Overall Study|Technical Problems|3|||
164227265|NCT02037984|593201431|FG004|Overall Study|Technical Problems|2|||
164227266|NCT02037984|593201432|FG005|Overall Study|Technical Problems|3|||
164227267|NCT02037984|593201433|FG006|Overall Study|Technical Problems|4|||
164227268|NCT02037984|593201434|FG007|Overall Study|Technical Problems|2|||
164227269|NCT02037984|593201427|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164227270|NCT02037984|593201428|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164081744|NCT01271933|592663309|FG001|Double-Blind Phase|Adverse Event|3|||
164081745|NCT01271933|592663310|FG002|Double-Blind Phase|Adverse Event|0|||
164081746|NCT01271933|592663308|FG000|Double-Blind Phase|Participant request-personal reason|0|||
164227271|NCT02037984|593201429|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
164227272|NCT02037984|593201430|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
164227273|NCT02037984|593201431|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
164227274|NCT02037984|593201432|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
164227275|NCT02037984|593201433|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
164227276|NCT02037984|593201434|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
164227277|NCT02037984|593201427|FG000|Overall Study|Withdrawal by Subject|0|||
164227278|NCT02037984|593201428|FG001|Overall Study|Withdrawal by Subject|0|||
164227279|NCT02037984|593201429|FG002|Overall Study|Withdrawal by Subject|0|||
164227280|NCT02037984|593201430|FG003|Overall Study|Withdrawal by Subject|1|||
164227281|NCT02037984|593201431|FG004|Overall Study|Withdrawal by Subject|1|||
164227282|NCT02037984|593201432|FG005|Overall Study|Withdrawal by Subject|3|||
164227283|NCT02037984|593201433|FG006|Overall Study|Withdrawal by Subject|0|||
164227284|NCT02037984|593201434|FG007|Overall Study|Withdrawal by Subject|1|||
164227285|NCT04924608|593202553|FG000|Overall Study|Adverse Event|10|||
164227286|NCT04924608|593202554|FG001|Overall Study|Adverse Event|6|||
164227287|NCT04924608|593202553|FG000|Overall Study|Lost to Follow-up|1|||
164227288|NCT04924608|593202554|FG001|Overall Study|Lost to Follow-up|1|||
164227289|NCT04924608|593202553|FG000|Overall Study|Ongoing at the data cut-off date|54|||
164227290|NCT04924608|593202554|FG001|Overall Study|Ongoing at the data cut-off date|60|||
164227291|NCT04924608|593202553|FG000|Overall Study|Progressive Disease|2|||
164227292|NCT04924608|593202554|FG001|Overall Study|Progressive Disease|0|||
164227293|NCT04924608|593202553|FG000|Overall Study|Withdrawal by Subject|3|||
164227294|NCT04924608|593202554|FG001|Overall Study|Withdrawal by Subject|6|||
164227295|NCT04924608|593202553|FG000|Overall Study|Other reason|1|||
164227296|NCT04924608|593202554|FG001|Overall Study|Other reason|1|||
164227297|NCT05415215|593202555|FG000|Neoadjuvant Phase|Adverse Event|0|||
164227298|NCT05415215|593202556|FG001|Neoadjuvant Phase|Adverse Event|8|||
164227299|NCT05415215|593202557|FG002|Neoadjuvant Phase|Adverse Event|0|||
164227300|NCT05415215|593202558|FG003|Neoadjuvant Phase|Adverse Event|0|||
164227301|NCT05415215|593202559|FG004|Neoadjuvant Phase|Adverse Event|0|||
164227302|NCT05415215|593202560|FG005|Neoadjuvant Phase|Adverse Event|0|||
164227303|NCT05415215|593202561|FG006|Neoadjuvant Phase|Adverse Event|0|||
164227304|NCT05415215|593202562|FG007|Neoadjuvant Phase|Adverse Event|0|||
164227305|NCT05415215|593202555|FG000|Neoadjuvant Phase|Death|0|||
164227306|NCT05415215|593202556|FG001|Neoadjuvant Phase|Death|4|||
164227307|NCT05415215|593202557|FG002|Neoadjuvant Phase|Death|0|||
164330893|NCT02766465|593588339|FG001|Overall Study|Withdrawal by Subject|10|||
164330894|NCT01505647|593588340|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
164330895|NCT01505647|593588341|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
164330896|NCT01505647|593588340|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
164330897|NCT01505647|593588341|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
164330898|NCT01505647|593588340|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
164330899|NCT01505647|593588341|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
164330900|NCT01505647|593588340|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
164330901|NCT01505647|593588341|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
164330902|NCT01505647|593588340|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
164330903|NCT01505647|593588341|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
164227308|NCT05415215|593202558|FG003|Neoadjuvant Phase|Death|0|||
164227309|NCT05415215|593202559|FG004|Neoadjuvant Phase|Death|0|||
164227310|NCT05415215|593202560|FG005|Neoadjuvant Phase|Death|0|||
164227311|NCT05415215|593202561|FG006|Neoadjuvant Phase|Death|0|||
164227312|NCT05415215|593202562|FG007|Neoadjuvant Phase|Death|0|||
164330904|NCT01907100|593588342|FG000|Overall Study|PD based on modified RECIST criteria|31|||
164081747|NCT01271933|592663309|FG001|Double-Blind Phase|Participant request-personal reason|1|||
164081748|NCT01271933|592663310|FG002|Double-Blind Phase|Participant request-personal reason|0|||
164227313|NCT05415215|593202555|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
164227314|NCT05415215|593202556|FG001|Neoadjuvant Phase|Withdrawal by Subject|11|||
164330905|NCT01907100|593588343|FG001|Overall Study|PD based on modified RECIST criteria|32|||
164081749|NCT01620983|592663311|FG000|Overall Study|Lost to Follow-up|8|||
164227315|NCT05415215|593202557|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227316|NCT05415215|593202558|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227317|NCT05415215|593202559|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
164330906|NCT01907100|593588344|FG002|Overall Study|PD based on modified RECIST criteria|95|||
164330907|NCT01907100|593588345|FG003|Overall Study|PD based on modified RECIST criteria|92|||
164330908|NCT01907100|593588342|FG000|Overall Study|Withdrawal by Subject|2|||
164330909|NCT01907100|593588343|FG001|Overall Study|Withdrawal by Subject|5|||
164330910|NCT01907100|593588344|FG002|Overall Study|Withdrawal by Subject|10|||
164330911|NCT01907100|593588345|FG003|Overall Study|Withdrawal by Subject|13|||
164081750|NCT01620983|592663312|FG001|Overall Study|Lost to Follow-up|4|||
164081751|NCT01620983|592663313|FG002|Overall Study|Lost to Follow-up|9|||
164081752|NCT01620983|592663311|FG000|Overall Study|Withdrawal by Subject|6|||
164081753|NCT01620983|592663312|FG001|Overall Study|Withdrawal by Subject|8|||
164081754|NCT01620983|592663313|FG002|Overall Study|Withdrawal by Subject|1|||
164081755|NCT01620983|592663311|FG000|Overall Study|Death|2|||
164081756|NCT01620983|592663312|FG001|Overall Study|Death|0|||
164081757|NCT01620983|592663313|FG002|Overall Study|Death|0|||
164081758|NCT01620983|592663311|FG000|Overall Study|Physician Decision|3|||
164081759|NCT01620983|592663312|FG001|Overall Study|Physician Decision|10|||
164081760|NCT01620983|592663313|FG002|Overall Study|Physician Decision|5|||
164081761|NCT03156270|592663316|FG000|Overall Study|Failed pre-treatment screening|1|||
164081762|NCT03156270|592663316|FG000|Overall Study|Lost to Follow-up|1|||
164081763|NCT00591253|592663317|FG000|Overall Study|Adverse Event|3|||
164081764|NCT00591253|592663318|FG001|Overall Study|Adverse Event|3|||
164081765|NCT00591253|592663319|FG002|Overall Study|Adverse Event|1|||
164081766|NCT00591253|592663317|FG000|Overall Study|Protocol Violation|2|||
164081767|NCT00591253|592663318|FG001|Overall Study|Protocol Violation|2|||
164081768|NCT00591253|592663319|FG002|Overall Study|Protocol Violation|2|||
164081769|NCT00591253|592663317|FG000|Overall Study|Lost to Follow-up|2|||
164081770|NCT00591253|592663318|FG001|Overall Study|Lost to Follow-up|4|||
164081771|NCT00591253|592663319|FG002|Overall Study|Lost to Follow-up|0|||
164081772|NCT00591253|592663317|FG000|Overall Study|Withdrawal by Subject|1|||
164081773|NCT00591253|592663318|FG001|Overall Study|Withdrawal by Subject|7|||
164081774|NCT00591253|592663319|FG002|Overall Study|Withdrawal by Subject|6|||
164081775|NCT00591253|592663317|FG000|Overall Study|Lack of Efficacy|1|||
164081776|NCT00591253|592663318|FG001|Overall Study|Lack of Efficacy|0|||
164081777|NCT00591253|592663319|FG002|Overall Study|Lack of Efficacy|3|||
164081778|NCT00591253|592663317|FG000|Overall Study|Other|5|||
164081779|NCT00591253|592663318|FG001|Overall Study|Other|5|||
164081780|NCT00591253|592663319|FG002|Overall Study|Other|3|||
164081781|NCT01783730|592663323|FG000|Overall Study|Failed to meet inclusion criteria|6|||
164081782|NCT01841359|592663324|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
164081783|NCT01841359|592663324|FG000|Overall Study|Concommitant medical issues|2|||
164081784|NCT01841359|592663324|FG000|Overall Study|Adverse Event|3|||
164081785|NCT01841359|592663324|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
164081786|NCT00871169|592663325|FG000|Overall Study|Protocol Violation|1|||
164081787|NCT00871169|592663325|FG000|Overall Study|Patient did not receive study treatment|2|||
164081788|NCT01752920|592663328|FG000|Overall Study|Adverse Event|1|||
164081789|NCT01752920|592663329|FG001|Overall Study|Adverse Event|0|||
164081790|NCT01752920|592663330|FG002|Overall Study|Adverse Event|5|||
164081791|NCT01752920|592663331|FG003|Overall Study|Adverse Event|10|||
164081792|NCT01752920|592663328|FG000|Overall Study|Clinical Disease Progression|6|||
164081793|NCT01752920|592663329|FG001|Overall Study|Clinical Disease Progression|4|||
164081794|NCT01752920|592663330|FG002|Overall Study|Clinical Disease Progression|1|||
164081795|NCT01752920|592663331|FG003|Overall Study|Clinical Disease Progression|13|||
164081796|NCT01752920|592663328|FG000|Overall Study|Physician Decision|1|||
164081797|NCT01752920|592663329|FG001|Overall Study|Physician Decision|0|||
164081798|NCT01752920|592663330|FG002|Overall Study|Physician Decision|0|||
164081799|NCT01752920|592663331|FG003|Overall Study|Physician Decision|3|||
164081800|NCT01752920|592663328|FG000|Overall Study|Radiographic Disease Progression|20|||
164081801|NCT01752920|592663329|FG001|Overall Study|Radiographic Disease Progression|7|||
164081802|NCT01752920|592663330|FG002|Overall Study|Radiographic Disease Progression|12|||
164081803|NCT01752920|592663331|FG003|Overall Study|Radiographic Disease Progression|29|||
164081804|NCT01752920|592663328|FG000|Overall Study|Study Terminated by Sponsor|0|||
164081805|NCT01752920|592663329|FG001|Overall Study|Study Terminated by Sponsor|0|||
164081806|NCT01752920|592663330|FG002|Overall Study|Study Terminated by Sponsor|0|||
164081807|NCT01752920|592663331|FG003|Overall Study|Study Terminated by Sponsor|1|||
164081808|NCT01752920|592663328|FG000|Overall Study|Withdrawal by Subject|0|||
164081809|NCT01752920|592663329|FG001|Overall Study|Withdrawal by Subject|1|||
164081810|NCT01752920|592663330|FG002|Overall Study|Withdrawal by Subject|0|||
164081811|NCT01752920|592663331|FG003|Overall Study|Withdrawal by Subject|1|||
164330912|NCT01907100|593588342|FG000|Overall Study|Protocol Violation|0|||
164081812|NCT01752920|592663328|FG000|Overall Study|Lack of clinical benefit|1|||
164081813|NCT01752920|592663329|FG001|Overall Study|Lack of clinical benefit|1|||
164081814|NCT01752920|592663330|FG002|Overall Study|Lack of clinical benefit|1|||
164081815|NCT01752920|592663331|FG003|Overall Study|Lack of clinical benefit|1|||
164081816|NCT00771901|592663334|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
164081817|NCT00771901|592663335|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
164081818|NCT00771901|592663336|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
164330913|NCT01907100|593588343|FG001|Overall Study|Protocol Violation|0|||
164330914|NCT01907100|593588344|FG002|Overall Study|Protocol Violation|1|||
164330915|NCT01907100|593588345|FG003|Overall Study|Protocol Violation|1|||
164330916|NCT01907100|593588342|FG000|Overall Study|Lost to Follow-up|0|||
164330917|NCT01907100|593588343|FG001|Overall Study|Lost to Follow-up|0|||
164330918|NCT01907100|593588344|FG002|Overall Study|Lost to Follow-up|0|||
164330919|NCT01907100|593588345|FG003|Overall Study|Lost to Follow-up|1|||
164330920|NCT01907100|593588342|FG000|Overall Study|Not treated|2|||
164330921|NCT01907100|593588343|FG001|Overall Study|Not treated|0|||
164330922|NCT01907100|593588344|FG002|Overall Study|Not treated|1|||
164330923|NCT01907100|593588345|FG003|Overall Study|Not treated|2|||
164081819|NCT01328054|592663339|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
164081820|NCT01328054|592663340|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
164081821|NCT01328054|592663339|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
164081822|NCT01328054|592663340|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
164081823|NCT01328054|592663339|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
164081824|NCT01328054|592663340|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
164081825|NCT01855126|592663341|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
164081826|NCT01855126|592663342|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
164081827|NCT01855126|592663341|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
164081828|NCT01855126|592663342|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
164081829|NCT01298596|592663345|FG000|Overall Study|Withdrawal by Subject|1|||
164081830|NCT01298596|592663346|FG001|Overall Study|Withdrawal by Subject|1|||
164081831|NCT01298596|592663345|FG000|Overall Study|Death|5|||
164081832|NCT01298596|592663346|FG001|Overall Study|Death|3|||
164081833|NCT01298596|592663345|FG000|Overall Study|Lost to Follow-up|6|||
164081834|NCT01298596|592663346|FG001|Overall Study|Lost to Follow-up|14|||
164081835|NCT01298596|592663345|FG000|Overall Study|Referred for further management|16|||
164081836|NCT01298596|592663346|FG001|Overall Study|Referred for further management|15|||
164081837|NCT01629693|592663347|FG000|Overall Study|Lost to Follow-up|2|||
164081838|NCT01629693|592663348|FG001|Overall Study|Lost to Follow-up|4|||
164081839|NCT01629693|592663347|FG000|Overall Study|Withdrawal by Subject|2|||
164081840|NCT01629693|592663348|FG001|Overall Study|Withdrawal by Subject|2|||
164330924|NCT01907100|593588342|FG000|Overall Study|Other than reasons specified|1|||
164330925|NCT01907100|593588343|FG001|Overall Study|Other than reasons specified|0|||
164330926|NCT01907100|593588344|FG002|Overall Study|Other than reasons specified|10|||
164081841|NCT01629693|592663347|FG000|Overall Study|Adverse Event|1|||
164081842|NCT01629693|592663348|FG001|Overall Study|Adverse Event|0|||
164081843|NCT01629693|592663347|FG000|Overall Study|Investigator decision|0|||
164081844|NCT01629693|592663348|FG001|Overall Study|Investigator decision|1|||
164081845|NCT01629693|592663347|FG000|Overall Study|Poor comfort of study lenses|0|||
164081846|NCT01629693|592663348|FG001|Overall Study|Poor comfort of study lenses|2|||
164081847|NCT01629693|592663347|FG000|Overall Study|Subject decision unrelated to AE|0|||
164081848|NCT01629693|592663348|FG001|Overall Study|Subject decision unrelated to AE|1|||
164081849|NCT03740100|592663349|FG000|Overall Study|Adverse Event|1|||
164081850|NCT03740100|592663349|FG000|Overall Study|Death|1|||
164081851|NCT00185211|592663355|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
164081852|NCT00185211|592663356|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
164081853|NCT00185211|592663355|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
164081854|NCT00185211|592663356|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
164081855|NCT00185211|592663355|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
164081856|NCT00185211|592663356|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
164081857|NCT00185211|592663355|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
164081858|NCT00185211|592663356|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
164081859|NCT00185211|592663355|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
164081860|NCT00185211|592663356|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
164081861|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
164081862|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
164081863|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
164081864|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
164081865|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
164081866|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
164081867|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
164081868|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
164081869|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
164081870|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
164081871|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
164081872|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
164081873|NCT00185211|592663355|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
164330927|NCT01907100|593588345|FG003|Overall Study|Other than reasons specified|6|||
164330928|NCT01907100|593588342|FG000|Overall Study|Adverse event (AE)|6|||
164227318|NCT05415215|593202560|FG005|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227319|NCT05415215|593202561|FG006|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227320|NCT05415215|593202562|FG007|Neoadjuvant Phase|Withdrawal by Subject|0|||
164227321|NCT05415215|593202555|FG000|Neoadjuvant Phase|Progressive Disease|0|||
164227322|NCT05415215|593202556|FG001|Neoadjuvant Phase|Progressive Disease|2|||
164227323|NCT05415215|593202557|FG002|Neoadjuvant Phase|Progressive Disease|0|||
164081874|NCT00185211|592663356|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
164227324|NCT05415215|593202558|FG003|Neoadjuvant Phase|Progressive Disease|0|||
164227325|NCT05415215|593202559|FG004|Neoadjuvant Phase|Progressive Disease|0|||
164081875|NCT00254397|592663357|FG000|Overall Study|Disease Progression|4|||
164081876|NCT00254397|592663358|FG001|Overall Study|Disease Progression|1|||
164081877|NCT00254397|592663359|FG002|Overall Study|Disease Progression|16|||
164081878|NCT00254397|592663360|FG003|Overall Study|Disease Progression|23|||
164081879|NCT00254397|592663357|FG000|Overall Study|Non-Compliant|0|||
164081880|NCT00254397|592663358|FG001|Overall Study|Non-Compliant|0|||
164081881|NCT00254397|592663359|FG002|Overall Study|Non-Compliant|0|||
164081882|NCT00254397|592663360|FG003|Overall Study|Non-Compliant|1|||
164081883|NCT00254397|592663357|FG000|Overall Study|Adverse Event|2|||
164081884|NCT00254397|592663358|FG001|Overall Study|Adverse Event|0|||
164081885|NCT00254397|592663359|FG002|Overall Study|Adverse Event|3|||
164081886|NCT00254397|592663360|FG003|Overall Study|Adverse Event|1|||
164227326|NCT05415215|593202560|FG005|Neoadjuvant Phase|Progressive Disease|0|||
164227327|NCT05415215|593202561|FG006|Neoadjuvant Phase|Progressive Disease|0|||
164227328|NCT05415215|593202562|FG007|Neoadjuvant Phase|Progressive Disease|0|||
164081887|NCT01759537|592663361|FG000|Overall Study|Death|1|||
164081888|NCT01759537|592663362|FG001|Overall Study|Death|1|||
164081889|NCT01759537|592663361|FG000|Overall Study|Pregnancy|1|||
164081890|NCT01759537|592663362|FG001|Overall Study|Pregnancy|1|||
164081891|NCT01759537|592663361|FG000|Overall Study|Lost to Follow-up|9|||
164081892|NCT01759537|592663362|FG001|Overall Study|Lost to Follow-up|9|||
164081893|NCT01759537|592663361|FG000|Overall Study|Accident involving jaw fracture|1|||
164081894|NCT01759537|592663362|FG001|Overall Study|Accident involving jaw fracture|1|||
164081895|NCT01759537|592663361|FG000|Overall Study|Subcrestal implant too coronal|1|||
164081896|NCT01759537|592663362|FG001|Overall Study|Subcrestal implant too coronal|1|||
164081897|NCT01715415|592663366|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
164081898|NCT01715415|592663367|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
164081899|NCT01715415|592663366|FG000|Double-blind Treatment|Adverse Event|3|||
164081900|NCT01715415|592663367|FG001|Double-blind Treatment|Adverse Event|0|||
164081901|NCT01715415|592663366|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
164081902|NCT01715415|592663367|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
164081903|NCT01715415|592663366|FG000|Double-blind Treatment|Other|1|||
164081904|NCT01715415|592663367|FG001|Double-blind Treatment|Other|0|||
164081905|NCT01715415|592663366|FG000|Open-label Treatment|Adverse Event|0|||
164081906|NCT01715415|592663367|FG001|Open-label Treatment|Adverse Event|1|||
164081907|NCT01715415|592663366|FG000|Open-label Treatment|Subject Noncompliant|0|||
164081908|NCT01715415|592663367|FG001|Open-label Treatment|Subject Noncompliant|1|||
164081909|NCT01015612|592663368|FG000|Overall Study|Death|113|||
164081910|NCT01015612|592663368|FG000|Overall Study|Withdrawal by Subject|40|||
164227329|NCT05415215|593202555|FG000|Neoadjuvant Phase|Reason not Specified|1|||
164081911|NCT00420290|592663369|FG000|Overall Study|Adverse Event|3|||
164081912|NCT00420290|592663370|FG001|Overall Study|Adverse Event|1|||
164081913|NCT00420290|592663369|FG000|Overall Study|Withdrawal by Subject|0|||
164227330|NCT05415215|593202556|FG001|Neoadjuvant Phase|Reason not Specified|4|||
164227331|NCT05415215|593202557|FG002|Neoadjuvant Phase|Reason not Specified|0|||
164227332|NCT05415215|593202558|FG003|Neoadjuvant Phase|Reason not Specified|0|||
164227333|NCT05415215|593202559|FG004|Neoadjuvant Phase|Reason not Specified|0|||
164227334|NCT05415215|593202560|FG005|Neoadjuvant Phase|Reason not Specified|0|||
164227335|NCT05415215|593202561|FG006|Neoadjuvant Phase|Reason not Specified|0|||
164227336|NCT05415215|593202562|FG007|Neoadjuvant Phase|Reason not Specified|0|||
164227337|NCT05415215|593202555|FG000|Neoadjuvant Phase|Treatment Intolerance|1|||
164227338|NCT05415215|593202556|FG001|Neoadjuvant Phase|Treatment Intolerance|1|||
164227339|NCT05415215|593202557|FG002|Neoadjuvant Phase|Treatment Intolerance|0|||
164227340|NCT05415215|593202558|FG003|Neoadjuvant Phase|Treatment Intolerance|0|||
164227341|NCT05415215|593202559|FG004|Neoadjuvant Phase|Treatment Intolerance|0|||
164227342|NCT05415215|593202560|FG005|Neoadjuvant Phase|Treatment Intolerance|0|||
164227343|NCT05415215|593202561|FG006|Neoadjuvant Phase|Treatment Intolerance|0|||
164227344|NCT05415215|593202562|FG007|Neoadjuvant Phase|Treatment Intolerance|0|||
164227345|NCT05415215|593202555|FG000|Neoadjuvant Phase|Lost to Follow-up|1|||
164227346|NCT05415215|593202556|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
164227347|NCT05415215|593202557|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
164227348|NCT05415215|593202558|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
164227349|NCT05415215|593202559|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
164227350|NCT05415215|593202560|FG005|Neoadjuvant Phase|Lost to Follow-up|0|||
164227351|NCT05415215|593202561|FG006|Neoadjuvant Phase|Lost to Follow-up|0|||
164227352|NCT05415215|593202562|FG007|Neoadjuvant Phase|Lost to Follow-up|0|||
164227353|NCT05415215|593202555|FG000|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227354|NCT05415215|593202556|FG001|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227355|NCT05415215|593202557|FG002|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227356|NCT05415215|593202558|FG003|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
164227357|NCT05415215|593202559|FG004|Adjuvant Phase: Cross-over Period|Adverse Event|1|||
164227358|NCT05415215|593202560|FG005|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227359|NCT05415215|593202561|FG006|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227360|NCT05415215|593202562|FG007|Adjuvant Phase: Cross-over Period|Adverse Event|0|||
164227361|NCT05415215|593202555|FG000|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227362|NCT05415215|593202556|FG001|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227363|NCT05415215|593202557|FG002|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227364|NCT05415215|593202558|FG003|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
164227365|NCT05415215|593202559|FG004|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|1|||
164081914|NCT00420290|592663370|FG001|Overall Study|Withdrawal by Subject|2|||
164081915|NCT00420290|592663369|FG000|Overall Study|did not meet inclusion/exclusion|1|||
164081916|NCT00420290|592663370|FG001|Overall Study|did not meet inclusion/exclusion|1|||
164081917|NCT05028751|592663371|FG000|Overall Study|Study Terminated by Sponsor|3|||
164081918|NCT05028751|592663372|FG001|Overall Study|Study Terminated by Sponsor|0|||
164081919|NCT05028751|592663373|FG002|Overall Study|Study Terminated by Sponsor|0|||
164081920|NCT05028751|592663374|FG003|Overall Study|Study Terminated by Sponsor|0|||
164227366|NCT05415215|593202560|FG005|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227367|NCT05415215|593202561|FG006|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227368|NCT05415215|593202562|FG007|Adjuvant Phase: Cross-over Period|Withdrawal by Subject|0|||
164227369|NCT05415215|593202555|FG000|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227370|NCT05415215|593202556|FG001|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164081921|NCT05028751|592663371|FG000|Overall Study|Death|9|||
164081922|NCT05028751|592663372|FG001|Overall Study|Death|3|||
164081923|NCT05028751|592663373|FG002|Overall Study|Death|2|||
164081924|NCT05028751|592663374|FG003|Overall Study|Death|4|||
164081925|NCT05028751|592663371|FG000|Overall Study|Withdrawal by Subject|0|||
164081926|NCT05028751|592663372|FG001|Overall Study|Withdrawal by Subject|0|||
164081927|NCT05028751|592663373|FG002|Overall Study|Withdrawal by Subject|1|||
164081928|NCT05028751|592663374|FG003|Overall Study|Withdrawal by Subject|0|||
164081929|NCT05028751|592663371|FG000|Overall Study|Miscellaneous|2|||
164081930|NCT05028751|592663372|FG001|Overall Study|Miscellaneous|0|||
164081931|NCT05028751|592663373|FG002|Overall Study|Miscellaneous|0|||
164081932|NCT05028751|592663374|FG003|Overall Study|Miscellaneous|0|||
164081933|NCT04578548|592663375|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
164081934|NCT04578548|592663376|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
164081935|NCT04578548|592663375|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
164081936|NCT04578548|592663376|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
164081937|NCT04578548|592663375|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
164081938|NCT04578548|592663376|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
164081939|NCT04578548|592663375|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
164081940|NCT04578548|592663376|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
164081941|NCT04578548|592663375|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
164081942|NCT04578548|592663376|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
164081943|NCT04578548|592663375|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
164081944|NCT04578548|592663376|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
164081945|NCT00972153|592663379|FG000|Overall Study|Equipment malfunction during case|0|||
164081946|NCT00972153|592663380|FG001|Overall Study|Equipment malfunction during case|1|||
164081947|NCT00972153|592663381|FG002|Overall Study|Equipment malfunction during case|0|||
164081948|NCT01077713|592663386|FG000|Overall Study|Withdrawal by Subject|1|||
164081949|NCT01077713|592663387|FG001|Overall Study|Withdrawal by Subject|2|||
164081950|NCT01077713|592663386|FG000|Overall Study|Progressive Disease (PD)|0|||
164081951|NCT01077713|592663387|FG001|Overall Study|Progressive Disease (PD)|1|||
164081952|NCT01077713|592663386|FG000|Overall Study|Death|28|||
164081953|NCT01077713|592663387|FG001|Overall Study|Death|29|||
164081954|NCT01077713|592663386|FG000|Overall Study|Lost to Follow-up|1|||
164081955|NCT01077713|592663387|FG001|Overall Study|Lost to Follow-up|1|||
164081956|NCT01077713|592663386|FG000|Overall Study|Adverse Event|2|||
164081957|NCT01077713|592663387|FG001|Overall Study|Adverse Event|1|||
164081958|NCT01077713|592663386|FG000|Overall Study|Other|4|||
164081959|NCT01077713|592663387|FG001|Overall Study|Other|2|||
164227371|NCT05415215|593202557|FG002|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164330929|NCT01907100|593588343|FG001|Overall Study|Adverse event (AE)|3|||
164081960|NCT04136626|592663388|FG000|Treatment Phase|Withdrawal by Subject|1|||
164227372|NCT05415215|593202558|FG003|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227373|NCT05415215|593202559|FG004|Adjuvant Phase: Cross-over Period|Treatment Intolerance|1|||
164330930|NCT01907100|593588344|FG002|Overall Study|Adverse event (AE)|22|||
164081961|NCT04136626|592663389|FG001|Treatment Phase|Withdrawal by Subject|9|||
164081962|NCT04136626|592663388|FG000|Treatment Phase|Adverse Event|1|||
164081963|NCT04136626|592663389|FG001|Treatment Phase|Adverse Event|0|||
164227374|NCT05415215|593202560|FG005|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227375|NCT05415215|593202561|FG006|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227376|NCT05415215|593202562|FG007|Adjuvant Phase: Cross-over Period|Treatment Intolerance|0|||
164227377|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227378|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227379|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227380|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227381|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227382|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227383|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Adverse Event|1|||
164227384|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Adverse Event|0|||
164227385|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227386|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227387|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227388|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227389|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227390|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|1|||
164227391|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227392|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Non-compliance With Study Drug|0|||
164227393|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227394|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227395|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227396|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227397|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227398|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Withdrawal by Subject|1|||
164227399|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227400|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Withdrawal by Subject|0|||
164227401|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227402|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227403|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227404|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227405|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227406|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
164227407|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Progressive Disease|1|||
164227408|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Progressive Disease|0|||
164227409|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227410|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227411|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227412|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227413|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227414|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227415|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Reason not Specified|1|||
164227416|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Reason not Specified|0|||
164227417|NCT05415215|593202555|FG000|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227418|NCT05415215|593202556|FG001|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227419|NCT05415215|593202557|FG002|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227420|NCT05415215|593202558|FG003|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227421|NCT05415215|593202559|FG004|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
164227422|NCT05415215|593202560|FG005|Adjuvant Phase: Continuation Period|Ongoing in Treatment|11|||
163882500|NCT03269136|591939401|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163882501|NCT03269136|591939402|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
163882502|NCT03269136|591939403|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882503|NCT03269136|591939404|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
163882504|NCT03269136|591939405|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
163882505|NCT03269136|591939388|FG000|Part 2A: Dose Expansion|Other|0|||
163882506|NCT03269136|591939389|FG001|Part 2A: Dose Expansion|Other|0|||
164081964|NCT04136626|592663388|FG000|Treatment Phase|Lost to Follow-up|1|||
164081965|NCT04136626|592663389|FG001|Treatment Phase|Lost to Follow-up|5|||
164081966|NCT04136626|592663388|FG000|12-month Follow-up|Lost to Follow-up|8|||
164081967|NCT04136626|592663389|FG001|12-month Follow-up|Lost to Follow-up|7|||
163882507|NCT03269136|591939390|FG002|Part 2A: Dose Expansion|Other|0|||
163882508|NCT03269136|591939391|FG003|Part 2A: Dose Expansion|Other|0|||
164227423|NCT05415215|593202561|FG006|Adjuvant Phase: Continuation Period|Ongoing in Treatment|9|||
164227424|NCT05415215|593202562|FG007|Adjuvant Phase: Continuation Period|Ongoing in Treatment|0|||
163882509|NCT03269136|591939392|FG004|Part 2A: Dose Expansion|Other|0|||
163882510|NCT03269136|591939393|FG005|Part 2A: Dose Expansion|Other|0|||
164227425|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227426|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227427|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227428|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227429|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227430|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227431|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|0|||
164227432|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Adverse Event|5|||
164227433|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227434|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227435|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227436|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227437|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227438|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227439|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Death|0|||
164227440|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Death|1|||
164227441|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227442|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227443|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227444|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227445|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227446|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227447|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|0|||
164227448|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Withdrawal by Subject|2|||
164227449|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227450|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227451|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227452|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227453|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227454|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227455|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|0|||
164227456|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Physician Decision|1|||
164227457|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227458|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227459|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227460|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227461|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227462|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227463|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|0|||
164227464|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Reason not Specified|2|||
164227465|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227466|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227467|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227468|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227469|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227470|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227471|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|0|||
164227472|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Treatment intolerance|4|||
164330931|NCT01907100|593588345|FG003|Overall Study|Adverse event (AE)|23|||
163882511|NCT03269136|591939394|FG006|Part 2A: Dose Expansion|Other|0|||
163882512|NCT03269136|591939395|FG007|Part 2A: Dose Expansion|Other|0|||
163882513|NCT03269136|591939396|FG008|Part 2A: Dose Expansion|Other|0|||
163882514|NCT03269136|591939397|FG009|Part 2A: Dose Expansion|Other|0|||
163882515|NCT03269136|591939398|FG010|Part 2A: Dose Expansion|Other|0|||
163882516|NCT03269136|591939399|FG011|Part 2A: Dose Expansion|Other|0|||
163882517|NCT03269136|591939400|FG012|Part 2A: Dose Expansion|Other|0|||
163882518|NCT03269136|591939401|FG013|Part 2A: Dose Expansion|Other|0|||
163882519|NCT03269136|591939402|FG014|Part 2A: Dose Expansion|Other|0|||
163882520|NCT03269136|591939403|FG015|Part 2A: Dose Expansion|Other|0|||
163882521|NCT03269136|591939404|FG016|Part 2A: Dose Expansion|Other|0|||
163882522|NCT03269136|591939405|FG017|Part 2A: Dose Expansion|Other|1|||
163882523|NCT03269136|591939388|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882524|NCT03269136|591939389|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882525|NCT03269136|591939390|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882526|NCT03269136|591939391|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882527|NCT03269136|591939392|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882528|NCT03269136|591939393|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882529|NCT03269136|591939394|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882530|NCT03269136|591939395|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882531|NCT03269136|591939396|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882532|NCT03269136|591939397|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882533|NCT03269136|591939398|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882534|NCT03269136|591939399|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882535|NCT03269136|591939400|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882536|NCT03269136|591939401|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882537|NCT03269136|591939402|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882538|NCT03269136|591939403|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882539|NCT03269136|591939404|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
163882540|NCT03269136|591939405|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
163882541|NCT03269136|591939388|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
163882542|NCT03269136|591939389|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
163882543|NCT03269136|591939390|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
163882544|NCT03269136|591939391|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
163882545|NCT03269136|591939392|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
163882546|NCT03269136|591939393|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
163882547|NCT03269136|591939394|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
163882548|NCT03269136|591939395|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
163882549|NCT03269136|591939396|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
163882550|NCT03269136|591939397|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
163882551|NCT03269136|591939398|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
163882552|NCT03269136|591939399|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
163882553|NCT03269136|591939400|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
163882554|NCT03269136|591939401|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
163882555|NCT03269136|591939402|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
163882556|NCT03269136|591939403|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
163882557|NCT03269136|591939404|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
163882558|NCT03269136|591939405|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
163882559|NCT03269136|591939388|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
163882560|NCT03269136|591939389|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
163882561|NCT03269136|591939390|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
163882562|NCT03269136|591939391|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
163882563|NCT03269136|591939392|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
163882564|NCT03269136|591939393|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
163882565|NCT03269136|591939394|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
163882566|NCT03269136|591939395|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
163882567|NCT03269136|591939396|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
163882568|NCT03269136|591939397|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
163882569|NCT03269136|591939398|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
163882570|NCT03269136|591939399|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
163882571|NCT03269136|591939400|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
163882572|NCT03269136|591939401|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
164227473|NCT05415215|593202555|FG000|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227474|NCT05415215|593202556|FG001|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227475|NCT05415215|593202557|FG002|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227476|NCT05415215|593202558|FG003|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
163882573|NCT03269136|591939402|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
163882574|NCT03269136|591939403|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
163882575|NCT03269136|591939404|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
163882576|NCT03269136|591939405|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
163882577|NCT03269136|591939388|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
163882578|NCT03269136|591939389|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
163882579|NCT03269136|591939390|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
163882580|NCT03269136|591939391|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
164227477|NCT05415215|593202559|FG004|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227478|NCT05415215|593202560|FG005|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227479|NCT05415215|593202561|FG006|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|0|||
164227480|NCT05415215|593202562|FG007|Adjuvant Phase: Trastuzumab Emtansine IV|Ongoing in Treatment|25|||
164227481|NCT05415215|593202555|FG000|Follow-up Period|Ongoing in Follow-up|0|||
164227482|NCT05415215|593202556|FG001|Follow-up Period|Ongoing in Follow-up|0|||
164227483|NCT05415215|593202557|FG002|Follow-up Period|Ongoing in Follow-up|0|||
164227484|NCT05415215|593202558|FG003|Follow-up Period|Ongoing in Follow-up|0|||
164227485|NCT05415215|593202559|FG004|Follow-up Period|Ongoing in Follow-up|0|||
164227486|NCT05415215|593202560|FG005|Follow-up Period|Ongoing in Follow-up|44|||
164227487|NCT05415215|593202561|FG006|Follow-up Period|Ongoing in Follow-up|45|||
164227488|NCT05415215|593202562|FG007|Follow-up Period|Ongoing in Follow-up|51|||
164227489|NCT05415215|593202555|FG000|Follow-up Period|Adverse Event|0|||
164227490|NCT05415215|593202556|FG001|Follow-up Period|Adverse Event|0|||
164227491|NCT05415215|593202557|FG002|Follow-up Period|Adverse Event|0|||
164227492|NCT05415215|593202558|FG003|Follow-up Period|Adverse Event|0|||
164227493|NCT05415215|593202559|FG004|Follow-up Period|Adverse Event|0|||
164227494|NCT05415215|593202560|FG005|Follow-up Period|Adverse Event|0|||
164227495|NCT05415215|593202561|FG006|Follow-up Period|Adverse Event|1|||
164227496|NCT05415215|593202562|FG007|Follow-up Period|Adverse Event|0|||
164227497|NCT05415215|593202555|FG000|Follow-up Period|Lost to Follow-up|0|||
164227498|NCT05415215|593202556|FG001|Follow-up Period|Lost to Follow-up|0|||
164227499|NCT05415215|593202557|FG002|Follow-up Period|Lost to Follow-up|0|||
164227500|NCT05415215|593202558|FG003|Follow-up Period|Lost to Follow-up|0|||
164227501|NCT05415215|593202559|FG004|Follow-up Period|Lost to Follow-up|0|||
164227502|NCT05415215|593202560|FG005|Follow-up Period|Lost to Follow-up|1|||
164227503|NCT05415215|593202561|FG006|Follow-up Period|Lost to Follow-up|1|||
164227504|NCT05415215|593202562|FG007|Follow-up Period|Lost to Follow-up|0|||
164227505|NCT05415215|593202555|FG000|Follow-up Period|Withdrawal by Subject|0|||
164227506|NCT05415215|593202556|FG001|Follow-up Period|Withdrawal by Subject|0|||
164227507|NCT05415215|593202557|FG002|Follow-up Period|Withdrawal by Subject|0|||
164227508|NCT05415215|593202558|FG003|Follow-up Period|Withdrawal by Subject|0|||
164227509|NCT05415215|593202559|FG004|Follow-up Period|Withdrawal by Subject|0|||
164227510|NCT05415215|593202560|FG005|Follow-up Period|Withdrawal by Subject|0|||
164227511|NCT05415215|593202561|FG006|Follow-up Period|Withdrawal by Subject|0|||
164227512|NCT05415215|593202562|FG007|Follow-up Period|Withdrawal by Subject|2|||
164227513|NCT02797522|593202563|FG000|Overall Study|Study Terminated by Sponsor|0|||
164227514|NCT02797522|593202564|FG001|Overall Study|Study Terminated by Sponsor|0|||
164227515|NCT02797522|593202565|FG002|Overall Study|Study Terminated by Sponsor|0|||
164227516|NCT02797522|593202566|FG003|Overall Study|Study Terminated by Sponsor|0|||
164227517|NCT02797522|593202567|FG004|Overall Study|Study Terminated by Sponsor|0|||
164227518|NCT02797522|593202568|FG005|Overall Study|Study Terminated by Sponsor|0|||
164227519|NCT02797522|593202569|FG006|Overall Study|Study Terminated by Sponsor|0|||
164227520|NCT02797522|593202570|FG007|Overall Study|Study Terminated by Sponsor|4|||
164227521|NCT02797522|593202571|FG008|Overall Study|Study Terminated by Sponsor|2|||
164227522|NCT02797522|593202572|FG009|Overall Study|Study Terminated by Sponsor|4|||
164227523|NCT02797522|593202573|FG010|Overall Study|Study Terminated by Sponsor|1|||
164227524|NCT04129398|593202574|FG000|Overall Study|Physician Decision|2|||
164227525|NCT02932410|593202575|FG000|Overall Study|Death|7|||
164227526|NCT02932410|593202576|FG001|Overall Study|Death|6|||
164227527|NCT02932410|593202577|FG002|Overall Study|Death|0|||
164227528|NCT02932410|593202578|FG003|Overall Study|Death|0|||
164227529|NCT02932410|593202575|FG000|Overall Study|Lost to Follow-up|1|||
164227530|NCT02932410|593202576|FG001|Overall Study|Lost to Follow-up|2|||
164227531|NCT02932410|593202577|FG002|Overall Study|Lost to Follow-up|0|||
164227532|NCT02932410|593202578|FG003|Overall Study|Lost to Follow-up|0|||
164227533|NCT02932410|593202575|FG000|Overall Study|Parent/Subjects decision|6|||
164227534|NCT02932410|593202576|FG001|Overall Study|Parent/Subjects decision|6|||
163882581|NCT03269136|591939392|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
163882582|NCT03269136|591939393|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
164227535|NCT02932410|593202577|FG002|Overall Study|Parent/Subjects decision|1|||
163882583|NCT03269136|591939394|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
163882584|NCT03269136|591939395|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
164330932|NCT01907100|593588342|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
164330933|NCT01907100|593588343|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
164330934|NCT01907100|593588344|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
164330935|NCT01907100|593588345|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
164330936|NCT01758289|593588346|FG000|Overall Study|Premature Study Termination|44|||
164330937|NCT01758289|593588346|FG000|Overall Study|Adverse Event|9|||
164330938|NCT01574079|593588347|FG000|Overall Study|Physician Decision|0|||
164330939|NCT01574079|593588348|FG001|Overall Study|Physician Decision|2|||
164330940|NCT01574079|593588347|FG000|Overall Study|Lost to Follow-up|1|||
164330941|NCT01574079|593588348|FG001|Overall Study|Lost to Follow-up|0|||
164330942|NCT00908011|593588349|FG000|Overall Study|Withdrawal by Subject|2|||
164330943|NCT00908011|593588350|FG001|Overall Study|Withdrawal by Subject|2|||
164330944|NCT00843726|593588351|FG000|Overall Study|Death|1|||
164330945|NCT00843726|593588352|FG001|Overall Study|Death|0|||
164330946|NCT00843726|593588351|FG000|Overall Study|Withdrawal by Subject|0|||
164330947|NCT00843726|593588352|FG001|Overall Study|Withdrawal by Subject|1|||
164330948|NCT00667602|593588353|FG000|Overall Study|Withdrawal by Subject|4|||
164330949|NCT00667602|593588354|FG001|Overall Study|Withdrawal by Subject|9|||
164330950|NCT00667602|593588355|FG002|Overall Study|Withdrawal by Subject|10|||
164330951|NCT00667602|593588353|FG000|Overall Study|Lost to Follow-up|4|||
163882585|NCT03269136|591939396|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
164330952|NCT00667602|593588354|FG001|Overall Study|Lost to Follow-up|5|||
164330953|NCT00667602|593588355|FG002|Overall Study|Lost to Follow-up|6|||
164330954|NCT00667602|593588353|FG000|Overall Study|Administrative reason|0|||
164330955|NCT00667602|593588354|FG001|Overall Study|Administrative reason|0|||
164330956|NCT00667602|593588355|FG002|Overall Study|Administrative reason|2|||
164330957|NCT00667602|593588353|FG000|Overall Study|Protocol Violation|0|||
164330958|NCT00667602|593588354|FG001|Overall Study|Protocol Violation|1|||
164330959|NCT00667602|593588355|FG002|Overall Study|Protocol Violation|0|||
164330960|NCT03640559|593588359|FG000|Overall Study|Physician Decision|1|||
163882586|NCT03269136|591939397|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
163882587|NCT03269136|591939398|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
163882588|NCT03269136|591939399|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
163882589|NCT03269136|591939400|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
164330961|NCT03640559|593588360|FG001|Overall Study|Physician Decision|1|||
164330962|NCT03640559|593588359|FG000|Overall Study|Withdrawal by Subject|1|||
163882590|NCT03269136|591939401|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
163882591|NCT03269136|591939402|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
163882592|NCT03269136|591939403|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
163882593|NCT03269136|591939404|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
163882594|NCT03269136|591939405|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
163882595|NCT05308004|591939406|FG000|Overall Study|Not seen by Palliative Care NP|0|||
163882596|NCT05308004|591939407|FG001|Overall Study|Not seen by Palliative Care NP|1|||
163882597|NCT04552223|591939414|FG000|Overall Study|Withdrawal by Subject|1|||
163882598|NCT04856163|591939415|FG000|Overall Study|Lost to Follow-up|97|||
163882599|NCT04856163|591939416|FG001|Overall Study|Lost to Follow-up|100|||
163882600|NCT02515773|591939419|FG000|Overall Study|Withdrawal by Subject|12|||
163882601|NCT02515773|591939420|FG001|Overall Study|Withdrawal by Subject|2|||
163882602|NCT02515773|591939419|FG000|Overall Study|Lost to Follow-up|119|||
163882603|NCT02515773|591939420|FG001|Overall Study|Lost to Follow-up|126|||
163882604|NCT02515773|591939419|FG000|Overall Study|Discharged from Clinic Services|53|||
163882605|NCT02515773|591939420|FG001|Overall Study|Discharged from Clinic Services|84|||
163882606|NCT02515773|591939419|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
163882607|NCT02515773|591939420|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
164330963|NCT03640559|593588360|FG001|Overall Study|Withdrawal by Subject|0|||
164330964|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
164330965|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
164330966|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
164330967|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
164330968|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
163882608|NCT02515773|591939419|FG000|Overall Study|Follow-up at non-study site|8|||
163882609|NCT02515773|591939420|FG001|Overall Study|Follow-up at non-study site|16|||
163882610|NCT02515773|591939419|FG000|Overall Study|Moved from area|9|||
163882611|NCT02515773|591939420|FG001|Overall Study|Moved from area|14|||
163882612|NCT04072380|591939422|FG000|Overall Study|Adverse Event|4|||
163882613|NCT04072380|591939423|FG001|Overall Study|Adverse Event|6|||
163882614|NCT04072380|591939424|FG002|Overall Study|Adverse Event|0|||
163882615|NCT04072380|591939422|FG000|Overall Study|Withdrawal by Subject|3|||
163882616|NCT04072380|591939423|FG001|Overall Study|Withdrawal by Subject|1|||
163882617|NCT04072380|591939424|FG002|Overall Study|Withdrawal by Subject|1|||
163882618|NCT04072380|591939422|FG000|Overall Study|Physician Decision|2|||
163882619|NCT04072380|591939423|FG001|Overall Study|Physician Decision|0|||
163986756|NCT03529773|592320193|FG000|Overall Study|Protocol Violation|0|||
163986757|NCT03529773|592320194|FG001|Overall Study|Protocol Violation|0|||
163986758|NCT03529773|592320195|FG002|Overall Study|Protocol Violation|0|||
163986759|NCT03529773|592320196|FG003|Overall Study|Protocol Violation|0|||
163986760|NCT03529773|592320197|FG004|Overall Study|Protocol Violation|0|||
163986761|NCT03529773|592320198|FG005|Overall Study|Protocol Violation|0|||
163986762|NCT03529773|592320199|FG006|Overall Study|Protocol Violation|0|||
163986763|NCT03529773|592320200|FG007|Overall Study|Protocol Violation|0|||
163986764|NCT03529773|592320201|FG008|Overall Study|Protocol Violation|0|||
163986765|NCT03529773|592320202|FG009|Overall Study|Protocol Violation|0|||
163986766|NCT03529773|592320203|FG010|Overall Study|Protocol Violation|0|||
163986767|NCT03529773|592320204|FG011|Overall Study|Protocol Violation|0|||
163986768|NCT03529773|592320205|FG012|Overall Study|Protocol Violation|0|||
163986769|NCT03529773|592320206|FG013|Overall Study|Protocol Violation|0|||
163986770|NCT03529773|592320207|FG014|Overall Study|Protocol Violation|0|||
163986771|NCT03529773|592320208|FG015|Overall Study|Protocol Violation|0|||
163986772|NCT03529773|592320209|FG016|Overall Study|Protocol Violation|0|||
163986773|NCT03529773|592320210|FG017|Overall Study|Protocol Violation|0|||
163986774|NCT03529773|592320211|FG018|Overall Study|Protocol Violation|0|||
163986775|NCT03529773|592320212|FG019|Overall Study|Protocol Violation|0|||
163986776|NCT03529773|592320213|FG020|Overall Study|Protocol Violation|0|||
163986777|NCT03529773|592320214|FG021|Overall Study|Protocol Violation|0|||
163986778|NCT03529773|592320215|FG022|Overall Study|Protocol Violation|0|||
163986779|NCT03529773|592320216|FG023|Overall Study|Protocol Violation|0|||
163986780|NCT03529773|592320217|FG024|Overall Study|Protocol Violation|0|||
163986781|NCT03529773|592320218|FG025|Overall Study|Protocol Violation|0|||
163986782|NCT03529773|592320219|FG026|Overall Study|Protocol Violation|0|||
163986783|NCT03529773|592320220|FG027|Overall Study|Protocol Violation|0|||
163986784|NCT03529773|592320221|FG028|Overall Study|Protocol Violation|0|||
163986785|NCT03529773|592320222|FG029|Overall Study|Protocol Violation|0|||
163986786|NCT03529773|592320223|FG030|Overall Study|Protocol Violation|1|||
163986787|NCT03529773|592320224|FG031|Overall Study|Protocol Violation|0|||
163986788|NCT03529773|592320225|FG032|Overall Study|Protocol Violation|0|||
163986789|NCT03529773|592320226|FG033|Overall Study|Protocol Violation|0|||
163986790|NCT03529773|592320227|FG034|Overall Study|Protocol Violation|0|||
163986791|NCT03529773|592320228|FG035|Overall Study|Protocol Violation|0|||
163986792|NCT03529773|592320229|FG036|Overall Study|Protocol Violation|0|||
163986793|NCT03529773|592320230|FG037|Overall Study|Protocol Violation|0|||
163986794|NCT03529773|592320231|FG038|Overall Study|Protocol Violation|0|||
163986795|NCT03529773|592320232|FG039|Overall Study|Protocol Violation|0|||
163986796|NCT03529773|592320193|FG000|Overall Study|Withdrawal by Subject|0|||
163986797|NCT03529773|592320194|FG001|Overall Study|Withdrawal by Subject|0|||
163986798|NCT03529773|592320195|FG002|Overall Study|Withdrawal by Subject|0|||
163986799|NCT03529773|592320196|FG003|Overall Study|Withdrawal by Subject|0|||
163986800|NCT03529773|592320197|FG004|Overall Study|Withdrawal by Subject|0|||
163986801|NCT03529773|592320198|FG005|Overall Study|Withdrawal by Subject|0|||
163986802|NCT03529773|592320199|FG006|Overall Study|Withdrawal by Subject|0|||
163986803|NCT03529773|592320200|FG007|Overall Study|Withdrawal by Subject|1|||
163986804|NCT03529773|592320201|FG008|Overall Study|Withdrawal by Subject|0|||
163986805|NCT03529773|592320202|FG009|Overall Study|Withdrawal by Subject|1|||
163986806|NCT03529773|592320203|FG010|Overall Study|Withdrawal by Subject|1|||
163986807|NCT03529773|592320204|FG011|Overall Study|Withdrawal by Subject|0|||
164227536|NCT02932410|593202578|FG003|Overall Study|Parent/Subjects decision|0|||
164227537|NCT02932410|593202575|FG000|Overall Study|Physician Decision|0|||
164227538|NCT02932410|593202576|FG001|Overall Study|Physician Decision|1|||
164227539|NCT02932410|593202577|FG002|Overall Study|Physician Decision|0|||
164227540|NCT02932410|593202578|FG003|Overall Study|Physician Decision|0|||
164227541|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Withdrawal by Subject|1|||
164227542|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Physician Decision|4|||
163986808|NCT03529773|592320205|FG012|Overall Study|Withdrawal by Subject|0|||
163986809|NCT03529773|592320206|FG013|Overall Study|Withdrawal by Subject|0|||
163986810|NCT03529773|592320207|FG014|Overall Study|Withdrawal by Subject|0|||
163986811|NCT03529773|592320208|FG015|Overall Study|Withdrawal by Subject|3|||
164227543|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Death|5|||
164227544|NCT04557735|593202581|FG000|Treatment Period (26 Weeks)|Adverse Event|2|||
163986812|NCT03529773|592320209|FG016|Overall Study|Withdrawal by Subject|0|||
163986813|NCT03529773|592320210|FG017|Overall Study|Withdrawal by Subject|2|||
163986814|NCT03529773|592320211|FG018|Overall Study|Withdrawal by Subject|3|||
163986815|NCT03529773|592320212|FG019|Overall Study|Withdrawal by Subject|1|||
163986816|NCT03529773|592320213|FG020|Overall Study|Withdrawal by Subject|3|||
163986817|NCT03529773|592320214|FG021|Overall Study|Withdrawal by Subject|1|||
163986818|NCT03529773|592320215|FG022|Overall Study|Withdrawal by Subject|1|||
163986819|NCT03529773|592320216|FG023|Overall Study|Withdrawal by Subject|2|||
163986820|NCT03529773|592320217|FG024|Overall Study|Withdrawal by Subject|2|||
163986821|NCT03529773|592320218|FG025|Overall Study|Withdrawal by Subject|4|||
163986822|NCT03529773|592320219|FG026|Overall Study|Withdrawal by Subject|2|||
163986823|NCT03529773|592320220|FG027|Overall Study|Withdrawal by Subject|1|||
163882620|NCT04072380|591939424|FG002|Overall Study|Physician Decision|0|||
163882621|NCT04072380|591939422|FG000|Overall Study|Protocol Violation|0|||
163882622|NCT04072380|591939423|FG001|Overall Study|Protocol Violation|2|||
163882623|NCT04072380|591939424|FG002|Overall Study|Protocol Violation|3|||
163882624|NCT04072380|591939422|FG000|Overall Study|Intercurrent Illness and Others|3|||
163882625|NCT04072380|591939423|FG001|Overall Study|Intercurrent Illness and Others|5|||
163882626|NCT04072380|591939424|FG002|Overall Study|Intercurrent Illness and Others|6|||
164227545|NCT04557735|593202581|FG000|Follow-Up Period (26 Weeks)|Physician Decision|1|||
164227546|NCT04557735|593202581|FG000|Follow-Up Period (26 Weeks)|Death|4|||
164227547|NCT05451329|593202588|FG000|Overall Study|Adverse Event|1|||
164227548|NCT05451329|593202589|FG001|Overall Study|Adverse Event|1|||
164227549|NCT05451329|593202590|FG002|Overall Study|Adverse Event|0|||
164227550|NCT05451329|593202588|FG000|Overall Study|Withdrawal by Subject|1|||
164227551|NCT05451329|593202589|FG001|Overall Study|Withdrawal by Subject|0|||
164227552|NCT05451329|593202590|FG002|Overall Study|Withdrawal by Subject|0|||
164227553|NCT05451329|593202588|FG000|Overall Study|Investigational Product Lot exchange|1|||
164227554|NCT05451329|593202589|FG001|Overall Study|Investigational Product Lot exchange|1|||
164227555|NCT05451329|593202590|FG002|Overall Study|Investigational Product Lot exchange|0|||
164227556|NCT04629521|593202593|FG000|Overall Study|Death|1|||
164227557|NCT04629521|593202593|FG000|Overall Study|Lost to Follow-up|3|||
164227558|NCT04629521|593202593|FG000|Overall Study|Subject withdrew consent|3|||
164227559|NCT04629521|593202593|FG000|Overall Study|Enrolled in error|1|||
164227560|NCT03019406|593202594|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
164227561|NCT03019406|593202595|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
164227562|NCT03019406|593202596|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
164227563|NCT03019406|593202597|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
164227564|NCT03163667|593202598|FG000|Overall Study|Death|15|||
164227565|NCT03163667|593202599|FG001|Overall Study|Death|27|||
164227566|NCT03163667|593202598|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
164227567|NCT03163667|593202599|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
164227568|NCT02556736|593202600|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
164227569|NCT02556736|593202601|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
164227570|NCT02556736|593202602|FG002|Open Label Treatment Period|Withdrawal by Subject|1|||
164227571|NCT02556736|593202603|FG003|Open Label Treatment Period|Withdrawal by Subject|1|||
164330969|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
164330970|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
164330971|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
164330972|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
164330973|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
164227572|NCT02556736|593202600|FG000|Open Label Treatment Period|Adverse Event|0|||
164227573|NCT02556736|593202601|FG001|Open Label Treatment Period|Adverse Event|0|||
164227574|NCT02556736|593202602|FG002|Open Label Treatment Period|Adverse Event|0|||
164227575|NCT02556736|593202603|FG003|Open Label Treatment Period|Adverse Event|1|||
164227576|NCT02556736|593202600|FG000|Long-Term Follow-up|Lost to Follow-up|1|||
164227577|NCT02556736|593202601|FG001|Long-Term Follow-up|Lost to Follow-up|0|||
164330974|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
164330975|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
164330976|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
164330977|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164330978|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
164330979|NCT01436162|593588361|FG000|Single-blind Lead-in Phase|Other|107|||
164330980|NCT01436162|593588362|FG001|Single-blind Lead-in Phase|Other|0|||
164330981|NCT01436162|593588363|FG002|Single-blind Lead-in Phase|Other|0|||
164227578|NCT02556736|593202602|FG002|Long-Term Follow-up|Lost to Follow-up|0|||
164227579|NCT02556736|593202603|FG003|Long-Term Follow-up|Lost to Follow-up|1|||
164227580|NCT01302834|593202611|FG000|Overall Study|Protocol Violation|17|||
164227581|NCT01302834|593202612|FG001|Overall Study|Protocol Violation|23|||
164227582|NCT01302834|593202611|FG000|Overall Study|HIV positive|1|||
163882632|NCT05816551|591941967|FG000|Overall Study|Withdrawal by Subject|0|||
163882633|NCT05816551|591941968|FG001|Overall Study|Withdrawal by Subject|1|||
163882634|NCT05816551|591941967|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
163882635|NCT05816551|591941968|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
163882636|NCT04353661|591941969|FG000|Overall Study|Protocol Violation|0|||
163882637|NCT04353661|591941970|FG001|Overall Study|Protocol Violation|0|||
163882638|NCT04353661|591941971|FG002|Overall Study|Protocol Violation|1|||
163882639|NCT04353661|591941969|FG000|Overall Study|Study termination by the Sponsor|1|||
163882640|NCT04353661|591941970|FG001|Overall Study|Study termination by the Sponsor|1|||
163882641|NCT04353661|591941971|FG002|Overall Study|Study termination by the Sponsor|1|||
163882642|NCT04024813|591941973|FG000|Overall Study|Study terminated by Sponsor|1|||
163882643|NCT04034251|591941974|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
163882644|NCT04034251|591941975|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
163900155|NCT02397096|592005615|FG001|Study Extension 3|Availability of study medication locally|3|||
163882645|NCT04034251|591941976|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
163882646|NCT00920621|591941979|FG000|Overall Study|Lost to Follow-up|16|||
163882647|NCT00920621|591941980|FG001|Overall Study|Lost to Follow-up|17|||
163882648|NCT00920621|591941981|FG002|Overall Study|Lost to Follow-up|19|||
163882649|NCT00920621|591941982|FG003|Overall Study|Lost to Follow-up|21|||
163882650|NCT00920621|591941979|FG000|Overall Study|Fetal/neonatal deaths|16|||
163882651|NCT00920621|591941980|FG001|Overall Study|Fetal/neonatal deaths|14|||
163882652|NCT00920621|591941981|FG002|Overall Study|Fetal/neonatal deaths|16|||
163882653|NCT00920621|591941982|FG003|Overall Study|Fetal/neonatal deaths|14|||
163882654|NCT00920621|591941979|FG000|Overall Study|Blood sample not collected|22|||
163882655|NCT00920621|591941980|FG001|Overall Study|Blood sample not collected|14|||
163882656|NCT00920621|591941981|FG002|Overall Study|Blood sample not collected|0|||
163882657|NCT00920621|591941982|FG003|Overall Study|Blood sample not collected|0|||
163882658|NCT05862870|591941987|FG000|Overall Study|Lost to Follow-up|3|||
163882659|NCT02543281|591941992|FG000|Overall Study|Lost to Follow-up|0|||
163882660|NCT02543281|591941993|FG001|Overall Study|Lost to Follow-up|0|||
163882661|NCT02543281|591941994|FG002|Overall Study|Lost to Follow-up|1|||
163882662|NCT02530671|591941995|FG000|Overall Study|Lost to Follow-up|2|||
164227583|NCT01302834|593202612|FG001|Overall Study|HIV positive|3|||
164227584|NCT05810597|593202613|FG000|Period 1|Adverse Event|2|||
164227585|NCT05810597|593202614|FG001|Period 1|Adverse Event|0|||
164227586|NCT05810597|593202613|FG000|Period 1|Physician Decision|1|||
164227587|NCT05810597|593202614|FG001|Period 1|Physician Decision|0|||
164227588|NCT05213624|593202615|FG000|Overall Study|Adverse Event|0|||
164227589|NCT05213624|593202616|FG001|Overall Study|Adverse Event|3|||
164227590|NCT05213624|593202617|FG002|Overall Study|Adverse Event|0|||
164227591|NCT05213624|593202618|FG003|Overall Study|Adverse Event|0|||
164227592|NCT05213624|593202615|FG000|Overall Study|Protocol deviation|0|||
164227593|NCT05213624|593202616|FG001|Overall Study|Protocol deviation|2|||
164227594|NCT05213624|593202617|FG002|Overall Study|Protocol deviation|0|||
164227595|NCT05213624|593202618|FG003|Overall Study|Protocol deviation|0|||
164227596|NCT05213624|593202615|FG000|Overall Study|Withdrawal by Subject|0|||
164227597|NCT05213624|593202616|FG001|Overall Study|Withdrawal by Subject|0|||
164227598|NCT05213624|593202617|FG002|Overall Study|Withdrawal by Subject|0|||
164330982|NCT01436162|593588361|FG000|Randomized Phase|Adverse Event|1|||
164227599|NCT05213624|593202618|FG003|Overall Study|Withdrawal by Subject|1|||
164227600|NCT05213624|593202615|FG000|Overall Study|Not treated|0|||
164227601|NCT05213624|593202616|FG001|Overall Study|Not treated|1|||
164227602|NCT05213624|593202617|FG002|Overall Study|Not treated|2|||
164330983|NCT01436162|593588362|FG001|Randomized Phase|Adverse Event|5|||
164330984|NCT01436162|593588363|FG002|Randomized Phase|Adverse Event|6|||
164330985|NCT01436162|593588361|FG000|Randomized Phase|Protocol Violation|4|||
163882663|NCT02530671|591941996|FG001|Overall Study|Lost to Follow-up|0|||
163882664|NCT02530671|591941995|FG000|Overall Study|Withdrawal by Subject|1|||
163882665|NCT02530671|591941996|FG001|Overall Study|Withdrawal by Subject|0|||
164227603|NCT05213624|593202618|FG003|Overall Study|Not treated|2|||
163986824|NCT03529773|592320221|FG028|Overall Study|Withdrawal by Subject|1|||
163986825|NCT03529773|592320222|FG029|Overall Study|Withdrawal by Subject|0|||
163986826|NCT03529773|592320223|FG030|Overall Study|Withdrawal by Subject|0|||
163986827|NCT03529773|592320224|FG031|Overall Study|Withdrawal by Subject|0|||
163986828|NCT03529773|592320225|FG032|Overall Study|Withdrawal by Subject|0|||
163986829|NCT03529773|592320226|FG033|Overall Study|Withdrawal by Subject|0|||
163986830|NCT03529773|592320227|FG034|Overall Study|Withdrawal by Subject|1|||
163986831|NCT03529773|592320228|FG035|Overall Study|Withdrawal by Subject|2|||
163986832|NCT03529773|592320229|FG036|Overall Study|Withdrawal by Subject|0|||
163986833|NCT03529773|592320230|FG037|Overall Study|Withdrawal by Subject|2|||
163986834|NCT03529773|592320231|FG038|Overall Study|Withdrawal by Subject|1|||
163986835|NCT03529773|592320232|FG039|Overall Study|Withdrawal by Subject|1|||
163986836|NCT03529773|592320193|FG000|Overall Study|Screen Failure|0|||
163986837|NCT03529773|592320194|FG001|Overall Study|Screen Failure|0|||
163986838|NCT03529773|592320195|FG002|Overall Study|Screen Failure|0|||
163986839|NCT03529773|592320196|FG003|Overall Study|Screen Failure|0|||
163986840|NCT03529773|592320197|FG004|Overall Study|Screen Failure|0|||
163986841|NCT03529773|592320198|FG005|Overall Study|Screen Failure|0|||
163986842|NCT03529773|592320199|FG006|Overall Study|Screen Failure|0|||
164227604|NCT01602380|593202619|FG000|Overall Study|Death|147|||
164227605|NCT01602380|593202620|FG001|Overall Study|Death|145|||
164227606|NCT01602380|593202619|FG000|Overall Study|Withdrawal by Subject|39|||
164227607|NCT01602380|593202620|FG001|Overall Study|Withdrawal by Subject|41|||
164227608|NCT01602380|593202619|FG000|Overall Study|Lost to Follow-up|15|||
163986843|NCT03529773|592320200|FG007|Overall Study|Screen Failure|0|||
163986844|NCT03529773|592320201|FG008|Overall Study|Screen Failure|0|||
163986845|NCT03529773|592320202|FG009|Overall Study|Screen Failure|0|||
163986846|NCT03529773|592320203|FG010|Overall Study|Screen Failure|0|||
163986847|NCT03529773|592320204|FG011|Overall Study|Screen Failure|0|||
163986848|NCT03529773|592320205|FG012|Overall Study|Screen Failure|0|||
163986849|NCT03529773|592320206|FG013|Overall Study|Screen Failure|0|||
163986850|NCT03529773|592320207|FG014|Overall Study|Screen Failure|0|||
163986851|NCT03529773|592320208|FG015|Overall Study|Screen Failure|0|||
163986852|NCT03529773|592320209|FG016|Overall Study|Screen Failure|0|||
163986853|NCT03529773|592320210|FG017|Overall Study|Screen Failure|0|||
163986854|NCT03529773|592320211|FG018|Overall Study|Screen Failure|0|||
163986855|NCT03529773|592320212|FG019|Overall Study|Screen Failure|0|||
163986856|NCT03529773|592320213|FG020|Overall Study|Screen Failure|0|||
163986857|NCT03529773|592320214|FG021|Overall Study|Screen Failure|0|||
163986858|NCT03529773|592320215|FG022|Overall Study|Screen Failure|0|||
163986859|NCT03529773|592320216|FG023|Overall Study|Screen Failure|0|||
163986860|NCT03529773|592320217|FG024|Overall Study|Screen Failure|0|||
163986861|NCT03529773|592320218|FG025|Overall Study|Screen Failure|0|||
163986862|NCT03529773|592320219|FG026|Overall Study|Screen Failure|0|||
163986863|NCT03529773|592320220|FG027|Overall Study|Screen Failure|0|||
163986864|NCT03529773|592320221|FG028|Overall Study|Screen Failure|0|||
163986865|NCT03529773|592320222|FG029|Overall Study|Screen Failure|0|||
163986866|NCT03529773|592320223|FG030|Overall Study|Screen Failure|0|||
163986867|NCT03529773|592320224|FG031|Overall Study|Screen Failure|0|||
163986868|NCT03529773|592320225|FG032|Overall Study|Screen Failure|0|||
163986869|NCT03529773|592320226|FG033|Overall Study|Screen Failure|0|||
163986870|NCT03529773|592320227|FG034|Overall Study|Screen Failure|0|||
163986871|NCT03529773|592320228|FG035|Overall Study|Screen Failure|0|||
163986872|NCT03529773|592320229|FG036|Overall Study|Screen Failure|1|||
163986873|NCT03529773|592320230|FG037|Overall Study|Screen Failure|1|||
163986874|NCT03529773|592320231|FG038|Overall Study|Screen Failure|0|||
163986875|NCT03529773|592320232|FG039|Overall Study|Screen Failure|1|||
164227609|NCT01602380|593202620|FG001|Overall Study|Lost to Follow-up|12|||
164227610|NCT01602380|593202619|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164227611|NCT01602380|593202620|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
164227612|NCT01602380|593202619|FG000|Overall Study|Other|2|||
163986876|NCT03529773|592320193|FG000|Overall Study|Randomized but not vaccinated|0|||
163986877|NCT03529773|592320194|FG001|Overall Study|Randomized but not vaccinated|0|||
163986878|NCT03529773|592320195|FG002|Overall Study|Randomized but not vaccinated|0|||
163986879|NCT03529773|592320196|FG003|Overall Study|Randomized but not vaccinated|0|||
163986880|NCT03529773|592320197|FG004|Overall Study|Randomized but not vaccinated|0|||
163986881|NCT03529773|592320198|FG005|Overall Study|Randomized but not vaccinated|0|||
164227613|NCT01602380|593202620|FG001|Overall Study|Other|0|||
164227614|NCT01044459|593202621|FG000|Overall Study|Withdrawal by Subject|21|||
164227615|NCT01044459|593202622|FG001|Overall Study|Withdrawal by Subject|28|||
164227616|NCT01044459|593202621|FG000|Overall Study|Terminated by Sponsor|22|||
164227617|NCT01044459|593202622|FG001|Overall Study|Terminated by Sponsor|21|||
164227618|NCT01044459|593202621|FG000|Overall Study|Adverse Event|22|||
163986882|NCT03529773|592320199|FG006|Overall Study|Randomized but not vaccinated|0|||
163986883|NCT03529773|592320200|FG007|Overall Study|Randomized but not vaccinated|0|||
163986884|NCT03529773|592320201|FG008|Overall Study|Randomized but not vaccinated|0|||
163986885|NCT03529773|592320202|FG009|Overall Study|Randomized but not vaccinated|0|||
164227619|NCT01044459|593202622|FG001|Overall Study|Adverse Event|20|||
164227620|NCT01044459|593202621|FG000|Overall Study|Lack of Efficacy|23|||
164227621|NCT01044459|593202622|FG001|Overall Study|Lack of Efficacy|12|||
164227622|NCT01044459|593202621|FG000|Overall Study|Protocol Violation|11|||
164227623|NCT01044459|593202622|FG001|Overall Study|Protocol Violation|16|||
163882666|NCT05247489|591941997|FG000|Overall Study|Lost to Follow-up|5|||
163882667|NCT05247489|591941998|FG001|Overall Study|Lost to Follow-up|1|||
163882668|NCT05247489|591941997|FG000|Overall Study|Withdrawal by Subject|6|||
163882669|NCT05247489|591941998|FG001|Overall Study|Withdrawal by Subject|7|||
163882670|NCT05247489|591941997|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
163882671|NCT05247489|591941998|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
163882672|NCT05247489|591941997|FG000|Overall Study|Left Country|1|||
163882673|NCT05247489|591941998|FG001|Overall Study|Left Country|0|||
163882674|NCT05247489|591941997|FG000|Overall Study|Noncompliance with Investigational Product|1|||
163882675|NCT05247489|591941998|FG001|Overall Study|Noncompliance with Investigational Product|0|||
163882676|NCT05247489|591941997|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
163882677|NCT05247489|591941998|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
163882678|NCT03126019|591941999|FG000|Overall Study|Death|5|||
163882679|NCT03126019|591942000|FG001|Overall Study|Death|27|||
163882680|NCT03126019|591941999|FG000|Overall Study|Lost to Follow-up|2|||
163882681|NCT03126019|591942000|FG001|Overall Study|Lost to Follow-up|4|||
163882682|NCT03126019|591941999|FG000|Overall Study|Withdrawal by Subject|1|||
163882683|NCT03126019|591942000|FG001|Overall Study|Withdrawal by Subject|9|||
163882684|NCT03126019|591941999|FG000|Overall Study|Physician Decision|1|||
163882685|NCT03126019|591942000|FG001|Overall Study|Physician Decision|0|||
164227624|NCT01044459|593202621|FG000|Overall Study|Other Reason|7|||
164227625|NCT01044459|593202622|FG001|Overall Study|Other Reason|14|||
164227626|NCT01044459|593202621|FG000|Overall Study|COPD exacerbation|9|||
164227627|NCT01044459|593202622|FG001|Overall Study|COPD exacerbation|8|||
164227628|NCT01044459|593202621|FG000|Overall Study|Lost to Follow-up|18|||
164227629|NCT01044459|593202622|FG001|Overall Study|Lost to Follow-up|12|||
164227630|NCT03369704|593202628|FG000|Treatment Epoch|technical problems|1|||
164227631|NCT03369704|593202629|FG001|Treatment Epoch|technical problems|0|||
164227632|NCT03369704|593202628|FG000|Treatment Epoch|Protocol Violation|1|||
164227633|NCT03369704|593202629|FG001|Treatment Epoch|Protocol Violation|0|||
164227634|NCT03369704|593202628|FG000|Treatment Epoch|Lost to Follow-up|0|||
164227635|NCT03369704|593202629|FG001|Treatment Epoch|Lost to Follow-up|1|||
164227636|NCT03369704|593202628|FG000|Treatment Epoch|Lack of Efficacy|0|||
164227637|NCT03369704|593202629|FG001|Treatment Epoch|Lack of Efficacy|2|||
164227638|NCT03369704|593202628|FG000|Treatment Epoch|Adverse Event|2|||
164227639|NCT03369704|593202629|FG001|Treatment Epoch|Adverse Event|0|||
164227640|NCT03369704|593202628|FG000|Follow-up Epoch|Lost to Follow-up|1|||
164227641|NCT03369704|593202629|FG001|Follow-up Epoch|Lost to Follow-up|0|||
164227642|NCT04153149|593202631|FG000|Double Blind Period|Death|63|||
164227643|NCT04153149|593202632|FG001|Double Blind Period|Death|49|||
164227644|NCT04153149|593202633|FG002|Double Blind Period|Death|0|||
164227645|NCT04153149|593202634|FG003|Double Blind Period|Death|0|||
164227646|NCT04153149|593202631|FG000|Double Blind Period|Withdrawal by Subject|16|||
164227647|NCT04153149|593202632|FG001|Double Blind Period|Withdrawal by Subject|11|||
164227648|NCT04153149|593202633|FG002|Double Blind Period|Withdrawal by Subject|0|||
164227649|NCT04153149|593202634|FG003|Double Blind Period|Withdrawal by Subject|0|||
164227650|NCT04153149|593202631|FG000|Double Blind Period|Adverse Event|6|||
164227651|NCT04153149|593202632|FG001|Double Blind Period|Adverse Event|2|||
164227652|NCT04153149|593202633|FG002|Double Blind Period|Adverse Event|0|||
164227653|NCT04153149|593202634|FG003|Double Blind Period|Adverse Event|0|||
164227654|NCT04153149|593202631|FG000|Double Blind Period|Lost to Follow-up|2|||
164227655|NCT04153149|593202632|FG001|Double Blind Period|Lost to Follow-up|1|||
164227656|NCT04153149|593202633|FG002|Double Blind Period|Lost to Follow-up|0|||
164227657|NCT04153149|593202634|FG003|Double Blind Period|Lost to Follow-up|0|||
164227658|NCT04153149|593202631|FG000|Double Blind Period|Withdrawal by guardian|0|||
164227659|NCT04153149|593202632|FG001|Double Blind Period|Withdrawal by guardian|2|||
164227660|NCT04153149|593202633|FG002|Double Blind Period|Withdrawal by guardian|0|||
164227661|NCT04153149|593202634|FG003|Double Blind Period|Withdrawal by guardian|0|||
164227662|NCT04153149|593202631|FG000|Double Blind Period|Reason Not Specified|5|||
164227663|NCT04153149|593202632|FG001|Double Blind Period|Reason Not Specified|4|||
164227664|NCT04153149|593202633|FG002|Double Blind Period|Reason Not Specified|0|||
164227665|NCT04153149|593202634|FG003|Double Blind Period|Reason Not Specified|0|||
164227666|NCT04153149|593202631|FG000|Double Blind Period|Physician Decision|2|||
164227667|NCT04153149|593202632|FG001|Double Blind Period|Physician Decision|0|||
164227668|NCT04153149|593202633|FG002|Double Blind Period|Physician Decision|0|||
164227669|NCT04153149|593202634|FG003|Double Blind Period|Physician Decision|0|||
163882686|NCT03126019|591941999|FG000|Overall Study|Transitioned to Rollover Study|0|||
163882687|NCT03126019|591942000|FG001|Overall Study|Transitioned to Rollover Study|11|||
163882688|NCT03126019|591941999|FG000|Overall Study|Did Not Return to Site for Care|0|||
163882689|NCT03126019|591942000|FG001|Overall Study|Did Not Return to Site for Care|1|||
164227670|NCT04153149|593202631|FG000|Open Label Extension Period|Death|0|||
164227671|NCT04153149|593202632|FG001|Open Label Extension Period|Death|0|||
164227672|NCT04153149|593202633|FG002|Open Label Extension Period|Death|7|||
164330986|NCT01436162|593588362|FG001|Randomized Phase|Protocol Violation|4|||
164330987|NCT01436162|593588363|FG002|Randomized Phase|Protocol Violation|2|||
164330988|NCT01436162|593588361|FG000|Randomized Phase|Withdrawal by Subject|16|||
164330989|NCT01436162|593588362|FG001|Randomized Phase|Withdrawal by Subject|9|||
164330990|NCT01436162|593588363|FG002|Randomized Phase|Withdrawal by Subject|8|||
164330991|NCT01436162|593588361|FG000|Randomized Phase|Lost to Follow-up|17|||
164330992|NCT01436162|593588362|FG001|Randomized Phase|Lost to Follow-up|5|||
164330993|NCT01436162|593588363|FG002|Randomized Phase|Lost to Follow-up|4|||
164330994|NCT01436162|593588361|FG000|Randomized Phase|Lack of Efficacy|0|||
164330995|NCT01436162|593588362|FG001|Randomized Phase|Lack of Efficacy|1|||
164330996|NCT01436162|593588363|FG002|Randomized Phase|Lack of Efficacy|1|||
164330997|NCT01436162|593588361|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
164330998|NCT01436162|593588362|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
164330999|NCT01436162|593588363|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
164331000|NCT01436162|593588361|FG000|Randomized Phase|Other|2|||
164331001|NCT01436162|593588362|FG001|Randomized Phase|Other|5|||
164331002|NCT01436162|593588363|FG002|Randomized Phase|Other|4|||
164331003|NCT02567552|593588364|FG000|Overall Study|Adverse Event|0|||
164331004|NCT02567552|593588365|FG001|Overall Study|Adverse Event|1|||
164331005|NCT04669535|593588370|FG000|Overall Study|Death|1|||
164331006|NCT04669535|593588371|FG001|Overall Study|Death|1|||
164331007|NCT04669535|593588372|FG002|Overall Study|Death|0|||
164331008|NCT04669535|593588373|FG003|Overall Study|Death|0|||
164331009|NCT01876810|593588374|FG000|Overall Study|Physician Decision|0|||
164331010|NCT01876810|593588375|FG001|Overall Study|Physician Decision|1|||
164331011|NCT00458536|593588380|FG000|Overall Study|Disease progression prior to treatment|7|||
164331012|NCT00458536|593588380|FG000|Overall Study|Unable to make vaccine|3|||
164331013|NCT00458536|593588380|FG000|Overall Study|No measurable disease after surgery|2|||
164331014|NCT00458536|593588380|FG000|Overall Study|Did not have renal cell carcinoma|2|||
164331015|NCT00458536|593588380|FG000|Overall Study|Patient did not have surgery|1|||
164331016|NCT00458536|593588380|FG000|Overall Study|Ineligible due to toxicity|1|||
164331017|NCT00458536|593588380|FG000|Overall Study|Withdrawal by Subject|1|||
164331018|NCT00458536|593588380|FG000|Overall Study|Progressive disease during treatment|2|||
164331019|NCT00285207|593588381|FG000|Overall Study|Lost to Follow-up|3|||
164331020|NCT00285207|593588382|FG001|Overall Study|Lost to Follow-up|2|||
164331021|NCT00285207|593588381|FG000|Overall Study|Withdrawal by Subject|5|||
164331022|NCT00285207|593588382|FG001|Overall Study|Withdrawal by Subject|2|||
164331023|NCT00285207|593588381|FG000|Overall Study|Pregnancy|1|||
164331024|NCT00285207|593588382|FG001|Overall Study|Pregnancy|1|||
164331025|NCT00285207|593588381|FG000|Overall Study|non-compliance|0|||
164331026|NCT00285207|593588382|FG001|Overall Study|non-compliance|1|||
164331027|NCT02160782|593589839|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
164331028|NCT02160782|593589840|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
164331029|NCT02160782|593589841|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
164331030|NCT02160782|593589842|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
164331031|NCT02160782|593589843|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
163986886|NCT03529773|592320203|FG010|Overall Study|Randomized but not vaccinated|0|||
163986887|NCT03529773|592320204|FG011|Overall Study|Randomized but not vaccinated|0|||
164227673|NCT04153149|593202634|FG003|Open Label Extension Period|Death|3|||
164227674|NCT04153149|593202631|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
164227675|NCT04153149|593202632|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
164227676|NCT04153149|593202633|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
164227677|NCT04153149|593202634|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
164227678|NCT04153149|593202631|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
164227679|NCT04153149|593202632|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
164227680|NCT04153149|593202633|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
164227681|NCT04153149|593202634|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
164227682|NCT04153149|593202631|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
164227683|NCT04153149|593202632|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
164227684|NCT04153149|593202633|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
164227685|NCT04153149|593202634|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
164227686|NCT03759379|593203779|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
164227687|NCT03759379|593203780|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
164227688|NCT03759379|593203779|FG000|Treatment Period|Death|2|||
164227689|NCT03759379|593203780|FG001|Treatment Period|Death|3|||
164227690|NCT03759379|593203779|FG000|Treatment Period|Lost to Follow-up|1|||
164227691|NCT03759379|593203780|FG001|Treatment Period|Lost to Follow-up|0|||
164227692|NCT03759379|593203779|FG000|Treatment Period|Physician Decision|0|||
164331032|NCT02160782|593589839|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331033|NCT02160782|593589840|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331034|NCT02160782|593589841|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331035|NCT02160782|593589842|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
164227693|NCT03759379|593203780|FG001|Treatment Period|Physician Decision|1|||
164227694|NCT00833703|593203781|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
164227695|NCT00833703|593203782|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
164227696|NCT00003907|593203783|FG000|Overall Study|Adverse Event|2|||
164227697|NCT00003907|593203784|FG001|Overall Study|Adverse Event|11|||
164227698|NCT00003907|593203783|FG000|Overall Study|Death|2|||
164227699|NCT00003907|593203784|FG001|Overall Study|Death|0|||
164227700|NCT00003907|593203783|FG000|Overall Study|Withdrawal by Subject|1|||
164227701|NCT00003907|593203784|FG001|Overall Study|Withdrawal by Subject|3|||
164227702|NCT00003907|593203783|FG000|Overall Study|Progressive disease|4|||
164227703|NCT00003907|593203784|FG001|Overall Study|Progressive disease|4|||
164227704|NCT00003907|593203783|FG000|Overall Study|Complicating disease|1|||
164227705|NCT00003907|593203784|FG001|Overall Study|Complicating disease|0|||
164227706|NCT00003907|593203783|FG000|Overall Study|Other|1|||
164227707|NCT00003907|593203784|FG001|Overall Study|Other|3|||
164227708|NCT00003907|593203783|FG000|Overall Study|ineligible or not treated|2|||
164227709|NCT00003907|593203784|FG001|Overall Study|ineligible or not treated|2|||
164227710|NCT00266032|593203785|FG000|Treatment|Adverse Event|42|||
164227711|NCT00266032|593203786|FG001|Treatment|Adverse Event|26|||
164227712|NCT00266032|593203787|FG002|Treatment|Adverse Event|10|||
164227713|NCT00266032|593203785|FG000|Treatment|Lost to Follow-up|19|||
164227714|NCT00266032|593203786|FG001|Treatment|Lost to Follow-up|4|||
164227715|NCT00266032|593203787|FG002|Treatment|Lost to Follow-up|2|||
164227716|NCT00266032|593203785|FG000|Treatment|Pregnancy|3|||
164227717|NCT00266032|593203786|FG001|Treatment|Pregnancy|2|||
164227718|NCT00266032|593203787|FG002|Treatment|Pregnancy|2|||
164227719|NCT00266032|593203785|FG000|Treatment|Protocol Violation|6|||
164227720|NCT00266032|593203786|FG001|Treatment|Protocol Violation|14|||
163882690|NCT03126019|591941999|FG000|Overall Study|Site Closed|0|||
164227721|NCT00266032|593203787|FG002|Treatment|Protocol Violation|13|||
164227722|NCT00266032|593203785|FG000|Treatment|Withdrawal by Subject|28|||
163882691|NCT03126019|591942000|FG001|Overall Study|Site Closed|1|||
163882692|NCT00170573|591942003|FG000|Overall Study|Violation of inclusion criteria|13|||
163882693|NCT05563246|591942031|FG000|Overall Study|Withdrawal by Subject|1|||
163882694|NCT05563246|591942032|FG001|Overall Study|Withdrawal by Subject|2|||
163882695|NCT05563246|591942033|FG002|Overall Study|Withdrawal by Subject|0|||
163882696|NCT05563246|591942034|FG003|Overall Study|Withdrawal by Subject|0|||
163882697|NCT05563246|591942031|FG000|Overall Study|Protocol Deviation|0|||
163882698|NCT05563246|591942032|FG001|Overall Study|Protocol Deviation|1|||
163882699|NCT05563246|591942033|FG002|Overall Study|Protocol Deviation|0|||
163882700|NCT05563246|591942034|FG003|Overall Study|Protocol Deviation|0|||
163882701|NCT05563246|591942031|FG000|Overall Study|Physician Decision|0|||
163882702|NCT05563246|591942032|FG001|Overall Study|Physician Decision|1|||
163882703|NCT05563246|591942033|FG002|Overall Study|Physician Decision|0|||
163882704|NCT05563246|591942034|FG003|Overall Study|Physician Decision|0|||
163882705|NCT05563246|591942031|FG000|Overall Study|Adverse Event|0|||
163882706|NCT05563246|591942032|FG001|Overall Study|Adverse Event|0|||
163882707|NCT05563246|591942033|FG002|Overall Study|Adverse Event|2|||
163882708|NCT05563246|591942034|FG003|Overall Study|Adverse Event|0|||
163882709|NCT05563246|591942031|FG000|Overall Study|Lost to Follow-up|0|||
163882710|NCT05563246|591942032|FG001|Overall Study|Lost to Follow-up|0|||
163882711|NCT05563246|591942033|FG002|Overall Study|Lost to Follow-up|1|||
163882712|NCT05563246|591942034|FG003|Overall Study|Lost to Follow-up|0|||
163882713|NCT03763708|591942035|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
163882714|NCT03763708|591942036|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882715|NCT03763708|591942037|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882716|NCT03763708|591942038|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882717|NCT03763708|591942039|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882718|NCT03763708|591942040|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882719|NCT03763708|591942041|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882720|NCT03763708|591942042|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882721|NCT03763708|591942043|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
163882722|NCT03763708|591942035|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882723|NCT03763708|591942036|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882724|NCT03763708|591942037|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
163882725|NCT03763708|591942038|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882726|NCT03763708|591942039|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882727|NCT03763708|591942040|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882728|NCT03763708|591942041|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882729|NCT03763708|591942042|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
163882730|NCT03763708|591942043|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
164227723|NCT00266032|593203786|FG001|Treatment|Withdrawal by Subject|13|||
164227724|NCT00266032|593203787|FG002|Treatment|Withdrawal by Subject|12|||
164227725|NCT00266032|593203785|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
164227726|NCT00266032|593203786|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
164227727|NCT00266032|593203787|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
163882731|NCT03763708|591942035|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882732|NCT03763708|591942036|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882733|NCT03763708|591942037|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882734|NCT03763708|591942038|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
163882735|NCT03763708|591942039|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882736|NCT03763708|591942040|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882737|NCT03763708|591942041|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882738|NCT03763708|591942042|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882739|NCT03763708|591942043|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
163882740|NCT03763708|591942035|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882741|NCT03763708|591942036|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882742|NCT03763708|591942037|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882743|NCT03763708|591942038|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882744|NCT03763708|591942039|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
163882745|NCT03763708|591942040|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882746|NCT03763708|591942041|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
164227728|NCT00266032|593203785|FG000|Open-label Safety Extension|Adverse Event|5|||
164227729|NCT00266032|593203786|FG001|Open-label Safety Extension|Adverse Event|0|||
164227730|NCT00266032|593203787|FG002|Open-label Safety Extension|Adverse Event|4|||
164227731|NCT00266032|593203785|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
163882747|NCT03763708|591942042|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882748|NCT03763708|591942043|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
163882749|NCT03763708|591942035|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882750|NCT03763708|591942036|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
164227732|NCT00266032|593203786|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
164227733|NCT00266032|593203787|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
163882751|NCT03763708|591942037|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882752|NCT03763708|591942038|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882753|NCT03763708|591942039|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882754|NCT03763708|591942040|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
163882755|NCT03763708|591942041|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882756|NCT03763708|591942042|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882757|NCT03763708|591942043|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
163882758|NCT03763708|591942035|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163882759|NCT03763708|591942036|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163882760|NCT03763708|591942037|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163882761|NCT03763708|591942038|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163882762|NCT03763708|591942039|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163882763|NCT03763708|591942040|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163882764|NCT03763708|591942041|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
163882765|NCT03763708|591942042|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
163986888|NCT03529773|592320205|FG012|Overall Study|Randomized but not vaccinated|0|||
163986889|NCT03529773|592320206|FG013|Overall Study|Randomized but not vaccinated|0|||
163986890|NCT03529773|592320207|FG014|Overall Study|Randomized but not vaccinated|0|||
163986891|NCT03529773|592320208|FG015|Overall Study|Randomized but not vaccinated|0|||
163986892|NCT03529773|592320209|FG016|Overall Study|Randomized but not vaccinated|0|||
163986893|NCT03529773|592320210|FG017|Overall Study|Randomized but not vaccinated|1|||
164227734|NCT00266032|593203785|FG000|Open-label Safety Extension|Pregnancy|4|||
164227735|NCT00266032|593203786|FG001|Open-label Safety Extension|Pregnancy|1|||
164227736|NCT00266032|593203787|FG002|Open-label Safety Extension|Pregnancy|2|||
164227737|NCT00266032|593203785|FG000|Open-label Safety Extension|Protocol Violation|1|||
164227738|NCT00266032|593203786|FG001|Open-label Safety Extension|Protocol Violation|3|||
164227739|NCT00266032|593203787|FG002|Open-label Safety Extension|Protocol Violation|2|||
164227740|NCT00266032|593203785|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
164227741|NCT00266032|593203786|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
164227742|NCT00266032|593203787|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
164227743|NCT00266032|593203785|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
164227744|NCT00266032|593203786|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
164227745|NCT00266032|593203787|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
163986894|NCT03529773|592320211|FG018|Overall Study|Randomized but not vaccinated|0|||
163986895|NCT03529773|592320212|FG019|Overall Study|Randomized but not vaccinated|0|||
163986896|NCT03529773|592320213|FG020|Overall Study|Randomized but not vaccinated|0|||
163986897|NCT03529773|592320214|FG021|Overall Study|Randomized but not vaccinated|0|||
163986898|NCT03529773|592320215|FG022|Overall Study|Randomized but not vaccinated|0|||
164227746|NCT00124657|593203789|FG000|Overall Study|Toxicity|0|||
163882766|NCT03763708|591942043|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
164227747|NCT00124657|593203790|FG001|Overall Study|Toxicity|0|||
164227748|NCT00124657|593203791|FG002|Overall Study|Toxicity|1|||
164227749|NCT00124657|593203789|FG000|Overall Study|Non-compliance|1|||
164227750|NCT00124657|593203790|FG001|Overall Study|Non-compliance|0|||
164227751|NCT00124657|593203791|FG002|Overall Study|Non-compliance|4|||
164227752|NCT00124657|593203789|FG000|Overall Study|Progressive disease|14|||
164227753|NCT00124657|593203790|FG001|Overall Study|Progressive disease|5|||
164227754|NCT00124657|593203791|FG002|Overall Study|Progressive disease|27|||
164227755|NCT00124657|593203789|FG000|Overall Study|Intercurrent illness|1|||
164227756|NCT00124657|593203790|FG001|Overall Study|Intercurrent illness|0|||
163882767|NCT03763708|591942035|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
163882768|NCT03763708|591942036|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
163882769|NCT03763708|591942037|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
163882770|NCT03763708|591942038|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
163882771|NCT03763708|591942039|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
163882772|NCT03763708|591942040|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
163882773|NCT03763708|591942041|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
163882774|NCT03763708|591942042|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
163882775|NCT03763708|591942043|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
163882776|NCT03763708|591942035|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
163882777|NCT03763708|591942036|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
163882778|NCT03763708|591942037|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
163882779|NCT03763708|591942038|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
163882780|NCT03763708|591942039|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
163882781|NCT03763708|591942040|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
163882782|NCT03763708|591942041|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
163882783|NCT03763708|591942042|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
163882784|NCT03763708|591942043|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
163882785|NCT03763708|591942035|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
163882786|NCT03763708|591942036|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
163882787|NCT03763708|591942037|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
163882788|NCT03763708|591942038|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
163882789|NCT03763708|591942039|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
163882790|NCT03763708|591942040|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
163882791|NCT03763708|591942041|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
163882792|NCT03763708|591942042|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
163882793|NCT03763708|591942043|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
163882794|NCT03332017|591942046|FG000|Overall Study|Lost to Follow-up|1|||
163882795|NCT03332017|591942047|FG001|Overall Study|Lost to Follow-up|2|||
163882796|NCT03332017|591942046|FG000|Overall Study|Death|17|||
163882797|NCT03332017|591942047|FG001|Overall Study|Death|16|||
163882798|NCT03332017|591942046|FG000|Overall Study|Withdrawal by Subject|6|||
163882799|NCT03332017|591942047|FG001|Overall Study|Withdrawal by Subject|14|||
163882800|NCT03332017|591942046|FG000|Overall Study|Other|1|||
163882801|NCT03332017|591942047|FG001|Overall Study|Other|3|||
163882802|NCT03332017|591942046|FG000|Overall Study|Remained in Study (Ongoing)|47|||
163882803|NCT03332017|591942047|FG001|Overall Study|Remained in Study (Ongoing)|110|||
163882804|NCT04005716|591942050|FG000|Overall Study|Death|175|||
163882805|NCT04005716|591942051|FG001|Overall Study|Death|196|||
163882806|NCT04005716|591942050|FG000|Overall Study|Withdrawal by Subject|1|||
163882807|NCT04005716|591942051|FG001|Overall Study|Withdrawal by Subject|6|||
163882808|NCT04005716|591942050|FG000|Overall Study|Lost to Follow-up|2|||
163882809|NCT04005716|591942051|FG001|Overall Study|Lost to Follow-up|2|||
163882810|NCT02783300|591942052|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882811|NCT02783300|591942053|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882812|NCT02783300|591942054|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882813|NCT02783300|591942055|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882814|NCT02783300|591942056|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882815|NCT02783300|591942057|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882816|NCT02783300|591942058|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
163882817|NCT02783300|591942059|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882818|NCT02783300|591942060|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882819|NCT02783300|591942061|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882820|NCT02783300|591942062|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882821|NCT02783300|591942063|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882822|NCT02783300|591942064|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882823|NCT02783300|591942065|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882824|NCT02783300|591942066|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882825|NCT02783300|591942067|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882826|NCT02783300|591942068|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882827|NCT02783300|591942069|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882828|NCT02783300|591942070|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882829|NCT02783300|591942071|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882830|NCT02783300|591942072|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
164227757|NCT00124657|593203791|FG002|Overall Study|Intercurrent illness|0|||
164227758|NCT04693715|593203798|FG000|Overall Study|Adverse Events Leading to Death|2|||
164227759|NCT04693715|593203799|FG001|Overall Study|Adverse Events Leading to Death|2|||
164227760|NCT04693715|593203800|FG002|Overall Study|Adverse Events Leading to Death|4|||
164227761|NCT04693715|593203798|FG000|Overall Study|Lost to Follow-up|0|||
164227762|NCT04693715|593203799|FG001|Overall Study|Lost to Follow-up|2|||
164227763|NCT04693715|593203800|FG002|Overall Study|Lost to Follow-up|2|||
164227764|NCT04693715|593203798|FG000|Overall Study|Physician Decision|0|||
164227765|NCT04693715|593203799|FG001|Overall Study|Physician Decision|1|||
164227766|NCT04693715|593203800|FG002|Overall Study|Physician Decision|0|||
164227767|NCT04693715|593203798|FG000|Overall Study|Withdrawal by Legal Authorized Representative|0|||
164227768|NCT04693715|593203799|FG001|Overall Study|Withdrawal by Legal Authorized Representative|1|||
164227769|NCT04693715|593203800|FG002|Overall Study|Withdrawal by Legal Authorized Representative|0|||
164227770|NCT04693715|593203798|FG000|Overall Study|Withdrawal by Subject|0|||
164227771|NCT04693715|593203799|FG001|Overall Study|Withdrawal by Subject|0|||
164227772|NCT04693715|593203800|FG002|Overall Study|Withdrawal by Subject|1|||
164227773|NCT02367885|593203801|FG000|Overall Study|Lost to Follow-up|1|||
164227774|NCT02367885|593203802|FG001|Overall Study|Lost to Follow-up|0|||
164227775|NCT02367885|593203803|FG002|Overall Study|Lost to Follow-up|0|||
164227776|NCT02367885|593203801|FG000|Overall Study|Withdrawal by Subject|1|||
164227777|NCT02367885|593203802|FG001|Overall Study|Withdrawal by Subject|0|||
164227778|NCT02367885|593203803|FG002|Overall Study|Withdrawal by Subject|0|||
164227779|NCT01378195|593203804|FG000|Overall Study|Lost to Follow-up|29|||
164227780|NCT01378195|593203805|FG001|Overall Study|Lost to Follow-up|18|||
164227781|NCT00752219|593203806|FG000|Overall Study|Clinical failure|0|||
164227782|NCT00752219|593203807|FG001|Overall Study|Clinical failure|1|||
164227783|NCT00752219|593203806|FG000|Overall Study|Adverse Event|5|||
164227784|NCT00752219|593203807|FG001|Overall Study|Adverse Event|3|||
164227785|NCT00752219|593203806|FG000|Overall Study|Protocol deviation|1|||
164227786|NCT00752219|593203807|FG001|Overall Study|Protocol deviation|0|||
164227787|NCT00752219|593203806|FG000|Overall Study|Lost to Follow-up|1|||
164227788|NCT00752219|593203807|FG001|Overall Study|Lost to Follow-up|2|||
164227789|NCT00752219|593203806|FG000|Overall Study|Randomized but not treated|1|||
164227790|NCT00752219|593203807|FG001|Overall Study|Randomized but not treated|0|||
164227791|NCT00752219|593203806|FG000|Overall Study|Other|3|||
164227792|NCT00752219|593203807|FG001|Overall Study|Other|0|||
164227793|NCT03533491|593203809|FG000|Overall Study|Lost to Follow-up|2|||
164227794|NCT06433908|593203813|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|1|||
164227795|NCT06433908|593203814|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
164227796|NCT06433908|593203815|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
164227797|NCT06433908|593203816|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Withdrawal by Subject|0|||
164227798|NCT06433908|593203813|FG000|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
164227799|NCT06433908|593203814|FG001|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|1|||
164227800|NCT06433908|593203815|FG002|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
164227801|NCT06433908|593203816|FG003|Cohort 1 - Treatment Period 3 (Day 7)|Physician Decision|0|||
164227802|NCT06433908|593203813|FG000|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
164227803|NCT06433908|593203814|FG001|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
164227804|NCT06433908|593203815|FG002|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|1|||
164227805|NCT06433908|593203816|FG003|Cohort 2 - Treatment Period 2 (Day 4)|Withdrawal by Subject|0|||
164227806|NCT05418426|593203817|FG000|Overall Study|Adverse Event|0|||
164227807|NCT05418426|593203818|FG001|Overall Study|Adverse Event|1|||
164227808|NCT05418426|593203819|FG002|Overall Study|Adverse Event|0|||
164227809|NCT05418426|593203817|FG000|Overall Study|Withdrawal by Subject|0|||
164227810|NCT05418426|593203818|FG001|Overall Study|Withdrawal by Subject|1|||
164227811|NCT05418426|593203819|FG002|Overall Study|Withdrawal by Subject|0|||
164227812|NCT05418426|593203817|FG000|Overall Study|Protocol Violation|0|||
164227813|NCT05418426|593203818|FG001|Overall Study|Protocol Violation|0|||
164227814|NCT05418426|593203819|FG002|Overall Study|Protocol Violation|1|||
164227815|NCT04403880|593203822|FG000|Overall Study|Death|1|||
164227816|NCT04403880|593203823|FG001|Overall Study|Death|0|||
164227817|NCT04403880|593203824|FG002|Overall Study|Death|2|||
164227818|NCT04403880|593203825|FG003|Overall Study|Death|0|||
164227819|NCT04403880|593203826|FG004|Overall Study|Death|0|||
163882831|NCT02783300|591942073|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882832|NCT02783300|591942074|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882833|NCT02783300|591942075|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882834|NCT02783300|591942076|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882835|NCT02783300|591942077|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882836|NCT02783300|591942078|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
163882837|NCT02783300|591942052|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882838|NCT02783300|591942053|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882839|NCT02783300|591942054|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882840|NCT02783300|591942055|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
164227820|NCT04403880|593203827|FG005|Overall Study|Death|0|||
164227821|NCT04403880|593203828|FG006|Overall Study|Death|0|||
164227822|NCT04403880|593203822|FG000|Overall Study|Physician Decision|0|||
164227823|NCT04403880|593203823|FG001|Overall Study|Physician Decision|0|||
164227824|NCT04403880|593203824|FG002|Overall Study|Physician Decision|0|||
164227825|NCT04403880|593203825|FG003|Overall Study|Physician Decision|0|||
164227826|NCT04403880|593203826|FG004|Overall Study|Physician Decision|1|||
164227827|NCT04403880|593203827|FG005|Overall Study|Physician Decision|0|||
164227828|NCT04403880|593203828|FG006|Overall Study|Physician Decision|0|||
164227829|NCT04403880|593203822|FG000|Overall Study|Lost to Follow-up|4|||
164227830|NCT04403880|593203823|FG001|Overall Study|Lost to Follow-up|3|||
164227831|NCT04403880|593203824|FG002|Overall Study|Lost to Follow-up|8|||
164227832|NCT04403880|593203825|FG003|Overall Study|Lost to Follow-up|7|||
164227833|NCT04403880|593203826|FG004|Overall Study|Lost to Follow-up|8|||
164227834|NCT04403880|593203827|FG005|Overall Study|Lost to Follow-up|1|||
164227835|NCT04403880|593203828|FG006|Overall Study|Lost to Follow-up|8|||
164227836|NCT04403880|593203822|FG000|Overall Study|Withdrawal by Subject|8|||
164227837|NCT04403880|593203823|FG001|Overall Study|Withdrawal by Subject|9|||
164227838|NCT04403880|593203824|FG002|Overall Study|Withdrawal by Subject|22|||
164227839|NCT04403880|593203825|FG003|Overall Study|Withdrawal by Subject|16|||
164227840|NCT04403880|593203826|FG004|Overall Study|Withdrawal by Subject|16|||
164227841|NCT04403880|593203827|FG005|Overall Study|Withdrawal by Subject|8|||
164227842|NCT04403880|593203828|FG006|Overall Study|Withdrawal by Subject|11|||
164227843|NCT04403880|593203822|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
164227844|NCT04403880|593203823|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|5|||
164227845|NCT04403880|593203824|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|12|||
164227846|NCT04403880|593203825|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
164227847|NCT04403880|593203826|FG004|Overall Study|Participant Unable to Adhere to Visit Schedule|8|||
164227848|NCT04403880|593203827|FG005|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164227849|NCT04403880|593203828|FG006|Overall Study|Participant Unable to Adhere to Visit Schedule|2|||
164227850|NCT04403880|593203822|FG000|Overall Study|Participant Unable to Comply with Study Procedure|7|||
164227851|NCT04403880|593203823|FG001|Overall Study|Participant Unable to Comply with Study Procedure|1|||
164227852|NCT04403880|593203824|FG002|Overall Study|Participant Unable to Comply with Study Procedure|7|||
164227853|NCT04403880|593203825|FG003|Overall Study|Participant Unable to Comply with Study Procedure|9|||
164227854|NCT04403880|593203826|FG004|Overall Study|Participant Unable to Comply with Study Procedure|8|||
164227855|NCT04403880|593203827|FG005|Overall Study|Participant Unable to Comply with Study Procedure|8|||
164227856|NCT04403880|593203828|FG006|Overall Study|Participant Unable to Comply with Study Procedure|19|||
164227857|NCT04403880|593203822|FG000|Overall Study|Pregnancy|2|||
164227858|NCT04403880|593203823|FG001|Overall Study|Pregnancy|0|||
164227859|NCT04403880|593203824|FG002|Overall Study|Pregnancy|5|||
164227860|NCT04403880|593203825|FG003|Overall Study|Pregnancy|0|||
164227861|NCT04403880|593203826|FG004|Overall Study|Pregnancy|1|||
164227862|NCT04403880|593203827|FG005|Overall Study|Pregnancy|0|||
164227863|NCT04403880|593203828|FG006|Overall Study|Pregnancy|1|||
164227864|NCT04403880|593203822|FG000|Overall Study|Sponsor Decision|2|||
164227865|NCT04403880|593203823|FG001|Overall Study|Sponsor Decision|0|||
164227866|NCT04403880|593203824|FG002|Overall Study|Sponsor Decision|14|||
164227867|NCT04403880|593203825|FG003|Overall Study|Sponsor Decision|1|||
164227868|NCT04403880|593203826|FG004|Overall Study|Sponsor Decision|1|||
164227869|NCT04403880|593203827|FG005|Overall Study|Sponsor Decision|0|||
164227870|NCT04403880|593203828|FG006|Overall Study|Sponsor Decision|2|||
164227871|NCT04403880|593203822|FG000|Overall Study|Other|18|||
164227872|NCT04403880|593203823|FG001|Overall Study|Other|9|||
163986899|NCT03529773|592320216|FG023|Overall Study|Randomized but not vaccinated|0|||
164227873|NCT04403880|593203824|FG002|Overall Study|Other|14|||
164227874|NCT04403880|593203825|FG003|Overall Study|Other|10|||
164227875|NCT04403880|593203826|FG004|Overall Study|Other|11|||
163986900|NCT03529773|592320217|FG024|Overall Study|Randomized but not vaccinated|0|||
163986901|NCT03529773|592320218|FG025|Overall Study|Randomized but not vaccinated|0|||
163986902|NCT03529773|592320219|FG026|Overall Study|Randomized but not vaccinated|0|||
163986903|NCT03529773|592320220|FG027|Overall Study|Randomized but not vaccinated|1|||
163986904|NCT03529773|592320221|FG028|Overall Study|Randomized but not vaccinated|0|||
163986905|NCT03529773|592320222|FG029|Overall Study|Randomized but not vaccinated|0|||
163986906|NCT03529773|592320223|FG030|Overall Study|Randomized but not vaccinated|0|||
163986907|NCT03529773|592320224|FG031|Overall Study|Randomized but not vaccinated|0|||
163986908|NCT03529773|592320225|FG032|Overall Study|Randomized but not vaccinated|0|||
163986909|NCT03529773|592320226|FG033|Overall Study|Randomized but not vaccinated|0|||
163986910|NCT03529773|592320227|FG034|Overall Study|Randomized but not vaccinated|0|||
164227876|NCT04403880|593203827|FG005|Overall Study|Other|12|||
164227877|NCT04403880|593203828|FG006|Overall Study|Other|15|||
164227878|NCT04138277|593203831|FG000|Pretreatment|Withdrawal by Subject|1|||
164227879|NCT04138277|593203832|FG001|Pretreatment|Withdrawal by Subject|0|||
164227880|NCT04138277|593203831|FG000|Treatment|Adverse Event|6|||
164227881|NCT04138277|593203832|FG001|Treatment|Adverse Event|2|||
164227882|NCT04138277|593203831|FG000|Treatment|Lost to Follow-up|1|||
164227883|NCT04138277|593203832|FG001|Treatment|Lost to Follow-up|0|||
164227884|NCT04138277|593203831|FG000|Treatment|Pregnancy|3|||
164227885|NCT04138277|593203832|FG001|Treatment|Pregnancy|0|||
164227886|NCT04138277|593203831|FG000|Treatment|COVID-19 pandemic|1|||
164227887|NCT04138277|593203832|FG001|Treatment|COVID-19 pandemic|0|||
164227888|NCT04138277|593203831|FG000|Treatment|Withdrawal by Subject|9|||
164227889|NCT04138277|593203832|FG001|Treatment|Withdrawal by Subject|3|||
164227890|NCT04138277|593203831|FG000|Treatment|Sponsor decision|1|||
164227891|NCT04138277|593203832|FG001|Treatment|Sponsor decision|0|||
164227892|NCT04138277|593203831|FG000|Treatment|Physician Decision|1|||
164227893|NCT04138277|593203832|FG001|Treatment|Physician Decision|0|||
164227894|NCT04138277|593203831|FG000|Treatment|Worsening of condition|1|||
164227895|NCT04138277|593203832|FG001|Treatment|Worsening of condition|2|||
164227896|NCT03768414|593203833|FG000|Overall Study|Adverse Event or side effects|72|||
164227897|NCT03768414|593203834|FG001|Overall Study|Adverse Event or side effects|28|||
164227898|NCT03768414|593203833|FG000|Overall Study|Refusal unrelated to adverse event|33|||
164331036|NCT02160782|593589843|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
164331037|NCT02160782|593589839|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331038|NCT02160782|593589840|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331039|NCT02160782|593589841|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331040|NCT02160782|593589842|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
164331041|NCT02160782|593589843|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
164331042|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164331043|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164355620|NCT00512707|593676483|FG001|Overall Study|Developed skin irritation|1|||
163882841|NCT02783300|591942056|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163986911|NCT03529773|592320228|FG035|Overall Study|Randomized but not vaccinated|0|||
163986912|NCT03529773|592320229|FG036|Overall Study|Randomized but not vaccinated|0|||
163986913|NCT03529773|592320230|FG037|Overall Study|Randomized but not vaccinated|0|||
163986914|NCT03529773|592320231|FG038|Overall Study|Randomized but not vaccinated|0|||
163986915|NCT03529773|592320232|FG039|Overall Study|Randomized but not vaccinated|0|||
163986916|NCT01496066|592320234|FG000|Overall Study|Lost to Follow-up|8|||
163986917|NCT01496066|592320235|FG001|Overall Study|Lost to Follow-up|5|||
163986918|NCT01496066|592320234|FG000|Overall Study|Explant|3|||
163986919|NCT01496066|592320235|FG001|Overall Study|Explant|0|||
163986920|NCT01496066|592320234|FG000|Overall Study|Death|1|||
163986921|NCT01496066|592320235|FG001|Overall Study|Death|4|||
163986922|NCT01340209|592320236|FG000|Overall Study|Adverse Event|1|||
163986923|NCT01340209|592320237|FG001|Overall Study|Adverse Event|1|||
163986924|NCT01340209|592320238|FG002|Overall Study|Adverse Event|2|||
163986925|NCT01340209|592320236|FG000|Overall Study|Protocol Violation|1|||
163986926|NCT01340209|592320237|FG001|Overall Study|Protocol Violation|2|||
164227899|NCT03768414|593203834|FG001|Overall Study|Refusal unrelated to adverse event|33|||
164227900|NCT03768414|593203833|FG000|Overall Study|Progression/relapse|132|||
164227901|NCT03768414|593203834|FG001|Overall Study|Progression/relapse|60|||
164227902|NCT03768414|593203833|FG000|Overall Study|Death|9|||
164227903|NCT03768414|593203834|FG001|Overall Study|Death|6|||
163882842|NCT02783300|591942057|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882843|NCT02783300|591942058|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882844|NCT02783300|591942059|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882845|NCT02783300|591942060|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882846|NCT02783300|591942061|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882847|NCT02783300|591942062|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882848|NCT02783300|591942063|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882849|NCT02783300|591942064|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882850|NCT02783300|591942065|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882851|NCT02783300|591942066|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882852|NCT02783300|591942067|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882853|NCT02783300|591942068|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882854|NCT02783300|591942069|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882855|NCT02783300|591942070|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882856|NCT02783300|591942071|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882857|NCT02783300|591942072|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882858|NCT02783300|591942073|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882859|NCT02783300|591942074|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882860|NCT02783300|591942075|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882861|NCT02783300|591942076|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882862|NCT02783300|591942077|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882863|NCT02783300|591942078|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
163882864|NCT02783300|591942052|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
163882865|NCT02783300|591942053|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
163882866|NCT02783300|591942054|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
163882867|NCT02783300|591942055|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
163986927|NCT01340209|592320238|FG002|Overall Study|Protocol Violation|1|||
163986928|NCT01340209|592320236|FG000|Overall Study|Withdrawal by Subject|0|||
164227904|NCT03768414|593203833|FG000|Overall Study|Other - not protocol specified|45|||
164227905|NCT03768414|593203834|FG001|Overall Study|Other - not protocol specified|18|||
164227906|NCT03768414|593203833|FG000|Overall Study|Reason under review|3|||
164227907|NCT03768414|593203834|FG001|Overall Study|Reason under review|2|||
164227908|NCT02528305|593203839|FG000|Overall Study|Withdrawal by Subject|1|||
164227909|NCT02528305|593203839|FG000|Overall Study|Adverse Event|1|||
164227910|NCT02528305|593203839|FG000|Overall Study|Physician Decision|1|||
163882868|NCT02783300|591942056|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
163882869|NCT02783300|591942057|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
163882870|NCT02783300|591942058|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
163882871|NCT02783300|591942059|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
163882872|NCT02783300|591942060|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
163882873|NCT02783300|591942061|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
163882874|NCT02783300|591942062|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
163882875|NCT02783300|591942063|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
163882876|NCT02783300|591942064|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
163882877|NCT02783300|591942065|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
163882878|NCT02783300|591942066|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
163882879|NCT02783300|591942067|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
163882880|NCT02783300|591942068|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
163882881|NCT02783300|591942069|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
163882882|NCT02783300|591942070|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
163882883|NCT02783300|591942071|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
163882884|NCT02783300|591942072|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
163882885|NCT02783300|591942073|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
163882886|NCT02783300|591942074|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
163882887|NCT02783300|591942075|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
163882888|NCT02783300|591942076|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
163882889|NCT02783300|591942077|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
163882890|NCT02783300|591942078|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
163882891|NCT02783300|591942052|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882892|NCT02783300|591942053|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882893|NCT02783300|591942054|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882894|NCT02783300|591942055|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882895|NCT02783300|591942056|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882896|NCT02783300|591942057|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882897|NCT02783300|591942058|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
163882898|NCT02783300|591942059|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882899|NCT02783300|591942060|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882900|NCT02783300|591942061|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882901|NCT02783300|591942062|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882902|NCT02783300|591942063|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882903|NCT02783300|591942064|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
163882904|NCT02783300|591942065|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882905|NCT02783300|591942066|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882906|NCT02783300|591942067|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882907|NCT02783300|591942068|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882908|NCT02783300|591942069|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882909|NCT02783300|591942070|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882910|NCT02783300|591942071|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882911|NCT02783300|591942072|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882912|NCT02783300|591942073|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882913|NCT02783300|591942074|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882914|NCT02783300|591942075|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882915|NCT02783300|591942076|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882916|NCT02783300|591942077|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882917|NCT02783300|591942078|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
163882918|NCT02783300|591942052|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882919|NCT02783300|591942053|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882920|NCT02783300|591942054|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882921|NCT02783300|591942055|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882922|NCT02783300|591942056|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
163882923|NCT02783300|591942057|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882924|NCT02783300|591942058|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
163882925|NCT02783300|591942059|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
164227911|NCT01308788|593203843|FG000|2-year Treatment|medication change by treating physician|4|||
164227912|NCT01308788|593203844|FG001|2-year Treatment|medication change by treating physician|11|||
164227913|NCT00322218|593203845|FG000|Overall Study|Death|3|||
164227914|NCT00322218|593203846|FG001|Overall Study|Death|6|||
164227915|NCT00124306|593203847|FG000|Overall Study|Adverse Event|7|||
164227916|NCT00124306|593203848|FG001|Overall Study|Adverse Event|2|||
164227917|NCT00124306|593203847|FG000|Overall Study|Lost to Follow-up|10|||
164227918|NCT00124306|593203848|FG001|Overall Study|Lost to Follow-up|6|||
164227919|NCT00124306|593203847|FG000|Overall Study|Lack of Efficacy|3|||
164227920|NCT00124306|593203848|FG001|Overall Study|Lack of Efficacy|6|||
164227921|NCT00124306|593203847|FG000|Overall Study|Personal constraints|0|||
164227922|NCT00124306|593203848|FG001|Overall Study|Personal constraints|2|||
164227923|NCT00124306|593203847|FG000|Overall Study|Use of unacceptable medication|1|||
164227924|NCT00124306|593203848|FG001|Overall Study|Use of unacceptable medication|0|||
164227925|NCT00124306|593203847|FG000|Overall Study|Abnormal lab result|0|||
164227926|NCT00124306|593203848|FG001|Overall Study|Abnormal lab result|1|||
164227927|NCT00124306|593203847|FG000|Overall Study|Other|2|||
164227928|NCT00124306|593203848|FG001|Overall Study|Other|0|||
164227929|NCT03596645|593203854|FG000|Overall Study|Adverse Event|17|||
164227930|NCT03596645|593203855|FG001|Overall Study|Adverse Event|0|||
164227931|NCT03596645|593203854|FG000|Overall Study|Lack of Efficacy|8|||
164227932|NCT03596645|593203855|FG001|Overall Study|Lack of Efficacy|0|||
164227933|NCT03596645|593203854|FG000|Overall Study|Lost to Follow-up|1|||
164227934|NCT03596645|593203855|FG001|Overall Study|Lost to Follow-up|1|||
164227935|NCT03596645|593203854|FG000|Overall Study|Physician Decision|1|||
163882926|NCT02783300|591942060|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882927|NCT02783300|591942061|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
163882928|NCT02783300|591942062|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882929|NCT02783300|591942063|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882930|NCT02783300|591942064|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
163882931|NCT02783300|591942065|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882932|NCT02783300|591942066|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882933|NCT02783300|591942067|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882934|NCT02783300|591942068|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882935|NCT02783300|591942069|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882936|NCT02783300|591942070|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882937|NCT02783300|591942071|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882938|NCT02783300|591942072|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882939|NCT02783300|591942073|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882940|NCT02783300|591942074|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882941|NCT02783300|591942075|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882942|NCT02783300|591942076|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882943|NCT02783300|591942077|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163882944|NCT02783300|591942078|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
163986929|NCT01340209|592320237|FG001|Overall Study|Withdrawal by Subject|0|||
163986930|NCT01340209|592320238|FG002|Overall Study|Withdrawal by Subject|1|||
163986931|NCT01340209|592320236|FG000|Overall Study|Other reason not defined above|3|||
163986932|NCT01340209|592320237|FG001|Overall Study|Other reason not defined above|5|||
163986933|NCT01340209|592320238|FG002|Overall Study|Other reason not defined above|4|||
163986934|NCT00253630|592320239|FG000|Overall Study|ineligible|2|||
163986935|NCT03237065|592320240|FG000|Overall Study|Adverse Event|0|||
163986936|NCT03237065|592320241|FG001|Overall Study|Adverse Event|2|||
163986937|NCT03237065|592320240|FG000|Overall Study|Protocol Violation|0|||
163986938|NCT03237065|592320241|FG001|Overall Study|Protocol Violation|1|||
163986939|NCT03237065|592320240|FG000|Overall Study|Withdrawal by Subject|3|||
163986940|NCT03237065|592320241|FG001|Overall Study|Withdrawal by Subject|0|||
163986941|NCT03237065|592320240|FG000|Overall Study|Lost to Follow-up|1|||
163986942|NCT03237065|592320241|FG001|Overall Study|Lost to Follow-up|0|||
163986943|NCT03237065|592320240|FG000|Overall Study|Unable to obtain venous access|0|||
163986944|NCT03237065|592320241|FG001|Overall Study|Unable to obtain venous access|1|||
163986945|NCT00209339|592320242|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
163986946|NCT00209339|592320242|FG000|At 12 Months Follow-up|Death|1|||
163986947|NCT00209339|592320242|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
163986948|NCT00209339|592320242|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
163986949|NCT00209339|592320242|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
163986950|NCT00209339|592320242|FG000|At 24 Months Follow-up|Death|1|||
163986951|NCT00209339|592320242|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
163986952|NCT00209339|592320242|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
164227936|NCT03596645|593203855|FG001|Overall Study|Physician Decision|1|||
164227937|NCT03596645|593203854|FG000|Overall Study|Protocol Violation|1|||
164227938|NCT03596645|593203855|FG001|Overall Study|Protocol Violation|0|||
164227939|NCT03596645|593203854|FG000|Overall Study|Initiated Prohibited Medication|1|||
163986953|NCT00209339|592320242|FG000|At 4 Years Follow-up|Death|1|||
164227940|NCT03596645|593203855|FG001|Overall Study|Initiated Prohibited Medication|0|||
164227941|NCT03596645|593203854|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163986954|NCT00209339|592320242|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
164331044|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164331045|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
164331046|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
164331047|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331048|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331049|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331050|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
164331051|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
164331052|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331053|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331054|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331055|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
164331056|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
164331057|NCT02160782|593589839|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164331058|NCT02160782|593589840|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164331059|NCT02160782|593589841|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
163882945|NCT02783300|591942052|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882946|NCT02783300|591942053|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882947|NCT02783300|591942054|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882948|NCT02783300|591942055|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882949|NCT02783300|591942056|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882950|NCT02783300|591942057|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882951|NCT02783300|591942058|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882952|NCT02783300|591942059|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882953|NCT02783300|591942060|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882954|NCT02783300|591942061|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882955|NCT02783300|591942062|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882956|NCT02783300|591942063|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882957|NCT02783300|591942064|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882958|NCT02783300|591942065|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882959|NCT02783300|591942066|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882960|NCT02783300|591942067|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
163882961|NCT02783300|591942068|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882962|NCT02783300|591942069|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
163882963|NCT02783300|591942070|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
163882964|NCT02783300|591942071|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
163882965|NCT02783300|591942072|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882966|NCT02783300|591942073|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882967|NCT02783300|591942074|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882968|NCT02783300|591942075|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882969|NCT02783300|591942076|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
163882970|NCT02783300|591942077|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882971|NCT02783300|591942078|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
163882972|NCT02783300|591942052|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882973|NCT02783300|591942053|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882974|NCT02783300|591942054|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882975|NCT02783300|591942055|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882976|NCT02783300|591942056|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882977|NCT02783300|591942057|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882978|NCT02783300|591942058|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882979|NCT02783300|591942059|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882980|NCT02783300|591942060|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882981|NCT02783300|591942061|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882982|NCT02783300|591942062|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882983|NCT02783300|591942063|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882984|NCT02783300|591942064|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882985|NCT02783300|591942065|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882986|NCT02783300|591942066|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882987|NCT02783300|591942067|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882988|NCT02783300|591942068|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
164331060|NCT02160782|593589842|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
164331061|NCT02160782|593589843|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
164227942|NCT03596645|593203855|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164227943|NCT03596645|593203854|FG000|Overall Study|No mucosal healing achieved|1|||
164227944|NCT03596645|593203855|FG001|Overall Study|No mucosal healing achieved|0|||
164227945|NCT03596645|593203854|FG000|Overall Study|Disease progression|1|||
164227946|NCT03596645|593203855|FG001|Overall Study|Disease progression|0|||
164227947|NCT03596645|593203854|FG000|Overall Study|Ongoing|37|||
164227948|NCT03596645|593203855|FG001|Overall Study|Ongoing|12|||
164227949|NCT03596645|593203854|FG000|Overall Study|Randomized but not treated|0|||
164227950|NCT03596645|593203855|FG001|Overall Study|Randomized but not treated|1|||
164227951|NCT00866775|593205361|FG000|Overall Study|Adverse Event|5|||
164227952|NCT00866775|593205362|FG001|Overall Study|Adverse Event|19|||
164227953|NCT00866775|593205361|FG000|Overall Study|Death|1|||
164227954|NCT00866775|593205362|FG001|Overall Study|Death|0|||
164227955|NCT00866775|593205361|FG000|Overall Study|Lost to Follow-up|0|||
164227956|NCT00866775|593205362|FG001|Overall Study|Lost to Follow-up|4|||
164227957|NCT00866775|593205361|FG000|Overall Study|Physician Decision|0|||
164227958|NCT00866775|593205362|FG001|Overall Study|Physician Decision|3|||
164227959|NCT00866775|593205361|FG000|Overall Study|Protocol Violation|3|||
164227960|NCT00866775|593205362|FG001|Overall Study|Protocol Violation|4|||
164227961|NCT00866775|593205361|FG000|Overall Study|Withdrawal by Subject|4|||
164227962|NCT00866775|593205362|FG001|Overall Study|Withdrawal by Subject|4|||
164227963|NCT00866775|593205361|FG000|Overall Study|met exit criteria|23|||
164227964|NCT00866775|593205362|FG001|Overall Study|met exit criteria|17|||
164227965|NCT00866775|593205361|FG000|Overall Study|discontinued due to communication error|0|||
164227966|NCT00866775|593205362|FG001|Overall Study|discontinued due to communication error|1|||
164227967|NCT01904279|593205367|FG000|Overall Study|Lack of Efficacy|2|||
164227968|NCT01904279|593205368|FG001|Overall Study|Lack of Efficacy|3|||
164227969|NCT01904279|593205367|FG000|Overall Study|Withdrawal by Subject|1|||
164227970|NCT01904279|593205368|FG001|Overall Study|Withdrawal by Subject|0|||
164227971|NCT03283241|593205371|FG000|Overall Study|Adverse Event|4|||
164227972|NCT03283241|593205372|FG001|Overall Study|Adverse Event|1|||
164227973|NCT03283241|593205371|FG000|Overall Study|Withdrawal by Subject|0|||
164227974|NCT03283241|593205372|FG001|Overall Study|Withdrawal by Subject|1|||
164227975|NCT03283241|593205371|FG000|Overall Study|Subject relocated to Finland|0|||
164227976|NCT03283241|593205372|FG001|Overall Study|Subject relocated to Finland|1|||
164227977|NCT00666263|593205373|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
164227978|NCT00666263|593205374|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
164227979|NCT00666263|593205373|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
164227980|NCT00666263|593205374|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
164227981|NCT00666263|593205373|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
164227982|NCT00666263|593205374|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
164227983|NCT02439957|593205375|FG000|Overall Study|Study Terminated|3|||
164227984|NCT02439957|593205376|FG001|Overall Study|Study Terminated|3|||
164227985|NCT00586157|593205377|FG000|First Intervention|Worsening behavior|1|||
164227986|NCT00586157|593205378|FG001|First Intervention|Worsening behavior|0|||
164227987|NCT00586157|593205377|FG000|Second Intervention|Withdrawal by Subject|1|||
164227988|NCT00586157|593205378|FG001|Second Intervention|Withdrawal by Subject|0|||
164227989|NCT00586157|593205377|FG000|Second Intervention|Worsening behavior|1|||
164227990|NCT00586157|593205378|FG001|Second Intervention|Worsening behavior|0|||
164227991|NCT00586157|593205377|FG000|Second Intervention|Adverse Event|0|||
164227992|NCT00586157|593205378|FG001|Second Intervention|Adverse Event|1|||
164331062|NCT01083485|593589849|FG000|Overall Study|Adverse Event|0|||
164331063|NCT01083485|593589850|FG001|Overall Study|Adverse Event|1|||
164331064|NCT01083485|593589849|FG000|Overall Study|Protocol Violation|1|||
164331065|NCT01083485|593589850|FG001|Overall Study|Protocol Violation|0|||
164331066|NCT01083485|593589849|FG000|Overall Study|Withdrawal by Subject|5|||
164331067|NCT01083485|593589850|FG001|Overall Study|Withdrawal by Subject|2|||
164227993|NCT00414609|593205379|FG000|Core Study|Adverse Event|9|||
164227994|NCT00414609|593205380|FG001|Core Study|Adverse Event|11|||
164331068|NCT01083485|593589849|FG000|Overall Study|Other|1|||
164227995|NCT00414609|593205381|FG002|Core Study|Adverse Event|0|||
164227996|NCT00414609|593205379|FG000|Core Study|Abnormal laboratory values|0|||
164227997|NCT00414609|593205380|FG001|Core Study|Abnormal laboratory values|1|||
164227998|NCT00414609|593205381|FG002|Core Study|Abnormal laboratory values|0|||
163882989|NCT02783300|591942069|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164227999|NCT00414609|593205379|FG000|Core Study|Abnormal test procedure results|1|||
164228000|NCT00414609|593205380|FG001|Core Study|Abnormal test procedure results|1|||
164228001|NCT00414609|593205381|FG002|Core Study|Abnormal test procedure results|0|||
164228002|NCT00414609|593205379|FG000|Core Study|Protocol deviation|0|||
164228003|NCT00414609|593205380|FG001|Core Study|Protocol deviation|1|||
164228004|NCT00414609|593205381|FG002|Core Study|Protocol deviation|0|||
164228005|NCT00414609|593205379|FG000|Core Study|Patient withdrew consent|10|||
164228006|NCT00414609|593205380|FG001|Core Study|Patient withdrew consent|11|||
164228007|NCT00414609|593205381|FG002|Core Study|Patient withdrew consent|0|||
164228008|NCT00414609|593205379|FG000|Core Study|Lost to Follow-up|7|||
164228009|NCT00414609|593205380|FG001|Core Study|Lost to Follow-up|4|||
164228010|NCT00414609|593205381|FG002|Core Study|Lost to Follow-up|0|||
164228011|NCT00414609|593205379|FG000|Core Study|Administrative problems|0|||
164228012|NCT00414609|593205380|FG001|Core Study|Administrative problems|2|||
164228013|NCT00414609|593205381|FG002|Core Study|Administrative problems|0|||
164228014|NCT00414609|593205379|FG000|Core Study|Death|7|||
164228015|NCT00414609|593205380|FG001|Core Study|Death|14|||
164228016|NCT00414609|593205381|FG002|Core Study|Death|0|||
164228017|NCT00414609|593205379|FG000|Extension Study|Adverse Event|0|||
164228018|NCT00414609|593205380|FG001|Extension Study|Adverse Event|0|||
164228019|NCT00414609|593205381|FG002|Extension Study|Adverse Event|14|||
164228020|NCT00414609|593205379|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
164228021|NCT00414609|593205380|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
164228022|NCT00414609|593205381|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
164228023|NCT00414609|593205379|FG000|Extension Study|Withdrawal by Subject|0|||
164228024|NCT00414609|593205380|FG001|Extension Study|Withdrawal by Subject|0|||
164228025|NCT00414609|593205381|FG002|Extension Study|Withdrawal by Subject|13|||
164228026|NCT00414609|593205379|FG000|Extension Study|Lost to Follow-up|0|||
164228027|NCT00414609|593205380|FG001|Extension Study|Lost to Follow-up|0|||
164228028|NCT00414609|593205381|FG002|Extension Study|Lost to Follow-up|10|||
164228029|NCT00414609|593205379|FG000|Extension Study|Administrative problems|0|||
164228030|NCT00414609|593205380|FG001|Extension Study|Administrative problems|0|||
164228031|NCT00414609|593205381|FG002|Extension Study|Administrative problems|1|||
164228032|NCT00414609|593205379|FG000|Extension Study|Death|0|||
164228033|NCT00414609|593205380|FG001|Extension Study|Death|0|||
164228034|NCT00414609|593205381|FG002|Extension Study|Death|17|||
164228035|NCT02853136|593205384|FG000|Wash-out|Adverse Event|0|||
164228036|NCT02853136|593205385|FG001|Wash-out|Adverse Event|0|||
164228037|NCT02853136|593205386|FG002|Wash-out|Adverse Event|0|||
164228038|NCT02853136|593205387|FG003|Wash-out|Adverse Event|1|||
164228039|NCT00841815|593205388|FG000|Washout|Withdrawal by Subject|0|||
164228040|NCT00841815|593205389|FG001|Washout|Withdrawal by Subject|1|||
164228041|NCT01682720|593205397|FG000|Overall Study|Randomized but Not Treated|0|||
164228042|NCT01682720|593205398|FG001|Overall Study|Randomized but Not Treated|1|||
164228043|NCT01682720|593205399|FG002|Overall Study|Randomized but Not Treated|1|||
164228044|NCT01682720|593205400|FG003|Overall Study|Randomized but Not Treated|0|||
164228045|NCT01682720|593205397|FG000|Overall Study|Terminated by Sponsor|83|||
164228046|NCT01682720|593205398|FG001|Overall Study|Terminated by Sponsor|0|||
164228047|NCT01682720|593205399|FG002|Overall Study|Terminated by Sponsor|0|||
164228048|NCT01682720|593205400|FG003|Overall Study|Terminated by Sponsor|0|||
164228049|NCT01682720|593205397|FG000|Overall Study|Efficacy Failure|0|||
164228050|NCT01682720|593205398|FG001|Overall Study|Efficacy Failure|3|||
164228051|NCT01682720|593205399|FG002|Overall Study|Efficacy Failure|3|||
164228052|NCT01682720|593205400|FG003|Overall Study|Efficacy Failure|30|||
164228053|NCT01682720|593205397|FG000|Overall Study|Lost to Follow-up|1|||
164228054|NCT01682720|593205398|FG001|Overall Study|Lost to Follow-up|1|||
164228055|NCT01682720|593205399|FG002|Overall Study|Lost to Follow-up|0|||
164228056|NCT01682720|593205400|FG003|Overall Study|Lost to Follow-up|6|||
164228057|NCT01682720|593205397|FG000|Overall Study|Subject Withdrew Consent|0|||
164228058|NCT01682720|593205398|FG001|Overall Study|Subject Withdrew Consent|0|||
164228059|NCT01682720|593205399|FG002|Overall Study|Subject Withdrew Consent|2|||
164228060|NCT01682720|593205400|FG003|Overall Study|Subject Withdrew Consent|2|||
164228061|NCT01682720|593205397|FG000|Overall Study|Adverse Event|1|||
164228062|NCT01682720|593205398|FG001|Overall Study|Adverse Event|0|||
164228063|NCT01682720|593205399|FG002|Overall Study|Adverse Event|1|||
164228064|NCT01682720|593205400|FG003|Overall Study|Adverse Event|1|||
164228065|NCT01687595|593205401|FG000|Overall Study|Withdrawal by Subject|8|||
164228066|NCT01687595|593205402|FG001|Overall Study|Withdrawal by Subject|0|||
164228067|NCT01687595|593205401|FG000|Overall Study|Lost to Follow-up|3|||
164228068|NCT01687595|593205402|FG001|Overall Study|Lost to Follow-up|1|||
164228069|NCT01687595|593205401|FG000|Overall Study|Investigator's decision|1|||
164228070|NCT01687595|593205402|FG001|Overall Study|Investigator's decision|0|||
164228071|NCT01687595|593205401|FG000|Overall Study|Sponsor's decision|1|||
164228072|NCT01687595|593205402|FG001|Overall Study|Sponsor's decision|0|||
164228073|NCT01687595|593205401|FG000|Overall Study|Noncompliance|1|||
164228074|NCT01687595|593205402|FG001|Overall Study|Noncompliance|2|||
164228075|NCT01687595|593205401|FG000|Overall Study|Other than specified|56|||
164228076|NCT01687595|593205402|FG001|Overall Study|Other than specified|7|||
164228077|NCT04204902|593205403|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
164228078|NCT04204902|593205404|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
164228079|NCT03647137|593205406|FG000|Overall Study|Scan Limitation|2|||
164228080|NCT03647137|593205407|FG001|Overall Study|Scan Limitation|1|||
164228081|NCT03647137|593205408|FG002|Overall Study|Scan Limitation|1|||
164228082|NCT03647137|593205409|FG003|Overall Study|Scan Limitation|2|||
164228083|NCT03900650|593205410|FG000|Overall Study|Withdrawal by Subject|1|||
164228084|NCT03900650|593205411|FG001|Overall Study|Withdrawal by Subject|1|||
164228085|NCT03900650|593205412|FG002|Overall Study|Withdrawal by Subject|0|||
164228086|NCT03900650|593205413|FG003|Overall Study|Withdrawal by Subject|0|||
164331069|NCT01083485|593589850|FG001|Overall Study|Other|0|||
164331070|NCT02171065|593589851|FG000|Overall Study|Withdrawal by Subject|1|||
164331071|NCT02171065|593589852|FG001|Overall Study|Withdrawal by Subject|0|||
164331072|NCT02171065|593589853|FG002|Overall Study|Withdrawal by Subject|0|||
164331073|NCT02171065|593589851|FG000|Overall Study|Lost to Follow-up|0|||
164331074|NCT02171065|593589852|FG001|Overall Study|Lost to Follow-up|0|||
164331075|NCT02171065|593589853|FG002|Overall Study|Lost to Follow-up|1|||
164331076|NCT00851630|593589855|FG000|Overall Study|Death|2|||
164331077|NCT00851630|593589856|FG001|Overall Study|Death|1|||
164331078|NCT00851630|593589855|FG000|Overall Study|Clinical failure|0|||
164331079|NCT00851630|593589856|FG001|Overall Study|Clinical failure|1|||
164228087|NCT03900650|593205410|FG000|Overall Study|Withdrawn by staff|1|||
164228088|NCT03900650|593205411|FG001|Overall Study|Withdrawn by staff|0|||
164228089|NCT03900650|593205412|FG002|Overall Study|Withdrawn by staff|0|||
164228090|NCT03900650|593205413|FG003|Overall Study|Withdrawn by staff|0|||
164228091|NCT00829868|593205414|FG000|Washout|Physician Decision|1|||
164228092|NCT00829868|593205415|FG001|Washout|Physician Decision|0|||
164228093|NCT01554904|593205419|FG000|Overall Study|Withdrawal by Subject|3|||
164331080|NCT03906461|593589861|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
164331081|NCT03906461|593589861|FG000|Completed 12-month Follow-up|Missed Visit|6|||
164331082|NCT01795638|593589866|FG000|Overall Study|Death|0|||
164331083|NCT01795638|593589867|FG001|Overall Study|Death|3|||
164331084|NCT01795638|593589866|FG000|Overall Study|transferred to quaternary hospital|2|||
164331085|NCT01795638|593589867|FG001|Overall Study|transferred to quaternary hospital|3|||
164331086|NCT01795638|593589866|FG000|Overall Study|Protocol Violation|3|||
164331087|NCT01795638|593589867|FG001|Overall Study|Protocol Violation|0|||
164331088|NCT01795638|593589866|FG000|Overall Study|discharged from hospital|7|||
164331089|NCT01795638|593589867|FG001|Overall Study|discharged from hospital|5|||
164331090|NCT01795638|593589866|FG000|Overall Study|Withdrawal by Subject|1|||
164331091|NCT01795638|593589867|FG001|Overall Study|Withdrawal by Subject|0|||
164331092|NCT03061097|593589868|FG000|Overall Study|Withdrawal by Subject|0|||
164228094|NCT01554904|593205419|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
164228095|NCT03829683|593205422|FG000|Overall Study|Lost to Follow-up|1|||
164228096|NCT03829683|593205423|FG001|Overall Study|Lost to Follow-up|0|||
164331093|NCT03061097|593589869|FG001|Overall Study|Withdrawal by Subject|3|||
164331094|NCT03956056|593589876|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
164331095|NCT03956056|593589876|FG000|Overall Study|Lack of Efficacy|1|||
164228097|NCT03829683|593205422|FG000|Overall Study|Physician Decision|3|||
164228098|NCT03829683|593205423|FG001|Overall Study|Physician Decision|1|||
164331096|NCT02231918|593589877|FG000|Overall Study|Withdrawal by Subject|0|||
164331097|NCT02231918|593589878|FG001|Overall Study|Withdrawal by Subject|1|||
164331098|NCT02231918|593589879|FG002|Overall Study|Withdrawal by Subject|0|||
164228099|NCT03829683|593205422|FG000|Overall Study|Withdrawal by Subject|0|||
164228100|NCT03829683|593205423|FG001|Overall Study|Withdrawal by Subject|1|||
164228101|NCT03829683|593205422|FG000|Overall Study|Discharge from hospital|1|||
164228102|NCT03829683|593205423|FG001|Overall Study|Discharge from hospital|0|||
164228103|NCT01681849|593205426|FG000|Overall Study|Protocol Violation|2|||
164228104|NCT01681849|593205427|FG001|Overall Study|Protocol Violation|0|||
164228105|NCT01681849|593205428|FG002|Overall Study|Protocol Violation|0|||
164228106|NCT01681849|593205426|FG000|Overall Study|Withdrawal by Subject|3|||
164228107|NCT01681849|593205427|FG001|Overall Study|Withdrawal by Subject|5|||
164228108|NCT01681849|593205428|FG002|Overall Study|Withdrawal by Subject|33|||
164228109|NCT01681849|593205426|FG000|Overall Study|Lost to Follow-up|3|||
164228110|NCT01681849|593205427|FG001|Overall Study|Lost to Follow-up|2|||
164331099|NCT02231918|593589877|FG000|Overall Study|Adverse Event|0|||
164331100|NCT02231918|593589878|FG001|Overall Study|Adverse Event|0|||
164331101|NCT02231918|593589879|FG002|Overall Study|Adverse Event|1|||
164331102|NCT00293215|593589885|FG000|Overall Study|Progressive disease|3|||
164331103|NCT00293215|593589886|FG001|Overall Study|Progressive disease|1|||
164331104|NCT00293215|593589885|FG000|Overall Study|Adverse Event|2|||
164331105|NCT00293215|593589886|FG001|Overall Study|Adverse Event|2|||
164331106|NCT01409434|593589887|FG000|Overall Study|Protocol Violation|4|||
164331107|NCT04629508|593589891|FG000|Overall Study|Adverse Event|1|||
164331108|NCT04629508|593589891|FG000|Overall Study|Death|2|||
164331109|NCT04629508|593589891|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
164331110|NCT04073368|593589894|FG000|Overall Study|Adverse Event|2|||
164331111|NCT04073368|593589895|FG001|Overall Study|Adverse Event|0|||
164331112|NCT04073368|593589896|FG002|Overall Study|Adverse Event|1|||
164331113|NCT04073368|593589897|FG003|Overall Study|Adverse Event|1|||
164331114|NCT04073368|593589894|FG000|Overall Study|Withdrawal by Subject|2|||
164331115|NCT04073368|593589895|FG001|Overall Study|Withdrawal by Subject|2|||
164331116|NCT04073368|593589896|FG002|Overall Study|Withdrawal by Subject|1|||
164331117|NCT04073368|593589897|FG003|Overall Study|Withdrawal by Subject|1|||
164331118|NCT04073368|593589894|FG000|Overall Study|Lost to Follow-up|1|||
164331119|NCT04073368|593589895|FG001|Overall Study|Lost to Follow-up|1|||
164331120|NCT04073368|593589896|FG002|Overall Study|Lost to Follow-up|1|||
164331121|NCT04073368|593589897|FG003|Overall Study|Lost to Follow-up|0|||
164331122|NCT04073368|593589894|FG000|Overall Study|Protocol Violation|0|||
164331123|NCT04073368|593589895|FG001|Overall Study|Protocol Violation|1|||
164331124|NCT04073368|593589896|FG002|Overall Study|Protocol Violation|0|||
164331125|NCT04073368|593589897|FG003|Overall Study|Protocol Violation|0|||
164331126|NCT04073368|593589894|FG000|Overall Study|Subject noncompliance|7|||
164331127|NCT04073368|593589895|FG001|Overall Study|Subject noncompliance|4|||
164331128|NCT04073368|593589896|FG002|Overall Study|Subject noncompliance|0|||
164331129|NCT04073368|593589897|FG003|Overall Study|Subject noncompliance|0|||
164331130|NCT03026088|593589898|FG000|Overall Study|Study termination|20|||
164331131|NCT00761579|593589899|FG000|Overall Study|Adverse Event|10|||
164331132|NCT00761579|593589899|FG000|Overall Study|Death|2|||
164331133|NCT00761579|593589899|FG000|Overall Study|Lack of Efficacy|21|||
164331134|NCT00761579|593589899|FG000|Overall Study|Lost to Follow-up|16|||
164331135|NCT00761579|593589899|FG000|Overall Study|Pregnancy|1|||
164331136|NCT00761579|593589899|FG000|Overall Study|Withdrawal by Subject|34|||
164331137|NCT00761579|593589899|FG000|Overall Study|Lack of compliance|2|||
164331138|NCT00761579|593589899|FG000|Overall Study|Protocol deviation|1|||
164331139|NCT00761579|593589899|FG000|Overall Study|Drug overdose|1|||
164331140|NCT00761579|593589899|FG000|Overall Study|Aggravation of depression|1|||
164331141|NCT00761579|593589899|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
164331142|NCT00761579|593589899|FG000|Overall Study|Lost survey form|1|||
164331143|NCT00761579|593589899|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
164331144|NCT00950911|593589900|FG000|Overall Study|Adverse Event|0|||
164331145|NCT00950911|593589901|FG001|Overall Study|Adverse Event|2|||
164331146|NCT00950911|593589900|FG000|Overall Study|Death|4|||
164331147|NCT00950911|593589901|FG001|Overall Study|Death|6|||
164331148|NCT00950911|593589900|FG000|Overall Study|Disease progression|2|||
164331149|NCT00950911|593589901|FG001|Overall Study|Disease progression|2|||
164331150|NCT00950911|593589900|FG000|Overall Study|Consent withdrawn|1|||
164331151|NCT00950911|593589901|FG001|Overall Study|Consent withdrawn|3|||
164331152|NCT00950911|593589900|FG000|Overall Study|Administrative decision|3|||
163882990|NCT02783300|591942070|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
164331153|NCT00950911|593589901|FG001|Overall Study|Administrative decision|1|||
164331154|NCT00950911|593589900|FG000|Overall Study|Ineligibility determined|1|||
164331155|NCT00950911|593589901|FG001|Overall Study|Ineligibility determined|0|||
164228111|NCT01681849|593205428|FG002|Overall Study|Lost to Follow-up|6|||
164228112|NCT04525183|593205431|FG000|Overall Study|Withdrawal by Subject|0|||
164228113|NCT04525183|593205432|FG001|Overall Study|Withdrawal by Subject|0|||
164331156|NCT00950911|593589900|FG000|Overall Study|Noncompliance|1|||
164331157|NCT00950911|593589901|FG001|Overall Study|Noncompliance|0|||
164331158|NCT00950911|593589900|FG000|Overall Study|Poor performance status|0|||
164331159|NCT00950911|593589901|FG001|Overall Study|Poor performance status|1|||
164331160|NCT02063880|593589902|FG000|Overall Study|Death|21|||
164331161|NCT02063880|593589903|FG001|Overall Study|Death|18|||
164331162|NCT02063880|593589902|FG000|Overall Study|Lost to Follow-up|7|||
164331163|NCT02063880|593589903|FG001|Overall Study|Lost to Follow-up|7|||
164331164|NCT02063880|593589902|FG000|Overall Study|Ineligible|0|||
164331165|NCT02063880|593589903|FG001|Overall Study|Ineligible|2|||
164331166|NCT02600351|593589904|FG000|Overall Study|Lack of Efficacy|3|||
164331167|NCT02600351|593589905|FG001|Overall Study|Lack of Efficacy|0|||
164331168|NCT02600351|593589906|FG002|Overall Study|Lack of Efficacy|5|||
164331169|NCT02600351|593589907|FG003|Overall Study|Lack of Efficacy|2|||
164331170|NCT02600351|593589904|FG000|Overall Study|Lost to Follow-up|1|||
164331171|NCT02600351|593589905|FG001|Overall Study|Lost to Follow-up|0|||
164331172|NCT02600351|593589906|FG002|Overall Study|Lost to Follow-up|0|||
164331173|NCT02600351|593589907|FG003|Overall Study|Lost to Follow-up|0|||
164331174|NCT02600351|593589904|FG000|Overall Study|Randomized but Not Treated|1|||
164331175|NCT02600351|593589905|FG001|Overall Study|Randomized but Not Treated|0|||
164331176|NCT02600351|593589906|FG002|Overall Study|Randomized but Not Treated|1|||
164331177|NCT02600351|593589907|FG003|Overall Study|Randomized but Not Treated|3|||
164331178|NCT00567593|593589910|FG000|Overall Study|Adverse Event|1|||
164331179|NCT00567593|593589910|FG000|Overall Study|Physician Decision|1|||
164331180|NCT02106910|593589911|FG000|Overall Study|Lost to Follow-up|1|||
164331181|NCT02106910|593589912|FG001|Overall Study|Lost to Follow-up|1|||
164331182|NCT04087213|593589913|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
164331183|NCT04087213|593589913|FG000|In-Facility Introduction|Adverse Event|1|||
164331184|NCT04087213|593589913|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
164331185|NCT04087213|593589913|FG000|Assisted Evaluable Period|Personal reasons|3|||
164331186|NCT04087213|593589913|FG000|Transition Period B|Renal Transplantation|1|||
164331187|NCT01272661|593589916|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
164331188|NCT01272661|593589917|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
164331189|NCT01272661|593589918|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
164331190|NCT01086423|593589919|FG000|Overall Study|Protocol Violation|0|||
164331191|NCT01086423|593589920|FG001|Overall Study|Protocol Violation|0|||
164331192|NCT01086423|593589921|FG002|Overall Study|Protocol Violation|1|||
164331193|NCT01086423|593589919|FG000|Overall Study|Migrated/moved from study area|2|||
164331194|NCT01086423|593589920|FG001|Overall Study|Migrated/moved from study area|0|||
164331195|NCT01086423|593589921|FG002|Overall Study|Migrated/moved from study area|4|||
164331196|NCT01086423|593589919|FG000|Overall Study|Adverse event, fatal|1|||
164331197|NCT01086423|593589920|FG001|Overall Study|Adverse event, fatal|1|||
164331198|NCT01086423|593589921|FG002|Overall Study|Adverse event, fatal|0|||
164331199|NCT01086423|593589919|FG000|Overall Study|Adverse event, non-fatal|2|||
164331200|NCT01086423|593589920|FG001|Overall Study|Adverse event, non-fatal|1|||
164331201|NCT01086423|593589921|FG002|Overall Study|Adverse event, non-fatal|0|||
164331202|NCT01086423|593589919|FG000|Overall Study|Withdrawal by Subject|5|||
164331203|NCT01086423|593589920|FG001|Overall Study|Withdrawal by Subject|1|||
164331204|NCT01086423|593589921|FG002|Overall Study|Withdrawal by Subject|3|||
164331205|NCT01086423|593589919|FG000|Overall Study|Lost to Follow-up|0|||
164331206|NCT01086423|593589920|FG001|Overall Study|Lost to Follow-up|0|||
164331207|NCT01086423|593589921|FG002|Overall Study|Lost to Follow-up|1|||
164331208|NCT02057393|593589922|FG000|Overall Study|Withdrawal by Subject|1|||
164331209|NCT02057393|593589922|FG000|Overall Study|Patient did not meet criteria|1|||
164331210|NCT02652767|593589923|FG000|Overall Study|Death|2|||
164331211|NCT02652767|593589923|FG000|Overall Study|Lost to Follow-up|1|||
164331212|NCT02652767|593589923|FG000|Overall Study|Withdrawal by Subject|1|||
164331213|NCT01130103|593589924|FG000|Randomized Treatment|Adverse Event|1|||
164331214|NCT01130103|593589925|FG001|Randomized Treatment|Adverse Event|1|||
164331215|NCT01130103|593589924|FG000|Randomized Treatment|Lost to Follow-up|1|||
164331216|NCT01130103|593589925|FG001|Randomized Treatment|Lost to Follow-up|0|||
164331217|NCT01130103|593589924|FG000|Randomized Treatment|Protocol Violation|3|||
164331218|NCT01130103|593589925|FG001|Randomized Treatment|Protocol Violation|2|||
164331219|NCT01130103|593589924|FG000|Randomized Treatment|Withdrawal by Subject|1|||
164331220|NCT01130103|593589925|FG001|Randomized Treatment|Withdrawal by Subject|2|||
164331221|NCT01130103|593589924|FG000|Maintenance Treatment|Lack of Efficacy|0|||
164331222|NCT01130103|593589925|FG001|Maintenance Treatment|Lack of Efficacy|1|||
164331223|NCT01130103|593589924|FG000|Maintenance Treatment|Lost to Follow-up|1|||
164331224|NCT01130103|593589925|FG001|Maintenance Treatment|Lost to Follow-up|1|||
164331225|NCT01130103|593589924|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
164331226|NCT01130103|593589925|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
164331227|NCT01028378|593589926|FG000|Overall Study|Lost to Follow-up|12|||
164331228|NCT01028378|593589926|FG000|Overall Study|Withdrawal by Subject|1|||
164331229|NCT01028378|593589926|FG000|Overall Study|Adminstrative Reasons|4|||
164331230|NCT00450385|593589927|FG000|Overall Study|Death|3|||
164331231|NCT00450385|593589927|FG000|Overall Study|Protocol Violation|1|||
164331232|NCT00450385|593589927|FG000|Overall Study|Withdrawal by Subject|2|||
164331233|NCT00450385|593589927|FG000|Overall Study|Lack of Efficacy|2|||
164331234|NCT00450385|593589927|FG000|Overall Study|Adverse Event|1|||
164331235|NCT00450385|593589927|FG000|Overall Study|Physician Decision|1|||
164331236|NCT00450385|593589927|FG000|Overall Study|Other|3|||
164228114|NCT04525183|593205433|FG002|Overall Study|Withdrawal by Subject|3|||
164228115|NCT04525183|593205431|FG000|Overall Study|Study non-compliance|0|||
164228116|NCT04525183|593205432|FG001|Overall Study|Study non-compliance|0|||
164228117|NCT04525183|593205433|FG002|Overall Study|Study non-compliance|1|||
164228118|NCT04525183|593205431|FG000|Overall Study|Recurrent disease before starting on study|0|||
164228119|NCT04525183|593205432|FG001|Overall Study|Recurrent disease before starting on study|0|||
164228120|NCT04525183|593205433|FG002|Overall Study|Recurrent disease before starting on study|1|||
164228121|NCT00803049|593205434|FG000|Overall Study|Adverse Event|21|||
164228122|NCT00803049|593205435|FG001|Overall Study|Adverse Event|33|||
164228123|NCT00803049|593205436|FG002|Overall Study|Adverse Event|13|||
164228124|NCT00803049|593205437|FG003|Overall Study|Adverse Event|27|||
164228125|NCT00803049|593205434|FG000|Overall Study|Lack of Efficacy|10|||
164228126|NCT00803049|593205435|FG001|Overall Study|Lack of Efficacy|19|||
164228127|NCT00803049|593205436|FG002|Overall Study|Lack of Efficacy|6|||
164228128|NCT00803049|593205437|FG003|Overall Study|Lack of Efficacy|13|||
164228129|NCT00803049|593205434|FG000|Overall Study|Lost to Follow-up|0|||
164228130|NCT00803049|593205435|FG001|Overall Study|Lost to Follow-up|2|||
164228131|NCT00803049|593205436|FG002|Overall Study|Lost to Follow-up|0|||
164228132|NCT00803049|593205437|FG003|Overall Study|Lost to Follow-up|3|||
164228133|NCT00803049|593205434|FG000|Overall Study|Death|2|||
164228134|NCT00803049|593205435|FG001|Overall Study|Death|1|||
164228135|NCT00803049|593205436|FG002|Overall Study|Death|0|||
164228136|NCT00803049|593205437|FG003|Overall Study|Death|2|||
164228137|NCT00803049|593205434|FG000|Overall Study|Progressive Disease|6|||
164228138|NCT00803049|593205435|FG001|Overall Study|Progressive Disease|10|||
164228139|NCT00803049|593205436|FG002|Overall Study|Progressive Disease|6|||
164228140|NCT00803049|593205437|FG003|Overall Study|Progressive Disease|6|||
164228141|NCT00803049|593205434|FG000|Overall Study|Withdrawal by Subject|19|||
164228142|NCT00803049|593205435|FG001|Overall Study|Withdrawal by Subject|43|||
164228143|NCT00803049|593205436|FG002|Overall Study|Withdrawal by Subject|16|||
164228144|NCT00803049|593205437|FG003|Overall Study|Withdrawal by Subject|44|||
164228145|NCT00803049|593205434|FG000|Overall Study|Protocol Violation|0|||
164228146|NCT00803049|593205435|FG001|Overall Study|Protocol Violation|1|||
164228147|NCT00803049|593205436|FG002|Overall Study|Protocol Violation|1|||
164228148|NCT00803049|593205437|FG003|Overall Study|Protocol Violation|0|||
164228149|NCT00803049|593205434|FG000|Overall Study|Randomized and Not Treated|0|||
164228150|NCT00803049|593205435|FG001|Overall Study|Randomized and Not Treated|0|||
164228151|NCT00803049|593205436|FG002|Overall Study|Randomized and Not Treated|0|||
164228152|NCT00803049|593205437|FG003|Overall Study|Randomized and Not Treated|2|||
164228153|NCT00803049|593205434|FG000|Overall Study|Other than Specified Above|3|||
164228154|NCT00803049|593205435|FG001|Overall Study|Other than Specified Above|9|||
164228155|NCT00803049|593205436|FG002|Overall Study|Other than Specified Above|2|||
164228156|NCT00803049|593205437|FG003|Overall Study|Other than Specified Above|5|||
164228157|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
164228158|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
164228159|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
164228160|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
164228161|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
164228162|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
164228163|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
164228164|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
164228165|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
164228166|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
164228167|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
164228168|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
164228169|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
164228170|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
164228171|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
164228172|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
164228173|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
164228174|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
164228175|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
164228176|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
164228177|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
164228178|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
164228179|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
164228180|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
164228181|NCT01272219|593205438|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
164228182|NCT01272219|593205439|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
164228183|NCT01272219|593205440|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
164228184|NCT01272219|593205441|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
164228185|NCT01272219|593205442|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
164228186|NCT01272219|593205443|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
164228187|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
164228188|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
164228189|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
164228190|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
164228191|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
164228192|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
164228193|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228194|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228195|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228196|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
164331237|NCT00471146|593589928|FG000|Overall Study|Adverse Event|32|||
164331238|NCT00471146|593589929|FG001|Overall Study|Adverse Event|33|||
164331239|NCT00471146|593589928|FG000|Overall Study|Withdrawal by Subject|14|||
164331240|NCT00471146|593589929|FG001|Overall Study|Withdrawal by Subject|11|||
164331241|NCT00471146|593589928|FG000|Overall Study|Death|11|||
164331242|NCT00471146|593589929|FG001|Overall Study|Death|12|||
164331243|NCT00471146|593589928|FG000|Overall Study|Lost to Follow-up|4|||
164331244|NCT00471146|593589929|FG001|Overall Study|Lost to Follow-up|2|||
164331245|NCT00471146|593589928|FG000|Overall Study|Protocol Violation|2|||
164331246|NCT00471146|593589929|FG001|Overall Study|Protocol Violation|2|||
164331247|NCT00471146|593589928|FG000|Overall Study|Objective progression or relapse|84|||
164331248|NCT00471146|593589929|FG001|Overall Study|Objective progression or relapse|87|||
164331249|NCT00471146|593589928|FG000|Overall Study|Global deterioration of health status|12|||
164331250|NCT00471146|593589929|FG001|Overall Study|Global deterioration of health status|14|||
164331251|NCT00471146|593589928|FG000|Overall Study|Randomized but not treated|9|||
164331252|NCT00471146|593589929|FG001|Overall Study|Randomized but not treated|8|||
164228197|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164331253|NCT00471146|593589928|FG000|Overall Study|Other|4|||
164331254|NCT00471146|593589929|FG001|Overall Study|Other|5|||
164331255|NCT00467610|593589932|FG000|Overall Study|Withdrawal by Subject|1|||
164331256|NCT02676466|593589933|FG000|Overall Study|Death|0|||
164228198|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
164228199|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228200|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
164228201|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228202|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
164228203|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228204|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
164228205|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
164228206|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
164228207|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
164228208|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
164228209|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
164228210|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
164228211|NCT01272219|593205438|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
164228212|NCT01272219|593205439|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
164228213|NCT01272219|593205440|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
164228214|NCT01272219|593205441|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
164228215|NCT01272219|593205442|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
164228216|NCT01272219|593205443|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
164228217|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228218|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228219|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228220|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
164228221|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
164228222|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
164228223|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228224|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228225|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228226|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
164228227|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
164228228|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
164228229|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228230|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228231|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228232|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
164228233|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
164228234|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
164228235|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228236|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228237|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228238|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
164228239|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
164228240|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
164228241|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
164228242|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
164228243|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
164228244|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
164228245|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
164228246|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
164228247|NCT01272219|593205438|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
164228248|NCT01272219|593205439|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
164228249|NCT01272219|593205440|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
164228250|NCT01272219|593205441|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
164228251|NCT01272219|593205442|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
164228252|NCT01272219|593205443|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
164228253|NCT05305651|593205444|FG000|Overall Study|Death|1|||
164228254|NCT05305651|593205444|FG000|Overall Study|Withdrawal by Subject|4|||
164228255|NCT05305651|593205444|FG000|Overall Study|Lost to Follow-up|4|||
164228256|NCT05021224|593205451|FG000|Overall Study|Did not complete all survey items|4|||
164228257|NCT05021224|593205452|FG001|Overall Study|Did not complete all survey items|1|||
164228258|NCT05021224|593205453|FG002|Overall Study|Did not complete all survey items|0|||
164228259|NCT05021224|593205454|FG003|Overall Study|Did not complete all survey items|2|||
164228260|NCT03996395|593205455|FG000|Overall Study|Lost to Follow-up|4|||
164228261|NCT03996395|593205455|FG000|Overall Study|Withdrawal by Subject|1|||
164228262|NCT03996395|593205455|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
164228263|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
164228264|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
164228265|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
164228266|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
164228267|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164228268|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164228269|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164228270|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164228271|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
164228272|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
164228273|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
164228274|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
164228275|NCT05375929|593205458|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
164228276|NCT05375929|593205459|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
164228277|NCT05375929|593205460|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
164228278|NCT05375929|593205461|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
164228279|NCT05375929|593205458|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
164228280|NCT05375929|593205459|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
164228281|NCT05375929|593205460|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
164228282|NCT05375929|593205461|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
164228283|NCT05375929|593205458|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
164228284|NCT05375929|593205459|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
164228285|NCT05375929|593205460|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
164228286|NCT05375929|593205461|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
164228287|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
164228288|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
164228289|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
164228290|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
164228291|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
164228292|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
164228293|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
164228294|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
164228295|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
164228296|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
164228297|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
164228298|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
164228299|NCT05375929|593205458|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
164228300|NCT05375929|593205459|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
164228301|NCT05375929|593205460|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
164228302|NCT05375929|593205461|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
164228303|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
164228304|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228305|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228306|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228307|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
164228308|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228309|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228310|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
164228311|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228312|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228313|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228314|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
164228315|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
164228316|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228317|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228318|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
164228319|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228320|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228321|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228322|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228323|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
164228324|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
163882991|NCT02783300|591942071|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
163882992|NCT02783300|591942072|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164228325|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
164228326|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
164228327|NCT03973489|593205467|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
164228328|NCT03973489|593205468|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228329|NCT03973489|593205469|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228330|NCT03973489|593205470|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
164228331|NCT03973489|593205471|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228332|NCT03973489|593205472|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228333|NCT03973489|593205473|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228334|NCT03973489|593205474|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
164228335|NCT03973489|593205467|FG000|Second Intervention (1 Day)|Adverse Event|0|||
164228336|NCT03973489|593205468|FG001|Second Intervention (1 Day)|Adverse Event|0|||
164228337|NCT03973489|593205469|FG002|Second Intervention (1 Day)|Adverse Event|0|||
164228338|NCT03973489|593205470|FG003|Second Intervention (1 Day)|Adverse Event|1|||
164228339|NCT03973489|593205471|FG004|Second Intervention (1 Day)|Adverse Event|0|||
164228340|NCT03973489|593205472|FG005|Second Intervention (1 Day)|Adverse Event|0|||
164228341|NCT03973489|593205473|FG006|Second Intervention (1 Day)|Adverse Event|0|||
164228342|NCT03973489|593205474|FG007|Second Intervention (1 Day)|Adverse Event|0|||
164228343|NCT03301415|593205475|FG000|Overall Study|Lost to Follow-up|2|||
164228344|NCT03301415|593205475|FG000|Overall Study|Unable to comply with visit schedule|2|||
164228345|NCT00392288|593205476|FG000|Overall Study|Adverse Event|17|||
164228346|NCT00392288|593205477|FG001|Overall Study|Adverse Event|7|||
164228347|NCT00392288|593205478|FG002|Overall Study|Adverse Event|8|||
164228348|NCT00392288|593205476|FG000|Overall Study|Lack of Efficacy|8|||
164228349|NCT00392288|593205477|FG001|Overall Study|Lack of Efficacy|5|||
164228350|NCT00392288|593205478|FG002|Overall Study|Lack of Efficacy|3|||
164228351|NCT00392288|593205476|FG000|Overall Study|Protocol Violation|1|||
164228352|NCT00392288|593205477|FG001|Overall Study|Protocol Violation|3|||
164228353|NCT00392288|593205478|FG002|Overall Study|Protocol Violation|1|||
164228354|NCT00392288|593205476|FG000|Overall Study|Lost to Follow-up|1|||
164228355|NCT00392288|593205477|FG001|Overall Study|Lost to Follow-up|1|||
164228356|NCT00392288|593205478|FG002|Overall Study|Lost to Follow-up|1|||
164228357|NCT00392288|593205476|FG000|Overall Study|Withdrawal by Subject|1|||
164228358|NCT00392288|593205477|FG001|Overall Study|Withdrawal by Subject|0|||
164228359|NCT00392288|593205478|FG002|Overall Study|Withdrawal by Subject|2|||
164228360|NCT00392288|593205476|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
164228361|NCT00392288|593205477|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
164228362|NCT00392288|593205478|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
164228363|NCT00392288|593205476|FG000|Overall Study|Other|3|||
164228364|NCT00392288|593205477|FG001|Overall Study|Other|4|||
164228365|NCT00392288|593205478|FG002|Overall Study|Other|1|||
164228366|NCT02544763|593205479|FG000|Overall Study|Adverse Event|8|||
164228367|NCT02544763|593205480|FG001|Overall Study|Adverse Event|8|||
164228368|NCT02544763|593205481|FG002|Overall Study|Adverse Event|0|||
164228369|NCT02544763|593205479|FG000|Overall Study|Withdrawn by parent/guardian|1|||
164228370|NCT02544763|593205480|FG001|Overall Study|Withdrawn by parent/guardian|1|||
164228371|NCT02544763|593205481|FG002|Overall Study|Withdrawn by parent/guardian|1|||
164228372|NCT02544763|593205479|FG000|Overall Study|Met withdrawal criteria|0|||
164228373|NCT02544763|593205480|FG001|Overall Study|Met withdrawal criteria|2|||
164228374|NCT02544763|593205481|FG002|Overall Study|Met withdrawal criteria|0|||
164228375|NCT02544763|593205479|FG000|Overall Study|Physician Decision|0|||
164228376|NCT02544763|593205480|FG001|Overall Study|Physician Decision|1|||
164228377|NCT02544763|593205481|FG002|Overall Study|Physician Decision|0|||
164228378|NCT02544763|593205479|FG000|Overall Study|Difficulties taking IMP|1|||
164228379|NCT02544763|593205480|FG001|Overall Study|Difficulties taking IMP|0|||
164228380|NCT02544763|593205481|FG002|Overall Study|Difficulties taking IMP|0|||
164228381|NCT02097225|593205482|FG000|Dose Level 4|Adverse Event|0|||
164228382|NCT02097225|593205483|FG001|Dose Level 4|Adverse Event|0|||
164228383|NCT02097225|593205484|FG002|Dose Level 4|Adverse Event|0|||
164228384|NCT02097225|593205485|FG003|Dose Level 4|Adverse Event|0|||
164228385|NCT02097225|593205486|FG004|Dose Level 4|Adverse Event|1|||
164228386|NCT03379870|593207304|FG000|Overall Study|Lost to Follow-up|1|||
164228387|NCT03379870|593207305|FG001|Overall Study|Lost to Follow-up|0|||
164228388|NCT03379870|593207304|FG000|Overall Study|Protocol Violation|1|||
164228389|NCT03379870|593207305|FG001|Overall Study|Protocol Violation|1|||
164228390|NCT00003645|593207306|FG000|Overall Study|Death|4|||
164228391|NCT00003645|593207307|FG001|Overall Study|Death|1|||
164228392|NCT00003645|593207306|FG000|Overall Study|Lost to Follow-up|7|||
164228393|NCT00003645|593207307|FG001|Overall Study|Lost to Follow-up|8|||
164228394|NCT00003645|593207306|FG000|Overall Study|Withdrawal by Subject|1|||
164228395|NCT00003645|593207307|FG001|Overall Study|Withdrawal by Subject|3|||
164228396|NCT04101331|593207308|FG000|Overall Study|Adverse Event|9|||
164228397|NCT04101331|593207308|FG000|Overall Study|Disease progression|82|||
164228398|NCT04101331|593207308|FG000|Overall Study|Withdrawal by Subject|1|||
164228399|NCT04101331|593207308|FG000|Overall Study|Investigator decision|6|||
164228400|NCT04101331|593207308|FG000|Overall Study|Death|6|||
164228401|NCT04101331|593207308|FG000|Overall Study|Allogenic transplant|1|||
164228402|NCT04616196|593207309|FG000|Overall Study|Progressive Disease|3|||
164228403|NCT04616196|593207310|FG001|Overall Study|Progressive Disease|0|||
164228404|NCT04616196|593207311|FG002|Overall Study|Progressive Disease|4|||
164228405|NCT04616196|593207312|FG003|Overall Study|Progressive Disease|1|||
164228406|NCT04616196|593207309|FG000|Overall Study|Death|2|||
164228407|NCT04616196|593207310|FG001|Overall Study|Death|4|||
164228408|NCT04616196|593207311|FG002|Overall Study|Death|1|||
164228409|NCT04616196|593207312|FG003|Overall Study|Death|0|||
164228410|NCT04616196|593207309|FG000|Overall Study|Withdrawal by Subject|0|||
164228411|NCT04616196|593207310|FG001|Overall Study|Withdrawal by Subject|2|||
163986955|NCT00209339|592320242|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
163986956|NCT00209339|592320242|FG000|At 5 Years Follow-up|Death|1|||
164228412|NCT04616196|593207311|FG002|Overall Study|Withdrawal by Subject|0|||
164228413|NCT04616196|593207312|FG003|Overall Study|Withdrawal by Subject|0|||
164228414|NCT04616196|593207309|FG000|Overall Study|Lost to Follow-up|1|||
164228415|NCT04616196|593207310|FG001|Overall Study|Lost to Follow-up|0|||
164228416|NCT04616196|593207311|FG002|Overall Study|Lost to Follow-up|0|||
164228417|NCT04616196|593207312|FG003|Overall Study|Lost to Follow-up|0|||
164228418|NCT04616196|593207309|FG000|Overall Study|Sponsor request|2|||
164228419|NCT04616196|593207310|FG001|Overall Study|Sponsor request|1|||
164228420|NCT04616196|593207311|FG002|Overall Study|Sponsor request|1|||
164228421|NCT04616196|593207312|FG003|Overall Study|Sponsor request|2|||
164228422|NCT03502681|593207313|FG000|Overall Study|Adverse Event|1|||
164228423|NCT03502681|593207314|FG001|Overall Study|Adverse Event|1|||
164228424|NCT03502681|593207313|FG000|Overall Study|Disease Progression|2|||
164228425|NCT03502681|593207314|FG001|Overall Study|Disease Progression|1|||
164228426|NCT02254291|593207315|FG000|Overall Study|Withdrawal by Subject|0|||
164228427|NCT02254291|593207316|FG001|Overall Study|Withdrawal by Subject|3|||
164228428|NCT02254291|593207317|FG002|Overall Study|Withdrawal by Subject|1|||
164228429|NCT02254291|593207315|FG000|Overall Study|Missing follow-up information|0|||
164228430|NCT02254291|593207316|FG001|Overall Study|Missing follow-up information|0|||
164228431|NCT02254291|593207317|FG002|Overall Study|Missing follow-up information|1|||
164228432|NCT06790303|593207320|FG000|Overall Study|Study Terminated by sponsor|4|||
164228433|NCT06790303|593207320|FG000|Overall Study|Death|4|||
163986957|NCT01239160|592320243|FG000|Overall Study|Lost to Follow-up|3|||
164228434|NCT02579759|593207323|FG000|Overall Study|Protocol Violation|2|||
164228435|NCT02579759|593207324|FG001|Overall Study|Protocol Violation|0|||
164228436|NCT02579759|593207325|FG002|Overall Study|Protocol Violation|0|||
164228437|NCT02579759|593207323|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
164228438|NCT02579759|593207324|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
164228439|NCT02579759|593207325|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
164228440|NCT02579759|593207323|FG000|Overall Study|BfArM hold|13|||
164228441|NCT02579759|593207324|FG001|Overall Study|BfArM hold|12|||
164228442|NCT02579759|593207325|FG002|Overall Study|BfArM hold|12|||
164228443|NCT02579759|593207323|FG000|Overall Study|Sponsor stopped Dose 2|0|||
164228444|NCT02579759|593207324|FG001|Overall Study|Sponsor stopped Dose 2|41|||
164228445|NCT02579759|593207325|FG002|Overall Study|Sponsor stopped Dose 2|0|||
164228446|NCT02579759|593207323|FG000|Overall Study|Non compliance|0|||
164228447|NCT02579759|593207324|FG001|Overall Study|Non compliance|1|||
164228448|NCT02579759|593207325|FG002|Overall Study|Non compliance|0|||
163986958|NCT01239160|592320244|FG001|Overall Study|Lost to Follow-up|5|||
163986959|NCT01239160|592320245|FG002|Overall Study|Lost to Follow-up|0|||
163986960|NCT01239160|592320243|FG000|Overall Study|Withdrawal by Subject|17|||
163986961|NCT01239160|592320244|FG001|Overall Study|Withdrawal by Subject|6|||
163986962|NCT01239160|592320245|FG002|Overall Study|Withdrawal by Subject|2|||
163986963|NCT01239160|592320243|FG000|Overall Study|Physician Decision|5|||
163986964|NCT01239160|592320244|FG001|Overall Study|Physician Decision|7|||
163986965|NCT01239160|592320245|FG002|Overall Study|Physician Decision|2|||
163986966|NCT01239160|592320243|FG000|Overall Study|Early Termination Due to Study Closure|0|||
163986967|NCT01239160|592320244|FG001|Overall Study|Early Termination Due to Study Closure|1|||
163986968|NCT01239160|592320245|FG002|Overall Study|Early Termination Due to Study Closure|6|||
164228449|NCT02579759|593207323|FG000|Overall Study|Pregnancy|0|||
163986969|NCT02062658|592320247|FG000|Overall Study|Withdrawal by Subject|1|||
163986970|NCT02062658|592320247|FG000|Overall Study|Lack of Efficacy|1|||
163986971|NCT00257010|592320254|FG000|Overall Study|Lack of Efficacy|11|||
164228450|NCT02579759|593207324|FG001|Overall Study|Pregnancy|1|||
164228451|NCT02579759|593207325|FG002|Overall Study|Pregnancy|0|||
164228452|NCT02579759|593207323|FG000|Overall Study|Inclusion/exclusion criteria|0|||
164228453|NCT02579759|593207324|FG001|Overall Study|Inclusion/exclusion criteria|0|||
164228454|NCT02579759|593207325|FG002|Overall Study|Inclusion/exclusion criteria|1|||
164228455|NCT02579759|593207323|FG000|Overall Study|Adverse Event|4|||
164228456|NCT02579759|593207324|FG001|Overall Study|Adverse Event|3|||
164228457|NCT02579759|593207325|FG002|Overall Study|Adverse Event|1|||
164228458|NCT02579759|593207323|FG000|Overall Study|Withdrawal by Subject|3|||
164228459|NCT02579759|593207324|FG001|Overall Study|Withdrawal by Subject|3|||
164228460|NCT02579759|593207325|FG002|Overall Study|Withdrawal by Subject|5|||
164228461|NCT02579759|593207323|FG000|Overall Study|Lost to Follow-up|2|||
164228462|NCT02579759|593207324|FG001|Overall Study|Lost to Follow-up|2|||
164228463|NCT02579759|593207325|FG002|Overall Study|Lost to Follow-up|2|||
164228464|NCT03436732|593207326|FG000|Overall Study|Not treated-enrolled in different study|1|||
164228465|NCT03436732|593207327|FG001|Overall Study|Not treated-enrolled in different study|0|||
164228466|NCT03436732|593207326|FG000|Overall Study|Off study after cycle 1|1|||
164228467|NCT03436732|593207327|FG001|Overall Study|Off study after cycle 1|0|||
164228468|NCT03436732|593207326|FG000|Overall Study|Adverse Event|2|||
164228469|NCT03436732|593207327|FG001|Overall Study|Adverse Event|0|||
164228470|NCT03436732|593207326|FG000|Overall Study|Death|0|||
164228471|NCT03436732|593207327|FG001|Overall Study|Death|1|||
164228472|NCT02014467|593207330|FG000|Overall Study|Adverse Event|4|||
164228473|NCT02014467|593207331|FG001|Overall Study|Adverse Event|0|||
164228474|NCT02014467|593207330|FG000|Overall Study|Protocol Violation|3|||
164228475|NCT02014467|593207331|FG001|Overall Study|Protocol Violation|0|||
164331257|NCT02676466|593589934|FG001|Overall Study|Death|2|||
164331258|NCT02676466|593589935|FG002|Overall Study|Death|1|||
164331259|NCT02676466|593589936|FG003|Overall Study|Death|0|||
164331260|NCT02676466|593589937|FG004|Overall Study|Death|0|||
164331261|NCT02676466|593589938|FG005|Overall Study|Death|0|||
164331262|NCT02676466|593589939|FG006|Overall Study|Death|0|||
164331263|NCT02676466|593589940|FG007|Overall Study|Death|0|||
164331264|NCT02676466|593589933|FG000|Overall Study|Withdrawal by Subject|4|||
164331265|NCT02676466|593589934|FG001|Overall Study|Withdrawal by Subject|3|||
164331266|NCT02676466|593589935|FG002|Overall Study|Withdrawal by Subject|1|||
164331267|NCT02676466|593589936|FG003|Overall Study|Withdrawal by Subject|0|||
164331268|NCT02676466|593589937|FG004|Overall Study|Withdrawal by Subject|3|||
164331269|NCT02676466|593589938|FG005|Overall Study|Withdrawal by Subject|1|||
164331270|NCT02676466|593589939|FG006|Overall Study|Withdrawal by Subject|1|||
164331271|NCT02676466|593589940|FG007|Overall Study|Withdrawal by Subject|1|||
164331272|NCT02001181|593589942|FG000|Overall Study|Adverse Event|0|||
164331273|NCT02001181|593589943|FG001|Overall Study|Adverse Event|2|||
164331274|NCT02001181|593589942|FG000|Overall Study|Lost to Follow-up|1|||
164331275|NCT02001181|593589943|FG001|Overall Study|Lost to Follow-up|0|||
164331276|NCT02001181|593589942|FG000|Overall Study|Withdrawal by Subject|0|||
164331277|NCT02001181|593589943|FG001|Overall Study|Withdrawal by Subject|1|||
164331278|NCT02436681|593589945|FG000|Overall Study|Lost to Follow-up|10|||
164331279|NCT02436681|593589945|FG000|Overall Study|Withdrawal by Subject|2|||
164331280|NCT02436681|593589945|FG000|Overall Study|Death|2|||
164331281|NCT00739596|593589946|FG000|Overall Study|Adverse Event|12|||
164331282|NCT00739596|593589947|FG001|Overall Study|Adverse Event|6|||
164331283|NCT00739596|593589946|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
163986972|NCT00257010|592320254|FG000|Overall Study|Lost to Follow-up|53|||
164228476|NCT02014467|593207330|FG000|Overall Study|Physician Decision|2|||
164228477|NCT02014467|593207331|FG001|Overall Study|Physician Decision|3|||
164228478|NCT02014467|593207330|FG000|Overall Study|Withdrawal by Subject|16|||
164228479|NCT02014467|593207331|FG001|Overall Study|Withdrawal by Subject|4|||
164228480|NCT01217892|593207333|FG000|Overall Study|Adverse Event|1|||
164228481|NCT01217892|593207334|FG001|Overall Study|Adverse Event|1|||
164228482|NCT01217892|593207335|FG002|Overall Study|Adverse Event|1|||
164228483|NCT01217892|593207336|FG003|Overall Study|Adverse Event|0|||
164228484|NCT01217892|593207333|FG000|Overall Study|Withdrawal by Subject|0|||
164228485|NCT01217892|593207334|FG001|Overall Study|Withdrawal by Subject|2|||
164228486|NCT01217892|593207335|FG002|Overall Study|Withdrawal by Subject|1|||
164331284|NCT00739596|593589947|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164331285|NCT00739596|593589946|FG000|Overall Study|Patient Withdrew Consent|8|||
164331286|NCT00739596|593589947|FG001|Overall Study|Patient Withdrew Consent|8|||
164331287|NCT00739596|593589946|FG000|Overall Study|Lost to Follow-up|0|||
164331288|NCT00739596|593589947|FG001|Overall Study|Lost to Follow-up|2|||
164228487|NCT01217892|593207336|FG003|Overall Study|Withdrawal by Subject|0|||
164228488|NCT01217892|593207333|FG000|Overall Study|Lab value|1|||
164228489|NCT01217892|593207334|FG001|Overall Study|Lab value|0|||
164228490|NCT01217892|593207335|FG002|Overall Study|Lab value|1|||
164228491|NCT01217892|593207336|FG003|Overall Study|Lab value|0|||
164228492|NCT01217892|593207333|FG000|Overall Study|Subject no longer meets study criteria|5|||
164228493|NCT01217892|593207334|FG001|Overall Study|Subject no longer meets study criteria|2|||
164228494|NCT01217892|593207335|FG002|Overall Study|Subject no longer meets study criteria|4|||
164228495|NCT01217892|593207336|FG003|Overall Study|Subject no longer meets study criteria|8|||
164228496|NCT01217892|593207333|FG000|Overall Study|Incorrect enrollment|0|||
164228497|NCT01217892|593207334|FG001|Overall Study|Incorrect enrollment|1|||
164228498|NCT01217892|593207335|FG002|Overall Study|Incorrect enrollment|1|||
164228499|NCT01217892|593207336|FG003|Overall Study|Incorrect enrollment|0|||
164228500|NCT01217892|593207333|FG000|Overall Study|Poor/Non-Compliance|0|||
164228501|NCT01217892|593207334|FG001|Overall Study|Poor/Non-Compliance|0|||
164228502|NCT01217892|593207335|FG002|Overall Study|Poor/Non-Compliance|1|||
164228503|NCT01217892|593207336|FG003|Overall Study|Poor/Non-Compliance|0|||
164228504|NCT00831389|593207338|FG000|Overall Study|Withdrawal by Subject|0|||
164228505|NCT00831389|593207339|FG001|Overall Study|Withdrawal by Subject|1|||
164228506|NCT00278161|593207341|FG000|Overall Study|Death|11|||
164228507|NCT01817777|593207342|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
164228508|NCT01817777|593207343|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
164228509|NCT01817777|593207344|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
164228510|NCT01817777|593207342|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
164228511|NCT01817777|593207343|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
164228512|NCT01817777|593207344|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
164228513|NCT01817777|593207342|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
164228514|NCT01817777|593207343|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
164228515|NCT01817777|593207344|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
164228516|NCT01817777|593207342|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
164228517|NCT01817777|593207343|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
164228518|NCT01817777|593207344|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
164228519|NCT01817777|593207342|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
164228520|NCT01817777|593207343|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
164228521|NCT01817777|593207344|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
164228522|NCT00443456|593207345|FG000|Overall Study|Adverse Event|16|||
164228523|NCT00443456|593207345|FG000|Overall Study|Move|1|||
164228524|NCT00443456|593207345|FG000|Overall Study|Withdrawal by Subject|1|||
164228525|NCT03242434|593207346|FG000|Overall Study|Death|0|||
164228526|NCT03242434|593207347|FG001|Overall Study|Death|2|||
164228527|NCT01592747|593207353|FG000|Overall Study|Loss of Therapeutic Response|107|||
164228528|NCT01592747|593207354|FG001|Overall Study|Loss of Therapeutic Response|108|||
164228529|NCT01592747|593207355|FG002|Overall Study|Loss of Therapeutic Response|100|||
164228530|NCT01592747|593207353|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164228531|NCT01592747|593207354|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
164228532|NCT01592747|593207355|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
164228533|NCT01592747|593207353|FG000|Overall Study|Adverse Event|1|||
164228534|NCT01592747|593207354|FG001|Overall Study|Adverse Event|0|||
164228535|NCT01592747|593207355|FG002|Overall Study|Adverse Event|0|||
164228536|NCT01592747|593207353|FG000|Overall Study|Protocol Violation|4|||
164228537|NCT01592747|593207354|FG001|Overall Study|Protocol Violation|0|||
164228538|NCT01592747|593207355|FG002|Overall Study|Protocol Violation|4|||
164228539|NCT01592747|593207353|FG000|Overall Study|Lack of Efficacy|0|||
164228540|NCT01592747|593207354|FG001|Overall Study|Lack of Efficacy|1|||
164228541|NCT01592747|593207355|FG002|Overall Study|Lack of Efficacy|0|||
164228542|NCT01592747|593207353|FG000|Overall Study|Withdrawal by Subject|2|||
164228543|NCT01592747|593207354|FG001|Overall Study|Withdrawal by Subject|0|||
164228544|NCT01592747|593207355|FG002|Overall Study|Withdrawal by Subject|2|||
164228545|NCT01592747|593207353|FG000|Overall Study|Lost to Follow-up|1|||
164228546|NCT01592747|593207354|FG001|Overall Study|Lost to Follow-up|0|||
164228547|NCT01592747|593207355|FG002|Overall Study|Lost to Follow-up|1|||
164228548|NCT01592747|593207353|FG000|Overall Study|Other Reasons|1|||
164228549|NCT01592747|593207354|FG001|Overall Study|Other Reasons|1|||
164331289|NCT00739596|593589946|FG000|Overall Study|Protocol Deviation|1|||
164331290|NCT00739596|593589947|FG001|Overall Study|Protocol Deviation|1|||
164331291|NCT02520661|593589952|FG000|Overall Study|Lost to Follow-up|7|||
164331292|NCT02520661|593589953|FG001|Overall Study|Lost to Follow-up|3|||
164331293|NCT02520661|593589952|FG000|Overall Study|Admitted from ED|49|||
164331294|NCT02520661|593589953|FG001|Overall Study|Admitted from ED|48|||
164228550|NCT01592747|593207355|FG002|Overall Study|Other Reasons|0|||
164228551|NCT01935947|593207358|FG000|Overall Study|Adverse Event|0|||
164228552|NCT01935947|593207359|FG001|Overall Study|Adverse Event|2|||
164228553|NCT01935947|593207360|FG002|Overall Study|Adverse Event|0|||
164228554|NCT01935947|593207358|FG000|Overall Study|Diease Progression|2|||
164331295|NCT02520661|593589952|FG000|Overall Study|ED greater than 24 hours|29|||
163882993|NCT02783300|591942073|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
164331296|NCT02520661|593589953|FG001|Overall Study|ED greater than 24 hours|38|||
163986973|NCT00257010|592320254|FG000|Overall Study|Withdrawal by Subject|34|||
163986974|NCT00257010|592320254|FG000|Overall Study|Adverse Event|10|||
163986975|NCT00257010|592320254|FG000|Overall Study|various|11|||
163986976|NCT00257010|592320254|FG000|Overall Study|no headache reported|9|||
163986977|NCT04016311|592320255|FG000|Overall Study|Withdrawal by Subject|1|||
163986978|NCT04016311|592320256|FG001|Overall Study|Withdrawal by Subject|0|||
163986979|NCT04029519|592320258|FG000|Overall Study|Protocol Violation|1|||
163986980|NCT04029519|592320258|FG000|Overall Study|Withdrawal by Subject|3|||
163986981|NCT04029519|592320258|FG000|Overall Study|Lost to Follow-up|1|||
163986982|NCT02706730|592320259|FG000|Overall Study|Adverse Event|3|||
163986983|NCT02706730|592320259|FG000|Overall Study|Lack of Efficacy|5|||
163986984|NCT02706730|592320259|FG000|Overall Study|Withdrawal by Subject|11|||
163986985|NCT02706730|592320259|FG000|Overall Study|Study Terminated by Sponsor|11|||
163986986|NCT02706730|592320259|FG000|Overall Study|Subject chose not to receive injection|3|||
163986987|NCT04823949|592320264|FG000|Overall Study|Withdrawal by Subject|0|||
163986988|NCT04823949|592320265|FG001|Overall Study|Withdrawal by Subject|4|||
163986989|NCT04823949|592320264|FG000|Overall Study|Physician Decision|0|||
164228555|NCT01935947|593207359|FG001|Overall Study|Diease Progression|2|||
163986990|NCT04823949|592320265|FG001|Overall Study|Physician Decision|1|||
164228556|NCT01935947|593207360|FG002|Overall Study|Diease Progression|2|||
163986991|NCT00756938|592320266|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
164228557|NCT01935947|593207358|FG000|Overall Study|Death|1|||
163986992|NCT00756938|592320267|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
163986993|NCT00756938|592320268|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
163986994|NCT00756938|592320269|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
163986995|NCT00756938|592320266|FG000|12-week Base Study|Protocol Violation|0|||
163986996|NCT00756938|592320267|FG001|12-week Base Study|Protocol Violation|0|||
163986997|NCT00756938|592320268|FG002|12-week Base Study|Protocol Violation|1|||
163986998|NCT00756938|592320269|FG003|12-week Base Study|Protocol Violation|0|||
163986999|NCT00756938|592320266|FG000|12-week Base Study|Lost to Follow-up|1|||
163987000|NCT00756938|592320267|FG001|12-week Base Study|Lost to Follow-up|0|||
163987001|NCT00756938|592320268|FG002|12-week Base Study|Lost to Follow-up|0|||
163987002|NCT00756938|592320269|FG003|12-week Base Study|Lost to Follow-up|0|||
163987003|NCT00756938|592320266|FG000|Optional Extension|Lack of Efficacy|0|||
163987004|NCT00756938|592320267|FG001|Optional Extension|Lack of Efficacy|0|||
163987005|NCT00756938|592320268|FG002|Optional Extension|Lack of Efficacy|0|||
163987006|NCT00756938|592320269|FG003|Optional Extension|Lack of Efficacy|1|||
163987007|NCT00756938|592320266|FG000|Optional Extension|End of Study|0|||
163987008|NCT00756938|592320267|FG001|Optional Extension|End of Study|0|||
163987009|NCT00756938|592320268|FG002|Optional Extension|End of Study|0|||
163987010|NCT00756938|592320269|FG003|Optional Extension|End of Study|11|||
163987011|NCT00756938|592320266|FG000|Optional Extension|Protocol-specific criteria met|0|||
163987012|NCT00756938|592320267|FG001|Optional Extension|Protocol-specific criteria met|0|||
163987013|NCT00756938|592320268|FG002|Optional Extension|Protocol-specific criteria met|0|||
163987014|NCT00756938|592320269|FG003|Optional Extension|Protocol-specific criteria met|9|||
163987015|NCT00756938|592320266|FG000|Optional Extension|Physician Decision|0|||
163987016|NCT00756938|592320267|FG001|Optional Extension|Physician Decision|0|||
163987017|NCT00756938|592320268|FG002|Optional Extension|Physician Decision|0|||
163987018|NCT00756938|592320269|FG003|Optional Extension|Physician Decision|3|||
163987019|NCT00756938|592320266|FG000|Optional Extension|Lost to Follow-up|0|||
163987020|NCT00756938|592320267|FG001|Optional Extension|Lost to Follow-up|0|||
163987021|NCT00756938|592320268|FG002|Optional Extension|Lost to Follow-up|0|||
163987022|NCT00756938|592320269|FG003|Optional Extension|Lost to Follow-up|1|||
163987023|NCT00756938|592320266|FG000|Optional Extension|Protocol Violation|0|||
164331297|NCT02520661|593589952|FG000|Overall Study|other ineligibility|14|||
164331298|NCT02520661|593589953|FG001|Overall Study|other ineligibility|22|||
164331299|NCT02520661|593589952|FG000|Overall Study|Withdrawal by Subject|7|||
164331300|NCT02520661|593589953|FG001|Overall Study|Withdrawal by Subject|16|||
164331301|NCT01414608|593589961|FG000|Overall Study|Ineligible|5|||
164331302|NCT01414608|593589962|FG001|Overall Study|Ineligible|2|||
164331303|NCT00760084|593589964|FG000|Overall Study|Physician Decision|5|||
164331304|NCT00760084|593589964|FG000|Overall Study|Withdrawal by Subject|2|||
164331305|NCT00760084|593589964|FG000|Overall Study|Progressive Disease|3|||
164331306|NCT02301988|593589965|FG000|Overall Study|Withdrawal by Subject|2|||
164331307|NCT02301988|593589966|FG001|Overall Study|Withdrawal by Subject|1|||
164331308|NCT02301988|593589965|FG000|Overall Study|Physician Decision|2|||
164331309|NCT02301988|593589966|FG001|Overall Study|Physician Decision|2|||
164331310|NCT02301988|593589965|FG000|Overall Study|Unknown Reason|1|||
164331311|NCT02301988|593589966|FG001|Overall Study|Unknown Reason|3|||
164331312|NCT02301988|593589965|FG000|Overall Study|Lack of Efficacy|3|||
164331313|NCT02301988|593589966|FG001|Overall Study|Lack of Efficacy|2|||
164331314|NCT02301988|593589965|FG000|Overall Study|Death|1|||
164331315|NCT02301988|593589966|FG001|Overall Study|Death|0|||
164331316|NCT02301988|593589965|FG000|Overall Study|Adverse Event|1|||
164331317|NCT02301988|593589966|FG001|Overall Study|Adverse Event|1|||
164331318|NCT02891161|593589967|FG000|Study Treatment|Disease Progression|2|||
164331319|NCT02891161|593589968|FG001|Study Treatment|Disease Progression|4|||
163987024|NCT00756938|592320267|FG001|Optional Extension|Protocol Violation|0|||
163987025|NCT00756938|592320268|FG002|Optional Extension|Protocol Violation|0|||
163987026|NCT00756938|592320269|FG003|Optional Extension|Protocol Violation|1|||
164331320|NCT02891161|593589967|FG000|Study Treatment|AE/Side Effects/Complications|1|||
164228558|NCT01935947|593207359|FG001|Overall Study|Death|0|||
164228559|NCT01935947|593207360|FG002|Overall Study|Death|0|||
164228560|NCT04102514|593207361|FG000|Overall Study|Death|3|||
164228561|NCT04102514|593207362|FG001|Overall Study|Death|0|||
164228562|NCT04102514|593207363|FG002|Overall Study|Death|0|||
164228563|NCT04102514|593207364|FG003|Overall Study|Death|0|||
164228564|NCT04102514|593207361|FG000|Overall Study|Lost to Follow-up|0|||
164228565|NCT04102514|593207362|FG001|Overall Study|Lost to Follow-up|0|||
164228566|NCT04102514|593207363|FG002|Overall Study|Lost to Follow-up|3|||
164228567|NCT04102514|593207364|FG003|Overall Study|Lost to Follow-up|0|||
164228568|NCT04102514|593207361|FG000|Overall Study|Physician Decision|0|||
164228569|NCT04102514|593207362|FG001|Overall Study|Physician Decision|0|||
164228570|NCT04102514|593207363|FG002|Overall Study|Physician Decision|1|||
164228571|NCT04102514|593207364|FG003|Overall Study|Physician Decision|0|||
163882994|NCT02783300|591942074|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882995|NCT02783300|591942075|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882996|NCT02783300|591942076|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882997|NCT02783300|591942077|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882998|NCT02783300|591942078|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
163882999|NCT02783300|591942052|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883000|NCT02783300|591942053|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883001|NCT02783300|591942054|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883002|NCT02783300|591942055|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883003|NCT02783300|591942056|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883004|NCT02783300|591942057|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883005|NCT02783300|591942058|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883006|NCT02783300|591942059|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883007|NCT02783300|591942060|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883008|NCT02783300|591942061|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883009|NCT02783300|591942062|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883010|NCT02783300|591942063|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883011|NCT02783300|591942064|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883012|NCT02783300|591942065|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883013|NCT02783300|591942066|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883014|NCT02783300|591942067|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883015|NCT02783300|591942068|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
163883016|NCT02783300|591942069|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883017|NCT02783300|591942070|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
163883018|NCT02783300|591942071|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
164228572|NCT04102514|593207361|FG000|Overall Study|Withdrawal by Subject|7|||
164228573|NCT04102514|593207362|FG001|Overall Study|Withdrawal by Subject|13|||
164228574|NCT04102514|593207363|FG002|Overall Study|Withdrawal by Subject|7|||
164228575|NCT04102514|593207364|FG003|Overall Study|Withdrawal by Subject|14|||
164228576|NCT04102514|593207361|FG000|Overall Study|Moved to longterm care facility|6|||
164228577|NCT04102514|593207362|FG001|Overall Study|Moved to longterm care facility|0|||
164228578|NCT04102514|593207363|FG002|Overall Study|Moved to longterm care facility|4|||
164228579|NCT04102514|593207364|FG003|Overall Study|Moved to longterm care facility|0|||
164228580|NCT00619918|593207365|FG000|Overall Study|Withdrawal by Subject|4|||
164228581|NCT00619918|593207366|FG001|Overall Study|Withdrawal by Subject|3|||
164228582|NCT00619918|593207365|FG000|Overall Study|Physician Decision|2|||
164228583|NCT00619918|593207366|FG001|Overall Study|Physician Decision|4|||
164228584|NCT00619918|593207365|FG000|Overall Study|Transfer to outside facility|3|||
164228585|NCT00619918|593207366|FG001|Overall Study|Transfer to outside facility|3|||
164228586|NCT00619918|593207365|FG000|Overall Study|Left before receiving first dose|7|||
164228587|NCT00619918|593207366|FG001|Overall Study|Left before receiving first dose|6|||
164228588|NCT00619918|593207365|FG000|Overall Study|ICU admission|4|||
164228589|NCT00619918|593207366|FG001|Overall Study|ICU admission|6|||
164228590|NCT02758626|593207373|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
164228591|NCT02758626|593207374|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
164228592|NCT02758626|593207373|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
164228593|NCT02758626|593207374|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
164331321|NCT02891161|593589968|FG001|Study Treatment|AE/Side Effects/Complications|5|||
164331322|NCT02891161|593589967|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
164228594|NCT02758626|593207373|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
164228595|NCT02758626|593207374|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
164228596|NCT02758626|593207373|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
164228597|NCT02758626|593207374|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
164331323|NCT02891161|593589968|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
164228598|NCT00456365|593207377|FG000|Overall Study|Lost to Follow-up|1|||
164228599|NCT00456365|593207378|FG001|Overall Study|Lost to Follow-up|3|||
164228600|NCT00456365|593207377|FG000|Overall Study|Withdrawal by Subject|4|||
164228601|NCT00456365|593207378|FG001|Overall Study|Withdrawal by Subject|7|||
164228602|NCT00456365|593207377|FG000|Overall Study|Pregnancy|1|||
164228603|NCT00456365|593207378|FG001|Overall Study|Pregnancy|1|||
164228604|NCT00456365|593207377|FG000|Overall Study|oncologic diagnosis|1|||
164228605|NCT00456365|593207378|FG001|Overall Study|oncologic diagnosis|1|||
164228606|NCT02096354|593207382|FG000|Overall Study|Physician Decision|4|||
164228607|NCT02096354|593207383|FG001|Overall Study|Physician Decision|5|||
164228608|NCT02096354|593207384|FG002|Overall Study|Physician Decision|0|||
164228609|NCT02096354|593207382|FG000|Overall Study|Withdrawal by Subject|3|||
164228610|NCT02096354|593207383|FG001|Overall Study|Withdrawal by Subject|1|||
164228611|NCT02096354|593207384|FG002|Overall Study|Withdrawal by Subject|0|||
164228612|NCT02096354|593207382|FG000|Overall Study|Adverse Event|7|||
164228613|NCT02096354|593207383|FG001|Overall Study|Adverse Event|4|||
164228614|NCT02096354|593207384|FG002|Overall Study|Adverse Event|0|||
164228615|NCT02096354|593207382|FG000|Overall Study|Ineligible|0|||
164228616|NCT02096354|593207383|FG001|Overall Study|Ineligible|0|||
164228617|NCT02096354|593207384|FG002|Overall Study|Ineligible|11|||
164228618|NCT03715829|593207385|FG000|Dose Ranging Period|Adverse Event|2|||
164228619|NCT03715829|593207386|FG001|Dose Ranging Period|Adverse Event|4|||
164228620|NCT03715829|593207387|FG002|Dose Ranging Period|Adverse Event|5|||
164228621|NCT03715829|593207388|FG003|Dose Ranging Period|Adverse Event|2|||
164228622|NCT03715829|593207389|FG004|Dose Ranging Period|Adverse Event|3|||
164228623|NCT03715829|593207390|FG005|Dose Ranging Period|Adverse Event|3|||
164228624|NCT03715829|593207391|FG006|Dose Ranging Period|Adverse Event|0|||
164228625|NCT03715829|593207392|FG007|Dose Ranging Period|Adverse Event|0|||
164228626|NCT03715829|593207393|FG008|Dose Ranging Period|Adverse Event|0|||
164228627|NCT03715829|593207394|FG009|Dose Ranging Period|Adverse Event|0|||
164228628|NCT03715829|593207395|FG010|Dose Ranging Period|Adverse Event|0|||
164228629|NCT03715829|593207385|FG000|Dose Ranging Period|Lack of Efficacy|0|||
164228630|NCT03715829|593207386|FG001|Dose Ranging Period|Lack of Efficacy|1|||
164228631|NCT03715829|593207387|FG002|Dose Ranging Period|Lack of Efficacy|0|||
164228632|NCT03715829|593207388|FG003|Dose Ranging Period|Lack of Efficacy|1|||
164228633|NCT03715829|593207389|FG004|Dose Ranging Period|Lack of Efficacy|0|||
164228634|NCT03715829|593207390|FG005|Dose Ranging Period|Lack of Efficacy|0|||
164228635|NCT03715829|593207391|FG006|Dose Ranging Period|Lack of Efficacy|0|||
164228636|NCT03715829|593207392|FG007|Dose Ranging Period|Lack of Efficacy|0|||
164228637|NCT03715829|593207393|FG008|Dose Ranging Period|Lack of Efficacy|0|||
164228638|NCT03715829|593207394|FG009|Dose Ranging Period|Lack of Efficacy|0|||
164228639|NCT03715829|593207395|FG010|Dose Ranging Period|Lack of Efficacy|0|||
164228640|NCT03715829|593207385|FG000|Dose Ranging Period|Lost to Follow-up|2|||
164228641|NCT03715829|593207386|FG001|Dose Ranging Period|Lost to Follow-up|0|||
164228642|NCT03715829|593207387|FG002|Dose Ranging Period|Lost to Follow-up|1|||
164228643|NCT03715829|593207388|FG003|Dose Ranging Period|Lost to Follow-up|1|||
164228644|NCT03715829|593207389|FG004|Dose Ranging Period|Lost to Follow-up|1|||
164228645|NCT03715829|593207390|FG005|Dose Ranging Period|Lost to Follow-up|2|||
164228646|NCT03715829|593207391|FG006|Dose Ranging Period|Lost to Follow-up|0|||
164228647|NCT03715829|593207392|FG007|Dose Ranging Period|Lost to Follow-up|0|||
164228648|NCT03715829|593207393|FG008|Dose Ranging Period|Lost to Follow-up|0|||
164228649|NCT03715829|593207394|FG009|Dose Ranging Period|Lost to Follow-up|0|||
164228650|NCT03715829|593207395|FG010|Dose Ranging Period|Lost to Follow-up|0|||
164228651|NCT03715829|593207385|FG000|Dose Ranging Period|Protocol Violation|0|||
164228652|NCT03715829|593207386|FG001|Dose Ranging Period|Protocol Violation|0|||
164228653|NCT03715829|593207387|FG002|Dose Ranging Period|Protocol Violation|0|||
164228654|NCT03715829|593207388|FG003|Dose Ranging Period|Protocol Violation|1|||
164228655|NCT03715829|593207389|FG004|Dose Ranging Period|Protocol Violation|0|||
164228656|NCT03715829|593207390|FG005|Dose Ranging Period|Protocol Violation|0|||
164228657|NCT03715829|593207391|FG006|Dose Ranging Period|Protocol Violation|0|||
164228658|NCT03715829|593207392|FG007|Dose Ranging Period|Protocol Violation|0|||
164228659|NCT03715829|593207393|FG008|Dose Ranging Period|Protocol Violation|0|||
164228660|NCT03715829|593207394|FG009|Dose Ranging Period|Protocol Violation|0|||
164228661|NCT03715829|593207395|FG010|Dose Ranging Period|Protocol Violation|0|||
164228662|NCT03715829|593207385|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
164228663|NCT03715829|593207386|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
164228664|NCT03715829|593207387|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
164228665|NCT03715829|593207388|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
164228666|NCT03715829|593207389|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
164228667|NCT03715829|593207390|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
164228668|NCT03715829|593207391|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
164228669|NCT03715829|593207392|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
164228670|NCT03715829|593207393|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
164228671|NCT03715829|593207394|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
164228672|NCT03715829|593207395|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
164228673|NCT03715829|593207385|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228674|NCT03715829|593207386|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164299708|NCT01217229|593472904|FG000|Overall Study|Disease progression not confirmed|2|||
163987027|NCT00756938|592320266|FG000|Optional Extension|Withdrawal by Subject|0|||
163987028|NCT00756938|592320267|FG001|Optional Extension|Withdrawal by Subject|0|||
163987029|NCT00756938|592320268|FG002|Optional Extension|Withdrawal by Subject|0|||
163987030|NCT00756938|592320269|FG003|Optional Extension|Withdrawal by Subject|10|||
163987031|NCT00756938|592320266|FG000|Optional Extension|Adverse Event|0|||
163987032|NCT00756938|592320267|FG001|Optional Extension|Adverse Event|0|||
163987033|NCT00756938|592320268|FG002|Optional Extension|Adverse Event|0|||
164228675|NCT03715829|593207387|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
164228676|NCT03715829|593207388|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228677|NCT03715829|593207389|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228678|NCT03715829|593207390|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228679|NCT03715829|593207391|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228680|NCT03715829|593207392|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228681|NCT03715829|593207393|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228682|NCT03715829|593207394|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228683|NCT03715829|593207395|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
164228684|NCT03715829|593207385|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228685|NCT03715829|593207386|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228686|NCT03715829|593207387|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
164228687|NCT03715829|593207388|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228688|NCT03715829|593207389|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
164228689|NCT03715829|593207390|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228690|NCT03715829|593207391|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228691|NCT03715829|593207392|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228692|NCT03715829|593207393|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228693|NCT03715829|593207394|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228694|NCT03715829|593207395|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
164228695|NCT03715829|593207385|FG000|Dose Ranging Period|Other|0|||
164228696|NCT03715829|593207386|FG001|Dose Ranging Period|Other|0|||
164228697|NCT03715829|593207387|FG002|Dose Ranging Period|Other|2|||
164228698|NCT03715829|593207388|FG003|Dose Ranging Period|Other|0|||
164228699|NCT03715829|593207389|FG004|Dose Ranging Period|Other|0|||
164228700|NCT03715829|593207390|FG005|Dose Ranging Period|Other|3|||
164228701|NCT03715829|593207391|FG006|Dose Ranging Period|Other|0|||
164228702|NCT03715829|593207392|FG007|Dose Ranging Period|Other|0|||
164228703|NCT03715829|593207393|FG008|Dose Ranging Period|Other|0|||
164228704|NCT03715829|593207394|FG009|Dose Ranging Period|Other|0|||
164228705|NCT03715829|593207395|FG010|Dose Ranging Period|Other|0|||
164228706|NCT03715829|593207385|FG000|Extension Period|Adverse Event|0|||
164228707|NCT03715829|593207386|FG001|Extension Period|Adverse Event|0|||
164228708|NCT03715829|593207387|FG002|Extension Period|Adverse Event|0|||
164228709|NCT03715829|593207388|FG003|Extension Period|Adverse Event|0|||
164228710|NCT03715829|593207389|FG004|Extension Period|Adverse Event|0|||
164228711|NCT03715829|593207390|FG005|Extension Period|Adverse Event|0|||
164228712|NCT03715829|593207391|FG006|Extension Period|Adverse Event|3|||
164228713|NCT03715829|593207392|FG007|Extension Period|Adverse Event|1|||
164228714|NCT03715829|593207393|FG008|Extension Period|Adverse Event|6|||
164228715|NCT03715829|593207394|FG009|Extension Period|Adverse Event|0|||
164228716|NCT03715829|593207395|FG010|Extension Period|Adverse Event|0|||
164228717|NCT03715829|593207385|FG000|Extension Period|Lack of Efficacy|0|||
164228718|NCT03715829|593207386|FG001|Extension Period|Lack of Efficacy|0|||
164228719|NCT03715829|593207387|FG002|Extension Period|Lack of Efficacy|0|||
164228720|NCT03715829|593207388|FG003|Extension Period|Lack of Efficacy|0|||
164228721|NCT03715829|593207389|FG004|Extension Period|Lack of Efficacy|0|||
164228722|NCT03715829|593207390|FG005|Extension Period|Lack of Efficacy|0|||
164228723|NCT03715829|593207391|FG006|Extension Period|Lack of Efficacy|1|||
164228724|NCT03715829|593207392|FG007|Extension Period|Lack of Efficacy|9|||
164228725|NCT03715829|593207393|FG008|Extension Period|Lack of Efficacy|2|||
164228726|NCT03715829|593207394|FG009|Extension Period|Lack of Efficacy|0|||
164228727|NCT03715829|593207395|FG010|Extension Period|Lack of Efficacy|0|||
164228728|NCT03715829|593207385|FG000|Extension Period|Lost to Follow-up|0|||
164228729|NCT03715829|593207386|FG001|Extension Period|Lost to Follow-up|0|||
164228730|NCT03715829|593207387|FG002|Extension Period|Lost to Follow-up|0|||
163987034|NCT00756938|592320269|FG003|Optional Extension|Adverse Event|1|||
163987035|NCT00094055|592320270|FG000|Overall Study|Adverse Event|11|||
164228731|NCT03715829|593207388|FG003|Extension Period|Lost to Follow-up|0|||
164228732|NCT03715829|593207389|FG004|Extension Period|Lost to Follow-up|0|||
164228733|NCT03715829|593207390|FG005|Extension Period|Lost to Follow-up|0|||
164228734|NCT03715829|593207391|FG006|Extension Period|Lost to Follow-up|0|||
164228735|NCT03715829|593207392|FG007|Extension Period|Lost to Follow-up|0|||
163987036|NCT00094055|592320270|FG000|Overall Study|Death|4|||
164228736|NCT03715829|593207393|FG008|Extension Period|Lost to Follow-up|2|||
164228737|NCT03715829|593207394|FG009|Extension Period|Lost to Follow-up|0|||
164228738|NCT03715829|593207395|FG010|Extension Period|Lost to Follow-up|0|||
164228739|NCT03715829|593207385|FG000|Extension Period|Protocol Violation|0|||
164228740|NCT03715829|593207386|FG001|Extension Period|Protocol Violation|0|||
164228741|NCT03715829|593207387|FG002|Extension Period|Protocol Violation|0|||
164228742|NCT03715829|593207388|FG003|Extension Period|Protocol Violation|0|||
164228743|NCT03715829|593207389|FG004|Extension Period|Protocol Violation|0|||
164228744|NCT03715829|593207390|FG005|Extension Period|Protocol Violation|0|||
164228745|NCT03715829|593207391|FG006|Extension Period|Protocol Violation|0|||
164228746|NCT03715829|593207392|FG007|Extension Period|Protocol Violation|0|||
164228747|NCT03715829|593207393|FG008|Extension Period|Protocol Violation|1|||
164228748|NCT03715829|593207394|FG009|Extension Period|Protocol Violation|0|||
164228749|NCT03715829|593207395|FG010|Extension Period|Protocol Violation|0|||
164228750|NCT03715829|593207385|FG000|Extension Period|Withdrawal by Subject|0|||
164228751|NCT03715829|593207386|FG001|Extension Period|Withdrawal by Subject|0|||
164228752|NCT03715829|593207387|FG002|Extension Period|Withdrawal by Subject|0|||
164228753|NCT03715829|593207388|FG003|Extension Period|Withdrawal by Subject|0|||
164228754|NCT03715829|593207389|FG004|Extension Period|Withdrawal by Subject|0|||
164228755|NCT03715829|593207390|FG005|Extension Period|Withdrawal by Subject|0|||
164228756|NCT03715829|593207391|FG006|Extension Period|Withdrawal by Subject|3|||
164228757|NCT03715829|593207392|FG007|Extension Period|Withdrawal by Subject|3|||
164228758|NCT03715829|593207393|FG008|Extension Period|Withdrawal by Subject|12|||
164228759|NCT03715829|593207394|FG009|Extension Period|Withdrawal by Subject|3|||
164228760|NCT03715829|593207395|FG010|Extension Period|Withdrawal by Subject|0|||
164228761|NCT03715829|593207385|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228762|NCT03715829|593207386|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228763|NCT03715829|593207387|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228764|NCT03715829|593207388|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228765|NCT03715829|593207389|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228766|NCT03715829|593207390|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228767|NCT03715829|593207391|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228768|NCT03715829|593207392|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
164228769|NCT03715829|593207393|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
164228770|NCT03715829|593207394|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228771|NCT03715829|593207395|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
164228772|NCT03715829|593207385|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228773|NCT03715829|593207386|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228774|NCT03715829|593207387|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228775|NCT03715829|593207388|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228776|NCT03715829|593207389|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228777|NCT03715829|593207390|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228778|NCT03715829|593207391|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228779|NCT03715829|593207392|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228780|NCT03715829|593207393|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
164228781|NCT03715829|593207394|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228782|NCT03715829|593207395|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
164228783|NCT03715829|593207385|FG000|Extension Period|Other|0|||
164228784|NCT03715829|593207386|FG001|Extension Period|Other|0|||
164228785|NCT03715829|593207387|FG002|Extension Period|Other|0|||
164228786|NCT03715829|593207388|FG003|Extension Period|Other|0|||
164228787|NCT03715829|593207389|FG004|Extension Period|Other|0|||
164228788|NCT03715829|593207390|FG005|Extension Period|Other|0|||
164228789|NCT03715829|593207391|FG006|Extension Period|Other|1|||
164228790|NCT03715829|593207392|FG007|Extension Period|Other|2|||
164331324|NCT02891161|593589967|FG000|Follow up|Death|4|||
164331325|NCT02891161|593589968|FG001|Follow up|Death|8|||
164331326|NCT02891161|593589967|FG000|Follow up|Refused to Follow up|0|||
164331327|NCT02891161|593589968|FG001|Follow up|Refused to Follow up|2|||
164331328|NCT02891161|593589967|FG000|Follow up|Symptomatic deterioration|0|||
164331329|NCT02891161|593589968|FG001|Follow up|Symptomatic deterioration|1|||
164331330|NCT02891161|593589967|FG000|Follow up|Study terminated|0|||
164331331|NCT02891161|593589968|FG001|Follow up|Study terminated|6|||
164331332|NCT01931202|593589971|FG000|Overall Study|Withdrawal by Subject|0|||
164331333|NCT01931202|593589972|FG001|Overall Study|Withdrawal by Subject|0|||
164331334|NCT01931202|593589973|FG002|Overall Study|Withdrawal by Subject|2|||
164331335|NCT01931202|593589971|FG000|Overall Study|Lost to Follow-up|0|||
164228791|NCT03715829|593207393|FG008|Extension Period|Other|4|||
164228792|NCT03715829|593207394|FG009|Extension Period|Other|0|||
164228793|NCT03715829|593207395|FG010|Extension Period|Other|0|||
164228794|NCT03579719|593207397|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
164228795|NCT01443026|593207398|FG000|Overall Study|Physician Decision|1|||
164228796|NCT01443026|593207399|FG001|Overall Study|Physician Decision|0|||
164228797|NCT01443026|593207398|FG000|Overall Study|Death|0|||
164228798|NCT01443026|593207399|FG001|Overall Study|Death|1|||
164331336|NCT01931202|593589972|FG001|Overall Study|Lost to Follow-up|5|||
164228799|NCT01443026|593207398|FG000|Overall Study|Withdrawal by Subject|0|||
164228800|NCT01443026|593207399|FG001|Overall Study|Withdrawal by Subject|3|||
164228801|NCT01443026|593207398|FG000|Overall Study|Lost to Follow-up|2|||
164228802|NCT01443026|593207399|FG001|Overall Study|Lost to Follow-up|1|||
164228803|NCT01051661|593207404|FG000|Overall Study|Adverse Event|1|||
164228804|NCT01051661|593207405|FG001|Overall Study|Adverse Event|1|||
164228805|NCT01051661|593207406|FG002|Overall Study|Adverse Event|1|||
164228806|NCT01051661|593207407|FG003|Overall Study|Adverse Event|1|||
164228807|NCT01051661|593207408|FG004|Overall Study|Adverse Event|0|||
164228808|NCT01051661|593207409|FG005|Overall Study|Adverse Event|0|||
164228809|NCT01051661|593207404|FG000|Overall Study|Lost to Follow-up|13|||
164228810|NCT01051661|593207405|FG001|Overall Study|Lost to Follow-up|22|||
164228811|NCT01051661|593207406|FG002|Overall Study|Lost to Follow-up|15|||
164228812|NCT01051661|593207407|FG003|Overall Study|Lost to Follow-up|17|||
164228813|NCT01051661|593207408|FG004|Overall Study|Lost to Follow-up|10|||
164228814|NCT01051661|593207409|FG005|Overall Study|Lost to Follow-up|24|||
164228815|NCT01051661|593207404|FG000|Overall Study|Migrated/moved from study area|1|||
164228816|NCT01051661|593207405|FG001|Overall Study|Migrated/moved from study area|6|||
164228817|NCT01051661|593207406|FG002|Overall Study|Migrated/moved from study area|6|||
164228818|NCT01051661|593207407|FG003|Overall Study|Migrated/moved from study area|8|||
164228819|NCT01051661|593207408|FG004|Overall Study|Migrated/moved from study area|7|||
164228820|NCT01051661|593207409|FG005|Overall Study|Migrated/moved from study area|3|||
164228821|NCT01051661|593207404|FG000|Overall Study|Refused blood sampling|0|||
164228822|NCT01051661|593207405|FG001|Overall Study|Refused blood sampling|0|||
164228823|NCT01051661|593207406|FG002|Overall Study|Refused blood sampling|0|||
164228824|NCT01051661|593207407|FG003|Overall Study|Refused blood sampling|0|||
164228825|NCT01051661|593207408|FG004|Overall Study|Refused blood sampling|0|||
164228826|NCT01051661|593207409|FG005|Overall Study|Refused blood sampling|1|||
164228827|NCT01051661|593207404|FG000|Overall Study|Data not reliable|1|||
164228828|NCT01051661|593207405|FG001|Overall Study|Data not reliable|0|||
164228829|NCT01051661|593207406|FG002|Overall Study|Data not reliable|0|||
164228830|NCT01051661|593207407|FG003|Overall Study|Data not reliable|0|||
164228831|NCT01051661|593207408|FG004|Overall Study|Data not reliable|0|||
164228832|NCT01051661|593207409|FG005|Overall Study|Data not reliable|1|||
164228833|NCT01051661|593207404|FG000|Overall Study|Unable to attend visit(s)|2|||
164228834|NCT01051661|593207405|FG001|Overall Study|Unable to attend visit(s)|4|||
164228835|NCT01051661|593207406|FG002|Overall Study|Unable to attend visit(s)|2|||
164228836|NCT01051661|593207407|FG003|Overall Study|Unable to attend visit(s)|1|||
164228837|NCT01051661|593207408|FG004|Overall Study|Unable to attend visit(s)|3|||
164228838|NCT01051661|593207409|FG005|Overall Study|Unable to attend visit(s)|2|||
164228839|NCT01051661|593207404|FG000|Overall Study|Consent not received from both parents|0|||
164228840|NCT01051661|593207405|FG001|Overall Study|Consent not received from both parents|0|||
164228841|NCT01051661|593207406|FG002|Overall Study|Consent not received from both parents|0|||
164228842|NCT01051661|593207407|FG003|Overall Study|Consent not received from both parents|0|||
164228843|NCT01051661|593207408|FG004|Overall Study|Consent not received from both parents|0|||
164228844|NCT01051661|593207409|FG005|Overall Study|Consent not received from both parents|1|||
164228845|NCT01051661|593207404|FG000|Overall Study|Failure to comply with protocol|0|||
164228846|NCT01051661|593207405|FG001|Overall Study|Failure to comply with protocol|0|||
164228847|NCT01051661|593207406|FG002|Overall Study|Failure to comply with protocol|2|||
164228848|NCT01051661|593207407|FG003|Overall Study|Failure to comply with protocol|0|||
164228849|NCT01051661|593207408|FG004|Overall Study|Failure to comply with protocol|0|||
164228850|NCT01051661|593207409|FG005|Overall Study|Failure to comply with protocol|0|||
164228851|NCT01051661|593207404|FG000|Overall Study|Subject lost legal representation|0|||
164228852|NCT01051661|593207405|FG001|Overall Study|Subject lost legal representation|0|||
164228853|NCT01051661|593207406|FG002|Overall Study|Subject lost legal representation|0|||
164228854|NCT01051661|593207407|FG003|Overall Study|Subject lost legal representation|0|||
164228855|NCT01051661|593207408|FG004|Overall Study|Subject lost legal representation|1|||
164228856|NCT01051661|593207409|FG005|Overall Study|Subject lost legal representation|0|||
164228857|NCT01051661|593207404|FG000|Overall Study|Protocol Violation|0|||
164228858|NCT01051661|593207405|FG001|Overall Study|Protocol Violation|0|||
164228859|NCT01051661|593207406|FG002|Overall Study|Protocol Violation|0|||
164228860|NCT01051661|593207407|FG003|Overall Study|Protocol Violation|1|||
164228861|NCT01051661|593207408|FG004|Overall Study|Protocol Violation|2|||
164228862|NCT01051661|593207409|FG005|Overall Study|Protocol Violation|1|||
164228863|NCT01051661|593207404|FG000|Overall Study|Withdrawal by Subject|16|||
164228864|NCT01051661|593207405|FG001|Overall Study|Withdrawal by Subject|30|||
164228865|NCT01051661|593207406|FG002|Overall Study|Withdrawal by Subject|13|||
164228866|NCT01051661|593207407|FG003|Overall Study|Withdrawal by Subject|28|||
164228867|NCT01051661|593207408|FG004|Overall Study|Withdrawal by Subject|12|||
164228868|NCT01051661|593207409|FG005|Overall Study|Withdrawal by Subject|34|||
164228869|NCT02852005|593207411|FG000|Overall Study|Lost to Follow-up|0|||
164228870|NCT02852005|593207412|FG001|Overall Study|Lost to Follow-up|0|||
164228871|NCT02852005|593207413|FG002|Overall Study|Lost to Follow-up|0|||
164228872|NCT02852005|593207414|FG003|Overall Study|Lost to Follow-up|0|||
164228873|NCT02852005|593207415|FG004|Overall Study|Lost to Follow-up|1|||
164228874|NCT02852005|593207411|FG000|Overall Study|Withdrawal by Subject|1|||
164228875|NCT02852005|593207412|FG001|Overall Study|Withdrawal by Subject|0|||
164228876|NCT02852005|593207413|FG002|Overall Study|Withdrawal by Subject|0|||
164228877|NCT02852005|593207414|FG003|Overall Study|Withdrawal by Subject|0|||
164228878|NCT02852005|593207415|FG004|Overall Study|Withdrawal by Subject|0|||
164228879|NCT04079920|593207418|FG000|Overall Study|Adverse event, not related to study drug|2|||
164228880|NCT04079920|593207418|FG000|Overall Study|Adverse event related to study drug|10|||
164228881|NCT04079920|593207418|FG000|Overall Study|Death|2|||
164228882|NCT04079920|593207418|FG000|Overall Study|Lost to Follow-up|22|||
164228883|NCT04079920|593207418|FG000|Overall Study|Physician Decision|1|||
164228884|NCT04079920|593207418|FG000|Overall Study|Withdrawal by Subject|11|||
164228885|NCT03760068|593207419|FG000|Overall Study|Withdrawal by Subject|7|||
164228886|NCT03760068|593207420|FG001|Overall Study|Withdrawal by Subject|8|||
164228887|NCT03760068|593207419|FG000|Overall Study|Adverse Event|1|||
164228888|NCT03760068|593207420|FG001|Overall Study|Adverse Event|2|||
164228889|NCT03760068|593207419|FG000|Overall Study|Administrative Decision by Sponsor|0|||
164228890|NCT03760068|593207420|FG001|Overall Study|Administrative Decision by Sponsor|2|||
164228891|NCT03760068|593207419|FG000|Overall Study|Physician Decision|1|||
164228892|NCT03760068|593207420|FG001|Overall Study|Physician Decision|2|||
164228893|NCT03760068|593207419|FG000|Overall Study|Lost to Follow-up|4|||
164228894|NCT03760068|593207420|FG001|Overall Study|Lost to Follow-up|9|||
164228895|NCT03760068|593207419|FG000|Overall Study|Subject Moved Out of State|1|||
164228896|NCT03760068|593207420|FG001|Overall Study|Subject Moved Out of State|0|||
164228897|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
164228898|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
164228899|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
164228900|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
164228901|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
164228902|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
164228903|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
164228904|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
164228905|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
164228906|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
164228907|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
164228908|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
164228909|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
164228910|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
164228911|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
164228912|NCT05014919|593207421|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
164228913|NCT05014919|593207422|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
164228914|NCT05014919|593207423|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
164228915|NCT05014919|593207421|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
164228916|NCT05014919|593207422|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
164228917|NCT05014919|593207423|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
164228918|NCT05014919|593207421|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
164228919|NCT05014919|593207422|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
164228920|NCT05014919|593207423|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
164228921|NCT04126174|593207429|FG000|Overall Study|Lost to Follow-up|3|||
164228922|NCT04126174|593207430|FG001|Overall Study|Lost to Follow-up|3|||
164228923|NCT03773562|593207431|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
164228924|NCT03773562|593207431|FG000|Overall Study|Lost to Follow-up|10|||
164331337|NCT01931202|593589973|FG002|Overall Study|Lost to Follow-up|2|||
164228925|NCT03773562|593207431|FG000|Overall Study|Withdrawal by Subject|1|||
164228926|NCT01491919|593207432|FG000|Overall Study|Insufficient PK sampling|1|||
164228927|NCT01491919|593207433|FG001|Overall Study|Insufficient PK sampling|2|||
164228928|NCT01491919|593207434|FG002|Overall Study|Insufficient PK sampling|1|||
164228929|NCT03204812|593207444|FG000|Overall Study|Adverse Event|3|||
164228930|NCT01027351|593207445|FG000|Overall Study|Withdrawal by Subject|1|||
164228931|NCT01027351|593207446|FG001|Overall Study|Withdrawal by Subject|0|||
164228932|NCT01027351|593207447|FG002|Overall Study|Withdrawal by Subject|1|||
164228933|NCT01027351|593207448|FG003|Overall Study|Withdrawal by Subject|0|||
164228934|NCT01027351|593207449|FG004|Overall Study|Withdrawal by Subject|3|||
164228935|NCT01027351|593207450|FG005|Overall Study|Withdrawal by Subject|5|||
164228936|NCT01027351|593207445|FG000|Overall Study|Lost to Follow-up|1|||
164228937|NCT01027351|593207446|FG001|Overall Study|Lost to Follow-up|1|||
164228938|NCT01027351|593207447|FG002|Overall Study|Lost to Follow-up|0|||
164331338|NCT01857583|593589975|FG000|Overall Study|Adverse Event|0|||
164331339|NCT01857583|593589976|FG001|Overall Study|Adverse Event|0|||
164331340|NCT01857583|593589977|FG002|Overall Study|Adverse Event|1|||
164331341|NCT01857583|593589978|FG003|Overall Study|Adverse Event|1|||
164331342|NCT01857583|593589975|FG000|Overall Study|Death|0|||
164331343|NCT01857583|593589976|FG001|Overall Study|Death|1|||
164331344|NCT01857583|593589977|FG002|Overall Study|Death|1|||
164331345|NCT01857583|593589978|FG003|Overall Study|Death|0|||
164331346|NCT01857583|593589975|FG000|Overall Study|Physician Decision|0|||
164331347|NCT01857583|593589976|FG001|Overall Study|Physician Decision|0|||
164331348|NCT01857583|593589977|FG002|Overall Study|Physician Decision|0|||
164331349|NCT01857583|593589978|FG003|Overall Study|Physician Decision|1|||
164331350|NCT01857583|593589975|FG000|Overall Study|Withdrawal by Subject|1|||
164331351|NCT01857583|593589976|FG001|Overall Study|Withdrawal by Subject|0|||
164331352|NCT01857583|593589977|FG002|Overall Study|Withdrawal by Subject|1|||
164331353|NCT01857583|593589978|FG003|Overall Study|Withdrawal by Subject|2|||
164331354|NCT02775903|593589983|FG000|Overall Study|Death|7|||
164331355|NCT02775903|593589984|FG001|Overall Study|Death|11|||
164331356|NCT02775903|593589985|FG002|Overall Study|Death|12|||
164331357|NCT02775903|593589986|FG003|Overall Study|Death|11|||
164331358|NCT02775903|593589983|FG000|Overall Study|Adverse Event|0|||
164331359|NCT02775903|593589984|FG001|Overall Study|Adverse Event|1|||
164331360|NCT02775903|593589985|FG002|Overall Study|Adverse Event|12|||
164331361|NCT02775903|593589986|FG003|Overall Study|Adverse Event|3|||
164331362|NCT02775903|593589983|FG000|Overall Study|Progressive disease|15|||
164331363|NCT02775903|593589984|FG001|Overall Study|Progressive disease|14|||
164331364|NCT02775903|593589985|FG002|Overall Study|Progressive disease|30|||
164331365|NCT02775903|593589986|FG003|Overall Study|Progressive disease|20|||
164331366|NCT02775903|593589983|FG000|Overall Study|Lack of Efficacy|2|||
164331367|NCT02775903|593589984|FG001|Overall Study|Lack of Efficacy|2|||
164331368|NCT02775903|593589985|FG002|Overall Study|Lack of Efficacy|2|||
164331369|NCT02775903|593589986|FG003|Overall Study|Lack of Efficacy|6|||
164331370|NCT02775903|593589983|FG000|Overall Study|Withdrawal by Subject|7|||
164331371|NCT02775903|593589984|FG001|Overall Study|Withdrawal by Subject|5|||
164331372|NCT02775903|593589985|FG002|Overall Study|Withdrawal by Subject|5|||
164331373|NCT02775903|593589986|FG003|Overall Study|Withdrawal by Subject|8|||
164331374|NCT02775903|593589983|FG000|Overall Study|Other reasons|7|||
164331375|NCT02775903|593589984|FG001|Overall Study|Other reasons|8|||
164331376|NCT02775903|593589985|FG002|Overall Study|Other reasons|2|||
164331377|NCT02775903|593589986|FG003|Overall Study|Other reasons|12|||
164228939|NCT01027351|593207448|FG003|Overall Study|Lost to Follow-up|1|||
164228940|NCT01027351|593207449|FG004|Overall Study|Lost to Follow-up|6|||
164228941|NCT01027351|593207450|FG005|Overall Study|Lost to Follow-up|0|||
164228942|NCT01027351|593207445|FG000|Overall Study|Inappropriate enrollment|0|||
164331378|NCT03552965|593589990|FG000|Overall Study|Death|1|||
164331379|NCT03552965|593589991|FG001|Overall Study|Death|1|||
164331380|NCT03552965|593589990|FG000|Overall Study|Lost to Follow-up|1|||
164331381|NCT03552965|593589991|FG001|Overall Study|Lost to Follow-up|1|||
164331382|NCT03552965|593589990|FG000|Overall Study|Physician Decision|1|||
164228943|NCT01027351|593207446|FG001|Overall Study|Inappropriate enrollment|0|||
164228944|NCT01027351|593207447|FG002|Overall Study|Inappropriate enrollment|0|||
164228945|NCT01027351|593207448|FG003|Overall Study|Inappropriate enrollment|0|||
164331383|NCT03552965|593589991|FG001|Overall Study|Physician Decision|1|||
164228946|NCT01027351|593207449|FG004|Overall Study|Inappropriate enrollment|1|||
164228947|NCT01027351|593207450|FG005|Overall Study|Inappropriate enrollment|0|||
164331384|NCT03552965|593589990|FG000|Overall Study|Withdrawal by Subject|0|||
164331385|NCT03552965|593589991|FG001|Overall Study|Withdrawal by Subject|2|||
164331386|NCT03552965|593589990|FG000|Overall Study|Continuation not in patient best interest|1|||
164228948|NCT01027351|593207445|FG000|Overall Study|Protocol Violation|1|||
164228949|NCT01027351|593207446|FG001|Overall Study|Protocol Violation|0|||
164228950|NCT01027351|593207447|FG002|Overall Study|Protocol Violation|0|||
164228951|NCT01027351|593207448|FG003|Overall Study|Protocol Violation|1|||
164228952|NCT01027351|593207449|FG004|Overall Study|Protocol Violation|1|||
164228953|NCT01027351|593207450|FG005|Overall Study|Protocol Violation|0|||
164228954|NCT00911157|593207451|FG000|Overall Study|Adverse Event|4|||
164228955|NCT00911157|593207452|FG001|Overall Study|Adverse Event|1|||
164228956|NCT00911157|593207451|FG000|Overall Study|Withdrawal by Subject|1|||
164228957|NCT00911157|593207452|FG001|Overall Study|Withdrawal by Subject|1|||
164228958|NCT00911157|593207451|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
164228959|NCT00911157|593207452|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
164228960|NCT00911157|593207451|FG000|Overall Study|Need to treat for lung cancer|1|||
164228961|NCT00911157|593207452|FG001|Overall Study|Need to treat for lung cancer|0|||
164228962|NCT01852214|593207453|FG000|Period 1|Adverse Event|1|||
164228963|NCT01852214|593207454|FG001|Period 1|Adverse Event|2|||
164228964|NCT01852214|593207453|FG000|Period 1|Withdrawal by Subject|0|||
164228965|NCT01852214|593207454|FG001|Period 1|Withdrawal by Subject|1|||
164228966|NCT01852214|593207453|FG000|Washout Period|Withdrawal by Subject|0|||
164228967|NCT01852214|593207454|FG001|Washout Period|Withdrawal by Subject|1|||
164228968|NCT04091438|593207455|FG000|Treatment Period 1 (1 Day)|Other|1|||
164228969|NCT04091438|593207456|FG001|Treatment Period 1 (1 Day)|Other|0|||
164228970|NCT04091438|593207455|FG000|Washout Period (1 Day)|Protocol deviation|0|||
164228971|NCT04091438|593207456|FG001|Washout Period (1 Day)|Protocol deviation|1|||
164228972|NCT04091438|593207455|FG000|Washout Period (1 Day)|Other|0|||
164228973|NCT04091438|593207456|FG001|Washout Period (1 Day)|Other|1|||
164228974|NCT00421408|593207457|FG000|Overall Study|Lost to Follow-up|30|||
164228975|NCT00421408|593207458|FG001|Overall Study|Lost to Follow-up|20|||
164228976|NCT00421408|593207457|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
164228977|NCT00421408|593207458|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
164228978|NCT04105725|593207459|FG000|Primary Intervention|Lost to Follow-up|0|||
164228979|NCT04105725|593207460|FG001|Primary Intervention|Lost to Follow-up|2|||
164228980|NCT04105725|593207459|FG000|Primary Intervention|Withdrawal by Subject|0|||
164228981|NCT04105725|593207460|FG001|Primary Intervention|Withdrawal by Subject|1|||
164228982|NCT04573881|593207461|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
164228983|NCT03058952|593209216|FG000|Overall Study|Adverse Event|1|||
164228984|NCT03058952|593209217|FG001|Overall Study|Adverse Event|0|||
164228985|NCT03058952|593209216|FG000|Overall Study|Lost to Follow-up|15|||
164228986|NCT03058952|593209217|FG001|Overall Study|Lost to Follow-up|15|||
164228987|NCT03058952|593209216|FG000|Overall Study|Withdrawal by Subject|7|||
164228988|NCT03058952|593209217|FG001|Overall Study|Withdrawal by Subject|11|||
164228989|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
164228990|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
164228991|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
164228992|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
164228993|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
164228994|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
164228995|NCT01373281|593209220|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
164228996|NCT01373281|593209221|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
164228997|NCT01373281|593209220|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
164228998|NCT01373281|593209221|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
164228999|NCT01373281|593209220|FG000|Surveillance Expansion Period|Protocol Violation|9|||
164229000|NCT01373281|593209221|FG001|Surveillance Expansion Period|Protocol Violation|1|||
164229001|NCT01373281|593209220|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
164229002|NCT01373281|593209221|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
164229003|NCT01373281|593209220|FG000|Surveillance Expansion Period|Serious adverse event|3|||
164229004|NCT01373281|593209221|FG001|Surveillance Expansion Period|Serious adverse event|4|||
164229005|NCT02296476|593209222|FG000|Overall Study|Disease Progression|6|||
164229006|NCT02296476|593209223|FG001|Overall Study|Disease Progression|4|||
164331387|NCT03552965|593589991|FG001|Overall Study|Continuation not in patient best interest|0|||
164331388|NCT03552965|593589990|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
164331389|NCT03552965|593589991|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
164331390|NCT03670836|593589992|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
164331391|NCT03670836|593589993|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
164331392|NCT03670836|593589992|FG000|Per Protocol Population (PP)|Physician Decision|9|||
164331393|NCT03670836|593589993|FG001|Per Protocol Population (PP)|Physician Decision|10|||
164331394|NCT03670836|593589992|FG000|Per Protocol Population (PP)|Physician Decision|4|||
164331395|NCT03670836|593589993|FG001|Per Protocol Population (PP)|Physician Decision|6|||
164331396|NCT03670836|593589992|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
164331397|NCT03670836|593589993|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
164331398|NCT05108922|593591221|FG000|Overall Study|Adverse Event|2|||
164331399|NCT05108922|593591222|FG001|Overall Study|Adverse Event|3|||
164331400|NCT05108922|593591221|FG000|Overall Study|Lost to Follow-up|2|||
164331401|NCT05108922|593591222|FG001|Overall Study|Lost to Follow-up|1|||
164331402|NCT05108922|593591221|FG000|Overall Study|Inadvertent enrollment|0|||
164331403|NCT05108922|593591222|FG001|Overall Study|Inadvertent enrollment|1|||
164331404|NCT05108922|593591221|FG000|Overall Study|Physician Decision|2|||
164331405|NCT05108922|593591222|FG001|Overall Study|Physician Decision|3|||
164331406|NCT05108922|593591221|FG000|Overall Study|Protocol deviation|1|||
164331407|NCT05108922|593591222|FG001|Overall Study|Protocol deviation|0|||
164331408|NCT05108922|593591221|FG000|Overall Study|Screen failure|1|||
164331409|NCT05108922|593591222|FG001|Overall Study|Screen failure|0|||
164331410|NCT05108922|593591221|FG000|Overall Study|Withdrawal by Subject|11|||
164331411|NCT05108922|593591222|FG001|Overall Study|Withdrawal by Subject|8|||
164331412|NCT05036369|593591223|FG000|Overall Study|Run In non compliance|1|||
164331413|NCT05036369|593591224|FG001|Overall Study|Run In non compliance|2|||
164331414|NCT05036369|593591223|FG000|Overall Study|Change in eligibility criteria|0|||
164331415|NCT05036369|593591224|FG001|Overall Study|Change in eligibility criteria|1|||
164331416|NCT01846104|593591225|FG000|Overall Study|Withdrawal by Subject|1|||
164331417|NCT01854658|593591230|FG000|Overall Study|Protocol Violation|6|||
164331418|NCT01854658|593591231|FG001|Overall Study|Protocol Violation|2|||
164331419|NCT01854658|593591232|FG002|Overall Study|Protocol Violation|2|||
164331420|NCT01854658|593591233|FG003|Overall Study|Protocol Violation|1|||
164331421|NCT01854658|593591230|FG000|Overall Study|Physician Decision|7|||
164331422|NCT01854658|593591231|FG001|Overall Study|Physician Decision|5|||
164331423|NCT01854658|593591232|FG002|Overall Study|Physician Decision|2|||
164331424|NCT01854658|593591233|FG003|Overall Study|Physician Decision|4|||
164331425|NCT01854658|593591230|FG000|Overall Study|Lost to Follow-up|8|||
164331426|NCT01854658|593591231|FG001|Overall Study|Lost to Follow-up|9|||
164331427|NCT01854658|593591232|FG002|Overall Study|Lost to Follow-up|8|||
164229007|NCT02296476|593209224|FG002|Overall Study|Disease Progression|2|||
164229008|NCT03345550|593209230|FG000|Overall Study|Withdrawal by Subject|1|||
164229009|NCT03345550|593209231|FG001|Overall Study|Withdrawal by Subject|0|||
164229010|NCT03345550|593209230|FG000|Overall Study|Lost to Follow-up|4|||
164229011|NCT03345550|593209231|FG001|Overall Study|Lost to Follow-up|5|||
164229012|NCT01149460|593209234|FG000|Overall Study|Withdrawal by Subject|0|||
164229013|NCT01149460|593209235|FG001|Overall Study|Withdrawal by Subject|2|||
164331428|NCT01854658|593591233|FG003|Overall Study|Lost to Follow-up|4|||
164229014|NCT03257657|593209236|FG000|Overall Study|Lost to Follow-up|0|||
164331429|NCT01854658|593591230|FG000|Overall Study|Withdrawal by Subject|28|||
164331430|NCT01854658|593591231|FG001|Overall Study|Withdrawal by Subject|21|||
164331431|NCT01854658|593591232|FG002|Overall Study|Withdrawal by Subject|29|||
164331432|NCT01854658|593591233|FG003|Overall Study|Withdrawal by Subject|15|||
164331433|NCT01854658|593591230|FG000|Overall Study|Protocol-specified criteria|15|||
164331434|NCT01854658|593591231|FG001|Overall Study|Protocol-specified criteria|15|||
164331435|NCT01854658|593591232|FG002|Overall Study|Protocol-specified criteria|10|||
163883019|NCT02783300|591942072|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
163883020|NCT02783300|591942073|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883021|NCT02783300|591942074|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883022|NCT02783300|591942075|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883023|NCT02783300|591942076|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
164229015|NCT03257657|593209237|FG001|Overall Study|Lost to Follow-up|3|||
164229016|NCT03257657|593209236|FG000|Overall Study|Withdrawn|0|||
164229017|NCT03257657|593209237|FG001|Overall Study|Withdrawn|1|||
164229018|NCT03257657|593209236|FG000|Overall Study|Noted not eligible right after enrolled|0|||
164229019|NCT03257657|593209237|FG001|Overall Study|Noted not eligible right after enrolled|1|||
164229020|NCT02801578|593209238|FG000|Overall Study|Adverse Event|2|||
164229021|NCT00668642|593209244|FG000|First Off-cycle|Cancer progression|1|||
164229022|NCT00668642|593209245|FG001|First Off-cycle|Cancer progression|0|||
164229023|NCT00668642|593209244|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
164229024|NCT00668642|593209245|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
164229025|NCT02272985|593209246|FG000|Overall Study|Withdrawal by Subject|1|||
164229026|NCT02272985|593209246|FG000|Overall Study|hip fracture|1|||
164229027|NCT02272985|593209246|FG000|Overall Study|kidney transplantation|1|||
164229028|NCT02489279|593209249|FG000|Overall Study|Lost to Follow-up|12|||
164229029|NCT02489279|593209250|FG001|Overall Study|Lost to Follow-up|10|||
164229030|NCT03440411|593209251|FG000|Overall Study|Adverse Event|0|||
164229031|NCT03440411|593209252|FG001|Overall Study|Adverse Event|0|||
164229032|NCT03440411|593209253|FG002|Overall Study|Adverse Event|1|||
164229033|NCT03440411|593209254|FG003|Overall Study|Adverse Event|0|||
164229034|NCT03440411|593209251|FG000|Overall Study|PD|2|||
164229035|NCT03440411|593209252|FG001|Overall Study|PD|1|||
164229036|NCT03440411|593209253|FG002|Overall Study|PD|1|||
164229037|NCT03440411|593209254|FG003|Overall Study|PD|1|||
164229038|NCT03440411|593209251|FG000|Overall Study|Withdrawal by Subject|1|||
164229039|NCT03440411|593209252|FG001|Overall Study|Withdrawal by Subject|0|||
164229040|NCT03440411|593209253|FG002|Overall Study|Withdrawal by Subject|0|||
164229041|NCT03440411|593209254|FG003|Overall Study|Withdrawal by Subject|0|||
164229042|NCT03440411|593209251|FG000|Overall Study|Closed study by sponsor|0|||
164229043|NCT03440411|593209252|FG001|Overall Study|Closed study by sponsor|0|||
164229044|NCT03440411|593209253|FG002|Overall Study|Closed study by sponsor|0|||
164229045|NCT03440411|593209254|FG003|Overall Study|Closed study by sponsor|1|||
164229046|NCT00505687|593209255|FG000|Overall Study|Important protocol violation|2|||
164229047|NCT00505687|593209255|FG000|Overall Study|Lack of Efficacy|15|||
164229048|NCT00505687|593209255|FG000|Overall Study|Adverse Event|48|||
164229049|NCT00505687|593209255|FG000|Overall Study|Subject withdrew consent|15|||
164229050|NCT00505687|593209255|FG000|Overall Study|Lost to Follow-up|1|||
164229051|NCT00505687|593209255|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
164229052|NCT00505687|593209255|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
164229053|NCT00505687|593209255|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
164229054|NCT00505687|593209255|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
164229055|NCT00505687|593209255|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
164229056|NCT00505687|593209255|FG000|Overall Study|Other: Disease Progression|1|||
164229057|NCT00505687|593209255|FG000|Overall Study|Other: As Per Sponsor|8|||
164229058|NCT03707821|593209256|FG000|Overall Study|Protocol Violation|0|||
163883024|NCT02783300|591942077|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163883025|NCT02783300|591942078|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
163987037|NCT00094055|592320270|FG000|Overall Study|Lack of Efficacy|17|||
164229059|NCT03707821|593209257|FG001|Overall Study|Protocol Violation|1|||
164229060|NCT03707821|593209256|FG000|Overall Study|Unsatisfactory Visual Response|1|||
164229061|NCT03707821|593209257|FG001|Overall Study|Unsatisfactory Visual Response|0|||
164229062|NCT03707821|593209256|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
164229063|NCT03707821|593209257|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
164229064|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
164229065|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
164229066|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
164229067|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
164229068|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
163987038|NCT00094055|592320270|FG000|Overall Study|Lost to Follow-up|2|||
164229069|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
164229070|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
164229071|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
164229072|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
164229073|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
164229074|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
164229075|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
164229076|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
164229077|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
164229078|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
164229079|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
164229080|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
164229081|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
164229082|NCT01432444|593209258|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
164229083|NCT01432444|593209259|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
164229084|NCT01432444|593209260|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
164229085|NCT01432444|593209258|FG000|Treatment Phase|Lost to Follow-up|0|||
164229086|NCT01432444|593209259|FG001|Treatment Phase|Lost to Follow-up|33|||
163883026|NCT02783300|591942052|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883027|NCT02783300|591942053|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883028|NCT02783300|591942054|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883029|NCT02783300|591942055|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164229087|NCT01432444|593209260|FG002|Treatment Phase|Lost to Follow-up|0|||
163883030|NCT02783300|591942056|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164229088|NCT01432444|593209258|FG000|Treatment Phase|Adverse Event|0|||
164229089|NCT01432444|593209259|FG001|Treatment Phase|Adverse Event|37|||
164229090|NCT01432444|593209260|FG002|Treatment Phase|Adverse Event|0|||
164229091|NCT01432444|593209258|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
164229092|NCT01432444|593209259|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
164229093|NCT01432444|593209260|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
164229094|NCT01432444|593209258|FG000|Treatment Phase|Physician Decision|0|||
163883031|NCT02783300|591942057|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883032|NCT02783300|591942058|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164229095|NCT01432444|593209259|FG001|Treatment Phase|Physician Decision|5|||
164229096|NCT01432444|593209260|FG002|Treatment Phase|Physician Decision|0|||
164229097|NCT01432444|593209258|FG000|Treatment Phase|Withdrawal by Subject|0|||
164229098|NCT01432444|593209259|FG001|Treatment Phase|Withdrawal by Subject|41|||
164229099|NCT01432444|593209260|FG002|Treatment Phase|Withdrawal by Subject|0|||
164229100|NCT01432444|593209258|FG000|Treatment Phase|Protocol Deviation|0|||
164229101|NCT01432444|593209259|FG001|Treatment Phase|Protocol Deviation|3|||
164229102|NCT01432444|593209260|FG002|Treatment Phase|Protocol Deviation|0|||
164229103|NCT01432444|593209258|FG000|Treatment Phase|Lack of Efficacy|0|||
164229104|NCT01432444|593209259|FG001|Treatment Phase|Lack of Efficacy|10|||
164229105|NCT01432444|593209260|FG002|Treatment Phase|Lack of Efficacy|0|||
164229106|NCT01432444|593209258|FG000|Extension Phase|Lost to Follow-up|0|||
164229107|NCT01432444|593209259|FG001|Extension Phase|Lost to Follow-up|0|||
164229108|NCT01432444|593209260|FG002|Extension Phase|Lost to Follow-up|17|||
164229109|NCT01432444|593209258|FG000|Extension Phase|Adverse Event|0|||
164229110|NCT01432444|593209259|FG001|Extension Phase|Adverse Event|0|||
164229111|NCT01432444|593209260|FG002|Extension Phase|Adverse Event|10|||
164229112|NCT01432444|593209258|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
164229113|NCT01432444|593209259|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
164229114|NCT01432444|593209260|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
164229115|NCT01432444|593209258|FG000|Extension Phase|Met Withdrawal Criteria|0|||
164229116|NCT01432444|593209259|FG001|Extension Phase|Met Withdrawal Criteria|0|||
164229117|NCT01432444|593209260|FG002|Extension Phase|Met Withdrawal Criteria|144|||
164229118|NCT01432444|593209258|FG000|Extension Phase|Physician Decision|0|||
164229119|NCT01432444|593209259|FG001|Extension Phase|Physician Decision|0|||
164229120|NCT01432444|593209260|FG002|Extension Phase|Physician Decision|1|||
164229121|NCT01432444|593209258|FG000|Extension Phase|Withdrawal by Subject|0|||
164229122|NCT01432444|593209259|FG001|Extension Phase|Withdrawal by Subject|0|||
164229123|NCT01432444|593209260|FG002|Extension Phase|Withdrawal by Subject|13|||
164229124|NCT03673176|593209261|FG000|Overall Study|Death prior to intervention|1|||
164229125|NCT03673176|593209261|FG000|Overall Study|Death following intervention|3|||
164229126|NCT03673176|593209261|FG000|Overall Study|Withdrawal by Subject|1|||
164229127|NCT02378480|593209262|FG000|Overall Study|Physician Decision|1|||
164229128|NCT02378480|593209263|FG001|Overall Study|Physician Decision|1|||
164229129|NCT02378480|593209262|FG000|Overall Study|Death|1|||
164229130|NCT02378480|593209263|FG001|Overall Study|Death|2|||
164229131|NCT02378480|593209262|FG000|Overall Study|Randomized, but Not Treated|6|||
164229132|NCT02378480|593209263|FG001|Overall Study|Randomized, but Not Treated|4|||
164229133|NCT02378480|593209262|FG000|Overall Study|Adverse Event|0|||
164229134|NCT02378480|593209263|FG001|Overall Study|Adverse Event|1|||
164229135|NCT02378480|593209262|FG000|Overall Study|Missed EOT/PTE Visit|1|||
164229136|NCT02378480|593209263|FG001|Overall Study|Missed EOT/PTE Visit|2|||
164229137|NCT02378480|593209262|FG000|Overall Study|Withdrawal by Subject|9|||
164229138|NCT02378480|593209263|FG001|Overall Study|Withdrawal by Subject|4|||
164229139|NCT02378480|593209262|FG000|Overall Study|Lost to Follow-up|10|||
164229140|NCT02378480|593209263|FG001|Overall Study|Lost to Follow-up|18|||
164229141|NCT01230060|593209267|FG000|Overall Study|Withdrawal by Subject|1|||
164229142|NCT03802916|593209268|FG000|Overall Study|Adverse Event|0|||
164229143|NCT03802916|593209269|FG001|Overall Study|Adverse Event|1|||
164229144|NCT03802916|593209268|FG000|Overall Study|Withdrawal by Subject|0|||
164229145|NCT03802916|593209269|FG001|Overall Study|Withdrawal by Subject|1|||
164229146|NCT01285102|593209270|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
164229147|NCT02157610|593209271|FG000|Overall Study|Death|4|||
164229148|NCT02157610|593209272|FG001|Overall Study|Death|4|||
164229149|NCT02327169|593209273|FG000|Overall Study|Progressive Disease|1|||
164229150|NCT02327169|593209274|FG001|Overall Study|Progressive Disease|3|||
164229151|NCT02327169|593209275|FG002|Overall Study|Progressive Disease|4|||
164229152|NCT02327169|593209276|FG003|Overall Study|Progressive Disease|3|||
164229153|NCT02327169|593209277|FG004|Overall Study|Progressive Disease|4|||
164229154|NCT02327169|593209278|FG005|Overall Study|Progressive Disease|3|||
164229155|NCT02327169|593209279|FG006|Overall Study|Progressive Disease|3|||
164229156|NCT02327169|593209280|FG007|Overall Study|Progressive Disease|3|||
164229157|NCT02327169|593209281|FG008|Overall Study|Progressive Disease|4|||
164229158|NCT02327169|593209282|FG009|Overall Study|Progressive Disease|4|||
164229159|NCT02327169|593209283|FG010|Overall Study|Progressive Disease|4|||
164229160|NCT02327169|593209284|FG011|Overall Study|Progressive Disease|3|||
164229161|NCT02327169|593209285|FG012|Overall Study|Progressive Disease|1|||
164229162|NCT02327169|593209286|FG013|Overall Study|Progressive Disease|3|||
164229163|NCT02327169|593209287|FG014|Overall Study|Progressive Disease|3|||
164229164|NCT02327169|593209273|FG000|Overall Study|Adverse Event|2|||
164229165|NCT02327169|593209274|FG001|Overall Study|Adverse Event|0|||
164229166|NCT02327169|593209275|FG002|Overall Study|Adverse Event|1|||
164229167|NCT02327169|593209276|FG003|Overall Study|Adverse Event|0|||
164229168|NCT02327169|593209277|FG004|Overall Study|Adverse Event|1|||
164229169|NCT02327169|593209278|FG005|Overall Study|Adverse Event|0|||
164229170|NCT02327169|593209279|FG006|Overall Study|Adverse Event|0|||
164229171|NCT02327169|593209280|FG007|Overall Study|Adverse Event|0|||
164229172|NCT02327169|593209281|FG008|Overall Study|Adverse Event|0|||
164229173|NCT02327169|593209282|FG009|Overall Study|Adverse Event|2|||
164229174|NCT02327169|593209283|FG010|Overall Study|Adverse Event|0|||
164229175|NCT02327169|593209284|FG011|Overall Study|Adverse Event|3|||
164229176|NCT02327169|593209285|FG012|Overall Study|Adverse Event|0|||
164229177|NCT02327169|593209286|FG013|Overall Study|Adverse Event|2|||
164229178|NCT02327169|593209287|FG014|Overall Study|Adverse Event|1|||
164229179|NCT02327169|593209273|FG000|Overall Study|Symptomatic Deterioration|0|||
164229180|NCT02327169|593209274|FG001|Overall Study|Symptomatic Deterioration|0|||
164229181|NCT02327169|593209275|FG002|Overall Study|Symptomatic Deterioration|1|||
164229182|NCT02327169|593209276|FG003|Overall Study|Symptomatic Deterioration|0|||
164229183|NCT02327169|593209277|FG004|Overall Study|Symptomatic Deterioration|1|||
164229184|NCT02327169|593209278|FG005|Overall Study|Symptomatic Deterioration|1|||
164229185|NCT02327169|593209279|FG006|Overall Study|Symptomatic Deterioration|0|||
164229186|NCT02327169|593209280|FG007|Overall Study|Symptomatic Deterioration|0|||
164229187|NCT02327169|593209281|FG008|Overall Study|Symptomatic Deterioration|2|||
164331436|NCT01854658|593591233|FG003|Overall Study|Protocol-specified criteria|7|||
164331437|NCT01854658|593591230|FG000|Overall Study|Lack of Efficacy|3|||
164331438|NCT01854658|593591231|FG001|Overall Study|Lack of Efficacy|8|||
164331439|NCT01854658|593591232|FG002|Overall Study|Lack of Efficacy|4|||
164331440|NCT01854658|593591233|FG003|Overall Study|Lack of Efficacy|7|||
164331441|NCT01854658|593591230|FG000|Overall Study|Adverse Event|21|||
164331442|NCT01854658|593591231|FG001|Overall Study|Adverse Event|14|||
164331443|NCT01854658|593591232|FG002|Overall Study|Adverse Event|23|||
164331444|NCT01854658|593591233|FG003|Overall Study|Adverse Event|19|||
164229188|NCT02327169|593209282|FG009|Overall Study|Symptomatic Deterioration|1|||
164229189|NCT02327169|593209283|FG010|Overall Study|Symptomatic Deterioration|0|||
164229190|NCT02327169|593209284|FG011|Overall Study|Symptomatic Deterioration|0|||
164229191|NCT02327169|593209285|FG012|Overall Study|Symptomatic Deterioration|0|||
164229192|NCT02327169|593209286|FG013|Overall Study|Symptomatic Deterioration|2|||
164229193|NCT02327169|593209287|FG014|Overall Study|Symptomatic Deterioration|1|||
164229194|NCT02327169|593209273|FG000|Overall Study|Reason Not Specified|0|||
164229195|NCT02327169|593209274|FG001|Overall Study|Reason Not Specified|0|||
164229196|NCT02327169|593209275|FG002|Overall Study|Reason Not Specified|1|||
164229197|NCT02327169|593209276|FG003|Overall Study|Reason Not Specified|0|||
164229198|NCT02327169|593209277|FG004|Overall Study|Reason Not Specified|0|||
164229199|NCT02327169|593209278|FG005|Overall Study|Reason Not Specified|0|||
164229200|NCT02327169|593209279|FG006|Overall Study|Reason Not Specified|0|||
164331445|NCT01854658|593591230|FG000|Overall Study|Administrative reasons|5|||
164229201|NCT02327169|593209280|FG007|Overall Study|Reason Not Specified|0|||
164229202|NCT02327169|593209281|FG008|Overall Study|Reason Not Specified|0|||
164229203|NCT02327169|593209282|FG009|Overall Study|Reason Not Specified|1|||
164229204|NCT02327169|593209283|FG010|Overall Study|Reason Not Specified|2|||
164229205|NCT02327169|593209284|FG011|Overall Study|Reason Not Specified|1|||
164229206|NCT02327169|593209285|FG012|Overall Study|Reason Not Specified|0|||
164229207|NCT02327169|593209286|FG013|Overall Study|Reason Not Specified|0|||
164229208|NCT02327169|593209287|FG014|Overall Study|Reason Not Specified|2|||
164331446|NCT01854658|593591231|FG001|Overall Study|Administrative reasons|1|||
164331447|NCT01854658|593591232|FG002|Overall Study|Administrative reasons|2|||
164229209|NCT02327169|593209273|FG000|Overall Study|Withdrawal by Subject|1|||
164229210|NCT02327169|593209274|FG001|Overall Study|Withdrawal by Subject|0|||
164229211|NCT02327169|593209275|FG002|Overall Study|Withdrawal by Subject|0|||
164229212|NCT02327169|593209276|FG003|Overall Study|Withdrawal by Subject|0|||
164229213|NCT02327169|593209277|FG004|Overall Study|Withdrawal by Subject|1|||
164229214|NCT02327169|593209278|FG005|Overall Study|Withdrawal by Subject|0|||
164229215|NCT02327169|593209279|FG006|Overall Study|Withdrawal by Subject|0|||
164229216|NCT02327169|593209280|FG007|Overall Study|Withdrawal by Subject|1|||
164229217|NCT02327169|593209281|FG008|Overall Study|Withdrawal by Subject|0|||
164229218|NCT02327169|593209282|FG009|Overall Study|Withdrawal by Subject|0|||
164229219|NCT02327169|593209283|FG010|Overall Study|Withdrawal by Subject|0|||
164229220|NCT02327169|593209284|FG011|Overall Study|Withdrawal by Subject|0|||
164229221|NCT02327169|593209285|FG012|Overall Study|Withdrawal by Subject|0|||
164229222|NCT02327169|593209286|FG013|Overall Study|Withdrawal by Subject|0|||
164229223|NCT02327169|593209287|FG014|Overall Study|Withdrawal by Subject|3|||
164229224|NCT02327169|593209273|FG000|Overall Study|Lost to Follow-up|0|||
164229225|NCT02327169|593209274|FG001|Overall Study|Lost to Follow-up|0|||
164229226|NCT02327169|593209275|FG002|Overall Study|Lost to Follow-up|0|||
164229227|NCT02327169|593209276|FG003|Overall Study|Lost to Follow-up|0|||
164229228|NCT02327169|593209277|FG004|Overall Study|Lost to Follow-up|1|||
164229229|NCT02327169|593209278|FG005|Overall Study|Lost to Follow-up|0|||
164229230|NCT02327169|593209279|FG006|Overall Study|Lost to Follow-up|0|||
164229231|NCT02327169|593209280|FG007|Overall Study|Lost to Follow-up|0|||
164229232|NCT02327169|593209281|FG008|Overall Study|Lost to Follow-up|0|||
164229233|NCT02327169|593209282|FG009|Overall Study|Lost to Follow-up|0|||
164229234|NCT02327169|593209283|FG010|Overall Study|Lost to Follow-up|0|||
164229235|NCT02327169|593209284|FG011|Overall Study|Lost to Follow-up|0|||
164229236|NCT02327169|593209285|FG012|Overall Study|Lost to Follow-up|0|||
164229237|NCT02327169|593209286|FG013|Overall Study|Lost to Follow-up|0|||
164229238|NCT02327169|593209287|FG014|Overall Study|Lost to Follow-up|0|||
164229239|NCT03787615|593209288|FG000|Overall Study|Withdrawal by Subject|2|||
164331448|NCT01854658|593591233|FG003|Overall Study|Administrative reasons|2|||
164331449|NCT00331864|593591236|FG000|Overall Study|Adverse Event|30|||
164331450|NCT00331864|593591237|FG001|Overall Study|Adverse Event|1|||
164331451|NCT00331864|593591236|FG000|Overall Study|Lack of Efficacy|4|||
164331452|NCT00331864|593591237|FG001|Overall Study|Lack of Efficacy|0|||
164331453|NCT00331864|593591236|FG000|Overall Study|Protocol Violation|3|||
164331454|NCT00331864|593591237|FG001|Overall Study|Protocol Violation|0|||
164331455|NCT00331864|593591236|FG000|Overall Study|Withdrawal by Subject|10|||
164331456|NCT00331864|593591237|FG001|Overall Study|Withdrawal by Subject|0|||
164331457|NCT00331864|593591236|FG000|Overall Study|Lost to Follow-up|4|||
164331458|NCT00331864|593591237|FG001|Overall Study|Lost to Follow-up|3|||
164331459|NCT00331864|593591236|FG000|Overall Study|Administrative Problems|1|||
164331460|NCT00331864|593591237|FG001|Overall Study|Administrative Problems|0|||
164331461|NCT00331864|593591236|FG000|Overall Study|Death|6|||
164331462|NCT00331864|593591237|FG001|Overall Study|Death|0|||
164331463|NCT02213042|593591239|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
164331464|NCT02213042|593591240|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
164331465|NCT02213042|593591241|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
164331466|NCT02213042|593591239|FG000|Overall Study|Adverse Event|2|||
164331467|NCT02213042|593591240|FG001|Overall Study|Adverse Event|1|||
164331468|NCT02213042|593591241|FG002|Overall Study|Adverse Event|0|||
164331469|NCT02213042|593591239|FG000|Overall Study|Withdrawal by Subject|0|||
164331470|NCT02213042|593591240|FG001|Overall Study|Withdrawal by Subject|1|||
164331471|NCT02213042|593591241|FG002|Overall Study|Withdrawal by Subject|1|||
164331472|NCT02213042|593591239|FG000|Overall Study|Protocol Violation|1|||
164331473|NCT02213042|593591240|FG001|Overall Study|Protocol Violation|0|||
164331474|NCT02213042|593591241|FG002|Overall Study|Protocol Violation|0|||
164331475|NCT02213042|593591239|FG000|Overall Study|Investigator discretion|0|||
164331476|NCT02213042|593591240|FG001|Overall Study|Investigator discretion|0|||
164331477|NCT02213042|593591241|FG002|Overall Study|Investigator discretion|1|||
164331478|NCT02007512|593591242|FG000|Double Blind Treatment Period|Adverse Event|4|||
164331479|NCT02007512|593591243|FG001|Double Blind Treatment Period|Adverse Event|6|||
164331480|NCT02007512|593591244|FG002|Double Blind Treatment Period|Adverse Event|2|||
164331481|NCT02007512|593591245|FG003|Double Blind Treatment Period|Adverse Event|2|||
164331482|NCT02007512|593591242|FG000|Double Blind Treatment Period|Death|1|||
164229240|NCT03787615|593209288|FG000|Overall Study|Lost to Follow-up|2|||
164229241|NCT01229111|593209290|FG000|Overall Study|Death|1|||
164229242|NCT01946880|593209291|FG000|Overall Study|Lost to Follow-up|1|||
164229243|NCT01946880|593209292|FG001|Overall Study|Lost to Follow-up|0|||
164229244|NCT01946880|593209291|FG000|Overall Study|Physician Decision|1|||
164331483|NCT02007512|593591243|FG001|Double Blind Treatment Period|Death|0|||
164331484|NCT02007512|593591244|FG002|Double Blind Treatment Period|Death|0|||
164331485|NCT02007512|593591245|FG003|Double Blind Treatment Period|Death|0|||
164331486|NCT02007512|593591242|FG000|Double Blind Treatment Period|Disease progression|51|||
164331487|NCT02007512|593591243|FG001|Double Blind Treatment Period|Disease progression|50|||
164331488|NCT02007512|593591244|FG002|Double Blind Treatment Period|Disease progression|57|||
164331489|NCT02007512|593591245|FG003|Double Blind Treatment Period|Disease progression|52|||
164331490|NCT02007512|593591242|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
164331491|NCT02007512|593591243|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
163883033|NCT02783300|591942059|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883034|NCT02783300|591942060|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883035|NCT02783300|591942061|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164331492|NCT02007512|593591244|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
164331493|NCT02007512|593591245|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
164331494|NCT02007512|593591242|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164331495|NCT02007512|593591243|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164331496|NCT02007512|593591244|FG002|Double Blind Treatment Period|Protocol Violation|0|||
164331497|NCT02007512|593591245|FG003|Double Blind Treatment Period|Protocol Violation|1|||
164331498|NCT02007512|593591242|FG000|Double Blind Treatment Period|Other|2|||
164331499|NCT02007512|593591243|FG001|Double Blind Treatment Period|Other|1|||
164331500|NCT02007512|593591244|FG002|Double Blind Treatment Period|Other|1|||
163883036|NCT02783300|591942062|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164229245|NCT01946880|593209292|FG001|Overall Study|Physician Decision|1|||
164229246|NCT01946880|593209291|FG000|Overall Study|Withdrawal by Subject|3|||
164229247|NCT01946880|593209292|FG001|Overall Study|Withdrawal by Subject|2|||
164229248|NCT01946880|593209291|FG000|Overall Study|Met Primary Endpoint|1|||
164229249|NCT01946880|593209292|FG001|Overall Study|Met Primary Endpoint|0|||
164229250|NCT01946880|593209291|FG000|Overall Study|Personal and Family Issues|1|||
164229251|NCT01946880|593209292|FG001|Overall Study|Personal and Family Issues|0|||
164229252|NCT00721110|593209295|FG000|Overall Study|Ultram use|1|||
164229253|NCT00721110|593209296|FG001|Overall Study|Ultram use|0|||
164229254|NCT00721110|593209297|FG002|Overall Study|Ultram use|0|||
164229255|NCT00721110|593209298|FG003|Overall Study|Ultram use|0|||
164229256|NCT00721110|593209295|FG000|Overall Study|vertical incision|0|||
164229257|NCT00721110|593209296|FG001|Overall Study|vertical incision|0|||
164229258|NCT00721110|593209297|FG002|Overall Study|vertical incision|1|||
164229259|NCT00721110|593209298|FG003|Overall Study|vertical incision|0|||
164229260|NCT02799043|593209299|FG000|Overall Study|Adverse Event|0|||
164229261|NCT02799043|593209300|FG001|Overall Study|Adverse Event|1|||
164229262|NCT02799043|593209299|FG000|Overall Study|Death|1|||
164229263|NCT02799043|593209300|FG001|Overall Study|Death|1|||
164229264|NCT02799043|593209299|FG000|Overall Study|Lost to Follow-up|3|||
164229265|NCT02799043|593209300|FG001|Overall Study|Lost to Follow-up|6|||
164229266|NCT02799043|593209299|FG000|Overall Study|Withdrawal by Subject|4|||
164229267|NCT02799043|593209300|FG001|Overall Study|Withdrawal by Subject|4|||
164229268|NCT02799043|593209299|FG000|Overall Study|Moved to different country|0|||
164229269|NCT02799043|593209300|FG001|Overall Study|Moved to different country|1|||
164229270|NCT02799043|593209299|FG000|Overall Study|Trial Screen Failure|1|||
164229271|NCT02799043|593209300|FG001|Overall Study|Trial Screen Failure|0|||
164229272|NCT02799043|593209299|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
164229273|NCT02799043|593209300|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
164229274|NCT02226653|593209301|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
164229275|NCT02226653|593209302|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
164229276|NCT02226653|593209301|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
164229277|NCT02226653|593209302|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
164229278|NCT01922895|593209303|FG000|Overall Study|Death|0|||
164229279|NCT01922895|593209304|FG001|Overall Study|Death|1|||
164229280|NCT01922895|593209303|FG000|Overall Study|Withdrawal by Subject|1|||
164229281|NCT01922895|593209304|FG001|Overall Study|Withdrawal by Subject|2|||
164229282|NCT01922895|593209303|FG000|Overall Study|Lost to Follow-up|5|||
164229283|NCT01922895|593209304|FG001|Overall Study|Lost to Follow-up|11|||
164229284|NCT01916226|593209305|FG000|Overall Study|Adverse Event|1|||
164229285|NCT01916226|593209306|FG001|Overall Study|Adverse Event|0|||
164229286|NCT01916226|593209307|FG002|Overall Study|Adverse Event|1|||
164229287|NCT01916226|593209308|FG003|Overall Study|Adverse Event|1|||
164229288|NCT01916226|593209305|FG000|Overall Study|Lack of Efficacy|0|||
164229289|NCT01916226|593209306|FG001|Overall Study|Lack of Efficacy|0|||
164229290|NCT01916226|593209307|FG002|Overall Study|Lack of Efficacy|2|||
164229291|NCT01916226|593209308|FG003|Overall Study|Lack of Efficacy|1|||
164229292|NCT01916226|593209305|FG000|Overall Study|Protocol Violation|0|||
164229293|NCT01916226|593209306|FG001|Overall Study|Protocol Violation|1|||
164229294|NCT01916226|593209307|FG002|Overall Study|Protocol Violation|0|||
164229295|NCT01916226|593209308|FG003|Overall Study|Protocol Violation|1|||
164229296|NCT01916226|593209305|FG000|Overall Study|Physician Decision|0|||
164229297|NCT01916226|593209306|FG001|Overall Study|Physician Decision|0|||
164229298|NCT01916226|593209307|FG002|Overall Study|Physician Decision|0|||
164229299|NCT01916226|593209308|FG003|Overall Study|Physician Decision|1|||
164229300|NCT01166646|593209310|FG000|Overall Study|Protocol Violation|0|||
164229301|NCT01166646|593209311|FG001|Overall Study|Protocol Violation|1|||
164229302|NCT01166646|593209310|FG000|Overall Study|Adverse Event|1|||
164229303|NCT01166646|593209311|FG001|Overall Study|Adverse Event|0|||
164229304|NCT05142306|593209312|FG000|Overall Study|Withdrawal by Subject|0|||
164229305|NCT05142306|593209313|FG001|Overall Study|Withdrawal by Subject|0|||
164229306|NCT05142306|593209314|FG002|Overall Study|Withdrawal by Subject|1|||
164229307|NCT05430919|593209315|FG000|Overall Study|Protocol Violation|0|||
164229308|NCT05430919|593209316|FG001|Overall Study|Protocol Violation|0|||
164229309|NCT05430919|593209317|FG002|Overall Study|Protocol Violation|1|||
164229310|NCT05430919|593209318|FG003|Overall Study|Protocol Violation|0|||
164229311|NCT05430919|593209315|FG000|Overall Study|Lost to Follow-up|0|||
164229312|NCT05430919|593209316|FG001|Overall Study|Lost to Follow-up|1|||
164229313|NCT05430919|593209317|FG002|Overall Study|Lost to Follow-up|0|||
164229314|NCT05430919|593209318|FG003|Overall Study|Lost to Follow-up|0|||
164229315|NCT05430919|593209315|FG000|Overall Study|Withdrawal by Subject|3|||
164229316|NCT05430919|593209316|FG001|Overall Study|Withdrawal by Subject|0|||
164229317|NCT05430919|593209317|FG002|Overall Study|Withdrawal by Subject|0|||
164229318|NCT05430919|593209318|FG003|Overall Study|Withdrawal by Subject|1|||
164229319|NCT04650893|593209333|FG000|Overall Study|Lost to Follow-up|11|||
164229320|NCT04650893|593209334|FG001|Overall Study|Lost to Follow-up|10|||
164229321|NCT04650893|593209335|FG002|Overall Study|Lost to Follow-up|11|||
163987039|NCT00094055|592320270|FG000|Overall Study|progressive disease|2|||
163987040|NCT00094055|592320270|FG000|Overall Study|clinical progression|1|||
163987041|NCT00094055|592320270|FG000|Overall Study|roll-over to another study|14|||
163987042|NCT00094055|592320270|FG000|Overall Study|Withdrawal by Subject|9|||
163987043|NCT00441545|592320271|FG000|First Intervention|Adverse Event|6|||
163987044|NCT00441545|592320272|FG001|First Intervention|Adverse Event|5|||
163987045|NCT00441545|592320271|FG000|First Intervention|Protocol Violation|2|||
163987046|NCT00441545|592320272|FG001|First Intervention|Protocol Violation|2|||
163987047|NCT00441545|592320271|FG000|First Intervention|Withdrawal by Subject|3|||
163987048|NCT00441545|592320272|FG001|First Intervention|Withdrawal by Subject|3|||
163987049|NCT00441545|592320271|FG000|First Intervention|Kidney transplant|1|||
163987050|NCT00441545|592320272|FG001|First Intervention|Kidney transplant|1|||
163987051|NCT00441545|592320271|FG000|First Intervention|Lack of Efficacy|2|||
163987052|NCT00441545|592320272|FG001|First Intervention|Lack of Efficacy|0|||
163987053|NCT00441545|592320271|FG000|First Intervention|Subject exceeded safety criteria|0|||
164229322|NCT04309500|593209340|FG000|Overall Study|Lost to Follow-up|1|||
164229323|NCT04309500|593209341|FG001|Overall Study|Lost to Follow-up|0|||
164229324|NCT04309500|593209342|FG002|Overall Study|Lost to Follow-up|0|||
164229325|NCT04309500|593209343|FG003|Overall Study|Lost to Follow-up|0|||
164229326|NCT00553475|593209344|FG000|Overall Study|Adverse Event|7|||
164229327|NCT00553475|593209345|FG001|Overall Study|Adverse Event|17|||
163987054|NCT00441545|592320272|FG001|First Intervention|Subject exceeded safety criteria|1|||
163987055|NCT00441545|592320271|FG000|First Intervention|Subject met an exclusionary criteria|1|||
164229328|NCT00553475|593209346|FG002|Overall Study|Adverse Event|13|||
164331501|NCT02007512|593591245|FG003|Double Blind Treatment Period|Other|2|||
164331502|NCT02007512|593591242|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
164331503|NCT02007512|593591243|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
164331504|NCT02007512|593591244|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
164331505|NCT02007512|593591245|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
164331506|NCT02007512|593591242|FG000|Open Label Treatment Period|Adverse Event|1|||
164331507|NCT02007512|593591243|FG001|Open Label Treatment Period|Adverse Event|0|||
164331508|NCT02007512|593591244|FG002|Open Label Treatment Period|Adverse Event|0|||
164331509|NCT02007512|593591245|FG003|Open Label Treatment Period|Adverse Event|0|||
164331510|NCT02007512|593591242|FG000|Open Label Treatment Period|Other|1|||
164331511|NCT02007512|593591243|FG001|Open Label Treatment Period|Other|1|||
164331512|NCT02007512|593591244|FG002|Open Label Treatment Period|Other|0|||
164331513|NCT02007512|593591245|FG003|Open Label Treatment Period|Other|0|||
164331514|NCT02007512|593591242|FG000|Open Label Treatment Period|Disease progression|23|||
164331515|NCT02007512|593591243|FG001|Open Label Treatment Period|Disease progression|11|||
164331516|NCT02007512|593591244|FG002|Open Label Treatment Period|Disease progression|0|||
164331517|NCT02007512|593591245|FG003|Open Label Treatment Period|Disease progression|0|||
164331518|NCT02360111|593591248|FG000|Overall Study|Death|2|||
164331519|NCT00611533|593591249|FG000|First Intervention (6 Weeks)|Never started study|0|||
164331520|NCT00611533|593591250|FG001|First Intervention (6 Weeks)|Never started study|1|||
164331521|NCT00611533|593591249|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
164331522|NCT00611533|593591250|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164331523|NCT00611533|593591249|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164331524|NCT00611533|593591250|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
164331525|NCT01933217|593591251|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
164331526|NCT01933217|593591252|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
164331527|NCT01933217|593591251|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
164331528|NCT01933217|593591252|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
164331529|NCT03923738|593591256|FG000|Period 1|Adverse Event|1|||
164331530|NCT03923738|593591256|FG000|Period 1|Withdrawal by Subject|1|||
164331531|NCT05246397|593591257|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
164331532|NCT03875768|593591259|FG000|Overall Study|Lost to Follow-up|16|||
164331533|NCT03875768|593591260|FG001|Overall Study|Lost to Follow-up|13|||
164331534|NCT03875768|593591259|FG000|Overall Study|Withdrawal by Subject|10|||
164331535|NCT03875768|593591260|FG001|Overall Study|Withdrawal by Subject|21|||
164331536|NCT03875768|593591259|FG000|Overall Study|Did not complete assessment|21|||
164331537|NCT03875768|593591260|FG001|Overall Study|Did not complete assessment|12|||
164331538|NCT03875768|593591259|FG000|Overall Study|Became ineligible|1|||
164331539|NCT03875768|593591260|FG001|Overall Study|Became ineligible|0|||
164331540|NCT01925274|593591261|FG000|Overall Study|Death|1|||
164331541|NCT01925274|593591262|FG001|Overall Study|Death|0|||
164331542|NCT01925274|593591263|FG002|Overall Study|Death|0|||
164331543|NCT01925274|593591261|FG000|Overall Study|Lost to Follow-up|0|||
164331544|NCT01925274|593591262|FG001|Overall Study|Lost to Follow-up|1|||
164139013|NCT02932306|592871956|FG000|Overall Study|Adverse Event|3|||
164331545|NCT01925274|593591263|FG002|Overall Study|Lost to Follow-up|0|||
164331546|NCT01925274|593591261|FG000|Overall Study|Withdrawal by Subject|1|||
164331547|NCT01925274|593591262|FG001|Overall Study|Withdrawal by Subject|2|||
164331548|NCT01925274|593591263|FG002|Overall Study|Withdrawal by Subject|0|||
164331549|NCT01925274|593591261|FG000|Overall Study|Study terminated by sponsor|4|||
164229329|NCT00553475|593209344|FG000|Overall Study|Lack of Efficacy|7|||
164229330|NCT00553475|593209345|FG001|Overall Study|Lack of Efficacy|1|||
164229331|NCT00553475|593209346|FG002|Overall Study|Lack of Efficacy|0|||
164229332|NCT00553475|593209344|FG000|Overall Study|Withdrawal by Subject|1|||
164229333|NCT00553475|593209345|FG001|Overall Study|Withdrawal by Subject|1|||
164229334|NCT00553475|593209346|FG002|Overall Study|Withdrawal by Subject|0|||
164229335|NCT00553475|593209344|FG000|Overall Study|Physician Decision|1|||
164229336|NCT00553475|593209345|FG001|Overall Study|Physician Decision|0|||
164229337|NCT00553475|593209346|FG002|Overall Study|Physician Decision|0|||
164229338|NCT00553475|593209344|FG000|Overall Study|Due to moving|0|||
164229339|NCT00553475|593209345|FG001|Overall Study|Due to moving|1|||
164229340|NCT00553475|593209346|FG002|Overall Study|Due to moving|0|||
164229341|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
164229342|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
164229343|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
164331550|NCT01925274|593591262|FG001|Overall Study|Study terminated by sponsor|0|||
164331551|NCT01925274|593591263|FG002|Overall Study|Study terminated by sponsor|0|||
164331552|NCT01925274|593591261|FG000|Overall Study|Protocol amendment|1|||
164331553|NCT01925274|593591262|FG001|Overall Study|Protocol amendment|3|||
164331554|NCT01925274|593591263|FG002|Overall Study|Protocol amendment|6|||
164331555|NCT04327674|593591265|FG000|Overall Study|Protocol Violation|19|||
164331556|NCT00723398|593591270|FG000|Overall Study|Withdrawal by Subject|2|||
164331557|NCT00723398|593591271|FG001|Overall Study|Withdrawal by Subject|6|||
164331558|NCT00723398|593591272|FG002|Overall Study|Withdrawal by Subject|4|||
164331559|NCT00723398|593591273|FG003|Overall Study|Withdrawal by Subject|4|||
164331560|NCT00723398|593591274|FG004|Overall Study|Withdrawal by Subject|4|||
164331561|NCT00723398|593591270|FG000|Overall Study|Protocol Violation|2|||
164331562|NCT00723398|593591271|FG001|Overall Study|Protocol Violation|1|||
164331563|NCT00723398|593591272|FG002|Overall Study|Protocol Violation|5|||
164331564|NCT00723398|593591273|FG003|Overall Study|Protocol Violation|0|||
164331565|NCT00723398|593591274|FG004|Overall Study|Protocol Violation|0|||
164331566|NCT00723398|593591270|FG000|Overall Study|Physician Decision|2|||
164331567|NCT00723398|593591271|FG001|Overall Study|Physician Decision|2|||
164331568|NCT00723398|593591272|FG002|Overall Study|Physician Decision|5|||
164331569|NCT00723398|593591273|FG003|Overall Study|Physician Decision|0|||
164331570|NCT00723398|593591274|FG004|Overall Study|Physician Decision|1|||
164331571|NCT00723398|593591270|FG000|Overall Study|Adverse Event|0|||
164331572|NCT00723398|593591271|FG001|Overall Study|Adverse Event|5|||
164331573|NCT00723398|593591272|FG002|Overall Study|Adverse Event|3|||
164331574|NCT00723398|593591273|FG003|Overall Study|Adverse Event|1|||
164331575|NCT00723398|593591274|FG004|Overall Study|Adverse Event|4|||
164331576|NCT00723398|593591270|FG000|Overall Study|Lost to Follow-up|0|||
164331577|NCT00723398|593591271|FG001|Overall Study|Lost to Follow-up|1|||
164331578|NCT00723398|593591272|FG002|Overall Study|Lost to Follow-up|0|||
164331579|NCT00723398|593591273|FG003|Overall Study|Lost to Follow-up|0|||
164331580|NCT00723398|593591274|FG004|Overall Study|Lost to Follow-up|0|||
164331581|NCT00267189|593591275|FG000|Overall Study|Patient withdrew consent|1|||
164331582|NCT00267189|593591276|FG001|Overall Study|Patient withdrew consent|1|||
164331583|NCT00267189|593591275|FG000|Overall Study|Death|1|||
164331584|NCT00267189|593591276|FG001|Overall Study|Death|0|||
164331585|NCT00267189|593591275|FG000|Overall Study|Missing|3|||
164331586|NCT00267189|593591276|FG001|Overall Study|Missing|0|||
164331587|NCT00751621|593591277|FG000|Overall Study|Adverse Event|1|||
164331588|NCT00751621|593591277|FG000|Overall Study|Withdrawal by Subject|1|||
164331589|NCT00751621|593591277|FG000|Overall Study|Subject moved to another country|1|||
164331590|NCT00751621|593591277|FG000|Overall Study|Poor adherence to asthma treatment|1|||
164331591|NCT01225887|593591280|FG000|Overall Study|Ineligible:required test not done|2|||
164331592|NCT01225887|593591280|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
164331593|NCT01225887|593591280|FG000|Overall Study|Ineligible:inadequate pathology|2|||
164331594|NCT04505540|593591283|FG000|Baseline|Protocol Violation|10|||
164331595|NCT04505540|593591283|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
164331596|NCT04505540|593591283|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
164331597|NCT04505540|593591283|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
164331598|NCT04505540|593591283|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
164331599|NCT04505540|593591283|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
164331600|NCT04505540|593591283|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
164331601|NCT04505540|593591283|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
164331602|NCT04505540|593591283|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
164331603|NCT04505540|593591283|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
164229344|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
164229345|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
164331604|NCT04505540|593591283|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
164331605|NCT04505540|593591283|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
164229346|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
164229347|NCT00913835|593209347|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
164229348|NCT00913835|593209348|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
164229349|NCT00913835|593209347|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
164229350|NCT00913835|593209348|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
164229351|NCT00773461|593209349|FG000|Overall Study|Adverse Event|1|||
164229352|NCT00773461|593209350|FG001|Overall Study|Adverse Event|3|||
164229353|NCT00773461|593209349|FG000|Overall Study|Withdrawal by Subject|4|||
164229354|NCT00773461|593209350|FG001|Overall Study|Withdrawal by Subject|1|||
164229355|NCT00637156|593209351|FG000|Overall Study|Withdrawal by Subject|0|||
164229356|NCT00637156|593209352|FG001|Overall Study|Withdrawal by Subject|7|||
164229357|NCT00637156|593209351|FG000|Overall Study|Death|0|||
164229358|NCT00637156|593209352|FG001|Overall Study|Death|1|||
164229359|NCT00637156|593209351|FG000|Overall Study|Lost to Follow-up|10|||
164229360|NCT00637156|593209352|FG001|Overall Study|Lost to Follow-up|16|||
164229361|NCT03193437|593209353|FG000|Overall Study|Adverse Event|4|||
164229362|NCT03193437|593209353|FG000|Overall Study|Withdrawal by Subject|2|||
164229363|NCT03193437|593209353|FG000|Overall Study|Disease Progression|2|||
164229364|NCT04976855|593209354|FG000|Part I|Withdrawal by Subject|0|||
164229365|NCT04976855|593209355|FG001|Part I|Withdrawal by Subject|1|||
164229366|NCT04976855|593209356|FG002|Part I|Withdrawal by Subject|0|||
164229367|NCT04976855|593209357|FG003|Part I|Withdrawal by Subject|0|||
164229368|NCT04976855|593209358|FG004|Part I|Withdrawal by Subject|0|||
164229369|NCT04976855|593209359|FG005|Part I|Withdrawal by Subject|0|||
164229370|NCT04976855|593209360|FG006|Part I|Withdrawal by Subject|0|||
164229371|NCT04976855|593209354|FG000|Part II|Adverse Event|0|||
164229372|NCT04976855|593209355|FG001|Part II|Adverse Event|0|||
164229373|NCT04976855|593209356|FG002|Part II|Adverse Event|0|||
164229374|NCT04976855|593209357|FG003|Part II|Adverse Event|1|||
164229375|NCT04976855|593209358|FG004|Part II|Adverse Event|0|||
164229376|NCT04976855|593209359|FG005|Part II|Adverse Event|0|||
164229377|NCT04976855|593209360|FG006|Part II|Adverse Event|0|||
164229378|NCT04976855|593209354|FG000|Part II|Withdrawal by Subject|0|||
164229379|NCT04976855|593209355|FG001|Part II|Withdrawal by Subject|0|||
164229380|NCT04976855|593209356|FG002|Part II|Withdrawal by Subject|0|||
164229381|NCT04976855|593209357|FG003|Part II|Withdrawal by Subject|0|||
164229382|NCT04976855|593209358|FG004|Part II|Withdrawal by Subject|1|||
164229383|NCT04976855|593209359|FG005|Part II|Withdrawal by Subject|0|||
164229384|NCT04976855|593209360|FG006|Part II|Withdrawal by Subject|0|||
164229385|NCT04976855|593209354|FG000|Part II|Lost to Follow-up|0|||
164229386|NCT04976855|593209355|FG001|Part II|Lost to Follow-up|0|||
164229387|NCT04976855|593209356|FG002|Part II|Lost to Follow-up|0|||
164229388|NCT04976855|593209357|FG003|Part II|Lost to Follow-up|0|||
164229389|NCT04976855|593209358|FG004|Part II|Lost to Follow-up|0|||
164229390|NCT04976855|593209359|FG005|Part II|Lost to Follow-up|1|||
164229391|NCT04976855|593209360|FG006|Part II|Lost to Follow-up|0|||
164229392|NCT02038036|593209361|FG000|Core Study|Adverse Event|7|||
164229393|NCT02038036|593209362|FG001|Core Study|Adverse Event|7|||
164229394|NCT02038036|593209361|FG000|Core Study|Death|1|||
164229395|NCT02038036|593209362|FG001|Core Study|Death|1|||
164229396|NCT02038036|593209361|FG000|Core Study|Disease progression|2|||
164229397|NCT02038036|593209362|FG001|Core Study|Disease progression|2|||
164229398|NCT02038036|593209361|FG000|Core Study|Lost to Follow-up|0|||
164229399|NCT02038036|593209362|FG001|Core Study|Lost to Follow-up|1|||
164229400|NCT02038036|593209361|FG000|Core Study|Physician Decision|2|||
164229401|NCT02038036|593209362|FG001|Core Study|Physician Decision|1|||
164229402|NCT02038036|593209361|FG000|Core Study|Subject/guardian decision|0|||
164229403|NCT02038036|593209362|FG001|Core Study|Subject/guardian decision|1|||
164331606|NCT04505540|593591283|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
164331607|NCT05342532|593591286|FG000|Overall Study|Adverse Event|5|||
164331608|NCT05342532|593591287|FG001|Overall Study|Adverse Event|20|||
164331609|NCT05342532|593591286|FG000|Overall Study|Lost to Follow-up|10|||
164331610|NCT05342532|593591287|FG001|Overall Study|Lost to Follow-up|15|||
164331611|NCT01123850|593591292|FG000|Overall Study|Slow enrollment|45|||
164331612|NCT03180684|593591293|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
164331613|NCT03180684|593591294|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
164331614|NCT03180684|593591293|FG000|Overall Study|Physician Decision|1|||
164331615|NCT03180684|593591294|FG001|Overall Study|Physician Decision|0|||
164229404|NCT02038036|593209361|FG000|Core Study|Withdrawal by Subject|3|||
164229405|NCT02038036|593209362|FG001|Core Study|Withdrawal by Subject|1|||
164229406|NCT02038036|593209361|FG000|Crossover Period|Withdrawal by Subject|0|||
164229407|NCT02038036|593209362|FG001|Crossover Period|Withdrawal by Subject|3|||
164229408|NCT02038036|593209361|FG000|Crossover Period|Adverse Event|0|||
164229409|NCT02038036|593209362|FG001|Crossover Period|Adverse Event|9|||
164229410|NCT02038036|593209361|FG000|Crossover Period|Death|0|||
164229411|NCT02038036|593209362|FG001|Crossover Period|Death|2|||
164229412|NCT02038036|593209361|FG000|Crossover Period|Disease progression|0|||
164229413|NCT02038036|593209362|FG001|Crossover Period|Disease progression|3|||
164229414|NCT02038036|593209361|FG000|Crossover Period|Lost to Follow-up|0|||
164229415|NCT02038036|593209362|FG001|Crossover Period|Lost to Follow-up|1|||
164229416|NCT02038036|593209361|FG000|Crossover Period|Physician Decision|0|||
164229417|NCT02038036|593209362|FG001|Crossover Period|Physician Decision|2|||
164229418|NCT00908141|593209373|FG000|Overall Study|Withdrawal by Subject|0|||
164229419|NCT00908141|593209374|FG001|Overall Study|Withdrawal by Subject|1|||
164229420|NCT02657356|593210753|FG000|Overall Study|Death|1|||
164229421|NCT02657356|593210754|FG001|Overall Study|Death|0|||
164229422|NCT02657356|593210753|FG000|Overall Study|Withdrawal by Subject|5|||
164229423|NCT02657356|593210754|FG001|Overall Study|Withdrawal by Subject|6|||
164229424|NCT02657356|593210753|FG000|Overall Study|Terminated by Sponsor|8|||
164229425|NCT02657356|593210754|FG001|Overall Study|Terminated by Sponsor|5|||
164229426|NCT02657356|593210753|FG000|Overall Study|Rolled over to EAP study|6|||
164229427|NCT02657356|593210754|FG001|Overall Study|Rolled over to EAP study|4|||
164229428|NCT03768336|593210755|FG000|Overall Study|Lost to Follow-up|3|||
164229429|NCT03768336|593210756|FG001|Overall Study|Lost to Follow-up|2|||
164229430|NCT03768336|593210755|FG000|Overall Study|Became Ineligible|2|||
164229431|NCT03768336|593210756|FG001|Overall Study|Became Ineligible|0|||
164229432|NCT03768336|593210755|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
164229433|NCT03768336|593210756|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
164229434|NCT03768336|593210755|FG000|Overall Study|Missed final survey (post-treatment|0|||
164229435|NCT03768336|593210756|FG001|Overall Study|Missed final survey (post-treatment|1|||
164229436|NCT02278003|593210757|FG000|Overall Study|Withdrawal by Subject|11|||
164229437|NCT02278003|593210758|FG001|Overall Study|Withdrawal by Subject|0|||
164229438|NCT02278003|593210757|FG000|Overall Study|Not Treated|1|||
164229439|NCT02278003|593210758|FG001|Overall Study|Not Treated|0|||
164229440|NCT02278003|593210757|FG000|Overall Study|Recognition task improperly completed|7|||
164229441|NCT02278003|593210758|FG001|Overall Study|Recognition task improperly completed|0|||
164229442|NCT00980044|593210759|FG000|Overall Study|Withdrawal by Subject|5|||
164229443|NCT00980044|593210760|FG001|Overall Study|Withdrawal by Subject|7|||
164229444|NCT00980044|593210761|FG002|Overall Study|Withdrawal by Subject|3|||
164229445|NCT00980044|593210759|FG000|Overall Study|Protocol Violation|0|||
164229446|NCT00980044|593210760|FG001|Overall Study|Protocol Violation|0|||
164229447|NCT00980044|593210761|FG002|Overall Study|Protocol Violation|2|||
164229448|NCT00442702|593210762|FG000|Titration Period|Adverse Event|2|||
164229449|NCT00442702|593210763|FG001|Titration Period|Adverse Event|0|||
164229450|NCT00442702|593210762|FG000|Titration Period|Death|3|||
164229451|NCT00442702|593210763|FG001|Titration Period|Death|2|||
164229452|NCT00442702|593210762|FG000|Titration Period|Insufficient Therapeutic Response|1|||
164229453|NCT00442702|593210763|FG001|Titration Period|Insufficient Therapeutic Response|0|||
164229454|NCT00442702|593210762|FG000|Titration Period|Refused Treatment|4|||
164229455|NCT00442702|593210763|FG001|Titration Period|Refused Treatment|1|||
164229456|NCT00442702|593210762|FG000|Titration Period|Failure to return|1|||
164229457|NCT00442702|593210763|FG001|Titration Period|Failure to return|0|||
164229458|NCT00442702|593210762|FG000|Titration Period|Hospitalized in another hospital|1|||
164229459|NCT00442702|593210763|FG001|Titration Period|Hospitalized in another hospital|0|||
164229460|NCT00442702|593210762|FG000|Evaluation Period|Adverse Event|1|||
164229461|NCT00442702|593210763|FG001|Evaluation Period|Adverse Event|0|||
164229462|NCT00442702|593210762|FG000|Evaluation Period|Death|1|||
164229463|NCT00442702|593210763|FG001|Evaluation Period|Death|1|||
164229464|NCT00442702|593210762|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
164229465|NCT00442702|593210763|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
164229466|NCT00442702|593210762|FG000|Evaluation Period|Refused treatment|1|||
164229467|NCT00442702|593210763|FG001|Evaluation Period|Refused treatment|1|||
164229468|NCT00442702|593210762|FG000|Evaluation Period|Renal transplant|0|||
164229469|NCT00442702|593210763|FG001|Evaluation Period|Renal transplant|1|||
164229470|NCT00442702|593210762|FG000|Evaluation Period|Failure to return|1|||
164229471|NCT00442702|593210763|FG001|Evaluation Period|Failure to return|0|||
164229472|NCT00442702|593210762|FG000|Evaluation Period|Site closure|0|||
164229473|NCT00442702|593210763|FG001|Evaluation Period|Site closure|1|||
164229474|NCT01444781|593210764|FG000|Overall Study|Lost to Follow-up|0|||
164229475|NCT01444781|593210765|FG001|Overall Study|Lost to Follow-up|3|||
164229476|NCT01444781|593210766|FG002|Overall Study|Lost to Follow-up|1|||
164229477|NCT01444781|593210764|FG000|Overall Study|Withdrawal by Subject|3|||
164229478|NCT01444781|593210765|FG001|Overall Study|Withdrawal by Subject|1|||
164229479|NCT01444781|593210766|FG002|Overall Study|Withdrawal by Subject|2|||
164229480|NCT00500331|593210768|FG000|Overall Study|Adverse Event|0|||
164229481|NCT00500331|593210769|FG001|Overall Study|Adverse Event|2|||
164229482|NCT00500331|593210770|FG002|Overall Study|Adverse Event|0|||
164229483|NCT00500331|593210771|FG003|Overall Study|Adverse Event|1|||
164229484|NCT00500331|593210772|FG004|Overall Study|Adverse Event|2|||
164229485|NCT00500331|593210773|FG005|Overall Study|Adverse Event|2|||
164229486|NCT00500331|593210774|FG006|Overall Study|Adverse Event|0|||
164229487|NCT00500331|593210768|FG000|Overall Study|Lost to Follow-up|1|||
164229488|NCT00500331|593210769|FG001|Overall Study|Lost to Follow-up|1|||
164229489|NCT00500331|593210770|FG002|Overall Study|Lost to Follow-up|1|||
164229490|NCT00500331|593210771|FG003|Overall Study|Lost to Follow-up|2|||
164229491|NCT00500331|593210772|FG004|Overall Study|Lost to Follow-up|1|||
164229492|NCT00500331|593210773|FG005|Overall Study|Lost to Follow-up|0|||
164229493|NCT00500331|593210774|FG006|Overall Study|Lost to Follow-up|0|||
164229494|NCT00500331|593210768|FG000|Overall Study|Protocol Violation|3|||
164229495|NCT00500331|593210769|FG001|Overall Study|Protocol Violation|1|||
164229496|NCT00500331|593210770|FG002|Overall Study|Protocol Violation|1|||
164229497|NCT00500331|593210771|FG003|Overall Study|Protocol Violation|0|||
164229498|NCT00500331|593210772|FG004|Overall Study|Protocol Violation|1|||
164229499|NCT00500331|593210773|FG005|Overall Study|Protocol Violation|1|||
164229500|NCT00500331|593210774|FG006|Overall Study|Protocol Violation|1|||
164229501|NCT00500331|593210768|FG000|Overall Study|Withdrawal by Subject|4|||
164229502|NCT00500331|593210769|FG001|Overall Study|Withdrawal by Subject|0|||
164229503|NCT00500331|593210770|FG002|Overall Study|Withdrawal by Subject|1|||
164229504|NCT00500331|593210771|FG003|Overall Study|Withdrawal by Subject|5|||
164229505|NCT00500331|593210772|FG004|Overall Study|Withdrawal by Subject|0|||
164229506|NCT00500331|593210773|FG005|Overall Study|Withdrawal by Subject|1|||
164229507|NCT00500331|593210774|FG006|Overall Study|Withdrawal by Subject|1|||
164229508|NCT00500331|593210768|FG000|Overall Study|Lack of Efficacy|3|||
164229509|NCT00500331|593210769|FG001|Overall Study|Lack of Efficacy|1|||
164229510|NCT00500331|593210770|FG002|Overall Study|Lack of Efficacy|0|||
164229511|NCT00500331|593210771|FG003|Overall Study|Lack of Efficacy|0|||
164229512|NCT00500331|593210772|FG004|Overall Study|Lack of Efficacy|0|||
164229513|NCT00500331|593210773|FG005|Overall Study|Lack of Efficacy|0|||
164229514|NCT00500331|593210774|FG006|Overall Study|Lack of Efficacy|0|||
164229515|NCT00500331|593210768|FG000|Overall Study|Liver function test abnormality|0|||
164229516|NCT00500331|593210769|FG001|Overall Study|Liver function test abnormality|0|||
164229517|NCT00500331|593210770|FG002|Overall Study|Liver function test abnormality|1|||
164229518|NCT00500331|593210771|FG003|Overall Study|Liver function test abnormality|0|||
164229519|NCT00500331|593210772|FG004|Overall Study|Liver function test abnormality|0|||
164229520|NCT00500331|593210773|FG005|Overall Study|Liver function test abnormality|0|||
164229521|NCT00500331|593210774|FG006|Overall Study|Liver function test abnormality|0|||
164229522|NCT00500331|593210768|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
164229523|NCT00500331|593210769|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
164229524|NCT00500331|593210770|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
164229525|NCT00500331|593210771|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
164229526|NCT00500331|593210772|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
164229527|NCT00500331|593210773|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
164229528|NCT00500331|593210774|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
164229529|NCT00500331|593210768|FG000|Overall Study|Didn't return for continuation of study|1|||
164229530|NCT00500331|593210769|FG001|Overall Study|Didn't return for continuation of study|0|||
164229531|NCT00500331|593210770|FG002|Overall Study|Didn't return for continuation of study|0|||
164229532|NCT00500331|593210771|FG003|Overall Study|Didn't return for continuation of study|0|||
164229533|NCT00500331|593210772|FG004|Overall Study|Didn't return for continuation of study|0|||
164229534|NCT00500331|593210773|FG005|Overall Study|Didn't return for continuation of study|0|||
164229535|NCT00500331|593210774|FG006|Overall Study|Didn't return for continuation of study|0|||
164229536|NCT00500331|593210768|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
164229537|NCT00500331|593210769|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229538|NCT00500331|593210770|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229539|NCT00500331|593210771|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229540|NCT00500331|593210772|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229541|NCT00500331|593210773|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229542|NCT00500331|593210774|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
164229543|NCT00500331|593210768|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
164229544|NCT00500331|593210769|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
164229545|NCT00500331|593210770|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
163987056|NCT00441545|592320272|FG001|First Intervention|Subject met an exclusionary criteria|0|||
163987057|NCT00441545|592320271|FG000|First Intervention|Extended hospitalization|1|||
163987058|NCT00441545|592320272|FG001|First Intervention|Extended hospitalization|0|||
164229546|NCT00500331|593210771|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
164229547|NCT00500331|593210772|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
164229548|NCT00500331|593210773|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
164229549|NCT00500331|593210774|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
163987059|NCT00441545|592320271|FG000|First Intervention|Site error|1|||
164229550|NCT00500331|593210768|FG000|Overall Study|Participant was randomized by mistake|1|||
164331616|NCT03180684|593591293|FG000|Overall Study|Lost to Follow-up|1|||
164331617|NCT03180684|593591294|FG001|Overall Study|Lost to Follow-up|0|||
164331618|NCT03180684|593591293|FG000|Overall Study|Progressive Disease|1|||
164331619|NCT03180684|593591294|FG001|Overall Study|Progressive Disease|0|||
164331620|NCT02495233|593591298|FG000|Overall Study|Miscellaneous|0|||
164331621|NCT02495233|593591299|FG001|Overall Study|Miscellaneous|1|||
164229551|NCT00500331|593210769|FG001|Overall Study|Participant was randomized by mistake|0|||
164229552|NCT00500331|593210770|FG002|Overall Study|Participant was randomized by mistake|0|||
164229553|NCT00500331|593210771|FG003|Overall Study|Participant was randomized by mistake|0|||
164229554|NCT00500331|593210772|FG004|Overall Study|Participant was randomized by mistake|0|||
164229555|NCT00500331|593210773|FG005|Overall Study|Participant was randomized by mistake|0|||
164229556|NCT00500331|593210774|FG006|Overall Study|Participant was randomized by mistake|0|||
164229557|NCT00500331|593210768|FG000|Overall Study|Diabetologist nurse in the study|0|||
164229558|NCT00500331|593210769|FG001|Overall Study|Diabetologist nurse in the study|0|||
164229559|NCT00500331|593210770|FG002|Overall Study|Diabetologist nurse in the study|1|||
164229560|NCT00500331|593210771|FG003|Overall Study|Diabetologist nurse in the study|0|||
164229561|NCT00500331|593210772|FG004|Overall Study|Diabetologist nurse in the study|0|||
164229562|NCT00500331|593210773|FG005|Overall Study|Diabetologist nurse in the study|0|||
164229563|NCT00500331|593210774|FG006|Overall Study|Diabetologist nurse in the study|0|||
164229564|NCT00500331|593210768|FG000|Overall Study|State ban of biological samples export|0|||
164229565|NCT00500331|593210769|FG001|Overall Study|State ban of biological samples export|0|||
164229566|NCT00500331|593210770|FG002|Overall Study|State ban of biological samples export|0|||
164229567|NCT00500331|593210771|FG003|Overall Study|State ban of biological samples export|1|||
164229568|NCT00500331|593210772|FG004|Overall Study|State ban of biological samples export|0|||
164229569|NCT00500331|593210773|FG005|Overall Study|State ban of biological samples export|0|||
164229570|NCT00500331|593210774|FG006|Overall Study|State ban of biological samples export|0|||
164229571|NCT00500331|593210768|FG000|Overall Study|Protocol violated|0|||
164229572|NCT00500331|593210769|FG001|Overall Study|Protocol violated|0|||
164229573|NCT00500331|593210770|FG002|Overall Study|Protocol violated|0|||
164229574|NCT00500331|593210771|FG003|Overall Study|Protocol violated|1|||
164229575|NCT00500331|593210772|FG004|Overall Study|Protocol violated|0|||
164229576|NCT00500331|593210773|FG005|Overall Study|Protocol violated|0|||
164229577|NCT00500331|593210774|FG006|Overall Study|Protocol violated|0|||
164229578|NCT03014089|593210780|FG000|Overall Study|Withdrawal by Subject|0|||
164229579|NCT03014089|593210781|FG001|Overall Study|Withdrawal by Subject|1|||
164229580|NCT03014089|593210782|FG002|Overall Study|Withdrawal by Subject|1|||
164229581|NCT03014089|593210783|FG003|Overall Study|Withdrawal by Subject|1|||
164229582|NCT03014089|593210780|FG000|Overall Study|Lost to Follow-up|1|||
164229583|NCT03014089|593210781|FG001|Overall Study|Lost to Follow-up|0|||
164229584|NCT03014089|593210782|FG002|Overall Study|Lost to Follow-up|0|||
164229585|NCT03014089|593210783|FG003|Overall Study|Lost to Follow-up|0|||
164229586|NCT03014089|593210780|FG000|Overall Study|Adverse Event|1|||
164229587|NCT03014089|593210781|FG001|Overall Study|Adverse Event|0|||
164229588|NCT03014089|593210782|FG002|Overall Study|Adverse Event|1|||
163883037|NCT02783300|591942063|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883038|NCT02783300|591942064|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883039|NCT02783300|591942065|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883040|NCT02783300|591942066|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883041|NCT02783300|591942067|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
163883042|NCT02783300|591942068|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883043|NCT02783300|591942069|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883044|NCT02783300|591942070|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883045|NCT02783300|591942071|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
164229589|NCT03014089|593210783|FG003|Overall Study|Adverse Event|0|||
164229590|NCT00321932|593210784|FG000|Overall Study|Death|3|||
164229591|NCT00321932|593210785|FG001|Overall Study|Death|6|||
164229592|NCT00321932|593210784|FG000|Overall Study|Withdrawal by Subject|3|||
164229593|NCT00321932|593210785|FG001|Overall Study|Withdrawal by Subject|6|||
164229594|NCT00321932|593210784|FG000|Overall Study|Early relapse|2|||
164229595|NCT00321932|593210785|FG001|Overall Study|Early relapse|8|||
164229596|NCT00321932|593210784|FG000|Overall Study|Missing data|2|||
164229597|NCT00321932|593210785|FG001|Overall Study|Missing data|1|||
164229598|NCT00734032|593210786|FG000|Overall Study|Adverse Event|0|||
164229599|NCT00734032|593210787|FG001|Overall Study|Adverse Event|1|||
164229600|NCT00734032|593210788|FG002|Overall Study|Adverse Event|0|||
164229601|NCT00734032|593210789|FG003|Overall Study|Adverse Event|0|||
164229602|NCT03468998|593210792|FG000|Overall Study|Withdrawal by Subject|1|||
164229603|NCT03468998|593210793|FG001|Overall Study|Withdrawal by Subject|1|||
164229604|NCT03468998|593210794|FG002|Overall Study|Withdrawal by Subject|0|||
164229605|NCT03468998|593210795|FG003|Overall Study|Withdrawal by Subject|4|||
164229606|NCT03468998|593210796|FG004|Overall Study|Withdrawal by Subject|1|||
164229607|NCT03468998|593210797|FG005|Overall Study|Withdrawal by Subject|0|||
164229608|NCT00137449|593210798|FG000|Overall Study|Disease Progression|8|||
164229609|NCT00137449|593210799|FG001|Overall Study|Disease Progression|13|||
164229610|NCT00137449|593210798|FG000|Overall Study|Death|4|||
164229611|NCT00137449|593210799|FG001|Overall Study|Death|3|||
164229612|NCT00137449|593210798|FG000|Overall Study|Adverse Event|3|||
164229613|NCT00137449|593210799|FG001|Overall Study|Adverse Event|1|||
164229614|NCT00137449|593210798|FG000|Overall Study|Withdrawal by Subject|1|||
164229615|NCT00137449|593210799|FG001|Overall Study|Withdrawal by Subject|1|||
164229616|NCT01356940|593210802|FG000|First Intervention (28 Days)|Adverse Event|1|||
164229617|NCT01356940|593210803|FG001|First Intervention (28 Days)|Adverse Event|0|||
164229618|NCT01356940|593210802|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
164229619|NCT01356940|593210803|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
164229620|NCT03412591|593210804|FG000|Overall Study|Withdrawal by Subject|1|||
164229621|NCT03412591|593210805|FG001|Overall Study|Withdrawal by Subject|8|||
164229622|NCT03412591|593210804|FG000|Overall Study|Adverse Event|0|||
164229623|NCT03412591|593210805|FG001|Overall Study|Adverse Event|1|||
164229624|NCT00480532|593210812|FG000|Overall Study|Withdrawal by Subject|2|||
164229625|NCT00480532|593210813|FG001|Overall Study|Withdrawal by Subject|4|||
164229626|NCT00480532|593210814|FG002|Overall Study|Withdrawal by Subject|3|||
164229627|NCT00480532|593210815|FG003|Overall Study|Withdrawal by Subject|1|||
164229628|NCT00480532|593210812|FG000|Overall Study|Protocol Violation|0|||
164229629|NCT00480532|593210813|FG001|Overall Study|Protocol Violation|0|||
164229630|NCT00480532|593210814|FG002|Overall Study|Protocol Violation|1|||
164229631|NCT00480532|593210815|FG003|Overall Study|Protocol Violation|0|||
164229632|NCT03322566|593210816|FG000|Overall Study|Death|34|||
164229633|NCT03322566|593210817|FG001|Overall Study|Death|35|||
164229634|NCT03322566|593210818|FG002|Overall Study|Death|23|||
164229635|NCT03322566|593210816|FG000|Overall Study|Physician Decision|6|||
164229636|NCT03322566|593210817|FG001|Overall Study|Physician Decision|7|||
164229637|NCT03322566|593210818|FG002|Overall Study|Physician Decision|2|||
164229638|NCT03322566|593210816|FG000|Overall Study|Withdrawal by Subject|4|||
164229639|NCT03322566|593210817|FG001|Overall Study|Withdrawal by Subject|3|||
164229640|NCT03322566|593210818|FG002|Overall Study|Withdrawal by Subject|6|||
163987060|NCT00441545|592320272|FG001|First Intervention|Site error|0|||
163987061|NCT00441545|592320271|FG000|First Intervention|Sponsor's request|1|||
163987062|NCT00441545|592320272|FG001|First Intervention|Sponsor's request|0|||
163987063|NCT00441545|592320271|FG000|Second Intervention|Adverse Event|5|||
164229641|NCT03322566|593210816|FG000|Overall Study|Lost to Follow-up|0|||
164229642|NCT03322566|593210817|FG001|Overall Study|Lost to Follow-up|0|||
164229643|NCT03322566|593210818|FG002|Overall Study|Lost to Follow-up|1|||
164229644|NCT03322566|593210816|FG000|Overall Study|Study terminated by sponsor|1|||
164229645|NCT03322566|593210817|FG001|Overall Study|Study terminated by sponsor|0|||
164229646|NCT03322566|593210818|FG002|Overall Study|Study terminated by sponsor|1|||
164229647|NCT01602484|593210819|FG000|Overall Study|Airway issues unrelated to study|0|||
164229648|NCT01602484|593210820|FG001|Overall Study|Airway issues unrelated to study|1|||
164229649|NCT00425555|593210823|FG000|Overall Study|Withdrawal by Subject|11|||
164229650|NCT00425555|593210824|FG001|Overall Study|Withdrawal by Subject|8|||
164229651|NCT00425555|593210823|FG000|Overall Study|Lost to Follow-up|0|||
164229652|NCT00425555|593210824|FG001|Overall Study|Lost to Follow-up|1|||
163987064|NCT00441545|592320272|FG001|Second Intervention|Adverse Event|2|||
164229653|NCT00425555|593210823|FG000|Overall Study|Administrative problems|3|||
163987065|NCT00441545|592320271|FG000|Second Intervention|Protocol Violation|4|||
164229654|NCT00425555|593210824|FG001|Overall Study|Administrative problems|0|||
164229655|NCT00425555|593210823|FG000|Overall Study|Death|1|||
164229656|NCT00425555|593210824|FG001|Overall Study|Death|2|||
164229657|NCT00425555|593210823|FG000|Overall Study|New cancer therapy|2|||
164229658|NCT00425555|593210824|FG001|Overall Study|New cancer therapy|1|||
164229659|NCT00425555|593210823|FG000|Overall Study|Disease progression|36|||
164229660|NCT00425555|593210824|FG001|Overall Study|Disease progression|33|||
164229661|NCT00425555|593210823|FG000|Overall Study|Adverse Event|25|||
164229662|NCT00425555|593210824|FG001|Overall Study|Adverse Event|15|||
164229663|NCT00425555|593210823|FG000|Overall Study|Protocol Violation|1|||
164229664|NCT00425555|593210824|FG001|Overall Study|Protocol Violation|0|||
164229665|NCT05763381|593210825|FG000|Overall Study|Lost to Follow-up|2|||
164229666|NCT05763381|593210826|FG001|Overall Study|Lost to Follow-up|3|||
164229667|NCT05763381|593210825|FG000|Overall Study|Withdrawal by Subject|1|||
164229668|NCT05763381|593210826|FG001|Overall Study|Withdrawal by Subject|2|||
164229669|NCT02697448|593210828|FG000|Overall Study|Protocol Violation|2|||
164229670|NCT02697448|593210829|FG001|Overall Study|Protocol Violation|4|||
164229671|NCT02697448|593210828|FG000|Overall Study|Clinical concerns during ablation|1|||
164229672|NCT02697448|593210829|FG001|Overall Study|Clinical concerns during ablation|1|||
164229673|NCT02697448|593210828|FG000|Overall Study|No data collected|2|||
164229674|NCT02697448|593210829|FG001|Overall Study|No data collected|0|||
164229675|NCT05473715|593210830|FG000|Overall Study|Trial terminate|2|||
164229676|NCT05473715|593210831|FG001|Overall Study|Trial terminate|1|||
164229677|NCT02592863|593210835|FG000|Overall Study|Withdrawal by Subject|2|||
164229678|NCT02592863|593210836|FG001|Overall Study|Withdrawal by Subject|2|||
164229679|NCT02592863|593210835|FG000|Overall Study|Lost to Follow-up|1|||
164229680|NCT02592863|593210836|FG001|Overall Study|Lost to Follow-up|1|||
164229681|NCT02743221|593210837|FG000|Overall Study|Progressive disease|29|||
164229682|NCT02743221|593210838|FG001|Overall Study|Progressive disease|38|||
164229683|NCT02743221|593210837|FG000|Overall Study|Adverse Event|17|||
164229684|NCT02743221|593210838|FG001|Overall Study|Adverse Event|14|||
164229685|NCT02743221|593210837|FG000|Overall Study|non medical reason|8|||
164229686|NCT02743221|593210838|FG001|Overall Study|non medical reason|2|||
164229687|NCT02743221|593210837|FG000|Overall Study|Physician Decision|2|||
164229688|NCT02743221|593210838|FG001|Overall Study|Physician Decision|5|||
164229689|NCT02743221|593210837|FG000|Overall Study|Patient not eligible, not treated|0|||
164229690|NCT02743221|593210838|FG001|Overall Study|Patient not eligible, not treated|1|||
164229691|NCT02609503|593210848|FG000|Overall Study|Adverse Event|1|||
164229692|NCT02609503|593210848|FG000|Overall Study|Death|1|||
164229693|NCT02609503|593210848|FG000|Overall Study|Withdrawal by Subject|1|||
164229694|NCT02609503|593210848|FG000|Overall Study|Disease progression|1|||
164229695|NCT01969409|593210849|FG000|Overall Study|Death|2|||
164229696|NCT01969409|593210850|FG001|Overall Study|Death|2|||
164229697|NCT01969409|593210849|FG000|Overall Study|Transplant|1|||
164229698|NCT01969409|593210850|FG001|Overall Study|Transplant|1|||
164229699|NCT01969409|593210849|FG000|Overall Study|Withdrawal by Subject|0|||
164229700|NCT01969409|593210850|FG001|Overall Study|Withdrawal by Subject|1|||
164229701|NCT04642079|593210851|FG000|Overall Study|Lost to Follow-up|2|||
164229702|NCT04642079|593210852|FG001|Overall Study|Lost to Follow-up|5|||
164229703|NCT04642079|593210853|FG002|Overall Study|Lost to Follow-up|2|||
164229704|NCT04642079|593210854|FG003|Overall Study|Lost to Follow-up|0|||
164229705|NCT04642079|593210851|FG000|Overall Study|Withdrawal by Subject|0|||
164229706|NCT04642079|593210852|FG001|Overall Study|Withdrawal by Subject|4|||
164229707|NCT04642079|593210853|FG002|Overall Study|Withdrawal by Subject|1|||
164229708|NCT04642079|593210854|FG003|Overall Study|Withdrawal by Subject|2|||
164229709|NCT04642079|593210851|FG000|Overall Study|Other|0|||
164229710|NCT04642079|593210852|FG001|Overall Study|Other|0|||
164229711|NCT04642079|593210853|FG002|Overall Study|Other|0|||
164229712|NCT04642079|593210854|FG003|Overall Study|Other|1|||
164229713|NCT04642079|593210851|FG000|Overall Study|No longer met eligibility criteria|1|||
164229714|NCT04642079|593210852|FG001|Overall Study|No longer met eligibility criteria|0|||
164229715|NCT04642079|593210853|FG002|Overall Study|No longer met eligibility criteria|1|||
164229716|NCT04642079|593210854|FG003|Overall Study|No longer met eligibility criteria|1|||
164229717|NCT00759395|593210858|FG000|Overall Study|Adverse Event|1|||
164229718|NCT00759395|593210859|FG001|Overall Study|Adverse Event|0|||
164229719|NCT00759395|593210858|FG000|Overall Study|Withdrawal by Subject|1|||
164229720|NCT00759395|593210859|FG001|Overall Study|Withdrawal by Subject|0|||
164229721|NCT00759395|593210858|FG000|Overall Study|Lack of Efficacy|0|||
164229722|NCT00759395|593210859|FG001|Overall Study|Lack of Efficacy|2|||
164229723|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
164229724|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
164229725|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
164229726|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
164229727|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
164229728|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
164229729|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
164229730|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
164229731|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
164229732|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
164229733|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
164229734|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
164229735|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
164229736|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
164229737|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
164229738|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
164229739|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
164331622|NCT01638819|593591303|FG000|Overall Study|Lost to Follow-up|1|||
164229740|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
164229741|NCT00086515|593210860|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
164229742|NCT00086515|593210861|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
164229743|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
164229744|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
164229745|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
164229746|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
164229747|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
164229748|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
164229749|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
164229750|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
164229751|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
164331623|NCT01638819|593591304|FG001|Overall Study|Lost to Follow-up|0|||
164331624|NCT00923936|593591305|FG000|Overall Study|progressive disease on study|2|||
164331625|NCT00923936|593591306|FG001|Overall Study|progressive disease on study|1|||
164331626|NCT00923936|593591305|FG000|Overall Study|Adverse Event|2|||
164331627|NCT00923936|593591306|FG001|Overall Study|Adverse Event|1|||
164331628|NCT00923936|593591305|FG000|Overall Study|Lost to follow up|2|||
164331629|NCT00923936|593591306|FG001|Overall Study|Lost to follow up|0|||
164331630|NCT00923936|593591305|FG000|Overall Study|Continuing in follow up period|2|||
164331631|NCT00923936|593591306|FG001|Overall Study|Continuing in follow up period|1|||
164331632|NCT04263454|593591307|FG000|Overall Study|Adverse Event|0|||
164331633|NCT04263454|593591308|FG001|Overall Study|Adverse Event|2|||
164331634|NCT04263454|593591307|FG000|Overall Study|Physician Decision|3|||
164331635|NCT04263454|593591308|FG001|Overall Study|Physician Decision|5|||
164331636|NCT04263454|593591307|FG000|Overall Study|Poor Data Quality|0|||
164331637|NCT04263454|593591308|FG001|Overall Study|Poor Data Quality|1|||
164331638|NCT01231347|593591309|FG000|Overall Study|Full Consent withdrawn|19|||
164331639|NCT01231347|593591310|FG001|Overall Study|Full Consent withdrawn|19|||
164331640|NCT01231347|593591311|FG002|Overall Study|Full Consent withdrawn|11|||
164331641|NCT01231347|593591309|FG000|Overall Study|Lost to Follow-up|4|||
164331642|NCT01231347|593591310|FG001|Overall Study|Lost to Follow-up|2|||
164331643|NCT01231347|593591311|FG002|Overall Study|Lost to Follow-up|2|||
164331644|NCT01231347|593591309|FG000|Overall Study|Death|202|||
164331645|NCT01231347|593591310|FG001|Overall Study|Death|210|||
164331646|NCT01231347|593591311|FG002|Overall Study|Death|101|||
164331647|NCT01231347|593591309|FG000|Overall Study|other event|7|||
164331648|NCT01231347|593591310|FG001|Overall Study|other event|9|||
164331649|NCT01231347|593591311|FG002|Overall Study|other event|3|||
164331650|NCT01460368|593591312|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331651|NCT01460368|593591313|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331652|NCT01460368|593591314|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331653|NCT01460368|593591315|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331654|NCT01460368|593591316|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
164331655|NCT01460368|593591317|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331656|NCT01460368|593591318|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
164331657|NCT01460368|593591312|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331658|NCT01460368|593591313|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
164331659|NCT01460368|593591314|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331660|NCT01460368|593591315|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331661|NCT01460368|593591316|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331662|NCT01460368|593591317|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
164331663|NCT01460368|593591318|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
164331664|NCT01460368|593591312|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331665|NCT01460368|593591313|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
164331666|NCT01460368|593591314|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331667|NCT01460368|593591315|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331668|NCT01460368|593591316|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331669|NCT01460368|593591317|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331670|NCT01460368|593591318|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
164331671|NCT01460368|593591312|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331672|NCT01460368|593591313|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331673|NCT01460368|593591314|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
164331674|NCT01460368|593591315|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331675|NCT01460368|593591316|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331676|NCT01460368|593591317|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164331677|NCT01460368|593591318|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
164229752|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
164331678|NCT01460368|593591312|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164229753|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
164229754|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
164229755|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
164229756|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
164229757|NCT00086515|593210860|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
164229758|NCT00086515|593210861|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
163883046|NCT02783300|591942072|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883047|NCT02783300|591942073|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883048|NCT02783300|591942074|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
163883049|NCT02783300|591942075|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883050|NCT02783300|591942076|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883051|NCT02783300|591942077|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883052|NCT02783300|591942078|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
163883053|NCT02783300|591942052|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883054|NCT02783300|591942053|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883055|NCT02783300|591942054|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883056|NCT02783300|591942055|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883057|NCT02783300|591942056|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883058|NCT02783300|591942057|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883059|NCT02783300|591942058|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883060|NCT02783300|591942059|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883061|NCT02783300|591942060|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883062|NCT02783300|591942061|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883063|NCT02783300|591942062|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883064|NCT02783300|591942063|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883065|NCT02783300|591942064|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883066|NCT02783300|591942065|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
164229759|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
163883067|NCT02783300|591942066|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
163883068|NCT02783300|591942067|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
163883069|NCT02783300|591942068|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
163883070|NCT02783300|591942069|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883071|NCT02783300|591942070|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
163883072|NCT02783300|591942071|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
163883073|NCT02783300|591942072|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883074|NCT02783300|591942073|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883075|NCT02783300|591942074|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883076|NCT02783300|591942075|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883077|NCT02783300|591942076|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883078|NCT02783300|591942077|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883079|NCT02783300|591942078|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
163883080|NCT02783300|591942052|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883081|NCT02783300|591942053|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164229760|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
164229761|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
164229762|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
164229763|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
164229764|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
164229765|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
164229766|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
164229767|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
164229768|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
164229769|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
164229770|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
164229771|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
164229772|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
164229773|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
164229774|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
164229775|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
164229776|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
164229777|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
164229778|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
164229779|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
163883082|NCT02783300|591942054|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883083|NCT02783300|591942055|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883084|NCT02783300|591942056|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883085|NCT02783300|591942057|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883086|NCT02783300|591942058|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883087|NCT02783300|591942059|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
164229780|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
164229781|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
164229782|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
164229783|NCT00086515|593210860|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
164229784|NCT00086515|593210861|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
164229785|NCT02420314|593210865|FG000|Overall Study|Withdrawal by Subject|1|||
164229786|NCT02420314|593210865|FG000|Overall Study|Protocol Violation|1|||
164229787|NCT02251041|593210866|FG000|Overall Study|Did not receive intervention|15|||
164229788|NCT02251041|593210867|FG001|Overall Study|Did not receive intervention|4|||
164229789|NCT01618708|593210870|FG000|Overall Study|Adverse Event|10|||
164229790|NCT01618708|593210871|FG001|Overall Study|Adverse Event|10|||
164229791|NCT01618708|593210870|FG000|Overall Study|Lost to Follow-up|3|||
164229792|NCT01618708|593210871|FG001|Overall Study|Lost to Follow-up|3|||
164229793|NCT01618708|593210870|FG000|Overall Study|Withdrawal by Subject|17|||
163883088|NCT02783300|591942060|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883089|NCT02783300|591942061|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883090|NCT02783300|591942062|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883091|NCT02783300|591942063|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883092|NCT02783300|591942064|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883093|NCT02783300|591942065|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
164229794|NCT01618708|593210871|FG001|Overall Study|Withdrawal by Subject|22|||
164229795|NCT01618708|593210870|FG000|Overall Study|Lack of Efficacy|8|||
164229796|NCT01618708|593210871|FG001|Overall Study|Lack of Efficacy|8|||
164229797|NCT01618708|593210870|FG000|Overall Study|Technical problems|2|||
164229798|NCT01618708|593210871|FG001|Overall Study|Technical problems|0|||
164229799|NCT01618708|593210870|FG000|Overall Study|Other than specified above|1|||
164229800|NCT01618708|593210871|FG001|Overall Study|Other than specified above|1|||
164229801|NCT01618708|593210870|FG000|Overall Study|Randomized but not treated|3|||
163883094|NCT02783300|591942066|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163883095|NCT02783300|591942067|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163883096|NCT02783300|591942068|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164229802|NCT01618708|593210871|FG001|Overall Study|Randomized but not treated|2|||
164229803|NCT00680914|593210874|FG000|Overall Study|Consent withdrawal|6|||
164229804|NCT00680914|593210875|FG001|Overall Study|Consent withdrawal|3|||
164229805|NCT00680914|593210874|FG000|Overall Study|Lost to Follow-up|4|||
164229806|NCT00680914|593210875|FG001|Overall Study|Lost to Follow-up|0|||
164229807|NCT00680914|593210874|FG000|Overall Study|serious adverse event (SAE)|0|||
164229808|NCT00680914|593210875|FG001|Overall Study|serious adverse event (SAE)|1|||
164229809|NCT01848457|593210876|FG000|Overall Study|Death|1|||
164229810|NCT01848457|593210877|FG001|Overall Study|Death|0|||
164229811|NCT01848457|593210878|FG002|Overall Study|Death|0|||
164229812|NCT01848457|593210879|FG003|Overall Study|Death|0|||
164229813|NCT03131479|593210880|FG000|Overall Study|Adverse Event|0|||
164229814|NCT03131479|593210881|FG001|Overall Study|Adverse Event|0|||
163883097|NCT02783300|591942069|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163883098|NCT02783300|591942070|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
163883099|NCT02783300|591942071|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
163883100|NCT02783300|591942072|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163883101|NCT02783300|591942073|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
163883102|NCT02783300|591942074|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
163883103|NCT02783300|591942075|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
164229815|NCT03131479|593210882|FG002|Overall Study|Adverse Event|1|||
164229816|NCT03131479|593210883|FG003|Overall Study|Adverse Event|1|||
163883104|NCT02783300|591942076|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
164229817|NCT03131479|593210884|FG004|Overall Study|Adverse Event|0|||
164229818|NCT03131479|593210880|FG000|Overall Study|Subject/Guardian Decision|0|||
164229819|NCT03131479|593210881|FG001|Overall Study|Subject/Guardian Decision|0|||
164229820|NCT03131479|593210882|FG002|Overall Study|Subject/Guardian Decision|0|||
164229821|NCT03131479|593210883|FG003|Overall Study|Subject/Guardian Decision|1|||
164229822|NCT03131479|593210884|FG004|Overall Study|Subject/Guardian Decision|0|||
164229823|NCT04439903|593210885|FG000|Overall Study|Withdrawal by Subject|2|||
164229824|NCT04439903|593210885|FG000|Overall Study|Screen Failure|1|||
164229825|NCT02181413|593210887|FG000|Overall Study|Withdrawal by Subject|45|||
164229826|NCT02181413|593210888|FG001|Overall Study|Withdrawal by Subject|61|||
164229827|NCT02181413|593210887|FG000|Overall Study|Reason Not Specified|2|||
164229828|NCT02181413|593210888|FG001|Overall Study|Reason Not Specified|5|||
164229829|NCT02181413|593210887|FG000|Overall Study|Lost to Follow-up|8|||
164229830|NCT02181413|593210888|FG001|Overall Study|Lost to Follow-up|7|||
164229831|NCT02298946|593210890|FG000|Overall Study|Did not receive treatment|2|||
164229832|NCT02298946|593210891|FG001|Overall Study|Did not receive treatment|0|||
164229833|NCT02298946|593210890|FG000|Overall Study|Unevaluable|2|||
164229834|NCT02298946|593210891|FG001|Overall Study|Unevaluable|1|||
164229835|NCT00050011|593210892|FG000|Overall Study|Adverse Event|41|||
164229836|NCT00050011|593210893|FG001|Overall Study|Adverse Event|46|||
164229837|NCT00050011|593210892|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164229838|NCT00050011|593210893|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164229839|NCT00050011|593210892|FG000|Overall Study|Abnormal test procedure results|0|||
164229840|NCT00050011|593210893|FG001|Overall Study|Abnormal test procedure results|1|||
164229841|NCT00050011|593210892|FG000|Overall Study|Lack of Efficacy|16|||
164229842|NCT00050011|593210893|FG001|Overall Study|Lack of Efficacy|21|||
164229843|NCT00050011|593210892|FG000|Overall Study|Participant condition no longer required|1|||
164229844|NCT00050011|593210893|FG001|Overall Study|Participant condition no longer required|0|||
164229845|NCT00050011|593210892|FG000|Overall Study|Protocol Violation|4|||
164229846|NCT00050011|593210893|FG001|Overall Study|Protocol Violation|10|||
164229847|NCT00050011|593210892|FG000|Overall Study|Withdrawal by Subject|34|||
164229848|NCT00050011|593210893|FG001|Overall Study|Withdrawal by Subject|26|||
164229849|NCT00050011|593210892|FG000|Overall Study|Lost to Follow-up|7|||
164229850|NCT00050011|593210893|FG001|Overall Study|Lost to Follow-up|9|||
164229851|NCT00050011|593210892|FG000|Overall Study|Administrative problems|10|||
164229852|NCT00050011|593210893|FG001|Overall Study|Administrative problems|6|||
164229853|NCT00050011|593210892|FG000|Overall Study|Death|7|||
164229854|NCT00050011|593210893|FG001|Overall Study|Death|4|||
164229855|NCT00050011|593210892|FG000|Overall Study|Unknown - Reason is missing|0|||
164229856|NCT00050011|593210893|FG001|Overall Study|Unknown - Reason is missing|2|||
164229857|NCT03034044|593210894|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
164229858|NCT02412436|593210895|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
164229859|NCT02412436|593210895|FG000|Overall Study|Lost to Follow-up|6|||
164229860|NCT02412436|593210895|FG000|Overall Study|Unable to get to clinic|3|||
164229861|NCT02412436|593210895|FG000|Overall Study|Death|1|||
164229862|NCT02412436|593210895|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
164229863|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
164229864|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229865|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229866|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229867|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164229868|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
164229869|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229870|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229871|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229872|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164229873|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
164229874|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229875|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229876|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229877|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164229878|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
164331679|NCT01460368|593591313|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164331680|NCT01460368|593591314|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
163883105|NCT02783300|591942077|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
163883106|NCT02783300|591942078|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
163883107|NCT02783300|591942052|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164229879|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229880|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229881|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229882|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
164229883|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
164229884|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229885|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229886|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229887|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
164229888|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
164229889|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229890|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229891|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229892|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
164229893|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
164229894|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229895|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229896|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229897|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164229898|NCT01111552|593210896|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
164229899|NCT01111552|593210897|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229900|NCT01111552|593210898|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229901|NCT01111552|593210899|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229902|NCT01111552|593210900|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
164229903|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229904|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229905|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229906|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
164229907|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164229908|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
164229909|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164229910|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
164229911|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
164229912|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164229913|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229914|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
164229915|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229916|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229917|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
164229918|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229919|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
164229920|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229921|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229922|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
164229923|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229924|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
164229925|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229926|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229927|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
164229928|NCT01111552|593210896|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229929|NCT01111552|593210897|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229930|NCT01111552|593210898|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
164229931|NCT01111552|593210899|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229932|NCT01111552|593210900|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164229933|NCT02679274|593210904|FG000|Overall Study|Withdrawal by Subject|1|||
164229934|NCT02679274|593210905|FG001|Overall Study|Withdrawal by Subject|0|||
164229935|NCT03514134|593212606|FG000|Overall Study|Lost to Follow-up|0|||
164229936|NCT03514134|593212607|FG001|Overall Study|Lost to Follow-up|1|||
164229937|NCT00462826|593212610|FG000|Overall Study|Ineligible - second primary|1|||
164229938|NCT00462826|593212610|FG000|Overall Study|Ineligible - wrong cell type|1|||
164229939|NCT00462826|593212610|FG000|Overall Study|Ineligible - wrong primary|2|||
164229940|NCT00462826|593212610|FG000|Overall Study|Never treated|1|||
164229941|NCT04976777|593212611|FG000|Overall Study|COVID-19 Infection|1|||
164229942|NCT04976777|593212612|FG001|Overall Study|COVID-19 Infection|0|||
164229943|NCT05654181|593212613|FG000|Overall Study|Adverse Event|1|||
164331681|NCT01460368|593591315|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
164331682|NCT01460368|593591316|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164331683|NCT01460368|593591317|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
164331684|NCT01460368|593591318|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
164331685|NCT02047227|593591319|FG000|Overall Study|Adverse Event|2|||
164331686|NCT02047227|593591320|FG001|Overall Study|Adverse Event|4|||
164229944|NCT05654181|593212614|FG001|Overall Study|Adverse Event|0|||
164229945|NCT05654181|593212615|FG002|Overall Study|Adverse Event|0|||
164229946|NCT05654181|593212616|FG003|Overall Study|Adverse Event|0|||
164229947|NCT05654181|593212617|FG004|Overall Study|Adverse Event|0|||
164229948|NCT05654181|593212618|FG005|Overall Study|Adverse Event|0|||
164229949|NCT05654181|593212619|FG006|Overall Study|Adverse Event|0|||
164229950|NCT05654181|593212620|FG007|Overall Study|Adverse Event|1|||
164229951|NCT05654181|593212621|FG008|Overall Study|Adverse Event|0|||
164229952|NCT05654181|593212622|FG009|Overall Study|Adverse Event|0|||
164229953|NCT05654181|593212613|FG000|Overall Study|Withdrawal by Subject|0|||
164229954|NCT05654181|593212614|FG001|Overall Study|Withdrawal by Subject|0|||
164229955|NCT05654181|593212615|FG002|Overall Study|Withdrawal by Subject|0|||
164229956|NCT05654181|593212616|FG003|Overall Study|Withdrawal by Subject|0|||
164229957|NCT05654181|593212617|FG004|Overall Study|Withdrawal by Subject|0|||
164229958|NCT05654181|593212618|FG005|Overall Study|Withdrawal by Subject|0|||
164229959|NCT05654181|593212619|FG006|Overall Study|Withdrawal by Subject|0|||
164229960|NCT05654181|593212620|FG007|Overall Study|Withdrawal by Subject|1|||
164229961|NCT05654181|593212621|FG008|Overall Study|Withdrawal by Subject|0|||
164229962|NCT05654181|593212622|FG009|Overall Study|Withdrawal by Subject|0|||
164229963|NCT05654181|593212613|FG000|Overall Study|Other|0|||
164229964|NCT05654181|593212614|FG001|Overall Study|Other|0|||
164229965|NCT05654181|593212615|FG002|Overall Study|Other|0|||
163883108|NCT02783300|591942053|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883109|NCT02783300|591942054|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883110|NCT02783300|591942055|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883111|NCT02783300|591942056|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883112|NCT02783300|591942057|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883113|NCT02783300|591942058|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883114|NCT02783300|591942059|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883115|NCT02783300|591942060|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883116|NCT02783300|591942061|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883117|NCT02783300|591942062|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883118|NCT02783300|591942063|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883119|NCT02783300|591942064|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883120|NCT02783300|591942065|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883121|NCT02783300|591942066|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883122|NCT02783300|591942067|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883123|NCT02783300|591942068|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883124|NCT02783300|591942069|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883125|NCT02783300|591942070|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883126|NCT02783300|591942071|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883127|NCT02783300|591942072|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883128|NCT02783300|591942073|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
164229966|NCT05654181|593212616|FG003|Overall Study|Other|0|||
164229967|NCT05654181|593212617|FG004|Overall Study|Other|1|||
164229968|NCT05654181|593212618|FG005|Overall Study|Other|1|||
164229969|NCT05654181|593212619|FG006|Overall Study|Other|0|||
164229970|NCT05654181|593212620|FG007|Overall Study|Other|0|||
164229971|NCT05654181|593212621|FG008|Overall Study|Other|0|||
164229972|NCT05654181|593212622|FG009|Overall Study|Other|0|||
164229973|NCT01397253|593212623|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
164229974|NCT01397253|593212624|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
164229975|NCT03033784|593212630|FG000|Overall Study|Anxiety related to MRI scanner|0|||
164229976|NCT03033784|593212631|FG001|Overall Study|Anxiety related to MRI scanner|1|||
164229977|NCT03033784|593212632|FG002|Overall Study|Anxiety related to MRI scanner|0|||
164229978|NCT03033784|593212633|FG003|Overall Study|Anxiety related to MRI scanner|0|||
164229979|NCT03033784|593212634|FG004|Overall Study|Anxiety related to MRI scanner|0|||
164229980|NCT03033784|593212635|FG005|Overall Study|Anxiety related to MRI scanner|0|||
164229981|NCT03033784|593212636|FG006|Overall Study|Anxiety related to MRI scanner|0|||
164229982|NCT03033784|593212637|FG007|Overall Study|Anxiety related to MRI scanner|0|||
164229983|NCT03033784|593212638|FG008|Overall Study|Anxiety related to MRI scanner|0|||
164229984|NCT03033784|593212639|FG009|Overall Study|Anxiety related to MRI scanner|0|||
164229985|NCT03033784|593212640|FG010|Overall Study|Anxiety related to MRI scanner|0|||
164229986|NCT03033784|593212641|FG011|Overall Study|Anxiety related to MRI scanner|0|||
164229987|NCT03033784|593212642|FG012|Overall Study|Anxiety related to MRI scanner|0|||
164229988|NCT03033784|593212630|FG000|Overall Study|Withdrawal by Subject|0|||
163883129|NCT02783300|591942074|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883130|NCT02783300|591942075|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883131|NCT02783300|591942076|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883132|NCT02783300|591942077|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
163883133|NCT02783300|591942078|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
163883134|NCT02783300|591942052|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
164229989|NCT03033784|593212631|FG001|Overall Study|Withdrawal by Subject|0|||
164229990|NCT03033784|593212632|FG002|Overall Study|Withdrawal by Subject|0|||
164229991|NCT03033784|593212633|FG003|Overall Study|Withdrawal by Subject|0|||
164229992|NCT03033784|593212634|FG004|Overall Study|Withdrawal by Subject|0|||
164229993|NCT03033784|593212635|FG005|Overall Study|Withdrawal by Subject|0|||
164229994|NCT03033784|593212636|FG006|Overall Study|Withdrawal by Subject|0|||
164229995|NCT03033784|593212637|FG007|Overall Study|Withdrawal by Subject|0|||
164229996|NCT03033784|593212638|FG008|Overall Study|Withdrawal by Subject|0|||
164229997|NCT03033784|593212639|FG009|Overall Study|Withdrawal by Subject|0|||
164229998|NCT03033784|593212640|FG010|Overall Study|Withdrawal by Subject|0|||
164229999|NCT03033784|593212641|FG011|Overall Study|Withdrawal by Subject|0|||
164230000|NCT03033784|593212642|FG012|Overall Study|Withdrawal by Subject|2|||
164230001|NCT00267488|593212643|FG000|Overall Study|Sponsor Terminated Study|9|||
164230002|NCT00267488|593212643|FG000|Overall Study|Protocol Violation|1|||
164230003|NCT00267488|593212643|FG000|Overall Study|Other (Disease Progression)|1|||
164230004|NCT02093520|593212644|FG000|Overall Study|Not treated|6|||
164230005|NCT02093520|593212645|FG001|Overall Study|Not treated|22|||
164230006|NCT00851084|593212646|FG000|Overall Study|Randomized but not treated|1|||
164230007|NCT00851084|593212647|FG001|Overall Study|Randomized but not treated|0|||
164230008|NCT00851084|593212646|FG000|Overall Study|Adverse Event|26|||
164230009|NCT00851084|593212647|FG001|Overall Study|Adverse Event|36|||
164230010|NCT00851084|593212646|FG000|Overall Study|Disease progression|52|||
164230011|NCT00851084|593212647|FG001|Overall Study|Disease progression|47|||
164230012|NCT00851084|593212646|FG000|Overall Study|Poor compliance to protocol|1|||
164230013|NCT00851084|593212647|FG001|Overall Study|Poor compliance to protocol|1|||
164230014|NCT00851084|593212646|FG000|Overall Study|Physician Decision|13|||
164230015|NCT00851084|593212647|FG001|Overall Study|Physician Decision|14|||
164230016|NCT00851084|593212646|FG000|Overall Study|Consent withdrawn|0|||
164230017|NCT00851084|593212647|FG001|Overall Study|Consent withdrawn|2|||
164230018|NCT00851084|593212646|FG000|Overall Study|Withdrawal by Subject|11|||
164230019|NCT00851084|593212647|FG001|Overall Study|Withdrawal by Subject|12|||
164230020|NCT00851084|593212646|FG000|Overall Study|Metastatic surgery|6|||
164230021|NCT00851084|593212647|FG001|Overall Study|Metastatic surgery|6|||
164230022|NCT00851084|593212646|FG000|Overall Study|Other|7|||
164230023|NCT00851084|593212647|FG001|Overall Study|Other|1|||
164230024|NCT01892189|593212650|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
164230025|NCT01892189|593212651|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
164230026|NCT01892189|593212652|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
164230027|NCT01892189|593212653|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
164230028|NCT01892189|593212654|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
164230029|NCT01892189|593212655|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
164230030|NCT01892189|593212656|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
164230031|NCT01892189|593212657|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
164230032|NCT01892189|593212658|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
164331687|NCT02047227|593591319|FG000|Overall Study|Lost to Follow-up|0|||
164331688|NCT02047227|593591320|FG001|Overall Study|Lost to Follow-up|3|||
164331689|NCT02047227|593591319|FG000|Overall Study|Protocol Violation|1|||
164331690|NCT02047227|593591320|FG001|Overall Study|Protocol Violation|0|||
164331691|NCT02047227|593591319|FG000|Overall Study|Spontaneous pregnancy|1|||
164331692|NCT02047227|593591320|FG001|Overall Study|Spontaneous pregnancy|0|||
164331693|NCT02047227|593591319|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
164331694|NCT02047227|593591320|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
164331695|NCT02047227|593591319|FG000|Overall Study|No oocytes retrieved|21|||
164331696|NCT02047227|593591320|FG001|Overall Study|No oocytes retrieved|20|||
164331697|NCT02047227|593591319|FG000|Overall Study|No fertilization|61|||
164331698|NCT02047227|593591320|FG001|Overall Study|No fertilization|51|||
164331699|NCT02047227|593591319|FG000|Overall Study|Intention to freeze all embryos|1|||
164331700|NCT02047227|593591320|FG001|Overall Study|Intention to freeze all embryos|0|||
164331701|NCT02047227|593591319|FG000|Overall Study|All embryos discarded|12|||
164331702|NCT02047227|593591320|FG001|Overall Study|All embryos discarded|11|||
164230033|NCT01892189|593212650|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230034|NCT01892189|593212651|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230035|NCT01892189|593212652|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
164230036|NCT01892189|593212653|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164230037|NCT01892189|593212654|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230038|NCT01892189|593212655|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164331703|NCT02047227|593591319|FG000|Overall Study|Other|10|||
164331704|NCT02047227|593591320|FG001|Overall Study|Other|9|||
164331705|NCT01385371|593591333|FG000|Overall Study|Adverse Event|54|||
164331706|NCT01385371|593591334|FG001|Overall Study|Adverse Event|19|||
164230039|NCT01892189|593212656|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164230040|NCT01892189|593212657|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164230041|NCT01892189|593212658|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164230042|NCT01892189|593212650|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230043|NCT01892189|593212651|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230044|NCT01892189|593212652|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230045|NCT01892189|593212653|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230046|NCT01892189|593212654|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230047|NCT01892189|593212655|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
164230048|NCT01892189|593212656|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230049|NCT01892189|593212657|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230050|NCT01892189|593212658|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
164230051|NCT02263547|593212661|FG000|Overall Study|Adverse Event|1|||
164230052|NCT02263547|593212661|FG000|Overall Study|Lost to Follow-up|2|||
164230053|NCT00856557|593212662|FG000|Overall Study|No patients with contextual flags|12|||
164230054|NCT00856557|593212663|FG001|Overall Study|No patients with contextual flags|16|||
164230055|NCT02301897|593212664|FG000|Treatment Course 1|Non-Compliance|0|||
164230056|NCT02301897|593212665|FG001|Treatment Course 1|Non-Compliance|0|||
164230057|NCT02301897|593212666|FG002|Treatment Course 1|Non-Compliance|1|||
164230058|NCT02301897|593212664|FG000|Treatment Course 1|Adverse Event|1|||
164230059|NCT02301897|593212665|FG001|Treatment Course 1|Adverse Event|1|||
164230060|NCT02301897|593212666|FG002|Treatment Course 1|Adverse Event|0|||
164230061|NCT02301897|593212664|FG000|Treatment Course 1|Lost to Follow-up|1|||
164230062|NCT02301897|593212665|FG001|Treatment Course 1|Lost to Follow-up|2|||
164230063|NCT02301897|593212666|FG002|Treatment Course 1|Lost to Follow-up|1|||
164230064|NCT02301897|593212664|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
164230065|NCT02301897|593212665|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
164230066|NCT02301897|593212666|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
164230067|NCT02301897|593212664|FG000|Treatment Course 1|Withdrawal by Subject|0|||
164230068|NCT02301897|593212665|FG001|Treatment Course 1|Withdrawal by Subject|0|||
164230069|NCT02301897|593212666|FG002|Treatment Course 1|Withdrawal by Subject|2|||
164230070|NCT02301897|593212664|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
163987066|NCT00441545|592320272|FG001|Second Intervention|Protocol Violation|1|||
163987067|NCT00441545|592320271|FG000|Second Intervention|Withdrawal by Subject|1|||
163987068|NCT00441545|592320272|FG001|Second Intervention|Withdrawal by Subject|1|||
164230071|NCT02301897|593212665|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
164230072|NCT02301897|593212666|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
164230073|NCT02301897|593212664|FG000|Treatment Course 2|Lost to Follow-up|0|||
164230074|NCT02301897|593212665|FG001|Treatment Course 2|Lost to Follow-up|2|||
164230075|NCT02301897|593212666|FG002|Treatment Course 2|Lost to Follow-up|0|||
164230076|NCT02301897|593212664|FG000|Treatment Course 2|Pregnancy|0|||
164230077|NCT02301897|593212665|FG001|Treatment Course 2|Pregnancy|1|||
164230078|NCT02301897|593212666|FG002|Treatment Course 2|Pregnancy|1|||
164230079|NCT02301897|593212664|FG000|Treatment Course 2|Withdrawal by Subject|0|||
164230080|NCT02301897|593212665|FG001|Treatment Course 2|Withdrawal by Subject|2|||
164230081|NCT02301897|593212666|FG002|Treatment Course 2|Withdrawal by Subject|0|||
164230082|NCT02301897|593212664|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
164230083|NCT02301897|593212665|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
164230084|NCT02301897|593212666|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
164230085|NCT00337168|593212667|FG000|Overall Study|Death|5|||
164230086|NCT00337168|593212667|FG000|Overall Study|Not protocol specified|2|||
164230087|NCT00337168|593212667|FG000|Overall Study|Did not start therapy|1|||
164230088|NCT02684461|593212670|FG000|Overall Study|Adverse Event|1|||
164230089|NCT02684461|593212671|FG001|Overall Study|Adverse Event|0|||
164230090|NCT02684461|593212672|FG002|Overall Study|Adverse Event|0|||
164230091|NCT02684461|593212670|FG000|Overall Study|Lack of Efficacy|1|||
164230092|NCT02684461|593212671|FG001|Overall Study|Lack of Efficacy|2|||
164230093|NCT02684461|593212672|FG002|Overall Study|Lack of Efficacy|0|||
164230094|NCT03663582|593212673|FG000|Overall Study|Physician Decision|1|||
164230095|NCT00557440|593212685|FG000|Treatment Period 1|Adverse Event|0|||
164230096|NCT00557440|593212686|FG001|Treatment Period 1|Adverse Event|0|||
164230097|NCT00557440|593212687|FG002|Treatment Period 1|Adverse Event|1|||
164230098|NCT00814983|593212688|FG000|Overall Study|Screen failure|1|||
164230099|NCT00814983|593212689|FG001|Overall Study|Screen failure|0|||
164230100|NCT00814983|593212688|FG000|Overall Study|Withdrawal by Subject|1|||
164230101|NCT00814983|593212689|FG001|Overall Study|Withdrawal by Subject|0|||
164230102|NCT00814983|593212688|FG000|Overall Study|Graft failure|1|||
164230103|NCT00814983|593212689|FG001|Overall Study|Graft failure|0|||
164230104|NCT04507763|593212690|FG000|Overall Study|Participants did not meet entrance criteria|201|||
164230105|NCT06582732|593212691|FG000|Initial Study Period|Adverse Event|0|||
164230106|NCT06582732|593212692|FG001|Initial Study Period|Adverse Event|0|||
164230107|NCT06582732|593212693|FG002|Initial Study Period|Adverse Event|0|||
164230108|NCT06582732|593212694|FG003|Initial Study Period|Adverse Event|2|||
164230109|NCT06582732|593212695|FG004|Initial Study Period|Adverse Event|0|||
164230110|NCT06582732|593212696|FG005|Initial Study Period|Adverse Event|0|||
164230111|NCT06582732|593212697|FG006|Initial Study Period|Adverse Event|0|||
164230112|NCT06582732|593212691|FG000|Initial Study Period|Death|1|||
164230113|NCT06582732|593212692|FG001|Initial Study Period|Death|0|||
164230114|NCT06582732|593212693|FG002|Initial Study Period|Death|0|||
164230115|NCT06582732|593212694|FG003|Initial Study Period|Death|0|||
164230116|NCT06582732|593212695|FG004|Initial Study Period|Death|1|||
164230117|NCT06582732|593212696|FG005|Initial Study Period|Death|0|||
164230118|NCT06582732|593212697|FG006|Initial Study Period|Death|0|||
164230119|NCT06582732|593212691|FG000|Initial Study Period|Lost to Follow-up|0|||
164230120|NCT06582732|593212692|FG001|Initial Study Period|Lost to Follow-up|0|||
164230121|NCT06582732|593212693|FG002|Initial Study Period|Lost to Follow-up|2|||
164230122|NCT06582732|593212694|FG003|Initial Study Period|Lost to Follow-up|0|||
164230123|NCT06582732|593212695|FG004|Initial Study Period|Lost to Follow-up|0|||
164230124|NCT06582732|593212696|FG005|Initial Study Period|Lost to Follow-up|0|||
164230125|NCT06582732|593212697|FG006|Initial Study Period|Lost to Follow-up|0|||
164230126|NCT06582732|593212691|FG000|Initial Study Period|Withdrawal by Subject|0|||
164230127|NCT06582732|593212692|FG001|Initial Study Period|Withdrawal by Subject|1|||
164230128|NCT06582732|593212693|FG002|Initial Study Period|Withdrawal by Subject|0|||
164230129|NCT06582732|593212694|FG003|Initial Study Period|Withdrawal by Subject|1|||
164230130|NCT06582732|593212695|FG004|Initial Study Period|Withdrawal by Subject|3|||
164230131|NCT06582732|593212696|FG005|Initial Study Period|Withdrawal by Subject|1|||
164230132|NCT06582732|593212697|FG006|Initial Study Period|Withdrawal by Subject|2|||
164230133|NCT06582732|593212691|FG000|Initial Study Period|Moved Away|0|||
164230134|NCT06582732|593212692|FG001|Initial Study Period|Moved Away|0|||
164230135|NCT06582732|593212693|FG002|Initial Study Period|Moved Away|0|||
164230136|NCT06582732|593212694|FG003|Initial Study Period|Moved Away|0|||
164230137|NCT06582732|593212695|FG004|Initial Study Period|Moved Away|1|||
164230138|NCT06582732|593212696|FG005|Initial Study Period|Moved Away|0|||
164230139|NCT06582732|593212697|FG006|Initial Study Period|Moved Away|0|||
164230140|NCT03931330|593212698|FG000|Overall Study|Physician Decision|1|||
164230141|NCT03412929|593212699|FG000|Overall Study|Protocol Violation|3|||
164230142|NCT01381679|593212704|FG000|Overall Study|Adverse Event|3|||
164230143|NCT01381679|593212704|FG000|Overall Study|Lost to Follow-up|885|||
164230144|NCT01674062|593212705|FG000|Overall Study|Insufficient Therapeutic Response|56|||
164230145|NCT01674062|593212706|FG001|Overall Study|Insufficient Therapeutic Response|26|||
164230146|NCT01674062|593212705|FG000|Overall Study|Other|8|||
164230147|NCT01674062|593212706|FG001|Overall Study|Other|1|||
164230148|NCT01674062|593212705|FG000|Overall Study|Adverse Event|1|||
164230149|NCT01674062|593212706|FG001|Overall Study|Adverse Event|1|||
164230150|NCT01674062|593212705|FG000|Overall Study|Death|0|||
164230151|NCT01674062|593212706|FG001|Overall Study|Death|1|||
164230152|NCT01674062|593212705|FG000|Overall Study|Programming Error|1|||
164230153|NCT01674062|593212706|FG001|Overall Study|Programming Error|0|||
164230154|NCT04661839|593212707|FG000|Overall Study|Not Treated|0|||
164230155|NCT04661839|593212708|FG001|Overall Study|Not Treated|0|||
164230156|NCT04661839|593212709|FG002|Overall Study|Not Treated|1|||
164230157|NCT04661839|593212710|FG003|Overall Study|Not Treated|0|||
164230158|NCT04661839|593212707|FG000|Overall Study|Lost to Follow-up|1|||
164230159|NCT04661839|593212708|FG001|Overall Study|Lost to Follow-up|0|||
164230160|NCT04661839|593212709|FG002|Overall Study|Lost to Follow-up|0|||
164230161|NCT04661839|593212710|FG003|Overall Study|Lost to Follow-up|1|||
164230162|NCT03895372|593212711|FG000|Investigational Treatment Period|Adverse Event|1|||
164230163|NCT03895372|593212712|FG001|Investigational Treatment Period|Adverse Event|0|||
164230164|NCT03895372|593212713|FG002|Investigational Treatment Period|Adverse Event|0|||
164230165|NCT03895372|593212714|FG003|Investigational Treatment Period|Adverse Event|0|||
164230166|NCT03895372|593212715|FG004|Investigational Treatment Period|Adverse Event|0|||
164230167|NCT03895372|593212716|FG005|Investigational Treatment Period|Adverse Event|0|||
164230168|NCT03895372|593212717|FG006|Investigational Treatment Period|Adverse Event|4|||
164230169|NCT03895372|593212718|FG007|Investigational Treatment Period|Adverse Event|3|||
164230170|NCT03895372|593212711|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
164230171|NCT03895372|593212712|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
164230172|NCT03895372|593212713|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
164230173|NCT03895372|593212714|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
164230174|NCT03895372|593212715|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
164230175|NCT03895372|593212716|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
164230176|NCT03895372|593212717|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
164230177|NCT03895372|593212718|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
164230178|NCT03895372|593212711|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
164230179|NCT03895372|593212712|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
164230180|NCT03895372|593212713|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
164230181|NCT03895372|593212714|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
164230182|NCT03895372|593212715|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
164230183|NCT03895372|593212716|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
164230184|NCT03895372|593212717|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
164230185|NCT03895372|593212718|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
164230186|NCT03895372|593212711|FG000|Investigational Treatment Period|Other|0|||
164230187|NCT03895372|593212712|FG001|Investigational Treatment Period|Other|0|||
164230188|NCT03895372|593212713|FG002|Investigational Treatment Period|Other|0|||
164230189|NCT03895372|593212714|FG003|Investigational Treatment Period|Other|0|||
164331707|NCT01385371|593591333|FG000|Overall Study|Lost to Follow-up|16|||
164331708|NCT01385371|593591334|FG001|Overall Study|Lost to Follow-up|16|||
164331709|NCT01385371|593591333|FG000|Overall Study|Withdrawal by Subject|52|||
164331710|NCT01385371|593591334|FG001|Overall Study|Withdrawal by Subject|39|||
164331711|NCT01385371|593591333|FG000|Overall Study|Protocol Violation|25|||
164331712|NCT01385371|593591334|FG001|Overall Study|Protocol Violation|21|||
164331713|NCT01385371|593591333|FG000|Overall Study|Administrative|2|||
164331714|NCT01385371|593591334|FG001|Overall Study|Administrative|2|||
164331715|NCT01090973|593591337|FG000|Overall Study|Disease progression|1|||
164331716|NCT03112590|593591340|FG000|Overall Study|Adverse Event|0|||
164331717|NCT03112590|593591341|FG001|Overall Study|Adverse Event|1|||
164331718|NCT03112590|593591342|FG002|Overall Study|Adverse Event|0|||
164331719|NCT03635788|593591343|FG000|Step 1|Death|1|||
164331720|NCT03635788|593591344|FG001|Step 1|Death|0|||
164331721|NCT03635788|593591345|FG002|Step 1|Death|0|||
164331722|NCT03635788|593591343|FG000|Step 1|Lost to Follow-up|31|||
164331723|NCT03635788|593591344|FG001|Step 1|Lost to Follow-up|0|||
164331724|NCT03635788|593591345|FG002|Step 1|Lost to Follow-up|0|||
164331725|NCT03635788|593591343|FG000|Step 1|Pregnancy|1|||
164230190|NCT03895372|593212715|FG004|Investigational Treatment Period|Other|0|||
164230191|NCT03895372|593212716|FG005|Investigational Treatment Period|Other|1|||
164230192|NCT03895372|593212717|FG006|Investigational Treatment Period|Other|0|||
164230193|NCT03895372|593212718|FG007|Investigational Treatment Period|Other|2|||
164230194|NCT03895372|593212711|FG000|Investigational Treatment Period|Protocol Violation|0|||
164230195|NCT03895372|593212712|FG001|Investigational Treatment Period|Protocol Violation|0|||
164230196|NCT03895372|593212713|FG002|Investigational Treatment Period|Protocol Violation|0|||
164230197|NCT03895372|593212714|FG003|Investigational Treatment Period|Protocol Violation|1|||
164331726|NCT03635788|593591344|FG001|Step 1|Pregnancy|0|||
164331727|NCT03635788|593591345|FG002|Step 1|Pregnancy|0|||
164331728|NCT03635788|593591343|FG000|Step 1|Protocol Violation|8|||
164331729|NCT03635788|593591344|FG001|Step 1|Protocol Violation|0|||
164331730|NCT03635788|593591345|FG002|Step 1|Protocol Violation|0|||
164331731|NCT03635788|593591343|FG000|Step 1|Withdrawal by Subject|13|||
164331732|NCT03635788|593591344|FG001|Step 1|Withdrawal by Subject|0|||
164331733|NCT03635788|593591345|FG002|Step 1|Withdrawal by Subject|0|||
164331734|NCT03635788|593591343|FG000|Step 1|Other reasons|12|||
164331735|NCT03635788|593591344|FG001|Step 1|Other reasons|0|||
164331736|NCT03635788|593591345|FG002|Step 1|Other reasons|0|||
164331737|NCT03635788|593591343|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
164331738|NCT03635788|593591344|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
164331739|NCT03635788|593591345|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
164331740|NCT03635788|593591343|FG000|Step 2|Lost to Follow-up|0|||
164331741|NCT03635788|593591344|FG001|Step 2|Lost to Follow-up|8|||
164331742|NCT03635788|593591345|FG002|Step 2|Lost to Follow-up|15|||
164331743|NCT03635788|593591343|FG000|Step 2|Withdrawal by Subject|0|||
164331744|NCT03635788|593591344|FG001|Step 2|Withdrawal by Subject|6|||
164331745|NCT03635788|593591345|FG002|Step 2|Withdrawal by Subject|6|||
164331746|NCT03635788|593591343|FG000|Step 2|Death|0|||
164331747|NCT03635788|593591344|FG001|Step 2|Death|2|||
164331748|NCT03635788|593591345|FG002|Step 2|Death|0|||
164331749|NCT03635788|593591343|FG000|Step 2|Incarceration|0|||
164331750|NCT03635788|593591344|FG001|Step 2|Incarceration|2|||
164331751|NCT03635788|593591345|FG002|Step 2|Incarceration|0|||
164331752|NCT03635788|593591343|FG000|Step 2|Non-Compliance With Study Requirements|0|||
164331753|NCT03635788|593591344|FG001|Step 2|Non-Compliance With Study Requirements|1|||
164331754|NCT03635788|593591345|FG002|Step 2|Non-Compliance With Study Requirements|1|||
164331755|NCT03635788|593591343|FG000|Step 2|Confounding Medical Condition|0|||
164331756|NCT03635788|593591344|FG001|Step 2|Confounding Medical Condition|0|||
164331757|NCT03635788|593591345|FG002|Step 2|Confounding Medical Condition|1|||
164331758|NCT03635788|593591343|FG000|Step 2|Out Of State With No Plan To Return|0|||
164331759|NCT03635788|593591344|FG001|Step 2|Out Of State With No Plan To Return|1|||
164331760|NCT03635788|593591345|FG002|Step 2|Out Of State With No Plan To Return|0|||
164331761|NCT03635788|593591343|FG000|Step 2|Switched To Injectables|0|||
164331762|NCT03635788|593591344|FG001|Step 2|Switched To Injectables|0|||
164331763|NCT03635788|593591345|FG002|Step 2|Switched To Injectables|1|||
164331764|NCT03635788|593591343|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
164331765|NCT03635788|593591344|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
164331766|NCT03635788|593591345|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
164331767|NCT04571515|593591349|FG000|Overall Study|Physician Decision|0|||
164331768|NCT04571515|593591350|FG001|Overall Study|Physician Decision|0|||
164331769|NCT04571515|593591351|FG002|Overall Study|Physician Decision|0|||
164331770|NCT04571515|593591352|FG003|Overall Study|Physician Decision|0|||
164331771|NCT04571515|593591353|FG004|Overall Study|Physician Decision|1|||
164331772|NCT04571515|593591349|FG000|Overall Study|Withdrawal by Subject|0|||
164331773|NCT04571515|593591350|FG001|Overall Study|Withdrawal by Subject|0|||
164331774|NCT04571515|593591351|FG002|Overall Study|Withdrawal by Subject|0|||
164331775|NCT04571515|593591352|FG003|Overall Study|Withdrawal by Subject|0|||
164331776|NCT04571515|593591353|FG004|Overall Study|Withdrawal by Subject|1|||
164331777|NCT04571515|593591349|FG000|Overall Study|insufficient pain|1|||
164331778|NCT04571515|593591350|FG001|Overall Study|insufficient pain|0|||
164331779|NCT04571515|593591351|FG002|Overall Study|insufficient pain|0|||
164331780|NCT04571515|593591352|FG003|Overall Study|insufficient pain|0|||
164331781|NCT04571515|593591353|FG004|Overall Study|insufficient pain|1|||
164331782|NCT05098938|593591362|FG000|Overall Study|Adverse Event|4|||
164331783|NCT05098938|593591363|FG001|Overall Study|Adverse Event|3|||
164331784|NCT05098938|593591362|FG000|Overall Study|inclusion/exclusion criteria change|11|||
164331785|NCT05098938|593591363|FG001|Overall Study|inclusion/exclusion criteria change|5|||
164331786|NCT05098938|593591362|FG000|Overall Study|lack of compliance|26|||
164331787|NCT05098938|593591363|FG001|Overall Study|lack of compliance|19|||
164331788|NCT05098938|593591362|FG000|Overall Study|Lost to Follow-up|37|||
164331789|NCT05098938|593591363|FG001|Overall Study|Lost to Follow-up|40|||
164331790|NCT05098938|593591362|FG000|Overall Study|Lost in treatment period|17|||
164331791|NCT05098938|593591363|FG001|Overall Study|Lost in treatment period|13|||
164331792|NCT05098938|593591362|FG000|Overall Study|Met an exclusion criterion|0|||
164331793|NCT05098938|593591363|FG001|Overall Study|Met an exclusion criterion|3|||
163883135|NCT02783300|591942053|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883136|NCT02783300|591942054|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883137|NCT02783300|591942055|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883138|NCT02783300|591942056|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883139|NCT02783300|591942057|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
164331794|NCT05098938|593591362|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
164331795|NCT05098938|593591363|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
164331796|NCT05098938|593591362|FG000|Overall Study|Physician Decision|25|||
164331797|NCT05098938|593591363|FG001|Overall Study|Physician Decision|32|||
164331798|NCT05098938|593591362|FG000|Overall Study|Run in failure in treatment phase|1|||
164331799|NCT05098938|593591363|FG001|Overall Study|Run in failure in treatment phase|1|||
164331800|NCT05098938|593591362|FG000|Overall Study|Withdrawal by Subject|0|||
164331801|NCT05098938|593591363|FG001|Overall Study|Withdrawal by Subject|3|||
164331802|NCT05098938|593591362|FG000|Overall Study|Run-in Failure in early study|505|||
164331803|NCT05098938|593591363|FG001|Overall Study|Run-in Failure in early study|514|||
164331804|NCT05098938|593591362|FG000|Overall Study|IMP delivery missed|1|||
164331805|NCT05098938|593591363|FG001|Overall Study|IMP delivery missed|5|||
164331806|NCT05098938|593591362|FG000|Overall Study|6 months visit was missed|2|||
164331807|NCT05098938|593591363|FG001|Overall Study|6 months visit was missed|0|||
164331808|NCT05098938|593591362|FG000|Overall Study|fit for use was not completed within window|3|||
164331809|NCT05098938|593591363|FG001|Overall Study|fit for use was not completed within window|0|||
164331810|NCT05098938|593591362|FG000|Overall Study|V2 visit was not completed within window|0|||
164331811|NCT05098938|593591363|FG001|Overall Study|V2 visit was not completed within window|1|||
164331812|NCT05098938|593591362|FG000|Overall Study|exclusionary medication use|1|||
164331813|NCT05098938|593591363|FG001|Overall Study|exclusionary medication use|2|||
164331814|NCT05098938|593591362|FG000|Overall Study|change in medication|1|||
164331815|NCT05098938|593591363|FG001|Overall Study|change in medication|0|||
164331816|NCT05098938|593591362|FG000|Overall Study|treatment failure|2|||
164331817|NCT05098938|593591363|FG001|Overall Study|treatment failure|1|||
164331818|NCT02570074|593593099|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
164331819|NCT02570074|593593100|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
164331820|NCT01859143|593593101|FG000|Overall Study|Lost to Follow-up|2|||
164331821|NCT01859143|593593102|FG001|Overall Study|Lost to Follow-up|0|||
164331822|NCT00760214|593593103|FG000|Overall Study|Adverse Event|8|||
164331823|NCT00760214|593593104|FG001|Overall Study|Adverse Event|9|||
164331824|NCT00760214|593593105|FG002|Overall Study|Adverse Event|12|||
164331825|NCT00760214|593593103|FG000|Overall Study|Protocol Violation|3|||
164331826|NCT00760214|593593104|FG001|Overall Study|Protocol Violation|0|||
164331827|NCT00760214|593593105|FG002|Overall Study|Protocol Violation|3|||
164331828|NCT00760214|593593103|FG000|Overall Study|Lost to Follow-up|0|||
164331829|NCT00760214|593593104|FG001|Overall Study|Lost to Follow-up|0|||
164331830|NCT00760214|593593105|FG002|Overall Study|Lost to Follow-up|1|||
164331831|NCT00760214|593593103|FG000|Overall Study|Withdrawal by Subject|12|||
164331832|NCT00760214|593593104|FG001|Overall Study|Withdrawal by Subject|14|||
164331833|NCT00760214|593593105|FG002|Overall Study|Withdrawal by Subject|13|||
164331834|NCT00760214|593593103|FG000|Overall Study|Lack of Efficacy|3|||
164331835|NCT00760214|593593104|FG001|Overall Study|Lack of Efficacy|2|||
164331836|NCT00760214|593593105|FG002|Overall Study|Lack of Efficacy|4|||
164331837|NCT00760214|593593103|FG000|Overall Study|Pregnancy|0|||
164331838|NCT00760214|593593104|FG001|Overall Study|Pregnancy|0|||
164331839|NCT00760214|593593105|FG002|Overall Study|Pregnancy|1|||
164331840|NCT00760214|593593103|FG000|Overall Study|Physician Decision|1|||
164331841|NCT00760214|593593104|FG001|Overall Study|Physician Decision|1|||
164331842|NCT00760214|593593105|FG002|Overall Study|Physician Decision|1|||
164331843|NCT00760214|593593103|FG000|Overall Study|Other|3|||
164331844|NCT00760214|593593104|FG001|Overall Study|Other|4|||
164331845|NCT00760214|593593105|FG002|Overall Study|Other|6|||
164331846|NCT00700570|593593106|FG000|Overall Study|Adverse Event|2|||
164331847|NCT00700570|593593107|FG001|Overall Study|Adverse Event|6|||
164331848|NCT00700570|593593106|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
164331849|NCT00700570|593593107|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
164331850|NCT00700570|593593106|FG000|Overall Study|Disease Progression|8|||
164331851|NCT00700570|593593107|FG001|Overall Study|Disease Progression|11|||
164331852|NCT00700570|593593106|FG000|Overall Study|Withdrawal by Subject|1|||
163883140|NCT02783300|591942058|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883141|NCT02783300|591942059|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883142|NCT02783300|591942060|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883143|NCT02783300|591942061|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883144|NCT02783300|591942062|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883145|NCT02783300|591942063|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883146|NCT02783300|591942064|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883147|NCT02783300|591942065|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
164331853|NCT00700570|593593107|FG001|Overall Study|Withdrawal by Subject|6|||
164331854|NCT01134315|593593108|FG000|Overall Study|Adverse Event|1|||
164331855|NCT01134315|593593109|FG001|Overall Study|Adverse Event|2|||
164331856|NCT01134315|593593108|FG000|Overall Study|Other Reason|8|||
164331857|NCT01134315|593593109|FG001|Overall Study|Other Reason|17|||
164331858|NCT04587271|593593110|FG000|Overall Study|Lost to Follow-up|2|||
163883148|NCT02783300|591942066|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
164331859|NCT04587271|593593111|FG001|Overall Study|Lost to Follow-up|2|||
164331860|NCT04587271|593593112|FG002|Overall Study|Lost to Follow-up|0|||
164331861|NCT04587271|593593113|FG003|Overall Study|Lost to Follow-up|2|||
164331862|NCT04587271|593593114|FG004|Overall Study|Lost to Follow-up|2|||
164331863|NCT04587271|593593115|FG005|Overall Study|Lost to Follow-up|0|||
164331864|NCT04587271|593593110|FG000|Overall Study|Caregiver brought child to visits|0|||
164331865|NCT04587271|593593111|FG001|Overall Study|Caregiver brought child to visits|0|||
164331866|NCT04587271|593593112|FG002|Overall Study|Caregiver brought child to visits|0|||
164331867|NCT04587271|593593113|FG003|Overall Study|Caregiver brought child to visits|1|||
164331868|NCT04587271|593593114|FG004|Overall Study|Caregiver brought child to visits|0|||
164230198|NCT03895372|593212715|FG004|Investigational Treatment Period|Protocol Violation|0|||
164230199|NCT03895372|593212716|FG005|Investigational Treatment Period|Protocol Violation|0|||
164230200|NCT03895372|593212717|FG006|Investigational Treatment Period|Protocol Violation|0|||
164230201|NCT03895372|593212718|FG007|Investigational Treatment Period|Protocol Violation|0|||
164230202|NCT03895372|593212711|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
164230203|NCT03895372|593212712|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
164230204|NCT03895372|593212713|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
164230205|NCT03895372|593212714|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
164230206|NCT03895372|593212715|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
164230207|NCT03895372|593212716|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
164230208|NCT03895372|593212717|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
164230209|NCT03895372|593212718|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
164230210|NCT03895372|593212711|FG000|Extension Treatment Period|Adverse Event|0|||
164230211|NCT03895372|593212712|FG001|Extension Treatment Period|Adverse Event|1|||
164230212|NCT03895372|593212713|FG002|Extension Treatment Period|Adverse Event|0|||
164230213|NCT03895372|593212714|FG003|Extension Treatment Period|Adverse Event|1|||
164230214|NCT03895372|593212715|FG004|Extension Treatment Period|Adverse Event|0|||
163883149|NCT02783300|591942067|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883150|NCT02783300|591942068|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883151|NCT02783300|591942069|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883152|NCT02783300|591942070|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883153|NCT02783300|591942071|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883154|NCT02783300|591942072|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883155|NCT02783300|591942073|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883156|NCT02783300|591942074|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883157|NCT02783300|591942075|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883158|NCT02783300|591942076|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883159|NCT02783300|591942077|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
163883160|NCT02783300|591942078|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
163883161|NCT00378105|591942081|FG000|Overall Study|Adverse Event|3|||
163883162|NCT00378105|591942082|FG001|Overall Study|Adverse Event|1|||
163883163|NCT00378105|591942081|FG000|Overall Study|Withdrawal by Subject|3|||
163883164|NCT00378105|591942082|FG001|Overall Study|Withdrawal by Subject|3|||
163883165|NCT00378105|591942081|FG000|Overall Study|Death|1|||
163883166|NCT00378105|591942082|FG001|Overall Study|Death|0|||
163883167|NCT00378105|591942081|FG000|Overall Study|Going to transplant|7|||
163883168|NCT00378105|591942082|FG001|Overall Study|Going to transplant|8|||
163883169|NCT00378105|591942081|FG000|Overall Study|Progressive disease|3|||
163883170|NCT00378105|591942082|FG001|Overall Study|Progressive disease|3|||
163883171|NCT00378105|591942081|FG000|Overall Study|remain on study|3|||
163883172|NCT00378105|591942082|FG001|Overall Study|remain on study|11|||
163883173|NCT00378105|591942081|FG000|Overall Study|Physician Decision|0|||
163883174|NCT00378105|591942082|FG001|Overall Study|Physician Decision|2|||
163883175|NCT00378105|591942081|FG000|Overall Study|Going non-protocol therapy|0|||
163883176|NCT00378105|591942082|FG001|Overall Study|Going non-protocol therapy|1|||
163883177|NCT00378105|591942081|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
163883178|NCT00378105|591942082|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
163883179|NCT02243709|591942084|FG000|Phase 1|Lost to Follow-up|0|||
163883180|NCT02243709|591942085|FG001|Phase 1|Lost to Follow-up|1|||
163883181|NCT02243709|591942084|FG000|Phase 1|Withdrawal by Subject|1|||
163883182|NCT02243709|591942085|FG001|Phase 1|Withdrawal by Subject|0|||
163883183|NCT02243709|591942084|FG000|Phase 1|Protocol Violation|0|||
163883184|NCT02243709|591942085|FG001|Phase 1|Protocol Violation|1|||
163883185|NCT02243709|591942084|FG000|Phase 1|Adverse Event|0|||
163883186|NCT02243709|591942085|FG001|Phase 1|Adverse Event|1|||
163883187|NCT03443323|591942091|FG000|Overall Study|Lost to Follow-up|2|||
163883188|NCT03443323|591942092|FG001|Overall Study|Lost to Follow-up|2|||
163883189|NCT03443323|591942091|FG000|Overall Study|PI withdrawal|1|||
163883190|NCT03443323|591942092|FG001|Overall Study|PI withdrawal|0|||
163883191|NCT05178316|591942099|FG000|Overall Study|Adverse Event|5|||
163883192|NCT05178316|591942100|FG001|Overall Study|Adverse Event|4|||
163883193|NCT05178316|591942101|FG002|Overall Study|Adverse Event|9|||
164230215|NCT03895372|593212716|FG005|Extension Treatment Period|Adverse Event|0|||
164230216|NCT03895372|593212717|FG006|Extension Treatment Period|Adverse Event|3|||
164230217|NCT03895372|593212718|FG007|Extension Treatment Period|Adverse Event|3|||
164230218|NCT03895372|593212711|FG000|Extension Treatment Period|Other|1|||
164230219|NCT03895372|593212712|FG001|Extension Treatment Period|Other|3|||
164230220|NCT03895372|593212713|FG002|Extension Treatment Period|Other|0|||
163883194|NCT05178316|591942099|FG000|Overall Study|Enrolled in Error|1|||
163883195|NCT05178316|591942100|FG001|Overall Study|Enrolled in Error|2|||
163883196|NCT05178316|591942101|FG002|Overall Study|Enrolled in Error|1|||
164230221|NCT03895372|593212714|FG003|Extension Treatment Period|Other|0|||
164230222|NCT03895372|593212715|FG004|Extension Treatment Period|Other|1|||
164230223|NCT03895372|593212716|FG005|Extension Treatment Period|Other|0|||
164230224|NCT03895372|593212717|FG006|Extension Treatment Period|Other|0|||
164230225|NCT03895372|593212718|FG007|Extension Treatment Period|Other|2|||
164230226|NCT03895372|593212711|FG000|Extension Treatment Period|Pregnancy|0|||
164230227|NCT03895372|593212712|FG001|Extension Treatment Period|Pregnancy|0|||
164230228|NCT03895372|593212713|FG002|Extension Treatment Period|Pregnancy|0|||
164230229|NCT03895372|593212714|FG003|Extension Treatment Period|Pregnancy|0|||
164230230|NCT03895372|593212715|FG004|Extension Treatment Period|Pregnancy|1|||
164230231|NCT03895372|593212716|FG005|Extension Treatment Period|Pregnancy|0|||
164230232|NCT03895372|593212717|FG006|Extension Treatment Period|Pregnancy|0|||
164230233|NCT03895372|593212718|FG007|Extension Treatment Period|Pregnancy|0|||
164230234|NCT03895372|593212711|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
164230235|NCT03895372|593212712|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
164230236|NCT03895372|593212713|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
164230237|NCT03895372|593212714|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
164230238|NCT03895372|593212715|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
164230239|NCT03895372|593212716|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
164230240|NCT03895372|593212717|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
164230241|NCT03895372|593212718|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
164230242|NCT03685149|593212719|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
164230243|NCT03685149|593212720|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
164230244|NCT03685149|593212719|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164230245|NCT03685149|593212720|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164230246|NCT03685149|593212719|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
164230247|NCT03685149|593212720|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
164230248|NCT02951819|593212722|FG000|Overall Study|Death|9|||
164230249|NCT02951819|593212723|FG001|Overall Study|Death|7|||
164230250|NCT02951819|593212722|FG000|Overall Study|Withdrawal by Subject|3|||
164230251|NCT02951819|593212723|FG001|Overall Study|Withdrawal by Subject|0|||
164230252|NCT02951819|593212722|FG000|Overall Study|Adverse Event|1|||
164230253|NCT02951819|593212723|FG001|Overall Study|Adverse Event|0|||
164230254|NCT02951819|593212722|FG000|Overall Study|Lack of Efficacy|4|||
164230255|NCT02951819|593212723|FG001|Overall Study|Lack of Efficacy|0|||
164230256|NCT02951819|593212722|FG000|Overall Study|Lost to Follow-up|1|||
164230257|NCT02951819|593212723|FG001|Overall Study|Lost to Follow-up|0|||
164230258|NCT02951819|593212722|FG000|Overall Study|Progressive Disease|1|||
164230259|NCT02951819|593212723|FG001|Overall Study|Progressive Disease|0|||
164230260|NCT02951819|593212722|FG000|Overall Study|Other|9|||
164230261|NCT02951819|593212723|FG001|Overall Study|Other|0|||
164230262|NCT00581919|593212727|FG000|Overall Study|Adverse Event|8|||
164230263|NCT00581919|593212727|FG000|Overall Study|Death|1|||
164230264|NCT00581919|593212727|FG000|Overall Study|Disease Progression|10|||
164230265|NCT00581919|593212727|FG000|Overall Study|Physician Decision|1|||
164230266|NCT00581919|593212727|FG000|Overall Study|Other Complicating Disease|1|||
164230267|NCT00581919|593212727|FG000|Overall Study|Started Non-Protocol Therapy|2|||
164230268|NCT00581919|593212727|FG000|Overall Study|Withdrawal by Subject|1|||
164230269|NCT02034565|593212728|FG000|Overall Study|Adverse Event|1|||
164230270|NCT02034565|593212729|FG001|Overall Study|Adverse Event|0|||
164230271|NCT03232567|593212732|FG000|Overall Study|Withdrawal by Subject|0|||
164230272|NCT03232567|593212733|FG001|Overall Study|Withdrawal by Subject|1|||
164230273|NCT03232567|593212734|FG002|Overall Study|Withdrawal by Subject|0|||
164230274|NCT03232567|593212735|FG003|Overall Study|Withdrawal by Subject|0|||
164230275|NCT02655601|593212736|FG000|Overall Study|Adverse Event|0|||
164230276|NCT02655601|593212737|FG001|Overall Study|Adverse Event|0|||
164230277|NCT02655601|593212738|FG002|Overall Study|Adverse Event|0|||
164230278|NCT02655601|593212739|FG003|Overall Study|Adverse Event|1|||
164230279|NCT02655601|593212740|FG004|Overall Study|Adverse Event|1|||
164230280|NCT02655601|593212741|FG005|Overall Study|Adverse Event|0|||
164331869|NCT04587271|593593115|FG005|Overall Study|Caregiver brought child to visits|0|||
163883197|NCT05178316|591942099|FG000|Overall Study|Lost to Follow-up|3|||
164230281|NCT02655601|593212736|FG000|Overall Study|Physician Decision|0|||
164230282|NCT02655601|593212737|FG001|Overall Study|Physician Decision|0|||
164230283|NCT02655601|593212738|FG002|Overall Study|Physician Decision|0|||
164230284|NCT02655601|593212739|FG003|Overall Study|Physician Decision|0|||
164230285|NCT02655601|593212740|FG004|Overall Study|Physician Decision|1|||
164230286|NCT02655601|593212741|FG005|Overall Study|Physician Decision|1|||
164230287|NCT02655601|593212736|FG000|Overall Study|Withdrawal by Subject|0|||
164230288|NCT02655601|593212737|FG001|Overall Study|Withdrawal by Subject|0|||
164230289|NCT02655601|593212738|FG002|Overall Study|Withdrawal by Subject|0|||
164230290|NCT02655601|593212739|FG003|Overall Study|Withdrawal by Subject|0|||
164230291|NCT02655601|593212740|FG004|Overall Study|Withdrawal by Subject|4|||
164230292|NCT02655601|593212741|FG005|Overall Study|Withdrawal by Subject|8|||
163883198|NCT05178316|591942100|FG001|Overall Study|Lost to Follow-up|15|||
164230293|NCT02655601|593212736|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
164230294|NCT02655601|593212737|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230295|NCT02655601|593212738|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230296|NCT02655601|593212739|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230297|NCT02655601|593212740|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230298|NCT02655601|593212741|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
164230299|NCT05837481|593212742|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
164230300|NCT05837481|593212743|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
164230301|NCT02014376|593212744|FG000|Overall Study|Adverse Event|1|||
164230302|NCT02014376|593212745|FG001|Overall Study|Adverse Event|1|||
164230303|NCT02014376|593212746|FG002|Overall Study|Adverse Event|0|||
164230304|NCT02014376|593212744|FG000|Overall Study|Lost to Follow-up|2|||
164230305|NCT02014376|593212745|FG001|Overall Study|Lost to Follow-up|0|||
164230306|NCT02014376|593212746|FG002|Overall Study|Lost to Follow-up|0|||
164230307|NCT02135133|593212748|FG000|Overall Study|Adverse Event|10|||
164230308|NCT02135133|593212748|FG000|Overall Study|regulatory mandate|5|||
164230309|NCT03312543|593212759|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
164230310|NCT03312543|593212760|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
164230311|NCT03312543|593212759|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
164230312|NCT03312543|593212760|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
164230313|NCT03312543|593212759|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
164230314|NCT03312543|593212760|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
164230315|NCT03312543|593212759|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
164230316|NCT03312543|593212760|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
164230317|NCT03312543|593212759|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
164230318|NCT03312543|593212760|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
164230319|NCT03312543|593212759|FG000|Regression (Week 12 to Week 24)|Death|0|||
164230320|NCT03312543|593212760|FG001|Regression (Week 12 to Week 24)|Death|1|||
164230321|NCT04507269|593212761|FG000|Overall Study|Withdrawal by Subject|1|||
164230322|NCT04507269|593212762|FG001|Overall Study|Withdrawal by Subject|1|||
164230323|NCT04507269|593212763|FG002|Overall Study|Withdrawal by Subject|0|||
164230324|NCT04507269|593212764|FG003|Overall Study|Withdrawal by Subject|0|||
164230325|NCT04507269|593212765|FG004|Overall Study|Withdrawal by Subject|0|||
164230326|NCT04507269|593212766|FG005|Overall Study|Withdrawal by Subject|0|||
164230327|NCT04507269|593212761|FG000|Overall Study|Lost to Follow-up|0|||
164230328|NCT04507269|593212762|FG001|Overall Study|Lost to Follow-up|0|||
164230329|NCT04507269|593212763|FG002|Overall Study|Lost to Follow-up|0|||
164230330|NCT04507269|593212764|FG003|Overall Study|Lost to Follow-up|0|||
164230331|NCT04507269|593212765|FG004|Overall Study|Lost to Follow-up|1|||
164230332|NCT04507269|593212766|FG005|Overall Study|Lost to Follow-up|0|||
164230333|NCT05852340|593212767|FG000|Period 5|Not completing the meal|0|||
164331870|NCT03719586|593593116|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
164331871|NCT03719586|593593117|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
164331872|NCT03719586|593593118|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
164331873|NCT03719586|593593119|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
164331874|NCT02791594|593593120|FG000|Overall Study|Physician Decision|2|||
164331875|NCT02310321|593593121|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
164331876|NCT02310321|593593122|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164331877|NCT02310321|593593123|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164331878|NCT02310321|593593121|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
164331879|NCT02310321|593593122|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331880|NCT02310321|593593123|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331881|NCT02310321|593593121|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
164331882|NCT02310321|593593122|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331883|NCT02310321|593593123|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
164331884|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
164331885|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
164331886|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
164331887|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
164331888|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
164331889|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
163987069|NCT00441545|592320271|FG000|Second Intervention|Kidney Transplant|1|||
164230334|NCT05852340|593212768|FG001|Period 5|Not completing the meal|1|||
164230335|NCT05852340|593212769|FG002|Period 5|Not completing the meal|0|||
163987070|NCT00441545|592320272|FG001|Second Intervention|Kidney Transplant|1|||
163987071|NCT00441545|592320271|FG000|Second Intervention|Lack of Efficacy|0|||
163987072|NCT00441545|592320272|FG001|Second Intervention|Lack of Efficacy|1|||
164230336|NCT05852340|593212770|FG003|Period 5|Not completing the meal|0|||
164230337|NCT05852340|593212767|FG000|Period 5|Adverse Event|0|||
164230338|NCT05852340|593212768|FG001|Period 5|Adverse Event|0|||
164230339|NCT05852340|593212769|FG002|Period 5|Adverse Event|0|||
164230340|NCT05852340|593212770|FG003|Period 5|Adverse Event|1|||
164230341|NCT00071032|593212773|FG000|Overall Study|Lost to Follow-up|1|||
164230342|NCT00071032|593212774|FG001|Overall Study|Lost to Follow-up|1|||
164230343|NCT00071032|593212773|FG000|Overall Study|Withdrawal by Subject|8|||
164230344|NCT00071032|593212774|FG001|Overall Study|Withdrawal by Subject|6|||
164230345|NCT00071032|593212773|FG000|Overall Study|Missing Primary Outcome|0|||
164230346|NCT00071032|593212774|FG001|Overall Study|Missing Primary Outcome|1|||
164230347|NCT04197583|593212775|FG000|Overall Study|Study Stent Replacement|34|||
164230348|NCT04197583|593212776|FG001|Overall Study|Study Stent Replacement|8|||
164230349|NCT04197583|593212775|FG000|Overall Study|Lost to Follow-up|14|||
164331890|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
164331891|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
164331892|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
164331893|NCT02310321|593593121|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
164331894|NCT02310321|593593122|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
164331895|NCT02310321|593593123|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
164331896|NCT02310321|593593121|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
164331897|NCT02310321|593593122|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
164331898|NCT02310321|593593123|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
164331899|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
164331900|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
164331901|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
164331902|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
164331903|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
164331904|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
164331905|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
164331906|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
164331907|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
164331908|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
164331909|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
164331910|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
164331911|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
164331912|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
164331913|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
164331914|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
164331915|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
164331916|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
164331917|NCT02310321|593593121|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
164331918|NCT02310321|593593122|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
164331919|NCT02310321|593593123|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
164331920|NCT02310321|593593121|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
164331921|NCT02310321|593593122|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
164331922|NCT02310321|593593123|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
164331923|NCT02310321|593593121|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
164331924|NCT02310321|593593122|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
164331925|NCT02310321|593593123|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
164331926|NCT02310321|593593121|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
164331927|NCT02310321|593593122|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
164331928|NCT02310321|593593123|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
164331929|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
164331930|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
164331931|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
164331932|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
164331933|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
164331934|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
164331935|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
164230350|NCT04197583|593212776|FG001|Overall Study|Lost to Follow-up|3|||
164230351|NCT04197583|593212775|FG000|Overall Study|Death|3|||
164230352|NCT04197583|593212776|FG001|Overall Study|Death|0|||
164230353|NCT04197583|593212775|FG000|Overall Study|Physician Decision|1|||
164230354|NCT04197583|593212776|FG001|Overall Study|Physician Decision|0|||
164230355|NCT04197583|593212775|FG000|Overall Study|Withdrawal by Subject|1|||
164331936|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
164230356|NCT04197583|593212776|FG001|Overall Study|Withdrawal by Subject|1|||
164230357|NCT04197583|593212775|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
164230358|NCT04197583|593212776|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
164230359|NCT04197583|593212775|FG000|Overall Study|Screen Failure|0|||
164230360|NCT04197583|593212776|FG001|Overall Study|Screen Failure|20|||
164230361|NCT04042311|593212783|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
164230362|NCT04042311|593212783|FG000|Overall Study|Unable to tolerate|4|||
164230363|NCT04042311|593212783|FG000|Overall Study|Concurrent illness|2|||
163883199|NCT05178316|591942101|FG002|Overall Study|Lost to Follow-up|11|||
163883200|NCT05178316|591942099|FG000|Overall Study|Noncompliance|1|||
163883201|NCT05178316|591942100|FG001|Overall Study|Noncompliance|3|||
163883202|NCT05178316|591942101|FG002|Overall Study|Noncompliance|1|||
163883203|NCT05178316|591942099|FG000|Overall Study|Other|0|||
164230364|NCT04042311|593212783|FG000|Overall Study|Adverse Event|2|||
164230365|NCT04042311|593212783|FG000|Overall Study|No longer meeting inclusion criteria|2|||
164230366|NCT04042311|593212783|FG000|Overall Study|No reason given|1|||
164331937|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
163883204|NCT05178316|591942100|FG001|Overall Study|Other|1|||
163883205|NCT05178316|591942101|FG002|Overall Study|Other|0|||
163883206|NCT05178316|591942099|FG000|Overall Study|Physician Decision|0|||
163883207|NCT05178316|591942100|FG001|Overall Study|Physician Decision|3|||
163883208|NCT05178316|591942101|FG002|Overall Study|Physician Decision|2|||
163883209|NCT05178316|591942099|FG000|Overall Study|Protocol deviation|1|||
163883210|NCT05178316|591942100|FG001|Overall Study|Protocol deviation|0|||
163883211|NCT05178316|591942101|FG002|Overall Study|Protocol deviation|1|||
163883212|NCT05178316|591942099|FG000|Overall Study|Sponsor decision|1|||
163883213|NCT05178316|591942100|FG001|Overall Study|Sponsor decision|0|||
163883214|NCT05178316|591942101|FG002|Overall Study|Sponsor decision|1|||
163883215|NCT05178316|591942099|FG000|Overall Study|Withdrawal by Subject|5|||
163883216|NCT05178316|591942100|FG001|Overall Study|Withdrawal by Subject|11|||
163883217|NCT05178316|591942101|FG002|Overall Study|Withdrawal by Subject|5|||
163883218|NCT04347161|591942102|FG000|Overall Study|Death|0|||
163883219|NCT04347161|591942103|FG001|Overall Study|Death|2|||
163883220|NCT04347161|591942102|FG000|Overall Study|Withdrawal by Subject|1|||
163883221|NCT04347161|591942103|FG001|Overall Study|Withdrawal by Subject|0|||
163883222|NCT04347161|591942102|FG000|Overall Study|Lost to Follow-up|0|||
163883223|NCT04347161|591942103|FG001|Overall Study|Lost to Follow-up|1|||
163883224|NCT04347161|591942102|FG000|Overall Study|No longer on study medication|1|||
163883225|NCT04347161|591942103|FG001|Overall Study|No longer on study medication|1|||
163883226|NCT04169373|591942104|FG000|Week 1 to Week 14|Adverse Event|1|||
163883227|NCT04169373|591942105|FG001|Week 1 to Week 14|Adverse Event|0|||
163883228|NCT04169373|591942106|FG002|Week 1 to Week 14|Adverse Event|1|||
163883229|NCT04169373|591942107|FG003|Week 1 to Week 14|Adverse Event|2|||
163883230|NCT04169373|591942104|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
164139014|NCT02932306|592871957|FG001|Overall Study|Adverse Event|0|||
163883231|NCT04169373|591942105|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
163883232|NCT04169373|591942106|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
163883233|NCT04169373|591942107|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
163883234|NCT04169373|591942104|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
163883235|NCT04169373|591942105|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
163883236|NCT04169373|591942106|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
163883237|NCT04169373|591942107|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
163883238|NCT04169373|591942104|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
163883239|NCT04169373|591942105|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
163883240|NCT04169373|591942106|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
164139015|NCT02932306|592871956|FG000|Overall Study|Pregnancy|2|||
164139016|NCT02932306|592871957|FG001|Overall Study|Pregnancy|0|||
164139017|NCT02932306|592871956|FG000|Overall Study|Protocol Violation|1|||
164139018|NCT02932306|592871957|FG001|Overall Study|Protocol Violation|1|||
164139019|NCT02932306|592871956|FG000|Overall Study|Noncompliance with Study Drug|1|||
164139020|NCT02932306|592871957|FG001|Overall Study|Noncompliance with Study Drug|1|||
164139021|NCT02932306|592871956|FG000|Overall Study|Lost to Follow-up|36|||
164139022|NCT02932306|592871957|FG001|Overall Study|Lost to Follow-up|40|||
164139023|NCT02932306|592871956|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
164139024|NCT02932306|592871957|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
164139025|NCT02932306|592871956|FG000|Overall Study|Lack of Efficacy|0|||
164139026|NCT02932306|592871957|FG001|Overall Study|Lack of Efficacy|2|||
164139027|NCT02932306|592871956|FG000|Overall Study|Worsening condition|2|||
164139028|NCT02932306|592871957|FG001|Overall Study|Worsening condition|0|||
164139029|NCT02932306|592871956|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
164139030|NCT02932306|592871957|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
164139031|NCT02448706|592871968|FG000|Overall Study|Withdrawal by Subject|4|||
164139032|NCT02448706|592871969|FG001|Overall Study|Withdrawal by Subject|3|||
164139033|NCT02448706|592871968|FG000|Overall Study|Protocol Violation|1|||
164139034|NCT02448706|592871969|FG001|Overall Study|Protocol Violation|1|||
164139035|NCT02065700|592871970|FG000|Overall Study|Adverse Event|165|||
164331938|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
164331939|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
164331940|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
164331941|NCT02310321|593593121|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
164331942|NCT02310321|593593122|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
164331943|NCT02310321|593593123|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
164331944|NCT04950166|593593124|FG000|Overall Study|Withdrawal by Subject|1|||
164331945|NCT01698905|593593125|FG000|Overall Study|Adverse Event|4|||
164331946|NCT01698905|593593125|FG000|Overall Study|Physician Decision|2|||
164331947|NCT01698905|593593125|FG000|Overall Study|Pregnancy|1|||
164331948|NCT01698905|593593125|FG000|Overall Study|Protocol Violation|1|||
164331949|NCT01698905|593593125|FG000|Overall Study|Subject/guardian decision|2|||
164331950|NCT01698905|593593125|FG000|Overall Study|Death|1|||
164331951|NCT05896748|593593126|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
164331952|NCT05896748|593593126|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
164331953|NCT05896748|593593126|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
164331954|NCT05896748|593593126|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
164331955|NCT05896748|593593126|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
164331956|NCT00857415|593593134|FG000|Overall Study|Image acquisition failure|2|||
164331957|NCT00857415|593593135|FG001|Overall Study|Image acquisition failure|0|||
164331958|NCT00857415|593593134|FG000|Overall Study|Invalid image or not imaged|3|||
164331959|NCT00857415|593593135|FG001|Overall Study|Invalid image or not imaged|0|||
164331960|NCT00857415|593593134|FG000|Overall Study|Subject still living at end of study|110|||
164331961|NCT00857415|593593135|FG001|Overall Study|Subject still living at end of study|0|||
164331962|NCT00857415|593593134|FG000|Overall Study|Deceased with no autopsy|2|||
164331963|NCT00857415|593593135|FG001|Overall Study|Deceased with no autopsy|0|||
164331964|NCT04508140|593593136|FG000|Overall Study|Adverse Event|2|||
164331965|NCT04508140|593593137|FG001|Overall Study|Adverse Event|2|||
164331966|NCT04508140|593593136|FG000|Overall Study|Withdrawal by Subject|0|||
164331967|NCT04508140|593593137|FG001|Overall Study|Withdrawal by Subject|2|||
164331968|NCT04508140|593593136|FG000|Overall Study|progressive disease|9|||
164331969|NCT04508140|593593137|FG001|Overall Study|progressive disease|3|||
164331970|NCT01822678|593593138|FG000|Overall Study|Withdrawal by Subject|5|||
164331971|NCT01822678|593593139|FG001|Overall Study|Withdrawal by Subject|4|||
164331972|NCT01822678|593593140|FG002|Overall Study|Withdrawal by Subject|4|||
164331973|NCT01822678|593593138|FG000|Overall Study|Adverse Event|4|||
164331974|NCT01822678|593593139|FG001|Overall Study|Adverse Event|3|||
164331975|NCT01822678|593593140|FG002|Overall Study|Adverse Event|1|||
164331976|NCT01822678|593593138|FG000|Overall Study|Lack of Efficacy|3|||
164331977|NCT01822678|593593139|FG001|Overall Study|Lack of Efficacy|6|||
164331978|NCT01822678|593593140|FG002|Overall Study|Lack of Efficacy|5|||
164331979|NCT01822678|593593138|FG000|Overall Study|Lost to Follow-up|0|||
164331980|NCT01822678|593593139|FG001|Overall Study|Lost to Follow-up|2|||
164331981|NCT01822678|593593140|FG002|Overall Study|Lost to Follow-up|1|||
164331982|NCT00764504|593593141|FG000|Overall Study|Death|12|||
164331983|NCT00764504|593593142|FG001|Overall Study|Death|6|||
164331984|NCT00764504|593593143|FG002|Overall Study|Death|13|||
164331985|NCT00764504|593593141|FG000|Overall Study|Revision of Device|12|||
164331986|NCT00764504|593593142|FG001|Overall Study|Revision of Device|23|||
164331987|NCT00764504|593593143|FG002|Overall Study|Revision of Device|14|||
164331988|NCT00764504|593593141|FG000|Overall Study|Physician Decision|1|||
163883241|NCT04169373|591942107|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
163883242|NCT04169373|591942104|FG000|Week 1 to Week 14|Other|1|||
163883243|NCT04169373|591942105|FG001|Week 1 to Week 14|Other|3|||
163883244|NCT04169373|591942106|FG002|Week 1 to Week 14|Other|3|||
163883245|NCT04169373|591942107|FG003|Week 1 to Week 14|Other|5|||
163883246|NCT04169373|591942104|FG000|Week 14 to Week 52|Adverse Event|1|||
163883247|NCT04169373|591942105|FG001|Week 14 to Week 52|Adverse Event|0|||
163883248|NCT04169373|591942106|FG002|Week 14 to Week 52|Adverse Event|0|||
163883249|NCT04169373|591942107|FG003|Week 14 to Week 52|Adverse Event|1|||
163883250|NCT04169373|591942104|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
163987073|NCT00441545|592320271|FG000|Second Intervention|Subject exceeded safety criteria|1|||
164139036|NCT02065700|592871971|FG001|Overall Study|Adverse Event|101|||
164331989|NCT00764504|593593142|FG001|Overall Study|Physician Decision|0|||
163883251|NCT04169373|591942105|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
163883252|NCT04169373|591942106|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
164331990|NCT00764504|593593143|FG002|Overall Study|Physician Decision|0|||
164331991|NCT00764504|593593141|FG000|Overall Study|Withdrawal by Subject|1|||
164331992|NCT00764504|593593142|FG001|Overall Study|Withdrawal by Subject|7|||
164331993|NCT00764504|593593143|FG002|Overall Study|Withdrawal by Subject|4|||
164331994|NCT00764504|593593141|FG000|Overall Study|Lost to Follow-up|40|||
164331995|NCT00764504|593593142|FG001|Overall Study|Lost to Follow-up|34|||
164331996|NCT00764504|593593143|FG002|Overall Study|Lost to Follow-up|72|||
164331997|NCT02456103|593593147|FG000|Overall Study|Study Closure|207|||
164331998|NCT02456103|593593147|FG000|Overall Study|Physician Decision|1|||
164331999|NCT02456103|593593147|FG000|Overall Study|Required prohibited medications|5|||
164230367|NCT04042311|593212783|FG000|Overall Study|Withdrawal by Subject|4|||
164230368|NCT04134936|593212784|FG000|Overall Study|Adverse Event|3|||
164230369|NCT04134936|593212785|FG001|Overall Study|Adverse Event|2|||
164230370|NCT04134936|593212784|FG000|Overall Study|Withdrawal by Subject|2|||
164230371|NCT04134936|593212785|FG001|Overall Study|Withdrawal by Subject|3|||
164230372|NCT04134936|593212784|FG000|Overall Study|Physician Decision|0|||
164230373|NCT04134936|593212785|FG001|Overall Study|Physician Decision|1|||
164230374|NCT04134936|593212784|FG000|Overall Study|Progressive disease, joined another trial|1|||
164230375|NCT04134936|593212785|FG001|Overall Study|Progressive disease, joined another trial|0|||
164230376|NCT04134936|593212784|FG000|Overall Study|Progressive disease|1|||
164230377|NCT04134936|593212785|FG001|Overall Study|Progressive disease|0|||
164230378|NCT03518060|593212786|FG000|Overall Study|Death|1|||
164230379|NCT03518060|593212786|FG000|Overall Study|Poor adherence|1|||
164230380|NCT03518060|593212786|FG000|Overall Study|Withdrawal of informed consent|2|||
164230381|NCT03518060|593212786|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
164230382|NCT03518060|593212786|FG000|Overall Study|Physician Decision|7|||
164230383|NCT03518060|593212786|FG000|Overall Study|Adverse drug reactions|23|||
164230384|NCT03518060|593212786|FG000|Overall Study|Withdrawal by Subject|25|||
164230385|NCT03518060|593212786|FG000|Overall Study|Lost to Follow-up|13|||
164230386|NCT00323622|593212787|FG000|Overall Study|Other|30|||
164230387|NCT00323622|593212788|FG001|Overall Study|Other|91|||
164230388|NCT00323622|593212789|FG002|Overall Study|Other|4|||
164230389|NCT00323622|593212790|FG003|Overall Study|Other|12|||
164230390|NCT00323622|593212791|FG004|Overall Study|Other|32|||
164230391|NCT00323622|593212792|FG005|Overall Study|Other|74|||
164230392|NCT00323622|593212793|FG006|Overall Study|Other|5|||
164230393|NCT00323622|593212794|FG007|Overall Study|Other|13|||
164230394|NCT00323622|593212787|FG000|Overall Study|Death|1|||
164230395|NCT00323622|593212788|FG001|Overall Study|Death|1|||
164230396|NCT00323622|593212789|FG002|Overall Study|Death|0|||
164230397|NCT00323622|593212790|FG003|Overall Study|Death|0|||
164230398|NCT00323622|593212791|FG004|Overall Study|Death|7|||
164230399|NCT00323622|593212792|FG005|Overall Study|Death|0|||
164230400|NCT00323622|593212793|FG006|Overall Study|Death|0|||
164230401|NCT00323622|593212794|FG007|Overall Study|Death|2|||
164230402|NCT02613507|593212803|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
164230403|NCT02613507|593212804|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
164230404|NCT02613507|593212803|FG000|Pre-Treamtent|Participant withdrew consent|0|||
164230405|NCT02613507|593212804|FG001|Pre-Treamtent|Participant withdrew consent|4|||
164230406|NCT02613507|593212803|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
164230407|NCT02613507|593212804|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
164230408|NCT02613507|593212803|FG000|Treatment|Not reported|3|||
164230409|NCT02613507|593212804|FG001|Treatment|Not reported|0|||
164230410|NCT02613507|593212803|FG000|Treatment|Other reasons|8|||
164230411|NCT02613507|593212804|FG001|Treatment|Other reasons|0|||
164230412|NCT02613507|593212803|FG000|Treatment|Participant no longer meets criteria|3|||
164230413|NCT02613507|593212804|FG001|Treatment|Participant no longer meets criteria|0|||
164230414|NCT02613507|593212803|FG000|Treatment|Maximum clinical benefit|5|||
164230415|NCT02613507|593212804|FG001|Treatment|Maximum clinical benefit|10|||
164230416|NCT02613507|593212803|FG000|Treatment|Lost to Follow-up|1|||
164230417|NCT02613507|593212804|FG001|Treatment|Lost to Follow-up|0|||
164230418|NCT02613507|593212803|FG000|Treatment|Participant withdrew consent|0|||
164230419|NCT02613507|593212804|FG001|Treatment|Participant withdrew consent|2|||
164230420|NCT02613507|593212803|FG000|Treatment|Participant request to discontinue study treatment|13|||
164230421|NCT02613507|593212804|FG001|Treatment|Participant request to discontinue study treatment|17|||
164230422|NCT02613507|593212803|FG000|Treatment|Adverse event unrelated to study drug|20|||
164230423|NCT02613507|593212804|FG001|Treatment|Adverse event unrelated to study drug|3|||
164230424|NCT02613507|593212803|FG000|Treatment|Death|2|||
164230425|NCT02613507|593212804|FG001|Treatment|Death|0|||
164230426|NCT02613507|593212803|FG000|Treatment|Study drug toxicity|19|||
164230427|NCT02613507|593212804|FG001|Treatment|Study drug toxicity|14|||
164230428|NCT02613507|593212803|FG000|Treatment|Disease progression|263|||
164230429|NCT02613507|593212804|FG001|Treatment|Disease progression|110|||
164230430|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
164230431|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
164230432|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
164230433|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
164230434|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
164230435|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
164230436|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
164230437|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
164230438|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
164230439|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
164230440|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
164230441|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230442|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230443|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230444|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
164230445|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230446|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230447|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230448|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230449|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230450|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230451|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
164230452|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230453|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230454|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
164230455|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230456|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230457|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230458|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230459|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230460|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230461|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230462|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
164230463|NCT02471144|593214023|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
164230464|NCT02471144|593214024|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
164230465|NCT02471144|593214025|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230466|NCT02471144|593214026|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230467|NCT02471144|593214027|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230468|NCT02471144|593214028|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230469|NCT02471144|593214029|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230470|NCT02471144|593214030|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230471|NCT02471144|593214031|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230472|NCT02471144|593214032|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230473|NCT02471144|593214033|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
164230474|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230475|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230476|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230477|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230478|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
164230479|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230480|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
164230481|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230482|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
164332000|NCT02456103|593593147|FG000|Overall Study|Protocol Violation|1|||
164332001|NCT02456103|593593147|FG000|Overall Study|Adverse Event|5|||
164332002|NCT02456103|593593147|FG000|Overall Study|Abnormal Laboratory Value|2|||
164332003|NCT02456103|593593147|FG000|Overall Study|Lost to Follow-up|1|||
164332004|NCT02456103|593593147|FG000|Overall Study|Withdrawal by Subject|24|||
164332005|NCT01465191|593593148|FG000|Overall Study|Protocol Violation|6|||
164332006|NCT01465191|593593149|FG001|Overall Study|Protocol Violation|3|||
164332007|NCT01465191|593593150|FG002|Overall Study|Protocol Violation|3|||
164332008|NCT01465191|593593148|FG000|Overall Study|Lost to Follow-up|3|||
164332009|NCT01465191|593593149|FG001|Overall Study|Lost to Follow-up|6|||
164332010|NCT01465191|593593150|FG002|Overall Study|Lost to Follow-up|4|||
164332011|NCT03614975|593593151|FG000|Overall Study|Physician Decision|7|||
164332012|NCT03614975|593593152|FG001|Overall Study|Physician Decision|5|||
164332013|NCT03614975|593593151|FG000|Overall Study|Withdrawal by Subject|2|||
164332014|NCT03614975|593593152|FG001|Overall Study|Withdrawal by Subject|2|||
164332015|NCT03614975|593593151|FG000|Overall Study|Specimens not in lab batch shipment|1|||
164332016|NCT03614975|593593152|FG001|Overall Study|Specimens not in lab batch shipment|1|||
164332017|NCT01390220|593593153|FG000|Test Dose Phase|Adverse Event|17|||
164332018|NCT01390220|593593154|FG001|Test Dose Phase|Adverse Event|0|||
164332019|NCT01390220|593593155|FG002|Test Dose Phase|Adverse Event|0|||
164332020|NCT01390220|593593153|FG000|Test Dose Phase|Withdrawal by Subject|8|||
164332021|NCT01390220|593593154|FG001|Test Dose Phase|Withdrawal by Subject|0|||
164332022|NCT01390220|593593155|FG002|Test Dose Phase|Withdrawal by Subject|0|||
164332023|NCT01390220|593593153|FG000|Test Dose Phase|Lost to Follow-up|2|||
164332024|NCT01390220|593593154|FG001|Test Dose Phase|Lost to Follow-up|0|||
164332025|NCT01390220|593593155|FG002|Test Dose Phase|Lost to Follow-up|0|||
164332026|NCT01390220|593593153|FG000|Test Dose Phase|Protocol Violation|8|||
164332027|NCT01390220|593593154|FG001|Test Dose Phase|Protocol Violation|0|||
164332028|NCT01390220|593593155|FG002|Test Dose Phase|Protocol Violation|0|||
164332029|NCT01390220|593593153|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
164332030|NCT01390220|593593154|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
164332031|NCT01390220|593593155|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
164332032|NCT01390220|593593153|FG000|Test Dose Phase|Study/Site closure|6|||
164332033|NCT01390220|593593154|FG001|Test Dose Phase|Study/Site closure|0|||
164332034|NCT01390220|593593155|FG002|Test Dose Phase|Study/Site closure|0|||
164332035|NCT01390220|593593153|FG000|Test Dose Phase|Caregiver no longer available|5|||
164332036|NCT01390220|593593154|FG001|Test Dose Phase|Caregiver no longer available|0|||
164332037|NCT01390220|593593155|FG002|Test Dose Phase|Caregiver no longer available|0|||
164332038|NCT01390220|593593153|FG000|Test Dose Phase|Noncompliance|2|||
164332039|NCT01390220|593593154|FG001|Test Dose Phase|Noncompliance|0|||
164332040|NCT01390220|593593155|FG002|Test Dose Phase|Noncompliance|0|||
164332041|NCT01390220|593593153|FG000|Test Dose Phase|Logistical|6|||
164332042|NCT01390220|593593154|FG001|Test Dose Phase|Logistical|0|||
164332043|NCT01390220|593593155|FG002|Test Dose Phase|Logistical|0|||
164332044|NCT01390220|593593153|FG000|Comparative Phase|Withdrawal by Subject|0|||
164332045|NCT01390220|593593154|FG001|Comparative Phase|Withdrawal by Subject|1|||
164332046|NCT01390220|593593155|FG002|Comparative Phase|Withdrawal by Subject|0|||
164332047|NCT00943124|593593156|FG000|Period 1|Withdrawal by Subject|1|||
164332048|NCT00943124|593593157|FG001|Period 1|Withdrawal by Subject|1|||
164332049|NCT00943124|593593156|FG000|Period 1|Did Not Follow Study Procedures|1|||
164332050|NCT00943124|593593157|FG001|Period 1|Did Not Follow Study Procedures|0|||
164332051|NCT00943124|593593156|FG000|Period 1|Personal Reasons|0|||
164332052|NCT00943124|593593157|FG001|Period 1|Personal Reasons|1|||
164332053|NCT03059446|593593158|FG000|Overall Study|Adverse Event|11|||
164332054|NCT03059446|593593158|FG000|Overall Study|Withdrawal of Consent|16|||
164332055|NCT03059446|593593158|FG000|Overall Study|Lost to Follow-up|3|||
164332056|NCT03059446|593593158|FG000|Overall Study|Protocol Violation|1|||
164332057|NCT03059446|593593158|FG000|Overall Study|Study Terminated by Sponsor|131|||
164332058|NCT03059446|593593158|FG000|Overall Study|Reason not Specified|5|||
164332059|NCT02992132|593593159|FG000|Overall Study|Adverse Event|4|||
164332060|NCT02992132|593593160|FG001|Overall Study|Adverse Event|1|||
164332061|NCT02992132|593593161|FG002|Overall Study|Adverse Event|3|||
164332062|NCT02992132|593593159|FG000|Overall Study|Lack of Efficacy|2|||
164332063|NCT02992132|593593160|FG001|Overall Study|Lack of Efficacy|0|||
164332064|NCT02992132|593593161|FG002|Overall Study|Lack of Efficacy|0|||
164332065|NCT02992132|593593159|FG000|Overall Study|Non-compliance with study drug|2|||
164332066|NCT02992132|593593160|FG001|Overall Study|Non-compliance with study drug|0|||
164332067|NCT02992132|593593161|FG002|Overall Study|Non-compliance with study drug|0|||
164332068|NCT02992132|593593159|FG000|Overall Study|Progressive disease|1|||
164332069|NCT02992132|593593160|FG001|Overall Study|Progressive disease|0|||
164332070|NCT02992132|593593161|FG002|Overall Study|Progressive disease|0|||
164332071|NCT02992132|593593159|FG000|Overall Study|Protocol Violation|2|||
164332072|NCT02992132|593593160|FG001|Overall Study|Protocol Violation|2|||
164332073|NCT02992132|593593161|FG002|Overall Study|Protocol Violation|0|||
164332074|NCT02992132|593593159|FG000|Overall Study|Caregiver withdrew consent|2|||
164332075|NCT02992132|593593160|FG001|Overall Study|Caregiver withdrew consent|3|||
164332076|NCT02992132|593593161|FG002|Overall Study|Caregiver withdrew consent|2|||
164332077|NCT02992132|593593159|FG000|Overall Study|Withdrawal by Subject|0|||
164332078|NCT02992132|593593160|FG001|Overall Study|Withdrawal by Subject|2|||
164332079|NCT02992132|593593161|FG002|Overall Study|Withdrawal by Subject|1|||
164332080|NCT02992132|593593159|FG000|Overall Study|Physician Decision|0|||
164332081|NCT02992132|593593160|FG001|Overall Study|Physician Decision|0|||
164332082|NCT02992132|593593161|FG002|Overall Study|Physician Decision|1|||
164332083|NCT02448810|593593162|FG000|Overall Study|Adverse Event|0|||
164332084|NCT02448810|593593163|FG001|Overall Study|Adverse Event|0|||
164332085|NCT02448810|593593164|FG002|Overall Study|Adverse Event|1|||
164332086|NCT02448810|593593165|FG003|Overall Study|Adverse Event|0|||
164332087|NCT02448810|593593166|FG004|Overall Study|Adverse Event|0|||
164332088|NCT02448810|593593167|FG005|Overall Study|Adverse Event|0|||
164332089|NCT02448810|593593168|FG006|Overall Study|Adverse Event|0|||
164332090|NCT02448810|593593169|FG007|Overall Study|Adverse Event|0|||
164332091|NCT02448810|593593162|FG000|Overall Study|Withdrawal by Subject|0|||
164332092|NCT02448810|593593163|FG001|Overall Study|Withdrawal by Subject|0|||
164332093|NCT02448810|593593164|FG002|Overall Study|Withdrawal by Subject|1|||
164332094|NCT02448810|593593165|FG003|Overall Study|Withdrawal by Subject|0|||
164332095|NCT02448810|593593166|FG004|Overall Study|Withdrawal by Subject|3|||
164332096|NCT02448810|593593167|FG005|Overall Study|Withdrawal by Subject|5|||
164332097|NCT02448810|593593168|FG006|Overall Study|Withdrawal by Subject|0|||
164332098|NCT02448810|593593169|FG007|Overall Study|Withdrawal by Subject|2|||
164332099|NCT02448810|593593162|FG000|Overall Study|Other (study terminated by sponsor)|0|||
164332100|NCT02448810|593593163|FG001|Overall Study|Other (study terminated by sponsor)|0|||
164332101|NCT02448810|593593164|FG002|Overall Study|Other (study terminated by sponsor)|0|||
164332102|NCT02448810|593593165|FG003|Overall Study|Other (study terminated by sponsor)|0|||
164332103|NCT02448810|593593166|FG004|Overall Study|Other (study terminated by sponsor)|4|||
164332104|NCT02448810|593593167|FG005|Overall Study|Other (study terminated by sponsor)|2|||
164332105|NCT02448810|593593168|FG006|Overall Study|Other (study terminated by sponsor)|2|||
164332106|NCT02448810|593593169|FG007|Overall Study|Other (study terminated by sponsor)|1|||
163987074|NCT00441545|592320272|FG001|Second Intervention|Subject exceeded safety criteria|0|||
163987075|NCT00441545|592320271|FG000|Second Intervention|Subject moved|0|||
163987076|NCT00441545|592320272|FG001|Second Intervention|Subject moved|1|||
163987077|NCT00939692|592320277|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
163987078|NCT00939692|592320278|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
163987079|NCT00939692|592320277|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
163987080|NCT00939692|592320278|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
163987081|NCT00699907|592320283|FG000|Overall Study|Withdrawal by Subject|2|||
163987082|NCT00699907|592320284|FG001|Overall Study|Withdrawal by Subject|1|||
163987083|NCT00699907|592320285|FG002|Overall Study|Withdrawal by Subject|0|||
163987084|NCT00699907|592320283|FG000|Overall Study|No usable sample|0|||
163987085|NCT00699907|592320284|FG001|Overall Study|No usable sample|9|||
163987086|NCT00699907|592320285|FG002|Overall Study|No usable sample|8|||
163987087|NCT01081795|592320286|FG000|Overall Study|Adverse Event|18|||
163987088|NCT01081795|592320287|FG001|Overall Study|Adverse Event|23|||
163987089|NCT01081795|592320288|FG002|Overall Study|Adverse Event|6|||
164332107|NCT02448810|593593162|FG000|Overall Study|Death|1|||
164332108|NCT02448810|593593163|FG001|Overall Study|Death|0|||
164332109|NCT02448810|593593164|FG002|Overall Study|Death|1|||
164332110|NCT02448810|593593165|FG003|Overall Study|Death|0|||
164332111|NCT02448810|593593166|FG004|Overall Study|Death|1|||
164332112|NCT02448810|593593167|FG005|Overall Study|Death|0|||
164332113|NCT02448810|593593168|FG006|Overall Study|Death|0|||
164332114|NCT02448810|593593169|FG007|Overall Study|Death|0|||
164332115|NCT02448810|593593162|FG000|Overall Study|Other (Progressive disease)|2|||
164332116|NCT02448810|593593163|FG001|Overall Study|Other (Progressive disease)|2|||
164332117|NCT02448810|593593164|FG002|Overall Study|Other (Progressive disease)|0|||
164332118|NCT02448810|593593165|FG003|Overall Study|Other (Progressive disease)|3|||
164332119|NCT02448810|593593166|FG004|Overall Study|Other (Progressive disease)|23|||
164332120|NCT02448810|593593167|FG005|Overall Study|Other (Progressive disease)|9|||
164332121|NCT02448810|593593168|FG006|Overall Study|Other (Progressive disease)|14|||
164332122|NCT02448810|593593169|FG007|Overall Study|Other (Progressive disease)|5|||
164332123|NCT02448810|593593162|FG000|Overall Study|Lost to Follow-up|0|||
164332124|NCT02448810|593593163|FG001|Overall Study|Lost to Follow-up|1|||
164332125|NCT02448810|593593164|FG002|Overall Study|Lost to Follow-up|0|||
164332126|NCT02448810|593593165|FG003|Overall Study|Lost to Follow-up|0|||
164332127|NCT02448810|593593166|FG004|Overall Study|Lost to Follow-up|0|||
164332128|NCT02448810|593593167|FG005|Overall Study|Lost to Follow-up|0|||
164332129|NCT02448810|593593168|FG006|Overall Study|Lost to Follow-up|0|||
164332130|NCT02448810|593593169|FG007|Overall Study|Lost to Follow-up|0|||
164332131|NCT02448810|593593162|FG000|Overall Study|Other (unspecified)|0|||
164332132|NCT02448810|593593163|FG001|Overall Study|Other (unspecified)|0|||
164332133|NCT02448810|593593164|FG002|Overall Study|Other (unspecified)|0|||
164332134|NCT02448810|593593165|FG003|Overall Study|Other (unspecified)|0|||
164332135|NCT02448810|593593166|FG004|Overall Study|Other (unspecified)|0|||
164332136|NCT02448810|593593167|FG005|Overall Study|Other (unspecified)|0|||
164332137|NCT02448810|593593168|FG006|Overall Study|Other (unspecified)|2|||
164332138|NCT02448810|593593169|FG007|Overall Study|Other (unspecified)|0|||
164332139|NCT00136604|593593170|FG000|Overall Study|Lost to Follow-up|1|||
164332140|NCT00136604|593593171|FG001|Overall Study|Lost to Follow-up|0|||
164332141|NCT00136604|593593172|FG002|Overall Study|Lost to Follow-up|0|||
164332142|NCT00136604|593593173|FG003|Overall Study|Lost to Follow-up|0|||
164332143|NCT00136604|593593174|FG004|Overall Study|Lost to Follow-up|1|||
164332144|NCT00136604|593593170|FG000|Overall Study|Migrated/moved from study area|0|||
164332145|NCT00136604|593593171|FG001|Overall Study|Migrated/moved from study area|1|||
164332146|NCT00136604|593593172|FG002|Overall Study|Migrated/moved from study area|0|||
164332147|NCT00136604|593593173|FG003|Overall Study|Migrated/moved from study area|0|||
164332148|NCT00136604|593593174|FG004|Overall Study|Migrated/moved from study area|0|||
164332149|NCT04795622|593593175|FG000|Overall Study|Adverse Event|1|||
164332150|NCT04795622|593593176|FG001|Overall Study|Adverse Event|0|||
164332151|NCT04795622|593593175|FG000|Overall Study|Withdrawal by Subject|3|||
164332152|NCT04795622|593593176|FG001|Overall Study|Withdrawal by Subject|3|||
164332153|NCT04795622|593593175|FG000|Overall Study|Protocol Violation|0|||
164332154|NCT04795622|593593176|FG001|Overall Study|Protocol Violation|2|||
164332155|NCT04795622|593593175|FG000|Overall Study|Lost to Follow-up|2|||
164332156|NCT04795622|593593176|FG001|Overall Study|Lost to Follow-up|3|||
164332157|NCT04795622|593593175|FG000|Overall Study|Other|7|||
164332158|NCT04795622|593593176|FG001|Overall Study|Other|8|||
164332159|NCT00470847|593593177|FG000|Overall Study|Pt still receiving treatment|1|||
164332160|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
164332161|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
164332162|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
164332163|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
164332164|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
164332165|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
164332166|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164230483|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230484|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
164230485|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230486|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230487|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230488|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230489|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230490|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
164230491|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230492|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230493|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
164230494|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230495|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
164230496|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230497|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230498|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230499|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230500|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230501|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230502|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230503|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230504|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
164230505|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230506|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
164230507|NCT02471144|593214023|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230508|NCT02471144|593214024|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230509|NCT02471144|593214025|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230510|NCT02471144|593214026|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230511|NCT02471144|593214027|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230512|NCT02471144|593214028|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230513|NCT02471144|593214029|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230514|NCT02471144|593214030|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
164230515|NCT02471144|593214031|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
164230516|NCT02471144|593214032|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230517|NCT02471144|593214033|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
164230518|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230519|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230520|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230521|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230522|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230523|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230524|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230525|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230526|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
164230527|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
164230528|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
164230529|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230530|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230531|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230532|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230533|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230534|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230535|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230536|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230537|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230538|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
164230539|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
164230540|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230541|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230542|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230543|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230544|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230545|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230546|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230547|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230548|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230549|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
164230550|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
164230551|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230552|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230553|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230554|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230555|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230556|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230557|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230558|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230559|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
164230560|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
164230561|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
164230562|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230563|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230564|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230565|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230566|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230567|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230568|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230569|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230570|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230571|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
164230572|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
164230573|NCT02471144|593214023|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164332167|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164332168|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
164332169|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
164332170|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164332171|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
164332172|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
164332173|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
164332174|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
164332175|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
164332176|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
164332177|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
163883253|NCT04169373|591942107|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
163883254|NCT04169373|591942104|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
163883255|NCT04169373|591942105|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
163883256|NCT04169373|591942106|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
163883257|NCT04169373|591942107|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
163883258|NCT04169373|591942104|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
163883259|NCT04169373|591942105|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
163883260|NCT04169373|591942106|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
163883261|NCT04169373|591942107|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
163883262|NCT04169373|591942104|FG000|Week 14 to Week 52|Other|4|||
163883263|NCT04169373|591942105|FG001|Week 14 to Week 52|Other|5|||
164230574|NCT02471144|593214024|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230575|NCT02471144|593214025|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230576|NCT02471144|593214026|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230577|NCT02471144|593214027|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230578|NCT02471144|593214028|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230579|NCT02471144|593214029|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230580|NCT02471144|593214030|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230581|NCT02471144|593214031|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
164230582|NCT02471144|593214032|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
164230583|NCT02471144|593214033|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
164230584|NCT03977155|593214038|FG000|Overall Study|Adverse Event|3|||
164230585|NCT03977155|593214039|FG001|Overall Study|Adverse Event|0|||
164230586|NCT03977155|593214040|FG002|Overall Study|Adverse Event|0|||
164230587|NCT03977155|593214038|FG000|Overall Study|Lost to Follow-up|0|||
164230588|NCT03977155|593214039|FG001|Overall Study|Lost to Follow-up|1|||
164230589|NCT03977155|593214040|FG002|Overall Study|Lost to Follow-up|0|||
164230590|NCT03977155|593214038|FG000|Overall Study|Withdrawal by Subject|1|||
164230591|NCT03977155|593214039|FG001|Overall Study|Withdrawal by Subject|1|||
164230592|NCT03977155|593214040|FG002|Overall Study|Withdrawal by Subject|2|||
164230593|NCT03977155|593214038|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
164230594|NCT03977155|593214039|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
164230595|NCT03977155|593214040|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
164230596|NCT00936936|593214041|FG000|Overall Study|Adverse Event|7|||
164230597|NCT00936936|593214042|FG001|Overall Study|Adverse Event|1|||
164230598|NCT00936936|593214041|FG000|Overall Study|Disease Progression|2|||
164230599|NCT00936936|593214042|FG001|Overall Study|Disease Progression|2|||
164230600|NCT00936936|593214041|FG000|Overall Study|Unrelated|3|||
164230601|NCT00936936|593214042|FG001|Overall Study|Unrelated|1|||
164230602|NCT03440385|593214052|FG000|Overall Study|Other Reason|4|||
164230603|NCT03440385|593214053|FG001|Overall Study|Other Reason|1|||
164230604|NCT03440385|593214052|FG000|Overall Study|Site Closed|1|||
164230605|NCT03440385|593214053|FG001|Overall Study|Site Closed|0|||
164230606|NCT03440385|593214052|FG000|Overall Study|Lost to Follow-up|2|||
164230607|NCT03440385|593214053|FG001|Overall Study|Lost to Follow-up|0|||
164230608|NCT03440385|593214052|FG000|Overall Study|Withdrawal by Subject|12|||
164230609|NCT03440385|593214053|FG001|Overall Study|Withdrawal by Subject|6|||
164230610|NCT03440385|593214052|FG000|Overall Study|Lack of Efficacy|9|||
164230611|NCT03440385|593214053|FG001|Overall Study|Lack of Efficacy|2|||
164230612|NCT03440385|593214052|FG000|Overall Study|Adverse Event|15|||
164230613|NCT03440385|593214053|FG001|Overall Study|Adverse Event|11|||
164230614|NCT00488293|593214054|FG000|Overall Study|Lost to Follow-up|28|||
164230615|NCT00488293|593214055|FG001|Overall Study|Lost to Follow-up|25|||
164230616|NCT00488293|593214054|FG000|Overall Study|Withdrawal by Subject|5|||
164230617|NCT00488293|593214055|FG001|Overall Study|Withdrawal by Subject|3|||
164230618|NCT00488293|593214054|FG000|Overall Study|Death|2|||
164230619|NCT00488293|593214055|FG001|Overall Study|Death|1|||
164230620|NCT00488293|593214054|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
164332178|NCT03963401|593593179|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332179|NCT03963401|593593180|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
164332180|NCT03963401|593593181|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332181|NCT03963401|593593182|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332182|NCT03963401|593593183|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332183|NCT03963401|593593184|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
164332184|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
164332185|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
164332186|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
164332187|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
164332188|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
164332189|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
164332190|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
164332191|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164230621|NCT00488293|593214055|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
164230622|NCT00939185|593214056|FG000|Overall Study|Adverse Event|3|||
164230623|NCT00939185|593214056|FG000|Overall Study|Lack of Efficacy|1|||
164230624|NCT00939185|593214056|FG000|Overall Study|Lost to Follow-up|6|||
164230625|NCT00939185|593214056|FG000|Overall Study|Other|3|||
164230626|NCT00939185|593214056|FG000|Overall Study|Withdrawal by Subject|2|||
164230627|NCT00939185|593214056|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
164230628|NCT00363298|593214057|FG000|First Study Week|Lack of Efficacy|6|||
164230629|NCT00363298|593214058|FG001|First Study Week|Lack of Efficacy|5|||
164230630|NCT00363298|593214057|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
164230631|NCT00363298|593214058|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
164230632|NCT02374255|593214059|FG000|Overall Study|Withdrawal by Subject|2|||
164230633|NCT02374255|593214060|FG001|Overall Study|Withdrawal by Subject|0|||
164230634|NCT02374255|593214061|FG002|Overall Study|Withdrawal by Subject|0|||
164230635|NCT02374255|593214062|FG003|Overall Study|Withdrawal by Subject|0|||
164230636|NCT00730327|593214063|FG000|Overall Study|Lost to Follow-up|14|||
164230637|NCT00730327|593214064|FG001|Overall Study|Lost to Follow-up|16|||
164230638|NCT00730327|593214063|FG000|Overall Study|Adverse Event|8|||
164230639|NCT00730327|593214064|FG001|Overall Study|Adverse Event|1|||
164230640|NCT00730327|593214063|FG000|Overall Study|Withdrawal by Subject|3|||
164230641|NCT00730327|593214064|FG001|Overall Study|Withdrawal by Subject|13|||
164230642|NCT00730327|593214063|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
164230643|NCT00730327|593214064|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
164230644|NCT00095576|593214065|FG000|Overall Study|Adverse Event|5|||
164230645|NCT00095576|593214066|FG001|Overall Study|Adverse Event|3|||
164230646|NCT00095576|593214065|FG000|Overall Study|Lost to Follow-up|233|||
164230647|NCT00095576|593214066|FG001|Overall Study|Lost to Follow-up|229|||
164230648|NCT00095576|593214065|FG000|Overall Study|Protocol Violation|1|||
164230649|NCT00095576|593214066|FG001|Overall Study|Protocol Violation|0|||
164230650|NCT00095576|593214065|FG000|Overall Study|Withdrawal by Subject|34|||
164230651|NCT00095576|593214066|FG001|Overall Study|Withdrawal by Subject|47|||
164230652|NCT00095576|593214065|FG000|Overall Study|Option to switch to a rollover study|1097|||
164230653|NCT00095576|593214066|FG001|Overall Study|Option to switch to a rollover study|1099|||
164230654|NCT00095576|593214065|FG000|Overall Study|Site terminated|75|||
164230655|NCT00095576|593214066|FG001|Overall Study|Site terminated|67|||
164230656|NCT00095576|593214065|FG000|Overall Study|Subject moved|30|||
164230657|NCT00095576|593214066|FG001|Overall Study|Subject moved|36|||
164230658|NCT02332928|593214069|FG000|Overall Study|Withdrawal by Subject|0|||
164230659|NCT02332928|593214070|FG001|Overall Study|Withdrawal by Subject|2|||
164230660|NCT02332928|593214069|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
164230661|NCT02332928|593214070|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
164230662|NCT01497197|593214071|FG000|Overall Study|Lost to Follow-up|1|||
164230663|NCT01497197|593214072|FG001|Overall Study|Lost to Follow-up|0|||
164230664|NCT01497197|593214071|FG000|Overall Study|Protocol Violation|0|||
164230665|NCT01497197|593214072|FG001|Overall Study|Protocol Violation|2|||
164230666|NCT01497197|593214071|FG000|Overall Study|Withdrawal by Subject|2|||
164230667|NCT01497197|593214072|FG001|Overall Study|Withdrawal by Subject|1|||
164230668|NCT01497197|593214071|FG000|Overall Study|Excessive/lack of response to treatment|1|||
164230669|NCT01497197|593214072|FG001|Overall Study|Excessive/lack of response to treatment|0|||
164230670|NCT01497197|593214071|FG000|Overall Study|Risk of OHSS|1|||
164230671|NCT01497197|593214072|FG001|Overall Study|Risk of OHSS|0|||
164230672|NCT01497197|593214071|FG000|Overall Study|No oocytes retrieved|3|||
164230673|NCT01497197|593214072|FG001|Overall Study|No oocytes retrieved|2|||
164230674|NCT01497197|593214071|FG000|Overall Study|No fertilisation|6|||
164230675|NCT01497197|593214072|FG001|Overall Study|No fertilisation|5|||
164230676|NCT01497197|593214071|FG000|Overall Study|Intention to freeze all embryos|0|||
164230677|NCT01497197|593214072|FG001|Overall Study|Intention to freeze all embryos|1|||
164230678|NCT01497197|593214071|FG000|Overall Study|All embryos discarded|0|||
164230679|NCT01497197|593214072|FG001|Overall Study|All embryos discarded|3|||
164230680|NCT01497197|593214071|FG000|Overall Study|Other|3|||
164230681|NCT01497197|593214072|FG001|Overall Study|Other|1|||
164230682|NCT01425814|593214074|FG000|Period 1|Stability criteria not fulfilled|0|||
164230683|NCT01425814|593214075|FG001|Period 1|Stability criteria not fulfilled|1|||
164230684|NCT01425814|593214076|FG002|Period 1|Stability criteria not fulfilled|0|||
164230685|NCT01425814|593214077|FG003|Period 1|Stability criteria not fulfilled|0|||
164230686|NCT01425814|593214078|FG004|Period 1|Stability criteria not fulfilled|0|||
164230687|NCT01425814|593214079|FG005|Period 1|Stability criteria not fulfilled|0|||
164230688|NCT01425814|593214074|FG000|Period 2|Stability criteria not fulfilled|0|||
164230689|NCT01425814|593214075|FG001|Period 2|Stability criteria not fulfilled|1|||
164230690|NCT01425814|593214076|FG002|Period 2|Stability criteria not fulfilled|0|||
164230691|NCT01425814|593214077|FG003|Period 2|Stability criteria not fulfilled|0|||
164230692|NCT01425814|593214078|FG004|Period 2|Stability criteria not fulfilled|0|||
164230693|NCT01425814|593214079|FG005|Period 2|Stability criteria not fulfilled|0|||
164230694|NCT01425814|593214074|FG000|Period 3|Adverse Event|0|||
164230695|NCT01425814|593214075|FG001|Period 3|Adverse Event|0|||
164230696|NCT01425814|593214076|FG002|Period 3|Adverse Event|0|||
164230697|NCT01425814|593214077|FG003|Period 3|Adverse Event|0|||
164230698|NCT01425814|593214078|FG004|Period 3|Adverse Event|0|||
164230699|NCT01425814|593214079|FG005|Period 3|Adverse Event|1|||
164230700|NCT01425814|593214074|FG000|Period 4|Adverse Event|1|||
164230701|NCT01425814|593214075|FG001|Period 4|Adverse Event|0|||
164230702|NCT01425814|593214076|FG002|Period 4|Adverse Event|1|||
164230703|NCT01425814|593214077|FG003|Period 4|Adverse Event|0|||
164230704|NCT01425814|593214078|FG004|Period 4|Adverse Event|0|||
164230705|NCT01425814|593214079|FG005|Period 4|Adverse Event|0|||
164230706|NCT01425814|593214074|FG000|Period 5|Stability criteria not fulfilled|0|||
164230707|NCT01425814|593214075|FG001|Period 5|Stability criteria not fulfilled|0|||
164230708|NCT01425814|593214076|FG002|Period 5|Stability criteria not fulfilled|1|||
164230709|NCT01425814|593214077|FG003|Period 5|Stability criteria not fulfilled|0|||
164230710|NCT01425814|593214078|FG004|Period 5|Stability criteria not fulfilled|0|||
164230711|NCT01425814|593214079|FG005|Period 5|Stability criteria not fulfilled|1|||
163883264|NCT04169373|591942106|FG002|Week 14 to Week 52|Other|4|||
163883265|NCT04169373|591942107|FG003|Week 14 to Week 52|Other|5|||
164230712|NCT01052779|593214080|FG000|Overall Study|Adverse Event|1|||
164230713|NCT01052779|593214081|FG001|Overall Study|Adverse Event|4|||
164230714|NCT01052779|593214080|FG000|Overall Study|Withdrawal by Subject|1|||
164230715|NCT01052779|593214081|FG001|Overall Study|Withdrawal by Subject|2|||
164230716|NCT01052779|593214080|FG000|Overall Study|Other-Protocol Violation|1|||
164230717|NCT01052779|593214081|FG001|Overall Study|Other-Protocol Violation|1|||
164230718|NCT01052779|593214080|FG000|Overall Study|Other-Surgery|0|||
164230719|NCT01052779|593214081|FG001|Overall Study|Other-Surgery|2|||
164230720|NCT01052779|593214080|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
164230721|NCT01052779|593214081|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
164230722|NCT03580044|593214082|FG000|Overall Study|Death|2|||
164230723|NCT03580044|593214083|FG001|Overall Study|Death|1|||
164230724|NCT03580044|593214082|FG000|Overall Study|Withdrawal by Subject|1|||
164230725|NCT03580044|593214083|FG001|Overall Study|Withdrawal by Subject|1|||
164230726|NCT03524157|593214084|FG000|Overall Study|cytology not readable|0|||
164230727|NCT03524157|593214085|FG001|Overall Study|cytology not readable|0|||
164230728|NCT03524157|593214086|FG002|Overall Study|cytology not readable|1|||
164230729|NCT01358734|593214087|FG000|Overall Study|Adverse Event|4|||
164230730|NCT01358734|593214088|FG001|Overall Study|Adverse Event|7|||
164230731|NCT01358734|593214089|FG002|Overall Study|Adverse Event|3|||
164230732|NCT01358734|593214087|FG000|Overall Study|Lack of Efficacy|0|||
164230733|NCT01358734|593214088|FG001|Overall Study|Lack of Efficacy|1|||
164230734|NCT01358734|593214089|FG002|Overall Study|Lack of Efficacy|3|||
164230735|NCT01358734|593214087|FG000|Overall Study|Withdrawal by Subject|1|||
164230736|NCT01358734|593214088|FG001|Overall Study|Withdrawal by Subject|6|||
164230737|NCT01358734|593214089|FG002|Overall Study|Withdrawal by Subject|3|||
164230738|NCT01358734|593214087|FG000|Overall Study|Death|3|||
164230739|NCT01358734|593214088|FG001|Overall Study|Death|7|||
164230740|NCT01358734|593214089|FG002|Overall Study|Death|2|||
164230741|NCT01358734|593214087|FG000|Overall Study|Progressive Disease|5|||
164230742|NCT01358734|593214088|FG001|Overall Study|Progressive Disease|13|||
164230743|NCT01358734|593214089|FG002|Overall Study|Progressive Disease|16|||
164230744|NCT01358734|593214087|FG000|Overall Study|Non-compliance with study drug|0|||
164230745|NCT01358734|593214088|FG001|Overall Study|Non-compliance with study drug|0|||
164230746|NCT01358734|593214089|FG002|Overall Study|Non-compliance with study drug|1|||
164230747|NCT01358734|593214087|FG000|Overall Study|Other|2|||
164230748|NCT01358734|593214088|FG001|Overall Study|Other|5|||
164230749|NCT01358734|593214089|FG002|Overall Study|Other|4|||
163883266|NCT04169373|591942104|FG000|Week 14 to Week 52|Ongoing|0|||
164230750|NCT01358734|593214087|FG000|Overall Study|Protocol Violation|0|||
164230751|NCT01358734|593214088|FG001|Overall Study|Protocol Violation|0|||
164230752|NCT01358734|593214089|FG002|Overall Study|Protocol Violation|2|||
164230753|NCT03427619|593214092|FG000|Overall Study|Physician Decision|3|||
164230754|NCT03427619|593214092|FG000|Overall Study|Withdrawal by Subject|4|||
164230755|NCT03427619|593214092|FG000|Overall Study|Lost to Follow-up|5|||
164230756|NCT03427619|593214092|FG000|Overall Study|Administrative|4|||
164230757|NCT03427619|593214092|FG000|Overall Study|Other|2|||
164230758|NCT03427619|593214092|FG000|Overall Study|Unknown or Missing Completion Status|48|||
164230759|NCT02743962|593214099|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
164230760|NCT02743962|593214100|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
164230761|NCT01055028|593214106|FG000|Screening|Screen Failure|1|||
164230762|NCT01055028|593214107|FG001|Screening|Screen Failure|1|||
164230763|NCT01055028|593214106|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
164230764|NCT01055028|593214107|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
163883267|NCT04169373|591942105|FG001|Week 14 to Week 52|Ongoing|1|||
164230765|NCT01055028|593214106|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
164230766|NCT01055028|593214107|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
164230767|NCT01055028|593214106|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
164332192|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
164332193|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164332194|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164332195|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
164332196|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332197|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332198|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
164332199|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332200|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332201|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
164332202|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
164332203|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332204|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332205|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332206|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332207|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
164332208|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
164332209|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
164332210|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
164332211|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
164332212|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
164332213|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
164332214|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
164332215|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332216|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332217|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332218|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332219|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
164332220|NCT03963401|593593179|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
164332221|NCT03963401|593593180|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
164332222|NCT03963401|593593181|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
164332223|NCT03963401|593593182|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
164332224|NCT03963401|593593183|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
164332225|NCT03963401|593593184|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
164332226|NCT01916967|593593185|FG000|Overall Study|Adverse Event|0|||
164332227|NCT01916967|593593186|FG001|Overall Study|Adverse Event|0|||
164332228|NCT01916967|593593187|FG002|Overall Study|Adverse Event|2|||
164332229|NCT01916967|593593185|FG000|Overall Study|Lack of Efficacy|0|||
164332230|NCT01916967|593593186|FG001|Overall Study|Lack of Efficacy|0|||
164332231|NCT01916967|593593187|FG002|Overall Study|Lack of Efficacy|6|||
164332232|NCT01916967|593593185|FG000|Overall Study|Physician Decision|0|||
164332233|NCT01916967|593593186|FG001|Overall Study|Physician Decision|0|||
164332234|NCT01916967|593593187|FG002|Overall Study|Physician Decision|1|||
164332235|NCT01916967|593593185|FG000|Overall Study|Protocol Violation|0|||
164332236|NCT01916967|593593186|FG001|Overall Study|Protocol Violation|1|||
164332237|NCT01916967|593593187|FG002|Overall Study|Protocol Violation|0|||
164332238|NCT01070043|593593192|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
164332239|NCT01070043|593593193|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
164332240|NCT01070043|593593194|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
164332241|NCT01070043|593593192|FG000|Double-Blind Treatment|Adverse Event|0|||
164332242|NCT01070043|593593193|FG001|Double-Blind Treatment|Adverse Event|0|||
164332243|NCT01070043|593593194|FG002|Double-Blind Treatment|Adverse Event|2|||
164332244|NCT01610271|593593197|FG000|Overall Study|Surgery not complete|0|||
164332245|NCT01610271|593593198|FG001|Overall Study|Surgery not complete|1|||
164332246|NCT01610271|593593197|FG000|Overall Study|Prosthesis not implanted|2|||
164332247|NCT01610271|593593198|FG001|Overall Study|Prosthesis not implanted|3|||
164332248|NCT02038452|593593199|FG000|Overall Study|Withdrawal by Subject|7|||
164332249|NCT02038452|593593200|FG001|Overall Study|Withdrawal by Subject|9|||
164332250|NCT02038452|593593199|FG000|Overall Study|Lost to Follow-up|31|||
164332251|NCT02038452|593593200|FG001|Overall Study|Lost to Follow-up|28|||
164332252|NCT01369615|593593201|FG000|Overall Study|Withdrawal by Subject|0|||
163883268|NCT04169373|591942106|FG002|Week 14 to Week 52|Ongoing|0|||
163883269|NCT04169373|591942107|FG003|Week 14 to Week 52|Ongoing|0|||
164332253|NCT01369615|593593202|FG001|Overall Study|Withdrawal by Subject|1|||
164332254|NCT01369615|593593201|FG000|Overall Study|Lost to Follow-up|0|||
164332255|NCT01369615|593593202|FG001|Overall Study|Lost to Follow-up|1|||
164332256|NCT02337738|593593203|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
164230768|NCT01055028|593214107|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
164230769|NCT03528902|593214111|FG000|Overall Study|Adverse Event|1|||
164230770|NCT03528902|593214112|FG001|Overall Study|Adverse Event|0|||
164230771|NCT04620668|593214113|FG000|Overall Study|Withdrawal by Subject|2|||
164230772|NCT04620668|593214114|FG001|Overall Study|Withdrawal by Subject|0|||
163883270|NCT04610892|591942108|FG000|Overall Study|Adverse Event|1|||
163883271|NCT04610892|591942109|FG001|Overall Study|Adverse Event|0|||
163883272|NCT04610892|591942110|FG002|Overall Study|Adverse Event|0|||
163883273|NCT04610892|591942111|FG003|Overall Study|Adverse Event|1|||
163883274|NCT04610892|591942112|FG004|Overall Study|Adverse Event|3|||
163883275|NCT04610892|591942108|FG000|Overall Study|Death|0|||
163883276|NCT04610892|591942109|FG001|Overall Study|Death|1|||
163883277|NCT04610892|591942110|FG002|Overall Study|Death|0|||
163883278|NCT04610892|591942111|FG003|Overall Study|Death|1|||
163883279|NCT04610892|591942112|FG004|Overall Study|Death|0|||
163883280|NCT04610892|591942108|FG000|Overall Study|Withdrawal by Subject|3|||
163883281|NCT04610892|591942109|FG001|Overall Study|Withdrawal by Subject|2|||
163883282|NCT04610892|591942110|FG002|Overall Study|Withdrawal by Subject|0|||
163883283|NCT04610892|591942111|FG003|Overall Study|Withdrawal by Subject|6|||
163883284|NCT04610892|591942112|FG004|Overall Study|Withdrawal by Subject|6|||
163883285|NCT04610892|591942108|FG000|Overall Study|Subjects who did not receive treatment|1|||
164230773|NCT04620668|593214113|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
164230774|NCT04620668|593214114|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
164230775|NCT04620668|593214113|FG000|Overall Study|Removed before analysis: missing data|2|||
164230776|NCT04620668|593214114|FG001|Overall Study|Removed before analysis: missing data|0|||
164230777|NCT04620668|593214113|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
164230778|NCT04620668|593214114|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
164230779|NCT04620668|593214113|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
164230780|NCT04620668|593214114|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
164230781|NCT00427700|593214121|FG000|Overall Study|Lost to Follow-up|2|||
164230782|NCT00427700|593214122|FG001|Overall Study|Lost to Follow-up|5|||
164230783|NCT00427700|593214121|FG000|Overall Study|no induction of menses|1|||
164230784|NCT00427700|593214122|FG001|Overall Study|no induction of menses|4|||
164230785|NCT00427700|593214121|FG000|Overall Study|Pregnancy|0|||
164230786|NCT00427700|593214122|FG001|Overall Study|Pregnancy|2|||
164230787|NCT04581395|593214123|FG000|Overall Study|Protocol Violation|4|||
164230788|NCT04581395|593214124|FG001|Overall Study|Protocol Violation|3|||
164230789|NCT04581395|593214125|FG002|Overall Study|Protocol Violation|2|||
164230790|NCT04581395|593214123|FG000|Overall Study|Physician Decision|0|||
164230791|NCT04581395|593214124|FG001|Overall Study|Physician Decision|1|||
164230792|NCT04581395|593214125|FG002|Overall Study|Physician Decision|0|||
164230793|NCT03709472|593214132|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
164230794|NCT03709472|593214133|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
164230795|NCT03709472|593214132|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
164230796|NCT03709472|593214133|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
164230797|NCT00112385|593214136|FG000|Overall Study|Lost to Follow-up|1|||
164230798|NCT00112385|593214137|FG001|Overall Study|Lost to Follow-up|0|||
164230799|NCT00112385|593214136|FG000|Overall Study|Withdrawal by Subject|0|||
164230800|NCT00112385|593214137|FG001|Overall Study|Withdrawal by Subject|1|||
164230801|NCT00959049|593215634|FG000|Overall Study|Adverse Event|1|||
164230802|NCT00959049|593215635|FG001|Overall Study|Adverse Event|0|||
164230803|NCT00959049|593215636|FG002|Overall Study|Adverse Event|0|||
164230804|NCT00959049|593215637|FG003|Overall Study|Adverse Event|0|||
164230805|NCT00959049|593215638|FG004|Overall Study|Adverse Event|0|||
164230806|NCT00959049|593215639|FG005|Overall Study|Adverse Event|0|||
164230807|NCT00959049|593215634|FG000|Overall Study|Lost to Follow-up|17|||
164230808|NCT00959049|593215635|FG001|Overall Study|Lost to Follow-up|5|||
164230809|NCT00959049|593215636|FG002|Overall Study|Lost to Follow-up|1|||
164230810|NCT00959049|593215637|FG003|Overall Study|Lost to Follow-up|10|||
164230811|NCT00959049|593215638|FG004|Overall Study|Lost to Follow-up|9|||
164230812|NCT00959049|593215639|FG005|Overall Study|Lost to Follow-up|1|||
164230813|NCT00959049|593215634|FG000|Overall Study|Contraindicated medication|0|||
164230814|NCT00959049|593215635|FG001|Overall Study|Contraindicated medication|0|||
163883286|NCT04610892|591942109|FG001|Overall Study|Subjects who did not receive treatment|0|||
163883287|NCT04610892|591942110|FG002|Overall Study|Subjects who did not receive treatment|0|||
163883288|NCT04610892|591942111|FG003|Overall Study|Subjects who did not receive treatment|0|||
163883289|NCT04610892|591942112|FG004|Overall Study|Subjects who did not receive treatment|2|||
163883290|NCT01413100|591942113|FG000|Overall Study|Withdrawal by Subject|1|||
163883291|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
164230815|NCT00959049|593215636|FG002|Overall Study|Contraindicated medication|0|||
164230816|NCT00959049|593215637|FG003|Overall Study|Contraindicated medication|1|||
164230817|NCT00959049|593215638|FG004|Overall Study|Contraindicated medication|0|||
164230818|NCT00959049|593215639|FG005|Overall Study|Contraindicated medication|0|||
164332257|NCT02337738|593593204|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
164332258|NCT02337738|593593205|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
164332259|NCT02337738|593593203|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164332260|NCT02337738|593593204|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
164332261|NCT02337738|593593205|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
164332262|NCT02337738|593593203|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
164332263|NCT02337738|593593204|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
164332264|NCT02337738|593593205|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
164332265|NCT02337738|593593203|FG000|Overall Study|Voluntary Withdrawal|10|||
164332266|NCT02337738|593593204|FG001|Overall Study|Voluntary Withdrawal|5|||
164332267|NCT02337738|593593205|FG002|Overall Study|Voluntary Withdrawal|2|||
164332268|NCT02337738|593593203|FG000|Overall Study|Lack of Efficacy|2|||
164332269|NCT02337738|593593204|FG001|Overall Study|Lack of Efficacy|4|||
164332270|NCT02337738|593593205|FG002|Overall Study|Lack of Efficacy|0|||
164332271|NCT02337738|593593203|FG000|Overall Study|Investigator's Judgment|1|||
164332272|NCT02337738|593593204|FG001|Overall Study|Investigator's Judgment|1|||
164332273|NCT02337738|593593205|FG002|Overall Study|Investigator's Judgment|3|||
164332274|NCT00986479|593593206|FG000|Period 1|Improved mood|1|||
164332275|NCT00986479|593593207|FG001|Period 1|Improved mood|0|||
164332276|NCT00986479|593593206|FG000|Period 1|Administrative reasons|1|||
164332277|NCT00986479|593593207|FG001|Period 1|Administrative reasons|0|||
164332278|NCT01721070|593593208|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
164332279|NCT02035475|593593209|FG000|Overall Study|Withdrawal by Subject|4|||
164332280|NCT02035475|593593209|FG000|Overall Study|Physician Decision|1|||
164332281|NCT02035475|593593209|FG000|Overall Study|Equipment Error|1|||
164332282|NCT01626495|593593217|FG000|Overall Study|Adverse Event|3|||
164332283|NCT01626495|593593217|FG000|Overall Study|Disease progression|27|||
164332284|NCT01626495|593593217|FG000|Overall Study|Withdrawal by Subject|1|||
164332285|NCT01626495|593593217|FG000|Overall Study|Administrative problem|1|||
164332286|NCT01626495|593593217|FG000|Overall Study|Death|2|||
164332287|NCT01626495|593593217|FG000|Overall Study|Physician Decision|1|||
164332288|NCT01626495|593593217|FG000|Overall Study|New cancer therapy|16|||
164332289|NCT01626495|593593217|FG000|Overall Study|Manufacturing failure|1|||
164332290|NCT00445978|593593218|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
164332291|NCT00445978|593593218|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
164332292|NCT00445978|593593218|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
164332293|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
164332294|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
164332295|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
164332296|NCT00445978|593593218|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
164332297|NCT00445978|593593218|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
164332298|NCT00445978|593593218|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
164332299|NCT00304239|593593219|FG000|Overall Study|Protocol Deviations/Violations|15|||
164332300|NCT00304239|593593220|FG001|Overall Study|Protocol Deviations/Violations|0|||
164332301|NCT00304239|593593219|FG000|Overall Study|Adverse Event|2|||
164332302|NCT00304239|593593220|FG001|Overall Study|Adverse Event|0|||
164332303|NCT02979197|593593221|FG000|Overall Study|Adverse Event|4|||
164332304|NCT02979197|593593222|FG001|Overall Study|Adverse Event|2|||
164332305|NCT02979197|593593223|FG002|Overall Study|Adverse Event|0|||
164332306|NCT02979197|593593221|FG000|Overall Study|Protocol Violation|0|||
164332307|NCT02979197|593593222|FG001|Overall Study|Protocol Violation|1|||
164332308|NCT02979197|593593223|FG002|Overall Study|Protocol Violation|0|||
164332309|NCT02979197|593593221|FG000|Overall Study|Subject unable to commit to study dates|0|||
164332310|NCT02979197|593593222|FG001|Overall Study|Subject unable to commit to study dates|1|||
164332311|NCT02979197|593593223|FG002|Overall Study|Subject unable to commit to study dates|0|||
164332312|NCT02949700|593593224|FG000|Phase I|Withdrawal by Subject|1|||
164332313|NCT02949700|593593225|FG001|Phase I|Withdrawal by Subject|1|||
164332314|NCT02949700|593593226|FG002|Phase I|Withdrawal by Subject|0|||
164332315|NCT02949700|593593227|FG003|Phase I|Withdrawal by Subject|0|||
164332316|NCT02949700|593593224|FG000|Phase I|Protocol Violation|1|||
164332317|NCT02949700|593593225|FG001|Phase I|Protocol Violation|0|||
163883292|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
163883293|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
163883294|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
163883295|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
164332318|NCT02949700|593593226|FG002|Phase I|Protocol Violation|0|||
163883296|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
163883297|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
163883298|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
163883299|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
163987090|NCT01081795|592320286|FG000|Overall Study|Lack of Efficacy|7|||
163987091|NCT01081795|592320287|FG001|Overall Study|Lack of Efficacy|5|||
164332319|NCT02949700|593593227|FG003|Phase I|Protocol Violation|0|||
163987092|NCT01081795|592320288|FG002|Overall Study|Lack of Efficacy|19|||
164230819|NCT00959049|593215634|FG000|Overall Study|Withdrawal by Subject|0|||
164230820|NCT00959049|593215635|FG001|Overall Study|Withdrawal by Subject|2|||
164230821|NCT00959049|593215636|FG002|Overall Study|Withdrawal by Subject|0|||
164230822|NCT00959049|593215637|FG003|Overall Study|Withdrawal by Subject|0|||
164230823|NCT00959049|593215638|FG004|Overall Study|Withdrawal by Subject|0|||
164230824|NCT00959049|593215639|FG005|Overall Study|Withdrawal by Subject|0|||
164230825|NCT00565747|593215640|FG000|Overall Study|No embryo transfer|67|||
164230826|NCT00565747|593215641|FG001|Overall Study|No embryo transfer|73|||
164230827|NCT04507204|593215642|FG000|Overall Study|Adverse Event|8|||
164230828|NCT04507204|593215643|FG001|Overall Study|Adverse Event|13|||
164230829|NCT04507204|593215642|FG000|Overall Study|Death|0|||
164230830|NCT04507204|593215643|FG001|Overall Study|Death|1|||
164230831|NCT04507204|593215642|FG000|Overall Study|Lost to Follow-up|15|||
164230832|NCT04507204|593215643|FG001|Overall Study|Lost to Follow-up|14|||
164230833|NCT04507204|593215642|FG000|Overall Study|Poor Compliance with Protocol|2|||
164230834|NCT04507204|593215643|FG001|Overall Study|Poor Compliance with Protocol|4|||
164230835|NCT04507204|593215642|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
164230836|NCT04507204|593215643|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
164230837|NCT04507204|593215642|FG000|Overall Study|Withdrawal of Patient Consent|21|||
164230838|NCT04507204|593215643|FG001|Overall Study|Withdrawal of Patient Consent|13|||
164230839|NCT01905540|593215646|FG000|Period 3|Other|1|||
164230840|NCT01905540|593215647|FG001|Period 3|Other|0|||
164230841|NCT01905540|593215648|FG002|Period 3|Other|1|||
164230842|NCT01905540|593215649|FG003|Period 3|Other|1|||
164230843|NCT03729609|593215650|FG000|Overall Study|Protocol Violation|1|||
164230844|NCT02919618|593215653|FG000|Overall Study|Death|1|||
164230845|NCT04770285|593215654|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
164230846|NCT04770285|593215655|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
164230847|NCT04770285|593215654|FG000|Overall Study|Lack of Efficacy|0|||
164230848|NCT04770285|593215655|FG001|Overall Study|Lack of Efficacy|1|||
164230849|NCT04770285|593215654|FG000|Overall Study|Lost to Follow-up|11|||
164230850|NCT04770285|593215655|FG001|Overall Study|Lost to Follow-up|8|||
164230851|NCT04770285|593215654|FG000|Overall Study|Protocol Deviation|6|||
164230852|NCT04770285|593215655|FG001|Overall Study|Protocol Deviation|6|||
164230853|NCT04770285|593215654|FG000|Overall Study|Technical Problem|0|||
164230854|NCT04770285|593215655|FG001|Overall Study|Technical Problem|1|||
164230855|NCT04770285|593215654|FG000|Overall Study|Withdrawal by Subject|9|||
164230856|NCT04770285|593215655|FG001|Overall Study|Withdrawal by Subject|8|||
164230857|NCT04770285|593215654|FG000|Overall Study|Reason Not Specified|0|||
164230858|NCT04770285|593215655|FG001|Overall Study|Reason Not Specified|1|||
164230859|NCT03411044|593215656|FG000|Overall Study|Death|30|||
164230860|NCT03411044|593215656|FG000|Overall Study|Withdrawal by Subject|48|||
164230861|NCT03411044|593215656|FG000|Overall Study|Lost to Follow-up|78|||
164230862|NCT03411044|593215656|FG000|Overall Study|Adverse Event|30|||
164230863|NCT03411044|593215656|FG000|Overall Study|Missing status|4|||
164230864|NCT00645658|593215657|FG000|Overall Study|Withdrawal by Subject|1|||
164230865|NCT00645658|593215658|FG001|Overall Study|Withdrawal by Subject|0|||
164230866|NCT00645658|593215657|FG000|Overall Study|Did not complete all assesments|0|||
164230867|NCT00645658|593215658|FG001|Overall Study|Did not complete all assesments|2|||
164230868|NCT00815633|593215669|FG000|Overall Study|study terminated|1|||
164230869|NCT02457065|593215670|FG000|Overall Study|Lost to Follow-up|9|||
164230870|NCT02457065|593215671|FG001|Overall Study|Lost to Follow-up|11|||
164230871|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
164230872|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230873|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230874|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
163883300|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
164332320|NCT02949700|593593224|FG000|Phase II|Withdrawal by Subject|0|||
164332321|NCT02949700|593593225|FG001|Phase II|Withdrawal by Subject|0|||
164332322|NCT02949700|593593226|FG002|Phase II|Withdrawal by Subject|0|||
164332323|NCT02949700|593593227|FG003|Phase II|Withdrawal by Subject|2|||
164332324|NCT02949700|593593224|FG000|Phase II|Protocol Violation|0|||
164332325|NCT02949700|593593225|FG001|Phase II|Protocol Violation|0|||
164332326|NCT02949700|593593226|FG002|Phase II|Protocol Violation|1|||
164332327|NCT02949700|593593227|FG003|Phase II|Protocol Violation|3|||
164332328|NCT05430022|593593238|FG000|Overall Study|Withdrawal by Subject|4|||
164332329|NCT05430022|593593239|FG001|Overall Study|Withdrawal by Subject|4|||
164332330|NCT05521906|593593240|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
164332331|NCT05521906|593593241|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
164332332|NCT01828320|593593242|FG000|Overall Study|Lost to Follow-up|1|||
164332333|NCT01828320|593593243|FG001|Overall Study|Lost to Follow-up|3|||
164332334|NCT01828320|593593242|FG000|Overall Study|Withdrawal by Subject|7|||
164332335|NCT01828320|593593243|FG001|Overall Study|Withdrawal by Subject|2|||
164355621|NCT00512707|593676482|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
164355622|NCT00512707|593676483|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
164355623|NCT00512707|593676482|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
164355624|NCT00512707|593676483|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
164355625|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
164355626|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
164355627|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
164355628|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
164355629|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
164355630|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
164355631|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355632|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355633|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355634|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
164355635|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
164355636|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
164355637|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
164355638|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
164355639|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
164355640|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
164355641|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
164355642|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
164355643|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355644|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355645|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355646|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
164355647|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
164355648|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
164355649|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
164355650|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
164355651|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
164355652|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
164355653|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
164355654|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
164355655|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
164355656|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
164355657|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
164355658|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
164355659|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
164355660|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
164355661|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355662|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355663|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355664|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
164355665|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
164355666|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
164355667|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
164355668|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
164355669|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
164230875|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230876|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230877|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
164230878|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
164230879|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
164230880|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
164230881|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
164230882|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
164230883|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
164230884|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
164230885|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
164230886|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
164230887|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
164230888|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
164230889|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
164230890|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
164230891|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
164230892|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
164230893|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
164230894|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
164230895|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
164230896|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
164230897|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
164230898|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
164230899|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
164230900|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
164230901|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
164230902|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
164230903|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
164230904|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
164230905|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
164230906|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
164230907|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
164230908|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
164230909|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
164230910|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
164230911|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
164230912|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
164230913|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
164230914|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230915|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230916|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230917|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230918|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230919|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
164230920|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230921|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
164230922|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230923|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230924|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230925|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230926|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
164230927|NCT01362790|593215672|FG000|Pilot Phase & Phase 2|Death on study|0|||
164230928|NCT01362790|593215673|FG001|Pilot Phase & Phase 2|Death on study|0|||
164230929|NCT01362790|593215674|FG002|Pilot Phase & Phase 2|Death on study|0|||
164230930|NCT01362790|593215675|FG003|Pilot Phase & Phase 2|Death on study|1|||
164230931|NCT01362790|593215676|FG004|Pilot Phase & Phase 2|Death on study|0|||
164230932|NCT01362790|593215677|FG005|Pilot Phase & Phase 2|Death on study|0|||
164230933|NCT01362790|593215678|FG006|Pilot Phase & Phase 2|Death on study|0|||
164230934|NCT01362790|593215672|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
164230935|NCT01362790|593215673|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
164230936|NCT01362790|593215674|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
164230937|NCT01362790|593215675|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
164230938|NCT01362790|593215676|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
164230939|NCT01362790|593215677|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
164230940|NCT01362790|593215678|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
164230941|NCT01362790|593215672|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230942|NCT01362790|593215673|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230943|NCT01362790|593215674|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230944|NCT01362790|593215675|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230945|NCT01362790|593215676|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
164230946|NCT01362790|593215677|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230947|NCT01362790|593215678|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
164230948|NCT01362790|593215672|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
164230949|NCT01362790|593215673|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
164230950|NCT01362790|593215674|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
164230951|NCT01362790|593215675|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
164230952|NCT01362790|593215676|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
164230953|NCT01362790|593215677|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
164230954|NCT01362790|593215678|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
164230955|NCT03038087|593215679|FG000|Overall Study|lost data|1|||
164230956|NCT00654355|593215680|FG000|Overall Study|Lost to Follow-up|2|||
164230957|NCT00654355|593215681|FG001|Overall Study|Lost to Follow-up|2|||
164230958|NCT01435356|593215683|FG000|Overall Study|Adverse Event|2|||
164230959|NCT01435356|593215684|FG001|Overall Study|Adverse Event|0|||
164230960|NCT01435356|593215683|FG000|Overall Study|Disease progression/recurrence|17|||
164230961|NCT01435356|593215684|FG001|Overall Study|Disease progression/recurrence|10|||
164230962|NCT01435356|593215683|FG000|Overall Study|Protocol Violation|0|||
164230963|NCT01435356|593215684|FG001|Overall Study|Protocol Violation|1|||
164230964|NCT01435356|593215683|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
164230965|NCT01435356|593215684|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
164230966|NCT01435356|593215683|FG000|Overall Study|Withdrawal by Subject|1|||
164230967|NCT01435356|593215684|FG001|Overall Study|Withdrawal by Subject|1|||
164230968|NCT01435356|593215683|FG000|Overall Study|Facial palsy|1|||
164230969|NCT01435356|593215684|FG001|Overall Study|Facial palsy|0|||
164230970|NCT01435356|593215683|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
164230971|NCT01435356|593215684|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
164230972|NCT01435356|593215683|FG000|Overall Study|Physician Decision|1|||
164230973|NCT01435356|593215684|FG001|Overall Study|Physician Decision|0|||
164230974|NCT01435356|593215683|FG000|Overall Study|Patient decision|3|||
163987093|NCT01081795|592320286|FG000|Overall Study|Subject's schedule|1|||
164230975|NCT01435356|593215684|FG001|Overall Study|Patient decision|0|||
164230976|NCT01435356|593215683|FG000|Overall Study|Patient moved to another city|1|||
164230977|NCT01435356|593215684|FG001|Overall Study|Patient moved to another city|1|||
164230978|NCT02796651|593215685|FG000|Overall Study|Adverse Event|6|||
164230979|NCT02796651|593215685|FG000|Overall Study|Lost to Follow-up|1|||
164230980|NCT02796651|593215685|FG000|Overall Study|Withdrawal by Subject|4|||
164230981|NCT02796651|593215685|FG000|Overall Study|Protocol Violation|4|||
164230982|NCT02796651|593215685|FG000|Overall Study|Lack of Efficacy|1|||
164230983|NCT02796651|593215685|FG000|Overall Study|Other|10|||
164230984|NCT00437073|593215686|FG000|Overall Study|Sponsor Terminated Study|1|||
164230985|NCT00437073|593215687|FG001|Overall Study|Sponsor Terminated Study|0|||
164230986|NCT00437073|593215686|FG000|Overall Study|Physician Decision|0|||
164230987|NCT00437073|593215687|FG001|Overall Study|Physician Decision|1|||
164230988|NCT03485157|593215688|FG000|Double Blind Phase|Lost to Follow-up|4|||
164230989|NCT03485157|593215689|FG001|Double Blind Phase|Lost to Follow-up|4|||
164230990|NCT03485157|593215688|FG000|Double Blind Phase|Adverse Event|2|||
164230991|NCT03485157|593215689|FG001|Double Blind Phase|Adverse Event|1|||
164230992|NCT03485157|593215688|FG000|Double Blind Phase|Withdrawal by Subject|6|||
164230993|NCT03485157|593215689|FG001|Double Blind Phase|Withdrawal by Subject|9|||
164332336|NCT00866788|593595546|FG000|Overall Study|Adverse Event|0|||
164332337|NCT00866788|593595547|FG001|Overall Study|Adverse Event|2|||
164332338|NCT00866788|593595548|FG002|Overall Study|Adverse Event|0|||
164332339|NCT00866788|593595549|FG003|Overall Study|Adverse Event|1|||
164332340|NCT00866788|593595546|FG000|Overall Study|Lost to Follow-up|1|||
164332341|NCT00866788|593595547|FG001|Overall Study|Lost to Follow-up|1|||
164332342|NCT00866788|593595548|FG002|Overall Study|Lost to Follow-up|0|||
164332343|NCT00866788|593595549|FG003|Overall Study|Lost to Follow-up|2|||
164332344|NCT00866788|593595546|FG000|Overall Study|Withdrawal by Subject|2|||
164230994|NCT03485157|593215688|FG000|Double Blind Phase|Removal by PI|3|||
164230995|NCT03485157|593215689|FG001|Double Blind Phase|Removal by PI|7|||
164230996|NCT03485157|593215688|FG000|Open Label Phase|Lost to Follow-up|1|||
164230997|NCT03485157|593215689|FG001|Open Label Phase|Lost to Follow-up|2|||
164230998|NCT03485157|593215688|FG000|Open Label Phase|Adverse Event|0|||
164230999|NCT03485157|593215689|FG001|Open Label Phase|Adverse Event|1|||
164231000|NCT03485157|593215688|FG000|Open Label Phase|Withdrawal by Subject|1|||
164231001|NCT03485157|593215689|FG001|Open Label Phase|Withdrawal by Subject|2|||
164231002|NCT03485157|593215688|FG000|Open Label Phase|Removal by PI|2|||
164231003|NCT03485157|593215689|FG001|Open Label Phase|Removal by PI|0|||
164231004|NCT04918771|593215693|FG000|Overall Study|Withdrawal by Subject|4|||
164231005|NCT04918771|593215694|FG001|Overall Study|Withdrawal by Subject|5|||
164231006|NCT04918771|593215693|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
164231007|NCT04918771|593215694|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
164231008|NCT01849276|593215695|FG000|Followed for Survival for 5 Years|Death|1|||
164231009|NCT01849276|593215695|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
164231010|NCT02657343|593215696|FG000|Overall Study|Death|0|||
164231011|NCT02657343|593215697|FG001|Overall Study|Death|2|||
164231012|NCT02657343|593215698|FG002|Overall Study|Death|0|||
164231013|NCT02657343|593215699|FG003|Overall Study|Death|0|||
164231014|NCT02657343|593215700|FG004|Overall Study|Death|0|||
164231015|NCT02657343|593215701|FG005|Overall Study|Death|0|||
164231016|NCT02657343|593215696|FG000|Overall Study|Patient went to hospice|1|||
164231017|NCT02657343|593215697|FG001|Overall Study|Patient went to hospice|0|||
164231018|NCT02657343|593215698|FG002|Overall Study|Patient went to hospice|0|||
164231019|NCT02657343|593215699|FG003|Overall Study|Patient went to hospice|0|||
164231020|NCT02657343|593215700|FG004|Overall Study|Patient went to hospice|0|||
164231021|NCT02657343|593215701|FG005|Overall Study|Patient went to hospice|0|||
164231022|NCT02657343|593215696|FG000|Overall Study|Withdrawal by Subject|0|||
164231023|NCT02657343|593215697|FG001|Overall Study|Withdrawal by Subject|0|||
164231024|NCT02657343|593215698|FG002|Overall Study|Withdrawal by Subject|0|||
164231025|NCT02657343|593215699|FG003|Overall Study|Withdrawal by Subject|0|||
164231026|NCT02657343|593215700|FG004|Overall Study|Withdrawal by Subject|1|||
164231027|NCT02657343|593215701|FG005|Overall Study|Withdrawal by Subject|0|||
164231028|NCT01813357|593215709|FG000|Overall Study|Lost to Follow-up|5|||
164231029|NCT01813357|593215710|FG001|Overall Study|Lost to Follow-up|6|||
164231030|NCT02607722|593215717|FG000|Overall Study|No data reliability|1|||
164231031|NCT02607722|593215717|FG000|Overall Study|no patient visit|18|||
164231032|NCT02607722|593215717|FG000|Overall Study|missing info in CRF|13|||
164231033|NCT02607722|593215717|FG000|Overall Study|Withdrawal by Subject|616|||
164231034|NCT02607722|593215717|FG000|Overall Study|Lost to Follow-up|312|||
164231035|NCT02607722|593215717|FG000|Overall Study|Improved|22|||
164231036|NCT02607722|593215717|FG000|Overall Study|Lack of Efficacy|316|||
164231037|NCT02607722|593215717|FG000|Overall Study|Adverse Event|2553|||
164231038|NCT02607722|593215717|FG000|Overall Study|Not treated|1|||
164231039|NCT02607722|593215717|FG000|Overall Study|No CRF collected|138|||
164231040|NCT02607722|593215717|FG000|Overall Study|without CRF|4225|||
164231041|NCT02607722|593215717|FG000|Overall Study|Physician Decision|367|||
164231042|NCT04347538|593215718|FG000|Overall Study|Lost to Follow-up|4|||
164231043|NCT04347538|593215719|FG001|Overall Study|Lost to Follow-up|5|||
164231044|NCT04347538|593215720|FG002|Overall Study|Lost to Follow-up|7|||
164231045|NCT02259231|593215721|FG000|Overall Study|Adverse Event|1|||
164231046|NCT02259231|593215722|FG001|Overall Study|Adverse Event|1|||
164231047|NCT02259231|593215723|FG002|Overall Study|Adverse Event|2|||
164231048|NCT02259231|593215724|FG003|Overall Study|Adverse Event|0|||
164231049|NCT02259231|593215725|FG004|Overall Study|Adverse Event|0|||
164231050|NCT02259231|593215726|FG005|Overall Study|Adverse Event|0|||
164231051|NCT02259231|593215727|FG006|Overall Study|Adverse Event|0|||
164231052|NCT02259231|593215721|FG000|Overall Study|Progressive Disease|4|||
164231053|NCT02259231|593215722|FG001|Overall Study|Progressive Disease|5|||
164231054|NCT02259231|593215723|FG002|Overall Study|Progressive Disease|4|||
164231055|NCT02259231|593215724|FG003|Overall Study|Progressive Disease|5|||
164231056|NCT02259231|593215725|FG004|Overall Study|Progressive Disease|4|||
164231057|NCT02259231|593215726|FG005|Overall Study|Progressive Disease|5|||
164231058|NCT02259231|593215727|FG006|Overall Study|Progressive Disease|4|||
164231059|NCT02259231|593215721|FG000|Overall Study|Sponsor termination of study|1|||
164231060|NCT02259231|593215722|FG001|Overall Study|Sponsor termination of study|0|||
164231061|NCT02259231|593215723|FG002|Overall Study|Sponsor termination of study|0|||
164231062|NCT02259231|593215724|FG003|Overall Study|Sponsor termination of study|1|||
164231063|NCT02259231|593215725|FG004|Overall Study|Sponsor termination of study|2|||
164231064|NCT02259231|593215726|FG005|Overall Study|Sponsor termination of study|1|||
164231065|NCT02259231|593215727|FG006|Overall Study|Sponsor termination of study|1|||
164231066|NCT02871219|593215728|FG000|Overall Study|Adverse Event|15|||
164231067|NCT02871219|593215728|FG000|Overall Study|Death|3|||
164231068|NCT02871219|593215728|FG000|Overall Study|Progression|3|||
164231069|NCT02871219|593215728|FG000|Overall Study|Infections|7|||
164231070|NCT02871219|593215728|FG000|Overall Study|Infusion Related|4|||
164231071|NCT03238196|593215729|FG000|Overall Study|Adverse Event|3|||
164231072|NCT03238196|593215730|FG001|Overall Study|Adverse Event|0|||
164231073|NCT03238196|593215731|FG002|Overall Study|Adverse Event|2|||
164231074|NCT03238196|593215732|FG003|Overall Study|Adverse Event|2|||
164231075|NCT03238196|593215729|FG000|Overall Study|Withdrawal by Subject|4|||
164231076|NCT03238196|593215730|FG001|Overall Study|Withdrawal by Subject|1|||
164231077|NCT03238196|593215731|FG002|Overall Study|Withdrawal by Subject|1|||
164231078|NCT03238196|593215732|FG003|Overall Study|Withdrawal by Subject|0|||
164231079|NCT03238196|593215729|FG000|Overall Study|Disease progression|14|||
164231080|NCT03238196|593215730|FG001|Overall Study|Disease progression|2|||
164231081|NCT03238196|593215731|FG002|Overall Study|Disease progression|3|||
164231082|NCT03238196|593215732|FG003|Overall Study|Disease progression|2|||
164231083|NCT03238196|593215729|FG000|Overall Study|Still on treatment|1|||
164231084|NCT03238196|593215730|FG001|Overall Study|Still on treatment|0|||
164231085|NCT03238196|593215731|FG002|Overall Study|Still on treatment|0|||
164231086|NCT03238196|593215732|FG003|Overall Study|Still on treatment|0|||
164231087|NCT05081843|593215733|FG000|Overall Study|Lost to Follow-up|135|||
164231088|NCT05081843|593215734|FG001|Overall Study|Lost to Follow-up|145|||
164231089|NCT04938427|593215735|FG000|Overall Study|Adverse Event|5|||
164231090|NCT04938427|593215736|FG001|Overall Study|Adverse Event|19|||
164231091|NCT04938427|593215735|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164231092|NCT04938427|593215736|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164231093|NCT04938427|593215735|FG000|Overall Study|Withdrawal by Subject|1|||
164231094|NCT04938427|593215736|FG001|Overall Study|Withdrawal by Subject|0|||
164231095|NCT04938427|593215735|FG000|Overall Study|Reason Not Specified|2|||
164231096|NCT04938427|593215736|FG001|Overall Study|Reason Not Specified|1|||
164231097|NCT04629196|593215737|FG000|Overall Study|Subject discontinued study drug|1|||
164231098|NCT04629196|593215738|FG001|Overall Study|Subject discontinued study drug|0|||
164231099|NCT04629196|593215737|FG000|Overall Study|Subject study drug dosing increased|1|||
164231100|NCT04629196|593215738|FG001|Overall Study|Subject study drug dosing increased|1|||
164231101|NCT04629196|593215737|FG000|Overall Study|Withdrawal by Subject|1|||
164231102|NCT04629196|593215738|FG001|Overall Study|Withdrawal by Subject|2|||
164231103|NCT00835354|593215742|FG000|First Intervention|Adverse Event|0|||
164231104|NCT00835354|593215743|FG001|First Intervention|Adverse Event|1|||
164231105|NCT02061085|593215746|FG000|Overall Study|Adverse Event|8|||
164231106|NCT05487378|593215747|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
164231107|NCT05487378|593215748|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
164231108|NCT05487378|593215747|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
164231109|NCT05487378|593215748|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
164231110|NCT01385995|593215750|FG000|Period 1, 2 Months|Physician Decision|1|||
164231111|NCT01385995|593215751|FG001|Period 1, 2 Months|Physician Decision|0|||
164231112|NCT02414841|593215752|FG000|Overall Study|Withdrawal by Subject|7|||
164231113|NCT02414841|593215753|FG001|Overall Study|Withdrawal by Subject|5|||
164231114|NCT02414841|593215752|FG000|Overall Study|Lost to Follow-up|13|||
164231115|NCT02414841|593215753|FG001|Overall Study|Lost to Follow-up|6|||
164231116|NCT02414841|593215752|FG000|Overall Study|Death|17|||
164231117|NCT02414841|593215753|FG001|Overall Study|Death|14|||
164231118|NCT02414841|593215752|FG000|Overall Study|Received a Kidney Transplant|13|||
164231119|NCT02414841|593215753|FG001|Overall Study|Received a Kidney Transplant|4|||
164231120|NCT02414841|593215752|FG000|Overall Study|Randomized But Not Treated|6|||
164231121|NCT02414841|593215753|FG001|Overall Study|Randomized But Not Treated|4|||
164231122|NCT03164356|593215760|FG000|Overall Study|Lost to Follow-up|1|||
164231123|NCT03164356|593215761|FG001|Overall Study|Lost to Follow-up|1|||
164231124|NCT03164356|593215762|FG002|Overall Study|Lost to Follow-up|2|||
164231125|NCT03164356|593215763|FG003|Overall Study|Lost to Follow-up|1|||
164231126|NCT03164356|593215760|FG000|Overall Study|Physician Decision|0|||
164231127|NCT03164356|593215761|FG001|Overall Study|Physician Decision|0|||
164231128|NCT03164356|593215762|FG002|Overall Study|Physician Decision|3|||
164231129|NCT03164356|593215763|FG003|Overall Study|Physician Decision|0|||
164231130|NCT03164356|593215760|FG000|Overall Study|Protocol Violation|2|||
164231131|NCT03164356|593215761|FG001|Overall Study|Protocol Violation|1|||
164231132|NCT03164356|593215762|FG002|Overall Study|Protocol Violation|0|||
164231133|NCT03164356|593215763|FG003|Overall Study|Protocol Violation|0|||
164231134|NCT03164356|593215760|FG000|Overall Study|Withdrawal by Subject|1|||
164231135|NCT03164356|593215761|FG001|Overall Study|Withdrawal by Subject|0|||
164231136|NCT03164356|593215762|FG002|Overall Study|Withdrawal by Subject|0|||
164231137|NCT03164356|593215763|FG003|Overall Study|Withdrawal by Subject|0|||
164231138|NCT03164356|593215760|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
164231139|NCT03164356|593215761|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
164231140|NCT03164356|593215762|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
164231141|NCT03164356|593215763|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
164231142|NCT03164356|593215760|FG000|Overall Study|Subject Incarcerated|0|||
164231143|NCT03164356|593215761|FG001|Overall Study|Subject Incarcerated|1|||
164231144|NCT03164356|593215762|FG002|Overall Study|Subject Incarcerated|0|||
164231145|NCT03164356|593215763|FG003|Overall Study|Subject Incarcerated|0|||
164231146|NCT03164356|593215760|FG000|Overall Study|Prosthetist unable to participate|0|||
164231147|NCT03164356|593215761|FG001|Overall Study|Prosthetist unable to participate|2|||
164231148|NCT03164356|593215762|FG002|Overall Study|Prosthetist unable to participate|1|||
164231149|NCT03164356|593215763|FG003|Overall Study|Prosthetist unable to participate|0|||
164231150|NCT03648372|593215764|FG000|Overall Study|Withdrawal by Subject|2|||
164231151|NCT03648372|593215765|FG001|Overall Study|Withdrawal by Subject|0|||
164231152|NCT03648372|593215766|FG002|Overall Study|Withdrawal by Subject|0|||
164231153|NCT03648372|593215767|FG003|Overall Study|Withdrawal by Subject|0|||
164231154|NCT03648372|593215768|FG004|Overall Study|Withdrawal by Subject|0|||
164231155|NCT03648372|593215769|FG005|Overall Study|Withdrawal by Subject|1|||
164231156|NCT03648372|593215770|FG006|Overall Study|Withdrawal by Subject|2|||
164231157|NCT03648372|593215771|FG007|Overall Study|Withdrawal by Subject|0|||
164231158|NCT03648372|593215772|FG008|Overall Study|Withdrawal by Subject|0|||
164231159|NCT03648372|593215773|FG009|Overall Study|Withdrawal by Subject|0|||
164231160|NCT03648372|593215774|FG010|Overall Study|Withdrawal by Subject|2|||
164231161|NCT03648372|593215775|FG011|Overall Study|Withdrawal by Subject|0|||
164231162|NCT03648372|593215776|FG012|Overall Study|Withdrawal by Subject|2|||
164231163|NCT03648372|593215777|FG013|Overall Study|Withdrawal by Subject|0|||
164231164|NCT03648372|593215778|FG014|Overall Study|Withdrawal by Subject|0|||
164231165|NCT03648372|593215779|FG015|Overall Study|Withdrawal by Subject|0|||
164231166|NCT03648372|593215780|FG016|Overall Study|Withdrawal by Subject|1|||
164231167|NCT03648372|593215781|FG017|Overall Study|Withdrawal by Subject|0|||
164231168|NCT03648372|593215782|FG018|Overall Study|Withdrawal by Subject|0|||
164231169|NCT03648372|593215783|FG019|Overall Study|Withdrawal by Subject|0|||
164231170|NCT03648372|593215784|FG020|Overall Study|Withdrawal by Subject|0|||
164231171|NCT03648372|593215764|FG000|Overall Study|Progressive Disease|2|||
164231172|NCT03648372|593215765|FG001|Overall Study|Progressive Disease|3|||
164231173|NCT03648372|593215766|FG002|Overall Study|Progressive Disease|4|||
164231174|NCT03648372|593215767|FG003|Overall Study|Progressive Disease|3|||
164231175|NCT03648372|593215768|FG004|Overall Study|Progressive Disease|2|||
164231176|NCT03648372|593215769|FG005|Overall Study|Progressive Disease|2|||
164231177|NCT03648372|593215770|FG006|Overall Study|Progressive Disease|3|||
164231178|NCT03648372|593215771|FG007|Overall Study|Progressive Disease|3|||
164231179|NCT03648372|593215772|FG008|Overall Study|Progressive Disease|5|||
164231180|NCT03648372|593215773|FG009|Overall Study|Progressive Disease|5|||
164231181|NCT03648372|593215774|FG010|Overall Study|Progressive Disease|2|||
164231182|NCT03648372|593215775|FG011|Overall Study|Progressive Disease|3|||
164231183|NCT03648372|593215776|FG012|Overall Study|Progressive Disease|3|||
164231184|NCT03648372|593215777|FG013|Overall Study|Progressive Disease|3|||
164231185|NCT03648372|593215778|FG014|Overall Study|Progressive Disease|6|||
164231186|NCT03648372|593215779|FG015|Overall Study|Progressive Disease|0|||
164231187|NCT03648372|593215780|FG016|Overall Study|Progressive Disease|0|||
164231188|NCT03648372|593215781|FG017|Overall Study|Progressive Disease|0|||
164231189|NCT03648372|593215782|FG018|Overall Study|Progressive Disease|0|||
164231190|NCT03648372|593215783|FG019|Overall Study|Progressive Disease|0|||
164231191|NCT03648372|593215784|FG020|Overall Study|Progressive Disease|0|||
164231192|NCT03648372|593215764|FG000|Overall Study|Other|0|||
164231193|NCT03648372|593215765|FG001|Overall Study|Other|0|||
164231194|NCT03648372|593215766|FG002|Overall Study|Other|0|||
164231195|NCT03648372|593215767|FG003|Overall Study|Other|0|||
164231196|NCT03648372|593215768|FG004|Overall Study|Other|1|||
164231197|NCT03648372|593215769|FG005|Overall Study|Other|0|||
164231198|NCT03648372|593215770|FG006|Overall Study|Other|0|||
164231199|NCT03648372|593215771|FG007|Overall Study|Other|0|||
164231200|NCT03648372|593215772|FG008|Overall Study|Other|0|||
164231201|NCT03648372|593215773|FG009|Overall Study|Other|0|||
164231202|NCT03648372|593215774|FG010|Overall Study|Other|1|||
164231203|NCT03648372|593215775|FG011|Overall Study|Other|2|||
164231204|NCT03648372|593215776|FG012|Overall Study|Other|1|||
164231205|NCT03648372|593215777|FG013|Overall Study|Other|3|||
164231206|NCT03648372|593215778|FG014|Overall Study|Other|0|||
164231207|NCT03648372|593215779|FG015|Overall Study|Other|5|||
164231208|NCT03648372|593215780|FG016|Overall Study|Other|1|||
164332345|NCT00866788|593595547|FG001|Overall Study|Withdrawal by Subject|1|||
163987094|NCT01081795|592320287|FG001|Overall Study|Subject's schedule|1|||
164231209|NCT03648372|593215781|FG017|Overall Study|Other|5|||
164231210|NCT03648372|593215782|FG018|Overall Study|Other|0|||
164231211|NCT03648372|593215783|FG019|Overall Study|Other|1|||
164231212|NCT03648372|593215784|FG020|Overall Study|Other|0|||
164231213|NCT03648372|593215764|FG000|Overall Study|Lost to Follow-up|0|||
164231214|NCT03648372|593215765|FG001|Overall Study|Lost to Follow-up|0|||
164231215|NCT03648372|593215766|FG002|Overall Study|Lost to Follow-up|0|||
164231216|NCT03648372|593215767|FG003|Overall Study|Lost to Follow-up|0|||
164231217|NCT03648372|593215768|FG004|Overall Study|Lost to Follow-up|0|||
164231218|NCT03648372|593215769|FG005|Overall Study|Lost to Follow-up|0|||
164231219|NCT03648372|593215770|FG006|Overall Study|Lost to Follow-up|0|||
164231220|NCT03648372|593215771|FG007|Overall Study|Lost to Follow-up|0|||
164231221|NCT03648372|593215772|FG008|Overall Study|Lost to Follow-up|0|||
164231222|NCT03648372|593215773|FG009|Overall Study|Lost to Follow-up|0|||
164231223|NCT03648372|593215774|FG010|Overall Study|Lost to Follow-up|0|||
164231224|NCT03648372|593215775|FG011|Overall Study|Lost to Follow-up|0|||
164231225|NCT03648372|593215776|FG012|Overall Study|Lost to Follow-up|0|||
164231226|NCT03648372|593215777|FG013|Overall Study|Lost to Follow-up|1|||
164231227|NCT03648372|593215778|FG014|Overall Study|Lost to Follow-up|0|||
164231228|NCT03648372|593215779|FG015|Overall Study|Lost to Follow-up|1|||
164231229|NCT03648372|593215780|FG016|Overall Study|Lost to Follow-up|0|||
164231230|NCT03648372|593215781|FG017|Overall Study|Lost to Follow-up|1|||
164231231|NCT03648372|593215782|FG018|Overall Study|Lost to Follow-up|0|||
164231232|NCT03648372|593215783|FG019|Overall Study|Lost to Follow-up|0|||
164231233|NCT03648372|593215784|FG020|Overall Study|Lost to Follow-up|0|||
164231234|NCT03648372|593215764|FG000|Overall Study|Start of a New Systemic Treatment|0|||
164231235|NCT03648372|593215765|FG001|Overall Study|Start of a New Systemic Treatment|0|||
164231236|NCT03648372|593215766|FG002|Overall Study|Start of a New Systemic Treatment|0|||
164231237|NCT03648372|593215767|FG003|Overall Study|Start of a New Systemic Treatment|0|||
164231238|NCT03648372|593215768|FG004|Overall Study|Start of a New Systemic Treatment|0|||
164231239|NCT03648372|593215769|FG005|Overall Study|Start of a New Systemic Treatment|0|||
164231240|NCT03648372|593215770|FG006|Overall Study|Start of a New Systemic Treatment|0|||
164231241|NCT03648372|593215771|FG007|Overall Study|Start of a New Systemic Treatment|2|||
164231242|NCT03648372|593215772|FG008|Overall Study|Start of a New Systemic Treatment|0|||
164231243|NCT03648372|593215773|FG009|Overall Study|Start of a New Systemic Treatment|0|||
164231244|NCT03648372|593215774|FG010|Overall Study|Start of a New Systemic Treatment|1|||
164231245|NCT03648372|593215775|FG011|Overall Study|Start of a New Systemic Treatment|0|||
164231246|NCT03648372|593215776|FG012|Overall Study|Start of a New Systemic Treatment|0|||
164231247|NCT03648372|593215777|FG013|Overall Study|Start of a New Systemic Treatment|0|||
164231248|NCT03648372|593215778|FG014|Overall Study|Start of a New Systemic Treatment|0|||
164231249|NCT03648372|593215779|FG015|Overall Study|Start of a New Systemic Treatment|0|||
164231250|NCT03648372|593215780|FG016|Overall Study|Start of a New Systemic Treatment|0|||
164231251|NCT03648372|593215781|FG017|Overall Study|Start of a New Systemic Treatment|0|||
164231252|NCT03648372|593215782|FG018|Overall Study|Start of a New Systemic Treatment|0|||
164231253|NCT03648372|593215783|FG019|Overall Study|Start of a New Systemic Treatment|0|||
164231254|NCT03648372|593215784|FG020|Overall Study|Start of a New Systemic Treatment|0|||
164231255|NCT03396445|593218026|FG000|Treatment Period|Death|2|||
164231256|NCT03396445|593218027|FG001|Treatment Period|Death|2|||
164231257|NCT03396445|593218028|FG002|Treatment Period|Death|1|||
164231258|NCT03396445|593218029|FG003|Treatment Period|Death|1|||
164231259|NCT03396445|593218030|FG004|Treatment Period|Death|3|||
164231260|NCT03396445|593218031|FG005|Treatment Period|Death|2|||
164231261|NCT03396445|593218032|FG006|Treatment Period|Death|5|||
164231262|NCT03396445|593218033|FG007|Treatment Period|Death|3|||
164231263|NCT03396445|593218034|FG008|Treatment Period|Death|3|||
164231264|NCT03396445|593218035|FG009|Treatment Period|Death|3|||
164231265|NCT03396445|593218036|FG010|Treatment Period|Death|7|||
164231266|NCT03396445|593218037|FG011|Treatment Period|Death|12|||
164231267|NCT03396445|593218038|FG012|Treatment Period|Death|28|||
164231268|NCT03396445|593218039|FG013|Treatment Period|Death|14|||
164231269|NCT03396445|593218040|FG014|Treatment Period|Death|10|||
164231270|NCT03396445|593218041|FG015|Treatment Period|Death|8|||
164231271|NCT03396445|593218042|FG016|Treatment Period|Death|18|||
164231272|NCT03396445|593218043|FG017|Treatment Period|Death|0|||
164231273|NCT03396445|593218044|FG018|Treatment Period|Death|0|||
164231274|NCT03396445|593218045|FG019|Treatment Period|Death|0|||
164231275|NCT03396445|593218046|FG020|Treatment Period|Death|0|||
164231276|NCT03396445|593218047|FG021|Treatment Period|Death|0|||
164231277|NCT03396445|593218048|FG022|Treatment Period|Death|0|||
164231278|NCT03396445|593218049|FG023|Treatment Period|Death|0|||
164231279|NCT03396445|593218050|FG024|Treatment Period|Death|0|||
164231280|NCT03396445|593218051|FG025|Treatment Period|Death|0|||
164231281|NCT03396445|593218026|FG000|Treatment Period|Lost to Follow-up|0|||
164231282|NCT03396445|593218027|FG001|Treatment Period|Lost to Follow-up|0|||
164231283|NCT03396445|593218028|FG002|Treatment Period|Lost to Follow-up|0|||
164231284|NCT03396445|593218029|FG003|Treatment Period|Lost to Follow-up|0|||
164231285|NCT03396445|593218030|FG004|Treatment Period|Lost to Follow-up|0|||
164231286|NCT03396445|593218031|FG005|Treatment Period|Lost to Follow-up|0|||
164231287|NCT03396445|593218032|FG006|Treatment Period|Lost to Follow-up|0|||
164231288|NCT03396445|593218033|FG007|Treatment Period|Lost to Follow-up|0|||
164231289|NCT03396445|593218034|FG008|Treatment Period|Lost to Follow-up|0|||
164231290|NCT03396445|593218035|FG009|Treatment Period|Lost to Follow-up|0|||
164231291|NCT03396445|593218036|FG010|Treatment Period|Lost to Follow-up|0|||
164332346|NCT00866788|593595548|FG002|Overall Study|Withdrawal by Subject|0|||
164332347|NCT00866788|593595549|FG003|Overall Study|Withdrawal by Subject|1|||
164231292|NCT03396445|593218037|FG011|Treatment Period|Lost to Follow-up|0|||
164231293|NCT03396445|593218038|FG012|Treatment Period|Lost to Follow-up|1|||
164231294|NCT03396445|593218039|FG013|Treatment Period|Lost to Follow-up|0|||
164231295|NCT03396445|593218040|FG014|Treatment Period|Lost to Follow-up|1|||
164231296|NCT03396445|593218041|FG015|Treatment Period|Lost to Follow-up|0|||
164231297|NCT03396445|593218042|FG016|Treatment Period|Lost to Follow-up|0|||
164231298|NCT03396445|593218043|FG017|Treatment Period|Lost to Follow-up|0|||
164231299|NCT03396445|593218044|FG018|Treatment Period|Lost to Follow-up|0|||
164231300|NCT03396445|593218045|FG019|Treatment Period|Lost to Follow-up|0|||
164231301|NCT03396445|593218046|FG020|Treatment Period|Lost to Follow-up|0|||
164231302|NCT03396445|593218047|FG021|Treatment Period|Lost to Follow-up|0|||
164231303|NCT03396445|593218048|FG022|Treatment Period|Lost to Follow-up|0|||
164231304|NCT03396445|593218049|FG023|Treatment Period|Lost to Follow-up|0|||
164231305|NCT03396445|593218050|FG024|Treatment Period|Lost to Follow-up|0|||
164231306|NCT03396445|593218051|FG025|Treatment Period|Lost to Follow-up|0|||
164231307|NCT03396445|593218026|FG000|Treatment Period|Physician Decision|0|||
164231308|NCT03396445|593218027|FG001|Treatment Period|Physician Decision|0|||
164231309|NCT03396445|593218028|FG002|Treatment Period|Physician Decision|0|||
164231310|NCT03396445|593218029|FG003|Treatment Period|Physician Decision|0|||
164231311|NCT03396445|593218030|FG004|Treatment Period|Physician Decision|1|||
164231312|NCT03396445|593218031|FG005|Treatment Period|Physician Decision|0|||
164231313|NCT03396445|593218032|FG006|Treatment Period|Physician Decision|0|||
164231314|NCT03396445|593218033|FG007|Treatment Period|Physician Decision|0|||
164231315|NCT03396445|593218034|FG008|Treatment Period|Physician Decision|0|||
164231316|NCT03396445|593218035|FG009|Treatment Period|Physician Decision|1|||
164231317|NCT03396445|593218036|FG010|Treatment Period|Physician Decision|0|||
164231318|NCT03396445|593218037|FG011|Treatment Period|Physician Decision|0|||
164231319|NCT03396445|593218038|FG012|Treatment Period|Physician Decision|0|||
164231320|NCT03396445|593218039|FG013|Treatment Period|Physician Decision|0|||
164231321|NCT03396445|593218040|FG014|Treatment Period|Physician Decision|0|||
164231322|NCT03396445|593218041|FG015|Treatment Period|Physician Decision|0|||
164231323|NCT03396445|593218042|FG016|Treatment Period|Physician Decision|0|||
164231324|NCT03396445|593218043|FG017|Treatment Period|Physician Decision|0|||
164231325|NCT03396445|593218044|FG018|Treatment Period|Physician Decision|0|||
164231326|NCT03396445|593218045|FG019|Treatment Period|Physician Decision|0|||
164231327|NCT03396445|593218046|FG020|Treatment Period|Physician Decision|0|||
163987095|NCT01081795|592320288|FG002|Overall Study|Subject's schedule|2|||
164231328|NCT03396445|593218047|FG021|Treatment Period|Physician Decision|0|||
164231329|NCT03396445|593218048|FG022|Treatment Period|Physician Decision|0|||
164231330|NCT03396445|593218049|FG023|Treatment Period|Physician Decision|0|||
164231331|NCT03396445|593218050|FG024|Treatment Period|Physician Decision|0|||
164231332|NCT03396445|593218051|FG025|Treatment Period|Physician Decision|0|||
164231333|NCT03396445|593218026|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231334|NCT03396445|593218027|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164332348|NCT00866788|593595546|FG000|Overall Study|Pregnancy|0|||
164332349|NCT00866788|593595547|FG001|Overall Study|Pregnancy|1|||
164332350|NCT00866788|593595548|FG002|Overall Study|Pregnancy|0|||
164332351|NCT00866788|593595549|FG003|Overall Study|Pregnancy|0|||
164332352|NCT00866788|593595546|FG000|Overall Study|Disease progression|3|||
164332353|NCT00866788|593595547|FG001|Overall Study|Disease progression|1|||
164332354|NCT00866788|593595548|FG002|Overall Study|Disease progression|1|||
164332355|NCT00866788|593595549|FG003|Overall Study|Disease progression|0|||
163987096|NCT01081795|592320286|FG000|Overall Study|Revocation of informed consent|2|||
163987097|NCT01081795|592320287|FG001|Overall Study|Revocation of informed consent|0|||
164231335|NCT03396445|593218028|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231336|NCT03396445|593218029|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231337|NCT03396445|593218030|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
163987098|NCT01081795|592320288|FG002|Overall Study|Revocation of informed consent|0|||
163987099|NCT01081795|592320286|FG000|Overall Study|Ineligible for participation|1|||
163987100|NCT01081795|592320287|FG001|Overall Study|Ineligible for participation|0|||
164231338|NCT03396445|593218031|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231339|NCT03396445|593218032|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231340|NCT03396445|593218033|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164332356|NCT00866788|593595546|FG000|Overall Study|Physician Decision|0|||
163987101|NCT01081795|592320288|FG002|Overall Study|Ineligible for participation|0|||
163987102|NCT01081795|592320286|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
163987103|NCT01081795|592320287|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
163987104|NCT01081795|592320288|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
163987105|NCT01081795|592320286|FG000|Overall Study|Using drug with restricted days of use|2|||
163987106|NCT01081795|592320287|FG001|Overall Study|Using drug with restricted days of use|3|||
164231341|NCT03396445|593218034|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231342|NCT03396445|593218035|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231343|NCT03396445|593218036|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231344|NCT03396445|593218037|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231345|NCT03396445|593218038|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
164231346|NCT03396445|593218039|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164332357|NCT00866788|593595547|FG001|Overall Study|Physician Decision|0|||
164332358|NCT00866788|593595548|FG002|Overall Study|Physician Decision|1|||
164332359|NCT00866788|593595549|FG003|Overall Study|Physician Decision|1|||
164332360|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
164332361|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
164332362|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
164332363|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
164332364|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
164332365|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
164332366|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
164332367|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
164332368|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
164332369|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
164332370|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
164332371|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
164332372|NCT02349061|593595551|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
164332373|NCT02349061|593595552|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
164332374|NCT02349061|593595553|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
164332375|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
164332376|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
164332377|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
164332378|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
164332379|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
164332380|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
164332381|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
164332382|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
164332383|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
164332384|NCT02349061|593595551|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
164332385|NCT02349061|593595552|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
164332386|NCT02349061|593595553|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
164332387|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
164332388|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
164332389|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
164332390|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
164332391|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
164332392|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
164332393|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
164332394|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
164332395|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
164332396|NCT02349061|593595551|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
164332397|NCT02349061|593595552|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
164332398|NCT02349061|593595553|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
164332399|NCT02095223|593595554|FG000|Overall Study|Withdrawal by Subject|1|||
164332400|NCT02095223|593595555|FG001|Overall Study|Withdrawal by Subject|0|||
164332401|NCT01397162|593595556|FG000|Overall Study|Adverse Event|4|||
164332402|NCT01397162|593595557|FG001|Overall Study|Adverse Event|0|||
164332403|NCT01397162|593595558|FG002|Overall Study|Adverse Event|0|||
164332404|NCT01397162|593595559|FG003|Overall Study|Adverse Event|0|||
164332405|NCT01397162|593595560|FG004|Overall Study|Adverse Event|0|||
164332406|NCT01397162|593595556|FG000|Overall Study|Not yet defined|3|||
164332407|NCT01397162|593595557|FG001|Overall Study|Not yet defined|4|||
164332408|NCT01397162|593595558|FG002|Overall Study|Not yet defined|3|||
164332409|NCT01397162|593595559|FG003|Overall Study|Not yet defined|5|||
164332410|NCT01397162|593595560|FG004|Overall Study|Not yet defined|3|||
164332411|NCT02339285|593595561|FG000|Overall Study|Withdrawal by Subject|0|||
164332412|NCT02339285|593595562|FG001|Overall Study|Withdrawal by Subject|1|||
164332413|NCT02339285|593595563|FG002|Overall Study|Withdrawal by Subject|1|||
164332414|NCT02339285|593595561|FG000|Overall Study|Lost to Follow-up|1|||
164332415|NCT02339285|593595562|FG001|Overall Study|Lost to Follow-up|1|||
164332416|NCT02339285|593595563|FG002|Overall Study|Lost to Follow-up|1|||
164332417|NCT02339285|593595561|FG000|Overall Study|Protocol Deviation|0|||
164332418|NCT02339285|593595562|FG001|Overall Study|Protocol Deviation|1|||
164332419|NCT02339285|593595563|FG002|Overall Study|Protocol Deviation|0|||
164332420|NCT01507298|593595566|FG000|Overall Study|Protocol Violation|0|||
164332421|NCT01507298|593595567|FG001|Overall Study|Protocol Violation|6|||
164332422|NCT01920555|593595568|FG000|Overall Study|Physician Decision|1|||
164332423|NCT01920555|593595569|FG001|Overall Study|Physician Decision|2|||
164332424|NCT01920555|593595570|FG002|Overall Study|Physician Decision|1|||
164332425|NCT01920555|593595571|FG003|Overall Study|Physician Decision|2|||
164332426|NCT01920555|593595572|FG004|Overall Study|Physician Decision|0|||
164332427|NCT01920555|593595568|FG000|Overall Study|Lack of Efficacy|2|||
164332428|NCT01920555|593595569|FG001|Overall Study|Lack of Efficacy|0|||
164332429|NCT01920555|593595570|FG002|Overall Study|Lack of Efficacy|0|||
164231347|NCT03396445|593218040|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
163883301|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
163883302|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
163883303|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
163883304|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
164231348|NCT03396445|593218041|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231349|NCT03396445|593218042|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231350|NCT03396445|593218043|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231351|NCT03396445|593218044|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231352|NCT03396445|593218045|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231353|NCT03396445|593218046|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231354|NCT03396445|593218047|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231355|NCT03396445|593218048|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231356|NCT03396445|593218049|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231357|NCT03396445|593218050|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231358|NCT03396445|593218051|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
164231359|NCT03396445|593218026|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
164231360|NCT03396445|593218027|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
164231361|NCT03396445|593218028|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
164231362|NCT03396445|593218029|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
164231363|NCT03396445|593218030|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
164231364|NCT03396445|593218031|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231365|NCT03396445|593218032|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
164231366|NCT03396445|593218033|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231367|NCT03396445|593218034|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231368|NCT03396445|593218035|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231369|NCT03396445|593218036|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231370|NCT03396445|593218037|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231371|NCT03396445|593218038|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231372|NCT03396445|593218039|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231373|NCT03396445|593218040|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231374|NCT03396445|593218041|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231375|NCT03396445|593218042|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231376|NCT03396445|593218043|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231377|NCT03396445|593218044|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231378|NCT03396445|593218045|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231379|NCT03396445|593218046|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164299709|NCT00888134|593472905|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
164299710|NCT00888134|593472905|FG000|Follow-up|being followed for long-term survival|1|||
164299711|NCT03783078|593472908|FG000|Overall Study|Death|31|||
164299712|NCT03783078|593472908|FG000|Overall Study|Sponsor Decision|23|||
164299713|NCT03783078|593472908|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164299714|NCT01903460|593472911|FG000|Overall Study|Adverse Event|0|||
164299715|NCT01903460|593472912|FG001|Overall Study|Adverse Event|0|||
164299716|NCT01903460|593472913|FG002|Overall Study|Adverse Event|0|||
164299717|NCT01903460|593472914|FG003|Overall Study|Adverse Event|1|||
164299718|NCT03104868|593472915|FG000|6 Week Follow up|Lost to Follow-up|5|||
164299719|NCT03104868|593472916|FG001|6 Week Follow up|Lost to Follow-up|8|||
164299720|NCT03104868|593472915|FG000|6 Week Follow up|Death|1|||
164299721|NCT03104868|593472916|FG001|6 Week Follow up|Death|1|||
164299722|NCT03104868|593472915|FG000|6 Week Follow up|Withdrawal by Subject|7|||
164299723|NCT03104868|593472916|FG001|6 Week Follow up|Withdrawal by Subject|6|||
164299724|NCT03104868|593472915|FG000|6 Week Follow up|Completed Later Timepoint|24|||
164299725|NCT03104868|593472916|FG001|6 Week Follow up|Completed Later Timepoint|22|||
164299726|NCT03104868|593472915|FG000|6 Month Follow up|Lost to Follow-up|2|||
164299727|NCT03104868|593472916|FG001|6 Month Follow up|Lost to Follow-up|2|||
164299728|NCT03104868|593472915|FG000|6 Month Follow up|Death|0|||
164231380|NCT03396445|593218047|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231381|NCT03396445|593218048|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231382|NCT03396445|593218049|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231383|NCT03396445|593218050|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231384|NCT03396445|593218051|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
164231385|NCT03396445|593218026|FG000|Treatment Period|Withdrawal by Subject|0|||
164231386|NCT03396445|593218027|FG001|Treatment Period|Withdrawal by Subject|0|||
164231387|NCT03396445|593218028|FG002|Treatment Period|Withdrawal by Subject|0|||
164231388|NCT03396445|593218029|FG003|Treatment Period|Withdrawal by Subject|0|||
164231389|NCT03396445|593218030|FG004|Treatment Period|Withdrawal by Subject|0|||
164231390|NCT03396445|593218031|FG005|Treatment Period|Withdrawal by Subject|0|||
164231391|NCT03396445|593218032|FG006|Treatment Period|Withdrawal by Subject|0|||
164231392|NCT03396445|593218033|FG007|Treatment Period|Withdrawal by Subject|0|||
164231393|NCT03396445|593218034|FG008|Treatment Period|Withdrawal by Subject|0|||
164231394|NCT03396445|593218035|FG009|Treatment Period|Withdrawal by Subject|0|||
164231395|NCT03396445|593218036|FG010|Treatment Period|Withdrawal by Subject|0|||
164231396|NCT03396445|593218037|FG011|Treatment Period|Withdrawal by Subject|0|||
164231397|NCT03396445|593218038|FG012|Treatment Period|Withdrawal by Subject|0|||
164231398|NCT03396445|593218039|FG013|Treatment Period|Withdrawal by Subject|0|||
164231399|NCT03396445|593218040|FG014|Treatment Period|Withdrawal by Subject|1|||
164231400|NCT03396445|593218041|FG015|Treatment Period|Withdrawal by Subject|0|||
164231401|NCT03396445|593218042|FG016|Treatment Period|Withdrawal by Subject|1|||
164231402|NCT03396445|593218043|FG017|Treatment Period|Withdrawal by Subject|0|||
164231403|NCT03396445|593218044|FG018|Treatment Period|Withdrawal by Subject|0|||
164231404|NCT03396445|593218045|FG019|Treatment Period|Withdrawal by Subject|0|||
164231405|NCT03396445|593218046|FG020|Treatment Period|Withdrawal by Subject|0|||
164231406|NCT03396445|593218047|FG021|Treatment Period|Withdrawal by Subject|0|||
164231407|NCT03396445|593218048|FG022|Treatment Period|Withdrawal by Subject|0|||
164231408|NCT03396445|593218049|FG023|Treatment Period|Withdrawal by Subject|0|||
164231409|NCT03396445|593218050|FG024|Treatment Period|Withdrawal by Subject|0|||
164231410|NCT03396445|593218051|FG025|Treatment Period|Withdrawal by Subject|0|||
163883305|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
163883306|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
163883307|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
163883308|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
163883309|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
163883310|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
163883311|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
163883312|NCT05369403|591942114|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
163883313|NCT05369403|591942115|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
163883314|NCT05369403|591942116|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
163883315|NCT05369403|591942114|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
163883316|NCT05369403|591942115|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
163883317|NCT05369403|591942116|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
163883318|NCT05369403|591942114|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
163883319|NCT05369403|591942115|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
163883320|NCT05369403|591942116|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
163883321|NCT05369403|591942114|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
163883322|NCT05369403|591942115|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
163883323|NCT05369403|591942116|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
163883324|NCT04760678|591942117|FG000|Overall Study|Death|13|||
163883325|NCT04760678|591942117|FG000|Overall Study|Lost to Follow-up|48|||
163883326|NCT04760678|591942117|FG000|Overall Study|Withdrawal by Subject|1|||
163883327|NCT01748448|591942122|FG000|Treatment Period|Consent withdrawn by subject|1|||
163883328|NCT01748448|591942123|FG001|Treatment Period|Consent withdrawn by subject|0|||
163883329|NCT01748448|591942122|FG000|Treatment Period|Adverse Event|1|||
163883330|NCT01748448|591942123|FG001|Treatment Period|Adverse Event|0|||
163883331|NCT01748448|591942122|FG000|Treatment Period|Personal|0|||
163883332|NCT01748448|591942123|FG001|Treatment Period|Personal|1|||
163883333|NCT03675282|591942127|FG000|Overall Study|Lost to Follow-up|4|||
163883334|NCT03675282|591942128|FG001|Overall Study|Lost to Follow-up|8|||
163883335|NCT03675282|591942129|FG002|Overall Study|Lost to Follow-up|1|||
163883336|NCT03675282|591942130|FG003|Overall Study|Lost to Follow-up|0|||
163883337|NCT03675282|591942131|FG004|Overall Study|Lost to Follow-up|2|||
164231411|NCT03396445|593218026|FG000|Switch-over Period|Death|0|||
164231412|NCT03396445|593218027|FG001|Switch-over Period|Death|0|||
164231413|NCT03396445|593218028|FG002|Switch-over Period|Death|0|||
163883338|NCT03675282|591942132|FG005|Overall Study|Lost to Follow-up|7|||
164332430|NCT01920555|593595571|FG003|Overall Study|Lack of Efficacy|0|||
164332431|NCT01920555|593595572|FG004|Overall Study|Lack of Efficacy|0|||
164332432|NCT01920555|593595568|FG000|Overall Study|Travel Difficulties|1|||
164332433|NCT01920555|593595569|FG001|Overall Study|Travel Difficulties|1|||
164332434|NCT01920555|593595570|FG002|Overall Study|Travel Difficulties|0|||
164332435|NCT01920555|593595571|FG003|Overall Study|Travel Difficulties|0|||
164332436|NCT01920555|593595572|FG004|Overall Study|Travel Difficulties|1|||
163883339|NCT03675282|591942127|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
164332437|NCT01920555|593595568|FG000|Overall Study|Lost to Follow-up|0|||
164332438|NCT01920555|593595569|FG001|Overall Study|Lost to Follow-up|1|||
164332439|NCT01920555|593595570|FG002|Overall Study|Lost to Follow-up|0|||
164332440|NCT01920555|593595571|FG003|Overall Study|Lost to Follow-up|1|||
164332441|NCT01920555|593595572|FG004|Overall Study|Lost to Follow-up|0|||
163883340|NCT03675282|591942128|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
163883341|NCT03675282|591942129|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
163883342|NCT03675282|591942130|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
163883343|NCT03675282|591942131|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
163883344|NCT03675282|591942132|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
163883345|NCT03675282|591942127|FG000|Overall Study|Physician Decision|1|||
163883346|NCT03675282|591942128|FG001|Overall Study|Physician Decision|0|||
163883347|NCT03675282|591942129|FG002|Overall Study|Physician Decision|0|||
163883348|NCT03675282|591942130|FG003|Overall Study|Physician Decision|0|||
163883349|NCT03675282|591942131|FG004|Overall Study|Physician Decision|0|||
163883350|NCT03675282|591942132|FG005|Overall Study|Physician Decision|0|||
163883351|NCT03232138|591942133|FG000|Overall Study|Physician Decision|1|||
163883352|NCT03232138|591942134|FG001|Overall Study|Physician Decision|0|||
163883353|NCT03232138|591942133|FG000|Overall Study|Adverse Event|2|||
163883354|NCT03232138|591942134|FG001|Overall Study|Adverse Event|0|||
163883355|NCT03232138|591942133|FG000|Overall Study|Withdrawal by Subject|1|||
163883356|NCT03232138|591942134|FG001|Overall Study|Withdrawal by Subject|2|||
163883357|NCT03853746|591942136|FG000|Overall Study|Withdrawal by Subject|1|||
163883358|NCT04952909|591942141|FG000|Overall Study|Death|3|||
163883359|NCT00881621|591942142|FG000|Overall Study|Physician Decision|34|||
163883360|NCT04359108|591942143|FG000|Overall Study|Withdrawal by Subject|1|||
163883361|NCT04359108|591942144|FG001|Overall Study|Withdrawal by Subject|0|||
163883362|NCT04359108|591942143|FG000|Overall Study|Unable or too feeble to walk independently|0|||
163883363|NCT04359108|591942144|FG001|Overall Study|Unable or too feeble to walk independently|2|||
163883364|NCT04359108|591942143|FG000|Overall Study|Argus II system stopped functioning|0|||
163883365|NCT04359108|591942144|FG001|Overall Study|Argus II system stopped functioning|1|||
163883366|NCT04359108|591942143|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
163883367|NCT04359108|591942144|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
163883368|NCT06393088|591942145|FG000|Overall Study|Withdrawal by Subject|0|||
163883369|NCT06393088|591942146|FG001|Overall Study|Withdrawal by Subject|2|||
163883370|NCT04176965|591942147|FG000|Overall Study|Death|1|||
163883371|NCT04176965|591942148|FG001|Overall Study|Death|2|||
163883372|NCT04176965|591942147|FG000|Overall Study|Lost to Follow-up|10|||
163883373|NCT04176965|591942148|FG001|Overall Study|Lost to Follow-up|2|||
163987107|NCT01081795|592320288|FG002|Overall Study|Using drug with restricted days of use|2|||
163987108|NCT01081795|592320286|FG000|Overall Study|Other|1|||
163987109|NCT01081795|592320287|FG001|Overall Study|Other|2|||
163987110|NCT01081795|592320288|FG002|Overall Study|Other|0|||
163987111|NCT02161211|592320289|FG000|Overall Study|Lost to Follow-up|21|||
163987112|NCT02161211|592320290|FG001|Overall Study|Lost to Follow-up|27|||
163987113|NCT02161211|592320291|FG002|Overall Study|Lost to Follow-up|21|||
163987114|NCT02161211|592320289|FG000|Overall Study|Dropped|12|||
163987115|NCT02161211|592320290|FG001|Overall Study|Dropped|5|||
163987116|NCT02161211|592320291|FG002|Overall Study|Dropped|9|||
163987117|NCT03115151|592320292|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
163987118|NCT03115151|592320293|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
163987119|NCT03115151|592320292|FG000|Overall Study|Epidural catheter removal|1|||
163987120|NCT03115151|592320293|FG001|Overall Study|Epidural catheter removal|0|||
163987121|NCT03115151|592320292|FG000|Overall Study|Withdrawal by Subject|0|||
163987122|NCT03115151|592320293|FG001|Overall Study|Withdrawal by Subject|1|||
163987123|NCT03115151|592320292|FG000|Overall Study|Intervention not received according to the protocol.|1|||
163987124|NCT03115151|592320293|FG001|Overall Study|Intervention not received according to the protocol.|1|||
163987125|NCT03115151|592320292|FG000|Overall Study|Physician Decision|1|||
163987126|NCT03115151|592320293|FG001|Overall Study|Physician Decision|0|||
163987127|NCT03115151|592320292|FG000|Overall Study|Randomization not applied|1|||
163987128|NCT03115151|592320293|FG001|Overall Study|Randomization not applied|1|||
163987129|NCT03713944|592320296|FG000|Study Treatment|Patient non-compliance|1|||
163987130|NCT03713944|592320296|FG000|Study Treatment|Alternative Cancer Therapy|3|||
163987131|NCT03713944|592320296|FG000|Study Treatment|Disease Progression|18|||
163987132|NCT03713944|592320296|FG000|Study Treatment|AE/Side Effects/Complications|2|||
163987133|NCT03713944|592320296|FG000|Study Treatment|Death|2|||
164332442|NCT00426231|593595573|FG000|Overall Study|Withdrawal by Subject|9|||
163987134|NCT03713944|592320296|FG000|Study Treatment|Withdrawal by Subject|1|||
163987135|NCT03713944|592320296|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
163987136|NCT03713944|592320296|FG000|Study Treatment|Symptomatic Deterioration|2|||
163987137|NCT03713944|592320296|FG000|Follow up|Withdrawal by Subject|2|||
163987138|NCT03713944|592320296|FG000|Follow up|Death|11|||
163987139|NCT03713944|592320296|FG000|Follow up|Study Terminated|3|||
163987140|NCT02902120|592320297|FG000|Overall Study|Lack of Efficacy|1|||
163987141|NCT01353703|592320299|FG000|Overall Study|Migrated/moved from study area|1|||
163987142|NCT01353703|592320300|FG001|Overall Study|Migrated/moved from study area|0|||
163987143|NCT03298022|592320301|FG000|Overall Study|Lack of Efficacy|4|||
163987144|NCT03298022|592320301|FG000|Overall Study|Withdrawal by Subject|7|||
163987145|NCT03298022|592320301|FG000|Overall Study|Adverse Event|1|||
163987146|NCT03298022|592320301|FG000|Overall Study|disease relapse|1|||
163987147|NCT00730639|592320304|FG000|Overall Study|Adverse Event|3|||
163987148|NCT00730639|592320305|FG001|Overall Study|Adverse Event|0|||
163987149|NCT00730639|592320306|FG002|Overall Study|Adverse Event|9|||
163987150|NCT00730639|592320307|FG003|Overall Study|Adverse Event|8|||
163987151|NCT00730639|592320308|FG004|Overall Study|Adverse Event|23|||
163987152|NCT00730639|592320304|FG000|Overall Study|Complete Response|0|||
163987153|NCT00730639|592320305|FG001|Overall Study|Complete Response|0|||
163987154|NCT00730639|592320306|FG002|Overall Study|Complete Response|2|||
163987155|NCT00730639|592320307|FG003|Overall Study|Complete Response|2|||
163987156|NCT00730639|592320308|FG004|Overall Study|Complete Response|1|||
163987157|NCT00730639|592320304|FG000|Overall Study|Completed Maximum Cycles|0|||
163987158|NCT00730639|592320305|FG001|Overall Study|Completed Maximum Cycles|0|||
163987159|NCT00730639|592320306|FG002|Overall Study|Completed Maximum Cycles|11|||
163987160|NCT00730639|592320307|FG003|Overall Study|Completed Maximum Cycles|3|||
163987161|NCT00730639|592320308|FG004|Overall Study|Completed Maximum Cycles|6|||
163987162|NCT00730639|592320304|FG000|Overall Study|Death|0|||
163987163|NCT00730639|592320305|FG001|Overall Study|Death|0|||
163987164|NCT00730639|592320306|FG002|Overall Study|Death|0|||
163987165|NCT00730639|592320307|FG003|Overall Study|Death|0|||
163987166|NCT00730639|592320308|FG004|Overall Study|Death|2|||
163987167|NCT00730639|592320304|FG000|Overall Study|Disease Progression|12|||
163987168|NCT00730639|592320305|FG001|Overall Study|Disease Progression|13|||
163987169|NCT00730639|592320306|FG002|Overall Study|Disease Progression|48|||
163987170|NCT00730639|592320307|FG003|Overall Study|Disease Progression|32|||
163987171|NCT00730639|592320308|FG004|Overall Study|Disease Progression|88|||
163987172|NCT00730639|592320304|FG000|Overall Study|non-specified|0|||
163987173|NCT00730639|592320305|FG001|Overall Study|non-specified|0|||
163987174|NCT00730639|592320306|FG002|Overall Study|non-specified|4|||
163987175|NCT00730639|592320307|FG003|Overall Study|non-specified|2|||
163987176|NCT00730639|592320308|FG004|Overall Study|non-specified|3|||
163987177|NCT00730639|592320304|FG000|Overall Study|Protocol Violation|0|||
163987178|NCT00730639|592320305|FG001|Overall Study|Protocol Violation|0|||
163987179|NCT00730639|592320306|FG002|Overall Study|Protocol Violation|1|||
163987180|NCT00730639|592320307|FG003|Overall Study|Protocol Violation|0|||
163987181|NCT00730639|592320308|FG004|Overall Study|Protocol Violation|0|||
163987182|NCT00730639|592320304|FG000|Overall Study|Withdrawal by Subject|0|||
164332443|NCT00426231|593595574|FG001|Overall Study|Withdrawal by Subject|12|||
164332444|NCT00108433|593595575|FG000|Overall Study|Lack of Efficacy|1|||
164332445|NCT00108433|593595576|FG001|Overall Study|Lack of Efficacy|2|||
164332446|NCT00108433|593595575|FG000|Overall Study|Death|3|||
164332447|NCT00108433|593595576|FG001|Overall Study|Death|0|||
164332448|NCT00108433|593595575|FG000|Overall Study|Adverse Event|3|||
164332449|NCT00108433|593595576|FG001|Overall Study|Adverse Event|1|||
164332450|NCT00108433|593595575|FG000|Overall Study|Other|14|||
164332451|NCT00108433|593595576|FG001|Overall Study|Other|14|||
164332452|NCT01193660|593595577|FG000|Overall Study|Withdrawal by Subject|2|||
164332453|NCT01193660|593595578|FG001|Overall Study|Withdrawal by Subject|3|||
164332454|NCT01193660|593595579|FG002|Overall Study|Withdrawal by Subject|1|||
164332455|NCT01193660|593595577|FG000|Overall Study|Death|1|||
164332456|NCT01193660|593595578|FG001|Overall Study|Death|0|||
164332457|NCT01193660|593595579|FG002|Overall Study|Death|0|||
163987183|NCT00730639|592320305|FG001|Overall Study|Withdrawal by Subject|0|||
163987184|NCT00730639|592320306|FG002|Overall Study|Withdrawal by Subject|6|||
163987185|NCT00730639|592320307|FG003|Overall Study|Withdrawal by Subject|3|||
163987186|NCT00730639|592320308|FG004|Overall Study|Withdrawal by Subject|4|||
163987187|NCT00730639|592320304|FG000|Overall Study|Treatment on-going|2|||
163987188|NCT00730639|592320305|FG001|Overall Study|Treatment on-going|5|||
163987189|NCT00730639|592320306|FG002|Overall Study|Treatment on-going|5|||
163987190|NCT00730639|592320307|FG003|Overall Study|Treatment on-going|4|||
163987191|NCT00730639|592320308|FG004|Overall Study|Treatment on-going|4|||
163987192|NCT00848354|592320312|FG000|Phase 1|Adverse Event|5|||
163987193|NCT00848354|592320313|FG001|Phase 1|Adverse Event|4|||
163987194|NCT00848354|592320312|FG000|Phase 1|Discontinuation of study by sponsor|2|||
163987195|NCT00848354|592320313|FG001|Phase 1|Discontinuation of study by sponsor|1|||
164332458|NCT01193660|593595577|FG000|Overall Study|Physician Decision|1|||
164332459|NCT01193660|593595578|FG001|Overall Study|Physician Decision|0|||
164332460|NCT01193660|593595579|FG002|Overall Study|Physician Decision|1|||
164332461|NCT00195273|593595580|FG000|Overall Study|Adverse Event|9|||
164332462|NCT00195273|593595581|FG001|Overall Study|Adverse Event|9|||
164332463|NCT00195273|593595580|FG000|Overall Study|Protocol deviation|0|||
164332464|NCT00195273|593595581|FG001|Overall Study|Protocol deviation|1|||
164332465|NCT00195273|593595580|FG000|Overall Study|Lack of Efficacy|3|||
164332466|NCT00195273|593595581|FG001|Overall Study|Lack of Efficacy|1|||
164332467|NCT00195273|593595580|FG000|Overall Study|Procedural complications|9|||
164332468|NCT00195273|593595581|FG001|Overall Study|Procedural complications|3|||
164332469|NCT01886716|593595582|FG000|Week 1|Lost to Follow-up|0|||
164332470|NCT01886716|593595583|FG001|Week 1|Lost to Follow-up|0|||
164332471|NCT01886716|593595584|FG002|Week 1|Lost to Follow-up|2|||
164332472|NCT01886716|593595585|FG003|Week 1|Lost to Follow-up|2|||
164332473|NCT01886716|593595582|FG000|Week 2|Lost to Follow-up|3|||
164332474|NCT01886716|593595583|FG001|Week 2|Lost to Follow-up|2|||
164332475|NCT01886716|593595584|FG002|Week 2|Lost to Follow-up|1|||
164332476|NCT01886716|593595585|FG003|Week 2|Lost to Follow-up|3|||
164332477|NCT01886716|593595582|FG000|Week 3|Lost to Follow-up|1|||
164332478|NCT01886716|593595583|FG001|Week 3|Lost to Follow-up|1|||
164332479|NCT01886716|593595584|FG002|Week 3|Lost to Follow-up|0|||
164332480|NCT01886716|593595585|FG003|Week 3|Lost to Follow-up|1|||
164332481|NCT02367131|593595586|FG000|Overall Study|Adverse Event|64|||
164332482|NCT02367131|593595586|FG000|Overall Study|No visit since the first visit|3|||
164332483|NCT02367131|593595586|FG000|Overall Study|Request by patient|53|||
164332484|NCT02367131|593595586|FG000|Overall Study|Improvement/remission|2|||
164332485|NCT02367131|593595586|FG000|Overall Study|No change/progressive disease|78|||
164332486|NCT02367131|593595586|FG000|Overall Study|Other than stated above|20|||
163987196|NCT00848354|592320312|FG000|Phase 1|Failed to return|0|||
163987197|NCT00848354|592320313|FG001|Phase 1|Failed to return|1|||
163987198|NCT00848354|592320312|FG000|Phase 1|Lost to Follow-up|1|||
163987199|NCT00848354|592320313|FG001|Phase 1|Lost to Follow-up|1|||
163987200|NCT00848354|592320312|FG000|Phase 1|Unspecified Reason|1|||
163987201|NCT00848354|592320313|FG001|Phase 1|Unspecified Reason|1|||
163987202|NCT00848354|592320312|FG000|Phase 1|Protocol Violation|1|||
163987203|NCT00848354|592320313|FG001|Phase 1|Protocol Violation|1|||
163987204|NCT00848354|592320312|FG000|Phase 1|Withdrawal by Subject|2|||
163987205|NCT00848354|592320313|FG001|Phase 1|Withdrawal by Subject|4|||
163987206|NCT00848354|592320312|FG000|Phase 1|Lack of Efficacy|0|||
163987207|NCT00848354|592320313|FG001|Phase 1|Lack of Efficacy|1|||
163987208|NCT00848354|592320312|FG000|Phase 2 Year 1|Adverse Event|7|||
163987209|NCT00848354|592320313|FG001|Phase 2 Year 1|Adverse Event|2|||
163987210|NCT00848354|592320312|FG000|Phase 2 Year 1|Death|1|||
163987211|NCT00848354|592320313|FG001|Phase 2 Year 1|Death|0|||
163987212|NCT00848354|592320312|FG000|Phase 2 Year 1|Failed to Return|1|||
163987213|NCT00848354|592320313|FG001|Phase 2 Year 1|Failed to Return|1|||
163987214|NCT00848354|592320312|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
163987215|NCT00848354|592320313|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
163987216|NCT00848354|592320312|FG000|Phase 2 Year 1|Unspecified Reason|3|||
163987217|NCT00848354|592320313|FG001|Phase 2 Year 1|Unspecified Reason|0|||
163987218|NCT00848354|592320312|FG000|Phase 2 Year 1|Protocol Violation|4|||
163987219|NCT00848354|592320313|FG001|Phase 2 Year 1|Protocol Violation|1|||
163987220|NCT00848354|592320312|FG000|Phase 2 Year 1|Subject Request|1|||
163987221|NCT00848354|592320313|FG001|Phase 2 Year 1|Subject Request|2|||
163987222|NCT00848354|592320312|FG000|Phase 2 Year 2|Adverse Event|12|||
163987223|NCT00848354|592320313|FG001|Phase 2 Year 2|Adverse Event|2|||
163987224|NCT00848354|592320312|FG000|Phase 2 Year 2|Death|2|||
163987225|NCT00848354|592320313|FG001|Phase 2 Year 2|Death|0|||
163987226|NCT00848354|592320312|FG000|Phase 2 Year 2|Failed to return|3|||
163987227|NCT00848354|592320313|FG001|Phase 2 Year 2|Failed to return|0|||
163987228|NCT00848354|592320312|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
163987229|NCT00848354|592320313|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
163987230|NCT00848354|592320312|FG000|Phase 2 Year 2|Unspecified Reason|1|||
163987231|NCT00848354|592320313|FG001|Phase 2 Year 2|Unspecified Reason|0|||
163987232|NCT00848354|592320312|FG000|Phase 2 Year 2|Protocol Violation|1|||
163987233|NCT00848354|592320313|FG001|Phase 2 Year 2|Protocol Violation|1|||
163987234|NCT00848354|592320312|FG000|Phase 2 Year 2|Subject Request|1|||
163987235|NCT00848354|592320313|FG001|Phase 2 Year 2|Subject Request|1|||
163987236|NCT00848354|592320312|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
163987237|NCT00848354|592320313|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
163987238|NCT03505021|592320316|FG000|Overall Study|Protocol Violation|1|||
163987239|NCT03505021|592320317|FG001|Overall Study|Protocol Violation|0|||
163987240|NCT03505021|592320316|FG000|Overall Study|Death|9|||
164231414|NCT03396445|593218029|FG003|Switch-over Period|Death|0|||
164231415|NCT03396445|593218030|FG004|Switch-over Period|Death|0|||
164231416|NCT03396445|593218031|FG005|Switch-over Period|Death|0|||
164231417|NCT03396445|593218032|FG006|Switch-over Period|Death|0|||
164231418|NCT03396445|593218033|FG007|Switch-over Period|Death|0|||
164332487|NCT02367131|593595586|FG000|Overall Study|Not treated|2|||
164332488|NCT01051466|593595593|FG000|Overall Study|Adverse Event|1|||
164332489|NCT01051466|593595594|FG001|Overall Study|Adverse Event|0|||
164332490|NCT01051466|593595593|FG000|Overall Study|Lost to Follow-up|1|||
164332491|NCT01051466|593595594|FG001|Overall Study|Lost to Follow-up|1|||
164332492|NCT01051466|593595593|FG000|Overall Study|Withdrawal by Subject|5|||
164332493|NCT01051466|593595594|FG001|Overall Study|Withdrawal by Subject|1|||
164332494|NCT01051466|593595593|FG000|Overall Study|Entry Criteria Not Met|0|||
164332495|NCT01051466|593595594|FG001|Overall Study|Entry Criteria Not Met|3|||
164332496|NCT01051466|593595593|FG000|Overall Study|Physician Decision|1|||
164332497|NCT01051466|593595594|FG001|Overall Study|Physician Decision|0|||
164332498|NCT00810108|593595595|FG000|Overall Study|Withdrawal by Subject|1|||
164332499|NCT00810108|593595596|FG001|Overall Study|Withdrawal by Subject|0|||
164332500|NCT04806503|593595600|FG000|Overall Study|Lost to Follow-up|0|||
164332501|NCT04806503|593595601|FG001|Overall Study|Lost to Follow-up|0|||
164332502|NCT04806503|593595602|FG002|Overall Study|Lost to Follow-up|1|||
164332503|NCT04806503|593595603|FG003|Overall Study|Lost to Follow-up|0|||
164332504|NCT04806503|593595604|FG004|Overall Study|Lost to Follow-up|0|||
164332505|NCT04806503|593595600|FG000|Overall Study|Withdrawal by Subject|1|||
164332506|NCT04806503|593595601|FG001|Overall Study|Withdrawal by Subject|0|||
164332507|NCT04806503|593595602|FG002|Overall Study|Withdrawal by Subject|1|||
164332508|NCT04806503|593595603|FG003|Overall Study|Withdrawal by Subject|1|||
164332509|NCT04806503|593595604|FG004|Overall Study|Withdrawal by Subject|1|||
164332510|NCT04806503|593595600|FG000|Overall Study|Adverse Event|1|||
164332511|NCT04806503|593595601|FG001|Overall Study|Adverse Event|1|||
164332512|NCT04806503|593595602|FG002|Overall Study|Adverse Event|0|||
164332513|NCT04806503|593595603|FG003|Overall Study|Adverse Event|1|||
164332514|NCT04806503|593595604|FG004|Overall Study|Adverse Event|0|||
164332515|NCT03589469|593595605|FG000|Overall Study|Withdrawal by Subject|8|||
164332516|NCT03589469|593595605|FG000|Overall Study|Physician Decision|20|||
164332517|NCT03589469|593595605|FG000|Overall Study|Death|97|||
164332518|NCT03589469|593595605|FG000|Overall Study|Lost to Follow-up|8|||
164332519|NCT03589469|593595605|FG000|Overall Study|Miscellaneous|1|||
164332520|NCT02556203|593595619|FG000|Overall Study|Withdrawal by Subject|21|||
164332521|NCT02556203|593595620|FG001|Overall Study|Withdrawal by Subject|21|||
164332522|NCT02556203|593595619|FG000|Overall Study|Lost to Follow-up|5|||
164332523|NCT02556203|593595620|FG001|Overall Study|Lost to Follow-up|5|||
164332524|NCT02556203|593595619|FG000|Overall Study|Adverse Event|1|||
164332525|NCT02556203|593595620|FG001|Overall Study|Adverse Event|0|||
164332526|NCT02180165|593595625|FG000|Overall Study|Not Treated|0|||
164332527|NCT02180165|593595626|FG001|Overall Study|Not Treated|0|||
163883374|NCT04176965|591942147|FG000|Overall Study|Withdrawal by Subject|6|||
164231419|NCT03396445|593218034|FG008|Switch-over Period|Death|0|||
164231420|NCT03396445|593218035|FG009|Switch-over Period|Death|0|||
164231421|NCT03396445|593218036|FG010|Switch-over Period|Death|0|||
164231422|NCT03396445|593218037|FG011|Switch-over Period|Death|0|||
164231423|NCT03396445|593218038|FG012|Switch-over Period|Death|0|||
164231424|NCT03396445|593218039|FG013|Switch-over Period|Death|0|||
164231425|NCT03396445|593218040|FG014|Switch-over Period|Death|0|||
164231426|NCT03396445|593218041|FG015|Switch-over Period|Death|0|||
164231427|NCT03396445|593218042|FG016|Switch-over Period|Death|0|||
164231428|NCT03396445|593218043|FG017|Switch-over Period|Death|0|||
164231429|NCT03396445|593218044|FG018|Switch-over Period|Death|1|||
164231430|NCT03396445|593218045|FG019|Switch-over Period|Death|2|||
164332528|NCT02180165|593595627|FG002|Overall Study|Not Treated|1|||
163883375|NCT04176965|591942148|FG001|Overall Study|Withdrawal by Subject|1|||
163883376|NCT03903146|591942149|FG000|Overall Study|Lost to Follow-up|6|||
163883377|NCT03903146|591942150|FG001|Overall Study|Lost to Follow-up|4|||
163883378|NCT03903146|591942149|FG000|Overall Study|Withdrawal by Subject|0|||
163883379|NCT03903146|591942150|FG001|Overall Study|Withdrawal by Subject|1|||
163883380|NCT03197662|591942155|FG000|Overall Study|Withdrawn by family|0|||
164231431|NCT03396445|593218046|FG020|Switch-over Period|Death|2|||
164332529|NCT02180165|593595628|FG003|Overall Study|Not Treated|0|||
164332530|NCT02180165|593595625|FG000|Overall Study|Adverse Event|7|||
164231432|NCT03396445|593218047|FG021|Switch-over Period|Death|1|||
164231433|NCT03396445|593218048|FG022|Switch-over Period|Death|2|||
164231434|NCT03396445|593218049|FG023|Switch-over Period|Death|0|||
164332531|NCT02180165|593595626|FG001|Overall Study|Adverse Event|0|||
164332532|NCT02180165|593595627|FG002|Overall Study|Adverse Event|18|||
164332533|NCT02180165|593595628|FG003|Overall Study|Adverse Event|3|||
164231435|NCT03396445|593218050|FG024|Switch-over Period|Death|1|||
164231436|NCT03396445|593218051|FG025|Switch-over Period|Death|6|||
164332534|NCT02180165|593595625|FG000|Overall Study|Lack of Efficacy|0|||
164332535|NCT02180165|593595626|FG001|Overall Study|Lack of Efficacy|1|||
164231437|NCT03396445|593218026|FG000|Switch-over Period|Lost to Follow-up|0|||
164231438|NCT03396445|593218027|FG001|Switch-over Period|Lost to Follow-up|0|||
164332536|NCT02180165|593595627|FG002|Overall Study|Lack of Efficacy|3|||
163883381|NCT03197662|591942156|FG001|Overall Study|Withdrawn by family|2|||
163883382|NCT03721952|591942157|FG000|Overall Study|Lost to Follow-up|0|||
163883383|NCT03721952|591942158|FG001|Overall Study|Lost to Follow-up|0|||
163883384|NCT03721952|591942159|FG002|Overall Study|Lost to Follow-up|2|||
163883385|NCT03721952|591942160|FG003|Overall Study|Lost to Follow-up|0|||
163883386|NCT03721952|591942161|FG004|Overall Study|Lost to Follow-up|0|||
163883387|NCT03721952|591942157|FG000|Overall Study|Protocol Violation|0|||
163883388|NCT03721952|591942158|FG001|Overall Study|Protocol Violation|1|||
163883389|NCT03721952|591942159|FG002|Overall Study|Protocol Violation|0|||
163883390|NCT03721952|591942160|FG003|Overall Study|Protocol Violation|0|||
163883391|NCT03721952|591942161|FG004|Overall Study|Protocol Violation|0|||
163883392|NCT03721952|591942157|FG000|Overall Study|Withdrawal by Subject|1|||
163883393|NCT03721952|591942158|FG001|Overall Study|Withdrawal by Subject|0|||
163883394|NCT03721952|591942159|FG002|Overall Study|Withdrawal by Subject|40|||
163883395|NCT03721952|591942160|FG003|Overall Study|Withdrawal by Subject|28|||
163883396|NCT03721952|591942161|FG004|Overall Study|Withdrawal by Subject|0|||
163883397|NCT04624633|591942162|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
163883398|NCT04624633|591942163|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
163883399|NCT04624633|591942162|FG000|Overall Study|Death|1|||
163883400|NCT04624633|591942163|FG001|Overall Study|Death|0|||
163883401|NCT01902173|591942167|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
163883402|NCT01902173|591942168|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163883403|NCT01902173|591942169|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163883404|NCT01902173|591942170|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163883405|NCT01902173|591942171|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
163883406|NCT01902173|591942172|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
164332537|NCT02180165|593595628|FG003|Overall Study|Lack of Efficacy|2|||
164332538|NCT02180165|593595625|FG000|Overall Study|Physician Decision|1|||
164332539|NCT02180165|593595626|FG001|Overall Study|Physician Decision|0|||
164332540|NCT02180165|593595627|FG002|Overall Study|Physician Decision|5|||
164332541|NCT02180165|593595628|FG003|Overall Study|Physician Decision|0|||
164332542|NCT02180165|593595625|FG000|Overall Study|Withdrawal by Subject|3|||
164332543|NCT02180165|593595626|FG001|Overall Study|Withdrawal by Subject|0|||
164332544|NCT02180165|593595627|FG002|Overall Study|Withdrawal by Subject|2|||
164332545|NCT02180165|593595628|FG003|Overall Study|Withdrawal by Subject|1|||
164332546|NCT02943460|593595630|FG000|Blinded Study Phase|Adverse Event|3|||
164332547|NCT02943460|593595631|FG001|Blinded Study Phase|Adverse Event|0|||
164332548|NCT02943460|593595632|FG002|Blinded Study Phase|Adverse Event|0|||
164332549|NCT02943460|593595630|FG000|Blinded Study Phase|Withdrew Consent|0|||
164332550|NCT02943460|593595631|FG001|Blinded Study Phase|Withdrew Consent|1|||
164332551|NCT02943460|593595632|FG002|Blinded Study Phase|Withdrew Consent|0|||
164332552|NCT02943460|593595630|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
164332553|NCT02943460|593595631|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
164332554|NCT02943460|593595632|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
164332555|NCT02943460|593595630|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
164332556|NCT02943460|593595631|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
164332557|NCT02943460|593595632|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
164332558|NCT02943460|593595630|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
164332559|NCT02943460|593595631|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
164332560|NCT02943460|593595632|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
164332561|NCT00369122|593595633|FG000|Overall Study|Ineligible|10|||
164332562|NCT00369122|593595633|FG000|Overall Study|No protocol treatment|1|||
164332563|NCT04171765|593595634|FG000|Overall Study|Adverse Event|2|||
164332564|NCT04171765|593595635|FG001|Overall Study|Adverse Event|0|||
164332565|NCT04171765|593595636|FG002|Overall Study|Adverse Event|1|||
164332566|NCT04171765|593595637|FG003|Overall Study|Adverse Event|0|||
163883407|NCT01902173|591942167|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
163883408|NCT01902173|591942168|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163883409|NCT01902173|591942169|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163883410|NCT01902173|591942170|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163883411|NCT01902173|591942171|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163883412|NCT01902173|591942172|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
163883413|NCT01902173|591942167|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163883414|NCT01902173|591942168|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
163883415|NCT01902173|591942169|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163883416|NCT01902173|591942170|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163883417|NCT01902173|591942171|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163883418|NCT01902173|591942172|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
163883419|NCT01902173|591942167|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163883420|NCT01902173|591942168|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
163883421|NCT01902173|591942169|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163883422|NCT01902173|591942170|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163987241|NCT03505021|592320317|FG001|Overall Study|Death|8|||
163987242|NCT03505021|592320316|FG000|Overall Study|Consent withdrawn by subject|6|||
163883423|NCT01902173|591942171|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163883424|NCT01902173|591942172|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
163883425|NCT01902173|591942167|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163883426|NCT01902173|591942168|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
163883427|NCT01902173|591942169|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163883428|NCT01902173|591942170|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163883429|NCT01902173|591942171|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163883430|NCT01902173|591942172|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
163883431|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163883432|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164231439|NCT03396445|593218028|FG002|Switch-over Period|Lost to Follow-up|0|||
164231440|NCT03396445|593218029|FG003|Switch-over Period|Lost to Follow-up|0|||
164231441|NCT03396445|593218030|FG004|Switch-over Period|Lost to Follow-up|0|||
164231442|NCT03396445|593218031|FG005|Switch-over Period|Lost to Follow-up|0|||
164231443|NCT03396445|593218032|FG006|Switch-over Period|Lost to Follow-up|0|||
164231444|NCT03396445|593218033|FG007|Switch-over Period|Lost to Follow-up|0|||
164231445|NCT03396445|593218034|FG008|Switch-over Period|Lost to Follow-up|0|||
164231446|NCT03396445|593218035|FG009|Switch-over Period|Lost to Follow-up|0|||
164231447|NCT03396445|593218036|FG010|Switch-over Period|Lost to Follow-up|0|||
164231448|NCT03396445|593218037|FG011|Switch-over Period|Lost to Follow-up|0|||
164231449|NCT03396445|593218038|FG012|Switch-over Period|Lost to Follow-up|0|||
164231450|NCT03396445|593218039|FG013|Switch-over Period|Lost to Follow-up|0|||
164231451|NCT03396445|593218040|FG014|Switch-over Period|Lost to Follow-up|0|||
163883433|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
163883434|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163883435|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
164231452|NCT03396445|593218041|FG015|Switch-over Period|Lost to Follow-up|0|||
163987243|NCT03505021|592320317|FG001|Overall Study|Consent withdrawn by subject|1|||
163987244|NCT03505021|592320316|FG000|Overall Study|Lost to Follow-up|5|||
164231453|NCT03396445|593218042|FG016|Switch-over Period|Lost to Follow-up|0|||
164299729|NCT03104868|593472916|FG001|6 Month Follow up|Death|1|||
164299730|NCT03104868|593472915|FG000|6 Month Follow up|Completed Later Timepoint|22|||
164299731|NCT03104868|593472916|FG001|6 Month Follow up|Completed Later Timepoint|32|||
164299732|NCT03104868|593472915|FG000|12 Month Follow up|Lost to Follow-up|1|||
164299733|NCT03104868|593472916|FG001|12 Month Follow up|Lost to Follow-up|2|||
164299734|NCT03104868|593472915|FG000|12 Month Follow up|Death|0|||
164299735|NCT03104868|593472916|FG001|12 Month Follow up|Death|1|||
164299736|NCT03104868|593472915|FG000|12 Month Follow up|Withdrawal by Subject|0|||
164299737|NCT03104868|593472916|FG001|12 Month Follow up|Withdrawal by Subject|3|||
164299738|NCT03104868|593472915|FG000|12 Month Follow up|Completed Later Timepoint|32|||
164299739|NCT03104868|593472916|FG001|12 Month Follow up|Completed Later Timepoint|29|||
164299740|NCT03104868|593472915|FG000|18 Month Follow up|Lost to Follow-up|7|||
164299741|NCT03104868|593472916|FG001|18 Month Follow up|Lost to Follow-up|11|||
164299742|NCT03104868|593472915|FG000|18 Month Follow up|Death|2|||
164299743|NCT03104868|593472916|FG001|18 Month Follow up|Death|1|||
164299744|NCT03104868|593472915|FG000|18 Month Follow up|Withdrawal by Subject|1|||
164299745|NCT03104868|593472916|FG001|18 Month Follow up|Withdrawal by Subject|2|||
164299746|NCT03104868|593472915|FG000|18 Month Follow up|Graft Loss|1|||
164299747|NCT03104868|593472916|FG001|18 Month Follow up|Graft Loss|1|||
164299748|NCT03104868|593472915|FG000|18 Month Follow up|Completed Later Timepoint|19|||
164299749|NCT03104868|593472916|FG001|18 Month Follow up|Completed Later Timepoint|20|||
164299750|NCT03104868|593472915|FG000|24 Month Follow up|Lost to Follow-up|15|||
164299751|NCT03104868|593472916|FG001|24 Month Follow up|Lost to Follow-up|16|||
164299752|NCT03104868|593472915|FG000|24 Month Follow up|Death|3|||
164299753|NCT03104868|593472916|FG001|24 Month Follow up|Death|2|||
164299754|NCT03104868|593472915|FG000|24 Month Follow up|Withdrawal by Subject|1|||
164299755|NCT03104868|593472916|FG001|24 Month Follow up|Withdrawal by Subject|0|||
164299756|NCT03104868|593472915|FG000|24 Month Follow up|Graft Loss|2|||
164299757|NCT03104868|593472916|FG001|24 Month Follow up|Graft Loss|0|||
164299758|NCT02059278|593472920|FG000|Overall Study|Adverse Event|1|||
164299759|NCT02059278|593472921|FG001|Overall Study|Adverse Event|1|||
164299760|NCT02059278|593472920|FG000|Overall Study|Lost to Follow-up|1|||
164299761|NCT02059278|593472921|FG001|Overall Study|Lost to Follow-up|0|||
164299762|NCT02059278|593472920|FG000|Overall Study|Withdrawal by Subject|0|||
164299763|NCT02059278|593472921|FG001|Overall Study|Withdrawal by Subject|3|||
164299764|NCT02059278|593472920|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
164299765|NCT02059278|593472921|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
164299766|NCT00888173|593472922|FG000|Overall Study|Wrong Primary|1|||
164299767|NCT00888173|593472922|FG000|Overall Study|Ineligible: required test not done|1|||
164299768|NCT01488890|593472923|FG000|Overall Study|Serious adverse event|2|||
164299769|NCT01488890|593472924|FG001|Overall Study|Serious adverse event|0|||
164299770|NCT01488890|593472925|FG002|Overall Study|Serious adverse event|0|||
164299771|NCT01488890|593472926|FG003|Overall Study|Serious adverse event|0|||
164332567|NCT04171765|593595634|FG000|Overall Study|Lost to Follow-up|0|||
164332568|NCT04171765|593595635|FG001|Overall Study|Lost to Follow-up|2|||
164332569|NCT04171765|593595636|FG002|Overall Study|Lost to Follow-up|2|||
164332570|NCT04171765|593595637|FG003|Overall Study|Lost to Follow-up|2|||
164332571|NCT04171765|593595634|FG000|Overall Study|Week 58 visit missed|0|||
164332572|NCT04171765|593595635|FG001|Overall Study|Week 58 visit missed|0|||
164332573|NCT04171765|593595636|FG002|Overall Study|Week 58 visit missed|1|||
164332574|NCT04171765|593595637|FG003|Overall Study|Week 58 visit missed|0|||
164332575|NCT04171765|593595634|FG000|Overall Study|Study terminated by sponsor|2|||
164332576|NCT04171765|593595635|FG001|Overall Study|Study terminated by sponsor|0|||
164332577|NCT04171765|593595636|FG002|Overall Study|Study terminated by sponsor|0|||
164332578|NCT04171765|593595637|FG003|Overall Study|Study terminated by sponsor|0|||
164332579|NCT04171765|593595634|FG000|Overall Study|Withdrawal by Subject|1|||
164332580|NCT04171765|593595635|FG001|Overall Study|Withdrawal by Subject|0|||
164332581|NCT04171765|593595636|FG002|Overall Study|Withdrawal by Subject|0|||
164332582|NCT04171765|593595637|FG003|Overall Study|Withdrawal by Subject|3|||
164332583|NCT03633617|593595638|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
164332584|NCT03633617|593595639|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
164332585|NCT03633617|593595640|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332586|NCT03633617|593595641|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332587|NCT03633617|593595642|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332588|NCT03633617|593595643|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332589|NCT03633617|593595644|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332590|NCT03633617|593595645|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332591|NCT03633617|593595646|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332592|NCT03633617|593595647|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332593|NCT03633617|593595648|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
164332594|NCT03633617|593595638|FG000|Part A|Unconfirmed early termination visit|1|||
164332595|NCT03633617|593595639|FG001|Part A|Unconfirmed early termination visit|0|||
164332596|NCT03633617|593595640|FG002|Part A|Unconfirmed early termination visit|0|||
164332597|NCT03633617|593595641|FG003|Part A|Unconfirmed early termination visit|0|||
164332598|NCT03633617|593595642|FG004|Part A|Unconfirmed early termination visit|0|||
164332599|NCT03633617|593595643|FG005|Part A|Unconfirmed early termination visit|0|||
164332600|NCT03633617|593595644|FG006|Part A|Unconfirmed early termination visit|0|||
164332601|NCT03633617|593595645|FG007|Part A|Unconfirmed early termination visit|0|||
164332602|NCT03633617|593595646|FG008|Part A|Unconfirmed early termination visit|0|||
164332603|NCT03633617|593595647|FG009|Part A|Unconfirmed early termination visit|0|||
164332604|NCT03633617|593595648|FG010|Part A|Unconfirmed early termination visit|0|||
164332605|NCT03633617|593595638|FG000|Part A|Adverse Event|0|||
164332606|NCT03633617|593595639|FG001|Part A|Adverse Event|1|||
164332607|NCT03633617|593595640|FG002|Part A|Adverse Event|0|||
164332608|NCT03633617|593595641|FG003|Part A|Adverse Event|0|||
164332609|NCT03633617|593595642|FG004|Part A|Adverse Event|0|||
164332610|NCT03633617|593595643|FG005|Part A|Adverse Event|0|||
164332611|NCT03633617|593595644|FG006|Part A|Adverse Event|0|||
164332612|NCT03633617|593595645|FG007|Part A|Adverse Event|0|||
164332613|NCT03633617|593595646|FG008|Part A|Adverse Event|0|||
164332614|NCT03633617|593595647|FG009|Part A|Adverse Event|0|||
164332615|NCT03633617|593595648|FG010|Part A|Adverse Event|0|||
164332616|NCT03633617|593595638|FG000|Part A|Pregnancy|1|||
164332617|NCT03633617|593595639|FG001|Part A|Pregnancy|0|||
164332618|NCT03633617|593595640|FG002|Part A|Pregnancy|0|||
164332619|NCT03633617|593595641|FG003|Part A|Pregnancy|0|||
164332620|NCT03633617|593595642|FG004|Part A|Pregnancy|0|||
164332621|NCT03633617|593595643|FG005|Part A|Pregnancy|0|||
164332622|NCT03633617|593595644|FG006|Part A|Pregnancy|0|||
164332623|NCT03633617|593595645|FG007|Part A|Pregnancy|0|||
164332624|NCT03633617|593595646|FG008|Part A|Pregnancy|0|||
164332625|NCT03633617|593595647|FG009|Part A|Pregnancy|0|||
164332626|NCT03633617|593595648|FG010|Part A|Pregnancy|0|||
164332627|NCT03633617|593595638|FG000|Part A|Withdrawal by Subject|0|||
164332628|NCT03633617|593595639|FG001|Part A|Withdrawal by Subject|1|||
164332629|NCT03633617|593595640|FG002|Part A|Withdrawal by Subject|0|||
164332630|NCT03633617|593595641|FG003|Part A|Withdrawal by Subject|0|||
164332631|NCT03633617|593595642|FG004|Part A|Withdrawal by Subject|0|||
164332632|NCT03633617|593595643|FG005|Part A|Withdrawal by Subject|0|||
164332633|NCT03633617|593595644|FG006|Part A|Withdrawal by Subject|0|||
164332634|NCT03633617|593595645|FG007|Part A|Withdrawal by Subject|0|||
164332635|NCT03633617|593595646|FG008|Part A|Withdrawal by Subject|0|||
164332636|NCT03633617|593595647|FG009|Part A|Withdrawal by Subject|0|||
164332637|NCT03633617|593595648|FG010|Part A|Withdrawal by Subject|0|||
164332638|NCT03633617|593595638|FG000|Part B|Adverse Event|0|||
164332639|NCT03633617|593595639|FG001|Part B|Adverse Event|0|||
164332640|NCT03633617|593595640|FG002|Part B|Adverse Event|2|||
163883436|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
163883437|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163883438|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163883439|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
163883440|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163883441|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163883442|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
163883443|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163883444|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163883445|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163883446|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
163883447|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
163883448|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
164231454|NCT03396445|593218043|FG017|Switch-over Period|Lost to Follow-up|0|||
164231455|NCT03396445|593218044|FG018|Switch-over Period|Lost to Follow-up|0|||
163883449|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163987245|NCT03505021|592320317|FG001|Overall Study|Lost to Follow-up|3|||
163987246|NCT03505021|592320316|FG000|Overall Study|Adverse Event|26|||
163987247|NCT03505021|592320317|FG001|Overall Study|Adverse Event|9|||
163987248|NCT03505021|592320316|FG000|Overall Study|Disease progression|33|||
163987249|NCT03505021|592320317|FG001|Overall Study|Disease progression|17|||
163987250|NCT03505021|592320316|FG000|Overall Study|Other|11|||
163987251|NCT03505021|592320317|FG001|Overall Study|Other|5|||
163987252|NCT03505021|592320316|FG000|Overall Study|Personal reason|21|||
163987253|NCT03505021|592320317|FG001|Overall Study|Personal reason|12|||
163987254|NCT03087955|592322244|FG000|Overall Study|Death|4|||
164231456|NCT03396445|593218045|FG019|Switch-over Period|Lost to Follow-up|0|||
164231457|NCT03396445|593218046|FG020|Switch-over Period|Lost to Follow-up|0|||
164231458|NCT03396445|593218047|FG021|Switch-over Period|Lost to Follow-up|0|||
164231459|NCT03396445|593218048|FG022|Switch-over Period|Lost to Follow-up|0|||
164231460|NCT03396445|593218049|FG023|Switch-over Period|Lost to Follow-up|1|||
164231461|NCT03396445|593218050|FG024|Switch-over Period|Lost to Follow-up|0|||
164231462|NCT03396445|593218051|FG025|Switch-over Period|Lost to Follow-up|0|||
164231463|NCT04123704|593218065|FG000|Overall Study|Disease progression|2|||
164231464|NCT03332056|593218071|FG000|Overall Study|Incomplete questionnaires|8|||
164231465|NCT03332056|593218072|FG001|Overall Study|Incomplete questionnaires|9|||
164231466|NCT03332056|593218071|FG000|Overall Study|Passed stone prior to surgery date|1|||
164231467|NCT03332056|593218072|FG001|Overall Study|Passed stone prior to surgery date|0|||
164231468|NCT03332056|593218071|FG000|Overall Study|Did not require a ureteral stent|0|||
164231469|NCT03332056|593218072|FG001|Overall Study|Did not require a ureteral stent|1|||
164231470|NCT03360344|593218075|FG000|Overall Study|Withdrawal by Subject|0|||
164231471|NCT03360344|593218076|FG001|Overall Study|Withdrawal by Subject|1|||
164231472|NCT03360344|593218077|FG002|Overall Study|Withdrawal by Subject|1|||
164231473|NCT00133705|593218082|FG000|Overall Study|Withdrawal by Subject|2|||
164231474|NCT00133705|593218083|FG001|Overall Study|Withdrawal by Subject|3|||
164231475|NCT00688740|593218094|FG000|Overall Study|Adverse Event|45|||
164231476|NCT00688740|593218095|FG001|Overall Study|Adverse Event|8|||
164231477|NCT00688740|593218094|FG000|Overall Study|Death|2|||
164231478|NCT00688740|593218095|FG001|Overall Study|Death|2|||
164231479|NCT00688740|593218094|FG000|Overall Study|Lost to Follow-up|0|||
164231480|NCT00688740|593218095|FG001|Overall Study|Lost to Follow-up|1|||
164231481|NCT00688740|593218094|FG000|Overall Study|Consent Withdrawn|17|||
164231482|NCT00688740|593218095|FG001|Overall Study|Consent Withdrawn|17|||
164231483|NCT00688740|593218094|FG000|Overall Study|Breast Cancer Relapse|1|||
164231484|NCT00688740|593218095|FG001|Overall Study|Breast Cancer Relapse|4|||
164332641|NCT03633617|593595641|FG003|Part B|Adverse Event|2|||
164332642|NCT03633617|593595642|FG004|Part B|Adverse Event|1|||
164332643|NCT03633617|593595643|FG005|Part B|Adverse Event|0|||
164332644|NCT03633617|593595644|FG006|Part B|Adverse Event|0|||
164332645|NCT03633617|593595645|FG007|Part B|Adverse Event|0|||
164332646|NCT03633617|593595646|FG008|Part B|Adverse Event|0|||
164332647|NCT03633617|593595647|FG009|Part B|Adverse Event|0|||
164332648|NCT03633617|593595648|FG010|Part B|Adverse Event|0|||
164332649|NCT03633617|593595638|FG000|Part B|Withdrawal by Subject|0|||
164332650|NCT03633617|593595639|FG001|Part B|Withdrawal by Subject|0|||
164332651|NCT03633617|593595640|FG002|Part B|Withdrawal by Subject|1|||
164332652|NCT03633617|593595641|FG003|Part B|Withdrawal by Subject|0|||
164332653|NCT03633617|593595642|FG004|Part B|Withdrawal by Subject|2|||
164332654|NCT03633617|593595643|FG005|Part B|Withdrawal by Subject|0|||
164332655|NCT03633617|593595644|FG006|Part B|Withdrawal by Subject|0|||
164332656|NCT03633617|593595645|FG007|Part B|Withdrawal by Subject|0|||
164332657|NCT03633617|593595646|FG008|Part B|Withdrawal by Subject|0|||
164332658|NCT03633617|593595647|FG009|Part B|Withdrawal by Subject|0|||
164332659|NCT03633617|593595648|FG010|Part B|Withdrawal by Subject|0|||
164332660|NCT03633617|593595638|FG000|Part B|Lost to Follow-up|0|||
164332661|NCT03633617|593595639|FG001|Part B|Lost to Follow-up|0|||
164332662|NCT03633617|593595640|FG002|Part B|Lost to Follow-up|0|||
164332663|NCT03633617|593595641|FG003|Part B|Lost to Follow-up|0|||
164332664|NCT03633617|593595642|FG004|Part B|Lost to Follow-up|1|||
164332665|NCT03633617|593595643|FG005|Part B|Lost to Follow-up|0|||
164332666|NCT03633617|593595644|FG006|Part B|Lost to Follow-up|0|||
164332667|NCT03633617|593595645|FG007|Part B|Lost to Follow-up|0|||
164332668|NCT03633617|593595646|FG008|Part B|Lost to Follow-up|0|||
164332669|NCT03633617|593595647|FG009|Part B|Lost to Follow-up|0|||
164332670|NCT03633617|593595648|FG010|Part B|Lost to Follow-up|0|||
164332671|NCT03633617|593595638|FG000|Part B|Physician Decision|0|||
164332672|NCT03633617|593595639|FG001|Part B|Physician Decision|0|||
164332673|NCT03633617|593595640|FG002|Part B|Physician Decision|0|||
163987255|NCT03087955|592322245|FG001|Overall Study|Death|0|||
163987256|NCT03087955|592322244|FG000|Overall Study|Lack of Efficacy|2|||
164231485|NCT00688740|593218094|FG000|Overall Study|Violation of Inclusion Criteria|1|||
164231486|NCT00688740|593218095|FG001|Overall Study|Violation of Inclusion Criteria|3|||
163987257|NCT03087955|592322245|FG001|Overall Study|Lack of Efficacy|0|||
163987258|NCT03087955|592322244|FG000|Overall Study|Lost to Follow-up|1|||
164332674|NCT03633617|593595641|FG003|Part B|Physician Decision|0|||
164332675|NCT03633617|593595642|FG004|Part B|Physician Decision|1|||
164332676|NCT03633617|593595643|FG005|Part B|Physician Decision|0|||
164332677|NCT03633617|593595644|FG006|Part B|Physician Decision|0|||
164332678|NCT03633617|593595645|FG007|Part B|Physician Decision|0|||
164332679|NCT03633617|593595646|FG008|Part B|Physician Decision|0|||
163883450|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163883451|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163883452|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
163883453|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163883454|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
163883455|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163883456|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163883457|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163883458|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163883459|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
163883460|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
163883461|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163883462|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163883463|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163883464|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163883465|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
163883466|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
163883467|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163883468|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163883469|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163883470|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163883471|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
163883472|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
163883473|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163883474|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163883475|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163883476|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163883477|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
163883478|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
163883479|NCT01902173|591942167|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163883480|NCT01902173|591942168|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163883481|NCT01902173|591942169|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163883482|NCT01902173|591942170|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163883483|NCT01902173|591942171|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
163883484|NCT01902173|591942172|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
163883485|NCT03640312|591942177|FG000|Overall Study|Lost to Follow-up|3|||
163883486|NCT03640312|591942178|FG001|Overall Study|Lost to Follow-up|6|||
163883487|NCT03536754|591942179|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
163883488|NCT03536754|591942180|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
163883489|NCT03536754|591942181|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
163883490|NCT03536754|591942182|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
163883491|NCT03536754|591942183|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
163883492|NCT03536754|591942179|FG000|Open Label Extension|Other|0|||
163883493|NCT03536754|591942180|FG001|Open Label Extension|Other|0|||
163883494|NCT03536754|591942181|FG002|Open Label Extension|Other|0|||
163883495|NCT03536754|591942182|FG003|Open Label Extension|Other|0|||
163883496|NCT03536754|591942183|FG004|Open Label Extension|Other|1|||
163883497|NCT03382652|591942186|FG000|Overall Study|Lost to Follow-up|6|||
163883498|NCT03382652|591942186|FG000|Overall Study|Death|4|||
163883499|NCT03382652|591942186|FG000|Overall Study|Revision|5|||
163883500|NCT03382652|591942186|FG000|Overall Study|Patient withdrew|3|||
163883501|NCT03382652|591942186|FG000|Overall Study|Other reasons|21|||
163883502|NCT04876118|591942189|FG000|Overall Study|Pregnancy|1|||
163883503|NCT04876118|591942189|FG000|Overall Study|Withdrawal by Subject|14|||
163883504|NCT04593472|591943856|FG000|Overall Study|Death|31|||
163883505|NCT04593472|591943857|FG001|Overall Study|Death|27|||
164090399|NCT03384745|592693435|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
163883506|NCT04593472|591943856|FG000|Overall Study|Withdrawal by Subject|12|||
163883507|NCT04593472|591943857|FG001|Overall Study|Withdrawal by Subject|12|||
163883508|NCT04593472|591943856|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
163883509|NCT04593472|591943857|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
163883510|NCT04593472|591943856|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
163883511|NCT04593472|591943857|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
163883512|NCT04593472|591943856|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
163883513|NCT04593472|591943857|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
163883514|NCT04593472|591943856|FG000|Overall Study|Lost to Follow-up|0|||
163883515|NCT04593472|591943857|FG001|Overall Study|Lost to Follow-up|2|||
163883516|NCT04593472|591943856|FG000|Overall Study|Still collecting 24-month assessment|17|||
163883517|NCT04593472|591943857|FG001|Overall Study|Still collecting 24-month assessment|10|||
163883518|NCT04806594|591943868|FG000|Overall Study|Withdrawal by Subject|2|||
163883519|NCT04806594|591943868|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
163883520|NCT04390048|591943869|FG000|Overall Study|Withdrawal by Subject|1|||
163883521|NCT04390048|591943870|FG001|Overall Study|Withdrawal by Subject|3|||
163883522|NCT05215314|591943871|FG000|Overall Study|Lost to Follow-up|2|||
163883523|NCT05215314|591943872|FG001|Overall Study|Lost to Follow-up|2|||
163883524|NCT05215314|591943871|FG000|Overall Study|Withdrawal by Subject|2|||
163883525|NCT05215314|591943872|FG001|Overall Study|Withdrawal by Subject|0|||
163883526|NCT05215314|591943871|FG000|Overall Study|Physician Decision|1|||
163883527|NCT05215314|591943872|FG001|Overall Study|Physician Decision|0|||
163883528|NCT04179500|591943873|FG000|Treatment|Withdrawal by Subject|1|||
163883529|NCT04179500|591943873|FG000|Treatment|Adverse Event|2|||
163883530|NCT04179500|591943873|FG000|Treatment|pyrazinamide resistance|1|||
163883531|NCT03138512|591943874|FG000|Randomization|Participants withdrew consent|0|||
163883532|NCT03138512|591943875|FG001|Randomization|Participants withdrew consent|1|||
163883533|NCT03138512|591943876|FG002|Randomization|Participants withdrew consent|1|||
163883534|NCT03138512|591943877|FG003|Randomization|Participants withdrew consent|0|||
163883535|NCT03138512|591943878|FG004|Randomization|Participants withdrew consent|0|||
163883536|NCT03138512|591943874|FG000|Randomization|Participant no longer meets study criteria|0|||
164332680|NCT03633617|593595647|FG009|Part B|Physician Decision|0|||
164332681|NCT03633617|593595648|FG010|Part B|Physician Decision|0|||
164332682|NCT03633617|593595638|FG000|Part B|COVID-19 Restrictions|0|||
164332683|NCT03633617|593595639|FG001|Part B|COVID-19 Restrictions|0|||
164332684|NCT03633617|593595640|FG002|Part B|COVID-19 Restrictions|1|||
164332685|NCT03633617|593595641|FG003|Part B|COVID-19 Restrictions|0|||
164332686|NCT03633617|593595642|FG004|Part B|COVID-19 Restrictions|0|||
164332687|NCT03633617|593595643|FG005|Part B|COVID-19 Restrictions|0|||
164332688|NCT03633617|593595644|FG006|Part B|COVID-19 Restrictions|0|||
164332689|NCT03633617|593595645|FG007|Part B|COVID-19 Restrictions|0|||
164332690|NCT03633617|593595646|FG008|Part B|COVID-19 Restrictions|0|||
164332691|NCT03633617|593595647|FG009|Part B|COVID-19 Restrictions|0|||
164332692|NCT03633617|593595648|FG010|Part B|COVID-19 Restrictions|0|||
163883537|NCT03138512|591943875|FG001|Randomization|Participant no longer meets study criteria|3|||
163883538|NCT03138512|591943876|FG002|Randomization|Participant no longer meets study criteria|1|||
163883539|NCT03138512|591943877|FG003|Randomization|Participant no longer meets study criteria|1|||
163883540|NCT03138512|591943878|FG004|Randomization|Participant no longer meets study criteria|3|||
163883541|NCT03138512|591943874|FG000|Randomization|Other reasons|1|||
163883542|NCT03138512|591943875|FG001|Randomization|Other reasons|0|||
164090400|NCT03384745|592693436|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
164332693|NCT03633617|593595638|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332694|NCT03633617|593595639|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332695|NCT03633617|593595640|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
164332696|NCT03633617|593595641|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164231487|NCT00366457|593218099|FG000|Overall Study|never began study therapy|2|||
164231488|NCT02829996|593218100|FG000|Overall Study|Withdrawal by Subject|1|||
164231489|NCT02829996|593218101|FG001|Overall Study|Withdrawal by Subject|0|||
164231490|NCT02829996|593218102|FG002|Overall Study|Withdrawal by Subject|0|||
164231491|NCT02829996|593218103|FG003|Overall Study|Withdrawal by Subject|0|||
164231492|NCT02829996|593218104|FG004|Overall Study|Withdrawal by Subject|0|||
164231493|NCT04484857|593218110|FG000|Overall Study|Adverse Event|2|||
164231494|NCT04484857|593218110|FG000|Overall Study|Death|10|||
164231495|NCT04484857|593218110|FG000|Overall Study|Withdrawal by Subject|3|||
164231496|NCT04484857|593218110|FG000|Overall Study|Transferred/Relocation|5|||
164231497|NCT04484857|593218110|FG000|Overall Study|Kidney Transplant|7|||
164231498|NCT04484857|593218110|FG000|Overall Study|Other than specified|4|||
164231499|NCT04484857|593218110|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
164231500|NCT01206517|593218114|FG000|Overall Study|Withdrawal by Subject|0|||
164231501|NCT01206517|593218115|FG001|Overall Study|Withdrawal by Subject|0|||
164231502|NCT01206517|593218116|FG002|Overall Study|Withdrawal by Subject|2|||
164231503|NCT01206517|593218117|FG003|Overall Study|Withdrawal by Subject|0|||
164231504|NCT01206517|593218118|FG004|Overall Study|Withdrawal by Subject|1|||
164231505|NCT01206517|593218119|FG005|Overall Study|Withdrawal by Subject|0|||
164231506|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Adverse Event|20|||
164231507|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Adverse Event|10|||
164231508|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Adverse Event|5|||
164231509|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Adverse Event|0|||
164231510|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Adverse Event|0|||
164231511|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Adverse Event|0|||
164231512|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Adverse Event|0|||
164231513|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Adverse Event|0|||
164231514|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Adverse Event|0|||
164231515|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Adverse Event|0|||
164231516|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Adverse Event|0|||
164231517|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Adverse Event|0|||
164231518|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231519|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231520|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
164231521|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231522|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231523|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231524|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231525|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231526|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231527|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231528|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231529|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
164231530|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
164231531|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
164231532|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
164231533|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
164231534|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
164231535|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
164231536|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
164231537|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
164231538|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
164231539|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
164231540|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
164231541|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
164231542|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
164231543|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
164231544|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
164231545|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
164231546|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
164231547|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
164231548|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
164231549|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
164231550|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
164231551|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
164231552|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
164231553|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
164231554|NCT00725985|593218120|FG000|ITP- Treatment Disposition|Other|50|||
164231555|NCT00725985|593218121|FG001|ITP- Treatment Disposition|Other|38|||
164231556|NCT00725985|593218122|FG002|ITP- Treatment Disposition|Other|24|||
164231557|NCT00725985|593218123|FG003|ITP- Treatment Disposition|Other|0|||
164231558|NCT00725985|593218124|FG004|ITP- Treatment Disposition|Other|0|||
164231559|NCT00725985|593218125|FG005|ITP- Treatment Disposition|Other|0|||
164231560|NCT00725985|593218126|FG006|ITP- Treatment Disposition|Other|0|||
164231561|NCT00725985|593218127|FG007|ITP- Treatment Disposition|Other|0|||
164231562|NCT00725985|593218128|FG008|ITP- Treatment Disposition|Other|0|||
164231563|NCT00725985|593218129|FG009|ITP- Treatment Disposition|Other|0|||
164231564|NCT00725985|593218130|FG010|ITP- Treatment Disposition|Other|0|||
164231565|NCT00725985|593218131|FG011|ITP- Treatment Disposition|Other|0|||
164231566|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164332697|NCT03633617|593595642|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332698|NCT03633617|593595643|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332699|NCT03633617|593595644|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332700|NCT03633617|593595645|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332701|NCT03633617|593595646|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332702|NCT03633617|593595647|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332703|NCT03633617|593595648|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
164332704|NCT03633617|593595638|FG000|Part C (& Follow-up)|Adverse Event|0|||
164332705|NCT03633617|593595639|FG001|Part C (& Follow-up)|Adverse Event|0|||
164332706|NCT03633617|593595640|FG002|Part C (& Follow-up)|Adverse Event|0|||
164332707|NCT03633617|593595641|FG003|Part C (& Follow-up)|Adverse Event|0|||
164332708|NCT03633617|593595642|FG004|Part C (& Follow-up)|Adverse Event|0|||
164332709|NCT03633617|593595643|FG005|Part C (& Follow-up)|Adverse Event|1|||
164332710|NCT03633617|593595644|FG006|Part C (& Follow-up)|Adverse Event|0|||
164332711|NCT03633617|593595645|FG007|Part C (& Follow-up)|Adverse Event|1|||
164332712|NCT03633617|593595646|FG008|Part C (& Follow-up)|Adverse Event|0|||
164332713|NCT03633617|593595647|FG009|Part C (& Follow-up)|Adverse Event|0|||
164332714|NCT03633617|593595648|FG010|Part C (& Follow-up)|Adverse Event|0|||
164332715|NCT03633617|593595638|FG000|Part C (& Follow-up)|Pregnancy|0|||
164332716|NCT03633617|593595639|FG001|Part C (& Follow-up)|Pregnancy|0|||
164332717|NCT03633617|593595640|FG002|Part C (& Follow-up)|Pregnancy|0|||
164332718|NCT03633617|593595641|FG003|Part C (& Follow-up)|Pregnancy|0|||
164332719|NCT03633617|593595642|FG004|Part C (& Follow-up)|Pregnancy|0|||
164332720|NCT03633617|593595643|FG005|Part C (& Follow-up)|Pregnancy|0|||
164332721|NCT03633617|593595644|FG006|Part C (& Follow-up)|Pregnancy|0|||
164332722|NCT03633617|593595645|FG007|Part C (& Follow-up)|Pregnancy|0|||
164332723|NCT03633617|593595646|FG008|Part C (& Follow-up)|Pregnancy|0|||
164332724|NCT03633617|593595647|FG009|Part C (& Follow-up)|Pregnancy|1|||
164332725|NCT03633617|593595648|FG010|Part C (& Follow-up)|Pregnancy|0|||
164332726|NCT03633617|593595638|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332727|NCT03633617|593595639|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332728|NCT03633617|593595640|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332729|NCT03633617|593595641|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332730|NCT03633617|593595642|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332731|NCT03633617|593595643|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
164231567|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164332732|NCT03633617|593595644|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
164332733|NCT03633617|593595645|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
164332734|NCT03633617|593595646|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
164332735|NCT03633617|593595647|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
164332736|NCT03633617|593595648|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
164231568|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231569|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
164231570|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
164231571|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
164231572|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231573|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231574|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231575|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231576|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231577|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
164231578|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Death|0|||
164231579|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Death|0|||
164231580|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Death|0|||
164231581|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Death|0|||
164231582|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Death|1|||
164231583|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Death|0|||
164231584|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Death|0|||
164231585|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Death|0|||
164231586|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Death|0|||
164231587|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Death|0|||
164231588|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Death|0|||
164231589|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Death|0|||
164231590|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231591|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231592|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231593|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
164231594|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231595|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231596|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231597|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231598|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231599|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231600|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231601|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
164231602|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231603|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231604|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231605|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231606|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231607|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
163883543|NCT03138512|591943876|FG002|Randomization|Other reasons|0|||
164231608|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231609|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231610|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231611|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231612|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231613|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
164231614|NCT00725985|593218120|FG000|OLMP (Up to 96 Weeks)|Other|0|||
164231615|NCT00725985|593218121|FG001|OLMP (Up to 96 Weeks)|Other|0|||
164231616|NCT00725985|593218122|FG002|OLMP (Up to 96 Weeks)|Other|0|||
164231617|NCT00725985|593218123|FG003|OLMP (Up to 96 Weeks)|Other|15|||
164231618|NCT00725985|593218124|FG004|OLMP (Up to 96 Weeks)|Other|20|||
164231619|NCT00725985|593218125|FG005|OLMP (Up to 96 Weeks)|Other|44|||
164231620|NCT00725985|593218126|FG006|OLMP (Up to 96 Weeks)|Other|0|||
164231621|NCT00725985|593218127|FG007|OLMP (Up to 96 Weeks)|Other|0|||
164231622|NCT00725985|593218128|FG008|OLMP (Up to 96 Weeks)|Other|0|||
164231623|NCT00725985|593218129|FG009|OLMP (Up to 96 Weeks)|Other|0|||
164231624|NCT00725985|593218130|FG010|OLMP (Up to 96 Weeks)|Other|0|||
164231625|NCT00725985|593218131|FG011|OLMP (Up to 96 Weeks)|Other|0|||
164231626|NCT00725985|593218120|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231627|NCT00725985|593218121|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231628|NCT00725985|593218122|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231629|NCT00725985|593218123|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231630|NCT00725985|593218124|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231631|NCT00725985|593218125|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231632|NCT00725985|593218126|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231633|NCT00725985|593218127|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
164231634|NCT00725985|593218128|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231635|NCT00725985|593218129|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231636|NCT00725985|593218130|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164332737|NCT03633617|593595638|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
164332738|NCT03633617|593595639|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
164332739|NCT03633617|593595640|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
164332740|NCT03633617|593595641|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
164332741|NCT03633617|593595642|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
163883544|NCT03138512|591943877|FG003|Randomization|Other reasons|0|||
164332742|NCT03633617|593595643|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
163883545|NCT03138512|591943878|FG004|Randomization|Other reasons|0|||
164231637|NCT00725985|593218131|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
164231638|NCT00725985|593218120|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231639|NCT00725985|593218121|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231640|NCT00725985|593218122|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231641|NCT00725985|593218123|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164332743|NCT03633617|593595644|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
163987259|NCT03087955|592322245|FG001|Overall Study|Lost to Follow-up|0|||
164332744|NCT03633617|593595645|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
164332745|NCT03633617|593595646|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
164332746|NCT03633617|593595647|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
164332747|NCT03633617|593595648|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
164332748|NCT03633617|593595638|FG000|Part C (& Follow-up)|Physician Decision|0|||
164332749|NCT03633617|593595639|FG001|Part C (& Follow-up)|Physician Decision|0|||
164332750|NCT03633617|593595640|FG002|Part C (& Follow-up)|Physician Decision|0|||
164332751|NCT03633617|593595641|FG003|Part C (& Follow-up)|Physician Decision|0|||
164332752|NCT03633617|593595642|FG004|Part C (& Follow-up)|Physician Decision|0|||
164332753|NCT03633617|593595643|FG005|Part C (& Follow-up)|Physician Decision|0|||
164332754|NCT03633617|593595644|FG006|Part C (& Follow-up)|Physician Decision|0|||
164332755|NCT03633617|593595645|FG007|Part C (& Follow-up)|Physician Decision|1|||
164332756|NCT03633617|593595646|FG008|Part C (& Follow-up)|Physician Decision|0|||
164332757|NCT03633617|593595647|FG009|Part C (& Follow-up)|Physician Decision|0|||
164332758|NCT03633617|593595648|FG010|Part C (& Follow-up)|Physician Decision|1|||
164332759|NCT03633617|593595638|FG000|Part C (& Follow-up)|COVID-19 related|0|||
164332760|NCT03633617|593595639|FG001|Part C (& Follow-up)|COVID-19 related|0|||
164332761|NCT03633617|593595640|FG002|Part C (& Follow-up)|COVID-19 related|0|||
164332762|NCT03633617|593595641|FG003|Part C (& Follow-up)|COVID-19 related|0|||
164332763|NCT03633617|593595642|FG004|Part C (& Follow-up)|COVID-19 related|0|||
164332764|NCT03633617|593595643|FG005|Part C (& Follow-up)|COVID-19 related|1|||
164332765|NCT03633617|593595644|FG006|Part C (& Follow-up)|COVID-19 related|0|||
164332766|NCT03633617|593595645|FG007|Part C (& Follow-up)|COVID-19 related|0|||
164332767|NCT03633617|593595646|FG008|Part C (& Follow-up)|COVID-19 related|0|||
164332768|NCT03633617|593595647|FG009|Part C (& Follow-up)|COVID-19 related|0|||
164332769|NCT03633617|593595648|FG010|Part C (& Follow-up)|COVID-19 related|0|||
164332770|NCT03633617|593595638|FG000|Part C (& Follow-up)|Protocol Violation|0|||
164332771|NCT03633617|593595639|FG001|Part C (& Follow-up)|Protocol Violation|0|||
164332772|NCT03633617|593595640|FG002|Part C (& Follow-up)|Protocol Violation|0|||
164332773|NCT03633617|593595641|FG003|Part C (& Follow-up)|Protocol Violation|0|||
164332774|NCT03633617|593595642|FG004|Part C (& Follow-up)|Protocol Violation|0|||
164332775|NCT03633617|593595643|FG005|Part C (& Follow-up)|Protocol Violation|0|||
163883546|NCT03138512|591943874|FG000|Treatment Part A|Disease recurrence|10|||
163883547|NCT03138512|591943875|FG001|Treatment Part A|Disease recurrence|20|||
163883548|NCT03138512|591943876|FG002|Treatment Part A|Disease recurrence|0|||
163883549|NCT03138512|591943877|FG003|Treatment Part A|Disease recurrence|0|||
164332776|NCT03633617|593595644|FG006|Part C (& Follow-up)|Protocol Violation|0|||
164332777|NCT03633617|593595645|FG007|Part C (& Follow-up)|Protocol Violation|0|||
164332778|NCT03633617|593595646|FG008|Part C (& Follow-up)|Protocol Violation|0|||
164231642|NCT00725985|593218124|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231643|NCT00725985|593218125|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231644|NCT00725985|593218126|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231645|NCT00725985|593218127|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231646|NCT00725985|593218128|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
164231647|NCT00725985|593218129|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231648|NCT00725985|593218130|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231649|NCT00725985|593218131|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
164231650|NCT00725985|593218120|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231651|NCT00725985|593218121|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231652|NCT00725985|593218122|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231653|NCT00725985|593218123|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231654|NCT00725985|593218124|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231655|NCT00725985|593218125|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231656|NCT00725985|593218126|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
164231657|NCT00725985|593218127|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
164231658|NCT00725985|593218128|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
164231659|NCT00725985|593218129|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231660|NCT00725985|593218130|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231661|NCT00725985|593218131|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
164231662|NCT00725985|593218120|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231663|NCT00725985|593218121|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231664|NCT00725985|593218122|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231665|NCT00725985|593218123|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231666|NCT00725985|593218124|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231667|NCT00725985|593218125|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231668|NCT00725985|593218126|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231669|NCT00725985|593218127|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231670|NCT00725985|593218128|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
164231671|NCT00725985|593218129|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
164231672|NCT00725985|593218130|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
164231673|NCT00725985|593218131|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
164231674|NCT02546323|593218132|FG000|Overall Study|Withdrawal by Subject|36|||
164231675|NCT02546323|593218133|FG001|Overall Study|Withdrawal by Subject|33|||
164231676|NCT02546323|593218132|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
164231677|NCT02546323|593218133|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
164231678|NCT02546323|593218132|FG000|Overall Study|Adverse Event|17|||
164231679|NCT02546323|593218133|FG001|Overall Study|Adverse Event|11|||
164231680|NCT02546323|593218132|FG000|Overall Study|Patient Specific Reasons|1|||
164231681|NCT02546323|593218133|FG001|Overall Study|Patient Specific Reasons|2|||
164231682|NCT02546323|593218132|FG000|Overall Study|Lost to Follow-up|2|||
164231683|NCT02546323|593218133|FG001|Overall Study|Lost to Follow-up|3|||
164231684|NCT02546323|593218132|FG000|Overall Study|Non-compliance with Study Drug|2|||
164231685|NCT02546323|593218133|FG001|Overall Study|Non-compliance with Study Drug|2|||
164231686|NCT02546323|593218132|FG000|Overall Study|Met Withdrawal Criteria|2|||
164231687|NCT02546323|593218133|FG001|Overall Study|Met Withdrawal Criteria|14|||
164231688|NCT04476784|593218134|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
164231689|NCT04476784|593218135|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
164231690|NCT00863304|593218142|FG000|Overall Study|Adverse Event|10|||
164231691|NCT00863304|593218143|FG001|Overall Study|Adverse Event|4|||
164231692|NCT00863304|593218144|FG002|Overall Study|Adverse Event|14|||
164231693|NCT00863304|593218145|FG003|Overall Study|Adverse Event|16|||
164231694|NCT00863304|593218142|FG000|Overall Study|Lost to Follow-up|1|||
164231695|NCT00863304|593218143|FG001|Overall Study|Lost to Follow-up|5|||
164231696|NCT00863304|593218144|FG002|Overall Study|Lost to Follow-up|4|||
164231697|NCT00863304|593218145|FG003|Overall Study|Lost to Follow-up|2|||
164231698|NCT00863304|593218142|FG000|Overall Study|Lack of Efficacy|57|||
164231699|NCT00863304|593218143|FG001|Overall Study|Lack of Efficacy|26|||
164231700|NCT00863304|593218144|FG002|Overall Study|Lack of Efficacy|30|||
164231701|NCT00863304|593218145|FG003|Overall Study|Lack of Efficacy|28|||
164231702|NCT00863304|593218142|FG000|Overall Study|Withdrawal by Subject|19|||
164231703|NCT00863304|593218143|FG001|Overall Study|Withdrawal by Subject|14|||
164231704|NCT00863304|593218144|FG002|Overall Study|Withdrawal by Subject|20|||
164231705|NCT00863304|593218145|FG003|Overall Study|Withdrawal by Subject|18|||
164231706|NCT00863304|593218142|FG000|Overall Study|Other|1|||
164231707|NCT00863304|593218143|FG001|Overall Study|Other|0|||
164332779|NCT03633617|593595647|FG009|Part C (& Follow-up)|Protocol Violation|3|||
164231708|NCT00863304|593218144|FG002|Overall Study|Other|0|||
164231709|NCT00863304|593218145|FG003|Overall Study|Other|1|||
164231710|NCT00863304|593218142|FG000|Overall Study|Protocol Violation|2|||
164231711|NCT00863304|593218143|FG001|Overall Study|Protocol Violation|6|||
164231712|NCT00863304|593218144|FG002|Overall Study|Protocol Violation|2|||
164231713|NCT00863304|593218145|FG003|Overall Study|Protocol Violation|0|||
164231714|NCT00863304|593218142|FG000|Overall Study|Randomized, but not Treated|3|||
163883550|NCT03138512|591943878|FG004|Treatment Part A|Disease recurrence|0|||
163883551|NCT03138512|591943874|FG000|Treatment Part A|Study Drug Toxicity|132|||
163883552|NCT03138512|591943875|FG001|Treatment Part A|Study Drug Toxicity|5|||
163883553|NCT03138512|591943876|FG002|Treatment Part A|Study Drug Toxicity|0|||
163883554|NCT03138512|591943877|FG003|Treatment Part A|Study Drug Toxicity|0|||
163883555|NCT03138512|591943878|FG004|Treatment Part A|Study Drug Toxicity|0|||
163883556|NCT03138512|591943874|FG000|Treatment Part A|Death|1|||
163883557|NCT03138512|591943875|FG001|Treatment Part A|Death|0|||
163883558|NCT03138512|591943876|FG002|Treatment Part A|Death|0|||
163883559|NCT03138512|591943877|FG003|Treatment Part A|Death|0|||
163883560|NCT03138512|591943878|FG004|Treatment Part A|Death|0|||
163883561|NCT03138512|591943874|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
163883562|NCT03138512|591943875|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
163883563|NCT03138512|591943876|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
163883564|NCT03138512|591943877|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
163883565|NCT03138512|591943878|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
163883566|NCT03138512|591943874|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
163883567|NCT03138512|591943875|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
163883568|NCT03138512|591943876|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
163883569|NCT03138512|591943877|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
163883570|NCT03138512|591943878|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
163883571|NCT03138512|591943874|FG000|Treatment Part A|Participant withdrew consent|2|||
163883572|NCT03138512|591943875|FG001|Treatment Part A|Participant withdrew consent|4|||
163883573|NCT03138512|591943876|FG002|Treatment Part A|Participant withdrew consent|0|||
163883574|NCT03138512|591943877|FG003|Treatment Part A|Participant withdrew consent|0|||
163883575|NCT03138512|591943878|FG004|Treatment Part A|Participant withdrew consent|0|||
163883576|NCT03138512|591943874|FG000|Treatment Part A|Lost to Follow-up|0|||
163883577|NCT03138512|591943875|FG001|Treatment Part A|Lost to Follow-up|1|||
163883578|NCT03138512|591943876|FG002|Treatment Part A|Lost to Follow-up|0|||
163883579|NCT03138512|591943877|FG003|Treatment Part A|Lost to Follow-up|0|||
163883580|NCT03138512|591943878|FG004|Treatment Part A|Lost to Follow-up|0|||
163883581|NCT03138512|591943874|FG000|Treatment Part A|Poor/non-compliance|1|||
163883582|NCT03138512|591943875|FG001|Treatment Part A|Poor/non-compliance|0|||
163883583|NCT03138512|591943876|FG002|Treatment Part A|Poor/non-compliance|0|||
163883584|NCT03138512|591943877|FG003|Treatment Part A|Poor/non-compliance|0|||
163883585|NCT03138512|591943878|FG004|Treatment Part A|Poor/non-compliance|0|||
163883586|NCT03138512|591943874|FG000|Treatment Part A|Pregnancy|0|||
163883587|NCT03138512|591943875|FG001|Treatment Part A|Pregnancy|1|||
163883588|NCT03138512|591943876|FG002|Treatment Part A|Pregnancy|0|||
163883589|NCT03138512|591943877|FG003|Treatment Part A|Pregnancy|0|||
163883590|NCT03138512|591943878|FG004|Treatment Part A|Pregnancy|0|||
163883591|NCT03138512|591943874|FG000|Treatment Part A|Other reasons|11|||
163883592|NCT03138512|591943875|FG001|Treatment Part A|Other reasons|8|||
163883593|NCT03138512|591943876|FG002|Treatment Part A|Other reasons|0|||
163883594|NCT03138512|591943877|FG003|Treatment Part A|Other reasons|0|||
163883595|NCT03138512|591943878|FG004|Treatment Part A|Other reasons|0|||
163883596|NCT03138512|591943874|FG000|Treatment Part B|Disease recurrence|0|||
163883597|NCT03138512|591943875|FG001|Treatment Part B|Disease recurrence|0|||
163883598|NCT03138512|591943876|FG002|Treatment Part B|Disease recurrence|6|||
163883599|NCT03138512|591943877|FG003|Treatment Part B|Disease recurrence|12|||
163883600|NCT03138512|591943878|FG004|Treatment Part B|Disease recurrence|10|||
163883601|NCT03138512|591943874|FG000|Treatment Part B|Study drug toxicity|0|||
163883602|NCT03138512|591943875|FG001|Treatment Part B|Study drug toxicity|0|||
163883603|NCT03138512|591943876|FG002|Treatment Part B|Study drug toxicity|63|||
163883604|NCT03138512|591943877|FG003|Treatment Part B|Study drug toxicity|3|||
163883605|NCT03138512|591943878|FG004|Treatment Part B|Study drug toxicity|45|||
163883606|NCT03138512|591943874|FG000|Treatment Part B|Death|0|||
163883607|NCT03138512|591943875|FG001|Treatment Part B|Death|0|||
163883608|NCT03138512|591943876|FG002|Treatment Part B|Death|1|||
163883609|NCT03138512|591943877|FG003|Treatment Part B|Death|0|||
163883610|NCT03138512|591943878|FG004|Treatment Part B|Death|0|||
163883611|NCT03138512|591943874|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
163883612|NCT03138512|591943875|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
163883613|NCT03138512|591943876|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
163883614|NCT03138512|591943877|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
163883615|NCT03138512|591943878|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
163883616|NCT03138512|591943874|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
163883617|NCT03138512|591943875|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
163883618|NCT03138512|591943876|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
163883619|NCT03138512|591943877|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
163883620|NCT03138512|591943878|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
163883621|NCT03138512|591943874|FG000|Treatment Part B|Participant withdrew consent|0|||
163883622|NCT03138512|591943875|FG001|Treatment Part B|Participant withdrew consent|0|||
164332780|NCT03633617|593595648|FG010|Part C (& Follow-up)|Protocol Violation|1|||
164332781|NCT03633617|593595638|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
164332782|NCT03633617|593595639|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
164332783|NCT03633617|593595640|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
164332784|NCT03633617|593595641|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
164332785|NCT03633617|593595642|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
164332786|NCT03633617|593595643|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
164332787|NCT03633617|593595644|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
164332788|NCT03633617|593595645|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
164332789|NCT03633617|593595646|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
164332790|NCT03633617|593595647|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
164332791|NCT03633617|593595648|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
164332792|NCT00809354|593595651|FG000|Overall Study|Adverse Event|32|||
164332793|NCT00809354|593595652|FG001|Overall Study|Adverse Event|45|||
164332794|NCT00809354|593595653|FG002|Overall Study|Adverse Event|37|||
164332795|NCT00809354|593595654|FG003|Overall Study|Adverse Event|53|||
164332796|NCT00809354|593595655|FG004|Overall Study|Adverse Event|26|||
164332797|NCT00809354|593595656|FG005|Overall Study|Adverse Event|33|||
164332798|NCT00809354|593595657|FG006|Overall Study|Adverse Event|44|||
164332799|NCT00809354|593595658|FG007|Overall Study|Adverse Event|40|||
164332800|NCT00809354|593595659|FG008|Overall Study|Adverse Event|46|||
164332801|NCT00809354|593595660|FG009|Overall Study|Adverse Event|26|||
164332802|NCT00809354|593595651|FG000|Overall Study|Lack of Efficacy|23|||
164332803|NCT00809354|593595652|FG001|Overall Study|Lack of Efficacy|23|||
164332804|NCT00809354|593595653|FG002|Overall Study|Lack of Efficacy|22|||
164332805|NCT00809354|593595654|FG003|Overall Study|Lack of Efficacy|15|||
164332806|NCT00809354|593595655|FG004|Overall Study|Lack of Efficacy|40|||
164332807|NCT00809354|593595656|FG005|Overall Study|Lack of Efficacy|19|||
164332808|NCT00809354|593595657|FG006|Overall Study|Lack of Efficacy|21|||
164332809|NCT00809354|593595658|FG007|Overall Study|Lack of Efficacy|15|||
164332810|NCT00809354|593595659|FG008|Overall Study|Lack of Efficacy|18|||
164332811|NCT00809354|593595660|FG009|Overall Study|Lack of Efficacy|38|||
164332812|NCT00809354|593595651|FG000|Overall Study|Lost to Follow-up|10|||
164332813|NCT00809354|593595652|FG001|Overall Study|Lost to Follow-up|11|||
164332814|NCT00809354|593595653|FG002|Overall Study|Lost to Follow-up|8|||
164332815|NCT00809354|593595654|FG003|Overall Study|Lost to Follow-up|13|||
164332816|NCT00809354|593595655|FG004|Overall Study|Lost to Follow-up|6|||
164332817|NCT00809354|593595656|FG005|Overall Study|Lost to Follow-up|2|||
164332818|NCT00809354|593595657|FG006|Overall Study|Lost to Follow-up|0|||
164332819|NCT00809354|593595658|FG007|Overall Study|Lost to Follow-up|5|||
164332820|NCT00809354|593595659|FG008|Overall Study|Lost to Follow-up|4|||
164332821|NCT00809354|593595660|FG009|Overall Study|Lost to Follow-up|0|||
164332822|NCT00809354|593595651|FG000|Overall Study|Protocol Violation|7|||
164332823|NCT00809354|593595652|FG001|Overall Study|Protocol Violation|14|||
164332824|NCT00809354|593595653|FG002|Overall Study|Protocol Violation|14|||
164332825|NCT00809354|593595654|FG003|Overall Study|Protocol Violation|12|||
164332826|NCT00809354|593595655|FG004|Overall Study|Protocol Violation|14|||
164332827|NCT00809354|593595656|FG005|Overall Study|Protocol Violation|6|||
164332828|NCT00809354|593595657|FG006|Overall Study|Protocol Violation|4|||
164332829|NCT00809354|593595658|FG007|Overall Study|Protocol Violation|6|||
164332830|NCT00809354|593595659|FG008|Overall Study|Protocol Violation|9|||
164332831|NCT00809354|593595660|FG009|Overall Study|Protocol Violation|3|||
164332832|NCT00809354|593595651|FG000|Overall Study|Withdrawal by Subject|32|||
164332833|NCT00809354|593595652|FG001|Overall Study|Withdrawal by Subject|27|||
164332834|NCT00809354|593595653|FG002|Overall Study|Withdrawal by Subject|31|||
164332835|NCT00809354|593595654|FG003|Overall Study|Withdrawal by Subject|33|||
164332836|NCT00809354|593595655|FG004|Overall Study|Withdrawal by Subject|34|||
164332837|NCT00809354|593595656|FG005|Overall Study|Withdrawal by Subject|29|||
164332838|NCT00809354|593595657|FG006|Overall Study|Withdrawal by Subject|27|||
164332839|NCT00809354|593595658|FG007|Overall Study|Withdrawal by Subject|19|||
164332840|NCT00809354|593595659|FG008|Overall Study|Withdrawal by Subject|18|||
164332841|NCT00809354|593595660|FG009|Overall Study|Withdrawal by Subject|20|||
164332842|NCT00809354|593595651|FG000|Overall Study|Other|10|||
164332843|NCT00809354|593595652|FG001|Overall Study|Other|2|||
164332844|NCT00809354|593595653|FG002|Overall Study|Other|7|||
164332845|NCT00809354|593595654|FG003|Overall Study|Other|10|||
164332846|NCT00809354|593595655|FG004|Overall Study|Other|5|||
164332847|NCT00809354|593595656|FG005|Overall Study|Other|3|||
164332848|NCT00809354|593595657|FG006|Overall Study|Other|2|||
164332849|NCT00809354|593595658|FG007|Overall Study|Other|3|||
164332850|NCT00809354|593595659|FG008|Overall Study|Other|4|||
164332851|NCT00809354|593595660|FG009|Overall Study|Other|3|||
164332852|NCT00809354|593595651|FG000|Overall Study|Study terminated by sponsor|138|||
164332853|NCT00809354|593595652|FG001|Overall Study|Study terminated by sponsor|134|||
164332854|NCT00809354|593595653|FG002|Overall Study|Study terminated by sponsor|129|||
164332855|NCT00809354|593595654|FG003|Overall Study|Study terminated by sponsor|120|||
164332856|NCT00809354|593595655|FG004|Overall Study|Study terminated by sponsor|126|||
164332857|NCT00809354|593595656|FG005|Overall Study|Study terminated by sponsor|133|||
164332858|NCT00809354|593595657|FG006|Overall Study|Study terminated by sponsor|124|||
164332859|NCT00809354|593595658|FG007|Overall Study|Study terminated by sponsor|148|||
164231715|NCT00863304|593218143|FG001|Overall Study|Randomized, but not Treated|1|||
164231716|NCT00863304|593218144|FG002|Overall Study|Randomized, but not Treated|4|||
164231717|NCT00863304|593218145|FG003|Overall Study|Randomized, but not Treated|1|||
164231718|NCT00863304|593218142|FG000|Overall Study|Entered extension study|101|||
164231719|NCT00863304|593218143|FG001|Overall Study|Entered extension study|129|||
164231720|NCT00863304|593218144|FG002|Overall Study|Entered extension study|113|||
164231721|NCT00863304|593218145|FG003|Overall Study|Entered extension study|125|||
164231722|NCT01182350|593218147|FG000|Overall Study|Adverse Event|5|||
164231723|NCT01182350|593218148|FG001|Overall Study|Adverse Event|0|||
164231724|NCT01182350|593218149|FG002|Overall Study|Adverse Event|0|||
164231725|NCT01182350|593218150|FG003|Overall Study|Adverse Event|0|||
164231726|NCT01182350|593218151|FG004|Overall Study|Adverse Event|0|||
164231727|NCT01182350|593218147|FG000|Overall Study|Disease Progression|15|||
164231728|NCT01182350|593218148|FG001|Overall Study|Disease Progression|12|||
164231729|NCT01182350|593218149|FG002|Overall Study|Disease Progression|0|||
164231730|NCT01182350|593218150|FG003|Overall Study|Disease Progression|1|||
164231731|NCT01182350|593218151|FG004|Overall Study|Disease Progression|0|||
164231732|NCT01182350|593218147|FG000|Overall Study|Death|0|||
164231733|NCT01182350|593218148|FG001|Overall Study|Death|1|||
164231734|NCT01182350|593218149|FG002|Overall Study|Death|1|||
164231735|NCT01182350|593218150|FG003|Overall Study|Death|0|||
164231736|NCT01182350|593218151|FG004|Overall Study|Death|0|||
164231737|NCT01182350|593218147|FG000|Overall Study|Withdrawal by Subject|3|||
164231738|NCT01182350|593218148|FG001|Overall Study|Withdrawal by Subject|1|||
164231739|NCT01182350|593218149|FG002|Overall Study|Withdrawal by Subject|0|||
164231740|NCT01182350|593218150|FG003|Overall Study|Withdrawal by Subject|1|||
164231741|NCT01182350|593218151|FG004|Overall Study|Withdrawal by Subject|0|||
164231742|NCT01182350|593218147|FG000|Overall Study|Alternative Therapy|2|||
164231743|NCT01182350|593218148|FG001|Overall Study|Alternative Therapy|0|||
164231744|NCT01182350|593218149|FG002|Overall Study|Alternative Therapy|1|||
164231745|NCT01182350|593218150|FG003|Overall Study|Alternative Therapy|0|||
164231746|NCT01182350|593218151|FG004|Overall Study|Alternative Therapy|0|||
164231747|NCT01182350|593218147|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
164231748|NCT01182350|593218148|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
164231749|NCT01182350|593218149|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
164231750|NCT01182350|593218150|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
164231751|NCT01182350|593218151|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
164231752|NCT01182350|593218147|FG000|Overall Study|Unevaluable for Biopsy|0|||
164231753|NCT01182350|593218148|FG001|Overall Study|Unevaluable for Biopsy|0|||
163883623|NCT03138512|591943876|FG002|Treatment Part B|Participant withdrew consent|1|||
163883624|NCT03138512|591943877|FG003|Treatment Part B|Participant withdrew consent|1|||
163883625|NCT03138512|591943878|FG004|Treatment Part B|Participant withdrew consent|2|||
163883626|NCT03138512|591943874|FG000|Treatment Part B|Lost to Follow-up|0|||
163883627|NCT03138512|591943875|FG001|Treatment Part B|Lost to Follow-up|0|||
163883628|NCT03138512|591943876|FG002|Treatment Part B|Lost to Follow-up|0|||
163883629|NCT03138512|591943877|FG003|Treatment Part B|Lost to Follow-up|1|||
163883630|NCT03138512|591943878|FG004|Treatment Part B|Lost to Follow-up|0|||
163883631|NCT03138512|591943874|FG000|Treatment Part B|Poor/non-compliance|0|||
163883632|NCT03138512|591943875|FG001|Treatment Part B|Poor/non-compliance|0|||
163883633|NCT03138512|591943876|FG002|Treatment Part B|Poor/non-compliance|1|||
163883634|NCT03138512|591943877|FG003|Treatment Part B|Poor/non-compliance|1|||
163883635|NCT03138512|591943878|FG004|Treatment Part B|Poor/non-compliance|1|||
163883636|NCT03138512|591943874|FG000|Treatment Part B|Other reasons|0|||
164231754|NCT01182350|593218149|FG002|Overall Study|Unevaluable for Biopsy|0|||
164231755|NCT01182350|593218150|FG003|Overall Study|Unevaluable for Biopsy|0|||
164231756|NCT01182350|593218151|FG004|Overall Study|Unevaluable for Biopsy|3|||
164231757|NCT04023487|593218152|FG000|Overall Study|Lost to Follow-up|5|||
164231758|NCT04023487|593218153|FG001|Overall Study|Lost to Follow-up|4|||
164231759|NCT04023487|593218152|FG000|Overall Study|Pregnancy|1|||
164332860|NCT00809354|593595659|FG008|Overall Study|Study terminated by sponsor|127|||
164332861|NCT00809354|593595660|FG009|Overall Study|Study terminated by sponsor|135|||
164332862|NCT00809354|593595651|FG000|Overall Study|Withdrawn due to pregnancy|0|||
164332863|NCT00809354|593595652|FG001|Overall Study|Withdrawn due to pregnancy|1|||
164332864|NCT00809354|593595653|FG002|Overall Study|Withdrawn due to pregnancy|0|||
164332865|NCT00809354|593595654|FG003|Overall Study|Withdrawn due to pregnancy|0|||
163883637|NCT03138512|591943875|FG001|Treatment Part B|Other reasons|0|||
164231760|NCT04023487|593218153|FG001|Overall Study|Pregnancy|2|||
164231761|NCT04023487|593218152|FG000|Overall Study|Withdrawal by Subject|4|||
164231762|NCT04023487|593218153|FG001|Overall Study|Withdrawal by Subject|5|||
164231763|NCT04023487|593218152|FG000|Overall Study|Partially completed testing|8|||
164332866|NCT00809354|593595655|FG004|Overall Study|Withdrawn due to pregnancy|0|||
164332867|NCT00809354|593595656|FG005|Overall Study|Withdrawn due to pregnancy|0|||
163883638|NCT03138512|591943876|FG002|Treatment Part B|Other reasons|3|||
164332868|NCT00809354|593595657|FG006|Overall Study|Withdrawn due to pregnancy|0|||
163883639|NCT03138512|591943877|FG003|Treatment Part B|Other reasons|1|||
163883640|NCT03138512|591943878|FG004|Treatment Part B|Other reasons|5|||
164231764|NCT04023487|593218153|FG001|Overall Study|Partially completed testing|4|||
164231765|NCT00605189|593218154|FG000|Overall Study|Adverse Event|1|||
164231766|NCT00605189|593218155|FG001|Overall Study|Adverse Event|0|||
164231767|NCT00605189|593218156|FG002|Overall Study|Adverse Event|0|||
164231768|NCT00605189|593218154|FG000|Overall Study|Other|2|||
164231769|NCT00605189|593218155|FG001|Overall Study|Other|2|||
164231770|NCT00605189|593218156|FG002|Overall Study|Other|0|||
164231771|NCT03898180|593218157|FG000|Overall Study|Death|178|||
164231772|NCT03898180|593218158|FG001|Overall Study|Death|173|||
164231773|NCT03898180|593218157|FG000|Overall Study|Physician Decision|1|||
164231774|NCT03898180|593218158|FG001|Overall Study|Physician Decision|0|||
164231775|NCT03898180|593218157|FG000|Overall Study|Sponsor Decision|3|||
164231776|NCT03898180|593218158|FG001|Overall Study|Sponsor Decision|0|||
164231777|NCT03898180|593218157|FG000|Overall Study|Lost to Follow-up|1|||
164231778|NCT03898180|593218158|FG001|Overall Study|Lost to Follow-up|0|||
164231779|NCT03898180|593218157|FG000|Overall Study|Withdrawal by Subject|5|||
164231780|NCT03898180|593218158|FG001|Overall Study|Withdrawal by Subject|4|||
164231781|NCT05030766|593218160|FG000|Phase 1 Participants|Lost to Follow-up|12|||
164231782|NCT05030766|593218161|FG001|Phase 1 Participants|Lost to Follow-up|22|||
164231783|NCT05030766|593218162|FG002|Phase 1 Participants|Lost to Follow-up|0|||
164231784|NCT05030766|593218163|FG003|Phase 1 Participants|Lost to Follow-up|0|||
164231785|NCT05030766|593218160|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
164231786|NCT05030766|593218161|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
164231787|NCT05030766|593218162|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
164231788|NCT05030766|593218163|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
164231789|NCT05030766|593218160|FG000|Phase 2 Participants|Lost to Follow-up|0|||
164231790|NCT05030766|593218161|FG001|Phase 2 Participants|Lost to Follow-up|0|||
164231791|NCT05030766|593218162|FG002|Phase 2 Participants|Lost to Follow-up|6|||
164231792|NCT05030766|593218163|FG003|Phase 2 Participants|Lost to Follow-up|2|||
164231793|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
164231794|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
164231795|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
164231796|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
164231797|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
164231798|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
164231799|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
164231800|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
164231801|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
164231802|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
164231803|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
164231804|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
164231805|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
164231806|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
164231807|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
164231808|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
164231809|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
164231810|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
164231811|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
164231812|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
164231813|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
164231814|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
164231815|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
164231816|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
164231817|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
164231818|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
164231819|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
164231820|NCT03093415|593218164|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
164231821|NCT03093415|593218165|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
164231822|NCT03093415|593218166|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
164231823|NCT03093415|593218164|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
164231824|NCT03093415|593218165|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
164231825|NCT03093415|593218166|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
164231826|NCT03559530|593218167|FG000|Overall Study|non-location of medical records|44|||
164231827|NCT03559530|593218168|FG001|Overall Study|non-location of medical records|0|||
164231828|NCT03559530|593218167|FG000|Overall Study|culture results not considered for treat|29|||
163883641|NCT03792555|591943892|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
164231829|NCT03559530|593218168|FG001|Overall Study|culture results not considered for treat|0|||
164231830|NCT03559530|593218167|FG000|Overall Study|duplicate cases|8|||
164332869|NCT00809354|593595658|FG007|Overall Study|Withdrawn due to pregnancy|0|||
164332870|NCT00809354|593595659|FG008|Overall Study|Withdrawn due to pregnancy|0|||
164332871|NCT00809354|593595660|FG009|Overall Study|Withdrawn due to pregnancy|0|||
164332872|NCT00809354|593595651|FG000|Overall Study|Randomized but not Treated|3|||
164332873|NCT00809354|593595652|FG001|Overall Study|Randomized but not Treated|1|||
164332874|NCT00809354|593595653|FG002|Overall Study|Randomized but not Treated|6|||
164332875|NCT00809354|593595654|FG003|Overall Study|Randomized but not Treated|0|||
164332876|NCT00809354|593595655|FG004|Overall Study|Randomized but not Treated|5|||
164332877|NCT00809354|593595656|FG005|Overall Study|Randomized but not Treated|0|||
164332878|NCT00809354|593595657|FG006|Overall Study|Randomized but not Treated|1|||
164332879|NCT00809354|593595658|FG007|Overall Study|Randomized but not Treated|1|||
164332880|NCT00809354|593595659|FG008|Overall Study|Randomized but not Treated|2|||
164332881|NCT00809354|593595660|FG009|Overall Study|Randomized but not Treated|1|||
164332882|NCT00809354|593595651|FG000|Overall Study|Death|0|||
164332883|NCT00809354|593595652|FG001|Overall Study|Death|0|||
164332884|NCT00809354|593595653|FG002|Overall Study|Death|0|||
164332885|NCT00809354|593595654|FG003|Overall Study|Death|0|||
164332886|NCT00809354|593595655|FG004|Overall Study|Death|0|||
164332887|NCT00809354|593595656|FG005|Overall Study|Death|0|||
164332888|NCT00809354|593595657|FG006|Overall Study|Death|0|||
164332889|NCT00809354|593595658|FG007|Overall Study|Death|1|||
164231831|NCT03559530|593218168|FG001|Overall Study|duplicate cases|0|||
164231832|NCT03559530|593218167|FG000|Overall Study|other species of Acinetobacte|7|||
164231833|NCT03559530|593218168|FG001|Overall Study|other species of Acinetobacte|0|||
164231834|NCT03559530|593218167|FG000|Overall Study|contamination / colonization|3|||
164231835|NCT03559530|593218168|FG001|Overall Study|contamination / colonization|0|||
164231836|NCT01472185|593218169|FG000|Overall Study|Randomized but Not Treated|0|||
164231837|NCT01472185|593218170|FG001|Overall Study|Randomized but Not Treated|1|||
164231838|NCT01472185|593218169|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
164231839|NCT01472185|593218170|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
164231840|NCT01472185|593218169|FG000|Overall Study|Hyperglycemia|5|||
164231841|NCT01472185|593218170|FG001|Overall Study|Hyperglycemia|2|||
164231842|NCT01472185|593218169|FG000|Overall Study|Investigator's Discretion|3|||
164231843|NCT01472185|593218170|FG001|Overall Study|Investigator's Discretion|1|||
164231844|NCT01472185|593218169|FG000|Overall Study|Lost to Follow-up|4|||
164231845|NCT01472185|593218170|FG001|Overall Study|Lost to Follow-up|1|||
164231846|NCT01472185|593218169|FG000|Overall Study|Protocol Violation|5|||
164231847|NCT01472185|593218170|FG001|Overall Study|Protocol Violation|1|||
164231848|NCT01472185|593218169|FG000|Overall Study|Subject Noncompliance|8|||
164231849|NCT01472185|593218170|FG001|Overall Study|Subject Noncompliance|15|||
164231850|NCT01472185|593218169|FG000|Overall Study|Subject Withdrew Consent|6|||
164231851|NCT01472185|593218170|FG001|Overall Study|Subject Withdrew Consent|3|||
164231852|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231853|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
164231854|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231855|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
164231856|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
164231857|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
164231858|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
164231859|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231860|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231861|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231862|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231863|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231864|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231865|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231866|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231867|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
164231868|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
164231869|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
164332890|NCT00809354|593595659|FG008|Overall Study|Death|0|||
164231870|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
164231871|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
164231872|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
164332891|NCT00809354|593595660|FG009|Overall Study|Death|0|||
164332892|NCT04137224|593595663|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
164332893|NCT04137224|593595664|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
164332894|NCT04137224|593595663|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
164332895|NCT04137224|593595664|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
164332896|NCT04137224|593595663|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
164332897|NCT04137224|593595664|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
164332898|NCT01199731|593595672|FG000|Overall Study|Adverse Event|0|||
164231873|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
164231874|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
164231875|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
164231876|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
164231877|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
164231878|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
164231879|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
164231880|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
164231881|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
164231882|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
164231883|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
164231884|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
164231885|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
164231886|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231887|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231888|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231889|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231890|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231891|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231892|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231893|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231894|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231895|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231896|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231897|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231898|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231899|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
164231900|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
164231901|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231902|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
164231903|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231904|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231905|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231906|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
164231907|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231908|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231909|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231910|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231911|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231912|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231913|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231914|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231915|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164231916|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231917|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231918|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231919|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
164231920|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231921|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231922|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
164231923|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231924|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231925|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231926|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231927|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231928|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231929|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231930|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231931|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
164231932|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231933|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231934|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
164231935|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231936|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231937|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231938|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231939|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231940|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231941|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231942|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231943|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231944|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231945|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231946|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231947|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
164231948|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164231949|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164231950|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164231951|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231952|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231953|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231954|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231955|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231956|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231957|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231958|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231959|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231960|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231961|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231962|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231963|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164231964|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
164231965|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
164231966|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
164231967|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
164231968|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
164231969|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
164231970|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
164231971|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
164231972|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
164231973|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
164231974|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
164231975|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
164231976|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
164231977|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
164231978|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
164231979|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
164231980|NCT02958865|593218171|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231981|NCT02958865|593218172|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231982|NCT02958865|593218173|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231983|NCT02958865|593218174|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231984|NCT02958865|593218175|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
164231985|NCT02958865|593218176|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231986|NCT02958865|593218177|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231987|NCT02958865|593218178|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231988|NCT02958865|593218179|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231989|NCT02958865|593218180|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231990|NCT02958865|593218181|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231991|NCT02958865|593218182|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231992|NCT02958865|593218183|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231993|NCT02958865|593218184|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231994|NCT02958865|593218185|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231995|NCT02958865|593218186|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164231996|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164231997|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164231998|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164231999|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232000|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232001|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232002|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232003|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232004|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232005|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
164232006|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
164232007|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232008|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
164232009|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232010|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
164232011|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
164232012|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232013|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232014|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232015|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232016|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232017|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232018|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232019|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232020|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
164232021|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
164232022|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232023|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
164232024|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232025|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
164232026|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
164232027|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
164332899|NCT01199731|593595673|FG001|Overall Study|Adverse Event|1|||
164332900|NCT01199731|593595674|FG002|Overall Study|Adverse Event|0|||
164332901|NCT01199731|593595672|FG000|Overall Study|Study closed/terminated|7|||
164332902|NCT01199731|593595673|FG001|Overall Study|Study closed/terminated|9|||
164332903|NCT01199731|593595674|FG002|Overall Study|Study closed/terminated|7|||
164332904|NCT01199731|593595672|FG000|Overall Study|Lost to Follow-up|0|||
164332905|NCT01199731|593595673|FG001|Overall Study|Lost to Follow-up|0|||
164332906|NCT01199731|593595674|FG002|Overall Study|Lost to Follow-up|2|||
164332907|NCT01199731|593595672|FG000|Overall Study|Physician Decision|0|||
164332908|NCT01199731|593595673|FG001|Overall Study|Physician Decision|1|||
164332909|NCT01199731|593595674|FG002|Overall Study|Physician Decision|1|||
164332910|NCT01199731|593595672|FG000|Overall Study|Withdrawal by Subject|2|||
164332911|NCT01199731|593595673|FG001|Overall Study|Withdrawal by Subject|0|||
164332912|NCT01199731|593595674|FG002|Overall Study|Withdrawal by Subject|0|||
164332913|NCT04010539|593595675|FG000|Overall Study|Withdrawal by Subject|4|||
164332914|NCT04010539|593595676|FG001|Overall Study|Withdrawal by Subject|1|||
164332915|NCT04010539|593595675|FG000|Overall Study|Physician Decision|0|||
164332916|NCT04010539|593595676|FG001|Overall Study|Physician Decision|2|||
164332917|NCT04010539|593595675|FG000|Overall Study|Lost to Follow-up|10|||
164332918|NCT04010539|593595676|FG001|Overall Study|Lost to Follow-up|14|||
164332919|NCT04010539|593595675|FG000|Overall Study|Adverse Event|3|||
164332920|NCT04010539|593595676|FG001|Overall Study|Adverse Event|0|||
164332921|NCT04010539|593595675|FG000|Overall Study|Participant Did Not Receive IP|0|||
164332922|NCT04010539|593595676|FG001|Overall Study|Participant Did Not Receive IP|1|||
164332923|NCT04010539|593595675|FG000|Overall Study|Protocol Deviation|0|||
164332924|NCT04010539|593595676|FG001|Overall Study|Protocol Deviation|1|||
164332925|NCT04010539|593595675|FG000|Overall Study|Randomized in Error/ Mistake|2|||
163883642|NCT03792555|591943893|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
164232028|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232029|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232030|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232031|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232032|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232033|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232034|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232035|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232036|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164332926|NCT04010539|593595676|FG001|Overall Study|Randomized in Error/ Mistake|0|||
164332927|NCT04010539|593595675|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
164332928|NCT04010539|593595676|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
164332929|NCT02028871|593595677|FG000|Overall Study|Positive urine drug screen|1|||
164332930|NCT02028871|593595678|FG001|Overall Study|Positive urine drug screen|1|||
164332931|NCT02028871|593595677|FG000|Overall Study|Withdrawal by Subject|1|||
164332932|NCT02028871|593595678|FG001|Overall Study|Withdrawal by Subject|2|||
163883643|NCT03792555|591943894|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
164232037|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
164232038|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232039|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232040|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232041|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232042|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
164232043|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
164232044|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232045|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232046|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232047|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232048|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232049|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232050|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232051|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232052|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232053|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232054|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
164232055|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
164232056|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
164232057|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
164232058|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
164232059|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
164232060|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
164232061|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
164232062|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
164232063|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
164232064|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
164232065|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
164232066|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
164232067|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
164232068|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
164232069|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
164232070|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
164232071|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
164232072|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
164232073|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
164232074|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
164232075|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
164232076|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232077|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232078|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232079|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232080|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232081|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232082|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232083|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232084|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232085|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164332933|NCT02028871|593595677|FG000|Overall Study|IV placement difficulty|1|||
164332934|NCT02028871|593595678|FG001|Overall Study|IV placement difficulty|0|||
163883644|NCT03792555|591943892|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
164232086|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164332935|NCT02028871|593595677|FG000|Overall Study|Current Illness|1|||
163883645|NCT03792555|591943893|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
163883646|NCT03792555|591943894|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
163883647|NCT03792555|591943892|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
163883648|NCT03792555|591943893|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
164232087|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232088|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232089|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
164232090|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164332936|NCT02028871|593595678|FG001|Overall Study|Current Illness|0|||
164332937|NCT02314143|593595681|FG000|Overall Study|Adverse Event|0|||
164332938|NCT02314143|593595682|FG001|Overall Study|Adverse Event|6|||
164332939|NCT02314143|593595683|FG002|Overall Study|Adverse Event|4|||
163883649|NCT03792555|591943894|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
163883650|NCT04485039|591943898|FG000|TPOXX Only|Adverse Event|2|||
163883651|NCT04485039|591943898|FG000|TPOXX Only|Physician Decision|1|||
163883652|NCT04485039|591943898|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
163883653|NCT04485039|591943898|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
164232091|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
164232092|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232093|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232094|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232095|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232096|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232097|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232098|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232099|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232100|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232101|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232102|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232103|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232104|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232105|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
164232106|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232107|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
164232108|NCT02958865|593218171|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232109|NCT02958865|593218172|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232110|NCT02958865|593218173|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232111|NCT02958865|593218174|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232112|NCT02958865|593218175|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232113|NCT02958865|593218176|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232114|NCT02958865|593218177|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232115|NCT02958865|593218178|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232116|NCT02958865|593218179|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232117|NCT02958865|593218180|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
163883654|NCT03535272|591943902|FG000|Overall Study|Lost to Follow-up|71|||
164232118|NCT02958865|593218181|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232119|NCT02958865|593218182|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232120|NCT02958865|593218183|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232121|NCT02958865|593218184|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232122|NCT02958865|593218185|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232123|NCT02958865|593218186|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
164232124|NCT01309230|593218187|FG000|Overall Study|Withdrawal by Subject|0|||
164232125|NCT01309230|593218188|FG001|Overall Study|Withdrawal by Subject|2|||
164232126|NCT01309230|593218187|FG000|Overall Study|Observation arm closed|0|||
164232127|NCT01309230|593218188|FG001|Overall Study|Observation arm closed|2|||
164232128|NCT02661815|593218189|FG000|Overall Study|Withdrawal by Subject|1|||
164232129|NCT02661815|593218190|FG001|Overall Study|Withdrawal by Subject|0|||
164232130|NCT02661815|593218191|FG002|Overall Study|Withdrawal by Subject|0|||
164232131|NCT02661815|593218192|FG003|Overall Study|Withdrawal by Subject|0|||
164232132|NCT00209131|593218193|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
164232133|NCT00209131|593218194|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
164232134|NCT05360784|593218195|FG000|Overall Study|Discontinued|25|||
164232135|NCT05360784|593218196|FG001|Overall Study|Discontinued|11|||
164232136|NCT04875533|593218197|FG000|Overall Study|Adverse Event|6|||
164232137|NCT04875533|593218198|FG001|Overall Study|Adverse Event|4|||
164232138|NCT04875533|593218197|FG000|Overall Study|Protocol Violation|4|||
164232139|NCT04875533|593218198|FG001|Overall Study|Protocol Violation|0|||
164232140|NCT04875533|593218197|FG000|Overall Study|Withdrawal by Subject|8|||
164232141|NCT04875533|593218198|FG001|Overall Study|Withdrawal by Subject|5|||
164232142|NCT04875533|593218197|FG000|Overall Study|No longer meets eligibility criteria|1|||
164232143|NCT04875533|593218198|FG001|Overall Study|No longer meets eligibility criteria|0|||
164232144|NCT04875533|593218197|FG000|Overall Study|Other|0|||
164232145|NCT04875533|593218198|FG001|Overall Study|Other|2|||
163883655|NCT03535272|591943903|FG001|Overall Study|Lost to Follow-up|73|||
163883656|NCT01744782|591943904|FG000|Overall Study|Death|1|||
164232146|NCT02971163|593218199|FG000|Overall Study|Lost to Follow-up|4|||
164232147|NCT02971163|593218200|FG001|Overall Study|Lost to Follow-up|2|||
164232148|NCT01299961|593218203|FG000|Overall Study|Adverse Event|3|||
164232149|NCT01299961|593218203|FG000|Overall Study|Lack of Efficacy|2|||
164232150|NCT01299961|593218203|FG000|Overall Study|Lost to Follow-up|1|||
164332940|NCT02314143|593595681|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
164332941|NCT02314143|593595682|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
164332942|NCT02314143|593595683|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
164332943|NCT02314143|593595681|FG000|Overall Study|Physician Decision|2|||
164332944|NCT02314143|593595682|FG001|Overall Study|Physician Decision|1|||
164332945|NCT02314143|593595683|FG002|Overall Study|Physician Decision|0|||
164332946|NCT02314143|593595681|FG000|Overall Study|Withdrawal by Subject|1|||
164332947|NCT02314143|593595682|FG001|Overall Study|Withdrawal by Subject|0|||
164332948|NCT02314143|593595683|FG002|Overall Study|Withdrawal by Subject|1|||
163987260|NCT04484285|592322246|FG000|Overall Study|Unable to operate stimulator|3|||
163987261|NCT04484285|592322247|FG001|Overall Study|Unable to operate stimulator|0|||
163987262|NCT06272370|592322248|FG000|Overall Study|Lost to Follow-up|0|||
163987263|NCT06272370|592322249|FG001|Overall Study|Lost to Follow-up|3|||
163987264|NCT06272370|592322250|FG002|Overall Study|Lost to Follow-up|1|||
163987265|NCT06272370|592322251|FG003|Overall Study|Lost to Follow-up|1|||
163987266|NCT05280756|592322252|FG000|Overall Study|Lost to Follow-up|1|||
164332949|NCT01528215|593595696|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
164332950|NCT01528215|593595697|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
164332951|NCT01528215|593595696|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
163987267|NCT05280756|592322253|FG001|Overall Study|Lost to Follow-up|1|||
163987268|NCT01299766|592322255|FG000|Overall Study|Death|5|||
163987269|NCT01299766|592322256|FG001|Overall Study|Death|4|||
164232151|NCT02904096|593218204|FG000|Overall Study|Adverse Event|1|||
164232152|NCT02904096|593218205|FG001|Overall Study|Adverse Event|0|||
164232153|NCT02904096|593218204|FG000|Overall Study|Withdrawal by Subject|4|||
164232154|NCT02904096|593218205|FG001|Overall Study|Withdrawal by Subject|3|||
163883657|NCT02120456|591943906|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883658|NCT02120456|591943907|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883659|NCT02120456|591943908|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883660|NCT02120456|591943909|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
164232155|NCT02904096|593218204|FG000|Overall Study|Lost to Follow-up|10|||
164232156|NCT02904096|593218205|FG001|Overall Study|Lost to Follow-up|17|||
164232157|NCT02904096|593218204|FG000|Overall Study|Non-compliant|3|||
164232158|NCT02904096|593218205|FG001|Overall Study|Non-compliant|1|||
164232159|NCT02904096|593218204|FG000|Overall Study|Sponsor instructed|1|||
164232160|NCT02904096|593218205|FG001|Overall Study|Sponsor instructed|0|||
164232161|NCT00526799|593218208|FG000|Overall Study|Withdrawal by Subject|1|||
164232162|NCT00526799|593218209|FG001|Overall Study|Withdrawal by Subject|0|||
164232163|NCT00526799|593218208|FG000|Overall Study|Intercurrent Complicating Disease|0|||
164232164|NCT00526799|593218209|FG001|Overall Study|Intercurrent Complicating Disease|1|||
164232165|NCT03633058|593218212|FG000|Overall Study|Adverse Event|0|||
164232166|NCT03633058|593218213|FG001|Overall Study|Adverse Event|0|||
164232167|NCT03633058|593218214|FG002|Overall Study|Adverse Event|1|||
164232168|NCT03633058|593218215|FG003|Overall Study|Adverse Event|0|||
164232169|NCT01107496|593218219|FG000|Overall Study|Adverse Event|1|||
164232170|NCT01107496|593218220|FG001|Overall Study|Adverse Event|0|||
164232171|NCT01107496|593218219|FG000|Overall Study|Lack of Efficacy|1|||
164232172|NCT01107496|593218220|FG001|Overall Study|Lack of Efficacy|0|||
164232173|NCT01107496|593218219|FG000|Overall Study|Protocol Violation|0|||
164232174|NCT01107496|593218220|FG001|Overall Study|Protocol Violation|1|||
164232175|NCT01107496|593218219|FG000|Overall Study|Lost to Follow-up|0|||
164232176|NCT01107496|593218220|FG001|Overall Study|Lost to Follow-up|1|||
164232177|NCT03559556|593218221|FG000|Overall Study|Withdrawal by Subject|1|||
164232178|NCT02496000|593218222|FG000|Overall Study|Withdrawal by Subject|1|||
164232179|NCT02496000|593218223|FG001|Overall Study|Withdrawal by Subject|2|||
164232180|NCT02496000|593218224|FG002|Overall Study|Withdrawal by Subject|0|||
164232181|NCT02496000|593218222|FG000|Overall Study|Lost to Follow-up|1|||
164232182|NCT02496000|593218223|FG001|Overall Study|Lost to Follow-up|0|||
164232183|NCT02496000|593218224|FG002|Overall Study|Lost to Follow-up|1|||
164232184|NCT02496000|593218222|FG000|Overall Study|Protocol Violation|0|||
164332952|NCT01528215|593595697|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
164332953|NCT01528215|593595696|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
164332954|NCT01528215|593595697|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
164332955|NCT01528215|593595696|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
164332956|NCT01528215|593595697|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
164332957|NCT02322021|593595698|FG000|Core Phase|Adverse Event|1|||
164332958|NCT02322021|593595699|FG001|Core Phase|Adverse Event|3|||
164332959|NCT02322021|593595700|FG002|Core Phase|Adverse Event|4|||
164332960|NCT02322021|593595701|FG003|Core Phase|Adverse Event|2|||
164332961|NCT02322021|593595702|FG004|Core Phase|Adverse Event|0|||
164332962|NCT02322021|593595698|FG000|Core Phase|Participant Choice|4|||
164332963|NCT02322021|593595699|FG001|Core Phase|Participant Choice|5|||
164332964|NCT02322021|593595700|FG002|Core Phase|Participant Choice|4|||
164332965|NCT02322021|593595701|FG003|Core Phase|Participant Choice|2|||
164332966|NCT02322021|593595702|FG004|Core Phase|Participant Choice|0|||
164332967|NCT02322021|593595698|FG000|Core Phase|Lost to Follow-up|0|||
164332968|NCT02322021|593595699|FG001|Core Phase|Lost to Follow-up|0|||
164332969|NCT02322021|593595700|FG002|Core Phase|Lost to Follow-up|0|||
164332970|NCT02322021|593595701|FG003|Core Phase|Lost to Follow-up|1|||
164332971|NCT02322021|593595702|FG004|Core Phase|Lost to Follow-up|0|||
164332972|NCT02322021|593595698|FG000|Core Phase|Other|0|||
164332973|NCT02322021|593595699|FG001|Core Phase|Other|0|||
164332974|NCT02322021|593595700|FG002|Core Phase|Other|1|||
164332975|NCT02322021|593595701|FG003|Core Phase|Other|0|||
164332976|NCT02322021|593595702|FG004|Core Phase|Other|0|||
164332977|NCT02322021|593595698|FG000|Extension Phase|Adverse Event|0|||
164332978|NCT02322021|593595699|FG001|Extension Phase|Adverse Event|0|||
164332979|NCT02322021|593595700|FG002|Extension Phase|Adverse Event|0|||
164332980|NCT02322021|593595701|FG003|Extension Phase|Adverse Event|0|||
164332981|NCT02322021|593595702|FG004|Extension Phase|Adverse Event|3|||
164332982|NCT02322021|593595698|FG000|Extension Phase|Participant Choice|0|||
164332983|NCT02322021|593595699|FG001|Extension Phase|Participant Choice|0|||
164332984|NCT02322021|593595700|FG002|Extension Phase|Participant Choice|0|||
164332985|NCT02322021|593595701|FG003|Extension Phase|Participant Choice|0|||
164332986|NCT02322021|593595702|FG004|Extension Phase|Participant Choice|6|||
164332987|NCT02322021|593595698|FG000|Extension Phase|Other|0|||
164332988|NCT02322021|593595699|FG001|Extension Phase|Other|0|||
164332989|NCT02322021|593595700|FG002|Extension Phase|Other|0|||
164332990|NCT02322021|593595701|FG003|Extension Phase|Other|0|||
164332991|NCT02322021|593595702|FG004|Extension Phase|Other|3|||
164332992|NCT02322021|593595698|FG000|Extension Phase|Lost to Follow-up|0|||
164232185|NCT02496000|593218223|FG001|Overall Study|Protocol Violation|0|||
164232186|NCT02496000|593218224|FG002|Overall Study|Protocol Violation|1|||
164232187|NCT02496000|593218222|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
164232188|NCT02496000|593218223|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
164232189|NCT02496000|593218224|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
164232190|NCT02496000|593218222|FG000|Overall Study|undetermined|0|||
164232191|NCT02496000|593218223|FG001|Overall Study|undetermined|1|||
164232192|NCT02496000|593218224|FG002|Overall Study|undetermined|0|||
164232193|NCT01877278|593218225|FG000|Overall Study|Lost to Follow-up|3|||
164232194|NCT01877278|593218226|FG001|Overall Study|Lost to Follow-up|3|||
164232195|NCT01969058|593218227|FG000|Overall Study|Withdrawal by Subject|2|||
164232196|NCT01969058|593218228|FG001|Overall Study|Withdrawal by Subject|0|||
164232197|NCT01969058|593218227|FG000|Overall Study|Adverse Event|1|||
164232198|NCT01969058|593218228|FG001|Overall Study|Adverse Event|0|||
164232199|NCT04090749|593218229|FG000|Open Label Pilot|Lost to Follow-up|1|||
164232200|NCT04090749|593218230|FG001|Open Label Pilot|Lost to Follow-up|0|||
164232201|NCT04090749|593218231|FG002|Open Label Pilot|Lost to Follow-up|0|||
164232202|NCT04090749|593218229|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
164232203|NCT04090749|593218230|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
164232204|NCT04090749|593218231|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
164232205|NCT04090749|593218229|FG000|Pilot Trial|Lost to Follow-up|0|||
164232206|NCT04090749|593218230|FG001|Pilot Trial|Lost to Follow-up|1|||
164232207|NCT04090749|593218231|FG002|Pilot Trial|Lost to Follow-up|1|||
164232208|NCT03510715|593218232|FG000|Overall Study|Adverse Event|1|||
164232209|NCT03510715|593218233|FG001|Overall Study|Adverse Event|0|||
164232210|NCT01972659|593218235|FG000|Overall Study|Protocol Violation|2|||
164232211|NCT01972659|593218236|FG001|Overall Study|Protocol Violation|2|||
164232212|NCT01972659|593218235|FG000|Overall Study|problems realted to acceleromyograph|2|||
164232213|NCT01972659|593218236|FG001|Overall Study|problems realted to acceleromyograph|1|||
164232214|NCT02457793|593218238|FG000|Overall Study|Reason not specified|0|||
164232215|NCT02457793|593218239|FG001|Overall Study|Reason not specified|0|||
164232216|NCT02457793|593218240|FG002|Overall Study|Reason not specified|0|||
164232217|NCT02457793|593218241|FG003|Overall Study|Reason not specified|1|||
164232218|NCT02457793|593218242|FG004|Overall Study|Reason not specified|1|||
164232219|NCT02457793|593218243|FG005|Overall Study|Reason not specified|1|||
164232220|NCT02457793|593218238|FG000|Overall Study|Withdrawal by Subject|0|||
164232221|NCT02457793|593218239|FG001|Overall Study|Withdrawal by Subject|4|||
164232222|NCT02457793|593218240|FG002|Overall Study|Withdrawal by Subject|2|||
164232223|NCT02457793|593218241|FG003|Overall Study|Withdrawal by Subject|2|||
164232224|NCT02457793|593218242|FG004|Overall Study|Withdrawal by Subject|2|||
164232225|NCT02457793|593218243|FG005|Overall Study|Withdrawal by Subject|2|||
163883661|NCT02120456|591943910|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883662|NCT02120456|591943911|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883663|NCT02120456|591943912|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
163883664|NCT02120456|591943913|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883665|NCT02120456|591943914|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
163883666|NCT02120456|591943906|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163883667|NCT02120456|591943907|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
164232226|NCT02457793|593218238|FG000|Overall Study|Adverse Event|0|||
164232227|NCT02457793|593218239|FG001|Overall Study|Adverse Event|0|||
164232228|NCT02457793|593218240|FG002|Overall Study|Adverse Event|0|||
164232229|NCT02457793|593218241|FG003|Overall Study|Adverse Event|1|||
164232230|NCT02457793|593218242|FG004|Overall Study|Adverse Event|0|||
164232231|NCT02457793|593218243|FG005|Overall Study|Adverse Event|0|||
164232232|NCT02457793|593218238|FG000|Overall Study|Physician Decision|1|||
164232233|NCT02457793|593218239|FG001|Overall Study|Physician Decision|0|||
164232234|NCT02457793|593218240|FG002|Overall Study|Physician Decision|1|||
164232235|NCT02457793|593218241|FG003|Overall Study|Physician Decision|1|||
164232236|NCT02457793|593218242|FG004|Overall Study|Physician Decision|1|||
164232237|NCT02457793|593218243|FG005|Overall Study|Physician Decision|3|||
164232238|NCT00791648|593219892|FG000|Overall Study|Physician Decision|0|||
164232239|NCT00791648|593219893|FG001|Overall Study|Physician Decision|1|||
164232240|NCT00791648|593219892|FG000|Overall Study|Withdrawal by Subject|0|||
164232241|NCT00791648|593219893|FG001|Overall Study|Withdrawal by Subject|1|||
164232242|NCT00836706|593219894|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
164232243|NCT00836706|593219895|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
164232244|NCT02989857|593219896|FG000|Randomization Phase|Not Treated|3|||
164232245|NCT02989857|593219897|FG001|Randomization Phase|Not Treated|2|||
164232246|NCT02989857|593219898|FG002|Randomization Phase|Not Treated|0|||
164232247|NCT01992757|593219899|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
164232248|NCT01344356|593219903|FG000|Overall Study|Physician Decision|0|||
164232249|NCT01344356|593219904|FG001|Overall Study|Physician Decision|3|||
164232250|NCT01344356|593219903|FG000|Overall Study|Lost to Follow-up|0|||
164232251|NCT01344356|593219904|FG001|Overall Study|Lost to Follow-up|6|||
164232252|NCT02390076|593219909|FG000|Overall Study|Lost to Follow-up|2|||
164232253|NCT02390076|593219910|FG001|Overall Study|Lost to Follow-up|1|||
164232254|NCT02390076|593219911|FG002|Overall Study|Lost to Follow-up|4|||
164232255|NCT02095106|593219914|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
164232256|NCT02095106|593219915|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
164232257|NCT00635050|593219920|FG000|Overall Study|Withdrawal by Subject|1|||
164232258|NCT03038620|593219921|FG000|Overall Study|Lost to Follow-up|18|||
164232259|NCT03038620|593219922|FG001|Overall Study|Lost to Follow-up|23|||
164232260|NCT03038620|593219921|FG000|Overall Study|Withdrawal by Subject|0|||
164232261|NCT03038620|593219922|FG001|Overall Study|Withdrawal by Subject|15|||
164232262|NCT03038620|593219921|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
164232263|NCT03038620|593219922|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
164232264|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Adverse Event|3|||
164232265|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Adverse Event|0|||
164232266|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Adverse Event|0|||
164232267|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
164232268|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
164232269|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
164232270|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
164232271|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
164232272|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
164232273|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
164232274|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
164232275|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
164232276|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
164232277|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
164232278|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
164232279|NCT04380142|593219927|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
164232280|NCT04380142|593219928|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
164232281|NCT04380142|593219929|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
164232282|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164232283|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164232284|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Adverse Event|14|||
164232285|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
164232286|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
164232287|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
164232288|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164232289|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
164232290|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
164232291|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
164232292|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
164232293|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
164232294|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
164232295|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
164232296|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
164232297|NCT04380142|593219927|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
164232298|NCT04380142|593219928|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
164232299|NCT04380142|593219929|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
164232300|NCT00539500|593219935|FG000|Overall Study|Disease Progression|1|||
164232301|NCT00539500|593219935|FG000|Overall Study|Lost to Follow-up|2|||
164232302|NCT02011542|593219937|FG000|Overall Study|Physician Decision|1|||
164232303|NCT03261505|593219938|FG000|Overall Study|Withdrawal by Subject|2|||
164232304|NCT03261505|593219939|FG001|Overall Study|Withdrawal by Subject|3|||
164232305|NCT03261505|593219940|FG002|Overall Study|Withdrawal by Subject|4|||
164232306|NCT03261505|593219941|FG003|Overall Study|Withdrawal by Subject|3|||
164232307|NCT03261505|593219938|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
164232308|NCT03261505|593219939|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
164232309|NCT03261505|593219940|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
164232310|NCT03261505|593219941|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
164232311|NCT03261505|593219938|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
164232312|NCT03261505|593219939|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
164232313|NCT03261505|593219940|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
164232314|NCT03261505|593219941|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
164232315|NCT03261505|593219938|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
164232316|NCT03261505|593219939|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
164232317|NCT03261505|593219940|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
164232318|NCT03261505|593219941|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
164232319|NCT00663260|593219943|FG000|Overall Study|Lack of Efficacy|2|||
163883668|NCT02120456|591943908|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163883669|NCT02120456|591943909|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163987270|NCT01299766|592322255|FG000|Overall Study|Withdrawal by Subject|29|||
163987271|NCT01299766|592322256|FG001|Overall Study|Withdrawal by Subject|19|||
163987272|NCT04002310|592322257|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
163987273|NCT04002310|592322258|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
163987274|NCT04002310|592322259|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
163987275|NCT04002310|592322260|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
163987276|NCT04002310|592322261|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
163987277|NCT00352534|592322262|FG000|Initial Staging|Ineligible|8|||
163987278|NCT00352534|592322263|FG001|Initial Staging|Ineligible|9|||
163987279|NCT00352534|592322264|FG002|Initial Staging|Ineligible|0|||
163883670|NCT02120456|591943910|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163987280|NCT00352534|592322265|FG003|Initial Staging|Ineligible|0|||
164332993|NCT02322021|593595699|FG001|Extension Phase|Lost to Follow-up|0|||
164332994|NCT02322021|593595700|FG002|Extension Phase|Lost to Follow-up|0|||
164332995|NCT02322021|593595701|FG003|Extension Phase|Lost to Follow-up|0|||
164332996|NCT02322021|593595702|FG004|Extension Phase|Lost to Follow-up|1|||
164332997|NCT02322021|593595698|FG000|Extension Phase|Study terminated by sponsor|0|||
164332998|NCT02322021|593595699|FG001|Extension Phase|Study terminated by sponsor|0|||
164332999|NCT02322021|593595700|FG002|Extension Phase|Study terminated by sponsor|0|||
164333000|NCT02322021|593595701|FG003|Extension Phase|Study terminated by sponsor|0|||
164333001|NCT02322021|593595702|FG004|Extension Phase|Study terminated by sponsor|28|||
164333002|NCT01934972|593595703|FG000|Overall Study|Withdrawal by Subject|9|||
164333003|NCT01934972|593595704|FG001|Overall Study|Withdrawal by Subject|6|||
164333004|NCT01278160|593595705|FG000|Overall Study|Adverse Event|1|||
163883671|NCT02120456|591943911|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163883672|NCT02120456|591943912|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
163883673|NCT02120456|591943913|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163883674|NCT02120456|591943914|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
163883675|NCT02120456|591943906|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883676|NCT02120456|591943907|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883677|NCT02120456|591943908|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883678|NCT02120456|591943909|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883679|NCT02120456|591943910|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883680|NCT02120456|591943911|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883681|NCT02120456|591943912|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883682|NCT02120456|591943913|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
163883683|NCT02120456|591943914|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
163883684|NCT05192200|591943915|FG000|Treatment Period|Other|1|||
163883685|NCT05192200|591943915|FG000|Treatment Period|Lack of Efficacy|1|||
163883686|NCT05192200|591943915|FG000|Treatment Period|Withdrawal by Subject|1|||
163883687|NCT05192200|591943915|FG000|Follow-up|Withdrawal by Subject|1|||
163883688|NCT03623321|591943916|FG000|Overall Study|Adverse Event|32|||
163883689|NCT03623321|591943916|FG000|Overall Study|Death|9|||
163883690|NCT03623321|591943916|FG000|Overall Study|Lack of Efficacy|9|||
163883691|NCT03623321|591943916|FG000|Overall Study|Lost to Follow-up|6|||
163883692|NCT03623321|591943916|FG000|Overall Study|Noncompliance with study drug|6|||
163883693|NCT03623321|591943916|FG000|Overall Study|Use of prohibited medication|3|||
163883694|NCT03623321|591943916|FG000|Overall Study|Physician Decision|5|||
163883695|NCT03623321|591943916|FG000|Overall Study|Protocol Violation|1|||
163883696|NCT03623321|591943916|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
163883697|NCT03623321|591943916|FG000|Overall Study|Not further specified|43|||
163883698|NCT04241068|591943917|FG000|Core Treatment Period|Adverse Event|91|||
163883699|NCT04241068|591943917|FG000|Core Treatment Period|Change of Treatment|4|||
163883700|NCT04241068|591943917|FG000|Core Treatment Period|Consent Withdrawn|143|||
163883701|NCT04241068|591943917|FG000|Core Treatment Period|Death|26|||
163883702|NCT04241068|591943917|FG000|Core Treatment Period|Disease Progression|67|||
163883703|NCT04241068|591943917|FG000|Core Treatment Period|Investigator Decision|40|||
163883704|NCT04241068|591943917|FG000|Core Treatment Period|Loss of Capacity|9|||
163883705|NCT04241068|591943917|FG000|Core Treatment Period|Lost to Follow-up|11|||
163883706|NCT04241068|591943917|FG000|Core Treatment Period|Relocation|4|||
163883707|NCT04241068|591943917|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
163883708|NCT04241068|591943917|FG000|Core Treatment Period|Study Visit Burden|40|||
163883709|NCT04241068|591943917|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
163987281|NCT00352534|592322266|FG004|Initial Staging|Ineligible|0|||
163883710|NCT04241068|591943917|FG000|Core Treatment Period|Missing|2|||
163883711|NCT04241068|591943917|FG000|Core Treatment Period|Reason Not Specified|41|||
163883712|NCT04241068|591943917|FG000|LTE Period|Adverse Event|19|||
163883713|NCT04241068|591943917|FG000|LTE Period|Change of Treatment|1|||
163987282|NCT00352534|592322267|FG005|Initial Staging|Ineligible|0|||
163987283|NCT00352534|592322268|FG006|Initial Staging|Ineligible|0|||
164333005|NCT01278160|593595706|FG001|Overall Study|Adverse Event|1|||
164232320|NCT00663260|593219944|FG001|Overall Study|Lack of Efficacy|0|||
164232321|NCT00663260|593219945|FG002|Overall Study|Lack of Efficacy|0|||
164232322|NCT00663260|593219943|FG000|Overall Study|Adverse Event|12|||
164232323|NCT00663260|593219944|FG001|Overall Study|Adverse Event|7|||
164232324|NCT00663260|593219945|FG002|Overall Study|Adverse Event|6|||
164232325|NCT00663260|593219943|FG000|Overall Study|Withdrawal by Subject|3|||
163883714|NCT04241068|591943917|FG000|LTE Period|Consent Withdrawn|71|||
163883715|NCT04241068|591943917|FG000|LTE Period|Death|8|||
164232326|NCT00663260|593219944|FG001|Overall Study|Withdrawal by Subject|1|||
164232327|NCT00663260|593219945|FG002|Overall Study|Withdrawal by Subject|6|||
164232328|NCT00663260|593219943|FG000|Overall Study|Death|1|||
164232329|NCT00663260|593219944|FG001|Overall Study|Death|0|||
164232330|NCT00663260|593219945|FG002|Overall Study|Death|1|||
163883716|NCT04241068|591943917|FG000|LTE Period|Disease Progression|11|||
164232331|NCT00663260|593219943|FG000|Overall Study|Lost to Follow-up|0|||
164232332|NCT00663260|593219944|FG001|Overall Study|Lost to Follow-up|1|||
164232333|NCT00663260|593219945|FG002|Overall Study|Lost to Follow-up|0|||
164299772|NCT01488890|593472923|FG000|Overall Study|Protocol Violation|3|||
164299773|NCT01488890|593472924|FG001|Overall Study|Protocol Violation|0|||
164299774|NCT01488890|593472925|FG002|Overall Study|Protocol Violation|4|||
164299775|NCT01488890|593472926|FG003|Overall Study|Protocol Violation|0|||
164299776|NCT01488890|593472923|FG000|Overall Study|Lost to Follow-up|13|||
164299777|NCT01488890|593472924|FG001|Overall Study|Lost to Follow-up|10|||
164299778|NCT01488890|593472925|FG002|Overall Study|Lost to Follow-up|20|||
164299779|NCT01488890|593472926|FG003|Overall Study|Lost to Follow-up|3|||
164299780|NCT01488890|593472923|FG000|Overall Study|Withdrawal by Subject|14|||
164299781|NCT01488890|593472924|FG001|Overall Study|Withdrawal by Subject|10|||
164299782|NCT01488890|593472925|FG002|Overall Study|Withdrawal by Subject|11|||
164299783|NCT01488890|593472926|FG003|Overall Study|Withdrawal by Subject|2|||
164299784|NCT00829426|593472927|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164299785|NCT00829426|593472928|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164299786|NCT02628873|593472929|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
164299787|NCT02628873|593472930|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
164299788|NCT02628873|593472929|FG000|Second Test (1 Hour)|Physician Decision|1|||
164299789|NCT02628873|593472930|FG001|Second Test (1 Hour)|Physician Decision|0|||
164299790|NCT03597347|593472933|FG000|Overall Study|Withdrawal by Subject|1|||
164299791|NCT03597347|593472934|FG001|Overall Study|Withdrawal by Subject|1|||
164299792|NCT03597347|593472935|FG002|Overall Study|Withdrawal by Subject|0|||
164299793|NCT03597347|593472933|FG000|Overall Study|Withdrawal due to Covid-19|3|||
164299794|NCT03597347|593472934|FG001|Overall Study|Withdrawal due to Covid-19|0|||
164299795|NCT03597347|593472935|FG002|Overall Study|Withdrawal due to Covid-19|0|||
164299796|NCT03597347|593472933|FG000|Overall Study|Sponsor decision to terminate study|3|||
164299797|NCT03597347|593472934|FG001|Overall Study|Sponsor decision to terminate study|2|||
164299798|NCT03597347|593472935|FG002|Overall Study|Sponsor decision to terminate study|4|||
164299799|NCT04606134|593472936|FG000|Overall Study|Adverse Event|0|||
164299800|NCT04606134|593472937|FG001|Overall Study|Adverse Event|1|||
164299801|NCT00107653|593472938|FG000|Overall Study|Adverse Event|24|||
164299802|NCT00107653|593472939|FG001|Overall Study|Adverse Event|43|||
164299803|NCT00107653|593472938|FG000|Overall Study|Insufficient Therapeutic Response|25|||
164299804|NCT00107653|593472939|FG001|Overall Study|Insufficient Therapeutic Response|11|||
164299805|NCT00107653|593472938|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164299806|NCT00107653|593472939|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164299807|NCT00107653|593472938|FG000|Overall Study|Protocol Violation|1|||
164299808|NCT00107653|593472939|FG001|Overall Study|Protocol Violation|0|||
164299809|NCT00107653|593472938|FG000|Overall Study|Withdrawal by Subject|12|||
164299810|NCT00107653|593472939|FG001|Overall Study|Withdrawal by Subject|13|||
164299811|NCT00107653|593472938|FG000|Overall Study|Lost to Follow-up|13|||
164299812|NCT00107653|593472939|FG001|Overall Study|Lost to Follow-up|5|||
164299813|NCT00107653|593472938|FG000|Overall Study|Administrative Reasons|3|||
164299814|NCT00107653|593472939|FG001|Overall Study|Administrative Reasons|3|||
164299815|NCT01099267|593472941|FG000|MDS-003 Study|Adverse Event|37|||
164299816|NCT01099267|593472941|FG000|MDS-003 Study|Lack of Efficacy|52|||
164299817|NCT01099267|593472941|FG000|MDS-003 Study|Withdrawal by Subject|8|||
164299818|NCT01099267|593472941|FG000|MDS-003 Study|Lost to Follow-up|1|||
164299819|NCT01099267|593472941|FG000|MDS-003 Study|Death|11|||
164299820|NCT01099267|593472941|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
164299821|NCT01099267|593472941|FG000|MDS-003 Study|Disease Progression|7|||
164299822|NCT01099267|593472941|FG000|MDS-003 Study|Investigator Decision|2|||
164299823|NCT01099267|593472941|FG000|MDS-003 Study|Non-Compliance|2|||
164299824|NCT01099267|593472941|FG000|MDS-003 Study|Loss of Response|1|||
164299825|NCT01099267|593472941|FG000|MDS-003 Study|Secondary Malign Disease|1|||
164299826|NCT04986904|593472942|FG000|Overall Study|Lost to Follow-up|11|||
164299827|NCT04986904|593472942|FG000|Overall Study|Withdrawal by Subject|1|||
164299828|NCT02532517|593472943|FG000|Overall Study|Did not complete 24-Month visit|4|||
164299829|NCT02532517|593472943|FG000|Overall Study|Failed Angiographic eligibility|1|||
164299830|NCT02532517|593472943|FG000|Overall Study|Lost to Follow-up|4|||
164232334|NCT00663260|593219943|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
164232335|NCT00663260|593219944|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
164232336|NCT00663260|593219945|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
164232337|NCT00980798|593219946|FG000|Overall Study|Adverse Event|7|||
164232338|NCT00980798|593219947|FG001|Overall Study|Adverse Event|36|||
164232339|NCT00980798|593219946|FG000|Overall Study|Lack of Efficacy|16|||
164232340|NCT00980798|593219947|FG001|Overall Study|Lack of Efficacy|5|||
164232341|NCT00980798|593219946|FG000|Overall Study|Lost to Follow-up|0|||
164232342|NCT00980798|593219947|FG001|Overall Study|Lost to Follow-up|1|||
164232343|NCT00980798|593219946|FG000|Overall Study|Physician Decision|2|||
164232344|NCT00980798|593219947|FG001|Overall Study|Physician Decision|1|||
164232345|NCT00980798|593219946|FG000|Overall Study|Withdrawal by Subject|8|||
164232346|NCT00980798|593219947|FG001|Overall Study|Withdrawal by Subject|11|||
164232347|NCT00980798|593219946|FG000|Overall Study|Other|0|||
164232348|NCT00980798|593219947|FG001|Overall Study|Other|1|||
164232349|NCT00522379|593219948|FG000|Overall Study|Adverse Event|12|||
164232350|NCT00522379|593219949|FG001|Overall Study|Adverse Event|15|||
164232351|NCT00522379|593219950|FG002|Overall Study|Adverse Event|12|||
164232352|NCT00522379|593219951|FG003|Overall Study|Adverse Event|5|||
164232353|NCT00522379|593219952|FG004|Overall Study|Adverse Event|17|||
164232354|NCT00522379|593219948|FG000|Overall Study|Lack of Efficacy|3|||
164232355|NCT00522379|593219949|FG001|Overall Study|Lack of Efficacy|0|||
164232356|NCT00522379|593219950|FG002|Overall Study|Lack of Efficacy|2|||
164232357|NCT00522379|593219951|FG003|Overall Study|Lack of Efficacy|2|||
164232358|NCT00522379|593219952|FG004|Overall Study|Lack of Efficacy|7|||
164232359|NCT00522379|593219948|FG000|Overall Study|Withdrawal by Subject|2|||
164232360|NCT00522379|593219949|FG001|Overall Study|Withdrawal by Subject|3|||
164232361|NCT00522379|593219950|FG002|Overall Study|Withdrawal by Subject|1|||
164232362|NCT00522379|593219951|FG003|Overall Study|Withdrawal by Subject|2|||
164232363|NCT00522379|593219952|FG004|Overall Study|Withdrawal by Subject|0|||
164232364|NCT00522379|593219948|FG000|Overall Study|Protocol Violation|1|||
164232365|NCT00522379|593219949|FG001|Overall Study|Protocol Violation|1|||
164232366|NCT00522379|593219950|FG002|Overall Study|Protocol Violation|2|||
164232367|NCT00522379|593219951|FG003|Overall Study|Protocol Violation|0|||
164232368|NCT00522379|593219952|FG004|Overall Study|Protocol Violation|0|||
164232369|NCT00522379|593219948|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
164232370|NCT00522379|593219949|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
164232371|NCT00522379|593219950|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
164232372|NCT00522379|593219951|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
164232373|NCT00522379|593219952|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
164232374|NCT00522379|593219948|FG000|Overall Study|Lost to Follow-up|1|||
164232375|NCT00522379|593219949|FG001|Overall Study|Lost to Follow-up|0|||
164232376|NCT00522379|593219950|FG002|Overall Study|Lost to Follow-up|4|||
164232377|NCT00522379|593219951|FG003|Overall Study|Lost to Follow-up|2|||
164232378|NCT00522379|593219952|FG004|Overall Study|Lost to Follow-up|2|||
164232379|NCT00522379|593219948|FG000|Overall Study|Randomization error|0|||
164232380|NCT00522379|593219949|FG001|Overall Study|Randomization error|0|||
164232381|NCT00522379|593219950|FG002|Overall Study|Randomization error|0|||
164232382|NCT00522379|593219951|FG003|Overall Study|Randomization error|0|||
164232383|NCT00522379|593219952|FG004|Overall Study|Randomization error|1|||
164232384|NCT00522379|593219948|FG000|Overall Study|Dispensing error|1|||
164232385|NCT00522379|593219949|FG001|Overall Study|Dispensing error|0|||
164232386|NCT00522379|593219950|FG002|Overall Study|Dispensing error|0|||
164232387|NCT00522379|593219951|FG003|Overall Study|Dispensing error|1|||
164232388|NCT00522379|593219952|FG004|Overall Study|Dispensing error|0|||
164232389|NCT00522379|593219948|FG000|Overall Study|Subject Moved|1|||
164232390|NCT00522379|593219949|FG001|Overall Study|Subject Moved|1|||
164232391|NCT00522379|593219950|FG002|Overall Study|Subject Moved|0|||
164232392|NCT00522379|593219951|FG003|Overall Study|Subject Moved|0|||
164232393|NCT00522379|593219952|FG004|Overall Study|Subject Moved|0|||
164232394|NCT00522379|593219948|FG000|Overall Study|Sponsor Request|0|||
164232395|NCT00522379|593219949|FG001|Overall Study|Sponsor Request|1|||
164232396|NCT00522379|593219950|FG002|Overall Study|Sponsor Request|0|||
164232397|NCT00522379|593219951|FG003|Overall Study|Sponsor Request|0|||
164232398|NCT00522379|593219952|FG004|Overall Study|Sponsor Request|0|||
164232399|NCT00522379|593219948|FG000|Overall Study|Family Problem|0|||
164232400|NCT00522379|593219949|FG001|Overall Study|Family Problem|0|||
164232401|NCT00522379|593219950|FG002|Overall Study|Family Problem|1|||
164232402|NCT00522379|593219951|FG003|Overall Study|Family Problem|0|||
164232403|NCT00522379|593219952|FG004|Overall Study|Family Problem|0|||
164232404|NCT00522379|593219948|FG000|Overall Study|Site Closed|0|||
164232405|NCT00522379|593219949|FG001|Overall Study|Site Closed|0|||
164232406|NCT00522379|593219950|FG002|Overall Study|Site Closed|0|||
164232407|NCT00522379|593219951|FG003|Overall Study|Site Closed|1|||
164232408|NCT00522379|593219952|FG004|Overall Study|Site Closed|0|||
164232409|NCT00522379|593219948|FG000|Overall Study|Subject Withdrawal|0|||
164232410|NCT00522379|593219949|FG001|Overall Study|Subject Withdrawal|0|||
164232411|NCT00522379|593219950|FG002|Overall Study|Subject Withdrawal|0|||
164232412|NCT00522379|593219951|FG003|Overall Study|Subject Withdrawal|1|||
164232413|NCT00522379|593219952|FG004|Overall Study|Subject Withdrawal|0|||
164232414|NCT03213509|593219953|FG000|Overall Study|Did not consent for verbal autopsy|4|||
164232415|NCT03213509|593219954|FG001|Overall Study|Did not consent for verbal autopsy|5|||
164232416|NCT04562090|593219955|FG000|Overall Study|Withdrawal by Subject|3|||
164232417|NCT04562090|593219956|FG001|Overall Study|Withdrawal by Subject|4|||
164232418|NCT04562090|593219955|FG000|Overall Study|Protocol Violation|2|||
164232419|NCT04562090|593219956|FG001|Overall Study|Protocol Violation|0|||
164232420|NCT04562090|593219955|FG000|Overall Study|Lack of Efficacy|0|||
164232421|NCT04562090|593219956|FG001|Overall Study|Lack of Efficacy|1|||
164232422|NCT04562090|593219955|FG000|Overall Study|Adverse Event|1|||
164232423|NCT04562090|593219956|FG001|Overall Study|Adverse Event|4|||
164232424|NCT04562090|593219955|FG000|Overall Study|Miscellaneous|0|||
164232425|NCT04562090|593219956|FG001|Overall Study|Miscellaneous|3|||
164232426|NCT00847730|593219957|FG000|Overall Study|Multiple interruptions in therapy|8|||
164232427|NCT00432965|593219958|FG000|Overall Study|Lost to Follow-up|22|||
164232428|NCT00432965|593219959|FG001|Overall Study|Lost to Follow-up|19|||
164232429|NCT00432965|593219958|FG000|Overall Study|Withdrawal by Subject|13|||
164232430|NCT00432965|593219959|FG001|Overall Study|Withdrawal by Subject|13|||
164232431|NCT00432965|593219958|FG000|Overall Study|Physician Decision|14|||
164232432|NCT00432965|593219959|FG001|Overall Study|Physician Decision|13|||
164232433|NCT00432965|593219958|FG000|Overall Study|Lack of Efficacy|8|||
164232434|NCT00432965|593219959|FG001|Overall Study|Lack of Efficacy|13|||
164232435|NCT00432965|593219958|FG000|Overall Study|Non-compliance|7|||
164232436|NCT00432965|593219959|FG001|Overall Study|Non-compliance|0|||
164232437|NCT00432965|593219958|FG000|Overall Study|Adverse Event|22|||
164232438|NCT00432965|593219959|FG001|Overall Study|Adverse Event|19|||
164232439|NCT00432965|593219958|FG000|Overall Study|Death|3|||
164232440|NCT00432965|593219959|FG001|Overall Study|Death|4|||
164232441|NCT00432965|593219958|FG000|Overall Study|Exclusionary Methods|1|||
164232442|NCT00432965|593219959|FG001|Overall Study|Exclusionary Methods|2|||
164232443|NCT00432965|593219958|FG000|Overall Study|Incomplete Data|4|||
164232444|NCT00432965|593219959|FG001|Overall Study|Incomplete Data|3|||
164232445|NCT01889251|593219960|FG000|Overall Study|Adverse Event|1|||
164232446|NCT01889251|593219961|FG001|Overall Study|Adverse Event|0|||
164232447|NCT01903863|593219962|FG000|Overall Study|Physician Decision|2|||
164232448|NCT01903863|593219963|FG001|Overall Study|Physician Decision|0|||
164232449|NCT01344226|593219970|FG000|Overall Study|Protocol Violation|2|||
164232450|NCT01344226|593219970|FG000|Overall Study|Withdrawal by Subject|3|||
164232451|NCT01344226|593219970|FG000|Overall Study|Lack of Efficacy|3|||
164232452|NCT03909971|593219977|FG000|Overall Study|Participant transition to rollover study|26|||
164333006|NCT01278160|593595705|FG000|Overall Study|Lost to Follow-up|0|||
164333007|NCT01278160|593595706|FG001|Overall Study|Lost to Follow-up|1|||
163987284|NCT00352534|592322262|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
163987285|NCT00352534|592322263|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
163987286|NCT00352534|592322264|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
163987287|NCT00352534|592322265|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
164333008|NCT01278160|593595705|FG000|Overall Study|Withdrawal by Subject|3|||
163987288|NCT00352534|592322266|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
163987289|NCT00352534|592322267|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
164232453|NCT03909971|593219978|FG001|Overall Study|Participant transition to rollover study|9|||
164232454|NCT03909971|593219977|FG000|Overall Study|Global Deterioration of Health Status|2|||
164232455|NCT03909971|593219978|FG001|Overall Study|Global Deterioration of Health Status|2|||
164232456|NCT03909971|593219977|FG000|Overall Study|Progressive Disease|28|||
164232457|NCT03909971|593219978|FG001|Overall Study|Progressive Disease|21|||
164232458|NCT03909971|593219977|FG000|Overall Study|Death|6|||
164232459|NCT03909971|593219978|FG001|Overall Study|Death|6|||
164232460|NCT03909971|593219977|FG000|Overall Study|Adverse Event|1|||
164333009|NCT01278160|593595706|FG001|Overall Study|Withdrawal by Subject|2|||
163987290|NCT00352534|592322268|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
164232461|NCT03909971|593219978|FG001|Overall Study|Adverse Event|2|||
164232462|NCT03909971|593219977|FG000|Overall Study|Withdrawal by Subject|2|||
164232463|NCT03909971|593219978|FG001|Overall Study|Withdrawal by Subject|1|||
164232464|NCT03909971|593219977|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
164232465|NCT03909971|593219978|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
164232466|NCT03909971|593219977|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
164232467|NCT03909971|593219978|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
164232468|NCT04727151|593219982|FG000|Overall Study|Death|0|||
164232469|NCT04727151|593219983|FG001|Overall Study|Death|0|||
164232470|NCT04727151|593219984|FG002|Overall Study|Death|0|||
164232471|NCT04727151|593219985|FG003|Overall Study|Death|0|||
164232472|NCT04727151|593219986|FG004|Overall Study|Death|3|||
164232473|NCT04727151|593219982|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232474|NCT04727151|593219983|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232475|NCT04727151|593219984|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232476|NCT04727151|593219985|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
164232477|NCT04727151|593219986|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
164232478|NCT01587196|593219987|FG000|Overall Study|Lost to Follow-up|50|||
164232479|NCT01587196|593219987|FG000|Overall Study|Withdrawal by Subject|4|||
164232480|NCT00642759|593219988|FG000|Overall Study|Protocol Violation|1|||
164232481|NCT03612570|593219992|FG000|Overall Study|Lost to Follow-up|1|||
164232482|NCT05318287|593219997|FG000|Overall Study|Lost to Follow-up|8|||
164232483|NCT05185453|593219998|FG000|Overall Study|Lost to Follow-up|13|||
164232484|NCT05185453|593219999|FG001|Overall Study|Lost to Follow-up|3|||
164232485|NCT03537508|593220000|FG000|Overall Study|Adverse Event|2|||
164232486|NCT03537508|593220001|FG001|Overall Study|Adverse Event|1|||
164232487|NCT03537508|593220000|FG000|Overall Study|Protocol Violation|65|||
164232488|NCT03537508|593220001|FG001|Overall Study|Protocol Violation|48|||
164232489|NCT03537508|593220000|FG000|Overall Study|Lost to Follow-up|86|||
164232490|NCT03537508|593220001|FG001|Overall Study|Lost to Follow-up|60|||
164232491|NCT03537508|593220000|FG000|Overall Study|Withdrawal by parent/guardian|263|||
164232492|NCT03537508|593220001|FG001|Overall Study|Withdrawal by parent/guardian|149|||
164232493|NCT03814044|593220021|FG000|Overall Study|Protocol deviation|1|||
164232494|NCT02757768|593220022|FG000|Overall Study|Randomized Never Received Study Drug|3|||
164232495|NCT02757768|593220023|FG001|Overall Study|Randomized Never Received Study Drug|4|||
164232496|NCT02757768|593220022|FG000|Overall Study|Adverse Event|5|||
164232497|NCT02757768|593220023|FG001|Overall Study|Adverse Event|3|||
164232498|NCT02757768|593220022|FG000|Overall Study|Lack of Efficacy|2|||
164232499|NCT02757768|593220023|FG001|Overall Study|Lack of Efficacy|1|||
164232500|NCT02757768|593220022|FG000|Overall Study|Lost to Follow-up|1|||
164232501|NCT02757768|593220023|FG001|Overall Study|Lost to Follow-up|0|||
164232502|NCT02757768|593220022|FG000|Overall Study|Protocol Deviation|2|||
164232503|NCT02757768|593220023|FG001|Overall Study|Protocol Deviation|9|||
164232504|NCT02757768|593220022|FG000|Overall Study|Withdrawal by Subject|16|||
164232505|NCT02757768|593220023|FG001|Overall Study|Withdrawal by Subject|9|||
164232506|NCT02757768|593220022|FG000|Overall Study|Miscellaneous|4|||
164232507|NCT02757768|593220023|FG001|Overall Study|Miscellaneous|2|||
164232508|NCT00835367|593220035|FG000|Washout|Adverse Event|2|||
164232509|NCT00835367|593220036|FG001|Washout|Adverse Event|0|||
164232510|NCT00835367|593220035|FG000|Washout|Withdrawal by Subject|1|||
164232511|NCT00835367|593220036|FG001|Washout|Withdrawal by Subject|0|||
164232512|NCT00835367|593220035|FG000|Second Intervention|Adverse Event|1|||
164232513|NCT00835367|593220036|FG001|Second Intervention|Adverse Event|1|||
164232514|NCT00835172|593220037|FG000|Washout|Protocol Violation|0|||
164232515|NCT00835172|593220038|FG001|Washout|Protocol Violation|1|||
164232516|NCT02495883|593220039|FG000|Overall Study|Excessive head motion|1|||
164232517|NCT02495883|593220040|FG001|Overall Study|Excessive head motion|0|||
164232518|NCT00964678|593220044|FG000|Overall Study|Physician Decision|4|||
164232519|NCT03552029|593221650|FG000|Overall Study|Death|3|||
164232520|NCT03552029|593221651|FG001|Overall Study|Death|0|||
164232521|NCT03552029|593221650|FG000|Overall Study|Adverse Event|1|||
164232522|NCT03552029|593221651|FG001|Overall Study|Adverse Event|0|||
164232523|NCT03552029|593221650|FG000|Overall Study|Lack of Efficacy|0|||
164232524|NCT03552029|593221651|FG001|Overall Study|Lack of Efficacy|2|||
163987291|NCT00352534|592322262|FG000|Final Risk Group Assignment|Physician Decision|0|||
164232525|NCT03552029|593221650|FG000|Overall Study|Physician Decision|0|||
164232526|NCT03552029|593221651|FG001|Overall Study|Physician Decision|1|||
164232527|NCT03552029|593221650|FG000|Overall Study|Study terminated by Sponsor|0|||
164232528|NCT03552029|593221651|FG001|Overall Study|Study terminated by Sponsor|1|||
164232529|NCT03552029|593221650|FG000|Overall Study|Other|0|||
164232530|NCT03552029|593221651|FG001|Overall Study|Other|2|||
164232531|NCT04490278|593221652|FG000|Overall Study|Lost to Follow-up|6|||
164232532|NCT00183248|593221655|FG000|Overall Study|Lost to Follow-up|0|||
164232533|NCT00183248|593221656|FG001|Overall Study|Lost to Follow-up|1|||
164232534|NCT00183248|593221655|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
164232535|NCT00183248|593221656|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
164232536|NCT03801525|593221657|FG000|Overall Study|Adverse Event|17|||
164232537|NCT03801525|593221658|FG001|Overall Study|Adverse Event|1|||
164232538|NCT03801525|593221659|FG002|Overall Study|Adverse Event|0|||
164232539|NCT03801525|593221657|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
164232540|NCT03801525|593221658|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
164299831|NCT02532517|593472943|FG000|Overall Study|Withdrawal by Subject|4|||
164232541|NCT03801525|593221659|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
164232542|NCT03801525|593221657|FG000|Overall Study|Death|29|||
164232543|NCT03801525|593221658|FG001|Overall Study|Death|1|||
164232544|NCT03801525|593221659|FG002|Overall Study|Death|4|||
164232545|NCT03801525|593221657|FG000|Overall Study|Disease Progression|6|||
164232546|NCT03801525|593221658|FG001|Overall Study|Disease Progression|0|||
164232547|NCT03801525|593221659|FG002|Overall Study|Disease Progression|1|||
164232548|NCT03801525|593221657|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
164232549|NCT03801525|593221658|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
164232550|NCT03801525|593221659|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
164232551|NCT03801525|593221657|FG000|Overall Study|Investigator Decision|18|||
164232552|NCT03801525|593221658|FG001|Overall Study|Investigator Decision|1|||
164232553|NCT03801525|593221659|FG002|Overall Study|Investigator Decision|0|||
164232554|NCT03801525|593221657|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
164232555|NCT03801525|593221658|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
164232556|NCT03801525|593221659|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
164232557|NCT03801525|593221657|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
164232558|NCT03801525|593221658|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
164232559|NCT03801525|593221659|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
164232560|NCT03801525|593221657|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
164232561|NCT03801525|593221658|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
164232562|NCT03801525|593221659|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
164232563|NCT03801525|593221657|FG000|Overall Study|Withdrawal of Subject Consent|38|||
164232564|NCT03801525|593221658|FG001|Overall Study|Withdrawal of Subject Consent|2|||
164232565|NCT03801525|593221659|FG002|Overall Study|Withdrawal of Subject Consent|1|||
164232566|NCT03801525|593221657|FG000|Overall Study|Reason not Specified|4|||
164232567|NCT03801525|593221658|FG001|Overall Study|Reason not Specified|0|||
164232568|NCT03801525|593221659|FG002|Overall Study|Reason not Specified|4|||
164232569|NCT03309202|593221660|FG000|Overall Study|Lost to Follow-up|1|||
164232570|NCT03309202|593221661|FG001|Overall Study|Lost to Follow-up|0|||
164232571|NCT03309202|593221662|FG002|Overall Study|Lost to Follow-up|0|||
164232572|NCT03309202|593221663|FG003|Overall Study|Lost to Follow-up|0|||
164232573|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
164232574|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
164232575|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
164232576|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
164232577|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
164232578|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
164232579|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
164232580|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
164232581|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
164232582|NCT04734210|593221664|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
164232583|NCT04734210|593221665|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
164232584|NCT04734210|593221666|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
164232585|NCT00573768|593221667|FG000|Overall Study|Adverse Event|1|||
164333010|NCT01278160|593595705|FG000|Overall Study|Unclassified|1|||
164333011|NCT01278160|593595706|FG001|Overall Study|Unclassified|2|||
164333012|NCT00560885|593595707|FG000|Overall Study|Death|7|||
164333013|NCT00560885|593595707|FG000|Overall Study|Withdrawal by Subject|1|||
164333014|NCT03148275|593595708|FG000|Overall Study|Death|6|||
164333015|NCT03148275|593595708|FG000|Overall Study|Adverse Event|3|||
164333016|NCT03148275|593595708|FG000|Overall Study|Liver transplant|2|||
164333017|NCT03148275|593595708|FG000|Overall Study|Patient decision|5|||
164333018|NCT03148275|593595708|FG000|Overall Study|transition to commercial drug|1|||
163883717|NCT04241068|591943917|FG000|LTE Period|Investigator Decision|12|||
163883718|NCT04241068|591943917|FG000|LTE Period|Loss of Capacity|2|||
163883719|NCT04241068|591943917|FG000|LTE Period|Lost to Follow-up|7|||
163883720|NCT04241068|591943917|FG000|LTE Period|Relocation|6|||
163883721|NCT04241068|591943917|FG000|LTE Period|Site Terminated by Sponsor|26|||
163883722|NCT04241068|591943917|FG000|LTE Period|Study Terminated by Sponsor|276|||
163883723|NCT04241068|591943917|FG000|LTE Period|Study Visit Burden|10|||
163883724|NCT04241068|591943917|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
163883725|NCT04241068|591943917|FG000|LTE Period|Reason Not Specified|65|||
163883726|NCT04492007|591943918|FG000|Overall Study|Lost to Follow-up|1|||
163883727|NCT04492007|591943919|FG001|Overall Study|Lost to Follow-up|1|||
164232586|NCT00573768|593221668|FG001|Overall Study|Adverse Event|1|||
164232587|NCT00573768|593221669|FG002|Overall Study|Adverse Event|2|||
164232588|NCT00573768|593221667|FG000|Overall Study|Protocol Violation|1|||
164232589|NCT00573768|593221668|FG001|Overall Study|Protocol Violation|0|||
164232590|NCT00573768|593221669|FG002|Overall Study|Protocol Violation|1|||
164232591|NCT00573768|593221667|FG000|Overall Study|Withdrawal by Subject|0|||
164232592|NCT00573768|593221668|FG001|Overall Study|Withdrawal by Subject|1|||
164232593|NCT00573768|593221669|FG002|Overall Study|Withdrawal by Subject|0|||
164232594|NCT00573768|593221667|FG000|Overall Study|Lost to Follow-up|0|||
164232595|NCT00573768|593221668|FG001|Overall Study|Lost to Follow-up|0|||
164232596|NCT00573768|593221669|FG002|Overall Study|Lost to Follow-up|1|||
164232597|NCT00553254|593221675|FG000|Overall Study|Death|3|||
164232598|NCT00553254|593221676|FG001|Overall Study|Death|6|||
164232599|NCT00553254|593221677|FG002|Overall Study|Death|25|||
164232600|NCT00553254|593221675|FG000|Overall Study|Lost to Follow-up|0|||
164232601|NCT00553254|593221676|FG001|Overall Study|Lost to Follow-up|0|||
164232602|NCT00553254|593221677|FG002|Overall Study|Lost to Follow-up|2|||
164232603|NCT00553254|593221675|FG000|Overall Study|Withdrawal by Subject|2|||
164232604|NCT00553254|593221676|FG001|Overall Study|Withdrawal by Subject|0|||
164232605|NCT00553254|593221677|FG002|Overall Study|Withdrawal by Subject|2|||
164232606|NCT00553254|593221675|FG000|Overall Study|Study terminated by Sponsor|0|||
164232607|NCT00553254|593221676|FG001|Overall Study|Study terminated by Sponsor|0|||
164232608|NCT00553254|593221677|FG002|Overall Study|Study terminated by Sponsor|1|||
164232609|NCT00553254|593221675|FG000|Overall Study|Other|1|||
164232610|NCT00553254|593221676|FG001|Overall Study|Other|0|||
164232611|NCT00553254|593221677|FG002|Overall Study|Other|13|||
164232612|NCT02314923|593221680|FG000|Overall Study|Death|0|||
164232613|NCT02314923|593221681|FG001|Overall Study|Death|0|||
164232614|NCT02314923|593221682|FG002|Overall Study|Death|0|||
164232615|NCT02314923|593221683|FG003|Overall Study|Death|1|||
164232616|NCT02314923|593221684|FG004|Overall Study|Death|0|||
164232617|NCT02314923|593221685|FG005|Overall Study|Death|0|||
164232618|NCT02314923|593221686|FG006|Overall Study|Death|0|||
164232619|NCT02314923|593221687|FG007|Overall Study|Death|0|||
164232620|NCT02314923|593221688|FG008|Overall Study|Death|0|||
164333019|NCT03148275|593595708|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
164333020|NCT03803683|593595710|FG000|Overall Study|Lost to Follow-up|41|||
164333021|NCT03803683|593595711|FG001|Overall Study|Lost to Follow-up|18|||
164333022|NCT03803683|593595712|FG002|Overall Study|Lost to Follow-up|12|||
164333023|NCT03803683|593595710|FG000|Overall Study|Withdrawal by Subject|9|||
164333024|NCT03803683|593595711|FG001|Overall Study|Withdrawal by Subject|1|||
164333025|NCT03803683|593595712|FG002|Overall Study|Withdrawal by Subject|4|||
164333026|NCT04493333|593597303|FG000|Overall Study|Withdrawal by Subject|1|||
164333027|NCT04493333|593597304|FG001|Overall Study|Withdrawal by Subject|1|||
164333028|NCT04493333|593597303|FG000|Overall Study|Ineligible|0|||
164333029|NCT04493333|593597304|FG001|Overall Study|Ineligible|1|||
164333030|NCT04493333|593597303|FG000|Overall Study|Noncompliance|2|||
164333031|NCT04493333|593597304|FG001|Overall Study|Noncompliance|1|||
164333032|NCT02925923|593597305|FG000|Overall Study|blood samples hemolyzed|0|||
164333033|NCT02925923|593597306|FG001|Overall Study|blood samples hemolyzed|2|||
164333034|NCT00697073|593597307|FG000|Overall Study|Withdrawal by Subject|2|||
164333035|NCT00697073|593597307|FG000|Overall Study|Pregnancy|1|||
164333036|NCT00697073|593597307|FG000|Overall Study|non compliance and other|6|||
164333037|NCT03911713|593597308|FG000|Overall Study|Lost to Follow-up|0|||
164333038|NCT03911713|593597309|FG001|Overall Study|Lost to Follow-up|2|||
164333039|NCT03911713|593597310|FG002|Overall Study|Lost to Follow-up|0|||
164333040|NCT03911713|593597311|FG003|Overall Study|Lost to Follow-up|0|||
163987292|NCT00352534|592322263|FG001|Final Risk Group Assignment|Physician Decision|0|||
163987293|NCT00352534|592322264|FG002|Final Risk Group Assignment|Physician Decision|0|||
164333041|NCT03911713|593597312|FG004|Overall Study|Lost to Follow-up|0|||
164333042|NCT03911713|593597308|FG000|Overall Study|Other|0|||
164333043|NCT03911713|593597309|FG001|Overall Study|Other|0|||
164333044|NCT03911713|593597310|FG002|Overall Study|Other|0|||
164333045|NCT03911713|593597311|FG003|Overall Study|Other|1|||
164333046|NCT03911713|593597312|FG004|Overall Study|Other|0|||
164333047|NCT03911713|593597308|FG000|Overall Study|Randomized, Never Dosed|1|||
164333048|NCT03911713|593597309|FG001|Overall Study|Randomized, Never Dosed|0|||
164333049|NCT03911713|593597310|FG002|Overall Study|Randomized, Never Dosed|0|||
164333050|NCT03911713|593597311|FG003|Overall Study|Randomized, Never Dosed|1|||
164333051|NCT03911713|593597312|FG004|Overall Study|Randomized, Never Dosed|0|||
164333052|NCT01845818|593597315|FG000|Overall Study|Withdrawal by Subject|0|||
164232621|NCT02314923|593221689|FG009|Overall Study|Death|0|||
164232622|NCT02314923|593221680|FG000|Overall Study|Lost to Follow-up|2|||
164232623|NCT02314923|593221681|FG001|Overall Study|Lost to Follow-up|3|||
164232624|NCT02314923|593221682|FG002|Overall Study|Lost to Follow-up|1|||
164232625|NCT02314923|593221683|FG003|Overall Study|Lost to Follow-up|0|||
164232626|NCT02314923|593221684|FG004|Overall Study|Lost to Follow-up|0|||
164232627|NCT02314923|593221685|FG005|Overall Study|Lost to Follow-up|0|||
164232628|NCT02314923|593221686|FG006|Overall Study|Lost to Follow-up|3|||
164232629|NCT02314923|593221687|FG007|Overall Study|Lost to Follow-up|4|||
164232630|NCT02314923|593221688|FG008|Overall Study|Lost to Follow-up|2|||
164232631|NCT02314923|593221689|FG009|Overall Study|Lost to Follow-up|0|||
164232632|NCT02314923|593221680|FG000|Overall Study|Withdrawal by Subject|0|||
164232633|NCT02314923|593221681|FG001|Overall Study|Withdrawal by Subject|0|||
164232634|NCT02314923|593221682|FG002|Overall Study|Withdrawal by Subject|1|||
164232635|NCT02314923|593221683|FG003|Overall Study|Withdrawal by Subject|0|||
164232636|NCT02314923|593221684|FG004|Overall Study|Withdrawal by Subject|1|||
164232637|NCT02314923|593221685|FG005|Overall Study|Withdrawal by Subject|0|||
164232638|NCT02314923|593221686|FG006|Overall Study|Withdrawal by Subject|1|||
164232639|NCT02314923|593221687|FG007|Overall Study|Withdrawal by Subject|0|||
164232640|NCT02314923|593221688|FG008|Overall Study|Withdrawal by Subject|0|||
164333053|NCT01845818|593597316|FG001|Overall Study|Withdrawal by Subject|1|||
164333054|NCT01845818|593597315|FG000|Overall Study|Lost to Follow-up|7|||
164333055|NCT01845818|593597316|FG001|Overall Study|Lost to Follow-up|5|||
164333056|NCT01845818|593597315|FG000|Overall Study|Administrative Reasons|3|||
164333057|NCT01845818|593597316|FG001|Overall Study|Administrative Reasons|1|||
164333058|NCT01845818|593597315|FG000|Overall Study|Serious Adverse Event|1|||
164333059|NCT01845818|593597316|FG001|Overall Study|Serious Adverse Event|1|||
164333060|NCT01845818|593597315|FG000|Overall Study|Other|25|||
164333061|NCT01845818|593597316|FG001|Overall Study|Other|8|||
164333062|NCT01845818|593597315|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
164333063|NCT01845818|593597316|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
164333064|NCT01845818|593597315|FG000|Overall Study|No Follow-Up Data Available|4|||
164333065|NCT01845818|593597316|FG001|Overall Study|No Follow-Up Data Available|1|||
164333066|NCT02595970|593597317|FG000|Overall Study|Withdrawal by Subject|2|||
164333067|NCT02595970|593597317|FG000|Overall Study|Physician Decision|2|||
164333068|NCT02595970|593597317|FG000|Overall Study|Protocol Violation|4|||
164333069|NCT02595970|593597317|FG000|Overall Study|Adverse Event|5|||
164333070|NCT02595970|593597317|FG000|Overall Study|Lack of Efficacy|7|||
164333071|NCT05061966|593597320|FG000|Overall Study|Lost to Follow-up|13|||
164333072|NCT05061966|593597321|FG001|Overall Study|Lost to Follow-up|13|||
164333073|NCT03793556|593597322|FG000|Overall Study|Withdrawal by Subject|12|||
164333074|NCT03793556|593597323|FG001|Overall Study|Withdrawal by Subject|1|||
164333075|NCT03793556|593597322|FG000|Overall Study|Lost to Follow-up|1|||
164333076|NCT03793556|593597323|FG001|Overall Study|Lost to Follow-up|1|||
164333077|NCT02923427|593597324|FG000|Overall Study|convert to laparatomy|2|||
164333078|NCT02923427|593597325|FG001|Overall Study|convert to laparatomy|2|||
164333079|NCT02923427|593597324|FG000|Overall Study|destaturation|1|||
164333080|NCT02923427|593597325|FG001|Overall Study|destaturation|0|||
164333081|NCT02923427|593597324|FG000|Overall Study|can not replace LMA|1|||
164333082|NCT02923427|593597325|FG001|Overall Study|can not replace LMA|0|||
164333083|NCT01325623|593597326|FG000|Overall Study|Withdrawal by Subject|3|||
164333084|NCT01539642|593597331|FG000|Overall Study|Lack of Efficacy|20|||
164333085|NCT01539642|593597332|FG001|Overall Study|Lack of Efficacy|18|||
164333086|NCT01539642|593597331|FG000|Overall Study|Patient ready for early discharge|8|||
164333087|NCT01539642|593597332|FG001|Overall Study|Patient ready for early discharge|7|||
164333088|NCT01539642|593597331|FG000|Overall Study|Adverse Event|6|||
164333089|NCT01539642|593597332|FG001|Overall Study|Adverse Event|4|||
164333090|NCT01539642|593597331|FG000|Overall Study|Withdrawal by Subject|2|||
164333091|NCT01539642|593597332|FG001|Overall Study|Withdrawal by Subject|2|||
164333092|NCT00598702|593597333|FG000|Overall Study|Other|0|||
164333093|NCT00598702|593597334|FG001|Overall Study|Other|2|||
163883728|NCT04492007|591943920|FG002|Overall Study|Lost to Follow-up|2|||
163883729|NCT04492007|591943921|FG003|Overall Study|Lost to Follow-up|2|||
163883730|NCT04492007|591943918|FG000|Overall Study|Protocol Violation|1|||
163883731|NCT04492007|591943919|FG001|Overall Study|Protocol Violation|1|||
163883732|NCT04492007|591943920|FG002|Overall Study|Protocol Violation|1|||
163883733|NCT04492007|591943921|FG003|Overall Study|Protocol Violation|1|||
163883734|NCT04492007|591943918|FG000|Overall Study|Withdrawal by Subject|0|||
163883735|NCT04492007|591943919|FG001|Overall Study|Withdrawal by Subject|0|||
163883736|NCT04492007|591943920|FG002|Overall Study|Withdrawal by Subject|1|||
163883737|NCT04492007|591943921|FG003|Overall Study|Withdrawal by Subject|1|||
163883738|NCT04229992|591943924|FG000|Overall Study|Withdrawal by Subject|0|||
163883739|NCT04229992|591943925|FG001|Overall Study|Withdrawal by Subject|2|||
163883740|NCT04229992|591943926|FG002|Overall Study|Withdrawal by Subject|1|||
163883741|NCT04229992|591943927|FG003|Overall Study|Withdrawal by Subject|1|||
163883742|NCT04229992|591943924|FG000|Overall Study|Adverse Event|1|||
163883743|NCT04229992|591943925|FG001|Overall Study|Adverse Event|1|||
163883744|NCT04229992|591943926|FG002|Overall Study|Adverse Event|3|||
163883745|NCT04229992|591943927|FG003|Overall Study|Adverse Event|1|||
163883746|NCT04229992|591943924|FG000|Overall Study|Lost to Follow-up|0|||
163883747|NCT04229992|591943925|FG001|Overall Study|Lost to Follow-up|0|||
163883748|NCT04229992|591943926|FG002|Overall Study|Lost to Follow-up|0|||
163883749|NCT04229992|591943927|FG003|Overall Study|Lost to Follow-up|1|||
163883750|NCT03770273|591943928|FG000|Overall Study|Adverse Event|2|||
163883751|NCT03770273|591943929|FG001|Overall Study|Adverse Event|0|||
164232641|NCT02314923|593221689|FG009|Overall Study|Withdrawal by Subject|0|||
164232642|NCT02314923|593221680|FG000|Overall Study|Physician Decision|0|||
164232643|NCT02314923|593221681|FG001|Overall Study|Physician Decision|1|||
164232644|NCT02314923|593221682|FG002|Overall Study|Physician Decision|0|||
164232645|NCT02314923|593221683|FG003|Overall Study|Physician Decision|0|||
164232646|NCT02314923|593221684|FG004|Overall Study|Physician Decision|0|||
164232647|NCT02314923|593221685|FG005|Overall Study|Physician Decision|0|||
164232648|NCT02314923|593221686|FG006|Overall Study|Physician Decision|0|||
164232649|NCT02314923|593221687|FG007|Overall Study|Physician Decision|0|||
164232650|NCT02314923|593221688|FG008|Overall Study|Physician Decision|0|||
164232651|NCT02314923|593221689|FG009|Overall Study|Physician Decision|0|||
164232652|NCT02314923|593221680|FG000|Overall Study|Participant unavailable|0|||
164232653|NCT02314923|593221681|FG001|Overall Study|Participant unavailable|0|||
164232654|NCT02314923|593221682|FG002|Overall Study|Participant unavailable|0|||
164232655|NCT02314923|593221683|FG003|Overall Study|Participant unavailable|0|||
164232656|NCT02314923|593221684|FG004|Overall Study|Participant unavailable|0|||
164232657|NCT02314923|593221685|FG005|Overall Study|Participant unavailable|1|||
164232658|NCT02314923|593221686|FG006|Overall Study|Participant unavailable|0|||
164232659|NCT02314923|593221687|FG007|Overall Study|Participant unavailable|0|||
164232660|NCT02314923|593221688|FG008|Overall Study|Participant unavailable|0|||
164232661|NCT02314923|593221689|FG009|Overall Study|Participant unavailable|0|||
164232662|NCT02314923|593221680|FG000|Overall Study|Screen failure|0|||
164232663|NCT02314923|593221681|FG001|Overall Study|Screen failure|0|||
164232664|NCT02314923|593221682|FG002|Overall Study|Screen failure|0|||
164232665|NCT02314923|593221683|FG003|Overall Study|Screen failure|0|||
164232666|NCT02314923|593221684|FG004|Overall Study|Screen failure|0|||
164232667|NCT02314923|593221685|FG005|Overall Study|Screen failure|0|||
164232668|NCT02314923|593221686|FG006|Overall Study|Screen failure|1|||
164232669|NCT02314923|593221687|FG007|Overall Study|Screen failure|0|||
164232670|NCT02314923|593221688|FG008|Overall Study|Screen failure|0|||
164232671|NCT02314923|593221689|FG009|Overall Study|Screen failure|0|||
164232672|NCT02314923|593221680|FG000|Overall Study|Participant relocation|1|||
164232673|NCT02314923|593221681|FG001|Overall Study|Participant relocation|0|||
164232674|NCT02314923|593221682|FG002|Overall Study|Participant relocation|0|||
164232675|NCT02314923|593221683|FG003|Overall Study|Participant relocation|0|||
164232676|NCT02314923|593221684|FG004|Overall Study|Participant relocation|0|||
164232677|NCT02314923|593221685|FG005|Overall Study|Participant relocation|0|||
164232678|NCT02314923|593221686|FG006|Overall Study|Participant relocation|0|||
164232679|NCT02314923|593221687|FG007|Overall Study|Participant relocation|1|||
164232680|NCT02314923|593221688|FG008|Overall Study|Participant relocation|0|||
164232681|NCT02314923|593221689|FG009|Overall Study|Participant relocation|0|||
164232682|NCT00976456|593221692|FG000|Overall Study|Adverse Event|17|||
164232683|NCT00976456|593221693|FG001|Overall Study|Adverse Event|22|||
164232684|NCT00976456|593221692|FG000|Overall Study|Death|7|||
164232685|NCT00976456|593221693|FG001|Overall Study|Death|9|||
164232686|NCT00976456|593221692|FG000|Overall Study|Lack of Efficacy|5|||
163987294|NCT00352534|592322265|FG003|Final Risk Group Assignment|Physician Decision|0|||
163987295|NCT00352534|592322266|FG004|Final Risk Group Assignment|Physician Decision|0|||
163987296|NCT00352534|592322267|FG005|Final Risk Group Assignment|Physician Decision|8|||
163987297|NCT00352534|592322268|FG006|Final Risk Group Assignment|Physician Decision|0|||
163987298|NCT00352534|592322262|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
163987299|NCT00352534|592322263|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
163987300|NCT00352534|592322264|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
164232687|NCT00976456|593221693|FG001|Overall Study|Lack of Efficacy|2|||
164232688|NCT00976456|593221692|FG000|Overall Study|Withdrawal by Subject|3|||
164232689|NCT00976456|593221693|FG001|Overall Study|Withdrawal by Subject|1|||
164232690|NCT00976456|593221692|FG000|Overall Study|screening failure, unknown|11|||
163987301|NCT00352534|592322265|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
163987302|NCT00352534|592322266|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
163987303|NCT00352534|592322267|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
163987304|NCT00352534|592322268|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
163987305|NCT00352534|592322262|FG000|Final Risk Group Assignment|Ineligible|0|||
163987306|NCT00352534|592322263|FG001|Final Risk Group Assignment|Ineligible|0|||
163987307|NCT00352534|592322264|FG002|Final Risk Group Assignment|Ineligible|3|||
163987308|NCT00352534|592322265|FG003|Final Risk Group Assignment|Ineligible|1|||
163987309|NCT00352534|592322266|FG004|Final Risk Group Assignment|Ineligible|0|||
163987310|NCT00352534|592322267|FG005|Final Risk Group Assignment|Ineligible|13|||
163987311|NCT00352534|592322268|FG006|Final Risk Group Assignment|Ineligible|0|||
163987312|NCT00352534|592322262|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163987313|NCT00352534|592322263|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
164232691|NCT00976456|593221693|FG001|Overall Study|screening failure, unknown|4|||
164232692|NCT00478257|593221694|FG000|Overall Study|Withdrawal by Subject|8|||
164232693|NCT00478257|593221695|FG001|Overall Study|Withdrawal by Subject|3|||
164232694|NCT00806585|593221696|FG000|Overall Study|Study terminated by Sponsor|0|||
164232695|NCT00806585|593221697|FG001|Overall Study|Study terminated by Sponsor|0|||
164232696|NCT00806585|593221698|FG002|Overall Study|Study terminated by Sponsor|1|||
164232697|NCT00806585|593221699|FG003|Overall Study|Study terminated by Sponsor|2|||
164232698|NCT00806585|593221700|FG004|Overall Study|Study terminated by Sponsor|0|||
164232699|NCT00806585|593221696|FG000|Overall Study|Protocol Violation|3|||
164232700|NCT00806585|593221697|FG001|Overall Study|Protocol Violation|1|||
164232701|NCT00806585|593221698|FG002|Overall Study|Protocol Violation|2|||
164232702|NCT00806585|593221699|FG003|Overall Study|Protocol Violation|0|||
164232703|NCT00806585|593221700|FG004|Overall Study|Protocol Violation|0|||
164232704|NCT00806585|593221696|FG000|Overall Study|Physician Decision|0|||
164232705|NCT00806585|593221697|FG001|Overall Study|Physician Decision|2|||
164232706|NCT00806585|593221698|FG002|Overall Study|Physician Decision|3|||
164232707|NCT00806585|593221699|FG003|Overall Study|Physician Decision|0|||
164232708|NCT00806585|593221700|FG004|Overall Study|Physician Decision|1|||
164232709|NCT00806585|593221696|FG000|Overall Study|Lost to Follow-up|2|||
164232710|NCT00806585|593221697|FG001|Overall Study|Lost to Follow-up|1|||
164232711|NCT00806585|593221698|FG002|Overall Study|Lost to Follow-up|2|||
164232712|NCT00806585|593221699|FG003|Overall Study|Lost to Follow-up|2|||
164232713|NCT00806585|593221700|FG004|Overall Study|Lost to Follow-up|5|||
164232714|NCT00806585|593221696|FG000|Overall Study|Lack of Efficacy|1|||
164232715|NCT00806585|593221697|FG001|Overall Study|Lack of Efficacy|0|||
164232716|NCT00806585|593221698|FG002|Overall Study|Lack of Efficacy|0|||
164232717|NCT00806585|593221699|FG003|Overall Study|Lack of Efficacy|0|||
164232718|NCT00806585|593221700|FG004|Overall Study|Lack of Efficacy|0|||
164232719|NCT00806585|593221696|FG000|Overall Study|Adverse Event|1|||
164232720|NCT00806585|593221697|FG001|Overall Study|Adverse Event|5|||
164232721|NCT00806585|593221698|FG002|Overall Study|Adverse Event|3|||
164232722|NCT00806585|593221699|FG003|Overall Study|Adverse Event|4|||
164232723|NCT00806585|593221700|FG004|Overall Study|Adverse Event|2|||
164232724|NCT00806585|593221696|FG000|Overall Study|Withdrawal by Subject|10|||
164232725|NCT00806585|593221697|FG001|Overall Study|Withdrawal by Subject|8|||
164232726|NCT00806585|593221698|FG002|Overall Study|Withdrawal by Subject|9|||
164232727|NCT00806585|593221699|FG003|Overall Study|Withdrawal by Subject|3|||
164232728|NCT00806585|593221700|FG004|Overall Study|Withdrawal by Subject|11|||
164232729|NCT00806585|593221696|FG000|Overall Study|Completion status unknown|15|||
164232730|NCT00806585|593221697|FG001|Overall Study|Completion status unknown|14|||
164232731|NCT00806585|593221698|FG002|Overall Study|Completion status unknown|12|||
164232732|NCT00806585|593221699|FG003|Overall Study|Completion status unknown|4|||
164232733|NCT00806585|593221700|FG004|Overall Study|Completion status unknown|12|||
164232734|NCT02507934|593221701|FG000|Overall Study|Lost to Follow-up|2|||
164232735|NCT02507934|593221702|FG001|Overall Study|Lost to Follow-up|0|||
164232736|NCT02507934|593221701|FG000|Overall Study|Withdrawal by Subject|2|||
164232737|NCT02507934|593221702|FG001|Overall Study|Withdrawal by Subject|0|||
164232738|NCT03766399|593221703|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232739|NCT03766399|593221704|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232740|NCT03766399|593221705|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232741|NCT03766399|593221706|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232742|NCT03766399|593221707|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232743|NCT03766399|593221708|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232744|NCT03766399|593221709|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232745|NCT03766399|593221710|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232746|NCT03766399|593221711|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232747|NCT03766399|593221712|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232748|NCT03766399|593221713|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232749|NCT03766399|593221714|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232750|NCT03766399|593221715|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164333094|NCT00598702|593597335|FG002|Overall Study|Other|0|||
164333095|NCT00598702|593597336|FG003|Overall Study|Other|0|||
164333096|NCT00598702|593597337|FG004|Overall Study|Other|0|||
164333097|NCT00598702|593597338|FG005|Overall Study|Other|1|||
164333098|NCT00598702|593597339|FG006|Overall Study|Other|0|||
164333099|NCT00598702|593597340|FG007|Overall Study|Other|0|||
164333100|NCT00598702|593597333|FG000|Overall Study|Early discharge from hospital|0|||
164333101|NCT00598702|593597334|FG001|Overall Study|Early discharge from hospital|0|||
164333102|NCT00598702|593597335|FG002|Overall Study|Early discharge from hospital|2|||
164333103|NCT00598702|593597336|FG003|Overall Study|Early discharge from hospital|5|||
164232751|NCT03766399|593221716|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
164232752|NCT03766399|593221717|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232753|NCT03766399|593221718|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232754|NCT03766399|593221719|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232755|NCT03766399|593221720|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
164232756|NCT03331354|593221721|FG000|Overall Study|Withdrawal by Subject|1|||
164232757|NCT03331354|593221722|FG001|Overall Study|Withdrawal by Subject|3|||
164232758|NCT03331354|593221721|FG000|Overall Study|Lost to Follow-up|3|||
164333104|NCT00598702|593597337|FG004|Overall Study|Early discharge from hospital|0|||
163883752|NCT03770273|591943928|FG000|Overall Study|Lost to Follow-up|1|||
164232759|NCT03331354|593221722|FG001|Overall Study|Lost to Follow-up|3|||
163987314|NCT00352534|592322264|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163987315|NCT00352534|592322265|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163987316|NCT00352534|592322266|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163987317|NCT00352534|592322267|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
163987318|NCT00352534|592322268|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
163987319|NCT00352534|592322262|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163987320|NCT00352534|592322263|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163987321|NCT00352534|592322264|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163987322|NCT00352534|592322265|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163987323|NCT00352534|592322266|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163987324|NCT00352534|592322267|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
163987325|NCT00352534|592322268|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
163987326|NCT00352534|592322262|FG000|Final Risk Group Assignment|Death|0|||
163987327|NCT00352534|592322263|FG001|Final Risk Group Assignment|Death|0|||
163987328|NCT00352534|592322264|FG002|Final Risk Group Assignment|Death|0|||
163987329|NCT00352534|592322265|FG003|Final Risk Group Assignment|Death|0|||
163987330|NCT00352534|592322266|FG004|Final Risk Group Assignment|Death|0|||
163987331|NCT00352534|592322267|FG005|Final Risk Group Assignment|Death|2|||
163987332|NCT00352534|592322268|FG006|Final Risk Group Assignment|Death|0|||
163987333|NCT00619502|592322269|FG000|Overall Study|Lost to Follow-up|8|||
163987334|NCT00619502|592322270|FG001|Overall Study|Lost to Follow-up|10|||
163987335|NCT01354028|592322281|FG000|Overall Study|Physician Decision|0|||
163987336|NCT01354028|592322282|FG001|Overall Study|Physician Decision|2|||
163987337|NCT01354028|592322281|FG000|Overall Study|Discharged before study start|2|||
163987338|NCT01354028|592322282|FG001|Overall Study|Discharged before study start|2|||
163987339|NCT01354028|592322281|FG000|Overall Study|No quiet alert state|0|||
163987340|NCT01354028|592322282|FG001|Overall Study|No quiet alert state|1|||
163987341|NCT01641939|592322283|FG000|Overall Study|Death|90|||
163987342|NCT01641939|592322284|FG001|Overall Study|Death|187|||
163987343|NCT01641939|592322285|FG002|Overall Study|Death|61|||
163987344|NCT01641939|592322283|FG000|Overall Study|Lost to Follow-up|3|||
163987345|NCT01641939|592322284|FG001|Overall Study|Lost to Follow-up|2|||
163987346|NCT01641939|592322285|FG002|Overall Study|Lost to Follow-up|1|||
163987347|NCT01641939|592322283|FG000|Overall Study|Withdrawal by Subject|14|||
163987348|NCT01641939|592322284|FG001|Overall Study|Withdrawal by Subject|11|||
163987349|NCT01641939|592322285|FG002|Overall Study|Withdrawal by Subject|5|||
163987350|NCT01641939|592322283|FG000|Overall Study|Study Terminated by Sponsor|10|||
163987351|NCT01641939|592322284|FG001|Overall Study|Study Terminated by Sponsor|28|||
163987352|NCT01641939|592322285|FG002|Overall Study|Study Terminated by Sponsor|3|||
163987353|NCT02894840|592322286|FG000|Overall Study|Lost to Follow-up|1|||
163987354|NCT02894840|592322287|FG001|Overall Study|Lost to Follow-up|0|||
163987355|NCT02894840|592322288|FG002|Overall Study|Lost to Follow-up|3|||
163987356|NCT02894840|592322289|FG003|Overall Study|Lost to Follow-up|0|||
163987357|NCT01072344|592322290|FG000|Overall Study|Relasped-reached end point|7|||
163987358|NCT01072344|592322291|FG001|Overall Study|Relasped-reached end point|12|||
163987359|NCT01072344|592322290|FG000|Overall Study|Protocol Violation|1|||
163987360|NCT01072344|592322291|FG001|Overall Study|Protocol Violation|2|||
164333105|NCT00598702|593597338|FG005|Overall Study|Early discharge from hospital|10|||
164333106|NCT00598702|593597339|FG006|Overall Study|Early discharge from hospital|1|||
164333107|NCT00598702|593597340|FG007|Overall Study|Early discharge from hospital|0|||
164333108|NCT00598702|593597333|FG000|Overall Study|Adverse Event|0|||
164333109|NCT00598702|593597334|FG001|Overall Study|Adverse Event|0|||
163987361|NCT01072344|592322290|FG000|Overall Study|Lost to Follow-up|3|||
163987362|NCT01072344|592322291|FG001|Overall Study|Lost to Follow-up|4|||
163987363|NCT00716976|592322292|FG000|Overall Study|Adverse Event|2|||
163987364|NCT00716976|592322293|FG001|Overall Study|Adverse Event|0|||
163987365|NCT00716976|592322292|FG000|Overall Study|Death|1|||
164333110|NCT00598702|593597335|FG002|Overall Study|Adverse Event|0|||
164333111|NCT00598702|593597336|FG003|Overall Study|Adverse Event|1|||
164333112|NCT00598702|593597337|FG004|Overall Study|Adverse Event|0|||
164333113|NCT00598702|593597338|FG005|Overall Study|Adverse Event|0|||
164333114|NCT00598702|593597339|FG006|Overall Study|Adverse Event|0|||
164333115|NCT00598702|593597340|FG007|Overall Study|Adverse Event|0|||
164333116|NCT00598702|593597333|FG000|Overall Study|Withdrawal by Subject|0|||
164333117|NCT00598702|593597334|FG001|Overall Study|Withdrawal by Subject|0|||
164333118|NCT00598702|593597335|FG002|Overall Study|Withdrawal by Subject|0|||
163987366|NCT00716976|592322293|FG001|Overall Study|Death|0|||
163987367|NCT00716976|592322292|FG000|Overall Study|Physician Decision|2|||
163987368|NCT00716976|592322293|FG001|Overall Study|Physician Decision|2|||
163987369|NCT00716976|592322292|FG000|Overall Study|Withdrawal by Subject|5|||
163987370|NCT00716976|592322293|FG001|Overall Study|Withdrawal by Subject|1|||
163987371|NCT00716976|592322292|FG000|Overall Study|Premature discontinuation cisplatin|5|||
163987372|NCT00716976|592322293|FG001|Overall Study|Premature discontinuation cisplatin|4|||
163987373|NCT00716976|592322292|FG000|Overall Study|Radiation during protocol|1|||
163987374|NCT00716976|592322293|FG001|Overall Study|Radiation during protocol|0|||
164333119|NCT00598702|593597336|FG003|Overall Study|Withdrawal by Subject|1|||
164333120|NCT00598702|593597337|FG004|Overall Study|Withdrawal by Subject|1|||
164333121|NCT00598702|593597338|FG005|Overall Study|Withdrawal by Subject|0|||
164333122|NCT00598702|593597339|FG006|Overall Study|Withdrawal by Subject|0|||
164333123|NCT00598702|593597340|FG007|Overall Study|Withdrawal by Subject|0|||
164333124|NCT00598702|593597333|FG000|Overall Study|Physician Decision|0|||
164333125|NCT00598702|593597334|FG001|Overall Study|Physician Decision|0|||
164333126|NCT00598702|593597335|FG002|Overall Study|Physician Decision|0|||
164333127|NCT00598702|593597336|FG003|Overall Study|Physician Decision|0|||
164333128|NCT00598702|593597337|FG004|Overall Study|Physician Decision|1|||
164333129|NCT00598702|593597338|FG005|Overall Study|Physician Decision|0|||
164333130|NCT00598702|593597339|FG006|Overall Study|Physician Decision|0|||
164333131|NCT00598702|593597340|FG007|Overall Study|Physician Decision|0|||
164333132|NCT00598702|593597333|FG000|Overall Study|Dose limiting toxicity|0|||
164333133|NCT00598702|593597334|FG001|Overall Study|Dose limiting toxicity|0|||
164333134|NCT00598702|593597335|FG002|Overall Study|Dose limiting toxicity|0|||
164333135|NCT00598702|593597336|FG003|Overall Study|Dose limiting toxicity|1|||
164333136|NCT00598702|593597337|FG004|Overall Study|Dose limiting toxicity|1|||
164333137|NCT00598702|593597338|FG005|Overall Study|Dose limiting toxicity|1|||
164333138|NCT00598702|593597339|FG006|Overall Study|Dose limiting toxicity|0|||
164333139|NCT00598702|593597340|FG007|Overall Study|Dose limiting toxicity|0|||
164333140|NCT02413372|593597344|FG000|Treatment|Lost to Follow-up|0|||
164333141|NCT02413372|593597345|FG001|Treatment|Lost to Follow-up|2|||
164333142|NCT02413372|593597346|FG002|Treatment|Lost to Follow-up|1|||
164333143|NCT02413372|593597344|FG000|Treatment|Withdrawal by Subject|1|||
163987375|NCT00716976|592322292|FG000|Overall Study|Ineligibles|4|||
164333144|NCT02413372|593597345|FG001|Treatment|Withdrawal by Subject|0|||
163987376|NCT00716976|592322293|FG001|Overall Study|Ineligibles|2|||
163987377|NCT05499559|592322294|FG000|Overall Study|Lost to Follow-up|467|||
163987378|NCT03472560|592322301|FG000|Overall Study|Subject transfer to continuation protocol|0|||
163987379|NCT03472560|592322302|FG001|Overall Study|Subject transfer to continuation protocol|1|||
163987380|NCT03472560|592322301|FG000|Overall Study|Withdrawal by Subject|4|||
163987381|NCT03472560|592322302|FG001|Overall Study|Withdrawal by Subject|0|||
163987382|NCT03472560|592322301|FG000|Overall Study|Progressive disease|24|||
163987383|NCT03472560|592322302|FG001|Overall Study|Progressive disease|8|||
163987384|NCT03472560|592322301|FG000|Overall Study|Physician Decision|1|||
163987385|NCT03472560|592322302|FG001|Overall Study|Physician Decision|0|||
163987386|NCT03472560|592322301|FG000|Overall Study|Death|7|||
163987387|NCT03472560|592322302|FG001|Overall Study|Death|4|||
163987388|NCT03472560|592322301|FG000|Overall Study|Adverse Event|5|||
163987389|NCT03472560|592322302|FG001|Overall Study|Adverse Event|3|||
163987390|NCT03472560|592322301|FG000|Overall Study|Global deterioration of health status|0|||
163987391|NCT03472560|592322302|FG001|Overall Study|Global deterioration of health status|4|||
163987392|NCT01946178|592322303|FG000|Overall Study|Pregnancy|1|||
163987393|NCT01946178|592322303|FG000|Overall Study|Lost to Follow-up|1|||
163987394|NCT01534676|592322309|FG000|Overall Study|Study closed due to poor enrollment|2|||
163987395|NCT01534676|592322310|FG001|Overall Study|Study closed due to poor enrollment|1|||
163987396|NCT02908880|592322311|FG000|Overall Study|Lost to Follow-up|4|||
163987397|NCT02908880|592322311|FG000|Overall Study|Explantation of the device|1|||
163987398|NCT02908880|592322311|FG000|Overall Study|Withdrawal by Subject|17|||
163987399|NCT02908880|592322311|FG000|Overall Study|Death|5|||
163987400|NCT01001702|592322314|FG000|Overall Study|Lost to Follow-up|7|||
163987401|NCT01001702|592322314|FG000|Overall Study|Adverse Event|7|||
163987402|NCT01001702|592322314|FG000|Overall Study|Sponsor Discontinued Study|4|||
163987403|NCT01001702|592322314|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
163987404|NCT01001702|592322314|FG000|Overall Study|Investigator withdrew Subject|10|||
163987405|NCT01001702|592322314|FG000|Overall Study|Withdrawal by Subject|19|||
163987406|NCT01001702|592322314|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
163987407|NCT00584233|592322317|FG000|Overall Study|Withdrawal by Subject|5|||
163987408|NCT00584233|592322317|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
163987409|NCT02494596|592322318|FG000|Overall Study|Insufficient Therapeutic Response|3|||
163987410|NCT02494596|592322319|FG001|Overall Study|Insufficient Therapeutic Response|3|||
163987411|NCT02494596|592322320|FG002|Overall Study|Insufficient Therapeutic Response|1|||
163987412|NCT02494596|592322318|FG000|Overall Study|Adverse Event|0|||
164333145|NCT02413372|593597346|FG002|Treatment|Withdrawal by Subject|0|||
164333146|NCT02413372|593597344|FG000|Follow-up|Lost to Follow-up|1|||
164333147|NCT02413372|593597345|FG001|Follow-up|Lost to Follow-up|1|||
163987413|NCT02494596|592322319|FG001|Overall Study|Adverse Event|1|||
163987414|NCT02494596|592322320|FG002|Overall Study|Adverse Event|0|||
163987415|NCT02494596|592322318|FG000|Overall Study|Refused Treatment|0|||
163987416|NCT02494596|592322319|FG001|Overall Study|Refused Treatment|1|||
163987417|NCT02494596|592322320|FG002|Overall Study|Refused Treatment|0|||
163987418|NCT02222714|592322321|FG000|Overall Study|Death|0|||
163987419|NCT02222714|592322322|FG001|Overall Study|Death|2|||
164333148|NCT02413372|593597346|FG002|Follow-up|Lost to Follow-up|0|||
163987420|NCT02222714|592322323|FG002|Overall Study|Death|3|||
164333149|NCT02413372|593597344|FG000|Follow-up|Subject Withdrew Consent|1|||
164232760|NCT03331354|593221721|FG000|Overall Study|Found employment before initiated active intervention|0|||
164232761|NCT03331354|593221722|FG001|Overall Study|Found employment before initiated active intervention|4|||
164232762|NCT01559935|593221725|FG000|Car Phase|Toxicity|4|||
164232763|NCT01559935|593221725|FG000|Car Phase|Death|1|||
164232764|NCT01559935|593221725|FG000|Car Phase|Lack of Efficacy|2|||
164232765|NCT01559935|593221725|FG000|Car Phase|Lost to Follow-up|1|||
164232766|NCT01559935|593221725|FG000|Car Phase|Physician Decision|1|||
164232767|NCT01559935|593221725|FG000|Car Phase|Withdrawal by Subject|2|||
164232768|NCT01559935|593221725|FG000|Car Phase|Per protocol|1|||
164232769|NCT01559935|593221725|FG000|Car Phase|Insurance|1|||
164232770|NCT01559935|593221725|FG000|Car Phase|non-compliance|1|||
164232771|NCT01559935|593221725|FG000|BiRD Phase|Toxicity|1|||
164232772|NCT01559935|593221725|FG000|BiRD Phase|Lack of Efficacy|1|||
164232773|NCT01559935|593221725|FG000|BiRD Phase|Withdrawal by Subject|2|||
164232774|NCT01559935|593221725|FG000|Maintenance Phase|Remains on study|28|||
164232775|NCT01559935|593221725|FG000|Maintenance Phase|Toxicity|1|||
164232776|NCT01559935|593221725|FG000|Maintenance Phase|Lack of Efficacy|18|||
164232777|NCT01559935|593221725|FG000|Maintenance Phase|Withdrawal by Subject|5|||
164232778|NCT01559935|593221725|FG000|Maintenance Phase|Non-compliance|2|||
164232779|NCT05889468|593221726|FG000|Overall Study|Lost to Follow-up|9|||
164232780|NCT05889468|593221727|FG001|Overall Study|Lost to Follow-up|2|||
164232781|NCT05889468|593221726|FG000|Overall Study|Withdrawal by Subject|2|||
164232782|NCT05889468|593221727|FG001|Overall Study|Withdrawal by Subject|2|||
164232783|NCT01767987|593221730|FG000|Overall Study|Physician Decision|4|||
164232784|NCT01767987|593221731|FG001|Overall Study|Physician Decision|1|||
164232785|NCT01153516|593221732|FG000|Overall Study|Both subjects refused surgery|2|||
164232786|NCT01153516|593221733|FG001|Overall Study|Both subjects refused surgery|0|||
164232787|NCT01605097|593221742|FG000|Overall Study|Protocol Violation|1|||
164232788|NCT02284893|593221750|FG000|26 Week (Short Term)|Adverse Event|1|||
164232789|NCT02284893|593221751|FG001|26 Week (Short Term)|Adverse Event|9|||
164232790|NCT02284893|593221750|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
164232791|NCT02284893|593221751|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
164232792|NCT02284893|593221750|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
164232793|NCT02284893|593221751|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
164232794|NCT02284893|593221750|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
164232795|NCT02284893|593221751|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
164232796|NCT02284893|593221750|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
164232797|NCT02284893|593221751|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
164232798|NCT02284893|593221750|FG000|26 Week (Short Term)|Other|1|||
164232799|NCT02284893|593221751|FG001|26 Week (Short Term)|Other|1|||
164232800|NCT02284893|593221750|FG000|52 Week (Long Term)|Adverse Event|3|||
164232801|NCT02284893|593221751|FG001|52 Week (Long Term)|Adverse Event|1|||
164232802|NCT02284893|593221750|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
164232803|NCT02284893|593221751|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
164232804|NCT02284893|593221750|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
164232805|NCT02284893|593221751|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
164232806|NCT02284893|593221750|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
164232807|NCT02284893|593221751|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
163883753|NCT03770273|591943929|FG001|Overall Study|Lost to Follow-up|1|||
163883754|NCT00418886|591943930|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
163883755|NCT00418886|591943931|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
163883756|NCT00418886|591943930|FG000|Randomized Period|Death|122|||
163883757|NCT00418886|591943931|FG001|Randomized Period|Death|147|||
163883758|NCT00418886|591943930|FG000|Randomized Period|Withdrawal by Subject|9|||
163883759|NCT00418886|591943931|FG001|Randomized Period|Withdrawal by Subject|10|||
163883760|NCT00418886|591943930|FG000|Randomized Period|Lost to Follow-up|4|||
163883761|NCT00418886|591943931|FG001|Randomized Period|Lost to Follow-up|6|||
163883762|NCT00418886|591943930|FG000|Randomized Period|withdrawn due to other reason|1|||
163883763|NCT00418886|591943931|FG001|Randomized Period|withdrawn due to other reason|0|||
163883764|NCT00418886|591943930|FG000|Randomized Period|randomised but no treatment received|0|||
163883765|NCT00418886|591943931|FG001|Randomized Period|randomised but no treatment received|1|||
163883766|NCT03907397|591943934|FG000|Overall Study|Lost to Follow-up|0|||
163883767|NCT03907397|591943935|FG001|Overall Study|Lost to Follow-up|1|||
163883768|NCT03907397|591943934|FG000|Overall Study|Physician Decision|2|||
163883769|NCT03907397|591943935|FG001|Overall Study|Physician Decision|1|||
163883770|NCT03907397|591943934|FG000|Overall Study|Withdrawal by Subject|5|||
163883771|NCT03907397|591943935|FG001|Overall Study|Withdrawal by Subject|4|||
163883772|NCT03907397|591943934|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
163883773|NCT03907397|591943935|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
163883774|NCT05948670|591943941|FG000|Overall Study|Protocol Violation|6|||
163883775|NCT05948670|591943942|FG001|Overall Study|Protocol Violation|8|||
163883776|NCT05948670|591943941|FG000|Overall Study|Withdrawal by Subject|0|||
163883777|NCT05948670|591943942|FG001|Overall Study|Withdrawal by Subject|1|||
163883778|NCT03056040|591943944|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
163987421|NCT02222714|592322324|FG003|Overall Study|Death|4|||
163987422|NCT02222714|592322325|FG004|Overall Study|Death|6|||
163987423|NCT02222714|592322321|FG000|Overall Study|Withdrawal by Subject|0|||
163987424|NCT02222714|592322322|FG001|Overall Study|Withdrawal by Subject|0|||
163987425|NCT02222714|592322323|FG002|Overall Study|Withdrawal by Subject|1|||
163987426|NCT02222714|592322324|FG003|Overall Study|Withdrawal by Subject|0|||
163987427|NCT02222714|592322325|FG004|Overall Study|Withdrawal by Subject|1|||
163987428|NCT00159432|592322326|FG000|Overall Study|Adverse Event|1|||
163987429|NCT00159432|592322326|FG000|Overall Study|Death|1|||
163987430|NCT00159432|592322326|FG000|Overall Study|Lack of Efficacy|8|||
163987431|NCT03286842|592322327|FG000|Overall Study|Patients rolled over to another study|80|||
163987432|NCT03178487|592322331|FG000|Period 1|Adverse Event|1|||
163987433|NCT03178487|592322332|FG001|Period 1|Adverse Event|2|||
163987434|NCT03178487|592322331|FG000|Period 1|Withdrawal by Subject|2|||
163987435|NCT03178487|592322332|FG001|Period 1|Withdrawal by Subject|1|||
163987436|NCT03178487|592322331|FG000|Period 1|Lost to Follow-up|1|||
163987437|NCT03178487|592322332|FG001|Period 1|Lost to Follow-up|0|||
163987438|NCT03178487|592322331|FG000|Period 1|Other|0|||
163987439|NCT03178487|592322332|FG001|Period 1|Other|1|||
163987440|NCT03178487|592322331|FG000|Period 2|Adverse Event|4|||
163987441|NCT03178487|592322332|FG001|Period 2|Adverse Event|4|||
163987442|NCT03178487|592322331|FG000|Period 2|Withdrawal by Subject|6|||
163987443|NCT03178487|592322332|FG001|Period 2|Withdrawal by Subject|6|||
163987444|NCT03178487|592322331|FG000|Period 2|Lost to Follow-up|2|||
163987445|NCT03178487|592322332|FG001|Period 2|Lost to Follow-up|2|||
164232808|NCT02284893|593221750|FG000|52 Week (Long Term)|Non-Compliance|2|||
164232809|NCT02284893|593221751|FG001|52 Week (Long Term)|Non-Compliance|3|||
164232810|NCT00105066|593221757|FG000|Overall Study|Adverse Event|2|||
163987446|NCT03178487|592322331|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
163987447|NCT03178487|592322332|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
163987448|NCT03178487|592322331|FG000|Period 2|Other|8|||
163987449|NCT03178487|592322332|FG001|Period 2|Other|7|||
163987450|NCT00197054|592322342|FG000|Overall Study|Withdrawal by Subject|9|||
163987451|NCT00197054|592322343|FG001|Overall Study|Withdrawal by Subject|3|||
163987452|NCT00197054|592322344|FG002|Overall Study|Withdrawal by Subject|3|||
163987453|NCT00197054|592322342|FG000|Overall Study|Moved from area|7|||
163987454|NCT00197054|592322343|FG001|Overall Study|Moved from area|14|||
163987455|NCT00197054|592322344|FG002|Overall Study|Moved from area|9|||
163987456|NCT00197054|592322342|FG000|Overall Study|Lost to Follow-up|1|||
163987457|NCT00197054|592322343|FG001|Overall Study|Lost to Follow-up|4|||
163987458|NCT00197054|592322344|FG002|Overall Study|Lost to Follow-up|0|||
164232811|NCT00105066|593221758|FG001|Overall Study|Adverse Event|5|||
164232812|NCT02231580|593221759|FG000|Overall Study|Adverse Event|5|||
164232813|NCT02231580|593221760|FG001|Overall Study|Adverse Event|0|||
164232814|NCT05552859|593221762|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
164232815|NCT05552859|593221763|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
164232816|NCT01722669|593221767|FG000|Overall Study|Withdrawal by Subject|0|||
164232817|NCT01722669|593221768|FG001|Overall Study|Withdrawal by Subject|0|||
164232818|NCT01722669|593221769|FG002|Overall Study|Withdrawal by Subject|0|||
164232819|NCT01722669|593221770|FG003|Overall Study|Withdrawal by Subject|0|||
164232820|NCT01722669|593221771|FG004|Overall Study|Withdrawal by Subject|0|||
164232821|NCT01722669|593221772|FG005|Overall Study|Withdrawal by Subject|2|||
164232822|NCT02255656|593221777|FG000|Overall Study|Adverse Event|11|||
164232823|NCT02255656|593221777|FG000|Overall Study|Poor compliance to protocol|3|||
164232824|NCT02255656|593221777|FG000|Overall Study|Lost to Follow-up|30|||
164232825|NCT02255656|593221777|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
164232826|NCT02255656|593221777|FG000|Overall Study|Other|126|||
164232827|NCT03734536|593221778|FG000|Overall Study|Withdrew Consent|1|||
164232828|NCT03734536|593221779|FG001|Overall Study|Withdrew Consent|5|||
164232829|NCT03734536|593221778|FG000|Overall Study|Lost to Follow-up|10|||
164232830|NCT03734536|593221779|FG001|Overall Study|Lost to Follow-up|7|||
164232831|NCT03448393|593221780|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232832|NCT03448393|593221781|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232833|NCT03448393|593221782|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
164232834|NCT03448393|593221783|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232835|NCT03448393|593221784|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232836|NCT03448393|593221785|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232837|NCT03448393|593221786|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232838|NCT03448393|593221787|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
164232839|NCT03448393|593221788|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
164232840|NCT03448393|593221780|FG000|Dose Expansion|Not treated - screen failure|0|||
164232841|NCT03448393|593221781|FG001|Dose Expansion|Not treated - screen failure|0|||
164232842|NCT03448393|593221782|FG002|Dose Expansion|Not treated - screen failure|0|||
164232843|NCT03448393|593221783|FG003|Dose Expansion|Not treated - screen failure|0|||
164232844|NCT03448393|593221784|FG004|Dose Expansion|Not treated - screen failure|0|||
164232845|NCT03448393|593221785|FG005|Dose Expansion|Not treated - screen failure|0|||
164232846|NCT03448393|593221786|FG006|Dose Expansion|Not treated - screen failure|0|||
164232847|NCT03448393|593221787|FG007|Dose Expansion|Not treated - screen failure|0|||
164232848|NCT03448393|593221788|FG008|Dose Expansion|Not treated - screen failure|7|||
164232849|NCT04144517|593221794|FG000|Overall Study|Physician Decision|0|||
164232850|NCT04144517|593221795|FG001|Overall Study|Physician Decision|1|||
164232851|NCT04144517|593221794|FG000|Overall Study|Other|2|||
164232852|NCT04144517|593221795|FG001|Overall Study|Other|2|||
164232853|NCT04144517|593221794|FG000|Overall Study|Death|6|||
164232854|NCT04144517|593221795|FG001|Overall Study|Death|3|||
164232855|NCT05929326|593221800|FG000|Overall Study|unqualified sample|2|||
164232856|NCT05929326|593221801|FG001|Overall Study|unqualified sample|3|||
164232857|NCT05929326|593221802|FG002|Overall Study|unqualified sample|7|||
164232858|NCT05212168|593221812|FG000|Overall Study|Lost to Follow-up|0|||
164232859|NCT05212168|593221813|FG001|Overall Study|Lost to Follow-up|3|||
164232860|NCT05212168|593221812|FG000|Overall Study|Study terminated by sponsor|30|||
164232861|NCT05212168|593221813|FG001|Overall Study|Study terminated by sponsor|27|||
164232862|NCT05212168|593221812|FG000|Overall Study|Other|4|||
164232863|NCT05212168|593221813|FG001|Overall Study|Other|7|||
164232864|NCT03941093|593221815|FG000|Overall Study|Protocol Violation|0|||
164232865|NCT03941093|593221816|FG001|Overall Study|Protocol Violation|1|||
164232866|NCT03941093|593221815|FG000|Overall Study|Withdrawal by Subject|9|||
164232867|NCT03941093|593221816|FG001|Overall Study|Withdrawal by Subject|6|||
164232868|NCT03359395|593221819|FG000|First Intervention A / B|Withdrawal by Subject|1|||
164232869|NCT03359395|593221820|FG001|First Intervention A / B|Withdrawal by Subject|0|||
164232870|NCT03359395|593221819|FG000|First Intervention A / B|Lost to Follow-up|2|||
164232871|NCT03359395|593221820|FG001|First Intervention A / B|Lost to Follow-up|3|||
164232872|NCT03359395|593221819|FG000|Second Intervention B/A|Exclusion criteria|0|||
164232873|NCT03359395|593221820|FG001|Second Intervention B/A|Exclusion criteria|1|||
164232874|NCT03359395|593221819|FG000|Second Intervention B/A|Lost to Follow-up|3|||
164232875|NCT03359395|593221820|FG001|Second Intervention B/A|Lost to Follow-up|2|||
164232876|NCT02333799|593223267|FG000|Treatment Period|Withdrawal by Subject|1|||
164232877|NCT02333799|593223267|FG000|Treatment Period|Death|6|||
164232878|NCT02333799|593223267|FG000|6 Month Follow Up Period|Physician Decision|1|||
164232879|NCT02333799|593223267|FG000|6 Month Follow Up Period|Death|1|||
164232880|NCT02333799|593223267|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
164232881|NCT02333799|593223267|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
164232882|NCT05484895|593223268|FG000|Overall Study|Lost to Follow-up|63|||
164232883|NCT05484895|593223269|FG001|Overall Study|Lost to Follow-up|64|||
164232884|NCT04795531|593223271|FG000|Overall Study|Withdrawal by Subject|4|||
164232885|NCT04795531|593223272|FG001|Overall Study|Withdrawal by Subject|4|||
164232886|NCT04795531|593223271|FG000|Overall Study|Lost to Follow-up|0|||
164333150|NCT02413372|593597345|FG001|Follow-up|Subject Withdrew Consent|0|||
164333151|NCT02413372|593597346|FG002|Follow-up|Subject Withdrew Consent|1|||
164333152|NCT02413372|593597344|FG000|Follow-up|Subject unable to return for visit|0|||
164333153|NCT02413372|593597345|FG001|Follow-up|Subject unable to return for visit|0|||
164333154|NCT02413372|593597346|FG002|Follow-up|Subject unable to return for visit|1|||
164333155|NCT03053271|593597356|FG000|Overall Study|Did not meet randomization criteria|3|||
164333156|NCT03053271|593597356|FG000|Overall Study|Withdrawal by Subject|1|||
164333157|NCT00580970|593597357|FG000|Pre-treatment|Non-compliance|1|||
164333158|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Non-compliance|6|||
164333159|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
164333160|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Physician Decision|4|||
164333161|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
164333162|NCT00580970|593597357|FG000|Treatment (Lovastatin)|Death|1|||
164333163|NCT03161093|593597360|FG000|Overall Study|Protocol Violation|11|||
164333164|NCT03161093|593597361|FG001|Overall Study|Protocol Violation|14|||
164333165|NCT03161093|593597362|FG002|Overall Study|Protocol Violation|6|||
164333166|NCT03161093|593597363|FG003|Overall Study|Protocol Violation|13|||
164333167|NCT03161093|593597364|FG004|Overall Study|Protocol Violation|1|||
164333168|NCT03161093|593597365|FG005|Overall Study|Protocol Violation|0|||
164333169|NCT03161093|593597360|FG000|Overall Study|Adverse Event|5|||
164232887|NCT04795531|593223272|FG001|Overall Study|Lost to Follow-up|1|||
164232888|NCT04795531|593223271|FG000|Overall Study|Physician Decision|0|||
164232889|NCT04795531|593223272|FG001|Overall Study|Physician Decision|2|||
164232890|NCT04795531|593223271|FG000|Overall Study|Death|2|||
164232891|NCT04795531|593223272|FG001|Overall Study|Death|1|||
164232892|NCT01323192|593223273|FG000|Overall Study|Adverse Event|6|||
164232893|NCT01323192|593223274|FG001|Overall Study|Adverse Event|1|||
164232894|NCT01323192|593223273|FG000|Overall Study|Withdrawal by Subject|3|||
164232895|NCT01323192|593223274|FG001|Overall Study|Withdrawal by Subject|1|||
164232896|NCT01323192|593223273|FG000|Overall Study|Noncompliance with study medication|0|||
164232897|NCT01323192|593223274|FG001|Overall Study|Noncompliance with study medication|3|||
164232898|NCT01323192|593223273|FG000|Overall Study|Nonmedical reasons|0|||
164232899|NCT01323192|593223274|FG001|Overall Study|Nonmedical reasons|1|||
164232900|NCT00633126|593223275|FG000|Overall Study|Did not receive full dose|1|||
164232901|NCT01276704|593223278|FG000|Overall Study|Lost to Follow-up|2|||
164232902|NCT01276704|593223279|FG001|Overall Study|Lost to Follow-up|3|||
164232903|NCT01276704|593223278|FG000|Overall Study|Non-compliant|2|||
164232904|NCT01276704|593223279|FG001|Overall Study|Non-compliant|2|||
164232905|NCT01276704|593223278|FG000|Overall Study|Withdrawal by Subject|7|||
164232906|NCT01276704|593223279|FG001|Overall Study|Withdrawal by Subject|1|||
164232907|NCT01276704|593223278|FG000|Overall Study|Physician Decision|3|||
164232908|NCT01276704|593223279|FG001|Overall Study|Physician Decision|5|||
164232909|NCT01168596|593223280|FG000|Overall Study|Withdrawal by Subject|3|||
164232910|NCT01168596|593223281|FG001|Overall Study|Withdrawal by Subject|1|||
164232911|NCT00710593|593223282|FG000|Overall Study|Incarceration|1|||
164232912|NCT00710593|593223283|FG001|Overall Study|Incarceration|0|||
164232913|NCT00710593|593223282|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
164232914|NCT00710593|593223283|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
164232915|NCT00710593|593223282|FG000|Overall Study|Lost to Follow-up|3|||
164232916|NCT00710593|593223283|FG001|Overall Study|Lost to Follow-up|1|||
164232917|NCT00710593|593223282|FG000|Overall Study|Moved out of area|1|||
164232918|NCT00710593|593223283|FG001|Overall Study|Moved out of area|0|||
164232919|NCT00710593|593223282|FG000|Overall Study|Failure to adhere or complete study eval|1|||
164232920|NCT00710593|593223283|FG001|Overall Study|Failure to adhere or complete study eval|1|||
164232921|NCT00710593|593223282|FG000|Overall Study|Protocol Violation|1|||
164232922|NCT00710593|593223283|FG001|Overall Study|Protocol Violation|1|||
164232923|NCT00710593|593223282|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
164333170|NCT03161093|593597361|FG001|Overall Study|Adverse Event|21|||
164232924|NCT00710593|593223283|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
164232925|NCT01441960|593223284|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
164333171|NCT03161093|593597362|FG002|Overall Study|Adverse Event|16|||
164232926|NCT01441960|593223285|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
164232927|NCT01441960|593223284|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
164232928|NCT01441960|593223285|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
164232929|NCT01441960|593223284|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
164232930|NCT01441960|593223285|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
164232931|NCT03243084|593223294|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
164232932|NCT03243084|593223295|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
163987459|NCT02574637|592322345|FG000|Double-blind Period|Adverse Event|1|||
163987460|NCT02574637|592322346|FG001|Double-blind Period|Adverse Event|0|||
163987461|NCT02574637|592322347|FG002|Double-blind Period|Adverse Event|0|||
163987462|NCT02574637|592322348|FG003|Double-blind Period|Adverse Event|0|||
163987463|NCT02574637|592322349|FG004|Double-blind Period|Adverse Event|0|||
164232933|NCT01500317|593223303|FG000|Overall Study|Withdrawal by Subject|3|||
164232934|NCT01500317|593223304|FG001|Overall Study|Withdrawal by Subject|2|||
164232935|NCT01500317|593223305|FG002|Overall Study|Withdrawal by Subject|0|||
164232936|NCT00335829|593223306|FG000|Overall Study|Withdrawal by Subject|1|||
164232937|NCT00335829|593223306|FG000|Overall Study|Lost to Follow-up|1|||
164232938|NCT00335829|593223306|FG000|Overall Study|Adverse Event|1|||
164232939|NCT02090764|593223307|FG000|Overall Study|Adverse Event|1|||
164232940|NCT02090764|593223308|FG001|Overall Study|Adverse Event|3|||
164232941|NCT02090764|593223307|FG000|Overall Study|Lack of Efficacy|0|||
164232942|NCT02090764|593223308|FG001|Overall Study|Lack of Efficacy|13|||
164232943|NCT02090764|593223307|FG000|Overall Study|Withdrawal by Subject|2|||
164232944|NCT02090764|593223308|FG001|Overall Study|Withdrawal by Subject|1|||
164232945|NCT02090764|593223307|FG000|Overall Study|Intercurrent illness and other|1|||
164232946|NCT02090764|593223308|FG001|Overall Study|Intercurrent illness and other|1|||
164232947|NCT02090764|593223307|FG000|Overall Study|Lost to Follow-up|2|||
164232948|NCT02090764|593223308|FG001|Overall Study|Lost to Follow-up|2|||
164232949|NCT00744861|593223309|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
164232950|NCT00744861|593223310|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
164232951|NCT00744861|593223311|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
164232952|NCT00744861|593223312|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
164232953|NCT00744861|593223309|FG000|Feasibility Stage 1|Pregnancy|0|||
164232954|NCT00744861|593223310|FG001|Feasibility Stage 1|Pregnancy|1|||
164232955|NCT00744861|593223311|FG002|Feasibility Stage 1|Pregnancy|0|||
164232956|NCT00744861|593223312|FG003|Feasibility Stage 1|Pregnancy|0|||
164232957|NCT00744861|593223309|FG000|Pivotal Stage 2|Adverse Event|0|||
164232958|NCT00744861|593223310|FG001|Pivotal Stage 2|Adverse Event|0|||
164232959|NCT00744861|593223311|FG002|Pivotal Stage 2|Adverse Event|6|||
164232960|NCT00744861|593223312|FG003|Pivotal Stage 2|Adverse Event|11|||
164232961|NCT00744861|593223309|FG000|Pivotal Stage 2|Death|0|||
164232962|NCT00744861|593223310|FG001|Pivotal Stage 2|Death|0|||
164232963|NCT00744861|593223311|FG002|Pivotal Stage 2|Death|0|||
164232964|NCT00744861|593223312|FG003|Pivotal Stage 2|Death|1|||
164232965|NCT00744861|593223309|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
164232966|NCT00744861|593223310|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
164232967|NCT00744861|593223311|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
164232968|NCT00744861|593223312|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
164232969|NCT00744861|593223309|FG000|Pivotal Stage 2|Physician Decision|0|||
164232970|NCT00744861|593223310|FG001|Pivotal Stage 2|Physician Decision|0|||
164232971|NCT00744861|593223311|FG002|Pivotal Stage 2|Physician Decision|3|||
164232972|NCT00744861|593223312|FG003|Pivotal Stage 2|Physician Decision|1|||
164232973|NCT00744861|593223309|FG000|Pivotal Stage 2|Protocol Violation|0|||
164232974|NCT00744861|593223310|FG001|Pivotal Stage 2|Protocol Violation|0|||
164232975|NCT00744861|593223311|FG002|Pivotal Stage 2|Protocol Violation|0|||
164232976|NCT00744861|593223312|FG003|Pivotal Stage 2|Protocol Violation|1|||
164232977|NCT00744861|593223309|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
164232978|NCT00744861|593223310|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
164232979|NCT00744861|593223311|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
164232980|NCT00744861|593223312|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
164232981|NCT00744861|593223309|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
164232982|NCT00744861|593223310|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
164232983|NCT00744861|593223311|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
164232984|NCT00744861|593223312|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
164232985|NCT04856527|593223313|FG000|Overall Study|Unable to complete experimental task|2|||
164232986|NCT04856527|593223314|FG001|Overall Study|Unable to complete experimental task|0|||
164232987|NCT04562116|593223317|FG000|Overall Study|Lost to Follow-up|1|||
164232988|NCT04562116|593223317|FG000|Overall Study|Withdrawal by Subject|3|||
164232989|NCT02038647|593223319|FG000|Overall Study|Progressive Disease|50|||
164232990|NCT02038647|593223320|FG001|Overall Study|Progressive Disease|59|||
163987464|NCT02574637|592322350|FG005|Double-blind Period|Adverse Event|0|||
163987465|NCT02574637|592322351|FG006|Double-blind Period|Adverse Event|0|||
163987466|NCT02574637|592322352|FG007|Double-blind Period|Adverse Event|0|||
163987467|NCT02574637|592322353|FG008|Double-blind Period|Adverse Event|0|||
164232991|NCT02038647|593223319|FG000|Overall Study|Adverse Event|18|||
164232992|NCT02038647|593223320|FG001|Overall Study|Adverse Event|10|||
164232993|NCT02038647|593223319|FG000|Overall Study|Symptomatic Deterioration|7|||
164232994|NCT02038647|593223320|FG001|Overall Study|Symptomatic Deterioration|7|||
164232995|NCT02038647|593223319|FG000|Overall Study|Withdrawal by Subject|5|||
164232996|NCT02038647|593223320|FG001|Overall Study|Withdrawal by Subject|2|||
164232997|NCT02038647|593223319|FG000|Overall Study|Not Reported|0|||
164232998|NCT02038647|593223320|FG001|Overall Study|Not Reported|1|||
164232999|NCT02038647|593223319|FG000|Overall Study|Ongoing at Datacut|9|||
163987468|NCT02574637|592322354|FG009|Double-blind Period|Adverse Event|0|||
163987469|NCT02574637|592322345|FG000|Double-blind Period|Lack of Efficacy|0|||
164233000|NCT02038647|593223320|FG001|Overall Study|Ongoing at Datacut|10|||
164233001|NCT02757430|593223321|FG000|Overall Study|Physician Decision|6|||
164233002|NCT02757430|593223321|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
164233003|NCT02757430|593223321|FG000|Overall Study|No informed consent|1|||
164233004|NCT02757430|593223321|FG000|Overall Study|No procedure performed|2|||
164233005|NCT03078868|593223324|FG000|Overall Study|Physician Decision|3|||
164233006|NCT01983111|593223325|FG000|Overall Study|Withdrawal by Subject|8|||
164233007|NCT01983111|593223326|FG001|Overall Study|Withdrawal by Subject|6|||
164233008|NCT01983111|593223325|FG000|Overall Study|Adverse Event|4|||
164233009|NCT01983111|593223326|FG001|Overall Study|Adverse Event|0|||
164233010|NCT01983111|593223325|FG000|Overall Study|Protocol Violation|0|||
164233011|NCT01983111|593223326|FG001|Overall Study|Protocol Violation|1|||
164233012|NCT03502200|593223327|FG000|Overall Study|Adverse Event|1|||
164233013|NCT03502200|593223328|FG001|Overall Study|Adverse Event|0|||
164233014|NCT03502200|593223327|FG000|Overall Study|Lost to Follow-up|36|||
164233015|NCT03502200|593223328|FG001|Overall Study|Lost to Follow-up|38|||
164233016|NCT03502200|593223327|FG000|Overall Study|Study Team Decision|1|||
164233017|NCT03502200|593223328|FG001|Overall Study|Study Team Decision|1|||
164233018|NCT03502200|593223327|FG000|Overall Study|Withdrawal by Subject|5|||
164233019|NCT03502200|593223328|FG001|Overall Study|Withdrawal by Subject|7|||
164233020|NCT03502200|593223327|FG000|Overall Study|Death|0|||
164233021|NCT03502200|593223328|FG001|Overall Study|Death|2|||
164233022|NCT00855335|593223329|FG000|Overall Study|Lost to Follow-up|0|||
164233023|NCT00855335|593223330|FG001|Overall Study|Lost to Follow-up|0|||
164233024|NCT00855335|593223331|FG002|Overall Study|Lost to Follow-up|3|||
164233025|NCT00855335|593223332|FG003|Overall Study|Lost to Follow-up|1|||
164233026|NCT00855335|593223333|FG004|Overall Study|Lost to Follow-up|0|||
164233027|NCT00855335|593223329|FG000|Overall Study|Withdrawal by Subject|0|||
164233028|NCT00855335|593223330|FG001|Overall Study|Withdrawal by Subject|0|||
164233029|NCT00855335|593223331|FG002|Overall Study|Withdrawal by Subject|0|||
164233030|NCT00855335|593223332|FG003|Overall Study|Withdrawal by Subject|1|||
164233031|NCT00855335|593223333|FG004|Overall Study|Withdrawal by Subject|0|||
164233032|NCT00855335|593223329|FG000|Overall Study|Adverse Event|2|||
164233033|NCT00855335|593223330|FG001|Overall Study|Adverse Event|0|||
164233034|NCT00855335|593223331|FG002|Overall Study|Adverse Event|0|||
164233035|NCT00855335|593223332|FG003|Overall Study|Adverse Event|0|||
164233036|NCT00855335|593223333|FG004|Overall Study|Adverse Event|0|||
164233037|NCT00855335|593223329|FG000|Overall Study|Physician Decision|1|||
164233038|NCT00855335|593223330|FG001|Overall Study|Physician Decision|1|||
164233039|NCT00855335|593223331|FG002|Overall Study|Physician Decision|0|||
164233040|NCT00855335|593223332|FG003|Overall Study|Physician Decision|0|||
164233041|NCT00855335|593223333|FG004|Overall Study|Physician Decision|0|||
164233042|NCT00855335|593223329|FG000|Overall Study|Other|2|||
164233043|NCT00855335|593223330|FG001|Overall Study|Other|1|||
164233044|NCT00855335|593223331|FG002|Overall Study|Other|2|||
164233045|NCT00855335|593223332|FG003|Overall Study|Other|5|||
164233046|NCT00855335|593223333|FG004|Overall Study|Other|1|||
164233047|NCT03097289|593223335|FG000|Overall Study|Adverse Event|1|||
164233048|NCT03097289|593223335|FG000|Overall Study|Equipment failure|2|||
164233049|NCT03097289|593223335|FG000|Overall Study|Collected platelet product unusable|3|||
164233050|NCT02526290|593223338|FG000|Overall Study|Adverse Event|3|||
164233051|NCT02526290|593223338|FG000|Overall Study|Withdrawal by Subject|4|||
164233052|NCT02526290|593223338|FG000|Overall Study|Physician Decision|1|||
164233053|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
164233054|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
164233055|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
164233056|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
164233057|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
164233058|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
164233059|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
164233060|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
164233061|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
164233062|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
164233063|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233064|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233065|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233066|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233067|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233068|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233069|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233070|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
164233071|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233072|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
164233073|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233074|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233075|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233076|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233077|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233078|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
164233079|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233080|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233081|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233082|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
164233083|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233084|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233085|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233086|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233087|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
164233088|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
164233089|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
164233090|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
164233091|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
164233092|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
164233093|NCT02082977|593223339|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233094|NCT02082977|593223340|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233095|NCT02082977|593223341|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233096|NCT02082977|593223342|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233097|NCT02082977|593223343|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233098|NCT02082977|593223344|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233099|NCT02082977|593223345|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233100|NCT02082977|593223346|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
164233101|NCT02082977|593223347|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233102|NCT02082977|593223348|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
164233103|NCT00049543|593223349|FG000|Overall Study|still on treatment|2|||
164233104|NCT00049543|593223350|FG001|Overall Study|still on treatment|9|||
164233105|NCT01506726|593223370|FG000|Overall Study|Adverse Event|1|||
164233106|NCT01506726|593223371|FG001|Overall Study|Adverse Event|2|||
164233107|NCT04079738|593223372|FG000|Study Treatment|Death|1|||
164233108|NCT04079738|593223373|FG001|Study Treatment|Death|0|||
164233109|NCT04079738|593223374|FG002|Study Treatment|Death|0|||
164233110|NCT04079738|593223375|FG003|Study Treatment|Death|0|||
164233111|NCT04079738|593223372|FG000|Study Treatment|Adverse Event|2|||
164233112|NCT04079738|593223373|FG001|Study Treatment|Adverse Event|0|||
164233113|NCT04079738|593223374|FG002|Study Treatment|Adverse Event|0|||
164233114|NCT04079738|593223375|FG003|Study Treatment|Adverse Event|0|||
164233115|NCT04079738|593223372|FG000|Study Treatment|withdrawal before treatment|1|||
164233116|NCT04079738|593223373|FG001|Study Treatment|withdrawal before treatment|0|||
164233117|NCT04079738|593223374|FG002|Study Treatment|withdrawal before treatment|0|||
164233118|NCT04079738|593223375|FG003|Study Treatment|withdrawal before treatment|0|||
164233119|NCT04079738|593223372|FG000|Study Treatment|symptomatic deterioration|2|||
164233120|NCT04079738|593223373|FG001|Study Treatment|symptomatic deterioration|0|||
164233121|NCT04079738|593223374|FG002|Study Treatment|symptomatic deterioration|0|||
164233122|NCT04079738|593223375|FG003|Study Treatment|symptomatic deterioration|0|||
164233123|NCT04079738|593223372|FG000|Study Treatment|Disease Progression|1|||
164233124|NCT04079738|593223373|FG001|Study Treatment|Disease Progression|0|||
164233125|NCT04079738|593223374|FG002|Study Treatment|Disease Progression|0|||
164233126|NCT04079738|593223375|FG003|Study Treatment|Disease Progression|0|||
164233127|NCT04079738|593223372|FG000|Study Treatment|withdrawal after treatment|1|||
164233128|NCT04079738|593223373|FG001|Study Treatment|withdrawal after treatment|0|||
164233129|NCT04079738|593223374|FG002|Study Treatment|withdrawal after treatment|0|||
164233130|NCT04079738|593223375|FG003|Study Treatment|withdrawal after treatment|0|||
164233131|NCT04079738|593223372|FG000|Follow up|Withdrawal by Subject|3|||
164233132|NCT04079738|593223373|FG001|Follow up|Withdrawal by Subject|0|||
164233133|NCT04079738|593223374|FG002|Follow up|Withdrawal by Subject|0|||
164233134|NCT04079738|593223375|FG003|Follow up|Withdrawal by Subject|0|||
164233135|NCT04079738|593223372|FG000|Follow up|Death|5|||
164233136|NCT04079738|593223373|FG001|Follow up|Death|0|||
164233137|NCT04079738|593223374|FG002|Follow up|Death|0|||
164233138|NCT04079738|593223375|FG003|Follow up|Death|0|||
164233139|NCT01380080|593223378|FG000|Overall Study|Death|36|||
164233140|NCT01380080|593223379|FG001|Overall Study|Death|44|||
164233141|NCT01380080|593223378|FG000|Overall Study|Site is closing|28|||
164233142|NCT01380080|593223379|FG001|Overall Study|Site is closing|31|||
164233143|NCT01380080|593223378|FG000|Overall Study|Not able to get to clinic|7|||
164233144|NCT01380080|593223379|FG001|Overall Study|Not able to get to clinic|1|||
164233145|NCT01380080|593223378|FG000|Overall Study|Not willing to adhere to requirements|6|||
164233146|NCT01380080|593223379|FG001|Overall Study|Not willing to adhere to requirements|2|||
164233147|NCT01380080|593223378|FG000|Overall Study|Withdrawal by Subject|5|||
164233148|NCT01380080|593223379|FG001|Overall Study|Withdrawal by Subject|2|||
164233149|NCT01380080|593223378|FG000|Overall Study|Lost to Follow-up|3|||
164233150|NCT01380080|593223379|FG001|Overall Study|Lost to Follow-up|3|||
164233151|NCT02303821|593223382|FG000|Overall Study|Withdrawal by Subject|0|||
164233152|NCT02303821|593223383|FG001|Overall Study|Withdrawal by Subject|0|||
164233153|NCT02303821|593223384|FG002|Overall Study|Withdrawal by Subject|0|||
164233154|NCT02303821|593223385|FG003|Overall Study|Withdrawal by Subject|0|||
164233155|NCT02303821|593223386|FG004|Overall Study|Withdrawal by Subject|0|||
164233156|NCT02303821|593223387|FG005|Overall Study|Withdrawal by Subject|0|||
164233157|NCT02303821|593223388|FG006|Overall Study|Withdrawal by Subject|0|||
164233158|NCT02303821|593223389|FG007|Overall Study|Withdrawal by Subject|2|||
164233159|NCT02303821|593223382|FG000|Overall Study|Death|0|||
164233160|NCT02303821|593223383|FG001|Overall Study|Death|2|||
164233161|NCT02303821|593223384|FG002|Overall Study|Death|0|||
164233162|NCT02303821|593223385|FG003|Overall Study|Death|0|||
164233163|NCT02303821|593223386|FG004|Overall Study|Death|0|||
164233164|NCT02303821|593223387|FG005|Overall Study|Death|3|||
164233165|NCT02303821|593223388|FG006|Overall Study|Death|41|||
164233166|NCT02303821|593223389|FG007|Overall Study|Death|29|||
164233167|NCT02303821|593223382|FG000|Overall Study|Lost to Follow-up|0|||
164233168|NCT02303821|593223383|FG001|Overall Study|Lost to Follow-up|0|||
164233169|NCT02303821|593223384|FG002|Overall Study|Lost to Follow-up|0|||
164233170|NCT02303821|593223385|FG003|Overall Study|Lost to Follow-up|0|||
164233171|NCT02303821|593223386|FG004|Overall Study|Lost to Follow-up|0|||
164233172|NCT02303821|593223387|FG005|Overall Study|Lost to Follow-up|0|||
164233173|NCT02303821|593223388|FG006|Overall Study|Lost to Follow-up|1|||
164233174|NCT02303821|593223389|FG007|Overall Study|Lost to Follow-up|0|||
164233175|NCT02303821|593223382|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233176|NCT02303821|593223383|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233177|NCT02303821|593223384|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233178|NCT02303821|593223385|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233179|NCT02303821|593223386|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233180|NCT02303821|593223387|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233181|NCT02303821|593223388|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
164233182|NCT02303821|593223389|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
164233183|NCT02303821|593223382|FG000|Overall Study|Decision by sponsor|0|||
164233184|NCT02303821|593223383|FG001|Overall Study|Decision by sponsor|0|||
164233185|NCT02303821|593223384|FG002|Overall Study|Decision by sponsor|0|||
164233186|NCT02303821|593223385|FG003|Overall Study|Decision by sponsor|0|||
164233187|NCT02303821|593223386|FG004|Overall Study|Decision by sponsor|0|||
164233188|NCT02303821|593223387|FG005|Overall Study|Decision by sponsor|1|||
164233189|NCT02303821|593223388|FG006|Overall Study|Decision by sponsor|0|||
164233190|NCT02303821|593223389|FG007|Overall Study|Decision by sponsor|0|||
164233191|NCT02303821|593223382|FG000|Overall Study|Protocol-specified criteria|0|||
164233192|NCT02303821|593223383|FG001|Overall Study|Protocol-specified criteria|1|||
164233193|NCT02303821|593223384|FG002|Overall Study|Protocol-specified criteria|0|||
164233194|NCT02303821|593223385|FG003|Overall Study|Protocol-specified criteria|0|||
164233195|NCT02303821|593223386|FG004|Overall Study|Protocol-specified criteria|0|||
164233196|NCT02303821|593223387|FG005|Overall Study|Protocol-specified criteria|1|||
164233197|NCT02303821|593223388|FG006|Overall Study|Protocol-specified criteria|0|||
164233198|NCT02303821|593223389|FG007|Overall Study|Protocol-specified criteria|0|||
164233199|NCT00210132|593223390|FG000|Overall Study|Protocol Violation|1|||
164233200|NCT00210132|593223391|FG001|Overall Study|Protocol Violation|4|||
164233201|NCT02711202|593223394|FG000|Overall Study|Adverse Event|3|||
164233202|NCT02711202|593223395|FG001|Overall Study|Adverse Event|0|||
164233203|NCT02711202|593223394|FG000|Overall Study|graft loss|1|||
164233204|NCT02711202|593223395|FG001|Overall Study|graft loss|0|||
164233205|NCT02402647|593223396|FG000|Overall Study|Lost to Follow-up|13|||
164233206|NCT02402647|593223397|FG001|Overall Study|Lost to Follow-up|7|||
164233207|NCT02402647|593223396|FG000|Overall Study|Protocol Violation|1|||
164233208|NCT02402647|593223397|FG001|Overall Study|Protocol Violation|1|||
164333172|NCT03161093|593597363|FG003|Overall Study|Adverse Event|35|||
164333173|NCT03161093|593597364|FG004|Overall Study|Adverse Event|2|||
164333174|NCT03161093|593597365|FG005|Overall Study|Adverse Event|1|||
164333175|NCT03161093|593597360|FG000|Overall Study|Lack of Efficacy|9|||
164333176|NCT03161093|593597361|FG001|Overall Study|Lack of Efficacy|13|||
164233209|NCT02402647|593223396|FG000|Overall Study|scheduled and timed out|2|||
164233210|NCT02402647|593223397|FG001|Overall Study|scheduled and timed out|1|||
164233211|NCT02402647|593223396|FG000|Overall Study|medical illness|2|||
164333177|NCT03161093|593597362|FG002|Overall Study|Lack of Efficacy|9|||
164333178|NCT03161093|593597363|FG003|Overall Study|Lack of Efficacy|24|||
164233212|NCT02402647|593223397|FG001|Overall Study|medical illness|4|||
164233213|NCT02402647|593223396|FG000|Overall Study|Moved|2|||
164233214|NCT02402647|593223397|FG001|Overall Study|Moved|0|||
164233215|NCT02402647|593223396|FG000|Overall Study|loved one illness|1|||
164233216|NCT02402647|593223397|FG001|Overall Study|loved one illness|0|||
164233217|NCT02402647|593223396|FG000|Overall Study|deceased preexisting condition|2|||
164233218|NCT02402647|593223397|FG001|Overall Study|deceased preexisting condition|0|||
164233219|NCT02402647|593223396|FG000|Overall Study|Other|2|||
164233220|NCT02402647|593223397|FG001|Overall Study|Other|1|||
164233221|NCT00618787|593223412|FG000|Overall Study|Adverse Event|0|||
164233222|NCT00618787|593223413|FG001|Overall Study|Adverse Event|1|||
164233223|NCT00618787|593223412|FG000|Overall Study|Withdrawal by Subject|2|||
164233224|NCT00618787|593223413|FG001|Overall Study|Withdrawal by Subject|1|||
164233225|NCT00618787|593223412|FG000|Overall Study|Lost to Follow-up|1|||
164233226|NCT00618787|593223413|FG001|Overall Study|Lost to Follow-up|0|||
164233227|NCT01994876|593223414|FG000|Test Period 1|Withdrawal by Subject|0|||
164233228|NCT01994876|593223415|FG001|Test Period 1|Withdrawal by Subject|1|||
164233229|NCT01994876|593223414|FG000|Test Period 1|Adverse Event|0|||
164233230|NCT01994876|593223415|FG001|Test Period 1|Adverse Event|1|||
164233231|NCT01994876|593223414|FG000|Test Period 2|Adverse Event|1|||
164233232|NCT01994876|593223415|FG001|Test Period 2|Adverse Event|0|||
164233233|NCT01994876|593223414|FG000|Test Period 2|Protocol Violation|0|||
164233234|NCT01994876|593223415|FG001|Test Period 2|Protocol Violation|1|||
164233235|NCT06022107|593223416|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
163883779|NCT03056040|591943945|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
163883780|NCT03056040|591943944|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
163883781|NCT03056040|591943945|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
163883782|NCT03056040|591943944|FG000|Primary Evaluation Period|Pregnancy|0|||
163883783|NCT03056040|591943945|FG001|Primary Evaluation Period|Pregnancy|1|||
163883784|NCT03056040|591943944|FG000|Primary Evaluation Period|Randomized, not treated|1|||
163883785|NCT03056040|591943945|FG001|Primary Evaluation Period|Randomized, not treated|1|||
163883786|NCT03056040|591943944|FG000|Extension Period|Physician Decision|3|||
163883787|NCT03056040|591943945|FG001|Extension Period|Physician Decision|3|||
163883788|NCT03056040|591943944|FG000|Extension Period|Lost to Follow-up|0|||
163883789|NCT03056040|591943945|FG001|Extension Period|Lost to Follow-up|1|||
163883790|NCT03056040|591943944|FG000|Extension Period|Death|0|||
163883791|NCT03056040|591943945|FG001|Extension Period|Death|3|||
163883792|NCT03056040|591943944|FG000|Extension Period|Withdrawal by Subject|1|||
163883793|NCT03056040|591943945|FG001|Extension Period|Withdrawal by Subject|0|||
163883794|NCT04142788|591943949|FG000|Overall Study|Trial terminated prematurely|2|||
163883795|NCT04142788|591943950|FG001|Overall Study|Trial terminated prematurely|2|||
163883796|NCT02035787|591943951|FG000|Overall Study- 12 Months|Adverse Event|3|||
163883797|NCT02035787|591943952|FG001|Overall Study- 12 Months|Adverse Event|0|||
163883798|NCT02035787|591943951|FG000|Overall Study- 12 Months|Complete response|4|||
163883799|NCT02035787|591943952|FG001|Overall Study- 12 Months|Complete response|1|||
163883800|NCT02035787|591943951|FG000|Overall Study- 12 Months|Protocol Violation|1|||
163883801|NCT02035787|591943952|FG001|Overall Study- 12 Months|Protocol Violation|1|||
163883802|NCT05028634|591943955|FG000|Overall Study|Withdrawal by Subject|0|||
163883803|NCT05028634|591943956|FG001|Overall Study|Withdrawal by Subject|1|||
163883804|NCT03850678|591943957|FG000|Overall Study|Withdrawal by Subject|3|||
163883805|NCT03850678|591943958|FG001|Overall Study|Withdrawal by Subject|0|||
163883806|NCT03850678|591943957|FG000|Overall Study|Experimenter Error|1|||
163883807|NCT03850678|591943958|FG001|Overall Study|Experimenter Error|1|||
163883808|NCT03850678|591943957|FG000|Overall Study|Did Not Condition To Experiment|7|||
163883809|NCT03850678|591943958|FG001|Overall Study|Did Not Condition To Experiment|2|||
163883810|NCT02724631|591943972|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
163883811|NCT05076708|591943973|FG000|Overall Study|Withdrawal by Subject|4|||
163883812|NCT05076708|591943973|FG000|Overall Study|Lost to study during switch phase|8|||
163883813|NCT02908477|591943974|FG000|Overall Study|Withdrawal by Subject|8|||
163883814|NCT02908477|591943975|FG001|Overall Study|Withdrawal by Subject|28|||
163883815|NCT05590403|591943978|FG000|Overall Study|Lost to Follow-up|13|||
163883816|NCT05590403|591943979|FG001|Overall Study|Lost to Follow-up|1|||
163883817|NCT05590403|591943980|FG002|Overall Study|Lost to Follow-up|7|||
163883818|NCT05590403|591943981|FG003|Overall Study|Lost to Follow-up|3|||
163883819|NCT05590403|591943982|FG004|Overall Study|Lost to Follow-up|4|||
163883820|NCT05590403|591943978|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
163883821|NCT05590403|591943979|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
163883822|NCT05590403|591943980|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
163883823|NCT05590403|591943981|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
163883824|NCT05590403|591943982|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
163883825|NCT05590403|591943978|FG000|Overall Study|Other|2|||
163883826|NCT05590403|591943979|FG001|Overall Study|Other|0|||
163883827|NCT05590403|591943980|FG002|Overall Study|Other|2|||
163883828|NCT05590403|591943981|FG003|Overall Study|Other|2|||
163883829|NCT05590403|591943982|FG004|Overall Study|Other|0|||
163883830|NCT05590403|591943978|FG000|Overall Study|Migrated / moved from the study area|1|||
163883831|NCT05590403|591943979|FG001|Overall Study|Migrated / moved from the study area|1|||
163883832|NCT05590403|591943980|FG002|Overall Study|Migrated / moved from the study area|0|||
164233236|NCT06022107|593223416|FG000|Overall Study|Dropped out of study for higher level of care|1|||
164233237|NCT06022107|593223416|FG000|Overall Study|Lost to Follow-up|2|||
164233238|NCT05847686|593226011|FG000|Overall Study|Withdrawal by Subject|3|||
164233239|NCT03716830|593226012|FG000|Overall Study|Withdrawal by Subject|2|||
164299832|NCT02532517|593472943|FG000|Overall Study|Death|4|||
164233240|NCT03716830|593226013|FG001|Overall Study|Withdrawal by Subject|2|||
164233241|NCT03716830|593226014|FG002|Overall Study|Withdrawal by Subject|6|||
164233242|NCT03716830|593226015|FG003|Overall Study|Withdrawal by Subject|5|||
164233243|NCT03716830|593226012|FG000|Overall Study|Adverse Event|1|||
164233244|NCT03716830|593226013|FG001|Overall Study|Adverse Event|2|||
164233245|NCT03716830|593226014|FG002|Overall Study|Adverse Event|0|||
164233246|NCT03716830|593226015|FG003|Overall Study|Adverse Event|1|||
164233247|NCT03716830|593226012|FG000|Overall Study|Lost to Follow-up|1|||
164233248|NCT03716830|593226013|FG001|Overall Study|Lost to Follow-up|1|||
164333179|NCT03161093|593597364|FG004|Overall Study|Lack of Efficacy|4|||
164333180|NCT03161093|593597365|FG005|Overall Study|Lack of Efficacy|1|||
164333181|NCT03161093|593597360|FG000|Overall Study|Physician Decision|0|||
164333182|NCT03161093|593597361|FG001|Overall Study|Physician Decision|1|||
164333183|NCT03161093|593597362|FG002|Overall Study|Physician Decision|0|||
164333184|NCT03161093|593597363|FG003|Overall Study|Physician Decision|2|||
164333185|NCT03161093|593597364|FG004|Overall Study|Physician Decision|17|||
164333186|NCT03161093|593597365|FG005|Overall Study|Physician Decision|15|||
164333187|NCT03161093|593597360|FG000|Overall Study|Withdrawal by Subject|24|||
164233249|NCT03716830|593226014|FG002|Overall Study|Lost to Follow-up|0|||
164333188|NCT03161093|593597361|FG001|Overall Study|Withdrawal by Subject|73|||
164333189|NCT03161093|593597362|FG002|Overall Study|Withdrawal by Subject|44|||
164233250|NCT03716830|593226015|FG003|Overall Study|Lost to Follow-up|0|||
164233251|NCT04887831|593226016|FG000|Overall Study|Death|26|||
164233252|NCT04887831|593226017|FG001|Overall Study|Death|26|||
164233253|NCT04887831|593226016|FG000|Overall Study|Lost to Follow-up|0|||
164233254|NCT04887831|593226017|FG001|Overall Study|Lost to Follow-up|1|||
164233255|NCT04887831|593226016|FG000|Overall Study|Withdrawal by Subject|2|||
164233256|NCT04887831|593226017|FG001|Overall Study|Withdrawal by Subject|1|||
164233257|NCT04887831|593226016|FG000|Overall Study|Study Terminated by Sponsor|18|||
164233258|NCT04887831|593226017|FG001|Overall Study|Study Terminated by Sponsor|17|||
164233259|NCT04887831|593226016|FG000|Overall Study|Other|1|||
164233260|NCT04887831|593226017|FG001|Overall Study|Other|0|||
164233261|NCT03698279|593226018|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164233262|NCT03698279|593226019|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164233263|NCT03698279|593226020|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164233264|NCT03698279|593226021|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164233265|NCT03698279|593226022|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164233266|NCT03698279|593226023|FG005|Overall Study|Withdrawal by parent/guardian|0|||
164233267|NCT03698279|593226018|FG000|Overall Study|Protocol deviation|1|||
164233268|NCT03698279|593226019|FG001|Overall Study|Protocol deviation|0|||
164233269|NCT03698279|593226020|FG002|Overall Study|Protocol deviation|1|||
164233270|NCT03698279|593226021|FG003|Overall Study|Protocol deviation|0|||
164233271|NCT03698279|593226022|FG004|Overall Study|Protocol deviation|0|||
164233272|NCT03698279|593226023|FG005|Overall Study|Protocol deviation|0|||
164233273|NCT03698279|593226018|FG000|Overall Study|Withdrawal by Subject|0|||
164233274|NCT03698279|593226019|FG001|Overall Study|Withdrawal by Subject|0|||
164233275|NCT03698279|593226020|FG002|Overall Study|Withdrawal by Subject|1|||
164233276|NCT03698279|593226021|FG003|Overall Study|Withdrawal by Subject|0|||
164233277|NCT03698279|593226022|FG004|Overall Study|Withdrawal by Subject|0|||
164233278|NCT03698279|593226023|FG005|Overall Study|Withdrawal by Subject|0|||
164233279|NCT03698279|593226018|FG000|Overall Study|Lost to Follow-up|3|||
164233280|NCT03698279|593226019|FG001|Overall Study|Lost to Follow-up|1|||
164233281|NCT03698279|593226020|FG002|Overall Study|Lost to Follow-up|4|||
164233282|NCT03698279|593226021|FG003|Overall Study|Lost to Follow-up|5|||
164233283|NCT03698279|593226022|FG004|Overall Study|Lost to Follow-up|0|||
164233284|NCT03698279|593226023|FG005|Overall Study|Lost to Follow-up|0|||
164233285|NCT02552225|593226024|FG000|Overall Study|Withdrawal by Subject|1|||
164233286|NCT02552225|593226025|FG001|Overall Study|Withdrawal by Subject|0|||
164233287|NCT03122184|593226029|FG000|Overall Study|Lost to Follow-up|4|||
164233288|NCT03122184|593226030|FG001|Overall Study|Lost to Follow-up|6|||
164233289|NCT03122184|593226029|FG000|Overall Study|Withdrawal by Subject|3|||
164233290|NCT03122184|593226030|FG001|Overall Study|Withdrawal by Subject|0|||
164233291|NCT03122184|593226029|FG000|Overall Study|Terminated due to cognitive problem|1|||
164233292|NCT03122184|593226030|FG001|Overall Study|Terminated due to cognitive problem|0|||
164233293|NCT02276040|593226033|FG000|Overall Study|Physician Decision|15|||
164233294|NCT00876447|593226034|FG000|Overall Study|Other miscellaneous reasons|3|||
164233295|NCT00876447|593226035|FG001|Overall Study|Other miscellaneous reasons|8|||
164233296|NCT00876447|593226034|FG000|Overall Study|Site closure|19|||
164233297|NCT00876447|593226035|FG001|Overall Study|Site closure|14|||
164233298|NCT00876447|593226034|FG000|Overall Study|Protocol Violation|9|||
164233299|NCT00876447|593226035|FG001|Overall Study|Protocol Violation|3|||
164233300|NCT00876447|593226034|FG000|Overall Study|Personal reasons|30|||
164233301|NCT00876447|593226035|FG001|Overall Study|Personal reasons|28|||
164233302|NCT00876447|593226034|FG000|Overall Study|Lost to Follow-up|6|||
164233303|NCT00876447|593226035|FG001|Overall Study|Lost to Follow-up|15|||
164233304|NCT00876447|593226034|FG000|Overall Study|Pregnancy|4|||
164233305|NCT00876447|593226035|FG001|Overall Study|Pregnancy|2|||
164233306|NCT00876447|593226034|FG000|Overall Study|Lack of Efficacy|5|||
164233307|NCT00876447|593226035|FG001|Overall Study|Lack of Efficacy|3|||
164233308|NCT00876447|593226034|FG000|Overall Study|Adverse Event|4|||
164233309|NCT00876447|593226035|FG001|Overall Study|Adverse Event|8|||
164233310|NCT00567502|593226036|FG000|Overall Study|Lost to Follow-up|91|||
164233311|NCT00567502|593226037|FG001|Overall Study|Lost to Follow-up|14|||
164233312|NCT00567502|593226038|FG002|Overall Study|Lost to Follow-up|351|||
164233313|NCT00567502|593226039|FG003|Overall Study|Lost to Follow-up|2|||
164233314|NCT00567502|593226036|FG000|Overall Study|Death|65|||
164333190|NCT03161093|593597363|FG003|Overall Study|Withdrawal by Subject|97|||
164333191|NCT03161093|593597364|FG004|Overall Study|Withdrawal by Subject|11|||
164333192|NCT03161093|593597365|FG005|Overall Study|Withdrawal by Subject|10|||
164333193|NCT03161093|593597360|FG000|Overall Study|Lost to Follow-up|3|||
164233315|NCT00567502|593226037|FG001|Overall Study|Death|16|||
164233316|NCT00567502|593226038|FG002|Overall Study|Death|360|||
164233317|NCT00567502|593226039|FG003|Overall Study|Death|5|||
164233318|NCT00567502|593226036|FG000|Overall Study|Other|64|||
164233319|NCT00567502|593226037|FG001|Overall Study|Other|2|||
164233320|NCT00567502|593226038|FG002|Overall Study|Other|134|||
164233321|NCT00567502|593226039|FG003|Overall Study|Other|6|||
164233322|NCT00567502|593226036|FG000|Overall Study|Participant request|12|||
164233323|NCT00567502|593226037|FG001|Overall Study|Participant request|1|||
164233324|NCT00567502|593226038|FG002|Overall Study|Participant request|33|||
164233325|NCT00567502|593226039|FG003|Overall Study|Participant request|1|||
164233326|NCT00567502|593226036|FG000|Overall Study|Sponsor request|9|||
164233327|NCT00567502|593226037|FG001|Overall Study|Sponsor request|0|||
164233328|NCT00567502|593226038|FG002|Overall Study|Sponsor request|30|||
164233329|NCT00567502|593226039|FG003|Overall Study|Sponsor request|1|||
164233330|NCT00567502|593226036|FG000|Overall Study|Never Initiated Treatment|0|||
164233331|NCT00567502|593226037|FG001|Overall Study|Never Initiated Treatment|0|||
164233332|NCT00567502|593226038|FG002|Overall Study|Never Initiated Treatment|0|||
164233333|NCT00567502|593226039|FG003|Overall Study|Never Initiated Treatment|72|||
164233334|NCT03728933|593226040|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164233335|NCT03728933|593226041|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164233336|NCT03728933|593226042|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164233337|NCT03728933|593226040|FG000|Overall Study|Withdrawal by Subject|0|||
164233338|NCT03728933|593226041|FG001|Overall Study|Withdrawal by Subject|0|||
164233339|NCT03728933|593226042|FG002|Overall Study|Withdrawal by Subject|1|||
164233340|NCT03728933|593226040|FG000|Overall Study|Lost to Follow-up|0|||
164233341|NCT03728933|593226041|FG001|Overall Study|Lost to Follow-up|1|||
164233342|NCT03728933|593226042|FG002|Overall Study|Lost to Follow-up|0|||
164233343|NCT03728933|593226040|FG000|Overall Study|Adverse Event|1|||
164233344|NCT03728933|593226041|FG001|Overall Study|Adverse Event|0|||
164233345|NCT03728933|593226042|FG002|Overall Study|Adverse Event|0|||
164233346|NCT02835690|593226043|FG000|Overall Study|Death|12|||
164233347|NCT02835690|593226044|FG001|Overall Study|Death|11|||
164233348|NCT02835690|593226045|FG002|Overall Study|Death|13|||
164233349|NCT02835690|593226043|FG000|Overall Study|Transferred to Extension Study|2|||
164233350|NCT02835690|593226044|FG001|Overall Study|Transferred to Extension Study|2|||
164233351|NCT02835690|593226045|FG002|Overall Study|Transferred to Extension Study|1|||
164233352|NCT02835690|593226043|FG000|Overall Study|Did Not Continue on Extension Study|0|||
164233353|NCT02835690|593226044|FG001|Overall Study|Did Not Continue on Extension Study|0|||
164233354|NCT02835690|593226045|FG002|Overall Study|Did Not Continue on Extension Study|1|||
164233355|NCT02835690|593226043|FG000|Overall Study|Not Treated|0|||
164233356|NCT02835690|593226044|FG001|Overall Study|Not Treated|2|||
164233357|NCT02835690|593226045|FG002|Overall Study|Not Treated|0|||
164233358|NCT02297516|593226046|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
164233359|NCT02297516|593226047|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
164233360|NCT02297516|593226046|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
164233361|NCT02297516|593226047|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
164233362|NCT02297516|593226046|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
164233363|NCT02297516|593226047|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
164233364|NCT03674281|593226048|FG000|Overall Study|screen failure|2|||
164233365|NCT03674281|593226049|FG001|Overall Study|screen failure|0|||
164233366|NCT03674281|593226050|FG002|Overall Study|screen failure|0|||
164233367|NCT03674281|593226048|FG000|Overall Study|Withdrawal by Subject|1|||
164233368|NCT03674281|593226049|FG001|Overall Study|Withdrawal by Subject|3|||
164233369|NCT03674281|593226050|FG002|Overall Study|Withdrawal by Subject|3|||
164233370|NCT00582907|593226053|FG000|1st Course|Withdrawal by Subject|1|||
164233371|NCT00582907|593226054|FG001|1st Course|Withdrawal by Subject|0|||
164233372|NCT00582907|593226055|FG002|1st Course|Withdrawal by Subject|0|||
164233373|NCT00582907|593226056|FG003|1st Course|Withdrawal by Subject|0|||
164233374|NCT00582907|593226053|FG000|1st Course|Lost to Follow-up|0|||
164233375|NCT00582907|593226054|FG001|1st Course|Lost to Follow-up|0|||
164233376|NCT00582907|593226055|FG002|1st Course|Lost to Follow-up|0|||
164233377|NCT00582907|593226056|FG003|1st Course|Lost to Follow-up|1|||
164233378|NCT00582907|593226053|FG000|2nd Course|Lack of Efficacy|1|||
164233379|NCT00582907|593226054|FG001|2nd Course|Lack of Efficacy|0|||
164233380|NCT00582907|593226055|FG002|2nd Course|Lack of Efficacy|0|||
164233381|NCT00582907|593226056|FG003|2nd Course|Lack of Efficacy|0|||
164333194|NCT03161093|593597361|FG001|Overall Study|Lost to Follow-up|12|||
164333195|NCT03161093|593597362|FG002|Overall Study|Lost to Follow-up|4|||
164333196|NCT03161093|593597363|FG003|Overall Study|Lost to Follow-up|7|||
164333197|NCT03161093|593597364|FG004|Overall Study|Lost to Follow-up|8|||
164333198|NCT03161093|593597365|FG005|Overall Study|Lost to Follow-up|13|||
164333199|NCT03161093|593597360|FG000|Overall Study|Death|3|||
164333200|NCT03161093|593597361|FG001|Overall Study|Death|9|||
164333201|NCT03161093|593597362|FG002|Overall Study|Death|7|||
164333202|NCT03161093|593597363|FG003|Overall Study|Death|9|||
164333203|NCT03161093|593597364|FG004|Overall Study|Death|0|||
164333204|NCT03161093|593597365|FG005|Overall Study|Death|0|||
164233382|NCT02538614|593226057|FG000|Overall Study|Progressive Disease|2|||
164233383|NCT00189423|593226064|FG000|Overall Study|Death|746|||
164233384|NCT00189423|593226065|FG001|Overall Study|Death|747|||
164233385|NCT00189423|593226064|FG000|Overall Study|Withdrawal by Subject|9|||
164233386|NCT00189423|593226065|FG001|Overall Study|Withdrawal by Subject|9|||
164233387|NCT00189423|593226064|FG000|Overall Study|Lost to Follow-up|10|||
164233388|NCT00189423|593226065|FG001|Overall Study|Lost to Follow-up|10|||
164233389|NCT04622592|593226066|FG000|Overall Study|Death|0|||
164233390|NCT04622592|593226067|FG001|Overall Study|Death|0|||
164233391|NCT04622592|593226068|FG002|Overall Study|Death|1|||
164233392|NCT04622592|593226069|FG003|Overall Study|Death|0|||
164233393|NCT04622592|593226070|FG004|Overall Study|Death|0|||
164233394|NCT04622592|593226071|FG005|Overall Study|Death|0|||
164233395|NCT04622592|593226072|FG006|Overall Study|Death|0|||
164233396|NCT04622592|593226073|FG007|Overall Study|Death|1|||
164233397|NCT04622592|593226066|FG000|Overall Study|Lost to Follow-up|0|||
164233398|NCT04622592|593226067|FG001|Overall Study|Lost to Follow-up|0|||
164233399|NCT04622592|593226068|FG002|Overall Study|Lost to Follow-up|0|||
164233400|NCT04622592|593226069|FG003|Overall Study|Lost to Follow-up|3|||
164233401|NCT04622592|593226070|FG004|Overall Study|Lost to Follow-up|1|||
164233402|NCT04622592|593226071|FG005|Overall Study|Lost to Follow-up|0|||
164233403|NCT04622592|593226072|FG006|Overall Study|Lost to Follow-up|2|||
164233404|NCT04622592|593226073|FG007|Overall Study|Lost to Follow-up|2|||
164233405|NCT04622592|593226066|FG000|Overall Study|Physician Decision|0|||
164233406|NCT04622592|593226067|FG001|Overall Study|Physician Decision|0|||
164233407|NCT04622592|593226068|FG002|Overall Study|Physician Decision|0|||
164233408|NCT04622592|593226069|FG003|Overall Study|Physician Decision|0|||
164233409|NCT04622592|593226070|FG004|Overall Study|Physician Decision|1|||
164233410|NCT04622592|593226071|FG005|Overall Study|Physician Decision|0|||
164233411|NCT04622592|593226072|FG006|Overall Study|Physician Decision|0|||
164233412|NCT04622592|593226073|FG007|Overall Study|Physician Decision|0|||
164233413|NCT04622592|593226066|FG000|Overall Study|Withdrawal by Subject|1|||
164233414|NCT04622592|593226067|FG001|Overall Study|Withdrawal by Subject|0|||
164233415|NCT04622592|593226068|FG002|Overall Study|Withdrawal by Subject|2|||
164233416|NCT04622592|593226069|FG003|Overall Study|Withdrawal by Subject|0|||
164233417|NCT04622592|593226070|FG004|Overall Study|Withdrawal by Subject|0|||
164233418|NCT04622592|593226071|FG005|Overall Study|Withdrawal by Subject|0|||
164233419|NCT04622592|593226072|FG006|Overall Study|Withdrawal by Subject|1|||
164233420|NCT04622592|593226073|FG007|Overall Study|Withdrawal by Subject|4|||
164233421|NCT04622592|593226066|FG000|Overall Study|Other than specified above|0|||
164233422|NCT04622592|593226067|FG001|Overall Study|Other than specified above|0|||
164233423|NCT04622592|593226068|FG002|Overall Study|Other than specified above|1|||
164233424|NCT04622592|593226069|FG003|Overall Study|Other than specified above|0|||
164233425|NCT04622592|593226070|FG004|Overall Study|Other than specified above|0|||
164233426|NCT04622592|593226071|FG005|Overall Study|Other than specified above|0|||
164233427|NCT04622592|593226072|FG006|Overall Study|Other than specified above|0|||
164233428|NCT04622592|593226073|FG007|Overall Study|Other than specified above|0|||
164233429|NCT00415636|593226074|FG000|Overall Study|Symptomatic deterioration|1|||
164233430|NCT00415636|593226075|FG001|Overall Study|Symptomatic deterioration|0|||
164233431|NCT00415636|593226076|FG002|Overall Study|Symptomatic deterioration|1|||
164233432|NCT00415636|593226077|FG003|Overall Study|Symptomatic deterioration|2|||
164233433|NCT00415636|593226078|FG004|Overall Study|Symptomatic deterioration|0|||
164233434|NCT00415636|593226079|FG005|Overall Study|Symptomatic deterioration|1|||
164233435|NCT00415636|593226074|FG000|Overall Study|Adverse Event|0|||
164233436|NCT00415636|593226075|FG001|Overall Study|Adverse Event|0|||
164233437|NCT00415636|593226076|FG002|Overall Study|Adverse Event|0|||
164233438|NCT00415636|593226077|FG003|Overall Study|Adverse Event|1|||
164233439|NCT00415636|593226078|FG004|Overall Study|Adverse Event|1|||
164233440|NCT00415636|593226079|FG005|Overall Study|Adverse Event|0|||
164233441|NCT00415636|593226074|FG000|Overall Study|Withdrawal by Subject|0|||
164233442|NCT00415636|593226075|FG001|Overall Study|Withdrawal by Subject|0|||
164233443|NCT00415636|593226076|FG002|Overall Study|Withdrawal by Subject|0|||
164233444|NCT00415636|593226077|FG003|Overall Study|Withdrawal by Subject|0|||
164233445|NCT00415636|593226078|FG004|Overall Study|Withdrawal by Subject|1|||
164233446|NCT00415636|593226079|FG005|Overall Study|Withdrawal by Subject|0|||
164233447|NCT00415636|593226074|FG000|Overall Study|Disease progression|0|||
164233448|NCT00415636|593226075|FG001|Overall Study|Disease progression|0|||
164233449|NCT00415636|593226076|FG002|Overall Study|Disease progression|0|||
164233450|NCT00415636|593226077|FG003|Overall Study|Disease progression|3|||
164233451|NCT00415636|593226078|FG004|Overall Study|Disease progression|0|||
164233452|NCT00415636|593226079|FG005|Overall Study|Disease progression|1|||
164233453|NCT01263119|593226080|FG000|Period 1|Protocol Violation|2|||
164233454|NCT01263119|593226080|FG000|Period 2|Adverse Event|2|||
164233455|NCT02138825|593226081|FG000|Main Study Treatment|Adverse Event|11|||
164233456|NCT02138825|593226082|FG001|Main Study Treatment|Adverse Event|3|||
164233457|NCT02138825|593226081|FG000|Main Study Treatment|Death|1|||
164233458|NCT02138825|593226082|FG001|Main Study Treatment|Death|2|||
164233459|NCT02138825|593226081|FG000|Main Study Treatment|Protocol Violation|2|||
164333205|NCT03161093|593597360|FG000|Overall Study|Unknown - Not reported|0|||
164333206|NCT03161093|593597361|FG001|Overall Study|Unknown - Not reported|1|||
164333207|NCT03161093|593597362|FG002|Overall Study|Unknown - Not reported|0|||
164233460|NCT02138825|593226082|FG001|Main Study Treatment|Protocol Violation|2|||
164233461|NCT02138825|593226081|FG000|Main Study Treatment|Sponsor decision|12|||
164233462|NCT02138825|593226082|FG001|Main Study Treatment|Sponsor decision|18|||
164233463|NCT02138825|593226081|FG000|Main Study Treatment|Study terminated by sponsor|10|||
164233464|NCT02138825|593226082|FG001|Main Study Treatment|Study terminated by sponsor|9|||
164233465|NCT02138825|593226081|FG000|Main Study Treatment|Withdrawal by Subject|3|||
164233466|NCT02138825|593226082|FG001|Main Study Treatment|Withdrawal by Subject|1|||
164233467|NCT02138825|593226081|FG000|Main Study Treatment|Medical decision|1|||
164233468|NCT02138825|593226082|FG001|Main Study Treatment|Medical decision|0|||
164233469|NCT02138825|593226081|FG000|Long-term Extension|Study termination by sponsor|32|||
164233470|NCT02138825|593226082|FG001|Long-term Extension|Study termination by sponsor|38|||
164233471|NCT02138825|593226081|FG000|Safety Follow-up|Adverse Event|4|||
164233472|NCT02138825|593226082|FG001|Safety Follow-up|Adverse Event|3|||
163883833|NCT05590403|591943981|FG003|Overall Study|Migrated / moved from the study area|3|||
164333208|NCT03161093|593597363|FG003|Overall Study|Unknown - Not reported|0|||
164333209|NCT03161093|593597364|FG004|Overall Study|Unknown - Not reported|0|||
164333210|NCT03161093|593597365|FG005|Overall Study|Unknown - Not reported|1|||
164333211|NCT00570765|593597366|FG000|DB Phase|Withdrawal by Subject|1|||
164333212|NCT00570765|593597367|FG001|DB Phase|Withdrawal by Subject|0|||
164333213|NCT00570765|593597368|FG002|DB Phase|Withdrawal by Subject|0|||
164333214|NCT00570765|593597369|FG003|DB Phase|Withdrawal by Subject|0|||
164333215|NCT00570765|593597366|FG000|DB Phase|Protocol Violation|0|||
164333216|NCT00570765|593597367|FG001|DB Phase|Protocol Violation|1|||
163987470|NCT02574637|592322346|FG001|Double-blind Period|Lack of Efficacy|0|||
163987471|NCT02574637|592322347|FG002|Double-blind Period|Lack of Efficacy|2|||
163987472|NCT02574637|592322348|FG003|Double-blind Period|Lack of Efficacy|0|||
163987473|NCT02574637|592322349|FG004|Double-blind Period|Lack of Efficacy|0|||
164233473|NCT02138825|593226081|FG000|Safety Follow-up|Death|11|||
163987474|NCT02574637|592322350|FG005|Double-blind Period|Lack of Efficacy|0|||
163987475|NCT02574637|592322351|FG006|Double-blind Period|Lack of Efficacy|0|||
163987476|NCT02574637|592322352|FG007|Double-blind Period|Lack of Efficacy|0|||
163987477|NCT02574637|592322353|FG008|Double-blind Period|Lack of Efficacy|0|||
163987478|NCT02574637|592322354|FG009|Double-blind Period|Lack of Efficacy|0|||
163987479|NCT02574637|592322345|FG000|Double-blind Period|Protocol Deviation|1|||
163987480|NCT02574637|592322346|FG001|Double-blind Period|Protocol Deviation|0|||
163987481|NCT02574637|592322347|FG002|Double-blind Period|Protocol Deviation|0|||
163987482|NCT02574637|592322348|FG003|Double-blind Period|Protocol Deviation|0|||
163987483|NCT02574637|592322349|FG004|Double-blind Period|Protocol Deviation|0|||
163987484|NCT02574637|592322350|FG005|Double-blind Period|Protocol Deviation|0|||
163987485|NCT02574637|592322351|FG006|Double-blind Period|Protocol Deviation|0|||
163987486|NCT02574637|592322352|FG007|Double-blind Period|Protocol Deviation|0|||
163987487|NCT02574637|592322353|FG008|Double-blind Period|Protocol Deviation|0|||
163987488|NCT02574637|592322354|FG009|Double-blind Period|Protocol Deviation|0|||
163987489|NCT02574637|592322345|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
163987490|NCT02574637|592322346|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
163987491|NCT02574637|592322347|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
163987492|NCT02574637|592322348|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
163987493|NCT02574637|592322349|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
163987494|NCT02574637|592322350|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
163987495|NCT02574637|592322351|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
163987496|NCT02574637|592322352|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
163987497|NCT02574637|592322353|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
163987498|NCT02574637|592322354|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
163987499|NCT02574637|592322345|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
163987500|NCT02574637|592322346|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
163987501|NCT02574637|592322347|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
163987502|NCT02574637|592322348|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
163987503|NCT02574637|592322349|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
163987504|NCT02574637|592322350|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
163987505|NCT02574637|592322351|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
163987506|NCT02574637|592322352|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
163987507|NCT02574637|592322353|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
163987508|NCT02574637|592322354|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
163987509|NCT02574637|592322345|FG000|Double-blind Period|Reason Not Specified|0|||
163987510|NCT02574637|592322346|FG001|Double-blind Period|Reason Not Specified|0|||
163987511|NCT02574637|592322347|FG002|Double-blind Period|Reason Not Specified|0|||
163987512|NCT02574637|592322348|FG003|Double-blind Period|Reason Not Specified|1|||
163987513|NCT02574637|592322349|FG004|Double-blind Period|Reason Not Specified|0|||
163987514|NCT02574637|592322350|FG005|Double-blind Period|Reason Not Specified|0|||
163987515|NCT02574637|592322351|FG006|Double-blind Period|Reason Not Specified|0|||
163987516|NCT02574637|592322352|FG007|Double-blind Period|Reason Not Specified|0|||
163987517|NCT02574637|592322353|FG008|Double-blind Period|Reason Not Specified|0|||
163987518|NCT02574637|592322354|FG009|Double-blind Period|Reason Not Specified|0|||
163987519|NCT02574637|592322345|FG000|Open-label (OL) Period|Adverse Event|0|||
163987520|NCT02574637|592322346|FG001|Open-label (OL) Period|Adverse Event|0|||
163987521|NCT02574637|592322347|FG002|Open-label (OL) Period|Adverse Event|0|||
163987522|NCT02574637|592322348|FG003|Open-label (OL) Period|Adverse Event|0|||
163987523|NCT02574637|592322349|FG004|Open-label (OL) Period|Adverse Event|0|||
163987524|NCT02574637|592322350|FG005|Open-label (OL) Period|Adverse Event|0|||
163987525|NCT02574637|592322351|FG006|Open-label (OL) Period|Adverse Event|0|||
163987526|NCT02574637|592322352|FG007|Open-label (OL) Period|Adverse Event|0|||
163987527|NCT02574637|592322353|FG008|Open-label (OL) Period|Adverse Event|1|||
163987528|NCT02574637|592322354|FG009|Open-label (OL) Period|Adverse Event|0|||
163987529|NCT02574637|592322345|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
163987530|NCT02574637|592322346|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
163987531|NCT02574637|592322347|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
163987532|NCT02574637|592322348|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
163987533|NCT02574637|592322349|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
163987534|NCT02574637|592322350|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
163987535|NCT02574637|592322351|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
163987536|NCT02574637|592322352|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
163987537|NCT02574637|592322353|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
163987538|NCT02574637|592322354|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
163987539|NCT02574637|592322345|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164233474|NCT02138825|593226082|FG001|Safety Follow-up|Death|5|||
164233475|NCT02138825|593226081|FG000|Safety Follow-up|Withdrawal by Subject|5|||
164233476|NCT02138825|593226082|FG001|Safety Follow-up|Withdrawal by Subject|3|||
164233477|NCT02138825|593226081|FG000|Safety Follow-up|clinic worsening|1|||
164233478|NCT02138825|593226082|FG001|Safety Follow-up|clinic worsening|0|||
164233479|NCT02138825|593226081|FG000|Safety Follow-up|withdrawal by PI|1|||
164233480|NCT02138825|593226082|FG001|Safety Follow-up|withdrawal by PI|0|||
164233481|NCT02138825|593226081|FG000|Safety Follow-up|logistical difficulties|0|||
164233482|NCT02138825|593226082|FG001|Safety Follow-up|logistical difficulties|1|||
164233483|NCT02138825|593226081|FG000|Safety Follow-up|progressive disease|0|||
164233484|NCT02138825|593226082|FG001|Safety Follow-up|progressive disease|2|||
164233485|NCT02138825|593226081|FG000|Safety Follow-up|too unwell to attend the visit|0|||
164233486|NCT02138825|593226082|FG001|Safety Follow-up|too unwell to attend the visit|1|||
164233487|NCT02138825|593226081|FG000|Safety Follow-up|treatment unblinded|0|||
164233488|NCT02138825|593226082|FG001|Safety Follow-up|treatment unblinded|1|||
164233489|NCT02138825|593226081|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
164233490|NCT02138825|593226082|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
164233491|NCT01702298|593226088|FG000|Overall Study|Withdrawal by Subject|1|||
164233492|NCT00560508|593226092|FG000|12 Week Double-blind Period|Adverse Event|3|||
164233493|NCT00560508|593226093|FG001|12 Week Double-blind Period|Adverse Event|2|||
164233494|NCT00560508|593226092|FG000|12 Week Double-blind Period|Protocol Violation|1|||
164233495|NCT00560508|593226093|FG001|12 Week Double-blind Period|Protocol Violation|0|||
164233496|NCT00560508|593226092|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
164233497|NCT00560508|593226093|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
164233498|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
164233499|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
164233500|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
164233501|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
164233502|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
164233503|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
164233504|NCT00560508|593226092|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
164233505|NCT00560508|593226093|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
164233506|NCT01822925|593226098|FG000|Overall Study|Adverse Event|1|||
164333217|NCT00570765|593597368|FG002|DB Phase|Protocol Violation|0|||
164333218|NCT00570765|593597369|FG003|DB Phase|Protocol Violation|0|||
164333219|NCT00570765|593597366|FG000|DB Phase|Adverse Event|3|||
164333220|NCT00570765|593597367|FG001|DB Phase|Adverse Event|6|||
164333221|NCT00570765|593597368|FG002|DB Phase|Adverse Event|0|||
164333222|NCT00570765|593597369|FG003|DB Phase|Adverse Event|0|||
164333223|NCT00570765|593597366|FG000|DB Phase|Did Not Receive Study Drug|0|||
164333224|NCT00570765|593597367|FG001|DB Phase|Did Not Receive Study Drug|0|||
164333225|NCT00570765|593597368|FG002|DB Phase|Did Not Receive Study Drug|1|||
164333226|NCT00570765|593597369|FG003|DB Phase|Did Not Receive Study Drug|0|||
164333227|NCT00570765|593597366|FG000|LTSE Phase|Withdrawal by Subject|0|||
164333228|NCT00570765|593597367|FG001|LTSE Phase|Withdrawal by Subject|0|||
164333229|NCT00570765|593597368|FG002|LTSE Phase|Withdrawal by Subject|0|||
164333230|NCT00570765|593597369|FG003|LTSE Phase|Withdrawal by Subject|1|||
164333231|NCT00570765|593597366|FG000|LTSE Phase|Adverse Event|0|||
164333232|NCT00570765|593597367|FG001|LTSE Phase|Adverse Event|0|||
164333233|NCT00570765|593597368|FG002|LTSE Phase|Adverse Event|0|||
164333234|NCT00570765|593597369|FG003|LTSE Phase|Adverse Event|7|||
164333235|NCT00570765|593597366|FG000|LTSE Phase|Physician Decision|0|||
164333236|NCT00570765|593597367|FG001|LTSE Phase|Physician Decision|0|||
164333237|NCT00570765|593597368|FG002|LTSE Phase|Physician Decision|0|||
164333238|NCT00570765|593597369|FG003|LTSE Phase|Physician Decision|4|||
164333239|NCT01031706|593597370|FG000|Overall Study|Adverse Event|1|||
164333240|NCT01031706|593597371|FG001|Overall Study|Adverse Event|0|||
163987540|NCT02574637|592322346|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163987541|NCT02574637|592322347|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163987542|NCT02574637|592322348|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
164233507|NCT01822925|593226099|FG001|Overall Study|Adverse Event|1|||
164233508|NCT01822925|593226100|FG002|Overall Study|Adverse Event|1|||
164233509|NCT01822925|593226101|FG003|Overall Study|Adverse Event|1|||
164233510|NCT01822925|593226098|FG000|Overall Study|Lost to Follow-up|0|||
164233511|NCT01822925|593226099|FG001|Overall Study|Lost to Follow-up|1|||
164233512|NCT01822925|593226100|FG002|Overall Study|Lost to Follow-up|0|||
164233513|NCT01822925|593226101|FG003|Overall Study|Lost to Follow-up|0|||
164233514|NCT01822925|593226098|FG000|Overall Study|Protocol Violation|1|||
164333241|NCT01031706|593597370|FG000|Overall Study|Withdrawal by Subject|1|||
164333242|NCT01031706|593597371|FG001|Overall Study|Withdrawal by Subject|1|||
164333243|NCT02124161|593597372|FG000|Overall Study|Other unspecified|0|||
164333244|NCT02124161|593597373|FG001|Overall Study|Other unspecified|1|||
164333245|NCT02124161|593597372|FG000|Overall Study|Death|1|||
164333246|NCT02124161|593597373|FG001|Overall Study|Death|0|||
164333247|NCT02124161|593597372|FG000|Overall Study|Protocol Violation|2|||
164333248|NCT02124161|593597373|FG001|Overall Study|Protocol Violation|1|||
164333249|NCT02124161|593597372|FG000|Overall Study|Withdrawal by Subject|1|||
164333250|NCT02124161|593597373|FG001|Overall Study|Withdrawal by Subject|2|||
164333251|NCT02124161|593597372|FG000|Overall Study|Adverse Event|2|||
164333252|NCT02124161|593597373|FG001|Overall Study|Adverse Event|0|||
164333253|NCT02124161|593597372|FG000|Overall Study|Does not meet entrance criteria|2|||
164333254|NCT02124161|593597373|FG001|Overall Study|Does not meet entrance criteria|3|||
164333255|NCT02124161|593597372|FG000|Overall Study|No longer meets eligibility criteria|5|||
164333256|NCT02124161|593597373|FG001|Overall Study|No longer meets eligibility criteria|4|||
164333257|NCT02124161|593597372|FG000|Overall Study|Lost to Follow-up|3|||
164333258|NCT02124161|593597373|FG001|Overall Study|Lost to Follow-up|4|||
164333259|NCT01669928|593597375|FG000|First Intervention|Withdrawal by Subject|3|||
164333260|NCT01669928|593597376|FG001|First Intervention|Withdrawal by Subject|5|||
164333261|NCT01954342|593597379|FG000|Overall Study|Missing data from 13-16week study visit|0|||
164333262|NCT01954342|593597380|FG001|Overall Study|Missing data from 13-16week study visit|0|||
164333263|NCT01954342|593597381|FG002|Overall Study|Missing data from 13-16week study visit|0|||
164333264|NCT01954342|593597382|FG003|Overall Study|Missing data from 13-16week study visit|1|||
164333265|NCT01954342|593597379|FG000|Overall Study|Miscarriage|0|||
164333266|NCT01954342|593597380|FG001|Overall Study|Miscarriage|0|||
164333267|NCT01954342|593597381|FG002|Overall Study|Miscarriage|0|||
164333268|NCT01954342|593597382|FG003|Overall Study|Miscarriage|3|||
164333269|NCT01954342|593597379|FG000|Overall Study|Lost to Follow-up|0|||
164333270|NCT01954342|593597380|FG001|Overall Study|Lost to Follow-up|0|||
164333271|NCT01954342|593597381|FG002|Overall Study|Lost to Follow-up|0|||
164333272|NCT01954342|593597382|FG003|Overall Study|Lost to Follow-up|5|||
164333273|NCT01954342|593597379|FG000|Overall Study|Preterm delivery|0|||
164333274|NCT01954342|593597380|FG001|Overall Study|Preterm delivery|0|||
164333275|NCT01954342|593597381|FG002|Overall Study|Preterm delivery|0|||
164333276|NCT01954342|593597382|FG003|Overall Study|Preterm delivery|3|||
164333277|NCT01954342|593597379|FG000|Overall Study|Pre-eclampsia|0|||
163883834|NCT05590403|591943982|FG004|Overall Study|Migrated / moved from the study area|1|||
163883835|NCT05590403|591943978|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
163883836|NCT05590403|591943979|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
163883837|NCT05590403|591943980|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
163883838|NCT05590403|591943981|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
163883839|NCT05590403|591943982|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
163883840|NCT04717492|591943985|FG000|Overall Study|Withdrawal by Subject|2|||
163883841|NCT04717492|591943986|FG001|Overall Study|Withdrawal by Subject|13|||
163883842|NCT04717492|591943985|FG000|Overall Study|Lost to Follow-up|2|||
163987543|NCT02574637|592322349|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163987544|NCT02574637|592322350|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
163987545|NCT02574637|592322351|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
163987546|NCT02574637|592322352|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
163987547|NCT02574637|592322353|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
163987548|NCT02574637|592322354|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
163987549|NCT03021642|592322359|FG000|Washout Period (21 Days)|Adverse Event|1|||
163987550|NCT03021642|592322360|FG001|Washout Period (21 Days)|Adverse Event|1|||
163987551|NCT01192347|592322361|FG000|Overall Study|Death|3|||
163987552|NCT01192347|592322361|FG000|Overall Study|Lost to Follow-up|3|||
163987553|NCT01192347|592322361|FG000|Overall Study|Withdrawal by Subject|1|||
163987554|NCT01192347|592322361|FG000|Overall Study|Adverse Event|1|||
163987555|NCT01192347|592322361|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
163987556|NCT01192347|592322361|FG000|Overall Study|Patient seen in different hospital|1|||
163987557|NCT01192347|592322361|FG000|Overall Study|Patient not visiting hospital regularly|1|||
163987558|NCT01192347|592322361|FG000|Overall Study|Patient did not show up for visits|1|||
163987559|NCT00090545|592322362|FG000|Overall Study|Disease progression on study|21|||
163987560|NCT00090545|592322363|FG001|Overall Study|Disease progression on study|17|||
163987561|NCT00090545|592322362|FG000|Overall Study|Refused further treatment|1|||
163987562|NCT00090545|592322363|FG001|Overall Study|Refused further treatment|4|||
163987563|NCT00090545|592322362|FG000|Overall Study|Death|0|||
163987564|NCT00090545|592322363|FG001|Overall Study|Death|1|||
163987565|NCT00090545|592322362|FG000|Overall Study|Adverse Event|0|||
163987566|NCT00090545|592322363|FG001|Overall Study|Adverse Event|2|||
163987567|NCT04317274|592322368|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
164333278|NCT01954342|593597380|FG001|Overall Study|Pre-eclampsia|0|||
164333279|NCT01954342|593597381|FG002|Overall Study|Pre-eclampsia|0|||
164333280|NCT01954342|593597382|FG003|Overall Study|Pre-eclampsia|4|||
164333281|NCT01954342|593597379|FG000|Overall Study|Unreliable Data|0|||
164333282|NCT01954342|593597380|FG001|Overall Study|Unreliable Data|0|||
164333283|NCT01954342|593597381|FG002|Overall Study|Unreliable Data|0|||
164333284|NCT01954342|593597382|FG003|Overall Study|Unreliable Data|2|||
164333285|NCT00984568|593597385|FG000|Overall Study|Withdrawal by Subject|1|||
164333286|NCT00984568|593597386|FG001|Overall Study|Withdrawal by Subject|2|||
164333287|NCT00984568|593597385|FG000|Overall Study|Lack of Efficacy|2|||
164333288|NCT00984568|593597386|FG001|Overall Study|Lack of Efficacy|0|||
164333289|NCT00984568|593597385|FG000|Overall Study|Adverse Event|2|||
164333290|NCT00984568|593597386|FG001|Overall Study|Adverse Event|0|||
164333291|NCT00984568|593597385|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
164333292|NCT00984568|593597386|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
164333293|NCT00984568|593597385|FG000|Overall Study|Lost to Follow-up|0|||
164333294|NCT00984568|593597386|FG001|Overall Study|Lost to Follow-up|1|||
164333295|NCT00984568|593597385|FG000|Overall Study|Opportunistic Infection|1|||
163987568|NCT04317274|592322369|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
163987569|NCT04317274|592322370|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
163987570|NCT04317274|592322371|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
163987571|NCT01164722|592322373|FG000|Overall Study|Adverse Event|0|||
163987572|NCT01164722|592322374|FG001|Overall Study|Adverse Event|1|||
163987573|NCT01164722|592322373|FG000|Overall Study|Withdrawal by Subject|3|||
163987574|NCT01164722|592322374|FG001|Overall Study|Withdrawal by Subject|4|||
163987575|NCT01164722|592322373|FG000|Overall Study|Lost to Follow-up|3|||
163987576|NCT01164722|592322374|FG001|Overall Study|Lost to Follow-up|6|||
163987577|NCT01164722|592322373|FG000|Overall Study|met protocol criteria for non-treatment|11|||
163987578|NCT01164722|592322374|FG001|Overall Study|met protocol criteria for non-treatment|1|||
163987579|NCT01164722|592322373|FG000|Overall Study|enrolled on other study, concomitant med|1|||
163987580|NCT01164722|592322374|FG001|Overall Study|enrolled on other study, concomitant med|3|||
163987581|NCT03889639|592322378|FG000|Overall Study|Withdrawal by Subject|0|||
163987582|NCT03889639|592322379|FG001|Overall Study|Withdrawal by Subject|0|||
163987583|NCT03889639|592322380|FG002|Overall Study|Withdrawal by Subject|0|||
163987584|NCT03889639|592322381|FG003|Overall Study|Withdrawal by Subject|0|||
163987585|NCT03889639|592322382|FG004|Overall Study|Withdrawal by Subject|0|||
163987586|NCT03889639|592322383|FG005|Overall Study|Withdrawal by Subject|0|||
163987587|NCT03889639|592322384|FG006|Overall Study|Withdrawal by Subject|0|||
163987588|NCT03889639|592322385|FG007|Overall Study|Withdrawal by Subject|1|||
163987589|NCT01703858|592322386|FG000|Overall Study|Withdrawal by Subject|0|||
163987590|NCT01703858|592322387|FG001|Overall Study|Withdrawal by Subject|1|||
163987591|NCT01703858|592322388|FG002|Overall Study|Withdrawal by Subject|0|||
163987592|NCT02556255|592322389|FG000|Overall Study|Lost to Follow-up|4|||
163987593|NCT00993031|592322392|FG000|Overall Study|Death|0|||
163987594|NCT00993031|592322393|FG001|Overall Study|Death|1|||
163987595|NCT00993031|592322392|FG000|Overall Study|Physician Decision|0|||
163987596|NCT00993031|592322393|FG001|Overall Study|Physician Decision|2|||
163987597|NCT00993031|592322392|FG000|Overall Study|Withdrawal by Subject|3|||
163987598|NCT00993031|592322393|FG001|Overall Study|Withdrawal by Subject|3|||
163987599|NCT00993031|592322392|FG000|Overall Study|Lost to Follow-up|19|||
163987600|NCT00993031|592322393|FG001|Overall Study|Lost to Follow-up|13|||
163987601|NCT01834729|592322397|FG000|Overall Study|Did not return bowel diaries|0|||
163987602|NCT01834729|592322398|FG001|Overall Study|Did not return bowel diaries|0|||
163987603|NCT01834729|592322399|FG002|Overall Study|Did not return bowel diaries|3|||
163987604|NCT01834729|592322400|FG003|Overall Study|Did not return bowel diaries|0|||
163987605|NCT01834729|592322397|FG000|Overall Study|Withdrawal by Subject|1|||
163987606|NCT01834729|592322398|FG001|Overall Study|Withdrawal by Subject|1|||
163987607|NCT01834729|592322399|FG002|Overall Study|Withdrawal by Subject|0|||
163987608|NCT01834729|592322400|FG003|Overall Study|Withdrawal by Subject|0|||
163987609|NCT01834729|592322397|FG000|Overall Study|Adverse Event|0|||
163987610|NCT01834729|592322398|FG001|Overall Study|Adverse Event|0|||
163987611|NCT01834729|592322399|FG002|Overall Study|Adverse Event|0|||
163987612|NCT01834729|592322400|FG003|Overall Study|Adverse Event|2|||
164139113|NCT03146962|592872004|FG004|Overall Study|Lost to Follow-up|0|||
163987613|NCT00288080|592322401|FG000|Overall Study|Withdrawal by Subject|1|||
163987614|NCT00288080|592322402|FG001|Overall Study|Withdrawal by Subject|3|||
163987615|NCT00288080|592322401|FG000|Overall Study|Protocol Violation|25|||
163987616|NCT00288080|592322402|FG001|Overall Study|Protocol Violation|20|||
163987617|NCT03403192|592322403|FG000|Overall Study|Lost to Follow-up|1|||
163987618|NCT03403192|592322404|FG001|Overall Study|Lost to Follow-up|2|||
164139114|NCT03146962|592872005|FG005|Overall Study|Lost to Follow-up|0|||
164139115|NCT03146962|592872006|FG006|Overall Study|Lost to Follow-up|0|||
164139116|NCT03146962|592872007|FG007|Overall Study|Lost to Follow-up|0|||
164139117|NCT03146962|592872008|FG008|Overall Study|Lost to Follow-up|0|||
164139118|NCT03146962|592872009|FG009|Overall Study|Lost to Follow-up|0|||
164139119|NCT03146962|592872000|FG000|Overall Study|Adverse Event|0|||
164139120|NCT03146962|592872001|FG001|Overall Study|Adverse Event|3|||
164139121|NCT03146962|592872002|FG002|Overall Study|Adverse Event|0|||
164139122|NCT03146962|592872003|FG003|Overall Study|Adverse Event|0|||
164139123|NCT03146962|592872004|FG004|Overall Study|Adverse Event|0|||
164139124|NCT03146962|592872005|FG005|Overall Study|Adverse Event|0|||
164139125|NCT03146962|592872006|FG006|Overall Study|Adverse Event|0|||
164139126|NCT03146962|592872007|FG007|Overall Study|Adverse Event|1|||
164139127|NCT03146962|592872008|FG008|Overall Study|Adverse Event|0|||
164233515|NCT01822925|593226099|FG001|Overall Study|Protocol Violation|0|||
164233516|NCT01822925|593226100|FG002|Overall Study|Protocol Violation|0|||
164233517|NCT01822925|593226101|FG003|Overall Study|Protocol Violation|1|||
164233518|NCT01822925|593226098|FG000|Overall Study|Withdrawal by Subject|2|||
164233519|NCT01822925|593226099|FG001|Overall Study|Withdrawal by Subject|0|||
164233520|NCT01822925|593226100|FG002|Overall Study|Withdrawal by Subject|2|||
164233521|NCT01822925|593226101|FG003|Overall Study|Withdrawal by Subject|2|||
164233522|NCT01822925|593226098|FG000|Overall Study|Taking prohibited medication|2|||
164233523|NCT01822925|593226099|FG001|Overall Study|Taking prohibited medication|0|||
164233524|NCT01822925|593226100|FG002|Overall Study|Taking prohibited medication|0|||
164233525|NCT01822925|593226101|FG003|Overall Study|Taking prohibited medication|1|||
164233526|NCT03847519|593226102|FG000|Overall Study|Death|5|||
164233527|NCT03847519|593226103|FG001|Overall Study|Death|8|||
163987619|NCT03403192|592322405|FG002|Overall Study|Lost to Follow-up|0|||
164233528|NCT03847519|593226104|FG002|Overall Study|Death|1|||
164233529|NCT03847519|593226102|FG000|Overall Study|Lost to Follow-up|1|||
164233530|NCT03847519|593226103|FG001|Overall Study|Lost to Follow-up|2|||
164233531|NCT03847519|593226104|FG002|Overall Study|Lost to Follow-up|0|||
164233532|NCT03847519|593226102|FG000|Overall Study|Study Terminated by Sponsor|0|||
164233533|NCT03847519|593226103|FG001|Overall Study|Study Terminated by Sponsor|3|||
164233534|NCT03847519|593226104|FG002|Overall Study|Study Terminated by Sponsor|2|||
164233535|NCT02300233|593226109|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
164233536|NCT02300233|593226110|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164233537|NCT02300233|593226111|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
164233538|NCT02300233|593226109|FG000|Overall Study|Withdrawal by Subject|1|||
164233539|NCT02300233|593226110|FG001|Overall Study|Withdrawal by Subject|0|||
164233540|NCT02300233|593226111|FG002|Overall Study|Withdrawal by Subject|3|||
164233541|NCT02300233|593226109|FG000|Overall Study|Investigator Judgement|0|||
164233542|NCT02300233|593226110|FG001|Overall Study|Investigator Judgement|0|||
164233543|NCT02300233|593226111|FG002|Overall Study|Investigator Judgement|1|||
164233544|NCT02300233|593226109|FG000|Overall Study|Reason Not Specified|0|||
164233545|NCT02300233|593226110|FG001|Overall Study|Reason Not Specified|0|||
164233546|NCT02300233|593226111|FG002|Overall Study|Reason Not Specified|5|||
164233547|NCT00833690|593226112|FG000|Overall Study|Withdrawal by Subject|1|||
164233548|NCT00833690|593226113|FG001|Overall Study|Withdrawal by Subject|0|||
164233549|NCT00833690|593226114|FG002|Overall Study|Withdrawal by Subject|0|||
164233550|NCT00833690|593226112|FG000|Overall Study|Discontinued study drug|3|||
164233551|NCT00833690|593226113|FG001|Overall Study|Discontinued study drug|2|||
164233552|NCT00833690|593226114|FG002|Overall Study|Discontinued study drug|0|||
164233553|NCT02115321|593226115|FG000|Overall Study|Death|1|||
164233554|NCT02115321|593226116|FG001|Overall Study|Death|0|||
164233555|NCT04403919|593226117|FG000|Overall Study|Lost to Follow-up|0|||
164233556|NCT04403919|593226118|FG001|Overall Study|Lost to Follow-up|0|||
164233557|NCT04403919|593226119|FG002|Overall Study|Lost to Follow-up|0|||
164233558|NCT04403919|593226120|FG003|Overall Study|Lost to Follow-up|1|||
164233559|NCT03605693|593226121|FG000|Overall Study|Lost to Follow-up|4|||
164233560|NCT03605693|593226122|FG001|Overall Study|Lost to Follow-up|0|||
164233561|NCT03605693|593226121|FG000|Overall Study|Physician Decision|1|||
164233562|NCT03605693|593226122|FG001|Overall Study|Physician Decision|0|||
164233563|NCT04752566|593226123|FG000|Overall Study|Protocol Violation|0|||
164233564|NCT04752566|593226124|FG001|Overall Study|Protocol Violation|1|||
164233565|NCT04752566|593226123|FG000|Overall Study|Death|1|||
164233566|NCT04752566|593226124|FG001|Overall Study|Death|0|||
164233567|NCT04752566|593226123|FG000|Overall Study|Adverse Event|1|||
164233568|NCT04752566|593226124|FG001|Overall Study|Adverse Event|0|||
163987620|NCT03403192|592322406|FG003|Overall Study|Lost to Follow-up|0|||
164233569|NCT04752566|593226123|FG000|Overall Study|Withdrawal by Subject|2|||
164233570|NCT04752566|593226124|FG001|Overall Study|Withdrawal by Subject|0|||
164233571|NCT04752566|593226123|FG000|Overall Study|Physician Decision|1|||
164233572|NCT04752566|593226124|FG001|Overall Study|Physician Decision|1|||
164333296|NCT00984568|593597386|FG001|Overall Study|Opportunistic Infection|0|||
164333297|NCT00984568|593597385|FG000|Overall Study|Unknown Reason|1|||
164333298|NCT00984568|593597386|FG001|Overall Study|Unknown Reason|3|||
164333299|NCT05085730|593597387|FG000|Overall Study|Withdrawal by Subject|4|||
163987621|NCT03403192|592322403|FG000|Overall Study|Unable to respond|0|||
163987622|NCT03403192|592322404|FG001|Overall Study|Unable to respond|1|||
163987623|NCT03403192|592322405|FG002|Overall Study|Unable to respond|0|||
164233573|NCT05134649|593226125|FG000|Overall Study|Lost to Follow-up|12|||
164233574|NCT05134649|593226125|FG000|Overall Study|Withdrawal by Subject|14|||
164233575|NCT05134649|593226125|FG000|Overall Study|Pregnancy|1|||
164233576|NCT05134649|593226125|FG000|Overall Study|Other, not specified|3|||
164233577|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
164233578|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
164233579|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
164233580|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
164233581|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
164333300|NCT05085730|593597387|FG000|Overall Study|Physician Decision|1|||
164233582|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
164233583|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
164233584|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
164233585|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
164233586|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
164233587|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
164233588|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
164233589|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
164233590|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
164233591|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
164233592|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
164233593|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
164233594|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
164233595|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
164233596|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
164233597|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
164233598|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
164233599|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
164233600|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
164233601|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
164233602|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
164233603|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
164233604|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
164233605|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
164233606|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
164233607|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
164233608|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
164233609|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
164233610|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
164233611|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
164233612|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
164233613|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
164233614|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
164233615|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
164233616|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
164233617|NCT04392154|593226128|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
164233618|NCT04392154|593226129|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
164233619|NCT04392154|593226130|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
164233620|NCT04392154|593226131|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
164233621|NCT04392154|593226128|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
164233622|NCT04392154|593226129|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
164233623|NCT04392154|593226130|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
164233624|NCT04392154|593226131|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
164233625|NCT04392154|593226128|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
164233626|NCT04392154|593226129|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
164233627|NCT04392154|593226130|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
164233628|NCT04392154|593226131|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
164233629|NCT04392154|593226128|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
164233630|NCT04392154|593226129|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
164233631|NCT04392154|593226130|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
164233632|NCT04392154|593226131|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
164233633|NCT00023595|593226134|FG000|5 Year Follow up|Lost to Follow-up|2|||
164233634|NCT00023595|593226135|FG001|5 Year Follow up|Lost to Follow-up|2|||
164233635|NCT00023595|593226136|FG002|5 Year Follow up|Lost to Follow-up|1|||
164233636|NCT00023595|593226137|FG003|5 Year Follow up|Lost to Follow-up|7|||
164233637|NCT00023595|593226138|FG004|5 Year Follow up|Lost to Follow-up|3|||
163883843|NCT04717492|591943986|FG001|Overall Study|Lost to Follow-up|9|||
164233638|NCT00023595|593226134|FG000|10 Year Follow up|Lost to Follow-up|12|||
164233639|NCT00023595|593226135|FG001|10 Year Follow up|Lost to Follow-up|10|||
164233640|NCT00023595|593226136|FG002|10 Year Follow up|Lost to Follow-up|3|||
164233641|NCT00023595|593226137|FG003|10 Year Follow up|Lost to Follow-up|0|||
163883844|NCT03766009|591943987|FG000|Usual Care|Death|0|||
163883845|NCT03766009|591943988|FG001|Usual Care|Death|0|||
163883846|NCT03766009|591943989|FG002|Usual Care|Death|0|||
163883847|NCT03766009|591943990|FG003|Usual Care|Death|1|||
163883848|NCT03766009|591943991|FG004|Usual Care|Death|0|||
163883849|NCT03766009|591943992|FG005|Usual Care|Death|0|||
164233642|NCT00023595|593226138|FG004|10 Year Follow up|Lost to Follow-up|0|||
164233643|NCT02106832|593226144|FG000|Overall Study|Adverse Event|1|||
164233644|NCT02106832|593226145|FG001|Overall Study|Adverse Event|2|||
164233645|NCT02106832|593226146|FG002|Overall Study|Adverse Event|3|||
164233646|NCT02106832|593226147|FG003|Overall Study|Adverse Event|0|||
164233647|NCT02106832|593226144|FG000|Overall Study|Death|4|||
164233648|NCT02106832|593226145|FG001|Overall Study|Death|4|||
164233649|NCT02106832|593226146|FG002|Overall Study|Death|1|||
164233650|NCT02106832|593226147|FG003|Overall Study|Death|4|||
164233651|NCT02106832|593226144|FG000|Overall Study|Deterioration of general conditions|0|||
164233652|NCT02106832|593226145|FG001|Overall Study|Deterioration of general conditions|0|||
164233653|NCT02106832|593226146|FG002|Overall Study|Deterioration of general conditions|1|||
164233654|NCT02106832|593226147|FG003|Overall Study|Deterioration of general conditions|0|||
164233655|NCT02106832|593226144|FG000|Overall Study|Lost to Follow-up|0|||
164233656|NCT02106832|593226145|FG001|Overall Study|Lost to Follow-up|1|||
164233657|NCT02106832|593226146|FG002|Overall Study|Lost to Follow-up|1|||
164233658|NCT02106832|593226147|FG003|Overall Study|Lost to Follow-up|3|||
164233659|NCT02106832|593226144|FG000|Overall Study|Physician Decision|1|||
164233660|NCT02106832|593226145|FG001|Overall Study|Physician Decision|0|||
164233661|NCT02106832|593226146|FG002|Overall Study|Physician Decision|0|||
164233662|NCT02106832|593226147|FG003|Overall Study|Physician Decision|0|||
164233663|NCT02106832|593226144|FG000|Overall Study|Protocol Violation|0|||
164233664|NCT02106832|593226145|FG001|Overall Study|Protocol Violation|0|||
164233665|NCT02106832|593226146|FG002|Overall Study|Protocol Violation|0|||
164233666|NCT02106832|593226147|FG003|Overall Study|Protocol Violation|1|||
164233667|NCT02106832|593226144|FG000|Overall Study|Withdrawal by Subject|17|||
164233668|NCT02106832|593226145|FG001|Overall Study|Withdrawal by Subject|17|||
164233669|NCT02106832|593226146|FG002|Overall Study|Withdrawal by Subject|10|||
164233670|NCT02106832|593226147|FG003|Overall Study|Withdrawal by Subject|7|||
164233671|NCT02106832|593226144|FG000|Overall Study|Technical problems|0|||
164233672|NCT02106832|593226145|FG001|Overall Study|Technical problems|1|||
164233673|NCT02106832|593226146|FG002|Overall Study|Technical problems|0|||
164233674|NCT02106832|593226147|FG003|Overall Study|Technical problems|0|||
164233675|NCT05205616|593226170|FG000|Overall Study|Lost to Follow-up|4|||
164233676|NCT05205616|593226171|FG001|Overall Study|Lost to Follow-up|4|||
164233677|NCT01467466|593226173|FG000|Overall Study|Withdrawal by Subject|15|||
164233678|NCT01467466|593226174|FG001|Overall Study|Withdrawal by Subject|18|||
164233679|NCT01467466|593226175|FG002|Overall Study|Withdrawal by Subject|13|||
164233680|NCT01467466|593226176|FG003|Overall Study|Withdrawal by Subject|11|||
164233681|NCT01467466|593226173|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
164233682|NCT01467466|593226174|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
164233683|NCT01467466|593226175|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
164233684|NCT01467466|593226176|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
164233685|NCT01467466|593226173|FG000|Overall Study|Procedure Cancelled|46|||
164233686|NCT01467466|593226174|FG001|Overall Study|Procedure Cancelled|45|||
164233687|NCT01467466|593226175|FG002|Overall Study|Procedure Cancelled|25|||
164233688|NCT01467466|593226176|FG003|Overall Study|Procedure Cancelled|29|||
164233689|NCT01467466|593226173|FG000|Overall Study|No Endpoint Blood Draw|38|||
164233690|NCT01467466|593226174|FG001|Overall Study|No Endpoint Blood Draw|32|||
164233691|NCT01467466|593226175|FG002|Overall Study|No Endpoint Blood Draw|51|||
164233692|NCT01467466|593226176|FG003|Overall Study|No Endpoint Blood Draw|43|||
164233693|NCT00787150|593226177|FG000|Overall Study|Adverse Event|4|||
164233694|NCT00787150|593226178|FG001|Overall Study|Adverse Event|4|||
164233695|NCT00787150|593226179|FG002|Overall Study|Adverse Event|4|||
164233696|NCT00787150|593226177|FG000|Overall Study|Physician Decision|1|||
164233697|NCT00787150|593226178|FG001|Overall Study|Physician Decision|2|||
164233698|NCT00787150|593226179|FG002|Overall Study|Physician Decision|1|||
164233699|NCT00787150|593226177|FG000|Overall Study|Withdrawal by Subject|2|||
164233700|NCT00787150|593226178|FG001|Overall Study|Withdrawal by Subject|1|||
164233701|NCT00787150|593226179|FG002|Overall Study|Withdrawal by Subject|0|||
164233702|NCT00787150|593226177|FG000|Overall Study|Dosing incorrect study durg|2|||
164233703|NCT00787150|593226178|FG001|Overall Study|Dosing incorrect study durg|0|||
164233704|NCT00787150|593226179|FG002|Overall Study|Dosing incorrect study durg|0|||
164233705|NCT00982280|593226187|FG000|Observation Period|Not eligible to be dosed|19|||
164233706|NCT00982280|593226187|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
164233707|NCT00982280|593226187|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
164233708|NCT00982280|593226187|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
164233709|NCT00982280|593226187|FG000|Maintenance Period|Adverse Event|1|||
164233710|NCT01979185|593226193|FG000|Period 2|Other|0|||
164233711|NCT01979185|593226194|FG001|Period 2|Other|1|||
164233712|NCT01121757|593226195|FG000|First Drug|Death|1|||
164233713|NCT01121757|593226196|FG001|First Drug|Death|0|||
164233714|NCT01121757|593226195|FG000|First Drug|Disease Progression|0|||
164233715|NCT01121757|593226196|FG001|First Drug|Disease Progression|2|||
164233716|NCT01121757|593226195|FG000|Combination|Physician Decision|0|||
164233717|NCT01121757|593226196|FG001|Combination|Physician Decision|1|||
164233718|NCT01121757|593226195|FG000|Combination|Disease Progression|2|||
164233719|NCT01121757|593226196|FG001|Combination|Disease Progression|0|||
164233720|NCT06028464|593226202|FG000|Washout|Positive drug test.|1|||
164233721|NCT03636022|593226203|FG000|Overall Study|Withdrawal by Subject|1|||
164233722|NCT03636022|593226204|FG001|Overall Study|Withdrawal by Subject|3|||
164233723|NCT03330847|593226205|FG000|Overall Study|Patients ongoing study|62|||
164233724|NCT03330847|593226206|FG001|Overall Study|Patients ongoing study|65|||
164233725|NCT03330847|593226207|FG002|Overall Study|Patients ongoing study|15|||
164233726|NCT01346592|593226210|FG000|Overall Study|Lost to Follow-up|62|||
164233727|NCT01346592|593226211|FG001|Overall Study|Lost to Follow-up|29|||
164233728|NCT01346592|593226212|FG002|Overall Study|Lost to Follow-up|29|||
164233729|NCT01346592|593226210|FG000|Overall Study|Protocol Violation|2|||
164233730|NCT01346592|593226211|FG001|Overall Study|Protocol Violation|1|||
164233731|NCT01346592|593226212|FG002|Overall Study|Protocol Violation|0|||
164233732|NCT01346592|593226210|FG000|Overall Study|Death|1|||
164233733|NCT01346592|593226211|FG001|Overall Study|Death|3|||
164233734|NCT01346592|593226212|FG002|Overall Study|Death|4|||
164333301|NCT01649804|593597388|FG000|Overall Study|Administrative/Other|8|||
164333302|NCT03845543|593597389|FG000|Overall Study|Death|25|||
164333303|NCT03845543|593597389|FG000|Overall Study|Withdrawal by Subject|2|||
164333304|NCT03845543|593597389|FG000|Overall Study|Lost to Follow-up|12|||
164333305|NCT03845543|593597389|FG000|Overall Study|Adverse Event|17|||
164333306|NCT01400815|593597390|FG000|Overall Study|Adverse Event|3|||
164333307|NCT01400815|593597391|FG001|Overall Study|Adverse Event|0|||
164333308|NCT01400815|593597390|FG000|Overall Study|Death|0|||
164333309|NCT01400815|593597391|FG001|Overall Study|Death|1|||
164333310|NCT01400815|593597390|FG000|Overall Study|Lost to Follow-up|18|||
164333311|NCT01400815|593597391|FG001|Overall Study|Lost to Follow-up|11|||
164333312|NCT01400815|593597390|FG000|Overall Study|Protocol Violation|0|||
164333313|NCT01400815|593597391|FG001|Overall Study|Protocol Violation|1|||
164333314|NCT01400815|593597390|FG000|Overall Study|Physician Decision|1|||
164333315|NCT01400815|593597391|FG001|Overall Study|Physician Decision|0|||
164333316|NCT01400815|593597390|FG000|Overall Study|Withdrawal by Subject|15|||
164333317|NCT01400815|593597391|FG001|Overall Study|Withdrawal by Subject|8|||
164333318|NCT01400815|593597390|FG000|Overall Study|Subject in jail|1|||
164333319|NCT01400815|593597391|FG001|Overall Study|Subject in jail|0|||
164333320|NCT01912963|593597397|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
164333321|NCT01912963|593597398|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
164333322|NCT01912963|593597399|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
164333323|NCT01912963|593597397|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
164333324|NCT01912963|593597398|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
164333325|NCT01912963|593597399|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
164333326|NCT01912963|593597397|FG000|Overall Study|Adverse Event|0|||
164333327|NCT01912963|593597398|FG001|Overall Study|Adverse Event|1|||
164333328|NCT01912963|593597399|FG002|Overall Study|Adverse Event|1|||
164333329|NCT01912963|593597397|FG000|Overall Study|Withdrawal by Subject|0|||
164333330|NCT01912963|593597398|FG001|Overall Study|Withdrawal by Subject|1|||
164333331|NCT01912963|593597399|FG002|Overall Study|Withdrawal by Subject|0|||
164333332|NCT01912963|593597397|FG000|Overall Study|Sought treatment locally|0|||
164333333|NCT01912963|593597398|FG001|Overall Study|Sought treatment locally|1|||
164333334|NCT01912963|593597399|FG002|Overall Study|Sought treatment locally|0|||
164333335|NCT01336569|593597403|FG000|Overall Study|Lost to Follow-up|4|||
164333336|NCT00406354|593597404|FG000|All Randomized Patients|Protocol Violation|0|||
164333337|NCT00406354|593597405|FG001|All Randomized Patients|Protocol Violation|0|||
164333338|NCT00406354|593597406|FG002|All Randomized Patients|Protocol Violation|1|||
164333339|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
164333340|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
164333341|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
163883850|NCT03766009|591943987|FG000|Usual Care|Lost to Follow-up|0|||
163883851|NCT03766009|591943988|FG001|Usual Care|Lost to Follow-up|0|||
164233735|NCT01346592|593226210|FG000|Overall Study|Adverse Event|0|||
164233736|NCT01346592|593226211|FG001|Overall Study|Adverse Event|1|||
164233737|NCT01346592|593226212|FG002|Overall Study|Adverse Event|0|||
164233738|NCT01346592|593226210|FG000|Overall Study|Withdrawal by Subject|77|||
164233739|NCT01346592|593226211|FG001|Overall Study|Withdrawal by Subject|51|||
164233740|NCT01346592|593226212|FG002|Overall Study|Withdrawal by Subject|38|||
164233741|NCT01346592|593226210|FG000|Overall Study|Inappropriate enrollment|3|||
164333342|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Adverse Event|6|||
164333343|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Adverse Event|2|||
164333344|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Adverse Event|1|||
164333345|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
164333346|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
164333347|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
163883852|NCT03766009|591943989|FG002|Usual Care|Lost to Follow-up|0|||
164233742|NCT01346592|593226211|FG001|Overall Study|Inappropriate enrollment|1|||
164233743|NCT01346592|593226212|FG002|Overall Study|Inappropriate enrollment|1|||
164233744|NCT01346592|593226210|FG000|Overall Study|Administrative reason|1|||
164233745|NCT01346592|593226211|FG001|Overall Study|Administrative reason|0|||
164233746|NCT01346592|593226212|FG002|Overall Study|Administrative reason|0|||
164233747|NCT01346592|593226210|FG000|Overall Study|Unable to Classify|7|||
164233748|NCT01346592|593226211|FG001|Overall Study|Unable to Classify|3|||
164233749|NCT01346592|593226212|FG002|Overall Study|Unable to Classify|6|||
164233750|NCT03557502|593226213|FG000|Protocol 2|Withdrawal by Subject|1|||
164233751|NCT03557502|593226214|FG001|Protocol 2|Withdrawal by Subject|1|||
164233752|NCT03557502|593226213|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
164233753|NCT03557502|593226214|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
164233754|NCT05819398|593226215|FG000|Overall Study|Withdrawal by Subject|11|||
164233755|NCT05819398|593226216|FG001|Overall Study|Withdrawal by Subject|7|||
164233756|NCT05819398|593226217|FG002|Overall Study|Withdrawal by Subject|6|||
164233757|NCT05819398|593226218|FG003|Overall Study|Withdrawal by Subject|6|||
164233758|NCT05819398|593226215|FG000|Overall Study|Lost to Follow-up|0|||
164233759|NCT05819398|593226216|FG001|Overall Study|Lost to Follow-up|2|||
164233760|NCT05819398|593226217|FG002|Overall Study|Lost to Follow-up|0|||
164233761|NCT05819398|593226218|FG003|Overall Study|Lost to Follow-up|1|||
164233762|NCT05819398|593226215|FG000|Overall Study|Adverse Event|1|||
164233763|NCT05819398|593226216|FG001|Overall Study|Adverse Event|3|||
164233764|NCT05819398|593226217|FG002|Overall Study|Adverse Event|4|||
164233765|NCT05819398|593226218|FG003|Overall Study|Adverse Event|5|||
164233766|NCT05819398|593226215|FG000|Overall Study|Other than listed|0|||
164233767|NCT05819398|593226216|FG001|Overall Study|Other than listed|2|||
164233768|NCT05819398|593226217|FG002|Overall Study|Other than listed|2|||
164233769|NCT05819398|593226218|FG003|Overall Study|Other than listed|0|||
164233770|NCT05819398|593226215|FG000|Overall Study|Lack of Efficacy|0|||
164233771|NCT05819398|593226216|FG001|Overall Study|Lack of Efficacy|1|||
164233772|NCT05819398|593226217|FG002|Overall Study|Lack of Efficacy|0|||
164233773|NCT05819398|593226218|FG003|Overall Study|Lack of Efficacy|0|||
164233774|NCT05819398|593226215|FG000|Overall Study|Study terminated by sponsor|20|||
164233775|NCT05819398|593226216|FG001|Overall Study|Study terminated by sponsor|18|||
164233776|NCT05819398|593226217|FG002|Overall Study|Study terminated by sponsor|20|||
164233777|NCT05819398|593226218|FG003|Overall Study|Study terminated by sponsor|22|||
164233778|NCT02520154|593226219|FG000|Overall Study|Death|1|||
164233779|NCT02520154|593226219|FG000|Overall Study|Withdrawal by Subject|2|||
164233780|NCT02520154|593226219|FG000|Overall Study|Physician Decision|2|||
164233781|NCT05943990|593226220|FG000|Overall Study|Study Terminated by Sponsor|0|||
164233782|NCT05943990|593226221|FG001|Overall Study|Study Terminated by Sponsor|0|||
164233783|NCT05943990|593226222|FG002|Overall Study|Study Terminated by Sponsor|1|||
164233784|NCT04696146|593227736|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
164233785|NCT04696146|593227737|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
164233786|NCT04696146|593227736|FG000|Overall Study|Off hours issue with product|1|||
164233787|NCT04696146|593227737|FG001|Overall Study|Off hours issue with product|0|||
164233788|NCT00276419|593227742|FG000|First Intervention|Adverse Event|1|||
163883853|NCT03766009|591943990|FG003|Usual Care|Lost to Follow-up|1|||
163883854|NCT03766009|591943991|FG004|Usual Care|Lost to Follow-up|0|||
163883855|NCT03766009|591943992|FG005|Usual Care|Lost to Follow-up|0|||
163883856|NCT03766009|591943987|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
164233789|NCT00276419|593227743|FG001|First Intervention|Adverse Event|0|||
164233790|NCT00276419|593227742|FG000|First Intervention|Withdrawal by Subject|0|||
164233791|NCT00276419|593227743|FG001|First Intervention|Withdrawal by Subject|2|||
164233792|NCT03493958|593227744|FG000|Overall Study|Withdrawal by Subject|6|||
164233793|NCT03493958|593227744|FG000|Overall Study|Lost to Follow-up|7|||
164233794|NCT03493958|593227744|FG000|Overall Study|Did not complete all required study procedures|2|||
164233795|NCT02448381|593227747|FG000|Overall Study|Adverse Event|2|||
164233796|NCT02448381|593227748|FG001|Overall Study|Adverse Event|0|||
164233797|NCT02448381|593227747|FG000|Overall Study|Lost to Follow-up|16|||
164139128|NCT03146962|592872009|FG009|Overall Study|Adverse Event|0|||
164139129|NCT03146962|592872000|FG000|Overall Study|Withdrawal by Subject|0|||
164139130|NCT03146962|592872001|FG001|Overall Study|Withdrawal by Subject|0|||
164139131|NCT03146962|592872002|FG002|Overall Study|Withdrawal by Subject|0|||
164139132|NCT03146962|592872003|FG003|Overall Study|Withdrawal by Subject|0|||
164139133|NCT03146962|592872004|FG004|Overall Study|Withdrawal by Subject|1|||
164139134|NCT03146962|592872005|FG005|Overall Study|Withdrawal by Subject|0|||
164139135|NCT03146962|592872006|FG006|Overall Study|Withdrawal by Subject|0|||
164139136|NCT03146962|592872007|FG007|Overall Study|Withdrawal by Subject|0|||
164139137|NCT03146962|592872008|FG008|Overall Study|Withdrawal by Subject|0|||
164139138|NCT03146962|592872009|FG009|Overall Study|Withdrawal by Subject|0|||
164139139|NCT03146962|592872000|FG000|Overall Study|Death|0|||
164139140|NCT03146962|592872001|FG001|Overall Study|Death|1|||
164139141|NCT03146962|592872002|FG002|Overall Study|Death|0|||
164139142|NCT03146962|592872003|FG003|Overall Study|Death|0|||
164139143|NCT03146962|592872004|FG004|Overall Study|Death|0|||
164139144|NCT03146962|592872005|FG005|Overall Study|Death|0|||
164139145|NCT03146962|592872006|FG006|Overall Study|Death|0|||
164139146|NCT03146962|592872007|FG007|Overall Study|Death|0|||
164139147|NCT03146962|592872008|FG008|Overall Study|Death|0|||
164139148|NCT03146962|592872009|FG009|Overall Study|Death|0|||
164139149|NCT03146962|592872000|FG000|Overall Study|COVID Precautions|1|||
164139150|NCT03146962|592872001|FG001|Overall Study|COVID Precautions|0|||
164139151|NCT03146962|592872002|FG002|Overall Study|COVID Precautions|0|||
164139152|NCT03146962|592872003|FG003|Overall Study|COVID Precautions|0|||
164139153|NCT03146962|592872004|FG004|Overall Study|COVID Precautions|0|||
164139154|NCT03146962|592872005|FG005|Overall Study|COVID Precautions|0|||
164139155|NCT03146962|592872006|FG006|Overall Study|COVID Precautions|0|||
164139156|NCT03146962|592872007|FG007|Overall Study|COVID Precautions|0|||
164139157|NCT03146962|592872008|FG008|Overall Study|COVID Precautions|0|||
164139158|NCT03146962|592872009|FG009|Overall Study|COVID Precautions|0|||
164139159|NCT03146962|592872000|FG000|Overall Study|Physician Decision|0|||
164139160|NCT03146962|592872001|FG001|Overall Study|Physician Decision|0|||
164139161|NCT03146962|592872002|FG002|Overall Study|Physician Decision|0|||
164139162|NCT03146962|592872003|FG003|Overall Study|Physician Decision|0|||
164139163|NCT03146962|592872004|FG004|Overall Study|Physician Decision|0|||
164139164|NCT03146962|592872005|FG005|Overall Study|Physician Decision|0|||
164139165|NCT03146962|592872006|FG006|Overall Study|Physician Decision|0|||
164139166|NCT03146962|592872007|FG007|Overall Study|Physician Decision|0|||
164139167|NCT03146962|592872008|FG008|Overall Study|Physician Decision|0|||
164139168|NCT03146962|592872009|FG009|Overall Study|Physician Decision|1|||
164139169|NCT03146962|592872000|FG000|Overall Study|Started New Treatment|0|||
164139170|NCT03146962|592872001|FG001|Overall Study|Started New Treatment|1|||
164139171|NCT03146962|592872002|FG002|Overall Study|Started New Treatment|0|||
164139172|NCT03146962|592872003|FG003|Overall Study|Started New Treatment|0|||
164139173|NCT03146962|592872004|FG004|Overall Study|Started New Treatment|0|||
164139174|NCT03146962|592872005|FG005|Overall Study|Started New Treatment|0|||
164139175|NCT03146962|592872006|FG006|Overall Study|Started New Treatment|0|||
164139176|NCT03146962|592872007|FG007|Overall Study|Started New Treatment|0|||
164139177|NCT03146962|592872008|FG008|Overall Study|Started New Treatment|0|||
164139178|NCT03146962|592872009|FG009|Overall Study|Started New Treatment|0|||
164139179|NCT02383810|592872010|FG000|Overall Study|Physician Decision|1|||
164139180|NCT02383810|592872011|FG001|Overall Study|Physician Decision|1|||
164139181|NCT02383810|592872012|FG002|Overall Study|Physician Decision|0|||
164139182|NCT02383810|592872013|FG003|Overall Study|Physician Decision|0|||
164139183|NCT02383810|592872014|FG004|Overall Study|Physician Decision|0|||
164139184|NCT02383810|592872015|FG005|Overall Study|Physician Decision|0|||
164139185|NCT02383810|592872016|FG006|Overall Study|Physician Decision|0|||
164139186|NCT02383810|592872017|FG007|Overall Study|Physician Decision|0|||
164139187|NCT02383810|592872010|FG000|Overall Study|Withdrawal by Subject|2|||
164139188|NCT02383810|592872011|FG001|Overall Study|Withdrawal by Subject|3|||
164139189|NCT02383810|592872012|FG002|Overall Study|Withdrawal by Subject|3|||
164139190|NCT02383810|592872013|FG003|Overall Study|Withdrawal by Subject|3|||
164139191|NCT02383810|592872014|FG004|Overall Study|Withdrawal by Subject|0|||
164139192|NCT02383810|592872015|FG005|Overall Study|Withdrawal by Subject|0|||
164139193|NCT02383810|592872016|FG006|Overall Study|Withdrawal by Subject|0|||
164139194|NCT02383810|592872017|FG007|Overall Study|Withdrawal by Subject|0|||
164139195|NCT02383810|592872010|FG000|Overall Study|Adverse Event|0|||
164139196|NCT02383810|592872011|FG001|Overall Study|Adverse Event|2|||
164139197|NCT02383810|592872012|FG002|Overall Study|Adverse Event|4|||
164139198|NCT02383810|592872013|FG003|Overall Study|Adverse Event|5|||
164139199|NCT02383810|592872014|FG004|Overall Study|Adverse Event|0|||
164139200|NCT02383810|592872015|FG005|Overall Study|Adverse Event|1|||
164139201|NCT02383810|592872016|FG006|Overall Study|Adverse Event|1|||
164139202|NCT02383810|592872017|FG007|Overall Study|Adverse Event|0|||
164233798|NCT02448381|593227748|FG001|Overall Study|Lost to Follow-up|9|||
164233799|NCT02448381|593227747|FG000|Overall Study|Physician Decision|1|||
164233800|NCT02448381|593227748|FG001|Overall Study|Physician Decision|1|||
164233801|NCT02448381|593227747|FG000|Overall Study|Pregnancy|1|||
164233802|NCT02448381|593227748|FG001|Overall Study|Pregnancy|0|||
164233803|NCT02448381|593227747|FG000|Overall Study|Withdrawal by Subject|13|||
164233804|NCT02448381|593227748|FG001|Overall Study|Withdrawal by Subject|9|||
164233805|NCT02448381|593227747|FG000|Overall Study|Noncompliance with Study Procedures|2|||
164233806|NCT02448381|593227748|FG001|Overall Study|Noncompliance with Study Procedures|0|||
164233807|NCT04617860|593227751|FG000|Overall Study|Adverse Event|0|||
164233808|NCT04617860|593227752|FG001|Overall Study|Adverse Event|2|||
164233809|NCT04617860|593227753|FG002|Overall Study|Adverse Event|2|||
164233810|NCT04617860|593227751|FG000|Overall Study|Withdrawal by Subject|0|||
164233811|NCT04617860|593227752|FG001|Overall Study|Withdrawal by Subject|0|||
164233812|NCT04617860|593227753|FG002|Overall Study|Withdrawal by Subject|2|||
164233813|NCT04617860|593227751|FG000|Overall Study|Physician Decision|0|||
164233814|NCT04617860|593227752|FG001|Overall Study|Physician Decision|1|||
164233815|NCT04617860|593227753|FG002|Overall Study|Physician Decision|0|||
164233816|NCT04617860|593227751|FG000|Overall Study|Sponsor Decision|0|||
164233817|NCT04617860|593227752|FG001|Overall Study|Sponsor Decision|3|||
164233818|NCT04617860|593227753|FG002|Overall Study|Sponsor Decision|1|||
164233819|NCT04617860|593227751|FG000|Overall Study|Termination of Study by Sponsor|8|||
164233820|NCT04617860|593227752|FG001|Overall Study|Termination of Study by Sponsor|4|||
164233821|NCT04617860|593227753|FG002|Overall Study|Termination of Study by Sponsor|13|||
164233822|NCT02735200|593227758|FG000|Overall Study|Lost to Follow-up|0|||
164233823|NCT02735200|593227759|FG001|Overall Study|Lost to Follow-up|5|||
164233824|NCT02735200|593227758|FG000|Overall Study|Withdrawal by Subject|8|||
164233825|NCT02735200|593227759|FG001|Overall Study|Withdrawal by Subject|0|||
164233826|NCT00619866|593227769|FG000|Weeks 1 - 12|Adverse Event|0|||
164233827|NCT00619866|593227770|FG001|Weeks 1 - 12|Adverse Event|1|||
164233828|NCT00619866|593227771|FG002|Weeks 1 - 12|Adverse Event|2|||
164233829|NCT00619866|593227772|FG003|Weeks 1 - 12|Adverse Event|0|||
164233830|NCT00619866|593227773|FG004|Weeks 1 - 12|Adverse Event|0|||
164233831|NCT00619866|593227769|FG000|Weeks 1 - 12|Non-compliance|0|||
164233832|NCT00619866|593227770|FG001|Weeks 1 - 12|Non-compliance|0|||
164233833|NCT00619866|593227771|FG002|Weeks 1 - 12|Non-compliance|1|||
164233834|NCT00619866|593227772|FG003|Weeks 1 - 12|Non-compliance|0|||
164233835|NCT00619866|593227773|FG004|Weeks 1 - 12|Non-compliance|0|||
164233836|NCT00619866|593227769|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
164233837|NCT00619866|593227770|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
164233838|NCT00619866|593227771|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
164233839|NCT00619866|593227772|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
164233840|NCT00619866|593227773|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
164233841|NCT00619866|593227769|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
164233842|NCT00619866|593227770|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
164233843|NCT00619866|593227771|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
164233844|NCT00619866|593227772|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
164233845|NCT00619866|593227773|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
164233846|NCT00619866|593227769|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
164233847|NCT00619866|593227770|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
164233848|NCT00619866|593227771|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
163883857|NCT03766009|591943988|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
164233849|NCT00619866|593227772|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
164233850|NCT00619866|593227773|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
164233851|NCT00619866|593227769|FG000|Weeks 1 - 12|Sponsor Decision|0|||
164233852|NCT00619866|593227770|FG001|Weeks 1 - 12|Sponsor Decision|1|||
164233853|NCT00619866|593227771|FG002|Weeks 1 - 12|Sponsor Decision|0|||
164233854|NCT00619866|593227772|FG003|Weeks 1 - 12|Sponsor Decision|0|||
164233855|NCT00619866|593227773|FG004|Weeks 1 - 12|Sponsor Decision|0|||
164233856|NCT00619866|593227769|FG000|Weeks 13 - 24|Adverse Event|0|||
164233857|NCT00619866|593227770|FG001|Weeks 13 - 24|Adverse Event|0|||
163883858|NCT03766009|591943989|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
163883859|NCT03766009|591943990|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
163883860|NCT03766009|591943991|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
163883861|NCT03766009|591943992|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
164233858|NCT00619866|593227771|FG002|Weeks 13 - 24|Adverse Event|2|||
164233859|NCT00619866|593227772|FG003|Weeks 13 - 24|Adverse Event|1|||
164233860|NCT00619866|593227773|FG004|Weeks 13 - 24|Adverse Event|0|||
164233861|NCT00619866|593227769|FG000|Weeks 13 - 24|Protocol Deviation|0|||
164233862|NCT00619866|593227770|FG001|Weeks 13 - 24|Protocol Deviation|0|||
164233863|NCT00619866|593227771|FG002|Weeks 13 - 24|Protocol Deviation|0|||
164233864|NCT00619866|593227772|FG003|Weeks 13 - 24|Protocol Deviation|1|||
164233865|NCT00619866|593227773|FG004|Weeks 13 - 24|Protocol Deviation|0|||
163900156|NCT02397096|592005614|FG000|Study Extension 3|Lost to Follow-up|1|||
164233866|NCT00619866|593227769|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
164233867|NCT00619866|593227770|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
164233868|NCT00619866|593227771|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
164233869|NCT00619866|593227772|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
164233870|NCT00619866|593227773|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
164233871|NCT00619866|593227769|FG000|Weeks 13 - 24|Non-compliance|0|||
164233872|NCT00619866|593227770|FG001|Weeks 13 - 24|Non-compliance|1|||
164233873|NCT00619866|593227771|FG002|Weeks 13 - 24|Non-compliance|1|||
164233874|NCT00619866|593227772|FG003|Weeks 13 - 24|Non-compliance|0|||
164233875|NCT00619866|593227773|FG004|Weeks 13 - 24|Non-compliance|0|||
164233876|NCT00619866|593227769|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
164233877|NCT00619866|593227770|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
164233878|NCT00619866|593227771|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
164233879|NCT00619866|593227772|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
164233880|NCT00619866|593227773|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
164233881|NCT01656161|593227774|FG000|Overall Study|Death|3|||
164233882|NCT01656161|593227774|FG000|Overall Study|Adverse Event|2|||
164233883|NCT01656161|593227774|FG000|Overall Study|Protocol Violation|1|||
164233884|NCT01656161|593227774|FG000|Overall Study|Withdrawal by Subject|1|||
164233885|NCT03510273|593227779|FG000|Overall Study|Withdrawal by Subject|2|||
164233886|NCT03510273|593227779|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
164233887|NCT03510273|593227779|FG000|Overall Study|Moved away from study area|4|||
164233888|NCT02589938|593227783|FG000|Overall Study|Withdrawal by Subject|11|||
164233889|NCT02589938|593227784|FG001|Overall Study|Withdrawal by Subject|5|||
164233890|NCT02589938|593227785|FG002|Overall Study|Withdrawal by Subject|6|||
164233891|NCT02589938|593227783|FG000|Overall Study|Lost to Follow-up|3|||
164233892|NCT02589938|593227784|FG001|Overall Study|Lost to Follow-up|3|||
164233893|NCT02589938|593227785|FG002|Overall Study|Lost to Follow-up|3|||
164233894|NCT02589938|593227783|FG000|Overall Study|Death|1|||
164233895|NCT02589938|593227784|FG001|Overall Study|Death|0|||
164233896|NCT02589938|593227785|FG002|Overall Study|Death|1|||
164233897|NCT02589938|593227783|FG000|Overall Study|Protocol Violation|6|||
164233898|NCT02589938|593227784|FG001|Overall Study|Protocol Violation|2|||
164233899|NCT02589938|593227785|FG002|Overall Study|Protocol Violation|3|||
164233900|NCT02589938|593227783|FG000|Overall Study|Physician Decision|1|||
164233901|NCT02589938|593227784|FG001|Overall Study|Physician Decision|0|||
164233902|NCT02589938|593227785|FG002|Overall Study|Physician Decision|0|||
164233903|NCT02589938|593227783|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
164233904|NCT02589938|593227784|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
164233905|NCT02589938|593227785|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
164233906|NCT04716894|593227786|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
164233907|NCT04716894|593227786|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
164233908|NCT03773484|593227793|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
164233909|NCT04724837|593227794|FG000|Overall Study|Other|4|||
164233910|NCT04724837|593227795|FG001|Overall Study|Other|16|||
164233911|NCT04724837|593227796|FG002|Overall Study|Other|0|||
164233912|NCT04724837|593227794|FG000|Overall Study|Withdrawal by Subject|2|||
164233913|NCT04724837|593227795|FG001|Overall Study|Withdrawal by Subject|9|||
164233914|NCT04724837|593227796|FG002|Overall Study|Withdrawal by Subject|9|||
164233915|NCT04724837|593227794|FG000|Overall Study|Adverse Event|2|||
164233916|NCT04724837|593227795|FG001|Overall Study|Adverse Event|7|||
164233917|NCT04724837|593227796|FG002|Overall Study|Adverse Event|4|||
164233918|NCT04724837|593227794|FG000|Overall Study|Lost to Follow-up|0|||
164233919|NCT04724837|593227795|FG001|Overall Study|Lost to Follow-up|1|||
164233920|NCT04724837|593227796|FG002|Overall Study|Lost to Follow-up|3|||
163883862|NCT03766009|591943987|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163883863|NCT03766009|591943988|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
164233921|NCT04724837|593227794|FG000|Overall Study|Physician Decision|1|||
164233922|NCT04724837|593227795|FG001|Overall Study|Physician Decision|2|||
164233923|NCT04724837|593227796|FG002|Overall Study|Physician Decision|0|||
164233924|NCT04724837|593227794|FG000|Overall Study|Death|0|||
164233925|NCT04724837|593227795|FG001|Overall Study|Death|0|||
164233926|NCT04724837|593227796|FG002|Overall Study|Death|1|||
164233927|NCT04724837|593227794|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164233928|NCT04724837|593227795|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
164233929|NCT04724837|593227796|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
164233930|NCT04724837|593227794|FG000|Overall Study|Study Terminated by Sponsor|0|||
164233931|NCT04724837|593227795|FG001|Overall Study|Study Terminated by Sponsor|1|||
164233932|NCT04724837|593227796|FG002|Overall Study|Study Terminated by Sponsor|0|||
164233933|NCT04222673|593227797|FG000|Overall Study|Lost to Follow-up|5|||
164233934|NCT03620981|593227808|FG000|Overall Study|Adverse Event|14|||
164233935|NCT03620981|593227809|FG001|Overall Study|Adverse Event|38|||
164233936|NCT03620981|593227810|FG002|Overall Study|Adverse Event|25|||
164233937|NCT03620981|593227808|FG000|Overall Study|Lack of Efficacy|2|||
164233938|NCT03620981|593227809|FG001|Overall Study|Lack of Efficacy|1|||
164233939|NCT03620981|593227810|FG002|Overall Study|Lack of Efficacy|1|||
164233940|NCT03620981|593227808|FG000|Overall Study|Physician Decision|7|||
164233941|NCT03620981|593227809|FG001|Overall Study|Physician Decision|4|||
164233942|NCT03620981|593227810|FG002|Overall Study|Physician Decision|4|||
164233943|NCT03620981|593227808|FG000|Overall Study|Protocol Violation|1|||
164233944|NCT03620981|593227809|FG001|Overall Study|Protocol Violation|2|||
164233945|NCT03620981|593227810|FG002|Overall Study|Protocol Violation|1|||
164233946|NCT03620981|593227808|FG000|Overall Study|Withdrawal by Legal Representative|2|||
164233947|NCT03620981|593227809|FG001|Overall Study|Withdrawal by Legal Representative|1|||
164233948|NCT03620981|593227810|FG002|Overall Study|Withdrawal by Legal Representative|1|||
164233949|NCT03620981|593227808|FG000|Overall Study|Withdrawal by Care Giver|2|||
164233950|NCT03620981|593227809|FG001|Overall Study|Withdrawal by Care Giver|0|||
164233951|NCT03620981|593227810|FG002|Overall Study|Withdrawal by Care Giver|1|||
164233952|NCT03620981|593227808|FG000|Overall Study|Non-compliance with Study Drug|1|||
164233953|NCT03620981|593227809|FG001|Overall Study|Non-compliance with Study Drug|1|||
164233954|NCT03620981|593227810|FG002|Overall Study|Non-compliance with Study Drug|0|||
164233955|NCT05852470|593227819|FG000|Overall Study|Withdrawal by Subject|0|||
164233956|NCT05852470|593227820|FG001|Overall Study|Withdrawal by Subject|1|||
164233957|NCT06071104|593227821|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
164233958|NCT02420717|593227826|FG000|Overall Study|Did not receive all study medication|2|||
164233959|NCT02420717|593227827|FG001|Overall Study|Did not receive all study medication|0|||
164233960|NCT02420717|593227828|FG002|Overall Study|Did not receive all study medication|0|||
164233961|NCT04116489|593227829|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
164233962|NCT04116489|593227829|FG000|Overall Study|Withdrawal by Subject|1|||
164233963|NCT03781570|593227830|FG000|Overall Study|Technical Issues (equipment failure)|31|||
164233964|NCT03781570|593227830|FG000|Overall Study|Withdrawal by Subject|7|||
164233965|NCT03781570|593227830|FG000|Overall Study|Physical Constraints|11|||
164233966|NCT03138564|593227831|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
164233967|NCT03138564|593227832|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
164233968|NCT03138564|593227831|FG000|Overall Study|Lost to Follow-up|16|||
164233969|NCT03138564|593227832|FG001|Overall Study|Lost to Follow-up|2|||
164233970|NCT03138564|593227831|FG000|Overall Study|Withdrawal by Subject|48|||
164233971|NCT03138564|593227832|FG001|Overall Study|Withdrawal by Subject|4|||
164233972|NCT03138564|593227831|FG000|Overall Study|No longer met eligibility criteria|2|||
164233973|NCT03138564|593227832|FG001|Overall Study|No longer met eligibility criteria|0|||
164233974|NCT03138564|593227831|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
164233975|NCT03138564|593227832|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
164233976|NCT03138564|593227831|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
164233977|NCT03138564|593227832|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
164233978|NCT03138564|593227831|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
164233979|NCT03138564|593227832|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
164233980|NCT03138564|593227831|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
163883864|NCT03766009|591943989|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163883865|NCT03766009|591943990|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
163883866|NCT03766009|591943991|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163883867|NCT03766009|591943992|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
163883868|NCT03766009|591943987|FG000|Usual Care|No treatment or declined surgery|0|||
163883869|NCT03766009|591943988|FG001|Usual Care|No treatment or declined surgery|0|||
163883870|NCT03766009|591943989|FG002|Usual Care|No treatment or declined surgery|0|||
163883871|NCT03766009|591943990|FG003|Usual Care|No treatment or declined surgery|2|||
163883872|NCT03766009|591943991|FG004|Usual Care|No treatment or declined surgery|0|||
163883873|NCT03766009|591943992|FG005|Usual Care|No treatment or declined surgery|0|||
164233981|NCT03138564|593227832|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
164233982|NCT05177354|593227834|FG000|Implant to 30-day Visit|Physician Decision|1|||
164233983|NCT05177354|593227834|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
164233984|NCT05177354|593227834|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
164233985|NCT05177354|593227834|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
164233986|NCT02936323|593227835|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233987|NCT02936323|593227836|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233988|NCT02936323|593227837|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233989|NCT02936323|593227838|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233990|NCT02936323|593227839|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233991|NCT02936323|593227840|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
164233992|NCT02936323|593227841|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233993|NCT02936323|593227842|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233994|NCT02936323|593227843|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233995|NCT02936323|593227844|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
164233996|NCT02936323|593227835|FG000|Phase 1 Dose Escalation|Death|2|||
164233997|NCT02936323|593227836|FG001|Phase 1 Dose Escalation|Death|1|||
164233998|NCT02936323|593227837|FG002|Phase 1 Dose Escalation|Death|3|||
164233999|NCT02936323|593227838|FG003|Phase 1 Dose Escalation|Death|1|||
164234000|NCT02936323|593227839|FG004|Phase 1 Dose Escalation|Death|2|||
164234001|NCT02936323|593227840|FG005|Phase 1 Dose Escalation|Death|3|||
164234002|NCT02936323|593227841|FG006|Phase 1 Dose Escalation|Death|3|||
164234003|NCT02936323|593227842|FG007|Phase 1 Dose Escalation|Death|0|||
164234004|NCT02936323|593227843|FG008|Phase 1 Dose Escalation|Death|0|||
164234005|NCT02936323|593227844|FG009|Phase 1 Dose Escalation|Death|0|||
164234006|NCT02936323|593227835|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234007|NCT02936323|593227836|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234008|NCT02936323|593227837|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234009|NCT02936323|593227838|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234010|NCT02936323|593227839|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234011|NCT02936323|593227840|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
164234012|NCT02936323|593227841|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234013|NCT02936323|593227842|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234014|NCT02936323|593227843|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234015|NCT02936323|593227844|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
164234016|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234017|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234018|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234019|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234020|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234021|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234022|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
164234023|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
164234024|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
164234025|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
164234026|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
164234027|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
163883874|NCT03766009|591943987|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
164234028|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
164234029|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
164234030|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
164234031|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
164234032|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
164234033|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
164234034|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
164234035|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
163883875|NCT03766009|591943988|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
163883876|NCT03766009|591943989|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
163883877|NCT03766009|591943990|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
163883878|NCT03766009|591943991|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
163883879|NCT03766009|591943992|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
163883880|NCT03766009|591943987|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163883881|NCT03766009|591943988|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
163883882|NCT03766009|591943989|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163883883|NCT03766009|591943990|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163883884|NCT03766009|591943991|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163883885|NCT03766009|591943992|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
163883886|NCT03766009|591943987|FG000|Usual Care|Ineligible|0|||
164234036|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234037|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234038|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234039|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234040|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234041|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234042|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234043|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
164234044|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
164234045|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
164234046|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234047|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234048|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234049|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234050|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234051|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234052|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234053|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234054|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
164234055|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
164234056|NCT02936323|593227835|FG000|Phase 2a Dose Expansion|Death|0|||
164234057|NCT02936323|593227836|FG001|Phase 2a Dose Expansion|Death|0|||
164234058|NCT02936323|593227837|FG002|Phase 2a Dose Expansion|Death|0|||
164234059|NCT02936323|593227838|FG003|Phase 2a Dose Expansion|Death|0|||
164234060|NCT02936323|593227839|FG004|Phase 2a Dose Expansion|Death|0|||
164234061|NCT02936323|593227840|FG005|Phase 2a Dose Expansion|Death|0|||
164234062|NCT02936323|593227841|FG006|Phase 2a Dose Expansion|Death|0|||
164234063|NCT02936323|593227842|FG007|Phase 2a Dose Expansion|Death|4|||
164234064|NCT02936323|593227843|FG008|Phase 2a Dose Expansion|Death|8|||
164234065|NCT02936323|593227844|FG009|Phase 2a Dose Expansion|Death|10|||
164234066|NCT06272383|593227845|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
164234067|NCT06272383|593227846|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
164234068|NCT05715827|593227847|FG000|Overall Study|Physician Decision|0|||
164234069|NCT05715827|593227848|FG001|Overall Study|Physician Decision|1|||
164234070|NCT05715827|593227847|FG000|Overall Study|console communication error|0|||
164234071|NCT05715827|593227848|FG001|Overall Study|console communication error|1|||
164234072|NCT04846868|593227849|FG000|Overall Study|Adverse Event|12|||
164234073|NCT04846868|593227850|FG001|Overall Study|Adverse Event|11|||
164234074|NCT04846868|593227849|FG000|Overall Study|Protocol deviation|6|||
164234075|NCT04846868|593227850|FG001|Overall Study|Protocol deviation|2|||
164234076|NCT04846868|593227849|FG000|Overall Study|Perceived lack of efficacy|3|||
164234077|NCT04846868|593227850|FG001|Overall Study|Perceived lack of efficacy|2|||
164234078|NCT04846868|593227849|FG000|Overall Study|Change of residence|2|||
164234079|NCT04846868|593227850|FG001|Overall Study|Change of residence|3|||
164234080|NCT04846868|593227849|FG000|Overall Study|Burden of study procedures|1|||
164234081|NCT04846868|593227850|FG001|Overall Study|Burden of study procedures|1|||
164234082|NCT04846868|593227849|FG000|Overall Study|No reason available|2|||
164234083|NCT04846868|593227850|FG001|Overall Study|No reason available|5|||
164234084|NCT04846868|593227849|FG000|Overall Study|Other reason listed|20|||
164234085|NCT04846868|593227850|FG001|Overall Study|Other reason listed|10|||
164234086|NCT04846868|593227849|FG000|Overall Study|Not treated|0|||
164234087|NCT04846868|593227850|FG001|Overall Study|Not treated|1|||
164234088|NCT04398706|593227851|FG000|Overall Study|Adverse Event|0|||
164234089|NCT04398706|593227852|FG001|Overall Study|Adverse Event|0|||
164234090|NCT04398706|593227853|FG002|Overall Study|Adverse Event|0|||
164234091|NCT04398706|593227854|FG003|Overall Study|Adverse Event|0|||
164234092|NCT04398706|593227855|FG004|Overall Study|Adverse Event|0|||
164234093|NCT04398706|593227856|FG005|Overall Study|Adverse Event|1|||
164234094|NCT04398706|593227857|FG006|Overall Study|Adverse Event|1|||
163883887|NCT03766009|591943988|FG001|Usual Care|Ineligible|1|||
163883888|NCT03766009|591943989|FG002|Usual Care|Ineligible|0|||
163883889|NCT03766009|591943990|FG003|Usual Care|Ineligible|0|||
163883890|NCT03766009|591943991|FG004|Usual Care|Ineligible|0|||
163883891|NCT03766009|591943992|FG005|Usual Care|Ineligible|0|||
163883892|NCT03766009|591943987|FG000|Usual Care|Other: Staff turnover|0|||
163883893|NCT03766009|591943988|FG001|Usual Care|Other: Staff turnover|0|||
163883894|NCT03766009|591943989|FG002|Usual Care|Other: Staff turnover|0|||
163883895|NCT03766009|591943990|FG003|Usual Care|Other: Staff turnover|0|||
163883896|NCT03766009|591943991|FG004|Usual Care|Other: Staff turnover|0|||
164234095|NCT04398706|593227858|FG007|Overall Study|Adverse Event|0|||
164234096|NCT04398706|593227851|FG000|Overall Study|Lost to Follow-up|0|||
164234097|NCT04398706|593227852|FG001|Overall Study|Lost to Follow-up|1|||
164234098|NCT04398706|593227853|FG002|Overall Study|Lost to Follow-up|2|||
164234099|NCT04398706|593227854|FG003|Overall Study|Lost to Follow-up|1|||
163883897|NCT03766009|591943992|FG005|Usual Care|Other: Staff turnover|2|||
163987624|NCT03403192|592322406|FG003|Overall Study|Unable to respond|0|||
163987625|NCT03403192|592322403|FG000|Overall Study|Incomplete|3|||
163987626|NCT03403192|592322404|FG001|Overall Study|Incomplete|1|||
163987627|NCT03403192|592322405|FG002|Overall Study|Incomplete|3|||
163987628|NCT03403192|592322406|FG003|Overall Study|Incomplete|6|||
163987629|NCT04673786|592322409|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
163987630|NCT04673786|592322410|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
163987631|NCT04673786|592322411|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
163987632|NCT04673786|592322409|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
163987633|NCT04673786|592322410|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
164139203|NCT02383810|592872010|FG000|Overall Study|Lost to Follow-up|0|||
164139204|NCT02383810|592872011|FG001|Overall Study|Lost to Follow-up|1|||
164139205|NCT02383810|592872012|FG002|Overall Study|Lost to Follow-up|0|||
164139206|NCT02383810|592872013|FG003|Overall Study|Lost to Follow-up|1|||
164139207|NCT02383810|592872014|FG004|Overall Study|Lost to Follow-up|0|||
164139208|NCT02383810|592872015|FG005|Overall Study|Lost to Follow-up|0|||
164139209|NCT02383810|592872016|FG006|Overall Study|Lost to Follow-up|0|||
164139210|NCT02383810|592872017|FG007|Overall Study|Lost to Follow-up|0|||
164139211|NCT02383810|592872010|FG000|Overall Study|other|0|||
164139212|NCT02383810|592872011|FG001|Overall Study|other|0|||
164139213|NCT02383810|592872012|FG002|Overall Study|other|0|||
164139214|NCT02383810|592872013|FG003|Overall Study|other|2|||
164139215|NCT02383810|592872014|FG004|Overall Study|other|0|||
164139216|NCT02383810|592872015|FG005|Overall Study|other|0|||
164139217|NCT02383810|592872016|FG006|Overall Study|other|0|||
164139218|NCT02383810|592872017|FG007|Overall Study|other|0|||
164139219|NCT02383810|592872010|FG000|Overall Study|subject did not receive study treatment|0|||
164139220|NCT02383810|592872011|FG001|Overall Study|subject did not receive study treatment|1|||
164139221|NCT02383810|592872012|FG002|Overall Study|subject did not receive study treatment|0|||
164139222|NCT02383810|592872013|FG003|Overall Study|subject did not receive study treatment|0|||
164139223|NCT02383810|592872014|FG004|Overall Study|subject did not receive study treatment|0|||
164139224|NCT02383810|592872015|FG005|Overall Study|subject did not receive study treatment|0|||
164139225|NCT02383810|592872016|FG006|Overall Study|subject did not receive study treatment|0|||
164139226|NCT02383810|592872017|FG007|Overall Study|subject did not receive study treatment|0|||
164139227|NCT02549027|592872020|FG000|Washout After Period 4|Withdrawal by Subject|0|||
164139228|NCT02549027|592872021|FG001|Washout After Period 4|Withdrawal by Subject|1|||
164139229|NCT02549027|592872022|FG002|Washout After Period 4|Withdrawal by Subject|1|||
164139230|NCT02549027|592872023|FG003|Washout After Period 4|Withdrawal by Subject|1|||
164139231|NCT02549027|592872024|FG004|Washout After Period 4|Withdrawal by Subject|0|||
164139232|NCT02549027|592872025|FG005|Washout After Period 4|Withdrawal by Subject|0|||
164139233|NCT02549027|592872020|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164139234|NCT02549027|592872021|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164139235|NCT02549027|592872022|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164139236|NCT02549027|592872023|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164139237|NCT02549027|592872024|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
164139238|NCT02549027|592872025|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
164139239|NCT02278055|592872026|FG000|Overall Study|Adverse Event|1|||
164139240|NCT02278055|592872026|FG000|Overall Study|Lost to Follow-up|1|||
164139241|NCT02278055|592872026|FG000|Overall Study|Withdrawal by Subject|2|||
164139242|NCT02278055|592872026|FG000|Overall Study|Progressive Disease|4|||
164139243|NCT01934335|592872027|FG000|Overall Study|Withdrawal by Subject|1|||
164139244|NCT01934335|592872028|FG001|Overall Study|Withdrawal by Subject|1|||
164139245|NCT03016975|592872039|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
164139246|NCT03016975|592872040|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
164139247|NCT03016975|592872041|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
164139248|NCT03016975|592872039|FG000|At 6 Months Follow-up|Death|2|||
164139249|NCT03016975|592872040|FG001|At 6 Months Follow-up|Death|0|||
164139250|NCT03016975|592872041|FG002|At 6 Months Follow-up|Death|0|||
164139251|NCT03016975|592872039|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
164139252|NCT03016975|592872040|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
164139253|NCT03016975|592872041|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
164139254|NCT03016975|592872039|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
164139255|NCT03016975|592872040|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
164139256|NCT03016975|592872041|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
164139257|NCT03016975|592872039|FG000|At 6 Months Follow-up|Aborted implant|1|||
164139258|NCT03016975|592872040|FG001|At 6 Months Follow-up|Aborted implant|0|||
164139259|NCT03016975|592872041|FG002|At 6 Months Follow-up|Aborted implant|0|||
164139260|NCT03016975|592872039|FG000|At 2 Year Follow-up|Death|1|||
164139261|NCT03016975|592872040|FG001|At 2 Year Follow-up|Death|0|||
164139262|NCT03016975|592872041|FG002|At 2 Year Follow-up|Death|0|||
164139263|NCT03016975|592872039|FG000|At 3 Year Follow-up|Death|1|||
164139264|NCT03016975|592872040|FG001|At 3 Year Follow-up|Death|0|||
164139265|NCT03016975|592872041|FG002|At 3 Year Follow-up|Death|0|||
164234100|NCT04398706|593227855|FG004|Overall Study|Lost to Follow-up|6|||
164234101|NCT04398706|593227856|FG005|Overall Study|Lost to Follow-up|3|||
164234102|NCT04398706|593227857|FG006|Overall Study|Lost to Follow-up|8|||
164234103|NCT04398706|593227858|FG007|Overall Study|Lost to Follow-up|2|||
164234104|NCT04398706|593227851|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164234105|NCT04398706|593227852|FG001|Overall Study|Withdrawal by parent/guardian|2|||
164234106|NCT04398706|593227853|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164234107|NCT04398706|593227854|FG003|Overall Study|Withdrawal by parent/guardian|2|||
164234108|NCT04398706|593227855|FG004|Overall Study|Withdrawal by parent/guardian|19|||
164234109|NCT04398706|593227856|FG005|Overall Study|Withdrawal by parent/guardian|23|||
164234110|NCT04398706|593227857|FG006|Overall Study|Withdrawal by parent/guardian|13|||
164234111|NCT04398706|593227858|FG007|Overall Study|Withdrawal by parent/guardian|11|||
164234112|NCT04398706|593227851|FG000|Overall Study|Protocol deviation|0|||
164234113|NCT04398706|593227852|FG001|Overall Study|Protocol deviation|1|||
164234114|NCT04398706|593227853|FG002|Overall Study|Protocol deviation|0|||
164234115|NCT04398706|593227854|FG003|Overall Study|Protocol deviation|0|||
164234116|NCT04398706|593227855|FG004|Overall Study|Protocol deviation|6|||
164234117|NCT04398706|593227856|FG005|Overall Study|Protocol deviation|4|||
164234118|NCT04398706|593227857|FG006|Overall Study|Protocol deviation|6|||
164234119|NCT04398706|593227858|FG007|Overall Study|Protocol deviation|3|||
164234120|NCT04890509|593227859|FG000|Overall Study|Death|4|||
164234121|NCT04890509|593227860|FG001|Overall Study|Death|4|||
163987634|NCT04673786|592322411|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
164234122|NCT04116853|593227861|FG000|Overall Study|Adverse Event|1|||
164234123|NCT04116853|593227862|FG001|Overall Study|Adverse Event|3|||
164234124|NCT04116853|593227861|FG000|Overall Study|Lost to Follow-up|2|||
164234125|NCT04116853|593227862|FG001|Overall Study|Lost to Follow-up|0|||
164234126|NCT04116853|593227861|FG000|Overall Study|Incarceration|0|||
164234127|NCT04116853|593227862|FG001|Overall Study|Incarceration|1|||
164234128|NCT04116853|593227861|FG000|Overall Study|Pregnancy|1|||
164234129|NCT04116853|593227862|FG001|Overall Study|Pregnancy|1|||
164234130|NCT04116853|593227861|FG000|Overall Study|Began Other Weight Loss program|4|||
164234131|NCT04116853|593227862|FG001|Overall Study|Began Other Weight Loss program|8|||
164234132|NCT04116853|593227861|FG000|Overall Study|Began Anti-Obesity Medication|3|||
164234133|NCT04116853|593227862|FG001|Overall Study|Began Anti-Obesity Medication|3|||
164234134|NCT04116853|593227861|FG000|Overall Study|Protocol Violation|0|||
164234135|NCT04116853|593227862|FG001|Overall Study|Protocol Violation|1|||
164234136|NCT02581930|593227866|FG000|Overall Study|Withdrawal by Subject|1|||
164234137|NCT02581930|593227866|FG000|Overall Study|patient declined further treatment|1|||
164234138|NCT02776735|593227867|FG000|Overall Study|Adverse Event|0|||
164234139|NCT02776735|593227868|FG001|Overall Study|Adverse Event|0|||
164234140|NCT02776735|593227869|FG002|Overall Study|Adverse Event|0|||
164234141|NCT02776735|593227870|FG003|Overall Study|Adverse Event|1|||
164234142|NCT02776735|593227871|FG004|Overall Study|Adverse Event|0|||
164234143|NCT02776735|593227872|FG005|Overall Study|Adverse Event|1|||
164234144|NCT02776735|593227867|FG000|Overall Study|Lost to Follow-up|0|||
163987635|NCT04673786|592322409|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
163987636|NCT04673786|592322410|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
163987637|NCT04673786|592322411|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
163987638|NCT04673786|592322409|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
163987639|NCT04673786|592322410|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
163987640|NCT04673786|592322411|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
164234145|NCT02776735|593227868|FG001|Overall Study|Lost to Follow-up|0|||
164234146|NCT02776735|593227869|FG002|Overall Study|Lost to Follow-up|0|||
164234147|NCT02776735|593227870|FG003|Overall Study|Lost to Follow-up|1|||
164234148|NCT02776735|593227871|FG004|Overall Study|Lost to Follow-up|0|||
164234149|NCT02776735|593227872|FG005|Overall Study|Lost to Follow-up|0|||
164234150|NCT02776735|593227867|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164234151|NCT02776735|593227868|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164234152|NCT02776735|593227869|FG002|Overall Study|Withdrawal by parent/guardian|2|||
164234153|NCT02776735|593227870|FG003|Overall Study|Withdrawal by parent/guardian|2|||
164234154|NCT02776735|593227871|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164234155|NCT02776735|593227872|FG005|Overall Study|Withdrawal by parent/guardian|0|||
164234156|NCT02776735|593227867|FG000|Overall Study|Withdrawal by Subject|1|||
164234157|NCT02776735|593227868|FG001|Overall Study|Withdrawal by Subject|0|||
164234158|NCT02776735|593227869|FG002|Overall Study|Withdrawal by Subject|0|||
164234159|NCT02776735|593227870|FG003|Overall Study|Withdrawal by Subject|0|||
164234160|NCT02776735|593227871|FG004|Overall Study|Withdrawal by Subject|0|||
164234161|NCT02776735|593227872|FG005|Overall Study|Withdrawal by Subject|1|||
164234162|NCT02776735|593227867|FG000|Overall Study|Other|0|||
164234163|NCT02776735|593227868|FG001|Overall Study|Other|0|||
164234164|NCT02776735|593227869|FG002|Overall Study|Other|3|||
164234165|NCT02776735|593227870|FG003|Overall Study|Other|0|||
164234166|NCT02776735|593227871|FG004|Overall Study|Other|0|||
164234167|NCT02776735|593227872|FG005|Overall Study|Other|0|||
164234168|NCT03186638|593229140|FG000|Overall Study|Withdrawal by Subject|4|||
164234169|NCT03186638|593229141|FG001|Overall Study|Withdrawal by Subject|4|||
164234170|NCT03186638|593229140|FG000|Overall Study|Withdrawn due to medical problem|3|||
164234171|NCT03186638|593229141|FG001|Overall Study|Withdrawn due to medical problem|2|||
164234172|NCT03186638|593229140|FG000|Overall Study|Lost to Follow-up|1|||
164234173|NCT03186638|593229141|FG001|Overall Study|Lost to Follow-up|0|||
164234174|NCT04099277|593229142|FG000|Overall Study|Physician Decision|1|||
164234175|NCT04099277|593229142|FG000|Overall Study|Withdrawal by Subject|1|||
164234176|NCT02367456|593229143|FG000|Overall Study|Death|8|||
164234177|NCT02367456|593229144|FG001|Overall Study|Death|24|||
164234178|NCT02367456|593229145|FG002|Overall Study|Death|17|||
164234179|NCT02367456|593229143|FG000|Overall Study|Lost to Follow-up|1|||
164234180|NCT02367456|593229144|FG001|Overall Study|Lost to Follow-up|3|||
164234181|NCT02367456|593229145|FG002|Overall Study|Lost to Follow-up|1|||
164234182|NCT02367456|593229143|FG000|Overall Study|Other reason|3|||
164234183|NCT02367456|593229144|FG001|Overall Study|Other reason|3|||
164234184|NCT02367456|593229145|FG002|Overall Study|Other reason|9|||
164234185|NCT02367456|593229143|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
164234186|NCT02367456|593229144|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
164234187|NCT02367456|593229145|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
164234188|NCT01645176|593229150|FG000|Overall Study|Lack of Efficacy|4|||
164234189|NCT01645176|593229150|FG000|Overall Study|did not complete final MRI|1|||
164234190|NCT02569853|593229153|FG000|Overall Study|Adverse Event|2|||
164234191|NCT02569853|593229154|FG001|Overall Study|Adverse Event|0|||
164234192|NCT02569853|593229153|FG000|Overall Study|Withdrawal by Subject|3|||
164234193|NCT02569853|593229154|FG001|Overall Study|Withdrawal by Subject|2|||
164234194|NCT02569853|593229153|FG000|Overall Study|Lost to Follow-up|3|||
164234195|NCT02569853|593229154|FG001|Overall Study|Lost to Follow-up|3|||
164234196|NCT02569853|593229153|FG000|Overall Study|Protocol Violation|1|||
164234197|NCT02569853|593229154|FG001|Overall Study|Protocol Violation|1|||
164234198|NCT02569853|593229153|FG000|Overall Study|Did not experience migraine attack|10|||
164234199|NCT02569853|593229154|FG001|Overall Study|Did not experience migraine attack|7|||
164234200|NCT02569853|593229153|FG000|Overall Study|Physician Decision|1|||
164234201|NCT02569853|593229154|FG001|Overall Study|Physician Decision|1|||
164234202|NCT00402987|593229155|FG000|Overall Study|Lack of Efficacy|0|||
164234203|NCT00402987|593229156|FG001|Overall Study|Lack of Efficacy|0|||
164234204|NCT00402987|593229157|FG002|Overall Study|Lack of Efficacy|1|||
164234205|NCT00402987|593229158|FG003|Overall Study|Lack of Efficacy|0|||
164234206|NCT01668004|593229159|FG000|Overall Study|Adverse Event|7|||
164234207|NCT01668004|593229159|FG000|Overall Study|Withdrawal by Subject|2|||
164234208|NCT01668004|593229159|FG000|Overall Study|Lost to Follow-up|5|||
164234209|NCT01668004|593229159|FG000|Overall Study|Lack of Efficacy|9|||
164234210|NCT01668004|593229159|FG000|Overall Study|Non-compliance with treatment|2|||
164234211|NCT00754572|593229162|FG000|Overall Study|Adverse Event|19|||
164234212|NCT00754572|593229162|FG000|Overall Study|Other|39|||
164234213|NCT00754572|593229162|FG000|Overall Study|Protocol Violation|3|||
163883898|NCT05071807|591943993|FG000|Overall Study|Withdrawal by Subject|4|||
163883899|NCT05071807|591943994|FG001|Overall Study|Withdrawal by Subject|0|||
163883900|NCT05071807|591943993|FG000|Overall Study|Unrelated medical issues|3|||
164234214|NCT00754572|593229162|FG000|Overall Study|Withdrawal by Subject|3|||
164234215|NCT00754572|593229162|FG000|Overall Study|Lack of Efficacy|2|||
164234216|NCT00754572|593229162|FG000|Overall Study|Death|1|||
164234217|NCT00754572|593229162|FG000|Overall Study|Administrative Reason|3|||
163883901|NCT05071807|591943994|FG001|Overall Study|Unrelated medical issues|0|||
164234218|NCT00754572|593229162|FG000|Overall Study|Lost to Follow-up|1|||
164234219|NCT01493414|593229168|FG000|Overall Study|Adverse Event|405|||
164234220|NCT01493414|593229168|FG000|Overall Study|Disease progression|204|||
164234221|NCT01493414|593229168|FG000|Overall Study|Death|101|||
164234222|NCT01493414|593229168|FG000|Overall Study|Physician Decision|93|||
164234223|NCT01493414|593229168|FG000|Overall Study|Withdrawal by Subject|79|||
164234224|NCT01493414|593229168|FG000|Overall Study|Protocol deviation|27|||
164234225|NCT01493414|593229168|FG000|Overall Study|Administrative problems|25|||
164234226|NCT01493414|593229168|FG000|Overall Study|Lost to Follow-up|16|||
164234227|NCT04846231|593229179|FG000|Overall Study|Lost to Follow-up|1|||
164234228|NCT04846231|593229180|FG001|Overall Study|Lost to Follow-up|0|||
164234229|NCT04846231|593229181|FG002|Overall Study|Lost to Follow-up|0|||
164234230|NCT04846231|593229182|FG003|Overall Study|Lost to Follow-up|0|||
164234231|NCT04846231|593229183|FG004|Overall Study|Lost to Follow-up|0|||
164234232|NCT04846231|593229184|FG005|Overall Study|Lost to Follow-up|0|||
164234233|NCT04846231|593229185|FG006|Overall Study|Lost to Follow-up|0|||
164234234|NCT04846231|593229186|FG007|Overall Study|Lost to Follow-up|1|||
164234235|NCT04846231|593229179|FG000|Overall Study|Withdrawal by Subject|0|||
164234236|NCT04846231|593229180|FG001|Overall Study|Withdrawal by Subject|1|||
164234237|NCT04846231|593229181|FG002|Overall Study|Withdrawal by Subject|2|||
164234238|NCT04846231|593229182|FG003|Overall Study|Withdrawal by Subject|1|||
164234239|NCT04846231|593229183|FG004|Overall Study|Withdrawal by Subject|0|||
164234240|NCT04846231|593229184|FG005|Overall Study|Withdrawal by Subject|0|||
164234241|NCT04846231|593229185|FG006|Overall Study|Withdrawal by Subject|0|||
164234242|NCT04846231|593229186|FG007|Overall Study|Withdrawal by Subject|0|||
164234243|NCT04846231|593229179|FG000|Overall Study|Protocol Violation|0|||
164234244|NCT04846231|593229180|FG001|Overall Study|Protocol Violation|1|||
164234245|NCT04846231|593229181|FG002|Overall Study|Protocol Violation|0|||
164234246|NCT04846231|593229182|FG003|Overall Study|Protocol Violation|0|||
164234247|NCT04846231|593229183|FG004|Overall Study|Protocol Violation|0|||
164234248|NCT04846231|593229184|FG005|Overall Study|Protocol Violation|0|||
164234249|NCT04846231|593229185|FG006|Overall Study|Protocol Violation|0|||
164234250|NCT04846231|593229186|FG007|Overall Study|Protocol Violation|0|||
164234251|NCT04846231|593229179|FG000|Overall Study|Adverse Event|0|||
164234252|NCT04846231|593229180|FG001|Overall Study|Adverse Event|0|||
164234253|NCT04846231|593229181|FG002|Overall Study|Adverse Event|0|||
164234254|NCT04846231|593229182|FG003|Overall Study|Adverse Event|0|||
164234255|NCT04846231|593229183|FG004|Overall Study|Adverse Event|0|||
164234256|NCT04846231|593229184|FG005|Overall Study|Adverse Event|0|||
164234257|NCT04846231|593229185|FG006|Overall Study|Adverse Event|1|||
164234258|NCT04846231|593229186|FG007|Overall Study|Adverse Event|1|||
164234259|NCT01143402|593229194|FG000|Overall Study|Rapid clinical decline|1|||
164234260|NCT01143402|593229195|FG001|Overall Study|Rapid clinical decline|1|||
164234261|NCT01143402|593229196|FG002|Overall Study|Rapid clinical decline|0|||
164234262|NCT01143402|593229194|FG000|Overall Study|Not Treated|0|||
164234263|NCT01143402|593229195|FG001|Overall Study|Not Treated|0|||
164234264|NCT01143402|593229196|FG002|Overall Study|Not Treated|1|||
164234265|NCT04462471|593229197|FG000|Overall Study|Adverse Event|0|||
164234266|NCT04462471|593229198|FG001|Overall Study|Adverse Event|1|||
164234267|NCT04462471|593229199|FG002|Overall Study|Adverse Event|0|||
164234268|NCT04462471|593229200|FG003|Overall Study|Adverse Event|0|||
164234269|NCT04462471|593229197|FG000|Overall Study|Disease progression|1|||
164234270|NCT04462471|593229198|FG001|Overall Study|Disease progression|0|||
164234271|NCT04462471|593229199|FG002|Overall Study|Disease progression|0|||
164234272|NCT04462471|593229200|FG003|Overall Study|Disease progression|0|||
164234273|NCT02706392|593229201|FG000|Overall Study|Death|1|||
164234274|NCT02706392|593229202|FG001|Overall Study|Death|0|||
164234275|NCT02706392|593229203|FG002|Overall Study|Death|2|||
164234276|NCT02706392|593229204|FG003|Overall Study|Death|2|||
164234277|NCT02706392|593229205|FG004|Overall Study|Death|5|||
164234278|NCT02706392|593229206|FG005|Overall Study|Death|2|||
164234279|NCT00265122|593229211|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
164234280|NCT00265122|593229212|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
164234281|NCT00265122|593229213|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
164234282|NCT00265122|593229214|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
164234283|NCT00265122|593229215|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
164234284|NCT00265122|593229216|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
164234285|NCT00265122|593229211|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
164234286|NCT00265122|593229212|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234287|NCT00265122|593229213|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234288|NCT00265122|593229214|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
164234289|NCT00265122|593229215|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234290|NCT00265122|593229216|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
164234291|NCT00265122|593229211|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
164234292|NCT00265122|593229212|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
164234293|NCT00265122|593229213|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
164234294|NCT00265122|593229214|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
164234295|NCT00265122|593229215|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
164234296|NCT00265122|593229216|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
164299833|NCT02234843|593472944|FG000|Overall Study|Death|1|||
164234297|NCT00265122|593229211|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
164234298|NCT00265122|593229212|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
164234299|NCT00265122|593229213|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
164234300|NCT00265122|593229214|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
164234301|NCT00265122|593229215|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
164234302|NCT00265122|593229216|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
164234303|NCT00265122|593229211|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
164234304|NCT00265122|593229212|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
164234305|NCT00265122|593229213|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
164234306|NCT00265122|593229214|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
164234307|NCT00265122|593229215|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
164234308|NCT00265122|593229216|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
164234309|NCT00265122|593229211|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
164234310|NCT00265122|593229212|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
164234311|NCT00265122|593229213|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
164234312|NCT00265122|593229214|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
164234313|NCT00265122|593229215|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
164234314|NCT00265122|593229216|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
164234315|NCT01276106|593229217|FG000|Overall Study|Adverse Event|3|||
164234316|NCT01276106|593229218|FG001|Overall Study|Adverse Event|3|||
164234317|NCT01276106|593229219|FG002|Overall Study|Adverse Event|11|||
164234318|NCT01276106|593229220|FG003|Overall Study|Adverse Event|3|||
164234319|NCT01276106|593229217|FG000|Overall Study|Withdrawal by Subject|6|||
164234320|NCT01276106|593229218|FG001|Overall Study|Withdrawal by Subject|3|||
164234321|NCT01276106|593229219|FG002|Overall Study|Withdrawal by Subject|1|||
164234322|NCT01276106|593229220|FG003|Overall Study|Withdrawal by Subject|6|||
164234323|NCT01276106|593229217|FG000|Overall Study|Lack of Efficacy|0|||
164234324|NCT01276106|593229218|FG001|Overall Study|Lack of Efficacy|1|||
164234325|NCT01276106|593229219|FG002|Overall Study|Lack of Efficacy|0|||
164234326|NCT01276106|593229220|FG003|Overall Study|Lack of Efficacy|1|||
164234327|NCT01276106|593229217|FG000|Overall Study|Lost to Follow-up|2|||
163987641|NCT04673786|592322409|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
163987642|NCT04673786|592322410|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
163987643|NCT04673786|592322411|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
163987644|NCT04673786|592322409|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
163987645|NCT04673786|592322410|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
163987646|NCT04673786|592322411|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
163987647|NCT01325428|592322412|FG000|Part A|Progressive disease according to RECIST|9|||
163987648|NCT01325428|592322412|FG000|Part A|Clinical signs, symptoms of progression|2|||
163987649|NCT01325428|592322412|FG000|Part A|Other adverse event|1|||
164234328|NCT01276106|593229218|FG001|Overall Study|Lost to Follow-up|1|||
164234329|NCT01276106|593229219|FG002|Overall Study|Lost to Follow-up|1|||
164234330|NCT01276106|593229220|FG003|Overall Study|Lost to Follow-up|0|||
164234331|NCT01276106|593229217|FG000|Overall Study|Physician Decision|0|||
164234332|NCT01276106|593229218|FG001|Overall Study|Physician Decision|0|||
164234333|NCT01276106|593229219|FG002|Overall Study|Physician Decision|1|||
164234334|NCT01276106|593229220|FG003|Overall Study|Physician Decision|1|||
164234335|NCT01276106|593229217|FG000|Overall Study|Protocol Violation|1|||
164234336|NCT01276106|593229218|FG001|Overall Study|Protocol Violation|1|||
164234337|NCT01276106|593229219|FG002|Overall Study|Protocol Violation|0|||
164234338|NCT01276106|593229220|FG003|Overall Study|Protocol Violation|2|||
164234339|NCT01276106|593229217|FG000|Overall Study|Insufficient therapeutic effects|0|||
164234340|NCT01276106|593229218|FG001|Overall Study|Insufficient therapeutic effects|0|||
164234341|NCT01276106|593229219|FG002|Overall Study|Insufficient therapeutic effects|2|||
164234342|NCT01276106|593229220|FG003|Overall Study|Insufficient therapeutic effects|0|||
164234343|NCT00862940|593229224|FG000|Overall Study|Adverse Event|15|||
164234344|NCT00862940|593229225|FG001|Overall Study|Adverse Event|12|||
164234345|NCT00862940|593229224|FG000|Overall Study|Lack of Efficacy|1|||
164234346|NCT00862940|593229225|FG001|Overall Study|Lack of Efficacy|3|||
164234347|NCT00862940|593229224|FG000|Overall Study|Protocol Violation|2|||
164234348|NCT00862940|593229225|FG001|Overall Study|Protocol Violation|5|||
164234349|NCT00862940|593229224|FG000|Overall Study|Withdrawal by Subject|4|||
164234350|NCT00862940|593229225|FG001|Overall Study|Withdrawal by Subject|6|||
164234351|NCT00862940|593229224|FG000|Overall Study|Non-compliance|4|||
164234352|NCT00862940|593229225|FG001|Overall Study|Non-compliance|0|||
164234353|NCT00862940|593229224|FG000|Overall Study|Lost to Follow-up|0|||
163987650|NCT01325428|592322412|FG000|Part A|Refused continue taking trial medication|2|||
164333348|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
164333349|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
164333350|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
163883902|NCT05071807|591943993|FG000|Overall Study|Relocated|0|||
163883903|NCT05071807|591943994|FG001|Overall Study|Relocated|1|||
163883904|NCT05434078|591943996|FG000|Overall Study|Lost to Follow-up|2|||
163883905|NCT05434078|591943997|FG001|Overall Study|Lost to Follow-up|1|||
163883906|NCT05434078|591943996|FG000|Overall Study|Withdrawal by Subject|1|||
163883907|NCT05434078|591943997|FG001|Overall Study|Withdrawal by Subject|0|||
163883908|NCT03652688|591943998|FG000|Baseline|Withdrawal by Subject|0|||
163883909|NCT03652688|591943999|FG001|Baseline|Withdrawal by Subject|3|||
163883910|NCT03652688|591943998|FG000|Follow-up|Lost to Follow-up|56|||
163883911|NCT03652688|591943999|FG001|Follow-up|Lost to Follow-up|54|||
163883912|NCT05179837|591944000|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
163883913|NCT05179837|591944000|FG000|Overall Study|Device malfunctioned|1|||
163883914|NCT05179837|591944000|FG000|Overall Study|Image quality too low|2|||
163883915|NCT00554788|591944001|FG000|Overall Study|Adverse Event|0|||
163883916|NCT00554788|591944002|FG001|Overall Study|Adverse Event|1|||
163883917|NCT00554788|591944003|FG002|Overall Study|Adverse Event|2|||
163883918|NCT00554788|591944001|FG000|Overall Study|Lost to Follow-up|4|||
163883919|NCT00554788|591944002|FG001|Overall Study|Lost to Follow-up|3|||
163883920|NCT00554788|591944003|FG002|Overall Study|Lost to Follow-up|3|||
163883921|NCT00554788|591944001|FG000|Overall Study|Physician Decision|1|||
163883922|NCT00554788|591944002|FG001|Overall Study|Physician Decision|1|||
163883923|NCT00554788|591944003|FG002|Overall Study|Physician Decision|3|||
163883924|NCT00554788|591944001|FG000|Overall Study|Withdrawal by Subject|0|||
163883925|NCT00554788|591944002|FG001|Overall Study|Withdrawal by Subject|0|||
163883926|NCT00554788|591944003|FG002|Overall Study|Withdrawal by Subject|1|||
163883927|NCT00554788|591944001|FG000|Overall Study|Refusal of further protocol therapy|0|||
163883928|NCT00554788|591944002|FG001|Overall Study|Refusal of further protocol therapy|1|||
163883929|NCT00554788|591944003|FG002|Overall Study|Refusal of further protocol therapy|1|||
163883930|NCT00554788|591944001|FG000|Overall Study|Progressive disease|0|||
163883931|NCT00554788|591944002|FG001|Overall Study|Progressive disease|0|||
163883932|NCT00554788|591944003|FG002|Overall Study|Progressive disease|3|||
163883933|NCT00554788|591944001|FG000|Overall Study|Ineligible|2|||
163883934|NCT00554788|591944002|FG001|Overall Study|Ineligible|0|||
163883935|NCT00554788|591944003|FG002|Overall Study|Ineligible|1|||
163883936|NCT03557697|591944004|FG000|Overall Study|Withdrawal by Subject|2|||
163883937|NCT03557697|591944005|FG001|Overall Study|Withdrawal by Subject|4|||
163883938|NCT05409183|591944008|FG000|Complete Study|Adverse Event|1|||
163883939|NCT05409183|591944009|FG001|Complete Study|Adverse Event|2|||
164139344|NCT02290223|592872060|FG000|12 Months|Lost to Follow-up|16|||
164139345|NCT02290223|592872061|FG001|12 Months|Lost to Follow-up|10|||
164139346|NCT02290223|592872060|FG000|12 Months|Refusal|0|||
164139347|NCT02290223|592872061|FG001|12 Months|Refusal|1|||
164139348|NCT05293639|592872062|FG000|Overall Study|Withdrawal by Subject|1|||
164139349|NCT05293639|592872063|FG001|Overall Study|Withdrawal by Subject|1|||
164139350|NCT05293639|592872064|FG002|Overall Study|Withdrawal by Subject|2|||
164139351|NCT05293639|592872062|FG000|Overall Study|Death|0|||
164139352|NCT05293639|592872063|FG001|Overall Study|Death|1|||
164139353|NCT05293639|592872064|FG002|Overall Study|Death|0|||
164139354|NCT05293639|592872062|FG000|Overall Study|Lost to Follow-up|0|||
164139355|NCT05293639|592872063|FG001|Overall Study|Lost to Follow-up|0|||
164139356|NCT05293639|592872064|FG002|Overall Study|Lost to Follow-up|5|||
164139357|NCT05293639|592872062|FG000|Overall Study|Other|0|||
164139358|NCT05293639|592872063|FG001|Overall Study|Other|0|||
164139359|NCT05293639|592872064|FG002|Overall Study|Other|1|||
164139360|NCT01860677|592872071|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
164139361|NCT01860677|592872072|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
164139362|NCT01671332|592872078|FG000|Overall Study|Withdrawal by Subject|1|||
164139363|NCT01671332|592872079|FG001|Overall Study|Withdrawal by Subject|1|||
164139364|NCT00371397|592872080|FG000|Session 1|Withdrawal by Subject|1|||
164139365|NCT00371397|592872081|FG001|Session 1|Withdrawal by Subject|0|||
164139366|NCT00371397|592872082|FG002|Session 1|Withdrawal by Subject|0|||
164139367|NCT00371397|592872083|FG003|Session 1|Withdrawal by Subject|0|||
164139368|NCT00371397|592872084|FG004|Session 1|Withdrawal by Subject|0|||
164139369|NCT00371397|592872085|FG005|Session 1|Withdrawal by Subject|0|||
164139370|NCT00371397|592872086|FG006|Session 1|Withdrawal by Subject|0|||
164139371|NCT00371397|592872087|FG007|Session 1|Withdrawal by Subject|1|||
164139372|NCT00371397|592872088|FG008|Session 1|Withdrawal by Subject|0|||
164139373|NCT00371397|592872089|FG009|Session 1|Withdrawal by Subject|0|||
164139374|NCT00371397|592872090|FG010|Session 1|Withdrawal by Subject|0|||
164139375|NCT00371397|592872091|FG011|Session 1|Withdrawal by Subject|0|||
164139376|NCT03753763|592872092|FG000|Overall Study|Adverse Event|2|||
164139377|NCT03753763|592872093|FG001|Overall Study|Adverse Event|0|||
164139378|NCT03753763|592872092|FG000|Overall Study|Withdrawal by Subject|3|||
164139379|NCT03753763|592872093|FG001|Overall Study|Withdrawal by Subject|1|||
164139380|NCT03753763|592872092|FG000|Overall Study|clinical deterioration|1|||
164333351|NCT00406354|593597404|FG000|All Randomized and Treated Patients|Physician Decision|0|||
164333352|NCT00406354|593597405|FG001|All Randomized and Treated Patients|Physician Decision|0|||
163883940|NCT05409183|591944008|FG000|Complete Study|Withdrawal by Subject|3|||
163883941|NCT05409183|591944009|FG001|Complete Study|Withdrawal by Subject|0|||
163883942|NCT02274662|591944010|FG000|Overall Study|Death|1|||
163883943|NCT02274662|591944010|FG000|Overall Study|Lost to Follow-up|3|||
163883944|NCT03364647|591944012|FG000|Overall Study|Withdrawal by Subject|3|||
163883945|NCT03364647|591944013|FG001|Overall Study|Withdrawal by Subject|1|||
163883946|NCT03476460|591944014|FG000|Overall Study|Withdrawal by Subject|3|||
163883947|NCT03476460|591944015|FG001|Overall Study|Withdrawal by Subject|2|||
163883948|NCT03476460|591944014|FG000|Overall Study|Non-compliance with treatment|3|||
163883949|NCT03476460|591944015|FG001|Overall Study|Non-compliance with treatment|0|||
163883950|NCT03476460|591944014|FG000|Overall Study|Missing laboratory tests|5|||
163883951|NCT03476460|591944015|FG001|Overall Study|Missing laboratory tests|5|||
163883952|NCT03476460|591944014|FG000|Overall Study|Adverse Event|0|||
163883953|NCT03476460|591944015|FG001|Overall Study|Adverse Event|1|||
163883954|NCT04810650|591944022|FG000|Overall Study|Disenrolled in error|0|||
163883955|NCT04810650|591944023|FG001|Overall Study|Disenrolled in error|0|||
163883956|NCT04810650|591944024|FG002|Overall Study|Disenrolled in error|0|||
164139458|NCT00359801|592874050|FG001|Overall Study|Sponsor Decision|16|||
163883957|NCT04810650|591944025|FG003|Overall Study|Disenrolled in error|0|||
163883958|NCT04810650|591944026|FG004|Overall Study|Disenrolled in error|0|||
163883959|NCT04810650|591944027|FG005|Overall Study|Disenrolled in error|0|||
163883960|NCT04810650|591944028|FG006|Overall Study|Disenrolled in error|0|||
163883961|NCT04810650|591944029|FG007|Overall Study|Disenrolled in error|0|||
163883962|NCT04810650|591944030|FG008|Overall Study|Disenrolled in error|1|||
164139459|NCT02929056|592874057|FG000|Overall Study|Lost to Follow-up|0|||
164139460|NCT02929056|592874058|FG001|Overall Study|Lost to Follow-up|1|||
164139461|NCT02245412|592874064|FG000|Treatment Period|Death|1|||
164139462|NCT02245412|592874065|FG001|Treatment Period|Death|1|||
164139463|NCT02245412|592874066|FG002|Treatment Period|Death|0|||
164139464|NCT02245412|592874064|FG000|Treatment Period|Physician Decision|1|||
164139465|NCT02245412|592874065|FG001|Treatment Period|Physician Decision|1|||
164139466|NCT02245412|592874066|FG002|Treatment Period|Physician Decision|0|||
164139467|NCT02245412|592874064|FG000|Treatment Period|Withdrawal by Subject|2|||
164139468|NCT02245412|592874065|FG001|Treatment Period|Withdrawal by Subject|1|||
164139469|NCT02245412|592874066|FG002|Treatment Period|Withdrawal by Subject|0|||
164139470|NCT02245412|592874064|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
164139471|NCT02245412|592874065|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
164139472|NCT02245412|592874066|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
164139473|NCT02245412|592874064|FG000|Follow-Up Period|Death|4|||
164139474|NCT02245412|592874065|FG001|Follow-Up Period|Death|2|||
164139475|NCT02245412|592874066|FG002|Follow-Up Period|Death|1|||
164139476|NCT02245412|592874064|FG000|Follow-Up Period|Physician Decision|1|||
164139477|NCT02245412|592874065|FG001|Follow-Up Period|Physician Decision|0|||
164139478|NCT02245412|592874066|FG002|Follow-Up Period|Physician Decision|0|||
164139479|NCT02245412|592874064|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
164139480|NCT02245412|592874065|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
164139481|NCT02245412|592874066|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
164139482|NCT01056289|592874067|FG000|Open-label Phase|Adverse Event|29|||
164139483|NCT01056289|592874068|FG001|Open-label Phase|Adverse Event|0|||
164139484|NCT01056289|592874069|FG002|Open-label Phase|Adverse Event|0|||
164139485|NCT01056289|592874070|FG003|Open-label Phase|Adverse Event|0|||
164139486|NCT01056289|592874067|FG000|Open-label Phase|Lost to Follow-up|30|||
164139487|NCT01056289|592874068|FG001|Open-label Phase|Lost to Follow-up|0|||
164139488|NCT01056289|592874069|FG002|Open-label Phase|Lost to Follow-up|0|||
164139489|NCT01056289|592874070|FG003|Open-label Phase|Lost to Follow-up|0|||
164139490|NCT01056289|592874067|FG000|Open-label Phase|Other|9|||
164139491|NCT01056289|592874068|FG001|Open-label Phase|Other|0|||
164139492|NCT01056289|592874069|FG002|Open-label Phase|Other|0|||
164139493|NCT01056289|592874070|FG003|Open-label Phase|Other|0|||
164139494|NCT01056289|592874067|FG000|Open-label Phase|Protocol Violation|6|||
164139495|NCT01056289|592874068|FG001|Open-label Phase|Protocol Violation|0|||
164139496|NCT01056289|592874069|FG002|Open-label Phase|Protocol Violation|0|||
164139497|NCT01056289|592874070|FG003|Open-label Phase|Protocol Violation|0|||
164139498|NCT01056289|592874067|FG000|Open-label Phase|Withdrawal by Subject|26|||
164139499|NCT01056289|592874068|FG001|Open-label Phase|Withdrawal by Subject|0|||
164139500|NCT01056289|592874069|FG002|Open-label Phase|Withdrawal by Subject|0|||
164139501|NCT01056289|592874070|FG003|Open-label Phase|Withdrawal by Subject|0|||
164139502|NCT01056289|592874067|FG000|Open-label Phase|Lack of Efficacy|18|||
164139503|NCT01056289|592874068|FG001|Open-label Phase|Lack of Efficacy|0|||
164139504|NCT01056289|592874069|FG002|Open-label Phase|Lack of Efficacy|0|||
164139505|NCT01056289|592874070|FG003|Open-label Phase|Lack of Efficacy|0|||
164139506|NCT01056289|592874067|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
164143353|NCT03597295|592886602|FG000|Overall Study|Lost to Follow-up|7|||
164333353|NCT00406354|593597406|FG002|All Randomized and Treated Patients|Physician Decision|1|||
164333354|NCT03438383|593597423|FG000|Overall Study|Protocol Violation|9|||
164333355|NCT03438383|593597424|FG001|Overall Study|Protocol Violation|3|||
164333356|NCT02435069|593597425|FG000|Dose Response - First Intervention|Adverse Event|0|||
164333357|NCT02435069|593597426|FG001|Dose Response - First Intervention|Adverse Event|1|||
164333358|NCT02435069|593597427|FG002|Dose Response - First Intervention|Adverse Event|1|||
164333359|NCT02435069|593597428|FG003|Dose Response - First Intervention|Adverse Event|0|||
164333360|NCT02435069|593597429|FG004|Dose Response - First Intervention|Adverse Event|0|||
164333361|NCT02435069|593597425|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333362|NCT02435069|593597426|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333363|NCT02435069|593597427|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333364|NCT02435069|593597428|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
164333365|NCT02435069|593597429|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
164333366|NCT02030938|593597434|FG000|Overall Study|Lost to Follow-up|4|||
164333367|NCT02030938|593597434|FG000|Overall Study|Withdrawal by Subject|1|||
164333368|NCT03954132|593597436|FG000|Overall Study|Adverse Event|2|||
164333369|NCT03954132|593597437|FG001|Overall Study|Adverse Event|0|||
164333370|NCT03954132|593597436|FG000|Overall Study|Patient's wish|5|||
164333371|NCT03954132|593597437|FG001|Overall Study|Patient's wish|0|||
164333372|NCT03954132|593597436|FG000|Overall Study|Lost to Follow-up|10|||
164333373|NCT03954132|593597437|FG001|Overall Study|Lost to Follow-up|0|||
164333374|NCT03954132|593597436|FG000|Overall Study|Screening failure|0|||
164333375|NCT03954132|593597437|FG001|Overall Study|Screening failure|1|||
164333376|NCT03954132|593597436|FG000|Overall Study|No registration after Visit 1|5|||
164333377|NCT03954132|593597437|FG001|Overall Study|No registration after Visit 1|2|||
164333378|NCT03954132|593597436|FG000|Overall Study|Other reason than listed|2|||
164333379|NCT03954132|593597437|FG001|Overall Study|Other reason than listed|2|||
164333380|NCT03954132|593597436|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
164333381|NCT03954132|593597437|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
164333382|NCT03954132|593597436|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
164333383|NCT03954132|593597437|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
164333384|NCT00932737|593597440|FG000|Overall Study|Not treated in second episode|1|||
164333385|NCT00932737|593597441|FG001|Overall Study|Not treated in second episode|0|||
164333386|NCT00932737|593597440|FG000|Overall Study|Adverse Event|0|||
164333387|NCT00932737|593597441|FG001|Overall Study|Adverse Event|1|||
164333388|NCT05156073|593597444|FG000|Overall Study|Patient canceled appointment with PCP|1|||
164333389|NCT00973349|593597445|FG000|Overall Study|Adverse Event|0|||
164333390|NCT00973349|593597446|FG001|Overall Study|Adverse Event|0|||
164333391|NCT00973349|593597447|FG002|Overall Study|Adverse Event|0|||
164333392|NCT00973349|593597448|FG003|Overall Study|Adverse Event|0|||
164333393|NCT00973349|593597449|FG004|Overall Study|Adverse Event|1|||
164333394|NCT00973349|593597450|FG005|Overall Study|Adverse Event|0|||
164333395|NCT00973349|593597451|FG006|Overall Study|Adverse Event|0|||
164333396|NCT00973349|593597452|FG007|Overall Study|Adverse Event|0|||
164333397|NCT00973349|593597453|FG008|Overall Study|Adverse Event|1|||
164333398|NCT00973349|593597454|FG009|Overall Study|Adverse Event|0|||
164333399|NCT00973349|593597455|FG010|Overall Study|Adverse Event|0|||
164333400|NCT00973349|593597456|FG011|Overall Study|Adverse Event|0|||
164333401|NCT00973349|593597457|FG012|Overall Study|Adverse Event|0|||
164333402|NCT00973349|593597458|FG013|Overall Study|Adverse Event|0|||
164333403|NCT00973349|593597459|FG014|Overall Study|Adverse Event|1|||
164333404|NCT00973349|593597460|FG015|Overall Study|Adverse Event|0|||
164333405|NCT00973349|593597445|FG000|Overall Study|Withdrawal by Subject|1|||
164333406|NCT00973349|593597446|FG001|Overall Study|Withdrawal by Subject|2|||
163883963|NCT04810650|591944031|FG009|Overall Study|Disenrolled in error|0|||
163883964|NCT04810650|591944032|FG010|Overall Study|Disenrolled in error|0|||
163883965|NCT04810650|591944033|FG011|Overall Study|Disenrolled in error|0|||
163883966|NCT04810650|591944034|FG012|Overall Study|Disenrolled in error|0|||
163883967|NCT04810650|591944035|FG013|Overall Study|Disenrolled in error|0|||
163883968|NCT04810650|591944022|FG000|Overall Study|Death|0|||
163883969|NCT04810650|591944023|FG001|Overall Study|Death|0|||
163883970|NCT04810650|591944024|FG002|Overall Study|Death|0|||
163883971|NCT04810650|591944025|FG003|Overall Study|Death|0|||
163883972|NCT04810650|591944026|FG004|Overall Study|Death|0|||
163883973|NCT04810650|591944027|FG005|Overall Study|Death|0|||
163883974|NCT04810650|591944028|FG006|Overall Study|Death|2|||
163883975|NCT04810650|591944029|FG007|Overall Study|Death|2|||
163883976|NCT04810650|591944030|FG008|Overall Study|Death|0|||
163883977|NCT04810650|591944031|FG009|Overall Study|Death|1|||
163883978|NCT04810650|591944032|FG010|Overall Study|Death|0|||
163883979|NCT04810650|591944033|FG011|Overall Study|Death|0|||
163883980|NCT04810650|591944034|FG012|Overall Study|Death|2|||
163883981|NCT04810650|591944035|FG013|Overall Study|Death|1|||
163883982|NCT04810650|591944022|FG000|Overall Study|Moved/transferred care|0|||
163883983|NCT04810650|591944023|FG001|Overall Study|Moved/transferred care|0|||
164333407|NCT00973349|593597447|FG002|Overall Study|Withdrawal by Subject|2|||
164333408|NCT00973349|593597448|FG003|Overall Study|Withdrawal by Subject|3|||
164333409|NCT00973349|593597449|FG004|Overall Study|Withdrawal by Subject|2|||
164333410|NCT00973349|593597450|FG005|Overall Study|Withdrawal by Subject|0|||
164333411|NCT00973349|593597451|FG006|Overall Study|Withdrawal by Subject|2|||
164333412|NCT00973349|593597452|FG007|Overall Study|Withdrawal by Subject|2|||
164333413|NCT00973349|593597453|FG008|Overall Study|Withdrawal by Subject|0|||
164333414|NCT00973349|593597454|FG009|Overall Study|Withdrawal by Subject|2|||
164333415|NCT00973349|593597455|FG010|Overall Study|Withdrawal by Subject|0|||
164333416|NCT00973349|593597456|FG011|Overall Study|Withdrawal by Subject|1|||
164333417|NCT00973349|593597457|FG012|Overall Study|Withdrawal by Subject|0|||
164333418|NCT00973349|593597458|FG013|Overall Study|Withdrawal by Subject|0|||
164333419|NCT00973349|593597459|FG014|Overall Study|Withdrawal by Subject|0|||
164333420|NCT00973349|593597460|FG015|Overall Study|Withdrawal by Subject|0|||
164333421|NCT00973349|593597445|FG000|Overall Study|Lost to Follow-up|3|||
164333422|NCT00973349|593597446|FG001|Overall Study|Lost to Follow-up|1|||
164234354|NCT00862940|593229225|FG001|Overall Study|Lost to Follow-up|1|||
164234355|NCT00862940|593229224|FG000|Overall Study|Administrative or other reason(s)|4|||
164234356|NCT00862940|593229225|FG001|Overall Study|Administrative or other reason(s)|3|||
164234357|NCT00485173|593229226|FG000|Overall Study|Death|4|||
164234358|NCT00485173|593229227|FG001|Overall Study|Death|3|||
164234359|NCT00485173|593229226|FG000|Overall Study|Lost to Follow-up|32|||
164234360|NCT00485173|593229227|FG001|Overall Study|Lost to Follow-up|61|||
164234361|NCT00879398|593229230|FG000|Overall Study|Visit Stop|399|||
164234362|NCT00879398|593229230|FG000|Overall Study|Lack of Efficacy|64|||
164234363|NCT00879398|593229230|FG000|Overall Study|Adverse Event|41|||
164234364|NCT00879398|593229230|FG000|Overall Study|Other Reasons|171|||
164234365|NCT00829244|593229231|FG000|Overall Study|Adverse Event|1|||
164234366|NCT00829244|593229232|FG001|Overall Study|Adverse Event|3|||
164234367|NCT00829244|593229231|FG000|Overall Study|Protocol Violation|1|||
164234368|NCT00829244|593229232|FG001|Overall Study|Protocol Violation|0|||
164234369|NCT00829244|593229231|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
164234370|NCT00829244|593229232|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
164234371|NCT00829244|593229231|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
164234372|NCT00829244|593229232|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
164234373|NCT00829244|593229231|FG000|Overall Study|No fertilization|2|||
164234374|NCT00829244|593229232|FG001|Overall Study|No fertilization|2|||
164234375|NCT00829244|593229231|FG000|Overall Study|All embryos discarded|0|||
164234376|NCT00829244|593229232|FG001|Overall Study|All embryos discarded|3|||
164234377|NCT00829244|593229231|FG000|Overall Study|No embryo cleavage|0|||
164234378|NCT00829244|593229232|FG001|Overall Study|No embryo cleavage|2|||
164234379|NCT04251533|593229237|FG000|Overall Study|Progressive disease|33|||
164234380|NCT04251533|593229238|FG001|Overall Study|Progressive disease|29|||
164234381|NCT04251533|593229239|FG002|Overall Study|Progressive disease|22|||
164234382|NCT04251533|593229237|FG000|Overall Study|Death|5|||
164234383|NCT04251533|593229238|FG001|Overall Study|Death|1|||
164234384|NCT04251533|593229239|FG002|Overall Study|Death|3|||
164234385|NCT04251533|593229237|FG000|Overall Study|Physician Decision|3|||
164234386|NCT04251533|593229238|FG001|Overall Study|Physician Decision|2|||
164234387|NCT04251533|593229239|FG002|Overall Study|Physician Decision|4|||
164234388|NCT04251533|593229237|FG000|Overall Study|Participant decision|1|||
164234389|NCT04251533|593229238|FG001|Overall Study|Participant decision|3|||
164234390|NCT04251533|593229239|FG002|Overall Study|Participant decision|1|||
164234391|NCT04251533|593229237|FG000|Overall Study|Adverse Event|2|||
164234392|NCT04251533|593229238|FG001|Overall Study|Adverse Event|1|||
164234393|NCT04251533|593229239|FG002|Overall Study|Adverse Event|1|||
164234394|NCT04583618|593229247|FG000|Overall Study|Adverse Event|0|||
164234395|NCT04583618|593229248|FG001|Overall Study|Adverse Event|0|||
164234396|NCT04583618|593229249|FG002|Overall Study|Adverse Event|1|||
164234397|NCT04583618|593229250|FG003|Overall Study|Adverse Event|0|||
164234398|NCT04583618|593229251|FG004|Overall Study|Adverse Event|0|||
163987651|NCT01325428|592322412|FG000|Part A|Other reason not defined above|2|||
163987652|NCT01325428|592322412|FG000|Part B|Refused continue taking trial medication|2|||
163987653|NCT01325428|592322412|FG000|Part B|Other reason not defined above|1|||
163987654|NCT04849780|592322413|FG000|Period 1|Covid-19 Related|1|||
163987655|NCT04849780|592322414|FG001|Period 1|Covid-19 Related|0|||
163987656|NCT04849780|592322413|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
163987657|NCT04849780|592322414|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
163987658|NCT04849780|592322413|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
164234399|NCT04583618|593229247|FG000|Overall Study|Protocol deviation|1|||
164333423|NCT00973349|593597447|FG002|Overall Study|Lost to Follow-up|2|||
164333424|NCT00973349|593597448|FG003|Overall Study|Lost to Follow-up|2|||
164333425|NCT00973349|593597449|FG004|Overall Study|Lost to Follow-up|1|||
164333426|NCT00973349|593597450|FG005|Overall Study|Lost to Follow-up|3|||
164234400|NCT04583618|593229248|FG001|Overall Study|Protocol deviation|1|||
164234401|NCT04583618|593229249|FG002|Overall Study|Protocol deviation|1|||
164234402|NCT04583618|593229250|FG003|Overall Study|Protocol deviation|0|||
164333427|NCT00973349|593597451|FG006|Overall Study|Lost to Follow-up|0|||
164333428|NCT00973349|593597452|FG007|Overall Study|Lost to Follow-up|1|||
164333429|NCT00973349|593597453|FG008|Overall Study|Lost to Follow-up|2|||
164333430|NCT00973349|593597454|FG009|Overall Study|Lost to Follow-up|1|||
164333431|NCT00973349|593597455|FG010|Overall Study|Lost to Follow-up|0|||
164333432|NCT00973349|593597456|FG011|Overall Study|Lost to Follow-up|1|||
164333433|NCT00973349|593597457|FG012|Overall Study|Lost to Follow-up|0|||
164333434|NCT00973349|593597458|FG013|Overall Study|Lost to Follow-up|0|||
164333435|NCT00973349|593597459|FG014|Overall Study|Lost to Follow-up|0|||
164333436|NCT00973349|593597460|FG015|Overall Study|Lost to Follow-up|1|||
164333437|NCT00973349|593597445|FG000|Overall Study|Inappropriate enrolment|0|||
164333438|NCT00973349|593597446|FG001|Overall Study|Inappropriate enrolment|0|||
164333439|NCT00973349|593597447|FG002|Overall Study|Inappropriate enrolment|1|||
164333440|NCT00973349|593597448|FG003|Overall Study|Inappropriate enrolment|0|||
164333441|NCT00973349|593597449|FG004|Overall Study|Inappropriate enrolment|0|||
164333442|NCT00973349|593597450|FG005|Overall Study|Inappropriate enrolment|0|||
164333443|NCT00973349|593597451|FG006|Overall Study|Inappropriate enrolment|0|||
164333444|NCT00973349|593597452|FG007|Overall Study|Inappropriate enrolment|0|||
164333445|NCT00973349|593597453|FG008|Overall Study|Inappropriate enrolment|0|||
164333446|NCT00973349|593597454|FG009|Overall Study|Inappropriate enrolment|2|||
164333447|NCT00973349|593597455|FG010|Overall Study|Inappropriate enrolment|0|||
164333448|NCT00973349|593597456|FG011|Overall Study|Inappropriate enrolment|0|||
164333449|NCT00973349|593597457|FG012|Overall Study|Inappropriate enrolment|1|||
164333450|NCT00973349|593597458|FG013|Overall Study|Inappropriate enrolment|0|||
164333451|NCT00973349|593597459|FG014|Overall Study|Inappropriate enrolment|1|||
164333452|NCT00973349|593597460|FG015|Overall Study|Inappropriate enrolment|1|||
164333453|NCT00973349|593597445|FG000|Overall Study|Protocol Violation|0|||
163883984|NCT04810650|591944024|FG002|Overall Study|Moved/transferred care|0|||
163883985|NCT04810650|591944025|FG003|Overall Study|Moved/transferred care|0|||
163883986|NCT04810650|591944026|FG004|Overall Study|Moved/transferred care|0|||
163883987|NCT04810650|591944027|FG005|Overall Study|Moved/transferred care|0|||
163883988|NCT04810650|591944028|FG006|Overall Study|Moved/transferred care|0|||
163883989|NCT04810650|591944029|FG007|Overall Study|Moved/transferred care|1|||
163883990|NCT04810650|591944030|FG008|Overall Study|Moved/transferred care|12|||
163883991|NCT04810650|591944031|FG009|Overall Study|Moved/transferred care|10|||
163883992|NCT04810650|591944032|FG010|Overall Study|Moved/transferred care|0|||
163883993|NCT04810650|591944033|FG011|Overall Study|Moved/transferred care|0|||
163883994|NCT04810650|591944034|FG012|Overall Study|Moved/transferred care|0|||
163883995|NCT04810650|591944035|FG013|Overall Study|Moved/transferred care|0|||
163883996|NCT04810650|591944022|FG000|Overall Study|Lost to Follow-up|15|||
163883997|NCT04810650|591944023|FG001|Overall Study|Lost to Follow-up|12|||
163883998|NCT04810650|591944024|FG002|Overall Study|Lost to Follow-up|7|||
163883999|NCT04810650|591944025|FG003|Overall Study|Lost to Follow-up|9|||
163884000|NCT04810650|591944026|FG004|Overall Study|Lost to Follow-up|10|||
163884001|NCT04810650|591944027|FG005|Overall Study|Lost to Follow-up|6|||
163884002|NCT04810650|591944028|FG006|Overall Study|Lost to Follow-up|0|||
163884003|NCT04810650|591944029|FG007|Overall Study|Lost to Follow-up|0|||
163884004|NCT04810650|591944030|FG008|Overall Study|Lost to Follow-up|0|||
163884005|NCT04810650|591944031|FG009|Overall Study|Lost to Follow-up|0|||
163884006|NCT04810650|591944032|FG010|Overall Study|Lost to Follow-up|1|||
163884007|NCT04810650|591944033|FG011|Overall Study|Lost to Follow-up|0|||
163884008|NCT04810650|591944034|FG012|Overall Study|Lost to Follow-up|3|||
163884009|NCT04810650|591944035|FG013|Overall Study|Lost to Follow-up|9|||
163884010|NCT04810650|591944022|FG000|Overall Study|Participant declined|0|||
163884011|NCT04810650|591944023|FG001|Overall Study|Participant declined|0|||
163884012|NCT04810650|591944024|FG002|Overall Study|Participant declined|0|||
163884013|NCT04810650|591944025|FG003|Overall Study|Participant declined|0|||
163884014|NCT04810650|591944026|FG004|Overall Study|Participant declined|0|||
163884015|NCT04810650|591944027|FG005|Overall Study|Participant declined|0|||
163884016|NCT04810650|591944028|FG006|Overall Study|Participant declined|0|||
163884017|NCT04810650|591944029|FG007|Overall Study|Participant declined|0|||
163884018|NCT04810650|591944030|FG008|Overall Study|Participant declined|0|||
163884019|NCT04810650|591944031|FG009|Overall Study|Participant declined|0|||
163884020|NCT04810650|591944032|FG010|Overall Study|Participant declined|2|||
163884021|NCT04810650|591944033|FG011|Overall Study|Participant declined|0|||
163884022|NCT04810650|591944034|FG012|Overall Study|Participant declined|0|||
163884023|NCT04810650|591944035|FG013|Overall Study|Participant declined|0|||
163884024|NCT05008835|591944037|FG000|Overall Study|Adverse Event|5|||
163884025|NCT05008835|591944038|FG001|Overall Study|Adverse Event|2|||
163884026|NCT05008835|591944039|FG002|Overall Study|Adverse Event|1|||
163884027|NCT05008835|591944037|FG000|Overall Study|Lack of Efficacy|0|||
163987659|NCT04849780|592322414|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
163987660|NCT00725075|592322415|FG000|Overall Study|Use of Excluded Medication|0|||
163987661|NCT00725075|592322416|FG001|Overall Study|Use of Excluded Medication|1|||
163987662|NCT00725075|592322417|FG002|Overall Study|Use of Excluded Medication|0|||
164333454|NCT00973349|593597446|FG001|Overall Study|Protocol Violation|0|||
164333455|NCT00973349|593597447|FG002|Overall Study|Protocol Violation|0|||
163987663|NCT00725075|592322415|FG000|Overall Study|Protocol Violation|0|||
163987664|NCT00725075|592322416|FG001|Overall Study|Protocol Violation|0|||
163987665|NCT00725075|592322417|FG002|Overall Study|Protocol Violation|1|||
163987666|NCT00725075|592322415|FG000|Overall Study|Lost to Follow-up|1|||
163987667|NCT00725075|592322416|FG001|Overall Study|Lost to Follow-up|0|||
163987668|NCT00725075|592322417|FG002|Overall Study|Lost to Follow-up|0|||
163987669|NCT00725075|592322415|FG000|Overall Study|Withdrawal by Subject|4|||
163987670|NCT00725075|592322416|FG001|Overall Study|Withdrawal by Subject|5|||
163987671|NCT00725075|592322417|FG002|Overall Study|Withdrawal by Subject|4|||
163987672|NCT00725075|592322415|FG000|Overall Study|Adverse Event|2|||
163987673|NCT00725075|592322416|FG001|Overall Study|Adverse Event|1|||
163987674|NCT00725075|592322417|FG002|Overall Study|Adverse Event|1|||
163987675|NCT00725075|592322415|FG000|Overall Study|Worsening of Disease|2|||
163987676|NCT00725075|592322416|FG001|Overall Study|Worsening of Disease|1|||
163987677|NCT00725075|592322417|FG002|Overall Study|Worsening of Disease|2|||
163987678|NCT00725075|592322415|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
163987679|NCT00725075|592322416|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
163987680|NCT00725075|592322417|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
163987681|NCT00725075|592322415|FG000|Overall Study|Other|1|||
163987682|NCT00725075|592322416|FG001|Overall Study|Other|0|||
163987683|NCT00725075|592322417|FG002|Overall Study|Other|0|||
163987684|NCT01298492|592322418|FG000|Overall Study|Death|2|||
163987685|NCT01298492|592322418|FG000|Overall Study|Insufficient Clinical Response|22|||
163987686|NCT01298492|592322418|FG000|Overall Study|Lost to Follow-up|12|||
163987687|NCT01298492|592322418|FG000|Overall Study|Withdrawal by Subject|47|||
163987688|NCT01298492|592322418|FG000|Overall Study|Other (Unspecified)|7|||
163987689|NCT01298492|592322418|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
163987690|NCT01298492|592322418|FG000|Overall Study|Protocol Violation|2|||
163987691|NCT01298492|592322418|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
163987692|NCT01298492|592322418|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
163987693|NCT02340663|592322419|FG000|Overall Study|Lost to Follow-up|1|||
163987694|NCT02340663|592322420|FG001|Overall Study|Lost to Follow-up|0|||
163987695|NCT02340663|592322419|FG000|Overall Study|Protocol Violation|1|||
163987696|NCT02340663|592322420|FG001|Overall Study|Protocol Violation|0|||
163987697|NCT02340663|592322419|FG000|Overall Study|Withdrawal by Subject|3|||
163987698|NCT02340663|592322420|FG001|Overall Study|Withdrawal by Subject|1|||
163987699|NCT00087646|592322421|FG000|Overall Study|Adverse Event|37|||
163987700|NCT00087646|592322422|FG001|Overall Study|Adverse Event|6|||
163987701|NCT00087646|592322423|FG002|Overall Study|Adverse Event|18|||
163987702|NCT00087646|592322424|FG003|Overall Study|Adverse Event|20|||
163987703|NCT00087646|592322421|FG000|Overall Study|Death|0|||
163987704|NCT00087646|592322422|FG001|Overall Study|Death|1|||
163987705|NCT00087646|592322423|FG002|Overall Study|Death|0|||
163987706|NCT00087646|592322424|FG003|Overall Study|Death|0|||
163987707|NCT00087646|592322421|FG000|Overall Study|Withdrawal by Subject|6|||
163987708|NCT00087646|592322422|FG001|Overall Study|Withdrawal by Subject|1|||
163987709|NCT00087646|592322423|FG002|Overall Study|Withdrawal by Subject|2|||
163987710|NCT00087646|592322424|FG003|Overall Study|Withdrawal by Subject|2|||
163987711|NCT00087646|592322421|FG000|Overall Study|Insufficient therapeutic response|64|||
163987712|NCT00087646|592322422|FG001|Overall Study|Insufficient therapeutic response|24|||
163987713|NCT00087646|592322423|FG002|Overall Study|Insufficient therapeutic response|38|||
163987714|NCT00087646|592322424|FG003|Overall Study|Insufficient therapeutic response|51|||
163987715|NCT00087646|592322421|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
163987716|NCT00087646|592322422|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
163987717|NCT00087646|592322423|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
163987718|NCT00087646|592322424|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
163987719|NCT00087646|592322421|FG000|Overall Study|Failure to Return|5|||
163987720|NCT00087646|592322422|FG001|Overall Study|Failure to Return|2|||
163987721|NCT00087646|592322423|FG002|Overall Study|Failure to Return|2|||
163987722|NCT00087646|592322424|FG003|Overall Study|Failure to Return|3|||
163987723|NCT00087646|592322421|FG000|Overall Study|Administrative/Other|6|||
163987724|NCT00087646|592322422|FG001|Overall Study|Administrative/Other|1|||
163987725|NCT00087646|592322423|FG002|Overall Study|Administrative/Other|1|||
163987726|NCT00087646|592322424|FG003|Overall Study|Administrative/Other|2|||
163987727|NCT00087646|592322421|FG000|Overall Study|Other Protocol Violation|3|||
163987728|NCT00087646|592322422|FG001|Overall Study|Other Protocol Violation|1|||
163987729|NCT00087646|592322423|FG002|Overall Study|Other Protocol Violation|0|||
163987730|NCT00087646|592322424|FG003|Overall Study|Other Protocol Violation|0|||
163987731|NCT00087646|592322421|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
163987732|NCT00087646|592322422|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
163987733|NCT00087646|592322423|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
163987734|NCT00087646|592322424|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
163987735|NCT03694925|592322427|FG000|Overall Study|Inadequate laboratory testing|0|||
163987736|NCT03694925|592322428|FG001|Overall Study|Inadequate laboratory testing|3|||
163987737|NCT03694925|592322429|FG002|Overall Study|Inadequate laboratory testing|0|||
163987738|NCT01422239|592322430|FG000|Overall Study|Lost to Follow-up|4|||
163987739|NCT01422239|592322431|FG001|Overall Study|Lost to Follow-up|3|||
163987740|NCT03033875|592322436|FG000|Overall Study|Withdrawal by Subject|5|||
163987741|NCT03033875|592322437|FG001|Overall Study|Withdrawal by Subject|9|||
163987742|NCT03033875|592322438|FG002|Overall Study|Withdrawal by Subject|4|||
163987743|NCT03033875|592322436|FG000|Overall Study|Other|14|||
163987744|NCT03033875|592322437|FG001|Overall Study|Other|15|||
163987745|NCT03033875|592322438|FG002|Overall Study|Other|8|||
163987746|NCT00911989|592322442|FG000|Overall Study|Adverse Event|1|||
163987747|NCT03434977|592322443|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
163987748|NCT03434977|592322444|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
163987749|NCT01145066|592322445|FG000|Overall Study|To resume NSAIDs|2|||
163987750|NCT01145066|592322446|FG001|Overall Study|To resume NSAIDs|2|||
163987751|NCT01145066|592322447|FG002|Overall Study|To resume NSAIDs|1|||
163987752|NCT01145066|592322445|FG000|Overall Study|Non-related surgery|0|||
164234403|NCT04583618|593229251|FG004|Overall Study|Protocol deviation|0|||
164234404|NCT04583618|593229247|FG000|Overall Study|Withdrawal by Subject|2|||
164234405|NCT04583618|593229248|FG001|Overall Study|Withdrawal by Subject|1|||
164234406|NCT04583618|593229249|FG002|Overall Study|Withdrawal by Subject|3|||
164234407|NCT04583618|593229250|FG003|Overall Study|Withdrawal by Subject|1|||
164234408|NCT04583618|593229251|FG004|Overall Study|Withdrawal by Subject|1|||
164234409|NCT04583618|593229247|FG000|Overall Study|Lost to Follow-up|0|||
164234410|NCT04583618|593229248|FG001|Overall Study|Lost to Follow-up|1|||
164234411|NCT04583618|593229249|FG002|Overall Study|Lost to Follow-up|3|||
164234412|NCT04583618|593229250|FG003|Overall Study|Lost to Follow-up|1|||
164234413|NCT04583618|593229251|FG004|Overall Study|Lost to Follow-up|1|||
164234414|NCT02302222|593229254|FG000|Overall Study|Physician Decision|0|||
164234415|NCT02302222|593229255|FG001|Overall Study|Physician Decision|4|||
164234416|NCT02302222|593229254|FG000|Overall Study|Lost to Follow-up|1|||
164234417|NCT02302222|593229255|FG001|Overall Study|Lost to Follow-up|0|||
164234418|NCT02302222|593229254|FG000|Overall Study|Treatment discontinued before day 5|0|||
164234419|NCT02302222|593229255|FG001|Overall Study|Treatment discontinued before day 5|1|||
164234420|NCT02302222|593229254|FG000|Overall Study|Withdrawn prior to any treatment|0|||
164234421|NCT02302222|593229255|FG001|Overall Study|Withdrawn prior to any treatment|1|||
164234422|NCT00016354|593229256|FG000|Overall Study|Lack of Efficacy|0|||
164234423|NCT00016354|593229257|FG001|Overall Study|Lack of Efficacy|0|||
163987753|NCT01145066|592322446|FG001|Overall Study|Non-related surgery|0|||
163987754|NCT01145066|592322447|FG002|Overall Study|Non-related surgery|1|||
163987755|NCT01145066|592322445|FG000|Overall Study|Withdrawal by Subject|0|||
163987756|NCT01145066|592322446|FG001|Overall Study|Withdrawal by Subject|0|||
164234424|NCT00016354|593229258|FG002|Overall Study|Lack of Efficacy|0|||
164234425|NCT00016354|593229259|FG003|Overall Study|Lack of Efficacy|0|||
164234426|NCT00016354|593229260|FG004|Overall Study|Lack of Efficacy|0|||
164234427|NCT00016354|593229261|FG005|Overall Study|Lack of Efficacy|0|||
164234428|NCT00016354|593229262|FG006|Overall Study|Lack of Efficacy|0|||
164234429|NCT00016354|593229263|FG007|Overall Study|Lack of Efficacy|1|||
164234430|NCT02769481|593229266|FG000|Overall Study|Protocol Violation|1|||
163987757|NCT01145066|592322447|FG002|Overall Study|Withdrawal by Subject|2|||
164234431|NCT02769481|593229267|FG001|Overall Study|Protocol Violation|0|||
164234432|NCT02769481|593229266|FG000|Overall Study|Adverse Event|3|||
164234433|NCT02769481|593229267|FG001|Overall Study|Adverse Event|6|||
164234434|NCT02769481|593229266|FG000|Overall Study|Entry Criteria Not Met|1|||
164234435|NCT02769481|593229267|FG001|Overall Study|Entry Criteria Not Met|2|||
164234436|NCT02769481|593229266|FG000|Overall Study|Withdrawal by Subject|14|||
164234437|NCT02769481|593229267|FG001|Overall Study|Withdrawal by Subject|16|||
164234438|NCT02769481|593229266|FG000|Overall Study|Lost to Follow-up|9|||
164234439|NCT02769481|593229267|FG001|Overall Study|Lost to Follow-up|9|||
164234440|NCT02769481|593229266|FG000|Overall Study|Physician Decision|0|||
164234441|NCT02769481|593229267|FG001|Overall Study|Physician Decision|1|||
164234442|NCT02769481|593229266|FG000|Overall Study|Terminated by Sponsor|1|||
164234443|NCT02769481|593229267|FG001|Overall Study|Terminated by Sponsor|0|||
164234444|NCT02769481|593229266|FG000|Overall Study|Death|0|||
164333456|NCT00973349|593597448|FG003|Overall Study|Protocol Violation|0|||
164234445|NCT02769481|593229267|FG001|Overall Study|Death|1|||
164234446|NCT02769481|593229266|FG000|Overall Study|Undefined|4|||
164234447|NCT02769481|593229267|FG001|Overall Study|Undefined|1|||
164234448|NCT02781558|593229268|FG000|Overall Study|Lost to Follow-up|2|||
163987758|NCT01145066|592322445|FG000|Overall Study|To start new med|1|||
163987759|NCT01145066|592322446|FG001|Overall Study|To start new med|0|||
163987760|NCT01145066|592322447|FG002|Overall Study|To start new med|0|||
163987761|NCT01145066|592322445|FG000|Overall Study|problems swallowing capsule|1|||
163987762|NCT01145066|592322446|FG001|Overall Study|problems swallowing capsule|0|||
163987763|NCT01145066|592322447|FG002|Overall Study|problems swallowing capsule|0|||
163987764|NCT01145066|592322445|FG000|Overall Study|Abdominal discomfort|0|||
163987765|NCT01145066|592322446|FG001|Overall Study|Abdominal discomfort|1|||
163987766|NCT01145066|592322447|FG002|Overall Study|Abdominal discomfort|0|||
163987767|NCT01145066|592322445|FG000|Overall Study|Low platelet count|0|||
163987768|NCT01145066|592322446|FG001|Overall Study|Low platelet count|1|||
164234449|NCT02781558|593229269|FG001|Overall Study|Lost to Follow-up|2|||
164234450|NCT02781558|593229268|FG000|Overall Study|Adverse Event|1|||
164234451|NCT02781558|593229269|FG001|Overall Study|Adverse Event|0|||
164234452|NCT00643279|593229272|FG000|Overall Study|Death|13|||
164234453|NCT00643279|593229273|FG001|Overall Study|Death|11|||
164234454|NCT00643279|593229272|FG000|Overall Study|Withdrawal by Subject|3|||
164234455|NCT00643279|593229273|FG001|Overall Study|Withdrawal by Subject|0|||
164234456|NCT00643279|593229272|FG000|Overall Study|Lost to Follow-up|0|||
164234457|NCT00643279|593229273|FG001|Overall Study|Lost to Follow-up|1|||
164234458|NCT00643279|593229272|FG000|Overall Study|Physician Decision|0|||
164234459|NCT00643279|593229273|FG001|Overall Study|Physician Decision|1|||
164234460|NCT03274466|593229274|FG000|Overall Study|Withdrawal by Subject|7|||
164234461|NCT03274466|593229275|FG001|Overall Study|Withdrawal by Subject|3|||
164234462|NCT03274466|593229274|FG000|Overall Study|Protocol Specified Withdrawal|5|||
164234463|NCT03274466|593229275|FG001|Overall Study|Protocol Specified Withdrawal|11|||
164234464|NCT03274466|593229274|FG000|Overall Study|Lost to Follow-up|5|||
164234465|NCT03274466|593229275|FG001|Overall Study|Lost to Follow-up|7|||
164234466|NCT03274466|593229274|FG000|Overall Study|Subject Non-compliance|0|||
164234467|NCT03274466|593229275|FG001|Overall Study|Subject Non-compliance|1|||
164234468|NCT03274466|593229274|FG000|Overall Study|Adverse Event|3|||
164234469|NCT03274466|593229275|FG001|Overall Study|Adverse Event|3|||
164333457|NCT00973349|593597449|FG004|Overall Study|Protocol Violation|0|||
164333458|NCT00973349|593597450|FG005|Overall Study|Protocol Violation|0|||
164333459|NCT00973349|593597451|FG006|Overall Study|Protocol Violation|0|||
164333460|NCT00973349|593597452|FG007|Overall Study|Protocol Violation|0|||
164333461|NCT00973349|593597453|FG008|Overall Study|Protocol Violation|1|||
163987769|NCT01145066|592322447|FG002|Overall Study|Low platelet count|0|||
163987770|NCT02527707|592324102|FG000|Overall Study|Adverse Event|1|||
163987771|NCT02527707|592324102|FG000|Overall Study|Adverse Event|1|||
163987772|NCT01916980|592324103|FG000|Overall Study|Adverse Event|4|||
163987773|NCT01916980|592324104|FG001|Overall Study|Adverse Event|2|||
163987774|NCT01916980|592324103|FG000|Overall Study|Lack of Efficacy|2|||
163987775|NCT01916980|592324104|FG001|Overall Study|Lack of Efficacy|2|||
163987776|NCT01916980|592324103|FG000|Overall Study|Withdrawal by Subject|1|||
163987777|NCT01916980|592324104|FG001|Overall Study|Withdrawal by Subject|0|||
163987778|NCT02090855|592324105|FG000|Overall Study|no evaluable Standard of Truth results|2|||
163987779|NCT03968419|592324107|FG000|Treatment Period|Adverse Event|0|||
163987780|NCT03968419|592324108|FG001|Treatment Period|Adverse Event|0|||
163987781|NCT03968419|592324109|FG002|Treatment Period|Adverse Event|1|||
163987782|NCT03968419|592324107|FG000|Safety Follow-up Period|Death|3|||
163987783|NCT03968419|592324108|FG001|Safety Follow-up Period|Death|2|||
163987784|NCT03968419|592324109|FG002|Safety Follow-up Period|Death|1|||
163987785|NCT03968419|592324107|FG000|Safety Follow-up Period|Subject Decision|2|||
163987786|NCT03968419|592324108|FG001|Safety Follow-up Period|Subject Decision|1|||
163987787|NCT03968419|592324109|FG002|Safety Follow-up Period|Subject Decision|0|||
163987788|NCT02968810|592324112|FG000|Overall Study|Lost to Follow-up|1|||
163987789|NCT02968810|592324113|FG001|Overall Study|Lost to Follow-up|0|||
163987790|NCT02968810|592324112|FG000|Overall Study|Physician Decision|1|||
163987791|NCT02968810|592324113|FG001|Overall Study|Physician Decision|0|||
163987792|NCT02968810|592324112|FG000|Overall Study|Withdrawal by Subject|1|||
163987793|NCT02968810|592324113|FG001|Overall Study|Withdrawal by Subject|3|||
163987794|NCT02968810|592324112|FG000|Overall Study|Disease Progression|0|||
163987795|NCT02968810|592324113|FG001|Overall Study|Disease Progression|1|||
163987796|NCT02971202|592324119|FG000|Overall Study|Pregnancy|1|||
163987797|NCT02971202|592324120|FG001|Overall Study|Pregnancy|0|||
163987798|NCT02971202|592324121|FG002|Overall Study|Pregnancy|0|||
163987799|NCT02971202|592324119|FG000|Overall Study|screen fail after consent|1|||
163987800|NCT02971202|592324120|FG001|Overall Study|screen fail after consent|0|||
163987801|NCT02971202|592324121|FG002|Overall Study|screen fail after consent|1|||
163987802|NCT05425563|592324124|FG000|Overall Study|Withdrawal by Subject|17|||
163987803|NCT04537208|592324125|FG000|Overall Study|Adverse Event|0|||
163987804|NCT04537208|592324126|FG001|Overall Study|Adverse Event|0|||
163987805|NCT04537208|592324127|FG002|Overall Study|Adverse Event|0|||
163987806|NCT04537208|592324128|FG003|Overall Study|Adverse Event|0|||
163987807|NCT04537208|592324129|FG004|Overall Study|Adverse Event|0|||
163987808|NCT04537208|592324130|FG005|Overall Study|Adverse Event|0|||
164333462|NCT00973349|593597454|FG009|Overall Study|Protocol Violation|0|||
163987809|NCT04537208|592324131|FG006|Overall Study|Adverse Event|0|||
163987810|NCT04537208|592324132|FG007|Overall Study|Adverse Event|0|||
164234470|NCT03274466|593229274|FG000|Overall Study|Physician Decision|0|||
163987811|NCT04537208|592324133|FG008|Overall Study|Adverse Event|1|||
163987812|NCT04537208|592324134|FG009|Overall Study|Adverse Event|0|||
163987813|NCT04537208|592324135|FG010|Overall Study|Adverse Event|0|||
163987814|NCT04537208|592324125|FG000|Overall Study|Protocol deviation|0|||
163987815|NCT04537208|592324126|FG001|Overall Study|Protocol deviation|0|||
163987816|NCT04537208|592324127|FG002|Overall Study|Protocol deviation|2|||
163987817|NCT04537208|592324128|FG003|Overall Study|Protocol deviation|0|||
164234471|NCT03274466|593229275|FG001|Overall Study|Physician Decision|1|||
164234472|NCT03274466|593229274|FG000|Overall Study|Protocol Violation|3|||
164333463|NCT00973349|593597455|FG010|Overall Study|Protocol Violation|0|||
164333464|NCT00973349|593597456|FG011|Overall Study|Protocol Violation|0|||
164234473|NCT03274466|593229275|FG001|Overall Study|Protocol Violation|3|||
164234474|NCT01107886|593229281|FG000|Overall Study|Lost to Follow-up|15|||
164234475|NCT01107886|593229282|FG001|Overall Study|Lost to Follow-up|13|||
164234476|NCT01107886|593229281|FG000|Overall Study|Withdrawal by Subject|180|||
164234477|NCT01107886|593229282|FG001|Overall Study|Withdrawal by Subject|196|||
164234478|NCT01107886|593229281|FG000|Overall Study|Administrative withdrawal of consent|7|||
164234479|NCT01107886|593229282|FG001|Overall Study|Administrative withdrawal of consent|5|||
164234480|NCT01346176|593229283|FG000|Recruited|Protocol Violation|1|||
163884028|NCT05008835|591944038|FG001|Overall Study|Lack of Efficacy|0|||
164234481|NCT01346176|593229284|FG001|Recruited|Protocol Violation|0|||
164234482|NCT01346176|593229285|FG002|Recruited|Protocol Violation|0|||
164234483|NCT01346176|593229283|FG000|Completed Advance Directive|Death|3|||
164234484|NCT01346176|593229284|FG001|Completed Advance Directive|Death|2|||
164234485|NCT01346176|593229285|FG002|Completed Advance Directive|Death|2|||
164234486|NCT01346176|593229283|FG000|Completed Advance Directive|Became Ineligible|3|||
164234487|NCT01346176|593229284|FG001|Completed Advance Directive|Became Ineligible|0|||
164333465|NCT00973349|593597457|FG012|Overall Study|Protocol Violation|0|||
164333466|NCT00973349|593597458|FG013|Overall Study|Protocol Violation|0|||
164333467|NCT00973349|593597459|FG014|Overall Study|Protocol Violation|0|||
164333468|NCT00973349|593597460|FG015|Overall Study|Protocol Violation|0|||
164333469|NCT00973349|593597445|FG000|Overall Study|Unable to classify|0|||
164333470|NCT00973349|593597446|FG001|Overall Study|Unable to classify|0|||
164333471|NCT00973349|593597447|FG002|Overall Study|Unable to classify|0|||
164333472|NCT00973349|593597448|FG003|Overall Study|Unable to classify|0|||
164333473|NCT00973349|593597449|FG004|Overall Study|Unable to classify|1|||
164333474|NCT00973349|593597450|FG005|Overall Study|Unable to classify|1|||
164333475|NCT00973349|593597451|FG006|Overall Study|Unable to classify|0|||
164333476|NCT00973349|593597452|FG007|Overall Study|Unable to classify|0|||
164333477|NCT00973349|593597453|FG008|Overall Study|Unable to classify|0|||
164333478|NCT00973349|593597454|FG009|Overall Study|Unable to classify|1|||
164333479|NCT00973349|593597455|FG010|Overall Study|Unable to classify|0|||
164333480|NCT00973349|593597456|FG011|Overall Study|Unable to classify|0|||
164333481|NCT00973349|593597457|FG012|Overall Study|Unable to classify|0|||
164333482|NCT00973349|593597458|FG013|Overall Study|Unable to classify|0|||
164333483|NCT00973349|593597459|FG014|Overall Study|Unable to classify|0|||
164333484|NCT00973349|593597460|FG015|Overall Study|Unable to classify|0|||
164333485|NCT02898116|593597465|FG000|Overall Study|Adverse Event|1|||
164333486|NCT02898116|593597465|FG000|Overall Study|Progressive disease|1|||
164333487|NCT02130024|593597466|FG000|Overall Study|Adverse Event|10|||
163987818|NCT04537208|592324129|FG004|Overall Study|Protocol deviation|0|||
163987819|NCT04537208|592324130|FG005|Overall Study|Protocol deviation|2|||
163987820|NCT04537208|592324131|FG006|Overall Study|Protocol deviation|4|||
163987821|NCT04537208|592324132|FG007|Overall Study|Protocol deviation|0|||
163987822|NCT04537208|592324133|FG008|Overall Study|Protocol deviation|1|||
163987823|NCT04537208|592324134|FG009|Overall Study|Protocol deviation|0|||
163987824|NCT04537208|592324135|FG010|Overall Study|Protocol deviation|2|||
163987825|NCT04537208|592324125|FG000|Overall Study|Withdrawal by Subject|4|||
163987826|NCT04537208|592324126|FG001|Overall Study|Withdrawal by Subject|2|||
163987827|NCT04537208|592324127|FG002|Overall Study|Withdrawal by Subject|1|||
163987828|NCT04537208|592324128|FG003|Overall Study|Withdrawal by Subject|3|||
163987829|NCT04537208|592324129|FG004|Overall Study|Withdrawal by Subject|5|||
163987830|NCT04537208|592324130|FG005|Overall Study|Withdrawal by Subject|1|||
163987831|NCT04537208|592324131|FG006|Overall Study|Withdrawal by Subject|6|||
163987832|NCT04537208|592324132|FG007|Overall Study|Withdrawal by Subject|1|||
163987833|NCT04537208|592324133|FG008|Overall Study|Withdrawal by Subject|7|||
163987834|NCT04537208|592324134|FG009|Overall Study|Withdrawal by Subject|2|||
163987835|NCT04537208|592324135|FG010|Overall Study|Withdrawal by Subject|4|||
163987836|NCT04537208|592324125|FG000|Overall Study|Lost to Follow-up|4|||
163987837|NCT04537208|592324126|FG001|Overall Study|Lost to Follow-up|1|||
163987838|NCT04537208|592324127|FG002|Overall Study|Lost to Follow-up|3|||
163987839|NCT04537208|592324128|FG003|Overall Study|Lost to Follow-up|4|||
163987840|NCT04537208|592324129|FG004|Overall Study|Lost to Follow-up|3|||
163987841|NCT04537208|592324130|FG005|Overall Study|Lost to Follow-up|2|||
163987842|NCT04537208|592324131|FG006|Overall Study|Lost to Follow-up|3|||
163987843|NCT04537208|592324132|FG007|Overall Study|Lost to Follow-up|2|||
163987844|NCT04537208|592324133|FG008|Overall Study|Lost to Follow-up|7|||
163987845|NCT04537208|592324134|FG009|Overall Study|Lost to Follow-up|2|||
163987846|NCT04537208|592324135|FG010|Overall Study|Lost to Follow-up|2|||
163987847|NCT01537211|592324138|FG000|Overall Study|Lost to Follow-up|0|||
163987848|NCT01537211|592324139|FG001|Overall Study|Lost to Follow-up|1|||
163987849|NCT00704964|592324140|FG000|Overall Study|Not completed on time|328|||
163987850|NCT02161562|592324142|FG000|Overall Study|Withdrawal by Subject|5|||
163987851|NCT02161562|592324143|FG001|Overall Study|Withdrawal by Subject|8|||
163987852|NCT02161562|592324142|FG000|Overall Study|Protocol Violation|9|||
163987853|NCT02161562|592324143|FG001|Overall Study|Protocol Violation|4|||
163987854|NCT02161562|592324142|FG000|Overall Study|Pregnancy|1|||
163987855|NCT02161562|592324143|FG001|Overall Study|Pregnancy|2|||
163987856|NCT02161562|592324142|FG000|Overall Study|Lost to Follow-up|3|||
163987857|NCT02161562|592324143|FG001|Overall Study|Lost to Follow-up|1|||
163987858|NCT02161562|592324142|FG000|Overall Study|Lack of Efficacy|4|||
163987859|NCT02161562|592324143|FG001|Overall Study|Lack of Efficacy|1|||
163987860|NCT02161562|592324142|FG000|Overall Study|Adverse Event|1|||
163987861|NCT02161562|592324143|FG001|Overall Study|Adverse Event|1|||
163987862|NCT02161562|592324142|FG000|Overall Study|Participant moved back to home country|1|||
163987863|NCT02161562|592324143|FG001|Overall Study|Participant moved back to home country|0|||
163987864|NCT02161562|592324142|FG000|Overall Study|Withdrew due to being out of the country|1|||
163987865|NCT02161562|592324143|FG001|Overall Study|Withdrew due to being out of the country|0|||
163987866|NCT02161562|592324142|FG000|Overall Study|Participant moved out of province|1|||
164333488|NCT02130024|593597467|FG001|Overall Study|Adverse Event|11|||
164333489|NCT02130024|593597466|FG000|Overall Study|Death|2|||
164333490|NCT02130024|593597467|FG001|Overall Study|Death|2|||
164333491|NCT02130024|593597466|FG000|Overall Study|Lost to Follow-up|1|||
164333492|NCT02130024|593597467|FG001|Overall Study|Lost to Follow-up|1|||
164333493|NCT02130024|593597466|FG000|Overall Study|Physician Decision|1|||
164333494|NCT02130024|593597467|FG001|Overall Study|Physician Decision|3|||
164234488|NCT01346176|593229285|FG002|Completed Advance Directive|Became Ineligible|1|||
164234489|NCT01346176|593229283|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
164333495|NCT02130024|593597466|FG000|Overall Study|Protocol Deviation|4|||
164333496|NCT02130024|593597467|FG001|Overall Study|Protocol Deviation|0|||
164333497|NCT02130024|593597466|FG000|Overall Study|Site Administration Problems|1|||
164333498|NCT02130024|593597467|FG001|Overall Study|Site Administration Problems|0|||
164333499|NCT02130024|593597466|FG000|Overall Study|Subject Withdrew Consent|6|||
164333500|NCT02130024|593597467|FG001|Overall Study|Subject Withdrew Consent|14|||
164333501|NCT05597020|593597471|FG000|Washout|Forbidden medication|2|||
164333502|NCT05597020|593597472|FG001|Washout|Forbidden medication|0|||
164333503|NCT05597020|593597471|FG000|Treatment Period II|Advice from primary care physician|1|||
164333504|NCT05597020|593597472|FG001|Treatment Period II|Advice from primary care physician|0|||
164333505|NCT05597020|593597471|FG000|Treatment Period II|Subject lost investigational product|1|||
164234490|NCT01346176|593229284|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
164234491|NCT01346176|593229285|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
164234492|NCT01346176|593229283|FG000|Completed Satisfaction Survey|Death|3|||
164234493|NCT01346176|593229284|FG001|Completed Satisfaction Survey|Death|0|||
164234494|NCT01346176|593229285|FG002|Completed Satisfaction Survey|Death|2|||
164234495|NCT01346176|593229283|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
164234496|NCT01346176|593229284|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
164234497|NCT01346176|593229285|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
164333506|NCT05597020|593597472|FG001|Treatment Period II|Subject lost investigational product|0|||
164333507|NCT05597020|593597471|FG000|Treatment Period II|Private reasons|0|||
164333508|NCT05597020|593597472|FG001|Treatment Period II|Private reasons|1|||
164333509|NCT05736224|593597473|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
164333510|NCT01015131|593597474|FG000|Overall Study|Physician Decision|1|||
164333511|NCT01015131|593597474|FG000|Overall Study|Protocol Violation|1|||
163987867|NCT02161562|592324143|FG001|Overall Study|Participant moved out of province|0|||
164234498|NCT01334918|593231338|FG000|Overall Study|Did not receive study drug|6|||
164234499|NCT01334918|593231339|FG001|Overall Study|Did not receive study drug|0|||
164234500|NCT01334918|593231338|FG000|Overall Study|Adverse Event|2|||
164234501|NCT01334918|593231339|FG001|Overall Study|Adverse Event|0|||
164234502|NCT01334918|593231338|FG000|Overall Study|Withdrawal by Subject|0|||
164234503|NCT01334918|593231339|FG001|Overall Study|Withdrawal by Subject|1|||
164234504|NCT01576783|593231343|FG000|Overall Study|Change in Medical Care|1|||
164234505|NCT01576783|593231344|FG001|Overall Study|Change in Medical Care|0|||
164234506|NCT01576783|593231343|FG000|Overall Study|Lost to Follow-up|14|||
164234507|NCT01576783|593231344|FG001|Overall Study|Lost to Follow-up|16|||
164234508|NCT01576783|593231343|FG000|Overall Study|Withdrawal by Subject|5|||
164234509|NCT01576783|593231344|FG001|Overall Study|Withdrawal by Subject|1|||
164234510|NCT05489328|593231345|FG000|Overall Study|Lost to Follow-up|0|||
164234511|NCT05489328|593231346|FG001|Overall Study|Lost to Follow-up|0|||
164234512|NCT05489328|593231347|FG002|Overall Study|Lost to Follow-up|1|||
164234513|NCT05489328|593231348|FG003|Overall Study|Lost to Follow-up|0|||
164234514|NCT05489328|593231349|FG004|Overall Study|Lost to Follow-up|2|||
164234515|NCT05489328|593231350|FG005|Overall Study|Lost to Follow-up|0|||
164234516|NCT05489328|593231351|FG006|Overall Study|Lost to Follow-up|0|||
164234517|NCT05489328|593231352|FG007|Overall Study|Lost to Follow-up|1|||
164234518|NCT05489328|593231353|FG008|Overall Study|Lost to Follow-up|0|||
164234519|NCT05489328|593231345|FG000|Overall Study|Withdrawal by Subject|0|||
164234520|NCT05489328|593231346|FG001|Overall Study|Withdrawal by Subject|0|||
164234521|NCT05489328|593231347|FG002|Overall Study|Withdrawal by Subject|0|||
164234522|NCT05489328|593231348|FG003|Overall Study|Withdrawal by Subject|0|||
164234523|NCT05489328|593231349|FG004|Overall Study|Withdrawal by Subject|0|||
164234524|NCT05489328|593231350|FG005|Overall Study|Withdrawal by Subject|0|||
164234525|NCT05489328|593231351|FG006|Overall Study|Withdrawal by Subject|1|||
164234526|NCT05489328|593231352|FG007|Overall Study|Withdrawal by Subject|1|||
164234527|NCT05489328|593231353|FG008|Overall Study|Withdrawal by Subject|0|||
164234528|NCT05489328|593231345|FG000|Overall Study|Other|0|||
164333512|NCT01015131|593597474|FG000|Overall Study|Withdrawal by Subject|2|||
163987868|NCT02624492|592324161|FG000|Overall Study|Adverse Event|2|||
163987869|NCT02624492|592324162|FG001|Overall Study|Adverse Event|2|||
163987870|NCT02624492|592324163|FG002|Overall Study|Adverse Event|2|||
163987871|NCT02624492|592324161|FG000|Overall Study|Progressive disease|0|||
163987872|NCT02624492|592324162|FG001|Overall Study|Progressive disease|2|||
163987873|NCT02624492|592324163|FG002|Overall Study|Progressive disease|3|||
164333513|NCT01015131|593597474|FG000|Overall Study|Other Protocol Specified Criteria|4|||
163987874|NCT01163786|592324164|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
164234529|NCT05489328|593231346|FG001|Overall Study|Other|0|||
164234530|NCT05489328|593231347|FG002|Overall Study|Other|0|||
164234531|NCT05489328|593231348|FG003|Overall Study|Other|0|||
164234532|NCT05489328|593231349|FG004|Overall Study|Other|0|||
164234533|NCT05489328|593231350|FG005|Overall Study|Other|0|||
164234534|NCT05489328|593231351|FG006|Overall Study|Other|0|||
164234535|NCT05489328|593231352|FG007|Overall Study|Other|1|||
164234536|NCT05489328|593231353|FG008|Overall Study|Other|1|||
164234537|NCT01083602|593231354|FG000|Overall Study|Adverse Event|11|||
164234538|NCT01083602|593231354|FG000|Overall Study|New Cancer Therapy|2|||
164234539|NCT01083602|593231354|FG000|Overall Study|Death|1|||
164234540|NCT01083602|593231354|FG000|Overall Study|Withdrawal by Subject|5|||
164234541|NCT01083602|593231354|FG000|Overall Study|Lack of Efficacy|36|||
164234542|NCT01657370|593231358|FG000|Overall Study|Withdrawal by Subject|0|||
164234543|NCT01657370|593231359|FG001|Overall Study|Withdrawal by Subject|0|||
164234544|NCT01657370|593231360|FG002|Overall Study|Withdrawal by Subject|1|||
164234545|NCT01657370|593231361|FG003|Overall Study|Withdrawal by Subject|0|||
164234546|NCT01657370|593231362|FG004|Overall Study|Withdrawal by Subject|0|||
164234547|NCT01657370|593231363|FG005|Overall Study|Withdrawal by Subject|1|||
164234548|NCT01657370|593231358|FG000|Overall Study|Physician Decision|2|||
164234549|NCT01657370|593231359|FG001|Overall Study|Physician Decision|3|||
164234550|NCT01657370|593231360|FG002|Overall Study|Physician Decision|1|||
164234551|NCT01657370|593231361|FG003|Overall Study|Physician Decision|2|||
164234552|NCT01657370|593231362|FG004|Overall Study|Physician Decision|5|||
164234553|NCT01657370|593231363|FG005|Overall Study|Physician Decision|0|||
164234554|NCT01657370|593231358|FG000|Overall Study|Lack of Qualifying Event|1|||
164234555|NCT01657370|593231359|FG001|Overall Study|Lack of Qualifying Event|0|||
164234556|NCT01657370|593231360|FG002|Overall Study|Lack of Qualifying Event|3|||
164234557|NCT01657370|593231361|FG003|Overall Study|Lack of Qualifying Event|2|||
164234558|NCT01657370|593231362|FG004|Overall Study|Lack of Qualifying Event|1|||
164234559|NCT01657370|593231363|FG005|Overall Study|Lack of Qualifying Event|2|||
164234560|NCT01657370|593231358|FG000|Overall Study|Adverse Event|0|||
164234561|NCT01657370|593231359|FG001|Overall Study|Adverse Event|0|||
164234562|NCT01657370|593231360|FG002|Overall Study|Adverse Event|0|||
164234563|NCT01657370|593231361|FG003|Overall Study|Adverse Event|0|||
164234564|NCT01657370|593231362|FG004|Overall Study|Adverse Event|1|||
163987875|NCT01163786|592324164|FG000|Treatment With Bortezomib|Adverse Event|2|||
163987876|NCT01163786|592324164|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
163987877|NCT02474082|592324169|FG000|Overall Study|Adverse Event|2|||
163987878|NCT02474082|592324170|FG001|Overall Study|Adverse Event|32|||
163987879|NCT02474082|592324169|FG000|Overall Study|Withdrawal of informed consent|1|||
163987880|NCT02474082|592324170|FG001|Overall Study|Withdrawal of informed consent|11|||
163987881|NCT02474082|592324169|FG000|Overall Study|Lost to Follow-up|2|||
163987882|NCT02474082|592324170|FG001|Overall Study|Lost to Follow-up|2|||
163987883|NCT02474082|592324169|FG000|Overall Study|Dose tapering not achieved|0|||
163987884|NCT02474082|592324170|FG001|Overall Study|Dose tapering not achieved|4|||
163987885|NCT02474082|592324169|FG000|Overall Study|Participant/guardian decision|1|||
163987886|NCT02474082|592324170|FG001|Overall Study|Participant/guardian decision|2|||
163987887|NCT02474082|592324169|FG000|Overall Study|Non-compliance with study treatment|0|||
163987888|NCT02474082|592324170|FG001|Overall Study|Non-compliance with study treatment|2|||
163987889|NCT02474082|592324169|FG000|Overall Study|Protocol deviation|0|||
163987890|NCT02474082|592324170|FG001|Overall Study|Protocol deviation|1|||
163987891|NCT00430508|592324171|FG000|Overall Study|Adverse Event|2|||
163987892|NCT00430508|592324172|FG001|Overall Study|Adverse Event|3|||
163987893|NCT00430508|592324173|FG002|Overall Study|Adverse Event|5|||
163987894|NCT00430508|592324174|FG003|Overall Study|Adverse Event|3|||
163987895|NCT00430508|592324171|FG000|Overall Study|Withdrawal by Subject|0|||
163987896|NCT00430508|592324172|FG001|Overall Study|Withdrawal by Subject|1|||
163987897|NCT00430508|592324173|FG002|Overall Study|Withdrawal by Subject|1|||
163987898|NCT00430508|592324174|FG003|Overall Study|Withdrawal by Subject|1|||
163987899|NCT00430508|592324171|FG000|Overall Study|responder at visit 4|0|||
163987900|NCT00430508|592324172|FG001|Overall Study|responder at visit 4|0|||
163987901|NCT00430508|592324173|FG002|Overall Study|responder at visit 4|2|||
163987902|NCT00430508|592324174|FG003|Overall Study|responder at visit 4|0|||
163987903|NCT00430508|592324171|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
163987904|NCT00430508|592324172|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
163987905|NCT00430508|592324173|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
163987906|NCT00430508|592324174|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
163987907|NCT00430508|592324171|FG000|Overall Study|Other|1|||
163987908|NCT00430508|592324172|FG001|Overall Study|Other|1|||
163987909|NCT00430508|592324173|FG002|Overall Study|Other|3|||
163987910|NCT00430508|592324174|FG003|Overall Study|Other|0|||
163987911|NCT03595553|592324180|FG000|Overall Study|Withdrawal by Subject|20|||
163987912|NCT03595553|592324181|FG001|Overall Study|Withdrawal by Subject|8|||
163987913|NCT03595553|592324180|FG000|Overall Study|Physician Decision|3|||
163987914|NCT03595553|592324181|FG001|Overall Study|Physician Decision|2|||
163987915|NCT03595553|592324180|FG000|Overall Study|Adverse Event|2|||
164333514|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
164333515|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333516|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333517|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333518|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333519|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164355670|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
163987916|NCT03595553|592324181|FG001|Overall Study|Adverse Event|5|||
163987917|NCT03595553|592324180|FG000|Overall Study|Death|24|||
163987918|NCT03595553|592324181|FG001|Overall Study|Death|22|||
163987919|NCT03595553|592324180|FG000|Overall Study|Lost to Follow-up|6|||
163987920|NCT03595553|592324181|FG001|Overall Study|Lost to Follow-up|7|||
163987921|NCT03595553|592324180|FG000|Overall Study|Other as indicated in CSR|3|||
163987922|NCT03595553|592324181|FG001|Overall Study|Other as indicated in CSR|3|||
163987923|NCT03595553|592324180|FG000|Overall Study|Sponsor Decision|0|||
163987924|NCT03595553|592324181|FG001|Overall Study|Sponsor Decision|1|||
163987925|NCT03467958|592324182|FG000|Overall Study|Adverse Event|20|||
163987926|NCT03467958|592324183|FG001|Overall Study|Adverse Event|32|||
163987927|NCT03467958|592324184|FG002|Overall Study|Adverse Event|5|||
163987928|NCT03467958|592324185|FG003|Overall Study|Adverse Event|3|||
163987929|NCT03467958|592324186|FG004|Overall Study|Adverse Event|3|||
163987930|NCT03467958|592324187|FG005|Overall Study|Adverse Event|3|||
163987931|NCT03467958|592324188|FG006|Overall Study|Adverse Event|6|||
163987932|NCT03467958|592324189|FG007|Overall Study|Adverse Event|5|||
163987933|NCT03467958|592324190|FG008|Overall Study|Adverse Event|0|||
163987934|NCT03467958|592324182|FG000|Overall Study|Lack of Efficacy|59|||
163987935|NCT03467958|592324183|FG001|Overall Study|Lack of Efficacy|120|||
163987936|NCT03467958|592324184|FG002|Overall Study|Lack of Efficacy|6|||
163987937|NCT03467958|592324185|FG003|Overall Study|Lack of Efficacy|9|||
163987938|NCT03467958|592324186|FG004|Overall Study|Lack of Efficacy|8|||
163987939|NCT03467958|592324187|FG005|Overall Study|Lack of Efficacy|9|||
163987940|NCT03467958|592324188|FG006|Overall Study|Lack of Efficacy|11|||
163987941|NCT03467958|592324189|FG007|Overall Study|Lack of Efficacy|9|||
163987942|NCT03467958|592324190|FG008|Overall Study|Lack of Efficacy|3|||
163884029|NCT05008835|591944039|FG002|Overall Study|Lack of Efficacy|1|||
164333520|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
164333521|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
164333522|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333523|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333524|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333525|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333526|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333527|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
164333528|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
164333529|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333530|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333531|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333532|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333533|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333534|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
164333535|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
164333536|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333537|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333538|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333539|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333540|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333541|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
164333542|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
164333543|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333544|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333545|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333546|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333547|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333548|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
164333549|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
164333550|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333551|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333552|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333553|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333554|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333555|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
164333556|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
164333557|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
163884030|NCT05008835|591944037|FG000|Overall Study|Study terminated by sponsor|0|||
163884031|NCT05008835|591944038|FG001|Overall Study|Study terminated by sponsor|0|||
163884032|NCT05008835|591944039|FG002|Overall Study|Study terminated by sponsor|1|||
163884033|NCT05008835|591944037|FG000|Overall Study|Not further specified|3|||
163884034|NCT05008835|591944038|FG001|Overall Study|Not further specified|2|||
163884035|NCT05008835|591944039|FG002|Overall Study|Not further specified|1|||
163884036|NCT02671903|591945823|FG000|Period 0 (Run-In)|Death|0|||
163884037|NCT02671903|591945824|FG001|Period 0 (Run-In)|Death|0|||
163884038|NCT02671903|591945825|FG002|Period 0 (Run-In)|Death|3|||
163884039|NCT02671903|591945823|FG000|Period 0 (Run-In)|Physician Decision|0|||
163884040|NCT02671903|591945824|FG001|Period 0 (Run-In)|Physician Decision|0|||
164234565|NCT01657370|593231363|FG005|Overall Study|Adverse Event|0|||
164234566|NCT01657370|593231358|FG000|Overall Study|Protocol Violation|1|||
164234567|NCT01657370|593231359|FG001|Overall Study|Protocol Violation|1|||
164234568|NCT01657370|593231360|FG002|Overall Study|Protocol Violation|1|||
164234569|NCT01657370|593231361|FG003|Overall Study|Protocol Violation|1|||
164234570|NCT01657370|593231362|FG004|Overall Study|Protocol Violation|0|||
164234571|NCT01657370|593231363|FG005|Overall Study|Protocol Violation|0|||
164234572|NCT01657370|593231358|FG000|Overall Study|Lost to Follow-up|2|||
164234573|NCT01657370|593231359|FG001|Overall Study|Lost to Follow-up|0|||
164234574|NCT01657370|593231360|FG002|Overall Study|Lost to Follow-up|1|||
164234575|NCT01657370|593231361|FG003|Overall Study|Lost to Follow-up|0|||
164234576|NCT01657370|593231362|FG004|Overall Study|Lost to Follow-up|0|||
164234577|NCT01657370|593231363|FG005|Overall Study|Lost to Follow-up|1|||
164234578|NCT02777086|593231364|FG000|Overall Study|Lost to Follow-up|96|||
164234579|NCT02777086|593231365|FG001|Overall Study|Lost to Follow-up|99|||
164234580|NCT01133665|593231366|FG000|Overall Study|Physician Decision|2|||
164234581|NCT01819272|593231367|FG000|Overall Study|Adverse Event|1|||
164234582|NCT01819272|593231368|FG001|Overall Study|Adverse Event|0|||
164234583|NCT01819272|593231369|FG002|Overall Study|Adverse Event|0|||
164234584|NCT01819272|593231370|FG003|Overall Study|Adverse Event|2|||
164234585|NCT01819272|593231371|FG004|Overall Study|Adverse Event|0|||
164234586|NCT01819272|593231372|FG005|Overall Study|Adverse Event|0|||
164234587|NCT01819272|593231367|FG000|Overall Study|Lost to Follow-up|3|||
164234588|NCT01819272|593231368|FG001|Overall Study|Lost to Follow-up|0|||
164234589|NCT01819272|593231369|FG002|Overall Study|Lost to Follow-up|1|||
164234590|NCT01819272|593231370|FG003|Overall Study|Lost to Follow-up|0|||
164234591|NCT01819272|593231371|FG004|Overall Study|Lost to Follow-up|0|||
164234592|NCT01819272|593231372|FG005|Overall Study|Lost to Follow-up|3|||
164234593|NCT01819272|593231367|FG000|Overall Study|Protocol Violation|0|||
164234594|NCT01819272|593231368|FG001|Overall Study|Protocol Violation|0|||
164234595|NCT01819272|593231369|FG002|Overall Study|Protocol Violation|0|||
164234596|NCT01819272|593231370|FG003|Overall Study|Protocol Violation|1|||
164234597|NCT01819272|593231371|FG004|Overall Study|Protocol Violation|2|||
164234598|NCT01819272|593231372|FG005|Overall Study|Protocol Violation|3|||
164234599|NCT01819272|593231367|FG000|Overall Study|Physician Decision|0|||
164234600|NCT01819272|593231368|FG001|Overall Study|Physician Decision|1|||
164234601|NCT01819272|593231369|FG002|Overall Study|Physician Decision|0|||
164234602|NCT01819272|593231370|FG003|Overall Study|Physician Decision|0|||
164234603|NCT01819272|593231371|FG004|Overall Study|Physician Decision|0|||
164234604|NCT01819272|593231372|FG005|Overall Study|Physician Decision|0|||
164234605|NCT01819272|593231367|FG000|Overall Study|Withdrawal of Consent|0|||
164234606|NCT01819272|593231368|FG001|Overall Study|Withdrawal of Consent|1|||
164234607|NCT01819272|593231369|FG002|Overall Study|Withdrawal of Consent|2|||
164234608|NCT01819272|593231370|FG003|Overall Study|Withdrawal of Consent|1|||
164234609|NCT01819272|593231371|FG004|Overall Study|Withdrawal of Consent|0|||
164234610|NCT01819272|593231372|FG005|Overall Study|Withdrawal of Consent|1|||
164234611|NCT01819272|593231367|FG000|Overall Study|Loss of Glucose Control|2|||
164234612|NCT01819272|593231368|FG001|Overall Study|Loss of Glucose Control|1|||
164234613|NCT01819272|593231369|FG002|Overall Study|Loss of Glucose Control|0|||
164234614|NCT01819272|593231370|FG003|Overall Study|Loss of Glucose Control|1|||
164234615|NCT01819272|593231371|FG004|Overall Study|Loss of Glucose Control|2|||
164234616|NCT01819272|593231372|FG005|Overall Study|Loss of Glucose Control|0|||
164234617|NCT03021486|593231373|FG000|Overall Study|Withdrawal by Subject|1|||
164234618|NCT03021486|593231374|FG001|Overall Study|Withdrawal by Subject|1|||
164234619|NCT03021486|593231375|FG002|Overall Study|Withdrawal by Subject|3|||
164234620|NCT03021486|593231373|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
164234621|NCT03021486|593231374|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
164234622|NCT03021486|593231375|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
164234623|NCT04043286|593231376|FG000|Overall Study|Withdrawal by Subject|2|||
164234624|NCT04043286|593231377|FG001|Overall Study|Withdrawal by Subject|2|||
164234625|NCT01732536|593231378|FG000|Overall Study|Withdrawal by Subject|1|||
164234626|NCT01732536|593231379|FG001|Overall Study|Withdrawal by Subject|1|||
164234627|NCT00805389|593231380|FG000|Overall Study|Adverse Event|0|||
164234628|NCT00805389|593231381|FG001|Overall Study|Adverse Event|0|||
164234629|NCT00805389|593231382|FG002|Overall Study|Adverse Event|1|||
164234630|NCT00805389|593231383|FG003|Overall Study|Adverse Event|2|||
164234631|NCT00805389|593231384|FG004|Overall Study|Adverse Event|0|||
164234632|NCT00805389|593231380|FG000|Overall Study|Lost to Follow-up|4|||
164234633|NCT00805389|593231381|FG001|Overall Study|Lost to Follow-up|3|||
164234634|NCT00805389|593231382|FG002|Overall Study|Lost to Follow-up|6|||
164234635|NCT00805389|593231383|FG003|Overall Study|Lost to Follow-up|10|||
164234636|NCT00805389|593231384|FG004|Overall Study|Lost to Follow-up|9|||
164234637|NCT00805389|593231380|FG000|Overall Study|Protocol Violation|0|||
164234638|NCT00805389|593231381|FG001|Overall Study|Protocol Violation|0|||
164234639|NCT00805389|593231382|FG002|Overall Study|Protocol Violation|1|||
164333558|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333559|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333560|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333561|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333562|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
164333563|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
164333564|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333565|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333566|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333567|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333568|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333569|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
164333570|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
164333571|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333572|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333573|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333574|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333575|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333576|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
164333577|NCT04526509|593597475|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
164333578|NCT04526509|593597476|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333579|NCT04526509|593597477|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333580|NCT04526509|593597478|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333581|NCT04526509|593597479|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333582|NCT04526509|593597480|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333583|NCT04526509|593597481|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
164333584|NCT04526509|593597475|FG000|Enrolled|Study Terminated by Sponsor|0|||
164333585|NCT04526509|593597476|FG001|Enrolled|Study Terminated by Sponsor|0|||
164333586|NCT04526509|593597477|FG002|Enrolled|Study Terminated by Sponsor|0|||
164333587|NCT04526509|593597478|FG003|Enrolled|Study Terminated by Sponsor|0|||
164333588|NCT04526509|593597479|FG004|Enrolled|Study Terminated by Sponsor|0|||
164333589|NCT04526509|593597480|FG005|Enrolled|Study Terminated by Sponsor|0|||
164333590|NCT04526509|593597481|FG006|Enrolled|Study Terminated by Sponsor|1|||
164333591|NCT04526509|593597475|FG000|Enrolled|Death prior to lymphodepletion|0|||
164333592|NCT04526509|593597476|FG001|Enrolled|Death prior to lymphodepletion|0|||
164333593|NCT04526509|593597477|FG002|Enrolled|Death prior to lymphodepletion|0|||
164333594|NCT04526509|593597478|FG003|Enrolled|Death prior to lymphodepletion|1|||
164333595|NCT04526509|593597479|FG004|Enrolled|Death prior to lymphodepletion|0|||
164333596|NCT04526509|593597480|FG005|Enrolled|Death prior to lymphodepletion|0|||
164333597|NCT04526509|593597481|FG006|Enrolled|Death prior to lymphodepletion|0|||
164333598|NCT04526509|593597475|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163987943|NCT03467958|592324182|FG000|Overall Study|Lost to Follow-up|1|||
163987944|NCT03467958|592324183|FG001|Overall Study|Lost to Follow-up|2|||
163987945|NCT03467958|592324184|FG002|Overall Study|Lost to Follow-up|1|||
163987946|NCT03467958|592324185|FG003|Overall Study|Lost to Follow-up|0|||
163987947|NCT03467958|592324186|FG004|Overall Study|Lost to Follow-up|4|||
163987948|NCT03467958|592324187|FG005|Overall Study|Lost to Follow-up|0|||
163987949|NCT03467958|592324188|FG006|Overall Study|Lost to Follow-up|0|||
163987950|NCT03467958|592324189|FG007|Overall Study|Lost to Follow-up|0|||
163987951|NCT03467958|592324190|FG008|Overall Study|Lost to Follow-up|0|||
163987952|NCT03467958|592324182|FG000|Overall Study|Other reasons|8|||
163987953|NCT03467958|592324183|FG001|Overall Study|Other reasons|14|||
163987954|NCT03467958|592324184|FG002|Overall Study|Other reasons|2|||
163987955|NCT03467958|592324185|FG003|Overall Study|Other reasons|1|||
163987956|NCT03467958|592324186|FG004|Overall Study|Other reasons|4|||
163987957|NCT03467958|592324187|FG005|Overall Study|Other reasons|0|||
163987958|NCT03467958|592324188|FG006|Overall Study|Other reasons|1|||
163987959|NCT03467958|592324189|FG007|Overall Study|Other reasons|0|||
163987960|NCT03467958|592324190|FG008|Overall Study|Other reasons|1|||
163987961|NCT03467958|592324182|FG000|Overall Study|Pregnancy|1|||
163987962|NCT03467958|592324183|FG001|Overall Study|Pregnancy|0|||
163987963|NCT03467958|592324184|FG002|Overall Study|Pregnancy|0|||
163987964|NCT03467958|592324185|FG003|Overall Study|Pregnancy|0|||
163987965|NCT03467958|592324186|FG004|Overall Study|Pregnancy|0|||
163987966|NCT03467958|592324187|FG005|Overall Study|Pregnancy|1|||
163987967|NCT03467958|592324188|FG006|Overall Study|Pregnancy|0|||
163987968|NCT03467958|592324189|FG007|Overall Study|Pregnancy|0|||
163987969|NCT03467958|592324190|FG008|Overall Study|Pregnancy|0|||
163987970|NCT03467958|592324182|FG000|Overall Study|Study terminated by sponsor|65|||
163987971|NCT03467958|592324183|FG001|Overall Study|Study terminated by sponsor|117|||
163987972|NCT03467958|592324184|FG002|Overall Study|Study terminated by sponsor|45|||
163987973|NCT03467958|592324185|FG003|Overall Study|Study terminated by sponsor|64|||
164234640|NCT00805389|593231383|FG003|Overall Study|Protocol Violation|0|||
164234641|NCT00805389|593231384|FG004|Overall Study|Protocol Violation|0|||
164234642|NCT00805389|593231380|FG000|Overall Study|Withdrawal by Subject|3|||
164234643|NCT00805389|593231381|FG001|Overall Study|Withdrawal by Subject|2|||
164234644|NCT00805389|593231382|FG002|Overall Study|Withdrawal by Subject|4|||
164234645|NCT00805389|593231383|FG003|Overall Study|Withdrawal by Subject|5|||
164234646|NCT00805389|593231384|FG004|Overall Study|Withdrawal by Subject|4|||
164234647|NCT01246960|593231385|FG000|Overall Study|Lost to Follow-up|3|||
164234648|NCT01246960|593231386|FG001|Overall Study|Lost to Follow-up|1|||
164234649|NCT01246960|593231385|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
164234650|NCT01246960|593231386|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
164234651|NCT03376516|593231391|FG000|Overall Study|Not treated|1|||
164234652|NCT03376516|593231391|FG000|Overall Study|Consent withdrawn|1|||
164234653|NCT01581684|593231392|FG000|Overall Study|Other reason not defined|0|||
164234654|NCT01581684|593231393|FG001|Overall Study|Other reason not defined|0|||
164234655|NCT01581684|593231394|FG002|Overall Study|Other reason not defined|0|||
164234656|NCT01581684|593231395|FG003|Overall Study|Other reason not defined|0|||
164234657|NCT01581684|593231396|FG004|Overall Study|Other reason not defined|0|||
164234658|NCT01581684|593231397|FG005|Overall Study|Other reason not defined|0|||
164234659|NCT01581684|593231398|FG006|Overall Study|Other reason not defined|0|||
164234660|NCT01581684|593231399|FG007|Overall Study|Other reason not defined|0|||
164234661|NCT01581684|593231400|FG008|Overall Study|Other reason not defined|1|||
164234662|NCT01581684|593231401|FG009|Overall Study|Other reason not defined|0|||
164234663|NCT02986074|593231402|FG000|First Trial Period|Adverse Event|1|||
164234664|NCT02986074|593231403|FG001|First Trial Period|Adverse Event|0|||
164234665|NCT02986074|593231404|FG002|First Trial Period|Adverse Event|0|||
164234666|NCT02986074|593231405|FG003|First Trial Period|Adverse Event|0|||
164234667|NCT02986074|593231402|FG000|Follow up Period|system explant|0|||
164234668|NCT02986074|593231403|FG001|Follow up Period|system explant|0|||
164234669|NCT02986074|593231404|FG002|Follow up Period|system explant|1|||
164234670|NCT02986074|593231405|FG003|Follow up Period|system explant|2|||
164234671|NCT02986074|593231402|FG000|Follow up Period|Physician Decision|0|||
164234672|NCT02986074|593231403|FG001|Follow up Period|Physician Decision|0|||
164234673|NCT02986074|593231404|FG002|Follow up Period|Physician Decision|0|||
164234674|NCT02986074|593231405|FG003|Follow up Period|Physician Decision|1|||
164234675|NCT02239926|593231408|FG000|Overall Study|Withdrawal by Subject|0|||
164234676|NCT02239926|593231409|FG001|Overall Study|Withdrawal by Subject|1|||
164234677|NCT00598650|593231412|FG000|Overall Study|Withdrawal by Subject|3|||
164234678|NCT00598650|593231412|FG000|Overall Study|Adverse Event|18|||
164234679|NCT00598650|593231412|FG000|Overall Study|No treatment for 3 weeks|1|||
164234680|NCT00598650|593231412|FG000|Overall Study|Not eligible|1|||
164234681|NCT00598650|593231412|FG000|Overall Study|Prohibited Concomitant Medication|2|||
164234682|NCT00598650|593231412|FG000|Overall Study|Physician Decision|2|||
164234683|NCT01628913|593231413|FG000|Overall Study|Adverse Event|12|||
164234684|NCT01628913|593231414|FG001|Overall Study|Adverse Event|5|||
164234685|NCT01628913|593231413|FG000|Overall Study|Disease Progression|11|||
164234686|NCT01628913|593231414|FG001|Overall Study|Disease Progression|14|||
164234687|NCT01628913|593231413|FG000|Overall Study|Protocol Violation|1|||
164234688|NCT01628913|593231414|FG001|Overall Study|Protocol Violation|0|||
164234689|NCT01628913|593231413|FG000|Overall Study|Death|1|||
164234690|NCT01628913|593231414|FG001|Overall Study|Death|0|||
164234691|NCT01628913|593231413|FG000|Overall Study|study terminated by Sponsor|4|||
164234692|NCT01628913|593231414|FG001|Overall Study|study terminated by Sponsor|9|||
164234693|NCT01628913|593231413|FG000|Overall Study|Withdrawal by Subject|1|||
164333599|NCT04526509|593597476|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333600|NCT04526509|593597477|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
163987974|NCT03467958|592324186|FG004|Overall Study|Study terminated by sponsor|66|||
163987975|NCT03467958|592324187|FG005|Overall Study|Study terminated by sponsor|17|||
163987976|NCT03467958|592324188|FG006|Overall Study|Study terminated by sponsor|11|||
163987977|NCT03467958|592324189|FG007|Overall Study|Study terminated by sponsor|5|||
163987978|NCT03467958|592324190|FG008|Overall Study|Study terminated by sponsor|5|||
163987979|NCT03467958|592324182|FG000|Overall Study|Withdrawal by Subject|25|||
163987980|NCT03467958|592324183|FG001|Overall Study|Withdrawal by Subject|44|||
163987981|NCT03467958|592324184|FG002|Overall Study|Withdrawal by Subject|7|||
163987982|NCT03467958|592324185|FG003|Overall Study|Withdrawal by Subject|8|||
163987983|NCT03467958|592324186|FG004|Overall Study|Withdrawal by Subject|6|||
163987984|NCT03467958|592324187|FG005|Overall Study|Withdrawal by Subject|8|||
163987985|NCT03467958|592324188|FG006|Overall Study|Withdrawal by Subject|4|||
163987986|NCT03467958|592324189|FG007|Overall Study|Withdrawal by Subject|1|||
163987987|NCT03467958|592324190|FG008|Overall Study|Withdrawal by Subject|4|||
163987988|NCT02286947|592324191|FG000|Overall Study|Withdrawal by Subject|2|||
164234694|NCT01628913|593231414|FG001|Overall Study|Withdrawal by Subject|0|||
164234695|NCT01628913|593231413|FG000|Overall Study|Physician Decision|1|||
164234696|NCT01628913|593231414|FG001|Overall Study|Physician Decision|3|||
164234697|NCT05201807|593231418|FG000|Overall Study|Adverse Event|1|||
164234698|NCT05201807|593231418|FG000|Overall Study|COVID-19 Related|1|||
164234699|NCT01664624|593231421|FG000|Overall Study|Adverse Event|0|||
164234700|NCT01664624|593231422|FG001|Overall Study|Adverse Event|1|||
164234701|NCT01664624|593231423|FG002|Overall Study|Adverse Event|0|||
164234702|NCT01664624|593231424|FG003|Overall Study|Adverse Event|0|||
164234703|NCT01029535|593231427|FG000|Overall Study|Lost to Follow-up|24|||
164234704|NCT01029535|593231427|FG000|Overall Study|Protocol Violation|2|||
164234705|NCT01029535|593231427|FG000|Overall Study|Participant Withdrew Consent|2|||
164234706|NCT01029535|593231427|FG000|Overall Study|Adverse Event|1|||
164234707|NCT01029535|593231427|FG000|Overall Study|Use of Another Treatment|1|||
164234708|NCT01029535|593231427|FG000|Overall Study|Death|1|||
164234709|NCT00524121|593231430|FG000|Overall Study|Disease progression|6|||
164234710|NCT00524121|593231430|FG000|Overall Study|Adverse Event|4|||
164234711|NCT00524121|593231430|FG000|Overall Study|Patient refused|2|||
164234712|NCT00524121|593231430|FG000|Overall Study|Other|1|||
164234713|NCT00524121|593231430|FG000|Overall Study|Death|1|||
164234714|NCT00524121|593231430|FG000|Overall Study|Not treated (became ineligible)|4|||
164234715|NCT00524121|593231430|FG000|Overall Study|Not treated (changed mind)|1|||
164234716|NCT02410772|593231434|FG000|Overall Study|Death|3|||
164234717|NCT02410772|593231435|FG001|Overall Study|Death|4|||
164234718|NCT02410772|593231436|FG002|Overall Study|Death|8|||
164234719|NCT02410772|593231434|FG000|Overall Study|Lost to Follow-up|31|||
164234720|NCT02410772|593231435|FG001|Overall Study|Lost to Follow-up|23|||
164234721|NCT02410772|593231436|FG002|Overall Study|Lost to Follow-up|22|||
164234722|NCT02410772|593231434|FG000|Overall Study|Pregnancy|8|||
164234723|NCT02410772|593231435|FG001|Overall Study|Pregnancy|4|||
164234724|NCT02410772|593231436|FG002|Overall Study|Pregnancy|5|||
164234725|NCT02410772|593231434|FG000|Overall Study|Protocol Violation|8|||
164234726|NCT02410772|593231435|FG001|Overall Study|Protocol Violation|8|||
164234727|NCT02410772|593231436|FG002|Overall Study|Protocol Violation|4|||
164234728|NCT02410772|593231434|FG000|Overall Study|Baseline Drug Resistance|49|||
164234729|NCT02410772|593231435|FG001|Overall Study|Baseline Drug Resistance|40|||
164234730|NCT02410772|593231436|FG002|Overall Study|Baseline Drug Resistance|51|||
164234731|NCT02410772|593231434|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
164234732|NCT02410772|593231435|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
164234733|NCT02410772|593231436|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
164234734|NCT02410772|593231434|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
164234735|NCT02410772|593231435|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
164234736|NCT02410772|593231436|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
164234737|NCT02164864|593231442|FG000|Overall Study|Trial disease worsening|7|||
164234738|NCT02164864|593231443|FG001|Overall Study|Trial disease worsening|5|||
164234739|NCT02164864|593231444|FG002|Overall Study|Trial disease worsening|1|||
164234740|NCT02164864|593231442|FG000|Overall Study|Other pre-existing disease worsening|6|||
164234741|NCT02164864|593231443|FG001|Overall Study|Other pre-existing disease worsening|4|||
164234742|NCT02164864|593231444|FG002|Overall Study|Other pre-existing disease worsening|9|||
164234743|NCT02164864|593231442|FG000|Overall Study|Other Adverse Event (AE)|52|||
164234744|NCT02164864|593231443|FG001|Overall Study|Other Adverse Event (AE)|32|||
164234745|NCT02164864|593231444|FG002|Overall Study|Other Adverse Event (AE)|49|||
164234746|NCT02164864|593231442|FG000|Overall Study|Protocol Violation|2|||
164234747|NCT02164864|593231443|FG001|Overall Study|Protocol Violation|4|||
164234748|NCT02164864|593231444|FG002|Overall Study|Protocol Violation|1|||
164234749|NCT02164864|593231442|FG000|Overall Study|Lost to Follow-up|4|||
164234750|NCT02164864|593231443|FG001|Overall Study|Lost to Follow-up|3|||
164234751|NCT02164864|593231444|FG002|Overall Study|Lost to Follow-up|2|||
164234752|NCT02164864|593231442|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
164234753|NCT02164864|593231443|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
164234754|NCT02164864|593231444|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
164234755|NCT02164864|593231442|FG000|Overall Study|Other than stated|3|||
164234756|NCT02164864|593231443|FG001|Overall Study|Other than stated|4|||
164234757|NCT02164864|593231444|FG002|Overall Study|Other than stated|14|||
164234758|NCT01870869|593231445|FG000|Overall Study|Implanted with nonstudy device|1|||
164234759|NCT01870869|593231446|FG001|Overall Study|Implanted with nonstudy device|3|||
164234760|NCT01870869|593231447|FG002|Overall Study|Implanted with nonstudy device|14|||
164234761|NCT01870869|593231448|FG003|Overall Study|Implanted with nonstudy device|4|||
164234762|NCT01870869|593231445|FG000|Overall Study|Death|0|||
164234763|NCT01870869|593231446|FG001|Overall Study|Death|0|||
164234764|NCT01870869|593231447|FG002|Overall Study|Death|7|||
164234765|NCT01870869|593231448|FG003|Overall Study|Death|1|||
164234766|NCT01870869|593231445|FG000|Overall Study|Subject choice|6|||
164234767|NCT01870869|593231446|FG001|Overall Study|Subject choice|2|||
164234768|NCT01870869|593231447|FG002|Overall Study|Subject choice|22|||
164234769|NCT01870869|593231448|FG003|Overall Study|Subject choice|8|||
164234770|NCT01870869|593231445|FG000|Overall Study|Lost to Follow-up|10|||
164234771|NCT01870869|593231446|FG001|Overall Study|Lost to Follow-up|2|||
164234772|NCT01870869|593231447|FG002|Overall Study|Lost to Follow-up|25|||
164234773|NCT01870869|593231448|FG003|Overall Study|Lost to Follow-up|3|||
164234774|NCT01870869|593231445|FG000|Overall Study|Reason not Specified|1|||
164234775|NCT01870869|593231446|FG001|Overall Study|Reason not Specified|2|||
164234776|NCT01870869|593231447|FG002|Overall Study|Reason not Specified|20|||
164234777|NCT01870869|593231448|FG003|Overall Study|Reason not Specified|4|||
164234778|NCT01870869|593231445|FG000|Overall Study|Not evaluable|10|||
164234779|NCT01870869|593231446|FG001|Overall Study|Not evaluable|5|||
164234780|NCT01870869|593231447|FG002|Overall Study|Not evaluable|42|||
164234781|NCT01870869|593231448|FG003|Overall Study|Not evaluable|10|||
164234782|NCT00904371|593231449|FG000|Overall Study|Adverse Event|2|||
164234783|NCT00904371|593231449|FG000|Overall Study|Lost to Follow-up|4|||
164234784|NCT00904371|593231449|FG000|Overall Study|Discontinued at target blood pressure|2|||
164234785|NCT00904371|593231449|FG000|Overall Study|Continued with Tritace|1|||
164234786|NCT02493764|593231450|FG000|Overall Study|Adverse Event|2|||
164234787|NCT02493764|593231451|FG001|Overall Study|Adverse Event|2|||
164234788|NCT02493764|593231450|FG000|Overall Study|Death|44|||
164234789|NCT02493764|593231451|FG001|Overall Study|Death|58|||
164234790|NCT02493764|593231450|FG000|Overall Study|Lost to Follow-up|2|||
164234791|NCT02493764|593231451|FG001|Overall Study|Lost to Follow-up|1|||
164234792|NCT02493764|593231450|FG000|Overall Study|Protocol Violation|6|||
164234793|NCT02493764|593231451|FG001|Overall Study|Protocol Violation|7|||
164234794|NCT02493764|593231450|FG000|Overall Study|Physician Decision|1|||
164234795|NCT02493764|593231451|FG001|Overall Study|Physician Decision|1|||
164234796|NCT02493764|593231450|FG000|Overall Study|Participant moved|17|||
164234797|NCT02493764|593231451|FG001|Overall Study|Participant moved|5|||
164234798|NCT02493764|593231450|FG000|Overall Study|Withdrawal parent/guardian|0|||
164234799|NCT02493764|593231451|FG001|Overall Study|Withdrawal parent/guardian|1|||
164234800|NCT02493764|593231450|FG000|Overall Study|Withdrawal by Subject|11|||
164234801|NCT02493764|593231451|FG001|Overall Study|Withdrawal by Subject|7|||
164234802|NCT05448950|593231454|FG000|Overall Study|Death|2|||
164234803|NCT05448950|593231454|FG000|Overall Study|Withdrawal by Subject|1|||
164234804|NCT05448950|593231454|FG000|Overall Study|AVG abandoned|4|||
164234805|NCT01646827|593231455|FG000|Overall Study|Lost to Follow-up|0|||
164234806|NCT01646827|593231456|FG001|Overall Study|Lost to Follow-up|3|||
164234807|NCT01646827|593231455|FG000|Overall Study|Physician Decision|1|||
164234808|NCT01646827|593231456|FG001|Overall Study|Physician Decision|2|||
164234809|NCT01646827|593231455|FG000|Overall Study|Withdrawal by Subject|1|||
164234810|NCT01646827|593231456|FG001|Overall Study|Withdrawal by Subject|0|||
164234811|NCT01242514|593231461|FG000|Overall Study|e.g., project closure|1042|||
164234812|NCT01242514|593231462|FG001|Overall Study|e.g., project closure|305|||
164234813|NCT01242514|593231463|FG002|Overall Study|e.g., project closure|171|||
164234814|NCT01242514|593231461|FG000|Overall Study|Subject decision|33|||
164234815|NCT01242514|593231462|FG001|Overall Study|Subject decision|8|||
164234816|NCT01242514|593231463|FG002|Overall Study|Subject decision|2|||
164234817|NCT01242514|593231461|FG000|Overall Study|Severe non-compliance to protocol|5|||
164234818|NCT01242514|593231462|FG001|Overall Study|Severe non-compliance to protocol|2|||
164234819|NCT01242514|593231463|FG002|Overall Study|Severe non-compliance to protocol|1|||
164234820|NCT01242514|593231461|FG000|Overall Study|Lack of therapeutic response|99|||
164234821|NCT01242514|593231462|FG001|Overall Study|Lack of therapeutic response|16|||
164234822|NCT01242514|593231463|FG002|Overall Study|Lack of therapeutic response|10|||
164234823|NCT01242514|593231461|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
164234824|NCT01242514|593231462|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
164234825|NCT01242514|593231463|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
164234826|NCT01242514|593231461|FG000|Overall Study|Lost to Follow-up|14|||
164234827|NCT01242514|593231462|FG001|Overall Study|Lost to Follow-up|5|||
164234828|NCT01242514|593231463|FG002|Overall Study|Lost to Follow-up|4|||
164234829|NCT01242514|593231461|FG000|Overall Study|Adverse Event|129|||
164234830|NCT01242514|593231462|FG001|Overall Study|Adverse Event|18|||
164234831|NCT01242514|593231463|FG002|Overall Study|Adverse Event|19|||
164234832|NCT05901636|593231469|FG000|Overall Study|Lost to Follow-up|0|||
164234833|NCT05901636|593231470|FG001|Overall Study|Lost to Follow-up|1|||
164234834|NCT05901636|593231471|FG002|Overall Study|Lost to Follow-up|0|||
164234835|NCT05901636|593231472|FG003|Overall Study|Lost to Follow-up|1|||
164234836|NCT05901636|593231473|FG004|Overall Study|Lost to Follow-up|1|||
164234837|NCT05901636|593231474|FG005|Overall Study|Lost to Follow-up|3|||
164234838|NCT05901636|593231475|FG006|Overall Study|Lost to Follow-up|1|||
164299834|NCT02234843|593472945|FG001|Overall Study|Death|0|||
164333601|NCT04526509|593597478|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
164333602|NCT04526509|593597479|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333603|NCT04526509|593597480|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333604|NCT04526509|593597481|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
164333605|NCT04526509|593597475|FG000|Enrolled|Physician Decision|0|||
164333606|NCT04526509|593597476|FG001|Enrolled|Physician Decision|1|||
163884041|NCT02671903|591945825|FG002|Period 0 (Run-In)|Physician Decision|4|||
163884042|NCT02671903|591945823|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
163884043|NCT02671903|591945824|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
163884044|NCT02671903|591945825|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
163884045|NCT02671903|591945823|FG000|Period 0 (Run-In)|Protocol Violation|0|||
164333607|NCT04526509|593597477|FG002|Enrolled|Physician Decision|0|||
163884046|NCT02671903|591945824|FG001|Period 0 (Run-In)|Protocol Violation|0|||
164333608|NCT04526509|593597478|FG003|Enrolled|Physician Decision|0|||
164333609|NCT04526509|593597479|FG004|Enrolled|Physician Decision|0|||
164333610|NCT04526509|593597480|FG005|Enrolled|Physician Decision|0|||
164333611|NCT04526509|593597481|FG006|Enrolled|Physician Decision|0|||
164333612|NCT02206048|593599581|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
164333613|NCT00282412|593599582|FG000|Overall Study|Death|2|||
164333614|NCT02203071|593599584|FG000|Overall Study|Lost to Follow-up|3|||
164333615|NCT02203071|593599585|FG001|Overall Study|Lost to Follow-up|1|||
164333616|NCT02572388|593599586|FG000|Overall Study|Withdrawal by Subject|1|||
164333617|NCT02572388|593599587|FG001|Overall Study|Withdrawal by Subject|1|||
164333618|NCT02572388|593599588|FG002|Overall Study|Withdrawal by Subject|2|||
164333619|NCT02572388|593599589|FG003|Overall Study|Withdrawal by Subject|2|||
164333620|NCT02202837|593599592|FG000|Overall Study|Enbrel treatment discontinued|36|||
164333621|NCT02202837|593599593|FG001|Overall Study|Enbrel treatment discontinued|4|||
164333622|NCT02202837|593599592|FG000|Overall Study|Other|10|||
164333623|NCT02202837|593599593|FG001|Overall Study|Other|0|||
164333624|NCT02202837|593599592|FG000|Overall Study|Lost to Follow-up|7|||
164333625|NCT02202837|593599593|FG001|Overall Study|Lost to Follow-up|1|||
164333626|NCT01871142|593599594|FG000|Overall Study|Adverse Event|1|||
164333627|NCT00231842|593599604|FG000|Overall Study|Withdrawal by Subject|3|||
164333628|NCT00231842|593599604|FG000|Overall Study|Did not complete the last 3 cycle|8|||
164333629|NCT02422303|593599605|FG000|Overall Study|Lost to Follow-up|1|||
164333630|NCT02422303|593599606|FG001|Overall Study|Lost to Follow-up|1|||
164333631|NCT00428792|593599608|FG000|Overall Study|Lack of Efficacy|1|||
164333632|NCT00428792|593599609|FG001|Overall Study|Lack of Efficacy|3|||
164333633|NCT00428792|593599608|FG000|Overall Study|Lost to Follow-up|0|||
164333634|NCT00428792|593599609|FG001|Overall Study|Lost to Follow-up|1|||
163884047|NCT02671903|591945825|FG002|Period 0 (Run-In)|Protocol Violation|1|||
163884048|NCT02671903|591945823|FG000|Period 0 (Run-In)|Adverse Event|0|||
163884049|NCT02671903|591945824|FG001|Period 0 (Run-In)|Adverse Event|0|||
163884050|NCT02671903|591945825|FG002|Period 0 (Run-In)|Adverse Event|1|||
163884051|NCT02671903|591945823|FG000|Period 0 (Run-In)|Implantation Failure|0|||
163884052|NCT02671903|591945824|FG001|Period 0 (Run-In)|Implantation Failure|0|||
163884053|NCT02671903|591945825|FG002|Period 0 (Run-In)|Implantation Failure|2|||
163884054|NCT02671903|591945823|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
163884055|NCT02671903|591945824|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
163884056|NCT02671903|591945825|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
163884057|NCT03673111|591945826|FG000|Overall Study|Protocol Violation|0|||
163884058|NCT03673111|591945827|FG001|Overall Study|Protocol Violation|0|||
163987989|NCT01687712|592324192|FG000|Cycle 1|Not Biochemically Pregnant|386|||
163987990|NCT01687712|592324193|FG001|Cycle 1|Not Biochemically Pregnant|348|||
163987991|NCT01687712|592324192|FG000|Cycle 1|Early Pregnancy Loss|43|||
163987992|NCT01687712|592324193|FG001|Cycle 1|Early Pregnancy Loss|60|||
163987993|NCT01687712|592324192|FG000|Cycle 1|Ectopic Pregnancy|5|||
163987994|NCT01687712|592324193|FG001|Cycle 1|Ectopic Pregnancy|5|||
163987995|NCT01687712|592324192|FG000|Cycle 1|Heterotropic Pregnancy|1|||
163987996|NCT01687712|592324193|FG001|Cycle 1|Heterotropic Pregnancy|0|||
163987997|NCT01687712|592324192|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
163987998|NCT01687712|592324193|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
163987999|NCT01687712|592324192|FG000|Cycle 1|Abortion|3|||
163988000|NCT01687712|592324193|FG001|Cycle 1|Abortion|0|||
163988001|NCT01687712|592324192|FG000|Cycle 1|Intrauterine Fetal Death|0|||
163988002|NCT01687712|592324193|FG001|Cycle 1|Intrauterine Fetal Death|1|||
163988003|NCT01687712|592324192|FG000|Cycle 1|Lost to Follow-up|1|||
163988004|NCT01687712|592324193|FG001|Cycle 1|Lost to Follow-up|1|||
163988005|NCT01687712|592324192|FG000|Cycle 2|Not Biochemically Pregnant|74|||
163988006|NCT01687712|592324193|FG001|Cycle 2|Not Biochemically Pregnant|77|||
163988007|NCT01687712|592324192|FG000|Cycle 2|Early Pregnancy Loss|18|||
163988008|NCT01687712|592324193|FG001|Cycle 2|Early Pregnancy Loss|16|||
163988009|NCT01687712|592324192|FG000|Cycle 2|Ectopic Pregnancy|0|||
163988010|NCT01687712|592324193|FG001|Cycle 2|Ectopic Pregnancy|1|||
163988011|NCT01687712|592324192|FG000|Cycle 2|Still Birth|1|||
163988012|NCT01687712|592324193|FG001|Cycle 2|Still Birth|0|||
163988013|NCT01687712|592324192|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
163988014|NCT01687712|592324193|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
163988015|NCT01687712|592324192|FG000|Cycle 3|Not Biochemically Pregnant|21|||
163988016|NCT01687712|592324193|FG001|Cycle 3|Not Biochemically Pregnant|22|||
163988017|NCT01687712|592324192|FG000|Cycle 3|Early Pregnancy Loss|1|||
163988018|NCT01687712|592324193|FG001|Cycle 3|Early Pregnancy Loss|2|||
163988019|NCT01687712|592324192|FG000|Cycle 3|Ectopic Pregnancy|1|||
163988020|NCT01687712|592324193|FG001|Cycle 3|Ectopic Pregnancy|0|||
163988021|NCT01687712|592324192|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
163988022|NCT01687712|592324193|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
163988023|NCT01060059|592324196|FG000|Overall Study|Adverse Event|1|||
163988024|NCT01060059|592324197|FG001|Overall Study|Adverse Event|1|||
163988025|NCT01060059|592324196|FG000|Overall Study|Death|2|||
163988026|NCT01060059|592324197|FG001|Overall Study|Death|3|||
163988027|NCT01060059|592324196|FG000|Overall Study|Lost to Follow-up|18|||
163988028|NCT01060059|592324197|FG001|Overall Study|Lost to Follow-up|34|||
163988029|NCT01060059|592324196|FG000|Overall Study|entry criteria not met|4|||
163988030|NCT01060059|592324197|FG001|Overall Study|entry criteria not met|3|||
163988031|NCT01060059|592324196|FG000|Overall Study|Withdrawal by Subject|35|||
163988032|NCT01060059|592324197|FG001|Overall Study|Withdrawal by Subject|23|||
163988033|NCT01060059|592324196|FG000|Overall Study|lack of glycemic control|2|||
163988034|NCT01060059|592324197|FG001|Overall Study|lack of glycemic control|1|||
163988035|NCT01060059|592324196|FG000|Overall Study|lack of compliance|5|||
163988036|NCT01060059|592324197|FG001|Overall Study|lack of compliance|2|||
163988037|NCT00516737|592324202|FG000|Overall Study|Lost to Follow-up|2|||
163988038|NCT00516737|592324203|FG001|Overall Study|Lost to Follow-up|0|||
163988039|NCT00516737|592324202|FG000|Overall Study|Physician Decision|0|||
163988040|NCT00516737|592324203|FG001|Overall Study|Physician Decision|1|||
163988041|NCT00516737|592324202|FG000|Overall Study|Withdrawal by Subject|0|||
163988042|NCT00516737|592324203|FG001|Overall Study|Withdrawal by Subject|1|||
163988043|NCT00516737|592324202|FG000|Overall Study|Lack of Qualifying Event|9|||
163988044|NCT00516737|592324203|FG001|Overall Study|Lack of Qualifying Event|6|||
163988045|NCT01816243|592324204|FG000|Overall Study|Adverse Event|6|||
163988046|NCT01816243|592324204|FG000|Overall Study|Lost to Follow-up|1|||
163988047|NCT01816243|592324204|FG000|Overall Study|Lack of Efficacy|1|||
163988048|NCT01816243|592324204|FG000|Overall Study|Not eligible for the study|1|||
163988049|NCT01816243|592324204|FG000|Overall Study|Amputation|3|||
163988050|NCT00512798|592324205|FG000|Overall Study|Death|0|||
163988051|NCT00512798|592324206|FG001|Overall Study|Death|3|||
163988052|NCT00512798|592324205|FG000|Overall Study|Adverse Event|2|||
163988053|NCT00512798|592324206|FG001|Overall Study|Adverse Event|4|||
163988054|NCT00512798|592324205|FG000|Overall Study|Progression of disease|14|||
163988055|NCT00512798|592324206|FG001|Overall Study|Progression of disease|20|||
163988056|NCT00512798|592324205|FG000|Overall Study|Withdrawal by Subject|3|||
163988057|NCT00512798|592324206|FG001|Overall Study|Withdrawal by Subject|0|||
163988058|NCT01920711|592324207|FG000|Overall Study|Death|347|||
163988059|NCT01920711|592324208|FG001|Overall Study|Death|356|||
163988060|NCT01920711|592324207|FG000|Overall Study|Lost to Follow-up|13|||
163988061|NCT01920711|592324208|FG001|Overall Study|Lost to Follow-up|14|||
164234839|NCT05901636|593231469|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
164234840|NCT05901636|593231470|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
164234841|NCT05901636|593231471|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
164234842|NCT05901636|593231472|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
164234843|NCT05901636|593231473|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
164234844|NCT05901636|593231474|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
164234845|NCT05901636|593231475|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
164234846|NCT05901636|593231469|FG000|Overall Study|Withdrawal by Subject|1|||
164234847|NCT05901636|593231470|FG001|Overall Study|Withdrawal by Subject|1|||
164234848|NCT05901636|593231471|FG002|Overall Study|Withdrawal by Subject|0|||
164234849|NCT05901636|593231472|FG003|Overall Study|Withdrawal by Subject|0|||
164234850|NCT05901636|593231473|FG004|Overall Study|Withdrawal by Subject|1|||
164234851|NCT05901636|593231474|FG005|Overall Study|Withdrawal by Subject|1|||
164234852|NCT05901636|593231475|FG006|Overall Study|Withdrawal by Subject|0|||
164234853|NCT05901636|593231469|FG000|Overall Study|Other|0|||
164234854|NCT05901636|593231470|FG001|Overall Study|Other|0|||
164234855|NCT05901636|593231471|FG002|Overall Study|Other|1|||
164234856|NCT05901636|593231472|FG003|Overall Study|Other|1|||
164234857|NCT05901636|593231473|FG004|Overall Study|Other|0|||
164234858|NCT05901636|593231474|FG005|Overall Study|Other|0|||
164234859|NCT05901636|593231475|FG006|Overall Study|Other|0|||
164234860|NCT03193801|593231476|FG000|Overall Study|Physician Decision|2|||
164234861|NCT03193801|593231476|FG000|Overall Study|Withdrawal by Subject|1|||
164234862|NCT03110562|593231477|FG000|Initial Treatment Period|Disease Progression|1|||
164234863|NCT03110562|593231478|FG001|Initial Treatment Period|Disease Progression|1|||
164234864|NCT03110562|593231479|FG002|Initial Treatment Period|Disease Progression|0|||
164234865|NCT03110562|593231480|FG003|Initial Treatment Period|Disease Progression|0|||
164234866|NCT03110562|593231477|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
164234867|NCT03110562|593231478|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
164234868|NCT03110562|593231479|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
164234869|NCT03110562|593231480|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
164234870|NCT03110562|593231477|FG000|Initial Treatment Period|Adverse Event|1|||
164234871|NCT03110562|593231478|FG001|Initial Treatment Period|Adverse Event|0|||
164234872|NCT03110562|593231479|FG002|Initial Treatment Period|Adverse Event|0|||
164234873|NCT03110562|593231480|FG003|Initial Treatment Period|Adverse Event|0|||
164333635|NCT00850343|593599610|FG000|Overall Study|Withdrawal by Subject|11|||
164333636|NCT00850343|593599611|FG001|Overall Study|Withdrawal by Subject|0|||
164333637|NCT00850343|593599612|FG002|Overall Study|Withdrawal by Subject|3|||
164333638|NCT00850343|593599613|FG003|Overall Study|Withdrawal by Subject|2|||
164333639|NCT00850343|593599610|FG000|Overall Study|Adverse Event|15|||
164333640|NCT00850343|593599611|FG001|Overall Study|Adverse Event|2|||
164333641|NCT00850343|593599612|FG002|Overall Study|Adverse Event|6|||
164333642|NCT00850343|593599613|FG003|Overall Study|Adverse Event|6|||
164333643|NCT00850343|593599610|FG000|Overall Study|Pregnancy|0|||
164333644|NCT00850343|593599611|FG001|Overall Study|Pregnancy|0|||
164333645|NCT00850343|593599612|FG002|Overall Study|Pregnancy|0|||
164333646|NCT00850343|593599613|FG003|Overall Study|Pregnancy|1|||
164333647|NCT00850343|593599610|FG000|Overall Study|Lack of Efficacy|17|||
164333648|NCT00850343|593599611|FG001|Overall Study|Lack of Efficacy|0|||
164333649|NCT00850343|593599612|FG002|Overall Study|Lack of Efficacy|3|||
164333650|NCT00850343|593599613|FG003|Overall Study|Lack of Efficacy|2|||
164333651|NCT00850343|593599610|FG000|Overall Study|Non-compliance with Study Procedures|1|||
164333652|NCT00850343|593599611|FG001|Overall Study|Non-compliance with Study Procedures|0|||
164333653|NCT00850343|593599612|FG002|Overall Study|Non-compliance with Study Procedures|1|||
164333654|NCT00850343|593599613|FG003|Overall Study|Non-compliance with Study Procedures|1|||
164333655|NCT00850343|593599610|FG000|Overall Study|Physician Decision|2|||
164333656|NCT00850343|593599611|FG001|Overall Study|Physician Decision|1|||
164333657|NCT00850343|593599612|FG002|Overall Study|Physician Decision|1|||
164333658|NCT00850343|593599613|FG003|Overall Study|Physician Decision|1|||
164333659|NCT02468232|593599614|FG000|Core Part of Study|Adverse Event|0|||
164333660|NCT02468232|593599615|FG001|Core Part of Study|Adverse Event|1|||
164333661|NCT02468232|593599616|FG002|Core Part of Study|Adverse Event|0|||
164333662|NCT02468232|593599617|FG003|Core Part of Study|Adverse Event|0|||
164333663|NCT02468232|593599614|FG000|Core Part of Study|Death|20|||
164333664|NCT02468232|593599615|FG001|Core Part of Study|Death|17|||
164333665|NCT02468232|593599616|FG002|Core Part of Study|Death|0|||
164333666|NCT02468232|593599617|FG003|Core Part of Study|Death|0|||
164333667|NCT02468232|593599614|FG000|Core Part of Study|Technical Problems|1|||
164333668|NCT02468232|593599615|FG001|Core Part of Study|Technical Problems|1|||
164333669|NCT02468232|593599616|FG002|Core Part of Study|Technical Problems|0|||
164333670|NCT02468232|593599617|FG003|Core Part of Study|Technical Problems|0|||
164333671|NCT02468232|593599614|FG000|OLE Part of Study|Adverse Event|0|||
164333672|NCT02468232|593599615|FG001|OLE Part of Study|Adverse Event|0|||
164333673|NCT02468232|593599616|FG002|OLE Part of Study|Adverse Event|4|||
164333674|NCT02468232|593599617|FG003|OLE Part of Study|Adverse Event|5|||
164333675|NCT02468232|593599614|FG000|OLE Part of Study|Death|0|||
164333676|NCT02468232|593599615|FG001|OLE Part of Study|Death|0|||
163884059|NCT03673111|591945828|FG002|Overall Study|Protocol Violation|0|||
163884060|NCT03673111|591945829|FG003|Overall Study|Protocol Violation|0|||
164333677|NCT02468232|593599616|FG002|OLE Part of Study|Death|4|||
164333678|NCT02468232|593599617|FG003|OLE Part of Study|Death|2|||
164333679|NCT02468232|593599614|FG000|OLE Part of Study|Physician Decision|0|||
164333680|NCT02468232|593599615|FG001|OLE Part of Study|Physician Decision|0|||
164333681|NCT02468232|593599616|FG002|OLE Part of Study|Physician Decision|4|||
164333682|NCT02468232|593599617|FG003|OLE Part of Study|Physician Decision|0|||
164333683|NCT02468232|593599614|FG000|OLE Part of Study|Subject/Guardian decision|0|||
164333684|NCT02468232|593599615|FG001|OLE Part of Study|Subject/Guardian decision|0|||
164333685|NCT02468232|593599616|FG002|OLE Part of Study|Subject/Guardian decision|2|||
164333686|NCT02468232|593599617|FG003|OLE Part of Study|Subject/Guardian decision|5|||
164333687|NCT01973569|593599618|FG000|Overall Study|Adverse Event|9|||
164333688|NCT01973569|593599619|FG001|Overall Study|Adverse Event|2|||
164333689|NCT01973569|593599620|FG002|Overall Study|Adverse Event|4|||
164333690|NCT01973569|593599618|FG000|Overall Study|Protocol Violation|2|||
164333691|NCT01973569|593599619|FG001|Overall Study|Protocol Violation|1|||
164333692|NCT01973569|593599620|FG002|Overall Study|Protocol Violation|3|||
164333693|NCT01973569|593599618|FG000|Overall Study|Withdrawal by Subject|7|||
164333694|NCT01973569|593599619|FG001|Overall Study|Withdrawal by Subject|5|||
164333695|NCT01973569|593599620|FG002|Overall Study|Withdrawal by Subject|2|||
163884061|NCT03673111|591945830|FG004|Overall Study|Protocol Violation|0|||
163884062|NCT03673111|591945831|FG005|Overall Study|Protocol Violation|0|||
163884063|NCT03673111|591945832|FG006|Overall Study|Protocol Violation|0|||
164333696|NCT01973569|593599618|FG000|Overall Study|Invasive dental treatment|3|||
164333697|NCT01973569|593599619|FG001|Overall Study|Invasive dental treatment|5|||
164333698|NCT01973569|593599620|FG002|Overall Study|Invasive dental treatment|6|||
164333699|NCT01973569|593599618|FG000|Overall Study|Prohibited concomitant d|1|||
164333700|NCT01973569|593599619|FG001|Overall Study|Prohibited concomitant d|5|||
164333701|NCT01973569|593599620|FG002|Overall Study|Prohibited concomitant d|0|||
164333702|NCT01973569|593599618|FG000|Overall Study|Disease progression|0|||
164333703|NCT01973569|593599619|FG001|Overall Study|Disease progression|3|||
164333704|NCT01973569|593599620|FG002|Overall Study|Disease progression|0|||
164333705|NCT01973569|593599618|FG000|Overall Study|Other|1|||
164333706|NCT01973569|593599619|FG001|Overall Study|Other|1|||
164234874|NCT03110562|593231477|FG000|Initial Treatment Period|Death|74|||
164234875|NCT03110562|593231478|FG001|Initial Treatment Period|Death|82|||
164234876|NCT03110562|593231479|FG002|Initial Treatment Period|Death|0|||
164234877|NCT03110562|593231480|FG003|Initial Treatment Period|Death|0|||
164234878|NCT03110562|593231477|FG000|Initial Treatment Period|Lost to Follow-up|13|||
164234879|NCT03110562|593231478|FG001|Initial Treatment Period|Lost to Follow-up|8|||
164234880|NCT03110562|593231479|FG002|Initial Treatment Period|Lost to Follow-up|0|||
164234881|NCT03110562|593231480|FG003|Initial Treatment Period|Lost to Follow-up|0|||
164234882|NCT03110562|593231477|FG000|Initial Treatment Period|Protocol Deviation|1|||
164234883|NCT03110562|593231478|FG001|Initial Treatment Period|Protocol Deviation|0|||
164234884|NCT03110562|593231479|FG002|Initial Treatment Period|Protocol Deviation|0|||
164234885|NCT03110562|593231480|FG003|Initial Treatment Period|Protocol Deviation|0|||
164234886|NCT03110562|593231477|FG000|Initial Treatment Period|Physician Decision|2|||
164234887|NCT03110562|593231478|FG001|Initial Treatment Period|Physician Decision|1|||
164234888|NCT03110562|593231479|FG002|Initial Treatment Period|Physician Decision|0|||
164234889|NCT03110562|593231480|FG003|Initial Treatment Period|Physician Decision|0|||
164234890|NCT03110562|593231477|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
164234891|NCT03110562|593231478|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
164234892|NCT03110562|593231479|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
164234893|NCT03110562|593231480|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
164234894|NCT03110562|593231477|FG000|Initial Treatment Period|Other|5|||
164234895|NCT03110562|593231478|FG001|Initial Treatment Period|Other|4|||
164234896|NCT03110562|593231479|FG002|Initial Treatment Period|Other|0|||
164234897|NCT03110562|593231480|FG003|Initial Treatment Period|Other|0|||
164234898|NCT03110562|593231477|FG000|Initial Treatment Period|Randomized but never treated|0|||
164234899|NCT03110562|593231478|FG001|Initial Treatment Period|Randomized but never treated|3|||
164234900|NCT03110562|593231479|FG002|Initial Treatment Period|Randomized but never treated|0|||
164234901|NCT03110562|593231480|FG003|Initial Treatment Period|Randomized but never treated|0|||
164234902|NCT03110562|593231477|FG000|Crossover Period|Disease Progression|0|||
164234903|NCT03110562|593231478|FG001|Crossover Period|Disease Progression|0|||
164234904|NCT03110562|593231479|FG002|Crossover Period|Disease Progression|1|||
164234905|NCT03110562|593231480|FG003|Crossover Period|Disease Progression|0|||
164234906|NCT03110562|593231477|FG000|Crossover Period|Withdrawal by Subject|0|||
164234907|NCT03110562|593231478|FG001|Crossover Period|Withdrawal by Subject|0|||
164234908|NCT03110562|593231479|FG002|Crossover Period|Withdrawal by Subject|8|||
164234909|NCT03110562|593231480|FG003|Crossover Period|Withdrawal by Subject|6|||
164234910|NCT03110562|593231477|FG000|Crossover Period|Death|0|||
164234911|NCT03110562|593231478|FG001|Crossover Period|Death|0|||
164234912|NCT03110562|593231479|FG002|Crossover Period|Death|37|||
164234913|NCT03110562|593231480|FG003|Crossover Period|Death|3|||
164234914|NCT03110562|593231477|FG000|Crossover Period|Lost to Follow-up|0|||
164234915|NCT03110562|593231478|FG001|Crossover Period|Lost to Follow-up|0|||
164333707|NCT01973569|593599620|FG002|Overall Study|Other|0|||
164333708|NCT01973569|593599618|FG000|Overall Study|Did not receive study drug|6|||
164333709|NCT01973569|593599619|FG001|Overall Study|Did not receive study drug|3|||
164333710|NCT01973569|593599620|FG002|Overall Study|Did not receive study drug|3|||
164333711|NCT00371826|593599621|FG000|Core Phase (12 Months)|Adverse Event|15|||
164333712|NCT00371826|593599622|FG001|Core Phase (12 Months)|Adverse Event|4|||
164333713|NCT00371826|593599623|FG002|Core Phase (12 Months)|Adverse Event|9|||
164333714|NCT00371826|593599621|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
164333715|NCT00371826|593599622|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
164333716|NCT00371826|593599623|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
164234916|NCT03110562|593231479|FG002|Crossover Period|Lost to Follow-up|0|||
164234917|NCT03110562|593231480|FG003|Crossover Period|Lost to Follow-up|1|||
164333717|NCT00371826|593599621|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
164333718|NCT00371826|593599622|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
164333719|NCT00371826|593599623|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
164333720|NCT00371826|593599621|FG000|Core Phase (12 Months)|Protocol Violation|1|||
164234918|NCT03110562|593231477|FG000|Crossover Period|Other|0|||
164234919|NCT03110562|593231478|FG001|Crossover Period|Other|0|||
164234920|NCT03110562|593231479|FG002|Crossover Period|Other|1|||
164234921|NCT03110562|593231480|FG003|Crossover Period|Other|1|||
164234922|NCT03110562|593231477|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
164234923|NCT03110562|593231478|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
164234924|NCT03110562|593231479|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
164234925|NCT03110562|593231480|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
164333721|NCT00371826|593599622|FG001|Core Phase (12 Months)|Protocol Violation|0|||
164333722|NCT00371826|593599623|FG002|Core Phase (12 Months)|Protocol Violation|1|||
164234926|NCT05239221|593231486|FG000|Overall Study|Adverse Event|0|||
164234927|NCT05239221|593231487|FG001|Overall Study|Adverse Event|0|||
164234928|NCT05239221|593231488|FG002|Overall Study|Adverse Event|0|||
164234929|NCT05239221|593231489|FG003|Overall Study|Adverse Event|0|||
164234930|NCT05239221|593231490|FG004|Overall Study|Adverse Event|0|||
164234931|NCT05239221|593231491|FG005|Overall Study|Adverse Event|0|||
164234932|NCT05239221|593231492|FG006|Overall Study|Adverse Event|1|||
164234933|NCT05239221|593231493|FG007|Overall Study|Adverse Event|0|||
164234934|NCT05239221|593231494|FG008|Overall Study|Adverse Event|0|||
164234935|NCT05239221|593231495|FG009|Overall Study|Adverse Event|0|||
164234936|NCT05239221|593231496|FG010|Overall Study|Adverse Event|1|||
164234937|NCT05239221|593231497|FG011|Overall Study|Adverse Event|1|||
164234938|NCT05239221|593231498|FG012|Overall Study|Adverse Event|0|||
164234939|NCT05239221|593231499|FG013|Overall Study|Adverse Event|0|||
164234940|NCT05239221|593231500|FG014|Overall Study|Adverse Event|0|||
164234941|NCT05239221|593231501|FG015|Overall Study|Adverse Event|0|||
164234942|NCT05239221|593231486|FG000|Overall Study|Withdrawal by Subject|0|||
164234943|NCT05239221|593231487|FG001|Overall Study|Withdrawal by Subject|0|||
164234944|NCT05239221|593231488|FG002|Overall Study|Withdrawal by Subject|0|||
164234945|NCT05239221|593231489|FG003|Overall Study|Withdrawal by Subject|0|||
164234946|NCT05239221|593231490|FG004|Overall Study|Withdrawal by Subject|0|||
164234947|NCT05239221|593231491|FG005|Overall Study|Withdrawal by Subject|0|||
164234948|NCT05239221|593231492|FG006|Overall Study|Withdrawal by Subject|0|||
164234949|NCT05239221|593231493|FG007|Overall Study|Withdrawal by Subject|0|||
164234950|NCT05239221|593231494|FG008|Overall Study|Withdrawal by Subject|0|||
164234951|NCT05239221|593231495|FG009|Overall Study|Withdrawal by Subject|0|||
164234952|NCT05239221|593231496|FG010|Overall Study|Withdrawal by Subject|1|||
164234953|NCT05239221|593231497|FG011|Overall Study|Withdrawal by Subject|0|||
164234954|NCT05239221|593231498|FG012|Overall Study|Withdrawal by Subject|0|||
164234955|NCT05239221|593231499|FG013|Overall Study|Withdrawal by Subject|0|||
164234956|NCT05239221|593231500|FG014|Overall Study|Withdrawal by Subject|0|||
164234957|NCT05239221|593231501|FG015|Overall Study|Withdrawal by Subject|1|||
164234958|NCT02114177|593233379|FG000|Overall Study|Lost to Follow-up|1|||
164234959|NCT02114177|593233380|FG001|Overall Study|Lost to Follow-up|2|||
164234960|NCT02114177|593233379|FG000|Overall Study|Withdrawal by Subject|6|||
164234961|NCT02114177|593233380|FG001|Overall Study|Withdrawal by Subject|1|||
164234962|NCT02114177|593233379|FG000|Overall Study|Other|2|||
164234963|NCT02114177|593233380|FG001|Overall Study|Other|1|||
163988062|NCT01920711|592324207|FG000|Overall Study|Withdrawal by Subject|4|||
164234964|NCT05111145|593233381|FG000|Overall Study|Commercial drug is available for participant|76|||
164234965|NCT05111145|593233381|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
164234966|NCT02336815|593233382|FG000|Overall Study|Disease Progression|45|||
164234967|NCT02336815|593233383|FG001|Overall Study|Disease Progression|70|||
164234968|NCT02336815|593233382|FG000|Overall Study|Adverse Event|18|||
164234969|NCT02336815|593233383|FG001|Overall Study|Adverse Event|39|||
164234970|NCT02336815|593233382|FG000|Overall Study|Physician Decision|11|||
164234971|NCT02336815|593233383|FG001|Overall Study|Physician Decision|4|||
164234972|NCT02336815|593233382|FG000|Overall Study|Withdrawal by Subject|3|||
164234973|NCT02336815|593233383|FG001|Overall Study|Withdrawal by Subject|2|||
164234974|NCT02336815|593233382|FG000|Overall Study|Lost to Follow-up|1|||
164234975|NCT02336815|593233383|FG001|Overall Study|Lost to Follow-up|3|||
164234976|NCT02336815|593233382|FG000|Overall Study|Other|1|||
164234977|NCT02336815|593233383|FG001|Overall Study|Other|5|||
164234978|NCT01359956|593233384|FG000|Overall Study|Death|58|||
164234979|NCT01359956|593233385|FG001|Overall Study|Death|60|||
164234980|NCT01359956|593233386|FG002|Overall Study|Death|66|||
164234981|NCT01359956|593233387|FG003|Overall Study|Death|57|||
164333723|NCT00371826|593599621|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
164333724|NCT00371826|593599622|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
163988063|NCT01920711|592324208|FG001|Overall Study|Withdrawal by Subject|3|||
163988064|NCT02317562|592324210|FG000|Overall Study|Physician Decision|1|||
163988065|NCT02317562|592324210|FG000|Overall Study|early termination of the study|8|||
164234982|NCT01359956|593233384|FG000|Overall Study|Lost to Follow-up|3|||
164234983|NCT01359956|593233385|FG001|Overall Study|Lost to Follow-up|4|||
164234984|NCT01359956|593233386|FG002|Overall Study|Lost to Follow-up|1|||
164234985|NCT01359956|593233387|FG003|Overall Study|Lost to Follow-up|1|||
164234986|NCT01784029|593233388|FG000|Overall Study|Lost to Follow-up|19|||
164234987|NCT01784029|593233389|FG001|Overall Study|Lost to Follow-up|20|||
164234988|NCT01784029|593233390|FG002|Overall Study|Lost to Follow-up|22|||
164333725|NCT00371826|593599623|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
163988066|NCT02317562|592324210|FG000|Overall Study|Lack of Efficacy|4|||
164234989|NCT02415556|593233393|FG000|Overall Study|Adverse Event|3|||
164234990|NCT02415556|593233394|FG001|Overall Study|Adverse Event|4|||
163988067|NCT02317562|592324210|FG000|Overall Study|Withdrawal by Subject|1|||
164234991|NCT02415556|593233395|FG002|Overall Study|Adverse Event|2|||
164234992|NCT02415556|593233396|FG003|Overall Study|Adverse Event|4|||
164234993|NCT02415556|593233393|FG000|Overall Study|Lost to Follow-up|4|||
164234994|NCT02415556|593233394|FG001|Overall Study|Lost to Follow-up|5|||
164234995|NCT02415556|593233395|FG002|Overall Study|Lost to Follow-up|4|||
164234996|NCT02415556|593233396|FG003|Overall Study|Lost to Follow-up|1|||
164234997|NCT02415556|593233393|FG000|Overall Study|Withdrawal by Subject|13|||
164234998|NCT02415556|593233394|FG001|Overall Study|Withdrawal by Subject|4|||
164234999|NCT02415556|593233395|FG002|Overall Study|Withdrawal by Subject|14|||
164235000|NCT02415556|593233396|FG003|Overall Study|Withdrawal by Subject|12|||
164235001|NCT02415556|593233393|FG000|Overall Study|Physician Decision|1|||
164235002|NCT02415556|593233394|FG001|Overall Study|Physician Decision|3|||
164235003|NCT02415556|593233395|FG002|Overall Study|Physician Decision|1|||
164235004|NCT02415556|593233396|FG003|Overall Study|Physician Decision|2|||
164235005|NCT02415556|593233393|FG000|Overall Study|Censored - study completion|4|||
164235006|NCT02415556|593233394|FG001|Overall Study|Censored - study completion|5|||
164235007|NCT02415556|593233395|FG002|Overall Study|Censored - study completion|1|||
164235008|NCT02415556|593233396|FG003|Overall Study|Censored - study completion|0|||
164235009|NCT02415556|593233393|FG000|Overall Study|Family-related issues|0|||
164235010|NCT02415556|593233394|FG001|Overall Study|Family-related issues|0|||
164235011|NCT02415556|593233395|FG002|Overall Study|Family-related issues|0|||
164235012|NCT02415556|593233396|FG003|Overall Study|Family-related issues|1|||
163988068|NCT03551743|592324211|FG000|Overall Study|Adverse Event|1|||
164235013|NCT01209767|593233397|FG000|Overall Study|Withdrawal by Subject|1|||
164235014|NCT01209767|593233397|FG000|Overall Study|Lost to Follow-up|3|||
164235015|NCT01621178|593233398|FG000|Overall Study|Adverse Event|5|||
164235016|NCT01621178|593233399|FG001|Overall Study|Adverse Event|2|||
164235017|NCT01621178|593233400|FG002|Overall Study|Adverse Event|8|||
164235018|NCT01621178|593233398|FG000|Overall Study|Death|6|||
164235019|NCT01621178|593233399|FG001|Overall Study|Death|7|||
164235020|NCT01621178|593233400|FG002|Overall Study|Death|2|||
164235021|NCT01621178|593233398|FG000|Overall Study|Lost to Follow-up|1|||
164235022|NCT01621178|593233399|FG001|Overall Study|Lost to Follow-up|2|||
164235023|NCT01621178|593233400|FG002|Overall Study|Lost to Follow-up|1|||
164235024|NCT01621178|593233398|FG000|Overall Study|Withdrawal by Subject|14|||
164235025|NCT01621178|593233399|FG001|Overall Study|Withdrawal by Subject|17|||
164235026|NCT01621178|593233400|FG002|Overall Study|Withdrawal by Subject|18|||
164235027|NCT01621178|593233398|FG000|Overall Study|Physician Decision|5|||
164235028|NCT01621178|593233399|FG001|Overall Study|Physician Decision|2|||
164235029|NCT01621178|593233400|FG002|Overall Study|Physician Decision|7|||
164235030|NCT00105534|593233401|FG000|Overall Study|Adverse Event|2|||
164235031|NCT00105534|593233402|FG001|Overall Study|Adverse Event|5|||
164235032|NCT00105534|593233401|FG000|Overall Study|Protocol Violation|1|||
164235033|NCT00105534|593233402|FG001|Overall Study|Protocol Violation|4|||
164235034|NCT00105534|593233401|FG000|Overall Study|Withdrawal by Subject|6|||
164235035|NCT00105534|593233402|FG001|Overall Study|Withdrawal by Subject|6|||
164235036|NCT00105534|593233401|FG000|Overall Study|Lost to Follow-up|5|||
164235037|NCT00105534|593233402|FG001|Overall Study|Lost to Follow-up|1|||
164235038|NCT00105534|593233401|FG000|Overall Study|Lack of Efficacy|7|||
164235039|NCT00105534|593233402|FG001|Overall Study|Lack of Efficacy|15|||
164235040|NCT00105534|593233401|FG000|Overall Study|Treatment unmasked|1|||
164235041|NCT00105534|593233402|FG001|Overall Study|Treatment unmasked|0|||
164235042|NCT00105534|593233401|FG000|Overall Study|Other Reason|0|||
164235043|NCT00105534|593233402|FG001|Overall Study|Other Reason|2|||
164235044|NCT02465931|593233403|FG000|Overall Study|Lost to Follow-up|9|||
164235045|NCT02465931|593233404|FG001|Overall Study|Lost to Follow-up|11|||
164235046|NCT02465931|593233403|FG000|Overall Study|Protocol Violation|1|||
164235047|NCT02465931|593233404|FG001|Overall Study|Protocol Violation|0|||
164235048|NCT02465931|593233403|FG000|Overall Study|Withdrawal by Subject|1|||
164235049|NCT02465931|593233404|FG001|Overall Study|Withdrawal by Subject|0|||
164235050|NCT00730756|593233406|FG000|Overall Study|Adverse Event|2|||
164235051|NCT00730756|593233407|FG001|Overall Study|Adverse Event|0|||
164235052|NCT00730756|593233406|FG000|Overall Study|Lack of Efficacy|1|||
164235053|NCT00730756|593233407|FG001|Overall Study|Lack of Efficacy|1|||
164235054|NCT00730756|593233406|FG000|Overall Study|Protocol Deviation|1|||
164235055|NCT00730756|593233407|FG001|Overall Study|Protocol Deviation|2|||
164235056|NCT00730756|593233406|FG000|Overall Study|Lost to Follow-up|0|||
163988069|NCT03551743|592324212|FG001|Overall Study|Adverse Event|0|||
164235057|NCT00730756|593233407|FG001|Overall Study|Lost to Follow-up|1|||
164235058|NCT00730756|593233406|FG000|Overall Study|Withdrew Consent|0|||
164235059|NCT00730756|593233407|FG001|Overall Study|Withdrew Consent|1|||
164235060|NCT04388826|593233408|FG000|Overall Study|Lost to Follow-up|3|||
164235061|NCT04388826|593233409|FG001|Overall Study|Lost to Follow-up|2|||
164235062|NCT04388826|593233408|FG000|Overall Study|Adverse Event|1|||
164235063|NCT04388826|593233409|FG001|Overall Study|Adverse Event|0|||
164235064|NCT01840943|593233410|FG000|Overall Study|Withdrawal by Subject|5|||
164235065|NCT01840943|593233411|FG001|Overall Study|Withdrawal by Subject|6|||
164235066|NCT01840943|593233410|FG000|Overall Study|Physician Decision|4|||
164235067|NCT01840943|593233411|FG001|Overall Study|Physician Decision|2|||
164235068|NCT01840943|593233410|FG000|Overall Study|Lost to Follow-up|4|||
164235069|NCT01840943|593233411|FG001|Overall Study|Lost to Follow-up|4|||
164235070|NCT02862574|593233412|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164235071|NCT02862574|593233413|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164235072|NCT02862574|593233414|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164235073|NCT02862574|593233412|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
164235074|NCT02862574|593233413|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
164235075|NCT02862574|593233414|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
164235076|NCT02862574|593233412|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
164235077|NCT02862574|593233413|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
164333726|NCT00371826|593599621|FG000|Core Phase (12 Months)|Administrative problems|1|||
164333727|NCT00371826|593599622|FG001|Core Phase (12 Months)|Administrative problems|0|||
164333728|NCT00371826|593599623|FG002|Core Phase (12 Months)|Administrative problems|8|||
164235078|NCT02862574|593233414|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
164235079|NCT01446874|593233415|FG000|Overall Study|Not eligible|1|||
164235080|NCT01446874|593233416|FG001|Overall Study|Not eligible|0|||
164333729|NCT00371826|593599621|FG000|Core Phase (12 Months)|Graft Loss|0|||
164333730|NCT00371826|593599622|FG001|Core Phase (12 Months)|Graft Loss|1|||
164333731|NCT00371826|593599623|FG002|Core Phase (12 Months)|Graft Loss|0|||
164333732|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Adverse Event|4|||
164333733|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Adverse Event|5|||
164333734|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Adverse Event|0|||
164333735|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
164333736|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
164333737|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
164333738|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
163884064|NCT03673111|591945833|FG007|Overall Study|Protocol Violation|0|||
164235081|NCT01446874|593233417|FG002|Overall Study|Not eligible|0|||
164333739|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
164235082|NCT01446874|593233415|FG000|Overall Study|No surgery/No qualifying surgery|1|||
164235083|NCT01446874|593233416|FG001|Overall Study|No surgery/No qualifying surgery|0|||
164235084|NCT01446874|593233417|FG002|Overall Study|No surgery/No qualifying surgery|12|||
164235085|NCT01446874|593233415|FG000|Overall Study|Non-compliance|0|||
164235086|NCT01446874|593233416|FG001|Overall Study|Non-compliance|4|||
164235087|NCT01446874|593233417|FG002|Overall Study|Non-compliance|0|||
164235088|NCT01446874|593233415|FG000|Overall Study|Antibiotics for pre-op infection|0|||
164235089|NCT01446874|593233416|FG001|Overall Study|Antibiotics for pre-op infection|0|||
164235090|NCT01446874|593233417|FG002|Overall Study|Antibiotics for pre-op infection|2|||
164235091|NCT01446874|593233415|FG000|Overall Study|Withdrawal by Subject|0|||
164235092|NCT01446874|593233416|FG001|Overall Study|Withdrawal by Subject|0|||
164235093|NCT01446874|593233417|FG002|Overall Study|Withdrawal by Subject|4|||
164235094|NCT03639610|593233421|FG000|Overall Study|Adverse Event|7|||
164235095|NCT03639610|593233422|FG001|Overall Study|Adverse Event|1|||
164235096|NCT03639610|593233423|FG002|Overall Study|Adverse Event|0|||
164235097|NCT03639610|593233421|FG000|Overall Study|Physician Decision|3|||
164235098|NCT03639610|593233422|FG001|Overall Study|Physician Decision|1|||
164235099|NCT03639610|593233423|FG002|Overall Study|Physician Decision|0|||
164235100|NCT03639610|593233421|FG000|Overall Study|Disease progression|8|||
164235101|NCT03639610|593233422|FG001|Overall Study|Disease progression|5|||
164235102|NCT03639610|593233423|FG002|Overall Study|Disease progression|3|||
164235103|NCT03639610|593233421|FG000|Overall Study|Study terminated by sponsor|2|||
164235104|NCT03639610|593233422|FG001|Overall Study|Study terminated by sponsor|1|||
164235105|NCT03639610|593233423|FG002|Overall Study|Study terminated by sponsor|1|||
164235106|NCT03639610|593233421|FG000|Overall Study|Patient request to stop treatment|1|||
164235107|NCT03639610|593233422|FG001|Overall Study|Patient request to stop treatment|2|||
164235108|NCT03639610|593233423|FG002|Overall Study|Patient request to stop treatment|0|||
164235109|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
164235110|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
164235111|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
164235112|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
164235113|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
164235114|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
164235115|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
164235116|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
164235117|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
164235118|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
164235119|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
164235120|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
164235121|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
164235122|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
164235123|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
164235124|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
164235125|NCT05067335|593233426|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
164235126|NCT05067335|593233427|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
164235127|NCT05067335|593233428|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
164235128|NCT05067335|593233429|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
164235129|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
164235130|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
164235131|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
163988070|NCT03551743|592324213|FG002|Overall Study|Adverse Event|0|||
163988071|NCT03551743|592324214|FG003|Overall Study|Adverse Event|0|||
164235132|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
164235133|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
164235134|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
164235135|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
164235136|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
164235137|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
164235138|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
164235139|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
164235140|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
164235141|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
164235142|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
164235143|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
164299835|NCT02234843|593472946|FG002|Overall Study|Death|0|||
164299836|NCT02234843|593472947|FG003|Overall Study|Death|0|||
163988072|NCT03551743|592324211|FG000|Overall Study|Withdrawal by Subject|1|||
163988073|NCT03551743|592324212|FG001|Overall Study|Withdrawal by Subject|0|||
163988074|NCT03551743|592324213|FG002|Overall Study|Withdrawal by Subject|0|||
163988075|NCT03551743|592324214|FG003|Overall Study|Withdrawal by Subject|0|||
163988076|NCT03891901|592324215|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
163988077|NCT03891901|592324216|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988078|NCT03891901|592324217|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988079|NCT03891901|592324218|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988080|NCT03891901|592324219|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988081|NCT03891901|592324220|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988082|NCT03891901|592324221|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988083|NCT03891901|592324222|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
164235144|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
164235145|NCT05067335|593233426|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
164235146|NCT05067335|593233427|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
164235147|NCT05067335|593233428|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
164235148|NCT05067335|593233429|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
164235149|NCT03610048|593233430|FG000|Overall Study|Study terminated by sponsor|84|||
164235150|NCT03610048|593233430|FG000|Overall Study|Adverse Event|32|||
164235151|NCT03610048|593233430|FG000|Overall Study|Withdrawal by Subject|31|||
164235152|NCT03610048|593233430|FG000|Overall Study|Lost to Follow-up|8|||
164235153|NCT03610048|593233430|FG000|Overall Study|Other|4|||
164235154|NCT03610048|593233430|FG000|Overall Study|Physician Decision|1|||
164235155|NCT03610048|593233430|FG000|Overall Study|Pregnancy|1|||
164235156|NCT01146613|593233431|FG000|Overall Study|Lost to Follow-up|3|||
164235157|NCT01146613|593233432|FG001|Overall Study|Lost to Follow-up|8|||
164235158|NCT01146613|593233431|FG000|Overall Study|Lack of Efficacy|0|||
164235159|NCT01146613|593233432|FG001|Overall Study|Lack of Efficacy|1|||
164235160|NCT01146613|593233431|FG000|Overall Study|Death|1|||
164235161|NCT01146613|593233432|FG001|Overall Study|Death|0|||
164235162|NCT01146613|593233431|FG000|Overall Study|Physician Decision|1|||
164235163|NCT01146613|593233432|FG001|Overall Study|Physician Decision|0|||
164235164|NCT01146613|593233431|FG000|Overall Study|Withdrawal by Subject|0|||
164235165|NCT01146613|593233432|FG001|Overall Study|Withdrawal by Subject|3|||
164235166|NCT01146613|593233431|FG000|Overall Study|schedule conflict|1|||
164235167|NCT01146613|593233432|FG001|Overall Study|schedule conflict|0|||
164235168|NCT01146613|593233431|FG000|Overall Study|Outpatient detox|1|||
164235169|NCT01146613|593233432|FG001|Overall Study|Outpatient detox|0|||
164235170|NCT02136914|593233433|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
164235171|NCT02136914|593233434|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
164235172|NCT02136914|593233433|FG000|Overall Study|Withdrawal by Subject|3|||
164235173|NCT02136914|593233434|FG001|Overall Study|Withdrawal by Subject|10|||
164235174|NCT02136914|593233433|FG000|Overall Study|Subject Unwilling to Proceed|7|||
164235175|NCT02136914|593233434|FG001|Overall Study|Subject Unwilling to Proceed|2|||
164235176|NCT02136914|593233433|FG000|Overall Study|Lost to Follow-up|1|||
164235177|NCT02136914|593233434|FG001|Overall Study|Lost to Follow-up|1|||
164235178|NCT02136914|593233433|FG000|Overall Study|Did Not Receive Study Drug|2|||
164235179|NCT02136914|593233434|FG001|Overall Study|Did Not Receive Study Drug|0|||
164235180|NCT02136914|593233433|FG000|Overall Study|Lack of Efficacy|1|||
164235181|NCT02136914|593233434|FG001|Overall Study|Lack of Efficacy|0|||
164235182|NCT02136914|593233433|FG000|Overall Study|Death|0|||
164235183|NCT02136914|593233434|FG001|Overall Study|Death|1|||
164139734|NCT03155945|592874170|FG001|Overall Study|Other Reason|1|||
164139735|NCT02013674|592874173|FG000|Overall Study|Death|0|||
164139736|NCT02013674|592874174|FG001|Overall Study|Death|1|||
164139737|NCT02013674|592874173|FG000|Overall Study|Lost to Follow-up|1|||
164139738|NCT02013674|592874174|FG001|Overall Study|Lost to Follow-up|0|||
164139739|NCT00416884|592874175|FG000|Overall Study|Study terminated due to low accrual|1|||
164139740|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
164139741|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
164139742|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139743|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139744|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139745|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139746|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139747|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139748|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139749|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139750|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139751|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139752|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164235184|NCT05878067|593233435|FG000|Overall Study|Lost to Follow-up|2|||
164235185|NCT00949533|593233436|FG000|Overall Study|Lost to Follow-up|0|||
164235186|NCT00949533|593233437|FG001|Overall Study|Lost to Follow-up|1|||
164235187|NCT01493089|593233438|FG000|Overall Study|Protocol Violation|2|||
164235188|NCT01493089|593233439|FG001|Overall Study|Protocol Violation|2|||
164235189|NCT01493089|593233438|FG000|Overall Study|Withdrawal by Subject|1|||
164235190|NCT01493089|593233439|FG001|Overall Study|Withdrawal by Subject|0|||
164235191|NCT01493089|593233438|FG000|Overall Study|Physician Decision|0|||
164235192|NCT01493089|593233439|FG001|Overall Study|Physician Decision|1|||
164235193|NCT02234362|593233440|FG000|Overall Study|Not eligible after first screening visit|17|||
164235194|NCT02234362|593233440|FG000|Overall Study|Lost to Follow-up|6|||
164235195|NCT02234362|593233440|FG000|Overall Study|Withdrawal by Subject|3|||
164235196|NCT00261833|593233441|FG000|Overall Study|Death|1|||
164235197|NCT00261833|593233442|FG001|Overall Study|Death|3|||
164235198|NCT00261833|593233441|FG000|Overall Study|Adverse Event|1|||
164235199|NCT00261833|593233442|FG001|Overall Study|Adverse Event|4|||
164235200|NCT00261833|593233441|FG000|Overall Study|Withdrawal by Subject|5|||
164235201|NCT00261833|593233442|FG001|Overall Study|Withdrawal by Subject|7|||
164235202|NCT00261833|593233441|FG000|Overall Study|Protocol Violation|0|||
164235203|NCT00261833|593233442|FG001|Overall Study|Protocol Violation|1|||
164235204|NCT00261833|593233441|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
164235205|NCT00261833|593233442|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
164235206|NCT00261833|593233441|FG000|Overall Study|Lung transplantation|1|||
164235207|NCT00261833|593233442|FG001|Overall Study|Lung transplantation|1|||
164235208|NCT00261833|593233441|FG000|Overall Study|Missing reason|1|||
164235209|NCT00261833|593233442|FG001|Overall Study|Missing reason|0|||
164333740|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
164333741|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
164333742|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
164333743|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
164333744|NCT00371826|593599621|FG000|Extension Phase (24 Months)|Administrative problems|0|||
164235210|NCT00261833|593233441|FG000|Overall Study|Not interested in being participant|0|||
164235211|NCT00261833|593233442|FG001|Overall Study|Not interested in being participant|1|||
164235212|NCT00419744|593233443|FG000|Overall Study|Adverse Event|39|||
164235213|NCT00419744|593233444|FG001|Overall Study|Adverse Event|40|||
164235214|NCT00419744|593233445|FG002|Overall Study|Adverse Event|50|||
164235215|NCT00419744|593233443|FG000|Overall Study|Withdrawal by Subject|45|||
164235216|NCT00419744|593233444|FG001|Overall Study|Withdrawal by Subject|49|||
164235217|NCT00419744|593233445|FG002|Overall Study|Withdrawal by Subject|52|||
164235218|NCT00419744|593233443|FG000|Overall Study|Lost to Follow-up|8|||
164235219|NCT00419744|593233444|FG001|Overall Study|Lost to Follow-up|10|||
164235220|NCT00419744|593233445|FG002|Overall Study|Lost to Follow-up|6|||
164235221|NCT00419744|593233443|FG000|Overall Study|Protocol Violation|4|||
164235222|NCT00419744|593233444|FG001|Overall Study|Protocol Violation|7|||
164235223|NCT00419744|593233445|FG002|Overall Study|Protocol Violation|8|||
164235224|NCT00419744|593233443|FG000|Overall Study|Randomized in error|9|||
164235225|NCT00419744|593233444|FG001|Overall Study|Randomized in error|6|||
164235226|NCT00419744|593233445|FG002|Overall Study|Randomized in error|7|||
164235227|NCT00419744|593233443|FG000|Overall Study|Moving out of state|2|||
164235228|NCT00419744|593233444|FG001|Overall Study|Moving out of state|0|||
164235229|NCT00419744|593233445|FG002|Overall Study|Moving out of state|1|||
164235230|NCT00419744|593233443|FG000|Overall Study|Physician Decision|10|||
164235231|NCT00419744|593233444|FG001|Overall Study|Physician Decision|5|||
164235232|NCT00419744|593233445|FG002|Overall Study|Physician Decision|6|||
164235233|NCT00419744|593233443|FG000|Overall Study|Spirometry mouthpiece issues|0|||
164235234|NCT00419744|593233444|FG001|Overall Study|Spirometry mouthpiece issues|1|||
164235235|NCT00419744|593233445|FG002|Overall Study|Spirometry mouthpiece issues|2|||
164235236|NCT00419744|593233443|FG000|Overall Study|Incorrect medication kit dispensed|0|||
164235237|NCT00419744|593233444|FG001|Overall Study|Incorrect medication kit dispensed|0|||
164235238|NCT00419744|593233445|FG002|Overall Study|Incorrect medication kit dispensed|1|||
164235239|NCT00583219|593233448|FG000|Phase 2|Withdrawal by Subject|1|||
164235240|NCT02131766|593233449|FG000|Overall Study|Withdrawal by Subject|4|||
164235241|NCT02271880|593233451|FG000|Overall Study|Premature discontinuation of study|3|||
164235242|NCT02271880|593233452|FG001|Overall Study|Premature discontinuation of study|4|||
164333745|NCT00371826|593599622|FG001|Extension Phase (24 Months)|Administrative problems|0|||
164333746|NCT00371826|593599623|FG002|Extension Phase (24 Months)|Administrative problems|2|||
164333747|NCT02436304|593599624|FG000|Overall Study|Lost to Follow-up|0|||
164235243|NCT00474903|593233454|FG000|Overall Study|Protocol Violation|1|||
164235244|NCT00474903|593233455|FG001|Overall Study|Protocol Violation|5|||
164235245|NCT00474903|593233456|FG002|Overall Study|Protocol Violation|2|||
164235246|NCT02006927|593233457|FG000|Overall Study|Adverse Event|2|||
164235247|NCT02006927|593233457|FG000|Overall Study|Withdrawal by Subject|1|||
164235248|NCT00673920|593233460|FG000|Baseline up to Week 48|Withdrew consent|1|||
164235249|NCT00673920|593233461|FG001|Baseline up to Week 48|Withdrew consent|0|||
164235250|NCT00673920|593233462|FG002|Baseline up to Week 48|Withdrew consent|2|||
164235251|NCT00673920|593233463|FG003|Baseline up to Week 48|Withdrew consent|0|||
164235252|NCT00673920|593233464|FG004|Baseline up to Week 48|Withdrew consent|0|||
164235253|NCT00673920|593233465|FG005|Baseline up to Week 48|Withdrew consent|0|||
164235254|NCT00673920|593233466|FG006|Baseline up to Week 48|Withdrew consent|0|||
164235255|NCT00673920|593233467|FG007|Baseline up to Week 48|Withdrew consent|0|||
164235256|NCT00673920|593233460|FG000|Baseline up to Week 48|Refused treatment|1|||
164235257|NCT00673920|593233461|FG001|Baseline up to Week 48|Refused treatment|0|||
164235258|NCT00673920|593233462|FG002|Baseline up to Week 48|Refused treatment|0|||
164235259|NCT00673920|593233463|FG003|Baseline up to Week 48|Refused treatment|0|||
164235260|NCT00673920|593233464|FG004|Baseline up to Week 48|Refused treatment|0|||
164235261|NCT00673920|593233465|FG005|Baseline up to Week 48|Refused treatment|0|||
164235262|NCT00673920|593233466|FG006|Baseline up to Week 48|Refused treatment|0|||
164235263|NCT00673920|593233467|FG007|Baseline up to Week 48|Refused treatment|0|||
164235264|NCT00673920|593233460|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
164235265|NCT00673920|593233461|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
164235266|NCT00673920|593233462|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235267|NCT00673920|593233463|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235268|NCT00673920|593233464|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235269|NCT00673920|593233465|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235270|NCT00673920|593233466|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235271|NCT00673920|593233467|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
164235272|NCT00673920|593233460|FG000|Baseline up to Week 48|Protocol Violation|0|||
164235273|NCT00673920|593233461|FG001|Baseline up to Week 48|Protocol Violation|0|||
164235274|NCT00673920|593233462|FG002|Baseline up to Week 48|Protocol Violation|1|||
164235275|NCT00673920|593233463|FG003|Baseline up to Week 48|Protocol Violation|0|||
164235276|NCT00673920|593233464|FG004|Baseline up to Week 48|Protocol Violation|0|||
164235277|NCT00673920|593233465|FG005|Baseline up to Week 48|Protocol Violation|0|||
164235278|NCT00673920|593233466|FG006|Baseline up to Week 48|Protocol Violation|0|||
164235279|NCT00673920|593233467|FG007|Baseline up to Week 48|Protocol Violation|0|||
164235280|NCT00673920|593233460|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235281|NCT00673920|593233461|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235282|NCT00673920|593233462|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
164235283|NCT00673920|593233463|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235284|NCT00673920|593233464|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235285|NCT00673920|593233465|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235286|NCT00673920|593233466|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235287|NCT00673920|593233467|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
164235288|NCT00673920|593233460|FG000|Baseline up to Week 48|Administrative/Other|0|||
164235289|NCT00673920|593233461|FG001|Baseline up to Week 48|Administrative/Other|1|||
164235290|NCT00673920|593233462|FG002|Baseline up to Week 48|Administrative/Other|2|||
164235291|NCT00673920|593233463|FG003|Baseline up to Week 48|Administrative/Other|0|||
164235292|NCT00673920|593233464|FG004|Baseline up to Week 48|Administrative/Other|0|||
164235293|NCT00673920|593233465|FG005|Baseline up to Week 48|Administrative/Other|0|||
164235294|NCT00673920|593233466|FG006|Baseline up to Week 48|Administrative/Other|0|||
164235295|NCT00673920|593233467|FG007|Baseline up to Week 48|Administrative/Other|0|||
164235296|NCT00673920|593233460|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235297|NCT00673920|593233461|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
164235298|NCT00673920|593233462|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
164235299|NCT00673920|593233463|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235300|NCT00673920|593233464|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235301|NCT00673920|593233465|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235302|NCT00673920|593233466|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235303|NCT00673920|593233467|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
164235304|NCT00673920|593233460|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235305|NCT00673920|593233461|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235306|NCT00673920|593233462|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235307|NCT00673920|593233463|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235308|NCT00673920|593233464|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
163988084|NCT03891901|592324223|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
163988085|NCT03891901|592324215|FG000|Overall Study|Adverse Event|2|||
163988086|NCT03891901|592324216|FG001|Overall Study|Adverse Event|2|||
163988087|NCT03891901|592324217|FG002|Overall Study|Adverse Event|0|||
163988088|NCT03891901|592324218|FG003|Overall Study|Adverse Event|0|||
164235309|NCT00673920|593233465|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235310|NCT00673920|593233466|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
164235311|NCT00673920|593233467|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
164235312|NCT00673920|593233460|FG000|Week 24 to Week 48|Failure to return|0|||
163988089|NCT03891901|592324219|FG004|Overall Study|Adverse Event|0|||
164235313|NCT00673920|593233461|FG001|Week 24 to Week 48|Failure to return|0|||
164235314|NCT00673920|593233462|FG002|Week 24 to Week 48|Failure to return|0|||
164235315|NCT00673920|593233463|FG003|Week 24 to Week 48|Failure to return|0|||
164235316|NCT00673920|593233464|FG004|Week 24 to Week 48|Failure to return|0|||
164235317|NCT00673920|593233465|FG005|Week 24 to Week 48|Failure to return|1|||
164235318|NCT00673920|593233466|FG006|Week 24 to Week 48|Failure to return|0|||
164235319|NCT00673920|593233467|FG007|Week 24 to Week 48|Failure to return|0|||
164235320|NCT00673920|593233460|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235321|NCT00673920|593233461|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235322|NCT00673920|593233462|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235323|NCT00673920|593233463|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235324|NCT00673920|593233464|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235325|NCT00673920|593233465|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
164235326|NCT00673920|593233466|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235327|NCT00673920|593233467|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
164235328|NCT00673920|593233460|FG000|Week 24 to Week 48|Death|0|||
164235329|NCT00673920|593233461|FG001|Week 24 to Week 48|Death|0|||
164235330|NCT00673920|593233462|FG002|Week 24 to Week 48|Death|0|||
164235331|NCT00673920|593233463|FG003|Week 24 to Week 48|Death|0|||
164235332|NCT00673920|593233464|FG004|Week 24 to Week 48|Death|0|||
164235333|NCT00673920|593233465|FG005|Week 24 to Week 48|Death|1|||
164235334|NCT00673920|593233466|FG006|Week 24 to Week 48|Death|0|||
164235335|NCT00673920|593233467|FG007|Week 24 to Week 48|Death|0|||
164235336|NCT00673920|593233460|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
164235337|NCT00673920|593233461|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
164235338|NCT00673920|593233462|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
164235339|NCT00673920|593233463|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
164235340|NCT00673920|593233464|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
164235341|NCT00673920|593233465|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
164235342|NCT00673920|593233466|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
164235343|NCT00673920|593233467|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
164235344|NCT02519842|593233468|FG000|Base Study: Cycle 1|Screening Failure|1|||
164235345|NCT02519842|593233469|FG001|Base Study: Cycle 1|Screening Failure|1|||
164235346|NCT02519842|593233470|FG002|Base Study: Cycle 1|Screening Failure|0|||
164235347|NCT02519842|593233468|FG000|Base Study: Cycle 1|Adverse Event|1|||
164235348|NCT02519842|593233469|FG001|Base Study: Cycle 1|Adverse Event|0|||
164235349|NCT02519842|593233470|FG002|Base Study: Cycle 1|Adverse Event|0|||
164235350|NCT02519842|593233468|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
164235351|NCT02519842|593233469|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
164235352|NCT02519842|593233470|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
164235353|NCT02519842|593233468|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
164235354|NCT02519842|593233469|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
164235355|NCT02519842|593233470|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
164235356|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
164235357|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
164235358|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
164235359|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
164235360|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
164235361|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
164235362|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164235363|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
164235364|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
164235365|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
164235366|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
164235367|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
164235368|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Death|0|||
164235369|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Death|0|||
164235370|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Death|1|||
164235371|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
164235372|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
164235373|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
164235374|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
164235375|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
164235376|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
164235377|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
164235378|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
164235379|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
164235380|NCT02519842|593233468|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
164235381|NCT02519842|593233469|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
164235382|NCT02519842|593233470|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
164235383|NCT01561976|593233475|FG000|Period 1|Adverse Event|0|||
164235384|NCT01561976|593233476|FG001|Period 1|Adverse Event|0|||
164235385|NCT01561976|593233477|FG002|Period 1|Adverse Event|1|||
164235386|NCT01561976|593233478|FG003|Period 1|Adverse Event|0|||
164235387|NCT01561976|593233479|FG004|Period 1|Adverse Event|0|||
164235388|NCT01561976|593233480|FG005|Period 1|Adverse Event|0|||
164235389|NCT01561976|593233475|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
164235390|NCT01561976|593233476|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
164235391|NCT01561976|593233477|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
164235392|NCT01561976|593233478|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
164235393|NCT01561976|593233479|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
164235394|NCT01561976|593233480|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
164235395|NCT01561976|593233475|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235396|NCT01561976|593233476|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235397|NCT01561976|593233477|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235398|NCT01561976|593233478|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235399|NCT01561976|593233479|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164235400|NCT01561976|593233480|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164235401|NCT01561976|593233475|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
164235402|NCT01561976|593233476|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
164235403|NCT01561976|593233477|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
164235404|NCT01561976|593233478|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
163988090|NCT03891901|592324220|FG005|Overall Study|Adverse Event|0|||
163988091|NCT03891901|592324221|FG006|Overall Study|Adverse Event|0|||
163988092|NCT03891901|592324222|FG007|Overall Study|Adverse Event|0|||
163988093|NCT03891901|592324223|FG008|Overall Study|Adverse Event|0|||
163988094|NCT03891901|592324215|FG000|Overall Study|Poor venous access|1|||
163988095|NCT03891901|592324216|FG001|Overall Study|Poor venous access|0|||
163988096|NCT03891901|592324217|FG002|Overall Study|Poor venous access|0|||
163988097|NCT03891901|592324218|FG003|Overall Study|Poor venous access|0|||
163988098|NCT03891901|592324219|FG004|Overall Study|Poor venous access|0|||
163988099|NCT03891901|592324220|FG005|Overall Study|Poor venous access|0|||
163988100|NCT03891901|592324221|FG006|Overall Study|Poor venous access|0|||
163988101|NCT03891901|592324222|FG007|Overall Study|Poor venous access|0|||
163988102|NCT03891901|592324223|FG008|Overall Study|Poor venous access|0|||
163988103|NCT03891901|592324215|FG000|Overall Study|Withdrawal by Subject|0|||
163988104|NCT03891901|592324216|FG001|Overall Study|Withdrawal by Subject|2|||
163988105|NCT03891901|592324217|FG002|Overall Study|Withdrawal by Subject|0|||
164235405|NCT01561976|593233479|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
164235406|NCT01561976|593233480|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
164235407|NCT02639390|593233481|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
164333748|NCT02436304|593599625|FG001|Overall Study|Lost to Follow-up|1|||
164333749|NCT02436304|593599626|FG002|Overall Study|Lost to Follow-up|0|||
164333750|NCT02436304|593599624|FG000|Overall Study|Withdrawal by Subject|0|||
164333751|NCT02436304|593599625|FG001|Overall Study|Withdrawal by Subject|1|||
164333752|NCT02436304|593599626|FG002|Overall Study|Withdrawal by Subject|0|||
164333753|NCT02436304|593599624|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
164333754|NCT02436304|593599625|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
164333755|NCT02436304|593599626|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
164333756|NCT04540497|593599631|FG000|Overall Study|Adverse Event|0|||
164333757|NCT04540497|593599632|FG001|Overall Study|Adverse Event|2|||
164333758|NCT04540497|593599631|FG000|Overall Study|Lost to Follow-up|1|||
164333759|NCT04540497|593599632|FG001|Overall Study|Lost to Follow-up|0|||
164333760|NCT04540497|593599631|FG000|Overall Study|Withdrawal by Subject|1|||
164333761|NCT04540497|593599632|FG001|Overall Study|Withdrawal by Subject|1|||
164333762|NCT04540497|593599631|FG000|Overall Study|Miscellaneous|2|||
164333763|NCT04540497|593599632|FG001|Overall Study|Miscellaneous|1|||
164333764|NCT05274815|593599636|FG000|Overall Study|Adverse Event|1|||
164333765|NCT05274815|593599636|FG000|Overall Study|Death|2|||
164333766|NCT05274815|593599636|FG000|Overall Study|Lost to Follow-up|4|||
164333767|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
164333768|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
163988106|NCT03891901|592324218|FG003|Overall Study|Withdrawal by Subject|0|||
164140280|NCT00402116|592876012|FG001|Overall Study|Adverse Event|1|||
163988107|NCT03891901|592324219|FG004|Overall Study|Withdrawal by Subject|0|||
163988108|NCT03891901|592324220|FG005|Overall Study|Withdrawal by Subject|0|||
163988109|NCT03891901|592324221|FG006|Overall Study|Withdrawal by Subject|0|||
163988110|NCT03891901|592324222|FG007|Overall Study|Withdrawal by Subject|0|||
164140281|NCT00402116|592876013|FG002|Overall Study|Adverse Event|6|||
164140282|NCT02899195|592876014|FG000|Concurrent Durvalumab|Adverse Event|4|||
164140283|NCT02899195|592876014|FG000|Concurrent Durvalumab|Physician Decision|1|||
164140284|NCT02899195|592876014|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
164140285|NCT02899195|592876014|FG000|Concurrent Durvalumab|Progressive Disease|5|||
164140286|NCT02899195|592876014|FG000|Maintenance Durvalumab|Adverse Event|1|||
164140287|NCT02899195|592876014|FG000|Maintenance Durvalumab|Physician Decision|1|||
164140288|NCT02899195|592876014|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
164140289|NCT02899195|592876014|FG000|Maintenance Durvalumab|Progressive Disease|31|||
163988111|NCT03891901|592324223|FG008|Overall Study|Withdrawal by Subject|0|||
163988112|NCT03920670|592324224|FG000|Overall Study|Protocol Violation|2|||
163988113|NCT03920670|592324225|FG001|Overall Study|Protocol Violation|2|||
163988114|NCT03920670|592324224|FG000|Overall Study|Adverse Event|1|||
163988115|NCT03920670|592324225|FG001|Overall Study|Adverse Event|0|||
163988116|NCT04820309|592324239|FG000|Overall Study|Adverse Event|96|||
163988117|NCT04820309|592324239|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
163988118|NCT04820309|592324239|FG000|Overall Study|Consent Withdrawn|93|||
163988119|NCT04820309|592324239|FG000|Overall Study|failure to adhere to protocol|32|||
163988120|NCT04820309|592324239|FG000|Overall Study|alcohol or drug use|6|||
163988121|NCT04820309|592324239|FG000|Overall Study|Lost to Follow-up|46|||
163988122|NCT04820309|592324239|FG000|Overall Study|Death|2|||
163988123|NCT04820309|592324239|FG000|Overall Study|Pregnancy|1|||
163988124|NCT04820309|592324239|FG000|Overall Study|Other reasons|12|||
163988125|NCT04202679|592324242|FG000|Overall Study|Adverse Event|2|||
163988126|NCT04202679|592324243|FG001|Overall Study|Adverse Event|0|||
163988127|NCT04202679|592324242|FG000|Overall Study|Poor compliance to protocol|1|||
163988128|NCT04202679|592324243|FG001|Overall Study|Poor compliance to protocol|0|||
163988129|NCT04202679|592324242|FG000|Overall Study|Withdrawal by Subject|23|||
163988130|NCT04202679|592324243|FG001|Overall Study|Withdrawal by Subject|6|||
163988131|NCT01250379|592324244|FG000|Overall Study|Death|141|||
163988132|NCT01250379|592324245|FG001|Overall Study|Death|148|||
163988133|NCT01250379|592324244|FG000|Overall Study|Withdrawal by Subject|32|||
163988134|NCT01250379|592324245|FG001|Overall Study|Withdrawal by Subject|20|||
163988135|NCT01250379|592324244|FG000|Overall Study|Physician Decision|11|||
163988136|NCT01250379|592324245|FG001|Overall Study|Physician Decision|3|||
163988137|NCT01250379|592324244|FG000|Overall Study|Protocol Violation|2|||
164140447|NCT02458287|592876086|FG000|Overall Study|Lost to Follow-up|0|||
164333769|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
164333770|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
164333771|NCT05274815|593599636|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
164333772|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
164333773|NCT05274815|593599636|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
164333774|NCT05274815|593599636|FG000|Overall Study|Withdrawal by Subject|11|||
164333775|NCT03914326|593599637|FG000|Overall Study|Withdrawal by Subject|27|||
164333776|NCT03914326|593599638|FG001|Overall Study|Withdrawal by Subject|34|||
164333777|NCT03914326|593599637|FG000|Overall Study|Lost to Follow-up|43|||
164333778|NCT03914326|593599638|FG001|Overall Study|Lost to Follow-up|51|||
164333779|NCT03914326|593599637|FG000|Overall Study|Randomised more than once|0|||
164333780|NCT03914326|593599638|FG001|Overall Study|Randomised more than once|1|||
164333781|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Death|1|||
164333782|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Death|1|||
164333783|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Death|0|||
164333784|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Death|0|||
164333785|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
164333786|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
164333787|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
164333788|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
164333789|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
164333790|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
164333791|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
164333792|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
164333793|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
164333794|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
164333795|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
164333796|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
164333797|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
164333798|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
164333799|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
164333800|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
164333801|NCT04612790|593599639|FG000|DB Period (Up to 36 Weeks)|Other|1|||
164333802|NCT04612790|593599640|FG001|DB Period (Up to 36 Weeks)|Other|0|||
164333803|NCT04612790|593599641|FG002|DB Period (Up to 36 Weeks)|Other|0|||
164333804|NCT04612790|593599642|FG003|DB Period (Up to 36 Weeks)|Other|0|||
163988138|NCT01250379|592324245|FG001|Overall Study|Protocol Violation|8|||
163988139|NCT01250379|592324244|FG000|Overall Study|Lost to Follow-up|9|||
163988140|NCT01250379|592324245|FG001|Overall Study|Lost to Follow-up|6|||
163988141|NCT01250379|592324244|FG000|Overall Study|Adverse Event|5|||
163988142|NCT01250379|592324245|FG001|Overall Study|Adverse Event|4|||
163988143|NCT01250379|592324244|FG000|Overall Study|Other|0|||
163988144|NCT01250379|592324245|FG001|Overall Study|Other|4|||
163988145|NCT01250379|592324244|FG000|Overall Study|Participant noncompliance|2|||
163988146|NCT01250379|592324245|FG001|Overall Study|Participant noncompliance|0|||
163988147|NCT03864653|592324246|FG000|Overall Study|Withdrawal by Subject|1|||
163988148|NCT02531646|592324247|FG000|Overall Study|equip. image processing issue|5|||
163988149|NCT02531646|592324248|FG001|Overall Study|equip. image processing issue|1|||
163988150|NCT02531646|592324249|FG002|Overall Study|equip. image processing issue|0|||
163988151|NCT00429585|592324250|FG000|Overall Study|Death|1|||
163988152|NCT00429585|592324251|FG001|Overall Study|Death|0|||
163988153|NCT00429585|592324250|FG000|Overall Study|Lost to Follow-up|27|||
163988154|NCT00429585|592324251|FG001|Overall Study|Lost to Follow-up|20|||
163988155|NCT00429585|592324250|FG000|Overall Study|Physician Decision|2|||
163988156|NCT00429585|592324251|FG001|Overall Study|Physician Decision|0|||
163988157|NCT01582308|592324252|FG000|Period 1|Withdrawal by Subject|0|||
163988158|NCT01582308|592324253|FG001|Period 1|Withdrawal by Subject|0|||
163988159|NCT01582308|592324254|FG002|Period 1|Withdrawal by Subject|0|||
163988160|NCT01582308|592324255|FG003|Period 1|Withdrawal by Subject|0|||
163988161|NCT01582308|592324256|FG004|Period 1|Withdrawal by Subject|0|||
163988162|NCT01582308|592324257|FG005|Period 1|Withdrawal by Subject|0|||
163988163|NCT01582308|592324258|FG006|Period 1|Withdrawal by Subject|1|||
163988164|NCT01582308|592324259|FG007|Period 1|Withdrawal by Subject|0|||
163988165|NCT01582308|592324260|FG008|Period 1|Withdrawal by Subject|0|||
163988166|NCT01582308|592324261|FG009|Period 1|Withdrawal by Subject|0|||
163988167|NCT01582308|592324252|FG000|10-day Washout Following Period 1|Physician Decision|0|||
163988168|NCT01582308|592324253|FG001|10-day Washout Following Period 1|Physician Decision|0|||
163988169|NCT01582308|592324254|FG002|10-day Washout Following Period 1|Physician Decision|0|||
163988170|NCT01582308|592324255|FG003|10-day Washout Following Period 1|Physician Decision|0|||
163988171|NCT01582308|592324256|FG004|10-day Washout Following Period 1|Physician Decision|1|||
163988172|NCT01582308|592324257|FG005|10-day Washout Following Period 1|Physician Decision|0|||
164235408|NCT02639390|593233482|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
164235409|NCT01463527|593233483|FG000|Overall Study|Protocol Violation|1|||
164235410|NCT01463527|593233484|FG001|Overall Study|Protocol Violation|1|||
164235411|NCT01463527|593233483|FG000|Overall Study|Crying >20% of sedation|5|||
164235412|NCT01463527|593233484|FG001|Overall Study|Crying >20% of sedation|6|||
164235413|NCT01977222|593233487|FG000|Overall Study|Withdrawal by Subject|1|||
164235414|NCT02980107|593233488|FG000|Overall Study|Withdrawal by Subject|51|||
164235415|NCT02980107|593233489|FG001|Overall Study|Withdrawal by Subject|62|||
164235416|NCT03746015|593233490|FG000|Overall Study|Withdrawal of Consent|1|||
164235417|NCT03746015|593233491|FG001|Overall Study|Withdrawal of Consent|0|||
164235418|NCT03746015|593233492|FG002|Overall Study|Withdrawal of Consent|0|||
164235419|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164235420|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
164235421|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164235422|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
163884065|NCT03673111|591945834|FG008|Overall Study|Protocol Violation|0|||
164235423|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
164235424|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
164235425|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
164235426|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
164333805|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
163884066|NCT03673111|591945835|FG009|Overall Study|Protocol Violation|0|||
163884067|NCT03673111|591945836|FG010|Overall Study|Protocol Violation|1|||
163884068|NCT03673111|591945837|FG011|Overall Study|Protocol Violation|0|||
163884069|NCT03673111|591945838|FG012|Overall Study|Protocol Violation|0|||
163884070|NCT03673111|591945839|FG013|Overall Study|Protocol Violation|0|||
163884071|NCT03673111|591945826|FG000|Overall Study|Adverse Event|1|||
163884072|NCT03673111|591945827|FG001|Overall Study|Adverse Event|0|||
163884073|NCT03673111|591945828|FG002|Overall Study|Adverse Event|0|||
163884074|NCT03673111|591945829|FG003|Overall Study|Adverse Event|0|||
163884075|NCT03673111|591945830|FG004|Overall Study|Adverse Event|0|||
163884076|NCT03673111|591945831|FG005|Overall Study|Adverse Event|0|||
163884077|NCT03673111|591945832|FG006|Overall Study|Adverse Event|0|||
163884078|NCT03673111|591945833|FG007|Overall Study|Adverse Event|0|||
164333806|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
164333807|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
164333808|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
164333809|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
164333810|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
163884079|NCT03673111|591945834|FG008|Overall Study|Adverse Event|0|||
163884080|NCT03673111|591945835|FG009|Overall Study|Adverse Event|0|||
163884081|NCT03673111|591945836|FG010|Overall Study|Adverse Event|0|||
163884082|NCT03673111|591945837|FG011|Overall Study|Adverse Event|0|||
163988173|NCT01582308|592324258|FG006|10-day Washout Following Period 1|Physician Decision|0|||
163988174|NCT01582308|592324259|FG007|10-day Washout Following Period 1|Physician Decision|0|||
163988175|NCT01582308|592324260|FG008|10-day Washout Following Period 1|Physician Decision|0|||
163988176|NCT01582308|592324261|FG009|10-day Washout Following Period 1|Physician Decision|0|||
163988177|NCT01582308|592324252|FG000|Period 4|Physician Decision|1|||
163988178|NCT01582308|592324253|FG001|Period 4|Physician Decision|0|||
163988179|NCT01582308|592324254|FG002|Period 4|Physician Decision|0|||
163988180|NCT01582308|592324255|FG003|Period 4|Physician Decision|0|||
163988181|NCT01582308|592324256|FG004|Period 4|Physician Decision|0|||
163988182|NCT01582308|592324257|FG005|Period 4|Physician Decision|1|||
163988183|NCT01582308|592324258|FG006|Period 4|Physician Decision|0|||
163988184|NCT01582308|592324259|FG007|Period 4|Physician Decision|0|||
163988185|NCT01582308|592324260|FG008|Period 4|Physician Decision|0|||
163988186|NCT01582308|592324261|FG009|Period 4|Physician Decision|1|||
163988187|NCT00772668|592324265|FG000|Overall Study|Physician Decision|3|||
163988188|NCT01182428|592324266|FG000|Overall Study|Physician Decision|1|||
163988189|NCT01182428|592324267|FG001|Overall Study|Physician Decision|0|||
163988190|NCT01182428|592324266|FG000|Overall Study|Lost to Follow-up|9|||
163988191|NCT01182428|592324267|FG001|Overall Study|Lost to Follow-up|1|||
163988192|NCT01182428|592324266|FG000|Overall Study|Withdrawal by Subject|1|||
163988193|NCT01182428|592324267|FG001|Overall Study|Withdrawal by Subject|0|||
164006621|NCT00847613|592391043|FG002|Overall Study|Ongoing at cut-off date|64|||
164006622|NCT00847613|592391044|FG003|Overall Study|Ongoing at cut-off date|64|||
164006623|NCT00847613|592391041|FG000|Overall Study|Death|1|||
164006624|NCT00847613|592391042|FG001|Overall Study|Death|1|||
164006625|NCT00847613|592391043|FG002|Overall Study|Death|0|||
164235427|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
164235428|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
164235429|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
164235430|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
164235431|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164235432|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164235433|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164235434|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164235435|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
164235436|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
164235437|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
164235438|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
164333811|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
164333812|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
164006626|NCT00847613|592391044|FG003|Overall Study|Death|0|||
164006627|NCT00847613|592391041|FG000|Overall Study|Adverse Event|36|||
164006628|NCT00847613|592391042|FG001|Overall Study|Adverse Event|26|||
164006629|NCT00847613|592391043|FG002|Overall Study|Adverse Event|5|||
163884083|NCT03673111|591945838|FG012|Overall Study|Adverse Event|0|||
164333813|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
164333814|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
164333815|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
164333816|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
163884084|NCT03673111|591945839|FG013|Overall Study|Adverse Event|0|||
164333817|NCT04612790|593599639|FG000|OLE Period (Up to 1 Year)|Other|0|||
164333818|NCT04612790|593599640|FG001|OLE Period (Up to 1 Year)|Other|0|||
164333819|NCT04612790|593599641|FG002|OLE Period (Up to 1 Year)|Other|0|||
164333820|NCT04612790|593599642|FG003|OLE Period (Up to 1 Year)|Other|1|||
164333821|NCT00785928|593599643|FG000|Treatment Phase|Adverse Event|1|||
164333822|NCT00785928|593599644|FG001|Treatment Phase|Adverse Event|1|||
164333823|NCT00785928|593599645|FG002|Treatment Phase|Adverse Event|2|||
163884085|NCT03457142|591945845|FG000|Overall Study|Death|1|||
163884086|NCT04060654|591945846|FG000|Overall Study|Withdrawal by Subject|1|||
163884087|NCT04060654|591945846|FG000|Overall Study|Lost to Follow-up|5|||
163884088|NCT03707951|591945847|FG000|Overall Study|Lost to Follow-up|8|||
163884089|NCT03707951|591945848|FG001|Overall Study|Lost to Follow-up|17|||
163884090|NCT03707951|591945847|FG000|Overall Study|Withdrawal by Subject|6|||
163884091|NCT03707951|591945848|FG001|Overall Study|Withdrawal by Subject|6|||
163884092|NCT01999075|591945850|FG000|Overall Study|Lost to Follow-up|0|||
163884093|NCT01999075|591945851|FG001|Overall Study|Lost to Follow-up|2|||
163884094|NCT01999075|591945850|FG000|Overall Study|Withdrawal by Subject|2|||
163884095|NCT01999075|591945851|FG001|Overall Study|Withdrawal by Subject|7|||
163884096|NCT01999075|591945850|FG000|Overall Study|Enrolled in drug trial|3|||
163884097|NCT01999075|591945851|FG001|Overall Study|Enrolled in drug trial|1|||
163884098|NCT01999075|591945850|FG000|Overall Study|Became ineligible|0|||
163884099|NCT01999075|591945851|FG001|Overall Study|Became ineligible|2|||
163884100|NCT04896476|591945856|FG000|Overall Study|Withdrawal by Subject|1|||
163884101|NCT04896476|591945856|FG000|Overall Study|Lost to Follow-up|2|||
163884102|NCT05268393|591945862|FG000|Overall Study|Withdrawal by Subject|2|||
163884103|NCT05268393|591945863|FG001|Overall Study|Withdrawal by Subject|1|||
163884104|NCT00999804|591945865|FG000|Overall Study|Lack of Efficacy|9|||
163884105|NCT00999804|591945866|FG001|Overall Study|Lack of Efficacy|2|||
163884106|NCT00999804|591945865|FG000|Overall Study|Adverse Event|4|||
163884107|NCT00999804|591945866|FG001|Overall Study|Adverse Event|3|||
163884108|NCT00999804|591945865|FG000|Overall Study|Withdrawal by Subject|4|||
163884109|NCT00999804|591945866|FG001|Overall Study|Withdrawal by Subject|0|||
163884110|NCT00999804|591945865|FG000|Overall Study|Death|1|||
163884111|NCT00999804|591945866|FG001|Overall Study|Death|0|||
163884112|NCT00999804|591945865|FG000|Overall Study|Ineligible|3|||
163884113|NCT00999804|591945866|FG001|Overall Study|Ineligible|0|||
163884114|NCT01997840|591945868|FG000|Overall Study|Lost to Follow-up|0|||
163884115|NCT01997840|591945869|FG001|Overall Study|Lost to Follow-up|0|||
163884116|NCT01997840|591945870|FG002|Overall Study|Lost to Follow-up|1|||
163884117|NCT01997840|591945871|FG003|Overall Study|Lost to Follow-up|0|||
163884118|NCT01997840|591945868|FG000|Overall Study|Withdrawal by participant|0|||
163884119|NCT01997840|591945869|FG001|Overall Study|Withdrawal by participant|0|||
163884120|NCT01997840|591945870|FG002|Overall Study|Withdrawal by participant|8|||
163884121|NCT01997840|591945871|FG003|Overall Study|Withdrawal by participant|1|||
163884122|NCT01997840|591945868|FG000|Overall Study|Physician Decision|0|||
163884123|NCT01997840|591945869|FG001|Overall Study|Physician Decision|0|||
163884124|NCT01997840|591945870|FG002|Overall Study|Physician Decision|3|||
163884125|NCT01997840|591945871|FG003|Overall Study|Physician Decision|0|||
163884126|NCT01997840|591945868|FG000|Overall Study|Progressive disease|3|||
163884127|NCT01997840|591945869|FG001|Overall Study|Progressive disease|4|||
163884128|NCT01997840|591945870|FG002|Overall Study|Progressive disease|57|||
163884129|NCT01997840|591945871|FG003|Overall Study|Progressive disease|8|||
163884130|NCT01997840|591945868|FG000|Overall Study|Other reasons|0|||
163884131|NCT01997840|591945869|FG001|Overall Study|Other reasons|0|||
163884132|NCT01997840|591945870|FG002|Overall Study|Other reasons|1|||
163884133|NCT01997840|591945871|FG003|Overall Study|Other reasons|0|||
163884134|NCT01997840|591945868|FG000|Overall Study|Adverse Event|0|||
163988194|NCT01227902|592326056|FG000|Overall Study|Adverse Event|12|||
163884135|NCT01997840|591945869|FG001|Overall Study|Adverse Event|0|||
163884136|NCT01997840|591945870|FG002|Overall Study|Adverse Event|15|||
163884137|NCT01997840|591945871|FG003|Overall Study|Adverse Event|2|||
163884138|NCT05311384|591945875|FG000|Overall Study|Uncontrolled health conditions|2|||
163884139|NCT05311384|591945875|FG000|Overall Study|Withdrawal by Subject|1|||
163884140|NCT03891667|591945878|FG000|Overall Study|Physician Decision|1|||
163884141|NCT03891667|591945879|FG001|Overall Study|Physician Decision|1|||
163884142|NCT03891667|591945878|FG000|Overall Study|COVID related pause|1|||
163884143|NCT03891667|591945879|FG001|Overall Study|COVID related pause|0|||
164333824|NCT00785928|593599646|FG003|Treatment Phase|Adverse Event|0|||
163884144|NCT03891667|591945878|FG000|Overall Study|Withdrawal by Subject|0|||
163884145|NCT03891667|591945879|FG001|Overall Study|Withdrawal by Subject|1|||
163884146|NCT03891667|591945878|FG000|Overall Study|Adverse Event|0|||
164333825|NCT00785928|593599647|FG004|Treatment Phase|Adverse Event|0|||
163884147|NCT03891667|591945879|FG001|Overall Study|Adverse Event|1|||
163988195|NCT01227902|592326057|FG001|Overall Study|Adverse Event|8|||
163988196|NCT01227902|592326058|FG002|Overall Study|Adverse Event|11|||
163988197|NCT01227902|592326059|FG003|Overall Study|Adverse Event|4|||
163988198|NCT01227902|592326056|FG000|Overall Study|Lack of Efficacy|1|||
163988199|NCT01227902|592326057|FG001|Overall Study|Lack of Efficacy|2|||
163988200|NCT01227902|592326058|FG002|Overall Study|Lack of Efficacy|2|||
163988201|NCT01227902|592326059|FG003|Overall Study|Lack of Efficacy|1|||
163988202|NCT01227902|592326056|FG000|Overall Study|Protocol Violation|1|||
163988203|NCT01227902|592326057|FG001|Overall Study|Protocol Violation|0|||
163988204|NCT01227902|592326058|FG002|Overall Study|Protocol Violation|0|||
164235439|NCT02836249|593233493|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
164235440|NCT02836249|593233494|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164235441|NCT02836249|593233495|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164235442|NCT02836249|593233496|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
164333826|NCT00785928|593599648|FG005|Treatment Phase|Adverse Event|0|||
164333827|NCT00785928|593599649|FG006|Treatment Phase|Adverse Event|2|||
164333828|NCT00785928|593599643|FG000|Treatment Phase|Inadequate Response|0|||
164333829|NCT00785928|593599644|FG001|Treatment Phase|Inadequate Response|1|||
164333830|NCT00785928|593599645|FG002|Treatment Phase|Inadequate Response|0|||
164333831|NCT00785928|593599646|FG003|Treatment Phase|Inadequate Response|0|||
164333832|NCT00785928|593599647|FG004|Treatment Phase|Inadequate Response|0|||
164333833|NCT00785928|593599648|FG005|Treatment Phase|Inadequate Response|0|||
164333834|NCT00785928|593599649|FG006|Treatment Phase|Inadequate Response|0|||
164333835|NCT00785928|593599643|FG000|Treatment Phase|Lack of Efficacy|0|||
164333836|NCT00785928|593599644|FG001|Treatment Phase|Lack of Efficacy|1|||
164333837|NCT00785928|593599645|FG002|Treatment Phase|Lack of Efficacy|1|||
164333838|NCT00785928|593599646|FG003|Treatment Phase|Lack of Efficacy|0|||
164333839|NCT00785928|593599647|FG004|Treatment Phase|Lack of Efficacy|0|||
164333840|NCT00785928|593599648|FG005|Treatment Phase|Lack of Efficacy|0|||
164333841|NCT00785928|593599649|FG006|Treatment Phase|Lack of Efficacy|0|||
164333842|NCT00785928|593599643|FG000|Treatment Phase|Physician Decision|0|||
164333843|NCT00785928|593599644|FG001|Treatment Phase|Physician Decision|0|||
164333844|NCT00785928|593599645|FG002|Treatment Phase|Physician Decision|0|||
164333845|NCT00785928|593599646|FG003|Treatment Phase|Physician Decision|0|||
164333846|NCT00785928|593599647|FG004|Treatment Phase|Physician Decision|1|||
164333847|NCT00785928|593599648|FG005|Treatment Phase|Physician Decision|0|||
164333848|NCT00785928|593599649|FG006|Treatment Phase|Physician Decision|0|||
164333849|NCT00785928|593599643|FG000|Treatment Phase|Sponsor Decision|1|||
164333850|NCT00785928|593599644|FG001|Treatment Phase|Sponsor Decision|0|||
164333851|NCT00785928|593599645|FG002|Treatment Phase|Sponsor Decision|0|||
164333852|NCT00785928|593599646|FG003|Treatment Phase|Sponsor Decision|0|||
164333853|NCT00785928|593599647|FG004|Treatment Phase|Sponsor Decision|0|||
164235443|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164235444|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164235445|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
164235446|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
164235447|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164235448|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164235449|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
164235450|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
164235451|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Death|0|||
164235452|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Death|0|||
164235453|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Death|1|||
164235454|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Death|0|||
164235455|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
164235456|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
164235457|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
164235458|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
164235459|NCT02836249|593233493|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
164235460|NCT02836249|593233494|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
164235461|NCT02836249|593233495|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
164235462|NCT02836249|593233496|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
164333854|NCT00785928|593599648|FG005|Treatment Phase|Sponsor Decision|0|||
164235463|NCT05200845|593233497|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
164235464|NCT05200845|593233498|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
164333855|NCT00785928|593599649|FG006|Treatment Phase|Sponsor Decision|1|||
164333856|NCT00785928|593599643|FG000|Treatment Phase|Withdrawal by Subject|1|||
164333857|NCT00785928|593599644|FG001|Treatment Phase|Withdrawal by Subject|2|||
164333858|NCT00785928|593599645|FG002|Treatment Phase|Withdrawal by Subject|0|||
164333859|NCT00785928|593599646|FG003|Treatment Phase|Withdrawal by Subject|0|||
164333860|NCT00785928|593599647|FG004|Treatment Phase|Withdrawal by Subject|1|||
163988205|NCT01227902|592326059|FG003|Overall Study|Protocol Violation|0|||
163988206|NCT01227902|592326056|FG000|Overall Study|Lost to Follow-up|0|||
164333861|NCT00785928|593599648|FG005|Treatment Phase|Withdrawal by Subject|0|||
163988207|NCT01227902|592326057|FG001|Overall Study|Lost to Follow-up|0|||
163988208|NCT01227902|592326058|FG002|Overall Study|Lost to Follow-up|1|||
163988209|NCT01227902|592326059|FG003|Overall Study|Lost to Follow-up|2|||
163988210|NCT01227902|592326056|FG000|Overall Study|Physician Decision|0|||
163988211|NCT01227902|592326057|FG001|Overall Study|Physician Decision|1|||
163988212|NCT01227902|592326058|FG002|Overall Study|Physician Decision|1|||
163988213|NCT01227902|592326059|FG003|Overall Study|Physician Decision|0|||
163988214|NCT01227902|592326056|FG000|Overall Study|Withdrawal by Subject|4|||
163988215|NCT01227902|592326057|FG001|Overall Study|Withdrawal by Subject|2|||
163988216|NCT01227902|592326058|FG002|Overall Study|Withdrawal by Subject|4|||
163988217|NCT01227902|592326059|FG003|Overall Study|Withdrawal by Subject|3|||
163988218|NCT02363478|592326064|FG000|Overall Study|Lost to Follow-up|4|||
163988219|NCT02363478|592326064|FG000|Overall Study|Adverse Event|4|||
163988220|NCT00930059|592326065|FG000|Overall Study|Death|1|||
163988221|NCT00930059|592326066|FG001|Overall Study|Death|0|||
163988222|NCT00930059|592326065|FG000|Overall Study|Did not meet entrance criteria|1|||
163988223|NCT00930059|592326066|FG001|Overall Study|Did not meet entrance criteria|1|||
163988224|NCT00930059|592326065|FG000|Overall Study|Withdrawal by Subject|3|||
163988225|NCT00930059|592326066|FG001|Overall Study|Withdrawal by Subject|4|||
163988226|NCT00930059|592326065|FG000|Overall Study|Other|1|||
163988227|NCT00930059|592326066|FG001|Overall Study|Other|0|||
163988228|NCT00930059|592326065|FG000|Overall Study|1 site terminated by sponsor|1|||
163988229|NCT00930059|592326066|FG001|Overall Study|1 site terminated by sponsor|1|||
163988230|NCT00930059|592326065|FG000|Overall Study|Adverse Event|1|||
163988231|NCT00930059|592326066|FG001|Overall Study|Adverse Event|6|||
163988232|NCT00546364|592326070|FG000|Overall Study|Disease progression|5|||
163988233|NCT00546364|592326071|FG001|Overall Study|Disease progression|11|||
163988234|NCT00546364|592326072|FG002|Overall Study|Disease progression|8|||
163988235|NCT00546364|592326070|FG000|Overall Study|Completed and off treatment|1|||
163988236|NCT00546364|592326071|FG001|Overall Study|Completed and off treatment|0|||
163988237|NCT00546364|592326072|FG002|Overall Study|Completed and off treatment|2|||
163988238|NCT00546364|592326070|FG000|Overall Study|Administrative reason by sponsor|1|||
163988239|NCT00546364|592326071|FG001|Overall Study|Administrative reason by sponsor|0|||
163988240|NCT00546364|592326072|FG002|Overall Study|Administrative reason by sponsor|0|||
163988241|NCT00546364|592326070|FG000|Overall Study|Poor compliance/noncompliance|0|||
163988242|NCT00546364|592326071|FG001|Overall Study|Poor compliance/noncompliance|0|||
163988243|NCT00546364|592326072|FG002|Overall Study|Poor compliance/noncompliance|1|||
163988244|NCT00546364|592326070|FG000|Overall Study|No longer meets study criteria|1|||
163988245|NCT00546364|592326071|FG001|Overall Study|No longer meets study criteria|1|||
163988246|NCT00546364|592326072|FG002|Overall Study|No longer meets study criteria|0|||
163988247|NCT00546364|592326070|FG000|Overall Study|Withdrawal by Subject|5|||
163988248|NCT00546364|592326071|FG001|Overall Study|Withdrawal by Subject|6|||
163988249|NCT00546364|592326072|FG002|Overall Study|Withdrawal by Subject|3|||
163988250|NCT00546364|592326070|FG000|Overall Study|Prior taxotere|1|||
163988251|NCT00546364|592326071|FG001|Overall Study|Prior taxotere|0|||
164235465|NCT05200845|593233499|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
164235466|NCT05200845|593233500|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
164235467|NCT05200845|593233497|FG000|Overall Study|Withdrawal by Subject|0|||
164235468|NCT05200845|593233498|FG001|Overall Study|Withdrawal by Subject|1|||
164235469|NCT05200845|593233499|FG002|Overall Study|Withdrawal by Subject|1|||
164235470|NCT05200845|593233500|FG003|Overall Study|Withdrawal by Subject|0|||
164235471|NCT00928668|593233503|FG000|Overall Study|Adverse Event|1|||
164235472|NCT00928668|593233504|FG001|Overall Study|Adverse Event|0|||
164235473|NCT00928668|593233505|FG002|Overall Study|Adverse Event|0|||
164235474|NCT00928668|593233506|FG003|Overall Study|Adverse Event|0|||
164235475|NCT00928668|593233507|FG004|Overall Study|Adverse Event|0|||
164235476|NCT00928668|593233503|FG000|Overall Study|Protocol Violation|0|||
164235477|NCT00928668|593233504|FG001|Overall Study|Protocol Violation|0|||
164235478|NCT00928668|593233505|FG002|Overall Study|Protocol Violation|0|||
164235479|NCT00928668|593233506|FG003|Overall Study|Protocol Violation|0|||
164235480|NCT00928668|593233507|FG004|Overall Study|Protocol Violation|1|||
164235481|NCT00928668|593233503|FG000|Overall Study|Withdrawal by Subject|0|||
164235482|NCT00928668|593233504|FG001|Overall Study|Withdrawal by Subject|1|||
164235483|NCT00928668|593233505|FG002|Overall Study|Withdrawal by Subject|1|||
164235484|NCT00928668|593233506|FG003|Overall Study|Withdrawal by Subject|0|||
164235485|NCT00928668|593233507|FG004|Overall Study|Withdrawal by Subject|0|||
164235486|NCT00928668|593233503|FG000|Overall Study|Other reasons not listed above|0|||
164235487|NCT00928668|593233504|FG001|Overall Study|Other reasons not listed above|0|||
164235488|NCT00928668|593233505|FG002|Overall Study|Other reasons not listed above|0|||
164235489|NCT00928668|593233506|FG003|Overall Study|Other reasons not listed above|1|||
163988252|NCT00546364|592326072|FG002|Overall Study|Prior taxotere|0|||
163988253|NCT00546364|592326070|FG000|Overall Study|Mixed response|1|||
163988254|NCT00546364|592326071|FG001|Overall Study|Mixed response|0|||
163988255|NCT00546364|592326072|FG002|Overall Study|Mixed response|0|||
163988256|NCT00546364|592326070|FG000|Overall Study|Palliative treatment|1|||
164006630|NCT00847613|592391044|FG003|Overall Study|Adverse Event|6|||
164006631|NCT00847613|592391041|FG000|Overall Study|Lack of Efficacy|7|||
163988257|NCT00546364|592326071|FG001|Overall Study|Palliative treatment|0|||
163988258|NCT00546364|592326072|FG002|Overall Study|Palliative treatment|1|||
163988259|NCT00546364|592326070|FG000|Overall Study|Target lesions resected|1|||
164235490|NCT00928668|593233507|FG004|Overall Study|Other reasons not listed above|0|||
164235491|NCT02412670|593233508|FG000|Overall Study|Adverse Event|4|||
164235492|NCT02412670|593233509|FG001|Overall Study|Adverse Event|1|||
164235493|NCT02412670|593233508|FG000|Overall Study|Physician Decision|1|||
164235494|NCT02412670|593233509|FG001|Overall Study|Physician Decision|0|||
163988260|NCT00546364|592326071|FG001|Overall Study|Target lesions resected|0|||
163988261|NCT00546364|592326072|FG002|Overall Study|Target lesions resected|0|||
163988262|NCT00546364|592326070|FG000|Overall Study|Physician Decision|0|||
163988263|NCT00546364|592326071|FG001|Overall Study|Physician Decision|0|||
163988264|NCT00546364|592326072|FG002|Overall Study|Physician Decision|1|||
163988265|NCT00546364|592326070|FG000|Overall Study|Sponsor decision|0|||
163988266|NCT00546364|592326071|FG001|Overall Study|Sponsor decision|0|||
163988267|NCT00546364|592326072|FG002|Overall Study|Sponsor decision|1|||
163988268|NCT03064763|592326073|FG000|Overall Study|Lost to Follow-up|1|||
163988269|NCT03064763|592326073|FG000|Overall Study|Death|8|||
163988270|NCT00388947|592326074|FG000|Overall Study|Protocol Violation|47|||
163988271|NCT00935883|592326077|FG000|Treatment Period|Physician Decision|1|||
163988272|NCT00935883|592326078|FG001|Treatment Period|Physician Decision|0|||
163988273|NCT00935883|592326077|FG000|Treatment Period|Withdrawal by Subject|0|||
163988274|NCT00935883|592326078|FG001|Treatment Period|Withdrawal by Subject|2|||
163988275|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
163988276|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
163988277|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
163988278|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
163988279|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
163988280|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
163988281|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
163988282|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
163988283|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
163988284|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
163988285|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
163988286|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
163988287|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
163988288|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
163988289|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
163988290|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
163988291|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
163988292|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
163988293|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
163988294|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
163988295|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
163988296|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
163988297|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
163988298|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
163988299|NCT04660643|592326079|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
163988300|NCT04660643|592326080|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
163988301|NCT04660643|592326081|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
163988302|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
163988303|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
163988304|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
163988305|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
163988306|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
163988307|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
163988308|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
163988309|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
163988310|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
163988311|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
163988312|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
163988313|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
163988314|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
163988315|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
163988316|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
163988317|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
163988318|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
163988319|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
163988320|NCT04660643|592326079|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
163988321|NCT04660643|592326080|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
163988322|NCT04660643|592326081|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
163988323|NCT01220414|592326089|FG000|Overall Study|Withdrawal by Subject|1|||
163988324|NCT01220414|592326090|FG001|Overall Study|Withdrawal by Subject|0|||
163988325|NCT01220414|592326091|FG002|Overall Study|Withdrawal by Subject|0|||
163988326|NCT01220414|592326092|FG003|Overall Study|Withdrawal by Subject|1|||
163988327|NCT00623831|592326093|FG000|Overall Study|Withdrawal by Subject|1|||
163988328|NCT00623831|592326094|FG001|Overall Study|Withdrawal by Subject|0|||
163988329|NCT00623831|592326093|FG000|Overall Study|Progressive Disease|0|||
163988330|NCT00623831|592326094|FG001|Overall Study|Progressive Disease|1|||
164235495|NCT02412670|593233508|FG000|Overall Study|Withdrawal by Subject|1|||
164235496|NCT02412670|593233509|FG001|Overall Study|Withdrawal by Subject|0|||
164235497|NCT02412670|593233508|FG000|Overall Study|Ineligible|1|||
164235498|NCT02412670|593233509|FG001|Overall Study|Ineligible|0|||
164235499|NCT02943473|593233513|FG000|Overall Study|enrolled but not dosed|1|||
163988331|NCT01276821|592326095|FG000|Overall Study|Protocol Violation|0|||
163988332|NCT01276821|592326096|FG001|Overall Study|Protocol Violation|1|||
163988333|NCT00066690|592326097|FG000|Overall Study|Adverse Event|145|||
163988334|NCT00066690|592326098|FG001|Overall Study|Adverse Event|58|||
163988335|NCT00066690|592326099|FG002|Overall Study|Adverse Event|126|||
163988336|NCT00066690|592326097|FG000|Overall Study|Death|3|||
163988337|NCT00066690|592326098|FG001|Overall Study|Death|0|||
163988338|NCT00066690|592326099|FG002|Overall Study|Death|2|||
163988339|NCT00066690|592326097|FG000|Overall Study|Lack of Efficacy|114|||
163988340|NCT00066690|592326098|FG001|Overall Study|Lack of Efficacy|110|||
163988341|NCT00066690|592326099|FG002|Overall Study|Lack of Efficacy|76|||
163988342|NCT00066690|592326097|FG000|Overall Study|Lost to Follow-up|40|||
163988343|NCT00066690|592326098|FG001|Overall Study|Lost to Follow-up|21|||
163988344|NCT00066690|592326099|FG002|Overall Study|Lost to Follow-up|29|||
163988345|NCT00066690|592326097|FG000|Overall Study|Withdrawal by Subject|50|||
163988346|NCT00066690|592326098|FG001|Overall Study|Withdrawal by Subject|55|||
163988347|NCT00066690|592326099|FG002|Overall Study|Withdrawal by Subject|49|||
163988348|NCT00066690|592326097|FG000|Overall Study|Treatment Ongoing|246|||
163988349|NCT00066690|592326098|FG001|Overall Study|Treatment Ongoing|278|||
163988350|NCT00066690|592326099|FG002|Overall Study|Treatment Ongoing|282|||
163988351|NCT00223496|592326100|FG000|Overall Study|screen failure|9|||
163988352|NCT00223496|592326100|FG000|Overall Study|Lost to Follow-up|4|||
163988353|NCT00223496|592326100|FG000|Overall Study|Lack of Efficacy|6|||
163988354|NCT00223496|592326100|FG000|Overall Study|Withdrawal by Subject|1|||
163988355|NCT00223496|592326100|FG000|Overall Study|Physician Decision|2|||
163988356|NCT02939131|592326103|FG000|Overall Study|Unable to get to clinic|6|||
163988357|NCT02939131|592326104|FG001|Overall Study|Unable to get to clinic|4|||
163988358|NCT02939131|592326103|FG000|Overall Study|Lost to Follow-up|2|||
163988359|NCT02939131|592326104|FG001|Overall Study|Lost to Follow-up|4|||
163988360|NCT02939131|592326103|FG000|Overall Study|severe debilitation|1|||
163988361|NCT02939131|592326104|FG001|Overall Study|severe debilitation|0|||
163988362|NCT02939131|592326103|FG000|Overall Study|Other|0|||
163988363|NCT02939131|592326104|FG001|Overall Study|Other|1|||
163988364|NCT02939131|592326103|FG000|Overall Study|not willing to adhere to protocol|2|||
163988365|NCT02939131|592326104|FG001|Overall Study|not willing to adhere to protocol|0|||
163988366|NCT04033367|592326105|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
163988367|NCT04033367|592326106|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
163988368|NCT04033367|592326105|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
163988369|NCT04033367|592326106|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
163988370|NCT04033367|592326105|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
163988371|NCT04033367|592326106|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
163988372|NCT04033367|592326105|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
163988373|NCT04033367|592326106|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
163988374|NCT02723201|592326107|FG000|Second Intervention Period|Protocol Violation|1|||
163988375|NCT02723201|592326108|FG001|Second Intervention Period|Protocol Violation|0|||
163988376|NCT02723201|592326109|FG002|Second Intervention Period|Protocol Violation|0|||
163988377|NCT02723201|592326107|FG000|Second Intervention Period|Adverse Event|1|||
163988378|NCT02723201|592326108|FG001|Second Intervention Period|Adverse Event|0|||
163988379|NCT02723201|592326109|FG002|Second Intervention Period|Adverse Event|0|||
163988380|NCT02415712|592326110|FG000|Overall Study|Protocol Violation|16|||
163988381|NCT00343512|592326111|FG000|Overall Study|Withdrawal by Subject|2|||
163988382|NCT01262976|592326112|FG000|Up to Month 2|Serious Adverse Event|0|||
163988383|NCT01262976|592326113|FG001|Up to Month 2|Serious Adverse Event|0|||
163988384|NCT01262976|592326114|FG002|Up to Month 2|Serious Adverse Event|1|||
163988385|NCT01262976|592326115|FG003|Up to Month 2|Serious Adverse Event|0|||
163988386|NCT01262976|592326116|FG004|Up to Month 2|Serious Adverse Event|0|||
163988387|NCT01262976|592326117|FG005|Up to Month 2|Serious Adverse Event|0|||
164235500|NCT02943473|593233513|FG000|Overall Study|screen failure|1|||
164235501|NCT02943473|593233513|FG000|Overall Study|Physician Decision|4|||
164235502|NCT01728246|593233514|FG000|Overall Study|Participant needed rescue medication|1|||
163988388|NCT01262976|592326112|FG000|Up to Month 2|Withdrawal by Subject|1|||
163988389|NCT01262976|592326113|FG001|Up to Month 2|Withdrawal by Subject|0|||
163988390|NCT01262976|592326114|FG002|Up to Month 2|Withdrawal by Subject|0|||
163988391|NCT01262976|592326115|FG003|Up to Month 2|Withdrawal by Subject|0|||
163988392|NCT01262976|592326116|FG004|Up to Month 2|Withdrawal by Subject|0|||
163988393|NCT01262976|592326117|FG005|Up to Month 2|Withdrawal by Subject|0|||
163988394|NCT01262976|592326112|FG000|Up to Month 2|Migrated/moved from study area|0|||
163988395|NCT01262976|592326113|FG001|Up to Month 2|Migrated/moved from study area|1|||
163988396|NCT01262976|592326114|FG002|Up to Month 2|Migrated/moved from study area|0|||
163988397|NCT01262976|592326115|FG003|Up to Month 2|Migrated/moved from study area|0|||
163988398|NCT01262976|592326116|FG004|Up to Month 2|Migrated/moved from study area|1|||
164299837|NCT02234843|593472948|FG004|Overall Study|Death|0|||
163988399|NCT01262976|592326117|FG005|Up to Month 2|Migrated/moved from study area|1|||
163988400|NCT01262976|592326112|FG000|Up to Month 2|Lost to Follow-up|1|||
163988401|NCT01262976|592326113|FG001|Up to Month 2|Lost to Follow-up|0|||
163988402|NCT01262976|592326114|FG002|Up to Month 2|Lost to Follow-up|0|||
163988403|NCT01262976|592326115|FG003|Up to Month 2|Lost to Follow-up|1|||
163988404|NCT01262976|592326116|FG004|Up to Month 2|Lost to Follow-up|1|||
163988405|NCT01262976|592326117|FG005|Up to Month 2|Lost to Follow-up|1|||
164235503|NCT01728246|593233515|FG001|Overall Study|Participant needed rescue medication|5|||
164235504|NCT01728246|593233514|FG000|Overall Study|Protocol Violation|1|||
164235505|NCT01728246|593233515|FG001|Overall Study|Protocol Violation|0|||
164235506|NCT01728246|593233514|FG000|Overall Study|Withdrawal by Subject|2|||
164235507|NCT01728246|593233515|FG001|Overall Study|Withdrawal by Subject|3|||
164235508|NCT01728246|593233514|FG000|Overall Study|Lost to Follow-up|23|||
164235509|NCT01728246|593233515|FG001|Overall Study|Lost to Follow-up|22|||
164235510|NCT01728246|593233514|FG000|Overall Study|Lack of Efficacy|1|||
163988406|NCT01262976|592326112|FG000|Up to Month 2|Other|1|||
163988407|NCT01262976|592326113|FG001|Up to Month 2|Other|0|||
163988408|NCT01262976|592326114|FG002|Up to Month 2|Other|0|||
163988409|NCT01262976|592326115|FG003|Up to Month 2|Other|1|||
163988410|NCT01262976|592326116|FG004|Up to Month 2|Other|0|||
163988411|NCT01262976|592326117|FG005|Up to Month 2|Other|2|||
163988412|NCT01262976|592326112|FG000|Up to Month 7|Serious Adverse Event|0|||
163988413|NCT01262976|592326113|FG001|Up to Month 7|Serious Adverse Event|0|||
163988414|NCT01262976|592326114|FG002|Up to Month 7|Serious Adverse Event|2|||
163988415|NCT01262976|592326115|FG003|Up to Month 7|Serious Adverse Event|0|||
163988416|NCT01262976|592326116|FG004|Up to Month 7|Serious Adverse Event|0|||
163988417|NCT01262976|592326117|FG005|Up to Month 7|Serious Adverse Event|0|||
163988418|NCT01262976|592326112|FG000|Up to Month 7|Withdrawal by Subject|1|||
163988419|NCT01262976|592326113|FG001|Up to Month 7|Withdrawal by Subject|0|||
163988420|NCT01262976|592326114|FG002|Up to Month 7|Withdrawal by Subject|0|||
163988421|NCT01262976|592326115|FG003|Up to Month 7|Withdrawal by Subject|0|||
164235511|NCT01728246|593233515|FG001|Overall Study|Lack of Efficacy|1|||
164235512|NCT01728246|593233514|FG000|Overall Study|Adverse Event|8|||
164235513|NCT01728246|593233515|FG001|Overall Study|Adverse Event|5|||
164235514|NCT05805150|593233516|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
164235515|NCT05805150|593233517|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
164235516|NCT00431964|593233520|FG000|Overall Study|Adverse Event|1|||
164235517|NCT00431964|593233521|FG001|Overall Study|Adverse Event|0|||
164235518|NCT00431964|593233520|FG000|Overall Study|Lost to Follow-up|1|||
164235519|NCT00431964|593233521|FG001|Overall Study|Lost to Follow-up|2|||
164235520|NCT00431964|593233520|FG000|Overall Study|Physician Decision|2|||
164235521|NCT00431964|593233521|FG001|Overall Study|Physician Decision|2|||
164235522|NCT00431964|593233520|FG000|Overall Study|Withdrawal by Subject|2|||
164235523|NCT00431964|593233521|FG001|Overall Study|Withdrawal by Subject|1|||
164235524|NCT00431964|593233520|FG000|Overall Study|Parental Consent Withdrawn|0|||
164235525|NCT00431964|593233521|FG001|Overall Study|Parental Consent Withdrawn|2|||
164235526|NCT00431964|593233520|FG000|Overall Study|Due to Unstable Health|0|||
164235527|NCT00431964|593233521|FG001|Overall Study|Due to Unstable Health|1|||
164235528|NCT04138056|593233522|FG000|Primary Study|Lost to Follow-up|3|||
164235529|NCT04138056|593233523|FG001|Primary Study|Lost to Follow-up|4|||
164235530|NCT04138056|593233524|FG002|Primary Study|Lost to Follow-up|1|||
163988422|NCT01262976|592326116|FG004|Up to Month 7|Withdrawal by Subject|0|||
163988423|NCT01262976|592326117|FG005|Up to Month 7|Withdrawal by Subject|0|||
164235531|NCT04138056|593233525|FG003|Primary Study|Lost to Follow-up|1|||
163988424|NCT01262976|592326112|FG000|Up to Month 7|Migrated/moved from study area|0|||
164235532|NCT04138056|593233526|FG004|Primary Study|Lost to Follow-up|4|||
164299838|NCT02234843|593472949|FG005|Overall Study|Death|0|||
163988425|NCT01262976|592326113|FG001|Up to Month 7|Migrated/moved from study area|0|||
163988426|NCT01262976|592326114|FG002|Up to Month 7|Migrated/moved from study area|1|||
163988427|NCT01262976|592326115|FG003|Up to Month 7|Migrated/moved from study area|3|||
163988428|NCT01262976|592326116|FG004|Up to Month 7|Migrated/moved from study area|1|||
163988429|NCT01262976|592326117|FG005|Up to Month 7|Migrated/moved from study area|1|||
163988430|NCT01262976|592326112|FG000|Up to Month 7|Lost to Follow-up|1|||
163988431|NCT01262976|592326113|FG001|Up to Month 7|Lost to Follow-up|0|||
164299839|NCT02234843|593472950|FG006|Overall Study|Death|0|||
164299840|NCT02234843|593472951|FG007|Overall Study|Death|0|||
164299841|NCT02234843|593472952|FG008|Overall Study|Death|0|||
164299842|NCT02234843|593472953|FG009|Overall Study|Death|0|||
164299843|NCT02234843|593472944|FG000|Overall Study|Protocol Violation|1|||
164299844|NCT02234843|593472945|FG001|Overall Study|Protocol Violation|0|||
164299845|NCT02234843|593472946|FG002|Overall Study|Protocol Violation|1|||
164299846|NCT02234843|593472947|FG003|Overall Study|Protocol Violation|0|||
164299847|NCT02234843|593472948|FG004|Overall Study|Protocol Violation|0|||
164299848|NCT02234843|593472949|FG005|Overall Study|Protocol Violation|0|||
164299849|NCT02234843|593472950|FG006|Overall Study|Protocol Violation|0|||
164299850|NCT02234843|593472951|FG007|Overall Study|Protocol Violation|0|||
164299851|NCT02234843|593472952|FG008|Overall Study|Protocol Violation|0|||
164235533|NCT04138056|593233522|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
164235534|NCT04138056|593233523|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
164235535|NCT04138056|593233524|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
163988432|NCT01262976|592326114|FG002|Up to Month 7|Lost to Follow-up|1|||
163988433|NCT01262976|592326115|FG003|Up to Month 7|Lost to Follow-up|3|||
163988434|NCT01262976|592326116|FG004|Up to Month 7|Lost to Follow-up|1|||
163988435|NCT01262976|592326117|FG005|Up to Month 7|Lost to Follow-up|3|||
163988436|NCT01262976|592326112|FG000|Up to Month 7|Other|3|||
163988437|NCT01262976|592326113|FG001|Up to Month 7|Other|0|||
163988438|NCT01262976|592326114|FG002|Up to Month 7|Other|2|||
163988439|NCT01262976|592326115|FG003|Up to Month 7|Other|0|||
163988440|NCT01262976|592326116|FG004|Up to Month 7|Other|0|||
163988441|NCT01262976|592326117|FG005|Up to Month 7|Other|0|||
164235536|NCT04138056|593233525|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
163988442|NCT01262976|592326112|FG000|Up to Year 1|Serious Adverse Event|0|||
163988443|NCT01262976|592326113|FG001|Up to Year 1|Serious Adverse Event|0|||
164235537|NCT04138056|593233526|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
164235538|NCT04138056|593233522|FG000|Extension Study|Lost to Follow-up|1|||
164235539|NCT04138056|593233523|FG001|Extension Study|Lost to Follow-up|2|||
164235540|NCT04138056|593233524|FG002|Extension Study|Lost to Follow-up|1|||
164235541|NCT04138056|593233525|FG003|Extension Study|Lost to Follow-up|0|||
164235542|NCT04138056|593233526|FG004|Extension Study|Lost to Follow-up|1|||
164235543|NCT01968980|593233530|FG000|Overall Study|Death|0|||
163988444|NCT01262976|592326114|FG002|Up to Year 1|Serious Adverse Event|2|||
163988445|NCT01262976|592326115|FG003|Up to Year 1|Serious Adverse Event|0|||
163988446|NCT01262976|592326116|FG004|Up to Year 1|Serious Adverse Event|0|||
163988447|NCT01262976|592326117|FG005|Up to Year 1|Serious Adverse Event|0|||
163988448|NCT01262976|592326112|FG000|Up to Year 1|Withdrawal by Subject|1|||
163988449|NCT01262976|592326113|FG001|Up to Year 1|Withdrawal by Subject|0|||
164235544|NCT01968980|593233531|FG001|Overall Study|Death|1|||
164333862|NCT00785928|593599649|FG006|Treatment Phase|Withdrawal by Subject|0|||
164333863|NCT03611010|593599656|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
164333864|NCT03611010|593599657|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
164333865|NCT03611010|593599658|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
164333866|NCT03611010|593599659|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
164333867|NCT01675427|593599660|FG000|Overall Study|Withdrawal by Subject|7|||
164333868|NCT01675427|593599660|FG000|Overall Study|Participant Refused Sample Collection|18|||
164333869|NCT01675427|593599660|FG000|Overall Study|Sample not Collected by Mistake|2|||
164333870|NCT01675427|593599660|FG000|Overall Study|Lost to Follow-up|5|||
164333871|NCT01675427|593599660|FG000|Overall Study|Other|2|||
164333872|NCT05021081|593599664|FG000|Phase 2|Subject enrolled in error|1|||
164333873|NCT05021081|593599665|FG001|Phase 2|Subject enrolled in error|1|||
163988450|NCT01262976|592326114|FG002|Up to Year 1|Withdrawal by Subject|0|||
163988451|NCT01262976|592326115|FG003|Up to Year 1|Withdrawal by Subject|0|||
163988452|NCT01262976|592326116|FG004|Up to Year 1|Withdrawal by Subject|0|||
164333874|NCT05021081|593599666|FG002|Phase 2|Subject enrolled in error|0|||
164333875|NCT03257371|593599671|FG000|Overall Study|Lost to Follow-up|1|||
163988453|NCT01262976|592326117|FG005|Up to Year 1|Withdrawal by Subject|0|||
163988454|NCT01262976|592326112|FG000|Up to Year 1|Migrated/moved from study area|1|||
163988455|NCT01262976|592326113|FG001|Up to Year 1|Migrated/moved from study area|0|||
164333876|NCT03387683|593599672|FG000|Overall Study|In receipt of disallowed medication|1|||
164333877|NCT03387683|593599673|FG001|Overall Study|In receipt of disallowed medication|0|||
164333878|NCT03387683|593599672|FG000|Overall Study|Did not receive treatment|1|||
164235545|NCT01968980|593233530|FG000|Overall Study|Adverse Event|1|||
164235546|NCT01968980|593233531|FG001|Overall Study|Adverse Event|3|||
164235547|NCT01968980|593233530|FG000|Overall Study|Does not meet entry criteria|1|||
164235548|NCT01968980|593233531|FG001|Overall Study|Does not meet entry criteria|3|||
164235549|NCT01968980|593233530|FG000|Overall Study|Withdrawal by Subject|13|||
164235550|NCT01968980|593233531|FG001|Overall Study|Withdrawal by Subject|5|||
164235551|NCT01968980|593233530|FG000|Overall Study|Other unspecified|1|||
164235552|NCT01968980|593233531|FG001|Overall Study|Other unspecified|2|||
164235553|NCT03189719|593233532|FG000|Overall Study|Death|325|||
164235554|NCT03189719|593233533|FG001|Overall Study|Death|361|||
164235555|NCT03189719|593233532|FG000|Overall Study|Physician Decision|1|||
163988456|NCT01262976|592326114|FG002|Up to Year 1|Migrated/moved from study area|0|||
163988457|NCT01262976|592326115|FG003|Up to Year 1|Migrated/moved from study area|3|||
163988458|NCT01262976|592326116|FG004|Up to Year 1|Migrated/moved from study area|3|||
163988459|NCT01262976|592326117|FG005|Up to Year 1|Migrated/moved from study area|2|||
163988460|NCT01262976|592326112|FG000|Up to Year 1|Lost to Follow-up|4|||
163988461|NCT01262976|592326113|FG001|Up to Year 1|Lost to Follow-up|0|||
163988462|NCT01262976|592326114|FG002|Up to Year 1|Lost to Follow-up|0|||
163988463|NCT01262976|592326115|FG003|Up to Year 1|Lost to Follow-up|1|||
163988464|NCT01262976|592326116|FG004|Up to Year 1|Lost to Follow-up|6|||
163988465|NCT01262976|592326117|FG005|Up to Year 1|Lost to Follow-up|5|||
163988466|NCT01262976|592326112|FG000|Up to Year 1|Other|3|||
163988467|NCT01262976|592326113|FG001|Up to Year 1|Other|1|||
163988468|NCT01262976|592326114|FG002|Up to Year 1|Other|0|||
163988469|NCT01262976|592326115|FG003|Up to Year 1|Other|0|||
163988470|NCT01262976|592326116|FG004|Up to Year 1|Other|2|||
163988471|NCT01262976|592326117|FG005|Up to Year 1|Other|1|||
163988472|NCT01262976|592326112|FG000|Up to Year 1|Subjects with unknown completion status|0|||
163988473|NCT01262976|592326113|FG001|Up to Year 1|Subjects with unknown completion status|0|||
163988474|NCT01262976|592326114|FG002|Up to Year 1|Subjects with unknown completion status|1|||
163988475|NCT01262976|592326115|FG003|Up to Year 1|Subjects with unknown completion status|0|||
163988476|NCT01262976|592326116|FG004|Up to Year 1|Subjects with unknown completion status|0|||
163988477|NCT01262976|592326117|FG005|Up to Year 1|Subjects with unknown completion status|1|||
163988478|NCT01262976|592326112|FG000|Up to Year 2|Serious Adverse Event|0|||
163988479|NCT01262976|592326113|FG001|Up to Year 2|Serious Adverse Event|0|||
163988480|NCT01262976|592326114|FG002|Up to Year 2|Serious Adverse Event|2|||
164235556|NCT03189719|593233533|FG001|Overall Study|Physician Decision|0|||
164235557|NCT03189719|593233532|FG000|Overall Study|Sponsor Decision|40|||
164235558|NCT03189719|593233533|FG001|Overall Study|Sponsor Decision|12|||
164235559|NCT03189719|593233532|FG000|Overall Study|Withdrawal by Subject|7|||
164235560|NCT03189719|593233533|FG001|Overall Study|Withdrawal by Subject|3|||
164235561|NCT03012880|593233534|FG000|Overall Study|Withdrawal by Subject|1|||
164235562|NCT03012880|593233535|FG001|Overall Study|Withdrawal by Subject|0|||
164235563|NCT03012880|593233534|FG000|Overall Study|Ineligible|1|||
164235564|NCT03012880|593233535|FG001|Overall Study|Ineligible|0|||
164235565|NCT05211596|593233536|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
164235566|NCT05211596|593233536|FG000|Baseline to 6 Months|Death|1|||
164235567|NCT05211596|593233536|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
164235568|NCT05211596|593233536|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
164235569|NCT02293551|593233537|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
164235570|NCT02293551|593233538|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
164235571|NCT02293551|593233539|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
164235572|NCT02293551|593233540|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
164235573|NCT02293551|593233541|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
164235574|NCT02293551|593233542|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
164235575|NCT02293551|593233537|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
164235576|NCT02293551|593233538|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
164235577|NCT02293551|593233539|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
164235578|NCT02293551|593233540|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
164235579|NCT02293551|593233541|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
164235580|NCT02293551|593233542|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
164235581|NCT02293551|593233537|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235582|NCT02293551|593233538|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235583|NCT02293551|593233539|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235584|NCT02293551|593233540|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
164235585|NCT02293551|593233541|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
164235586|NCT02293551|593233542|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
164235587|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
164235588|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
164235589|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
164235590|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
164235591|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
164235592|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
163988481|NCT01262976|592326115|FG003|Up to Year 2|Serious Adverse Event|0|||
163988482|NCT01262976|592326116|FG004|Up to Year 2|Serious Adverse Event|0|||
163988483|NCT01262976|592326117|FG005|Up to Year 2|Serious Adverse Event|0|||
163988484|NCT01262976|592326112|FG000|Up to Year 2|Withdrawal by Subject|1|||
163988485|NCT01262976|592326113|FG001|Up to Year 2|Withdrawal by Subject|0|||
163988486|NCT01262976|592326114|FG002|Up to Year 2|Withdrawal by Subject|0|||
163988487|NCT01262976|592326115|FG003|Up to Year 2|Withdrawal by Subject|0|||
163988488|NCT01262976|592326116|FG004|Up to Year 2|Withdrawal by Subject|0|||
163988489|NCT01262976|592326117|FG005|Up to Year 2|Withdrawal by Subject|0|||
163988490|NCT01262976|592326112|FG000|Up to Year 2|Migrated/moved from study area|0|||
163988491|NCT01262976|592326113|FG001|Up to Year 2|Migrated/moved from study area|0|||
163988492|NCT01262976|592326114|FG002|Up to Year 2|Migrated/moved from study area|0|||
163988493|NCT01262976|592326115|FG003|Up to Year 2|Migrated/moved from study area|2|||
163988494|NCT01262976|592326116|FG004|Up to Year 2|Migrated/moved from study area|1|||
163988495|NCT01262976|592326117|FG005|Up to Year 2|Migrated/moved from study area|2|||
163988496|NCT01262976|592326112|FG000|Up to Year 2|Lost to Follow-up|1|||
163988497|NCT01262976|592326113|FG001|Up to Year 2|Lost to Follow-up|1|||
163988498|NCT01262976|592326114|FG002|Up to Year 2|Lost to Follow-up|2|||
163988499|NCT01262976|592326115|FG003|Up to Year 2|Lost to Follow-up|2|||
163988500|NCT01262976|592326116|FG004|Up to Year 2|Lost to Follow-up|3|||
163988501|NCT01262976|592326117|FG005|Up to Year 2|Lost to Follow-up|3|||
163988502|NCT01262976|592326112|FG000|Up to Year 2|Subjects with unknown completion status|0|||
163988503|NCT01262976|592326113|FG001|Up to Year 2|Subjects with unknown completion status|0|||
163988504|NCT01262976|592326114|FG002|Up to Year 2|Subjects with unknown completion status|1|||
163988505|NCT01262976|592326115|FG003|Up to Year 2|Subjects with unknown completion status|0|||
163988506|NCT01262976|592326116|FG004|Up to Year 2|Subjects with unknown completion status|0|||
163988507|NCT01262976|592326117|FG005|Up to Year 2|Subjects with unknown completion status|0|||
163988508|NCT01262976|592326112|FG000|Up to Year 2|Other|3|||
163988509|NCT01262976|592326113|FG001|Up to Year 2|Other|0|||
163988510|NCT01262976|592326114|FG002|Up to Year 2|Other|0|||
163988511|NCT01262976|592326115|FG003|Up to Year 2|Other|0|||
163988512|NCT01262976|592326116|FG004|Up to Year 2|Other|0|||
164235593|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
164235594|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
164235595|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
164235596|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
164235597|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
164235598|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
164235599|NCT04532749|593233543|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
164235600|NCT04532749|593233544|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
164235601|NCT04532749|593233543|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
164235602|NCT04532749|593233544|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
164235603|NCT04532749|593233543|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
164235604|NCT04532749|593233544|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
164235605|NCT04532749|593233543|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
164235606|NCT04532749|593233544|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
164235607|NCT00529633|593235449|FG000|Overall Study|Withdrawal by Subject|1|||
164235608|NCT00529633|593235450|FG001|Overall Study|Withdrawal by Subject|1|||
164235609|NCT01897493|593235452|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
164235610|NCT03235050|593235455|FG000|Overall Study|Adverse Event|0|||
164235611|NCT03235050|593235456|FG001|Overall Study|Adverse Event|0|||
164235612|NCT03235050|593235457|FG002|Overall Study|Adverse Event|1|||
164235613|NCT03235050|593235458|FG003|Overall Study|Adverse Event|4|||
164235614|NCT03235050|593235459|FG004|Overall Study|Adverse Event|1|||
164235615|NCT03235050|593235455|FG000|Overall Study|Death|0|||
164235616|NCT03235050|593235456|FG001|Overall Study|Death|0|||
164235617|NCT03235050|593235457|FG002|Overall Study|Death|0|||
164235618|NCT03235050|593235458|FG003|Overall Study|Death|2|||
164235619|NCT03235050|593235459|FG004|Overall Study|Death|1|||
164235620|NCT03235050|593235455|FG000|Overall Study|Lost to Follow-up|1|||
164235621|NCT03235050|593235456|FG001|Overall Study|Lost to Follow-up|2|||
164235622|NCT03235050|593235457|FG002|Overall Study|Lost to Follow-up|1|||
164235623|NCT03235050|593235458|FG003|Overall Study|Lost to Follow-up|2|||
164235624|NCT03235050|593235459|FG004|Overall Study|Lost to Follow-up|0|||
164235625|NCT03235050|593235455|FG000|Overall Study|Withdrawal by Subject|3|||
164235626|NCT03235050|593235456|FG001|Overall Study|Withdrawal by Subject|2|||
164235627|NCT03235050|593235457|FG002|Overall Study|Withdrawal by Subject|2|||
164235628|NCT03235050|593235458|FG003|Overall Study|Withdrawal by Subject|5|||
164235629|NCT03235050|593235459|FG004|Overall Study|Withdrawal by Subject|7|||
164235630|NCT03235050|593235455|FG000|Overall Study|Other reasons|0|||
164235631|NCT03235050|593235456|FG001|Overall Study|Other reasons|1|||
164235632|NCT03235050|593235457|FG002|Overall Study|Other reasons|0|||
164235633|NCT03235050|593235458|FG003|Overall Study|Other reasons|1|||
164235634|NCT03235050|593235459|FG004|Overall Study|Other reasons|2|||
164235635|NCT00370292|593235460|FG000|Overall Study|Disease Progression|4|||
164235636|NCT00370292|593235460|FG000|Overall Study|Adverse Event|7|||
164235637|NCT00370292|593235460|FG000|Overall Study|Physician Decision|2|||
164235638|NCT02704208|593235461|FG000|Overall Study|Lost to Follow-up|42|||
164235639|NCT02704208|593235462|FG001|Overall Study|Lost to Follow-up|37|||
164235640|NCT03545672|593235463|FG000|Overall Study|Uncertain diagnosis|2|||
164235641|NCT03545672|593235464|FG001|Overall Study|Uncertain diagnosis|1|||
164235642|NCT03545672|593235463|FG000|Overall Study|Protocol Violation|2|||
164235643|NCT03545672|593235464|FG001|Overall Study|Protocol Violation|2|||
164235644|NCT02935192|593235465|FG000|Overall Study|Withdrawal by Subject|8|||
164235645|NCT02935192|593235466|FG001|Overall Study|Withdrawal by Subject|4|||
164235646|NCT00492557|593235468|FG000|Overall Study|Subject request|12|||
164235647|NCT00492557|593235469|FG001|Overall Study|Subject request|11|||
163988513|NCT01262976|592326117|FG005|Up to Year 2|Other|0|||
164235648|NCT00492557|593235468|FG000|Overall Study|Protocol Violation|7|||
164235649|NCT00492557|593235469|FG001|Overall Study|Protocol Violation|8|||
164235650|NCT00492557|593235468|FG000|Overall Study|Other|2|||
164235651|NCT00492557|593235469|FG001|Overall Study|Other|2|||
164235652|NCT00492557|593235468|FG000|Overall Study|Death|1|||
163988514|NCT01262976|592326112|FG000|Up to Year 3|Serious Adverse Event|0|||
164235653|NCT00492557|593235469|FG001|Overall Study|Death|1|||
164235654|NCT00492557|593235468|FG000|Overall Study|Adverse Event|1|||
164235655|NCT00492557|593235469|FG001|Overall Study|Adverse Event|0|||
164235656|NCT00492557|593235468|FG000|Overall Study|Failed to return|1|||
164235657|NCT00492557|593235469|FG001|Overall Study|Failed to return|0|||
164235658|NCT00492557|593235468|FG000|Overall Study|Lost to Follow-up|0|||
164235659|NCT00492557|593235469|FG001|Overall Study|Lost to Follow-up|1|||
164235660|NCT03423121|593235473|FG000|Overall Study|Lost to Follow-up|2|||
164235661|NCT03423121|593235474|FG001|Overall Study|Lost to Follow-up|6|||
164235662|NCT03423121|593235473|FG000|Overall Study|Adverse Event|1|||
164235663|NCT03423121|593235474|FG001|Overall Study|Adverse Event|0|||
164235664|NCT04102007|593235479|FG000|Overall Study|Adverse Event|4|||
164235665|NCT04102007|593235479|FG000|Overall Study|Lost to Follow-up|3|||
164235666|NCT04102007|593235479|FG000|Overall Study|Withdrawal by Subject|12|||
164235667|NCT04102007|593235479|FG000|Overall Study|Eligibility Violation|5|||
164235668|NCT04102007|593235479|FG000|Overall Study|Lack of Efficacy|6|||
164235669|NCT04102007|593235479|FG000|Overall Study|Protocol Deviation|5|||
164235670|NCT04102007|593235479|FG000|Overall Study|Protocol Compliance|1|||
164235671|NCT04102007|593235479|FG000|Overall Study|Withdrew Treatment|2|||
164235672|NCT04102007|593235479|FG000|Overall Study|Pregnancy|1|||
164235673|NCT05173974|593235480|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
164235674|NCT05173974|593235481|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
164235675|NCT05173974|593235482|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
164235676|NCT05173974|593235483|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
164235677|NCT05173974|593235480|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
164235678|NCT05173974|593235481|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
164235679|NCT05173974|593235482|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
164235680|NCT05173974|593235483|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
164235681|NCT03289143|593235484|FG000|Overall Study|Caregiver Unavailability|1|||
164235682|NCT03289143|593235485|FG001|Overall Study|Caregiver Unavailability|1|||
164235683|NCT03289143|593235486|FG002|Overall Study|Caregiver Unavailability|0|||
164235684|NCT03289143|593235487|FG003|Overall Study|Caregiver Unavailability|0|||
164235685|NCT03289143|593235484|FG000|Overall Study|Research Department Closure|0|||
164235686|NCT03289143|593235485|FG001|Overall Study|Research Department Closure|0|||
164235687|NCT03289143|593235486|FG002|Overall Study|Research Department Closure|1|||
164235688|NCT03289143|593235487|FG003|Overall Study|Research Department Closure|0|||
164235689|NCT03289143|593235484|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
164235690|NCT03289143|593235485|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
164235691|NCT03289143|593235486|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
164235692|NCT03289143|593235487|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
164235693|NCT03289143|593235484|FG000|Overall Study|Medical Monitor Decision|1|||
164235694|NCT03289143|593235485|FG001|Overall Study|Medical Monitor Decision|0|||
164235695|NCT03289143|593235486|FG002|Overall Study|Medical Monitor Decision|0|||
164235696|NCT03289143|593235487|FG003|Overall Study|Medical Monitor Decision|0|||
164235697|NCT03289143|593235484|FG000|Overall Study|Participant Non-Compliance|0|||
164235698|NCT03289143|593235485|FG001|Overall Study|Participant Non-Compliance|0|||
164235699|NCT03289143|593235486|FG002|Overall Study|Participant Non-Compliance|1|||
164235700|NCT03289143|593235487|FG003|Overall Study|Participant Non-Compliance|0|||
164235701|NCT03289143|593235484|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
164235702|NCT03289143|593235485|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
164235703|NCT03289143|593235486|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
164235704|NCT03289143|593235487|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
164235705|NCT03289143|593235484|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
164235706|NCT03289143|593235485|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
164235707|NCT03289143|593235486|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
164235708|NCT03289143|593235487|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
164235709|NCT03289143|593235484|FG000|Overall Study|Caregiver Passed Away|1|||
164235710|NCT03289143|593235485|FG001|Overall Study|Caregiver Passed Away|0|||
164235711|NCT03289143|593235486|FG002|Overall Study|Caregiver Passed Away|0|||
164235712|NCT03289143|593235487|FG003|Overall Study|Caregiver Passed Away|0|||
164235713|NCT03289143|593235484|FG000|Overall Study|Physician Decision|0|||
164235714|NCT03289143|593235485|FG001|Overall Study|Physician Decision|2|||
163988515|NCT01262976|592326113|FG001|Up to Year 3|Serious Adverse Event|0|||
163988516|NCT01262976|592326114|FG002|Up to Year 3|Serious Adverse Event|2|||
163988517|NCT01262976|592326115|FG003|Up to Year 3|Serious Adverse Event|0|||
163988518|NCT01262976|592326116|FG004|Up to Year 3|Serious Adverse Event|0|||
163988519|NCT01262976|592326117|FG005|Up to Year 3|Serious Adverse Event|0|||
163988520|NCT01262976|592326112|FG000|Up to Year 3|Withdrawal by Subject|1|||
163988521|NCT01262976|592326113|FG001|Up to Year 3|Withdrawal by Subject|0|||
163988522|NCT01262976|592326114|FG002|Up to Year 3|Withdrawal by Subject|0|||
163988523|NCT01262976|592326115|FG003|Up to Year 3|Withdrawal by Subject|0|||
163988524|NCT01262976|592326116|FG004|Up to Year 3|Withdrawal by Subject|0|||
163988525|NCT01262976|592326117|FG005|Up to Year 3|Withdrawal by Subject|0|||
163988526|NCT01262976|592326112|FG000|Up to Year 3|Migrated/moved from study area|0|||
163988527|NCT01262976|592326113|FG001|Up to Year 3|Migrated/moved from study area|0|||
163988528|NCT01262976|592326114|FG002|Up to Year 3|Migrated/moved from study area|0|||
163988529|NCT01262976|592326115|FG003|Up to Year 3|Migrated/moved from study area|2|||
164235715|NCT03289143|593235486|FG002|Overall Study|Physician Decision|2|||
164235716|NCT03289143|593235487|FG003|Overall Study|Physician Decision|2|||
163884148|NCT02100813|591945886|FG000|Overall Study|Adverse Event|0|||
163884149|NCT02100813|591945887|FG001|Overall Study|Adverse Event|0|||
163884150|NCT02100813|591945888|FG002|Overall Study|Adverse Event|0|||
163884151|NCT02100813|591945889|FG003|Overall Study|Adverse Event|0|||
163884152|NCT02100813|591945890|FG004|Overall Study|Adverse Event|0|||
163884153|NCT02100813|591945891|FG005|Overall Study|Adverse Event|0|||
163884154|NCT02100813|591945892|FG006|Overall Study|Adverse Event|0|||
163884155|NCT02100813|591945893|FG007|Overall Study|Adverse Event|1|||
163884156|NCT03575897|591945895|FG000|Overall Study|Lost to Follow-up|12|||
163884157|NCT03575897|591945896|FG001|Overall Study|Lost to Follow-up|13|||
163884158|NCT03150810|591945902|FG000|Overall Study|Death|4|||
163884159|NCT03150810|591945903|FG001|Overall Study|Death|8|||
163884160|NCT03150810|591945904|FG002|Overall Study|Death|7|||
163884161|NCT03150810|591945905|FG003|Overall Study|Death|2|||
163884162|NCT03150810|591945906|FG004|Overall Study|Death|2|||
163884163|NCT03150810|591945907|FG005|Overall Study|Death|10|||
163884164|NCT03150810|591945908|FG006|Overall Study|Death|8|||
163884165|NCT03150810|591945909|FG007|Overall Study|Death|6|||
163884166|NCT03150810|591945910|FG008|Overall Study|Death|18|||
163884167|NCT03150810|591945911|FG009|Overall Study|Death|3|||
163884168|NCT03150810|591945912|FG010|Overall Study|Death|19|||
163884169|NCT03150810|591945913|FG011|Overall Study|Death|1|||
163884170|NCT03150810|591945914|FG012|Overall Study|Death|19|||
163884171|NCT03150810|591945902|FG000|Overall Study|Withdrawal by Subject|0|||
163884172|NCT03150810|591945903|FG001|Overall Study|Withdrawal by Subject|1|||
163884173|NCT03150810|591945904|FG002|Overall Study|Withdrawal by Subject|1|||
163884174|NCT03150810|591945905|FG003|Overall Study|Withdrawal by Subject|1|||
163884175|NCT03150810|591945906|FG004|Overall Study|Withdrawal by Subject|0|||
163884176|NCT03150810|591945907|FG005|Overall Study|Withdrawal by Subject|0|||
163884177|NCT03150810|591945908|FG006|Overall Study|Withdrawal by Subject|2|||
163884178|NCT03150810|591945909|FG007|Overall Study|Withdrawal by Subject|0|||
163884179|NCT03150810|591945910|FG008|Overall Study|Withdrawal by Subject|2|||
163884180|NCT03150810|591945911|FG009|Overall Study|Withdrawal by Subject|0|||
163884181|NCT03150810|591945912|FG010|Overall Study|Withdrawal by Subject|1|||
163884182|NCT03150810|591945913|FG011|Overall Study|Withdrawal by Subject|0|||
163884183|NCT03150810|591945914|FG012|Overall Study|Withdrawal by Subject|1|||
163884184|NCT03150810|591945902|FG000|Overall Study|Sponsor Decision|0|||
163884185|NCT03150810|591945903|FG001|Overall Study|Sponsor Decision|2|||
163884186|NCT03150810|591945904|FG002|Overall Study|Sponsor Decision|0|||
163884187|NCT03150810|591945905|FG003|Overall Study|Sponsor Decision|0|||
163884188|NCT03150810|591945906|FG004|Overall Study|Sponsor Decision|1|||
163884189|NCT03150810|591945907|FG005|Overall Study|Sponsor Decision|1|||
163884190|NCT03150810|591945908|FG006|Overall Study|Sponsor Decision|0|||
163884191|NCT03150810|591945909|FG007|Overall Study|Sponsor Decision|0|||
163884192|NCT03150810|591945910|FG008|Overall Study|Sponsor Decision|1|||
163884193|NCT03150810|591945911|FG009|Overall Study|Sponsor Decision|0|||
163884194|NCT03150810|591945912|FG010|Overall Study|Sponsor Decision|0|||
163884195|NCT03150810|591945913|FG011|Overall Study|Sponsor Decision|0|||
163884196|NCT03150810|591945914|FG012|Overall Study|Sponsor Decision|5|||
163884197|NCT03150810|591945902|FG000|Overall Study|Lost to Follow-up|0|||
163884198|NCT03150810|591945903|FG001|Overall Study|Lost to Follow-up|1|||
163884199|NCT03150810|591945904|FG002|Overall Study|Lost to Follow-up|1|||
163884200|NCT03150810|591945905|FG003|Overall Study|Lost to Follow-up|0|||
163884201|NCT03150810|591945906|FG004|Overall Study|Lost to Follow-up|0|||
163884202|NCT03150810|591945907|FG005|Overall Study|Lost to Follow-up|0|||
163884203|NCT03150810|591945908|FG006|Overall Study|Lost to Follow-up|1|||
163884204|NCT03150810|591945909|FG007|Overall Study|Lost to Follow-up|0|||
163884205|NCT03150810|591945910|FG008|Overall Study|Lost to Follow-up|0|||
163884206|NCT03150810|591945911|FG009|Overall Study|Lost to Follow-up|0|||
163884207|NCT03150810|591945912|FG010|Overall Study|Lost to Follow-up|1|||
163884208|NCT03150810|591945913|FG011|Overall Study|Lost to Follow-up|0|||
163884209|NCT03150810|591945914|FG012|Overall Study|Lost to Follow-up|0|||
163884210|NCT03150810|591945902|FG000|Overall Study|Physician Decision|0|||
163884211|NCT03150810|591945903|FG001|Overall Study|Physician Decision|0|||
163884212|NCT03150810|591945904|FG002|Overall Study|Physician Decision|0|||
163884213|NCT03150810|591945905|FG003|Overall Study|Physician Decision|0|||
163884214|NCT03150810|591945906|FG004|Overall Study|Physician Decision|0|||
163884215|NCT03150810|591945907|FG005|Overall Study|Physician Decision|1|||
163884216|NCT03150810|591945908|FG006|Overall Study|Physician Decision|1|||
163884217|NCT03150810|591945909|FG007|Overall Study|Physician Decision|0|||
163884218|NCT03150810|591945910|FG008|Overall Study|Physician Decision|0|||
163884219|NCT03150810|591945911|FG009|Overall Study|Physician Decision|0|||
163884220|NCT03150810|591945912|FG010|Overall Study|Physician Decision|0|||
163884221|NCT03150810|591945913|FG011|Overall Study|Physician Decision|0|||
163884222|NCT03150810|591945914|FG012|Overall Study|Physician Decision|0|||
163884223|NCT03150810|591945902|FG000|Overall Study|Site withdrawal from study|0|||
163884224|NCT03150810|591945903|FG001|Overall Study|Site withdrawal from study|1|||
163884225|NCT03150810|591945904|FG002|Overall Study|Site withdrawal from study|0|||
163884226|NCT03150810|591945905|FG003|Overall Study|Site withdrawal from study|0|||
164235717|NCT03289143|593235484|FG000|Overall Study|Protocol Deviation|2|||
164235718|NCT03289143|593235485|FG001|Overall Study|Protocol Deviation|1|||
164235719|NCT03289143|593235486|FG002|Overall Study|Protocol Deviation|3|||
164235720|NCT03289143|593235487|FG003|Overall Study|Protocol Deviation|1|||
164235721|NCT03289143|593235484|FG000|Overall Study|Study Terminated By Sponsor|101|||
164235722|NCT03289143|593235485|FG001|Overall Study|Study Terminated By Sponsor|75|||
164235723|NCT03289143|593235486|FG002|Overall Study|Study Terminated By Sponsor|100|||
164235724|NCT03289143|593235487|FG003|Overall Study|Study Terminated By Sponsor|69|||
164235725|NCT03289143|593235484|FG000|Overall Study|Withdrawal by Subject|14|||
164235726|NCT03289143|593235485|FG001|Overall Study|Withdrawal by Subject|6|||
164235727|NCT03289143|593235486|FG002|Overall Study|Withdrawal by Subject|14|||
164235728|NCT03289143|593235487|FG003|Overall Study|Withdrawal by Subject|12|||
164235729|NCT03289143|593235484|FG000|Overall Study|Adverse Event|10|||
164235730|NCT03289143|593235485|FG001|Overall Study|Adverse Event|7|||
164235731|NCT03289143|593235486|FG002|Overall Study|Adverse Event|6|||
164235732|NCT03289143|593235487|FG003|Overall Study|Adverse Event|5|||
164235733|NCT03289143|593235484|FG000|Overall Study|Death|2|||
164235734|NCT03289143|593235485|FG001|Overall Study|Death|0|||
164235735|NCT03289143|593235486|FG002|Overall Study|Death|2|||
164235736|NCT03289143|593235487|FG003|Overall Study|Death|1|||
164235737|NCT03289143|593235484|FG000|Overall Study|Lost to Follow-up|2|||
164235738|NCT03289143|593235485|FG001|Overall Study|Lost to Follow-up|1|||
164235739|NCT03289143|593235486|FG002|Overall Study|Lost to Follow-up|1|||
164235740|NCT03289143|593235487|FG003|Overall Study|Lost to Follow-up|0|||
164235741|NCT03289143|593235484|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
164235742|NCT03289143|593235485|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
164235743|NCT03289143|593235486|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
164235744|NCT03289143|593235487|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
164235745|NCT03289143|593235484|FG000|Overall Study|Withdrawal by Caregiver|0|||
164235746|NCT03289143|593235485|FG001|Overall Study|Withdrawal by Caregiver|1|||
164235747|NCT03289143|593235486|FG002|Overall Study|Withdrawal by Caregiver|0|||
164235748|NCT03289143|593235487|FG003|Overall Study|Withdrawal by Caregiver|0|||
164235749|NCT03289143|593235484|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
164235750|NCT03289143|593235485|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
163884227|NCT03150810|591945906|FG004|Overall Study|Site withdrawal from study|0|||
163884228|NCT03150810|591945907|FG005|Overall Study|Site withdrawal from study|0|||
163884229|NCT03150810|591945908|FG006|Overall Study|Site withdrawal from study|0|||
163884230|NCT03150810|591945909|FG007|Overall Study|Site withdrawal from study|0|||
163884231|NCT03150810|591945910|FG008|Overall Study|Site withdrawal from study|0|||
163884232|NCT03150810|591945911|FG009|Overall Study|Site withdrawal from study|1|||
163884233|NCT03150810|591945912|FG010|Overall Study|Site withdrawal from study|1|||
163884234|NCT03150810|591945913|FG011|Overall Study|Site withdrawal from study|0|||
163884235|NCT03150810|591945914|FG012|Overall Study|Site withdrawal from study|0|||
163884236|NCT03150810|591945902|FG000|Overall Study|Hospice|0|||
163884237|NCT03150810|591945903|FG001|Overall Study|Hospice|0|||
163884238|NCT03150810|591945904|FG002|Overall Study|Hospice|0|||
163884239|NCT03150810|591945905|FG003|Overall Study|Hospice|0|||
163884240|NCT03150810|591945906|FG004|Overall Study|Hospice|0|||
163884241|NCT03150810|591945907|FG005|Overall Study|Hospice|1|||
163884242|NCT03150810|591945908|FG006|Overall Study|Hospice|0|||
163884243|NCT03150810|591945909|FG007|Overall Study|Hospice|0|||
163884244|NCT03150810|591945910|FG008|Overall Study|Hospice|0|||
163884245|NCT03150810|591945911|FG009|Overall Study|Hospice|0|||
163884246|NCT03150810|591945912|FG010|Overall Study|Hospice|0|||
163884247|NCT03150810|591945913|FG011|Overall Study|Hospice|0|||
163884248|NCT03150810|591945914|FG012|Overall Study|Hospice|0|||
163988530|NCT01262976|592326116|FG004|Up to Year 3|Migrated/moved from study area|1|||
164235751|NCT03289143|593235486|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
163884249|NCT03150810|591945902|FG000|Overall Study|Participant relocated abroad.|0|||
163988531|NCT01262976|592326117|FG005|Up to Year 3|Migrated/moved from study area|1|||
164235752|NCT03289143|593235487|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
164235753|NCT03289143|593235484|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
163884250|NCT03150810|591945903|FG001|Overall Study|Participant relocated abroad.|0|||
163884251|NCT03150810|591945904|FG002|Overall Study|Participant relocated abroad.|0|||
163884252|NCT03150810|591945905|FG003|Overall Study|Participant relocated abroad.|0|||
164235754|NCT03289143|593235485|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
164299852|NCT02234843|593472953|FG009|Overall Study|Protocol Violation|0|||
164299853|NCT02234843|593472944|FG000|Overall Study|Efficacy outcome reached|2|||
164299854|NCT02234843|593472945|FG001|Overall Study|Efficacy outcome reached|0|||
164299855|NCT02234843|593472946|FG002|Overall Study|Efficacy outcome reached|0|||
164299856|NCT02234843|593472947|FG003|Overall Study|Efficacy outcome reached|0|||
164299857|NCT02234843|593472948|FG004|Overall Study|Efficacy outcome reached|0|||
164299858|NCT02234843|593472949|FG005|Overall Study|Efficacy outcome reached|2|||
164299859|NCT02234843|593472950|FG006|Overall Study|Efficacy outcome reached|0|||
164299860|NCT02234843|593472951|FG007|Overall Study|Efficacy outcome reached|0|||
164299861|NCT02234843|593472952|FG008|Overall Study|Efficacy outcome reached|0|||
164235755|NCT03289143|593235486|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
164235756|NCT03289143|593235487|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
164235757|NCT00948688|593235488|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
164235758|NCT00948688|593235489|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
164235759|NCT00948688|593235488|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
164235760|NCT00948688|593235489|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
164235761|NCT00948688|593235488|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
164235762|NCT00948688|593235489|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
164235763|NCT04047446|593235490|FG000|Overall Study|Physician Decision|1|||
164235764|NCT04047446|593235491|FG001|Overall Study|Physician Decision|0|||
164235765|NCT00329420|593235492|FG000|Re-induction Phase|Lack of Efficacy|0|||
164235766|NCT00329420|593235493|FG001|Re-induction Phase|Lack of Efficacy|1|||
164235767|NCT00329420|593235494|FG002|Re-induction Phase|Lack of Efficacy|0|||
164235768|NCT00329420|593235492|FG000|Re-induction Phase|Withdrawal of Consent|0|||
164235769|NCT00329420|593235493|FG001|Re-induction Phase|Withdrawal of Consent|0|||
164235770|NCT00329420|593235494|FG002|Re-induction Phase|Withdrawal of Consent|1|||
164235771|NCT00329420|593235492|FG000|Re-induction Phase|Did not respond to re-induction|6|||
164235772|NCT00329420|593235493|FG001|Re-induction Phase|Did not respond to re-induction|5|||
164235773|NCT00329420|593235494|FG002|Re-induction Phase|Did not respond to re-induction|7|||
164235774|NCT00329420|593235492|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
164235775|NCT00329420|593235493|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
164235776|NCT00329420|593235494|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
164235777|NCT00329420|593235492|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
164235778|NCT00329420|593235493|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
164235779|NCT00329420|593235494|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
164235780|NCT00329420|593235492|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
164235781|NCT00329420|593235493|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
164235782|NCT00329420|593235494|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
164235783|NCT02660229|593235496|FG000|Overall Study|Adverse Event|2|||
164235784|NCT02660229|593235497|FG001|Overall Study|Adverse Event|0|||
164235785|NCT02660229|593235496|FG000|Overall Study|Withdrawal by Subject|0|||
164235786|NCT02660229|593235497|FG001|Overall Study|Withdrawal by Subject|1|||
164235787|NCT02727322|593235501|FG000|Overall Study|Withdrawal by Subject|1|||
164235788|NCT02727322|593235502|FG001|Overall Study|Withdrawal by Subject|1|||
164235789|NCT02727322|593235501|FG000|Overall Study|Protocol Violation|1|||
164235790|NCT02727322|593235502|FG001|Overall Study|Protocol Violation|0|||
164235791|NCT00329030|593235508|FG000|Overall Study|Withdrawal by Subject|1|||
164235792|NCT00329030|593235509|FG001|Overall Study|Withdrawal by Subject|3|||
164235793|NCT00329030|593235508|FG000|Overall Study|Progressive Disease|6|||
164235794|NCT00329030|593235509|FG001|Overall Study|Progressive Disease|2|||
164235795|NCT00329030|593235508|FG000|Overall Study|Ineligible Pathology|1|||
164235796|NCT00329030|593235509|FG001|Overall Study|Ineligible Pathology|1|||
164235797|NCT00560417|593235510|FG000|Overall Study|Adverse Event|3|||
164235798|NCT00560417|593235511|FG001|Overall Study|Adverse Event|2|||
164235799|NCT00560417|593235510|FG000|Overall Study|Entry Criteria Not Met|1|||
164235800|NCT00560417|593235511|FG001|Overall Study|Entry Criteria Not Met|0|||
164235801|NCT00560417|593235510|FG000|Overall Study|Lost to Follow-up|0|||
164235802|NCT00560417|593235511|FG001|Overall Study|Lost to Follow-up|1|||
164235803|NCT00560417|593235510|FG000|Overall Study|Physician Decision|2|||
164235804|NCT00560417|593235511|FG001|Overall Study|Physician Decision|6|||
164235805|NCT00560417|593235510|FG000|Overall Study|Protocol Violation|6|||
164235806|NCT00560417|593235511|FG001|Overall Study|Protocol Violation|5|||
164235807|NCT00560417|593235510|FG000|Overall Study|Sponsor Decision|2|||
164235808|NCT00560417|593235511|FG001|Overall Study|Sponsor Decision|0|||
164235809|NCT00560417|593235510|FG000|Overall Study|Withdrawal by Subject|3|||
164235810|NCT00560417|593235511|FG001|Overall Study|Withdrawal by Subject|3|||
164235811|NCT00320606|593235512|FG000|Overall Study|Adverse Event|1|||
164235812|NCT00320606|593235512|FG000|Overall Study|Protocol Violation|1|||
164235813|NCT00320606|593235512|FG000|Overall Study|Withdrawal by Subject|1|||
164235814|NCT01948427|593235515|FG000|Overall Study|Serious Adverse Event|3|||
164235815|NCT01948427|593235516|FG001|Overall Study|Serious Adverse Event|0|||
164235816|NCT01948427|593235517|FG002|Overall Study|Serious Adverse Event|0|||
163988532|NCT01262976|592326112|FG000|Up to Year 3|Lost to Follow-up|2|||
164235817|NCT01948427|593235518|FG003|Overall Study|Serious Adverse Event|0|||
164235818|NCT01948427|593235519|FG004|Overall Study|Serious Adverse Event|1|||
164235819|NCT01948427|593235515|FG000|Overall Study|Investigator Request|0|||
164235820|NCT01948427|593235516|FG001|Overall Study|Investigator Request|8|||
164235821|NCT01948427|593235517|FG002|Overall Study|Investigator Request|0|||
164235822|NCT01948427|593235518|FG003|Overall Study|Investigator Request|0|||
164235823|NCT01948427|593235519|FG004|Overall Study|Investigator Request|6|||
164235824|NCT01948427|593235515|FG000|Overall Study|Lost to Follow-up|1|||
164235825|NCT01948427|593235516|FG001|Overall Study|Lost to Follow-up|0|||
163988533|NCT01262976|592326113|FG001|Up to Year 3|Lost to Follow-up|2|||
164235826|NCT01948427|593235517|FG002|Overall Study|Lost to Follow-up|0|||
164235827|NCT01948427|593235518|FG003|Overall Study|Lost to Follow-up|0|||
164235828|NCT01948427|593235519|FG004|Overall Study|Lost to Follow-up|4|||
164235829|NCT01948427|593235515|FG000|Overall Study|Withdrawal by Subject|2|||
164235830|NCT01948427|593235516|FG001|Overall Study|Withdrawal by Subject|0|||
164235831|NCT01948427|593235517|FG002|Overall Study|Withdrawal by Subject|0|||
164235832|NCT01948427|593235518|FG003|Overall Study|Withdrawal by Subject|0|||
164235833|NCT01948427|593235519|FG004|Overall Study|Withdrawal by Subject|1|||
164235834|NCT01948427|593235515|FG000|Overall Study|Other, Not Specified|1|||
164235835|NCT01948427|593235516|FG001|Overall Study|Other, Not Specified|9|||
164235836|NCT01948427|593235517|FG002|Overall Study|Other, Not Specified|0|||
164235837|NCT01948427|593235518|FG003|Overall Study|Other, Not Specified|0|||
164235838|NCT01948427|593235519|FG004|Overall Study|Other, Not Specified|2|||
164235839|NCT00256126|593235520|FG000|Overall Study|Adverse Event|1|||
164235840|NCT00256126|593235521|FG001|Overall Study|Adverse Event|0|||
164235841|NCT00256126|593235520|FG000|Overall Study|Other|1|||
164235842|NCT00256126|593235521|FG001|Overall Study|Other|2|||
164235843|NCT02434081|593235522|FG000|Overall Study|Death (never started treatment)|2|||
164235844|NCT02434081|593235522|FG000|Overall Study|Death|2|||
164235845|NCT02434081|593235522|FG000|Overall Study|Progression|20|||
164235846|NCT02434081|593235522|FG000|Overall Study|Adverse Event|20|||
164235847|NCT02434081|593235522|FG000|Overall Study|Physician Decision|2|||
164235848|NCT02434081|593235522|FG000|Overall Study|Withdrawal by Subject|1|||
164235849|NCT02434081|593235522|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
164235850|NCT00854360|593235529|FG000|Overall Study|Adverse Event|0|||
164235851|NCT00854360|593235530|FG001|Overall Study|Adverse Event|1|||
164235852|NCT00854360|593235531|FG002|Overall Study|Adverse Event|2|||
164235853|NCT00854360|593235532|FG003|Overall Study|Adverse Event|6|||
164235854|NCT00854360|593235529|FG000|Overall Study|Withdrawal by Subject|0|||
164235855|NCT00854360|593235530|FG001|Overall Study|Withdrawal by Subject|0|||
164235856|NCT00854360|593235531|FG002|Overall Study|Withdrawal by Subject|0|||
164333879|NCT03387683|593599673|FG001|Overall Study|Did not receive treatment|0|||
164333880|NCT00566501|593599676|FG000|Overall Study|Adverse Event|68|||
164333881|NCT00566501|593599677|FG001|Overall Study|Adverse Event|59|||
164333882|NCT00566501|593599676|FG000|Overall Study|Medication Non-compliance|5|||
164333883|NCT00566501|593599677|FG001|Overall Study|Medication Non-compliance|0|||
164333884|NCT00566501|593599676|FG000|Overall Study|Protocol Violation|2|||
164333885|NCT00566501|593599677|FG001|Overall Study|Protocol Violation|2|||
164333886|NCT00566501|593599676|FG000|Overall Study|Request of Investigator or Sponsor|6|||
164333887|NCT00566501|593599677|FG001|Overall Study|Request of Investigator or Sponsor|7|||
164333888|NCT00566501|593599676|FG000|Overall Study|Withdrawal by Subject|33|||
164333889|NCT00566501|593599677|FG001|Overall Study|Withdrawal by Subject|30|||
164333890|NCT00566501|593599676|FG000|Overall Study|Lack of Efficacy|8|||
164333891|NCT00566501|593599677|FG001|Overall Study|Lack of Efficacy|3|||
164333892|NCT00566501|593599676|FG000|Overall Study|Other|25|||
164333893|NCT00566501|593599677|FG001|Overall Study|Other|21|||
164333894|NCT05095454|593599678|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
164333895|NCT05095454|593599679|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
164333896|NCT00057876|593599680|FG000|Overall Study|Adverse Event|8|||
164333897|NCT00057876|593599681|FG001|Overall Study|Adverse Event|8|||
164333898|NCT00057876|593599680|FG000|Overall Study|Death|2|||
164333899|NCT00057876|593599681|FG001|Overall Study|Death|1|||
164333900|NCT00057876|593599680|FG000|Overall Study|Withdrawal by Subject|5|||
164333901|NCT00057876|593599681|FG001|Overall Study|Withdrawal by Subject|6|||
164333902|NCT00057876|593599680|FG000|Overall Study|Lack of Efficacy|10|||
164333903|NCT00057876|593599681|FG001|Overall Study|Lack of Efficacy|8|||
164333904|NCT00057876|593599680|FG000|Overall Study|Ineligible|1|||
164333905|NCT00057876|593599681|FG001|Overall Study|Ineligible|2|||
164333906|NCT00057876|593599680|FG000|Overall Study|other reason|2|||
163988534|NCT01262976|592326114|FG002|Up to Year 3|Lost to Follow-up|4|||
163988535|NCT01262976|592326115|FG003|Up to Year 3|Lost to Follow-up|3|||
163988536|NCT01262976|592326116|FG004|Up to Year 3|Lost to Follow-up|1|||
164235857|NCT00854360|593235532|FG003|Overall Study|Withdrawal by Subject|1|||
164235858|NCT00854360|593235529|FG000|Overall Study|Pregnancy|0|||
164333907|NCT00057876|593599681|FG001|Overall Study|other reason|2|||
164333908|NCT00057876|593599680|FG000|Overall Study|other complicating disease|1|||
164333909|NCT00057876|593599681|FG001|Overall Study|other complicating disease|0|||
164333910|NCT01368432|593599682|FG000|Overall Study|Lost to Follow-up|0|||
163988537|NCT01262976|592326117|FG005|Up to Year 3|Lost to Follow-up|3|||
163988538|NCT01262976|592326112|FG000|Up to Year 3|Subjects with unknown completion status|0|||
164235859|NCT00854360|593235530|FG001|Overall Study|Pregnancy|1|||
164235860|NCT00854360|593235531|FG002|Overall Study|Pregnancy|0|||
164235861|NCT00854360|593235532|FG003|Overall Study|Pregnancy|0|||
164235862|NCT00854360|593235529|FG000|Overall Study|Lack of Efficacy|2|||
164235863|NCT00854360|593235530|FG001|Overall Study|Lack of Efficacy|1|||
164235864|NCT00854360|593235531|FG002|Overall Study|Lack of Efficacy|0|||
164333911|NCT01368432|593599683|FG001|Overall Study|Lost to Follow-up|1|||
164235865|NCT00854360|593235532|FG003|Overall Study|Lack of Efficacy|0|||
163988539|NCT01262976|592326113|FG001|Up to Year 3|Subjects with unknown completion status|0|||
164235866|NCT00854360|593235529|FG000|Overall Study|Other|0|||
164235867|NCT00854360|593235530|FG001|Overall Study|Other|0|||
164235868|NCT00854360|593235531|FG002|Overall Study|Other|0|||
164235869|NCT00854360|593235532|FG003|Overall Study|Other|3|||
164235870|NCT02037529|593235533|FG000|Overall Study|Withdrawal by Subject|1|||
164235871|NCT02037529|593235534|FG001|Overall Study|Withdrawal by Subject|3|||
164235872|NCT02037529|593235533|FG000|Overall Study|Adverse Event|0|||
164235873|NCT02037529|593235534|FG001|Overall Study|Adverse Event|1|||
164235874|NCT00718315|593235535|FG000|Overall Study|Adverse Event|1|||
164235875|NCT00718315|593235536|FG001|Overall Study|Adverse Event|2|||
164235876|NCT00718315|593235537|FG002|Overall Study|Adverse Event|3|||
163988540|NCT01262976|592326114|FG002|Up to Year 3|Subjects with unknown completion status|1|||
163988541|NCT01262976|592326115|FG003|Up to Year 3|Subjects with unknown completion status|0|||
163988542|NCT01262976|592326116|FG004|Up to Year 3|Subjects with unknown completion status|0|||
163988543|NCT01262976|592326117|FG005|Up to Year 3|Subjects with unknown completion status|0|||
163988544|NCT01262976|592326112|FG000|Up to Year 3|Other|3|||
163988545|NCT01262976|592326113|FG001|Up to Year 3|Other|0|||
163988546|NCT01262976|592326114|FG002|Up to Year 3|Other|0|||
163988547|NCT01262976|592326115|FG003|Up to Year 3|Other|0|||
163988548|NCT01262976|592326116|FG004|Up to Year 3|Other|0|||
163988549|NCT01262976|592326117|FG005|Up to Year 3|Other|0|||
163988550|NCT03433781|592326118|FG000|Overall Study|Progression of Disease|1|||
163988551|NCT03433781|592326119|FG001|Overall Study|Progression of Disease|0|||
163988552|NCT03433781|592326120|FG002|Overall Study|Progression of Disease|0|||
163988553|NCT03433781|592326118|FG000|Overall Study|Physician Decision|0|||
163988554|NCT03433781|592326119|FG001|Overall Study|Physician Decision|1|||
163988555|NCT03433781|592326120|FG002|Overall Study|Physician Decision|0|||
164235877|NCT00718315|593235535|FG000|Overall Study|Death|6|||
164235878|NCT00718315|593235536|FG001|Overall Study|Death|6|||
164235879|NCT00718315|593235537|FG002|Overall Study|Death|5|||
164235880|NCT00718315|593235535|FG000|Overall Study|Lost to Follow-up|2|||
164235881|NCT00718315|593235536|FG001|Overall Study|Lost to Follow-up|3|||
163988556|NCT02809833|592326121|FG000|Overall Study|Death|3|||
163988557|NCT02809833|592326121|FG000|Overall Study|Intolerance|54|||
163988558|NCT02809833|592326121|FG000|Overall Study|Lack of Efficacy|89|||
163988559|NCT02809833|592326121|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
163988560|NCT02809833|592326121|FG000|Overall Study|Noncompliance|1|||
163988561|NCT02809833|592326121|FG000|Overall Study|Withdrawal by Subject|34|||
163988562|NCT02809833|592326121|FG000|Overall Study|Lost to Follow-up|35|||
163988563|NCT02809833|592326121|FG000|Overall Study|Adverse Event (AE)|24|||
163988564|NCT02809833|592326121|FG000|Overall Study|Other|5|||
163988565|NCT02809833|592326121|FG000|Overall Study|Missing Information|52|||
163988566|NCT02971670|592326125|FG000|Overall Study|Withdrawal by Subject|4|||
163988567|NCT02971670|592326126|FG001|Overall Study|Withdrawal by Subject|1|||
163988568|NCT02971670|592326127|FG002|Overall Study|Withdrawal by Subject|1|||
163988569|NCT02971670|592326128|FG003|Overall Study|Withdrawal by Subject|2|||
163988570|NCT00379795|592326129|FG000|Overall Study|Death|31|||
163988571|NCT00379795|592326130|FG001|Overall Study|Death|8|||
163988572|NCT00379795|592326131|FG002|Overall Study|Death|6|||
163988573|NCT00379795|592326132|FG003|Overall Study|Death|4|||
163988574|NCT00379795|592326133|FG004|Overall Study|Death|7|||
163988575|NCT00379795|592326129|FG000|Overall Study|Adverse Event|17|||
163988576|NCT00379795|592326130|FG001|Overall Study|Adverse Event|3|||
164235882|NCT00718315|593235537|FG002|Overall Study|Lost to Follow-up|4|||
164235883|NCT00718315|593235535|FG000|Overall Study|Protocol Violation|5|||
164333912|NCT02758171|593599684|FG000|Wash-out|Withdrawal by Subject|1|||
164333913|NCT02758171|593599685|FG001|Wash-out|Withdrawal by Subject|0|||
164333914|NCT02758171|593599684|FG000|Wash-out|Other reason|1|||
164333915|NCT02758171|593599685|FG001|Wash-out|Other reason|0|||
164333916|NCT00853073|593599686|FG000|Overall Study|Withdrawal by Subject|3|||
164333917|NCT00853073|593599687|FG001|Overall Study|Withdrawal by Subject|2|||
164333918|NCT01999114|593599688|FG000|Overall Study|Adverse Event|8|||
164333919|NCT01999114|593599689|FG001|Overall Study|Adverse Event|7|||
164333920|NCT01999114|593599690|FG002|Overall Study|Adverse Event|2|||
163988577|NCT00379795|592326131|FG002|Overall Study|Adverse Event|3|||
163988578|NCT00379795|592326132|FG003|Overall Study|Adverse Event|1|||
163988579|NCT00379795|592326133|FG004|Overall Study|Adverse Event|4|||
163988580|NCT00379795|592326129|FG000|Overall Study|Lost to Follow-up|8|||
163988581|NCT00379795|592326130|FG001|Overall Study|Lost to Follow-up|1|||
164235884|NCT00718315|593235536|FG001|Overall Study|Protocol Violation|5|||
164235885|NCT00718315|593235537|FG002|Overall Study|Protocol Violation|3|||
164235886|NCT00718315|593235535|FG000|Overall Study|Erlotinib dose decreased|4|||
164235887|NCT00718315|593235536|FG001|Overall Study|Erlotinib dose decreased|3|||
164235888|NCT00718315|593235537|FG002|Overall Study|Erlotinib dose decreased|1|||
164333921|NCT01999114|593599691|FG003|Overall Study|Adverse Event|2|||
164333922|NCT01999114|593599692|FG004|Overall Study|Adverse Event|1|||
163988582|NCT00379795|592326131|FG002|Overall Study|Lost to Follow-up|2|||
163988583|NCT00379795|592326132|FG003|Overall Study|Lost to Follow-up|1|||
163988584|NCT00379795|592326133|FG004|Overall Study|Lost to Follow-up|4|||
163988585|NCT00379795|592326129|FG000|Overall Study|Physician Decision|25|||
164333923|NCT01999114|593599688|FG000|Overall Study|Withdrawal by Subject|0|||
164235889|NCT00718315|593235535|FG000|Overall Study|Use of Minocyclin|1|||
164235890|NCT00718315|593235536|FG001|Overall Study|Use of Minocyclin|1|||
164235891|NCT00718315|593235537|FG002|Overall Study|Use of Minocyclin|1|||
164235892|NCT00718315|593235535|FG000|Overall Study|Disease progression|0|||
164235893|NCT00718315|593235536|FG001|Overall Study|Disease progression|1|||
164235894|NCT00718315|593235537|FG002|Overall Study|Disease progression|1|||
164235895|NCT00718315|593235535|FG000|Overall Study|Other|0|||
164235896|NCT00718315|593235536|FG001|Overall Study|Other|0|||
164235897|NCT00718315|593235537|FG002|Overall Study|Other|1|||
164235898|NCT00718315|593235535|FG000|Overall Study|Use of ATB and Corticoids|0|||
164235899|NCT00718315|593235536|FG001|Overall Study|Use of ATB and Corticoids|1|||
164235900|NCT00718315|593235537|FG002|Overall Study|Use of ATB and Corticoids|2|||
164235901|NCT00399529|593235539|FG000|Overall Study|Off Study Prior to Treatment|2|||
164235902|NCT03435380|593235540|FG000|Overall Study|Death|1|||
164235903|NCT03435380|593235541|FG001|Overall Study|Death|2|||
164235904|NCT03435380|593235542|FG002|Overall Study|Death|1|||
164235905|NCT03435380|593235540|FG000|Overall Study|Lost to Follow-up|12|||
164235906|NCT03435380|593235541|FG001|Overall Study|Lost to Follow-up|8|||
164235907|NCT03435380|593235542|FG002|Overall Study|Lost to Follow-up|6|||
164235908|NCT03435380|593235540|FG000|Overall Study|Physician Decision|1|||
164235909|NCT03435380|593235541|FG001|Overall Study|Physician Decision|0|||
164333924|NCT01999114|593599689|FG001|Overall Study|Withdrawal by Subject|0|||
164333925|NCT01999114|593599690|FG002|Overall Study|Withdrawal by Subject|1|||
164333926|NCT01999114|593599691|FG003|Overall Study|Withdrawal by Subject|0|||
164333927|NCT01999114|593599692|FG004|Overall Study|Withdrawal by Subject|1|||
164333928|NCT01999114|593599688|FG000|Overall Study|Lost to Follow-up|0|||
164333929|NCT01999114|593599689|FG001|Overall Study|Lost to Follow-up|0|||
163884253|NCT03150810|591945906|FG004|Overall Study|Participant relocated abroad.|0|||
163884254|NCT03150810|591945907|FG005|Overall Study|Participant relocated abroad.|1|||
163884255|NCT03150810|591945908|FG006|Overall Study|Participant relocated abroad.|0|||
163884256|NCT03150810|591945909|FG007|Overall Study|Participant relocated abroad.|0|||
163884257|NCT03150810|591945910|FG008|Overall Study|Participant relocated abroad.|0|||
163884258|NCT03150810|591945911|FG009|Overall Study|Participant relocated abroad.|0|||
163884259|NCT03150810|591945912|FG010|Overall Study|Participant relocated abroad.|0|||
163884260|NCT03150810|591945913|FG011|Overall Study|Participant relocated abroad.|0|||
163884261|NCT03150810|591945914|FG012|Overall Study|Participant relocated abroad.|0|||
163884262|NCT03150810|591945902|FG000|Overall Study|Transferred care to oncologist|0|||
163884263|NCT03150810|591945903|FG001|Overall Study|Transferred care to oncologist|0|||
163884264|NCT03150810|591945904|FG002|Overall Study|Transferred care to oncologist|0|||
163884265|NCT03150810|591945905|FG003|Overall Study|Transferred care to oncologist|0|||
163884266|NCT03150810|591945906|FG004|Overall Study|Transferred care to oncologist|0|||
163884267|NCT03150810|591945907|FG005|Overall Study|Transferred care to oncologist|0|||
163884268|NCT03150810|591945908|FG006|Overall Study|Transferred care to oncologist|2|||
163884269|NCT03150810|591945909|FG007|Overall Study|Transferred care to oncologist|0|||
163884270|NCT03150810|591945910|FG008|Overall Study|Transferred care to oncologist|0|||
163884271|NCT03150810|591945911|FG009|Overall Study|Transferred care to oncologist|0|||
163884272|NCT03150810|591945912|FG010|Overall Study|Transferred care to oncologist|0|||
163884273|NCT03150810|591945913|FG011|Overall Study|Transferred care to oncologist|0|||
163884274|NCT03150810|591945914|FG012|Overall Study|Transferred care to oncologist|0|||
163884275|NCT04526704|591945915|FG000|Overall Study|Adverse Event|1|||
163884276|NCT04526704|591945916|FG001|Overall Study|Adverse Event|0|||
163884277|NCT04526704|591945915|FG000|Overall Study|Physician Decision|1|||
163884278|NCT04526704|591945916|FG001|Overall Study|Physician Decision|0|||
163884279|NCT04526704|591945915|FG000|Overall Study|Withdrawal by Subject|2|||
163884280|NCT04526704|591945916|FG001|Overall Study|Withdrawal by Subject|0|||
163884281|NCT02737436|591945920|FG000|Washout Period|Lost to Follow-up|5|||
163884282|NCT02737436|591945921|FG001|Washout Period|Lost to Follow-up|11|||
163884283|NCT02737436|591945920|FG000|Data Analysis|Scanning data problems|5|||
163884284|NCT02737436|591945921|FG001|Data Analysis|Scanning data problems|8|||
163884285|NCT03936322|591945922|FG000|Overall Study|Lost to Follow-up|1|||
163884286|NCT03936322|591945922|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
163884287|NCT01160211|591945923|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
163884288|NCT01160211|591945924|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
163884289|NCT01160211|591945925|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
163884290|NCT01160211|591945923|FG000|Overall Study|Lost to Follow-up|4|||
164235910|NCT03435380|593235542|FG002|Overall Study|Physician Decision|0|||
164235911|NCT03435380|593235540|FG000|Overall Study|Withdrawal by Subject|0|||
163884291|NCT01160211|591945924|FG001|Overall Study|Lost to Follow-up|8|||
163884292|NCT01160211|591945925|FG002|Overall Study|Lost to Follow-up|4|||
163884293|NCT01160211|591945923|FG000|Overall Study|Physician Decision|1|||
163884294|NCT01160211|591945924|FG001|Overall Study|Physician Decision|0|||
164235912|NCT03435380|593235541|FG001|Overall Study|Withdrawal by Subject|1|||
164235913|NCT03435380|593235542|FG002|Overall Study|Withdrawal by Subject|1|||
164235914|NCT03435380|593235540|FG000|Overall Study|Ineligible|0|||
164235915|NCT03435380|593235541|FG001|Overall Study|Ineligible|1|||
164235916|NCT03435380|593235542|FG002|Overall Study|Ineligible|1|||
163988586|NCT00379795|592326130|FG001|Overall Study|Physician Decision|0|||
163988587|NCT00379795|592326131|FG002|Overall Study|Physician Decision|2|||
163988588|NCT00379795|592326132|FG003|Overall Study|Physician Decision|2|||
163988589|NCT00379795|592326133|FG004|Overall Study|Physician Decision|2|||
163988590|NCT00379795|592326129|FG000|Overall Study|Withdrawal by Subject|94|||
163988591|NCT00379795|592326130|FG001|Overall Study|Withdrawal by Subject|11|||
163988592|NCT00379795|592326131|FG002|Overall Study|Withdrawal by Subject|19|||
163988593|NCT00379795|592326132|FG003|Overall Study|Withdrawal by Subject|7|||
163988594|NCT00379795|592326133|FG004|Overall Study|Withdrawal by Subject|14|||
163988595|NCT00379795|592326129|FG000|Overall Study|Subject non-compliance|7|||
163988596|NCT00379795|592326130|FG001|Overall Study|Subject non-compliance|2|||
163988597|NCT00379795|592326131|FG002|Overall Study|Subject non-compliance|0|||
163988598|NCT00379795|592326132|FG003|Overall Study|Subject non-compliance|0|||
163988599|NCT00379795|592326133|FG004|Overall Study|Subject non-compliance|1|||
163988600|NCT00379795|592326129|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
163988601|NCT00379795|592326130|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
163988602|NCT00379795|592326131|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
163988603|NCT00379795|592326132|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
163988604|NCT00379795|592326133|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
163988605|NCT00379795|592326129|FG000|Overall Study|Subjects condition mandated intervention|34|||
163988606|NCT00379795|592326130|FG001|Overall Study|Subjects condition mandated intervention|9|||
163988607|NCT00379795|592326131|FG002|Overall Study|Subjects condition mandated intervention|7|||
163988608|NCT00379795|592326132|FG003|Overall Study|Subjects condition mandated intervention|5|||
163988609|NCT00379795|592326133|FG004|Overall Study|Subjects condition mandated intervention|7|||
163988610|NCT00379795|592326129|FG000|Overall Study|Sponsor's decision|257|||
163988611|NCT00379795|592326130|FG001|Overall Study|Sponsor's decision|17|||
163988612|NCT00379795|592326131|FG002|Overall Study|Sponsor's decision|54|||
163988613|NCT00379795|592326132|FG003|Overall Study|Sponsor's decision|47|||
163988614|NCT00379795|592326133|FG004|Overall Study|Sponsor's decision|10|||
163988615|NCT01127165|592326134|FG000|Overall Study|Adverse Event|2|||
163988616|NCT01127165|592326135|FG001|Overall Study|Adverse Event|2|||
163988617|NCT01127165|592326134|FG000|Overall Study|Lack of Efficacy|10|||
163988618|NCT01127165|592326135|FG001|Overall Study|Lack of Efficacy|8|||
163988619|NCT01127165|592326134|FG000|Overall Study|Lost to Follow-up|3|||
163988620|NCT01127165|592326135|FG001|Overall Study|Lost to Follow-up|5|||
163988621|NCT01127165|592326134|FG000|Overall Study|Withdrawal by Subject|1|||
163988622|NCT01127165|592326135|FG001|Overall Study|Withdrawal by Subject|3|||
163988623|NCT01127165|592326134|FG000|Overall Study|Protocol Violation|0|||
163988624|NCT01127165|592326135|FG001|Overall Study|Protocol Violation|1|||
163988625|NCT00763321|592326136|FG000|Open-label Period|Adverse Event|24|||
164333930|NCT01999114|593599690|FG002|Overall Study|Lost to Follow-up|1|||
164333931|NCT01999114|593599691|FG003|Overall Study|Lost to Follow-up|0|||
164333932|NCT01999114|593599692|FG004|Overall Study|Lost to Follow-up|0|||
163988626|NCT00763321|592326137|FG001|Open-label Period|Adverse Event|0|||
163988627|NCT00763321|592326138|FG002|Open-label Period|Adverse Event|0|||
163988628|NCT00763321|592326136|FG000|Open-label Period|Lost to Follow-up|14|||
163988629|NCT00763321|592326137|FG001|Open-label Period|Lost to Follow-up|0|||
163988630|NCT00763321|592326138|FG002|Open-label Period|Lost to Follow-up|0|||
163988631|NCT00763321|592326136|FG000|Open-label Period|Withdrawal by Subject|7|||
163988632|NCT00763321|592326137|FG001|Open-label Period|Withdrawal by Subject|0|||
164140448|NCT02458287|592876087|FG001|Overall Study|Lost to Follow-up|1|||
163988633|NCT00763321|592326138|FG002|Open-label Period|Withdrawal by Subject|0|||
164140449|NCT02458287|592876088|FG002|Overall Study|Lost to Follow-up|1|||
164140450|NCT02458287|592876089|FG003|Overall Study|Lost to Follow-up|0|||
164140451|NCT02458287|592876086|FG000|Overall Study|Protocol Violation|0|||
164140452|NCT02458287|592876087|FG001|Overall Study|Protocol Violation|1|||
164140453|NCT02458287|592876088|FG002|Overall Study|Protocol Violation|0|||
164140454|NCT02458287|592876089|FG003|Overall Study|Protocol Violation|0|||
164140455|NCT02458287|592876086|FG000|Overall Study|Withdrawal by Subject|0|||
164140456|NCT02458287|592876087|FG001|Overall Study|Withdrawal by Subject|2|||
164140457|NCT02458287|592876088|FG002|Overall Study|Withdrawal by Subject|2|||
164140458|NCT02458287|592876089|FG003|Overall Study|Withdrawal by Subject|1|||
164140459|NCT02458287|592876086|FG000|Overall Study|Relocated Out of State|0|||
164140460|NCT02458287|592876087|FG001|Overall Study|Relocated Out of State|0|||
164140461|NCT02458287|592876088|FG002|Overall Study|Relocated Out of State|0|||
164140462|NCT02458287|592876089|FG003|Overall Study|Relocated Out of State|1|||
164140463|NCT00813800|592876092|FG000|Overall Study|Screen Failure after Consent|2|||
164140464|NCT00813800|592876092|FG000|Overall Study|Adverse Event|1|||
164140465|NCT00813800|592876092|FG000|Overall Study|Worsening of depression|2|||
164140466|NCT00813800|592876092|FG000|Overall Study|Physician Decision|1|||
164140467|NCT02365558|592876093|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
164140468|NCT02365558|592876094|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
164140469|NCT02365558|592876093|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
164140470|NCT02365558|592876094|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
164140471|NCT00642278|592876095|FG000|Overall Study|Adverse Event|2|||
164333933|NCT01999114|593599688|FG000|Overall Study|Administrative|0|||
164333934|NCT01999114|593599689|FG001|Overall Study|Administrative|0|||
164333935|NCT01999114|593599690|FG002|Overall Study|Administrative|1|||
164333936|NCT01999114|593599691|FG003|Overall Study|Administrative|1|||
164333937|NCT01999114|593599692|FG004|Overall Study|Administrative|2|||
164333938|NCT03840174|593599693|FG000|Overall Study|Withdrawal by Subject|1|||
164333939|NCT03840174|593599694|FG001|Overall Study|Withdrawal by Subject|0|||
164333940|NCT03840174|593599695|FG002|Overall Study|Withdrawal by Subject|0|||
164333941|NCT03840174|593599696|FG003|Overall Study|Withdrawal by Subject|0|||
164333942|NCT01008150|593599697|FG000|Overall Study|did not receive study drug|1|||
164333943|NCT01008150|593599698|FG001|Overall Study|did not receive study drug|1|||
164333944|NCT01008150|593599699|FG002|Overall Study|did not receive study drug|1|||
164333945|NCT01008150|593599700|FG003|Overall Study|did not receive study drug|0|||
164333946|NCT00178633|593599708|FG000|Overall Study|Lost to Follow-up|6|||
163884295|NCT01160211|591945925|FG002|Overall Study|Physician Decision|0|||
163884296|NCT01160211|591945923|FG000|Overall Study|Withdrawal by Subject|4|||
163884297|NCT01160211|591945924|FG001|Overall Study|Withdrawal by Subject|2|||
163884298|NCT01160211|591945925|FG002|Overall Study|Withdrawal by Subject|2|||
163884299|NCT01160211|591945923|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
163884300|NCT01160211|591945924|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
163884301|NCT01160211|591945925|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
163884302|NCT05551637|591945926|FG000|Overall Study|Lack of Efficacy|0|||
163884303|NCT05551637|591945927|FG001|Overall Study|Lack of Efficacy|6|||
163884304|NCT05551637|591945926|FG000|Overall Study|Lost to Follow-up|1|||
163884305|NCT05551637|591945927|FG001|Overall Study|Lost to Follow-up|1|||
163884306|NCT02734290|591945930|FG000|Overall Study|Adverse Event|1|||
163884307|NCT02734290|591945931|FG001|Overall Study|Adverse Event|0|||
163884308|NCT02734290|591945930|FG000|Overall Study|Death|1|||
163884309|NCT02734290|591945931|FG001|Overall Study|Death|0|||
163884310|NCT03829410|591945933|FG000|Overall Study|Adverse Event|1|||
163884311|NCT03829410|591945934|FG001|Overall Study|Adverse Event|0|||
163884312|NCT03829410|591945935|FG002|Overall Study|Adverse Event|1|||
163884313|NCT03829410|591945936|FG003|Overall Study|Adverse Event|4|||
163884314|NCT03829410|591945933|FG000|Overall Study|Physician Decision|0|||
163884315|NCT03829410|591945934|FG001|Overall Study|Physician Decision|0|||
163884316|NCT03829410|591945935|FG002|Overall Study|Physician Decision|0|||
163884317|NCT03829410|591945936|FG003|Overall Study|Physician Decision|2|||
163884318|NCT03829410|591945933|FG000|Overall Study|Disease Progressing|3|||
163884319|NCT03829410|591945934|FG001|Overall Study|Disease Progressing|4|||
163884320|NCT03829410|591945935|FG002|Overall Study|Disease Progressing|2|||
163884321|NCT03829410|591945936|FG003|Overall Study|Disease Progressing|31|||
163884322|NCT03829410|591945933|FG000|Overall Study|Miscellaneous|2|||
163884323|NCT03829410|591945934|FG001|Overall Study|Miscellaneous|4|||
163884324|NCT03829410|591945935|FG002|Overall Study|Miscellaneous|3|||
163884325|NCT03829410|591945936|FG003|Overall Study|Miscellaneous|10|||
163884326|NCT04924660|591945937|FG000|United States|Death|29|||
163884327|NCT04924660|591945938|FG001|United States|Death|32|||
163884328|NCT04924660|591945939|FG002|United States|Death|34|||
163884329|NCT04924660|591945940|FG003|United States|Death|25|||
163884330|NCT04924660|591945941|FG004|United States|Death|26|||
164333947|NCT04810481|593599710|FG000|Overall Study|Disqualified data sets|10|||
164333948|NCT04810481|593599711|FG001|Overall Study|Disqualified data sets|28|||
163884331|NCT04924660|591945942|FG005|United States|Death|23|||
163884332|NCT04924660|591945937|FG000|United States|Lost to Follow-up|15|||
163884333|NCT04924660|591945938|FG001|United States|Lost to Follow-up|10|||
163884334|NCT04924660|591945939|FG002|United States|Lost to Follow-up|13|||
163884335|NCT04924660|591945940|FG003|United States|Lost to Follow-up|5|||
163884336|NCT04924660|591945941|FG004|United States|Lost to Follow-up|19|||
163884337|NCT04924660|591945942|FG005|United States|Lost to Follow-up|20|||
163884338|NCT04924660|591945937|FG000|United States|Withdrawal by Subject|8|||
163884339|NCT04924660|591945938|FG001|United States|Withdrawal by Subject|3|||
163988634|NCT00763321|592326136|FG000|Open-label Period|Subject noncompliant|7|||
163988635|NCT00763321|592326137|FG001|Open-label Period|Subject noncompliant|0|||
163988636|NCT00763321|592326138|FG002|Open-label Period|Subject noncompliant|0|||
163988637|NCT00763321|592326136|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
164235917|NCT01164007|593235543|FG000|Overall Study|Adverse Event|5|||
164235918|NCT01164007|593235543|FG000|Overall Study|Progression of Disease|30|||
164235919|NCT01164007|593235543|FG000|Overall Study|Protocol Violation|1|||
164235920|NCT01164007|593235543|FG000|Overall Study|Withdrawal by Subject|1|||
164235921|NCT01164007|593235543|FG000|Overall Study|Medical Decision|3|||
164235922|NCT03218917|593235545|FG000|Overall Study|Adverse Event|3|||
164235923|NCT03218917|593235546|FG001|Overall Study|Adverse Event|3|||
164235924|NCT03218917|593235547|FG002|Overall Study|Adverse Event|2|||
164235925|NCT03218917|593235545|FG000|Overall Study|Subject withdrew consent|2|||
164235926|NCT03218917|593235546|FG001|Overall Study|Subject withdrew consent|4|||
164235927|NCT03218917|593235547|FG002|Overall Study|Subject withdrew consent|10|||
164235928|NCT03218917|593235545|FG000|Overall Study|Physician Decision|0|||
164333949|NCT00381381|593599719|FG000|Overall Study|Adverse Event|3|||
164333950|NCT00381381|593599719|FG000|Overall Study|Lost to Follow-up|52|||
164333951|NCT00381381|593599719|FG000|Overall Study|Withdrawal by Subject|9|||
164333952|NCT00568685|593599720|FG000|Overall Study|Adverse Event|2|||
164333953|NCT00568685|593599721|FG001|Overall Study|Adverse Event|3|||
163884340|NCT04924660|591945939|FG002|United States|Withdrawal by Subject|3|||
163884341|NCT04924660|591945940|FG003|United States|Withdrawal by Subject|3|||
163884342|NCT04924660|591945941|FG004|United States|Withdrawal by Subject|8|||
163884343|NCT04924660|591945942|FG005|United States|Withdrawal by Subject|4|||
163884344|NCT04924660|591945937|FG000|Spain|Death|0|||
164333954|NCT00568685|593599722|FG002|Overall Study|Adverse Event|3|||
164333955|NCT00568685|593599720|FG000|Overall Study|Withdrawal by Subject|7|||
164333956|NCT00568685|593599721|FG001|Overall Study|Withdrawal by Subject|2|||
164333957|NCT00568685|593599722|FG002|Overall Study|Withdrawal by Subject|2|||
164333958|NCT00568685|593599720|FG000|Overall Study|Protocol Violation|1|||
164333959|NCT00568685|593599721|FG001|Overall Study|Protocol Violation|0|||
164333960|NCT00568685|593599722|FG002|Overall Study|Protocol Violation|0|||
164333961|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Adverse Event|10|||
164333962|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Adverse Event|0|||
164333963|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
164333964|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
164333965|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
164333966|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
164333967|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
164333968|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
163884345|NCT04924660|591945938|FG001|Spain|Death|0|||
163884346|NCT04924660|591945939|FG002|Spain|Death|0|||
163884347|NCT04924660|591945940|FG003|Spain|Death|0|||
163884348|NCT04924660|591945941|FG004|Spain|Death|0|||
163884349|NCT04924660|591945942|FG005|Spain|Death|2|||
163884350|NCT04924660|591945937|FG000|Spain|Lost to Follow-up|0|||
163884351|NCT04924660|591945938|FG001|Spain|Lost to Follow-up|0|||
163884352|NCT04924660|591945939|FG002|Spain|Lost to Follow-up|0|||
163884353|NCT04924660|591945940|FG003|Spain|Lost to Follow-up|0|||
163884354|NCT04924660|591945941|FG004|Spain|Lost to Follow-up|1|||
163884355|NCT04924660|591945942|FG005|Spain|Lost to Follow-up|0|||
163884356|NCT04924660|591945937|FG000|Brazil|Death|0|||
163884357|NCT04924660|591945938|FG001|Brazil|Death|0|||
163884358|NCT04924660|591945939|FG002|Brazil|Death|0|||
163884359|NCT04924660|591945940|FG003|Brazil|Death|0|||
163884360|NCT04924660|591945941|FG004|Brazil|Death|1|||
163884361|NCT04924660|591945942|FG005|Brazil|Death|0|||
163988638|NCT00763321|592326137|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
163884362|NCT04924660|591945937|FG000|Italy|Lost to Follow-up|0|||
164333969|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
164333970|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
163884363|NCT04924660|591945938|FG001|Italy|Lost to Follow-up|0|||
163884364|NCT04924660|591945939|FG002|Italy|Lost to Follow-up|0|||
164235929|NCT03218917|593235546|FG001|Overall Study|Physician Decision|1|||
164235930|NCT03218917|593235547|FG002|Overall Study|Physician Decision|1|||
164235931|NCT03218917|593235545|FG000|Overall Study|Lost to Follow-up|1|||
164235932|NCT03218917|593235546|FG001|Overall Study|Lost to Follow-up|0|||
164235933|NCT03218917|593235547|FG002|Overall Study|Lost to Follow-up|0|||
164235934|NCT03218917|593235545|FG000|Overall Study|Reason Missing|0|||
164235935|NCT03218917|593235546|FG001|Overall Study|Reason Missing|2|||
164235936|NCT03218917|593235547|FG002|Overall Study|Reason Missing|0|||
164235937|NCT03218917|593235545|FG000|Overall Study|Death|0|||
164235938|NCT03218917|593235546|FG001|Overall Study|Death|1|||
164235939|NCT03218917|593235547|FG002|Overall Study|Death|0|||
164333971|NCT02787551|593599723|FG000|Core Period: 26 Weeks|Other than specified|3|||
164333972|NCT02787551|593599724|FG001|Core Period: 26 Weeks|Other than specified|1|||
164333973|NCT02787551|593599723|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
164333974|NCT02787551|593599724|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
164333975|NCT02787551|593599723|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
164333976|NCT02787551|593599724|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
164333977|NCT02787551|593599723|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
164333978|NCT02787551|593599724|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
164333979|NCT03799211|593599725|FG000|Overall Study|Lost to Follow-up|2|||
164333980|NCT03799211|593599726|FG001|Overall Study|Lost to Follow-up|13|||
164333981|NCT03799211|593599725|FG000|Overall Study|Withdrawal by Subject|2|||
164333982|NCT03799211|593599726|FG001|Overall Study|Withdrawal by Subject|0|||
164333983|NCT00764491|593599727|FG000|Overall Study|Lost to Follow-up|35|||
164333984|NCT00764491|593599728|FG001|Overall Study|Lost to Follow-up|17|||
164333985|NCT03139279|593599731|FG000|Overall Study|Physician Decision|2|||
164333986|NCT03139279|593599732|FG001|Overall Study|Physician Decision|0|||
164333987|NCT03139279|593599731|FG000|Overall Study|Protocol Violation|5|||
164333988|NCT03139279|593599732|FG001|Overall Study|Protocol Violation|4|||
164333989|NCT03139279|593599731|FG000|Overall Study|Withdrawal by Subject|0|||
164333990|NCT03139279|593599732|FG001|Overall Study|Withdrawal by Subject|2|||
164333991|NCT02027376|593599735|FG000|Overall Study|Death|1|||
164333992|NCT02027376|593599736|FG001|Overall Study|Death|0|||
164333993|NCT02027376|593599737|FG002|Overall Study|Death|0|||
164333994|NCT01565642|593599738|FG000|Overall Study|Withdrawal by Subject|2|||
164333995|NCT01565642|593599739|FG001|Overall Study|Withdrawal by Subject|1|||
164333996|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
164333997|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
164333998|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
164333999|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
164334000|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|Death|2|||
164334001|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|Death|2|||
164334002|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
164334003|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
164334004|NCT01528033|593599743|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
164334005|NCT01528033|593599744|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
164334006|NCT01528033|593599743|FG000|Follow Up|No data available|46|||
164334007|NCT01528033|593599744|FG001|Follow Up|No data available|44|||
164334008|NCT02452697|593599749|FG000|Overall Study|Physician Decision|4|||
164334009|NCT02452697|593599750|FG001|Overall Study|Physician Decision|4|||
164334010|NCT02452697|593599751|FG002|Overall Study|Physician Decision|3|||
164334011|NCT02452697|593599752|FG003|Overall Study|Physician Decision|2|||
164334012|NCT02452697|593599749|FG000|Overall Study|Withdrawal by Subject|1|||
164334013|NCT02452697|593599750|FG001|Overall Study|Withdrawal by Subject|0|||
164334014|NCT02452697|593599751|FG002|Overall Study|Withdrawal by Subject|0|||
164334015|NCT02452697|593599752|FG003|Overall Study|Withdrawal by Subject|0|||
164334016|NCT02452697|593599749|FG000|Overall Study|still in follow-up|2|||
164334017|NCT02452697|593599750|FG001|Overall Study|still in follow-up|2|||
164334018|NCT02452697|593599751|FG002|Overall Study|still in follow-up|1|||
164334019|NCT02452697|593599752|FG003|Overall Study|still in follow-up|3|||
164334020|NCT01554397|593599753|FG000|Overall Study|Withdrawal by Subject|1|||
164334021|NCT01554397|593599754|FG001|Overall Study|Withdrawal by Subject|0|||
164334022|NCT01554397|593599753|FG000|Overall Study|Ineligible|7|||
164334023|NCT01554397|593599754|FG001|Overall Study|Ineligible|0|||
164334024|NCT04246372|593601438|FG000|Overall Study|Adverse Event|1|||
164334025|NCT04246372|593601438|FG000|Overall Study|Withdrawal by Subject|1|||
164334026|NCT04246372|593601438|FG000|Overall Study|Protocol Violation|2|||
164334027|NCT04246372|593601438|FG000|Overall Study|Physician Decision|1|||
164334028|NCT00257608|593601440|FG000|Chemotherapy Phase|Adverse Event|138|||
164235940|NCT03218917|593235545|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164235941|NCT03218917|593235546|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164235942|NCT03218917|593235547|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164334029|NCT00257608|593601441|FG001|Chemotherapy Phase|Adverse Event|0|||
164334030|NCT00257608|593601442|FG002|Chemotherapy Phase|Adverse Event|0|||
164334031|NCT00257608|593601440|FG000|Chemotherapy Phase|Disease progression|139|||
164235943|NCT02581891|593235550|FG000|Overall Study|Adverse Event|4|||
163884365|NCT04924660|591945940|FG003|Italy|Lost to Follow-up|0|||
163884366|NCT04924660|591945941|FG004|Italy|Lost to Follow-up|0|||
163884367|NCT04924660|591945942|FG005|Italy|Lost to Follow-up|1|||
164235944|NCT02581891|593235551|FG001|Overall Study|Adverse Event|6|||
164235945|NCT02581891|593235550|FG000|Overall Study|Death|3|||
164235946|NCT02581891|593235551|FG001|Overall Study|Death|4|||
164235947|NCT02581891|593235550|FG000|Overall Study|Lost to Follow-up|1|||
164235948|NCT02581891|593235551|FG001|Overall Study|Lost to Follow-up|2|||
164235949|NCT02581891|593235550|FG000|Overall Study|Physician Decision|0|||
164235950|NCT02581891|593235551|FG001|Overall Study|Physician Decision|1|||
164235951|NCT02581891|593235550|FG000|Overall Study|Withdrawal by Subject|4|||
164235952|NCT02581891|593235551|FG001|Overall Study|Withdrawal by Subject|5|||
164235953|NCT02581891|593235550|FG000|Overall Study|Other Reasons|3|||
164235954|NCT02581891|593235551|FG001|Overall Study|Other Reasons|1|||
164235955|NCT02581891|593235550|FG000|Overall Study|Discontinued during followup|1|||
164235956|NCT02581891|593235551|FG001|Overall Study|Discontinued during followup|0|||
164235957|NCT01612676|593235552|FG000|Overall Study|Adverse Event|2|||
164235958|NCT01612676|593235553|FG001|Overall Study|Adverse Event|3|||
164235959|NCT01612676|593235554|FG002|Overall Study|Adverse Event|1|||
164235960|NCT01612676|593235555|FG003|Overall Study|Adverse Event|3|||
164235961|NCT01612676|593235552|FG000|Overall Study|Protocol Violation|0|||
164235962|NCT01612676|593235553|FG001|Overall Study|Protocol Violation|1|||
164235963|NCT01612676|593235554|FG002|Overall Study|Protocol Violation|0|||
164235964|NCT01612676|593235555|FG003|Overall Study|Protocol Violation|0|||
164235965|NCT00181844|593235562|FG000|Signed Consent|Withdrawal by Subject|5|||
164235966|NCT00181844|593235562|FG000|Signed Consent|Did not meet entrance criteria|7|||
164235967|NCT00181844|593235562|FG000|Exposed to Study Medication|Adverse Event|10|||
163884368|NCT04924660|591945937|FG000|South Africa|Death|0|||
164235968|NCT00181844|593235562|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
164235969|NCT00181844|593235562|FG000|Exposed to Study Medication|Non-compliance|2|||
164235970|NCT00181844|593235562|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
164235971|NCT00181844|593235562|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
164235972|NCT02303262|593235565|FG000|Overall Study|Withdrawal by Subject|2|||
164235973|NCT01959932|593235570|FG000|Overall Study|Withdrawal by Subject|1|||
164235974|NCT01959932|593235571|FG001|Overall Study|Withdrawal by Subject|0|||
164235975|NCT01959932|593235572|FG002|Overall Study|Withdrawal by Subject|0|||
164235976|NCT00060944|593235575|FG000|Overall Study|Adverse Event|12|||
164235977|NCT00060944|593235576|FG001|Overall Study|Adverse Event|10|||
163884369|NCT04924660|591945938|FG001|South Africa|Death|0|||
163884370|NCT04924660|591945939|FG002|South Africa|Death|0|||
164235978|NCT00060944|593235575|FG000|Overall Study|Death|2|||
164235979|NCT00060944|593235576|FG001|Overall Study|Death|3|||
164235980|NCT00060944|593235575|FG000|Overall Study|Withdrawal by Subject|18|||
164235981|NCT00060944|593235576|FG001|Overall Study|Withdrawal by Subject|5|||
164235982|NCT00060944|593235575|FG000|Overall Study|Disease Progression|93|||
164235983|NCT00060944|593235576|FG001|Overall Study|Disease Progression|94|||
164235984|NCT00060944|593235575|FG000|Overall Study|Lost to Follow-up|1|||
164235985|NCT00060944|593235576|FG001|Overall Study|Lost to Follow-up|0|||
164235986|NCT00060944|593235575|FG000|Overall Study|Subject Ineligible To Continue|2|||
164235987|NCT00060944|593235576|FG001|Overall Study|Subject Ineligible To Continue|1|||
164235988|NCT00060944|593235575|FG000|Overall Study|Treatment Switch|0|||
163884371|NCT04924660|591945940|FG003|South Africa|Death|0|||
164334032|NCT00257608|593601441|FG001|Chemotherapy Phase|Disease progression|0|||
164334033|NCT00257608|593601442|FG002|Chemotherapy Phase|Disease progression|0|||
164334034|NCT00257608|593601440|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
164334035|NCT00257608|593601441|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
164334036|NCT00257608|593601442|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
164334037|NCT00257608|593601440|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
164334038|NCT00257608|593601441|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
164334039|NCT00257608|593601442|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
164334040|NCT00257608|593601440|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
164334041|NCT00257608|593601441|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
164334042|NCT00257608|593601442|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
164334043|NCT00257608|593601440|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
164334044|NCT00257608|593601441|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334045|NCT00257608|593601442|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334046|NCT00257608|593601440|FG000|Chemotherapy Phase|Physician Decision|28|||
164334047|NCT00257608|593601441|FG001|Chemotherapy Phase|Physician Decision|0|||
164334048|NCT00257608|593601442|FG002|Chemotherapy Phase|Physician Decision|0|||
164334049|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Adverse Event|0|||
164334050|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Adverse Event|34|||
164334051|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Adverse Event|38|||
164334052|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Disease progression|0|||
164334053|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Disease progression|204|||
164334054|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Disease progression|168|||
164334055|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
164334056|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
164334057|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
164334058|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
164334059|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
164334060|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
164334061|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
164334062|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
164334063|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
164334064|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334065|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
164334066|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
164334067|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
164334068|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
164334069|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
164334070|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Physician Decision|0|||
164334071|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Physician Decision|8|||
164334072|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Physician Decision|11|||
164334073|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
164334074|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
164334075|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
164334076|NCT00257608|593601440|FG000|Post Chemotherapy Phase|Not treated|0|||
164334077|NCT00257608|593601441|FG001|Post Chemotherapy Phase|Not treated|4|||
164334078|NCT00257608|593601442|FG002|Post Chemotherapy Phase|Not treated|7|||
164334079|NCT03673046|593601443|FG000|Overall Study|Adverse Event|1|||
164334080|NCT03673046|593601444|FG001|Overall Study|Adverse Event|1|||
164334081|NCT03673046|593601443|FG000|Overall Study|Withdrawal by Subject|8|||
164334082|NCT03673046|593601444|FG001|Overall Study|Withdrawal by Subject|2|||
164334083|NCT03817879|593601445|FG000|Overall Study|Drop out|5|||
164334084|NCT03817879|593601446|FG001|Overall Study|Drop out|12|||
164334085|NCT03817879|593601445|FG000|Overall Study|Withdrawal by Subject|0|||
164334086|NCT03817879|593601446|FG001|Overall Study|Withdrawal by Subject|1|||
164334087|NCT01896050|593601447|FG000|Overall Study|Adverse Event|37|||
164334088|NCT01896050|593601448|FG001|Overall Study|Adverse Event|2|||
164334089|NCT01896050|593601447|FG000|Overall Study|Death|1|||
164334090|NCT01896050|593601448|FG001|Overall Study|Death|0|||
164334091|NCT00392015|593601450|FG000|Overall Study|Lost to Follow-up|2|||
164334092|NCT00392015|593601451|FG001|Overall Study|Lost to Follow-up|0|||
164334093|NCT00392015|593601452|FG002|Overall Study|Lost to Follow-up|2|||
164334094|NCT00392015|593601453|FG003|Overall Study|Lost to Follow-up|1|||
164334095|NCT00392015|593601454|FG004|Overall Study|Lost to Follow-up|1|||
164334096|NCT00392015|593601455|FG005|Overall Study|Lost to Follow-up|0|||
164334097|NCT00392015|593601450|FG000|Overall Study|Withdrawal by Subject|0|||
164334098|NCT00392015|593601451|FG001|Overall Study|Withdrawal by Subject|0|||
164334099|NCT00392015|593601452|FG002|Overall Study|Withdrawal by Subject|2|||
164334100|NCT00392015|593601453|FG003|Overall Study|Withdrawal by Subject|0|||
164334101|NCT00392015|593601454|FG004|Overall Study|Withdrawal by Subject|0|||
163988639|NCT00763321|592326138|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
164235989|NCT00060944|593235576|FG001|Overall Study|Treatment Switch|13|||
164235990|NCT00060944|593235575|FG000|Overall Study|Other|2|||
164235991|NCT00060944|593235576|FG001|Overall Study|Other|4|||
164235992|NCT00060944|593235575|FG000|Overall Study|randomized but not treated|6|||
163884372|NCT04924660|591945941|FG004|South Africa|Death|0|||
163884373|NCT04924660|591945942|FG005|South Africa|Death|1|||
164235993|NCT00060944|593235576|FG001|Overall Study|randomized but not treated|4|||
164235994|NCT00776230|593235580|FG000|Overall Study|Lost to Follow-up|2|||
164235995|NCT00776230|593235581|FG001|Overall Study|Lost to Follow-up|1|||
164235996|NCT00776230|593235582|FG002|Overall Study|Lost to Follow-up|5|||
164235997|NCT00776230|593235580|FG000|Overall Study|Not vaccinated at Day 0|1|||
164235998|NCT00776230|593235581|FG001|Overall Study|Not vaccinated at Day 0|0|||
164235999|NCT00776230|593235582|FG002|Overall Study|Not vaccinated at Day 0|0|||
164236000|NCT00776230|593235580|FG000|Overall Study|Withdrawal by Subject|0|||
164236001|NCT00776230|593235581|FG001|Overall Study|Withdrawal by Subject|1|||
164236002|NCT00776230|593235582|FG002|Overall Study|Withdrawal by Subject|0|||
164236003|NCT00776230|593235580|FG000|Overall Study|Subject missed Visit 4|0|||
164236004|NCT00776230|593235581|FG001|Overall Study|Subject missed Visit 4|1|||
164236005|NCT00776230|593235582|FG002|Overall Study|Subject missed Visit 4|0|||
164236006|NCT01215851|593235583|FG000|Treatment Period|Adverse Event|1|||
163884374|NCT04924660|591945937|FG000|South Africa|Lost to Follow-up|0|||
164334102|NCT00392015|593601455|FG005|Overall Study|Withdrawal by Subject|0|||
164334103|NCT00392015|593601450|FG000|Overall Study|Adverse Event|0|||
164334104|NCT00392015|593601451|FG001|Overall Study|Adverse Event|0|||
164334105|NCT00392015|593601452|FG002|Overall Study|Adverse Event|0|||
164334106|NCT00392015|593601453|FG003|Overall Study|Adverse Event|0|||
164334107|NCT00392015|593601454|FG004|Overall Study|Adverse Event|1|||
164334108|NCT00392015|593601455|FG005|Overall Study|Adverse Event|0|||
164334109|NCT00392015|593601450|FG000|Overall Study|Previous trial recipient|0|||
164334110|NCT00392015|593601451|FG001|Overall Study|Previous trial recipient|0|||
164334111|NCT00392015|593601452|FG002|Overall Study|Previous trial recipient|0|||
164334112|NCT00392015|593601453|FG003|Overall Study|Previous trial recipient|0|||
164334113|NCT00392015|593601454|FG004|Overall Study|Previous trial recipient|1|||
164334114|NCT00392015|593601455|FG005|Overall Study|Previous trial recipient|0|||
164334115|NCT03693300|593601456|FG000|Overall Study|Withdrawal by Subject|6|||
164334116|NCT03693300|593601457|FG001|Overall Study|Withdrawal by Subject|0|||
164334117|NCT03693300|593601456|FG000|Overall Study|Death|50|||
164334118|NCT03693300|593601457|FG001|Overall Study|Death|2|||
164334119|NCT03693300|593601456|FG000|Overall Study|Lost to Follow-up|2|||
164334120|NCT03693300|593601457|FG001|Overall Study|Lost to Follow-up|0|||
164334121|NCT02742441|593601458|FG000|Overall Study|Lost to Follow-up|4|||
164334122|NCT02742441|593601459|FG001|Overall Study|Lost to Follow-up|4|||
163988640|NCT00763321|592326136|FG000|Open-label Period|Lack of Efficacy|2|||
164334123|NCT02742441|593601458|FG000|Overall Study|Withdrawal by Subject|2|||
164334124|NCT02742441|593601459|FG001|Overall Study|Withdrawal by Subject|2|||
164334125|NCT02742441|593601458|FG000|Overall Study|Adverse Event|0|||
164334126|NCT02742441|593601459|FG001|Overall Study|Adverse Event|2|||
163988641|NCT00763321|592326137|FG001|Open-label Period|Lack of Efficacy|0|||
163988642|NCT00763321|592326138|FG002|Open-label Period|Lack of Efficacy|0|||
163988643|NCT00763321|592326136|FG000|Open-label Period|Other|4|||
163988644|NCT00763321|592326137|FG001|Open-label Period|Other|0|||
163988645|NCT00763321|592326138|FG002|Open-label Period|Other|0|||
163988646|NCT00763321|592326136|FG000|Double-blind Period|Lack of Efficacy|0|||
163988647|NCT00763321|592326137|FG001|Double-blind Period|Lack of Efficacy|9|||
163988648|NCT00763321|592326138|FG002|Double-blind Period|Lack of Efficacy|17|||
163988649|NCT00763321|592326136|FG000|Double-blind Period|Adverse Event|0|||
163988650|NCT00763321|592326137|FG001|Double-blind Period|Adverse Event|4|||
163988651|NCT00763321|592326138|FG002|Double-blind Period|Adverse Event|4|||
163988652|NCT00763321|592326136|FG000|Double-blind Period|Lost to Follow-up|0|||
163988653|NCT00763321|592326137|FG001|Double-blind Period|Lost to Follow-up|4|||
163988654|NCT00763321|592326138|FG002|Double-blind Period|Lost to Follow-up|2|||
163988655|NCT00763321|592326136|FG000|Double-blind Period|Withdrawal by Subject|0|||
163988656|NCT00763321|592326137|FG001|Double-blind Period|Withdrawal by Subject|2|||
163884375|NCT04924660|591945938|FG001|South Africa|Lost to Follow-up|0|||
164236007|NCT01215851|593235584|FG001|Treatment Period|Adverse Event|1|||
164236008|NCT01215851|593235585|FG002|Treatment Period|Adverse Event|1|||
164236009|NCT01215851|593235586|FG003|Treatment Period|Adverse Event|3|||
164236010|NCT01215851|593235587|FG004|Treatment Period|Adverse Event|0|||
164236011|NCT01215851|593235588|FG005|Treatment Period|Adverse Event|1|||
164236012|NCT01215851|593235583|FG000|Follow up Period|Lost to Follow-up|0|||
164236013|NCT01215851|593235584|FG001|Follow up Period|Lost to Follow-up|0|||
164236014|NCT01215851|593235585|FG002|Follow up Period|Lost to Follow-up|0|||
164236015|NCT01215851|593235586|FG003|Follow up Period|Lost to Follow-up|0|||
164236016|NCT01215851|593235587|FG004|Follow up Period|Lost to Follow-up|0|||
163884376|NCT04924660|591945939|FG002|South Africa|Lost to Follow-up|0|||
163884377|NCT04924660|591945940|FG003|South Africa|Lost to Follow-up|0|||
164236017|NCT01215851|593235588|FG005|Follow up Period|Lost to Follow-up|1|||
164236018|NCT03961308|593235589|FG000|Overall Study|Withdrawal by Subject|1|||
164236019|NCT03961308|593235590|FG001|Overall Study|Withdrawal by Subject|0|||
164236020|NCT03961308|593235589|FG000|Overall Study|Other|1|||
164236021|NCT03961308|593235590|FG001|Overall Study|Other|0|||
164236022|NCT03961308|593235589|FG000|Overall Study|Lost to Follow-up|0|||
164236023|NCT03961308|593235590|FG001|Overall Study|Lost to Follow-up|1|||
164236024|NCT03961308|593235589|FG000|Overall Study|Adverse Event|0|||
164236025|NCT03961308|593235590|FG001|Overall Study|Adverse Event|1|||
164236026|NCT02297412|593235596|FG000|Overall Study|Canceled|1|||
164236027|NCT02297412|593235597|FG001|Overall Study|Canceled|1|||
164236028|NCT04549454|593235598|FG000|T1 to T2|Lost to Follow-up|22|||
164236029|NCT04549454|593235599|FG001|T1 to T2|Lost to Follow-up|26|||
164236030|NCT04549454|593235598|FG000|T1 to T3|Lost to Follow-up|31|||
164236031|NCT04549454|593235599|FG001|T1 to T3|Lost to Follow-up|36|||
164236032|NCT00545779|593235610|FG000|Overall Study|Violation of selection criteria at entry|8|||
164236033|NCT00545779|593235610|FG000|Overall Study|Other protocol violation|1|||
164236034|NCT00545779|593235610|FG000|Overall Study|Did not cooperate|7|||
164236035|NCT00545779|593235610|FG000|Overall Study|Withdrawal by Subject|20|||
164236036|NCT00545779|593235610|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
164236037|NCT00545779|593235610|FG000|Overall Study|Failure to return|3|||
164236038|NCT01405196|593235611|FG000|Overall Study|Study Terminated by Sponsor|0|||
164236039|NCT01405196|593235612|FG001|Overall Study|Study Terminated by Sponsor|0|||
164236040|NCT01405196|593235613|FG002|Overall Study|Study Terminated by Sponsor|9|||
164236041|NCT01405196|593235614|FG003|Overall Study|Study Terminated by Sponsor|0|||
164236042|NCT01405196|593235611|FG000|Overall Study|Other|2|||
164236043|NCT01405196|593235612|FG001|Overall Study|Other|2|||
164236044|NCT01405196|593235613|FG002|Overall Study|Other|5|||
164236045|NCT01405196|593235614|FG003|Overall Study|Other|0|||
164236046|NCT01405196|593235611|FG000|Overall Study|Withdrawal by Subject|4|||
164236047|NCT01405196|593235612|FG001|Overall Study|Withdrawal by Subject|6|||
164236048|NCT01405196|593235613|FG002|Overall Study|Withdrawal by Subject|3|||
164236049|NCT01405196|593235614|FG003|Overall Study|Withdrawal by Subject|6|||
164236050|NCT01405196|593235611|FG000|Overall Study|Adverse Event|2|||
164236051|NCT01405196|593235612|FG001|Overall Study|Adverse Event|2|||
164236052|NCT01405196|593235613|FG002|Overall Study|Adverse Event|0|||
164236053|NCT01405196|593235614|FG003|Overall Study|Adverse Event|2|||
164236054|NCT01405196|593235611|FG000|Overall Study|Death|1|||
164236055|NCT01405196|593235612|FG001|Overall Study|Death|0|||
164236056|NCT01405196|593235613|FG002|Overall Study|Death|3|||
164236057|NCT01405196|593235614|FG003|Overall Study|Death|0|||
164236058|NCT01405196|593235611|FG000|Overall Study|Lost to Follow-up|2|||
164236059|NCT01405196|593235612|FG001|Overall Study|Lost to Follow-up|2|||
164236060|NCT01405196|593235613|FG002|Overall Study|Lost to Follow-up|3|||
164236061|NCT01405196|593235614|FG003|Overall Study|Lost to Follow-up|1|||
164236062|NCT01542788|593235615|FG000|Overall Study|Randomized but Not Treated|2|||
164236063|NCT01542788|593235616|FG001|Overall Study|Randomized but Not Treated|0|||
164236064|NCT01542788|593235615|FG000|Overall Study|Lack of Efficacy|41|||
164236065|NCT01542788|593235616|FG001|Overall Study|Lack of Efficacy|71|||
164236066|NCT01542788|593235615|FG000|Overall Study|Lost to Follow-up|5|||
164236067|NCT01542788|593235616|FG001|Overall Study|Lost to Follow-up|0|||
164236068|NCT01542788|593235615|FG000|Overall Study|Death|3|||
164236069|NCT01542788|593235616|FG001|Overall Study|Death|0|||
164236070|NCT01542788|593235615|FG000|Overall Study|Protocol Violation|2|||
164236071|NCT01542788|593235616|FG001|Overall Study|Protocol Violation|0|||
164236072|NCT01542788|593235615|FG000|Overall Study|Physician Decision|1|||
164236073|NCT01542788|593235616|FG001|Overall Study|Physician Decision|0|||
164236074|NCT01542788|593235615|FG000|Overall Study|Withdrawal by Subject|1|||
164236075|NCT01542788|593235616|FG001|Overall Study|Withdrawal by Subject|0|||
164236076|NCT01400412|593235617|FG000|Overall Study|Lost to Follow-up|4|||
164236077|NCT01400412|593235618|FG001|Overall Study|Lost to Follow-up|7|||
164236078|NCT01400412|593235617|FG000|Overall Study|Withdrawal by Subject|3|||
164236079|NCT01400412|593235618|FG001|Overall Study|Withdrawal by Subject|4|||
164236080|NCT01400412|593235617|FG000|Overall Study|Unable to complete|3|||
164236081|NCT01400412|593235618|FG001|Overall Study|Unable to complete|3|||
164236082|NCT01400412|593235617|FG000|Overall Study|Never started study treatment|0|||
164236083|NCT01400412|593235618|FG001|Overall Study|Never started study treatment|3|||
164236084|NCT01649869|593235619|FG000|Overall Study|Family member illness|1|||
164236085|NCT01649869|593235620|FG001|Overall Study|Family member illness|0|||
164236086|NCT01649869|593235619|FG000|Overall Study|Required treatment outside protocol|1|||
164236087|NCT01649869|593235620|FG001|Overall Study|Required treatment outside protocol|0|||
164236088|NCT01649869|593235619|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
164236089|NCT01649869|593235620|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
164236090|NCT00069641|593236774|FG000|Overall Study|Death|1|||
164236091|NCT00069641|593236775|FG001|Overall Study|Death|0|||
164236092|NCT00069641|593236776|FG002|Overall Study|Death|1|||
164236093|NCT04778592|593236777|FG000|Overall Study|Adverse Event|1|||
164236094|NCT04778592|593236778|FG001|Overall Study|Adverse Event|2|||
164236095|NCT04778592|593236777|FG000|Overall Study|Withdrawal by Subject|1|||
164236096|NCT04778592|593236778|FG001|Overall Study|Withdrawal by Subject|2|||
164236097|NCT01354223|593236780|FG000|Overall Study|Withdrawal by Subject|3|||
164236098|NCT01354223|593236781|FG001|Overall Study|Withdrawal by Subject|1|||
164236099|NCT01126190|593236785|FG000|Double-Blind Phase|Death|0|||
164236100|NCT01126190|593236786|FG001|Double-Blind Phase|Death|1|||
164236101|NCT01126190|593236787|FG002|Double-Blind Phase|Death|0|||
164236102|NCT01126190|593236785|FG000|Double-Blind Phase|Adverse Event|1|||
164236103|NCT01126190|593236786|FG001|Double-Blind Phase|Adverse Event|2|||
164236104|NCT01126190|593236787|FG002|Double-Blind Phase|Adverse Event|0|||
164236105|NCT01126190|593236785|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164236106|NCT01126190|593236786|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
164236107|NCT01126190|593236787|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164236108|NCT01126190|593236785|FG000|Double-Blind Phase|Request of Investigator|1|||
164236109|NCT01126190|593236786|FG001|Double-Blind Phase|Request of Investigator|0|||
164236110|NCT01126190|593236787|FG002|Double-Blind Phase|Request of Investigator|0|||
164236111|NCT01126190|593236785|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
164236112|NCT01126190|593236786|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
164236113|NCT01126190|593236787|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
164236114|NCT01126190|593236785|FG000|Double-Blind Phase|Non-compliance|1|||
164236115|NCT01126190|593236786|FG001|Double-Blind Phase|Non-compliance|0|||
164236116|NCT01126190|593236787|FG002|Double-Blind Phase|Non-compliance|0|||
164236117|NCT01126190|593236785|FG000|Double-Blind Phase|Lost to Follow-up|1|||
164236118|NCT01126190|593236786|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164236119|NCT01126190|593236787|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164236120|NCT01126190|593236785|FG000|Open-Label Phase|Death|0|||
164236121|NCT01126190|593236786|FG001|Open-Label Phase|Death|0|||
164236122|NCT01126190|593236787|FG002|Open-Label Phase|Death|1|||
164236123|NCT01126190|593236785|FG000|Open-Label Phase|Adverse Event|0|||
164236124|NCT01126190|593236786|FG001|Open-Label Phase|Adverse Event|0|||
164236125|NCT01126190|593236787|FG002|Open-Label Phase|Adverse Event|4|||
164236126|NCT01126190|593236785|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164236127|NCT01126190|593236786|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164236128|NCT01126190|593236787|FG002|Open-Label Phase|Withdrawal by Subject|6|||
164236129|NCT01135992|593236788|FG000|Overall Study|Adverse Event|1|||
164236130|NCT01135992|593236788|FG000|Overall Study|Lack of Efficacy|1|||
164236131|NCT01135992|593236788|FG000|Overall Study|Protocol Violation|2|||
164236132|NCT01135992|593236788|FG000|Overall Study|Withdrawal criteria|10|||
164236133|NCT01135992|593236788|FG000|Overall Study|Unclassified|7|||
164236134|NCT01977898|593236789|FG000|Overall Study|Non functioning catheter|1|||
164236135|NCT01977898|593236790|FG001|Overall Study|Non functioning catheter|1|||
163884378|NCT04924660|591945941|FG004|South Africa|Lost to Follow-up|0|||
163884379|NCT04924660|591945942|FG005|South Africa|Lost to Follow-up|1|||
164236136|NCT03983421|593236791|FG000|Overall Study|Lost to Follow-up|1|||
164236137|NCT01049373|593236792|FG000|Overall Study|Protocol Violation|9|||
164236138|NCT01049373|593236793|FG001|Overall Study|Protocol Violation|9|||
164236139|NCT01049373|593236792|FG000|Overall Study|Withdrawal by Subject|8|||
164236140|NCT01049373|593236793|FG001|Overall Study|Withdrawal by Subject|5|||
164236141|NCT01049373|593236792|FG000|Overall Study|Adverse Event|3|||
164236142|NCT01049373|593236793|FG001|Overall Study|Adverse Event|3|||
164236143|NCT01049373|593236792|FG000|Overall Study|Lost to Follow-up|9|||
164236144|NCT01049373|593236793|FG001|Overall Study|Lost to Follow-up|4|||
164236145|NCT01049373|593236792|FG000|Overall Study|no evaluable study values|9|||
164236146|NCT01049373|593236793|FG001|Overall Study|no evaluable study values|21|||
164236147|NCT01049373|593236792|FG000|Overall Study|Other|1|||
164236148|NCT01049373|593236793|FG001|Overall Study|Other|1|||
164236149|NCT01049373|593236792|FG000|Overall Study|Non-cooperation|0|||
164236150|NCT01049373|593236793|FG001|Overall Study|Non-cooperation|1|||
164236151|NCT04573972|593236794|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
164236152|NCT04573972|593236795|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
164236153|NCT01517984|593236796|FG000|Overall Study|Lost to Follow-up|0|||
164236154|NCT01517984|593236797|FG001|Overall Study|Lost to Follow-up|1|||
164236155|NCT01517984|593236798|FG002|Overall Study|Lost to Follow-up|0|||
164236156|NCT01517984|593236799|FG003|Overall Study|Lost to Follow-up|0|||
164236157|NCT01517984|593236796|FG000|Overall Study|Withdrawal by Subject|1|||
164236158|NCT01517984|593236797|FG001|Overall Study|Withdrawal by Subject|8|||
164236159|NCT01517984|593236798|FG002|Overall Study|Withdrawal by Subject|4|||
164236160|NCT01517984|593236799|FG003|Overall Study|Withdrawal by Subject|1|||
164236161|NCT01517984|593236796|FG000|Overall Study|Screen Failure|4|||
164236162|NCT01517984|593236797|FG001|Overall Study|Screen Failure|0|||
164236163|NCT01517984|593236798|FG002|Overall Study|Screen Failure|0|||
164236164|NCT01517984|593236799|FG003|Overall Study|Screen Failure|0|||
164236165|NCT01517984|593236796|FG000|Overall Study|Ineligible for randomization|0|||
164236166|NCT01517984|593236797|FG001|Overall Study|Ineligible for randomization|14|||
164236167|NCT01517984|593236798|FG002|Overall Study|Ineligible for randomization|0|||
163884380|NCT02105766|591945943|FG000|Overall Study|Physician Decision|1|||
163884381|NCT02105766|591945944|FG001|Overall Study|Physician Decision|1|||
163884382|NCT02105766|591945945|FG002|Overall Study|Physician Decision|0|||
163884383|NCT02105766|591945943|FG000|Overall Study|Lost to Follow-up|2|||
163884384|NCT02105766|591945944|FG001|Overall Study|Lost to Follow-up|0|||
164236168|NCT01517984|593236799|FG003|Overall Study|Ineligible for randomization|0|||
164236169|NCT02724839|593236802|FG000|Overall Study|Withdrawal by Subject|1|||
164236170|NCT02724839|593236803|FG001|Overall Study|Withdrawal by Subject|1|||
164236171|NCT02724839|593236804|FG002|Overall Study|Withdrawal by Subject|0|||
164236172|NCT02724839|593236802|FG000|Overall Study|Lost to Follow-up|0|||
164236173|NCT02724839|593236803|FG001|Overall Study|Lost to Follow-up|3|||
164236174|NCT02724839|593236804|FG002|Overall Study|Lost to Follow-up|2|||
164236175|NCT02724839|593236802|FG000|Overall Study|Physician Decision|0|||
164236176|NCT02724839|593236803|FG001|Overall Study|Physician Decision|0|||
164236177|NCT02724839|593236804|FG002|Overall Study|Physician Decision|3|||
164236178|NCT01155050|593236805|FG000|Overall Study|Lost to Follow-up|15|||
164236179|NCT01155050|593236806|FG001|Overall Study|Lost to Follow-up|20|||
164236180|NCT01155050|593236807|FG002|Overall Study|Lost to Follow-up|19|||
164236181|NCT01155050|593236808|FG003|Overall Study|Lost to Follow-up|22|||
164236182|NCT01198587|593236809|FG000|Overall Study|Lost to Follow-up|8|||
164236183|NCT01198587|593236810|FG001|Overall Study|Lost to Follow-up|0|||
164236184|NCT01198587|593236811|FG002|Overall Study|Lost to Follow-up|9|||
164236185|NCT01198587|593236812|FG003|Overall Study|Lost to Follow-up|0|||
164236186|NCT01496287|593236813|FG000|Overall Study|Lost to Follow-up|1|||
164236187|NCT01496287|593236813|FG000|Overall Study|Incomplete anesthesia|5|||
164236188|NCT01959529|593236814|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
164236189|NCT01959529|593236815|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
164236190|NCT01959529|593236814|FG000|Overall Study|Lost to Follow-up|4|||
164236191|NCT01959529|593236815|FG001|Overall Study|Lost to Follow-up|1|||
164236192|NCT01959529|593236814|FG000|Overall Study|Other|70|||
164236193|NCT01959529|593236815|FG001|Overall Study|Other|68|||
164236194|NCT01959529|593236814|FG000|Overall Study|Hypoglycaemia|1|||
164236195|NCT01959529|593236815|FG001|Overall Study|Hypoglycaemia|1|||
164236196|NCT01959529|593236814|FG000|Overall Study|Lack of glycaemic control|1|||
164236197|NCT01959529|593236815|FG001|Overall Study|Lack of glycaemic control|1|||
164236198|NCT00557193|593236825|FG000|Induction|Adverse Event|2|||
164236199|NCT00557193|593236826|FG001|Induction|Adverse Event|0|||
164236200|NCT00557193|593236827|FG002|Induction|Adverse Event|0|||
164236201|NCT00557193|593236828|FG003|Induction|Adverse Event|0|||
164236202|NCT00557193|593236829|FG004|Induction|Adverse Event|0|||
164236203|NCT00557193|593236830|FG005|Induction|Adverse Event|0|||
164236204|NCT00557193|593236825|FG000|Induction|Death|6|||
164236205|NCT00557193|593236826|FG001|Induction|Death|0|||
164236206|NCT00557193|593236827|FG002|Induction|Death|0|||
164236207|NCT00557193|593236828|FG003|Induction|Death|0|||
164236208|NCT00557193|593236829|FG004|Induction|Death|0|||
164236209|NCT00557193|593236830|FG005|Induction|Death|0|||
164236210|NCT00557193|593236825|FG000|Induction|Physician Decision|3|||
164236211|NCT00557193|593236826|FG001|Induction|Physician Decision|0|||
164236212|NCT00557193|593236827|FG002|Induction|Physician Decision|0|||
164236213|NCT00557193|593236828|FG003|Induction|Physician Decision|0|||
164236214|NCT00557193|593236829|FG004|Induction|Physician Decision|0|||
164236215|NCT00557193|593236830|FG005|Induction|Physician Decision|0|||
164236216|NCT00557193|593236825|FG000|Induction|Withdrawal by Subject|1|||
164236217|NCT00557193|593236826|FG001|Induction|Withdrawal by Subject|0|||
164236218|NCT00557193|593236827|FG002|Induction|Withdrawal by Subject|0|||
164236219|NCT00557193|593236828|FG003|Induction|Withdrawal by Subject|0|||
164236220|NCT00557193|593236829|FG004|Induction|Withdrawal by Subject|0|||
164236221|NCT00557193|593236830|FG005|Induction|Withdrawal by Subject|0|||
164236222|NCT00557193|593236825|FG000|Induction|Refusal of Further Protocol Therapy|2|||
164236223|NCT00557193|593236826|FG001|Induction|Refusal of Further Protocol Therapy|0|||
164236224|NCT00557193|593236827|FG002|Induction|Refusal of Further Protocol Therapy|0|||
164236225|NCT00557193|593236828|FG003|Induction|Refusal of Further Protocol Therapy|0|||
164236226|NCT00557193|593236829|FG004|Induction|Refusal of Further Protocol Therapy|0|||
164236227|NCT00557193|593236830|FG005|Induction|Refusal of Further Protocol Therapy|0|||
164236228|NCT00557193|593236825|FG000|Induction|Ineligible|8|||
164236229|NCT00557193|593236826|FG001|Induction|Ineligible|0|||
164236230|NCT00557193|593236827|FG002|Induction|Ineligible|0|||
164236231|NCT00557193|593236828|FG003|Induction|Ineligible|0|||
164236232|NCT00557193|593236829|FG004|Induction|Ineligible|0|||
164236233|NCT00557193|593236830|FG005|Induction|Ineligible|0|||
164236234|NCT00557193|593236825|FG000|Induction|Inevaluable for post Induction|2|||
164236235|NCT00557193|593236826|FG001|Induction|Inevaluable for post Induction|0|||
164236236|NCT00557193|593236827|FG002|Induction|Inevaluable for post Induction|0|||
164236237|NCT00557193|593236828|FG003|Induction|Inevaluable for post Induction|0|||
164236238|NCT00557193|593236829|FG004|Induction|Inevaluable for post Induction|0|||
164236239|NCT00557193|593236830|FG005|Induction|Inevaluable for post Induction|0|||
164236240|NCT00557193|593236825|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
163884385|NCT02105766|591945945|FG002|Overall Study|Lost to Follow-up|0|||
164236241|NCT00557193|593236826|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236242|NCT00557193|593236827|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236243|NCT00557193|593236828|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236244|NCT00557193|593236829|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164334127|NCT03265665|593601460|FG000|24-week Data Collection|Withdrawal by Subject|2|||
164334128|NCT03265665|593601461|FG001|24-week Data Collection|Withdrawal by Subject|2|||
164334129|NCT03265665|593601460|FG000|24-week Data Collection|Lost to Follow-up|4|||
164334130|NCT03265665|593601461|FG001|24-week Data Collection|Lost to Follow-up|5|||
164334131|NCT03265665|593601460|FG000|36-week Data Collection|Lost to Follow-up|6|||
164334132|NCT03265665|593601461|FG001|36-week Data Collection|Lost to Follow-up|8|||
164334133|NCT01858376|593601462|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
164334134|NCT01680965|593601465|FG000|Overall Study|Death|0|||
164334135|NCT01680965|593601466|FG001|Overall Study|Death|0|||
164334136|NCT01680965|593601467|FG002|Overall Study|Death|0|||
164334137|NCT01680965|593601468|FG003|Overall Study|Death|6|||
164334138|NCT02486302|593601480|FG000|Overall Study|Discontinued prematurely|410|||
164334139|NCT02486302|593601480|FG000|Overall Study|Documentation not completed|255|||
164334140|NCT02486302|593601480|FG000|Overall Study|Excluded due to legal reasons|8|||
164334141|NCT02486302|593601480|FG000|Overall Study|Not treated|3|||
164334142|NCT00734474|593601483|FG000|Overall Study|Entry Criteria Not Met|0|||
164334143|NCT00734474|593601484|FG001|Overall Study|Entry Criteria Not Met|0|||
164334144|NCT00734474|593601485|FG002|Overall Study|Entry Criteria Not Met|5|||
164334145|NCT00734474|593601486|FG003|Overall Study|Entry Criteria Not Met|0|||
164334146|NCT00734474|593601487|FG004|Overall Study|Entry Criteria Not Met|3|||
164334147|NCT00734474|593601488|FG005|Overall Study|Entry Criteria Not Met|1|||
164334148|NCT00734474|593601489|FG006|Overall Study|Entry Criteria Not Met|0|||
164334149|NCT00734474|593601490|FG007|Overall Study|Entry Criteria Not Met|1|||
164334150|NCT00734474|593601491|FG008|Overall Study|Entry Criteria Not Met|1|||
164334151|NCT00734474|593601483|FG000|Overall Study|Lost to Follow-up|1|||
164334152|NCT00734474|593601484|FG001|Overall Study|Lost to Follow-up|0|||
164334153|NCT00734474|593601485|FG002|Overall Study|Lost to Follow-up|13|||
164334154|NCT00734474|593601486|FG003|Overall Study|Lost to Follow-up|0|||
164334155|NCT00734474|593601487|FG004|Overall Study|Lost to Follow-up|11|||
164334156|NCT00734474|593601488|FG005|Overall Study|Lost to Follow-up|1|||
164334157|NCT00734474|593601489|FG006|Overall Study|Lost to Follow-up|0|||
164334158|NCT00734474|593601490|FG007|Overall Study|Lost to Follow-up|9|||
164334159|NCT00734474|593601491|FG008|Overall Study|Lost to Follow-up|4|||
164334160|NCT00734474|593601483|FG000|Overall Study|Withdrawal by Subject|2|||
164334161|NCT00734474|593601484|FG001|Overall Study|Withdrawal by Subject|1|||
164334162|NCT00734474|593601485|FG002|Overall Study|Withdrawal by Subject|18|||
164334163|NCT00734474|593601486|FG003|Overall Study|Withdrawal by Subject|0|||
164334164|NCT00734474|593601487|FG004|Overall Study|Withdrawal by Subject|24|||
164334165|NCT00734474|593601488|FG005|Overall Study|Withdrawal by Subject|2|||
164334166|NCT00734474|593601489|FG006|Overall Study|Withdrawal by Subject|0|||
164334167|NCT00734474|593601490|FG007|Overall Study|Withdrawal by Subject|36|||
164334168|NCT00734474|593601491|FG008|Overall Study|Withdrawal by Subject|21|||
164334169|NCT00734474|593601483|FG000|Overall Study|Physician Decision|0|||
164334170|NCT00734474|593601484|FG001|Overall Study|Physician Decision|0|||
164334171|NCT00734474|593601485|FG002|Overall Study|Physician Decision|4|||
164334172|NCT00734474|593601486|FG003|Overall Study|Physician Decision|1|||
164334173|NCT00734474|593601487|FG004|Overall Study|Physician Decision|11|||
164334174|NCT00734474|593601488|FG005|Overall Study|Physician Decision|0|||
164334175|NCT00734474|593601489|FG006|Overall Study|Physician Decision|0|||
164334176|NCT00734474|593601490|FG007|Overall Study|Physician Decision|9|||
164334177|NCT00734474|593601491|FG008|Overall Study|Physician Decision|9|||
164334178|NCT00734474|593601483|FG000|Overall Study|Adverse Event|4|||
164334179|NCT00734474|593601484|FG001|Overall Study|Adverse Event|4|||
164334180|NCT00734474|593601485|FG002|Overall Study|Adverse Event|63|||
164334181|NCT00734474|593601486|FG003|Overall Study|Adverse Event|1|||
164334182|NCT00734474|593601487|FG004|Overall Study|Adverse Event|64|||
164334183|NCT00734474|593601488|FG005|Overall Study|Adverse Event|0|||
164334184|NCT00734474|593601489|FG006|Overall Study|Adverse Event|1|||
164334185|NCT00734474|593601490|FG007|Overall Study|Adverse Event|65|||
164334186|NCT00734474|593601491|FG008|Overall Study|Adverse Event|39|||
164334187|NCT00734474|593601483|FG000|Overall Study|Protocol Violation|0|||
164334188|NCT00734474|593601484|FG001|Overall Study|Protocol Violation|0|||
164334189|NCT00734474|593601485|FG002|Overall Study|Protocol Violation|4|||
163884386|NCT02105766|591945943|FG000|Overall Study|Death|1|||
164334190|NCT00734474|593601486|FG003|Overall Study|Protocol Violation|0|||
164334191|NCT00734474|593601487|FG004|Overall Study|Protocol Violation|3|||
164334192|NCT00734474|593601488|FG005|Overall Study|Protocol Violation|0|||
164334193|NCT00734474|593601489|FG006|Overall Study|Protocol Violation|0|||
164334194|NCT00734474|593601490|FG007|Overall Study|Protocol Violation|3|||
164334195|NCT00734474|593601491|FG008|Overall Study|Protocol Violation|1|||
164334196|NCT00734474|593601483|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
163884387|NCT02105766|591945944|FG001|Overall Study|Death|1|||
163884388|NCT02105766|591945945|FG002|Overall Study|Death|0|||
163884389|NCT02936752|591945957|FG000|Overall Study|Death|2|||
164334197|NCT00734474|593601484|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
164334198|NCT00734474|593601485|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164334199|NCT00734474|593601486|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
163884390|NCT02936752|591945958|FG001|Overall Study|Death|1|||
164334200|NCT00734474|593601487|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164236245|NCT00557193|593236830|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
164236246|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164236247|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
164236248|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
164236249|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
164236250|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164236251|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
164236252|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
164236253|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
164236254|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
164236255|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
164236256|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
164236257|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
164236258|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
164236259|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
164236260|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
164236261|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
164236262|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
164236263|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
164236264|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
164236265|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
164236266|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
164236267|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
164236268|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
164236269|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
164236270|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
164236271|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
164236272|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
164236273|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
164236274|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
163988657|NCT00763321|592326138|FG002|Double-blind Period|Withdrawal by Subject|3|||
163988658|NCT00763321|592326136|FG000|Double-blind Period|Other|0|||
163988659|NCT00763321|592326137|FG001|Double-blind Period|Other|2|||
164236275|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
164236276|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236277|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236278|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
164236279|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236280|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236281|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
164236282|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236283|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236284|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
164236285|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236286|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236287|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
164236288|NCT00557193|593236825|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236289|NCT00557193|593236826|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236290|NCT00557193|593236827|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
164236291|NCT00557193|593236828|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236292|NCT00557193|593236829|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
164236293|NCT00557193|593236830|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
164236294|NCT03036852|593236831|FG000|Overall Study|Death|2|||
164236295|NCT03036852|593236831|FG000|Overall Study|Lack of Efficacy|2|||
164236296|NCT03036852|593236831|FG000|Overall Study|Adverse Event|1|||
164236297|NCT03036852|593236831|FG000|Overall Study|Lost to Follow-up|1|||
164236298|NCT00652834|593236832|FG000|Overall Study|Withdrawal by Subject|3|||
164236299|NCT00652834|593236832|FG000|Overall Study|Lost to Follow-up|2|||
164236300|NCT03984825|593236835|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
164236301|NCT03984825|593236835|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
164236302|NCT03984825|593236835|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
164236303|NCT00742625|593236838|FG000|Remission Induction|Progression|6|||
164236304|NCT00742625|593236838|FG000|Remission Induction|Failed induction|8|||
164236305|NCT00742625|593236838|FG000|Remission Induction|Adverse Event|3|||
164236306|NCT00742625|593236838|FG000|Remission Induction|Death|10|||
164236307|NCT00742625|593236838|FG000|Remission Induction|Refusal|5|||
164236308|NCT00742625|593236838|FG000|Remission Induction|Non protocol treatment|17|||
164236309|NCT00742625|593236838|FG000|Remission Induction|Other, not specified|5|||
164236310|NCT00742625|593236838|FG000|Consolidation|Progression|5|||
164236311|NCT00742625|593236838|FG000|Consolidation|Adverse Event|1|||
164236312|NCT00742625|593236838|FG000|Consolidation|Death|1|||
164236313|NCT00742625|593236838|FG000|Consolidation|Refused|1|||
164236314|NCT00742625|593236838|FG000|Consolidation|Non protocol therapy|13|||
164236315|NCT01908140|593236843|FG000|Overall Study|Other or Progressive Disease|5|||
164236316|NCT01908140|593236844|FG001|Overall Study|Other or Progressive Disease|12|||
164236317|NCT01908140|593236843|FG000|Overall Study|Lack of Efficacy|7|||
164236318|NCT01908140|593236844|FG001|Overall Study|Lack of Efficacy|5|||
164236319|NCT01908140|593236843|FG000|Overall Study|Withdrawal by Subject|23|||
164236320|NCT01908140|593236844|FG001|Overall Study|Withdrawal by Subject|24|||
164236321|NCT01908140|593236843|FG000|Overall Study|Lost to Follow-up|1|||
164236322|NCT01908140|593236844|FG001|Overall Study|Lost to Follow-up|6|||
164236323|NCT01908140|593236843|FG000|Overall Study|Protocol Violation|8|||
164236324|NCT01908140|593236844|FG001|Overall Study|Protocol Violation|9|||
164236325|NCT01908140|593236843|FG000|Overall Study|Adverse Event|22|||
164236326|NCT01908140|593236844|FG001|Overall Study|Adverse Event|23|||
164236327|NCT01307449|593236845|FG000|Overall Study|Adverse Event|1|||
164236328|NCT01307449|593236846|FG001|Overall Study|Adverse Event|0|||
164236329|NCT01307449|593236847|FG002|Overall Study|Adverse Event|0|||
164236330|NCT01307449|593236848|FG003|Overall Study|Adverse Event|0|||
164236331|NCT02927795|593236851|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
164236332|NCT02927795|593236851|FG000|Overall Study|Not Treated|4|||
164236333|NCT01076010|593236852|FG000|Overall Study|Death|15|||
164236334|NCT01076010|593236853|FG001|Overall Study|Death|1|||
164236335|NCT01076010|593236854|FG002|Overall Study|Death|0|||
164236336|NCT01076010|593236852|FG000|Overall Study|Adverse Event|7|||
164236337|NCT01076010|593236853|FG001|Overall Study|Adverse Event|2|||
164236338|NCT01076010|593236854|FG002|Overall Study|Adverse Event|0|||
164236339|NCT01076010|593236852|FG000|Overall Study|Progressive disease|90|||
164236340|NCT01076010|593236853|FG001|Overall Study|Progressive disease|30|||
164236341|NCT01076010|593236854|FG002|Overall Study|Progressive disease|1|||
164236342|NCT01076010|593236852|FG000|Overall Study|Lack of Efficacy|4|||
164236343|NCT01076010|593236853|FG001|Overall Study|Lack of Efficacy|0|||
164236344|NCT01076010|593236854|FG002|Overall Study|Lack of Efficacy|0|||
164236345|NCT01076010|593236852|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
164236346|NCT01076010|593236853|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
164236347|NCT01076010|593236854|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
164236348|NCT01076010|593236852|FG000|Overall Study|Significant Surgical Procedure|0|||
164236349|NCT01076010|593236853|FG001|Overall Study|Significant Surgical Procedure|1|||
164236350|NCT01076010|593236854|FG002|Overall Study|Significant Surgical Procedure|0|||
164236351|NCT01076010|593236852|FG000|Overall Study|Protocol Violation|0|||
164236352|NCT01076010|593236853|FG001|Overall Study|Protocol Violation|1|||
164236353|NCT01076010|593236854|FG002|Overall Study|Protocol Violation|0|||
164236354|NCT01076010|593236852|FG000|Overall Study|Noncompliance|1|||
164236355|NCT01076010|593236853|FG001|Overall Study|Noncompliance|1|||
164236356|NCT01076010|593236854|FG002|Overall Study|Noncompliance|0|||
164236357|NCT01076010|593236852|FG000|Overall Study|Withdrawal by Subject|3|||
164236358|NCT01076010|593236853|FG001|Overall Study|Withdrawal by Subject|0|||
164236359|NCT01076010|593236854|FG002|Overall Study|Withdrawal by Subject|1|||
164236360|NCT01076010|593236852|FG000|Overall Study|Other|5|||
164236361|NCT01076010|593236853|FG001|Overall Study|Other|2|||
164236362|NCT01076010|593236854|FG002|Overall Study|Other|0|||
164236363|NCT00397540|593236863|FG000|Overall Study|short follow-up duration < 12 months|1|||
164236364|NCT00397540|593236864|FG001|Overall Study|short follow-up duration < 12 months|0|||
164236365|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
164236366|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
164236367|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
164236368|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Death|0|||
164236369|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Death|0|||
164236370|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Death|1|||
164236371|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
164236372|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
164236373|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
164236374|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
164236375|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
164236376|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
164236377|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
164236378|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
164236379|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
164236380|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Graft loss|0|||
164236381|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Graft loss|0|||
164236382|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Graft loss|7|||
164236383|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
164236384|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
164236385|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
164236386|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
164236387|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
164236388|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
164236389|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
163988660|NCT00763321|592326138|FG002|Double-blind Period|Other|3|||
164236390|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
164236391|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
163988661|NCT02486757|592326139|FG000|Overall Study|Lost to Follow-up|1|||
163988662|NCT02793232|592326140|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988663|NCT02793232|592326141|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988664|NCT02793232|592326142|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988665|NCT02793232|592326143|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988666|NCT02793232|592326144|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
163988667|NCT02793232|592326145|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988668|NCT02793232|592326146|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
163988669|NCT02793232|592326147|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988670|NCT02793232|592326148|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
163988671|NCT02387580|592326151|FG000|Overall Study|Withdrawal by Subject|0|||
163988672|NCT02387580|592326152|FG001|Overall Study|Withdrawal by Subject|0|||
163988673|NCT02387580|592326153|FG002|Overall Study|Withdrawal by Subject|0|||
163988674|NCT02387580|592326154|FG003|Overall Study|Withdrawal by Subject|1|||
163988675|NCT02387580|592326155|FG004|Overall Study|Withdrawal by Subject|0|||
163988676|NCT02387580|592326156|FG005|Overall Study|Withdrawal by Subject|0|||
163988677|NCT01064167|592326157|FG000|Overall Study|Protocol Violation|14|||
163988678|NCT01064167|592326158|FG001|Overall Study|Protocol Violation|15|||
163988679|NCT03984305|592326160|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
163988680|NCT03984305|592326161|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
163988681|NCT03984305|592326160|FG000|Overall Study|Withdrawal by Subject|3|||
163988682|NCT03984305|592326161|FG001|Overall Study|Withdrawal by Subject|3|||
164334201|NCT00734474|593601488|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
164334202|NCT00734474|593601489|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
164334203|NCT00734474|593601490|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164334204|NCT00734474|593601491|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
164334205|NCT00734474|593601483|FG000|Overall Study|Sponsor Decision|0|||
164334206|NCT00734474|593601484|FG001|Overall Study|Sponsor Decision|0|||
164334207|NCT00734474|593601485|FG002|Overall Study|Sponsor Decision|0|||
164334208|NCT00734474|593601486|FG003|Overall Study|Sponsor Decision|0|||
164334209|NCT00734474|593601487|FG004|Overall Study|Sponsor Decision|2|||
164334210|NCT00734474|593601488|FG005|Overall Study|Sponsor Decision|0|||
164334211|NCT00734474|593601489|FG006|Overall Study|Sponsor Decision|0|||
164334212|NCT00734474|593601490|FG007|Overall Study|Sponsor Decision|0|||
164334213|NCT00734474|593601491|FG008|Overall Study|Sponsor Decision|0|||
164334214|NCT00734474|593601483|FG000|Overall Study|Death|0|||
164334215|NCT00734474|593601484|FG001|Overall Study|Death|0|||
164334216|NCT00734474|593601485|FG002|Overall Study|Death|1|||
164334217|NCT00734474|593601486|FG003|Overall Study|Death|0|||
164334218|NCT00734474|593601487|FG004|Overall Study|Death|0|||
164334219|NCT00734474|593601488|FG005|Overall Study|Death|0|||
164334220|NCT00734474|593601489|FG006|Overall Study|Death|0|||
164334221|NCT00734474|593601490|FG007|Overall Study|Death|2|||
164334222|NCT00734474|593601491|FG008|Overall Study|Death|1|||
164334223|NCT00734474|593601483|FG000|Overall Study|Lack of Efficacy|0|||
164334224|NCT00734474|593601484|FG001|Overall Study|Lack of Efficacy|0|||
164334225|NCT00734474|593601485|FG002|Overall Study|Lack of Efficacy|4|||
164334226|NCT00734474|593601486|FG003|Overall Study|Lack of Efficacy|0|||
164334227|NCT00734474|593601487|FG004|Overall Study|Lack of Efficacy|0|||
164334228|NCT00734474|593601488|FG005|Overall Study|Lack of Efficacy|0|||
164334229|NCT00734474|593601489|FG006|Overall Study|Lack of Efficacy|0|||
164334230|NCT00734474|593601490|FG007|Overall Study|Lack of Efficacy|4|||
164334231|NCT00734474|593601491|FG008|Overall Study|Lack of Efficacy|6|||
164334232|NCT02104752|593601494|FG000|Overall Study|Withdrawal by Subject|1|||
164334233|NCT02104752|593601495|FG001|Overall Study|Withdrawal by Subject|0|||
164334234|NCT02104752|593601494|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
164334235|NCT02104752|593601495|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
164334236|NCT02899299|593601496|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
164334237|NCT02899299|593601497|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
164334238|NCT02899299|593601496|FG000|Pre-treatment|Participant withdrew consent|1|||
164334239|NCT02899299|593601497|FG001|Pre-treatment|Participant withdrew consent|11|||
164334240|NCT02899299|593601496|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
164334241|NCT02899299|593601497|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
164334242|NCT02899299|593601496|FG000|Pre-treatment|Not reported|0|||
164334243|NCT02899299|593601497|FG001|Pre-treatment|Not reported|1|||
164334244|NCT02899299|593601496|FG000|Treatment|Disease Progression|182|||
164334245|NCT02899299|593601497|FG001|Treatment|Disease Progression|43|||
164334246|NCT02899299|593601496|FG000|Treatment|Study Drug Toxicity|60|||
164334247|NCT02899299|593601497|FG001|Treatment|Study Drug Toxicity|24|||
164334248|NCT02899299|593601496|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
164334249|NCT02899299|593601497|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
164334250|NCT02899299|593601496|FG000|Treatment|Participant request to discontinue Study treatment|4|||
164334251|NCT02899299|593601497|FG001|Treatment|Participant request to discontinue Study treatment|10|||
164334252|NCT02899299|593601496|FG000|Treatment|Participant withdrew consent|6|||
164334253|NCT02899299|593601497|FG001|Treatment|Participant withdrew consent|3|||
164334254|NCT02899299|593601496|FG000|Treatment|Lost to Follow-up|0|||
164334255|NCT02899299|593601497|FG001|Treatment|Lost to Follow-up|2|||
164334256|NCT02899299|593601496|FG000|Treatment|Maximum Clinical Benefit|11|||
164334257|NCT02899299|593601497|FG001|Treatment|Maximum Clinical Benefit|2|||
164334258|NCT02899299|593601496|FG000|Treatment|Poor/Non-compliance|1|||
164334259|NCT02899299|593601497|FG001|Treatment|Poor/Non-compliance|0|||
164334260|NCT02899299|593601496|FG000|Treatment|Participant no longer meets Study criteria|4|||
164334261|NCT02899299|593601497|FG001|Treatment|Participant no longer meets Study criteria|0|||
164334262|NCT02899299|593601496|FG000|Treatment|Administrative reason by Sponsor|2|||
164334263|NCT02899299|593601497|FG001|Treatment|Administrative reason by Sponsor|0|||
164334264|NCT02899299|593601496|FG000|Treatment|Other reasons|12|||
164334265|NCT02899299|593601497|FG001|Treatment|Other reasons|2|||
164334266|NCT02899299|593601496|FG000|Treatment|Not reported|7|||
164334267|NCT02899299|593601497|FG001|Treatment|Not reported|0|||
164334268|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
164334269|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
164334270|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
164334271|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
164334272|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
164334273|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
164334274|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
164334275|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
164334276|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
164334277|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
164334278|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
164334279|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
164334280|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
164334281|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
164334282|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
164334283|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
164334284|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
164334285|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
164334286|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
164334287|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
164334288|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
164334289|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
164334290|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
164334291|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
164334292|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
164334293|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
164334294|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
164334295|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
164334296|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
164334297|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
164334298|NCT00313300|593601498|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
164334299|NCT00313300|593601499|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334300|NCT00313300|593601500|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334301|NCT00313300|593601501|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334302|NCT00313300|593601502|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
164334303|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
164334304|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
164334305|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
164334306|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
164334307|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
164334308|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
164334309|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
164334310|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
164334311|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
164334312|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
164334313|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
164334314|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
164334315|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
164334316|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
164334317|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
164334318|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
164334319|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
164334320|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
164334321|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
164334322|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
164334323|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
164334324|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
164334325|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
164334326|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
164334327|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
164334328|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
164334329|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
164334330|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
164334331|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
164334332|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
164334333|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
164334334|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
164334335|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
164334336|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
164334337|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
164334338|NCT00313300|593601498|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
164334339|NCT00313300|593601499|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334340|NCT00313300|593601500|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334341|NCT00313300|593601501|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334342|NCT00313300|593601502|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
164334343|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
164334344|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
164334345|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
164334346|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
164334347|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
164334348|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334349|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
164334350|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334351|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334352|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
164334353|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
164334354|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
164334355|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
164334356|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
164334357|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
164334358|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
164334359|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334360|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334361|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334362|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
164334363|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
164334364|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
164334365|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
164334366|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
164334367|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
164334368|NCT00313300|593601498|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
164334369|NCT00313300|593601499|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
164334370|NCT00313300|593601500|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
164334371|NCT00313300|593601501|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
164334372|NCT00313300|593601502|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
164334373|NCT00639678|593601505|FG000|Overall Study|Withdrawal by Subject|3|||
164334374|NCT00639678|593601506|FG001|Overall Study|Withdrawal by Subject|0|||
164334375|NCT00639678|593601507|FG002|Overall Study|Withdrawal by Subject|4|||
164334376|NCT00639678|593601508|FG003|Overall Study|Withdrawal by Subject|0|||
164334377|NCT00639678|593601505|FG000|Overall Study|Lost to Follow-up|1|||
164334378|NCT00639678|593601506|FG001|Overall Study|Lost to Follow-up|0|||
164334379|NCT00639678|593601507|FG002|Overall Study|Lost to Follow-up|6|||
164334380|NCT00639678|593601508|FG003|Overall Study|Lost to Follow-up|0|||
164334381|NCT00639678|593601505|FG000|Overall Study|Adverse Event|0|||
164334382|NCT00639678|593601506|FG001|Overall Study|Adverse Event|1|||
164334383|NCT00639678|593601507|FG002|Overall Study|Adverse Event|0|||
164334384|NCT00639678|593601508|FG003|Overall Study|Adverse Event|0|||
164334385|NCT00639678|593601505|FG000|Overall Study|Lack of Compliance|0|||
164334386|NCT00639678|593601506|FG001|Overall Study|Lack of Compliance|0|||
164334387|NCT00639678|593601507|FG002|Overall Study|Lack of Compliance|1|||
164334388|NCT00639678|593601508|FG003|Overall Study|Lack of Compliance|0|||
164334389|NCT01926015|593601509|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164334390|NCT01926015|593601510|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164334391|NCT01926015|593601509|FG000|Overall Study|Randomized not treated|2|||
164334392|NCT01926015|593601510|FG001|Overall Study|Randomized not treated|0|||
164334393|NCT01364649|593601511|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
164334394|NCT01364649|593601512|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
164334395|NCT01364649|593601511|FG000|Overall Study|Lack of Efficacy|6|||
164334396|NCT01364649|593601512|FG001|Overall Study|Lack of Efficacy|0|||
164334397|NCT01364649|593601511|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
164334398|NCT01364649|593601512|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
164334399|NCT01364649|593601511|FG000|Overall Study|Protocol Deviations|4|||
164334400|NCT01364649|593601512|FG001|Overall Study|Protocol Deviations|8|||
164334401|NCT01364649|593601511|FG000|Overall Study|Withdrawal of Consent|9|||
164334402|NCT01364649|593601512|FG001|Overall Study|Withdrawal of Consent|7|||
164334403|NCT01364649|593601511|FG000|Overall Study|Lost to Follow-up|12|||
164334404|NCT01364649|593601512|FG001|Overall Study|Lost to Follow-up|13|||
164334405|NCT01364649|593601511|FG000|Overall Study|Other|4|||
164334406|NCT01364649|593601512|FG001|Overall Study|Other|1|||
164334407|NCT01826604|593601513|FG000|Overall Study|Lost to Follow-up|8|||
164334408|NCT01826604|593601514|FG001|Overall Study|Lost to Follow-up|9|||
164334409|NCT04416633|593601515|FG000|Overall Study|Death|1|||
164334410|NCT04416633|593601515|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
164334411|NCT04416633|593601515|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
164334412|NCT04416633|593601515|FG000|Overall Study|Adverse Event|6|||
164334413|NCT04416633|593601515|FG000|Overall Study|Withdrawal by Subject|6|||
164334414|NCT03323502|593601516|FG000|Overall Study|Resident could not be linked to CMS data|594|||
164334415|NCT03323502|593601517|FG001|Overall Study|Resident could not be linked to CMS data|435|||
164334416|NCT03323502|593601516|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
164334417|NCT03323502|593601517|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
164334418|NCT03323502|593601516|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
164334419|NCT03323502|593601517|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
164334420|NCT03323502|593601516|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
164334421|NCT03323502|593601517|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
164334422|NCT03323502|593601516|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
164334423|NCT03323502|593601517|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
164334424|NCT00902668|593601528|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
164334425|NCT01914757|593601529|FG000|Overall Study|Severe non-compliance to protocol|3|||
164334426|NCT01914757|593601530|FG001|Overall Study|Severe non-compliance to protocol|1|||
164334427|NCT01914757|593601531|FG002|Overall Study|Severe non-compliance to protocol|2|||
164334428|NCT01914757|593601529|FG000|Overall Study|Lost to Follow-up|5|||
164334429|NCT01914757|593601530|FG001|Overall Study|Lost to Follow-up|8|||
164334430|NCT01914757|593601531|FG002|Overall Study|Lost to Follow-up|6|||
164334431|NCT01914757|593601529|FG000|Overall Study|Withdrawal by Subject|15|||
164334432|NCT01914757|593601530|FG001|Overall Study|Withdrawal by Subject|27|||
164236392|NCT00956293|593236866|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
164236393|NCT00956293|593236867|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
164236394|NCT00956293|593236868|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
164236395|NCT00956293|593236866|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
164236396|NCT00956293|593236867|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
164236397|NCT00956293|593236868|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
164236398|NCT00956293|593236866|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
164236399|NCT00956293|593236867|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
164236400|NCT00956293|593236868|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
164236401|NCT00956293|593236866|FG000|Main Period (Randomization)|Adverse Event|0|||
164236402|NCT00956293|593236867|FG001|Main Period (Randomization)|Adverse Event|15|||
164236403|NCT00956293|593236868|FG002|Main Period (Randomization)|Adverse Event|0|||
164236404|NCT00956293|593236866|FG000|Follow-up Period|Follow-up period was terminated.|20|||
164236405|NCT00956293|593236867|FG001|Follow-up Period|Follow-up period was terminated.|32|||
164236406|NCT00956293|593236868|FG002|Follow-up Period|Follow-up period was terminated.|0|||
164236407|NCT02536664|593236869|FG000|Overall Study|Inadequate completion of documentation|2|||
164236408|NCT02536664|593236870|FG001|Overall Study|Inadequate completion of documentation|4|||
164236409|NCT02536664|593236869|FG000|Overall Study|Progression|13|||
164236410|NCT02536664|593236870|FG001|Overall Study|Progression|18|||
164236411|NCT02536664|593236869|FG000|Overall Study|Death due to lymphoma|2|||
164236412|NCT02536664|593236870|FG001|Overall Study|Death due to lymphoma|1|||
164236413|NCT02536664|593236869|FG000|Overall Study|Death due to other reason|3|||
164236414|NCT02536664|593236870|FG001|Overall Study|Death due to other reason|2|||
164236415|NCT02536664|593236869|FG000|Overall Study|Intolerability|8|||
164236416|NCT02536664|593236870|FG001|Overall Study|Intolerability|6|||
164236417|NCT02536664|593236869|FG000|Overall Study|Withdrawal by Subject|8|||
164236418|NCT02536664|593236870|FG001|Overall Study|Withdrawal by Subject|5|||
164236419|NCT02536664|593236869|FG000|Overall Study|Other|18|||
164334433|NCT01914757|593601531|FG002|Overall Study|Withdrawal by Subject|19|||
164334434|NCT01914757|593601529|FG000|Overall Study|Death|2|||
164334435|NCT01914757|593601530|FG001|Overall Study|Death|2|||
164334436|NCT01914757|593601531|FG002|Overall Study|Death|1|||
164334437|NCT01914757|593601529|FG000|Overall Study|Adverse Event|4|||
164334438|NCT01914757|593601530|FG001|Overall Study|Adverse Event|3|||
164334439|NCT01914757|593601531|FG002|Overall Study|Adverse Event|4|||
164334440|NCT01914757|593601529|FG000|Overall Study|Study specific withdrawal criteria|0|||
164334441|NCT01914757|593601530|FG001|Overall Study|Study specific withdrawal criteria|1|||
164334442|NCT01914757|593601531|FG002|Overall Study|Study specific withdrawal criteria|0|||
164334443|NCT01914757|593601529|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164334444|NCT01914757|593601530|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164334445|NCT01914757|593601531|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
164334446|NCT01914757|593601529|FG000|Overall Study|Other reasons|5|||
164334447|NCT01914757|593601530|FG001|Overall Study|Other reasons|9|||
164334448|NCT01914757|593601531|FG002|Overall Study|Other reasons|4|||
164334449|NCT00408629|593601536|FG000|Overall Study|Adverse Event|13|||
164334450|NCT00408629|593601537|FG001|Overall Study|Adverse Event|27|||
164334451|NCT00408629|593601536|FG000|Overall Study|Withdrawal by Subject|8|||
164334452|NCT00408629|593601537|FG001|Overall Study|Withdrawal by Subject|4|||
164334453|NCT00408629|593601536|FG000|Overall Study|Lost to Follow-up|1|||
164334454|NCT00408629|593601537|FG001|Overall Study|Lost to Follow-up|1|||
164334455|NCT00408629|593601536|FG000|Overall Study|Lack of Efficacy|63|||
164334456|NCT00408629|593601537|FG001|Overall Study|Lack of Efficacy|73|||
164334457|NCT00408629|593601536|FG000|Overall Study|Protocol Violation|1|||
164334458|NCT00408629|593601537|FG001|Overall Study|Protocol Violation|5|||
164334459|NCT00408629|593601536|FG000|Overall Study|Miscellaneous|11|||
164334460|NCT00408629|593601537|FG001|Overall Study|Miscellaneous|15|||
164334461|NCT01461980|593601538|FG000|Overall Study|Other|9|||
164334462|NCT01461980|593601539|FG001|Overall Study|Other|8|||
164334463|NCT01461980|593601540|FG002|Overall Study|Other|6|||
164334464|NCT01461980|593601538|FG000|Overall Study|Medication error|7|||
164334465|NCT01461980|593601539|FG001|Overall Study|Medication error|5|||
164334466|NCT01461980|593601540|FG002|Overall Study|Medication error|6|||
164334467|NCT01461980|593601538|FG000|Overall Study|Adverse Event|12|||
164334468|NCT01461980|593601539|FG001|Overall Study|Adverse Event|5|||
164334469|NCT01461980|593601540|FG002|Overall Study|Adverse Event|6|||
164334470|NCT01461980|593601538|FG000|Overall Study|Protocol Violation|12|||
164334471|NCT01461980|593601539|FG001|Overall Study|Protocol Violation|19|||
164334472|NCT01461980|593601540|FG002|Overall Study|Protocol Violation|16|||
164334473|NCT01461980|593601538|FG000|Overall Study|No longer meets eligibility criteria|18|||
164334474|NCT01461980|593601539|FG001|Overall Study|No longer meets eligibility criteria|9|||
164334475|NCT01461980|593601540|FG002|Overall Study|No longer meets eligibility criteria|19|||
164334476|NCT01461980|593601538|FG000|Overall Study|Lost to Follow-up|52|||
164334477|NCT01461980|593601539|FG001|Overall Study|Lost to Follow-up|53|||
164236420|NCT02536664|593236870|FG001|Overall Study|Other|24|||
164236421|NCT02536664|593236869|FG000|Overall Study|Missing|53|||
164236422|NCT02536664|593236870|FG001|Overall Study|Missing|20|||
164334478|NCT01461980|593601540|FG002|Overall Study|Lost to Follow-up|51|||
163884391|NCT02936752|591945957|FG000|Overall Study|Physician Decision|4|||
163884392|NCT02936752|591945958|FG001|Overall Study|Physician Decision|0|||
164334479|NCT01461980|593601538|FG000|Overall Study|No longer willing to participate|52|||
164334480|NCT01461980|593601539|FG001|Overall Study|No longer willing to participate|38|||
164334481|NCT01461980|593601540|FG002|Overall Study|No longer willing to participate|54|||
164334482|NCT01461980|593601538|FG000|Overall Study|Randomized but not vaccinated|4|||
164334483|NCT01461980|593601539|FG001|Overall Study|Randomized but not vaccinated|8|||
164334484|NCT01461980|593601540|FG002|Overall Study|Randomized but not vaccinated|7|||
164334485|NCT00122109|593601541|FG000|Overall Study|Did not meet criteria|6|||
164334486|NCT00122109|593601542|FG001|Overall Study|Did not meet criteria|7|||
164334487|NCT01890746|593601543|FG000|Overall Study|Death|39|||
164334488|NCT01890746|593601544|FG001|Overall Study|Death|30|||
164334489|NCT01890746|593601543|FG000|Overall Study|Adverse Event|1|||
164334490|NCT01890746|593601544|FG001|Overall Study|Adverse Event|0|||
164334491|NCT01890746|593601543|FG000|Overall Study|Lost to Follow-up|4|||
164334492|NCT01890746|593601544|FG001|Overall Study|Lost to Follow-up|1|||
164334493|NCT01890746|593601543|FG000|Overall Study|Physician Decision|3|||
163884393|NCT02936752|591945957|FG000|Overall Study|Withdrawal by Subject|0|||
163884394|NCT02936752|591945958|FG001|Overall Study|Withdrawal by Subject|2|||
163884395|NCT05894577|591945959|FG000|Overall Study|No receipt of study drug|14|||
163884396|NCT05894577|591945960|FG001|Overall Study|No receipt of study drug|13|||
163884397|NCT05894577|591945959|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
163884398|NCT05894577|591945960|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
163884399|NCT05894577|591945959|FG000|Overall Study|Screen Fail|2|||
163884400|NCT05894577|591945960|FG001|Overall Study|Screen Fail|0|||
163884401|NCT05894577|591945959|FG000|Overall Study|Study drug recall|86|||
163884402|NCT05894577|591945960|FG001|Overall Study|Study drug recall|63|||
163884403|NCT04495894|591945971|FG000|Overall Study|Withdrawal by Subject|2|||
163884404|NCT04495894|591945972|FG001|Overall Study|Withdrawal by Subject|0|||
163884405|NCT04495894|591945973|FG002|Overall Study|Withdrawal by Subject|2|||
163884406|NCT04495894|591945974|FG003|Overall Study|Withdrawal by Subject|3|||
163884407|NCT04495894|591945971|FG000|Overall Study|Early termination|0|||
163884408|NCT04495894|591945972|FG001|Overall Study|Early termination|0|||
163884409|NCT04495894|591945973|FG002|Overall Study|Early termination|3|||
163884410|NCT04495894|591945974|FG003|Overall Study|Early termination|0|||
163884411|NCT04064164|591945975|FG000|Overall Study|Withdrawal by Subject|8|||
163884412|NCT04064164|591945976|FG001|Overall Study|Withdrawal by Subject|8|||
163884413|NCT01000961|591945977|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
163884414|NCT01000961|591945978|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
163884415|NCT01000961|591945977|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
163884416|NCT01000961|591945978|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
163884417|NCT05746455|591945982|FG000|Overall Study|Discharged from Clinical Service|1|||
163884418|NCT05746455|591945982|FG000|Overall Study|Lost to Follow-up|1|||
164334494|NCT01890746|593601544|FG001|Overall Study|Physician Decision|2|||
164236423|NCT03507127|593236873|FG000|Overall Study|Withdrawal by Subject|1|||
164236424|NCT03507127|593236874|FG001|Overall Study|Withdrawal by Subject|0|||
164236425|NCT03507127|593236873|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
164236426|NCT03507127|593236874|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
164236427|NCT02081586|593236876|FG000|Overall Study|Lost to Follow-up|0|||
164236428|NCT02081586|593236877|FG001|Overall Study|Lost to Follow-up|1|||
164236429|NCT02081586|593236878|FG002|Overall Study|Lost to Follow-up|0|||
164236430|NCT02081586|593236879|FG003|Overall Study|Lost to Follow-up|1|||
164236431|NCT02081586|593236876|FG000|Overall Study|Head injury not related to study|0|||
164236432|NCT02081586|593236877|FG001|Overall Study|Head injury not related to study|0|||
164236433|NCT02081586|593236878|FG002|Overall Study|Head injury not related to study|1|||
164236434|NCT02081586|593236879|FG003|Overall Study|Head injury not related to study|0|||
164236435|NCT01355627|593236881|FG000|Overall Study|Request By the Patient to Discontinue|5|||
164236436|NCT01355627|593236882|FG001|Overall Study|Request By the Patient to Discontinue|7|||
164236437|NCT01355627|593236881|FG000|Overall Study|Lost to Follow-up|8|||
164236438|NCT01355627|593236882|FG001|Overall Study|Lost to Follow-up|7|||
164236439|NCT01355627|593236881|FG000|Overall Study|Fatal Adverse Event|19|||
164236440|NCT01355627|593236882|FG001|Overall Study|Fatal Adverse Event|23|||
164236441|NCT01355627|593236881|FG000|Overall Study|Other|1|||
164236442|NCT01355627|593236882|FG001|Overall Study|Other|1|||
164236443|NCT00789555|593236891|FG000|Overall Study|Protocol Amendment|78|||
164236444|NCT00789555|593236892|FG001|Overall Study|Protocol Amendment|76|||
164236445|NCT00789555|593236893|FG002|Overall Study|Protocol Amendment|80|||
164236446|NCT00789555|593236891|FG000|Overall Study|Adverse Event|17|||
164236447|NCT00789555|593236892|FG001|Overall Study|Adverse Event|7|||
164236448|NCT00789555|593236893|FG002|Overall Study|Adverse Event|10|||
164236449|NCT00789555|593236891|FG000|Overall Study|Lost to Follow-up|9|||
164236450|NCT00789555|593236892|FG001|Overall Study|Lost to Follow-up|10|||
164236451|NCT00789555|593236893|FG002|Overall Study|Lost to Follow-up|18|||
164236452|NCT00789555|593236891|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
164236453|NCT00789555|593236892|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
164334495|NCT01890746|593601543|FG000|Overall Study|Withdrawal by Subject|5|||
164334496|NCT01890746|593601544|FG001|Overall Study|Withdrawal by Subject|8|||
164334497|NCT00100178|593601545|FG000|Overall Study|Lost to Follow-up|0|||
164334498|NCT00100178|593601546|FG001|Overall Study|Lost to Follow-up|6|||
164334499|NCT00100178|593601547|FG002|Overall Study|Lost to Follow-up|5|||
164334500|NCT00100178|593601545|FG000|Overall Study|Adverse Event|2|||
164334501|NCT00100178|593601546|FG001|Overall Study|Adverse Event|2|||
163988683|NCT03984305|592326160|FG000|Overall Study|Lost to Follow-up|1|||
164334502|NCT00100178|593601547|FG002|Overall Study|Adverse Event|1|||
164334503|NCT00100178|593601545|FG000|Overall Study|Withdrawal by Subject|1|||
164334504|NCT00100178|593601546|FG001|Overall Study|Withdrawal by Subject|1|||
164334505|NCT00100178|593601547|FG002|Overall Study|Withdrawal by Subject|1|||
164334506|NCT00100178|593601545|FG000|Overall Study|Physician Decision|6|||
164334507|NCT00100178|593601546|FG001|Overall Study|Physician Decision|1|||
164334508|NCT00100178|593601547|FG002|Overall Study|Physician Decision|3|||
164334509|NCT00631696|593601548|FG000|Overall Study|Entered, not randomized to treatment|1|||
164334510|NCT00631696|593601549|FG001|Overall Study|Entered, not randomized to treatment|1|||
164334511|NCT00631696|593601548|FG000|Overall Study|Discontinued after database release date|1|||
164334512|NCT00631696|593601549|FG001|Overall Study|Discontinued after database release date|0|||
164334513|NCT00631696|593601548|FG000|Overall Study|Follow up after database release date|1|||
164334514|NCT00631696|593601549|FG001|Overall Study|Follow up after database release date|0|||
164334515|NCT00631696|593601548|FG000|Overall Study|Lost to Follow-up|7|||
164334516|NCT00631696|593601549|FG001|Overall Study|Lost to Follow-up|10|||
164334517|NCT00631696|593601548|FG000|Overall Study|Withdrawal by Subject|2|||
164334518|NCT00631696|593601549|FG001|Overall Study|Withdrawal by Subject|9|||
164334519|NCT00631696|593601548|FG000|Overall Study|Other|8|||
164334520|NCT00631696|593601549|FG001|Overall Study|Other|8|||
164334521|NCT00631696|593601548|FG000|Overall Study|Protocol Violation|9|||
164334522|NCT00631696|593601549|FG001|Overall Study|Protocol Violation|9|||
164334523|NCT00631696|593601548|FG000|Overall Study|Study terminated by sponsor|3|||
164334524|NCT00631696|593601549|FG001|Overall Study|Study terminated by sponsor|3|||
164334525|NCT00631696|593601548|FG000|Overall Study|Adverse Event|5|||
164334526|NCT00631696|593601549|FG001|Overall Study|Adverse Event|0|||
164334527|NCT03198078|593601552|FG000|Overall Study|Adverse Event|0|||
164334528|NCT03198078|593601553|FG001|Overall Study|Adverse Event|1|||
164334529|NCT03198078|593601554|FG002|Overall Study|Adverse Event|2|||
164334530|NCT03198078|593601552|FG000|Overall Study|Lack of Efficacy|0|||
164334531|NCT03198078|593601553|FG001|Overall Study|Lack of Efficacy|0|||
164334532|NCT03198078|593601554|FG002|Overall Study|Lack of Efficacy|3|||
164334533|NCT03198078|593601552|FG000|Overall Study|Lost to Follow-up|1|||
164334534|NCT03198078|593601553|FG001|Overall Study|Lost to Follow-up|0|||
164334535|NCT03198078|593601554|FG002|Overall Study|Lost to Follow-up|0|||
164334536|NCT03198078|593601552|FG000|Overall Study|Pregnancy|0|||
164334537|NCT03198078|593601553|FG001|Overall Study|Pregnancy|1|||
164334538|NCT03198078|593601554|FG002|Overall Study|Pregnancy|0|||
164334539|NCT03198078|593601552|FG000|Overall Study|Withdrawal by Subject|1|||
164334540|NCT03198078|593601553|FG001|Overall Study|Withdrawal by Subject|0|||
164334541|NCT03198078|593601554|FG002|Overall Study|Withdrawal by Subject|2|||
164334542|NCT03198078|593601552|FG000|Overall Study|Withdrawal by Caregiver|1|||
164334543|NCT03198078|593601553|FG001|Overall Study|Withdrawal by Caregiver|3|||
164334544|NCT03198078|593601554|FG002|Overall Study|Withdrawal by Caregiver|5|||
164334545|NCT01676727|593601555|FG000|Overall Study|Death|18|||
164334546|NCT01676727|593601555|FG000|Overall Study|Withdrawal by Subject|6|||
164334547|NCT01676727|593601555|FG000|Overall Study|Screening failure|5|||
164334548|NCT01676727|593601555|FG000|Overall Study|Not willing to attend 1-year visit|2|||
164334549|NCT01676727|593601555|FG000|Overall Study|Valve explanted|1|||
164334550|NCT01578330|593601556|FG000|Overall Study|Adverse Event|2|||
164334551|NCT01578330|593601556|FG000|Overall Study|Protocol Violation|5|||
164334552|NCT02517866|593601558|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164334553|NCT02517866|593601559|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164334554|NCT02517866|593601560|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164334555|NCT02517866|593601558|FG000|Overall Study|Significant Protocol Deviation|4|||
164334556|NCT02517866|593601559|FG001|Overall Study|Significant Protocol Deviation|1|||
164334557|NCT02517866|593601560|FG002|Overall Study|Significant Protocol Deviation|0|||
164334558|NCT02517866|593601558|FG000|Overall Study|Lost to Follow-up|1|||
164334559|NCT02517866|593601559|FG001|Overall Study|Lost to Follow-up|0|||
164334560|NCT02517866|593601560|FG002|Overall Study|Lost to Follow-up|0|||
164334561|NCT02517866|593601558|FG000|Overall Study|Voluntary Withdrawal|2|||
164334562|NCT02517866|593601559|FG001|Overall Study|Voluntary Withdrawal|2|||
164334563|NCT02517866|593601560|FG002|Overall Study|Voluntary Withdrawal|0|||
164334564|NCT02517866|593601558|FG000|Overall Study|Investigator Decision|2|||
164334565|NCT02517866|593601559|FG001|Overall Study|Investigator Decision|1|||
164334566|NCT02517866|593601560|FG002|Overall Study|Investigator Decision|0|||
164334567|NCT02517866|593601558|FG000|Overall Study|Reason not specified|2|||
164334568|NCT02517866|593601559|FG001|Overall Study|Reason not specified|0|||
164334569|NCT02517866|593601560|FG002|Overall Study|Reason not specified|0|||
164334570|NCT03114488|593601561|FG000|Time Period 2|Withdrawal by Subject|1|||
163884419|NCT02023866|591945983|FG000|Overall Study|Non-compliance|2|||
163884420|NCT02023866|591945983|FG000|Overall Study|Adverse Event|3|||
163884421|NCT02023866|591945983|FG000|Overall Study|Withdrawal by Subject|1|||
164236454|NCT00789555|593236893|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
164236455|NCT00789555|593236891|FG000|Overall Study|Treatment failure|11|||
164236456|NCT00789555|593236892|FG001|Overall Study|Treatment failure|8|||
164236457|NCT00789555|593236893|FG002|Overall Study|Treatment failure|12|||
164236458|NCT00789555|593236891|FG000|Overall Study|Protocol Violation|6|||
164236459|NCT00789555|593236892|FG001|Overall Study|Protocol Violation|9|||
164236460|NCT00789555|593236893|FG002|Overall Study|Protocol Violation|13|||
164236461|NCT04712669|593236894|FG000|Double Blind Phase|Adverse Event|4|||
164236462|NCT04712669|593236895|FG001|Double Blind Phase|Adverse Event|4|||
164236463|NCT04712669|593236896|FG002|Double Blind Phase|Adverse Event|3|||
164236464|NCT04712669|593236897|FG003|Double Blind Phase|Adverse Event|0|||
164236465|NCT04712669|593236898|FG004|Double Blind Phase|Adverse Event|0|||
164236466|NCT04712669|593236899|FG005|Double Blind Phase|Adverse Event|0|||
164236467|NCT04712669|593236900|FG006|Double Blind Phase|Adverse Event|0|||
164236468|NCT04712669|593236901|FG007|Double Blind Phase|Adverse Event|0|||
164236469|NCT04712669|593236894|FG000|Double Blind Phase|Physician Decision|1|||
164236470|NCT04712669|593236895|FG001|Double Blind Phase|Physician Decision|0|||
164236471|NCT04712669|593236896|FG002|Double Blind Phase|Physician Decision|0|||
164236472|NCT04712669|593236897|FG003|Double Blind Phase|Physician Decision|0|||
164236473|NCT04712669|593236898|FG004|Double Blind Phase|Physician Decision|0|||
164236474|NCT04712669|593236899|FG005|Double Blind Phase|Physician Decision|0|||
164236475|NCT04712669|593236900|FG006|Double Blind Phase|Physician Decision|0|||
164236476|NCT04712669|593236901|FG007|Double Blind Phase|Physician Decision|0|||
164236477|NCT04712669|593236894|FG000|Double Blind Phase|Withdrawal by Subject|3|||
164236478|NCT04712669|593236895|FG001|Double Blind Phase|Withdrawal by Subject|6|||
164236479|NCT04712669|593236896|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164236480|NCT04712669|593236897|FG003|Double Blind Phase|Withdrawal by Subject|0|||
164236481|NCT04712669|593236898|FG004|Double Blind Phase|Withdrawal by Subject|0|||
164334571|NCT03114488|593601562|FG001|Time Period 2|Withdrawal by Subject|3|||
164334572|NCT03711266|593601564|FG000|Overall Study|Lost to Follow-up|10|||
164334573|NCT01646073|593601567|FG000|Period A (12 Weeks)|Adverse Event|0|||
164334574|NCT01646073|593601568|FG001|Period A (12 Weeks)|Adverse Event|2|||
164334575|NCT01646073|593601567|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
164334576|NCT01646073|593601568|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
164334577|NCT01646073|593601567|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
164334578|NCT01646073|593601568|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
164334579|NCT01646073|593601567|FG000|Period A (12 Weeks)|Protocol Violation|0|||
164334580|NCT01646073|593601568|FG001|Period A (12 Weeks)|Protocol Violation|1|||
164334581|NCT01646073|593601567|FG000|Period A (12 Weeks)|Other|0|||
164334582|NCT01646073|593601568|FG001|Period A (12 Weeks)|Other|1|||
164334583|NCT01646073|593601567|FG000|Period B (12 Weeks)|Adverse Event|0|||
164334584|NCT01646073|593601568|FG001|Period B (12 Weeks)|Adverse Event|7|||
164334585|NCT01646073|593601567|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
164334586|NCT01646073|593601568|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
164334587|NCT01646073|593601567|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
164334588|NCT01646073|593601568|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
164334589|NCT00679055|593601571|FG000|Overall Study|Adverse Event|0|||
164334590|NCT00679055|593601572|FG001|Overall Study|Adverse Event|1|||
164334591|NCT00679055|593601571|FG000|Overall Study|Other|0|||
164334592|NCT00679055|593601572|FG001|Overall Study|Other|3|||
164334593|NCT00679055|593601571|FG000|Overall Study|Study Terminated|2|||
164334594|NCT00679055|593601572|FG001|Overall Study|Study Terminated|1|||
164334595|NCT00629772|593601573|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
164334596|NCT00629772|593601574|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
164334597|NCT00629772|593601573|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
164334598|NCT00629772|593601574|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
164334599|NCT01393301|593601577|FG000|Overall Study|Lost to Follow-up|5|||
164334600|NCT01393301|593601578|FG001|Overall Study|Lost to Follow-up|3|||
164334601|NCT01393301|593601577|FG000|Overall Study|Withdrawal by Subject|2|||
164334602|NCT01393301|593601578|FG001|Overall Study|Withdrawal by Subject|0|||
164334603|NCT01393301|593601577|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
164334604|NCT01393301|593601578|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
164334605|NCT03342963|593601581|FG000|Overall Study|Adverse Event|1|||
164334606|NCT03342963|593601582|FG001|Overall Study|Adverse Event|2|||
164334607|NCT03342963|593601583|FG002|Overall Study|Adverse Event|0|||
164334608|NCT03342963|593601584|FG003|Overall Study|Adverse Event|0|||
164334609|NCT03342963|593601581|FG000|Overall Study|Withdrawal by Subject|1|||
164334610|NCT03342963|593601582|FG001|Overall Study|Withdrawal by Subject|0|||
163884422|NCT03307343|591945984|FG000|Overall Study|Withdrawal by Subject|1|||
164236482|NCT04712669|593236899|FG005|Double Blind Phase|Withdrawal by Subject|0|||
164236483|NCT04712669|593236900|FG006|Double Blind Phase|Withdrawal by Subject|0|||
164334611|NCT03342963|593601583|FG002|Overall Study|Withdrawal by Subject|0|||
164334612|NCT03342963|593601584|FG003|Overall Study|Withdrawal by Subject|0|||
164334613|NCT01309165|593601586|FG000|Overall Study|Lost to Follow-up|4|||
163884423|NCT03307343|591945985|FG001|Overall Study|Withdrawal by Subject|2|||
163884424|NCT03307343|591945984|FG000|Overall Study|Pregnancy|0|||
164334614|NCT01309165|593601587|FG001|Overall Study|Lost to Follow-up|3|||
164334615|NCT01309165|593601586|FG000|Overall Study|Return to work|1|||
164334616|NCT01309165|593601587|FG001|Overall Study|Return to work|2|||
164334617|NCT01309165|593601586|FG000|Overall Study|Left country|0|||
164334618|NCT01309165|593601587|FG001|Overall Study|Left country|1|||
164334619|NCT01309165|593601586|FG000|Overall Study|No transportation|0|||
164334620|NCT01309165|593601587|FG001|Overall Study|No transportation|1|||
164334621|NCT01309165|593601586|FG000|Overall Study|Admitted to hospital for second stroke|1|||
164334622|NCT01309165|593601587|FG001|Overall Study|Admitted to hospital for second stroke|0|||
164334623|NCT01497275|593601588|FG000|Overall Study|Death|1|||
164334624|NCT01497275|593601588|FG000|Overall Study|Adverse Event|1|||
164334625|NCT01484132|593601589|FG000|Overall Study|Lost to Follow-up|8|||
164334626|NCT01484132|593601589|FG000|Overall Study|Difficulty with time commitment|2|||
164334627|NCT01484132|593601589|FG000|Overall Study|Ineligible|1|||
164334628|NCT01484132|593601589|FG000|Overall Study|No pre-treatment urine sample collected|1|||
164334629|NCT01484132|593601589|FG000|Overall Study|No post-treatment urine sample collected|10|||
164334630|NCT03538431|593601590|FG000|Overall Study|Physician Decision|0|||
164334631|NCT03538431|593601591|FG001|Overall Study|Physician Decision|1|||
164334632|NCT03538431|593601590|FG000|Overall Study|Withdrawal by Subject|1|||
164334633|NCT03538431|593601591|FG001|Overall Study|Withdrawal by Subject|0|||
164334634|NCT00620464|593601592|FG000|Overall Study|Adverse Event|15|||
164334635|NCT00620464|593601593|FG001|Overall Study|Adverse Event|17|||
164334636|NCT00620464|593601592|FG000|Overall Study|Lost to Follow-up|1|||
164334637|NCT00620464|593601593|FG001|Overall Study|Lost to Follow-up|1|||
164334638|NCT00620464|593601592|FG000|Overall Study|Planning Pregnancy|1|||
164334639|NCT00620464|593601593|FG001|Overall Study|Planning Pregnancy|4|||
164334640|NCT00620464|593601592|FG000|Overall Study|Personal|2|||
164334641|NCT00620464|593601593|FG001|Overall Study|Personal|2|||
164334642|NCT00620464|593601592|FG000|Overall Study|Used prohibited medication|1|||
164334643|NCT00620464|593601593|FG001|Overall Study|Used prohibited medication|0|||
164334644|NCT05394350|593601594|FG000|Overall Study|Death|2|||
164334645|NCT05394350|593601595|FG001|Overall Study|Death|2|||
164334646|NCT05394350|593601596|FG002|Overall Study|Death|4|||
164334647|NCT05394350|593601597|FG003|Overall Study|Death|0|||
164334648|NCT05394350|593601598|FG004|Overall Study|Death|1|||
164334649|NCT05394350|593601599|FG005|Overall Study|Death|0|||
164334650|NCT05394350|593601594|FG000|Overall Study|Study terminated by sponsor|1|||
164334651|NCT05394350|593601595|FG001|Overall Study|Study terminated by sponsor|1|||
164334652|NCT05394350|593601596|FG002|Overall Study|Study terminated by sponsor|7|||
164334653|NCT05394350|593601597|FG003|Overall Study|Study terminated by sponsor|3|||
164334654|NCT05394350|593601598|FG004|Overall Study|Study terminated by sponsor|2|||
164334655|NCT05394350|593601599|FG005|Overall Study|Study terminated by sponsor|4|||
164334656|NCT02024555|593601600|FG000|Overall Study|Lost to Follow-up|1|||
164334657|NCT02024555|593601601|FG001|Overall Study|Lost to Follow-up|1|||
164334658|NCT02024555|593601600|FG000|Overall Study|Withdrawal by Subject|5|||
164334659|NCT02024555|593601601|FG001|Overall Study|Withdrawal by Subject|1|||
164334660|NCT02887859|593601602|FG000|Overall Study|Ongoing|6|||
164334661|NCT02887859|593601602|FG000|Overall Study|Adverse Event|7|||
164334662|NCT02887859|593601602|FG000|Overall Study|Death|1|||
164334663|NCT02887859|593601602|FG000|Overall Study|Physician Decision|1|||
164334664|NCT00492050|593601603|FG000|Overall Study|Adverse Event|1|||
164334665|NCT00492050|593601603|FG000|Overall Study|Lack of Efficacy|1|||
164334666|NCT00492050|593601603|FG000|Overall Study|Withdrawal by Subject|3|||
164334667|NCT00492050|593601603|FG000|Overall Study|Unable to collect SCT|2|||
164334668|NCT00492050|593601603|FG000|Overall Study|Progressive Disease|2|||
164334669|NCT04063384|593603187|FG000|Overall Study|placebo manipulation issue|1|||
164334670|NCT04063384|593603188|FG001|Overall Study|placebo manipulation issue|2|||
164334671|NCT04063384|593603189|FG002|Overall Study|placebo manipulation issue|1|||
164334672|NCT04063384|593603190|FG003|Overall Study|placebo manipulation issue|1|||
164334673|NCT00537238|593603191|FG000|Overall Study|Death|1|||
164334674|NCT00537238|593603192|FG001|Overall Study|Death|2|||
163884425|NCT03307343|591945985|FG001|Overall Study|Pregnancy|2|||
164334675|NCT00537238|593603191|FG000|Overall Study|Adverse Event|31|||
164334676|NCT00537238|593603192|FG001|Overall Study|Adverse Event|22|||
163884426|NCT03307343|591945984|FG000|Overall Study|Physician Decision|1|||
163884427|NCT03307343|591945985|FG001|Overall Study|Physician Decision|0|||
164334677|NCT00537238|593603191|FG000|Overall Study|Lack of Efficacy|20|||
164334678|NCT00537238|593603192|FG001|Overall Study|Lack of Efficacy|21|||
164334679|NCT00537238|593603191|FG000|Overall Study|Lost to Follow-up|12|||
164334680|NCT00537238|593603192|FG001|Overall Study|Lost to Follow-up|8|||
164334681|NCT00537238|593603191|FG000|Overall Study|Withdrawal by Subject|51|||
164334682|NCT00537238|593603192|FG001|Overall Study|Withdrawal by Subject|47|||
164334683|NCT00537238|593603191|FG000|Overall Study|Protocol Violation|15|||
164334684|NCT00537238|593603192|FG001|Overall Study|Protocol Violation|19|||
164334685|NCT00537238|593603191|FG000|Overall Study|Does not meet entrance criteria|0|||
164334686|NCT00537238|593603192|FG001|Overall Study|Does not meet entrance criteria|2|||
164334687|NCT00537238|593603191|FG000|Overall Study|Other|44|||
164334688|NCT00537238|593603192|FG001|Overall Study|Other|52|||
164334689|NCT01824342|593603200|FG000|Overall Study|Withdrawal by Subject|0|||
164334690|NCT01824342|593603201|FG001|Overall Study|Withdrawal by Subject|3|||
164334691|NCT01824342|593603200|FG000|Overall Study|Adverse Event|1|||
164334692|NCT01824342|593603201|FG001|Overall Study|Adverse Event|1|||
164334693|NCT01824342|593603200|FG000|Overall Study|Disease Progression|1|||
164334694|NCT01824342|593603201|FG001|Overall Study|Disease Progression|1|||
164334695|NCT01824342|593603200|FG000|Overall Study|Physician Decision|5|||
164334696|NCT01824342|593603201|FG001|Overall Study|Physician Decision|0|||
164334697|NCT01824342|593603200|FG000|Overall Study|Death|2|||
164334698|NCT01824342|593603201|FG001|Overall Study|Death|0|||
164334699|NCT06132659|593603202|FG000|Overall Study|Lost to Follow-up|0|||
164334700|NCT06132659|593603203|FG001|Overall Study|Lost to Follow-up|1|||
164334701|NCT06132659|593603204|FG002|Overall Study|Lost to Follow-up|0|||
164334702|NCT03615326|593603205|FG000|Overall Study|Death|266|||
164334703|NCT03615326|593603206|FG001|Overall Study|Death|286|||
164334704|NCT03615326|593603207|FG002|Overall Study|Death|14|||
164334705|NCT03615326|593603208|FG003|Overall Study|Death|17|||
164334706|NCT03615326|593603205|FG000|Overall Study|Lost to Follow-up|0|||
164334707|NCT03615326|593603206|FG001|Overall Study|Lost to Follow-up|1|||
164334708|NCT03615326|593603207|FG002|Overall Study|Lost to Follow-up|0|||
164334709|NCT03615326|593603208|FG003|Overall Study|Lost to Follow-up|0|||
164334710|NCT03615326|593603205|FG000|Overall Study|Withdrawal by Subject|1|||
164334711|NCT03615326|593603206|FG001|Overall Study|Withdrawal by Subject|3|||
164334712|NCT03615326|593603207|FG002|Overall Study|Withdrawal by Subject|0|||
164334713|NCT03615326|593603208|FG003|Overall Study|Withdrawal by Subject|0|||
164334714|NCT03615326|593603205|FG000|Overall Study|Participants Ongoing|83|||
164334715|NCT03615326|593603206|FG001|Overall Study|Participants Ongoing|58|||
164334716|NCT03615326|593603207|FG002|Overall Study|Participants Ongoing|6|||
164334717|NCT03615326|593603208|FG003|Overall Study|Participants Ongoing|3|||
164334718|NCT03794583|593603209|FG000|Overall Study|Death|8|||
164334719|NCT03794583|593603209|FG000|Overall Study|Study Terminated by Sponsor|24|||
164334720|NCT03794583|593603209|FG000|Overall Study|Withdrawal by Subject|9|||
164334721|NCT02497612|593603210|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
164334722|NCT02497612|593603211|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
164334723|NCT02497612|593603212|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
164334724|NCT02497612|593603213|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
164334725|NCT02497612|593603210|FG000|Overall Study|Participant's request|2|||
164334726|NCT02497612|593603211|FG001|Overall Study|Participant's request|3|||
164334727|NCT02497612|593603212|FG002|Overall Study|Participant's request|4|||
164334728|NCT02497612|593603213|FG003|Overall Study|Participant's request|1|||
164334729|NCT02497612|593603210|FG000|Overall Study|Investigator's judgement|1|||
164334730|NCT02497612|593603211|FG001|Overall Study|Investigator's judgement|0|||
164334731|NCT02497612|593603212|FG002|Overall Study|Investigator's judgement|0|||
164334732|NCT02497612|593603213|FG003|Overall Study|Investigator's judgement|2|||
164334733|NCT02497612|593603210|FG000|Overall Study|Adverse Event|3|||
164334734|NCT02497612|593603211|FG001|Overall Study|Adverse Event|1|||
164334735|NCT02497612|593603212|FG002|Overall Study|Adverse Event|4|||
164334736|NCT02497612|593603213|FG003|Overall Study|Adverse Event|1|||
164334737|NCT02497612|593603210|FG000|Overall Study|Lost to Follow-up|1|||
164334738|NCT02497612|593603211|FG001|Overall Study|Lost to Follow-up|1|||
164334739|NCT02497612|593603212|FG002|Overall Study|Lost to Follow-up|0|||
164334740|NCT02497612|593603213|FG003|Overall Study|Lost to Follow-up|1|||
164334741|NCT02497612|593603210|FG000|Overall Study|Other unspecified|1|||
164334742|NCT02497612|593603211|FG001|Overall Study|Other unspecified|1|||
164334743|NCT02497612|593603212|FG002|Overall Study|Other unspecified|2|||
164334744|NCT02497612|593603213|FG003|Overall Study|Other unspecified|0|||
164334745|NCT02497612|593603210|FG000|Overall Study|Not eligible|1|||
164334746|NCT02497612|593603211|FG001|Overall Study|Not eligible|0|||
164334747|NCT02497612|593603212|FG002|Overall Study|Not eligible|0|||
164334748|NCT02497612|593603213|FG003|Overall Study|Not eligible|1|||
164334749|NCT02651467|593603214|FG000|Overall Study|Withdrawal by Subject|0|||
163884428|NCT03307343|591945984|FG000|Overall Study|Lost to Follow-up|0|||
164334750|NCT02651467|593603215|FG001|Overall Study|Withdrawal by Subject|0|||
164334751|NCT02651467|593603216|FG002|Overall Study|Withdrawal by Subject|2|||
164334752|NCT02651467|593603214|FG000|Overall Study|Other (Not specified)|1|||
164334753|NCT02651467|593603215|FG001|Overall Study|Other (Not specified)|0|||
164334754|NCT02651467|593603216|FG002|Overall Study|Other (Not specified)|2|||
164334755|NCT02477839|593603219|FG000|Overall Study|Adverse Event|0|||
164334756|NCT02477839|593603220|FG001|Overall Study|Adverse Event|1|||
164334757|NCT02477839|593603219|FG000|Overall Study|Protocol Violation|0|||
164334758|NCT02477839|593603220|FG001|Overall Study|Protocol Violation|2|||
164334759|NCT02477839|593603219|FG000|Overall Study|Withdrawal by Subject|3|||
164334760|NCT02477839|593603220|FG001|Overall Study|Withdrawal by Subject|3|||
164334761|NCT02477839|593603219|FG000|Overall Study|Participant had PGS during V6|0|||
164334762|NCT02477839|593603220|FG001|Overall Study|Participant had PGS during V6|1|||
164334763|NCT02477839|593603219|FG000|Overall Study|Parents decided to stop medication|0|||
164334764|NCT02477839|593603220|FG001|Overall Study|Parents decided to stop medication|1|||
164236484|NCT04712669|593236901|FG007|Double Blind Phase|Withdrawal by Subject|0|||
164236485|NCT04712669|593236894|FG000|Double Blind Phase|Termination by Sponsor|0|||
164236486|NCT04712669|593236895|FG001|Double Blind Phase|Termination by Sponsor|0|||
164236487|NCT04712669|593236896|FG002|Double Blind Phase|Termination by Sponsor|1|||
164236488|NCT04712669|593236897|FG003|Double Blind Phase|Termination by Sponsor|0|||
164236489|NCT04712669|593236898|FG004|Double Blind Phase|Termination by Sponsor|0|||
164236490|NCT04712669|593236899|FG005|Double Blind Phase|Termination by Sponsor|0|||
164236491|NCT04712669|593236900|FG006|Double Blind Phase|Termination by Sponsor|0|||
164236492|NCT04712669|593236901|FG007|Double Blind Phase|Termination by Sponsor|0|||
164236493|NCT04712669|593236894|FG000|Open Label Phase|Adverse Event|0|||
164236494|NCT04712669|593236895|FG001|Open Label Phase|Adverse Event|0|||
164236495|NCT04712669|593236896|FG002|Open Label Phase|Adverse Event|0|||
164236496|NCT04712669|593236897|FG003|Open Label Phase|Adverse Event|1|||
164236497|NCT04712669|593236898|FG004|Open Label Phase|Adverse Event|1|||
164236498|NCT04712669|593236899|FG005|Open Label Phase|Adverse Event|3|||
164236499|NCT04712669|593236900|FG006|Open Label Phase|Adverse Event|1|||
164236500|NCT04712669|593236901|FG007|Open Label Phase|Adverse Event|2|||
164236501|NCT04712669|593236894|FG000|Open Label Phase|Death|0|||
164236502|NCT04712669|593236895|FG001|Open Label Phase|Death|0|||
164236503|NCT04712669|593236896|FG002|Open Label Phase|Death|0|||
164236504|NCT04712669|593236897|FG003|Open Label Phase|Death|1|||
164236505|NCT04712669|593236898|FG004|Open Label Phase|Death|0|||
164236506|NCT04712669|593236899|FG005|Open Label Phase|Death|0|||
164236507|NCT04712669|593236900|FG006|Open Label Phase|Death|0|||
164236508|NCT04712669|593236901|FG007|Open Label Phase|Death|0|||
164236509|NCT04712669|593236894|FG000|Open Label Phase|Lack of Efficacy|0|||
164236510|NCT04712669|593236895|FG001|Open Label Phase|Lack of Efficacy|0|||
164236511|NCT04712669|593236896|FG002|Open Label Phase|Lack of Efficacy|0|||
164236512|NCT04712669|593236897|FG003|Open Label Phase|Lack of Efficacy|0|||
164236513|NCT04712669|593236898|FG004|Open Label Phase|Lack of Efficacy|1|||
164236514|NCT04712669|593236899|FG005|Open Label Phase|Lack of Efficacy|0|||
164236515|NCT04712669|593236900|FG006|Open Label Phase|Lack of Efficacy|0|||
164236516|NCT04712669|593236901|FG007|Open Label Phase|Lack of Efficacy|0|||
164236517|NCT04712669|593236894|FG000|Open Label Phase|Lost to Follow-up|0|||
164236518|NCT04712669|593236895|FG001|Open Label Phase|Lost to Follow-up|0|||
164236519|NCT04712669|593236896|FG002|Open Label Phase|Lost to Follow-up|0|||
164236520|NCT04712669|593236897|FG003|Open Label Phase|Lost to Follow-up|0|||
164236521|NCT04712669|593236898|FG004|Open Label Phase|Lost to Follow-up|0|||
164236522|NCT04712669|593236899|FG005|Open Label Phase|Lost to Follow-up|0|||
164236523|NCT04712669|593236900|FG006|Open Label Phase|Lost to Follow-up|1|||
164236524|NCT04712669|593236901|FG007|Open Label Phase|Lost to Follow-up|1|||
164236525|NCT04712669|593236894|FG000|Open Label Phase|Physician Decision|0|||
164236526|NCT04712669|593236895|FG001|Open Label Phase|Physician Decision|0|||
164236527|NCT04712669|593236896|FG002|Open Label Phase|Physician Decision|0|||
164236528|NCT04712669|593236897|FG003|Open Label Phase|Physician Decision|1|||
164236529|NCT04712669|593236898|FG004|Open Label Phase|Physician Decision|0|||
164236530|NCT04712669|593236899|FG005|Open Label Phase|Physician Decision|0|||
164236531|NCT04712669|593236900|FG006|Open Label Phase|Physician Decision|0|||
164236532|NCT04712669|593236901|FG007|Open Label Phase|Physician Decision|0|||
164236533|NCT04712669|593236894|FG000|Open Label Phase|Withdrawal by Subject|0|||
164236534|NCT04712669|593236895|FG001|Open Label Phase|Withdrawal by Subject|0|||
164236535|NCT04712669|593236896|FG002|Open Label Phase|Withdrawal by Subject|0|||
164236536|NCT04712669|593236897|FG003|Open Label Phase|Withdrawal by Subject|1|||
164236537|NCT04712669|593236898|FG004|Open Label Phase|Withdrawal by Subject|5|||
164236538|NCT04712669|593236899|FG005|Open Label Phase|Withdrawal by Subject|5|||
164236539|NCT04712669|593236900|FG006|Open Label Phase|Withdrawal by Subject|0|||
164236540|NCT04712669|593236901|FG007|Open Label Phase|Withdrawal by Subject|4|||
164236541|NCT04712669|593236894|FG000|Open Label Phase|Termination by Sponsor|0|||
164236542|NCT04712669|593236895|FG001|Open Label Phase|Termination by Sponsor|0|||
164236543|NCT04712669|593236896|FG002|Open Label Phase|Termination by Sponsor|0|||
164236544|NCT04712669|593236897|FG003|Open Label Phase|Termination by Sponsor|11|||
164236545|NCT04712669|593236898|FG004|Open Label Phase|Termination by Sponsor|9|||
164236546|NCT04712669|593236899|FG005|Open Label Phase|Termination by Sponsor|14|||
164236547|NCT04712669|593236900|FG006|Open Label Phase|Termination by Sponsor|0|||
164236548|NCT04712669|593236901|FG007|Open Label Phase|Termination by Sponsor|14|||
164236549|NCT00639457|593238824|FG000|Overall Study|Withdrawal by Subject|2|||
164236550|NCT00639457|593238825|FG001|Overall Study|Withdrawal by Subject|3|||
164236551|NCT03386773|593238826|FG000|Overall Study|Lost to Follow-up|24|||
164334765|NCT02477839|593603219|FG000|Overall Study|Lack of tolerability|0|||
164334766|NCT02477839|593603220|FG001|Overall Study|Lack of tolerability|1|||
164236552|NCT03386773|593238827|FG001|Overall Study|Lost to Follow-up|33|||
164236553|NCT03386773|593238826|FG000|Overall Study|Withdrawal by Subject|3|||
164236554|NCT03386773|593238827|FG001|Overall Study|Withdrawal by Subject|2|||
164236555|NCT00892008|593238828|FG000|Overall Study|Death|5|||
164236556|NCT00892008|593238828|FG000|Overall Study|Lack of Efficacy|3|||
164236557|NCT00892008|593238828|FG000|Overall Study|Lost to Follow-up|142|||
164236558|NCT00892008|593238828|FG000|Overall Study|Other|378|||
164236559|NCT00892008|593238828|FG000|Overall Study|Adverse Event|37|||
163988684|NCT03984305|592326161|FG001|Overall Study|Lost to Follow-up|0|||
163988685|NCT02883244|592326162|FG000|Overall Study|Lost to Follow-up|0|||
163988686|NCT02883244|592326163|FG001|Overall Study|Lost to Follow-up|1|||
163988687|NCT03979274|592326178|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163988688|NCT03979274|592326179|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163988689|NCT02301403|592326180|FG000|Overall Study|Withdrawal by Subject|28|||
163988690|NCT02301403|592326181|FG001|Overall Study|Withdrawal by Subject|41|||
163988691|NCT02302963|592326182|FG000|Overall Study|Withdrawal by Subject|2|||
163988692|NCT02302963|592326183|FG001|Overall Study|Withdrawal by Subject|1|||
163988693|NCT02302963|592326182|FG000|Overall Study|Steroid injection|0|||
163988694|NCT02302963|592326183|FG001|Overall Study|Steroid injection|1|||
163988695|NCT02302963|592326182|FG000|Overall Study|Physician Decision|1|||
163988696|NCT02302963|592326183|FG001|Overall Study|Physician Decision|0|||
163988697|NCT01614093|592326186|FG000|Overall Study|Withdrawal by Subject|1|||
163988698|NCT00603915|592326187|FG000|Overall Study|Physician Decision|1|||
163988699|NCT03064841|592326188|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
163988700|NCT03064841|592326188|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
163988701|NCT03064841|592326188|FG000|Overall Study|Screen failure|2|||
163988702|NCT00573794|592326189|FG000|Overall Study|Adverse Event|81|||
163988703|NCT00573794|592326189|FG000|Overall Study|Withdrew Consent|90|||
163988704|NCT00573794|592326189|FG000|Overall Study|Lost to Follow-up|13|||
163988705|NCT00573794|592326189|FG000|Overall Study|Protocol Violation|6|||
163988706|NCT00573794|592326189|FG000|Overall Study|Lack of Efficacy|94|||
163988707|NCT00573794|592326189|FG000|Overall Study|Other|46|||
163988708|NCT01724528|592326199|FG000|Overall Study|Death|3|||
163988709|NCT01724528|592326200|FG001|Overall Study|Death|0|||
163988710|NCT01724528|592326199|FG000|Overall Study|Withdrawal by Subject|0|||
163988711|NCT01724528|592326200|FG001|Overall Study|Withdrawal by Subject|2|||
163988712|NCT01724528|592326199|FG000|Overall Study|Protocol Violation|0|||
163988713|NCT01724528|592326200|FG001|Overall Study|Protocol Violation|1|||
163988714|NCT01724528|592326199|FG000|Overall Study|Patient refused to attend last visit|1|||
163988715|NCT01724528|592326200|FG001|Overall Study|Patient refused to attend last visit|0|||
163988716|NCT02183519|592326204|FG000|Overall Study|computer error|3|||
163988717|NCT02183519|592326205|FG001|Overall Study|computer error|0|||
163988718|NCT02183519|592326204|FG000|Overall Study|Did not respond to cough inducter|0|||
163988719|NCT02183519|592326205|FG001|Overall Study|Did not respond to cough inducter|3|||
163988720|NCT04556617|592326210|FG000|Overall Study|progressive disease|0|||
163988721|NCT04556617|592326211|FG001|Overall Study|progressive disease|2|||
163988722|NCT04556617|592326212|FG002|Overall Study|progressive disease|2|||
163988723|NCT04556617|592326213|FG003|Overall Study|progressive disease|1|||
163988724|NCT04556617|592326214|FG004|Overall Study|progressive disease|1|||
163988725|NCT04556617|592326210|FG000|Overall Study|Physician Decision|0|||
163988726|NCT04556617|592326211|FG001|Overall Study|Physician Decision|0|||
163988727|NCT04556617|592326212|FG002|Overall Study|Physician Decision|2|||
163988728|NCT04556617|592326213|FG003|Overall Study|Physician Decision|0|||
163988729|NCT04556617|592326214|FG004|Overall Study|Physician Decision|0|||
163988730|NCT04556617|592326210|FG000|Overall Study|Adverse Event|0|||
163988731|NCT04556617|592326211|FG001|Overall Study|Adverse Event|0|||
163988732|NCT04556617|592326212|FG002|Overall Study|Adverse Event|2|||
163988733|NCT04556617|592326213|FG003|Overall Study|Adverse Event|3|||
163988734|NCT04556617|592326214|FG004|Overall Study|Adverse Event|0|||
163988735|NCT04556617|592326210|FG000|Overall Study|Withdrawal by Subject|0|||
163988736|NCT04556617|592326211|FG001|Overall Study|Withdrawal by Subject|2|||
163988737|NCT04556617|592326212|FG002|Overall Study|Withdrawal by Subject|1|||
163988738|NCT04556617|592326213|FG003|Overall Study|Withdrawal by Subject|1|||
163988739|NCT04556617|592326214|FG004|Overall Study|Withdrawal by Subject|0|||
163988740|NCT04556617|592326210|FG000|Overall Study|PSA increase|0|||
163988741|NCT04556617|592326211|FG001|Overall Study|PSA increase|1|||
163988742|NCT04556617|592326212|FG002|Overall Study|PSA increase|0|||
163988743|NCT04556617|592326213|FG003|Overall Study|PSA increase|0|||
163988744|NCT04556617|592326214|FG004|Overall Study|PSA increase|0|||
163988745|NCT04556617|592326210|FG000|Overall Study|Sponsor study termination|1|||
163988746|NCT04556617|592326211|FG001|Overall Study|Sponsor study termination|0|||
163988747|NCT04556617|592326212|FG002|Overall Study|Sponsor study termination|0|||
164236560|NCT00355030|593238829|FG000|Study Period 1 Treatment|Adverse Event|1|||
164236561|NCT00355030|593238830|FG001|Study Period 1 Treatment|Adverse Event|1|||
164236562|NCT00355030|593238829|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
164236563|NCT00355030|593238830|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
164236564|NCT00355030|593238829|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
164236565|NCT00355030|593238830|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
164236566|NCT00355030|593238829|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
164236567|NCT00355030|593238830|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
164236568|NCT00355030|593238829|FG000|Study Period 1 Treatment|Physician Decision|0|||
164236569|NCT00355030|593238830|FG001|Study Period 1 Treatment|Physician Decision|1|||
164236570|NCT00355030|593238829|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
164236571|NCT00355030|593238830|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
164236572|NCT00355030|593238829|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
164236573|NCT00355030|593238830|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
164236574|NCT00355030|593238829|FG000|Study Period 1 Treatment|Other|2|||
164236575|NCT00355030|593238830|FG001|Study Period 1 Treatment|Other|6|||
164236576|NCT00355030|593238829|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
164236577|NCT00355030|593238830|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
164236578|NCT00355030|593238829|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
164236579|NCT00355030|593238830|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
164236580|NCT01693367|593238833|FG000|Overall Study|Withdrawal by Subject|1|||
164236581|NCT01693367|593238834|FG001|Overall Study|Withdrawal by Subject|1|||
164236582|NCT01693367|593238833|FG000|Overall Study|Physician Decision|0|||
164236583|NCT01693367|593238834|FG001|Overall Study|Physician Decision|1|||
164236584|NCT00622726|593238835|FG000|March, 2008 to August, 2010|Death|5|||
164236585|NCT00622726|593238836|FG001|March, 2008 to August, 2010|Death|2|||
164236586|NCT00622726|593238835|FG000|August, 2010 to April, 2013|Death|1|||
164236587|NCT00622726|593238836|FG001|August, 2010 to April, 2013|Death|5|||
164236588|NCT00399035|593238837|FG000|Overall Study|Death|289|||
164236589|NCT00399035|593238838|FG001|Overall Study|Death|141|||
164236590|NCT00399035|593238839|FG002|Overall Study|Death|234|||
164236591|NCT00399035|593238837|FG000|Overall Study|Lost to Follow-up|2|||
164236592|NCT00399035|593238838|FG001|Overall Study|Lost to Follow-up|1|||
164236593|NCT00399035|593238839|FG002|Overall Study|Lost to Follow-up|5|||
164236594|NCT00399035|593238837|FG000|Overall Study|Withdrawal by Subject|19|||
164236595|NCT00399035|593238838|FG001|Overall Study|Withdrawal by Subject|15|||
164236596|NCT00399035|593238839|FG002|Overall Study|Withdrawal by Subject|12|||
164236597|NCT00399035|593238837|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
164236598|NCT00399035|593238838|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
164236599|NCT00399035|593238839|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
164236600|NCT00399035|593238837|FG000|Overall Study|Severe non-compliance with protocol|2|||
164236601|NCT00399035|593238838|FG001|Overall Study|Severe non-compliance with protocol|1|||
164236602|NCT00399035|593238839|FG002|Overall Study|Severe non-compliance with protocol|0|||
164236603|NCT02746809|593238842|FG000|Enrollment|Inclusion Exclusion not met|9|||
164236604|NCT02746809|593238842|FG000|Enrollment|Withdrawal by Subject|1|||
164236605|NCT02746809|593238842|FG000|Enrollment|Expected Enrollment Met|2|||
164236606|NCT02746809|593238842|FG000|Procedure|Death|1|||
164236607|NCT02746809|593238842|FG000|1-Month|Death|5|||
164236608|NCT02746809|593238842|FG000|6-Month|Death|2|||
164236609|NCT02746809|593238842|FG000|6-Month|Withdrawal by Subject|1|||
164236610|NCT02746809|593238842|FG000|12-Month|Death|3|||
164236611|NCT02746809|593238842|FG000|12-Month|Withdrawal by Subject|2|||
164236612|NCT02746809|593238842|FG000|24-Month|Death|1|||
164236613|NCT02746809|593238842|FG000|24-Month|Withdrawal by Subject|1|||
164236614|NCT02746809|593238842|FG000|36-Month|Death|8|||
164236615|NCT02746809|593238842|FG000|36-Month|Withdrawal by Subject|1|||
164236616|NCT02746809|593238842|FG000|48-Month|Death|7|||
164236617|NCT02746809|593238842|FG000|48-Month|Withdrawal by Subject|1|||
164236618|NCT02746809|593238842|FG000|60-Month|Death|1|||
164236619|NCT02746809|593238842|FG000|60-Month|Lost to Follow-up|2|||
164236620|NCT03500211|593238845|FG000|Overall Study|Withdrawal by Subject|1|||
164236621|NCT03500211|593238846|FG001|Overall Study|Withdrawal by Subject|1|||
164236622|NCT02431325|593238847|FG000|Overall Study|Adverse Event|3|||
164334767|NCT02477839|593603219|FG000|Overall Study|Exclusion criterion|0|||
164334768|NCT02477839|593603220|FG001|Overall Study|Exclusion criterion|1|||
164334769|NCT01439568|593603224|FG000|Overall Study|Lost to Follow-up|1|||
164334770|NCT01439568|593603225|FG001|Overall Study|Lost to Follow-up|0|||
164334771|NCT01439568|593603224|FG000|Overall Study|Withdrawal by Subject|2|||
164334772|NCT01439568|593603225|FG001|Overall Study|Withdrawal by Subject|2|||
164236623|NCT02431325|593238848|FG001|Overall Study|Adverse Event|0|||
164236624|NCT02431325|593238847|FG000|Overall Study|Lost to Follow-up|0|||
164236625|NCT02431325|593238848|FG001|Overall Study|Lost to Follow-up|1|||
164236626|NCT02431325|593238847|FG000|Overall Study|Withdrawal by Subject|1|||
164236627|NCT02431325|593238848|FG001|Overall Study|Withdrawal by Subject|2|||
164236628|NCT02431325|593238847|FG000|Overall Study|Declined to take study medication|1|||
164236629|NCT02431325|593238848|FG001|Overall Study|Declined to take study medication|0|||
164334773|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
164236630|NCT02431325|593238847|FG000|Overall Study|Withdrew before starting study medication|1|||
164236631|NCT02431325|593238848|FG001|Overall Study|Withdrew before starting study medication|0|||
164236632|NCT02431325|593238847|FG000|Overall Study|Placebo shortage|2|||
164236633|NCT02431325|593238848|FG001|Overall Study|Placebo shortage|0|||
164236634|NCT01865487|593238849|FG000|Overall Study|Lost to Follow-up|0|||
164236635|NCT01865487|593238850|FG001|Overall Study|Lost to Follow-up|0|||
164236636|NCT01865487|593238851|FG002|Overall Study|Lost to Follow-up|0|||
164236637|NCT01865487|593238852|FG003|Overall Study|Lost to Follow-up|1|||
164236638|NCT01865487|593238853|FG004|Overall Study|Lost to Follow-up|0|||
164236639|NCT01865487|593238854|FG005|Overall Study|Lost to Follow-up|0|||
164236640|NCT01865487|593238855|FG006|Overall Study|Lost to Follow-up|1|||
164236641|NCT01865487|593238856|FG007|Overall Study|Lost to Follow-up|0|||
164236642|NCT01865487|593238857|FG008|Overall Study|Lost to Follow-up|0|||
164236643|NCT01865487|593238858|FG009|Overall Study|Lost to Follow-up|0|||
164236644|NCT01865487|593238849|FG000|Overall Study|Withdrawal by Subject|0|||
164236645|NCT01865487|593238850|FG001|Overall Study|Withdrawal by Subject|0|||
164236646|NCT01865487|593238851|FG002|Overall Study|Withdrawal by Subject|0|||
164236647|NCT01865487|593238852|FG003|Overall Study|Withdrawal by Subject|0|||
164236648|NCT01865487|593238853|FG004|Overall Study|Withdrawal by Subject|1|||
164236649|NCT01865487|593238854|FG005|Overall Study|Withdrawal by Subject|0|||
164236650|NCT01865487|593238855|FG006|Overall Study|Withdrawal by Subject|0|||
164236651|NCT01865487|593238856|FG007|Overall Study|Withdrawal by Subject|0|||
164236652|NCT01865487|593238857|FG008|Overall Study|Withdrawal by Subject|0|||
164236653|NCT01865487|593238858|FG009|Overall Study|Withdrawal by Subject|0|||
164236654|NCT01213082|593238862|FG000|Overall Study|Lost to Follow-up|6|||
164236655|NCT01213082|593238863|FG001|Overall Study|Lost to Follow-up|7|||
164236656|NCT01213082|593238864|FG002|Overall Study|Lost to Follow-up|4|||
164236657|NCT01213082|593238862|FG000|Overall Study|Physician Decision|0|||
164236658|NCT01213082|593238863|FG001|Overall Study|Physician Decision|0|||
164236659|NCT01213082|593238864|FG002|Overall Study|Physician Decision|1|||
164236660|NCT01627691|593238865|FG000|Overall Study|Death|11|||
164236661|NCT01627691|593238865|FG000|Overall Study|Lost to Follow-up|3|||
164236662|NCT01627691|593238865|FG000|Overall Study|Withdrawal by Subject|1|||
164236663|NCT01627691|593238865|FG000|Overall Study|Missed the visit|3|||
164236664|NCT00698828|593238871|FG000|Overall Study|Adverse Event|3|||
164236665|NCT00698828|593238872|FG001|Overall Study|Adverse Event|4|||
164236666|NCT00698828|593238873|FG002|Overall Study|Adverse Event|4|||
164236667|NCT00698828|593238871|FG000|Overall Study|Death|0|||
164236668|NCT00698828|593238872|FG001|Overall Study|Death|0|||
164334774|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
164334775|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
164334776|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
164334777|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
164334778|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
164334779|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
164334780|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
164334781|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
164334782|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
164334783|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
164334784|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
164334785|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
164334786|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
164334787|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
164334788|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
164334789|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
164334790|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
164334791|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
164334792|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
164334793|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
164334794|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
164334795|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
164334796|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
164236669|NCT00698828|593238873|FG002|Overall Study|Death|1|||
164334797|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Death|2|||
164334798|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Death|1|||
164334799|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Death|0|||
164236670|NCT00698828|593238871|FG000|Overall Study|Exacerbation of COPD|1|||
164236671|NCT00698828|593238872|FG001|Overall Study|Exacerbation of COPD|3|||
164236672|NCT00698828|593238873|FG002|Overall Study|Exacerbation of COPD|0|||
164236673|NCT00698828|593238871|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
164236674|NCT00698828|593238872|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
164236675|NCT00698828|593238873|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
164236676|NCT00698828|593238871|FG000|Overall Study|Investigator/Sponsor decision|1|||
164236677|NCT00698828|593238872|FG001|Overall Study|Investigator/Sponsor decision|0|||
164236678|NCT00698828|593238873|FG002|Overall Study|Investigator/Sponsor decision|2|||
164236679|NCT00698828|593238871|FG000|Overall Study|Lost to Follow-up|1|||
164236680|NCT00698828|593238872|FG001|Overall Study|Lost to Follow-up|1|||
164236681|NCT00698828|593238873|FG002|Overall Study|Lost to Follow-up|0|||
164236682|NCT00698828|593238871|FG000|Overall Study|Withdrew consent|0|||
164236683|NCT00698828|593238872|FG001|Overall Study|Withdrew consent|7|||
164236684|NCT00698828|593238873|FG002|Overall Study|Withdrew consent|4|||
164236685|NCT00698828|593238871|FG000|Overall Study|Withdrew consent (not treated)|2|||
164236686|NCT00698828|593238872|FG001|Overall Study|Withdrew consent (not treated)|0|||
164236687|NCT00698828|593238873|FG002|Overall Study|Withdrew consent (not treated)|0|||
164236688|NCT02013609|593238876|FG000|Overall Study|Withdrawal by Subject|9|||
164236689|NCT02013609|593238876|FG000|Overall Study|Lost to Follow-up|3|||
164236690|NCT02013609|593238876|FG000|Overall Study|Adverse Event|3|||
164236691|NCT02013609|593238876|FG000|Overall Study|Met Withdrawal Criteria|3|||
164236692|NCT01531998|593238878|FG000|Overall Study|Withdrawal by Subject|3|||
164236693|NCT01156844|593238880|FG000|Overall Study|Adverse Event|0|||
164236694|NCT01156844|593238881|FG001|Overall Study|Adverse Event|0|||
164236695|NCT01156844|593238882|FG002|Overall Study|Adverse Event|1|||
164236696|NCT01156844|593238883|FG003|Overall Study|Adverse Event|1|||
164236697|NCT01156844|593238880|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164236698|NCT01156844|593238881|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164236699|NCT01156844|593238882|FG002|Overall Study|Abnormal test procedure result(s)|2|||
164236700|NCT01156844|593238883|FG003|Overall Study|Abnormal test procedure result(s)|2|||
164236701|NCT01156844|593238880|FG000|Overall Study|Withdrawal by Subject|0|||
164236702|NCT01156844|593238881|FG001|Overall Study|Withdrawal by Subject|0|||
164236703|NCT01156844|593238882|FG002|Overall Study|Withdrawal by Subject|2|||
164236704|NCT01156844|593238883|FG003|Overall Study|Withdrawal by Subject|2|||
164236705|NCT01156844|593238880|FG000|Overall Study|Lost to Follow-up|0|||
164236706|NCT01156844|593238881|FG001|Overall Study|Lost to Follow-up|0|||
164236707|NCT01156844|593238882|FG002|Overall Study|Lost to Follow-up|1|||
164236708|NCT01156844|593238883|FG003|Overall Study|Lost to Follow-up|0|||
164236709|NCT01156844|593238880|FG000|Overall Study|Administrative problems|0|||
164236710|NCT01156844|593238881|FG001|Overall Study|Administrative problems|1|||
164236711|NCT01156844|593238882|FG002|Overall Study|Administrative problems|0|||
164236712|NCT01156844|593238883|FG003|Overall Study|Administrative problems|1|||
164236713|NCT01156844|593238880|FG000|Overall Study|Protocol deviation|2|||
164236714|NCT01156844|593238881|FG001|Overall Study|Protocol deviation|0|||
164236715|NCT01156844|593238882|FG002|Overall Study|Protocol deviation|0|||
164236716|NCT01156844|593238883|FG003|Overall Study|Protocol deviation|0|||
164236717|NCT04067011|593238886|FG000|Overall Study|Not Treated|8|||
164236718|NCT04067011|593238887|FG001|Overall Study|Not Treated|7|||
164236719|NCT04067011|593238888|FG002|Overall Study|Not Treated|5|||
164236720|NCT04067011|593238886|FG000|Overall Study|Adverse Event|2|||
164236721|NCT04067011|593238887|FG001|Overall Study|Adverse Event|1|||
164236722|NCT04067011|593238888|FG002|Overall Study|Adverse Event|0|||
164236723|NCT04067011|593238886|FG000|Overall Study|Withdrawal by Subject|6|||
164236724|NCT04067011|593238887|FG001|Overall Study|Withdrawal by Subject|2|||
164236725|NCT04067011|593238888|FG002|Overall Study|Withdrawal by Subject|1|||
164236726|NCT04067011|593238886|FG000|Overall Study|Lost to Follow-up|0|||
164236727|NCT04067011|593238887|FG001|Overall Study|Lost to Follow-up|0|||
164236728|NCT04067011|593238888|FG002|Overall Study|Lost to Follow-up|1|||
164236729|NCT04067011|593238886|FG000|Overall Study|Physician Decision|1|||
164236730|NCT04067011|593238887|FG001|Overall Study|Physician Decision|1|||
164236731|NCT04067011|593238888|FG002|Overall Study|Physician Decision|0|||
164236732|NCT04067011|593238886|FG000|Overall Study|Other Reasons|2|||
164236733|NCT04067011|593238887|FG001|Overall Study|Other Reasons|0|||
164236734|NCT04067011|593238888|FG002|Overall Study|Other Reasons|1|||
164236735|NCT04067011|593238886|FG000|Overall Study|Missing|0|||
164236736|NCT04067011|593238887|FG001|Overall Study|Missing|2|||
164236737|NCT04067011|593238888|FG002|Overall Study|Missing|0|||
164236738|NCT05209386|593238889|FG000|Overall Study|Withdrawal by Subject|8|||
164236739|NCT05209386|593238889|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
164334800|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Death|0|||
164334801|NCT02607930|593603226|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
163988748|NCT04556617|592326213|FG003|Overall Study|Sponsor study termination|0|||
163988749|NCT04556617|592326214|FG004|Overall Study|Sponsor study termination|0|||
163988750|NCT04949841|592326215|FG000|Overall Study|Adverse Event|7|||
164236740|NCT04661033|593238890|FG000|Overall Study|Adverse Event|0|||
164236741|NCT04661033|593238891|FG001|Overall Study|Adverse Event|0|||
164236742|NCT04661033|593238892|FG002|Overall Study|Adverse Event|1|||
164236743|NCT04661033|593238893|FG003|Overall Study|Adverse Event|0|||
164236744|NCT04661033|593238890|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
164236745|NCT04661033|593238891|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
164236746|NCT04661033|593238892|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
164236747|NCT04661033|593238893|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
164236748|NCT04661033|593238890|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
164236749|NCT04661033|593238891|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
164236750|NCT04661033|593238892|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
164236751|NCT04661033|593238893|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
164236752|NCT04661033|593238890|FG000|Overall Study|Early discontinuation as per PI|1|||
164236753|NCT04661033|593238891|FG001|Overall Study|Early discontinuation as per PI|0|||
164236754|NCT04661033|593238892|FG002|Overall Study|Early discontinuation as per PI|0|||
164236755|NCT04661033|593238893|FG003|Overall Study|Early discontinuation as per PI|0|||
164236756|NCT03440008|593238894|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
164236757|NCT03440008|593238895|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
164236758|NCT03440008|593238894|FG000|Overall Study|Withdrawal by Subject|1|||
164236759|NCT03440008|593238895|FG001|Overall Study|Withdrawal by Subject|0|||
164236760|NCT02284191|593238896|FG000|Overall Study|Withdrawal by Subject|1|||
164236761|NCT02284191|593238897|FG001|Overall Study|Withdrawal by Subject|3|||
164236762|NCT02284191|593238896|FG000|Overall Study|Lost to Follow-up|1|||
164236763|NCT02284191|593238897|FG001|Overall Study|Lost to Follow-up|0|||
164236764|NCT04064905|593238900|FG000|Overall Study|Lost to Follow-up|0|||
164236765|NCT04064905|593238901|FG001|Overall Study|Lost to Follow-up|3|||
164236766|NCT04064905|593238902|FG002|Overall Study|Lost to Follow-up|1|||
164236767|NCT04064905|593238903|FG003|Overall Study|Lost to Follow-up|4|||
164236768|NCT04064905|593238904|FG004|Overall Study|Lost to Follow-up|2|||
164236769|NCT01734902|593238905|FG000|Overall Study|Other than listed|0|||
164236770|NCT01734902|593238906|FG001|Overall Study|Other than listed|2|||
164236771|NCT04436744|593238907|FG000|Overall Study|Adverse Event|1|||
164236772|NCT04436744|593238908|FG001|Overall Study|Adverse Event|1|||
164236773|NCT04436744|593238907|FG000|Overall Study|Death|1|||
164236774|NCT04436744|593238908|FG001|Overall Study|Death|0|||
164236775|NCT04436744|593238907|FG000|Overall Study|Lost to Follow-up|0|||
164236776|NCT04436744|593238908|FG001|Overall Study|Lost to Follow-up|2|||
164236777|NCT04436744|593238907|FG000|Overall Study|Physician Decision|0|||
164236778|NCT04436744|593238908|FG001|Overall Study|Physician Decision|1|||
164236779|NCT04436744|593238907|FG000|Overall Study|Progressive Disease|0|||
164236780|NCT04436744|593238908|FG001|Overall Study|Progressive Disease|4|||
164236781|NCT04436744|593238907|FG000|Overall Study|Protocol Deviation|1|||
164236782|NCT04436744|593238908|FG001|Overall Study|Protocol Deviation|1|||
164236783|NCT04436744|593238907|FG000|Overall Study|Withdrawal by Subject|1|||
164236784|NCT04436744|593238908|FG001|Overall Study|Withdrawal by Subject|2|||
164236785|NCT01463033|593238909|FG000|Overall Study|Lost to Follow-up|4|||
164236786|NCT01463033|593238910|FG001|Overall Study|Lost to Follow-up|4|||
164236787|NCT01463033|593238909|FG000|Overall Study|Death|3|||
164236788|NCT01463033|593238910|FG001|Overall Study|Death|2|||
164236789|NCT02359903|593238914|FG000|Overall Study|Adverse Event|0|||
164236790|NCT02359903|593238915|FG001|Overall Study|Adverse Event|2|||
164236791|NCT03383666|593238916|FG000|Overall Study|Withdrawal by Subject|2|||
164236792|NCT03383666|593238916|FG000|Overall Study|Lost to Follow-up|2|||
164236793|NCT01240863|593238918|FG000|Open-label Titration Period|Adverse Event|47|||
164236794|NCT01240863|593238919|FG001|Open-label Titration Period|Adverse Event|0|||
164236795|NCT01240863|593238920|FG002|Open-label Titration Period|Adverse Event|0|||
164236796|NCT01240863|593238918|FG000|Open-label Titration Period|Lack of Efficacy|19|||
164236797|NCT01240863|593238919|FG001|Open-label Titration Period|Lack of Efficacy|0|||
164236798|NCT01240863|593238920|FG002|Open-label Titration Period|Lack of Efficacy|0|||
164236799|NCT01240863|593238918|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
164236800|NCT01240863|593238919|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
164236801|NCT01240863|593238920|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
164236802|NCT01240863|593238918|FG000|Open-label Titration Period|Protocol Violation|7|||
164236803|NCT01240863|593238919|FG001|Open-label Titration Period|Protocol Violation|0|||
164236804|NCT01240863|593238920|FG002|Open-label Titration Period|Protocol Violation|0|||
164236805|NCT01240863|593238918|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
164236806|NCT01240863|593238919|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
164236807|NCT01240863|593238920|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
164236808|NCT01240863|593238918|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
164236809|NCT01240863|593238919|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
164236810|NCT01240863|593238920|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
164236811|NCT01240863|593238918|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
164236812|NCT01240863|593238919|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
164236813|NCT01240863|593238920|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
164236814|NCT01240863|593238918|FG000|Open-label Titration Period|Other|7|||
164236815|NCT01240863|593238919|FG001|Open-label Titration Period|Other|0|||
164236816|NCT01240863|593238920|FG002|Open-label Titration Period|Other|0|||
164236817|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
164236818|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
164236819|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
164236820|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164334802|NCT02607930|593603227|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
164334803|NCT02607930|593603228|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
164334804|NCT02607930|593603229|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
164334805|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164334806|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
163988751|NCT04949841|592326215|FG000|Overall Study|Death|1|||
164140472|NCT00642278|592876096|FG001|Overall Study|Adverse Event|1|||
164334807|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
164334808|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
163988752|NCT04949841|592326215|FG000|Overall Study|Withdrawal by Subject|52|||
163988753|NCT04949841|592326215|FG000|Overall Study|Pregnancy|4|||
163988754|NCT04949841|592326215|FG000|Overall Study|Lost to Follow-up|9|||
163988755|NCT04949841|592326215|FG000|Overall Study|Lack of Efficacy|55|||
163988756|NCT04949841|592326215|FG000|Overall Study|Various reasons|9|||
163988757|NCT01984268|592326217|FG000|Overall Study|Study Terminated|15|||
163988758|NCT01314716|592326218|FG000|Double-Blind Phase|Randomized but not treated|1|||
163988759|NCT01314716|592326219|FG001|Double-Blind Phase|Randomized but not treated|1|||
163988760|NCT01314716|592326218|FG000|Double-Blind Phase|Adverse Event|10|||
163988761|NCT01314716|592326219|FG001|Double-Blind Phase|Adverse Event|4|||
163988762|NCT01314716|592326218|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
163988763|NCT01314716|592326219|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
163988764|NCT01314716|592326218|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163988765|NCT01314716|592326219|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163988766|NCT01314716|592326218|FG000|Double-Blind Phase|Sponsor request|1|||
163988767|NCT01314716|592326219|FG001|Double-Blind Phase|Sponsor request|2|||
163988768|NCT01314716|592326218|FG000|Double-Blind Phase|Physician Decision|0|||
163988769|NCT01314716|592326219|FG001|Double-Blind Phase|Physician Decision|1|||
163988770|NCT01314716|592326218|FG000|Open-Label Phase|Adverse Event|4|||
163988771|NCT01314716|592326219|FG001|Open-Label Phase|Adverse Event|6|||
163988772|NCT01314716|592326218|FG000|Open-Label Phase|Withdrawal by Subject|1|||
163988773|NCT01314716|592326219|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163988774|NCT01314716|592326218|FG000|Open-Label Phase|Physician Decision|5|||
163988775|NCT01314716|592326219|FG001|Open-Label Phase|Physician Decision|4|||
163988776|NCT01928381|592326223|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
163988777|NCT01928381|592326224|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163988778|NCT01928381|592326225|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163988779|NCT01928381|592326226|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163988780|NCT01928381|592326227|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163988781|NCT01928381|592326228|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163988782|NCT01928381|592326229|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
163988783|NCT01928381|592326223|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
163988784|NCT01928381|592326224|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
163988785|NCT01928381|592326225|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
163988786|NCT01928381|592326226|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
164236821|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
164236822|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
164236823|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164236824|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
164236825|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
164236826|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164236827|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
164236828|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
164236829|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
164236830|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
164236831|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
164236832|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
164334809|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
164334810|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
164334811|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
164334812|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
164334813|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
164334814|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
164334815|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
164334816|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
164236833|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
164236834|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
164236835|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
164236836|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
164236837|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
164236838|NCT01240863|593238918|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
164236839|NCT01240863|593238919|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
164236840|NCT01240863|593238920|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
164236841|NCT00746811|593238921|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
164236842|NCT00746811|593238922|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
164236843|NCT01538199|593238923|FG000|Overall Study|Lost to Follow-up|1|||
164236844|NCT01538199|593238924|FG001|Overall Study|Lost to Follow-up|2|||
164236845|NCT01538199|593238925|FG002|Overall Study|Lost to Follow-up|1|||
164236846|NCT01538199|593238926|FG003|Overall Study|Lost to Follow-up|0|||
164236847|NCT01538199|593238923|FG000|Overall Study|participant did not have time|1|||
164236848|NCT01538199|593238924|FG001|Overall Study|participant did not have time|0|||
164236849|NCT01538199|593238925|FG002|Overall Study|participant did not have time|0|||
164236850|NCT01538199|593238926|FG003|Overall Study|participant did not have time|2|||
164236851|NCT01538199|593238923|FG000|Overall Study|Lack of Efficacy|0|||
164236852|NCT01538199|593238924|FG001|Overall Study|Lack of Efficacy|1|||
164236853|NCT01538199|593238925|FG002|Overall Study|Lack of Efficacy|0|||
164236854|NCT01538199|593238926|FG003|Overall Study|Lack of Efficacy|0|||
164236855|NCT03358030|593238927|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
164236856|NCT03358030|593238928|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
164334817|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
164334818|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
164334819|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
164334820|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
164334821|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
164334822|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
164334823|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
164334824|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
164334825|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
164334826|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
164334827|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
164334828|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
164334829|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
164334830|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
164334831|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
164334832|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
164334833|NCT02607930|593603226|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
164334834|NCT02607930|593603227|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
164334835|NCT02607930|593603228|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
164334836|NCT02607930|593603229|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
164334837|NCT01134731|593603230|FG000|Overall Study|Adverse Event|3|||
164334838|NCT01134731|593603231|FG001|Overall Study|Adverse Event|2|||
164334839|NCT01134731|593603232|FG002|Overall Study|Adverse Event|1|||
164334840|NCT01134731|593603230|FG000|Overall Study|Physician Decision|2|||
164334841|NCT01134731|593603231|FG001|Overall Study|Physician Decision|2|||
164334842|NCT01134731|593603232|FG002|Overall Study|Physician Decision|2|||
164334843|NCT01134731|593603230|FG000|Overall Study|Lack of Efficacy|0|||
164334844|NCT01134731|593603231|FG001|Overall Study|Lack of Efficacy|0|||
164334845|NCT01134731|593603232|FG002|Overall Study|Lack of Efficacy|1|||
164334846|NCT01134731|593603230|FG000|Overall Study|Withdrawal by Subject|3|||
164334847|NCT01134731|593603231|FG001|Overall Study|Withdrawal by Subject|3|||
164334848|NCT01134731|593603232|FG002|Overall Study|Withdrawal by Subject|1|||
164334849|NCT01134731|593603230|FG000|Overall Study|Lost to Follow-up|5|||
164334850|NCT01134731|593603231|FG001|Overall Study|Lost to Follow-up|4|||
164334851|NCT01134731|593603232|FG002|Overall Study|Lost to Follow-up|3|||
164334852|NCT01050543|593603233|FG000|Overall Study|Withdrawal by Subject|0|||
164334853|NCT01050543|593603234|FG001|Overall Study|Withdrawal by Subject|2|||
164334854|NCT01050543|593603233|FG000|Overall Study|Protocol Violation|0|||
164334855|NCT01050543|593603234|FG001|Overall Study|Protocol Violation|1|||
164334856|NCT01050543|593603233|FG000|Overall Study|Administrative|4|||
164334857|NCT01050543|593603234|FG001|Overall Study|Administrative|1|||
164334858|NCT01950169|593603237|FG000|Overall Study|Withdrawal by Subject|2|||
164334859|NCT01950169|593603238|FG001|Overall Study|Withdrawal by Subject|8|||
164334860|NCT01950169|593603239|FG002|Overall Study|Withdrawal by Subject|1|||
164334861|NCT01950169|593603237|FG000|Overall Study|Death|1|||
164334862|NCT01950169|593603238|FG001|Overall Study|Death|0|||
164334863|NCT01950169|593603239|FG002|Overall Study|Death|0|||
164334864|NCT00437320|593603240|FG000|Overall Study|Participant request|2|||
164334865|NCT00437320|593603241|FG001|Overall Study|Participant request|1|||
164334866|NCT00437320|593603242|FG002|Overall Study|Participant request|4|||
164334867|NCT01938573|593603243|FG000|Overall Study|Lack of Efficacy|1|||
164334868|NCT01938573|593603244|FG001|Overall Study|Lack of Efficacy|0|||
164334869|NCT01938573|593603243|FG000|Overall Study|Operation at other hospital|1|||
164334870|NCT01938573|593603244|FG001|Overall Study|Operation at other hospital|0|||
164334871|NCT00737438|593603245|FG000|Overall Study|Withdrawal by Subject|2|||
164334872|NCT00737438|593603245|FG000|Overall Study|Patient ineligible|1|||
164334873|NCT02410551|593603246|FG000|Overall Study|Adverse Event|1|||
164334874|NCT02410551|593603246|FG000|Overall Study|Withdrawal by Subject|1|||
164334875|NCT02410551|593603246|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
164334876|NCT01739309|593603247|FG000|Overall Study|Adverse Event|1|||
164334877|NCT01739309|593603247|FG000|Overall Study|Withdrawal by Subject|1|||
164334878|NCT05469113|593603248|FG000|Period 2|Adverse Event|0|||
164334879|NCT05469113|593603249|FG001|Period 2|Adverse Event|3|||
164334880|NCT05447897|593603250|FG000|Overall Study|Did not participate in survey|2|||
164334881|NCT04553679|593603251|FG000|Overall Study|Withdrawal by Subject|2|||
164334882|NCT04553679|593603252|FG001|Overall Study|Withdrawal by Subject|0|||
164334883|NCT04553679|593603251|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
164334884|NCT04553679|593603252|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
164334885|NCT01230710|593603254|FG000|Overall Study|Disease Progression|41|||
164334886|NCT01230710|593603254|FG000|Overall Study|Lost to Follow-up|3|||
164334887|NCT01230710|593603254|FG000|Overall Study|Death|4|||
164334888|NCT01230710|593603254|FG000|Overall Study|Withdrawal of Consent|1|||
164334889|NCT02905149|593603255|FG000|Overall Study|Lost to Follow-up|2|||
164334890|NCT02905149|593603256|FG001|Overall Study|Lost to Follow-up|0|||
164334891|NCT00747812|593603257|FG000|Overall Study|Research Site Staff Relocation|5|||
164334892|NCT00747812|593603258|FG001|Overall Study|Research Site Staff Relocation|3|||
164334893|NCT01708161|593603261|FG000|Overall Study|Adverse Event|1|||
164334894|NCT01708161|593603262|FG001|Overall Study|Adverse Event|3|||
164334895|NCT01708161|593603263|FG002|Overall Study|Adverse Event|4|||
164334896|NCT01708161|593603264|FG003|Overall Study|Adverse Event|2|||
164334897|NCT01708161|593603265|FG004|Overall Study|Adverse Event|3|||
164334898|NCT01708161|593603266|FG005|Overall Study|Adverse Event|0|||
164334899|NCT01708161|593603261|FG000|Overall Study|Death|0|||
164334900|NCT01708161|593603262|FG001|Overall Study|Death|0|||
164334901|NCT01708161|593603263|FG002|Overall Study|Death|0|||
164334902|NCT01708161|593603264|FG003|Overall Study|Death|1|||
164334903|NCT01708161|593603265|FG004|Overall Study|Death|0|||
163988787|NCT01928381|592326227|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
163988788|NCT01928381|592326228|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
164006632|NCT00847613|592391042|FG001|Overall Study|Lack of Efficacy|3|||
164334904|NCT01708161|593603266|FG005|Overall Study|Death|1|||
164334905|NCT01708161|593603261|FG000|Overall Study|Withdrawal by Subject|0|||
164334906|NCT01708161|593603262|FG001|Overall Study|Withdrawal by Subject|1|||
164334907|NCT01708161|593603263|FG002|Overall Study|Withdrawal by Subject|1|||
164334908|NCT01708161|593603264|FG003|Overall Study|Withdrawal by Subject|0|||
164236857|NCT03358030|593238929|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
164236858|NCT03358030|593238930|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
164236859|NCT03358030|593238927|FG000|Overall Study|Ineligibility|0|||
164236860|NCT03358030|593238928|FG001|Overall Study|Ineligibility|0|||
164236861|NCT03358030|593238929|FG002|Overall Study|Ineligibility|0|||
164236862|NCT03358030|593238930|FG003|Overall Study|Ineligibility|2|||
164236863|NCT03358030|593238927|FG000|Overall Study|Voluntary Withdrawal|1|||
164236864|NCT03358030|593238928|FG001|Overall Study|Voluntary Withdrawal|1|||
164236865|NCT03358030|593238929|FG002|Overall Study|Voluntary Withdrawal|3|||
164236866|NCT03358030|593238930|FG003|Overall Study|Voluntary Withdrawal|1|||
164236867|NCT03358030|593238927|FG000|Overall Study|Other|0|||
164236868|NCT03358030|593238928|FG001|Overall Study|Other|0|||
164236869|NCT03358030|593238929|FG002|Overall Study|Other|1|||
164236870|NCT03358030|593238930|FG003|Overall Study|Other|0|||
164236871|NCT03770286|593238931|FG000|Overall Study|Lost to Follow-up|6|||
164236872|NCT03770286|593238932|FG001|Overall Study|Lost to Follow-up|4|||
164236873|NCT03770286|593238933|FG002|Overall Study|Lost to Follow-up|3|||
164236874|NCT03770286|593238931|FG000|Overall Study|Protocol Violation|1|||
164236875|NCT03770286|593238932|FG001|Overall Study|Protocol Violation|0|||
164236876|NCT03770286|593238933|FG002|Overall Study|Protocol Violation|2|||
164236877|NCT02505425|593238934|FG000|Overall Study|Lost to Follow-up|41|||
164236878|NCT02505425|593238935|FG001|Overall Study|Lost to Follow-up|61|||
164236879|NCT02505425|593238936|FG002|Overall Study|Lost to Follow-up|31|||
164236880|NCT02505425|593238937|FG003|Overall Study|Lost to Follow-up|19|||
164236881|NCT02505425|593238934|FG000|Overall Study|Withdrawal by Subject|39|||
164236882|NCT02505425|593238935|FG001|Overall Study|Withdrawal by Subject|9|||
164236883|NCT02505425|593238936|FG002|Overall Study|Withdrawal by Subject|19|||
164236884|NCT02505425|593238937|FG003|Overall Study|Withdrawal by Subject|7|||
164236885|NCT02505425|593238934|FG000|Overall Study|Death|8|||
164236886|NCT02505425|593238935|FG001|Overall Study|Death|12|||
164236887|NCT02505425|593238936|FG002|Overall Study|Death|0|||
164236888|NCT02505425|593238937|FG003|Overall Study|Death|0|||
164236889|NCT04756531|593238944|FG000|Overall Study|Adverse Event|0|||
164236890|NCT04756531|593238945|FG001|Overall Study|Adverse Event|0|||
164236891|NCT04756531|593238946|FG002|Overall Study|Adverse Event|0|||
164236892|NCT04756531|593238947|FG003|Overall Study|Adverse Event|0|||
164236893|NCT04756531|593238948|FG004|Overall Study|Adverse Event|1|||
164236894|NCT04756531|593238949|FG005|Overall Study|Adverse Event|0|||
164334909|NCT01708161|593603265|FG004|Overall Study|Withdrawal by Subject|0|||
164334910|NCT01708161|593603266|FG005|Overall Study|Withdrawal by Subject|0|||
164334911|NCT01708161|593603261|FG000|Overall Study|Administrative problems|0|||
164334912|NCT01708161|593603262|FG001|Overall Study|Administrative problems|1|||
164334913|NCT01708161|593603263|FG002|Overall Study|Administrative problems|0|||
164334914|NCT01708161|593603264|FG003|Overall Study|Administrative problems|0|||
164334915|NCT01708161|593603265|FG004|Overall Study|Administrative problems|0|||
164334916|NCT01708161|593603266|FG005|Overall Study|Administrative problems|0|||
164334917|NCT01708161|593603261|FG000|Overall Study|Disease progression|3|||
164334918|NCT01708161|593603262|FG001|Overall Study|Disease progression|5|||
164334919|NCT01708161|593603263|FG002|Overall Study|Disease progression|5|||
164334920|NCT01708161|593603264|FG003|Overall Study|Disease progression|13|||
164334921|NCT01708161|593603265|FG004|Overall Study|Disease progression|3|||
164334922|NCT01708161|593603266|FG005|Overall Study|Disease progression|0|||
164334923|NCT01986140|593603268|FG000|Overall Study|Withdrawal by Subject|31|||
164334924|NCT01986140|593603269|FG001|Overall Study|Withdrawal by Subject|25|||
164334925|NCT01986140|593603268|FG000|Overall Study|alternative treatment|1|||
164334926|NCT01986140|593603269|FG001|Overall Study|alternative treatment|1|||
164334927|NCT01986140|593603268|FG000|Overall Study|found not eligible|3|||
164334928|NCT01986140|593603269|FG001|Overall Study|found not eligible|0|||
164334929|NCT01986140|593603268|FG000|Overall Study|Adverse Event|0|||
164334930|NCT01986140|593603269|FG001|Overall Study|Adverse Event|1|||
164334931|NCT01986140|593603268|FG000|Overall Study|progression disease|0|||
164334932|NCT01986140|593603269|FG001|Overall Study|progression disease|1|||
164334933|NCT01069627|593603285|FG000|Overall Study|Disease progression|7|||
164334934|NCT01069627|593603285|FG000|Overall Study|Adverse Event|12|||
164334935|NCT01069627|593603285|FG000|Overall Study|Protocol Violation|1|||
164236895|NCT04756531|593238950|FG006|Overall Study|Adverse Event|0|||
164334936|NCT02963935|593603286|FG000|Overall Study|Adverse Event|12|||
164334937|NCT02963935|593603287|FG001|Overall Study|Adverse Event|6|||
164236896|NCT04756531|593238951|FG007|Overall Study|Adverse Event|0|||
164334938|NCT02963935|593603286|FG000|Overall Study|Protocol Violation|2|||
164334939|NCT02963935|593603287|FG001|Overall Study|Protocol Violation|1|||
164334940|NCT02963935|593603286|FG000|Overall Study|Lack of Efficacy|0|||
164334941|NCT02963935|593603287|FG001|Overall Study|Lack of Efficacy|2|||
164334942|NCT02963935|593603286|FG000|Overall Study|Lost to Follow-up|1|||
164236897|NCT04756531|593238952|FG008|Overall Study|Adverse Event|0|||
164236898|NCT04756531|593238953|FG009|Overall Study|Adverse Event|0|||
164236899|NCT04756531|593238954|FG010|Overall Study|Adverse Event|0|||
164236900|NCT04756531|593238955|FG011|Overall Study|Adverse Event|0|||
164236901|NCT04756531|593238956|FG012|Overall Study|Adverse Event|0|||
164334943|NCT02963935|593603287|FG001|Overall Study|Lost to Follow-up|6|||
164236902|NCT04756531|593238957|FG013|Overall Study|Adverse Event|0|||
164236903|NCT04756531|593238958|FG014|Overall Study|Adverse Event|0|||
164236904|NCT04756531|593238959|FG015|Overall Study|Adverse Event|0|||
164236905|NCT04756531|593238960|FG016|Overall Study|Adverse Event|0|||
164236906|NCT04756531|593238961|FG017|Overall Study|Adverse Event|0|||
164236907|NCT04756531|593238944|FG000|Overall Study|Withdrawal by Subject|0|||
164236908|NCT04756531|593238945|FG001|Overall Study|Withdrawal by Subject|0|||
164236909|NCT04756531|593238946|FG002|Overall Study|Withdrawal by Subject|0|||
164236910|NCT04756531|593238947|FG003|Overall Study|Withdrawal by Subject|0|||
164236911|NCT04756531|593238948|FG004|Overall Study|Withdrawal by Subject|0|||
164236912|NCT04756531|593238949|FG005|Overall Study|Withdrawal by Subject|0|||
164236913|NCT04756531|593238950|FG006|Overall Study|Withdrawal by Subject|1|||
164236914|NCT04756531|593238951|FG007|Overall Study|Withdrawal by Subject|0|||
164236915|NCT04756531|593238952|FG008|Overall Study|Withdrawal by Subject|0|||
164236916|NCT04756531|593238953|FG009|Overall Study|Withdrawal by Subject|0|||
164236917|NCT04756531|593238954|FG010|Overall Study|Withdrawal by Subject|0|||
164236918|NCT04756531|593238955|FG011|Overall Study|Withdrawal by Subject|0|||
164236919|NCT04756531|593238956|FG012|Overall Study|Withdrawal by Subject|0|||
164236920|NCT04756531|593238957|FG013|Overall Study|Withdrawal by Subject|0|||
164236921|NCT04756531|593238958|FG014|Overall Study|Withdrawal by Subject|0|||
164236922|NCT04756531|593238959|FG015|Overall Study|Withdrawal by Subject|0|||
164236923|NCT04756531|593238960|FG016|Overall Study|Withdrawal by Subject|0|||
164236924|NCT04756531|593238961|FG017|Overall Study|Withdrawal by Subject|0|||
164236925|NCT05643495|593238962|FG000|Overall Study|Adverse Event|0|||
164236926|NCT05643495|593238963|FG001|Overall Study|Adverse Event|1|||
164236927|NCT05643495|593238962|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164236928|NCT05643495|593238963|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
164236929|NCT02257528|593238964|FG000|Overall Study|Never received study treatment|1|||
164236930|NCT01729039|593238965|FG000|Overall Study|disqualified|2|||
164236931|NCT01729039|593238966|FG001|Overall Study|disqualified|5|||
164236932|NCT01729039|593238965|FG000|Overall Study|Withdrawal by Subject|8|||
164236933|NCT01729039|593238966|FG001|Overall Study|Withdrawal by Subject|7|||
164236934|NCT00404248|593238969|FG000|Overall Study|pts declining status|0|||
164334944|NCT02963935|593603286|FG000|Overall Study|Unclassified|13|||
164334945|NCT02963935|593603287|FG001|Overall Study|Unclassified|22|||
164334946|NCT00464269|593603288|FG000|Overall Study|Lack of Efficacy|1|||
164334947|NCT00464269|593603289|FG001|Overall Study|Lack of Efficacy|0|||
164334948|NCT00464269|593603290|FG002|Overall Study|Lack of Efficacy|0|||
164334949|NCT00464269|593603291|FG003|Overall Study|Lack of Efficacy|0|||
164334950|NCT00464269|593603288|FG000|Overall Study|Lost to Follow-up|0|||
163884429|NCT03307343|591945985|FG001|Overall Study|Lost to Follow-up|2|||
164236935|NCT00404248|593238970|FG001|Overall Study|pts declining status|1|||
164236936|NCT00404248|593238971|FG002|Overall Study|pts declining status|0|||
164236937|NCT00404248|593238972|FG003|Overall Study|pts declining status|0|||
164236938|NCT00404248|593238973|FG004|Overall Study|pts declining status|0|||
164236939|NCT00404248|593238974|FG005|Overall Study|pts declining status|0|||
164236940|NCT00404248|593238975|FG006|Overall Study|pts declining status|0|||
164334951|NCT00464269|593603289|FG001|Overall Study|Lost to Follow-up|4|||
164334952|NCT00464269|593603290|FG002|Overall Study|Lost to Follow-up|0|||
164334953|NCT00464269|593603291|FG003|Overall Study|Lost to Follow-up|1|||
164334954|NCT00464269|593603288|FG000|Overall Study|Withdrawal by Subject|0|||
164334955|NCT00464269|593603289|FG001|Overall Study|Withdrawal by Subject|2|||
164334956|NCT00464269|593603290|FG002|Overall Study|Withdrawal by Subject|1|||
164334957|NCT00464269|593603291|FG003|Overall Study|Withdrawal by Subject|1|||
164334958|NCT00464269|593603288|FG000|Overall Study|Other reason|3|||
164334959|NCT00464269|593603289|FG001|Overall Study|Other reason|3|||
164334960|NCT00464269|593603290|FG002|Overall Study|Other reason|1|||
164334961|NCT00464269|593603291|FG003|Overall Study|Other reason|1|||
164334962|NCT00464269|593603288|FG000|Overall Study|AE, serious fatal|0|||
164334963|NCT00464269|593603289|FG001|Overall Study|AE, serious fatal|0|||
164334964|NCT00464269|593603290|FG002|Overall Study|AE, serious fatal|1|||
164334965|NCT00464269|593603291|FG003|Overall Study|AE, serious fatal|1|||
164334966|NCT00464269|593603288|FG000|Overall Study|SAE, non-fatal|0|||
164334967|NCT00464269|593603289|FG001|Overall Study|SAE, non-fatal|0|||
164334968|NCT00464269|593603290|FG002|Overall Study|SAE, non-fatal|0|||
164334969|NCT00464269|593603291|FG003|Overall Study|SAE, non-fatal|1|||
164334970|NCT00464269|593603288|FG000|Overall Study|AE, non-serious non-fatal|2|||
164334971|NCT00464269|593603289|FG001|Overall Study|AE, non-serious non-fatal|8|||
163884430|NCT05184192|591945994|FG000|Overall Study|Lost to Follow-up|4|||
164236941|NCT00404248|593238976|FG007|Overall Study|pts declining status|0|||
164236942|NCT00404248|593238977|FG008|Overall Study|pts declining status|0|||
164236943|NCT00698841|593238978|FG000|Overall Study|Withdrawal by Subject|2|||
164236944|NCT00698841|593238978|FG000|Overall Study|Adverse Event|3|||
164334972|NCT00464269|593603290|FG002|Overall Study|AE, non-serious non-fatal|3|||
164334973|NCT00464269|593603291|FG003|Overall Study|AE, non-serious non-fatal|4|||
164334974|NCT00464269|593603288|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164334975|NCT00464269|593603289|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164236945|NCT00698841|593238978|FG000|Overall Study|Disease progression|7|||
164236946|NCT00698841|593238978|FG000|Overall Study|Failure to meet eligibility criteria|2|||
164236947|NCT00698841|593238978|FG000|Overall Study|Study drug toxicity|2|||
164236948|NCT00698841|593238978|FG000|Overall Study|Other|2|||
164236949|NCT04646005|593238982|FG000|Overall Study|Adverse Event|1|||
164236950|NCT04646005|593238982|FG000|Overall Study|Progressive Disease|71|||
164236951|NCT04646005|593238982|FG000|Overall Study|Death|20|||
164236952|NCT04646005|593238982|FG000|Overall Study|Withdrawal by Subject|12|||
164236953|NCT04646005|593238982|FG000|Overall Study|Sponsor Request|9|||
164236954|NCT05788991|593238984|FG000|Overall Study|Not treated with study medication|1|||
164334976|NCT00464269|593603290|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
164334977|NCT00464269|593603291|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
164334978|NCT03911154|593603292|FG000|Overall Study|Withdrawal by Subject|1|||
164334979|NCT00299182|593603293|FG000|Overall Study|Withdrawal by Subject|0|||
164334980|NCT00299182|593603294|FG001|Overall Study|Withdrawal by Subject|0|||
164334981|NCT00299182|593603295|FG002|Overall Study|Withdrawal by Subject|1|||
164334982|NCT00299182|593603296|FG003|Overall Study|Withdrawal by Subject|0|||
164334983|NCT00299182|593603297|FG004|Overall Study|Withdrawal by Subject|1|||
164334984|NCT00299182|593603298|FG005|Overall Study|Withdrawal by Subject|2|||
164334985|NCT00299182|593603299|FG006|Overall Study|Withdrawal by Subject|0|||
164334986|NCT00299182|593603293|FG000|Overall Study|Chemotherapy Changed|0|||
164334987|NCT00299182|593603294|FG001|Overall Study|Chemotherapy Changed|0|||
164334988|NCT00299182|593603295|FG002|Overall Study|Chemotherapy Changed|1|||
164334989|NCT00299182|593603296|FG003|Overall Study|Chemotherapy Changed|0|||
164334990|NCT00299182|593603297|FG004|Overall Study|Chemotherapy Changed|1|||
164334991|NCT00299182|593603298|FG005|Overall Study|Chemotherapy Changed|0|||
164334992|NCT00299182|593603299|FG006|Overall Study|Chemotherapy Changed|1|||
164334993|NCT00299182|593603293|FG000|Overall Study|Adverse Event|0|||
164334994|NCT00299182|593603294|FG001|Overall Study|Adverse Event|0|||
164334995|NCT00299182|593603295|FG002|Overall Study|Adverse Event|0|||
164334996|NCT00299182|593603296|FG003|Overall Study|Adverse Event|0|||
164334997|NCT00299182|593603297|FG004|Overall Study|Adverse Event|0|||
164334998|NCT00299182|593603298|FG005|Overall Study|Adverse Event|1|||
164334999|NCT00299182|593603299|FG006|Overall Study|Adverse Event|0|||
164335000|NCT00299182|593603293|FG000|Overall Study|Not Eligible|0|||
164335001|NCT00299182|593603294|FG001|Overall Study|Not Eligible|0|||
164335002|NCT00299182|593603295|FG002|Overall Study|Not Eligible|0|||
164335003|NCT00299182|593603296|FG003|Overall Study|Not Eligible|0|||
164335004|NCT00299182|593603297|FG004|Overall Study|Not Eligible|1|||
164335005|NCT00299182|593603298|FG005|Overall Study|Not Eligible|0|||
164335006|NCT00299182|593603299|FG006|Overall Study|Not Eligible|0|||
164335007|NCT00292318|593603301|FG000|Overall Study|Study terminated by officials|2|||
164335008|NCT00292318|593603302|FG001|Overall Study|Study terminated by officials|1|||
164335009|NCT00771316|593603303|FG000|Overall Study|Adverse Event|0|||
164335010|NCT00771316|593603304|FG001|Overall Study|Adverse Event|1|||
164335011|NCT00771316|593603303|FG000|Overall Study|Patient withdrew consent|1|||
164335012|NCT00771316|593603304|FG001|Overall Study|Patient withdrew consent|0|||
164335013|NCT00771316|593603303|FG000|Overall Study|Discontinued due to early termination|1|||
164335014|NCT00771316|593603304|FG001|Overall Study|Discontinued due to early termination|0|||
164335015|NCT01822496|593603305|FG000|Overall Study|Protocol Violation|2|||
164335016|NCT01822496|593603306|FG001|Overall Study|Protocol Violation|2|||
164335017|NCT01822496|593603307|FG002|Overall Study|Protocol Violation|0|||
164335018|NCT01822496|593603308|FG003|Overall Study|Protocol Violation|1|||
164335019|NCT01822496|593603305|FG000|Overall Study|Withdrawal by Subject|0|||
164335020|NCT01822496|593603306|FG001|Overall Study|Withdrawal by Subject|0|||
164335021|NCT01822496|593603307|FG002|Overall Study|Withdrawal by Subject|0|||
164335022|NCT01822496|593603308|FG003|Overall Study|Withdrawal by Subject|3|||
164335023|NCT01631812|593603309|FG000|Overall Study|Adverse Event|25|||
164335024|NCT01631812|593603309|FG000|Overall Study|Lack of Efficacy|5|||
164335025|NCT01631812|593603309|FG000|Overall Study|Withdrawal by Subject|4|||
164335026|NCT01631812|593603309|FG000|Overall Study|Physician Decision|3|||
164335027|NCT00543543|593603310|FG000|Base Study|Adverse Event|1|||
164335028|NCT00543543|593603311|FG001|Base Study|Adverse Event|11|||
164335029|NCT00543543|593603312|FG002|Base Study|Adverse Event|0|||
164335030|NCT00543543|593603313|FG003|Base Study|Adverse Event|5|||
164335031|NCT00543543|593603310|FG000|Base Study|Lost to Follow-up|12|||
164335032|NCT00543543|593603311|FG001|Base Study|Lost to Follow-up|749|||
164335033|NCT00543543|593603312|FG002|Base Study|Lost to Follow-up|9|||
164335034|NCT00543543|593603313|FG003|Base Study|Lost to Follow-up|701|||
164335035|NCT00543543|593603310|FG000|Base Study|Physician Decision|0|||
164335036|NCT00543543|593603311|FG001|Base Study|Physician Decision|4|||
164335037|NCT00543543|593603312|FG002|Base Study|Physician Decision|0|||
164335038|NCT00543543|593603313|FG003|Base Study|Physician Decision|7|||
164335039|NCT00543543|593603310|FG000|Base Study|Protocol Violation|0|||
164335040|NCT00543543|593603311|FG001|Base Study|Protocol Violation|6|||
164236955|NCT05788991|593238985|FG001|Overall Study|Not treated with study medication|3|||
164236956|NCT05788991|593238984|FG000|Overall Study|Withdrawal by Subject|1|||
164335041|NCT00543543|593603312|FG002|Base Study|Protocol Violation|0|||
164236957|NCT05788991|593238985|FG001|Overall Study|Withdrawal by Subject|0|||
164236958|NCT05788991|593238984|FG000|Overall Study|Lack of Efficacy|0|||
164236959|NCT05788991|593238985|FG001|Overall Study|Lack of Efficacy|1|||
164236960|NCT05788991|593238984|FG000|Overall Study|Protocol Violation|1|||
164236961|NCT05788991|593238985|FG001|Overall Study|Protocol Violation|2|||
164236962|NCT04464473|593238986|FG000|Overall Study|New piercing could not be removed for scanning|0|||
164236963|NCT04464473|593238987|FG001|Overall Study|New piercing could not be removed for scanning|0|||
164236964|NCT04464473|593238988|FG002|Overall Study|New piercing could not be removed for scanning|0|||
164236965|NCT04464473|593238989|FG003|Overall Study|New piercing could not be removed for scanning|1|||
164236966|NCT04464473|593238990|FG004|Overall Study|New piercing could not be removed for scanning|0|||
164236967|NCT04464473|593238991|FG005|Overall Study|New piercing could not be removed for scanning|0|||
164236968|NCT04464473|593238986|FG000|Overall Study|Adverse Event|0|||
164236969|NCT04464473|593238987|FG001|Overall Study|Adverse Event|0|||
164236970|NCT04464473|593238988|FG002|Overall Study|Adverse Event|0|||
164236971|NCT04464473|593238989|FG003|Overall Study|Adverse Event|1|||
164236972|NCT04464473|593238990|FG004|Overall Study|Adverse Event|0|||
164236973|NCT04464473|593238991|FG005|Overall Study|Adverse Event|0|||
164236974|NCT04464473|593238986|FG000|Overall Study|Lost to Follow-up|0|||
164236975|NCT04464473|593238987|FG001|Overall Study|Lost to Follow-up|0|||
164236976|NCT04464473|593238988|FG002|Overall Study|Lost to Follow-up|0|||
164236977|NCT04464473|593238989|FG003|Overall Study|Lost to Follow-up|1|||
164236978|NCT04464473|593238990|FG004|Overall Study|Lost to Follow-up|0|||
164236979|NCT04464473|593238991|FG005|Overall Study|Lost to Follow-up|0|||
164236980|NCT03802396|593238992|FG000|Overall Study|Withdrawal by Subject|2|||
164236981|NCT03802396|593238993|FG001|Overall Study|Withdrawal by Subject|0|||
164236982|NCT03802396|593238992|FG000|Overall Study|Surgery Cancelled|1|||
164236983|NCT03802396|593238993|FG001|Overall Study|Surgery Cancelled|0|||
164236984|NCT04237584|593239004|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
164236985|NCT04237584|593239005|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
164236986|NCT04237584|593239006|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
164236987|NCT04237584|593239007|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
164236988|NCT04237584|593239004|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
164236989|NCT04237584|593239005|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
164236990|NCT04237584|593239006|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
164236991|NCT04237584|593239007|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
163884431|NCT05184192|591945995|FG001|Overall Study|Lost to Follow-up|7|||
163884432|NCT05184192|591945994|FG000|Overall Study|Adverse Event|1|||
163884433|NCT05184192|591945995|FG001|Overall Study|Adverse Event|4|||
164236992|NCT04237584|593239004|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
164236993|NCT04237584|593239005|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
164335042|NCT00543543|593603313|FG003|Base Study|Protocol Violation|6|||
164335043|NCT00543543|593603310|FG000|Base Study|Withdrawal by Subject|7|||
164335044|NCT00543543|593603311|FG001|Base Study|Withdrawal by Subject|482|||
164335045|NCT00543543|593603312|FG002|Base Study|Withdrawal by Subject|5|||
164335046|NCT00543543|593603313|FG003|Base Study|Withdrawal by Subject|503|||
164335047|NCT00543543|593603310|FG000|Extension Study|Adverse Event|0|||
164335048|NCT00543543|593603311|FG001|Extension Study|Adverse Event|0|||
164335049|NCT00543543|593603312|FG002|Extension Study|Adverse Event|0|||
164335050|NCT00543543|593603313|FG003|Extension Study|Adverse Event|5|||
164335051|NCT00543543|593603310|FG000|Extension Study|Lost to Follow-up|0|||
164335052|NCT00543543|593603311|FG001|Extension Study|Lost to Follow-up|0|||
164335053|NCT00543543|593603312|FG002|Extension Study|Lost to Follow-up|0|||
164335054|NCT00543543|593603313|FG003|Extension Study|Lost to Follow-up|77|||
164335055|NCT00543543|593603310|FG000|Extension Study|Physician Decision|0|||
164335056|NCT00543543|593603311|FG001|Extension Study|Physician Decision|0|||
164335057|NCT00543543|593603312|FG002|Extension Study|Physician Decision|0|||
164335058|NCT00543543|593603313|FG003|Extension Study|Physician Decision|7|||
164335059|NCT00543543|593603310|FG000|Extension Study|Pregnancy|0|||
164335060|NCT00543543|593603311|FG001|Extension Study|Pregnancy|0|||
164335061|NCT00543543|593603312|FG002|Extension Study|Pregnancy|0|||
164335062|NCT00543543|593603313|FG003|Extension Study|Pregnancy|6|||
164335063|NCT00543543|593603310|FG000|Extension Study|Protocol Violation|0|||
164335064|NCT00543543|593603311|FG001|Extension Study|Protocol Violation|0|||
164335065|NCT00543543|593603312|FG002|Extension Study|Protocol Violation|0|||
164335066|NCT00543543|593603313|FG003|Extension Study|Protocol Violation|11|||
164335067|NCT00543543|593603310|FG000|Extension Study|Withdrawal by Subject|0|||
164335068|NCT00543543|593603311|FG001|Extension Study|Withdrawal by Subject|0|||
164335069|NCT00543543|593603312|FG002|Extension Study|Withdrawal by Subject|0|||
164335070|NCT00543543|593603313|FG003|Extension Study|Withdrawal by Subject|120|||
164335071|NCT00945555|593603314|FG000|Overall Study|Referred to another hospital|5|||
164335072|NCT00945555|593603314|FG000|Overall Study|Worsening condition, intensive care unit|1|||
164335073|NCT00945555|593603314|FG000|Overall Study|Withdrawal by Subject|2|||
164335074|NCT00945555|593603314|FG000|Overall Study|Participant continued treatment at home|1|||
164335075|NCT00945555|593603314|FG000|Overall Study|Death|18|||
164236994|NCT04237584|593239006|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
164236995|NCT04237584|593239007|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
164236996|NCT04237584|593239004|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
164236997|NCT04237584|593239005|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
164236998|NCT04237584|593239006|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
164236999|NCT04237584|593239007|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
164237000|NCT04237584|593239004|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
164237001|NCT04237584|593239005|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
164237002|NCT04237584|593239006|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
164237003|NCT04237584|593239007|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
164237004|NCT03549338|593240459|FG000|Overall Study|Progressive Disease|1|||
164237005|NCT03549338|593240460|FG001|Overall Study|Progressive Disease|0|||
164237006|NCT03549338|593240461|FG002|Overall Study|Progressive Disease|0|||
164237007|NCT03549338|593240459|FG000|Overall Study|Clinical Progression|0|||
164237008|NCT03549338|593240460|FG001|Overall Study|Clinical Progression|1|||
164237009|NCT03549338|593240461|FG002|Overall Study|Clinical Progression|0|||
164237010|NCT01492426|593240462|FG000|Treatment|Death|0|||
164237011|NCT01492426|593240463|FG001|Treatment|Death|1|||
164237012|NCT01492426|593240462|FG000|Treatment|Other|1|||
164237013|NCT01492426|593240463|FG001|Treatment|Other|0|||
164237014|NCT01492426|593240462|FG000|Treatment|Adverse Event|25|||
164237015|NCT01492426|593240463|FG001|Treatment|Adverse Event|25|||
164237016|NCT01492426|593240462|FG000|Treatment|Lack of Efficacy|38|||
164237017|NCT01492426|593240463|FG001|Treatment|Lack of Efficacy|5|||
164237018|NCT01492426|593240462|FG000|Treatment|Participant withdrew consent|1|||
164237019|NCT01492426|593240463|FG001|Treatment|Participant withdrew consent|2|||
164237020|NCT01492426|593240462|FG000|Treatment|Poor compliance/noncompliance|1|||
164237021|NCT01492426|593240463|FG001|Treatment|Poor compliance/noncompliance|0|||
164237022|NCT01492426|593240462|FG000|Treatment|Subject requested discontinue study drug|7|||
164237023|NCT01492426|593240463|FG001|Treatment|Subject requested discontinue study drug|3|||
164237024|NCT01492426|593240462|FG000|Treatment|Lost to Follow-up|9|||
164237025|NCT01492426|593240463|FG001|Treatment|Lost to Follow-up|4|||
164237026|NCT01492426|593240462|FG000|Treatment|Participant does not meet study criteria|1|||
164237027|NCT01492426|593240463|FG001|Treatment|Participant does not meet study criteria|0|||
164237028|NCT01492426|593240462|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
164237029|NCT01492426|593240463|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
164237030|NCT01492426|593240462|FG000|Follow-Up|Death|1|||
164237031|NCT01492426|593240463|FG001|Follow-Up|Death|0|||
164237032|NCT01492426|593240462|FG000|Follow-Up|Other|4|||
164237033|NCT01492426|593240463|FG001|Follow-Up|Other|2|||
164237034|NCT01492426|593240462|FG000|Follow-Up|Participant Withdrew Consent|6|||
164237035|NCT01492426|593240463|FG001|Follow-Up|Participant Withdrew Consent|1|||
164237036|NCT01492426|593240462|FG000|Follow-Up|Lost to Follow-up|12|||
164237037|NCT01492426|593240463|FG001|Follow-Up|Lost to Follow-up|6|||
164237038|NCT00269113|593240464|FG000|Overall Study|Adverse Event|14|||
164237039|NCT00269113|593240465|FG001|Overall Study|Adverse Event|7|||
164237040|NCT00269113|593240464|FG000|Overall Study|Lack of Efficacy|35|||
164237041|NCT00269113|593240465|FG001|Overall Study|Lack of Efficacy|18|||
164237042|NCT00269113|593240464|FG000|Overall Study|Early Improvement|2|||
164237043|NCT00269113|593240465|FG001|Overall Study|Early Improvement|0|||
164237044|NCT00269113|593240464|FG000|Overall Study|Withdrawal by Subject|0|||
164237045|NCT00269113|593240465|FG001|Overall Study|Withdrawal by Subject|2|||
164237046|NCT00269113|593240464|FG000|Overall Study|Death|6|||
164237047|NCT00269113|593240465|FG001|Overall Study|Death|2|||
164335076|NCT00945555|593603314|FG000|Overall Study|Other|1|||
164335077|NCT04502979|593603315|FG000|Overall Study|Lost to Follow-up|1|||
164335078|NCT04502979|593603316|FG001|Overall Study|Lost to Follow-up|3|||
164335079|NCT04502979|593603315|FG000|Overall Study|Withdrawal by Subject|2|||
164335080|NCT04502979|593603316|FG001|Overall Study|Withdrawal by Subject|1|||
164335081|NCT00586625|593603320|FG000|Overall Study|Adverse Event|6|||
164335082|NCT00586625|593603321|FG001|Overall Study|Adverse Event|6|||
164237048|NCT00269113|593240464|FG000|Overall Study|Lost to Follow-up|2|||
164237049|NCT00269113|593240465|FG001|Overall Study|Lost to Follow-up|1|||
164237050|NCT00269113|593240464|FG000|Overall Study|Protocol Violation|15|||
164237051|NCT00269113|593240465|FG001|Overall Study|Protocol Violation|5|||
164237052|NCT00269113|593240464|FG000|Overall Study|Other|0|||
164237053|NCT00269113|593240465|FG001|Overall Study|Other|2|||
164237054|NCT00652743|593240466|FG000|Months 12-18|Lost to Follow-up|1|||
164237055|NCT00652743|593240467|FG001|Months 12-18|Lost to Follow-up|2|||
164237056|NCT00652743|593240468|FG002|Months 12-18|Lost to Follow-up|7|||
164237057|NCT00652743|593240466|FG000|Months 24-30|Other|5|||
164237058|NCT00652743|593240467|FG001|Months 24-30|Other|1|||
164237059|NCT00652743|593240468|FG002|Months 24-30|Other|11|||
164237060|NCT00652743|593240466|FG000|Months 36-42|Serious Adverse Events|0|||
164335083|NCT00586625|593603320|FG000|Overall Study|Protocol Violation|3|||
164335084|NCT00586625|593603321|FG001|Overall Study|Protocol Violation|0|||
164335085|NCT00586625|593603320|FG000|Overall Study|Withdrawal by Subject|32|||
164237061|NCT00652743|593240467|FG001|Months 36-42|Serious Adverse Events|1|||
164237062|NCT00652743|593240468|FG002|Months 36-42|Serious Adverse Events|1|||
164237063|NCT00652743|593240466|FG000|Months 36-42|Withdrawal by Subject|1|||
164237064|NCT00652743|593240467|FG001|Months 36-42|Withdrawal by Subject|1|||
164237065|NCT00652743|593240468|FG002|Months 36-42|Withdrawal by Subject|0|||
164237066|NCT00652743|593240466|FG000|Months 36-42|Lost to Follow-up|0|||
164237067|NCT00652743|593240467|FG001|Months 36-42|Lost to Follow-up|1|||
164237068|NCT00652743|593240468|FG002|Months 36-42|Lost to Follow-up|0|||
164237069|NCT00652743|593240466|FG000|Months 36-42|Migrated/moved from study area|1|||
164237070|NCT00652743|593240467|FG001|Months 36-42|Migrated/moved from study area|0|||
164237071|NCT00652743|593240468|FG002|Months 36-42|Migrated/moved from study area|0|||
164237072|NCT00652743|593240466|FG000|Months 36-42|Other|4|||
164237073|NCT00652743|593240467|FG001|Months 36-42|Other|2|||
164335086|NCT00586625|593603321|FG001|Overall Study|Withdrawal by Subject|10|||
164335087|NCT00586625|593603320|FG000|Overall Study|Subject non-compliance|0|||
164335088|NCT00586625|593603321|FG001|Overall Study|Subject non-compliance|1|||
164335089|NCT00586625|593603320|FG000|Overall Study|Subject unable to return for visit|2|||
164335090|NCT00586625|593603321|FG001|Overall Study|Subject unable to return for visit|0|||
164335091|NCT02906332|593603323|FG000|Overall Study|Withdrawal by Subject|1|||
164335092|NCT00165984|593603324|FG000|Overall Study|Death|15|||
164335093|NCT01686828|593603328|FG000|Overall Study|Physician Decision|1|||
164335094|NCT01686828|593603329|FG001|Overall Study|Physician Decision|0|||
164335095|NCT01686828|593603330|FG002|Overall Study|Physician Decision|0|||
164335096|NCT01686828|593603331|FG003|Overall Study|Physician Decision|0|||
164335097|NCT01686828|593603328|FG000|Overall Study|New Job|0|||
164335098|NCT01686828|593603329|FG001|Overall Study|New Job|1|||
164335099|NCT01686828|593603330|FG002|Overall Study|New Job|0|||
164335100|NCT01686828|593603331|FG003|Overall Study|New Job|0|||
164335101|NCT01686828|593603328|FG000|Overall Study|Weight Loss|0|||
164335102|NCT01686828|593603329|FG001|Overall Study|Weight Loss|0|||
164335103|NCT01686828|593603330|FG002|Overall Study|Weight Loss|1|||
164335104|NCT01686828|593603331|FG003|Overall Study|Weight Loss|0|||
164335105|NCT02734433|593603332|FG000|Overall Study|Disease progression|1|||
164335106|NCT02734433|593603333|FG001|Overall Study|Disease progression|5|||
164335107|NCT02734433|593603332|FG000|Overall Study|Clinical progression|0|||
164335108|NCT02734433|593603333|FG001|Overall Study|Clinical progression|1|||
164335109|NCT02734433|593603332|FG000|Overall Study|Withdrawal by Subject|1|||
164335110|NCT02734433|593603333|FG001|Overall Study|Withdrawal by Subject|2|||
164335111|NCT03698331|593603336|FG000|Overall Study|Adverse Event|2|||
164335112|NCT03698331|593603337|FG001|Overall Study|Adverse Event|3|||
164335113|NCT03698331|593603336|FG000|Overall Study|Withdrawal by Subject|1|||
164335114|NCT03698331|593603337|FG001|Overall Study|Withdrawal by Subject|1|||
164335115|NCT03698331|593603336|FG000|Overall Study|Lost to Follow-up|0|||
164335116|NCT03698331|593603337|FG001|Overall Study|Lost to Follow-up|2|||
164335117|NCT03698331|593603336|FG000|Overall Study|Non-compliance with study drug|1|||
164335118|NCT03698331|593603337|FG001|Overall Study|Non-compliance with study drug|0|||
164335119|NCT04916769|593603339|FG000|Period 1|Physician Decision|0|||
164335120|NCT04916769|593603340|FG001|Period 1|Physician Decision|0|||
164335121|NCT04916769|593603341|FG002|Period 1|Physician Decision|0|||
164335122|NCT04916769|593603342|FG003|Period 1|Physician Decision|0|||
164335123|NCT04916769|593603343|FG004|Period 1|Physician Decision|0|||
164335124|NCT04916769|593603344|FG005|Period 1|Physician Decision|1|||
164335125|NCT04916769|593603339|FG000|Period 2|Physician Decision|0|||
164335126|NCT04916769|593603340|FG001|Period 2|Physician Decision|1|||
164335127|NCT04916769|593603341|FG002|Period 2|Physician Decision|0|||
164335128|NCT04916769|593603342|FG003|Period 2|Physician Decision|0|||
164335129|NCT04916769|593603343|FG004|Period 2|Physician Decision|0|||
164335130|NCT04916769|593603344|FG005|Period 2|Physician Decision|0|||
164335131|NCT04941456|593603345|FG000|Overall Study|Withdrawal by Subject|1|||
164335132|NCT04941456|593603346|FG001|Overall Study|Withdrawal by Subject|0|||
164335133|NCT04941456|593603345|FG000|Overall Study|Protocol Violation|1|||
164335134|NCT04941456|593603346|FG001|Overall Study|Protocol Violation|0|||
164335135|NCT03894046|593604814|FG000|Overall Study|Protocol Violation|1|||
164237074|NCT00652743|593240468|FG002|Months 36-42|Other|8|||
164237075|NCT00140140|593240469|FG000|Overall Study|Unacceptable toxicity|1|||
164237076|NCT00140140|593240470|FG001|Overall Study|Unacceptable toxicity|1|||
164237077|NCT00140140|593240471|FG002|Overall Study|Unacceptable toxicity|2|||
164237078|NCT00140140|593240469|FG000|Overall Study|Physician Decision|1|||
164237079|NCT00140140|593240470|FG001|Overall Study|Physician Decision|1|||
164237080|NCT00140140|593240471|FG002|Overall Study|Physician Decision|0|||
164237081|NCT00690794|593240472|FG000|Overall Study|Adverse Event|12|||
164335136|NCT03894046|593604815|FG001|Overall Study|Protocol Violation|0|||
164335137|NCT03894046|593604816|FG002|Overall Study|Protocol Violation|0|||
164335138|NCT03894046|593604814|FG000|Overall Study|Adverse Event|0|||
164335139|NCT03894046|593604815|FG001|Overall Study|Adverse Event|1|||
164335140|NCT03894046|593604816|FG002|Overall Study|Adverse Event|0|||
164335141|NCT03894046|593604814|FG000|Overall Study|Withdrawal by Subject|2|||
164335142|NCT03894046|593604815|FG001|Overall Study|Withdrawal by Subject|3|||
164237082|NCT00690794|593240473|FG001|Overall Study|Adverse Event|10|||
164237083|NCT00690794|593240472|FG000|Overall Study|Lost to Follow-up|1|||
164237084|NCT00690794|593240473|FG001|Overall Study|Lost to Follow-up|4|||
164237085|NCT00690794|593240472|FG000|Overall Study|Withdrawal by Subject|0|||
164237086|NCT00690794|593240473|FG001|Overall Study|Withdrawal by Subject|9|||
164237087|NCT00690794|593240472|FG000|Overall Study|Protocol Violation|6|||
164237088|NCT00690794|593240473|FG001|Overall Study|Protocol Violation|7|||
164237089|NCT00690794|593240472|FG000|Overall Study|Noncompliance|1|||
164237090|NCT00690794|593240473|FG001|Overall Study|Noncompliance|2|||
164237091|NCT00690794|593240472|FG000|Overall Study|Other not specified|1|||
164237092|NCT00690794|593240473|FG001|Overall Study|Other not specified|3|||
164237093|NCT00325143|593240474|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
164237094|NCT00325143|593240474|FG000|Overall Study|Migrated/moved from study area|1|||
164237095|NCT00325143|593240474|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
164237096|NCT00325143|593240474|FG000|Overall Study|Withdrawal by Subject|8|||
164237097|NCT02286895|593240475|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
164237098|NCT02286895|593240476|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
164237099|NCT02286895|593240475|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
164237100|NCT02286895|593240476|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
164237101|NCT02286895|593240475|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
164237102|NCT02286895|593240476|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
164335143|NCT03894046|593604816|FG002|Overall Study|Withdrawal by Subject|1|||
164335144|NCT03894046|593604814|FG000|Overall Study|Death|15|||
164335145|NCT03894046|593604815|FG001|Overall Study|Death|21|||
164335146|NCT03894046|593604816|FG002|Overall Study|Death|4|||
164335147|NCT03894046|593604814|FG000|Overall Study|No growth of ABC|2|||
164335148|NCT03894046|593604815|FG001|Overall Study|No growth of ABC|1|||
164335149|NCT03894046|593604816|FG002|Overall Study|No growth of ABC|0|||
164335150|NCT03894046|593604814|FG000|Overall Study|Physician Decision|1|||
164335151|NCT03894046|593604815|FG001|Overall Study|Physician Decision|1|||
164335152|NCT03894046|593604816|FG002|Overall Study|Physician Decision|1|||
164335153|NCT03894046|593604814|FG000|Overall Study|Prohibited concomitant medication|1|||
164335154|NCT03894046|593604815|FG001|Overall Study|Prohibited concomitant medication|0|||
164335155|NCT03894046|593604816|FG002|Overall Study|Prohibited concomitant medication|0|||
164335156|NCT03894046|593604814|FG000|Overall Study|Transferred to other arm/group|1|||
164335157|NCT03894046|593604815|FG001|Overall Study|Transferred to other arm/group|1|||
164335158|NCT03894046|593604816|FG002|Overall Study|Transferred to other arm/group|0|||
164335159|NCT03270644|593604817|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
164335160|NCT03270644|593604817|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
164335161|NCT00333801|593604818|FG000|Overall Study|Moved to another state|5|||
164335162|NCT00333801|593604819|FG001|Overall Study|Moved to another state|3|||
164335163|NCT00333801|593604818|FG000|Overall Study|Lost to Follow-up|2|||
164335164|NCT00333801|593604819|FG001|Overall Study|Lost to Follow-up|0|||
164335165|NCT00333801|593604818|FG000|Overall Study|Incarcerated|1|||
164335166|NCT00333801|593604819|FG001|Overall Study|Incarcerated|2|||
164335167|NCT00333801|593604818|FG000|Overall Study|Withdrawal by Subject|0|||
164335168|NCT00333801|593604819|FG001|Overall Study|Withdrawal by Subject|1|||
164335169|NCT02476201|593604820|FG000|Overall Study|Unable to program MPP|9|||
164335170|NCT02476201|593604820|FG000|Overall Study|Study echo not performed|5|||
164335171|NCT02476201|593604820|FG000|Overall Study|Adverse Event|4|||
164335172|NCT02476201|593604820|FG000|Overall Study|Death|2|||
164335173|NCT02476201|593604820|FG000|Overall Study|Lost to Follow-up|2|||
164335174|NCT02476201|593604820|FG000|Overall Study|MPP programmed to OFF|2|||
164335175|NCT02476201|593604820|FG000|Overall Study|Withdrawal by Subject|1|||
164335176|NCT02476201|593604820|FG000|Overall Study|Unsuccessful implant|1|||
164335177|NCT00777205|593604821|FG000|Overall Study|Lost to Follow-up|25|||
164335178|NCT00777205|593604822|FG001|Overall Study|Lost to Follow-up|9|||
164335179|NCT00777205|593604821|FG000|Overall Study|Withdrawal by Subject|6|||
164335180|NCT00777205|593604822|FG001|Overall Study|Withdrawal by Subject|4|||
164335181|NCT00777205|593604821|FG000|Overall Study|Death|0|||
164335182|NCT00777205|593604822|FG001|Overall Study|Death|2|||
164335183|NCT00777205|593604821|FG000|Overall Study|Protocol Violation|0|||
164335184|NCT00777205|593604822|FG001|Overall Study|Protocol Violation|56|||
164335185|NCT05055128|593604826|FG000|Overall Study|Adverse Event|0|||
164335186|NCT05055128|593604827|FG001|Overall Study|Adverse Event|0|||
164335187|NCT05055128|593604828|FG002|Overall Study|Adverse Event|0|||
164335188|NCT05055128|593604829|FG003|Overall Study|Adverse Event|1|||
164335189|NCT05055128|593604830|FG004|Overall Study|Adverse Event|1|||
164335190|NCT05055128|593604826|FG000|Overall Study|Protocol Violation|0|||
164335191|NCT05055128|593604827|FG001|Overall Study|Protocol Violation|0|||
164335192|NCT05055128|593604828|FG002|Overall Study|Protocol Violation|0|||
164335193|NCT05055128|593604829|FG003|Overall Study|Protocol Violation|1|||
164335194|NCT05055128|593604830|FG004|Overall Study|Protocol Violation|0|||
164335195|NCT05055128|593604826|FG000|Overall Study|Withdrawal by Subject|5|||
164237103|NCT02949011|593240478|FG000|Overall Study|Adverse Event|6|||
164335196|NCT05055128|593604827|FG001|Overall Study|Withdrawal by Subject|2|||
164335197|NCT05055128|593604828|FG002|Overall Study|Withdrawal by Subject|2|||
164335198|NCT05055128|593604829|FG003|Overall Study|Withdrawal by Subject|4|||
164335199|NCT05055128|593604830|FG004|Overall Study|Withdrawal by Subject|2|||
164335200|NCT05055128|593604826|FG000|Overall Study|Randomized By Mistake|0|||
164335201|NCT05055128|593604827|FG001|Overall Study|Randomized By Mistake|1|||
164335202|NCT05055128|593604828|FG002|Overall Study|Randomized By Mistake|0|||
164335203|NCT05055128|593604829|FG003|Overall Study|Randomized By Mistake|0|||
164335204|NCT05055128|593604830|FG004|Overall Study|Randomized By Mistake|0|||
163884434|NCT05184192|591945994|FG000|Overall Study|PI withdrawal|1|||
164237104|NCT02949011|593240479|FG001|Overall Study|Adverse Event|7|||
164237105|NCT02949011|593240480|FG002|Overall Study|Adverse Event|3|||
164237106|NCT02949011|593240478|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164237107|NCT02949011|593240479|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164237108|NCT02949011|593240480|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
164237109|NCT02949011|593240478|FG000|Overall Study|Protocol Deviation|5|||
164237110|NCT02949011|593240479|FG001|Overall Study|Protocol Deviation|3|||
164237111|NCT02949011|593240480|FG002|Overall Study|Protocol Deviation|3|||
164237112|NCT02949011|593240478|FG000|Overall Study|Lack of Efficacy|0|||
164237113|NCT02949011|593240479|FG001|Overall Study|Lack of Efficacy|2|||
164237114|NCT02949011|593240480|FG002|Overall Study|Lack of Efficacy|0|||
164237115|NCT02949011|593240478|FG000|Overall Study|Withdrawal by Subject|13|||
164237116|NCT02949011|593240479|FG001|Overall Study|Withdrawal by Subject|13|||
164237117|NCT02949011|593240480|FG002|Overall Study|Withdrawal by Subject|21|||
164237118|NCT02949011|593240478|FG000|Overall Study|Lost to Follow-up|7|||
164237119|NCT02949011|593240479|FG001|Overall Study|Lost to Follow-up|5|||
164237120|NCT02949011|593240480|FG002|Overall Study|Lost to Follow-up|5|||
164237121|NCT02949011|593240478|FG000|Overall Study|Death|0|||
164237122|NCT02949011|593240479|FG001|Overall Study|Death|0|||
164237123|NCT02949011|593240480|FG002|Overall Study|Death|1|||
164237124|NCT02949011|593240478|FG000|Overall Study|Miscellaneous|2|||
164237125|NCT02949011|593240479|FG001|Overall Study|Miscellaneous|4|||
164237126|NCT02949011|593240480|FG002|Overall Study|Miscellaneous|6|||
164237127|NCT00163189|593240482|FG000|Overall Study|Other|6|||
164237128|NCT00163189|593240482|FG000|Overall Study|Lost to Follow-up|1|||
164237129|NCT00163189|593240482|FG000|Overall Study|Protocol Violation|2|||
164237130|NCT00163189|593240482|FG000|Overall Study|Death|3|||
164237131|NCT00163189|593240482|FG000|Overall Study|Adverse Event|6|||
164237132|NCT00163189|593240482|FG000|Overall Study|Lack of Efficacy|7|||
164335205|NCT05055128|593604826|FG000|Overall Study|Other|1|||
164335206|NCT05055128|593604827|FG001|Overall Study|Other|0|||
164335207|NCT05055128|593604828|FG002|Overall Study|Other|0|||
164335208|NCT05055128|593604829|FG003|Overall Study|Other|0|||
164335209|NCT05055128|593604830|FG004|Overall Study|Other|0|||
164335210|NCT00747461|593604831|FG000|Overall Study|study terminated by sponsor|5|||
164335211|NCT02149875|593604832|FG000|Overall Study|Lost to Follow-up|3|||
164335212|NCT02149875|593604833|FG001|Overall Study|Lost to Follow-up|4|||
164335213|NCT02149875|593604834|FG002|Overall Study|Lost to Follow-up|5|||
164335214|NCT02149875|593604832|FG000|Overall Study|Withdrawal by Subject|3|||
164335215|NCT02149875|593604833|FG001|Overall Study|Withdrawal by Subject|2|||
164335216|NCT02149875|593604834|FG002|Overall Study|Withdrawal by Subject|2|||
164335217|NCT02149875|593604832|FG000|Overall Study|Physician Decision|1|||
164335218|NCT02149875|593604833|FG001|Overall Study|Physician Decision|2|||
164335219|NCT02149875|593604834|FG002|Overall Study|Physician Decision|2|||
164335220|NCT03643159|593604838|FG000|Overall Study|Adverse Event|1|||
164335221|NCT03643159|593604838|FG000|Overall Study|Withdrawal by Subject|1|||
164335222|NCT04308304|593604841|FG000|Overall Study|Withdrawal by Subject|4|||
164335223|NCT04308304|593604842|FG001|Overall Study|Withdrawal by Subject|0|||
164335224|NCT04308304|593604841|FG000|Overall Study|Protocol Violation|1|||
164335225|NCT04308304|593604842|FG001|Overall Study|Protocol Violation|0|||
164335226|NCT02840721|593604843|FG000|Treatment Period|Adverse Event|1|||
164335227|NCT02840721|593604843|FG000|Follow-Up|Lack of Efficacy|1|||
164335228|NCT02840721|593604843|FG000|Follow-Up|Withdrawal by Subject|4|||
164335229|NCT02840721|593604843|FG000|Follow-Up|Withdrawal of Consent|2|||
164335230|NCT05535972|593604845|FG000|Overall Study|Withdrawal by Subject|31|||
164335231|NCT05535972|593604845|FG000|Overall Study|Lost to Follow-up|5|||
164237133|NCT00163189|593240482|FG000|Overall Study|Study terminated by sponsor|11|||
164237134|NCT00163189|593240482|FG000|Overall Study|Withdrawal by Subject|11|||
164237135|NCT00163189|593240482|FG000|Overall Study|Did not meet continuation criterion|16|||
164335232|NCT05535972|593604845|FG000|Overall Study|Adverse Event|6|||
164335233|NCT05535972|593604845|FG000|Overall Study|Protocol Deviation|2|||
163884435|NCT05184192|591945995|FG001|Overall Study|PI withdrawal|2|||
163884436|NCT05184192|591945994|FG000|Overall Study|Withdrew due to adverse effect|1|||
164237136|NCT01170663|593240483|FG000|Overall Study|Lost to Follow-up|3|||
164335234|NCT03945266|593604850|FG000|Overall Study|Withdrawal by Subject|1|||
164335235|NCT03945266|593604851|FG001|Overall Study|Withdrawal by Subject|0|||
164335236|NCT03945266|593604850|FG000|Overall Study|Miscarriage|0|||
163884437|NCT05184192|591945995|FG001|Overall Study|Withdrew due to adverse effect|0|||
164237137|NCT01170663|593240484|FG001|Overall Study|Lost to Follow-up|9|||
164237138|NCT01170663|593240483|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
164237139|NCT01170663|593240484|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
164237140|NCT00454116|593240485|FG000|Overall Study|Adverse Event|5|||
164237141|NCT00454116|593240486|FG001|Overall Study|Adverse Event|11|||
164237142|NCT00454116|593240487|FG002|Overall Study|Adverse Event|9|||
164335237|NCT03945266|593604851|FG001|Overall Study|Miscarriage|2|||
164335238|NCT03945266|593604850|FG000|Overall Study|Lost to Follow-up|1|||
164335239|NCT03945266|593604851|FG001|Overall Study|Lost to Follow-up|0|||
164335240|NCT03805646|593604869|FG000|Overall Study|Death|40|||
164335241|NCT03805646|593604870|FG001|Overall Study|Death|49|||
164237143|NCT00454116|593240485|FG000|Overall Study|Condition under investigation worsened|17|||
164237144|NCT00454116|593240486|FG001|Overall Study|Condition under investigation worsened|13|||
164237145|NCT00454116|593240487|FG002|Overall Study|Condition under investigation worsened|18|||
164237146|NCT00454116|593240485|FG000|Overall Study|Withdrawal by Subject|3|||
164237147|NCT00454116|593240486|FG001|Overall Study|Withdrawal by Subject|3|||
164237148|NCT00454116|593240487|FG002|Overall Study|Withdrawal by Subject|1|||
164237149|NCT00454116|593240485|FG000|Overall Study|Other|2|||
164237150|NCT00454116|593240486|FG001|Overall Study|Other|2|||
164237151|NCT00454116|593240487|FG002|Overall Study|Other|0|||
164237152|NCT01917318|593240488|FG000|First Treatment|Withdrawal by Subject|0|||
164237153|NCT01917318|593240489|FG001|First Treatment|Withdrawal by Subject|1|||
164237154|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Physician Decision|2|||
164237155|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Physician Decision|0|||
164237156|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Physician Decision|0|||
164237157|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Adverse Event|33|||
164237158|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Adverse Event|0|||
164237159|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Adverse Event|0|||
164237160|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
164237161|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
164237162|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
164237163|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
164237164|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
164237165|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
164237166|NCT01008618|593240490|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
164237167|NCT01008618|593240491|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
164237168|NCT01008618|593240492|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
164237169|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
164237170|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
164237171|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
164237172|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
164237173|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
164237174|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
164237175|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
164237176|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
164237177|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
164237178|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
164237179|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
164237180|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
164237181|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
164237182|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
164237183|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
164237184|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
164237185|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
164237186|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
164237187|NCT01008618|593240490|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
164237188|NCT01008618|593240491|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
164237189|NCT01008618|593240492|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
164237190|NCT04460183|593240496|FG000|Overall Study|Lost to Follow-up|3|||
164237191|NCT04460183|593240497|FG001|Overall Study|Lost to Follow-up|1|||
164237192|NCT04460183|593240496|FG000|Overall Study|Withdrawal by Subject|1|||
164237193|NCT04460183|593240497|FG001|Overall Study|Withdrawal by Subject|0|||
164237194|NCT00894387|593240498|FG000|Overall Study|Adverse Event|44|||
164237195|NCT00894387|593240499|FG001|Overall Study|Adverse Event|45|||
164237196|NCT00894387|593240498|FG000|Overall Study|Abnormal Laboratory values|2|||
164237197|NCT00894387|593240499|FG001|Overall Study|Abnormal Laboratory values|2|||
164237198|NCT00894387|593240498|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164237199|NCT00894387|593240499|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164237200|NCT00894387|593240498|FG000|Overall Study|Lost to Follow-up|3|||
164237201|NCT00894387|593240499|FG001|Overall Study|Lost to Follow-up|5|||
164237202|NCT00894387|593240498|FG000|Overall Study|Administrative problems|2|||
164237203|NCT00894387|593240499|FG001|Overall Study|Administrative problems|2|||
164335242|NCT03805646|593604869|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
164335243|NCT03805646|593604870|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
164335244|NCT04452344|593604872|FG000|Overall Study|Withdrawal by Subject|3|||
164335245|NCT04452344|593604873|FG001|Overall Study|Withdrawal by Subject|6|||
164335246|NCT04452344|593604872|FG000|Overall Study|Adverse Event|1|||
164335247|NCT04452344|593604873|FG001|Overall Study|Adverse Event|2|||
164335248|NCT04452344|593604872|FG000|Overall Study|Lost to Follow-up|2|||
164335249|NCT04452344|593604873|FG001|Overall Study|Lost to Follow-up|2|||
164335250|NCT04452344|593604872|FG000|Overall Study|No Post-Op Visit|6|||
164237204|NCT00894387|593240498|FG000|Overall Study|Death|77|||
164237205|NCT00894387|593240499|FG001|Overall Study|Death|76|||
164237206|NCT00894387|593240498|FG000|Overall Study|Protocol Deviation|4|||
164237207|NCT00894387|593240499|FG001|Overall Study|Protocol Deviation|0|||
164237208|NCT00894387|593240498|FG000|Overall Study|Patient's request|25|||
164237209|NCT00894387|593240499|FG001|Overall Study|Patient's request|30|||
164237210|NCT00894387|593240498|FG000|Overall Study|Other (Missing)|5|||
164237211|NCT00894387|593240499|FG001|Overall Study|Other (Missing)|3|||
164237212|NCT00894387|593240498|FG000|Overall Study|Mis-randomized|13|||
164237213|NCT00894387|593240499|FG001|Overall Study|Mis-randomized|9|||
164237214|NCT00894387|593240498|FG000|Overall Study|GCP non-compliance|0|||
164237215|NCT00894387|593240499|FG001|Overall Study|GCP non-compliance|2|||
164237216|NCT01128569|593240500|FG000|Washout Period 1|Adverse Event|0|||
164237217|NCT01128569|593240501|FG001|Washout Period 1|Adverse Event|0|||
164237218|NCT01128569|593240502|FG002|Washout Period 1|Adverse Event|1|||
164237219|NCT01128569|593240503|FG003|Washout Period 1|Adverse Event|0|||
164237220|NCT01128569|593240504|FG004|Washout Period 1|Adverse Event|0|||
164237221|NCT01128569|593240505|FG005|Washout Period 1|Adverse Event|0|||
164237222|NCT01128569|593240500|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164237223|NCT01128569|593240501|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164335251|NCT04452344|593604873|FG001|Overall Study|No Post-Op Visit|7|||
164335252|NCT05171777|593604874|FG000|Treatment Crossover Period|Adverse Event|9|||
164335253|NCT05171777|593604875|FG001|Treatment Crossover Period|Adverse Event|6|||
164335254|NCT05171777|593604876|FG002|Treatment Crossover Period|Adverse Event|0|||
164335255|NCT05171777|593604877|FG003|Treatment Crossover Period|Adverse Event|0|||
164335256|NCT05171777|593604874|FG000|Treatment Crossover Period|Death|5|||
164335257|NCT05171777|593604875|FG001|Treatment Crossover Period|Death|5|||
164335258|NCT05171777|593604876|FG002|Treatment Crossover Period|Death|0|||
164335259|NCT05171777|593604877|FG003|Treatment Crossover Period|Death|0|||
164335260|NCT05171777|593604874|FG000|Treatment Crossover Period|Disease Relapse|1|||
164335261|NCT05171777|593604875|FG001|Treatment Crossover Period|Disease Relapse|0|||
164335262|NCT05171777|593604876|FG002|Treatment Crossover Period|Disease Relapse|0|||
164335263|NCT05171777|593604877|FG003|Treatment Crossover Period|Disease Relapse|0|||
164335264|NCT05171777|593604874|FG000|Treatment Crossover Period|Reason not Specified|1|||
164335265|NCT05171777|593604875|FG001|Treatment Crossover Period|Reason not Specified|1|||
164335266|NCT05171777|593604876|FG002|Treatment Crossover Period|Reason not Specified|0|||
164335267|NCT05171777|593604877|FG003|Treatment Crossover Period|Reason not Specified|0|||
164335268|NCT05171777|593604874|FG000|Treatment Crossover Period|Physician Decision|0|||
164335269|NCT05171777|593604875|FG001|Treatment Crossover Period|Physician Decision|1|||
164335270|NCT05171777|593604876|FG002|Treatment Crossover Period|Physician Decision|0|||
164335271|NCT05171777|593604877|FG003|Treatment Crossover Period|Physician Decision|0|||
164335272|NCT05171777|593604874|FG000|Treatment Crossover Period|Progressive Disease|14|||
164335273|NCT05171777|593604875|FG001|Treatment Crossover Period|Progressive Disease|10|||
164335274|NCT05171777|593604876|FG002|Treatment Crossover Period|Progressive Disease|0|||
164335275|NCT05171777|593604877|FG003|Treatment Crossover Period|Progressive Disease|0|||
164335276|NCT05171777|593604874|FG000|Treatment Crossover Period|Protocol Violation|0|||
164335277|NCT05171777|593604875|FG001|Treatment Crossover Period|Protocol Violation|2|||
164335278|NCT05171777|593604876|FG002|Treatment Crossover Period|Protocol Violation|0|||
164335279|NCT05171777|593604877|FG003|Treatment Crossover Period|Protocol Violation|0|||
164335280|NCT05171777|593604874|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
164335281|NCT05171777|593604875|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
164335282|NCT05171777|593604876|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
164335283|NCT05171777|593604877|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
164335284|NCT05171777|593604874|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
164335285|NCT05171777|593604875|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
164335286|NCT05171777|593604876|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
163884438|NCT05184192|591945994|FG000|Overall Study|Medication schedule|1|||
164335287|NCT05171777|593604877|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
164237224|NCT01128569|593240502|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164335288|NCT05171777|593604874|FG000|Treatment Continuation Period|Adverse Event|0|||
164335289|NCT05171777|593604875|FG001|Treatment Continuation Period|Adverse Event|0|||
164237225|NCT01128569|593240503|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164237226|NCT01128569|593240504|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164237227|NCT01128569|593240505|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164237228|NCT03338400|593240506|FG000|Overall Study|Lost to Follow-up|1|||
164237229|NCT03338400|593240507|FG001|Overall Study|Lost to Follow-up|2|||
164237230|NCT00487981|593240508|FG000|Overall Study|Hypothyroidism diagnosis|1|||
164237231|NCT00856609|593240513|FG000|Overall Study|Adverse Event|1|||
164237232|NCT00856609|593240514|FG001|Overall Study|Adverse Event|0|||
164237233|NCT01788943|593240515|FG000|Overall Study|Withdrawal by Subject|1|||
164237234|NCT01788943|593240516|FG001|Overall Study|Withdrawal by Subject|0|||
164237235|NCT01816295|593240517|FG000|Double Blind Phase|Adverse Event|11|||
164237236|NCT01816295|593240518|FG001|Double Blind Phase|Adverse Event|8|||
164237237|NCT01816295|593240517|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
164237238|NCT01816295|593240518|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
164237239|NCT01816295|593240517|FG000|Double Blind Phase|Lost to Follow-up|3|||
164237240|NCT01816295|593240518|FG001|Double Blind Phase|Lost to Follow-up|5|||
164237241|NCT01816295|593240517|FG000|Double Blind Phase|Physician Decision|2|||
164237242|NCT01816295|593240518|FG001|Double Blind Phase|Physician Decision|2|||
164237243|NCT01816295|593240517|FG000|Double Blind Phase|Protocol Violation|17|||
164237244|NCT01816295|593240518|FG001|Double Blind Phase|Protocol Violation|11|||
164237245|NCT01816295|593240517|FG000|Double Blind Phase|Sponsor Decision|8|||
164237246|NCT01816295|593240518|FG001|Double Blind Phase|Sponsor Decision|8|||
164237247|NCT01816295|593240517|FG000|Double Blind Phase|Withdrawal by Subject|22|||
164237248|NCT01816295|593240518|FG001|Double Blind Phase|Withdrawal by Subject|20|||
164237249|NCT01816295|593240517|FG000|OLE Phase|Adverse Event|17|||
164237250|NCT01816295|593240518|FG001|OLE Phase|Adverse Event|15|||
164237251|NCT01816295|593240517|FG000|OLE Phase|Death|1|||
164237252|NCT01816295|593240518|FG001|OLE Phase|Death|0|||
164237253|NCT01816295|593240517|FG000|OLE Phase|Entry Criteria Not Met|3|||
164237254|NCT01816295|593240518|FG001|OLE Phase|Entry Criteria Not Met|5|||
164237255|NCT01816295|593240517|FG000|OLE Phase|Lost to Follow-up|5|||
164237256|NCT01816295|593240518|FG001|OLE Phase|Lost to Follow-up|5|||
164237257|NCT01816295|593240517|FG000|OLE Phase|Physician Decision|3|||
164237258|NCT01816295|593240518|FG001|OLE Phase|Physician Decision|1|||
164237259|NCT01816295|593240517|FG000|OLE Phase|Protocol Violation|4|||
164237260|NCT01816295|593240518|FG001|OLE Phase|Protocol Violation|4|||
164237261|NCT01816295|593240517|FG000|OLE Phase|Sponsor Decision|7|||
164237262|NCT01816295|593240518|FG001|OLE Phase|Sponsor Decision|9|||
164237263|NCT01816295|593240517|FG000|OLE Phase|Withdrawal by Subject|10|||
164237264|NCT01816295|593240518|FG001|OLE Phase|Withdrawal by Subject|10|||
164237265|NCT01816295|593240517|FG000|OLE Phase|Lack of Efficacy|3|||
164237266|NCT01816295|593240518|FG001|OLE Phase|Lack of Efficacy|7|||
164237267|NCT01119287|593240519|FG000|Overall Study|Patient Decision, not related to AE|0|||
164237268|NCT01119287|593240520|FG001|Overall Study|Patient Decision, not related to AE|0|||
164237269|NCT01119287|593240521|FG002|Overall Study|Patient Decision, not related to AE|2|||
164237270|NCT01119287|593240522|FG003|Overall Study|Patient Decision, not related to AE|2|||
164237271|NCT01119287|593240523|FG004|Overall Study|Patient Decision, not related to AE|1|||
164237272|NCT01119287|593240524|FG005|Overall Study|Patient Decision, not related to AE|0|||
164237273|NCT00783432|593240525|FG000|Overall Study|Adverse Event|22|||
164237274|NCT00783432|593240526|FG001|Overall Study|Adverse Event|17|||
164237275|NCT00783432|593240525|FG000|Overall Study|Lack of Efficacy|20|||
164237276|NCT00783432|593240526|FG001|Overall Study|Lack of Efficacy|21|||
164237277|NCT00783432|593240525|FG000|Overall Study|Lost to Follow-up|11|||
164237278|NCT00783432|593240526|FG001|Overall Study|Lost to Follow-up|6|||
164237279|NCT00783432|593240525|FG000|Overall Study|Withdrawal by Subject|23|||
164237280|NCT00783432|593240526|FG001|Overall Study|Withdrawal by Subject|20|||
164237281|NCT00783432|593240525|FG000|Overall Study|subject moved|3|||
164237282|NCT00783432|593240526|FG001|Overall Study|subject moved|5|||
164237283|NCT00783432|593240525|FG000|Overall Study|Protocol Violation|6|||
164237284|NCT00783432|593240526|FG001|Overall Study|Protocol Violation|9|||
164237285|NCT00186628|593240527|FG000|Overall Study|Death|2|||
164237286|NCT00186628|593240527|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
164237287|NCT01331681|593240529|FG000|Overall Study|Adverse Event|10|||
164237288|NCT01331681|593240530|FG001|Overall Study|Adverse Event|13|||
164237289|NCT01331681|593240531|FG002|Overall Study|Adverse Event|10|||
164237290|NCT01331681|593240529|FG000|Overall Study|Death|6|||
164237291|NCT01331681|593240530|FG001|Overall Study|Death|6|||
164237292|NCT01331681|593240531|FG002|Overall Study|Death|2|||
164237293|NCT01331681|593240529|FG000|Overall Study|Lack of Efficacy|0|||
164237294|NCT01331681|593240530|FG001|Overall Study|Lack of Efficacy|1|||
164237295|NCT01331681|593240531|FG002|Overall Study|Lack of Efficacy|0|||
164237296|NCT01331681|593240529|FG000|Overall Study|Withdrawal by Subject|12|||
164237297|NCT01331681|593240530|FG001|Overall Study|Withdrawal by Subject|8|||
164237298|NCT01331681|593240531|FG002|Overall Study|Withdrawal by Subject|15|||
164237299|NCT01331681|593240529|FG000|Overall Study|Protocol Violation|1|||
164237300|NCT01331681|593240530|FG001|Overall Study|Protocol Violation|1|||
164237301|NCT01331681|593240531|FG002|Overall Study|Protocol Violation|0|||
164237302|NCT01331681|593240529|FG000|Overall Study|Lost to Follow-up|2|||
164237303|NCT01331681|593240530|FG001|Overall Study|Lost to Follow-up|4|||
164237304|NCT01331681|593240531|FG002|Overall Study|Lost to Follow-up|1|||
164237305|NCT01331681|593240529|FG000|Overall Study|Physician Decision|2|||
164237306|NCT01331681|593240530|FG001|Overall Study|Physician Decision|0|||
164237307|NCT01331681|593240531|FG002|Overall Study|Physician Decision|4|||
164237308|NCT01331681|593240529|FG000|Overall Study|Therapeutic procedure required|1|||
164237309|NCT01331681|593240530|FG001|Overall Study|Therapeutic procedure required|0|||
164237310|NCT01331681|593240531|FG002|Overall Study|Therapeutic procedure required|0|||
164237311|NCT01331681|593240529|FG000|Overall Study|Sponsor decision|1|||
164237312|NCT01331681|593240530|FG001|Overall Study|Sponsor decision|1|||
164237313|NCT01331681|593240531|FG002|Overall Study|Sponsor decision|0|||
164237314|NCT01331681|593240529|FG000|Overall Study|Switching to other therapy|0|||
164335290|NCT05171777|593604876|FG002|Treatment Continuation Period|Adverse Event|3|||
164335291|NCT05171777|593604877|FG003|Treatment Continuation Period|Adverse Event|6|||
164335292|NCT05171777|593604874|FG000|Treatment Continuation Period|Death|0|||
164237315|NCT01331681|593240530|FG001|Overall Study|Switching to other therapy|0|||
164237316|NCT01331681|593240531|FG002|Overall Study|Switching to other therapy|1|||
164237317|NCT01331681|593240529|FG000|Overall Study|Not Received Study Treatment|0|||
164237318|NCT01331681|593240530|FG001|Overall Study|Not Received Study Treatment|0|||
164237319|NCT01331681|593240531|FG002|Overall Study|Not Received Study Treatment|2|||
164237320|NCT01130337|593240532|FG000|Overall Study|Withdrawal by Subject|3|||
164237321|NCT01130337|593240532|FG000|Overall Study|Principal investigator decision|1|||
164237322|NCT01130337|593240532|FG000|Overall Study|Death|1|||
164237323|NCT01130337|593240532|FG000|Overall Study|Disease progression|1|||
164237324|NCT01130337|593240532|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
164237325|NCT01130337|593240532|FG000|Overall Study|Surgical resection (R2)|1|||
164237326|NCT05525910|593240533|FG000|Period 4|Per sponsor due to study timelines|0|||
164237327|NCT05525910|593240534|FG001|Period 4|Per sponsor due to study timelines|0|||
164237328|NCT05525910|593240535|FG002|Period 4|Per sponsor due to study timelines|1|||
164237329|NCT05525910|593240536|FG003|Period 4|Per sponsor due to study timelines|1|||
164237330|NCT05525910|593240537|FG004|Period 4|Per sponsor due to study timelines|1|||
164237331|NCT03886493|593240538|FG000|Overall Study|Adverse Event|1|||
164237332|NCT00107276|593240539|FG000|Overall Study|Progression|46|||
164237333|NCT00107276|593240539|FG000|Overall Study|Adverse Event|6|||
164237334|NCT00107276|593240539|FG000|Overall Study|M.D. decision|2|||
164237335|NCT00107276|593240539|FG000|Overall Study|Patient refusal|1|||
164237336|NCT00107276|593240539|FG000|Overall Study|Death|1|||
164237337|NCT00107276|593240539|FG000|Overall Study|Ineligible|16|||
164237338|NCT03498716|593240549|FG000|Overall Study|Withdrawal by Subject|88|||
164237339|NCT03498716|593240550|FG001|Overall Study|Withdrawal by Subject|73|||
164237340|NCT03498716|593240549|FG000|Overall Study|Study Terminated By Sponsor|933|||
164237341|NCT03498716|593240550|FG001|Overall Study|Study Terminated By Sponsor|927|||
164237342|NCT03498716|593240549|FG000|Overall Study|Lost to Follow-up|15|||
164237343|NCT03498716|593240550|FG001|Overall Study|Lost to Follow-up|26|||
164237344|NCT03498716|593240549|FG000|Overall Study|Disease Relapse|0|||
164237345|NCT03498716|593240550|FG001|Overall Study|Disease Relapse|1|||
164237346|NCT03498716|593240549|FG000|Overall Study|Death|58|||
164237347|NCT03498716|593240550|FG001|Overall Study|Death|72|||
164237348|NCT03498716|593240549|FG000|Overall Study|Physician Decision|4|||
164237349|NCT03498716|593240550|FG001|Overall Study|Physician Decision|2|||
164237350|NCT02257684|593240551|FG000|Overall Study|Adverse Event|2|||
164237351|NCT02257684|593240551|FG000|Overall Study|Lack of Efficacy|1|||
164237352|NCT02257684|593240551|FG000|Overall Study|Sponsor's Decision|1|||
164237353|NCT03139448|593240555|FG000|Overall Study|Lack of Efficacy|6|||
164237354|NCT03139448|593240556|FG001|Overall Study|Lack of Efficacy|7|||
164237355|NCT03139448|593240555|FG000|Overall Study|Location of procedure changed|2|||
164237356|NCT03139448|593240556|FG001|Overall Study|Location of procedure changed|8|||
164237357|NCT03139448|593240555|FG000|Overall Study|Withdrawal by Subject|3|||
164237358|NCT03139448|593240556|FG001|Overall Study|Withdrawal by Subject|6|||
164237359|NCT03139448|593240555|FG000|Overall Study|Screen fail|1|||
164237360|NCT03139448|593240556|FG001|Overall Study|Screen fail|3|||
164237361|NCT03139448|593240555|FG000|Overall Study|Physician Decision|0|||
164237362|NCT03139448|593240556|FG001|Overall Study|Physician Decision|2|||
164237363|NCT01987557|593240557|FG000|Overall Study|Protocol Violation|1|||
164237364|NCT01987557|593240558|FG001|Overall Study|Protocol Violation|0|||
164237365|NCT01987557|593240559|FG002|Overall Study|Protocol Violation|1|||
164237366|NCT01987557|593240557|FG000|Overall Study|Withdrawal by Subject|2|||
164237367|NCT01987557|593240558|FG001|Overall Study|Withdrawal by Subject|1|||
164237368|NCT01987557|593240559|FG002|Overall Study|Withdrawal by Subject|2|||
164237369|NCT01987557|593240557|FG000|Overall Study|Adverse Event|0|||
164237370|NCT01987557|593240558|FG001|Overall Study|Adverse Event|2|||
164237371|NCT01987557|593240559|FG002|Overall Study|Adverse Event|0|||
164237372|NCT00760552|593240560|FG000|Overall Study|Death|2|||
164237373|NCT00760552|593240561|FG001|Overall Study|Death|0|||
164237374|NCT00760552|593240560|FG000|Overall Study|Lost to Follow-up|11|||
164237375|NCT00760552|593240561|FG001|Overall Study|Lost to Follow-up|10|||
164237376|NCT01038323|593240562|FG000|Overall Study|Withdrawal by Subject|3|||
164237377|NCT01038323|593240563|FG001|Overall Study|Withdrawal by Subject|2|||
164237378|NCT01038323|593240564|FG002|Overall Study|Withdrawal by Subject|4|||
164237379|NCT01832727|593240575|FG000|Overall Study|Adverse Event|4|||
164335293|NCT05171777|593604875|FG001|Treatment Continuation Period|Death|0|||
164237380|NCT01832727|593240576|FG001|Overall Study|Adverse Event|6|||
164237381|NCT01832727|593240577|FG002|Overall Study|Adverse Event|1|||
164237382|NCT01832727|593240578|FG003|Overall Study|Adverse Event|0|||
164335294|NCT05171777|593604876|FG002|Treatment Continuation Period|Death|1|||
164335295|NCT05171777|593604877|FG003|Treatment Continuation Period|Death|3|||
164335296|NCT05171777|593604874|FG000|Treatment Continuation Period|Disease Relapse|0|||
164335297|NCT05171777|593604875|FG001|Treatment Continuation Period|Disease Relapse|0|||
164335298|NCT05171777|593604876|FG002|Treatment Continuation Period|Disease Relapse|1|||
164335299|NCT05171777|593604877|FG003|Treatment Continuation Period|Disease Relapse|0|||
164335300|NCT05171777|593604874|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
164335301|NCT05171777|593604875|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
164335302|NCT05171777|593604876|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
164335303|NCT05171777|593604877|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
164335304|NCT05171777|593604874|FG000|Treatment Continuation Period|Physician Decision|0|||
164335305|NCT05171777|593604875|FG001|Treatment Continuation Period|Physician Decision|0|||
164335306|NCT05171777|593604876|FG002|Treatment Continuation Period|Physician Decision|0|||
164335307|NCT05171777|593604877|FG003|Treatment Continuation Period|Physician Decision|4|||
164335308|NCT05171777|593604874|FG000|Treatment Continuation Period|Progressive Disease|0|||
164335309|NCT05171777|593604875|FG001|Treatment Continuation Period|Progressive Disease|0|||
164335310|NCT05171777|593604876|FG002|Treatment Continuation Period|Progressive Disease|6|||
164335311|NCT05171777|593604877|FG003|Treatment Continuation Period|Progressive Disease|20|||
164335312|NCT05171777|593604874|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
164335313|NCT05171777|593604875|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
164335314|NCT05171777|593604876|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
164335315|NCT05171777|593604877|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
164335316|NCT05171777|593604874|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
164335317|NCT05171777|593604875|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
164335318|NCT05171777|593604876|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
164335319|NCT05171777|593604877|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
164335320|NCT05171777|593604874|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
164335321|NCT05171777|593604875|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
164335322|NCT05171777|593604876|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
164335323|NCT05171777|593604877|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
164335324|NCT02364713|593604878|FG000|Overall Study|Ineligible|2|||
164335325|NCT02364713|593604879|FG001|Overall Study|Ineligible|2|||
164335326|NCT04686786|593604882|FG000|Overall Study|Adverse Event|9|||
164335327|NCT04686786|593604882|FG000|Overall Study|Death|1|||
164335328|NCT04686786|593604882|FG000|Overall Study|Lack of Efficacy|25|||
164335329|NCT04686786|593604882|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
164335330|NCT04686786|593604882|FG000|Overall Study|Study Terminated by Sponsor|14|||
164335331|NCT04686786|593604882|FG000|Overall Study|Withdrawal by Subject|15|||
164335332|NCT04686786|593604882|FG000|Overall Study|Other than specified|1|||
164335333|NCT05628103|593604885|FG000|Overall Study|Adverse Event|7|||
164335334|NCT05628103|593604885|FG000|Overall Study|Withdrawal by Subject|3|||
164335335|NCT05628103|593604885|FG000|Overall Study|Lost to Follow-up|3|||
164335336|NCT05628103|593604885|FG000|Overall Study|Lack of Efficacy|1|||
164335337|NCT05628103|593604885|FG000|Overall Study|Non-Compliance With Study Drug|4|||
164335338|NCT04840888|593604886|FG000|Period 1|Withdrawal by Subject|0|||
164335339|NCT04840888|593604887|FG001|Period 1|Withdrawal by Subject|0|||
164335340|NCT04840888|593604888|FG002|Period 1|Withdrawal by Subject|0|||
164335341|NCT04840888|593604889|FG003|Period 1|Withdrawal by Subject|0|||
164335342|NCT04840888|593604890|FG004|Period 1|Withdrawal by Subject|1|||
164335343|NCT04840888|593604891|FG005|Period 1|Withdrawal by Subject|0|||
164335344|NCT04840888|593604886|FG000|Period 1|Adverse Event|0|||
164335345|NCT04840888|593604887|FG001|Period 1|Adverse Event|0|||
164335346|NCT04840888|593604888|FG002|Period 1|Adverse Event|1|||
164335347|NCT04840888|593604889|FG003|Period 1|Adverse Event|1|||
164335348|NCT04840888|593604890|FG004|Period 1|Adverse Event|10|||
164335349|NCT04840888|593604891|FG005|Period 1|Adverse Event|1|||
164335350|NCT04340193|593604894|FG000|Overall Study|Other reason|0|||
164335351|NCT04340193|593604895|FG001|Overall Study|Other reason|0|||
164335352|NCT04340193|593604896|FG002|Overall Study|Other reason|1|||
164335353|NCT04340193|593604894|FG000|Overall Study|Disease recurrence|0|||
164335354|NCT04340193|593604895|FG001|Overall Study|Disease recurrence|1|||
164335355|NCT04340193|593604896|FG002|Overall Study|Disease recurrence|0|||
164335356|NCT04340193|593604894|FG000|Overall Study|Study drug toxicity|1|||
164335357|NCT04340193|593604895|FG001|Overall Study|Study drug toxicity|0|||
164335358|NCT04340193|593604896|FG002|Overall Study|Study drug toxicity|0|||
164335359|NCT04340193|593604894|FG000|Overall Study|Disease progression|1|||
164335360|NCT04340193|593604895|FG001|Overall Study|Disease progression|2|||
164335361|NCT04340193|593604896|FG002|Overall Study|Disease progression|3|||
164335362|NCT04340193|593604894|FG000|Overall Study|Administrative reasons by sponsor|0|||
164335363|NCT04340193|593604895|FG001|Overall Study|Administrative reasons by sponsor|1|||
164335364|NCT04340193|593604896|FG002|Overall Study|Administrative reasons by sponsor|0|||
164335365|NCT04340193|593604894|FG000|Overall Study|Adverse Event|1|||
164335366|NCT04340193|593604895|FG001|Overall Study|Adverse Event|1|||
164335367|NCT04340193|593604896|FG002|Overall Study|Adverse Event|0|||
164335368|NCT03924869|593604897|FG000|Overall Study|Death|73|||
163884439|NCT05184192|591945995|FG001|Overall Study|Medication schedule|0|||
163884440|NCT05184192|591945994|FG000|Overall Study|Concern for adverse effects|0|||
163884441|NCT05184192|591945995|FG001|Overall Study|Concern for adverse effects|4|||
164237383|NCT01832727|593240579|FG004|Overall Study|Adverse Event|1|||
163884442|NCT05609760|591946005|FG000|Overall Study|Lost to Follow-up|0|||
164237384|NCT01832727|593240580|FG005|Overall Study|Adverse Event|1|||
164237385|NCT01832727|593240581|FG006|Overall Study|Adverse Event|2|||
164237386|NCT01832727|593240582|FG007|Overall Study|Adverse Event|1|||
164237387|NCT01832727|593240583|FG008|Overall Study|Adverse Event|9|||
164237388|NCT01832727|593240575|FG000|Overall Study|Disease progression|3|||
164237389|NCT01832727|593240576|FG001|Overall Study|Disease progression|0|||
164237390|NCT01832727|593240577|FG002|Overall Study|Disease progression|2|||
164237391|NCT01832727|593240578|FG003|Overall Study|Disease progression|1|||
164237392|NCT01832727|593240579|FG004|Overall Study|Disease progression|3|||
164237393|NCT01832727|593240580|FG005|Overall Study|Disease progression|3|||
164237394|NCT01832727|593240581|FG006|Overall Study|Disease progression|6|||
164237395|NCT01832727|593240582|FG007|Overall Study|Disease progression|2|||
164237396|NCT01832727|593240583|FG008|Overall Study|Disease progression|7|||
164237397|NCT01832727|593240575|FG000|Overall Study|Lost to Follow-up|0|||
164237398|NCT01832727|593240576|FG001|Overall Study|Lost to Follow-up|0|||
164237399|NCT01832727|593240577|FG002|Overall Study|Lost to Follow-up|0|||
164237400|NCT01832727|593240578|FG003|Overall Study|Lost to Follow-up|1|||
164237401|NCT01832727|593240579|FG004|Overall Study|Lost to Follow-up|0|||
164237402|NCT01832727|593240580|FG005|Overall Study|Lost to Follow-up|0|||
164237403|NCT01832727|593240581|FG006|Overall Study|Lost to Follow-up|0|||
164237404|NCT01832727|593240582|FG007|Overall Study|Lost to Follow-up|0|||
164237405|NCT01832727|593240583|FG008|Overall Study|Lost to Follow-up|0|||
164237406|NCT01832727|593240575|FG000|Overall Study|Physician Decision|1|||
164237407|NCT01832727|593240576|FG001|Overall Study|Physician Decision|0|||
164237408|NCT01832727|593240577|FG002|Overall Study|Physician Decision|0|||
164237409|NCT01832727|593240578|FG003|Overall Study|Physician Decision|1|||
164237410|NCT01832727|593240579|FG004|Overall Study|Physician Decision|0|||
164237411|NCT01832727|593240580|FG005|Overall Study|Physician Decision|1|||
164237412|NCT01832727|593240581|FG006|Overall Study|Physician Decision|0|||
164237413|NCT01832727|593240582|FG007|Overall Study|Physician Decision|0|||
164237414|NCT01832727|593240583|FG008|Overall Study|Physician Decision|0|||
164237415|NCT01832727|593240575|FG000|Overall Study|Withdrawal by Subject|1|||
164237416|NCT01832727|593240576|FG001|Overall Study|Withdrawal by Subject|1|||
164237417|NCT01832727|593240577|FG002|Overall Study|Withdrawal by Subject|0|||
164237418|NCT01832727|593240578|FG003|Overall Study|Withdrawal by Subject|1|||
164237419|NCT01832727|593240579|FG004|Overall Study|Withdrawal by Subject|0|||
164237420|NCT01832727|593240580|FG005|Overall Study|Withdrawal by Subject|1|||
164237421|NCT01832727|593240581|FG006|Overall Study|Withdrawal by Subject|0|||
164237422|NCT01832727|593240582|FG007|Overall Study|Withdrawal by Subject|2|||
164237423|NCT01832727|593240583|FG008|Overall Study|Withdrawal by Subject|1|||
164237424|NCT01832727|593240575|FG000|Overall Study|Study terminated by sponsor|0|||
164237425|NCT01832727|593240576|FG001|Overall Study|Study terminated by sponsor|0|||
164237426|NCT01832727|593240577|FG002|Overall Study|Study terminated by sponsor|0|||
164237427|NCT01832727|593240578|FG003|Overall Study|Study terminated by sponsor|0|||
164237428|NCT01832727|593240579|FG004|Overall Study|Study terminated by sponsor|0|||
164237429|NCT01832727|593240580|FG005|Overall Study|Study terminated by sponsor|0|||
164237430|NCT01832727|593240581|FG006|Overall Study|Study terminated by sponsor|0|||
164237431|NCT01832727|593240582|FG007|Overall Study|Study terminated by sponsor|1|||
164237432|NCT01832727|593240583|FG008|Overall Study|Study terminated by sponsor|1|||
164237433|NCT03323164|593240584|FG000|Overall Study|Poor quality imaging/scans|2|||
164237434|NCT03323164|593240585|FG001|Overall Study|Poor quality imaging/scans|2|||
164237435|NCT00461708|593240586|FG000|Overall Study|Adverse Event|17|||
164237436|NCT00461708|593240587|FG001|Overall Study|Adverse Event|7|||
164237437|NCT00461708|593240586|FG000|Overall Study|Lack of Efficacy|68|||
164237438|NCT00461708|593240587|FG001|Overall Study|Lack of Efficacy|20|||
164237439|NCT00461708|593240586|FG000|Overall Study|Physician Decision|10|||
164237440|NCT00461708|593240587|FG001|Overall Study|Physician Decision|4|||
164237441|NCT00461708|593240586|FG000|Overall Study|Withdrawal by Subject|8|||
164237442|NCT00461708|593240587|FG001|Overall Study|Withdrawal by Subject|2|||
164237443|NCT00461708|593240586|FG000|Overall Study|Other|4|||
164237444|NCT00461708|593240587|FG001|Overall Study|Other|4|||
164237445|NCT00461708|593240586|FG000|Overall Study|Death|8|||
164237446|NCT00461708|593240587|FG001|Overall Study|Death|1|||
164237447|NCT00501644|593240588|FG000|Overall Study|Adverse Event|4|||
164237448|NCT00501644|593240588|FG000|Overall Study|Withdrawal by Subject|1|||
164237449|NCT02394561|593240589|FG000|CORE Phase|Adverse Event|7|||
164237450|NCT02394561|593240590|FG001|CORE Phase|Adverse Event|9|||
164237451|NCT02394561|593240589|FG000|CORE Phase|Death|0|||
164237452|NCT02394561|593240590|FG001|CORE Phase|Death|1|||
164237453|NCT02394561|593240589|FG000|CORE Phase|Pregnancy|1|||
164237454|NCT02394561|593240590|FG001|CORE Phase|Pregnancy|0|||
164237455|NCT02394561|593240589|FG000|CORE Phase|Lost to Follow-up|1|||
164237456|NCT02394561|593240590|FG001|CORE Phase|Lost to Follow-up|0|||
164237457|NCT02394561|593240589|FG000|CORE Phase|Physician Decision|1|||
164237458|NCT02394561|593240590|FG001|CORE Phase|Physician Decision|1|||
164237459|NCT02394561|593240589|FG000|CORE Phase|Withdrawal by Subject|2|||
164237460|NCT02394561|593240590|FG001|CORE Phase|Withdrawal by Subject|2|||
164237461|NCT02394561|593240589|FG000|CORE Phase|Lack of Efficacy|1|||
164237462|NCT02394561|593240590|FG001|CORE Phase|Lack of Efficacy|6|||
164237463|NCT02394561|593240589|FG000|Extension Phase|Adverse Event|6|||
164237464|NCT02394561|593240590|FG001|Extension Phase|Adverse Event|1|||
164237465|NCT02394561|593240589|FG000|Extension Phase|Death|0|||
164237466|NCT02394561|593240590|FG001|Extension Phase|Death|1|||
164237467|NCT02394561|593240589|FG000|Extension Phase|Protocol Violation|1|||
164237468|NCT02394561|593240590|FG001|Extension Phase|Protocol Violation|0|||
164237469|NCT02394561|593240589|FG000|Extension Phase|Lost to Follow-up|1|||
164237470|NCT02394561|593240590|FG001|Extension Phase|Lost to Follow-up|0|||
164237471|NCT02394561|593240589|FG000|Extension Phase|Physician Decision|0|||
164237472|NCT02394561|593240590|FG001|Extension Phase|Physician Decision|2|||
164237473|NCT02394561|593240589|FG000|Extension Phase|Withdrawal by Subject|0|||
163884443|NCT05609760|591946006|FG001|Overall Study|Lost to Follow-up|1|||
163884444|NCT05609760|591946005|FG000|Overall Study|Withdrawal by Subject|1|||
163884445|NCT05609760|591946006|FG001|Overall Study|Withdrawal by Subject|0|||
164237474|NCT02394561|593240590|FG001|Extension Phase|Withdrawal by Subject|5|||
164237475|NCT02394561|593240589|FG000|Extension Phase|Lack of Efficacy|3|||
164237476|NCT02394561|593240590|FG001|Extension Phase|Lack of Efficacy|3|||
164237477|NCT02553629|593240591|FG000|Overall Study|Logistic reasons|3|||
164237478|NCT02553629|593240592|FG001|Overall Study|Logistic reasons|6|||
164335369|NCT03924869|593604898|FG001|Overall Study|Death|62|||
164335370|NCT03924869|593604897|FG000|Overall Study|Lost to Follow-up|3|||
164335371|NCT03924869|593604898|FG001|Overall Study|Lost to Follow-up|0|||
164335372|NCT03924869|593604897|FG000|Overall Study|Physician Decision|0|||
164335373|NCT03924869|593604898|FG001|Overall Study|Physician Decision|3|||
164335374|NCT03924869|593604897|FG000|Overall Study|Withdrawal by Subject|7|||
164335375|NCT03924869|593604898|FG001|Overall Study|Withdrawal by Subject|3|||
164335376|NCT03924869|593604897|FG000|Overall Study|Study Terminated By Sponsor|144|||
164335377|NCT03924869|593604898|FG001|Overall Study|Study Terminated By Sponsor|153|||
164335378|NCT03001882|593604901|FG000|Overall Study|Death|1|||
164335379|NCT03001882|593604902|FG001|Overall Study|Death|0|||
164335380|NCT03001882|593604903|FG002|Overall Study|Death|0|||
164335381|NCT03001882|593604904|FG003|Overall Study|Death|3|||
164335382|NCT03001882|593604901|FG000|Overall Study|Participant withdrew consent|0|||
164335383|NCT03001882|593604902|FG001|Overall Study|Participant withdrew consent|1|||
164335384|NCT03001882|593604903|FG002|Overall Study|Participant withdrew consent|0|||
164335385|NCT03001882|593604904|FG003|Overall Study|Participant withdrew consent|5|||
164335386|NCT03001882|593604901|FG000|Overall Study|Other reasons|1|||
164335387|NCT03001882|593604902|FG001|Overall Study|Other reasons|2|||
164335388|NCT03001882|593604903|FG002|Overall Study|Other reasons|0|||
164335389|NCT03001882|593604904|FG003|Overall Study|Other reasons|5|||
164335390|NCT03001882|593604901|FG000|Overall Study|Administrative reason by sponsor|0|||
164335391|NCT03001882|593604902|FG001|Overall Study|Administrative reason by sponsor|0|||
164335392|NCT03001882|593604903|FG002|Overall Study|Administrative reason by sponsor|0|||
164335393|NCT03001882|593604904|FG003|Overall Study|Administrative reason by sponsor|1|||
164335394|NCT03001882|593604901|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
164335395|NCT03001882|593604902|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
164335396|NCT03001882|593604903|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
164335397|NCT03001882|593604904|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
164237479|NCT01880957|593240593|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
164237480|NCT01880957|593240594|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
164237481|NCT01880957|593240593|FG000|Overall Study|Lost to Follow-up|11|||
164237482|NCT01880957|593240594|FG001|Overall Study|Lost to Follow-up|0|||
164237483|NCT01880957|593240593|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
164237484|NCT01880957|593240594|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
164237485|NCT03342560|593240595|FG000|Overall Study|Lost to Follow-up|2|||
164237486|NCT02604511|593240596|FG000|Overall Study|Adverse Event|3|||
164237487|NCT02604511|593240596|FG000|Overall Study|Disease Progression|4|||
164237488|NCT02604511|593240596|FG000|Overall Study|Withdrawal by Subject|3|||
164237489|NCT02604511|593240596|FG000|Overall Study|Participant ineligible|1|||
164237490|NCT02604511|593240596|FG000|Overall Study|Intercurrent illness|1|||
164237491|NCT03586973|593240597|FG000|Overall Study|Death|15|||
164237492|NCT03586973|593240598|FG001|Overall Study|Death|8|||
164237493|NCT03586973|593240597|FG000|Overall Study|Site Terminated by Sponsor|3|||
164237494|NCT03586973|593240598|FG001|Overall Study|Site Terminated by Sponsor|6|||
164237495|NCT03586973|593240597|FG000|Overall Study|Withdrawal by Subject|1|||
164237496|NCT03586973|593240598|FG001|Overall Study|Withdrawal by Subject|0|||
164237497|NCT03586973|593240597|FG000|Overall Study|Lost to Follow-up|1|||
164237498|NCT03586973|593240598|FG001|Overall Study|Lost to Follow-up|0|||
164237499|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
164237500|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
164237501|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
164237502|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
164237503|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
164237504|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
164237505|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
164237506|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
164237507|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
164237508|NCT01150357|593240599|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
164237509|NCT01150357|593240600|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
164237510|NCT01150357|593240601|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
164237511|NCT01150357|593240599|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
164237512|NCT01150357|593240600|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
164237513|NCT01150357|593240601|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
164237514|NCT01150357|593240599|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
164237515|NCT01150357|593240600|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
164237516|NCT01150357|593240601|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
164237517|NCT01150357|593240599|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
164237518|NCT01150357|593240600|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
164237519|NCT01150357|593240601|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
164237520|NCT02661672|593240602|FG000|Overall Study|Lost to Follow-up|1|||
164237521|NCT02661672|593240602|FG000|Overall Study|Death|4|||
164237522|NCT01248793|593242323|FG000|Overall Study|Lost to Follow-up|0|||
164237523|NCT01248793|593242324|FG001|Overall Study|Lost to Follow-up|1|||
164237524|NCT01248793|593242323|FG000|Overall Study|Adverse Event|1|||
164237525|NCT01248793|593242324|FG001|Overall Study|Adverse Event|1|||
164237526|NCT01248793|593242323|FG000|Overall Study|Protocol Violation|0|||
164237527|NCT01248793|593242324|FG001|Overall Study|Protocol Violation|1|||
164237528|NCT01248793|593242323|FG000|Overall Study|Withdrawal by Subject|3|||
164237529|NCT01248793|593242324|FG001|Overall Study|Withdrawal by Subject|3|||
164237530|NCT00517699|593242325|FG000|Overall Study|Withdrawal by Subject|1|||
164237531|NCT00517699|593242325|FG000|Overall Study|Lack of Efficacy|1|||
164237532|NCT00517699|593242325|FG000|Overall Study|Administrative error|1|||
164237533|NCT00517699|593242325|FG000|Overall Study|Study terminated by Sponsor|2|||
164237534|NCT01114737|593242326|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
164237535|NCT01114737|593242327|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
164237536|NCT01114737|593242326|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
164237537|NCT01114737|593242327|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
164237538|NCT01114737|593242326|FG000|Randomized Treatment Period|Pregnancy|1|||
164237539|NCT01114737|593242327|FG001|Randomized Treatment Period|Pregnancy|0|||
164237540|NCT01114737|593242326|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
164237541|NCT01114737|593242327|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
164237542|NCT01114737|593242326|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
163884446|NCT05089734|591946007|FG000|Overall Study|Still on study|122|||
164237543|NCT01114737|593242327|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
164237544|NCT01114737|593242326|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
164237545|NCT01114737|593242327|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
164237546|NCT02580877|593242330|FG000|Overall Study|Withdrawal by Subject|1|||
164237547|NCT02580877|593242331|FG001|Overall Study|Withdrawal by Subject|3|||
164237548|NCT02580877|593242330|FG000|Overall Study|Adverse Event|0|||
164237549|NCT02580877|593242331|FG001|Overall Study|Adverse Event|1|||
164237550|NCT01466491|593242332|FG000|Overall Study|Protocol Violation|0|||
164237551|NCT01466491|593242333|FG001|Overall Study|Protocol Violation|3|||
164237552|NCT01466491|593242334|FG002|Overall Study|Protocol Violation|2|||
164237553|NCT01466491|593242335|FG003|Overall Study|Protocol Violation|0|||
164237554|NCT01466491|593242332|FG000|Overall Study|Missing Data|0|||
164237555|NCT01466491|593242333|FG001|Overall Study|Missing Data|0|||
164237556|NCT01466491|593242334|FG002|Overall Study|Missing Data|1|||
164237557|NCT01466491|593242335|FG003|Overall Study|Missing Data|0|||
164237558|NCT01123148|593242336|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
164237559|NCT01123148|593242336|FG000|Overall Study|Didn't meet milestone criteria|1|||
164237560|NCT03604497|593242340|FG000|Overall Study|Protocol Violation|52|||
164237561|NCT00811954|593242341|FG000|Overall Study|Death|10|||
164237562|NCT00811954|593242342|FG001|Overall Study|Death|6|||
164237563|NCT00811954|593242343|FG002|Overall Study|Death|13|||
164237564|NCT00811954|593242341|FG000|Overall Study|Lost to Follow-up|29|||
164237565|NCT00811954|593242342|FG001|Overall Study|Lost to Follow-up|23|||
164237566|NCT00811954|593242343|FG002|Overall Study|Lost to Follow-up|34|||
164237567|NCT00811954|593242341|FG000|Overall Study|Not able to get to clinic|28|||
164237568|NCT00811954|593242342|FG001|Overall Study|Not able to get to clinic|35|||
164237569|NCT00811954|593242343|FG002|Overall Study|Not able to get to clinic|30|||
164237570|NCT00811954|593242341|FG000|Overall Study|Not willing to adhere to requirements|12|||
164237571|NCT00811954|593242342|FG001|Overall Study|Not willing to adhere to requirements|2|||
164237572|NCT00811954|593242343|FG002|Overall Study|Not willing to adhere to requirements|16|||
164237573|NCT00811954|593242341|FG000|Overall Study|Withdraw consent prior study completion|4|||
164237574|NCT00811954|593242342|FG001|Overall Study|Withdraw consent prior study completion|6|||
164237575|NCT00811954|593242343|FG002|Overall Study|Withdraw consent prior study completion|5|||
164237576|NCT00811954|593242341|FG000|Overall Study|Site Closure|4|||
164237577|NCT00811954|593242342|FG001|Overall Study|Site Closure|0|||
164237578|NCT00811954|593242343|FG002|Overall Study|Site Closure|1|||
164237579|NCT00811954|593242341|FG000|Overall Study|Severe Debilitation|2|||
164237580|NCT00811954|593242342|FG001|Overall Study|Severe Debilitation|0|||
164237581|NCT00811954|593242343|FG002|Overall Study|Severe Debilitation|1|||
164237582|NCT00811954|593242341|FG000|Overall Study|Complete Protocol: No follow-up|0|||
164237583|NCT00811954|593242342|FG001|Overall Study|Complete Protocol: No follow-up|0|||
164237584|NCT00811954|593242343|FG002|Overall Study|Complete Protocol: No follow-up|1|||
164237585|NCT01534481|593242350|FG000|Overall Study|Lost to Follow-up|29|||
164237586|NCT01534481|593242351|FG001|Overall Study|Lost to Follow-up|24|||
164237587|NCT01534481|593242350|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
164237588|NCT01534481|593242351|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
164237589|NCT01664247|593242355|FG000|Overall Study|Adverse Event|5|||
164237590|NCT01664247|593242356|FG001|Overall Study|Adverse Event|3|||
164237591|NCT01664247|593242355|FG000|Overall Study|Protocol Violation|3|||
164237592|NCT01664247|593242356|FG001|Overall Study|Protocol Violation|5|||
164237593|NCT01664247|593242355|FG000|Overall Study|Withdrawal Criteria|1|||
164237594|NCT01664247|593242356|FG001|Overall Study|Withdrawal Criteria|4|||
164237595|NCT01664247|593242355|FG000|Overall Study|Unclassified|5|||
164237596|NCT01664247|593242356|FG001|Overall Study|Unclassified|29|||
164237597|NCT00945659|593242357|FG000|Overall Study|Lost to Follow-up|7|||
164237598|NCT00945659|593242358|FG001|Overall Study|Lost to Follow-up|20|||
164237599|NCT00945659|593242359|FG002|Overall Study|Lost to Follow-up|17|||
164237600|NCT00658541|593242360|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164237601|NCT00658541|593242361|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164237602|NCT00658541|593242360|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164237603|NCT00658541|593242361|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164237604|NCT03179761|593242362|FG000|Overall Study|Death|2|||
164237605|NCT03179761|593242363|FG001|Overall Study|Death|5|||
164237606|NCT03179761|593242362|FG000|Overall Study|Lost to Follow-up|2|||
164237607|NCT03179761|593242363|FG001|Overall Study|Lost to Follow-up|2|||
164237608|NCT03179761|593242362|FG000|Overall Study|Protocol Violation|1|||
164237609|NCT03179761|593242363|FG001|Overall Study|Protocol Violation|0|||
164237610|NCT03179761|593242362|FG000|Overall Study|Withdrawal by Subject|1|||
164237611|NCT03179761|593242363|FG001|Overall Study|Withdrawal by Subject|4|||
164237612|NCT03179761|593242362|FG000|Overall Study|Investigator Request|0|||
164237613|NCT03179761|593242363|FG001|Overall Study|Investigator Request|2|||
164237614|NCT00565409|593242364|FG000|Period 1 Open Label|Adverse Event|17|||
164237615|NCT00565409|593242365|FG001|Period 1 Open Label|Adverse Event|0|||
164237616|NCT00565409|593242366|FG002|Period 1 Open Label|Adverse Event|0|||
164237617|NCT00565409|593242367|FG003|Period 1 Open Label|Adverse Event|0|||
164237618|NCT00565409|593242364|FG000|Period 1 Open Label|Death|2|||
164237619|NCT00565409|593242365|FG001|Period 1 Open Label|Death|0|||
164237620|NCT00565409|593242366|FG002|Period 1 Open Label|Death|0|||
164237621|NCT00565409|593242367|FG003|Period 1 Open Label|Death|0|||
164237622|NCT00565409|593242364|FG000|Period 1 Open Label|Lost to Follow-up|1|||
164237623|NCT00565409|593242365|FG001|Period 1 Open Label|Lost to Follow-up|0|||
164237624|NCT00565409|593242366|FG002|Period 1 Open Label|Lost to Follow-up|0|||
164237625|NCT00565409|593242367|FG003|Period 1 Open Label|Lost to Follow-up|0|||
164237626|NCT00565409|593242364|FG000|Period 1 Open Label|Other|21|||
164237627|NCT00565409|593242365|FG001|Period 1 Open Label|Other|0|||
164237628|NCT00565409|593242366|FG002|Period 1 Open Label|Other|0|||
164237629|NCT00565409|593242367|FG003|Period 1 Open Label|Other|0|||
164237630|NCT00565409|593242364|FG000|Period 1 Open Label|Protocol Violation|14|||
164237631|NCT00565409|593242365|FG001|Period 1 Open Label|Protocol Violation|0|||
164237632|NCT00565409|593242366|FG002|Period 1 Open Label|Protocol Violation|0|||
164237633|NCT00565409|593242367|FG003|Period 1 Open Label|Protocol Violation|0|||
164237634|NCT00565409|593242364|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
164237635|NCT00565409|593242365|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
164237636|NCT00565409|593242366|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
164237637|NCT00565409|593242367|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
164237638|NCT00565409|593242364|FG000|Period 1 Open Label|no conclusion of participation record|1|||
164237639|NCT00565409|593242365|FG001|Period 1 Open Label|no conclusion of participation record|0|||
164237640|NCT00565409|593242366|FG002|Period 1 Open Label|no conclusion of participation record|0|||
164237641|NCT00565409|593242367|FG003|Period 1 Open Label|no conclusion of participation record|0|||
164237642|NCT00565409|593242364|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
164237643|NCT00565409|593242365|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
164237644|NCT00565409|593242366|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
164237645|NCT00565409|593242367|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
164237646|NCT00565409|593242364|FG000|Period 2 Double-Blind|Adverse Event|0|||
164237647|NCT00565409|593242365|FG001|Period 2 Double-Blind|Adverse Event|7|||
164237648|NCT00565409|593242366|FG002|Period 2 Double-Blind|Adverse Event|4|||
164237649|NCT00565409|593242367|FG003|Period 2 Double-Blind|Adverse Event|5|||
164237650|NCT00565409|593242364|FG000|Period 2 Double-Blind|Death|0|||
164237651|NCT00565409|593242365|FG001|Period 2 Double-Blind|Death|2|||
164237652|NCT00565409|593242366|FG002|Period 2 Double-Blind|Death|0|||
164237653|NCT00565409|593242367|FG003|Period 2 Double-Blind|Death|0|||
164237654|NCT00565409|593242364|FG000|Period 2 Double-Blind|Protocol Violation|0|||
164237655|NCT00565409|593242365|FG001|Period 2 Double-Blind|Protocol Violation|4|||
164237656|NCT00565409|593242366|FG002|Period 2 Double-Blind|Protocol Violation|6|||
164237657|NCT00565409|593242367|FG003|Period 2 Double-Blind|Protocol Violation|2|||
164237658|NCT00565409|593242364|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
164237659|NCT00565409|593242365|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
164237660|NCT00565409|593242366|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
164237661|NCT00565409|593242367|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
164237662|NCT00565409|593242364|FG000|Period 2 Double-Blind|Other|0|||
164237663|NCT00565409|593242365|FG001|Period 2 Double-Blind|Other|4|||
164335398|NCT03001882|593604901|FG000|Overall Study|Not reported|0|||
164335399|NCT03001882|593604902|FG001|Overall Study|Not reported|0|||
164335400|NCT03001882|593604903|FG002|Overall Study|Not reported|0|||
163884447|NCT05089734|591946008|FG001|Overall Study|Still on study|101|||
164237664|NCT00565409|593242366|FG002|Period 2 Double-Blind|Other|5|||
164237665|NCT00565409|593242367|FG003|Period 2 Double-Blind|Other|9|||
164237666|NCT00565409|593242364|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
164237667|NCT00565409|593242365|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
164237668|NCT00565409|593242366|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
164237669|NCT00565409|593242367|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
164237670|NCT04828707|593242368|FG000|Overall Study|Lost to Follow-up|3|||
164335401|NCT03001882|593604904|FG003|Overall Study|Not reported|6|||
164237671|NCT04828707|593242369|FG001|Overall Study|Lost to Follow-up|2|||
164237672|NCT04828707|593242368|FG000|Overall Study|Withdrawal by Subject|2|||
164237673|NCT04828707|593242369|FG001|Overall Study|Withdrawal by Subject|1|||
164237674|NCT04211363|593242378|FG000|Overall Study|Adverse Event|5|||
164237675|NCT04211363|593242379|FG001|Overall Study|Adverse Event|2|||
164237676|NCT04211363|593242378|FG000|Overall Study|Physician Decision|0|||
164237677|NCT04211363|593242379|FG001|Overall Study|Physician Decision|1|||
164237678|NCT04211363|593242378|FG000|Overall Study|Protocol Violation|1|||
164237679|NCT04211363|593242379|FG001|Overall Study|Protocol Violation|0|||
164237680|NCT04211363|593242378|FG000|Overall Study|Pregnancy|1|||
164237681|NCT04211363|593242379|FG001|Overall Study|Pregnancy|0|||
164237682|NCT04211363|593242378|FG000|Overall Study|Lost to Follow-up|12|||
164237683|NCT04211363|593242379|FG001|Overall Study|Lost to Follow-up|4|||
164237684|NCT04211363|593242378|FG000|Overall Study|Withdrawal by Subject|11|||
164237685|NCT04211363|593242379|FG001|Overall Study|Withdrawal by Subject|11|||
164237686|NCT04211363|593242378|FG000|Overall Study|Other|1|||
164237687|NCT04211363|593242379|FG001|Overall Study|Other|2|||
164237688|NCT03434834|593242382|FG000|Overall Study|unable to swallow OCT probe|16|||
164237689|NCT01823289|593242383|FG000|Overall Study|Lost to Follow-up|5|||
164237690|NCT01823289|593242383|FG000|Overall Study|Adverse Event|5|||
164237691|NCT01823289|593242383|FG000|Overall Study|Lack of Efficacy|1|||
164237692|NCT01823289|593242383|FG000|Overall Study|Physician Decision|9|||
164237693|NCT01823289|593242383|FG000|Overall Study|Administered contraindicated medicine|1|||
164237694|NCT01823289|593242383|FG000|Overall Study|Transaminase increased more than 3 times|1|||
164237695|NCT01823289|593242383|FG000|Overall Study|Drug affected efficacy and safety|1|||
164237696|NCT01823289|593242383|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
164237697|NCT01812057|593242391|FG000|Overall Study|Protocol Violation|1|||
164237698|NCT01812057|593242392|FG001|Overall Study|Protocol Violation|0|||
164237699|NCT01812057|593242391|FG000|Overall Study|Physician Decision|1|||
164237700|NCT01812057|593242392|FG001|Overall Study|Physician Decision|0|||
164237701|NCT01736917|593242393|FG000|Overall Study|Adverse Event|1|||
164237702|NCT01736917|593242393|FG000|Overall Study|Protocol Violation|10|||
164237703|NCT00654732|593242398|FG000|Overall Study|Adverse Event|4|||
164237704|NCT00654732|593242399|FG001|Overall Study|Adverse Event|6|||
164237705|NCT01133847|593242406|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
164237706|NCT01133847|593242407|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
164237707|NCT01133847|593242408|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
164237708|NCT01133847|593242406|FG000|Follow-Up Phase|Lost to Follow-up|1|||
164237709|NCT01133847|593242407|FG001|Follow-Up Phase|Lost to Follow-up|3|||
164237710|NCT01133847|593242408|FG002|Follow-Up Phase|Lost to Follow-up|7|||
164237711|NCT01378117|593242409|FG000|Overall Study|withdrawal|2|||
164237712|NCT01378117|593242410|FG001|Overall Study|withdrawal|1|||
164237713|NCT01378117|593242411|FG002|Overall Study|withdrawal|2|||
164237714|NCT01378117|593242409|FG000|Overall Study|discharged before med given|2|||
164237715|NCT01378117|593242410|FG001|Overall Study|discharged before med given|0|||
164237716|NCT01378117|593242411|FG002|Overall Study|discharged before med given|1|||
164237717|NCT02961244|593242412|FG000|Overall Study|Protocol Violation|0|||
164237718|NCT02961244|593242413|FG001|Overall Study|Protocol Violation|1|||
164237719|NCT02961244|593242412|FG000|Overall Study|Withdrawal by Subject|1|||
164237720|NCT02961244|593242413|FG001|Overall Study|Withdrawal by Subject|2|||
164237721|NCT02961244|593242412|FG000|Overall Study|Surgery plan change after study approval|0|||
164237722|NCT02961244|593242413|FG001|Overall Study|Surgery plan change after study approval|2|||
164237723|NCT02961244|593242412|FG000|Overall Study|Lost to Follow-up|0|||
164237724|NCT02961244|593242413|FG001|Overall Study|Lost to Follow-up|2|||
164237725|NCT02961244|593242412|FG000|Overall Study|İnadequate data|0|||
164237726|NCT02961244|593242413|FG001|Overall Study|İnadequate data|2|||
164237727|NCT01854528|593242414|FG000|Overall Study|Adverse Event|0|||
164237728|NCT01854528|593242415|FG001|Overall Study|Adverse Event|4|||
164237729|NCT01854528|593242414|FG000|Overall Study|Withdrawal by Subject|0|||
164237730|NCT01854528|593242415|FG001|Overall Study|Withdrawal by Subject|2|||
164237731|NCT01854528|593242414|FG000|Overall Study|Virologic Failure|0|||
164237732|NCT01854528|593242415|FG001|Overall Study|Virologic Failure|9|||
164237733|NCT01368614|593242417|FG000|Screening Period|Screen Failure|58|||
164237734|NCT01368614|593242418|FG001|Screening Period|Screen Failure|0|||
164237735|NCT01368614|593242419|FG002|Screening Period|Screen Failure|0|||
164237736|NCT01368614|593242420|FG003|Screening Period|Screen Failure|0|||
164237737|NCT01368614|593242417|FG000|Study Period|Withdrawal by Subject|0|||
164237738|NCT01368614|593242418|FG001|Study Period|Withdrawal by Subject|1|||
164237739|NCT01368614|593242419|FG002|Study Period|Withdrawal by Subject|1|||
164237740|NCT01368614|593242420|FG003|Study Period|Withdrawal by Subject|3|||
164237741|NCT01368614|593242417|FG000|Study Period|Lost to Follow-up|0|||
164237742|NCT01368614|593242418|FG001|Study Period|Lost to Follow-up|0|||
164237743|NCT01368614|593242419|FG002|Study Period|Lost to Follow-up|1|||
164237744|NCT01368614|593242420|FG003|Study Period|Lost to Follow-up|0|||
164237745|NCT00518180|593242421|FG000|Overall Study|Withdrawal by Subject|29|||
164237746|NCT00518180|593242422|FG001|Overall Study|Withdrawal by Subject|30|||
164237747|NCT00518180|593242423|FG002|Overall Study|Withdrawal by Subject|42|||
164237748|NCT00518180|593242421|FG000|Overall Study|Lost to Follow-up|30|||
164237749|NCT00518180|593242422|FG001|Overall Study|Lost to Follow-up|28|||
164237750|NCT00518180|593242423|FG002|Overall Study|Lost to Follow-up|34|||
164237751|NCT00518180|593242421|FG000|Overall Study|Administrative reason|0|||
164237752|NCT00518180|593242422|FG001|Overall Study|Administrative reason|2|||
164237753|NCT00518180|593242423|FG002|Overall Study|Administrative reason|2|||
164237754|NCT00518180|593242421|FG000|Overall Study|Protocol Violation|5|||
164237755|NCT00518180|593242422|FG001|Overall Study|Protocol Violation|7|||
164237756|NCT00518180|593242423|FG002|Overall Study|Protocol Violation|4|||
164237757|NCT00518180|593242421|FG000|Overall Study|Unable to classify|0|||
164237758|NCT00518180|593242422|FG001|Overall Study|Unable to classify|2|||
164237759|NCT00518180|593242423|FG002|Overall Study|Unable to classify|0|||
164237760|NCT00518180|593242421|FG000|Overall Study|Adverse Event|1|||
164237761|NCT00518180|593242422|FG001|Overall Study|Adverse Event|0|||
164237762|NCT00518180|593242423|FG002|Overall Study|Adverse Event|0|||
164237763|NCT02347085|593242430|FG000|Overall Study|Adverse Event|2|||
164237764|NCT02347085|593242430|FG000|Overall Study|Lack of Efficacy|1|||
164237765|NCT02347085|593242430|FG000|Overall Study|Withdrawal by Subject|4|||
164237766|NCT02347085|593242430|FG000|Overall Study|Lost to Follow-up|1|||
164237767|NCT02347085|593242430|FG000|Overall Study|Protocol Criteria|2|||
164237768|NCT01957865|593242431|FG000|Overall Study|Found HIV negative|0|||
164237769|NCT01957865|593242432|FG001|Overall Study|Found HIV negative|0|||
164237770|NCT01957865|593242433|FG002|Overall Study|Found HIV negative|1|||
164237771|NCT01957865|593242431|FG000|Overall Study|Lost to Follow-up|0|||
164237772|NCT01957865|593242432|FG001|Overall Study|Lost to Follow-up|2|||
164237773|NCT01957865|593242433|FG002|Overall Study|Lost to Follow-up|2|||
164237774|NCT01082614|593242434|FG000|Overall Study|Adverse Event|1|||
164237775|NCT01082614|593242435|FG001|Overall Study|Adverse Event|4|||
164237776|NCT01082614|593242434|FG000|Overall Study|Equipment Malfunction|0|||
164237777|NCT01082614|593242435|FG001|Overall Study|Equipment Malfunction|1|||
164237778|NCT01082614|593242434|FG000|Overall Study|Physician Decision|2|||
164237779|NCT01082614|593242435|FG001|Overall Study|Physician Decision|0|||
164237780|NCT00950651|593242443|FG000|Overall Study|Adverse Event|17|||
164237781|NCT00950651|593242444|FG001|Overall Study|Adverse Event|20|||
164237782|NCT00950651|593242443|FG000|Overall Study|Death|1|||
164237783|NCT00950651|593242444|FG001|Overall Study|Death|0|||
164237784|NCT00950651|593242443|FG000|Overall Study|Lack of Efficacy|2|||
164237785|NCT00950651|593242444|FG001|Overall Study|Lack of Efficacy|2|||
164237786|NCT00950651|593242443|FG000|Overall Study|Protocol Violation|3|||
164237787|NCT00950651|593242444|FG001|Overall Study|Protocol Violation|4|||
164237788|NCT00950651|593242443|FG000|Overall Study|Withdrawal by Subject|8|||
164237789|NCT00950651|593242444|FG001|Overall Study|Withdrawal by Subject|9|||
164237790|NCT03783780|593242445|FG000|Overall Study|Withdrawn prior to completion|1|||
164237791|NCT03768427|593242446|FG000|Overall Study|Death|0|||
164237792|NCT03768427|593242447|FG001|Overall Study|Death|0|||
164237793|NCT03768427|593242448|FG002|Overall Study|Death|1|||
164237794|NCT03768427|593242449|FG003|Overall Study|Death|0|||
164237795|NCT03768427|593242446|FG000|Overall Study|Lost to Follow-up|2|||
164237796|NCT03768427|593242447|FG001|Overall Study|Lost to Follow-up|0|||
164237797|NCT03768427|593242448|FG002|Overall Study|Lost to Follow-up|0|||
164237798|NCT03768427|593242449|FG003|Overall Study|Lost to Follow-up|0|||
164237799|NCT03768427|593242446|FG000|Overall Study|Physician Decision|3|||
164237800|NCT03768427|593242447|FG001|Overall Study|Physician Decision|2|||
164237801|NCT03768427|593242448|FG002|Overall Study|Physician Decision|4|||
164237802|NCT03768427|593242449|FG003|Overall Study|Physician Decision|4|||
164237803|NCT03768427|593242446|FG000|Overall Study|Withdrawal by Subject|7|||
164237804|NCT03768427|593242447|FG001|Overall Study|Withdrawal by Subject|2|||
164237805|NCT03768427|593242448|FG002|Overall Study|Withdrawal by Subject|6|||
164237806|NCT03768427|593242449|FG003|Overall Study|Withdrawal by Subject|7|||
164237807|NCT03710889|593242452|FG000|Overall Study|Adverse Event|2|||
164237808|NCT03710889|593242452|FG000|Overall Study|Protocol Deviation|1|||
164237809|NCT00659425|593242456|FG000|Overall Study|Disease progression|1|||
164237810|NCT00659425|593242457|FG001|Overall Study|Disease progression|0|||
164237811|NCT00659425|593242458|FG002|Overall Study|Disease progression|0|||
164237812|NCT00659425|593242459|FG003|Overall Study|Disease progression|1|||
164237813|NCT00659425|593242460|FG004|Overall Study|Disease progression|0|||
164237814|NCT00659425|593242461|FG005|Overall Study|Disease progression|2|||
164237815|NCT00659425|593242462|FG006|Overall Study|Disease progression|4|||
164237816|NCT00659425|593242463|FG007|Overall Study|Disease progression|3|||
164237817|NCT00659425|593242464|FG008|Overall Study|Disease progression|5|||
164237818|NCT00659425|593242465|FG009|Overall Study|Disease progression|3|||
164237819|NCT00659425|593242456|FG000|Overall Study|Death|0|||
164237820|NCT00659425|593242457|FG001|Overall Study|Death|0|||
164237821|NCT00659425|593242458|FG002|Overall Study|Death|0|||
164237822|NCT00659425|593242459|FG003|Overall Study|Death|1|||
164237823|NCT00659425|593242460|FG004|Overall Study|Death|0|||
164237824|NCT00659425|593242461|FG005|Overall Study|Death|0|||
164237825|NCT00659425|593242462|FG006|Overall Study|Death|1|||
164237826|NCT00659425|593242463|FG007|Overall Study|Death|0|||
164237827|NCT00659425|593242464|FG008|Overall Study|Death|0|||
164237828|NCT00659425|593242465|FG009|Overall Study|Death|0|||
164237829|NCT00659425|593242456|FG000|Overall Study|Adverse Event|0|||
164335402|NCT03001882|593604901|FG000|Overall Study|Maximum clinical benefit|2|||
164335403|NCT03001882|593604902|FG001|Overall Study|Maximum clinical benefit|3|||
164335404|NCT03001882|593604903|FG002|Overall Study|Maximum clinical benefit|0|||
164335405|NCT03001882|593604904|FG003|Overall Study|Maximum clinical benefit|10|||
164335406|NCT03001882|593604901|FG000|Overall Study|AE unrelated to study drug|3|||
164335407|NCT03001882|593604902|FG001|Overall Study|AE unrelated to study drug|3|||
164335408|NCT03001882|593604903|FG002|Overall Study|AE unrelated to study drug|0|||
164335409|NCT03001882|593604904|FG003|Overall Study|AE unrelated to study drug|11|||
164335410|NCT03001882|593604901|FG000|Overall Study|Study Drug Toxicity|8|||
164335411|NCT03001882|593604902|FG001|Overall Study|Study Drug Toxicity|5|||
164335412|NCT03001882|593604903|FG002|Overall Study|Study Drug Toxicity|0|||
164335413|NCT03001882|593604904|FG003|Overall Study|Study Drug Toxicity|37|||
164335414|NCT03001882|593604901|FG000|Overall Study|Disease progression|16|||
164335415|NCT03001882|593604902|FG001|Overall Study|Disease progression|14|||
164335416|NCT03001882|593604903|FG002|Overall Study|Disease progression|1|||
164335417|NCT03001882|593604904|FG003|Overall Study|Disease progression|90|||
164335418|NCT02718300|593604905|FG000|Overall Study|Death|4|||
164335419|NCT02718300|593604906|FG001|Overall Study|Death|5|||
164335420|NCT02718300|593604907|FG002|Overall Study|Death|17|||
164335421|NCT02718300|593604905|FG000|Overall Study|Lost to Follow-up|1|||
164335422|NCT02718300|593604906|FG001|Overall Study|Lost to Follow-up|0|||
164335423|NCT02718300|593604907|FG002|Overall Study|Lost to Follow-up|2|||
164335424|NCT02718300|593604905|FG000|Overall Study|Physician Decision|1|||
164335425|NCT02718300|593604906|FG001|Overall Study|Physician Decision|0|||
164335426|NCT02718300|593604907|FG002|Overall Study|Physician Decision|2|||
164335427|NCT02718300|593604905|FG000|Overall Study|Study Terminated by Sponsor|6|||
164335428|NCT02718300|593604906|FG001|Overall Study|Study Terminated by Sponsor|3|||
164335429|NCT02718300|593604907|FG002|Overall Study|Study Terminated by Sponsor|4|||
164335430|NCT02718300|593604905|FG000|Overall Study|Withdrawal by Subject|0|||
164335431|NCT02718300|593604906|FG001|Overall Study|Withdrawal by Subject|4|||
164335432|NCT02718300|593604907|FG002|Overall Study|Withdrawal by Subject|3|||
164335433|NCT02718300|593604905|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
164335434|NCT02718300|593604906|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
164335435|NCT02718300|593604907|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
164335436|NCT05268055|593604909|FG000|Overall Study|Lost to Follow-up|68|||
164335437|NCT05268055|593604910|FG001|Overall Study|Lost to Follow-up|68|||
164335438|NCT05268055|593604909|FG000|Overall Study|Withdrawal by Subject|12|||
164335439|NCT05268055|593604910|FG001|Overall Study|Withdrawal by Subject|8|||
164335440|NCT03507400|593604911|FG000|Overall Study|discontinued|5|||
164335441|NCT03507400|593604912|FG001|Overall Study|discontinued|1|||
164335442|NCT03507400|593604911|FG000|Overall Study|Lost to Follow-up|8|||
164140473|NCT00642278|592876097|FG002|Overall Study|Adverse Event|3|||
164335443|NCT03507400|593604912|FG001|Overall Study|Lost to Follow-up|6|||
164335444|NCT03507400|593604911|FG000|Overall Study|Protocol Violation|0|||
164335445|NCT03507400|593604912|FG001|Overall Study|Protocol Violation|1|||
164335446|NCT01555983|593604913|FG000|Overall Study|Withdrawal by Subject|1|||
164335447|NCT01555983|593604914|FG001|Overall Study|Withdrawal by Subject|0|||
163988789|NCT01928381|592326229|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
163988790|NCT01928381|592326223|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
163988791|NCT01928381|592326224|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
163988792|NCT01928381|592326225|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
163988793|NCT01928381|592326226|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
163988794|NCT01928381|592326227|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
163988795|NCT01928381|592326228|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
163988796|NCT01928381|592326229|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
163988797|NCT01928381|592326223|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
163988798|NCT01928381|592326224|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
164237830|NCT00659425|593242457|FG001|Overall Study|Adverse Event|0|||
164237831|NCT00659425|593242458|FG002|Overall Study|Adverse Event|0|||
164237832|NCT00659425|593242459|FG003|Overall Study|Adverse Event|0|||
164237833|NCT00659425|593242460|FG004|Overall Study|Adverse Event|0|||
164237834|NCT00659425|593242461|FG005|Overall Study|Adverse Event|1|||
164237835|NCT00659425|593242462|FG006|Overall Study|Adverse Event|0|||
164237836|NCT00659425|593242463|FG007|Overall Study|Adverse Event|3|||
163988799|NCT01928381|592326225|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
164237837|NCT00659425|593242464|FG008|Overall Study|Adverse Event|1|||
164237838|NCT00659425|593242465|FG009|Overall Study|Adverse Event|4|||
164237839|NCT00659425|593242456|FG000|Overall Study|Investigator Discretion|0|||
164237840|NCT00659425|593242457|FG001|Overall Study|Investigator Discretion|0|||
164237841|NCT00659425|593242458|FG002|Overall Study|Investigator Discretion|0|||
163988800|NCT01928381|592326226|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
163988801|NCT01928381|592326227|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
163988802|NCT01928381|592326228|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
163988803|NCT01928381|592326229|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
163988804|NCT01928381|592326223|FG000|Part 1 - Pain Training|Protocol Violation|1|||
163988805|NCT01928381|592326224|FG001|Part 1 - Pain Training|Protocol Violation|0|||
163988806|NCT01928381|592326225|FG002|Part 1 - Pain Training|Protocol Violation|0|||
163988807|NCT01928381|592326226|FG003|Part 1 - Pain Training|Protocol Violation|0|||
163988808|NCT01928381|592326227|FG004|Part 1 - Pain Training|Protocol Violation|0|||
163988809|NCT01928381|592326228|FG005|Part 1 - Pain Training|Protocol Violation|0|||
163988810|NCT01928381|592326229|FG006|Part 1 - Pain Training|Protocol Violation|0|||
163988811|NCT01928381|592326223|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
163988812|NCT01928381|592326224|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163988813|NCT01928381|592326225|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163988814|NCT01928381|592326226|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163988815|NCT01928381|592326227|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163988816|NCT01928381|592326228|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
163988817|NCT01928381|592326229|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
164335448|NCT01555983|593604915|FG002|Overall Study|Withdrawal by Subject|0|||
164335449|NCT01555983|593604916|FG003|Overall Study|Withdrawal by Subject|0|||
164335450|NCT01555983|593604917|FG004|Overall Study|Withdrawal by Subject|1|||
164335451|NCT01555983|593604918|FG005|Overall Study|Withdrawal by Subject|1|||
164335452|NCT04026711|593604922|FG000|Overall Study|Withdrawal by Subject|1|||
164335453|NCT04026711|593604923|FG001|Overall Study|Withdrawal by Subject|0|||
164335454|NCT04026711|593604922|FG000|Overall Study|mental health crisis|1|||
164335455|NCT04026711|593604923|FG001|Overall Study|mental health crisis|0|||
164335456|NCT05985395|593604928|FG000|Overall Study|Physician Decision|2|||
164335457|NCT05985395|593604929|FG001|Overall Study|Physician Decision|1|||
164335458|NCT05985395|593604928|FG000|Overall Study|Withdrawal by Subject|1|||
164335459|NCT05985395|593604929|FG001|Overall Study|Withdrawal by Subject|0|||
164335460|NCT05741528|593604930|FG000|Overall Study|Withdrawal by Subject|11|||
164335461|NCT05741528|593604930|FG000|Overall Study|Lost to Follow-up|3|||
164335462|NCT05741528|593604930|FG000|Overall Study|Adverse Event|2|||
164335463|NCT05741528|593604930|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164335464|NCT05741528|593604930|FG000|Overall Study|Reason Not Specified|1|||
164335465|NCT04823650|593604931|FG000|Overall Study|Withdrawal by Subject|0|||
164335466|NCT04823650|593604932|FG001|Overall Study|Withdrawal by Subject|0|||
163988818|NCT01928381|592326223|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
163988819|NCT01928381|592326224|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163988820|NCT01928381|592326225|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
164237842|NCT00659425|593242459|FG003|Overall Study|Investigator Discretion|0|||
164237843|NCT00659425|593242460|FG004|Overall Study|Investigator Discretion|0|||
164237844|NCT00659425|593242461|FG005|Overall Study|Investigator Discretion|1|||
164335467|NCT04823650|593604933|FG002|Overall Study|Withdrawal by Subject|0|||
164335468|NCT04823650|593604934|FG003|Overall Study|Withdrawal by Subject|0|||
164335469|NCT04823650|593604935|FG004|Overall Study|Withdrawal by Subject|1|||
164237845|NCT00659425|593242462|FG006|Overall Study|Investigator Discretion|0|||
164237846|NCT00659425|593242463|FG007|Overall Study|Investigator Discretion|3|||
164335470|NCT04823650|593604936|FG005|Overall Study|Withdrawal by Subject|0|||
164335471|NCT02699697|593605977|FG000|Overall Study|Death|18|||
164335472|NCT02699697|593605978|FG001|Overall Study|Death|15|||
164335473|NCT02699697|593605977|FG000|Overall Study|Physician Decision|0|||
164237847|NCT00659425|593242464|FG008|Overall Study|Investigator Discretion|0|||
164237848|NCT00659425|593242465|FG009|Overall Study|Investigator Discretion|0|||
164237849|NCT00659425|593242456|FG000|Overall Study|Other|0|||
164237850|NCT00659425|593242457|FG001|Overall Study|Other|1|||
164237851|NCT00659425|593242458|FG002|Overall Study|Other|1|||
164237852|NCT00659425|593242459|FG003|Overall Study|Other|2|||
164237853|NCT00659425|593242460|FG004|Overall Study|Other|4|||
164237854|NCT00659425|593242461|FG005|Overall Study|Other|0|||
164237855|NCT00659425|593242462|FG006|Overall Study|Other|3|||
164237856|NCT00659425|593242463|FG007|Overall Study|Other|2|||
164237857|NCT00659425|593242464|FG008|Overall Study|Other|0|||
164237858|NCT00659425|593242465|FG009|Overall Study|Other|6|||
164237859|NCT02121509|593242469|FG000|Washout Period (35 Days)|Adverse Event|1|||
164237860|NCT02121509|593242470|FG001|Washout Period (35 Days)|Adverse Event|1|||
164237861|NCT02121509|593242471|FG002|Washout Period (35 Days)|Adverse Event|0|||
164237862|NCT02121509|593242472|FG003|Washout Period (35 Days)|Adverse Event|0|||
164237863|NCT02121509|593242469|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
164237864|NCT02121509|593242470|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
164237865|NCT02121509|593242471|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
164237866|NCT02121509|593242472|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
164237867|NCT02121509|593242469|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
164237868|NCT02121509|593242470|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
164237869|NCT02121509|593242471|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
164237870|NCT02121509|593242472|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
164237871|NCT00636181|593242475|FG000|Overall Study|Withdrawal by Subject|8|||
164237872|NCT00636181|593242476|FG001|Overall Study|Withdrawal by Subject|6|||
164237873|NCT00636181|593242477|FG002|Overall Study|Withdrawal by Subject|10|||
164237874|NCT02993263|593242479|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
164237875|NCT02561962|593242480|FG000|Overall Study|Withdrawal by Subject|1|||
164237876|NCT02561962|593242481|FG001|Overall Study|Withdrawal by Subject|0|||
164237877|NCT02561962|593242482|FG002|Overall Study|Withdrawal by Subject|0|||
164237878|NCT02561962|593242483|FG003|Overall Study|Withdrawal by Subject|0|||
164237879|NCT02561962|593242484|FG004|Overall Study|Withdrawal by Subject|1|||
164237880|NCT02561962|593242485|FG005|Overall Study|Withdrawal by Subject|1|||
164237881|NCT02561962|593242486|FG006|Overall Study|Withdrawal by Subject|2|||
164237882|NCT02561962|593242487|FG007|Overall Study|Withdrawal by Subject|1|||
164237883|NCT02561962|593242488|FG008|Overall Study|Withdrawal by Subject|0|||
164237884|NCT02561962|593242480|FG000|Overall Study|Decision by sponsor|0|||
164237885|NCT02561962|593242481|FG001|Overall Study|Decision by sponsor|0|||
164237886|NCT02561962|593242482|FG002|Overall Study|Decision by sponsor|0|||
164237887|NCT02561962|593242483|FG003|Overall Study|Decision by sponsor|0|||
164237888|NCT02561962|593242484|FG004|Overall Study|Decision by sponsor|1|||
164237889|NCT02561962|593242485|FG005|Overall Study|Decision by sponsor|1|||
164237890|NCT02561962|593242486|FG006|Overall Study|Decision by sponsor|0|||
164237891|NCT02561962|593242487|FG007|Overall Study|Decision by sponsor|3|||
164237892|NCT02561962|593242488|FG008|Overall Study|Decision by sponsor|0|||
164237893|NCT02561962|593242480|FG000|Overall Study|Lost to Follow-up|0|||
164237894|NCT02561962|593242481|FG001|Overall Study|Lost to Follow-up|0|||
164237895|NCT02561962|593242482|FG002|Overall Study|Lost to Follow-up|0|||
164237896|NCT02561962|593242483|FG003|Overall Study|Lost to Follow-up|0|||
164237897|NCT02561962|593242484|FG004|Overall Study|Lost to Follow-up|0|||
164237898|NCT02561962|593242485|FG005|Overall Study|Lost to Follow-up|1|||
164237899|NCT02561962|593242486|FG006|Overall Study|Lost to Follow-up|0|||
164237900|NCT02561962|593242487|FG007|Overall Study|Lost to Follow-up|0|||
164335474|NCT02699697|593605978|FG001|Overall Study|Physician Decision|1|||
163884448|NCT05089734|591946007|FG000|Overall Study|Death|161|||
163884449|NCT05089734|591946008|FG001|Overall Study|Death|179|||
163884450|NCT05089734|591946007|FG000|Overall Study|Withdrew consent|11|||
163884451|NCT05089734|591946008|FG001|Overall Study|Withdrew consent|24|||
163884452|NCT05089734|591946007|FG000|Overall Study|Lost to Follow-up|5|||
163884453|NCT05089734|591946008|FG001|Overall Study|Lost to Follow-up|0|||
163884454|NCT05179395|591946009|FG000|Overall Study|Lack of Efficacy|1|||
163884455|NCT04318548|591947733|FG000|Overall Study|Adverse Event|0|||
163884456|NCT04318548|591947734|FG001|Overall Study|Adverse Event|0|||
163884457|NCT04318548|591947735|FG002|Overall Study|Adverse Event|1|||
163884458|NCT04318548|591947733|FG000|Overall Study|Lost to Follow-up|6|||
163884459|NCT04318548|591947734|FG001|Overall Study|Lost to Follow-up|13|||
163884460|NCT04318548|591947735|FG002|Overall Study|Lost to Follow-up|9|||
163884461|NCT04318548|591947733|FG000|Overall Study|Protocol Violation|1|||
163884462|NCT04318548|591947734|FG001|Overall Study|Protocol Violation|0|||
163884463|NCT04318548|591947735|FG002|Overall Study|Protocol Violation|2|||
163884464|NCT04318548|591947733|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
163884465|NCT04318548|591947734|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
163884466|NCT04318548|591947735|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
163884467|NCT04318548|591947733|FG000|Overall Study|Migrated / moved from the study area|0|||
163884468|NCT04318548|591947734|FG001|Overall Study|Migrated / moved from the study area|0|||
164237901|NCT02561962|593242488|FG008|Overall Study|Lost to Follow-up|0|||
164237902|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
164237903|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
164237904|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
164237905|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
164237906|NCT02735421|593244089|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
164237907|NCT02735421|593244089|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
164237908|NCT02735421|593244089|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
164237909|NCT00322049|593244091|FG000|Overall Study|Moved out of area|0|||
164237910|NCT00322049|593244092|FG001|Overall Study|Moved out of area|0|||
164237911|NCT00322049|593244093|FG002|Overall Study|Moved out of area|0|||
164237912|NCT00322049|593244094|FG003|Overall Study|Moved out of area|1|||
164237913|NCT00322049|593244091|FG000|Overall Study|Infected with Dengue during study|0|||
164237914|NCT00322049|593244092|FG001|Overall Study|Infected with Dengue during study|1|||
164237915|NCT00322049|593244093|FG002|Overall Study|Infected with Dengue during study|0|||
164237916|NCT00322049|593244094|FG003|Overall Study|Infected with Dengue during study|0|||
164237917|NCT01978145|593244095|FG000|Treatment Period 1|Adverse Event|1|||
164237918|NCT01978145|593244096|FG001|Treatment Period 1|Adverse Event|9|||
163988821|NCT01928381|592326226|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163988822|NCT01928381|592326227|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163988823|NCT01928381|592326228|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163988824|NCT01928381|592326229|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
163988825|NCT01928381|592326223|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
163988826|NCT01928381|592326224|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163988827|NCT01928381|592326225|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163988828|NCT01928381|592326226|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163988829|NCT01928381|592326227|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163988830|NCT01928381|592326228|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163988831|NCT01928381|592326229|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
163988832|NCT01928381|592326223|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
163988833|NCT01928381|592326224|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163988834|NCT01928381|592326225|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163988835|NCT01928381|592326226|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163988836|NCT01928381|592326227|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163988837|NCT01928381|592326228|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163988838|NCT01928381|592326229|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
163988839|NCT01928381|592326223|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
163988840|NCT01928381|592326224|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
164237919|NCT01978145|593244095|FG000|Treatment Period 1|Physician Decision|1|||
164237920|NCT01978145|593244096|FG001|Treatment Period 1|Physician Decision|0|||
164237921|NCT01978145|593244095|FG000|Treatment Period 1|Withdrawal by Subject|5|||
164237922|NCT01978145|593244096|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164237923|NCT01978145|593244095|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
164237924|NCT01978145|593244096|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
164237925|NCT01978145|593244095|FG000|Washout Period 1|Adverse Event|0|||
164237926|NCT01978145|593244096|FG001|Washout Period 1|Adverse Event|1|||
164237927|NCT01978145|593244095|FG000|Washout Period 1|Withdrawal by Subject|1|||
164237928|NCT01978145|593244096|FG001|Washout Period 1|Withdrawal by Subject|1|||
164237929|NCT01978145|593244095|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
164237930|NCT01978145|593244096|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
163988841|NCT01928381|592326225|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
163988842|NCT01928381|592326226|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
163988843|NCT01928381|592326227|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
163988844|NCT01928381|592326228|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
163988845|NCT01928381|592326229|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
163988846|NCT01928381|592326223|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163988847|NCT01928381|592326224|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163988848|NCT01928381|592326225|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
163988849|NCT01928381|592326226|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163988850|NCT01928381|592326227|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163988851|NCT01928381|592326228|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
163988852|NCT01928381|592326229|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
164237931|NCT01978145|593244095|FG000|Treatment Period 2|Adverse Event|3|||
164237932|NCT01978145|593244096|FG001|Treatment Period 2|Adverse Event|3|||
164237933|NCT01978145|593244095|FG000|Treatment Period 2|Protocol Violation|0|||
164237934|NCT01978145|593244096|FG001|Treatment Period 2|Protocol Violation|1|||
164237935|NCT01978145|593244095|FG000|Treatment Period 2|Lost to Follow-up|1|||
164237936|NCT01978145|593244096|FG001|Treatment Period 2|Lost to Follow-up|1|||
163988853|NCT01928381|592326223|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
163988854|NCT01928381|592326224|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
163988855|NCT01928381|592326225|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
163988856|NCT01928381|592326226|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
163988857|NCT01928381|592326227|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
163988858|NCT01928381|592326228|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
163988859|NCT01928381|592326229|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
163988860|NCT01928381|592326223|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
163988861|NCT01928381|592326224|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
163988862|NCT01928381|592326225|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
163988863|NCT01928381|592326226|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
163988864|NCT01928381|592326227|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
163988865|NCT01928381|592326228|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
163988866|NCT01928381|592326229|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
163988867|NCT01928381|592326223|FG000|Washout First Intervention|Protocol Violation|0|||
163988868|NCT01928381|592326224|FG001|Washout First Intervention|Protocol Violation|0|||
163988869|NCT01928381|592326225|FG002|Washout First Intervention|Protocol Violation|0|||
163988870|NCT01928381|592326226|FG003|Washout First Intervention|Protocol Violation|0|||
163988871|NCT01928381|592326227|FG004|Washout First Intervention|Protocol Violation|1|||
163988872|NCT01928381|592326228|FG005|Washout First Intervention|Protocol Violation|0|||
163988873|NCT01928381|592326229|FG006|Washout First Intervention|Protocol Violation|0|||
163988874|NCT01928381|592326223|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
163988875|NCT01928381|592326224|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
163988876|NCT01928381|592326225|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
163988877|NCT01928381|592326226|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
163988878|NCT01928381|592326227|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
163988879|NCT01928381|592326228|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
163988880|NCT01928381|592326229|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
163988881|NCT01928381|592326223|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
163988882|NCT01928381|592326224|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
163988883|NCT01928381|592326225|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
163988884|NCT01928381|592326226|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
163988885|NCT01928381|592326227|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
163988886|NCT01928381|592326228|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
163988887|NCT01928381|592326229|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
163988888|NCT03631706|592326233|FG000|Overall Study|Randomized, not treated|1|||
163988889|NCT03631706|592326234|FG001|Overall Study|Randomized, not treated|0|||
163988890|NCT02554929|592328192|FG000|Overall Study|Lost to Follow-up|4|||
163988891|NCT02554929|592328193|FG001|Overall Study|Lost to Follow-up|4|||
163988892|NCT02554929|592328192|FG000|Overall Study|Withdrawal by Subject|2|||
163988893|NCT02554929|592328193|FG001|Overall Study|Withdrawal by Subject|8|||
163988894|NCT04187092|592328194|FG000|Overall Study|Lost to Follow-up|1|||
163988895|NCT04187092|592328195|FG001|Overall Study|Lost to Follow-up|1|||
163988896|NCT04187092|592328194|FG000|Overall Study|Withdrawal by Subject|1|||
163988897|NCT04187092|592328195|FG001|Overall Study|Withdrawal by Subject|1|||
163988898|NCT04187092|592328194|FG000|Overall Study|Adverse Event|0|||
163988899|NCT04187092|592328195|FG001|Overall Study|Adverse Event|1|||
163988900|NCT05162066|592328199|FG000|Overall Study|Adverse Event|1|||
163988901|NCT05162066|592328200|FG001|Overall Study|Adverse Event|0|||
163988902|NCT05162066|592328201|FG002|Overall Study|Adverse Event|0|||
163988903|NCT05162066|592328199|FG000|Overall Study|Perceived lack of efficacy|1|||
163988904|NCT05162066|592328200|FG001|Overall Study|Perceived lack of efficacy|0|||
163988905|NCT05162066|592328201|FG002|Overall Study|Perceived lack of efficacy|0|||
163884469|NCT04318548|591947735|FG002|Overall Study|Migrated / moved from the study area|1|||
163884470|NCT04318548|591947733|FG000|Overall Study|Other|1|||
163884471|NCT04318548|591947734|FG001|Overall Study|Other|2|||
163884472|NCT04318548|591947735|FG002|Overall Study|Other|3|||
163884473|NCT06283173|591947736|FG000|Overall Study|Did not show for first visit|10|||
163884474|NCT06283173|591947736|FG000|Overall Study|Lost to Follow-up|12|||
163884475|NCT06283173|591947736|FG000|Overall Study|Physician Decision|7|||
163884476|NCT03366649|591947739|FG000|Overall Study|Failed preoperative screening|4|||
163884477|NCT03366649|591947740|FG001|Overall Study|Failed preoperative screening|0|||
163884478|NCT03366649|591947741|FG002|Overall Study|Failed preoperative screening|0|||
163884479|NCT03366649|591947739|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
163884480|NCT03366649|591947740|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
163884481|NCT03366649|591947741|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
163884482|NCT04887129|591947744|FG000|Overall Study|Lost to Follow-up|0|||
163884483|NCT04887129|591947745|FG001|Overall Study|Lost to Follow-up|24|||
163884484|NCT04887129|591947744|FG000|Overall Study|Withdrawal by Subject|9|||
163884485|NCT04887129|591947745|FG001|Overall Study|Withdrawal by Subject|57|||
163884486|NCT04887129|591947744|FG000|Overall Study|Other|2|||
163884487|NCT04887129|591947745|FG001|Overall Study|Other|9|||
163884488|NCT04533347|591947746|FG000|Overall Study|Adverse Event|1|||
163884489|NCT04533347|591947747|FG001|Overall Study|Adverse Event|2|||
163884490|NCT04533347|591947746|FG000|Overall Study|Lost to Follow-up|2|||
163884491|NCT04533347|591947747|FG001|Overall Study|Lost to Follow-up|0|||
163884492|NCT04533347|591947746|FG000|Overall Study|Withdrawal by Subject|1|||
163884493|NCT04533347|591947747|FG001|Overall Study|Withdrawal by Subject|0|||
163884494|NCT05520190|591947748|FG000|Overall Study|Lost to Follow-up|7|||
163884495|NCT05520190|591947748|FG000|Overall Study|Withdrawal by Subject|2|||
163884496|NCT03476187|591947752|FG000|Overall Study|Protocol Violation|7|||
163884497|NCT03476187|591947752|FG000|Overall Study|Physician Decision|5|||
163884498|NCT03445988|591947753|FG000|Overall Study|Lost to Follow-up|14|||
163884499|NCT03445988|591947754|FG001|Overall Study|Lost to Follow-up|26|||
163884500|NCT03445988|591947755|FG002|Overall Study|Lost to Follow-up|27|||
163884501|NCT03445988|591947756|FG003|Overall Study|Lost to Follow-up|66|||
163884502|NCT03445988|591947753|FG000|Overall Study|Withdrawal by Subject|7|||
163884503|NCT03445988|591947754|FG001|Overall Study|Withdrawal by Subject|4|||
163884504|NCT03445988|591947755|FG002|Overall Study|Withdrawal by Subject|3|||
163884505|NCT03445988|591947756|FG003|Overall Study|Withdrawal by Subject|5|||
163884506|NCT03445988|591947753|FG000|Overall Study|Death (unrelated to study)|5|||
163884507|NCT03445988|591947754|FG001|Overall Study|Death (unrelated to study)|1|||
163884508|NCT03445988|591947755|FG002|Overall Study|Death (unrelated to study)|2|||
163884509|NCT03445988|591947756|FG003|Overall Study|Death (unrelated to study)|4|||
163884510|NCT02921230|591947757|FG000|Overall Study|Withdrawal by Subject|20|||
163884511|NCT02921230|591947758|FG001|Overall Study|Withdrawal by Subject|8|||
163884512|NCT02921230|591947757|FG000|Overall Study|Death|12|||
163884513|NCT02921230|591947758|FG001|Overall Study|Death|3|||
163884514|NCT02921230|591947757|FG000|Overall Study|Protocol Violation|17|||
163884515|NCT02921230|591947758|FG001|Overall Study|Protocol Violation|6|||
163884516|NCT02921230|591947757|FG000|Overall Study|Early completion|5|||
163884517|NCT02921230|591947758|FG001|Overall Study|Early completion|1|||
163884518|NCT02921230|591947757|FG000|Overall Study|Pending data entry|1|||
163884519|NCT02921230|591947758|FG001|Overall Study|Pending data entry|0|||
163884520|NCT04977947|591947759|FG000|Overall Study|Lost to Follow-up|1|||
163884521|NCT04977947|591947760|FG001|Overall Study|Lost to Follow-up|1|||
163884522|NCT05875142|591947761|FG000|Overall Study|Lost to Follow-up|0|||
163884523|NCT05875142|591947762|FG001|Overall Study|Lost to Follow-up|1|||
163988906|NCT00669617|592328204|FG000|Period 1|Withdrawal by Subject|0|||
163988907|NCT00669617|592328205|FG001|Period 1|Withdrawal by Subject|0|||
163988908|NCT00669617|592328206|FG002|Period 1|Withdrawal by Subject|1|||
163988909|NCT00669617|592328207|FG003|Period 1|Withdrawal by Subject|0|||
163988910|NCT00669617|592328208|FG004|Period 1|Withdrawal by Subject|0|||
163988911|NCT00669617|592328204|FG000|Period 1|Protocol Deviation|0|||
163988912|NCT00669617|592328205|FG001|Period 1|Protocol Deviation|0|||
163988913|NCT00669617|592328206|FG002|Period 1|Protocol Deviation|0|||
163988914|NCT00669617|592328207|FG003|Period 1|Protocol Deviation|0|||
163988915|NCT00669617|592328208|FG004|Period 1|Protocol Deviation|1|||
163988916|NCT00669617|592328204|FG000|Period 3|Lost to Follow-up|1|||
163988917|NCT00669617|592328205|FG001|Period 3|Lost to Follow-up|0|||
163988918|NCT00669617|592328206|FG002|Period 3|Lost to Follow-up|0|||
163988919|NCT00669617|592328207|FG003|Period 3|Lost to Follow-up|0|||
163988920|NCT00669617|592328208|FG004|Period 3|Lost to Follow-up|0|||
163988921|NCT03569202|592328213|FG000|Part 3|Physician Decision|1|||
163988922|NCT03569202|592328214|FG001|Part 3|Physician Decision|0|||
163988923|NCT03569202|592328213|FG000|Part 3|Other|1|||
163988924|NCT03569202|592328214|FG001|Part 3|Other|1|||
163988925|NCT00454779|592328215|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
163988926|NCT00454779|592328216|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
163988927|NCT00454779|592328215|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
163988928|NCT00454779|592328216|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
163988929|NCT00454779|592328215|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
163988930|NCT00454779|592328216|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
163988931|NCT00454779|592328215|FG000|First-line Treatment Phase|Protocol Violation|0|||
163988932|NCT00454779|592328216|FG001|First-line Treatment Phase|Protocol Violation|1|||
163988933|NCT00454779|592328215|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
163988934|NCT00454779|592328216|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
163988935|NCT00454779|592328215|FG000|First-line Treatment Phase|Ongoing|1|||
163988936|NCT00454779|592328216|FG001|First-line Treatment Phase|Ongoing|0|||
163988937|NCT00454779|592328215|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
163988938|NCT00454779|592328216|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
163988939|NCT00454779|592328215|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
163988940|NCT00454779|592328216|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
163988941|NCT00454779|592328215|FG000|Second-line Treatment Phase|Ongoing|0|||
163988942|NCT00454779|592328216|FG001|Second-line Treatment Phase|Ongoing|1|||
163988943|NCT00323557|592328218|FG000|Overall Study|Physician Decision|1|||
163988944|NCT00323557|592328219|FG001|Overall Study|Physician Decision|0|||
163988945|NCT00684515|592328220|FG000|Overall Study|Adverse Event|3|||
163988946|NCT00684515|592328221|FG001|Overall Study|Adverse Event|3|||
163988947|NCT00684515|592328222|FG002|Overall Study|Adverse Event|1|||
163988948|NCT00684515|592328220|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
163988949|NCT00684515|592328221|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
163988950|NCT00684515|592328222|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
163988951|NCT02450578|592328223|FG000|Overall Study|ECG abnormality so not treated|1|||
163988952|NCT02450578|592328224|FG001|Overall Study|ECG abnormality so not treated|0|||
163988953|NCT02450578|592328225|FG002|Overall Study|ECG abnormality so not treated|0|||
163988954|NCT02450578|592328226|FG003|Overall Study|ECG abnormality so not treated|0|||
163988955|NCT02167945|592328228|FG000|Overall Study|Adverse Event|16|||
163988956|NCT02167945|592328228|FG000|Overall Study|Withdrew Consent|42|||
163988957|NCT02167945|592328228|FG000|Overall Study|Lost to Follow-up|122|||
163988958|NCT02167945|592328228|FG000|Overall Study|COVID-19 logistical restrictions|6|||
163988959|NCT02167945|592328228|FG000|Overall Study|Other, not specified|63|||
164237937|NCT01978145|593244095|FG000|Treatment Period 2|Withdrawal by Subject|7|||
164237938|NCT01978145|593244096|FG001|Treatment Period 2|Withdrawal by Subject|4|||
164237939|NCT01978145|593244095|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
164237940|NCT01978145|593244096|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
164237941|NCT01173679|593244097|FG000|Overall Study|Death|1|||
163884524|NCT05875142|591947763|FG002|Overall Study|Lost to Follow-up|1|||
163884525|NCT03436290|591947764|FG000|Overall Study|Post-randomization Exclusion|1|||
163884526|NCT03436290|591947765|FG001|Overall Study|Post-randomization Exclusion|0|||
163884527|NCT03436290|591947764|FG000|Overall Study|Death|6|||
163884528|NCT03436290|591947765|FG001|Overall Study|Death|0|||
163884529|NCT03436290|591947764|FG000|Overall Study|Withdrawal by Subject|4|||
163884530|NCT03436290|591947765|FG001|Overall Study|Withdrawal by Subject|0|||
163884531|NCT03436290|591947764|FG000|Overall Study|Protocol Violation|30|||
163884532|NCT03436290|591947765|FG001|Overall Study|Protocol Violation|0|||
163884533|NCT04274764|591947773|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
163884534|NCT04274764|591947774|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
163884535|NCT03396926|591947777|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
163884536|NCT03396926|591947778|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
163884537|NCT01396278|591947779|FG000|Overall Study|Adverse Event|0|||
163884538|NCT01396278|591947780|FG001|Overall Study|Adverse Event|0|||
163884539|NCT01396278|591947781|FG002|Overall Study|Adverse Event|0|||
163884540|NCT01396278|591947782|FG003|Overall Study|Adverse Event|2|||
163884541|NCT01396278|591947783|FG004|Overall Study|Adverse Event|0|||
163884542|NCT01396278|591947779|FG000|Overall Study|Withdraw due to trial termination|2|||
163884543|NCT01396278|591947780|FG001|Overall Study|Withdraw due to trial termination|1|||
163884544|NCT01396278|591947781|FG002|Overall Study|Withdraw due to trial termination|1|||
163884545|NCT01396278|591947782|FG003|Overall Study|Withdraw due to trial termination|0|||
163884546|NCT01396278|591947783|FG004|Overall Study|Withdraw due to trial termination|2|||
163884547|NCT00450658|591947784|FG000|Overall Study|Adverse Event|24|||
163884548|NCT00450658|591947785|FG001|Overall Study|Adverse Event|15|||
163884549|NCT00450658|591947784|FG000|Overall Study|Withdrawal by Subject|43|||
163884550|NCT00450658|591947785|FG001|Overall Study|Withdrawal by Subject|26|||
163884551|NCT00450658|591947784|FG000|Overall Study|Lost to Follow-up|22|||
163884552|NCT00450658|591947785|FG001|Overall Study|Lost to Follow-up|5|||
163884553|NCT00450658|591947784|FG000|Overall Study|UGI ulcer|33|||
163884554|NCT00450658|591947785|FG001|Overall Study|UGI ulcer|34|||
163884555|NCT00450658|591947784|FG000|Overall Study|misc|21|||
163884556|NCT00450658|591947785|FG001|Overall Study|misc|10|||
163884557|NCT04727554|591947787|FG000|Overall Study|Lost to Follow-up|0|||
163884558|NCT04727554|591947788|FG001|Overall Study|Lost to Follow-up|1|||
163884559|NCT04727554|591947787|FG000|Overall Study|Death|2|||
163884560|NCT04727554|591947788|FG001|Overall Study|Death|6|||
163884561|NCT04727554|591947787|FG000|Overall Study|Withdrawal by Subject|1|||
163884562|NCT04727554|591947788|FG001|Overall Study|Withdrawal by Subject|0|||
163884563|NCT05763823|591947789|FG000|Overall Study|Death|6|||
163884564|NCT05763823|591947789|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163884565|NCT05763823|591947789|FG000|Overall Study|Withdrawal by Subject|6|||
163884566|NCT05659537|591947795|FG000|Overall Study|Adverse Event|5|||
163884567|NCT05659537|591947795|FG000|Overall Study|Lost to Follow-up|4|||
163884568|NCT05659537|591947795|FG000|Overall Study|Withdrawal by Subject|13|||
163884569|NCT05659537|591947795|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
163884570|NCT05659537|591947795|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
163884571|NCT05659537|591947795|FG000|Overall Study|Participant was suffering from anaemia|1|||
163884572|NCT04971395|591947796|FG000|Overall Study|Withdrawal by Subject|0|||
163884573|NCT04971395|591947797|FG001|Overall Study|Withdrawal by Subject|1|||
163884574|NCT04971395|591947798|FG002|Overall Study|Withdrawal by Subject|0|||
163884575|NCT04456517|591947799|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
163884576|NCT04456517|591947800|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
163884577|NCT00506519|591947807|FG000|Overall Study|Death|4|||
163884578|NCT00506519|591947808|FG001|Overall Study|Death|6|||
163884579|NCT00506519|591947809|FG002|Overall Study|Death|0|||
163884580|NCT00506519|591947807|FG000|Overall Study|Adverse Event|1|||
163884581|NCT00506519|591947808|FG001|Overall Study|Adverse Event|0|||
163884582|NCT00506519|591947809|FG002|Overall Study|Adverse Event|0|||
163884583|NCT01186367|591947810|FG000|Overall Study|Lost to Follow-up|7|||
163884584|NCT01186367|591947811|FG001|Overall Study|Lost to Follow-up|4|||
163884585|NCT01186367|591947812|FG002|Overall Study|Lost to Follow-up|7|||
163884586|NCT01186367|591947810|FG000|Overall Study|Did not receive study treatment|0|||
163884587|NCT01186367|591947811|FG001|Overall Study|Did not receive study treatment|1|||
163884588|NCT01186367|591947812|FG002|Overall Study|Did not receive study treatment|0|||
163884589|NCT02975882|591947813|FG000|Overall Study|Adverse Event|1|||
163884590|NCT02975882|591947814|FG001|Overall Study|Adverse Event|2|||
163884591|NCT02975882|591947815|FG002|Overall Study|Adverse Event|1|||
163884592|NCT02975882|591947816|FG003|Overall Study|Adverse Event|1|||
163884593|NCT02975882|591947813|FG000|Overall Study|Death|0|||
163988960|NCT00132730|592328229|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
163988961|NCT00132730|592328230|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
163988962|NCT00132730|592328231|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
163988963|NCT00132730|592328232|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
163988964|NCT00132730|592328233|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
163988965|NCT00132730|592328234|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
163988966|NCT00132730|592328229|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
163988967|NCT00132730|592328230|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
163988968|NCT00132730|592328231|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163988969|NCT00132730|592328232|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163988970|NCT00132730|592328233|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163988971|NCT00132730|592328234|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
163988972|NCT00132730|592328229|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
163988973|NCT00132730|592328230|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
163988974|NCT00132730|592328231|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
163988975|NCT00132730|592328232|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
163988976|NCT00132730|592328233|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
163988977|NCT00132730|592328234|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
163988978|NCT00132730|592328229|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163988979|NCT00132730|592328230|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163988980|NCT00132730|592328231|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
163988981|NCT00132730|592328232|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
163988982|NCT00132730|592328233|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163988983|NCT00132730|592328234|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
163988984|NCT00132730|592328229|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163988985|NCT00132730|592328230|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163988986|NCT00132730|592328231|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
163988987|NCT00132730|592328232|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
163988988|NCT00132730|592328233|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163988989|NCT00132730|592328234|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
163988990|NCT00132730|592328229|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163988991|NCT00132730|592328230|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163988992|NCT00132730|592328231|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163988993|NCT00132730|592328232|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
164335475|NCT02699697|593605977|FG000|Overall Study|Lost to Follow-up|2|||
164335476|NCT02699697|593605978|FG001|Overall Study|Lost to Follow-up|3|||
164335477|NCT02699697|593605977|FG000|Overall Study|Refused to follow up|1|||
163988994|NCT00132730|592328233|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163988995|NCT00132730|592328234|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
163988996|NCT00132730|592328229|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163988997|NCT00132730|592328230|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163988998|NCT00132730|592328231|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
163988999|NCT00132730|592328232|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
163989000|NCT00132730|592328233|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
164335478|NCT02699697|593605978|FG001|Overall Study|Refused to follow up|1|||
164335479|NCT02699697|593605977|FG000|Overall Study|Entered hospice care|5|||
163989001|NCT00132730|592328234|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
163989002|NCT00132730|592328229|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163989003|NCT00132730|592328230|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
164335480|NCT02699697|593605978|FG001|Overall Study|Entered hospice care|2|||
164335481|NCT02699697|593605977|FG000|Overall Study|Missing reason for discontinuation|6|||
164335482|NCT02699697|593605978|FG001|Overall Study|Missing reason for discontinuation|5|||
164335483|NCT02362035|593605979|FG000|Overall Study|Death|67|||
164335484|NCT02362035|593605979|FG000|Overall Study|Lost to Follow-up|3|||
164335485|NCT02362035|593605979|FG000|Overall Study|Adverse Event|1|||
164335486|NCT02362035|593605979|FG000|Overall Study|Physician Decision|1|||
164335487|NCT02362035|593605979|FG000|Overall Study|Subject started another cancer therapy|10|||
164335488|NCT02362035|593605979|FG000|Overall Study|Study terminated by sponsor|45|||
164335489|NCT02362035|593605979|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
164335490|NCT02362035|593605979|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
164335491|NCT02362035|593605979|FG000|Overall Study|Disease progression|11|||
164335492|NCT02362035|593605979|FG000|Overall Study|Withdrawal by Subject|20|||
164335493|NCT00004635|593605980|FG000|Period One|refused|2|||
164335494|NCT00004635|593605981|FG001|Period One|refused|1|||
164335495|NCT00004635|593605980|FG000|Period One|Withdrawal by Subject|1|||
164335496|NCT00004635|593605981|FG001|Period One|Withdrawal by Subject|1|||
163989004|NCT00132730|592328231|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163989005|NCT00132730|592328232|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
163989006|NCT00132730|592328233|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
163989007|NCT00132730|592328234|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
163989008|NCT00132730|592328229|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163989009|NCT00132730|592328230|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163989010|NCT00132730|592328231|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163989011|NCT00132730|592328232|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163989012|NCT00132730|592328233|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
163989013|NCT00132730|592328234|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
163989014|NCT00132730|592328229|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163989015|NCT00132730|592328230|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163989016|NCT00132730|592328231|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163989017|NCT00132730|592328232|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163989018|NCT00132730|592328233|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
163989019|NCT00132730|592328234|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
163989020|NCT00132730|592328229|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163989021|NCT00132730|592328230|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163989022|NCT00132730|592328231|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163989023|NCT00132730|592328232|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
163989024|NCT00132730|592328233|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
163989025|NCT00132730|592328234|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
164335497|NCT00004635|593605980|FG000|Period One|Protocol Violation|1|||
164335498|NCT00004635|593605981|FG001|Period One|Protocol Violation|0|||
164335499|NCT00004635|593605980|FG000|Period One|PSA did not go <5 ng/mL|1|||
164335500|NCT00004635|593605981|FG001|Period One|PSA did not go <5 ng/mL|0|||
164335501|NCT00004635|593605980|FG000|Period One|second malignancy|1|||
164335502|NCT00004635|593605981|FG001|Period One|second malignancy|0|||
164335503|NCT00004635|593605980|FG000|Period One|progressed|0|||
164335504|NCT00004635|593605981|FG001|Period One|progressed|2|||
164335505|NCT00004635|593605980|FG000|Period One|health problem|0|||
164335506|NCT00004635|593605981|FG001|Period One|health problem|1|||
164335507|NCT00004635|593605980|FG000|Period One|discrepancy in data entry|0|||
164335508|NCT00004635|593605981|FG001|Period One|discrepancy in data entry|1|||
164335509|NCT00004635|593605980|FG000|Period Two|progression|2|||
164335510|NCT00004635|593605981|FG001|Period Two|progression|3|||
164335511|NCT00004635|593605980|FG000|Period Two|Adverse Event|1|||
164335512|NCT00004635|593605981|FG001|Period Two|Adverse Event|0|||
164335513|NCT00004635|593605980|FG000|Period Two|refused|0|||
164335514|NCT00004635|593605981|FG001|Period Two|refused|2|||
164335515|NCT00004635|593605980|FG000|Period Two|health problem|1|||
164335516|NCT00004635|593605981|FG001|Period Two|health problem|1|||
164335517|NCT00004635|593605980|FG000|Period Two|travel issues|0|||
164335518|NCT00004635|593605981|FG001|Period Two|travel issues|1|||
164335519|NCT00004635|593605980|FG000|Period Two|secondary malignancy|1|||
164335520|NCT00004635|593605981|FG001|Period Two|secondary malignancy|1|||
164335521|NCT00004635|593605980|FG000|Period Two|Lost to Follow-up|1|||
164335522|NCT00004635|593605981|FG001|Period Two|Lost to Follow-up|0|||
164335523|NCT00004635|593605980|FG000|Period Two|discrepancy in data entry|0|||
164335524|NCT00004635|593605981|FG001|Period Two|discrepancy in data entry|1|||
164335525|NCT00354614|593605982|FG000|Overall Study|Lack of Efficacy|28|||
164335526|NCT00191906|593605983|FG000|Study Period II|Adverse Event|0|||
164335527|NCT00191906|593605984|FG001|Study Period II|Adverse Event|1|||
164335528|NCT00191906|593605985|FG002|Study Period II|Adverse Event|0|||
164335529|NCT00191906|593605986|FG003|Study Period II|Adverse Event|0|||
164335530|NCT00191906|593605983|FG000|Study Period II|Withdrawal by Subject|0|||
164335531|NCT00191906|593605984|FG001|Study Period II|Withdrawal by Subject|3|||
164335532|NCT00191906|593605985|FG002|Study Period II|Withdrawal by Subject|0|||
164335533|NCT00191906|593605986|FG003|Study Period II|Withdrawal by Subject|0|||
164335534|NCT00191906|593605983|FG000|Study Period II|Parent/Caregiver Decision|0|||
163989026|NCT00132730|592328229|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
164335535|NCT00191906|593605984|FG001|Study Period II|Parent/Caregiver Decision|1|||
164335536|NCT00191906|593605985|FG002|Study Period II|Parent/Caregiver Decision|0|||
164335537|NCT00191906|593605986|FG003|Study Period II|Parent/Caregiver Decision|0|||
164335538|NCT00191906|593605983|FG000|Study Period II|Entry Criteria Exclusion|0|||
164335539|NCT00191906|593605984|FG001|Study Period II|Entry Criteria Exclusion|0|||
164335540|NCT00191906|593605985|FG002|Study Period II|Entry Criteria Exclusion|1|||
164335541|NCT00191906|593605986|FG003|Study Period II|Entry Criteria Exclusion|0|||
164335542|NCT00191906|593605983|FG000|Study Period III|Adverse Event|1|||
164335543|NCT00191906|593605984|FG001|Study Period III|Adverse Event|0|||
163989027|NCT00132730|592328230|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
164237942|NCT01250054|593244098|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
164237943|NCT01250054|593244099|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
164237944|NCT02026011|593244100|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
163989028|NCT00132730|592328231|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
163989029|NCT00132730|592328232|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
163989030|NCT00132730|592328233|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
163989031|NCT00132730|592328234|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
163989032|NCT00094757|592328235|FG000|Overall Study|Adverse Event|11|||
163989033|NCT00094757|592328236|FG001|Overall Study|Adverse Event|9|||
163989034|NCT00094757|592328237|FG002|Overall Study|Adverse Event|6|||
163989035|NCT00094757|592328235|FG000|Overall Study|Lack of Efficacy|11|||
163989036|NCT00094757|592328236|FG001|Overall Study|Lack of Efficacy|15|||
163989037|NCT00094757|592328237|FG002|Overall Study|Lack of Efficacy|8|||
163989038|NCT00094757|592328235|FG000|Overall Study|Lost to Follow-up|3|||
163989039|NCT00094757|592328236|FG001|Overall Study|Lost to Follow-up|5|||
163989040|NCT00094757|592328237|FG002|Overall Study|Lost to Follow-up|6|||
164237945|NCT02026011|593244101|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
164237946|NCT02026011|593244100|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
164237947|NCT02026011|593244101|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
164237948|NCT02026011|593244100|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
164237949|NCT02026011|593244101|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
164237950|NCT02026011|593244100|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
163989041|NCT00094757|592328235|FG000|Overall Study|Patient Moved|2|||
163989042|NCT00094757|592328236|FG001|Overall Study|Patient Moved|1|||
163989043|NCT00094757|592328237|FG002|Overall Study|Patient Moved|1|||
163989044|NCT00094757|592328235|FG000|Overall Study|Protocol Violation|8|||
163989045|NCT00094757|592328236|FG001|Overall Study|Protocol Violation|5|||
163989046|NCT00094757|592328237|FG002|Overall Study|Protocol Violation|3|||
163989047|NCT00094757|592328235|FG000|Overall Study|Withdrawal by Subject|14|||
163989048|NCT00094757|592328236|FG001|Overall Study|Withdrawal by Subject|21|||
163989049|NCT00094757|592328237|FG002|Overall Study|Withdrawal by Subject|5|||
163989050|NCT00094757|592328235|FG000|Overall Study|Other|3|||
163989051|NCT00094757|592328236|FG001|Overall Study|Other|3|||
163989052|NCT00094757|592328237|FG002|Overall Study|Other|1|||
163989053|NCT00094757|592328235|FG000|Overall Study|Protocol specified discontinuation|1|||
163989054|NCT00094757|592328236|FG001|Overall Study|Protocol specified discontinuation|3|||
163989055|NCT00094757|592328237|FG002|Overall Study|Protocol specified discontinuation|0|||
163989056|NCT02623335|592328238|FG000|Overall Study|Death|8|||
163989057|NCT02623335|592328239|FG001|Overall Study|Death|7|||
163989058|NCT02623335|592328238|FG000|Overall Study|Lost to Follow-up|15|||
163989059|NCT02623335|592328239|FG001|Overall Study|Lost to Follow-up|23|||
163989060|NCT02623335|592328238|FG000|Overall Study|Withdrawal by Subject|2|||
163989061|NCT02623335|592328239|FG001|Overall Study|Withdrawal by Subject|5|||
163989062|NCT02623335|592328238|FG000|Overall Study|Protocol Violation|2|||
163989063|NCT02623335|592328239|FG001|Overall Study|Protocol Violation|1|||
163989064|NCT01463098|592328240|FG000|Part A (11 Days)|Participant Choice|2|||
163989065|NCT01463098|592328241|FG001|Part A (11 Days)|Participant Choice|0|||
163989066|NCT01463098|592328242|FG002|Part A (11 Days)|Participant Choice|0|||
163989067|NCT01463098|592328243|FG003|Part A (11 Days)|Participant Choice|0|||
163989068|NCT01463098|592328244|FG004|Part A (11 Days)|Participant Choice|0|||
163989069|NCT01463098|592328245|FG005|Part A (11 Days)|Participant Choice|0|||
163989070|NCT01463098|592328246|FG006|Part A (11 Days)|Participant Choice|0|||
164237951|NCT02026011|593244101|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
164237952|NCT01770743|593244102|FG000|Overall Study|Adverse Event|1|||
164237953|NCT01770743|593244103|FG001|Overall Study|Adverse Event|0|||
163989071|NCT01463098|592328247|FG007|Part A (11 Days)|Participant Choice|0|||
164335544|NCT00191906|593605985|FG002|Study Period III|Adverse Event|0|||
164335545|NCT00191906|593605986|FG003|Study Period III|Adverse Event|0|||
164335546|NCT00191906|593605983|FG000|Study Period III|Lost to Follow-up|0|||
164335547|NCT00191906|593605984|FG001|Study Period III|Lost to Follow-up|1|||
164335548|NCT00191906|593605985|FG002|Study Period III|Lost to Follow-up|0|||
164335549|NCT00191906|593605986|FG003|Study Period III|Lost to Follow-up|0|||
164335550|NCT00191906|593605983|FG000|Study Period III|Parent/Caregiver Decision|1|||
164335551|NCT00191906|593605984|FG001|Study Period III|Parent/Caregiver Decision|0|||
164335552|NCT00191906|593605985|FG002|Study Period III|Parent/Caregiver Decision|0|||
164335553|NCT00191906|593605986|FG003|Study Period III|Parent/Caregiver Decision|0|||
164335554|NCT00191906|593605983|FG000|Study Period III|Lack of Efficacy|3|||
164335555|NCT00191906|593605984|FG001|Study Period III|Lack of Efficacy|3|||
164335556|NCT00191906|593605985|FG002|Study Period III|Lack of Efficacy|0|||
164335557|NCT00191906|593605986|FG003|Study Period III|Lack of Efficacy|0|||
164335558|NCT00573937|593605987|FG000|Overall Study|Study Terminated|0|||
164335559|NCT00573937|593605988|FG001|Overall Study|Study Terminated|1|||
164335560|NCT01797731|593605994|FG000|Overall Study|Didn't have proper radiographs required|3|||
164335561|NCT01797731|593605995|FG001|Overall Study|Didn't have proper radiographs required|3|||
164335562|NCT01604408|593605996|FG000|Treatment Period 1|Protocol Violation|0|||
164335563|NCT01604408|593605997|FG001|Treatment Period 1|Protocol Violation|1|||
164335564|NCT01604408|593605996|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164335565|NCT01604408|593605997|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164335566|NCT01604408|593605996|FG000|Treatment Period 2|Protocol Violation|1|||
164335567|NCT01604408|593605997|FG001|Treatment Period 2|Protocol Violation|0|||
164335568|NCT01604408|593605996|FG000|Treatment Period 2|Adverse Event|0|||
164335569|NCT01604408|593605997|FG001|Treatment Period 2|Adverse Event|1|||
164335570|NCT01604408|593605996|FG000|Treatment Period 3|Protocol Violation|1|||
164335571|NCT01604408|593605997|FG001|Treatment Period 3|Protocol Violation|1|||
164335572|NCT01604408|593605996|FG000|Treatment Period 3|Adverse Event|0|||
164335573|NCT01604408|593605997|FG001|Treatment Period 3|Adverse Event|3|||
164335574|NCT01604408|593605996|FG000|Treatment Period 3|Withdrawal by Subject|3|||
164335575|NCT01604408|593605997|FG001|Treatment Period 3|Withdrawal by Subject|1|||
164335576|NCT01604408|593605996|FG000|Treatment Period 3|Sponsor Decision|1|||
164335577|NCT01604408|593605997|FG001|Treatment Period 3|Sponsor Decision|0|||
164335578|NCT01604408|593605996|FG000|Treatment Period 4|Death|1|||
164335579|NCT01604408|593605997|FG001|Treatment Period 4|Death|0|||
164335580|NCT01604408|593605996|FG000|Treatment Period 4|Withdrawal by Subject|2|||
164335581|NCT01604408|593605997|FG001|Treatment Period 4|Withdrawal by Subject|1|||
164335582|NCT01604408|593605996|FG000|Treatment Period 4|Adverse Event|0|||
164335583|NCT01604408|593605997|FG001|Treatment Period 4|Adverse Event|1|||
164335584|NCT01604408|593605996|FG000|Treatment Period 5|Adverse Event|4|||
164335585|NCT01604408|593605997|FG001|Treatment Period 5|Adverse Event|0|||
164335586|NCT01604408|593605996|FG000|Treatment Period 6|Lost to Follow-up|0|||
164335587|NCT01604408|593605997|FG001|Treatment Period 6|Lost to Follow-up|1|||
164335588|NCT01604408|593605996|FG000|Treatment Period 6|Adverse Event|2|||
164335589|NCT01604408|593605997|FG001|Treatment Period 6|Adverse Event|0|||
164335590|NCT01604408|593605996|FG000|Treatment Period 6|Sponsor decision|0|||
164335591|NCT01604408|593605997|FG001|Treatment Period 6|Sponsor decision|1|||
164335592|NCT01604408|593605996|FG000|Observation Period|Adverse Event|1|||
164335593|NCT01604408|593605997|FG001|Observation Period|Adverse Event|1|||
164335594|NCT01604408|593605996|FG000|Observation Period|Withdrawal by Subject|0|||
164335595|NCT01604408|593605997|FG001|Observation Period|Withdrawal by Subject|2|||
164335596|NCT00722423|593606003|FG000|Overall Study|Protocol Violation|0|||
164335597|NCT00722423|593606004|FG001|Overall Study|Protocol Violation|1|||
164335598|NCT01189604|593606006|FG000|Overall Study|Impossible to visit|0|||
164335599|NCT01189604|593606007|FG001|Overall Study|Impossible to visit|0|||
164335600|NCT01189604|593606008|FG002|Overall Study|Impossible to visit|0|||
164335601|NCT01189604|593606009|FG003|Overall Study|Impossible to visit|0|||
164335602|NCT01189604|593606010|FG004|Overall Study|Impossible to visit|0|||
164335603|NCT01189604|593606011|FG005|Overall Study|Impossible to visit|1|||
164335604|NCT01189604|593606012|FG006|Overall Study|Impossible to visit|0|||
164335605|NCT01189604|593606006|FG000|Overall Study|Adverse Event|0|||
164335606|NCT01189604|593606007|FG001|Overall Study|Adverse Event|1|||
164335607|NCT01189604|593606008|FG002|Overall Study|Adverse Event|0|||
164335608|NCT01189604|593606009|FG003|Overall Study|Adverse Event|0|||
164335609|NCT01189604|593606010|FG004|Overall Study|Adverse Event|2|||
164335610|NCT01189604|593606011|FG005|Overall Study|Adverse Event|0|||
164335611|NCT01189604|593606012|FG006|Overall Study|Adverse Event|1|||
164335612|NCT01189604|593606006|FG000|Overall Study|Withdrawal by Subject|1|||
164335613|NCT01189604|593606007|FG001|Overall Study|Withdrawal by Subject|0|||
164335614|NCT01189604|593606008|FG002|Overall Study|Withdrawal by Subject|0|||
164335615|NCT01189604|593606009|FG003|Overall Study|Withdrawal by Subject|0|||
164335616|NCT01189604|593606010|FG004|Overall Study|Withdrawal by Subject|0|||
164335617|NCT01189604|593606011|FG005|Overall Study|Withdrawal by Subject|0|||
164237954|NCT01770743|593244104|FG002|Overall Study|Adverse Event|0|||
164237955|NCT01770743|593244105|FG003|Overall Study|Adverse Event|0|||
164237956|NCT01770743|593244106|FG004|Overall Study|Adverse Event|0|||
164237957|NCT01770743|593244102|FG000|Overall Study|Withdrawal by Subject|0|||
164237958|NCT01770743|593244103|FG001|Overall Study|Withdrawal by Subject|0|||
164237959|NCT01770743|593244104|FG002|Overall Study|Withdrawal by Subject|1|||
164237960|NCT01770743|593244105|FG003|Overall Study|Withdrawal by Subject|1|||
164237961|NCT01770743|593244106|FG004|Overall Study|Withdrawal by Subject|1|||
164237962|NCT01770743|593244102|FG000|Overall Study|Lost to Follow-up|0|||
164237963|NCT01770743|593244103|FG001|Overall Study|Lost to Follow-up|2|||
164237964|NCT01770743|593244104|FG002|Overall Study|Lost to Follow-up|0|||
164237965|NCT01770743|593244105|FG003|Overall Study|Lost to Follow-up|0|||
164237966|NCT01770743|593244106|FG004|Overall Study|Lost to Follow-up|1|||
164237967|NCT01770743|593244102|FG000|Overall Study|Sponsor Terminated Subject|1|||
164237968|NCT01770743|593244103|FG001|Overall Study|Sponsor Terminated Subject|0|||
164237969|NCT01770743|593244104|FG002|Overall Study|Sponsor Terminated Subject|0|||
164237970|NCT01770743|593244105|FG003|Overall Study|Sponsor Terminated Subject|1|||
164237971|NCT01770743|593244106|FG004|Overall Study|Sponsor Terminated Subject|0|||
164237972|NCT01770743|593244102|FG000|Overall Study|Moving Out of State|0|||
164237973|NCT01770743|593244103|FG001|Overall Study|Moving Out of State|1|||
164237974|NCT01770743|593244104|FG002|Overall Study|Moving Out of State|0|||
164237975|NCT01770743|593244105|FG003|Overall Study|Moving Out of State|0|||
163884594|NCT02975882|591947814|FG001|Overall Study|Death|1|||
164237976|NCT01770743|593244106|FG004|Overall Study|Moving Out of State|0|||
164237977|NCT00755807|593244111|FG000|Acute Phase|Adverse Event|16|||
164237978|NCT00755807|593244112|FG001|Acute Phase|Adverse Event|5|||
164237979|NCT00755807|593244111|FG000|Acute Phase|Protocol Violation|1|||
164237980|NCT00755807|593244112|FG001|Acute Phase|Protocol Violation|3|||
164237981|NCT00755807|593244111|FG000|Acute Phase|Withdrawal by Subject|1|||
164237982|NCT00755807|593244112|FG001|Acute Phase|Withdrawal by Subject|2|||
164335618|NCT01189604|593606012|FG006|Overall Study|Withdrawal by Subject|0|||
164335619|NCT03945214|593606013|FG000|Overall Study|Lost to Follow-up|3|||
164335620|NCT03945214|593606014|FG001|Overall Study|Lost to Follow-up|4|||
164335621|NCT03945214|593606015|FG002|Overall Study|Lost to Follow-up|7|||
164335622|NCT03945214|593606016|FG003|Overall Study|Lost to Follow-up|4|||
164335623|NCT04102098|593606022|FG000|Main Study Period|Ongoing in study|302|||
164335624|NCT04102098|593606023|FG001|Main Study Period|Ongoing in study|291|||
164335625|NCT04102098|593606022|FG000|Main Study Period|Death|20|||
164335626|NCT04102098|593606023|FG001|Main Study Period|Death|27|||
164335627|NCT04102098|593606022|FG000|Main Study Period|Lost to Follow-up|1|||
164335628|NCT04102098|593606023|FG001|Main Study Period|Lost to Follow-up|1|||
164335629|NCT04102098|593606022|FG000|Main Study Period|Physician Decision|0|||
164335630|NCT04102098|593606023|FG001|Main Study Period|Physician Decision|1|||
164335631|NCT04102098|593606022|FG000|Main Study Period|Withdrawal by Subject|11|||
164335632|NCT04102098|593606023|FG001|Main Study Period|Withdrawal by Subject|14|||
164335633|NCT04102098|593606022|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
164335634|NCT04102098|593606023|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
164335635|NCT04102098|593606022|FG000|Crossover: AS Who Crossed Over|Death|11|||
164335636|NCT04102098|593606023|FG001|Crossover: AS Who Crossed Over|Death|0|||
163884595|NCT02975882|591947815|FG002|Overall Study|Death|0|||
163884596|NCT02975882|591947816|FG003|Overall Study|Death|0|||
163884597|NCT02975882|591947813|FG000|Overall Study|Lack of Efficacy|3|||
163884598|NCT02975882|591947814|FG001|Overall Study|Lack of Efficacy|7|||
163884599|NCT02975882|591947815|FG002|Overall Study|Lack of Efficacy|4|||
163884600|NCT02975882|591947816|FG003|Overall Study|Lack of Efficacy|3|||
163884601|NCT02975882|591947813|FG000|Overall Study|Physician Decision|0|||
163884602|NCT02975882|591947814|FG001|Overall Study|Physician Decision|2|||
163884603|NCT02975882|591947815|FG002|Overall Study|Physician Decision|4|||
163884604|NCT02975882|591947816|FG003|Overall Study|Physician Decision|2|||
163884605|NCT02975882|591947813|FG000|Overall Study|Ineligible|0|||
163884606|NCT02975882|591947814|FG001|Overall Study|Ineligible|1|||
163884607|NCT02975882|591947815|FG002|Overall Study|Ineligible|0|||
163884608|NCT02975882|591947816|FG003|Overall Study|Ineligible|0|||
163884609|NCT05116787|591947817|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
163884610|NCT05116787|591947818|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
163884611|NCT05116787|591947817|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
163884612|NCT05116787|591947818|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
163884613|NCT05116787|591947817|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
163884614|NCT05116787|591947818|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
163884615|NCT05116787|591947817|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
163884616|NCT05116787|591947818|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
163884617|NCT03158129|591947820|FG000|Overall Study|Adverse Event|0|||
163884618|NCT03158129|591947821|FG001|Overall Study|Adverse Event|1|||
163884619|NCT03158129|591947822|FG002|Overall Study|Adverse Event|0|||
163884620|NCT03158129|591947823|FG003|Overall Study|Adverse Event|0|||
163884621|NCT03158129|591947820|FG000|Overall Study|Death|0|||
163884622|NCT03158129|591947821|FG001|Overall Study|Death|0|||
163884623|NCT03158129|591947822|FG002|Overall Study|Death|0|||
164237983|NCT00755807|593244111|FG000|Acute Phase|Lack of Efficacy|0|||
164237984|NCT00755807|593244112|FG001|Acute Phase|Lack of Efficacy|1|||
164237985|NCT00755807|593244111|FG000|Acute Phase|Physician Decision|0|||
164237986|NCT00755807|593244112|FG001|Acute Phase|Physician Decision|1|||
164237987|NCT00755807|593244111|FG000|Open-label Extension Phase|Adverse Event|7|||
164237988|NCT00755807|593244112|FG001|Open-label Extension Phase|Adverse Event|7|||
164237989|NCT00755807|593244111|FG000|Open-label Extension Phase|Protocol Violation|5|||
164237990|NCT00755807|593244112|FG001|Open-label Extension Phase|Protocol Violation|2|||
164237991|NCT00755807|593244111|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
164237992|NCT00755807|593244112|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
164237993|NCT00755807|593244111|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
164237994|NCT00755807|593244112|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
164237995|NCT00755807|593244111|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
164237996|NCT00755807|593244112|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
164237997|NCT00755807|593244111|FG000|Open-label Extension Phase|Sponsor Decision|0|||
164237998|NCT00755807|593244112|FG001|Open-label Extension Phase|Sponsor Decision|1|||
164237999|NCT00939107|593244113|FG000|Overall Study|Lost to Follow-up|14|||
164238000|NCT00939107|593244114|FG001|Overall Study|Lost to Follow-up|12|||
164238001|NCT05010070|593244115|FG000|Overall Study|Lost to Follow-up|1|||
164238002|NCT05010070|593244115|FG000|Overall Study|Withdrawal by Subject|1|||
163989072|NCT01463098|592328248|FG008|Part A (11 Days)|Participant Choice|1|||
163989073|NCT01463098|592328249|FG009|Part A (11 Days)|Participant Choice|0|||
163989074|NCT01463098|592328250|FG010|Part A (11 Days)|Participant Choice|0|||
163989075|NCT01463098|592328251|FG011|Part A (11 Days)|Participant Choice|0|||
163989076|NCT01463098|592328252|FG012|Part A (11 Days)|Participant Choice|0|||
163989077|NCT01463098|592328253|FG013|Part A (11 Days)|Participant Choice|0|||
163989078|NCT01463098|592328240|FG000|Part A (11 Days)|Lost to Follow-up|0|||
163989079|NCT01463098|592328241|FG001|Part A (11 Days)|Lost to Follow-up|0|||
163989080|NCT01463098|592328242|FG002|Part A (11 Days)|Lost to Follow-up|0|||
163989081|NCT01463098|592328243|FG003|Part A (11 Days)|Lost to Follow-up|0|||
163989082|NCT01463098|592328244|FG004|Part A (11 Days)|Lost to Follow-up|1|||
163989083|NCT01463098|592328245|FG005|Part A (11 Days)|Lost to Follow-up|0|||
163989084|NCT01463098|592328246|FG006|Part A (11 Days)|Lost to Follow-up|0|||
163989085|NCT01463098|592328247|FG007|Part A (11 Days)|Lost to Follow-up|0|||
163989086|NCT01463098|592328248|FG008|Part A (11 Days)|Lost to Follow-up|0|||
163989087|NCT01463098|592328249|FG009|Part A (11 Days)|Lost to Follow-up|0|||
163989088|NCT01463098|592328250|FG010|Part A (11 Days)|Lost to Follow-up|0|||
163989089|NCT01463098|592328251|FG011|Part A (11 Days)|Lost to Follow-up|0|||
163989090|NCT01463098|592328252|FG012|Part A (11 Days)|Lost to Follow-up|0|||
163989091|NCT01463098|592328253|FG013|Part A (11 Days)|Lost to Follow-up|0|||
163989092|NCT01463098|592328240|FG000|Part B (11 Days)|Participant Choice|0|||
163989093|NCT01463098|592328241|FG001|Part B (11 Days)|Participant Choice|0|||
163989094|NCT01463098|592328242|FG002|Part B (11 Days)|Participant Choice|0|||
163989095|NCT01463098|592328243|FG003|Part B (11 Days)|Participant Choice|0|||
163989096|NCT01463098|592328244|FG004|Part B (11 Days)|Participant Choice|0|||
163989097|NCT01463098|592328245|FG005|Part B (11 Days)|Participant Choice|0|||
163989098|NCT01463098|592328246|FG006|Part B (11 Days)|Participant Choice|0|||
163989099|NCT01463098|592328247|FG007|Part B (11 Days)|Participant Choice|0|||
163989100|NCT01463098|592328248|FG008|Part B (11 Days)|Participant Choice|0|||
163989101|NCT01463098|592328249|FG009|Part B (11 Days)|Participant Choice|0|||
163989102|NCT01463098|592328250|FG010|Part B (11 Days)|Participant Choice|0|||
163989103|NCT01463098|592328251|FG011|Part B (11 Days)|Participant Choice|1|||
163989104|NCT01463098|592328252|FG012|Part B (11 Days)|Participant Choice|0|||
163989105|NCT01463098|592328253|FG013|Part B (11 Days)|Participant Choice|0|||
163989106|NCT00395967|592328254|FG000|Treatment Period|Failed Mobilization|1|||
163989107|NCT00395967|592328254|FG000|Follow-up Period|Death|1|||
163989108|NCT00395967|592328254|FG000|Follow-up Period|Lost to Follow-up|1|||
163989109|NCT01528787|592328255|FG000|Overall Study|Withdrawal by Subject|0|||
164238003|NCT01585025|593244122|FG000|Overall Study|Withdrawal by Subject|0|||
164238004|NCT01585025|593244123|FG001|Overall Study|Withdrawal by Subject|3|||
164238005|NCT01585025|593244124|FG002|Overall Study|Withdrawal by Subject|4|||
164238006|NCT00503984|593244125|FG000|Overall Study|Protocol Violation|0|||
164238007|NCT00503984|593244126|FG001|Overall Study|Protocol Violation|1|||
164238008|NCT00503984|593244127|FG002|Overall Study|Protocol Violation|0|||
164238009|NCT00503984|593244128|FG003|Overall Study|Protocol Violation|0|||
164238010|NCT00503984|593244129|FG004|Overall Study|Protocol Violation|0|||
164238011|NCT00503984|593244130|FG005|Overall Study|Protocol Violation|0|||
164238012|NCT00503984|593244125|FG000|Overall Study|Adverse Event|0|||
164238013|NCT00503984|593244126|FG001|Overall Study|Adverse Event|1|||
164238014|NCT00503984|593244127|FG002|Overall Study|Adverse Event|0|||
164238015|NCT00503984|593244128|FG003|Overall Study|Adverse Event|0|||
164238016|NCT00503984|593244129|FG004|Overall Study|Adverse Event|0|||
164238017|NCT00503984|593244130|FG005|Overall Study|Adverse Event|0|||
164238018|NCT00503984|593244125|FG000|Overall Study|Death|0|||
164238019|NCT00503984|593244126|FG001|Overall Study|Death|0|||
164238020|NCT00503984|593244127|FG002|Overall Study|Death|0|||
164238021|NCT00503984|593244128|FG003|Overall Study|Death|0|||
164238022|NCT00503984|593244129|FG004|Overall Study|Death|1|||
164238023|NCT00503984|593244130|FG005|Overall Study|Death|0|||
164238024|NCT02122380|593244133|FG000|First Intervention (30 Days)|Adverse Event|1|||
164238025|NCT02122380|593244134|FG001|First Intervention (30 Days)|Adverse Event|0|||
164238026|NCT02122380|593244133|FG000|First Intervention (30 Days)|Physician Decision|0|||
164238027|NCT02122380|593244134|FG001|First Intervention (30 Days)|Physician Decision|1|||
164238028|NCT02122380|593244133|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
164238029|NCT02122380|593244134|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
164238030|NCT02122380|593244133|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
164238031|NCT02122380|593244134|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
164238032|NCT02122380|593244133|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
164238033|NCT02122380|593244134|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
164238034|NCT00441272|593244136|FG000|Overall Study|Study terminated prior to enrollment|25|||
164238035|NCT00441272|593244137|FG001|Overall Study|Study terminated prior to enrollment|25|||
164238036|NCT00427011|593244138|FG000|Overall Study|Adverse Event|10|||
164238037|NCT00427011|593244138|FG000|Overall Study|Withdrawal by Subject|1|||
164238038|NCT00427011|593244138|FG000|Overall Study|Lack of Efficacy|2|||
164238039|NCT00427011|593244138|FG000|Overall Study|Other|12|||
164238040|NCT00952705|593244139|FG000|Overall Study|Lost to Follow-up|24|||
164238041|NCT00952705|593244140|FG001|Overall Study|Lost to Follow-up|8|||
164238042|NCT00952705|593244141|FG002|Overall Study|Lost to Follow-up|9|||
164238043|NCT00952705|593244139|FG000|Overall Study|Withdrawal by Subject|2|||
164238044|NCT00952705|593244140|FG001|Overall Study|Withdrawal by Subject|1|||
164238045|NCT00952705|593244141|FG002|Overall Study|Withdrawal by Subject|1|||
164238046|NCT00952705|593244139|FG000|Overall Study|Death|2|||
164238047|NCT00952705|593244140|FG001|Overall Study|Death|0|||
164238048|NCT00952705|593244141|FG002|Overall Study|Death|0|||
164238049|NCT00952705|593244139|FG000|Overall Study|Incarcerated post dose|5|||
164238050|NCT00952705|593244140|FG001|Overall Study|Incarcerated post dose|0|||
164238051|NCT00952705|593244141|FG002|Overall Study|Incarcerated post dose|0|||
164238052|NCT00952705|593244139|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
164238053|NCT00952705|593244140|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
164238054|NCT00952705|593244141|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
164238055|NCT02921789|593244145|FG000|Overall Study|Adverse Event|0|||
164238056|NCT02921789|593244146|FG001|Overall Study|Adverse Event|1|||
164238057|NCT02921789|593244145|FG000|Overall Study|Lost to Follow-up|1|||
164238058|NCT02921789|593244146|FG001|Overall Study|Lost to Follow-up|0|||
164238059|NCT02921789|593244145|FG000|Overall Study|Protocol Deviation|2|||
164238060|NCT02921789|593244146|FG001|Overall Study|Protocol Deviation|0|||
164238061|NCT02921789|593244145|FG000|Overall Study|Withdrawal by Subject|2|||
164238062|NCT02921789|593244146|FG001|Overall Study|Withdrawal by Subject|1|||
164238063|NCT02921789|593244145|FG000|Overall Study|Miscellaneous|3|||
164238064|NCT02921789|593244146|FG001|Overall Study|Miscellaneous|2|||
164238065|NCT01944020|593244147|FG000|Overall Study|Withdrawal by Subject|5|||
164238066|NCT01944020|593244148|FG001|Overall Study|Withdrawal by Subject|0|||
164238067|NCT01192126|593244149|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
164238068|NCT01192126|593244150|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
164238069|NCT01192126|593244149|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
164238070|NCT01192126|593244150|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
164238071|NCT01669902|593244151|FG000|Overall Study|Adverse Event|11|||
164238072|NCT01669902|593244151|FG000|Overall Study|Lack of Efficacy|10|||
164238073|NCT01669902|593244151|FG000|Overall Study|Other|8|||
164238074|NCT02391311|593244154|FG000|Overall Study|Lost to Follow-up|2|||
164238075|NCT02391311|593244155|FG001|Overall Study|Lost to Follow-up|1|||
164238076|NCT02391311|593244154|FG000|Overall Study|deemed ineligible after baseline|1|||
164238077|NCT02391311|593244155|FG001|Overall Study|deemed ineligible after baseline|1|||
164238078|NCT00688467|593244158|FG000|Treatment Period 1|Adverse Event|2|||
164238079|NCT00688467|593244159|FG001|Treatment Period 1|Adverse Event|1|||
164238080|NCT00688467|593244158|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
164238081|NCT00688467|593244159|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
164238082|NCT00688467|593244158|FG000|Treatment Period 2|Protocol Violation|0|||
164238083|NCT00688467|593244159|FG001|Treatment Period 2|Protocol Violation|1|||
164238084|NCT00688467|593244158|FG000|Treatment Period 2|Adverse Event|0|||
164238085|NCT00688467|593244159|FG001|Treatment Period 2|Adverse Event|1|||
164238086|NCT02808897|593244160|FG000|Overall Study|Lost to Follow-up|9|||
164238087|NCT02808897|593244161|FG001|Overall Study|Lost to Follow-up|11|||
164238088|NCT00305448|593244162|FG000|Overall Study|Protocol Violation|0|||
164238089|NCT00305448|593244163|FG001|Overall Study|Protocol Violation|1|||
164238090|NCT00305448|593244164|FG002|Overall Study|Protocol Violation|0|||
164238091|NCT00305448|593244162|FG000|Overall Study|Withdrawal by Subject|2|||
164238092|NCT00305448|593244163|FG001|Overall Study|Withdrawal by Subject|0|||
164238093|NCT00305448|593244164|FG002|Overall Study|Withdrawal by Subject|1|||
164238094|NCT00305448|593244162|FG000|Overall Study|Adverse Event|1|||
164238095|NCT00305448|593244163|FG001|Overall Study|Adverse Event|0|||
164238096|NCT00305448|593244164|FG002|Overall Study|Adverse Event|1|||
164238097|NCT00305448|593244162|FG000|Overall Study|Disease Progression|27|||
164238098|NCT00305448|593244163|FG001|Overall Study|Disease Progression|31|||
164238099|NCT00305448|593244164|FG002|Overall Study|Disease Progression|28|||
164238100|NCT00305448|593244162|FG000|Overall Study|Subjective Disease Progression|1|||
164238101|NCT00305448|593244163|FG001|Overall Study|Subjective Disease Progression|2|||
164238102|NCT00305448|593244164|FG002|Overall Study|Subjective Disease Progression|2|||
164238103|NCT00305448|593244162|FG000|Overall Study|Tumor Marker Elevation|0|||
164238104|NCT00305448|593244163|FG001|Overall Study|Tumor Marker Elevation|0|||
164238105|NCT00305448|593244164|FG002|Overall Study|Tumor Marker Elevation|1|||
164238106|NCT00002766|593244165|FG000|Overall Study|Withdrawal by Subject|0|||
164238107|NCT00002766|593244166|FG001|Overall Study|Withdrawal by Subject|1|||
164238108|NCT00002766|593244165|FG000|Overall Study|Patient Not Treated|1|||
164238109|NCT00002766|593244166|FG001|Overall Study|Patient Not Treated|2|||
164238110|NCT00002766|593244165|FG000|Overall Study|Adverse Event|1|||
164238111|NCT00002766|593244166|FG001|Overall Study|Adverse Event|1|||
164238112|NCT00002766|593244165|FG000|Overall Study|Protocol Violation|1|||
164238113|NCT00002766|593244166|FG001|Overall Study|Protocol Violation|0|||
164238114|NCT00387088|593244177|FG000|Overall Study|Adverse Event|143|||
164238115|NCT00387088|593244178|FG001|Overall Study|Adverse Event|156|||
164238116|NCT00387088|593244177|FG000|Overall Study|Protocol Violation|47|||
164238117|NCT00387088|593244178|FG001|Overall Study|Protocol Violation|35|||
164238118|NCT00387088|593244177|FG000|Overall Study|Withdrawal by Subject|20|||
164238119|NCT00387088|593244178|FG001|Overall Study|Withdrawal by Subject|35|||
164238120|NCT00387088|593244177|FG000|Overall Study|Lack of Efficacy|28|||
164238121|NCT00387088|593244178|FG001|Overall Study|Lack of Efficacy|67|||
164238122|NCT00387088|593244177|FG000|Overall Study|Lost to Follow-up|22|||
164238123|NCT00387088|593244178|FG001|Overall Study|Lost to Follow-up|28|||
164238124|NCT00387088|593244177|FG000|Overall Study|Other|58|||
164238125|NCT00387088|593244178|FG001|Overall Study|Other|52|||
164238126|NCT04108273|593244179|FG000|Overall Study|COVID Pandemic|1|||
164238127|NCT04108273|593244180|FG001|Overall Study|COVID Pandemic|0|||
164238128|NCT02441218|593244181|FG000|Overall Study|Death|503|||
164238129|NCT02441218|593244182|FG001|Overall Study|Death|553|||
164238130|NCT02441218|593244181|FG000|Overall Study|Withdrawal by Subject|73|||
164238131|NCT02441218|593244182|FG001|Overall Study|Withdrawal by Subject|58|||
164238132|NCT02441218|593244181|FG000|Overall Study|Lost to Follow-up|2|||
164238133|NCT02441218|593244182|FG001|Overall Study|Lost to Follow-up|1|||
164238134|NCT01541371|593244183|FG000|Overall Study|Withdrawal by Subject|14|||
164238135|NCT01541371|593244183|FG000|Overall Study|Lost to Follow-up|21|||
164238136|NCT01541371|593244183|FG000|Overall Study|Adverse Event|15|||
164238137|NCT01541371|593244183|FG000|Overall Study|Lack of Efficacy|12|||
164238138|NCT01541371|593244183|FG000|Overall Study|Protocol Violation|6|||
164238139|NCT01541371|593244183|FG000|Overall Study|Study medication non-compliance|3|||
164238140|NCT01541371|593244183|FG000|Overall Study|Other|6|||
164238141|NCT02154061|593244184|FG000|Overall Study|Pregnancy|1|||
164238142|NCT02154061|593244185|FG001|Overall Study|Pregnancy|0|||
164238143|NCT02154061|593244184|FG000|Overall Study|enrolled but not vaccinated|1|||
164238144|NCT02154061|593244185|FG001|Overall Study|enrolled but not vaccinated|0|||
164238145|NCT01936831|593244186|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238146|NCT01936831|593244187|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238147|NCT01936831|593244188|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238148|NCT01936831|593244189|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238149|NCT01936831|593244190|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238150|NCT01936831|593244191|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
164238151|NCT01936831|593244192|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238152|NCT01936831|593244193|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238153|NCT01936831|593244194|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
164238154|NCT01570387|593244200|FG000|Overall Study|Adverse Event|1|||
164238155|NCT01570387|593244201|FG001|Overall Study|Adverse Event|0|||
164238156|NCT01570387|593244202|FG002|Overall Study|Adverse Event|0|||
164238157|NCT01570387|593244203|FG003|Overall Study|Adverse Event|0|||
164238158|NCT01570387|593244200|FG000|Overall Study|Death|0|||
164238159|NCT01570387|593244201|FG001|Overall Study|Death|0|||
164238160|NCT01570387|593244202|FG002|Overall Study|Death|0|||
164238161|NCT01570387|593244203|FG003|Overall Study|Death|1|||
164238162|NCT01570387|593244200|FG000|Overall Study|Withdrawal by Subject|0|||
164238163|NCT01570387|593244201|FG001|Overall Study|Withdrawal by Subject|0|||
164238164|NCT01570387|593244202|FG002|Overall Study|Withdrawal by Subject|0|||
164238165|NCT01570387|593244203|FG003|Overall Study|Withdrawal by Subject|1|||
164238166|NCT01876381|593244204|FG000|Overall Study|Lack of Efficacy|5|||
164238167|NCT01876381|593244204|FG000|Overall Study|Physician Decision|1|||
164238168|NCT01876381|593244204|FG000|Overall Study|Withdrawal by Subject|1|||
164238169|NCT00523978|593244207|FG000|Overall Study|Withdrawal by Subject|3|||
164238170|NCT00523978|593244208|FG001|Overall Study|Withdrawal by Subject|7|||
164238171|NCT00523978|593244207|FG000|Overall Study|Screen Failures|5|||
164238172|NCT00523978|593244208|FG001|Overall Study|Screen Failures|1|||
164238173|NCT00523978|593244207|FG000|Overall Study|Death|1|||
164238174|NCT00523978|593244208|FG001|Overall Study|Death|0|||
164238175|NCT02170064|593244209|FG000|Overall Study|Withdrawal by Subject|5|||
164238176|NCT02170064|593244210|FG001|Overall Study|Withdrawal by Subject|1|||
164238177|NCT02170064|593244211|FG002|Overall Study|Withdrawal by Subject|1|||
164238178|NCT02170064|593244209|FG000|Overall Study|Physician Decision|1|||
164238179|NCT02170064|593244210|FG001|Overall Study|Physician Decision|1|||
164238180|NCT02170064|593244211|FG002|Overall Study|Physician Decision|0|||
164238181|NCT01696643|593244216|FG000|Overall Study|Adverse Event|15|||
164238182|NCT01696643|593244217|FG001|Overall Study|Adverse Event|7|||
164238183|NCT01696643|593244216|FG000|Overall Study|Death|1|||
164238184|NCT01696643|593244217|FG001|Overall Study|Death|2|||
164238185|NCT01696643|593244216|FG000|Overall Study|Lack of Efficacy|3|||
164238186|NCT01696643|593244217|FG001|Overall Study|Lack of Efficacy|0|||
164238187|NCT01696643|593244216|FG000|Overall Study|Lost to Follow-up|67|||
164238188|NCT01696643|593244217|FG001|Overall Study|Lost to Follow-up|67|||
164238189|NCT01696643|593244216|FG000|Overall Study|Physician Decision|3|||
164238190|NCT01696643|593244217|FG001|Overall Study|Physician Decision|2|||
164238191|NCT01696643|593244216|FG000|Overall Study|Pregnancy|0|||
164238192|NCT01696643|593244217|FG001|Overall Study|Pregnancy|1|||
164238193|NCT01696643|593244216|FG000|Overall Study|Protocol Violation|7|||
164238194|NCT01696643|593244217|FG001|Overall Study|Protocol Violation|7|||
164238195|NCT01696643|593244216|FG000|Overall Study|Study Terminated by Sponsor|286|||
164238196|NCT01696643|593244217|FG001|Overall Study|Study Terminated by Sponsor|294|||
164238197|NCT01696643|593244216|FG000|Overall Study|Withdrawal by Subject|142|||
164238198|NCT01696643|593244217|FG001|Overall Study|Withdrawal by Subject|149|||
164238199|NCT01696643|593244216|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
164238200|NCT01696643|593244217|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
164238201|NCT01696643|593244216|FG000|Overall Study|Site Error|2|||
164238202|NCT01696643|593244217|FG001|Overall Study|Site Error|1|||
164238203|NCT01696643|593244216|FG000|Overall Study|Participant Incarcerated|0|||
164238204|NCT01696643|593244217|FG001|Overall Study|Participant Incarcerated|1|||
164238205|NCT01696643|593244216|FG000|Overall Study|Medical Monitor Decision|0|||
164238206|NCT01696643|593244217|FG001|Overall Study|Medical Monitor Decision|2|||
164238207|NCT01696643|593244216|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
164238208|NCT01696643|593244217|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
164238209|NCT01193101|593244221|FG000|Overall Study|Adverse Event|0|||
164238210|NCT01193101|593244222|FG001|Overall Study|Adverse Event|1|||
164238211|NCT01193101|593244223|FG002|Overall Study|Adverse Event|1|||
164238212|NCT01193101|593244224|FG003|Overall Study|Adverse Event|3|||
164238213|NCT01193101|593244221|FG000|Overall Study|Lack of Efficacy|3|||
164238214|NCT01193101|593244222|FG001|Overall Study|Lack of Efficacy|1|||
164238215|NCT01193101|593244223|FG002|Overall Study|Lack of Efficacy|0|||
164238216|NCT01193101|593244224|FG003|Overall Study|Lack of Efficacy|8|||
164238217|NCT01193101|593244221|FG000|Overall Study|Withdrawal by Subject|2|||
164238218|NCT01193101|593244222|FG001|Overall Study|Withdrawal by Subject|4|||
164238219|NCT01193101|593244223|FG002|Overall Study|Withdrawal by Subject|1|||
164335637|NCT04102098|593606022|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
164335638|NCT04102098|593606023|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
164335639|NCT03150173|593606026|FG000|Overall Study|Lost to Follow-up|13|||
164335640|NCT03150173|593606027|FG001|Overall Study|Lost to Follow-up|5|||
164335641|NCT01756053|593606029|FG000|Period 1 (10 Days)|Protocol Violation|1|||
164238220|NCT01193101|593244224|FG003|Overall Study|Withdrawal by Subject|1|||
164238221|NCT01193101|593244221|FG000|Overall Study|Administrative problems|0|||
164238222|NCT01193101|593244222|FG001|Overall Study|Administrative problems|0|||
164238223|NCT01193101|593244223|FG002|Overall Study|Administrative problems|1|||
164335642|NCT01756053|593606030|FG001|Period 1 (10 Days)|Protocol Violation|1|||
164335643|NCT01756053|593606029|FG000|Period 2 (10 Days)|Protocol Violation|0|||
164238224|NCT01193101|593244224|FG003|Overall Study|Administrative problems|0|||
164238225|NCT01193101|593244221|FG000|Overall Study|Abnormal test procedure results|0|||
164238226|NCT01193101|593244222|FG001|Overall Study|Abnormal test procedure results|1|||
164238227|NCT01193101|593244223|FG002|Overall Study|Abnormal test procedure results|0|||
164238228|NCT01193101|593244224|FG003|Overall Study|Abnormal test procedure results|0|||
164238229|NCT03508050|593244225|FG000|Overall Study|Pleural adhesions|1|||
164238230|NCT03508050|593244226|FG001|Overall Study|Pleural adhesions|0|||
164335644|NCT01756053|593606030|FG001|Period 2 (10 Days)|Protocol Violation|2|||
164238231|NCT03508050|593244225|FG000|Overall Study|Mucus plug|1|||
164238232|NCT03508050|593244226|FG001|Overall Study|Mucus plug|0|||
164238233|NCT03508050|593244225|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
164238234|NCT03508050|593244226|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
164238235|NCT03508050|593244225|FG000|Overall Study|Sustained desaturation|0|||
164238236|NCT03508050|593244226|FG001|Overall Study|Sustained desaturation|1|||
164238237|NCT04389866|593244227|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
164238238|NCT04389866|593244228|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
164238239|NCT00776789|593244231|FG000|Overall Study|Consent refusal|2|||
164238240|NCT00776789|593244232|FG001|Overall Study|Consent refusal|2|||
164238241|NCT00776789|593244231|FG000|Overall Study|Poor quality video|1|||
164238242|NCT00776789|593244232|FG001|Overall Study|Poor quality video|1|||
164238243|NCT00401843|593244233|FG000|Overall Study|Achieved Complete Response|1|||
164238244|NCT00401843|593244234|FG001|Overall Study|Achieved Complete Response|5|||
164238245|NCT00401843|593244235|FG002|Overall Study|Achieved Complete Response|11|||
164238246|NCT00401843|593244233|FG000|Overall Study|Adverse Event|7|||
164238247|NCT00401843|593244234|FG001|Overall Study|Adverse Event|26|||
164238248|NCT00401843|593244235|FG002|Overall Study|Adverse Event|27|||
164238249|NCT00401843|593244233|FG000|Overall Study|Death|0|||
164238250|NCT00401843|593244234|FG001|Overall Study|Death|8|||
164238251|NCT00401843|593244235|FG002|Overall Study|Death|10|||
164238252|NCT00401843|593244233|FG000|Overall Study|Disease progression|10|||
164238253|NCT00401843|593244234|FG001|Overall Study|Disease progression|60|||
164238254|NCT00401843|593244235|FG002|Overall Study|Disease progression|49|||
164238255|NCT00401843|593244233|FG000|Overall Study|End of Study|1|||
164238256|NCT00401843|593244234|FG001|Overall Study|End of Study|1|||
164238257|NCT00401843|593244235|FG002|Overall Study|End of Study|2|||
164238258|NCT00401843|593244233|FG000|Overall Study|Lost to Follow-up|0|||
164238259|NCT00401843|593244234|FG001|Overall Study|Lost to Follow-up|0|||
164238260|NCT00401843|593244235|FG002|Overall Study|Lost to Follow-up|2|||
164238261|NCT00401843|593244233|FG000|Overall Study|Other Unspecified|0|||
164238262|NCT00401843|593244234|FG001|Overall Study|Other Unspecified|3|||
164238263|NCT00401843|593244235|FG002|Overall Study|Other Unspecified|5|||
164238264|NCT00401843|593244233|FG000|Overall Study|Physician Decision|0|||
164238265|NCT00401843|593244234|FG001|Overall Study|Physician Decision|16|||
164238266|NCT00401843|593244235|FG002|Overall Study|Physician Decision|10|||
164238267|NCT00401843|593244233|FG000|Overall Study|Protocol Violation|0|||
164238268|NCT00401843|593244234|FG001|Overall Study|Protocol Violation|0|||
164238269|NCT00401843|593244235|FG002|Overall Study|Protocol Violation|1|||
164238270|NCT00401843|593244233|FG000|Overall Study|Withdrawal by Subject|1|||
164238271|NCT00401843|593244234|FG001|Overall Study|Withdrawal by Subject|5|||
164238272|NCT00401843|593244235|FG002|Overall Study|Withdrawal by Subject|5|||
164238273|NCT00401843|593244233|FG000|Overall Study|Withdrawal of consent to study agent|1|||
164238274|NCT00401843|593244234|FG001|Overall Study|Withdrawal of consent to study agent|15|||
163884624|NCT03158129|591947823|FG003|Overall Study|Death|1|||
164238275|NCT00401843|593244235|FG002|Overall Study|Withdrawal of consent to study agent|17|||
164238276|NCT00401843|593244233|FG000|Overall Study|Randomized but not Treated|0|||
164238277|NCT00401843|593244234|FG001|Overall Study|Randomized but not Treated|2|||
163884625|NCT03158129|591947820|FG000|Overall Study|High surgical risk|1|||
164238278|NCT00401843|593244235|FG002|Overall Study|Randomized but not Treated|3|||
164238279|NCT00401843|593244233|FG000|Overall Study|Received incorrect treatment|0|||
164238280|NCT00401843|593244234|FG001|Overall Study|Received incorrect treatment|3|||
164238281|NCT00401843|593244235|FG002|Overall Study|Received incorrect treatment|0|||
164090401|NCT03384745|592693437|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
164090402|NCT03384745|592693438|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
164090403|NCT03384745|592693439|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
164090404|NCT03384745|592693434|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164090405|NCT03384745|592693435|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164090406|NCT03384745|592693436|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164090407|NCT03384745|592693437|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
164090408|NCT03384745|592693438|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
164090409|NCT03384745|592693439|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
164090410|NCT03384745|592693434|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
164090411|NCT03384745|592693435|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
164090412|NCT03384745|592693436|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
164090413|NCT03384745|592693437|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
164090414|NCT03384745|592693438|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
164090415|NCT03384745|592693439|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
164090416|NCT03384745|592693434|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164090417|NCT03384745|592693435|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164090418|NCT03384745|592693436|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
164090419|NCT03384745|592693437|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164090420|NCT03384745|592693438|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164090421|NCT03384745|592693439|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
164090422|NCT03384745|592693434|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164090423|NCT03384745|592693435|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164090424|NCT03384745|592693436|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164090425|NCT03384745|592693437|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
164090426|NCT03384745|592693438|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
164090427|NCT03384745|592693439|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
164090428|NCT03384745|592693434|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164090429|NCT03384745|592693435|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164090430|NCT03384745|592693436|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164090431|NCT03384745|592693437|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164090432|NCT03384745|592693438|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
164090433|NCT03384745|592693439|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
164090434|NCT03384745|592693434|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164090435|NCT03384745|592693435|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164090436|NCT03384745|592693436|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
164090437|NCT03384745|592693437|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
164090438|NCT03384745|592693438|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164090439|NCT03384745|592693439|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
164090440|NCT03384745|592693434|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
164090441|NCT03384745|592693435|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
164090442|NCT03384745|592693436|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
164090443|NCT03384745|592693437|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
164090444|NCT03384745|592693438|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
164090445|NCT03384745|592693439|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
164090446|NCT03384745|592693434|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
164090447|NCT03384745|592693435|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
164090448|NCT03384745|592693436|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
164090449|NCT03384745|592693437|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
164090450|NCT03384745|592693438|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
164090451|NCT03384745|592693439|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
164090452|NCT03384745|592693434|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164090453|NCT03384745|592693435|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164090454|NCT03384745|592693436|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164090455|NCT03384745|592693437|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
164090456|NCT03384745|592693438|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164090457|NCT03384745|592693439|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
164090458|NCT03384745|592693434|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
164090459|NCT03384745|592693435|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
164090460|NCT03384745|592693436|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
164090461|NCT03384745|592693437|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
164140474|NCT00642278|592876098|FG003|Overall Study|Adverse Event|1|||
164238282|NCT01182298|593244238|FG000|Overall Study|Lack of Efficacy|4|||
164238283|NCT01182298|593244238|FG000|Overall Study|Withdrawal by Subject|2|||
164238284|NCT04881760|593244239|FG000|Overall Study|Adverse Event|0|||
164238285|NCT04881760|593244240|FG001|Overall Study|Adverse Event|1|||
164238286|NCT04881760|593244241|FG002|Overall Study|Adverse Event|1|||
164238287|NCT04881760|593244242|FG003|Overall Study|Adverse Event|0|||
164238288|NCT04881760|593244243|FG004|Overall Study|Adverse Event|1|||
164238289|NCT04881760|593244244|FG005|Overall Study|Adverse Event|1|||
164238290|NCT04881760|593244245|FG006|Overall Study|Adverse Event|2|||
164238291|NCT04881760|593244239|FG000|Overall Study|Death|0|||
164238292|NCT04881760|593244240|FG001|Overall Study|Death|0|||
164238293|NCT04881760|593244241|FG002|Overall Study|Death|0|||
164238294|NCT04881760|593244242|FG003|Overall Study|Death|1|||
164238295|NCT04881760|593244243|FG004|Overall Study|Death|0|||
164238296|NCT04881760|593244244|FG005|Overall Study|Death|0|||
164238297|NCT04881760|593244245|FG006|Overall Study|Death|0|||
164238298|NCT04881760|593244239|FG000|Overall Study|Lost to Follow-up|5|||
164238299|NCT04881760|593244240|FG001|Overall Study|Lost to Follow-up|7|||
164238300|NCT04881760|593244241|FG002|Overall Study|Lost to Follow-up|5|||
164238301|NCT04881760|593244242|FG003|Overall Study|Lost to Follow-up|1|||
164238302|NCT04881760|593244243|FG004|Overall Study|Lost to Follow-up|2|||
164238303|NCT04881760|593244244|FG005|Overall Study|Lost to Follow-up|4|||
164238304|NCT04881760|593244245|FG006|Overall Study|Lost to Follow-up|4|||
164238305|NCT04881760|593244239|FG000|Overall Study|Withdrawal by Subject|13|||
164238306|NCT04881760|593244240|FG001|Overall Study|Withdrawal by Subject|1|||
164238307|NCT04881760|593244241|FG002|Overall Study|Withdrawal by Subject|1|||
164238308|NCT04881760|593244242|FG003|Overall Study|Withdrawal by Subject|4|||
164238309|NCT04881760|593244243|FG004|Overall Study|Withdrawal by Subject|2|||
164238310|NCT04881760|593244244|FG005|Overall Study|Withdrawal by Subject|1|||
164238311|NCT04881760|593244245|FG006|Overall Study|Withdrawal by Subject|2|||
164238312|NCT04881760|593244239|FG000|Overall Study|Randomized but Never Treated|0|||
164238313|NCT04881760|593244240|FG001|Overall Study|Randomized but Never Treated|0|||
164238314|NCT04881760|593244241|FG002|Overall Study|Randomized but Never Treated|0|||
164238315|NCT04881760|593244242|FG003|Overall Study|Randomized but Never Treated|1|||
164238316|NCT04881760|593244243|FG004|Overall Study|Randomized but Never Treated|0|||
164238317|NCT04881760|593244244|FG005|Overall Study|Randomized but Never Treated|0|||
164238318|NCT04881760|593244245|FG006|Overall Study|Randomized but Never Treated|0|||
164238319|NCT04881760|593244239|FG000|Overall Study|Inadvertent Enrollment|2|||
164238320|NCT04881760|593244240|FG001|Overall Study|Inadvertent Enrollment|0|||
164238321|NCT04881760|593244241|FG002|Overall Study|Inadvertent Enrollment|0|||
164238322|NCT04881760|593244242|FG003|Overall Study|Inadvertent Enrollment|0|||
164238323|NCT04881760|593244243|FG004|Overall Study|Inadvertent Enrollment|0|||
164238324|NCT04881760|593244244|FG005|Overall Study|Inadvertent Enrollment|0|||
164238325|NCT04881760|593244245|FG006|Overall Study|Inadvertent Enrollment|0|||
164238326|NCT04881760|593244239|FG000|Overall Study|Site Closure|0|||
164238327|NCT04881760|593244240|FG001|Overall Study|Site Closure|0|||
164238328|NCT04881760|593244241|FG002|Overall Study|Site Closure|0|||
164238329|NCT04881760|593244242|FG003|Overall Study|Site Closure|1|||
164238330|NCT04881760|593244243|FG004|Overall Study|Site Closure|0|||
164238331|NCT04881760|593244244|FG005|Overall Study|Site Closure|0|||
164238332|NCT04881760|593244245|FG006|Overall Study|Site Closure|0|||
164238333|NCT01508910|593244246|FG000|Treatment|Death|2|||
164238334|NCT01508910|593244247|FG001|Treatment|Death|3|||
164238335|NCT01508910|593244248|FG002|Treatment|Death|2|||
164238336|NCT01508910|593244249|FG003|Treatment|Death|0|||
164238337|NCT01508910|593244246|FG000|Treatment|Lost to Follow-up|0|||
164238338|NCT01508910|593244247|FG001|Treatment|Lost to Follow-up|0|||
164238339|NCT01508910|593244248|FG002|Treatment|Lost to Follow-up|2|||
164238340|NCT01508910|593244249|FG003|Treatment|Lost to Follow-up|1|||
164238341|NCT01508910|593244246|FG000|Treatment|Withdrawal by Subject|0|||
164238342|NCT01508910|593244247|FG001|Treatment|Withdrawal by Subject|1|||
164238343|NCT01508910|593244248|FG002|Treatment|Withdrawal by Subject|6|||
164238344|NCT01508910|593244249|FG003|Treatment|Withdrawal by Subject|1|||
164238345|NCT01508910|593244246|FG000|Treatment|Sponsor Decision|0|||
164238346|NCT01508910|593244247|FG001|Treatment|Sponsor Decision|0|||
164238347|NCT01508910|593244248|FG002|Treatment|Sponsor Decision|0|||
164238348|NCT01508910|593244249|FG003|Treatment|Sponsor Decision|1|||
164238349|NCT01595529|593244250|FG000|Overall Study|Adverse Event|2|||
164238350|NCT01595529|593244251|FG001|Overall Study|Adverse Event|0|||
164238351|NCT01595529|593244250|FG000|Overall Study|Subject Non-Compliant|2|||
164238352|NCT01595529|593244251|FG001|Overall Study|Subject Non-Compliant|0|||
164238353|NCT01595529|593244250|FG000|Overall Study|Lost to Follow-up|8|||
164238354|NCT01595529|593244251|FG001|Overall Study|Lost to Follow-up|14|||
164238355|NCT01595529|593244250|FG000|Overall Study|Protocol Violation|1|||
164238356|NCT01595529|593244251|FG001|Overall Study|Protocol Violation|2|||
164238357|NCT01595529|593244250|FG000|Overall Study|Physician Decision|1|||
164238358|NCT01595529|593244251|FG001|Overall Study|Physician Decision|0|||
164238359|NCT01595529|593244250|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
164238360|NCT01595529|593244251|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
164238361|NCT01595529|593244250|FG000|Overall Study|Administrative Decision|1|||
164238362|NCT01595529|593244251|FG001|Overall Study|Administrative Decision|0|||
164238363|NCT01595529|593244250|FG000|Overall Study|Entry Failure/Screening Failure|6|||
164238364|NCT01595529|593244251|FG001|Overall Study|Entry Failure/Screening Failure|1|||
164238365|NCT04016714|593244252|FG000|Overall Study|Death|1|||
164238366|NCT04016714|593244253|FG001|Overall Study|Death|0|||
164238367|NCT04016714|593244252|FG000|Overall Study|Lost to Follow-up|3|||
164238368|NCT04016714|593244253|FG001|Overall Study|Lost to Follow-up|1|||
164238369|NCT04016714|593244252|FG000|Overall Study|Physician Decision|3|||
164238370|NCT04016714|593244253|FG001|Overall Study|Physician Decision|3|||
164238371|NCT04016714|593244252|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
164238372|NCT04016714|593244253|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
164238373|NCT01822665|593244254|FG000|Overall Study|Adverse Event|3|||
164238374|NCT01822665|593244254|FG000|Overall Study|Other Reason|5|||
164238375|NCT00867035|593244255|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
164238376|NCT00867035|593244256|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
164238377|NCT00867035|593244255|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
164238378|NCT00867035|593244256|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
164238379|NCT00542178|593244258|FG000|Overall Study|did not complete year 4 follow-up|75|||
164238380|NCT00542178|593244259|FG001|Overall Study|did not complete year 4 follow-up|80|||
164238381|NCT00542178|593244260|FG002|Overall Study|did not complete year 4 follow-up|74|||
164238382|NCT00542178|593244261|FG003|Overall Study|did not complete year 4 follow-up|62|||
164238383|NCT00542178|593244262|FG004|Overall Study|did not complete year 4 follow-up|64|||
164238384|NCT00542178|593244263|FG005|Overall Study|did not complete year 4 follow-up|89|||
164238385|NCT00542178|593244264|FG006|Overall Study|did not complete year 4 follow-up|87|||
164238386|NCT00542178|593244265|FG007|Overall Study|did not complete year 4 follow-up|85|||
164238387|NCT00829998|593244266|FG000|Washout|Adverse Event|0|||
164238388|NCT00829998|593244267|FG001|Washout|Adverse Event|1|||
164238389|NCT06164691|593246407|FG000|Overall Study|Withdrawal by Subject|2|||
164238390|NCT06164691|593246408|FG001|Overall Study|Withdrawal by Subject|0|||
164238391|NCT06164691|593246409|FG002|Overall Study|Withdrawal by Subject|0|||
164238392|NCT00812955|593246410|FG000|Overall Study|Adverse Event|7|||
164238393|NCT00812955|593246411|FG001|Overall Study|Adverse Event|6|||
164238394|NCT00812955|593246412|FG002|Overall Study|Adverse Event|3|||
164238395|NCT00812955|593246413|FG003|Overall Study|Adverse Event|4|||
164238396|NCT00812955|593246410|FG000|Overall Study|Lost to Follow-up|2|||
164238397|NCT00812955|593246411|FG001|Overall Study|Lost to Follow-up|1|||
164238398|NCT00812955|593246412|FG002|Overall Study|Lost to Follow-up|1|||
164238399|NCT00812955|593246413|FG003|Overall Study|Lost to Follow-up|2|||
164238400|NCT00812955|593246410|FG000|Overall Study|Withdrawal by Subject|1|||
164238401|NCT00812955|593246411|FG001|Overall Study|Withdrawal by Subject|0|||
164238402|NCT00812955|593246412|FG002|Overall Study|Withdrawal by Subject|1|||
164238403|NCT00812955|593246413|FG003|Overall Study|Withdrawal by Subject|2|||
164238404|NCT00812955|593246410|FG000|Overall Study|randomized in error|0|||
164238405|NCT00812955|593246411|FG001|Overall Study|randomized in error|0|||
164238406|NCT00812955|593246412|FG002|Overall Study|randomized in error|1|||
164238407|NCT00812955|593246413|FG003|Overall Study|randomized in error|0|||
164238408|NCT03046446|593246414|FG000|Overall Study|Lack of Efficacy|7|||
164238409|NCT03046446|593246414|FG000|Overall Study|Adverse Event|6|||
164238410|NCT03046446|593246414|FG000|Overall Study|Lost to Follow-up|3|||
164238411|NCT03046446|593246414|FG000|Overall Study|Withdrawal by Subject|14|||
164238412|NCT03046446|593246414|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
164238413|NCT03046446|593246414|FG000|Overall Study|Disease Progression (see caveats)|25|||
164238414|NCT03046446|593246414|FG000|Overall Study|Non OA related knee surgery|1|||
164335645|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
164335646|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
164335647|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Physician Decision|1|||
164335648|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Physician Decision|0|||
164335649|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
164335650|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
164335651|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
164335652|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
164083324|NCT02224456|592670116|FG000|Overall Study|Lack of Efficacy|1|||
164083325|NCT02224456|592670116|FG000|Overall Study|Lost to Follow-up|15|||
164238415|NCT03183063|593246415|FG000|Overall Study|Withdrawal by Subject|2|||
164238416|NCT03183063|593246416|FG001|Overall Study|Withdrawal by Subject|0|||
164238417|NCT03183063|593246417|FG002|Overall Study|Withdrawal by Subject|0|||
164238418|NCT03183063|593246415|FG000|Overall Study|Physician Decision|3|||
164238419|NCT03183063|593246416|FG001|Overall Study|Physician Decision|4|||
164238420|NCT03183063|593246417|FG002|Overall Study|Physician Decision|4|||
164238421|NCT00399568|593246418|FG000|Overall Study|Adverse Event|1|||
164238422|NCT00399568|593246419|FG001|Overall Study|Adverse Event|2|||
164238423|NCT00399568|593246418|FG000|Overall Study|Withdrawal by Subject|7|||
164238424|NCT00399568|593246419|FG001|Overall Study|Withdrawal by Subject|3|||
164238425|NCT00399568|593246418|FG000|Overall Study|Protocol non-compliance|2|||
164238426|NCT00399568|593246419|FG001|Overall Study|Protocol non-compliance|2|||
164238427|NCT00399568|593246418|FG000|Overall Study|Lost to Follow-up|2|||
164238428|NCT00399568|593246419|FG001|Overall Study|Lost to Follow-up|2|||
164238429|NCT00925002|593246420|FG000|Overall Study|Other|1|||
164238430|NCT00925002|593246421|FG001|Overall Study|Other|4|||
164238431|NCT00925002|593246422|FG002|Overall Study|Other|0|||
164238432|NCT00925002|593246420|FG000|Overall Study|Death|1|||
164238433|NCT00925002|593246421|FG001|Overall Study|Death|1|||
164238434|NCT00925002|593246422|FG002|Overall Study|Death|5|||
164238435|NCT00925002|593246420|FG000|Overall Study|Adverse Event|3|||
164238436|NCT00925002|593246421|FG001|Overall Study|Adverse Event|1|||
164238437|NCT00925002|593246422|FG002|Overall Study|Adverse Event|2|||
164238438|NCT00925002|593246420|FG000|Overall Study|Participant withdrew consent|1|||
164238439|NCT00925002|593246421|FG001|Overall Study|Participant withdrew consent|3|||
164238440|NCT00925002|593246422|FG002|Overall Study|Participant withdrew consent|3|||
164238441|NCT01343888|593246425|FG000|Overall Study|Adverse Event|12|||
164238442|NCT01343888|593246426|FG001|Overall Study|Adverse Event|22|||
164238443|NCT01343888|593246427|FG002|Overall Study|Adverse Event|5|||
164238444|NCT01343888|593246425|FG000|Overall Study|Lack of Efficacy|9|||
164238445|NCT01343888|593246426|FG001|Overall Study|Lack of Efficacy|9|||
164238446|NCT01343888|593246427|FG002|Overall Study|Lack of Efficacy|13|||
164238447|NCT01343888|593246425|FG000|Overall Study|Lost to Follow-up|0|||
164238448|NCT01343888|593246426|FG001|Overall Study|Lost to Follow-up|2|||
164238449|NCT01343888|593246427|FG002|Overall Study|Lost to Follow-up|1|||
164238450|NCT01343888|593246425|FG000|Overall Study|Protocol Violation|0|||
164238451|NCT01343888|593246426|FG001|Overall Study|Protocol Violation|2|||
164238452|NCT01343888|593246427|FG002|Overall Study|Protocol Violation|0|||
164238453|NCT01343888|593246425|FG000|Overall Study|Withdrawal by Subject|4|||
164238454|NCT01343888|593246426|FG001|Overall Study|Withdrawal by Subject|4|||
164238455|NCT01343888|593246427|FG002|Overall Study|Withdrawal by Subject|2|||
164238456|NCT01343888|593246425|FG000|Overall Study|other than stated above|0|||
164238457|NCT01343888|593246426|FG001|Overall Study|other than stated above|0|||
164238458|NCT01343888|593246427|FG002|Overall Study|other than stated above|1|||
164238459|NCT00558636|593246428|FG000|Treatment|Adverse Event|9|||
164238460|NCT00558636|593246429|FG001|Treatment|Adverse Event|2|||
164238461|NCT00558636|593246428|FG000|Treatment|Withdrawal by Subject|2|||
164238462|NCT00558636|593246429|FG001|Treatment|Withdrawal by Subject|0|||
164238463|NCT00558636|593246428|FG000|Treatment|Premature termination of the study|35|||
164238464|NCT00558636|593246429|FG001|Treatment|Premature termination of the study|37|||
164238465|NCT00558636|593246428|FG000|Treatment|Disease progression|1|||
164238466|NCT00558636|593246429|FG001|Treatment|Disease progression|5|||
164238467|NCT00558636|593246428|FG000|Follow-up|Premature termination of the study|12|||
164238468|NCT00558636|593246429|FG001|Follow-up|Premature termination of the study|7|||
164238469|NCT01990742|593246430|FG000|Overall Study|Withdrawal by facility|407|||
164238470|NCT01990742|593246431|FG001|Overall Study|Withdrawal by facility|1083|||
164238471|NCT01990742|593246430|FG000|Overall Study|Facility closed|0|||
164238472|NCT01990742|593246431|FG001|Overall Study|Facility closed|270|||
164238473|NCT00800735|593246432|FG000|Overall Study|Administrative/Other|2|||
164238474|NCT00800735|593246432|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164238475|NCT00800735|593246432|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
164238476|NCT00800735|593246432|FG000|Overall Study|Withdrew Consent|3|||
164238477|NCT00506142|593246433|FG000|Overall Study|Adverse Event|8|||
164238478|NCT00506142|593246434|FG001|Overall Study|Adverse Event|7|||
164238479|NCT00506142|593246433|FG000|Overall Study|Lack of Efficacy|21|||
164238480|NCT00506142|593246434|FG001|Overall Study|Lack of Efficacy|7|||
164238481|NCT00506142|593246433|FG000|Overall Study|Withdrawal by Subject|4|||
164238482|NCT00506142|593246434|FG001|Overall Study|Withdrawal by Subject|5|||
164238483|NCT00506142|593246433|FG000|Overall Study|Physician Decision|1|||
164238484|NCT00506142|593246434|FG001|Overall Study|Physician Decision|0|||
164238485|NCT00506142|593246433|FG000|Overall Study|New health condition|1|||
164238486|NCT00506142|593246434|FG001|Overall Study|New health condition|0|||
164238487|NCT02133573|593246440|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
164238488|NCT02133573|593246441|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
164238489|NCT02133573|593246440|FG000|Overall Study|Child Deaths|3|||
164238490|NCT02133573|593246441|FG001|Overall Study|Child Deaths|5|||
164335653|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Adverse Event|15|||
164335654|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Adverse Event|0|||
164335655|NCT03277690|593606031|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
164335656|NCT03277690|593606032|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
164335657|NCT03277690|593606031|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
164238491|NCT02133573|593246440|FG000|Overall Study|Child Declined Follow Ups|2|||
164238492|NCT02133573|593246441|FG001|Overall Study|Child Declined Follow Ups|1|||
164238493|NCT02133573|593246440|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
164238494|NCT02133573|593246441|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
164238495|NCT03848416|593246453|FG000|Overall Study|Withdrawal by Subject|1|||
164238496|NCT03848416|593246454|FG001|Overall Study|Withdrawal by Subject|0|||
164238497|NCT03848416|593246455|FG002|Overall Study|Withdrawal by Subject|0|||
164238498|NCT03848416|593246453|FG000|Overall Study|Death|0|||
164238499|NCT03848416|593246454|FG001|Overall Study|Death|0|||
164238500|NCT03848416|593246455|FG002|Overall Study|Death|1|||
164238501|NCT02808429|593246456|FG000|Overall Study|Lost to Follow-up|1|||
164238502|NCT02808429|593246457|FG001|Overall Study|Lost to Follow-up|0|||
164238503|NCT02808429|593246458|FG002|Overall Study|Lost to Follow-up|0|||
164238504|NCT02808429|593246456|FG000|Overall Study|Protocol Violation|0|||
164238505|NCT02808429|593246457|FG001|Overall Study|Protocol Violation|1|||
164238506|NCT02808429|593246458|FG002|Overall Study|Protocol Violation|0|||
164238507|NCT02808429|593246456|FG000|Overall Study|Premature study termination by sponsor|2|||
164238508|NCT02808429|593246457|FG001|Overall Study|Premature study termination by sponsor|0|||
164238509|NCT02808429|593246458|FG002|Overall Study|Premature study termination by sponsor|1|||
164238510|NCT02808429|593246456|FG000|Overall Study|Relocation|0|||
164238511|NCT02808429|593246457|FG001|Overall Study|Relocation|0|||
164238512|NCT02808429|593246458|FG002|Overall Study|Relocation|1|||
164238513|NCT01436110|593246459|FG000|Overall Study|Lack of Efficacy|23|||
164238514|NCT01436110|593246460|FG001|Overall Study|Lack of Efficacy|14|||
164238515|NCT01436110|593246461|FG002|Overall Study|Lack of Efficacy|9|||
164238516|NCT01436110|593246459|FG000|Overall Study|Withdrawal by Subject|6|||
164238517|NCT01436110|593246460|FG001|Overall Study|Withdrawal by Subject|8|||
164238518|NCT01436110|593246461|FG002|Overall Study|Withdrawal by Subject|4|||
164238519|NCT01436110|593246459|FG000|Overall Study|Adverse Event|2|||
164238520|NCT01436110|593246460|FG001|Overall Study|Adverse Event|1|||
164238521|NCT01436110|593246461|FG002|Overall Study|Adverse Event|2|||
164238522|NCT01436110|593246459|FG000|Overall Study|Physician Decision|3|||
164238523|NCT01436110|593246460|FG001|Overall Study|Physician Decision|1|||
164238524|NCT01436110|593246461|FG002|Overall Study|Physician Decision|1|||
164238525|NCT01436110|593246459|FG000|Overall Study|Lost to Follow-up|1|||
164238526|NCT01436110|593246460|FG001|Overall Study|Lost to Follow-up|1|||
164238527|NCT01436110|593246461|FG002|Overall Study|Lost to Follow-up|3|||
164238528|NCT01436110|593246459|FG000|Overall Study|Protocol Violation|3|||
164238529|NCT01436110|593246460|FG001|Overall Study|Protocol Violation|1|||
164238530|NCT01436110|593246461|FG002|Overall Study|Protocol Violation|1|||
164238531|NCT01436110|593246459|FG000|Overall Study|Did Not Receive Trial Medication|1|||
164238532|NCT01436110|593246460|FG001|Overall Study|Did Not Receive Trial Medication|0|||
164238533|NCT01436110|593246461|FG002|Overall Study|Did Not Receive Trial Medication|3|||
164238534|NCT03273907|593246463|FG000|Overall Study|Death|1|||
164238535|NCT03273907|593246463|FG000|Overall Study|Lost to Follow-up|4|||
164238536|NCT03273907|593246463|FG000|Overall Study|Withdrawal by Subject|2|||
164238537|NCT03273907|593246463|FG000|Overall Study|COVID 19|2|||
164238538|NCT00110214|593246464|FG000|Overall Study|Never started treatment|21|||
164238539|NCT00110214|593246465|FG001|Overall Study|Never started treatment|20|||
164238540|NCT00110214|593246464|FG000|Overall Study|Disease progression or death|260|||
164238541|NCT00110214|593246465|FG001|Overall Study|Disease progression or death|151|||
164238542|NCT00110214|593246464|FG000|Overall Study|Adverse Event|115|||
164238543|NCT00110214|593246465|FG001|Overall Study|Adverse Event|192|||
164238544|NCT00110214|593246464|FG000|Overall Study|Refused further treatment|52|||
164238545|NCT00110214|593246465|FG001|Overall Study|Refused further treatment|65|||
164238546|NCT00110214|593246464|FG000|Overall Study|Other (not specified)|61|||
164238547|NCT00110214|593246465|FG001|Overall Study|Other (not specified)|75|||
164238548|NCT01088503|593246466|FG000|Overall Study|Withdrawal by Subject|118|||
164335658|NCT03277690|593606032|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
164335659|NCT03109847|593606033|FG000|Overall Study|Withdrawal by Subject|1|||
164335660|NCT03109847|593606034|FG001|Overall Study|Withdrawal by Subject|0|||
164335661|NCT02633501|593606035|FG000|Overall Study|Adverse Event|0|||
164335662|NCT02633501|593606036|FG001|Overall Study|Adverse Event|0|||
164335663|NCT02633501|593606037|FG002|Overall Study|Adverse Event|1|||
164335664|NCT02633501|593606038|FG003|Overall Study|Adverse Event|0|||
163884626|NCT03158129|591947821|FG001|Overall Study|High surgical risk|1|||
164238549|NCT01088503|593246467|FG001|Overall Study|Withdrawal by Subject|327|||
164238550|NCT01088503|593246468|FG002|Overall Study|Withdrawal by Subject|10|||
164238551|NCT01088503|593246466|FG000|Overall Study|Death|64|||
164238552|NCT01088503|593246467|FG001|Overall Study|Death|358|||
164238553|NCT01088503|593246468|FG002|Overall Study|Death|7|||
164238554|NCT01847092|593246469|FG000|Overall Study|Adverse Event|12|||
164238555|NCT01847092|593246470|FG001|Overall Study|Adverse Event|3|||
164238556|NCT01847092|593246469|FG000|Overall Study|Withdrawal by Subject|5|||
164238557|NCT01847092|593246470|FG001|Overall Study|Withdrawal by Subject|5|||
164238558|NCT01847092|593246469|FG000|Overall Study|Protocol Specified|8|||
164238559|NCT01847092|593246470|FG001|Overall Study|Protocol Specified|0|||
164238560|NCT01847092|593246469|FG000|Overall Study|Physician Decision|1|||
163884627|NCT03158129|591947822|FG002|Overall Study|High surgical risk|0|||
164335665|NCT02633501|593606039|FG004|Overall Study|Adverse Event|1|||
164238561|NCT01847092|593246470|FG001|Overall Study|Physician Decision|1|||
164238562|NCT01847092|593246469|FG000|Overall Study|Protocol Violation|0|||
164238563|NCT01847092|593246470|FG001|Overall Study|Protocol Violation|2|||
164238564|NCT01016067|593246471|FG000|Overall Study|Lost to Follow-up|1|||
164238565|NCT01016067|593246472|FG001|Overall Study|Lost to Follow-up|2|||
164238566|NCT01016067|593246471|FG000|Overall Study|Physician Decision|1|||
164238567|NCT01016067|593246472|FG001|Overall Study|Physician Decision|1|||
164238568|NCT01016067|593246471|FG000|Overall Study|Withdrew due to Relocation|0|||
164238569|NCT01016067|593246472|FG001|Overall Study|Withdrew due to Relocation|1|||
164238570|NCT01673646|593246475|FG000|Overall Study|Adverse Event|2|||
164238571|NCT01673646|593246476|FG001|Overall Study|Adverse Event|1|||
164238572|NCT01673646|593246477|FG002|Overall Study|Adverse Event|1|||
164238573|NCT01673646|593246475|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164238574|NCT01673646|593246476|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164238575|NCT01673646|593246477|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164238576|NCT01673646|593246475|FG000|Overall Study|Condition no longer requires study drug|0|||
164238577|NCT01673646|593246476|FG001|Overall Study|Condition no longer requires study drug|1|||
164238578|NCT01673646|593246477|FG002|Overall Study|Condition no longer requires study drug|0|||
164238579|NCT01673646|593246475|FG000|Overall Study|Withdrawal by Subject|0|||
164238580|NCT01673646|593246476|FG001|Overall Study|Withdrawal by Subject|2|||
164238581|NCT01673646|593246477|FG002|Overall Study|Withdrawal by Subject|2|||
164238582|NCT01673646|593246475|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
164238583|NCT01673646|593246476|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
164238584|NCT01673646|593246477|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
164238585|NCT01000506|593246478|FG000|Overall Study|Adverse Event|6|||
164238586|NCT01000506|593246479|FG001|Overall Study|Adverse Event|5|||
164238587|NCT01000506|593246480|FG002|Overall Study|Adverse Event|8|||
164238588|NCT01000506|593246481|FG003|Overall Study|Adverse Event|9|||
164238589|NCT01000506|593246478|FG000|Overall Study|Lack of Efficacy|8|||
164238590|NCT01000506|593246479|FG001|Overall Study|Lack of Efficacy|6|||
164238591|NCT01000506|593246480|FG002|Overall Study|Lack of Efficacy|4|||
164238592|NCT01000506|593246481|FG003|Overall Study|Lack of Efficacy|4|||
164238593|NCT01000506|593246478|FG000|Overall Study|Protocol Violation|1|||
164238594|NCT01000506|593246479|FG001|Overall Study|Protocol Violation|1|||
164238595|NCT01000506|593246480|FG002|Overall Study|Protocol Violation|0|||
164238596|NCT01000506|593246481|FG003|Overall Study|Protocol Violation|0|||
164238597|NCT01000506|593246478|FG000|Overall Study|Lost to Follow-up|1|||
164238598|NCT01000506|593246479|FG001|Overall Study|Lost to Follow-up|1|||
164238599|NCT01000506|593246480|FG002|Overall Study|Lost to Follow-up|4|||
164238600|NCT01000506|593246481|FG003|Overall Study|Lost to Follow-up|0|||
164238601|NCT01000506|593246478|FG000|Overall Study|Physician Decision|1|||
164238602|NCT01000506|593246479|FG001|Overall Study|Physician Decision|3|||
164238603|NCT01000506|593246480|FG002|Overall Study|Physician Decision|3|||
164238604|NCT01000506|593246481|FG003|Overall Study|Physician Decision|3|||
164238605|NCT01000506|593246478|FG000|Overall Study|Withdrawal by Subject|11|||
163884628|NCT03158129|591947823|FG003|Overall Study|High surgical risk|0|||
164238606|NCT01000506|593246479|FG001|Overall Study|Withdrawal by Subject|8|||
164238607|NCT01000506|593246480|FG002|Overall Study|Withdrawal by Subject|2|||
164238608|NCT01000506|593246481|FG003|Overall Study|Withdrawal by Subject|7|||
164238609|NCT03064074|593246482|FG000|Overall Study|Physician Decision|0|||
164238610|NCT03064074|593246483|FG001|Overall Study|Physician Decision|0|||
164238611|NCT03064074|593246484|FG002|Overall Study|Physician Decision|0|||
164238612|NCT03064074|593246485|FG003|Overall Study|Physician Decision|1|||
164238613|NCT00269087|593246489|FG000|Overall Study|Adverse Event|20|||
164238614|NCT00269087|593246489|FG000|Overall Study|Withdrawal by Subject|1|||
164238615|NCT00269087|593246489|FG000|Overall Study|Exacerbation of COPD|13|||
164238616|NCT01188967|593246495|FG000|Overall Study|Withdrawal by Subject|1|||
164238617|NCT01188967|593246496|FG001|Overall Study|Withdrawal by Subject|1|||
164238618|NCT01188967|593246495|FG000|Overall Study|Physician Decision|1|||
164238619|NCT01188967|593246496|FG001|Overall Study|Physician Decision|1|||
164238620|NCT01188967|593246495|FG000|Overall Study|Lost to Follow-up|3|||
164238621|NCT01188967|593246496|FG001|Overall Study|Lost to Follow-up|2|||
164238622|NCT01448616|593246497|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
164238623|NCT01448616|593246498|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
164238624|NCT01448616|593246499|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
164238625|NCT01448616|593246500|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
163884629|NCT03158129|591947820|FG000|Overall Study|Progression|1|||
164238626|NCT01448616|593246497|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
164238627|NCT01448616|593246498|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
164238628|NCT01448616|593246499|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
164238629|NCT01448616|593246500|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
164238630|NCT01448616|593246497|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
164238631|NCT01448616|593246498|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
164238632|NCT01448616|593246499|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
164238633|NCT01448616|593246500|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
164335666|NCT02633501|593606040|FG005|Overall Study|Adverse Event|1|||
164238634|NCT01448616|593246497|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
164238635|NCT01448616|593246498|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
164238636|NCT01448616|593246499|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
164238637|NCT01448616|593246500|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
164238638|NCT01448616|593246497|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
164238639|NCT01448616|593246498|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
164238640|NCT01448616|593246499|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
164238641|NCT01448616|593246500|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
164238642|NCT04577781|593246501|FG000|Overall Study|Adverse Event|2|||
164238643|NCT04577781|593246502|FG001|Overall Study|Adverse Event|2|||
164238644|NCT04577781|593246501|FG000|Overall Study|Physician Decision|1|||
164238645|NCT04577781|593246502|FG001|Overall Study|Physician Decision|0|||
164238646|NCT01464879|593246503|FG000|Overall Study|Physician Decision|1|||
164238647|NCT01464879|593246503|FG000|Overall Study|Non-compliance|1|||
164238648|NCT02951780|593246508|FG000|Period 1|Adverse Event|0|||
164238649|NCT02951780|593246509|FG001|Period 1|Adverse Event|0|||
164238650|NCT02951780|593246510|FG002|Period 1|Adverse Event|0|||
164238651|NCT02951780|593246511|FG003|Period 1|Adverse Event|1|||
164238652|NCT02951780|593246512|FG004|Period 1|Adverse Event|0|||
164238653|NCT02951780|593246513|FG005|Period 1|Adverse Event|0|||
164238654|NCT02951780|593246514|FG006|Period 1|Adverse Event|0|||
164238655|NCT02951780|593246515|FG007|Period 1|Adverse Event|0|||
164238656|NCT02951780|593246516|FG008|Period 1|Adverse Event|0|||
164238657|NCT02951780|593246508|FG000|Period 1|Scheduling Conflicts|0|||
164238658|NCT02951780|593246509|FG001|Period 1|Scheduling Conflicts|0|||
164238659|NCT02951780|593246510|FG002|Period 1|Scheduling Conflicts|0|||
164238660|NCT02951780|593246511|FG003|Period 1|Scheduling Conflicts|0|||
164238661|NCT02951780|593246512|FG004|Period 1|Scheduling Conflicts|0|||
164238662|NCT02951780|593246513|FG005|Period 1|Scheduling Conflicts|0|||
164238663|NCT02951780|593246514|FG006|Period 1|Scheduling Conflicts|0|||
164238664|NCT02951780|593246515|FG007|Period 1|Scheduling Conflicts|1|||
164238665|NCT02951780|593246516|FG008|Period 1|Scheduling Conflicts|0|||
164238666|NCT02951780|593246508|FG000|Period 2|Scheduling Conflicts|0|||
164238667|NCT02951780|593246509|FG001|Period 2|Scheduling Conflicts|0|||
164238668|NCT02951780|593246510|FG002|Period 2|Scheduling Conflicts|0|||
164238669|NCT02951780|593246511|FG003|Period 2|Scheduling Conflicts|0|||
164238670|NCT02951780|593246512|FG004|Period 2|Scheduling Conflicts|0|||
164238671|NCT02951780|593246513|FG005|Period 2|Scheduling Conflicts|0|||
164238672|NCT02951780|593246514|FG006|Period 2|Scheduling Conflicts|0|||
164238673|NCT02951780|593246515|FG007|Period 2|Scheduling Conflicts|1|||
164238674|NCT02951780|593246516|FG008|Period 2|Scheduling Conflicts|0|||
164238675|NCT00508482|593246517|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
164238676|NCT00508482|593246518|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
164238677|NCT00508482|593246519|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
164238678|NCT00508482|593246517|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
164238679|NCT00508482|593246518|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
164238680|NCT00508482|593246519|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
164238681|NCT00508482|593246517|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
164238682|NCT00508482|593246518|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
164238683|NCT00508482|593246519|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
164238684|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
164238685|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
164238686|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
164238687|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
164238688|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
164238689|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
164238690|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
164238691|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
164238692|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
164238693|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
164238694|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
164238695|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
164238696|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
164238697|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
164238698|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
163989110|NCT01528787|592328256|FG001|Overall Study|Withdrawal by Subject|0|||
164238699|NCT00546481|593246520|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
164238700|NCT00546481|593246521|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
164238701|NCT00546481|593246522|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
164238702|NCT00546481|593246520|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
164238703|NCT00546481|593246521|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
164238704|NCT00546481|593246522|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
163884630|NCT03158129|591947821|FG001|Overall Study|Progression|1|||
163884631|NCT03158129|591947822|FG002|Overall Study|Progression|0|||
163884632|NCT03158129|591947823|FG003|Overall Study|Progression|0|||
163884633|NCT03158129|591947820|FG000|Overall Study|Lack of resectability|0|||
164083326|NCT02224456|592670116|FG000|Overall Study|Withdrawal by Subject|9|||
164083327|NCT02224456|592670116|FG000|Overall Study|Physician Decision|3|||
164083328|NCT02224456|592670116|FG000|Overall Study|Death|2|||
164238705|NCT00546481|593246520|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
164238706|NCT00546481|593246521|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
164238707|NCT00546481|593246522|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
164238708|NCT00546481|593246520|FG000|Maintenance Phase (CERA)|Other Reason|0|||
164238709|NCT00546481|593246521|FG001|Maintenance Phase (CERA)|Other Reason|0|||
164238710|NCT00546481|593246522|FG002|Maintenance Phase (CERA)|Other Reason|1|||
164238711|NCT00244621|593246523|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164238712|NCT00244621|593246524|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164238713|NCT00244621|593246525|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164238714|NCT00244621|593246523|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164238715|NCT00244621|593246524|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164238716|NCT00244621|593246525|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164238717|NCT00244621|593246523|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164238718|NCT00244621|593246524|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
164238719|NCT00244621|593246525|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164238720|NCT00244621|593246523|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
164238721|NCT00244621|593246524|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
164238722|NCT00244621|593246525|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
164238723|NCT00244621|593246523|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164238724|NCT00244621|593246524|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
164238725|NCT00244621|593246525|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
164238726|NCT00244621|593246523|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
164238727|NCT00244621|593246524|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164238728|NCT00244621|593246525|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
164238729|NCT00244621|593246523|FG000|Open-label Treatment Period|Adverse Event|0|||
164238730|NCT00244621|593246524|FG001|Open-label Treatment Period|Adverse Event|0|||
164238731|NCT00244621|593246525|FG002|Open-label Treatment Period|Adverse Event|1|||
164238732|NCT00244621|593246523|FG000|Open-label Treatment Period|Moved abroad|0|||
164238733|NCT00244621|593246524|FG001|Open-label Treatment Period|Moved abroad|0|||
164238734|NCT00244621|593246525|FG002|Open-label Treatment Period|Moved abroad|1|||
164238735|NCT02271529|593246528|FG000|Overall Study|Withdrawal by Subject|1|||
164238736|NCT00811720|593246532|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
164238737|NCT00811720|593246533|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
164238738|NCT00811720|593246532|FG000|All Treated Patients|Adverse Event|20|||
164238739|NCT00811720|593246533|FG001|All Treated Patients|Adverse Event|62|||
164238740|NCT00811720|593246532|FG000|All Treated Patients|Lack of Efficacy|22|||
164238741|NCT00811720|593246533|FG001|All Treated Patients|Lack of Efficacy|18|||
164238742|NCT00811720|593246532|FG000|All Treated Patients|Non-compliance|0|||
164238743|NCT00811720|593246533|FG001|All Treated Patients|Non-compliance|14|||
164238744|NCT00811720|593246532|FG000|All Treated Patients|Protocol Violation|9|||
164238745|NCT00811720|593246533|FG001|All Treated Patients|Protocol Violation|16|||
164238746|NCT00811720|593246532|FG000|All Treated Patients|Withdrawal by Subject|28|||
164238747|NCT00811720|593246533|FG001|All Treated Patients|Withdrawal by Subject|34|||
164238748|NCT00811720|593246532|FG000|All Treated Patients|Lost to Follow-up|10|||
164238749|NCT00811720|593246533|FG001|All Treated Patients|Lost to Follow-up|16|||
164238750|NCT00811720|593246532|FG000|All Treated Patients|Other Reason|7|||
164238751|NCT00811720|593246533|FG001|All Treated Patients|Other Reason|4|||
164238752|NCT03894891|593246534|FG000|Overall Study|Withdrawal by Subject|1|||
164238753|NCT03894891|593246534|FG000|Overall Study|Completed protocol treatment per protocol|5|||
164238754|NCT01644643|593246542|FG000|Overall Study|Death|1|||
164238755|NCT01644643|593246543|FG001|Overall Study|Death|0|||
164238756|NCT01644643|593246544|FG002|Overall Study|Death|3|||
164335667|NCT02633501|593606035|FG000|Overall Study|Withdrawal by Subject|2|||
164335668|NCT02633501|593606036|FG001|Overall Study|Withdrawal by Subject|1|||
164335669|NCT02633501|593606037|FG002|Overall Study|Withdrawal by Subject|2|||
164335670|NCT02633501|593606038|FG003|Overall Study|Withdrawal by Subject|2|||
164335671|NCT02633501|593606039|FG004|Overall Study|Withdrawal by Subject|1|||
164335672|NCT02633501|593606040|FG005|Overall Study|Withdrawal by Subject|3|||
164335673|NCT02633501|593606035|FG000|Overall Study|Various other reasons|0|||
164238757|NCT01644643|593246545|FG003|Overall Study|Death|3|||
164335674|NCT02633501|593606036|FG001|Overall Study|Various other reasons|2|||
164335675|NCT02633501|593606037|FG002|Overall Study|Various other reasons|4|||
164335676|NCT02633501|593606038|FG003|Overall Study|Various other reasons|1|||
164335677|NCT02633501|593606039|FG004|Overall Study|Various other reasons|7|||
164335678|NCT02633501|593606040|FG005|Overall Study|Various other reasons|11|||
164335679|NCT02633501|593606035|FG000|Overall Study|Lost to Follow-up|0|||
164335680|NCT02633501|593606036|FG001|Overall Study|Lost to Follow-up|0|||
164335681|NCT02633501|593606037|FG002|Overall Study|Lost to Follow-up|0|||
164335682|NCT02633501|593606038|FG003|Overall Study|Lost to Follow-up|1|||
164238758|NCT01644643|593246542|FG000|Overall Study|Lost to Follow-up|0|||
164238759|NCT01644643|593246543|FG001|Overall Study|Lost to Follow-up|0|||
164335683|NCT02633501|593606039|FG004|Overall Study|Lost to Follow-up|2|||
164335684|NCT02633501|593606040|FG005|Overall Study|Lost to Follow-up|0|||
164335685|NCT01104155|593606042|FG000|Overall Study|Adverse Event|15|||
164238760|NCT01644643|593246544|FG002|Overall Study|Lost to Follow-up|0|||
164238761|NCT01644643|593246545|FG003|Overall Study|Lost to Follow-up|4|||
164238762|NCT01644643|593246542|FG000|Overall Study|Withdrawal by Subject|1|||
164238763|NCT01644643|593246543|FG001|Overall Study|Withdrawal by Subject|0|||
164238764|NCT01644643|593246544|FG002|Overall Study|Withdrawal by Subject|2|||
164238765|NCT01644643|593246545|FG003|Overall Study|Withdrawal by Subject|1|||
164238766|NCT01644643|593246542|FG000|Overall Study|Other Eligibility criteria|0|||
164238767|NCT01644643|593246543|FG001|Overall Study|Other Eligibility criteria|0|||
164238768|NCT01644643|593246544|FG002|Overall Study|Other Eligibility criteria|0|||
164238769|NCT01644643|593246545|FG003|Overall Study|Other Eligibility criteria|2|||
164238770|NCT04940130|593246546|FG000|Overall Study|Travel|1|||
164238771|NCT04940130|593246547|FG001|Overall Study|Travel|0|||
164238772|NCT04940130|593246548|FG002|Overall Study|Travel|2|||
164238773|NCT04940130|593246546|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
164238774|NCT04940130|593246547|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
164238775|NCT04940130|593246548|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
164238776|NCT04940130|593246546|FG000|Overall Study|Adverse Event|0|||
164238777|NCT04940130|593246547|FG001|Overall Study|Adverse Event|0|||
164238778|NCT04940130|593246548|FG002|Overall Study|Adverse Event|2|||
164238779|NCT04940130|593246546|FG000|Overall Study|Disease progression/treatment failure|0|||
164238780|NCT04940130|593246547|FG001|Overall Study|Disease progression/treatment failure|0|||
164238781|NCT04940130|593246548|FG002|Overall Study|Disease progression/treatment failure|1|||
164238782|NCT04940130|593246546|FG000|Overall Study|Participant refusal|0|||
164238783|NCT04940130|593246547|FG001|Overall Study|Participant refusal|0|||
164238784|NCT04940130|593246548|FG002|Overall Study|Participant refusal|1|||
164238785|NCT00421148|593246551|FG000|Overall Study|Lost to Follow-up|0|||
164238786|NCT00421148|593246552|FG001|Overall Study|Lost to Follow-up|0|||
164238787|NCT00421148|593246553|FG002|Overall Study|Lost to Follow-up|0|||
164238788|NCT00421148|593246554|FG003|Overall Study|Lost to Follow-up|0|||
164238789|NCT00421148|593246555|FG004|Overall Study|Lost to Follow-up|0|||
164238790|NCT00421148|593246556|FG005|Overall Study|Lost to Follow-up|0|||
164238791|NCT00421148|593246557|FG006|Overall Study|Lost to Follow-up|0|||
164238792|NCT00421148|593246558|FG007|Overall Study|Lost to Follow-up|0|||
164238793|NCT00421148|593246559|FG008|Overall Study|Lost to Follow-up|0|||
164238794|NCT00421148|593246560|FG009|Overall Study|Lost to Follow-up|0|||
164238795|NCT00421148|593246561|FG010|Overall Study|Lost to Follow-up|0|||
164238796|NCT00421148|593246562|FG011|Overall Study|Lost to Follow-up|0|||
164238797|NCT00421148|593246563|FG012|Overall Study|Lost to Follow-up|0|||
164238798|NCT00421148|593246564|FG013|Overall Study|Lost to Follow-up|0|||
164238799|NCT00421148|593246565|FG014|Overall Study|Lost to Follow-up|0|||
164238800|NCT00421148|593246566|FG015|Overall Study|Lost to Follow-up|0|||
164238801|NCT00421148|593246567|FG016|Overall Study|Lost to Follow-up|0|||
164238802|NCT00421148|593246568|FG017|Overall Study|Lost to Follow-up|1|||
164238803|NCT00421148|593246569|FG018|Overall Study|Lost to Follow-up|0|||
164238804|NCT00421148|593246570|FG019|Overall Study|Lost to Follow-up|0|||
164238805|NCT00421148|593246551|FG000|Overall Study|Withdrawal by Subject|0|||
164238806|NCT00421148|593246552|FG001|Overall Study|Withdrawal by Subject|0|||
164238807|NCT00421148|593246553|FG002|Overall Study|Withdrawal by Subject|0|||
164238808|NCT00421148|593246554|FG003|Overall Study|Withdrawal by Subject|0|||
164238809|NCT00421148|593246555|FG004|Overall Study|Withdrawal by Subject|0|||
164238810|NCT00421148|593246556|FG005|Overall Study|Withdrawal by Subject|0|||
164006633|NCT00847613|592391043|FG002|Overall Study|Lack of Efficacy|3|||
164238811|NCT00421148|593246557|FG006|Overall Study|Withdrawal by Subject|0|||
164238812|NCT00421148|593246558|FG007|Overall Study|Withdrawal by Subject|0|||
164238813|NCT00421148|593246559|FG008|Overall Study|Withdrawal by Subject|0|||
164238814|NCT00421148|593246560|FG009|Overall Study|Withdrawal by Subject|0|||
164238815|NCT00421148|593246561|FG010|Overall Study|Withdrawal by Subject|0|||
164238816|NCT00421148|593246562|FG011|Overall Study|Withdrawal by Subject|0|||
164238817|NCT00421148|593246563|FG012|Overall Study|Withdrawal by Subject|0|||
164238818|NCT00421148|593246564|FG013|Overall Study|Withdrawal by Subject|0|||
164238819|NCT00421148|593246565|FG014|Overall Study|Withdrawal by Subject|0|||
164238820|NCT00421148|593246566|FG015|Overall Study|Withdrawal by Subject|0|||
164238821|NCT00421148|593246567|FG016|Overall Study|Withdrawal by Subject|0|||
164238822|NCT00421148|593246568|FG017|Overall Study|Withdrawal by Subject|1|||
164238823|NCT00421148|593246569|FG018|Overall Study|Withdrawal by Subject|0|||
164238824|NCT00421148|593246570|FG019|Overall Study|Withdrawal by Subject|0|||
164238825|NCT00421148|593246551|FG000|Overall Study|Protocol Violation|0|||
164238826|NCT00421148|593246552|FG001|Overall Study|Protocol Violation|0|||
164238827|NCT00421148|593246553|FG002|Overall Study|Protocol Violation|0|||
164238828|NCT00421148|593246554|FG003|Overall Study|Protocol Violation|0|||
164238829|NCT00421148|593246555|FG004|Overall Study|Protocol Violation|0|||
164238830|NCT00421148|593246556|FG005|Overall Study|Protocol Violation|1|||
164238831|NCT00421148|593246557|FG006|Overall Study|Protocol Violation|0|||
164238832|NCT00421148|593246558|FG007|Overall Study|Protocol Violation|0|||
164238833|NCT00421148|593246559|FG008|Overall Study|Protocol Violation|0|||
164238834|NCT00421148|593246560|FG009|Overall Study|Protocol Violation|0|||
164238835|NCT00421148|593246561|FG010|Overall Study|Protocol Violation|0|||
164238836|NCT00421148|593246562|FG011|Overall Study|Protocol Violation|0|||
164238837|NCT00421148|593246563|FG012|Overall Study|Protocol Violation|0|||
164238838|NCT00421148|593246564|FG013|Overall Study|Protocol Violation|0|||
164238839|NCT00421148|593246565|FG014|Overall Study|Protocol Violation|0|||
164238840|NCT00421148|593246566|FG015|Overall Study|Protocol Violation|0|||
164238841|NCT00421148|593246567|FG016|Overall Study|Protocol Violation|0|||
164238842|NCT00421148|593246568|FG017|Overall Study|Protocol Violation|0|||
164238843|NCT00421148|593246569|FG018|Overall Study|Protocol Violation|1|||
164238844|NCT00421148|593246570|FG019|Overall Study|Protocol Violation|0|||
164238845|NCT03289533|593246571|FG000|Overall Study|Death|12|||
164238846|NCT03289533|593246571|FG000|Overall Study|Terminated from study by sponsor|10|||
164238847|NCT00539240|593246572|FG000|Overall Study|Withdrawal by Subject|0|||
164238848|NCT00539240|593246573|FG001|Overall Study|Withdrawal by Subject|2|||
164238849|NCT00539240|593246574|FG002|Overall Study|Withdrawal by Subject|0|||
164238850|NCT00539240|593246572|FG000|Overall Study|Protocol Violation|1|||
164335686|NCT01104155|593606043|FG001|Overall Study|Adverse Event|8|||
164335687|NCT01104155|593606042|FG000|Overall Study|Participant choice|6|||
164335688|NCT01104155|593606043|FG001|Overall Study|Participant choice|5|||
164335689|NCT01104155|593606042|FG000|Overall Study|Withdrawal of consent|1|||
164335690|NCT01104155|593606043|FG001|Overall Study|Withdrawal of consent|1|||
164335691|NCT01104155|593606042|FG000|Overall Study|Other|3|||
164335692|NCT01104155|593606043|FG001|Overall Study|Other|4|||
164335693|NCT01672736|593606044|FG000|Overall Study|Available drug expired on 31 May 16|3|||
164335694|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
164335695|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
164335696|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Death|1|||
164335697|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Death|0|||
164335698|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
164335699|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
164335700|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
164335701|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
164335702|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
164335703|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
164335704|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
164335705|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
164335706|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
164335707|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
164335708|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
164335709|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
164335710|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
164335711|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
164335712|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
164335713|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
164335714|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
164335715|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
164335716|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
164335717|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
164335718|NCT02927262|593606047|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
164335719|NCT02927262|593606048|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
164335720|NCT02927262|593606047|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
164335721|NCT02927262|593606048|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
164335722|NCT02927262|593606047|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
164335723|NCT02927262|593606048|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
164335724|NCT02927262|593606047|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
164335725|NCT02927262|593606048|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
164335726|NCT02853344|593606051|FG000|Overall Study|Lost to Follow-up|1|||
164335727|NCT02853344|593606052|FG001|Overall Study|Lost to Follow-up|1|||
164335728|NCT02853344|593606051|FG000|Overall Study|Withdrawal by Subject|2|||
164335729|NCT02853344|593606052|FG001|Overall Study|Withdrawal by Subject|4|||
163884634|NCT03158129|591947821|FG001|Overall Study|Lack of resectability|1|||
163884635|NCT03158129|591947822|FG002|Overall Study|Lack of resectability|0|||
163884636|NCT03158129|591947823|FG003|Overall Study|Lack of resectability|0|||
163884637|NCT03158129|591947820|FG000|Overall Study|Declined surgery|0|||
163884638|NCT03158129|591947821|FG001|Overall Study|Declined surgery|1|||
163884639|NCT03158129|591947822|FG002|Overall Study|Declined surgery|0|||
164238851|NCT00539240|593246573|FG001|Overall Study|Protocol Violation|1|||
164238852|NCT00539240|593246574|FG002|Overall Study|Protocol Violation|4|||
164238853|NCT00539240|593246572|FG000|Overall Study|Lost to Follow-up|2|||
164238854|NCT00539240|593246573|FG001|Overall Study|Lost to Follow-up|3|||
164238855|NCT00539240|593246574|FG002|Overall Study|Lost to Follow-up|1|||
164238856|NCT00539240|593246572|FG000|Overall Study|Adverse Event|3|||
164238857|NCT00539240|593246573|FG001|Overall Study|Adverse Event|1|||
164238858|NCT00539240|593246574|FG002|Overall Study|Adverse Event|10|||
164238859|NCT01284959|593246575|FG000|Overall Study|Withdrawal by Subject|1|||
164238860|NCT01284959|593246576|FG001|Overall Study|Withdrawal by Subject|0|||
163989111|NCT01528787|592328257|FG002|Overall Study|Withdrawal by Subject|0|||
164238861|NCT01284959|593246577|FG002|Overall Study|Withdrawal by Subject|0|||
164238862|NCT01284959|593246575|FG000|Overall Study|Adverse Event|0|||
164238863|NCT01284959|593246576|FG001|Overall Study|Adverse Event|0|||
164238864|NCT01284959|593246577|FG002|Overall Study|Adverse Event|1|||
164238865|NCT01055613|593246578|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
164238866|NCT01055613|593246579|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164238867|NCT01055613|593246578|FG000|Overall Study|Unacceptable lens fit|1|||
164238868|NCT01055613|593246579|FG001|Overall Study|Unacceptable lens fit|0|||
164238869|NCT01055613|593246578|FG000|Overall Study|Discomfort|2|||
164238870|NCT01055613|593246579|FG001|Overall Study|Discomfort|1|||
164238871|NCT01055613|593246578|FG000|Overall Study|Lost to Follow-up|1|||
164238872|NCT01055613|593246579|FG001|Overall Study|Lost to Follow-up|1|||
164238873|NCT01055613|593246578|FG000|Overall Study|Protocol Violation|1|||
164238874|NCT01055613|593246579|FG001|Overall Study|Protocol Violation|1|||
164238875|NCT01055613|593246578|FG000|Overall Study|Subject Disinterest|1|||
164238876|NCT01055613|593246579|FG001|Overall Study|Subject Disinterest|1|||
164238877|NCT00363311|593246580|FG000|Overall Study|Adverse Event|6|||
164238878|NCT00363311|593246581|FG001|Overall Study|Adverse Event|4|||
164238879|NCT00363311|593246580|FG000|Overall Study|Lost to Follow-up|3|||
164238880|NCT00363311|593246581|FG001|Overall Study|Lost to Follow-up|0|||
164238881|NCT00363311|593246580|FG000|Overall Study|Protocol Violation|1|||
164238882|NCT00363311|593246581|FG001|Overall Study|Protocol Violation|2|||
164238883|NCT00363311|593246580|FG000|Overall Study|Withdrawal by Subject|12|||
164238884|NCT00363311|593246581|FG001|Overall Study|Withdrawal by Subject|6|||
164238885|NCT00363311|593246580|FG000|Overall Study|Physician Decision|1|||
164238886|NCT00363311|593246581|FG001|Overall Study|Physician Decision|1|||
164238887|NCT00363311|593246580|FG000|Overall Study|Sponsor Terminated Study|2|||
164238888|NCT00363311|593246581|FG001|Overall Study|Sponsor Terminated Study|2|||
164238889|NCT00363311|593246580|FG000|Overall Study|Disease Progression|46|||
164238890|NCT00363311|593246581|FG001|Overall Study|Disease Progression|26|||
164238891|NCT00363311|593246580|FG000|Overall Study|Non-Compliance|1|||
164238892|NCT00363311|593246581|FG001|Overall Study|Non-Compliance|1|||
164238893|NCT00363311|593246580|FG000|Overall Study|Participant Refused Biopsy|1|||
164238894|NCT00363311|593246581|FG001|Overall Study|Participant Refused Biopsy|0|||
164238895|NCT00363311|593246580|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
164238896|NCT00363311|593246581|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
164238897|NCT00363311|593246580|FG000|Overall Study|Participant Opted for Treatment|1|||
164238898|NCT00363311|593246581|FG001|Overall Study|Participant Opted for Treatment|0|||
164238899|NCT00363311|593246580|FG000|Overall Study|Participant Moved to Another Country|1|||
164238900|NCT00363311|593246581|FG001|Overall Study|Participant Moved to Another Country|0|||
164238901|NCT00363311|593246580|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
164238902|NCT00363311|593246581|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
164238903|NCT00363311|593246580|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
164238904|NCT00363311|593246581|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
164238905|NCT00363311|593246580|FG000|Overall Study|Participant Moved to Louisiana|0|||
164238906|NCT00363311|593246581|FG001|Overall Study|Participant Moved to Louisiana|1|||
164238907|NCT01677988|593246587|FG000|Overall Study|Lack of Efficacy|2|||
164238908|NCT02629861|593246604|FG000|Overall Study|Adverse Event|7|||
164238909|NCT02629861|593246605|FG001|Overall Study|Adverse Event|5|||
164238910|NCT02629861|593246606|FG002|Overall Study|Adverse Event|4|||
164335730|NCT02853344|593606051|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
164335731|NCT02853344|593606052|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
164335732|NCT02853344|593606051|FG000|Overall Study|Death|70|||
164335733|NCT02853344|593606052|FG001|Overall Study|Death|112|||
164335734|NCT02913612|593606053|FG000|Overall Study|Lost to Follow-up|6|||
164335735|NCT02913612|593606054|FG001|Overall Study|Lost to Follow-up|5|||
164335736|NCT02913612|593606055|FG002|Overall Study|Lost to Follow-up|2|||
164335737|NCT02913612|593606056|FG003|Overall Study|Lost to Follow-up|0|||
163989112|NCT01528787|592328258|FG003|Overall Study|Withdrawal by Subject|1|||
164238911|NCT02629861|593246604|FG000|Overall Study|Withdrawal by Subject|5|||
164238912|NCT02629861|593246605|FG001|Overall Study|Withdrawal by Subject|8|||
164238913|NCT02629861|593246606|FG002|Overall Study|Withdrawal by Subject|13|||
164238914|NCT02629861|593246604|FG000|Overall Study|Protocol Violation|2|||
164238915|NCT02629861|593246605|FG001|Overall Study|Protocol Violation|3|||
164335738|NCT02913612|593606053|FG000|Overall Study|Physician Decision|1|||
164238916|NCT02629861|593246606|FG002|Overall Study|Protocol Violation|7|||
164238917|NCT02629861|593246604|FG000|Overall Study|Lost to Follow-up|12|||
164335739|NCT02913612|593606054|FG001|Overall Study|Physician Decision|4|||
164335740|NCT02913612|593606055|FG002|Overall Study|Physician Decision|1|||
163989113|NCT01528787|592328255|FG000|Overall Study|Family Emergency|0|||
164238918|NCT02629861|593246605|FG001|Overall Study|Lost to Follow-up|9|||
164238919|NCT02629861|593246606|FG002|Overall Study|Lost to Follow-up|4|||
164238920|NCT02629861|593246604|FG000|Overall Study|Other|1|||
164238921|NCT02629861|593246605|FG001|Overall Study|Other|1|||
164238922|NCT02629861|593246606|FG002|Overall Study|Other|0|||
164238923|NCT02629861|593246604|FG000|Overall Study|Pregnancy|2|||
164238924|NCT02629861|593246605|FG001|Overall Study|Pregnancy|1|||
164238925|NCT02629861|593246606|FG002|Overall Study|Pregnancy|0|||
164238926|NCT00271544|593246607|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
164238927|NCT00271544|593246607|FG000|Overall Study|Model 4196 lead not attempted|9|||
164238928|NCT00271544|593246607|FG000|Overall Study|Implant not attempted|4|||
164238929|NCT00902330|593246614|FG000|Overall Study|Too overwhelmed by treatment|2|||
164238930|NCT00902330|593246615|FG001|Overall Study|Too overwhelmed by treatment|5|||
164238931|NCT00902330|593246614|FG000|Overall Study|Adverse Event|1|||
164238932|NCT00902330|593246615|FG001|Overall Study|Adverse Event|0|||
164238933|NCT00902330|593246614|FG000|Overall Study|No post baseline data|1|||
164238934|NCT00902330|593246615|FG001|Overall Study|No post baseline data|0|||
164238935|NCT00165789|593246616|FG000|Overall Study|Adverse Event|0|||
164238936|NCT00165789|593246617|FG001|Overall Study|Adverse Event|3|||
164238937|NCT00165789|593246618|FG002|Overall Study|Adverse Event|0|||
164238938|NCT00165789|593246619|FG003|Overall Study|Adverse Event|12|||
164238939|NCT00165789|593246616|FG000|Overall Study|Withdrawal by Subject|0|||
164238940|NCT00165789|593246617|FG001|Overall Study|Withdrawal by Subject|1|||
164238941|NCT00165789|593246618|FG002|Overall Study|Withdrawal by Subject|1|||
164238942|NCT00165789|593246619|FG003|Overall Study|Withdrawal by Subject|2|||
164238943|NCT03571971|593246620|FG000|Overall Study|Lost to Follow-up|2|||
164238944|NCT03571971|593246621|FG001|Overall Study|Lost to Follow-up|2|||
164238945|NCT03571971|593246620|FG000|Overall Study|Protocol Violation|2|||
164238946|NCT03571971|593246621|FG001|Overall Study|Protocol Violation|3|||
164238947|NCT03571971|593246620|FG000|Overall Study|Withdrawal by Subject|2|||
164238948|NCT03571971|593246621|FG001|Overall Study|Withdrawal by Subject|0|||
164238949|NCT03571971|593246620|FG000|Overall Study|Incomplete primary outcome data|2|||
164238950|NCT03571971|593246621|FG001|Overall Study|Incomplete primary outcome data|0|||
164238951|NCT03950856|593246625|FG000|Overall Study|Death|1|||
164238952|NCT03950856|593246626|FG001|Overall Study|Death|2|||
164238953|NCT03950856|593246627|FG002|Overall Study|Death|0|||
164238954|NCT03950856|593246628|FG003|Overall Study|Death|0|||
164238955|NCT03950856|593246625|FG000|Overall Study|Lost to Follow-up|5|||
164238956|NCT03950856|593246626|FG001|Overall Study|Lost to Follow-up|6|||
164238957|NCT03950856|593246627|FG002|Overall Study|Lost to Follow-up|8|||
164238958|NCT03950856|593246628|FG003|Overall Study|Lost to Follow-up|2|||
164238959|NCT03950856|593246625|FG000|Overall Study|Protocol Violation|2|||
164238960|NCT03950856|593246626|FG001|Overall Study|Protocol Violation|0|||
164238961|NCT03950856|593246627|FG002|Overall Study|Protocol Violation|0|||
164238962|NCT03950856|593246628|FG003|Overall Study|Protocol Violation|1|||
164238963|NCT03950856|593246625|FG000|Overall Study|Withdrawal by Subject|4|||
164238964|NCT03950856|593246626|FG001|Overall Study|Withdrawal by Subject|1|||
164238965|NCT03950856|593246627|FG002|Overall Study|Withdrawal by Subject|3|||
164238966|NCT03950856|593246628|FG003|Overall Study|Withdrawal by Subject|1|||
164238967|NCT03950856|593246625|FG000|Overall Study|Unable to phone|7|||
164238968|NCT03950856|593246626|FG001|Overall Study|Unable to phone|6|||
164238969|NCT03950856|593246627|FG002|Overall Study|Unable to phone|7|||
164238970|NCT03950856|593246628|FG003|Overall Study|Unable to phone|2|||
164238971|NCT01816984|593246629|FG000|Overall Study|declining health status|1|||
164238972|NCT00810277|593247737|FG000|Overall Study|Adverse Event|1|||
164238973|NCT00529243|593247741|FG000|Overall Study|Adverse Event|1|||
164238974|NCT00529243|593247741|FG000|Overall Study|Death|1|||
164238975|NCT00529243|593247741|FG000|Overall Study|Relocated|1|||
164238976|NCT01856322|593247742|FG000|Overall Study|off study due to lack of accrual|0|||
164238977|NCT01856322|593247743|FG001|Overall Study|off study due to lack of accrual|0|||
164238978|NCT01856322|593247744|FG002|Overall Study|off study due to lack of accrual|3|||
164238979|NCT04592341|593247745|FG000|Overall Study|Physician Decision|5|||
164238980|NCT04592341|593247745|FG000|Overall Study|Study Terminated by Sponsor|5|||
164238981|NCT04592341|593247745|FG000|Overall Study|Withdrawal by Subject|53|||
164238982|NCT04592341|593247745|FG000|Overall Study|Lost to Follow-up|3|||
164238983|NCT04592341|593247745|FG000|Overall Study|Death|1|||
164238984|NCT04592341|593247745|FG000|Overall Study|Adverse Event|5|||
164238985|NCT04592341|593247745|FG000|Overall Study|other|4|||
164238986|NCT02896257|593247746|FG000|Providers|Without eligible patients|21|||
164238987|NCT02896257|593247747|FG001|Providers|Without eligible patients|28|||
164238988|NCT02896257|593247746|FG000|Patients|PFT entry criteria not met|43|||
164238989|NCT02896257|593247747|FG001|Patients|PFT entry criteria not met|50|||
164238990|NCT02896257|593247746|FG000|Patients|No capacity to review|8|||
164238991|NCT02896257|593247747|FG001|Patients|No capacity to review|11|||
164238992|NCT02896257|593247746|FG000|Patients|Appointment rescheduled/cancelled|5|||
164238993|NCT02896257|593247747|FG001|Patients|Appointment rescheduled/cancelled|7|||
164238994|NCT02896257|593247746|FG000|Patients|PCP not assigned a clinic|4|||
164238995|NCT02896257|593247747|FG001|Patients|PCP not assigned a clinic|0|||
164238996|NCT02896257|593247746|FG000|Patients|No history of COPD|0|||
164238997|NCT02896257|593247747|FG001|Patients|No history of COPD|1|||
164238998|NCT02896257|593247746|FG000|Patients|Deceased between review and index date|0|||
164238999|NCT02896257|593247747|FG001|Patients|Deceased between review and index date|1|||
164239000|NCT02896257|593247746|FG000|Patients|No ICS Rx upon review|1|||
164239001|NCT02896257|593247747|FG001|Patients|No ICS Rx upon review|1|||
164239002|NCT02896257|593247746|FG000|Patients|Protocol Violation|2|||
164239003|NCT02896257|593247747|FG001|Patients|Protocol Violation|1|||
164239004|NCT02896257|593247746|FG000|Patients|Hospice care|0|||
164239005|NCT02896257|593247747|FG001|Patients|Hospice care|1|||
164239006|NCT03423602|593247752|FG000|Overall Study|Death|1|||
164239007|NCT03423602|593247752|FG000|Overall Study|Lost to Follow-up|6|||
164239008|NCT03423602|593247752|FG000|Overall Study|Protocol Violation|1|||
164239009|NCT03423602|593247752|FG000|Overall Study|Withdrawal by Subject|4|||
164239010|NCT00692003|593247753|FG000|Overall Study|Sponsor Decision|5|||
164239011|NCT00692003|593247754|FG001|Overall Study|Sponsor Decision|1|||
164239012|NCT03257358|593247755|FG000|Overall Study|Adverse Event|25|||
164239013|NCT03257358|593247756|FG001|Overall Study|Adverse Event|12|||
164239014|NCT03257358|593247755|FG000|Overall Study|Lack of Efficacy|1|||
164239015|NCT03257358|593247756|FG001|Overall Study|Lack of Efficacy|1|||
164239016|NCT03257358|593247755|FG000|Overall Study|Lost to Follow-up|12|||
164239017|NCT03257358|593247756|FG001|Overall Study|Lost to Follow-up|4|||
164239018|NCT03257358|593247755|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
164239019|NCT03257358|593247756|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
164239020|NCT03257358|593247755|FG000|Overall Study|Physician Decision|2|||
164239021|NCT03257358|593247756|FG001|Overall Study|Physician Decision|2|||
164239022|NCT03257358|593247755|FG000|Overall Study|Protocol Violation|5|||
164239023|NCT03257358|593247756|FG001|Overall Study|Protocol Violation|3|||
164239024|NCT03257358|593247755|FG000|Overall Study|Technical problems|4|||
164239025|NCT03257358|593247756|FG001|Overall Study|Technical problems|1|||
164239026|NCT03257358|593247755|FG000|Overall Study|Withdrawal by Subject|8|||
164239027|NCT03257358|593247756|FG001|Overall Study|Withdrawal by Subject|3|||
164239028|NCT03257358|593247755|FG000|Overall Study|Withdrawal of informed consent|9|||
164239029|NCT03257358|593247756|FG001|Overall Study|Withdrawal of informed consent|5|||
164239030|NCT03257358|593247755|FG000|Overall Study|New therapy for study indication|1|||
164239031|NCT03257358|593247756|FG001|Overall Study|New therapy for study indication|0|||
164239032|NCT03257358|593247755|FG000|Overall Study|No longer requires treatment|0|||
164239033|NCT03257358|593247756|FG001|Overall Study|No longer requires treatment|1|||
164239034|NCT02332187|593247757|FG000|Overall Study|Withdrawal by Subject|2|||
164239035|NCT02332187|593247758|FG001|Overall Study|Withdrawal by Subject|2|||
164239036|NCT02332187|593247757|FG000|Overall Study|Adverse Event|0|||
164239037|NCT02332187|593247758|FG001|Overall Study|Adverse Event|1|||
164239038|NCT01747915|593247759|FG000|Overall Study|Other|1|||
164239039|NCT01747915|593247760|FG001|Overall Study|Other|1|||
164239040|NCT01747915|593247761|FG002|Overall Study|Other|1|||
164239041|NCT01747915|593247759|FG000|Overall Study|Adverse Event|8|||
164239042|NCT01747915|593247760|FG001|Overall Study|Adverse Event|5|||
164239043|NCT01747915|593247761|FG002|Overall Study|Adverse Event|2|||
164239044|NCT01747915|593247759|FG000|Overall Study|Death|0|||
164239045|NCT01747915|593247760|FG001|Overall Study|Death|0|||
164239046|NCT01747915|593247761|FG002|Overall Study|Death|1|||
164239047|NCT01747915|593247759|FG000|Overall Study|Lack of Efficacy|0|||
164239048|NCT01747915|593247760|FG001|Overall Study|Lack of Efficacy|1|||
164239049|NCT01747915|593247761|FG002|Overall Study|Lack of Efficacy|0|||
164239050|NCT01747915|593247759|FG000|Overall Study|Lost to Follow-up|1|||
164239051|NCT01747915|593247760|FG001|Overall Study|Lost to Follow-up|0|||
164239052|NCT01747915|593247761|FG002|Overall Study|Lost to Follow-up|0|||
164239053|NCT01747915|593247759|FG000|Overall Study|Withdrawal by Subject|4|||
164239054|NCT01747915|593247760|FG001|Overall Study|Withdrawal by Subject|4|||
164239055|NCT01747915|593247761|FG002|Overall Study|Withdrawal by Subject|1|||
164239056|NCT01747915|593247759|FG000|Overall Study|Protocol Violation|1|||
164239057|NCT01747915|593247760|FG001|Overall Study|Protocol Violation|0|||
164239058|NCT01747915|593247761|FG002|Overall Study|Protocol Violation|0|||
164239059|NCT01747915|593247759|FG000|Overall Study|Pregnancy|0|||
164239060|NCT01747915|593247760|FG001|Overall Study|Pregnancy|0|||
164239061|NCT01747915|593247761|FG002|Overall Study|Pregnancy|1|||
164239062|NCT03443687|593247766|FG000|Overall Study|Lost to Follow-up|3|||
164239063|NCT03443687|593247767|FG001|Overall Study|Lost to Follow-up|5|||
164239064|NCT03443687|593247766|FG000|Overall Study|Withdrawal by Subject|1|||
164239065|NCT03443687|593247767|FG001|Overall Study|Withdrawal by Subject|0|||
164239066|NCT03443687|593247766|FG000|Overall Study|Discontinued intervention|1|||
164239067|NCT03443687|593247767|FG001|Overall Study|Discontinued intervention|1|||
164239068|NCT02805790|593247768|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
164239069|NCT02805790|593247769|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
164239070|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Physician Decision|0|||
164239071|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Physician Decision|0|||
164239072|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Physician Decision|1|||
164239073|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Physician Decision|0|||
164239074|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
163989114|NCT01528787|592328256|FG001|Overall Study|Family Emergency|0|||
163989115|NCT01528787|592328257|FG002|Overall Study|Family Emergency|1|||
163989116|NCT01528787|592328258|FG003|Overall Study|Family Emergency|0|||
164083329|NCT02224456|592670116|FG000|Overall Study|Pregnancy|4|||
164083330|NCT02224456|592670116|FG000|Overall Study|Protocol Violation|1|||
163989117|NCT02400255|592328266|FG000|Overall Study|Relapse|4|||
163989118|NCT02400255|592328267|FG001|Overall Study|Relapse|1|||
163989119|NCT02400255|592328268|FG002|Overall Study|Relapse|1|||
163989120|NCT02400255|592328269|FG003|Overall Study|Relapse|2|||
163989121|NCT02400255|592328266|FG000|Overall Study|Adverse Event|6|||
163989122|NCT02400255|592328267|FG001|Overall Study|Adverse Event|3|||
163989123|NCT02400255|592328268|FG002|Overall Study|Adverse Event|0|||
163989124|NCT02400255|592328269|FG003|Overall Study|Adverse Event|0|||
163989125|NCT02400255|592328266|FG000|Overall Study|Physician Decision|6|||
163989126|NCT02400255|592328267|FG001|Overall Study|Physician Decision|0|||
163989127|NCT02400255|592328268|FG002|Overall Study|Physician Decision|0|||
163989128|NCT02400255|592328269|FG003|Overall Study|Physician Decision|0|||
163989129|NCT02400255|592328266|FG000|Overall Study|Loss of insurance|1|||
163989130|NCT02400255|592328267|FG001|Overall Study|Loss of insurance|0|||
163989131|NCT02400255|592328268|FG002|Overall Study|Loss of insurance|0|||
163989132|NCT02400255|592328269|FG003|Overall Study|Loss of insurance|0|||
163989133|NCT02568046|592328270|FG000|Overall Study|Adverse Event|0|||
163989134|NCT02568046|592328271|FG001|Overall Study|Adverse Event|1|||
163989135|NCT02568046|592328270|FG000|Overall Study|Death|2|||
163989136|NCT02568046|592328271|FG001|Overall Study|Death|0|||
163989137|NCT02568046|592328270|FG000|Overall Study|Progressive Disease|1|||
163989138|NCT02568046|592328271|FG001|Overall Study|Progressive Disease|0|||
163989139|NCT02568046|592328270|FG000|Overall Study|Withdrawal by Subject|2|||
163989140|NCT02568046|592328271|FG001|Overall Study|Withdrawal by Subject|1|||
164083331|NCT02224456|592670116|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
164083332|NCT01241461|592670117|FG000|Overall Study|Progressive Disease|3|||
164083333|NCT01241461|592670118|FG001|Overall Study|Progressive Disease|6|||
164083334|NCT01379781|592670119|FG000|Overall Study|Lost to Follow-up|11|||
164083335|NCT01379781|592670120|FG001|Overall Study|Lost to Follow-up|8|||
164083336|NCT02247479|592670121|FG000|Overall Study|Adverse Event|8|||
164083337|NCT02247479|592670122|FG001|Overall Study|Adverse Event|9|||
164083338|NCT02247479|592670123|FG002|Overall Study|Adverse Event|8|||
164083339|NCT02247479|592670121|FG000|Overall Study|Death|5|||
164083340|NCT02247479|592670122|FG001|Overall Study|Death|4|||
164083341|NCT02247479|592670123|FG002|Overall Study|Death|6|||
164083342|NCT02247479|592670121|FG000|Overall Study|Lost to Follow-up|3|||
164083343|NCT02247479|592670122|FG001|Overall Study|Lost to Follow-up|3|||
164083344|NCT02247479|592670123|FG002|Overall Study|Lost to Follow-up|1|||
164083345|NCT02247479|592670121|FG000|Overall Study|Non-compliance|0|||
164083346|NCT02247479|592670122|FG001|Overall Study|Non-compliance|0|||
164083347|NCT02247479|592670123|FG002|Overall Study|Non-compliance|1|||
164083348|NCT02247479|592670121|FG000|Overall Study|Withdrawal by Subject|25|||
164083349|NCT02247479|592670122|FG001|Overall Study|Withdrawal by Subject|29|||
164083350|NCT02247479|592670123|FG002|Overall Study|Withdrawal by Subject|24|||
164083351|NCT02247479|592670121|FG000|Overall Study|Study Terminated by Sponsor|98|||
164083352|NCT02247479|592670122|FG001|Overall Study|Study Terminated by Sponsor|88|||
164083353|NCT02247479|592670123|FG002|Overall Study|Study Terminated by Sponsor|94|||
164083354|NCT02247479|592670121|FG000|Overall Study|Physician Decision|1|||
164083355|NCT02247479|592670122|FG001|Overall Study|Physician Decision|0|||
164083356|NCT02247479|592670123|FG002|Overall Study|Physician Decision|2|||
164083357|NCT02247479|592670121|FG000|Overall Study|Unspecified Reason|2|||
164083358|NCT02247479|592670122|FG001|Overall Study|Unspecified Reason|5|||
164083359|NCT02247479|592670123|FG002|Overall Study|Unspecified Reason|2|||
164083360|NCT03740698|592670124|FG000|Overall Study|Physician Decision|0|||
164083361|NCT03740698|592670125|FG001|Overall Study|Physician Decision|1|||
164083362|NCT03740698|592670126|FG002|Overall Study|Physician Decision|1|||
164083363|NCT05216978|592670136|FG000|Overall Study|Withdrawal by Subject|3|||
164083364|NCT05216978|592670136|FG000|Overall Study|Lost to Follow-up|5|||
164083365|NCT03433001|592670153|FG000|Overall Study|Lack of Efficacy|109|||
164083366|NCT03433001|592670153|FG000|Overall Study|Adverse Event|69|||
164083367|NCT03433001|592670153|FG000|Overall Study|Withdrawal by Subject|10|||
164083368|NCT03433001|592670153|FG000|Overall Study|Death|12|||
163989141|NCT02568046|592328270|FG000|Overall Study|Other Events|0|||
163989142|NCT02568046|592328271|FG001|Overall Study|Other Events|1|||
163989143|NCT00408694|592328272|FG000|Overall Study|Ineligible|1|||
164083369|NCT03433001|592670153|FG000|Overall Study|Lost to Follow-up|4|||
163989144|NCT00408694|592328272|FG000|Overall Study|No protocol treatment|1|||
163989145|NCT00523991|592328273|FG000|Overall Study|Adverse Event|6|||
163989146|NCT00523991|592328274|FG001|Overall Study|Adverse Event|5|||
164083370|NCT03433001|592670153|FG000|Overall Study|Other|25|||
164083371|NCT01299038|592670156|FG000|Overall Study|Withdrawal by Subject|1|||
164083372|NCT01299038|592670157|FG001|Overall Study|Withdrawal by Subject|0|||
164083373|NCT01162499|592670158|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
164083374|NCT01162499|592670159|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
164083375|NCT00322556|592670160|FG000|Overall Study|Adverse Event|1|||
164239075|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
164239076|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
164239077|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
164239078|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
164239079|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
164239080|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
164239081|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
164239082|NCT02266147|593247772|FG000|PART 1: Dose Escalation|Other|1|||
164239083|NCT02266147|593247773|FG001|PART 1: Dose Escalation|Other|1|||
164239084|NCT02266147|593247774|FG002|PART 1: Dose Escalation|Other|0|||
164239085|NCT02266147|593247775|FG003|PART 1: Dose Escalation|Other|0|||
164239086|NCT02266147|593247772|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
164239087|NCT02266147|593247773|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
164239088|NCT02266147|593247774|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
164239089|NCT02266147|593247775|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
164239090|NCT02266147|593247772|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
164239091|NCT02266147|593247773|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
164239092|NCT02266147|593247774|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
164239093|NCT02266147|593247775|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
164239094|NCT00382174|593247776|FG000|Overall Study|Lost to Follow-up|1|||
164239095|NCT00382174|593247777|FG001|Overall Study|Lost to Follow-up|4|||
164239096|NCT00382174|593247778|FG002|Overall Study|Lost to Follow-up|5|||
164239097|NCT00382174|593247776|FG000|Overall Study|Adverse Event|1|||
164239098|NCT00382174|593247777|FG001|Overall Study|Adverse Event|4|||
164239099|NCT00382174|593247778|FG002|Overall Study|Adverse Event|5|||
164239100|NCT00382174|593247776|FG000|Overall Study|Withdrawal by Subject|1|||
164239101|NCT00382174|593247777|FG001|Overall Study|Withdrawal by Subject|4|||
164239102|NCT00382174|593247778|FG002|Overall Study|Withdrawal by Subject|5|||
164239103|NCT00382174|593247776|FG000|Overall Study|Non compliance|1|||
164239104|NCT00382174|593247777|FG001|Overall Study|Non compliance|0|||
164239105|NCT00382174|593247778|FG002|Overall Study|Non compliance|1|||
164239106|NCT00382174|593247776|FG000|Overall Study|Physician Decision|0|||
164239107|NCT00382174|593247777|FG001|Overall Study|Physician Decision|2|||
164239108|NCT00382174|593247778|FG002|Overall Study|Physician Decision|2|||
164239109|NCT00382174|593247776|FG000|Overall Study|Failed to meet criteria|0|||
164239110|NCT00382174|593247777|FG001|Overall Study|Failed to meet criteria|1|||
164239111|NCT00382174|593247778|FG002|Overall Study|Failed to meet criteria|1|||
164239112|NCT00382174|593247776|FG000|Overall Study|Wounds merged|0|||
164239113|NCT00382174|593247777|FG001|Overall Study|Wounds merged|2|||
164239114|NCT00382174|593247778|FG002|Overall Study|Wounds merged|2|||
164239115|NCT01911260|593247779|FG000|Supplementation Period|transference or evasion of school|7|||
164239116|NCT01911260|593247780|FG001|Supplementation Period|transference or evasion of school|9|||
164239117|NCT01911260|593247781|FG002|Supplementation Period|transference or evasion of school|7|||
164239118|NCT01911260|593247782|FG003|Supplementation Period|transference or evasion of school|6|||
164239119|NCT01911260|593247779|FG000|Supplementation Period|Adverse Event|2|||
164239120|NCT01911260|593247780|FG001|Supplementation Period|Adverse Event|0|||
164239121|NCT01911260|593247781|FG002|Supplementation Period|Adverse Event|1|||
164239122|NCT01911260|593247782|FG003|Supplementation Period|Adverse Event|0|||
164239123|NCT01911260|593247779|FG000|Supplementation Period|refused to receive supplement|1|||
164239124|NCT01911260|593247780|FG001|Supplementation Period|refused to receive supplement|0|||
164239125|NCT01911260|593247781|FG002|Supplementation Period|refused to receive supplement|1|||
164239126|NCT01911260|593247782|FG003|Supplementation Period|refused to receive supplement|0|||
164239127|NCT01911260|593247779|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
164239128|NCT01911260|593247780|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
164239129|NCT01911260|593247781|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
164239130|NCT01911260|593247782|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
164239131|NCT01911260|593247779|FG000|Follow-up Period|transference or evasion of school|13|||
164335741|NCT02913612|593606056|FG003|Overall Study|Physician Decision|0|||
164335742|NCT02913612|593606053|FG000|Overall Study|Withdrawal by Subject|2|||
164335743|NCT02913612|593606054|FG001|Overall Study|Withdrawal by Subject|4|||
164335744|NCT02913612|593606055|FG002|Overall Study|Withdrawal by Subject|0|||
164335745|NCT02913612|593606056|FG003|Overall Study|Withdrawal by Subject|0|||
164335746|NCT02913612|593606053|FG000|Overall Study|Hemangioma resolved|1|||
164335747|NCT02913612|593606054|FG001|Overall Study|Hemangioma resolved|0|||
164335748|NCT02913612|593606055|FG002|Overall Study|Hemangioma resolved|0|||
164239132|NCT01911260|593247780|FG001|Follow-up Period|transference or evasion of school|20|||
164239133|NCT01911260|593247781|FG002|Follow-up Period|transference or evasion of school|15|||
164239134|NCT01911260|593247782|FG003|Follow-up Period|transference or evasion of school|12|||
164239135|NCT01657305|593247783|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
164335749|NCT02913612|593606056|FG003|Overall Study|Hemangioma resolved|0|||
164239136|NCT01657305|593247783|FG000|Overall Study|Withdrawal by Subject|4|||
164239137|NCT01657305|593247783|FG000|Overall Study|Adverse Event|1|||
164239138|NCT01657305|593247783|FG000|Overall Study|Lost to Follow-up|1|||
164335750|NCT02913612|593606053|FG000|Overall Study|Local IRB decision|1|||
164239139|NCT01657305|593247783|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
164239140|NCT00940602|593247784|FG000|Overall Study|Administrative problems|1|||
164239141|NCT00940602|593247785|FG001|Overall Study|Administrative problems|1|||
164239142|NCT00940602|593247784|FG000|Overall Study|Patient/guardian decision|13|||
164239143|NCT00940602|593247785|FG001|Overall Study|Patient/guardian decision|28|||
164239144|NCT00940602|593247784|FG000|Overall Study|Physician Decision|8|||
164239145|NCT00940602|593247785|FG001|Overall Study|Physician Decision|5|||
164239146|NCT00940602|593247784|FG000|Overall Study|Pregnancy|1|||
164239147|NCT00940602|593247785|FG001|Overall Study|Pregnancy|0|||
164239148|NCT00940602|593247784|FG000|Overall Study|Protocol Deviation (untreated)|1|||
164239149|NCT00940602|593247785|FG001|Overall Study|Protocol Deviation (untreated)|0|||
164239150|NCT00940602|593247784|FG000|Overall Study|Disease progression|8|||
164239151|NCT00940602|593247785|FG001|Overall Study|Disease progression|2|||
164239152|NCT00940602|593247784|FG000|Overall Study|Death|38|||
164239153|NCT00940602|593247785|FG001|Overall Study|Death|19|||
164239154|NCT00940602|593247784|FG000|Overall Study|Lost to Follow-up|3|||
164239155|NCT00940602|593247785|FG001|Overall Study|Lost to Follow-up|1|||
164239156|NCT00940602|593247784|FG000|Overall Study|Patient withdrew consent|26|||
164239157|NCT00940602|593247785|FG001|Overall Study|Patient withdrew consent|13|||
164239158|NCT00940602|593247784|FG000|Overall Study|Adverse Event|7|||
164239159|NCT00940602|593247785|FG001|Overall Study|Adverse Event|2|||
164239160|NCT00940602|593247784|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
164239161|NCT00940602|593247785|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
164239162|NCT00575666|593247786|FG000|Overall Study|Withdrawal by Subject|3|||
164239163|NCT00575666|593247787|FG001|Overall Study|Withdrawal by Subject|2|||
164239164|NCT00575666|593247786|FG000|Overall Study|Physician Decision|1|||
164239165|NCT00575666|593247787|FG001|Overall Study|Physician Decision|1|||
164239166|NCT01374425|593247788|FG000|Overall Study|Radiographic Disease Progression|86|||
164239167|NCT01374425|593247789|FG001|Overall Study|Radiographic Disease Progression|81|||
164239168|NCT01374425|593247788|FG000|Overall Study|Clinical Disease Progression|9|||
164239169|NCT01374425|593247789|FG001|Overall Study|Clinical Disease Progression|6|||
164239170|NCT01374425|593247788|FG000|Overall Study|Adverse Event|29|||
164239171|NCT01374425|593247789|FG001|Overall Study|Adverse Event|18|||
164239172|NCT01374425|593247788|FG000|Overall Study|Death (Progression of Disease)|1|||
164239173|NCT01374425|593247789|FG001|Overall Study|Death (Progression of Disease)|0|||
164239174|NCT01374425|593247788|FG000|Overall Study|Death (Adverse Event)|2|||
164239175|NCT01374425|593247789|FG001|Overall Study|Death (Adverse Event)|4|||
164239176|NCT01374425|593247788|FG000|Overall Study|Withdrawal by Subject|6|||
164239177|NCT01374425|593247789|FG001|Overall Study|Withdrawal by Subject|7|||
164239178|NCT01374425|593247788|FG000|Overall Study|Refused Treatment|10|||
164239179|NCT01374425|593247789|FG001|Overall Study|Refused Treatment|24|||
164239180|NCT01374425|593247788|FG000|Overall Study|Protocol Violation|2|||
164239181|NCT01374425|593247789|FG001|Overall Study|Protocol Violation|3|||
164239182|NCT01374425|593247788|FG000|Overall Study|Sponsor Decision|0|||
164239183|NCT01374425|593247789|FG001|Overall Study|Sponsor Decision|1|||
164239184|NCT01374425|593247788|FG000|Overall Study|Lost to Follow-up|2|||
164239185|NCT01374425|593247789|FG001|Overall Study|Lost to Follow-up|1|||
164239186|NCT01374425|593247788|FG000|Overall Study|Other|41|||
164239187|NCT01374425|593247789|FG001|Overall Study|Other|43|||
164239188|NCT02289469|593247790|FG000|Overall Study|Unable to match a control|6|||
164239189|NCT02289469|593247791|FG001|Overall Study|Unable to match a control|0|||
164239190|NCT01904721|593247793|FG000|Overall Study|Other Reasons|0|||
164239191|NCT01904721|593247794|FG001|Overall Study|Other Reasons|0|||
164239192|NCT01904721|593247795|FG002|Overall Study|Other Reasons|1|||
164239193|NCT01904721|593247796|FG003|Overall Study|Other Reasons|1|||
164239194|NCT01904721|593247797|FG004|Overall Study|Other Reasons|2|||
164239195|NCT01904721|593247798|FG005|Overall Study|Other Reasons|2|||
164239196|NCT01904721|593247799|FG006|Overall Study|Other Reasons|2|||
164239197|NCT01904721|593247793|FG000|Overall Study|Personal Reasons|0|||
164239198|NCT01904721|593247794|FG001|Overall Study|Personal Reasons|0|||
164239199|NCT01904721|593247795|FG002|Overall Study|Personal Reasons|0|||
164239200|NCT01904721|593247796|FG003|Overall Study|Personal Reasons|0|||
164239201|NCT01904721|593247797|FG004|Overall Study|Personal Reasons|2|||
164239202|NCT01904721|593247798|FG005|Overall Study|Personal Reasons|3|||
164239203|NCT01904721|593247799|FG006|Overall Study|Personal Reasons|3|||
164239204|NCT01904721|593247793|FG000|Overall Study|Lost to Follow-up|0|||
164239205|NCT01904721|593247794|FG001|Overall Study|Lost to Follow-up|0|||
164239206|NCT01904721|593247795|FG002|Overall Study|Lost to Follow-up|0|||
164239207|NCT01904721|593247796|FG003|Overall Study|Lost to Follow-up|0|||
164239208|NCT01904721|593247797|FG004|Overall Study|Lost to Follow-up|1|||
163884640|NCT03158129|591947823|FG003|Overall Study|Declined surgery|0|||
164239209|NCT01904721|593247798|FG005|Overall Study|Lost to Follow-up|3|||
164239210|NCT01904721|593247799|FG006|Overall Study|Lost to Follow-up|1|||
164239211|NCT01904721|593247793|FG000|Overall Study|Lack of Efficacy|0|||
164239212|NCT01904721|593247794|FG001|Overall Study|Lack of Efficacy|0|||
164239213|NCT01904721|593247795|FG002|Overall Study|Lack of Efficacy|0|||
163989147|NCT00523991|592328273|FG000|Overall Study|Protocol Violation|1|||
163989148|NCT00523991|592328274|FG001|Overall Study|Protocol Violation|4|||
163989149|NCT00523991|592328273|FG000|Overall Study|Lost to Follow-up|4|||
163989150|NCT00523991|592328274|FG001|Overall Study|Lost to Follow-up|1|||
163989151|NCT00523991|592328273|FG000|Overall Study|Withdrawal by Subject|7|||
163989152|NCT00523991|592328274|FG001|Overall Study|Withdrawal by Subject|17|||
163989153|NCT00523991|592328273|FG000|Overall Study|Other reason (not specified)|3|||
163989154|NCT00523991|592328274|FG001|Overall Study|Other reason (not specified)|0|||
163989155|NCT00193063|592328275|FG000|Overall Study|Lack of Efficacy|3|||
163989156|NCT00193063|592328275|FG000|Overall Study|Adverse Event|1|||
163989157|NCT03261531|592328276|FG000|Overall Study|Withdrawal by Subject|4|||
163989158|NCT01700192|592328277|FG000|Overall Study|Adverse Event|73|||
163989159|NCT01700192|592328278|FG001|Overall Study|Adverse Event|18|||
163989160|NCT01700192|592328277|FG000|Overall Study|Lack of Efficacy|1|||
163989161|NCT01700192|592328278|FG001|Overall Study|Lack of Efficacy|0|||
163989162|NCT01700192|592328277|FG000|Overall Study|Lost to Follow-up|42|||
163989163|NCT01700192|592328278|FG001|Overall Study|Lost to Follow-up|29|||
163989164|NCT01700192|592328277|FG000|Overall Study|Noncompliance with study drug|0|||
163989165|NCT01700192|592328278|FG001|Overall Study|Noncompliance with study drug|5|||
163989166|NCT01700192|592328277|FG000|Overall Study|Physician Decision|2|||
163989167|NCT01700192|592328278|FG001|Overall Study|Physician Decision|3|||
163989168|NCT01700192|592328277|FG000|Overall Study|Pregnancy|1|||
163989169|NCT01700192|592328278|FG001|Overall Study|Pregnancy|4|||
164083376|NCT00322556|592670160|FG000|Overall Study|Withdrawal by Subject|1|||
164083377|NCT00322556|592670160|FG000|Overall Study|Lost to Follow-up|3|||
164083378|NCT00322556|592670160|FG000|Overall Study|Other Reason|7|||
164083379|NCT01506323|592670161|FG000|Overall Study|Lost to Follow-up|5|||
164083380|NCT01506323|592670162|FG001|Overall Study|Lost to Follow-up|4|||
164083381|NCT01506323|592670161|FG000|Overall Study|Withdrawal by Subject|4|||
164083382|NCT01506323|592670162|FG001|Overall Study|Withdrawal by Subject|4|||
164083383|NCT01506323|592670161|FG000|Overall Study|Lack of Efficacy|1|||
164083384|NCT01506323|592670162|FG001|Overall Study|Lack of Efficacy|3|||
164083385|NCT01506323|592670161|FG000|Overall Study|Moved out of area|5|||
164083386|NCT01506323|592670162|FG001|Overall Study|Moved out of area|2|||
164083387|NCT01506323|592670161|FG000|Overall Study|Schedule or Transportation conflict|8|||
164083388|NCT01506323|592670162|FG001|Overall Study|Schedule or Transportation conflict|0|||
164083389|NCT01506323|592670161|FG000|Overall Study|Started another treatment|1|||
164083390|NCT01506323|592670162|FG001|Overall Study|Started another treatment|0|||
164083391|NCT03907280|592670163|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
164083392|NCT03907280|592670164|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
164083393|NCT03907280|592670165|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
164083394|NCT02637076|592670169|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
164083395|NCT02637076|592670170|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
164083396|NCT02637076|592670169|FG000|Overall Study|Withdrawal by Subject|0|||
164083397|NCT02637076|592670170|FG001|Overall Study|Withdrawal by Subject|4|||
164083398|NCT00130520|592670171|FG000|Overall Study|Adverse Event|11|||
164083399|NCT00130520|592670171|FG000|Overall Study|Death|1|||
164083400|NCT00130520|592670171|FG000|Overall Study|Physician Decision|1|||
164083401|NCT00130520|592670171|FG000|Overall Study|Withdrawal by Subject|1|||
164083402|NCT00130520|592670171|FG000|Overall Study|Disease Progression|23|||
164083403|NCT00130520|592670171|FG000|Overall Study|Protocol non-compliance|1|||
164083404|NCT00130520|592670171|FG000|Overall Study|Did not meet re-treatment criteria|1|||
164083405|NCT03487796|592670172|FG000|Overall Study|Lost to Follow-up|18|||
164083406|NCT03487796|592670173|FG001|Overall Study|Lost to Follow-up|6|||
164083407|NCT00613574|592670177|FG000|Overall Study|Adverse Event|3|||
164083408|NCT00613574|592670177|FG000|Overall Study|Lost to Follow-up|2|||
164083409|NCT00613574|592670177|FG000|Overall Study|Other|1|||
164083410|NCT04604184|592670181|FG000|Overall Study|Adverse Event|5|||
164083411|NCT04604184|592670182|FG001|Overall Study|Adverse Event|5|||
164083412|NCT04604184|592670181|FG000|Overall Study|Death|2|||
164083413|NCT04604184|592670182|FG001|Overall Study|Death|1|||
164083414|NCT04604184|592670181|FG000|Overall Study|Withdrawal by Subject|1|||
164083415|NCT04604184|592670182|FG001|Overall Study|Withdrawal by Subject|3|||
164083416|NCT04604184|592670181|FG000|Overall Study|Not treated|2|||
164083417|NCT04604184|592670182|FG001|Overall Study|Not treated|2|||
164083418|NCT04604184|592670181|FG000|Overall Study|Due to sponsor decision|9|||
164083419|NCT04604184|592670182|FG001|Overall Study|Due to sponsor decision|7|||
164083420|NCT04604184|592670181|FG000|Overall Study|Physician Decision|0|||
164083421|NCT04604184|592670182|FG001|Overall Study|Physician Decision|1|||
164083422|NCT04604184|592670181|FG000|Overall Study|Transfer to healthcare|1|||
164083423|NCT04604184|592670182|FG001|Overall Study|Transfer to healthcare|0|||
164083424|NCT01751412|592670183|FG000|Overall Study|Disease Progression Before Treatment|1|||
164140475|NCT00642278|592876099|FG004|Overall Study|Adverse Event|2|||
164335751|NCT02913612|593606054|FG001|Overall Study|Local IRB decision|0|||
163989170|NCT01700192|592328277|FG000|Overall Study|Progressive disease|1|||
164239214|NCT01904721|593247796|FG003|Overall Study|Lack of Efficacy|0|||
164239215|NCT01904721|593247797|FG004|Overall Study|Lack of Efficacy|0|||
164239216|NCT01904721|593247798|FG005|Overall Study|Lack of Efficacy|0|||
164239217|NCT01904721|593247799|FG006|Overall Study|Lack of Efficacy|1|||
164239218|NCT01904721|593247793|FG000|Overall Study|Adverse Event|0|||
164239219|NCT01904721|593247794|FG001|Overall Study|Adverse Event|0|||
164239220|NCT01904721|593247795|FG002|Overall Study|Adverse Event|0|||
164239221|NCT01904721|593247796|FG003|Overall Study|Adverse Event|0|||
164239222|NCT01904721|593247797|FG004|Overall Study|Adverse Event|3|||
164239223|NCT01904721|593247798|FG005|Overall Study|Adverse Event|1|||
164239224|NCT01904721|593247799|FG006|Overall Study|Adverse Event|0|||
164239225|NCT00532844|593247800|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
164239226|NCT00532844|593247801|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
164239227|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
164239228|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
164239229|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
164239230|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
164239231|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
164239232|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
164239233|NCT00532844|593247800|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
164239234|NCT00532844|593247801|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
164239235|NCT01077063|593247803|FG000|Overall Study|Adverse Event|3|||
164239236|NCT01077063|593247804|FG001|Overall Study|Adverse Event|0|||
164239237|NCT01077063|593247803|FG000|Overall Study|Death|1|||
164239238|NCT01077063|593247804|FG001|Overall Study|Death|1|||
164239239|NCT01077063|593247803|FG000|Overall Study|Withdrawal by Subject|0|||
164239240|NCT01077063|593247804|FG001|Overall Study|Withdrawal by Subject|2|||
164239241|NCT02750930|593247805|FG000|Overall Study|Study closed/terminated|8|||
164239242|NCT00553631|593247807|FG000|Overall Study|Withdrawal by Subject|0|||
164239243|NCT00553631|593247808|FG001|Overall Study|Withdrawal by Subject|1|||
164239244|NCT00553631|593247807|FG000|Overall Study|Lost to Follow-up|1|||
164239245|NCT00553631|593247808|FG001|Overall Study|Lost to Follow-up|0|||
164239246|NCT02761642|593247809|FG000|Overall Study|Did not Receive Study Treatment|3|||
164239247|NCT02761642|593247809|FG000|Overall Study|Adverse Event|13|||
164239248|NCT02761642|593247809|FG000|Overall Study|Withdrawal by Subject|2|||
164239249|NCT02761642|593247809|FG000|Overall Study|Non-compliant|7|||
164239250|NCT02761642|593247809|FG000|Overall Study|Death|3|||
164239251|NCT02761642|593247809|FG000|Overall Study|Lack of Efficacy|20|||
164239252|NCT02761642|593247809|FG000|Overall Study|Physician Decision|1|||
164239253|NCT02761642|593247809|FG000|Overall Study|Reason Unspecified|21|||
164239254|NCT02850978|593247810|FG000|Overall Study|Uncollectable CRF|27|||
164239255|NCT02850978|593247810|FG000|Overall Study|No visit since the first visit|35|||
164239256|NCT02850978|593247810|FG000|Overall Study|Adverse Event|81|||
164239257|NCT02850978|593247810|FG000|Overall Study|Lack of Efficacy|40|||
164239258|NCT02850978|593247810|FG000|Overall Study|Improvement in condition|34|||
164239259|NCT02850978|593247810|FG000|Overall Study|Lost to Follow-up|121|||
164239260|NCT02850978|593247810|FG000|Overall Study|Reason not listed|88|||
164239261|NCT00114127|593247811|FG000|Overall Study|Adverse Event|2|||
164239262|NCT00114127|593247812|FG001|Overall Study|Adverse Event|1|||
164239263|NCT00114127|593247811|FG000|Overall Study|Lost to Follow-up|1|||
164239264|NCT00114127|593247812|FG001|Overall Study|Lost to Follow-up|0|||
164239265|NCT00114127|593247811|FG000|Overall Study|Withdrawal by Subject|1|||
164239266|NCT00114127|593247812|FG001|Overall Study|Withdrawal by Subject|3|||
164239267|NCT00251693|593247813|FG000|Overall Study|Adverse Event|17|||
164239268|NCT00251693|593247814|FG001|Overall Study|Adverse Event|9|||
164239269|NCT00251693|593247815|FG002|Overall Study|Adverse Event|9|||
164239270|NCT00251693|593247813|FG000|Overall Study|Protocol Violation|2|||
164239271|NCT00251693|593247814|FG001|Overall Study|Protocol Violation|0|||
164239272|NCT00251693|593247815|FG002|Overall Study|Protocol Violation|2|||
164239273|NCT00251693|593247813|FG000|Overall Study|Lost to Follow-up|12|||
164239274|NCT00251693|593247814|FG001|Overall Study|Lost to Follow-up|7|||
164239275|NCT00251693|593247815|FG002|Overall Study|Lost to Follow-up|8|||
164239276|NCT00251693|593247813|FG000|Overall Study|Withdrawal by Subject|11|||
164239277|NCT00251693|593247814|FG001|Overall Study|Withdrawal by Subject|17|||
164239278|NCT00251693|593247815|FG002|Overall Study|Withdrawal by Subject|14|||
164239279|NCT00251693|593247813|FG000|Overall Study|Lack of Efficacy|0|||
164239280|NCT00251693|593247814|FG001|Overall Study|Lack of Efficacy|1|||
164239281|NCT00251693|593247815|FG002|Overall Study|Lack of Efficacy|0|||
164239282|NCT00251693|593247813|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
164239283|NCT00251693|593247814|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
164239284|NCT00251693|593247815|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
164239285|NCT00251693|593247813|FG000|Overall Study|Noncompliant|0|||
164239286|NCT00251693|593247814|FG001|Overall Study|Noncompliant|0|||
164239287|NCT00251693|593247815|FG002|Overall Study|Noncompliant|2|||
164239288|NCT00251693|593247813|FG000|Overall Study|Possible Barrett's esophagus|3|||
164239289|NCT00251693|593247814|FG001|Overall Study|Possible Barrett's esophagus|5|||
164239290|NCT00251693|593247815|FG002|Overall Study|Possible Barrett's esophagus|2|||
164239291|NCT00251693|593247813|FG000|Overall Study|Subject request/subject unavailable|1|||
164239292|NCT00251693|593247814|FG001|Overall Study|Subject request/subject unavailable|2|||
164239293|NCT00251693|593247815|FG002|Overall Study|Subject request/subject unavailable|0|||
164239294|NCT00251693|593247813|FG000|Overall Study|Abnormal laboratory findings|0|||
164239295|NCT00251693|593247814|FG001|Overall Study|Abnormal laboratory findings|0|||
164239296|NCT00251693|593247815|FG002|Overall Study|Abnormal laboratory findings|1|||
164239297|NCT00570713|593247816|FG000|Overall Study|Adverse Event|16|||
164239298|NCT00570713|593247817|FG001|Overall Study|Adverse Event|9|||
164239299|NCT00570713|593247816|FG000|Overall Study|Death|7|||
164239300|NCT00570713|593247817|FG001|Overall Study|Death|7|||
164239301|NCT00570713|593247816|FG000|Overall Study|Lack of Efficacy|40|||
164239302|NCT00570713|593247817|FG001|Overall Study|Lack of Efficacy|49|||
164239303|NCT00570713|593247816|FG000|Overall Study|Physician Decision|2|||
164239304|NCT00570713|593247817|FG001|Overall Study|Physician Decision|2|||
164239305|NCT00570713|593247816|FG000|Overall Study|Withdrawal by Subject|3|||
164239306|NCT00570713|593247817|FG001|Overall Study|Withdrawal by Subject|3|||
164239307|NCT00570713|593247816|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
164239308|NCT00570713|593247817|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
164239309|NCT00469833|593247819|FG000|Overall Study|No IV access|2|||
164239310|NCT01816048|593247823|FG000|Overall Study|Adverse Event|1|||
164239311|NCT01816048|593247823|FG000|Overall Study|Death|1|||
164239312|NCT01816048|593247823|FG000|Overall Study|Withdrawal by Subject|1|||
164239313|NCT01816048|593247823|FG000|Overall Study|Disease Progression|3|||
164239314|NCT04422431|593247824|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
164239315|NCT04422431|593247824|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
164239316|NCT04422431|593247824|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
164239317|NCT04422431|593247824|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
164239318|NCT04422431|593247824|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
164239319|NCT04422431|593247824|FG000|Extension Period (48 Weeks)|Other than specified|2|||
164239320|NCT01174563|593247825|FG000|Overall Study|Progressive Disease|45|||
164239321|NCT01174563|593247825|FG000|Overall Study|Death|5|||
164239322|NCT01174563|593247825|FG000|Overall Study|Investigator's Discretion|5|||
164239323|NCT01174563|593247825|FG000|Overall Study|Participant Withdrew Consent|3|||
164239324|NCT01174563|593247825|FG000|Overall Study|Rash Adverse Event|1|||
164239325|NCT01174563|593247825|FG000|Overall Study|Sponsor's decision|1|||
164239326|NCT03402841|593247826|FG000|Overall Study|Withdrawal by Subject|3|||
164239327|NCT03402841|593247826|FG000|Overall Study|Lost to Follow-up|2|||
164239328|NCT03402841|593247826|FG000|Overall Study|Death|146|||
164335752|NCT02913612|593606055|FG002|Overall Study|Local IRB decision|0|||
164335753|NCT02913612|593606056|FG003|Overall Study|Local IRB decision|0|||
164335754|NCT02913612|593606053|FG000|Overall Study|Study drug non-compliance|1|||
164335755|NCT02913612|593606054|FG001|Overall Study|Study drug non-compliance|1|||
164335756|NCT02913612|593606055|FG002|Overall Study|Study drug non-compliance|0|||
164335757|NCT02913612|593606056|FG003|Overall Study|Study drug non-compliance|0|||
164335758|NCT02913612|593606053|FG000|Overall Study|Insurance issues|0|||
164335759|NCT02913612|593606054|FG001|Overall Study|Insurance issues|1|||
164335760|NCT02913612|593606055|FG002|Overall Study|Insurance issues|0|||
164335761|NCT02913612|593606056|FG003|Overall Study|Insurance issues|0|||
164335762|NCT02913612|593606053|FG000|Overall Study|Needed to treat second hemangioma|0|||
163989171|NCT01700192|592328278|FG001|Overall Study|Progressive disease|0|||
163989172|NCT01700192|592328277|FG000|Overall Study|Protocol Violation|3|||
163989173|NCT01700192|592328278|FG001|Overall Study|Protocol Violation|4|||
163989174|NCT01700192|592328277|FG000|Overall Study|Technical problems|0|||
163989175|NCT01700192|592328278|FG001|Overall Study|Technical problems|1|||
163989176|NCT01700192|592328277|FG000|Overall Study|Withdrawal by Subject|56|||
163989177|NCT01700192|592328278|FG001|Overall Study|Withdrawal by Subject|64|||
163989178|NCT01700192|592328277|FG000|Overall Study|Never received study drug|1|||
163989179|NCT01700192|592328278|FG001|Overall Study|Never received study drug|0|||
163989180|NCT00744874|592328281|FG000|Overall Study|Lost to Follow-up|1|||
163989181|NCT00744874|592328281|FG000|Overall Study|Withdrawal by Subject|1|||
163989182|NCT00744874|592328281|FG000|Overall Study|Study Device not available at procedure|1|||
163989183|NCT00744874|592328281|FG000|Overall Study|Unable to accomodate schedule|1|||
163989184|NCT02435849|592328287|FG000|Overall Study|Death|23|||
163989185|NCT02435849|592328288|FG001|Overall Study|Death|0|||
163989186|NCT02435849|592328287|FG000|Overall Study|Lack of Efficacy|10|||
163989187|NCT02435849|592328288|FG001|Overall Study|Lack of Efficacy|0|||
163989188|NCT02435849|592328287|FG000|Overall Study|New therapy for study indication|8|||
163989189|NCT02435849|592328288|FG001|Overall Study|New therapy for study indication|0|||
163989190|NCT02435849|592328287|FG000|Overall Study|Subject/guardian decision|5|||
163989191|NCT02435849|592328288|FG001|Overall Study|Subject/guardian decision|1|||
163989192|NCT02435849|592328287|FG000|Overall Study|Lost to Follow-up|1|||
163989193|NCT02435849|592328288|FG001|Overall Study|Lost to Follow-up|0|||
163989194|NCT02435849|592328287|FG000|Overall Study|Physician Decision|1|||
163989195|NCT02435849|592328288|FG001|Overall Study|Physician Decision|0|||
164335763|NCT02913612|593606054|FG001|Overall Study|Needed to treat second hemangioma|1|||
163989196|NCT03175549|592328289|FG000|Overall Study|Lost to Follow-up|2|||
164239329|NCT00444106|593247829|FG000|Overall Study|Lost to Follow-up|2|||
164239330|NCT00444106|593247830|FG001|Overall Study|Lost to Follow-up|1|||
164239331|NCT00444106|593247831|FG002|Overall Study|Lost to Follow-up|0|||
164239332|NCT00444106|593247829|FG000|Overall Study|Abnormal Test Procedure Results|0|||
164239333|NCT00444106|593247830|FG001|Overall Study|Abnormal Test Procedure Results|0|||
164239334|NCT00444106|593247831|FG002|Overall Study|Abnormal Test Procedure Results|1|||
164239335|NCT00038948|593247832|FG000|Overall Study|Adverse Event|131|||
164239336|NCT00038948|593247833|FG001|Overall Study|Adverse Event|43|||
164239337|NCT00038948|593247832|FG000|Overall Study|Lost to Follow-up|4|||
164239338|NCT00038948|593247833|FG001|Overall Study|Lost to Follow-up|4|||
164239339|NCT00038948|593247832|FG000|Overall Study|Nonmedical event|5|||
164239340|NCT00038948|593247833|FG001|Overall Study|Nonmedical event|7|||
164239341|NCT00038948|593247832|FG000|Overall Study|Withdrawal by Subject|23|||
164239342|NCT00038948|593247833|FG001|Overall Study|Withdrawal by Subject|10|||
164239343|NCT00038948|593247832|FG000|Overall Study|Protocol Violation|3|||
164239344|NCT00038948|593247833|FG001|Overall Study|Protocol Violation|7|||
164239345|NCT00038948|593247832|FG000|Overall Study|Lack of Efficacy|3|||
164239346|NCT00038948|593247833|FG001|Overall Study|Lack of Efficacy|6|||
164239347|NCT05270863|593247834|FG000|Visit 2 First Intervention|Randomization error|0|||
164239348|NCT05270863|593247835|FG001|Visit 2 First Intervention|Randomization error|0|||
164239349|NCT05270863|593247836|FG002|Visit 2 First Intervention|Randomization error|0|||
164239350|NCT05270863|593247837|FG003|Visit 2 First Intervention|Randomization error|1|||
164239351|NCT05270863|593247838|FG004|Visit 2 First Intervention|Randomization error|0|||
164239352|NCT05270863|593247839|FG005|Visit 2 First Intervention|Randomization error|0|||
164239353|NCT05270863|593247834|FG000|First Washout|Withdrawal by Subject|0|||
164239354|NCT05270863|593247835|FG001|First Washout|Withdrawal by Subject|0|||
164239355|NCT05270863|593247836|FG002|First Washout|Withdrawal by Subject|0|||
164239356|NCT05270863|593247837|FG003|First Washout|Withdrawal by Subject|0|||
164239357|NCT05270863|593247838|FG004|First Washout|Withdrawal by Subject|1|||
164239358|NCT05270863|593247839|FG005|First Washout|Withdrawal by Subject|1|||
164239359|NCT05270863|593247834|FG000|First Washout|Lost to Follow-up|0|||
164239360|NCT05270863|593247835|FG001|First Washout|Lost to Follow-up|0|||
164239361|NCT05270863|593247836|FG002|First Washout|Lost to Follow-up|0|||
164239362|NCT05270863|593247837|FG003|First Washout|Lost to Follow-up|0|||
164239363|NCT05270863|593247838|FG004|First Washout|Lost to Follow-up|0|||
164239364|NCT05270863|593247839|FG005|First Washout|Lost to Follow-up|1|||
164239365|NCT05270863|593247834|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
164239366|NCT05270863|593247835|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239367|NCT05270863|593247836|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
164239368|NCT05270863|593247837|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239369|NCT05270863|593247838|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239370|NCT05270863|593247839|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
164239371|NCT05270863|593247834|FG000|Second Washout|Withdrawal by Subject|1|||
164239372|NCT05270863|593247835|FG001|Second Washout|Withdrawal by Subject|1|||
164239373|NCT05270863|593247836|FG002|Second Washout|Withdrawal by Subject|0|||
164239374|NCT05270863|593247837|FG003|Second Washout|Withdrawal by Subject|0|||
164239375|NCT05270863|593247838|FG004|Second Washout|Withdrawal by Subject|0|||
164239376|NCT05270863|593247839|FG005|Second Washout|Withdrawal by Subject|0|||
164239377|NCT05270863|593247834|FG000|Second Washout|Lost to Follow-up|0|||
164239378|NCT05270863|593247835|FG001|Second Washout|Lost to Follow-up|0|||
164239379|NCT05270863|593247836|FG002|Second Washout|Lost to Follow-up|0|||
164239380|NCT05270863|593247837|FG003|Second Washout|Lost to Follow-up|1|||
164239381|NCT05270863|593247838|FG004|Second Washout|Lost to Follow-up|0|||
164239382|NCT05270863|593247839|FG005|Second Washout|Lost to Follow-up|0|||
164239383|NCT03984188|593247840|FG000|Overall Study|Death|2|||
164239384|NCT03984188|593247841|FG001|Overall Study|Death|4|||
164239385|NCT03984188|593247840|FG000|Overall Study|Physician Decision|0|||
164239386|NCT03984188|593247841|FG001|Overall Study|Physician Decision|2|||
164239387|NCT03984188|593247840|FG000|Overall Study|Lost to Follow-up|3|||
164239388|NCT03984188|593247841|FG001|Overall Study|Lost to Follow-up|2|||
164239389|NCT03984188|593247840|FG000|Overall Study|Withdrawal by Subject|6|||
164239390|NCT03984188|593247841|FG001|Overall Study|Withdrawal by Subject|0|||
164239391|NCT00552071|593250013|FG000|Overall Study|Adverse Event|1|||
164239392|NCT00552071|593250014|FG001|Overall Study|Adverse Event|0|||
164239393|NCT00552071|593250013|FG000|Overall Study|Lack of Efficacy|1|||
164239394|NCT00552071|593250014|FG001|Overall Study|Lack of Efficacy|0|||
164239395|NCT00552071|593250013|FG000|Overall Study|Physician Decision|1|||
164239396|NCT00552071|593250014|FG001|Overall Study|Physician Decision|0|||
164239397|NCT00552071|593250013|FG000|Overall Study|Pregnancy|1|||
164239398|NCT00552071|593250014|FG001|Overall Study|Pregnancy|0|||
164239399|NCT00552071|593250013|FG000|Overall Study|Death|0|||
164239400|NCT00552071|593250014|FG001|Overall Study|Death|1|||
164239401|NCT00552071|593250013|FG000|Overall Study|Withdrawal by Subject|0|||
164239402|NCT00552071|593250014|FG001|Overall Study|Withdrawal by Subject|1|||
164239403|NCT00272792|593250015|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
164239404|NCT00272792|593250016|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
164239405|NCT00272792|593250015|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
164239406|NCT00272792|593250016|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
164239407|NCT00272792|593250015|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
164239408|NCT00272792|593250016|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
164239409|NCT00272792|593250015|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
164239410|NCT00272792|593250016|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
164239411|NCT00937495|593250021|FG000|Overall Study|Protocol Violation|2|||
164239412|NCT02549989|593250022|FG000|Overall Study|Adverse Event|4|||
164239413|NCT02549989|593250022|FG000|Overall Study|Death|1|||
164239414|NCT02549989|593250022|FG000|Overall Study|Lack of Efficacy|19|||
164239415|NCT02549989|593250022|FG000|Overall Study|Withdrawal by Subject|3|||
164239416|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
164239417|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239418|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239419|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239420|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239421|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239422|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239423|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239424|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
164239425|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239426|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
164239427|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
164239428|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239429|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239430|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239431|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239432|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239433|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
164239434|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
164239435|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
164239436|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
164239437|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239438|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239439|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239440|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239441|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239442|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239443|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
164239444|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
164239445|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
164239446|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239447|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239448|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239449|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239450|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239451|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
164239452|NCT02628444|593250026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
164239453|NCT02628444|593250027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
164239454|NCT02628444|593250028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
164239455|NCT02628444|593250029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239456|NCT02628444|593250030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239457|NCT02628444|593250031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239458|NCT02628444|593250032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239459|NCT02628444|593250033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239460|NCT02628444|593250034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
164239461|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239462|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239463|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239464|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
164239465|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239466|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239467|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239468|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
163884641|NCT03158129|591947820|FG000|Overall Study|No longer surgical candidate|0|||
163884642|NCT03158129|591947821|FG001|Overall Study|No longer surgical candidate|0|||
164239469|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
164239470|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
164239471|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
164239472|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
164239473|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
164239474|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
164239475|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
164239476|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
164239477|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
164239478|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
164239479|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239480|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239481|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
164239482|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
164239483|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
164239484|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
164239485|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
164239486|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
164239487|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
164239488|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239489|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239490|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239491|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239492|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
164239493|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239494|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
164239495|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
164239496|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
164239497|NCT02628444|593250026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
164239498|NCT02628444|593250027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
164239499|NCT02628444|593250028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
164239500|NCT02628444|593250029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
164239501|NCT02628444|593250030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
164239502|NCT02628444|593250031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
164239503|NCT02628444|593250032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
164239504|NCT02628444|593250033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
164239505|NCT02628444|593250034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
164239506|NCT00288015|593250035|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
164239507|NCT00288015|593250035|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
164239508|NCT00288015|593250035|FG000|First Response Assessment|Withdrawal by Subject|1|||
164239509|NCT00288015|593250035|FG000|First Response Assessment|Death|1|||
164239510|NCT00288015|593250035|FG000|First Response Assessment|Physician Decision|2|||
164239511|NCT00288015|593250035|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
164239512|NCT00288015|593250035|FG000|Follow up for Survival x 2 Years|Death|13|||
164239513|NCT00288015|593250035|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
164239514|NCT00288015|593250035|FG000|Follow up for Survival x 2 Years|Other|9|||
164239515|NCT00443703|593250036|FG000|Overall Study|Never Treated|3|||
164239516|NCT00443703|593250037|FG001|Overall Study|Never Treated|1|||
164239517|NCT00443703|593250036|FG000|Overall Study|Adverse Event|7|||
163884643|NCT03158129|591947822|FG002|Overall Study|No longer surgical candidate|0|||
163884644|NCT03158129|591947823|FG003|Overall Study|No longer surgical candidate|1|||
164239518|NCT00443703|593250037|FG001|Overall Study|Adverse Event|3|||
164239519|NCT00443703|593250036|FG000|Overall Study|Lack of Efficacy|3|||
164239520|NCT00443703|593250037|FG001|Overall Study|Lack of Efficacy|1|||
164239521|NCT00443703|593250036|FG000|Overall Study|Lost to Follow-up|0|||
164239522|NCT00443703|593250037|FG001|Overall Study|Lost to Follow-up|4|||
164239523|NCT00443703|593250036|FG000|Overall Study|Physician Decision|4|||
164239524|NCT00443703|593250037|FG001|Overall Study|Physician Decision|2|||
164239525|NCT00443703|593250036|FG000|Overall Study|Protocol Violation|1|||
164239526|NCT00443703|593250037|FG001|Overall Study|Protocol Violation|1|||
164239527|NCT00443703|593250036|FG000|Overall Study|Withdrawal by Subject|9|||
164239528|NCT00443703|593250037|FG001|Overall Study|Withdrawal by Subject|6|||
164239529|NCT00443703|593250036|FG000|Overall Study|Progressive Disease|1|||
164239530|NCT00443703|593250037|FG001|Overall Study|Progressive Disease|0|||
164239531|NCT01333722|593250038|FG000|Overall Study|Lack of Efficacy|0|||
164239532|NCT01333722|593250039|FG001|Overall Study|Lack of Efficacy|2|||
164239533|NCT01333722|593250038|FG000|Overall Study|Withdrawal by Subject|0|||
164239534|NCT01333722|593250039|FG001|Overall Study|Withdrawal by Subject|1|||
164239535|NCT00784368|593250042|FG000|Overall Study|Physician Decision|0|||
164239536|NCT00784368|593250043|FG001|Overall Study|Physician Decision|0|||
164239537|NCT00784368|593250044|FG002|Overall Study|Physician Decision|6|||
164083425|NCT00582036|592670184|FG000|Overall Study|Withdrawal by Subject|0|||
164083426|NCT00582036|592670185|FG001|Overall Study|Withdrawal by Subject|1|||
164239538|NCT00784368|593250042|FG000|Overall Study|Lack of Efficacy|2|||
164239539|NCT00784368|593250043|FG001|Overall Study|Lack of Efficacy|0|||
164239540|NCT00784368|593250044|FG002|Overall Study|Lack of Efficacy|1|||
164239541|NCT00784368|593250042|FG000|Overall Study|Adverse Event|6|||
164239542|NCT00784368|593250043|FG001|Overall Study|Adverse Event|9|||
164239543|NCT00784368|593250044|FG002|Overall Study|Adverse Event|2|||
164239544|NCT00784368|593250042|FG000|Overall Study|Diagnosis of fever|0|||
164239545|NCT00784368|593250043|FG001|Overall Study|Diagnosis of fever|0|||
164239546|NCT00784368|593250044|FG002|Overall Study|Diagnosis of fever|1|||
164239547|NCT00784368|593250042|FG000|Overall Study|Worsening of complications|0|||
164239548|NCT00784368|593250043|FG001|Overall Study|Worsening of complications|0|||
164239549|NCT00784368|593250044|FG002|Overall Study|Worsening of complications|1|||
164239550|NCT00784368|593250042|FG000|Overall Study|Worsening of symptoms|0|||
164239551|NCT00784368|593250043|FG001|Overall Study|Worsening of symptoms|1|||
164239552|NCT00784368|593250044|FG002|Overall Study|Worsening of symptoms|0|||
164239553|NCT00784368|593250042|FG000|Overall Study|Withdrawal of informed consent|0|||
164239554|NCT00784368|593250043|FG001|Overall Study|Withdrawal of informed consent|1|||
164239555|NCT00784368|593250044|FG002|Overall Study|Withdrawal of informed consent|0|||
164239556|NCT02079909|593250045|FG000|Overall Study|Adverse Event|23|||
164239557|NCT02079909|593250046|FG001|Overall Study|Adverse Event|23|||
164239558|NCT02079909|593250047|FG002|Overall Study|Adverse Event|7|||
164239559|NCT02079909|593250045|FG000|Overall Study|Withdrawal by Subject|9|||
164239560|NCT02079909|593250046|FG001|Overall Study|Withdrawal by Subject|17|||
164239561|NCT02079909|593250047|FG002|Overall Study|Withdrawal by Subject|4|||
164239562|NCT02079909|593250045|FG000|Overall Study|Lost to Follow-up|2|||
163884645|NCT05051124|591947824|FG000|Overall Study|Lost to Follow-up|2|||
164239563|NCT02079909|593250046|FG001|Overall Study|Lost to Follow-up|3|||
164239564|NCT02079909|593250047|FG002|Overall Study|Lost to Follow-up|1|||
164239565|NCT02079909|593250045|FG000|Overall Study|Death|2|||
164239566|NCT02079909|593250046|FG001|Overall Study|Death|2|||
164239567|NCT02079909|593250047|FG002|Overall Study|Death|0|||
164239568|NCT02079909|593250045|FG000|Overall Study|Lack of Efficacy|0|||
164239569|NCT02079909|593250046|FG001|Overall Study|Lack of Efficacy|0|||
164239570|NCT02079909|593250047|FG002|Overall Study|Lack of Efficacy|1|||
164239571|NCT02079909|593250045|FG000|Overall Study|Protocol Violation|0|||
164239572|NCT02079909|593250046|FG001|Overall Study|Protocol Violation|1|||
164239573|NCT02079909|593250047|FG002|Overall Study|Protocol Violation|1|||
164239574|NCT02079909|593250045|FG000|Overall Study|Physician Decision|0|||
164239575|NCT02079909|593250046|FG001|Overall Study|Physician Decision|1|||
164239576|NCT02079909|593250047|FG002|Overall Study|Physician Decision|1|||
164239577|NCT02079909|593250045|FG000|Overall Study|Relocation etc.|2|||
164239578|NCT02079909|593250046|FG001|Overall Study|Relocation etc.|2|||
164239579|NCT02079909|593250047|FG002|Overall Study|Relocation etc.|3|||
164239580|NCT00720356|593250052|FG000|Registration to Study|Determined to have methylated MGMT|67|||
164239581|NCT00720356|593250052|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
164239582|NCT00720356|593250052|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
164239583|NCT00720356|593250052|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
163884646|NCT05051124|591947824|FG000|Overall Study|Withdrawal by Subject|1|||
164239584|NCT00720356|593250052|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
164239585|NCT00720356|593250052|FG000|Follow up Until Death|Withdrawal by Subject|1|||
164239586|NCT00720356|593250052|FG000|Follow up Until Death|Alive at last data collection|4|||
164239587|NCT02237001|593250055|FG000|Overall Study|Lost to Follow-up|2|||
164239588|NCT02237001|593250055|FG000|Overall Study|Withdrawal by Subject|1|||
164239589|NCT02237001|593250055|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
164239590|NCT02237001|593250055|FG000|Overall Study|Re-operation|4|||
164239591|NCT02237001|593250055|FG000|Overall Study|Incarceration|1|||
164239592|NCT01047007|593250056|FG000|Overall Study|Adverse Event|0|||
164239593|NCT01047007|593250057|FG001|Overall Study|Adverse Event|2|||
164239594|NCT01047007|593250058|FG002|Overall Study|Adverse Event|1|||
164239595|NCT01047007|593250059|FG003|Overall Study|Adverse Event|0|||
164239596|NCT01047007|593250056|FG000|Overall Study|Progressive Disease|2|||
164239597|NCT01047007|593250057|FG001|Overall Study|Progressive Disease|4|||
164239598|NCT01047007|593250058|FG002|Overall Study|Progressive Disease|1|||
164239599|NCT01047007|593250059|FG003|Overall Study|Progressive Disease|0|||
164239600|NCT03759600|593250062|FG000|Overall Study|Adverse Event|2|||
164239601|NCT03759600|593250062|FG000|Overall Study|Progressive Disease|15|||
164239602|NCT03759600|593250062|FG000|Overall Study|Site Terminated by Sponsor|3|||
164239603|NCT00457392|593250064|FG000|Overall Study|Objective Progression or Relapse|229|||
164239604|NCT00457392|593250065|FG001|Overall Study|Objective Progression or Relapse|296|||
164239605|NCT00457392|593250064|FG000|Overall Study|Death|106|||
164239606|NCT00457392|593250065|FG001|Overall Study|Death|106|||
164239607|NCT00457392|593250064|FG000|Overall Study|Adverse Event|84|||
164239608|NCT00457392|593250065|FG001|Overall Study|Adverse Event|41|||
164239609|NCT00457392|593250064|FG000|Overall Study|Global Deterioration of Health Status|22|||
164239610|NCT00457392|593250065|FG001|Overall Study|Global Deterioration of Health Status|8|||
164239611|NCT00457392|593250064|FG000|Overall Study|Withdrawal by Subject|14|||
164239612|NCT00457392|593250065|FG001|Overall Study|Withdrawal by Subject|8|||
164239613|NCT00457392|593250064|FG000|Overall Study|Lost to Follow-up|6|||
164239614|NCT00457392|593250065|FG001|Overall Study|Lost to Follow-up|7|||
164239615|NCT00457392|593250064|FG000|Overall Study|Protocol Violation|4|||
164239616|NCT00457392|593250065|FG001|Overall Study|Protocol Violation|3|||
164239617|NCT00457392|593250064|FG000|Overall Study|Other|7|||
164239618|NCT00457392|593250065|FG001|Overall Study|Other|4|||
164239619|NCT00457392|593250064|FG000|Overall Study|Study Terminated by Sponsor|1|||
164239620|NCT00457392|593250065|FG001|Overall Study|Study Terminated by Sponsor|4|||
164239621|NCT00457392|593250064|FG000|Overall Study|Randomized, Not Treated|7|||
164239622|NCT00457392|593250065|FG001|Overall Study|Randomized, Not Treated|3|||
164239623|NCT00756275|593250066|FG000|Overall Study|Lost to Follow-up|25|||
164239624|NCT00756275|593250067|FG001|Overall Study|Lost to Follow-up|21|||
164239625|NCT00756275|593250066|FG000|Overall Study|Withdrawal by Subject|4|||
164239626|NCT00756275|593250067|FG001|Overall Study|Withdrawal by Subject|7|||
164239627|NCT00980148|593250068|FG000|Overall Study|Discharged from facility|89|||
164239628|NCT00980148|593250069|FG001|Overall Study|Discharged from facility|96|||
164239629|NCT00980148|593250068|FG000|Overall Study|Received other antichlamydia treatment|20|||
164239630|NCT00980148|593250069|FG001|Overall Study|Received other antichlamydia treatment|14|||
164239631|NCT00980148|593250068|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
164239632|NCT00980148|593250069|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
164239633|NCT00980148|593250068|FG000|Overall Study|Various other reasons|8|||
164239634|NCT00980148|593250069|FG001|Overall Study|Various other reasons|9|||
164239635|NCT02903823|593250070|FG000|Overall Study|Physician Decision|5|||
164239636|NCT02903823|593250070|FG000|Overall Study|Could not advance catheter|1|||
164239637|NCT02903823|593250070|FG000|Overall Study|Catheter dislodgement|1|||
164239638|NCT02852967|593250071|FG000|Overall Study|Adverse Event|3|||
164239639|NCT02852967|593250072|FG001|Overall Study|Adverse Event|1|||
164239640|NCT02852967|593250073|FG002|Overall Study|Adverse Event|0|||
163884647|NCT05051124|591947824|FG000|Overall Study|Residential relocation|2|||
163884648|NCT05051124|591947824|FG000|Overall Study|Death|1|||
163884649|NCT04782973|591947825|FG000|Overall Study|Withdrawal by Subject|5|||
163884650|NCT04782973|591947825|FG000|Overall Study|Protocol Violation|6|||
163884651|NCT04782973|591947825|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
164239641|NCT02852967|593250074|FG003|Overall Study|Adverse Event|1|||
164239642|NCT02852967|593250075|FG004|Overall Study|Adverse Event|0|||
164239643|NCT02852967|593250071|FG000|Overall Study|Death|1|||
164239644|NCT02852967|593250072|FG001|Overall Study|Death|0|||
164239645|NCT02852967|593250073|FG002|Overall Study|Death|0|||
164239646|NCT02852967|593250074|FG003|Overall Study|Death|0|||
164239647|NCT02852967|593250075|FG004|Overall Study|Death|0|||
164239648|NCT02852967|593250071|FG000|Overall Study|Lost to Follow-up|1|||
164239649|NCT02852967|593250072|FG001|Overall Study|Lost to Follow-up|2|||
164239650|NCT02852967|593250073|FG002|Overall Study|Lost to Follow-up|3|||
164239651|NCT02852967|593250074|FG003|Overall Study|Lost to Follow-up|4|||
164239652|NCT02852967|593250075|FG004|Overall Study|Lost to Follow-up|4|||
164239653|NCT02852967|593250071|FG000|Overall Study|Withdrawal by Subject|6|||
164239654|NCT02852967|593250072|FG001|Overall Study|Withdrawal by Subject|12|||
164239655|NCT02852967|593250073|FG002|Overall Study|Withdrawal by Subject|7|||
164239656|NCT02852967|593250074|FG003|Overall Study|Withdrawal by Subject|10|||
164239657|NCT02852967|593250075|FG004|Overall Study|Withdrawal by Subject|10|||
164239658|NCT02852967|593250071|FG000|Overall Study|SAE|0|||
164239659|NCT02852967|593250072|FG001|Overall Study|SAE|0|||
164239660|NCT02852967|593250073|FG002|Overall Study|SAE|0|||
164239661|NCT02852967|593250074|FG003|Overall Study|SAE|3|||
164239662|NCT02852967|593250075|FG004|Overall Study|SAE|0|||
164239663|NCT02852967|593250071|FG000|Overall Study|Elevated Liver Enzymes|2|||
163884652|NCT03867500|591947830|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
163884653|NCT06205407|591947831|FG000|Period 2|Withdrawal by Subject|0|||
163884654|NCT06205407|591947832|FG001|Period 2|Withdrawal by Subject|1|||
163884655|NCT06205407|591947831|FG000|Period 2|Adverse Event|2|||
163884656|NCT06205407|591947832|FG001|Period 2|Adverse Event|1|||
164239664|NCT02852967|593250072|FG001|Overall Study|Elevated Liver Enzymes|0|||
164239665|NCT02852967|593250073|FG002|Overall Study|Elevated Liver Enzymes|0|||
164239666|NCT02852967|593250074|FG003|Overall Study|Elevated Liver Enzymes|2|||
164239667|NCT02852967|593250075|FG004|Overall Study|Elevated Liver Enzymes|2|||
164239668|NCT02852967|593250071|FG000|Overall Study|Physician Decision|0|||
164239669|NCT02852967|593250072|FG001|Overall Study|Physician Decision|0|||
164239670|NCT02852967|593250073|FG002|Overall Study|Physician Decision|0|||
164239671|NCT02852967|593250074|FG003|Overall Study|Physician Decision|1|||
164239672|NCT02852967|593250075|FG004|Overall Study|Physician Decision|0|||
164239673|NCT02852967|593250071|FG000|Overall Study|Lack of Efficacy|0|||
164239674|NCT02852967|593250072|FG001|Overall Study|Lack of Efficacy|1|||
164239675|NCT02852967|593250073|FG002|Overall Study|Lack of Efficacy|0|||
164239676|NCT02852967|593250074|FG003|Overall Study|Lack of Efficacy|0|||
164239677|NCT02852967|593250075|FG004|Overall Study|Lack of Efficacy|0|||
164239678|NCT02852967|593250071|FG000|Overall Study|Non-compliance|0|||
164239679|NCT02852967|593250072|FG001|Overall Study|Non-compliance|0|||
164239680|NCT02852967|593250073|FG002|Overall Study|Non-compliance|1|||
164239681|NCT02852967|593250074|FG003|Overall Study|Non-compliance|1|||
164239682|NCT02852967|593250075|FG004|Overall Study|Non-compliance|0|||
164239683|NCT02852967|593250071|FG000|Overall Study|Dispensing Drug Violation|0|||
164239684|NCT02852967|593250072|FG001|Overall Study|Dispensing Drug Violation|0|||
164239685|NCT02852967|593250073|FG002|Overall Study|Dispensing Drug Violation|1|||
164239686|NCT02852967|593250074|FG003|Overall Study|Dispensing Drug Violation|0|||
164239687|NCT02852967|593250075|FG004|Overall Study|Dispensing Drug Violation|0|||
164239688|NCT02852967|593250071|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
164239689|NCT02852967|593250072|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
164239690|NCT02852967|593250073|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
164239691|NCT02852967|593250074|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
164239692|NCT02852967|593250075|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
164239693|NCT00339040|593250082|FG000|Stage I|Not able to attend clinic|1|||
164239694|NCT00339040|593250083|FG001|Stage I|Not able to attend clinic|0|||
164239695|NCT00339040|593250082|FG000|Stage I|Protocol Violation|1|||
164239696|NCT00339040|593250083|FG001|Stage I|Protocol Violation|1|||
164239697|NCT00339040|593250082|FG000|Stage II|Lost to Follow-up|3|||
164239698|NCT00339040|593250083|FG001|Stage II|Lost to Follow-up|0|||
164239699|NCT00339040|593250082|FG000|Stage II|Withdrawal by Subject|1|||
164239700|NCT00339040|593250083|FG001|Stage II|Withdrawal by Subject|2|||
164239701|NCT00339040|593250082|FG000|Stage II|Protocol Violation|3|||
164239702|NCT00339040|593250083|FG001|Stage II|Protocol Violation|0|||
164239703|NCT00339040|593250082|FG000|Stage II|Not able to attend clinic|1|||
164239704|NCT00339040|593250083|FG001|Stage II|Not able to attend clinic|0|||
164239705|NCT00339040|593250082|FG000|Stage II|Site closing|2|||
164239706|NCT00339040|593250083|FG001|Stage II|Site closing|0|||
164239707|NCT03341637|593250084|FG000|Overall Study|Lost to Follow-up|1|||
164239708|NCT03341637|593250085|FG001|Overall Study|Lost to Follow-up|0|||
164239709|NCT03341637|593250084|FG000|Overall Study|Withdrawal by Subject|3|||
164239710|NCT03341637|593250085|FG001|Overall Study|Withdrawal by Subject|3|||
164239711|NCT03341637|593250084|FG000|Overall Study|Reason not Specified|1|||
164239712|NCT03341637|593250085|FG001|Overall Study|Reason not Specified|1|||
164239713|NCT01462929|593250092|FG000|Overall Study|Adverse Event|3|||
164239714|NCT01462929|593250093|FG001|Overall Study|Adverse Event|3|||
164239715|NCT01462929|593250094|FG002|Overall Study|Adverse Event|4|||
164239716|NCT01462929|593250092|FG000|Overall Study|Withdrawal by Subject|2|||
164239717|NCT01462929|593250093|FG001|Overall Study|Withdrawal by Subject|1|||
164239718|NCT01462929|593250094|FG002|Overall Study|Withdrawal by Subject|0|||
164239719|NCT01462929|593250092|FG000|Overall Study|Lack of Efficacy|0|||
164239720|NCT01462929|593250093|FG001|Overall Study|Lack of Efficacy|0|||
164239721|NCT01462929|593250094|FG002|Overall Study|Lack of Efficacy|1|||
164239722|NCT00887159|593250095|FG000|Overall Study|Disease progression|6|||
164239723|NCT00887159|593250096|FG001|Overall Study|Disease progression|39|||
164239724|NCT00887159|593250097|FG002|Overall Study|Disease progression|33|||
164239725|NCT00887159|593250095|FG000|Overall Study|Adverse Event|3|||
164239726|NCT00887159|593250096|FG001|Overall Study|Adverse Event|4|||
164239727|NCT00887159|593250097|FG002|Overall Study|Adverse Event|17|||
164239728|NCT00887159|593250095|FG000|Overall Study|Death|2|||
164239729|NCT00887159|593250096|FG001|Overall Study|Death|2|||
164239730|NCT00887159|593250097|FG002|Overall Study|Death|0|||
164239731|NCT00887159|593250095|FG000|Overall Study|Withdrawal by Subject|4|||
164239732|NCT00887159|593250096|FG001|Overall Study|Withdrawal by Subject|4|||
164239733|NCT00887159|593250097|FG002|Overall Study|Withdrawal by Subject|2|||
164239734|NCT00887159|593250095|FG000|Overall Study|Alternative therapy|2|||
164239735|NCT00887159|593250096|FG001|Overall Study|Alternative therapy|0|||
164239736|NCT00887159|593250097|FG002|Overall Study|Alternative therapy|0|||
164239737|NCT00887159|593250095|FG000|Overall Study|Physician Decision|1|||
164239738|NCT00887159|593250096|FG001|Overall Study|Physician Decision|1|||
164239739|NCT00887159|593250097|FG002|Overall Study|Physician Decision|0|||
164239740|NCT00887159|593250095|FG000|Overall Study|Sympomatic deterioration|1|||
164239741|NCT00887159|593250096|FG001|Overall Study|Sympomatic deterioration|0|||
164239742|NCT00887159|593250097|FG002|Overall Study|Sympomatic deterioration|0|||
164239743|NCT00887159|593250095|FG000|Overall Study|Treatment delayed|1|||
164239744|NCT00887159|593250096|FG001|Overall Study|Treatment delayed|1|||
164239745|NCT00887159|593250097|FG002|Overall Study|Treatment delayed|0|||
164239746|NCT00887159|593250095|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
164239747|NCT00887159|593250096|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
164239748|NCT00887159|593250097|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
164239749|NCT00887159|593250095|FG000|Overall Study|Received more tx instead of observation|1|||
164239750|NCT00887159|593250096|FG001|Overall Study|Received more tx instead of observation|0|||
164239751|NCT00887159|593250097|FG002|Overall Study|Received more tx instead of observation|0|||
164239752|NCT00887159|593250095|FG000|Overall Study|Ineligible|5|||
164239753|NCT00887159|593250096|FG001|Overall Study|Ineligible|1|||
164239754|NCT00887159|593250097|FG002|Overall Study|Ineligible|0|||
164239755|NCT00887159|593250095|FG000|Overall Study|Never started assigned therapy|3|||
164239756|NCT00887159|593250096|FG001|Overall Study|Never started assigned therapy|3|||
164239757|NCT00887159|593250097|FG002|Overall Study|Never started assigned therapy|4|||
164239758|NCT02071771|593250102|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
164239759|NCT02071771|593250103|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
164239760|NCT02071771|593250102|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
164239761|NCT02071771|593250103|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
164239762|NCT02078752|593250104|FG000|Overall Study|Death|0|||
164239763|NCT02078752|593250105|FG001|Overall Study|Death|3|||
164239764|NCT02078752|593250106|FG002|Overall Study|Death|0|||
164239765|NCT02078752|593250107|FG003|Overall Study|Death|0|||
164239766|NCT02078752|593250108|FG004|Overall Study|Death|0|||
164239767|NCT02078752|593250109|FG005|Overall Study|Death|1|||
164239768|NCT02078752|593250110|FG006|Overall Study|Death|0|||
164239769|NCT02078752|593250111|FG007|Overall Study|Death|1|||
164239770|NCT02078752|593250112|FG008|Overall Study|Death|0|||
164239771|NCT02078752|593250113|FG009|Overall Study|Death|4|||
164239772|NCT02078752|593250104|FG000|Overall Study|Lost to Follow-up|1|||
164239773|NCT02078752|593250105|FG001|Overall Study|Lost to Follow-up|0|||
164239774|NCT02078752|593250106|FG002|Overall Study|Lost to Follow-up|0|||
164239775|NCT02078752|593250107|FG003|Overall Study|Lost to Follow-up|1|||
164239776|NCT02078752|593250108|FG004|Overall Study|Lost to Follow-up|0|||
164239777|NCT02078752|593250109|FG005|Overall Study|Lost to Follow-up|0|||
164239778|NCT02078752|593250110|FG006|Overall Study|Lost to Follow-up|0|||
164239779|NCT02078752|593250111|FG007|Overall Study|Lost to Follow-up|0|||
164239780|NCT02078752|593250112|FG008|Overall Study|Lost to Follow-up|0|||
164239781|NCT02078752|593250113|FG009|Overall Study|Lost to Follow-up|0|||
164239782|NCT02078752|593250104|FG000|Overall Study|Withdrawal by Subject|1|||
164239783|NCT02078752|593250105|FG001|Overall Study|Withdrawal by Subject|1|||
164239784|NCT02078752|593250106|FG002|Overall Study|Withdrawal by Subject|1|||
164239785|NCT02078752|593250107|FG003|Overall Study|Withdrawal by Subject|1|||
164239786|NCT02078752|593250108|FG004|Overall Study|Withdrawal by Subject|0|||
164239787|NCT02078752|593250109|FG005|Overall Study|Withdrawal by Subject|3|||
164239788|NCT02078752|593250110|FG006|Overall Study|Withdrawal by Subject|2|||
164239789|NCT02078752|593250111|FG007|Overall Study|Withdrawal by Subject|1|||
164239790|NCT02078752|593250112|FG008|Overall Study|Withdrawal by Subject|0|||
164239791|NCT02078752|593250113|FG009|Overall Study|Withdrawal by Subject|1|||
164239792|NCT02078752|593250104|FG000|Overall Study|Other|0|||
164239793|NCT02078752|593250105|FG001|Overall Study|Other|3|||
164239794|NCT02078752|593250106|FG002|Overall Study|Other|0|||
164239795|NCT02078752|593250107|FG003|Overall Study|Other|0|||
164239796|NCT02078752|593250108|FG004|Overall Study|Other|1|||
164239797|NCT02078752|593250109|FG005|Overall Study|Other|0|||
164239798|NCT02078752|593250110|FG006|Overall Study|Other|0|||
164239799|NCT02078752|593250111|FG007|Overall Study|Other|1|||
164239800|NCT02078752|593250112|FG008|Overall Study|Other|0|||
164239801|NCT02078752|593250113|FG009|Overall Study|Other|0|||
164239802|NCT02078752|593250104|FG000|Overall Study|Study terminated by sponsor|0|||
164239803|NCT02078752|593250105|FG001|Overall Study|Study terminated by sponsor|0|||
164239804|NCT02078752|593250106|FG002|Overall Study|Study terminated by sponsor|0|||
164239805|NCT02078752|593250107|FG003|Overall Study|Study terminated by sponsor|0|||
164239806|NCT02078752|593250108|FG004|Overall Study|Study terminated by sponsor|0|||
164239807|NCT02078752|593250109|FG005|Overall Study|Study terminated by sponsor|0|||
164239808|NCT02078752|593250110|FG006|Overall Study|Study terminated by sponsor|0|||
164239809|NCT02078752|593250111|FG007|Overall Study|Study terminated by sponsor|0|||
164239810|NCT02078752|593250112|FG008|Overall Study|Study terminated by sponsor|0|||
164239811|NCT02078752|593250113|FG009|Overall Study|Study terminated by sponsor|5|||
164239812|NCT00592631|593250119|FG000|Overall Study|Lost to Follow-up|0|||
164239813|NCT00592631|593250120|FG001|Overall Study|Lost to Follow-up|2|||
164239814|NCT01244035|593250121|FG000|Part 1: Period 1|Adverse Event|0|||
164239815|NCT01244035|593250122|FG001|Part 1: Period 1|Adverse Event|0|||
164239816|NCT01244035|593250123|FG002|Part 1: Period 1|Adverse Event|0|||
164239817|NCT01244035|593250124|FG003|Part 1: Period 1|Adverse Event|0|||
164239818|NCT01244035|593250125|FG004|Part 1: Period 1|Adverse Event|0|||
164239819|NCT01244035|593250126|FG005|Part 1: Period 1|Adverse Event|1|||
164239820|NCT01244035|593250121|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
164239821|NCT01244035|593250122|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
164239822|NCT01244035|593250123|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
164239823|NCT01244035|593250124|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
164239824|NCT01244035|593250125|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
164239825|NCT01244035|593250126|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
164239826|NCT01244035|593250121|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
164239827|NCT01244035|593250122|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
164239828|NCT01244035|593250123|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
164239829|NCT01244035|593250124|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
164239830|NCT01244035|593250125|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
164239831|NCT01244035|593250126|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
164239832|NCT01244035|593250121|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239833|NCT01244035|593250122|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239834|NCT01244035|593250123|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
164239835|NCT01244035|593250124|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239836|NCT01244035|593250125|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239837|NCT01244035|593250126|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
164239838|NCT01244035|593250121|FG000|Part 1: Period 3|Adverse Event|0|||
164239839|NCT01244035|593250122|FG001|Part 1: Period 3|Adverse Event|0|||
164239840|NCT01244035|593250123|FG002|Part 1: Period 3|Adverse Event|0|||
164239841|NCT01244035|593250124|FG003|Part 1: Period 3|Adverse Event|0|||
164239842|NCT01244035|593250125|FG004|Part 1: Period 3|Adverse Event|0|||
164239843|NCT01244035|593250126|FG005|Part 1: Period 3|Adverse Event|1|||
164239844|NCT01244035|593250121|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
164239845|NCT01244035|593250122|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
164239846|NCT01244035|593250123|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
164239847|NCT01244035|593250124|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
164239848|NCT01244035|593250125|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
164239849|NCT01244035|593250126|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
164239850|NCT01244035|593250121|FG000|Part 1: Period 3|Protocol Deviation|0|||
164239851|NCT01244035|593250122|FG001|Part 1: Period 3|Protocol Deviation|1|||
164239852|NCT01244035|593250123|FG002|Part 1: Period 3|Protocol Deviation|0|||
164239853|NCT01244035|593250124|FG003|Part 1: Period 3|Protocol Deviation|0|||
164239854|NCT01244035|593250125|FG004|Part 1: Period 3|Protocol Deviation|0|||
164239855|NCT01244035|593250126|FG005|Part 1: Period 3|Protocol Deviation|0|||
164239856|NCT02776683|593250128|FG000|Pre-switch Period|Protocol Violation|1|||
164239857|NCT02776683|593250129|FG001|Pre-switch Period|Protocol Violation|0|||
164239858|NCT02776683|593250128|FG000|Pre-switch Period|Adverse Event|21|||
164239859|NCT02776683|593250129|FG001|Pre-switch Period|Adverse Event|0|||
164239860|NCT02776683|593250128|FG000|Pre-switch Period|Withdrawal by Subject|9|||
164239861|NCT02776683|593250129|FG001|Pre-switch Period|Withdrawal by Subject|0|||
164239862|NCT02776683|593250128|FG000|Pre-switch Period|Physician Decision|7|||
164239863|NCT02776683|593250129|FG001|Pre-switch Period|Physician Decision|0|||
164239864|NCT02776683|593250128|FG000|Pre-switch Period|Progressive disease|39|||
164239865|NCT02776683|593250129|FG001|Pre-switch Period|Progressive disease|0|||
164239866|NCT02776683|593250128|FG000|Pre-switch Period|Other than listed|3|||
164239867|NCT02776683|593250129|FG001|Pre-switch Period|Other than listed|0|||
164239868|NCT02776683|593250128|FG000|Post-switch Period|Adverse Event|0|||
164239869|NCT02776683|593250129|FG001|Post-switch Period|Adverse Event|3|||
164239870|NCT02776683|593250128|FG000|Post-switch Period|Withdrawal by Subject|0|||
164239871|NCT02776683|593250129|FG001|Post-switch Period|Withdrawal by Subject|2|||
164239872|NCT02776683|593250128|FG000|Post-switch Period|Physician Decision|0|||
164239873|NCT02776683|593250129|FG001|Post-switch Period|Physician Decision|3|||
164239874|NCT02776683|593250128|FG000|Post-switch Period|Progressive disease|0|||
164239875|NCT02776683|593250129|FG001|Post-switch Period|Progressive disease|20|||
164239876|NCT02776683|593250128|FG000|Post-switch Period|Other than listed|0|||
164239877|NCT02776683|593250129|FG001|Post-switch Period|Other than listed|15|||
164239878|NCT00616642|593250131|FG000|Overall Study|Withdrawal by Subject|0|||
164239879|NCT00616642|593250132|FG001|Overall Study|Withdrawal by Subject|1|||
164239880|NCT00570323|593250133|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
164239881|NCT00570323|593250134|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
164239882|NCT00570323|593250133|FG000|Started Treatment After Randomization|Protocol Violation|1|||
164239883|NCT00570323|593250134|FG001|Started Treatment After Randomization|Protocol Violation|0|||
164239884|NCT00570323|593250133|FG000|Started Treatment After Randomization|Physician Decision|1|||
164239885|NCT00570323|593250134|FG001|Started Treatment After Randomization|Physician Decision|0|||
164239886|NCT00570323|593250133|FG000|Complete Study After Start|Lost to Follow-up|0|||
164239887|NCT00570323|593250134|FG001|Complete Study After Start|Lost to Follow-up|1|||
164239888|NCT00570323|593250133|FG000|Complete Study After Start|Withdrawal by Subject|2|||
164239889|NCT00570323|593250134|FG001|Complete Study After Start|Withdrawal by Subject|0|||
164239890|NCT00570323|593250133|FG000|Complete Study After Start|Physician Decision|1|||
164239891|NCT00570323|593250134|FG001|Complete Study After Start|Physician Decision|0|||
164239892|NCT01023217|593250136|FG000|Overall Study|Withdrawal by Subject|1|||
164239893|NCT01023217|593250137|FG001|Overall Study|Withdrawal by Subject|0|||
164335764|NCT02913612|593606055|FG002|Overall Study|Needed to treat second hemangioma|0|||
164335765|NCT02913612|593606056|FG003|Overall Study|Needed to treat second hemangioma|0|||
164335766|NCT02913612|593606053|FG000|Overall Study|Study completion criteria not met|0|||
164335767|NCT02913612|593606054|FG001|Overall Study|Study completion criteria not met|1|||
164335768|NCT02913612|593606055|FG002|Overall Study|Study completion criteria not met|0|||
164335769|NCT02913612|593606056|FG003|Overall Study|Study completion criteria not met|0|||
164335770|NCT02913612|593606053|FG000|Overall Study|Ineligible|0|||
164335771|NCT02913612|593606054|FG001|Overall Study|Ineligible|1|||
164335772|NCT02913612|593606055|FG002|Overall Study|Ineligible|0|||
164335773|NCT02913612|593606056|FG003|Overall Study|Ineligible|0|||
164335774|NCT04251273|593606057|FG000|Overall Study|Lost to Follow-up|331|||
164335775|NCT04251273|593606058|FG001|Overall Study|Lost to Follow-up|290|||
164335776|NCT04402060|593606059|FG000|Overall Study|Death|1|||
164335777|NCT04402060|593606060|FG001|Overall Study|Death|12|||
164335778|NCT04402060|593606061|FG002|Overall Study|Death|7|||
164335779|NCT04402060|593606059|FG000|Overall Study|Adverse Event|0|||
164335780|NCT04402060|593606060|FG001|Overall Study|Adverse Event|0|||
164335781|NCT04402060|593606061|FG002|Overall Study|Adverse Event|1|||
164335782|NCT04402060|593606059|FG000|Overall Study|Withdrawal by Subject|0|||
164335783|NCT04402060|593606060|FG001|Overall Study|Withdrawal by Subject|1|||
164335784|NCT04402060|593606061|FG002|Overall Study|Withdrawal by Subject|2|||
164335785|NCT04402060|593606059|FG000|Overall Study|Sponsor Request|0|||
164335786|NCT04402060|593606060|FG001|Overall Study|Sponsor Request|2|||
164335787|NCT04402060|593606061|FG002|Overall Study|Sponsor Request|0|||
164335788|NCT04402060|593606059|FG000|Overall Study|Physician Decision|0|||
164335789|NCT04402060|593606060|FG001|Overall Study|Physician Decision|0|||
164335790|NCT04402060|593606061|FG002|Overall Study|Physician Decision|1|||
164335791|NCT04402060|593606059|FG000|Overall Study|Other|0|||
164335792|NCT04402060|593606060|FG001|Overall Study|Other|1|||
164335793|NCT04402060|593606061|FG002|Overall Study|Other|0|||
164335794|NCT00936611|593606069|FG000|Overall Study|Progressive Disease|3|||
164335795|NCT00936611|593606069|FG000|Overall Study|New Systemic Therapy|22|||
164335796|NCT00936611|593606069|FG000|Overall Study|Lost to Follow-up|1|||
164335797|NCT00936611|593606069|FG000|Overall Study|Withdrawal by Subject|2|||
164335798|NCT00936611|593606069|FG000|Overall Study|Still on Follow-up|1|||
164335799|NCT00936611|593606069|FG000|Overall Study|Still on Active Therapy|7|||
164335800|NCT00936611|593606069|FG000|Overall Study|Ineligible for Study Drug|3|||
164335801|NCT02955797|593606070|FG000|Overall Study|Protocol Violation|1|||
164335802|NCT02955797|593606071|FG001|Overall Study|Protocol Violation|0|||
164335803|NCT02955797|593606072|FG002|Overall Study|Protocol Violation|0|||
164335804|NCT02955797|593606073|FG003|Overall Study|Protocol Violation|1|||
164335805|NCT02955797|593606070|FG000|Overall Study|Withdrawal by Subject|2|||
164335806|NCT02955797|593606071|FG001|Overall Study|Withdrawal by Subject|2|||
164335807|NCT02955797|593606072|FG002|Overall Study|Withdrawal by Subject|0|||
164335808|NCT02955797|593606073|FG003|Overall Study|Withdrawal by Subject|1|||
164335809|NCT02955797|593606070|FG000|Overall Study|Lost to Follow-up|0|||
164335810|NCT02955797|593606071|FG001|Overall Study|Lost to Follow-up|1|||
164335811|NCT02955797|593606072|FG002|Overall Study|Lost to Follow-up|0|||
164335812|NCT02955797|593606073|FG003|Overall Study|Lost to Follow-up|0|||
164335813|NCT03131453|593606075|FG000|Overall Study|Study terminated by Sponsor|424|||
164335814|NCT03131453|593606076|FG001|Overall Study|Study terminated by Sponsor|222|||
164335815|NCT03131453|593606077|FG002|Overall Study|Study terminated by Sponsor|438|||
164335816|NCT03131453|593606075|FG000|Overall Study|Withdrawal by Subject|18|||
164335817|NCT03131453|593606076|FG001|Overall Study|Withdrawal by Subject|7|||
164335818|NCT03131453|593606077|FG002|Overall Study|Withdrawal by Subject|13|||
164335819|NCT03131453|593606075|FG000|Overall Study|Adverse Event|10|||
164335820|NCT03131453|593606076|FG001|Overall Study|Adverse Event|3|||
164335821|NCT03131453|593606077|FG002|Overall Study|Adverse Event|3|||
164335822|NCT03131453|593606075|FG000|Overall Study|Lost to Follow-up|1|||
164335823|NCT03131453|593606076|FG001|Overall Study|Lost to Follow-up|0|||
164335824|NCT03131453|593606077|FG002|Overall Study|Lost to Follow-up|1|||
164335825|NCT03131453|593606075|FG000|Overall Study|Physician Decision|1|||
164335826|NCT03131453|593606076|FG001|Overall Study|Physician Decision|0|||
164335827|NCT03131453|593606077|FG002|Overall Study|Physician Decision|1|||
164335828|NCT03131453|593606075|FG000|Overall Study|Non-compliance with study treatment|1|||
164335829|NCT03131453|593606076|FG001|Overall Study|Non-compliance with study treatment|0|||
164335830|NCT03131453|593606077|FG002|Overall Study|Non-compliance with study treatment|0|||
164335831|NCT03131453|593606075|FG000|Overall Study|Technical problems|1|||
164335832|NCT03131453|593606076|FG001|Overall Study|Technical problems|0|||
164335833|NCT03131453|593606077|FG002|Overall Study|Technical problems|0|||
164335834|NCT03131453|593606075|FG000|Overall Study|Protocol deviation|0|||
164335835|NCT03131453|593606076|FG001|Overall Study|Protocol deviation|1|||
164335836|NCT03131453|593606077|FG002|Overall Study|Protocol deviation|0|||
164335837|NCT02081183|593606078|FG000|Overall Study|Lost to Follow-up|0|||
164335838|NCT02081183|593606079|FG001|Overall Study|Lost to Follow-up|1|||
164335839|NCT02081183|593606078|FG000|Overall Study|Protocol Violation|1|||
164335840|NCT02081183|593606079|FG001|Overall Study|Protocol Violation|0|||
164239894|NCT01567722|593250146|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
164239895|NCT01567722|593250147|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
164239896|NCT01567722|593250148|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
164239897|NCT01567722|593250146|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
164239898|NCT01567722|593250147|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
164239899|NCT01567722|593250148|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
164239900|NCT01567722|593250146|FG000|Overall Study|Protocol closure by the OCG|2|||
164335841|NCT02081183|593606078|FG000|Overall Study|Other|3|||
164335842|NCT02081183|593606079|FG001|Overall Study|Other|3|||
164335843|NCT02282358|593606086|FG000|Overall Study|Nonevaluable|1|||
164335844|NCT01898208|593606087|FG000|Overall Study|Positive blood culture|17|||
164335845|NCT01898208|593606088|FG001|Overall Study|Positive blood culture|23|||
164335846|NCT01898208|593606089|FG002|Overall Study|Positive blood culture|15|||
164335847|NCT01898208|593606087|FG000|Overall Study|Death/comfort care within 24 hours|10|||
164335848|NCT01898208|593606088|FG001|Overall Study|Death/comfort care within 24 hours|9|||
164335849|NCT01898208|593606089|FG002|Overall Study|Death/comfort care within 24 hours|8|||
164335850|NCT01898208|593606087|FG000|Overall Study|Negative Gram Stain|6|||
164335851|NCT01898208|593606088|FG001|Overall Study|Negative Gram Stain|9|||
164335852|NCT01898208|593606089|FG002|Overall Study|Negative Gram Stain|6|||
164335853|NCT01898208|593606087|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
164335854|NCT01898208|593606088|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
164335855|NCT01898208|593606089|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
164335856|NCT01898208|593606087|FG000|Overall Study|System/Technical Error|1|||
164335857|NCT01898208|593606088|FG001|Overall Study|System/Technical Error|2|||
164335858|NCT01898208|593606089|FG002|Overall Study|System/Technical Error|3|||
164335859|NCT01898208|593606087|FG000|Overall Study|Lost to Follow-up|3|||
164335860|NCT01898208|593606088|FG001|Overall Study|Lost to Follow-up|1|||
164335861|NCT01898208|593606089|FG002|Overall Study|Lost to Follow-up|1|||
164335862|NCT04043728|593606090|FG000|Overall Study|Lost to Follow-up|1|||
164335863|NCT04043728|593606091|FG001|Overall Study|Lost to Follow-up|2|||
164335864|NCT04043728|593606092|FG002|Overall Study|Lost to Follow-up|0|||
164335865|NCT03780543|593606094|FG000|Overall Study|Adverse Event|1|||
164335866|NCT03780543|593606095|FG001|Overall Study|Adverse Event|0|||
164335867|NCT03780543|593606096|FG002|Overall Study|Adverse Event|2|||
164335868|NCT03780543|593606094|FG000|Overall Study|Lost to Follow-up|2|||
164335869|NCT03780543|593606095|FG001|Overall Study|Lost to Follow-up|0|||
164335870|NCT03780543|593606096|FG002|Overall Study|Lost to Follow-up|1|||
164335871|NCT03780543|593606094|FG000|Overall Study|Study terminated by Sponsor|8|||
164335872|NCT03780543|593606095|FG001|Overall Study|Study terminated by Sponsor|7|||
164335873|NCT03780543|593606096|FG002|Overall Study|Study terminated by Sponsor|13|||
164335874|NCT03780543|593606094|FG000|Overall Study|Withdrawal by Subject|1|||
164335875|NCT03780543|593606095|FG001|Overall Study|Withdrawal by Subject|8|||
164335876|NCT03780543|593606096|FG002|Overall Study|Withdrawal by Subject|1|||
164335877|NCT03780543|593606094|FG000|Overall Study|Noncompliance with study drug|1|||
164335878|NCT03780543|593606095|FG001|Overall Study|Noncompliance with study drug|0|||
164335879|NCT03780543|593606096|FG002|Overall Study|Noncompliance with study drug|0|||
164335880|NCT02649894|593606099|FG000|Overall Study|Adverse Event|1|||
164335881|NCT02649894|593606100|FG001|Overall Study|Adverse Event|0|||
164335882|NCT02649894|593606099|FG000|Overall Study|Physician Decision|0|||
164335883|NCT02649894|593606100|FG001|Overall Study|Physician Decision|1|||
164335884|NCT02649894|593606099|FG000|Overall Study|Withdrawal by Subject|5|||
164335885|NCT02649894|593606100|FG001|Overall Study|Withdrawal by Subject|2|||
164335886|NCT02649894|593606099|FG000|Overall Study|Lost to Follow-up|2|||
164335887|NCT02649894|593606100|FG001|Overall Study|Lost to Follow-up|1|||
164335888|NCT02649894|593606099|FG000|Overall Study|Death|30|||
164335889|NCT02649894|593606100|FG001|Overall Study|Death|7|||
164335890|NCT02649894|593606099|FG000|Overall Study|Other, not specified|6|||
164335891|NCT02649894|593606100|FG001|Overall Study|Other, not specified|0|||
164335892|NCT01736124|593606101|FG000|Post-intervention Assessment|Death|2|||
164335893|NCT01736124|593606102|FG001|Post-intervention Assessment|Death|2|||
164335894|NCT01736124|593606101|FG000|Post-intervention Assessment|lost computer access|1|||
164335895|NCT01736124|593606102|FG001|Post-intervention Assessment|lost computer access|1|||
164335896|NCT01736124|593606101|FG000|Post-intervention Assessment|Moved away|3|||
164335897|NCT01736124|593606102|FG001|Post-intervention Assessment|Moved away|1|||
164335898|NCT01736124|593606101|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
164239901|NCT01567722|593250147|FG001|Overall Study|Protocol closure by the OCG|0|||
164239902|NCT01567722|593250148|FG002|Overall Study|Protocol closure by the OCG|0|||
164239903|NCT01567722|593250146|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
164239904|NCT01567722|593250147|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
164239905|NCT01567722|593250148|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
164239906|NCT00332696|593250149|FG000|Overall Study|Death|24|||
164239907|NCT00332696|593250150|FG001|Overall Study|Death|14|||
164239908|NCT00332696|593250149|FG000|Overall Study|Insufficient therapeutic effect|4|||
164239909|NCT00332696|593250150|FG001|Overall Study|Insufficient therapeutic effect|11|||
164239910|NCT00332696|593250149|FG000|Overall Study|Adverse Event|1|||
164239911|NCT00332696|593250150|FG001|Overall Study|Adverse Event|2|||
164239912|NCT00332696|593250149|FG000|Overall Study|Condition does not justify treatment|0|||
164239913|NCT00332696|593250150|FG001|Overall Study|Condition does not justify treatment|2|||
164239914|NCT00332696|593250149|FG000|Overall Study|Lost to Follow-up|0|||
164239915|NCT00332696|593250150|FG001|Overall Study|Lost to Follow-up|1|||
164239916|NCT00332696|593250149|FG000|Overall Study|Withdrawal by Subject|1|||
164239917|NCT00332696|593250150|FG001|Overall Study|Withdrawal by Subject|0|||
164239918|NCT02216526|593250151|FG000|Overall Study|Adverse Event|1|||
164239919|NCT02216526|593250152|FG001|Overall Study|Adverse Event|1|||
164239920|NCT02216526|593250153|FG002|Overall Study|Adverse Event|0|||
164239921|NCT02216526|593250151|FG000|Overall Study|Death|0|||
164239922|NCT02216526|593250152|FG001|Overall Study|Death|1|||
164239923|NCT02216526|593250153|FG002|Overall Study|Death|3|||
164239924|NCT02216526|593250151|FG000|Overall Study|Protocol Violation|2|||
164239925|NCT02216526|593250152|FG001|Overall Study|Protocol Violation|0|||
164239926|NCT02216526|593250153|FG002|Overall Study|Protocol Violation|2|||
164239927|NCT02216526|593250151|FG000|Overall Study|Hospitalization|2|||
164239928|NCT02216526|593250152|FG001|Overall Study|Hospitalization|1|||
164239929|NCT02216526|593250153|FG002|Overall Study|Hospitalization|3|||
164239930|NCT04103450|593250158|FG000|Overall Study|Adverse Event|4|||
164239931|NCT04103450|593250159|FG001|Overall Study|Adverse Event|2|||
164239932|NCT04103450|593250158|FG000|Overall Study|Lack of Efficacy|3|||
164239933|NCT04103450|593250159|FG001|Overall Study|Lack of Efficacy|0|||
164239934|NCT04103450|593250158|FG000|Overall Study|Withdrawal by Subject|5|||
164239935|NCT04103450|593250159|FG001|Overall Study|Withdrawal by Subject|3|||
164239936|NCT04103450|593250158|FG000|Overall Study|Lost to Follow-up|1|||
164239937|NCT04103450|593250159|FG001|Overall Study|Lost to Follow-up|2|||
164239938|NCT04103450|593250158|FG000|Overall Study|Physician Decision|1|||
164239939|NCT04103450|593250159|FG001|Overall Study|Physician Decision|2|||
164239940|NCT04103450|593250158|FG000|Overall Study|Protocol Violation|1|||
164239941|NCT04103450|593250159|FG001|Overall Study|Protocol Violation|0|||
164239942|NCT04103450|593250158|FG000|Overall Study|Other|1|||
164239943|NCT04103450|593250159|FG001|Overall Study|Other|1|||
164239944|NCT02259114|593250161|FG000|Overall Study|Progressive Disease|14|||
164239945|NCT02259114|593250162|FG001|Overall Study|Progressive Disease|2|||
164239946|NCT02259114|593250163|FG002|Overall Study|Progressive Disease|10|||
164239947|NCT02259114|593250164|FG003|Overall Study|Progressive Disease|2|||
164239948|NCT02259114|593250165|FG004|Overall Study|Progressive Disease|5|||
164239949|NCT02259114|593250161|FG000|Overall Study|Adverse Event|2|||
164239950|NCT02259114|593250162|FG001|Overall Study|Adverse Event|1|||
164239951|NCT02259114|593250163|FG002|Overall Study|Adverse Event|0|||
164239952|NCT02259114|593250164|FG003|Overall Study|Adverse Event|0|||
164239953|NCT02259114|593250165|FG004|Overall Study|Adverse Event|1|||
164239954|NCT02259114|593250161|FG000|Overall Study|Death|3|||
164239955|NCT02259114|593250162|FG001|Overall Study|Death|0|||
164239956|NCT02259114|593250163|FG002|Overall Study|Death|1|||
164239957|NCT02259114|593250164|FG003|Overall Study|Death|0|||
164239958|NCT02259114|593250165|FG004|Overall Study|Death|0|||
164239959|NCT02259114|593250161|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239960|NCT02259114|593250162|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239961|NCT02259114|593250163|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
164239962|NCT02259114|593250164|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239963|NCT02259114|593250165|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
164239964|NCT02259114|593250161|FG000|Overall Study|Withdrawal by Subject|0|||
164239965|NCT02259114|593250162|FG001|Overall Study|Withdrawal by Subject|0|||
164239966|NCT02259114|593250163|FG002|Overall Study|Withdrawal by Subject|1|||
164239967|NCT02259114|593250164|FG003|Overall Study|Withdrawal by Subject|1|||
164239968|NCT02259114|593250165|FG004|Overall Study|Withdrawal by Subject|0|||
164239969|NCT02259114|593250161|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
164239970|NCT02259114|593250162|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
164239971|NCT02259114|593250163|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
164239972|NCT02259114|593250164|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
164239973|NCT02259114|593250165|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
164239974|NCT02259114|593250161|FG000|Overall Study|Not Treated|1|||
164239975|NCT02259114|593250162|FG001|Overall Study|Not Treated|0|||
164239976|NCT02259114|593250163|FG002|Overall Study|Not Treated|0|||
164239977|NCT02259114|593250164|FG003|Overall Study|Not Treated|0|||
164239978|NCT02259114|593250165|FG004|Overall Study|Not Treated|0|||
164239979|NCT03937479|593250166|FG000|Overall Study|Adverse Event|2|||
164239980|NCT03937479|593250167|FG001|Overall Study|Adverse Event|3|||
164239981|NCT03937479|593250168|FG002|Overall Study|Adverse Event|0|||
164239982|NCT03937479|593250169|FG003|Overall Study|Adverse Event|0|||
164239983|NCT03937479|593250170|FG004|Overall Study|Adverse Event|1|||
164239984|NCT03937479|593250166|FG000|Overall Study|Withdrawal by Subject|3|||
164239985|NCT03937479|593250167|FG001|Overall Study|Withdrawal by Subject|5|||
164239986|NCT03937479|593250168|FG002|Overall Study|Withdrawal by Subject|2|||
164239987|NCT03937479|593250169|FG003|Overall Study|Withdrawal by Subject|2|||
164239988|NCT03937479|593250170|FG004|Overall Study|Withdrawal by Subject|1|||
164239989|NCT03937479|593250166|FG000|Overall Study|Protocol Violation|5|||
164239990|NCT03937479|593250167|FG001|Overall Study|Protocol Violation|6|||
164239991|NCT03937479|593250168|FG002|Overall Study|Protocol Violation|4|||
164239992|NCT03937479|593250169|FG003|Overall Study|Protocol Violation|3|||
164239993|NCT03937479|593250170|FG004|Overall Study|Protocol Violation|2|||
164239994|NCT03937479|593250166|FG000|Overall Study|Lost to Follow-up|0|||
164239995|NCT03937479|593250167|FG001|Overall Study|Lost to Follow-up|1|||
164239996|NCT03937479|593250168|FG002|Overall Study|Lost to Follow-up|0|||
164239997|NCT03937479|593250169|FG003|Overall Study|Lost to Follow-up|1|||
164239998|NCT03937479|593250170|FG004|Overall Study|Lost to Follow-up|0|||
164239999|NCT03937479|593250166|FG000|Overall Study|Physician Decision|0|||
164240000|NCT03937479|593250167|FG001|Overall Study|Physician Decision|0|||
164240001|NCT03937479|593250168|FG002|Overall Study|Physician Decision|1|||
164240002|NCT03937479|593250169|FG003|Overall Study|Physician Decision|0|||
164240003|NCT03937479|593250170|FG004|Overall Study|Physician Decision|1|||
164240004|NCT02712788|593250173|FG000|Overall Study|Physician Decision|1|||
164240005|NCT02712788|593250174|FG001|Overall Study|Physician Decision|0|||
164240006|NCT02712788|593250173|FG000|Overall Study|Protocol Violation|1|||
164240007|NCT02712788|593250174|FG001|Overall Study|Protocol Violation|0|||
164240008|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
164240009|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
164240010|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
164240011|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
164240012|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
164240013|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
164240014|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
164240015|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
164240016|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
164240017|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
164240018|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
164240019|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
164240020|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
164240021|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
164240022|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
164240023|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
164240024|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
164240025|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
164240026|NCT03789292|593250179|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
164240027|NCT03789292|593250180|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
164240028|NCT03789292|593250181|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
164240029|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
164335899|NCT01736124|593606102|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
164335900|NCT01736124|593606101|FG000|Post-intervention Assessment|Illness|3|||
164335901|NCT01736124|593606102|FG001|Post-intervention Assessment|Illness|2|||
164335902|NCT01736124|593606101|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
164335903|NCT01736124|593606102|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
164335904|NCT01736124|593606101|FG000|Post-intervention Assessment|Temporarily away|3|||
164335905|NCT01736124|593606102|FG001|Post-intervention Assessment|Temporarily away|1|||
164335906|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
164335907|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
164335908|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
164335909|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
163884657|NCT03611491|591947833|FG000|Overall Study|Lost to Follow-up|1|||
164240030|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
164240031|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
164240032|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
164240033|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
164240034|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
164335910|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
163884658|NCT04676022|591947834|FG000|Overall Study|Screen Failure/|1|||
164240035|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
164240036|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
164240037|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
164240038|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
164240039|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
164240040|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
164240041|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
164240042|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
164240043|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
164240044|NCT03789292|593250179|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
164240045|NCT03789292|593250180|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
164240046|NCT03789292|593250181|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
164240047|NCT02230189|593250182|FG000|Overall Study|Withdrawal by Subject|3|||
164240048|NCT02230189|593250183|FG001|Overall Study|Withdrawal by Subject|0|||
164240049|NCT02230189|593250184|FG002|Overall Study|Withdrawal by Subject|1|||
164240050|NCT02230189|593250182|FG000|Overall Study|Lost to Follow-up|1|||
164240051|NCT02230189|593250183|FG001|Overall Study|Lost to Follow-up|0|||
164240052|NCT02230189|593250184|FG002|Overall Study|Lost to Follow-up|0|||
164240053|NCT02230189|593250182|FG000|Overall Study|Physician Decision|1|||
164240054|NCT02230189|593250183|FG001|Overall Study|Physician Decision|0|||
164240055|NCT02230189|593250184|FG002|Overall Study|Physician Decision|0|||
164240056|NCT00699413|593250189|FG000|Overall Study|Withdrawal by Subject|0|||
164240057|NCT00699413|593250190|FG001|Overall Study|Withdrawal by Subject|2|||
164240058|NCT00699413|593250189|FG000|Overall Study|Study terminated by sponsor|4|||
164240059|NCT00699413|593250190|FG001|Overall Study|Study terminated by sponsor|2|||
164240060|NCT02779777|593250191|FG000|Overall Study|Disease Progression|1|||
164240061|NCT02779777|593250192|FG001|Overall Study|Disease Progression|0|||
164240062|NCT02779777|593250193|FG002|Overall Study|Disease Progression|0|||
164240063|NCT02779777|593250191|FG000|Overall Study|Adverse Event|3|||
164240064|NCT02779777|593250192|FG001|Overall Study|Adverse Event|1|||
164240065|NCT02779777|593250193|FG002|Overall Study|Adverse Event|0|||
164240066|NCT02779777|593250191|FG000|Overall Study|Physician Decision|9|||
164240067|NCT02779777|593250192|FG001|Overall Study|Physician Decision|0|||
164240068|NCT02779777|593250193|FG002|Overall Study|Physician Decision|1|||
164240069|NCT02779777|593250191|FG000|Overall Study|Withdrawal by Subject|1|||
164240070|NCT02779777|593250192|FG001|Overall Study|Withdrawal by Subject|0|||
164240071|NCT02779777|593250193|FG002|Overall Study|Withdrawal by Subject|0|||
164240072|NCT00730886|593250194|FG000|Overall Study|Lost to Follow-up|1|||
164240073|NCT00730886|593250195|FG001|Overall Study|Lost to Follow-up|0|||
164240074|NCT00730886|593250194|FG000|Overall Study|Physician Decision|1|||
164240075|NCT00730886|593250195|FG001|Overall Study|Physician Decision|0|||
164240076|NCT02031302|593250196|FG000|Overall Study|Death|115|||
164240077|NCT02031302|593250197|FG001|Overall Study|Death|0|||
164240078|NCT02031302|593250196|FG000|Overall Study|Not treated with study valve system|18|||
164240079|NCT02031302|593250197|FG001|Overall Study|Not treated with study valve system|0|||
164240080|NCT02031302|593250196|FG000|Overall Study|Missed Follow Up|27|||
164240081|NCT02031302|593250197|FG001|Overall Study|Missed Follow Up|0|||
164240082|NCT02031302|593250196|FG000|Overall Study|Lost to Follow-up|4|||
164240083|NCT02031302|593250197|FG001|Overall Study|Lost to Follow-up|0|||
164240084|NCT01847443|593250198|FG000|Study Period 1|Withdrawal by Subject|0|||
164240085|NCT01847443|593250199|FG001|Study Period 1|Withdrawal by Subject|1|||
164240086|NCT01847443|593250200|FG002|Study Period 1|Withdrawal by Subject|0|||
164240087|NCT01847443|593250201|FG003|Study Period 1|Withdrawal by Subject|0|||
164240088|NCT01847443|593250198|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
164240089|NCT01847443|593250199|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
164240090|NCT01847443|593250200|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
164240091|NCT01847443|593250201|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
164240092|NCT01847443|593250198|FG000|Washout Period Before Study Period 2|Other reason|1|||
164240093|NCT01847443|593250199|FG001|Washout Period Before Study Period 2|Other reason|0|||
164240094|NCT01847443|593250200|FG002|Washout Period Before Study Period 2|Other reason|0|||
164240095|NCT01847443|593250201|FG003|Washout Period Before Study Period 2|Other reason|0|||
164240096|NCT01847443|593250198|FG000|Washout Period Before Study Period 3|Other reason|1|||
164240097|NCT01847443|593250199|FG001|Washout Period Before Study Period 3|Other reason|0|||
164240098|NCT01847443|593250200|FG002|Washout Period Before Study Period 3|Other reason|0|||
164240099|NCT01847443|593250201|FG003|Washout Period Before Study Period 3|Other reason|0|||
164240100|NCT01847443|593250198|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
164240101|NCT01847443|593250199|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
164240102|NCT01847443|593250200|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
164240103|NCT01847443|593250201|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
164240104|NCT01847443|593250198|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
164240105|NCT01847443|593250199|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
164240106|NCT01847443|593250200|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
164240107|NCT01847443|593250201|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
164240108|NCT04067492|593250202|FG000|Overall Study|Lost to Follow-up|0|||
164240109|NCT04067492|593250203|FG001|Overall Study|Lost to Follow-up|0|||
164240110|NCT04067492|593250204|FG002|Overall Study|Lost to Follow-up|0|||
164240111|NCT04067492|593250205|FG003|Overall Study|Lost to Follow-up|0|||
164240112|NCT04067492|593250206|FG004|Overall Study|Lost to Follow-up|0|||
164240113|NCT04067492|593250207|FG005|Overall Study|Lost to Follow-up|1|||
164240114|NCT04067492|593250202|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240115|NCT04067492|593250203|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
164335911|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
164335912|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
164335913|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
164335914|NCT01736124|593606101|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
164335915|NCT01736124|593606102|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
164335916|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
164335917|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
164335918|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
164335919|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
164335920|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
164335921|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
164335922|NCT01736124|593606101|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
164335923|NCT01736124|593606102|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
164335924|NCT01467583|593606103|FG000|Overall Study|Death|1|||
164335925|NCT01467583|593606104|FG001|Overall Study|Death|1|||
164335926|NCT01467583|593606105|FG002|Overall Study|Death|0|||
164335927|NCT01467583|593606103|FG000|Overall Study|Withdrawal by Subject|1|||
164335928|NCT01467583|593606104|FG001|Overall Study|Withdrawal by Subject|0|||
164335929|NCT01467583|593606105|FG002|Overall Study|Withdrawal by Subject|0|||
164335930|NCT01467583|593606103|FG000|Overall Study|Protocol Violation|0|||
164335931|NCT01467583|593606104|FG001|Overall Study|Protocol Violation|0|||
164335932|NCT01467583|593606105|FG002|Overall Study|Protocol Violation|2|||
164335933|NCT05274165|593606107|FG000|Overall Study|Withdrawal by Subject|3|||
164335934|NCT05274165|593606108|FG001|Overall Study|Withdrawal by Subject|3|||
164335935|NCT02719327|593606110|FG000|Overall Study|Withdrawal by Subject|11|||
164335936|NCT02719327|593606111|FG001|Overall Study|Withdrawal by Subject|8|||
164335937|NCT00717093|593607773|FG000|Overall Study|Adverse Event|19|||
164335938|NCT00717093|593607774|FG001|Overall Study|Adverse Event|9|||
164335939|NCT00717093|593607773|FG000|Overall Study|Lack of Efficacy|3|||
164335940|NCT00717093|593607774|FG001|Overall Study|Lack of Efficacy|13|||
164335941|NCT00717093|593607773|FG000|Overall Study|Lost to Follow-up|9|||
164335942|NCT00717093|593607774|FG001|Overall Study|Lost to Follow-up|6|||
164335943|NCT00717093|593607773|FG000|Overall Study|Withdrawal by Subject|12|||
164335944|NCT00717093|593607774|FG001|Overall Study|Withdrawal by Subject|19|||
164335945|NCT00717093|593607773|FG000|Overall Study|Other|0|||
164335946|NCT00717093|593607774|FG001|Overall Study|Other|1|||
164335947|NCT00717093|593607773|FG000|Overall Study|Randomized but not treated|1|||
164335948|NCT00717093|593607774|FG001|Overall Study|Randomized but not treated|0|||
164335949|NCT00217620|593607775|FG000|Overall Study|Adverse Event|2|||
164335950|NCT00217620|593607775|FG000|Overall Study|Progression|31|||
164335951|NCT00217620|593607775|FG000|Overall Study|Not Protocol Specified|4|||
164335952|NCT00217620|593607775|FG000|Overall Study|Ineligible|13|||
164335953|NCT00217620|593607775|FG000|Overall Study|Never received treatment|1|||
164335954|NCT01314703|593607791|FG000|Overall Study|screen failure and closed enrollment|8|||
164335955|NCT04195906|593607795|FG000|Part 1|Adverse Event|3|||
164335956|NCT04195906|593607796|FG001|Part 1|Adverse Event|7|||
164335957|NCT04195906|593607795|FG000|Part 1|Withdrawal by Subject|0|||
164335958|NCT04195906|593607796|FG001|Part 1|Withdrawal by Subject|1|||
164335959|NCT04195906|593607795|FG000|Part 2|Adverse Event|1|||
164335960|NCT04195906|593607796|FG001|Part 2|Adverse Event|1|||
164335961|NCT04195906|593607795|FG000|Part 2|Withdrawal by Subject|0|||
164335962|NCT04195906|593607796|FG001|Part 2|Withdrawal by Subject|3|||
164335963|NCT04195906|593607795|FG000|Part 2|Other|1|||
164335964|NCT04195906|593607796|FG001|Part 2|Other|3|||
164335965|NCT01823146|593607798|FG000|Overall Study|Withdrawal by Subject|0|||
164335966|NCT01823146|593607799|FG001|Overall Study|Withdrawal by Subject|1|||
164335967|NCT01823146|593607798|FG000|Overall Study|Lost to Follow-up|2|||
164335968|NCT01823146|593607799|FG001|Overall Study|Lost to Follow-up|1|||
163884659|NCT04676022|591947835|FG001|Overall Study|Screen Failure/|1|||
163884660|NCT04676022|591947836|FG002|Overall Study|Screen Failure/|85|||
163884661|NCT04676022|591947834|FG000|Overall Study|Lost to Follow-up|1|||
163884662|NCT04676022|591947835|FG001|Overall Study|Lost to Follow-up|1|||
163884663|NCT04676022|591947836|FG002|Overall Study|Lost to Follow-up|0|||
163884664|NCT04676022|591947834|FG000|Overall Study|Adverse Event|2|||
164240116|NCT04067492|593250204|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
163989197|NCT03175549|592328290|FG001|Overall Study|Lost to Follow-up|2|||
163989198|NCT03175549|592328289|FG000|Overall Study|Medication non-compliance|2|||
163989199|NCT03175549|592328290|FG001|Overall Study|Medication non-compliance|2|||
163989200|NCT01017952|592328291|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
163989201|NCT01017952|592328292|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163989202|NCT01017952|592328293|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163989203|NCT01017952|592328294|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163989204|NCT01017952|592328295|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
163989205|NCT01017952|592328291|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
163989206|NCT01017952|592328292|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
163989207|NCT01017952|592328293|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
163989208|NCT01017952|592328294|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
163989209|NCT01017952|592328295|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
163989210|NCT01017952|592328291|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
163989211|NCT01017952|592328292|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163989212|NCT01017952|592328293|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163989213|NCT01017952|592328294|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163989214|NCT01017952|592328295|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
163989215|NCT01017952|592328291|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
163989216|NCT01017952|592328292|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163989217|NCT01017952|592328293|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163989218|NCT01017952|592328294|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163989219|NCT01017952|592328295|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
163989220|NCT01017952|592328291|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
163989221|NCT01017952|592328292|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
163989222|NCT01017952|592328293|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
163989223|NCT01017952|592328294|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
163989224|NCT01017952|592328295|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
163989225|NCT01017952|592328291|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
163989226|NCT01017952|592328292|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163989227|NCT01017952|592328293|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163989228|NCT01017952|592328294|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163989229|NCT01017952|592328295|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
163989230|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
163989231|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
163989232|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
163989233|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
163989234|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
163989235|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
163989236|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
163989237|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
163989238|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
163989239|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
163989240|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
163989241|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
163989242|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
163989243|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
163989244|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
163989245|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
163989246|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
163989247|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
163989248|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
163989249|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
163989250|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
163989251|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
163989252|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
163989253|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
163989254|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
163989255|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163989256|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
163989257|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
163989258|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
163989259|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164240117|NCT04067492|593250205|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240118|NCT04067492|593250206|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240119|NCT04067492|593250207|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
164240120|NCT04067492|593250202|FG000|Overall Study|COVID-19 epidemiological situation|0|||
164240121|NCT04067492|593250203|FG001|Overall Study|COVID-19 epidemiological situation|0|||
164240122|NCT04067492|593250204|FG002|Overall Study|COVID-19 epidemiological situation|0|||
164240123|NCT04067492|593250205|FG003|Overall Study|COVID-19 epidemiological situation|1|||
164240124|NCT04067492|593250206|FG004|Overall Study|COVID-19 epidemiological situation|0|||
164240125|NCT04067492|593250207|FG005|Overall Study|COVID-19 epidemiological situation|0|||
164240126|NCT05899829|593250212|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
164240127|NCT05899829|593250213|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
164240128|NCT05899829|593250212|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
164240129|NCT05899829|593250213|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
164240130|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
164240131|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
164240132|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
164240133|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
164240134|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
164240135|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
164240136|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
164240137|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
164240138|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
164240139|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
164240140|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
164335969|NCT01426438|593607800|FG000|Overall Study|Lost to Follow-up|1|||
164335970|NCT01426438|593607801|FG001|Overall Study|Lost to Follow-up|3|||
164335971|NCT01426438|593607800|FG000|Overall Study|Off study Treatment|9|||
164335972|NCT01426438|593607801|FG001|Overall Study|Off study Treatment|3|||
164335973|NCT01426438|593607800|FG000|Overall Study|Poor scan quality|3|||
163989260|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164240141|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
164240142|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
164335974|NCT01426438|593607801|FG001|Overall Study|Poor scan quality|2|||
164335975|NCT01426438|593607800|FG000|Overall Study|Missed Scan|2|||
164335976|NCT01426438|593607801|FG001|Overall Study|Missed Scan|2|||
164335977|NCT02122458|593607802|FG000|Overall Study|Withdrawal by Subject|0|||
164335978|NCT02122458|593607803|FG001|Overall Study|Withdrawal by Subject|0|||
164335979|NCT02122458|593607804|FG002|Overall Study|Withdrawal by Subject|0|||
164335980|NCT02122458|593607805|FG003|Overall Study|Withdrawal by Subject|4|||
164335981|NCT02122458|593607806|FG004|Overall Study|Withdrawal by Subject|4|||
164335982|NCT02122458|593607807|FG005|Overall Study|Withdrawal by Subject|4|||
164335983|NCT02122458|593607808|FG006|Overall Study|Withdrawal by Subject|0|||
164335984|NCT02122458|593607802|FG000|Overall Study|Lost to Follow-up|1|||
164335985|NCT02122458|593607803|FG001|Overall Study|Lost to Follow-up|3|||
164335986|NCT02122458|593607804|FG002|Overall Study|Lost to Follow-up|0|||
164335987|NCT02122458|593607805|FG003|Overall Study|Lost to Follow-up|7|||
164335988|NCT02122458|593607806|FG004|Overall Study|Lost to Follow-up|5|||
164240143|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
164240144|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
164240145|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
164240146|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
164240147|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
164240148|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
164240149|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
164240150|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
164240151|NCT04021290|593250216|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
164240152|NCT04021290|593250217|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
164240153|NCT04021290|593250218|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
164240154|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
164240155|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
164240156|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
164240157|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
164240158|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
164240159|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
164240160|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
164240161|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
164240162|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
164240163|NCT04021290|593250216|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
164240164|NCT04021290|593250217|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
164240165|NCT04021290|593250218|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
164240166|NCT05076045|593250219|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
164240167|NCT05076045|593250220|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
164240168|NCT03391882|593250221|FG000|Study Overall|Adverse Event|3|||
164240169|NCT03391882|593250222|FG001|Study Overall|Adverse Event|6|||
164240170|NCT03391882|593250223|FG002|Study Overall|Adverse Event|1|||
164240171|NCT03391882|593250224|FG003|Study Overall|Adverse Event|1|||
164240172|NCT03391882|593250225|FG004|Study Overall|Adverse Event|3|||
164240173|NCT03391882|593250226|FG005|Study Overall|Adverse Event|1|||
164240174|NCT03391882|593250221|FG000|Study Overall|Lack of Efficacy|13|||
164240175|NCT03391882|593250222|FG001|Study Overall|Lack of Efficacy|9|||
164240176|NCT03391882|593250223|FG002|Study Overall|Lack of Efficacy|0|||
164240177|NCT03391882|593250224|FG003|Study Overall|Lack of Efficacy|0|||
164240178|NCT03391882|593250225|FG004|Study Overall|Lack of Efficacy|0|||
164240179|NCT03391882|593250226|FG005|Study Overall|Lack of Efficacy|0|||
164240180|NCT03391882|593250221|FG000|Study Overall|Withdrawal by Subject|3|||
164240181|NCT03391882|593250222|FG001|Study Overall|Withdrawal by Subject|3|||
164240182|NCT03391882|593250223|FG002|Study Overall|Withdrawal by Subject|2|||
164240183|NCT03391882|593250224|FG003|Study Overall|Withdrawal by Subject|2|||
164240184|NCT03391882|593250225|FG004|Study Overall|Withdrawal by Subject|1|||
164240185|NCT03391882|593250226|FG005|Study Overall|Withdrawal by Subject|3|||
164240186|NCT03391882|593250221|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240187|NCT03391882|593250222|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
164240188|NCT03391882|593250223|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240189|NCT03391882|593250224|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240190|NCT03391882|593250225|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240191|NCT03391882|593250226|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
164240192|NCT03391882|593250221|FG000|Study Overall|Protocol Violation|1|||
164240193|NCT03391882|593250222|FG001|Study Overall|Protocol Violation|0|||
164240194|NCT03391882|593250223|FG002|Study Overall|Protocol Violation|0|||
164240195|NCT03391882|593250224|FG003|Study Overall|Protocol Violation|0|||
164240196|NCT03391882|593250225|FG004|Study Overall|Protocol Violation|0|||
164240197|NCT03391882|593250226|FG005|Study Overall|Protocol Violation|0|||
164240198|NCT03391882|593250221|FG000|Part A - Titration Phase|Adverse Event|3|||
164240199|NCT03391882|593250222|FG001|Part A - Titration Phase|Adverse Event|6|||
164240200|NCT03391882|593250223|FG002|Part A - Titration Phase|Adverse Event|0|||
164240201|NCT03391882|593250224|FG003|Part A - Titration Phase|Adverse Event|0|||
164240202|NCT03391882|593250225|FG004|Part A - Titration Phase|Adverse Event|0|||
164240203|NCT03391882|593250226|FG005|Part A - Titration Phase|Adverse Event|0|||
164240204|NCT03391882|593250221|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
164240205|NCT03391882|593250222|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
164240206|NCT03391882|593250223|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
164240207|NCT03391882|593250224|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
164240208|NCT03391882|593250225|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
164240209|NCT03391882|593250226|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
164240210|NCT03391882|593250221|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
164240211|NCT03391882|593250222|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
164240212|NCT03391882|593250223|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
164240213|NCT03391882|593250224|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
164335989|NCT02122458|593607807|FG005|Overall Study|Lost to Follow-up|15|||
164240214|NCT03391882|593250225|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
164240215|NCT03391882|593250226|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
164240216|NCT03391882|593250221|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240217|NCT03391882|593250222|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
164240218|NCT03391882|593250223|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240219|NCT03391882|593250224|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240220|NCT03391882|593250225|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164335990|NCT02122458|593607808|FG006|Overall Study|Lost to Follow-up|1|||
164335991|NCT02122458|593607802|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
164335992|NCT02122458|593607803|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335993|NCT02122458|593607804|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335994|NCT02122458|593607805|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335995|NCT02122458|593607806|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335996|NCT02122458|593607807|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335997|NCT02122458|593607808|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
164335998|NCT02122458|593607802|FG000|Overall Study|Adverse Event|1|||
164335999|NCT02122458|593607803|FG001|Overall Study|Adverse Event|0|||
164336000|NCT02122458|593607804|FG002|Overall Study|Adverse Event|0|||
164336001|NCT02122458|593607805|FG003|Overall Study|Adverse Event|0|||
164336002|NCT02122458|593607806|FG004|Overall Study|Adverse Event|0|||
164336003|NCT02122458|593607807|FG005|Overall Study|Adverse Event|0|||
164336004|NCT02122458|593607808|FG006|Overall Study|Adverse Event|0|||
164336005|NCT02122458|593607802|FG000|Overall Study|Experimental Error|0|||
164336006|NCT02122458|593607803|FG001|Overall Study|Experimental Error|0|||
164336007|NCT02122458|593607804|FG002|Overall Study|Experimental Error|0|||
164336008|NCT02122458|593607805|FG003|Overall Study|Experimental Error|0|||
164336009|NCT02122458|593607806|FG004|Overall Study|Experimental Error|3|||
164336010|NCT02122458|593607807|FG005|Overall Study|Experimental Error|0|||
164336011|NCT02122458|593607808|FG006|Overall Study|Experimental Error|0|||
164336012|NCT02122458|593607802|FG000|Overall Study|Deployed or Moved|0|||
164336013|NCT02122458|593607803|FG001|Overall Study|Deployed or Moved|0|||
164336014|NCT02122458|593607804|FG002|Overall Study|Deployed or Moved|0|||
164336015|NCT02122458|593607805|FG003|Overall Study|Deployed or Moved|0|||
164336016|NCT02122458|593607806|FG004|Overall Study|Deployed or Moved|1|||
164336017|NCT02122458|593607807|FG005|Overall Study|Deployed or Moved|0|||
164336018|NCT02122458|593607808|FG006|Overall Study|Deployed or Moved|0|||
164336019|NCT02122458|593607802|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
164336020|NCT02122458|593607803|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
164336021|NCT02122458|593607804|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
164336022|NCT02122458|593607805|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
164336023|NCT02122458|593607806|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
164336024|NCT02122458|593607807|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
164336025|NCT02122458|593607808|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
163989261|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
163989262|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
163989263|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
163989264|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
163989265|NCT01017952|592328291|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
163989266|NCT01017952|592328292|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
164336026|NCT02122458|593607802|FG000|Overall Study|Noncompliance|0|||
163989267|NCT01017952|592328293|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
163989268|NCT01017952|592328294|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
163989269|NCT01017952|592328295|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
164336027|NCT02122458|593607803|FG001|Overall Study|Noncompliance|1|||
164336028|NCT02122458|593607804|FG002|Overall Study|Noncompliance|0|||
164240221|NCT03391882|593250226|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
164240222|NCT03391882|593250221|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
164240223|NCT03391882|593250222|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
164240224|NCT03391882|593250223|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240225|NCT03391882|593250224|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240226|NCT03391882|593250225|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240227|NCT03391882|593250226|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
164240228|NCT03391882|593250221|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
164336029|NCT02122458|593607805|FG003|Overall Study|Noncompliance|0|||
164336030|NCT02122458|593607806|FG004|Overall Study|Noncompliance|0|||
164336031|NCT02122458|593607807|FG005|Overall Study|Noncompliance|0|||
164336032|NCT02122458|593607808|FG006|Overall Study|Noncompliance|0|||
164336033|NCT00412542|593607809|FG000|Overall Study|Withdrawal by Subject|0|||
164336034|NCT00412542|593607810|FG001|Overall Study|Withdrawal by Subject|2|||
164336035|NCT00412542|593607809|FG000|Overall Study|Not Eligible|0|||
164336036|NCT00412542|593607810|FG001|Overall Study|Not Eligible|1|||
164240229|NCT03391882|593250222|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
164240230|NCT03391882|593250223|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
164240231|NCT03391882|593250224|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
164240232|NCT03391882|593250225|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
164240233|NCT03391882|593250226|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
164240234|NCT03391882|593250221|FG000|Part B - Treatment Phase|Adverse Event|0|||
164240235|NCT03391882|593250222|FG001|Part B - Treatment Phase|Adverse Event|0|||
164240236|NCT03391882|593250223|FG002|Part B - Treatment Phase|Adverse Event|1|||
164240237|NCT03391882|593250224|FG003|Part B - Treatment Phase|Adverse Event|1|||
164240238|NCT03391882|593250225|FG004|Part B - Treatment Phase|Adverse Event|3|||
164240239|NCT03391882|593250226|FG005|Part B - Treatment Phase|Adverse Event|1|||
164240240|NCT03391882|593250221|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
164240241|NCT03391882|593250222|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
164240242|NCT03391882|593250223|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
164240243|NCT03391882|593250224|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
164240244|NCT03391882|593250225|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
164240245|NCT03391882|593250226|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
164240246|NCT03092479|593250227|FG000|Overall Study|Lost to Follow-up|3|||
164240247|NCT03092479|593250228|FG001|Overall Study|Lost to Follow-up|2|||
164240248|NCT03092479|593250227|FG000|Overall Study|Withdrawal by Subject|4|||
164240249|NCT03092479|593250228|FG001|Overall Study|Withdrawal by Subject|0|||
164240250|NCT03913130|593250231|FG000|Overall Study|Sponsor Decision|1|||
164240251|NCT04046939|593250240|FG000|Primary Assessment Period|Adverse Event|1|||
164240252|NCT04046939|593250241|FG001|Primary Assessment Period|Adverse Event|0|||
164240253|NCT04046939|593250242|FG002|Primary Assessment Period|Adverse Event|0|||
164240254|NCT04046939|593250243|FG003|Primary Assessment Period|Adverse Event|0|||
164240255|NCT04046939|593250240|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
164240256|NCT04046939|593250241|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
164240257|NCT04046939|593250242|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
164240258|NCT04046939|593250243|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
164240259|NCT04046939|593250240|FG000|Primary Assessment Period|Physician Decision|0|||
164240260|NCT04046939|593250241|FG001|Primary Assessment Period|Physician Decision|0|||
164240261|NCT04046939|593250242|FG002|Primary Assessment Period|Physician Decision|1|||
164240262|NCT04046939|593250243|FG003|Primary Assessment Period|Physician Decision|0|||
164240263|NCT04046939|593250240|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
164240264|NCT04046939|593250241|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
164240265|NCT04046939|593250242|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
164240266|NCT04046939|593250243|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
164240267|NCT04704193|593250244|FG000|Overall Study|Withdrawal by Subject|1|||
164240268|NCT03384875|593250245|FG000|Overall Study|Death|1|||
164240269|NCT03384875|593250246|FG001|Overall Study|Death|1|||
164240270|NCT03384875|593250247|FG002|Overall Study|Death|0|||
164240271|NCT03384875|593250245|FG000|Overall Study|Reason not provided|1|||
164240272|NCT03384875|593250246|FG001|Overall Study|Reason not provided|0|||
164240273|NCT03384875|593250247|FG002|Overall Study|Reason not provided|0|||
164240274|NCT04790279|593252345|FG000|Overall Study|Did not meet medication start criteria|27|||
164240275|NCT04790279|593252346|FG001|Overall Study|Did not meet medication start criteria|15|||
164240276|NCT04790279|593252345|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
164240277|NCT04790279|593252346|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
164240278|NCT04790279|593252345|FG000|Overall Study|Protocol Violation|8|||
164240279|NCT04790279|593252346|FG001|Overall Study|Protocol Violation|3|||
164240280|NCT04790279|593252345|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
164240281|NCT04790279|593252346|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
164240282|NCT00678288|593252349|FG000|Overall Study|Adverse Event|0|||
164240283|NCT00678288|593252350|FG001|Overall Study|Adverse Event|2|||
164240284|NCT00678288|593252349|FG000|Overall Study|Withdrawal by Subject|1|||
164240285|NCT00678288|593252350|FG001|Overall Study|Withdrawal by Subject|1|||
164240286|NCT00678288|593252349|FG000|Overall Study|Study terminated by the sponsor|2|||
164240287|NCT00678288|593252350|FG001|Overall Study|Study terminated by the sponsor|0|||
164240288|NCT00678288|593252349|FG000|Overall Study|Not compliant with study medication|0|||
164240289|NCT00678288|593252350|FG001|Overall Study|Not compliant with study medication|1|||
164240290|NCT00678288|593252349|FG000|Overall Study|Switch to commercial drug|0|||
164240291|NCT00678288|593252350|FG001|Overall Study|Switch to commercial drug|1|||
164240292|NCT00678288|593252349|FG000|Overall Study|Reason not reported|1|||
164240293|NCT00678288|593252350|FG001|Overall Study|Reason not reported|0|||
164240294|NCT00678288|593252349|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
164240295|NCT00678288|593252350|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
164240296|NCT04472650|593252359|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
164240297|NCT04472650|593252360|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
164240298|NCT03247829|593252363|FG000|Overall Study|Death|3|||
164240299|NCT03247829|593252364|FG001|Overall Study|Death|4|||
163884665|NCT04676022|591947835|FG001|Overall Study|Adverse Event|0|||
164240300|NCT03247829|593252363|FG000|Overall Study|Enter Hospice Care|1|||
164240301|NCT03247829|593252364|FG001|Overall Study|Enter Hospice Care|0|||
164240302|NCT03247829|593252363|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
164240303|NCT03247829|593252364|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
164240304|NCT03247829|593252363|FG000|Overall Study|LVAD Explant|1|||
164240305|NCT03247829|593252364|FG001|Overall Study|LVAD Explant|1|||
164240306|NCT03247829|593252363|FG000|Overall Study|Transplant|1|||
164240307|NCT03247829|593252364|FG001|Overall Study|Transplant|1|||
164240308|NCT01783444|593252365|FG000|Treatment Phase|Adverse Event|9|||
164240309|NCT01783444|593252366|FG001|Treatment Phase|Adverse Event|20|||
164240310|NCT01783444|593252367|FG002|Treatment Phase|Adverse Event|19|||
164240311|NCT01783444|593252365|FG000|Treatment Phase|Disease Progression|76|||
164240312|NCT01783444|593252366|FG001|Treatment Phase|Disease Progression|66|||
164240313|NCT01783444|593252367|FG002|Treatment Phase|Disease Progression|64|||
164240314|NCT01783444|593252365|FG000|Treatment Phase|Death|2|||
164240315|NCT01783444|593252366|FG001|Treatment Phase|Death|2|||
164240316|NCT01783444|593252367|FG002|Treatment Phase|Death|2|||
164240317|NCT01783444|593252365|FG000|Treatment Phase|Protocol Violation|1|||
164240318|NCT01783444|593252366|FG001|Treatment Phase|Protocol Violation|1|||
164240319|NCT01783444|593252367|FG002|Treatment Phase|Protocol Violation|2|||
164240320|NCT01783444|593252365|FG000|Treatment Phase|Withdrawal by Subject|6|||
164240321|NCT01783444|593252366|FG001|Treatment Phase|Withdrawal by Subject|8|||
164240322|NCT01783444|593252367|FG002|Treatment Phase|Withdrawal by Subject|9|||
164240323|NCT01783444|593252365|FG000|Treatment Phase|Administrative problems|2|||
164240324|NCT01783444|593252366|FG001|Treatment Phase|Administrative problems|0|||
164240325|NCT01783444|593252367|FG002|Treatment Phase|Administrative problems|1|||
164240326|NCT01783444|593252365|FG000|Treatment Phase|Physician Decision|8|||
164240327|NCT01783444|593252366|FG001|Treatment Phase|Physician Decision|6|||
164240328|NCT01783444|593252367|FG002|Treatment Phase|Physician Decision|5|||
164240329|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
164240330|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
164240331|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
164240332|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
164240333|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
164240334|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
164240335|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
164240336|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
164240337|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
164240338|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
164240339|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
164240340|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
164240341|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
164240342|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
164240343|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
164240344|NCT01783444|593252365|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
164240345|NCT01783444|593252366|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
164240346|NCT01783444|593252367|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
164240347|NCT01713582|593252371|FG000|Overall Study|Disease progression|3|||
164240348|NCT01713582|593252372|FG001|Overall Study|Disease progression|3|||
164240349|NCT01713582|593252373|FG002|Overall Study|Disease progression|3|||
164240350|NCT01713582|593252374|FG003|Overall Study|Disease progression|2|||
164240351|NCT01713582|593252375|FG004|Overall Study|Disease progression|3|||
164240352|NCT01713582|593252376|FG005|Overall Study|Disease progression|3|||
164240353|NCT01713582|593252377|FG006|Overall Study|Disease progression|3|||
164240354|NCT01713582|593252378|FG007|Overall Study|Disease progression|3|||
164240355|NCT01713582|593252379|FG008|Overall Study|Disease progression|3|||
164240356|NCT01713582|593252380|FG009|Overall Study|Disease progression|11|||
164240357|NCT01713582|593252381|FG010|Overall Study|Disease progression|10|||
164240358|NCT01713582|593252382|FG011|Overall Study|Disease progression|5|||
164240359|NCT01713582|593252383|FG012|Overall Study|Disease progression|3|||
164240360|NCT01713582|593252384|FG013|Overall Study|Disease progression|3|||
164240361|NCT01713582|593252385|FG014|Overall Study|Disease progression|6|||
164240362|NCT01713582|593252386|FG015|Overall Study|Disease progression|6|||
164240363|NCT01713582|593252387|FG016|Overall Study|Disease progression|5|||
164240364|NCT01713582|593252388|FG017|Overall Study|Disease progression|2|||
164240365|NCT01713582|593252389|FG018|Overall Study|Disease progression|3|||
164240366|NCT01713582|593252390|FG019|Overall Study|Disease progression|5|||
164240367|NCT01713582|593252391|FG020|Overall Study|Disease progression|15|||
164240368|NCT01713582|593252371|FG000|Overall Study|Death|0|||
164240369|NCT01713582|593252372|FG001|Overall Study|Death|0|||
164240370|NCT01713582|593252373|FG002|Overall Study|Death|0|||
164240371|NCT01713582|593252374|FG003|Overall Study|Death|1|||
164240372|NCT01713582|593252375|FG004|Overall Study|Death|1|||
164240373|NCT01713582|593252376|FG005|Overall Study|Death|3|||
164240374|NCT01713582|593252377|FG006|Overall Study|Death|3|||
164240375|NCT01713582|593252378|FG007|Overall Study|Death|2|||
164240376|NCT01713582|593252379|FG008|Overall Study|Death|3|||
164240377|NCT01713582|593252380|FG009|Overall Study|Death|4|||
164240378|NCT01713582|593252381|FG010|Overall Study|Death|3|||
164240379|NCT01713582|593252382|FG011|Overall Study|Death|0|||
164240380|NCT01713582|593252383|FG012|Overall Study|Death|0|||
164240381|NCT01713582|593252384|FG013|Overall Study|Death|0|||
164240382|NCT01713582|593252385|FG014|Overall Study|Death|0|||
164240383|NCT01713582|593252386|FG015|Overall Study|Death|0|||
164240384|NCT01713582|593252387|FG016|Overall Study|Death|0|||
164240385|NCT01713582|593252388|FG017|Overall Study|Death|0|||
164240386|NCT01713582|593252389|FG018|Overall Study|Death|0|||
164240387|NCT01713582|593252390|FG019|Overall Study|Death|0|||
164240388|NCT01713582|593252391|FG020|Overall Study|Death|0|||
164240389|NCT01713582|593252371|FG000|Overall Study|Adverse event-related|0|||
164240390|NCT01713582|593252372|FG001|Overall Study|Adverse event-related|0|||
164240391|NCT01713582|593252373|FG002|Overall Study|Adverse event-related|0|||
164240392|NCT01713582|593252374|FG003|Overall Study|Adverse event-related|0|||
164240393|NCT01713582|593252375|FG004|Overall Study|Adverse event-related|0|||
164240394|NCT01713582|593252376|FG005|Overall Study|Adverse event-related|0|||
164240395|NCT01713582|593252377|FG006|Overall Study|Adverse event-related|0|||
164240396|NCT01713582|593252378|FG007|Overall Study|Adverse event-related|0|||
164240397|NCT01713582|593252379|FG008|Overall Study|Adverse event-related|0|||
164240398|NCT01713582|593252380|FG009|Overall Study|Adverse event-related|1|||
164240399|NCT01713582|593252381|FG010|Overall Study|Adverse event-related|1|||
164240400|NCT01713582|593252382|FG011|Overall Study|Adverse event-related|0|||
164240401|NCT01713582|593252383|FG012|Overall Study|Adverse event-related|0|||
164240402|NCT01713582|593252384|FG013|Overall Study|Adverse event-related|0|||
164240403|NCT01713582|593252385|FG014|Overall Study|Adverse event-related|0|||
164240404|NCT01713582|593252386|FG015|Overall Study|Adverse event-related|0|||
164240405|NCT01713582|593252387|FG016|Overall Study|Adverse event-related|0|||
164240406|NCT01713582|593252388|FG017|Overall Study|Adverse event-related|0|||
164240407|NCT01713582|593252389|FG018|Overall Study|Adverse event-related|1|||
164240408|NCT01713582|593252390|FG019|Overall Study|Adverse event-related|0|||
164240409|NCT01713582|593252391|FG020|Overall Study|Adverse event-related|0|||
164240410|NCT01713582|593252371|FG000|Overall Study|Adverse event-unrelated|0|||
164240411|NCT01713582|593252372|FG001|Overall Study|Adverse event-unrelated|0|||
164240412|NCT01713582|593252373|FG002|Overall Study|Adverse event-unrelated|0|||
164240413|NCT01713582|593252374|FG003|Overall Study|Adverse event-unrelated|0|||
164240414|NCT01713582|593252375|FG004|Overall Study|Adverse event-unrelated|0|||
164240415|NCT01713582|593252376|FG005|Overall Study|Adverse event-unrelated|1|||
164240416|NCT01713582|593252377|FG006|Overall Study|Adverse event-unrelated|1|||
164240417|NCT01713582|593252378|FG007|Overall Study|Adverse event-unrelated|1|||
164240418|NCT01713582|593252379|FG008|Overall Study|Adverse event-unrelated|0|||
164240419|NCT01713582|593252380|FG009|Overall Study|Adverse event-unrelated|0|||
164240420|NCT01713582|593252381|FG010|Overall Study|Adverse event-unrelated|0|||
164240421|NCT01713582|593252382|FG011|Overall Study|Adverse event-unrelated|0|||
164336037|NCT02833350|593607811|FG000|Overall Study|Adverse Event|0|||
164240422|NCT01713582|593252383|FG012|Overall Study|Adverse event-unrelated|0|||
164240423|NCT01713582|593252384|FG013|Overall Study|Adverse event-unrelated|1|||
164336038|NCT02833350|593607812|FG001|Overall Study|Adverse Event|3|||
164336039|NCT02833350|593607813|FG002|Overall Study|Adverse Event|4|||
164336040|NCT02833350|593607814|FG003|Overall Study|Adverse Event|4|||
164336041|NCT02833350|593607815|FG004|Overall Study|Adverse Event|1|||
164336042|NCT02833350|593607816|FG005|Overall Study|Adverse Event|0|||
164336043|NCT02833350|593607817|FG006|Overall Study|Adverse Event|1|||
164336044|NCT02833350|593607811|FG000|Overall Study|Death|0|||
164336045|NCT02833350|593607812|FG001|Overall Study|Death|0|||
164336046|NCT02833350|593607813|FG002|Overall Study|Death|1|||
164336047|NCT02833350|593607814|FG003|Overall Study|Death|0|||
164336048|NCT02833350|593607815|FG004|Overall Study|Death|0|||
164336049|NCT02833350|593607816|FG005|Overall Study|Death|0|||
164336050|NCT02833350|593607817|FG006|Overall Study|Death|0|||
163989270|NCT00352105|592328297|FG000|Overall Study|Death|5|||
164240424|NCT01713582|593252385|FG014|Overall Study|Adverse event-unrelated|1|||
164240425|NCT01713582|593252386|FG015|Overall Study|Adverse event-unrelated|0|||
164240426|NCT01713582|593252387|FG016|Overall Study|Adverse event-unrelated|0|||
164336051|NCT02833350|593607811|FG000|Overall Study|Lack of Efficacy|0|||
164336052|NCT02833350|593607812|FG001|Overall Study|Lack of Efficacy|2|||
164336053|NCT02833350|593607813|FG002|Overall Study|Lack of Efficacy|1|||
164336054|NCT02833350|593607814|FG003|Overall Study|Lack of Efficacy|4|||
164336055|NCT02833350|593607815|FG004|Overall Study|Lack of Efficacy|0|||
163989271|NCT00352105|592328297|FG000|Overall Study|Withdrawal by Subject|5|||
164240427|NCT01713582|593252388|FG017|Overall Study|Adverse event-unrelated|0|||
164240428|NCT01713582|593252389|FG018|Overall Study|Adverse event-unrelated|0|||
164240429|NCT01713582|593252390|FG019|Overall Study|Adverse event-unrelated|0|||
164240430|NCT01713582|593252391|FG020|Overall Study|Adverse event-unrelated|0|||
164336056|NCT02833350|593607816|FG005|Overall Study|Lack of Efficacy|1|||
164336057|NCT02833350|593607817|FG006|Overall Study|Lack of Efficacy|1|||
164240431|NCT01713582|593252371|FG000|Overall Study|Withdrawal of consent|0|||
164240432|NCT01713582|593252372|FG001|Overall Study|Withdrawal of consent|0|||
164240433|NCT01713582|593252373|FG002|Overall Study|Withdrawal of consent|1|||
164240434|NCT01713582|593252374|FG003|Overall Study|Withdrawal of consent|0|||
164240435|NCT01713582|593252375|FG004|Overall Study|Withdrawal of consent|0|||
164240436|NCT01713582|593252376|FG005|Overall Study|Withdrawal of consent|1|||
164240437|NCT01713582|593252377|FG006|Overall Study|Withdrawal of consent|0|||
164240438|NCT01713582|593252378|FG007|Overall Study|Withdrawal of consent|0|||
164240439|NCT01713582|593252379|FG008|Overall Study|Withdrawal of consent|0|||
164240440|NCT01713582|593252380|FG009|Overall Study|Withdrawal of consent|1|||
164240441|NCT01713582|593252381|FG010|Overall Study|Withdrawal of consent|0|||
164240442|NCT01713582|593252382|FG011|Overall Study|Withdrawal of consent|0|||
164240443|NCT01713582|593252383|FG012|Overall Study|Withdrawal of consent|0|||
164240444|NCT01713582|593252384|FG013|Overall Study|Withdrawal of consent|0|||
164240445|NCT01713582|593252385|FG014|Overall Study|Withdrawal of consent|0|||
164240446|NCT01713582|593252386|FG015|Overall Study|Withdrawal of consent|0|||
164240447|NCT01713582|593252387|FG016|Overall Study|Withdrawal of consent|0|||
164240448|NCT01713582|593252388|FG017|Overall Study|Withdrawal of consent|0|||
164240449|NCT01713582|593252389|FG018|Overall Study|Withdrawal of consent|1|||
164240450|NCT01713582|593252390|FG019|Overall Study|Withdrawal of consent|0|||
164240451|NCT01713582|593252391|FG020|Overall Study|Withdrawal of consent|0|||
164240452|NCT01713582|593252371|FG000|Overall Study|Lack of Efficacy|0|||
164240453|NCT01713582|593252372|FG001|Overall Study|Lack of Efficacy|0|||
164240454|NCT01713582|593252373|FG002|Overall Study|Lack of Efficacy|0|||
164240455|NCT01713582|593252374|FG003|Overall Study|Lack of Efficacy|0|||
164240456|NCT01713582|593252375|FG004|Overall Study|Lack of Efficacy|0|||
164240457|NCT01713582|593252376|FG005|Overall Study|Lack of Efficacy|0|||
164240458|NCT01713582|593252377|FG006|Overall Study|Lack of Efficacy|0|||
164240459|NCT01713582|593252378|FG007|Overall Study|Lack of Efficacy|0|||
164240460|NCT01713582|593252379|FG008|Overall Study|Lack of Efficacy|0|||
164240461|NCT01713582|593252380|FG009|Overall Study|Lack of Efficacy|1|||
164240462|NCT01713582|593252381|FG010|Overall Study|Lack of Efficacy|2|||
164240463|NCT01713582|593252382|FG011|Overall Study|Lack of Efficacy|0|||
164240464|NCT01713582|593252383|FG012|Overall Study|Lack of Efficacy|0|||
164240465|NCT01713582|593252384|FG013|Overall Study|Lack of Efficacy|0|||
164240466|NCT01713582|593252385|FG014|Overall Study|Lack of Efficacy|0|||
164240467|NCT01713582|593252386|FG015|Overall Study|Lack of Efficacy|0|||
164240468|NCT01713582|593252387|FG016|Overall Study|Lack of Efficacy|0|||
164240469|NCT01713582|593252388|FG017|Overall Study|Lack of Efficacy|0|||
164240470|NCT01713582|593252389|FG018|Overall Study|Lack of Efficacy|0|||
164240471|NCT01713582|593252390|FG019|Overall Study|Lack of Efficacy|0|||
164240472|NCT01713582|593252391|FG020|Overall Study|Lack of Efficacy|0|||
164240473|NCT01713582|593252371|FG000|Overall Study|Withdrawal by Subject|0|||
164240474|NCT01713582|593252372|FG001|Overall Study|Withdrawal by Subject|0|||
164240475|NCT01713582|593252373|FG002|Overall Study|Withdrawal by Subject|0|||
164240476|NCT01713582|593252374|FG003|Overall Study|Withdrawal by Subject|0|||
164240477|NCT01713582|593252375|FG004|Overall Study|Withdrawal by Subject|0|||
164240478|NCT01713582|593252376|FG005|Overall Study|Withdrawal by Subject|0|||
164240479|NCT01713582|593252377|FG006|Overall Study|Withdrawal by Subject|0|||
164240480|NCT01713582|593252378|FG007|Overall Study|Withdrawal by Subject|0|||
164240481|NCT01713582|593252379|FG008|Overall Study|Withdrawal by Subject|0|||
164240482|NCT01713582|593252380|FG009|Overall Study|Withdrawal by Subject|0|||
164336058|NCT02833350|593607811|FG000|Overall Study|Lost to Follow-up|0|||
164336059|NCT02833350|593607812|FG001|Overall Study|Lost to Follow-up|1|||
164336060|NCT02833350|593607813|FG002|Overall Study|Lost to Follow-up|0|||
164336061|NCT02833350|593607814|FG003|Overall Study|Lost to Follow-up|0|||
164336062|NCT02833350|593607815|FG004|Overall Study|Lost to Follow-up|0|||
164336063|NCT02833350|593607816|FG005|Overall Study|Lost to Follow-up|0|||
164336064|NCT02833350|593607817|FG006|Overall Study|Lost to Follow-up|1|||
164336065|NCT02833350|593607811|FG000|Overall Study|Withdrawal by Subject|3|||
164336066|NCT02833350|593607812|FG001|Overall Study|Withdrawal by Subject|3|||
164336067|NCT02833350|593607813|FG002|Overall Study|Withdrawal by Subject|2|||
164240483|NCT01713582|593252381|FG010|Overall Study|Withdrawal by Subject|0|||
164240484|NCT01713582|593252382|FG011|Overall Study|Withdrawal by Subject|0|||
164240485|NCT01713582|593252383|FG012|Overall Study|Withdrawal by Subject|0|||
164240486|NCT01713582|593252384|FG013|Overall Study|Withdrawal by Subject|0|||
164240487|NCT01713582|593252385|FG014|Overall Study|Withdrawal by Subject|0|||
164336068|NCT02833350|593607814|FG003|Overall Study|Withdrawal by Subject|0|||
164240488|NCT01713582|593252386|FG015|Overall Study|Withdrawal by Subject|0|||
164240489|NCT01713582|593252387|FG016|Overall Study|Withdrawal by Subject|0|||
164240490|NCT01713582|593252388|FG017|Overall Study|Withdrawal by Subject|1|||
164240491|NCT01713582|593252389|FG018|Overall Study|Withdrawal by Subject|0|||
164240492|NCT01713582|593252390|FG019|Overall Study|Withdrawal by Subject|0|||
164240493|NCT01713582|593252391|FG020|Overall Study|Withdrawal by Subject|0|||
164240494|NCT01713582|593252371|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
164240495|NCT01713582|593252372|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
164240496|NCT01713582|593252373|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
164240497|NCT01713582|593252374|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
164240498|NCT01713582|593252375|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
164240499|NCT01713582|593252376|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
164240500|NCT01713582|593252377|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
164240501|NCT01713582|593252378|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
164240502|NCT01713582|593252379|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
164240503|NCT01713582|593252380|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
164240504|NCT01713582|593252381|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
164240505|NCT01713582|593252382|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
164240506|NCT01713582|593252383|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
164240507|NCT01713582|593252384|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
164240508|NCT01713582|593252385|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
164240509|NCT01713582|593252386|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
164240510|NCT01713582|593252387|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
164240511|NCT01713582|593252388|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
164240512|NCT01713582|593252389|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
164240513|NCT01713582|593252390|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
164240514|NCT01713582|593252391|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
164240515|NCT01713582|593252371|FG000|Overall Study|Disease progression and adverse event|0|||
164240516|NCT01713582|593252372|FG001|Overall Study|Disease progression and adverse event|0|||
164240517|NCT01713582|593252373|FG002|Overall Study|Disease progression and adverse event|0|||
164240518|NCT01713582|593252374|FG003|Overall Study|Disease progression and adverse event|0|||
164240519|NCT01713582|593252375|FG004|Overall Study|Disease progression and adverse event|0|||
164240520|NCT01713582|593252376|FG005|Overall Study|Disease progression and adverse event|0|||
164240521|NCT01713582|593252377|FG006|Overall Study|Disease progression and adverse event|0|||
164240522|NCT01713582|593252378|FG007|Overall Study|Disease progression and adverse event|0|||
164240523|NCT01713582|593252379|FG008|Overall Study|Disease progression and adverse event|0|||
164240524|NCT01713582|593252380|FG009|Overall Study|Disease progression and adverse event|0|||
164240525|NCT01713582|593252381|FG010|Overall Study|Disease progression and adverse event|0|||
164240526|NCT01713582|593252382|FG011|Overall Study|Disease progression and adverse event|0|||
164240527|NCT01713582|593252383|FG012|Overall Study|Disease progression and adverse event|0|||
164240528|NCT01713582|593252384|FG013|Overall Study|Disease progression and adverse event|0|||
164240529|NCT01713582|593252385|FG014|Overall Study|Disease progression and adverse event|0|||
164240530|NCT01713582|593252386|FG015|Overall Study|Disease progression and adverse event|0|||
164240531|NCT01713582|593252387|FG016|Overall Study|Disease progression and adverse event|1|||
164240532|NCT01713582|593252388|FG017|Overall Study|Disease progression and adverse event|0|||
164240533|NCT01713582|593252389|FG018|Overall Study|Disease progression and adverse event|0|||
164240534|NCT01713582|593252390|FG019|Overall Study|Disease progression and adverse event|0|||
164240535|NCT01713582|593252391|FG020|Overall Study|Disease progression and adverse event|0|||
164240536|NCT04551898|593252392|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
164240537|NCT04551898|593252393|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
164240538|NCT04551898|593252394|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
164240539|NCT04551898|593252395|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
164240540|NCT04551898|593252392|FG000|Overall Study|Withdrawal by Subject|5|||
164240541|NCT04551898|593252393|FG001|Overall Study|Withdrawal by Subject|1|||
164240542|NCT04551898|593252394|FG002|Overall Study|Withdrawal by Subject|2|||
164240543|NCT04551898|593252395|FG003|Overall Study|Withdrawal by Subject|2|||
164240544|NCT04551898|593252392|FG000|Overall Study|Lost to Follow-up|2|||
164240545|NCT04551898|593252393|FG001|Overall Study|Lost to Follow-up|1|||
164240546|NCT04551898|593252394|FG002|Overall Study|Lost to Follow-up|2|||
164240547|NCT04551898|593252395|FG003|Overall Study|Lost to Follow-up|2|||
164240548|NCT04551898|593252392|FG000|Overall Study|Death|1|||
163884666|NCT04676022|591947836|FG002|Overall Study|Adverse Event|1|||
163884667|NCT04676022|591947834|FG000|Overall Study|Physician Decision|2|||
164240549|NCT04551898|593252393|FG001|Overall Study|Death|0|||
164240550|NCT04551898|593252394|FG002|Overall Study|Death|0|||
164240551|NCT04551898|593252395|FG003|Overall Study|Death|0|||
163884668|NCT04676022|591947835|FG001|Overall Study|Physician Decision|0|||
163884669|NCT04676022|591947836|FG002|Overall Study|Physician Decision|1|||
163884670|NCT04676022|591947834|FG000|Overall Study|Withdrawal by Subject|3|||
163884671|NCT04676022|591947835|FG001|Overall Study|Withdrawal by Subject|1|||
163884672|NCT04676022|591947836|FG002|Overall Study|Withdrawal by Subject|6|||
163989272|NCT00352105|592328297|FG000|Overall Study|Lack of Efficacy|9|||
164240552|NCT04551898|593252392|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
164240553|NCT04551898|593252393|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
164240554|NCT04551898|593252394|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
164240555|NCT04551898|593252395|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
164240556|NCT03427814|593252396|FG000|Overall Study|Withdrawal by Subject|4|||
164240557|NCT03427814|593252397|FG001|Overall Study|Withdrawal by Subject|4|||
164240558|NCT03427814|593252396|FG000|Overall Study|Lost to Follow-up|0|||
164240559|NCT03427814|593252397|FG001|Overall Study|Lost to Follow-up|2|||
164240560|NCT03427814|593252396|FG000|Overall Study|Death|42|||
164240561|NCT03427814|593252397|FG001|Overall Study|Death|31|||
164240562|NCT03427814|593252396|FG000|Overall Study|Sponsor's Decision|1|||
164240563|NCT03427814|593252397|FG001|Overall Study|Sponsor's Decision|0|||
164240564|NCT03427814|593252396|FG000|Overall Study|Investigator's Decision|1|||
164240565|NCT03427814|593252397|FG001|Overall Study|Investigator's Decision|2|||
164240566|NCT03427814|593252396|FG000|Overall Study|Disease progression|1|||
164240567|NCT03427814|593252397|FG001|Overall Study|Disease progression|0|||
164240568|NCT03427814|593252396|FG000|Overall Study|Treatment Completed|0|||
164240569|NCT03427814|593252397|FG001|Overall Study|Treatment Completed|1|||
164240570|NCT03427814|593252396|FG000|Overall Study|Sponsor's Decision to End study|21|||
164240571|NCT03427814|593252397|FG001|Overall Study|Sponsor's Decision to End study|25|||
164240572|NCT03427814|593252396|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
164240573|NCT03427814|593252397|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
164240574|NCT03846427|593252398|FG000|Overall Study|Death|13|||
164240575|NCT03846427|593252398|FG000|Overall Study|Withdrawal by Subject|3|||
164240576|NCT03846427|593252398|FG000|Overall Study|Physician Decision|1|||
164240577|NCT01334554|593252399|FG000|Overall Study|Adverse Event|4|||
164240578|NCT01334554|593252400|FG001|Overall Study|Adverse Event|2|||
164240579|NCT02393859|593252402|FG000|Overall Study|Decision by Sponsor|2|||
164240580|NCT02393859|593252403|FG001|Overall Study|Decision by Sponsor|4|||
164240581|NCT02393859|593252402|FG000|Overall Study|Withdrawal by Subject|11|||
164240582|NCT02393859|593252403|FG001|Overall Study|Withdrawal by Subject|6|||
164240583|NCT02393859|593252402|FG000|Overall Study|Death|27|||
164240584|NCT02393859|593252403|FG001|Overall Study|Death|10|||
164240585|NCT02393859|593252402|FG000|Overall Study|Lost to Follow-up|1|||
164240586|NCT02393859|593252403|FG001|Overall Study|Lost to Follow-up|1|||
164240587|NCT00954447|593252404|FG000|Overall Study|Adverse Event|33|||
164240588|NCT00954447|593252405|FG001|Overall Study|Adverse Event|25|||
164240589|NCT00954447|593252404|FG000|Overall Study|Lack of Efficacy|17|||
164240590|NCT00954447|593252405|FG001|Overall Study|Lack of Efficacy|3|||
164240591|NCT00954447|593252404|FG000|Overall Study|Protocol Violation|5|||
164240592|NCT00954447|593252405|FG001|Overall Study|Protocol Violation|7|||
164240593|NCT00954447|593252404|FG000|Overall Study|Lost to Follow-up|8|||
164240594|NCT00954447|593252405|FG001|Overall Study|Lost to Follow-up|14|||
164240595|NCT00954447|593252404|FG000|Overall Study|Withdrawal by Subject|26|||
164240596|NCT00954447|593252405|FG001|Overall Study|Withdrawal by Subject|21|||
164240597|NCT00954447|593252404|FG000|Overall Study|Other|21|||
164240598|NCT00954447|593252405|FG001|Overall Study|Other|18|||
164240599|NCT01979614|593252406|FG000|Overall Study|Adverse Event|1|||
164240600|NCT01979614|593252407|FG001|Overall Study|Adverse Event|1|||
164240601|NCT00488514|593252408|FG000|Overall Study|Adverse Event|41|||
164240602|NCT00488514|593252408|FG000|Overall Study|Lost to Follow-up|44|||
164240603|NCT00488514|593252408|FG000|Overall Study|Protocol Violation|32|||
164240604|NCT00488514|593252408|FG000|Overall Study|Withdrawal by Subject|106|||
164240605|NCT00488514|593252408|FG000|Overall Study|Lack of Efficacy|28|||
164240606|NCT00488514|593252408|FG000|Overall Study|Did not meet criteria for treatment|30|||
164240607|NCT00488514|593252408|FG000|Overall Study|Postive drug screen|1|||
164240608|NCT00488514|593252408|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
164240609|NCT00488514|593252408|FG000|Overall Study|Investigator decision|1|||
164240610|NCT00488514|593252408|FG000|Overall Study|Participant had too few migraines|5|||
164240611|NCT00488514|593252408|FG000|Overall Study|Increase in number of migraines|2|||
164240612|NCT00488514|593252408|FG000|Overall Study|Increased use of concomitant medication|1|||
164240613|NCT00305877|593252409|FG000|Overall Study|Lack of Efficacy|6|||
164240614|NCT00305877|593252410|FG001|Overall Study|Lack of Efficacy|9|||
164240615|NCT00305877|593252409|FG000|Overall Study|Adverse Event|9|||
164240616|NCT00305877|593252410|FG001|Overall Study|Adverse Event|14|||
164240617|NCT00305877|593252409|FG000|Overall Study|Death|0|||
164240618|NCT00305877|593252410|FG001|Overall Study|Death|1|||
164240619|NCT00305877|593252409|FG000|Overall Study|Withdrawal by Subject|4|||
164240620|NCT00305877|593252410|FG001|Overall Study|Withdrawal by Subject|2|||
164240621|NCT00305877|593252409|FG000|Overall Study|Physician Decision|1|||
164240622|NCT00305877|593252410|FG001|Overall Study|Physician Decision|1|||
164240623|NCT00305877|593252409|FG000|Overall Study|Never start treatment|2|||
164240624|NCT00305877|593252410|FG001|Overall Study|Never start treatment|5|||
164240625|NCT00305877|593252409|FG000|Overall Study|Ineligible|2|||
164240626|NCT00305877|593252410|FG001|Overall Study|Ineligible|1|||
164240627|NCT00305877|593252409|FG000|Overall Study|Transportation issue with daily RT|0|||
164240628|NCT00305877|593252410|FG001|Overall Study|Transportation issue with daily RT|1|||
164240629|NCT01535287|593252411|FG000|Overall Study|drug not prepared in time|5|||
164240630|NCT01535287|593252412|FG001|Overall Study|drug not prepared in time|6|||
164240631|NCT00628446|593252415|FG000|Overall Study|Lost to Follow-up|3|||
164240632|NCT00628446|593252415|FG000|Overall Study|Withdrawal by Subject|1|||
164240633|NCT00628446|593252415|FG000|Overall Study|Protocol Violation|3|||
164240634|NCT04971967|593252418|FG000|Overall Study|Lost to Follow-up|6|||
164240635|NCT04971967|593252419|FG001|Overall Study|Lost to Follow-up|7|||
164240636|NCT00682929|593252422|FG000|Overall Study|Adverse Event|4|||
164240637|NCT00682929|593252423|FG001|Overall Study|Adverse Event|1|||
164240638|NCT00682929|593252424|FG002|Overall Study|Adverse Event|1|||
164240639|NCT00682929|593252422|FG000|Overall Study|Withdrawal by Subject|1|||
164240640|NCT00682929|593252423|FG001|Overall Study|Withdrawal by Subject|2|||
164240641|NCT00682929|593252424|FG002|Overall Study|Withdrawal by Subject|1|||
164240642|NCT00682929|593252422|FG000|Overall Study|dosing compliance < 80%|0|||
164240643|NCT00682929|593252423|FG001|Overall Study|dosing compliance < 80%|2|||
164240644|NCT00682929|593252424|FG002|Overall Study|dosing compliance < 80%|0|||
164240645|NCT00682929|593252422|FG000|Overall Study|lag in DEA renewal|1|||
164240646|NCT00682929|593252423|FG001|Overall Study|lag in DEA renewal|0|||
164240647|NCT00682929|593252424|FG002|Overall Study|lag in DEA renewal|0|||
164240648|NCT00938912|593252425|FG000|Overall Study|Withdrawal by Subject|28|||
164240649|NCT00938912|593252425|FG000|Overall Study|Lost to Follow-up|4|||
164240650|NCT00938912|593252425|FG000|Overall Study|Lack of Efficacy|43|||
164240651|NCT00938912|593252425|FG000|Overall Study|Adverse event, non-fatal|24|||
164240652|NCT00938912|593252425|FG000|Overall Study|Adverse event, fatal|1|||
164240653|NCT00938912|593252425|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
164240654|NCT00938912|593252425|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
164240655|NCT00938912|593252425|FG000|Overall Study|Participant needed prohibit medication|1|||
164240656|NCT00938912|593252425|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
164240657|NCT00938912|593252425|FG000|Overall Study|Did not meet Eligibility criteria|1|||
164240658|NCT00938912|593252425|FG000|Overall Study|Participant relocated not related to AE|1|||
164240659|NCT00938912|593252425|FG000|Overall Study|Participant moved to another city|1|||
164240660|NCT00938912|593252425|FG000|Overall Study|Participant experienced break through seizures|1|||
164240661|NCT00938912|593252425|FG000|Overall Study|No longer wished to participate in the study|1|||
164240662|NCT00938912|593252425|FG000|Overall Study|Protocol Deviation|2|||
164240663|NCT00803738|593252431|FG000|Overall Study|Adverse Event|3|||
164240664|NCT00803738|593252432|FG001|Overall Study|Adverse Event|5|||
164240665|NCT00803738|593252431|FG000|Overall Study|Lost to Follow-up|4|||
164240666|NCT00803738|593252432|FG001|Overall Study|Lost to Follow-up|4|||
164240667|NCT00803738|593252431|FG000|Overall Study|Protocol Violation|18|||
164240668|NCT00803738|593252432|FG001|Overall Study|Protocol Violation|10|||
164240669|NCT00803738|593252431|FG000|Overall Study|Withdrawal by Subject|1|||
164240670|NCT00803738|593252432|FG001|Overall Study|Withdrawal by Subject|4|||
164240671|NCT00803738|593252431|FG000|Overall Study|Lack of Efficacy|10|||
164240672|NCT00803738|593252432|FG001|Overall Study|Lack of Efficacy|16|||
164240673|NCT00803738|593252431|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
164240674|NCT00803738|593252432|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
164240675|NCT00803738|593252431|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
164240676|NCT00803738|593252432|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
164240677|NCT02964273|593252433|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
164240678|NCT02964273|593252434|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
164240679|NCT02964273|593252435|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
164240680|NCT02964273|593252436|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
164240681|NCT02964273|593252433|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
164240682|NCT02964273|593252434|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
164240683|NCT02964273|593252435|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
164240684|NCT02964273|593252436|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
164240685|NCT02964273|593252433|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
164240686|NCT02964273|593252434|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
164336069|NCT02833350|593607815|FG004|Overall Study|Withdrawal by Subject|2|||
164336070|NCT02833350|593607816|FG005|Overall Study|Withdrawal by Subject|0|||
164240687|NCT02964273|593252435|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
164240688|NCT02964273|593252436|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
164240689|NCT02964273|593252433|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
164336071|NCT02833350|593607817|FG006|Overall Study|Withdrawal by Subject|2|||
164336072|NCT00131508|593607820|FG000|Overall Study|Disease progression|0|||
164336073|NCT00131508|593607821|FG001|Overall Study|Disease progression|2|||
164336074|NCT00131508|593607820|FG000|Overall Study|Non-Compliance|2|||
164336075|NCT00131508|593607821|FG001|Overall Study|Non-Compliance|4|||
164336076|NCT00131508|593607820|FG000|Overall Study|Withdrawal by Subject|1|||
164336077|NCT00131508|593607821|FG001|Overall Study|Withdrawal by Subject|2|||
164240690|NCT02964273|593252434|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
164336078|NCT01495975|593607823|FG000|Overall Study|Lost to Follow-up|1|||
164336079|NCT01495975|593607824|FG001|Overall Study|Lost to Follow-up|0|||
163884673|NCT04676022|591947834|FG000|Overall Study|Will not move forward with permanent implant|6|||
163989273|NCT00352105|592328297|FG000|Overall Study|Adverse Event|19|||
163989274|NCT00352105|592328297|FG000|Overall Study|Protocol Violation|2|||
163989275|NCT02979431|592328300|FG000|Overall Study|Parent/guardian withdrew consent|2|||
163989276|NCT02979431|592328301|FG001|Overall Study|Parent/guardian withdrew consent|1|||
163989277|NCT02979431|592328302|FG002|Overall Study|Parent/guardian withdrew consent|1|||
163989278|NCT02979431|592328303|FG003|Overall Study|Parent/guardian withdrew consent|1|||
163989279|NCT02979431|592328300|FG000|Overall Study|Randomized but received no study drug|1|||
163989280|NCT02979431|592328301|FG001|Overall Study|Randomized but received no study drug|1|||
163989281|NCT02979431|592328302|FG002|Overall Study|Randomized but received no study drug|0|||
163989282|NCT02979431|592328303|FG003|Overall Study|Randomized but received no study drug|0|||
163989283|NCT02979431|592328300|FG000|Overall Study|Adverse Event|0|||
163989284|NCT02979431|592328301|FG001|Overall Study|Adverse Event|0|||
163989285|NCT02979431|592328302|FG002|Overall Study|Adverse Event|1|||
163989286|NCT02979431|592328303|FG003|Overall Study|Adverse Event|0|||
163989287|NCT02979431|592328300|FG000|Overall Study|Subject left country after Day14|1|||
163989288|NCT02979431|592328301|FG001|Overall Study|Subject left country after Day14|0|||
163989289|NCT02979431|592328302|FG002|Overall Study|Subject left country after Day14|0|||
163989290|NCT02979431|592328303|FG003|Overall Study|Subject left country after Day14|0|||
163989291|NCT01656434|592328304|FG000|Overall Study|Adverse Event|199|||
163989292|NCT01656434|592328305|FG001|Overall Study|Adverse Event|63|||
163989293|NCT01656434|592328304|FG000|Overall Study|Enrollment terminated at trial site|2|||
163989294|NCT01656434|592328305|FG001|Overall Study|Enrollment terminated at trial site|0|||
163989295|NCT01656434|592328304|FG000|Overall Study|Lost to Follow-up|309|||
163989296|NCT01656434|592328305|FG001|Overall Study|Lost to Follow-up|76|||
163989297|NCT01656434|592328304|FG000|Overall Study|Site discontinued study participation|24|||
163989298|NCT01656434|592328305|FG001|Overall Study|Site discontinued study participation|9|||
163989299|NCT01656434|592328304|FG000|Overall Study|Screen failure|2|||
163989300|NCT01656434|592328305|FG001|Overall Study|Screen failure|0|||
163989301|NCT01656434|592328304|FG000|Overall Study|Protocol Violation|7|||
163989302|NCT01656434|592328305|FG001|Overall Study|Protocol Violation|0|||
163989303|NCT01656434|592328304|FG000|Overall Study|Pregnancy wish|18|||
163989304|NCT01656434|592328305|FG001|Overall Study|Pregnancy wish|6|||
163989305|NCT01656434|592328304|FG000|Overall Study|Pregnancy|45|||
163989306|NCT01656434|592328305|FG001|Overall Study|Pregnancy|10|||
163989307|NCT01656434|592328304|FG000|Overall Study|Physician Decision|7|||
163989308|NCT01656434|592328305|FG001|Overall Study|Physician Decision|2|||
163989309|NCT01656434|592328304|FG000|Overall Study|Non-compliance with study drug|48|||
163989310|NCT01656434|592328305|FG001|Overall Study|Non-compliance with study drug|9|||
163989311|NCT01656434|592328304|FG000|Overall Study|Study terminated by sponsor|1501|||
163989312|NCT01656434|592328305|FG001|Overall Study|Study terminated by sponsor|348|||
163989313|NCT01656434|592328304|FG000|Overall Study|Participant discontinued; drug related|13|||
163989314|NCT01656434|592328305|FG001|Overall Study|Participant discontinued; drug related|4|||
163989315|NCT01656434|592328304|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
163989316|NCT01656434|592328305|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
163989317|NCT01656434|592328304|FG000|Overall Study|Non-compliance with protocol|39|||
163989318|NCT01656434|592328305|FG001|Overall Study|Non-compliance with protocol|15|||
163989319|NCT01656434|592328304|FG000|Overall Study|Participant moved|40|||
163989320|NCT01656434|592328305|FG001|Overall Study|Participant moved|12|||
163989321|NCT01656434|592328304|FG000|Overall Study|Participant withdrew consent|28|||
163989322|NCT01656434|592328305|FG001|Overall Study|Participant withdrew consent|9|||
163989323|NCT01656434|592328304|FG000|Overall Study|Withdrawal by Subject|64|||
163989324|NCT01656434|592328305|FG001|Overall Study|Withdrawal by Subject|7|||
163989325|NCT02435914|592328306|FG000|Overall Study|Ocular Adverse Event|1|||
163989326|NCT02435914|592328307|FG001|Overall Study|Ocular Adverse Event|0|||
163989327|NCT02435914|592328308|FG002|Overall Study|Ocular Adverse Event|0|||
163989328|NCT02435914|592328309|FG003|Overall Study|Ocular Adverse Event|0|||
163989329|NCT02435914|592328306|FG000|Overall Study|Withdrawal by Subject|0|||
163989330|NCT02435914|592328307|FG001|Overall Study|Withdrawal by Subject|1|||
163989331|NCT02435914|592328308|FG002|Overall Study|Withdrawal by Subject|0|||
163989332|NCT02435914|592328309|FG003|Overall Study|Withdrawal by Subject|0|||
163989333|NCT02435914|592328306|FG000|Overall Study|Other Miscellaneous Reason|0|||
163989334|NCT02435914|592328307|FG001|Overall Study|Other Miscellaneous Reason|0|||
163989335|NCT02435914|592328308|FG002|Overall Study|Other Miscellaneous Reason|1|||
164240691|NCT02964273|593252435|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
164240692|NCT02964273|593252436|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
164240693|NCT02964273|593252433|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
164240694|NCT02964273|593252434|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
164240695|NCT02964273|593252435|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
164240696|NCT02964273|593252436|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
164240697|NCT02964273|593252433|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
164240698|NCT02964273|593252434|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
164240699|NCT02964273|593252435|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
164240700|NCT02964273|593252436|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
164240701|NCT03012334|593252437|FG000|Period 1|Withdrawal by Subject|0|||
164240702|NCT03012334|593252438|FG001|Period 1|Withdrawal by Subject|0|||
164240703|NCT03012334|593252439|FG002|Period 1|Withdrawal by Subject|0|||
164240704|NCT03012334|593252440|FG003|Period 1|Withdrawal by Subject|0|||
163989336|NCT02435914|592328309|FG003|Overall Study|Other Miscellaneous Reason|0|||
163989337|NCT00130286|592328317|FG000|Overall Study|Withdrawal by Subject|0|||
163989338|NCT00130286|592328318|FG001|Overall Study|Withdrawal by Subject|1|||
163989339|NCT00130286|592328319|FG002|Overall Study|Withdrawal by Subject|2|||
163989340|NCT00130286|592328320|FG003|Overall Study|Withdrawal by Subject|2|||
163989341|NCT00130286|592328317|FG000|Overall Study|Adverse Event|0|||
163989342|NCT00130286|592328318|FG001|Overall Study|Adverse Event|0|||
163989343|NCT00130286|592328319|FG002|Overall Study|Adverse Event|2|||
163989344|NCT00130286|592328320|FG003|Overall Study|Adverse Event|0|||
163989345|NCT00130286|592328317|FG000|Overall Study|Missing lab specimens|0|||
163989346|NCT00130286|592328318|FG001|Overall Study|Missing lab specimens|2|||
164240705|NCT03012334|593252441|FG004|Period 1|Withdrawal by Subject|0|||
164240706|NCT03012334|593252442|FG005|Period 1|Withdrawal by Subject|0|||
164240707|NCT03012334|593252443|FG006|Period 1|Withdrawal by Subject|0|||
164336080|NCT00808483|593607827|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
164336081|NCT00808483|593607828|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
164336082|NCT00808483|593607827|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
164336083|NCT00808483|593607828|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
164336084|NCT00808483|593607827|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
164336085|NCT00808483|593607828|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
164336086|NCT02038881|593607829|FG000|Overall Study|Withdrawal by Subject|0|||
164336087|NCT02038881|593607830|FG001|Overall Study|Withdrawal by Subject|0|||
164336088|NCT02038881|593607831|FG002|Overall Study|Withdrawal by Subject|1|||
164336089|NCT02038881|593607829|FG000|Overall Study|Lost to Follow-up|2|||
164336090|NCT02038881|593607830|FG001|Overall Study|Lost to Follow-up|0|||
164336091|NCT02038881|593607831|FG002|Overall Study|Lost to Follow-up|0|||
164336092|NCT02038881|593607829|FG000|Overall Study|incarcerated|1|||
164336093|NCT02038881|593607830|FG001|Overall Study|incarcerated|0|||
164336094|NCT02038881|593607831|FG002|Overall Study|incarcerated|0|||
164336095|NCT00333840|593607832|FG000|First-line Treatment Period|Adverse Event|38|||
164336096|NCT00333840|593607833|FG001|First-line Treatment Period|Adverse Event|37|||
164336097|NCT00333840|593607834|FG002|First-line Treatment Period|Adverse Event|0|||
164336098|NCT00333840|593607835|FG003|First-line Treatment Period|Adverse Event|0|||
164336099|NCT00333840|593607832|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
164336100|NCT00333840|593607833|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
164336101|NCT00333840|593607834|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
164336102|NCT00333840|593607835|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
164336103|NCT00333840|593607832|FG000|First-line Treatment Period|Abnormal procedure|2|||
164336104|NCT00333840|593607833|FG001|First-line Treatment Period|Abnormal procedure|0|||
164336105|NCT00333840|593607834|FG002|First-line Treatment Period|Abnormal procedure|0|||
164336106|NCT00333840|593607835|FG003|First-line Treatment Period|Abnormal procedure|0|||
164336107|NCT00333840|593607832|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
164336108|NCT00333840|593607833|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
164336109|NCT00333840|593607834|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336110|NCT00333840|593607835|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336111|NCT00333840|593607832|FG000|First-line Treatment Period|No longer required study drug|21|||
163989347|NCT00130286|592328319|FG002|Overall Study|Missing lab specimens|0|||
164240708|NCT03012334|593252444|FG007|Period 1|Withdrawal by Subject|0|||
164240709|NCT03012334|593252445|FG008|Period 1|Withdrawal by Subject|0|||
164336112|NCT00333840|593607833|FG001|First-line Treatment Period|No longer required study drug|8|||
164336113|NCT00333840|593607834|FG002|First-line Treatment Period|No longer required study drug|0|||
164336114|NCT00333840|593607835|FG003|First-line Treatment Period|No longer required study drug|0|||
164336115|NCT00333840|593607832|FG000|First-line Treatment Period|Protocol Violation|17|||
164336116|NCT00333840|593607833|FG001|First-line Treatment Period|Protocol Violation|17|||
163989348|NCT00130286|592328320|FG003|Overall Study|Missing lab specimens|0|||
163989349|NCT01818726|592328326|FG000|Overall Study|Administrative reasons|5|||
163989350|NCT01818726|592328327|FG001|Overall Study|Administrative reasons|1|||
164240710|NCT03012334|593252446|FG009|Period 1|Withdrawal by Subject|1|||
164240711|NCT03012334|593252437|FG000|Period 2|Withdrawal by Subject|0|||
164240712|NCT03012334|593252438|FG001|Period 2|Withdrawal by Subject|1|||
164240713|NCT03012334|593252439|FG002|Period 2|Withdrawal by Subject|0|||
164240714|NCT03012334|593252440|FG003|Period 2|Withdrawal by Subject|0|||
164240715|NCT03012334|593252441|FG004|Period 2|Withdrawal by Subject|0|||
164240716|NCT03012334|593252442|FG005|Period 2|Withdrawal by Subject|0|||
164240717|NCT03012334|593252443|FG006|Period 2|Withdrawal by Subject|0|||
164240718|NCT03012334|593252444|FG007|Period 2|Withdrawal by Subject|0|||
164240719|NCT03012334|593252445|FG008|Period 2|Withdrawal by Subject|0|||
164240720|NCT03012334|593252446|FG009|Period 2|Withdrawal by Subject|0|||
164240721|NCT03012334|593252437|FG000|Period 2|Protocol Violation|0|||
164240722|NCT03012334|593252438|FG001|Period 2|Protocol Violation|0|||
164240723|NCT03012334|593252439|FG002|Period 2|Protocol Violation|1|||
164240724|NCT03012334|593252440|FG003|Period 2|Protocol Violation|0|||
164240725|NCT03012334|593252441|FG004|Period 2|Protocol Violation|0|||
164240726|NCT03012334|593252442|FG005|Period 2|Protocol Violation|0|||
164240727|NCT03012334|593252443|FG006|Period 2|Protocol Violation|0|||
164240728|NCT03012334|593252444|FG007|Period 2|Protocol Violation|1|||
164240729|NCT03012334|593252445|FG008|Period 2|Protocol Violation|0|||
164240730|NCT03012334|593252446|FG009|Period 2|Protocol Violation|0|||
164240731|NCT03012334|593252437|FG000|Period 4|Non-Compliance|0|||
164240732|NCT03012334|593252438|FG001|Period 4|Non-Compliance|0|||
164240733|NCT03012334|593252439|FG002|Period 4|Non-Compliance|0|||
164240734|NCT03012334|593252440|FG003|Period 4|Non-Compliance|0|||
164240735|NCT03012334|593252441|FG004|Period 4|Non-Compliance|0|||
164240736|NCT03012334|593252442|FG005|Period 4|Non-Compliance|0|||
164240737|NCT03012334|593252443|FG006|Period 4|Non-Compliance|1|||
164240738|NCT03012334|593252444|FG007|Period 4|Non-Compliance|0|||
164240739|NCT03012334|593252445|FG008|Period 4|Non-Compliance|0|||
164240740|NCT03012334|593252446|FG009|Period 4|Non-Compliance|0|||
164240741|NCT03012334|593252437|FG000|Period 4|Adverse Event|0|||
164240742|NCT03012334|593252438|FG001|Period 4|Adverse Event|0|||
164240743|NCT03012334|593252439|FG002|Period 4|Adverse Event|0|||
164240744|NCT03012334|593252440|FG003|Period 4|Adverse Event|0|||
164240745|NCT03012334|593252441|FG004|Period 4|Adverse Event|0|||
164240746|NCT03012334|593252442|FG005|Period 4|Adverse Event|0|||
164240747|NCT03012334|593252443|FG006|Period 4|Adverse Event|0|||
164240748|NCT03012334|593252444|FG007|Period 4|Adverse Event|0|||
164240749|NCT03012334|593252445|FG008|Period 4|Adverse Event|1|||
164240750|NCT03012334|593252446|FG009|Period 4|Adverse Event|0|||
164240751|NCT01823107|593252447|FG000|Overall Study|Withdrawal by Subject|1|||
164240752|NCT00328172|593252450|FG000|Overall Study|Adverse Event|3|||
164240753|NCT00328172|593252451|FG001|Overall Study|Adverse Event|2|||
164240754|NCT00328172|593252452|FG002|Overall Study|Adverse Event|1|||
164240755|NCT00328172|593252453|FG003|Overall Study|Adverse Event|2|||
164240756|NCT00328172|593252454|FG004|Overall Study|Adverse Event|1|||
164240757|NCT00328172|593252450|FG000|Overall Study|Protocol Violation|0|||
164240758|NCT00328172|593252451|FG001|Overall Study|Protocol Violation|1|||
164240759|NCT00328172|593252452|FG002|Overall Study|Protocol Violation|1|||
164240760|NCT00328172|593252453|FG003|Overall Study|Protocol Violation|0|||
164240761|NCT00328172|593252454|FG004|Overall Study|Protocol Violation|0|||
164240762|NCT00328172|593252450|FG000|Overall Study|Lost to Follow-up|1|||
164240763|NCT00328172|593252451|FG001|Overall Study|Lost to Follow-up|1|||
164240764|NCT00328172|593252452|FG002|Overall Study|Lost to Follow-up|2|||
164240765|NCT00328172|593252453|FG003|Overall Study|Lost to Follow-up|1|||
164240766|NCT00328172|593252454|FG004|Overall Study|Lost to Follow-up|1|||
164240767|NCT00328172|593252450|FG000|Overall Study|Withdrawal by Subject|1|||
164240768|NCT00328172|593252451|FG001|Overall Study|Withdrawal by Subject|1|||
164240769|NCT00328172|593252452|FG002|Overall Study|Withdrawal by Subject|1|||
164240770|NCT00328172|593252453|FG003|Overall Study|Withdrawal by Subject|6|||
164240771|NCT00328172|593252454|FG004|Overall Study|Withdrawal by Subject|0|||
164240772|NCT00328172|593252450|FG000|Overall Study|Lack of Efficacy|14|||
164240773|NCT00328172|593252451|FG001|Overall Study|Lack of Efficacy|9|||
164240774|NCT00328172|593252452|FG002|Overall Study|Lack of Efficacy|4|||
164240775|NCT00328172|593252453|FG003|Overall Study|Lack of Efficacy|4|||
164240776|NCT00328172|593252454|FG004|Overall Study|Lack of Efficacy|3|||
164240777|NCT00328172|593252450|FG000|Overall Study|Other reason (not specified)|3|||
164240778|NCT00328172|593252451|FG001|Overall Study|Other reason (not specified)|0|||
164240779|NCT00328172|593252452|FG002|Overall Study|Other reason (not specified)|1|||
164240780|NCT00328172|593252453|FG003|Overall Study|Other reason (not specified)|0|||
164240781|NCT00328172|593252454|FG004|Overall Study|Other reason (not specified)|0|||
164240782|NCT00077974|593252455|FG000|Overall Study|Adverse Event|22|||
164240783|NCT00077974|593252455|FG000|Overall Study|Protocol Violation|1|||
164240784|NCT00077974|593252455|FG000|Overall Study|Withdrawal by Subject|3|||
164240785|NCT00077974|593252455|FG000|Overall Study|Lack of Efficacy|76|||
164240786|NCT00077974|593252455|FG000|Overall Study|Decision of Sponsor|2|||
164240787|NCT02897115|593252458|FG000|Overall Study|Early termination of study by sponsor|11|||
164240788|NCT02897115|593252459|FG001|Overall Study|Early termination of study by sponsor|8|||
164240789|NCT00420381|593252460|FG000|Overall Study|Protocol Violation|1|||
164240790|NCT04512001|593252468|FG000|Week 0 to Week 24|Adverse Event|14|||
164240791|NCT04512001|593252469|FG001|Week 0 to Week 24|Adverse Event|10|||
164240792|NCT04512001|593252470|FG002|Week 0 to Week 24|Adverse Event|0|||
164240793|NCT04512001|593252471|FG003|Week 0 to Week 24|Adverse Event|0|||
164240794|NCT04512001|593252472|FG004|Week 0 to Week 24|Adverse Event|0|||
164240795|NCT04512001|593252468|FG000|Week 0 to Week 24|Death|0|||
164240796|NCT04512001|593252469|FG001|Week 0 to Week 24|Death|2|||
164240797|NCT04512001|593252470|FG002|Week 0 to Week 24|Death|0|||
164240798|NCT04512001|593252471|FG003|Week 0 to Week 24|Death|0|||
164240799|NCT04512001|593252472|FG004|Week 0 to Week 24|Death|0|||
164240800|NCT04512001|593252468|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
164240801|NCT04512001|593252469|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
164240802|NCT04512001|593252470|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
164240803|NCT04512001|593252471|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
164240804|NCT04512001|593252472|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
164240805|NCT04512001|593252468|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
164240806|NCT04512001|593252469|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
164240807|NCT04512001|593252470|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
164240808|NCT04512001|593252471|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
164240809|NCT04512001|593252472|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
164240810|NCT04512001|593252468|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
164240811|NCT04512001|593252469|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240812|NCT04512001|593252470|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240813|NCT04512001|593252471|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240814|NCT04512001|593252472|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
164240815|NCT04512001|593252468|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240816|NCT04512001|593252469|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
164240817|NCT04512001|593252470|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240818|NCT04512001|593252471|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240819|NCT04512001|593252472|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
164240820|NCT04512001|593252468|FG000|Week 24 to Week 63|Adverse Event|0|||
164240821|NCT04512001|593252469|FG001|Week 24 to Week 63|Adverse Event|0|||
164240822|NCT04512001|593252470|FG002|Week 24 to Week 63|Adverse Event|13|||
164240823|NCT04512001|593252471|FG003|Week 24 to Week 63|Adverse Event|8|||
164240824|NCT04512001|593252472|FG004|Week 24 to Week 63|Adverse Event|6|||
164240825|NCT04512001|593252468|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
164240826|NCT04512001|593252469|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
164240827|NCT04512001|593252470|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
164240828|NCT04512001|593252471|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
164240829|NCT04512001|593252472|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
164240830|NCT04512001|593252468|FG000|Week 24 to Week 63|Death|0|||
164240831|NCT04512001|593252469|FG001|Week 24 to Week 63|Death|0|||
164240832|NCT04512001|593252470|FG002|Week 24 to Week 63|Death|0|||
164240833|NCT04512001|593252471|FG003|Week 24 to Week 63|Death|1|||
164336117|NCT00333840|593607834|FG002|First-line Treatment Period|Protocol Violation|0|||
164336118|NCT00333840|593607835|FG003|First-line Treatment Period|Protocol Violation|0|||
164336119|NCT00333840|593607832|FG000|First-line Treatment Period|Subject withdrew consent|57|||
164336120|NCT00333840|593607833|FG001|First-line Treatment Period|Subject withdrew consent|77|||
164336121|NCT00333840|593607834|FG002|First-line Treatment Period|Subject withdrew consent|0|||
164336122|NCT00333840|593607835|FG003|First-line Treatment Period|Subject withdrew consent|0|||
164336123|NCT00333840|593607832|FG000|First-line Treatment Period|Lost to Follow-up|15|||
164240834|NCT04512001|593252472|FG004|Week 24 to Week 63|Death|1|||
164240835|NCT04512001|593252468|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
164240836|NCT04512001|593252469|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
164240837|NCT04512001|593252470|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
164240838|NCT04512001|593252471|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
164240839|NCT04512001|593252472|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
164240840|NCT04512001|593252468|FG000|Week 24 to Week 63|Miscellaneous|0|||
164240841|NCT04512001|593252469|FG001|Week 24 to Week 63|Miscellaneous|0|||
164240842|NCT04512001|593252470|FG002|Week 24 to Week 63|Miscellaneous|3|||
164240843|NCT04512001|593252471|FG003|Week 24 to Week 63|Miscellaneous|2|||
164240844|NCT04512001|593252472|FG004|Week 24 to Week 63|Miscellaneous|1|||
164240845|NCT03389308|593252473|FG000|Overall Study|Withdrawal by Subject|5|||
164240846|NCT03389308|593252473|FG000|Overall Study|Lost to Follow-up|3|||
164240847|NCT03389308|593252473|FG000|Overall Study|Adverse Event|2|||
164240848|NCT03389308|593252473|FG000|Overall Study|Sponsor Request|2|||
164240849|NCT03896477|593252481|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
164240850|NCT03896477|593252482|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
164240851|NCT03896477|593252483|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
164240852|NCT03896477|593252481|FG000|Overall Study|Parent Requested Withdrawal|8|||
164240853|NCT03896477|593252482|FG001|Overall Study|Parent Requested Withdrawal|12|||
164240854|NCT03896477|593252483|FG002|Overall Study|Parent Requested Withdrawal|9|||
164240855|NCT03896477|593252481|FG000|Overall Study|Adverse Event|0|||
164240856|NCT03896477|593252482|FG001|Overall Study|Adverse Event|0|||
164240857|NCT03896477|593252483|FG002|Overall Study|Adverse Event|1|||
164240858|NCT03896477|593252481|FG000|Overall Study|Death|1|||
164240859|NCT03896477|593252482|FG001|Overall Study|Death|0|||
164240860|NCT03896477|593252483|FG002|Overall Study|Death|0|||
164240861|NCT03896477|593252481|FG000|Overall Study|Other|5|||
164240862|NCT03896477|593252482|FG001|Overall Study|Other|6|||
164240863|NCT03896477|593252483|FG002|Overall Study|Other|7|||
164240864|NCT03896477|593252481|FG000|Overall Study|Lost to Follow-up|2|||
164240865|NCT03896477|593252482|FG001|Overall Study|Lost to Follow-up|1|||
164240866|NCT03896477|593252483|FG002|Overall Study|Lost to Follow-up|1|||
164240867|NCT01106157|593252488|FG000|Overall Study|Withdrawal by Subject|1|||
164240868|NCT01106157|593252489|FG001|Overall Study|Withdrawal by Subject|0|||
164240869|NCT02298868|593252493|FG000|Overall Study|Adverse Event|1|||
163884674|NCT04676022|591947835|FG001|Overall Study|Will not move forward with permanent implant|0|||
164240870|NCT02298868|593252493|FG000|Overall Study|Death|1|||
164240871|NCT02298868|593252493|FG000|Overall Study|Patient underwent transplant|1|||
164240872|NCT01063348|593252494|FG000|Overall Study|Lost to Follow-up|3|||
164240873|NCT01063348|593252495|FG001|Overall Study|Lost to Follow-up|10|||
164240874|NCT00696878|593252496|FG000|Overall Study|Adverse Event|8|||
164240875|NCT00696878|593252496|FG000|Overall Study|Withdrawal by Subject|87|||
164240876|NCT00696878|593252496|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
164240877|NCT00696878|593252496|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
164240878|NCT00696878|593252496|FG000|Overall Study|Trial stopped|32|||
163884675|NCT04676022|591947836|FG002|Overall Study|Will not move forward with permanent implant|0|||
164240879|NCT00696878|593252496|FG000|Overall Study|Other reason (not specified)|55|||
164240880|NCT03824392|593252499|FG000|Overall Study|Adverse Event|1|||
164240881|NCT03824392|593252500|FG001|Overall Study|Adverse Event|0|||
164240882|NCT03824392|593252501|FG002|Overall Study|Adverse Event|0|||
164240883|NCT03824392|593252502|FG003|Overall Study|Adverse Event|0|||
164240884|NCT03824392|593252499|FG000|Overall Study|Investigator Decision|0|||
164240885|NCT03824392|593252500|FG001|Overall Study|Investigator Decision|1|||
164240886|NCT03824392|593252501|FG002|Overall Study|Investigator Decision|0|||
164240887|NCT03824392|593252502|FG003|Overall Study|Investigator Decision|0|||
164240888|NCT03824392|593252499|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
164240889|NCT03824392|593252500|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
164240890|NCT03824392|593252501|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
164240891|NCT03824392|593252502|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
164240892|NCT00967616|593252503|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
164240893|NCT00967616|593252504|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
164240894|NCT00967616|593252503|FG000|Overall Study|Death|0|||
164240895|NCT00967616|593252504|FG001|Overall Study|Death|3|||
164240896|NCT00967616|593252503|FG000|Overall Study|Withdrawal by Subject|8|||
164240897|NCT00967616|593252504|FG001|Overall Study|Withdrawal by Subject|4|||
164240898|NCT00967616|593252503|FG000|Overall Study|Progressive Disease|31|||
163884676|NCT04676022|591947834|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
163884677|NCT04676022|591947835|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
163884678|NCT04676022|591947836|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
163884679|NCT04806451|591947842|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
163884680|NCT04806451|591947843|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
163884681|NCT04806451|591947842|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
163884682|NCT04806451|591947843|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
163884683|NCT04806451|591947842|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
163884684|NCT04806451|591947843|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
163884685|NCT03134196|591947847|FG000|Overall Study|Death|2|||
163884686|NCT03134196|591947848|FG001|Overall Study|Death|1|||
163884687|NCT03134196|591947847|FG000|Overall Study|Lost to Follow-up|13|||
163884688|NCT03134196|591947848|FG001|Overall Study|Lost to Follow-up|15|||
163884689|NCT03134196|591947847|FG000|Overall Study|Physician Decision|0|||
163884690|NCT03134196|591947848|FG001|Overall Study|Physician Decision|1|||
163884691|NCT03134196|591947847|FG000|Overall Study|Withdrawal by Subject|19|||
163989351|NCT01818726|592328326|FG000|Overall Study|Withdrawal by Subject|0|||
163989352|NCT01818726|592328327|FG001|Overall Study|Withdrawal by Subject|1|||
164240899|NCT00967616|593252504|FG001|Overall Study|Progressive Disease|18|||
163989353|NCT01818726|592328326|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
163989354|NCT01818726|592328327|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
163989355|NCT00357500|592328328|FG000|Overall Study|Adverse Event|3|||
163989356|NCT00357500|592328328|FG000|Overall Study|Withdrawal by Subject|5|||
163989357|NCT00357500|592328328|FG000|Overall Study|Progressive Disease|65|||
163989358|NCT00357500|592328328|FG000|Overall Study|Not Started Protocol Therapy|4|||
163989359|NCT00993928|592328329|FG000|Overall Study|Withdrawal by Subject|4|||
163989360|NCT00993928|592328330|FG001|Overall Study|Withdrawal by Subject|7|||
163989361|NCT00993928|592328329|FG000|Overall Study|ineligible|1|||
163989362|NCT00993928|592328330|FG001|Overall Study|ineligible|0|||
163989363|NCT02154087|592328333|FG000|Overall Study|Study Termination|1|||
163989364|NCT05574062|592328335|FG000|Pre Run-In|Screening failure|3|||
163989365|NCT05574062|592328336|FG001|Pre Run-In|Screening failure|0|||
163989366|NCT05574062|592328337|FG002|Pre Run-In|Screening failure|0|||
163989367|NCT05574062|592328338|FG003|Pre Run-In|Screening failure|0|||
163989368|NCT05574062|592328339|FG004|Pre Run-In|Screening failure|0|||
163989369|NCT05574062|592328335|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
163989370|NCT05574062|592328336|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
163989371|NCT05574062|592328337|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
164240900|NCT00967616|593252503|FG000|Overall Study|Other|8|||
164240901|NCT00967616|593252504|FG001|Overall Study|Other|8|||
163884692|NCT03134196|591947848|FG001|Overall Study|Withdrawal by Subject|12|||
163884693|NCT03134196|591947847|FG000|Overall Study|Site Unable to Contact Participant|2|||
163884694|NCT03134196|591947848|FG001|Overall Study|Site Unable to Contact Participant|0|||
163989372|NCT05574062|592328338|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
164240902|NCT00967616|593252503|FG000|Overall Study|Protocol Violation|1|||
164240903|NCT00967616|593252504|FG001|Overall Study|Protocol Violation|0|||
163884695|NCT03134196|591947847|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
163989373|NCT05574062|592328339|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
163989374|NCT05574062|592328335|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
163989375|NCT05574062|592328336|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
163989376|NCT05574062|592328337|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
164240904|NCT01847755|593252505|FG000|Overall Study|Adverse Event|2|||
164240905|NCT01847755|593252505|FG000|Overall Study|Withdrawal by Subject|2|||
164240906|NCT01847755|593252505|FG000|Overall Study|Physician Decision|1|||
164240907|NCT03188263|593252514|FG000|Overall Study|Withdrawal by Subject|3|||
164240908|NCT03188263|593252515|FG001|Overall Study|Withdrawal by Subject|0|||
164240909|NCT03188263|593252514|FG000|Overall Study|Physician Decision|1|||
164240910|NCT03188263|593252515|FG001|Overall Study|Physician Decision|0|||
164240911|NCT01030822|593252516|FG000|Overall Study|Moved/migrated from study area|6|||
164240912|NCT01030822|593252517|FG001|Overall Study|Moved/migrated from study area|7|||
164240913|NCT01030822|593252518|FG002|Overall Study|Moved/migrated from study area|3|||
164240914|NCT01030822|593252516|FG000|Overall Study|Withdrawal by Subject|16|||
164240915|NCT01030822|593252517|FG001|Overall Study|Withdrawal by Subject|13|||
164240916|NCT01030822|593252518|FG002|Overall Study|Withdrawal by Subject|16|||
164240917|NCT01030822|593252516|FG000|Overall Study|Lost to Follow-up|9|||
164240918|NCT01030822|593252517|FG001|Overall Study|Lost to Follow-up|4|||
164240919|NCT01030822|593252518|FG002|Overall Study|Lost to Follow-up|7|||
164240920|NCT00120627|593252526|FG000|Overall Study|Withdrawal by Subject|5|||
164240921|NCT00120627|593252527|FG001|Overall Study|Withdrawal by Subject|5|||
164240922|NCT03386435|593252528|FG000|Overall Study|Protocol Violation|5|||
164240923|NCT03386435|593252529|FG001|Overall Study|Protocol Violation|7|||
164240924|NCT04068922|593252530|FG000|Overall Study|Lost to Follow-up|5|||
164240925|NCT04068922|593252530|FG000|Overall Study|Withdrawal by Subject|7|||
164240926|NCT04068922|593252530|FG000|Overall Study|Adverse Event|1|||
164240927|NCT04540367|593252531|FG000|Overall Study|Withdrawal by Subject|0|||
164240928|NCT04540367|593252532|FG001|Overall Study|Withdrawal by Subject|0|||
164240929|NCT04540367|593252533|FG002|Overall Study|Withdrawal by Subject|0|||
164240930|NCT04540367|593252534|FG003|Overall Study|Withdrawal by Subject|2|||
164240931|NCT04540367|593252531|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
164240932|NCT04540367|593252532|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
164240933|NCT04540367|593252533|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
164240934|NCT04540367|593252534|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
164240935|NCT04540367|593252531|FG000|Overall Study|Adverse Event|0|||
164240936|NCT04540367|593252532|FG001|Overall Study|Adverse Event|0|||
164240937|NCT04540367|593252533|FG002|Overall Study|Adverse Event|1|||
164240938|NCT04540367|593252534|FG003|Overall Study|Adverse Event|1|||
164240939|NCT00907621|593252536|FG000|Overall Study|Lost to Follow-up|6|||
164240940|NCT00907621|593252537|FG001|Overall Study|Lost to Follow-up|3|||
164240941|NCT00907621|593252536|FG000|Overall Study|intercurrent febrile illness|1|||
164240942|NCT00907621|593252537|FG001|Overall Study|intercurrent febrile illness|1|||
164240943|NCT01815424|593254346|FG000|Week 0 to 16|Adverse Event|1|||
164240944|NCT01815424|593254347|FG001|Week 0 to 16|Adverse Event|3|||
164240945|NCT01815424|593254348|FG002|Week 0 to 16|Adverse Event|3|||
164240946|NCT01815424|593254349|FG003|Week 0 to 16|Adverse Event|0|||
164240947|NCT01815424|593254350|FG004|Week 0 to 16|Adverse Event|0|||
164240948|NCT01815424|593254346|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
164240949|NCT01815424|593254347|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240950|NCT01815424|593254348|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240951|NCT01815424|593254349|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240952|NCT01815424|593254350|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
164240953|NCT01815424|593254346|FG000|Week 0 to 16|Lost to Follow-up|0|||
164240954|NCT01815424|593254347|FG001|Week 0 to 16|Lost to Follow-up|1|||
164240955|NCT01815424|593254348|FG002|Week 0 to 16|Lost to Follow-up|0|||
164240956|NCT01815424|593254349|FG003|Week 0 to 16|Lost to Follow-up|0|||
164240957|NCT01815424|593254350|FG004|Week 0 to 16|Lost to Follow-up|0|||
164240958|NCT01815424|593254346|FG000|Week 0 to 16|Withdrawal by Subject|0|||
164240959|NCT01815424|593254347|FG001|Week 0 to 16|Withdrawal by Subject|0|||
164240960|NCT01815424|593254348|FG002|Week 0 to 16|Withdrawal by Subject|1|||
164240961|NCT01815424|593254349|FG003|Week 0 to 16|Withdrawal by Subject|0|||
164240962|NCT01815424|593254350|FG004|Week 0 to 16|Withdrawal by Subject|0|||
164240963|NCT01815424|593254346|FG000|Week 0 to 16|Other|1|||
164240964|NCT01815424|593254347|FG001|Week 0 to 16|Other|0|||
164240965|NCT01815424|593254348|FG002|Week 0 to 16|Other|3|||
164240966|NCT01815424|593254349|FG003|Week 0 to 16|Other|0|||
164240967|NCT01815424|593254350|FG004|Week 0 to 16|Other|0|||
164240968|NCT01815424|593254346|FG000|Week 0 to 16|Protocol Violation|1|||
164240969|NCT01815424|593254347|FG001|Week 0 to 16|Protocol Violation|0|||
164240970|NCT01815424|593254348|FG002|Week 0 to 16|Protocol Violation|0|||
164240971|NCT01815424|593254349|FG003|Week 0 to 16|Protocol Violation|0|||
164240972|NCT01815424|593254350|FG004|Week 0 to 16|Protocol Violation|0|||
164240973|NCT01815424|593254346|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
164240974|NCT01815424|593254347|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
164240975|NCT01815424|593254348|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
164240976|NCT01815424|593254349|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
164240977|NCT01815424|593254350|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
164240978|NCT01815424|593254346|FG000|Week 16 to 52|Other|0|||
164240979|NCT01815424|593254347|FG001|Week 16 to 52|Other|1|||
164240980|NCT01815424|593254348|FG002|Week 16 to 52|Other|0|||
164240981|NCT01815424|593254349|FG003|Week 16 to 52|Other|0|||
164240982|NCT01815424|593254350|FG004|Week 16 to 52|Other|0|||
164240983|NCT01815424|593254346|FG000|Week 16 to 52|Adverse Event|0|||
164240984|NCT01815424|593254347|FG001|Week 16 to 52|Adverse Event|0|||
164240985|NCT01815424|593254348|FG002|Week 16 to 52|Adverse Event|0|||
164240986|NCT01815424|593254349|FG003|Week 16 to 52|Adverse Event|0|||
164240987|NCT01815424|593254350|FG004|Week 16 to 52|Adverse Event|1|||
164240988|NCT01815424|593254346|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
164240989|NCT01815424|593254347|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
164240990|NCT01815424|593254348|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
164240991|NCT01815424|593254349|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
164240992|NCT01815424|593254350|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
164240993|NCT01815424|593254346|FG000|Week 16 to 52|Lost to Follow-up|0|||
164240994|NCT01815424|593254347|FG001|Week 16 to 52|Lost to Follow-up|2|||
164240995|NCT01815424|593254348|FG002|Week 16 to 52|Lost to Follow-up|0|||
164240996|NCT01815424|593254349|FG003|Week 16 to 52|Lost to Follow-up|2|||
164240997|NCT01815424|593254350|FG004|Week 16 to 52|Lost to Follow-up|1|||
164240998|NCT01815424|593254346|FG000|Week 16 to 52|Withdrawal by Subject|1|||
164240999|NCT01815424|593254347|FG001|Week 16 to 52|Withdrawal by Subject|2|||
164241000|NCT01815424|593254348|FG002|Week 16 to 52|Withdrawal by Subject|0|||
164241001|NCT01815424|593254349|FG003|Week 16 to 52|Withdrawal by Subject|0|||
164241002|NCT01815424|593254350|FG004|Week 16 to 52|Withdrawal by Subject|0|||
164241003|NCT01309204|593254351|FG000|Overall Study|Adverse Event|48|||
164241004|NCT01309204|593254352|FG001|Overall Study|Adverse Event|58|||
164241005|NCT01309204|593254351|FG000|Overall Study|Lost to Follow-up|2|||
164241006|NCT01309204|593254352|FG001|Overall Study|Lost to Follow-up|2|||
164241007|NCT01309204|593254351|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
164241008|NCT01309204|593254352|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
164241009|NCT01309204|593254351|FG000|Overall Study|Inadequate control of IOP|4|||
164241010|NCT01309204|593254352|FG001|Overall Study|Inadequate control of IOP|4|||
164241011|NCT01309204|593254351|FG000|Overall Study|Other|4|||
164241012|NCT01309204|593254352|FG001|Overall Study|Other|1|||
164336124|NCT00333840|593607833|FG001|First-line Treatment Period|Lost to Follow-up|6|||
164336125|NCT00333840|593607834|FG002|First-line Treatment Period|Lost to Follow-up|0|||
164336126|NCT00333840|593607835|FG003|First-line Treatment Period|Lost to Follow-up|0|||
164336127|NCT00333840|593607832|FG000|First-line Treatment Period|Administrative problems|12|||
164336128|NCT00333840|593607833|FG001|First-line Treatment Period|Administrative problems|6|||
164336129|NCT00333840|593607834|FG002|First-line Treatment Period|Administrative problems|0|||
164336130|NCT00333840|593607835|FG003|First-line Treatment Period|Administrative problems|0|||
164336131|NCT00333840|593607832|FG000|First-line Treatment Period|Death|19|||
164336132|NCT00333840|593607833|FG001|First-line Treatment Period|Death|2|||
164336133|NCT00333840|593607834|FG002|First-line Treatment Period|Death|0|||
164336134|NCT00333840|593607835|FG003|First-line Treatment Period|Death|0|||
164336135|NCT00333840|593607832|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
164336136|NCT00333840|593607833|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
164336137|NCT00333840|593607834|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
164336138|NCT00333840|593607835|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
164336139|NCT00333840|593607832|FG000|Second-line Treatment Period|Adverse Event|0|||
164336140|NCT00333840|593607833|FG001|Second-line Treatment Period|Adverse Event|0|||
164336141|NCT00333840|593607834|FG002|Second-line Treatment Period|Adverse Event|3|||
164336142|NCT00333840|593607835|FG003|Second-line Treatment Period|Adverse Event|34|||
164336143|NCT00333840|593607832|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
164336144|NCT00333840|593607833|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
164336145|NCT00333840|593607834|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
164336146|NCT00333840|593607835|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
164336147|NCT00333840|593607832|FG000|Second-line Treatment Period|Abnormal procedure|0|||
164336148|NCT00333840|593607833|FG001|Second-line Treatment Period|Abnormal procedure|0|||
164336149|NCT00333840|593607834|FG002|Second-line Treatment Period|Abnormal procedure|0|||
164336150|NCT00333840|593607835|FG003|Second-line Treatment Period|Abnormal procedure|1|||
164336151|NCT00333840|593607832|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336152|NCT00333840|593607833|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
164336153|NCT00333840|593607834|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
164336154|NCT00333840|593607835|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
164006634|NCT00847613|592391044|FG003|Overall Study|Lack of Efficacy|1|||
164336155|NCT00333840|593607832|FG000|Second-line Treatment Period|No longer required study drug|0|||
164006635|NCT00847613|592391041|FG000|Overall Study|Study terminated by Sponsor|1|||
164006636|NCT00847613|592391042|FG001|Overall Study|Study terminated by Sponsor|0|||
164006637|NCT00847613|592391043|FG002|Overall Study|Study terminated by Sponsor|2|||
164006638|NCT00847613|592391044|FG003|Overall Study|Study terminated by Sponsor|1|||
164006639|NCT00847613|592391041|FG000|Overall Study|Lost to Follow-up|5|||
164006640|NCT00847613|592391042|FG001|Overall Study|Lost to Follow-up|0|||
164241013|NCT04723355|593254353|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
164241014|NCT04723355|593254353|FG000|Overall Study|Errors in the informed consent form|2|||
164241015|NCT03374358|593254354|FG000|Overall Study|Withdrawal by Subject|0|||
164241016|NCT03374358|593254355|FG001|Overall Study|Withdrawal by Subject|2|||
164241017|NCT01127633|593254357|FG000|Overall Study|Adverse Event|74|||
164241018|NCT01127633|593254358|FG001|Overall Study|Adverse Event|73|||
164241019|NCT01127633|593254357|FG000|Overall Study|Death|40|||
164241020|NCT01127633|593254358|FG001|Overall Study|Death|43|||
164241021|NCT01127633|593254357|FG000|Overall Study|Lost to Follow-up|4|||
164241022|NCT01127633|593254358|FG001|Overall Study|Lost to Follow-up|0|||
164241023|NCT01127633|593254357|FG000|Overall Study|Parent/Caregiver Decision|246|||
164241024|NCT01127633|593254358|FG001|Overall Study|Parent/Caregiver Decision|228|||
164241025|NCT01127633|593254357|FG000|Overall Study|Physician Decision|60|||
164241026|NCT01127633|593254358|FG001|Overall Study|Physician Decision|45|||
164241027|NCT01127633|593254357|FG000|Overall Study|Withdrawal by Subject|57|||
164241028|NCT01127633|593254358|FG001|Overall Study|Withdrawal by Subject|72|||
164241029|NCT01127633|593254357|FG000|Overall Study|Sponsor Decision|163|||
164241030|NCT01127633|593254358|FG001|Overall Study|Sponsor Decision|195|||
164336156|NCT00333840|593607833|FG001|Second-line Treatment Period|No longer required study drug|0|||
164336157|NCT00333840|593607834|FG002|Second-line Treatment Period|No longer required study drug|1|||
164336158|NCT00333840|593607835|FG003|Second-line Treatment Period|No longer required study drug|14|||
164241031|NCT01127633|593254357|FG000|Overall Study|Protocol Violation|8|||
164241032|NCT01127633|593254358|FG001|Overall Study|Protocol Violation|16|||
164241033|NCT01127633|593254357|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
164241034|NCT01127633|593254358|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
164241035|NCT01127633|593254357|FG000|Overall Study|Not treated|1|||
164241036|NCT01127633|593254358|FG001|Overall Study|Not treated|0|||
164241037|NCT01073293|593254360|FG000|Overall Study|Lost to Follow-up|0|||
164241038|NCT01073293|593254361|FG001|Overall Study|Lost to Follow-up|1|||
164241039|NCT01073293|593254360|FG000|Overall Study|Withdrawal by Subject|5|||
164241040|NCT01073293|593254361|FG001|Overall Study|Withdrawal by Subject|10|||
164241041|NCT02168101|593254363|FG000|Overall Study|Death|2|||
164241042|NCT02168101|593254364|FG001|Overall Study|Death|2|||
164241043|NCT02168101|593254365|FG002|Overall Study|Death|1|||
164241044|NCT00400517|593254366|FG000|Overall Study|Withdrawal by Subject|1|||
164241045|NCT00400517|593254366|FG000|Overall Study|Physician Decision|1|||
164241046|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
164241047|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241048|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241049|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241050|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
164241051|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
164241052|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241053|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241054|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241055|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
164241056|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
164241057|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241058|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241059|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241060|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
164241061|NCT01194245|593254367|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
164241062|NCT01194245|593254368|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241063|NCT01194245|593254369|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241064|NCT01194245|593254370|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241065|NCT01194245|593254371|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
164241066|NCT01194245|593254367|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241067|NCT01194245|593254368|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241068|NCT01194245|593254369|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241069|NCT01194245|593254370|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164241070|NCT01194245|593254371|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
164241071|NCT01194245|593254367|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164241072|NCT01194245|593254368|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164241073|NCT01194245|593254369|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
164241074|NCT01194245|593254370|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
164241075|NCT01194245|593254371|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
164241076|NCT05518461|593254372|FG000|Overall Study|Lost to Follow-up|25|||
164336159|NCT00333840|593607832|FG000|Second-line Treatment Period|Protocol Violation|0|||
164241077|NCT02457247|593254373|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
164241078|NCT02457247|593254374|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
164241079|NCT02457247|593254375|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
164241080|NCT02457247|593254376|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
164241081|NCT02457247|593254373|FG000|Period 1|Significant Protocol Deviation|1|||
164241082|NCT02457247|593254374|FG001|Period 1|Significant Protocol Deviation|1|||
164241083|NCT02457247|593254375|FG002|Period 1|Significant Protocol Deviation|0|||
164241084|NCT02457247|593254376|FG003|Period 1|Significant Protocol Deviation|0|||
164241085|NCT02457247|593254373|FG000|Period 1|Voluntary Withdrawal|1|||
164241086|NCT02457247|593254374|FG001|Period 1|Voluntary Withdrawal|0|||
164336160|NCT00333840|593607833|FG001|Second-line Treatment Period|Protocol Violation|0|||
163989377|NCT05574062|592328338|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
163989378|NCT05574062|592328339|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
163989379|NCT05574062|592328335|FG000|Continuation Phase Period 1|Physician Decision|1|||
163989380|NCT05574062|592328336|FG001|Continuation Phase Period 1|Physician Decision|0|||
163989381|NCT05574062|592328337|FG002|Continuation Phase Period 1|Physician Decision|0|||
164241087|NCT02457247|593254375|FG002|Period 1|Voluntary Withdrawal|0|||
164241088|NCT02457247|593254376|FG003|Period 1|Voluntary Withdrawal|0|||
164241089|NCT02457247|593254373|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
164241090|NCT02457247|593254374|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
164241091|NCT02457247|593254375|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
164241092|NCT02457247|593254376|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
164241093|NCT02457247|593254373|FG000|Period 2|Significant Protocol Deviation|1|||
164241094|NCT02457247|593254374|FG001|Period 2|Significant Protocol Deviation|0|||
164241095|NCT02457247|593254375|FG002|Period 2|Significant Protocol Deviation|0|||
164241096|NCT02457247|593254376|FG003|Period 2|Significant Protocol Deviation|0|||
164241097|NCT02457247|593254373|FG000|Period 2|Lost to Follow-up|0|||
164241098|NCT02457247|593254374|FG001|Period 2|Lost to Follow-up|1|||
164241099|NCT02457247|593254375|FG002|Period 2|Lost to Follow-up|0|||
164241100|NCT02457247|593254376|FG003|Period 2|Lost to Follow-up|0|||
164241101|NCT02457247|593254373|FG000|Period 2|Voluntary Withdrawal|1|||
164241102|NCT02457247|593254374|FG001|Period 2|Voluntary Withdrawal|1|||
164241103|NCT02457247|593254375|FG002|Period 2|Voluntary Withdrawal|0|||
164241104|NCT02457247|593254376|FG003|Period 2|Voluntary Withdrawal|0|||
164241105|NCT00739310|593254377|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
164241106|NCT00739310|593254377|FG000|Overall Study|Withdrawal by Subject|1|||
164241107|NCT00739310|593254377|FG000|Overall Study|Lost to Follow-up|2|||
164241108|NCT02954887|593254378|FG000|Overall Study|Withdrawal by Subject|3|||
164241109|NCT02954887|593254378|FG000|Overall Study|Lack of Efficacy|3|||
164241110|NCT02954887|593254378|FG000|Overall Study|Other|1|||
164241111|NCT01882465|593254380|FG000|Period 1|Lens Discomfort|0|||
164241112|NCT01882465|593254381|FG001|Period 1|Lens Discomfort|0|||
164241113|NCT01882465|593254382|FG002|Period 1|Lens Discomfort|0|||
164241114|NCT01882465|593254383|FG003|Period 1|Lens Discomfort|1|||
164241115|NCT01882465|593254384|FG004|Period 1|Lens Discomfort|0|||
164241116|NCT01882465|593254385|FG005|Period 1|Lens Discomfort|0|||
164241117|NCT01882465|593254386|FG006|Period 1|Lens Discomfort|0|||
164241118|NCT01882465|593254380|FG000|Period 1|Withdrawal by Subject|0|||
164241119|NCT01882465|593254381|FG001|Period 1|Withdrawal by Subject|0|||
164241120|NCT01882465|593254382|FG002|Period 1|Withdrawal by Subject|0|||
164241121|NCT01882465|593254383|FG003|Period 1|Withdrawal by Subject|0|||
164241122|NCT01882465|593254384|FG004|Period 1|Withdrawal by Subject|0|||
164241123|NCT01882465|593254385|FG005|Period 1|Withdrawal by Subject|0|||
164241124|NCT01882465|593254386|FG006|Period 1|Withdrawal by Subject|1|||
164241125|NCT01882465|593254380|FG000|Period 2|Protocol Violation|0|||
164241126|NCT01882465|593254381|FG001|Period 2|Protocol Violation|0|||
164241127|NCT01882465|593254382|FG002|Period 2|Protocol Violation|0|||
164241128|NCT01882465|593254383|FG003|Period 2|Protocol Violation|0|||
164241129|NCT01882465|593254384|FG004|Period 2|Protocol Violation|1|||
164241130|NCT01882465|593254385|FG005|Period 2|Protocol Violation|0|||
164241131|NCT01882465|593254386|FG006|Period 2|Protocol Violation|0|||
164241132|NCT01824290|593254389|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
164241133|NCT01824290|593254390|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
164241134|NCT01824290|593254391|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
164241135|NCT01824290|593254392|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
164241136|NCT01824290|593254389|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
164241137|NCT01824290|593254390|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
164241138|NCT01824290|593254391|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
164241139|NCT01824290|593254392|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
164241140|NCT01824290|593254389|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
164241141|NCT01824290|593254390|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
164241142|NCT01824290|593254391|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
164241143|NCT01824290|593254392|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
164241144|NCT01824290|593254389|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
164241145|NCT01824290|593254390|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
164241146|NCT01824290|593254391|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
163989382|NCT05574062|592328338|FG003|Continuation Phase Period 1|Physician Decision|0|||
164241147|NCT01824290|593254392|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
164241148|NCT01824290|593254389|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
164241149|NCT01824290|593254390|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
164241150|NCT01824290|593254391|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
164241151|NCT01824290|593254392|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
164241152|NCT01824290|593254389|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
164241153|NCT01824290|593254390|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
164241154|NCT01824290|593254391|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
164241155|NCT01824290|593254392|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
164241156|NCT00800982|593254393|FG000|Overall Study|Lost to Follow-up|1|||
164241157|NCT00800982|593254394|FG001|Overall Study|Lost to Follow-up|2|||
164241158|NCT00800982|593254393|FG000|Overall Study|Withdrawal by Subject|0|||
164241159|NCT00800982|593254394|FG001|Overall Study|Withdrawal by Subject|1|||
164241160|NCT00800982|593254393|FG000|Overall Study|Patient moved out of state|1|||
164241161|NCT00800982|593254394|FG001|Overall Study|Patient moved out of state|0|||
164241162|NCT01490918|593254395|FG000|Overall Study|Lost to Follow-up|2|||
164241163|NCT01490918|593254396|FG001|Overall Study|Lost to Follow-up|1|||
164241164|NCT01490918|593254397|FG002|Overall Study|Lost to Follow-up|0|||
164241165|NCT01490918|593254395|FG000|Overall Study|Withdrawal by Subject|7|||
164241166|NCT01490918|593254396|FG001|Overall Study|Withdrawal by Subject|8|||
164241167|NCT01490918|593254397|FG002|Overall Study|Withdrawal by Subject|3|||
164241168|NCT01490918|593254395|FG000|Overall Study|Adverse Event|0|||
164241169|NCT01490918|593254396|FG001|Overall Study|Adverse Event|0|||
164241170|NCT01490918|593254397|FG002|Overall Study|Adverse Event|1|||
164241171|NCT01490918|593254395|FG000|Overall Study|other cause|4|||
164241172|NCT01490918|593254396|FG001|Overall Study|other cause|5|||
164241173|NCT01490918|593254397|FG002|Overall Study|other cause|8|||
164241174|NCT00003631|593254411|FG000|Overall Study|Patient not treated|1|||
164241175|NCT00003631|593254412|FG001|Overall Study|Patient not treated|0|||
164241176|NCT00003631|593254413|FG002|Overall Study|Patient not treated|1|||
164241177|NCT00003631|593254411|FG000|Overall Study|Protocol Violation|1|||
164241178|NCT00003631|593254412|FG001|Overall Study|Protocol Violation|0|||
164241179|NCT00003631|593254413|FG002|Overall Study|Protocol Violation|0|||
164241180|NCT00003631|593254411|FG000|Overall Study|Adverse Event|1|||
164241181|NCT00003631|593254412|FG001|Overall Study|Adverse Event|1|||
164241182|NCT00003631|593254413|FG002|Overall Study|Adverse Event|5|||
164241183|NCT00003631|593254411|FG000|Overall Study|Death|0|||
164241184|NCT00003631|593254412|FG001|Overall Study|Death|0|||
164241185|NCT00003631|593254413|FG002|Overall Study|Death|1|||
164241186|NCT00003631|593254411|FG000|Overall Study|Evaluable for toxicity only|0|||
164241187|NCT00003631|593254412|FG001|Overall Study|Evaluable for toxicity only|0|||
164241188|NCT00003631|593254413|FG002|Overall Study|Evaluable for toxicity only|2|||
164241189|NCT00959907|593254414|FG000|Overall Study|Protocol Violation|0|||
164241190|NCT00959907|593254415|FG001|Overall Study|Protocol Violation|1|||
164241191|NCT00959907|593254414|FG000|Overall Study|Adverse Event|1|||
164241192|NCT00959907|593254415|FG001|Overall Study|Adverse Event|0|||
164241193|NCT00959907|593254414|FG000|Overall Study|Withdrawal by Subject|2|||
164241194|NCT00959907|593254415|FG001|Overall Study|Withdrawal by Subject|0|||
164241195|NCT01261975|593254420|FG000|Overall Study|Surgical complication|1|||
164241196|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
164241197|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241198|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241199|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241200|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241201|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
164241202|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
164241203|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
164241204|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
164241205|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
164241206|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
164241207|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
164241208|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
164241209|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241210|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241211|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241212|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164336161|NCT00333840|593607834|FG002|Second-line Treatment Period|Protocol Violation|1|||
164241213|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
164241214|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
164241215|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
164241216|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
164241217|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
164241218|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
164241219|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
164241220|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
164241221|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
163884696|NCT03134196|591947848|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
163884697|NCT03134196|591947847|FG000|Overall Study|Scheduling Conflict|1|||
163884698|NCT03134196|591947848|FG001|Overall Study|Scheduling Conflict|0|||
163884699|NCT04683744|591947860|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
163884700|NCT04683744|591947861|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
163884701|NCT04683744|591947862|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
163884702|NCT01798498|591947863|FG000|Overall Study|Lost to Follow-up|1|||
163884703|NCT04592549|591947868|FG000|Overall Study|Withdrawal by Subject|0|||
163884704|NCT04592549|591947869|FG001|Overall Study|Withdrawal by Subject|1|||
163884705|NCT04592549|591947870|FG002|Overall Study|Withdrawal by Subject|0|||
163884706|NCT04592549|591947871|FG003|Overall Study|Withdrawal by Subject|1|||
163884707|NCT04592549|591947872|FG004|Overall Study|Withdrawal by Subject|1|||
163884708|NCT04592549|591947873|FG005|Overall Study|Withdrawal by Subject|0|||
163884709|NCT04592549|591947868|FG000|Overall Study|Lost to Follow-up|2|||
163884710|NCT04592549|591947869|FG001|Overall Study|Lost to Follow-up|0|||
163884711|NCT04592549|591947870|FG002|Overall Study|Lost to Follow-up|0|||
163884712|NCT04592549|591947871|FG003|Overall Study|Lost to Follow-up|1|||
163884713|NCT04592549|591947872|FG004|Overall Study|Lost to Follow-up|1|||
163884714|NCT04592549|591947873|FG005|Overall Study|Lost to Follow-up|1|||
163884715|NCT02919306|591947877|FG000|Overall Study|Withdrawal by Subject|1|||
163884716|NCT02919306|591947878|FG001|Overall Study|Withdrawal by Subject|0|||
163884717|NCT02919306|591947877|FG000|Overall Study|Protocol Violation|1|||
163884718|NCT02919306|591947878|FG001|Overall Study|Protocol Violation|0|||
163884719|NCT04293055|591947879|FG000|Overall Study|Lost to Follow-up|1|||
163884720|NCT04293055|591947880|FG001|Overall Study|Lost to Follow-up|1|||
163884721|NCT04293055|591947879|FG000|Overall Study|Did not trigger randomization|6|||
163884722|NCT04293055|591947880|FG001|Overall Study|Did not trigger randomization|5|||
163884723|NCT04625283|591947882|FG000|Overall Study|post randomization exclusion|28|||
163884724|NCT04625283|591947883|FG001|Overall Study|post randomization exclusion|20|||
163884725|NCT01824394|591947884|FG000|Overall Study|Early Termination|1|||
163884726|NCT01824394|591947885|FG001|Overall Study|Early Termination|1|||
163884727|NCT01824394|591947886|FG002|Overall Study|Early Termination|3|||
163884728|NCT01824394|591947884|FG000|Overall Study|Withdrawn due to Study Termination|91|||
163884729|NCT01824394|591947885|FG001|Overall Study|Withdrawn due to Study Termination|83|||
163884730|NCT01824394|591947886|FG002|Overall Study|Withdrawn due to Study Termination|41|||
163884731|NCT01824394|591947884|FG000|Overall Study|Lost to Follow-up|0|||
163884732|NCT01824394|591947885|FG001|Overall Study|Lost to Follow-up|9|||
163884733|NCT01824394|591947886|FG002|Overall Study|Lost to Follow-up|3|||
163884734|NCT01824394|591947884|FG000|Overall Study|Death|3|||
163884735|NCT01824394|591947885|FG001|Overall Study|Death|2|||
163884736|NCT01824394|591947886|FG002|Overall Study|Death|4|||
163884737|NCT01824394|591947884|FG000|Overall Study|Discontinued Subjects|1|||
163884738|NCT01824394|591947885|FG001|Overall Study|Discontinued Subjects|1|||
163884739|NCT01824394|591947886|FG002|Overall Study|Discontinued Subjects|2|||
163884740|NCT01824394|591947884|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
163884741|NCT01824394|591947885|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
163884742|NCT01824394|591947886|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
163884743|NCT05364671|591947887|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
163884744|NCT05364671|591947888|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
163884745|NCT05364671|591947887|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
163884746|NCT05364671|591947888|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
163884747|NCT05364671|591947887|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
163884748|NCT05364671|591947888|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
163884749|NCT05364671|591947887|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
163884750|NCT05364671|591947888|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
163884751|NCT05364671|591947887|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
163884752|NCT05364671|591947888|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
163884753|NCT05794243|591947889|FG000|Overall Study|Withdrawal by Subject|1|||
163884754|NCT05794243|591947890|FG001|Overall Study|Withdrawal by Subject|0|||
164083427|NCT03734237|592670186|FG000|Overall Study|Lost to Follow-up|1|||
164241222|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163884755|NCT05794243|591947891|FG002|Overall Study|Withdrawal by Subject|1|||
163884756|NCT05794243|591947889|FG000|Overall Study|Physician Decision|0|||
163884757|NCT05794243|591947890|FG001|Overall Study|Physician Decision|3|||
163884758|NCT05794243|591947891|FG002|Overall Study|Physician Decision|1|||
163884759|NCT05093829|591947897|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163884760|NCT05093829|591947898|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
164083428|NCT03734237|592670187|FG001|Overall Study|Lost to Follow-up|3|||
164083429|NCT03734237|592670188|FG002|Overall Study|Lost to Follow-up|0|||
164241223|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
164241224|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
163884761|NCT05093829|591947899|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
163884762|NCT05093829|591947900|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163884763|NCT05093829|591947901|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
163884764|NCT01785719|591949678|FG000|4-week Baseline Evaluation|Physician Decision|1|||
163884765|NCT01785719|591949679|FG001|4-week Baseline Evaluation|Physician Decision|0|||
163884766|NCT01785719|591949678|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
163884767|NCT01785719|591949679|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
163884768|NCT01785719|591949678|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
163884769|NCT01785719|591949679|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
163884770|NCT01785719|591949678|FG000|4-week Baseline Evaluation|Pregnancy|0|||
163884771|NCT01785719|591949679|FG001|4-week Baseline Evaluation|Pregnancy|2|||
163884772|NCT01785719|591949678|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
163884773|NCT01785719|591949679|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
163884774|NCT01785719|591949678|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
163884775|NCT01785719|591949679|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
163884776|NCT01785719|591949678|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
163884777|NCT01785719|591949679|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
163884778|NCT01785719|591949678|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
163884779|NCT01785719|591949679|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
163884780|NCT01785719|591949678|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
163884781|NCT01785719|591949679|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
163884782|NCT01785719|591949678|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
163884783|NCT01785719|591949679|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
163884784|NCT01785719|591949678|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
163884785|NCT01785719|591949679|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
163884786|NCT01785719|591949678|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
163884787|NCT01785719|591949679|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
164241225|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
164241226|NCT00716274|593254422|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241227|NCT00716274|593254423|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
164241228|NCT00716274|593254424|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241229|NCT00716274|593254425|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241230|NCT00716274|593254426|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241231|NCT00716274|593254427|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
164241232|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241233|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241234|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
164241235|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241236|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241237|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
164241238|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
164241239|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
164241240|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
164241241|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
164241242|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
164241243|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
164241244|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164241245|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164241246|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
163884788|NCT01785719|591949678|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
163884789|NCT01785719|591949679|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
163884790|NCT01785719|591949678|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
163989383|NCT05574062|592328339|FG004|Continuation Phase Period 1|Physician Decision|0|||
164241247|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
163884791|NCT01785719|591949679|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
163884792|NCT01785719|591949678|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
164241248|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
164241249|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
164241250|NCT00716274|593254422|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
164241251|NCT00716274|593254423|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
164241252|NCT00716274|593254424|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
164241253|NCT00716274|593254425|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
164241254|NCT00716274|593254426|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
164241255|NCT00716274|593254427|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
164241256|NCT01932788|593254428|FG000|Overall Study|Protocol Violation|18|||
164241257|NCT01932788|593254429|FG001|Overall Study|Protocol Violation|0|||
164241258|NCT01932788|593254428|FG000|Overall Study|Lost to Follow-up|18|||
164241259|NCT01932788|593254429|FG001|Overall Study|Lost to Follow-up|46|||
164336162|NCT00333840|593607835|FG003|Second-line Treatment Period|Protocol Violation|10|||
164336163|NCT00333840|593607832|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
164336164|NCT00333840|593607833|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
164336165|NCT00333840|593607834|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
164336166|NCT00333840|593607835|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
164336167|NCT00333840|593607832|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
164336168|NCT00333840|593607833|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
164336169|NCT00333840|593607834|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
164336170|NCT00333840|593607835|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
164336171|NCT00333840|593607832|FG000|Second-line Treatment Period|Administrative problems|0|||
164336172|NCT00333840|593607833|FG001|Second-line Treatment Period|Administrative problems|0|||
164336173|NCT00333840|593607834|FG002|Second-line Treatment Period|Administrative problems|0|||
164336174|NCT00333840|593607835|FG003|Second-line Treatment Period|Administrative problems|7|||
164336175|NCT00333840|593607832|FG000|Second-line Treatment Period|Death|0|||
164336176|NCT00333840|593607833|FG001|Second-line Treatment Period|Death|0|||
164336177|NCT00333840|593607834|FG002|Second-line Treatment Period|Death|0|||
164336178|NCT00333840|593607835|FG003|Second-line Treatment Period|Death|9|||
164336179|NCT02357979|593607836|FG000|Overall Study|Lost to Follow-up|5|||
164336180|NCT02357979|593607837|FG001|Overall Study|Lost to Follow-up|5|||
164336181|NCT01453725|593607838|FG000|Overall Study|Adverse Event|3|||
164336182|NCT01453725|593607839|FG001|Overall Study|Adverse Event|3|||
164336183|NCT01453725|593607838|FG000|Overall Study|Lost to Follow-up|4|||
164336184|NCT01453725|593607839|FG001|Overall Study|Lost to Follow-up|0|||
164336185|NCT01453725|593607838|FG000|Overall Study|Non-compliance With Protocol|1|||
164336186|NCT01453725|593607839|FG001|Overall Study|Non-compliance With Protocol|2|||
164336187|NCT01453725|593607838|FG000|Overall Study|Protocol Violation|1|||
164336188|NCT01453725|593607839|FG001|Overall Study|Protocol Violation|0|||
164336189|NCT01453725|593607838|FG000|Overall Study|Withdrawal by Subject|2|||
164336190|NCT01453725|593607839|FG001|Overall Study|Withdrawal by Subject|3|||
164336191|NCT01453725|593607838|FG000|Overall Study|Pregnancy Wish|0|||
164336192|NCT01453725|593607839|FG001|Overall Study|Pregnancy Wish|2|||
164336193|NCT01453725|593607838|FG000|Overall Study|Pregnancy|1|||
164336194|NCT01453725|593607839|FG001|Overall Study|Pregnancy|0|||
164336195|NCT01453725|593607838|FG000|Overall Study|Physician Decision|1|||
164336196|NCT01453725|593607839|FG001|Overall Study|Physician Decision|1|||
164336197|NCT03449901|593607850|FG000|Overall Study|Progression|57|||
164336198|NCT03449901|593607851|FG001|Overall Study|Progression|12|||
164336199|NCT03449901|593607850|FG000|Overall Study|Adverse Event|3|||
164336200|NCT03449901|593607851|FG001|Overall Study|Adverse Event|0|||
164336201|NCT03449901|593607850|FG000|Overall Study|Death|6|||
164336202|NCT03449901|593607851|FG001|Overall Study|Death|2|||
164336203|NCT03449901|593607850|FG000|Overall Study|Withdrawal by Subject|12|||
164336204|NCT03449901|593607851|FG001|Overall Study|Withdrawal by Subject|1|||
164336205|NCT03449901|593607850|FG000|Overall Study|Physician Decision|1|||
163884793|NCT01785719|591949679|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
163884794|NCT04029688|591949687|FG000|Overall Study|Death|8|||
163884795|NCT04029688|591949688|FG001|Overall Study|Death|3|||
163884796|NCT04029688|591949689|FG002|Overall Study|Death|6|||
164241260|NCT01932788|593254428|FG000|Overall Study|Lack of Efficacy|2|||
164241261|NCT01932788|593254429|FG001|Overall Study|Lack of Efficacy|0|||
164336206|NCT03449901|593607851|FG001|Overall Study|Physician Decision|0|||
164336207|NCT03449901|593607850|FG000|Overall Study|Patient elected for surgical intervention|1|||
164336208|NCT03449901|593607851|FG001|Overall Study|Patient elected for surgical intervention|0|||
164336209|NCT03449901|593607850|FG000|Overall Study|Patient off for other complicating disease|1|||
164336210|NCT03449901|593607851|FG001|Overall Study|Patient off for other complicating disease|0|||
164336211|NCT03755791|593607854|FG000|Overall Study|Did not receive any study treatment|3|||
164336212|NCT03755791|593607855|FG001|Overall Study|Did not receive any study treatment|0|||
164336213|NCT03755791|593607856|FG002|Overall Study|Did not receive any study treatment|10|||
164336214|NCT03755791|593607854|FG000|Overall Study|Radiographic progression|204|||
164336215|NCT03755791|593607855|FG001|Overall Study|Radiographic progression|92|||
164241262|NCT01932788|593254428|FG000|Overall Study|Withdrawal by Subject|0|||
164241263|NCT01932788|593254429|FG001|Overall Study|Withdrawal by Subject|5|||
164241264|NCT04290624|593254430|FG000|Overall Study|Adverse Event|1|||
164241265|NCT04290624|593254431|FG001|Overall Study|Adverse Event|0|||
164241266|NCT01171677|593254432|FG000|Overall Study|Withdrawal by Subject|0|||
164241267|NCT01171677|593254433|FG001|Overall Study|Withdrawal by Subject|3|||
164241268|NCT01171677|593254432|FG000|Overall Study|Adverse Event|1|||
164241269|NCT01171677|593254433|FG001|Overall Study|Adverse Event|0|||
164241270|NCT01171677|593254432|FG000|Overall Study|completed <70% IntenSati classes|5|||
164241271|NCT01171677|593254433|FG001|Overall Study|completed <70% IntenSati classes|0|||
164241272|NCT00656370|593254436|FG000|Overall Study|Screen Failures|7|||
164241273|NCT00656370|593254436|FG000|Overall Study|Alternates|3|||
164241274|NCT01342094|593254437|FG000|Overall Study|Adverse Event|5|||
164241275|NCT01342094|593254438|FG001|Overall Study|Adverse Event|0|||
164241276|NCT01342094|593254437|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164241277|NCT01342094|593254438|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164241278|NCT01342094|593254437|FG000|Overall Study|Withdrawal by Subject|0|||
164241279|NCT01342094|593254438|FG001|Overall Study|Withdrawal by Subject|2|||
164241280|NCT02806414|593254443|FG000|Overall Study|Lost to Follow-up|2|||
164241281|NCT05653700|593254459|FG000|Overall Study|Non Responders|9|||
164241282|NCT05653700|593254460|FG001|Overall Study|Non Responders|0|||
164083430|NCT03734237|592670186|FG000|Overall Study|Withdrawal by Subject|7|||
164241283|NCT00543985|593254465|FG000|Overall Study|Withdrawal by Subject|4|||
164241284|NCT01634152|593254466|FG000|Overall Study|Adverse Event|2|||
164241285|NCT01634152|593254467|FG001|Overall Study|Adverse Event|0|||
164241286|NCT01634152|593254468|FG002|Overall Study|Adverse Event|2|||
164241287|NCT01634152|593254466|FG000|Overall Study|Consent withdrawn not due to AE|1|||
164241288|NCT01634152|593254467|FG001|Overall Study|Consent withdrawn not due to AE|0|||
164241289|NCT01634152|593254468|FG002|Overall Study|Consent withdrawn not due to AE|1|||
164241290|NCT01634152|593254466|FG000|Overall Study|Not treated|0|||
164241291|NCT01634152|593254467|FG001|Overall Study|Not treated|1|||
164241292|NCT01634152|593254468|FG002|Overall Study|Not treated|0|||
164241293|NCT01634152|593254466|FG000|Overall Study|Other reason not defined above|1|||
164241294|NCT01634152|593254467|FG001|Overall Study|Other reason not defined above|0|||
164241295|NCT01634152|593254468|FG002|Overall Study|Other reason not defined above|1|||
164241296|NCT01900665|593254475|FG000|Placebo Controlled Period|Death|9|||
164241297|NCT01900665|593254476|FG001|Placebo Controlled Period|Death|16|||
164241298|NCT01900665|593254475|FG000|Placebo Controlled Period|Adverse Event|48|||
164241299|NCT01900665|593254476|FG001|Placebo Controlled Period|Adverse Event|39|||
164241300|NCT01900665|593254475|FG000|Placebo Controlled Period|Protocol Violation|1|||
164241301|NCT01900665|593254476|FG001|Placebo Controlled Period|Protocol Violation|7|||
164241302|NCT01900665|593254475|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
164241303|NCT01900665|593254476|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
164241304|NCT01900665|593254475|FG000|Placebo Controlled Period|Physician Decision|11|||
164241305|NCT01900665|593254476|FG001|Placebo Controlled Period|Physician Decision|7|||
164241306|NCT01900665|593254475|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
164241307|NCT01900665|593254476|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
164241308|NCT01900665|593254475|FG000|Placebo Controlled Period|Caregiver Decision|33|||
164241309|NCT01900665|593254476|FG001|Placebo Controlled Period|Caregiver Decision|41|||
164241310|NCT01900665|593254475|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
164241311|NCT01900665|593254476|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
164241312|NCT01900665|593254475|FG000|Open Label Period|Adverse Event|16|||
164241313|NCT01900665|593254476|FG001|Open Label Period|Adverse Event|20|||
164241314|NCT01900665|593254475|FG000|Open Label Period|Death|5|||
164241315|NCT01900665|593254476|FG001|Open Label Period|Death|6|||
164241316|NCT01900665|593254475|FG000|Open Label Period|Lost to Follow-up|1|||
164336216|NCT03755791|593607856|FG002|Overall Study|Radiographic progression|115|||
164336217|NCT03755791|593607854|FG000|Overall Study|Adverse Event|140|||
164336218|NCT03755791|593607855|FG001|Overall Study|Adverse Event|60|||
164336219|NCT03755791|593607856|FG002|Overall Study|Adverse Event|51|||
164336220|NCT03755791|593607854|FG000|Overall Study|Lack of Efficacy|12|||
164336221|NCT03755791|593607855|FG001|Overall Study|Lack of Efficacy|6|||
164336222|NCT03755791|593607856|FG002|Overall Study|Lack of Efficacy|6|||
164241317|NCT01900665|593254476|FG001|Open Label Period|Lost to Follow-up|1|||
164241318|NCT01900665|593254475|FG000|Open Label Period|Parent/Caregiver Decision|33|||
164241319|NCT01900665|593254476|FG001|Open Label Period|Parent/Caregiver Decision|34|||
164241320|NCT01900665|593254475|FG000|Open Label Period|Physician Decision|4|||
164241321|NCT01900665|593254476|FG001|Open Label Period|Physician Decision|4|||
164241322|NCT01900665|593254475|FG000|Open Label Period|Protocol Violation|0|||
164241323|NCT01900665|593254476|FG001|Open Label Period|Protocol Violation|1|||
164241324|NCT01900665|593254475|FG000|Open Label Period|Sponsor Decision|802|||
164241325|NCT01900665|593254476|FG001|Open Label Period|Sponsor Decision|765|||
164241326|NCT01900665|593254475|FG000|Open Label Period|Withdrawal by Subject|20|||
164241327|NCT01900665|593254476|FG001|Open Label Period|Withdrawal by Subject|28|||
164336223|NCT03755791|593607854|FG000|Overall Study|Withdrawal by Subject|26|||
164336224|NCT03755791|593607855|FG001|Overall Study|Withdrawal by Subject|23|||
164336225|NCT03755791|593607856|FG002|Overall Study|Withdrawal by Subject|24|||
164241328|NCT02317627|593254478|FG000|Overall Study|Withdrawal by Subject|0|||
164241329|NCT02317627|593254479|FG001|Overall Study|Withdrawal by Subject|1|||
164241330|NCT02317627|593254480|FG002|Overall Study|Withdrawal by Subject|1|||
164241331|NCT02317627|593254478|FG000|Overall Study|Lost to Follow-up|2|||
164241332|NCT02317627|593254479|FG001|Overall Study|Lost to Follow-up|0|||
164241333|NCT02317627|593254480|FG002|Overall Study|Lost to Follow-up|0|||
164241334|NCT02317627|593254478|FG000|Overall Study|Stopped by Investigator|0|||
164241335|NCT02317627|593254479|FG001|Overall Study|Stopped by Investigator|1|||
164241336|NCT02317627|593254480|FG002|Overall Study|Stopped by Investigator|0|||
164241337|NCT02317627|593254478|FG000|Overall Study|Adverse Event|0|||
164241338|NCT02317627|593254479|FG001|Overall Study|Adverse Event|2|||
164241339|NCT02317627|593254480|FG002|Overall Study|Adverse Event|3|||
164241340|NCT02317627|593254478|FG000|Overall Study|Non-compliance with study drug|0|||
164241341|NCT02317627|593254479|FG001|Overall Study|Non-compliance with study drug|1|||
164241342|NCT02317627|593254480|FG002|Overall Study|Non-compliance with study drug|0|||
164241343|NCT04749914|593254481|FG000|Period 1|Adverse Event|1|||
164241344|NCT04749914|593254482|FG001|Period 1|Adverse Event|0|||
164241345|NCT04749914|593254483|FG002|Period 1|Adverse Event|0|||
164241346|NCT04749914|593254484|FG003|Period 1|Adverse Event|0|||
164241347|NCT04749914|593254481|FG000|Period 1|Withdrawal by Subject|1|||
164241348|NCT04749914|593254482|FG001|Period 1|Withdrawal by Subject|0|||
164241349|NCT04749914|593254483|FG002|Period 1|Withdrawal by Subject|1|||
164241350|NCT04749914|593254484|FG003|Period 1|Withdrawal by Subject|0|||
164241351|NCT00279214|593254485|FG000|Overall Study|Physician Decision|3|||
164241352|NCT00279214|593254486|FG001|Overall Study|Physician Decision|2|||
164241353|NCT00403130|593254487|FG000|2 Years From Start of Treatment|Not Eligible|3|||
164241354|NCT00403130|593254487|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
164241355|NCT00403130|593254487|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
164241356|NCT00403130|593254487|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
164241357|NCT01280968|593254488|FG000|Overall Study|Lost to Follow-up|8|||
164241358|NCT01280968|593254489|FG001|Overall Study|Lost to Follow-up|2|||
164241359|NCT01280968|593254488|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
164241360|NCT01280968|593254489|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
164241361|NCT01280968|593254488|FG000|Overall Study|Commuting Problems|2|||
164241362|NCT01280968|593254489|FG001|Overall Study|Commuting Problems|0|||
164241363|NCT01280968|593254488|FG000|Overall Study|Anxiety|2|||
164241364|NCT01280968|593254489|FG001|Overall Study|Anxiety|0|||
164241365|NCT01280968|593254488|FG000|Overall Study|Adverse Event|1|||
164241366|NCT01280968|593254489|FG001|Overall Study|Adverse Event|0|||
164241367|NCT01280968|593254488|FG000|Overall Study|Scheduling Conflicts|1|||
164241368|NCT01280968|593254489|FG001|Overall Study|Scheduling Conflicts|1|||
164241369|NCT01280968|593254488|FG000|Overall Study|Pre-existing Neurological Condition|1|||
164241370|NCT01280968|593254489|FG001|Overall Study|Pre-existing Neurological Condition|0|||
164241371|NCT01280968|593254488|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
164241372|NCT01280968|593254489|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
164241373|NCT00806260|593254490|FG000|Period 1 (1 Day)|Adverse Event|0|||
164336226|NCT03755791|593607854|FG000|Overall Study|Sponsor decision,|41|||
164336227|NCT03755791|593607855|FG001|Overall Study|Sponsor decision,|5|||
164336228|NCT03755791|593607856|FG002|Overall Study|Sponsor decision,|7|||
164336229|NCT03755791|593607854|FG000|Overall Study|Lost to Follow-up|1|||
164336230|NCT03755791|593607855|FG001|Overall Study|Lost to Follow-up|0|||
164336231|NCT03755791|593607856|FG002|Overall Study|Lost to Follow-up|2|||
164336232|NCT03755791|593607854|FG000|Overall Study|Protocol Violation|0|||
164336233|NCT03755791|593607855|FG001|Overall Study|Protocol Violation|0|||
164336234|NCT03755791|593607856|FG002|Overall Study|Protocol Violation|2|||
164336235|NCT03755791|593607854|FG000|Overall Study|Other than specified|5|||
164336236|NCT03755791|593607855|FG001|Overall Study|Other than specified|2|||
164336237|NCT03755791|593607856|FG002|Overall Study|Other than specified|0|||
164336238|NCT03605212|593607862|FG000|Treatment Period|Adverse Event|1|||
164336239|NCT03605212|593607863|FG001|Treatment Period|Adverse Event|0|||
164336240|NCT03605212|593607864|FG002|Treatment Period|Adverse Event|0|||
164336241|NCT03605212|593607865|FG003|Treatment Period|Adverse Event|0|||
164336242|NCT03605212|593607866|FG004|Treatment Period|Adverse Event|0|||
164336243|NCT03605212|593607862|FG000|Treatment Period|Physician Decision|0|||
164241374|NCT00806260|593254491|FG001|Period 1 (1 Day)|Adverse Event|0|||
164241375|NCT00806260|593254492|FG002|Period 1 (1 Day)|Adverse Event|0|||
164241376|NCT00806260|593254493|FG003|Period 1 (1 Day)|Adverse Event|0|||
164241377|NCT00806260|593254494|FG004|Period 1 (1 Day)|Adverse Event|3|||
164241378|NCT00806260|593254495|FG005|Period 1 (1 Day)|Adverse Event|0|||
164336244|NCT03605212|593607863|FG001|Treatment Period|Physician Decision|0|||
164336245|NCT03605212|593607864|FG002|Treatment Period|Physician Decision|0|||
164241379|NCT00806260|593254490|FG000|Period 2|Adverse Event|0|||
164241380|NCT00806260|593254491|FG001|Period 2|Adverse Event|0|||
164241381|NCT00806260|593254492|FG002|Period 2|Adverse Event|0|||
164241382|NCT00806260|593254493|FG003|Period 2|Adverse Event|1|||
164336246|NCT03605212|593607865|FG003|Treatment Period|Physician Decision|0|||
163884797|NCT04029688|591949690|FG003|Overall Study|Death|2|||
163884798|NCT04029688|591949691|FG004|Overall Study|Death|5|||
164241383|NCT00806260|593254494|FG004|Period 2|Adverse Event|0|||
164241384|NCT00806260|593254495|FG005|Period 2|Adverse Event|0|||
164241385|NCT00806260|593254490|FG000|Period 2|Protocol Violation|1|||
164241386|NCT00806260|593254491|FG001|Period 2|Protocol Violation|0|||
164241387|NCT00806260|593254492|FG002|Period 2|Protocol Violation|1|||
164241388|NCT00806260|593254493|FG003|Period 2|Protocol Violation|0|||
164241389|NCT00806260|593254494|FG004|Period 2|Protocol Violation|0|||
164241390|NCT00806260|593254495|FG005|Period 2|Protocol Violation|0|||
164241391|NCT00806260|593254490|FG000|Period 2|Need to take concomitant medication|1|||
163989384|NCT05574062|592328335|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
163989385|NCT05574062|592328336|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
163989386|NCT05574062|592328337|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
164241392|NCT00806260|593254491|FG001|Period 2|Need to take concomitant medication|0|||
164241393|NCT00806260|593254492|FG002|Period 2|Need to take concomitant medication|0|||
164241394|NCT00806260|593254493|FG003|Period 2|Need to take concomitant medication|0|||
164241395|NCT00806260|593254494|FG004|Period 2|Need to take concomitant medication|0|||
164241396|NCT00806260|593254495|FG005|Period 2|Need to take concomitant medication|0|||
164241397|NCT00806260|593254490|FG000|Period 2|sponsor request|0|||
164336247|NCT03605212|593607866|FG004|Treatment Period|Physician Decision|1|||
164336248|NCT01254292|593607867|FG000|Comparative Phase|Adverse Event|25|||
164241398|NCT00806260|593254491|FG001|Period 2|sponsor request|0|||
164336249|NCT01254292|593607868|FG001|Comparative Phase|Adverse Event|25|||
164336250|NCT01254292|593607867|FG000|Comparative Phase|Lost to Follow-up|3|||
164336251|NCT01254292|593607868|FG001|Comparative Phase|Lost to Follow-up|21|||
164336252|NCT01254292|593607867|FG000|Comparative Phase|Pregnancy|2|||
164336253|NCT01254292|593607868|FG001|Comparative Phase|Pregnancy|6|||
164336254|NCT01254292|593607867|FG000|Comparative Phase|Withdrawal by Subject|20|||
164336255|NCT01254292|593607868|FG001|Comparative Phase|Withdrawal by Subject|21|||
164336256|NCT01254292|593607867|FG000|Comparative Phase|Protocol Violation|1|||
164336257|NCT01254292|593607868|FG001|Comparative Phase|Protocol Violation|2|||
164336258|NCT01254292|593607867|FG000|Comparative Phase|Wish for pregnancy|4|||
164336259|NCT01254292|593607868|FG001|Comparative Phase|Wish for pregnancy|6|||
164336260|NCT01254292|593607867|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
164336261|NCT01254292|593607868|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
164336262|NCT01254292|593607867|FG000|LCS12 Extension Phase|Adverse Event|9|||
164336263|NCT01254292|593607868|FG001|LCS12 Extension Phase|Adverse Event|0|||
164336264|NCT01254292|593607867|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
164336265|NCT01254292|593607868|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
164336266|NCT01254292|593607867|FG000|LCS12 Extension Phase|Other unknown|4|||
164336267|NCT01254292|593607868|FG001|LCS12 Extension Phase|Other unknown|0|||
164336268|NCT01254292|593607867|FG000|LCS12 Extension Phase|Pregnancy|2|||
164336269|NCT01254292|593607868|FG001|LCS12 Extension Phase|Pregnancy|0|||
164336270|NCT01254292|593607867|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
164336271|NCT01254292|593607868|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
164336272|NCT02083081|593607869|FG000|Overall Study|Lost to Follow-up|31|||
164336273|NCT02083081|593607870|FG001|Overall Study|Lost to Follow-up|9|||
164336274|NCT00285818|593607871|FG000|Overall Study|Withdrawal by Subject|3|||
164336275|NCT00285818|593607872|FG001|Overall Study|Withdrawal by Subject|2|||
164336276|NCT00285818|593607871|FG000|Overall Study|Lost to Follow-up|1|||
164336277|NCT00285818|593607872|FG001|Overall Study|Lost to Follow-up|0|||
164336278|NCT01268150|593607880|FG000|Treatment Phase|Progression of disease|18|||
164336279|NCT01268150|593607880|FG000|Treatment Phase|Adverse Event|3|||
164336280|NCT01268150|593607880|FG000|Treatment Phase|Withdrawal by Subject|3|||
164336281|NCT01268150|593607880|FG000|Treatment Phase|Other|4|||
164336282|NCT01268150|593607880|FG000|Extension Phase|Adverse Event|3|||
164336283|NCT01268150|593607880|FG000|Extension Phase|Disease progression|18|||
164336284|NCT01268150|593607880|FG000|Extension Phase|Other|6|||
164336285|NCT04209348|593607881|FG000|Overall Study|Lost to Follow-up|1|||
164336286|NCT04209348|593607882|FG001|Overall Study|Lost to Follow-up|0|||
164241399|NCT00806260|593254492|FG002|Period 2|sponsor request|1|||
164241400|NCT00806260|593254493|FG003|Period 2|sponsor request|1|||
164336287|NCT02507973|593607884|FG000|Overall Study|Adverse Event|1|||
164336288|NCT01033851|593607887|FG000|Overall Study|Withdrawal by Subject|3|||
164336289|NCT01033851|593607888|FG001|Overall Study|Withdrawal by Subject|7|||
164336290|NCT04068610|593607889|FG000|Overall Study|Death|4|||
164336291|NCT04068610|593607890|FG001|Overall Study|Death|8|||
164336292|NCT04068610|593607891|FG002|Overall Study|Death|13|||
164336293|NCT04068610|593607889|FG000|Overall Study|Lost to Follow-up|0|||
164336294|NCT04068610|593607890|FG001|Overall Study|Lost to Follow-up|2|||
164336295|NCT04068610|593607891|FG002|Overall Study|Lost to Follow-up|0|||
164336296|NCT04068610|593607889|FG000|Overall Study|Withdrawal by Subject|0|||
164336297|NCT04068610|593607890|FG001|Overall Study|Withdrawal by Subject|4|||
164336298|NCT04068610|593607891|FG002|Overall Study|Withdrawal by Subject|2|||
163989387|NCT05574062|592328338|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
164241401|NCT00806260|593254494|FG004|Period 2|sponsor request|0|||
164241402|NCT00806260|593254495|FG005|Period 2|sponsor request|0|||
164241403|NCT00806260|593254490|FG000|Period 3|Protocol Violation|0|||
164241404|NCT00806260|593254491|FG001|Period 3|Protocol Violation|1|||
164241405|NCT00806260|593254492|FG002|Period 3|Protocol Violation|1|||
164241406|NCT00806260|593254493|FG003|Period 3|Protocol Violation|0|||
164241407|NCT00806260|593254494|FG004|Period 3|Protocol Violation|0|||
164241408|NCT00806260|593254495|FG005|Period 3|Protocol Violation|0|||
164241409|NCT00806260|593254490|FG000|Period 3|Pregnancy|1|||
164241410|NCT00806260|593254491|FG001|Period 3|Pregnancy|0|||
164241411|NCT00806260|593254492|FG002|Period 3|Pregnancy|0|||
164241412|NCT00806260|593254493|FG003|Period 3|Pregnancy|0|||
164241413|NCT00806260|593254494|FG004|Period 3|Pregnancy|0|||
164241414|NCT00806260|593254495|FG005|Period 3|Pregnancy|0|||
164241415|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
164241416|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
164241417|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
164241418|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
164241419|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
164241420|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
164241421|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
164241422|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
164241423|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
164241424|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
164241425|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
164241426|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
164241427|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
164241428|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
164241429|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
164241430|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
164241431|NCT00953706|593254499|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
164241432|NCT00953706|593254500|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
164241433|NCT00953706|593254501|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
164241434|NCT00953706|593254502|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
164241435|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
164241436|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
164241437|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
164241438|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
164241439|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
164241440|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
164241441|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
164241442|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
164241443|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
164241444|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
164241445|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
164241446|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
164241447|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
164241448|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
164241449|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
164241450|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
164241451|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
164241452|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
164241453|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
164241454|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
164241455|NCT00953706|593254499|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
164241456|NCT00953706|593254500|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
164241457|NCT00953706|593254501|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
164241458|NCT00953706|593254502|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
164241459|NCT02670473|593254503|FG000|Overall Study|Withdrawal by Subject|1|||
164241460|NCT01404234|593254504|FG000|Overall Study|Withdrawal by Subject|2|||
164241461|NCT01214837|593254505|FG000|Overall Study|Death|0|||
164241462|NCT01214837|593254506|FG001|Overall Study|Death|0|||
164241463|NCT01214837|593254507|FG002|Overall Study|Death|1|||
164241464|NCT01214837|593254505|FG000|Overall Study|Adverse Event|1|||
164241465|NCT01214837|593254506|FG001|Overall Study|Adverse Event|2|||
164241466|NCT01214837|593254507|FG002|Overall Study|Adverse Event|1|||
164241467|NCT01214837|593254505|FG000|Overall Study|Withdrawal by Subject|27|||
164241468|NCT01214837|593254506|FG001|Overall Study|Withdrawal by Subject|36|||
164241469|NCT01214837|593254507|FG002|Overall Study|Withdrawal by Subject|28|||
164336299|NCT04068610|593607889|FG000|Overall Study|Other|3|||
164336300|NCT04068610|593607890|FG001|Overall Study|Other|12|||
164241470|NCT01214837|593254505|FG000|Overall Study|Lost to Follow-up|20|||
164241471|NCT01214837|593254506|FG001|Overall Study|Lost to Follow-up|15|||
164241472|NCT01214837|593254507|FG002|Overall Study|Lost to Follow-up|21|||
164241473|NCT01214837|593254505|FG000|Overall Study|Inappropriate Enrolment|0|||
164241474|NCT01214837|593254506|FG001|Overall Study|Inappropriate Enrolment|1|||
164241475|NCT01214837|593254507|FG002|Overall Study|Inappropriate Enrolment|2|||
164241476|NCT01214837|593254505|FG000|Overall Study|Administrative Reason|2|||
164241477|NCT01214837|593254506|FG001|Overall Study|Administrative Reason|6|||
164241478|NCT01214837|593254507|FG002|Overall Study|Administrative Reason|4|||
164241479|NCT01214837|593254505|FG000|Overall Study|Protocol Violation|3|||
164241480|NCT01214837|593254506|FG001|Overall Study|Protocol Violation|1|||
164241481|NCT01214837|593254507|FG002|Overall Study|Protocol Violation|5|||
164241482|NCT01214837|593254505|FG000|Overall Study|Unable to Classify|1|||
164241483|NCT01214837|593254506|FG001|Overall Study|Unable to Classify|3|||
164241484|NCT01214837|593254507|FG002|Overall Study|Unable to Classify|0|||
164241485|NCT05414175|593254508|FG000|Overall Study|Withdrawal by Subject|1|||
164241486|NCT05414175|593254508|FG000|Overall Study|Other Reasons|1|||
164241487|NCT00027560|593254511|FG000|Overall Study|Withdrawal by Subject|1|||
164241488|NCT03559270|593254515|FG000|Overall Study|Adverse Event|6|||
164241489|NCT03559270|593254516|FG001|Overall Study|Adverse Event|5|||
164241490|NCT03559270|593254517|FG002|Overall Study|Adverse Event|3|||
164241491|NCT03559270|593254518|FG003|Overall Study|Adverse Event|0|||
164241492|NCT03559270|593254515|FG000|Overall Study|Lack of Efficacy|34|||
164241493|NCT03559270|593254516|FG001|Overall Study|Lack of Efficacy|52|||
164241494|NCT03559270|593254517|FG002|Overall Study|Lack of Efficacy|37|||
164241495|NCT03559270|593254518|FG003|Overall Study|Lack of Efficacy|2|||
164241496|NCT03559270|593254515|FG000|Overall Study|Death|0|||
164241497|NCT03559270|593254516|FG001|Overall Study|Death|2|||
164241498|NCT03559270|593254517|FG002|Overall Study|Death|0|||
164241499|NCT03559270|593254518|FG003|Overall Study|Death|0|||
164241500|NCT03559270|593254515|FG000|Overall Study|Lost to Follow-up|16|||
164241501|NCT03559270|593254516|FG001|Overall Study|Lost to Follow-up|4|||
164241502|NCT03559270|593254517|FG002|Overall Study|Lost to Follow-up|12|||
164241503|NCT03559270|593254518|FG003|Overall Study|Lost to Follow-up|3|||
164241504|NCT03559270|593254515|FG000|Overall Study|Sponsor Decision|38|||
164241505|NCT03559270|593254516|FG001|Overall Study|Sponsor Decision|31|||
164241506|NCT03559270|593254517|FG002|Overall Study|Sponsor Decision|35|||
164241507|NCT03559270|593254518|FG003|Overall Study|Sponsor Decision|18|||
164241508|NCT03559270|593254515|FG000|Overall Study|Withdrawal by Subject|19|||
164241509|NCT03559270|593254516|FG001|Overall Study|Withdrawal by Subject|21|||
164241510|NCT03559270|593254517|FG002|Overall Study|Withdrawal by Subject|18|||
164241511|NCT03559270|593254518|FG003|Overall Study|Withdrawal by Subject|7|||
164241512|NCT03559270|593254515|FG000|Overall Study|Physician Decision|3|||
164241513|NCT03559270|593254516|FG001|Overall Study|Physician Decision|2|||
164241514|NCT03559270|593254517|FG002|Overall Study|Physician Decision|1|||
164241515|NCT03559270|593254518|FG003|Overall Study|Physician Decision|0|||
164241516|NCT03559270|593254515|FG000|Overall Study|Pregnancy|0|||
164241517|NCT03559270|593254516|FG001|Overall Study|Pregnancy|1|||
164241518|NCT03559270|593254517|FG002|Overall Study|Pregnancy|0|||
164241519|NCT03559270|593254518|FG003|Overall Study|Pregnancy|0|||
164241520|NCT03559270|593254515|FG000|Overall Study|Protocol Violation|1|||
164241521|NCT03559270|593254516|FG001|Overall Study|Protocol Violation|0|||
164241522|NCT03559270|593254517|FG002|Overall Study|Protocol Violation|2|||
163884799|NCT04029688|591949692|FG005|Overall Study|Death|0|||
164241523|NCT03559270|593254518|FG003|Overall Study|Protocol Violation|0|||
164241524|NCT04776161|593255951|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
164241525|NCT04776161|593255952|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
164241526|NCT04776161|593255953|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
164241527|NCT04776161|593255951|FG000|Overall Study|Withdrawal by Subject|1|||
164241528|NCT04776161|593255952|FG001|Overall Study|Withdrawal by Subject|0|||
164241529|NCT04776161|593255953|FG002|Overall Study|Withdrawal by Subject|1|||
164241530|NCT04776161|593255951|FG000|Overall Study|Adverse Event|0|||
164241531|NCT04776161|593255952|FG001|Overall Study|Adverse Event|1|||
164241532|NCT04776161|593255953|FG002|Overall Study|Adverse Event|1|||
164241533|NCT00342628|593255954|FG000|Overall Study|Withdrawal by Subject|19|||
164241534|NCT00342628|593255955|FG001|Overall Study|Withdrawal by Subject|19|||
164241535|NCT00342628|593255956|FG002|Overall Study|Withdrawal by Subject|18|||
164241536|NCT00342628|593255954|FG000|Overall Study|Death|1|||
164241537|NCT00342628|593255955|FG001|Overall Study|Death|1|||
164241538|NCT00342628|593255956|FG002|Overall Study|Death|0|||
164241539|NCT00342628|593255954|FG000|Overall Study|moved residence|0|||
164241540|NCT00342628|593255955|FG001|Overall Study|moved residence|1|||
164241541|NCT00342628|593255956|FG002|Overall Study|moved residence|1|||
163884800|NCT04029688|591949693|FG006|Overall Study|Death|2|||
164241542|NCT00456755|593255961|FG000|Overall Study|Lost to Follow-up|2|||
164241543|NCT00456755|593255962|FG001|Overall Study|Lost to Follow-up|1|||
164241544|NCT01475721|593255965|FG000|Overall Study|Death|3|||
164241545|NCT01475721|593255966|FG001|Overall Study|Death|6|||
164241546|NCT01475721|593255965|FG000|Overall Study|Withdrawal by Subject|8|||
164241547|NCT01475721|593255966|FG001|Overall Study|Withdrawal by Subject|8|||
164241548|NCT01048242|593255967|FG000|Overall Study|See study flow chart|4|||
164241549|NCT01048242|593255968|FG001|Overall Study|See study flow chart|2|||
164241550|NCT01772550|593255971|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
164241551|NCT01772550|593255972|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
164241552|NCT01772550|593255973|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
164241553|NCT01772550|593255971|FG000|Overall Study|Adverse Event|0|||
164241554|NCT01772550|593255972|FG001|Overall Study|Adverse Event|0|||
164241555|NCT01772550|593255973|FG002|Overall Study|Adverse Event|1|||
164241556|NCT00559104|593255974|FG000|Overall Study|Lack of Efficacy|9|||
164241557|NCT00559104|593255975|FG001|Overall Study|Lack of Efficacy|0|||
164241558|NCT04567524|593255976|FG000|Overall Study|Adverse Event|1|||
164241559|NCT04567524|593255977|FG001|Overall Study|Adverse Event|1|||
164241560|NCT04567524|593255978|FG002|Overall Study|Adverse Event|0|||
164241561|NCT04567524|593255979|FG003|Overall Study|Adverse Event|0|||
164241562|NCT04567524|593255976|FG000|Overall Study|Withdrawal by Subject|2|||
164241563|NCT04567524|593255977|FG001|Overall Study|Withdrawal by Subject|0|||
164241564|NCT04567524|593255978|FG002|Overall Study|Withdrawal by Subject|0|||
164241565|NCT04567524|593255979|FG003|Overall Study|Withdrawal by Subject|1|||
164241566|NCT01147393|593255980|FG000|Dose Level 1|Dose limiting Toxicity|2|||
164241567|NCT01147393|593255980|FG000|Dose Level -1|Dose Limited Toxicity|1|||
164241568|NCT03432494|593255989|FG000|Overall Study|Death|1|||
164241569|NCT03432494|593255989|FG000|Overall Study|Noncompliance|1|||
164241570|NCT00775268|593255990|FG000|Baseline|Drug not synthesize dose|1|||
164241571|NCT00775268|593255991|FG001|Baseline|Drug not synthesize dose|0|||
164241572|NCT00775268|593255990|FG000|Baseline|Not treated-ineligible per CT|0|||
164241573|NCT00775268|593255991|FG001|Baseline|Not treated-ineligible per CT|1|||
164241574|NCT00775268|593255990|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
164241575|NCT00775268|593255991|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
164241576|NCT00775268|593255990|FG000|After Completion|Participant missed scan appointment|1|||
164241577|NCT00775268|593255991|FG001|After Completion|Participant missed scan appointment|0|||
164241578|NCT00825994|593255992|FG000|Overall Study|Withdrawal by Subject|2|||
164241579|NCT00825994|593255992|FG000|Overall Study|Lost to Follow-up|1|||
164241580|NCT00825994|593255992|FG000|Overall Study|Protocol Violation|1|||
164241581|NCT00825994|593255992|FG000|Overall Study|Placebo Responder at V2|1|||
164241582|NCT01833494|593255995|FG000|Overall Study|Adverse Event|24|||
164241583|NCT01833494|593255995|FG000|Overall Study|Physician Decision|6|||
164241584|NCT01833494|593255995|FG000|Overall Study|Withdrawal by Subject|6|||
164241585|NCT01833494|593255995|FG000|Overall Study|Decrease in serum phosphorus|4|||
164241586|NCT01833494|593255995|FG000|Overall Study|Decrease in serum calcium|4|||
164241587|NCT01833494|593255995|FG000|Overall Study|Increase in serum ferritin|1|||
164241588|NCT03745768|593256000|FG000|Overall Study|discontinued study|2|||
164241589|NCT03745768|593256001|FG001|Overall Study|discontinued study|0|||
164241590|NCT00443118|593256002|FG000|Overall Study|unknown primary outcome|3|||
164241591|NCT00443118|593256003|FG001|Overall Study|unknown primary outcome|1|||
164241592|NCT00443118|593256004|FG002|Overall Study|unknown primary outcome|0|||
164241593|NCT00443118|593256002|FG000|Overall Study|Withdrawal by Subject|1|||
164241594|NCT00443118|593256003|FG001|Overall Study|Withdrawal by Subject|0|||
164241595|NCT00443118|593256004|FG002|Overall Study|Withdrawal by Subject|0|||
164241596|NCT00506779|593256009|FG000|Overall Study|Withdrawal by Subject|1|||
164241597|NCT00506779|593256010|FG001|Overall Study|Withdrawal by Subject|0|||
164241598|NCT00506779|593256011|FG002|Overall Study|Withdrawal by Subject|1|||
164336301|NCT04068610|593607891|FG002|Overall Study|Other|11|||
164336302|NCT00072176|593607892|FG000|Overall Study|Withdrawal by Subject|1|||
164336303|NCT00072176|593607893|FG001|Overall Study|Withdrawal by Subject|0|||
164336304|NCT00072176|593607892|FG000|Overall Study|Protocol Violation|0|||
164336305|NCT00072176|593607893|FG001|Overall Study|Protocol Violation|1|||
164336306|NCT02586064|593607894|FG000|Overall Study|Other Obligations|6|||
164336307|NCT02586064|593607895|FG001|Overall Study|Other Obligations|6|||
164336308|NCT02586064|593607894|FG000|Overall Study|Other|3|||
164336309|NCT02586064|593607895|FG001|Overall Study|Other|7|||
164241599|NCT00506779|593256012|FG003|Overall Study|Withdrawal by Subject|0|||
164241600|NCT00506779|593256009|FG000|Overall Study|Adverse Event|0|||
164241601|NCT00506779|593256010|FG001|Overall Study|Adverse Event|1|||
164241602|NCT00506779|593256011|FG002|Overall Study|Adverse Event|1|||
164241603|NCT00506779|593256012|FG003|Overall Study|Adverse Event|1|||
164241604|NCT04263766|593256013|FG000|Overall Study|Withdrawal by Subject|6|||
164241605|NCT04263766|593256014|FG001|Overall Study|Withdrawal by Subject|4|||
164336310|NCT02586064|593607894|FG000|Overall Study|Never Started|3|||
164336311|NCT02586064|593607895|FG001|Overall Study|Never Started|3|||
164241606|NCT04263766|593256013|FG000|Overall Study|Lack of Efficacy|1|||
164241607|NCT04263766|593256014|FG001|Overall Study|Lack of Efficacy|3|||
164241608|NCT04232943|593256015|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
164241609|NCT04232943|593256016|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
164241610|NCT04232943|593256017|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
164241611|NCT04232943|593256015|FG000|Overall Study|Withdrawal by Subject|1|||
164241612|NCT04232943|593256016|FG001|Overall Study|Withdrawal by Subject|1|||
164241613|NCT04232943|593256017|FG002|Overall Study|Withdrawal by Subject|0|||
164241614|NCT02639247|593256018|FG000|Overall Study|Lost to Follow-up|2|||
164241615|NCT02639247|593256019|FG001|Overall Study|Lost to Follow-up|1|||
164241616|NCT02639247|593256018|FG000|Overall Study|Death|2|||
164241617|NCT02639247|593256019|FG001|Overall Study|Death|0|||
164241618|NCT02639247|593256018|FG000|Overall Study|Withdrew Consent|0|||
164241619|NCT02639247|593256019|FG001|Overall Study|Withdrew Consent|1|||
164241620|NCT02639247|593256018|FG000|Overall Study|Protocol Violation|1|||
164241621|NCT02639247|593256019|FG001|Overall Study|Protocol Violation|0|||
164241622|NCT01891396|593256020|FG000|Overall Study|Withdrawal by Subject|4|||
164241623|NCT01891396|593256021|FG001|Overall Study|Withdrawal by Subject|4|||
164241624|NCT01891396|593256022|FG002|Overall Study|Withdrawal by Subject|3|||
164241625|NCT01891396|593256020|FG000|Overall Study|Lost to Follow-up|0|||
164241626|NCT01891396|593256021|FG001|Overall Study|Lost to Follow-up|1|||
164241627|NCT01891396|593256022|FG002|Overall Study|Lost to Follow-up|0|||
164241628|NCT00573391|593256023|FG000|Overall Study|study stopped|2|||
164241629|NCT00573391|593256024|FG001|Overall Study|study stopped|2|||
164241630|NCT00573391|593256023|FG000|Overall Study|Death|1|||
164241631|NCT00573391|593256024|FG001|Overall Study|Death|0|||
164241632|NCT04011735|593256027|FG000|Overall Study|Withdrawal by Subject|1|||
164241633|NCT04011735|593256028|FG001|Overall Study|Withdrawal by Subject|0|||
164241634|NCT04011735|593256029|FG002|Overall Study|Withdrawal by Subject|1|||
164241635|NCT04011735|593256027|FG000|Overall Study|Met exclusion criteria after study entry|0|||
164241636|NCT04011735|593256028|FG001|Overall Study|Met exclusion criteria after study entry|1|||
164241637|NCT04011735|593256029|FG002|Overall Study|Met exclusion criteria after study entry|0|||
164241638|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
164083431|NCT03734237|592670187|FG001|Overall Study|Withdrawal by Subject|9|||
164083432|NCT03734237|592670188|FG002|Overall Study|Withdrawal by Subject|10|||
164083433|NCT02711956|592670189|FG000|Overall Study|Adverse Event|0|||
164241639|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
164241640|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
164241641|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
164241642|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
164241643|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
164241644|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
164241645|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
164241646|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
164241647|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
164241648|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
164241649|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
164241650|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
164241651|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
164241652|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
164241653|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
164241654|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
164241655|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
164241656|NCT02831855|593256030|FG000|Open Label Phase (24 Weeks)|Other|4|||
164241657|NCT02831855|593256031|FG001|Open Label Phase (24 Weeks)|Other|0|||
164241658|NCT02831855|593256032|FG002|Open Label Phase (24 Weeks)|Other|0|||
164241659|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
164241660|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
164241661|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
164336312|NCT02586064|593607894|FG000|Overall Study|Lost Interest|1|||
164336313|NCT02586064|593607895|FG001|Overall Study|Lost Interest|4|||
164336314|NCT02586064|593607894|FG000|Overall Study|Miscellaneous Life Issues|0|||
164336315|NCT02586064|593607895|FG001|Overall Study|Miscellaneous Life Issues|5|||
164336316|NCT02586064|593607894|FG000|Overall Study|Infrequent Attendance|2|||
164336317|NCT02586064|593607895|FG001|Overall Study|Infrequent Attendance|1|||
164336318|NCT02586064|593607894|FG000|Overall Study|Timed Out|2|||
164336319|NCT02586064|593607895|FG001|Overall Study|Timed Out|0|||
164336320|NCT02586064|593607894|FG000|Overall Study|AUD relapse|0|||
164336321|NCT02586064|593607895|FG001|Overall Study|AUD relapse|2|||
164336322|NCT02586064|593607894|FG000|Overall Study|Legal Issue|1|||
164336323|NCT02586064|593607895|FG001|Overall Study|Legal Issue|0|||
164336324|NCT02158975|593607896|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
164336325|NCT02728596|593607899|FG000|Overall Study|Refusal unrelated to adverse event|3|||
163884801|NCT04029688|591949694|FG007|Overall Study|Death|3|||
164083434|NCT02711956|592670190|FG001|Overall Study|Adverse Event|0|||
164241662|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Death|0|||
164241663|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Death|0|||
164336326|NCT02728596|593607900|FG001|Overall Study|Refusal unrelated to adverse event|6|||
164336327|NCT02728596|593607901|FG002|Overall Study|Refusal unrelated to adverse event|7|||
164336328|NCT02728596|593607902|FG003|Overall Study|Refusal unrelated to adverse event|7|||
163884802|NCT04029688|591949687|FG000|Overall Study|Study Terminated by Sponsor|0|||
163884803|NCT04029688|591949688|FG001|Overall Study|Study Terminated by Sponsor|0|||
163884804|NCT04029688|591949689|FG002|Overall Study|Study Terminated by Sponsor|0|||
163884805|NCT04029688|591949690|FG003|Overall Study|Study Terminated by Sponsor|0|||
163884806|NCT04029688|591949691|FG004|Overall Study|Study Terminated by Sponsor|1|||
163884807|NCT04029688|591949692|FG005|Overall Study|Study Terminated by Sponsor|3|||
164241664|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Death|2|||
164241665|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
164241666|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
164241667|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
164241668|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
164241669|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
164241670|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
164241671|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
164241672|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
164241673|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
164241674|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Other|0|||
164241675|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Other|2|||
164241676|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Other|5|||
164241677|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
164241678|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
164241679|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
164241680|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
164241681|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
164241682|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
164241683|NCT02831855|593256030|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
164241684|NCT02831855|593256031|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
164241685|NCT02831855|593256032|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
164241686|NCT01118780|593256034|FG000|Overall Study|Adverse Event|15|||
164241687|NCT01118780|593256035|FG001|Overall Study|Adverse Event|15|||
164241688|NCT01118780|593256034|FG000|Overall Study|Death|1|||
164241689|NCT01118780|593256035|FG001|Overall Study|Death|0|||
164241690|NCT01118780|593256034|FG000|Overall Study|Lack of Efficacy|2|||
164241691|NCT01118780|593256035|FG001|Overall Study|Lack of Efficacy|6|||
164241692|NCT01118780|593256034|FG000|Overall Study|Physician Decision|2|||
164241693|NCT01118780|593256035|FG001|Overall Study|Physician Decision|0|||
164241694|NCT01118780|593256034|FG000|Overall Study|Protocol Violation|3|||
164241695|NCT01118780|593256035|FG001|Overall Study|Protocol Violation|6|||
164241696|NCT01118780|593256034|FG000|Overall Study|Withdrawal by Subject|13|||
164241697|NCT01118780|593256035|FG001|Overall Study|Withdrawal by Subject|8|||
164241698|NCT03962855|593256036|FG000|Overall Study|Death|0|||
164241699|NCT03962855|593256037|FG001|Overall Study|Death|1|||
164241700|NCT03962855|593256036|FG000|Overall Study|Lost to Follow-up|0|||
164241701|NCT03962855|593256037|FG001|Overall Study|Lost to Follow-up|1|||
164241702|NCT03962855|593256036|FG000|Overall Study|Adverse Event|0|||
164241703|NCT03962855|593256037|FG001|Overall Study|Adverse Event|1|||
164241704|NCT03962855|593256036|FG000|Overall Study|Physician Decision|0|||
164241705|NCT03962855|593256037|FG001|Overall Study|Physician Decision|2|||
164241706|NCT03326063|593256038|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
164241707|NCT03326063|593256039|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
164241708|NCT02750514|593256040|FG000|Track 1|Disease progression|20|||
164241709|NCT02750514|593256041|FG001|Track 1|Disease progression|1|||
164241710|NCT02750514|593256042|FG002|Track 1|Disease progression|0|||
164241711|NCT02750514|593256043|FG003|Track 1|Disease progression|1|||
164241712|NCT02750514|593256044|FG004|Track 1|Disease progression|0|||
164241713|NCT02750514|593256040|FG000|Track 1|Adverse event unrelated to study drug|1|||
164241714|NCT02750514|593256041|FG001|Track 1|Adverse event unrelated to study drug|0|||
164241715|NCT02750514|593256042|FG002|Track 1|Adverse event unrelated to study drug|0|||
164241716|NCT02750514|593256043|FG003|Track 1|Adverse event unrelated to study drug|0|||
164241717|NCT02750514|593256044|FG004|Track 1|Adverse event unrelated to study drug|0|||
164241718|NCT02750514|593256040|FG000|Track 1|Study drug toxicity|4|||
164241719|NCT02750514|593256041|FG001|Track 1|Study drug toxicity|1|||
164336329|NCT02728596|593607899|FG000|Overall Study|Death|44|||
164336330|NCT02728596|593607900|FG001|Overall Study|Death|42|||
164336331|NCT02728596|593607901|FG002|Overall Study|Death|123|||
164336332|NCT02728596|593607902|FG003|Overall Study|Death|68|||
164336333|NCT04590963|593607903|FG000|Overall Study|Death|118|||
164336334|NCT04590963|593607904|FG001|Overall Study|Death|59|||
164336335|NCT04590963|593607903|FG000|Overall Study|Lost to Follow-up|1|||
164336336|NCT04590963|593607904|FG001|Overall Study|Lost to Follow-up|1|||
164336337|NCT04590963|593607903|FG000|Overall Study|Progressive disease|0|||
164336338|NCT04590963|593607904|FG001|Overall Study|Progressive disease|1|||
163884808|NCT04029688|591949693|FG006|Overall Study|Study Terminated by Sponsor|1|||
163884809|NCT04029688|591949694|FG007|Overall Study|Study Terminated by Sponsor|3|||
163884810|NCT04029688|591949687|FG000|Overall Study|Withdrawal by Subject|0|||
163884811|NCT04029688|591949688|FG001|Overall Study|Withdrawal by Subject|0|||
163884812|NCT04029688|591949689|FG002|Overall Study|Withdrawal by Subject|0|||
163884813|NCT04029688|591949690|FG003|Overall Study|Withdrawal by Subject|1|||
164241720|NCT02750514|593256042|FG002|Track 1|Study drug toxicity|0|||
164241721|NCT02750514|593256043|FG003|Track 1|Study drug toxicity|1|||
164241722|NCT02750514|593256044|FG004|Track 1|Study drug toxicity|0|||
164241723|NCT02750514|593256040|FG000|Track 1|Participant request to discontinue|1|||
164241724|NCT02750514|593256041|FG001|Track 1|Participant request to discontinue|0|||
164241725|NCT02750514|593256042|FG002|Track 1|Participant request to discontinue|0|||
164241726|NCT02750514|593256043|FG003|Track 1|Participant request to discontinue|0|||
164241727|NCT02750514|593256044|FG004|Track 1|Participant request to discontinue|0|||
164241728|NCT02750514|593256040|FG000|Track 1|Other reasons|1|||
164241729|NCT02750514|593256041|FG001|Track 1|Other reasons|0|||
164241730|NCT02750514|593256042|FG002|Track 1|Other reasons|0|||
164241731|NCT02750514|593256043|FG003|Track 1|Other reasons|0|||
164241732|NCT02750514|593256044|FG004|Track 1|Other reasons|0|||
164241733|NCT02750514|593256040|FG000|Track 2|Disease progression|4|||
164241734|NCT02750514|593256041|FG001|Track 2|Disease progression|5|||
164241735|NCT02750514|593256042|FG002|Track 2|Disease progression|2|||
164241736|NCT02750514|593256043|FG003|Track 2|Disease progression|5|||
164241737|NCT02750514|593256044|FG004|Track 2|Disease progression|0|||
164241738|NCT02750514|593256040|FG000|Track 2|Adverse event unrelated to study drug|1|||
164241739|NCT02750514|593256041|FG001|Track 2|Adverse event unrelated to study drug|0|||
164241740|NCT02750514|593256042|FG002|Track 2|Adverse event unrelated to study drug|0|||
164241741|NCT02750514|593256043|FG003|Track 2|Adverse event unrelated to study drug|0|||
164241742|NCT02750514|593256044|FG004|Track 2|Adverse event unrelated to study drug|0|||
164241743|NCT02750514|593256040|FG000|Track 2|Study drug toxicity|1|||
164241744|NCT02750514|593256041|FG001|Track 2|Study drug toxicity|2|||
164241745|NCT02750514|593256042|FG002|Track 2|Study drug toxicity|0|||
164241746|NCT02750514|593256043|FG003|Track 2|Study drug toxicity|2|||
164241747|NCT02750514|593256044|FG004|Track 2|Study drug toxicity|0|||
164241748|NCT02750514|593256040|FG000|Track 2|Participant withdrew consent|0|||
164241749|NCT02750514|593256041|FG001|Track 2|Participant withdrew consent|1|||
164241750|NCT02750514|593256042|FG002|Track 2|Participant withdrew consent|0|||
164241751|NCT02750514|593256043|FG003|Track 2|Participant withdrew consent|0|||
164241752|NCT02750514|593256044|FG004|Track 2|Participant withdrew consent|0|||
164241753|NCT02750514|593256040|FG000|Track 3|Disease progression|0|||
164241754|NCT02750514|593256041|FG001|Track 3|Disease progression|24|||
164241755|NCT02750514|593256042|FG002|Track 3|Disease progression|13|||
164241756|NCT02750514|593256043|FG003|Track 3|Disease progression|14|||
164241757|NCT02750514|593256044|FG004|Track 3|Disease progression|0|||
164241758|NCT02750514|593256040|FG000|Track 3|Adverse event unrelated to study drug|0|||
164241759|NCT02750514|593256041|FG001|Track 3|Adverse event unrelated to study drug|1|||
164241760|NCT02750514|593256042|FG002|Track 3|Adverse event unrelated to study drug|1|||
164241761|NCT02750514|593256043|FG003|Track 3|Adverse event unrelated to study drug|1|||
164241762|NCT02750514|593256044|FG004|Track 3|Adverse event unrelated to study drug|0|||
164241763|NCT02750514|593256040|FG000|Track 3|Study drug toxicity|0|||
164241764|NCT02750514|593256041|FG001|Track 3|Study drug toxicity|3|||
164241765|NCT02750514|593256042|FG002|Track 3|Study drug toxicity|0|||
164241766|NCT02750514|593256043|FG003|Track 3|Study drug toxicity|1|||
164241767|NCT02750514|593256044|FG004|Track 3|Study drug toxicity|0|||
164241768|NCT02750514|593256040|FG000|Track 3|Participant request to discontinue|0|||
163884814|NCT04029688|591949691|FG004|Overall Study|Withdrawal by Subject|0|||
163884815|NCT04029688|591949692|FG005|Overall Study|Withdrawal by Subject|0|||
163884816|NCT04029688|591949693|FG006|Overall Study|Withdrawal by Subject|0|||
163884817|NCT04029688|591949694|FG007|Overall Study|Withdrawal by Subject|0|||
163884818|NCT02924272|591949706|FG000|Overall Study|Site Terminated by Sponsor|4|||
164241769|NCT02750514|593256041|FG001|Track 3|Participant request to discontinue|2|||
164241770|NCT02750514|593256042|FG002|Track 3|Participant request to discontinue|0|||
164241771|NCT02750514|593256043|FG003|Track 3|Participant request to discontinue|0|||
163884819|NCT02924272|591949707|FG001|Overall Study|Site Terminated by Sponsor|1|||
163884820|NCT02924272|591949706|FG000|Overall Study|Withdrawal by Subject|2|||
164241772|NCT02750514|593256044|FG004|Track 3|Participant request to discontinue|0|||
164241773|NCT02750514|593256040|FG000|Track 3|Participant withdrew consent|0|||
164241774|NCT02750514|593256041|FG001|Track 3|Participant withdrew consent|3|||
163884821|NCT02924272|591949707|FG001|Overall Study|Withdrawal by Subject|0|||
163884822|NCT02924272|591949706|FG000|Overall Study|Adverse Event|3|||
163884823|NCT02924272|591949707|FG001|Overall Study|Adverse Event|0|||
163884824|NCT02924272|591949706|FG000|Overall Study|Progressive Disease|11|||
163884825|NCT02924272|591949707|FG001|Overall Study|Progressive Disease|8|||
163884826|NCT02924272|591949706|FG000|Overall Study|Clinical Deterioration|1|||
164241775|NCT02750514|593256042|FG002|Track 3|Participant withdrew consent|1|||
163884827|NCT02924272|591949707|FG001|Overall Study|Clinical Deterioration|0|||
164241776|NCT02750514|593256043|FG003|Track 3|Participant withdrew consent|0|||
164241777|NCT02750514|593256044|FG004|Track 3|Participant withdrew consent|0|||
164241778|NCT02750514|593256040|FG000|Track 3|Other reasons|0|||
164241779|NCT02750514|593256041|FG001|Track 3|Other reasons|3|||
164006641|NCT00847613|592391043|FG002|Overall Study|Lost to Follow-up|0|||
164241780|NCT02750514|593256042|FG002|Track 3|Other reasons|0|||
164241781|NCT02750514|593256043|FG003|Track 3|Other reasons|0|||
164241782|NCT02750514|593256044|FG004|Track 3|Other reasons|0|||
164241783|NCT02750514|593256040|FG000|Track 4|Study drug toxicity|0|||
164241784|NCT02750514|593256041|FG001|Track 4|Study drug toxicity|6|||
164241785|NCT02750514|593256042|FG002|Track 4|Study drug toxicity|0|||
164241786|NCT02750514|593256043|FG003|Track 4|Study drug toxicity|5|||
164241787|NCT02750514|593256044|FG004|Track 4|Study drug toxicity|0|||
164241788|NCT02750514|593256040|FG000|Track 4|Participant request to discontinue|0|||
164241789|NCT02750514|593256041|FG001|Track 4|Participant request to discontinue|1|||
164241790|NCT02750514|593256042|FG002|Track 4|Participant request to discontinue|0|||
164241791|NCT02750514|593256043|FG003|Track 4|Participant request to discontinue|1|||
164241792|NCT02750514|593256044|FG004|Track 4|Participant request to discontinue|0|||
164241793|NCT02750514|593256040|FG000|Track 4|Participant withdrew consent|0|||
164241794|NCT02750514|593256041|FG001|Track 4|Participant withdrew consent|1|||
164241795|NCT02750514|593256042|FG002|Track 4|Participant withdrew consent|0|||
164241796|NCT02750514|593256043|FG003|Track 4|Participant withdrew consent|0|||
164241797|NCT02750514|593256044|FG004|Track 4|Participant withdrew consent|0|||
164241798|NCT02750514|593256040|FG000|Track 4|Other reasons|0|||
164241799|NCT02750514|593256041|FG001|Track 4|Other reasons|5|||
164241800|NCT02750514|593256042|FG002|Track 4|Other reasons|0|||
164241801|NCT02750514|593256043|FG003|Track 4|Other reasons|3|||
164241802|NCT02750514|593256044|FG004|Track 4|Other reasons|0|||
164241803|NCT02750514|593256040|FG000|Track 4|Disease progression|0|||
164241804|NCT02750514|593256041|FG001|Track 4|Disease progression|33|||
164241805|NCT02750514|593256042|FG002|Track 4|Disease progression|0|||
164241806|NCT02750514|593256043|FG003|Track 4|Disease progression|32|||
164241807|NCT02750514|593256044|FG004|Track 4|Disease progression|0|||
164241808|NCT02750514|593256040|FG000|Track 4|Adverse event unrelated to study drug|0|||
164241809|NCT02750514|593256041|FG001|Track 4|Adverse event unrelated to study drug|5|||
164241810|NCT02750514|593256042|FG002|Track 4|Adverse event unrelated to study drug|0|||
164241811|NCT02750514|593256043|FG003|Track 4|Adverse event unrelated to study drug|0|||
164241812|NCT02750514|593256044|FG004|Track 4|Adverse event unrelated to study drug|0|||
164241813|NCT02750514|593256040|FG000|Track 4|Death|0|||
164241814|NCT02750514|593256041|FG001|Track 4|Death|0|||
164241815|NCT02750514|593256042|FG002|Track 4|Death|0|||
164241816|NCT02750514|593256043|FG003|Track 4|Death|1|||
164241817|NCT02750514|593256044|FG004|Track 4|Death|0|||
164241818|NCT02750514|593256040|FG000|Track 5|Disease progression|0|||
164241819|NCT02750514|593256041|FG001|Track 5|Disease progression|0|||
164241820|NCT02750514|593256042|FG002|Track 5|Disease progression|0|||
164241821|NCT02750514|593256043|FG003|Track 5|Disease progression|0|||
164241822|NCT02750514|593256044|FG004|Track 5|Disease progression|34|||
164241823|NCT02750514|593256040|FG000|Track 5|Adverse event unrelated to study drug|0|||
164241824|NCT02750514|593256041|FG001|Track 5|Adverse event unrelated to study drug|0|||
164241825|NCT02750514|593256042|FG002|Track 5|Adverse event unrelated to study drug|0|||
164241826|NCT02750514|593256043|FG003|Track 5|Adverse event unrelated to study drug|0|||
164241827|NCT02750514|593256044|FG004|Track 5|Adverse event unrelated to study drug|2|||
164241828|NCT02750514|593256040|FG000|Track 5|Study drug toxicity|0|||
164241829|NCT02750514|593256041|FG001|Track 5|Study drug toxicity|0|||
164241830|NCT02750514|593256042|FG002|Track 5|Study drug toxicity|0|||
164241831|NCT02750514|593256043|FG003|Track 5|Study drug toxicity|0|||
164241832|NCT02750514|593256044|FG004|Track 5|Study drug toxicity|2|||
164241833|NCT02750514|593256040|FG000|Track 5|Participant request to discontinue|0|||
164241834|NCT02750514|593256041|FG001|Track 5|Participant request to discontinue|0|||
164241835|NCT02750514|593256042|FG002|Track 5|Participant request to discontinue|0|||
164241836|NCT02750514|593256043|FG003|Track 5|Participant request to discontinue|0|||
164241837|NCT02750514|593256044|FG004|Track 5|Participant request to discontinue|3|||
164241838|NCT02750514|593256040|FG000|Track 5|Other reasons|0|||
164241839|NCT02750514|593256041|FG001|Track 5|Other reasons|0|||
164241840|NCT02750514|593256042|FG002|Track 5|Other reasons|0|||
164241841|NCT02750514|593256043|FG003|Track 5|Other reasons|0|||
164241842|NCT02750514|593256044|FG004|Track 5|Other reasons|2|||
164241843|NCT02756403|593256046|FG000|Overall Study|Unable to swallow medication|0|||
164241844|NCT02756403|593256047|FG001|Overall Study|Unable to swallow medication|1|||
164241845|NCT02756403|593256048|FG002|Overall Study|Unable to swallow medication|1|||
164241846|NCT02756403|593256049|FG003|Overall Study|Unable to swallow medication|1|||
164241847|NCT02756403|593256046|FG000|Overall Study|Did not complete Procedure|0|||
164241848|NCT02756403|593256047|FG001|Overall Study|Did not complete Procedure|1|||
164241849|NCT02756403|593256048|FG002|Overall Study|Did not complete Procedure|0|||
164336339|NCT04590963|593607903|FG000|Overall Study|Study terminated by sponsor|103|||
164241850|NCT02756403|593256049|FG003|Overall Study|Did not complete Procedure|0|||
164241851|NCT02756403|593256046|FG000|Overall Study|Changed Mind About Procedure|0|||
164241852|NCT02756403|593256047|FG001|Overall Study|Changed Mind About Procedure|0|||
164241853|NCT02756403|593256048|FG002|Overall Study|Changed Mind About Procedure|1|||
164241854|NCT02756403|593256049|FG003|Overall Study|Changed Mind About Procedure|0|||
164241855|NCT02756403|593256046|FG000|Overall Study|Protocol Violation|0|||
164241856|NCT02756403|593256047|FG001|Overall Study|Protocol Violation|1|||
164241857|NCT02756403|593256048|FG002|Overall Study|Protocol Violation|0|||
164241858|NCT02756403|593256049|FG003|Overall Study|Protocol Violation|1|||
164241859|NCT00527618|593256050|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
164241860|NCT00527618|593256051|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
164241861|NCT00527618|593256050|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
164241862|NCT00527618|593256051|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
164241863|NCT00527618|593256050|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
164241864|NCT00527618|593256051|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
164241865|NCT00527618|593256050|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
164241866|NCT00527618|593256051|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
164241867|NCT00527618|593256050|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
164241868|NCT00527618|593256051|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
164241869|NCT00527618|593256050|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
164241870|NCT00527618|593256051|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
164336340|NCT04590963|593607904|FG001|Overall Study|Study terminated by sponsor|50|||
164336341|NCT04590963|593607903|FG000|Overall Study|Withdrawal by Subject|15|||
164336342|NCT04590963|593607904|FG001|Overall Study|Withdrawal by Subject|8|||
164336343|NCT04590963|593607903|FG000|Overall Study|Ongoing at data cut-off|9|||
164336344|NCT04590963|593607904|FG001|Overall Study|Ongoing at data cut-off|4|||
164336345|NCT04590963|593607903|FG000|Overall Study|Screen failure|1|||
164336346|NCT04590963|593607904|FG001|Overall Study|Screen failure|0|||
164336347|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Death|1|||
164336348|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Death|4|||
164336349|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Death|4|||
164336350|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Death|1|||
164336351|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Death|6|||
164336352|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Death|0|||
164336353|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
164336354|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
164336355|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
164336356|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
164336357|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
164336358|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
164336359|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336360|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
164336361|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336362|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
164336363|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336364|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
164336365|NCT04430738|593607905|FG000|Phase 1: Dose Escalation|Other|1|||
164336366|NCT04430738|593607906|FG001|Phase 1: Dose Escalation|Other|0|||
164336367|NCT04430738|593607907|FG002|Phase 1: Dose Escalation|Other|0|||
164336368|NCT04430738|593607908|FG003|Phase 1: Dose Escalation|Other|0|||
164336369|NCT04430738|593607909|FG004|Phase 1: Dose Escalation|Other|0|||
164336370|NCT04430738|593607910|FG005|Phase 1: Dose Escalation|Other|0|||
164336371|NCT04430738|593607905|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336372|NCT04430738|593607906|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336373|NCT04430738|593607907|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336374|NCT04430738|593607908|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336375|NCT04430738|593607909|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
164336376|NCT04430738|593607910|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
164336377|NCT04430738|593607905|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336378|NCT04430738|593607906|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336379|NCT04430738|593607907|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336380|NCT04430738|593607908|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336381|NCT04430738|593607909|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
164336382|NCT04430738|593607910|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
164336383|NCT04176705|593607912|FG000|Overall Study|Withdrawal by Subject|4|||
164336384|NCT04176705|593607913|FG001|Overall Study|Withdrawal by Subject|4|||
164336385|NCT04176705|593607912|FG000|Overall Study|Death|1|||
164336386|NCT04176705|593607913|FG001|Overall Study|Death|1|||
164336387|NCT04176705|593607912|FG000|Overall Study|Lost to Follow-up|3|||
164241871|NCT02240121|593256056|FG000|Overall Study|Protocol Violation|1|||
164336388|NCT04176705|593607913|FG001|Overall Study|Lost to Follow-up|3|||
163884828|NCT02924272|591949706|FG000|Overall Study|Death|1|||
164336389|NCT02628769|593607914|FG000|First Intervention|Adverse Event|1|||
164241872|NCT02240121|593256057|FG001|Overall Study|Protocol Violation|2|||
164241873|NCT02240121|593256056|FG000|Overall Study|Physician Decision|0|||
164241874|NCT02240121|593256057|FG001|Overall Study|Physician Decision|1|||
164241875|NCT02240121|593256056|FG000|Overall Study|Change in protocol interpretation|1|||
164241876|NCT02240121|593256057|FG001|Overall Study|Change in protocol interpretation|0|||
164241877|NCT02240121|593256056|FG000|Overall Study|Lack of Efficacy|2|||
164241878|NCT02240121|593256057|FG001|Overall Study|Lack of Efficacy|3|||
164241879|NCT02240121|593256056|FG000|Overall Study|Site closed|1|||
164241880|NCT02240121|593256057|FG001|Overall Study|Site closed|1|||
164241881|NCT02240121|593256056|FG000|Overall Study|Pregnancy|1|||
164241882|NCT02240121|593256057|FG001|Overall Study|Pregnancy|0|||
164241883|NCT02240121|593256056|FG000|Overall Study|Adverse Event|2|||
164241884|NCT02240121|593256057|FG001|Overall Study|Adverse Event|4|||
164241885|NCT02240121|593256056|FG000|Overall Study|Withdrawal by Subject|6|||
164241886|NCT02240121|593256057|FG001|Overall Study|Withdrawal by Subject|2|||
164241887|NCT02240121|593256056|FG000|Overall Study|Lost to Follow-up|3|||
164241888|NCT02240121|593256057|FG001|Overall Study|Lost to Follow-up|4|||
164241889|NCT02240121|593256056|FG000|Overall Study|Other than specified|1|||
164241890|NCT02240121|593256057|FG001|Overall Study|Other than specified|3|||
164241891|NCT02967679|593256058|FG000|Overall Study|Adverse Event|1|||
164241892|NCT04571060|593256063|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
164336390|NCT02628769|593607915|FG001|First Intervention|Adverse Event|0|||
164336391|NCT02628769|593607914|FG000|First Intervention|Withdrawal by Subject|0|||
164336392|NCT02628769|593607915|FG001|First Intervention|Withdrawal by Subject|1|||
164336393|NCT02628769|593607914|FG000|Second Intervention|Adverse Event|2|||
164336394|NCT02628769|593607915|FG001|Second Intervention|Adverse Event|0|||
164336395|NCT02628769|593607914|FG000|Second Intervention|Physician Decision|0|||
164336396|NCT02628769|593607915|FG001|Second Intervention|Physician Decision|1|||
164336397|NCT04102189|593607917|FG000|Overall Study|Withdrawal by Subject|1|||
164336398|NCT04102189|593607918|FG001|Overall Study|Withdrawal by Subject|2|||
164336399|NCT04102189|593607917|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164336400|NCT04102189|593607918|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164336401|NCT04102189|593607917|FG000|Overall Study|Lost to Follow-up|1|||
164336402|NCT04102189|593607918|FG001|Overall Study|Lost to Follow-up|0|||
164336403|NCT01543698|593609720|FG000|Phase 1b|Disease progression|2|||
164336404|NCT01543698|593609721|FG001|Phase 1b|Disease progression|4|||
164336405|NCT01543698|593609722|FG002|Phase 1b|Disease progression|3|||
164336406|NCT01543698|593609723|FG003|Phase 1b|Disease progression|2|||
164336407|NCT01543698|593609724|FG004|Phase 1b|Disease progression|10|||
164336408|NCT01543698|593609725|FG005|Phase 1b|Disease progression|6|||
164336409|NCT01543698|593609726|FG006|Phase 1b|Disease progression|5|||
164336410|NCT01543698|593609727|FG007|Phase 1b|Disease progression|3|||
164336411|NCT01543698|593609728|FG008|Phase 1b|Disease progression|4|||
164336412|NCT01543698|593609729|FG009|Phase 1b|Disease progression|5|||
164336413|NCT01543698|593609730|FG010|Phase 1b|Disease progression|1|||
164336414|NCT01543698|593609731|FG011|Phase 1b|Disease progression|0|||
164336415|NCT01543698|593609732|FG012|Phase 1b|Disease progression|0|||
164336416|NCT01543698|593609733|FG013|Phase 1b|Disease progression|0|||
164336417|NCT01543698|593609734|FG014|Phase 1b|Disease progression|0|||
164336418|NCT01543698|593609720|FG000|Phase 1b|Death|0|||
164336419|NCT01543698|593609721|FG001|Phase 1b|Death|0|||
164336420|NCT01543698|593609722|FG002|Phase 1b|Death|1|||
164336421|NCT01543698|593609723|FG003|Phase 1b|Death|1|||
164336422|NCT01543698|593609724|FG004|Phase 1b|Death|0|||
164336423|NCT01543698|593609725|FG005|Phase 1b|Death|0|||
164336424|NCT01543698|593609726|FG006|Phase 1b|Death|0|||
164336425|NCT01543698|593609727|FG007|Phase 1b|Death|0|||
164336426|NCT01543698|593609728|FG008|Phase 1b|Death|0|||
164336427|NCT01543698|593609729|FG009|Phase 1b|Death|0|||
164241893|NCT04571060|593256064|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
164241894|NCT04571060|593256063|FG000|Overall Study|Never treated migraine|47|||
164241895|NCT04571060|593256064|FG001|Overall Study|Never treated migraine|36|||
164336428|NCT01543698|593609730|FG010|Phase 1b|Death|1|||
164336429|NCT01543698|593609731|FG011|Phase 1b|Death|0|||
164336430|NCT01543698|593609732|FG012|Phase 1b|Death|0|||
164336431|NCT01543698|593609733|FG013|Phase 1b|Death|0|||
164241896|NCT04571060|593256063|FG000|Overall Study|Protocol Violation|4|||
164336432|NCT01543698|593609734|FG014|Phase 1b|Death|0|||
164336433|NCT01543698|593609720|FG000|Phase 1b|Withdrawal by Subject|0|||
164336434|NCT01543698|593609721|FG001|Phase 1b|Withdrawal by Subject|1|||
164241897|NCT04571060|593256064|FG001|Overall Study|Protocol Violation|2|||
164241898|NCT04571060|593256063|FG000|Overall Study|Withdrawal by Subject|6|||
164336435|NCT01543698|593609722|FG002|Phase 1b|Withdrawal by Subject|0|||
164336436|NCT01543698|593609723|FG003|Phase 1b|Withdrawal by Subject|1|||
164336437|NCT01543698|593609724|FG004|Phase 1b|Withdrawal by Subject|0|||
164336438|NCT01543698|593609725|FG005|Phase 1b|Withdrawal by Subject|0|||
164336439|NCT01543698|593609726|FG006|Phase 1b|Withdrawal by Subject|1|||
164241899|NCT04571060|593256064|FG001|Overall Study|Withdrawal by Subject|2|||
164241900|NCT04571060|593256063|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
164241901|NCT04571060|593256064|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
164241902|NCT01253369|593256065|FG000|Overall Study|Adverse Event|4|||
164241903|NCT01253369|593256065|FG000|Overall Study|Withdrawal by Subject|2|||
164241904|NCT01253369|593256065|FG000|Overall Study|Death|1|||
164241905|NCT01253369|593256065|FG000|Overall Study|Progressive disease|23|||
164241906|NCT01253369|593256065|FG000|Overall Study|Not Evaluable|3|||
164241907|NCT01220401|593256070|FG000|Overall Study|Withdrawal by Subject|2|||
164241908|NCT01220401|593256070|FG000|Overall Study|Protocol Violation|1|||
164241909|NCT01853462|593256071|FG000|Overall Study|Withdrawal by Subject|1|||
164241910|NCT01853462|593256072|FG001|Overall Study|Withdrawal by Subject|1|||
164241911|NCT02030821|593256074|FG000|Overall Study|Physician Decision|2|||
164241912|NCT02030821|593256075|FG001|Overall Study|Physician Decision|2|||
164241913|NCT02030821|593256076|FG002|Overall Study|Physician Decision|5|||
164241914|NCT02030821|593256077|FG003|Overall Study|Physician Decision|2|||
164241915|NCT03132467|593256078|FG000|Overall Study|Adverse Event|2|||
164241916|NCT03132467|593256078|FG000|Overall Study|Withdrawal by Subject|2|||
164241917|NCT01088906|593256079|FG000|Overall Study|Inclusion error|1|||
164241918|NCT01088906|593256079|FG000|Overall Study|Did not receive study treatment|3|||
164241919|NCT01088906|593256079|FG000|Overall Study|Missing data|1|||
164241920|NCT00457626|593256082|FG000|Overall Study|Adverse Event|3|||
164241921|NCT00457626|593256082|FG000|Overall Study|Administrative Problems|2|||
164241922|NCT00457626|593256082|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
164241923|NCT03965403|593256083|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
164241924|NCT02364037|593257129|FG000|Overall Study|Withdrawal by Subject|7|||
164241925|NCT02364037|593257130|FG001|Overall Study|Withdrawal by Subject|4|||
164241926|NCT02364037|593257129|FG000|Overall Study|Lost to Follow-up|37|||
164241927|NCT02364037|593257130|FG001|Overall Study|Lost to Follow-up|49|||
164241928|NCT01453036|593257131|FG000|Overall Study|Lost to Follow-up|26|||
164241929|NCT01453036|593257132|FG001|Overall Study|Lost to Follow-up|115|||
164241930|NCT01453036|593257133|FG002|Overall Study|Lost to Follow-up|31|||
164241931|NCT04072835|593257134|FG000|Overall Study|Overall trial ended|603|||
164241932|NCT04072835|593257134|FG000|Overall Study|Ablation|97|||
164241933|NCT04072835|593257134|FG000|Overall Study|Withdrawal of consent|66|||
164241934|NCT04072835|593257134|FG000|Overall Study|Physician Decision|50|||
164241935|NCT04072835|593257134|FG000|Overall Study|Lost to Follow-up|39|||
164241936|NCT04072835|593257134|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
164241937|NCT04072835|593257134|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
164241938|NCT04072835|593257134|FG000|Overall Study|Adverse Event|25|||
164241939|NCT04072835|593257134|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
164241940|NCT04072835|593257134|FG000|Overall Study|Death|11|||
164241941|NCT04072835|593257134|FG000|Overall Study|Participant felt the drug did not work|8|||
164241942|NCT04072835|593257134|FG000|Overall Study|Participant tolerability|5|||
164241943|NCT04072835|593257134|FG000|Overall Study|Missing|5|||
164241944|NCT04072835|593257134|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
164241945|NCT04072835|593257134|FG000|Overall Study|Pregnancy|3|||
164241946|NCT01336712|593257135|FG000|Overall Study|Death|2|||
164241947|NCT01336712|593257135|FG000|Overall Study|Lack of Efficacy|1|||
164241948|NCT00841776|593257136|FG000|Overall Study|Lack of Efficacy|0|||
164241949|NCT00841776|593257137|FG001|Overall Study|Lack of Efficacy|1|||
164241950|NCT00841776|593257136|FG000|Overall Study|Lost to Follow-up|2|||
164241951|NCT00841776|593257137|FG001|Overall Study|Lost to Follow-up|1|||
164241952|NCT00841776|593257136|FG000|Overall Study|Withdrawal by Subject|0|||
164241953|NCT00841776|593257137|FG001|Overall Study|Withdrawal by Subject|1|||
164241954|NCT02848092|593257138|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
164241955|NCT02848092|593257139|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
164241956|NCT02848092|593257138|FG000|1-month Post-training Follow-up|Adverse Event|2|||
164241957|NCT02848092|593257139|FG001|1-month Post-training Follow-up|Adverse Event|1|||
164241958|NCT02848092|593257138|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
164241959|NCT02848092|593257139|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
164241960|NCT02848092|593257138|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
164241961|NCT02848092|593257139|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
164241962|NCT02848092|593257138|FG000|1-month Post-training Follow-up|fatigue|0|||
164241963|NCT02848092|593257139|FG001|1-month Post-training Follow-up|fatigue|1|||
164241964|NCT02848092|593257138|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
164241965|NCT02848092|593257139|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
164241966|NCT02848092|593257138|FG000|6-month Post-training Follow-up|Adverse Event|1|||
164241967|NCT02848092|593257139|FG001|6-month Post-training Follow-up|Adverse Event|1|||
164241968|NCT02848092|593257138|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
164241969|NCT02848092|593257139|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
164241970|NCT02848092|593257138|FG000|6-month Post-training Follow-up|frustrated with task|1|||
163884829|NCT02924272|591949707|FG001|Overall Study|Death|0|||
163884830|NCT02924272|591949706|FG000|Overall Study|Reason Not Specified|1|||
163884831|NCT02924272|591949707|FG001|Overall Study|Reason Not Specified|0|||
163884832|NCT02919683|591949708|FG000|Post-Surgery Follow-Up|Death|2|||
164241971|NCT02848092|593257139|FG001|6-month Post-training Follow-up|frustrated with task|0|||
164241972|NCT02848092|593257138|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
164241973|NCT02848092|593257139|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
164241974|NCT02848092|593257138|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
164241975|NCT02848092|593257139|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
164241976|NCT01428219|593257145|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
163884833|NCT02919683|591949709|FG001|Post-Surgery Follow-Up|Death|2|||
163884834|NCT02919683|591949708|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
163884835|NCT02919683|591949709|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
163884836|NCT06491433|591949710|FG000|Overall Study|Protocol Violation|51|||
163884837|NCT06491433|591949710|FG000|Overall Study|consent withdrawal|2|||
163884838|NCT06491433|591949710|FG000|Overall Study|screen failure|1|||
163884839|NCT04749615|591949712|FG000|Overall Study|Lost to Follow-up|6|||
163884840|NCT04749615|591949713|FG001|Overall Study|Lost to Follow-up|10|||
163884841|NCT05292365|591949716|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
163884842|NCT05292365|591949717|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
163884843|NCT05292365|591949718|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
163884844|NCT05292365|591949719|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
163884845|NCT05282173|591949720|FG000|Overall Study|Missed|3|||
163884846|NCT05282173|591949721|FG001|Overall Study|Missed|2|||
163884847|NCT05282173|591949722|FG002|Overall Study|Missed|4|||
163884848|NCT04295798|591949729|FG000|Overall Study|Lost to Follow-up|1|||
163884849|NCT03524118|591949730|FG000|Overall Study|Lost to Follow-up|0|||
163884850|NCT03524118|591949731|FG001|Overall Study|Lost to Follow-up|0|||
164241977|NCT00355368|593257148|FG000|Overall Study|Protocol Violation|8|||
164241978|NCT00355368|593257149|FG001|Overall Study|Protocol Violation|7|||
164241979|NCT00355368|593257148|FG000|Overall Study|cardiac arrest prior to intubation|2|||
164241980|NCT00355368|593257149|FG001|Overall Study|cardiac arrest prior to intubation|2|||
164241981|NCT01694433|593257151|FG000|Overall Study|Adverse Event|7|||
164241982|NCT01694433|593257152|FG001|Overall Study|Adverse Event|0|||
164241983|NCT01694433|593257151|FG000|Overall Study|Physician Decision|1|||
164241984|NCT01694433|593257152|FG001|Overall Study|Physician Decision|0|||
164241985|NCT01694433|593257151|FG000|Overall Study|Withdrawal by Subject|3|||
164241986|NCT01694433|593257152|FG001|Overall Study|Withdrawal by Subject|4|||
164241987|NCT00374595|593257155|FG000|Overall Study|Death|23|||
164241988|NCT00374595|593257155|FG000|Overall Study|Withdrawal by Subject|39|||
164241989|NCT00374595|593257155|FG000|Overall Study|Lost to Follow-up|3|||
164241990|NCT00374595|593257155|FG000|Overall Study|too much time commitment|1|||
164241991|NCT00374595|593257155|FG000|Overall Study|transfer care to other clinical site|1|||
163884851|NCT03524118|591949732|FG002|Overall Study|Lost to Follow-up|0|||
163884852|NCT03524118|591949733|FG003|Overall Study|Lost to Follow-up|0|||
163884853|NCT03524118|591949734|FG004|Overall Study|Lost to Follow-up|1|||
163884854|NCT03524118|591949735|FG005|Overall Study|Lost to Follow-up|0|||
163884855|NCT03524118|591949730|FG000|Overall Study|Other|0|||
163884856|NCT03524118|591949731|FG001|Overall Study|Other|1|||
163884857|NCT03524118|591949732|FG002|Overall Study|Other|0|||
163884858|NCT03524118|591949733|FG003|Overall Study|Other|0|||
163884859|NCT03524118|591949734|FG004|Overall Study|Other|1|||
163884860|NCT03524118|591949735|FG005|Overall Study|Other|1|||
163884861|NCT03524118|591949730|FG000|Overall Study|Physician Decision|0|||
163884862|NCT03524118|591949731|FG001|Overall Study|Physician Decision|0|||
163884863|NCT03524118|591949732|FG002|Overall Study|Physician Decision|0|||
163884864|NCT03524118|591949733|FG003|Overall Study|Physician Decision|0|||
163884865|NCT03524118|591949734|FG004|Overall Study|Physician Decision|1|||
164241992|NCT00374595|593257155|FG000|Overall Study|relocation|3|||
164241993|NCT01665911|593257159|FG000|Overall Study|Protocol Violation|4|||
164241994|NCT01665911|593257159|FG000|Overall Study|Withdrawal by Subject|1|||
164241995|NCT01665911|593257159|FG000|Overall Study|Adverse Event|1|||
164241996|NCT01881009|593257160|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
164241997|NCT01881009|593257161|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
164241998|NCT01151020|593257162|FG000|Overall Study|Death|25|||
164241999|NCT01151020|593257162|FG000|Overall Study|Conversion to open repair|1|||
164242000|NCT01151020|593257162|FG000|Overall Study|Lost to Follow-up|4|||
164242001|NCT01151020|593257162|FG000|Overall Study|Withdrawal by Subject|22|||
164242002|NCT01151020|593257162|FG000|Overall Study|Patients did not receive the device|2|||
164242003|NCT00648037|593257163|FG000|Overall Study|Not Treated|1|||
164242004|NCT00648037|593257163|FG000|Overall Study|Withdrawal by Subject|1|||
164242005|NCT00648037|593257163|FG000|Overall Study|Adverse Event|11|||
164242006|NCT00648037|593257163|FG000|Overall Study|Relapse|2|||
164242007|NCT00648037|593257163|FG000|Overall Study|Other|1|||
164242008|NCT01635998|593257164|FG000|Overall Study|Death|1|||
164242009|NCT01635998|593257165|FG001|Overall Study|Death|1|||
164242010|NCT01635998|593257164|FG000|Overall Study|Lost to Follow-up|2|||
164242011|NCT01635998|593257165|FG001|Overall Study|Lost to Follow-up|1|||
164242012|NCT01635998|593257164|FG000|Overall Study|Withdrawal by Subject|1|||
164242013|NCT01635998|593257165|FG001|Overall Study|Withdrawal by Subject|5|||
164242014|NCT00846846|593257166|FG000|Overall Study|Death|56|||
164242015|NCT00846846|593257166|FG000|Overall Study|Withdrawal by Subject|19|||
164242016|NCT04419467|593257167|FG000|Overall Study|Not treated with IP|0|||
164242017|NCT04419467|593257168|FG001|Overall Study|Not treated with IP|0|||
164242018|NCT04419467|593257169|FG002|Overall Study|Not treated with IP|2|||
164242019|NCT04419467|593257167|FG000|Overall Study|Adverse Event|0|||
164242020|NCT04419467|593257168|FG001|Overall Study|Adverse Event|2|||
164242021|NCT04419467|593257169|FG002|Overall Study|Adverse Event|0|||
164242022|NCT04419467|593257167|FG000|Overall Study|Death|1|||
164242023|NCT04419467|593257168|FG001|Overall Study|Death|0|||
164242024|NCT04419467|593257169|FG002|Overall Study|Death|0|||
164242025|NCT04419467|593257167|FG000|Overall Study|Lost to Follow-up|0|||
164242026|NCT04419467|593257168|FG001|Overall Study|Lost to Follow-up|1|||
164242027|NCT04419467|593257169|FG002|Overall Study|Lost to Follow-up|2|||
164242028|NCT04419467|593257167|FG000|Overall Study|Withdrawal by Subject|0|||
164242029|NCT04419467|593257168|FG001|Overall Study|Withdrawal by Subject|0|||
164242030|NCT04419467|593257169|FG002|Overall Study|Withdrawal by Subject|4|||
164242031|NCT04419467|593257167|FG000|Overall Study|Pandemic related|0|||
164242032|NCT04419467|593257168|FG001|Overall Study|Pandemic related|0|||
164242033|NCT04419467|593257169|FG002|Overall Study|Pandemic related|1|||
164242034|NCT04419467|593257167|FG000|Overall Study|Reason not known|1|||
164242035|NCT04419467|593257168|FG001|Overall Study|Reason not known|0|||
164242036|NCT04419467|593257169|FG002|Overall Study|Reason not known|0|||
164242037|NCT00600067|593257173|FG000|Overall Study|Adverse Event|0|||
164242038|NCT00600067|593257174|FG001|Overall Study|Adverse Event|1|||
164242039|NCT00600067|593257173|FG000|Overall Study|Lost to Follow-up|2|||
164242040|NCT00600067|593257174|FG001|Overall Study|Lost to Follow-up|3|||
164242041|NCT00600067|593257173|FG000|Overall Study|protocol non-compliance|0|||
164242042|NCT00600067|593257174|FG001|Overall Study|protocol non-compliance|3|||
164242043|NCT00600067|593257173|FG000|Overall Study|Lack of Efficacy|1|||
164242044|NCT00600067|593257174|FG001|Overall Study|Lack of Efficacy|0|||
164242045|NCT00881894|593257177|FG000|Overall Study|Consent withdrawn|0|||
164242046|NCT00881894|593257178|FG001|Overall Study|Consent withdrawn|1|||
164242047|NCT00881894|593257177|FG000|Overall Study|Other reasons for premature termination|1|||
164242048|NCT00881894|593257178|FG001|Overall Study|Other reasons for premature termination|2|||
164242049|NCT03943290|593257180|FG000|Overall Study|Sponsor Terminated Study|6|||
164242050|NCT03943290|593257181|FG001|Overall Study|Sponsor Terminated Study|1|||
164242051|NCT03943290|593257182|FG002|Overall Study|Sponsor Terminated Study|11|||
164242052|NCT03943290|593257183|FG003|Overall Study|Sponsor Terminated Study|6|||
164242053|NCT03943290|593257184|FG004|Overall Study|Sponsor Terminated Study|7|||
164242054|NCT03943290|593257185|FG005|Overall Study|Sponsor Terminated Study|6|||
164242055|NCT03943290|593257186|FG006|Overall Study|Sponsor Terminated Study|6|||
164242056|NCT03943290|593257187|FG007|Overall Study|Sponsor Terminated Study|7|||
164242057|NCT03943290|593257188|FG008|Overall Study|Sponsor Terminated Study|8|||
164242058|NCT03943290|593257180|FG000|Overall Study|Lost to Follow-up|1|||
164242059|NCT03943290|593257181|FG001|Overall Study|Lost to Follow-up|0|||
164242060|NCT03943290|593257182|FG002|Overall Study|Lost to Follow-up|1|||
164242061|NCT03943290|593257183|FG003|Overall Study|Lost to Follow-up|0|||
164242062|NCT03943290|593257184|FG004|Overall Study|Lost to Follow-up|0|||
164242063|NCT03943290|593257185|FG005|Overall Study|Lost to Follow-up|0|||
164242064|NCT03943290|593257186|FG006|Overall Study|Lost to Follow-up|0|||
164242065|NCT03943290|593257187|FG007|Overall Study|Lost to Follow-up|1|||
164242066|NCT03943290|593257188|FG008|Overall Study|Lost to Follow-up|0|||
164242067|NCT03943290|593257180|FG000|Overall Study|Withdrawal by Subject|0|||
164242068|NCT03943290|593257181|FG001|Overall Study|Withdrawal by Subject|0|||
164242069|NCT03943290|593257182|FG002|Overall Study|Withdrawal by Subject|1|||
164242070|NCT03943290|593257183|FG003|Overall Study|Withdrawal by Subject|0|||
164242071|NCT03943290|593257184|FG004|Overall Study|Withdrawal by Subject|0|||
164242072|NCT03943290|593257185|FG005|Overall Study|Withdrawal by Subject|0|||
164242073|NCT03943290|593257186|FG006|Overall Study|Withdrawal by Subject|0|||
164242074|NCT03943290|593257187|FG007|Overall Study|Withdrawal by Subject|0|||
164242075|NCT03943290|593257188|FG008|Overall Study|Withdrawal by Subject|0|||
164242076|NCT02765399|593257189|FG000|Overall Study|Nausea|1|||
164242077|NCT02765399|593257190|FG001|Overall Study|Nausea|0|||
164242078|NCT02103062|593257191|FG000|Overall Study|Adverse Event|1|||
164242079|NCT02103062|593257192|FG001|Overall Study|Adverse Event|2|||
164242080|NCT02103062|593257191|FG000|Overall Study|Progressive Disease|17|||
164242081|NCT02103062|593257192|FG001|Overall Study|Progressive Disease|20|||
164242082|NCT02103062|593257191|FG000|Overall Study|Death|0|||
164242083|NCT02103062|593257192|FG001|Overall Study|Death|1|||
164242084|NCT03958331|593257193|FG000|Overall Study|Withdrawal by Subject|3|||
164242085|NCT03958331|593257194|FG001|Overall Study|Withdrawal by Subject|1|||
164242086|NCT03958331|593257195|FG002|Overall Study|Withdrawal by Subject|5|||
164242087|NCT03958331|593257193|FG000|Overall Study|Weaned from medicine|2|||
164242088|NCT03958331|593257194|FG001|Overall Study|Weaned from medicine|0|||
164242089|NCT03958331|593257195|FG002|Overall Study|Weaned from medicine|0|||
164242090|NCT03958331|593257193|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
164242091|NCT03958331|593257194|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
164242092|NCT03958331|593257195|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
164242093|NCT01991483|593257196|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
164242094|NCT01991483|593257197|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
164242095|NCT01991483|593257198|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
164242096|NCT01991483|593257199|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
164242097|NCT01991483|593257196|FG000|Dose Level 600 mg|Physician Decision|0|||
164242098|NCT01991483|593257197|FG001|Dose Level 600 mg|Physician Decision|0|||
164242099|NCT01991483|593257198|FG002|Dose Level 600 mg|Physician Decision|1|||
164242100|NCT01991483|593257199|FG003|Dose Level 600 mg|Physician Decision|0|||
164242101|NCT01991483|593257196|FG000|Dose Level 1000 mg|Protocol Violation|0|||
164242102|NCT01991483|593257197|FG001|Dose Level 1000 mg|Protocol Violation|0|||
164242103|NCT01991483|593257198|FG002|Dose Level 1000 mg|Protocol Violation|0|||
164242104|NCT01991483|593257199|FG003|Dose Level 1000 mg|Protocol Violation|1|||
164242105|NCT03192137|593257200|FG000|Overall Study|Adverse Event|10|||
164242106|NCT03192137|593257201|FG001|Overall Study|Adverse Event|11|||
164242107|NCT03192137|593257200|FG000|Overall Study|Physician Decision|1|||
164242108|NCT03192137|593257201|FG001|Overall Study|Physician Decision|0|||
164242109|NCT03192137|593257200|FG000|Overall Study|Lack of Efficacy|20|||
164242110|NCT03192137|593257201|FG001|Overall Study|Lack of Efficacy|37|||
164242111|NCT03192137|593257200|FG000|Overall Study|Withdrawal by Subject|3|||
164242112|NCT03192137|593257201|FG001|Overall Study|Withdrawal by Subject|3|||
164242113|NCT03192137|593257200|FG000|Overall Study|Protocol Violation|4|||
164242114|NCT03192137|593257201|FG001|Overall Study|Protocol Violation|3|||
164242115|NCT03192137|593257200|FG000|Overall Study|Surgery Cancelled|4|||
164242116|NCT03192137|593257201|FG001|Overall Study|Surgery Cancelled|1|||
164242117|NCT03192137|593257200|FG000|Overall Study|Other - Various Administrative Reasons|8|||
164242118|NCT03192137|593257201|FG001|Overall Study|Other - Various Administrative Reasons|3|||
164242119|NCT01070979|593257202|FG000|Overall Study|Adverse Event|2|||
164242120|NCT01070979|593257203|FG001|Overall Study|Adverse Event|3|||
164242121|NCT01070979|593257204|FG002|Overall Study|Adverse Event|3|||
164242122|NCT01070979|593257202|FG000|Overall Study|Lost to Follow-up|2|||
164242123|NCT01070979|593257203|FG001|Overall Study|Lost to Follow-up|1|||
164242124|NCT01070979|593257204|FG002|Overall Study|Lost to Follow-up|1|||
164242125|NCT01070979|593257202|FG000|Overall Study|Protocol Violation|0|||
164242126|NCT01070979|593257203|FG001|Overall Study|Protocol Violation|2|||
164242127|NCT01070979|593257204|FG002|Overall Study|Protocol Violation|6|||
164242128|NCT01070979|593257202|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
164242129|NCT01070979|593257203|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
164242130|NCT01070979|593257204|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
164242131|NCT01070979|593257202|FG000|Overall Study|Withdrawal by Subject|3|||
164242132|NCT01070979|593257203|FG001|Overall Study|Withdrawal by Subject|1|||
163884866|NCT03524118|591949735|FG005|Overall Study|Physician Decision|0|||
163884867|NCT03524118|591949730|FG000|Overall Study|Protocol Violation|0|||
164242133|NCT01070979|593257204|FG002|Overall Study|Withdrawal by Subject|1|||
164242134|NCT01070979|593257202|FG000|Overall Study|No study drug taken|0|||
164242135|NCT01070979|593257203|FG001|Overall Study|No study drug taken|1|||
164242136|NCT01070979|593257204|FG002|Overall Study|No study drug taken|0|||
164242137|NCT00437268|593257205|FG000|Overall Study|Adverse Event|1|||
164242138|NCT00437268|593257206|FG001|Overall Study|Adverse Event|1|||
164242139|NCT00437268|593257205|FG000|Overall Study|Withdrawal by Subject|2|||
164242140|NCT00437268|593257206|FG001|Overall Study|Withdrawal by Subject|2|||
164242141|NCT00437268|593257205|FG000|Overall Study|Progressive disease|9|||
164242142|NCT00437268|593257206|FG001|Overall Study|Progressive disease|9|||
164242143|NCT00437268|593257205|FG000|Overall Study|Physician Decision|1|||
164242144|NCT00437268|593257206|FG001|Overall Study|Physician Decision|0|||
164242145|NCT00437268|593257205|FG000|Overall Study|Death|0|||
164242146|NCT00437268|593257206|FG001|Overall Study|Death|1|||
164242147|NCT04417257|593257211|FG000|Pilot Phase 2|Adverse Event|2|||
164242148|NCT04417257|593257212|FG001|Pilot Phase 2|Adverse Event|0|||
163884868|NCT03524118|591949731|FG001|Overall Study|Protocol Violation|0|||
163884869|NCT03524118|591949732|FG002|Overall Study|Protocol Violation|1|||
164242149|NCT04417257|593257211|FG000|Pilot Phase 2|Death|14|||
163884870|NCT03524118|591949733|FG003|Overall Study|Protocol Violation|0|||
163884871|NCT03524118|591949734|FG004|Overall Study|Protocol Violation|1|||
163884872|NCT03524118|591949735|FG005|Overall Study|Protocol Violation|0|||
164242150|NCT04417257|593257212|FG001|Pilot Phase 2|Death|11|||
164242151|NCT04417257|593257211|FG000|Pilot Phase 2|Lost to Follow-up|3|||
164242152|NCT04417257|593257212|FG001|Pilot Phase 2|Lost to Follow-up|5|||
164242153|NCT04417257|593257211|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
164242154|NCT04417257|593257212|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
164336440|NCT01543698|593609727|FG007|Phase 1b|Withdrawal by Subject|0|||
164242155|NCT04417257|593257211|FG000|Pilot Phase 2|Hepatic impairment|1|||
164242156|NCT04417257|593257212|FG001|Pilot Phase 2|Hepatic impairment|0|||
164242157|NCT04417257|593257211|FG000|Pilot Phase 2|Unblinding|1|||
164242158|NCT04417257|593257212|FG001|Pilot Phase 2|Unblinding|0|||
164242159|NCT04417257|593257211|FG000|Pilot Phase 2|All other|0|||
164242160|NCT04417257|593257212|FG001|Pilot Phase 2|All other|2|||
164242161|NCT04417257|593257211|FG000|Phase 3 Extension|Death|3|||
164242162|NCT04417257|593257212|FG001|Phase 3 Extension|Death|1|||
164242163|NCT04417257|593257211|FG000|Phase 3 Extension|Lost to Follow-up|4|||
164242164|NCT04417257|593257212|FG001|Phase 3 Extension|Lost to Follow-up|2|||
164242165|NCT04417257|593257211|FG000|Phase 3 Extension|Patient withdrawal|2|||
164242166|NCT04417257|593257212|FG001|Phase 3 Extension|Patient withdrawal|2|||
164242167|NCT04417257|593257211|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
164242168|NCT04417257|593257212|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
164242169|NCT03484429|593257216|FG000|Overall Study|Withdrawal by Subject|1|||
164242170|NCT03484429|593257217|FG001|Overall Study|Withdrawal by Subject|0|||
164242171|NCT03484429|593257216|FG000|Overall Study|Adverse Event|2|||
164242172|NCT03484429|593257217|FG001|Overall Study|Adverse Event|0|||
164242173|NCT04466384|593257218|FG000|First Phase|Protocol Violation|1|||
164242174|NCT04466384|593257219|FG001|First Phase|Protocol Violation|0|||
164242175|NCT04466384|593257218|FG000|First Phase|Missing data|1|||
164242176|NCT04466384|593257219|FG001|First Phase|Missing data|0|||
164242177|NCT04466384|593257218|FG000|Cross Over Phase|Physician Decision|1|||
164242178|NCT04466384|593257219|FG001|Cross Over Phase|Physician Decision|0|||
164242179|NCT04466384|593257218|FG000|Cross Over Phase|Withdrawal by Subject|0|||
164242180|NCT04466384|593257219|FG001|Cross Over Phase|Withdrawal by Subject|1|||
164242181|NCT01152437|593257223|FG000|Overall Study|Other Adverse Event|8|||
164242182|NCT01152437|593257224|FG001|Overall Study|Other Adverse Event|1|||
164242183|NCT01152437|593257225|FG002|Overall Study|Other Adverse Event|7|||
164242184|NCT01152437|593257223|FG000|Overall Study|Not treated|0|||
164242185|NCT01152437|593257224|FG001|Overall Study|Not treated|1|||
164242186|NCT01152437|593257225|FG002|Overall Study|Not treated|2|||
164242187|NCT01152437|593257223|FG000|Overall Study|Progressive disease|27|||
164242188|NCT01152437|593257224|FG001|Overall Study|Progressive disease|13|||
164242189|NCT01152437|593257225|FG002|Overall Study|Progressive disease|32|||
164242190|NCT01152437|593257223|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
164242191|NCT01152437|593257224|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
164242192|NCT01152437|593257225|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
164242193|NCT02015039|593257226|FG000|Overall Study|Not eligible|0|||
164242194|NCT02015039|593257227|FG001|Overall Study|Not eligible|1|||
164242195|NCT01897532|593257228|FG000|Discontinuation From Treatment|Not Treated|7|||
164242196|NCT01897532|593257229|FG001|Discontinuation From Treatment|Not Treated|5|||
164242197|NCT01897532|593257228|FG000|Discontinuation From Treatment|Other reason than specified|196|||
164242198|NCT01897532|593257229|FG001|Discontinuation From Treatment|Other reason than specified|176|||
164242199|NCT01897532|593257228|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
164336441|NCT01543698|593609728|FG008|Phase 1b|Withdrawal by Subject|0|||
164336442|NCT01543698|593609729|FG009|Phase 1b|Withdrawal by Subject|0|||
164336443|NCT01543698|593609730|FG010|Phase 1b|Withdrawal by Subject|0|||
164336444|NCT01543698|593609731|FG011|Phase 1b|Withdrawal by Subject|0|||
164336445|NCT01543698|593609732|FG012|Phase 1b|Withdrawal by Subject|0|||
164336446|NCT01543698|593609733|FG013|Phase 1b|Withdrawal by Subject|0|||
164336447|NCT01543698|593609734|FG014|Phase 1b|Withdrawal by Subject|0|||
164336448|NCT01543698|593609720|FG000|Phase 1b|Adverse Event|1|||
164336449|NCT01543698|593609721|FG001|Phase 1b|Adverse Event|0|||
164336450|NCT01543698|593609722|FG002|Phase 1b|Adverse Event|0|||
164336451|NCT01543698|593609723|FG003|Phase 1b|Adverse Event|1|||
164336452|NCT01543698|593609724|FG004|Phase 1b|Adverse Event|2|||
164336453|NCT01543698|593609725|FG005|Phase 1b|Adverse Event|2|||
164336454|NCT01543698|593609726|FG006|Phase 1b|Adverse Event|0|||
164336455|NCT01543698|593609727|FG007|Phase 1b|Adverse Event|0|||
164336456|NCT01543698|593609728|FG008|Phase 1b|Adverse Event|1|||
164336457|NCT01543698|593609729|FG009|Phase 1b|Adverse Event|1|||
164336458|NCT01543698|593609730|FG010|Phase 1b|Adverse Event|2|||
164242200|NCT01897532|593257229|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
164242201|NCT01897532|593257228|FG000|Discontinuation From Treatment|Non compliance|24|||
164242202|NCT01897532|593257229|FG001|Discontinuation From Treatment|Non compliance|15|||
164242203|NCT01897532|593257228|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
164336459|NCT01543698|593609731|FG011|Phase 1b|Adverse Event|0|||
164336460|NCT01543698|593609732|FG012|Phase 1b|Adverse Event|0|||
164336461|NCT01543698|593609733|FG013|Phase 1b|Adverse Event|0|||
164336462|NCT01543698|593609734|FG014|Phase 1b|Adverse Event|0|||
164242204|NCT01897532|593257229|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
164242205|NCT01897532|593257228|FG000|Discontinuation From Trial|Not Treated|7|||
164242206|NCT01897532|593257229|FG001|Discontinuation From Trial|Not Treated|5|||
164242207|NCT01897532|593257228|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
164242208|NCT01897532|593257229|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
164336463|NCT01543698|593609720|FG000|Phase 1b|Administrative problems|1|||
164336464|NCT01543698|593609721|FG001|Phase 1b|Administrative problems|0|||
164242209|NCT01074931|593257234|FG000|Overall Study|Economic reasons|1|||
164242210|NCT01074931|593257234|FG000|Overall Study|Death|5|||
164242211|NCT00972023|593258443|FG000|Overall Study|Withdrawal by Subject|1|||
164242212|NCT03052608|593258444|FG000|Treatment Phase|Adverse Event|10|||
164242213|NCT03052608|593258445|FG001|Treatment Phase|Adverse Event|12|||
164242214|NCT03052608|593258444|FG000|Treatment Phase|Death|6|||
164242215|NCT03052608|593258445|FG001|Treatment Phase|Death|4|||
164242216|NCT03052608|593258444|FG000|Treatment Phase|Withdrawal by Subject|4|||
164242217|NCT03052608|593258445|FG001|Treatment Phase|Withdrawal by Subject|12|||
164242218|NCT03052608|593258444|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
164242219|NCT03052608|593258445|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
164242220|NCT03052608|593258444|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
164242221|NCT03052608|593258445|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
164242222|NCT03052608|593258444|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
164242223|NCT03052608|593258445|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
164242224|NCT03052608|593258444|FG000|Treatment Phase|Ongoing|103|||
164242225|NCT03052608|593258445|FG001|Treatment Phase|Ongoing|31|||
164242226|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Death|23|||
164242227|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Death|28|||
164242228|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
164242229|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
164242230|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
164242231|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
164242232|NCT03052608|593258444|FG000|Long-Term Follow-up Phase|Ongoing|122|||
164242233|NCT03052608|593258445|FG001|Long-Term Follow-up Phase|Ongoing|99|||
164242234|NCT05554146|593258452|FG000|Overall Study|Adverse Event|0|||
164242235|NCT05554146|593258453|FG001|Overall Study|Adverse Event|1|||
164242236|NCT05554146|593258454|FG002|Overall Study|Adverse Event|0|||
164242237|NCT05554146|593258455|FG003|Overall Study|Adverse Event|0|||
164242238|NCT05554146|593258452|FG000|Overall Study|Protocol Violation|0|||
164242239|NCT05554146|593258453|FG001|Overall Study|Protocol Violation|1|||
164242240|NCT05554146|593258454|FG002|Overall Study|Protocol Violation|0|||
164242241|NCT05554146|593258455|FG003|Overall Study|Protocol Violation|0|||
164242242|NCT05554146|593258452|FG000|Overall Study|No longer interested in participating|0|||
164242243|NCT05554146|593258453|FG001|Overall Study|No longer interested in participating|0|||
164242244|NCT05554146|593258454|FG002|Overall Study|No longer interested in participating|1|||
164242245|NCT05554146|593258455|FG003|Overall Study|No longer interested in participating|0|||
164242246|NCT05554146|593258452|FG000|Overall Study|Lost to Follow-up|1|||
164242247|NCT05554146|593258453|FG001|Overall Study|Lost to Follow-up|0|||
164242248|NCT05554146|593258454|FG002|Overall Study|Lost to Follow-up|0|||
164242249|NCT05554146|593258455|FG003|Overall Study|Lost to Follow-up|0|||
164242250|NCT03073525|593258458|FG000|Overall Study|Withdrawal by Subject|0|||
164242251|NCT03073525|593258459|FG001|Overall Study|Withdrawal by Subject|0|||
164242252|NCT03073525|593258460|FG002|Overall Study|Withdrawal by Subject|3|||
164242253|NCT01976299|593258461|FG000|Overall Study|Withdrawal by Subject|3|||
164242254|NCT01976299|593258462|FG001|Overall Study|Withdrawal by Subject|1|||
164242255|NCT01976299|593258461|FG000|Overall Study|Death|4|||
164242256|NCT01976299|593258462|FG001|Overall Study|Death|2|||
164242257|NCT01976299|593258461|FG000|Overall Study|Lost to Follow-up|7|||
164242258|NCT01976299|593258462|FG001|Overall Study|Lost to Follow-up|1|||
164242259|NCT01976299|593258461|FG000|Overall Study|See clarification above in comments|9|||
164242260|NCT01976299|593258462|FG001|Overall Study|See clarification above in comments|2|||
164242261|NCT00856323|593258464|FG000|Overall Study|Withdrawal by Subject|2|||
164242262|NCT01639469|593258465|FG000|Overall Study|Death|4|||
164242263|NCT01639469|593258466|FG001|Overall Study|Death|2|||
164242264|NCT01639469|593258465|FG000|Overall Study|Lost to Follow-up|1|||
164242265|NCT01639469|593258466|FG001|Overall Study|Lost to Follow-up|1|||
164242266|NCT01119443|593258467|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
164242267|NCT01119443|593258468|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
164242268|NCT02329743|593258471|FG000|Overall Study|Adverse Event|1|||
164242269|NCT02329743|593258472|FG001|Overall Study|Adverse Event|1|||
164242270|NCT02329743|593258473|FG002|Overall Study|Adverse Event|3|||
164242271|NCT02329743|593258471|FG000|Overall Study|Lost to Follow-up|1|||
164242272|NCT02329743|593258472|FG001|Overall Study|Lost to Follow-up|0|||
164242273|NCT02329743|593258473|FG002|Overall Study|Lost to Follow-up|1|||
164242274|NCT02329743|593258471|FG000|Overall Study|Withdrawal by Subject|4|||
164242275|NCT02329743|593258472|FG001|Overall Study|Withdrawal by Subject|4|||
164242276|NCT02329743|593258473|FG002|Overall Study|Withdrawal by Subject|1|||
164242277|NCT02329743|593258471|FG000|Overall Study|Other|0|||
164242278|NCT02329743|593258472|FG001|Overall Study|Other|2|||
164242279|NCT02329743|593258473|FG002|Overall Study|Other|3|||
164242280|NCT00347932|593258484|FG000|Overall Study|Adverse Event|4|||
164242281|NCT00347932|593258485|FG001|Overall Study|Adverse Event|5|||
164242282|NCT00347932|593258484|FG000|Overall Study|Lack of Efficacy|3|||
164242283|NCT00347932|593258485|FG001|Overall Study|Lack of Efficacy|14|||
164242284|NCT00347932|593258484|FG000|Overall Study|Lost to Follow-up|10|||
164242285|NCT00347932|593258485|FG001|Overall Study|Lost to Follow-up|9|||
164242286|NCT00347932|593258484|FG000|Overall Study|Withdrawal by Subject|10|||
164242287|NCT00347932|593258485|FG001|Overall Study|Withdrawal by Subject|16|||
164242288|NCT00347932|593258484|FG000|Overall Study|Did not meet inclusion criteria|4|||
164242289|NCT00347932|593258485|FG001|Overall Study|Did not meet inclusion criteria|8|||
164242290|NCT01484496|593258486|FG000|Period 1|Protocol Violation|3|||
164242291|NCT01484496|593258487|FG001|Period 1|Protocol Violation|4|||
164242292|NCT01484496|593258488|FG002|Period 1|Protocol Violation|0|||
164242293|NCT01484496|593258489|FG003|Period 1|Protocol Violation|0|||
164242294|NCT01484496|593258486|FG000|Period 1|Physician Decision|5|||
164242295|NCT01484496|593258487|FG001|Period 1|Physician Decision|1|||
164242296|NCT01484496|593258488|FG002|Period 1|Physician Decision|0|||
164242297|NCT01484496|593258489|FG003|Period 1|Physician Decision|0|||
164242298|NCT01484496|593258486|FG000|Period 1|Lack of Efficacy|10|||
164242299|NCT01484496|593258487|FG001|Period 1|Lack of Efficacy|15|||
164242300|NCT01484496|593258488|FG002|Period 1|Lack of Efficacy|0|||
164242301|NCT01484496|593258489|FG003|Period 1|Lack of Efficacy|0|||
164242302|NCT01484496|593258486|FG000|Period 1|Adverse Event|25|||
164242303|NCT01484496|593258487|FG001|Period 1|Adverse Event|40|||
164242304|NCT01484496|593258488|FG002|Period 1|Adverse Event|0|||
164242305|NCT01484496|593258489|FG003|Period 1|Adverse Event|0|||
164242306|NCT01484496|593258486|FG000|Period 1|Withdrawal by Subject|15|||
164242307|NCT01484496|593258487|FG001|Period 1|Withdrawal by Subject|12|||
164242308|NCT01484496|593258488|FG002|Period 1|Withdrawal by Subject|0|||
164242309|NCT01484496|593258489|FG003|Period 1|Withdrawal by Subject|0|||
164242310|NCT01484496|593258486|FG000|Period 1|Lost to Follow-up|2|||
164242311|NCT01484496|593258487|FG001|Period 1|Lost to Follow-up|6|||
164242312|NCT01484496|593258488|FG002|Period 1|Lost to Follow-up|0|||
164242313|NCT01484496|593258489|FG003|Period 1|Lost to Follow-up|0|||
164242314|NCT01484496|593258486|FG000|Period 1|Positive Pregnancy|1|||
164242315|NCT01484496|593258487|FG001|Period 1|Positive Pregnancy|6|||
164242316|NCT01484496|593258488|FG002|Period 1|Positive Pregnancy|0|||
164242317|NCT01484496|593258489|FG003|Period 1|Positive Pregnancy|0|||
164242318|NCT01484496|593258486|FG000|Period 1|Treatment Failure|3|||
164242319|NCT01484496|593258487|FG001|Period 1|Treatment Failure|6|||
164242320|NCT01484496|593258488|FG002|Period 1|Treatment Failure|0|||
164242321|NCT01484496|593258489|FG003|Period 1|Treatment Failure|0|||
164242322|NCT01484496|593258486|FG000|Period 1|Lack of Compliance|2|||
164242323|NCT01484496|593258487|FG001|Period 1|Lack of Compliance|1|||
164242324|NCT01484496|593258488|FG002|Period 1|Lack of Compliance|0|||
164242325|NCT01484496|593258489|FG003|Period 1|Lack of Compliance|0|||
164242326|NCT01484496|593258486|FG000|Period 1|Unable to Visit Site|0|||
164242327|NCT01484496|593258487|FG001|Period 1|Unable to Visit Site|2|||
164242328|NCT01484496|593258488|FG002|Period 1|Unable to Visit Site|0|||
164242329|NCT01484496|593258489|FG003|Period 1|Unable to Visit Site|0|||
164242330|NCT01484496|593258486|FG000|Period 2|Lack of Efficacy|0|||
164242331|NCT01484496|593258487|FG001|Period 2|Lack of Efficacy|0|||
164242332|NCT01484496|593258488|FG002|Period 2|Lack of Efficacy|1|||
164242333|NCT01484496|593258489|FG003|Period 2|Lack of Efficacy|3|||
164242334|NCT01484496|593258486|FG000|Period 2|Adverse Event|0|||
164242335|NCT01484496|593258487|FG001|Period 2|Adverse Event|0|||
164242336|NCT01484496|593258488|FG002|Period 2|Adverse Event|5|||
164242337|NCT01484496|593258489|FG003|Period 2|Adverse Event|13|||
164242338|NCT01484496|593258486|FG000|Period 2|Other|0|||
164242339|NCT01484496|593258487|FG001|Period 2|Other|0|||
164242340|NCT01484496|593258488|FG002|Period 2|Other|9|||
163884873|NCT03524118|591949730|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164242341|NCT01484496|593258489|FG003|Period 2|Other|6|||
163884874|NCT03524118|591949731|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164242342|NCT01645735|593258490|FG000|Overall Study|Physician Decision|2|||
164242343|NCT01645735|593258491|FG001|Overall Study|Physician Decision|0|||
164242344|NCT01645735|593258490|FG000|Overall Study|Withdrawal by Subject|1|||
164242345|NCT01645735|593258491|FG001|Overall Study|Withdrawal by Subject|0|||
164242346|NCT01645735|593258490|FG000|Overall Study|Protocol Violation|1|||
164242347|NCT01645735|593258491|FG001|Overall Study|Protocol Violation|0|||
164242348|NCT01645735|593258490|FG000|Overall Study|Adverse Event|0|||
164242349|NCT01645735|593258491|FG001|Overall Study|Adverse Event|1|||
164242350|NCT04860869|593258496|FG000|Overall Study|Withdrawal by Subject|1|||
164242351|NCT04860869|593258497|FG001|Overall Study|Withdrawal by Subject|0|||
163884875|NCT03524118|591949732|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164242352|NCT01775553|593258498|FG000|Overall Study|Adverse Event|1|||
164006642|NCT00847613|592391044|FG003|Overall Study|Lost to Follow-up|3|||
164242353|NCT01775553|593258498|FG000|Overall Study|Disease Progression|12|||
164242354|NCT01492088|593258508|FG000|Overall Study|Withdrawal by Patient|0|||
164242355|NCT01492088|593258509|FG001|Overall Study|Withdrawal by Patient|2|||
164242356|NCT01492088|593258510|FG002|Overall Study|Withdrawal by Patient|0|||
163884876|NCT03524118|591949733|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
163884877|NCT03524118|591949734|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
163884878|NCT03524118|591949735|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163884879|NCT04650269|591949738|FG000|Overall Study|Death|3|||
163884880|NCT04650269|591949738|FG000|Overall Study|Lost to Follow-up|6|||
163884881|NCT01437709|591949739|FG000|Overall Study|Adverse Event|0|||
163884882|NCT01437709|591949740|FG001|Overall Study|Adverse Event|1|||
163884883|NCT01437709|591949741|FG002|Overall Study|Adverse Event|0|||
163884884|NCT01437709|591949739|FG000|Overall Study|Pt trasnferred care|0|||
163884885|NCT01437709|591949740|FG001|Overall Study|Pt trasnferred care|1|||
163884886|NCT01437709|591949741|FG002|Overall Study|Pt trasnferred care|0|||
163884887|NCT04091750|591949742|FG000|Overall Study|Adverse Event|4|||
163884888|NCT04091750|591949742|FG000|Overall Study|Withdrawal by Subject|1|||
163884889|NCT02619838|591949743|FG000|Overall Study|Lost to Follow-up|9|||
163884890|NCT02619838|591949743|FG000|Overall Study|Withdrawal by Subject|15|||
163884891|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
163884892|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
163884893|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
163884894|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
163884895|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
163884896|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
163884897|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
163884898|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
163884899|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
163884900|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
163884901|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
163884902|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
163884903|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
163884904|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
164242357|NCT01492088|593258508|FG000|Overall Study|Death|1|||
164242358|NCT01492088|593258509|FG001|Overall Study|Death|6|||
164242359|NCT01492088|593258510|FG002|Overall Study|Death|2|||
164242360|NCT01492088|593258508|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
164242361|NCT01492088|593258509|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
164242362|NCT01492088|593258510|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
164242363|NCT01492088|593258508|FG000|Overall Study|Alive at Last Follow-up|0|||
164242364|NCT01492088|593258509|FG001|Overall Study|Alive at Last Follow-up|6|||
164242365|NCT01492088|593258510|FG002|Overall Study|Alive at Last Follow-up|11|||
164242366|NCT00590967|593258511|FG000|Overall Study|Withdrawal by Subject|1|||
164242367|NCT00590967|593258512|FG001|Overall Study|Withdrawal by Subject|1|||
164242368|NCT00590967|593258511|FG000|Overall Study|Ineligible|1|||
164242369|NCT00590967|593258512|FG001|Overall Study|Ineligible|0|||
164242370|NCT00590967|593258511|FG000|Overall Study|Poor performance status|0|||
164242371|NCT00590967|593258512|FG001|Overall Study|Poor performance status|1|||
164242372|NCT00590967|593258511|FG000|Overall Study|Non-compliant|0|||
164242373|NCT00590967|593258512|FG001|Overall Study|Non-compliant|2|||
164242374|NCT00590967|593258511|FG000|Overall Study|Did not sign consent form|0|||
164242375|NCT00590967|593258512|FG001|Overall Study|Did not sign consent form|1|||
164242376|NCT00590967|593258511|FG000|Overall Study|Did not receive chemo per protocol|1|||
164242377|NCT00590967|593258512|FG001|Overall Study|Did not receive chemo per protocol|0|||
164242378|NCT01881789|593258513|FG000|Overall Study|Withdrawal by Subject|0|||
164242379|NCT01881789|593258514|FG001|Overall Study|Withdrawal by Subject|2|||
164242380|NCT01881789|593258515|FG002|Overall Study|Withdrawal by Subject|1|||
164242381|NCT01881789|593258516|FG003|Overall Study|Withdrawal by Subject|0|||
164242382|NCT01881789|593258517|FG004|Overall Study|Withdrawal by Subject|1|||
164242383|NCT01881789|593258518|FG005|Overall Study|Withdrawal by Subject|1|||
164242384|NCT01881789|593258513|FG000|Overall Study|Study Terminated by Sponsor|0|||
164242385|NCT01881789|593258514|FG001|Overall Study|Study Terminated by Sponsor|0|||
164242386|NCT01881789|593258515|FG002|Overall Study|Study Terminated by Sponsor|0|||
164242387|NCT01881789|593258516|FG003|Overall Study|Study Terminated by Sponsor|0|||
164242388|NCT01881789|593258517|FG004|Overall Study|Study Terminated by Sponsor|0|||
164242389|NCT01881789|593258518|FG005|Overall Study|Study Terminated by Sponsor|1|||
164242390|NCT01881789|593258513|FG000|Overall Study|Other|3|||
164242391|NCT01881789|593258514|FG001|Overall Study|Other|5|||
164242392|NCT01881789|593258515|FG002|Overall Study|Other|2|||
164242393|NCT01881789|593258516|FG003|Overall Study|Other|3|||
164242394|NCT01881789|593258517|FG004|Overall Study|Other|1|||
164242395|NCT01881789|593258518|FG005|Overall Study|Other|1|||
164242396|NCT00920556|593258519|FG000|Overall Study|Adverse Event|16|||
164242397|NCT00920556|593258519|FG000|Overall Study|Physician Decision|7|||
164242398|NCT00920556|593258519|FG000|Overall Study|Withdrawal by Subject|1|||
164242399|NCT01299389|593258520|FG000|Double-blind|Adverse Event|45|||
164242400|NCT01299389|593258521|FG001|Double-blind|Adverse Event|27|||
164242401|NCT01299389|593258522|FG002|Double-blind|Adverse Event|0|||
164242402|NCT01299389|593258523|FG003|Double-blind|Adverse Event|0|||
164336465|NCT01543698|593609722|FG002|Phase 1b|Administrative problems|0|||
164336466|NCT01543698|593609723|FG003|Phase 1b|Administrative problems|0|||
164336467|NCT01543698|593609724|FG004|Phase 1b|Administrative problems|1|||
164336468|NCT01543698|593609725|FG005|Phase 1b|Administrative problems|0|||
164336469|NCT01543698|593609726|FG006|Phase 1b|Administrative problems|0|||
164336470|NCT01543698|593609727|FG007|Phase 1b|Administrative problems|1|||
164336471|NCT01543698|593609728|FG008|Phase 1b|Administrative problems|0|||
164336472|NCT01543698|593609729|FG009|Phase 1b|Administrative problems|0|||
164336473|NCT01543698|593609730|FG010|Phase 1b|Administrative problems|2|||
164336474|NCT01543698|593609731|FG011|Phase 1b|Administrative problems|0|||
164336475|NCT01543698|593609732|FG012|Phase 1b|Administrative problems|0|||
164336476|NCT01543698|593609733|FG013|Phase 1b|Administrative problems|0|||
164336477|NCT01543698|593609734|FG014|Phase 1b|Administrative problems|0|||
164336478|NCT01543698|593609720|FG000|Phase 1b|Protocol Violation|2|||
164336479|NCT01543698|593609721|FG001|Phase 1b|Protocol Violation|0|||
164336480|NCT01543698|593609722|FG002|Phase 1b|Protocol Violation|0|||
164336481|NCT01543698|593609723|FG003|Phase 1b|Protocol Violation|0|||
164336482|NCT01543698|593609724|FG004|Phase 1b|Protocol Violation|0|||
164336483|NCT01543698|593609725|FG005|Phase 1b|Protocol Violation|0|||
164336484|NCT01543698|593609726|FG006|Phase 1b|Protocol Violation|0|||
164336485|NCT01543698|593609727|FG007|Phase 1b|Protocol Violation|0|||
164336486|NCT01543698|593609728|FG008|Phase 1b|Protocol Violation|0|||
164336487|NCT01543698|593609729|FG009|Phase 1b|Protocol Violation|0|||
163989388|NCT05574062|592328339|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
163989389|NCT05574062|592328335|FG000|Continuation Phase Period 1|Adverse Event|1|||
164242403|NCT01299389|593258520|FG000|Double-blind|Lack of Efficacy|45|||
164242404|NCT01299389|593258521|FG001|Double-blind|Lack of Efficacy|21|||
164242405|NCT01299389|593258522|FG002|Double-blind|Lack of Efficacy|0|||
164242406|NCT01299389|593258523|FG003|Double-blind|Lack of Efficacy|0|||
164242407|NCT01299389|593258520|FG000|Double-blind|Lost to Follow-up|2|||
164242408|NCT01299389|593258521|FG001|Double-blind|Lost to Follow-up|1|||
164242409|NCT01299389|593258522|FG002|Double-blind|Lost to Follow-up|0|||
164242410|NCT01299389|593258523|FG003|Double-blind|Lost to Follow-up|0|||
164242411|NCT01299389|593258520|FG000|Double-blind|Withdrawal by Subject|16|||
164242412|NCT01299389|593258521|FG001|Double-blind|Withdrawal by Subject|13|||
164242413|NCT01299389|593258522|FG002|Double-blind|Withdrawal by Subject|0|||
164242414|NCT01299389|593258523|FG003|Double-blind|Withdrawal by Subject|0|||
164242415|NCT01299389|593258520|FG000|Double-blind|Other|1|||
164242416|NCT01299389|593258521|FG001|Double-blind|Other|1|||
164242417|NCT01299389|593258522|FG002|Double-blind|Other|0|||
164242418|NCT01299389|593258523|FG003|Double-blind|Other|0|||
164242419|NCT01299389|593258520|FG000|Double-blind|"fail to meet study population criteria"|0|||
164242420|NCT01299389|593258521|FG001|Double-blind|"fail to meet study population criteria"|1|||
164242421|NCT01299389|593258522|FG002|Double-blind|"fail to meet study population criteria"|0|||
164242422|NCT01299389|593258523|FG003|Double-blind|"fail to meet study population criteria"|0|||
164242423|NCT01299389|593258520|FG000|Post-observational|Other|0|||
164242424|NCT01299389|593258521|FG001|Post-observational|Other|0|||
164242425|NCT01299389|593258522|FG002|Post-observational|Other|12|||
164242426|NCT01299389|593258523|FG003|Post-observational|Other|6|||
164242427|NCT02834819|593258524|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
164242428|NCT02834819|593258525|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
164242429|NCT03637491|593258526|FG000|Overall Study|Death|9|||
164242430|NCT03637491|593258527|FG001|Overall Study|Death|9|||
164242431|NCT03637491|593258528|FG002|Overall Study|Death|5|||
164242432|NCT03637491|593258529|FG003|Overall Study|Death|3|||
164242433|NCT03637491|593258526|FG000|Overall Study|Lost to Follow-up|0|||
164242434|NCT03637491|593258527|FG001|Overall Study|Lost to Follow-up|1|||
164242435|NCT03637491|593258528|FG002|Overall Study|Lost to Follow-up|0|||
164242436|NCT03637491|593258529|FG003|Overall Study|Lost to Follow-up|1|||
164242437|NCT03637491|593258526|FG000|Overall Study|Study Terminated By Sponsor|0|||
164242438|NCT03637491|593258527|FG001|Overall Study|Study Terminated By Sponsor|2|||
164242439|NCT03637491|593258528|FG002|Overall Study|Study Terminated By Sponsor|1|||
164242440|NCT03637491|593258529|FG003|Overall Study|Study Terminated By Sponsor|0|||
164242441|NCT03637491|593258526|FG000|Overall Study|Withdrawal by Subject|1|||
164336488|NCT01543698|593609730|FG010|Phase 1b|Protocol Violation|0|||
164336489|NCT01543698|593609731|FG011|Phase 1b|Protocol Violation|0|||
164336490|NCT01543698|593609732|FG012|Phase 1b|Protocol Violation|0|||
164336491|NCT01543698|593609733|FG013|Phase 1b|Protocol Violation|0|||
164242442|NCT03637491|593258527|FG001|Overall Study|Withdrawal by Subject|0|||
164336492|NCT01543698|593609734|FG014|Phase 1b|Protocol Violation|0|||
164336493|NCT01543698|593609720|FG000|Phase 2|Protocol Violation|0|||
163989390|NCT05574062|592328336|FG001|Continuation Phase Period 1|Adverse Event|0|||
164336494|NCT01543698|593609721|FG001|Phase 2|Protocol Violation|0|||
163989391|NCT05574062|592328337|FG002|Continuation Phase Period 1|Adverse Event|0|||
164242443|NCT03637491|593258528|FG002|Overall Study|Withdrawal by Subject|1|||
164336495|NCT01543698|593609722|FG002|Phase 2|Protocol Violation|0|||
164336496|NCT01543698|593609723|FG003|Phase 2|Protocol Violation|0|||
164336497|NCT01543698|593609724|FG004|Phase 2|Protocol Violation|0|||
164336498|NCT01543698|593609725|FG005|Phase 2|Protocol Violation|0|||
164242444|NCT03637491|593258529|FG003|Overall Study|Withdrawal by Subject|2|||
164242445|NCT00889707|593258530|FG000|Overall Study|Adverse Event|1|||
164242446|NCT00889707|593258531|FG001|Overall Study|Adverse Event|0|||
164242447|NCT00889707|593258530|FG000|Overall Study|Withdrawal by Subject|4|||
164242448|NCT00889707|593258531|FG001|Overall Study|Withdrawal by Subject|3|||
164242449|NCT00889707|593258530|FG000|Overall Study|Lost to Follow-up|0|||
164242450|NCT00889707|593258531|FG001|Overall Study|Lost to Follow-up|2|||
164242451|NCT00889707|593258530|FG000|Overall Study|Lack of Efficacy|2|||
164242452|NCT00889707|593258531|FG001|Overall Study|Lack of Efficacy|5|||
164242453|NCT02185534|593258532|FG000|First Period|Withdrawal by Subject|0|||
164242454|NCT02185534|593258533|FG001|First Period|Withdrawal by Subject|0|||
164242455|NCT02185534|593258534|FG002|First Period|Withdrawal by Subject|0|||
164242456|NCT02185534|593258535|FG003|First Period|Withdrawal by Subject|1|||
164242457|NCT02185534|593258536|FG004|First Period|Withdrawal by Subject|0|||
164242458|NCT02185534|593258537|FG005|First Period|Withdrawal by Subject|0|||
164242459|NCT02185534|593258532|FG000|First Washout Period|Withdrawal by Subject|1|||
164242460|NCT02185534|593258533|FG001|First Washout Period|Withdrawal by Subject|0|||
164242461|NCT02185534|593258534|FG002|First Washout Period|Withdrawal by Subject|0|||
164242462|NCT02185534|593258535|FG003|First Washout Period|Withdrawal by Subject|0|||
164242463|NCT02185534|593258536|FG004|First Washout Period|Withdrawal by Subject|1|||
164242464|NCT02185534|593258537|FG005|First Washout Period|Withdrawal by Subject|0|||
164242465|NCT02185534|593258532|FG000|First Washout Period|Protocol Violation|0|||
164242466|NCT02185534|593258533|FG001|First Washout Period|Protocol Violation|0|||
164242467|NCT02185534|593258534|FG002|First Washout Period|Protocol Violation|0|||
164242468|NCT02185534|593258535|FG003|First Washout Period|Protocol Violation|0|||
164242469|NCT02185534|593258536|FG004|First Washout Period|Protocol Violation|0|||
164242470|NCT02185534|593258537|FG005|First Washout Period|Protocol Violation|1|||
164242471|NCT02737501|593258547|FG000|Randomized Phase|Died|41|||
164242472|NCT02737501|593258548|FG001|Randomized Phase|Died|29|||
164242473|NCT02737501|593258549|FG002|Randomized Phase|Died|0|||
164242474|NCT02737501|593258547|FG000|Randomized Phase|Withdrawal by Subject|16|||
164242475|NCT02737501|593258548|FG001|Randomized Phase|Withdrawal by Subject|6|||
164242476|NCT02737501|593258549|FG002|Randomized Phase|Withdrawal by Subject|0|||
164242477|NCT02737501|593258547|FG000|Randomized Phase|Lost to Follow-up|0|||
164242478|NCT02737501|593258548|FG001|Randomized Phase|Lost to Follow-up|1|||
164242479|NCT02737501|593258549|FG002|Randomized Phase|Lost to Follow-up|0|||
164242480|NCT02737501|593258547|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
164242481|NCT02737501|593258548|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
164242482|NCT02737501|593258549|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
164242483|NCT02737501|593258547|FG000|Randomized Phase|Reason not Specified|1|||
164242484|NCT02737501|593258548|FG001|Randomized Phase|Reason not Specified|1|||
164242485|NCT02737501|593258549|FG002|Randomized Phase|Reason not Specified|0|||
164242486|NCT02737501|593258547|FG000|Randomized Phase|Never Treated|1|||
164242487|NCT02737501|593258548|FG001|Randomized Phase|Never Treated|1|||
164242488|NCT02737501|593258549|FG002|Randomized Phase|Never Treated|0|||
164242489|NCT02737501|593258547|FG000|Crossover Phase|Died|0|||
164242490|NCT02737501|593258548|FG001|Crossover Phase|Died|0|||
164242491|NCT02737501|593258549|FG002|Crossover Phase|Died|22|||
164242492|NCT02737501|593258547|FG000|Crossover Phase|Withdrew Consent|0|||
164242493|NCT02737501|593258548|FG001|Crossover Phase|Withdrew Consent|0|||
164242494|NCT02737501|593258549|FG002|Crossover Phase|Withdrew Consent|9|||
164242495|NCT02737501|593258547|FG000|Crossover Phase|Physician Decision|0|||
163884905|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
163884906|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
164242496|NCT02737501|593258548|FG001|Crossover Phase|Physician Decision|0|||
164242497|NCT02737501|593258549|FG002|Crossover Phase|Physician Decision|1|||
164242498|NCT02737501|593258547|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
164242499|NCT02737501|593258548|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
164242500|NCT02737501|593258549|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
164242501|NCT02012218|593258550|FG000|Overall Study|Withdrawal by Subject|1|||
164242502|NCT02012218|593258551|FG001|Overall Study|Withdrawal by Subject|0|||
164242503|NCT02012218|593258552|FG002|Overall Study|Withdrawal by Subject|1|||
164242504|NCT02012218|593258553|FG003|Overall Study|Withdrawal by Subject|1|||
164242505|NCT02012218|593258554|FG004|Overall Study|Withdrawal by Subject|1|||
164242506|NCT02012218|593258550|FG000|Overall Study|Adverse Event|1|||
164242507|NCT02012218|593258551|FG001|Overall Study|Adverse Event|0|||
164242508|NCT02012218|593258552|FG002|Overall Study|Adverse Event|0|||
164242509|NCT02012218|593258553|FG003|Overall Study|Adverse Event|1|||
164242510|NCT02012218|593258554|FG004|Overall Study|Adverse Event|0|||
164242511|NCT02012218|593258550|FG000|Overall Study|Lost to Follow-up|0|||
164242512|NCT02012218|593258551|FG001|Overall Study|Lost to Follow-up|1|||
164242513|NCT02012218|593258552|FG002|Overall Study|Lost to Follow-up|1|||
164242514|NCT02012218|593258553|FG003|Overall Study|Lost to Follow-up|0|||
164242515|NCT02012218|593258554|FG004|Overall Study|Lost to Follow-up|0|||
164242516|NCT02012218|593258550|FG000|Overall Study|Protocol Specified|1|||
164242517|NCT02012218|593258551|FG001|Overall Study|Protocol Specified|0|||
164242518|NCT02012218|593258552|FG002|Overall Study|Protocol Specified|0|||
164242519|NCT02012218|593258553|FG003|Overall Study|Protocol Specified|0|||
164242520|NCT02012218|593258554|FG004|Overall Study|Protocol Specified|0|||
164242521|NCT02012218|593258550|FG000|Overall Study|Protocol Deviation|1|||
164242522|NCT02012218|593258551|FG001|Overall Study|Protocol Deviation|0|||
164242523|NCT02012218|593258552|FG002|Overall Study|Protocol Deviation|0|||
164242524|NCT02012218|593258553|FG003|Overall Study|Protocol Deviation|0|||
164242525|NCT02012218|593258554|FG004|Overall Study|Protocol Deviation|0|||
164242526|NCT04819113|593258555|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164242527|NCT04819113|593258555|FG000|Overall Study|Lost to Follow-up|1|||
164242528|NCT04819113|593258555|FG000|Overall Study|Withdrawn before vaccination|2|||
164242529|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Death|2|||
164242530|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
164242531|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
164242532|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Physician Decision|1|||
164242533|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
164242534|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
164242535|NCT00786422|593258556|FG000|Rivaroxaban Treatment|Adverse Event|2|||
164242536|NCT00786422|593258556|FG000|Follow-up Period|Death|1|||
164242537|NCT00786422|593258556|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
164242538|NCT01085214|593258559|FG000|Overall Study|Alternate treatment required|1|||
164242539|NCT01985022|593258573|FG000|Overall Study|Lost to Follow-up|0|||
164242540|NCT01985022|593258574|FG001|Overall Study|Lost to Follow-up|1|||
164336499|NCT01543698|593609726|FG006|Phase 2|Protocol Violation|0|||
164336500|NCT01543698|593609727|FG007|Phase 2|Protocol Violation|0|||
164336501|NCT01543698|593609728|FG008|Phase 2|Protocol Violation|0|||
164336502|NCT01543698|593609729|FG009|Phase 2|Protocol Violation|0|||
164336503|NCT01543698|593609730|FG010|Phase 2|Protocol Violation|0|||
164336504|NCT01543698|593609731|FG011|Phase 2|Protocol Violation|0|||
164336505|NCT01543698|593609732|FG012|Phase 2|Protocol Violation|1|||
164336506|NCT01543698|593609733|FG013|Phase 2|Protocol Violation|0|||
164336507|NCT01543698|593609734|FG014|Phase 2|Protocol Violation|0|||
164336508|NCT01543698|593609720|FG000|Phase 2|Disease progression|0|||
164336509|NCT01543698|593609721|FG001|Phase 2|Disease progression|0|||
164336510|NCT01543698|593609722|FG002|Phase 2|Disease progression|0|||
164336511|NCT01543698|593609723|FG003|Phase 2|Disease progression|0|||
164336512|NCT01543698|593609724|FG004|Phase 2|Disease progression|0|||
164336513|NCT01543698|593609725|FG005|Phase 2|Disease progression|0|||
164336514|NCT01543698|593609726|FG006|Phase 2|Disease progression|0|||
164336515|NCT01543698|593609727|FG007|Phase 2|Disease progression|0|||
164336516|NCT01543698|593609728|FG008|Phase 2|Disease progression|0|||
163989392|NCT05574062|592328338|FG003|Continuation Phase Period 1|Adverse Event|0|||
163989393|NCT05574062|592328339|FG004|Continuation Phase Period 1|Adverse Event|0|||
163989394|NCT05574062|592328335|FG000|Continuation Phase Period 1|Death|1|||
164242541|NCT01985022|593258573|FG000|Overall Study|Protocol Violation|0|||
164242542|NCT01985022|593258574|FG001|Overall Study|Protocol Violation|1|||
164242543|NCT01985022|593258573|FG000|Overall Study|Withdrawal by Subject|4|||
164242544|NCT01985022|593258574|FG001|Overall Study|Withdrawal by Subject|1|||
164242545|NCT03761056|593258579|FG000|Overall Study|Death|8|||
164242546|NCT03761056|593258579|FG000|Overall Study|Enrolled but never treated|2|||
164242547|NCT03761056|593258579|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
164242548|NCT03761056|593258579|FG000|Overall Study|Investigator decision|1|||
164242549|NCT00996658|593258580|FG000|Overall Study|Adverse Event|2|||
164336517|NCT01543698|593609729|FG009|Phase 2|Disease progression|0|||
164336518|NCT01543698|593609730|FG010|Phase 2|Disease progression|0|||
164336519|NCT01543698|593609731|FG011|Phase 2|Disease progression|10|||
164336520|NCT01543698|593609732|FG012|Phase 2|Disease progression|21|||
164336521|NCT01543698|593609733|FG013|Phase 2|Disease progression|30|||
164336522|NCT01543698|593609734|FG014|Phase 2|Disease progression|25|||
164336523|NCT01543698|593609720|FG000|Phase 2|Death|0|||
163989395|NCT05574062|592328336|FG001|Continuation Phase Period 1|Death|0|||
163989396|NCT05574062|592328337|FG002|Continuation Phase Period 1|Death|0|||
163989397|NCT05574062|592328338|FG003|Continuation Phase Period 1|Death|0|||
163989398|NCT05574062|592328339|FG004|Continuation Phase Period 1|Death|0|||
163989399|NCT05574062|592328335|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
163989400|NCT05574062|592328336|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
163989401|NCT05574062|592328337|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
163989402|NCT05574062|592328338|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
163989403|NCT05574062|592328339|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
163989404|NCT05702736|592328341|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
163989405|NCT05702736|592328342|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
163989406|NCT05702736|592328341|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
163989407|NCT05702736|592328342|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
163989408|NCT05902364|592328361|FG000|Overall Study|Adverse Event|1|||
163989409|NCT05902364|592328362|FG001|Overall Study|Adverse Event|0|||
163989410|NCT02270242|592328363|FG000|Overall Study|Withdrawal by Subject|18|||
163989411|NCT02270242|592328364|FG001|Overall Study|Withdrawal by Subject|25|||
163989412|NCT02270242|592328363|FG000|Overall Study|Lost to Follow-up|41|||
163989413|NCT02270242|592328364|FG001|Overall Study|Lost to Follow-up|27|||
163989414|NCT02270242|592328363|FG000|Overall Study|Physician Decision|0|||
163989415|NCT02270242|592328364|FG001|Overall Study|Physician Decision|1|||
163989416|NCT02321436|592328365|FG000|Overall Study|Withdrawal by Subject|1|||
163989417|NCT02321436|592328366|FG001|Overall Study|Withdrawal by Subject|0|||
163989418|NCT02321436|592328365|FG000|Overall Study|Lost to Follow-up|0|||
163989419|NCT02321436|592328366|FG001|Overall Study|Lost to Follow-up|1|||
163989420|NCT03355300|592328367|FG000|Overall Study|Physician Decision|0|||
163989421|NCT03355300|592328368|FG001|Overall Study|Physician Decision|1|||
163989422|NCT03355300|592328367|FG000|Overall Study|Lack of Efficacy|2|||
163989423|NCT03355300|592328368|FG001|Overall Study|Lack of Efficacy|1|||
163989424|NCT03355300|592328367|FG000|Overall Study|Other reason|1|||
163989425|NCT03355300|592328368|FG001|Overall Study|Other reason|0|||
163989426|NCT00546052|592328369|FG000|Overall Study|Adverse Event|47|||
163989427|NCT00546052|592328369|FG000|Overall Study|Lost to Follow-up|144|||
163989428|NCT00546052|592328369|FG000|Overall Study|Protocol Violation|9|||
163989429|NCT00546052|592328369|FG000|Overall Study|Withdrawal by Subject|20|||
163989430|NCT00546052|592328369|FG000|Overall Study|Non Compliance|7|||
163989431|NCT01031446|592328372|FG000|Overall Study|Disease Progression|38|||
163989432|NCT01031446|592328372|FG000|Overall Study|Adverse Event|9|||
163989433|NCT01031446|592328372|FG000|Overall Study|Physician Decision|4|||
163989434|NCT01031446|592328372|FG000|Overall Study|Withdrawal by Subject|3|||
163989435|NCT01031446|592328372|FG000|Overall Study|Still on treatment|1|||
163989436|NCT01877083|592328373|FG000|Treatment Phase|Disease Progression|10|||
163989437|NCT01877083|592328373|FG000|Treatment Phase|Clinical Progression|1|||
163989438|NCT01877083|592328373|FG000|Treatment Phase|Adverse Event|6|||
163989439|NCT01877083|592328373|FG000|Treatment Phase|Withdrawal by Subject|2|||
163989440|NCT01877083|592328373|FG000|Treatment Phase|Lost to Follow-up|1|||
163989441|NCT01877083|592328373|FG000|Extension Phase|Disease Progression|3|||
163989442|NCT01877083|592328373|FG000|Extension Phase|Adverse Event|2|||
163989443|NCT02324270|592329597|FG000|Overall Study|Withdrawal by Subject|0|||
163989444|NCT02324270|592329598|FG001|Overall Study|Withdrawal by Subject|1|||
163989445|NCT02324270|592329599|FG002|Overall Study|Withdrawal by Subject|0|||
163989446|NCT02324270|592329597|FG000|Overall Study|Lost to Follow-up|4|||
163989447|NCT02324270|592329598|FG001|Overall Study|Lost to Follow-up|3|||
164083435|NCT02711956|592670191|FG002|Overall Study|Adverse Event|0|||
164083436|NCT02711956|592670192|FG003|Overall Study|Adverse Event|1|||
164083437|NCT02711956|592670193|FG004|Overall Study|Adverse Event|2|||
164083438|NCT02711956|592670194|FG005|Overall Study|Adverse Event|0|||
164083439|NCT02711956|592670195|FG006|Overall Study|Adverse Event|0|||
164083440|NCT02711956|592670196|FG007|Overall Study|Adverse Event|1|||
163989448|NCT02324270|592329599|FG002|Overall Study|Lost to Follow-up|4|||
163989449|NCT02324270|592329597|FG000|Overall Study|Protocol Violation|0|||
163989450|NCT02324270|592329598|FG001|Overall Study|Protocol Violation|1|||
163989451|NCT02324270|592329599|FG002|Overall Study|Protocol Violation|1|||
163989452|NCT02324270|592329597|FG000|Overall Study|Non Compliance with Study Drug|1|||
163989453|NCT02324270|592329598|FG001|Overall Study|Non Compliance with Study Drug|2|||
163989454|NCT02324270|592329599|FG002|Overall Study|Non Compliance with Study Drug|0|||
163989455|NCT03521791|592329600|FG000|Overall Study|Protocol Violation|7|||
163989456|NCT03521791|592329601|FG001|Overall Study|Protocol Violation|17|||
163989457|NCT00680836|592329603|FG000|Overall Study|Withdrawal by Subject|3|||
163989458|NCT00680836|592329604|FG001|Overall Study|Withdrawal by Subject|0|||
163989459|NCT00680836|592329603|FG000|Overall Study|Lost to Follow-up|3|||
163989460|NCT00680836|592329604|FG001|Overall Study|Lost to Follow-up|1|||
163989461|NCT00680836|592329603|FG000|Overall Study|Physician Decision|2|||
163989462|NCT00680836|592329604|FG001|Overall Study|Physician Decision|1|||
163989463|NCT03786432|592329605|FG000|Overall Study|Screen Failure after consent|1|||
164083441|NCT02711956|592670197|FG008|Overall Study|Adverse Event|1|||
164083442|NCT02711956|592670198|FG009|Overall Study|Adverse Event|1|||
163989464|NCT03786432|592329605|FG000|Overall Study|Lost to Follow-up|4|||
163989465|NCT03786432|592329605|FG000|Overall Study|did not complete 12 month CT scan|1|||
163989466|NCT03038308|592329606|FG000|Overall Study|Surgical resection|1|||
163989467|NCT03038308|592329606|FG000|Overall Study|Withdrawal by Subject|2|||
163989468|NCT03038308|592329606|FG000|Overall Study|Lost to Follow-up|1|||
163989469|NCT01475734|592329608|FG000|Overall Study|Withdrawal by Subject|1|||
163989470|NCT01475734|592329609|FG001|Overall Study|Withdrawal by Subject|0|||
163989471|NCT01475734|592329608|FG000|Overall Study|Protocol Violation|1|||
163989472|NCT01475734|592329609|FG001|Overall Study|Protocol Violation|0|||
163989473|NCT01475734|592329608|FG000|Overall Study|Physician Decision|0|||
163989474|NCT01475734|592329609|FG001|Overall Study|Physician Decision|1|||
163989475|NCT00771472|592329610|FG000|Overall Study|Physician Decision|2|||
163989476|NCT00771472|592329611|FG001|Overall Study|Physician Decision|3|||
163989477|NCT00771472|592329610|FG000|Overall Study|Progressive Disease|3|||
164336524|NCT01543698|593609721|FG001|Phase 2|Death|0|||
164336525|NCT01543698|593609722|FG002|Phase 2|Death|0|||
164336526|NCT01543698|593609723|FG003|Phase 2|Death|0|||
163884907|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
163884908|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
163884909|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
163884910|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
163884911|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
163884912|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
163884913|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
163884914|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
163884915|NCT01715285|591949744|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
163884916|NCT01715285|591949745|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
163884917|NCT01715285|591949746|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
163884918|NCT01715285|591949744|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
163884919|NCT01715285|591949745|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
163884920|NCT01715285|591949746|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
163884921|NCT01715285|591949744|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
163884922|NCT01715285|591949745|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
163884923|NCT01715285|591949746|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
163884924|NCT01715285|591949744|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
163884925|NCT01715285|591949745|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
163884926|NCT01715285|591949746|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
163884927|NCT01715285|591949744|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
163884928|NCT01715285|591949745|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
163884929|NCT01715285|591949746|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
163884930|NCT01715285|591949744|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
163884931|NCT01715285|591949745|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
163884932|NCT01715285|591949746|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
163884933|NCT05020249|591949747|FG000|Overall Study|Protocol Violation|1|||
163884934|NCT05020249|591949748|FG001|Overall Study|Protocol Violation|0|||
163884935|NCT04015167|591949749|FG000|Overall Study|Lost to Follow-up|40|||
163884936|NCT04015167|591949749|FG000|Overall Study|Adverse Event|5|||
163884937|NCT04015167|591949749|FG000|Overall Study|Withdrawal by Subject|2|||
163884938|NCT04015167|591949749|FG000|Overall Study|Subject went to jail|1|||
163884939|NCT04376502|591949754|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
163884940|NCT04111536|591949755|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163884941|NCT04111536|591949756|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163884942|NCT04111536|591949755|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
163884943|NCT04111536|591949756|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
163884944|NCT04111536|591949755|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
163884945|NCT04111536|591949756|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163884946|NCT04111536|591949755|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
163884947|NCT04111536|591949756|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
163884948|NCT06037369|591949758|FG000|Overall Study|Lost to Follow-up|0|||
163884949|NCT06037369|591949759|FG001|Overall Study|Lost to Follow-up|1|||
163884950|NCT04209465|591949760|FG000|Overall Study|Adverse Event|0|||
163884951|NCT04209465|591949761|FG001|Overall Study|Adverse Event|0|||
164336527|NCT01543698|593609724|FG004|Phase 2|Death|0|||
164336528|NCT01543698|593609725|FG005|Phase 2|Death|0|||
163884952|NCT04209465|591949762|FG002|Overall Study|Adverse Event|0|||
163884953|NCT04209465|591949763|FG003|Overall Study|Adverse Event|0|||
163884954|NCT04209465|591949764|FG004|Overall Study|Adverse Event|0|||
163884955|NCT04209465|591949765|FG005|Overall Study|Adverse Event|1|||
163884956|NCT04209465|591949766|FG006|Overall Study|Adverse Event|0|||
163884957|NCT04209465|591949767|FG007|Overall Study|Adverse Event|0|||
163884958|NCT04209465|591949768|FG008|Overall Study|Adverse Event|1|||
163989478|NCT00771472|592329611|FG001|Overall Study|Progressive Disease|1|||
163989479|NCT00771472|592329610|FG000|Overall Study|Protocol Violation|1|||
163989480|NCT00771472|592329611|FG001|Overall Study|Protocol Violation|0|||
164336529|NCT01543698|593609726|FG006|Phase 2|Death|0|||
164336530|NCT01543698|593609727|FG007|Phase 2|Death|0|||
164336531|NCT01543698|593609728|FG008|Phase 2|Death|0|||
164336532|NCT01543698|593609729|FG009|Phase 2|Death|0|||
164336533|NCT01543698|593609730|FG010|Phase 2|Death|0|||
164336534|NCT01543698|593609731|FG011|Phase 2|Death|0|||
164336535|NCT01543698|593609732|FG012|Phase 2|Death|1|||
164336536|NCT01543698|593609733|FG013|Phase 2|Death|1|||
164336537|NCT01543698|593609734|FG014|Phase 2|Death|1|||
164336538|NCT01543698|593609720|FG000|Phase 2|Administrative problems|0|||
163884959|NCT04209465|591949769|FG009|Overall Study|Adverse Event|0|||
164336539|NCT01543698|593609721|FG001|Phase 2|Administrative problems|0|||
164336540|NCT01543698|593609722|FG002|Phase 2|Administrative problems|0|||
164336541|NCT01543698|593609723|FG003|Phase 2|Administrative problems|0|||
164336542|NCT01543698|593609724|FG004|Phase 2|Administrative problems|0|||
164336543|NCT01543698|593609725|FG005|Phase 2|Administrative problems|0|||
164336544|NCT01543698|593609726|FG006|Phase 2|Administrative problems|0|||
164336545|NCT01543698|593609727|FG007|Phase 2|Administrative problems|0|||
164336546|NCT01543698|593609728|FG008|Phase 2|Administrative problems|0|||
164336547|NCT01543698|593609729|FG009|Phase 2|Administrative problems|0|||
164336548|NCT01543698|593609730|FG010|Phase 2|Administrative problems|0|||
164336549|NCT01543698|593609731|FG011|Phase 2|Administrative problems|0|||
164336550|NCT01543698|593609732|FG012|Phase 2|Administrative problems|0|||
163884960|NCT04209465|591949770|FG010|Overall Study|Adverse Event|2|||
163884961|NCT04209465|591949771|FG011|Overall Study|Adverse Event|1|||
163884962|NCT04209465|591949772|FG012|Overall Study|Adverse Event|1|||
163884963|NCT04209465|591949760|FG000|Overall Study|Death|1|||
163884964|NCT04209465|591949761|FG001|Overall Study|Death|0|||
163884965|NCT04209465|591949762|FG002|Overall Study|Death|0|||
163884966|NCT04209465|591949763|FG003|Overall Study|Death|0|||
163884967|NCT04209465|591949764|FG004|Overall Study|Death|2|||
163884968|NCT04209465|591949765|FG005|Overall Study|Death|7|||
163884969|NCT04209465|591949766|FG006|Overall Study|Death|2|||
163884970|NCT04209465|591949767|FG007|Overall Study|Death|2|||
163884971|NCT04209465|591949768|FG008|Overall Study|Death|1|||
163884972|NCT04209465|591949769|FG009|Overall Study|Death|1|||
163884973|NCT04209465|591949770|FG010|Overall Study|Death|1|||
163884974|NCT04209465|591949771|FG011|Overall Study|Death|0|||
163884975|NCT04209465|591949772|FG012|Overall Study|Death|10|||
163884976|NCT04209465|591949760|FG000|Overall Study|Physician Decision|0|||
163884977|NCT04209465|591949761|FG001|Overall Study|Physician Decision|1|||
163884978|NCT04209465|591949762|FG002|Overall Study|Physician Decision|0|||
163884979|NCT04209465|591949763|FG003|Overall Study|Physician Decision|0|||
163884980|NCT04209465|591949764|FG004|Overall Study|Physician Decision|0|||
163884981|NCT04209465|591949765|FG005|Overall Study|Physician Decision|0|||
163884982|NCT04209465|591949766|FG006|Overall Study|Physician Decision|0|||
163884983|NCT04209465|591949767|FG007|Overall Study|Physician Decision|0|||
163884984|NCT04209465|591949768|FG008|Overall Study|Physician Decision|0|||
163884985|NCT04209465|591949769|FG009|Overall Study|Physician Decision|0|||
163884986|NCT04209465|591949770|FG010|Overall Study|Physician Decision|0|||
163884987|NCT04209465|591949771|FG011|Overall Study|Physician Decision|0|||
163884988|NCT04209465|591949772|FG012|Overall Study|Physician Decision|0|||
163884989|NCT04209465|591949760|FG000|Overall Study|Progressive Disease|0|||
163884990|NCT04209465|591949761|FG001|Overall Study|Progressive Disease|0|||
163884991|NCT04209465|591949762|FG002|Overall Study|Progressive Disease|1|||
163884992|NCT04209465|591949763|FG003|Overall Study|Progressive Disease|2|||
163884993|NCT04209465|591949764|FG004|Overall Study|Progressive Disease|8|||
163884994|NCT04209465|591949765|FG005|Overall Study|Progressive Disease|5|||
163884995|NCT04209465|591949766|FG006|Overall Study|Progressive Disease|3|||
163884996|NCT04209465|591949767|FG007|Overall Study|Progressive Disease|4|||
163884997|NCT04209465|591949768|FG008|Overall Study|Progressive Disease|1|||
163884998|NCT04209465|591949769|FG009|Overall Study|Progressive Disease|3|||
164336551|NCT01543698|593609733|FG013|Phase 2|Administrative problems|3|||
164336552|NCT01543698|593609734|FG014|Phase 2|Administrative problems|1|||
164336553|NCT01543698|593609720|FG000|Phase 2|Withdrawal by Subject|0|||
163884999|NCT04209465|591949770|FG010|Overall Study|Progressive Disease|2|||
163885000|NCT04209465|591949771|FG011|Overall Study|Progressive Disease|1|||
163885001|NCT04209465|591949772|FG012|Overall Study|Progressive Disease|0|||
163885002|NCT04209465|591949760|FG000|Overall Study|Withdrawal by Subject|0|||
163885003|NCT04209465|591949761|FG001|Overall Study|Withdrawal by Subject|0|||
163885004|NCT04209465|591949762|FG002|Overall Study|Withdrawal by Subject|0|||
164336554|NCT01543698|593609721|FG001|Phase 2|Withdrawal by Subject|0|||
164336555|NCT01543698|593609722|FG002|Phase 2|Withdrawal by Subject|0|||
164336556|NCT01543698|593609723|FG003|Phase 2|Withdrawal by Subject|0|||
164336557|NCT01543698|593609724|FG004|Phase 2|Withdrawal by Subject|0|||
163885005|NCT04209465|591949763|FG003|Overall Study|Withdrawal by Subject|0|||
163885006|NCT04209465|591949764|FG004|Overall Study|Withdrawal by Subject|0|||
164336558|NCT01543698|593609725|FG005|Phase 2|Withdrawal by Subject|0|||
164336559|NCT01543698|593609726|FG006|Phase 2|Withdrawal by Subject|0|||
164336560|NCT01543698|593609727|FG007|Phase 2|Withdrawal by Subject|0|||
164336561|NCT01543698|593609728|FG008|Phase 2|Withdrawal by Subject|0|||
163885007|NCT04209465|591949765|FG005|Overall Study|Withdrawal by Subject|1|||
163885008|NCT04209465|591949766|FG006|Overall Study|Withdrawal by Subject|2|||
164336562|NCT01543698|593609729|FG009|Phase 2|Withdrawal by Subject|0|||
163989481|NCT00667576|592329617|FG000|Overall Study|Withdrawal by Subject|1|||
163989482|NCT00667576|592329618|FG001|Overall Study|Withdrawal by Subject|0|||
163989483|NCT00667576|592329619|FG002|Overall Study|Withdrawal by Subject|1|||
163989484|NCT00667576|592329620|FG003|Overall Study|Withdrawal by Subject|1|||
163989485|NCT00667576|592329621|FG004|Overall Study|Withdrawal by Subject|1|||
163989486|NCT00667576|592329617|FG000|Overall Study|Adverse Event|1|||
163989487|NCT00667576|592329618|FG001|Overall Study|Adverse Event|1|||
163989488|NCT00667576|592329619|FG002|Overall Study|Adverse Event|0|||
163989489|NCT00667576|592329620|FG003|Overall Study|Adverse Event|0|||
163989490|NCT00667576|592329621|FG004|Overall Study|Adverse Event|0|||
163989491|NCT00667576|592329617|FG000|Overall Study|Lost to Follow-up|0|||
163989492|NCT00667576|592329618|FG001|Overall Study|Lost to Follow-up|0|||
163989493|NCT00667576|592329619|FG002|Overall Study|Lost to Follow-up|1|||
163989494|NCT00667576|592329620|FG003|Overall Study|Lost to Follow-up|0|||
163989495|NCT00667576|592329621|FG004|Overall Study|Lost to Follow-up|0|||
163989496|NCT00667576|592329617|FG000|Overall Study|Protocol Violation|0|||
163989497|NCT00667576|592329618|FG001|Overall Study|Protocol Violation|0|||
163989498|NCT00667576|592329619|FG002|Overall Study|Protocol Violation|0|||
163989499|NCT00667576|592329620|FG003|Overall Study|Protocol Violation|1|||
163989500|NCT00667576|592329621|FG004|Overall Study|Protocol Violation|0|||
163989501|NCT00667576|592329617|FG000|Overall Study|Physician Decision|0|||
163989502|NCT00667576|592329618|FG001|Overall Study|Physician Decision|0|||
163989503|NCT00667576|592329619|FG002|Overall Study|Physician Decision|0|||
163989504|NCT00667576|592329620|FG003|Overall Study|Physician Decision|1|||
163989505|NCT00667576|592329621|FG004|Overall Study|Physician Decision|0|||
163989506|NCT00667576|592329617|FG000|Overall Study|Missed Visit|0|||
163989507|NCT00667576|592329618|FG001|Overall Study|Missed Visit|0|||
163989508|NCT00667576|592329619|FG002|Overall Study|Missed Visit|0|||
163989509|NCT00667576|592329620|FG003|Overall Study|Missed Visit|1|||
163989510|NCT00667576|592329621|FG004|Overall Study|Missed Visit|0|||
164242550|NCT00996658|593258581|FG001|Overall Study|Adverse Event|5|||
164242551|NCT00996658|593258580|FG000|Overall Study|Protocol Violation|0|||
164242552|NCT00996658|593258581|FG001|Overall Study|Protocol Violation|1|||
164242553|NCT00996658|593258580|FG000|Overall Study|Lost to Follow-up|2|||
164242554|NCT00996658|593258581|FG001|Overall Study|Lost to Follow-up|5|||
164242555|NCT00996658|593258580|FG000|Overall Study|Non-compliance issues|3|||
164242556|NCT00996658|593258581|FG001|Overall Study|Non-compliance issues|3|||
164242557|NCT00996658|593258580|FG000|Overall Study|Other|9|||
164242558|NCT00996658|593258581|FG001|Overall Study|Other|7|||
164242559|NCT04267926|593260283|FG000|Overall Study|abnormal labs. No longer eligible|0|||
164242560|NCT04267926|593260284|FG001|Overall Study|abnormal labs. No longer eligible|0|||
164242561|NCT04267926|593260285|FG002|Overall Study|abnormal labs. No longer eligible|1|||
164242562|NCT04267926|593260283|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
164242563|NCT04267926|593260284|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
164242564|NCT04267926|593260285|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
164242565|NCT00532129|593260286|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
164242566|NCT00532129|593260286|FG000|Treatment Period|Physician Decision|15|||
164242567|NCT00532129|593260286|FG000|Treatment Period|Disease progression|3|||
164242568|NCT00532129|593260286|FG000|Treatment Period|Protocol Violation|1|||
164242569|NCT00532129|593260286|FG000|Treatment Period|Other|5|||
164242570|NCT00532129|593260286|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
164242571|NCT00532129|593260286|FG000|Follow-up Period|Disease progression|57|||
164242572|NCT00532129|593260286|FG000|Follow-up Period|Lost to Follow-up|1|||
164242573|NCT00532129|593260286|FG000|Follow-up Period|Other|6|||
164242574|NCT01396187|593260287|FG000|Overall Study|Adverse Event|0|||
164242575|NCT01396187|593260288|FG001|Overall Study|Adverse Event|1|||
164242576|NCT01396187|593260289|FG002|Overall Study|Adverse Event|0|||
164242577|NCT01396187|593260290|FG003|Overall Study|Adverse Event|0|||
164242578|NCT01396187|593260291|FG004|Overall Study|Adverse Event|0|||
164242579|NCT01396187|593260287|FG000|Overall Study|Withdrawal by Subject|0|||
164242580|NCT01396187|593260288|FG001|Overall Study|Withdrawal by Subject|1|||
164242581|NCT01396187|593260289|FG002|Overall Study|Withdrawal by Subject|1|||
164242582|NCT01396187|593260290|FG003|Overall Study|Withdrawal by Subject|0|||
164242583|NCT01396187|593260291|FG004|Overall Study|Withdrawal by Subject|0|||
164242584|NCT01396187|593260287|FG000|Overall Study|Other|1|||
164242585|NCT01396187|593260288|FG001|Overall Study|Other|1|||
164242586|NCT01396187|593260289|FG002|Overall Study|Other|0|||
164242587|NCT01396187|593260290|FG003|Overall Study|Other|0|||
164242588|NCT01396187|593260291|FG004|Overall Study|Other|1|||
164242589|NCT00551031|593260292|FG000|Overall Study|Adverse Event|0|||
164242590|NCT00551031|593260293|FG001|Overall Study|Adverse Event|1|||
164242591|NCT00551031|593260294|FG002|Overall Study|Adverse Event|0|||
164242592|NCT00551031|593260295|FG003|Overall Study|Adverse Event|0|||
164242593|NCT00551031|593260296|FG004|Overall Study|Adverse Event|0|||
164336563|NCT01543698|593609730|FG010|Phase 2|Withdrawal by Subject|0|||
163989511|NCT01231555|592329626|FG000|Overall Study|Study terminated|8|||
164242594|NCT00551031|593260292|FG000|Overall Study|Protocol Violation|1|||
164242595|NCT00551031|593260293|FG001|Overall Study|Protocol Violation|1|||
163989512|NCT01231555|592329627|FG001|Overall Study|Study terminated|5|||
163989513|NCT01231555|592329628|FG002|Overall Study|Study terminated|8|||
163989514|NCT01231555|592329626|FG000|Overall Study|Withdrawal by Subject|0|||
163989515|NCT01231555|592329627|FG001|Overall Study|Withdrawal by Subject|2|||
163989516|NCT01231555|592329628|FG002|Overall Study|Withdrawal by Subject|0|||
163989517|NCT01748071|592329632|FG000|Overall Study|Adverse Event|2|||
163989518|NCT01748071|592329633|FG001|Overall Study|Adverse Event|2|||
163989519|NCT01748071|592329634|FG002|Overall Study|Adverse Event|0|||
163989520|NCT03068325|592329635|FG000|Overall Study|Lost to Follow-up|5|||
163989521|NCT00700180|592329636|FG000|Overall Study|Death|99|||
163989522|NCT00700180|592329637|FG001|Overall Study|Death|114|||
163989523|NCT00700180|592329636|FG000|Overall Study|Alive on treatment|5|||
163989524|NCT00700180|592329637|FG001|Overall Study|Alive on treatment|3|||
163989525|NCT00700180|592329636|FG000|Overall Study|Alive in follow-up|46|||
163989526|NCT00700180|592329637|FG001|Overall Study|Alive in follow-up|27|||
163989527|NCT00700180|592329636|FG000|Overall Study|Lost to Follow-up|4|||
163989528|NCT00700180|592329637|FG001|Overall Study|Lost to Follow-up|5|||
163989529|NCT03588741|592329638|FG000|Overall Study|Withdrawal by Subject|1|||
163989530|NCT01445535|592329639|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163989531|NCT01445535|592329640|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163989532|NCT01445535|592329641|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
163989533|NCT01445535|592329642|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
163989534|NCT01445535|592329639|FG000|Overall Study|Disease progression|1|||
163989535|NCT01445535|592329640|FG001|Overall Study|Disease progression|0|||
163989536|NCT01445535|592329641|FG002|Overall Study|Disease progression|1|||
163989537|NCT01445535|592329642|FG003|Overall Study|Disease progression|0|||
163989538|NCT01445535|592329639|FG000|Overall Study|PI discretion|0|||
163989539|NCT01445535|592329640|FG001|Overall Study|PI discretion|0|||
163989540|NCT01445535|592329641|FG002|Overall Study|PI discretion|0|||
163989541|NCT01445535|592329642|FG003|Overall Study|PI discretion|1|||
163989542|NCT00420511|592329648|FG000|Overall Study|Adverse Event|1|||
163989543|NCT00420511|592329649|FG001|Overall Study|Adverse Event|1|||
163989544|NCT00420511|592329648|FG000|Overall Study|Lost to Follow-up|1|||
163989545|NCT00420511|592329649|FG001|Overall Study|Lost to Follow-up|0|||
163989546|NCT01668654|592329650|FG000|Overall Study|Study Closed/Terminated|3|||
163989547|NCT01668654|592329650|FG000|Overall Study|Withdrawal by Subject|1|||
163989548|NCT01337973|592329651|FG000|Overall Study|Lost to Follow-up|2|||
163989549|NCT01337973|592329652|FG001|Overall Study|Lost to Follow-up|4|||
163989550|NCT01337973|592329653|FG002|Overall Study|Lost to Follow-up|3|||
163989551|NCT01337973|592329651|FG000|Overall Study|Death|1|||
163989552|NCT01337973|592329652|FG001|Overall Study|Death|2|||
163989553|NCT01337973|592329653|FG002|Overall Study|Death|1|||
163989554|NCT01337973|592329651|FG000|Overall Study|Withdrawal by Subject|10|||
163989555|NCT01337973|592329652|FG001|Overall Study|Withdrawal by Subject|8|||
163989556|NCT01337973|592329653|FG002|Overall Study|Withdrawal by Subject|4|||
163989557|NCT01337973|592329651|FG000|Overall Study|missing data on primary outcome|3|||
163989558|NCT01337973|592329652|FG001|Overall Study|missing data on primary outcome|1|||
163989559|NCT01337973|592329653|FG002|Overall Study|missing data on primary outcome|3|||
163989560|NCT03634800|592329654|FG000|Overall Study|Adverse Event|1|||
163989561|NCT03634800|592329654|FG000|Overall Study|Disease Progression|4|||
163989562|NCT03634800|592329654|FG000|Overall Study|Withdrawal by Subject|1|||
163989563|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
163989564|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
163989565|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
163989566|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
163989567|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
163989568|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
163989569|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
163989570|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
164336564|NCT01543698|593609731|FG011|Phase 2|Withdrawal by Subject|0|||
164336565|NCT01543698|593609732|FG012|Phase 2|Withdrawal by Subject|0|||
164336566|NCT01543698|593609733|FG013|Phase 2|Withdrawal by Subject|3|||
164336567|NCT01543698|593609734|FG014|Phase 2|Withdrawal by Subject|1|||
164336568|NCT01543698|593609720|FG000|Phase 2|Adverse Event|0|||
164336569|NCT01543698|593609721|FG001|Phase 2|Adverse Event|0|||
164336570|NCT01543698|593609722|FG002|Phase 2|Adverse Event|0|||
164336571|NCT01543698|593609723|FG003|Phase 2|Adverse Event|0|||
164336572|NCT01543698|593609724|FG004|Phase 2|Adverse Event|0|||
164336573|NCT01543698|593609725|FG005|Phase 2|Adverse Event|0|||
164336574|NCT01543698|593609726|FG006|Phase 2|Adverse Event|0|||
164336575|NCT01543698|593609727|FG007|Phase 2|Adverse Event|0|||
164336576|NCT01543698|593609728|FG008|Phase 2|Adverse Event|0|||
164336577|NCT01543698|593609729|FG009|Phase 2|Adverse Event|0|||
164336578|NCT01543698|593609730|FG010|Phase 2|Adverse Event|0|||
163989571|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
163989572|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
164006643|NCT00847613|592391041|FG000|Overall Study|Protocol Violation|6|||
163989573|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
163989574|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
163989575|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
163989576|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
163989577|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
163989578|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
163989579|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
163989580|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
163989581|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
163989582|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
163989583|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
163989584|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
163989585|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
163989586|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
163989587|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Death|2|||
163989588|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Death|1|||
163989589|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Death|2|||
163989590|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Graft loss|0|||
163989591|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Graft loss|2|||
163989592|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Graft loss|0|||
163989593|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
163989594|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
163989595|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
163989596|NCT01114529|592329655|FG000|Completed Study Medication at Month 24|Missing|2|||
163989597|NCT01114529|592329656|FG001|Completed Study Medication at Month 24|Missing|0|||
163989598|NCT01114529|592329657|FG002|Completed Study Medication at Month 24|Missing|0|||
163989599|NCT01114529|592329655|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
163989600|NCT01114529|592329656|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
163989601|NCT01114529|592329657|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
163989602|NCT01114529|592329655|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
163989603|NCT01114529|592329656|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
163989604|NCT01114529|592329657|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
163989605|NCT01114529|592329655|FG000|Completed Study Phase at Month 24|Death|8|||
163989606|NCT01114529|592329656|FG001|Completed Study Phase at Month 24|Death|5|||
163989607|NCT01114529|592329657|FG002|Completed Study Phase at Month 24|Death|4|||
163989608|NCT01114529|592329655|FG000|Completed Study Phase at Month 24|Other|2|||
163989609|NCT01114529|592329656|FG001|Completed Study Phase at Month 24|Other|0|||
163989610|NCT01114529|592329657|FG002|Completed Study Phase at Month 24|Other|0|||
163989611|NCT01114529|592329655|FG000|Completed Study Phase at Month 24|Missing|2|||
163989612|NCT01114529|592329656|FG001|Completed Study Phase at Month 24|Missing|0|||
163989613|NCT01114529|592329657|FG002|Completed Study Phase at Month 24|Missing|0|||
163989614|NCT04428411|592329660|FG000|Overall Study|Lost to Follow-up|114|||
163989615|NCT00634569|592329661|FG000|Overall Study|Withdrawal by Subject|0|||
163989616|NCT00634569|592329662|FG001|Overall Study|Withdrawal by Subject|4|||
163989617|NCT00634569|592329661|FG000|Overall Study|Physician Decision|0|||
163989618|NCT00634569|592329662|FG001|Overall Study|Physician Decision|1|||
163989619|NCT02918019|592329663|FG000|Overall Study|Death|0|||
163989620|NCT02918019|592329664|FG001|Overall Study|Death|0|||
163989621|NCT02918019|592329665|FG002|Overall Study|Death|1|||
163989622|NCT02918019|592329666|FG003|Overall Study|Death|0|||
163989623|NCT02918019|592329663|FG000|Overall Study|Lost to Follow-up|1|||
163989624|NCT02918019|592329664|FG001|Overall Study|Lost to Follow-up|1|||
163989625|NCT02918019|592329665|FG002|Overall Study|Lost to Follow-up|0|||
163989626|NCT02918019|592329666|FG003|Overall Study|Lost to Follow-up|1|||
163989627|NCT02918019|592329663|FG000|Overall Study|Principal investigator request|0|||
163989628|NCT02918019|592329664|FG001|Overall Study|Principal investigator request|0|||
163989629|NCT02918019|592329665|FG002|Overall Study|Principal investigator request|0|||
164336579|NCT01543698|593609731|FG011|Phase 2|Adverse Event|1|||
164336580|NCT01543698|593609732|FG012|Phase 2|Adverse Event|3|||
164336581|NCT01543698|593609733|FG013|Phase 2|Adverse Event|5|||
164336582|NCT01543698|593609734|FG014|Phase 2|Adverse Event|14|||
164336583|NCT00316719|593609735|FG000|Overall Study|Adverse Event|0|||
163989630|NCT02918019|592329666|FG003|Overall Study|Principal investigator request|1|||
163989631|NCT02918019|592329663|FG000|Overall Study|Physician Decision|1|||
163989632|NCT02918019|592329664|FG001|Overall Study|Physician Decision|3|||
164336584|NCT00316719|593609736|FG001|Overall Study|Adverse Event|6|||
164336585|NCT00316719|593609735|FG000|Overall Study|Consent withdrawn|2|||
163989633|NCT02918019|592329665|FG002|Overall Study|Physician Decision|2|||
163989634|NCT02918019|592329666|FG003|Overall Study|Physician Decision|0|||
163989635|NCT02918019|592329663|FG000|Overall Study|Protocol deviation|1|||
164336586|NCT00316719|593609736|FG001|Overall Study|Consent withdrawn|0|||
164336587|NCT01863953|593609737|FG000|Overall Study|Adverse Event|0|||
163989636|NCT02918019|592329664|FG001|Overall Study|Protocol deviation|1|||
163989637|NCT02918019|592329665|FG002|Overall Study|Protocol deviation|0|||
163989638|NCT02918019|592329666|FG003|Overall Study|Protocol deviation|2|||
163989639|NCT02918019|592329663|FG000|Overall Study|Withdrawal by Subject|3|||
163989640|NCT02918019|592329664|FG001|Overall Study|Withdrawal by Subject|4|||
163989641|NCT02918019|592329665|FG002|Overall Study|Withdrawal by Subject|6|||
163989642|NCT02918019|592329666|FG003|Overall Study|Withdrawal by Subject|4|||
163989643|NCT02918019|592329663|FG000|Overall Study|Adverse Event|0|||
163989644|NCT02918019|592329664|FG001|Overall Study|Adverse Event|1|||
163989645|NCT02918019|592329665|FG002|Overall Study|Adverse Event|0|||
163989646|NCT02918019|592329666|FG003|Overall Study|Adverse Event|1|||
163989647|NCT01212185|592329667|FG000|Overall Study|Protocol Violation|2|||
163989648|NCT01212185|592329668|FG001|Overall Study|Protocol Violation|1|||
163989649|NCT03555266|592329669|FG000|Overall Study|Protocol Violation|6|||
163989650|NCT03555266|592329670|FG001|Overall Study|Protocol Violation|4|||
163989651|NCT03370770|592329671|FG000|Overall Study|Patient was followed in another hospital center|1|||
163989652|NCT03370770|592329671|FG000|Overall Study|Progressive Disease|98|||
163989653|NCT03370770|592329671|FG000|Overall Study|Adverse Event|2|||
163989654|NCT03370770|592329671|FG000|Overall Study|Death|5|||
163989655|NCT01699087|592329672|FG000|Overall Study|Lost to Follow-up|7|||
163989656|NCT01699087|592329672|FG000|Overall Study|Screen failure (prior to treatment)|15|||
163989657|NCT01699087|592329672|FG000|Overall Study|Unable to make future visits|2|||
163989658|NCT00797823|592329677|FG000|First Period (Initial Randomization)|Physician Decision|1|||
163989659|NCT00797823|592329678|FG001|First Period (Initial Randomization)|Physician Decision|0|||
163989660|NCT00797823|592329679|FG002|First Period (Initial Randomization)|Physician Decision|0|||
163989661|NCT01405053|592329680|FG000|Overall Study|Adverse Event|3|||
163989662|NCT01405053|592329681|FG001|Overall Study|Adverse Event|0|||
163989663|NCT01405053|592329680|FG000|Overall Study|Lost to Follow-up|0|||
163989664|NCT01405053|592329681|FG001|Overall Study|Lost to Follow-up|1|||
163989665|NCT01405053|592329680|FG000|Overall Study|Participant choice|2|||
163989666|NCT01405053|592329681|FG001|Overall Study|Participant choice|1|||
163989667|NCT01405053|592329680|FG000|Overall Study|Inadequate therapeutic effect|2|||
163989668|NCT01405053|592329681|FG001|Overall Study|Inadequate therapeutic effect|1|||
163989669|NCT01405053|592329680|FG000|Overall Study|Withdrawal by Subject|3|||
163989670|NCT01405053|592329681|FG001|Overall Study|Withdrawal by Subject|4|||
163989671|NCT01405053|592329680|FG000|Overall Study|Other|0|||
163989672|NCT01405053|592329681|FG001|Overall Study|Other|1|||
163989673|NCT02817087|592329682|FG000|Overall Study|Withdrawal by Subject|2|||
163989674|NCT02817087|592329683|FG001|Overall Study|Withdrawal by Subject|0|||
163989675|NCT04871711|592329684|FG000|Overall Study|Withdrawal by Subject|11|||
163989676|NCT04871711|592329685|FG001|Overall Study|Withdrawal by Subject|5|||
163989677|NCT04871711|592329684|FG000|Overall Study|Lack of Efficacy|5|||
163989678|NCT04871711|592329685|FG001|Overall Study|Lack of Efficacy|7|||
163989679|NCT04871711|592329684|FG000|Overall Study|Adverse Event|2|||
163989680|NCT04871711|592329685|FG001|Overall Study|Adverse Event|6|||
163989681|NCT04871711|592329684|FG000|Overall Study|Various reasons|2|||
163989682|NCT04871711|592329685|FG001|Overall Study|Various reasons|1|||
163989683|NCT04871711|592329684|FG000|Overall Study|Lost to Follow-up|0|||
163989684|NCT04871711|592329685|FG001|Overall Study|Lost to Follow-up|2|||
163989685|NCT01665144|592329686|FG000|Core Part|Withdrawal by Subject|96|||
163989686|NCT01665144|592329687|FG001|Core Part|Withdrawal by Subject|77|||
163989687|NCT01665144|592329688|FG002|Core Part|Withdrawal by Subject|0|||
163989688|NCT01665144|592329686|FG000|Core Part|Adverse Event|45|||
163989689|NCT01665144|592329687|FG001|Core Part|Adverse Event|18|||
163989690|NCT01665144|592329688|FG002|Core Part|Adverse Event|0|||
163989691|NCT01665144|592329686|FG000|Core Part|Lack of Efficacy|16|||
163989692|NCT01665144|592329687|FG001|Core Part|Lack of Efficacy|11|||
163989693|NCT01665144|592329688|FG002|Core Part|Lack of Efficacy|0|||
163989694|NCT01665144|592329686|FG000|Core Part|Lost to Follow-up|9|||
164336588|NCT01863953|593609738|FG001|Overall Study|Adverse Event|0|||
163989695|NCT01665144|592329687|FG001|Core Part|Lost to Follow-up|8|||
163989696|NCT01665144|592329688|FG002|Core Part|Lost to Follow-up|0|||
163989697|NCT01665144|592329686|FG000|Core Part|Physician Decision|13|||
163989698|NCT01665144|592329687|FG001|Core Part|Physician Decision|1|||
163989699|NCT01665144|592329688|FG002|Core Part|Physician Decision|0|||
164336589|NCT01863953|593609739|FG002|Overall Study|Adverse Event|1|||
164336590|NCT00573183|593609740|FG000|Overall Study|Lost to Follow-up|52|||
163989700|NCT01665144|592329686|FG000|Core Part|Progressive disease|8|||
163989701|NCT01665144|592329687|FG001|Core Part|Progressive disease|4|||
163989702|NCT01665144|592329688|FG002|Core Part|Progressive disease|0|||
163989703|NCT01665144|592329686|FG000|Core Part|Non-compliance with study treatment|5|||
163989704|NCT01665144|592329687|FG001|Core Part|Non-compliance with study treatment|0|||
163989705|NCT01665144|592329688|FG002|Core Part|Non-compliance with study treatment|0|||
163989706|NCT01665144|592329686|FG000|Core Part|Death|3|||
163989707|NCT01665144|592329687|FG001|Core Part|Death|1|||
163989708|NCT01665144|592329688|FG002|Core Part|Death|0|||
163989709|NCT01665144|592329686|FG000|Core Part|Protocol deviation|3|||
163989710|NCT01665144|592329687|FG001|Core Part|Protocol deviation|1|||
163989711|NCT01665144|592329688|FG002|Core Part|Protocol deviation|0|||
163989712|NCT01665144|592329686|FG000|Core Part|New therapy for study indication|2|||
164083443|NCT02711956|592670199|FG010|Overall Study|Adverse Event|1|||
164083444|NCT02711956|592670200|FG011|Overall Study|Adverse Event|0|||
164083445|NCT02711956|592670201|FG012|Overall Study|Adverse Event|0|||
164083446|NCT02711956|592670202|FG013|Overall Study|Adverse Event|0|||
164083447|NCT02711956|592670203|FG014|Overall Study|Adverse Event|2|||
164083448|NCT02711956|592670189|FG000|Overall Study|Physician Decision|0|||
164083449|NCT02711956|592670190|FG001|Overall Study|Physician Decision|0|||
164083450|NCT02711956|592670191|FG002|Overall Study|Physician Decision|0|||
163989713|NCT01665144|592329687|FG001|Core Part|New therapy for study indication|1|||
163989714|NCT01665144|592329688|FG002|Core Part|New therapy for study indication|0|||
163989715|NCT01665144|592329686|FG000|Core Part|Technical problems|2|||
163989716|NCT01665144|592329687|FG001|Core Part|Technical problems|0|||
163989717|NCT01665144|592329688|FG002|Core Part|Technical problems|0|||
163989718|NCT01665144|592329686|FG000|Extension Part|Patient/guardian decision|180|||
163989719|NCT01665144|592329687|FG001|Extension Part|Patient/guardian decision|0|||
163989720|NCT01665144|592329688|FG002|Extension Part|Patient/guardian decision|98|||
163989721|NCT01665144|592329686|FG000|Extension Part|Adverse Event|104|||
163989722|NCT01665144|592329687|FG001|Extension Part|Adverse Event|0|||
163989723|NCT01665144|592329688|FG002|Extension Part|Adverse Event|59|||
163989724|NCT01665144|592329686|FG000|Extension Part|Study closed early|42|||
163989725|NCT01665144|592329687|FG001|Extension Part|Study closed early|0|||
164083451|NCT02711956|592670192|FG003|Overall Study|Physician Decision|2|||
164083452|NCT02711956|592670193|FG004|Overall Study|Physician Decision|0|||
163989726|NCT01665144|592329688|FG002|Extension Part|Study closed early|19|||
163989727|NCT01665144|592329686|FG000|Extension Part|Progressive disease|36|||
163989728|NCT01665144|592329687|FG001|Extension Part|Progressive disease|0|||
163989729|NCT01665144|592329688|FG002|Extension Part|Progressive disease|14|||
163989730|NCT01665144|592329686|FG000|Extension Part|Lack of Efficacy|37|||
163989731|NCT01665144|592329687|FG001|Extension Part|Lack of Efficacy|0|||
164083453|NCT02711956|592670194|FG005|Overall Study|Physician Decision|0|||
164083454|NCT02711956|592670195|FG006|Overall Study|Physician Decision|0|||
164083455|NCT02711956|592670196|FG007|Overall Study|Physician Decision|0|||
163989732|NCT01665144|592329688|FG002|Extension Part|Lack of Efficacy|12|||
164083456|NCT02711956|592670197|FG008|Overall Study|Physician Decision|0|||
164083457|NCT02711956|592670198|FG009|Overall Study|Physician Decision|0|||
164083458|NCT02711956|592670199|FG010|Overall Study|Physician Decision|0|||
164083459|NCT02711956|592670200|FG011|Overall Study|Physician Decision|0|||
163989733|NCT01665144|592329686|FG000|Extension Part|Physician Decision|29|||
163989734|NCT01665144|592329687|FG001|Extension Part|Physician Decision|0|||
163989735|NCT01665144|592329688|FG002|Extension Part|Physician Decision|13|||
163989736|NCT01665144|592329686|FG000|Extension Part|Technical problems|20|||
163989737|NCT01665144|592329687|FG001|Extension Part|Technical problems|0|||
163989738|NCT01665144|592329688|FG002|Extension Part|Technical problems|8|||
163989739|NCT01665144|592329686|FG000|Extension Part|Death|20|||
163989740|NCT01665144|592329687|FG001|Extension Part|Death|0|||
163989741|NCT01665144|592329688|FG002|Extension Part|Death|4|||
164083460|NCT02711956|592670201|FG012|Overall Study|Physician Decision|0|||
164083461|NCT02711956|592670202|FG013|Overall Study|Physician Decision|0|||
164083462|NCT02711956|592670203|FG014|Overall Study|Physician Decision|0|||
164083463|NCT02711956|592670189|FG000|Overall Study|Withdrawal by Subject|0|||
164083464|NCT02711956|592670190|FG001|Overall Study|Withdrawal by Subject|0|||
164083465|NCT02711956|592670191|FG002|Overall Study|Withdrawal by Subject|0|||
164083466|NCT02711956|592670192|FG003|Overall Study|Withdrawal by Subject|0|||
164083467|NCT02711956|592670193|FG004|Overall Study|Withdrawal by Subject|0|||
164083468|NCT02711956|592670194|FG005|Overall Study|Withdrawal by Subject|0|||
164083469|NCT02711956|592670195|FG006|Overall Study|Withdrawal by Subject|1|||
164083470|NCT02711956|592670196|FG007|Overall Study|Withdrawal by Subject|0|||
164083471|NCT02711956|592670197|FG008|Overall Study|Withdrawal by Subject|0|||
164083472|NCT02711956|592670198|FG009|Overall Study|Withdrawal by Subject|0|||
164083473|NCT02711956|592670199|FG010|Overall Study|Withdrawal by Subject|0|||
164083474|NCT02711956|592670200|FG011|Overall Study|Withdrawal by Subject|1|||
164083475|NCT02711956|592670201|FG012|Overall Study|Withdrawal by Subject|6|||
164083476|NCT02711956|592670202|FG013|Overall Study|Withdrawal by Subject|0|||
164083477|NCT02711956|592670203|FG014|Overall Study|Withdrawal by Subject|1|||
164083478|NCT02711956|592670189|FG000|Overall Study|Clinical progression|1|||
164083479|NCT02711956|592670190|FG001|Overall Study|Clinical progression|0|||
164083480|NCT02711956|592670191|FG002|Overall Study|Clinical progression|0|||
164083481|NCT02711956|592670192|FG003|Overall Study|Clinical progression|0|||
163989742|NCT01665144|592329686|FG000|Extension Part|Missing|12|||
163989743|NCT01665144|592329687|FG001|Extension Part|Missing|0|||
163989744|NCT01665144|592329688|FG002|Extension Part|Missing|6|||
164140476|NCT00642278|592876100|FG005|Overall Study|Adverse Event|2|||
164140477|NCT00642278|592876101|FG006|Overall Study|Adverse Event|0|||
164140478|NCT00642278|592876095|FG000|Overall Study|Lack of Efficacy|0|||
164140479|NCT00642278|592876096|FG001|Overall Study|Lack of Efficacy|1|||
164140480|NCT00642278|592876097|FG002|Overall Study|Lack of Efficacy|0|||
164140481|NCT00642278|592876098|FG003|Overall Study|Lack of Efficacy|0|||
164140482|NCT00642278|592876099|FG004|Overall Study|Lack of Efficacy|0|||
164242596|NCT00551031|593260294|FG002|Overall Study|Protocol Violation|0|||
164242597|NCT00551031|593260295|FG003|Overall Study|Protocol Violation|0|||
164242598|NCT00551031|593260296|FG004|Overall Study|Protocol Violation|0|||
164242599|NCT00551031|593260292|FG000|Overall Study|Lost to Follow-up|0|||
164242600|NCT00551031|593260293|FG001|Overall Study|Lost to Follow-up|1|||
163989745|NCT01665144|592329686|FG000|Extension Part|Lost to Follow-up|9|||
163989746|NCT01665144|592329687|FG001|Extension Part|Lost to Follow-up|0|||
163989747|NCT01665144|592329688|FG002|Extension Part|Lost to Follow-up|5|||
163989748|NCT01665144|592329686|FG000|Extension Part|New therapy for study indication|3|||
163989749|NCT01665144|592329687|FG001|Extension Part|New therapy for study indication|0|||
163989750|NCT01665144|592329688|FG002|Extension Part|New therapy for study indication|2|||
163989751|NCT01665144|592329686|FG000|Extension Part|Protocol deviation|3|||
163989752|NCT01665144|592329687|FG001|Extension Part|Protocol deviation|0|||
163989753|NCT01665144|592329688|FG002|Extension Part|Protocol deviation|0|||
163989754|NCT04811716|592329693|FG000|Overall Study|Withdrawal by Subject|2|||
163989755|NCT04811716|592329694|FG001|Overall Study|Withdrawal by Subject|0|||
163989756|NCT02320487|592329695|FG000|Overall Study|Reason not Specified|1|||
163989757|NCT02320487|592329695|FG000|Overall Study|Physician Decision|5|||
163989758|NCT02320487|592329695|FG000|Overall Study|Withdrawal by Subject|1|||
163989759|NCT02320487|592329695|FG000|Overall Study|Death|3|||
163989760|NCT02320487|592329695|FG000|Overall Study|Adverse Event|11|||
163989761|NCT03344003|592329696|FG000|Overall Study|Switched to alternative treatment|1|||
163989762|NCT03344003|592329697|FG001|Overall Study|Switched to alternative treatment|0|||
163989763|NCT03344003|592329696|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
164083482|NCT02711956|592670193|FG004|Overall Study|Clinical progression|0|||
164083483|NCT02711956|592670194|FG005|Overall Study|Clinical progression|0|||
164242601|NCT00551031|593260294|FG002|Overall Study|Lost to Follow-up|0|||
164242602|NCT00551031|593260295|FG003|Overall Study|Lost to Follow-up|1|||
164242603|NCT00551031|593260296|FG004|Overall Study|Lost to Follow-up|1|||
164242604|NCT00551031|593260292|FG000|Overall Study|Withdrawal by Subject|0|||
164242605|NCT00551031|593260293|FG001|Overall Study|Withdrawal by Subject|4|||
164242606|NCT00551031|593260294|FG002|Overall Study|Withdrawal by Subject|1|||
164242607|NCT00551031|593260295|FG003|Overall Study|Withdrawal by Subject|2|||
164242608|NCT00551031|593260296|FG004|Overall Study|Withdrawal by Subject|0|||
164242609|NCT00551031|593260292|FG000|Overall Study|Serious Adverse Event|0|||
164242610|NCT00551031|593260293|FG001|Overall Study|Serious Adverse Event|2|||
164242611|NCT00551031|593260294|FG002|Overall Study|Serious Adverse Event|1|||
164242612|NCT00551031|593260295|FG003|Overall Study|Serious Adverse Event|0|||
164242613|NCT00551031|593260296|FG004|Overall Study|Serious Adverse Event|0|||
164242614|NCT00551031|593260292|FG000|Overall Study|Did not receive vaccine|1|||
164242615|NCT00551031|593260293|FG001|Overall Study|Did not receive vaccine|2|||
164242616|NCT00551031|593260294|FG002|Overall Study|Did not receive vaccine|0|||
164242617|NCT00551031|593260295|FG003|Overall Study|Did not receive vaccine|0|||
164242618|NCT00551031|593260296|FG004|Overall Study|Did not receive vaccine|0|||
164242619|NCT01273038|593260297|FG000|Second Intervention (14 Days)|Adverse Event|0|||
164242620|NCT01273038|593260298|FG001|Second Intervention (14 Days)|Adverse Event|1|||
164242621|NCT01273038|593260297|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
164242622|NCT01273038|593260298|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
164242623|NCT00413660|593260299|FG000|Up To Week 12|Adverse Event|1|||
164242624|NCT00413660|593260300|FG001|Up To Week 12|Adverse Event|3|||
164242625|NCT00413660|593260301|FG002|Up To Week 12|Adverse Event|1|||
164242626|NCT00413660|593260302|FG003|Up To Week 12|Adverse Event|4|||
164242627|NCT00413660|593260303|FG004|Up To Week 12|Adverse Event|6|||
164242628|NCT00413660|593260304|FG005|Up To Week 12|Adverse Event|4|||
164242629|NCT00413660|593260305|FG006|Up To Week 12|Adverse Event|1|||
164242630|NCT00413660|593260306|FG007|Up To Week 12|Adverse Event|0|||
164242631|NCT00413660|593260307|FG008|Up To Week 12|Adverse Event|0|||
164242632|NCT00413660|593260308|FG009|Up To Week 12|Adverse Event|0|||
164242633|NCT00413660|593260309|FG010|Up To Week 12|Adverse Event|0|||
164242634|NCT00413660|593260299|FG000|Up To Week 12|Lack of Efficacy|2|||
164242635|NCT00413660|593260300|FG001|Up To Week 12|Lack of Efficacy|0|||
164242636|NCT00413660|593260301|FG002|Up To Week 12|Lack of Efficacy|0|||
164242637|NCT00413660|593260302|FG003|Up To Week 12|Lack of Efficacy|0|||
164242638|NCT00413660|593260303|FG004|Up To Week 12|Lack of Efficacy|0|||
164242639|NCT00413660|593260304|FG005|Up To Week 12|Lack of Efficacy|0|||
164242640|NCT00413660|593260305|FG006|Up To Week 12|Lack of Efficacy|5|||
163885009|NCT04209465|591949767|FG007|Overall Study|Withdrawal by Subject|0|||
163885010|NCT04209465|591949768|FG008|Overall Study|Withdrawal by Subject|1|||
163885011|NCT04209465|591949769|FG009|Overall Study|Withdrawal by Subject|0|||
163885012|NCT04209465|591949770|FG010|Overall Study|Withdrawal by Subject|0|||
163885013|NCT04209465|591949771|FG011|Overall Study|Withdrawal by Subject|2|||
163885014|NCT04209465|591949772|FG012|Overall Study|Withdrawal by Subject|2|||
163885015|NCT04209465|591949760|FG000|Overall Study|Lost to Follow-up|0|||
163885016|NCT04209465|591949761|FG001|Overall Study|Lost to Follow-up|0|||
163885017|NCT04209465|591949762|FG002|Overall Study|Lost to Follow-up|0|||
163989764|NCT03344003|592329697|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
163989765|NCT00684957|592329701|FG000|Overall Study|Withdrawal by Subject|1|||
163989766|NCT00684957|592329702|FG001|Overall Study|Withdrawal by Subject|1|||
163989767|NCT00684957|592329701|FG000|Overall Study|Lost to Follow-up|1|||
163989768|NCT00684957|592329702|FG001|Overall Study|Lost to Follow-up|0|||
163989769|NCT04341948|592329703|FG000|Overall Study|Adverse Event|0|||
163989770|NCT04341948|592329704|FG001|Overall Study|Adverse Event|1|||
163989771|NCT04341948|592329703|FG000|Overall Study|Lost to Follow-up|6|||
163989772|NCT04341948|592329704|FG001|Overall Study|Lost to Follow-up|1|||
163989773|NCT04341948|592329703|FG000|Overall Study|Physician Decision|1|||
163989774|NCT04341948|592329704|FG001|Overall Study|Physician Decision|2|||
163989775|NCT04341948|592329703|FG000|Overall Study|Withdrawal by Participant|6|||
163989776|NCT04341948|592329704|FG001|Overall Study|Withdrawal by Participant|3|||
163989777|NCT04341948|592329703|FG000|Overall Study|Lack of compliance by Participant|1|||
163989778|NCT04341948|592329704|FG001|Overall Study|Lack of compliance by Participant|0|||
163989779|NCT03406897|592329705|FG000|Overall Study|Lost to Follow-up|1|||
163989780|NCT03406897|592329706|FG001|Overall Study|Lost to Follow-up|2|||
163989781|NCT03406897|592329705|FG000|Overall Study|Withdrawal by Subject|4|||
163989782|NCT03406897|592329706|FG001|Overall Study|Withdrawal by Subject|4|||
163989783|NCT03406897|592329705|FG000|Overall Study|Physician Decision|0|||
163989784|NCT03406897|592329706|FG001|Overall Study|Physician Decision|1|||
163989785|NCT05900115|592330974|FG000|Overall Study|Lost to Follow-up|129|||
163989786|NCT05900115|592330975|FG001|Overall Study|Lost to Follow-up|98|||
163989787|NCT02949128|592330976|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
163989788|NCT02949128|592330976|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
163989789|NCT02949128|592330976|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
163989790|NCT02949128|592330976|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
163989791|NCT02949128|592330976|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
163989792|NCT02949128|592330976|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
163989793|NCT02949128|592330976|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
163989794|NCT02949128|592330976|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
163989795|NCT02949128|592330976|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
163989796|NCT02949128|592330976|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
163989797|NCT01602341|592330977|FG000|Overall Study|Adverse Event|0|||
163989798|NCT01602341|592330978|FG001|Overall Study|Adverse Event|1|||
163989799|NCT02152345|592330979|FG000|Overall Study|Case Cancellations|2|||
163989800|NCT02152345|592330980|FG001|Overall Study|Case Cancellations|4|||
163989801|NCT02152345|592330979|FG000|Overall Study|Withdrawal by Subject|2|||
163989802|NCT02152345|592330980|FG001|Overall Study|Withdrawal by Subject|1|||
163989803|NCT00880750|592330987|FG000|First Intervention|Adverse Event|1|||
163989804|NCT00880750|592330988|FG001|First Intervention|Adverse Event|0|||
163989805|NCT00880750|592330987|FG000|First Intervention|Unable to collect urine|4|||
163989806|NCT00880750|592330988|FG001|First Intervention|Unable to collect urine|0|||
163989807|NCT00880750|592330987|FG000|First Intervention|Non-compliance with meals|0|||
163989808|NCT00880750|592330988|FG001|First Intervention|Non-compliance with meals|1|||
163989809|NCT00880750|592330987|FG000|First Intervention|Withdrawal by Subject|2|||
163989810|NCT00880750|592330988|FG001|First Intervention|Withdrawal by Subject|0|||
163989811|NCT00880750|592330987|FG000|First Intervention|Lost to Follow-up|2|||
163989812|NCT00880750|592330988|FG001|First Intervention|Lost to Follow-up|0|||
163989813|NCT00880750|592330987|FG000|Second Intervention|Withdrawal by Subject|2|||
163989814|NCT00880750|592330988|FG001|Second Intervention|Withdrawal by Subject|2|||
163989815|NCT00880750|592330987|FG000|Second Intervention|Protocol Violation|1|||
163989816|NCT00880750|592330988|FG001|Second Intervention|Protocol Violation|0|||
163989817|NCT00880750|592330987|FG000|Second Intervention|Unable to collect urine|1|||
163989818|NCT00880750|592330988|FG001|Second Intervention|Unable to collect urine|0|||
163989819|NCT00483327|592330994|FG000|Overall Study|Adverse Event|1|||
163989820|NCT00483327|592330994|FG000|Overall Study|Withdrawal by Subject|3|||
163989821|NCT00483327|592330994|FG000|Overall Study|Lost to Follow-up|4|||
163989822|NCT00483327|592330994|FG000|Overall Study|Patient Non Compliance|2|||
163989823|NCT00568555|592330997|FG000|Overall Study|Withdrawal by Subject|1|||
163989824|NCT00568555|592330998|FG001|Overall Study|Withdrawal by Subject|1|||
163989825|NCT01705691|592330999|FG000|Overall Study|Death|1|||
164083484|NCT02711956|592670195|FG006|Overall Study|Clinical progression|1|||
164242641|NCT00413660|593260306|FG007|Up To Week 12|Lack of Efficacy|0|||
164242642|NCT00413660|593260307|FG008|Up To Week 12|Lack of Efficacy|0|||
164242643|NCT00413660|593260308|FG009|Up To Week 12|Lack of Efficacy|0|||
164242644|NCT00413660|593260309|FG010|Up To Week 12|Lack of Efficacy|0|||
164242645|NCT00413660|593260299|FG000|Up To Week 12|Lost to Follow-up|0|||
163989826|NCT01705691|592331000|FG001|Overall Study|Death|2|||
163989827|NCT01705691|592330999|FG000|Overall Study|Withdrawal by Subject|1|||
163989828|NCT01705691|592331000|FG001|Overall Study|Withdrawal by Subject|2|||
164242646|NCT00413660|593260300|FG001|Up To Week 12|Lost to Follow-up|1|||
163989829|NCT01705691|592330999|FG000|Overall Study|Lost to Follow-up|1|||
163989830|NCT01705691|592331000|FG001|Overall Study|Lost to Follow-up|1|||
163989831|NCT01705691|592330999|FG000|Overall Study|Other|0|||
163989832|NCT01705691|592331000|FG001|Overall Study|Other|1|||
163989833|NCT03106779|592331001|FG000|Overall Study|Lack of Efficacy|33|||
164242647|NCT00413660|593260301|FG002|Up To Week 12|Lost to Follow-up|0|||
164242648|NCT00413660|593260302|FG003|Up To Week 12|Lost to Follow-up|0|||
164242649|NCT00413660|593260303|FG004|Up To Week 12|Lost to Follow-up|1|||
164242650|NCT00413660|593260304|FG005|Up To Week 12|Lost to Follow-up|0|||
164242651|NCT00413660|593260305|FG006|Up To Week 12|Lost to Follow-up|0|||
164242652|NCT00413660|593260306|FG007|Up To Week 12|Lost to Follow-up|0|||
164242653|NCT00413660|593260307|FG008|Up To Week 12|Lost to Follow-up|0|||
164242654|NCT00413660|593260308|FG009|Up To Week 12|Lost to Follow-up|0|||
164242655|NCT00413660|593260309|FG010|Up To Week 12|Lost to Follow-up|0|||
164242656|NCT00413660|593260299|FG000|Up To Week 12|Withdrawal by Subject|0|||
164242657|NCT00413660|593260300|FG001|Up To Week 12|Withdrawal by Subject|2|||
164242658|NCT00413660|593260301|FG002|Up To Week 12|Withdrawal by Subject|0|||
164336591|NCT00573183|593609741|FG001|Overall Study|Lost to Follow-up|50|||
164336592|NCT00573183|593609740|FG000|Overall Study|Withdrawal by Subject|8|||
164336593|NCT00573183|593609741|FG001|Overall Study|Withdrawal by Subject|2|||
164336594|NCT00573183|593609740|FG000|Overall Study|Death|0|||
164336595|NCT00573183|593609741|FG001|Overall Study|Death|1|||
164336596|NCT00573183|593609740|FG000|Overall Study|Adverse Event|2|||
163885018|NCT04209465|591949763|FG003|Overall Study|Lost to Follow-up|0|||
163885019|NCT04209465|591949764|FG004|Overall Study|Lost to Follow-up|0|||
163885020|NCT04209465|591949765|FG005|Overall Study|Lost to Follow-up|1|||
163885021|NCT04209465|591949766|FG006|Overall Study|Lost to Follow-up|0|||
163885022|NCT04209465|591949767|FG007|Overall Study|Lost to Follow-up|0|||
163885023|NCT04209465|591949768|FG008|Overall Study|Lost to Follow-up|1|||
163885024|NCT04209465|591949769|FG009|Overall Study|Lost to Follow-up|0|||
163885025|NCT04209465|591949770|FG010|Overall Study|Lost to Follow-up|0|||
163885026|NCT04209465|591949771|FG011|Overall Study|Lost to Follow-up|1|||
163885027|NCT04209465|591949772|FG012|Overall Study|Lost to Follow-up|0|||
163885028|NCT04209465|591949760|FG000|Overall Study|Started new therapy|0|||
163885029|NCT04209465|591949761|FG001|Overall Study|Started new therapy|0|||
163885030|NCT04209465|591949762|FG002|Overall Study|Started new therapy|0|||
163885031|NCT04209465|591949763|FG003|Overall Study|Started new therapy|0|||
163885032|NCT04209465|591949764|FG004|Overall Study|Started new therapy|0|||
163885033|NCT04209465|591949765|FG005|Overall Study|Started new therapy|1|||
163885034|NCT04209465|591949766|FG006|Overall Study|Started new therapy|0|||
163885035|NCT04209465|591949767|FG007|Overall Study|Started new therapy|0|||
163885036|NCT04209465|591949768|FG008|Overall Study|Started new therapy|0|||
163885037|NCT04209465|591949769|FG009|Overall Study|Started new therapy|0|||
163885038|NCT04209465|591949770|FG010|Overall Study|Started new therapy|0|||
163885039|NCT04209465|591949771|FG011|Overall Study|Started new therapy|0|||
163885040|NCT04209465|591949772|FG012|Overall Study|Started new therapy|0|||
163885041|NCT04209465|591949760|FG000|Overall Study|Study terminated early by sponsor|0|||
163885042|NCT04209465|591949761|FG001|Overall Study|Study terminated early by sponsor|0|||
163885043|NCT04209465|591949762|FG002|Overall Study|Study terminated early by sponsor|0|||
163885044|NCT04209465|591949763|FG003|Overall Study|Study terminated early by sponsor|0|||
163885045|NCT04209465|591949764|FG004|Overall Study|Study terminated early by sponsor|0|||
163885046|NCT04209465|591949765|FG005|Overall Study|Study terminated early by sponsor|0|||
163885047|NCT04209465|591949766|FG006|Overall Study|Study terminated early by sponsor|3|||
163885048|NCT04209465|591949767|FG007|Overall Study|Study terminated early by sponsor|0|||
163885049|NCT04209465|591949768|FG008|Overall Study|Study terminated early by sponsor|0|||
163885050|NCT04209465|591949769|FG009|Overall Study|Study terminated early by sponsor|0|||
163885051|NCT04209465|591949770|FG010|Overall Study|Study terminated early by sponsor|0|||
163885052|NCT04209465|591949771|FG011|Overall Study|Study terminated early by sponsor|0|||
163885053|NCT04209465|591949772|FG012|Overall Study|Study terminated early by sponsor|3|||
163885054|NCT04209465|591949760|FG000|Overall Study|Other|0|||
163885055|NCT04209465|591949761|FG001|Overall Study|Other|0|||
163885056|NCT04209465|591949762|FG002|Overall Study|Other|0|||
163885057|NCT04209465|591949763|FG003|Overall Study|Other|0|||
163885058|NCT04209465|591949764|FG004|Overall Study|Other|0|||
163885059|NCT04209465|591949765|FG005|Overall Study|Other|0|||
163885060|NCT04209465|591949766|FG006|Overall Study|Other|0|||
163885061|NCT04209465|591949767|FG007|Overall Study|Other|0|||
163885062|NCT04209465|591949768|FG008|Overall Study|Other|1|||
163885063|NCT04209465|591949769|FG009|Overall Study|Other|0|||
163885064|NCT04209465|591949770|FG010|Overall Study|Other|0|||
163885065|NCT04209465|591949771|FG011|Overall Study|Other|0|||
163885066|NCT04209465|591949772|FG012|Overall Study|Other|0|||
163885067|NCT05603143|591949773|FG000|Overall Study|Withdrew consent|6|||
164336597|NCT00573183|593609741|FG001|Overall Study|Adverse Event|0|||
164336598|NCT00573183|593609740|FG000|Overall Study|Incarceration|5|||
164336599|NCT00573183|593609741|FG001|Overall Study|Incarceration|8|||
163885068|NCT05603143|591949774|FG001|Overall Study|Withdrew consent|2|||
163885069|NCT05603143|591949773|FG000|Overall Study|Randomized but never treated|0|||
163885070|NCT05603143|591949774|FG001|Overall Study|Randomized but never treated|3|||
163885071|NCT05603143|591949773|FG000|Overall Study|Adverse Event|2|||
163885072|NCT05603143|591949774|FG001|Overall Study|Adverse Event|0|||
164242659|NCT00413660|593260302|FG003|Up To Week 12|Withdrawal by Subject|2|||
164242660|NCT00413660|593260303|FG004|Up To Week 12|Withdrawal by Subject|0|||
164242661|NCT00413660|593260304|FG005|Up To Week 12|Withdrawal by Subject|2|||
164242662|NCT00413660|593260305|FG006|Up To Week 12|Withdrawal by Subject|2|||
164242663|NCT00413660|593260306|FG007|Up To Week 12|Withdrawal by Subject|0|||
164242664|NCT00413660|593260307|FG008|Up To Week 12|Withdrawal by Subject|0|||
164242665|NCT00413660|593260308|FG009|Up To Week 12|Withdrawal by Subject|0|||
164242666|NCT00413660|593260309|FG010|Up To Week 12|Withdrawal by Subject|0|||
164242667|NCT00413660|593260299|FG000|Up To Week 12|Randomized, Not Treated|1|||
164242668|NCT00413660|593260300|FG001|Up To Week 12|Randomized, Not Treated|0|||
164242669|NCT00413660|593260301|FG002|Up To Week 12|Randomized, Not Treated|0|||
164242670|NCT00413660|593260302|FG003|Up To Week 12|Randomized, Not Treated|1|||
164242671|NCT00413660|593260303|FG004|Up To Week 12|Randomized, Not Treated|0|||
164242672|NCT00413660|593260304|FG005|Up To Week 12|Randomized, Not Treated|0|||
164336600|NCT00573183|593609740|FG000|Overall Study|Other|5|||
163885073|NCT05603143|591949773|FG000|Overall Study|Death|0|||
163885074|NCT05603143|591949774|FG001|Overall Study|Death|1|||
163885075|NCT05603143|591949773|FG000|Overall Study|Investigator's discretion|1|||
163885076|NCT05603143|591949774|FG001|Overall Study|Investigator's discretion|0|||
163885077|NCT05603143|591949773|FG000|Overall Study|Lost to Follow-up|0|||
163885078|NCT05603143|591949774|FG001|Overall Study|Lost to Follow-up|1|||
163885079|NCT05603143|591949773|FG000|Overall Study|Protocol Violation|0|||
163885080|NCT05603143|591949774|FG001|Overall Study|Protocol Violation|1|||
163885081|NCT05647304|591949775|FG000|Overall Study|Withdrawal by Subject|1|||
163885082|NCT05647304|591949776|FG001|Overall Study|Withdrawal by Subject|0|||
163885083|NCT04171999|591949777|FG000|Overall Study|deemed ineligible after randomization|2|||
163885084|NCT04171999|591949778|FG001|Overall Study|deemed ineligible after randomization|1|||
163885085|NCT04505904|591949783|FG000|Overall Study|Withdrawal by Subject|1|||
163885086|NCT04505904|591949784|FG001|Overall Study|Withdrawal by Subject|2|||
163885087|NCT04505904|591949785|FG002|Overall Study|Withdrawal by Subject|0|||
163885088|NCT04505904|591949786|FG003|Overall Study|Withdrawal by Subject|0|||
163885089|NCT04505904|591949783|FG000|Overall Study|Physician Decision|1|||
163885090|NCT04505904|591949784|FG001|Overall Study|Physician Decision|0|||
163885091|NCT04505904|591949785|FG002|Overall Study|Physician Decision|0|||
163885092|NCT04505904|591949786|FG003|Overall Study|Physician Decision|0|||
163885093|NCT04505904|591949783|FG000|Overall Study|Adverse Event|0|||
163885094|NCT04505904|591949784|FG001|Overall Study|Adverse Event|1|||
163885095|NCT04505904|591949785|FG002|Overall Study|Adverse Event|0|||
163885096|NCT04505904|591949786|FG003|Overall Study|Adverse Event|0|||
163885097|NCT04277442|591949789|FG000|Overall Study|Death|1|||
163885098|NCT03092518|591949790|FG000|Overall Study|Ineligible|2|||
163885099|NCT02547987|591949793|FG000|Overall Study|Withdrawal by Subject|1|||
163885100|NCT02547987|591949793|FG000|Overall Study|Adverse Event|2|||
163885101|NCT04282148|591949794|FG000|Overall Study|Death|7|||
163885102|NCT04282148|591949794|FG000|Overall Study|Withdrawal by Subject|1|||
163885103|NCT04282148|591949794|FG000|Overall Study|Physician Decision|1|||
163885104|NCT03808818|591949795|FG000|Overall Study|Death|6|||
163885105|NCT03808818|591949796|FG001|Overall Study|Death|6|||
163885106|NCT03808818|591949795|FG000|Overall Study|Withdrawal by Subject|7|||
163885107|NCT03808818|591949796|FG001|Overall Study|Withdrawal by Subject|18|||
163885108|NCT03808818|591949795|FG000|Overall Study|Lost to Follow-up|31|||
163885109|NCT03808818|591949796|FG001|Overall Study|Lost to Follow-up|33|||
163885110|NCT03865498|591949798|FG000|Overall Study|Lack of Efficacy|12|||
163885111|NCT03865498|591949799|FG001|Overall Study|Lack of Efficacy|11|||
163885112|NCT03865498|591949798|FG000|Overall Study|Lost to Follow-up|125|||
163885113|NCT03865498|591949799|FG001|Overall Study|Lost to Follow-up|133|||
163885114|NCT03865498|591949798|FG000|Overall Study|Withdrawal by Subject|2|||
163885115|NCT03865498|591949799|FG001|Overall Study|Withdrawal by Subject|4|||
163885116|NCT05084508|591949800|FG000|Overall Study|Lost to Follow-up|6|||
163885117|NCT05084508|591949801|FG001|Overall Study|Lost to Follow-up|3|||
163885118|NCT05084508|591949802|FG002|Overall Study|Lost to Follow-up|7|||
163885119|NCT05084508|591949803|FG003|Overall Study|Lost to Follow-up|3|||
163885120|NCT05084508|591949800|FG000|Overall Study|Withdrawal by Subject|0|||
163885121|NCT05084508|591949801|FG001|Overall Study|Withdrawal by Subject|2|||
163885122|NCT05084508|591949802|FG002|Overall Study|Withdrawal by Subject|3|||
163885123|NCT05084508|591949803|FG003|Overall Study|Withdrawal by Subject|1|||
163885124|NCT05084508|591949800|FG000|Overall Study|Other|0|||
163885125|NCT05084508|591949801|FG001|Overall Study|Other|0|||
163885126|NCT05084508|591949802|FG002|Overall Study|Other|0|||
163885127|NCT05084508|591949803|FG003|Overall Study|Other|1|||
164242673|NCT00413660|593260305|FG006|Up To Week 12|Randomized, Not Treated|0|||
164242674|NCT00413660|593260306|FG007|Up To Week 12|Randomized, Not Treated|0|||
164242675|NCT00413660|593260307|FG008|Up To Week 12|Randomized, Not Treated|0|||
164242676|NCT00413660|593260308|FG009|Up To Week 12|Randomized, Not Treated|0|||
164336601|NCT00573183|593609741|FG001|Overall Study|Other|2|||
163885128|NCT04137289|591949804|FG000|Overall Study|Death|0|||
163885129|NCT04137289|591949805|FG001|Overall Study|Death|0|||
163885130|NCT04137289|591949806|FG002|Overall Study|Death|0|||
163885131|NCT04137289|591949807|FG003|Overall Study|Death|0|||
163885132|NCT04137289|591949808|FG004|Overall Study|Death|0|||
163885133|NCT04137289|591949809|FG005|Overall Study|Death|0|||
163885134|NCT04137289|591949810|FG006|Overall Study|Death|1|||
163885135|NCT04137289|591949811|FG007|Overall Study|Death|0|||
163989834|NCT03106779|592331002|FG001|Overall Study|Lack of Efficacy|24|||
163989835|NCT03106779|592331001|FG000|Overall Study|Adverse Event|8|||
163989836|NCT03106779|592331002|FG001|Overall Study|Adverse Event|16|||
163989837|NCT03106779|592331001|FG000|Overall Study|Physician Decision|10|||
163989838|NCT03106779|592331002|FG001|Overall Study|Physician Decision|6|||
163989839|NCT03106779|592331001|FG000|Overall Study|Patient/guardian decision|4|||
163989840|NCT03106779|592331002|FG001|Overall Study|Patient/guardian decision|3|||
163989841|NCT03106779|592331001|FG000|Overall Study|Progressive disease|1|||
163989842|NCT03106779|592331002|FG001|Overall Study|Progressive disease|3|||
163989843|NCT03106779|592331001|FG000|Overall Study|Lost to Follow-up|1|||
163989844|NCT03106779|592331002|FG001|Overall Study|Lost to Follow-up|2|||
163989845|NCT03106779|592331001|FG000|Overall Study|Death|1|||
163989846|NCT03106779|592331002|FG001|Overall Study|Death|0|||
163989847|NCT03106779|592331001|FG000|Overall Study|Protocol Violation|1|||
163989848|NCT03106779|592331002|FG001|Overall Study|Protocol Violation|0|||
163989849|NCT03106779|592331001|FG000|Overall Study|Not treated|1|||
163989850|NCT03106779|592331002|FG001|Overall Study|Not treated|0|||
163989851|NCT04233229|592331003|FG000|Overall Study|Withdrawal by Subject|0|||
163989852|NCT04233229|592331004|FG001|Overall Study|Withdrawal by Subject|1|||
163989853|NCT04233229|592331003|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
163989854|NCT04233229|592331004|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
163989855|NCT04233229|592331003|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
163989856|NCT04233229|592331004|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
163989857|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
163989858|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
163989859|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
163989860|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
163989861|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
163989862|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
163989863|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
164242677|NCT00413660|593260309|FG010|Up To Week 12|Randomized, Not Treated|0|||
164242678|NCT00413660|593260299|FG000|Up To Week 12|Other|3|||
164242679|NCT00413660|593260300|FG001|Up To Week 12|Other|1|||
164242680|NCT00413660|593260301|FG002|Up To Week 12|Other|6|||
164242681|NCT00413660|593260302|FG003|Up To Week 12|Other|1|||
164242682|NCT00413660|593260303|FG004|Up To Week 12|Other|2|||
164242683|NCT00413660|593260304|FG005|Up To Week 12|Other|4|||
164242684|NCT00413660|593260305|FG006|Up To Week 12|Other|3|||
164242685|NCT00413660|593260306|FG007|Up To Week 12|Other|0|||
164242686|NCT00413660|593260307|FG008|Up To Week 12|Other|0|||
164242687|NCT00413660|593260308|FG009|Up To Week 12|Other|0|||
164242688|NCT00413660|593260309|FG010|Up To Week 12|Other|0|||
164242689|NCT00413660|593260299|FG000|Post Week 12|Adverse Event|2|||
164242690|NCT00413660|593260300|FG001|Post Week 12|Adverse Event|0|||
164242691|NCT00413660|593260301|FG002|Post Week 12|Adverse Event|2|||
164242692|NCT00413660|593260302|FG003|Post Week 12|Adverse Event|1|||
164242693|NCT00413660|593260303|FG004|Post Week 12|Adverse Event|4|||
164242694|NCT00413660|593260304|FG005|Post Week 12|Adverse Event|2|||
164242695|NCT00413660|593260305|FG006|Post Week 12|Adverse Event|2|||
164242696|NCT00413660|593260306|FG007|Post Week 12|Adverse Event|0|||
164242697|NCT00413660|593260307|FG008|Post Week 12|Adverse Event|0|||
164242698|NCT00413660|593260308|FG009|Post Week 12|Adverse Event|0|||
164242699|NCT00413660|593260309|FG010|Post Week 12|Adverse Event|0|||
164242700|NCT00413660|593260299|FG000|Post Week 12|Lack of Efficacy|0|||
164242701|NCT00413660|593260300|FG001|Post Week 12|Lack of Efficacy|0|||
164242702|NCT00413660|593260301|FG002|Post Week 12|Lack of Efficacy|1|||
164242703|NCT00413660|593260302|FG003|Post Week 12|Lack of Efficacy|0|||
163989864|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
163989865|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
164006644|NCT00847613|592391042|FG001|Overall Study|Protocol Violation|6|||
164242704|NCT00413660|593260303|FG004|Post Week 12|Lack of Efficacy|0|||
164242705|NCT00413660|593260304|FG005|Post Week 12|Lack of Efficacy|0|||
164242706|NCT00413660|593260305|FG006|Post Week 12|Lack of Efficacy|0|||
164242707|NCT00413660|593260306|FG007|Post Week 12|Lack of Efficacy|0|||
164242708|NCT00413660|593260307|FG008|Post Week 12|Lack of Efficacy|0|||
164242709|NCT00413660|593260308|FG009|Post Week 12|Lack of Efficacy|1|||
164242710|NCT00413660|593260309|FG010|Post Week 12|Lack of Efficacy|0|||
164242711|NCT00413660|593260299|FG000|Post Week 12|Lost to Follow-up|0|||
164242712|NCT00413660|593260300|FG001|Post Week 12|Lost to Follow-up|1|||
163989866|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
163989867|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
163989868|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
163989869|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
163989870|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
163989871|NCT02288247|592331005|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
163989872|NCT02288247|592331006|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
163989873|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
163989874|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
163989875|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
163989876|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
163989877|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
163989878|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
163989879|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
163989880|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
163989881|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
163989882|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
163989883|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
163989884|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
163989885|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
163989886|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
163989887|NCT02288247|592331005|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
163989888|NCT02288247|592331006|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
163989889|NCT04652804|592331007|FG000|Overall Study|Ineligible post randomization|1|||
163989890|NCT04652804|592331008|FG001|Overall Study|Ineligible post randomization|0|||
163989891|NCT04652804|592331009|FG002|Overall Study|Ineligible post randomization|1|||
163989892|NCT04652804|592331010|FG003|Overall Study|Ineligible post randomization|0|||
163989893|NCT04652804|592331011|FG004|Overall Study|Ineligible post randomization|1|||
163989894|NCT04652804|592331012|FG005|Overall Study|Ineligible post randomization|1|||
163989895|NCT04652804|592331007|FG000|Overall Study|Missing SVR lab results|2|||
163989896|NCT04652804|592331008|FG001|Overall Study|Missing SVR lab results|0|||
163989897|NCT04652804|592331009|FG002|Overall Study|Missing SVR lab results|0|||
163989898|NCT04652804|592331010|FG003|Overall Study|Missing SVR lab results|0|||
163989899|NCT04652804|592331011|FG004|Overall Study|Missing SVR lab results|0|||
163989900|NCT04652804|592331012|FG005|Overall Study|Missing SVR lab results|0|||
163989901|NCT04093531|592331013|FG000|Overall Study|failed screening|4|||
163989902|NCT01580397|592331014|FG000|Overall Study|Lack of Efficacy|14|||
163989903|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
163989904|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
163989905|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
163989906|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Death|28|||
163989907|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Death|0|||
163989908|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Death|0|||
163989909|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
163989910|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
163989911|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
163989912|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
163989913|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
163989914|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
163989915|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
163989916|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
163989917|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
163989918|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
163989919|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
163989920|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
163989921|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
163989922|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
163989923|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
163989924|NCT00820755|592331015|FG000|Period 1: Combination Therapy Phase|Other|11|||
163989925|NCT00820755|592331016|FG001|Period 1: Combination Therapy Phase|Other|0|||
164242713|NCT00413660|593260301|FG002|Post Week 12|Lost to Follow-up|1|||
164242714|NCT00413660|593260302|FG003|Post Week 12|Lost to Follow-up|0|||
164242715|NCT00413660|593260303|FG004|Post Week 12|Lost to Follow-up|0|||
164242716|NCT00413660|593260304|FG005|Post Week 12|Lost to Follow-up|0|||
164242717|NCT00413660|593260305|FG006|Post Week 12|Lost to Follow-up|0|||
163989926|NCT00820755|592331017|FG002|Period 1: Combination Therapy Phase|Other|0|||
164242718|NCT00413660|593260306|FG007|Post Week 12|Lost to Follow-up|0|||
164242719|NCT00413660|593260307|FG008|Post Week 12|Lost to Follow-up|0|||
164336602|NCT05439941|593609742|FG000|Overall Study|Lack of Efficacy|8|||
164336603|NCT05439941|593609743|FG001|Overall Study|Lack of Efficacy|5|||
164336604|NCT05439941|593609744|FG002|Overall Study|Lack of Efficacy|3|||
164336605|NCT05439941|593609742|FG000|Overall Study|Treatment Failure|0|||
164336606|NCT05439941|593609743|FG001|Overall Study|Treatment Failure|1|||
164336607|NCT05439941|593609744|FG002|Overall Study|Treatment Failure|0|||
164336608|NCT05439941|593609742|FG000|Overall Study|Adverse Event|1|||
163885136|NCT04137289|591949812|FG008|Overall Study|Death|0|||
163885137|NCT04137289|591949804|FG000|Overall Study|Clinical disease progression|0|||
163885138|NCT04137289|591949805|FG001|Overall Study|Clinical disease progression|0|||
163885139|NCT04137289|591949806|FG002|Overall Study|Clinical disease progression|0|||
163885140|NCT04137289|591949807|FG003|Overall Study|Clinical disease progression|4|||
163885141|NCT04137289|591949808|FG004|Overall Study|Clinical disease progression|4|||
163885142|NCT04137289|591949809|FG005|Overall Study|Clinical disease progression|2|||
163885143|NCT04137289|591949810|FG006|Overall Study|Clinical disease progression|5|||
163885144|NCT04137289|591949811|FG007|Overall Study|Clinical disease progression|1|||
163885145|NCT04137289|591949812|FG008|Overall Study|Clinical disease progression|0|||
163885146|NCT04137289|591949804|FG000|Overall Study|Lost to Follow-up|0|||
163885147|NCT04137289|591949805|FG001|Overall Study|Lost to Follow-up|0|||
163885148|NCT04137289|591949806|FG002|Overall Study|Lost to Follow-up|0|||
163885149|NCT04137289|591949807|FG003|Overall Study|Lost to Follow-up|1|||
163885150|NCT04137289|591949808|FG004|Overall Study|Lost to Follow-up|0|||
163885151|NCT04137289|591949809|FG005|Overall Study|Lost to Follow-up|0|||
163885152|NCT04137289|591949810|FG006|Overall Study|Lost to Follow-up|0|||
163885153|NCT04137289|591949811|FG007|Overall Study|Lost to Follow-up|0|||
163885154|NCT04137289|591949812|FG008|Overall Study|Lost to Follow-up|0|||
163885155|NCT04137289|591949804|FG000|Overall Study|Adverse Event|0|||
163885156|NCT04137289|591949805|FG001|Overall Study|Adverse Event|0|||
163885157|NCT04137289|591949806|FG002|Overall Study|Adverse Event|1|||
163885158|NCT04137289|591949807|FG003|Overall Study|Adverse Event|0|||
163885159|NCT04137289|591949808|FG004|Overall Study|Adverse Event|0|||
163885160|NCT04137289|591949809|FG005|Overall Study|Adverse Event|1|||
163885161|NCT04137289|591949810|FG006|Overall Study|Adverse Event|0|||
163885162|NCT04137289|591949811|FG007|Overall Study|Adverse Event|0|||
163885163|NCT04137289|591949812|FG008|Overall Study|Adverse Event|0|||
163885164|NCT04137289|591949804|FG000|Overall Study|Lack of clinical benefit|0|||
163885165|NCT04137289|591949805|FG001|Overall Study|Lack of clinical benefit|0|||
163885166|NCT04137289|591949806|FG002|Overall Study|Lack of clinical benefit|0|||
163885167|NCT04137289|591949807|FG003|Overall Study|Lack of clinical benefit|0|||
163885168|NCT04137289|591949808|FG004|Overall Study|Lack of clinical benefit|0|||
163885169|NCT04137289|591949809|FG005|Overall Study|Lack of clinical benefit|0|||
163885170|NCT04137289|591949810|FG006|Overall Study|Lack of clinical benefit|0|||
163885171|NCT04137289|591949811|FG007|Overall Study|Lack of clinical benefit|0|||
163885172|NCT04137289|591949812|FG008|Overall Study|Lack of clinical benefit|1|||
163885173|NCT04137289|591949804|FG000|Overall Study|Objective disease progression|1|||
163885174|NCT04137289|591949805|FG001|Overall Study|Objective disease progression|1|||
163885175|NCT04137289|591949806|FG002|Overall Study|Objective disease progression|6|||
163885176|NCT04137289|591949807|FG003|Overall Study|Objective disease progression|18|||
163885177|NCT04137289|591949808|FG004|Overall Study|Objective disease progression|12|||
163885178|NCT04137289|591949809|FG005|Overall Study|Objective disease progression|20|||
163885179|NCT04137289|591949810|FG006|Overall Study|Objective disease progression|18|||
163885180|NCT04137289|591949811|FG007|Overall Study|Objective disease progression|7|||
163885181|NCT04137289|591949812|FG008|Overall Study|Objective disease progression|6|||
163885182|NCT03931174|591949817|FG000|Providers|Staff left organization|26|||
163885183|NCT03931174|591949818|FG001|Providers|Staff left organization|25|||
163885184|NCT03931174|591949817|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
163885185|NCT03931174|591949818|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
163885186|NCT03931174|591949817|FG000|Providers|Lost to Follow-up|4|||
163885187|NCT03931174|591949818|FG001|Providers|Lost to Follow-up|4|||
163885188|NCT03931174|591949817|FG000|Patients|Post-consent screening failure|1|||
163885189|NCT03931174|591949818|FG001|Patients|Post-consent screening failure|1|||
163885190|NCT03931174|591949817|FG000|Patients|Death|1|||
163885191|NCT03931174|591949818|FG001|Patients|Death|1|||
163885192|NCT03931174|591949817|FG000|Patients|Lost to Follow-up|60|||
163885193|NCT03931174|591949818|FG001|Patients|Lost to Follow-up|89|||
163885194|NCT05386030|591949819|FG000|Overall Study|Death|1|||
163885195|NCT05386030|591949820|FG001|Overall Study|Death|0|||
163885196|NCT05386030|591949819|FG000|Overall Study|Physician Decision|2|||
163885197|NCT05386030|591949820|FG001|Overall Study|Physician Decision|1|||
163885198|NCT05386030|591949819|FG000|Overall Study|Lost to Follow-up|19|||
163989927|NCT00820755|592331015|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
163989928|NCT00820755|592331016|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
163989929|NCT00820755|592331017|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
164336609|NCT05439941|593609743|FG001|Overall Study|Adverse Event|3|||
164006645|NCT00847613|592391043|FG002|Overall Study|Protocol Violation|3|||
164336610|NCT05439941|593609744|FG002|Overall Study|Adverse Event|0|||
164242720|NCT00413660|593260308|FG009|Post Week 12|Lost to Follow-up|0|||
164242721|NCT00413660|593260309|FG010|Post Week 12|Lost to Follow-up|0|||
164242722|NCT00413660|593260299|FG000|Post Week 12|Withdrawal by Subject|0|||
164242723|NCT00413660|593260300|FG001|Post Week 12|Withdrawal by Subject|1|||
164242724|NCT00413660|593260301|FG002|Post Week 12|Withdrawal by Subject|1|||
164242725|NCT00413660|593260302|FG003|Post Week 12|Withdrawal by Subject|0|||
164242726|NCT00413660|593260303|FG004|Post Week 12|Withdrawal by Subject|1|||
164242727|NCT00413660|593260304|FG005|Post Week 12|Withdrawal by Subject|0|||
164242728|NCT00413660|593260305|FG006|Post Week 12|Withdrawal by Subject|0|||
164242729|NCT00413660|593260306|FG007|Post Week 12|Withdrawal by Subject|0|||
164242730|NCT00413660|593260307|FG008|Post Week 12|Withdrawal by Subject|0|||
164242731|NCT00413660|593260308|FG009|Post Week 12|Withdrawal by Subject|0|||
164242732|NCT00413660|593260309|FG010|Post Week 12|Withdrawal by Subject|1|||
164242733|NCT00413660|593260299|FG000|Post Week 12|Other|1|||
164242734|NCT00413660|593260300|FG001|Post Week 12|Other|2|||
164242735|NCT00413660|593260301|FG002|Post Week 12|Other|3|||
164242736|NCT00413660|593260302|FG003|Post Week 12|Other|0|||
164242737|NCT00413660|593260303|FG004|Post Week 12|Other|1|||
164242738|NCT00413660|593260304|FG005|Post Week 12|Other|1|||
164242739|NCT00413660|593260305|FG006|Post Week 12|Other|1|||
164242740|NCT00413660|593260306|FG007|Post Week 12|Other|0|||
164242741|NCT00413660|593260307|FG008|Post Week 12|Other|0|||
164242742|NCT00413660|593260308|FG009|Post Week 12|Other|0|||
164242743|NCT00413660|593260309|FG010|Post Week 12|Other|0|||
164242744|NCT01791517|593260310|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
163885199|NCT05386030|591949820|FG001|Overall Study|Lost to Follow-up|7|||
163885200|NCT05386030|591949819|FG000|Overall Study|Withdrawal by Subject|20|||
163885201|NCT05386030|591949820|FG001|Overall Study|Withdrawal by Subject|10|||
163885202|NCT05386030|591949819|FG000|Overall Study|Eligibility criteria violation|1|||
163885203|NCT05386030|591949820|FG001|Overall Study|Eligibility criteria violation|1|||
164242745|NCT01791517|593260311|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
164242746|NCT01791517|593260312|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
164242747|NCT01791517|593260313|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
163885204|NCT05386030|591949819|FG000|Overall Study|Personal Reasons|1|||
163885205|NCT05386030|591949820|FG001|Overall Study|Personal Reasons|0|||
163885206|NCT05228457|591949821|FG000|Overall Study|Withdrawal by Subject|1|||
163885207|NCT05228457|591949822|FG001|Overall Study|Withdrawal by Subject|1|||
163885208|NCT03213691|591949827|FG000|Overall Study|Adverse Event|2|||
163885209|NCT03213691|591949827|FG000|Overall Study|Death|3|||
163885210|NCT03213691|591949827|FG000|Overall Study|Physician Decision|1|||
163885211|NCT03213691|591949827|FG000|Overall Study|Progressive Disease|14|||
163885212|NCT03213691|591949827|FG000|Overall Study|Ineligible|1|||
163885213|NCT03161028|591949830|FG000|Overall Study|Withdrawal by Subject|6|||
163885214|NCT03161028|591949831|FG001|Overall Study|Withdrawal by Subject|4|||
163885215|NCT03161028|591949830|FG000|Overall Study|Adverse Event|5|||
163885216|NCT03161028|591949831|FG001|Overall Study|Adverse Event|1|||
163885217|NCT03161028|591949830|FG000|Overall Study|Study drug side effects|2|||
163885218|NCT03161028|591949831|FG001|Overall Study|Study drug side effects|2|||
163885219|NCT03161028|591949830|FG000|Overall Study|Administrative PD/UP|4|||
163885220|NCT03161028|591949831|FG001|Overall Study|Administrative PD/UP|2|||
163885221|NCT03161028|591949830|FG000|Overall Study|Lost to Follow-up|2|||
163885222|NCT03161028|591949831|FG001|Overall Study|Lost to Follow-up|0|||
163885223|NCT03161028|591949830|FG000|Overall Study|Unable to comply with procedures|1|||
163885224|NCT03161028|591949831|FG001|Overall Study|Unable to comply with procedures|1|||
163885225|NCT03492216|591949832|FG000|Overall Study|Death|1|||
163885226|NCT03492216|591949833|FG001|Overall Study|Death|0|||
163885227|NCT03492216|591949834|FG002|Overall Study|Death|4|||
164083485|NCT02711956|592670196|FG007|Overall Study|Clinical progression|0|||
164242748|NCT01791517|593260314|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
164242749|NCT01791517|593260315|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
164242750|NCT01791517|593260316|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
164242751|NCT01791517|593260317|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
164242752|NCT01791517|593260318|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
164242753|NCT01791517|593260319|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
164242754|NCT01791517|593260320|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
164242755|NCT01791517|593260321|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
164336611|NCT05439941|593609742|FG000|Overall Study|Adverse Event - Parent Study|1|||
164336612|NCT05439941|593609743|FG001|Overall Study|Adverse Event - Parent Study|0|||
163885228|NCT03492216|591949835|FG003|Overall Study|Death|0|||
163885229|NCT03492216|591949832|FG000|Overall Study|Withdrawal by Subject|5|||
163885230|NCT03492216|591949833|FG001|Overall Study|Withdrawal by Subject|3|||
163885231|NCT03492216|591949834|FG002|Overall Study|Withdrawal by Subject|1|||
163885232|NCT03492216|591949835|FG003|Overall Study|Withdrawal by Subject|1|||
163885233|NCT03492216|591949832|FG000|Overall Study|Lost to Follow-up|9|||
163885234|NCT03492216|591949833|FG001|Overall Study|Lost to Follow-up|2|||
164242756|NCT01791517|593260310|FG000|Phase I: Period 1|Adverse Event|0|||
164242757|NCT01791517|593260311|FG001|Phase I: Period 1|Adverse Event|0|||
164242758|NCT01791517|593260312|FG002|Phase I: Period 1|Adverse Event|1|||
164242759|NCT01791517|593260313|FG003|Phase I: Period 1|Adverse Event|1|||
164336613|NCT05439941|593609744|FG002|Overall Study|Adverse Event - Parent Study|0|||
164336614|NCT05439941|593609742|FG000|Overall Study|Pregnancy|1|||
164336615|NCT05439941|593609743|FG001|Overall Study|Pregnancy|0|||
164336616|NCT05439941|593609744|FG002|Overall Study|Pregnancy|0|||
164336617|NCT05439941|593609742|FG000|Overall Study|Withdrawal by Subject|9|||
164336618|NCT05439941|593609743|FG001|Overall Study|Withdrawal by Subject|6|||
164336619|NCT05439941|593609744|FG002|Overall Study|Withdrawal by Subject|10|||
164336620|NCT05439941|593609742|FG000|Overall Study|Non-Compliance|1|||
164336621|NCT05439941|593609743|FG001|Overall Study|Non-Compliance|1|||
164336622|NCT05439941|593609744|FG002|Overall Study|Non-Compliance|1|||
164336623|NCT05439941|593609742|FG000|Overall Study|Lost to Follow-up|2|||
164336624|NCT05439941|593609743|FG001|Overall Study|Lost to Follow-up|2|||
164336625|NCT05439941|593609744|FG002|Overall Study|Lost to Follow-up|0|||
164336626|NCT05439941|593609742|FG000|Overall Study|Physician Decision|1|||
164336627|NCT05439941|593609743|FG001|Overall Study|Physician Decision|0|||
163885235|NCT03492216|591949834|FG002|Overall Study|Lost to Follow-up|7|||
163885236|NCT03492216|591949835|FG003|Overall Study|Lost to Follow-up|8|||
163885237|NCT03492216|591949832|FG000|Overall Study|Moved|5|||
163885238|NCT03492216|591949833|FG001|Overall Study|Moved|3|||
163885239|NCT03492216|591949834|FG002|Overall Study|Moved|3|||
163885240|NCT03492216|591949835|FG003|Overall Study|Moved|5|||
163885241|NCT03492216|591949832|FG000|Overall Study|Too ill|0|||
163885242|NCT03492216|591949833|FG001|Overall Study|Too ill|1|||
163885243|NCT03492216|591949834|FG002|Overall Study|Too ill|0|||
163885244|NCT03492216|591949835|FG003|Overall Study|Too ill|0|||
163885245|NCT03492216|591949832|FG000|Overall Study|Incarcerated|0|||
163885246|NCT03492216|591949833|FG001|Overall Study|Incarcerated|0|||
163885247|NCT03492216|591949834|FG002|Overall Study|Incarcerated|2|||
163885248|NCT03492216|591949835|FG003|Overall Study|Incarcerated|0|||
163885249|NCT00736723|591949836|FG000|Overall Study|Withdrawal by Subject|4|||
163885250|NCT00736723|591949837|FG001|Overall Study|Withdrawal by Subject|3|||
164140483|NCT00642278|592876100|FG005|Overall Study|Lack of Efficacy|0|||
163885251|NCT01799265|591949840|FG000|Overall Study|Lost to Follow-up|1|||
163885252|NCT01799265|591949841|FG001|Overall Study|Lost to Follow-up|0|||
163885253|NCT01799265|591949840|FG000|Overall Study|Protocol Violation|2|||
164140484|NCT00642278|592876101|FG006|Overall Study|Lack of Efficacy|0|||
164140485|NCT00642278|592876095|FG000|Overall Study|Lost to Follow-up|5|||
164140486|NCT00642278|592876096|FG001|Overall Study|Lost to Follow-up|1|||
164140487|NCT00642278|592876097|FG002|Overall Study|Lost to Follow-up|0|||
164140488|NCT00642278|592876098|FG003|Overall Study|Lost to Follow-up|1|||
164140489|NCT00642278|592876099|FG004|Overall Study|Lost to Follow-up|0|||
164140490|NCT00642278|592876100|FG005|Overall Study|Lost to Follow-up|1|||
164140491|NCT00642278|592876101|FG006|Overall Study|Lost to Follow-up|1|||
164140492|NCT00642278|592876095|FG000|Overall Study|Physician Decision|0|||
164140493|NCT00642278|592876096|FG001|Overall Study|Physician Decision|0|||
164140494|NCT00642278|592876097|FG002|Overall Study|Physician Decision|0|||
164140495|NCT00642278|592876098|FG003|Overall Study|Physician Decision|1|||
164140496|NCT00642278|592876099|FG004|Overall Study|Physician Decision|0|||
164140497|NCT00642278|592876100|FG005|Overall Study|Physician Decision|0|||
164140498|NCT00642278|592876101|FG006|Overall Study|Physician Decision|0|||
164140499|NCT00642278|592876095|FG000|Overall Study|Protocol Violation|0|||
164140500|NCT00642278|592876096|FG001|Overall Study|Protocol Violation|0|||
164140501|NCT00642278|592876097|FG002|Overall Study|Protocol Violation|1|||
164140502|NCT00642278|592876098|FG003|Overall Study|Protocol Violation|1|||
164140503|NCT00642278|592876099|FG004|Overall Study|Protocol Violation|0|||
164140504|NCT00642278|592876100|FG005|Overall Study|Protocol Violation|1|||
163989930|NCT01486199|592331018|FG000|Two Year Period Between Study Days|Physician Decision|1|||
163989931|NCT01486199|592331019|FG001|Two Year Period Between Study Days|Physician Decision|0|||
163989932|NCT03604445|592331023|FG000|Overall Study|Death|0|||
163989933|NCT03604445|592331024|FG001|Overall Study|Death|0|||
163989934|NCT03604445|592331025|FG002|Overall Study|Death|0|||
163989935|NCT03604445|592331026|FG003|Overall Study|Death|0|||
163989936|NCT03604445|592331027|FG004|Overall Study|Death|0|||
163989937|NCT03604445|592331028|FG005|Overall Study|Death|0|||
163989938|NCT03604445|592331029|FG006|Overall Study|Death|0|||
163989939|NCT03604445|592331030|FG007|Overall Study|Death|0|||
163989940|NCT03604445|592331031|FG008|Overall Study|Death|1|||
163989941|NCT03604445|592331023|FG000|Overall Study|Withdrawal by Subject|0|||
163989942|NCT03604445|592331024|FG001|Overall Study|Withdrawal by Subject|0|||
163989943|NCT03604445|592331025|FG002|Overall Study|Withdrawal by Subject|0|||
163989944|NCT03604445|592331026|FG003|Overall Study|Withdrawal by Subject|0|||
163989945|NCT03604445|592331027|FG004|Overall Study|Withdrawal by Subject|0|||
163989946|NCT03604445|592331028|FG005|Overall Study|Withdrawal by Subject|0|||
163989947|NCT03604445|592331029|FG006|Overall Study|Withdrawal by Subject|1|||
163989948|NCT03604445|592331030|FG007|Overall Study|Withdrawal by Subject|0|||
163989949|NCT03604445|592331031|FG008|Overall Study|Withdrawal by Subject|0|||
163989950|NCT03604445|592331023|FG000|Overall Study|Missing visit|0|||
163989951|NCT03604445|592331024|FG001|Overall Study|Missing visit|0|||
163989952|NCT03604445|592331025|FG002|Overall Study|Missing visit|0|||
163989953|NCT03604445|592331026|FG003|Overall Study|Missing visit|0|||
163989954|NCT03604445|592331027|FG004|Overall Study|Missing visit|0|||
163989955|NCT03604445|592331028|FG005|Overall Study|Missing visit|1|||
163989956|NCT03604445|592331029|FG006|Overall Study|Missing visit|0|||
163989957|NCT03604445|592331030|FG007|Overall Study|Missing visit|1|||
163989958|NCT03604445|592331031|FG008|Overall Study|Missing visit|0|||
163989959|NCT03604445|592331023|FG000|Overall Study|Adverse Event|0|||
163989960|NCT03604445|592331024|FG001|Overall Study|Adverse Event|0|||
163989961|NCT03604445|592331025|FG002|Overall Study|Adverse Event|0|||
163989962|NCT03604445|592331026|FG003|Overall Study|Adverse Event|1|||
163989963|NCT03604445|592331027|FG004|Overall Study|Adverse Event|0|||
163989964|NCT03604445|592331028|FG005|Overall Study|Adverse Event|0|||
163989965|NCT03604445|592331029|FG006|Overall Study|Adverse Event|0|||
163989966|NCT03604445|592331030|FG007|Overall Study|Adverse Event|0|||
163989967|NCT03604445|592331031|FG008|Overall Study|Adverse Event|1|||
163989968|NCT02154425|592331032|FG000|Screening Period|Adverse Event|1|||
163989969|NCT00480857|592331037|FG000|Overall Study|Lack of Efficacy|2|||
163989970|NCT00611247|592331038|FG000|Overall Study|Death|1|||
163989971|NCT00611247|592331039|FG001|Overall Study|Death|5|||
163989972|NCT00611247|592331038|FG000|Overall Study|Lack of Efficacy|1|||
163989973|NCT00611247|592331039|FG001|Overall Study|Lack of Efficacy|16|||
163989974|NCT02551159|592331042|FG000|Overall Study|Death|352|||
163989975|NCT02551159|592331043|FG001|Overall Study|Death|174|||
163989976|NCT02551159|592331044|FG002|Overall Study|Death|161|||
163989977|NCT02551159|592331042|FG000|Overall Study|Withdrawal by Subject|8|||
163989978|NCT02551159|592331043|FG001|Overall Study|Withdrawal by Subject|5|||
163989979|NCT02551159|592331044|FG002|Overall Study|Withdrawal by Subject|16|||
163989980|NCT02551159|592331042|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
163989981|NCT02551159|592331043|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
163989982|NCT02551159|592331044|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
163989983|NCT00243659|592331045|FG000|Overall Study|Withdrawal by Subject|1|||
163989984|NCT00243659|592331046|FG001|Overall Study|Withdrawal by Subject|1|||
163989985|NCT00243659|592331045|FG000|Overall Study|Protocol Violation|1|||
163989986|NCT00243659|592331046|FG001|Overall Study|Protocol Violation|2|||
163989987|NCT06098729|592331047|FG000|Overall Study|Withdrawal by Subject|1|||
163989988|NCT01890421|592331053|FG000|Overall Study|Adverse Event|1|||
163989989|NCT01890421|592331053|FG000|Overall Study|Other reason|10|||
163989990|NCT01972074|592331060|FG000|Overall Study|Adverse Event|4|||
163989991|NCT01972074|592331061|FG001|Overall Study|Adverse Event|1|||
163989992|NCT01972074|592331062|FG002|Overall Study|Adverse Event|0|||
163989993|NCT01972074|592331060|FG000|Overall Study|Lack of Efficacy|1|||
163989994|NCT01972074|592331061|FG001|Overall Study|Lack of Efficacy|1|||
163989995|NCT01972074|592331062|FG002|Overall Study|Lack of Efficacy|0|||
163989996|NCT01972074|592331060|FG000|Overall Study|Lost to Follow-up|0|||
163989997|NCT01972074|592331061|FG001|Overall Study|Lost to Follow-up|1|||
163989998|NCT01972074|592331062|FG002|Overall Study|Lost to Follow-up|1|||
163989999|NCT01972074|592331060|FG000|Overall Study|Withdrawal by Subject|1|||
163990000|NCT01972074|592331061|FG001|Overall Study|Withdrawal by Subject|1|||
164242760|NCT01791517|593260314|FG004|Phase I: Period 1|Adverse Event|0|||
164242761|NCT01791517|593260315|FG005|Phase I: Period 1|Adverse Event|0|||
164242762|NCT01791517|593260316|FG006|Phase I: Period 1|Adverse Event|0|||
164242763|NCT01791517|593260317|FG007|Phase I: Period 1|Adverse Event|0|||
164242764|NCT01791517|593260318|FG008|Phase I: Period 1|Adverse Event|0|||
164242765|NCT01791517|593260319|FG009|Phase I: Period 1|Adverse Event|0|||
164242766|NCT01791517|593260320|FG010|Phase I: Period 1|Adverse Event|0|||
164242767|NCT01791517|593260321|FG011|Phase I: Period 1|Adverse Event|0|||
164242768|NCT01791517|593260310|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
164242769|NCT01791517|593260311|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242770|NCT01791517|593260312|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242771|NCT01791517|593260313|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242772|NCT01791517|593260314|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242773|NCT01791517|593260315|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242774|NCT01791517|593260316|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242775|NCT01791517|593260317|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242776|NCT01791517|593260318|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242777|NCT01791517|593260319|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242778|NCT01791517|593260320|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242779|NCT01791517|593260321|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
164242780|NCT01791517|593260310|FG000|Phase I: Period 1|Protocol Violation|0|||
164242781|NCT01791517|593260311|FG001|Phase I: Period 1|Protocol Violation|1|||
164242782|NCT01791517|593260312|FG002|Phase I: Period 1|Protocol Violation|0|||
164242783|NCT01791517|593260313|FG003|Phase I: Period 1|Protocol Violation|0|||
164242784|NCT01791517|593260314|FG004|Phase I: Period 1|Protocol Violation|0|||
164242785|NCT01791517|593260315|FG005|Phase I: Period 1|Protocol Violation|0|||
164242786|NCT01791517|593260316|FG006|Phase I: Period 1|Protocol Violation|0|||
164242787|NCT01791517|593260317|FG007|Phase I: Period 1|Protocol Violation|0|||
164242788|NCT01791517|593260318|FG008|Phase I: Period 1|Protocol Violation|0|||
164242789|NCT01791517|593260319|FG009|Phase I: Period 1|Protocol Violation|0|||
164242790|NCT01791517|593260320|FG010|Phase I: Period 1|Protocol Violation|0|||
164242791|NCT01791517|593260321|FG011|Phase I: Period 1|Protocol Violation|0|||
164242792|NCT01791517|593260310|FG000|Phase I: Period 1|Lost to Follow-up|0|||
164242793|NCT01791517|593260311|FG001|Phase I: Period 1|Lost to Follow-up|0|||
164242794|NCT01791517|593260312|FG002|Phase I: Period 1|Lost to Follow-up|0|||
164242795|NCT01791517|593260313|FG003|Phase I: Period 1|Lost to Follow-up|1|||
164242796|NCT01791517|593260314|FG004|Phase I: Period 1|Lost to Follow-up|0|||
164242797|NCT01791517|593260315|FG005|Phase I: Period 1|Lost to Follow-up|0|||
164242798|NCT01791517|593260316|FG006|Phase I: Period 1|Lost to Follow-up|1|||
164242799|NCT01791517|593260317|FG007|Phase I: Period 1|Lost to Follow-up|0|||
164242800|NCT01791517|593260318|FG008|Phase I: Period 1|Lost to Follow-up|1|||
164242801|NCT01791517|593260319|FG009|Phase I: Period 1|Lost to Follow-up|1|||
164242802|NCT01791517|593260320|FG010|Phase I: Period 1|Lost to Follow-up|0|||
164242803|NCT01791517|593260321|FG011|Phase I: Period 1|Lost to Follow-up|0|||
164242804|NCT01791517|593260310|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242805|NCT01791517|593260311|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242806|NCT01791517|593260312|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242807|NCT01791517|593260313|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242808|NCT01791517|593260314|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242809|NCT01791517|593260315|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242810|NCT01791517|593260316|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242811|NCT01791517|593260317|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242812|NCT01791517|593260318|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242813|NCT01791517|593260319|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242814|NCT01791517|593260320|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
164242815|NCT01791517|593260321|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
164242816|NCT01791517|593260310|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
164242817|NCT01791517|593260311|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242818|NCT01791517|593260312|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242819|NCT01791517|593260313|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242820|NCT01791517|593260314|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242821|NCT01791517|593260315|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242822|NCT01791517|593260316|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164336628|NCT05439941|593609744|FG002|Overall Study|Physician Decision|0|||
164336629|NCT05439941|593609742|FG000|Overall Study|Trial Termination by Sponsor|78|||
164336630|NCT05439941|593609743|FG001|Overall Study|Trial Termination by Sponsor|83|||
164242823|NCT01791517|593260317|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242824|NCT01791517|593260318|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242825|NCT01791517|593260319|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242826|NCT01791517|593260320|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242827|NCT01791517|593260321|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
164242828|NCT01791517|593260310|FG000|Phase I: Period 2|Protocol Violation|0|||
164242829|NCT01791517|593260311|FG001|Phase I: Period 2|Protocol Violation|0|||
164336631|NCT05439941|593609744|FG002|Overall Study|Trial Termination by Sponsor|65|||
164242830|NCT01791517|593260312|FG002|Phase I: Period 2|Protocol Violation|0|||
164242831|NCT01791517|593260313|FG003|Phase I: Period 2|Protocol Violation|1|||
164242832|NCT01791517|593260314|FG004|Phase I: Period 2|Protocol Violation|0|||
164242833|NCT01791517|593260315|FG005|Phase I: Period 2|Protocol Violation|0|||
164242834|NCT01791517|593260316|FG006|Phase I: Period 2|Protocol Violation|0|||
164242835|NCT01791517|593260317|FG007|Phase I: Period 2|Protocol Violation|0|||
164242836|NCT01791517|593260318|FG008|Phase I: Period 2|Protocol Violation|0|||
164242837|NCT01791517|593260319|FG009|Phase I: Period 2|Protocol Violation|0|||
164242838|NCT01791517|593260320|FG010|Phase I: Period 2|Protocol Violation|0|||
164242839|NCT01791517|593260321|FG011|Phase I: Period 2|Protocol Violation|0|||
164242840|NCT01791517|593260310|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
164242841|NCT01791517|593260311|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
164242842|NCT01791517|593260312|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
164242843|NCT01791517|593260313|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
164242844|NCT01791517|593260314|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
164242845|NCT01791517|593260315|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
164242846|NCT01791517|593260316|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
164242847|NCT01791517|593260317|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
164242848|NCT01791517|593260318|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
164242849|NCT01791517|593260319|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
164242850|NCT01791517|593260320|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
164242851|NCT01791517|593260321|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
164242852|NCT01791517|593260310|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242853|NCT01791517|593260311|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242854|NCT01791517|593260312|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242855|NCT01791517|593260313|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242856|NCT01791517|593260314|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242857|NCT01791517|593260315|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242858|NCT01791517|593260316|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242859|NCT01791517|593260317|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242860|NCT01791517|593260318|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242861|NCT01791517|593260319|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242862|NCT01791517|593260320|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
164242863|NCT01791517|593260321|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
164242864|NCT01791517|593260310|FG000|Phase I: Period 2|Lens Discomfort|0|||
164242865|NCT01791517|593260311|FG001|Phase I: Period 2|Lens Discomfort|0|||
164242866|NCT01791517|593260312|FG002|Phase I: Period 2|Lens Discomfort|0|||
164242867|NCT01791517|593260313|FG003|Phase I: Period 2|Lens Discomfort|0|||
164242868|NCT01791517|593260314|FG004|Phase I: Period 2|Lens Discomfort|0|||
164242869|NCT01791517|593260315|FG005|Phase I: Period 2|Lens Discomfort|1|||
164242870|NCT01791517|593260316|FG006|Phase I: Period 2|Lens Discomfort|0|||
164242871|NCT01791517|593260317|FG007|Phase I: Period 2|Lens Discomfort|0|||
164242872|NCT01791517|593260318|FG008|Phase I: Period 2|Lens Discomfort|0|||
164336632|NCT05439941|593609742|FG000|Overall Study|Other than Reasons Listed|2|||
164336633|NCT05439941|593609743|FG001|Overall Study|Other than Reasons Listed|1|||
164336634|NCT05439941|593609744|FG002|Overall Study|Other than Reasons Listed|0|||
164336635|NCT02336373|593609747|FG000|Overall Study|Protocol closed early|4|||
164336636|NCT02336373|593609747|FG000|Overall Study|Physician Decision|14|||
164336637|NCT04798781|593609750|FG000|Overall Study|Withdrawal by Subject|1|||
164336638|NCT00615108|593609753|FG000|Overall Study|Adverse Event|122|||
164336639|NCT00615108|593609753|FG000|Overall Study|Other|370|||
164336640|NCT00615108|593609753|FG000|Overall Study|Lost to Follow-up|15|||
164336641|NCT02024529|593609754|FG000|Overall Study|Withdrawal by Subject|11|||
164336642|NCT02024529|593609755|FG001|Overall Study|Withdrawal by Subject|21|||
164336643|NCT02024529|593609754|FG000|Overall Study|Lost to Follow-up|2|||
163990001|NCT01972074|592331062|FG002|Overall Study|Withdrawal by Subject|1|||
163990002|NCT01972074|592331060|FG000|Overall Study|Scanner Unavailable|0|||
163990003|NCT01972074|592331061|FG001|Overall Study|Scanner Unavailable|0|||
163990004|NCT01972074|592331062|FG002|Overall Study|Scanner Unavailable|1|||
163990005|NCT02319044|592331063|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
164242873|NCT01791517|593260319|FG009|Phase I: Period 2|Lens Discomfort|0|||
164242874|NCT01791517|593260320|FG010|Phase I: Period 2|Lens Discomfort|0|||
164242875|NCT01791517|593260321|FG011|Phase I: Period 2|Lens Discomfort|0|||
164242876|NCT01791517|593260310|FG000|Phase I: Period 2|Lost to Follow-up|0|||
164242877|NCT01791517|593260311|FG001|Phase I: Period 2|Lost to Follow-up|3|||
163990006|NCT02319044|592331064|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
163990007|NCT02319044|592331065|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
164242878|NCT01791517|593260312|FG002|Phase I: Period 2|Lost to Follow-up|2|||
164242879|NCT01791517|593260313|FG003|Phase I: Period 2|Lost to Follow-up|0|||
164336644|NCT02024529|593609755|FG001|Overall Study|Lost to Follow-up|4|||
164336645|NCT00691301|593609756|FG000|Overall Study|Adverse Event|10|||
164336646|NCT00691301|593609756|FG000|Overall Study|Death|2|||
164336647|NCT00691301|593609756|FG000|Overall Study|Lack of Efficacy|32|||
164242880|NCT01791517|593260314|FG004|Phase I: Period 2|Lost to Follow-up|0|||
164242881|NCT01791517|593260315|FG005|Phase I: Period 2|Lost to Follow-up|0|||
164242882|NCT01791517|593260316|FG006|Phase I: Period 2|Lost to Follow-up|0|||
164242883|NCT01791517|593260317|FG007|Phase I: Period 2|Lost to Follow-up|0|||
164242884|NCT01791517|593260318|FG008|Phase I: Period 2|Lost to Follow-up|0|||
164242885|NCT01791517|593260319|FG009|Phase I: Period 2|Lost to Follow-up|0|||
164242886|NCT01791517|593260320|FG010|Phase I: Period 2|Lost to Follow-up|0|||
164242887|NCT01791517|593260321|FG011|Phase I: Period 2|Lost to Follow-up|0|||
164242888|NCT01791517|593260310|FG000|Phase I: Period 3|Lens Discomfort|0|||
164242889|NCT01791517|593260311|FG001|Phase I: Period 3|Lens Discomfort|0|||
164242890|NCT01791517|593260312|FG002|Phase I: Period 3|Lens Discomfort|0|||
164242891|NCT01791517|593260313|FG003|Phase I: Period 3|Lens Discomfort|0|||
164242892|NCT01791517|593260314|FG004|Phase I: Period 3|Lens Discomfort|0|||
164242893|NCT01791517|593260315|FG005|Phase I: Period 3|Lens Discomfort|0|||
164242894|NCT01791517|593260316|FG006|Phase I: Period 3|Lens Discomfort|0|||
164242895|NCT01791517|593260317|FG007|Phase I: Period 3|Lens Discomfort|0|||
164242896|NCT01791517|593260318|FG008|Phase I: Period 3|Lens Discomfort|0|||
164242897|NCT01791517|593260319|FG009|Phase I: Period 3|Lens Discomfort|0|||
164242898|NCT01791517|593260320|FG010|Phase I: Period 3|Lens Discomfort|0|||
164242899|NCT01791517|593260321|FG011|Phase I: Period 3|Lens Discomfort|1|||
164242900|NCT01791517|593260310|FG000|Phase I: Period 3|Lost to Follow-up|0|||
164242901|NCT01791517|593260311|FG001|Phase I: Period 3|Lost to Follow-up|1|||
164242902|NCT01791517|593260312|FG002|Phase I: Period 3|Lost to Follow-up|0|||
164242903|NCT01791517|593260313|FG003|Phase I: Period 3|Lost to Follow-up|0|||
164242904|NCT01791517|593260314|FG004|Phase I: Period 3|Lost to Follow-up|1|||
164242905|NCT01791517|593260315|FG005|Phase I: Period 3|Lost to Follow-up|0|||
164242906|NCT01791517|593260316|FG006|Phase I: Period 3|Lost to Follow-up|0|||
164242907|NCT01791517|593260317|FG007|Phase I: Period 3|Lost to Follow-up|0|||
164242908|NCT01791517|593260318|FG008|Phase I: Period 3|Lost to Follow-up|0|||
164242909|NCT01791517|593260319|FG009|Phase I: Period 3|Lost to Follow-up|0|||
164242910|NCT01791517|593260320|FG010|Phase I: Period 3|Lost to Follow-up|0|||
164242911|NCT01791517|593260321|FG011|Phase I: Period 3|Lost to Follow-up|0|||
164242912|NCT01791517|593260310|FG000|Phase I: Period 3|Adverse Event|0|||
164242913|NCT01791517|593260311|FG001|Phase I: Period 3|Adverse Event|0|||
164242914|NCT01791517|593260312|FG002|Phase I: Period 3|Adverse Event|0|||
164242915|NCT01791517|593260313|FG003|Phase I: Period 3|Adverse Event|1|||
164242916|NCT01791517|593260314|FG004|Phase I: Period 3|Adverse Event|0|||
164242917|NCT01791517|593260315|FG005|Phase I: Period 3|Adverse Event|0|||
164242918|NCT01791517|593260316|FG006|Phase I: Period 3|Adverse Event|0|||
164242919|NCT01791517|593260317|FG007|Phase I: Period 3|Adverse Event|0|||
164242920|NCT01791517|593260318|FG008|Phase I: Period 3|Adverse Event|0|||
164242921|NCT01791517|593260319|FG009|Phase I: Period 3|Adverse Event|0|||
164242922|NCT01791517|593260320|FG010|Phase I: Period 3|Adverse Event|0|||
163885254|NCT01799265|591949841|FG001|Overall Study|Protocol Violation|1|||
163885255|NCT01799265|591949840|FG000|Overall Study|inadequate sleep study|0|||
163885256|NCT01799265|591949841|FG001|Overall Study|inadequate sleep study|2|||
163885257|NCT05704543|591949845|FG000|Overall Study|Withdrawal by Subject|1|||
163885258|NCT05704543|591949846|FG001|Overall Study|Withdrawal by Subject|1|||
163885259|NCT05704543|591949847|FG002|Overall Study|Withdrawal by Subject|0|||
163885260|NCT05704543|591949848|FG003|Overall Study|Withdrawal by Subject|2|||
163885261|NCT05704543|591949845|FG000|Overall Study|Lost to Follow-up|1|||
163885262|NCT05704543|591949846|FG001|Overall Study|Lost to Follow-up|2|||
163885263|NCT05704543|591949847|FG002|Overall Study|Lost to Follow-up|0|||
163885264|NCT05704543|591949848|FG003|Overall Study|Lost to Follow-up|0|||
163885265|NCT05351554|591949853|FG000|Overall Study|Study terminated by sponsor|1|||
163885266|NCT05030233|591949854|FG000|Overall Study|withdrawn for transfer|1|||
163885267|NCT05030233|591949855|FG001|Overall Study|withdrawn for transfer|0|||
163885268|NCT02727699|591952187|FG000|Overall Study|Adverse Event|2|||
163885269|NCT02727699|591952188|FG001|Overall Study|Adverse Event|0|||
163885270|NCT02727699|591952187|FG000|Overall Study|Withdrawal by Subject|5|||
163885271|NCT02727699|591952188|FG001|Overall Study|Withdrawal by Subject|3|||
163885272|NCT02727699|591952187|FG000|Overall Study|Protocol Violation|0|||
163885273|NCT02727699|591952188|FG001|Overall Study|Protocol Violation|1|||
163990008|NCT02319044|592331063|FG000|Overall Study|Withdrawal by Subject|3|||
163990009|NCT02319044|592331064|FG001|Overall Study|Withdrawal by Subject|3|||
164242923|NCT01791517|593260321|FG011|Phase I: Period 3|Adverse Event|0|||
164242924|NCT01791517|593260310|FG000|Phase II|Lost to Follow-up|1|||
164242925|NCT01791517|593260311|FG001|Phase II|Lost to Follow-up|0|||
164242926|NCT01791517|593260312|FG002|Phase II|Lost to Follow-up|1|||
164242927|NCT01791517|593260313|FG003|Phase II|Lost to Follow-up|0|||
163885274|NCT02727699|591952187|FG000|Overall Study|Physician Decision|0|||
163885275|NCT02727699|591952188|FG001|Overall Study|Physician Decision|1|||
164242928|NCT01791517|593260314|FG004|Phase II|Lost to Follow-up|1|||
164242929|NCT01791517|593260315|FG005|Phase II|Lost to Follow-up|2|||
164242930|NCT01791517|593260316|FG006|Phase II|Lost to Follow-up|0|||
164242931|NCT01791517|593260317|FG007|Phase II|Lost to Follow-up|1|||
164242932|NCT01791517|593260318|FG008|Phase II|Lost to Follow-up|1|||
164242933|NCT01791517|593260319|FG009|Phase II|Lost to Follow-up|1|||
164242934|NCT01791517|593260320|FG010|Phase II|Lost to Follow-up|0|||
164242935|NCT01791517|593260321|FG011|Phase II|Lost to Follow-up|0|||
164242936|NCT01791517|593260310|FG000|Phase II|Withdrawal by Subject|1|||
164242937|NCT01791517|593260311|FG001|Phase II|Withdrawal by Subject|0|||
164242938|NCT01791517|593260312|FG002|Phase II|Withdrawal by Subject|0|||
164242939|NCT01791517|593260313|FG003|Phase II|Withdrawal by Subject|0|||
164242940|NCT01791517|593260314|FG004|Phase II|Withdrawal by Subject|0|||
164242941|NCT01791517|593260315|FG005|Phase II|Withdrawal by Subject|2|||
164242942|NCT01791517|593260316|FG006|Phase II|Withdrawal by Subject|0|||
164242943|NCT01791517|593260317|FG007|Phase II|Withdrawal by Subject|1|||
164242944|NCT01791517|593260318|FG008|Phase II|Withdrawal by Subject|0|||
164242945|NCT01791517|593260319|FG009|Phase II|Withdrawal by Subject|0|||
164242946|NCT01791517|593260320|FG010|Phase II|Withdrawal by Subject|1|||
164242947|NCT01791517|593260321|FG011|Phase II|Withdrawal by Subject|0|||
164242948|NCT01791517|593260310|FG000|Phase II|Lack of Efficacy|0|||
164242949|NCT01791517|593260311|FG001|Phase II|Lack of Efficacy|0|||
164242950|NCT01791517|593260312|FG002|Phase II|Lack of Efficacy|0|||
164242951|NCT01791517|593260313|FG003|Phase II|Lack of Efficacy|0|||
164242952|NCT01791517|593260314|FG004|Phase II|Lack of Efficacy|1|||
164242953|NCT01791517|593260315|FG005|Phase II|Lack of Efficacy|0|||
164242954|NCT01791517|593260316|FG006|Phase II|Lack of Efficacy|0|||
164242955|NCT01791517|593260317|FG007|Phase II|Lack of Efficacy|0|||
164242956|NCT01791517|593260318|FG008|Phase II|Lack of Efficacy|0|||
164242957|NCT01791517|593260319|FG009|Phase II|Lack of Efficacy|0|||
164242958|NCT01791517|593260320|FG010|Phase II|Lack of Efficacy|0|||
164242959|NCT01791517|593260321|FG011|Phase II|Lack of Efficacy|0|||
164242960|NCT01791517|593260310|FG000|Phase II|Adverse Event|0|||
164242961|NCT01791517|593260311|FG001|Phase II|Adverse Event|0|||
164242962|NCT01791517|593260312|FG002|Phase II|Adverse Event|0|||
164242963|NCT01791517|593260313|FG003|Phase II|Adverse Event|0|||
164242964|NCT01791517|593260314|FG004|Phase II|Adverse Event|0|||
164242965|NCT01791517|593260315|FG005|Phase II|Adverse Event|0|||
164242966|NCT01791517|593260316|FG006|Phase II|Adverse Event|2|||
164242967|NCT01791517|593260317|FG007|Phase II|Adverse Event|1|||
164242968|NCT01791517|593260318|FG008|Phase II|Adverse Event|0|||
163885276|NCT02727699|591952187|FG000|Overall Study|Lost to Follow-up|1|||
163885277|NCT02727699|591952188|FG001|Overall Study|Lost to Follow-up|0|||
163885278|NCT02727699|591952187|FG000|Overall Study|Sponsor Decision|1|||
163885279|NCT02727699|591952188|FG001|Overall Study|Sponsor Decision|0|||
163885280|NCT05251909|591952189|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
163885281|NCT05251909|591952190|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
163885282|NCT02677298|591952191|FG000|Double Blind Phase|Adverse Event|2|||
163885283|NCT02677298|591952192|FG001|Double Blind Phase|Adverse Event|1|||
163885284|NCT02677298|591952193|FG002|Double Blind Phase|Adverse Event|0|||
163885285|NCT02677298|591952191|FG000|Double Blind Phase|Physician Decision|5|||
163885286|NCT02677298|591952192|FG001|Double Blind Phase|Physician Decision|0|||
163885287|NCT02677298|591952193|FG002|Double Blind Phase|Physician Decision|0|||
163885288|NCT02677298|591952191|FG000|Double Blind Phase|Lost to Follow-up|11|||
163885289|NCT02677298|591952192|FG001|Double Blind Phase|Lost to Follow-up|7|||
163885290|NCT02677298|591952193|FG002|Double Blind Phase|Lost to Follow-up|0|||
163885291|NCT02677298|591952191|FG000|Double Blind Phase|Withdrawal by Subject|11|||
163885292|NCT02677298|591952192|FG001|Double Blind Phase|Withdrawal by Subject|8|||
163885293|NCT02677298|591952193|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163885294|NCT02677298|591952191|FG000|Double Blind Phase|No study drug available at site|0|||
163885295|NCT02677298|591952192|FG001|Double Blind Phase|No study drug available at site|1|||
163885296|NCT02677298|591952193|FG002|Double Blind Phase|No study drug available at site|0|||
163885297|NCT02677298|591952191|FG000|Open Label Phase|Adverse Event|0|||
163885298|NCT02677298|591952192|FG001|Open Label Phase|Adverse Event|0|||
163885299|NCT02677298|591952193|FG002|Open Label Phase|Adverse Event|4|||
163885300|NCT02677298|591952191|FG000|Open Label Phase|Physician Decision|0|||
163885301|NCT02677298|591952192|FG001|Open Label Phase|Physician Decision|0|||
163885302|NCT02677298|591952193|FG002|Open Label Phase|Physician Decision|1|||
163885303|NCT02677298|591952191|FG000|Open Label Phase|Lost to Follow-up|0|||
163885304|NCT02677298|591952192|FG001|Open Label Phase|Lost to Follow-up|0|||
163885305|NCT02677298|591952193|FG002|Open Label Phase|Lost to Follow-up|17|||
163885306|NCT02677298|591952191|FG000|Open Label Phase|Withdrawal by Subject|0|||
164242969|NCT01791517|593260319|FG009|Phase II|Adverse Event|1|||
164242970|NCT01791517|593260320|FG010|Phase II|Adverse Event|0|||
164242971|NCT01791517|593260321|FG011|Phase II|Adverse Event|0|||
164242972|NCT01791517|593260310|FG000|Phase II|Lens Handling Difficulties|0|||
164242973|NCT01791517|593260311|FG001|Phase II|Lens Handling Difficulties|0|||
164242974|NCT01791517|593260312|FG002|Phase II|Lens Handling Difficulties|0|||
164242975|NCT01791517|593260313|FG003|Phase II|Lens Handling Difficulties|0|||
164242976|NCT01791517|593260314|FG004|Phase II|Lens Handling Difficulties|0|||
164242977|NCT01791517|593260315|FG005|Phase II|Lens Handling Difficulties|0|||
164242978|NCT01791517|593260316|FG006|Phase II|Lens Handling Difficulties|0|||
164242979|NCT01791517|593260317|FG007|Phase II|Lens Handling Difficulties|0|||
164242980|NCT01791517|593260318|FG008|Phase II|Lens Handling Difficulties|1|||
164242981|NCT01791517|593260319|FG009|Phase II|Lens Handling Difficulties|0|||
164242982|NCT01791517|593260320|FG010|Phase II|Lens Handling Difficulties|0|||
164242983|NCT01791517|593260321|FG011|Phase II|Lens Handling Difficulties|0|||
164242984|NCT01791517|593260310|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
164242985|NCT01791517|593260311|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
164242986|NCT01791517|593260312|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
164242987|NCT01791517|593260313|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
164242988|NCT01791517|593260314|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
164242989|NCT01791517|593260315|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
164242990|NCT01791517|593260316|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
164242991|NCT01791517|593260317|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
164242992|NCT01791517|593260318|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
164242993|NCT01791517|593260319|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
163990010|NCT02319044|592331065|FG002|Overall Study|Withdrawal by Subject|6|||
163990011|NCT02319044|592331063|FG000|Overall Study|Condition under investigation worsened|100|||
163990012|NCT02319044|592331064|FG001|Overall Study|Condition under investigation worsened|50|||
163990013|NCT02319044|592331065|FG002|Overall Study|Condition under investigation worsened|46|||
163990014|NCT02319044|592331063|FG000|Overall Study|Adverse Event|17|||
163990015|NCT02319044|592331064|FG001|Overall Study|Adverse Event|2|||
163990016|NCT02319044|592331065|FG002|Overall Study|Adverse Event|8|||
163990017|NCT02319044|592331063|FG000|Overall Study|Study specific discontinuation criteria|2|||
163990018|NCT02319044|592331064|FG001|Overall Study|Study specific discontinuation criteria|2|||
163990019|NCT02319044|592331065|FG002|Overall Study|Study specific discontinuation criteria|1|||
163990020|NCT02319044|592331063|FG000|Overall Study|Not treated|0|||
163990021|NCT02319044|592331064|FG001|Overall Study|Not treated|2|||
163990022|NCT02319044|592331065|FG002|Overall Study|Not treated|2|||
163990023|NCT02026063|592331072|FG000|Overall Study|Physician Decision|0|||
163990024|NCT02026063|592331073|FG001|Overall Study|Physician Decision|10|||
163990025|NCT02026063|592331072|FG000|Overall Study|Noncompliance with Study Drug|1|||
163990026|NCT02026063|592331073|FG001|Overall Study|Noncompliance with Study Drug|1|||
163990027|NCT02026063|592331072|FG000|Overall Study|Withdrawal of Consent|1|||
163990028|NCT02026063|592331073|FG001|Overall Study|Withdrawal of Consent|6|||
163990029|NCT02026063|592331072|FG000|Overall Study|Adverse Event|5|||
163990030|NCT02026063|592331073|FG001|Overall Study|Adverse Event|20|||
163990031|NCT02026063|592331072|FG000|Overall Study|Lack of Efficacy|0|||
163990032|NCT02026063|592331073|FG001|Overall Study|Lack of Efficacy|4|||
163990033|NCT02026063|592331072|FG000|Overall Study|Lost to Follow-up|0|||
163990034|NCT02026063|592331073|FG001|Overall Study|Lost to Follow-up|1|||
163990035|NCT02026063|592331072|FG000|Overall Study|Reason not Specified|2|||
163990036|NCT02026063|592331073|FG001|Overall Study|Reason not Specified|7|||
163990037|NCT03687502|592331074|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
163990038|NCT03687502|592331074|FG000|Overall Study|Lumason not available|1|||
163990039|NCT00486278|592331075|FG000|Overall Study|Adverse Event|5|||
163990040|NCT00486278|592331075|FG000|Overall Study|Withdrawal by Subject|2|||
163990041|NCT00486278|592331075|FG000|Overall Study|Physician Decision|2|||
163990042|NCT01777581|592331081|FG000|Overall Study|Lost to Follow-up|1|||
163990043|NCT01777581|592331082|FG001|Overall Study|Lost to Follow-up|1|||
163990044|NCT01777581|592331081|FG000|Overall Study|Adverse Event|2|||
163990045|NCT01777581|592331082|FG001|Overall Study|Adverse Event|0|||
163990046|NCT01777581|592331081|FG000|Overall Study|Lack of Efficacy|0|||
163990047|NCT01777581|592331082|FG001|Overall Study|Lack of Efficacy|1|||
163990048|NCT02887521|592331085|FG000|Overall Study|Withdrawal by Subject|0|||
163990049|NCT02887521|592331086|FG001|Overall Study|Withdrawal by Subject|3|||
163990050|NCT00695565|592331087|FG000|Overall Study|Lost to Follow-up|4|||
163990051|NCT00695565|592331088|FG001|Overall Study|Lost to Follow-up|4|||
163990052|NCT00695565|592331087|FG000|Overall Study|Adverse Event|3|||
164242994|NCT01791517|593260320|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
164242995|NCT01791517|593260321|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
164242996|NCT01791517|593260310|FG000|Phase II|Pre-Existing Ocular Issue|0|||
164242997|NCT01791517|593260311|FG001|Phase II|Pre-Existing Ocular Issue|0|||
164242998|NCT01791517|593260312|FG002|Phase II|Pre-Existing Ocular Issue|0|||
164242999|NCT01791517|593260313|FG003|Phase II|Pre-Existing Ocular Issue|0|||
163990053|NCT00695565|592331088|FG001|Overall Study|Adverse Event|1|||
163990054|NCT00695565|592331087|FG000|Overall Study|Protocol Violation|3|||
163990055|NCT00695565|592331088|FG001|Overall Study|Protocol Violation|1|||
163990056|NCT00695565|592331087|FG000|Overall Study|Withdrawal by Subject|1|||
163990057|NCT00695565|592331088|FG001|Overall Study|Withdrawal by Subject|1|||
163990058|NCT00695565|592331087|FG000|Overall Study|Lack of Efficacy|1|||
163990059|NCT00695565|592331088|FG001|Overall Study|Lack of Efficacy|1|||
163990060|NCT00695565|592331087|FG000|Overall Study|Subject did not follow instructions|1|||
163990061|NCT00695565|592331088|FG001|Overall Study|Subject did not follow instructions|1|||
164243000|NCT01791517|593260314|FG004|Phase II|Pre-Existing Ocular Issue|0|||
164243001|NCT01791517|593260315|FG005|Phase II|Pre-Existing Ocular Issue|0|||
164243002|NCT01791517|593260316|FG006|Phase II|Pre-Existing Ocular Issue|0|||
163990062|NCT01462266|592331089|FG000|Overall Study|Adverse Event|7|||
163990063|NCT01462266|592331090|FG001|Overall Study|Adverse Event|6|||
163990064|NCT01462266|592331089|FG000|Overall Study|Death|2|||
163990065|NCT01462266|592331090|FG001|Overall Study|Death|1|||
163990066|NCT01462266|592331089|FG000|Overall Study|Lack of Efficacy|0|||
163990067|NCT01462266|592331090|FG001|Overall Study|Lack of Efficacy|2|||
163990068|NCT01462266|592331089|FG000|Overall Study|Lost to Follow-up|4|||
163990069|NCT01462266|592331090|FG001|Overall Study|Lost to Follow-up|3|||
164243003|NCT01791517|593260317|FG007|Phase II|Pre-Existing Ocular Issue|0|||
164243004|NCT01791517|593260318|FG008|Phase II|Pre-Existing Ocular Issue|0|||
164243005|NCT01791517|593260319|FG009|Phase II|Pre-Existing Ocular Issue|0|||
164243006|NCT01791517|593260320|FG010|Phase II|Pre-Existing Ocular Issue|0|||
164243007|NCT01791517|593260321|FG011|Phase II|Pre-Existing Ocular Issue|1|||
164243008|NCT00589797|593260322|FG000|Overall Study|Death|1|||
164243009|NCT00589797|593260323|FG001|Overall Study|Death|0|||
164243010|NCT00589797|593260322|FG000|Overall Study|Lost to Follow-up|12|||
164243011|NCT00589797|593260323|FG001|Overall Study|Lost to Follow-up|9|||
164243012|NCT00589797|593260322|FG000|Overall Study|Physician Decision|8|||
164243013|NCT00589797|593260323|FG001|Overall Study|Physician Decision|3|||
164243014|NCT00589797|593260322|FG000|Overall Study|Withdrawal by Subject|6|||
164243015|NCT00589797|593260323|FG001|Overall Study|Withdrawal by Subject|5|||
164243016|NCT00589797|593260322|FG000|Overall Study|Non-Randomized Training Subjects|46|||
164243017|NCT00589797|593260323|FG001|Overall Study|Non-Randomized Training Subjects|6|||
164243018|NCT02141672|593260325|FG000|Overall Study|Adverse Event|0|||
164243019|NCT02141672|593260326|FG001|Overall Study|Adverse Event|1|||
164243020|NCT02141672|593260327|FG002|Overall Study|Adverse Event|0|||
164243021|NCT02141672|593260325|FG000|Overall Study|Death|10|||
164243022|NCT02141672|593260326|FG001|Overall Study|Death|2|||
164243023|NCT02141672|593260327|FG002|Overall Study|Death|1|||
164243024|NCT02141672|593260325|FG000|Overall Study|Lack of Efficacy|0|||
164243025|NCT02141672|593260326|FG001|Overall Study|Lack of Efficacy|0|||
164243026|NCT02141672|593260327|FG002|Overall Study|Lack of Efficacy|2|||
164243027|NCT02141672|593260325|FG000|Overall Study|Lost to Follow-up|1|||
164243028|NCT02141672|593260326|FG001|Overall Study|Lost to Follow-up|1|||
164243029|NCT02141672|593260327|FG002|Overall Study|Lost to Follow-up|3|||
164243030|NCT02141672|593260325|FG000|Overall Study|Physician Decision|1|||
164243031|NCT02141672|593260326|FG001|Overall Study|Physician Decision|2|||
164243032|NCT02141672|593260327|FG002|Overall Study|Physician Decision|5|||
164243033|NCT02141672|593260325|FG000|Overall Study|Protocol Violation|0|||
164243034|NCT02141672|593260326|FG001|Overall Study|Protocol Violation|0|||
164336648|NCT00691301|593609756|FG000|Overall Study|Withdrawal by Subject|4|||
164336649|NCT00691301|593609756|FG000|Overall Study|Concurrent illness|2|||
164336650|NCT00691301|593609756|FG000|Overall Study|other reason|3|||
163885307|NCT02677298|591952192|FG001|Open Label Phase|Withdrawal by Subject|0|||
163885308|NCT02677298|591952193|FG002|Open Label Phase|Withdrawal by Subject|38|||
163885309|NCT03611621|591952207|FG000|Overall Study|Graft loss|3|||
163885310|NCT03611621|591952207|FG000|Overall Study|Death|3|||
163885311|NCT03611621|591952207|FG000|Overall Study|Lost to Follow-up|1|||
163885312|NCT03812679|591952210|FG000|Overall Study|Adverse Event|2|||
163885313|NCT03812679|591952210|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
163885314|NCT03812679|591952210|FG000|Overall Study|Renal transplant|1|||
163885315|NCT03812679|591952210|FG000|Overall Study|Withdrawal by Subject|1|||
163885316|NCT03812679|591952210|FG000|Overall Study|Termination of study|2|||
163885317|NCT03812679|591952210|FG000|Overall Study|Water device replacement|1|||
163885318|NCT05653427|591952211|FG000|Overall Study|Study Terminated by Sponsor|13|||
163885319|NCT03016754|591952221|FG000|Overall Study|Death|5|||
163885320|NCT03016754|591952222|FG001|Overall Study|Death|4|||
163885321|NCT03016754|591952223|FG002|Overall Study|Death|5|||
163885322|NCT03016754|591952224|FG003|Overall Study|Death|1|||
163885323|NCT03016754|591952221|FG000|Overall Study|Lost to Follow-up|23|||
163885324|NCT03016754|591952222|FG001|Overall Study|Lost to Follow-up|17|||
163885325|NCT03016754|591952223|FG002|Overall Study|Lost to Follow-up|4|||
163885326|NCT03016754|591952224|FG003|Overall Study|Lost to Follow-up|2|||
163885327|NCT03016754|591952221|FG000|Overall Study|Withdrawal by Subject|6|||
163885328|NCT03016754|591952222|FG001|Overall Study|Withdrawal by Subject|6|||
163885329|NCT03016754|591952223|FG002|Overall Study|Withdrawal by Subject|2|||
164243035|NCT02141672|593260327|FG002|Overall Study|Protocol Violation|1|||
164243036|NCT02141672|593260325|FG000|Overall Study|Withdrawal by Subject|3|||
164243037|NCT02141672|593260326|FG001|Overall Study|Withdrawal by Subject|2|||
164243038|NCT02141672|593260327|FG002|Overall Study|Withdrawal by Subject|5|||
164243039|NCT02141672|593260325|FG000|Overall Study|refused to follow-up|1|||
164243040|NCT02141672|593260326|FG001|Overall Study|refused to follow-up|0|||
164243041|NCT02141672|593260327|FG002|Overall Study|refused to follow-up|1|||
164243042|NCT02688192|593260328|FG000|Overall Study|Lost to Follow-up|11|||
164243043|NCT02688192|593260329|FG001|Overall Study|Lost to Follow-up|5|||
163885330|NCT03016754|591952224|FG003|Overall Study|Withdrawal by Subject|2|||
163885331|NCT03016754|591952221|FG000|Overall Study|Other/Unknown|2|||
164243044|NCT02688192|593260328|FG000|Overall Study|Physician Decision|1|||
164243045|NCT02688192|593260329|FG001|Overall Study|Physician Decision|0|||
164336651|NCT00691301|593609756|FG000|Overall Study|Did not initiate study treatment|1|||
164243046|NCT02817594|593260333|FG000|Overall Study|Withdrawal by Subject|1|||
164243047|NCT02817594|593260333|FG000|Overall Study|Other|1|||
164243048|NCT02817594|593260333|FG000|Overall Study|Did Not Receive Treatment|1|||
164243049|NCT02010593|593260334|FG000|Overall Study|Lost to Follow-up|1|||
164243050|NCT02010593|593260335|FG001|Overall Study|Lost to Follow-up|0|||
164243051|NCT02010593|593260334|FG000|Overall Study|Physician Decision|1|||
164243052|NCT02010593|593260335|FG001|Overall Study|Physician Decision|0|||
164243053|NCT02010593|593260334|FG000|Overall Study|Unable to adhere to visit schedule|0|||
164243054|NCT02010593|593260335|FG001|Overall Study|Unable to adhere to visit schedule|2|||
164243055|NCT01773967|593260336|FG000|Overall Study|Lost to Follow-up|15|||
164243056|NCT01773967|593260337|FG001|Overall Study|Lost to Follow-up|13|||
164243057|NCT01135459|593260338|FG000|Overall Study|Adverse Event|8|||
164243058|NCT01135459|593260339|FG001|Overall Study|Adverse Event|10|||
164243059|NCT01135459|593260338|FG000|Overall Study|Lack of Efficacy|3|||
164243060|NCT01135459|593260339|FG001|Overall Study|Lack of Efficacy|1|||
164243061|NCT01135459|593260338|FG000|Overall Study|Withdrawal by Subject|2|||
164243062|NCT01135459|593260339|FG001|Overall Study|Withdrawal by Subject|3|||
164243063|NCT01135459|593260338|FG000|Overall Study|Protocol Violation|5|||
164243064|NCT01135459|593260339|FG001|Overall Study|Protocol Violation|3|||
164243065|NCT01135459|593260338|FG000|Overall Study|Lost to Follow-up|2|||
164243066|NCT01135459|593260339|FG001|Overall Study|Lost to Follow-up|1|||
164243067|NCT01135459|593260338|FG000|Overall Study|Non-compliance to study procedures|0|||
164243068|NCT01135459|593260339|FG001|Overall Study|Non-compliance to study procedures|1|||
164243069|NCT01135459|593260338|FG000|Overall Study|Other than specified|1|||
164243070|NCT01135459|593260339|FG001|Overall Study|Other than specified|1|||
164243071|NCT01803880|593260340|FG000|Overall Study|Adverse Event|1|||
164243072|NCT01803880|593260341|FG001|Overall Study|Adverse Event|0|||
164243073|NCT01803880|593260342|FG002|Overall Study|Adverse Event|0|||
164243074|NCT01803880|593260340|FG000|Overall Study|Withdrawal by Subject|1|||
164243075|NCT01803880|593260341|FG001|Overall Study|Withdrawal by Subject|1|||
164243076|NCT01803880|593260342|FG002|Overall Study|Withdrawal by Subject|4|||
164243077|NCT01803880|593260340|FG000|Overall Study|Physician Decision|0|||
164243078|NCT01803880|593260341|FG001|Overall Study|Physician Decision|0|||
164243079|NCT01803880|593260342|FG002|Overall Study|Physician Decision|1|||
164243080|NCT01803880|593260340|FG000|Overall Study|Unable to return for follow-up visits|0|||
164243081|NCT01803880|593260341|FG001|Overall Study|Unable to return for follow-up visits|1|||
164243082|NCT01803880|593260342|FG002|Overall Study|Unable to return for follow-up visits|2|||
164243083|NCT01803880|593260340|FG000|Overall Study|Lost to Follow-up|1|||
164243084|NCT01803880|593260341|FG001|Overall Study|Lost to Follow-up|2|||
164243085|NCT01803880|593260342|FG002|Overall Study|Lost to Follow-up|3|||
164243086|NCT01803880|593260340|FG000|Overall Study|Protocol Violation|1|||
164243087|NCT01803880|593260341|FG001|Overall Study|Protocol Violation|0|||
164243088|NCT01803880|593260342|FG002|Overall Study|Protocol Violation|0|||
164243089|NCT01803880|593260340|FG000|Overall Study|Early study termination|0|||
164243090|NCT01803880|593260341|FG001|Overall Study|Early study termination|6|||
164243091|NCT01803880|593260342|FG002|Overall Study|Early study termination|5|||
164243092|NCT01803880|593260340|FG000|Overall Study|Incomplete data entry by sites|2|||
164243093|NCT01803880|593260341|FG001|Overall Study|Incomplete data entry by sites|0|||
164243094|NCT01803880|593260342|FG002|Overall Study|Incomplete data entry by sites|0|||
164083486|NCT02711956|592670197|FG008|Overall Study|Clinical progression|1|||
164083487|NCT02711956|592670198|FG009|Overall Study|Clinical progression|0|||
164243095|NCT00579553|593260353|FG000|Overall Study|Lost to Follow-up|16|||
164243096|NCT00579553|593260354|FG001|Overall Study|Lost to Follow-up|13|||
164243097|NCT02651116|593260359|FG000|Overall Study|Adverse Event|0|||
164243098|NCT02651116|593260360|FG001|Overall Study|Adverse Event|1|||
164243099|NCT02651116|593260359|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
164243100|NCT02651116|593260360|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
164243101|NCT02803203|593260361|FG000|Overall Study|Adverse Event|4|||
164243102|NCT02803203|593260361|FG000|Overall Study|Death|4|||
164243103|NCT02803203|593260361|FG000|Overall Study|Progressive disease|29|||
164243104|NCT02803203|593260361|FG000|Overall Study|Withdrawal by Subject|8|||
164243105|NCT02803203|593260361|FG000|Overall Study|Complete resection of target disease|2|||
164243106|NCT02803203|593260361|FG000|Overall Study|Switched to commercial Osi|1|||
164243107|NCT02803203|593260361|FG000|Overall Study|Participant moved away|1|||
164243108|NCT01887717|593260362|FG000|Overall Study|Withdrawal by Subject|1|||
164243109|NCT01887717|593260363|FG001|Overall Study|Withdrawal by Subject|7|||
164243110|NCT01887717|593260362|FG000|Overall Study|Physician Decision|0|||
164243111|NCT01887717|593260363|FG001|Overall Study|Physician Decision|2|||
164243112|NCT01887717|593260362|FG000|Overall Study|Administrative reasons|5|||
164243113|NCT01887717|593260363|FG001|Overall Study|Administrative reasons|2|||
164243114|NCT02041299|593260369|FG000|Overall Study|Adverse Event|9|||
164243115|NCT02041299|593260370|FG001|Overall Study|Adverse Event|3|||
164243116|NCT02041299|593260369|FG000|Overall Study|Lost to Follow-up|4|||
164083488|NCT02711956|592670199|FG010|Overall Study|Clinical progression|0|||
164243117|NCT02041299|593260370|FG001|Overall Study|Lost to Follow-up|1|||
164243118|NCT02041299|593260369|FG000|Overall Study|Physician Decision|1|||
164243119|NCT02041299|593260370|FG001|Overall Study|Physician Decision|1|||
164243120|NCT02041299|593260369|FG000|Overall Study|Withdrawal by Subject|13|||
164243121|NCT02041299|593260370|FG001|Overall Study|Withdrawal by Subject|7|||
164243122|NCT02041299|593260369|FG000|Overall Study|Protocol Violation|11|||
164243123|NCT02041299|593260370|FG001|Overall Study|Protocol Violation|4|||
164243124|NCT02041299|593260369|FG000|Overall Study|Termination of the study|7|||
164243125|NCT02041299|593260370|FG001|Overall Study|Termination of the study|3|||
164243126|NCT02041299|593260369|FG000|Overall Study|Required bone marrow transplant|0|||
163990070|NCT01462266|592331089|FG000|Overall Study|Non-compliance with study drug|3|||
163990071|NCT01462266|592331090|FG001|Overall Study|Non-compliance with study drug|0|||
163990072|NCT01462266|592331089|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
163990073|NCT01462266|592331090|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
163990074|NCT01462266|592331089|FG000|Overall Study|Physician Decision|2|||
163990075|NCT01462266|592331090|FG001|Overall Study|Physician Decision|5|||
163990076|NCT01462266|592331089|FG000|Overall Study|Protocol Violation|1|||
163990077|NCT01462266|592331090|FG001|Overall Study|Protocol Violation|3|||
163990078|NCT01462266|592331089|FG000|Overall Study|Withdrawal by Subject|7|||
163990079|NCT01462266|592331090|FG001|Overall Study|Withdrawal by Subject|2|||
163990080|NCT01462266|592331089|FG000|Overall Study|Screen failure|1|||
163990081|NCT01462266|592331090|FG001|Overall Study|Screen failure|1|||
163990082|NCT01106846|592331091|FG000|Overall Study|Change in surgical procedure|0|||
163990083|NCT01106846|592331092|FG001|Overall Study|Change in surgical procedure|1|||
163990084|NCT03110900|592331093|FG000|Overall Study|Sponsor withdrew|1|||
163990085|NCT03110900|592331094|FG001|Overall Study|Sponsor withdrew|1|||
163990086|NCT00644787|592331095|FG000|Period 1: Titration Phase|Adverse Event|11|||
163990087|NCT00644787|592331096|FG001|Period 1: Titration Phase|Adverse Event|0|||
163990088|NCT00644787|592331097|FG002|Period 1: Titration Phase|Adverse Event|0|||
163990089|NCT00644787|592331095|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
163990090|NCT00644787|592331096|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
163990091|NCT00644787|592331097|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
163990092|NCT00644787|592331095|FG000|Period 1: Titration Phase|Physician Decision|1|||
163990093|NCT00644787|592331096|FG001|Period 1: Titration Phase|Physician Decision|0|||
163990094|NCT00644787|592331097|FG002|Period 1: Titration Phase|Physician Decision|0|||
163990095|NCT00644787|592331095|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
163990096|NCT00644787|592331096|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
163990097|NCT00644787|592331097|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
163990098|NCT00644787|592331095|FG000|Period 1: Titration Phase|Worsening of complications|1|||
163990099|NCT00644787|592331096|FG001|Period 1: Titration Phase|Worsening of complications|0|||
163990100|NCT00644787|592331097|FG002|Period 1: Titration Phase|Worsening of complications|0|||
163990101|NCT00644787|592331095|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
163990102|NCT00644787|592331096|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
163990103|NCT00644787|592331097|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
163990104|NCT00644787|592331095|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
163990105|NCT00644787|592331096|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
163990106|NCT00644787|592331097|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
163990107|NCT00644787|592331095|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
163990108|NCT00644787|592331096|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
164243127|NCT02041299|593260370|FG001|Overall Study|Required bone marrow transplant|1|||
164243128|NCT02041299|593260369|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
164243129|NCT02041299|593260370|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
164243130|NCT02389465|593260371|FG000|Overall Study|Lost to Follow-up|1|||
164243131|NCT02389465|593260372|FG001|Overall Study|Lost to Follow-up|3|||
164243132|NCT02389465|593260373|FG002|Overall Study|Lost to Follow-up|3|||
164243133|NCT02389465|593260374|FG003|Overall Study|Lost to Follow-up|0|||
164243134|NCT02389465|593260371|FG000|Overall Study|Physician Decision|0|||
164243135|NCT02389465|593260372|FG001|Overall Study|Physician Decision|0|||
164243136|NCT02389465|593260373|FG002|Overall Study|Physician Decision|0|||
164243137|NCT02389465|593260374|FG003|Overall Study|Physician Decision|1|||
164243138|NCT02389465|593260371|FG000|Overall Study|Withdrawal by Subject|0|||
164243139|NCT02389465|593260372|FG001|Overall Study|Withdrawal by Subject|1|||
164243140|NCT02389465|593260373|FG002|Overall Study|Withdrawal by Subject|2|||
164243141|NCT02389465|593260374|FG003|Overall Study|Withdrawal by Subject|2|||
164243142|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
164243143|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
164243144|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
164243145|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
164243146|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
164243147|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
164243148|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
164336652|NCT02642029|593609757|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
164243149|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
164243150|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
163990109|NCT00644787|592331097|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
163990110|NCT00644787|592331095|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
163990111|NCT00644787|592331096|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
163990112|NCT00644787|592331097|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
163990113|NCT00644787|592331095|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
163990114|NCT00644787|592331096|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
163990115|NCT00644787|592331097|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
163990116|NCT00644787|592331095|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
163990117|NCT00644787|592331096|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
163990118|NCT00644787|592331097|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
163990119|NCT00644787|592331095|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
163990120|NCT00644787|592331096|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
163990121|NCT00644787|592331097|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
163990122|NCT03048422|592331100|FG000|Overall Study|Death|1|||
163990123|NCT03048422|592331101|FG001|Overall Study|Death|0|||
163990124|NCT03048422|592331102|FG002|Overall Study|Death|0|||
163990125|NCT03048422|592331100|FG000|Overall Study|Lost to Follow-up|5|||
163990126|NCT03048422|592331101|FG001|Overall Study|Lost to Follow-up|0|||
163990127|NCT03048422|592331102|FG002|Overall Study|Lost to Follow-up|1|||
163990128|NCT03048422|592331100|FG000|Overall Study|Withdrawal by Subject|5|||
163990129|NCT03048422|592331101|FG001|Overall Study|Withdrawal by Subject|7|||
163990130|NCT03048422|592331102|FG002|Overall Study|Withdrawal by Subject|4|||
163990131|NCT03048422|592331100|FG000|Overall Study|Moved|3|||
164140505|NCT00642278|592876101|FG006|Overall Study|Protocol Violation|2|||
164336653|NCT02642029|593609758|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336654|NCT02642029|593609759|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336655|NCT02642029|593609760|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336656|NCT02642029|593609761|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336657|NCT02642029|593609762|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
164336658|NCT02642029|593609757|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336659|NCT02642029|593609758|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
164336660|NCT02642029|593609759|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336661|NCT02642029|593609760|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336662|NCT02642029|593609761|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336663|NCT02642029|593609762|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
164336664|NCT02642029|593609757|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336665|NCT02642029|593609758|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336666|NCT02642029|593609759|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336667|NCT02642029|593609760|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336668|NCT02642029|593609761|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
163885332|NCT03016754|591952222|FG001|Overall Study|Other/Unknown|4|||
163885333|NCT03016754|591952223|FG002|Overall Study|Other/Unknown|2|||
163885334|NCT03016754|591952224|FG003|Overall Study|Other/Unknown|1|||
163885335|NCT03016754|591952221|FG000|Overall Study|Protocol Violation|0|||
163885336|NCT03016754|591952222|FG001|Overall Study|Protocol Violation|0|||
163885337|NCT03016754|591952223|FG002|Overall Study|Protocol Violation|0|||
163885338|NCT03016754|591952224|FG003|Overall Study|Protocol Violation|4|||
163885339|NCT04185298|591952225|FG000|Overall Study|Lost to Follow-up|1|||
163885340|NCT04185298|591952226|FG001|Overall Study|Lost to Follow-up|3|||
163885341|NCT04185298|591952225|FG000|Overall Study|Withdrawal by Subject|0|||
163885342|NCT04185298|591952226|FG001|Overall Study|Withdrawal by Subject|3|||
163885343|NCT04316871|591952227|FG000|Overall Study|Protocol Violation|2|||
163885344|NCT04316871|591952228|FG001|Overall Study|Protocol Violation|2|||
163885345|NCT04316871|591952229|FG002|Overall Study|Protocol Violation|2|||
163885346|NCT04316871|591952230|FG003|Overall Study|Protocol Violation|2|||
163885347|NCT01842542|591952231|FG000|Overall Study|Withdrawal by Subject|2|||
163885348|NCT01842542|591952231|FG000|Overall Study|Lack of Efficacy|1|||
163885349|NCT01842542|591952231|FG000|Overall Study|Protocol Non-compliance|2|||
163885350|NCT01842542|591952231|FG000|Overall Study|Lost to Follow-up|1|||
163885351|NCT02262728|591952232|FG000|Follow-up Phase (3 Years)|Death|0|||
163885352|NCT02262728|591952233|FG001|Follow-up Phase (3 Years)|Death|1|||
163885353|NCT02262728|591952232|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
163885354|NCT02262728|591952233|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
163885355|NCT02262728|591952232|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
163885356|NCT02262728|591952233|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
163885357|NCT03452579|591952245|FG000|Overall Study|Death|0|||
163885358|NCT03452579|591952246|FG001|Overall Study|Death|1|||
163885359|NCT03452579|591952245|FG000|Overall Study|Withdrawal by Subject|2|||
163885360|NCT03452579|591952246|FG001|Overall Study|Withdrawal by Subject|0|||
163885361|NCT03452579|591952245|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
163885362|NCT03452579|591952246|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
163885363|NCT03452579|591952245|FG000|Overall Study|Physician Decision|1|||
163885364|NCT03452579|591952246|FG001|Overall Study|Physician Decision|1|||
163885365|NCT03452579|591952245|FG000|Overall Study|Adverse Event|1|||
163885366|NCT03452579|591952246|FG001|Overall Study|Adverse Event|4|||
163885367|NCT03474679|591952247|FG000|Overall Study|Death|7|||
163885368|NCT03474679|591952247|FG000|Overall Study|Withdrawal by Subject|1|||
163885369|NCT04858321|591952254|FG000|Overall Study|Withdrawal by Subject|3|||
163885370|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
163885371|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
163885372|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
163885373|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
163885374|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
163885375|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
163885376|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Death|6|||
163885377|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Death|0|||
163885378|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Death|0|||
163885379|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
163885380|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
163885381|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
163885382|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
163885383|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
163885384|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
163885385|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
163885386|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
163885387|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
163885388|NCT01539083|591952255|FG000|Before Randomization (VCD Induction)|Other|5|||
163885389|NCT01539083|591952256|FG001|Before Randomization (VCD Induction)|Other|0|||
163885390|NCT01539083|591952257|FG002|Before Randomization (VCD Induction)|Other|0|||
163885391|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
163885392|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
163885393|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
163885394|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Other|0|||
163885395|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Other|1|||
163885396|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Other|1|||
163885397|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
163885398|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
163885399|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
163885400|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
163885401|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
163885402|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
163885403|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
163885404|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
163885405|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
163885406|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
163885407|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
163885408|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
163885409|NCT01539083|591952255|FG000|After Randomization (TP and VTP)|Death|0|||
163885410|NCT01539083|591952256|FG001|After Randomization (TP and VTP)|Death|6|||
163885411|NCT01539083|591952257|FG002|After Randomization (TP and VTP)|Death|11|||
163885412|NCT02573493|591952272|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
163885413|NCT02573493|591952273|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
163990132|NCT03048422|592331101|FG001|Overall Study|Moved|2|||
163990133|NCT03048422|592331102|FG002|Overall Study|Moved|2|||
164243151|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
164243152|NCT01925768|593260375|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
164243153|NCT01925768|593260376|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
164243154|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
164243155|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
164243156|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
164243157|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
164243158|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
164243159|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
164243160|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
164243161|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
164336669|NCT02642029|593609762|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
164336670|NCT02642029|593609757|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
164336671|NCT02642029|593609758|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
164336672|NCT02642029|593609759|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
164336673|NCT02642029|593609760|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
164336674|NCT02642029|593609761|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
164336675|NCT02642029|593609762|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
164336676|NCT02642029|593609757|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
164336677|NCT02642029|593609758|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336678|NCT02642029|593609759|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336679|NCT02642029|593609760|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336680|NCT02642029|593609761|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336681|NCT02642029|593609762|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
164336682|NCT02642029|593609757|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
164336683|NCT02642029|593609758|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336684|NCT02642029|593609759|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336685|NCT02642029|593609760|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336686|NCT02642029|593609761|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336687|NCT02642029|593609762|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
164336688|NCT00463580|593609763|FG000|Overall Study|Lost to Follow-up|1|||
164336689|NCT00463580|593609764|FG001|Overall Study|Lost to Follow-up|0|||
164336690|NCT00463580|593609763|FG000|Overall Study|Schedule conflict|2|||
164336691|NCT00463580|593609764|FG001|Overall Study|Schedule conflict|0|||
164336692|NCT00463580|593609763|FG000|Overall Study|Medical/psychiatric complications|0|||
164336693|NCT00463580|593609764|FG001|Overall Study|Medical/psychiatric complications|2|||
164336694|NCT00676338|593609765|FG000|Overall Study|Adverse Event|6|||
164336695|NCT00676338|593609766|FG001|Overall Study|Adverse Event|6|||
164336696|NCT00676338|593609767|FG002|Overall Study|Adverse Event|5|||
164336697|NCT00676338|593609768|FG003|Overall Study|Adverse Event|1|||
164336698|NCT00676338|593609765|FG000|Overall Study|Lost to Follow-up|4|||
164336699|NCT00676338|593609766|FG001|Overall Study|Lost to Follow-up|1|||
164336700|NCT00676338|593609767|FG002|Overall Study|Lost to Follow-up|3|||
164336701|NCT00676338|593609768|FG003|Overall Study|Lost to Follow-up|4|||
164336702|NCT00676338|593609765|FG000|Overall Study|Physician Decision|3|||
164336703|NCT00676338|593609766|FG001|Overall Study|Physician Decision|3|||
164336704|NCT00676338|593609767|FG002|Overall Study|Physician Decision|2|||
164336705|NCT00676338|593609768|FG003|Overall Study|Physician Decision|3|||
164336706|NCT00676338|593609765|FG000|Overall Study|Protocol Violation|5|||
164336707|NCT00676338|593609766|FG001|Overall Study|Protocol Violation|9|||
164336708|NCT00676338|593609767|FG002|Overall Study|Protocol Violation|2|||
164336709|NCT00676338|593609768|FG003|Overall Study|Protocol Violation|5|||
164336710|NCT00676338|593609765|FG000|Overall Study|Withdrawal by Subject|17|||
164336711|NCT00676338|593609766|FG001|Overall Study|Withdrawal by Subject|9|||
164336712|NCT00676338|593609767|FG002|Overall Study|Withdrawal by Subject|12|||
164336713|NCT00676338|593609768|FG003|Overall Study|Withdrawal by Subject|6|||
164336714|NCT00676338|593609765|FG000|Overall Study|Entry Criteria Not Met|0|||
164336715|NCT00676338|593609766|FG001|Overall Study|Entry Criteria Not Met|2|||
164336716|NCT00676338|593609767|FG002|Overall Study|Entry Criteria Not Met|1|||
164336717|NCT00676338|593609768|FG003|Overall Study|Entry Criteria Not Met|1|||
164336718|NCT00676338|593609765|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
164336719|NCT00676338|593609766|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
164336720|NCT00676338|593609767|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
164336721|NCT00676338|593609768|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
164336722|NCT01788046|593609769|FG000|Overall Study|Withdrawal by Subject|12|||
164336723|NCT01788046|593609770|FG001|Overall Study|Withdrawal by Subject|12|||
164336724|NCT01788046|593609769|FG000|Overall Study|Lost to Follow-up|12|||
164336725|NCT01788046|593609770|FG001|Overall Study|Lost to Follow-up|19|||
164336726|NCT01788046|593609769|FG000|Overall Study|Death|7|||
164336727|NCT01788046|593609770|FG001|Overall Study|Death|5|||
164336728|NCT01788046|593609769|FG000|Overall Study|Protocol Specified Criteria|25|||
163990134|NCT03048422|592331100|FG000|Overall Study|Noncompliant with Study Requirements|2|||
163990135|NCT03048422|592331101|FG001|Overall Study|Noncompliant with Study Requirements|1|||
163990136|NCT03048422|592331102|FG002|Overall Study|Noncompliant with Study Requirements|2|||
163990137|NCT03048422|592331100|FG000|Overall Study|Not Able to Get to Clinic|1|||
163990138|NCT03048422|592331101|FG001|Overall Study|Not Able to Get to Clinic|0|||
163990139|NCT03048422|592331102|FG002|Overall Study|Not Able to Get to Clinic|0|||
163990140|NCT02482129|592331104|FG000|Overall Study|Adverse Event-prior to treatment|0|||
163990141|NCT02482129|592331105|FG001|Overall Study|Adverse Event-prior to treatment|1|||
163990142|NCT02482129|592331104|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
163990143|NCT02482129|592331105|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
163990144|NCT02482129|592331104|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
163990145|NCT02482129|592331105|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
163990146|NCT02482129|592331104|FG000|Overall Study|Criteria not met-prior to treatment|1|||
163990147|NCT02482129|592331105|FG001|Overall Study|Criteria not met-prior to treatment|0|||
163990148|NCT02482129|592331104|FG000|Overall Study|Adverse Event|1|||
163990149|NCT02482129|592331105|FG001|Overall Study|Adverse Event|0|||
163990150|NCT02482129|592331104|FG000|Overall Study|Withdrawal by Subject|2|||
163990151|NCT02482129|592331105|FG001|Overall Study|Withdrawal by Subject|0|||
163990152|NCT02482129|592331104|FG000|Overall Study|Criteria not met|1|||
163990153|NCT02482129|592331105|FG001|Overall Study|Criteria not met|0|||
163990154|NCT00670007|592332965|FG000|Overall Study|Drug abuse|1|||
163990155|NCT00670007|592332965|FG000|Overall Study|Lung transplant|1|||
163990156|NCT00670007|592332965|FG000|Overall Study|Travel/Vacation|1|||
163990157|NCT00670007|592332965|FG000|Overall Study|Adverse event, serious fatal|1|||
163990158|NCT00670007|592332965|FG000|Overall Study|Adverse Event|1|||
163990159|NCT00670007|592332965|FG000|Overall Study|Withdrawal by Subject|4|||
163990160|NCT00618722|592332966|FG000|Overall Study|Refusal of Treatment|0|||
163990161|NCT00618722|592332967|FG001|Overall Study|Refusal of Treatment|0|||
163990162|NCT00618722|592332968|FG002|Overall Study|Refusal of Treatment|1|||
163990163|NCT00618722|592332969|FG003|Overall Study|Refusal of Treatment|0|||
163990164|NCT00618722|592332966|FG000|Overall Study|Patient Request|1|||
163990165|NCT00618722|592332967|FG001|Overall Study|Patient Request|1|||
163990166|NCT00618722|592332968|FG002|Overall Study|Patient Request|1|||
163990167|NCT00618722|592332969|FG003|Overall Study|Patient Request|1|||
163990168|NCT00618722|592332966|FG000|Overall Study|Inability to Complete Study Procedure|0|||
163990169|NCT00618722|592332967|FG001|Overall Study|Inability to Complete Study Procedure|1|||
163990170|NCT00618722|592332968|FG002|Overall Study|Inability to Complete Study Procedure|0|||
163990171|NCT00618722|592332969|FG003|Overall Study|Inability to Complete Study Procedure|0|||
163990172|NCT00618722|592332966|FG000|Overall Study|Lost to Follow-up|2|||
163990173|NCT00618722|592332967|FG001|Overall Study|Lost to Follow-up|0|||
163990174|NCT00618722|592332968|FG002|Overall Study|Lost to Follow-up|0|||
163990175|NCT00618722|592332969|FG003|Overall Study|Lost to Follow-up|2|||
163990176|NCT00618722|592332966|FG000|Overall Study|Miscellaneous Reasons|0|||
163990177|NCT00618722|592332967|FG001|Overall Study|Miscellaneous Reasons|0|||
163990178|NCT00618722|592332968|FG002|Overall Study|Miscellaneous Reasons|1|||
163990179|NCT00618722|592332969|FG003|Overall Study|Miscellaneous Reasons|1|||
163990180|NCT00925600|592332970|FG000|Overall Study|Withdrawal by Subject|16|||
163990181|NCT00925600|592332971|FG001|Overall Study|Withdrawal by Subject|14|||
163990182|NCT00925600|592332970|FG000|Overall Study|Death|4|||
163990183|NCT00925600|592332971|FG001|Overall Study|Death|3|||
163990184|NCT00925600|592332970|FG000|Overall Study|Lost to Follow-up|2|||
164083489|NCT02711956|592670200|FG011|Overall Study|Clinical progression|2|||
163990185|NCT00925600|592332971|FG001|Overall Study|Lost to Follow-up|2|||
163990186|NCT00925600|592332970|FG000|Overall Study|Disease Progression|1|||
163990187|NCT00925600|592332971|FG001|Overall Study|Disease Progression|3|||
163990188|NCT00925600|592332970|FG000|Overall Study|Administrative Decision|1|||
163990189|NCT00925600|592332971|FG001|Overall Study|Administrative Decision|1|||
163990190|NCT00925600|592332970|FG000|Overall Study|Noncompliance|2|||
164243162|NCT01925768|593260375|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
164243163|NCT01925768|593260376|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
164243164|NCT00087698|593260382|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
164243165|NCT00087698|593260382|FG000|Overall Study|Death from Other Causes|3|||
164243166|NCT00087698|593260382|FG000|Overall Study|Adverse Event|4|||
164243167|NCT00087698|593260382|FG000|Overall Study|Withdrawal by Subject|4|||
164243168|NCT00087698|593260382|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
164243169|NCT00087698|593260382|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
164243170|NCT00087698|593260382|FG000|Overall Study|Clinical Relapse|1|||
164243171|NCT00087698|593260382|FG000|Overall Study|Death from Study Disease|2|||
164243172|NCT00087698|593260382|FG000|Overall Study|Death from Study Drug Toxicity|2|||
164243173|NCT00087698|593260382|FG000|Overall Study|Protocol Violation|1|||
164243174|NCT04179305|593260387|FG000|Overall Study|Death|1|||
164243175|NCT04179305|593260388|FG001|Overall Study|Death|1|||
164243176|NCT04179305|593260389|FG002|Overall Study|Death|0|||
164243177|NCT04179305|593260390|FG003|Overall Study|Death|0|||
164243178|NCT04179305|593260387|FG000|Overall Study|Lost to Follow-up|1|||
164243179|NCT04179305|593260388|FG001|Overall Study|Lost to Follow-up|1|||
164243180|NCT04179305|593260389|FG002|Overall Study|Lost to Follow-up|0|||
164243181|NCT04179305|593260390|FG003|Overall Study|Lost to Follow-up|0|||
164243182|NCT04179305|593260387|FG000|Overall Study|Withdrawal by Subject|0|||
164243183|NCT04179305|593260388|FG001|Overall Study|Withdrawal by Subject|1|||
164243184|NCT04179305|593260389|FG002|Overall Study|Withdrawal by Subject|0|||
164243185|NCT04179305|593260390|FG003|Overall Study|Withdrawal by Subject|0|||
164243186|NCT04179305|593260387|FG000|Overall Study|Did not have scan|1|||
164243187|NCT04179305|593260388|FG001|Overall Study|Did not have scan|0|||
164243188|NCT04179305|593260389|FG002|Overall Study|Did not have scan|0|||
164243189|NCT04179305|593260390|FG003|Overall Study|Did not have scan|0|||
164243190|NCT04179305|593260387|FG000|Overall Study|In hospice care|3|||
164243191|NCT04179305|593260388|FG001|Overall Study|In hospice care|0|||
164243192|NCT04179305|593260389|FG002|Overall Study|In hospice care|0|||
164243193|NCT04179305|593260390|FG003|Overall Study|In hospice care|0|||
164243194|NCT01737762|593260393|FG000|Overall Study|Adverse Event|2|||
164336729|NCT01788046|593609770|FG001|Overall Study|Protocol Specified Criteria|1|||
164336730|NCT00075218|593609771|FG000|Double-Blind Treatment|Adverse Event|23|||
164336731|NCT00075218|593609772|FG001|Double-Blind Treatment|Adverse Event|4|||
164336732|NCT00075218|593609773|FG002|Double-Blind Treatment|Adverse Event|0|||
164336733|NCT00075218|593609771|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
164336734|NCT00075218|593609772|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
164336735|NCT00075218|593609773|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
164336736|NCT00075218|593609771|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
164336737|NCT00075218|593609772|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
164336738|NCT00075218|593609773|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
164336739|NCT00075218|593609771|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
164336740|NCT00075218|593609772|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
164336741|NCT00075218|593609773|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
164336742|NCT00075218|593609771|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
164336743|NCT00075218|593609772|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
164336744|NCT00075218|593609773|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
164336745|NCT00075218|593609771|FG000|Double-Blind Treatment|No study medication taken|2|||
164336746|NCT00075218|593609772|FG001|Double-Blind Treatment|No study medication taken|0|||
164336747|NCT00075218|593609773|FG002|Double-Blind Treatment|No study medication taken|0|||
164336748|NCT00075218|593609771|FG000|Open-Label Treatment|Lack of Efficacy|0|||
164336749|NCT00075218|593609772|FG001|Open-Label Treatment|Lack of Efficacy|0|||
164336750|NCT00075218|593609773|FG002|Open-Label Treatment|Lack of Efficacy|174|||
164336751|NCT00075218|593609771|FG000|Open-Label Treatment|Adverse Event|0|||
164336752|NCT00075218|593609772|FG001|Open-Label Treatment|Adverse Event|0|||
164336753|NCT00075218|593609773|FG002|Open-Label Treatment|Adverse Event|51|||
164336754|NCT00075218|593609771|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
164336755|NCT00075218|593609772|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164336756|NCT00075218|593609773|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
164336757|NCT00075218|593609771|FG000|Open-Label Treatment|Decision of Sponsor|0|||
164336758|NCT00075218|593609772|FG001|Open-Label Treatment|Decision of Sponsor|0|||
164336759|NCT00075218|593609773|FG002|Open-Label Treatment|Decision of Sponsor|8|||
164336760|NCT00075218|593609771|FG000|Open-Label Treatment|Protocol Violation|0|||
164336761|NCT00075218|593609772|FG001|Open-Label Treatment|Protocol Violation|0|||
164336762|NCT00075218|593609773|FG002|Open-Label Treatment|Protocol Violation|1|||
164336763|NCT00075218|593609771|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
164336764|NCT00075218|593609772|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
164336765|NCT00075218|593609773|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
164336766|NCT03643575|593609774|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
164336767|NCT03643575|593609775|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
164336768|NCT03643575|593609776|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
164336769|NCT03643575|593609777|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
164336770|NCT03643575|593609778|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
164336771|NCT03643575|593609779|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
164336772|NCT03643575|593609774|FG000|Washout: 7 Days|Adverse Event|1|||
164336773|NCT03643575|593609775|FG001|Washout: 7 Days|Adverse Event|0|||
164336774|NCT03643575|593609776|FG002|Washout: 7 Days|Adverse Event|0|||
164336775|NCT03643575|593609777|FG003|Washout: 7 Days|Adverse Event|0|||
164243195|NCT01737762|593260394|FG001|Overall Study|Adverse Event|2|||
164336776|NCT03643575|593609778|FG004|Washout: 7 Days|Adverse Event|0|||
164336777|NCT03643575|593609779|FG005|Washout: 7 Days|Adverse Event|0|||
164336778|NCT03643575|593609774|FG000|Washout: 7 Days|Non compliance check in|0|||
164336779|NCT03643575|593609775|FG001|Washout: 7 Days|Non compliance check in|1|||
164336780|NCT03643575|593609776|FG002|Washout: 7 Days|Non compliance check in|0|||
164243196|NCT01737762|593260393|FG000|Overall Study|Lost to Follow-up|1|||
164243197|NCT01737762|593260394|FG001|Overall Study|Lost to Follow-up|0|||
164336781|NCT03643575|593609777|FG003|Washout: 7 Days|Non compliance check in|0|||
164243198|NCT01737762|593260393|FG000|Overall Study|Withdrawal by Subject|2|||
164243199|NCT01737762|593260394|FG001|Overall Study|Withdrawal by Subject|2|||
164243200|NCT01737762|593260393|FG000|Overall Study|Progressive disease|1|||
164243201|NCT01737762|593260394|FG001|Overall Study|Progressive disease|2|||
164243202|NCT01737762|593260393|FG000|Overall Study|Physician Decision|1|||
164243203|NCT01737762|593260394|FG001|Overall Study|Physician Decision|1|||
164243204|NCT01737762|593260393|FG000|Overall Study|Moved from area|2|||
164243205|NCT01737762|593260394|FG001|Overall Study|Moved from area|1|||
164243206|NCT01737762|593260393|FG000|Overall Study|Trial termination|11|||
164243207|NCT01737762|593260394|FG001|Overall Study|Trial termination|9|||
164243208|NCT00326599|593260395|FG000|Overall Study|Withdrawal by Subject|1|||
164243209|NCT00326599|593260396|FG001|Overall Study|Withdrawal by Subject|0|||
164243210|NCT00326599|593260397|FG002|Overall Study|Withdrawal by Subject|5|||
164243211|NCT00326599|593260398|FG003|Overall Study|Withdrawal by Subject|2|||
164243212|NCT00326599|593260395|FG000|Overall Study|Adverse Event|1|||
164243213|NCT00326599|593260396|FG001|Overall Study|Adverse Event|0|||
164243214|NCT00326599|593260397|FG002|Overall Study|Adverse Event|32|||
164243215|NCT00326599|593260398|FG003|Overall Study|Adverse Event|3|||
164083490|NCT02711956|592670201|FG012|Overall Study|Clinical progression|4|||
164243216|NCT00326599|593260395|FG000|Overall Study|Disease Progression|3|||
164243217|NCT00326599|593260396|FG001|Overall Study|Disease Progression|1|||
164243218|NCT00326599|593260397|FG002|Overall Study|Disease Progression|13|||
164243219|NCT00326599|593260398|FG003|Overall Study|Disease Progression|11|||
164243220|NCT00326599|593260395|FG000|Overall Study|Alternate Treatment|1|||
164243221|NCT00326599|593260396|FG001|Overall Study|Alternate Treatment|0|||
164243222|NCT00326599|593260397|FG002|Overall Study|Alternate Treatment|0|||
164243223|NCT00326599|593260398|FG003|Overall Study|Alternate Treatment|0|||
164243224|NCT00326599|593260395|FG000|Overall Study|Death|0|||
164243225|NCT00326599|593260396|FG001|Overall Study|Death|0|||
164243226|NCT00326599|593260397|FG002|Overall Study|Death|1|||
164243227|NCT00326599|593260398|FG003|Overall Study|Death|2|||
164243228|NCT00326599|593260395|FG000|Overall Study|Other Unspecified Reason|0|||
164243229|NCT00326599|593260396|FG001|Overall Study|Other Unspecified Reason|0|||
164243230|NCT00326599|593260397|FG002|Overall Study|Other Unspecified Reason|2|||
164243231|NCT00326599|593260398|FG003|Overall Study|Other Unspecified Reason|1|||
164243232|NCT03542266|593260399|FG000|Treatment Phase|Withdrawal by Subject|1|||
164243233|NCT03542266|593260399|FG000|Treatment Phase|Adverse Event|1|||
164243234|NCT03542266|593260399|FG000|Treatment Phase|PD|1|||
164243235|NCT00625586|593260400|FG000|Overall Study|Adverse Event|1|||
164243236|NCT00625586|593260400|FG000|Overall Study|Progressive disease|1|||
164243237|NCT04721158|593260408|FG000|Overall Study|Lost to Follow-up|4|||
164243238|NCT04721158|593260408|FG000|Overall Study|Device did not connect|1|||
164243239|NCT00142792|593260411|FG000|Overall Study|Death|0|||
164243240|NCT00142792|593260412|FG001|Overall Study|Death|0|||
164243241|NCT00142792|593260413|FG002|Overall Study|Death|1|||
164243242|NCT00142792|593260411|FG000|Overall Study|Withdrawal by Subject|3|||
164243243|NCT00142792|593260412|FG001|Overall Study|Withdrawal by Subject|2|||
164243244|NCT00142792|593260413|FG002|Overall Study|Withdrawal by Subject|3|||
164243245|NCT00142792|593260411|FG000|Overall Study|Lost to Follow-up|8|||
164243246|NCT00142792|593260412|FG001|Overall Study|Lost to Follow-up|11|||
164243247|NCT00142792|593260413|FG002|Overall Study|Lost to Follow-up|7|||
164243248|NCT00142792|593260411|FG000|Overall Study|No category|1|||
164243249|NCT00142792|593260412|FG001|Overall Study|No category|2|||
164243250|NCT00142792|593260413|FG002|Overall Study|No category|1|||
164243251|NCT00833027|593260415|FG000|Overall Study|Adverse Event|33|||
164243252|NCT00833027|593260415|FG000|Overall Study|Death|1|||
164243253|NCT00833027|593260415|FG000|Overall Study|Lack of Efficacy|12|||
164243254|NCT00833027|593260415|FG000|Overall Study|Lost to Follow-up|24|||
164243255|NCT00833027|593260415|FG000|Overall Study|Protocol Violation|115|||
164243256|NCT00833027|593260415|FG000|Overall Study|Withdrawal by Subject|16|||
164336782|NCT03643575|593609778|FG004|Washout: 7 Days|Non compliance check in|0|||
164336783|NCT03643575|593609779|FG005|Washout: 7 Days|Non compliance check in|0|||
164336784|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
164336785|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
164336786|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
164336787|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
164336788|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
164336789|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
164336790|NCT00875979|593609780|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
164336791|NCT00875979|593609781|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
164336792|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
164336793|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
164336794|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
164336795|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
164336796|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
163885414|NCT02573493|591952274|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
163885415|NCT02573493|591952275|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
163885416|NCT02761057|591952276|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
163885417|NCT02761057|591952277|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
163885418|NCT02761057|591952278|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
163885419|NCT02761057|591952279|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
163885420|NCT02761057|591952276|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
163885421|NCT02761057|591952277|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
163885422|NCT02761057|591952278|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
163885423|NCT02761057|591952279|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
163885424|NCT02761057|591952276|FG000|Overall Study|Currently On Study Treatment|0|||
163885425|NCT02761057|591952277|FG001|Overall Study|Currently On Study Treatment|3|||
163885426|NCT02761057|591952278|FG002|Overall Study|Currently On Study Treatment|0|||
163885427|NCT02761057|591952279|FG003|Overall Study|Currently On Study Treatment|0|||
163885428|NCT02761057|591952276|FG000|Overall Study|Adverse Event|11|||
163885429|NCT02761057|591952277|FG001|Overall Study|Adverse Event|9|||
163885430|NCT02761057|591952278|FG002|Overall Study|Adverse Event|5|||
163885431|NCT02761057|591952279|FG003|Overall Study|Adverse Event|3|||
163885432|NCT02761057|591952276|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
163885433|NCT02761057|591952277|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
163885434|NCT02761057|591952278|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
163885435|NCT02761057|591952279|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
163885436|NCT02761057|591952276|FG000|Overall Study|Progression/Relapse|29|||
163885437|NCT02761057|591952277|FG001|Overall Study|Progression/Relapse|27|||
163885438|NCT02761057|591952278|FG002|Overall Study|Progression/Relapse|20|||
163885439|NCT02761057|591952279|FG003|Overall Study|Progression/Relapse|23|||
163885440|NCT02761057|591952276|FG000|Overall Study|Death|2|||
163885441|NCT02761057|591952277|FG001|Overall Study|Death|2|||
163885442|NCT02761057|591952278|FG002|Overall Study|Death|1|||
163885443|NCT02761057|591952279|FG003|Overall Study|Death|1|||
163885444|NCT02761057|591952276|FG000|Overall Study|Other - Not Protocol Specified|2|||
163885445|NCT02761057|591952277|FG001|Overall Study|Other - Not Protocol Specified|1|||
163885446|NCT02761057|591952278|FG002|Overall Study|Other - Not Protocol Specified|2|||
163885447|NCT02761057|591952279|FG003|Overall Study|Other - Not Protocol Specified|0|||
163885448|NCT04971681|591952280|FG000|Followup|Lost to Follow-up|1|||
163885449|NCT04971681|591952281|FG001|Followup|Lost to Follow-up|0|||
163885450|NCT00686335|591952282|FG000|Run-in Period|Adverse Event|1|||
163885451|NCT00686335|591952282|FG000|Run-in Period|asthma exacerbation|1|||
163885452|NCT00686335|591952282|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
163885453|NCT04632992|591952291|FG000|Overall Study|Adverse Event|0|||
163885454|NCT04632992|591952292|FG001|Overall Study|Adverse Event|0|||
163885455|NCT04632992|591952293|FG002|Overall Study|Adverse Event|0|||
163885456|NCT04632992|591952294|FG003|Overall Study|Adverse Event|0|||
163885457|NCT04632992|591952295|FG004|Overall Study|Adverse Event|0|||
163885458|NCT04632992|591952296|FG005|Overall Study|Adverse Event|0|||
163885459|NCT04632992|591952297|FG006|Overall Study|Adverse Event|0|||
163885460|NCT04632992|591952298|FG007|Overall Study|Adverse Event|0|||
163885461|NCT04632992|591952299|FG008|Overall Study|Adverse Event|0|||
163885462|NCT04632992|591952300|FG009|Overall Study|Adverse Event|0|||
163885463|NCT04632992|591952301|FG010|Overall Study|Adverse Event|0|||
163885464|NCT04632992|591952302|FG011|Overall Study|Adverse Event|0|||
163885465|NCT04632992|591952303|FG012|Overall Study|Adverse Event|1|||
163885466|NCT04632992|591952304|FG013|Overall Study|Adverse Event|0|||
163885467|NCT04632992|591952291|FG000|Overall Study|Death|17|||
163885468|NCT04632992|591952292|FG001|Overall Study|Death|1|||
163885469|NCT04632992|591952293|FG002|Overall Study|Death|14|||
163990191|NCT00925600|592332971|FG001|Overall Study|Noncompliance|0|||
163990192|NCT00925600|592332970|FG000|Overall Study|Ineligibility Determined|2|||
164243257|NCT00833027|593260415|FG000|Overall Study|Missing|10|||
164243258|NCT00444925|593260416|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
164243259|NCT00444925|593260417|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
164243260|NCT00444925|593260418|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
164243261|NCT00444925|593260416|FG000|Double-blind Treatment Period|Death|2|||
164243262|NCT00444925|593260417|FG001|Double-blind Treatment Period|Death|0|||
164243263|NCT00444925|593260418|FG002|Double-blind Treatment Period|Death|0|||
164243264|NCT00444925|593260416|FG000|Double-blind Treatment Period|Adverse Event|6|||
164243265|NCT00444925|593260417|FG001|Double-blind Treatment Period|Adverse Event|28|||
164243266|NCT00444925|593260418|FG002|Double-blind Treatment Period|Adverse Event|44|||
164243267|NCT00444925|593260416|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
164243268|NCT00444925|593260417|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
164243269|NCT00444925|593260418|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
164243270|NCT00444925|593260416|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
164243271|NCT00444925|593260417|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
164243272|NCT00444925|593260418|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
164243273|NCT00444925|593260416|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
164243274|NCT00444925|593260417|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
164243275|NCT00444925|593260418|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
164243276|NCT00444925|593260416|FG000|Double-blind Treatment Period|Other|7|||
164243277|NCT00444925|593260417|FG001|Double-blind Treatment Period|Other|7|||
164243278|NCT00444925|593260418|FG002|Double-blind Treatment Period|Other|12|||
164243279|NCT03069716|593260422|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
164243280|NCT03069716|593260423|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
164243281|NCT03069716|593260424|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
164243282|NCT03069716|593260422|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
164243283|NCT03069716|593260423|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
164243284|NCT03069716|593260424|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
164243285|NCT03069716|593260422|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
164243286|NCT03069716|593260423|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
164243287|NCT03069716|593260424|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
164083491|NCT02711956|592670202|FG013|Overall Study|Clinical progression|1|||
164083492|NCT02711956|592670203|FG014|Overall Study|Clinical progression|1|||
164243288|NCT03069716|593260422|FG000|Randomized Treatment|Withdrawal by Subject|0|||
164243289|NCT03069716|593260423|FG001|Randomized Treatment|Withdrawal by Subject|2|||
164243290|NCT03069716|593260424|FG002|Randomized Treatment|Withdrawal by Subject|0|||
164243291|NCT00714948|593260425|FG000|Overall Study|Adverse Event|2|||
164243292|NCT01673126|593260426|FG000|Overall Study|change of diagnosis|4|||
164243293|NCT01673126|593260427|FG001|Overall Study|change of diagnosis|3|||
164243294|NCT00237042|593260430|FG000|Treatment|Became ineligible post-randomization|0|||
164243295|NCT00237042|593260431|FG001|Treatment|Became ineligible post-randomization|1|||
164243296|NCT00237042|593260432|FG002|Treatment|Became ineligible post-randomization|16|||
164336797|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
164336798|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
164336799|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
164336800|NCT00875979|593609780|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
164336801|NCT00875979|593609781|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
164336802|NCT01696695|593609783|FG000|Overall Study|Disease progression|373|||
164336803|NCT01696695|593609783|FG000|Overall Study|Death|29|||
164336804|NCT01696695|593609783|FG000|Overall Study|Adverse Event|74|||
164336805|NCT01696695|593609783|FG000|Overall Study|Withdrawal by Subject|92|||
164336806|NCT01696695|593609783|FG000|Overall Study|Lost to Follow-up|48|||
164336807|NCT01696695|593609783|FG000|Overall Study|Other|74|||
164336808|NCT01696695|593609783|FG000|Overall Study|Major Protocol Violation|192|||
164336809|NCT01904058|593609791|FG000|Overall Study|Adverse Event|2|||
164336810|NCT01904058|593609792|FG001|Overall Study|Adverse Event|0|||
164336811|NCT01904058|593609793|FG002|Overall Study|Adverse Event|0|||
164336812|NCT01904058|593609794|FG003|Overall Study|Adverse Event|0|||
164336813|NCT01904058|593609791|FG000|Overall Study|Withdrawal by Subject|1|||
164336814|NCT01904058|593609792|FG001|Overall Study|Withdrawal by Subject|0|||
164336815|NCT01904058|593609793|FG002|Overall Study|Withdrawal by Subject|1|||
164336816|NCT01904058|593609794|FG003|Overall Study|Withdrawal by Subject|0|||
164336817|NCT01904058|593609791|FG000|Overall Study|Pregnancy|0|||
164336818|NCT01904058|593609792|FG001|Overall Study|Pregnancy|0|||
164336819|NCT01904058|593609793|FG002|Overall Study|Pregnancy|0|||
164336820|NCT01904058|593609794|FG003|Overall Study|Pregnancy|1|||
164336821|NCT04041375|593609796|FG000|Intervention Phase|Withdrawal by Subject|2|||
164336822|NCT04041375|593609797|FG001|Intervention Phase|Withdrawal by Subject|2|||
164336823|NCT04041375|593609796|FG000|Follow-up Phase|Death|2|||
164336824|NCT04041375|593609797|FG001|Follow-up Phase|Death|0|||
164336825|NCT04041375|593609796|FG000|Follow-up Phase|Lost to Follow-up|2|||
164336826|NCT04041375|593609797|FG001|Follow-up Phase|Lost to Follow-up|1|||
164336827|NCT04041375|593609796|FG000|Follow-up Phase|Too ill|3|||
164336828|NCT04041375|593609797|FG001|Follow-up Phase|Too ill|0|||
164336829|NCT02404220|593609803|FG000|Overall Study|Adverse Event|0|||
164336830|NCT02404220|593609804|FG001|Overall Study|Adverse Event|0|||
164336831|NCT02404220|593609805|FG002|Overall Study|Adverse Event|1|||
164336832|NCT02404220|593609806|FG003|Overall Study|Adverse Event|0|||
164336833|NCT02404220|593609803|FG000|Overall Study|Death|5|||
164336834|NCT02404220|593609804|FG001|Overall Study|Death|5|||
164336835|NCT02404220|593609805|FG002|Overall Study|Death|3|||
164336836|NCT02404220|593609806|FG003|Overall Study|Death|8|||
164336837|NCT02404220|593609803|FG000|Overall Study|Progressive Disease|0|||
164336838|NCT02404220|593609804|FG001|Overall Study|Progressive Disease|0|||
164336839|NCT02404220|593609805|FG002|Overall Study|Progressive Disease|1|||
164336840|NCT02404220|593609806|FG003|Overall Study|Progressive Disease|1|||
164336841|NCT02404220|593609803|FG000|Overall Study|Study Terminated by Sponsor|0|||
164336842|NCT02404220|593609804|FG001|Overall Study|Study Terminated by Sponsor|0|||
164336843|NCT02404220|593609805|FG002|Overall Study|Study Terminated by Sponsor|2|||
164336844|NCT02404220|593609806|FG003|Overall Study|Study Terminated by Sponsor|1|||
164336845|NCT02404220|593609803|FG000|Overall Study|Withdrawal by Subject|0|||
164336846|NCT02404220|593609804|FG001|Overall Study|Withdrawal by Subject|1|||
164336847|NCT02404220|593609805|FG002|Overall Study|Withdrawal by Subject|0|||
164336848|NCT02404220|593609806|FG003|Overall Study|Withdrawal by Subject|0|||
164336849|NCT02404220|593609803|FG000|Overall Study|Enrolled but Never Treated|0|||
164336850|NCT02404220|593609804|FG001|Overall Study|Enrolled but Never Treated|2|||
164083493|NCT02711956|592670189|FG000|Overall Study|Radiographic progression|1|||
164243297|NCT00237042|593260430|FG000|Treatment|Moved out of state|1|||
164243298|NCT00237042|593260431|FG001|Treatment|Moved out of state|1|||
164243299|NCT00237042|593260432|FG002|Treatment|Moved out of state|1|||
164243300|NCT00237042|593260430|FG000|Treatment|Completed no treatment|5|||
164243301|NCT00237042|593260431|FG001|Treatment|Completed no treatment|5|||
164243302|NCT00237042|593260432|FG002|Treatment|Completed no treatment|21|||
164243303|NCT00237042|593260430|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
164243304|NCT00237042|593260431|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
164243305|NCT00237042|593260432|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
164243306|NCT00237042|593260430|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
164243307|NCT00237042|593260431|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
164243308|NCT00237042|593260432|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
164243309|NCT01913327|593260439|FG000|Overall Study|Withdrawal by Subject|0|||
164243310|NCT01913327|593260440|FG001|Overall Study|Withdrawal by Subject|1|||
164243311|NCT02151786|593260441|FG000|Overall Study|Unavailability of Case Report Form|26|||
164243312|NCT02151786|593260441|FG000|Overall Study|Outside the Contract Period|1|||
164243313|NCT02151786|593260441|FG000|Overall Study|Randomized, not Treated|1|||
164243314|NCT02151786|593260441|FG000|Overall Study|Unavailability of Information|8|||
164243315|NCT02112656|593260442|FG000|Overall Study|Death|78|||
164243316|NCT02112656|593260443|FG001|Overall Study|Death|82|||
164243317|NCT02112656|593260442|FG000|Overall Study|Withdrawal by Subject|9|||
164243318|NCT02112656|593260443|FG001|Overall Study|Withdrawal by Subject|11|||
164243319|NCT02112656|593260442|FG000|Overall Study|Lost to Follow-up|2|||
164243320|NCT02112656|593260443|FG001|Overall Study|Lost to Follow-up|4|||
163885470|NCT04632992|591952294|FG003|Overall Study|Death|14|||
163885471|NCT04632992|591952295|FG004|Overall Study|Death|13|||
163885472|NCT04632992|591952296|FG005|Overall Study|Death|6|||
163885473|NCT04632992|591952297|FG006|Overall Study|Death|7|||
163885474|NCT04632992|591952298|FG007|Overall Study|Death|12|||
163885475|NCT04632992|591952299|FG008|Overall Study|Death|15|||
163885476|NCT04632992|591952300|FG009|Overall Study|Death|20|||
163885477|NCT04632992|591952301|FG010|Overall Study|Death|8|||
163885478|NCT04632992|591952302|FG011|Overall Study|Death|2|||
163885479|NCT04632992|591952303|FG012|Overall Study|Death|10|||
163885480|NCT04632992|591952304|FG013|Overall Study|Death|1|||
163885481|NCT04632992|591952291|FG000|Overall Study|Lost to Follow-up|1|||
163885482|NCT04632992|591952292|FG001|Overall Study|Lost to Follow-up|0|||
163885483|NCT04632992|591952293|FG002|Overall Study|Lost to Follow-up|1|||
163885484|NCT04632992|591952294|FG003|Overall Study|Lost to Follow-up|0|||
163885485|NCT04632992|591952295|FG004|Overall Study|Lost to Follow-up|2|||
163885486|NCT04632992|591952296|FG005|Overall Study|Lost to Follow-up|0|||
163885487|NCT04632992|591952297|FG006|Overall Study|Lost to Follow-up|1|||
163885488|NCT04632992|591952298|FG007|Overall Study|Lost to Follow-up|1|||
163885489|NCT04632992|591952299|FG008|Overall Study|Lost to Follow-up|1|||
163885490|NCT04632992|591952300|FG009|Overall Study|Lost to Follow-up|1|||
163885491|NCT04632992|591952301|FG010|Overall Study|Lost to Follow-up|2|||
163885492|NCT04632992|591952302|FG011|Overall Study|Lost to Follow-up|0|||
163885493|NCT04632992|591952303|FG012|Overall Study|Lost to Follow-up|0|||
163885494|NCT04632992|591952304|FG013|Overall Study|Lost to Follow-up|0|||
163885495|NCT04632992|591952291|FG000|Overall Study|Reason not Specified|2|||
163885496|NCT04632992|591952292|FG001|Overall Study|Reason not Specified|0|||
163885497|NCT04632992|591952293|FG002|Overall Study|Reason not Specified|1|||
163885498|NCT04632992|591952294|FG003|Overall Study|Reason not Specified|1|||
163885499|NCT04632992|591952295|FG004|Overall Study|Reason not Specified|0|||
163885500|NCT04632992|591952296|FG005|Overall Study|Reason not Specified|0|||
163885501|NCT04632992|591952297|FG006|Overall Study|Reason not Specified|0|||
163885502|NCT04632992|591952298|FG007|Overall Study|Reason not Specified|0|||
163885503|NCT04632992|591952299|FG008|Overall Study|Reason not Specified|0|||
163885504|NCT04632992|591952300|FG009|Overall Study|Reason not Specified|0|||
163885505|NCT04632992|591952301|FG010|Overall Study|Reason not Specified|1|||
163885506|NCT04632992|591952302|FG011|Overall Study|Reason not Specified|0|||
163885507|NCT04632992|591952303|FG012|Overall Study|Reason not Specified|0|||
163885508|NCT04632992|591952304|FG013|Overall Study|Reason not Specified|0|||
164243321|NCT02112656|593260442|FG000|Overall Study|Noncompliance|1|||
163885509|NCT04632992|591952291|FG000|Overall Study|Physician Decision|0|||
163885510|NCT04632992|591952292|FG001|Overall Study|Physician Decision|0|||
163885511|NCT04632992|591952293|FG002|Overall Study|Physician Decision|0|||
163885512|NCT04632992|591952294|FG003|Overall Study|Physician Decision|2|||
163885513|NCT04632992|591952295|FG004|Overall Study|Physician Decision|1|||
163885514|NCT04632992|591952296|FG005|Overall Study|Physician Decision|0|||
163885515|NCT04632992|591952297|FG006|Overall Study|Physician Decision|0|||
163885516|NCT04632992|591952298|FG007|Overall Study|Physician Decision|0|||
164243322|NCT02112656|593260443|FG001|Overall Study|Noncompliance|2|||
164243323|NCT04749745|593260444|FG000|Overall Study|Withdrawal by Subject|1|||
164243324|NCT04749745|593260445|FG001|Overall Study|Withdrawal by Subject|0|||
164243325|NCT01365455|593260446|FG000|Induction Period|Adverse Event|5|||
164243326|NCT01365455|593260447|FG001|Induction Period|Adverse Event|3|||
163885517|NCT04632992|591952299|FG008|Overall Study|Physician Decision|0|||
164243327|NCT01365455|593260448|FG002|Induction Period|Adverse Event|4|||
164243328|NCT01365455|593260449|FG003|Induction Period|Adverse Event|0|||
164243329|NCT01365455|593260450|FG004|Induction Period|Adverse Event|0|||
164243330|NCT01365455|593260446|FG000|Induction Period|Lack of Efficacy|1|||
164243331|NCT01365455|593260447|FG001|Induction Period|Lack of Efficacy|1|||
164243332|NCT01365455|593260448|FG002|Induction Period|Lack of Efficacy|0|||
164243333|NCT01365455|593260449|FG003|Induction Period|Lack of Efficacy|0|||
164243334|NCT01365455|593260450|FG004|Induction Period|Lack of Efficacy|0|||
164243335|NCT01365455|593260446|FG000|Induction Period|Pregnancy|0|||
164243336|NCT01365455|593260447|FG001|Induction Period|Pregnancy|1|||
164243337|NCT01365455|593260448|FG002|Induction Period|Pregnancy|0|||
164243338|NCT01365455|593260449|FG003|Induction Period|Pregnancy|0|||
164243339|NCT01365455|593260450|FG004|Induction Period|Pregnancy|0|||
164243340|NCT01365455|593260446|FG000|Induction Period|Protocol deviation|0|||
164243341|NCT01365455|593260447|FG001|Induction Period|Protocol deviation|1|||
164243342|NCT01365455|593260448|FG002|Induction Period|Protocol deviation|1|||
164243343|NCT01365455|593260449|FG003|Induction Period|Protocol deviation|0|||
164243344|NCT01365455|593260450|FG004|Induction Period|Protocol deviation|0|||
164243345|NCT01365455|593260446|FG000|Induction Period|Subject/guardian decision|9|||
164243346|NCT01365455|593260447|FG001|Induction Period|Subject/guardian decision|1|||
164243347|NCT01365455|593260448|FG002|Induction Period|Subject/guardian decision|8|||
164243348|NCT01365455|593260449|FG003|Induction Period|Subject/guardian decision|0|||
164243349|NCT01365455|593260450|FG004|Induction Period|Subject/guardian decision|0|||
164243350|NCT01365455|593260446|FG000|Induction Period|Lost to Follow-up|0|||
163885518|NCT04632992|591952300|FG009|Overall Study|Physician Decision|0|||
163885519|NCT04632992|591952301|FG010|Overall Study|Physician Decision|0|||
163885520|NCT04632992|591952302|FG011|Overall Study|Physician Decision|0|||
163885521|NCT04632992|591952303|FG012|Overall Study|Physician Decision|3|||
163885522|NCT04632992|591952304|FG013|Overall Study|Physician Decision|0|||
164243351|NCT01365455|593260447|FG001|Induction Period|Lost to Follow-up|0|||
164243352|NCT01365455|593260448|FG002|Induction Period|Lost to Follow-up|3|||
163885523|NCT04632992|591952291|FG000|Overall Study|Progressive Disease|0|||
164243353|NCT01365455|593260449|FG003|Induction Period|Lost to Follow-up|0|||
164243354|NCT01365455|593260450|FG004|Induction Period|Lost to Follow-up|0|||
164243355|NCT01365455|593260446|FG000|Maintenance Period|Adverse Event|12|||
164243356|NCT01365455|593260447|FG001|Maintenance Period|Adverse Event|5|||
164243357|NCT01365455|593260448|FG002|Maintenance Period|Adverse Event|1|||
164243358|NCT01365455|593260449|FG003|Maintenance Period|Adverse Event|2|||
164243359|NCT01365455|593260450|FG004|Maintenance Period|Adverse Event|4|||
164243360|NCT01365455|593260446|FG000|Maintenance Period|Lack of Efficacy|10|||
164243361|NCT01365455|593260447|FG001|Maintenance Period|Lack of Efficacy|2|||
164243362|NCT01365455|593260448|FG002|Maintenance Period|Lack of Efficacy|0|||
164243363|NCT01365455|593260449|FG003|Maintenance Period|Lack of Efficacy|2|||
164243364|NCT01365455|593260450|FG004|Maintenance Period|Lack of Efficacy|2|||
164243365|NCT01365455|593260446|FG000|Maintenance Period|Lost to Follow-up|2|||
164243366|NCT01365455|593260447|FG001|Maintenance Period|Lost to Follow-up|4|||
164243367|NCT01365455|593260448|FG002|Maintenance Period|Lost to Follow-up|0|||
164243368|NCT01365455|593260449|FG003|Maintenance Period|Lost to Follow-up|0|||
164243369|NCT01365455|593260450|FG004|Maintenance Period|Lost to Follow-up|3|||
164243370|NCT01365455|593260446|FG000|Maintenance Period|Non-compliance with study treatment|0|||
164243371|NCT01365455|593260447|FG001|Maintenance Period|Non-compliance with study treatment|0|||
164243372|NCT01365455|593260448|FG002|Maintenance Period|Non-compliance with study treatment|0|||
164243373|NCT01365455|593260449|FG003|Maintenance Period|Non-compliance with study treatment|1|||
164243374|NCT01365455|593260450|FG004|Maintenance Period|Non-compliance with study treatment|0|||
164243375|NCT01365455|593260446|FG000|Maintenance Period|Physician Decision|0|||
164243376|NCT01365455|593260447|FG001|Maintenance Period|Physician Decision|1|||
164243377|NCT01365455|593260448|FG002|Maintenance Period|Physician Decision|0|||
164243378|NCT01365455|593260449|FG003|Maintenance Period|Physician Decision|0|||
164243379|NCT01365455|593260450|FG004|Maintenance Period|Physician Decision|1|||
164243380|NCT01365455|593260446|FG000|Maintenance Period|Pregnancy|0|||
164243381|NCT01365455|593260447|FG001|Maintenance Period|Pregnancy|4|||
164243382|NCT01365455|593260448|FG002|Maintenance Period|Pregnancy|0|||
164243383|NCT01365455|593260449|FG003|Maintenance Period|Pregnancy|0|||
164243384|NCT01365455|593260450|FG004|Maintenance Period|Pregnancy|2|||
164243385|NCT01365455|593260446|FG000|Maintenance Period|Protocol deviation|1|||
164243386|NCT01365455|593260447|FG001|Maintenance Period|Protocol deviation|1|||
164243387|NCT01365455|593260448|FG002|Maintenance Period|Protocol deviation|0|||
164243388|NCT01365455|593260449|FG003|Maintenance Period|Protocol deviation|0|||
164243389|NCT01365455|593260450|FG004|Maintenance Period|Protocol deviation|0|||
164243390|NCT01365455|593260446|FG000|Maintenance Period|Subject/guardian decision|4|||
164243391|NCT01365455|593260447|FG001|Maintenance Period|Subject/guardian decision|6|||
164243392|NCT01365455|593260448|FG002|Maintenance Period|Subject/guardian decision|2|||
164243393|NCT01365455|593260449|FG003|Maintenance Period|Subject/guardian decision|4|||
164243394|NCT01365455|593260450|FG004|Maintenance Period|Subject/guardian decision|1|||
164243395|NCT01234480|593261993|FG000|Overall Study|Pregnancy|88|||
164243396|NCT01234480|593261993|FG000|Overall Study|>36/Normal History|50|||
164243397|NCT01234480|593261993|FG000|Overall Study|Age|3|||
164243398|NCT01234480|593261993|FG000|Overall Study|HPV Vaccine History|28|||
164243399|NCT01234480|593261993|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
164243400|NCT01234480|593261993|FG000|Overall Study|Hysterectomy|2|||
164243401|NCT01234480|593261993|FG000|Overall Study|Hysterectomy post enrollment|1|||
164243402|NCT01234480|593261993|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
164243403|NCT01234480|593261993|FG000|Overall Study|Informed Consent Form Violation|30|||
164243404|NCT01234480|593261993|FG000|Overall Study|Incorrect Visit|3|||
164243405|NCT01234480|593261993|FG000|Overall Study|No Florida Lab License|20|||
164243406|NCT01234480|593261993|FG000|Overall Study|Out of Window|42|||
164243407|NCT01234480|593261993|FG000|Overall Study|Sample Processing/Storage|92|||
164243408|NCT01234480|593261993|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
164243409|NCT01234480|593261993|FG000|Overall Study|Site/Subject non-compliance|44|||
164243410|NCT01234480|593261993|FG000|Overall Study|Missing Sample|9|||
164243411|NCT03370419|593261994|FG000|Overall Study|Lost to Follow-up|16|||
164243412|NCT02595879|593262000|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
164243413|NCT02595879|593262001|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
164243414|NCT03145064|593262002|FG000|Overall Study|Death|24|||
164243415|NCT03145064|593262002|FG000|Overall Study|Lost to Follow-up|3|||
164243416|NCT03145064|593262002|FG000|Overall Study|Withdrawal by Subject|6|||
164243417|NCT03145064|593262002|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
164243418|NCT03145064|593262002|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
164243419|NCT00661830|593262003|FG000|Overall Study|Death|37|||
164243420|NCT00661830|593262004|FG001|Overall Study|Death|33|||
164243421|NCT00661830|593262003|FG000|Overall Study|Lost to Follow-up|1|||
164243422|NCT00661830|593262004|FG001|Overall Study|Lost to Follow-up|3|||
164243423|NCT00661830|593262003|FG000|Overall Study|Withdrawal by Subject|1|||
164243424|NCT00661830|593262004|FG001|Overall Study|Withdrawal by Subject|1|||
164243425|NCT00661830|593262003|FG000|Overall Study|Other reason|1|||
164243426|NCT00661830|593262004|FG001|Overall Study|Other reason|5|||
164243427|NCT01898286|593262005|FG000|Overall Study|Withdrawal by Subject|1|||
164243428|NCT01898286|593262005|FG000|Overall Study|Protocol Violation|1|||
164243429|NCT01898286|593262005|FG000|Overall Study|Lost to Follow-up|1|||
164243430|NCT01650831|593262006|FG000|Overall Study|Screen failure|1|||
164243431|NCT01897727|593262009|FG000|Overall Study|Exclusion: central sleep apnea|0|||
164243432|NCT01897727|593262010|FG001|Overall Study|Exclusion: central sleep apnea|1|||
164243433|NCT04245449|593262011|FG000|Overall Study|COVID shutdown|7|||
164243434|NCT02477527|593262012|FG000|Overall Study|Lost to Follow-up|2|||
164243435|NCT02477527|593262012|FG000|Overall Study|Withdrawal by Subject|1|||
164243436|NCT02477527|593262012|FG000|Overall Study|Screen Failure|3|||
164243437|NCT03692403|593262013|FG000|Overall Study|Withdrawal by Subject|1|||
164243438|NCT03692403|593262014|FG001|Overall Study|Withdrawal by Subject|0|||
164243439|NCT03692403|593262015|FG002|Overall Study|Withdrawal by Subject|1|||
164243440|NCT03692403|593262016|FG003|Overall Study|Withdrawal by Subject|0|||
164243441|NCT03692403|593262013|FG000|Overall Study|Adverse Event|0|||
164243442|NCT03692403|593262014|FG001|Overall Study|Adverse Event|0|||
164336851|NCT02404220|593609805|FG002|Overall Study|Enrolled but Never Treated|0|||
164336852|NCT02404220|593609806|FG003|Overall Study|Enrolled but Never Treated|0|||
164336853|NCT00395733|593609807|FG000|Period 2|Withdrawal by Subject|1|||
164336854|NCT00395733|593609808|FG001|Period 2|Withdrawal by Subject|2|||
164336855|NCT00395733|593609807|FG000|Period 2|Protocol Violation|0|||
164336856|NCT00395733|593609808|FG001|Period 2|Protocol Violation|1|||
164336857|NCT00395733|593609807|FG000|Period 2|Adverse Event|0|||
164336858|NCT00395733|593609808|FG001|Period 2|Adverse Event|2|||
164336859|NCT00395733|593609807|FG000|Period 2|Technical problems|1|||
164336860|NCT00395733|593609808|FG001|Period 2|Technical problems|0|||
164336861|NCT01147172|593609814|FG000|Overall Study|Withdrawal by Subject|2|||
164336862|NCT01147172|593609814|FG000|Overall Study|Lost to Follow-up|2|||
164336863|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
164336864|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
164140710|NCT02092467|592876131|FG002|Overall Study|Death|38|||
164336865|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
164336866|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
163885524|NCT04632992|591952292|FG001|Overall Study|Progressive Disease|0|||
164140711|NCT02092467|592876129|FG000|Overall Study|Lost to Follow-up|38|||
164140712|NCT02092467|592876130|FG001|Overall Study|Lost to Follow-up|35|||
164140713|NCT02092467|592876131|FG002|Overall Study|Lost to Follow-up|40|||
164140714|NCT02092467|592876129|FG000|Overall Study|Global Deterioration of Health Status|1|||
164140715|NCT02092467|592876130|FG001|Overall Study|Global Deterioration of Health Status|0|||
164140716|NCT02092467|592876131|FG002|Overall Study|Global Deterioration of Health Status|0|||
164140717|NCT02092467|592876129|FG000|Overall Study|Other|32|||
164140718|NCT02092467|592876130|FG001|Overall Study|Other|30|||
164140719|NCT02092467|592876131|FG002|Overall Study|Other|24|||
164140720|NCT02092467|592876129|FG000|Overall Study|Withdrawal by Subject|282|||
164140721|NCT02092467|592876130|FG001|Overall Study|Withdrawal by Subject|327|||
164140722|NCT02092467|592876131|FG002|Overall Study|Withdrawal by Subject|289|||
164140723|NCT02092467|592876129|FG000|Overall Study|Randomized but not treated|2|||
164140724|NCT02092467|592876130|FG001|Overall Study|Randomized but not treated|1|||
164140725|NCT02092467|592876131|FG002|Overall Study|Randomized but not treated|7|||
164140726|NCT01284621|592876132|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164140727|NCT01284621|592876133|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164140728|NCT01284621|592876134|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164140729|NCT01284621|592876135|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164140730|NCT01284621|592876136|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
164140731|NCT01284621|592876137|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
164140732|NCT02377427|592876140|FG000|Part A (Up to Week 20)|Physician Decision|1|||
164140733|NCT02377427|592876141|FG001|Part A (Up to Week 20)|Physician Decision|0|||
164140734|NCT02377427|592876142|FG002|Part A (Up to Week 20)|Physician Decision|0|||
164140735|NCT02377427|592876143|FG003|Part A (Up to Week 20)|Physician Decision|0|||
164140736|NCT02377427|592876144|FG004|Part A (Up to Week 20)|Physician Decision|0|||
164140737|NCT02377427|592876140|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
164140738|NCT02377427|592876141|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164140739|NCT02377427|592876142|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164140740|NCT02377427|592876143|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164140741|NCT02377427|592876144|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
164140742|NCT02377427|592876140|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
164140743|NCT02377427|592876141|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164140744|NCT02377427|592876142|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164140745|NCT02377427|592876143|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164140746|NCT02377427|592876144|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
164140747|NCT02377427|592876140|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164140748|NCT02377427|592876141|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164140749|NCT02377427|592876142|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
164140750|NCT02377427|592876143|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164083494|NCT02711956|592670190|FG001|Overall Study|Radiographic progression|1|||
164083495|NCT02711956|592670191|FG002|Overall Study|Radiographic progression|2|||
164083496|NCT02711956|592670192|FG003|Overall Study|Radiographic progression|0|||
164083497|NCT02711956|592670193|FG004|Overall Study|Radiographic progression|1|||
164083498|NCT02711956|592670194|FG005|Overall Study|Radiographic progression|0|||
164083499|NCT02711956|592670195|FG006|Overall Study|Radiographic progression|0|||
163990193|NCT00925600|592332971|FG001|Overall Study|Ineligibility Determined|0|||
163990194|NCT00925600|592332970|FG000|Overall Study|Protocol Deviation|0|||
163990195|NCT00925600|592332971|FG001|Overall Study|Protocol Deviation|1|||
163990196|NCT00925600|592332970|FG000|Overall Study|Requirement for Alternative Therapy|0|||
163990197|NCT00925600|592332971|FG001|Overall Study|Requirement for Alternative Therapy|1|||
163990198|NCT00925600|592332970|FG000|Overall Study|Other|3|||
163990199|NCT00925600|592332971|FG001|Overall Study|Other|1|||
163990200|NCT00925600|592332970|FG000|Overall Study|Adverse Event|1|||
163990201|NCT00925600|592332971|FG001|Overall Study|Adverse Event|2|||
163990202|NCT00127127|592332976|FG000|Overall Study|Adverse Event|0|||
164083500|NCT02711956|592670196|FG007|Overall Study|Radiographic progression|0|||
163990203|NCT00127127|592332977|FG001|Overall Study|Adverse Event|2|||
163990204|NCT00127127|592332978|FG002|Overall Study|Adverse Event|0|||
163990205|NCT00127127|592332979|FG003|Overall Study|Adverse Event|1|||
163990206|NCT00127127|592332976|FG000|Overall Study|Lack of Efficacy|1|||
163990207|NCT00127127|592332977|FG001|Overall Study|Lack of Efficacy|3|||
163990208|NCT00127127|592332978|FG002|Overall Study|Lack of Efficacy|0|||
163990209|NCT00127127|592332979|FG003|Overall Study|Lack of Efficacy|2|||
163990210|NCT00200057|592332980|FG000|Overall Study|Lack of Efficacy|3|||
163990211|NCT00200057|592332980|FG000|Overall Study|Exited due to terminal illness of PI|2|||
163990212|NCT00200057|592332980|FG000|Overall Study|Withdrawal by Subject|1|||
163990213|NCT00200057|592332980|FG000|Overall Study|Change in medical condition|1|||
163990214|NCT00200057|592332980|FG000|Overall Study|Infection|1|||
163990215|NCT00200057|592332980|FG000|Overall Study|Death|1|||
163990216|NCT01059448|592332982|FG000|Overall Study|Adverse Event|1|||
163990217|NCT01059448|592332983|FG001|Overall Study|Adverse Event|3|||
163990218|NCT01059448|592332984|FG002|Overall Study|Adverse Event|0|||
163990219|NCT01059448|592332985|FG003|Overall Study|Adverse Event|1|||
163990220|NCT01059448|592332982|FG000|Overall Study|Withdrawal by Subject|2|||
163990221|NCT01059448|592332983|FG001|Overall Study|Withdrawal by Subject|0|||
163990222|NCT01059448|592332984|FG002|Overall Study|Withdrawal by Subject|2|||
163990223|NCT01059448|592332985|FG003|Overall Study|Withdrawal by Subject|4|||
163990224|NCT01059448|592332982|FG000|Overall Study|Disease Progression|2|||
163990225|NCT01059448|592332983|FG001|Overall Study|Disease Progression|1|||
163990226|NCT01059448|592332984|FG002|Overall Study|Disease Progression|4|||
163990227|NCT01059448|592332985|FG003|Overall Study|Disease Progression|2|||
163990228|NCT01059448|592332982|FG000|Overall Study|Administrative Decision|43|||
163990229|NCT01059448|592332983|FG001|Overall Study|Administrative Decision|49|||
163990230|NCT01059448|592332984|FG002|Overall Study|Administrative Decision|45|||
163990231|NCT01059448|592332985|FG003|Overall Study|Administrative Decision|46|||
163990232|NCT01059448|592332982|FG000|Overall Study|Lost to Follow-up|0|||
163990233|NCT01059448|592332983|FG001|Overall Study|Lost to Follow-up|0|||
163990234|NCT01059448|592332984|FG002|Overall Study|Lost to Follow-up|2|||
163990235|NCT01059448|592332985|FG003|Overall Study|Lost to Follow-up|0|||
163990236|NCT01059448|592332982|FG000|Overall Study|Death|0|||
163990237|NCT01059448|592332983|FG001|Overall Study|Death|1|||
163990238|NCT01059448|592332984|FG002|Overall Study|Death|0|||
163990239|NCT01059448|592332985|FG003|Overall Study|Death|0|||
163990240|NCT01059448|592332982|FG000|Overall Study|Other|1|||
163990241|NCT01059448|592332983|FG001|Overall Study|Other|1|||
163990242|NCT01059448|592332984|FG002|Overall Study|Other|0|||
163990243|NCT01059448|592332985|FG003|Overall Study|Other|1|||
163990244|NCT01390389|592332986|FG000|Overall Study|Withdrawal by Subject|2|||
163990245|NCT01390389|592332987|FG001|Overall Study|Withdrawal by Subject|0|||
163990246|NCT01390389|592332986|FG000|Overall Study|Screen Fail|2|||
163990247|NCT01390389|592332987|FG001|Overall Study|Screen Fail|1|||
163990248|NCT00778830|592332988|FG000|Overall Study|Ongoing at data cut-off|0|||
163990249|NCT00778830|592332989|FG001|Overall Study|Ongoing at data cut-off|1|||
163990250|NCT05512949|592332990|FG000|Overall Study|Lost to Follow-up|4|||
163990251|NCT05512949|592332991|FG001|Overall Study|Lost to Follow-up|6|||
163990252|NCT05512949|592332992|FG002|Overall Study|Lost to Follow-up|2|||
163990253|NCT05512949|592332990|FG000|Overall Study|Protocol Violation|0|||
163990254|NCT05512949|592332991|FG001|Overall Study|Protocol Violation|0|||
163990255|NCT05512949|592332992|FG002|Overall Study|Protocol Violation|1|||
163990256|NCT05512949|592332990|FG000|Overall Study|Withdrawal by Subject|1|||
163990257|NCT05512949|592332991|FG001|Overall Study|Withdrawal by Subject|1|||
163990258|NCT05512949|592332992|FG002|Overall Study|Withdrawal by Subject|2|||
163990259|NCT05512949|592332990|FG000|Overall Study|Completion status unknown|1|||
163990260|NCT05512949|592332991|FG001|Overall Study|Completion status unknown|3|||
163990261|NCT05512949|592332992|FG002|Overall Study|Completion status unknown|0|||
163990262|NCT03593915|592332993|FG000|Overall Study|Adverse Event|0|||
163990263|NCT03593915|592332994|FG001|Overall Study|Adverse Event|0|||
163990264|NCT03593915|592332995|FG002|Overall Study|Adverse Event|0|||
163990265|NCT03593915|592332996|FG003|Overall Study|Adverse Event|1|||
163990266|NCT03593915|592332997|FG004|Overall Study|Adverse Event|0|||
163990267|NCT03593915|592332998|FG005|Overall Study|Adverse Event|0|||
163990268|NCT03593915|592332993|FG000|Overall Study|Physician Decision|0|||
163990269|NCT03593915|592332994|FG001|Overall Study|Physician Decision|0|||
163990270|NCT03593915|592332995|FG002|Overall Study|Physician Decision|0|||
163990271|NCT03593915|592332996|FG003|Overall Study|Physician Decision|0|||
163990272|NCT03593915|592332997|FG004|Overall Study|Physician Decision|0|||
163990273|NCT03593915|592332998|FG005|Overall Study|Physician Decision|1|||
163990274|NCT01583179|592332999|FG000|Overall Study|Screen failure|1|||
163990275|NCT01583179|592333000|FG001|Overall Study|Screen failure|2|||
163990276|NCT01246206|592333001|FG000|Overall Study|Patient did not receive study regiments.|1|||
163990277|NCT02002975|592333002|FG000|Overall Study|Case Report Forms Uncollected|135|||
163990278|NCT02002975|592333002|FG000|Overall Study|Protocol Deviation|437|||
163990279|NCT03988907|592333003|FG000|Overall Study|Unable to complete visit|0|||
164243443|NCT03692403|593262015|FG002|Overall Study|Adverse Event|0|||
164243444|NCT03692403|593262016|FG003|Overall Study|Adverse Event|1|||
164243445|NCT03692403|593262013|FG000|Overall Study|Pregnancy|0|||
164243446|NCT03692403|593262014|FG001|Overall Study|Pregnancy|1|||
164243447|NCT03692403|593262015|FG002|Overall Study|Pregnancy|0|||
164243448|NCT03692403|593262016|FG003|Overall Study|Pregnancy|0|||
164243449|NCT03692403|593262013|FG000|Overall Study|Other|0|||
164243450|NCT03692403|593262014|FG001|Overall Study|Other|0|||
164243451|NCT03692403|593262015|FG002|Overall Study|Other|1|||
164243452|NCT03692403|593262016|FG003|Overall Study|Other|0|||
164243453|NCT02479880|593262017|FG000|Overall Study|Study Terminated by Sponsor|13|||
164243454|NCT02479880|593262018|FG001|Overall Study|Study Terminated by Sponsor|12|||
164243455|NCT02479880|593262017|FG000|Overall Study|Pregnancy|0|||
164243456|NCT02479880|593262018|FG001|Overall Study|Pregnancy|1|||
164243457|NCT02840253|593262019|FG000|Overall Study|Unsuccessful block|4|||
164243458|NCT00856635|593262020|FG000|Overall Study|Lost to Follow-up|2|||
164243459|NCT00856635|593262021|FG001|Overall Study|Lost to Follow-up|5|||
164243460|NCT00856635|593262020|FG000|Overall Study|Pregnancy|1|||
164243461|NCT00856635|593262021|FG001|Overall Study|Pregnancy|0|||
164243462|NCT00856635|593262020|FG000|Overall Study|Withdrawal by Subject|3|||
164243463|NCT00856635|593262021|FG001|Overall Study|Withdrawal by Subject|1|||
164243464|NCT00856635|593262020|FG000|Overall Study|Serious Adverse Event|1|||
164243465|NCT00856635|593262021|FG001|Overall Study|Serious Adverse Event|0|||
164243466|NCT00856635|593262020|FG000|Overall Study|Other|1|||
164243467|NCT00856635|593262021|FG001|Overall Study|Other|0|||
164243468|NCT00856635|593262020|FG000|Overall Study|Discontinued at Randomization|2|||
164243469|NCT00856635|593262021|FG001|Overall Study|Discontinued at Randomization|2|||
164243470|NCT01349673|593262022|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
164243471|NCT01349673|593262022|FG000|Overall Study|No Longer Qualified For Study|1|||
164243472|NCT01349673|593262022|FG000|Overall Study|Site Closure|10|||
164243473|NCT01349673|593262022|FG000|Overall Study|Withdrawal by Subject|21|||
164243474|NCT01349673|593262022|FG000|Overall Study|Lost to Follow-up|6|||
164243475|NCT01349673|593262022|FG000|Overall Study|Adverse Event|17|||
164243476|NCT01349673|593262022|FG000|Overall Study|Study Terminated By Sponsor|50|||
164243477|NCT01349673|593262022|FG000|Overall Study|Lack of Efficacy|8|||
164243478|NCT03688919|593262023|FG000|Overall Study|Lost to Follow-up|2|||
164243479|NCT03688919|593262024|FG001|Overall Study|Lost to Follow-up|1|||
164243480|NCT03688919|593262023|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
164243481|NCT03688919|593262024|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
164243482|NCT00564733|593262029|FG000|Overall Study|Withdrawal by Subject|4|||
164243483|NCT00564733|593262029|FG000|Overall Study|Ineligible|5|||
164243484|NCT03198767|593262034|FG000|Overall Study|Protocol Violation|0|||
164243485|NCT03198767|593262035|FG001|Overall Study|Protocol Violation|0|||
164243486|NCT03198767|593262036|FG002|Overall Study|Protocol Violation|0|||
164243487|NCT03198767|593262037|FG003|Overall Study|Protocol Violation|6|||
164243488|NCT03198767|593262038|FG004|Overall Study|Protocol Violation|0|||
164243489|NCT03198767|593262039|FG005|Overall Study|Protocol Violation|0|||
164243490|NCT03198767|593262040|FG006|Overall Study|Protocol Violation|0|||
164243491|NCT03462758|593262041|FG000|Overall Study|Chose no or other method of contraception|20|||
164243492|NCT03462758|593262042|FG001|Overall Study|Chose no or other method of contraception|23|||
164243493|NCT03462758|593262041|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
164243494|NCT03462758|593262042|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
164243495|NCT03462758|593262041|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
164243496|NCT03462758|593262042|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
164243497|NCT03462758|593262041|FG000|Overall Study|Medical contraindication|2|||
164243498|NCT03462758|593262042|FG001|Overall Study|Medical contraindication|2|||
164243499|NCT03462758|593262041|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
164243500|NCT03462758|593262042|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
164243501|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
164243502|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
164243503|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243504|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243505|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243506|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
164243507|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
164243508|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
164243509|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243510|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243511|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
164243512|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
163990280|NCT03988907|592333004|FG001|Overall Study|Unable to complete visit|1|||
164243513|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243514|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
164243515|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243516|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243517|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243518|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
164243519|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
164243520|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
164243521|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243522|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243523|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243524|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
164243525|NCT02820844|593262043|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
164243526|NCT02820844|593262044|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243527|NCT02820844|593262045|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243528|NCT02820844|593262046|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243529|NCT02820844|593262047|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243530|NCT02820844|593262048|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
164243531|NCT02820844|593262043|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243532|NCT02820844|593262044|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243533|NCT02820844|593262045|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
164243534|NCT02820844|593262046|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
164243535|NCT02820844|593262047|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243536|NCT02820844|593262048|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
164243537|NCT02820844|593262043|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243538|NCT02820844|593262044|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243539|NCT02820844|593262045|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
164243540|NCT02820844|593262046|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243541|NCT02820844|593262047|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243542|NCT02820844|593262048|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
164243543|NCT02820844|593262043|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243544|NCT02820844|593262044|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243545|NCT02820844|593262045|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
164243546|NCT02820844|593262046|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
164243547|NCT02820844|593262047|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243548|NCT02820844|593262048|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243549|NCT02820844|593262043|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243550|NCT02820844|593262044|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243551|NCT02820844|593262045|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243552|NCT02820844|593262046|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
163885525|NCT04632992|591952293|FG002|Overall Study|Progressive Disease|0|||
163885526|NCT04632992|591952294|FG003|Overall Study|Progressive Disease|0|||
164243553|NCT02820844|593262047|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
164243554|NCT02820844|593262048|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
164243555|NCT02820844|593262043|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243556|NCT02820844|593262044|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243557|NCT02820844|593262045|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243558|NCT02820844|593262046|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243559|NCT02820844|593262047|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
164243560|NCT02820844|593262048|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
164243561|NCT04423939|593262049|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
164243562|NCT04423939|593262050|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
164243563|NCT04423939|593262049|FG000|Overall Study|Death|3|||
164243564|NCT04423939|593262050|FG001|Overall Study|Death|0|||
164243565|NCT04423939|593262049|FG000|Overall Study|Withdrawal by Subject|3|||
164243566|NCT04423939|593262050|FG001|Overall Study|Withdrawal by Subject|0|||
164243567|NCT04423939|593262049|FG000|Overall Study|Caregiver to patient who died|0|||
164243568|NCT04423939|593262050|FG001|Overall Study|Caregiver to patient who died|3|||
164243569|NCT04423939|593262049|FG000|Overall Study|Caregiver to patient who withdrew|0|||
164243570|NCT04423939|593262050|FG001|Overall Study|Caregiver to patient who withdrew|3|||
164243571|NCT01722994|593262055|FG000|Overall Study|Missing data|25|||
164243572|NCT01722994|593262056|FG001|Overall Study|Missing data|17|||
164243573|NCT01206140|593262057|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
164243574|NCT01206140|593262058|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
164243575|NCT02655887|593262059|FG000|Overall Study|Lost to Follow-up|3|||
164243576|NCT02655887|593262059|FG000|Overall Study|Death|4|||
164243577|NCT02655887|593262059|FG000|Overall Study|Withdrawal by Subject|3|||
164243578|NCT02655887|593262059|FG000|Overall Study|Missed 12-month follow-up visit|4|||
164336867|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
163885527|NCT04632992|591952295|FG004|Overall Study|Progressive Disease|1|||
163885528|NCT04632992|591952296|FG005|Overall Study|Progressive Disease|0|||
163885529|NCT04632992|591952297|FG006|Overall Study|Progressive Disease|0|||
164243579|NCT04245709|593262062|FG000|Overall Study|Adverse Event|13|||
164243580|NCT04245709|593262062|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
164243581|NCT04339413|593262063|FG000|Overall Study|Reason Not Specified|2|||
164243582|NCT04339413|593262064|FG001|Overall Study|Reason Not Specified|7|||
164243583|NCT04339413|593262063|FG000|Overall Study|Study Terminated by Sponsor|30|||
164243584|NCT04339413|593262064|FG001|Overall Study|Study Terminated by Sponsor|33|||
164243585|NCT04339413|593262063|FG000|Overall Study|Progressive Disease|9|||
164243586|NCT04339413|593262064|FG001|Overall Study|Progressive Disease|6|||
164243587|NCT04339413|593262063|FG000|Overall Study|Withdrawal by Subject|9|||
164243588|NCT04339413|593262064|FG001|Overall Study|Withdrawal by Subject|10|||
164243589|NCT04339413|593262063|FG000|Overall Study|Physician Decision|3|||
164243590|NCT04339413|593262064|FG001|Overall Study|Physician Decision|1|||
164243591|NCT04339413|593262063|FG000|Overall Study|Death|2|||
164243592|NCT04339413|593262064|FG001|Overall Study|Death|0|||
164243593|NCT04339413|593262063|FG000|Overall Study|Adverse Event|3|||
164243594|NCT04339413|593262064|FG001|Overall Study|Adverse Event|0|||
164243595|NCT00442416|593262065|FG000|Overall Study|Adverse Event|4|||
164243596|NCT00442416|593262066|FG001|Overall Study|Adverse Event|1|||
164243597|NCT00442416|593262065|FG000|Overall Study|Death|1|||
164243598|NCT00442416|593262066|FG001|Overall Study|Death|0|||
164243599|NCT00442416|593262065|FG000|Overall Study|Lack of Efficacy|2|||
164243600|NCT00442416|593262066|FG001|Overall Study|Lack of Efficacy|0|||
164243601|NCT00442416|593262065|FG000|Overall Study|Protocol Violation|2|||
164243602|NCT00442416|593262066|FG001|Overall Study|Protocol Violation|3|||
164243603|NCT00442416|593262065|FG000|Overall Study|Withdrew consent|1|||
164243604|NCT00442416|593262066|FG001|Overall Study|Withdrew consent|2|||
164243605|NCT00442416|593262065|FG000|Overall Study|Administrative/Other|27|||
164243606|NCT00442416|593262066|FG001|Overall Study|Administrative/Other|33|||
164243607|NCT01964378|593262070|FG000|Overall Study|Disc. due to death before first dosing|0|||
164243608|NCT01964378|593262071|FG001|Overall Study|Disc. due to death before first dosing|1|||
164243609|NCT01964378|593262070|FG000|Overall Study|Disc. due to AE before first dosing|1|||
164243610|NCT01964378|593262071|FG001|Overall Study|Disc. due to AE before first dosing|0|||
164243611|NCT01964378|593262070|FG000|Overall Study|Death|3|||
164243612|NCT01964378|593262071|FG001|Overall Study|Death|2|||
164243613|NCT01964378|593262070|FG000|Overall Study|Adverse Event|12|||
164243614|NCT01964378|593262071|FG001|Overall Study|Adverse Event|5|||
164243615|NCT01964378|593262070|FG000|Overall Study|Lack of Efficacy|0|||
164243616|NCT01964378|593262071|FG001|Overall Study|Lack of Efficacy|1|||
164243617|NCT01964378|593262070|FG000|Overall Study|Protocol Violation|0|||
164243618|NCT01964378|593262071|FG001|Overall Study|Protocol Violation|1|||
164243619|NCT01964378|593262070|FG000|Overall Study|Lost to Follow-up|0|||
164243620|NCT01964378|593262071|FG001|Overall Study|Lost to Follow-up|1|||
164243621|NCT01964378|593262070|FG000|Overall Study|Withdrawal by Subject|7|||
164243622|NCT01964378|593262071|FG001|Overall Study|Withdrawal by Subject|5|||
164243623|NCT01964378|593262070|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
164243624|NCT01964378|593262071|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
164243625|NCT01964378|593262070|FG000|Overall Study|Other|1|||
164243626|NCT01964378|593262071|FG001|Overall Study|Other|2|||
164243627|NCT00657267|593262079|FG000|Overall Study|Progressive disease|45|||
164243628|NCT00657267|593262079|FG000|Overall Study|Adverse Event|9|||
164243629|NCT04872569|593262080|FG000|Overall Study|Withdrawal by Subject|2|||
164243630|NCT02382991|593262086|FG000|Overall Study|Adverse Event|1|||
164243631|NCT02382991|593262087|FG001|Overall Study|Adverse Event|2|||
164243632|NCT02382991|593262086|FG000|Overall Study|Lost to Follow-up|1|||
163885530|NCT04632992|591952298|FG007|Overall Study|Progressive Disease|0|||
164083501|NCT02711956|592670197|FG008|Overall Study|Radiographic progression|2|||
164243633|NCT02382991|593262087|FG001|Overall Study|Lost to Follow-up|0|||
164243634|NCT02382991|593262086|FG000|Overall Study|Withdrawal by Subject|0|||
164243635|NCT02382991|593262087|FG001|Overall Study|Withdrawal by Subject|1|||
164243636|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
164336868|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
164336869|NCT01697358|593609815|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
163885531|NCT04632992|591952299|FG008|Overall Study|Progressive Disease|0|||
164243637|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
164243638|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
164243639|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
164243640|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
164243641|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
164243642|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
164243643|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
164243644|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
164243645|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
164243646|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
164243647|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
164243648|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
164243649|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
164243650|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
164243651|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243652|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
164243653|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243654|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243655|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
164243656|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
164243657|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
164243658|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
164243659|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
164243660|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
164243661|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243662|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
164243663|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243664|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243665|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
164243666|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
164243667|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243668|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243669|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243670|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
164243671|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
164243672|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243673|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243674|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243675|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
164243676|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
164243677|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243678|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243679|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243680|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
164243681|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243682|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
164243683|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243684|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243685|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
164243686|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
164243687|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164243688|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164243689|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164336870|NCT01697358|593609816|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
164336871|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
164243690|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
164336872|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
164336873|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
164336874|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
164336875|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
164336876|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
164336877|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
164336878|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
164336879|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
164336880|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
164336881|NCT01697358|593609815|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
164336882|NCT01697358|593609816|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
164336883|NCT02711345|593609819|FG000|Overall Study|Adverse Event|0|||
163885532|NCT04632992|591952300|FG009|Overall Study|Progressive Disease|1|||
163885533|NCT04632992|591952301|FG010|Overall Study|Progressive Disease|1|||
163885534|NCT04632992|591952302|FG011|Overall Study|Progressive Disease|0|||
163885535|NCT04632992|591952303|FG012|Overall Study|Progressive Disease|2|||
163885536|NCT04632992|591952304|FG013|Overall Study|Progressive Disease|0|||
163885537|NCT04632992|591952291|FG000|Overall Study|Withdrawal by Subject|4|||
163885538|NCT04632992|591952292|FG001|Overall Study|Withdrawal by Subject|1|||
163885539|NCT04632992|591952293|FG002|Overall Study|Withdrawal by Subject|5|||
163885540|NCT04632992|591952294|FG003|Overall Study|Withdrawal by Subject|4|||
164006646|NCT00847613|592391044|FG003|Overall Study|Protocol Violation|1|||
164243691|NCT04951622|593262088|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243692|NCT04951622|593262089|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
164243693|NCT04951622|593262090|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243694|NCT04951622|593262091|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243695|NCT04951622|593262092|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
164243696|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
164243697|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
164243698|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
164243699|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
164243700|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
164243701|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
164243702|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
164243703|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
164336884|NCT02711345|593609820|FG001|Overall Study|Adverse Event|0|||
164336885|NCT02711345|593609821|FG002|Overall Study|Adverse Event|0|||
164336886|NCT02711345|593609822|FG003|Overall Study|Adverse Event|1|||
164336887|NCT02711345|593609823|FG004|Overall Study|Adverse Event|1|||
164336888|NCT02711345|593609824|FG005|Overall Study|Adverse Event|2|||
164336889|NCT02711345|593609825|FG006|Overall Study|Adverse Event|1|||
164336890|NCT02711345|593609826|FG007|Overall Study|Adverse Event|0|||
164336891|NCT02711345|593609827|FG008|Overall Study|Adverse Event|0|||
164336892|NCT02711345|593609828|FG009|Overall Study|Adverse Event|2|||
164336893|NCT02711345|593609819|FG000|Overall Study|Physician Decision|0|||
164336894|NCT02711345|593609820|FG001|Overall Study|Physician Decision|0|||
164336895|NCT02711345|593609821|FG002|Overall Study|Physician Decision|1|||
164336896|NCT02711345|593609822|FG003|Overall Study|Physician Decision|0|||
164336897|NCT02711345|593609823|FG004|Overall Study|Physician Decision|0|||
164336898|NCT02711345|593609824|FG005|Overall Study|Physician Decision|0|||
164336899|NCT02711345|593609825|FG006|Overall Study|Physician Decision|0|||
164336900|NCT02711345|593609826|FG007|Overall Study|Physician Decision|0|||
164336901|NCT02711345|593609827|FG008|Overall Study|Physician Decision|1|||
164336902|NCT02711345|593609828|FG009|Overall Study|Physician Decision|0|||
164336903|NCT02711345|593609819|FG000|Overall Study|Progressive disease|1|||
164336904|NCT02711345|593609820|FG001|Overall Study|Progressive disease|3|||
164336905|NCT02711345|593609821|FG002|Overall Study|Progressive disease|5|||
164336906|NCT02711345|593609822|FG003|Overall Study|Progressive disease|3|||
164336907|NCT02711345|593609823|FG004|Overall Study|Progressive disease|7|||
164336908|NCT02711345|593609824|FG005|Overall Study|Progressive disease|2|||
164336909|NCT02711345|593609825|FG006|Overall Study|Progressive disease|8|||
164336910|NCT02711345|593609826|FG007|Overall Study|Progressive disease|4|||
164336911|NCT02711345|593609827|FG008|Overall Study|Progressive disease|5|||
164336912|NCT02711345|593609828|FG009|Overall Study|Progressive disease|6|||
164336913|NCT02711345|593609819|FG000|Overall Study|Subject/guardian decision|0|||
164336914|NCT02711345|593609820|FG001|Overall Study|Subject/guardian decision|0|||
164336915|NCT02711345|593609821|FG002|Overall Study|Subject/guardian decision|0|||
164336916|NCT02711345|593609822|FG003|Overall Study|Subject/guardian decision|0|||
164336917|NCT02711345|593609823|FG004|Overall Study|Subject/guardian decision|0|||
164336918|NCT02711345|593609824|FG005|Overall Study|Subject/guardian decision|2|||
164336919|NCT02711345|593609825|FG006|Overall Study|Subject/guardian decision|3|||
164336920|NCT02711345|593609826|FG007|Overall Study|Subject/guardian decision|1|||
164336921|NCT02711345|593609827|FG008|Overall Study|Subject/guardian decision|0|||
164336922|NCT02711345|593609828|FG009|Overall Study|Subject/guardian decision|4|||
164336923|NCT02711345|593609819|FG000|Overall Study|Death|1|||
164336924|NCT02711345|593609820|FG001|Overall Study|Death|0|||
164336925|NCT02711345|593609821|FG002|Overall Study|Death|0|||
164336926|NCT02711345|593609822|FG003|Overall Study|Death|0|||
164336927|NCT02711345|593609823|FG004|Overall Study|Death|0|||
164336928|NCT02711345|593609824|FG005|Overall Study|Death|0|||
164336929|NCT02711345|593609825|FG006|Overall Study|Death|0|||
164336930|NCT02711345|593609826|FG007|Overall Study|Death|1|||
163990281|NCT02810964|592333005|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
164336931|NCT02711345|593609827|FG008|Overall Study|Death|0|||
164336932|NCT02711345|593609828|FG009|Overall Study|Death|0|||
164336933|NCT00961649|593609829|FG000|Overall Study|Adverse Event|4|||
164336934|NCT00961649|593609830|FG001|Overall Study|Adverse Event|0|||
164336935|NCT00961649|593609831|FG002|Overall Study|Adverse Event|0|||
164336936|NCT00961649|593609832|FG003|Overall Study|Adverse Event|2|||
164336937|NCT00961649|593609829|FG000|Overall Study|Inadequate control of IOP|0|||
164336938|NCT00961649|593609830|FG001|Overall Study|Inadequate control of IOP|0|||
164336939|NCT00961649|593609831|FG002|Overall Study|Inadequate control of IOP|0|||
164243704|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
164243705|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
164243706|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
164243707|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
164243708|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
164243709|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
164243710|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
164243711|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
164243712|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
164243713|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
164243714|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
164243715|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
164243716|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243717|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243718|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
164243719|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243720|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
164243721|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
164243722|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
164243723|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
164243724|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
164243725|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
164243726|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
164243727|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
164243728|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
164243729|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
164243730|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
164243731|NCT04951622|593262088|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243732|NCT04951622|593262089|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243733|NCT04951622|593262090|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243734|NCT04951622|593262091|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
164243735|NCT04951622|593262092|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
164243736|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
164243737|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
164243738|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
164243739|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243740|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243741|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243742|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243743|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243744|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243745|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243746|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243747|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243748|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243749|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243750|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243751|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
164243752|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
164243753|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
164336940|NCT00961649|593609832|FG003|Overall Study|Inadequate control of IOP|1|||
164336941|NCT00961649|593609829|FG000|Overall Study|Patient has travel plans during holidays|0|||
164336942|NCT00961649|593609830|FG001|Overall Study|Patient has travel plans during holidays|0|||
164336943|NCT00961649|593609831|FG002|Overall Study|Patient has travel plans during holidays|1|||
164336944|NCT00961649|593609832|FG003|Overall Study|Patient has travel plans during holidays|0|||
164336945|NCT00961649|593609829|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
164336946|NCT00961649|593609830|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
164336947|NCT00961649|593609831|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
164336948|NCT00961649|593609832|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
164336949|NCT00961649|593609829|FG000|Overall Study|Study terminated by sponsor|4|||
164243754|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243755|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243756|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243757|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243758|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164336950|NCT00961649|593609830|FG001|Overall Study|Study terminated by sponsor|4|||
163885541|NCT04632992|591952295|FG004|Overall Study|Withdrawal by Subject|3|||
163885542|NCT04632992|591952296|FG005|Overall Study|Withdrawal by Subject|3|||
164243759|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243760|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243761|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243762|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243763|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243764|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243765|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243766|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
163885543|NCT04632992|591952297|FG006|Overall Study|Withdrawal by Subject|0|||
163885544|NCT04632992|591952298|FG007|Overall Study|Withdrawal by Subject|5|||
164243767|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
164243768|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243769|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243770|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243771|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
164243772|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243773|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243774|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243775|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243776|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243777|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243778|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243779|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243780|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243781|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243782|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243783|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
164243784|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243785|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243786|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
164243787|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243788|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243789|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243790|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243791|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243792|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243793|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243794|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243795|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243796|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243797|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243798|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243799|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
164243800|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243801|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164336951|NCT00961649|593609831|FG002|Overall Study|Study terminated by sponsor|4|||
164336952|NCT00961649|593609832|FG003|Overall Study|Study terminated by sponsor|1|||
164336953|NCT02155881|593609833|FG000|Overall Study|Withdrawal by Subject|0|||
163885545|NCT04632992|591952299|FG008|Overall Study|Withdrawal by Subject|0|||
163885546|NCT04632992|591952300|FG009|Overall Study|Withdrawal by Subject|2|||
163885547|NCT04632992|591952301|FG010|Overall Study|Withdrawal by Subject|8|||
163885548|NCT04632992|591952302|FG011|Overall Study|Withdrawal by Subject|0|||
163885549|NCT04632992|591952303|FG012|Overall Study|Withdrawal by Subject|1|||
163885550|NCT04632992|591952304|FG013|Overall Study|Withdrawal by Subject|1|||
163885551|NCT02677805|591952305|FG000|Double Blind Phase|Lost to Follow-up|8|||
163885552|NCT02677805|591952306|FG001|Double Blind Phase|Lost to Follow-up|3|||
163885553|NCT02677805|591952307|FG002|Double Blind Phase|Lost to Follow-up|0|||
163885554|NCT02677805|591952305|FG000|Double Blind Phase|Withdrawal by Subject|5|||
163885555|NCT02677805|591952306|FG001|Double Blind Phase|Withdrawal by Subject|2|||
164243802|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243803|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
164243804|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243805|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243806|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
163885556|NCT02677805|591952307|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163885557|NCT02677805|591952305|FG000|Open Label Phase|Lost to Follow-up|0|||
164006647|NCT00847613|592391041|FG000|Overall Study|Pregnancy|1|||
164006648|NCT00847613|592391042|FG001|Overall Study|Pregnancy|1|||
164006649|NCT00847613|592391043|FG002|Overall Study|Pregnancy|0|||
164006650|NCT00847613|592391044|FG003|Overall Study|Pregnancy|0|||
164243807|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243808|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243809|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243810|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243811|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243812|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243813|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243814|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243815|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
164243816|NCT02891226|593262097|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243817|NCT02891226|593262098|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243818|NCT02891226|593262099|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243819|NCT02891226|593262100|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
164243820|NCT02891226|593262101|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243821|NCT02891226|593262102|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243822|NCT02891226|593262103|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243823|NCT02891226|593262104|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243824|NCT02891226|593262105|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243825|NCT02891226|593262106|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243826|NCT02891226|593262107|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243827|NCT02891226|593262108|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243828|NCT02891226|593262109|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243829|NCT02891226|593262110|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243830|NCT02891226|593262111|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243831|NCT02891226|593262112|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
164243832|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243833|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243834|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243835|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243836|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243837|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243838|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
164243839|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
164243840|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
164243841|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
164243842|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243843|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243844|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243845|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243846|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243847|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
164243848|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243849|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243850|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243851|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243852|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243853|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
164243854|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243855|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243856|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243857|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
164243858|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243859|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243860|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243861|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243862|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243863|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
164243864|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243865|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243866|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243867|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243868|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243869|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243870|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
164243871|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
164243872|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
164243873|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
164243874|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243875|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243876|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243877|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243878|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
163885558|NCT02677805|591952306|FG001|Open Label Phase|Lost to Follow-up|0|||
163885559|NCT02677805|591952307|FG002|Open Label Phase|Lost to Follow-up|10|||
163885560|NCT02677805|591952305|FG000|Open Label Phase|Withdrawal by Subject|0|||
163885561|NCT02677805|591952306|FG001|Open Label Phase|Withdrawal by Subject|0|||
163885562|NCT02677805|591952307|FG002|Open Label Phase|Withdrawal by Subject|6|||
163885563|NCT04350463|591952312|FG000|Overall Study|Other reason|0|||
163885564|NCT04350463|591952313|FG001|Overall Study|Other reason|0|||
163885565|NCT04350463|591952314|FG002|Overall Study|Other reason|0|||
163885566|NCT04350463|591952315|FG003|Overall Study|Other reason|1|||
163885567|NCT04350463|591952312|FG000|Overall Study|Lost to Follow-up|0|||
163885568|NCT04350463|591952313|FG001|Overall Study|Lost to Follow-up|0|||
163885569|NCT04350463|591952314|FG002|Overall Study|Lost to Follow-up|0|||
163885570|NCT04350463|591952315|FG003|Overall Study|Lost to Follow-up|2|||
163885571|NCT04350463|591952312|FG000|Overall Study|Withdrawal by Subject|4|||
163885572|NCT04350463|591952313|FG001|Overall Study|Withdrawal by Subject|0|||
163885573|NCT04350463|591952314|FG002|Overall Study|Withdrawal by Subject|1|||
163885574|NCT04350463|591952315|FG003|Overall Study|Withdrawal by Subject|4|||
163885575|NCT04350463|591952312|FG000|Overall Study|Adverse Event|0|||
163885576|NCT04350463|591952313|FG001|Overall Study|Adverse Event|0|||
163885577|NCT04350463|591952314|FG002|Overall Study|Adverse Event|0|||
163885578|NCT04350463|591952315|FG003|Overall Study|Adverse Event|2|||
163885579|NCT04350463|591952312|FG000|Overall Study|Death|27|||
163885580|NCT04350463|591952313|FG001|Overall Study|Death|2|||
163885581|NCT04350463|591952314|FG002|Overall Study|Death|13|||
163885582|NCT04350463|591952315|FG003|Overall Study|Death|26|||
163885583|NCT04652700|591952316|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
163885584|NCT04652700|591952317|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
163885585|NCT04652700|591952316|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
163885586|NCT04652700|591952317|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
163885587|NCT04652700|591952316|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
163885588|NCT04652700|591952317|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
163885589|NCT04652700|591952316|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
163885590|NCT04652700|591952317|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
163885591|NCT04652700|591952316|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
163885592|NCT04652700|591952317|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
163885593|NCT04652700|591952316|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
163885594|NCT04652700|591952317|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
163885595|NCT04652700|591952316|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
163885596|NCT04652700|591952317|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
163885597|NCT04652700|591952316|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
163885598|NCT04652700|591952317|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
163885599|NCT04652700|591952316|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
163885600|NCT04652700|591952317|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
163885601|NCT04187833|591952318|FG000|Overall Study|Withdrawal by Subject|1|||
163885602|NCT03097549|591952321|FG000|Overall Study|Withdrawal by Subject|1|||
163885603|NCT03097549|591952322|FG001|Overall Study|Withdrawal by Subject|0|||
163885604|NCT03097549|591952321|FG000|Overall Study|Lost to Follow-up|1|||
164243879|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
164243880|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243881|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243882|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243883|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243884|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
164243885|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243886|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243887|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243888|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243889|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243890|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243891|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243892|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
163885605|NCT03097549|591952322|FG001|Overall Study|Lost to Follow-up|0|||
163885606|NCT01824537|591952323|FG000|Overall Study|Lost to Follow-up|78|||
163885607|NCT01824537|591952324|FG001|Overall Study|Lost to Follow-up|87|||
163885608|NCT02146378|591952325|FG000|Overall Study|No information of administration|2|||
163885609|NCT06215521|591952334|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
163885610|NCT06215521|591952335|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
163885611|NCT06215521|591952336|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
163885612|NCT06215521|591952337|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
163885613|NCT06215521|591952338|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
163885614|NCT06215521|591952339|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
163885615|NCT04096040|591952340|FG000|Overall Study|Protocol Violation|12|||
163885616|NCT04096040|591952340|FG000|Overall Study|Non-compliant site|4|||
163885617|NCT04044768|591952341|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
163885618|NCT04044768|591952342|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
163885619|NCT05089019|591952346|FG000|Period 1|Withdrawal by Subject|0|||
163885620|NCT05089019|591952347|FG001|Period 1|Withdrawal by Subject|1|||
163885621|NCT05089019|591952346|FG000|Washout Period|Adverse Event|3|||
163885622|NCT05089019|591952347|FG001|Washout Period|Adverse Event|4|||
163885623|NCT05089019|591952346|FG000|Washout Period|Lost to Follow-up|1|||
163885624|NCT05089019|591952347|FG001|Washout Period|Lost to Follow-up|0|||
163885625|NCT05089019|591952346|FG000|Washout Period|Physician Decision|2|||
163885626|NCT05089019|591952347|FG001|Washout Period|Physician Decision|0|||
163885627|NCT05089019|591952346|FG000|Washout Period|Withdrawal by Subject|6|||
163885628|NCT05089019|591952347|FG001|Washout Period|Withdrawal by Subject|3|||
163885629|NCT05089019|591952346|FG000|Period 2|Adverse Event|4|||
163885630|NCT05089019|591952347|FG001|Period 2|Adverse Event|2|||
163885631|NCT05089019|591952346|FG000|Period 2|Lost to Follow-up|1|||
163885632|NCT05089019|591952347|FG001|Period 2|Lost to Follow-up|0|||
163885633|NCT05089019|591952346|FG000|Period 2|Withdrawal by Subject|0|||
163885634|NCT05089019|591952347|FG001|Period 2|Withdrawal by Subject|1|||
163885635|NCT04925986|591952348|FG000|Overall Study|Death|0|||
163885636|NCT04925986|591952349|FG001|Overall Study|Death|0|||
163885637|NCT04925986|591952350|FG002|Overall Study|Death|2|||
163885638|NCT04925986|591952351|FG003|Overall Study|Death|0|||
163885639|NCT04925986|591952348|FG000|Overall Study|Lack of Efficacy|1|||
163885640|NCT04925986|591952349|FG001|Overall Study|Lack of Efficacy|2|||
163885641|NCT04925986|591952350|FG002|Overall Study|Lack of Efficacy|0|||
163885642|NCT04925986|591952351|FG003|Overall Study|Lack of Efficacy|1|||
163885643|NCT04925986|591952348|FG000|Overall Study|Withdrawal by Subject|0|||
163885644|NCT04925986|591952349|FG001|Overall Study|Withdrawal by Subject|0|||
163885645|NCT04925986|591952350|FG002|Overall Study|Withdrawal by Subject|1|||
163885646|NCT04925986|591952351|FG003|Overall Study|Withdrawal by Subject|2|||
163885647|NCT03858634|591952352|FG000|Overall Study|Withdrawal by Subject|1|||
163885648|NCT03858634|591952353|FG001|Overall Study|Withdrawal by Subject|0|||
163885649|NCT03858634|591952352|FG000|Overall Study|Adverse Event|1|||
163885650|NCT03858634|591952353|FG001|Overall Study|Adverse Event|0|||
163885651|NCT03858634|591952352|FG000|Overall Study|Lost to Follow-up|0|||
163885652|NCT03858634|591952353|FG001|Overall Study|Lost to Follow-up|1|||
163885653|NCT03858634|591952352|FG000|Overall Study|Other, Not Specified|1|||
163885654|NCT03858634|591952353|FG001|Overall Study|Other, Not Specified|1|||
163885655|NCT06181760|591952354|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
163885656|NCT06181760|591952355|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
163885657|NCT06181760|591952356|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
163885658|NCT06181760|591952357|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
163885659|NCT05415722|591952359|FG000|Overall Study|Lost to Follow-up|0|||
163885660|NCT05415722|591952360|FG001|Overall Study|Lost to Follow-up|2|||
163885661|NCT05415722|591952361|FG002|Overall Study|Lost to Follow-up|0|||
163885662|NCT05415722|591952362|FG003|Overall Study|Lost to Follow-up|1|||
163885663|NCT05415722|591952363|FG004|Overall Study|Lost to Follow-up|0|||
163885664|NCT05415722|591952364|FG005|Overall Study|Lost to Follow-up|0|||
163885665|NCT05415722|591952365|FG006|Overall Study|Lost to Follow-up|1|||
163885666|NCT05415722|591952359|FG000|Overall Study|Physician Decision|0|||
163885667|NCT05415722|591952360|FG001|Overall Study|Physician Decision|0|||
163885668|NCT05415722|591952361|FG002|Overall Study|Physician Decision|0|||
163885669|NCT05415722|591952362|FG003|Overall Study|Physician Decision|1|||
163885670|NCT05415722|591952363|FG004|Overall Study|Physician Decision|0|||
163885671|NCT05415722|591952364|FG005|Overall Study|Physician Decision|0|||
163885672|NCT05415722|591952365|FG006|Overall Study|Physician Decision|1|||
163885673|NCT05415722|591952359|FG000|Overall Study|Protocol Violation|0|||
163885674|NCT05415722|591952360|FG001|Overall Study|Protocol Violation|0|||
163885675|NCT05415722|591952361|FG002|Overall Study|Protocol Violation|0|||
163885676|NCT05415722|591952362|FG003|Overall Study|Protocol Violation|1|||
163885677|NCT05415722|591952363|FG004|Overall Study|Protocol Violation|0|||
163885678|NCT05415722|591952364|FG005|Overall Study|Protocol Violation|0|||
163885679|NCT05415722|591952365|FG006|Overall Study|Protocol Violation|0|||
163885680|NCT05415722|591952359|FG000|Overall Study|Sponsor Discretion|0|||
163990282|NCT02810964|592333006|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
163990283|NCT02810964|592333005|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
163990284|NCT02810964|592333006|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
163990285|NCT02810964|592333005|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
163990286|NCT02810964|592333006|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
163990287|NCT02810964|592333005|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
163990288|NCT02810964|592333006|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
163990289|NCT03523351|592333007|FG000|Overall Study|Death|13|||
163990290|NCT03523351|592333008|FG001|Overall Study|Death|11|||
163885681|NCT05415722|591952360|FG001|Overall Study|Sponsor Discretion|0|||
163885682|NCT05415722|591952361|FG002|Overall Study|Sponsor Discretion|0|||
164243893|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243894|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243895|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
164243896|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243897|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243898|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243899|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243900|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243901|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243902|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
164243903|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243904|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243905|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243906|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243907|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243908|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243909|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243910|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243911|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
164243912|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243913|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243914|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243915|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243916|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
163990291|NCT03523351|592333007|FG000|Overall Study|Lost to Follow-up|2|||
163990292|NCT03523351|592333008|FG001|Overall Study|Lost to Follow-up|3|||
163990293|NCT03523351|592333007|FG000|Overall Study|Withdrawal by Subject|4|||
163990294|NCT03523351|592333008|FG001|Overall Study|Withdrawal by Subject|0|||
163990295|NCT03523351|592333007|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
163990296|NCT03523351|592333008|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
163990297|NCT03609619|592333009|FG000|Overall Study|Adverse Event|1|||
164243917|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243918|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243919|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
164243920|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
164243921|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
164243922|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243923|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243924|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243925|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243926|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243927|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
164243928|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243929|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243930|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243931|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243932|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243933|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243934|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243935|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
164243936|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243937|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243938|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243939|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243940|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243941|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243942|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164243943|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
164336954|NCT02155881|593609834|FG001|Overall Study|Withdrawal by Subject|2|||
164336955|NCT02155881|593609833|FG000|Overall Study|Inappropriately randomized|2|||
164336956|NCT02155881|593609834|FG001|Overall Study|Inappropriately randomized|2|||
164336957|NCT04357782|593609835|FG000|Overall Study|Discharged from hospital|1|||
164336958|NCT04357782|593609836|FG001|Overall Study|Discharged from hospital|0|||
163990298|NCT03609619|592333010|FG001|Overall Study|Adverse Event|0|||
164243944|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243945|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243946|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243947|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243948|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243949|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243950|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243951|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243952|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
164243953|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243954|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243955|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243956|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243957|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243958|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243959|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
164243960|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243961|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243962|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243963|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243964|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243965|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243966|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243967|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243968|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243969|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
164243970|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243971|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243972|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243973|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243974|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243975|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
164243976|NCT02891226|593262097|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243977|NCT02891226|593262098|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243978|NCT02891226|593262099|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243979|NCT02891226|593262100|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243980|NCT02891226|593262101|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243981|NCT02891226|593262102|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243982|NCT02891226|593262103|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243983|NCT02891226|593262104|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243984|NCT02891226|593262105|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243985|NCT02891226|593262106|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
164243986|NCT02891226|593262107|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243987|NCT02891226|593262108|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243988|NCT02891226|593262109|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243989|NCT02891226|593262110|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243990|NCT02891226|593262111|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243991|NCT02891226|593262112|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
164243992|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243993|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243994|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243995|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243996|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243997|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243998|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164243999|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244000|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244001|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244002|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
164244003|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244004|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244005|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
163885683|NCT05415722|591952362|FG003|Overall Study|Sponsor Discretion|0|||
163885684|NCT05415722|591952363|FG004|Overall Study|Sponsor Discretion|1|||
163885685|NCT05415722|591952364|FG005|Overall Study|Sponsor Discretion|1|||
163885686|NCT05415722|591952365|FG006|Overall Study|Sponsor Discretion|0|||
163885687|NCT05415722|591952359|FG000|Overall Study|Withdrawal by Subject|0|||
163885688|NCT05415722|591952360|FG001|Overall Study|Withdrawal by Subject|1|||
163885689|NCT05415722|591952361|FG002|Overall Study|Withdrawal by Subject|0|||
163885690|NCT05415722|591952362|FG003|Overall Study|Withdrawal by Subject|1|||
163885691|NCT05415722|591952363|FG004|Overall Study|Withdrawal by Subject|1|||
163885692|NCT05415722|591952364|FG005|Overall Study|Withdrawal by Subject|0|||
163885693|NCT05415722|591952365|FG006|Overall Study|Withdrawal by Subject|1|||
163885694|NCT03524612|591952366|FG000|Overall Study|Lack of Efficacy|10|||
163885695|NCT03524612|591952366|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
163885696|NCT03524612|591952366|FG000|Overall Study|Adverse Event|10|||
163885697|NCT03524612|591952366|FG000|Overall Study|Withdrawal by Subject|7|||
163885698|NCT03524612|591952366|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
163885699|NCT03524612|591952366|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
163885700|NCT03524612|591952366|FG000|Overall Study|New therapy for study indication|6|||
163885701|NCT03524612|591952366|FG000|Overall Study|Death|3|||
164244006|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244007|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
164244008|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244009|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244010|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244011|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244012|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244013|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244014|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244015|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244016|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244017|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244018|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
164244019|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244020|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244021|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244022|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244023|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
164244024|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244025|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244026|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244027|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244028|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244029|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244030|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244031|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244032|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244033|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244034|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
164244035|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244036|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244037|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244038|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244039|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
164244040|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244041|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244042|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244043|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244044|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244045|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244046|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244047|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244048|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244049|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
163885702|NCT03524612|591952366|FG000|Overall Study|Lost to Follow-up|2|||
163885703|NCT03524612|591952366|FG000|Overall Study|Protocol Violation|1|||
163885704|NCT04537715|591952367|FG000|Overall Study|Death|3|||
163885705|NCT04537715|591952368|FG001|Overall Study|Death|1|||
163885706|NCT04537715|591952367|FG000|Overall Study|Withdrawal by Subject|3|||
163885707|NCT04537715|591952368|FG001|Overall Study|Withdrawal by Subject|1|||
163885708|NCT04537715|591952367|FG000|Overall Study|Other|4|||
163885709|NCT04537715|591952368|FG001|Overall Study|Other|3|||
163885710|NCT04537715|591952367|FG000|Overall Study|Progressive disease|1|||
163885711|NCT04537715|591952368|FG001|Overall Study|Progressive disease|0|||
163885712|NCT05457647|591952370|FG000|Overall Study|Lost to Follow-up|3|||
164244050|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
164244051|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244052|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244053|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244054|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244055|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
164244056|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
163990299|NCT03609619|592333009|FG000|Overall Study|Lack of Efficacy|1|||
163990300|NCT03609619|592333010|FG001|Overall Study|Lack of Efficacy|2|||
164244057|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244058|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244059|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244060|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244061|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244062|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244063|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244064|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244065|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244066|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
164244067|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244068|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244069|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244070|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164244071|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
164336959|NCT04357782|593609835|FG000|Overall Study|Death|0|||
164336960|NCT04357782|593609836|FG001|Overall Study|Death|2|||
163990301|NCT03609619|592333009|FG000|Overall Study|Protocol Violation|5|||
163990302|NCT03609619|592333010|FG001|Overall Study|Protocol Violation|0|||
163990303|NCT03609619|592333009|FG000|Overall Study|Withdrawal by Subject|2|||
163990304|NCT03609619|592333010|FG001|Overall Study|Withdrawal by Subject|3|||
163990305|NCT03609619|592333009|FG000|Overall Study|Lost to Follow-up|1|||
163990306|NCT03609619|592333010|FG001|Overall Study|Lost to Follow-up|1|||
163990307|NCT00688909|592333011|FG000|Overall Study|Adverse Event|28|||
163990308|NCT00688909|592333011|FG000|Overall Study|Patient withdrew consent|2|||
163990309|NCT00688909|592333011|FG000|Overall Study|Administrative problems|1|||
163990310|NCT00688909|592333011|FG000|Overall Study|Protocol Violation|2|||
163990311|NCT02472847|592333013|FG000|Overall Study|Withdrawal by Subject|1|||
164336961|NCT01786148|593609837|FG000|Overall Study|Lost to Follow-up|21|||
164336962|NCT01786148|593609838|FG001|Overall Study|Lost to Follow-up|13|||
164336963|NCT01786148|593609837|FG000|Overall Study|Death|0|||
164336964|NCT01786148|593609838|FG001|Overall Study|Death|1|||
164336965|NCT01786148|593609837|FG000|Overall Study|Withdrawal by Subject|0|||
164336966|NCT01786148|593609838|FG001|Overall Study|Withdrawal by Subject|7|||
164336967|NCT01786148|593609837|FG000|Overall Study|Incarceration|1|||
164336968|NCT01786148|593609838|FG001|Overall Study|Incarceration|1|||
164336969|NCT00338104|593609839|FG000|Overall Study|Protocol Violation|2|||
164336970|NCT00338104|593609840|FG001|Overall Study|Protocol Violation|1|||
164336971|NCT00338104|593609841|FG002|Overall Study|Protocol Violation|3|||
164336972|NCT02362269|593609844|FG000|Overall Study|Moved|1|||
164336973|NCT02362269|593609845|FG001|Overall Study|Moved|0|||
164336974|NCT02362269|593609844|FG000|Overall Study|Lost to Follow-up|0|||
164336975|NCT02362269|593609845|FG001|Overall Study|Lost to Follow-up|6|||
164336976|NCT02349542|593609846|FG000|Overall Study|Withdrawal by Subject|5|||
164336977|NCT03841448|593609849|FG000|Double-blind Treatment (DBT) Period|Death|1|||
164336978|NCT03841448|593609850|FG001|Double-blind Treatment (DBT) Period|Death|1|||
164336979|NCT03841448|593609851|FG002|Double-blind Treatment (DBT) Period|Death|0|||
164336980|NCT03841448|593609852|FG003|Double-blind Treatment (DBT) Period|Death|0|||
164336981|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
164336982|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
164336983|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
164336984|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
164336985|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Death|0|||
164336986|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Death|0|||
164336987|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Death|0|||
164336988|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Death|1|||
163990312|NCT02472847|592333014|FG001|Overall Study|Withdrawal by Subject|5|||
163990313|NCT04656990|592333015|FG000|Baseline|pandemic|20|||
163990314|NCT04656990|592333016|FG001|Baseline|pandemic|24|||
163990315|NCT04656990|592333015|FG000|Follow Up Period|Lost to Follow-up|61|||
164244072|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244073|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244074|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244075|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244076|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244077|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244078|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244079|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244080|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244081|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244082|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
164244083|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244084|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244085|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244086|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244087|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
164244088|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244089|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244090|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244091|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244092|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244093|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244094|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244095|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244096|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244097|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244098|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
164244099|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244100|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244101|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244102|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244103|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
164244104|NCT02891226|593262097|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244105|NCT02891226|593262098|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244106|NCT02891226|593262099|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244107|NCT02891226|593262100|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244108|NCT02891226|593262101|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244109|NCT02891226|593262102|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244110|NCT02891226|593262103|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244111|NCT02891226|593262104|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244112|NCT02891226|593262105|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244113|NCT02891226|593262106|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244114|NCT02891226|593262107|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
164244115|NCT02891226|593262108|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244116|NCT02891226|593262109|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244117|NCT02891226|593262110|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244118|NCT02891226|593262111|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244119|NCT02891226|593262112|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
164244120|NCT02891226|593262097|FG000|Follow-up Period|Withdrawal by Subject|0|||
164244121|NCT02891226|593262098|FG001|Follow-up Period|Withdrawal by Subject|0|||
164244122|NCT02891226|593262099|FG002|Follow-up Period|Withdrawal by Subject|0|||
164244123|NCT02891226|593262100|FG003|Follow-up Period|Withdrawal by Subject|0|||
164244124|NCT02891226|593262101|FG004|Follow-up Period|Withdrawal by Subject|0|||
164244125|NCT02891226|593262102|FG005|Follow-up Period|Withdrawal by Subject|0|||
164244126|NCT02891226|593262103|FG006|Follow-up Period|Withdrawal by Subject|0|||
164244127|NCT02891226|593262104|FG007|Follow-up Period|Withdrawal by Subject|0|||
164244128|NCT02891226|593262105|FG008|Follow-up Period|Withdrawal by Subject|0|||
164244129|NCT02891226|593262106|FG009|Follow-up Period|Withdrawal by Subject|0|||
164336989|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
164336990|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
164336991|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
164336992|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
164244130|NCT02891226|593262107|FG010|Follow-up Period|Withdrawal by Subject|0|||
164244131|NCT02891226|593262108|FG011|Follow-up Period|Withdrawal by Subject|1|||
164244132|NCT02891226|593262109|FG012|Follow-up Period|Withdrawal by Subject|0|||
164244133|NCT02891226|593262110|FG013|Follow-up Period|Withdrawal by Subject|0|||
164244134|NCT02891226|593262111|FG014|Follow-up Period|Withdrawal by Subject|1|||
164244135|NCT02891226|593262112|FG015|Follow-up Period|Withdrawal by Subject|1|||
164244136|NCT01445847|593262115|FG000|Overall Study|Protocol Violation|13|||
164244137|NCT01445847|593262116|FG001|Overall Study|Protocol Violation|14|||
164244138|NCT01445847|593262115|FG000|Overall Study|Missed Data|1|||
164244139|NCT01445847|593262116|FG001|Overall Study|Missed Data|0|||
164244140|NCT04570384|593262117|FG000|Overall Study|Adverse Event|2|||
164244141|NCT04570384|593262118|FG001|Overall Study|Adverse Event|1|||
164244142|NCT04570384|593262117|FG000|Overall Study|Death|2|||
164244143|NCT04570384|593262118|FG001|Overall Study|Death|5|||
164244144|NCT04570384|593262117|FG000|Overall Study|Lost to Follow-up|1|||
164244145|NCT04570384|593262118|FG001|Overall Study|Lost to Follow-up|0|||
164244146|NCT04570384|593262117|FG000|Overall Study|Other|1|||
164244147|NCT04570384|593262118|FG001|Overall Study|Other|0|||
164244148|NCT04570384|593262117|FG000|Overall Study|Protocol Violation|0|||
164244149|NCT04570384|593262118|FG001|Overall Study|Protocol Violation|1|||
164244150|NCT04570384|593262117|FG000|Overall Study|Sponsor Decision|1|||
164244151|NCT04570384|593262118|FG001|Overall Study|Sponsor Decision|0|||
164244152|NCT04570384|593262117|FG000|Overall Study|Withdrawal by Subject|4|||
164244153|NCT04570384|593262118|FG001|Overall Study|Withdrawal by Subject|2|||
164244154|NCT03654274|593262119|FG000|Overall Study|Adverse Event|19|||
164244155|NCT03654274|593262120|FG001|Overall Study|Adverse Event|23|||
164244156|NCT03654274|593262121|FG002|Overall Study|Adverse Event|24|||
164244157|NCT03654274|593262119|FG000|Overall Study|Protocol Deviation|0|||
164244158|NCT03654274|593262120|FG001|Overall Study|Protocol Deviation|2|||
164244159|NCT03654274|593262121|FG002|Overall Study|Protocol Deviation|0|||
164244160|NCT03654274|593262119|FG000|Overall Study|Lost to Follow-up|8|||
164244161|NCT03654274|593262120|FG001|Overall Study|Lost to Follow-up|6|||
164244162|NCT03654274|593262121|FG002|Overall Study|Lost to Follow-up|5|||
164244163|NCT03654274|593262119|FG000|Overall Study|Withdrawal by Subject|46|||
164244164|NCT03654274|593262120|FG001|Overall Study|Withdrawal by Subject|25|||
164244165|NCT03654274|593262121|FG002|Overall Study|Withdrawal by Subject|33|||
164244166|NCT03654274|593262119|FG000|Overall Study|Lack of Efficacy|4|||
164244167|NCT03654274|593262120|FG001|Overall Study|Lack of Efficacy|5|||
164244168|NCT03654274|593262121|FG002|Overall Study|Lack of Efficacy|7|||
164244169|NCT03654274|593262119|FG000|Overall Study|Pregnancy|2|||
164244170|NCT03654274|593262120|FG001|Overall Study|Pregnancy|2|||
164244171|NCT03654274|593262121|FG002|Overall Study|Pregnancy|1|||
164244172|NCT03654274|593262119|FG000|Overall Study|Other|27|||
164244173|NCT03654274|593262120|FG001|Overall Study|Other|29|||
164244174|NCT03654274|593262121|FG002|Overall Study|Other|32|||
164244175|NCT03654274|593262119|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
164244176|NCT03654274|593262120|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
164244177|NCT03654274|593262121|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
164244178|NCT02454530|593262122|FG000|Overall Study|Other|8|||
164244179|NCT02454530|593262123|FG001|Overall Study|Other|13|||
164244180|NCT02454530|593262122|FG000|Overall Study|Missing information|56|||
164244181|NCT02454530|593262123|FG001|Overall Study|Missing information|69|||
164244182|NCT02454530|593262122|FG000|Overall Study|Death|2|||
164244183|NCT02454530|593262123|FG001|Overall Study|Death|41|||
164244184|NCT02454530|593262122|FG000|Overall Study|Lost to Follow-up|4|||
164244185|NCT02454530|593262123|FG001|Overall Study|Lost to Follow-up|4|||
164244186|NCT00326001|593262124|FG000|Overall Study|Adverse Event|4|||
164244187|NCT00326001|593262125|FG001|Overall Study|Adverse Event|5|||
164244188|NCT00326001|593262124|FG000|Overall Study|Physician Decision|3|||
164244189|NCT00326001|593262125|FG001|Overall Study|Physician Decision|3|||
164244190|NCT03265145|593262126|FG000|Overall Study|Protocol Violation|2|||
164244191|NCT03265145|593262127|FG001|Overall Study|Protocol Violation|0|||
164244192|NCT03265145|593262126|FG000|Overall Study|Adverse Event|1|||
164244193|NCT03265145|593262127|FG001|Overall Study|Adverse Event|0|||
164244194|NCT03265145|593262126|FG000|Overall Study|Withdrawal by Subject|23|||
164244195|NCT03265145|593262127|FG001|Overall Study|Withdrawal by Subject|19|||
164244196|NCT03265145|593262126|FG000|Overall Study|Death|12|||
164244197|NCT03265145|593262127|FG001|Overall Study|Death|12|||
164244198|NCT03265145|593262126|FG000|Overall Study|Lost to Follow-up|13|||
164244199|NCT03265145|593262127|FG001|Overall Study|Lost to Follow-up|9|||
164244200|NCT03265145|593262126|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
164244201|NCT03265145|593262127|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
164244202|NCT03265145|593262126|FG000|Overall Study|Switched back to previous medication|1|||
164244203|NCT03265145|593262127|FG001|Overall Study|Switched back to previous medication|0|||
164244204|NCT03265145|593262126|FG000|Overall Study|Did not want to take medication|1|||
164244205|NCT03265145|593262127|FG001|Overall Study|Did not want to take medication|0|||
164244206|NCT03265145|593262126|FG000|Overall Study|Subject could not afford medication|0|||
164244207|NCT03265145|593262127|FG001|Overall Study|Subject could not afford medication|1|||
163990316|NCT04656990|592333016|FG001|Follow Up Period|Lost to Follow-up|73|||
163990317|NCT03244059|592333017|FG000|Specific Aim 1|Physician Decision|1|||
163990318|NCT03244059|592333018|FG001|Specific Aim 1|Physician Decision|0|||
163990319|NCT03244059|592333017|FG000|Specific Aim 2|Physician Decision|1|||
163990320|NCT03244059|592333018|FG001|Specific Aim 2|Physician Decision|0|||
163990321|NCT05499520|592333022|FG000|Overall Study|Lost to Follow-up|0|||
163990322|NCT05499520|592333023|FG001|Overall Study|Lost to Follow-up|0|||
163990323|NCT05499520|592333024|FG002|Overall Study|Lost to Follow-up|38|||
164244208|NCT03265145|593262126|FG000|Overall Study|Site closed|2|||
164244209|NCT03265145|593262127|FG001|Overall Study|Site closed|3|||
164244210|NCT03265145|593262126|FG000|Overall Study|Incorrectly randomized|16|||
164244211|NCT03265145|593262127|FG001|Overall Study|Incorrectly randomized|6|||
164244212|NCT03265145|593262126|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
164244213|NCT03265145|593262127|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
164244214|NCT03265145|593262126|FG000|Overall Study|Physician Decision|0|||
164244215|NCT03265145|593262127|FG001|Overall Study|Physician Decision|3|||
164244216|NCT03265145|593262126|FG000|Overall Study|Subject transferred to another facility|0|||
164244217|NCT03265145|593262127|FG001|Overall Study|Subject transferred to another facility|1|||
164244218|NCT03640325|593263808|FG000|Overall Study|Withdrawal by Subject|4|||
164244219|NCT03640325|593263809|FG001|Overall Study|Withdrawal by Subject|1|||
164244220|NCT03640325|593263810|FG002|Overall Study|Withdrawal by Subject|0|||
164244221|NCT03640325|593263808|FG000|Overall Study|Lost to Follow-up|4|||
164244222|NCT03640325|593263809|FG001|Overall Study|Lost to Follow-up|5|||
164244223|NCT03640325|593263810|FG002|Overall Study|Lost to Follow-up|21|||
164244224|NCT03640325|593263808|FG000|Overall Study|Death|5|||
164244225|NCT03640325|593263809|FG001|Overall Study|Death|5|||
164244226|NCT03640325|593263810|FG002|Overall Study|Death|0|||
164244227|NCT01566149|593263813|FG000|Overall Study|Adverse Event|0|||
164244228|NCT01566149|593263814|FG001|Overall Study|Adverse Event|1|||
164244229|NCT01566149|593263813|FG000|Overall Study|Non-compliance with study medication|2|||
164244230|NCT01566149|593263814|FG001|Overall Study|Non-compliance with study medication|0|||
164244231|NCT01566149|593263813|FG000|Overall Study|Protocol Violation|0|||
164244232|NCT01566149|593263814|FG001|Overall Study|Protocol Violation|1|||
164244233|NCT01566149|593263813|FG000|Overall Study|Withdrawal by Subject|1|||
164244234|NCT01566149|593263814|FG001|Overall Study|Withdrawal by Subject|0|||
164244235|NCT03687957|593263816|FG000|Overall Study|Withdrawal by Subject|0|||
164244236|NCT03687957|593263817|FG001|Overall Study|Withdrawal by Subject|0|||
164244237|NCT03687957|593263818|FG002|Overall Study|Withdrawal by Subject|0|||
164244238|NCT03687957|593263819|FG003|Overall Study|Withdrawal by Subject|2|||
164244239|NCT03687957|593263820|FG004|Overall Study|Withdrawal by Subject|0|||
164244240|NCT03687957|593263821|FG005|Overall Study|Withdrawal by Subject|0|||
164244241|NCT03687957|593263822|FG006|Overall Study|Withdrawal by Subject|3|||
164244242|NCT03687957|593263823|FG007|Overall Study|Withdrawal by Subject|1|||
164244243|NCT03687957|593263824|FG008|Overall Study|Withdrawal by Subject|1|||
164244244|NCT03687957|593263825|FG009|Overall Study|Withdrawal by Subject|0|||
163990324|NCT05499520|592333025|FG003|Overall Study|Lost to Follow-up|41|||
164244245|NCT03687957|593263816|FG000|Overall Study|Disease progression|0|||
164244246|NCT03687957|593263817|FG001|Overall Study|Disease progression|1|||
164244247|NCT03687957|593263818|FG002|Overall Study|Disease progression|1|||
164244248|NCT03687957|593263819|FG003|Overall Study|Disease progression|2|||
164244249|NCT03687957|593263820|FG004|Overall Study|Disease progression|2|||
164244250|NCT03687957|593263821|FG005|Overall Study|Disease progression|0|||
164244251|NCT03687957|593263822|FG006|Overall Study|Disease progression|2|||
164244252|NCT03687957|593263823|FG007|Overall Study|Disease progression|1|||
164244253|NCT03687957|593263824|FG008|Overall Study|Disease progression|0|||
164244254|NCT03687957|593263825|FG009|Overall Study|Disease progression|0|||
164244255|NCT03687957|593263816|FG000|Overall Study|Physician Decision|0|||
164244256|NCT03687957|593263817|FG001|Overall Study|Physician Decision|0|||
164244257|NCT03687957|593263818|FG002|Overall Study|Physician Decision|0|||
164244258|NCT03687957|593263819|FG003|Overall Study|Physician Decision|2|||
164244259|NCT03687957|593263820|FG004|Overall Study|Physician Decision|1|||
164244260|NCT03687957|593263821|FG005|Overall Study|Physician Decision|0|||
164244261|NCT03687957|593263822|FG006|Overall Study|Physician Decision|1|||
164244262|NCT03687957|593263823|FG007|Overall Study|Physician Decision|0|||
164244263|NCT03687957|593263824|FG008|Overall Study|Physician Decision|0|||
164244264|NCT03687957|593263825|FG009|Overall Study|Physician Decision|0|||
164244265|NCT03687957|593263816|FG000|Overall Study|New malignancy|0|||
164244266|NCT03687957|593263817|FG001|Overall Study|New malignancy|0|||
164244267|NCT03687957|593263818|FG002|Overall Study|New malignancy|0|||
164244268|NCT03687957|593263819|FG003|Overall Study|New malignancy|0|||
164244269|NCT03687957|593263820|FG004|Overall Study|New malignancy|1|||
164244270|NCT03687957|593263821|FG005|Overall Study|New malignancy|0|||
163990325|NCT05499520|592333026|FG004|Overall Study|Lost to Follow-up|46|||
164244271|NCT03687957|593263822|FG006|Overall Study|New malignancy|0|||
164244272|NCT03687957|593263823|FG007|Overall Study|New malignancy|0|||
164244273|NCT03687957|593263824|FG008|Overall Study|New malignancy|0|||
164244274|NCT03687957|593263825|FG009|Overall Study|New malignancy|0|||
164244275|NCT03687957|593263816|FG000|Overall Study|Adverse Event|0|||
164244276|NCT03687957|593263817|FG001|Overall Study|Adverse Event|0|||
164244277|NCT03687957|593263818|FG002|Overall Study|Adverse Event|0|||
164244278|NCT03687957|593263819|FG003|Overall Study|Adverse Event|0|||
164244279|NCT03687957|593263820|FG004|Overall Study|Adverse Event|0|||
164244280|NCT03687957|593263821|FG005|Overall Study|Adverse Event|2|||
164244281|NCT03687957|593263822|FG006|Overall Study|Adverse Event|0|||
164244282|NCT03687957|593263823|FG007|Overall Study|Adverse Event|3|||
164244283|NCT03687957|593263824|FG008|Overall Study|Adverse Event|0|||
164244284|NCT03687957|593263825|FG009|Overall Study|Adverse Event|0|||
164244285|NCT03687957|593263816|FG000|Overall Study|Patient went on hospice|0|||
164244286|NCT03687957|593263817|FG001|Overall Study|Patient went on hospice|0|||
164244287|NCT03687957|593263818|FG002|Overall Study|Patient went on hospice|0|||
164244288|NCT03687957|593263819|FG003|Overall Study|Patient went on hospice|0|||
164244289|NCT03687957|593263820|FG004|Overall Study|Patient went on hospice|0|||
164244290|NCT03687957|593263821|FG005|Overall Study|Patient went on hospice|0|||
164244291|NCT03687957|593263822|FG006|Overall Study|Patient went on hospice|1|||
164244292|NCT03687957|593263823|FG007|Overall Study|Patient went on hospice|0|||
164244293|NCT03687957|593263824|FG008|Overall Study|Patient went on hospice|0|||
164244294|NCT03687957|593263825|FG009|Overall Study|Patient went on hospice|0|||
164244295|NCT03687957|593263816|FG000|Overall Study|Death|0|||
164244296|NCT03687957|593263817|FG001|Overall Study|Death|0|||
164244297|NCT03687957|593263818|FG002|Overall Study|Death|0|||
164244298|NCT03687957|593263819|FG003|Overall Study|Death|0|||
164244299|NCT03687957|593263820|FG004|Overall Study|Death|0|||
164244300|NCT03687957|593263821|FG005|Overall Study|Death|0|||
164244301|NCT03687957|593263822|FG006|Overall Study|Death|0|||
164244302|NCT03687957|593263823|FG007|Overall Study|Death|1|||
164244303|NCT03687957|593263824|FG008|Overall Study|Death|0|||
164244304|NCT03687957|593263825|FG009|Overall Study|Death|0|||
164244305|NCT03718325|593263826|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
164244306|NCT03718325|593263827|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
164244307|NCT03718325|593263828|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
164244308|NCT03718325|593263826|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
164244309|NCT03718325|593263827|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
164244310|NCT03718325|593263828|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
164244311|NCT02197572|593263829|FG000|Overall Study|Progressive Disease|28|||
164244312|NCT02197572|593263829|FG000|Overall Study|Withdrawal by Subject|9|||
164244313|NCT02197572|593263829|FG000|Overall Study|Adverse Event|3|||
164244314|NCT02197572|593263829|FG000|Overall Study|Reason Not Specified|4|||
164244315|NCT02383862|593263834|FG000|3 Month Follow up|Lost to Follow-up|23|||
164244316|NCT02383862|593263835|FG001|3 Month Follow up|Lost to Follow-up|21|||
164244317|NCT02630693|593263838|FG000|Overall Study|No receive treatment|0|||
164244318|NCT02630693|593263839|FG001|Overall Study|No receive treatment|1|||
164244319|NCT03801928|593263840|FG000|Overall Study|Adverse Event|1|||
164244320|NCT03801928|593263841|FG001|Overall Study|Adverse Event|0|||
164244321|NCT03801928|593263842|FG002|Overall Study|Adverse Event|1|||
164244322|NCT03801928|593263843|FG003|Overall Study|Adverse Event|2|||
164244323|NCT03801928|593263844|FG004|Overall Study|Adverse Event|0|||
164244324|NCT03801928|593263845|FG005|Overall Study|Adverse Event|2|||
164244325|NCT03801928|593263840|FG000|Overall Study|Lack of Efficacy|0|||
164244326|NCT03801928|593263841|FG001|Overall Study|Lack of Efficacy|0|||
164244327|NCT03801928|593263842|FG002|Overall Study|Lack of Efficacy|1|||
164244328|NCT03801928|593263843|FG003|Overall Study|Lack of Efficacy|0|||
164244329|NCT03801928|593263844|FG004|Overall Study|Lack of Efficacy|0|||
164244330|NCT03801928|593263845|FG005|Overall Study|Lack of Efficacy|0|||
164244331|NCT03801928|593263840|FG000|Overall Study|Lost to Follow-up|5|||
164244332|NCT03801928|593263841|FG001|Overall Study|Lost to Follow-up|1|||
164244333|NCT03801928|593263842|FG002|Overall Study|Lost to Follow-up|1|||
164244334|NCT03801928|593263843|FG003|Overall Study|Lost to Follow-up|4|||
164244335|NCT03801928|593263844|FG004|Overall Study|Lost to Follow-up|4|||
164244336|NCT03801928|593263845|FG005|Overall Study|Lost to Follow-up|2|||
164244337|NCT03801928|593263840|FG000|Overall Study|Withdrawal by Subject|0|||
164244338|NCT03801928|593263841|FG001|Overall Study|Withdrawal by Subject|0|||
164244339|NCT03801928|593263842|FG002|Overall Study|Withdrawal by Subject|2|||
164244340|NCT03801928|593263843|FG003|Overall Study|Withdrawal by Subject|1|||
164244341|NCT03801928|593263844|FG004|Overall Study|Withdrawal by Subject|0|||
164244342|NCT03801928|593263845|FG005|Overall Study|Withdrawal by Subject|0|||
164244343|NCT03801928|593263840|FG000|Overall Study|Other|0|||
164244344|NCT03801928|593263841|FG001|Overall Study|Other|2|||
164244345|NCT03801928|593263842|FG002|Overall Study|Other|0|||
164244346|NCT03801928|593263843|FG003|Overall Study|Other|1|||
164244347|NCT03801928|593263844|FG004|Overall Study|Other|0|||
164244348|NCT03801928|593263845|FG005|Overall Study|Other|1|||
164244349|NCT02763059|593263846|FG000|Overall Study|Lost to Follow-up|4|||
164244350|NCT02763059|593263847|FG001|Overall Study|Lost to Follow-up|1|||
164244351|NCT02763059|593263848|FG002|Overall Study|Lost to Follow-up|6|||
164244352|NCT02763059|593263846|FG000|Overall Study|Withdrawal by Subject|1|||
164244353|NCT02763059|593263847|FG001|Overall Study|Withdrawal by Subject|0|||
164244354|NCT02763059|593263848|FG002|Overall Study|Withdrawal by Subject|3|||
164244355|NCT01724216|593263849|FG000|Overall Study|Scan was not completed|1|||
164244356|NCT00175916|593263850|FG000|Overall Study|Death|19|||
164244357|NCT00175916|593263850|FG000|Overall Study|Adverse Event|81|||
164244358|NCT00175916|593263850|FG000|Overall Study|Lack of Efficacy|354|||
164244359|NCT00175916|593263850|FG000|Overall Study|Lost to Follow-up|17|||
164244360|NCT00175916|593263850|FG000|Overall Study|Subject Choice|98|||
164244361|NCT00175916|593263850|FG000|Overall Study|Lack of compliance|8|||
164244362|NCT00175916|593263850|FG000|Overall Study|Patient cannot record seizures|1|||
164244363|NCT00175916|593263850|FG000|Overall Study|Sponsor decision|17|||
164244364|NCT00175916|593263850|FG000|Overall Study|Vigabatrin intake|1|||
164244365|NCT00175916|593263850|FG000|Overall Study|Suicidal behaviour|1|||
164244366|NCT00175916|593263850|FG000|Overall Study|Withdrawal by Subject|1|||
164244367|NCT00175916|593263850|FG000|Overall Study|Seizure - free|4|||
164244368|NCT00175916|593263850|FG000|Overall Study|Administrative reason|1|||
164244369|NCT00175916|593263850|FG000|Overall Study|Pregnancy|1|||
164244370|NCT00175916|593263850|FG000|Overall Study|Patient's request|2|||
164244371|NCT00175916|593263850|FG000|Overall Study|Treating physiciant's choice|1|||
164244372|NCT00175916|593263850|FG000|Overall Study|Moved overseas|1|||
164244373|NCT00175916|593263850|FG000|Overall Study|Loss of job and economic burden|1|||
164244374|NCT00175916|593263850|FG000|Overall Study|Site was closed|9|||
164244375|NCT00175916|593263850|FG000|Overall Study|Patient went to prison|1|||
164244376|NCT01456130|593263852|FG000|Overall Study|Adverse Event|4|||
164244377|NCT01456130|593263852|FG000|Overall Study|Voluntary Withdrawal|1|||
164244378|NCT01456130|593263852|FG000|Overall Study|Lack of Efficacy|4|||
164244379|NCT01456130|593263852|FG000|Overall Study|Other|1|||
164244380|NCT03369665|593263857|FG000|Overall Study|Adverse Event|3|||
164244381|NCT03369665|593263857|FG000|Overall Study|Lost to Follow-up|7|||
164244382|NCT03369665|593263857|FG000|Overall Study|Withdrawal by Subject|15|||
164244383|NCT03369665|593263857|FG000|Overall Study|Progression Disease|2|||
164244384|NCT03369665|593263857|FG000|Overall Study|Not classified|3|||
164244385|NCT03230318|593263858|FG000|Overall Study|Radiographic disease progression|72|||
164244386|NCT03230318|593263859|FG001|Overall Study|Radiographic disease progression|19|||
164244387|NCT03230318|593263858|FG000|Overall Study|Clinical progression|17|||
164244388|NCT03230318|593263859|FG001|Overall Study|Clinical progression|7|||
164244389|NCT03230318|593263858|FG000|Overall Study|Adverse Event|5|||
164244390|NCT03230318|593263859|FG001|Overall Study|Adverse Event|3|||
164244391|NCT03230318|593263858|FG000|Overall Study|Physician Decision|2|||
164244392|NCT03230318|593263859|FG001|Overall Study|Physician Decision|3|||
164244393|NCT03230318|593263858|FG000|Overall Study|Death|3|||
164244394|NCT03230318|593263859|FG001|Overall Study|Death|2|||
164244395|NCT03230318|593263858|FG000|Overall Study|Lost to Follow-up|1|||
164244396|NCT03230318|593263859|FG001|Overall Study|Lost to Follow-up|0|||
164244397|NCT03230318|593263858|FG000|Overall Study|Withdrawal by Subject|1|||
164244398|NCT03230318|593263859|FG001|Overall Study|Withdrawal by Subject|3|||
163885713|NCT04938492|591952371|FG000|Overall Study|Lost to Follow-up|17|||
164083502|NCT02711956|592670198|FG009|Overall Study|Radiographic progression|1|||
164083503|NCT02711956|592670199|FG010|Overall Study|Radiographic progression|0|||
164083504|NCT02711956|592670200|FG011|Overall Study|Radiographic progression|5|||
164083505|NCT02711956|592670201|FG012|Overall Study|Radiographic progression|3|||
164083506|NCT02711956|592670202|FG013|Overall Study|Radiographic progression|0|||
164083507|NCT02711956|592670203|FG014|Overall Study|Radiographic progression|1|||
164083508|NCT02711956|592670189|FG000|Overall Study|PSA progression with clinical progression|0|||
164083509|NCT02711956|592670190|FG001|Overall Study|PSA progression with clinical progression|0|||
164083510|NCT02711956|592670191|FG002|Overall Study|PSA progression with clinical progression|0|||
164083511|NCT02711956|592670192|FG003|Overall Study|PSA progression with clinical progression|0|||
164083512|NCT02711956|592670193|FG004|Overall Study|PSA progression with clinical progression|1|||
164083513|NCT02711956|592670194|FG005|Overall Study|PSA progression with clinical progression|0|||
164083514|NCT02711956|592670195|FG006|Overall Study|PSA progression with clinical progression|0|||
164083515|NCT02711956|592670196|FG007|Overall Study|PSA progression with clinical progression|0|||
164083516|NCT02711956|592670197|FG008|Overall Study|PSA progression with clinical progression|0|||
164083517|NCT02711956|592670198|FG009|Overall Study|PSA progression with clinical progression|0|||
164083518|NCT02711956|592670199|FG010|Overall Study|PSA progression with clinical progression|0|||
164083519|NCT02711956|592670200|FG011|Overall Study|PSA progression with clinical progression|0|||
164244399|NCT03230318|593263858|FG000|Overall Study|Other|3|||
164244400|NCT03230318|593263859|FG001|Overall Study|Other|7|||
164244401|NCT00075764|593263863|FG000|Overall Study|Adverse Event|5|||
164244402|NCT00075764|593263864|FG001|Overall Study|Adverse Event|12|||
164244403|NCT00075764|593263863|FG000|Overall Study|Death|4|||
164244404|NCT00075764|593263864|FG001|Overall Study|Death|8|||
164244405|NCT00075764|593263863|FG000|Overall Study|Withdrawal by Subject|28|||
164244406|NCT00075764|593263864|FG001|Overall Study|Withdrawal by Subject|18|||
164244407|NCT00075764|593263863|FG000|Overall Study|Progression|269|||
164244408|NCT00075764|593263864|FG001|Overall Study|Progression|274|||
164244409|NCT00075764|593263863|FG000|Overall Study|Still on treatment|8|||
164244410|NCT00075764|593263864|FG001|Overall Study|Still on treatment|15|||
164244411|NCT00075764|593263863|FG000|Overall Study|Delinquent|4|||
164244412|NCT00075764|593263864|FG001|Overall Study|Delinquent|2|||
164244413|NCT00075764|593263863|FG000|Overall Study|Not protocol specified|27|||
164244414|NCT00075764|593263864|FG001|Overall Study|Not protocol specified|19|||
164244415|NCT00075764|593263863|FG000|Overall Study|Under review|0|||
164244416|NCT00075764|593263864|FG001|Overall Study|Under review|1|||
164244417|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
164244418|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
164244419|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
164244420|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
164244421|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
164244422|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
164244423|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
164336993|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
164336994|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
164336995|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
164336996|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
164336997|NCT03841448|593609849|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
164336998|NCT03841448|593609850|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
164336999|NCT03841448|593609851|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
164337000|NCT03841448|593609852|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
164337001|NCT03896165|593609853|FG000|Overall Study|Withdrawal by Subject|2|||
164337002|NCT01163266|593609854|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
164337003|NCT01163266|593609855|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
164337004|NCT01163266|593609856|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
164337005|NCT01163266|593609854|FG000|Overall Study|Lack of Efficacy|1|||
164337006|NCT01163266|593609855|FG001|Overall Study|Lack of Efficacy|3|||
164337007|NCT01163266|593609856|FG002|Overall Study|Lack of Efficacy|1|||
164337008|NCT01163266|593609854|FG000|Overall Study|Noncompliance with Study Drug|0|||
164337009|NCT01163266|593609855|FG001|Overall Study|Noncompliance with Study Drug|2|||
164337010|NCT01163266|593609856|FG002|Overall Study|Noncompliance with Study Drug|0|||
164337011|NCT01163266|593609854|FG000|Overall Study|Protocol Deviations|2|||
164337012|NCT01163266|593609855|FG001|Overall Study|Protocol Deviations|2|||
164337013|NCT01163266|593609856|FG002|Overall Study|Protocol Deviations|5|||
164337014|NCT01163266|593609854|FG000|Overall Study|Withdrawal of Consent|5|||
164337015|NCT01163266|593609855|FG001|Overall Study|Withdrawal of Consent|7|||
164337016|NCT01163266|593609856|FG002|Overall Study|Withdrawal of Consent|3|||
164337017|NCT01163266|593609854|FG000|Overall Study|Lost to Follow-up|7|||
164337018|NCT01163266|593609855|FG001|Overall Study|Lost to Follow-up|7|||
164337019|NCT01163266|593609856|FG002|Overall Study|Lost to Follow-up|10|||
164337020|NCT01163266|593609854|FG000|Overall Study|Other|1|||
164337021|NCT01163266|593609855|FG001|Overall Study|Other|1|||
164337022|NCT01163266|593609856|FG002|Overall Study|Other|2|||
164337023|NCT02919696|593609857|FG000|Overall Study|Adverse Event|1|||
164337024|NCT02919696|593609858|FG001|Overall Study|Adverse Event|2|||
164337025|NCT02919696|593609857|FG000|Overall Study|Withdrawal by Subject|2|||
164337026|NCT02919696|593609858|FG001|Overall Study|Withdrawal by Subject|1|||
164337027|NCT02919696|593609857|FG000|Overall Study|Sponsor Decision|1|||
164337028|NCT02919696|593609858|FG001|Overall Study|Sponsor Decision|1|||
164337029|NCT02919696|593609857|FG000|Overall Study|Never Treated|0|||
164337030|NCT02919696|593609858|FG001|Overall Study|Never Treated|1|||
164337031|NCT03181893|593609859|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337032|NCT03181893|593609860|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
164337033|NCT03181893|593609861|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337034|NCT03181893|593609862|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337035|NCT03181893|593609863|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337036|NCT03181893|593609864|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337037|NCT03181893|593609865|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337038|NCT03181893|593609866|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337039|NCT03181893|593609867|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337040|NCT03181893|593609868|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337041|NCT03181893|593609869|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
164337042|NCT03181893|593609859|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
164337043|NCT03181893|593609860|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
164337044|NCT03181893|593609861|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337045|NCT03181893|593609862|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337046|NCT03181893|593609863|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164244424|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
164244425|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
164244426|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
164244427|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
164244428|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
164337047|NCT03181893|593609864|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337048|NCT03181893|593609865|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337049|NCT03181893|593609866|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337050|NCT03181893|593609867|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337051|NCT03181893|593609868|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337052|NCT03181893|593609869|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
164337053|NCT03181893|593609859|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337054|NCT03181893|593609860|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337055|NCT03181893|593609861|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337056|NCT03181893|593609862|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337057|NCT03181893|593609863|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337058|NCT03181893|593609864|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337059|NCT03181893|593609865|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337060|NCT03181893|593609866|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
164337061|NCT03181893|593609867|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
164337062|NCT03181893|593609868|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337063|NCT03181893|593609869|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
164337064|NCT03181893|593609859|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337065|NCT03181893|593609860|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337066|NCT03181893|593609861|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337067|NCT03181893|593609862|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337068|NCT03181893|593609863|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337069|NCT03181893|593609864|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337070|NCT03181893|593609865|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337071|NCT03181893|593609866|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337072|NCT03181893|593609867|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337073|NCT03181893|593609868|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
164337074|NCT03181893|593609869|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
164337075|NCT03181893|593609859|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337076|NCT03181893|593609860|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337077|NCT03181893|593609861|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337078|NCT03181893|593609862|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337079|NCT03181893|593609863|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337080|NCT03181893|593609864|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337081|NCT03181893|593609865|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337082|NCT03181893|593609866|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337083|NCT03181893|593609867|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337084|NCT03181893|593609868|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
164337085|NCT03181893|593609869|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
164337086|NCT04128371|593609870|FG000|Overall Study|Lack of Efficacy|1|||
164337087|NCT04815031|593609872|FG000|Overall Study|No adverse event information (missing information)|33|||
164337088|NCT01361568|593609875|FG000|Overall Study|Adverse Event|0|||
164337089|NCT01361568|593609876|FG001|Overall Study|Adverse Event|0|||
164337090|NCT01361568|593609877|FG002|Overall Study|Adverse Event|0|||
164337091|NCT01361568|593609878|FG003|Overall Study|Adverse Event|0|||
164337092|NCT01361568|593609879|FG004|Overall Study|Adverse Event|1|||
164337093|NCT01361568|593609880|FG005|Overall Study|Adverse Event|0|||
164337094|NCT01361568|593609875|FG000|Overall Study|Physician Decision|0|||
164337095|NCT01361568|593609876|FG001|Overall Study|Physician Decision|0|||
164337096|NCT01361568|593609877|FG002|Overall Study|Physician Decision|0|||
164337097|NCT01361568|593609878|FG003|Overall Study|Physician Decision|0|||
164337098|NCT01361568|593609879|FG004|Overall Study|Physician Decision|0|||
164337099|NCT01361568|593609880|FG005|Overall Study|Physician Decision|1|||
164337100|NCT01361568|593609875|FG000|Overall Study|Withdrawal by Subject|2|||
164337101|NCT01361568|593609876|FG001|Overall Study|Withdrawal by Subject|1|||
164337102|NCT01361568|593609877|FG002|Overall Study|Withdrawal by Subject|0|||
164337103|NCT01361568|593609878|FG003|Overall Study|Withdrawal by Subject|0|||
164337104|NCT01361568|593609879|FG004|Overall Study|Withdrawal by Subject|0|||
164337105|NCT01361568|593609880|FG005|Overall Study|Withdrawal by Subject|1|||
164337106|NCT00484094|593609881|FG000|Overall Study|Discontinued|39|||
164337107|NCT00484094|593609881|FG000|Overall Study|Other|3|||
163885714|NCT04938492|591952372|FG001|Overall Study|Lost to Follow-up|18|||
164337108|NCT03594994|593609882|FG000|Overall Study|Adverse Event|1|||
164337109|NCT03594994|593609883|FG001|Overall Study|Adverse Event|0|||
164337110|NCT03594994|593609882|FG000|Overall Study|Withdrawal by Subject|0|||
163885715|NCT04623671|591952373|FG000|Overall Study|Adverse Event|0|||
163885716|NCT04623671|591952374|FG001|Overall Study|Adverse Event|1|||
163885717|NCT04623671|591952373|FG000|Overall Study|Lost to Follow-up|2|||
164337111|NCT03594994|593609883|FG001|Overall Study|Withdrawal by Subject|1|||
163885718|NCT04623671|591952374|FG001|Overall Study|Lost to Follow-up|1|||
163885719|NCT04623671|591952373|FG000|Overall Study|Death|5|||
163990326|NCT05499520|592333027|FG005|Overall Study|Lost to Follow-up|0|||
163990327|NCT05499520|592333028|FG006|Overall Study|Lost to Follow-up|31|||
163990328|NCT05499520|592333029|FG007|Overall Study|Lost to Follow-up|45|||
164337112|NCT03308786|593609885|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
164337113|NCT00761631|593609886|FG000|Overall Study|Parent/legal guardian request|8|||
164337114|NCT00761631|593609887|FG001|Overall Study|Parent/legal guardian request|3|||
164337115|NCT00761631|593609888|FG002|Overall Study|Parent/legal guardian request|8|||
164337116|NCT00761631|593609889|FG003|Overall Study|Parent/legal guardian request|0|||
164337117|NCT00761631|593609890|FG004|Overall Study|Parent/legal guardian request|5|||
164337118|NCT00761631|593609891|FG005|Overall Study|Parent/legal guardian request|0|||
164337119|NCT00761631|593609886|FG000|Overall Study|Lost to Follow-up|2|||
164337120|NCT00761631|593609887|FG001|Overall Study|Lost to Follow-up|4|||
164337121|NCT00761631|593609888|FG002|Overall Study|Lost to Follow-up|7|||
164337122|NCT00761631|593609889|FG003|Overall Study|Lost to Follow-up|1|||
164337123|NCT00761631|593609890|FG004|Overall Study|Lost to Follow-up|6|||
164337124|NCT00761631|593609891|FG005|Overall Study|Lost to Follow-up|1|||
164337125|NCT00761631|593609886|FG000|Overall Study|Protocol Violation|2|||
164337126|NCT00761631|593609887|FG001|Overall Study|Protocol Violation|0|||
164337127|NCT00761631|593609888|FG002|Overall Study|Protocol Violation|0|||
164337128|NCT00761631|593609889|FG003|Overall Study|Protocol Violation|1|||
164337129|NCT00761631|593609890|FG004|Overall Study|Protocol Violation|5|||
164337130|NCT00761631|593609891|FG005|Overall Study|Protocol Violation|1|||
164337131|NCT00761631|593609886|FG000|Overall Study|Randomized, not treated|1|||
164337132|NCT00761631|593609887|FG001|Overall Study|Randomized, not treated|0|||
164337133|NCT00761631|593609888|FG002|Overall Study|Randomized, not treated|0|||
164337134|NCT00761631|593609889|FG003|Overall Study|Randomized, not treated|0|||
164337135|NCT00761631|593609890|FG004|Overall Study|Randomized, not treated|0|||
164337136|NCT00761631|593609891|FG005|Overall Study|Randomized, not treated|0|||
164337137|NCT00761631|593609886|FG000|Overall Study|Failed to return|1|||
164337138|NCT00761631|593609887|FG001|Overall Study|Failed to return|0|||
164337139|NCT00761631|593609888|FG002|Overall Study|Failed to return|1|||
164337140|NCT00761631|593609889|FG003|Overall Study|Failed to return|1|||
164337141|NCT00761631|593609890|FG004|Overall Study|Failed to return|5|||
164337142|NCT00761631|593609891|FG005|Overall Study|Failed to return|2|||
164337143|NCT00761631|593609886|FG000|Overall Study|Physician Decision|1|||
164337144|NCT00761631|593609887|FG001|Overall Study|Physician Decision|0|||
164337145|NCT00761631|593609888|FG002|Overall Study|Physician Decision|0|||
164337146|NCT00761631|593609889|FG003|Overall Study|Physician Decision|0|||
164337147|NCT00761631|593609890|FG004|Overall Study|Physician Decision|0|||
164337148|NCT00761631|593609891|FG005|Overall Study|Physician Decision|0|||
164337149|NCT00761631|593609886|FG000|Overall Study|Other|0|||
164337150|NCT00761631|593609887|FG001|Overall Study|Other|0|||
164337151|NCT00761631|593609888|FG002|Overall Study|Other|0|||
164337152|NCT00761631|593609889|FG003|Overall Study|Other|0|||
164337153|NCT00761631|593609890|FG004|Overall Study|Other|1|||
164337154|NCT00761631|593609891|FG005|Overall Study|Other|1|||
164337155|NCT00309985|593609892|FG000|Overall Study|Disease progression|12|||
164337156|NCT00309985|593609893|FG001|Overall Study|Disease progression|0|||
164337157|NCT00309985|593609892|FG000|Overall Study|Adverse Event|30|||
164337158|NCT00309985|593609893|FG001|Overall Study|Adverse Event|0|||
164337159|NCT00309985|593609892|FG000|Overall Study|Death|2|||
164337160|NCT00309985|593609893|FG001|Overall Study|Death|0|||
164337161|NCT00309985|593609892|FG000|Overall Study|Withdrawal by Subject|5|||
164337162|NCT00309985|593609893|FG001|Overall Study|Withdrawal by Subject|1|||
164337163|NCT00309985|593609892|FG000|Overall Study|Physician Decision|3|||
164337164|NCT00309985|593609893|FG001|Overall Study|Physician Decision|0|||
164337165|NCT00309985|593609892|FG000|Overall Study|Never started treatment|7|||
164337166|NCT00309985|593609893|FG001|Overall Study|Never started treatment|0|||
164337167|NCT00309985|593609892|FG000|Overall Study|Complicating disease|1|||
164337168|NCT00309985|593609893|FG001|Overall Study|Complicating disease|0|||
164337169|NCT00309985|593609892|FG000|Overall Study|Non-compliance|1|||
164337170|NCT00309985|593609893|FG001|Overall Study|Non-compliance|0|||
164337171|NCT00309985|593609892|FG000|Overall Study|Chemotherapy discontinued only|1|||
164337172|NCT00309985|593609893|FG001|Overall Study|Chemotherapy discontinued only|0|||
164337173|NCT03672643|593609894|FG000|Overall Study|Adverse Event|3|||
164337174|NCT03672643|593609894|FG000|Overall Study|Death|2|||
164337175|NCT03672643|593609894|FG000|Overall Study|Withdrawal by Subject|1|||
164337176|NCT03672643|593609894|FG000|Overall Study|Progressive disease|11|||
164337177|NCT03672643|593609894|FG000|Overall Study|Global deterioration of health status|1|||
164337178|NCT03672643|593609894|FG000|Overall Study|Refused further treatment|7|||
163990329|NCT05499520|592333030|FG008|Overall Study|Lost to Follow-up|42|||
163990330|NCT05499520|592333031|FG009|Overall Study|Lost to Follow-up|0|||
163990331|NCT05499520|592333032|FG010|Overall Study|Lost to Follow-up|0|||
163990332|NCT05499520|592333033|FG011|Overall Study|Lost to Follow-up|37|||
163990333|NCT05499520|592333034|FG012|Overall Study|Lost to Follow-up|53|||
163990334|NCT05499520|592333035|FG013|Overall Study|Lost to Follow-up|49|||
164244429|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
164244430|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
164244431|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
164244432|NCT01057693|593263866|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
164244433|NCT01057693|593263867|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
164244434|NCT01057693|593263868|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
164244435|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
164244436|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
164244437|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
164244438|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
164244439|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
164244440|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
164244441|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
164244442|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
164244443|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
164244444|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
164244445|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
164244446|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
164244447|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
164244448|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
164244449|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
164337179|NCT03672643|593609894|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
164337180|NCT01950390|593609895|FG000|Overall Study|Never started treatment|3|||
164337181|NCT01950390|593609896|FG001|Overall Study|Never started treatment|2|||
164337182|NCT01950390|593609895|FG000|Overall Study|Disease progression|45|||
164337183|NCT01950390|593609896|FG001|Overall Study|Disease progression|52|||
164337184|NCT01950390|593609895|FG000|Overall Study|Adverse Event|22|||
164337185|NCT01950390|593609896|FG001|Overall Study|Adverse Event|16|||
164337186|NCT01950390|593609895|FG000|Overall Study|Death|5|||
164337187|NCT01950390|593609896|FG001|Overall Study|Death|3|||
164337188|NCT01950390|593609895|FG000|Overall Study|Withdrawal by Subject|5|||
164337189|NCT01950390|593609896|FG001|Overall Study|Withdrawal by Subject|1|||
164337190|NCT01950390|593609895|FG000|Overall Study|Alternative therapy|0|||
164337191|NCT01950390|593609896|FG001|Overall Study|Alternative therapy|3|||
164337192|NCT01950390|593609895|FG000|Overall Study|Complicating disease|1|||
164337193|NCT01950390|593609896|FG001|Overall Study|Complicating disease|0|||
164337194|NCT01950390|593609895|FG000|Overall Study|On treatment|1|||
164337195|NCT01950390|593609896|FG001|Overall Study|On treatment|0|||
164337196|NCT01950390|593609895|FG000|Overall Study|Symptomatic deterioration|2|||
164337197|NCT01950390|593609896|FG001|Overall Study|Symptomatic deterioration|1|||
164337198|NCT01950390|593609895|FG000|Overall Study|Physician Decision|0|||
164337199|NCT01950390|593609896|FG001|Overall Study|Physician Decision|4|||
164337200|NCT01950390|593609895|FG000|Overall Study|Lack of clinical benefit|0|||
164244450|NCT01057693|593263866|FG000|Between Single-Blind and Double-Blind|Other|6|||
164244451|NCT01057693|593263867|FG001|Between Single-Blind and Double-Blind|Other|0|||
164244452|NCT01057693|593263868|FG002|Between Single-Blind and Double-Blind|Other|0|||
164244453|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
164244454|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
164244455|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
164244456|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
164244457|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
164244458|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
164337201|NCT01950390|593609896|FG001|Overall Study|Lack of clinical benefit|1|||
164337202|NCT01950390|593609895|FG000|Overall Study|Maintained PR and moved to observation only|0|||
164337203|NCT01950390|593609896|FG001|Overall Study|Maintained PR and moved to observation only|1|||
164337204|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Adverse Event|16|||
164337205|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Adverse Event|17|||
164337206|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Adverse Event|13|||
164337207|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Adverse Event|18|||
164337208|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Adverse Event|0|||
163990335|NCT05499520|592333036|FG014|Overall Study|Lost to Follow-up|0|||
164244459|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
164337209|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Adverse Event|0|||
164337210|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Adverse Event|0|||
164337211|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Adverse Event|0|||
164337212|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
164337213|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
164083520|NCT02711956|592670201|FG012|Overall Study|PSA progression with clinical progression|1|||
164083521|NCT02711956|592670202|FG013|Overall Study|PSA progression with clinical progression|1|||
164083522|NCT02711956|592670203|FG014|Overall Study|PSA progression with clinical progression|0|||
164083523|NCT02711956|592670189|FG000|Overall Study|PSA progression with radiographic progression|0|||
164083524|NCT02711956|592670190|FG001|Overall Study|PSA progression with radiographic progression|1|||
164083525|NCT02711956|592670191|FG002|Overall Study|PSA progression with radiographic progression|0|||
164083526|NCT02711956|592670192|FG003|Overall Study|PSA progression with radiographic progression|0|||
164244460|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
164244461|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
164244462|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
164244463|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
164244464|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
164244465|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
164244466|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
164244467|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
164244468|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
164244469|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
164244470|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
164244471|NCT01057693|593263866|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
164244472|NCT01057693|593263867|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
164244473|NCT01057693|593263868|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
164244474|NCT02959463|593263869|FG000|Overall Study|Adverse Event|1|||
164244475|NCT02959463|593263870|FG001|Overall Study|Adverse Event|1|||
164244476|NCT02959463|593263869|FG000|Overall Study|Death|1|||
164244477|NCT02959463|593263870|FG001|Overall Study|Death|0|||
164244478|NCT02959463|593263869|FG000|Overall Study|Withdrawal by Subject|1|||
164244479|NCT02959463|593263870|FG001|Overall Study|Withdrawal by Subject|0|||
164244480|NCT02413996|593263871|FG000|Overall Study|not comfortable with the intervention|9|||
164244481|NCT02413996|593263872|FG001|Overall Study|not comfortable with the intervention|2|||
164244482|NCT00709319|593263873|FG000|Overall Study|Death|4|||
164244483|NCT00709319|593263873|FG000|Overall Study|Withdrawal by Subject|2|||
164244484|NCT00090779|593263874|FG000|Step 1|Withdrawal by Subject|4|||
164244485|NCT00090779|593263875|FG001|Step 1|Withdrawal by Subject|2|||
164244486|NCT00090779|593263874|FG000|Step 1|Lost to Follow-up|3|||
164244487|NCT00090779|593263875|FG001|Step 1|Lost to Follow-up|2|||
164244488|NCT00090779|593263874|FG000|Step 1|Death|0|||
164244489|NCT00090779|593263875|FG001|Step 1|Death|2|||
164244490|NCT00090779|593263874|FG000|Step 1|Physician Decision|1|||
164244491|NCT00090779|593263875|FG001|Step 1|Physician Decision|0|||
164244492|NCT00090779|593263874|FG000|Step 1|Pregnancy|1|||
164244493|NCT00090779|593263875|FG001|Step 1|Pregnancy|0|||
164244494|NCT00090779|593263874|FG000|Step 1|Non-compliance to study requirements|0|||
164244495|NCT00090779|593263875|FG001|Step 1|Non-compliance to study requirements|1|||
164244496|NCT00090779|593263874|FG000|Step 1|Subject relocated|2|||
164244497|NCT00090779|593263875|FG001|Step 1|Subject relocated|8|||
164244498|NCT00090779|593263874|FG000|Step 2|Off study per study closure|6|||
164244499|NCT00090779|593263875|FG001|Step 2|Off study per study closure|16|||
164244500|NCT00090779|593263874|FG000|Step 2|Subject relocated|0|||
164244501|NCT00090779|593263875|FG001|Step 2|Subject relocated|1|||
164244502|NCT00090779|593263874|FG000|Step 2|Non-compliance to study requirements|0|||
164244503|NCT00090779|593263875|FG001|Step 2|Non-compliance to study requirements|1|||
164244504|NCT00090779|593263874|FG000|Step 3|Initiation of ART and off extended study|3|||
164244505|NCT00090779|593263875|FG001|Step 3|Initiation of ART and off extended study|2|||
164244506|NCT00090779|593263874|FG000|Step 3|Off extended study due to study closure|4|||
164244507|NCT00090779|593263875|FG001|Step 3|Off extended study due to study closure|3|||
164244508|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
164244509|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
164244510|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
164244511|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
164244512|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
164244513|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
164244514|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
164244515|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
164244516|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
164244517|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
164244518|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
164244519|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
164244520|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
164244521|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
164337214|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
164337215|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
164337216|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337217|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337218|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337219|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
164337220|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
164337221|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
164337222|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
164337223|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
164337224|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
164337225|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
164337226|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
164337227|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
164337228|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
164337229|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
164337230|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
164337231|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
164337232|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337233|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337234|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337235|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
164337236|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
164337237|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337238|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
164337239|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
164337240|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337241|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337242|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337243|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
164337244|NCT02975336|593611487|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
164337245|NCT02975336|593611488|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
164337246|NCT02975336|593611489|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
164337247|NCT02975336|593611490|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
164337248|NCT02975336|593611491|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
164337249|NCT02975336|593611492|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
164337250|NCT02975336|593611493|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
164337251|NCT02975336|593611494|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
164337252|NCT02975336|593611487|FG000|LTE (104 Weeks)|Adverse Event|0|||
164337253|NCT02975336|593611488|FG001|LTE (104 Weeks)|Adverse Event|0|||
164337254|NCT02975336|593611489|FG002|LTE (104 Weeks)|Adverse Event|0|||
164337255|NCT02975336|593611490|FG003|LTE (104 Weeks)|Adverse Event|0|||
164337256|NCT02975336|593611491|FG004|LTE (104 Weeks)|Adverse Event|7|||
164337257|NCT02975336|593611492|FG005|LTE (104 Weeks)|Adverse Event|4|||
164337258|NCT02975336|593611493|FG006|LTE (104 Weeks)|Adverse Event|2|||
164337259|NCT02975336|593611494|FG007|LTE (104 Weeks)|Adverse Event|0|||
164337260|NCT02975336|593611487|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
164337261|NCT02975336|593611488|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
164337262|NCT02975336|593611489|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
164337263|NCT02975336|593611490|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
164337264|NCT02975336|593611491|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
164337265|NCT02975336|593611492|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
164337266|NCT02975336|593611493|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
164337267|NCT02975336|593611494|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
164337268|NCT02975336|593611487|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
164337269|NCT02975336|593611488|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
164337270|NCT02975336|593611489|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
164337271|NCT02975336|593611490|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
164337272|NCT02975336|593611491|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
164337273|NCT02975336|593611492|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
164337274|NCT02975336|593611493|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
164337275|NCT02975336|593611494|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
164337276|NCT02975336|593611487|FG000|LTE (104 Weeks)|Other|0|||
164083527|NCT02711956|592670193|FG004|Overall Study|PSA progression with radiographic progression|0|||
164337277|NCT02975336|593611488|FG001|LTE (104 Weeks)|Other|0|||
164337278|NCT02975336|593611489|FG002|LTE (104 Weeks)|Other|0|||
164337279|NCT02975336|593611490|FG003|LTE (104 Weeks)|Other|0|||
164337280|NCT02975336|593611491|FG004|LTE (104 Weeks)|Other|55|||
164337281|NCT02975336|593611492|FG005|LTE (104 Weeks)|Other|63|||
164337282|NCT02975336|593611493|FG006|LTE (104 Weeks)|Other|76|||
164337283|NCT02975336|593611494|FG007|LTE (104 Weeks)|Other|72|||
164337284|NCT02008318|593611497|FG000|Overall Study|Adverse Event|4|||
164337285|NCT02008318|593611498|FG001|Overall Study|Adverse Event|0|||
164337286|NCT02008318|593611497|FG000|Overall Study|Physician Decision|2|||
164337287|NCT02008318|593611498|FG001|Overall Study|Physician Decision|0|||
164337288|NCT02008318|593611497|FG000|Overall Study|Progressive Disease|2|||
164337289|NCT02008318|593611498|FG001|Overall Study|Progressive Disease|0|||
164337290|NCT02008318|593611497|FG000|Overall Study|Protocol Violation|1|||
164337291|NCT02008318|593611498|FG001|Overall Study|Protocol Violation|1|||
164337292|NCT02008318|593611497|FG000|Overall Study|Withdrawal by Subject|3|||
164337293|NCT02008318|593611498|FG001|Overall Study|Withdrawal by Subject|0|||
164337294|NCT02281773|593611499|FG000|Overall Study|Adverse Event|6|||
164337295|NCT02281773|593611500|FG001|Overall Study|Adverse Event|1|||
164337296|NCT02281773|593611501|FG002|Overall Study|Adverse Event|4|||
164337297|NCT02281773|593611502|FG003|Overall Study|Adverse Event|8|||
164337298|NCT02281773|593611503|FG004|Overall Study|Adverse Event|9|||
164337299|NCT02281773|593611499|FG000|Overall Study|Protocol Violation|1|||
164337300|NCT02281773|593611500|FG001|Overall Study|Protocol Violation|0|||
164337301|NCT02281773|593611501|FG002|Overall Study|Protocol Violation|0|||
164337302|NCT02281773|593611502|FG003|Overall Study|Protocol Violation|2|||
164337303|NCT02281773|593611503|FG004|Overall Study|Protocol Violation|2|||
164337304|NCT02281773|593611499|FG000|Overall Study|Lost to Follow-up|2|||
164337305|NCT02281773|593611500|FG001|Overall Study|Lost to Follow-up|2|||
164337306|NCT02281773|593611501|FG002|Overall Study|Lost to Follow-up|6|||
164337307|NCT02281773|593611502|FG003|Overall Study|Lost to Follow-up|2|||
164337308|NCT02281773|593611503|FG004|Overall Study|Lost to Follow-up|10|||
164337309|NCT02281773|593611499|FG000|Overall Study|Withdrawal by Subject|2|||
164337310|NCT02281773|593611500|FG001|Overall Study|Withdrawal by Subject|8|||
164337311|NCT02281773|593611501|FG002|Overall Study|Withdrawal by Subject|6|||
164337312|NCT02281773|593611502|FG003|Overall Study|Withdrawal by Subject|6|||
164337313|NCT02281773|593611503|FG004|Overall Study|Withdrawal by Subject|8|||
164337314|NCT02281773|593611499|FG000|Overall Study|Other Reason|0|||
164337315|NCT02281773|593611500|FG001|Overall Study|Other Reason|4|||
164337316|NCT02281773|593611501|FG002|Overall Study|Other Reason|2|||
164337317|NCT02281773|593611502|FG003|Overall Study|Other Reason|3|||
164337318|NCT02281773|593611503|FG004|Overall Study|Other Reason|1|||
164337319|NCT00385762|593611504|FG000|Overall Study|Adverse Event|1|||
164337320|NCT00385762|593611504|FG000|Overall Study|Lost to Follow-up|1|||
164337321|NCT01147640|593611522|FG000|Overall Study|Adverse Event|2|||
164337322|NCT01147640|593611523|FG001|Overall Study|Adverse Event|0|||
164337323|NCT01147640|593611522|FG000|Overall Study|Physician Decision|1|||
164337324|NCT01147640|593611523|FG001|Overall Study|Physician Decision|0|||
164337325|NCT01147640|593611522|FG000|Overall Study|Withdrawal by Subject|1|||
164337326|NCT01147640|593611523|FG001|Overall Study|Withdrawal by Subject|0|||
164337327|NCT01147640|593611522|FG000|Overall Study|Lost to Follow-up|0|||
164337328|NCT01147640|593611523|FG001|Overall Study|Lost to Follow-up|1|||
164337329|NCT01147640|593611522|FG000|Overall Study|Didn't meet eligibility criteria|1|||
164337330|NCT01147640|593611523|FG001|Overall Study|Didn't meet eligibility criteria|0|||
164337331|NCT01856907|593611526|FG000|Overall Study|Pregnancy|0|||
164337332|NCT01856907|593611527|FG001|Overall Study|Pregnancy|1|||
164337333|NCT01856907|593611528|FG002|Overall Study|Pregnancy|0|||
164337334|NCT01856907|593611526|FG000|Overall Study|Pregnancy|0|||
164337335|NCT01856907|593611527|FG001|Overall Study|Pregnancy|1|||
164337336|NCT01856907|593611528|FG002|Overall Study|Pregnancy|0|||
164337337|NCT01856907|593611526|FG000|Overall Study|Withdrawal by Subject|0|||
164337338|NCT01856907|593611527|FG001|Overall Study|Withdrawal by Subject|1|||
164337339|NCT01856907|593611528|FG002|Overall Study|Withdrawal by Subject|0|||
164337340|NCT00091442|593611529|FG000|Overall Study|Progressive Disease|220|||
164337341|NCT00091442|593611530|FG001|Overall Study|Progressive Disease|189|||
164337342|NCT00091442|593611529|FG000|Overall Study|Physician Decision|61|||
164337343|NCT00091442|593611530|FG001|Overall Study|Physician Decision|58|||
164337344|NCT00091442|593611529|FG000|Overall Study|Withdrawal by Subject|38|||
164337345|NCT00091442|593611530|FG001|Overall Study|Withdrawal by Subject|46|||
164337346|NCT00091442|593611529|FG000|Overall Study|Adverse Event|29|||
164337347|NCT00091442|593611530|FG001|Overall Study|Adverse Event|48|||
164337348|NCT00091442|593611529|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
164337349|NCT00091442|593611530|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
164337350|NCT00091442|593611529|FG000|Overall Study|Death|9|||
164337351|NCT00091442|593611530|FG001|Overall Study|Death|7|||
164337352|NCT00091442|593611529|FG000|Overall Study|Lost to Follow-up|1|||
164337353|NCT00091442|593611530|FG001|Overall Study|Lost to Follow-up|3|||
164337354|NCT00091442|593611529|FG000|Overall Study|Other|2|||
164337355|NCT00091442|593611530|FG001|Overall Study|Other|6|||
164337356|NCT00986830|593611533|FG000|Overall Study|Death|1|||
164337357|NCT00986830|593611533|FG000|Overall Study|Lost to Follow-up|1|||
164337358|NCT00986830|593611533|FG000|Overall Study|Lack of Efficacy|1|||
164337359|NCT00986830|593611533|FG000|Overall Study|Unable to access sinus with device|5|||
164337360|NCT00845858|593611534|FG000|Overall Study|Withdrawal by Subject|5|||
164337361|NCT00845858|593611535|FG001|Overall Study|Withdrawal by Subject|1|||
164337362|NCT00845858|593611536|FG002|Overall Study|Withdrawal by Subject|1|||
164337363|NCT00845858|593611534|FG000|Overall Study|Adverse Event|3|||
164337364|NCT00845858|593611535|FG001|Overall Study|Adverse Event|8|||
164337365|NCT00845858|593611536|FG002|Overall Study|Adverse Event|4|||
164337366|NCT00845858|593611534|FG000|Overall Study|Protocol Violation|0|||
164337367|NCT00845858|593611535|FG001|Overall Study|Protocol Violation|0|||
164337368|NCT00845858|593611536|FG002|Overall Study|Protocol Violation|1|||
164337369|NCT00845858|593611534|FG000|Overall Study|not eligible|0|||
164337370|NCT00845858|593611535|FG001|Overall Study|not eligible|3|||
164337371|NCT00845858|593611536|FG002|Overall Study|not eligible|2|||
164337372|NCT01436396|593611537|FG000|Overall Study|Protocol Violation|7|||
164337373|NCT01436396|593611538|FG001|Overall Study|Protocol Violation|5|||
164337374|NCT01436396|593611537|FG000|Overall Study|Adverse Event|1|||
164337375|NCT01436396|593611538|FG001|Overall Study|Adverse Event|2|||
164337376|NCT01436396|593611537|FG000|Overall Study|Withdrawal by Subject|19|||
164337377|NCT01436396|593611538|FG001|Overall Study|Withdrawal by Subject|29|||
164337378|NCT01436396|593611537|FG000|Overall Study|Serious adverse event|2|||
164337379|NCT01436396|593611538|FG001|Overall Study|Serious adverse event|3|||
164337380|NCT01436396|593611537|FG000|Overall Study|Lost to Follow-up|3|||
164337381|NCT01436396|593611538|FG001|Overall Study|Lost to Follow-up|3|||
164337382|NCT04674644|593611540|FG000|Overall Study|with missing data|37|||
164337383|NCT03469934|593611541|FG000|Overall Study|Withdrawal by Subject|0|||
164337384|NCT03469934|593611542|FG001|Overall Study|Withdrawal by Subject|1|||
164337385|NCT01024231|593611544|FG000|Overall Study|Other Reasons|1|||
164337386|NCT01024231|593611545|FG001|Overall Study|Other Reasons|2|||
164337387|NCT01024231|593611546|FG002|Overall Study|Other Reasons|0|||
164337388|NCT01024231|593611547|FG003|Overall Study|Other Reasons|0|||
164337389|NCT01024231|593611548|FG004|Overall Study|Other Reasons|2|||
164337390|NCT01024231|593611549|FG005|Overall Study|Other Reasons|0|||
164337391|NCT01024231|593611550|FG006|Overall Study|Other Reasons|1|||
164337392|NCT01024231|593611544|FG000|Overall Study|Maximum Clinical Benefit|1|||
164337393|NCT01024231|593611545|FG001|Overall Study|Maximum Clinical Benefit|2|||
164337394|NCT01024231|593611546|FG002|Overall Study|Maximum Clinical Benefit|0|||
164337395|NCT01024231|593611547|FG003|Overall Study|Maximum Clinical Benefit|1|||
164337396|NCT01024231|593611548|FG004|Overall Study|Maximum Clinical Benefit|1|||
164337397|NCT01024231|593611549|FG005|Overall Study|Maximum Clinical Benefit|0|||
164337398|NCT01024231|593611550|FG006|Overall Study|Maximum Clinical Benefit|0|||
164337399|NCT01024231|593611544|FG000|Overall Study|Disease Progression|3|||
164337400|NCT01024231|593611545|FG001|Overall Study|Disease Progression|1|||
164337401|NCT01024231|593611546|FG002|Overall Study|Disease Progression|3|||
164337402|NCT01024231|593611547|FG003|Overall Study|Disease Progression|0|||
164337403|NCT01024231|593611548|FG004|Overall Study|Disease Progression|4|||
164337404|NCT01024231|593611549|FG005|Overall Study|Disease Progression|11|||
164337405|NCT01024231|593611550|FG006|Overall Study|Disease Progression|6|||
164337406|NCT01024231|593611544|FG000|Overall Study|AE unrelated to Study Drug|0|||
164337407|NCT01024231|593611545|FG001|Overall Study|AE unrelated to Study Drug|1|||
164337408|NCT01024231|593611546|FG002|Overall Study|AE unrelated to Study Drug|0|||
164337409|NCT01024231|593611547|FG003|Overall Study|AE unrelated to Study Drug|0|||
164337410|NCT01024231|593611548|FG004|Overall Study|AE unrelated to Study Drug|0|||
164337411|NCT01024231|593611549|FG005|Overall Study|AE unrelated to Study Drug|0|||
164337412|NCT01024231|593611550|FG006|Overall Study|AE unrelated to Study Drug|0|||
164337413|NCT01024231|593611544|FG000|Overall Study|No longer meets criteria|0|||
164337414|NCT01024231|593611545|FG001|Overall Study|No longer meets criteria|0|||
164337415|NCT01024231|593611546|FG002|Overall Study|No longer meets criteria|0|||
164337416|NCT01024231|593611547|FG003|Overall Study|No longer meets criteria|0|||
164337417|NCT01024231|593611548|FG004|Overall Study|No longer meets criteria|1|||
164337418|NCT01024231|593611549|FG005|Overall Study|No longer meets criteria|0|||
164337419|NCT01024231|593611550|FG006|Overall Study|No longer meets criteria|1|||
164337420|NCT01024231|593611544|FG000|Overall Study|Study Drug Toxicity|1|||
164337421|NCT01024231|593611545|FG001|Overall Study|Study Drug Toxicity|6|||
164337422|NCT01024231|593611546|FG002|Overall Study|Study Drug Toxicity|6|||
164337423|NCT01024231|593611547|FG003|Overall Study|Study Drug Toxicity|4|||
164337424|NCT01024231|593611548|FG004|Overall Study|Study Drug Toxicity|2|||
163885720|NCT04623671|591952374|FG001|Overall Study|Death|5|||
164083528|NCT02711956|592670194|FG005|Overall Study|PSA progression with radiographic progression|2|||
164337425|NCT01024231|593611549|FG005|Overall Study|Study Drug Toxicity|0|||
164337426|NCT01024231|593611550|FG006|Overall Study|Study Drug Toxicity|7|||
164337427|NCT01024231|593611544|FG000|Overall Study|Death|6|||
164337428|NCT01024231|593611545|FG001|Overall Study|Death|2|||
164337429|NCT01024231|593611546|FG002|Overall Study|Death|1|||
164337430|NCT01024231|593611547|FG003|Overall Study|Death|0|||
164337431|NCT01024231|593611548|FG004|Overall Study|Death|4|||
164337432|NCT01024231|593611549|FG005|Overall Study|Death|3|||
164337433|NCT01024231|593611550|FG006|Overall Study|Death|5|||
164337434|NCT01024231|593611544|FG000|Overall Study|Lost to Follow-up|0|||
164337435|NCT01024231|593611545|FG001|Overall Study|Lost to Follow-up|0|||
164337436|NCT01024231|593611546|FG002|Overall Study|Lost to Follow-up|0|||
164337437|NCT01024231|593611547|FG003|Overall Study|Lost to Follow-up|0|||
164337438|NCT01024231|593611548|FG004|Overall Study|Lost to Follow-up|0|||
164337439|NCT01024231|593611549|FG005|Overall Study|Lost to Follow-up|0|||
164337440|NCT01024231|593611550|FG006|Overall Study|Lost to Follow-up|1|||
164337441|NCT01024231|593611544|FG000|Overall Study|Withdrew Consent|0|||
164337442|NCT01024231|593611545|FG001|Overall Study|Withdrew Consent|1|||
164337443|NCT01024231|593611546|FG002|Overall Study|Withdrew Consent|0|||
164337444|NCT01024231|593611547|FG003|Overall Study|Withdrew Consent|0|||
163885721|NCT03448107|591952375|FG000|Overall Study|Lost to Follow-up|229|||
163885722|NCT03448107|591952376|FG001|Overall Study|Lost to Follow-up|258|||
163885723|NCT04025554|591952377|FG000|Overall Study|Adverse Event|3|||
163885724|NCT01802788|591952378|FG000|Overall Study|Withdrawal by Subject|102|||
163885725|NCT01802788|591952379|FG001|Overall Study|Withdrawal by Subject|5|||
163885726|NCT01802788|591952378|FG000|Overall Study|Death|382|||
164337445|NCT01024231|593611548|FG004|Overall Study|Withdrew Consent|0|||
164337446|NCT01024231|593611549|FG005|Overall Study|Withdrew Consent|0|||
163885727|NCT01802788|591952379|FG001|Overall Study|Death|18|||
164337447|NCT01024231|593611550|FG006|Overall Study|Withdrew Consent|0|||
164337448|NCT01024231|593611544|FG000|Overall Study|Continuing on Treatment|0|||
164337449|NCT01024231|593611545|FG001|Overall Study|Continuing on Treatment|0|||
164337450|NCT01024231|593611546|FG002|Overall Study|Continuing on Treatment|0|||
164337451|NCT01024231|593611547|FG003|Overall Study|Continuing on Treatment|0|||
164337452|NCT01024231|593611548|FG004|Overall Study|Continuing on Treatment|3|||
164337453|NCT01024231|593611549|FG005|Overall Study|Continuing on Treatment|2|||
164337454|NCT01024231|593611550|FG006|Overall Study|Continuing on Treatment|0|||
164337455|NCT02761733|593611552|FG000|Overall Study|Death|3|||
164337456|NCT02761733|593611553|FG001|Overall Study|Death|5|||
164337457|NCT02761733|593611554|FG002|Overall Study|Death|1|||
164337458|NCT02761733|593611555|FG003|Overall Study|Death|1|||
164337459|NCT02761733|593611552|FG000|Overall Study|Lost to Follow-up|6|||
164337460|NCT02761733|593611553|FG001|Overall Study|Lost to Follow-up|7|||
164337461|NCT02761733|593611554|FG002|Overall Study|Lost to Follow-up|0|||
164337462|NCT02761733|593611555|FG003|Overall Study|Lost to Follow-up|3|||
164337463|NCT02761733|593611552|FG000|Overall Study|Physician Decision|4|||
164337464|NCT02761733|593611553|FG001|Overall Study|Physician Decision|0|||
164337465|NCT02761733|593611554|FG002|Overall Study|Physician Decision|0|||
164337466|NCT02761733|593611555|FG003|Overall Study|Physician Decision|0|||
164337467|NCT02761733|593611552|FG000|Overall Study|Withdrawal by Subject|2|||
164337468|NCT02761733|593611553|FG001|Overall Study|Withdrawal by Subject|0|||
164337469|NCT02761733|593611554|FG002|Overall Study|Withdrawal by Subject|0|||
164337470|NCT02761733|593611555|FG003|Overall Study|Withdrawal by Subject|0|||
164337471|NCT02761733|593611552|FG000|Overall Study|Discharged from Study Site|10|||
164337472|NCT02761733|593611553|FG001|Overall Study|Discharged from Study Site|9|||
164337473|NCT02761733|593611554|FG002|Overall Study|Discharged from Study Site|25|||
164337474|NCT02761733|593611555|FG003|Overall Study|Discharged from Study Site|11|||
164337475|NCT02761733|593611552|FG000|Overall Study|Cognitive Impairment|5|||
164337476|NCT02761733|593611553|FG001|Overall Study|Cognitive Impairment|0|||
164337477|NCT02761733|593611554|FG002|Overall Study|Cognitive Impairment|1|||
164337478|NCT02761733|593611555|FG003|Overall Study|Cognitive Impairment|0|||
164337479|NCT00669396|593611556|FG000|Overall Study|Lost to Follow-up|10|||
164337480|NCT00669396|593611557|FG001|Overall Study|Lost to Follow-up|12|||
164337481|NCT01262573|593611558|FG000|Overall Study|Withdrawal by Subject|0|||
164337482|NCT01262573|593611559|FG001|Overall Study|Withdrawal by Subject|1|||
164337483|NCT00810693|593611562|FG000|Treatment Period|Adverse Event|8|||
164337484|NCT00810693|593611563|FG001|Treatment Period|Adverse Event|1|||
164337485|NCT00810693|593611564|FG002|Treatment Period|Adverse Event|7|||
164337486|NCT00810693|593611562|FG000|Treatment Period|Death|0|||
164337487|NCT00810693|593611563|FG001|Treatment Period|Death|1|||
164337488|NCT00810693|593611564|FG002|Treatment Period|Death|2|||
164337489|NCT00810693|593611562|FG000|Treatment Period|Lack of Efficacy|0|||
164337490|NCT00810693|593611563|FG001|Treatment Period|Lack of Efficacy|0|||
164337491|NCT00810693|593611564|FG002|Treatment Period|Lack of Efficacy|1|||
164337492|NCT00810693|593611562|FG000|Treatment Period|Lost to Follow-up|1|||
164337493|NCT00810693|593611563|FG001|Treatment Period|Lost to Follow-up|0|||
164337494|NCT00810693|593611564|FG002|Treatment Period|Lost to Follow-up|0|||
164337495|NCT00810693|593611562|FG000|Treatment Period|Non-compliance|1|||
164337496|NCT00810693|593611563|FG001|Treatment Period|Non-compliance|0|||
164337497|NCT00810693|593611564|FG002|Treatment Period|Non-compliance|0|||
164337498|NCT00810693|593611562|FG000|Treatment Period|Protocol Violation|1|||
164337499|NCT00810693|593611563|FG001|Treatment Period|Protocol Violation|2|||
163885728|NCT01802788|591952378|FG000|Overall Study|Lost to Follow-up|31|||
163885729|NCT01802788|591952379|FG001|Overall Study|Lost to Follow-up|2|||
164337500|NCT00810693|593611564|FG002|Treatment Period|Protocol Violation|2|||
164337501|NCT00810693|593611562|FG000|Treatment Period|Withdrawal by Subject|6|||
164337502|NCT00810693|593611563|FG001|Treatment Period|Withdrawal by Subject|2|||
164337503|NCT00810693|593611564|FG002|Treatment Period|Withdrawal by Subject|3|||
164337504|NCT00810693|593611562|FG000|Treatment Period|Not treated|0|||
164337505|NCT00810693|593611563|FG001|Treatment Period|Not treated|1|||
163885730|NCT01802788|591952378|FG000|Overall Study|Physician Decision|3|||
163885731|NCT01802788|591952379|FG001|Overall Study|Physician Decision|0|||
164337506|NCT00810693|593611564|FG002|Treatment Period|Not treated|1|||
164337507|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Adverse Event|3|||
164337508|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Adverse Event|1|||
164337509|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Adverse Event|1|||
164337510|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Death|2|||
164337511|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Death|0|||
163885732|NCT01802788|591952378|FG000|Overall Study|Patient Non-Compliance|1|||
163885733|NCT01802788|591952379|FG001|Overall Study|Patient Non-Compliance|0|||
163885734|NCT01802788|591952378|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
164244522|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
164244523|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
164244524|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
164244525|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
164244526|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
164244527|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
164244528|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
164244529|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
164244530|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
164244531|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
164244532|NCT01672879|593263878|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
164244533|NCT01672879|593263879|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
164244534|NCT01672879|593263880|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
164244535|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
164244536|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
164244537|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
164244538|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
164244539|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
164244540|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
164244541|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
164244542|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
164244543|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
164244544|NCT01672879|593263878|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
164244545|NCT01672879|593263879|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
164244546|NCT01672879|593263880|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
164244547|NCT03951766|593263889|FG000|Treatment Phase|Lost to Follow-up|1|||
164244548|NCT03951766|593263889|FG000|Follow-up Phase|Lost to Follow-up|10|||
164244549|NCT00041470|593263890|FG000|Overall Study|Loss of Funding|38|||
164244550|NCT04158375|593263895|FG000|Overall Study|Withdrawal by Subject|0|||
164244551|NCT04158375|593263896|FG001|Overall Study|Withdrawal by Subject|3|||
164244552|NCT04158375|593263897|FG002|Overall Study|Withdrawal by Subject|0|||
164244553|NCT04847843|593263898|FG000|Overall Study|Scheduling Conflicts|6|||
164244554|NCT04847843|593263899|FG001|Overall Study|Scheduling Conflicts|9|||
164244555|NCT04847843|593263898|FG000|Overall Study|Withdrawal by Subject|1|||
164244556|NCT04847843|593263899|FG001|Overall Study|Withdrawal by Subject|0|||
164244557|NCT04847843|593263898|FG000|Overall Study|Lost to Follow-up|1|||
164244558|NCT04847843|593263899|FG001|Overall Study|Lost to Follow-up|1|||
164244559|NCT04847843|593263898|FG000|Overall Study|Pregnancy|0|||
164244560|NCT04847843|593263899|FG001|Overall Study|Pregnancy|2|||
164244561|NCT04847843|593263898|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
164244562|NCT04847843|593263899|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
164244563|NCT02734004|593263900|FG000|Overall Study|Death|36|||
164244564|NCT02734004|593263901|FG001|Overall Study|Death|24|||
164244565|NCT02734004|593263902|FG002|Overall Study|Death|26|||
164244566|NCT02734004|593263903|FG003|Overall Study|Death|35|||
164244567|NCT02734004|593263904|FG004|Overall Study|Death|13|||
164244568|NCT02734004|593263905|FG005|Overall Study|Death|17|||
164244569|NCT02734004|593263906|FG006|Overall Study|Death|20|||
164244570|NCT02734004|593263900|FG000|Overall Study|Lost to Follow-up|1|||
164244571|NCT02734004|593263901|FG001|Overall Study|Lost to Follow-up|1|||
164244572|NCT02734004|593263902|FG002|Overall Study|Lost to Follow-up|0|||
164244573|NCT02734004|593263903|FG003|Overall Study|Lost to Follow-up|0|||
164244574|NCT02734004|593263904|FG004|Overall Study|Lost to Follow-up|1|||
164244575|NCT02734004|593263905|FG005|Overall Study|Lost to Follow-up|0|||
164244576|NCT02734004|593263906|FG006|Overall Study|Lost to Follow-up|0|||
164244577|NCT02734004|593263900|FG000|Overall Study|Withdrawal by Subject|3|||
164244578|NCT02734004|593263901|FG001|Overall Study|Withdrawal by Subject|1|||
164244579|NCT02734004|593263902|FG002|Overall Study|Withdrawal by Subject|1|||
164244580|NCT02734004|593263903|FG003|Overall Study|Withdrawal by Subject|1|||
164244581|NCT02734004|593263904|FG004|Overall Study|Withdrawal by Subject|3|||
164244582|NCT02734004|593263905|FG005|Overall Study|Withdrawal by Subject|0|||
164244583|NCT02734004|593263906|FG006|Overall Study|Withdrawal by Subject|2|||
164244584|NCT02734004|593263900|FG000|Overall Study|Other|0|||
164244585|NCT02734004|593263901|FG001|Overall Study|Other|8|||
164244586|NCT02734004|593263902|FG002|Overall Study|Other|7|||
164244587|NCT02734004|593263903|FG003|Overall Study|Other|4|||
164244588|NCT02734004|593263904|FG004|Overall Study|Other|34|||
164244589|NCT02734004|593263905|FG005|Overall Study|Other|14|||
164244590|NCT02734004|593263906|FG006|Overall Study|Other|10|||
164244591|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
164244592|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
164244593|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
164244594|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
164244595|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
164244596|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
164244597|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
164244598|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
164244599|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
164244600|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
164244601|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
164244602|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
164244603|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
164244604|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
164244605|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
164244606|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
163885735|NCT01802788|591952379|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
164244607|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
164244608|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
164244609|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
163885736|NCT01802788|591952378|FG000|Overall Study|Other Reasons|19|||
163885737|NCT01802788|591952379|FG001|Overall Study|Other Reasons|0|||
163885738|NCT01648023|591952382|FG000|Overall Study|Screen Fail Post Randomization|1|||
164244610|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
164244611|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
164244612|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
164244613|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
164244614|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
164244615|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Other|6|||
164244616|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Other|0|||
164244617|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Other|0|||
164244618|NCT05615220|593263907|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
164244619|NCT05615220|593263908|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
164244620|NCT05615220|593263909|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
164244621|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
164244622|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
164244623|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
164244624|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
164244625|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
164244626|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
164244627|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
164244628|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
164244629|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
164244630|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
164244631|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
164244632|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
164244633|NCT05615220|593263907|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
164244634|NCT05615220|593263908|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
164244635|NCT05615220|593263909|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
164244636|NCT01459666|593263911|FG000|Overall Study|PI left institution|5|||
164244637|NCT01459666|593263912|FG001|Overall Study|PI left institution|4|||
164337512|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Death|1|||
164337513|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
164337514|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
164337515|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
164337516|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
164337517|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
163885739|NCT01648023|591952383|FG001|Overall Study|Screen Fail Post Randomization|2|||
163885740|NCT00764751|591952388|FG000|Overall Study|Adverse Event|1|||
163885741|NCT00764751|591952389|FG001|Overall Study|Adverse Event|1|||
163885742|NCT00764751|591952388|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
163885743|NCT00764751|591952389|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
163885744|NCT05296525|591952393|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
163885745|NCT05296525|591952394|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
163885746|NCT05296525|591952395|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
163885747|NCT05296525|591952396|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
163885748|NCT04830800|591952397|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
164244638|NCT01061385|593263913|FG000|Overall Study|Lost to Follow-up|1|||
164244639|NCT01061385|593263914|FG001|Overall Study|Lost to Follow-up|0|||
164244640|NCT01061385|593263913|FG000|Overall Study|subject decision not related to AE|0|||
164244641|NCT01061385|593263914|FG001|Overall Study|subject decision not related to AE|1|||
164244642|NCT00533429|593263916|FG000|Overall Study|Adverse Event|3|||
164244643|NCT00533429|593263917|FG001|Overall Study|Adverse Event|1|||
164244644|NCT00533429|593263916|FG000|Overall Study|Death|1|||
164244645|NCT00533429|593263917|FG001|Overall Study|Death|0|||
164244646|NCT00533429|593263916|FG000|Overall Study|Withdrawal by Subject|2|||
164244647|NCT00533429|593263917|FG001|Overall Study|Withdrawal by Subject|0|||
164244648|NCT00533429|593263916|FG000|Overall Study|Progressive Disease|12|||
164244649|NCT00533429|593263917|FG001|Overall Study|Progressive Disease|13|||
164244650|NCT00533429|593263916|FG000|Overall Study|Symptomatic deterioration|1|||
164244651|NCT00533429|593263917|FG001|Overall Study|Symptomatic deterioration|2|||
164244652|NCT02379052|593263929|FG000|Overall Study|Protocol Violation|0|||
164244653|NCT02379052|593263930|FG001|Overall Study|Protocol Violation|1|||
164244654|NCT02379052|593263929|FG000|Overall Study|Adverse Event|0|||
164244655|NCT02379052|593263930|FG001|Overall Study|Adverse Event|1|||
164244656|NCT02379052|593263929|FG000|Overall Study|Physician Decision|1|||
164244657|NCT02379052|593263930|FG001|Overall Study|Physician Decision|1|||
164244658|NCT02379052|593263929|FG000|Overall Study|Withdrawal by Subject|2|||
164244659|NCT02379052|593263930|FG001|Overall Study|Withdrawal by Subject|0|||
164244660|NCT02379052|593263929|FG000|Overall Study|Lost to Follow-up|2|||
164244661|NCT02379052|593263930|FG001|Overall Study|Lost to Follow-up|1|||
164244662|NCT02379052|593263929|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
164244663|NCT02379052|593263930|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
164244664|NCT02379052|593263929|FG000|Overall Study|Subject was Incarcerated|0|||
164244665|NCT02379052|593263930|FG001|Overall Study|Subject was Incarcerated|1|||
164244666|NCT00127855|593263932|FG000|Primary Vaccination Course|Adverse Event|0|||
164244667|NCT00127855|593263933|FG001|Primary Vaccination Course|Adverse Event|0|||
164244668|NCT00127855|593263934|FG002|Primary Vaccination Course|Adverse Event|1|||
164244669|NCT00127855|593263935|FG003|Primary Vaccination Course|Adverse Event|0|||
164244670|NCT00127855|593263936|FG004|Primary Vaccination Course|Adverse Event|0|||
164244671|NCT00127855|593263932|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
164244672|NCT00127855|593263933|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
164244673|NCT00127855|593263934|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
164244674|NCT00127855|593263935|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
164244675|NCT00127855|593263936|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
164244676|NCT00127855|593263932|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
164244677|NCT00127855|593263933|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
164244678|NCT00127855|593263934|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
164244679|NCT00127855|593263935|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
164244680|NCT00127855|593263936|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
164244681|NCT00127855|593263932|FG000|Primary Vaccination Course|Other|0|||
164244682|NCT00127855|593263933|FG001|Primary Vaccination Course|Other|0|||
164244683|NCT00127855|593263934|FG002|Primary Vaccination Course|Other|0|||
164244684|NCT00127855|593263935|FG003|Primary Vaccination Course|Other|0|||
164244685|NCT00127855|593263936|FG004|Primary Vaccination Course|Other|1|||
164244686|NCT02343302|593263937|FG000|Overall Study|Physician Decision|1|||
164244687|NCT02343302|593263938|FG001|Overall Study|Physician Decision|1|||
164244688|NCT01282866|593263941|FG000|Overall Study|Adverse Event|1|||
164244689|NCT04834726|593263942|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
164244690|NCT04834726|593263943|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
164244691|NCT04834726|593263944|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
164244692|NCT04834726|593263945|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
164244693|NCT04834726|593263946|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
164244694|NCT04834726|593263947|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
164244695|NCT04834726|593263948|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
164244696|NCT04834726|593263949|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
164244697|NCT04834726|593263950|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
164244698|NCT02948582|593263956|FG000|Washout Period 1|Adverse Event|0|||
164244699|NCT02948582|593263957|FG001|Washout Period 1|Adverse Event|2|||
164244700|NCT02948582|593263958|FG002|Washout Period 1|Adverse Event|0|||
164337518|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
164244701|NCT02948582|593263959|FG003|Washout Period 1|Adverse Event|0|||
164244702|NCT02948582|593263960|FG004|Washout Period 1|Adverse Event|0|||
164244703|NCT02948582|593263961|FG005|Washout Period 1|Adverse Event|0|||
164337519|NCT00810693|593611562|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
163990336|NCT05499520|592333037|FG015|Overall Study|Lost to Follow-up|36|||
163990337|NCT05499520|592333038|FG016|Overall Study|Lost to Follow-up|58|||
164337520|NCT00810693|593611563|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
164337521|NCT00810693|593611564|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
163990338|NCT05499520|592333039|FG017|Overall Study|Lost to Follow-up|53|||
164244704|NCT02948582|593263956|FG000|Washout Period 1|Protocol Violation|0|||
164244705|NCT02948582|593263957|FG001|Washout Period 1|Protocol Violation|0|||
164244706|NCT02948582|593263958|FG002|Washout Period 1|Protocol Violation|0|||
164244707|NCT02948582|593263959|FG003|Washout Period 1|Protocol Violation|0|||
164244708|NCT02948582|593263960|FG004|Washout Period 1|Protocol Violation|0|||
164244709|NCT02948582|593263961|FG005|Washout Period 1|Protocol Violation|1|||
164244710|NCT02948582|593263956|FG000|Washout Period 2|Adverse Event|0|||
164244711|NCT02948582|593263957|FG001|Washout Period 2|Adverse Event|1|||
164244712|NCT02948582|593263958|FG002|Washout Period 2|Adverse Event|0|||
164244713|NCT02948582|593263959|FG003|Washout Period 2|Adverse Event|0|||
164244714|NCT02948582|593263960|FG004|Washout Period 2|Adverse Event|0|||
164244715|NCT02948582|593263961|FG005|Washout Period 2|Adverse Event|0|||
164244716|NCT02948582|593263956|FG000|Washout Period 2|personal reasons|0|||
164244717|NCT02948582|593263957|FG001|Washout Period 2|personal reasons|0|||
164244718|NCT02948582|593263958|FG002|Washout Period 2|personal reasons|0|||
164244719|NCT02948582|593263959|FG003|Washout Period 2|personal reasons|1|||
164244720|NCT02948582|593263960|FG004|Washout Period 2|personal reasons|0|||
164244721|NCT02948582|593263961|FG005|Washout Period 2|personal reasons|0|||
164244722|NCT02948582|593263956|FG000|Washout Period 4|Adverse Event|1|||
164244723|NCT02948582|593263957|FG001|Washout Period 4|Adverse Event|0|||
164244724|NCT02948582|593263958|FG002|Washout Period 4|Adverse Event|1|||
164244725|NCT02948582|593263959|FG003|Washout Period 4|Adverse Event|0|||
164244726|NCT02948582|593263960|FG004|Washout Period 4|Adverse Event|0|||
164244727|NCT02948582|593263961|FG005|Washout Period 4|Adverse Event|0|||
164244728|NCT03606486|593263962|FG000|Overall Study|Unable to collect sample|5|||
164244729|NCT01265992|593263970|FG000|Overall Study|Lost to Follow-up|1|||
164244730|NCT01265992|593263970|FG000|Overall Study|Withdrawal by Subject|1|||
164244731|NCT01265992|593263970|FG000|Overall Study|Adverse Event|1|||
164244732|NCT01265992|593263970|FG000|Overall Study|Administrative reasons|2|||
164244733|NCT01265992|593263970|FG000|Overall Study|Stopped treatment|3|||
164244734|NCT01265992|593263970|FG000|Overall Study|Did not receive treatment|1|||
164244735|NCT02137070|593263971|FG000|Overall Study|Adverse Event|12|||
164244736|NCT02137070|593263972|FG001|Overall Study|Adverse Event|3|||
164244737|NCT02137070|593263971|FG000|Overall Study|Death|2|||
164244738|NCT02137070|593263972|FG001|Overall Study|Death|0|||
164244739|NCT02137070|593263971|FG000|Overall Study|Lost to Follow-up|24|||
164244740|NCT02137070|593263972|FG001|Overall Study|Lost to Follow-up|9|||
164244741|NCT02137070|593263971|FG000|Overall Study|Physician Decision|0|||
164244742|NCT02137070|593263972|FG001|Overall Study|Physician Decision|1|||
164244743|NCT02137070|593263971|FG000|Overall Study|Protocol Violation|18|||
164244744|NCT02137070|593263972|FG001|Overall Study|Protocol Violation|4|||
164244745|NCT02137070|593263971|FG000|Overall Study|Withdrawal by Subject|18|||
164244746|NCT02137070|593263972|FG001|Overall Study|Withdrawal by Subject|1|||
164244747|NCT03941483|593263973|FG000|Overall Study|Miscellaneous|2|||
164244748|NCT03941483|593263974|FG001|Overall Study|Miscellaneous|3|||
164244749|NCT03941483|593263975|FG002|Overall Study|Miscellaneous|0|||
164244750|NCT03941483|593263973|FG000|Overall Study|Study Terminated by Sponsor|1|||
164244751|NCT03941483|593263974|FG001|Overall Study|Study Terminated by Sponsor|0|||
164244752|NCT03941483|593263975|FG002|Overall Study|Study Terminated by Sponsor|0|||
164244753|NCT03941483|593263973|FG000|Overall Study|Withdrawal by Subject|1|||
164244754|NCT03941483|593263974|FG001|Overall Study|Withdrawal by Subject|4|||
164244755|NCT03941483|593263975|FG002|Overall Study|Withdrawal by Subject|1|||
164244756|NCT03941483|593263973|FG000|Overall Study|Lost to Follow-up|2|||
164244757|NCT03941483|593263974|FG001|Overall Study|Lost to Follow-up|1|||
164244758|NCT03941483|593263975|FG002|Overall Study|Lost to Follow-up|8|||
164244759|NCT03941483|593263973|FG000|Overall Study|Death|3|||
164244760|NCT03941483|593263974|FG001|Overall Study|Death|2|||
164244761|NCT03941483|593263975|FG002|Overall Study|Death|6|||
164244762|NCT03154476|593263980|FG000|Overall Study|Lost to Follow-up|4|||
164244763|NCT03154476|593263981|FG001|Overall Study|Lost to Follow-up|4|||
164244764|NCT01444430|593263982|FG000|Overall Study|Withdrawal by Subject|53|||
164244765|NCT01444430|593263983|FG001|Overall Study|Withdrawal by Subject|72|||
164244766|NCT01444430|593263982|FG000|Overall Study|Death|6|||
164244767|NCT01444430|593263983|FG001|Overall Study|Death|8|||
164244768|NCT01444430|593263982|FG000|Overall Study|Lost to Follow-up|2|||
164244769|NCT01444430|593263983|FG001|Overall Study|Lost to Follow-up|0|||
164244770|NCT01444430|593263982|FG000|Overall Study|CRF termination module not completed.|0|||
164244771|NCT01444430|593263983|FG001|Overall Study|CRF termination module not completed.|1|||
164244772|NCT01142388|593265509|FG000|Overall Study|Lack of Efficacy|21|||
164244773|NCT01142388|593265510|FG001|Overall Study|Lack of Efficacy|31|||
164244774|NCT01142388|593265509|FG000|Overall Study|Adverse Event|9|||
164244775|NCT01142388|593265510|FG001|Overall Study|Adverse Event|5|||
164244776|NCT01142388|593265509|FG000|Overall Study|Death|3|||
164244777|NCT01142388|593265510|FG001|Overall Study|Death|2|||
164244778|NCT01142388|593265509|FG000|Overall Study|Withdrawal by Subject|5|||
164244779|NCT01142388|593265510|FG001|Overall Study|Withdrawal by Subject|3|||
164244780|NCT01142388|593265509|FG000|Overall Study|Alternative therapy|1|||
164244781|NCT01142388|593265510|FG001|Overall Study|Alternative therapy|0|||
164244782|NCT01142388|593265509|FG000|Overall Study|Other complications|0|||
164244783|NCT01142388|593265510|FG001|Overall Study|Other complications|2|||
164244784|NCT01142388|593265509|FG000|Overall Study|Other|1|||
164244785|NCT01142388|593265510|FG001|Overall Study|Other|1|||
164244786|NCT01142388|593265509|FG000|Overall Study|Never started therapy|7|||
164244787|NCT01142388|593265510|FG001|Overall Study|Never started therapy|3|||
163990339|NCT01613326|592333040|FG000|Overall Study|Adverse Event|7|||
163990340|NCT01613326|592333041|FG001|Overall Study|Adverse Event|5|||
163990341|NCT01613326|592333040|FG000|Overall Study|Withdrawal by Subject|3|||
163990342|NCT01613326|592333041|FG001|Overall Study|Withdrawal by Subject|4|||
163990343|NCT01613326|592333040|FG000|Overall Study|Abnormal test procedure result(s)|2|||
163990344|NCT01613326|592333041|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163990345|NCT01613326|592333040|FG000|Overall Study|inability to use device|1|||
163990346|NCT01613326|592333041|FG001|Overall Study|inability to use device|0|||
163990347|NCT01613326|592333040|FG000|Overall Study|Lack of Efficacy|0|||
163990348|NCT01613326|592333041|FG001|Overall Study|Lack of Efficacy|1|||
163990349|NCT01613326|592333040|FG000|Overall Study|Lost to Follow-up|0|||
163990350|NCT01613326|592333041|FG001|Overall Study|Lost to Follow-up|1|||
163990351|NCT01613326|592333040|FG000|Overall Study|Administrative|0|||
163990352|NCT01613326|592333041|FG001|Overall Study|Administrative|2|||
163990353|NCT01613326|592333040|FG000|Overall Study|Protocol Violation|0|||
163990354|NCT01613326|592333041|FG001|Overall Study|Protocol Violation|1|||
163990355|NCT00793793|592333042|FG000|Overall Study|Adverse Event|0|||
163990356|NCT00793793|592333043|FG001|Overall Study|Adverse Event|0|||
163990357|NCT00793793|592333044|FG002|Overall Study|Adverse Event|1|||
163990358|NCT00793793|592333045|FG003|Overall Study|Adverse Event|1|||
163990359|NCT00793793|592333046|FG004|Overall Study|Adverse Event|0|||
163990360|NCT00793793|592333047|FG005|Overall Study|Adverse Event|1|||
163990361|NCT00793793|592333048|FG006|Overall Study|Adverse Event|2|||
163990362|NCT00793793|592333049|FG007|Overall Study|Adverse Event|0|||
163990363|NCT00793793|592333050|FG008|Overall Study|Adverse Event|0|||
163990364|NCT00793793|592333051|FG009|Overall Study|Adverse Event|0|||
163990365|NCT00793793|592333052|FG010|Overall Study|Adverse Event|0|||
163990366|NCT00793793|592333053|FG011|Overall Study|Adverse Event|2|||
163990367|NCT00793793|592333042|FG000|Overall Study|Protocol Violation|0|||
163990368|NCT00793793|592333043|FG001|Overall Study|Protocol Violation|0|||
163990369|NCT00793793|592333044|FG002|Overall Study|Protocol Violation|0|||
163990370|NCT00793793|592333045|FG003|Overall Study|Protocol Violation|1|||
163990371|NCT00793793|592333046|FG004|Overall Study|Protocol Violation|0|||
163990372|NCT00793793|592333047|FG005|Overall Study|Protocol Violation|0|||
163990373|NCT00793793|592333048|FG006|Overall Study|Protocol Violation|0|||
163990374|NCT00793793|592333049|FG007|Overall Study|Protocol Violation|0|||
163990375|NCT00793793|592333050|FG008|Overall Study|Protocol Violation|0|||
163990376|NCT00793793|592333051|FG009|Overall Study|Protocol Violation|0|||
163990377|NCT00793793|592333052|FG010|Overall Study|Protocol Violation|0|||
163990378|NCT00793793|592333053|FG011|Overall Study|Protocol Violation|0|||
163990379|NCT00793793|592333042|FG000|Overall Study|Lost to Follow-up|0|||
163990380|NCT00793793|592333043|FG001|Overall Study|Lost to Follow-up|0|||
163990381|NCT00793793|592333044|FG002|Overall Study|Lost to Follow-up|1|||
163990382|NCT00793793|592333045|FG003|Overall Study|Lost to Follow-up|0|||
163990383|NCT00793793|592333046|FG004|Overall Study|Lost to Follow-up|0|||
163990384|NCT00793793|592333047|FG005|Overall Study|Lost to Follow-up|0|||
163990385|NCT00793793|592333048|FG006|Overall Study|Lost to Follow-up|0|||
163990386|NCT00793793|592333049|FG007|Overall Study|Lost to Follow-up|0|||
163990387|NCT00793793|592333050|FG008|Overall Study|Lost to Follow-up|1|||
163990388|NCT00793793|592333051|FG009|Overall Study|Lost to Follow-up|3|||
163990389|NCT00793793|592333052|FG010|Overall Study|Lost to Follow-up|1|||
163990390|NCT00793793|592333053|FG011|Overall Study|Lost to Follow-up|0|||
163990391|NCT00793793|592333042|FG000|Overall Study|Withdrawal by Subject|0|||
163990392|NCT00793793|592333043|FG001|Overall Study|Withdrawal by Subject|0|||
163990393|NCT00793793|592333044|FG002|Overall Study|Withdrawal by Subject|0|||
163990394|NCT00793793|592333045|FG003|Overall Study|Withdrawal by Subject|0|||
163990395|NCT00793793|592333046|FG004|Overall Study|Withdrawal by Subject|1|||
163990396|NCT00793793|592333047|FG005|Overall Study|Withdrawal by Subject|0|||
163990397|NCT00793793|592333048|FG006|Overall Study|Withdrawal by Subject|0|||
163990398|NCT00793793|592333049|FG007|Overall Study|Withdrawal by Subject|0|||
163990399|NCT00793793|592333050|FG008|Overall Study|Withdrawal by Subject|1|||
163990400|NCT00793793|592333051|FG009|Overall Study|Withdrawal by Subject|0|||
163990401|NCT00793793|592333052|FG010|Overall Study|Withdrawal by Subject|0|||
163990402|NCT00793793|592333053|FG011|Overall Study|Withdrawal by Subject|0|||
163990403|NCT00793793|592333042|FG000|Overall Study|reason not specified|0|||
163990404|NCT00793793|592333043|FG001|Overall Study|reason not specified|1|||
163990405|NCT00793793|592333044|FG002|Overall Study|reason not specified|0|||
163990406|NCT00793793|592333045|FG003|Overall Study|reason not specified|1|||
163990407|NCT00793793|592333046|FG004|Overall Study|reason not specified|1|||
163990408|NCT00793793|592333047|FG005|Overall Study|reason not specified|1|||
163990409|NCT00793793|592333048|FG006|Overall Study|reason not specified|2|||
163990410|NCT00793793|592333049|FG007|Overall Study|reason not specified|0|||
163990411|NCT00793793|592333050|FG008|Overall Study|reason not specified|7|||
164006651|NCT00847613|592391041|FG000|Overall Study|Site closure|1|||
164244788|NCT05265728|593265516|FG000|Overall Study|Adverse Event|1|||
164244789|NCT05265728|593265516|FG000|Overall Study|Study Terminated by Sponsor|5|||
164244790|NCT05265728|593265516|FG000|Overall Study|Withdrawal by Subject|2|||
164244791|NCT03493451|593265517|FG000|Overall Study|Death|11|||
164244792|NCT03493451|593265518|FG001|Overall Study|Death|26|||
164244793|NCT03493451|593265519|FG002|Overall Study|Death|3|||
164244794|NCT03493451|593265517|FG000|Overall Study|Lost to Follow-up|1|||
164244795|NCT03493451|593265518|FG001|Overall Study|Lost to Follow-up|4|||
164244796|NCT03493451|593265519|FG002|Overall Study|Lost to Follow-up|1|||
164244797|NCT03493451|593265517|FG000|Overall Study|Withdrawal by Subject|1|||
164244798|NCT03493451|593265518|FG001|Overall Study|Withdrawal by Subject|1|||
164244799|NCT03493451|593265519|FG002|Overall Study|Withdrawal by Subject|2|||
164244800|NCT03493451|593265517|FG000|Overall Study|Progressive Disease|1|||
164244801|NCT03493451|593265518|FG001|Overall Study|Progressive Disease|0|||
164244802|NCT03493451|593265519|FG002|Overall Study|Progressive Disease|0|||
164244803|NCT03493451|593265517|FG000|Overall Study|Transferred to long term extension study|8|||
164244804|NCT03493451|593265518|FG001|Overall Study|Transferred to long term extension study|13|||
164244805|NCT03493451|593265519|FG002|Overall Study|Transferred to long term extension study|5|||
164244806|NCT01693250|593265528|FG000|Overall Study|Lost to Follow-up|2|||
164244807|NCT01693250|593265529|FG001|Overall Study|Lost to Follow-up|2|||
164244808|NCT01147965|593265530|FG000|Overall Study|Progressive Disease|3|||
164244809|NCT01147965|593265531|FG001|Overall Study|Progressive Disease|3|||
164244810|NCT01147965|593265532|FG002|Overall Study|Progressive Disease|5|||
164244811|NCT01147965|593265533|FG003|Overall Study|Progressive Disease|9|||
164244812|NCT01147965|593265534|FG004|Overall Study|Progressive Disease|5|||
164244813|NCT01147965|593265535|FG005|Overall Study|Progressive Disease|5|||
164244814|NCT01147965|593265530|FG000|Overall Study|Death|0|||
164337522|NCT01297920|593611565|FG000|Overall Study|Adverse Event|42|||
164337523|NCT01297920|593611566|FG001|Overall Study|Adverse Event|10|||
164337524|NCT01297920|593611567|FG002|Overall Study|Adverse Event|38|||
163885749|NCT04830800|591952398|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
164337525|NCT01297920|593611565|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
164337526|NCT01297920|593611566|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
164337527|NCT01297920|593611567|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
164337528|NCT01297920|593611565|FG000|Overall Study|Noncompliance|1|||
164337529|NCT01297920|593611566|FG001|Overall Study|Noncompliance|0|||
164337530|NCT01297920|593611567|FG002|Overall Study|Noncompliance|0|||
164337531|NCT01297920|593611565|FG000|Overall Study|Protocol Violation|1|||
164337532|NCT01297920|593611566|FG001|Overall Study|Protocol Violation|3|||
164337533|NCT01297920|593611567|FG002|Overall Study|Protocol Violation|0|||
164337534|NCT01297920|593611565|FG000|Overall Study|Inadequate Control of IOP|7|||
164337535|NCT01297920|593611566|FG001|Overall Study|Inadequate Control of IOP|9|||
164337536|NCT01297920|593611567|FG002|Overall Study|Inadequate Control of IOP|17|||
164337537|NCT01297920|593611565|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
164337538|NCT01297920|593611566|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
164337539|NCT01297920|593611567|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
164337540|NCT04295772|593611570|FG000|Overall Study|Protocol Violation|1|||
164337541|NCT04295772|593611571|FG001|Overall Study|Protocol Violation|0|||
164337542|NCT04295772|593611570|FG000|Overall Study|Ongoing for safety monitoring|14|||
164337543|NCT04295772|593611571|FG001|Overall Study|Ongoing for safety monitoring|1|||
164337544|NCT04295772|593611570|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
164337545|NCT04295772|593611571|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
164337546|NCT00331422|593611572|FG000|Overall Study|Did not receive entire study regimen|5|||
163885750|NCT04830800|591952399|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
163900157|NCT02397096|592005615|FG001|Study Extension 3|Lost to Follow-up|0|||
164083529|NCT02711956|592670195|FG006|Overall Study|PSA progression with radiographic progression|2|||
164337547|NCT02345226|593611573|FG000|Double-Blind Phase|Adverse Event|5|||
164244815|NCT01147965|593265531|FG001|Overall Study|Death|0|||
164244816|NCT01147965|593265532|FG002|Overall Study|Death|1|||
164244817|NCT01147965|593265533|FG003|Overall Study|Death|1|||
164337548|NCT02345226|593611574|FG001|Double-Blind Phase|Adverse Event|6|||
164337549|NCT02345226|593611573|FG000|Double-Blind Phase|Death|3|||
164337550|NCT02345226|593611574|FG001|Double-Blind Phase|Death|0|||
164337551|NCT02345226|593611573|FG000|Double-Blind Phase|Pregnancy|0|||
163990412|NCT00793793|592333051|FG009|Overall Study|reason not specified|6|||
164337552|NCT02345226|593611574|FG001|Double-Blind Phase|Pregnancy|1|||
164337553|NCT02345226|593611573|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164337554|NCT02345226|593611574|FG001|Double-Blind Phase|Lack of Efficacy|0|||
164337555|NCT02345226|593611573|FG000|Double-Blind Phase|Investigator's Discretion|4|||
164337556|NCT02345226|593611574|FG001|Double-Blind Phase|Investigator's Discretion|3|||
164337557|NCT02345226|593611573|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164337558|NCT02345226|593611574|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
164337559|NCT02345226|593611573|FG000|Double-Blind Phase|Withdrew Consent|41|||
164337560|NCT02345226|593611574|FG001|Double-Blind Phase|Withdrew Consent|39|||
164337561|NCT02345226|593611573|FG000|Double-Blind Phase|Lost to Follow-up|12|||
164337562|NCT02345226|593611574|FG001|Double-Blind Phase|Lost to Follow-up|16|||
164337563|NCT02345226|593611573|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
164337564|NCT02345226|593611574|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
164337565|NCT02345226|593611573|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164337566|NCT02345226|593611574|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
164337567|NCT01710046|593611580|FG000|Overall Study|Lost to Follow-up|1|||
164337568|NCT01710046|593611581|FG001|Overall Study|Lost to Follow-up|0|||
163990413|NCT00793793|592333052|FG010|Overall Study|reason not specified|2|||
163990414|NCT00793793|592333053|FG011|Overall Study|reason not specified|4|||
163990415|NCT00840827|592333054|FG000|Overall Study|Adverse Event|1|||
164337569|NCT03386474|593611584|FG000|Overall Study|Death|1|||
164337570|NCT03386474|593611585|FG001|Overall Study|Death|0|||
164337571|NCT03386474|593611584|FG000|Overall Study|Adverse Event|0|||
164337572|NCT03386474|593611585|FG001|Overall Study|Adverse Event|1|||
164244818|NCT01147965|593265534|FG004|Overall Study|Death|0|||
164244819|NCT01147965|593265535|FG005|Overall Study|Death|2|||
164244820|NCT01147965|593265530|FG000|Overall Study|Withdrawal by Subject|0|||
164244821|NCT01147965|593265531|FG001|Overall Study|Withdrawal by Subject|0|||
164244822|NCT01147965|593265532|FG002|Overall Study|Withdrawal by Subject|1|||
164244823|NCT01147965|593265533|FG003|Overall Study|Withdrawal by Subject|1|||
164244824|NCT01147965|593265534|FG004|Overall Study|Withdrawal by Subject|0|||
164244825|NCT01147965|593265535|FG005|Overall Study|Withdrawal by Subject|0|||
164244826|NCT01147965|593265530|FG000|Overall Study|Administration Of Alternative Therapy|0|||
164244827|NCT01147965|593265531|FG001|Overall Study|Administration Of Alternative Therapy|0|||
164244828|NCT01147965|593265532|FG002|Overall Study|Administration Of Alternative Therapy|0|||
164244829|NCT01147965|593265533|FG003|Overall Study|Administration Of Alternative Therapy|0|||
164244830|NCT01147965|593265534|FG004|Overall Study|Administration Of Alternative Therapy|0|||
164244831|NCT01147965|593265535|FG005|Overall Study|Administration Of Alternative Therapy|1|||
164244832|NCT01147965|593265530|FG000|Overall Study|Other|0|||
164244833|NCT01147965|593265531|FG001|Overall Study|Other|0|||
164244834|NCT01147965|593265532|FG002|Overall Study|Other|0|||
164244835|NCT01147965|593265533|FG003|Overall Study|Other|3|||
164244836|NCT01147965|593265534|FG004|Overall Study|Other|1|||
164244837|NCT01147965|593265535|FG005|Overall Study|Other|0|||
164244838|NCT02257242|593265536|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
164244839|NCT02257242|593265537|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
163885751|NCT04830800|591952400|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
163885752|NCT04830800|591952401|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
163885753|NCT03396588|591952404|FG000|Overall Study|Physician Decision|2|||
163885754|NCT03396588|591952405|FG001|Overall Study|Physician Decision|3|||
163885755|NCT00812461|591952406|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
163885756|NCT00812461|591952407|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
163885757|NCT00812461|591952406|FG000|All Treated Patients|Adverse Event|8|||
163885758|NCT00812461|591952407|FG001|All Treated Patients|Adverse Event|15|||
164244840|NCT02257242|593265538|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244841|NCT02257242|593265539|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244842|NCT02257242|593265540|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244843|NCT02257242|593265541|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244844|NCT02257242|593265542|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244845|NCT02257242|593265543|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244846|NCT02257242|593265544|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
164244847|NCT00600106|593265545|FG000|Overall Study|Withdrawal by Subject|1|||
164244848|NCT00600106|593265546|FG001|Overall Study|Withdrawal by Subject|1|||
164244849|NCT00620373|593265547|FG000|Overall Study|Unverified cancer status|33|||
164244850|NCT02213926|593265552|FG000|Overall Study|Death|59|||
164244851|NCT02213926|593265552|FG000|Overall Study|Withdrawal by Subject|10|||
164244852|NCT02213926|593265552|FG000|Overall Study|study terminated by sponsor|51|||
164244853|NCT02213926|593265552|FG000|Overall Study|Lost to Follow-up|3|||
164244854|NCT02213926|593265552|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
164244855|NCT01465386|593265553|FG000|Overall Study|Lack of Efficacy|3|||
164244856|NCT01465386|593265553|FG000|Overall Study|Adverse Event|1|||
164244857|NCT01279044|593265556|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
164244858|NCT01279044|593265557|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
164244859|NCT01279044|593265558|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
164244860|NCT01279044|593265556|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
164244861|NCT01279044|593265557|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
164244862|NCT01279044|593265558|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
164244863|NCT01279044|593265556|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
164244864|NCT01279044|593265557|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
164244865|NCT01279044|593265558|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
164244866|NCT01408277|593265561|FG000|Overall Study|Adverse Event|3|||
163885759|NCT00812461|591952406|FG000|All Treated Patients|Lack of Efficacy|13|||
163885760|NCT00812461|591952407|FG001|All Treated Patients|Lack of Efficacy|7|||
163885761|NCT00812461|591952406|FG000|All Treated Patients|Non-compliance|6|||
163990416|NCT00840827|592333054|FG000|Overall Study|Lack of Efficacy|4|||
164244867|NCT01408277|593265562|FG001|Overall Study|Adverse Event|4|||
164244868|NCT01408277|593265561|FG000|Overall Study|Lost to Follow-up|1|||
164244869|NCT01408277|593265562|FG001|Overall Study|Lost to Follow-up|0|||
164244870|NCT01408277|593265561|FG000|Overall Study|Withdrawal by Subject|2|||
164244871|NCT01408277|593265562|FG001|Overall Study|Withdrawal by Subject|0|||
164244872|NCT01408277|593265561|FG000|Overall Study|Protocol Violation|2|||
164244873|NCT01408277|593265562|FG001|Overall Study|Protocol Violation|0|||
164244874|NCT03783962|593265563|FG000|Overall Study|Lost to Follow-up|3|||
164244875|NCT03783962|593265564|FG001|Overall Study|Lost to Follow-up|6|||
164244876|NCT03783962|593265563|FG000|Overall Study|Protocol Violation|0|||
164244877|NCT03783962|593265564|FG001|Overall Study|Protocol Violation|1|||
164244878|NCT02370368|593265565|FG000|Overall Study|Adverse Event|1|||
164244879|NCT02370368|593265566|FG001|Overall Study|Adverse Event|2|||
164244880|NCT02370368|593265565|FG000|Overall Study|Withdrawal by Subject|5|||
164244881|NCT02370368|593265566|FG001|Overall Study|Withdrawal by Subject|4|||
164244882|NCT01169337|593265567|FG000|Overall Study|Lack of Efficacy|5|||
164244883|NCT01169337|593265568|FG001|Overall Study|Lack of Efficacy|7|||
164244884|NCT01169337|593265569|FG002|Overall Study|Lack of Efficacy|0|||
164244885|NCT01169337|593265567|FG000|Overall Study|Adverse Event|12|||
164244886|NCT01169337|593265568|FG001|Overall Study|Adverse Event|18|||
164244887|NCT01169337|593265569|FG002|Overall Study|Adverse Event|0|||
164244888|NCT01169337|593265567|FG000|Overall Study|Death|2|||
164244889|NCT01169337|593265568|FG001|Overall Study|Death|0|||
164244890|NCT01169337|593265569|FG002|Overall Study|Death|0|||
164244891|NCT01169337|593265567|FG000|Overall Study|Withdrawal by Subject|11|||
164244892|NCT01169337|593265568|FG001|Overall Study|Withdrawal by Subject|11|||
164244893|NCT01169337|593265569|FG002|Overall Study|Withdrawal by Subject|6|||
164244894|NCT01169337|593265567|FG000|Overall Study|Noncompliance|2|||
164244895|NCT01169337|593265568|FG001|Overall Study|Noncompliance|0|||
164244896|NCT01169337|593265569|FG002|Overall Study|Noncompliance|0|||
164244897|NCT01169337|593265567|FG000|Overall Study|Other complicating disease|1|||
164244898|NCT01169337|593265568|FG001|Overall Study|Other complicating disease|1|||
164244899|NCT01169337|593265569|FG002|Overall Study|Other complicating disease|0|||
164244900|NCT01169337|593265567|FG000|Overall Study|Physician Decision|1|||
164244901|NCT01169337|593265568|FG001|Overall Study|Physician Decision|5|||
164244902|NCT01169337|593265569|FG002|Overall Study|Physician Decision|0|||
164244903|NCT01169337|593265567|FG000|Overall Study|Alternative therapy|0|||
164244904|NCT01169337|593265568|FG001|Overall Study|Alternative therapy|2|||
164244905|NCT01169337|593265569|FG002|Overall Study|Alternative therapy|0|||
164244906|NCT01169337|593265567|FG000|Overall Study|Changed hospital|0|||
164244907|NCT01169337|593265568|FG001|Overall Study|Changed hospital|1|||
164244908|NCT01169337|593265569|FG002|Overall Study|Changed hospital|0|||
164244909|NCT01169337|593265567|FG000|Overall Study|Never started treatment|0|||
164244910|NCT01169337|593265568|FG001|Overall Study|Never started treatment|2|||
164337573|NCT00066729|593611587|FG000|Overall Study|Lost to Follow-up|1|||
164337574|NCT00066729|593611587|FG000|Overall Study|Disease progression|1|||
164337575|NCT02215096|593611590|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
164337576|NCT02215096|593611591|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337577|NCT02215096|593611592|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337578|NCT02215096|593611593|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337579|NCT02215096|593611594|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
164337580|NCT02215096|593611590|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337581|NCT02215096|593611591|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337582|NCT02215096|593611592|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337583|NCT02215096|593611593|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
164337584|NCT02215096|593611594|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
164337585|NCT02215096|593611590|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337586|NCT02215096|593611591|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337587|NCT02215096|593611592|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337588|NCT02215096|593611593|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
164337589|NCT02215096|593611594|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
164337590|NCT02215096|593611590|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
164337591|NCT02215096|593611591|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
164337592|NCT02215096|593611592|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
164337593|NCT02215096|593611593|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
164337594|NCT02215096|593611594|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
164337595|NCT03021304|593611595|FG000|Overall Study|Lack of Efficacy|1|||
164337596|NCT00370071|593611596|FG000|Overall Study|Withdrawal by Subject|2|||
164337597|NCT03350620|593611600|FG000|Stage 2|Adverse Event|0|||
164337598|NCT03350620|593611601|FG001|Stage 2|Adverse Event|1|||
164337599|NCT03350620|593611602|FG002|Stage 2|Adverse Event|1|||
164337600|NCT03350620|593611600|FG000|Stage 2|Lack of Efficacy|0|||
164337601|NCT03350620|593611601|FG001|Stage 2|Lack of Efficacy|2|||
164337602|NCT03350620|593611602|FG002|Stage 2|Lack of Efficacy|0|||
163885762|NCT00812461|591952407|FG001|All Treated Patients|Non-compliance|9|||
163885763|NCT00812461|591952406|FG000|All Treated Patients|Protocol Violation|36|||
164244911|NCT01169337|593265569|FG002|Overall Study|Never started treatment|0|||
164244912|NCT01169337|593265567|FG000|Overall Study|Reason not reported|1|||
164244913|NCT01169337|593265568|FG001|Overall Study|Reason not reported|0|||
164244914|NCT01169337|593265569|FG002|Overall Study|Reason not reported|0|||
164244915|NCT01169337|593265567|FG000|Overall Study|Continuing lenalidomide|9|||
164244916|NCT01169337|593265568|FG001|Overall Study|Continuing lenalidomide|43|||
163990417|NCT00840827|592333054|FG000|Overall Study|Physician Decision|1|||
164244917|NCT01169337|593265569|FG002|Overall Study|Continuing lenalidomide|0|||
164244918|NCT01643408|593265571|FG000|Overall Study|Adverse Event|12|||
164244919|NCT01643408|593265571|FG000|Overall Study|Other|2|||
164244920|NCT03726658|593265572|FG000|Overall Study|Lost to Follow-up|0|||
164244921|NCT03726658|593265573|FG001|Overall Study|Lost to Follow-up|0|||
164244922|NCT03726658|593265574|FG002|Overall Study|Lost to Follow-up|2|||
164244923|NCT03726658|593265575|FG003|Overall Study|Lost to Follow-up|0|||
164244924|NCT03726658|593265576|FG004|Overall Study|Lost to Follow-up|0|||
164244925|NCT03726658|593265577|FG005|Overall Study|Lost to Follow-up|1|||
164244926|NCT03726658|593265578|FG006|Overall Study|Lost to Follow-up|1|||
164244927|NCT03726658|593265572|FG000|Overall Study|Withdrawal by Subject|1|||
164244928|NCT03726658|593265573|FG001|Overall Study|Withdrawal by Subject|0|||
164244929|NCT03726658|593265574|FG002|Overall Study|Withdrawal by Subject|0|||
164244930|NCT03726658|593265575|FG003|Overall Study|Withdrawal by Subject|0|||
164244931|NCT03726658|593265576|FG004|Overall Study|Withdrawal by Subject|6|||
164244932|NCT03726658|593265577|FG005|Overall Study|Withdrawal by Subject|4|||
164244933|NCT03726658|593265578|FG006|Overall Study|Withdrawal by Subject|2|||
164244934|NCT03726658|593265572|FG000|Overall Study|Pregnancy|0|||
164244935|NCT03726658|593265573|FG001|Overall Study|Pregnancy|0|||
164244936|NCT03726658|593265574|FG002|Overall Study|Pregnancy|0|||
164244937|NCT03726658|593265575|FG003|Overall Study|Pregnancy|0|||
164244938|NCT03726658|593265576|FG004|Overall Study|Pregnancy|0|||
164244939|NCT03726658|593265577|FG005|Overall Study|Pregnancy|0|||
164244940|NCT03726658|593265578|FG006|Overall Study|Pregnancy|1|||
164244941|NCT03726658|593265572|FG000|Overall Study|Not Reported|0|||
164244942|NCT03726658|593265573|FG001|Overall Study|Not Reported|0|||
164244943|NCT03726658|593265574|FG002|Overall Study|Not Reported|0|||
164244944|NCT03726658|593265575|FG003|Overall Study|Not Reported|0|||
164244945|NCT03726658|593265576|FG004|Overall Study|Not Reported|0|||
164244946|NCT03726658|593265577|FG005|Overall Study|Not Reported|0|||
164244947|NCT03726658|593265578|FG006|Overall Study|Not Reported|1|||
164244948|NCT05710640|593265579|FG000|Overall Study|Physician Decision|0|||
164244949|NCT05710640|593265580|FG001|Overall Study|Physician Decision|1|||
164244950|NCT05710640|593265579|FG000|Overall Study|Withdrawal by Subject|1|||
164244951|NCT05710640|593265580|FG001|Overall Study|Withdrawal by Subject|0|||
164244952|NCT05710640|593265579|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
164244953|NCT05710640|593265580|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
164244954|NCT04188509|593265581|FG000|Overall Study|Adverse Event|2|||
164244955|NCT04188509|593265581|FG000|Overall Study|Lost to Follow-up|1|||
164244956|NCT04188509|593265581|FG000|Overall Study|Withdrawal of Consent|1|||
164244957|NCT04188509|593265581|FG000|Overall Study|Discretion of Investigator|1|||
164244958|NCT04188509|593265581|FG000|Overall Study|Noncompliance|3|||
164244959|NCT04188509|593265581|FG000|Overall Study|Sponsor Decision|127|||
164244960|NCT04188509|593265581|FG000|Overall Study|Other|2|||
164244961|NCT03810014|593265589|FG000|Overall Study|Pregnancy|2|||
164244962|NCT03810014|593265590|FG001|Overall Study|Pregnancy|2|||
164244963|NCT03810014|593265591|FG002|Overall Study|Pregnancy|0|||
164244964|NCT03810014|593265592|FG003|Overall Study|Pregnancy|2|||
164244965|NCT00049322|593265597|FG000|Overall Study|disease burden|0|||
164244966|NCT00049322|593265598|FG001|Overall Study|disease burden|3|||
164244967|NCT00049322|593265597|FG000|Overall Study|Adverse Event|1|||
164244968|NCT00049322|593265598|FG001|Overall Study|Adverse Event|0|||
164244969|NCT00049322|593265597|FG000|Overall Study|refused angio|0|||
164244970|NCT00049322|593265598|FG001|Overall Study|refused angio|3|||
163990418|NCT01940484|592333055|FG000|Overall Study|Withdrawal by Subject|3|||
163990419|NCT01940484|592333055|FG000|Overall Study|Underwent transplantation|4|||
163990420|NCT01940484|592333055|FG000|Overall Study|Death|2|||
163990421|NCT01940484|592333055|FG000|Overall Study|Adverse Event|1|||
163990422|NCT02658448|592333058|FG000|Overall Study|Lost to Follow-up|1|||
163990423|NCT00584194|592333059|FG000|Overall Study|Other|135|||
163990424|NCT00331409|592333060|FG000|Overall Study|Lack of Efficacy|4|||
163990425|NCT01482910|592333061|FG000|Overall Study|Adverse Event|6|||
163990426|NCT01482910|592333062|FG001|Overall Study|Adverse Event|5|||
163990427|NCT01482910|592333061|FG000|Overall Study|Lost to Follow-up|0|||
164244971|NCT00703963|593265599|FG000|Overall Study|Withdrawal by Subject|7|||
164244972|NCT00703963|593265600|FG001|Overall Study|Withdrawal by Subject|13|||
164244973|NCT00703963|593265599|FG000|Overall Study|Physician Decision|0|||
164244974|NCT00703963|593265600|FG001|Overall Study|Physician Decision|1|||
164244975|NCT03994211|593265607|FG000|Core Phase|Adverse Event|0|||
164244976|NCT03994211|593265608|FG001|Core Phase|Adverse Event|1|||
164244977|NCT03994211|593265609|FG002|Core Phase|Adverse Event|0|||
164244978|NCT03994211|593265607|FG000|Extension Phase|Adverse Event|0|||
164244979|NCT03994211|593265608|FG001|Extension Phase|Adverse Event|0|||
164244980|NCT03994211|593265609|FG002|Extension Phase|Adverse Event|1|||
164244981|NCT03994211|593265607|FG000|Extension Phase|Physician Decision|0|||
164244982|NCT03994211|593265608|FG001|Extension Phase|Physician Decision|0|||
164244983|NCT03994211|593265609|FG002|Extension Phase|Physician Decision|1|||
164244984|NCT03994211|593265607|FG000|Extension Phase|Progressive Disease|0|||
164244985|NCT03994211|593265608|FG001|Extension Phase|Progressive Disease|0|||
163885764|NCT00812461|591952407|FG001|All Treated Patients|Protocol Violation|27|||
163885765|NCT00812461|591952406|FG000|All Treated Patients|Withdrawal by Subject|45|||
164244986|NCT03994211|593265609|FG002|Extension Phase|Progressive Disease|20|||
164244987|NCT03994211|593265607|FG000|Extension Phase|Withdrawal by Subject|0|||
164244988|NCT03994211|593265608|FG001|Extension Phase|Withdrawal by Subject|0|||
164244989|NCT03994211|593265609|FG002|Extension Phase|Withdrawal by Subject|2|||
164244990|NCT00955474|593265613|FG000|Overall Study|Physician Decision|7|||
164244991|NCT00955474|593265614|FG001|Overall Study|Physician Decision|5|||
164244992|NCT02148263|593265616|FG000|Overall Study|Withdrawal by Subject|3|||
164244993|NCT02148263|593265617|FG001|Overall Study|Withdrawal by Subject|2|||
164244994|NCT03900728|593265618|FG000|Overall Study|No text responses|0|||
164244995|NCT03900728|593265619|FG001|Overall Study|No text responses|0|||
164244996|NCT03900728|593265620|FG002|Overall Study|No text responses|4|||
164244997|NCT01272037|593265629|FG000|Overall Study|Death|25|||
164244998|NCT01272037|593265630|FG001|Overall Study|Death|28|||
164244999|NCT01272037|593265629|FG000|Overall Study|Adverse Event|12|||
164245000|NCT01272037|593265630|FG001|Overall Study|Adverse Event|7|||
164245001|NCT01272037|593265629|FG000|Overall Study|Withdrawal by Subject|175|||
164245002|NCT01272037|593265630|FG001|Overall Study|Withdrawal by Subject|93|||
164245003|NCT01272037|593265629|FG000|Overall Study|Disease progression|70|||
164245004|NCT01272037|593265630|FG001|Overall Study|Disease progression|111|||
164245005|NCT01272037|593265629|FG000|Overall Study|Other reason|42|||
164245006|NCT01272037|593265630|FG001|Overall Study|Other reason|41|||
164245007|NCT01272037|593265629|FG000|Overall Study|Delinquent data|24|||
164245008|NCT01272037|593265630|FG001|Overall Study|Delinquent data|19|||
164245009|NCT01272037|593265629|FG000|Overall Study|Reason under review|33|||
164245010|NCT01272037|593265630|FG001|Overall Study|Reason under review|29|||
164245011|NCT01272037|593265629|FG000|Overall Study|On treatment|626|||
164245012|NCT01272037|593265630|FG001|Overall Study|On treatment|632|||
164245013|NCT01393899|593265631|FG000|Overall Study|Study terminated by sponsor|1|||
164245014|NCT01393899|593265632|FG001|Overall Study|Study terminated by sponsor|0|||
164245015|NCT01393899|593265633|FG002|Overall Study|Study terminated by sponsor|1|||
164245016|NCT01393899|593265631|FG000|Overall Study|Other|1|||
164245017|NCT01393899|593265632|FG001|Overall Study|Other|0|||
164245018|NCT01393899|593265633|FG002|Overall Study|Other|0|||
164245019|NCT01393899|593265631|FG000|Overall Study|Withdrawal by Subject|2|||
164245020|NCT01393899|593265632|FG001|Overall Study|Withdrawal by Subject|2|||
164245021|NCT01393899|593265633|FG002|Overall Study|Withdrawal by Subject|1|||
164245022|NCT01393899|593265631|FG000|Overall Study|Lost to Follow-up|0|||
164245023|NCT01393899|593265632|FG001|Overall Study|Lost to Follow-up|0|||
164245024|NCT01393899|593265633|FG002|Overall Study|Lost to Follow-up|1|||
164245025|NCT01393899|593265631|FG000|Overall Study|Does not meet entrance criteria|1|||
164245026|NCT01393899|593265632|FG001|Overall Study|Does not meet entrance criteria|0|||
164245027|NCT01393899|593265633|FG002|Overall Study|Does not meet entrance criteria|1|||
164245028|NCT01393899|593265631|FG000|Overall Study|Lack of Efficacy|26|||
164245029|NCT01393899|593265632|FG001|Overall Study|Lack of Efficacy|21|||
164245030|NCT01393899|593265633|FG002|Overall Study|Lack of Efficacy|16|||
164245031|NCT01393899|593265631|FG000|Overall Study|Adverse Event|1|||
164245032|NCT01393899|593265632|FG001|Overall Study|Adverse Event|5|||
164245033|NCT01393899|593265633|FG002|Overall Study|Adverse Event|3|||
164245034|NCT02503085|593265634|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
164245035|NCT02503085|593265635|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
164245036|NCT02503085|593265636|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
164245037|NCT02503085|593265637|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
164245038|NCT01162473|593265641|FG000|Overall Study|Adverse Event|2|||
164245039|NCT01162473|593265642|FG001|Overall Study|Adverse Event|1|||
164245040|NCT01162473|593265641|FG000|Overall Study|Withdrawal by Subject|0|||
164245041|NCT01162473|593265642|FG001|Overall Study|Withdrawal by Subject|4|||
164245042|NCT01144416|593265643|FG000|Intervention Period|Adverse Event|5|||
163885766|NCT00812461|591952407|FG001|All Treated Patients|Withdrawal by Subject|54|||
163885767|NCT00812461|591952406|FG000|All Treated Patients|Lost to Follow-up|11|||
163885768|NCT00812461|591952407|FG001|All Treated Patients|Lost to Follow-up|14|||
163885769|NCT00812461|591952406|FG000|All Treated Patients|Other Reason|13|||
163885770|NCT00812461|591952407|FG001|All Treated Patients|Other Reason|21|||
163885771|NCT03287817|591953978|FG000|Overall Study|Progressive disease|4|||
163885772|NCT03287817|591953979|FG001|Overall Study|Progressive disease|2|||
164245043|NCT01144416|593265644|FG001|Intervention Period|Adverse Event|6|||
164245044|NCT01144416|593265643|FG000|Intervention Period|Insufficient ovarian response|11|||
164245045|NCT01144416|593265644|FG001|Intervention Period|Insufficient ovarian response|17|||
163885773|NCT03287817|591953980|FG002|Overall Study|Progressive disease|3|||
164245046|NCT01144416|593265643|FG000|Intervention Period|Risk of OHSS|0|||
164245047|NCT01144416|593265644|FG001|Intervention Period|Risk of OHSS|1|||
164245048|NCT01144416|593265643|FG000|Intervention Period|Too high ovarian response|4|||
164245049|NCT01144416|593265644|FG001|Intervention Period|Too high ovarian response|2|||
164245050|NCT01144416|593265643|FG000|Intervention Period|No/too few/bad oocytes|7|||
164245051|NCT01144416|593265644|FG001|Intervention Period|No/too few/bad oocytes|5|||
164245052|NCT01144416|593265643|FG000|Intervention Period|No or abnormal fertilization|25|||
163885774|NCT03287817|591953981|FG003|Overall Study|Progressive disease|10|||
163885775|NCT03287817|591953982|FG004|Overall Study|Progressive disease|8|||
163885776|NCT03287817|591953978|FG000|Overall Study|Death|0|||
163885777|NCT03287817|591953979|FG001|Overall Study|Death|0|||
163885778|NCT03287817|591953980|FG002|Overall Study|Death|2|||
163885779|NCT03287817|591953981|FG003|Overall Study|Death|3|||
163885780|NCT03287817|591953982|FG004|Overall Study|Death|4|||
163990428|NCT01482910|592333062|FG001|Overall Study|Lost to Follow-up|1|||
163990429|NCT01482910|592333061|FG000|Overall Study|Protocol Violation|1|||
163990430|NCT01482910|592333062|FG001|Overall Study|Protocol Violation|1|||
163990431|NCT01482910|592333061|FG000|Overall Study|Withdrawal by Subject|7|||
163990432|NCT01482910|592333062|FG001|Overall Study|Withdrawal by Subject|2|||
163990433|NCT01482910|592333061|FG000|Overall Study|Death|1|||
163990434|NCT01482910|592333062|FG001|Overall Study|Death|0|||
163990435|NCT02614079|592333063|FG000|Overall Study|Withdrawal by Subject|1|||
163990436|NCT01961544|592333064|FG000|Overall Study|Protocol Violation|1|||
163885781|NCT03287817|591953978|FG000|Overall Study|Physician Decision|0|||
163885782|NCT03287817|591953979|FG001|Overall Study|Physician Decision|0|||
163885783|NCT03287817|591953980|FG002|Overall Study|Physician Decision|0|||
163990437|NCT01961544|592333064|FG000|Overall Study|Withdrawal by Subject|7|||
163990438|NCT01961544|592333064|FG000|Overall Study|Adverse Event|1|||
163990439|NCT01961544|592333064|FG000|Overall Study|Physician Decision|2|||
163990440|NCT01961544|592333064|FG000|Overall Study|Poor Tolerance|1|||
163990441|NCT01961544|592333064|FG000|Overall Study|Aggravation of Steral Pain|1|||
163990442|NCT03665285|592333067|FG000|Overall Study|Started New Anticancer Treatment|1|||
163990443|NCT03665285|592333068|FG001|Overall Study|Started New Anticancer Treatment|1|||
163990444|NCT03665285|592333069|FG002|Overall Study|Started New Anticancer Treatment|2|||
163990445|NCT03665285|592333070|FG003|Overall Study|Started New Anticancer Treatment|4|||
163990446|NCT03665285|592333071|FG004|Overall Study|Started New Anticancer Treatment|1|||
163990447|NCT03665285|592333072|FG005|Overall Study|Started New Anticancer Treatment|1|||
163990448|NCT03665285|592333073|FG006|Overall Study|Started New Anticancer Treatment|2|||
163990449|NCT03665285|592333074|FG007|Overall Study|Started New Anticancer Treatment|15|||
163990450|NCT03665285|592333075|FG008|Overall Study|Started New Anticancer Treatment|1|||
163990451|NCT03665285|592333067|FG000|Overall Study|Disease Progression|0|||
163990452|NCT03665285|592333068|FG001|Overall Study|Disease Progression|0|||
163990453|NCT03665285|592333069|FG002|Overall Study|Disease Progression|3|||
163990454|NCT03665285|592333070|FG003|Overall Study|Disease Progression|1|||
163990455|NCT03665285|592333071|FG004|Overall Study|Disease Progression|0|||
163990456|NCT03665285|592333072|FG005|Overall Study|Disease Progression|0|||
163990457|NCT03665285|592333073|FG006|Overall Study|Disease Progression|0|||
163990458|NCT03665285|592333074|FG007|Overall Study|Disease Progression|7|||
163990459|NCT03665285|592333075|FG008|Overall Study|Disease Progression|1|||
163990460|NCT03665285|592333067|FG000|Overall Study|Hospice|0|||
163990461|NCT03665285|592333068|FG001|Overall Study|Hospice|0|||
163990462|NCT03665285|592333069|FG002|Overall Study|Hospice|0|||
163990463|NCT03665285|592333070|FG003|Overall Study|Hospice|0|||
163990464|NCT03665285|592333071|FG004|Overall Study|Hospice|0|||
163990465|NCT03665285|592333072|FG005|Overall Study|Hospice|0|||
163990466|NCT03665285|592333073|FG006|Overall Study|Hospice|0|||
163990467|NCT03665285|592333074|FG007|Overall Study|Hospice|2|||
163990468|NCT03665285|592333075|FG008|Overall Study|Hospice|0|||
163990469|NCT03665285|592333067|FG000|Overall Study|Withdrawal by Subject|0|||
163990470|NCT03665285|592333068|FG001|Overall Study|Withdrawal by Subject|0|||
163990471|NCT03665285|592333069|FG002|Overall Study|Withdrawal by Subject|0|||
163990472|NCT03665285|592333070|FG003|Overall Study|Withdrawal by Subject|0|||
163990473|NCT03665285|592333071|FG004|Overall Study|Withdrawal by Subject|1|||
163990474|NCT03665285|592333072|FG005|Overall Study|Withdrawal by Subject|0|||
163990475|NCT03665285|592333073|FG006|Overall Study|Withdrawal by Subject|0|||
163990476|NCT03665285|592333074|FG007|Overall Study|Withdrawal by Subject|2|||
163990477|NCT03665285|592333075|FG008|Overall Study|Withdrawal by Subject|0|||
163990478|NCT03665285|592333067|FG000|Overall Study|Physician Decision|0|||
163990479|NCT03665285|592333068|FG001|Overall Study|Physician Decision|0|||
163990480|NCT03665285|592333069|FG002|Overall Study|Physician Decision|0|||
163990481|NCT03665285|592333070|FG003|Overall Study|Physician Decision|0|||
163990482|NCT03665285|592333071|FG004|Overall Study|Physician Decision|0|||
163990483|NCT03665285|592333072|FG005|Overall Study|Physician Decision|0|||
163990484|NCT03665285|592333073|FG006|Overall Study|Physician Decision|0|||
163990485|NCT03665285|592333074|FG007|Overall Study|Physician Decision|2|||
163990486|NCT03665285|592333075|FG008|Overall Study|Physician Decision|0|||
163990487|NCT03157531|592333076|FG000|Overall Study|Death|2|||
163990488|NCT03157531|592333076|FG000|Overall Study|Lost to Follow-up|4|||
163990489|NCT01235962|592333079|FG000|Overall Study|Withdrawal by Subject|20|||
163990490|NCT01235962|592333080|FG001|Overall Study|Withdrawal by Subject|19|||
163990491|NCT01235962|592333081|FG002|Overall Study|Withdrawal by Subject|62|||
163990492|NCT01235962|592333082|FG003|Overall Study|Withdrawal by Subject|49|||
163990493|NCT01235962|592333079|FG000|Overall Study|Lost to Follow-up|21|||
163990494|NCT01235962|592333080|FG001|Overall Study|Lost to Follow-up|16|||
163990495|NCT01235962|592333081|FG002|Overall Study|Lost to Follow-up|47|||
163990496|NCT01235962|592333082|FG003|Overall Study|Lost to Follow-up|32|||
163990497|NCT01235962|592333079|FG000|Overall Study|Physician Decision|5|||
164245053|NCT01144416|593265644|FG001|Intervention Period|No or abnormal fertilization|10|||
164245054|NCT01144416|593265643|FG000|Intervention Period|No/too few/bad quality embryos|3|||
164245055|NCT01144416|593265644|FG001|Intervention Period|No/too few/bad quality embryos|3|||
164245056|NCT01144416|593265643|FG000|Intervention Period|Other|7|||
164245057|NCT01144416|593265644|FG001|Intervention Period|Other|5|||
164245058|NCT02534883|593265646|FG000|Overall Study|Early Termination|8|||
164245059|NCT02534883|593265647|FG001|Overall Study|Early Termination|3|||
164245060|NCT03328832|593265648|FG000|Overall Study|Lost to Follow-up|0|||
164245061|NCT03328832|593265649|FG001|Overall Study|Lost to Follow-up|1|||
164245062|NCT00886769|593265650|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164245063|NCT00886769|593265651|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
164245064|NCT00049257|593265652|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
164245065|NCT00049257|593265652|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
164245066|NCT00049257|593265652|FG000|Carboplatin, Paclitaxel|Death|2|||
164245067|NCT00049257|593265652|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
164245068|NCT00132301|593265653|FG000|Overall Study|Death|7|||
164245069|NCT00132301|593265654|FG001|Overall Study|Death|6|||
164245070|NCT00132301|593265653|FG000|Overall Study|Withdrawal by Subject|5|||
164245071|NCT00132301|593265654|FG001|Overall Study|Withdrawal by Subject|2|||
164245072|NCT00132301|593265653|FG000|Overall Study|Physician Decision|1|||
164245073|NCT00132301|593265654|FG001|Overall Study|Physician Decision|1|||
164245074|NCT00132301|593265653|FG000|Overall Study|Lost to Follow-up|5|||
164245075|NCT00132301|593265654|FG001|Overall Study|Lost to Follow-up|3|||
164245076|NCT00132301|593265653|FG000|Overall Study|Other|1|||
164245077|NCT00132301|593265654|FG001|Overall Study|Other|1|||
164245078|NCT00132301|593265653|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
164245079|NCT00132301|593265654|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
164245080|NCT01890265|593265657|FG000|Overall Study|Other (Unspecified reason)|0|||
164245081|NCT01890265|593265658|FG001|Overall Study|Other (Unspecified reason)|1|||
164245082|NCT01890265|593265659|FG002|Overall Study|Other (Unspecified reason)|0|||
164245083|NCT01890265|593265660|FG003|Overall Study|Other (Unspecified reason)|0|||
164245084|NCT01890265|593265661|FG004|Overall Study|Other (Unspecified reason)|0|||
164245085|NCT01890265|593265662|FG005|Overall Study|Other (Unspecified reason)|0|||
164245086|NCT01890265|593265657|FG000|Overall Study|Progressive disease|6|||
164245087|NCT01890265|593265658|FG001|Overall Study|Progressive disease|6|||
164245088|NCT01890265|593265659|FG002|Overall Study|Progressive disease|0|||
164245089|NCT01890265|593265660|FG003|Overall Study|Progressive disease|0|||
164245090|NCT01890265|593265661|FG004|Overall Study|Progressive disease|0|||
164245091|NCT01890265|593265662|FG005|Overall Study|Progressive disease|0|||
164245092|NCT01890265|593265657|FG000|Overall Study|Adverse Event|2|||
164245093|NCT01890265|593265658|FG001|Overall Study|Adverse Event|1|||
164245094|NCT01890265|593265659|FG002|Overall Study|Adverse Event|0|||
164245095|NCT01890265|593265660|FG003|Overall Study|Adverse Event|0|||
164245096|NCT01890265|593265661|FG004|Overall Study|Adverse Event|0|||
164245097|NCT01890265|593265662|FG005|Overall Study|Adverse Event|0|||
164245098|NCT01890265|593265657|FG000|Overall Study|Death|2|||
164245099|NCT01890265|593265658|FG001|Overall Study|Death|3|||
164245100|NCT01890265|593265659|FG002|Overall Study|Death|1|||
164245101|NCT01890265|593265660|FG003|Overall Study|Death|0|||
164245102|NCT01890265|593265661|FG004|Overall Study|Death|0|||
164245103|NCT01890265|593265662|FG005|Overall Study|Death|0|||
164245104|NCT01890265|593265657|FG000|Overall Study|Withdrawal by Subject|0|||
164245105|NCT01890265|593265658|FG001|Overall Study|Withdrawal by Subject|2|||
164245106|NCT01890265|593265659|FG002|Overall Study|Withdrawal by Subject|3|||
164245107|NCT01890265|593265660|FG003|Overall Study|Withdrawal by Subject|0|||
164245108|NCT01890265|593265661|FG004|Overall Study|Withdrawal by Subject|2|||
164245109|NCT01890265|593265662|FG005|Overall Study|Withdrawal by Subject|0|||
164245110|NCT03670355|593265668|FG000|Overall Study|Adverse Event|1|||
164245111|NCT03670355|593265669|FG001|Overall Study|Adverse Event|0|||
164245112|NCT03670355|593265668|FG000|Overall Study|Unable to comply with study procedures|0|||
164245113|NCT03670355|593265669|FG001|Overall Study|Unable to comply with study procedures|1|||
164245114|NCT03670355|593265668|FG000|Overall Study|Participant refused|0|||
164245115|NCT03670355|593265669|FG001|Overall Study|Participant refused|1|||
164245116|NCT03517436|593265670|FG000|Overall Study|Death|3|||
164245117|NCT03517436|593265670|FG000|Overall Study|Withdrawal by Subject|4|||
164245118|NCT03517436|593265670|FG000|Overall Study|Did not receive study valve.|1|||
164245119|NCT04271540|593265671|FG000|Overall Study|Lost to Follow-up|1|||
164245120|NCT04271540|593265671|FG000|Overall Study|Screen Fail|5|||
163885784|NCT03287817|591953981|FG003|Overall Study|Physician Decision|1|||
163885785|NCT03287817|591953982|FG004|Overall Study|Physician Decision|0|||
163885786|NCT03287817|591953978|FG000|Overall Study|Withdrawal by Subject|0|||
163885787|NCT03287817|591953979|FG001|Overall Study|Withdrawal by Subject|0|||
163885788|NCT03287817|591953980|FG002|Overall Study|Withdrawal by Subject|0|||
163885789|NCT03287817|591953981|FG003|Overall Study|Withdrawal by Subject|0|||
163885790|NCT03287817|591953982|FG004|Overall Study|Withdrawal by Subject|4|||
163885791|NCT04130438|591953987|FG000|Overall Study|Lost to Follow-up|0|||
164083530|NCT02711956|592670196|FG007|Overall Study|PSA progression with radiographic progression|1|||
164083531|NCT02711956|592670197|FG008|Overall Study|PSA progression with radiographic progression|0|||
164083532|NCT02711956|592670198|FG009|Overall Study|PSA progression with radiographic progression|1|||
164083533|NCT02711956|592670199|FG010|Overall Study|PSA progression with radiographic progression|0|||
164083534|NCT02711956|592670200|FG011|Overall Study|PSA progression with radiographic progression|1|||
164083535|NCT02711956|592670201|FG012|Overall Study|PSA progression with radiographic progression|2|||
164083536|NCT02711956|592670202|FG013|Overall Study|PSA progression with radiographic progression|3|||
164083537|NCT02711956|592670203|FG014|Overall Study|PSA progression with radiographic progression|3|||
164083538|NCT01844583|592670204|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
164083539|NCT01844583|592670205|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
164083540|NCT01625377|592670206|FG000|Overall Study|Death|1|||
164083541|NCT01625377|592670207|FG001|Overall Study|Death|1|||
164083542|NCT01625377|592670206|FG000|Overall Study|Administrative Problem|1|||
164083543|NCT01625377|592670207|FG001|Overall Study|Administrative Problem|1|||
164083544|NCT01625377|592670206|FG000|Overall Study|Protocol Violation|0|||
164083545|NCT01625377|592670207|FG001|Overall Study|Protocol Violation|3|||
164083546|NCT01625377|592670206|FG000|Overall Study|Adverse Event|3|||
164083547|NCT01625377|592670207|FG001|Overall Study|Adverse Event|16|||
164083548|NCT01625377|592670206|FG000|Overall Study|Graft loss|1|||
164083549|NCT01625377|592670207|FG001|Overall Study|Graft loss|0|||
164083550|NCT01625377|592670206|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164083551|NCT01625377|592670207|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164083552|NCT01625377|592670206|FG000|Overall Study|Abnormal laboratory values|1|||
164083553|NCT01625377|592670207|FG001|Overall Study|Abnormal laboratory values|0|||
164083554|NCT03294538|592670212|FG000|Overall Study|Adverse Event|0|||
164083555|NCT03294538|592670213|FG001|Overall Study|Adverse Event|1|||
164083556|NCT03294538|592670214|FG002|Overall Study|Adverse Event|1|||
164083557|NCT03294538|592670212|FG000|Overall Study|Lost to Follow-up|1|||
164083558|NCT03294538|592670213|FG001|Overall Study|Lost to Follow-up|0|||
164083559|NCT03294538|592670214|FG002|Overall Study|Lost to Follow-up|0|||
164083560|NCT03294538|592670212|FG000|Overall Study|Outside of Visit Window|4|||
164083561|NCT03294538|592670213|FG001|Overall Study|Outside of Visit Window|4|||
164083562|NCT03294538|592670214|FG002|Overall Study|Outside of Visit Window|1|||
164083563|NCT01090765|592670216|FG000|Overall Study|Patient withdrew consent|0|||
164083564|NCT01090765|592670217|FG001|Overall Study|Patient withdrew consent|0|||
164083565|NCT01090765|592670218|FG002|Overall Study|Patient withdrew consent|0|||
164083566|NCT01090765|592670219|FG003|Overall Study|Patient withdrew consent|0|||
164083567|NCT01090765|592670220|FG004|Overall Study|Patient withdrew consent|1|||
164083568|NCT01090765|592670221|FG005|Overall Study|Patient withdrew consent|1|||
164083569|NCT01090765|592670216|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
164083570|NCT01090765|592670217|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
164083571|NCT01090765|592670218|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
164083572|NCT01090765|592670219|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
164083573|NCT01090765|592670220|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
164083574|NCT01090765|592670221|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
164083575|NCT01090765|592670216|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
164083576|NCT01090765|592670217|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
164083577|NCT01090765|592670218|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
164083578|NCT01090765|592670219|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
164083579|NCT01090765|592670220|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
164083580|NCT01090765|592670221|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
164083581|NCT01787825|592670222|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
164083582|NCT01787825|592670223|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
164083583|NCT01787825|592670222|FG000|Overall Study|Data Not Analyzable|5|||
164083584|NCT01787825|592670223|FG001|Overall Study|Data Not Analyzable|1|||
164083585|NCT00718159|592670228|FG000|Overall Study|Progressive Disease|3|||
164083586|NCT00718159|592670229|FG001|Overall Study|Progressive Disease|3|||
164083587|NCT00718159|592670230|FG002|Overall Study|Progressive Disease|2|||
164083588|NCT00718159|592670231|FG003|Overall Study|Progressive Disease|0|||
164083589|NCT00718159|592670232|FG004|Overall Study|Progressive Disease|6|||
164083590|NCT00718159|592670233|FG005|Overall Study|Progressive Disease|0|||
164083591|NCT00718159|592670234|FG006|Overall Study|Progressive Disease|0|||
164083592|NCT00718159|592670228|FG000|Overall Study|Death due to Adverse Event|0|||
164083593|NCT00718159|592670229|FG001|Overall Study|Death due to Adverse Event|0|||
164083594|NCT00718159|592670230|FG002|Overall Study|Death due to Adverse Event|0|||
164083595|NCT00718159|592670231|FG003|Overall Study|Death due to Adverse Event|2|||
164083596|NCT00718159|592670232|FG004|Overall Study|Death due to Adverse Event|2|||
164083597|NCT00718159|592670233|FG005|Overall Study|Death due to Adverse Event|0|||
164337603|NCT03350620|593611600|FG000|Stage 2|Lost to Follow-up|1|||
164337604|NCT03350620|593611601|FG001|Stage 2|Lost to Follow-up|2|||
164083598|NCT00718159|592670234|FG006|Overall Study|Death due to Adverse Event|0|||
164083599|NCT00718159|592670228|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
164337605|NCT03350620|593611602|FG002|Stage 2|Lost to Follow-up|2|||
164245121|NCT04587869|593265674|FG000|Overall Study|Death|1|||
164245122|NCT04587869|593265675|FG001|Overall Study|Death|0|||
164245123|NCT04587869|593265674|FG000|Overall Study|Lost to Follow-up|27|||
164245124|NCT04587869|593265675|FG001|Overall Study|Lost to Follow-up|34|||
164245125|NCT04587869|593265674|FG000|Overall Study|Grant Termination|13|||
164245126|NCT04587869|593265675|FG001|Overall Study|Grant Termination|25|||
164245127|NCT04587869|593265674|FG000|Overall Study|too busy|2|||
164245128|NCT04587869|593265675|FG001|Overall Study|too busy|0|||
164245129|NCT04587869|593265674|FG000|Overall Study|Withdrawal by Subject|2|||
164245130|NCT04587869|593265675|FG001|Overall Study|Withdrawal by Subject|2|||
164245131|NCT04587869|593265674|FG000|Overall Study|Other|1|||
164245132|NCT04587869|593265675|FG001|Overall Study|Other|0|||
164245133|NCT01102491|593265678|FG000|Overall Study|Protocol Violation|11|||
164245134|NCT01102491|593265679|FG001|Overall Study|Protocol Violation|12|||
164245135|NCT05823974|593267629|FG000|Overall Study|Lost to Follow-up|0|||
164245136|NCT05823974|593267630|FG001|Overall Study|Lost to Follow-up|3|||
164245137|NCT05823974|593267631|FG002|Overall Study|Lost to Follow-up|1|||
164245138|NCT05823974|593267632|FG003|Overall Study|Lost to Follow-up|0|||
164245139|NCT05823974|593267633|FG004|Overall Study|Lost to Follow-up|1|||
164245140|NCT05823974|593267634|FG005|Overall Study|Lost to Follow-up|0|||
164245141|NCT05823974|593267635|FG006|Overall Study|Lost to Follow-up|1|||
164245142|NCT05823974|593267636|FG007|Overall Study|Lost to Follow-up|0|||
164245143|NCT05823974|593267637|FG008|Overall Study|Lost to Follow-up|0|||
164245144|NCT05823974|593267638|FG009|Overall Study|Lost to Follow-up|1|||
164245145|NCT05823974|593267639|FG010|Overall Study|Lost to Follow-up|1|||
164245146|NCT05823974|593267640|FG011|Overall Study|Lost to Follow-up|0|||
164245147|NCT05823974|593267641|FG012|Overall Study|Lost to Follow-up|1|||
164245148|NCT05823974|593267642|FG013|Overall Study|Lost to Follow-up|2|||
164245149|NCT05823974|593267643|FG014|Overall Study|Lost to Follow-up|1|||
164245150|NCT05823974|593267644|FG015|Overall Study|Lost to Follow-up|1|||
164245151|NCT05823974|593267645|FG016|Overall Study|Lost to Follow-up|1|||
164245152|NCT05823974|593267646|FG017|Overall Study|Lost to Follow-up|0|||
164245153|NCT05823974|593267647|FG018|Overall Study|Lost to Follow-up|0|||
164245154|NCT05823974|593267648|FG019|Overall Study|Lost to Follow-up|2|||
164245155|NCT05823974|593267649|FG020|Overall Study|Lost to Follow-up|0|||
164245156|NCT05823974|593267629|FG000|Overall Study|Physician Decision|0|||
164245157|NCT05823974|593267630|FG001|Overall Study|Physician Decision|0|||
164245158|NCT05823974|593267631|FG002|Overall Study|Physician Decision|0|||
164245159|NCT05823974|593267632|FG003|Overall Study|Physician Decision|0|||
164245160|NCT05823974|593267633|FG004|Overall Study|Physician Decision|0|||
164245161|NCT05823974|593267634|FG005|Overall Study|Physician Decision|0|||
164245162|NCT05823974|593267635|FG006|Overall Study|Physician Decision|0|||
164245163|NCT05823974|593267636|FG007|Overall Study|Physician Decision|0|||
164245164|NCT05823974|593267637|FG008|Overall Study|Physician Decision|0|||
164245165|NCT05823974|593267638|FG009|Overall Study|Physician Decision|0|||
164245166|NCT05823974|593267639|FG010|Overall Study|Physician Decision|0|||
164245167|NCT05823974|593267640|FG011|Overall Study|Physician Decision|0|||
164245168|NCT05823974|593267641|FG012|Overall Study|Physician Decision|0|||
164245169|NCT05823974|593267642|FG013|Overall Study|Physician Decision|0|||
164245170|NCT05823974|593267643|FG014|Overall Study|Physician Decision|0|||
164245171|NCT05823974|593267644|FG015|Overall Study|Physician Decision|1|||
164245172|NCT05823974|593267645|FG016|Overall Study|Physician Decision|0|||
164245173|NCT05823974|593267646|FG017|Overall Study|Physician Decision|1|||
164245174|NCT05823974|593267647|FG018|Overall Study|Physician Decision|1|||
164245175|NCT05823974|593267648|FG019|Overall Study|Physician Decision|0|||
164245176|NCT05823974|593267649|FG020|Overall Study|Physician Decision|0|||
164245177|NCT05823974|593267629|FG000|Overall Study|Withdrawal by Subject|1|||
164245178|NCT05823974|593267630|FG001|Overall Study|Withdrawal by Subject|1|||
164245179|NCT05823974|593267631|FG002|Overall Study|Withdrawal by Subject|2|||
163990498|NCT01235962|592333080|FG001|Overall Study|Physician Decision|0|||
163990499|NCT01235962|592333081|FG002|Overall Study|Physician Decision|9|||
163990500|NCT01235962|592333082|FG003|Overall Study|Physician Decision|5|||
163990501|NCT03543410|592333083|FG000|Overall Study|Adverse Event|10|||
164245180|NCT05823974|593267632|FG003|Overall Study|Withdrawal by Subject|0|||
164245181|NCT05823974|593267633|FG004|Overall Study|Withdrawal by Subject|2|||
164245182|NCT05823974|593267634|FG005|Overall Study|Withdrawal by Subject|3|||
164245183|NCT05823974|593267635|FG006|Overall Study|Withdrawal by Subject|1|||
164245184|NCT05823974|593267636|FG007|Overall Study|Withdrawal by Subject|1|||
164245185|NCT05823974|593267637|FG008|Overall Study|Withdrawal by Subject|2|||
164245186|NCT05823974|593267638|FG009|Overall Study|Withdrawal by Subject|1|||
164245187|NCT05823974|593267639|FG010|Overall Study|Withdrawal by Subject|1|||
164245188|NCT05823974|593267640|FG011|Overall Study|Withdrawal by Subject|0|||
164245189|NCT05823974|593267641|FG012|Overall Study|Withdrawal by Subject|0|||
163990502|NCT03543410|592333084|FG001|Overall Study|Adverse Event|8|||
164245190|NCT05823974|593267642|FG013|Overall Study|Withdrawal by Subject|1|||
164245191|NCT05823974|593267643|FG014|Overall Study|Withdrawal by Subject|1|||
164245192|NCT05823974|593267644|FG015|Overall Study|Withdrawal by Subject|3|||
164245193|NCT05823974|593267645|FG016|Overall Study|Withdrawal by Subject|0|||
164245194|NCT05823974|593267646|FG017|Overall Study|Withdrawal by Subject|2|||
164245195|NCT05823974|593267647|FG018|Overall Study|Withdrawal by Subject|2|||
163990503|NCT03543410|592333085|FG002|Overall Study|Adverse Event|2|||
163990504|NCT03543410|592333083|FG000|Overall Study|Lack of Efficacy|0|||
163990505|NCT03543410|592333084|FG001|Overall Study|Lack of Efficacy|1|||
163990506|NCT03543410|592333085|FG002|Overall Study|Lack of Efficacy|0|||
163990507|NCT03543410|592333083|FG000|Overall Study|Lost to Follow-up|0|||
163990508|NCT03543410|592333084|FG001|Overall Study|Lost to Follow-up|1|||
163990509|NCT03543410|592333085|FG002|Overall Study|Lost to Follow-up|0|||
163990510|NCT03543410|592333083|FG000|Overall Study|Withdrawal by Subject|5|||
163990511|NCT03543410|592333084|FG001|Overall Study|Withdrawal by Subject|2|||
163990512|NCT03543410|592333085|FG002|Overall Study|Withdrawal by Subject|8|||
163990513|NCT03543410|592333083|FG000|Overall Study|Protocol Violation|0|||
163990514|NCT03543410|592333084|FG001|Overall Study|Protocol Violation|1|||
163990515|NCT03543410|592333085|FG002|Overall Study|Protocol Violation|0|||
163990516|NCT03543410|592333083|FG000|Overall Study|Due to COVID-19|4|||
163990517|NCT03543410|592333084|FG001|Overall Study|Due to COVID-19|0|||
163990518|NCT03543410|592333085|FG002|Overall Study|Due to COVID-19|2|||
163990519|NCT03543410|592333083|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
163990520|NCT03543410|592333084|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
163990521|NCT03543410|592333085|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
163990522|NCT03543410|592333083|FG000|Overall Study|Not Due to COVID-19|2|||
163990523|NCT03543410|592333084|FG001|Overall Study|Not Due to COVID-19|0|||
163990524|NCT03543410|592333085|FG002|Overall Study|Not Due to COVID-19|1|||
163990525|NCT01727258|592333086|FG000|Overall Study|Adverse Event|0|||
163990526|NCT01727258|592333087|FG001|Overall Study|Adverse Event|2|||
163990527|NCT01727258|592333088|FG002|Overall Study|Adverse Event|0|||
163990528|NCT01727258|592333086|FG000|Overall Study|Noncompliance with Study Drug|0|||
164245196|NCT05823974|593267648|FG019|Overall Study|Withdrawal by Subject|0|||
164245197|NCT05823974|593267649|FG020|Overall Study|Withdrawal by Subject|1|||
164245198|NCT05823974|593267629|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245199|NCT05823974|593267630|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245200|NCT05823974|593267631|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164245201|NCT05823974|593267632|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245202|NCT05823974|593267633|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245203|NCT05823974|593267634|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245204|NCT05823974|593267635|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245205|NCT05823974|593267636|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245206|NCT05823974|593267637|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245207|NCT05823974|593267638|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164337606|NCT03350620|593611600|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
164337607|NCT03350620|593611601|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
164337608|NCT03350620|593611602|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
164337609|NCT00566111|593611603|FG000|Overall Study|Adverse Event|0|||
164337610|NCT00566111|593611604|FG001|Overall Study|Adverse Event|2|||
164337611|NCT03774082|593611608|FG000|Overall Study|Death|6|||
164337612|NCT03774082|593611609|FG001|Overall Study|Death|3|||
164337613|NCT03774082|593611610|FG002|Overall Study|Death|2|||
164337614|NCT03774082|593611608|FG000|Overall Study|Subject decision|0|||
164337615|NCT03774082|593611609|FG001|Overall Study|Subject decision|3|||
164337616|NCT03774082|593611610|FG002|Overall Study|Subject decision|0|||
164337617|NCT03774082|593611608|FG000|Overall Study|Lost to Follow-up|2|||
164337618|NCT03774082|593611609|FG001|Overall Study|Lost to Follow-up|0|||
164337619|NCT03774082|593611610|FG002|Overall Study|Lost to Follow-up|0|||
164337620|NCT03774082|593611608|FG000|Overall Study|Guardian decision|0|||
164337621|NCT03774082|593611609|FG001|Overall Study|Guardian decision|0|||
164337622|NCT03774082|593611610|FG002|Overall Study|Guardian decision|1|||
164337623|NCT03774082|593611608|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
164337624|NCT03774082|593611609|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
164337625|NCT03774082|593611610|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
164337626|NCT05938920|593611611|FG000|Overall Study|Adverse Event|1|||
164337627|NCT05938920|593611612|FG001|Overall Study|Adverse Event|3|||
164337628|NCT05938920|593611613|FG002|Overall Study|Adverse Event|2|||
164337629|NCT05938920|593611614|FG003|Overall Study|Adverse Event|1|||
164337630|NCT05938920|593611611|FG000|Overall Study|Death|0|||
163990529|NCT01727258|592333087|FG001|Overall Study|Noncompliance with Study Drug|0|||
163990530|NCT01727258|592333088|FG002|Overall Study|Noncompliance with Study Drug|1|||
164083600|NCT00718159|592670229|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
163990531|NCT01727258|592333086|FG000|Overall Study|Withdrawal by Subject|1|||
163990532|NCT01727258|592333087|FG001|Overall Study|Withdrawal by Subject|1|||
163990533|NCT01727258|592333088|FG002|Overall Study|Withdrawal by Subject|0|||
163990534|NCT01727258|592333086|FG000|Overall Study|Lost to Follow-up|1|||
164245208|NCT05823974|593267639|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245209|NCT05823974|593267640|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245210|NCT05823974|593267641|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245211|NCT05823974|593267642|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245212|NCT05823974|593267643|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164245213|NCT05823974|593267644|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245214|NCT05823974|593267645|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245215|NCT05823974|593267646|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245216|NCT05823974|593267647|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245217|NCT05823974|593267648|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245218|NCT05823974|593267649|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164245219|NCT05823974|593267629|FG000|Overall Study|Other|0|||
164245220|NCT05823974|593267630|FG001|Overall Study|Other|1|||
164245221|NCT05823974|593267631|FG002|Overall Study|Other|1|||
164245222|NCT05823974|593267632|FG003|Overall Study|Other|1|||
164245223|NCT05823974|593267633|FG004|Overall Study|Other|0|||
164245224|NCT05823974|593267634|FG005|Overall Study|Other|1|||
164245225|NCT05823974|593267635|FG006|Overall Study|Other|1|||
164245226|NCT05823974|593267636|FG007|Overall Study|Other|1|||
164245227|NCT05823974|593267637|FG008|Overall Study|Other|1|||
164245228|NCT05823974|593267638|FG009|Overall Study|Other|0|||
164245229|NCT05823974|593267639|FG010|Overall Study|Other|0|||
164245230|NCT05823974|593267640|FG011|Overall Study|Other|0|||
164245231|NCT05823974|593267641|FG012|Overall Study|Other|2|||
164245232|NCT05823974|593267642|FG013|Overall Study|Other|1|||
164245233|NCT05823974|593267643|FG014|Overall Study|Other|0|||
164245234|NCT05823974|593267644|FG015|Overall Study|Other|1|||
164245235|NCT05823974|593267645|FG016|Overall Study|Other|0|||
164245236|NCT05823974|593267646|FG017|Overall Study|Other|0|||
164245237|NCT05823974|593267647|FG018|Overall Study|Other|0|||
164245238|NCT05823974|593267648|FG019|Overall Study|Other|0|||
164245239|NCT05823974|593267649|FG020|Overall Study|Other|0|||
164245240|NCT00316706|593267650|FG000|Overall Study|Lost to Follow-up|38|||
164245241|NCT00316706|593267651|FG001|Overall Study|Lost to Follow-up|48|||
164245242|NCT01134614|593267655|FG000|Overall Study|Still on treatment as of March 2013|21|||
164245243|NCT01134614|593267656|FG001|Overall Study|Still on treatment as of March 2013|13|||
164245244|NCT01134614|593267655|FG000|Overall Study|Progressive disease|60|||
164245245|NCT01134614|593267656|FG001|Overall Study|Progressive disease|54|||
164245246|NCT01134614|593267655|FG000|Overall Study|Adverse Event|26|||
164245247|NCT01134614|593267656|FG001|Overall Study|Adverse Event|39|||
164245248|NCT01134614|593267655|FG000|Overall Study|Death|5|||
164245249|NCT01134614|593267656|FG001|Overall Study|Death|8|||
164245250|NCT01134614|593267655|FG000|Overall Study|Withdrawal by Subject|3|||
164245251|NCT01134614|593267656|FG001|Overall Study|Withdrawal by Subject|2|||
164245252|NCT01134614|593267655|FG000|Overall Study|Alternative therapy|2|||
164245253|NCT01134614|593267656|FG001|Overall Study|Alternative therapy|0|||
164245254|NCT01134614|593267655|FG000|Overall Study|Complicating disease|2|||
164245255|NCT01134614|593267656|FG001|Overall Study|Complicating disease|1|||
164245256|NCT01134614|593267655|FG000|Overall Study|Physician's decision|0|||
164245257|NCT01134614|593267656|FG001|Overall Study|Physician's decision|1|||
164245258|NCT01134614|593267655|FG000|Overall Study|Never started treatment|4|||
164245259|NCT01134614|593267656|FG001|Overall Study|Never started treatment|1|||
164245260|NCT01134614|593267655|FG000|Overall Study|Pt received tx not allowed on study|0|||
164245261|NCT01134614|593267656|FG001|Overall Study|Pt received tx not allowed on study|1|||
164245262|NCT01134614|593267655|FG000|Overall Study|Symptomatic deterioration|0|||
164245263|NCT01134614|593267656|FG001|Overall Study|Symptomatic deterioration|1|||
164245264|NCT01134614|593267655|FG000|Overall Study|Patient in hospice care|0|||
164245265|NCT01134614|593267656|FG001|Overall Study|Patient in hospice care|1|||
164245266|NCT01485796|593267658|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
164245267|NCT01485796|593267658|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
164245268|NCT01485796|593267658|FG000|Period 2: Epoch 2|Adverse Event|3|||
164245269|NCT01485796|593267658|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
164245270|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
164245271|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
164245272|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
164245273|NCT01485796|593267658|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
164245274|NCT01766037|593267660|FG000|Overall Study|Adverse Event|1|||
164245275|NCT01766037|593267661|FG001|Overall Study|Adverse Event|0|||
164245276|NCT01766037|593267660|FG000|Overall Study|Lack of Efficacy|1|||
164245277|NCT01766037|593267661|FG001|Overall Study|Lack of Efficacy|0|||
164245278|NCT01766037|593267660|FG000|Overall Study|Lost to Follow-up|0|||
164245279|NCT01766037|593267661|FG001|Overall Study|Lost to Follow-up|10|||
164245280|NCT01766037|593267660|FG000|Overall Study|Physician Decision|0|||
164245281|NCT01766037|593267661|FG001|Overall Study|Physician Decision|1|||
164245282|NCT01766037|593267660|FG000|Overall Study|Withdrawal by Subject|18|||
164245283|NCT01766037|593267661|FG001|Overall Study|Withdrawal by Subject|16|||
164245284|NCT01766037|593267660|FG000|Overall Study|Moved from area|5|||
164083601|NCT00718159|592670230|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
164083602|NCT00718159|592670231|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
164083603|NCT00718159|592670232|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
164083604|NCT00718159|592670233|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
164083605|NCT00718159|592670234|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
164083606|NCT00718159|592670228|FG000|Overall Study|Investigator Decision|0|||
164083607|NCT00718159|592670229|FG001|Overall Study|Investigator Decision|0|||
164083608|NCT00718159|592670230|FG002|Overall Study|Investigator Decision|0|||
164083609|NCT00718159|592670231|FG003|Overall Study|Investigator Decision|0|||
164083610|NCT00718159|592670232|FG004|Overall Study|Investigator Decision|0|||
164083611|NCT00718159|592670233|FG005|Overall Study|Investigator Decision|1|||
164083612|NCT00718159|592670234|FG006|Overall Study|Investigator Decision|1|||
164083613|NCT01238848|592670236|FG000|Overall Study|Physician Decision|13|||
164083614|NCT01238848|592670237|FG001|Overall Study|Physician Decision|5|||
164083615|NCT01894984|592670239|FG000|Overall Study|Other|314|||
164083616|NCT01894984|592670240|FG001|Overall Study|Other|175|||
164083617|NCT01427803|592670241|FG000|Overall Study|Lost to Follow-up|32|||
164083618|NCT01427803|592670242|FG001|Overall Study|Lost to Follow-up|26|||
164083619|NCT01427803|592670241|FG000|Overall Study|Withdrawal by Subject|20|||
164083620|NCT01427803|592670242|FG001|Overall Study|Withdrawal by Subject|0|||
164083621|NCT01427803|592670241|FG000|Overall Study|Unable to complete full treatment period|6|||
164083622|NCT01427803|592670242|FG001|Overall Study|Unable to complete full treatment period|0|||
164083623|NCT01427803|592670241|FG000|Overall Study|Protocol Violation|1|||
164083624|NCT01427803|592670242|FG001|Overall Study|Protocol Violation|0|||
164083625|NCT01427803|592670241|FG000|Overall Study|Physician Decision|3|||
164083626|NCT01427803|592670242|FG001|Overall Study|Physician Decision|0|||
164083627|NCT01427803|592670241|FG000|Overall Study|did not take product|1|||
164245285|NCT01766037|593267661|FG001|Overall Study|Moved from area|0|||
164245286|NCT01766037|593267660|FG000|Overall Study|medical - unrelated|1|||
164245287|NCT01766037|593267661|FG001|Overall Study|medical - unrelated|2|||
164245288|NCT01766037|593267660|FG000|Overall Study|nausea / discomfort|3|||
164245289|NCT01766037|593267661|FG001|Overall Study|nausea / discomfort|0|||
164245290|NCT00292045|593267665|FG000|Core Study (Through Week 13)|Adverse Event|1|||
164245291|NCT00292045|593267665|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
164245292|NCT02236572|593267666|FG000|Overall Study|Withdrawal by Subject|1|||
164245293|NCT02236572|593267666|FG000|Overall Study|Protocol Violation|1|||
164245294|NCT02236572|593267666|FG000|Overall Study|Lost to Follow-up|1|||
164245295|NCT00606411|593267667|FG000|Overall Study|Adverse Event|1|||
164245296|NCT00606411|593267668|FG001|Overall Study|Adverse Event|2|||
164245297|NCT00606411|593267667|FG000|Overall Study|Lack of Adherence|1|||
164245298|NCT00606411|593267668|FG001|Overall Study|Lack of Adherence|1|||
164245299|NCT00606411|593267667|FG000|Overall Study|Lack of Efficacy|1|||
164245300|NCT00606411|593267668|FG001|Overall Study|Lack of Efficacy|1|||
164245301|NCT00606411|593267667|FG000|Overall Study|Withdrawal by Subject|2|||
164245302|NCT00606411|593267668|FG001|Overall Study|Withdrawal by Subject|0|||
164245303|NCT00606411|593267667|FG000|Overall Study|Lost to Follow-up|1|||
164245304|NCT00606411|593267668|FG001|Overall Study|Lost to Follow-up|2|||
164245305|NCT00606411|593267667|FG000|Overall Study|Move out of state|0|||
164245306|NCT00606411|593267668|FG001|Overall Study|Move out of state|1|||
164245307|NCT00412958|593267669|FG000|Overall Study|Withdrawal by Subject|3|||
164245308|NCT00412958|593267670|FG001|Overall Study|Withdrawal by Subject|0|||
164245309|NCT00412958|593267671|FG002|Overall Study|Withdrawal by Subject|0|||
164245310|NCT00412958|593267672|FG003|Overall Study|Withdrawal by Subject|1|||
164245311|NCT00412958|593267669|FG000|Overall Study|Adverse Event|0|||
164245312|NCT00412958|593267670|FG001|Overall Study|Adverse Event|1|||
164245313|NCT00412958|593267671|FG002|Overall Study|Adverse Event|0|||
164245314|NCT00412958|593267672|FG003|Overall Study|Adverse Event|0|||
164083628|NCT01427803|592670242|FG001|Overall Study|did not take product|0|||
164083629|NCT03412019|592670243|FG000|Overall Study|Withdrawal by Subject|1|||
164083630|NCT03412019|592670244|FG001|Overall Study|Withdrawal by Subject|1|||
164083631|NCT01952574|592670246|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
164083632|NCT01952574|592670247|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
164083633|NCT01952574|592670248|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
164083634|NCT01952574|592670249|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
164245315|NCT00412958|593267669|FG000|Overall Study|Lost to Follow-up|0|||
164245316|NCT00412958|593267670|FG001|Overall Study|Lost to Follow-up|1|||
164245317|NCT00412958|593267671|FG002|Overall Study|Lost to Follow-up|0|||
164245318|NCT00412958|593267672|FG003|Overall Study|Lost to Follow-up|0|||
164245319|NCT00412958|593267669|FG000|Overall Study|Death|0|||
164245320|NCT00412958|593267670|FG001|Overall Study|Death|1|||
164245321|NCT00412958|593267671|FG002|Overall Study|Death|0|||
164245322|NCT00412958|593267672|FG003|Overall Study|Death|0|||
164245323|NCT00412958|593267669|FG000|Overall Study|Transport issue|0|||
164245324|NCT00412958|593267670|FG001|Overall Study|Transport issue|1|||
164245325|NCT00412958|593267671|FG002|Overall Study|Transport issue|0|||
164245326|NCT00412958|593267672|FG003|Overall Study|Transport issue|0|||
164245327|NCT01318135|593267673|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
164245328|NCT01318135|593267674|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245329|NCT01318135|593267675|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245330|NCT01318135|593267676|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245331|NCT01318135|593267677|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163885792|NCT04130438|591953988|FG001|Overall Study|Lost to Follow-up|0|||
163885793|NCT04130438|591953989|FG002|Overall Study|Lost to Follow-up|1|||
163885794|NCT03338933|591953991|FG000|Screening Visit|Lost to Follow-up|1|||
163885795|NCT03338933|591953992|FG001|Screening Visit|Lost to Follow-up|3|||
163885796|NCT03338933|591953993|FG002|Screening Visit|Lost to Follow-up|1|||
163885797|NCT03338933|591953994|FG003|Screening Visit|Lost to Follow-up|4|||
163885798|NCT03338933|591953991|FG000|Screening Visit|Screen fail after consent|2|||
163990535|NCT01727258|592333087|FG001|Overall Study|Lost to Follow-up|0|||
164245332|NCT01318135|593267678|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245333|NCT01318135|593267679|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245334|NCT01318135|593267680|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
164245335|NCT01318135|593267673|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
164245336|NCT01318135|593267674|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245337|NCT01318135|593267675|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245338|NCT01318135|593267676|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245339|NCT01318135|593267677|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245340|NCT01318135|593267678|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245341|NCT01318135|593267679|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245342|NCT01318135|593267680|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
164245343|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
164245344|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
164245345|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
164245346|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
164245347|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
164245348|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
164245349|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
164245350|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
164245351|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
164245352|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
164245353|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245354|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245355|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
164245356|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245357|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245358|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
164245359|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245360|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245361|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245362|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164245363|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164245364|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164245365|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
164245366|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
164245367|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
164245368|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
164245369|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245370|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
164245371|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245372|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245373|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164245374|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
164245375|NCT01318135|593267673|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245376|NCT01318135|593267674|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245377|NCT01318135|593267675|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245378|NCT01318135|593267676|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245379|NCT01318135|593267677|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245380|NCT01318135|593267678|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245381|NCT01318135|593267679|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
164245382|NCT01318135|593267680|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
164245383|NCT03465722|593267685|FG000|Overall Study|Withdrawal by Subject|21|||
164245384|NCT03465722|593267686|FG001|Overall Study|Withdrawal by Subject|14|||
164245385|NCT03465722|593267685|FG000|Overall Study|Death|89|||
164245386|NCT03465722|593267686|FG001|Overall Study|Death|87|||
164245387|NCT03465722|593267685|FG000|Overall Study|Lost to Follow-up|5|||
164245388|NCT03465722|593267686|FG001|Overall Study|Lost to Follow-up|3|||
164245389|NCT03465722|593267685|FG000|Overall Study|Administrative/Other|33|||
164245390|NCT03465722|593267686|FG001|Overall Study|Administrative/Other|32|||
164245391|NCT03465722|593267685|FG000|Overall Study|Not treated|1|||
164245392|NCT03465722|593267686|FG001|Overall Study|Not treated|2|||
164245393|NCT03465722|593267685|FG000|Overall Study|Sponsor decision|91|||
164245394|NCT03465722|593267686|FG001|Overall Study|Sponsor decision|98|||
164245395|NCT01541865|593267687|FG000|Overall Study|Lost to Follow-up|11|||
164245396|NCT01541865|593267687|FG000|Overall Study|Withdrawal by Subject|9|||
164245397|NCT01541865|593267687|FG000|Overall Study|Adverse Event|1|||
164245398|NCT01541865|593267687|FG000|Overall Study|Protocol Violation|1|||
164245399|NCT01140867|593267690|FG000|Overall Study|Adverse Event|22|||
164245400|NCT01140867|593267690|FG000|Overall Study|Lack of Efficacy|3|||
164245401|NCT01140867|593267690|FG000|Overall Study|Lost to Follow-up|2|||
164245402|NCT01140867|593267690|FG000|Overall Study|Withdrawal by Subject|1|||
164245403|NCT01140867|593267690|FG000|Overall Study|Protocol Violation|1|||
164245404|NCT01140867|593267690|FG000|Overall Study|Uncooperative patient|2|||
164245405|NCT01140867|593267690|FG000|Overall Study|Medication Noncompliance|2|||
164245406|NCT00503425|593267701|FG000|Overall Study|Participant files lost|6|||
164245407|NCT00503425|593267701|FG000|Overall Study|Adverse Event|5|||
164245408|NCT00503425|593267701|FG000|Overall Study|Lack of Efficacy|25|||
164245409|NCT00503425|593267701|FG000|Overall Study|Withdrawal by Subject|8|||
164245410|NCT00503425|593267701|FG000|Overall Study|Lost to Follow-up|3|||
164245411|NCT00503425|593267701|FG000|Overall Study|Death|3|||
164245412|NCT00503425|593267701|FG000|Overall Study|Missing Data/Unknown|4|||
164245413|NCT00881530|593267702|FG000|Overall Study|Adverse Event|5|||
164245414|NCT00881530|593267703|FG001|Overall Study|Adverse Event|1|||
164245415|NCT00881530|593267704|FG002|Overall Study|Adverse Event|1|||
164245416|NCT00881530|593267705|FG003|Overall Study|Adverse Event|4|||
164245417|NCT00881530|593267706|FG004|Overall Study|Adverse Event|10|||
164245418|NCT00881530|593267707|FG005|Overall Study|Adverse Event|2|||
164245419|NCT00881530|593267702|FG000|Overall Study|Lack of Efficacy|1|||
164245420|NCT00881530|593267703|FG001|Overall Study|Lack of Efficacy|0|||
164245421|NCT00881530|593267704|FG002|Overall Study|Lack of Efficacy|0|||
164245422|NCT00881530|593267705|FG003|Overall Study|Lack of Efficacy|0|||
164245423|NCT00881530|593267706|FG004|Overall Study|Lack of Efficacy|1|||
164245424|NCT00881530|593267707|FG005|Overall Study|Lack of Efficacy|1|||
164245425|NCT00881530|593267702|FG000|Overall Study|Not compliant with the protocol|0|||
164245426|NCT00881530|593267703|FG001|Overall Study|Not compliant with the protocol|0|||
164245427|NCT00881530|593267704|FG002|Overall Study|Not compliant with the protocol|0|||
163990536|NCT01727258|592333088|FG002|Overall Study|Lost to Follow-up|0|||
163990537|NCT01318122|592333091|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163990538|NCT01318122|592333092|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163990539|NCT01318122|592333093|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
163990540|NCT01318122|592333094|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
163990541|NCT01318122|592333091|FG000|Enrolled - Long-Term Extension Study|Other|1|||
164245428|NCT00881530|593267705|FG003|Overall Study|Not compliant with the protocol|0|||
164245429|NCT00881530|593267706|FG004|Overall Study|Not compliant with the protocol|2|||
164245430|NCT00881530|593267707|FG005|Overall Study|Not compliant with the protocol|0|||
164245431|NCT00881530|593267702|FG000|Overall Study|Lost to Follow-up|0|||
164245432|NCT00881530|593267703|FG001|Overall Study|Lost to Follow-up|1|||
164245433|NCT00881530|593267704|FG002|Overall Study|Lost to Follow-up|1|||
164245434|NCT00881530|593267705|FG003|Overall Study|Lost to Follow-up|3|||
164245435|NCT00881530|593267706|FG004|Overall Study|Lost to Follow-up|1|||
163990542|NCT01318122|592333092|FG001|Enrolled - Long-Term Extension Study|Other|0|||
163885799|NCT03338933|591953992|FG001|Screening Visit|Screen fail after consent|7|||
163885800|NCT03338933|591953993|FG002|Screening Visit|Screen fail after consent|1|||
163885801|NCT03338933|591953994|FG003|Screening Visit|Screen fail after consent|4|||
163885802|NCT03338933|591953991|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
163885803|NCT03338933|591953992|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
163885804|NCT03338933|591953993|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
163885805|NCT03338933|591953994|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
163885806|NCT03338933|591953991|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
163885807|NCT03338933|591953992|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
163885808|NCT03338933|591953993|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
163885809|NCT03338933|591953994|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
163885810|NCT03338933|591953991|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
163885811|NCT03338933|591953992|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
163885812|NCT03338933|591953993|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
163885813|NCT03338933|591953994|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
163885814|NCT01084876|591953995|FG000|Main Study Treatment Period|Adverse Event|12|||
163885815|NCT01084876|591953996|FG001|Main Study Treatment Period|Adverse Event|7|||
163885816|NCT01084876|591953995|FG000|Main Study Treatment Period|Disease Progression|41|||
163885817|NCT01084876|591953996|FG001|Main Study Treatment Period|Disease Progression|24|||
163885818|NCT01084876|591953995|FG000|Main Study Treatment Period|Physician Decision|2|||
163885819|NCT01084876|591953996|FG001|Main Study Treatment Period|Physician Decision|0|||
163885820|NCT01084876|591953995|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
163885821|NCT01084876|591953996|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
164006652|NCT00847613|592391042|FG001|Overall Study|Site closure|0|||
164006653|NCT00847613|592391043|FG002|Overall Study|Site closure|0|||
164006654|NCT00847613|592391044|FG003|Overall Study|Site closure|1|||
164006655|NCT00847613|592391041|FG000|Overall Study|Withdrawal by Subject|8|||
164006656|NCT00847613|592391042|FG001|Overall Study|Withdrawal by Subject|11|||
164006657|NCT00847613|592391043|FG002|Overall Study|Withdrawal by Subject|2|||
164006658|NCT00847613|592391044|FG003|Overall Study|Withdrawal by Subject|2|||
164006659|NCT00847613|592391041|FG000|Overall Study|Participant moved|4|||
164006660|NCT00847613|592391042|FG001|Overall Study|Participant moved|1|||
164006661|NCT00847613|592391043|FG002|Overall Study|Participant moved|0|||
164006662|NCT00847613|592391044|FG003|Overall Study|Participant moved|0|||
164006663|NCT00847613|592391041|FG000|Overall Study|Sponsor request|0|||
164006664|NCT00847613|592391042|FG001|Overall Study|Sponsor request|1|||
164006665|NCT00847613|592391043|FG002|Overall Study|Sponsor request|0|||
164006666|NCT00847613|592391044|FG003|Overall Study|Sponsor request|0|||
164006667|NCT00847613|592391041|FG000|Overall Study|Randomized, but not treated|0|||
164006668|NCT00847613|592391042|FG001|Overall Study|Randomized, but not treated|3|||
164006669|NCT00847613|592391043|FG002|Overall Study|Randomized, but not treated|0|||
164006670|NCT00847613|592391044|FG003|Overall Study|Randomized, but not treated|0|||
164006671|NCT00847613|592391041|FG000|Overall Study|Other|1|||
164006672|NCT00847613|592391042|FG001|Overall Study|Other|1|||
164006673|NCT00847613|592391043|FG002|Overall Study|Other|2|||
164006674|NCT00847613|592391044|FG003|Overall Study|Other|0|||
164006675|NCT00754390|592391045|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
164006676|NCT00754390|592391045|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
164006677|NCT00754390|592391045|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
164006678|NCT00754390|592391045|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
164006679|NCT00587223|592391048|FG000|Overall Study|Adverse Event|1|||
164006680|NCT03519178|592391049|FG000|PF-06873600 Treatment|Adverse Event|0|||
164006681|NCT03519178|592391050|FG001|PF-06873600 Treatment|Adverse Event|0|||
164006682|NCT03519178|592391051|FG002|PF-06873600 Treatment|Adverse Event|0|||
164006683|NCT03519178|592391052|FG003|PF-06873600 Treatment|Adverse Event|0|||
164006684|NCT03519178|592391053|FG004|PF-06873600 Treatment|Adverse Event|0|||
164006685|NCT03519178|592391054|FG005|PF-06873600 Treatment|Adverse Event|0|||
164006686|NCT03519178|592391055|FG006|PF-06873600 Treatment|Adverse Event|0|||
164006687|NCT03519178|592391056|FG007|PF-06873600 Treatment|Adverse Event|2|||
164006688|NCT03519178|592391057|FG008|PF-06873600 Treatment|Adverse Event|1|||
164006689|NCT03519178|592391058|FG009|PF-06873600 Treatment|Adverse Event|0|||
164006690|NCT03519178|592391059|FG010|PF-06873600 Treatment|Adverse Event|0|||
164006691|NCT03519178|592391060|FG011|PF-06873600 Treatment|Adverse Event|0|||
164006692|NCT03519178|592391061|FG012|PF-06873600 Treatment|Adverse Event|1|||
164006693|NCT03519178|592391062|FG013|PF-06873600 Treatment|Adverse Event|3|||
164006694|NCT03519178|592391063|FG014|PF-06873600 Treatment|Adverse Event|2|||
164006695|NCT03519178|592391049|FG000|PF-06873600 Treatment|Death|0|||
164006696|NCT03519178|592391050|FG001|PF-06873600 Treatment|Death|0|||
164006697|NCT03519178|592391051|FG002|PF-06873600 Treatment|Death|0|||
164245436|NCT00881530|593267707|FG005|Overall Study|Lost to Follow-up|0|||
164245437|NCT00881530|593267702|FG000|Overall Study|Refused to continue medication|7|||
164245438|NCT00881530|593267703|FG001|Overall Study|Refused to continue medication|2|||
164245439|NCT00881530|593267704|FG002|Overall Study|Refused to continue medication|1|||
164245440|NCT00881530|593267705|FG003|Overall Study|Refused to continue medication|2|||
164245441|NCT00881530|593267706|FG004|Overall Study|Refused to continue medication|0|||
164245442|NCT00881530|593267707|FG005|Overall Study|Refused to continue medication|0|||
164245443|NCT00881530|593267702|FG000|Overall Study|Other reason not defined above|1|||
164245444|NCT00881530|593267703|FG001|Overall Study|Other reason not defined above|1|||
164245445|NCT00881530|593267704|FG002|Overall Study|Other reason not defined above|2|||
164245446|NCT00881530|593267705|FG003|Overall Study|Other reason not defined above|0|||
164245447|NCT00881530|593267706|FG004|Overall Study|Other reason not defined above|0|||
164245448|NCT00881530|593267707|FG005|Overall Study|Other reason not defined above|2|||
164245449|NCT00003869|593267709|FG000|Overall Study|Adverse Event|14|||
164245450|NCT00003869|593267710|FG001|Overall Study|Adverse Event|3|||
164245451|NCT00003869|593267709|FG000|Overall Study|Withdrawal by Subject|21|||
164245452|NCT00003869|593267710|FG001|Overall Study|Withdrawal by Subject|3|||
164245453|NCT00003869|593267709|FG000|Overall Study|Death|1|||
164245454|NCT00003869|593267710|FG001|Overall Study|Death|2|||
164245455|NCT00003869|593267709|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
164245456|NCT00003869|593267710|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
164245457|NCT00763256|593267711|FG000|Overall Study|Didn't return for appointments|7|||
164245458|NCT00763256|593267712|FG001|Overall Study|Didn't return for appointments|10|||
164245459|NCT03364231|593267713|FG000|Overall Study|Adverse Event|1|||
164245460|NCT03364231|593267714|FG001|Overall Study|Adverse Event|4|||
164245461|NCT03364231|593267713|FG000|Overall Study|Death|1|||
164245462|NCT03364231|593267714|FG001|Overall Study|Death|0|||
164245463|NCT03364231|593267713|FG000|Overall Study|Investigator Decision|2|||
164245464|NCT03364231|593267714|FG001|Overall Study|Investigator Decision|2|||
164245465|NCT03364231|593267713|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
164245466|NCT03364231|593267714|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
164245467|NCT03364231|593267713|FG000|Overall Study|Withdrawal of Subject Consent|1|||
164245468|NCT03364231|593267714|FG001|Overall Study|Withdrawal of Subject Consent|0|||
164245469|NCT03364231|593267713|FG000|Overall Study|Reason Not Specified|1|||
164245470|NCT03364231|593267714|FG001|Overall Study|Reason Not Specified|0|||
164245471|NCT03364231|593267713|FG000|Overall Study|Disease Progression|0|||
164245472|NCT03364231|593267714|FG001|Overall Study|Disease Progression|6|||
164245473|NCT00124072|593267717|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
164245474|NCT00124072|593267718|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
164245475|NCT00124072|593267719|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
164245476|NCT00124072|593267720|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
164245477|NCT00124072|593267717|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
164245478|NCT00124072|593267718|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
164245479|NCT00124072|593267719|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
163990543|NCT01318122|592333093|FG002|Enrolled - Long-Term Extension Study|Other|0|||
163990544|NCT01318122|592333094|FG003|Enrolled - Long-Term Extension Study|Other|0|||
163990545|NCT01318122|592333091|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
163990546|NCT01318122|592333092|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
163990547|NCT01318122|592333093|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
163990548|NCT01318122|592333094|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
163990549|NCT01318122|592333091|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
163990550|NCT01318122|592333092|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163990551|NCT01318122|592333093|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163990552|NCT01318122|592333094|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163990553|NCT01318122|592333091|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163990554|NCT01318122|592333092|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
163990555|NCT01318122|592333093|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163990556|NCT01318122|592333094|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163990557|NCT01318122|592333091|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
164245480|NCT00124072|593267720|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
164245481|NCT00124072|593267717|FG000|Overall Study|Death|499|||
164245482|NCT00124072|593267718|FG001|Overall Study|Death|484|||
164245483|NCT00124072|593267719|FG002|Overall Study|Death|471|||
164245484|NCT00124072|593267720|FG003|Overall Study|Death|480|||
163990558|NCT01318122|592333092|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
164245485|NCT00943761|593267726|FG000|Overall Study|Lost to Follow-up|2|||
164245486|NCT00943761|593267727|FG001|Overall Study|Lost to Follow-up|0|||
164245487|NCT00943761|593267726|FG000|Overall Study|Withdrawal by Subject|2|||
164245488|NCT00943761|593267727|FG001|Overall Study|Withdrawal by Subject|1|||
164245489|NCT02268383|593267728|FG000|Overall Study|Death|12|||
163990559|NCT01318122|592333093|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
163990560|NCT01318122|592333094|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163990561|NCT01738971|592333097|FG000|Overall Study|Lost to Follow-up|19|||
164337631|NCT05938920|593611612|FG001|Overall Study|Death|1|||
164337632|NCT05938920|593611613|FG002|Overall Study|Death|0|||
164337633|NCT05938920|593611614|FG003|Overall Study|Death|0|||
164337634|NCT05938920|593611611|FG000|Overall Study|Lost to Follow-up|0|||
164337635|NCT05938920|593611612|FG001|Overall Study|Lost to Follow-up|0|||
164337636|NCT05938920|593611613|FG002|Overall Study|Lost to Follow-up|1|||
164337637|NCT05938920|593611614|FG003|Overall Study|Lost to Follow-up|0|||
164337638|NCT05938920|593611611|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
163885822|NCT01084876|591953995|FG000|Main Study Treatment Period|Other Reason|0|||
164083635|NCT01952574|592670250|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164083636|NCT01952574|592670251|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164083637|NCT01952574|592670252|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164083638|NCT01952574|592670246|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
164083639|NCT01952574|592670247|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
164083640|NCT01952574|592670248|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
164083641|NCT01952574|592670249|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
164083642|NCT01952574|592670250|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
164083643|NCT01952574|592670251|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
164083644|NCT01952574|592670252|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
164083645|NCT01952574|592670246|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
164083646|NCT01952574|592670247|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
164083647|NCT01952574|592670248|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
164083648|NCT01952574|592670249|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
164083649|NCT01952574|592670250|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
164083650|NCT01952574|592670251|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
164083651|NCT01952574|592670252|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
164083652|NCT01952574|592670246|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
164083653|NCT01952574|592670247|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
164083654|NCT01952574|592670248|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
164083655|NCT01952574|592670249|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
164083656|NCT01952574|592670250|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
164083657|NCT01952574|592670251|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
164083658|NCT01952574|592670252|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
164083659|NCT01952574|592670246|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
164083660|NCT01952574|592670247|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
164083661|NCT01952574|592670248|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
164083662|NCT01952574|592670249|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
164083663|NCT01952574|592670250|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
164083664|NCT01952574|592670251|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
164083665|NCT01952574|592670252|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
164083666|NCT01952574|592670246|FG000|Open-label Treatment Phase|Missing|0|||
164083667|NCT01952574|592670247|FG001|Open-label Treatment Phase|Missing|0|||
164083668|NCT01952574|592670248|FG002|Open-label Treatment Phase|Missing|0|||
164083669|NCT01952574|592670249|FG003|Open-label Treatment Phase|Missing|0|||
164083670|NCT01952574|592670250|FG004|Open-label Treatment Phase|Missing|4|||
164083671|NCT01952574|592670251|FG005|Open-label Treatment Phase|Missing|0|||
164083672|NCT01952574|592670252|FG006|Open-label Treatment Phase|Missing|0|||
164083673|NCT01952574|592670246|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
164083674|NCT01952574|592670247|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
164083675|NCT01952574|592670248|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
164083676|NCT01952574|592670249|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
164083677|NCT01952574|592670250|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
164083678|NCT01952574|592670251|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
164083679|NCT01952574|592670252|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
164083680|NCT01952574|592670246|FG000|Open-label Treatment Phase|Death|0|||
164083681|NCT01952574|592670247|FG001|Open-label Treatment Phase|Death|0|||
164083682|NCT01952574|592670248|FG002|Open-label Treatment Phase|Death|0|||
164083683|NCT01952574|592670249|FG003|Open-label Treatment Phase|Death|0|||
164083684|NCT01952574|592670250|FG004|Open-label Treatment Phase|Death|1|||
164083685|NCT01952574|592670251|FG005|Open-label Treatment Phase|Death|0|||
164083686|NCT01952574|592670252|FG006|Open-label Treatment Phase|Death|0|||
164083687|NCT01952574|592670246|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164083688|NCT01952574|592670247|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164083689|NCT01952574|592670248|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164083690|NCT01952574|592670249|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
163885823|NCT01084876|591953996|FG001|Main Study Treatment Period|Other Reason|1|||
164083691|NCT01952574|592670250|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164083692|NCT01952574|592670251|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
164083693|NCT01952574|592670252|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
164083694|NCT01952574|592670246|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
164337639|NCT05938920|593611612|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
164337640|NCT05938920|593611613|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
164245490|NCT02268383|593267728|FG000|Overall Study|Lost to Follow-up|2|||
164245491|NCT02268383|593267728|FG000|Overall Study|Withdrawal by Subject|9|||
164245492|NCT02268383|593267728|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
164245493|NCT02268383|593267728|FG000|Overall Study|Protocol deviation|3|||
164245494|NCT02268383|593267728|FG000|Overall Study|Sponsor decision|22|||
164245495|NCT02268383|593267728|FG000|Overall Study|Not reported|12|||
164245496|NCT02708680|593267731|FG000|Overall Study|Withdrawal by Subject|4|||
164245497|NCT02708680|593267732|FG001|Overall Study|Withdrawal by Subject|12|||
164245498|NCT02708680|593267733|FG002|Overall Study|Withdrawal by Subject|12|||
164245499|NCT02708680|593267731|FG000|Overall Study|Death|4|||
164245500|NCT02708680|593267732|FG001|Overall Study|Death|19|||
164245501|NCT02708680|593267733|FG002|Overall Study|Death|21|||
164245502|NCT02708680|593267731|FG000|Overall Study|Lost to Follow-up|0|||
164245503|NCT02708680|593267732|FG001|Overall Study|Lost to Follow-up|3|||
164245504|NCT02708680|593267733|FG002|Overall Study|Lost to Follow-up|3|||
164245505|NCT02708680|593267731|FG000|Overall Study|Study Terminated By Sponsor|0|||
164245506|NCT02708680|593267732|FG001|Overall Study|Study Terminated By Sponsor|5|||
164245507|NCT02708680|593267733|FG002|Overall Study|Study Terminated By Sponsor|4|||
164245508|NCT02708680|593267731|FG000|Overall Study|Other than Specified|0|||
164245509|NCT02708680|593267732|FG001|Overall Study|Other than Specified|0|||
164245510|NCT02708680|593267733|FG002|Overall Study|Other than Specified|1|||
164245511|NCT02708680|593267731|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
164245512|NCT02708680|593267732|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
164245513|NCT02708680|593267733|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
164245514|NCT01342926|593267734|FG000|Overall Study|Adverse Event|5|||
163885824|NCT01084876|591953995|FG000|Main Study Treatment Period|Other|0|||
163885825|NCT01084876|591953996|FG001|Main Study Treatment Period|Other|1|||
163885826|NCT01084876|591953995|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
163885827|NCT01084876|591953996|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
163885828|NCT01084876|591953995|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
164245515|NCT01342926|593267735|FG001|Overall Study|Adverse Event|8|||
164245516|NCT01342926|593267736|FG002|Overall Study|Adverse Event|10|||
164245517|NCT01342926|593267737|FG003|Overall Study|Adverse Event|7|||
163885829|NCT01084876|591953996|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
163885830|NCT01084876|591953995|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
163885831|NCT01084876|591953996|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
163885832|NCT01084876|591953995|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
163885833|NCT01084876|591953996|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
163885834|NCT01084876|591953995|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
163885835|NCT01084876|591953996|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
163885836|NCT01084876|591953995|FG000|Treatment Period Beyond Cycle 8|Other|6|||
164245518|NCT01342926|593267734|FG000|Overall Study|Lost to Follow-up|0|||
164245519|NCT01342926|593267735|FG001|Overall Study|Lost to Follow-up|1|||
164245520|NCT01342926|593267736|FG002|Overall Study|Lost to Follow-up|1|||
164245521|NCT01342926|593267737|FG003|Overall Study|Lost to Follow-up|0|||
164245522|NCT01342926|593267734|FG000|Overall Study|Investigator Discretion|2|||
164245523|NCT01342926|593267735|FG001|Overall Study|Investigator Discretion|2|||
164245524|NCT01342926|593267736|FG002|Overall Study|Investigator Discretion|0|||
164245525|NCT01342926|593267737|FG003|Overall Study|Investigator Discretion|0|||
164245526|NCT01342926|593267734|FG000|Overall Study|Withdrawal by Subject|2|||
164245527|NCT01342926|593267735|FG001|Overall Study|Withdrawal by Subject|4|||
164245528|NCT01342926|593267736|FG002|Overall Study|Withdrawal by Subject|3|||
164245529|NCT01342926|593267737|FG003|Overall Study|Withdrawal by Subject|5|||
164245530|NCT04162470|593267738|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
164245531|NCT03382912|593267739|FG000|Overall Study|Physician Decision|0|||
164245532|NCT03382912|593267740|FG001|Overall Study|Physician Decision|1|||
164245533|NCT03382912|593267739|FG000|Overall Study|Sponsor Decision|6|||
164245534|NCT03382912|593267740|FG001|Overall Study|Sponsor Decision|6|||
164245535|NCT03382912|593267739|FG000|Overall Study|Withdrawal by Subject|0|||
164245536|NCT03382912|593267740|FG001|Overall Study|Withdrawal by Subject|5|||
164245537|NCT01402869|593267745|FG000|Overall Study|Required Tooth Extraction|0|||
164245538|NCT01402869|593267746|FG001|Overall Study|Required Tooth Extraction|0|||
164245539|NCT01402869|593267747|FG002|Overall Study|Required Tooth Extraction|1|||
164245540|NCT01544348|593267748|FG000|Overall Study|Lost to Follow-up|1|||
164245541|NCT01544348|593267749|FG001|Overall Study|Lost to Follow-up|0|||
164245542|NCT01544348|593267750|FG002|Overall Study|Lost to Follow-up|0|||
164245543|NCT01544348|593267751|FG003|Overall Study|Lost to Follow-up|0|||
164245544|NCT01544348|593267752|FG004|Overall Study|Lost to Follow-up|0|||
164245545|NCT01544348|593267753|FG005|Overall Study|Lost to Follow-up|0|||
164245546|NCT01544348|593267754|FG006|Overall Study|Lost to Follow-up|1|||
164245547|NCT01544348|593267755|FG007|Overall Study|Lost to Follow-up|0|||
164245548|NCT01544348|593267748|FG000|Overall Study|Withdrawal by Subject|1|||
163885837|NCT01084876|591953996|FG001|Treatment Period Beyond Cycle 8|Other|9|||
163885838|NCT04515576|591953997|FG000|Overall Study|Withdrawal by Subject|0|||
163885839|NCT04515576|591953998|FG001|Overall Study|Withdrawal by Subject|0|||
163885840|NCT04515576|591953999|FG002|Overall Study|Withdrawal by Subject|0|||
163885841|NCT04515576|591954000|FG003|Overall Study|Withdrawal by Subject|0|||
163885842|NCT04515576|591954001|FG004|Overall Study|Withdrawal by Subject|0|||
163885843|NCT04515576|591954002|FG005|Overall Study|Withdrawal by Subject|1|||
163885844|NCT04256941|591954004|FG000|Overall Study|Withdrawal by Subject|0|||
163885845|NCT04256941|591954005|FG001|Overall Study|Withdrawal by Subject|1|||
163885846|NCT04256941|591954004|FG000|Overall Study|Death|1|||
163885847|NCT04256941|591954005|FG001|Overall Study|Death|0|||
163885848|NCT04256941|591954004|FG000|Overall Study|Disease Progession|0|||
163885849|NCT04256941|591954005|FG001|Overall Study|Disease Progession|2|||
163885850|NCT02140554|591954010|FG000|Overall Study|Withdrawal of consent|1|||
163990562|NCT01738971|592333098|FG001|Overall Study|Lost to Follow-up|30|||
163990563|NCT01738971|592333099|FG002|Overall Study|Lost to Follow-up|17|||
163990564|NCT04698629|592333105|FG000|Overall Study|Adverse Event|1|||
163990565|NCT06228586|592333110|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
163990566|NCT06228586|592333111|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
163990567|NCT00865020|592333122|FG000|Overall Study|Withdrawal by Subject|22|||
163990568|NCT00865020|592333123|FG001|Overall Study|Withdrawal by Subject|16|||
163990569|NCT00865020|592333122|FG000|Overall Study|Adverse Event|9|||
163885851|NCT02140554|591954011|FG001|Overall Study|Withdrawal of consent|0|||
163885852|NCT02140554|591954012|FG002|Overall Study|Withdrawal of consent|4|||
163885853|NCT02140554|591954010|FG000|Overall Study|Physician Decision|1|||
163990570|NCT00865020|592333123|FG001|Overall Study|Adverse Event|14|||
163990571|NCT00865020|592333122|FG000|Overall Study|Abnormal test procedure result(s)|6|||
163990572|NCT00865020|592333123|FG001|Overall Study|Abnormal test procedure result(s)|8|||
163990573|NCT00865020|592333122|FG000|Overall Study|Lost to Follow-up|6|||
163990574|NCT00865020|592333123|FG001|Overall Study|Lost to Follow-up|4|||
163990575|NCT00865020|592333122|FG000|Overall Study|Protocol deviation|4|||
163990576|NCT00865020|592333123|FG001|Overall Study|Protocol deviation|1|||
163990577|NCT00865020|592333122|FG000|Overall Study|Administrative problems|0|||
163990578|NCT00865020|592333123|FG001|Overall Study|Administrative problems|2|||
163990579|NCT00865020|592333122|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163990580|NCT00865020|592333123|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163990581|NCT00865020|592333122|FG000|Overall Study|Death|0|||
163990582|NCT00865020|592333123|FG001|Overall Study|Death|1|||
163990583|NCT00865020|592333122|FG000|Overall Study|Randomized but discontinued|2|||
163990584|NCT00865020|592333123|FG001|Overall Study|Randomized but discontinued|4|||
163990585|NCT00947531|592335035|FG000|Overall Study|Withdrawal by Subject|10|||
163990586|NCT00947531|592335036|FG001|Overall Study|Withdrawal by Subject|7|||
163990587|NCT00947531|592335035|FG000|Overall Study|Administrative Reason|0|||
163990588|NCT00947531|592335036|FG001|Overall Study|Administrative Reason|1|||
163990589|NCT00947531|592335035|FG000|Overall Study|Adverse Event|2|||
163990590|NCT00947531|592335036|FG001|Overall Study|Adverse Event|2|||
163990591|NCT00947531|592335035|FG000|Overall Study|Lack of Efficacy|1|||
163990592|NCT00947531|592335036|FG001|Overall Study|Lack of Efficacy|0|||
163990593|NCT00947531|592335035|FG000|Overall Study|Other|1|||
163990594|NCT00947531|592335036|FG001|Overall Study|Other|1|||
163990595|NCT02327260|592335038|FG000|Overall Study|Lost to Follow-up|2|||
163990596|NCT02327260|592335039|FG001|Overall Study|Lost to Follow-up|3|||
163990597|NCT02327260|592335040|FG002|Overall Study|Lost to Follow-up|2|||
163990598|NCT02327260|592335038|FG000|Overall Study|invalid phone number|1|||
163990599|NCT02327260|592335039|FG001|Overall Study|invalid phone number|1|||
163990600|NCT02327260|592335040|FG002|Overall Study|invalid phone number|0|||
163990601|NCT02327260|592335038|FG000|Overall Study|non-adherence to protocol|2|||
163990602|NCT02327260|592335039|FG001|Overall Study|non-adherence to protocol|0|||
163990603|NCT02327260|592335040|FG002|Overall Study|non-adherence to protocol|0|||
163990604|NCT02327260|592335038|FG000|Overall Study|cognitive concerns|1|||
163990605|NCT02327260|592335039|FG001|Overall Study|cognitive concerns|0|||
163990606|NCT02327260|592335040|FG002|Overall Study|cognitive concerns|0|||
163990607|NCT03502330|592335041|FG000|Overall Study|Adverse Event|2|||
163990608|NCT03502330|592335042|FG001|Overall Study|Adverse Event|1|||
163990609|NCT03502330|592335043|FG002|Overall Study|Adverse Event|0|||
163990610|NCT03502330|592335044|FG003|Overall Study|Adverse Event|0|||
163990611|NCT03502330|592335045|FG004|Overall Study|Adverse Event|1|||
163990612|NCT03502330|592335046|FG005|Overall Study|Adverse Event|0|||
163990613|NCT03502330|592335047|FG006|Overall Study|Adverse Event|1|||
163990614|NCT03502330|592335048|FG007|Overall Study|Adverse Event|1|||
163885854|NCT02140554|591954011|FG001|Overall Study|Physician Decision|0|||
164083695|NCT01952574|592670247|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
164083696|NCT01952574|592670248|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
164083697|NCT01952574|592670249|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
164083698|NCT01952574|592670250|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
164083699|NCT01952574|592670251|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
164083700|NCT01952574|592670252|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
164083701|NCT02040766|592670256|FG000|Overall Study|Adverse Event|1|||
164083702|NCT02040766|592670257|FG001|Overall Study|Adverse Event|1|||
164083703|NCT02040766|592670258|FG002|Overall Study|Adverse Event|1|||
164083704|NCT02040766|592670259|FG003|Overall Study|Adverse Event|0|||
164083705|NCT02040766|592670260|FG004|Overall Study|Adverse Event|2|||
164083706|NCT02040766|592670256|FG000|Overall Study|Withdrawal by Subject|4|||
164083707|NCT02040766|592670257|FG001|Overall Study|Withdrawal by Subject|3|||
164083708|NCT02040766|592670258|FG002|Overall Study|Withdrawal by Subject|2|||
164083709|NCT02040766|592670259|FG003|Overall Study|Withdrawal by Subject|3|||
164083710|NCT02040766|592670260|FG004|Overall Study|Withdrawal by Subject|2|||
164083711|NCT02040766|592670256|FG000|Overall Study|Non-compliance|0|||
164083712|NCT02040766|592670257|FG001|Overall Study|Non-compliance|1|||
164083713|NCT02040766|592670258|FG002|Overall Study|Non-compliance|0|||
164083714|NCT02040766|592670259|FG003|Overall Study|Non-compliance|0|||
164083715|NCT02040766|592670260|FG004|Overall Study|Non-compliance|0|||
164083716|NCT02040766|592670256|FG000|Overall Study|Protocol Violation|2|||
164083717|NCT02040766|592670257|FG001|Overall Study|Protocol Violation|1|||
164083718|NCT02040766|592670258|FG002|Overall Study|Protocol Violation|2|||
164083719|NCT02040766|592670259|FG003|Overall Study|Protocol Violation|3|||
164083720|NCT02040766|592670260|FG004|Overall Study|Protocol Violation|0|||
164083721|NCT02040766|592670256|FG000|Overall Study|Lost to Follow-up|4|||
164083722|NCT02040766|592670257|FG001|Overall Study|Lost to Follow-up|1|||
164083723|NCT02040766|592670258|FG002|Overall Study|Lost to Follow-up|3|||
164083724|NCT02040766|592670259|FG003|Overall Study|Lost to Follow-up|1|||
164083725|NCT02040766|592670260|FG004|Overall Study|Lost to Follow-up|4|||
164083726|NCT02040766|592670256|FG000|Overall Study|Not reported|1|||
164083727|NCT02040766|592670257|FG001|Overall Study|Not reported|0|||
164083728|NCT02040766|592670258|FG002|Overall Study|Not reported|0|||
164083729|NCT02040766|592670259|FG003|Overall Study|Not reported|0|||
164083730|NCT02040766|592670260|FG004|Overall Study|Not reported|0|||
164083731|NCT02040766|592670256|FG000|Overall Study|Lack of Efficacy|6|||
164083732|NCT02040766|592670257|FG001|Overall Study|Lack of Efficacy|3|||
164083733|NCT02040766|592670258|FG002|Overall Study|Lack of Efficacy|4|||
164083734|NCT02040766|592670259|FG003|Overall Study|Lack of Efficacy|6|||
164083735|NCT02040766|592670260|FG004|Overall Study|Lack of Efficacy|5|||
164083736|NCT00798889|592670266|FG000|Overall Study|Adverse Event|53|||
164083737|NCT00798889|592670266|FG000|Overall Study|Protocol Violation|2|||
164083738|NCT00798889|592670266|FG000|Overall Study|Withdrawal by Subject|31|||
164083739|NCT00798889|592670266|FG000|Overall Study|Lost to Follow-up|1|||
164083740|NCT00798889|592670266|FG000|Overall Study|Lack of Efficacy|213|||
164083741|NCT00798889|592670266|FG000|Overall Study|Decision of Sponsor|11|||
164083742|NCT00798889|592670266|FG000|Overall Study|Enrolled, Not treated|3|||
164083743|NCT00617461|592670267|FG000|First Treatment Intervention Period|Adverse Event|2|||
164083744|NCT00617461|592670268|FG001|First Treatment Intervention Period|Adverse Event|0|||
164083745|NCT00617461|592670267|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
164083746|NCT00617461|592670268|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
164083747|NCT00617461|592670267|FG000|First Treatment Intervention Period|Protocol Violation|2|||
164083748|NCT00617461|592670268|FG001|First Treatment Intervention Period|Protocol Violation|1|||
164083749|NCT00617461|592670267|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
164083750|NCT00617461|592670268|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
164083751|NCT00617461|592670267|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
164083752|NCT00617461|592670268|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
164083753|NCT00617461|592670267|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
164083754|NCT00617461|592670268|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
164083755|NCT00617461|592670267|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
164083756|NCT00617461|592670268|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
164083757|NCT00617461|592670267|FG000|Second Treatment Intervention Period|Adverse Event|0|||
164083758|NCT00617461|592670268|FG001|Second Treatment Intervention Period|Adverse Event|1|||
164083759|NCT00617461|592670267|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
164083760|NCT00617461|592670268|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
164140969|NCT01371747|592878607|FG000|Overall Study|Physician Decision|0|||
164245549|NCT01544348|593267749|FG001|Overall Study|Withdrawal by Subject|0|||
164245550|NCT01544348|593267750|FG002|Overall Study|Withdrawal by Subject|0|||
164245551|NCT01544348|593267751|FG003|Overall Study|Withdrawal by Subject|0|||
164245552|NCT01544348|593267752|FG004|Overall Study|Withdrawal by Subject|1|||
164245553|NCT01544348|593267753|FG005|Overall Study|Withdrawal by Subject|2|||
164245554|NCT01544348|593267754|FG006|Overall Study|Withdrawal by Subject|1|||
164245555|NCT01544348|593267755|FG007|Overall Study|Withdrawal by Subject|0|||
164245556|NCT01544348|593267748|FG000|Overall Study|Physician Decision|0|||
164245557|NCT01544348|593267749|FG001|Overall Study|Physician Decision|0|||
164245558|NCT01544348|593267750|FG002|Overall Study|Physician Decision|0|||
164245559|NCT01544348|593267751|FG003|Overall Study|Physician Decision|0|||
164245560|NCT01544348|593267752|FG004|Overall Study|Physician Decision|0|||
164245561|NCT01544348|593267753|FG005|Overall Study|Physician Decision|1|||
164245562|NCT01544348|593267754|FG006|Overall Study|Physician Decision|0|||
164245563|NCT01544348|593267755|FG007|Overall Study|Physician Decision|0|||
164245564|NCT00642707|593267756|FG000|Overall Study|Adverse Event|0|||
164245565|NCT00642707|593267757|FG001|Overall Study|Adverse Event|0|||
164245566|NCT00642707|593267758|FG002|Overall Study|Adverse Event|0|||
164245567|NCT00642707|593267759|FG003|Overall Study|Adverse Event|2|||
164245568|NCT00642707|593267756|FG000|Overall Study|Withdrawal by Subject|1|||
164245569|NCT00642707|593267757|FG001|Overall Study|Withdrawal by Subject|0|||
164245570|NCT00642707|593267758|FG002|Overall Study|Withdrawal by Subject|0|||
164245571|NCT00642707|593267759|FG003|Overall Study|Withdrawal by Subject|0|||
164245572|NCT02573948|593267765|FG000|Longitudinal Cohort|Death|9|||
164245573|NCT02573948|593267765|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
164245574|NCT02573948|593267765|FG000|Longitudinal Cohort|Incarcerated|25|||
164245575|NCT00707993|593267766|FG000|Overall Study|Adverse Event|16|||
164245576|NCT00707993|593267767|FG001|Overall Study|Adverse Event|20|||
164245577|NCT00707993|593267766|FG000|Overall Study|Protocol Violation|4|||
164245578|NCT00707993|593267767|FG001|Overall Study|Protocol Violation|7|||
164245579|NCT00707993|593267766|FG000|Overall Study|Lost to Follow-up|0|||
164245580|NCT00707993|593267767|FG001|Overall Study|Lost to Follow-up|4|||
164245581|NCT00707993|593267766|FG000|Overall Study|Withdrawal by Subject|12|||
164245582|NCT00707993|593267767|FG001|Overall Study|Withdrawal by Subject|16|||
164245583|NCT00707993|593267766|FG000|Overall Study|Hyperglycemic Rescue|55|||
164245584|NCT00707993|593267767|FG001|Overall Study|Hyperglycemic Rescue|47|||
164245585|NCT00707993|593267766|FG000|Overall Study|Other|2|||
164245586|NCT00707993|593267767|FG001|Overall Study|Other|0|||
164245587|NCT00436436|593267770|FG000|Overall Study|Progression|4|||
164245588|NCT00436436|593267770|FG000|Overall Study|Adverse Event|2|||
164245589|NCT00436436|593267770|FG000|Overall Study|Death|6|||
164245590|NCT01837680|593267774|FG000|Overall Study|Lost to Follow-up|2|||
164245591|NCT01837680|593267775|FG001|Overall Study|Lost to Follow-up|2|||
164245592|NCT01837680|593267774|FG000|Overall Study|lack of insurance|0|||
164245593|NCT01837680|593267775|FG001|Overall Study|lack of insurance|2|||
164245594|NCT01837680|593267774|FG000|Overall Study|allergic reaction|6|||
164245595|NCT01837680|593267775|FG001|Overall Study|allergic reaction|0|||
164245596|NCT01837680|593267774|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
164245597|NCT01837680|593267775|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
164245598|NCT03008070|593267776|FG000|Overall Study|Adverse Event|3|||
164245599|NCT03008070|593267777|FG001|Overall Study|Adverse Event|3|||
164245600|NCT03008070|593267778|FG002|Overall Study|Adverse Event|3|||
164245601|NCT03008070|593267776|FG000|Overall Study|Lost to Follow-up|1|||
164245602|NCT03008070|593267777|FG001|Overall Study|Lost to Follow-up|1|||
164245603|NCT03008070|593267778|FG002|Overall Study|Lost to Follow-up|0|||
164245604|NCT03008070|593267776|FG000|Overall Study|Non compliance|0|||
164245605|NCT03008070|593267777|FG001|Overall Study|Non compliance|1|||
164245606|NCT03008070|593267778|FG002|Overall Study|Non compliance|1|||
164245607|NCT03008070|593267776|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
164245608|NCT03008070|593267777|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
164245609|NCT03008070|593267778|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
164245610|NCT03008070|593267776|FG000|Overall Study|Withdrawal by Subject|2|||
163885855|NCT02140554|591954012|FG002|Overall Study|Physician Decision|2|||
163885856|NCT02140554|591954010|FG000|Overall Study|Death|0|||
163885857|NCT02140554|591954011|FG001|Overall Study|Death|0|||
163885858|NCT02140554|591954012|FG002|Overall Study|Death|1|||
164245611|NCT03008070|593267777|FG001|Overall Study|Withdrawal by Subject|0|||
163885859|NCT02140554|591954010|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
163885860|NCT02140554|591954011|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
164245612|NCT03008070|593267778|FG002|Overall Study|Withdrawal by Subject|1|||
164245613|NCT03008070|593267776|FG000|Overall Study|Use of prohibited drug|0|||
164245614|NCT03008070|593267777|FG001|Overall Study|Use of prohibited drug|0|||
164337641|NCT05938920|593611614|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
164245615|NCT03008070|593267778|FG002|Overall Study|Use of prohibited drug|2|||
164245616|NCT05005273|593267779|FG000|Overall Study|Study Terminated|1|||
164245617|NCT05005273|593267780|FG001|Overall Study|Study Terminated|0|||
164245618|NCT04409834|593267781|FG000|Overall Study|Death|55|||
164245619|NCT04409834|593267782|FG001|Overall Study|Death|62|||
164245620|NCT03960684|593267784|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
164245621|NCT05223673|593267785|FG000|Overall Study|Protocol Violation|1|||
164245622|NCT05223673|593267785|FG000|Overall Study|Study termination|6|||
164245623|NCT04266912|593267786|FG000|Overall Study|Withdrawal by Subject|1|||
164245624|NCT04266912|593267787|FG001|Overall Study|Withdrawal by Subject|0|||
164245625|NCT04266912|593267788|FG002|Overall Study|Withdrawal by Subject|0|||
164245626|NCT04266912|593267789|FG003|Overall Study|Withdrawal by Subject|0|||
164245627|NCT04266912|593267786|FG000|Overall Study|Progression|6|||
164245628|NCT04266912|593267787|FG001|Overall Study|Progression|6|||
164245629|NCT04266912|593267788|FG002|Overall Study|Progression|0|||
164245630|NCT04266912|593267789|FG003|Overall Study|Progression|10|||
164245631|NCT02685826|593267790|FG000|Overall Study|Adverse Event|2|||
164245632|NCT02685826|593267791|FG001|Overall Study|Adverse Event|0|||
164245633|NCT02685826|593267792|FG002|Overall Study|Adverse Event|1|||
164245634|NCT02685826|593267790|FG000|Overall Study|Progressive Disease|2|||
164245635|NCT02685826|593267791|FG001|Overall Study|Progressive Disease|1|||
164245636|NCT02685826|593267792|FG002|Overall Study|Progressive Disease|0|||
164245637|NCT02685826|593267790|FG000|Overall Study|Withdrawal by Subject|2|||
164245638|NCT02685826|593267791|FG001|Overall Study|Withdrawal by Subject|0|||
164245639|NCT02685826|593267792|FG002|Overall Study|Withdrawal by Subject|0|||
164245640|NCT02685826|593267790|FG000|Overall Study|Full Clinical Hold by FDA|19|||
164245641|NCT02685826|593267791|FG001|Overall Study|Full Clinical Hold by FDA|9|||
164245642|NCT02685826|593267792|FG002|Overall Study|Full Clinical Hold by FDA|20|||
164245643|NCT01133756|593269226|FG000|Overall Study|Adverse Event|1|||
164245644|NCT01133756|593269227|FG001|Overall Study|Adverse Event|2|||
164245645|NCT01133756|593269228|FG002|Overall Study|Adverse Event|1|||
164245646|NCT01133756|593269226|FG000|Overall Study|Investigator Decision|1|||
164245647|NCT01133756|593269227|FG001|Overall Study|Investigator Decision|0|||
164245648|NCT01133756|593269228|FG002|Overall Study|Investigator Decision|0|||
164245649|NCT01133756|593269226|FG000|Overall Study|Withdrawal by Subject|0|||
164245650|NCT01133756|593269227|FG001|Overall Study|Withdrawal by Subject|1|||
164245651|NCT01133756|593269228|FG002|Overall Study|Withdrawal by Subject|0|||
164245652|NCT01133756|593269226|FG000|Overall Study|Progression of Disease|0|||
164245653|NCT01133756|593269227|FG001|Overall Study|Progression of Disease|0|||
164245654|NCT01133756|593269228|FG002|Overall Study|Progression of Disease|1|||
164245655|NCT03941873|593269231|FG000|Overall Study|Death|0|||
164245656|NCT03941873|593269232|FG001|Overall Study|Death|12|||
164245657|NCT03941873|593269233|FG002|Overall Study|Death|2|||
164245658|NCT03941873|593269234|FG003|Overall Study|Death|53|||
164245659|NCT03941873|593269231|FG000|Overall Study|Withdrawal by Subject|1|||
164245660|NCT03941873|593269232|FG001|Overall Study|Withdrawal by Subject|1|||
164245661|NCT03941873|593269233|FG002|Overall Study|Withdrawal by Subject|0|||
164245662|NCT03941873|593269234|FG003|Overall Study|Withdrawal by Subject|5|||
164337642|NCT05938920|593611611|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
164337643|NCT05938920|593611612|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
164337644|NCT05938920|593611613|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
164337645|NCT05938920|593611614|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
164337646|NCT05938920|593611611|FG000|Overall Study|Participant Refused to Come In|0|||
164337647|NCT05938920|593611612|FG001|Overall Study|Participant Refused to Come In|0|||
164337648|NCT05938920|593611613|FG002|Overall Study|Participant Refused to Come In|1|||
164337649|NCT05938920|593611614|FG003|Overall Study|Participant Refused to Come In|0|||
164337650|NCT01251861|593611615|FG000|Overall Study|Disease progression|6|||
164337651|NCT01251861|593611616|FG001|Overall Study|Disease progression|6|||
164337652|NCT01251861|593611615|FG000|Overall Study|Adverse Event|2|||
164337653|NCT01251861|593611616|FG001|Overall Study|Adverse Event|17|||
164337654|NCT01251861|593611615|FG000|Overall Study|Withdrawal by Subject|2|||
164337655|NCT01251861|593611616|FG001|Overall Study|Withdrawal by Subject|2|||
164337656|NCT01251861|593611615|FG000|Overall Study|Alternative therapy|1|||
164337657|NCT01251861|593611616|FG001|Overall Study|Alternative therapy|0|||
164337658|NCT01251861|593611615|FG000|Overall Study|Other complicating disease|0|||
164337659|NCT01251861|593611616|FG001|Overall Study|Other complicating disease|1|||
164337660|NCT01251861|593611615|FG000|Overall Study|Physician Decision|1|||
164337661|NCT01251861|593611616|FG001|Overall Study|Physician Decision|0|||
164337662|NCT01251861|593611615|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
164337663|NCT01251861|593611616|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
164337664|NCT01251861|593611615|FG000|Overall Study|Other|1|||
164337665|NCT01251861|593611616|FG001|Overall Study|Other|0|||
164337666|NCT01251861|593611615|FG000|Overall Study|Never started therapy|4|||
164337667|NCT01251861|593611616|FG001|Overall Study|Never started therapy|1|||
164245663|NCT03941873|593269231|FG000|Overall Study|Lost to Follow-up|1|||
164245664|NCT03941873|593269232|FG001|Overall Study|Lost to Follow-up|2|||
164245665|NCT03941873|593269233|FG002|Overall Study|Lost to Follow-up|0|||
164245666|NCT03941873|593269234|FG003|Overall Study|Lost to Follow-up|0|||
164245667|NCT03941873|593269231|FG000|Overall Study|Sponsor Decision|0|||
164245668|NCT03941873|593269232|FG001|Overall Study|Sponsor Decision|6|||
164245669|NCT03941873|593269233|FG002|Overall Study|Sponsor Decision|0|||
163885861|NCT02140554|591954012|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
163885862|NCT03953508|591954014|FG000|Baseline|Lost to Follow-up|3|||
163885863|NCT03953508|591954015|FG001|Baseline|Lost to Follow-up|2|||
163885864|NCT03953508|591954014|FG000|6-month Follow-up|Lost to Follow-up|62|||
164245670|NCT03941873|593269234|FG003|Overall Study|Sponsor Decision|15|||
163885865|NCT03953508|591954015|FG001|6-month Follow-up|Lost to Follow-up|70|||
164245671|NCT03276728|593269235|FG000|Overall Study|Lost to Follow-up|0|||
164245672|NCT03276728|593269236|FG001|Overall Study|Lost to Follow-up|0|||
164245673|NCT03276728|593269237|FG002|Overall Study|Lost to Follow-up|2|||
164245674|NCT03276728|593269238|FG003|Overall Study|Lost to Follow-up|2|||
164245675|NCT03276728|593269239|FG004|Overall Study|Lost to Follow-up|0|||
164245676|NCT03276728|593269240|FG005|Overall Study|Lost to Follow-up|0|||
164245677|NCT03276728|593269241|FG006|Overall Study|Lost to Follow-up|0|||
164245678|NCT03276728|593269242|FG007|Overall Study|Lost to Follow-up|0|||
164245679|NCT03276728|593269235|FG000|Overall Study|Withdrawal by Subject|0|||
164245680|NCT03276728|593269236|FG001|Overall Study|Withdrawal by Subject|0|||
163885866|NCT03771417|591954016|FG000|Overall Study|Withdrawal by Subject|1|||
163885867|NCT03771417|591954017|FG001|Overall Study|Withdrawal by Subject|0|||
163885868|NCT03771417|591954018|FG002|Overall Study|Withdrawal by Subject|0|||
163885869|NCT03771417|591954016|FG000|Overall Study|Covid-19 Shutdown|0|||
163885870|NCT03771417|591954017|FG001|Overall Study|Covid-19 Shutdown|1|||
163885871|NCT03771417|591954018|FG002|Overall Study|Covid-19 Shutdown|0|||
163885872|NCT03869866|591954021|FG000|Overall Study|Protocol Violation|1|||
163885873|NCT03869866|591954021|FG000|Overall Study|Withdrawal by Subject|3|||
163885874|NCT06181227|591954022|FG000|Overall Study|Study terminated by sponsor|7|||
163885875|NCT06181227|591954023|FG001|Overall Study|Study terminated by sponsor|9|||
163885876|NCT05543915|591954024|FG000|Overall Study|Lost to Follow-up|0|||
163885877|NCT05543915|591954025|FG001|Overall Study|Lost to Follow-up|1|||
163885878|NCT02577835|591954026|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
163885879|NCT04342494|591954027|FG000|Overall Study|Questionnaire partially completed|1|||
163885880|NCT04342494|591954028|FG001|Overall Study|Questionnaire partially completed|0|||
163885881|NCT04342494|591954029|FG002|Overall Study|Questionnaire partially completed|2|||
163885882|NCT04342494|591954030|FG003|Overall Study|Questionnaire partially completed|0|||
163885883|NCT04342494|591954031|FG004|Overall Study|Questionnaire partially completed|1|||
163990615|NCT03502330|592335049|FG008|Overall Study|Adverse Event|0|||
163990616|NCT03502330|592335041|FG000|Overall Study|Lack of Efficacy|1|||
163990617|NCT03502330|592335042|FG001|Overall Study|Lack of Efficacy|5|||
163990618|NCT03502330|592335043|FG002|Overall Study|Lack of Efficacy|3|||
163990619|NCT03502330|592335044|FG003|Overall Study|Lack of Efficacy|5|||
164245681|NCT03276728|593269237|FG002|Overall Study|Withdrawal by Subject|0|||
164245682|NCT03276728|593269238|FG003|Overall Study|Withdrawal by Subject|3|||
164245683|NCT03276728|593269239|FG004|Overall Study|Withdrawal by Subject|0|||
164245684|NCT03276728|593269240|FG005|Overall Study|Withdrawal by Subject|0|||
164245685|NCT03276728|593269241|FG006|Overall Study|Withdrawal by Subject|0|||
164245686|NCT03276728|593269242|FG007|Overall Study|Withdrawal by Subject|0|||
163885884|NCT04342494|591954027|FG000|Overall Study|Lost to Follow-up|49|||
163885885|NCT04342494|591954028|FG001|Overall Study|Lost to Follow-up|38|||
163885886|NCT04342494|591954029|FG002|Overall Study|Lost to Follow-up|34|||
163885887|NCT04342494|591954030|FG003|Overall Study|Lost to Follow-up|34|||
163885888|NCT04342494|591954031|FG004|Overall Study|Lost to Follow-up|35|||
163885889|NCT05119023|591954033|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
163885890|NCT05119023|591954033|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
163885891|NCT05119023|591954033|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
163885892|NCT03194217|591954034|FG000|Overall Study|Adverse Event|0|||
163885893|NCT03194217|591954035|FG001|Overall Study|Adverse Event|2|||
163885894|NCT03194217|591954036|FG002|Overall Study|Adverse Event|3|||
163885895|NCT03194217|591954037|FG003|Overall Study|Adverse Event|3|||
163885896|NCT03194217|591954034|FG000|Overall Study|Failure to meet randomisation criteria|0|||
163990620|NCT03502330|592335045|FG004|Overall Study|Lack of Efficacy|1|||
163990621|NCT03502330|592335046|FG005|Overall Study|Lack of Efficacy|5|||
163990622|NCT03502330|592335047|FG006|Overall Study|Lack of Efficacy|5|||
163990623|NCT03502330|592335048|FG007|Overall Study|Lack of Efficacy|6|||
163990624|NCT03502330|592335049|FG008|Overall Study|Lack of Efficacy|0|||
163990625|NCT03502330|592335041|FG000|Overall Study|Physician Decision|0|||
163990626|NCT03502330|592335042|FG001|Overall Study|Physician Decision|0|||
163990627|NCT03502330|592335043|FG002|Overall Study|Physician Decision|0|||
163990628|NCT03502330|592335044|FG003|Overall Study|Physician Decision|0|||
163990629|NCT03502330|592335045|FG004|Overall Study|Physician Decision|1|||
163885897|NCT03194217|591954035|FG001|Overall Study|Failure to meet randomisation criteria|0|||
163885898|NCT03194217|591954036|FG002|Overall Study|Failure to meet randomisation criteria|0|||
163885899|NCT03194217|591954037|FG003|Overall Study|Failure to meet randomisation criteria|1|||
163990630|NCT03502330|592335046|FG005|Overall Study|Physician Decision|0|||
163990631|NCT03502330|592335047|FG006|Overall Study|Physician Decision|0|||
163990632|NCT03502330|592335048|FG007|Overall Study|Physician Decision|0|||
164245687|NCT03276728|593269235|FG000|Overall Study|Decision by sponsor|0|||
164245688|NCT03276728|593269236|FG001|Overall Study|Decision by sponsor|0|||
164245689|NCT03276728|593269237|FG002|Overall Study|Decision by sponsor|0|||
164245690|NCT03276728|593269238|FG003|Overall Study|Decision by sponsor|0|||
164245691|NCT03276728|593269239|FG004|Overall Study|Decision by sponsor|1|||
164245692|NCT03276728|593269240|FG005|Overall Study|Decision by sponsor|0|||
164245693|NCT03276728|593269241|FG006|Overall Study|Decision by sponsor|2|||
164245694|NCT03276728|593269242|FG007|Overall Study|Decision by sponsor|1|||
164245695|NCT00617084|593269245|FG000|Overall Study|Withdrawal by Subject|5|||
164245696|NCT00617084|593269246|FG001|Overall Study|Withdrawal by Subject|7|||
164245697|NCT00617084|593269245|FG000|Overall Study|Missed 12 Months visit|16|||
164245698|NCT00617084|593269246|FG001|Overall Study|Missed 12 Months visit|19|||
164245699|NCT02574078|593269250|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245700|NCT02574078|593269251|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245701|NCT02574078|593269252|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245702|NCT02574078|593269253|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245703|NCT02574078|593269254|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245704|NCT02574078|593269255|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164245705|NCT02574078|593269256|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
164245706|NCT02574078|593269257|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245707|NCT02574078|593269258|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164245708|NCT02574078|593269259|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245709|NCT02574078|593269260|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245710|NCT02574078|593269261|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245711|NCT02574078|593269262|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164245712|NCT02574078|593269250|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
164245713|NCT02574078|593269251|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164245714|NCT02574078|593269252|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
164245715|NCT02574078|593269253|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
164245716|NCT02574078|593269254|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
164245717|NCT02574078|593269255|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
164245718|NCT02574078|593269256|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
164245719|NCT02574078|593269257|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
164245720|NCT02574078|593269258|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
164245721|NCT02574078|593269259|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
164245722|NCT02574078|593269260|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
164245723|NCT02574078|593269261|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
164245724|NCT02574078|593269262|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
164245725|NCT02574078|593269250|FG000|Pre-Treatment Period|Other reasons|0|||
164245726|NCT02574078|593269251|FG001|Pre-Treatment Period|Other reasons|0|||
164245727|NCT02574078|593269252|FG002|Pre-Treatment Period|Other reasons|0|||
164245728|NCT02574078|593269253|FG003|Pre-Treatment Period|Other reasons|0|||
164245729|NCT02574078|593269254|FG004|Pre-Treatment Period|Other reasons|0|||
164245730|NCT02574078|593269255|FG005|Pre-Treatment Period|Other reasons|0|||
164245731|NCT02574078|593269256|FG006|Pre-Treatment Period|Other reasons|2|||
164245732|NCT02574078|593269257|FG007|Pre-Treatment Period|Other reasons|0|||
164245733|NCT02574078|593269258|FG008|Pre-Treatment Period|Other reasons|0|||
164245734|NCT02574078|593269259|FG009|Pre-Treatment Period|Other reasons|0|||
164245735|NCT02574078|593269260|FG010|Pre-Treatment Period|Other reasons|2|||
164245736|NCT02574078|593269261|FG011|Pre-Treatment Period|Other reasons|0|||
164245737|NCT02574078|593269262|FG012|Pre-Treatment Period|Other reasons|0|||
164245738|NCT02574078|593269250|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
164245739|NCT02574078|593269251|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
164245740|NCT02574078|593269252|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
164245741|NCT02574078|593269253|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
164245742|NCT02574078|593269254|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
164245743|NCT02574078|593269255|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
164245744|NCT02574078|593269256|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
164245745|NCT02574078|593269257|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
164245746|NCT02574078|593269258|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
164245747|NCT02574078|593269259|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
164245748|NCT02574078|593269260|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
164245749|NCT02574078|593269261|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
164245750|NCT02574078|593269262|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
164245751|NCT02574078|593269250|FG000|Treatment Period|Disease progression|6|||
164245752|NCT02574078|593269251|FG001|Treatment Period|Disease progression|4|||
164245753|NCT02574078|593269252|FG002|Treatment Period|Disease progression|7|||
164245754|NCT02574078|593269253|FG003|Treatment Period|Disease progression|18|||
164245755|NCT02574078|593269254|FG004|Treatment Period|Disease progression|16|||
164245756|NCT02574078|593269255|FG005|Treatment Period|Disease progression|26|||
164245757|NCT02574078|593269256|FG006|Treatment Period|Disease progression|5|||
164245758|NCT02574078|593269257|FG007|Treatment Period|Disease progression|9|||
164245759|NCT02574078|593269258|FG008|Treatment Period|Disease progression|8|||
164245760|NCT02574078|593269259|FG009|Treatment Period|Disease progression|5|||
164245761|NCT02574078|593269260|FG010|Treatment Period|Disease progression|20|||
164245762|NCT02574078|593269261|FG011|Treatment Period|Disease progression|29|||
164245763|NCT02574078|593269262|FG012|Treatment Period|Disease progression|2|||
164245764|NCT02574078|593269250|FG000|Treatment Period|Study drug toxicity|1|||
164245765|NCT02574078|593269251|FG001|Treatment Period|Study drug toxicity|1|||
164245766|NCT02574078|593269252|FG002|Treatment Period|Study drug toxicity|0|||
164245767|NCT02574078|593269253|FG003|Treatment Period|Study drug toxicity|5|||
164245768|NCT02574078|593269254|FG004|Treatment Period|Study drug toxicity|3|||
164245769|NCT02574078|593269255|FG005|Treatment Period|Study drug toxicity|1|||
164245770|NCT02574078|593269256|FG006|Treatment Period|Study drug toxicity|2|||
164245771|NCT02574078|593269257|FG007|Treatment Period|Study drug toxicity|0|||
164245772|NCT02574078|593269258|FG008|Treatment Period|Study drug toxicity|2|||
164245773|NCT02574078|593269259|FG009|Treatment Period|Study drug toxicity|1|||
164245774|NCT02574078|593269260|FG010|Treatment Period|Study drug toxicity|16|||
164245775|NCT02574078|593269261|FG011|Treatment Period|Study drug toxicity|2|||
164245776|NCT02574078|593269262|FG012|Treatment Period|Study drug toxicity|4|||
164245777|NCT02574078|593269250|FG000|Treatment Period|Death|2|||
164245778|NCT02574078|593269251|FG001|Treatment Period|Death|0|||
164245779|NCT02574078|593269252|FG002|Treatment Period|Death|0|||
164245780|NCT02574078|593269253|FG003|Treatment Period|Death|0|||
164245781|NCT02574078|593269254|FG004|Treatment Period|Death|1|||
164245782|NCT02574078|593269255|FG005|Treatment Period|Death|1|||
164245783|NCT02574078|593269256|FG006|Treatment Period|Death|1|||
164245784|NCT02574078|593269257|FG007|Treatment Period|Death|1|||
164245785|NCT02574078|593269258|FG008|Treatment Period|Death|7|||
164245786|NCT02574078|593269259|FG009|Treatment Period|Death|1|||
164245787|NCT02574078|593269260|FG010|Treatment Period|Death|0|||
164245788|NCT02574078|593269261|FG011|Treatment Period|Death|2|||
164245789|NCT02574078|593269262|FG012|Treatment Period|Death|1|||
164245790|NCT02574078|593269250|FG000|Treatment Period|Adverse event unrelated to drug|0|||
164245791|NCT02574078|593269251|FG001|Treatment Period|Adverse event unrelated to drug|0|||
164337668|NCT01251861|593611615|FG000|Overall Study|Potential interaction of drugs|0|||
164083761|NCT00617461|592670267|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
164083762|NCT00617461|592670268|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
164083763|NCT00617461|592670267|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
164083764|NCT00617461|592670268|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
164083765|NCT05085964|592670269|FG000|Overall Study|Premature termination of study|21|||
164083766|NCT05085964|592670270|FG001|Overall Study|Premature termination of study|0|||
164083767|NCT01821625|592670271|FG000|Overall Study|Withdrawal by Subject|2|||
164083768|NCT01821625|592670271|FG000|Overall Study|Lack of Efficacy|2|||
164083769|NCT01821625|592670271|FG000|Overall Study|Adverse Event|1|||
164083770|NCT01821625|592670271|FG000|Overall Study|Medical contraindication|1|||
164083771|NCT01620489|592670273|FG000|Overall Study|Adverse Event|17|||
164083772|NCT01620489|592670274|FG001|Overall Study|Adverse Event|4|||
164083773|NCT01620489|592670273|FG000|Overall Study|Protocol Violation|0|||
164083774|NCT01620489|592670274|FG001|Overall Study|Protocol Violation|3|||
164083775|NCT01620489|592670273|FG000|Overall Study|Withdrawal Criteria|17|||
164083776|NCT01620489|592670274|FG001|Overall Study|Withdrawal Criteria|25|||
164083777|NCT01620489|592670273|FG000|Overall Study|Unclassified|1|||
164083778|NCT01620489|592670274|FG001|Overall Study|Unclassified|2|||
164083779|NCT00947856|592670275|FG000|Treatment Period|Progressive Disease|33|||
164083780|NCT00947856|592670276|FG001|Treatment Period|Progressive Disease|12|||
164083781|NCT00947856|592670275|FG000|Treatment Period|Adverse Event|15|||
164083782|NCT00947856|592670276|FG001|Treatment Period|Adverse Event|9|||
164083783|NCT00947856|592670275|FG000|Treatment Period|Physician Decision|14|||
164083784|NCT00947856|592670276|FG001|Treatment Period|Physician Decision|6|||
164083785|NCT00947856|592670275|FG000|Treatment Period|Study Stopped by Sponsor|4|||
164083786|NCT00947856|592670276|FG001|Treatment Period|Study Stopped by Sponsor|4|||
164083787|NCT00947856|592670275|FG000|Treatment Period|Withdrawal by Subject|12|||
164083788|NCT00947856|592670276|FG001|Treatment Period|Withdrawal by Subject|1|||
164083789|NCT00947856|592670275|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
164083790|NCT00947856|592670276|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
164083791|NCT00947856|592670275|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
164337669|NCT01251861|593611616|FG001|Overall Study|Potential interaction of drugs|1|||
164083792|NCT00947856|592670276|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
164083793|NCT00947856|592670275|FG000|Follow-up Period|Lost to Follow-up|7|||
164083794|NCT00947856|592670276|FG001|Follow-up Period|Lost to Follow-up|0|||
164083795|NCT00947856|592670275|FG000|Follow-up Period|Patient unavailable for site visits|1|||
164245792|NCT02574078|593269252|FG002|Treatment Period|Adverse event unrelated to drug|1|||
164245793|NCT02574078|593269253|FG003|Treatment Period|Adverse event unrelated to drug|0|||
164245794|NCT02574078|593269254|FG004|Treatment Period|Adverse event unrelated to drug|2|||
164245795|NCT02574078|593269255|FG005|Treatment Period|Adverse event unrelated to drug|3|||
164245796|NCT02574078|593269256|FG006|Treatment Period|Adverse event unrelated to drug|0|||
164245797|NCT02574078|593269257|FG007|Treatment Period|Adverse event unrelated to drug|0|||
164245798|NCT02574078|593269258|FG008|Treatment Period|Adverse event unrelated to drug|1|||
164245799|NCT02574078|593269259|FG009|Treatment Period|Adverse event unrelated to drug|2|||
164245800|NCT02574078|593269260|FG010|Treatment Period|Adverse event unrelated to drug|4|||
164245801|NCT02574078|593269261|FG011|Treatment Period|Adverse event unrelated to drug|1|||
164245802|NCT02574078|593269262|FG012|Treatment Period|Adverse event unrelated to drug|0|||
164245803|NCT02574078|593269250|FG000|Treatment Period|Administrative reason by Sponsor|0|||
164245804|NCT02574078|593269251|FG001|Treatment Period|Administrative reason by Sponsor|1|||
164245805|NCT02574078|593269252|FG002|Treatment Period|Administrative reason by Sponsor|0|||
164245806|NCT02574078|593269253|FG003|Treatment Period|Administrative reason by Sponsor|0|||
164245807|NCT02574078|593269254|FG004|Treatment Period|Administrative reason by Sponsor|0|||
164245808|NCT02574078|593269255|FG005|Treatment Period|Administrative reason by Sponsor|0|||
164245809|NCT02574078|593269256|FG006|Treatment Period|Administrative reason by Sponsor|1|||
164245810|NCT02574078|593269257|FG007|Treatment Period|Administrative reason by Sponsor|0|||
164245811|NCT02574078|593269258|FG008|Treatment Period|Administrative reason by Sponsor|0|||
164245812|NCT02574078|593269259|FG009|Treatment Period|Administrative reason by Sponsor|0|||
164245813|NCT02574078|593269260|FG010|Treatment Period|Administrative reason by Sponsor|0|||
164245814|NCT02574078|593269261|FG011|Treatment Period|Administrative reason by Sponsor|0|||
164245815|NCT02574078|593269262|FG012|Treatment Period|Administrative reason by Sponsor|3|||
164245816|NCT02574078|593269250|FG000|Treatment Period|Other reasons|1|||
164245817|NCT02574078|593269251|FG001|Treatment Period|Other reasons|0|||
164245818|NCT02574078|593269252|FG002|Treatment Period|Other reasons|1|||
164245819|NCT02574078|593269253|FG003|Treatment Period|Other reasons|3|||
164245820|NCT02574078|593269254|FG004|Treatment Period|Other reasons|3|||
164245821|NCT02574078|593269255|FG005|Treatment Period|Other reasons|1|||
164245822|NCT02574078|593269256|FG006|Treatment Period|Other reasons|2|||
164245823|NCT02574078|593269257|FG007|Treatment Period|Other reasons|1|||
164245824|NCT02574078|593269258|FG008|Treatment Period|Other reasons|3|||
164245825|NCT02574078|593269259|FG009|Treatment Period|Other reasons|1|||
164245826|NCT02574078|593269260|FG010|Treatment Period|Other reasons|1|||
164245827|NCT02574078|593269261|FG011|Treatment Period|Other reasons|3|||
164245828|NCT02574078|593269262|FG012|Treatment Period|Other reasons|1|||
164245829|NCT02574078|593269250|FG000|Treatment Period|Participant request to stop drug|0|||
164245830|NCT02574078|593269251|FG001|Treatment Period|Participant request to stop drug|0|||
164245831|NCT02574078|593269252|FG002|Treatment Period|Participant request to stop drug|0|||
164245832|NCT02574078|593269253|FG003|Treatment Period|Participant request to stop drug|2|||
164245833|NCT02574078|593269254|FG004|Treatment Period|Participant request to stop drug|4|||
164245834|NCT02574078|593269255|FG005|Treatment Period|Participant request to stop drug|0|||
164245835|NCT02574078|593269256|FG006|Treatment Period|Participant request to stop drug|1|||
164245836|NCT02574078|593269257|FG007|Treatment Period|Participant request to stop drug|0|||
164245837|NCT02574078|593269258|FG008|Treatment Period|Participant request to stop drug|3|||
164337670|NCT00531934|593613103|FG000|Overall Study|Adverse Event|4|||
164337671|NCT00531934|593613104|FG001|Overall Study|Adverse Event|8|||
164337672|NCT00531934|593613103|FG000|Overall Study|Progression|52|||
164337673|NCT00531934|593613104|FG001|Overall Study|Progression|42|||
163885900|NCT03194217|591954034|FG000|Overall Study|Other|0|||
163885901|NCT03194217|591954035|FG001|Overall Study|Other|1|||
163885902|NCT03194217|591954036|FG002|Overall Study|Other|1|||
163885903|NCT03194217|591954037|FG003|Overall Study|Other|0|||
163885904|NCT02962895|591954038|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
163885905|NCT02962895|591954039|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
163885906|NCT02962895|591954040|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
163885907|NCT02962895|591954041|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163885908|NCT02962895|591954042|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163885909|NCT02962895|591954043|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163885910|NCT02962895|591954044|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
163885911|NCT02962895|591954038|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163885912|NCT02962895|591954039|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
163885913|NCT02962895|591954040|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163885914|NCT02962895|591954041|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164245838|NCT02574078|593269259|FG009|Treatment Period|Participant request to stop drug|2|||
164245839|NCT02574078|593269260|FG010|Treatment Period|Participant request to stop drug|2|||
164245840|NCT02574078|593269261|FG011|Treatment Period|Participant request to stop drug|4|||
164245841|NCT02574078|593269262|FG012|Treatment Period|Participant request to stop drug|1|||
164245842|NCT02574078|593269250|FG000|Treatment Period|Participant withdrew consent|0|||
164245843|NCT02574078|593269251|FG001|Treatment Period|Participant withdrew consent|0|||
164245844|NCT02574078|593269252|FG002|Treatment Period|Participant withdrew consent|0|||
164245845|NCT02574078|593269253|FG003|Treatment Period|Participant withdrew consent|0|||
164337674|NCT00531934|593613103|FG000|Overall Study|Death|7|||
163885915|NCT02962895|591954042|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163990633|NCT03502330|592335049|FG008|Overall Study|Physician Decision|0|||
164245846|NCT02574078|593269254|FG004|Treatment Period|Participant withdrew consent|1|||
164337675|NCT00531934|593613104|FG001|Overall Study|Death|10|||
164245847|NCT02574078|593269255|FG005|Treatment Period|Participant withdrew consent|1|||
164245848|NCT02574078|593269256|FG006|Treatment Period|Participant withdrew consent|0|||
164245849|NCT02574078|593269257|FG007|Treatment Period|Participant withdrew consent|1|||
164245850|NCT02574078|593269258|FG008|Treatment Period|Participant withdrew consent|0|||
164245851|NCT02574078|593269259|FG009|Treatment Period|Participant withdrew consent|2|||
164245852|NCT02574078|593269260|FG010|Treatment Period|Participant withdrew consent|1|||
164245853|NCT02574078|593269261|FG011|Treatment Period|Participant withdrew consent|4|||
164245854|NCT02574078|593269262|FG012|Treatment Period|Participant withdrew consent|1|||
164245855|NCT02574078|593269250|FG000|Treatment Period|Participant no longer meets criteria|0|||
164245856|NCT02574078|593269251|FG001|Treatment Period|Participant no longer meets criteria|0|||
164245857|NCT02574078|593269252|FG002|Treatment Period|Participant no longer meets criteria|0|||
164245858|NCT02574078|593269253|FG003|Treatment Period|Participant no longer meets criteria|0|||
164245859|NCT02574078|593269254|FG004|Treatment Period|Participant no longer meets criteria|1|||
164245860|NCT02574078|593269255|FG005|Treatment Period|Participant no longer meets criteria|0|||
164245861|NCT02574078|593269256|FG006|Treatment Period|Participant no longer meets criteria|0|||
164245862|NCT02574078|593269257|FG007|Treatment Period|Participant no longer meets criteria|0|||
164245863|NCT02574078|593269258|FG008|Treatment Period|Participant no longer meets criteria|0|||
164245864|NCT02574078|593269259|FG009|Treatment Period|Participant no longer meets criteria|1|||
164245865|NCT02574078|593269260|FG010|Treatment Period|Participant no longer meets criteria|1|||
164245866|NCT02574078|593269261|FG011|Treatment Period|Participant no longer meets criteria|1|||
164245867|NCT02574078|593269262|FG012|Treatment Period|Participant no longer meets criteria|0|||
164245868|NCT02574078|593269250|FG000|Treatment Period|Lost to Follow-up|0|||
164245869|NCT02574078|593269251|FG001|Treatment Period|Lost to Follow-up|0|||
164245870|NCT02574078|593269252|FG002|Treatment Period|Lost to Follow-up|0|||
164245871|NCT02574078|593269253|FG003|Treatment Period|Lost to Follow-up|0|||
164245872|NCT02574078|593269254|FG004|Treatment Period|Lost to Follow-up|0|||
164245873|NCT02574078|593269255|FG005|Treatment Period|Lost to Follow-up|0|||
164245874|NCT02574078|593269256|FG006|Treatment Period|Lost to Follow-up|0|||
164245875|NCT02574078|593269257|FG007|Treatment Period|Lost to Follow-up|0|||
164245876|NCT02574078|593269258|FG008|Treatment Period|Lost to Follow-up|0|||
164245877|NCT02574078|593269259|FG009|Treatment Period|Lost to Follow-up|1|||
164245878|NCT02574078|593269260|FG010|Treatment Period|Lost to Follow-up|0|||
164245879|NCT02574078|593269261|FG011|Treatment Period|Lost to Follow-up|1|||
164083796|NCT00947856|592670276|FG001|Follow-up Period|Patient unavailable for site visits|0|||
164083797|NCT00947856|592670275|FG000|Follow-up Period|Withdrawal by Subject|1|||
164083798|NCT00947856|592670276|FG001|Follow-up Period|Withdrawal by Subject|0|||
164083799|NCT00982410|592672164|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
164083800|NCT00982410|592672165|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
164083801|NCT00982410|592672164|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
164083802|NCT00982410|592672165|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
164083803|NCT00982410|592672164|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
164083804|NCT00982410|592672165|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
164083805|NCT00982410|592672164|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
164083806|NCT00982410|592672165|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
164083807|NCT00982410|592672164|FG000|6-month Follow-up Assessment|participant no transportation|1|||
164083808|NCT00982410|592672165|FG001|6-month Follow-up Assessment|participant no transportation|0|||
164083809|NCT00982410|592672164|FG000|6-month Follow-up Assessment|incarceration|0|||
164083810|NCT00982410|592672165|FG001|6-month Follow-up Assessment|incarceration|2|||
164083811|NCT00982410|592672164|FG000|6-month Follow-up Assessment|patent surgery|0|||
164083812|NCT00982410|592672165|FG001|6-month Follow-up Assessment|patent surgery|1|||
164083813|NCT00982410|592672164|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
164083814|NCT00982410|592672165|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
164083815|NCT00982410|592672164|FG000|12-month Follow-up Assessment|Death|0|||
164083816|NCT00982410|592672165|FG001|12-month Follow-up Assessment|Death|2|||
164083817|NCT00982410|592672164|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
164083818|NCT00982410|592672165|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
164245880|NCT02574078|593269262|FG012|Treatment Period|Lost to Follow-up|0|||
164245881|NCT02574078|593269250|FG000|Treatment Period|Maximum clinical benefit|0|||
164245882|NCT02574078|593269251|FG001|Treatment Period|Maximum clinical benefit|0|||
164245883|NCT02574078|593269252|FG002|Treatment Period|Maximum clinical benefit|0|||
164245884|NCT02574078|593269253|FG003|Treatment Period|Maximum clinical benefit|0|||
164337676|NCT00531934|593613103|FG000|Overall Study|Withdrawal by Subject|1|||
164083819|NCT00982410|592672164|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
164083820|NCT00982410|592672165|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
164083821|NCT00982410|592672164|FG000|12-month Follow-up Assessment|incarceration|2|||
164083822|NCT00982410|592672165|FG001|12-month Follow-up Assessment|incarceration|1|||
164083823|NCT00982410|592672164|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
164245885|NCT02574078|593269254|FG004|Treatment Period|Maximum clinical benefit|0|||
164245886|NCT02574078|593269255|FG005|Treatment Period|Maximum clinical benefit|0|||
164245887|NCT02574078|593269256|FG006|Treatment Period|Maximum clinical benefit|0|||
164245888|NCT02574078|593269257|FG007|Treatment Period|Maximum clinical benefit|0|||
164245889|NCT02574078|593269258|FG008|Treatment Period|Maximum clinical benefit|0|||
164245890|NCT02574078|593269259|FG009|Treatment Period|Maximum clinical benefit|1|||
164245891|NCT02574078|593269260|FG010|Treatment Period|Maximum clinical benefit|0|||
164245892|NCT02574078|593269261|FG011|Treatment Period|Maximum clinical benefit|0|||
164245893|NCT02574078|593269262|FG012|Treatment Period|Maximum clinical benefit|0|||
164245894|NCT02222688|593269263|FG000|Overall Study|Withdrawal by Subject|0|||
164245895|NCT02222688|593269264|FG001|Overall Study|Withdrawal by Subject|0|||
164245896|NCT02222688|593269265|FG002|Overall Study|Withdrawal by Subject|0|||
164245897|NCT02222688|593269266|FG003|Overall Study|Withdrawal by Subject|2|||
164245898|NCT02222688|593269267|FG004|Overall Study|Withdrawal by Subject|1|||
164245899|NCT02222688|593269268|FG005|Overall Study|Withdrawal by Subject|0|||
164245900|NCT02222688|593269269|FG006|Overall Study|Withdrawal by Subject|1|||
164245901|NCT02222688|593269263|FG000|Overall Study|Disease progression|1|||
164337677|NCT00531934|593613104|FG001|Overall Study|Withdrawal by Subject|1|||
164337678|NCT00531934|593613103|FG000|Overall Study|Other|2|||
164337679|NCT00531934|593613104|FG001|Overall Study|Other|2|||
164337680|NCT00150709|593613105|FG000|Overall Study|Protocol Violation|7|||
164337681|NCT00150709|593613106|FG001|Overall Study|Protocol Violation|8|||
164337682|NCT00150709|593613107|FG002|Overall Study|Protocol Violation|3|||
164337683|NCT00150709|593613108|FG003|Overall Study|Protocol Violation|1|||
164337684|NCT00150709|593613105|FG000|Overall Study|Adverse Event|8|||
164337685|NCT00150709|593613106|FG001|Overall Study|Adverse Event|2|||
164337686|NCT00150709|593613107|FG002|Overall Study|Adverse Event|2|||
164337687|NCT00150709|593613108|FG003|Overall Study|Adverse Event|3|||
164337688|NCT00150709|593613105|FG000|Overall Study|Lack of Efficacy|6|||
164337689|NCT00150709|593613106|FG001|Overall Study|Lack of Efficacy|11|||
164337690|NCT00150709|593613107|FG002|Overall Study|Lack of Efficacy|9|||
164337691|NCT00150709|593613108|FG003|Overall Study|Lack of Efficacy|0|||
164337692|NCT00150709|593613105|FG000|Overall Study|Withdrawal by Subject|7|||
164337693|NCT00150709|593613106|FG001|Overall Study|Withdrawal by Subject|10|||
164337694|NCT00150709|593613107|FG002|Overall Study|Withdrawal by Subject|5|||
164337695|NCT00150709|593613108|FG003|Overall Study|Withdrawal by Subject|0|||
164337696|NCT00150709|593613105|FG000|Overall Study|Lost to Follow-up|3|||
164337697|NCT00150709|593613106|FG001|Overall Study|Lost to Follow-up|2|||
164337698|NCT00150709|593613107|FG002|Overall Study|Lost to Follow-up|0|||
164337699|NCT00150709|593613108|FG003|Overall Study|Lost to Follow-up|0|||
164337700|NCT00150709|593613105|FG000|Overall Study|Sponsor decision|0|||
164337701|NCT00150709|593613106|FG001|Overall Study|Sponsor decision|0|||
164337702|NCT00150709|593613107|FG002|Overall Study|Sponsor decision|0|||
164337703|NCT00150709|593613108|FG003|Overall Study|Sponsor decision|1|||
164337704|NCT00150709|593613105|FG000|Overall Study|Site/Investigator discontinued the study|5|||
164337705|NCT00150709|593613106|FG001|Overall Study|Site/Investigator discontinued the study|5|||
164337706|NCT00150709|593613107|FG002|Overall Study|Site/Investigator discontinued the study|2|||
164337707|NCT00150709|593613108|FG003|Overall Study|Site/Investigator discontinued the study|0|||
164337708|NCT00150709|593613105|FG000|Overall Study|Decision of parent(s)|1|||
164337709|NCT00150709|593613106|FG001|Overall Study|Decision of parent(s)|2|||
164337710|NCT00150709|593613107|FG002|Overall Study|Decision of parent(s)|0|||
164337711|NCT00150709|593613108|FG003|Overall Study|Decision of parent(s)|0|||
164337712|NCT00150709|593613105|FG000|Overall Study|Decision of parent(s) and investigator|3|||
164337713|NCT00150709|593613106|FG001|Overall Study|Decision of parent(s) and investigator|0|||
164337714|NCT00150709|593613107|FG002|Overall Study|Decision of parent(s) and investigator|0|||
164337715|NCT00150709|593613108|FG003|Overall Study|Decision of parent(s) and investigator|0|||
164337716|NCT00150709|593613105|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
164337717|NCT00150709|593613106|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
164337718|NCT00150709|593613107|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
164337719|NCT00150709|593613108|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
164337720|NCT00150709|593613105|FG000|Overall Study|Investigator decision|1|||
164337721|NCT00150709|593613106|FG001|Overall Study|Investigator decision|0|||
164337722|NCT00150709|593613107|FG002|Overall Study|Investigator decision|0|||
164337723|NCT00150709|593613108|FG003|Overall Study|Investigator decision|1|||
164337724|NCT00150709|593613105|FG000|Overall Study|Subject relocated|2|||
164337725|NCT00150709|593613106|FG001|Overall Study|Subject relocated|2|||
164337726|NCT00150709|593613107|FG002|Overall Study|Subject relocated|1|||
164337727|NCT00150709|593613108|FG003|Overall Study|Subject relocated|0|||
164337728|NCT00150709|593613105|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
164337729|NCT00150709|593613106|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
164337730|NCT00150709|593613107|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
164337731|NCT00150709|593613108|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
164337732|NCT00150709|593613105|FG000|Overall Study|Convenience|0|||
164337733|NCT00150709|593613106|FG001|Overall Study|Convenience|1|||
164337734|NCT00150709|593613107|FG002|Overall Study|Convenience|0|||
164337735|NCT00150709|593613108|FG003|Overall Study|Convenience|0|||
164337736|NCT00150709|593613105|FG000|Overall Study|Subject entered new drug study|0|||
164245902|NCT02222688|593269264|FG001|Overall Study|Disease progression|0|||
164245903|NCT02222688|593269265|FG002|Overall Study|Disease progression|0|||
164245904|NCT02222688|593269266|FG003|Overall Study|Disease progression|0|||
164245905|NCT02222688|593269267|FG004|Overall Study|Disease progression|0|||
164245906|NCT02222688|593269268|FG005|Overall Study|Disease progression|0|||
164245907|NCT02222688|593269269|FG006|Overall Study|Disease progression|0|||
164245908|NCT05935878|593269276|FG000|Overall Study|Death|1|||
164245909|NCT05935878|593269277|FG001|Overall Study|Death|2|||
164245910|NCT05935878|593269276|FG000|Overall Study|Withdrawal by Subject|5|||
164245911|NCT05935878|593269277|FG001|Overall Study|Withdrawal by Subject|5|||
164245912|NCT05935878|593269276|FG000|Overall Study|Revision of implant|1|||
164245913|NCT05935878|593269277|FG001|Overall Study|Revision of implant|1|||
164245914|NCT05935878|593269276|FG000|Overall Study|Mobile bearing dislocation|0|||
164245915|NCT05935878|593269277|FG001|Overall Study|Mobile bearing dislocation|1|||
164245916|NCT02297815|593269293|FG000|Overall Study|Lost to Follow-up|236|||
164245917|NCT02297815|593269294|FG001|Overall Study|Lost to Follow-up|140|||
164245918|NCT00662831|593269295|FG000|Overall Study|Death|4|||
164245919|NCT00662831|593269296|FG001|Overall Study|Death|1|||
164245920|NCT00662831|593269295|FG000|Overall Study|Lack of Efficacy|6|||
164245921|NCT00662831|593269296|FG001|Overall Study|Lack of Efficacy|6|||
164245922|NCT00662831|593269295|FG000|Overall Study|Lost to Follow-up|1|||
164245923|NCT00662831|593269296|FG001|Overall Study|Lost to Follow-up|0|||
164245924|NCT00662831|593269295|FG000|Overall Study|Withdrawal by Subject|2|||
164245925|NCT00662831|593269296|FG001|Overall Study|Withdrawal by Subject|1|||
164245926|NCT00662831|593269295|FG000|Overall Study|Other|62|||
164245927|NCT00662831|593269296|FG001|Overall Study|Other|31|||
164245928|NCT00662831|593269295|FG000|Overall Study|Protocol Violation|8|||
164245929|NCT00662831|593269296|FG001|Overall Study|Protocol Violation|4|||
164245930|NCT00662831|593269295|FG000|Overall Study|Adverse Event|23|||
164245931|NCT00662831|593269296|FG001|Overall Study|Adverse Event|16|||
164245932|NCT02397915|593269306|FG000|Period 1|Protocol Violation|0|||
164245933|NCT02397915|593269307|FG001|Period 1|Protocol Violation|1|||
164245934|NCT02397915|593269308|FG002|Period 1|Protocol Violation|0|||
164245935|NCT02397915|593269309|FG003|Period 1|Protocol Violation|0|||
164245936|NCT02397915|593269306|FG000|Period 1|Physician Decision|1|||
164083824|NCT00982410|592672165|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
164083825|NCT02034799|592672168|FG000|Overall Study|Withdrawal by Subject|0|||
164083826|NCT02034799|592672169|FG001|Overall Study|Withdrawal by Subject|2|||
164083827|NCT02034799|592672168|FG000|Overall Study|Lost to Follow-up|0|||
164083828|NCT02034799|592672169|FG001|Overall Study|Lost to Follow-up|1|||
164245937|NCT02397915|593269307|FG001|Period 1|Physician Decision|0|||
164245938|NCT02397915|593269308|FG002|Period 1|Physician Decision|0|||
164245939|NCT02397915|593269309|FG003|Period 1|Physician Decision|0|||
164245940|NCT03292874|593269310|FG000|Overall Study|Due to pandemic|5|||
164245941|NCT00368745|593269311|FG000|Double-blind Treatment Period|Adverse Event|6|||
164245942|NCT00368745|593269312|FG001|Double-blind Treatment Period|Adverse Event|6|||
164245943|NCT00368745|593269311|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
164245944|NCT00368745|593269312|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
164245945|NCT00368745|593269311|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164245946|NCT00368745|593269312|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164245947|NCT00368745|593269311|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
164245948|NCT00368745|593269312|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
164245949|NCT00368745|593269311|FG000|Double-blind Treatment Period|Other|7|||
164245950|NCT00368745|593269312|FG001|Double-blind Treatment Period|Other|6|||
164245951|NCT00293813|593269316|FG000|Overall Study|Physician Decision|0|||
164245952|NCT00293813|593269317|FG001|Overall Study|Physician Decision|1|||
164245953|NCT00293813|593269318|FG002|Overall Study|Physician Decision|0|||
164245954|NCT00293813|593269316|FG000|Overall Study|Adverse Event|3|||
164245955|NCT00293813|593269317|FG001|Overall Study|Adverse Event|1|||
163885916|NCT02962895|591954043|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
164006698|NCT03519178|592391052|FG003|PF-06873600 Treatment|Death|0|||
164006699|NCT03519178|592391053|FG004|PF-06873600 Treatment|Death|0|||
164006700|NCT03519178|592391054|FG005|PF-06873600 Treatment|Death|0|||
164006701|NCT03519178|592391055|FG006|PF-06873600 Treatment|Death|0|||
164006702|NCT03519178|592391056|FG007|PF-06873600 Treatment|Death|0|||
164006703|NCT03519178|592391057|FG008|PF-06873600 Treatment|Death|1|||
164006704|NCT03519178|592391058|FG009|PF-06873600 Treatment|Death|1|||
164006705|NCT03519178|592391059|FG010|PF-06873600 Treatment|Death|0|||
164006706|NCT03519178|592391060|FG011|PF-06873600 Treatment|Death|0|||
164006707|NCT03519178|592391061|FG012|PF-06873600 Treatment|Death|0|||
164006708|NCT03519178|592391062|FG013|PF-06873600 Treatment|Death|0|||
164006709|NCT03519178|592391063|FG014|PF-06873600 Treatment|Death|1|||
164006710|NCT03519178|592391049|FG000|PF-06873600 Treatment|Physician Decision|0|||
164006711|NCT03519178|592391050|FG001|PF-06873600 Treatment|Physician Decision|0|||
164006712|NCT03519178|592391051|FG002|PF-06873600 Treatment|Physician Decision|0|||
164006713|NCT03519178|592391052|FG003|PF-06873600 Treatment|Physician Decision|0|||
164006714|NCT03519178|592391053|FG004|PF-06873600 Treatment|Physician Decision|0|||
164006715|NCT03519178|592391054|FG005|PF-06873600 Treatment|Physician Decision|0|||
164006716|NCT03519178|592391055|FG006|PF-06873600 Treatment|Physician Decision|0|||
164006717|NCT03519178|592391056|FG007|PF-06873600 Treatment|Physician Decision|1|||
164245956|NCT00293813|593269318|FG002|Overall Study|Adverse Event|1|||
164245957|NCT00293813|593269316|FG000|Overall Study|Withdrawal by Subject|7|||
164245958|NCT00293813|593269317|FG001|Overall Study|Withdrawal by Subject|4|||
164245959|NCT00293813|593269318|FG002|Overall Study|Withdrawal by Subject|4|||
164245960|NCT00293813|593269316|FG000|Overall Study|Lost to Follow-up|3|||
164245961|NCT00293813|593269317|FG001|Overall Study|Lost to Follow-up|2|||
164245962|NCT00293813|593269318|FG002|Overall Study|Lost to Follow-up|3|||
164245963|NCT00293813|593269316|FG000|Overall Study|Noncompliance|0|||
164245964|NCT00293813|593269317|FG001|Overall Study|Noncompliance|1|||
164245965|NCT00293813|593269318|FG002|Overall Study|Noncompliance|0|||
164245966|NCT01188551|593269319|FG000|Overall Study|Pharmacy issues|1|||
164245967|NCT01188551|593269320|FG001|Overall Study|Pharmacy issues|0|||
164245968|NCT01188551|593269321|FG002|Overall Study|Pharmacy issues|0|||
164245969|NCT01188551|593269322|FG003|Overall Study|Pharmacy issues|0|||
164245970|NCT01306643|593269327|FG000|Overall Study|Adverse Event|5|||
164245971|NCT01306643|593269327|FG000|Overall Study|Disease Progression|7|||
164245972|NCT01306643|593269327|FG000|Overall Study|Other: Change in Eligibility Status|1|||
164245973|NCT03458325|593269332|FG000|Overall Study|Withdrawal by Subject|1|||
164245974|NCT00414076|593269333|FG000|Overall Study|Progression|1|||
164245975|NCT00414076|593269334|FG001|Overall Study|Progression|2|||
164245976|NCT00414076|593269333|FG000|Overall Study|Withdrawal by Subject|1|||
164245977|NCT00414076|593269334|FG001|Overall Study|Withdrawal by Subject|3|||
164245978|NCT00414076|593269333|FG000|Overall Study|Adverse Event|1|||
164245979|NCT00414076|593269334|FG001|Overall Study|Adverse Event|0|||
164245980|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245981|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245982|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
164245983|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
164245984|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245985|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245986|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
164245987|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
164245988|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245989|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245990|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245991|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245992|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245993|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164245994|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
164245995|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245996|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245997|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245998|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164245999|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164246000|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
164246001|NCT02720523|593269335|FG000|Period 1: Placebo-controlled Period|Other|0|||
164246002|NCT02720523|593269336|FG001|Period 1: Placebo-controlled Period|Other|0|||
164246003|NCT02720523|593269337|FG002|Period 1: Placebo-controlled Period|Other|1|||
164246004|NCT02720523|593269338|FG003|Period 1: Placebo-controlled Period|Other|1|||
164246005|NCT02720523|593269339|FG004|Period 1: Placebo-controlled Period|Other|0|||
164246006|NCT02720523|593269340|FG005|Period 1: Placebo-controlled Period|Other|0|||
164246007|NCT02720523|593269341|FG006|Period 1: Placebo-controlled Period|Other|0|||
164246008|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
164246009|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
164246010|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
164246011|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
164246012|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
164246013|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
164337737|NCT00150709|593613106|FG001|Overall Study|Subject entered new drug study|1|||
164337738|NCT00150709|593613107|FG002|Overall Study|Subject entered new drug study|0|||
164337739|NCT00150709|593613108|FG003|Overall Study|Subject entered new drug study|0|||
164337740|NCT00150709|593613105|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
164246014|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
164246015|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
164246016|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
163990634|NCT03502330|592335041|FG000|Overall Study|Withdrawal by Subject|0|||
164246017|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
164246018|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
164246019|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
164246020|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
164246021|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
164246022|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246023|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246024|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246025|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
164246026|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
164246027|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
164246028|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
164246029|NCT02720523|593269335|FG000|Period 2: Long-term Extension Period|Other|0|||
164246030|NCT02720523|593269336|FG001|Period 2: Long-term Extension Period|Other|0|||
164246031|NCT02720523|593269337|FG002|Period 2: Long-term Extension Period|Other|0|||
164246032|NCT02720523|593269338|FG003|Period 2: Long-term Extension Period|Other|0|||
164246033|NCT02720523|593269339|FG004|Period 2: Long-term Extension Period|Other|2|||
164246034|NCT02720523|593269340|FG005|Period 2: Long-term Extension Period|Other|0|||
164246035|NCT02720523|593269341|FG006|Period 2: Long-term Extension Period|Other|3|||
164246036|NCT03146663|593269342|FG000|Overall Study|Did not receive study treatment|1|||
164246037|NCT03146663|593269343|FG001|Overall Study|Did not receive study treatment|1|||
164246038|NCT05588440|593269350|FG000|Overall Study|Sponsor Decision|2|||
164246039|NCT05588440|593269351|FG001|Overall Study|Sponsor Decision|0|||
164246040|NCT05588440|593269352|FG002|Overall Study|Sponsor Decision|1|||
164246041|NCT05588440|593269350|FG000|Overall Study|Death|1|||
164246042|NCT05588440|593269351|FG001|Overall Study|Death|1|||
164246043|NCT05588440|593269352|FG002|Overall Study|Death|1|||
164246044|NCT05588440|593269350|FG000|Overall Study|Screen Fail|0|||
164246045|NCT05588440|593269351|FG001|Overall Study|Screen Fail|1|||
164246046|NCT05588440|593269352|FG002|Overall Study|Screen Fail|1|||
164246047|NCT05588440|593269350|FG000|Overall Study|Withdrawal by Subject|0|||
164246048|NCT05588440|593269351|FG001|Overall Study|Withdrawal by Subject|0|||
164246049|NCT05588440|593269352|FG002|Overall Study|Withdrawal by Subject|1|||
164246050|NCT05526521|593269353|FG000|Overall Study|Withdrawal by Subject|0|||
164246051|NCT05526521|593269354|FG001|Overall Study|Withdrawal by Subject|1|||
164246052|NCT05526521|593269355|FG002|Overall Study|Withdrawal by Subject|0|||
164246053|NCT05526521|593269356|FG003|Overall Study|Withdrawal by Subject|0|||
164246054|NCT03929913|593269357|FG000|Overall Study|Death|4|||
164246055|NCT03929913|593269357|FG000|Overall Study|Lost to Follow-up|1|||
164246056|NCT03929913|593269357|FG000|Overall Study|Failed Procedure|2|||
164246057|NCT03919929|593269360|FG000|Overall Study|Withdrawal by Subject|0|||
164246058|NCT03919929|593269361|FG001|Overall Study|Withdrawal by Subject|4|||
164246059|NCT03919929|593269360|FG000|Overall Study|Screen Failure|0|||
164246060|NCT03919929|593269361|FG001|Overall Study|Screen Failure|5|||
164246061|NCT03533660|593269362|FG000|Overall Study|Withdrawal by Subject|2|||
164246062|NCT03533660|593269363|FG001|Overall Study|Withdrawal by Subject|2|||
164246063|NCT03533660|593269362|FG000|Overall Study|Death|2|||
164246064|NCT03533660|593269363|FG001|Overall Study|Death|4|||
164246065|NCT03533660|593269362|FG000|Overall Study|Adverse Event|0|||
164246066|NCT03533660|593269363|FG001|Overall Study|Adverse Event|2|||
164246067|NCT01671956|593269364|FG000|Overall Study|Disease progression|0|||
164246068|NCT01671956|593269365|FG001|Overall Study|Disease progression|1|||
164246069|NCT01671956|593269364|FG000|Overall Study|Withdrawal by Subject|1|||
164246070|NCT01671956|593269365|FG001|Overall Study|Withdrawal by Subject|1|||
164246071|NCT01671956|593269364|FG000|Overall Study|Adverse Event|1|||
164246072|NCT01671956|593269365|FG001|Overall Study|Adverse Event|0|||
164246073|NCT03816176|593269373|FG000|Overall Study|Miscellaneous|5|||
164246074|NCT03816176|593269373|FG000|Overall Study|Lack of Efficacy|4|||
164246075|NCT03816176|593269373|FG000|Overall Study|Adverse Event|3|||
164246076|NCT03581292|593269374|FG000|Overall Study|Physician Decision|9|||
164246077|NCT03581292|593269375|FG001|Overall Study|Physician Decision|5|||
164246078|NCT03581292|593269374|FG000|Overall Study|Withdrawal by Subject|3|||
164246079|NCT03581292|593269375|FG001|Overall Study|Withdrawal by Subject|0|||
164246080|NCT03581292|593269374|FG000|Overall Study|Withdrawal before Therapy Start|1|||
164246081|NCT03581292|593269375|FG001|Overall Study|Withdrawal before Therapy Start|0|||
164246082|NCT05200572|593269376|FG000|Overall Study|Withdrawal by Subject|14|||
164246083|NCT02524145|593269380|FG000|Overall Study|Withdrawal by Subject|2|||
164246084|NCT02524145|593269381|FG001|Overall Study|Withdrawal by Subject|2|||
164246085|NCT02524145|593269382|FG002|Overall Study|Withdrawal by Subject|3|||
164246086|NCT07214935|593269385|FG000|Overall Study|Adverse Event|1|||
164246087|NCT07214935|593269386|FG001|Overall Study|Adverse Event|1|||
164246088|NCT07214935|593269387|FG002|Overall Study|Adverse Event|1|||
164246089|NCT07214935|593269388|FG003|Overall Study|Adverse Event|0|||
164246090|NCT07214935|593269385|FG000|Overall Study|Lost to Follow-up|0|||
164246091|NCT07214935|593269386|FG001|Overall Study|Lost to Follow-up|1|||
164246092|NCT07214935|593269387|FG002|Overall Study|Lost to Follow-up|0|||
164246093|NCT07214935|593269388|FG003|Overall Study|Lost to Follow-up|0|||
164246094|NCT07214935|593269385|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
164246095|NCT07214935|593269386|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
164246096|NCT07214935|593269387|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
164246097|NCT07214935|593269388|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
164246098|NCT07214935|593269385|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
164246099|NCT07214935|593269386|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
164246100|NCT07214935|593269387|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
164246101|NCT07214935|593269388|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
164299862|NCT02234843|593472953|FG009|Overall Study|Efficacy outcome reached|0|||
164299863|NCT02234843|593472944|FG000|Overall Study|Patient convenience|2|||
164299864|NCT02234843|593472945|FG001|Overall Study|Patient convenience|0|||
164299865|NCT02234843|593472946|FG002|Overall Study|Patient convenience|0|||
164299866|NCT02234843|593472947|FG003|Overall Study|Patient convenience|0|||
164299867|NCT02234843|593472948|FG004|Overall Study|Patient convenience|0|||
164299868|NCT02234843|593472949|FG005|Overall Study|Patient convenience|1|||
164299869|NCT02234843|593472950|FG006|Overall Study|Patient convenience|0|||
164299870|NCT02234843|593472951|FG007|Overall Study|Patient convenience|0|||
164299871|NCT02234843|593472952|FG008|Overall Study|Patient convenience|0|||
164299872|NCT02234843|593472953|FG009|Overall Study|Patient convenience|0|||
164299873|NCT02234843|593472944|FG000|Overall Study|Withdrawal by Subject|5|||
164299874|NCT02234843|593472945|FG001|Overall Study|Withdrawal by Subject|1|||
164299875|NCT02234843|593472946|FG002|Overall Study|Withdrawal by Subject|1|||
164299876|NCT02234843|593472947|FG003|Overall Study|Withdrawal by Subject|0|||
164299877|NCT02234843|593472948|FG004|Overall Study|Withdrawal by Subject|0|||
164299878|NCT02234843|593472949|FG005|Overall Study|Withdrawal by Subject|7|||
164299879|NCT02234843|593472950|FG006|Overall Study|Withdrawal by Subject|0|||
164299880|NCT02234843|593472951|FG007|Overall Study|Withdrawal by Subject|0|||
164299881|NCT02234843|593472952|FG008|Overall Study|Withdrawal by Subject|0|||
164299882|NCT02234843|593472953|FG009|Overall Study|Withdrawal by Subject|0|||
164299883|NCT02234843|593472944|FG000|Overall Study|Recovery|1|||
164299884|NCT02234843|593472945|FG001|Overall Study|Recovery|0|||
164299885|NCT02234843|593472946|FG002|Overall Study|Recovery|0|||
164299886|NCT02234843|593472947|FG003|Overall Study|Recovery|0|||
164299887|NCT02234843|593472948|FG004|Overall Study|Recovery|0|||
164299888|NCT02234843|593472949|FG005|Overall Study|Recovery|0|||
164299889|NCT02234843|593472950|FG006|Overall Study|Recovery|0|||
164299890|NCT02234843|593472951|FG007|Overall Study|Recovery|0|||
164299891|NCT02234843|593472952|FG008|Overall Study|Recovery|0|||
164299892|NCT02234843|593472953|FG009|Overall Study|Recovery|0|||
164299893|NCT02234843|593472944|FG000|Overall Study|Other|0|||
164299894|NCT02234843|593472945|FG001|Overall Study|Other|2|||
164299895|NCT02234843|593472946|FG002|Overall Study|Other|0|||
164299896|NCT02234843|593472947|FG003|Overall Study|Other|1|||
164299897|NCT02234843|593472948|FG004|Overall Study|Other|0|||
164299898|NCT02234843|593472949|FG005|Overall Study|Other|1|||
164299899|NCT02234843|593472950|FG006|Overall Study|Other|0|||
164299900|NCT02234843|593472951|FG007|Overall Study|Other|1|||
164299901|NCT02234843|593472952|FG008|Overall Study|Other|0|||
164299902|NCT02234843|593472953|FG009|Overall Study|Other|0|||
164299903|NCT02234843|593472944|FG000|Overall Study|Physician Decision|4|||
164299904|NCT02234843|593472945|FG001|Overall Study|Physician Decision|1|||
164299905|NCT02234843|593472946|FG002|Overall Study|Physician Decision|0|||
164299906|NCT02234843|593472947|FG003|Overall Study|Physician Decision|1|||
164299907|NCT02234843|593472948|FG004|Overall Study|Physician Decision|0|||
164299908|NCT02234843|593472949|FG005|Overall Study|Physician Decision|0|||
164299909|NCT02234843|593472950|FG006|Overall Study|Physician Decision|0|||
164299910|NCT02234843|593472951|FG007|Overall Study|Physician Decision|1|||
164299911|NCT02234843|593472952|FG008|Overall Study|Physician Decision|0|||
164299912|NCT02234843|593472953|FG009|Overall Study|Physician Decision|0|||
163885917|NCT02962895|591954044|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
163885918|NCT02962895|591954038|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164299913|NCT02234843|593472944|FG000|Overall Study|Adverse Event|5|||
164299914|NCT02234843|593472945|FG001|Overall Study|Adverse Event|1|||
164299915|NCT02234843|593472946|FG002|Overall Study|Adverse Event|1|||
164299916|NCT02234843|593472947|FG003|Overall Study|Adverse Event|3|||
164299917|NCT02234843|593472948|FG004|Overall Study|Adverse Event|2|||
164299918|NCT02234843|593472949|FG005|Overall Study|Adverse Event|1|||
164299919|NCT02234843|593472950|FG006|Overall Study|Adverse Event|0|||
164299920|NCT02234843|593472951|FG007|Overall Study|Adverse Event|0|||
164299921|NCT02234843|593472952|FG008|Overall Study|Adverse Event|1|||
164299922|NCT02234843|593472953|FG009|Overall Study|Adverse Event|0|||
164246102|NCT01945216|593271735|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
164246103|NCT01945216|593271735|FG000|Overall Study|Protocol Violation|42|||
164246104|NCT01945216|593271735|FG000|Overall Study|CRF not assured by investigators|5|||
164246105|NCT02982772|593271737|FG000|Intervention|Lost to Follow-up|19|||
164246106|NCT02982772|593271738|FG001|Intervention|Lost to Follow-up|13|||
164246107|NCT02982772|593271737|FG000|1M Follow-Up|Lost to Follow-up|21|||
164246108|NCT02982772|593271738|FG001|1M Follow-Up|Lost to Follow-up|18|||
164246109|NCT02982772|593271737|FG000|3M Follow-Up|Lost to Follow-up|17|||
164246110|NCT02982772|593271738|FG001|3M Follow-Up|Lost to Follow-up|11|||
164246111|NCT02982772|593271737|FG000|6M Follow-Up|Lost to Follow-up|11|||
164246112|NCT02982772|593271738|FG001|6M Follow-Up|Lost to Follow-up|9|||
164246113|NCT02982772|593271737|FG000|12M Follow-Up|Lost to Follow-up|11|||
164246114|NCT02982772|593271738|FG001|12M Follow-Up|Lost to Follow-up|5|||
164246115|NCT03107052|593271742|FG000|Overall Study|Adverse Event|6|||
164246116|NCT03107052|593271743|FG001|Overall Study|Adverse Event|1|||
164246117|NCT03107052|593271744|FG002|Overall Study|Adverse Event|2|||
164246118|NCT03107052|593271742|FG000|Overall Study|Withdrawal by Subject|9|||
164246119|NCT03107052|593271743|FG001|Overall Study|Withdrawal by Subject|5|||
164246120|NCT03107052|593271744|FG002|Overall Study|Withdrawal by Subject|8|||
164246121|NCT03107052|593271742|FG000|Overall Study|Protocol Violation|6|||
164246122|NCT03107052|593271743|FG001|Overall Study|Protocol Violation|0|||
164246123|NCT03107052|593271744|FG002|Overall Study|Protocol Violation|3|||
164246124|NCT03107052|593271742|FG000|Overall Study|Lost to Follow-up|4|||
164246125|NCT03107052|593271743|FG001|Overall Study|Lost to Follow-up|0|||
164246126|NCT03107052|593271744|FG002|Overall Study|Lost to Follow-up|1|||
164246127|NCT03107052|593271742|FG000|Overall Study|Lack of Efficacy|23|||
164246128|NCT03107052|593271743|FG001|Overall Study|Lack of Efficacy|7|||
164246129|NCT03107052|593271744|FG002|Overall Study|Lack of Efficacy|4|||
164246130|NCT03107052|593271742|FG000|Overall Study|Other than specified|4|||
164246131|NCT03107052|593271743|FG001|Overall Study|Other than specified|2|||
164246132|NCT03107052|593271744|FG002|Overall Study|Other than specified|0|||
164246133|NCT03107052|593271742|FG000|Overall Study|Study terminated due to futility|67|||
164246134|NCT03107052|593271743|FG001|Overall Study|Study terminated due to futility|31|||
164246135|NCT03107052|593271744|FG002|Overall Study|Study terminated due to futility|23|||
164246136|NCT03015363|593271745|FG000|Overall Study|Physician Decision|14|||
164246137|NCT03015363|593271745|FG000|Overall Study|Withdrawal by Subject|3|||
164246138|NCT00958360|593271746|FG000|Overall Study|Withdrawal by Subject|3|||
164246139|NCT00958360|593271747|FG001|Overall Study|Withdrawal by Subject|1|||
164246140|NCT00958360|593271746|FG000|Overall Study|Death|6|||
164246141|NCT00958360|593271747|FG001|Overall Study|Death|7|||
164246142|NCT00958360|593271746|FG000|Overall Study|Physician Decision|2|||
164246143|NCT00958360|593271747|FG001|Overall Study|Physician Decision|1|||
164246144|NCT00958360|593271746|FG000|Overall Study|Lost to Follow-up|0|||
164246145|NCT00958360|593271747|FG001|Overall Study|Lost to Follow-up|1|||
164246146|NCT01061723|593271748|FG000|Overall Study|Adverse Event|0|||
164246147|NCT01061723|593271749|FG001|Overall Study|Adverse Event|2|||
164246148|NCT01061723|593271750|FG002|Overall Study|Adverse Event|5|||
164246149|NCT01061723|593271751|FG003|Overall Study|Adverse Event|5|||
164246150|NCT01061723|593271752|FG004|Overall Study|Adverse Event|2|||
164246151|NCT01061723|593271753|FG005|Overall Study|Adverse Event|6|||
164246152|NCT01061723|593271748|FG000|Overall Study|Lack of Efficacy|2|||
164246153|NCT01061723|593271749|FG001|Overall Study|Lack of Efficacy|3|||
164246154|NCT01061723|593271750|FG002|Overall Study|Lack of Efficacy|4|||
164246155|NCT01061723|593271751|FG003|Overall Study|Lack of Efficacy|2|||
164246156|NCT01061723|593271752|FG004|Overall Study|Lack of Efficacy|1|||
164246157|NCT01061723|593271753|FG005|Overall Study|Lack of Efficacy|1|||
164246158|NCT01061723|593271748|FG000|Overall Study|Randomized but not treated|0|||
164246159|NCT01061723|593271749|FG001|Overall Study|Randomized but not treated|0|||
164246160|NCT01061723|593271750|FG002|Overall Study|Randomized but not treated|0|||
164246161|NCT01061723|593271751|FG003|Overall Study|Randomized but not treated|0|||
164246162|NCT01061723|593271752|FG004|Overall Study|Randomized but not treated|0|||
164246163|NCT01061723|593271753|FG005|Overall Study|Randomized but not treated|1|||
164246164|NCT01061723|593271748|FG000|Overall Study|Other than specified above|2|||
164246165|NCT01061723|593271749|FG001|Overall Study|Other than specified above|1|||
164246166|NCT01061723|593271750|FG002|Overall Study|Other than specified above|1|||
164246167|NCT01061723|593271751|FG003|Overall Study|Other than specified above|1|||
164246168|NCT01061723|593271752|FG004|Overall Study|Other than specified above|0|||
164246169|NCT01061723|593271753|FG005|Overall Study|Other than specified above|1|||
164246170|NCT00500357|593271754|FG000|Overall Study|Death|1|||
164246171|NCT02263326|593271755|FG000|Overall Study|Lost to Follow-up|1|||
164246172|NCT02263326|593271756|FG001|Overall Study|Lost to Follow-up|1|||
164246173|NCT01734785|593271757|FG000|Open-Label Period|Adverse Event|0|||
164246174|NCT01734785|593271758|FG001|Open-Label Period|Adverse Event|0|||
164246175|NCT01734785|593271759|FG002|Open-Label Period|Adverse Event|0|||
164246176|NCT01734785|593271760|FG003|Open-Label Period|Adverse Event|9|||
164246177|NCT01734785|593271757|FG000|Open-Label Period|Lack of Efficacy|0|||
164246178|NCT01734785|593271758|FG001|Open-Label Period|Lack of Efficacy|0|||
164246179|NCT01734785|593271759|FG002|Open-Label Period|Lack of Efficacy|0|||
164246180|NCT01734785|593271760|FG003|Open-Label Period|Lack of Efficacy|1|||
164246181|NCT01734785|593271757|FG000|Open-Label Period|Protocol Violation|0|||
164246182|NCT01734785|593271758|FG001|Open-Label Period|Protocol Violation|0|||
164246183|NCT01734785|593271759|FG002|Open-Label Period|Protocol Violation|0|||
164246184|NCT01734785|593271760|FG003|Open-Label Period|Protocol Violation|13|||
164246185|NCT01734785|593271757|FG000|Open-Label Period|Lost to Follow-up|0|||
164246186|NCT01734785|593271758|FG001|Open-Label Period|Lost to Follow-up|0|||
164246187|NCT01734785|593271759|FG002|Open-Label Period|Lost to Follow-up|0|||
164246188|NCT01734785|593271760|FG003|Open-Label Period|Lost to Follow-up|14|||
164246189|NCT01734785|593271757|FG000|Open-Label Period|Withdrawal by Subject|0|||
164246190|NCT01734785|593271758|FG001|Open-Label Period|Withdrawal by Subject|0|||
164246191|NCT01734785|593271759|FG002|Open-Label Period|Withdrawal by Subject|0|||
164246192|NCT01734785|593271760|FG003|Open-Label Period|Withdrawal by Subject|12|||
164246193|NCT01734785|593271757|FG000|Open-Label Period|Other Reasons|0|||
164246194|NCT01734785|593271758|FG001|Open-Label Period|Other Reasons|0|||
163885919|NCT02962895|591954039|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
163885920|NCT02962895|591954040|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
163885921|NCT02962895|591954041|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163885922|NCT02962895|591954042|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
164246195|NCT01734785|593271759|FG002|Open-Label Period|Other Reasons|0|||
164246196|NCT01734785|593271760|FG003|Open-Label Period|Other Reasons|224|||
164246197|NCT01734785|593271757|FG000|Double-Blind Period|Adverse Event|0|||
164246198|NCT01734785|593271758|FG001|Double-Blind Period|Adverse Event|3|||
163885923|NCT02962895|591954043|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163885924|NCT02962895|591954044|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
163885925|NCT02962895|591954038|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
163885926|NCT02962895|591954039|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163885927|NCT02962895|591954040|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163885928|NCT02962895|591954041|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163885929|NCT02962895|591954042|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163885930|NCT02962895|591954043|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163885931|NCT02962895|591954044|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
163885932|NCT02962895|591954038|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163885933|NCT02962895|591954039|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
163885934|NCT02962895|591954040|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163885935|NCT02962895|591954041|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163885936|NCT02962895|591954042|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163885937|NCT02962895|591954043|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163885938|NCT02962895|591954044|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
163885939|NCT02962895|591954038|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163885940|NCT02962895|591954039|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163885941|NCT02962895|591954040|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163885942|NCT02962895|591954041|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
163885943|NCT02962895|591954042|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163885944|NCT02962895|591954043|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163885945|NCT02962895|591954044|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
163885946|NCT02962895|591954038|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163885947|NCT02962895|591954039|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163885948|NCT02962895|591954040|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163885949|NCT02962895|591954041|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163885950|NCT02962895|591954042|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163885951|NCT02962895|591954043|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
163885952|NCT02962895|591954044|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
163885953|NCT02962895|591954038|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163885954|NCT02962895|591954039|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163885955|NCT02962895|591954040|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163885956|NCT02962895|591954041|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163885957|NCT02962895|591954042|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
163885958|NCT02962895|591954043|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
163885959|NCT02962895|591954044|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
164246199|NCT01734785|593271759|FG002|Double-Blind Period|Adverse Event|2|||
163885960|NCT02962895|591954038|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163885961|NCT02962895|591954039|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
164246200|NCT01734785|593271760|FG003|Double-Blind Period|Adverse Event|0|||
164246201|NCT01734785|593271757|FG000|Double-Blind Period|Lack of Efficacy|0|||
164246202|NCT01734785|593271758|FG001|Double-Blind Period|Lack of Efficacy|1|||
164246203|NCT01734785|593271759|FG002|Double-Blind Period|Lack of Efficacy|0|||
164246204|NCT01734785|593271760|FG003|Double-Blind Period|Lack of Efficacy|0|||
164246205|NCT01734785|593271757|FG000|Double-Blind Period|Protocol Violation|0|||
164246206|NCT01734785|593271758|FG001|Double-Blind Period|Protocol Violation|1|||
164246207|NCT01734785|593271759|FG002|Double-Blind Period|Protocol Violation|1|||
164246208|NCT01734785|593271760|FG003|Double-Blind Period|Protocol Violation|0|||
164246209|NCT01734785|593271757|FG000|Double-Blind Period|Lost to Follow-up|2|||
164246210|NCT01734785|593271758|FG001|Double-Blind Period|Lost to Follow-up|4|||
164246211|NCT01734785|593271759|FG002|Double-Blind Period|Lost to Follow-up|2|||
164246212|NCT01734785|593271760|FG003|Double-Blind Period|Lost to Follow-up|0|||
164246213|NCT01734785|593271757|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164246214|NCT01734785|593271758|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164246215|NCT01734785|593271759|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164246216|NCT01734785|593271760|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164246217|NCT01734785|593271757|FG000|Double-Blind Period|Not treated|1|||
164246218|NCT01734785|593271758|FG001|Double-Blind Period|Not treated|0|||
164246219|NCT01734785|593271759|FG002|Double-Blind Period|Not treated|0|||
164246220|NCT01734785|593271760|FG003|Double-Blind Period|Not treated|0|||
164246221|NCT02482298|593271761|FG000|Overall Study|Withdrawal by Subject|2|||
164246222|NCT02482298|593271762|FG001|Overall Study|Withdrawal by Subject|1|||
163990635|NCT03502330|592335042|FG001|Overall Study|Withdrawal by Subject|0|||
163990636|NCT03502330|592335043|FG002|Overall Study|Withdrawal by Subject|0|||
163990637|NCT03502330|592335044|FG003|Overall Study|Withdrawal by Subject|0|||
163990638|NCT03502330|592335045|FG004|Overall Study|Withdrawal by Subject|0|||
164246223|NCT02482298|593271763|FG002|Overall Study|Withdrawal by Subject|2|||
164246224|NCT02482298|593271761|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
164246225|NCT02482298|593271762|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
164246226|NCT02482298|593271763|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
164246227|NCT02482298|593271761|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
164246228|NCT02482298|593271762|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
164246229|NCT02482298|593271763|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
164246230|NCT02482298|593271761|FG000|Overall Study|Lost to Follow-up|0|||
164246231|NCT02482298|593271762|FG001|Overall Study|Lost to Follow-up|1|||
164246232|NCT02482298|593271763|FG002|Overall Study|Lost to Follow-up|0|||
164246233|NCT01582009|593271768|FG000|Overall Study|Withdrawal by Subject|1|||
164246234|NCT01582009|593271768|FG000|Overall Study|Physician Decision|1|||
164246235|NCT03592771|593271769|FG000|Overall Study|Adverse Event|2|||
164246236|NCT03592771|593271770|FG001|Overall Study|Adverse Event|0|||
164246237|NCT03592771|593271771|FG002|Overall Study|Adverse Event|1|||
164246238|NCT03592771|593271769|FG000|Overall Study|Death|0|||
164246239|NCT03592771|593271770|FG001|Overall Study|Death|1|||
164246240|NCT03592771|593271771|FG002|Overall Study|Death|1|||
164246241|NCT03592771|593271769|FG000|Overall Study|Lost to Follow-up|5|||
164246242|NCT03592771|593271770|FG001|Overall Study|Lost to Follow-up|11|||
164246243|NCT03592771|593271771|FG002|Overall Study|Lost to Follow-up|15|||
164246244|NCT03592771|593271769|FG000|Overall Study|Withdrawal by Subject|0|||
164246245|NCT03592771|593271770|FG001|Overall Study|Withdrawal by Subject|2|||
164246246|NCT03592771|593271771|FG002|Overall Study|Withdrawal by Subject|0|||
164246247|NCT01642901|593271772|FG000|12-month Follow-up|Withdrawal by Subject|1|||
164246248|NCT01642901|593271773|FG001|12-month Follow-up|Withdrawal by Subject|0|||
164246249|NCT05069597|593271776|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164246250|NCT05069597|593271777|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
164246251|NCT03650413|593271778|FG000|Overall Study|Adverse Event|1|||
164246252|NCT03650413|593271778|FG000|Overall Study|Lack of Efficacy|17|||
164246253|NCT03650413|593271778|FG000|Overall Study|Other|9|||
164246254|NCT03650413|593271778|FG000|Overall Study|Physician Decision|2|||
164246255|NCT03650413|593271778|FG000|Overall Study|Study Terminated By Sponsor|16|||
164246256|NCT03650413|593271778|FG000|Overall Study|Withdrawal by Subject|16|||
164246257|NCT00310375|593271781|FG000|Primary Reporting Phase|Adverse Event|28|||
164246258|NCT00310375|593271782|FG001|Primary Reporting Phase|Adverse Event|22|||
164246259|NCT00310375|593271783|FG002|Primary Reporting Phase|Adverse Event|0|||
164246260|NCT00310375|593271781|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
164246261|NCT00310375|593271782|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
164246262|NCT00310375|593271783|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
164246263|NCT00310375|593271781|FG000|Primary Reporting Phase|Pregnancy|2|||
164246264|NCT00310375|593271782|FG001|Primary Reporting Phase|Pregnancy|2|||
164246265|NCT00310375|593271783|FG002|Primary Reporting Phase|Pregnancy|0|||
164246266|NCT00310375|593271781|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
164246267|NCT00310375|593271782|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
163990639|NCT03502330|592335046|FG005|Overall Study|Withdrawal by Subject|1|||
163990640|NCT03502330|592335047|FG006|Overall Study|Withdrawal by Subject|0|||
164246268|NCT00310375|593271783|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
164246269|NCT00310375|593271781|FG000|Primary Reporting Phase|Protocol Violation|8|||
164246270|NCT00310375|593271782|FG001|Primary Reporting Phase|Protocol Violation|5|||
164246271|NCT00310375|593271783|FG002|Primary Reporting Phase|Protocol Violation|0|||
164246272|NCT00310375|593271781|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
163885962|NCT02962895|591954040|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163885963|NCT02962895|591954041|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163885964|NCT02962895|591954042|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163885965|NCT02962895|591954043|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
163885966|NCT02962895|591954044|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
163885967|NCT02962895|591954038|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163885968|NCT02962895|591954039|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
163885969|NCT02962895|591954040|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163885970|NCT02962895|591954041|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163885971|NCT02962895|591954042|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163990641|NCT03502330|592335048|FG007|Overall Study|Withdrawal by Subject|1|||
163990642|NCT03502330|592335049|FG008|Overall Study|Withdrawal by Subject|0|||
164246273|NCT00310375|593271782|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
164246274|NCT00310375|593271783|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
164246275|NCT00310375|593271781|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
164246276|NCT00310375|593271782|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
164246277|NCT00310375|593271783|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
164246278|NCT00310375|593271781|FG000|Primary Reporting Phase|Physician Decision|5|||
164246279|NCT00310375|593271782|FG001|Primary Reporting Phase|Physician Decision|3|||
164246280|NCT00310375|593271783|FG002|Primary Reporting Phase|Physician Decision|0|||
164246281|NCT00310375|593271781|FG000|Primary Reporting Phase|Request of the sponsor|2|||
164246282|NCT00310375|593271782|FG001|Primary Reporting Phase|Request of the sponsor|2|||
164246283|NCT00310375|593271783|FG002|Primary Reporting Phase|Request of the sponsor|0|||
164246284|NCT00310375|593271781|FG000|Primary Reporting Phase|Failed to return|1|||
164246285|NCT00310375|593271782|FG001|Primary Reporting Phase|Failed to return|3|||
164246286|NCT00310375|593271783|FG002|Primary Reporting Phase|Failed to return|0|||
164246287|NCT00310375|593271781|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
164246288|NCT00310375|593271782|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
164246289|NCT00310375|593271783|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
164246290|NCT00310375|593271781|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
164246291|NCT00310375|593271782|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
164246292|NCT00310375|593271783|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
164246293|NCT00310375|593271781|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
164246294|NCT00310375|593271782|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
164246295|NCT00310375|593271783|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
164246296|NCT00310375|593271781|FG000|Primary Reporting Phase|Site closure|3|||
164246297|NCT00310375|593271782|FG001|Primary Reporting Phase|Site closure|0|||
164246298|NCT00310375|593271783|FG002|Primary Reporting Phase|Site closure|0|||
164246299|NCT00310375|593271781|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
164246300|NCT00310375|593271782|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
164246301|NCT00310375|593271783|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
164246302|NCT00310375|593271781|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
164246303|NCT00310375|593271782|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
164246304|NCT00310375|593271783|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
164246305|NCT00310375|593271781|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
164246306|NCT00310375|593271782|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
164246307|NCT00310375|593271783|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
164246308|NCT00310375|593271781|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
164246309|NCT00310375|593271782|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
164246310|NCT00310375|593271783|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
164246311|NCT03332173|593271784|FG000|Overall Study|Death|7|||
164246312|NCT03332173|593271784|FG000|Overall Study|Withdrawal by Subject|6|||
164246313|NCT03332173|593271784|FG000|Overall Study|Lost to Follow-up|2|||
164246314|NCT03332173|593271784|FG000|Overall Study|Transferred to long-term extension study|29|||
164246315|NCT04024436|593271785|FG000|Overall Study|Death|10|||
164246316|NCT04024436|593271786|FG001|Overall Study|Death|14|||
164246317|NCT04024436|593271787|FG002|Overall Study|Death|2|||
164246318|NCT04024436|593271788|FG003|Overall Study|Death|7|||
163885972|NCT02962895|591954043|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163885973|NCT02962895|591954044|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
163885974|NCT02962895|591954038|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163990643|NCT03502330|592335041|FG000|Overall Study|Death|0|||
163990644|NCT03502330|592335042|FG001|Overall Study|Death|0|||
163990645|NCT03502330|592335043|FG002|Overall Study|Death|0|||
163990646|NCT03502330|592335044|FG003|Overall Study|Death|0|||
164246319|NCT04024436|593271785|FG000|Overall Study|Loss to follow up|1|||
164246320|NCT04024436|593271786|FG001|Overall Study|Loss to follow up|0|||
164246321|NCT04024436|593271787|FG002|Overall Study|Loss to follow up|0|||
164246322|NCT04024436|593271788|FG003|Overall Study|Loss to follow up|1|||
163990647|NCT03502330|592335045|FG004|Overall Study|Death|0|||
163990648|NCT03502330|592335046|FG005|Overall Study|Death|0|||
164246323|NCT04024436|593271785|FG000|Overall Study|Withdrawal of consent|2|||
164246324|NCT04024436|593271786|FG001|Overall Study|Withdrawal of consent|0|||
164246325|NCT04024436|593271787|FG002|Overall Study|Withdrawal of consent|0|||
164246326|NCT04024436|593271788|FG003|Overall Study|Withdrawal of consent|1|||
164246327|NCT04024436|593271785|FG000|Overall Study|Study termination by sponsor|4|||
164246328|NCT04024436|593271786|FG001|Overall Study|Study termination by sponsor|6|||
164246329|NCT04024436|593271787|FG002|Overall Study|Study termination by sponsor|2|||
164246330|NCT04024436|593271788|FG003|Overall Study|Study termination by sponsor|11|||
164246331|NCT04024436|593271785|FG000|Overall Study|Reason Not Specified|0|||
164246332|NCT04024436|593271786|FG001|Overall Study|Reason Not Specified|1|||
164246333|NCT04024436|593271787|FG002|Overall Study|Reason Not Specified|0|||
164246334|NCT04024436|593271788|FG003|Overall Study|Reason Not Specified|2|||
164246335|NCT00540592|593271789|FG000|Overall Study|Adverse Event|0|||
164246336|NCT00540592|593271790|FG001|Overall Study|Adverse Event|1|||
164246337|NCT00540592|593271791|FG002|Overall Study|Adverse Event|0|||
164246338|NCT00540592|593271792|FG003|Overall Study|Adverse Event|0|||
164246339|NCT00540592|593271793|FG004|Overall Study|Adverse Event|1|||
164246340|NCT00540592|593271794|FG005|Overall Study|Adverse Event|0|||
164246341|NCT00540592|593271795|FG006|Overall Study|Adverse Event|0|||
164246342|NCT00540592|593271796|FG007|Overall Study|Adverse Event|1|||
164246343|NCT00540592|593271797|FG008|Overall Study|Adverse Event|1|||
164246344|NCT00540592|593271798|FG009|Overall Study|Adverse Event|2|||
164246345|NCT00540592|593271789|FG000|Overall Study|Lost to Follow-up|2|||
164246346|NCT00540592|593271790|FG001|Overall Study|Lost to Follow-up|0|||
164246347|NCT00540592|593271791|FG002|Overall Study|Lost to Follow-up|0|||
164246348|NCT00540592|593271792|FG003|Overall Study|Lost to Follow-up|0|||
164246349|NCT00540592|593271793|FG004|Overall Study|Lost to Follow-up|0|||
164246350|NCT00540592|593271794|FG005|Overall Study|Lost to Follow-up|0|||
164246351|NCT00540592|593271795|FG006|Overall Study|Lost to Follow-up|0|||
164246352|NCT00540592|593271796|FG007|Overall Study|Lost to Follow-up|0|||
164246353|NCT00540592|593271797|FG008|Overall Study|Lost to Follow-up|0|||
164246354|NCT00540592|593271798|FG009|Overall Study|Lost to Follow-up|0|||
163990649|NCT03502330|592335047|FG006|Overall Study|Death|2|||
163990650|NCT03502330|592335048|FG007|Overall Study|Death|0|||
163990651|NCT03502330|592335049|FG008|Overall Study|Death|0|||
163990652|NCT01400932|592335053|FG000|Overall Study|Adverse Event|10|||
163990653|NCT01400932|592335054|FG001|Overall Study|Adverse Event|5|||
163990654|NCT01400932|592335053|FG000|Overall Study|Lack of Efficacy|0|||
163990655|NCT01400932|592335054|FG001|Overall Study|Lack of Efficacy|3|||
163990656|NCT01400932|592335053|FG000|Overall Study|Withdrawal by Subject|2|||
163990657|NCT01400932|592335054|FG001|Overall Study|Withdrawal by Subject|6|||
163990658|NCT01400932|592335053|FG000|Overall Study|Lost to Follow-up|1|||
163990659|NCT01400932|592335054|FG001|Overall Study|Lost to Follow-up|0|||
163990660|NCT01400932|592335053|FG000|Overall Study|Protocol Deviation|0|||
164246355|NCT00540592|593271789|FG000|Overall Study|Withdrawal by Subject|0|||
164246356|NCT00540592|593271790|FG001|Overall Study|Withdrawal by Subject|0|||
164246357|NCT00540592|593271791|FG002|Overall Study|Withdrawal by Subject|1|||
164246358|NCT00540592|593271792|FG003|Overall Study|Withdrawal by Subject|1|||
164246359|NCT00540592|593271793|FG004|Overall Study|Withdrawal by Subject|0|||
164246360|NCT00540592|593271794|FG005|Overall Study|Withdrawal by Subject|0|||
164246361|NCT00540592|593271795|FG006|Overall Study|Withdrawal by Subject|0|||
164246362|NCT00540592|593271796|FG007|Overall Study|Withdrawal by Subject|0|||
164246363|NCT00540592|593271797|FG008|Overall Study|Withdrawal by Subject|0|||
164246364|NCT00540592|593271798|FG009|Overall Study|Withdrawal by Subject|0|||
163885975|NCT02962895|591954039|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163885976|NCT02962895|591954040|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163885977|NCT02962895|591954041|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163885978|NCT02962895|591954042|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
163885979|NCT02962895|591954043|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163885980|NCT02962895|591954044|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
163885981|NCT02962895|591954038|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163885982|NCT02962895|591954039|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163885983|NCT02962895|591954040|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163885984|NCT02962895|591954041|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163885985|NCT02962895|591954042|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
163885986|NCT02962895|591954043|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163990661|NCT01400932|592335054|FG001|Overall Study|Protocol Deviation|1|||
163990662|NCT01400932|592335053|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164246365|NCT00131352|593271799|FG000|Initial Treatment Period|Adverse Event|1|||
164246366|NCT00131352|593271800|FG001|Initial Treatment Period|Adverse Event|3|||
164246367|NCT00131352|593271799|FG000|Initial Treatment Period|Non-compliant|1|||
164246368|NCT00131352|593271800|FG001|Initial Treatment Period|Non-compliant|2|||
164246369|NCT00131352|593271799|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
164246370|NCT00131352|593271800|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
164246371|NCT00131352|593271799|FG000|Initial Treatment Period|Lack of Efficacy|6|||
163990663|NCT01400932|592335054|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
164246372|NCT00131352|593271800|FG001|Initial Treatment Period|Lack of Efficacy|4|||
164246373|NCT00131352|593271799|FG000|Initial Treatment Period|Other|0|||
164246374|NCT00131352|593271800|FG001|Initial Treatment Period|Other|2|||
164246375|NCT00131352|593271799|FG000|Repeat Treatment Period|Adverse Event|1|||
164246376|NCT00131352|593271800|FG001|Repeat Treatment Period|Adverse Event|0|||
164246377|NCT00131352|593271799|FG000|Repeat Treatment Period|Other|1|||
164246378|NCT00131352|593271800|FG001|Repeat Treatment Period|Other|0|||
164246379|NCT02553928|593271801|FG000|Overall Study|Adverse Event|2|||
164246380|NCT02553928|593271802|FG001|Overall Study|Adverse Event|1|||
164246381|NCT02553928|593271801|FG000|Overall Study|Lost to Follow-up|0|||
164246382|NCT02553928|593271802|FG001|Overall Study|Lost to Follow-up|1|||
164246383|NCT02553928|593271801|FG000|Overall Study|Administrative reason(s)|0|||
164246384|NCT02553928|593271802|FG001|Overall Study|Administrative reason(s)|1|||
164246385|NCT05507567|593271803|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
164246386|NCT05507567|593271804|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
164246387|NCT05507567|593271805|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
164246388|NCT05507567|593271803|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
164246389|NCT05507567|593271804|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
164246390|NCT05507567|593271805|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
164246391|NCT05507567|593271803|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
164246392|NCT05507567|593271804|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
164246393|NCT05507567|593271805|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
163990664|NCT03980938|592335056|FG000|Treatment Period 1|Study Terminated|1|||
163990665|NCT03980938|592335057|FG001|Treatment Period 1|Study Terminated|1|||
163990666|NCT03980938|592335056|FG000|Treatment Period 2|Study Terminated|2|||
163990667|NCT03980938|592335057|FG001|Treatment Period 2|Study Terminated|2|||
163990668|NCT03706365|592335059|FG000|Overall Study|Lost to Follow-up|7|||
163990669|NCT03706365|592335060|FG001|Overall Study|Lost to Follow-up|0|||
163990670|NCT03706365|592335059|FG000|Overall Study|Withdrawal by Subject|17|||
163990671|NCT03706365|592335060|FG001|Overall Study|Withdrawal by Subject|15|||
163990672|NCT03706365|592335059|FG000|Overall Study|On Study Treatment|51|||
163990673|NCT03706365|592335060|FG001|Overall Study|On Study Treatment|51|||
163990674|NCT00605267|592335061|FG000|Overall Study|Adverse Event|0|||
163990675|NCT00605267|592335062|FG001|Overall Study|Adverse Event|1|||
163990676|NCT00605267|592335061|FG000|Overall Study|Lack of Efficacy|1|||
163990677|NCT00605267|592335062|FG001|Overall Study|Lack of Efficacy|5|||
163990678|NCT00605267|592335061|FG000|Overall Study|Withdrawal by Subject|2|||
163990679|NCT00605267|592335062|FG001|Overall Study|Withdrawal by Subject|3|||
163990680|NCT04557384|592335064|FG000|Overall Study|Study Terminated by Sponsor|1|||
164246394|NCT05507567|593271803|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
164246395|NCT05507567|593271804|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
164246396|NCT05507567|593271805|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
164246397|NCT00383331|593271806|FG000|Overall Study|Protocol Violation|0|||
164246398|NCT00383331|593271807|FG001|Overall Study|Protocol Violation|1|||
164337741|NCT00150709|593613106|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
164337742|NCT00150709|593613107|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
164337743|NCT00150709|593613108|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
164337744|NCT00150709|593613105|FG000|Overall Study|Lack of ease of swallowing|0|||
164337745|NCT00150709|593613106|FG001|Overall Study|Lack of ease of swallowing|1|||
164337746|NCT00150709|593613107|FG002|Overall Study|Lack of ease of swallowing|0|||
164337747|NCT00150709|593613108|FG003|Overall Study|Lack of ease of swallowing|0|||
164337748|NCT04092582|593613109|FG000|Overall Study|Death|1|||
164337749|NCT04092582|593613110|FG001|Overall Study|Death|1|||
164337750|NCT04092582|593613109|FG000|Overall Study|Withdrawal by Subject|4|||
164337751|NCT04092582|593613110|FG001|Overall Study|Withdrawal by Subject|1|||
164337752|NCT04092582|593613109|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
164337753|NCT04092582|593613110|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
164337754|NCT01816074|593613114|FG000|Phase 1|Time commitment issues|0|||
164337755|NCT01816074|593613115|FG001|Phase 1|Time commitment issues|0|||
164337756|NCT01816074|593613116|FG002|Phase 1|Time commitment issues|1|||
164337757|NCT01816074|593613117|FG003|Phase 1|Time commitment issues|0|||
164337758|NCT01816074|593613114|FG000|Phase 2|Time commitment Issues|0|||
164337759|NCT01816074|593613115|FG001|Phase 2|Time commitment Issues|2|||
164337760|NCT01816074|593613116|FG002|Phase 2|Time commitment Issues|0|||
164337761|NCT01816074|593613117|FG003|Phase 2|Time commitment Issues|0|||
164337762|NCT01816074|593613114|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
164337763|NCT01816074|593613115|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
164337764|NCT01816074|593613116|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
164337765|NCT01816074|593613117|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
164337766|NCT01816074|593613114|FG000|Phase 2|Physician Decision|0|||
164337767|NCT01816074|593613115|FG001|Phase 2|Physician Decision|0|||
164337768|NCT01816074|593613116|FG002|Phase 2|Physician Decision|0|||
164337769|NCT01816074|593613117|FG003|Phase 2|Physician Decision|1|||
164337770|NCT01816074|593613114|FG000|Phase 2|Withdrawal by Subject|1|||
164337771|NCT01816074|593613115|FG001|Phase 2|Withdrawal by Subject|0|||
164337772|NCT01816074|593613116|FG002|Phase 2|Withdrawal by Subject|0|||
164337773|NCT01816074|593613117|FG003|Phase 2|Withdrawal by Subject|0|||
164337774|NCT03355365|593613121|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
164337775|NCT03355365|593613122|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
164337776|NCT03355365|593613121|FG000|Year 1, First Intervention|Protocol Violation|1|||
164337777|NCT03355365|593613122|FG001|Year 1, First Intervention|Protocol Violation|0|||
164337778|NCT03355365|593613121|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
164337779|NCT03355365|593613122|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
164337780|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
164337781|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
164337782|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
164337783|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
164337784|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|severe COVID|0|||
164337785|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|severe COVID|1|||
163990681|NCT04557384|592335064|FG000|Overall Study|Death|1|||
163990682|NCT01505894|592335068|FG000|Overall Study|Adverse Event|1|||
163990683|NCT01505894|592335069|FG001|Overall Study|Adverse Event|0|||
163990684|NCT01505894|592335070|FG002|Overall Study|Adverse Event|0|||
163990685|NCT01505894|592335071|FG003|Overall Study|Adverse Event|0|||
163990686|NCT01505894|592335072|FG004|Overall Study|Adverse Event|0|||
163990687|NCT01505894|592335073|FG005|Overall Study|Adverse Event|0|||
163990688|NCT01505894|592335074|FG006|Overall Study|Adverse Event|0|||
163990689|NCT01505894|592335075|FG007|Overall Study|Adverse Event|0|||
163990690|NCT01505894|592335076|FG008|Overall Study|Adverse Event|0|||
163990691|NCT01505894|592335068|FG000|Overall Study|Other than specified|0|||
163990692|NCT01505894|592335069|FG001|Overall Study|Other than specified|0|||
163990693|NCT01505894|592335070|FG002|Overall Study|Other than specified|0|||
163990694|NCT01505894|592335071|FG003|Overall Study|Other than specified|0|||
163990695|NCT01505894|592335072|FG004|Overall Study|Other than specified|1|||
163990696|NCT01505894|592335073|FG005|Overall Study|Other than specified|0|||
163990697|NCT01505894|592335074|FG006|Overall Study|Other than specified|0|||
163990698|NCT01505894|592335075|FG007|Overall Study|Other than specified|0|||
163990699|NCT01505894|592335076|FG008|Overall Study|Other than specified|0|||
163990700|NCT00254566|592335077|FG000|Overall Study|Death|1|||
163990701|NCT00254566|592335078|FG001|Overall Study|Death|0|||
163990702|NCT00254566|592335077|FG000|Overall Study|Adverse Event|5|||
164337786|NCT03355365|593613121|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
164337787|NCT03355365|593613122|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
164337788|NCT01303861|593613126|FG000|Overall Study|Lost to Follow-up|34|||
164337789|NCT01303861|593613127|FG001|Overall Study|Lost to Follow-up|14|||
164337790|NCT01303861|593613128|FG002|Overall Study|Lost to Follow-up|27|||
164337791|NCT01303861|593613129|FG003|Overall Study|Lost to Follow-up|31|||
164337792|NCT01303861|593613126|FG000|Overall Study|Lack of Efficacy|3|||
164337793|NCT01303861|593613127|FG001|Overall Study|Lack of Efficacy|2|||
164337794|NCT01303861|593613128|FG002|Overall Study|Lack of Efficacy|1|||
164083829|NCT02034799|592672168|FG000|Overall Study|Death|2|||
164337795|NCT01303861|593613129|FG003|Overall Study|Lack of Efficacy|0|||
164337796|NCT01303861|593613126|FG000|Overall Study|Withdrawal by Subject|16|||
164337797|NCT01303861|593613127|FG001|Overall Study|Withdrawal by Subject|8|||
164337798|NCT01303861|593613128|FG002|Overall Study|Withdrawal by Subject|8|||
163990703|NCT00254566|592335078|FG001|Overall Study|Adverse Event|4|||
163990704|NCT00254566|592335077|FG000|Overall Study|Lack of Efficacy|12|||
163990705|NCT00254566|592335078|FG001|Overall Study|Lack of Efficacy|9|||
163990706|NCT00254566|592335077|FG000|Overall Study|Other|1|||
163990707|NCT00254566|592335078|FG001|Overall Study|Other|5|||
164246399|NCT04830215|593271808|FG000|Overall Study|Adverse Event|6|||
164246400|NCT04830215|593271808|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
164246401|NCT04830215|593271808|FG000|Overall Study|Withdrawal by Subject|3|||
164246402|NCT04830215|593271808|FG000|Overall Study|Protocol Deviation|1|||
164246403|NCT00770562|593271813|FG000|Overall Study|Did not take treatment|1|||
164246404|NCT00770562|593271814|FG001|Overall Study|Did not take treatment|1|||
164246405|NCT05338710|593271815|FG000|Overall Study|Withdrawal by Subject|3|||
164246406|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
164246407|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
164246408|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
163885987|NCT02962895|591954044|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
163885988|NCT02962895|591954038|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163885989|NCT02962895|591954039|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
163885990|NCT02962895|591954040|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
163885991|NCT02962895|591954041|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
163885992|NCT02962895|591954042|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163885993|NCT02962895|591954043|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163885994|NCT02962895|591954044|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
163885995|NCT02962895|591954038|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
163885996|NCT02962895|591954039|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
163885997|NCT02962895|591954040|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
163885998|NCT02962895|591954041|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
163885999|NCT02962895|591954042|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
163886000|NCT02962895|591954043|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
163886001|NCT02962895|591954044|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
163886002|NCT04719390|591954048|FG000|Overall Study|Withdrawal by Subject|1|||
163886003|NCT04019873|591954050|FG000|Overall Study|Discontinued from the treatment|1|||
163886004|NCT04019873|591954051|FG001|Overall Study|Discontinued from the treatment|39|||
163886005|NCT04019873|591954052|FG002|Overall Study|Discontinued from the treatment|2|||
164246409|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246410|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246411|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246412|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246413|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246414|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246415|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
164246416|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
164246417|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
164246418|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246419|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246420|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246421|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246422|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246423|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246424|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246425|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
164246426|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
164246427|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246428|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246429|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246430|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246431|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246432|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246433|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246434|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246435|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
164246436|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
164246437|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
164246438|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246439|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246440|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246441|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246442|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246443|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246444|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246445|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
164246446|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163990708|NCT00254566|592335077|FG000|Overall Study|Withdrawal by Subject|5|||
163990709|NCT00254566|592335078|FG001|Overall Study|Withdrawal by Subject|6|||
163990710|NCT00254566|592335077|FG000|Overall Study|Lost to Follow-up|7|||
163990711|NCT00254566|592335078|FG001|Overall Study|Lost to Follow-up|2|||
163990712|NCT00059202|592335081|FG000|Overall Study|Withdrawal by Subject|5|||
163990713|NCT00059202|592335082|FG001|Overall Study|Withdrawal by Subject|9|||
163990714|NCT00059202|592335081|FG000|Overall Study|Protocol Violation|1|||
163990715|NCT00059202|592335082|FG001|Overall Study|Protocol Violation|3|||
163990716|NCT00059202|592335081|FG000|Overall Study|drug toxicity|0|||
163990717|NCT00059202|592335082|FG001|Overall Study|drug toxicity|3|||
163990718|NCT04088409|592335085|FG000|Part A|Withdrawal by Subject|2|||
163990719|NCT04088409|592335086|FG001|Part A|Withdrawal by Subject|1|||
163990720|NCT04088409|592335085|FG000|Part A|Did Not Meet Randomization Criteria|2|||
163990721|NCT04088409|592335086|FG001|Part A|Did Not Meet Randomization Criteria|0|||
163990722|NCT04088409|592335085|FG000|Part A|Lack of Efficacy|9|||
163990723|NCT04088409|592335086|FG001|Part A|Lack of Efficacy|0|||
163990724|NCT04088409|592335085|FG000|Part A|Lost to Follow-up|1|||
163990725|NCT04088409|592335086|FG001|Part A|Lost to Follow-up|0|||
163990726|NCT04088409|592335085|FG000|Part A|Adverse Event|1|||
163990727|NCT04088409|592335086|FG001|Part A|Adverse Event|0|||
163990728|NCT04088409|592335085|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
163990729|NCT04088409|592335086|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
163990730|NCT04088409|592335085|FG000|Part B|Ongoing Treatment|10|||
163990731|NCT04088409|592335086|FG001|Part B|Ongoing Treatment|0|||
164246447|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
164246448|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246449|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
163990736|NCT00841763|592335089|FG000|Overall Study|Withdrawal by Subject|60|||
163990737|NCT00841763|592335090|FG001|Overall Study|Withdrawal by Subject|17|||
163990738|NCT00841763|592335091|FG002|Overall Study|Withdrawal by Subject|4|||
163990739|NCT00841763|592335092|FG003|Overall Study|Withdrawal by Subject|1|||
163990740|NCT00841763|592335089|FG000|Overall Study|Adverse Event|9|||
163990741|NCT00841763|592335090|FG001|Overall Study|Adverse Event|10|||
163990742|NCT00841763|592335091|FG002|Overall Study|Adverse Event|3|||
163990743|NCT00841763|592335092|FG003|Overall Study|Adverse Event|2|||
163990744|NCT00841763|592335089|FG000|Overall Study|Lost to Follow-up|63|||
163990745|NCT00841763|592335090|FG001|Overall Study|Lost to Follow-up|25|||
163990746|NCT00841763|592335091|FG002|Overall Study|Lost to Follow-up|0|||
163990747|NCT00841763|592335092|FG003|Overall Study|Lost to Follow-up|0|||
163990748|NCT00841763|592335089|FG000|Overall Study|Protocol Violation|20|||
163990749|NCT00841763|592335090|FG001|Overall Study|Protocol Violation|3|||
163990750|NCT00841763|592335091|FG002|Overall Study|Protocol Violation|1|||
163990751|NCT00841763|592335092|FG003|Overall Study|Protocol Violation|0|||
163990752|NCT00841763|592335089|FG000|Overall Study|Administrative Reasons|3|||
163990753|NCT00841763|592335090|FG001|Overall Study|Administrative Reasons|1|||
163990754|NCT00841763|592335091|FG002|Overall Study|Administrative Reasons|0|||
163990755|NCT00841763|592335092|FG003|Overall Study|Administrative Reasons|0|||
163990756|NCT00841763|592335089|FG000|Overall Study|Unable to Classify|7|||
163990757|NCT00841763|592335090|FG001|Overall Study|Unable to Classify|1|||
163990758|NCT00841763|592335091|FG002|Overall Study|Unable to Classify|0|||
163990759|NCT00841763|592335092|FG003|Overall Study|Unable to Classify|0|||
163990760|NCT00400400|592335093|FG000|Overall Study|Adverse Event|9|||
163990761|NCT00400400|592335094|FG001|Overall Study|Adverse Event|8|||
163990762|NCT00400400|592335093|FG000|Overall Study|Protocol Violation|2|||
163990763|NCT00400400|592335094|FG001|Overall Study|Protocol Violation|0|||
163990764|NCT00400400|592335093|FG000|Overall Study|Withdrawal by Subject|1|||
163990765|NCT00400400|592335094|FG001|Overall Study|Withdrawal by Subject|3|||
163990766|NCT00400400|592335093|FG000|Overall Study|Administrative Problem|1|||
163990767|NCT00400400|592335094|FG001|Overall Study|Administrative Problem|0|||
163990768|NCT00400400|592335093|FG000|Overall Study|Lost to Follow-up|0|||
163990769|NCT00400400|592335094|FG001|Overall Study|Lost to Follow-up|1|||
163990770|NCT00400400|592335093|FG000|Overall Study|Did not receive study drug|1|||
163990771|NCT00400400|592335094|FG001|Overall Study|Did not receive study drug|3|||
163990772|NCT00648167|592335095|FG000|Overall Study|Adverse Event|6|||
163990773|NCT00648167|592335095|FG000|Overall Study|unable to swallow tablets|1|||
163990774|NCT01688050|592335096|FG000|Overall Study|Death|7|||
163990775|NCT01688050|592335096|FG000|Overall Study|Conversion to open repair|1|||
163990776|NCT01688050|592335096|FG000|Overall Study|Lost to Follow-up|13|||
163990777|NCT01688050|592335096|FG000|Overall Study|Withdrawal by Subject|10|||
163990778|NCT00927368|592335097|FG000|Overall Study|enrollment in another study|1|||
163990779|NCT00927368|592335098|FG001|Overall Study|enrollment in another study|1|||
163990780|NCT00927368|592335099|FG002|Overall Study|enrollment in another study|2|||
163990781|NCT00927368|592335097|FG000|Overall Study|Lost to Follow-up|4|||
163990782|NCT00927368|592335098|FG001|Overall Study|Lost to Follow-up|0|||
163990783|NCT00927368|592335099|FG002|Overall Study|Lost to Follow-up|0|||
163990784|NCT00927368|592335097|FG000|Overall Study|equipment failure|1|||
163990785|NCT00927368|592335098|FG001|Overall Study|equipment failure|0|||
163990786|NCT00927368|592335099|FG002|Overall Study|equipment failure|0|||
164246450|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246451|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246452|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246453|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246454|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164246455|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
164083830|NCT02034799|592672169|FG001|Overall Study|Death|1|||
164246456|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
164246457|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
164246458|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246459|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246460|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246461|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246462|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246463|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246464|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246465|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
164246466|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
164246467|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
164246468|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246469|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246470|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246471|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246472|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246473|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246474|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246475|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
164246476|NCT01194219|593271816|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
164246477|NCT01194219|593271817|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
164246478|NCT01194219|593271818|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246479|NCT01194219|593271819|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246480|NCT01194219|593271820|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246481|NCT01194219|593271821|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246482|NCT01194219|593271822|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246483|NCT01194219|593271823|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246484|NCT01194219|593271824|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246485|NCT01194219|593271825|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
164246486|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246487|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246488|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
164246489|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
164246490|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246491|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246492|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246493|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246494|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246495|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
164246496|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246497|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246498|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
164246499|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
164246500|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246501|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246502|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246503|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246504|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246505|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
164246506|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246507|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246508|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
164246509|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
164246510|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246511|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246512|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246513|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246514|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246515|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
164246516|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246517|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246518|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
164246519|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
164246520|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246521|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246522|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246523|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246524|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
163990787|NCT00927368|592335097|FG000|Overall Study|ineligible post randomization|0|||
163990788|NCT00927368|592335098|FG001|Overall Study|ineligible post randomization|3|||
163990789|NCT00927368|592335099|FG002|Overall Study|ineligible post randomization|1|||
163990790|NCT00927368|592335097|FG000|Overall Study|cancellation of surgery|0|||
163990791|NCT00927368|592335098|FG001|Overall Study|cancellation of surgery|1|||
163990792|NCT00927368|592335099|FG002|Overall Study|cancellation of surgery|2|||
163990793|NCT00191451|592335105|FG000|Overall Study|Withdrawal by Subject|2|||
163990794|NCT00191451|592335106|FG001|Overall Study|Withdrawal by Subject|3|||
163990795|NCT00191451|592335107|FG002|Overall Study|Withdrawal by Subject|5|||
163990796|NCT00191451|592335105|FG000|Overall Study|Physician Decision|2|||
163990797|NCT00191451|592335106|FG001|Overall Study|Physician Decision|9|||
163990798|NCT00191451|592335107|FG002|Overall Study|Physician Decision|6|||
163990799|NCT00191451|592335105|FG000|Overall Study|Sponsor Decision|1|||
163990800|NCT00191451|592335106|FG001|Overall Study|Sponsor Decision|0|||
163990801|NCT00191451|592335107|FG002|Overall Study|Sponsor Decision|0|||
163990802|NCT00191451|592335105|FG000|Overall Study|Ineligible|0|||
163990803|NCT00191451|592335106|FG001|Overall Study|Ineligible|1|||
163990804|NCT00191451|592335107|FG002|Overall Study|Ineligible|0|||
163990805|NCT00191451|592335105|FG000|Overall Study|Reason Not Specified|2|||
163990806|NCT00191451|592335106|FG001|Overall Study|Reason Not Specified|1|||
163990807|NCT00191451|592335107|FG002|Overall Study|Reason Not Specified|3|||
163990808|NCT00272987|592335116|FG000|Overall Study|Adverse Event|1|||
163990809|NCT00272987|592335117|FG001|Overall Study|Adverse Event|0|||
163990810|NCT00272987|592335118|FG002|Overall Study|Adverse Event|0|||
163990811|NCT00272987|592335116|FG000|Overall Study|Lost to Follow-up|3|||
163990812|NCT00272987|592335117|FG001|Overall Study|Lost to Follow-up|1|||
163990813|NCT00272987|592335118|FG002|Overall Study|Lost to Follow-up|1|||
163990814|NCT00272987|592335116|FG000|Overall Study|Withdrawal by Subject|1|||
163990815|NCT00272987|592335117|FG001|Overall Study|Withdrawal by Subject|0|||
163990816|NCT00272987|592335118|FG002|Overall Study|Withdrawal by Subject|3|||
163990817|NCT00272987|592335116|FG000|Overall Study|Sponsor Terminated study|0|||
163990818|NCT00272987|592335117|FG001|Overall Study|Sponsor Terminated study|1|||
163990819|NCT00272987|592335118|FG002|Overall Study|Sponsor Terminated study|1|||
163990820|NCT00272987|592335116|FG000|Overall Study|Disease progression|1|||
163990821|NCT00272987|592335117|FG001|Overall Study|Disease progression|1|||
163990822|NCT00272987|592335118|FG002|Overall Study|Disease progression|2|||
163990823|NCT00272987|592335116|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
163990824|NCT00272987|592335117|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
163990825|NCT00272987|592335118|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
163990826|NCT00272987|592335116|FG000|Overall Study|Death|1|||
163990827|NCT00272987|592335117|FG001|Overall Study|Death|0|||
163990828|NCT00272987|592335118|FG002|Overall Study|Death|0|||
163990829|NCT03222349|592335122|FG000|Overall Study|Treatment B not done|5|||
163990830|NCT03222349|592335123|FG001|Overall Study|Treatment B not done|0|||
163990831|NCT03222349|592335122|FG000|Overall Study|Lost to Follow-up|1|||
164246525|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
164246526|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246527|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246528|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
164246529|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246530|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
163990832|NCT03222349|592335123|FG001|Overall Study|Lost to Follow-up|2|||
163990833|NCT03222349|592335122|FG000|Overall Study|Withdrawal by Subject|1|||
163990834|NCT03222349|592335123|FG001|Overall Study|Withdrawal by Subject|0|||
163990835|NCT03222349|592335122|FG000|Overall Study|Treatment A not done|0|||
163990836|NCT03222349|592335123|FG001|Overall Study|Treatment A not done|5|||
163990837|NCT03222349|592335122|FG000|Overall Study|Study terminated by sponsor|1|||
163990838|NCT03222349|592335123|FG001|Overall Study|Study terminated by sponsor|0|||
163990839|NCT01058096|592335124|FG000|Double-blind Treatment Phase|Adverse Event|11|||
163990840|NCT01058096|592335125|FG001|Double-blind Treatment Phase|Adverse Event|15|||
163990841|NCT01058096|592335124|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
163990842|NCT01058096|592335125|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
163990843|NCT01058096|592335124|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
163990844|NCT01058096|592335125|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
163990845|NCT01058096|592335124|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
163990846|NCT01058096|592335125|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
164246531|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246532|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246533|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246534|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246535|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
164246536|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246537|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246538|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246539|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
164246540|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246541|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246542|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246543|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246544|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246545|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
164246546|NCT01194219|593271816|FG000|Maintenance Phase Weeks16-32|Other|0|||
164246547|NCT01194219|593271817|FG001|Maintenance Phase Weeks16-32|Other|0|||
164246548|NCT01194219|593271818|FG002|Maintenance Phase Weeks16-32|Other|2|||
164246549|NCT01194219|593271819|FG003|Maintenance Phase Weeks16-32|Other|1|||
164246550|NCT01194219|593271820|FG004|Maintenance Phase Weeks16-32|Other|0|||
164246551|NCT01194219|593271821|FG005|Maintenance Phase Weeks16-32|Other|0|||
164246552|NCT01194219|593271822|FG006|Maintenance Phase Weeks16-32|Other|0|||
164246553|NCT01194219|593271823|FG007|Maintenance Phase Weeks16-32|Other|0|||
164246554|NCT01194219|593271824|FG008|Maintenance Phase Weeks16-32|Other|0|||
164246555|NCT01194219|593271825|FG009|Maintenance Phase Weeks16-32|Other|0|||
164246556|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246557|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246558|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246559|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246560|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246561|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
164246562|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
164246563|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
164246564|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246565|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
164246566|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246567|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246568|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246569|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246570|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
164246571|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
164246572|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
164246573|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
164246574|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246575|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
164246576|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246577|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246578|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246579|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246580|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
164246581|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246582|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
164246583|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246584|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246585|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
164246586|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246587|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246588|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246589|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164337799|NCT01303861|593613129|FG003|Overall Study|Withdrawal by Subject|23|||
164337800|NCT01303861|593613126|FG000|Overall Study|Adverse Event|4|||
163886006|NCT01606215|591954054|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
163886007|NCT01606215|591954055|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
163886008|NCT05087992|591954057|FG000|Overall Study|Adverse Event|0|||
163886009|NCT05087992|591954058|FG001|Overall Study|Adverse Event|1|||
163886010|NCT05087992|591954059|FG002|Overall Study|Adverse Event|0|||
164246590|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
164246591|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246592|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
164246593|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
164246594|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246595|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
164246596|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
163990847|NCT01058096|592335124|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
163990848|NCT01058096|592335125|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
163990849|NCT01058096|592335124|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
163990850|NCT01058096|592335125|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
163990851|NCT04451330|592335126|FG000|Overall Study|Adverse Event|1|||
163990852|NCT04451330|592335127|FG001|Overall Study|Adverse Event|2|||
163990853|NCT04451330|592335126|FG000|Overall Study|Lost to Follow-up|5|||
163990854|NCT04451330|592335127|FG001|Overall Study|Lost to Follow-up|0|||
163990855|NCT04451330|592335126|FG000|Overall Study|Withdrawal by Subject|3|||
163990856|NCT04451330|592335127|FG001|Overall Study|Withdrawal by Subject|1|||
163990857|NCT04451330|592335126|FG000|Overall Study|Withdrawal by parent/guardian|1|||
163990858|NCT04451330|592335127|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163990859|NCT04451330|592335126|FG000|Overall Study|Other than specified|0|||
163990860|NCT04451330|592335127|FG001|Overall Study|Other than specified|1|||
163990861|NCT05099640|592335128|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
164083831|NCT03381248|592672172|FG000|0-6 Months|Withdrawal by Subject|4|||
164083832|NCT03381248|592672173|FG001|0-6 Months|Withdrawal by Subject|1|||
164083833|NCT03381248|592672172|FG000|0-6 Months|Lost to Follow-up|3|||
164083834|NCT03381248|592672173|FG001|0-6 Months|Lost to Follow-up|2|||
164083835|NCT03381248|592672172|FG000|0-6 Months|Lack of Efficacy|1|||
164083836|NCT03381248|592672173|FG001|0-6 Months|Lack of Efficacy|0|||
164083837|NCT03381248|592672172|FG000|0-6 Months|Adverse Event|1|||
164246597|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246598|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164337801|NCT01303861|593613127|FG001|Overall Study|Adverse Event|1|||
164337802|NCT01303861|593613128|FG002|Overall Study|Adverse Event|0|||
164337803|NCT01303861|593613129|FG003|Overall Study|Adverse Event|5|||
164337804|NCT01303861|593613126|FG000|Overall Study|Pregnancy|1|||
164337805|NCT01303861|593613127|FG001|Overall Study|Pregnancy|0|||
164337806|NCT01303861|593613128|FG002|Overall Study|Pregnancy|0|||
164337807|NCT01303861|593613129|FG003|Overall Study|Pregnancy|0|||
164337808|NCT03650556|593613135|FG000|Overall Study|Death|2|||
164337809|NCT03650556|593613135|FG000|Overall Study|Withdrawal by Subject|20|||
164337810|NCT03650556|593613135|FG000|Overall Study|Physician Decision|2|||
164337811|NCT03650556|593613135|FG000|Overall Study|Lost to Follow-up|8|||
164337812|NCT03650556|593613135|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
164337813|NCT03650556|593613135|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
164337814|NCT03917459|593613138|FG000|Overall Study|Adverse Event|1|||
164337815|NCT03917459|593613139|FG001|Overall Study|Adverse Event|0|||
164337816|NCT03917459|593613138|FG000|Overall Study|Withdrawal by Subject|0|||
164337817|NCT03917459|593613139|FG001|Overall Study|Withdrawal by Subject|1|||
164337818|NCT01500031|593613143|FG000|Overall Study|Death|1|||
164337819|NCT01500031|593613143|FG000|Overall Study|Withdrawal by Subject|4|||
164337820|NCT00917501|593613144|FG000|Overall Study|Lost to Follow-up|4|||
164337821|NCT00917501|593613145|FG001|Overall Study|Lost to Follow-up|1|||
164337822|NCT00917501|593613144|FG000|Overall Study|Withdrawal by Subject|3|||
164337823|NCT00917501|593613145|FG001|Overall Study|Withdrawal by Subject|1|||
164337824|NCT00917501|593613144|FG000|Overall Study|Lack of Efficacy|1|||
164337825|NCT00917501|593613145|FG001|Overall Study|Lack of Efficacy|2|||
164337826|NCT00917501|593613144|FG000|Overall Study|trouble swollowing capsules|0|||
164337827|NCT00917501|593613145|FG001|Overall Study|trouble swollowing capsules|1|||
164337828|NCT00850070|593613148|FG000|Overall Study|Lack of Efficacy|1|||
164337829|NCT00850070|593613149|FG001|Overall Study|Lack of Efficacy|1|||
164337830|NCT00850070|593613148|FG000|Overall Study|Adverse Event|2|||
164337831|NCT00850070|593613149|FG001|Overall Study|Adverse Event|0|||
164337832|NCT01522248|593613156|FG000|Overall Study|Lost to Follow-up|1|||
164337833|NCT01522248|593613157|FG001|Overall Study|Lost to Follow-up|0|||
164337834|NCT02191137|593613159|FG000|Treatment|Death|4|||
164337835|NCT02191137|593613159|FG000|Treatment|Withdrawal by Subject|3|||
163990862|NCT05099640|592335129|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
163990863|NCT05099640|592335130|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
163990864|NCT05099640|592335128|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
163990865|NCT05099640|592335129|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
163990866|NCT05099640|592335130|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
163990867|NCT05099640|592335128|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
163990868|NCT05099640|592335129|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
164083838|NCT03381248|592672173|FG001|0-6 Months|Adverse Event|0|||
164083839|NCT03381248|592672172|FG000|0-6 Months|Protocol Violation|2|||
164337836|NCT02191137|593613159|FG000|Treatment|Adverse Event|2|||
164337837|NCT02191137|593613159|FG000|Treatment|Other|1|||
164337838|NCT02191137|593613159|FG000|Follow-up|Lost to Follow-up|2|||
164337839|NCT02191137|593613159|FG000|Follow-up|Ongoing/unknown|2|||
164337840|NCT02191137|593613159|FG000|Follow-up|Adverse Event|1|||
164337841|NCT01332331|593613160|FG000|Overall Study|Lost to Follow-up|0|||
164337842|NCT01332331|593613161|FG001|Overall Study|Lost to Follow-up|1|||
164337843|NCT01332331|593613160|FG000|Overall Study|Adverse Event|1|||
164337844|NCT01332331|593613161|FG001|Overall Study|Adverse Event|1|||
164337845|NCT01332331|593613160|FG000|Overall Study|Physician Decision|1|||
164337846|NCT01332331|593613161|FG001|Overall Study|Physician Decision|0|||
164337847|NCT00538291|593613162|FG000|Overall Study|Adverse Event|2|||
164337848|NCT00538291|593613162|FG000|Overall Study|Withdrawal by Subject|1|||
164337849|NCT00694707|593613163|FG000|Overall Study|Did Not Receive Treatment|0|||
164337850|NCT00694707|593613164|FG001|Overall Study|Did Not Receive Treatment|0|||
164337851|NCT00694707|593613165|FG002|Overall Study|Did Not Receive Treatment|1|||
164337852|NCT00694707|593613166|FG003|Overall Study|Did Not Receive Treatment|1|||
164337853|NCT00694707|593613167|FG004|Overall Study|Did Not Receive Treatment|1|||
164337854|NCT00694707|593613163|FG000|Overall Study|Adverse Event|22|||
164337855|NCT00694707|593613164|FG001|Overall Study|Adverse Event|14|||
164337856|NCT00694707|593613165|FG002|Overall Study|Adverse Event|8|||
164337857|NCT00694707|593613166|FG003|Overall Study|Adverse Event|12|||
164337858|NCT00694707|593613167|FG004|Overall Study|Adverse Event|13|||
164337859|NCT00694707|593613163|FG000|Overall Study|Insufficient Therapeutic Response|33|||
164337860|NCT00694707|593613164|FG001|Overall Study|Insufficient Therapeutic Response|18|||
164337861|NCT00694707|593613165|FG002|Overall Study|Insufficient Therapeutic Response|17|||
164337862|NCT00694707|593613166|FG003|Overall Study|Insufficient Therapeutic Response|15|||
164337863|NCT00694707|593613167|FG004|Overall Study|Insufficient Therapeutic Response|10|||
164337864|NCT00694707|593613163|FG000|Overall Study|Protocol Violation|1|||
164337865|NCT00694707|593613164|FG001|Overall Study|Protocol Violation|2|||
164337866|NCT00694707|593613165|FG002|Overall Study|Protocol Violation|1|||
164337867|NCT00694707|593613166|FG003|Overall Study|Protocol Violation|3|||
164337868|NCT00694707|593613167|FG004|Overall Study|Protocol Violation|1|||
164337869|NCT00694707|593613163|FG000|Overall Study|Withdrawal of Consent|14|||
164337870|NCT00694707|593613164|FG001|Overall Study|Withdrawal of Consent|18|||
164337871|NCT00694707|593613165|FG002|Overall Study|Withdrawal of Consent|22|||
164337872|NCT00694707|593613166|FG003|Overall Study|Withdrawal of Consent|16|||
164337873|NCT00694707|593613167|FG004|Overall Study|Withdrawal of Consent|15|||
164337874|NCT00694707|593613163|FG000|Overall Study|Lost to Follow-up|0|||
164337875|NCT00694707|593613164|FG001|Overall Study|Lost to Follow-up|1|||
164337876|NCT00694707|593613165|FG002|Overall Study|Lost to Follow-up|2|||
164337877|NCT00694707|593613166|FG003|Overall Study|Lost to Follow-up|0|||
164337878|NCT00694707|593613167|FG004|Overall Study|Lost to Follow-up|0|||
164337879|NCT00694707|593613163|FG000|Overall Study|Jeopardizing Parole Status|1|||
164337880|NCT00694707|593613164|FG001|Overall Study|Jeopardizing Parole Status|0|||
164337881|NCT00694707|593613165|FG002|Overall Study|Jeopardizing Parole Status|0|||
164337882|NCT00694707|593613166|FG003|Overall Study|Jeopardizing Parole Status|0|||
164337883|NCT00694707|593613167|FG004|Overall Study|Jeopardizing Parole Status|0|||
164337884|NCT00694707|593613163|FG000|Overall Study|Death in the Family|1|||
164337885|NCT00694707|593613164|FG001|Overall Study|Death in the Family|0|||
164337886|NCT00694707|593613165|FG002|Overall Study|Death in the Family|0|||
164337887|NCT00694707|593613166|FG003|Overall Study|Death in the Family|0|||
164337888|NCT00694707|593613167|FG004|Overall Study|Death in the Family|0|||
164337889|NCT00694707|593613163|FG000|Overall Study|Arrest by Police|0|||
164337890|NCT00694707|593613164|FG001|Overall Study|Arrest by Police|1|||
164337891|NCT00694707|593613165|FG002|Overall Study|Arrest by Police|0|||
164337892|NCT00694707|593613166|FG003|Overall Study|Arrest by Police|0|||
164337893|NCT00694707|593613167|FG004|Overall Study|Arrest by Police|0|||
164337894|NCT00694707|593613163|FG000|Overall Study|Administrative Reasons|0|||
164337895|NCT00694707|593613164|FG001|Overall Study|Administrative Reasons|1|||
164337896|NCT00694707|593613165|FG002|Overall Study|Administrative Reasons|0|||
164337897|NCT00694707|593613166|FG003|Overall Study|Administrative Reasons|2|||
164337898|NCT00694707|593613167|FG004|Overall Study|Administrative Reasons|0|||
164337899|NCT00694707|593613163|FG000|Overall Study|Notification of Past Head Injury|0|||
164337900|NCT00694707|593613164|FG001|Overall Study|Notification of Past Head Injury|0|||
164337901|NCT00694707|593613165|FG002|Overall Study|Notification of Past Head Injury|0|||
164337902|NCT00694707|593613166|FG003|Overall Study|Notification of Past Head Injury|1|||
164337903|NCT00694707|593613167|FG004|Overall Study|Notification of Past Head Injury|0|||
164337904|NCT03096483|593613169|FG000|Overall Study|Withdrawal by site|1|||
164337905|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
164337906|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
164337907|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
164337908|NCT00369707|593613170|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
164337909|NCT00369707|593613170|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
164337910|NCT00369707|593613170|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
164337911|NCT00369707|593613170|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
164246599|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246600|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
164246601|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
164246602|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
164246603|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246604|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246605|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
164246606|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246607|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246608|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246609|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246610|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246611|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246612|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246613|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
164246614|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246615|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
164246616|NCT01194219|593271816|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246617|NCT01194219|593271817|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246618|NCT01194219|593271818|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246619|NCT01194219|593271819|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246620|NCT01194219|593271820|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246621|NCT01194219|593271821|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246622|NCT01194219|593271822|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
164246623|NCT01194219|593271823|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246624|NCT01194219|593271824|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246625|NCT01194219|593271825|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
164246626|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246627|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246628|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246629|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246630|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246631|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246632|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246633|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
164246634|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
164246635|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
164246636|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246637|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246638|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246639|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246640|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246641|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246642|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246643|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
164246644|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
164246645|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
164246646|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246647|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246648|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246649|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246650|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246651|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246652|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246653|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
164246654|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
164246655|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
164246656|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246657|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246658|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246659|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246660|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246661|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246662|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246663|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
164246664|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
164246665|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
164246666|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
164246667|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
164246668|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
164246669|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
164246670|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
164246671|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
164246672|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
164246673|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
164246674|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
164246675|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
164246676|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246677|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246678|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246679|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246680|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246681|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246682|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246683|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
164246684|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
164246685|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
164246686|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246687|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246688|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246689|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246690|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246691|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246692|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246693|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164246694|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
164246695|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
164337912|NCT00369707|593613170|FG000|Follow up for 2 Years After Treatment|Death|1|||
164337913|NCT00369707|593613170|FG000|Follow up for 2 Years After Treatment|Other|2|||
164337914|NCT05224141|593613171|FG000|Overall Study|Ongoing|75|||
164337915|NCT05224141|593613172|FG001|Overall Study|Ongoing|88|||
164337916|NCT05224141|593613171|FG000|Overall Study|Withdrawal by Subject|2|||
164337917|NCT05224141|593613172|FG001|Overall Study|Withdrawal by Subject|4|||
164337918|NCT05224141|593613171|FG000|Overall Study|Death|153|||
164337919|NCT05224141|593613172|FG001|Overall Study|Death|138|||
164337920|NCT02046733|593613173|FG000|Overall Study|never initiated 'treatment visits'|6|||
164337921|NCT02046733|593613174|FG001|Overall Study|never initiated 'treatment visits'|0|||
164337922|NCT04515394|593613185|FG000|Overall Study|Participant did not receive treatment|1|||
164337923|NCT00199875|593613186|FG000|Overall Study|Withdrawal by Subject|0|||
164337924|NCT00199875|593613187|FG001|Overall Study|Withdrawal by Subject|0|||
164337925|NCT00199875|593613188|FG002|Overall Study|Withdrawal by Subject|0|||
164246696|NCT01194219|593271816|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246697|NCT01194219|593271817|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164337926|NCT00199875|593613189|FG003|Overall Study|Withdrawal by Subject|0|||
164337927|NCT00199875|593613190|FG004|Overall Study|Withdrawal by Subject|1|||
164337928|NCT01691898|593613192|FG000|Overall Study|Death|34|||
163886011|NCT05087992|591954057|FG000|Overall Study|Withdrawal by Subject|2|||
163886012|NCT05087992|591954058|FG001|Overall Study|Withdrawal by Subject|0|||
163886013|NCT05087992|591954059|FG002|Overall Study|Withdrawal by Subject|0|||
163886014|NCT05087992|591954057|FG000|Overall Study|clinical disease progression|3|||
163886015|NCT05087992|591954058|FG001|Overall Study|clinical disease progression|1|||
163886016|NCT05087992|591954059|FG002|Overall Study|clinical disease progression|0|||
163886017|NCT05087992|591954057|FG000|Overall Study|objective disease progression|4|||
163886018|NCT05087992|591954058|FG001|Overall Study|objective disease progression|1|||
163886019|NCT05087992|591954059|FG002|Overall Study|objective disease progression|0|||
163886020|NCT04149704|591954068|FG000|Three Month Follow-up|Death|2|||
163886021|NCT04149704|591954069|FG001|Three Month Follow-up|Death|0|||
163886022|NCT04149704|591954070|FG002|Three Month Follow-up|Death|0|||
163886023|NCT04149704|591954071|FG003|Three Month Follow-up|Death|0|||
163886024|NCT04149704|591954068|FG000|Three Month Follow-up|Lost to Follow-up|1|||
164246698|NCT01194219|593271818|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246699|NCT01194219|593271819|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246700|NCT01194219|593271820|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246701|NCT01194219|593271821|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246702|NCT01194219|593271822|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246703|NCT01194219|593271823|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
164246704|NCT01194219|593271824|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
164246705|NCT01194219|593271825|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
164246706|NCT01081951|593271826|FG000|Overall Study|Death|54|||
164246707|NCT01081951|593271827|FG001|Overall Study|Death|47|||
164246708|NCT01081951|593271826|FG000|Overall Study|Withdrawal by Subject|2|||
164246709|NCT01081951|593271827|FG001|Overall Study|Withdrawal by Subject|6|||
164246710|NCT01081951|593271826|FG000|Overall Study|Allocated treatment but did not take it|0|||
164246711|NCT01081951|593271827|FG001|Overall Study|Allocated treatment but did not take it|1|||
164246712|NCT01081951|593271826|FG000|Overall Study|Lost to Follow-up|0|||
164246713|NCT01081951|593271827|FG001|Overall Study|Lost to Follow-up|1|||
164246714|NCT05226598|593271830|FG000|Overall Study|Death|186|||
164246715|NCT05226598|593271831|FG001|Overall Study|Death|191|||
164246716|NCT05226598|593271830|FG000|Overall Study|Withdrawal by Subject|6|||
164246717|NCT05226598|593271831|FG001|Overall Study|Withdrawal by Subject|6|||
164246718|NCT05226598|593271830|FG000|Overall Study|Ongoing|174|||
164246719|NCT05226598|593271831|FG001|Overall Study|Ongoing|176|||
164246720|NCT04503551|593271832|FG000|Overall Study|Withdrawal by Subject|5|||
164246721|NCT04503551|593271833|FG001|Overall Study|Withdrawal by Subject|3|||
164246722|NCT04503551|593271832|FG000|Overall Study|Physician Decision|1|||
164246723|NCT04503551|593271833|FG001|Overall Study|Physician Decision|0|||
164246724|NCT04503551|593271832|FG000|Overall Study|Death|0|||
164246725|NCT04503551|593271833|FG001|Overall Study|Death|1|||
164246726|NCT04503551|593271832|FG000|Overall Study|Lost to Follow-up|1|||
164246727|NCT04503551|593271833|FG001|Overall Study|Lost to Follow-up|2|||
164246728|NCT04503551|593271832|FG000|Overall Study|Ongoing at Week 52|99|||
164246729|NCT04503551|593271833|FG001|Overall Study|Ongoing at Week 52|62|||
164246730|NCT01871545|593271836|FG000|Overall Study|Death|2|||
164246731|NCT01871545|593271837|FG001|Overall Study|Death|0|||
164246732|NCT01871545|593271836|FG000|Overall Study|Lack of Efficacy|11|||
164246733|NCT01871545|593271837|FG001|Overall Study|Lack of Efficacy|2|||
164246734|NCT01871545|593271836|FG000|Overall Study|Physician Decision|4|||
164246735|NCT01871545|593271837|FG001|Overall Study|Physician Decision|0|||
164246736|NCT01871545|593271836|FG000|Overall Study|Withdrawal by Subject|0|||
164246737|NCT01871545|593271837|FG001|Overall Study|Withdrawal by Subject|1|||
164246738|NCT02569476|593271838|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
164246739|NCT02569476|593271838|FG000|Overall Study|Death|33|||
164246740|NCT02569476|593271838|FG000|Overall Study|Withdrawal by Subject|9|||
164246741|NCT02569476|593271838|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
164246742|NCT02569476|593271838|FG000|Overall Study|Palliative care|1|||
164246743|NCT02569476|593271838|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
163886025|NCT04149704|591954069|FG001|Three Month Follow-up|Lost to Follow-up|4|||
163990869|NCT05099640|592335130|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
163990870|NCT05099640|592335128|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
163990871|NCT05099640|592335129|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
164246744|NCT02569476|593271838|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
164246745|NCT01071954|593271839|FG000|Overall Study|Noncompliance|4|||
164246746|NCT01071954|593271839|FG000|Overall Study|Adverse Event|1|||
164246747|NCT01071954|593271839|FG000|Overall Study|Withdrawal by Subject|11|||
164246748|NCT01071954|593271839|FG000|Overall Study|Requirement for Alternative Therapy|5|||
164246749|NCT01071954|593271839|FG000|Overall Study|Administrative Decision|5|||
164246750|NCT01071954|593271839|FG000|Overall Study|Protocol Specified Criteria|1|||
164246751|NCT01152788|593271840|FG000|Overall Study|Withdrawal by Subject|0|||
164246752|NCT01152788|593271841|FG001|Overall Study|Withdrawal by Subject|3|||
164246753|NCT01152788|593271840|FG000|Overall Study|No treatment|0|||
164246754|NCT01152788|593271841|FG001|Overall Study|No treatment|1|||
164246755|NCT00778336|593271844|FG000|Index Procedure-Discharge|Death|6|||
164246756|NCT00778336|593271845|FG001|Index Procedure-Discharge|Death|3|||
164246757|NCT00778336|593271846|FG002|Index Procedure-Discharge|Death|2|||
164246758|NCT00778336|593271847|FG003|Index Procedure-Discharge|Death|0|||
164246759|NCT00778336|593271844|FG000|3 Month Follow Up|Lost to Follow-up|15|||
164246760|NCT00778336|593271845|FG001|3 Month Follow Up|Lost to Follow-up|20|||
164246761|NCT00778336|593271846|FG002|3 Month Follow Up|Lost to Follow-up|3|||
164246762|NCT00778336|593271847|FG003|3 Month Follow Up|Lost to Follow-up|0|||
164246763|NCT00778336|593271844|FG000|3 Month Follow Up|Death|8|||
164246764|NCT00778336|593271845|FG001|3 Month Follow Up|Death|3|||
164246765|NCT00778336|593271846|FG002|3 Month Follow Up|Death|2|||
164246766|NCT00778336|593271847|FG003|3 Month Follow Up|Death|0|||
164246767|NCT04585269|593271848|FG000|Intervention|Withdrawal by Subject|9|||
164246768|NCT04585269|593271849|FG001|Intervention|Withdrawal by Subject|0|||
164246769|NCT04585269|593271848|FG000|Intervention|Unable to schedule|15|||
164246770|NCT04585269|593271849|FG001|Intervention|Unable to schedule|0|||
164246771|NCT04585269|593271848|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
164246772|NCT04585269|593271849|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
164246773|NCT04585269|593271848|FG000|FU Time 2 (3 months)|Death|2|||
164246774|NCT04585269|593271849|FG001|FU Time 2 (3 months)|Death|2|||
164246775|NCT04585269|593271848|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
164246776|NCT04585269|593271849|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
164246777|NCT04585269|593271848|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
164246778|NCT04585269|593271849|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
164246779|NCT04585269|593271848|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
164246780|NCT04585269|593271849|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
164246781|NCT04585269|593271848|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
164246782|NCT04585269|593271849|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
164246783|NCT04585269|593271848|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
164246784|NCT04585269|593271849|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
164246785|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
164246786|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246787|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246788|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246789|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246790|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246791|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246792|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246793|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246794|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246795|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246796|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246797|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
164246798|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
164246799|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
164246800|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246801|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246802|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246803|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246804|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246805|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246806|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246807|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246808|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246809|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246810|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
164246811|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
164246812|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
164246813|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246814|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246815|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246816|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246817|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246818|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246819|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246820|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246821|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246822|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246823|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
164246824|NCT03307785|593271852|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
164246825|NCT03307785|593271853|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
164246826|NCT03307785|593271854|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246827|NCT03307785|593271855|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246828|NCT03307785|593271856|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246829|NCT03307785|593271857|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246830|NCT03307785|593271858|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246831|NCT03307785|593271859|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246832|NCT03307785|593271860|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246833|NCT03307785|593271861|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246834|NCT03307785|593271862|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246835|NCT03307785|593271863|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246836|NCT03307785|593271864|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
164246837|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246838|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246839|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
164246840|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246841|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246842|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246843|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246844|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246845|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246846|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246847|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246848|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164246849|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
164337929|NCT01691898|593613193|FG001|Overall Study|Death|32|||
164337930|NCT01691898|593613194|FG002|Overall Study|Death|6|||
164337931|NCT01691898|593613195|FG003|Overall Study|Death|3|||
164337932|NCT01691898|593613196|FG004|Overall Study|Death|8|||
164337933|NCT01691898|593613197|FG005|Overall Study|Death|31|||
164337934|NCT01691898|593613192|FG000|Overall Study|Adverse Event|0|||
164337935|NCT01691898|593613193|FG001|Overall Study|Adverse Event|1|||
164246850|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246851|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246852|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
164337936|NCT01691898|593613194|FG002|Overall Study|Adverse Event|0|||
164337937|NCT01691898|593613195|FG003|Overall Study|Adverse Event|1|||
164337938|NCT01691898|593613196|FG004|Overall Study|Adverse Event|1|||
164246853|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246854|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246855|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246856|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246857|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246858|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246859|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246860|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246861|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246862|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
164246863|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246864|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246865|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
164246866|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246867|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246868|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246869|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246870|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246871|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246872|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246873|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246874|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246875|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
164246876|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246877|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246878|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
164246879|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246880|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246881|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246882|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246883|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246884|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246885|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246886|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246887|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246888|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
164246889|NCT03307785|593271852|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246890|NCT03307785|593271853|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164337939|NCT01691898|593613197|FG005|Overall Study|Adverse Event|0|||
164337940|NCT01691898|593613192|FG000|Overall Study|Progression of Disease|1|||
164337941|NCT01691898|593613193|FG001|Overall Study|Progression of Disease|2|||
164337942|NCT01691898|593613194|FG002|Overall Study|Progression of Disease|1|||
164337943|NCT01691898|593613195|FG003|Overall Study|Progression of Disease|0|||
164337944|NCT01691898|593613196|FG004|Overall Study|Progression of Disease|0|||
164337945|NCT01691898|593613197|FG005|Overall Study|Progression of Disease|1|||
164337946|NCT01691898|593613192|FG000|Overall Study|Lost to Follow-up|3|||
164337947|NCT01691898|593613193|FG001|Overall Study|Lost to Follow-up|1|||
164246891|NCT03307785|593271854|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
164337948|NCT01691898|593613194|FG002|Overall Study|Lost to Follow-up|0|||
164337949|NCT01691898|593613195|FG003|Overall Study|Lost to Follow-up|0|||
164083840|NCT03381248|592672173|FG001|0-6 Months|Protocol Violation|1|||
163886026|NCT04149704|591954070|FG002|Three Month Follow-up|Lost to Follow-up|5|||
163886027|NCT04149704|591954071|FG003|Three Month Follow-up|Lost to Follow-up|5|||
163886028|NCT04149704|591954068|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
163886029|NCT04149704|591954069|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
163886030|NCT04149704|591954070|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
163886031|NCT04149704|591954071|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
163886032|NCT04149704|591954068|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
163886033|NCT04149704|591954069|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
163886034|NCT04149704|591954070|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
163886035|NCT04149704|591954071|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
163886036|NCT05362487|591954076|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
163886037|NCT04973254|591954077|FG000|Overall Study|Not adherent|0|||
163886038|NCT04973254|591954078|FG001|Overall Study|Not adherent|1|||
163886039|NCT04973254|591954079|FG002|Overall Study|Not adherent|0|||
163886040|NCT03115476|591954081|FG000|LP0084-1369|Death|1|||
163886041|NCT03115476|591954082|FG001|LP0084-1369|Death|0|||
163886042|NCT03115476|591954083|FG002|LP0084-1369|Death|2|||
163886043|NCT03115476|591954081|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
163886044|NCT03115476|591954082|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
163886045|NCT03115476|591954083|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
163886046|NCT05257486|591954087|FG000|Overall Study|Protocol Violation|3|||
164246892|NCT03307785|593271855|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164337950|NCT01691898|593613196|FG004|Overall Study|Lost to Follow-up|1|||
163886047|NCT04542317|591954088|FG000|Overall Study|Care recipients passed away|18|||
163886048|NCT04542317|591954089|FG001|Overall Study|Care recipients passed away|13|||
164337951|NCT01691898|593613197|FG005|Overall Study|Lost to Follow-up|0|||
164337952|NCT01691898|593613192|FG000|Overall Study|Withdrawal by Subject|9|||
164337953|NCT01691898|593613193|FG001|Overall Study|Withdrawal by Subject|8|||
164337954|NCT01691898|593613194|FG002|Overall Study|Withdrawal by Subject|2|||
164337955|NCT01691898|593613195|FG003|Overall Study|Withdrawal by Subject|1|||
164337956|NCT01691898|593613196|FG004|Overall Study|Withdrawal by Subject|3|||
164337957|NCT01691898|593613197|FG005|Overall Study|Withdrawal by Subject|3|||
164337958|NCT01691898|593613192|FG000|Overall Study|Non-Compliance|0|||
164337959|NCT01691898|593613193|FG001|Overall Study|Non-Compliance|0|||
164337960|NCT01691898|593613194|FG002|Overall Study|Non-Compliance|0|||
164337961|NCT01691898|593613195|FG003|Overall Study|Non-Compliance|0|||
164337962|NCT01691898|593613196|FG004|Overall Study|Non-Compliance|1|||
164337963|NCT01691898|593613197|FG005|Overall Study|Non-Compliance|0|||
164337964|NCT01013350|593613198|FG000|Overall Study|Lost to Follow-up|15|||
164337965|NCT01013350|593613199|FG001|Overall Study|Lost to Follow-up|95|||
164337966|NCT01013350|593613198|FG000|Overall Study|Adverse Event|0|||
164337967|NCT01013350|593613199|FG001|Overall Study|Adverse Event|1|||
164337968|NCT01013350|593613198|FG000|Overall Study|Physician Decision|4|||
164337969|NCT01013350|593613199|FG001|Overall Study|Physician Decision|20|||
164337970|NCT01013350|593613198|FG000|Overall Study|Withdrawal by Subject|15|||
164337971|NCT01013350|593613199|FG001|Overall Study|Withdrawal by Subject|38|||
164337972|NCT01013350|593613198|FG000|Overall Study|Death|3|||
164337973|NCT01013350|593613199|FG001|Overall Study|Death|5|||
164337974|NCT01013350|593613198|FG000|Overall Study|Participant entered interventional study|0|||
164337975|NCT01013350|593613199|FG001|Overall Study|Participant entered interventional study|8|||
164337976|NCT01013350|593613198|FG000|Overall Study|Other|1|||
164337977|NCT01013350|593613199|FG001|Overall Study|Other|25|||
164337978|NCT02019277|593613200|FG000|Overall Study|Withdrawal by Subject|3|||
164337979|NCT02019277|593613200|FG000|Overall Study|Death|7|||
164337980|NCT02019277|593613200|FG000|Overall Study|Did no Cooperate|1|||
164337981|NCT02019277|593613200|FG000|Overall Study|Adverse Event|1|||
164337982|NCT03725852|593613201|FG000|Overall Study|Death|1|||
164337983|NCT03725852|593613202|FG001|Overall Study|Death|0|||
164337984|NCT03725852|593613201|FG000|Overall Study|Withdrawal by Subject|1|||
164337985|NCT03725852|593613202|FG001|Overall Study|Withdrawal by Subject|0|||
164337986|NCT03725852|593613201|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
164337987|NCT03725852|593613202|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
164337988|NCT01787331|593613206|FG000|Overall Study|Physician Decision|1|||
164337989|NCT01787331|593613206|FG000|Overall Study|Withdrawal by Subject|1|||
164337990|NCT01999868|593613207|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
164337991|NCT01999868|593613208|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
164337992|NCT01999868|593613209|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
164337993|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
164337994|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
164337995|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
164337996|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
163886049|NCT04542317|591954088|FG000|Overall Study|No longer a primary caregiver|5|||
164246893|NCT03307785|593271856|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246894|NCT03307785|593271857|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246895|NCT03307785|593271858|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246896|NCT03307785|593271859|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246897|NCT03307785|593271860|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246898|NCT03307785|593271861|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246899|NCT03307785|593271862|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246900|NCT03307785|593271863|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246901|NCT03307785|593271864|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
164246902|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246903|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246904|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246905|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
164246906|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
164246907|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246908|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246909|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246910|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246911|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246912|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246913|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246914|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
164246915|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246916|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246917|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246918|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
164246919|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
164246920|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246921|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246922|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
164337997|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
164337998|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
164337999|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
164338000|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
164338001|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
164338002|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
164338003|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
164338004|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
164338005|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
164338006|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
164338007|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
164338008|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
164338009|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
164338010|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
164338011|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
164338012|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
164338013|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
164338014|NCT01999868|593613207|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
164338015|NCT01999868|593613208|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
164338016|NCT01999868|593613209|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
164338017|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
164338018|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
164338019|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
164338020|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
164338021|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
164338022|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
164338023|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
164338024|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
164338025|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
164338026|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
164246923|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246924|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246925|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
163886050|NCT04542317|591954089|FG001|Overall Study|No longer a primary caregiver|1|||
163886051|NCT04542317|591954088|FG000|Overall Study|Withdrawal by Subject|4|||
163886052|NCT04542317|591954089|FG001|Overall Study|Withdrawal by Subject|2|||
163886053|NCT04542317|591954088|FG000|Overall Study|Caregivers passed away|0|||
163886054|NCT04542317|591954089|FG001|Overall Study|Caregivers passed away|2|||
163886055|NCT04700163|591954090|FG000|Overall Study|Lost to Follow-up|0|||
163886056|NCT04700163|591954091|FG001|Overall Study|Lost to Follow-up|0|||
163886057|NCT04700163|591954092|FG002|Overall Study|Lost to Follow-up|0|||
163886058|NCT04700163|591954093|FG003|Overall Study|Lost to Follow-up|0|||
163886059|NCT04700163|591954094|FG004|Overall Study|Lost to Follow-up|0|||
163886060|NCT04700163|591954095|FG005|Overall Study|Lost to Follow-up|1|||
163990872|NCT05099640|592335130|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
163990873|NCT05099640|592335128|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
163990874|NCT05099640|592335129|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
163990875|NCT05099640|592335130|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
163886061|NCT03848065|591954098|FG000|Overall Study|Death|0|||
163886062|NCT03848065|591954099|FG001|Overall Study|Death|1|||
163886063|NCT03848065|591954100|FG002|Overall Study|Death|0|||
163886064|NCT03848065|591954098|FG000|Overall Study|Lost to Follow-up|0|||
163886065|NCT03848065|591954099|FG001|Overall Study|Lost to Follow-up|0|||
163886066|NCT03848065|591954100|FG002|Overall Study|Lost to Follow-up|1|||
163886067|NCT03848065|591954098|FG000|Overall Study|Physician Decision|0|||
163886068|NCT03848065|591954099|FG001|Overall Study|Physician Decision|0|||
163886069|NCT03848065|591954100|FG002|Overall Study|Physician Decision|1|||
163886070|NCT04564742|591954103|FG000|Overall Study|Lost to Follow-up|1|||
163886071|NCT04564742|591954104|FG001|Overall Study|Lost to Follow-up|0|||
163886072|NCT04564742|591954103|FG000|Overall Study|Consent Withdrawal|4|||
163990876|NCT05099640|592335128|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
163990877|NCT05099640|592335129|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
163990878|NCT05099640|592335130|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
163990879|NCT00179959|592335131|FG000|Overall Study|Lost to Follow-up|3|||
163990880|NCT00179959|592335132|FG001|Overall Study|Lost to Follow-up|1|||
163990881|NCT00179959|592335131|FG000|Overall Study|Withdrawal by Subject|3|||
163990882|NCT00179959|592335132|FG001|Overall Study|Withdrawal by Subject|2|||
163990883|NCT01552681|592335137|FG000|Overall Study|Withdrawal by Subject|4|||
163990884|NCT01552681|592335138|FG001|Overall Study|Withdrawal by Subject|0|||
163990885|NCT01552681|592335137|FG000|Overall Study|Physician Decision|1|||
163990886|NCT01552681|592335138|FG001|Overall Study|Physician Decision|0|||
163990887|NCT01552681|592335137|FG000|Overall Study|Subject moved away|0|||
163990888|NCT01552681|592335138|FG001|Overall Study|Subject moved away|1|||
163990889|NCT03075163|592335139|FG000|Overall Study|not eligible for treatment limb|138|||
163990890|NCT03075163|592335140|FG001|Overall Study|not eligible for treatment limb|138|||
163990891|NCT01299727|592335141|FG000|Overall Study|Withdrawal by Subject|1|||
163990892|NCT01299727|592335142|FG001|Overall Study|Withdrawal by Subject|0|||
163990893|NCT01299727|592335143|FG002|Overall Study|Withdrawal by Subject|0|||
163990894|NCT01299727|592335141|FG000|Overall Study|Adverse Event|0|||
163990895|NCT01299727|592335142|FG001|Overall Study|Adverse Event|0|||
163990896|NCT01299727|592335143|FG002|Overall Study|Adverse Event|1|||
163990897|NCT01299727|592335141|FG000|Overall Study|Completed the Treatment Period|3|||
163886073|NCT04564742|591954104|FG001|Overall Study|Consent Withdrawal|4|||
163886074|NCT03313076|591954107|FG000|Overall Study|Withdrawal by Subject|2|||
163886075|NCT03313076|591954108|FG001|Overall Study|Withdrawal by Subject|0|||
163886076|NCT03313076|591954109|FG002|Overall Study|Withdrawal by Subject|0|||
163886077|NCT03313076|591954110|FG003|Overall Study|Withdrawal by Subject|0|||
163886078|NCT03313076|591954107|FG000|Overall Study|Lost to Follow-up|0|||
163990898|NCT01299727|592335142|FG001|Overall Study|Completed the Treatment Period|4|||
163990899|NCT01299727|592335143|FG002|Overall Study|Completed the Treatment Period|3|||
163990900|NCT03882424|592335144|FG000|Overall Study|Lost to Follow-up|3|||
163990901|NCT03882424|592335145|FG001|Overall Study|Lost to Follow-up|0|||
163990902|NCT03882424|592335146|FG002|Overall Study|Lost to Follow-up|0|||
163990903|NCT03882424|592335144|FG000|Overall Study|schedule conflict|1|||
163990904|NCT03882424|592335145|FG001|Overall Study|schedule conflict|0|||
163990905|NCT03882424|592335146|FG002|Overall Study|schedule conflict|0|||
163990906|NCT00236080|592335147|FG000|Overall Study|Adverse Event|0|||
163990907|NCT00236080|592335148|FG001|Overall Study|Adverse Event|0|||
163990908|NCT00236080|592335149|FG002|Overall Study|Adverse Event|3|||
163990909|NCT00236080|592335150|FG003|Overall Study|Adverse Event|1|||
163990910|NCT00236080|592335151|FG004|Overall Study|Adverse Event|0|||
163990911|NCT00236080|592335147|FG000|Overall Study|Lost to Follow-up|0|||
163990912|NCT00236080|592335148|FG001|Overall Study|Lost to Follow-up|1|||
163990913|NCT00236080|592335149|FG002|Overall Study|Lost to Follow-up|0|||
163990914|NCT00236080|592335150|FG003|Overall Study|Lost to Follow-up|0|||
163886079|NCT03313076|591954108|FG001|Overall Study|Lost to Follow-up|2|||
163990915|NCT00236080|592335151|FG004|Overall Study|Lost to Follow-up|0|||
163990916|NCT00236080|592335147|FG000|Overall Study|Physician Decision|1|||
163990917|NCT00236080|592335148|FG001|Overall Study|Physician Decision|0|||
163990918|NCT00236080|592335149|FG002|Overall Study|Physician Decision|1|||
163990919|NCT00236080|592335150|FG003|Overall Study|Physician Decision|1|||
163990920|NCT00236080|592335151|FG004|Overall Study|Physician Decision|1|||
163990921|NCT00236080|592335147|FG000|Overall Study|Withdrawal by Subject|1|||
163990922|NCT00236080|592335148|FG001|Overall Study|Withdrawal by Subject|0|||
163990923|NCT00236080|592335149|FG002|Overall Study|Withdrawal by Subject|0|||
163990924|NCT00236080|592335150|FG003|Overall Study|Withdrawal by Subject|0|||
163990925|NCT00236080|592335151|FG004|Overall Study|Withdrawal by Subject|0|||
163990926|NCT00236080|592335147|FG000|Overall Study|Miscellaneous|0|||
163990927|NCT00236080|592335148|FG001|Overall Study|Miscellaneous|0|||
164246926|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246927|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
164246928|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246929|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246930|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246931|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
164246932|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246933|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246934|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246935|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246936|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246937|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246938|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246939|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246940|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
164246941|NCT03307785|593271852|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246942|NCT03307785|593271853|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246943|NCT03307785|593271854|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246944|NCT03307785|593271855|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246945|NCT03307785|593271856|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
164246946|NCT03307785|593271857|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164338027|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
164338028|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
164338029|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
164338030|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
164338031|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
164338032|NCT01999868|593613207|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
164338033|NCT01999868|593613208|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
164338034|NCT01999868|593613209|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
164338035|NCT00289016|593613212|FG000|Overall Study|Disease Progression|29|||
164338036|NCT00289016|593613212|FG000|Overall Study|Death|2|||
164338037|NCT00289016|593613212|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
164338038|NCT00289016|593613212|FG000|Overall Study|Withdrawal by Subject|2|||
164338039|NCT00289016|593613212|FG000|Overall Study|Adverse Event|1|||
164338040|NCT00289016|593613212|FG000|Overall Study|Other|1|||
164338041|NCT00667875|593613213|FG000|Overall Study|Adverse Event|0|||
164338042|NCT00667875|593613214|FG001|Overall Study|Adverse Event|2|||
164338043|NCT00667875|593613215|FG002|Overall Study|Adverse Event|6|||
164338044|NCT00667875|593613213|FG000|Overall Study|Withdrawal by Subject|10|||
164338045|NCT00667875|593613214|FG001|Overall Study|Withdrawal by Subject|9|||
164338046|NCT00667875|593613215|FG002|Overall Study|Withdrawal by Subject|7|||
164338047|NCT00450255|593613216|FG000|Overall Study|Prior RFA ablation of liver|1|||
164338048|NCT03553927|593613218|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
164338049|NCT03553927|593613219|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
164338050|NCT03553927|593613218|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
163990928|NCT00236080|592335149|FG002|Overall Study|Miscellaneous|1|||
163990929|NCT00236080|592335150|FG003|Overall Study|Miscellaneous|0|||
163990930|NCT00236080|592335151|FG004|Overall Study|Miscellaneous|0|||
164246947|NCT03307785|593271858|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246948|NCT03307785|593271859|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246949|NCT03307785|593271860|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246950|NCT03307785|593271861|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246951|NCT03307785|593271862|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164246952|NCT03307785|593271863|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164338051|NCT03553927|593613219|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
164338052|NCT03019185|593615033|FG000|Overall Study|Lost to Follow-up|3|||
164338053|NCT03019185|593615034|FG001|Overall Study|Lost to Follow-up|0|||
164338054|NCT03019185|593615035|FG002|Overall Study|Lost to Follow-up|2|||
164246953|NCT03307785|593271864|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
164338055|NCT03019185|593615033|FG000|Overall Study|Withdrawal by Subject|1|||
164338056|NCT03019185|593615034|FG001|Overall Study|Withdrawal by Subject|1|||
164338057|NCT03019185|593615035|FG002|Overall Study|Withdrawal by Subject|0|||
164246954|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246955|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246956|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246957|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246958|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246959|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
164246960|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246961|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246962|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246963|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246964|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246965|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246966|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
164246967|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246968|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246969|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164338058|NCT03019185|593615033|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
164338059|NCT03019185|593615034|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
164338060|NCT03019185|593615035|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
164338061|NCT03019185|593615033|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
164338062|NCT03019185|593615034|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
164338063|NCT03019185|593615035|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
164338064|NCT02764333|593615041|FG000|Overall Study|Ineligible|1|||
164338065|NCT01200524|593615044|FG000|Overall Study|Withdrawal by Subject|1|||
164338066|NCT01200524|593615045|FG001|Overall Study|Withdrawal by Subject|1|||
164338067|NCT01200524|593615046|FG002|Overall Study|Withdrawal by Subject|3|||
164338068|NCT01200524|593615044|FG000|Overall Study|Adverse Event|1|||
164338069|NCT01200524|593615045|FG001|Overall Study|Adverse Event|0|||
164338070|NCT01200524|593615046|FG002|Overall Study|Adverse Event|0|||
164338071|NCT01200524|593615044|FG000|Overall Study|Non availability of study nurse|0|||
164246970|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246971|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246972|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
164246973|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246974|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246975|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246976|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246977|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246978|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246979|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
164246980|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246981|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246982|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246983|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246984|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246985|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
164246986|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246987|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246988|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246989|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246990|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246991|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246992|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
164246993|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246994|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246995|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246996|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246997|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164246998|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
164246999|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247000|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247001|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247002|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247003|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247004|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247005|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
164247006|NCT03307785|593271852|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247007|NCT03307785|593271853|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247008|NCT03307785|593271854|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247009|NCT03307785|593271855|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247010|NCT03307785|593271856|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247011|NCT03307785|593271857|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
164247012|NCT03307785|593271858|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247013|NCT03307785|593271859|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247014|NCT03307785|593271860|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247015|NCT03307785|593271861|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247016|NCT03307785|593271862|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247017|NCT03307785|593271863|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247018|NCT03307785|593271864|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
164247019|NCT03307785|593271852|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247020|NCT03307785|593271853|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247021|NCT03307785|593271854|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247022|NCT03307785|593271855|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247023|NCT03307785|593271856|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247024|NCT03307785|593271857|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247025|NCT03307785|593271858|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
164247026|NCT03307785|593271859|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247027|NCT03307785|593271860|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247028|NCT03307785|593271861|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247029|NCT03307785|593271862|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247030|NCT03307785|593271863|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247031|NCT03307785|593271864|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
164247032|NCT03307785|593271852|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247033|NCT03307785|593271853|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247034|NCT03307785|593271854|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247035|NCT03307785|593271855|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247036|NCT03307785|593271856|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247037|NCT03307785|593271857|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247038|NCT03307785|593271858|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
164247039|NCT03307785|593271859|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
163886080|NCT03313076|591954109|FG002|Overall Study|Lost to Follow-up|2|||
163886081|NCT03313076|591954110|FG003|Overall Study|Lost to Follow-up|2|||
164247040|NCT03307785|593271860|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247041|NCT03307785|593271861|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247042|NCT03307785|593271862|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247043|NCT03307785|593271863|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247044|NCT03307785|593271864|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
164247045|NCT03307785|593271852|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247046|NCT03307785|593271853|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247047|NCT03307785|593271854|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247048|NCT03307785|593271855|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247049|NCT03307785|593271856|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247050|NCT03307785|593271857|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247051|NCT03307785|593271858|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247052|NCT03307785|593271859|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
164247053|NCT03307785|593271860|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247054|NCT03307785|593271861|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247055|NCT03307785|593271862|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247056|NCT03307785|593271863|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247057|NCT03307785|593271864|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
164247058|NCT03307785|593271852|FG000|PACT Phase: Up to 19 Months|Death|0|||
164247059|NCT03307785|593271853|FG001|PACT Phase: Up to 19 Months|Death|0|||
164247060|NCT03307785|593271854|FG002|PACT Phase: Up to 19 Months|Death|0|||
164247061|NCT03307785|593271855|FG003|PACT Phase: Up to 19 Months|Death|0|||
164247062|NCT03307785|593271856|FG004|PACT Phase: Up to 19 Months|Death|0|||
164247063|NCT03307785|593271857|FG005|PACT Phase: Up to 19 Months|Death|0|||
164247064|NCT03307785|593271858|FG006|PACT Phase: Up to 19 Months|Death|0|||
164247065|NCT03307785|593271859|FG007|PACT Phase: Up to 19 Months|Death|0|||
164247066|NCT03307785|593271860|FG008|PACT Phase: Up to 19 Months|Death|0|||
164247067|NCT03307785|593271861|FG009|PACT Phase: Up to 19 Months|Death|0|||
164247068|NCT03307785|593271862|FG010|PACT Phase: Up to 19 Months|Death|0|||
164247069|NCT03307785|593271863|FG011|PACT Phase: Up to 19 Months|Death|0|||
164247070|NCT03307785|593271864|FG012|PACT Phase: Up to 19 Months|Death|1|||
164247071|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247072|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
164247073|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
164247074|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247075|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247076|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
164247077|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Other|0|||
164247078|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Other|1|||
164247079|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Other|1|||
164247080|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Other|0|||
164247081|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Other|0|||
164247082|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Other|0|||
164247083|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
164247084|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
164247085|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
164247086|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
164247087|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
164247088|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
164247089|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247090|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247091|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
164247092|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247093|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247094|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
164247095|NCT03666988|593271865|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
164247096|NCT03666988|593271866|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247097|NCT03666988|593271867|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
163886082|NCT05869383|591954111|FG000|Overall Study|Withdrawal by Subject|2|||
164247098|NCT03666988|593271868|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247099|NCT03666988|593271869|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247100|NCT03666988|593271870|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
164247101|NCT02517398|593271871|FG000|Overall Study|Death|2|||
164247102|NCT02517398|593271872|FG001|Overall Study|Death|3|||
164247103|NCT02517398|593271873|FG002|Overall Study|Death|4|||
164247104|NCT02517398|593271874|FG003|Overall Study|Death|2|||
164247105|NCT02517398|593271875|FG004|Overall Study|Death|3|||
164247106|NCT02517398|593271876|FG005|Overall Study|Death|8|||
164247107|NCT02517398|593271877|FG006|Overall Study|Death|3|||
164247108|NCT02517398|593271878|FG007|Overall Study|Death|2|||
164247109|NCT02517398|593271879|FG008|Overall Study|Death|6|||
164247110|NCT02517398|593271880|FG009|Overall Study|Death|24|||
164247111|NCT02517398|593271881|FG010|Overall Study|Death|53|||
164338072|NCT01200524|593615045|FG001|Overall Study|Non availability of study nurse|0|||
164338073|NCT01200524|593615046|FG002|Overall Study|Non availability of study nurse|1|||
164338074|NCT01868503|593615047|FG000|Overall Study|Withdrawal by Subject|1|||
164338075|NCT01868503|593615047|FG000|Overall Study|Protocol Violation|1|||
164338076|NCT00736944|593615048|FG000|Induction|Death|1|||
164338077|NCT00736944|593615048|FG000|Definitive Treatment|Physician Decision|1|||
164338078|NCT00491764|593615049|FG000|Overall Study|Adverse Event|1|||
164338079|NCT00491764|593615050|FG001|Overall Study|Adverse Event|2|||
164338080|NCT00491764|593615051|FG002|Overall Study|Adverse Event|4|||
164338081|NCT00491764|593615052|FG003|Overall Study|Adverse Event|4|||
164338082|NCT00491764|593615053|FG004|Overall Study|Adverse Event|0|||
164338083|NCT00491764|593615054|FG005|Overall Study|Adverse Event|1|||
164338084|NCT00491764|593615049|FG000|Overall Study|Lost to Follow-up|0|||
164338085|NCT00491764|593615050|FG001|Overall Study|Lost to Follow-up|1|||
164338086|NCT00491764|593615051|FG002|Overall Study|Lost to Follow-up|0|||
164338087|NCT00491764|593615052|FG003|Overall Study|Lost to Follow-up|1|||
164338088|NCT00491764|593615053|FG004|Overall Study|Lost to Follow-up|0|||
164338089|NCT00491764|593615054|FG005|Overall Study|Lost to Follow-up|3|||
164338090|NCT00491764|593615049|FG000|Overall Study|Withdrawal by Subject|2|||
164338091|NCT00491764|593615050|FG001|Overall Study|Withdrawal by Subject|3|||
164338092|NCT00491764|593615051|FG002|Overall Study|Withdrawal by Subject|1|||
164338093|NCT00491764|593615052|FG003|Overall Study|Withdrawal by Subject|2|||
164338094|NCT00491764|593615053|FG004|Overall Study|Withdrawal by Subject|2|||
164338095|NCT00491764|593615054|FG005|Overall Study|Withdrawal by Subject|4|||
164338096|NCT00491764|593615049|FG000|Overall Study|Non Compliance with the Protocol|1|||
164338097|NCT00491764|593615050|FG001|Overall Study|Non Compliance with the Protocol|0|||
163886083|NCT05869383|591954112|FG001|Overall Study|Withdrawal by Subject|0|||
163886084|NCT03270501|591954117|FG000|Overall Study|Screen failure|6|||
163886085|NCT03270501|591954117|FG000|Overall Study|Lost to Follow-up|2|||
163886086|NCT03270501|591954117|FG000|Overall Study|Adverse Event|1|||
163886087|NCT05270408|591954126|FG000|Started Treatment|Withdrawal by Subject|0|||
163886088|NCT05270408|591954127|FG001|Started Treatment|Withdrawal by Subject|0|||
163886089|NCT05270408|591954128|FG002|Started Treatment|Withdrawal by Subject|3|||
163886090|NCT05270408|591954126|FG000|Started Treatment|Adverse Event|0|||
163886091|NCT05270408|591954127|FG001|Started Treatment|Adverse Event|0|||
163886092|NCT05270408|591954128|FG002|Started Treatment|Adverse Event|1|||
163886093|NCT05270408|591954126|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
163886094|NCT05270408|591954127|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
164083841|NCT03381248|592672172|FG000|0-6 Months|Physician Decision|1|||
164247112|NCT02517398|593271882|FG011|Overall Study|Death|25|||
164247113|NCT02517398|593271883|FG012|Overall Study|Death|73|||
164247114|NCT02517398|593271884|FG013|Overall Study|Death|29|||
164338098|NCT00491764|593615051|FG002|Overall Study|Non Compliance with the Protocol|0|||
164338099|NCT00491764|593615052|FG003|Overall Study|Non Compliance with the Protocol|0|||
164338100|NCT00491764|593615053|FG004|Overall Study|Non Compliance with the Protocol|0|||
164338101|NCT00491764|593615054|FG005|Overall Study|Non Compliance with the Protocol|0|||
164338102|NCT00491764|593615049|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
164338103|NCT00491764|593615050|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
164338104|NCT00491764|593615051|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
164338105|NCT00491764|593615052|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
164338106|NCT00491764|593615053|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
164247115|NCT02517398|593271885|FG014|Overall Study|Death|26|||
164247116|NCT02517398|593271886|FG015|Overall Study|Death|23|||
164247117|NCT02517398|593271887|FG016|Overall Study|Death|26|||
164247118|NCT02517398|593271888|FG017|Overall Study|Death|25|||
164247119|NCT02517398|593271889|FG018|Overall Study|Death|22|||
164247120|NCT02517398|593271890|FG019|Overall Study|Death|7|||
164247121|NCT02517398|593271891|FG020|Overall Study|Death|26|||
164247122|NCT02517398|593271892|FG021|Overall Study|Death|30|||
164247123|NCT02517398|593271893|FG022|Overall Study|Death|20|||
164247124|NCT02517398|593271871|FG000|Overall Study|Other|0|||
164247125|NCT02517398|593271872|FG001|Overall Study|Other|0|||
164247126|NCT02517398|593271873|FG002|Overall Study|Other|0|||
164247127|NCT02517398|593271874|FG003|Overall Study|Other|1|||
164247128|NCT02517398|593271875|FG004|Overall Study|Other|0|||
164247129|NCT02517398|593271876|FG005|Overall Study|Other|0|||
164247130|NCT02517398|593271877|FG006|Overall Study|Other|0|||
164247131|NCT02517398|593271878|FG007|Overall Study|Other|0|||
164247132|NCT02517398|593271879|FG008|Overall Study|Other|0|||
164247133|NCT02517398|593271880|FG009|Overall Study|Other|1|||
164247134|NCT02517398|593271881|FG010|Overall Study|Other|0|||
164247135|NCT02517398|593271882|FG011|Overall Study|Other|0|||
164247136|NCT02517398|593271883|FG012|Overall Study|Other|0|||
164247137|NCT02517398|593271884|FG013|Overall Study|Other|1|||
164247138|NCT02517398|593271885|FG014|Overall Study|Other|0|||
164247139|NCT02517398|593271886|FG015|Overall Study|Other|1|||
164247140|NCT02517398|593271887|FG016|Overall Study|Other|1|||
164247141|NCT02517398|593271888|FG017|Overall Study|Other|0|||
164247142|NCT02517398|593271889|FG018|Overall Study|Other|0|||
164247143|NCT02517398|593271890|FG019|Overall Study|Other|1|||
164247144|NCT02517398|593271891|FG020|Overall Study|Other|0|||
164247145|NCT02517398|593271892|FG021|Overall Study|Other|0|||
164247146|NCT02517398|593271893|FG022|Overall Study|Other|0|||
164247147|NCT02517398|593271871|FG000|Overall Study|Lost to Follow-up|0|||
164247148|NCT02517398|593271872|FG001|Overall Study|Lost to Follow-up|0|||
164247149|NCT02517398|593271873|FG002|Overall Study|Lost to Follow-up|0|||
164247150|NCT02517398|593271874|FG003|Overall Study|Lost to Follow-up|0|||
164247151|NCT02517398|593271875|FG004|Overall Study|Lost to Follow-up|0|||
164247152|NCT02517398|593271876|FG005|Overall Study|Lost to Follow-up|0|||
164247153|NCT02517398|593271877|FG006|Overall Study|Lost to Follow-up|0|||
164247154|NCT02517398|593271878|FG007|Overall Study|Lost to Follow-up|0|||
164247155|NCT02517398|593271879|FG008|Overall Study|Lost to Follow-up|0|||
164247156|NCT02517398|593271880|FG009|Overall Study|Lost to Follow-up|1|||
164247157|NCT02517398|593271881|FG010|Overall Study|Lost to Follow-up|0|||
164247158|NCT02517398|593271882|FG011|Overall Study|Lost to Follow-up|2|||
164247159|NCT02517398|593271883|FG012|Overall Study|Lost to Follow-up|2|||
164247160|NCT02517398|593271884|FG013|Overall Study|Lost to Follow-up|0|||
164247161|NCT02517398|593271885|FG014|Overall Study|Lost to Follow-up|1|||
164247162|NCT02517398|593271886|FG015|Overall Study|Lost to Follow-up|1|||
164247163|NCT02517398|593271887|FG016|Overall Study|Lost to Follow-up|0|||
164247164|NCT02517398|593271888|FG017|Overall Study|Lost to Follow-up|3|||
164247165|NCT02517398|593271889|FG018|Overall Study|Lost to Follow-up|1|||
164247166|NCT02517398|593271890|FG019|Overall Study|Lost to Follow-up|0|||
164247167|NCT02517398|593271891|FG020|Overall Study|Lost to Follow-up|1|||
164247168|NCT02517398|593271892|FG021|Overall Study|Lost to Follow-up|0|||
164247169|NCT02517398|593271893|FG022|Overall Study|Lost to Follow-up|2|||
164247170|NCT02517398|593271871|FG000|Overall Study|Withdrew Consent|0|||
164247171|NCT02517398|593271872|FG001|Overall Study|Withdrew Consent|0|||
164247172|NCT02517398|593271873|FG002|Overall Study|Withdrew Consent|0|||
164247173|NCT02517398|593271874|FG003|Overall Study|Withdrew Consent|0|||
164247174|NCT02517398|593271875|FG004|Overall Study|Withdrew Consent|0|||
164247175|NCT02517398|593271876|FG005|Overall Study|Withdrew Consent|0|||
164247176|NCT02517398|593271877|FG006|Overall Study|Withdrew Consent|1|||
164247177|NCT02517398|593271878|FG007|Overall Study|Withdrew Consent|0|||
164247178|NCT02517398|593271879|FG008|Overall Study|Withdrew Consent|0|||
164247179|NCT02517398|593271880|FG009|Overall Study|Withdrew Consent|2|||
164247180|NCT02517398|593271881|FG010|Overall Study|Withdrew Consent|7|||
164247181|NCT02517398|593271882|FG011|Overall Study|Withdrew Consent|1|||
164247182|NCT02517398|593271883|FG012|Overall Study|Withdrew Consent|5|||
164247183|NCT02517398|593271884|FG013|Overall Study|Withdrew Consent|4|||
164247184|NCT02517398|593271885|FG014|Overall Study|Withdrew Consent|2|||
164247185|NCT02517398|593271886|FG015|Overall Study|Withdrew Consent|5|||
164247186|NCT02517398|593271887|FG016|Overall Study|Withdrew Consent|4|||
164247187|NCT02517398|593271888|FG017|Overall Study|Withdrew Consent|2|||
164247188|NCT02517398|593271889|FG018|Overall Study|Withdrew Consent|3|||
164247189|NCT02517398|593271890|FG019|Overall Study|Withdrew Consent|2|||
164247190|NCT02517398|593271891|FG020|Overall Study|Withdrew Consent|9|||
164247191|NCT02517398|593271892|FG021|Overall Study|Withdrew Consent|3|||
164247192|NCT02517398|593271893|FG022|Overall Study|Withdrew Consent|1|||
164247193|NCT01154452|593271898|FG000|Phase Ib|Not Treated|1|||
164247194|NCT01154452|593271899|FG001|Phase Ib|Not Treated|0|||
164247195|NCT01154452|593271900|FG002|Phase Ib|Not Treated|0|||
164247196|NCT01154452|593271901|FG003|Phase Ib|Not Treated|0|||
164247197|NCT01154452|593271898|FG000|Phase Ib|Adverse Event|2|||
164247198|NCT01154452|593271899|FG001|Phase Ib|Adverse Event|1|||
164247199|NCT01154452|593271900|FG002|Phase Ib|Adverse Event|0|||
164247200|NCT01154452|593271901|FG003|Phase Ib|Adverse Event|0|||
164247201|NCT01154452|593271898|FG000|Phase II|Withdrawal by Subject|0|||
164247202|NCT01154452|593271899|FG001|Phase II|Withdrawal by Subject|0|||
164247203|NCT01154452|593271900|FG002|Phase II|Withdrawal by Subject|1|||
164247204|NCT01154452|593271901|FG003|Phase II|Withdrawal by Subject|2|||
164247205|NCT01154452|593271898|FG000|Phase II|Adverse Event|0|||
164247206|NCT01154452|593271899|FG001|Phase II|Adverse Event|0|||
164247207|NCT01154452|593271900|FG002|Phase II|Adverse Event|4|||
164247208|NCT01154452|593271901|FG003|Phase II|Adverse Event|4|||
164247209|NCT01392573|593271902|FG000|Overall Study|Adverse Event|1|||
164247210|NCT01392573|593271903|FG001|Overall Study|Adverse Event|3|||
164247211|NCT01392573|593271902|FG000|Overall Study|Lack of Efficacy|1|||
164247212|NCT01392573|593271903|FG001|Overall Study|Lack of Efficacy|2|||
164247213|NCT01392573|593271902|FG000|Overall Study|Protocol Violation|0|||
164247214|NCT01392573|593271903|FG001|Overall Study|Protocol Violation|2|||
164247215|NCT01392573|593271902|FG000|Overall Study|Withdrawal Criteria|13|||
164247216|NCT01392573|593271903|FG001|Overall Study|Withdrawal Criteria|15|||
164247217|NCT01392573|593271902|FG000|Overall Study|Site closure|8|||
164247218|NCT01392573|593271903|FG001|Overall Study|Site closure|7|||
164247219|NCT01392573|593271902|FG000|Overall Study|Unclassified|9|||
164247220|NCT01392573|593271903|FG001|Overall Study|Unclassified|6|||
164247221|NCT00325130|593271938|FG000|Overall Study|Lost to Follow-up|6|||
164247222|NCT00325130|593271939|FG001|Overall Study|Lost to Follow-up|14|||
164247223|NCT00325130|593271938|FG000|Overall Study|Withdrawal by Subject|12|||
164247224|NCT00325130|593271939|FG001|Overall Study|Withdrawal by Subject|14|||
164247225|NCT00325130|593271938|FG000|Overall Study|Protocol Deviation|0|||
164247226|NCT00325130|593271939|FG001|Overall Study|Protocol Deviation|1|||
164247227|NCT00325130|593271938|FG000|Overall Study|Moved|0|||
164247228|NCT00325130|593271939|FG001|Overall Study|Moved|1|||
164247229|NCT00325130|593271938|FG000|Overall Study|Patient Discontinued for Other|1|||
164247230|NCT00325130|593271939|FG001|Overall Study|Patient Discontinued for Other|0|||
164247231|NCT03744910|593273224|FG000|Overall Study|Withdrew Consent|1|||
164247232|NCT03744910|593273225|FG001|Overall Study|Withdrew Consent|8|||
164247233|NCT03744910|593273224|FG000|Overall Study|Physician Decision|5|||
164247234|NCT03744910|593273225|FG001|Overall Study|Physician Decision|4|||
164247235|NCT03744910|593273224|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
164247236|NCT03744910|593273225|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
164247237|NCT03744910|593273224|FG000|Overall Study|Lost to Follow-up|0|||
164247238|NCT03744910|593273225|FG001|Overall Study|Lost to Follow-up|1|||
164247239|NCT03744910|593273224|FG000|Overall Study|Other-unspecified|4|||
164247240|NCT03744910|593273225|FG001|Overall Study|Other-unspecified|1|||
164247241|NCT02744612|593273226|FG000|Overall Study|Withdrawal by Subject|0|||
164247242|NCT02744612|593273227|FG001|Overall Study|Withdrawal by Subject|2|||
164247243|NCT00283803|593273228|FG000|Overall Study|Physician Decision|9|||
164247244|NCT00283803|593273228|FG000|Overall Study|Withdrawal by Subject|4|||
164247245|NCT01127607|593273229|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
164247246|NCT01127607|593273230|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
164247247|NCT01127607|593273229|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
164247248|NCT01127607|593273230|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
164247249|NCT02220855|593273231|FG000|Overall Study|Adverse Event|8|||
164247250|NCT02220855|593273231|FG000|Overall Study|Disease Progression|5|||
164247251|NCT02220855|593273231|FG000|Overall Study|Withdrawal by Subject|1|||
164247252|NCT03419897|593273232|FG000|Overall Study|Death|180|||
164247253|NCT03419897|593273232|FG000|Overall Study|Lost to Follow-up|1|||
164247254|NCT03419897|593273232|FG000|Overall Study|Withdrawal by Subject|6|||
164247255|NCT03419897|593273232|FG000|Overall Study|Sponsor Decision|61|||
164247256|NCT03419897|593273232|FG000|Overall Study|Physician Decision|1|||
164247257|NCT05730725|593273235|FG000|Overall Study|Withdrawal by Subject|3|||
164338107|NCT00491764|593615054|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
164338108|NCT00491764|593615049|FG000|Overall Study|Administrative|1|||
164338109|NCT00491764|593615050|FG001|Overall Study|Administrative|0|||
164338110|NCT00491764|593615051|FG002|Overall Study|Administrative|2|||
164338111|NCT00491764|593615052|FG003|Overall Study|Administrative|1|||
164338112|NCT00491764|593615053|FG004|Overall Study|Administrative|0|||
164338113|NCT00491764|593615054|FG005|Overall Study|Administrative|0|||
164338114|NCT00894166|593615055|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
164338115|NCT00894166|593615056|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
164338116|NCT00894166|593615057|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
164338117|NCT00894166|593615058|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
164338118|NCT00894166|593615059|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
164338119|NCT00894166|593615060|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
164338120|NCT00894166|593615061|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
164338121|NCT00894166|593615062|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
164338122|NCT00894166|593615055|FG000|Overall Study|Death|0|||
164338123|NCT00894166|593615056|FG001|Overall Study|Death|0|||
164338124|NCT00894166|593615057|FG002|Overall Study|Death|0|||
164338125|NCT00894166|593615058|FG003|Overall Study|Death|1|||
164338126|NCT00894166|593615059|FG004|Overall Study|Death|0|||
164338127|NCT00894166|593615060|FG005|Overall Study|Death|0|||
164338128|NCT00894166|593615061|FG006|Overall Study|Death|0|||
164338129|NCT00894166|593615062|FG007|Overall Study|Death|0|||
164338130|NCT01601132|593615063|FG000|Overall Study|Patient withdrew consent|1|||
164338131|NCT01601132|593615063|FG000|Overall Study|Protocol deviation|1|||
164338132|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Adverse Event|3|||
164338133|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Adverse Event|0|||
164338134|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
164338135|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
164338136|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
164338137|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
164338138|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Physician Decision|0|||
164083842|NCT03381248|592672173|FG001|0-6 Months|Physician Decision|0|||
164247258|NCT05730725|593273236|FG001|Overall Study|Withdrawal by Subject|0|||
164247259|NCT05730725|593273237|FG002|Overall Study|Withdrawal by Subject|0|||
164247260|NCT05730725|593273238|FG003|Overall Study|Withdrawal by Subject|1|||
164247261|NCT05730725|593273235|FG000|Overall Study|Not Reported|1|||
164247262|NCT05730725|593273236|FG001|Overall Study|Not Reported|1|||
164247263|NCT05730725|593273237|FG002|Overall Study|Not Reported|1|||
164247264|NCT05730725|593273238|FG003|Overall Study|Not Reported|1|||
164247265|NCT03053440|593273245|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
164338139|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Physician Decision|2|||
164338140|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
164338141|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
164338142|NCT02110238|593615064|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
164338143|NCT02110238|593615065|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
164338144|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
164338145|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
164247266|NCT03053440|593273246|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
164247267|NCT03053440|593273245|FG000|Overall Study|Death|18|||
164247268|NCT03053440|593273246|FG001|Overall Study|Death|14|||
164247269|NCT03053440|593273245|FG000|Overall Study|Withdrawal by Subject|9|||
164247270|NCT03053440|593273246|FG001|Overall Study|Withdrawal by Subject|8|||
164247271|NCT03053440|593273245|FG000|Overall Study|Lost to Follow-up|1|||
164247272|NCT03053440|593273246|FG001|Overall Study|Lost to Follow-up|0|||
164247273|NCT03053440|593273245|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
164247274|NCT03053440|593273246|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
164338146|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
164247275|NCT03053440|593273245|FG000|Overall Study|Physician Decision|2|||
164338147|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
164338148|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
164338149|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
164338150|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
164338151|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
164338152|NCT02110238|593615064|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
164338153|NCT02110238|593615065|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
164338154|NCT03228433|593615070|FG000|Overall Study|Lost to Follow-up|1|||
164338155|NCT03228433|593615071|FG001|Overall Study|Lost to Follow-up|0|||
164338156|NCT03228433|593615072|FG002|Overall Study|Lost to Follow-up|0|||
164338157|NCT03228433|593615073|FG003|Overall Study|Lost to Follow-up|0|||
164338158|NCT03228433|593615074|FG004|Overall Study|Lost to Follow-up|0|||
164338159|NCT03228433|593615075|FG005|Overall Study|Lost to Follow-up|0|||
164338160|NCT03228433|593615070|FG000|Overall Study|Positive alcohol test|0|||
164338161|NCT03228433|593615071|FG001|Overall Study|Positive alcohol test|0|||
164338162|NCT03228433|593615072|FG002|Overall Study|Positive alcohol test|0|||
164338163|NCT03228433|593615073|FG003|Overall Study|Positive alcohol test|1|||
164338164|NCT03228433|593615074|FG004|Overall Study|Positive alcohol test|0|||
164338165|NCT03228433|593615075|FG005|Overall Study|Positive alcohol test|0|||
164338166|NCT03626168|593615078|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164338167|NCT03626168|593615079|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164338168|NCT03626168|593615078|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
164338169|NCT03626168|593615079|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
164338170|NCT03626168|593615078|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164338171|NCT03626168|593615079|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
164338172|NCT00216476|593615080|FG000|Overall Study|Withdrawal by Subject|59|||
164338173|NCT00216476|593615081|FG001|Overall Study|Withdrawal by Subject|72|||
164338174|NCT00216476|593615082|FG002|Overall Study|Withdrawal by Subject|9|||
164338175|NCT00216476|593615080|FG000|Overall Study|Lost to Follow-up|10|||
164338176|NCT00216476|593615081|FG001|Overall Study|Lost to Follow-up|9|||
164338177|NCT00216476|593615082|FG002|Overall Study|Lost to Follow-up|1|||
164338178|NCT00216476|593615080|FG000|Overall Study|Adverse Event|6|||
164338179|NCT00216476|593615081|FG001|Overall Study|Adverse Event|10|||
164338180|NCT00216476|593615082|FG002|Overall Study|Adverse Event|1|||
164338181|NCT00216476|593615080|FG000|Overall Study|Lack of Efficacy|4|||
164338182|NCT00216476|593615081|FG001|Overall Study|Lack of Efficacy|3|||
164338183|NCT00216476|593615082|FG002|Overall Study|Lack of Efficacy|0|||
164338184|NCT00216476|593615080|FG000|Overall Study|Death|2|||
164338185|NCT00216476|593615081|FG001|Overall Study|Death|0|||
164338186|NCT00216476|593615082|FG002|Overall Study|Death|0|||
164338187|NCT00216476|593615080|FG000|Overall Study|Pregnancy|0|||
164338188|NCT00216476|593615081|FG001|Overall Study|Pregnancy|1|||
164338189|NCT00216476|593615082|FG002|Overall Study|Pregnancy|1|||
164338190|NCT00216476|593615080|FG000|Overall Study|Other|0|||
164338191|NCT00216476|593615081|FG001|Overall Study|Other|0|||
164338192|NCT00216476|593615082|FG002|Overall Study|Other|1|||
164338193|NCT00216476|593615080|FG000|Overall Study|Refuses Injection|11|||
164338194|NCT00216476|593615081|FG001|Overall Study|Refuses Injection|0|||
164338195|NCT00216476|593615082|FG002|Overall Study|Refuses Injection|0|||
164338196|NCT00216476|593615080|FG000|Overall Study|No Further Need for Treatment|3|||
164247276|NCT03053440|593273246|FG001|Overall Study|Physician Decision|1|||
164247277|NCT03053440|593273245|FG000|Overall Study|Participant Randomized but died before dosing|1|||
164338197|NCT00216476|593615081|FG001|Overall Study|No Further Need for Treatment|4|||
164338198|NCT00216476|593615082|FG002|Overall Study|No Further Need for Treatment|1|||
164338199|NCT00216476|593615080|FG000|Overall Study|Non-compliance|0|||
164338200|NCT00216476|593615081|FG001|Overall Study|Non-compliance|4|||
164338201|NCT00216476|593615082|FG002|Overall Study|Non-compliance|1|||
164338202|NCT00216476|593615080|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
164338203|NCT00216476|593615081|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
164338204|NCT00216476|593615082|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
164247278|NCT03053440|593273246|FG001|Overall Study|Participant Randomized but died before dosing|0|||
164338205|NCT00216476|593615080|FG000|Overall Study|Administrative Reasons|1|||
164338206|NCT00216476|593615081|FG001|Overall Study|Administrative Reasons|1|||
164338207|NCT00216476|593615082|FG002|Overall Study|Administrative Reasons|0|||
164247279|NCT00391053|593273252|FG000|Overall Study|Serious Adverse Events|1|||
164247280|NCT00391053|593273253|FG001|Overall Study|Serious Adverse Events|0|||
164247281|NCT00391053|593273254|FG002|Overall Study|Serious Adverse Events|1|||
164247282|NCT00391053|593273255|FG003|Overall Study|Serious Adverse Events|4|||
164247283|NCT00391053|593273252|FG000|Overall Study|Protocol Violation|2|||
164247284|NCT00391053|593273253|FG001|Overall Study|Protocol Violation|0|||
164247285|NCT00391053|593273254|FG002|Overall Study|Protocol Violation|0|||
164247286|NCT00391053|593273255|FG003|Overall Study|Protocol Violation|0|||
164247287|NCT00391053|593273252|FG000|Overall Study|Lost to Follow-up|1|||
164247288|NCT00391053|593273253|FG001|Overall Study|Lost to Follow-up|0|||
164247289|NCT00391053|593273254|FG002|Overall Study|Lost to Follow-up|0|||
164247290|NCT00391053|593273255|FG003|Overall Study|Lost to Follow-up|5|||
164247291|NCT00391053|593273252|FG000|Overall Study|Withdrawal by Subject|5|||
164247292|NCT00391053|593273253|FG001|Overall Study|Withdrawal by Subject|1|||
164247293|NCT00391053|593273254|FG002|Overall Study|Withdrawal by Subject|1|||
164247294|NCT00391053|593273255|FG003|Overall Study|Withdrawal by Subject|1|||
164247295|NCT00473889|593273257|FG000|Overall Study|Did not receive study medication|1|||
164247296|NCT00473889|593273258|FG001|Overall Study|Did not receive study medication|4|||
164247297|NCT00473889|593273257|FG000|Overall Study|Adverse Event|30|||
164247298|NCT00473889|593273258|FG001|Overall Study|Adverse Event|17|||
164247299|NCT00473889|593273257|FG000|Overall Study|Protocol Violation|4|||
164247300|NCT00473889|593273258|FG001|Overall Study|Protocol Violation|2|||
164247301|NCT00473889|593273257|FG000|Overall Study|Lack of Efficacy|28|||
164247302|NCT00473889|593273258|FG001|Overall Study|Lack of Efficacy|29|||
164338208|NCT00216476|593615080|FG000|Overall Study|Protocol Deviation|5|||
163886095|NCT05270408|591954128|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
163886096|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
163886097|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
163886098|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
163886099|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
163886100|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
163886101|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
163886102|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
163886103|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
163886104|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
163886105|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
163886106|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
163886107|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
163886108|NCT04338061|591954129|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
163886109|NCT04338061|591954130|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
163886110|NCT04338061|591954129|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
163886111|NCT04338061|591954130|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
163886112|NCT04338061|591954129|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
163886113|NCT04338061|591954130|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
163886114|NCT04338061|591954129|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
163886115|NCT04338061|591954130|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
163886116|NCT04338061|591954129|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
163886117|NCT04338061|591954130|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
163886118|NCT04338061|591954129|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
163886119|NCT04338061|591954130|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
163886120|NCT03631784|591954131|FG000|Overall Study|Participants Ongoing|1|||
163886121|NCT03631784|591954132|FG001|Overall Study|Participants Ongoing|0|||
163886122|NCT03631784|591954131|FG000|Overall Study|Withdrawal by Subject|3|||
163886123|NCT03631784|591954132|FG001|Overall Study|Withdrawal by Subject|3|||
163886124|NCT03631784|591954131|FG000|Overall Study|Sponsor's Decision|36|||
163886125|NCT03631784|591954132|FG001|Overall Study|Sponsor's Decision|52|||
163886126|NCT03631784|591954131|FG000|Overall Study|Lost to Follow-up|1|||
163886127|NCT03631784|591954132|FG001|Overall Study|Lost to Follow-up|0|||
163886128|NCT03631784|591954131|FG000|Overall Study|Death|71|||
164247303|NCT00473889|593273257|FG000|Overall Study|Lost to Follow-up|2|||
164247304|NCT00473889|593273258|FG001|Overall Study|Lost to Follow-up|1|||
164247305|NCT00473889|593273257|FG000|Overall Study|Physician Decision|10|||
164247306|NCT00473889|593273258|FG001|Overall Study|Physician Decision|5|||
164247307|NCT00473889|593273257|FG000|Overall Study|Trial Terminated|3|||
164247308|NCT00473889|593273258|FG001|Overall Study|Trial Terminated|6|||
164247309|NCT00473889|593273257|FG000|Overall Study|Withdrawal by Subject|5|||
164247310|NCT00473889|593273258|FG001|Overall Study|Withdrawal by Subject|0|||
164247311|NCT02140970|593273259|FG000|Overall Study|Lost to Follow-up|1|||
164247312|NCT02140970|593273260|FG001|Overall Study|Lost to Follow-up|2|||
164247313|NCT02140970|593273259|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
164247314|NCT02140970|593273260|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
164247315|NCT02140970|593273259|FG000|Overall Study|Did not meet inclusion criteria|0|||
164247316|NCT02140970|593273260|FG001|Overall Study|Did not meet inclusion criteria|1|||
164247317|NCT00460655|593273264|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
164247318|NCT00460655|593273265|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164247319|NCT00460655|593273266|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164247320|NCT00460655|593273267|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
164247321|NCT00460655|593273264|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
164247322|NCT00460655|593273265|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164247323|NCT00460655|593273266|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164247324|NCT00460655|593273267|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164247325|NCT00460655|593273264|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
164247326|NCT00460655|593273265|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
164247327|NCT00460655|593273266|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
164247328|NCT00460655|593273267|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
164247329|NCT00460655|593273264|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164247330|NCT00460655|593273265|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
164247331|NCT00460655|593273266|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
164247332|NCT00460655|593273267|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
164247333|NCT00460655|593273264|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164247334|NCT00460655|593273265|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
164247335|NCT00460655|593273266|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
164247336|NCT00460655|593273267|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
164247337|NCT00460655|593273264|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
164247338|NCT00460655|593273265|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
164247339|NCT00460655|593273266|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
164247340|NCT00460655|593273267|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
164247341|NCT00590122|593273268|FG000|Overall Study|swallowed oral dissolving dose|1|||
164247342|NCT00590122|593273269|FG001|Overall Study|swallowed oral dissolving dose|0|||
164247343|NCT03050450|593273270|FG000|Overall Study|Physician Decision|1|||
164247344|NCT03050450|593273271|FG001|Overall Study|Physician Decision|0|||
164247345|NCT03050450|593273272|FG002|Overall Study|Physician Decision|0|||
164247346|NCT03050450|593273273|FG003|Overall Study|Physician Decision|0|||
164247347|NCT03050450|593273274|FG004|Overall Study|Physician Decision|0|||
164247348|NCT00735553|593273278|FG000|Overall Study|Study prematurely terminated|77|||
164247349|NCT02705105|593273279|FG000|Treatment|Objective Disease Progression|1|||
164247350|NCT02705105|593273280|FG001|Treatment|Objective Disease Progression|50|||
164247351|NCT02705105|593273279|FG000|Treatment|Withdrawal by Subject|3|||
164247352|NCT02705105|593273280|FG001|Treatment|Withdrawal by Subject|5|||
164247353|NCT02705105|593273279|FG000|Treatment|Adverse Event|0|||
164247354|NCT02705105|593273280|FG001|Treatment|Adverse Event|17|||
164247355|NCT02705105|593273279|FG000|Treatment|Clinical Disease Progression|0|||
164247356|NCT02705105|593273280|FG001|Treatment|Clinical Disease Progression|32|||
164247357|NCT02705105|593273279|FG000|Treatment|Physician Decision|0|||
164247358|NCT02705105|593273280|FG001|Treatment|Physician Decision|3|||
164247359|NCT02705105|593273279|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
164247360|NCT02705105|593273280|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
164247361|NCT02705105|593273279|FG000|Follow-Up|Death|3|||
164247362|NCT02705105|593273280|FG001|Follow-Up|Death|68|||
164247363|NCT02705105|593273279|FG000|Follow-Up|Withdrawal by Subject|1|||
164247364|NCT02705105|593273280|FG001|Follow-Up|Withdrawal by Subject|14|||
164247365|NCT02705105|593273279|FG000|Follow-Up|Study Terminated|0|||
164247366|NCT02705105|593273280|FG001|Follow-Up|Study Terminated|26|||
164247367|NCT02705105|593273279|FG000|Follow-Up|Discontinued per Amendment 3|0|||
164247368|NCT02705105|593273280|FG001|Follow-Up|Discontinued per Amendment 3|2|||
164247369|NCT04908683|593273281|FG000|Overall Study|Failure to meet continuation criteria|34|||
164247370|NCT04908683|593273282|FG001|Overall Study|Failure to meet continuation criteria|22|||
164247371|NCT04908683|593273281|FG000|Overall Study|Initiated prohibited medication|3|||
164247372|NCT04908683|593273282|FG001|Overall Study|Initiated prohibited medication|0|||
164247373|NCT04908683|593273281|FG000|Overall Study|Randomized by mistake|1|||
164247374|NCT04908683|593273282|FG001|Overall Study|Randomized by mistake|0|||
164247375|NCT04908683|593273281|FG000|Overall Study|Lost to Follow-up|679|||
164247376|NCT04908683|593273282|FG001|Overall Study|Lost to Follow-up|341|||
164247377|NCT04908683|593273281|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
163886129|NCT03631784|591954132|FG001|Overall Study|Death|49|||
164083843|NCT03381248|592672172|FG000|0-6 Months|Planning another procedure|1|||
163886130|NCT02465268|591954134|FG000|Overall Study|Withdrawal by Subject|4|||
163886131|NCT02465268|591954135|FG001|Overall Study|Withdrawal by Subject|3|||
163886132|NCT02465268|591954136|FG002|Overall Study|Withdrawal by Subject|1|||
163886133|NCT02465268|591954134|FG000|Overall Study|Not evaluable per protocol criteria|3|||
163886134|NCT02465268|591954135|FG001|Overall Study|Not evaluable per protocol criteria|2|||
164247378|NCT04908683|593273282|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
164247379|NCT04908683|593273281|FG000|Overall Study|Physician Decision|44|||
164247380|NCT04908683|593273282|FG001|Overall Study|Physician Decision|35|||
164247381|NCT04908683|593273281|FG000|Overall Study|Technical problems|12|||
164247382|NCT04908683|593273282|FG001|Overall Study|Technical problems|9|||
164247383|NCT04908683|593273281|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
164247384|NCT04908683|593273282|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
164247385|NCT04908683|593273281|FG000|Overall Study|Protocol Violation|2|||
164247386|NCT04908683|593273282|FG001|Overall Study|Protocol Violation|0|||
164247387|NCT04908683|593273281|FG000|Overall Study|Withdrawal by Subject|1188|||
164247388|NCT04908683|593273282|FG001|Overall Study|Withdrawal by Subject|570|||
163886135|NCT02465268|591954136|FG002|Overall Study|Not evaluable per protocol criteria|1|||
163886136|NCT02465268|591954134|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
164247389|NCT04908683|593273281|FG000|Overall Study|Site Closure by Sponsor|6|||
164247390|NCT04908683|593273282|FG001|Overall Study|Site Closure by Sponsor|3|||
164247391|NCT04908683|593273281|FG000|Overall Study|Adverse Event|21|||
164247392|NCT04908683|593273282|FG001|Overall Study|Adverse Event|11|||
164247393|NCT04908683|593273281|FG000|Overall Study|Death|101|||
164247394|NCT04908683|593273282|FG001|Overall Study|Death|61|||
164247395|NCT04908683|593273281|FG000|Overall Study|Sponsor's decision|14398|||
164247396|NCT04908683|593273282|FG001|Overall Study|Sponsor's decision|7205|||
164247397|NCT04908683|593273281|FG000|Overall Study|Other|92|||
164247398|NCT04908683|593273282|FG001|Overall Study|Other|50|||
164247399|NCT04908683|593273281|FG000|Overall Study|Randomized not vaccinated|108|||
164247400|NCT04908683|593273282|FG001|Overall Study|Randomized not vaccinated|52|||
164247401|NCT00910910|593273283|FG000|Overall Study|Adverse Event|63|||
164247402|NCT00910910|593273284|FG001|Overall Study|Adverse Event|35|||
164247403|NCT00910910|593273283|FG000|Overall Study|PD without histologic change|27|||
164247404|NCT00910910|593273284|FG001|Overall Study|PD without histologic change|23|||
164247405|NCT00910910|593273283|FG000|Overall Study|PD with histologic change|0|||
164247406|NCT00910910|593273284|FG001|Overall Study|PD with histologic change|2|||
164247407|NCT00910910|593273283|FG000|Overall Study|Withdrawal by Subject|7|||
164247408|NCT00910910|593273284|FG001|Overall Study|Withdrawal by Subject|5|||
164247409|NCT00910910|593273283|FG000|Overall Study|Lost to Follow-up|2|||
164247410|NCT00910910|593273284|FG001|Overall Study|Lost to Follow-up|2|||
164247411|NCT00910910|593273283|FG000|Overall Study|Death|9|||
164247412|NCT00910910|593273284|FG001|Overall Study|Death|3|||
164247413|NCT00910910|593273283|FG000|Overall Study|Protocol Violation|2|||
164247414|NCT00910910|593273284|FG001|Overall Study|Protocol Violation|2|||
164247415|NCT00910910|593273283|FG000|Overall Study|Completed 13 cycles of treatment|0|||
164247416|NCT00910910|593273284|FG001|Overall Study|Completed 13 cycles of treatment|118|||
164247417|NCT00910910|593273283|FG000|Overall Study|Other|114|||
164338209|NCT00216476|593615081|FG001|Overall Study|Protocol Deviation|1|||
164338210|NCT00216476|593615082|FG002|Overall Study|Protocol Deviation|0|||
164338211|NCT00216476|593615080|FG000|Overall Study|Patient Moved|2|||
164338212|NCT00216476|593615081|FG001|Overall Study|Patient Moved|2|||
164338213|NCT00216476|593615082|FG002|Overall Study|Patient Moved|0|||
164338214|NCT04738734|593615092|FG000|Overall Study|Withdrawal by Subject|2|||
164338215|NCT04738734|593615093|FG001|Overall Study|Withdrawal by Subject|4|||
164338216|NCT04738734|593615092|FG000|Overall Study|Lost to Follow-up|5|||
164338217|NCT04738734|593615093|FG001|Overall Study|Lost to Follow-up|2|||
164338218|NCT04738734|593615092|FG000|Overall Study|Physician Decision|0|||
164338219|NCT04738734|593615093|FG001|Overall Study|Physician Decision|1|||
163886137|NCT02465268|591954135|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
164338220|NCT04738734|593615092|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
164338221|NCT04738734|593615093|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
164338222|NCT02808650|593615094|FG000|Overall Study|Death|0|||
163886138|NCT02465268|591954136|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
163886139|NCT02465268|591954134|FG000|Overall Study|Study drug did not pass QA/QC|1|||
164247418|NCT00910910|593273284|FG001|Overall Study|Other|32|||
164247419|NCT00910910|593273283|FG000|Overall Study|Untreated before cycle 1|1|||
164338223|NCT02808650|593615095|FG001|Overall Study|Death|0|||
164338224|NCT02808650|593615096|FG002|Overall Study|Death|0|||
164247420|NCT00910910|593273284|FG001|Overall Study|Untreated before cycle 1|2|||
164247421|NCT01973231|593273285|FG000|Overall Study|Protocol Violation|1|||
164247422|NCT01973231|593273286|FG001|Overall Study|Protocol Violation|1|||
164247423|NCT01973231|593273285|FG000|Overall Study|Lost to Follow-up|1|||
164247424|NCT01973231|593273286|FG001|Overall Study|Lost to Follow-up|1|||
164338225|NCT02808650|593615097|FG003|Overall Study|Death|0|||
164338226|NCT02808650|593615098|FG004|Overall Study|Death|1|||
164338227|NCT02808650|593615094|FG000|Overall Study|Lack of Efficacy|5|||
163886140|NCT02465268|591954135|FG001|Overall Study|Study drug did not pass QA/QC|0|||
163886141|NCT02465268|591954136|FG002|Overall Study|Study drug did not pass QA/QC|0|||
163886142|NCT02465268|591954134|FG000|Overall Study|Adverse Event|0|||
163886143|NCT02465268|591954135|FG001|Overall Study|Adverse Event|1|||
163886144|NCT02465268|591954136|FG002|Overall Study|Adverse Event|0|||
163886145|NCT02465268|591954134|FG000|Overall Study|Physician Decision|0|||
163886146|NCT02465268|591954135|FG001|Overall Study|Physician Decision|1|||
163886147|NCT02465268|591954136|FG002|Overall Study|Physician Decision|0|||
163886148|NCT02547363|591954140|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
163886149|NCT02547363|591954141|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
163886150|NCT02547363|591954140|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
164140970|NCT01371747|592878608|FG001|Overall Study|Physician Decision|0|||
164140971|NCT01371747|592878609|FG002|Overall Study|Physician Decision|0|||
164140972|NCT01371747|592878610|FG003|Overall Study|Physician Decision|0|||
164140973|NCT01371747|592878611|FG004|Overall Study|Physician Decision|1|||
164140974|NCT01371747|592878612|FG005|Overall Study|Physician Decision|0|||
164140975|NCT01371747|592878607|FG000|Overall Study|Withdrawal by Subject|6|||
164140976|NCT01371747|592878608|FG001|Overall Study|Withdrawal by Subject|12|||
164140977|NCT01371747|592878609|FG002|Overall Study|Withdrawal by Subject|5|||
164140978|NCT01371747|592878610|FG003|Overall Study|Withdrawal by Subject|2|||
164140979|NCT01371747|592878611|FG004|Overall Study|Withdrawal by Subject|2|||
164140980|NCT01371747|592878612|FG005|Overall Study|Withdrawal by Subject|4|||
164140981|NCT01371747|592878607|FG000|Overall Study|Other Reasons|2|||
164140982|NCT01371747|592878608|FG001|Overall Study|Other Reasons|1|||
164140983|NCT01371747|592878609|FG002|Overall Study|Other Reasons|2|||
164140984|NCT01371747|592878610|FG003|Overall Study|Other Reasons|0|||
164140985|NCT01371747|592878611|FG004|Overall Study|Other Reasons|0|||
164140986|NCT01371747|592878612|FG005|Overall Study|Other Reasons|1|||
164140987|NCT03092219|592878613|FG000|Overall Study|Protocol Violation|7|||
164140988|NCT03092219|592878614|FG001|Overall Study|Protocol Violation|4|||
164140989|NCT05013008|592878621|FG000|Overall Study|Exclusion from mBFAS|5|||
164140990|NCT05013008|592878622|FG001|Overall Study|Exclusion from mBFAS|25|||
164140991|NCT02094417|592878623|FG000|Overall Study|Adverse Event|0|||
164140992|NCT02094417|592878624|FG001|Overall Study|Adverse Event|0|||
164140993|NCT02094417|592878625|FG002|Overall Study|Adverse Event|0|||
164140994|NCT02094417|592878626|FG003|Overall Study|Adverse Event|1|||
164140995|NCT02094417|592878623|FG000|Overall Study|Eligibility criteria|0|||
164140996|NCT02094417|592878624|FG001|Overall Study|Eligibility criteria|1|||
164140997|NCT02094417|592878625|FG002|Overall Study|Eligibility criteria|0|||
164140998|NCT02094417|592878626|FG003|Overall Study|Eligibility criteria|0|||
164140999|NCT02094417|592878623|FG000|Overall Study|No responder|4|||
164141000|NCT02094417|592878624|FG001|Overall Study|No responder|4|||
164141001|NCT02094417|592878625|FG002|Overall Study|No responder|4|||
164141002|NCT02094417|592878626|FG003|Overall Study|No responder|3|||
164141003|NCT02094417|592878623|FG000|Overall Study|Unable to conduct observations or assess|0|||
164141004|NCT02094417|592878624|FG001|Overall Study|Unable to conduct observations or assess|1|||
164141005|NCT02094417|592878625|FG002|Overall Study|Unable to conduct observations or assess|0|||
164141006|NCT02094417|592878626|FG003|Overall Study|Unable to conduct observations or assess|0|||
164141007|NCT02094417|592878623|FG000|Overall Study|Withdrawal by Subject|1|||
164141008|NCT02094417|592878624|FG001|Overall Study|Withdrawal by Subject|2|||
164141009|NCT02094417|592878625|FG002|Overall Study|Withdrawal by Subject|1|||
164141010|NCT02094417|592878626|FG003|Overall Study|Withdrawal by Subject|3|||
164141011|NCT01443728|592878627|FG000|Overall Study|Lost to Follow-up|2|||
164141012|NCT01443728|592878628|FG001|Overall Study|Lost to Follow-up|0|||
164141013|NCT01443728|592878627|FG000|Overall Study|Withdrawal by Subject|1|||
164141014|NCT01443728|592878628|FG001|Overall Study|Withdrawal by Subject|1|||
164141015|NCT01443728|592878627|FG000|Overall Study|Adverse Event|0|||
164141016|NCT01443728|592878628|FG001|Overall Study|Adverse Event|2|||
164141017|NCT00887289|592878631|FG000|Overall Study|Lack of Efficacy|14|||
164141018|NCT00887289|592878631|FG000|Overall Study|Adverse Event|27|||
164141019|NCT00887289|592878631|FG000|Overall Study|Withdrawal by Subject|26|||
164141020|NCT00887289|592878631|FG000|Overall Study|Lost to Follow-up|8|||
164141021|NCT00887289|592878631|FG000|Overall Study|Other|20|||
164141022|NCT00591773|592878634|FG000|Overall Study|Adverse Event|9|||
164141023|NCT00591773|592878635|FG001|Overall Study|Adverse Event|9|||
164141024|NCT00591773|592878636|FG002|Overall Study|Adverse Event|6|||
164141025|NCT00591773|592878634|FG000|Overall Study|Protocol Violation|2|||
164141026|NCT00591773|592878635|FG001|Overall Study|Protocol Violation|3|||
164141027|NCT00591773|592878636|FG002|Overall Study|Protocol Violation|0|||
164141028|NCT00591773|592878634|FG000|Overall Study|Lost to Follow-up|1|||
164141029|NCT00591773|592878635|FG001|Overall Study|Lost to Follow-up|4|||
164141030|NCT00591773|592878636|FG002|Overall Study|Lost to Follow-up|1|||
164141031|NCT00591773|592878634|FG000|Overall Study|Withdrawal by Subject|2|||
164141032|NCT00591773|592878635|FG001|Overall Study|Withdrawal by Subject|5|||
164141033|NCT00591773|592878636|FG002|Overall Study|Withdrawal by Subject|3|||
164247425|NCT01973231|593273285|FG000|Overall Study|unclassified|2|||
164247426|NCT01973231|593273286|FG001|Overall Study|unclassified|1|||
164247427|NCT01973231|593273285|FG000|Overall Study|Withdrawal by Subject|7|||
164247428|NCT01973231|593273286|FG001|Overall Study|Withdrawal by Subject|9|||
164247429|NCT00040742|593273290|FG000|Overall Study|Death|0|||
164247430|NCT00040742|593273291|FG001|Overall Study|Death|0|||
164247431|NCT00040742|593273292|FG002|Overall Study|Death|1|||
164247432|NCT00040742|593273293|FG003|Overall Study|Death|0|||
164247433|NCT00040742|593273290|FG000|Overall Study|Adverse Event|15|||
164247434|NCT00040742|593273291|FG001|Overall Study|Adverse Event|16|||
164247435|NCT00040742|593273292|FG002|Overall Study|Adverse Event|21|||
164247436|NCT00040742|593273293|FG003|Overall Study|Adverse Event|9|||
164247437|NCT00040742|593273290|FG000|Overall Study|Withdrawal by Subject|7|||
164247438|NCT00040742|593273291|FG001|Overall Study|Withdrawal by Subject|15|||
164247439|NCT00040742|593273292|FG002|Overall Study|Withdrawal by Subject|10|||
164247440|NCT00040742|593273293|FG003|Overall Study|Withdrawal by Subject|13|||
164247441|NCT00040742|593273290|FG000|Overall Study|Chemotoxicity|4|||
164247442|NCT00040742|593273291|FG001|Overall Study|Chemotoxicity|3|||
164247443|NCT00040742|593273292|FG002|Overall Study|Chemotoxicity|5|||
164247444|NCT00040742|593273293|FG003|Overall Study|Chemotoxicity|2|||
164247445|NCT00040742|593273290|FG000|Overall Study|Incomplete Forms|6|||
164247446|NCT00040742|593273291|FG001|Overall Study|Incomplete Forms|10|||
164247447|NCT00040742|593273292|FG002|Overall Study|Incomplete Forms|4|||
164247448|NCT00040742|593273293|FG003|Overall Study|Incomplete Forms|5|||
164247449|NCT00040742|593273290|FG000|Overall Study|Other medical|7|||
164247450|NCT00040742|593273291|FG001|Overall Study|Other medical|5|||
164247451|NCT00040742|593273292|FG002|Overall Study|Other medical|5|||
164247452|NCT00040742|593273293|FG003|Overall Study|Other medical|5|||
164247453|NCT00624468|593273294|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
164247454|NCT00624468|593273295|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
164247455|NCT00624468|593273296|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
164247456|NCT00624468|593273297|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
164247457|NCT00624468|593273294|FG000|Double-blind Period|Withdrew Prematurely|1|||
164247458|NCT00624468|593273295|FG001|Double-blind Period|Withdrew Prematurely|1|||
164247459|NCT00624468|593273296|FG002|Double-blind Period|Withdrew Prematurely|0|||
164247460|NCT00624468|593273297|FG003|Double-blind Period|Withdrew Prematurely|0|||
164247461|NCT00624468|593273294|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
164247462|NCT00624468|593273295|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
164247463|NCT00624468|593273296|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
164247464|NCT00624468|593273297|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
164247465|NCT00624468|593273294|FG000|Safety Follow-up (SFU) Period|Other|0|||
164247466|NCT00624468|593273295|FG001|Safety Follow-up (SFU) Period|Other|0|||
164247467|NCT00624468|593273296|FG002|Safety Follow-up (SFU) Period|Other|1|||
163990931|NCT01214044|592335152|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
163990932|NCT01214044|592335152|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
163990933|NCT01214044|592335152|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
163990934|NCT01214044|592335152|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
164247468|NCT00624468|593273297|FG003|Safety Follow-up (SFU) Period|Other|1|||
164247469|NCT05384834|593273298|FG000|Overall Study|Lost to Follow-up|43|||
164247470|NCT05384834|593273298|FG000|Overall Study|Withdrawal by Subject|5|||
164247471|NCT01523743|593273299|FG000|Period 1|Adverse Event|1|||
164247472|NCT01523743|593273300|FG001|Period 1|Adverse Event|0|||
164247473|NCT01523743|593273299|FG000|Period 1|Withdrawal by Subject|6|||
164247474|NCT01523743|593273300|FG001|Period 1|Withdrawal by Subject|2|||
164247475|NCT01523743|593273299|FG000|Period 1|Lost to Follow-up|1|||
164247476|NCT01523743|593273300|FG001|Period 1|Lost to Follow-up|0|||
164247477|NCT01523743|593273299|FG000|Period 1|Lack of Efficacy|1|||
164247478|NCT01523743|593273300|FG001|Period 1|Lack of Efficacy|0|||
164247479|NCT01523743|593273299|FG000|Period 1|Felt unable to empty bladder|1|||
163990935|NCT01214044|592335152|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
164247480|NCT01523743|593273300|FG001|Period 1|Felt unable to empty bladder|0|||
164247481|NCT01523743|593273299|FG000|Period 2|Withdrawal by Subject|0|||
164247482|NCT01523743|593273300|FG001|Period 2|Withdrawal by Subject|2|||
163990936|NCT01214044|592335152|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
163990937|NCT02772757|592335154|FG000|Overall Study|Withdrawal by Subject|1|||
164247483|NCT01523743|593273299|FG000|Period 2|Adverse Event|1|||
164247484|NCT01523743|593273300|FG001|Period 2|Adverse Event|0|||
164247485|NCT01434654|593273301|FG000|Overall Study|Withdrawal by Subject|1|||
164247486|NCT01434654|593273302|FG001|Overall Study|Withdrawal by Subject|0|||
164247487|NCT01434654|593273301|FG000|Overall Study|Lost to Follow-up|1|||
163886151|NCT02547363|591954141|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
163886152|NCT02547363|591954140|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
163886153|NCT02547363|591954141|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
163886154|NCT02547363|591954140|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
164247488|NCT01434654|593273302|FG001|Overall Study|Lost to Follow-up|0|||
164247489|NCT00363142|593273303|FG000|Overall Study|Adverse Event|2|||
164247490|NCT00363142|593273304|FG001|Overall Study|Adverse Event|0|||
163886155|NCT02547363|591954141|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
163886156|NCT02547363|591954140|FG000|12-month Follow-up|Withdrawal by Subject|4|||
163886157|NCT02547363|591954141|FG001|12-month Follow-up|Withdrawal by Subject|3|||
163886158|NCT02547363|591954140|FG000|12-month Follow-up|Lost to Follow-up|4|||
163886159|NCT02547363|591954141|FG001|12-month Follow-up|Lost to Follow-up|1|||
163886160|NCT02547363|591954140|FG000|12-month Follow-up|Lack of Efficacy|1|||
163886161|NCT02547363|591954141|FG001|12-month Follow-up|Lack of Efficacy|1|||
163886162|NCT02547363|591954140|FG000|12-month Follow-up|Other|1|||
163886163|NCT02547363|591954141|FG001|12-month Follow-up|Other|0|||
163886164|NCT03322267|591954143|FG000|Overall Study|Lack of Efficacy|11|||
163886165|NCT03322267|591954143|FG000|Overall Study|Adverse Event|1|||
163886166|NCT03322267|591954143|FG000|Overall Study|Withdrawal by Subject|2|||
163886167|NCT03084536|591954146|FG000|Overall Study|Determined to be ineligible|0|||
163886168|NCT03084536|591954147|FG001|Overall Study|Determined to be ineligible|0|||
163886169|NCT03084536|591954148|FG002|Overall Study|Determined to be ineligible|16|||
164247491|NCT00363142|593273303|FG000|Overall Study|Lack of Efficacy|0|||
164247492|NCT00363142|593273304|FG001|Overall Study|Lack of Efficacy|1|||
163886170|NCT03084536|591954146|FG000|Overall Study|Withdrawal by Subject|0|||
163886171|NCT03084536|591954147|FG001|Overall Study|Withdrawal by Subject|0|||
163886172|NCT03084536|591954148|FG002|Overall Study|Withdrawal by Subject|4|||
163886173|NCT03084536|591954146|FG000|Overall Study|Physician Decision|0|||
163886174|NCT03084536|591954147|FG001|Overall Study|Physician Decision|0|||
163886175|NCT03084536|591954148|FG002|Overall Study|Physician Decision|3|||
163886176|NCT03084536|591954146|FG000|Overall Study|Death|0|||
163886177|NCT03084536|591954147|FG001|Overall Study|Death|0|||
163886178|NCT03084536|591954148|FG002|Overall Study|Death|1|||
163886179|NCT03084536|591954146|FG000|Overall Study|Lost to Follow-up|0|||
163886180|NCT03084536|591954147|FG001|Overall Study|Lost to Follow-up|0|||
163886181|NCT03084536|591954148|FG002|Overall Study|Lost to Follow-up|1|||
163886182|NCT03084536|591954146|FG000|Overall Study|Protocol Violation|0|||
163886183|NCT03084536|591954147|FG001|Overall Study|Protocol Violation|0|||
163886184|NCT03084536|591954148|FG002|Overall Study|Protocol Violation|1|||
163886185|NCT03084536|591954146|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
163886186|NCT03084536|591954147|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
163886187|NCT03084536|591954148|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
163886188|NCT05302596|591954160|FG000|Overall Study|Withdrawal by Subject|1|||
163886189|NCT05302596|591954161|FG001|Overall Study|Withdrawal by Subject|1|||
163886190|NCT04764448|591956382|FG000|Overall Study|Study terminated by sponsor|2|||
163886191|NCT04764448|591956383|FG001|Overall Study|Study terminated by sponsor|2|||
163886192|NCT04764448|591956384|FG002|Overall Study|Study terminated by sponsor|5|||
163886193|NCT04764448|591956382|FG000|Overall Study|Withdrawal by Subject|3|||
163886194|NCT04764448|591956383|FG001|Overall Study|Withdrawal by Subject|3|||
163886195|NCT04764448|591956384|FG002|Overall Study|Withdrawal by Subject|1|||
163886196|NCT04728347|591956385|FG000|Overall Study|Sponsor decision|0|||
163886197|NCT04728347|591956386|FG001|Overall Study|Sponsor decision|0|||
163886198|NCT04728347|591956387|FG002|Overall Study|Sponsor decision|1|||
163886199|NCT04728347|591956388|FG003|Overall Study|Sponsor decision|0|||
163886200|NCT05835336|591956390|FG000|Overall Study|Withdrawal by Subject|5|||
163886201|NCT05835336|591956390|FG000|Overall Study|Did not complete the personalization process|3|||
163886202|NCT04509674|591956391|FG000|Overall Study|Not treated|33|||
163886203|NCT04509674|591956392|FG001|Overall Study|Not treated|26|||
163886204|NCT04509674|591956391|FG000|Overall Study|Protocol Violation|9|||
163886205|NCT04509674|591956392|FG001|Overall Study|Protocol Violation|10|||
163886206|NCT04509674|591956391|FG000|Overall Study|Lost to Follow-up|31|||
163886207|NCT04509674|591956392|FG001|Overall Study|Lost to Follow-up|39|||
163886208|NCT04509674|591956391|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
163990938|NCT02772757|592335155|FG001|Overall Study|Withdrawal by Subject|0|||
163886209|NCT04509674|591956392|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
163886210|NCT04509674|591956391|FG000|Overall Study|Adverse event, serious fatal event|11|||
163886211|NCT04509674|591956392|FG001|Overall Study|Adverse event, serious fatal event|4|||
163990939|NCT02772757|592335156|FG002|Overall Study|Withdrawal by Subject|1|||
163886212|NCT04509674|591956391|FG000|Overall Study|Adverse event, non-fatal event|107|||
163886213|NCT04509674|591956392|FG001|Overall Study|Adverse event, non-fatal event|118|||
163886214|NCT04509674|591956391|FG000|Overall Study|Other reason than listed|106|||
163886215|NCT04509674|591956392|FG001|Overall Study|Other reason than listed|95|||
163886216|NCT06190691|591956402|FG000|Overall Study|Adverse Event|2|||
163886217|NCT06190691|591956403|FG001|Overall Study|Adverse Event|0|||
163990940|NCT02772757|592335154|FG000|Overall Study|Protocol Violation|0|||
164247493|NCT00363142|593273303|FG000|Overall Study|Lost to Follow-up|1|||
164247494|NCT00363142|593273304|FG001|Overall Study|Lost to Follow-up|0|||
164247495|NCT00363142|593273303|FG000|Overall Study|Non-compliance|1|||
164247496|NCT00363142|593273304|FG001|Overall Study|Non-compliance|1|||
164247497|NCT00363142|593273303|FG000|Overall Study|Withdrawal by Subject|3|||
164247498|NCT00363142|593273304|FG001|Overall Study|Withdrawal by Subject|1|||
163990941|NCT02772757|592335155|FG001|Overall Study|Protocol Violation|0|||
163990942|NCT02772757|592335156|FG002|Overall Study|Protocol Violation|1|||
163990943|NCT02772757|592335154|FG000|Overall Study|Physician Decision|0|||
163990944|NCT02772757|592335155|FG001|Overall Study|Physician Decision|3|||
163990945|NCT02772757|592335156|FG002|Overall Study|Physician Decision|3|||
163990946|NCT04698525|592335157|FG000|Overall Study|Lost to Follow-up|1|||
163990947|NCT04698525|592335158|FG001|Overall Study|Lost to Follow-up|2|||
163990948|NCT04698525|592335157|FG000|Overall Study|Three suffered of Covid-19|2|||
163990949|NCT04698525|592335158|FG001|Overall Study|Three suffered of Covid-19|1|||
163990950|NCT00441792|592335159|FG000|Overall Study|Lost to Follow-up|0|||
163990951|NCT00441792|592335160|FG001|Overall Study|Lost to Follow-up|2|||
163990952|NCT01731678|592335161|FG000|Overall Study|Withdrawal by Subject|3|||
163990953|NCT01731678|592335161|FG000|Overall Study|Did not meet inclusion criteria|1|||
163990954|NCT01731678|592335161|FG000|Overall Study|RMT too high, making TMS difficult|3|||
163990955|NCT00888355|592335164|FG000|Overall Study|Adverse Event|10|||
163990956|NCT00888355|592335165|FG001|Overall Study|Adverse Event|0|||
163990957|NCT00888355|592335166|FG002|Overall Study|Adverse Event|3|||
163990958|NCT00888355|592335167|FG003|Overall Study|Adverse Event|3|||
163990959|NCT00888355|592335164|FG000|Overall Study|Lack of Efficacy|9|||
163990960|NCT00888355|592335165|FG001|Overall Study|Lack of Efficacy|2|||
163990961|NCT00888355|592335166|FG002|Overall Study|Lack of Efficacy|5|||
163990962|NCT00888355|592335167|FG003|Overall Study|Lack of Efficacy|2|||
163990963|NCT00888355|592335164|FG000|Overall Study|Lost to Follow-up|0|||
163990964|NCT00888355|592335165|FG001|Overall Study|Lost to Follow-up|2|||
163990965|NCT00888355|592335166|FG002|Overall Study|Lost to Follow-up|2|||
163990966|NCT00888355|592335167|FG003|Overall Study|Lost to Follow-up|0|||
163990967|NCT00888355|592335164|FG000|Overall Study|Protocol Violation|3|||
164247499|NCT01340664|593273307|FG000|Overall Study|Adverse Event|0|||
164247500|NCT01340664|593273308|FG001|Overall Study|Adverse Event|1|||
164247501|NCT01340664|593273309|FG002|Overall Study|Adverse Event|7|||
164247502|NCT01340664|593273307|FG000|Overall Study|Lost to Follow-up|2|||
164247503|NCT01340664|593273308|FG001|Overall Study|Lost to Follow-up|0|||
164247504|NCT01340664|593273309|FG002|Overall Study|Lost to Follow-up|2|||
164247505|NCT01340664|593273307|FG000|Overall Study|Withdrawal by Subject|2|||
164247506|NCT01340664|593273308|FG001|Overall Study|Withdrawal by Subject|4|||
164247507|NCT01340664|593273309|FG002|Overall Study|Withdrawal by Subject|0|||
164338228|NCT02808650|593615095|FG001|Overall Study|Lack of Efficacy|5|||
164338229|NCT02808650|593615096|FG002|Overall Study|Lack of Efficacy|6|||
164338230|NCT02808650|593615097|FG003|Overall Study|Lack of Efficacy|5|||
164338231|NCT02808650|593615098|FG004|Overall Study|Lack of Efficacy|4|||
164338232|NCT02808650|593615094|FG000|Overall Study|Physician Decision|1|||
164338233|NCT02808650|593615095|FG001|Overall Study|Physician Decision|1|||
164338234|NCT02808650|593615096|FG002|Overall Study|Physician Decision|0|||
164338235|NCT02808650|593615097|FG003|Overall Study|Physician Decision|0|||
164338236|NCT02808650|593615098|FG004|Overall Study|Physician Decision|0|||
164338237|NCT02808650|593615094|FG000|Overall Study|Withdrawal by Subject|0|||
164338238|NCT02808650|593615095|FG001|Overall Study|Withdrawal by Subject|0|||
164338239|NCT02808650|593615096|FG002|Overall Study|Withdrawal by Subject|0|||
164338240|NCT02808650|593615097|FG003|Overall Study|Withdrawal by Subject|1|||
164338241|NCT02808650|593615098|FG004|Overall Study|Withdrawal by Subject|1|||
164338242|NCT04093414|593615101|FG000|3 Month Follow up|Physician Decision|0|||
164338243|NCT04093414|593615102|FG001|3 Month Follow up|Physician Decision|1|||
164338244|NCT04093414|593615101|FG000|6month Follow up|Physician Decision|1|||
164338245|NCT04093414|593615102|FG001|6month Follow up|Physician Decision|3|||
164338246|NCT04889222|593615103|FG000|Overall Study|Did not meet eligibility criteria|8|||
164338247|NCT04889222|593615103|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
164338248|NCT04889222|593615103|FG000|Overall Study|Did not proceed due to time constraints|5|||
164338249|NCT01180647|593615104|FG000|Overall Study|Lost to Follow-up|5|||
164338250|NCT01180647|593615105|FG001|Overall Study|Lost to Follow-up|6|||
164338251|NCT00071396|593615112|FG000|Overall Study|Withdrawal by Subject|1|||
164338252|NCT00071396|593615112|FG000|Overall Study|Physician Decision|2|||
164338253|NCT04545554|593615113|FG000|Overall Study|Withdrawal by Subject|0|||
164338254|NCT04545554|593615114|FG001|Overall Study|Withdrawal by Subject|0|||
164338255|NCT04545554|593615115|FG002|Overall Study|Withdrawal by Subject|0|||
164338256|NCT04545554|593615116|FG003|Overall Study|Withdrawal by Subject|1|||
164338257|NCT04545554|593615117|FG004|Overall Study|Withdrawal by Subject|0|||
164338258|NCT04545554|593615118|FG005|Overall Study|Withdrawal by Subject|0|||
164338259|NCT02639546|593615119|FG000|Overall Study|Death|2|||
163990968|NCT00888355|592335165|FG001|Overall Study|Protocol Violation|2|||
163990969|NCT00888355|592335166|FG002|Overall Study|Protocol Violation|1|||
163990970|NCT00888355|592335167|FG003|Overall Study|Protocol Violation|2|||
163990971|NCT00888355|592335164|FG000|Overall Study|Withdrawal by Subject|0|||
164338260|NCT02639546|593615120|FG001|Overall Study|Death|2|||
164338261|NCT02639546|593615121|FG002|Overall Study|Death|1|||
164338262|NCT02639546|593615122|FG003|Overall Study|Death|2|||
164338263|NCT02639546|593615123|FG004|Overall Study|Death|2|||
164338264|NCT02639546|593615124|FG005|Overall Study|Death|2|||
164338265|NCT02639546|593615125|FG006|Overall Study|Death|0|||
164338266|NCT02639546|593615126|FG007|Overall Study|Death|0|||
164338267|NCT02639546|593615119|FG000|Overall Study|Lost to Follow-up|0|||
164338268|NCT02639546|593615120|FG001|Overall Study|Lost to Follow-up|0|||
164338269|NCT02639546|593615121|FG002|Overall Study|Lost to Follow-up|1|||
163886218|NCT06190691|591956404|FG002|Overall Study|Adverse Event|0|||
163886219|NCT06190691|591956405|FG003|Overall Study|Adverse Event|0|||
163886220|NCT04633122|591956406|FG000|Overall Study|Remained on treatment|19|||
163886221|NCT04633122|591956407|FG001|Overall Study|Remained on treatment|14|||
164338270|NCT02639546|593615122|FG003|Overall Study|Lost to Follow-up|0|||
164338271|NCT02639546|593615123|FG004|Overall Study|Lost to Follow-up|1|||
164338272|NCT02639546|593615124|FG005|Overall Study|Lost to Follow-up|1|||
164338273|NCT02639546|593615125|FG006|Overall Study|Lost to Follow-up|0|||
164338274|NCT02639546|593615126|FG007|Overall Study|Lost to Follow-up|1|||
164338275|NCT02639546|593615119|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
164338276|NCT02639546|593615120|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
164338277|NCT02639546|593615121|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
163886222|NCT04633122|591956406|FG000|Overall Study|Survival follow-up stopped|22|||
163886223|NCT04633122|591956407|FG001|Overall Study|Survival follow-up stopped|25|||
163886224|NCT03241745|591956408|FG000|Overall Study|Adverse Event|7|||
163886225|NCT03241745|591956408|FG000|Overall Study|Death|1|||
164338278|NCT02639546|593615122|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
164338279|NCT02639546|593615123|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
164338280|NCT02639546|593615124|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
164338281|NCT02639546|593615125|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
164338282|NCT02639546|593615126|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
164338283|NCT02639546|593615119|FG000|Overall Study|Study Terminated By Sponsor|0|||
164338284|NCT02639546|593615120|FG001|Overall Study|Study Terminated By Sponsor|2|||
164338285|NCT02639546|593615121|FG002|Overall Study|Study Terminated By Sponsor|3|||
164338286|NCT02639546|593615122|FG003|Overall Study|Study Terminated By Sponsor|4|||
163886226|NCT03241745|591956408|FG000|Overall Study|Withdrawal by Subject|5|||
163990972|NCT00888355|592335165|FG001|Overall Study|Withdrawal by Subject|3|||
163990973|NCT00888355|592335166|FG002|Overall Study|Withdrawal by Subject|1|||
163990974|NCT00888355|592335167|FG003|Overall Study|Withdrawal by Subject|3|||
163990975|NCT02211261|592335172|FG000|Overall Study|Withdrawal by Subject|0|||
163990976|NCT02211261|592335173|FG001|Overall Study|Withdrawal by Subject|0|||
163990977|NCT02211261|592335174|FG002|Overall Study|Withdrawal by Subject|1|||
163990978|NCT02211261|592335175|FG003|Overall Study|Withdrawal by Subject|0|||
164083844|NCT03381248|592672173|FG001|0-6 Months|Planning another procedure|2|||
164083845|NCT03381248|592672172|FG000|6-12 Months|Withdrawal by Subject|1|||
164083846|NCT03381248|592672173|FG001|6-12 Months|Withdrawal by Subject|3|||
164083847|NCT03381248|592672172|FG000|6-12 Months|Lost to Follow-up|0|||
164083848|NCT03381248|592672173|FG001|6-12 Months|Lost to Follow-up|2|||
164083849|NCT03381248|592672172|FG000|6-12 Months|Protocol Violation|3|||
164083850|NCT03381248|592672173|FG001|6-12 Months|Protocol Violation|2|||
164083851|NCT03381248|592672172|FG000|6-12 Months|Planning another procedure|6|||
164083852|NCT03381248|592672173|FG001|6-12 Months|Planning another procedure|2|||
164083853|NCT03381248|592672172|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
164083854|NCT03381248|592672173|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
164083855|NCT03381248|592672172|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
164083856|NCT03381248|592672173|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
164083857|NCT03381248|592672172|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
164083858|NCT03381248|592672173|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
164083859|NCT01341639|592672178|FG000|Infant Series|Protocol Violation|1|||
164083860|NCT01341639|592672179|FG001|Infant Series|Protocol Violation|0|||
164083861|NCT01341639|592672178|FG000|Infant Series|Not Vaccinated|0|||
164083862|NCT01341639|592672179|FG001|Infant Series|Not Vaccinated|1|||
164083863|NCT01341639|592672178|FG000|Infant Series|Adverse Event|0|||
164083864|NCT01341639|592672179|FG001|Infant Series|Adverse Event|5|||
164083865|NCT01341639|592672178|FG000|Infant Series|Withdrawal by Subject|11|||
163990979|NCT02211261|592335176|FG004|Overall Study|Withdrawal by Subject|2|||
163990980|NCT02211261|592335177|FG005|Overall Study|Withdrawal by Subject|0|||
163990981|NCT02211261|592335178|FG006|Overall Study|Withdrawal by Subject|0|||
164247508|NCT01340664|593273307|FG000|Overall Study|Glycemic withdrawal criteria|2|||
164247509|NCT01340664|593273308|FG001|Overall Study|Glycemic withdrawal criteria|0|||
164247510|NCT01340664|593273309|FG002|Overall Study|Glycemic withdrawal criteria|0|||
164247511|NCT01340664|593273307|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
164247512|NCT01340664|593273308|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
164247513|NCT01340664|593273309|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
164247514|NCT01340664|593273307|FG000|Overall Study|Other|1|||
164247515|NCT01340664|593273308|FG001|Overall Study|Other|2|||
164247516|NCT01340664|593273309|FG002|Overall Study|Other|2|||
164247517|NCT01926444|593273311|FG000|Overall Study|Colonoscopy not performed|0|||
164247518|NCT01926444|593273312|FG001|Overall Study|Colonoscopy not performed|0|||
164247519|NCT01926444|593273313|FG002|Overall Study|Colonoscopy not performed|4|||
164247520|NCT01926444|593273314|FG003|Overall Study|Colonoscopy not performed|2|||
164247521|NCT02243371|593273322|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
163886227|NCT03241745|591956408|FG000|Overall Study|Treatment delay >28 days|2|||
163886228|NCT03241745|591956408|FG000|Overall Study|Lack of Efficacy|14|||
163886229|NCT02561247|591956415|FG000|Overall Study|Protocol Violation|1|||
163886230|NCT02561247|591956415|FG000|Overall Study|Withdrawal by Subject|1|||
163886231|NCT02561247|591956415|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
163886232|NCT03896789|591956416|FG000|Baseline|Lost to Follow-up|1|||
163886233|NCT03896789|591956417|FG001|Baseline|Lost to Follow-up|2|||
163886234|NCT03896789|591956416|FG000|Baseline|Death|3|||
163886235|NCT03896789|591956417|FG001|Baseline|Death|6|||
163886236|NCT03896789|591956416|FG000|Post-Randomization|Lost to Follow-up|12|||
163886237|NCT03896789|591956417|FG001|Post-Randomization|Lost to Follow-up|11|||
163886238|NCT03896789|591956416|FG000|Post-Randomization|Death|12|||
163886239|NCT03896789|591956417|FG001|Post-Randomization|Death|13|||
163886240|NCT04473222|591956422|FG000|Overall Study|Lost to Follow-up|13|||
163886241|NCT04473222|591956423|FG001|Overall Study|Lost to Follow-up|13|||
163886242|NCT04473222|591956422|FG000|Overall Study|Withdrawal by Subject|0|||
163886243|NCT04473222|591956423|FG001|Overall Study|Withdrawal by Subject|1|||
163886244|NCT04473222|591956422|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
163886245|NCT04473222|591956423|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
163886246|NCT01098812|591956424|FG000|Overall Study|Death|2|||
163886247|NCT01098812|591956425|FG001|Overall Study|Death|0|||
163886248|NCT01098812|591956426|FG002|Overall Study|Death|1|||
163886249|NCT01098812|591956424|FG000|Overall Study|Lost to Follow-up|0|||
163886250|NCT01098812|591956425|FG001|Overall Study|Lost to Follow-up|1|||
163886251|NCT01098812|591956426|FG002|Overall Study|Lost to Follow-up|0|||
163886252|NCT04908722|591956427|FG000|Overall Study|Protocol deviation|1|||
163886253|NCT04908722|591956428|FG001|Overall Study|Protocol deviation|0|||
163886254|NCT04908722|591956429|FG002|Overall Study|Protocol deviation|0|||
163886255|NCT04908722|591956430|FG003|Overall Study|Protocol deviation|0|||
163886256|NCT04908722|591956431|FG004|Overall Study|Protocol deviation|0|||
163886257|NCT04908722|591956432|FG005|Overall Study|Protocol deviation|1|||
163886258|NCT04908722|591956427|FG000|Overall Study|Lost to Follow-up|33|||
164247522|NCT02243371|593273323|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
164247523|NCT02243371|593273322|FG000|Overall Study|Death (unrelated)|2|||
163886259|NCT04908722|591956428|FG001|Overall Study|Lost to Follow-up|33|||
163886260|NCT04908722|591956429|FG002|Overall Study|Lost to Follow-up|36|||
163886261|NCT04908722|591956430|FG003|Overall Study|Lost to Follow-up|30|||
163886262|NCT04908722|591956431|FG004|Overall Study|Lost to Follow-up|32|||
164247524|NCT02243371|593273323|FG001|Overall Study|Death (unrelated)|4|||
164247525|NCT02243371|593273322|FG000|Overall Study|Adverse Event (unrelated)|0|||
164247526|NCT02243371|593273323|FG001|Overall Study|Adverse Event (unrelated)|1|||
164247527|NCT02243371|593273322|FG000|Overall Study|Lack of Clinical Benefit|0|||
164247528|NCT02243371|593273323|FG001|Overall Study|Lack of Clinical Benefit|1|||
164247529|NCT02243371|593273322|FG000|Overall Study|Withdrawal by Subject|0|||
164247530|NCT02243371|593273323|FG001|Overall Study|Withdrawal by Subject|2|||
164247531|NCT02441101|593273324|FG000|Overall Study|Withdrawal by Subject|1|||
164247532|NCT02441101|593273325|FG001|Overall Study|Withdrawal by Subject|0|||
164247533|NCT02441101|593273324|FG000|Overall Study|Lost to Follow-up|1|||
164247534|NCT02441101|593273325|FG001|Overall Study|Lost to Follow-up|0|||
163886263|NCT04908722|591956432|FG005|Overall Study|Lost to Follow-up|34|||
163886264|NCT04908722|591956427|FG000|Overall Study|Physician Decision|1|||
164247535|NCT02441101|593273324|FG000|Overall Study|PI relocated and study terminated|1|||
164247536|NCT02441101|593273325|FG001|Overall Study|PI relocated and study terminated|0|||
163886265|NCT04908722|591956428|FG001|Overall Study|Physician Decision|1|||
163886266|NCT04908722|591956429|FG002|Overall Study|Physician Decision|1|||
164247537|NCT02528942|593273328|FG000|Overall Study|Did not meet imaging criteria|9|||
164247538|NCT02528942|593273328|FG000|Overall Study|Lost to Follow-up|25|||
164247539|NCT00271856|593273329|FG000|Overall Study|Withdrawal by Subject|1|||
164247540|NCT00271856|593273330|FG001|Overall Study|Withdrawal by Subject|7|||
164247541|NCT00271856|593273329|FG000|Overall Study|Lost to Follow-up|10|||
164247542|NCT00271856|593273330|FG001|Overall Study|Lost to Follow-up|11|||
164247543|NCT04599803|593273331|FG000|Overall Study|Withdrawal by Subject|5|||
164247544|NCT04599803|593273331|FG000|Overall Study|Lost to Follow-up|26|||
164247545|NCT02544750|593273332|FG000|Overall Study|Physician Decision|3|||
164247546|NCT02544750|593273333|FG001|Overall Study|Physician Decision|1|||
164247547|NCT02544750|593273332|FG000|Overall Study|Other reasons|69|||
164247548|NCT02544750|593273333|FG001|Overall Study|Other reasons|39|||
164247549|NCT02544750|593273332|FG000|Overall Study|Met withdrawal criteria|2|||
164247550|NCT02544750|593273333|FG001|Overall Study|Met withdrawal criteria|2|||
164247551|NCT02544750|593273332|FG000|Overall Study|Transition To Commercial Product|1|||
164247552|NCT02544750|593273333|FG001|Overall Study|Transition To Commercial Product|0|||
164247553|NCT02544750|593273332|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
164247554|NCT02544750|593273333|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
164247555|NCT02544750|593273332|FG000|Overall Study|Adverse Event|8|||
164247556|NCT02544750|593273333|FG001|Overall Study|Adverse Event|10|||
164247557|NCT02544750|593273332|FG000|Overall Study|Withdrawal by Subject|10|||
164247558|NCT02544750|593273333|FG001|Overall Study|Withdrawal by Subject|4|||
164247559|NCT02544750|593273332|FG000|Overall Study|Lost to Follow-up|1|||
164247560|NCT02544750|593273333|FG001|Overall Study|Lost to Follow-up|0|||
164247561|NCT03035864|593273336|FG000|Treatment Period|Adverse Event|1|||
164247562|NCT03035864|593273337|FG001|Treatment Period|Adverse Event|0|||
164247563|NCT03035864|593273336|FG000|Treatment Period|Other|3|||
164247564|NCT03035864|593273337|FG001|Treatment Period|Other|1|||
164247565|NCT03035864|593273336|FG000|Follow-up Period|Adverse Event|1|||
164247566|NCT03035864|593273337|FG001|Follow-up Period|Adverse Event|0|||
164247567|NCT03035864|593273336|FG000|Follow-up Period|Lost to Follow-up|6|||
164247568|NCT03035864|593273337|FG001|Follow-up Period|Lost to Follow-up|2|||
163886267|NCT04908722|591956430|FG003|Overall Study|Physician Decision|2|||
163886268|NCT04908722|591956431|FG004|Overall Study|Physician Decision|0|||
164247569|NCT03035864|593273336|FG000|Follow-up Period|Physician Decision|1|||
164247570|NCT03035864|593273337|FG001|Follow-up Period|Physician Decision|0|||
164247571|NCT03035864|593273336|FG000|Follow-up Period|Other|3|||
163886269|NCT04908722|591956432|FG005|Overall Study|Physician Decision|0|||
163886270|NCT04908722|591956427|FG000|Overall Study|Death|1|||
164247572|NCT03035864|593273337|FG001|Follow-up Period|Other|2|||
164247573|NCT00100802|593273340|FG000|Overall Study|Adverse Event|9|||
164247574|NCT00100802|593273340|FG000|Overall Study|Death|1|||
164247575|NCT00100802|593273340|FG000|Overall Study|Lack of Efficacy|47|||
164247576|NCT00100802|593273340|FG000|Overall Study|Physician Decision|5|||
164247577|NCT00100802|593273340|FG000|Overall Study|Protocol Violation|1|||
164247578|NCT00100802|593273340|FG000|Overall Study|Withdrawal by Subject|5|||
164247579|NCT00100802|593273340|FG000|Overall Study|Ineligible|12|||
164247580|NCT02712983|593275288|FG000|Treatment Phase|Adverse Event|3|||
164247581|NCT02712983|593275289|FG001|Treatment Phase|Adverse Event|1|||
164247582|NCT02712983|593275290|FG002|Treatment Phase|Adverse Event|1|||
164247583|NCT02712983|593275291|FG003|Treatment Phase|Adverse Event|4|||
164247584|NCT02712983|593275292|FG004|Treatment Phase|Adverse Event|3|||
164247585|NCT02712983|593275293|FG005|Treatment Phase|Adverse Event|0|||
164247586|NCT02712983|593275294|FG006|Treatment Phase|Adverse Event|6|||
164247587|NCT02712983|593275295|FG007|Treatment Phase|Adverse Event|6|||
164247588|NCT02712983|593275296|FG008|Treatment Phase|Adverse Event|1|||
164247589|NCT02712983|593275288|FG000|Treatment Phase|Protocol Deviation|0|||
164247590|NCT02712983|593275289|FG001|Treatment Phase|Protocol Deviation|0|||
164247591|NCT02712983|593275290|FG002|Treatment Phase|Protocol Deviation|0|||
164247592|NCT02712983|593275291|FG003|Treatment Phase|Protocol Deviation|2|||
164247593|NCT02712983|593275292|FG004|Treatment Phase|Protocol Deviation|0|||
164338287|NCT02639546|593615123|FG004|Overall Study|Study Terminated By Sponsor|4|||
164338288|NCT02639546|593615124|FG005|Overall Study|Study Terminated By Sponsor|3|||
164338289|NCT02639546|593615125|FG006|Overall Study|Study Terminated By Sponsor|3|||
164338290|NCT02639546|593615126|FG007|Overall Study|Study Terminated By Sponsor|9|||
164338291|NCT02639546|593615119|FG000|Overall Study|Withdrawal by Subject|2|||
164338292|NCT02639546|593615120|FG001|Overall Study|Withdrawal by Subject|2|||
163990982|NCT02211261|592335179|FG007|Overall Study|Withdrawal by Subject|0|||
164247594|NCT02712983|593275293|FG005|Treatment Phase|Protocol Deviation|0|||
164338293|NCT02639546|593615121|FG002|Overall Study|Withdrawal by Subject|1|||
164338294|NCT02639546|593615122|FG003|Overall Study|Withdrawal by Subject|0|||
164338295|NCT02639546|593615123|FG004|Overall Study|Withdrawal by Subject|0|||
164338296|NCT02639546|593615124|FG005|Overall Study|Withdrawal by Subject|1|||
164338297|NCT02639546|593615125|FG006|Overall Study|Withdrawal by Subject|2|||
164247595|NCT02712983|593275294|FG006|Treatment Phase|Protocol Deviation|1|||
164247596|NCT02712983|593275295|FG007|Treatment Phase|Protocol Deviation|0|||
164247597|NCT02712983|593275296|FG008|Treatment Phase|Protocol Deviation|0|||
164247598|NCT02712983|593275288|FG000|Treatment Phase|Technical Problems|0|||
163990983|NCT02211261|592335180|FG008|Overall Study|Withdrawal by Subject|0|||
164247599|NCT02712983|593275289|FG001|Treatment Phase|Technical Problems|0|||
164083866|NCT01341639|592672179|FG001|Infant Series|Withdrawal by Subject|8|||
164338298|NCT02639546|593615126|FG007|Overall Study|Withdrawal by Subject|1|||
164338299|NCT02478372|593615127|FG000|Overall Study|Protocol Violation|12|||
164338300|NCT02478372|593615128|FG001|Overall Study|Protocol Violation|8|||
164338301|NCT02478372|593615127|FG000|Overall Study|Lost to Follow-up|1|||
164338302|NCT02478372|593615128|FG001|Overall Study|Lost to Follow-up|4|||
164338303|NCT02478372|593615127|FG000|Overall Study|Death|0|||
164338304|NCT02478372|593615128|FG001|Overall Study|Death|2|||
164338305|NCT00116428|593615129|FG000|Overall Study|Withdrawal by Subject|2|||
164338306|NCT00116428|593615130|FG001|Overall Study|Withdrawal by Subject|5|||
164338307|NCT00116428|593615129|FG000|Overall Study|Did not meet inclusion criteria|1|||
164338308|NCT00116428|593615130|FG001|Overall Study|Did not meet inclusion criteria|0|||
164338309|NCT01032174|593615131|FG000|Overall Study|Adverse Event|0|||
164338310|NCT01032174|593615132|FG001|Overall Study|Adverse Event|1|||
164338311|NCT00113087|593615133|FG000|Overall Study|Death or Transplant|14|||
164338312|NCT00113087|593615134|FG001|Overall Study|Death or Transplant|16|||
164338313|NCT00113087|593615133|FG000|Overall Study|Family or MD withdrew subject|10|||
164247600|NCT02712983|593275290|FG002|Treatment Phase|Technical Problems|0|||
164247601|NCT02712983|593275291|FG003|Treatment Phase|Technical Problems|0|||
164247602|NCT02712983|593275292|FG004|Treatment Phase|Technical Problems|0|||
164247603|NCT02712983|593275293|FG005|Treatment Phase|Technical Problems|0|||
164247604|NCT02712983|593275294|FG006|Treatment Phase|Technical Problems|1|||
164247605|NCT02712983|593275295|FG007|Treatment Phase|Technical Problems|0|||
163990984|NCT02211261|592335181|FG009|Overall Study|Withdrawal by Subject|0|||
164247606|NCT02712983|593275296|FG008|Treatment Phase|Technical Problems|0|||
164247607|NCT02712983|593275288|FG000|Treatment Phase|Physician Decision|0|||
164247608|NCT02712983|593275289|FG001|Treatment Phase|Physician Decision|0|||
164247609|NCT02712983|593275290|FG002|Treatment Phase|Physician Decision|0|||
164247610|NCT02712983|593275291|FG003|Treatment Phase|Physician Decision|0|||
164247611|NCT02712983|593275292|FG004|Treatment Phase|Physician Decision|0|||
164247612|NCT02712983|593275293|FG005|Treatment Phase|Physician Decision|0|||
164247613|NCT02712983|593275294|FG006|Treatment Phase|Physician Decision|0|||
164338314|NCT00113087|593615134|FG001|Overall Study|Family or MD withdrew subject|5|||
164338315|NCT03452228|593615135|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164338316|NCT03452228|593615136|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
164338317|NCT03452228|593615137|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164338318|NCT03452228|593615135|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164338319|NCT03452228|593615136|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164338320|NCT03452228|593615137|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164338321|NCT03452228|593615135|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
164338322|NCT03452228|593615136|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
164338323|NCT03452228|593615137|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
164338324|NCT03452228|593615135|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164338325|NCT03452228|593615136|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
164338326|NCT03452228|593615137|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164338327|NCT03212690|593615138|FG000|Overall Study|Protocol Violation|1|||
164338328|NCT03208127|593615140|FG000|Overall Study|Death|1|||
164338329|NCT01254331|593615145|FG000|Initial Phase|Adverse Event|3|||
164338330|NCT01254331|593615145|FG000|Initial Phase|Withdrawal by Subject|1|||
164338331|NCT01254331|593615145|FG000|Initial Phase|Pregnancy|1|||
164338332|NCT01254331|593615145|FG000|Extension Phase|Lack of Efficacy|1|||
164338333|NCT01254331|593615145|FG000|Extension Phase|Lost to Follow-up|3|||
164338334|NCT01011738|593615146|FG000|Overall Study|Death|12|||
164338335|NCT01011738|593615147|FG001|Overall Study|Death|3|||
164338336|NCT01011738|593615148|FG002|Overall Study|Death|0|||
164338337|NCT01011738|593615146|FG000|Overall Study|Unknown reasons|312|||
164338338|NCT01011738|593615147|FG001|Overall Study|Unknown reasons|291|||
164338339|NCT01011738|593615148|FG002|Overall Study|Unknown reasons|17|||
164338340|NCT00287365|593615149|FG000|Overall Study|sample not acquired|13|||
164338341|NCT00968864|593615150|FG000|Overall Study|Protocol exception/ not evaluable|1|||
164338342|NCT01967173|593615151|FG000|Overall Study|Lost to Follow-up|5|||
164338343|NCT01967173|593615152|FG001|Overall Study|Lost to Follow-up|3|||
164338344|NCT01967173|593615153|FG002|Overall Study|Lost to Follow-up|2|||
164338345|NCT01967173|593615154|FG003|Overall Study|Lost to Follow-up|4|||
164338346|NCT01967173|593615155|FG004|Overall Study|Lost to Follow-up|8|||
164338347|NCT01967173|593615156|FG005|Overall Study|Lost to Follow-up|12|||
164338348|NCT01967173|593615157|FG006|Overall Study|Lost to Follow-up|6|||
164338349|NCT01967173|593615158|FG007|Overall Study|Lost to Follow-up|8|||
164338350|NCT01967173|593615151|FG000|Overall Study|Physician Decision|2|||
164338351|NCT01967173|593615152|FG001|Overall Study|Physician Decision|0|||
164338352|NCT01967173|593615153|FG002|Overall Study|Physician Decision|2|||
164338353|NCT01967173|593615154|FG003|Overall Study|Physician Decision|1|||
164338354|NCT01967173|593615155|FG004|Overall Study|Physician Decision|1|||
164338355|NCT01967173|593615156|FG005|Overall Study|Physician Decision|1|||
164338356|NCT01967173|593615157|FG006|Overall Study|Physician Decision|1|||
164338357|NCT01967173|593615158|FG007|Overall Study|Physician Decision|0|||
164338358|NCT01967173|593615151|FG000|Overall Study|Lack of Efficacy|2|||
164338359|NCT01967173|593615152|FG001|Overall Study|Lack of Efficacy|0|||
164338360|NCT01967173|593615153|FG002|Overall Study|Lack of Efficacy|2|||
164338361|NCT01967173|593615154|FG003|Overall Study|Lack of Efficacy|2|||
164338362|NCT01967173|593615155|FG004|Overall Study|Lack of Efficacy|0|||
164338363|NCT01967173|593615156|FG005|Overall Study|Lack of Efficacy|1|||
164338364|NCT01967173|593615157|FG006|Overall Study|Lack of Efficacy|0|||
164338365|NCT01967173|593615158|FG007|Overall Study|Lack of Efficacy|2|||
164338366|NCT01967173|593615151|FG000|Overall Study|Pregnancy|0|||
164338367|NCT01967173|593615152|FG001|Overall Study|Pregnancy|0|||
164338368|NCT01967173|593615153|FG002|Overall Study|Pregnancy|0|||
163990985|NCT02211261|592335182|FG010|Overall Study|Withdrawal by Subject|0|||
164338369|NCT01967173|593615154|FG003|Overall Study|Pregnancy|0|||
164338370|NCT01967173|593615155|FG004|Overall Study|Pregnancy|0|||
164338371|NCT01967173|593615156|FG005|Overall Study|Pregnancy|0|||
164338372|NCT01967173|593615157|FG006|Overall Study|Pregnancy|1|||
163990986|NCT02211261|592335172|FG000|Overall Study|Other|0|||
164338373|NCT01967173|593615158|FG007|Overall Study|Pregnancy|1|||
164247614|NCT02712983|593275295|FG007|Treatment Phase|Physician Decision|1|||
164247615|NCT02712983|593275296|FG008|Treatment Phase|Physician Decision|1|||
164247616|NCT02712983|593275288|FG000|Treatment Phase|Subject Decision|2|||
164247617|NCT02712983|593275289|FG001|Treatment Phase|Subject Decision|0|||
164247618|NCT02712983|593275290|FG002|Treatment Phase|Subject Decision|0|||
164247619|NCT02712983|593275291|FG003|Treatment Phase|Subject Decision|2|||
164247620|NCT02712983|593275292|FG004|Treatment Phase|Subject Decision|1|||
164247621|NCT02712983|593275293|FG005|Treatment Phase|Subject Decision|0|||
164247622|NCT02712983|593275294|FG006|Treatment Phase|Subject Decision|1|||
164247623|NCT02712983|593275295|FG007|Treatment Phase|Subject Decision|2|||
164247624|NCT02712983|593275296|FG008|Treatment Phase|Subject Decision|0|||
164083867|NCT01341639|592672178|FG000|Infant Series|Lost to Follow-up|0|||
164247625|NCT02712983|593275288|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247626|NCT02712983|593275289|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
164247627|NCT02712983|593275290|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247628|NCT02712983|593275291|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247629|NCT02712983|593275292|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247630|NCT02712983|593275293|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247631|NCT02712983|593275294|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
164247632|NCT02712983|593275295|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
164247633|NCT02712983|593275296|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164247634|NCT02712983|593275288|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247635|NCT02712983|593275289|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247636|NCT02712983|593275290|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247637|NCT02712983|593275291|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
164247638|NCT02712983|593275292|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247639|NCT02712983|593275293|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247640|NCT02712983|593275294|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247641|NCT02712983|593275295|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247642|NCT02712983|593275296|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
164247643|NCT02712983|593275288|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247644|NCT02712983|593275289|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247645|NCT02712983|593275290|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247646|NCT02712983|593275291|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247647|NCT02712983|593275292|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
164247648|NCT02712983|593275293|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
164247649|NCT02712983|593275294|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
164247650|NCT02712983|593275295|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
164247651|NCT02712983|593275296|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
164247652|NCT03280303|593275297|FG000|Overall Study|Death|505|||
164247653|NCT03280303|593275297|FG000|Overall Study|Study terminated by sponsor|383|||
164247654|NCT03280303|593275297|FG000|Overall Study|Other|148|||
164247655|NCT03280303|593275297|FG000|Overall Study|No longer willing to participate in study|101|||
164247656|NCT03280303|593275297|FG000|Overall Study|Lost to follow up|39|||
164247657|NCT03280303|593275297|FG000|Overall Study|Adverse Event|20|||
164247658|NCT00064259|593275298|FG000|Overall Study|Adverse Event|1|||
164247659|NCT00064259|593275299|FG001|Overall Study|Adverse Event|0|||
164247660|NCT00064259|593275300|FG002|Overall Study|Adverse Event|0|||
164247661|NCT00064259|593275301|FG003|Overall Study|Adverse Event|1|||
164247662|NCT01132651|593275304|FG000|Overall Study|Lost to Follow-up|1|||
164247663|NCT01132651|593275305|FG001|Overall Study|Lost to Follow-up|1|||
163886271|NCT04908722|591956428|FG001|Overall Study|Death|0|||
163886272|NCT04908722|591956429|FG002|Overall Study|Death|0|||
163886273|NCT04908722|591956430|FG003|Overall Study|Death|0|||
164247664|NCT00948857|593275306|FG000|Overall Study|Lost to Follow-up|1|||
164247665|NCT00948857|593275307|FG001|Overall Study|Lost to Follow-up|0|||
164247666|NCT03430843|593275309|FG000|Overall Study|Death|233|||
164247667|NCT03430843|593275310|FG001|Overall Study|Death|233|||
164247668|NCT03430843|593275309|FG000|Overall Study|Sponsor Decision|17|||
164247669|NCT03430843|593275310|FG001|Overall Study|Sponsor Decision|6|||
164247670|NCT03430843|593275309|FG000|Overall Study|Withdrawal by Subject|5|||
164247671|NCT03430843|593275310|FG001|Overall Study|Withdrawal by Subject|14|||
164247672|NCT03430843|593275309|FG000|Overall Study|Lost to Follow-up|1|||
164247673|NCT03430843|593275310|FG001|Overall Study|Lost to Follow-up|3|||
164247674|NCT05360966|593275319|FG000|Overall Study|Adverse Event|5|||
164247675|NCT05360966|593275320|FG001|Overall Study|Adverse Event|5|||
164247676|NCT05360966|593275319|FG000|Overall Study|Withdrawal of Consent|5|||
164247677|NCT05360966|593275320|FG001|Overall Study|Withdrawal of Consent|3|||
164247678|NCT05360966|593275319|FG000|Overall Study|Noncompliance|2|||
164247679|NCT05360966|593275320|FG001|Overall Study|Noncompliance|1|||
164247680|NCT05360966|593275319|FG000|Overall Study|Lost to Follow-up|2|||
164247681|NCT05360966|593275320|FG001|Overall Study|Lost to Follow-up|3|||
164247682|NCT05360966|593275319|FG000|Overall Study|Protocol Deviation|2|||
164247683|NCT05360966|593275320|FG001|Overall Study|Protocol Deviation|1|||
164247684|NCT05360966|593275319|FG000|Overall Study|As specified in the Clinical Study Report|1|||
164247685|NCT05360966|593275320|FG001|Overall Study|As specified in the Clinical Study Report|3|||
164247686|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
164247687|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247688|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247689|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247690|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247691|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247692|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247693|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247694|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247695|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247696|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247697|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247698|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247699|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
164247700|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247701|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247702|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247703|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247704|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247705|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247706|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247707|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247708|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247709|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247710|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247711|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247712|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
164247713|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247714|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247715|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247716|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247717|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247718|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247719|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247720|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247721|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247722|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247723|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247724|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247725|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
164247726|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247727|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
163886274|NCT04908722|591956431|FG004|Overall Study|Death|0|||
163886275|NCT04908722|591956432|FG005|Overall Study|Death|1|||
164247728|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
164247729|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
164247730|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
163886276|NCT04908722|591956427|FG000|Overall Study|Withdrawal by Subject|12|||
163886277|NCT04908722|591956428|FG001|Overall Study|Withdrawal by Subject|8|||
164083868|NCT01341639|592672179|FG001|Infant Series|Lost to Follow-up|2|||
164083869|NCT01341639|592672178|FG000|Infant Series|Site 0048 Participants|17|||
164083870|NCT01341639|592672179|FG001|Infant Series|Site 0048 Participants|16|||
164083871|NCT01341639|592672178|FG000|Interim Period|Withdrawal by Subject|6|||
164247731|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247732|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247733|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247734|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247735|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247736|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247737|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247738|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247739|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247740|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247741|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247742|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
164247743|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247744|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247745|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247746|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247747|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247748|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247749|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247750|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247751|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247752|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247753|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164338374|NCT01967173|593615151|FG000|Overall Study|Adverse Event|0|||
164338375|NCT01967173|593615152|FG001|Overall Study|Adverse Event|0|||
164338376|NCT01967173|593615153|FG002|Overall Study|Adverse Event|0|||
164338377|NCT01967173|593615154|FG003|Overall Study|Adverse Event|0|||
164338378|NCT01967173|593615155|FG004|Overall Study|Adverse Event|0|||
164338379|NCT01967173|593615156|FG005|Overall Study|Adverse Event|0|||
164338380|NCT01967173|593615157|FG006|Overall Study|Adverse Event|0|||
164338381|NCT01967173|593615158|FG007|Overall Study|Adverse Event|1|||
164338382|NCT01967173|593615151|FG000|Overall Study|Withdrawal by Subject|15|||
164338383|NCT01967173|593615152|FG001|Overall Study|Withdrawal by Subject|14|||
164338384|NCT01967173|593615153|FG002|Overall Study|Withdrawal by Subject|10|||
164338385|NCT01967173|593615154|FG003|Overall Study|Withdrawal by Subject|7|||
164338386|NCT01967173|593615155|FG004|Overall Study|Withdrawal by Subject|8|||
164338387|NCT01967173|593615156|FG005|Overall Study|Withdrawal by Subject|9|||
164338388|NCT01967173|593615157|FG006|Overall Study|Withdrawal by Subject|10|||
164338389|NCT01967173|593615158|FG007|Overall Study|Withdrawal by Subject|12|||
164338390|NCT01346969|593615159|FG000|Overall Study|Withdrawal by Subject|0|||
164338391|NCT01346969|593615160|FG001|Overall Study|Withdrawal by Subject|0|||
164338392|NCT01346969|593615161|FG002|Overall Study|Withdrawal by Subject|1|||
164338393|NCT01346969|593615162|FG003|Overall Study|Withdrawal by Subject|0|||
164338394|NCT01346969|593615159|FG000|Overall Study|Lost to Follow-up|1|||
164338395|NCT01346969|593615160|FG001|Overall Study|Lost to Follow-up|0|||
164338396|NCT01346969|593615161|FG002|Overall Study|Lost to Follow-up|2|||
164338397|NCT01346969|593615162|FG003|Overall Study|Lost to Follow-up|0|||
164338398|NCT01346969|593615159|FG000|Overall Study|Physician Decision|0|||
164338399|NCT01346969|593615160|FG001|Overall Study|Physician Decision|0|||
164338400|NCT01346969|593615161|FG002|Overall Study|Physician Decision|0|||
164338401|NCT01346969|593615162|FG003|Overall Study|Physician Decision|1|||
163886278|NCT04908722|591956429|FG002|Overall Study|Withdrawal by Subject|7|||
164338402|NCT01346969|593615159|FG000|Overall Study|Randomized but not treated|1|||
164338403|NCT01346969|593615160|FG001|Overall Study|Randomized but not treated|0|||
164083872|NCT01341639|592672179|FG001|Interim Period|Withdrawal by Subject|7|||
164247754|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247755|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
164247756|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247757|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247758|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247759|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247760|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247761|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247762|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247763|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247764|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247765|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247766|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247767|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247768|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
164247769|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247770|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247771|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
164247772|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
164247773|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247774|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247775|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247776|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247777|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247778|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247779|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247780|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247781|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247782|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247783|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247784|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247785|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
164247786|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247787|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247788|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247789|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247790|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247791|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247792|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247793|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247794|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247795|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247796|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247797|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247798|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
164247799|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247800|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247801|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247802|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247803|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247804|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247805|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247806|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247807|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247808|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247809|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247810|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247811|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
164247812|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247813|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247814|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
164247815|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247816|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247817|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247818|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247819|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247820|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247821|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247822|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247823|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247824|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247825|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247826|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247827|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247828|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247829|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247830|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247831|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247832|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247833|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247834|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247835|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247836|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247837|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247838|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247839|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247840|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247841|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
164247842|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247843|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247844|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247845|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247846|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
163886279|NCT04908722|591956430|FG003|Overall Study|Withdrawal by Subject|6|||
164247847|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247848|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247849|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247850|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247851|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247852|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247853|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247854|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
164247855|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247856|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247857|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
164247858|NCT05396014|593275321|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247859|NCT05396014|593275322|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247860|NCT05396014|593275323|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247861|NCT05396014|593275324|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247862|NCT05396014|593275325|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247863|NCT05396014|593275326|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247864|NCT05396014|593275327|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247865|NCT05396014|593275328|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247866|NCT05396014|593275329|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247867|NCT05396014|593275330|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247868|NCT05396014|593275331|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247869|NCT05396014|593275332|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247870|NCT05396014|593275333|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247871|NCT05396014|593275334|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247872|NCT05396014|593275335|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247873|NCT05396014|593275336|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247874|NCT05396014|593275337|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247875|NCT05396014|593275338|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247876|NCT05396014|593275339|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247877|NCT05396014|593275340|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247878|NCT05396014|593275341|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247879|NCT05396014|593275342|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247880|NCT05396014|593275343|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247881|NCT05396014|593275344|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247882|NCT05396014|593275345|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247883|NCT05396014|593275346|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247884|NCT05396014|593275347|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
164247885|NCT05396014|593275348|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247886|NCT05396014|593275349|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247887|NCT05396014|593275350|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247888|NCT05396014|593275351|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247889|NCT05396014|593275352|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247890|NCT05396014|593275353|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247891|NCT05396014|593275354|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247892|NCT05396014|593275355|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247893|NCT05396014|593275356|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247894|NCT05396014|593275357|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247895|NCT05396014|593275358|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247896|NCT05396014|593275359|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247897|NCT05396014|593275360|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247898|NCT05396014|593275361|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247899|NCT05396014|593275362|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247900|NCT05396014|593275363|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
164247901|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247902|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247903|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247904|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247905|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247906|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247907|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247908|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247909|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247910|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247911|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247912|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
163886280|NCT04908722|591956431|FG004|Overall Study|Withdrawal by Subject|12|||
164247913|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247914|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
163886281|NCT04908722|591956432|FG005|Overall Study|Withdrawal by Subject|14|||
163886282|NCT04908722|591956427|FG000|Overall Study|Other|3|||
163886283|NCT04908722|591956428|FG001|Overall Study|Other|1|||
164247915|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247916|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247917|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247918|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247919|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247920|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247921|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247922|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247923|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247924|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247925|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247926|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247927|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247928|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247929|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247930|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247931|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247932|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247933|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247934|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247935|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247936|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247937|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247938|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247939|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247940|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247941|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247942|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247943|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
164247944|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
164247945|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247946|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247947|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247948|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164338404|NCT01346969|593615161|FG002|Overall Study|Randomized but not treated|0|||
164338405|NCT01346969|593615162|FG003|Overall Study|Randomized but not treated|0|||
164338406|NCT03666624|593615164|FG000|Overall Study|participant grieving over recent death of parent|1|||
164338407|NCT03666624|593615165|FG001|Overall Study|participant grieving over recent death of parent|0|||
164338408|NCT05213481|593615167|FG000|Overall Study|Adverse Event|3|||
164338409|NCT05213481|593615167|FG000|Overall Study|Lost to Follow-up|1|||
164338410|NCT00447005|593615169|FG000|Overall Study|Adverse Event|1|||
164338411|NCT00447005|593615169|FG000|Overall Study|Lack of Efficacy|11|||
164338412|NCT00397215|593615170|FG000|Month 0 (Day 0)|Adverse Event|0|||
164338413|NCT00397215|593615171|FG001|Month 0 (Day 0)|Adverse Event|1|||
164338414|NCT00397215|593615172|FG002|Month 0 (Day 0)|Adverse Event|0|||
164338415|NCT00397215|593615173|FG003|Month 0 (Day 0)|Adverse Event|0|||
164338416|NCT00397215|593615170|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
164338417|NCT00397215|593615171|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
164338418|NCT00397215|593615172|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
164338419|NCT00397215|593615173|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
164338420|NCT00397215|593615170|FG000|Month 0 (Day 0)|Other|4|||
164338421|NCT00397215|593615171|FG001|Month 0 (Day 0)|Other|1|||
164338422|NCT00397215|593615172|FG002|Month 0 (Day 0)|Other|3|||
164338423|NCT00397215|593615173|FG003|Month 0 (Day 0)|Other|3|||
164338424|NCT00397215|593615170|FG000|Month 6 (Day 180)|Adverse Event|0|||
164338425|NCT00397215|593615171|FG001|Month 6 (Day 180)|Adverse Event|3|||
164338426|NCT00397215|593615172|FG002|Month 6 (Day 180)|Adverse Event|2|||
164338427|NCT00397215|593615173|FG003|Month 6 (Day 180)|Adverse Event|0|||
164338428|NCT00397215|593615170|FG000|Month 6 (Day 180)|Other|2|||
164338429|NCT00397215|593615171|FG001|Month 6 (Day 180)|Other|0|||
164338430|NCT00397215|593615172|FG002|Month 6 (Day 180)|Other|3|||
164338431|NCT00397215|593615173|FG003|Month 6 (Day 180)|Other|0|||
164338432|NCT00423514|593615174|FG000|Overall Study|Ineligible|1|||
164338433|NCT00423514|593615175|FG001|Overall Study|Ineligible|0|||
164247949|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247950|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247951|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247952|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247953|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247954|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247955|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247956|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247957|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
164247958|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247959|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247960|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247961|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247962|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247963|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247964|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247965|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247966|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247967|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247968|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247969|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247970|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247971|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247972|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247973|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247974|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247975|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247976|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247977|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247978|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247979|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247980|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247981|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247982|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247983|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
164247984|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247985|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247986|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
164247987|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
163886284|NCT04908722|591956429|FG002|Overall Study|Other|3|||
163886285|NCT04908722|591956430|FG003|Overall Study|Other|2|||
164247988|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247989|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247990|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247991|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247992|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247993|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247994|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247995|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247996|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247997|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247998|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164247999|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248000|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248001|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163886286|NCT04908722|591956431|FG004|Overall Study|Other|4|||
163886287|NCT04908722|591956432|FG005|Overall Study|Other|1|||
163886288|NCT04908722|591956427|FG000|Overall Study|Initiated prohibited medication|0|||
163886289|NCT04908722|591956428|FG001|Overall Study|Initiated prohibited medication|0|||
163886290|NCT04908722|591956429|FG002|Overall Study|Initiated prohibited medication|0|||
164248002|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248003|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
163886291|NCT04908722|591956430|FG003|Overall Study|Initiated prohibited medication|1|||
164248004|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248005|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248006|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248007|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248008|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248009|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248010|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248011|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248012|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248013|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
164248014|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248015|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248016|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248017|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248018|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248019|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248020|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248021|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248022|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248023|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248024|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248025|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248026|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248027|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248028|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248029|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
164248030|NCT05396014|593275321|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248031|NCT05396014|593275322|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248032|NCT05396014|593275323|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248033|NCT05396014|593275324|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248034|NCT05396014|593275325|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248035|NCT05396014|593275326|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248036|NCT05396014|593275327|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248037|NCT05396014|593275328|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248038|NCT05396014|593275329|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248039|NCT05396014|593275330|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248040|NCT05396014|593275331|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248041|NCT05396014|593275332|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248042|NCT05396014|593275333|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248043|NCT05396014|593275334|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
164248044|NCT05396014|593275335|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248045|NCT05396014|593275336|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248046|NCT05396014|593275337|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248047|NCT05396014|593275338|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248048|NCT05396014|593275339|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248049|NCT05396014|593275340|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248050|NCT05396014|593275341|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248051|NCT05396014|593275342|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248052|NCT05396014|593275343|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248053|NCT05396014|593275344|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248054|NCT05396014|593275345|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248055|NCT05396014|593275346|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248056|NCT05396014|593275347|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248057|NCT05396014|593275348|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248058|NCT05396014|593275349|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248059|NCT05396014|593275350|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248060|NCT05396014|593275351|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248061|NCT05396014|593275352|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248062|NCT05396014|593275353|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248063|NCT05396014|593275354|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248064|NCT05396014|593275355|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248065|NCT05396014|593275356|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
163990987|NCT02211261|592335173|FG001|Overall Study|Other|0|||
164248066|NCT05396014|593275357|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248067|NCT05396014|593275358|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248068|NCT05396014|593275359|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248069|NCT05396014|593275360|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248070|NCT05396014|593275361|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248071|NCT05396014|593275362|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248072|NCT05396014|593275363|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
164248073|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248074|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248075|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248076|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248077|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248078|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248079|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248080|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248081|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248082|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248083|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248084|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248085|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248086|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248087|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248088|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248089|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248090|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248091|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248092|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248093|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248094|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248095|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248096|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248097|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248098|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248099|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248100|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248101|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248102|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248103|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248104|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248105|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248106|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248107|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248108|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248109|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248110|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248111|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248112|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
164248113|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
164248114|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
164248115|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
164248116|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248117|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248118|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248119|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248120|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248121|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248122|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248123|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248124|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
164248125|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248126|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248127|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163990988|NCT02211261|592335174|FG002|Overall Study|Other|0|||
163990989|NCT02211261|592335175|FG003|Overall Study|Other|0|||
163990990|NCT02211261|592335176|FG004|Overall Study|Other|0|||
163990991|NCT02211261|592335177|FG005|Overall Study|Other|1|||
163990992|NCT02211261|592335178|FG006|Overall Study|Other|0|||
163990993|NCT02211261|592335179|FG007|Overall Study|Other|0|||
163990994|NCT02211261|592335180|FG008|Overall Study|Other|0|||
163990995|NCT02211261|592335181|FG009|Overall Study|Other|2|||
163990996|NCT02211261|592335182|FG010|Overall Study|Other|0|||
163990997|NCT02211261|592335172|FG000|Overall Study|Lost to Follow-up|0|||
163990998|NCT02211261|592335173|FG001|Overall Study|Lost to Follow-up|0|||
164083873|NCT01341639|592672178|FG000|Interim Period|Lost to Follow-up|2|||
164083874|NCT01341639|592672179|FG001|Interim Period|Lost to Follow-up|0|||
164083875|NCT01341639|592672178|FG000|Interim Period|Physician Decision|0|||
164083876|NCT01341639|592672179|FG001|Interim Period|Physician Decision|1|||
164083877|NCT01341639|592672178|FG000|Interim Period|Protocol Violation|0|||
163990999|NCT02211261|592335174|FG002|Overall Study|Lost to Follow-up|0|||
164083878|NCT01341639|592672179|FG001|Interim Period|Protocol Violation|1|||
164083879|NCT01341639|592672178|FG000|Post-Treatment|Withdrawal by Subject|0|||
164083880|NCT01341639|592672179|FG001|Post-Treatment|Withdrawal by Subject|1|||
164083881|NCT01341639|592672178|FG000|Post-Treatment|Adverse Event|0|||
164083882|NCT01341639|592672179|FG001|Post-Treatment|Adverse Event|2|||
164083883|NCT01590433|592672180|FG000|Overall Study|Lost to Follow-up|20|||
164083884|NCT01590433|592672181|FG001|Overall Study|Lost to Follow-up|8|||
164083885|NCT01590433|592672180|FG000|Overall Study|Withdrawal by Subject|21|||
164083886|NCT01590433|592672181|FG001|Overall Study|Withdrawal by Subject|11|||
164083887|NCT01590433|592672180|FG000|Overall Study|Adverse Event|11|||
164083888|NCT01590433|592672181|FG001|Overall Study|Adverse Event|3|||
164083889|NCT00555009|592672182|FG000|Overall Study|Withdrawal by Subject|0|||
164083890|NCT00555009|592672183|FG001|Overall Study|Withdrawal by Subject|1|||
164083891|NCT00555009|592672182|FG000|Overall Study|Terminated by Sponsor|2|||
164083892|NCT00555009|592672183|FG001|Overall Study|Terminated by Sponsor|5|||
164083893|NCT02040428|592672184|FG000|Overall Study|Death|4|||
164083894|NCT02040428|592672185|FG001|Overall Study|Death|3|||
164083895|NCT02040428|592672184|FG000|Overall Study|Withdrawal by Subject|1|||
164083896|NCT02040428|592672185|FG001|Overall Study|Withdrawal by Subject|1|||
163991000|NCT02211261|592335175|FG003|Overall Study|Lost to Follow-up|0|||
163991001|NCT02211261|592335176|FG004|Overall Study|Lost to Follow-up|0|||
163991002|NCT02211261|592335177|FG005|Overall Study|Lost to Follow-up|0|||
164083897|NCT02058628|592672186|FG000|Overall Study|Adverse Event|1|||
163991003|NCT02211261|592335178|FG006|Overall Study|Lost to Follow-up|0|||
163991004|NCT02211261|592335179|FG007|Overall Study|Lost to Follow-up|1|||
163991005|NCT02211261|592335180|FG008|Overall Study|Lost to Follow-up|0|||
163991006|NCT02211261|592335181|FG009|Overall Study|Lost to Follow-up|0|||
164083898|NCT02058628|592672187|FG001|Overall Study|Adverse Event|0|||
164141034|NCT00591773|592878634|FG000|Overall Study|Lack of Efficacy|1|||
164141035|NCT00591773|592878635|FG001|Overall Study|Lack of Efficacy|2|||
164141036|NCT00591773|592878636|FG002|Overall Study|Lack of Efficacy|2|||
164141037|NCT00591773|592878634|FG000|Overall Study|Other|1|||
164141038|NCT00591773|592878635|FG001|Overall Study|Other|1|||
164141039|NCT00591773|592878636|FG002|Overall Study|Other|4|||
164141040|NCT02135614|592878637|FG000|Overall Study|Randomized but Not Treated|2|||
164141041|NCT02135614|592878638|FG001|Overall Study|Randomized but Not Treated|1|||
164141042|NCT02135614|592878637|FG000|Overall Study|Adverse Event|0|||
164141043|NCT02135614|592878638|FG001|Overall Study|Adverse Event|1|||
164141044|NCT02135614|592878637|FG000|Overall Study|Death|1|||
164141045|NCT02135614|592878638|FG001|Overall Study|Death|0|||
164141046|NCT02135614|592878637|FG000|Overall Study|Investigator's Discretion|0|||
164141047|NCT02135614|592878638|FG001|Overall Study|Investigator's Discretion|1|||
164141048|NCT02135614|592878637|FG000|Overall Study|Withdrew Consent|2|||
164141049|NCT02135614|592878638|FG001|Overall Study|Withdrew Consent|2|||
164141050|NCT02135614|592878637|FG000|Overall Study|Lost to Follow-up|3|||
164141051|NCT02135614|592878638|FG001|Overall Study|Lost to Follow-up|0|||
164141052|NCT03022084|592878639|FG000|Overall Study|Lost to Follow-up|2|||
164141053|NCT03022084|592878640|FG001|Overall Study|Lost to Follow-up|3|||
164141054|NCT02640482|592878641|FG000|Overall Study|Lost to Follow-up|3|||
164141055|NCT02640482|592878642|FG001|Overall Study|Lost to Follow-up|0|||
164141056|NCT00554606|592878643|FG000|Overall Study|Adverse Event|3|||
164141057|NCT00554606|592878643|FG000|Overall Study|Abnormal laboratory values|1|||
164141058|NCT00554606|592878643|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
164141059|NCT00554606|592878643|FG000|Overall Study|Subject withdrew consent|2|||
164141060|NCT00554606|592878643|FG000|Overall Study|Lost to Follow-up|2|||
164141061|NCT00554606|592878643|FG000|Overall Study|Administrative problems|60|||
164141062|NCT00554606|592878643|FG000|Overall Study|Death|1|||
164141063|NCT00554606|592878643|FG000|Overall Study|Protocol deviation|2|||
164141064|NCT00605540|592878645|FG000|Overall Study|Death|15|||
164141065|NCT00605540|592878645|FG000|Overall Study|Lost to Follow-up|23|||
164141066|NCT00509366|592878646|FG000|Overall Study|Not Treated (Screen Failure)|1|||
164144025|NCT00086281|592888579|FG008|Phase 1|Serious Adverse Event|0|||
163886292|NCT04908722|591956431|FG004|Overall Study|Initiated prohibited medication|0|||
163886293|NCT04908722|591956432|FG005|Overall Study|Initiated prohibited medication|1|||
163886294|NCT04908722|591956427|FG000|Overall Study|Randomized but not vaccinated|3|||
163886295|NCT04908722|591956428|FG001|Overall Study|Randomized but not vaccinated|1|||
163886296|NCT04908722|591956429|FG002|Overall Study|Randomized but not vaccinated|2|||
163886297|NCT04908722|591956430|FG003|Overall Study|Randomized but not vaccinated|2|||
163886298|NCT04908722|591956431|FG004|Overall Study|Randomized but not vaccinated|3|||
163886299|NCT04908722|591956432|FG005|Overall Study|Randomized but not vaccinated|4|||
163886300|NCT01369355|591956437|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
163886301|NCT01369355|591956438|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
163886302|NCT01369355|591956439|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
163886303|NCT01369355|591956440|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
163886304|NCT01369355|591956441|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
163886305|NCT01369355|591956442|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
163886306|NCT01369355|591956443|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
163886307|NCT01369355|591956444|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
163886308|NCT01369355|591956445|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
163886309|NCT01369355|591956437|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
163886310|NCT01369355|591956438|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
163886311|NCT01369355|591956439|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
163886312|NCT01369355|591956440|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
163886313|NCT01369355|591956441|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
163886314|NCT01369355|591956442|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
163886315|NCT01369355|591956443|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
163886316|NCT01369355|591956444|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
163886317|NCT01369355|591956445|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
163886318|NCT01369355|591956437|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163886319|NCT01369355|591956438|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
163886320|NCT01369355|591956439|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
163886321|NCT01369355|591956440|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163886322|NCT01369355|591956441|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163886323|NCT01369355|591956442|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
163886324|NCT01369355|591956443|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163886325|NCT01369355|591956444|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163886326|NCT01369355|591956445|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
163886327|NCT01369355|591956437|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
163886328|NCT01369355|591956438|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163886329|NCT01369355|591956439|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
163886330|NCT01369355|591956440|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
163886331|NCT01369355|591956441|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
163886332|NCT01369355|591956442|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
163886333|NCT01369355|591956443|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163886334|NCT01369355|591956444|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163886335|NCT01369355|591956445|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
163886336|NCT01369355|591956437|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
163886337|NCT01369355|591956438|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
163886338|NCT01369355|591956439|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
163886339|NCT01369355|591956440|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
163886340|NCT01369355|591956441|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
163886341|NCT01369355|591956442|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
163886342|NCT01369355|591956443|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
163886343|NCT01369355|591956444|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
163886344|NCT01369355|591956445|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
163886345|NCT01369355|591956437|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
163886346|NCT01369355|591956438|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
164338434|NCT02128932|593615176|FG000|Overall Study|Withdrawal by Subject|11|||
164338435|NCT02128932|593615177|FG001|Overall Study|Withdrawal by Subject|7|||
164338436|NCT02128932|593615178|FG002|Overall Study|Withdrawal by Subject|8|||
164338437|NCT02128932|593615176|FG000|Overall Study|Death|2|||
164338438|NCT02128932|593615177|FG001|Overall Study|Death|0|||
164338439|NCT02128932|593615178|FG002|Overall Study|Death|2|||
164338440|NCT02128932|593615176|FG000|Overall Study|Lost to Follow-up|2|||
164338441|NCT02128932|593615177|FG001|Overall Study|Lost to Follow-up|1|||
164338442|NCT02128932|593615178|FG002|Overall Study|Lost to Follow-up|1|||
164338443|NCT02128932|593615176|FG000|Overall Study|No reason for withdrawal|12|||
163886347|NCT01369355|591956439|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
163886348|NCT01369355|591956440|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
163886349|NCT01369355|591956441|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
164338444|NCT02128932|593615177|FG001|Overall Study|No reason for withdrawal|11|||
164338445|NCT02128932|593615178|FG002|Overall Study|No reason for withdrawal|7|||
163886350|NCT01369355|591956442|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
164338446|NCT03685123|593615183|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
164338447|NCT03685123|593615184|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
164338448|NCT03685123|593615185|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
164338449|NCT03685123|593615183|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
164338450|NCT03685123|593615184|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
164338451|NCT03685123|593615185|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
164338452|NCT03685123|593615183|FG000|Weight Loss Phase|Lost to Follow-up|1|||
164338453|NCT03685123|593615184|FG001|Weight Loss Phase|Lost to Follow-up|0|||
164338454|NCT03685123|593615185|FG002|Weight Loss Phase|Lost to Follow-up|0|||
164338455|NCT03685123|593615183|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
164338456|NCT03685123|593615184|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
164338457|NCT03685123|593615185|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
164338458|NCT03685123|593615183|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
164338459|NCT03685123|593615184|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
164338460|NCT03685123|593615185|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
164338461|NCT03685123|593615183|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
164338462|NCT03685123|593615184|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
164338463|NCT03685123|593615185|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
164338464|NCT02959983|593615186|FG000|Overall Study|Protocol Violation|0|||
164338465|NCT02959983|593615187|FG001|Overall Study|Protocol Violation|1|||
164338466|NCT02959983|593615186|FG000|Overall Study|Lack of Efficacy|0|||
164338467|NCT02959983|593615187|FG001|Overall Study|Lack of Efficacy|1|||
164338468|NCT02959983|593615186|FG000|Overall Study|Lost to Follow-up|12|||
164338469|NCT02959983|593615187|FG001|Overall Study|Lost to Follow-up|9|||
164338470|NCT02959983|593615186|FG000|Overall Study|Other|1|||
164338471|NCT02959983|593615187|FG001|Overall Study|Other|1|||
164338472|NCT02959983|593615186|FG000|Overall Study|Physician Decision|1|||
164338473|NCT02959983|593615187|FG001|Overall Study|Physician Decision|0|||
164338474|NCT02959983|593615186|FG000|Overall Study|Adverse Event|5|||
164338475|NCT02959983|593615187|FG001|Overall Study|Adverse Event|1|||
164338476|NCT02959983|593615186|FG000|Overall Study|Withdrawal by Subject|7|||
164338477|NCT02959983|593615187|FG001|Overall Study|Withdrawal by Subject|12|||
164338478|NCT01254630|593615188|FG000|Overall Study|Adverse Event|36|||
164338479|NCT01254630|593615189|FG001|Overall Study|Adverse Event|15|||
164338480|NCT01254630|593615190|FG002|Overall Study|Adverse Event|40|||
164338481|NCT01254630|593615191|FG003|Overall Study|Adverse Event|8|||
164338482|NCT01254630|593615188|FG000|Overall Study|Death|461|||
164338483|NCT01254630|593615189|FG001|Overall Study|Death|151|||
164338484|NCT01254630|593615190|FG002|Overall Study|Death|478|||
164338485|NCT01254630|593615191|FG003|Overall Study|Death|139|||
164338486|NCT01254630|593615188|FG000|Overall Study|Lost to Follow-up|80|||
164338487|NCT01254630|593615189|FG001|Overall Study|Lost to Follow-up|26|||
164338488|NCT01254630|593615190|FG002|Overall Study|Lost to Follow-up|89|||
164338489|NCT01254630|593615191|FG003|Overall Study|Lost to Follow-up|32|||
164338490|NCT01254630|593615188|FG000|Overall Study|Physician Decision|24|||
164338491|NCT01254630|593615189|FG001|Overall Study|Physician Decision|8|||
163991007|NCT02211261|592335182|FG010|Overall Study|Lost to Follow-up|0|||
163991008|NCT01573910|592335183|FG000|Overall Study|Adverse Event|4|||
163991009|NCT01573910|592335184|FG001|Overall Study|Adverse Event|4|||
163991010|NCT01573910|592335183|FG000|Overall Study|Lost to Follow-up|2|||
163991011|NCT01573910|592335184|FG001|Overall Study|Lost to Follow-up|1|||
163991012|NCT01573910|592335183|FG000|Overall Study|Withdrawal by Subject|0|||
163991013|NCT01573910|592335184|FG001|Overall Study|Withdrawal by Subject|1|||
163991014|NCT01573910|592335183|FG000|Overall Study|Protocol Violation|3|||
163991015|NCT01573910|592335184|FG001|Overall Study|Protocol Violation|0|||
163991016|NCT01573910|592335183|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
163991017|NCT01573910|592335184|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
163991018|NCT02251912|592335185|FG000|Overall Study|Withdrawal by Subject|2|||
163991019|NCT02251912|592335186|FG001|Overall Study|Withdrawal by Subject|3|||
163991020|NCT02251912|592335185|FG000|Overall Study|Adverse Event|0|||
164338492|NCT01254630|593615190|FG002|Overall Study|Physician Decision|16|||
164338493|NCT01254630|593615191|FG003|Overall Study|Physician Decision|7|||
164338494|NCT01254630|593615188|FG000|Overall Study|Withdrawal by Subject|201|||
164338495|NCT01254630|593615189|FG001|Overall Study|Withdrawal by Subject|94|||
164338496|NCT01254630|593615190|FG002|Overall Study|Withdrawal by Subject|188|||
164338497|NCT01254630|593615191|FG003|Overall Study|Withdrawal by Subject|89|||
163991021|NCT02251912|592335186|FG001|Overall Study|Adverse Event|2|||
163991022|NCT00268242|592335188|FG000|Overall Study|Death|1|||
163991023|NCT02175680|592335189|FG000|Overall Study|non-compliance|1|||
163991024|NCT02175680|592335189|FG000|Overall Study|other non-medical reason|1|||
163991025|NCT01913483|592335190|FG000|Overall Study|Withdrawal by Subject|1|||
163991026|NCT01913483|592335191|FG001|Overall Study|Withdrawal by Subject|2|||
163991027|NCT01913483|592335190|FG000|Overall Study|Lost to Follow-up|6|||
163991028|NCT01913483|592335191|FG001|Overall Study|Lost to Follow-up|3|||
164083899|NCT02058628|592672186|FG000|Overall Study|Withdrawal by Subject|2|||
164248128|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248129|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248130|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248131|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248132|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248133|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248134|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248135|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248136|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248137|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248138|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
164248139|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
163886351|NCT01369355|591956443|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
163886352|NCT01369355|591956444|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
163886353|NCT01369355|591956445|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
163886354|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
163886355|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
163886356|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
163886357|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
163886358|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
163886359|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
163886360|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
163886361|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
163886362|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
163886363|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Death|0|||
163886364|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Death|0|||
163886365|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Death|0|||
163886366|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Death|0|||
163886367|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Death|0|||
163886368|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Death|0|||
163886369|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Death|0|||
163886370|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Death|1|||
163886371|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Death|3|||
163886372|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163886373|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163886374|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163886375|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
164083900|NCT02058628|592672187|FG001|Overall Study|Withdrawal by Subject|2|||
164248140|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248141|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248142|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248143|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
163886376|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163886377|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
163886378|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
163886379|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
163886380|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
163886381|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163886382|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163991029|NCT01913483|592335190|FG000|Overall Study|Death|14|||
163991030|NCT01913483|592335191|FG001|Overall Study|Death|17|||
163991031|NCT03969888|592335192|FG000|Overall Study|Never Received Study Drug|0|||
164248144|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248145|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248146|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248147|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248148|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248149|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248150|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248151|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
164248152|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248153|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248154|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248155|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
164248156|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248157|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
164248158|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
164248159|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248160|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248161|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248162|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248163|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248164|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248165|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248166|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248167|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248168|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248169|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248170|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248171|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248172|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164248173|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248174|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248175|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248176|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248177|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248178|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248179|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248180|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248181|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248182|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248183|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248184|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248185|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164083901|NCT02058628|592672186|FG000|Overall Study|Lost to Follow-up|2|||
164248186|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248187|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248188|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248189|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248190|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248191|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248192|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248193|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164248194|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248195|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248196|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248197|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248198|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248199|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248200|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
164248201|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
164248202|NCT05396014|593275321|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248203|NCT05396014|593275322|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248204|NCT05396014|593275323|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248205|NCT05396014|593275324|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248206|NCT05396014|593275325|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248207|NCT05396014|593275326|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248208|NCT05396014|593275327|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248209|NCT05396014|593275328|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248210|NCT05396014|593275329|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248211|NCT05396014|593275330|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248212|NCT05396014|593275331|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248213|NCT05396014|593275332|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248214|NCT05396014|593275333|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248215|NCT05396014|593275334|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248216|NCT05396014|593275335|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248217|NCT05396014|593275336|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248218|NCT05396014|593275337|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248219|NCT05396014|593275338|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248220|NCT05396014|593275339|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248221|NCT05396014|593275340|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248222|NCT05396014|593275341|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248223|NCT05396014|593275342|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248224|NCT05396014|593275343|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248225|NCT05396014|593275344|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248226|NCT05396014|593275345|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248227|NCT05396014|593275346|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248228|NCT05396014|593275347|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
164248229|NCT05396014|593275348|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248230|NCT05396014|593275349|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248231|NCT05396014|593275350|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248232|NCT05396014|593275351|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248233|NCT05396014|593275352|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248234|NCT05396014|593275353|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248235|NCT05396014|593275354|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248236|NCT05396014|593275355|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248237|NCT05396014|593275356|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248238|NCT05396014|593275357|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248239|NCT05396014|593275358|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248240|NCT05396014|593275359|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248241|NCT05396014|593275360|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248242|NCT05396014|593275361|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248243|NCT05396014|593275362|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248244|NCT05396014|593275363|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
164248245|NCT05258890|593275371|FG000|Overall Study|Patient withdrawal|6|||
164248246|NCT05258890|593275372|FG001|Overall Study|Patient withdrawal|7|||
164248247|NCT05258890|593275371|FG000|Overall Study|Patient lost to follow-up|10|||
164248248|NCT05258890|593275372|FG001|Overall Study|Patient lost to follow-up|3|||
164248249|NCT05258890|593275371|FG000|Overall Study|Social network member withdrawal|1|||
164248250|NCT05258890|593275372|FG001|Overall Study|Social network member withdrawal|0|||
164248251|NCT05258890|593275371|FG000|Overall Study|Social network member lost to follow-up|5|||
164248252|NCT05258890|593275372|FG001|Overall Study|Social network member lost to follow-up|0|||
164248253|NCT02974140|593275373|FG000|Overall Study|Adverse Event|2|||
164248254|NCT02974140|593275373|FG000|Overall Study|Lost to Follow-up|1|||
164248255|NCT02974140|593275373|FG000|Overall Study|Study Terminated by Sponsor|36|||
164248256|NCT01905943|593275374|FG000|Overall Study|Withdrawal of consent|90|||
164248257|NCT01905943|593275374|FG000|Overall Study|Lost to Follow-up|16|||
164248258|NCT01905943|593275374|FG000|Overall Study|Investigator discretion|7|||
164248259|NCT01905943|593275374|FG000|Overall Study|Death|186|||
164248260|NCT01905943|593275374|FG000|Overall Study|Adverse Event|3|||
164248261|NCT01905943|593275374|FG000|Overall Study|Other|12|||
164248262|NCT01238991|593275375|FG000|Overall Study|Adverse Event|1|||
164248263|NCT01238991|593275376|FG001|Overall Study|Adverse Event|0|||
164248264|NCT01238991|593275377|FG002|Overall Study|Adverse Event|3|||
164248265|NCT01238991|593275378|FG003|Overall Study|Adverse Event|1|||
164248266|NCT01238991|593275379|FG004|Overall Study|Adverse Event|1|||
164248267|NCT01238991|593275380|FG005|Overall Study|Adverse Event|0|||
164248268|NCT01238991|593275381|FG006|Overall Study|Adverse Event|1|||
164248269|NCT01238991|593275382|FG007|Overall Study|Adverse Event|1|||
164248270|NCT01238991|593275383|FG008|Overall Study|Adverse Event|0|||
164248271|NCT01238991|593275384|FG009|Overall Study|Adverse Event|0|||
164248272|NCT01238991|593275375|FG000|Overall Study|Death|0|||
164248273|NCT01238991|593275376|FG001|Overall Study|Death|0|||
164248274|NCT01238991|593275377|FG002|Overall Study|Death|0|||
164248275|NCT01238991|593275378|FG003|Overall Study|Death|1|||
164248276|NCT01238991|593275379|FG004|Overall Study|Death|0|||
164248277|NCT01238991|593275380|FG005|Overall Study|Death|0|||
164248278|NCT01238991|593275381|FG006|Overall Study|Death|0|||
164248279|NCT01238991|593275382|FG007|Overall Study|Death|0|||
164248280|NCT01238991|593275383|FG008|Overall Study|Death|0|||
164248281|NCT01238991|593275384|FG009|Overall Study|Death|0|||
164248282|NCT01238991|593275375|FG000|Overall Study|Lack of Efficacy|0|||
164248283|NCT01238991|593275376|FG001|Overall Study|Lack of Efficacy|0|||
164248284|NCT01238991|593275377|FG002|Overall Study|Lack of Efficacy|1|||
164248285|NCT01238991|593275378|FG003|Overall Study|Lack of Efficacy|0|||
164248286|NCT01238991|593275379|FG004|Overall Study|Lack of Efficacy|0|||
164248287|NCT01238991|593275380|FG005|Overall Study|Lack of Efficacy|0|||
164248288|NCT01238991|593275381|FG006|Overall Study|Lack of Efficacy|0|||
164248289|NCT01238991|593275382|FG007|Overall Study|Lack of Efficacy|0|||
164248290|NCT01238991|593275383|FG008|Overall Study|Lack of Efficacy|1|||
164248291|NCT01238991|593275384|FG009|Overall Study|Lack of Efficacy|0|||
164248292|NCT01238991|593275375|FG000|Overall Study|Withdrawal by Subject|0|||
164248293|NCT01238991|593275376|FG001|Overall Study|Withdrawal by Subject|0|||
164248294|NCT01238991|593275377|FG002|Overall Study|Withdrawal by Subject|1|||
164248295|NCT01238991|593275378|FG003|Overall Study|Withdrawal by Subject|0|||
164248296|NCT01238991|593275379|FG004|Overall Study|Withdrawal by Subject|0|||
164248297|NCT01238991|593275380|FG005|Overall Study|Withdrawal by Subject|0|||
164248298|NCT01238991|593275381|FG006|Overall Study|Withdrawal by Subject|0|||
164248299|NCT01238991|593275382|FG007|Overall Study|Withdrawal by Subject|0|||
164248300|NCT01238991|593275383|FG008|Overall Study|Withdrawal by Subject|0|||
164248301|NCT01238991|593275384|FG009|Overall Study|Withdrawal by Subject|0|||
164248302|NCT01238991|593275375|FG000|Overall Study|Study Terminated by Sponsor|0|||
164248303|NCT01238991|593275376|FG001|Overall Study|Study Terminated by Sponsor|0|||
164338498|NCT01254630|593615188|FG000|Overall Study|Study terminated by sponsor|0|||
164338499|NCT01254630|593615189|FG001|Overall Study|Study terminated by sponsor|994|||
164338500|NCT01254630|593615190|FG002|Overall Study|Study terminated by sponsor|0|||
164338501|NCT01254630|593615191|FG003|Overall Study|Study terminated by sponsor|1010|||
164338502|NCT01254630|593615188|FG000|Overall Study|Status not recorded|0|||
164338503|NCT01254630|593615189|FG001|Overall Study|Status not recorded|0|||
164338504|NCT01254630|593615190|FG002|Overall Study|Status not recorded|1|||
164338505|NCT01254630|593615191|FG003|Overall Study|Status not recorded|0|||
164338506|NCT03439657|593615196|FG000|Overall Study|Adverse Event|2|||
164338507|NCT03439657|593615197|FG001|Overall Study|Adverse Event|3|||
164338508|NCT03439657|593615196|FG000|Overall Study|Lost to Follow-up|1|||
164338509|NCT03439657|593615197|FG001|Overall Study|Lost to Follow-up|0|||
164338510|NCT03439657|593615196|FG000|Overall Study|Protocol Violation|1|||
164248304|NCT01238991|593275377|FG002|Overall Study|Study Terminated by Sponsor|0|||
164248305|NCT01238991|593275378|FG003|Overall Study|Study Terminated by Sponsor|0|||
164248306|NCT01238991|593275379|FG004|Overall Study|Study Terminated by Sponsor|1|||
164248307|NCT01238991|593275380|FG005|Overall Study|Study Terminated by Sponsor|0|||
164248308|NCT01238991|593275381|FG006|Overall Study|Study Terminated by Sponsor|7|||
164248309|NCT01238991|593275382|FG007|Overall Study|Study Terminated by Sponsor|4|||
164248310|NCT01238991|593275383|FG008|Overall Study|Study Terminated by Sponsor|2|||
164248311|NCT01238991|593275384|FG009|Overall Study|Study Terminated by Sponsor|2|||
164248312|NCT01238991|593275375|FG000|Overall Study|Caregiver's request|0|||
164338511|NCT03439657|593615197|FG001|Overall Study|Protocol Violation|1|||
164338512|NCT03439657|593615196|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
164338513|NCT03439657|593615197|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
164083902|NCT02058628|592672187|FG001|Overall Study|Lost to Follow-up|4|||
164248313|NCT01238991|593275376|FG001|Overall Study|Caregiver's request|0|||
164248314|NCT01238991|593275377|FG002|Overall Study|Caregiver's request|0|||
164248315|NCT01238991|593275378|FG003|Overall Study|Caregiver's request|0|||
164338514|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
164338515|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
164248316|NCT01238991|593275379|FG004|Overall Study|Caregiver's request|0|||
164248317|NCT01238991|593275380|FG005|Overall Study|Caregiver's request|0|||
163991032|NCT03969888|592335193|FG001|Overall Study|Never Received Study Drug|0|||
163991033|NCT03969888|592335194|FG002|Overall Study|Never Received Study Drug|1|||
163991034|NCT03969888|592335195|FG003|Overall Study|Never Received Study Drug|0|||
163991035|NCT03969888|592335196|FG004|Overall Study|Never Received Study Drug|0|||
163991036|NCT03969888|592335197|FG005|Overall Study|Never Received Study Drug|0|||
164248318|NCT01238991|593275381|FG006|Overall Study|Caregiver's request|0|||
164248319|NCT01238991|593275382|FG007|Overall Study|Caregiver's request|0|||
164248320|NCT01238991|593275383|FG008|Overall Study|Caregiver's request|1|||
164248321|NCT01238991|593275384|FG009|Overall Study|Caregiver's request|0|||
164248322|NCT01238991|593275375|FG000|Overall Study|Admission to a nursing home|1|||
164248323|NCT01238991|593275376|FG001|Overall Study|Admission to a nursing home|0|||
164248324|NCT01238991|593275377|FG002|Overall Study|Admission to a nursing home|1|||
164248325|NCT01238991|593275378|FG003|Overall Study|Admission to a nursing home|0|||
164248326|NCT01238991|593275379|FG004|Overall Study|Admission to a nursing home|0|||
164248327|NCT01238991|593275380|FG005|Overall Study|Admission to a nursing home|0|||
164248328|NCT01238991|593275381|FG006|Overall Study|Admission to a nursing home|0|||
164248329|NCT01238991|593275382|FG007|Overall Study|Admission to a nursing home|0|||
164248330|NCT01238991|593275383|FG008|Overall Study|Admission to a nursing home|0|||
164248331|NCT01238991|593275384|FG009|Overall Study|Admission to a nursing home|0|||
164248332|NCT05959447|593275391|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
164248333|NCT05959447|593275392|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
164248334|NCT05959447|593275391|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
164248335|NCT05959447|593275392|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
164248336|NCT05959447|593275391|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
164248337|NCT05959447|593275392|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
164248338|NCT05959447|593275391|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
164248339|NCT05959447|593275392|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
164248340|NCT02522429|593275393|FG000|Overall Study|Lost to Follow-up|8|||
164248341|NCT02522429|593275393|FG000|Overall Study|Adverse Event|2|||
164248342|NCT02522429|593275393|FG000|Overall Study|Death|1|||
164248343|NCT02522429|593275393|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
164248344|NCT00294671|593275394|FG000|Overall Study|Lack of Efficacy|11|||
164248345|NCT00294671|593275395|FG001|Overall Study|Lack of Efficacy|23|||
164248346|NCT00294671|593275394|FG000|Overall Study|Liver transplant|7|||
164248347|NCT00294671|593275395|FG001|Overall Study|Liver transplant|9|||
164248348|NCT00294671|593275394|FG000|Overall Study|Drug related adverse event (AE)|4|||
164248349|NCT00294671|593275395|FG001|Overall Study|Drug related adverse event (AE)|2|||
164248350|NCT00294671|593275394|FG000|Overall Study|Non-drug related AE|3|||
164248351|NCT00294671|593275395|FG001|Overall Study|Non-drug related AE|2|||
164248352|NCT00294671|593275394|FG000|Overall Study|Lost to Follow-up|1|||
164248353|NCT00294671|593275395|FG001|Overall Study|Lost to Follow-up|3|||
164248354|NCT00294671|593275394|FG000|Overall Study|Non-compliance|1|||
164248355|NCT00294671|593275395|FG001|Overall Study|Non-compliance|0|||
164248356|NCT00294671|593275394|FG000|Overall Study|Death|0|||
164248357|NCT00294671|593275395|FG001|Overall Study|Death|1|||
164248358|NCT01893411|593275400|FG000|Overall Study|Protocol Violation|1|||
164248359|NCT01893411|593275401|FG001|Overall Study|Protocol Violation|0|||
164248360|NCT01893411|593275402|FG002|Overall Study|Protocol Violation|0|||
164248361|NCT01893411|593275400|FG000|Overall Study|Physician Decision|1|||
164248362|NCT01893411|593275401|FG001|Overall Study|Physician Decision|1|||
164248363|NCT01893411|593275402|FG002|Overall Study|Physician Decision|2|||
164248364|NCT01893411|593275400|FG000|Overall Study|Lack of Efficacy|2|||
164248365|NCT01893411|593275401|FG001|Overall Study|Lack of Efficacy|1|||
164248366|NCT01893411|593275402|FG002|Overall Study|Lack of Efficacy|0|||
164248367|NCT01893411|593275400|FG000|Overall Study|Other|3|||
164248368|NCT01893411|593275401|FG001|Overall Study|Other|1|||
164338516|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
164338517|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
164338518|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338519|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338520|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338521|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163991037|NCT03969888|592335198|FG006|Overall Study|Never Received Study Drug|1|||
163991038|NCT03969888|592335199|FG007|Overall Study|Never Received Study Drug|0|||
163991039|NCT03969888|592335192|FG000|Overall Study|Reason Not Specified|0|||
163991040|NCT03969888|592335193|FG001|Overall Study|Reason Not Specified|0|||
164248369|NCT01893411|593275402|FG002|Overall Study|Other|3|||
164248370|NCT01893411|593275400|FG000|Overall Study|Adverse Event|1|||
164248371|NCT01893411|593275401|FG001|Overall Study|Adverse Event|0|||
164248372|NCT01893411|593275402|FG002|Overall Study|Adverse Event|0|||
164248373|NCT01893411|593275400|FG000|Overall Study|Withdrawal by Subject|7|||
164248374|NCT01893411|593275401|FG001|Overall Study|Withdrawal by Subject|4|||
164338522|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338523|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164248375|NCT01893411|593275402|FG002|Overall Study|Withdrawal by Subject|3|||
164248376|NCT01893411|593275400|FG000|Overall Study|Lost to Follow-up|2|||
164248377|NCT01893411|593275401|FG001|Overall Study|Lost to Follow-up|0|||
164248378|NCT01893411|593275402|FG002|Overall Study|Lost to Follow-up|1|||
164248379|NCT00566982|593275403|FG000|Overall Study|Adverse Event|6|||
164248380|NCT00566982|593275404|FG001|Overall Study|Adverse Event|48|||
164248381|NCT00566982|593275403|FG000|Overall Study|Withdrawal by Subject|1|||
163991041|NCT03969888|592335194|FG002|Overall Study|Reason Not Specified|0|||
163991042|NCT03969888|592335195|FG003|Overall Study|Reason Not Specified|0|||
163991043|NCT03969888|592335196|FG004|Overall Study|Reason Not Specified|0|||
163991044|NCT03969888|592335197|FG005|Overall Study|Reason Not Specified|0|||
163991045|NCT03969888|592335198|FG006|Overall Study|Reason Not Specified|0|||
163991046|NCT03969888|592335199|FG007|Overall Study|Reason Not Specified|1|||
163991047|NCT04062214|592335202|FG000|Week 12|Death|1|||
163991048|NCT04062214|592335203|FG001|Week 12|Death|1|||
163991049|NCT04062214|592335202|FG000|Week 12|Withdrawal by Subject|14|||
163991050|NCT04062214|592335203|FG001|Week 12|Withdrawal by Subject|13|||
164248382|NCT00566982|593275404|FG001|Overall Study|Withdrawal by Subject|14|||
164248383|NCT00566982|593275403|FG000|Overall Study|Protocol Violation|1|||
164248384|NCT00566982|593275404|FG001|Overall Study|Protocol Violation|4|||
164248385|NCT00566982|593275403|FG000|Overall Study|Lost to Follow-up|0|||
164248386|NCT00566982|593275404|FG001|Overall Study|Lost to Follow-up|1|||
164248387|NCT00566982|593275403|FG000|Overall Study|Other-family problems & doctor's request|0|||
164248388|NCT00566982|593275404|FG001|Overall Study|Other-family problems & doctor's request|2|||
164248389|NCT01961297|593275407|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
164248390|NCT01961297|593275408|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
164248391|NCT01947283|593275409|FG000|Overall Study|Death|1|||
164248392|NCT01947283|593275410|FG001|Overall Study|Death|1|||
164248393|NCT01947283|593275411|FG002|Overall Study|Death|1|||
164248394|NCT01947283|593275412|FG003|Overall Study|Death|0|||
164248395|NCT01947283|593275413|FG004|Overall Study|Death|0|||
164248396|NCT01947283|593275414|FG005|Overall Study|Death|0|||
164248397|NCT01947283|593275415|FG006|Overall Study|Death|0|||
164248398|NCT01947283|593275409|FG000|Overall Study|Lost to Follow-up|4|||
164248399|NCT01947283|593275410|FG001|Overall Study|Lost to Follow-up|6|||
164248400|NCT01947283|593275411|FG002|Overall Study|Lost to Follow-up|5|||
164248401|NCT01947283|593275412|FG003|Overall Study|Lost to Follow-up|5|||
164248402|NCT01947283|593275413|FG004|Overall Study|Lost to Follow-up|0|||
164248403|NCT01947283|593275414|FG005|Overall Study|Lost to Follow-up|2|||
163991051|NCT04062214|592335202|FG000|Week 12|Lost to Follow-up|55|||
163991052|NCT04062214|592335203|FG001|Week 12|Lost to Follow-up|68|||
164248404|NCT01947283|593275415|FG006|Overall Study|Lost to Follow-up|5|||
164248405|NCT01947283|593275409|FG000|Overall Study|Withdrawal by Subject|10|||
164248406|NCT01947283|593275410|FG001|Overall Study|Withdrawal by Subject|8|||
164248407|NCT01947283|593275411|FG002|Overall Study|Withdrawal by Subject|4|||
163991053|NCT04062214|592335202|FG000|Week 12|Intermittent missing|31|||
164248408|NCT01947283|593275412|FG003|Overall Study|Withdrawal by Subject|1|||
163991054|NCT04062214|592335203|FG001|Week 12|Intermittent missing|29|||
164248409|NCT01947283|593275413|FG004|Overall Study|Withdrawal by Subject|0|||
163991055|NCT04062214|592335202|FG000|Week 36|Withdrawal by Subject|4|||
163991056|NCT04062214|592335203|FG001|Week 36|Withdrawal by Subject|5|||
163991057|NCT04062214|592335202|FG000|Week 36|Lost to Follow-up|50|||
164248410|NCT01947283|593275414|FG005|Overall Study|Withdrawal by Subject|0|||
163991058|NCT04062214|592335203|FG001|Week 36|Lost to Follow-up|46|||
164248411|NCT01947283|593275415|FG006|Overall Study|Withdrawal by Subject|2|||
164248412|NCT01947283|593275409|FG000|Overall Study|No Clinical Recording|12|||
163886383|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163886384|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163886385|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
164248413|NCT01947283|593275410|FG001|Overall Study|No Clinical Recording|6|||
164248414|NCT01947283|593275411|FG002|Overall Study|No Clinical Recording|8|||
164248415|NCT01947283|593275412|FG003|Overall Study|No Clinical Recording|10|||
164248416|NCT01947283|593275413|FG004|Overall Study|No Clinical Recording|0|||
164248417|NCT01947283|593275414|FG005|Overall Study|No Clinical Recording|0|||
164248418|NCT01947283|593275415|FG006|Overall Study|No Clinical Recording|0|||
164248419|NCT01947283|593275409|FG000|Overall Study|Non-coding Clinical Recording language|0|||
164248420|NCT01947283|593275410|FG001|Overall Study|Non-coding Clinical Recording language|0|||
164248421|NCT01947283|593275411|FG002|Overall Study|Non-coding Clinical Recording language|0|||
164248422|NCT01947283|593275412|FG003|Overall Study|Non-coding Clinical Recording language|1|||
164248423|NCT01947283|593275413|FG004|Overall Study|Non-coding Clinical Recording language|0|||
164248424|NCT01947283|593275414|FG005|Overall Study|Non-coding Clinical Recording language|0|||
164248425|NCT01947283|593275415|FG006|Overall Study|Non-coding Clinical Recording language|0|||
164248426|NCT01947283|593275409|FG000|Overall Study|Missing Follow-up Assessment|2|||
164248427|NCT01947283|593275410|FG001|Overall Study|Missing Follow-up Assessment|2|||
164248428|NCT01947283|593275411|FG002|Overall Study|Missing Follow-up Assessment|3|||
164248429|NCT01947283|593275412|FG003|Overall Study|Missing Follow-up Assessment|0|||
163886386|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163886387|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
163886388|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
164248430|NCT01947283|593275413|FG004|Overall Study|Missing Follow-up Assessment|0|||
164248431|NCT01947283|593275414|FG005|Overall Study|Missing Follow-up Assessment|2|||
164248432|NCT01947283|593275415|FG006|Overall Study|Missing Follow-up Assessment|0|||
164248433|NCT01947283|593275409|FG000|Overall Study|No patients were enrolled in study|0|||
164248434|NCT01947283|593275410|FG001|Overall Study|No patients were enrolled in study|0|||
164248435|NCT01947283|593275411|FG002|Overall Study|No patients were enrolled in study|0|||
164248436|NCT01947283|593275412|FG003|Overall Study|No patients were enrolled in study|0|||
164248437|NCT01947283|593275413|FG004|Overall Study|No patients were enrolled in study|0|||
164248438|NCT01947283|593275414|FG005|Overall Study|No patients were enrolled in study|3|||
164248439|NCT01947283|593275415|FG006|Overall Study|No patients were enrolled in study|1|||
164248440|NCT01498692|593275416|FG000|Overall Study|Death|4|||
164248441|NCT01498692|593275416|FG000|Overall Study|Withdrawal by Subject|1|||
164248442|NCT01498692|593275416|FG000|Overall Study|Missed 12-month visit|3|||
164248443|NCT04729972|593275417|FG000|Overall Study|Adverse Event|1|||
164248444|NCT05002985|593275418|FG000|Overall Study|Withdrawal by Subject|1|||
164248445|NCT03782259|593275419|FG000|Overall Study|Lost to Follow-up|1|||
164248446|NCT03782259|593275420|FG001|Overall Study|Lost to Follow-up|1|||
164248447|NCT03782259|593275419|FG000|Overall Study|Moved out of state|0|||
164248448|NCT03782259|593275420|FG001|Overall Study|Moved out of state|2|||
164248449|NCT03782259|593275419|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
164248450|NCT03782259|593275420|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
164248451|NCT03782259|593275419|FG000|Overall Study|Subject discontinued intervention|1|||
164248452|NCT03782259|593275420|FG001|Overall Study|Subject discontinued intervention|0|||
164248453|NCT00603941|593275421|FG000|Overall Study|Disease progression|6|||
164248454|NCT00603941|593275422|FG001|Overall Study|Disease progression|7|||
164248455|NCT00603941|593275423|FG002|Overall Study|Disease progression|1|||
164248456|NCT00603941|593275421|FG000|Overall Study|Adverse Event|1|||
164248457|NCT00603941|593275422|FG001|Overall Study|Adverse Event|0|||
164248458|NCT00603941|593275423|FG002|Overall Study|Adverse Event|1|||
164338524|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
163886389|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
163886390|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
163991059|NCT04062214|592335202|FG000|Week 36|Death|0|||
163991060|NCT04062214|592335203|FG001|Week 36|Death|1|||
163991061|NCT00464178|592335206|FG000|Overall Study|Protocol Violation|1|||
163991062|NCT00464178|592335206|FG000|Overall Study|Withdrawal by Subject|1|||
163991063|NCT04506294|592335209|FG000|Overall Study|Lost to Follow-up|70|||
163991064|NCT04506294|592335210|FG001|Overall Study|Lost to Follow-up|20|||
163991065|NCT04506294|592335209|FG000|Overall Study|Withdrawal by Subject|16|||
164248459|NCT00603941|593275421|FG000|Overall Study|Physician Decision|0|||
164248460|NCT00603941|593275422|FG001|Overall Study|Physician Decision|1|||
164248461|NCT00603941|593275423|FG002|Overall Study|Physician Decision|0|||
164248462|NCT00603941|593275421|FG000|Overall Study|Withdrawal by Subject|0|||
164248463|NCT00603941|593275422|FG001|Overall Study|Withdrawal by Subject|2|||
164338525|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
164338526|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
164338527|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
164141146|NCT00106964|592878674|FG002|Overall Study|Incarceration|0|||
164141147|NCT00106964|592878672|FG000|Overall Study|Site Funding Terminated|0|||
164141148|NCT00106964|592878673|FG001|Overall Study|Site Funding Terminated|1|||
164141149|NCT00106964|592878674|FG002|Overall Study|Site Funding Terminated|1|||
164141150|NCT00106964|592878672|FG000|Overall Study|Failure to adhere|2|||
164141151|NCT00106964|592878673|FG001|Overall Study|Failure to adhere|0|||
164141152|NCT00106964|592878674|FG002|Overall Study|Failure to adhere|0|||
164141153|NCT00106964|592878672|FG000|Overall Study|Did not meet eligibility criteria|0|||
164141154|NCT00106964|592878673|FG001|Overall Study|Did not meet eligibility criteria|2|||
164141155|NCT00106964|592878674|FG002|Overall Study|Did not meet eligibility criteria|2|||
164141156|NCT00106964|592878672|FG000|Overall Study|Required disallowed medication|0|||
164141157|NCT00106964|592878673|FG001|Overall Study|Required disallowed medication|1|||
164141158|NCT00106964|592878674|FG002|Overall Study|Required disallowed medication|0|||
164141159|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
164141160|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
164141161|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
164141162|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
164141163|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
164141164|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
164141165|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
164141166|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
164141167|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
164141168|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
164141169|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
164141170|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
164141171|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
164141172|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
164141173|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
164141174|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
164141175|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
164141176|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
164141177|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
164141178|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
164141179|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
164141180|NCT04040192|592878675|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
164141181|NCT04040192|592878676|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
164141182|NCT04040192|592878677|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
164141183|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
164141184|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
164141185|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
164141186|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
164141187|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
164141188|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
164141189|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
164141190|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
164141191|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
164141192|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
164141193|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
164141194|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
164141195|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164141196|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
164141197|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
164141198|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
164141199|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
164141200|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
164141201|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
164141202|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
164141203|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
164141204|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
164141205|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
164141206|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
164141207|NCT04040192|592878675|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
164141208|NCT04040192|592878676|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
164248464|NCT00603941|593275423|FG002|Overall Study|Withdrawal by Subject|0|||
164248465|NCT02707965|593275425|FG000|Overall Study|Withdrawal by Subject|0|||
164248466|NCT02707965|593275426|FG001|Overall Study|Withdrawal by Subject|0|||
164248467|NCT02707965|593275427|FG002|Overall Study|Withdrawal by Subject|1|||
164248468|NCT02707965|593275428|FG003|Overall Study|Withdrawal by Subject|0|||
164248469|NCT02707965|593275429|FG004|Overall Study|Withdrawal by Subject|0|||
164248470|NCT02707965|593275430|FG005|Overall Study|Withdrawal by Subject|0|||
164248471|NCT02707965|593275431|FG006|Overall Study|Withdrawal by Subject|0|||
164248472|NCT02707965|593275432|FG007|Overall Study|Withdrawal by Subject|2|||
164248473|NCT02707965|593275433|FG008|Overall Study|Withdrawal by Subject|0|||
164248474|NCT02707965|593275434|FG009|Overall Study|Withdrawal by Subject|0|||
164248475|NCT02707965|593275435|FG010|Overall Study|Withdrawal by Subject|0|||
164248476|NCT02707965|593275436|FG011|Overall Study|Withdrawal by Subject|0|||
164248477|NCT02707965|593275437|FG012|Overall Study|Withdrawal by Subject|0|||
164248478|NCT02707965|593275438|FG013|Overall Study|Withdrawal by Subject|0|||
164248479|NCT02707965|593275439|FG014|Overall Study|Withdrawal by Subject|0|||
164248480|NCT02707965|593275440|FG015|Overall Study|Withdrawal by Subject|0|||
164248481|NCT02707965|593275425|FG000|Overall Study|PI decisions|0|||
164248482|NCT02707965|593275426|FG001|Overall Study|PI decisions|0|||
164248483|NCT02707965|593275427|FG002|Overall Study|PI decisions|0|||
164248484|NCT02707965|593275428|FG003|Overall Study|PI decisions|0|||
164248485|NCT02707965|593275429|FG004|Overall Study|PI decisions|0|||
164248486|NCT02707965|593275430|FG005|Overall Study|PI decisions|0|||
164248487|NCT02707965|593275431|FG006|Overall Study|PI decisions|0|||
164248488|NCT02707965|593275432|FG007|Overall Study|PI decisions|0|||
164248489|NCT02707965|593275433|FG008|Overall Study|PI decisions|0|||
164248490|NCT02707965|593275434|FG009|Overall Study|PI decisions|0|||
164248491|NCT02707965|593275435|FG010|Overall Study|PI decisions|0|||
164248492|NCT02707965|593275436|FG011|Overall Study|PI decisions|0|||
164248493|NCT02707965|593275437|FG012|Overall Study|PI decisions|0|||
164248494|NCT02707965|593275438|FG013|Overall Study|PI decisions|0|||
164248495|NCT02707965|593275439|FG014|Overall Study|PI decisions|2|||
164248496|NCT02707965|593275440|FG015|Overall Study|PI decisions|0|||
164248497|NCT02707965|593275425|FG000|Overall Study|Protocol deviation|1|||
164248498|NCT02707965|593275426|FG001|Overall Study|Protocol deviation|1|||
164248499|NCT02707965|593275427|FG002|Overall Study|Protocol deviation|0|||
164248500|NCT02707965|593275428|FG003|Overall Study|Protocol deviation|0|||
164248501|NCT02707965|593275429|FG004|Overall Study|Protocol deviation|0|||
164248502|NCT02707965|593275430|FG005|Overall Study|Protocol deviation|0|||
164248503|NCT02707965|593275431|FG006|Overall Study|Protocol deviation|0|||
164248504|NCT02707965|593275432|FG007|Overall Study|Protocol deviation|1|||
164248505|NCT02707965|593275433|FG008|Overall Study|Protocol deviation|0|||
164248506|NCT02707965|593275434|FG009|Overall Study|Protocol deviation|0|||
164248507|NCT02707965|593275435|FG010|Overall Study|Protocol deviation|0|||
164248508|NCT02707965|593275436|FG011|Overall Study|Protocol deviation|0|||
164248509|NCT02707965|593275437|FG012|Overall Study|Protocol deviation|0|||
164248510|NCT02707965|593275438|FG013|Overall Study|Protocol deviation|0|||
164248511|NCT02707965|593275439|FG014|Overall Study|Protocol deviation|0|||
164248512|NCT02707965|593275440|FG015|Overall Study|Protocol deviation|0|||
164248513|NCT00249808|593275441|FG000|Overall Study|Other|27|||
164248514|NCT00249808|593275441|FG000|Overall Study|Protocol Violation|3|||
164248515|NCT00249808|593275441|FG000|Overall Study|Lost to Follow-up|8|||
164248516|NCT00249808|593275441|FG000|Overall Study|Adverse Event|81|||
164248517|NCT00249808|593275441|FG000|Overall Study|Lack of Efficacy|52|||
164248518|NCT00249808|593275441|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
164248519|NCT00711594|593275442|FG000|Overall Study|Progressive disease|2|||
164248520|NCT00711594|593275443|FG001|Overall Study|Progressive disease|2|||
164248521|NCT00711594|593275444|FG002|Overall Study|Progressive disease|6|||
164248522|NCT00711594|593275445|FG003|Overall Study|Progressive disease|44|||
164248523|NCT00711594|593275442|FG000|Overall Study|Other Adverse Event|1|||
164248524|NCT00711594|593275443|FG001|Overall Study|Other Adverse Event|0|||
164248525|NCT00711594|593275444|FG002|Overall Study|Other Adverse Event|0|||
164248526|NCT00711594|593275445|FG003|Overall Study|Other Adverse Event|16|||
164248527|NCT00711594|593275442|FG000|Overall Study|Withdrawal by Subject|0|||
164248528|NCT00711594|593275443|FG001|Overall Study|Withdrawal by Subject|1|||
164248529|NCT00711594|593275444|FG002|Overall Study|Withdrawal by Subject|0|||
164248530|NCT00711594|593275445|FG003|Overall Study|Withdrawal by Subject|2|||
164248531|NCT00485758|593275450|FG000|Overall Study|Adverse Event|102|||
164248532|NCT00485758|593275451|FG001|Overall Study|Adverse Event|31|||
164248533|NCT00485758|593275450|FG000|Overall Study|Death|0|||
164248534|NCT00485758|593275451|FG001|Overall Study|Death|1|||
164248535|NCT00485758|593275450|FG000|Overall Study|Lost to Follow-up|5|||
164248536|NCT00485758|593275451|FG001|Overall Study|Lost to Follow-up|1|||
164248537|NCT00485758|593275450|FG000|Overall Study|Physician Decision|3|||
164248538|NCT00485758|593275451|FG001|Overall Study|Physician Decision|3|||
164248539|NCT00485758|593275450|FG000|Overall Study|Protocol Violation|11|||
164248540|NCT00485758|593275451|FG001|Overall Study|Protocol Violation|2|||
164248541|NCT00485758|593275450|FG000|Overall Study|Withdrawal by Subject|32|||
164248542|NCT00485758|593275451|FG001|Overall Study|Withdrawal by Subject|27|||
164248543|NCT00485758|593275450|FG000|Overall Study|Study Terminated by Sponsor|3|||
164248544|NCT00485758|593275451|FG001|Overall Study|Study Terminated by Sponsor|0|||
164248545|NCT00211172|593275454|FG000|Overall Study|Died or lost health plan eligibility|39|||
164248546|NCT00211172|593275455|FG001|Overall Study|Died or lost health plan eligibility|32|||
164248547|NCT02253433|593275459|FG000|Overall Study|Unable to Contact|9|||
163991066|NCT04506294|592335210|FG001|Overall Study|Withdrawal by Subject|2|||
163991067|NCT01469000|592335216|FG000|Overall Study|Withdrawal by Subject|16|||
163991068|NCT01469000|592335217|FG001|Overall Study|Withdrawal by Subject|3|||
163991069|NCT01469000|592335216|FG000|Overall Study|Sponsor Decision|4|||
163991070|NCT01469000|592335217|FG001|Overall Study|Sponsor Decision|1|||
163991071|NCT00769119|592335220|FG000|Overall Study|Voluntary discontinuation|0|||
163991072|NCT00769119|592335221|FG001|Overall Study|Voluntary discontinuation|2|||
163991073|NCT00769119|592335220|FG000|Overall Study|Adverse Event|1|||
163991074|NCT00769119|592335221|FG001|Overall Study|Adverse Event|1|||
163991075|NCT00769119|592335220|FG000|Overall Study|Disallowed medication|1|||
163991076|NCT00769119|592335221|FG001|Overall Study|Disallowed medication|0|||
163991077|NCT01116544|592335224|FG000|Overall Study|Protocol Violation|1|||
163991078|NCT01116544|592335225|FG001|Overall Study|Protocol Violation|0|||
163991079|NCT01116544|592335224|FG000|Overall Study|Withdrawal by Subject|1|||
163991080|NCT01116544|592335225|FG001|Overall Study|Withdrawal by Subject|1|||
163991081|NCT05168267|592335226|FG000|Overall Study|Withdrawal by Subject|2|||
163991082|NCT05168267|592335227|FG001|Overall Study|Withdrawal by Subject|1|||
163991083|NCT05168267|592335226|FG000|Overall Study|Withdrawn by Therapist|1|||
163991084|NCT05168267|592335227|FG001|Overall Study|Withdrawn by Therapist|1|||
163991085|NCT05168267|592335226|FG000|Overall Study|Left Facility|1|||
163991086|NCT05168267|592335227|FG001|Overall Study|Left Facility|0|||
163991087|NCT02937350|592335228|FG000|Overall Study|Withdrawal by Subject|0|||
164248548|NCT02253433|593275460|FG001|Overall Study|Unable to Contact|16|||
164248549|NCT02253433|593275459|FG000|Overall Study|Death|1|||
164248550|NCT02253433|593275460|FG001|Overall Study|Death|1|||
164248551|NCT02253433|593275459|FG000|Overall Study|No Longer Interested|3|||
163991088|NCT02937350|592335229|FG001|Overall Study|Withdrawal by Subject|1|||
163991089|NCT02937350|592335230|FG002|Overall Study|Withdrawal by Subject|0|||
164248552|NCT02253433|593275460|FG001|Overall Study|No Longer Interested|15|||
164083903|NCT02058628|592672186|FG000|Overall Study|Not in time schedule|0|||
164248553|NCT02253433|593275459|FG000|Overall Study|Out of Study Area|2|||
164248554|NCT02253433|593275460|FG001|Overall Study|Out of Study Area|7|||
163991090|NCT02419508|592335231|FG000|Overall Study|Adverse Event|9|||
163991091|NCT02419508|592335232|FG001|Overall Study|Adverse Event|3|||
163991092|NCT02419508|592335231|FG000|Overall Study|Withdrawal by Subject|1|||
163991093|NCT02419508|592335232|FG001|Overall Study|Withdrawal by Subject|0|||
163991094|NCT02419508|592335231|FG000|Overall Study|Other - Reason not specified|0|||
164248555|NCT02253433|593275459|FG000|Overall Study|Uncomfortable with home visitors|0|||
164248556|NCT02253433|593275460|FG001|Overall Study|Uncomfortable with home visitors|3|||
164248557|NCT02253433|593275459|FG000|Overall Study|Unstable Housing/Homeless|0|||
164248558|NCT02253433|593275460|FG001|Overall Study|Unstable Housing/Homeless|7|||
164248559|NCT02253433|593275459|FG000|Overall Study|Too Busy|0|||
164248560|NCT02253433|593275460|FG001|Overall Study|Too Busy|4|||
164248561|NCT02253433|593275459|FG000|Overall Study|Medical or Other Concerns|1|||
164248562|NCT02253433|593275460|FG001|Overall Study|Medical or Other Concerns|2|||
164248563|NCT04283656|593275462|FG000|Overall Study|Adverse Event|1|||
164248564|NCT04283656|593275463|FG001|Overall Study|Adverse Event|0|||
164248565|NCT04283656|593275462|FG000|Overall Study|Lost to Follow-up|0|||
164248566|NCT04283656|593275463|FG001|Overall Study|Lost to Follow-up|1|||
164248567|NCT00803361|593275464|FG000|Overall Study|Adverse Event|13|||
164248568|NCT00803361|593275465|FG001|Overall Study|Adverse Event|3|||
164248569|NCT00803361|593275464|FG000|Overall Study|Lack of Efficacy|4|||
164248570|NCT00803361|593275465|FG001|Overall Study|Lack of Efficacy|13|||
164248571|NCT00803361|593275464|FG000|Overall Study|Lost to Follow-up|1|||
164248572|NCT00803361|593275465|FG001|Overall Study|Lost to Follow-up|2|||
164248573|NCT00803361|593275464|FG000|Overall Study|Physician Decision|1|||
164248574|NCT00803361|593275465|FG001|Overall Study|Physician Decision|0|||
164248575|NCT00803361|593275464|FG000|Overall Study|Protocol Violation|2|||
164248576|NCT00803361|593275465|FG001|Overall Study|Protocol Violation|4|||
164248577|NCT00803361|593275464|FG000|Overall Study|Withdrawal by Subject|5|||
164248578|NCT00803361|593275465|FG001|Overall Study|Withdrawal by Subject|6|||
164248579|NCT04445519|593275466|FG000|Overall Study|Due to adaptive design|3|||
164248580|NCT04445519|593275467|FG001|Overall Study|Due to adaptive design|0|||
164248581|NCT04445519|593275468|FG002|Overall Study|Due to adaptive design|0|||
164248582|NCT04445519|593275466|FG000|Overall Study|Lost to Follow-up|0|||
164248583|NCT04445519|593275467|FG001|Overall Study|Lost to Follow-up|1|||
164248584|NCT04445519|593275468|FG002|Overall Study|Lost to Follow-up|4|||
164248585|NCT04445519|593275466|FG000|Overall Study|Sponsor or IRB Decision|0|||
164248586|NCT04445519|593275467|FG001|Overall Study|Sponsor or IRB Decision|1|||
164248587|NCT04445519|593275468|FG002|Overall Study|Sponsor or IRB Decision|2|||
164248588|NCT04445519|593275466|FG000|Overall Study|Withdrawal by Subject|0|||
164248589|NCT04445519|593275467|FG001|Overall Study|Withdrawal by Subject|3|||
164248590|NCT04445519|593275468|FG002|Overall Study|Withdrawal by Subject|3|||
164248591|NCT04445519|593275466|FG000|Overall Study|Adverse Event|0|||
164248592|NCT04445519|593275467|FG001|Overall Study|Adverse Event|8|||
164248593|NCT04445519|593275468|FG002|Overall Study|Adverse Event|6|||
164248594|NCT04445519|593275466|FG000|Overall Study|Other Reason|0|||
164248595|NCT04445519|593275467|FG001|Overall Study|Other Reason|1|||
164248596|NCT04445519|593275468|FG002|Overall Study|Other Reason|1|||
163991095|NCT02419508|592335232|FG001|Overall Study|Other - Reason not specified|1|||
163991096|NCT01891643|592337045|FG000|Overall Study|Adverse event unrelated to study drug|2|||
163991097|NCT01891643|592337046|FG001|Overall Study|Adverse event unrelated to study drug|5|||
163991098|NCT01891643|592337045|FG000|Overall Study|Disease Progression|4|||
163991099|NCT01891643|592337046|FG001|Overall Study|Disease Progression|3|||
163991100|NCT01891643|592337045|FG000|Overall Study|Study Drug Toxicity|3|||
164248597|NCT04445519|593275466|FG000|Overall Study|Protocol Violation|0|||
164248598|NCT04445519|593275467|FG001|Overall Study|Protocol Violation|0|||
164248599|NCT04445519|593275468|FG002|Overall Study|Protocol Violation|1|||
164248600|NCT03782064|593275469|FG000|Overall Study|Lack of Efficacy|2|||
164338528|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
164338529|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338530|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338531|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338532|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338533|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163991101|NCT01891643|592337046|FG001|Overall Study|Study Drug Toxicity|0|||
164248601|NCT03782064|593275469|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
164338534|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338535|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164248602|NCT02446769|593275474|FG000|Screening Period|Screen Failure|11|||
164248603|NCT02446769|593275475|FG001|Screening Period|Screen Failure|0|||
164248604|NCT02446769|593275476|FG002|Screening Period|Screen Failure|0|||
164248605|NCT02446769|593275474|FG000|Study Period|Randomized in Error|0|||
164338536|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
163991102|NCT01891643|592337045|FG000|Overall Study|Maximum Clinical Benefit|0|||
163991103|NCT01891643|592337046|FG001|Overall Study|Maximum Clinical Benefit|1|||
163991104|NCT01891643|592337045|FG000|Overall Study|Poor/Non-compliance|0|||
163991105|NCT01891643|592337046|FG001|Overall Study|Poor/Non-compliance|1|||
163991106|NCT01891643|592337045|FG000|Overall Study|Participant request to discontinue|1|||
163991107|NCT01891643|592337046|FG001|Overall Study|Participant request to discontinue|0|||
163991108|NCT04047797|592337054|FG000|Overall Study|Progressive Disease|1|||
163991109|NCT01430442|592337055|FG000|Overall Study|Subject Withdrew Consent|3|||
163991110|NCT01430442|592337056|FG001|Overall Study|Subject Withdrew Consent|0|||
163991111|NCT01430442|592337057|FG002|Overall Study|Subject Withdrew Consent|1|||
163991112|NCT01430442|592337058|FG003|Overall Study|Subject Withdrew Consent|0|||
163991113|NCT01430442|592337059|FG004|Overall Study|Subject Withdrew Consent|2|||
163991114|NCT01430442|592337060|FG005|Overall Study|Subject Withdrew Consent|1|||
163991115|NCT01430442|592337061|FG006|Overall Study|Subject Withdrew Consent|5|||
163991116|NCT01430442|592337062|FG007|Overall Study|Subject Withdrew Consent|2|||
163991117|NCT01430442|592337055|FG000|Overall Study|Lost to Follow-up|2|||
163991118|NCT01430442|592337056|FG001|Overall Study|Lost to Follow-up|0|||
163991119|NCT01430442|592337057|FG002|Overall Study|Lost to Follow-up|1|||
163991120|NCT01430442|592337058|FG003|Overall Study|Lost to Follow-up|2|||
164248606|NCT02446769|593275475|FG001|Study Period|Randomized in Error|2|||
164248607|NCT02446769|593275476|FG002|Study Period|Randomized in Error|0|||
164248608|NCT04482439|593275477|FG000|Overall Study|Lost to Follow-up|1|||
164248609|NCT04482439|593275477|FG000|Overall Study|Unrelated illness|1|||
164248610|NCT03072043|593275480|FG000|Overall Study|Death|0|||
164248611|NCT03072043|593275481|FG001|Overall Study|Death|0|||
164248612|NCT03072043|593275482|FG002|Overall Study|Death|3|||
164248613|NCT03072043|593275480|FG000|Overall Study|Adverse Event|0|||
164248614|NCT03072043|593275481|FG001|Overall Study|Adverse Event|0|||
164248615|NCT03072043|593275482|FG002|Overall Study|Adverse Event|2|||
164248616|NCT03072043|593275480|FG000|Overall Study|Withdrawal by Subject|0|||
164248617|NCT03072043|593275481|FG001|Overall Study|Withdrawal by Subject|0|||
164248618|NCT03072043|593275482|FG002|Overall Study|Withdrawal by Subject|4|||
164248619|NCT00645840|593275483|FG000|Overall Study|Protocol Violation|3|||
164248620|NCT01823198|593275484|FG000|Overall Study|Physician Decision|0|||
164248621|NCT01823198|593275485|FG001|Overall Study|Physician Decision|1|||
163991121|NCT01430442|592337059|FG004|Overall Study|Lost to Follow-up|2|||
163991122|NCT01430442|592337060|FG005|Overall Study|Lost to Follow-up|1|||
164248622|NCT01823198|593275486|FG002|Overall Study|Physician Decision|0|||
164248623|NCT01823198|593275487|FG003|Overall Study|Physician Decision|0|||
164248624|NCT01823198|593275488|FG004|Overall Study|Physician Decision|0|||
164248625|NCT01823198|593275489|FG005|Overall Study|Physician Decision|3|||
164248626|NCT01823198|593275490|FG006|Overall Study|Physician Decision|3|||
164248627|NCT04677543|593275491|FG000|Overall Study|Withdrawal by Subject|4|||
164248628|NCT04677543|593275492|FG001|Overall Study|Withdrawal by Subject|1|||
164248629|NCT04677543|593275491|FG000|Overall Study|Physician Decision|0|||
164248630|NCT04677543|593275492|FG001|Overall Study|Physician Decision|1|||
164248631|NCT04677543|593275491|FG000|Overall Study|Adverse Event|0|||
164248632|NCT04677543|593275492|FG001|Overall Study|Adverse Event|1|||
164248633|NCT02342288|593275494|FG000|Overall Study|no protocol anesthesiologist available|3|||
164248634|NCT02342288|593275495|FG001|Overall Study|no protocol anesthesiologist available|2|||
164248635|NCT02342288|593275494|FG000|Overall Study|anesthesia leak in system|1|||
164248636|NCT02342288|593275495|FG001|Overall Study|anesthesia leak in system|0|||
164248637|NCT02342288|593275494|FG000|Overall Study|Withdrawal by Subject|1|||
164248638|NCT02342288|593275495|FG001|Overall Study|Withdrawal by Subject|0|||
164248639|NCT02342288|593275494|FG000|Overall Study|coordinator contaminated with blood|0|||
164248640|NCT02342288|593275495|FG001|Overall Study|coordinator contaminated with blood|1|||
164248641|NCT02342288|593275494|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
164248642|NCT02342288|593275495|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
164248643|NCT02342288|593275494|FG000|Overall Study|coordinator not available|0|||
164248644|NCT02342288|593275495|FG001|Overall Study|coordinator not available|2|||
163991123|NCT01430442|592337061|FG006|Overall Study|Lost to Follow-up|5|||
163991124|NCT01430442|592337062|FG007|Overall Study|Lost to Follow-up|1|||
163991125|NCT01430442|592337055|FG000|Overall Study|Pregnancy|1|||
163991126|NCT01430442|592337056|FG001|Overall Study|Pregnancy|0|||
163991127|NCT01430442|592337057|FG002|Overall Study|Pregnancy|0|||
164248645|NCT04188834|593275497|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
164248646|NCT00553436|593275498|FG000|Overall Study|Conversion to another procedure|1|||
164248647|NCT02455336|593275499|FG000|Overall Study|Withdrawal by Subject|0|||
164248648|NCT02455336|593275500|FG001|Overall Study|Withdrawal by Subject|2|||
164248649|NCT02455336|593275499|FG000|Overall Study|Adverse Event|3|||
164248650|NCT02455336|593275500|FG001|Overall Study|Adverse Event|0|||
164248651|NCT02455336|593275499|FG000|Overall Study|Non-responder to treatment|2|||
164248652|NCT02455336|593275500|FG001|Overall Study|Non-responder to treatment|0|||
163991128|NCT01430442|592337058|FG003|Overall Study|Pregnancy|0|||
163991129|NCT01430442|592337059|FG004|Overall Study|Pregnancy|0|||
163991130|NCT01430442|592337060|FG005|Overall Study|Pregnancy|1|||
163991131|NCT01430442|592337061|FG006|Overall Study|Pregnancy|0|||
163991132|NCT01430442|592337062|FG007|Overall Study|Pregnancy|0|||
164248653|NCT00391430|593275501|FG000|Overall Study|Withdrawal by Subject|3|||
164248654|NCT00391430|593275502|FG001|Overall Study|Withdrawal by Subject|0|||
163991133|NCT01430442|592337055|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
163991134|NCT01430442|592337056|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
164248655|NCT00391430|593275503|FG002|Overall Study|Withdrawal by Subject|12|||
164248656|NCT00577707|593275506|FG000|Overall Study|Withdrawal by Subject|3|||
164248657|NCT03299244|593275507|FG000|Overall Study|Withdrawal by Subject|34|||
164248658|NCT03299244|593275508|FG001|Overall Study|Withdrawal by Subject|29|||
164248659|NCT03299244|593275507|FG000|Overall Study|Decision by Sponsor|4|||
164248660|NCT03299244|593275508|FG001|Overall Study|Decision by Sponsor|5|||
164248661|NCT03299244|593275507|FG000|Overall Study|Death|9|||
164248662|NCT03299244|593275508|FG001|Overall Study|Death|4|||
164248663|NCT03706430|593275519|FG000|Overall Study|No A-Line placed|5|||
164248664|NCT03706430|593275519|FG000|Overall Study|Subject had gel nail polish|1|||
164248665|NCT03706430|593275519|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
164248666|NCT03706430|593275519|FG000|Overall Study|Cancelled Case|6|||
164248667|NCT03706430|593275519|FG000|Overall Study|Physician Decision|2|||
164248668|NCT01928433|593275520|FG000|Overall Study|Adverse Event|5|||
164248669|NCT01928433|593275521|FG001|Overall Study|Adverse Event|2|||
164248670|NCT01928433|593275522|FG002|Overall Study|Adverse Event|5|||
164248671|NCT01928433|593275520|FG000|Overall Study|Protocol Violation|0|||
164248672|NCT01928433|593275521|FG001|Overall Study|Protocol Violation|0|||
164248673|NCT01928433|593275522|FG002|Overall Study|Protocol Violation|2|||
164248674|NCT01928433|593275520|FG000|Overall Study|Lack of Efficacy|5|||
164248675|NCT01928433|593275521|FG001|Overall Study|Lack of Efficacy|4|||
164248676|NCT01928433|593275522|FG002|Overall Study|Lack of Efficacy|4|||
164248677|NCT01928433|593275520|FG000|Overall Study|Withdrawal by Subject|0|||
164248678|NCT01928433|593275521|FG001|Overall Study|Withdrawal by Subject|4|||
164248679|NCT01928433|593275522|FG002|Overall Study|Withdrawal by Subject|0|||
164248680|NCT01928433|593275520|FG000|Overall Study|Negative screening urine culture|7|||
164248681|NCT01928433|593275521|FG001|Overall Study|Negative screening urine culture|6|||
164248682|NCT01928433|593275522|FG002|Overall Study|Negative screening urine culture|10|||
164248683|NCT01928433|593275520|FG000|Overall Study|Lost to Follow-up|0|||
164248684|NCT01928433|593275521|FG001|Overall Study|Lost to Follow-up|2|||
164248685|NCT01928433|593275522|FG002|Overall Study|Lost to Follow-up|3|||
164248686|NCT01928433|593275520|FG000|Overall Study|Other reasons|3|||
164248687|NCT01928433|593275521|FG001|Overall Study|Other reasons|3|||
164248688|NCT01928433|593275522|FG002|Overall Study|Other reasons|4|||
164248689|NCT00145626|593275523|FG000|Overall Study|Did not have NK infusions|2|||
164248690|NCT00145626|593275523|FG000|Overall Study|Turned 2 years old before treatment|1|||
164248691|NCT00145626|593275523|FG000|Overall Study|Death|1|||
164248692|NCT00145626|593275523|FG000|Overall Study|Withdrawal by Subject|1|||
164248693|NCT03381287|593275525|FG000|Overall Study|Withdrawal by Subject|0|||
164248694|NCT03381287|593275526|FG001|Overall Study|Withdrawal by Subject|1|||
164248695|NCT03381287|593275527|FG002|Overall Study|Withdrawal by Subject|0|||
164248696|NCT03381287|593275528|FG003|Overall Study|Withdrawal by Subject|0|||
164338537|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
164338538|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
164338539|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
163886391|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
163886392|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
163886393|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
163886394|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
163886395|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
163886396|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
163886397|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
163886398|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
163886399|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
164141419|NCT04630158|592878739|FG002|Overall Study|Physician Decision|0|||
164141420|NCT04630158|592878737|FG000|Overall Study|Protocol Violation|1|||
164141421|NCT04630158|592878738|FG001|Overall Study|Protocol Violation|0|||
164141422|NCT04630158|592878739|FG002|Overall Study|Protocol Violation|1|||
164141423|NCT04630158|592878737|FG000|Overall Study|Withdrawal by Subject|2|||
164141424|NCT04630158|592878738|FG001|Overall Study|Withdrawal by Subject|1|||
164141425|NCT04630158|592878739|FG002|Overall Study|Withdrawal by Subject|2|||
164141426|NCT03136965|592878742|FG000|Overall Study|Lost to Follow-up|0|||
164141427|NCT03136965|592878743|FG001|Overall Study|Lost to Follow-up|1|||
164141428|NCT03136965|592878744|FG002|Overall Study|Lost to Follow-up|0|||
164141429|NCT01210612|592878747|FG000|Overall Study|Withdrawal by Subject|0|||
164141430|NCT01210612|592878748|FG001|Overall Study|Withdrawal by Subject|2|||
164141431|NCT02752087|592878749|FG000|Washout|Physician Decision|1|||
164141432|NCT02752087|592878750|FG001|Washout|Physician Decision|0|||
164141433|NCT00843635|592878751|FG000|Overall Study|Adverse Event|2|||
164141434|NCT00843635|592878752|FG001|Overall Study|Adverse Event|2|||
164141435|NCT00843635|592878753|FG002|Overall Study|Adverse Event|0|||
164141436|NCT05819203|592878758|FG000|Overall Study|Protocol Violation|1|||
164141437|NCT05819203|592878759|FG001|Overall Study|Protocol Violation|2|||
164141438|NCT05819203|592878758|FG000|Overall Study|Withdrawal by Subject|1|||
164141439|NCT05819203|592878759|FG001|Overall Study|Withdrawal by Subject|0|||
164248697|NCT03381287|593275525|FG000|Overall Study|Adverse Event|0|||
164248698|NCT03381287|593275526|FG001|Overall Study|Adverse Event|0|||
164248699|NCT03381287|593275527|FG002|Overall Study|Adverse Event|0|||
164248700|NCT03381287|593275528|FG003|Overall Study|Adverse Event|1|||
164248701|NCT03381287|593275525|FG000|Overall Study|Physician Decision|0|||
164248702|NCT03381287|593275526|FG001|Overall Study|Physician Decision|0|||
164248703|NCT03381287|593275527|FG002|Overall Study|Physician Decision|0|||
164248704|NCT03381287|593275528|FG003|Overall Study|Physician Decision|1|||
164248705|NCT02709720|593275529|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
163991135|NCT01430442|592337057|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
164248706|NCT02709720|593275529|FG000|Overall Study|Protocol Violation|1|||
164248707|NCT02709720|593275529|FG000|Overall Study|Not take study medication|1|||
164248708|NCT01198574|593275531|FG000|Overall Study|Resigned from schools|4|||
164248709|NCT01198574|593275532|FG001|Overall Study|Resigned from schools|1|||
164248710|NCT01198574|593275533|FG002|Overall Study|Resigned from schools|1|||
164248711|NCT01198574|593275534|FG003|Overall Study|Resigned from schools|4|||
164248712|NCT04439539|593277662|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
164248713|NCT04439539|593277663|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
164248714|NCT04439539|593277664|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
163886400|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163886401|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163886402|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163886403|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163991136|NCT01430442|592337058|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
163991137|NCT01430442|592337059|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
164083904|NCT02058628|592672187|FG001|Overall Study|Not in time schedule|1|||
164083905|NCT02058628|592672186|FG000|Overall Study|The visit date was not in timeline|0|||
164083906|NCT02058628|592672187|FG001|Overall Study|The visit date was not in timeline|1|||
164083907|NCT02058628|592672186|FG000|Overall Study|A lot of time for study for participant|1|||
164083908|NCT02058628|592672187|FG001|Overall Study|A lot of time for study for participant|0|||
164083909|NCT02058628|592672186|FG000|Overall Study|Non compliance|1|||
164083910|NCT02058628|592672187|FG001|Overall Study|Non compliance|0|||
164083911|NCT00832078|592672188|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
164083912|NCT00832078|592672189|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
164083913|NCT00832078|592672188|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
164083914|NCT00832078|592672189|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
164083915|NCT02961920|592672190|FG000|Overall Study|did not achive stydy protocol schedule|1|||
164083916|NCT02961920|592672191|FG001|Overall Study|did not achive stydy protocol schedule|1|||
164083917|NCT01452529|592672194|FG000|Run-in Period|Adverse Event|96|||
163991138|NCT01430442|592337060|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
163991139|NCT01430442|592337061|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
163991140|NCT01430442|592337062|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
163991141|NCT00772629|592337064|FG000|Overall Study|Subject was not vaccinated|1|||
163991142|NCT00772629|592337065|FG001|Overall Study|Subject was not vaccinated|0|||
163991143|NCT00132041|592337072|FG000|Baseline|Ineligible|6|||
163991144|NCT00132041|592337072|FG000|3 Months Post Ablation|Transplant|1|||
163991145|NCT00132041|592337072|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
163991146|NCT00132041|592337072|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
163991147|NCT00132041|592337072|FG000|6 Months Post Ablation|Death|2|||
163991148|NCT00132041|592337072|FG000|6 Months Post Ablation|Transplant|6|||
163991149|NCT00132041|592337072|FG000|9 Months Post Ablation|Death|1|||
163991150|NCT00132041|592337072|FG000|9 Months Post Ablation|Transplant|1|||
163991151|NCT00132041|592337072|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
163991152|NCT00132041|592337072|FG000|12 Months Post Ablation|Death|1|||
163991153|NCT00132041|592337072|FG000|12 Months Post Ablation|Transplant|1|||
163991154|NCT00132041|592337072|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
164083918|NCT01452529|592672195|FG001|Run-in Period|Adverse Event|0|||
164248715|NCT04439539|593277662|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
163886404|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
163886405|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
164083919|NCT01452529|592672196|FG002|Run-in Period|Adverse Event|0|||
164083920|NCT01452529|592672194|FG000|Run-in Period|Withdrawal by Subject|49|||
164083921|NCT01452529|592672195|FG001|Run-in Period|Withdrawal by Subject|0|||
164248716|NCT04439539|593277663|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
164248717|NCT04439539|593277664|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
163886406|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
163886407|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
163991155|NCT00132041|592337072|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
163991156|NCT00132041|592337072|FG000|15 Months Post Ablation|Death|1|||
163991157|NCT00132041|592337072|FG000|15 Months Post Ablation|Transplant|5|||
164083922|NCT01452529|592672196|FG002|Run-in Period|Withdrawal by Subject|0|||
164083923|NCT01452529|592672194|FG000|Run-in Period|Lost to Follow-up|19|||
164083924|NCT01452529|592672195|FG001|Run-in Period|Lost to Follow-up|0|||
164083925|NCT01452529|592672196|FG002|Run-in Period|Lost to Follow-up|0|||
164083926|NCT01452529|592672194|FG000|Run-in Period|Lack of Efficacy|46|||
164083927|NCT01452529|592672195|FG001|Run-in Period|Lack of Efficacy|0|||
164083928|NCT01452529|592672196|FG002|Run-in Period|Lack of Efficacy|0|||
164083929|NCT01452529|592672194|FG000|Run-in Period|Confirmed or suspected diversion|23|||
164083930|NCT01452529|592672195|FG001|Run-in Period|Confirmed or suspected diversion|0|||
164083931|NCT01452529|592672196|FG002|Run-in Period|Confirmed or suspected diversion|0|||
164083932|NCT01452529|592672194|FG000|Run-in Period|Administrative|21|||
164083933|NCT01452529|592672195|FG001|Run-in Period|Administrative|0|||
164083934|NCT01452529|592672196|FG002|Run-in Period|Administrative|0|||
164083935|NCT01452529|592672194|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
164083936|NCT01452529|592672195|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
164083937|NCT01452529|592672196|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
164083938|NCT01452529|592672194|FG000|Double-blind (DB) Period|Adverse Event|0|||
164083939|NCT01452529|592672195|FG001|Double-blind (DB) Period|Adverse Event|18|||
164083940|NCT01452529|592672196|FG002|Double-blind (DB) Period|Adverse Event|11|||
164083941|NCT01452529|592672194|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
164083942|NCT01452529|592672195|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
164083943|NCT01452529|592672196|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
164083944|NCT01452529|592672194|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
164083945|NCT01452529|592672195|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
164083946|NCT01452529|592672196|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
164083947|NCT01452529|592672194|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
164083948|NCT01452529|592672195|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
164083949|NCT01452529|592672196|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
164083950|NCT01452529|592672194|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
164083951|NCT01452529|592672195|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
164083952|NCT01452529|592672196|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
164083953|NCT01452529|592672194|FG000|Double-blind (DB) Period|Administrative|0|||
164083954|NCT01452529|592672195|FG001|Double-blind (DB) Period|Administrative|11|||
164083955|NCT01452529|592672196|FG002|Double-blind (DB) Period|Administrative|7|||
164083956|NCT03551730|592672197|FG000|Overall Study|Adverse Event|1|||
164083957|NCT03551730|592672198|FG001|Overall Study|Adverse Event|0|||
164083958|NCT03551730|592672199|FG002|Overall Study|Adverse Event|0|||
164083959|NCT03551730|592672200|FG003|Overall Study|Adverse Event|0|||
164083960|NCT03347695|592672207|FG000|Overall Study|Death|0|||
164083961|NCT03347695|592672208|FG001|Overall Study|Death|4|||
164083962|NCT03347695|592672207|FG000|Overall Study|Lost to Follow-up|0|||
164083963|NCT03347695|592672208|FG001|Overall Study|Lost to Follow-up|1|||
164083964|NCT00671879|592672211|FG000|Overall Study|Withdrawal by Subject|0|||
164083965|NCT00671879|592672212|FG001|Overall Study|Withdrawal by Subject|4|||
164083966|NCT00671879|592672213|FG002|Overall Study|Withdrawal by Subject|6|||
164083967|NCT04633837|592672214|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
164083968|NCT04633837|592672215|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
164083969|NCT04527471|592672218|FG000|Overall Study|Adverse Event|1|||
164083970|NCT04527471|592672219|FG001|Overall Study|Adverse Event|0|||
164083971|NCT04527471|592672218|FG000|Overall Study|Lost to Follow-up|1|||
164083972|NCT04527471|592672219|FG001|Overall Study|Lost to Follow-up|0|||
164083973|NCT02884206|592672228|FG000|Valsartan Run-in Period|Death|1|||
164083974|NCT02884206|592672229|FG001|Valsartan Run-in Period|Death|0|||
164083975|NCT02884206|592672230|FG002|Valsartan Run-in Period|Death|0|||
164083976|NCT02884206|592672228|FG000|Valsartan Run-in Period|Adverse Event|31|||
164083977|NCT02884206|592672229|FG001|Valsartan Run-in Period|Adverse Event|0|||
164083978|NCT02884206|592672230|FG002|Valsartan Run-in Period|Adverse Event|0|||
164083979|NCT02884206|592672228|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
164083980|NCT02884206|592672229|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
164083981|NCT02884206|592672230|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
164083982|NCT02884206|592672228|FG000|Valsartan Run-in Period|Protocol deviation|4|||
164083983|NCT02884206|592672229|FG001|Valsartan Run-in Period|Protocol deviation|0|||
164083984|NCT02884206|592672230|FG002|Valsartan Run-in Period|Protocol deviation|0|||
164083985|NCT02884206|592672228|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
164083986|NCT02884206|592672229|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
164083987|NCT02884206|592672230|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
164083988|NCT02884206|592672228|FG000|Valsartan Run-in Period|Physician Decision|1|||
164083989|NCT02884206|592672229|FG001|Valsartan Run-in Period|Physician Decision|0|||
164083990|NCT02884206|592672230|FG002|Valsartan Run-in Period|Physician Decision|0|||
164083991|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Adverse Event|38|||
164083992|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Adverse Event|0|||
164083993|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Adverse Event|0|||
164083994|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Death|2|||
164083995|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Death|0|||
164083996|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Death|0|||
164083997|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
164141715|NCT01762800|592880714|FG000|Overall Study|Lack of Efficacy|3|||
163991158|NCT00132041|592337072|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
163991159|NCT00132041|592337072|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
163991160|NCT00132041|592337072|FG000|18 Months Post Ablation|Transplant|1|||
163991161|NCT00132041|592337072|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
163991162|NCT00132041|592337072|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
163991163|NCT01171820|592337073|FG000|Overall Study|Death|3|||
163991164|NCT01171820|592337074|FG001|Overall Study|Death|3|||
163991165|NCT01171820|592337073|FG000|Overall Study|Lost to Follow-up|0|||
163991166|NCT01171820|592337074|FG001|Overall Study|Lost to Follow-up|1|||
163991167|NCT01171820|592337073|FG000|Overall Study|Withdrawal by Subject|2|||
163991168|NCT01171820|592337074|FG001|Overall Study|Withdrawal by Subject|0|||
163991169|NCT01171820|592337073|FG000|Overall Study|Physician Decision|0|||
163991170|NCT01171820|592337074|FG001|Overall Study|Physician Decision|1|||
163991171|NCT01171820|592337073|FG000|Overall Study|1-Year Missed Visit|1|||
163991172|NCT01171820|592337074|FG001|Overall Study|1-Year Missed Visit|1|||
163991173|NCT03969875|592337075|FG000|Overall Study|did not receive allocated intervention|3|||
163991174|NCT03969875|592337076|FG001|Overall Study|did not receive allocated intervention|3|||
163991175|NCT03969875|592337077|FG002|Overall Study|did not receive allocated intervention|4|||
163991176|NCT03969875|592337075|FG000|Overall Study|Protocol Violation|4|||
163991177|NCT03969875|592337076|FG001|Overall Study|Protocol Violation|2|||
163991178|NCT03969875|592337077|FG002|Overall Study|Protocol Violation|2|||
163991179|NCT00167245|592337078|FG000|Overall Study|Lost to Follow-up|20|||
163991180|NCT00167245|592337079|FG001|Overall Study|Lost to Follow-up|31|||
163991181|NCT00167245|592337078|FG000|Overall Study|Withdrawal by Subject|5|||
163991182|NCT00167245|592337079|FG001|Overall Study|Withdrawal by Subject|8|||
163991183|NCT00167245|592337078|FG000|Overall Study|Incarcerated|3|||
163991184|NCT00167245|592337079|FG001|Overall Study|Incarcerated|2|||
163991185|NCT00167245|592337078|FG000|Overall Study|Drowsy|1|||
163991186|NCT00167245|592337079|FG001|Overall Study|Drowsy|0|||
163991187|NCT01871090|592337080|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
163991188|NCT01871090|592337081|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
163991189|NCT01871090|592337080|FG000|Overall Study|Interrogation not completed correctly|1|||
163991190|NCT01871090|592337081|FG001|Overall Study|Interrogation not completed correctly|0|||
163991191|NCT01871090|592337080|FG000|Overall Study|Subject Non-Compliance|0|||
163991192|NCT01871090|592337081|FG001|Overall Study|Subject Non-Compliance|1|||
163991193|NCT02911688|592337087|FG000|Washout|Lost to Follow-up|1|||
163991194|NCT02911688|592337088|FG001|Washout|Lost to Follow-up|1|||
163991195|NCT02911688|592337087|FG000|Washout|Withdrawal by Subject|0|||
163991196|NCT02911688|592337088|FG001|Washout|Withdrawal by Subject|1|||
163991197|NCT01307033|592337089|FG000|8-week Double-blind Period|Adverse Event|2|||
163991198|NCT01307033|592337090|FG001|8-week Double-blind Period|Adverse Event|0|||
163991199|NCT01307033|592337091|FG002|8-week Double-blind Period|Adverse Event|0|||
163991200|NCT01307033|592337092|FG003|8-week Double-blind Period|Adverse Event|0|||
163991201|NCT01307033|592337089|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
163991202|NCT01307033|592337090|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
163991203|NCT01307033|592337091|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
163991204|NCT01307033|592337092|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
163991205|NCT01307033|592337089|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
163991206|NCT01307033|592337090|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
163991207|NCT01307033|592337091|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
163991208|NCT01307033|592337092|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
163991209|NCT01307033|592337089|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
163991210|NCT01307033|592337090|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
163991211|NCT01307033|592337091|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
163991212|NCT01307033|592337092|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
163991213|NCT01307033|592337089|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
163991214|NCT01307033|592337090|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
163991215|NCT01307033|592337091|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
163991216|NCT01307033|592337092|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
163991217|NCT01307033|592337089|FG000|44-week Open-label Extension|Adverse Event|0|||
163991218|NCT01307033|592337090|FG001|44-week Open-label Extension|Adverse Event|0|||
163991219|NCT01307033|592337091|FG002|44-week Open-label Extension|Adverse Event|2|||
163991220|NCT01307033|592337092|FG003|44-week Open-label Extension|Adverse Event|1|||
163991221|NCT01307033|592337089|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
163991222|NCT01307033|592337090|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
163991223|NCT01307033|592337091|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
163991224|NCT01307033|592337092|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
163991225|NCT01307033|592337089|FG000|44-week Open-label Extension|Physician Decision|0|||
163991226|NCT01307033|592337090|FG001|44-week Open-label Extension|Physician Decision|0|||
164083998|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
164083999|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
164084000|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
163991227|NCT01307033|592337091|FG002|44-week Open-label Extension|Physician Decision|1|||
163991228|NCT01307033|592337092|FG003|44-week Open-label Extension|Physician Decision|0|||
163991229|NCT01307033|592337089|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
163991230|NCT01307033|592337090|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
163991231|NCT01307033|592337091|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
163991232|NCT01307033|592337092|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
163991233|NCT01307033|592337089|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
163991234|NCT01307033|592337090|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
163991235|NCT01307033|592337091|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
163991236|NCT01307033|592337092|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
163991237|NCT01307033|592337089|FG000|44-week Open-label Extension|Death|0|||
163991238|NCT01307033|592337090|FG001|44-week Open-label Extension|Death|0|||
163991239|NCT01307033|592337091|FG002|44-week Open-label Extension|Death|0|||
163991240|NCT01307033|592337092|FG003|44-week Open-label Extension|Death|1|||
163991241|NCT01793792|592337097|FG000|Overall Study|Death|5|||
163991242|NCT01793792|592337097|FG000|Overall Study|Lost to Follow-up|5|||
163991243|NCT01793792|592337097|FG000|Overall Study|Withdrawal by Subject|1|||
163991244|NCT01793792|592337097|FG000|Overall Study|Device Not Implanted|1|||
163991245|NCT01773421|592337098|FG000|Treatment Phase|Other|0|||
163991246|NCT01773421|592337099|FG001|Treatment Phase|Other|0|||
163991247|NCT01773421|592337100|FG002|Treatment Phase|Other|2|||
163991248|NCT01773421|592337101|FG003|Treatment Phase|Other|0|||
163991249|NCT01773421|592337102|FG004|Treatment Phase|Other|0|||
163991250|NCT01773421|592337103|FG005|Treatment Phase|Other|0|||
163991251|NCT01773421|592337104|FG006|Treatment Phase|Other|0|||
163991252|NCT01773421|592337098|FG000|Treatment Phase|Adverse Event|0|||
163991253|NCT01773421|592337099|FG001|Treatment Phase|Adverse Event|0|||
163991254|NCT01773421|592337100|FG002|Treatment Phase|Adverse Event|3|||
163991255|NCT01773421|592337101|FG003|Treatment Phase|Adverse Event|1|||
163991256|NCT01773421|592337102|FG004|Treatment Phase|Adverse Event|0|||
163991257|NCT01773421|592337103|FG005|Treatment Phase|Adverse Event|0|||
163991258|NCT01773421|592337104|FG006|Treatment Phase|Adverse Event|0|||
163991259|NCT01773421|592337098|FG000|Treatment Phase|Withdrawal by Subject|0|||
163991260|NCT01773421|592337099|FG001|Treatment Phase|Withdrawal by Subject|0|||
163991261|NCT01773421|592337100|FG002|Treatment Phase|Withdrawal by Subject|1|||
163991262|NCT01773421|592337101|FG003|Treatment Phase|Withdrawal by Subject|1|||
163991263|NCT01773421|592337102|FG004|Treatment Phase|Withdrawal by Subject|0|||
163991264|NCT01773421|592337103|FG005|Treatment Phase|Withdrawal by Subject|0|||
163991265|NCT01773421|592337104|FG006|Treatment Phase|Withdrawal by Subject|0|||
163991266|NCT01773421|592337098|FG000|Extension Phase|Other|0|||
163991267|NCT01773421|592337099|FG001|Extension Phase|Other|0|||
163991268|NCT01773421|592337100|FG002|Extension Phase|Other|0|||
163991269|NCT01773421|592337101|FG003|Extension Phase|Other|0|||
163991270|NCT01773421|592337102|FG004|Extension Phase|Other|1|||
163991271|NCT01773421|592337103|FG005|Extension Phase|Other|2|||
163991272|NCT01773421|592337104|FG006|Extension Phase|Other|0|||
163991273|NCT01773421|592337098|FG000|Extension Phase|Adverse Event|0|||
163991274|NCT01773421|592337099|FG001|Extension Phase|Adverse Event|0|||
163991275|NCT01773421|592337100|FG002|Extension Phase|Adverse Event|0|||
163991276|NCT01773421|592337101|FG003|Extension Phase|Adverse Event|0|||
163991277|NCT01773421|592337102|FG004|Extension Phase|Adverse Event|2|||
163991278|NCT01773421|592337103|FG005|Extension Phase|Adverse Event|0|||
163991279|NCT01773421|592337104|FG006|Extension Phase|Adverse Event|0|||
163991280|NCT02804763|592337105|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
163991281|NCT02804763|592337106|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
163991282|NCT02804763|592337107|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
163991283|NCT02804763|592337108|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
163991284|NCT02804763|592337105|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
163991285|NCT02804763|592337106|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
163991286|NCT02804763|592337107|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
163991287|NCT02804763|592337108|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
164338540|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163991288|NCT02804763|592337105|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
163991289|NCT02804763|592337106|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
163991290|NCT02804763|592337107|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
163991291|NCT02804763|592337108|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
163991292|NCT02804763|592337105|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
163991293|NCT02804763|592337106|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
163991294|NCT02804763|592337107|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
164084001|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
164084002|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
164084003|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
164338541|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
163991295|NCT02804763|592337108|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
164248718|NCT04439539|593277662|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
164248719|NCT04439539|593277663|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
164248720|NCT04439539|593277664|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
164248721|NCT02013778|593277665|FG000|Overall Study|Death|4|||
164248722|NCT02013778|593277665|FG000|Overall Study|Withdrawal by Subject|1|||
164248723|NCT02013778|593277665|FG000|Overall Study|Physician Decision|1|||
164248724|NCT02013778|593277665|FG000|Overall Study|Adverse Event|1|||
164248725|NCT02719691|593277666|FG000|Overall Study|Physician Decision|0|||
164248726|NCT02719691|593277667|FG001|Overall Study|Physician Decision|0|||
164248727|NCT02719691|593277668|FG002|Overall Study|Physician Decision|1|||
164248728|NCT02719691|593277669|FG003|Overall Study|Physician Decision|0|||
164248729|NCT02719691|593277670|FG004|Overall Study|Physician Decision|0|||
164248730|NCT02719691|593277671|FG005|Overall Study|Physician Decision|0|||
164248731|NCT02719691|593277672|FG006|Overall Study|Physician Decision|0|||
164248732|NCT02719691|593277666|FG000|Overall Study|Withdrawal by Subject|0|||
164248733|NCT02719691|593277667|FG001|Overall Study|Withdrawal by Subject|0|||
164248734|NCT02719691|593277668|FG002|Overall Study|Withdrawal by Subject|0|||
164248735|NCT02719691|593277669|FG003|Overall Study|Withdrawal by Subject|0|||
164248736|NCT02719691|593277670|FG004|Overall Study|Withdrawal by Subject|0|||
164248737|NCT02719691|593277671|FG005|Overall Study|Withdrawal by Subject|1|||
164248738|NCT02719691|593277672|FG006|Overall Study|Withdrawal by Subject|0|||
164248739|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
164248740|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
164248741|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
164248742|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
164248743|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
164248744|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
164248745|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
164248746|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
164248747|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
164248748|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
164248749|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
164248750|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
164248751|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
164248752|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
164248753|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
164248754|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
164248755|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
164248756|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
163991296|NCT02804763|592337105|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
163991297|NCT02804763|592337106|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
163991298|NCT02804763|592337107|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
163991299|NCT02804763|592337108|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
163991300|NCT02804763|592337105|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
163991301|NCT02804763|592337106|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
163991302|NCT02804763|592337107|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
163991303|NCT02804763|592337108|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
163991304|NCT00860158|592337115|FG000|Overall Study|Study Terminated|1|||
163991305|NCT00282243|592337116|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
163991306|NCT00282243|592337116|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
163991307|NCT00282243|592337116|FG000|Extension Treatment Period|Adverse Event|15|||
163991308|NCT00282243|592337116|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
163991309|NCT00282243|592337116|FG000|Extension Treatment Period|Non-compliance|2|||
163991310|NCT00282243|592337116|FG000|Extension Treatment Period|Physician Decision|1|||
163991311|NCT00851903|592337117|FG000|Overall Study|Withdrawal by Subject|2|||
163991312|NCT00270894|592337118|FG000|Overall Study|Adverse Event|1|||
163991313|NCT00270894|592337118|FG000|Overall Study|Withdrawal by Subject|1|||
163991314|NCT01070329|592337119|FG000|Overall Study|Adverse Event|13|||
163991315|NCT01070329|592337120|FG001|Overall Study|Adverse Event|10|||
163991316|NCT01070329|592337119|FG000|Overall Study|Lost to Follow-up|22|||
163991317|NCT01070329|592337120|FG001|Overall Study|Lost to Follow-up|12|||
163991318|NCT01070329|592337119|FG000|Overall Study|Withdrawal by Subject|9|||
164248757|NCT03308968|593277673|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
163991319|NCT01070329|592337120|FG001|Overall Study|Withdrawal by Subject|11|||
164248758|NCT03308968|593277674|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
164248759|NCT03308968|593277675|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
164248760|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
164248761|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
164248762|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
164248763|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
163991320|NCT01070329|592337119|FG000|Overall Study|Protocol Violation|3|||
163991321|NCT01070329|592337120|FG001|Overall Study|Protocol Violation|8|||
163991322|NCT01070329|592337119|FG000|Overall Study|Lack of Efficacy|2|||
163991323|NCT01070329|592337120|FG001|Overall Study|Lack of Efficacy|6|||
163991324|NCT01070329|592337119|FG000|Overall Study|Physician Decision|2|||
163991325|NCT01070329|592337120|FG001|Overall Study|Physician Decision|1|||
163991326|NCT01070329|592337119|FG000|Overall Study|Entry Criteria Not Met|1|||
163991327|NCT01070329|592337120|FG001|Overall Study|Entry Criteria Not Met|0|||
163991328|NCT01070329|592337119|FG000|Overall Study|Sponsor Decision|0|||
163991329|NCT01070329|592337120|FG001|Overall Study|Sponsor Decision|1|||
163991330|NCT02863848|592337121|FG000|Overall Study|Lost to Follow-up|1|||
163991331|NCT02863848|592337122|FG001|Overall Study|Lost to Follow-up|1|||
163991332|NCT02863848|592337121|FG000|Overall Study|Protocol Violation|1|||
163991333|NCT02863848|592337122|FG001|Overall Study|Protocol Violation|2|||
163991334|NCT02487108|592337130|FG000|Overall Study|Adverse Event|1|||
163991335|NCT02487108|592337131|FG001|Overall Study|Adverse Event|6|||
163991336|NCT02487108|592337132|FG002|Overall Study|Adverse Event|12|||
163991337|NCT02487108|592337133|FG003|Overall Study|Adverse Event|6|||
163991338|NCT02487108|592337130|FG000|Overall Study|Withdrawal by Subject|8|||
163991339|NCT02487108|592337131|FG001|Overall Study|Withdrawal by Subject|5|||
163991340|NCT02487108|592337132|FG002|Overall Study|Withdrawal by Subject|5|||
163991341|NCT02487108|592337133|FG003|Overall Study|Withdrawal by Subject|0|||
163991342|NCT02487108|592337130|FG000|Overall Study|Non-compliance to study medication|3|||
163991343|NCT02487108|592337131|FG001|Overall Study|Non-compliance to study medication|2|||
163991344|NCT02487108|592337132|FG002|Overall Study|Non-compliance to study medication|5|||
163991345|NCT02487108|592337133|FG003|Overall Study|Non-compliance to study medication|4|||
163991346|NCT02487108|592337130|FG000|Overall Study|Protocol Violation|1|||
163991347|NCT02487108|592337131|FG001|Overall Study|Protocol Violation|1|||
163991348|NCT02487108|592337132|FG002|Overall Study|Protocol Violation|2|||
163991349|NCT02487108|592337133|FG003|Overall Study|Protocol Violation|0|||
164084004|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
164248764|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
164248765|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
164248766|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
164248767|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
164248768|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
164248769|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
164248770|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
164248771|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
164248772|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
164248773|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
164248774|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
164248775|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
164248776|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
164248777|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
164248778|NCT03308968|593277673|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
164248779|NCT03308968|593277674|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
164248780|NCT03308968|593277675|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
164248781|NCT01521923|593277681|FG000|Overall Study|AE, serious fatal|1|||
163991350|NCT02487108|592337130|FG000|Overall Study|Non-compliance to study procedures|0|||
163991351|NCT02487108|592337131|FG001|Overall Study|Non-compliance to study procedures|0|||
163991352|NCT02487108|592337132|FG002|Overall Study|Non-compliance to study procedures|0|||
163991353|NCT02487108|592337133|FG003|Overall Study|Non-compliance to study procedures|1|||
163991354|NCT02487108|592337130|FG000|Overall Study|Other than specified|3|||
163991355|NCT02487108|592337131|FG001|Overall Study|Other than specified|2|||
163991356|NCT02487108|592337132|FG002|Overall Study|Other than specified|2|||
163991357|NCT02487108|592337133|FG003|Overall Study|Other than specified|0|||
163991358|NCT00469612|592337134|FG000|Overall Study|Study terminated before data collected|2|||
163991359|NCT00469612|592337135|FG001|Overall Study|Study terminated before data collected|0|||
163991360|NCT00883493|592337136|FG000|Overall Study|Adverse Event|11|||
163991361|NCT00883493|592337137|FG001|Overall Study|Adverse Event|12|||
163991362|NCT00883493|592337136|FG000|Overall Study|Lack of Efficacy|4|||
163991363|NCT00883493|592337137|FG001|Overall Study|Lack of Efficacy|3|||
163991364|NCT00883493|592337136|FG000|Overall Study|Lost to Follow-up|7|||
163991365|NCT00883493|592337137|FG001|Overall Study|Lost to Follow-up|6|||
163991366|NCT00883493|592337136|FG000|Overall Study|Withdrawal by Subject|11|||
163991367|NCT00883493|592337137|FG001|Overall Study|Withdrawal by Subject|20|||
163991368|NCT00883493|592337136|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
164248782|NCT01521923|593277682|FG001|Overall Study|AE, serious fatal|0|||
163991369|NCT00883493|592337137|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
163991370|NCT00883493|592337136|FG000|Overall Study|Study specific disc. criteria|2|||
163991371|NCT00883493|592337137|FG001|Overall Study|Study specific disc. criteria|0|||
163991372|NCT00883493|592337136|FG000|Overall Study|Other|5|||
163991373|NCT00883493|592337137|FG001|Overall Study|Other|3|||
164248783|NCT01521923|593277683|FG002|Overall Study|AE, serious fatal|0|||
164248784|NCT01521923|593277684|FG003|Overall Study|AE, serious fatal|0|||
164248785|NCT01521923|593277681|FG000|Overall Study|SAE, non-fatal|0|||
164248786|NCT01521923|593277682|FG001|Overall Study|SAE, non-fatal|2|||
164248787|NCT01521923|593277683|FG002|Overall Study|SAE, non-fatal|2|||
164248788|NCT01521923|593277684|FG003|Overall Study|SAE, non-fatal|0|||
164248789|NCT01521923|593277681|FG000|Overall Study|AE, non-serious, non-fatal|1|||
164248790|NCT01521923|593277682|FG001|Overall Study|AE, non-serious, non-fatal|3|||
164248791|NCT01521923|593277683|FG002|Overall Study|AE, non-serious, non-fatal|6|||
164248792|NCT01521923|593277684|FG003|Overall Study|AE, non-serious, non-fatal|2|||
164248793|NCT01521923|593277681|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
164248794|NCT01521923|593277682|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
164248795|NCT01521923|593277683|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
164248796|NCT01521923|593277684|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
164248797|NCT01521923|593277681|FG000|Overall Study|Lack of Efficacy|1|||
164248798|NCT01521923|593277682|FG001|Overall Study|Lack of Efficacy|1|||
164248799|NCT01521923|593277683|FG002|Overall Study|Lack of Efficacy|0|||
164248800|NCT01521923|593277684|FG003|Overall Study|Lack of Efficacy|0|||
164248801|NCT01521923|593277681|FG000|Overall Study|Protocol Violation|0|||
164248802|NCT01521923|593277682|FG001|Overall Study|Protocol Violation|0|||
164248803|NCT01521923|593277683|FG002|Overall Study|Protocol Violation|1|||
164248804|NCT01521923|593277684|FG003|Overall Study|Protocol Violation|0|||
164248805|NCT01521923|593277681|FG000|Overall Study|Lost to Follow-up|1|||
164248806|NCT01521923|593277682|FG001|Overall Study|Lost to Follow-up|0|||
164248807|NCT01521923|593277683|FG002|Overall Study|Lost to Follow-up|2|||
164248808|NCT01521923|593277684|FG003|Overall Study|Lost to Follow-up|1|||
164248809|NCT01521923|593277681|FG000|Overall Study|Withdrawal by Subject|1|||
164248810|NCT01521923|593277682|FG001|Overall Study|Withdrawal by Subject|1|||
164248811|NCT01521923|593277683|FG002|Overall Study|Withdrawal by Subject|1|||
164248812|NCT01521923|593277684|FG003|Overall Study|Withdrawal by Subject|2|||
164248813|NCT01521923|593277681|FG000|Overall Study|Other|2|||
164248814|NCT01521923|593277682|FG001|Overall Study|Other|1|||
164248815|NCT01521923|593277683|FG002|Overall Study|Other|3|||
164248816|NCT01521923|593277684|FG003|Overall Study|Other|6|||
164248817|NCT01521923|593277681|FG000|Overall Study|AE, captured in Period 1|0|||
164248818|NCT01521923|593277682|FG001|Overall Study|AE, captured in Period 1|1|||
164248819|NCT01521923|593277683|FG002|Overall Study|AE, captured in Period 1|0|||
164248820|NCT01521923|593277684|FG003|Overall Study|AE, captured in Period 1|1|||
163886408|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163886409|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
164248821|NCT03037476|593277685|FG000|Overall Study|Lost to Follow-up|63|||
164248822|NCT03037476|593277686|FG001|Overall Study|Lost to Follow-up|46|||
164248823|NCT02403817|593277687|FG000|Overall Study|Withdrawal by Subject|5|||
164248824|NCT02403817|593277688|FG001|Overall Study|Withdrawal by Subject|0|||
164248825|NCT01208324|593277694|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
164248826|NCT01208324|593277695|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
164248827|NCT01208324|593277696|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
164248828|NCT01208324|593277697|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
164248829|NCT04556591|593277700|FG000|Overall Study|Lost to Follow-up|1|||
164248830|NCT04556591|593277701|FG001|Overall Study|Lost to Follow-up|0|||
164248831|NCT04556591|593277700|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
164248832|NCT04556591|593277701|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
164248833|NCT00984165|593277702|FG000|Overall Study|Death on study|2|||
164248834|NCT00984165|593277703|FG001|Overall Study|Death on study|0|||
164248835|NCT00984165|593277704|FG002|Overall Study|Death on study|0|||
164248836|NCT00984165|593277705|FG003|Overall Study|Death on study|0|||
164248837|NCT00984165|593277702|FG000|Overall Study|Disease progression on study|5|||
164248838|NCT00984165|593277703|FG001|Overall Study|Disease progression on study|1|||
163886410|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163886411|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163886412|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163886413|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
163886414|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
164248839|NCT00984165|593277704|FG002|Overall Study|Disease progression on study|0|||
164248840|NCT00984165|593277705|FG003|Overall Study|Disease progression on study|0|||
164248841|NCT00984165|593277702|FG000|Overall Study|Death of recipient|0|||
164248842|NCT00984165|593277703|FG001|Overall Study|Death of recipient|0|||
164248843|NCT00984165|593277704|FG002|Overall Study|Death of recipient|0|||
164248844|NCT00984165|593277705|FG003|Overall Study|Death of recipient|1|||
164248845|NCT00984165|593277702|FG000|Overall Study|New protocol|0|||
164248846|NCT00984165|593277703|FG001|Overall Study|New protocol|0|||
164248847|NCT00984165|593277704|FG002|Overall Study|New protocol|0|||
164248848|NCT00984165|593277705|FG003|Overall Study|New protocol|1|||
164248849|NCT00984165|593277702|FG000|Overall Study|P+/donor pair removed from protocol|0|||
164248850|NCT00984165|593277703|FG001|Overall Study|P+/donor pair removed from protocol|0|||
164248851|NCT00984165|593277704|FG002|Overall Study|P+/donor pair removed from protocol|0|||
164248852|NCT00984165|593277705|FG003|Overall Study|P+/donor pair removed from protocol|1|||
164248853|NCT00984165|593277702|FG000|Overall Study|removed with a pair recipient|0|||
164248854|NCT00984165|593277703|FG001|Overall Study|removed with a pair recipient|0|||
164248855|NCT00984165|593277704|FG002|Overall Study|removed with a pair recipient|0|||
164248856|NCT00984165|593277705|FG003|Overall Study|removed with a pair recipient|1|||
164248857|NCT00135330|593277707|FG000|Overall Study|Adverse Event|2|||
164248858|NCT00135330|593277708|FG001|Overall Study|Adverse Event|5|||
164248859|NCT00135330|593277709|FG002|Overall Study|Adverse Event|1|||
164248860|NCT00135330|593277707|FG000|Overall Study|Lost to Follow-up|0|||
164248861|NCT00135330|593277708|FG001|Overall Study|Lost to Follow-up|2|||
164248862|NCT00135330|593277709|FG002|Overall Study|Lost to Follow-up|3|||
164248863|NCT00135330|593277707|FG000|Overall Study|Physician Decision|1|||
164248864|NCT00135330|593277708|FG001|Overall Study|Physician Decision|1|||
164248865|NCT00135330|593277709|FG002|Overall Study|Physician Decision|0|||
164248866|NCT00135330|593277707|FG000|Overall Study|Protocol Violation|4|||
164248867|NCT00135330|593277708|FG001|Overall Study|Protocol Violation|3|||
164248868|NCT00135330|593277709|FG002|Overall Study|Protocol Violation|3|||
164248869|NCT00135330|593277707|FG000|Overall Study|Patient Decision|5|||
164248870|NCT00135330|593277708|FG001|Overall Study|Patient Decision|1|||
164248871|NCT00135330|593277709|FG002|Overall Study|Patient Decision|4|||
164248872|NCT00135330|593277707|FG000|Overall Study|Sponsor Decision|0|||
164248873|NCT00135330|593277708|FG001|Overall Study|Sponsor Decision|1|||
164248874|NCT00135330|593277709|FG002|Overall Study|Sponsor Decision|0|||
164248875|NCT02229825|593277715|FG000|Overall Study|Personal Reasons|0|||
164248876|NCT02229825|593277716|FG001|Overall Study|Personal Reasons|1|||
164248877|NCT02229825|593277715|FG000|Overall Study|Refused continuing medication|7|||
164248878|NCT02229825|593277716|FG001|Overall Study|Refused continuing medication|6|||
164248879|NCT02229825|593277715|FG000|Overall Study|Lost to Follow-up|1|||
164248880|NCT02229825|593277716|FG001|Overall Study|Lost to Follow-up|2|||
164248881|NCT02229825|593277715|FG000|Overall Study|Protocol Violation|1|||
164248882|NCT02229825|593277716|FG001|Overall Study|Protocol Violation|1|||
164248883|NCT02229825|593277715|FG000|Overall Study|Lack of Efficacy|4|||
164248884|NCT02229825|593277716|FG001|Overall Study|Lack of Efficacy|10|||
164248885|NCT02229825|593277715|FG000|Overall Study|Adverse Event|11|||
164338542|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338543|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338544|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338545|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338546|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338547|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338548|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338549|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
164338550|NCT02925117|593615199|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
164338551|NCT02925117|593615200|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
164338552|NCT02925117|593615201|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
164338553|NCT02925117|593615202|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
164338554|NCT02925117|593615203|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
164338555|NCT02925117|593615204|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
164338556|NCT02925117|593615205|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
164338557|NCT02925117|593615206|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
164338558|NCT02925117|593615207|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
164338559|NCT02925117|593615208|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
164338560|NCT02925117|593615209|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
164338561|NCT02925117|593615210|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
164338562|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338563|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
163991374|NCT01622569|592337138|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
163991375|NCT01622569|592337139|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
163991376|NCT01622569|592337140|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
163991377|NCT01622569|592337141|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
163991378|NCT01622569|592337138|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
164248886|NCT02229825|593277716|FG001|Overall Study|Adverse Event|9|||
164248887|NCT02229825|593277715|FG000|Overall Study|Not treated|0|||
164248888|NCT02229825|593277716|FG001|Overall Study|Not treated|1|||
164248889|NCT01309997|593277717|FG000|Overall Study|Adverse Event|1|||
164248890|NCT01309997|593277718|FG001|Overall Study|Adverse Event|0|||
164248891|NCT01309997|593277717|FG000|Overall Study|Death|1|||
164248892|NCT01309997|593277718|FG001|Overall Study|Death|3|||
164248893|NCT01309997|593277717|FG000|Overall Study|Lack of Efficacy|2|||
164338564|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338565|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338566|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338567|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
164338568|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164248894|NCT01309997|593277718|FG001|Overall Study|Lack of Efficacy|2|||
164248895|NCT01309997|593277717|FG000|Overall Study|Withdrawal by Subject|1|||
164248896|NCT01309997|593277718|FG001|Overall Study|Withdrawal by Subject|1|||
163886415|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
163886416|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
163886417|NCT01369355|591956437|FG000|Long-term Extension (Week 44-272)|Other|0|||
163886418|NCT01369355|591956438|FG001|Long-term Extension (Week 44-272)|Other|0|||
163886419|NCT01369355|591956439|FG002|Long-term Extension (Week 44-272)|Other|0|||
163886420|NCT01369355|591956440|FG003|Long-term Extension (Week 44-272)|Other|0|||
163886421|NCT01369355|591956441|FG004|Long-term Extension (Week 44-272)|Other|0|||
163886422|NCT01369355|591956442|FG005|Long-term Extension (Week 44-272)|Other|0|||
163886423|NCT01369355|591956443|FG006|Long-term Extension (Week 44-272)|Other|110|||
163886424|NCT01369355|591956444|FG007|Long-term Extension (Week 44-272)|Other|9|||
163886425|NCT01369355|591956445|FG008|Long-term Extension (Week 44-272)|Other|17|||
163886426|NCT02319759|591956446|FG000|Week 0 - 16|Lack of Efficacy|1|||
163886427|NCT02319759|591956447|FG001|Week 0 - 16|Lack of Efficacy|0|||
163886428|NCT02319759|591956448|FG002|Week 0 - 16|Lack of Efficacy|0|||
163886429|NCT02319759|591956449|FG003|Week 0 - 16|Lack of Efficacy|0|||
163886430|NCT02319759|591956450|FG004|Week 0 - 16|Lack of Efficacy|0|||
163886431|NCT02319759|591956446|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
163886432|NCT02319759|591956447|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
163886433|NCT02319759|591956448|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
163886434|NCT02319759|591956449|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
163886435|NCT02319759|591956450|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
163886436|NCT02319759|591956446|FG000|Week 16 - 24|Lack of Efficacy|1|||
163886437|NCT02319759|591956447|FG001|Week 16 - 24|Lack of Efficacy|0|||
163886438|NCT02319759|591956448|FG002|Week 16 - 24|Lack of Efficacy|1|||
163886439|NCT02319759|591956449|FG003|Week 16 - 24|Lack of Efficacy|0|||
163886440|NCT02319759|591956450|FG004|Week 16 - 24|Lack of Efficacy|0|||
163886441|NCT02319759|591956446|FG000|Week 16 - 24|Lost to Follow-up|1|||
163886442|NCT02319759|591956447|FG001|Week 16 - 24|Lost to Follow-up|0|||
163886443|NCT02319759|591956448|FG002|Week 16 - 24|Lost to Follow-up|0|||
163886444|NCT02319759|591956449|FG003|Week 16 - 24|Lost to Follow-up|0|||
163886445|NCT02319759|591956450|FG004|Week 16 - 24|Lost to Follow-up|0|||
163886446|NCT02319759|591956446|FG000|Week 16 - 24|Withdrawal by Subject|0|||
163886447|NCT02319759|591956447|FG001|Week 16 - 24|Withdrawal by Subject|0|||
163886448|NCT02319759|591956448|FG002|Week 16 - 24|Withdrawal by Subject|2|||
163886449|NCT02319759|591956449|FG003|Week 16 - 24|Withdrawal by Subject|0|||
163886450|NCT02319759|591956450|FG004|Week 16 - 24|Withdrawal by Subject|0|||
163886451|NCT02319759|591956446|FG000|Week 24 - 56|Adverse Event|0|||
163886452|NCT02319759|591956447|FG001|Week 24 - 56|Adverse Event|0|||
163886453|NCT02319759|591956448|FG002|Week 24 - 56|Adverse Event|2|||
163886454|NCT02319759|591956449|FG003|Week 24 - 56|Adverse Event|0|||
163886455|NCT02319759|591956450|FG004|Week 24 - 56|Adverse Event|0|||
163886456|NCT02319759|591956446|FG000|Week 24 - 56|Lack of Efficacy|0|||
163886457|NCT02319759|591956447|FG001|Week 24 - 56|Lack of Efficacy|0|||
163886458|NCT02319759|591956448|FG002|Week 24 - 56|Lack of Efficacy|0|||
163886459|NCT02319759|591956449|FG003|Week 24 - 56|Lack of Efficacy|2|||
163886460|NCT02319759|591956450|FG004|Week 24 - 56|Lack of Efficacy|1|||
163886461|NCT02319759|591956446|FG000|Week 24 - 56|Withdrawal by Subject|0|||
163886462|NCT02319759|591956447|FG001|Week 24 - 56|Withdrawal by Subject|1|||
163886463|NCT02319759|591956448|FG002|Week 24 - 56|Withdrawal by Subject|0|||
163886464|NCT02319759|591956449|FG003|Week 24 - 56|Withdrawal by Subject|0|||
163886465|NCT02319759|591956450|FG004|Week 24 - 56|Withdrawal by Subject|0|||
163886466|NCT02319759|591956446|FG000|Week 24 - 56|Lost to Follow-up|0|||
163886467|NCT02319759|591956447|FG001|Week 24 - 56|Lost to Follow-up|0|||
163886468|NCT02319759|591956448|FG002|Week 24 - 56|Lost to Follow-up|0|||
163886469|NCT02319759|591956449|FG003|Week 24 - 56|Lost to Follow-up|0|||
163886470|NCT02319759|591956450|FG004|Week 24 - 56|Lost to Follow-up|1|||
163886471|NCT06424236|591956455|FG000|Overall Study|Adverse Event|0|||
163886472|NCT06424236|591956456|FG001|Overall Study|Adverse Event|1|||
163886473|NCT06424236|591956457|FG002|Overall Study|Adverse Event|0|||
163886474|NCT06424236|591956455|FG000|Overall Study|Withdrawal by Subject|3|||
163886475|NCT06424236|591956456|FG001|Overall Study|Withdrawal by Subject|1|||
163886476|NCT06424236|591956457|FG002|Overall Study|Withdrawal by Subject|2|||
163886477|NCT06424236|591956455|FG000|Overall Study|Physician Decision|0|||
163886478|NCT06424236|591956456|FG001|Overall Study|Physician Decision|1|||
163886479|NCT06424236|591956457|FG002|Overall Study|Physician Decision|0|||
163886480|NCT06424236|591956455|FG000|Overall Study|Study Terminated by Sponsor|11|||
163886481|NCT06424236|591956456|FG001|Overall Study|Study Terminated by Sponsor|20|||
163886482|NCT06424236|591956457|FG002|Overall Study|Study Terminated by Sponsor|16|||
163886483|NCT06424236|591956455|FG000|Overall Study|Lost to Follow-up|0|||
163886484|NCT06424236|591956456|FG001|Overall Study|Lost to Follow-up|1|||
163886485|NCT06424236|591956457|FG002|Overall Study|Lost to Follow-up|0|||
163886486|NCT06424236|591956455|FG000|Overall Study|Disease Progression|0|||
163886487|NCT06424236|591956456|FG001|Overall Study|Disease Progression|1|||
163886488|NCT06424236|591956457|FG002|Overall Study|Disease Progression|2|||
163886489|NCT06424236|591956455|FG000|Overall Study|Other|0|||
163886490|NCT06424236|591956456|FG001|Overall Study|Other|0|||
164084005|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
164084006|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Physician Decision|1|||
164084007|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Physician Decision|0|||
164248897|NCT04474197|593277719|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
164248898|NCT04474197|593277720|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
164248899|NCT04474197|593277721|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
164248900|NCT04474197|593277722|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
164248901|NCT01532921|593277723|FG000|Overall Study|Death|3|||
164248902|NCT01532921|593277723|FG000|Overall Study|Withdrawal by Subject|2|||
164248903|NCT01532921|593277723|FG000|Overall Study|Lost to Follow-up|3|||
164248904|NCT01532921|593277723|FG000|Overall Study|Physician Decision|7|||
164248905|NCT01532921|593277723|FG000|Overall Study|Device was explanted during procedure|1|||
164248906|NCT02526212|593277724|FG000|Overall Study|Incarceration|1|||
164248907|NCT02526212|593277725|FG001|Overall Study|Incarceration|0|||
164248908|NCT02526212|593277724|FG000|Overall Study|Lost to Follow-up|1|||
164248909|NCT02526212|593277725|FG001|Overall Study|Lost to Follow-up|0|||
164248910|NCT02526212|593277724|FG000|Overall Study|Death|0|||
164248911|NCT02526212|593277725|FG001|Overall Study|Death|1|||
164248912|NCT00588237|593277729|FG000|Overall Study|Evaluable for toxicity only|3|||
164248913|NCT00588237|593277729|FG000|Overall Study|Patien not treated|1|||
164248914|NCT01390298|593277730|FG000|Overall Study|Death|1|||
164248915|NCT01390298|593277730|FG000|Overall Study|long term ICU admission|1|||
164248916|NCT01390298|593277730|FG000|Overall Study|Withdrawal by Subject|14|||
164248917|NCT01390298|593277730|FG000|Overall Study|Lost to Follow-up|7|||
164248918|NCT01390298|593277730|FG000|Overall Study|Surgery cancelled|1|||
164248919|NCT02443337|593277734|FG000|Overall Study|Adverse Event|0|||
164248920|NCT02443337|593277735|FG001|Overall Study|Adverse Event|1|||
164248921|NCT02443337|593277734|FG000|Overall Study|Clinical Progressive Disease|3|||
164248922|NCT02443337|593277735|FG001|Overall Study|Clinical Progressive Disease|0|||
164248923|NCT02443337|593277734|FG000|Overall Study|Withdrawal by Subject|2|||
164248924|NCT02443337|593277735|FG001|Overall Study|Withdrawal by Subject|1|||
164248925|NCT02096952|593277742|FG000|Overall Study|Adverse Event|1|||
163886491|NCT06424236|591956457|FG002|Overall Study|Other|1|||
163886492|NCT03339713|591956459|FG000|Overall Study|Lost to Follow-up|2|||
164084008|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Physician Decision|0|||
164084009|NCT02884206|592672228|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
164084010|NCT02884206|592672229|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
163886493|NCT03339713|591956460|FG001|Overall Study|Lost to Follow-up|1|||
163886494|NCT03339713|591956459|FG000|Overall Study|Protocol Violation|1|||
163886495|NCT03339713|591956460|FG001|Overall Study|Protocol Violation|0|||
163886496|NCT03339713|591956459|FG000|Overall Study|Withdrawal by Subject|1|||
163886497|NCT03339713|591956460|FG001|Overall Study|Withdrawal by Subject|1|||
163886498|NCT01959425|591956461|FG000|Overall Study|Withdrawal by Subject|5|||
163886499|NCT01959425|591956462|FG001|Overall Study|Withdrawal by Subject|4|||
163886500|NCT01959425|591956461|FG000|Overall Study|Lost to Follow-up|1|||
163886501|NCT01959425|591956462|FG001|Overall Study|Lost to Follow-up|0|||
163886502|NCT01959425|591956461|FG000|Overall Study|Discontinued Subjects|6|||
163886503|NCT01959425|591956462|FG001|Overall Study|Discontinued Subjects|4|||
163886504|NCT01987895|591956466|FG000|Overall Study|Withdrawal by Subject|12|||
163886505|NCT01987895|591956467|FG001|Overall Study|Withdrawal by Subject|7|||
163886506|NCT01987895|591956466|FG000|Overall Study|Physician Decision|8|||
164141716|NCT01762800|592880715|FG001|Overall Study|Lack of Efficacy|2|||
163886507|NCT01987895|591956467|FG001|Overall Study|Physician Decision|10|||
163886508|NCT01987895|591956466|FG000|Overall Study|Death|7|||
164141717|NCT01762800|592880714|FG000|Overall Study|Study Closed/Terminated|0|||
164141718|NCT01762800|592880715|FG001|Overall Study|Study Closed/Terminated|1|||
164141719|NCT01762800|592880714|FG000|Overall Study|Physician Decision|1|||
164141720|NCT01762800|592880715|FG001|Overall Study|Physician Decision|1|||
164141721|NCT01762800|592880714|FG000|Overall Study|Withdrawal by Subject|7|||
164141722|NCT01762800|592880715|FG001|Overall Study|Withdrawal by Subject|4|||
164141723|NCT00517881|592880716|FG000|Overall Study|Protocol Violation|2|||
164141724|NCT00517881|592880716|FG000|Overall Study|Adverse Event|1|||
164141725|NCT00517881|592880716|FG000|Overall Study|Renal transplantation|2|||
164141726|NCT01207583|592880717|FG000|Overall Study|Withdrawal by Subject|0|||
164141727|NCT01207583|592880718|FG001|Overall Study|Withdrawal by Subject|3|||
164141728|NCT01207583|592880719|FG002|Overall Study|Withdrawal by Subject|1|||
164141729|NCT01207583|592880717|FG000|Overall Study|Participant failed to return|1|||
164141730|NCT01207583|592880718|FG001|Overall Study|Participant failed to return|0|||
164141731|NCT01207583|592880719|FG002|Overall Study|Participant failed to return|0|||
164141732|NCT01207583|592880717|FG000|Overall Study|Lost to Follow-up|0|||
164141733|NCT01207583|592880718|FG001|Overall Study|Lost to Follow-up|2|||
164141734|NCT01207583|592880719|FG002|Overall Study|Lost to Follow-up|0|||
164141735|NCT01433549|592880721|FG000|Phase 2: Second Study Product|Adverse Event|0|||
164141736|NCT01433549|592880722|FG001|Phase 2: Second Study Product|Adverse Event|1|||
164141737|NCT05384171|592880723|FG000|Overall Study|Lost to Follow-up|9|||
164141738|NCT05384171|592880724|FG001|Overall Study|Lost to Follow-up|9|||
164248926|NCT03520920|593277743|FG000|Overall Study|Death|13|||
164248927|NCT03520920|593277744|FG001|Overall Study|Death|1|||
164248928|NCT03520920|593277745|FG002|Overall Study|Death|0|||
164248929|NCT03520920|593277743|FG000|Overall Study|Withdrawal by Subject|2|||
164248930|NCT03520920|593277744|FG001|Overall Study|Withdrawal by Subject|1|||
164248931|NCT03520920|593277745|FG002|Overall Study|Withdrawal by Subject|0|||
164248932|NCT03520920|593277743|FG000|Overall Study|Study Terminated by the Sponsor|5|||
164248933|NCT03520920|593277744|FG001|Overall Study|Study Terminated by the Sponsor|14|||
164248934|NCT03520920|593277745|FG002|Overall Study|Study Terminated by the Sponsor|5|||
164248935|NCT00372619|593277748|FG000|Overall Study|Ineligible|0|||
164248936|NCT00372619|593277749|FG001|Overall Study|Ineligible|0|||
164248937|NCT00372619|593277750|FG002|Overall Study|Ineligible|0|||
164248938|NCT00372619|593277751|FG003|Overall Study|Ineligible|0|||
164248939|NCT00372619|593277752|FG004|Overall Study|Ineligible|0|||
164248940|NCT00372619|593277753|FG005|Overall Study|Ineligible|2|||
164248941|NCT00372619|593277754|FG006|Overall Study|Ineligible|0|||
164248942|NCT00372619|593277748|FG000|Overall Study|Inevaluable|0|||
164248943|NCT00372619|593277749|FG001|Overall Study|Inevaluable|0|||
164248944|NCT00372619|593277750|FG002|Overall Study|Inevaluable|0|||
164248945|NCT00372619|593277751|FG003|Overall Study|Inevaluable|0|||
164248946|NCT00372619|593277752|FG004|Overall Study|Inevaluable|0|||
164248947|NCT00372619|593277753|FG005|Overall Study|Inevaluable|1|||
164248948|NCT00372619|593277754|FG006|Overall Study|Inevaluable|0|||
164248949|NCT00066222|593277755|FG000|Overall Study|No protocol treatment received|1|||
164248950|NCT00635349|593277756|FG000|Overall Study|Other|8|||
164248951|NCT00635349|593277757|FG001|Overall Study|Other|6|||
164248952|NCT00635349|593277756|FG000|Overall Study|Protocol Violation|18|||
164248953|NCT00635349|593277757|FG001|Overall Study|Protocol Violation|22|||
164248954|NCT00635349|593277756|FG000|Overall Study|Withdrawal by Subject|3|||
164248955|NCT00635349|593277757|FG001|Overall Study|Withdrawal by Subject|8|||
164248956|NCT00635349|593277756|FG000|Overall Study|Lost to Follow-up|4|||
164248957|NCT00635349|593277757|FG001|Overall Study|Lost to Follow-up|3|||
164248958|NCT00635349|593277756|FG000|Overall Study|Adverse Event|11|||
164248959|NCT00635349|593277757|FG001|Overall Study|Adverse Event|9|||
164248960|NCT01524224|593277768|FG000|Overall Study|Progressive Disease|1|||
164248961|NCT01524224|593277769|FG001|Overall Study|Progressive Disease|0|||
164248962|NCT01524224|593277770|FG002|Overall Study|Progressive Disease|2|||
164248963|NCT01524224|593277771|FG003|Overall Study|Progressive Disease|1|||
164248964|NCT01524224|593277772|FG004|Overall Study|Progressive Disease|2|||
164248965|NCT01524224|593277773|FG005|Overall Study|Progressive Disease|1|||
164248966|NCT01524224|593277774|FG006|Overall Study|Progressive Disease|1|||
164248967|NCT01524224|593277775|FG007|Overall Study|Progressive Disease|5|||
164248968|NCT01524224|593277768|FG000|Overall Study|Withdrawal by Subject|2|||
164248969|NCT01524224|593277769|FG001|Overall Study|Withdrawal by Subject|0|||
164248970|NCT01524224|593277770|FG002|Overall Study|Withdrawal by Subject|0|||
164248971|NCT01524224|593277771|FG003|Overall Study|Withdrawal by Subject|0|||
164248972|NCT01524224|593277772|FG004|Overall Study|Withdrawal by Subject|0|||
164248973|NCT01524224|593277773|FG005|Overall Study|Withdrawal by Subject|0|||
164248974|NCT01524224|593277774|FG006|Overall Study|Withdrawal by Subject|2|||
163991379|NCT01622569|592337139|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
164248975|NCT01524224|593277775|FG007|Overall Study|Withdrawal by Subject|0|||
164248976|NCT01524224|593277768|FG000|Overall Study|Adverse Event|0|||
164248977|NCT01524224|593277769|FG001|Overall Study|Adverse Event|1|||
164248978|NCT01524224|593277770|FG002|Overall Study|Adverse Event|0|||
164248979|NCT01524224|593277771|FG003|Overall Study|Adverse Event|0|||
164248980|NCT01524224|593277772|FG004|Overall Study|Adverse Event|0|||
164248981|NCT01524224|593277773|FG005|Overall Study|Adverse Event|1|||
164248982|NCT01524224|593277774|FG006|Overall Study|Adverse Event|0|||
164248983|NCT01524224|593277775|FG007|Overall Study|Adverse Event|0|||
164248984|NCT01524224|593277768|FG000|Overall Study|Physician Decision|0|||
164248985|NCT01524224|593277769|FG001|Overall Study|Physician Decision|0|||
164248986|NCT01524224|593277770|FG002|Overall Study|Physician Decision|0|||
164248987|NCT01524224|593277771|FG003|Overall Study|Physician Decision|1|||
164248988|NCT01524224|593277772|FG004|Overall Study|Physician Decision|1|||
164248989|NCT01524224|593277773|FG005|Overall Study|Physician Decision|0|||
163991380|NCT01622569|592337140|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
164248990|NCT01524224|593277774|FG006|Overall Study|Physician Decision|0|||
164248991|NCT01524224|593277775|FG007|Overall Study|Physician Decision|1|||
164248992|NCT01524224|593277768|FG000|Overall Study|Sponsor Decision|0|||
164248993|NCT01524224|593277769|FG001|Overall Study|Sponsor Decision|0|||
164248994|NCT01524224|593277770|FG002|Overall Study|Sponsor Decision|0|||
164248995|NCT01524224|593277771|FG003|Overall Study|Sponsor Decision|0|||
164248996|NCT01524224|593277772|FG004|Overall Study|Sponsor Decision|1|||
164248997|NCT01524224|593277773|FG005|Overall Study|Sponsor Decision|0|||
164248998|NCT01524224|593277774|FG006|Overall Study|Sponsor Decision|0|||
164248999|NCT01524224|593277775|FG007|Overall Study|Sponsor Decision|0|||
164249000|NCT05420961|593277783|FG000|Overall Study|Withdrawal by Subject|2|||
164249001|NCT05420961|593277784|FG001|Overall Study|Withdrawal by Subject|1|||
164249002|NCT05420961|593277785|FG002|Overall Study|Withdrawal by Subject|1|||
164249003|NCT05420961|593277786|FG003|Overall Study|Withdrawal by Subject|0|||
164338569|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338570|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338571|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
164338572|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
164338573|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
164338574|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338575|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338576|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338577|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338578|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
164338579|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
164338580|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
164338581|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
163991381|NCT01622569|592337141|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
163991382|NCT01622569|592337138|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
163991383|NCT01622569|592337139|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
163991384|NCT01622569|592337140|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
163991385|NCT01622569|592337141|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
164141818|NCT03066258|592880783|FG001|Overall Study|Death|0|||
164141819|NCT03066258|592880784|FG002|Overall Study|Death|0|||
164141820|NCT03066258|592880785|FG003|Overall Study|Death|0|||
164141821|NCT03066258|592880786|FG004|Overall Study|Death|1|||
164141822|NCT02784795|592880787|FG000|Overall Study|Progressive Disease|2|||
164141823|NCT02784795|592880788|FG001|Overall Study|Progressive Disease|1|||
164141824|NCT02784795|592880789|FG002|Overall Study|Progressive Disease|1|||
164141825|NCT02784795|592880790|FG003|Overall Study|Progressive Disease|0|||
164141826|NCT02784795|592880791|FG004|Overall Study|Progressive Disease|2|||
164141827|NCT02784795|592880792|FG005|Overall Study|Progressive Disease|0|||
164141828|NCT02784795|592880793|FG006|Overall Study|Progressive Disease|2|||
164141829|NCT02784795|592880794|FG007|Overall Study|Progressive Disease|0|||
164141830|NCT02784795|592880795|FG008|Overall Study|Progressive Disease|0|||
164141831|NCT02784795|592880796|FG009|Overall Study|Progressive Disease|0|||
164141832|NCT02784795|592880797|FG010|Overall Study|Progressive Disease|1|||
164141833|NCT02784795|592880798|FG011|Overall Study|Progressive Disease|0|||
164141834|NCT02784795|592880787|FG000|Overall Study|Adverse Event|1|||
164141835|NCT02784795|592880788|FG001|Overall Study|Adverse Event|0|||
164141836|NCT02784795|592880789|FG002|Overall Study|Adverse Event|0|||
164141837|NCT02784795|592880790|FG003|Overall Study|Adverse Event|1|||
164141838|NCT02784795|592880791|FG004|Overall Study|Adverse Event|0|||
164141839|NCT02784795|592880792|FG005|Overall Study|Adverse Event|0|||
164141840|NCT02784795|592880793|FG006|Overall Study|Adverse Event|1|||
164141841|NCT02784795|592880794|FG007|Overall Study|Adverse Event|0|||
164141842|NCT02784795|592880795|FG008|Overall Study|Adverse Event|0|||
164141843|NCT02784795|592880796|FG009|Overall Study|Adverse Event|0|||
164141844|NCT02784795|592880797|FG010|Overall Study|Adverse Event|0|||
164141845|NCT02784795|592880798|FG011|Overall Study|Adverse Event|2|||
164141846|NCT02784795|592880787|FG000|Overall Study|Withdrawal by Subject|1|||
164141847|NCT02784795|592880788|FG001|Overall Study|Withdrawal by Subject|0|||
164141848|NCT02784795|592880789|FG002|Overall Study|Withdrawal by Subject|2|||
164141849|NCT02784795|592880790|FG003|Overall Study|Withdrawal by Subject|1|||
164141850|NCT02784795|592880791|FG004|Overall Study|Withdrawal by Subject|3|||
164141851|NCT02784795|592880792|FG005|Overall Study|Withdrawal by Subject|0|||
164141852|NCT02784795|592880793|FG006|Overall Study|Withdrawal by Subject|0|||
164141853|NCT02784795|592880794|FG007|Overall Study|Withdrawal by Subject|1|||
164141854|NCT02784795|592880795|FG008|Overall Study|Withdrawal by Subject|0|||
164141855|NCT02784795|592880796|FG009|Overall Study|Withdrawal by Subject|0|||
164141856|NCT02784795|592880797|FG010|Overall Study|Withdrawal by Subject|0|||
164141857|NCT02784795|592880798|FG011|Overall Study|Withdrawal by Subject|2|||
164141858|NCT02784795|592880787|FG000|Overall Study|Death|0|||
164141859|NCT02784795|592880788|FG001|Overall Study|Death|0|||
164141860|NCT02784795|592880789|FG002|Overall Study|Death|0|||
164141861|NCT02784795|592880790|FG003|Overall Study|Death|0|||
164141862|NCT02784795|592880791|FG004|Overall Study|Death|1|||
164141863|NCT02784795|592880792|FG005|Overall Study|Death|0|||
164141864|NCT02784795|592880793|FG006|Overall Study|Death|0|||
164141865|NCT02784795|592880794|FG007|Overall Study|Death|0|||
164141866|NCT02784795|592880795|FG008|Overall Study|Death|0|||
164141867|NCT02784795|592880796|FG009|Overall Study|Death|0|||
164141868|NCT02784795|592880797|FG010|Overall Study|Death|0|||
164141869|NCT02784795|592880798|FG011|Overall Study|Death|0|||
164141870|NCT02784795|592880787|FG000|Overall Study|Physician Decision|0|||
164141871|NCT02784795|592880788|FG001|Overall Study|Physician Decision|0|||
164141872|NCT02784795|592880789|FG002|Overall Study|Physician Decision|0|||
164141873|NCT02784795|592880790|FG003|Overall Study|Physician Decision|0|||
164141874|NCT02784795|592880791|FG004|Overall Study|Physician Decision|0|||
164141875|NCT02784795|592880792|FG005|Overall Study|Physician Decision|0|||
164141876|NCT02784795|592880793|FG006|Overall Study|Physician Decision|1|||
164249004|NCT05420961|593277787|FG004|Overall Study|Withdrawal by Subject|0|||
164249005|NCT05420961|593277783|FG000|Overall Study|Lost to Follow-up|0|||
164249006|NCT05420961|593277784|FG001|Overall Study|Lost to Follow-up|0|||
164249007|NCT05420961|593277785|FG002|Overall Study|Lost to Follow-up|1|||
164249008|NCT05420961|593277786|FG003|Overall Study|Lost to Follow-up|0|||
164249009|NCT05420961|593277787|FG004|Overall Study|Lost to Follow-up|0|||
164249010|NCT05420961|593277783|FG000|Overall Study|Randomized by mistake without study treatment|0|||
164249011|NCT05420961|593277784|FG001|Overall Study|Randomized by mistake without study treatment|0|||
164249012|NCT05420961|593277785|FG002|Overall Study|Randomized by mistake without study treatment|1|||
164249013|NCT05420961|593277786|FG003|Overall Study|Randomized by mistake without study treatment|0|||
164249014|NCT05420961|593277787|FG004|Overall Study|Randomized by mistake without study treatment|1|||
164249015|NCT02625220|593277788|FG000|Overall Study|Adverse Event|2|||
164249016|NCT02625220|593277788|FG000|Overall Study|Lost to Follow-up|2|||
164249017|NCT02625220|593277788|FG000|Overall Study|Protocol Violation|1|||
164249018|NCT02625220|593277788|FG000|Overall Study|Study discontinued at site|2|||
164249019|NCT01119066|593277789|FG000|Overall Study|Withdrawal by Subject|4|||
164084011|NCT02884206|592672230|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
164084012|NCT02884206|592672228|FG000|Double-Blind Period|Death|0|||
164249020|NCT01119066|593277790|FG001|Overall Study|Withdrawal by Subject|6|||
164249021|NCT01119066|593277791|FG002|Overall Study|Withdrawal by Subject|0|||
164249022|NCT01119066|593277792|FG003|Overall Study|Withdrawal by Subject|0|||
164249023|NCT01119066|593277789|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
164249024|NCT01119066|593277790|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
164249025|NCT01119066|593277791|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
164249026|NCT01119066|593277792|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
164249027|NCT01119066|593277789|FG000|Overall Study|Relapse identified before transplant|1|||
164249028|NCT01119066|593277790|FG001|Overall Study|Relapse identified before transplant|0|||
164249029|NCT01119066|593277791|FG002|Overall Study|Relapse identified before transplant|0|||
164249030|NCT01119066|593277792|FG003|Overall Study|Relapse identified before transplant|0|||
164249031|NCT01119066|593277789|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
164249032|NCT01119066|593277790|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
164249033|NCT01119066|593277791|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
164249034|NCT01119066|593277792|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
164249035|NCT01119066|593277789|FG000|Overall Study|Relapse identified before transplant|0|||
164249036|NCT01119066|593277790|FG001|Overall Study|Relapse identified before transplant|4|||
164249037|NCT01119066|593277791|FG002|Overall Study|Relapse identified before transplant|0|||
164249038|NCT01119066|593277792|FG003|Overall Study|Relapse identified before transplant|0|||
164249039|NCT00783835|593277793|FG000|Overall Study|Adverse Event|3|||
164249040|NCT00783835|593277793|FG000|Overall Study|Medical Criteria|1|||
164249041|NCT00783835|593277793|FG000|Overall Study|Withdrawal by Subject|2|||
164249042|NCT00783835|593277793|FG000|Overall Study|Lost to Follow-up|1|||
164249043|NCT00783835|593277793|FG000|Overall Study|Participant not Adherent|3|||
164249044|NCT00295646|593277794|FG000|Overall Study|Protocol Violation|18|||
164249045|NCT00295646|593277795|FG001|Overall Study|Protocol Violation|20|||
164249046|NCT00295646|593277796|FG002|Overall Study|Protocol Violation|20|||
164249047|NCT00295646|593277797|FG003|Overall Study|Protocol Violation|18|||
164249048|NCT00295646|593277794|FG000|Overall Study|Withdrawal by Subject|8|||
164249049|NCT00295646|593277795|FG001|Overall Study|Withdrawal by Subject|9|||
164249050|NCT00295646|593277796|FG002|Overall Study|Withdrawal by Subject|11|||
164249051|NCT00295646|593277797|FG003|Overall Study|Withdrawal by Subject|14|||
164249052|NCT00295646|593277794|FG000|Overall Study|Lost to Follow-up|0|||
164249053|NCT00295646|593277795|FG001|Overall Study|Lost to Follow-up|5|||
164249054|NCT00295646|593277796|FG002|Overall Study|Lost to Follow-up|1|||
164249055|NCT00295646|593277797|FG003|Overall Study|Lost to Follow-up|5|||
164249056|NCT00295646|593277794|FG000|Overall Study|Death|9|||
164249057|NCT00295646|593277795|FG001|Overall Study|Death|7|||
164249058|NCT00295646|593277796|FG002|Overall Study|Death|18|||
164249059|NCT00295646|593277797|FG003|Overall Study|Death|8|||
164249060|NCT00995436|593277798|FG000|Overall Study|Withdrawal by Subject|2|||
164249061|NCT00995436|593277799|FG001|Overall Study|Withdrawal by Subject|5|||
164249062|NCT00995436|593277800|FG002|Overall Study|Withdrawal by Subject|0|||
164249063|NCT01232127|593277802|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
164249064|NCT01232127|593277803|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
164338582|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164249065|NCT01232127|593277804|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
164249066|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
164249067|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
164249068|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
164249069|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
164249070|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
164249071|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
164338583|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164338584|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164338585|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
164338586|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338587|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338588|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
163886509|NCT01987895|591956467|FG001|Overall Study|Death|7|||
164338589|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338590|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338591|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
164338592|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338593|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338594|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338595|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338596|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
164338597|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
164338598|NCT02925117|593615199|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
164338599|NCT02925117|593615200|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
164338600|NCT02925117|593615201|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
164338601|NCT02925117|593615202|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
164338602|NCT02925117|593615203|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
164338603|NCT02925117|593615204|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
164338604|NCT02925117|593615205|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
164338605|NCT02925117|593615206|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
164338606|NCT02925117|593615207|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
164338607|NCT02925117|593615208|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
164338608|NCT02925117|593615209|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
163886510|NCT01987895|591956466|FG000|Overall Study|Lost to Follow-up|3|||
163886511|NCT01987895|591956467|FG001|Overall Study|Lost to Follow-up|5|||
163886512|NCT01987895|591956466|FG000|Overall Study|randomized before giving IC|0|||
163886513|NCT01987895|591956467|FG001|Overall Study|randomized before giving IC|1|||
163886514|NCT02979327|591956468|FG000|First Intervention|Protocol Violation|1|||
163886515|NCT02979327|591956469|FG001|First Intervention|Protocol Violation|0|||
163886516|NCT03628924|591956471|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
163886517|NCT03628924|591956472|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163886518|NCT03628924|591956473|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163886519|NCT03628924|591956474|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
164084013|NCT02884206|592672229|FG001|Double-Blind Period|Death|28|||
164338609|NCT02925117|593615210|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
164338610|NCT04032652|593615211|FG000|Overall Study|The study was terminated and the PI has|1|||
164338611|NCT04032652|593615212|FG001|Overall Study|The study was terminated and the PI has|1|||
164338612|NCT02663908|593615213|FG000|Overall Study|Withdrawal by Subject|8|||
164338613|NCT02663908|593615214|FG001|Overall Study|Withdrawal by Subject|5|||
164338614|NCT02663908|593615213|FG000|Overall Study|Lost to Follow-up|1|||
164338615|NCT02663908|593615214|FG001|Overall Study|Lost to Follow-up|5|||
164338616|NCT02663908|593615213|FG000|Overall Study|Adverse Event|13|||
164338617|NCT02663908|593615214|FG001|Overall Study|Adverse Event|11|||
164338618|NCT02663908|593615213|FG000|Overall Study|Protocol Violation|1|||
164338619|NCT02663908|593615214|FG001|Overall Study|Protocol Violation|2|||
164338620|NCT02663908|593615213|FG000|Overall Study|Lack of therapeutic response|2|||
164084014|NCT02884206|592672230|FG002|Double-Blind Period|Death|39|||
164338621|NCT02663908|593615214|FG001|Overall Study|Lack of therapeutic response|0|||
164338622|NCT02663908|593615213|FG000|Overall Study|COVID-19|1|||
163886520|NCT03628924|591956475|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163886521|NCT03628924|591956476|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163886522|NCT03628924|591956477|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
163886523|NCT03628924|591956471|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163886524|NCT03628924|591956472|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163886525|NCT03628924|591956473|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
163886526|NCT03628924|591956474|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163886527|NCT03628924|591956475|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163886528|NCT03628924|591956476|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
164141877|NCT02784795|592880794|FG007|Overall Study|Physician Decision|0|||
164141878|NCT02784795|592880795|FG008|Overall Study|Physician Decision|0|||
164141879|NCT02784795|592880796|FG009|Overall Study|Physician Decision|0|||
164141880|NCT02784795|592880797|FG010|Overall Study|Physician Decision|0|||
164141881|NCT02784795|592880798|FG011|Overall Study|Physician Decision|0|||
164141882|NCT01994850|592880799|FG000|Overall Study|Physician Decision|1|||
164141883|NCT01994850|592880799|FG000|Overall Study|Withdrawal by Subject|1|||
164141884|NCT00339144|592880834|FG000|Overall Study|Disease progression|5|||
164141885|NCT00339144|592880835|FG001|Overall Study|Disease progression|2|||
164141886|NCT00339144|592880836|FG002|Overall Study|Disease progression|2|||
164141887|NCT00339144|592880834|FG000|Overall Study|Study drug toxicity|3|||
164141888|NCT00339144|592880835|FG001|Overall Study|Study drug toxicity|1|||
164141889|NCT00339144|592880836|FG002|Overall Study|Study drug toxicity|1|||
164141890|NCT00339144|592880834|FG000|Overall Study|Participant's request to discontinuation|1|||
164141891|NCT00339144|592880835|FG001|Overall Study|Participant's request to discontinuation|0|||
164141892|NCT00339144|592880836|FG002|Overall Study|Participant's request to discontinuation|1|||
164141893|NCT01292226|592880837|FG000|Overall Study|Adverse Event|5|||
164141894|NCT01292226|592880837|FG000|Overall Study|Death|1|||
164141895|NCT01292226|592880837|FG000|Overall Study|Graft loss|1|||
164141896|NCT01292226|592880837|FG000|Overall Study|Protocol Violation|3|||
164141897|NCT01292226|592880837|FG000|Overall Study|Withdrawal by Subject|1|||
164141898|NCT01292226|592880837|FG000|Overall Study|Other|2|||
164141899|NCT00468650|592880843|FG000|Overall Study|Lost to Follow-up|4|||
164141900|NCT00468650|592880843|FG000|Overall Study|Withdrawal by Subject|2|||
164141901|NCT00468650|592880843|FG000|Overall Study|Protocol Violation|1|||
164141902|NCT01267994|592880844|FG000|Overall Study|Adverse Event|2|||
164141903|NCT01144715|592880847|FG000|Overall Study|Lost to Follow-up|2|||
164141904|NCT01144715|592880848|FG001|Overall Study|Lost to Follow-up|1|||
164141905|NCT01144715|592880847|FG000|Overall Study|Withdrawal by Subject|2|||
164141906|NCT01144715|592880848|FG001|Overall Study|Withdrawal by Subject|1|||
164141907|NCT01144715|592880847|FG000|Overall Study|Adverse Event|0|||
164141908|NCT01144715|592880848|FG001|Overall Study|Adverse Event|1|||
164141909|NCT00857584|592880854|FG000|Overall Study|Lack of Efficacy|1|||
164141910|NCT00857584|592880855|FG001|Overall Study|Lack of Efficacy|2|||
164141911|NCT00857584|592880854|FG000|Overall Study|Adverse Event|2|||
164141912|NCT00857584|592880855|FG001|Overall Study|Adverse Event|2|||
164141913|NCT00857584|592880854|FG000|Overall Study|Physician Decision|1|||
164141914|NCT00857584|592880855|FG001|Overall Study|Physician Decision|1|||
164141915|NCT00673387|592880856|FG000|Overall Study|Withdrawal by Subject|15|||
164141916|NCT00673387|592880857|FG001|Overall Study|Withdrawal by Subject|16|||
164141917|NCT00673387|592880858|FG002|Overall Study|Withdrawal by Subject|20|||
164141918|NCT00673387|592880859|FG003|Overall Study|Withdrawal by Subject|16|||
164141919|NCT00673387|592880860|FG004|Overall Study|Withdrawal by Subject|18|||
164141920|NCT00673387|592880861|FG005|Overall Study|Withdrawal by Subject|21|||
164141921|NCT00673387|592880862|FG006|Overall Study|Withdrawal by Subject|15|||
164141922|NCT00673387|592880863|FG007|Overall Study|Withdrawal by Subject|21|||
164141923|NCT00673387|592880856|FG000|Overall Study|Adverse Event|3|||
164141924|NCT00673387|592880857|FG001|Overall Study|Adverse Event|1|||
164141925|NCT00673387|592880858|FG002|Overall Study|Adverse Event|5|||
164141926|NCT00673387|592880859|FG003|Overall Study|Adverse Event|2|||
164141927|NCT00673387|592880860|FG004|Overall Study|Adverse Event|6|||
164141928|NCT00673387|592880861|FG005|Overall Study|Adverse Event|2|||
164141929|NCT00673387|592880862|FG006|Overall Study|Adverse Event|5|||
164141930|NCT00673387|592880863|FG007|Overall Study|Adverse Event|5|||
164141931|NCT00673387|592880856|FG000|Overall Study|Physician Decision|0|||
164141932|NCT00673387|592880857|FG001|Overall Study|Physician Decision|0|||
164141933|NCT00673387|592880858|FG002|Overall Study|Physician Decision|0|||
164141934|NCT00673387|592880859|FG003|Overall Study|Physician Decision|0|||
164141935|NCT00673387|592880860|FG004|Overall Study|Physician Decision|0|||
164141936|NCT00673387|592880861|FG005|Overall Study|Physician Decision|5|||
164141937|NCT00673387|592880862|FG006|Overall Study|Physician Decision|1|||
164141938|NCT00673387|592880863|FG007|Overall Study|Physician Decision|1|||
164141939|NCT00673387|592880856|FG000|Overall Study|Protocol Violation|3|||
164141940|NCT00673387|592880857|FG001|Overall Study|Protocol Violation|0|||
164141941|NCT00673387|592880858|FG002|Overall Study|Protocol Violation|1|||
164141942|NCT00673387|592880859|FG003|Overall Study|Protocol Violation|2|||
164141943|NCT00673387|592880860|FG004|Overall Study|Protocol Violation|0|||
164141944|NCT00673387|592880861|FG005|Overall Study|Protocol Violation|1|||
164141945|NCT00673387|592880862|FG006|Overall Study|Protocol Violation|1|||
164141946|NCT00673387|592880863|FG007|Overall Study|Protocol Violation|3|||
164141947|NCT00673387|592880856|FG000|Overall Study|Lost to Follow-up|8|||
164141948|NCT00673387|592880857|FG001|Overall Study|Lost to Follow-up|6|||
164141949|NCT00673387|592880858|FG002|Overall Study|Lost to Follow-up|5|||
164141950|NCT00673387|592880859|FG003|Overall Study|Lost to Follow-up|6|||
164249072|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
164249073|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
164249074|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
164249075|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
164249076|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164249077|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
164249078|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
164249079|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
164249080|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
164249081|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
164249082|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
164249083|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
164249084|NCT03162796|593277808|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
164249085|NCT03162796|593277809|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
164249086|NCT03162796|593277810|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
164249087|NCT03162796|593277808|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
164249088|NCT03162796|593277809|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
164249089|NCT03162796|593277810|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
164249090|NCT03162796|593277808|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
164249091|NCT03162796|593277809|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
164249092|NCT03162796|593277810|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
164249093|NCT03162796|593277808|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
164249094|NCT03162796|593277809|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
164249095|NCT03162796|593277810|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
164249096|NCT03162796|593277808|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
164249097|NCT03162796|593277809|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
164249098|NCT03162796|593277810|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
164249099|NCT02623205|593277811|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
164249100|NCT02623205|593277812|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
164249101|NCT02375373|593277816|FG000|Overall Study|Withdrawal by Subject|11|||
164249102|NCT02725476|593277817|FG000|Overall Study|Physician Decision|2|||
164249103|NCT02725476|593277818|FG001|Overall Study|Physician Decision|0|||
164249104|NCT02725476|593277817|FG000|Overall Study|Adverse Event|1|||
164249105|NCT02725476|593277818|FG001|Overall Study|Adverse Event|1|||
164249106|NCT00289289|593277820|FG000|Overall Study|Withdrawal by Subject|5|||
164249107|NCT00289289|593277821|FG001|Overall Study|Withdrawal by Subject|3|||
164249108|NCT00289289|593277822|FG002|Overall Study|Withdrawal by Subject|15|||
164249109|NCT00289289|593277820|FG000|Overall Study|Lost to Follow-up|1|||
164249110|NCT00289289|593277821|FG001|Overall Study|Lost to Follow-up|0|||
164249111|NCT00289289|593277822|FG002|Overall Study|Lost to Follow-up|1|||
164249112|NCT00289289|593277820|FG000|Overall Study|Death|4|||
164249113|NCT00289289|593277821|FG001|Overall Study|Death|2|||
163991386|NCT01622569|592337138|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
164249114|NCT00289289|593277822|FG002|Overall Study|Death|5|||
164249115|NCT00289289|593277820|FG000|Overall Study|No implant attempted|0|||
164249116|NCT00289289|593277821|FG001|Overall Study|No implant attempted|0|||
164249117|NCT00289289|593277822|FG002|Overall Study|No implant attempted|1|||
164249118|NCT00289289|593277820|FG000|Overall Study|Physician Decision|1|||
164249119|NCT00289289|593277821|FG001|Overall Study|Physician Decision|0|||
164249120|NCT00289289|593277822|FG002|Overall Study|Physician Decision|6|||
164249121|NCT00289289|593277820|FG000|Overall Study|Non-study device implanted|2|||
164249122|NCT00289289|593277821|FG001|Overall Study|Non-study device implanted|1|||
164249123|NCT00289289|593277822|FG002|Overall Study|Non-study device implanted|3|||
164249124|NCT00289289|593277820|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
164249125|NCT00289289|593277821|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
164249126|NCT00289289|593277822|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
163991387|NCT01622569|592337139|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
163991388|NCT01622569|592337140|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
163991389|NCT01622569|592337141|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
164249127|NCT00289289|593277820|FG000|Overall Study|Other Exit Reason|6|||
164249128|NCT00289289|593277821|FG001|Overall Study|Other Exit Reason|4|||
164249129|NCT00289289|593277822|FG002|Overall Study|Other Exit Reason|12|||
164249130|NCT01445613|593277823|FG000|30-day Follow-up|Withdrawal by Subject|6|||
164249131|NCT01445613|593277823|FG000|30-day Follow-up|Physician Decision|3|||
164249132|NCT01445613|593277823|FG000|30-day Follow-up|Missed visit|23|||
164249133|NCT01445613|593277823|FG000|30-day Follow-up|Death|3|||
164249134|NCT01445613|593277823|FG000|1-year Follow-up|Withdrawal by Subject|12|||
164249135|NCT01445613|593277823|FG000|1-year Follow-up|Missed visit|29|||
164249136|NCT01445613|593277823|FG000|1-year Follow-up|Lost to Follow-up|2|||
164249137|NCT01445613|593277823|FG000|1-year Follow-up|Death|30|||
164249138|NCT01445613|593277823|FG000|1-year Follow-up|Physician Decision|2|||
164249139|NCT01445613|593277823|FG000|1-year Follow-up|Received a non-study stent|2|||
164249140|NCT00407602|593277824|FG000|Overall Study|Death - unrelated to device|1|||
164249141|NCT00407602|593277824|FG000|Overall Study|Device explanted|5|||
164249142|NCT00407602|593277824|FG000|Overall Study|Withdrawal by Subject|1|||
164249143|NCT01169701|593277825|FG000|Overall Study|Lost to Follow-up|1|||
164249144|NCT01169701|593277826|FG001|Overall Study|Lost to Follow-up|1|||
164249145|NCT01169701|593277825|FG000|Overall Study|Withdrawal by Subject|1|||
164249146|NCT01169701|593277826|FG001|Overall Study|Withdrawal by Subject|3|||
164249147|NCT01169701|593277825|FG000|Overall Study|Adverse Event|1|||
164249148|NCT01169701|593277826|FG001|Overall Study|Adverse Event|2|||
164249149|NCT01169701|593277825|FG000|Overall Study|Exclusion criteria|2|||
164249150|NCT01169701|593277826|FG001|Overall Study|Exclusion criteria|0|||
164249151|NCT01169701|593277825|FG000|Overall Study|Death|0|||
164249152|NCT01169701|593277826|FG001|Overall Study|Death|1|||
164249153|NCT01169701|593277825|FG000|Overall Study|Administrative problems|0|||
164249154|NCT01169701|593277826|FG001|Overall Study|Administrative problems|1|||
164249155|NCT01169701|593277825|FG000|Overall Study|Serious adverse event|0|||
164249156|NCT01169701|593277826|FG001|Overall Study|Serious adverse event|1|||
164249157|NCT01169701|593277825|FG000|Overall Study|Sponsor decision|0|||
164249158|NCT01169701|593277826|FG001|Overall Study|Sponsor decision|1|||
164249159|NCT02141633|593279069|FG000|Overall Study|Physician Decision|1|||
164249160|NCT02141633|593279070|FG001|Overall Study|Physician Decision|0|||
164249161|NCT00833469|593279071|FG000|Overall Study|Withdrawal by Subject|1|||
164249162|NCT00833469|593279071|FG000|Overall Study|Lost to Follow-up|1|||
164249163|NCT02943070|593279072|FG000|Overall Study|Physician Decision|1|||
164249164|NCT02943070|593279072|FG000|Overall Study|Adverse Event|2|||
164249165|NCT02943070|593279072|FG000|Overall Study|Death|2|||
164249166|NCT02943070|593279072|FG000|Overall Study|Withdrawal by Subject|3|||
164249167|NCT02943070|593279072|FG000|Overall Study|Lost to Follow-up|4|||
164249168|NCT02943070|593279072|FG000|Overall Study|Retreatment or TURP|13|||
164249169|NCT02943070|593279072|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
164249170|NCT01701362|593279073|FG000|Overall Study|Adverse events not related to study drug|1|||
164249171|NCT01701362|593279074|FG001|Overall Study|Adverse events not related to study drug|6|||
164249172|NCT01701362|593279073|FG000|Overall Study|Adverse events related to study drug|12|||
164249173|NCT01701362|593279074|FG001|Overall Study|Adverse events related to study drug|10|||
164249174|NCT01701362|593279073|FG000|Overall Study|Protocol Violation|5|||
164249175|NCT01701362|593279074|FG001|Overall Study|Protocol Violation|3|||
164249176|NCT01701362|593279073|FG000|Overall Study|No longer willing to participate|8|||
164249177|NCT01701362|593279074|FG001|Overall Study|No longer willing to participate|14|||
164249178|NCT01701362|593279073|FG000|Overall Study|Lost to Follow-up|6|||
164249179|NCT01701362|593279074|FG001|Overall Study|Lost to Follow-up|9|||
164249180|NCT01701362|593279073|FG000|Overall Study|Insufficient clinical response|6|||
164249181|NCT01701362|593279074|FG001|Overall Study|Insufficient clinical response|6|||
164249182|NCT01701362|593279073|FG000|Overall Study|Death|0|||
164249183|NCT01701362|593279074|FG001|Overall Study|Death|1|||
164249184|NCT01701362|593279073|FG000|Overall Study|Randomized but not treated|1|||
164249185|NCT01701362|593279074|FG001|Overall Study|Randomized but not treated|2|||
164249186|NCT01701362|593279073|FG000|Overall Study|Reasons other than those mentioned above|3|||
164249187|NCT01701362|593279074|FG001|Overall Study|Reasons other than those mentioned above|5|||
164249188|NCT00570778|593279075|FG000|Overall Study|Protocol deviation|2|||
164249189|NCT00570778|593279076|FG001|Overall Study|Protocol deviation|1|||
164249190|NCT00570778|593279077|FG002|Overall Study|Protocol deviation|2|||
164249191|NCT00570778|593279078|FG003|Overall Study|Protocol deviation|2|||
164249192|NCT00570778|593279075|FG000|Overall Study|Adverse Event|0|||
164249193|NCT00570778|593279076|FG001|Overall Study|Adverse Event|1|||
164249194|NCT00570778|593279077|FG002|Overall Study|Adverse Event|4|||
164249195|NCT00570778|593279078|FG003|Overall Study|Adverse Event|1|||
164249196|NCT00570778|593279075|FG000|Overall Study|Subject withdrew consent|0|||
164249197|NCT00570778|593279076|FG001|Overall Study|Subject withdrew consent|1|||
164249198|NCT00570778|593279077|FG002|Overall Study|Subject withdrew consent|0|||
164249199|NCT00570778|593279078|FG003|Overall Study|Subject withdrew consent|1|||
164249200|NCT00570778|593279075|FG000|Overall Study|Abnormal test procedure|1|||
164249201|NCT00570778|593279076|FG001|Overall Study|Abnormal test procedure|0|||
164249202|NCT00570778|593279077|FG002|Overall Study|Abnormal test procedure|0|||
164249203|NCT00570778|593279078|FG003|Overall Study|Abnormal test procedure|0|||
163886529|NCT03628924|591956477|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
163886530|NCT03628924|591956471|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
163886531|NCT03628924|591956472|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
163886532|NCT03628924|591956473|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
164084015|NCT02884206|592672228|FG000|Double-Blind Period|Patient/guardian decision|0|||
164084016|NCT02884206|592672229|FG001|Double-Blind Period|Patient/guardian decision|10|||
164249204|NCT00570778|593279075|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164249205|NCT00570778|593279076|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164249206|NCT00570778|593279077|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164249207|NCT00570778|593279078|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164249208|NCT00570778|593279075|FG000|Overall Study|Lost to Follow-up|0|||
164249209|NCT00570778|593279076|FG001|Overall Study|Lost to Follow-up|0|||
164249210|NCT00570778|593279077|FG002|Overall Study|Lost to Follow-up|1|||
164249211|NCT00570778|593279078|FG003|Overall Study|Lost to Follow-up|0|||
164249212|NCT00570778|593279075|FG000|Overall Study|Subject no longer requires study drug|0|||
164249213|NCT00570778|593279076|FG001|Overall Study|Subject no longer requires study drug|1|||
164249214|NCT00570778|593279077|FG002|Overall Study|Subject no longer requires study drug|0|||
164249215|NCT00570778|593279078|FG003|Overall Study|Subject no longer requires study drug|0|||
164249216|NCT00443872|593279081|FG000|Overall Study|Protocol Violation|7|||
164249217|NCT00443872|593279081|FG000|Overall Study|Lost to Follow-up|2|||
164249218|NCT00443872|593279081|FG000|Overall Study|Adverse Event|8|||
164249219|NCT01014767|593279082|FG000|Overall Study|PI left institution, data unavailable|12|||
164249220|NCT01014767|593279083|FG001|Overall Study|PI left institution, data unavailable|1|||
164249221|NCT01014767|593279084|FG002|Overall Study|PI left institution, data unavailable|4|||
164249222|NCT01014767|593279085|FG003|Overall Study|PI left institution, data unavailable|1|||
164249223|NCT00700622|593279086|FG000|Overall Study|Adverse Event|4|||
164249224|NCT00700622|593279087|FG001|Overall Study|Adverse Event|0|||
164249225|NCT00700622|593279086|FG000|Overall Study|Lost to Follow-up|0|||
164249226|NCT00700622|593279087|FG001|Overall Study|Lost to Follow-up|1|||
164249227|NCT00700622|593279086|FG000|Overall Study|Physician Decision|2|||
164249228|NCT00700622|593279087|FG001|Overall Study|Physician Decision|1|||
164249229|NCT00700622|593279086|FG000|Overall Study|Protocol Violation|0|||
164249230|NCT00700622|593279087|FG001|Overall Study|Protocol Violation|1|||
164249231|NCT00700622|593279086|FG000|Overall Study|Withdrawal by Subject|4|||
164249232|NCT00700622|593279087|FG001|Overall Study|Withdrawal by Subject|1|||
164249233|NCT00700622|593279086|FG000|Overall Study|Other|3|||
164249234|NCT00700622|593279087|FG001|Overall Study|Other|1|||
164249235|NCT00282087|593279088|FG000|Overall Study|Death|1|||
164249236|NCT00405392|593279089|FG000|Overall Study|Adverse Event|15|||
164249237|NCT00405392|593279090|FG001|Overall Study|Adverse Event|14|||
164249238|NCT00405392|593279089|FG000|Overall Study|Did not meet Eligibility criteria|7|||
164249239|NCT00405392|593279090|FG001|Overall Study|Did not meet Eligibility criteria|2|||
164249240|NCT00405392|593279089|FG000|Overall Study|Withdrawal by Subject|4|||
164249241|NCT00405392|593279090|FG001|Overall Study|Withdrawal by Subject|3|||
164249242|NCT00405392|593279089|FG000|Overall Study|Lost to Follow-up|1|||
164249243|NCT00405392|593279090|FG001|Overall Study|Lost to Follow-up|2|||
164249244|NCT00405392|593279089|FG000|Overall Study|Data missing|2|||
164249245|NCT00405392|593279090|FG001|Overall Study|Data missing|0|||
164249246|NCT00405392|593279089|FG000|Overall Study|Non-compliance|0|||
164249247|NCT00405392|593279090|FG001|Overall Study|Non-compliance|1|||
164249248|NCT00405392|593279089|FG000|Overall Study|Other|1|||
164249249|NCT00405392|593279090|FG001|Overall Study|Other|5|||
164249250|NCT01703091|593279093|FG000|Overall Study|Adverse Event|5|||
164249251|NCT01703091|593279094|FG001|Overall Study|Adverse Event|3|||
164249252|NCT01703091|593279093|FG000|Overall Study|Physician Decision|2|||
164249253|NCT01703091|593279094|FG001|Overall Study|Physician Decision|1|||
164249254|NCT01703091|593279093|FG000|Overall Study|Withdrawal by Subject|1|||
164249255|NCT01703091|593279094|FG001|Overall Study|Withdrawal by Subject|0|||
164249256|NCT01703091|593279093|FG000|Overall Study|Sponsor Decision|1|||
164249257|NCT01703091|593279094|FG001|Overall Study|Sponsor Decision|0|||
164249258|NCT02550288|593279095|FG000|Overall Study|Adverse Event|0|||
164249259|NCT02550288|593279096|FG001|Overall Study|Adverse Event|1|||
164249260|NCT02550288|593279097|FG002|Overall Study|Adverse Event|0|||
164249261|NCT02550288|593279098|FG003|Overall Study|Adverse Event|0|||
164249262|NCT02550288|593279099|FG004|Overall Study|Adverse Event|0|||
164249263|NCT02550288|593279095|FG000|Overall Study|Physician Decision|0|||
164249264|NCT02550288|593279096|FG001|Overall Study|Physician Decision|0|||
164249265|NCT02550288|593279097|FG002|Overall Study|Physician Decision|0|||
164249266|NCT02550288|593279098|FG003|Overall Study|Physician Decision|1|||
164249267|NCT02550288|593279099|FG004|Overall Study|Physician Decision|0|||
164249268|NCT02550288|593279095|FG000|Overall Study|Protocol Violation|2|||
164249269|NCT02550288|593279096|FG001|Overall Study|Protocol Violation|2|||
164249270|NCT02550288|593279097|FG002|Overall Study|Protocol Violation|1|||
164249271|NCT02550288|593279098|FG003|Overall Study|Protocol Violation|0|||
164249272|NCT02550288|593279099|FG004|Overall Study|Protocol Violation|3|||
164249273|NCT02550288|593279095|FG000|Overall Study|Participant moved|0|||
164249274|NCT02550288|593279096|FG001|Overall Study|Participant moved|0|||
164249275|NCT02550288|593279097|FG002|Overall Study|Participant moved|0|||
164249276|NCT02550288|593279098|FG003|Overall Study|Participant moved|1|||
164249277|NCT02550288|593279099|FG004|Overall Study|Participant moved|0|||
164249278|NCT02550288|593279095|FG000|Overall Study|Withdrawal by Subject|0|||
164249279|NCT02550288|593279096|FG001|Overall Study|Withdrawal by Subject|0|||
164249280|NCT02550288|593279097|FG002|Overall Study|Withdrawal by Subject|0|||
164249281|NCT02550288|593279098|FG003|Overall Study|Withdrawal by Subject|1|||
164249282|NCT02550288|593279099|FG004|Overall Study|Withdrawal by Subject|0|||
164249283|NCT00988052|593279100|FG000|Overall Study|Missing|1|||
164249284|NCT00988052|593279101|FG001|Overall Study|Missing|0|||
164249285|NCT00988052|593279100|FG000|Overall Study|Teva requested subject withdrawal|3|||
164249286|NCT00988052|593279101|FG001|Overall Study|Teva requested subject withdrawal|1|||
164249287|NCT00988052|593279100|FG000|Overall Study|Death|1|||
164249288|NCT00988052|593279101|FG001|Overall Study|Death|3|||
164249289|NCT00988052|593279100|FG000|Overall Study|Protocol Violation|6|||
164249290|NCT00988052|593279101|FG001|Overall Study|Protocol Violation|5|||
164249291|NCT00988052|593279100|FG000|Overall Study|Pregnancy|6|||
164249292|NCT00988052|593279101|FG001|Overall Study|Pregnancy|6|||
164249293|NCT00988052|593279100|FG000|Overall Study|Lack of Efficacy|8|||
164249294|NCT00988052|593279101|FG001|Overall Study|Lack of Efficacy|7|||
164249295|NCT00988052|593279100|FG000|Overall Study|Lost to Follow-up|6|||
164249296|NCT00988052|593279101|FG001|Overall Study|Lost to Follow-up|11|||
164249297|NCT00988052|593279100|FG000|Overall Study|Physician Decision|27|||
164249298|NCT00988052|593279101|FG001|Overall Study|Physician Decision|28|||
164249299|NCT00988052|593279100|FG000|Overall Study|Adverse Event|35|||
164249300|NCT00988052|593279101|FG001|Overall Study|Adverse Event|28|||
164249301|NCT00988052|593279100|FG000|Overall Study|Withdrawal by Subject|90|||
164249302|NCT00988052|593279101|FG001|Overall Study|Withdrawal by Subject|91|||
164249303|NCT00988052|593279100|FG000|Overall Study|Study terminated by sponsor|240|||
164249304|NCT00988052|593279101|FG001|Overall Study|Study terminated by sponsor|236|||
164249305|NCT00842153|593279102|FG000|Overall Study|Adverse Event|0|||
164249306|NCT00842153|593279103|FG001|Overall Study|Adverse Event|1|||
164249307|NCT00842153|593279102|FG000|Overall Study|Lost to Follow-up|1|||
164249308|NCT00842153|593279103|FG001|Overall Study|Lost to Follow-up|2|||
164249309|NCT05312697|593279105|FG000|Overall Study|Sponsor Terminated Trial|2|||
164249310|NCT02858440|593279106|FG000|Overall Study|Lost to Follow-up|3|||
164249311|NCT02858440|593279106|FG000|Overall Study|Protocol Violation|2|||
164249312|NCT02858440|593279106|FG000|Overall Study|Consent withdrawal|3|||
164249313|NCT02858440|593279106|FG000|Overall Study|Migrated/moved from study area|4|||
164249314|NCT00402324|593279107|FG000|Overall Study|Lost to Follow-up|11|||
164249315|NCT00402324|593279108|FG001|Overall Study|Lost to Follow-up|11|||
164249316|NCT00402324|593279107|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
164249317|NCT00402324|593279108|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
164249318|NCT00402324|593279107|FG000|Overall Study|Protocol Violation|8|||
164249319|NCT00402324|593279108|FG001|Overall Study|Protocol Violation|7|||
164249320|NCT00402324|593279107|FG000|Overall Study|Withdrawal by Subject|5|||
164249321|NCT00402324|593279108|FG001|Overall Study|Withdrawal by Subject|2|||
164249322|NCT00402324|593279107|FG000|Overall Study|Physician Decision|2|||
164249323|NCT00402324|593279108|FG001|Overall Study|Physician Decision|4|||
164249324|NCT00402324|593279107|FG000|Overall Study|Sponsor Decision|4|||
164249325|NCT00402324|593279108|FG001|Overall Study|Sponsor Decision|5|||
164249326|NCT00402324|593279107|FG000|Overall Study|Lack of Efficacy|1|||
164249327|NCT00402324|593279108|FG001|Overall Study|Lack of Efficacy|4|||
164249328|NCT00402324|593279107|FG000|Overall Study|Adverse Event|6|||
164249329|NCT00402324|593279108|FG001|Overall Study|Adverse Event|4|||
164249330|NCT00402324|593279107|FG000|Overall Study|Death|1|||
164249331|NCT00402324|593279108|FG001|Overall Study|Death|0|||
164249332|NCT01277822|593279109|FG000|Overall Study|Adverse Event|2|||
164249333|NCT01277822|593279110|FG001|Overall Study|Adverse Event|1|||
164249334|NCT01277822|593279109|FG000|Overall Study|Withdrawal by Subject|6|||
164249335|NCT01277822|593279110|FG001|Overall Study|Withdrawal by Subject|7|||
164249336|NCT01277822|593279109|FG000|Overall Study|Physician Decision|1|||
164249337|NCT01277822|593279110|FG001|Overall Study|Physician Decision|1|||
164249338|NCT01277822|593279109|FG000|Overall Study|Protocol Violation|1|||
164249339|NCT01277822|593279110|FG001|Overall Study|Protocol Violation|0|||
164249340|NCT01277822|593279109|FG000|Overall Study|Lost to Follow-up|2|||
164249341|NCT01277822|593279110|FG001|Overall Study|Lost to Follow-up|1|||
164249342|NCT01277822|593279109|FG000|Overall Study|Contraindicated medication used|2|||
164338623|NCT02663908|593615214|FG001|Overall Study|COVID-19|0|||
164338624|NCT02663908|593615213|FG000|Overall Study|Site closed|1|||
164249343|NCT01277822|593279110|FG001|Overall Study|Contraindicated medication used|1|||
164249344|NCT01277822|593279109|FG000|Overall Study|Participant moved|1|||
164249345|NCT01277822|593279110|FG001|Overall Study|Participant moved|0|||
164249346|NCT00997984|593279111|FG000|Overall Study|Adverse Event|1|||
164249347|NCT00997984|593279112|FG001|Overall Study|Adverse Event|8|||
164338625|NCT02663908|593615214|FG001|Overall Study|Site closed|0|||
164338626|NCT02663908|593615213|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
164249348|NCT00997984|593279113|FG002|Overall Study|Adverse Event|8|||
164249349|NCT00997984|593279111|FG000|Overall Study|Protocol Violation|1|||
164249350|NCT00997984|593279112|FG001|Overall Study|Protocol Violation|3|||
164249351|NCT00997984|593279113|FG002|Overall Study|Protocol Violation|0|||
164249352|NCT00997984|593279111|FG000|Overall Study|Withdrawal by Subject|6|||
164249353|NCT00997984|593279112|FG001|Overall Study|Withdrawal by Subject|9|||
164249354|NCT00997984|593279113|FG002|Overall Study|Withdrawal by Subject|5|||
164249355|NCT00997984|593279111|FG000|Overall Study|Lost to Follow-up|8|||
164249356|NCT00997984|593279112|FG001|Overall Study|Lost to Follow-up|5|||
164249357|NCT00997984|593279113|FG002|Overall Study|Lost to Follow-up|4|||
164249358|NCT00997984|593279111|FG000|Overall Study|Lack of Efficacy|20|||
164249359|NCT00997984|593279112|FG001|Overall Study|Lack of Efficacy|6|||
164249360|NCT00997984|593279113|FG002|Overall Study|Lack of Efficacy|3|||
164249361|NCT00997984|593279111|FG000|Overall Study|Met exclusion criteria|1|||
164249362|NCT00997984|593279112|FG001|Overall Study|Met exclusion criteria|0|||
164249363|NCT00997984|593279113|FG002|Overall Study|Met exclusion criteria|0|||
164249364|NCT00997984|593279111|FG000|Overall Study|non-compliance|0|||
164249365|NCT00997984|593279112|FG001|Overall Study|non-compliance|2|||
164249366|NCT00997984|593279113|FG002|Overall Study|non-compliance|3|||
164249367|NCT00997984|593279111|FG000|Overall Study|Wrong medication dispensed|0|||
164249368|NCT00997984|593279112|FG001|Overall Study|Wrong medication dispensed|1|||
164249369|NCT00997984|593279113|FG002|Overall Study|Wrong medication dispensed|0|||
164249370|NCT00997984|593279111|FG000|Overall Study|Suicidal ideation|0|||
164249371|NCT00997984|593279112|FG001|Overall Study|Suicidal ideation|0|||
164249372|NCT00997984|593279113|FG002|Overall Study|Suicidal ideation|1|||
164249373|NCT00997984|593279111|FG000|Overall Study|Work schedule|0|||
164249374|NCT00997984|593279112|FG001|Overall Study|Work schedule|0|||
164249375|NCT00997984|593279113|FG002|Overall Study|Work schedule|2|||
164249376|NCT01945996|593279115|FG000|Overall Study|Lost to Follow-up|3|||
164249377|NCT01945996|593279116|FG001|Overall Study|Lost to Follow-up|5|||
164249378|NCT04396795|593279117|FG000|Month 1|Lost to Follow-up|2|||
164249379|NCT04396795|593279118|FG001|Month 1|Lost to Follow-up|3|||
164249380|NCT04396795|593279117|FG000|Month 3|Lost to Follow-up|1|||
164249381|NCT04396795|593279118|FG001|Month 3|Lost to Follow-up|3|||
164249382|NCT04396795|593279117|FG000|Month 6|Lost to Follow-up|3|||
164249383|NCT04396795|593279118|FG001|Month 6|Lost to Follow-up|3|||
164249384|NCT01107392|593279120|FG000|Overall Study|Adverse Event|2|||
164249385|NCT01107392|593279121|FG001|Overall Study|Adverse Event|0|||
164249386|NCT01107392|593279120|FG000|Overall Study|Personal Reasons|2|||
164249387|NCT01107392|593279121|FG001|Overall Study|Personal Reasons|3|||
164249388|NCT01107392|593279120|FG000|Overall Study|Administrative decision|1|||
164249389|NCT01107392|593279121|FG001|Overall Study|Administrative decision|0|||
164249390|NCT02689206|593279124|FG000|Overall Study|Adverse Event|0|||
164249391|NCT02689206|593279125|FG001|Overall Study|Adverse Event|0|||
164249392|NCT02689206|593279126|FG002|Overall Study|Adverse Event|1|||
164249393|NCT02689206|593279127|FG003|Overall Study|Adverse Event|0|||
164249394|NCT02689206|593279128|FG004|Overall Study|Adverse Event|2|||
164249395|NCT02689206|593279124|FG000|Overall Study|Protocol Violation|1|||
164249396|NCT02689206|593279125|FG001|Overall Study|Protocol Violation|0|||
164249397|NCT02689206|593279126|FG002|Overall Study|Protocol Violation|0|||
164249398|NCT02689206|593279127|FG003|Overall Study|Protocol Violation|1|||
164249399|NCT02689206|593279128|FG004|Overall Study|Protocol Violation|2|||
164249400|NCT02689206|593279124|FG000|Overall Study|Other: Reached stopping criteria|0|||
164249401|NCT02689206|593279125|FG001|Overall Study|Other: Reached stopping criteria|1|||
164249402|NCT02689206|593279126|FG002|Overall Study|Other: Reached stopping criteria|2|||
164249403|NCT02689206|593279127|FG003|Overall Study|Other: Reached stopping criteria|3|||
164249404|NCT02689206|593279128|FG004|Overall Study|Other: Reached stopping criteria|4|||
164249405|NCT02689206|593279124|FG000|Overall Study|Physician Decision|1|||
164249406|NCT02689206|593279125|FG001|Overall Study|Physician Decision|0|||
164249407|NCT02689206|593279126|FG002|Overall Study|Physician Decision|0|||
164249408|NCT02689206|593279127|FG003|Overall Study|Physician Decision|0|||
164249409|NCT02689206|593279128|FG004|Overall Study|Physician Decision|0|||
164249410|NCT02689206|593279124|FG000|Overall Study|Withdrawal by Subject|1|||
164249411|NCT02689206|593279125|FG001|Overall Study|Withdrawal by Subject|0|||
164249412|NCT02689206|593279126|FG002|Overall Study|Withdrawal by Subject|1|||
164249413|NCT02689206|593279127|FG003|Overall Study|Withdrawal by Subject|0|||
164249414|NCT02689206|593279128|FG004|Overall Study|Withdrawal by Subject|0|||
164249415|NCT02520388|593279129|FG000|Overall Study|Physician Decision|1|||
164249416|NCT02520388|593279130|FG001|Overall Study|Physician Decision|0|||
164249417|NCT02520388|593279129|FG000|Overall Study|Subject or parent/guardian request|0|||
164249418|NCT02520388|593279130|FG001|Overall Study|Subject or parent/guardian request|6|||
164249419|NCT02520388|593279129|FG000|Overall Study|Adverse Event|1|||
164249420|NCT02520388|593279130|FG001|Overall Study|Adverse Event|4|||
164249421|NCT02520388|593279129|FG000|Overall Study|Lost to Follow-up|3|||
164249422|NCT02520388|593279130|FG001|Overall Study|Lost to Follow-up|2|||
164141951|NCT00673387|592880860|FG004|Overall Study|Lost to Follow-up|6|||
164141952|NCT00673387|592880861|FG005|Overall Study|Lost to Follow-up|5|||
164141953|NCT00673387|592880862|FG006|Overall Study|Lost to Follow-up|8|||
164141954|NCT00673387|592880863|FG007|Overall Study|Lost to Follow-up|5|||
164141955|NCT02533375|592880864|FG000|Overall Study|Lack of Efficacy|3|||
164141956|NCT02533375|592880864|FG000|Overall Study|Adverse Event|2|||
164141957|NCT00960115|592880865|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
164141958|NCT00960115|592880866|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
164141959|NCT01104792|592880867|FG000|Overall Study|Adverse Event|77|||
164141960|NCT01104792|592880867|FG000|Overall Study|Insufficient Therapeutic Response|22|||
164141961|NCT01104792|592880867|FG000|Overall Study|Protocol Violation|45|||
164141962|NCT01104792|592880867|FG000|Overall Study|Withdrawal of Consent|179|||
164141963|NCT01104792|592880867|FG000|Overall Study|Lost to Follow-up|43|||
164141964|NCT01104792|592880867|FG000|Overall Study|Reasons Not Specified|27|||
164249423|NCT02520388|593279129|FG000|Overall Study|Other (reason not defined)|4|||
164249424|NCT02520388|593279130|FG001|Overall Study|Other (reason not defined)|4|||
164249425|NCT00431444|593279133|FG000|Overall Study|Protocol Violation|1|||
164249426|NCT00431444|593279134|FG001|Overall Study|Protocol Violation|4|||
164249427|NCT00431444|593279133|FG000|Overall Study|Adverse Event|2|||
164249428|NCT00431444|593279134|FG001|Overall Study|Adverse Event|1|||
164249429|NCT00431444|593279133|FG000|Overall Study|Withdrawal by Subject|1|||
164249430|NCT00431444|593279134|FG001|Overall Study|Withdrawal by Subject|1|||
164249431|NCT00431444|593279133|FG000|Overall Study|Lost to Follow-up|1|||
164249432|NCT00431444|593279134|FG001|Overall Study|Lost to Follow-up|0|||
164249433|NCT00431444|593279133|FG000|Overall Study|Administrative Problems|0|||
164249434|NCT00431444|593279134|FG001|Overall Study|Administrative Problems|1|||
164249435|NCT01352221|593279138|FG000|Double-blind Phase|Adverse Event|6|||
164249436|NCT01352221|593279139|FG001|Double-blind Phase|Adverse Event|4|||
164249437|NCT01352221|593279140|FG002|Double-blind Phase|Adverse Event|0|||
164249438|NCT01352221|593279141|FG003|Double-blind Phase|Adverse Event|0|||
164249439|NCT01352221|593279138|FG000|Double-blind Phase|Withdrawal by Subject|3|||
164249440|NCT01352221|593279139|FG001|Double-blind Phase|Withdrawal by Subject|5|||
164249441|NCT01352221|593279140|FG002|Double-blind Phase|Withdrawal by Subject|0|||
164249442|NCT01352221|593279141|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164249443|NCT01352221|593279138|FG000|Double-blind Phase|Lost to Follow-up|0|||
164249444|NCT01352221|593279139|FG001|Double-blind Phase|Lost to Follow-up|1|||
164249445|NCT01352221|593279140|FG002|Double-blind Phase|Lost to Follow-up|0|||
164249446|NCT01352221|593279141|FG003|Double-blind Phase|Lost to Follow-up|0|||
164249447|NCT01352221|593279138|FG000|Double-blind Phase|Protocol Violation|0|||
164249448|NCT01352221|593279139|FG001|Double-blind Phase|Protocol Violation|1|||
164249449|NCT01352221|593279140|FG002|Double-blind Phase|Protocol Violation|0|||
164249450|NCT01352221|593279141|FG003|Double-blind Phase|Protocol Violation|0|||
164249451|NCT01352221|593279138|FG000|Open-label Phase|Physician Decision|0|||
164249452|NCT01352221|593279139|FG001|Open-label Phase|Physician Decision|0|||
164249453|NCT01352221|593279140|FG002|Open-label Phase|Physician Decision|2|||
164249454|NCT01352221|593279141|FG003|Open-label Phase|Physician Decision|1|||
164249455|NCT01352221|593279138|FG000|Open-label Phase|Pregnancy|0|||
164249456|NCT01352221|593279139|FG001|Open-label Phase|Pregnancy|0|||
164249457|NCT01352221|593279140|FG002|Open-label Phase|Pregnancy|1|||
164249458|NCT01352221|593279141|FG003|Open-label Phase|Pregnancy|0|||
164249459|NCT01352221|593279138|FG000|Open-label Phase|Adverse Event|0|||
163991390|NCT01622569|592337138|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
164249460|NCT01352221|593279139|FG001|Open-label Phase|Adverse Event|0|||
164249461|NCT01352221|593279140|FG002|Open-label Phase|Adverse Event|8|||
164249462|NCT01352221|593279141|FG003|Open-label Phase|Adverse Event|4|||
164249463|NCT01352221|593279138|FG000|Open-label Phase|Withdrawal by Subject|0|||
164249464|NCT01352221|593279139|FG001|Open-label Phase|Withdrawal by Subject|0|||
164249465|NCT01352221|593279140|FG002|Open-label Phase|Withdrawal by Subject|1|||
164249466|NCT01352221|593279141|FG003|Open-label Phase|Withdrawal by Subject|6|||
164249467|NCT01352221|593279138|FG000|Open-label Phase|Worsening of IBD|0|||
164249468|NCT01352221|593279139|FG001|Open-label Phase|Worsening of IBD|0|||
164249469|NCT01352221|593279140|FG002|Open-label Phase|Worsening of IBD|1|||
164249470|NCT01352221|593279141|FG003|Open-label Phase|Worsening of IBD|0|||
164249471|NCT00200967|593279142|FG000|First Treatment Period|Withdrawal by Subject|5|||
164249472|NCT00200967|593279143|FG001|First Treatment Period|Withdrawal by Subject|1|||
164249473|NCT00200967|593279142|FG000|First Treatment Period|Pregnancy|1|||
164249474|NCT00200967|593279143|FG001|First Treatment Period|Pregnancy|0|||
164249475|NCT00200967|593279142|FG000|Wash-out Period|Lost to Follow-up|0|||
164249476|NCT00200967|593279143|FG001|Wash-out Period|Lost to Follow-up|1|||
164249477|NCT00200967|593279142|FG000|Second Treatment Period|Withdrawal by Subject|1|||
164249478|NCT00200967|593279143|FG001|Second Treatment Period|Withdrawal by Subject|2|||
163991391|NCT01622569|592337139|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
163991392|NCT01622569|592337140|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
163991393|NCT01622569|592337141|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
163991394|NCT01622569|592337138|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
163991395|NCT01622569|592337139|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
164249479|NCT00200967|593279142|FG000|Run-out Period|Lost to Follow-up|1|||
164249480|NCT00200967|593279143|FG001|Run-out Period|Lost to Follow-up|0|||
164249481|NCT00980460|593279144|FG000|Overall Study|Death|0|||
164249482|NCT00980460|593279145|FG001|Overall Study|Death|0|||
164249483|NCT00980460|593279146|FG002|Overall Study|Death|1|||
164249484|NCT00980460|593279147|FG003|Overall Study|Death|2|||
164249485|NCT00980460|593279148|FG004|Overall Study|Death|1|||
164249486|NCT00980460|593279144|FG000|Overall Study|Lack of Efficacy|0|||
164249487|NCT00980460|593279145|FG001|Overall Study|Lack of Efficacy|0|||
164249488|NCT00980460|593279146|FG002|Overall Study|Lack of Efficacy|10|||
164249489|NCT00980460|593279147|FG003|Overall Study|Lack of Efficacy|6|||
164249490|NCT00980460|593279148|FG004|Overall Study|Lack of Efficacy|8|||
164249491|NCT00980460|593279144|FG000|Overall Study|Lost to Follow-up|0|||
164249492|NCT00980460|593279145|FG001|Overall Study|Lost to Follow-up|0|||
164249493|NCT00980460|593279146|FG002|Overall Study|Lost to Follow-up|0|||
164249494|NCT00980460|593279147|FG003|Overall Study|Lost to Follow-up|1|||
164249495|NCT00980460|593279148|FG004|Overall Study|Lost to Follow-up|0|||
164249496|NCT00980460|593279144|FG000|Overall Study|Physician Decision|0|||
164249497|NCT00980460|593279145|FG001|Overall Study|Physician Decision|0|||
164249498|NCT00980460|593279146|FG002|Overall Study|Physician Decision|11|||
164249499|NCT00980460|593279147|FG003|Overall Study|Physician Decision|5|||
164249500|NCT00980460|593279148|FG004|Overall Study|Physician Decision|3|||
164249501|NCT00980460|593279144|FG000|Overall Study|Withdrawal by Subject|0|||
164249502|NCT00980460|593279145|FG001|Overall Study|Withdrawal by Subject|0|||
164249503|NCT00980460|593279146|FG002|Overall Study|Withdrawal by Subject|1|||
164249504|NCT00980460|593279147|FG003|Overall Study|Withdrawal by Subject|0|||
164249505|NCT00980460|593279148|FG004|Overall Study|Withdrawal by Subject|0|||
164249506|NCT00980460|593279144|FG000|Overall Study|Ineligible|0|||
164249507|NCT00980460|593279145|FG001|Overall Study|Ineligible|2|||
164249508|NCT00980460|593279146|FG002|Overall Study|Ineligible|3|||
164249509|NCT00980460|593279147|FG003|Overall Study|Ineligible|1|||
164249510|NCT00980460|593279148|FG004|Overall Study|Ineligible|4|||
164249511|NCT00980460|593279144|FG000|Overall Study|Refusal of further therapy|0|||
164249512|NCT00980460|593279145|FG001|Overall Study|Refusal of further therapy|2|||
164249513|NCT00980460|593279146|FG002|Overall Study|Refusal of further therapy|3|||
164249514|NCT00980460|593279147|FG003|Overall Study|Refusal of further therapy|2|||
164249515|NCT00980460|593279148|FG004|Overall Study|Refusal of further therapy|0|||
164249516|NCT00980460|593279144|FG000|Overall Study|No therapy within 42 days of resection|0|||
164249517|NCT00980460|593279145|FG001|Overall Study|No therapy within 42 days of resection|0|||
164249518|NCT00980460|593279146|FG002|Overall Study|No therapy within 42 days of resection|3|||
164249519|NCT00980460|593279147|FG003|Overall Study|No therapy within 42 days of resection|1|||
164249520|NCT00980460|593279148|FG004|Overall Study|No therapy within 42 days of resection|0|||
164249521|NCT00980460|593279144|FG000|Overall Study|No transplant by protocol timepoints|0|||
164249522|NCT00980460|593279145|FG001|Overall Study|No transplant by protocol timepoints|0|||
164249523|NCT00980460|593279146|FG002|Overall Study|No transplant by protocol timepoints|3|||
164249524|NCT00980460|593279147|FG003|Overall Study|No transplant by protocol timepoints|0|||
164249525|NCT00980460|593279148|FG004|Overall Study|No transplant by protocol timepoints|0|||
164249526|NCT02842086|593279149|FG000|Overall Study|Randomized but Never Treated|6|||
164249527|NCT02842086|593279150|FG001|Overall Study|Randomized but Never Treated|6|||
164249528|NCT02842086|593279149|FG000|Overall Study|Still in Double-Blind Phase|7|||
164249529|NCT02842086|593279150|FG001|Overall Study|Still in Double-Blind Phase|3|||
164249530|NCT02842086|593279149|FG000|Overall Study|Adverse Event|18|||
164249531|NCT02842086|593279150|FG001|Overall Study|Adverse Event|20|||
164249532|NCT02842086|593279149|FG000|Overall Study|Death|3|||
164249533|NCT02842086|593279150|FG001|Overall Study|Death|3|||
164249534|NCT02842086|593279149|FG000|Overall Study|Investigator's Discretion|9|||
164249535|NCT02842086|593279150|FG001|Overall Study|Investigator's Discretion|13|||
164249536|NCT02842086|593279149|FG000|Overall Study|Non-Compliance with Study Drug|9|||
164249537|NCT02842086|593279150|FG001|Overall Study|Non-Compliance with Study Drug|8|||
164249538|NCT02842086|593279149|FG000|Overall Study|Protocol Violation|8|||
164249539|NCT02842086|593279150|FG001|Overall Study|Protocol Violation|4|||
164249540|NCT02842086|593279149|FG000|Overall Study|Withdrew Consent|205|||
164249541|NCT02842086|593279150|FG001|Overall Study|Withdrew Consent|194|||
164249542|NCT02842086|593279149|FG000|Overall Study|Lost to Follow-up|274|||
164249543|NCT02842086|593279150|FG001|Overall Study|Lost to Follow-up|236|||
163991396|NCT01622569|592337140|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
163991397|NCT01622569|592337141|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
163991398|NCT01622569|592337138|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
163991399|NCT01622569|592337139|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
163991400|NCT01622569|592337140|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
163991401|NCT01622569|592337141|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
163991402|NCT01622569|592337138|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
163991403|NCT01622569|592337139|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164249544|NCT02842086|593279149|FG000|Overall Study|HIV-1 Infection|5|||
164249545|NCT02842086|593279150|FG001|Overall Study|HIV-1 Infection|6|||
164249546|NCT00928187|593279151|FG000|Overall Study|Death|1|||
164249547|NCT00928187|593279152|FG001|Overall Study|Death|2|||
164249548|NCT00928187|593279153|FG002|Overall Study|Death|3|||
164249549|NCT00928187|593279151|FG000|Overall Study|Lost to Follow-up|1|||
164249550|NCT00928187|593279152|FG001|Overall Study|Lost to Follow-up|2|||
164249551|NCT00928187|593279153|FG002|Overall Study|Lost to Follow-up|1|||
164249552|NCT00928187|593279151|FG000|Overall Study|Withdrawal by Subject|0|||
164249553|NCT00928187|593279152|FG001|Overall Study|Withdrawal by Subject|1|||
164084017|NCT02884206|592672230|FG002|Double-Blind Period|Patient/guardian decision|13|||
164084018|NCT02884206|592672228|FG000|Double-Blind Period|Lost to Follow-up|0|||
164084019|NCT02884206|592672229|FG001|Double-Blind Period|Lost to Follow-up|4|||
164084020|NCT02884206|592672230|FG002|Double-Blind Period|Lost to Follow-up|4|||
164084021|NCT02884206|592672228|FG000|Double-Blind Period|Physician Decision|0|||
164084022|NCT02884206|592672229|FG001|Double-Blind Period|Physician Decision|2|||
164084023|NCT02884206|592672230|FG002|Double-Blind Period|Physician Decision|0|||
164084024|NCT02884206|592672228|FG000|Double-Blind Period|Adverse Event|0|||
164084025|NCT02884206|592672229|FG001|Double-Blind Period|Adverse Event|0|||
164084026|NCT02884206|592672230|FG002|Double-Blind Period|Adverse Event|3|||
164084027|NCT02884206|592672228|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
164084028|NCT02884206|592672229|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
164084029|NCT02884206|592672230|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
164084030|NCT01628120|592672231|FG000|Overall Study|Withdrawal by Subject|7|||
164084031|NCT01628120|592672231|FG000|Overall Study|Adverse Event|12|||
164084032|NCT01628120|592672231|FG000|Overall Study|Lost to Follow-up|1|||
164338627|NCT02663908|593615214|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
164338628|NCT02663908|593615213|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
163886533|NCT03628924|591956474|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163886534|NCT03628924|591956475|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163886535|NCT03628924|591956476|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163886536|NCT03628924|591956477|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
163886537|NCT03628924|591956471|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163886538|NCT03628924|591956472|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
163886539|NCT03628924|591956473|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163886540|NCT03628924|591956474|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163886541|NCT03628924|591956475|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163886542|NCT03628924|591956476|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163886543|NCT03628924|591956477|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163886544|NCT03628924|591956471|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
163886545|NCT03628924|591956472|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163886546|NCT03628924|591956473|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
163886547|NCT03628924|591956474|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163886548|NCT03628924|591956475|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163886549|NCT03628924|591956476|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163886550|NCT03628924|591956477|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
163886551|NCT03628924|591956471|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
163886552|NCT03628924|591956472|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
163886553|NCT03628924|591956473|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
163886554|NCT03628924|591956474|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
163886555|NCT03628924|591956475|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
163886556|NCT03628924|591956476|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
163886557|NCT03628924|591956477|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
163886558|NCT03628924|591956471|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163886559|NCT03628924|591956472|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163886560|NCT03628924|591956473|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163886561|NCT03628924|591956474|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
163886562|NCT03628924|591956475|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
163886563|NCT03628924|591956476|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
163886564|NCT03628924|591956477|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
163886565|NCT03628924|591956471|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163886566|NCT03628924|591956472|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163886567|NCT03628924|591956473|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163886568|NCT03628924|591956474|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
163886569|NCT03628924|591956475|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
163886570|NCT03628924|591956476|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
163886571|NCT03628924|591956477|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
163886572|NCT03628924|591956471|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
163886573|NCT03628924|591956472|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
163886574|NCT03628924|591956473|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
163886575|NCT03628924|591956474|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
163886576|NCT03628924|591956475|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
163886577|NCT03628924|591956476|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
163886578|NCT03628924|591956477|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
163886579|NCT03628924|591956471|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163886580|NCT03628924|591956472|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163886581|NCT03628924|591956473|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
164249554|NCT00928187|593279153|FG002|Overall Study|Withdrawal by Subject|1|||
164249555|NCT00928187|593279151|FG000|Overall Study|Protocol Violation|0|||
163991404|NCT01622569|592337140|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
164249556|NCT00928187|593279152|FG001|Overall Study|Protocol Violation|1|||
164249557|NCT00928187|593279153|FG002|Overall Study|Protocol Violation|0|||
164249558|NCT05696444|593279154|FG000|Treatment|Physician Decision|0|||
164249559|NCT05696444|593279155|FG001|Treatment|Physician Decision|1|||
164249560|NCT05696444|593279156|FG002|Treatment|Physician Decision|0|||
164249561|NCT05696444|593279154|FG000|30 Days|Death|1|||
164249562|NCT05696444|593279155|FG001|30 Days|Death|1|||
164249563|NCT05696444|593279156|FG002|30 Days|Death|0|||
164249564|NCT05696444|593279154|FG000|30 Days|Missed Visit|1|||
164249565|NCT05696444|593279155|FG001|30 Days|Missed Visit|1|||
164249566|NCT05696444|593279156|FG002|30 Days|Missed Visit|1|||
164249567|NCT00078806|593279996|FG000|Part 1A|Adverse Event|2|||
164249568|NCT00078806|593279997|FG001|Part 1A|Adverse Event|0|||
164249569|NCT00078806|593279998|FG002|Part 1A|Adverse Event|0|||
164249570|NCT00078806|593279999|FG003|Part 1A|Adverse Event|0|||
164249571|NCT00078806|593279996|FG000|Part 1A|Lack of Efficacy|7|||
164249572|NCT00078806|593279997|FG001|Part 1A|Lack of Efficacy|0|||
164249573|NCT00078806|593279998|FG002|Part 1A|Lack of Efficacy|0|||
164249574|NCT00078806|593279999|FG003|Part 1A|Lack of Efficacy|0|||
164249575|NCT00078806|593279996|FG000|Part 1A|Other|1|||
164249576|NCT00078806|593279997|FG001|Part 1A|Other|0|||
164249577|NCT00078806|593279998|FG002|Part 1A|Other|0|||
163991405|NCT01622569|592337141|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
163991406|NCT02522767|592337142|FG000|Double-blind|Withdrawal by Subject|8|||
163991407|NCT02522767|592337143|FG001|Double-blind|Withdrawal by Subject|11|||
164249578|NCT00078806|593279999|FG003|Part 1A|Other|0|||
164249579|NCT00078806|593279996|FG000|Part 1B|Adverse Event|1|||
164249580|NCT00078806|593279997|FG001|Part 1B|Adverse Event|0|||
164249581|NCT00078806|593279998|FG002|Part 1B|Adverse Event|0|||
164249582|NCT00078806|593279999|FG003|Part 1B|Adverse Event|0|||
164249583|NCT00078806|593279996|FG000|Part 1B|Lack of Efficacy|7|||
164249584|NCT00078806|593279997|FG001|Part 1B|Lack of Efficacy|0|||
164249585|NCT00078806|593279998|FG002|Part 1B|Lack of Efficacy|0|||
164249586|NCT00078806|593279999|FG003|Part 1B|Lack of Efficacy|0|||
164249587|NCT00078806|593279996|FG000|Part 2|Adverse Event|0|||
164249588|NCT00078806|593279997|FG001|Part 2|Adverse Event|1|||
164249589|NCT00078806|593279998|FG002|Part 2|Adverse Event|0|||
164249590|NCT00078806|593279999|FG003|Part 2|Adverse Event|0|||
164249591|NCT00161616|593280000|FG000|Overall Study|Withdrawal by Subject|6|||
164249592|NCT00161616|593280001|FG001|Overall Study|Withdrawal by Subject|5|||
164249593|NCT00161616|593280000|FG000|Overall Study|Physician Decision|1|||
164249594|NCT00161616|593280001|FG001|Overall Study|Physician Decision|0|||
163991408|NCT02522767|592337142|FG000|Double-blind|Lost to Follow-up|1|||
163991409|NCT02522767|592337143|FG001|Double-blind|Lost to Follow-up|0|||
163991410|NCT02522767|592337142|FG000|Double-blind|Adverse Event|1|||
163991411|NCT02522767|592337143|FG001|Double-blind|Adverse Event|10|||
163991412|NCT02522767|592337142|FG000|Double-blind|Protocol Violation|0|||
163991413|NCT02522767|592337143|FG001|Double-blind|Protocol Violation|1|||
163991414|NCT02522767|592337142|FG000|Double-blind|Lack of Efficacy|0|||
163991415|NCT02522767|592337143|FG001|Double-blind|Lack of Efficacy|2|||
163991416|NCT02522767|592337142|FG000|Double-blind|Protocol Deviation|1|||
163991417|NCT02522767|592337143|FG001|Double-blind|Protocol Deviation|0|||
163991418|NCT02522767|592337142|FG000|Open-label|Withdrawal by Subject|2|||
163991419|NCT02522767|592337143|FG001|Open-label|Withdrawal by Subject|3|||
163991420|NCT02522767|592337142|FG000|Open-label|Lost to Follow-up|0|||
164084033|NCT01628120|592672231|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
164084034|NCT01628120|592672231|FG000|Overall Study|Non-compliant with Study Procedures|1|||
164084035|NCT01628120|592672231|FG000|Overall Study|Not Treated|3|||
164249595|NCT00161616|593280000|FG000|Overall Study|Death|1|||
164249596|NCT00161616|593280001|FG001|Overall Study|Death|1|||
163991421|NCT02522767|592337143|FG001|Open-label|Lost to Follow-up|1|||
163991422|NCT02522767|592337142|FG000|Open-label|Adverse Event|2|||
163991423|NCT02522767|592337143|FG001|Open-label|Adverse Event|1|||
163991424|NCT02522767|592337142|FG000|Open-label|Lack of Efficacy|1|||
163991425|NCT02522767|592337143|FG001|Open-label|Lack of Efficacy|1|||
164084036|NCT01628120|592672231|FG000|Overall Study|Sponsor Decision|5|||
164249597|NCT00161616|593280000|FG000|Overall Study|Lost to Follow-up|17|||
164249598|NCT00161616|593280001|FG001|Overall Study|Lost to Follow-up|13|||
164249599|NCT00161616|593280000|FG000|Overall Study|Protocol deviation|1|||
164249600|NCT00161616|593280001|FG001|Overall Study|Protocol deviation|0|||
164249601|NCT00336284|593280002|FG000|Overall Study|Death|52|||
163991426|NCT02522767|592337142|FG000|Open-label|Protocol Violation|0|||
163991427|NCT02522767|592337143|FG001|Open-label|Protocol Violation|1|||
164249602|NCT00336284|593280003|FG001|Overall Study|Death|26|||
164249603|NCT00336284|593280002|FG000|Overall Study|Lost to Follow-up|82|||
164249604|NCT00336284|593280003|FG001|Overall Study|Lost to Follow-up|61|||
164249605|NCT00336284|593280002|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
164249606|NCT00336284|593280003|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
164249607|NCT00861757|593280006|FG000|Overall Study|Adverse Event|1|||
164249608|NCT00861757|593280007|FG001|Overall Study|Adverse Event|5|||
163991428|NCT00548548|592337144|FG000|Overall Study|Death|345|||
163991429|NCT00548548|592337145|FG001|Overall Study|Death|348|||
163991430|NCT00548548|592337144|FG000|Overall Study|Lost to Follow-up|17|||
163991431|NCT00548548|592337145|FG001|Overall Study|Lost to Follow-up|18|||
163991432|NCT01848145|592337146|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
163991433|NCT01848145|592337146|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
163991434|NCT01848145|592337146|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
163991435|NCT01848145|592337146|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
163991436|NCT01848145|592337146|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
163991437|NCT01848145|592337146|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
163991438|NCT01848145|592337146|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
163991439|NCT00364689|592337147|FG000|Overall Study|Lost to Follow-up|1|||
163991440|NCT03683394|592337152|FG000|Overall Study|Withdrawal by Subject|4|||
163991441|NCT03683394|592337153|FG001|Overall Study|Withdrawal by Subject|8|||
163991442|NCT03683394|592337152|FG000|Overall Study|Lost to Follow-up|7|||
163991443|NCT03683394|592337153|FG001|Overall Study|Lost to Follow-up|0|||
163991444|NCT03683394|592337152|FG000|Overall Study|Death|3|||
163991445|NCT03683394|592337153|FG001|Overall Study|Death|1|||
163991446|NCT03739528|592337154|FG000|Overall Study|Not treated|8|||
163991447|NCT03739528|592337155|FG001|Overall Study|Not treated|12|||
164249609|NCT00861757|593280008|FG002|Overall Study|Adverse Event|7|||
164249610|NCT00861757|593280009|FG003|Overall Study|Adverse Event|2|||
164249611|NCT00861757|593280006|FG000|Overall Study|Entry Criteria Not Met|1|||
164249612|NCT00861757|593280007|FG001|Overall Study|Entry Criteria Not Met|2|||
164249613|NCT00861757|593280008|FG002|Overall Study|Entry Criteria Not Met|1|||
164249614|NCT00861757|593280009|FG003|Overall Study|Entry Criteria Not Met|1|||
164249615|NCT00861757|593280006|FG000|Overall Study|Lack of Efficacy|3|||
164249616|NCT00861757|593280007|FG001|Overall Study|Lack of Efficacy|1|||
164249617|NCT00861757|593280008|FG002|Overall Study|Lack of Efficacy|0|||
164249618|NCT00861757|593280009|FG003|Overall Study|Lack of Efficacy|1|||
164249619|NCT00861757|593280006|FG000|Overall Study|Lost to Follow-up|1|||
164249620|NCT00861757|593280007|FG001|Overall Study|Lost to Follow-up|0|||
164249621|NCT00861757|593280008|FG002|Overall Study|Lost to Follow-up|1|||
164249622|NCT00861757|593280009|FG003|Overall Study|Lost to Follow-up|1|||
164249623|NCT00861757|593280006|FG000|Overall Study|Physician Decision|0|||
164249624|NCT00861757|593280007|FG001|Overall Study|Physician Decision|0|||
164249625|NCT00861757|593280008|FG002|Overall Study|Physician Decision|0|||
164249626|NCT00861757|593280009|FG003|Overall Study|Physician Decision|1|||
164249627|NCT00861757|593280006|FG000|Overall Study|Protocol Violation|2|||
164249628|NCT00861757|593280007|FG001|Overall Study|Protocol Violation|2|||
164249629|NCT00861757|593280008|FG002|Overall Study|Protocol Violation|4|||
164249630|NCT00861757|593280009|FG003|Overall Study|Protocol Violation|1|||
164249631|NCT00861757|593280006|FG000|Overall Study|Withdrawal by Subject|1|||
164249632|NCT00861757|593280007|FG001|Overall Study|Withdrawal by Subject|5|||
164249633|NCT00861757|593280008|FG002|Overall Study|Withdrawal by Subject|5|||
164249634|NCT00861757|593280009|FG003|Overall Study|Withdrawal by Subject|2|||
164249635|NCT04908384|593280010|FG000|Overall Study|Lost to Follow-up|4|||
164249636|NCT04908384|593280011|FG001|Overall Study|Lost to Follow-up|4|||
164249637|NCT04908384|593280012|FG002|Overall Study|Lost to Follow-up|0|||
164249638|NCT04908384|593280013|FG003|Overall Study|Lost to Follow-up|0|||
164249639|NCT04123093|593280014|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
163991448|NCT03739528|592337154|FG000|Overall Study|Treatment and study discontinued|6|||
163991449|NCT03739528|592337155|FG001|Overall Study|Treatment and study discontinued|2|||
163991450|NCT03739528|592337154|FG000|Overall Study|Treatment discontinued + study completed|1|||
163991451|NCT03739528|592337155|FG001|Overall Study|Treatment discontinued + study completed|3|||
164249640|NCT04123093|593280015|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
164249641|NCT04123093|593280014|FG000|Phase 2|Physician Decision|0|||
164249642|NCT04123093|593280015|FG001|Phase 2|Physician Decision|1|||
163886582|NCT03628924|591956474|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
163886583|NCT03628924|591956475|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
163886584|NCT03628924|591956476|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
163886585|NCT03628924|591956477|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
163886586|NCT05006872|591956480|FG000|Overall Study|Lost to Follow-up|37|||
163886587|NCT05006872|591956481|FG001|Overall Study|Lost to Follow-up|31|||
163886588|NCT05499377|591956486|FG000|Overall Study|Withdrawal by Subject|2|||
163886589|NCT05499377|591956487|FG001|Overall Study|Withdrawal by Subject|0|||
163886590|NCT05499377|591956486|FG000|Overall Study|Physician Decision|1|||
163886591|NCT05499377|591956487|FG001|Overall Study|Physician Decision|0|||
164249643|NCT04123093|593280014|FG000|Phase 2|Withdrawal by Subject|0|||
164249644|NCT04123093|593280015|FG001|Phase 2|Withdrawal by Subject|1|||
164249645|NCT03462641|593280019|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
164249646|NCT03462641|593280020|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
164338629|NCT02663908|593615214|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
163886592|NCT04332926|591956488|FG000|Overall Study|Withdrawal by Subject|6|||
163886593|NCT04332926|591956488|FG000|Overall Study|Physician Decision|6|||
164249647|NCT03462641|593280019|FG000|Visit 2|Withdrawal by Subject|0|||
164249648|NCT03462641|593280020|FG001|Visit 2|Withdrawal by Subject|1|||
164249649|NCT02923531|593280025|FG000|Overall Study|Adverse Event|4|||
164249650|NCT02923531|593280025|FG000|Overall Study|Clinical Deterioration|1|||
164249651|NCT02923531|593280025|FG000|Overall Study|Disease Progression|3|||
164249652|NCT02923531|593280025|FG000|Overall Study|Study Termination|1|||
164249653|NCT02201329|593280026|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
164249654|NCT02201329|593280026|FG000|Overall Study|Withdrawal by Subject|2|||
164249655|NCT02997865|593280027|FG000|Overall Study|Death|2|||
164249656|NCT02997865|593280028|FG001|Overall Study|Death|1|||
164249657|NCT02997865|593280027|FG000|Overall Study|Lost to Follow-up|6|||
164249658|NCT02997865|593280028|FG001|Overall Study|Lost to Follow-up|3|||
164338630|NCT02663908|593615213|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
164338631|NCT02663908|593615214|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
164338632|NCT02663908|593615213|FG000|Overall Study|Death|1|||
164338633|NCT02663908|593615214|FG001|Overall Study|Death|0|||
164338634|NCT02663908|593615213|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
164338635|NCT02663908|593615214|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
164338636|NCT02663908|593615213|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
164338637|NCT02663908|593615214|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
164338638|NCT02004522|593615215|FG000|Overall Study|Adverse Event|55|||
164338639|NCT02004522|593615216|FG001|Overall Study|Adverse Event|6|||
164338640|NCT02004522|593615215|FG000|Overall Study|Withdrawal by Subject|13|||
164338641|NCT02004522|593615216|FG001|Overall Study|Withdrawal by Subject|7|||
164338642|NCT02004522|593615215|FG000|Overall Study|Death|12|||
164338643|NCT02004522|593615216|FG001|Overall Study|Death|3|||
164338644|NCT02004522|593615215|FG000|Overall Study|Physician Decision|3|||
164338645|NCT02004522|593615216|FG001|Overall Study|Physician Decision|4|||
164338646|NCT02004522|593615215|FG000|Overall Study|Protocol Violation|1|||
164338647|NCT02004522|593615216|FG001|Overall Study|Protocol Violation|0|||
164338648|NCT02004522|593615215|FG000|Overall Study|Other is reason listed by PI|4|||
164338649|NCT02004522|593615216|FG001|Overall Study|Other is reason listed by PI|1|||
163886594|NCT05783102|591956489|FG000|Overall Study|Lost to Follow-up|1|||
163886595|NCT05783102|591956489|FG000|Overall Study|Withdrawal by Subject|2|||
163886596|NCT06019559|591956490|FG000|Overall Study|Withdrawal by Subject|7|||
163886597|NCT06019559|591956491|FG001|Overall Study|Withdrawal by Subject|6|||
163886598|NCT06019559|591956492|FG002|Overall Study|Withdrawal by Subject|5|||
163886599|NCT06019559|591956490|FG000|Overall Study|Lost to Follow-up|2|||
163886600|NCT06019559|591956491|FG001|Overall Study|Lost to Follow-up|0|||
163886601|NCT06019559|591956492|FG002|Overall Study|Lost to Follow-up|3|||
163886602|NCT05170009|591956494|FG000|Overall Study|Physician Decision|0|||
163886603|NCT05170009|591956495|FG001|Overall Study|Physician Decision|1|||
163886604|NCT04629716|591956496|FG000|Overall Study|Lost to Follow-up|7|||
163886605|NCT04629716|591956497|FG001|Overall Study|Lost to Follow-up|3|||
163886606|NCT00613106|591956505|FG000|Overall Study|Adverse Event|3|||
163886607|NCT00613106|591956506|FG001|Overall Study|Adverse Event|1|||
163886608|NCT00613106|591956505|FG000|Overall Study|Withdrawal by Subject|6|||
163886609|NCT00613106|591956506|FG001|Overall Study|Withdrawal by Subject|3|||
163886610|NCT00613106|591956505|FG000|Overall Study|Lost to Follow-up|7|||
163886611|NCT00613106|591956506|FG001|Overall Study|Lost to Follow-up|2|||
163886612|NCT00613106|591956505|FG000|Overall Study|misc|4|||
163886613|NCT00613106|591956506|FG001|Overall Study|misc|3|||
163886614|NCT03496168|591956507|FG000|Overall Study|Other Reasons|1|||
163886615|NCT03496168|591956507|FG000|Overall Study|Adverse Event|1|||
163886616|NCT05543629|591956510|FG000|Overall Study|Death|1|||
163886617|NCT05543629|591956511|FG001|Overall Study|Death|0|||
163886618|NCT05543629|591956512|FG002|Overall Study|Death|1|||
163886619|NCT05543629|591956513|FG003|Overall Study|Death|0|||
163886620|NCT05543629|591956514|FG004|Overall Study|Death|0|||
163991452|NCT02239263|592337156|FG000|Overall Study|Protocol Violation|6|||
163991453|NCT04303000|592337157|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
164249659|NCT02997865|593280027|FG000|Overall Study|Withdrawal by Subject|5|||
164249660|NCT02997865|593280028|FG001|Overall Study|Withdrawal by Subject|0|||
164249661|NCT04660552|593280030|FG000|Overall Study|Withdrawal by Subject|3|||
164249662|NCT04660552|593280031|FG001|Overall Study|Withdrawal by Subject|1|||
164249663|NCT03012828|593280032|FG000|Overall Study|Lost to Follow-up|1|||
163886621|NCT05543629|591956515|FG005|Overall Study|Death|1|||
163886622|NCT05543629|591956516|FG006|Overall Study|Death|2|||
163886623|NCT05543629|591956517|FG007|Overall Study|Death|2|||
163886624|NCT05543629|591956510|FG000|Overall Study|Other Reasons|0|||
163886625|NCT05543629|591956511|FG001|Overall Study|Other Reasons|0|||
163886626|NCT05543629|591956512|FG002|Overall Study|Other Reasons|0|||
163886627|NCT05543629|591956513|FG003|Overall Study|Other Reasons|0|||
163886628|NCT05543629|591956514|FG004|Overall Study|Other Reasons|1|||
164249664|NCT03012828|593280033|FG001|Overall Study|Lost to Follow-up|0|||
164249665|NCT03012828|593280034|FG002|Overall Study|Lost to Follow-up|1|||
164249666|NCT03012828|593280035|FG003|Overall Study|Lost to Follow-up|0|||
164249667|NCT03012828|593280036|FG004|Overall Study|Lost to Follow-up|1|||
164249668|NCT03012828|593280037|FG005|Overall Study|Lost to Follow-up|0|||
164249669|NCT03012828|593280032|FG000|Overall Study|Withdrawal by Subject|0|||
164249670|NCT03012828|593280033|FG001|Overall Study|Withdrawal by Subject|0|||
164249671|NCT03012828|593280034|FG002|Overall Study|Withdrawal by Subject|1|||
164249672|NCT03012828|593280035|FG003|Overall Study|Withdrawal by Subject|0|||
164249673|NCT03012828|593280036|FG004|Overall Study|Withdrawal by Subject|0|||
164249674|NCT03012828|593280037|FG005|Overall Study|Withdrawal by Subject|1|||
164249675|NCT03012828|593280032|FG000|Overall Study|Non-compliance with protocol|0|||
163886629|NCT05543629|591956515|FG005|Overall Study|Other Reasons|0|||
163886630|NCT05543629|591956516|FG006|Overall Study|Other Reasons|0|||
163886631|NCT05543629|591956517|FG007|Overall Study|Other Reasons|0|||
163886632|NCT05543629|591956510|FG000|Overall Study|Physician Decision|0|||
163886633|NCT05543629|591956511|FG001|Overall Study|Physician Decision|0|||
163886634|NCT05543629|591956512|FG002|Overall Study|Physician Decision|3|||
163886635|NCT05543629|591956513|FG003|Overall Study|Physician Decision|0|||
163886636|NCT05543629|591956514|FG004|Overall Study|Physician Decision|0|||
163886637|NCT05543629|591956515|FG005|Overall Study|Physician Decision|0|||
163886638|NCT05543629|591956516|FG006|Overall Study|Physician Decision|1|||
164249676|NCT03012828|593280033|FG001|Overall Study|Non-compliance with protocol|0|||
164249677|NCT03012828|593280034|FG002|Overall Study|Non-compliance with protocol|0|||
164249678|NCT03012828|593280035|FG003|Overall Study|Non-compliance with protocol|0|||
164249679|NCT03012828|593280036|FG004|Overall Study|Non-compliance with protocol|1|||
164249680|NCT03012828|593280037|FG005|Overall Study|Non-compliance with protocol|0|||
164249681|NCT03012828|593280032|FG000|Overall Study|Delay to last visit would delay DBL|0|||
164249682|NCT03012828|593280033|FG001|Overall Study|Delay to last visit would delay DBL|0|||
164249683|NCT03012828|593280034|FG002|Overall Study|Delay to last visit would delay DBL|0|||
164249684|NCT03012828|593280035|FG003|Overall Study|Delay to last visit would delay DBL|0|||
164249685|NCT03012828|593280036|FG004|Overall Study|Delay to last visit would delay DBL|0|||
164249686|NCT03012828|593280037|FG005|Overall Study|Delay to last visit would delay DBL|1|||
164249687|NCT01509846|593280038|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
164249688|NCT01509846|593280039|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
164249689|NCT01509846|593280040|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
164249690|NCT01509846|593280041|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
164249691|NCT01509846|593280042|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
164249692|NCT01509846|593280038|FG000|Received Vaccination 2|Illness|0|||
164249693|NCT01509846|593280039|FG001|Received Vaccination 2|Illness|0|||
164249694|NCT01509846|593280040|FG002|Received Vaccination 2|Illness|0|||
164249695|NCT01509846|593280041|FG003|Received Vaccination 2|Illness|0|||
164249696|NCT01509846|593280042|FG004|Received Vaccination 2|Illness|1|||
164249697|NCT01509846|593280038|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
164249698|NCT01509846|593280039|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
164249699|NCT01509846|593280040|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
164249700|NCT01509846|593280041|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
164249701|NCT01509846|593280042|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
164249702|NCT01509846|593280038|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
164249703|NCT01509846|593280039|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
164249704|NCT01509846|593280040|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
164249705|NCT01509846|593280041|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
164249706|NCT01509846|593280042|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
164249707|NCT01509846|593280038|FG000|Received Vaccination 3|Pregnancy|0|||
164249708|NCT01509846|593280039|FG001|Received Vaccination 3|Pregnancy|0|||
164249709|NCT01509846|593280040|FG002|Received Vaccination 3|Pregnancy|0|||
164249710|NCT01509846|593280041|FG003|Received Vaccination 3|Pregnancy|1|||
164249711|NCT01509846|593280042|FG004|Received Vaccination 3|Pregnancy|0|||
164249712|NCT01509846|593280038|FG000|Received Vaccination 3|Lost to Follow-up|0|||
164249713|NCT01509846|593280039|FG001|Received Vaccination 3|Lost to Follow-up|0|||
164249714|NCT01509846|593280040|FG002|Received Vaccination 3|Lost to Follow-up|1|||
164249715|NCT01509846|593280041|FG003|Received Vaccination 3|Lost to Follow-up|0|||
164249716|NCT01509846|593280042|FG004|Received Vaccination 3|Lost to Follow-up|0|||
164249717|NCT01637584|593280044|FG000|Overall Study|Withdrawal by Subject|1|||
164249718|NCT01637584|593280045|FG001|Overall Study|Withdrawal by Subject|3|||
164249719|NCT02366923|593280046|FG000|Overall Study|Withdrawal by Subject|1|||
164249720|NCT02366923|593280046|FG000|Overall Study|Positive Slit Lamp Findings|2|||
164249721|NCT02366923|593280046|FG000|Overall Study|High Astigmatism|3|||
164249722|NCT02484443|593280047|FG000|Overall Study|Lack of Efficacy|28|||
164249723|NCT02484443|593280047|FG000|Overall Study|Physician Decision|2|||
164249724|NCT02484443|593280047|FG000|Overall Study|Ineligible|2|||
164249725|NCT01970241|593280048|FG000|Overall Study|Withdrawal by Subject|2|||
163886639|NCT05543629|591956517|FG007|Overall Study|Physician Decision|0|||
163886640|NCT05543629|591956510|FG000|Overall Study|Study terminated by Sponsor|1|||
163886641|NCT05543629|591956511|FG001|Overall Study|Study terminated by Sponsor|0|||
164249726|NCT01970241|593280049|FG001|Overall Study|Withdrawal by Subject|0|||
164249727|NCT01970241|593280048|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
164249728|NCT01970241|593280049|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
164249729|NCT00992056|593280050|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
164249730|NCT00992056|593280051|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
164249731|NCT00992056|593280050|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
164249732|NCT00992056|593280051|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
164249733|NCT02595866|593280052|FG000|Overall Study|Adverse Event|2|||
164249734|NCT02595866|593280053|FG001|Overall Study|Adverse Event|5|||
164249735|NCT02595866|593280052|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
164249736|NCT02595866|593280053|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
164249737|NCT02595866|593280052|FG000|Overall Study|Death|0|||
164249738|NCT02595866|593280053|FG001|Overall Study|Death|1|||
164249739|NCT02595866|593280052|FG000|Overall Study|Incarceration|1|||
164249740|NCT02595866|593280053|FG001|Overall Study|Incarceration|0|||
164249741|NCT02595866|593280052|FG000|Overall Study|Lack of Efficacy|17|||
164249742|NCT02595866|593280053|FG001|Overall Study|Lack of Efficacy|7|||
164249743|NCT02595866|593280052|FG000|Overall Study|Physician Decision|4|||
164249744|NCT02595866|593280053|FG001|Overall Study|Physician Decision|3|||
164249745|NCT02595866|593280052|FG000|Overall Study|Switched to Alternative Treatment|1|||
164249746|NCT02595866|593280053|FG001|Overall Study|Switched to Alternative Treatment|0|||
164249747|NCT02595866|593280052|FG000|Overall Study|Study Terminated|0|||
164249748|NCT02595866|593280053|FG001|Overall Study|Study Terminated|4|||
164249749|NCT02595866|593280052|FG000|Overall Study|Withdrawal by Subject|6|||
164249750|NCT02595866|593280053|FG001|Overall Study|Withdrawal by Subject|1|||
164249751|NCT01001767|593280056|FG000|Overall Study|no baseline study performed|1|||
164249752|NCT01001767|593280057|FG001|Overall Study|no baseline study performed|0|||
164249753|NCT01001767|593280056|FG000|Overall Study|Protocol Violation|1|||
164249754|NCT01001767|593280057|FG001|Overall Study|Protocol Violation|0|||
164249755|NCT01001767|593280056|FG000|Overall Study|Lost to Follow-up|1|||
164249756|NCT01001767|593280057|FG001|Overall Study|Lost to Follow-up|0|||
164249757|NCT01001767|593280056|FG000|Overall Study|Physician Decision|1|||
164249758|NCT01001767|593280057|FG001|Overall Study|Physician Decision|0|||
164249759|NCT00177294|593280058|FG000|Overall Study|Withdrawal by Subject|7|||
164249760|NCT00177294|593280059|FG001|Overall Study|Withdrawal by Subject|5|||
164249761|NCT02131311|593280060|FG000|Overall Study|Adverse Event|2|||
164249762|NCT02131311|593280060|FG000|Overall Study|Protocol Violation|1|||
164249763|NCT02131311|593280060|FG000|Overall Study|Lost to Follow-up|1|||
164249764|NCT01479764|593280061|FG000|Randomized|Adverse Event|1|||
164249765|NCT01479764|593280062|FG001|Randomized|Adverse Event|1|||
164249766|NCT01479764|593280061|FG000|Randomized|Withdrawal by Subject|1|||
164249767|NCT01479764|593280062|FG001|Randomized|Withdrawal by Subject|0|||
164249768|NCT01479764|593280061|FG000|Treated|Lost to Follow-up|0|||
164249769|NCT01479764|593280062|FG001|Treated|Lost to Follow-up|2|||
164249770|NCT03082677|593280063|FG000|Overall Study|Not Treated|2|||
164249771|NCT00255723|593280065|FG000|Overall Study|Adverse Event|1|||
164249772|NCT00255723|593280066|FG001|Overall Study|Adverse Event|1|||
164249773|NCT00255723|593280065|FG000|Overall Study|Death|0|||
164249774|NCT00255723|593280066|FG001|Overall Study|Death|1|||
164249775|NCT00255723|593280065|FG000|Overall Study|Response Data Not Available|1|||
164249776|NCT00255723|593280066|FG001|Overall Study|Response Data Not Available|0|||
164249777|NCT03711370|593280067|FG000|Overall Study|Lost to Follow-up|16|||
164249778|NCT03711370|593280068|FG001|Overall Study|Lost to Follow-up|10|||
164249779|NCT03711370|593280067|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
164249780|NCT03711370|593280068|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
164249781|NCT01030952|593280069|FG000|Overall Study|Protocol Violation|0|||
164249782|NCT01030952|593280070|FG001|Overall Study|Protocol Violation|1|||
164249783|NCT01030952|593280069|FG000|Overall Study|Informed consent withdrawal|1|||
164249784|NCT01030952|593280070|FG001|Overall Study|Informed consent withdrawal|0|||
164249785|NCT01030952|593280069|FG000|Overall Study|Lost to Follow-up|0|||
164249786|NCT01030952|593280070|FG001|Overall Study|Lost to Follow-up|1|||
164338650|NCT02004522|593615215|FG000|Overall Study|Never Dosed|2|||
164338651|NCT02004522|593615216|FG001|Overall Study|Never Dosed|4|||
164338652|NCT02004522|593615215|FG000|Overall Study|Disease Progression|35|||
164338653|NCT02004522|593615216|FG001|Overall Study|Disease Progression|31|||
164338654|NCT02004522|593615215|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
164249787|NCT01030952|593280069|FG000|Overall Study|Unexplained|1|||
164249788|NCT01030952|593280070|FG001|Overall Study|Unexplained|1|||
164249789|NCT03554018|593280075|FG000|Overall Study|Lost to Follow-up|3|||
164249790|NCT03554018|593280076|FG001|Overall Study|Lost to Follow-up|7|||
164249791|NCT00130039|593280077|FG000|Overall Study|Withdrawal by Subject|15|||
164249792|NCT00130039|593280078|FG001|Overall Study|Withdrawal by Subject|11|||
164249793|NCT00130039|593280077|FG000|Overall Study|Lost to Follow-up|3|||
164249794|NCT00130039|593280078|FG001|Overall Study|Lost to Follow-up|1|||
164249795|NCT00130039|593280077|FG000|Overall Study|Adverse Event|4|||
164249796|NCT00130039|593280078|FG001|Overall Study|Adverse Event|2|||
164249797|NCT00130039|593280077|FG000|Overall Study|Physician Decision|3|||
164338655|NCT02004522|593615216|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
164249798|NCT00130039|593280078|FG001|Overall Study|Physician Decision|0|||
164249799|NCT00130039|593280077|FG000|Overall Study|clinical events without follow up MRI|5|||
164249800|NCT00130039|593280078|FG001|Overall Study|clinical events without follow up MRI|4|||
164249801|NCT01740687|593280079|FG000|Overall Study|Lost to Follow-up|11|||
164249802|NCT01740687|593280079|FG000|Overall Study|Withdrawal by Subject|2|||
164249803|NCT01740687|593280079|FG000|Overall Study|other reason|22|||
164249804|NCT01740687|593280079|FG000|Overall Study|treatment not received|2|||
164249805|NCT00556439|593280084|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
164249806|NCT00556439|593280085|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
164249807|NCT00556439|593280086|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
164249808|NCT00556439|593280087|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
164249809|NCT00556439|593280084|FG000|Study Entry to Week 12|Physician Decision|1|||
164249810|NCT00556439|593280085|FG001|Study Entry to Week 12|Physician Decision|0|||
164249811|NCT00556439|593280086|FG002|Study Entry to Week 12|Physician Decision|0|||
164249812|NCT00556439|593280087|FG003|Study Entry to Week 12|Physician Decision|0|||
164249813|NCT00556439|593280084|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
164249814|NCT00556439|593280085|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
164249815|NCT00556439|593280086|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
164249816|NCT00556439|593280087|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
164249817|NCT00556439|593280084|FG000|Study Entry to Week 12|Recurrent infection|1|||
164249818|NCT00556439|593280085|FG001|Study Entry to Week 12|Recurrent infection|0|||
164249819|NCT00556439|593280086|FG002|Study Entry to Week 12|Recurrent infection|0|||
164249820|NCT00556439|593280087|FG003|Study Entry to Week 12|Recurrent infection|0|||
164249821|NCT00556439|593280084|FG000|Study Entry to Week 12|Malignancy|0|||
164249822|NCT00556439|593280085|FG001|Study Entry to Week 12|Malignancy|0|||
164249823|NCT00556439|593280086|FG002|Study Entry to Week 12|Malignancy|1|||
164249824|NCT00556439|593280087|FG003|Study Entry to Week 12|Malignancy|0|||
164249825|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
164249826|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
164249827|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
164249828|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
164249829|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
164249830|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
164249831|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
164249832|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
164249833|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
164249834|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
164249835|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
164249836|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
164249837|NCT00556439|593280084|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
164249838|NCT00556439|593280085|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
164249839|NCT00556439|593280086|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
164249840|NCT00556439|593280087|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
164249841|NCT02100423|593280088|FG000|Overall Study|Death|1|||
164249842|NCT02100423|593280088|FG000|Overall Study|Withdrawal by Subject|3|||
164249843|NCT02100423|593280088|FG000|Overall Study|Adverse Event|1|||
164249844|NCT02100423|593280088|FG000|Overall Study|Physician Decision|1|||
164249845|NCT00703846|593280089|FG000|Overall Study|Adverse Event|8|||
164249846|NCT00703846|593280089|FG000|Overall Study|Lost to Follow-up|55|||
164249847|NCT00703846|593280089|FG000|Overall Study|Lack of Efficacy|15|||
164249848|NCT00703846|593280089|FG000|Overall Study|Noncompliance with Study Treatment|2|||
164249849|NCT00703846|593280089|FG000|Overall Study|Withdrawal by Subject|40|||
164249850|NCT00703846|593280089|FG000|Overall Study|Death|1|||
164249851|NCT00703846|593280089|FG000|Overall Study|Other|14|||
164249852|NCT00703846|593280089|FG000|Overall Study|Did Not Receive Study Drug|2|||
164249853|NCT04601532|593280090|FG000|Overall Study|Lost to Follow-up|1|||
164249854|NCT04601532|593280091|FG001|Overall Study|Lost to Follow-up|2|||
164249855|NCT04601532|593280090|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
164249856|NCT04601532|593280091|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
164249857|NCT02195700|593280092|FG000|Overall Study|Protocol Violation|0|||
164249858|NCT02195700|593280093|FG001|Overall Study|Protocol Violation|2|||
164249859|NCT02195700|593280092|FG000|Overall Study|Noncompliance|1|||
164249860|NCT02195700|593280093|FG001|Overall Study|Noncompliance|0|||
164249861|NCT02195700|593280092|FG000|Overall Study|Adverse Event|1|||
164249862|NCT02195700|593280093|FG001|Overall Study|Adverse Event|2|||
164249863|NCT02195700|593280092|FG000|Overall Study|Withdrawal by Subject|3|||
164249864|NCT02195700|593280093|FG001|Overall Study|Withdrawal by Subject|2|||
164249865|NCT02195700|593280092|FG000|Overall Study|Lost to Follow-up|1|||
164249866|NCT02195700|593280093|FG001|Overall Study|Lost to Follow-up|1|||
164249867|NCT00670930|593280094|FG000|Overall Study|Adminstrative Problem|0|||
164249868|NCT00670930|593280095|FG001|Overall Study|Adminstrative Problem|1|||
164249869|NCT00670930|593280094|FG000|Overall Study|Lost to Follow-up|1|||
164249870|NCT00670930|593280095|FG001|Overall Study|Lost to Follow-up|0|||
164249871|NCT03062280|593282049|FG000|Overall Study|Adverse Event|1|||
164249872|NCT03062280|593282049|FG000|Overall Study|Death|1|||
164249873|NCT03062280|593282049|FG000|Overall Study|Fertility Treatment|2|||
164249874|NCT03062280|593282049|FG000|Overall Study|Physician Decision|2|||
164249875|NCT03062280|593282049|FG000|Overall Study|Pregnancy|5|||
164249876|NCT03062280|593282049|FG000|Overall Study|Withdrawal by Subject|11|||
164249877|NCT01340625|593282050|FG000|First Intervention|Adverse Event|1|||
164249878|NCT01340625|593282051|FG001|First Intervention|Adverse Event|0|||
164249879|NCT01340625|593282050|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
164249880|NCT01340625|593282051|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
164249881|NCT00854724|593282052|FG000|First Intervention|Withdrawal by Subject|1|||
164249882|NCT00854724|593282053|FG001|First Intervention|Withdrawal by Subject|1|||
164249883|NCT00854724|593282052|FG000|Washout|Protocol Violation|1|||
164249884|NCT00854724|593282053|FG001|Washout|Protocol Violation|0|||
164249885|NCT00854724|593282052|FG000|Washout|Withdrawal by Subject|0|||
164249886|NCT00854724|593282053|FG001|Washout|Withdrawal by Subject|1|||
164249887|NCT00854724|593282052|FG000|Second Intervention|Protocol Violation|1|||
164249888|NCT00854724|593282053|FG001|Second Intervention|Protocol Violation|0|||
164249889|NCT00854724|593282052|FG000|Second Intervention|Physician Decision|0|||
164249890|NCT00854724|593282053|FG001|Second Intervention|Physician Decision|1|||
164249891|NCT01519791|593282060|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
164249892|NCT01519791|593282061|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
164249893|NCT01519791|593282060|FG000|Overall Study|Protocol Violation|6|||
164249894|NCT01519791|593282061|FG001|Overall Study|Protocol Violation|19|||
164249895|NCT01519791|593282060|FG000|Overall Study|Other Reason|87|||
164249896|NCT01519791|593282061|FG001|Overall Study|Other Reason|222|||
164249897|NCT01519791|593282060|FG000|Overall Study|subjects randomized in error|2|||
164249898|NCT01519791|593282061|FG001|Overall Study|subjects randomized in error|0|||
164249899|NCT01519791|593282060|FG000|Overall Study|Lack of Efficacy|16|||
164249900|NCT01519791|593282061|FG001|Overall Study|Lack of Efficacy|20|||
164249901|NCT01519791|593282060|FG000|Overall Study|SAE, non-fatal|6|||
164249902|NCT01519791|593282061|FG001|Overall Study|SAE, non-fatal|22|||
164249903|NCT01519791|593282060|FG000|Overall Study|AE, serious fatal|0|||
164249904|NCT01519791|593282061|FG001|Overall Study|AE, serious fatal|1|||
164249905|NCT01519791|593282060|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
164249906|NCT01519791|593282061|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
164249907|NCT01519791|593282060|FG000|Overall Study|AE, non-serious non-fatal|12|||
164249908|NCT01519791|593282061|FG001|Overall Study|AE, non-serious non-fatal|31|||
164249909|NCT01519791|593282060|FG000|Overall Study|Withdrawal by Subject|15|||
164249910|NCT01519791|593282061|FG001|Overall Study|Withdrawal by Subject|37|||
164249911|NCT01519791|593282060|FG000|Overall Study|Lost to Follow-up|6|||
164249912|NCT01519791|593282061|FG001|Overall Study|Lost to Follow-up|14|||
164249913|NCT00459875|593282062|FG000|Overall Study|Ineligible participant|1|||
164249914|NCT00459875|593282062|FG000|Overall Study|Adverse Event|2|||
164249915|NCT00576628|593282064|FG000|Overall Study|Adverse Event|11|||
164249916|NCT00576628|593282064|FG000|Overall Study|Death|2|||
164249917|NCT00576628|593282064|FG000|Overall Study|Failure to return|1|||
164249918|NCT00576628|593282064|FG000|Overall Study|Refused Treatment|8|||
164249919|NCT00576628|593282064|FG000|Overall Study|Pregnancy|1|||
164249920|NCT00576628|593282064|FG000|Overall Study|RBC transfusion|1|||
164249921|NCT00576628|593282064|FG000|Overall Study|Progression of Kidney Disease|1|||
164249922|NCT00576628|593282064|FG000|Overall Study|Progression of Renal Failure|1|||
164249923|NCT00576628|593282064|FG000|Overall Study|The patient move into other town|1|||
164249924|NCT00576628|593282064|FG000|Overall Study|Transplantation|1|||
164249925|NCT00576628|593282064|FG000|Overall Study|Dialysis|15|||
164249926|NCT02789345|593282075|FG000|Overall Study|Adverse Event|0|||
164249927|NCT02789345|593282076|FG001|Overall Study|Adverse Event|0|||
164249928|NCT02789345|593282077|FG002|Overall Study|Adverse Event|1|||
164249929|NCT02789345|593282075|FG000|Overall Study|Death|0|||
164249930|NCT02789345|593282076|FG001|Overall Study|Death|0|||
164249931|NCT02789345|593282077|FG002|Overall Study|Death|1|||
163886642|NCT05543629|591956512|FG002|Overall Study|Study terminated by Sponsor|0|||
163886643|NCT05543629|591956513|FG003|Overall Study|Study terminated by Sponsor|1|||
164249932|NCT02789345|593282075|FG000|Overall Study|Physician Decision|2|||
164249933|NCT02789345|593282076|FG001|Overall Study|Physician Decision|0|||
164249934|NCT02789345|593282077|FG002|Overall Study|Physician Decision|1|||
164249935|NCT02789345|593282075|FG000|Overall Study|Progressive Disease|1|||
164249936|NCT02789345|593282076|FG001|Overall Study|Progressive Disease|3|||
164249937|NCT02789345|593282077|FG002|Overall Study|Progressive Disease|14|||
164249938|NCT01709110|593282078|FG000|Overall Study|Adverse Event|56|||
164249939|NCT01709110|593282079|FG001|Overall Study|Adverse Event|48|||
164249940|NCT01709110|593282078|FG000|Overall Study|Death|14|||
164249941|NCT01709110|593282079|FG001|Overall Study|Death|6|||
164249942|NCT01709110|593282078|FG000|Overall Study|Lost to Follow-up|7|||
164249943|NCT01709110|593282079|FG001|Overall Study|Lost to Follow-up|5|||
164249944|NCT01709110|593282078|FG000|Overall Study|Protocol Violation|4|||
164249945|NCT01709110|593282079|FG001|Overall Study|Protocol Violation|6|||
164249946|NCT01709110|593282078|FG000|Overall Study|Withdrawal by Subject|96|||
163991454|NCT04303000|592337158|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
163991455|NCT04303000|592337159|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
163991456|NCT05655377|592337160|FG000|Overall Study|Withdrawal by Subject|2|||
163991457|NCT03118947|592337163|FG000|Overall Study|Adverse Event|7|||
163991458|NCT03118947|592337163|FG000|Overall Study|Death|3|||
163991459|NCT03118947|592337163|FG000|Overall Study|Lack of Efficacy|4|||
163991460|NCT03118947|592337163|FG000|Overall Study|Non-compliance with study drug|1|||
163991461|NCT03118947|592337163|FG000|Overall Study|Protocol Violation|2|||
163991462|NCT03118947|592337163|FG000|Overall Study|Withdrawal by Subject|3|||
163991463|NCT03118947|592337163|FG000|Overall Study|Withdrawal by caregiver|3|||
163991464|NCT03118947|592337163|FG000|Overall Study|Change in patient's living situation|4|||
163991465|NCT03118947|592337163|FG000|Overall Study|Lost to Follow-up|2|||
163991466|NCT01109940|592337164|FG000|Overall Study|Administrative problems|2|||
163991467|NCT01109940|592337165|FG001|Overall Study|Administrative problems|0|||
163991468|NCT01109940|592337166|FG002|Overall Study|Administrative problems|0|||
163991469|NCT01109940|592337167|FG003|Overall Study|Administrative problems|0|||
163991470|NCT01109940|592337164|FG000|Overall Study|Serious Adverse Event|2|||
163991471|NCT01109940|592337165|FG001|Overall Study|Serious Adverse Event|1|||
163991472|NCT01109940|592337166|FG002|Overall Study|Serious Adverse Event|0|||
163991473|NCT01109940|592337167|FG003|Overall Study|Serious Adverse Event|0|||
163991474|NCT01109940|592337164|FG000|Overall Study|Lost to Follow-up|1|||
163991475|NCT01109940|592337165|FG001|Overall Study|Lost to Follow-up|0|||
163991476|NCT01109940|592337166|FG002|Overall Study|Lost to Follow-up|0|||
163991477|NCT01109940|592337167|FG003|Overall Study|Lost to Follow-up|0|||
163991478|NCT01109940|592337164|FG000|Overall Study|Patient withdrew consent|1|||
163991479|NCT01109940|592337165|FG001|Overall Study|Patient withdrew consent|1|||
163991480|NCT01109940|592337166|FG002|Overall Study|Patient withdrew consent|0|||
163991481|NCT01109940|592337167|FG003|Overall Study|Patient withdrew consent|0|||
163991482|NCT01109940|592337164|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163991483|NCT01109940|592337165|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163991484|NCT01109940|592337166|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
163991485|NCT01109940|592337167|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163991486|NCT02769624|592337168|FG000|Overall Study|Lost to Follow-up|0|||
163991487|NCT02769624|592337169|FG001|Overall Study|Lost to Follow-up|1|||
163991488|NCT01987908|592337179|FG000|Placebo Lead-in Period|Adverse Event|2|||
163991489|NCT01987908|592337180|FG001|Placebo Lead-in Period|Adverse Event|0|||
163991490|NCT01987908|592337181|FG002|Placebo Lead-in Period|Adverse Event|0|||
163991491|NCT01987908|592337179|FG000|Placebo Lead-in Period|Physician Decision|2|||
163991492|NCT01987908|592337180|FG001|Placebo Lead-in Period|Physician Decision|0|||
163991493|NCT01987908|592337181|FG002|Placebo Lead-in Period|Physician Decision|0|||
163991494|NCT01987908|592337179|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
163991495|NCT01987908|592337180|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
163991496|NCT01987908|592337181|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
163991497|NCT01987908|592337179|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
163991498|NCT01987908|592337180|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
163991499|NCT01987908|592337181|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
163991500|NCT01987908|592337179|FG000|Treatment Period|Adverse Event|0|||
163991501|NCT01987908|592337180|FG001|Treatment Period|Adverse Event|1|||
163991502|NCT01987908|592337181|FG002|Treatment Period|Adverse Event|1|||
163991503|NCT01987908|592337179|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
163991504|NCT01987908|592337180|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
163991505|NCT01987908|592337181|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
163991506|NCT01987908|592337179|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
163991507|NCT01987908|592337180|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
163991508|NCT01987908|592337181|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
163991509|NCT01869348|592337183|FG000|Overall Study|Withdrawal by Subject|1|||
163991510|NCT01869348|592337184|FG001|Overall Study|Withdrawal by Subject|1|||
163991511|NCT02789657|592337185|FG000|Overall Study|Withdrawal by Subject|2|||
163991512|NCT02789657|592337186|FG001|Overall Study|Withdrawal by Subject|0|||
163991513|NCT02789657|592337187|FG002|Overall Study|Withdrawal by Subject|0|||
163991514|NCT02789657|592337188|FG003|Overall Study|Withdrawal by Subject|0|||
163991515|NCT01728779|592337189|FG000|Overall Study|Withdrawal by Subject|1|||
163991516|NCT00448708|592337190|FG000|Overall Study|Death|21|||
163991517|NCT00448708|592337191|FG001|Overall Study|Death|17|||
163991518|NCT00448708|592337190|FG000|Overall Study|Withdrawal by Subject|8|||
163991519|NCT00448708|592337191|FG001|Overall Study|Withdrawal by Subject|4|||
164084037|NCT01628120|592672231|FG000|Overall Study|Switched Dialysis Method|2|||
163991520|NCT00448708|592337190|FG000|Overall Study|Lost to Follow-up|6|||
163991521|NCT00448708|592337191|FG001|Overall Study|Lost to Follow-up|8|||
163991522|NCT00448708|592337190|FG000|Overall Study|not listed|0|||
163991523|NCT00448708|592337191|FG001|Overall Study|not listed|2|||
163991524|NCT01925209|592337192|FG000|Treatment Epoch|Physician Decision|1|||
163991525|NCT01925209|592337193|FG001|Treatment Epoch|Physician Decision|0|||
163991526|NCT01925209|592337194|FG002|Treatment Epoch|Physician Decision|0|||
164249947|NCT01709110|593282079|FG001|Overall Study|Withdrawal by Subject|89|||
164249948|NCT01709110|593282078|FG000|Overall Study|Physician Decision|4|||
164249949|NCT01709110|593282079|FG001|Overall Study|Physician Decision|10|||
164249950|NCT01709110|593282078|FG000|Overall Study|Sponsor Decision|2|||
164249951|NCT01709110|593282079|FG001|Overall Study|Sponsor Decision|2|||
164249952|NCT01709110|593282078|FG000|Overall Study|Lack of Efficacy|1|||
164249953|NCT01709110|593282079|FG001|Overall Study|Lack of Efficacy|1|||
164249954|NCT01709110|593282078|FG000|Overall Study|Caregiver Decision|1|||
164249955|NCT01709110|593282079|FG001|Overall Study|Caregiver Decision|1|||
164249956|NCT03286543|593282080|FG000|Consented|Screen failure before randomization|2|||
164249957|NCT03286543|593282081|FG001|Consented|Screen failure before randomization|0|||
164249958|NCT03286543|593282082|FG002|Consented|Screen failure before randomization|0|||
164249959|NCT03286543|593282080|FG000|Consented|Screen failure before enrollment|4|||
164249960|NCT03286543|593282081|FG001|Consented|Screen failure before enrollment|0|||
164249961|NCT03286543|593282082|FG002|Consented|Screen failure before enrollment|0|||
164249962|NCT03286543|593282080|FG000|Consented|TKA cancelled after enrollment|1|||
164249963|NCT03286543|593282081|FG001|Consented|TKA cancelled after enrollment|0|||
164249964|NCT03286543|593282082|FG002|Consented|TKA cancelled after enrollment|0|||
164249965|NCT03286543|593282080|FG000|Consented|Withdrawn from study|12|||
164249966|NCT03286543|593282081|FG001|Consented|Withdrawn from study|0|||
163886644|NCT05543629|591956514|FG004|Overall Study|Study terminated by Sponsor|0|||
163886645|NCT05543629|591956515|FG005|Overall Study|Study terminated by Sponsor|4|||
163886646|NCT05543629|591956516|FG006|Overall Study|Study terminated by Sponsor|1|||
163886647|NCT05543629|591956517|FG007|Overall Study|Study terminated by Sponsor|0|||
163886648|NCT05543629|591956510|FG000|Overall Study|Withdrawal by Subject|1|||
163886649|NCT05543629|591956511|FG001|Overall Study|Withdrawal by Subject|1|||
163886650|NCT05543629|591956512|FG002|Overall Study|Withdrawal by Subject|0|||
163886651|NCT05543629|591956513|FG003|Overall Study|Withdrawal by Subject|2|||
163886652|NCT05543629|591956514|FG004|Overall Study|Withdrawal by Subject|1|||
163886653|NCT05543629|591956515|FG005|Overall Study|Withdrawal by Subject|1|||
163886654|NCT05543629|591956516|FG006|Overall Study|Withdrawal by Subject|1|||
163886655|NCT05543629|591956517|FG007|Overall Study|Withdrawal by Subject|1|||
163886656|NCT05543629|591956510|FG000|Overall Study|Not Reported|2|||
163886657|NCT05543629|591956511|FG001|Overall Study|Not Reported|2|||
163886658|NCT05543629|591956512|FG002|Overall Study|Not Reported|0|||
163886659|NCT05543629|591956513|FG003|Overall Study|Not Reported|0|||
163886660|NCT05543629|591956514|FG004|Overall Study|Not Reported|1|||
163886661|NCT05543629|591956515|FG005|Overall Study|Not Reported|1|||
163886662|NCT05543629|591956516|FG006|Overall Study|Not Reported|3|||
163886663|NCT05543629|591956517|FG007|Overall Study|Not Reported|0|||
163886664|NCT04568603|591956518|FG000|Overall Study|Physician Decision|1|||
163886665|NCT04137367|591956522|FG000|Overall Study|Lost to Follow-up|8|||
163886666|NCT04137367|591956523|FG001|Overall Study|Lost to Follow-up|6|||
163886667|NCT04137367|591956524|FG002|Overall Study|Lost to Follow-up|4|||
163886668|NCT05144009|591956525|FG000|Overall Study|Lost to Follow-up|0|||
163886669|NCT05144009|591956526|FG001|Overall Study|Lost to Follow-up|1|||
163886670|NCT05144009|591956525|FG000|Overall Study|Study Termination by the Sponsor|11|||
163886671|NCT05144009|591956526|FG001|Overall Study|Study Termination by the Sponsor|11|||
163886672|NCT05144009|591956525|FG000|Overall Study|Disease Progression|1|||
163886673|NCT05144009|591956526|FG001|Overall Study|Disease Progression|0|||
163886674|NCT05144009|591956525|FG000|Overall Study|Participant Decision|0|||
163886675|NCT05144009|591956526|FG001|Overall Study|Participant Decision|2|||
163886676|NCT05144009|591956525|FG000|Overall Study|Death|5|||
163886677|NCT05144009|591956526|FG001|Overall Study|Death|10|||
163886678|NCT04492722|591956528|FG000|Overall Study|Adverse Event|7|||
163886679|NCT04492722|591956529|FG001|Overall Study|Adverse Event|2|||
163886680|NCT04492722|591956530|FG002|Overall Study|Adverse Event|3|||
163886681|NCT04492722|591956531|FG003|Overall Study|Adverse Event|0|||
163886682|NCT04492722|591956528|FG000|Overall Study|Death|0|||
163886683|NCT04492722|591956529|FG001|Overall Study|Death|0|||
163886684|NCT04492722|591956530|FG002|Overall Study|Death|0|||
163886685|NCT04492722|591956531|FG003|Overall Study|Death|1|||
163886686|NCT04492722|591956528|FG000|Overall Study|Lost to Follow-up|0|||
164249967|NCT03286543|593282082|FG002|Consented|Withdrawn from study|0|||
164249968|NCT03286543|593282080|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
164249969|NCT03286543|593282081|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
163886687|NCT04492722|591956529|FG001|Overall Study|Lost to Follow-up|1|||
163886688|NCT04492722|591956530|FG002|Overall Study|Lost to Follow-up|0|||
163886689|NCT04492722|591956531|FG003|Overall Study|Lost to Follow-up|1|||
163886690|NCT04492722|591956528|FG000|Overall Study|Physician Decision|0|||
163886691|NCT04492722|591956529|FG001|Overall Study|Physician Decision|3|||
163886692|NCT04492722|591956530|FG002|Overall Study|Physician Decision|1|||
163886693|NCT04492722|591956531|FG003|Overall Study|Physician Decision|1|||
163886694|NCT04492722|591956528|FG000|Overall Study|Withdrawal by Subject|6|||
163886695|NCT04492722|591956529|FG001|Overall Study|Withdrawal by Subject|6|||
163886696|NCT04492722|591956530|FG002|Overall Study|Withdrawal by Subject|0|||
163886697|NCT04492722|591956531|FG003|Overall Study|Withdrawal by Subject|3|||
164249970|NCT03286543|593282082|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
164249971|NCT03286543|593282080|FG000|Study Enrollment|Withdrawn from study|0|||
164249972|NCT03286543|593282081|FG001|Study Enrollment|Withdrawn from study|6|||
164249973|NCT03286543|593282082|FG002|Study Enrollment|Withdrawn from study|6|||
164249974|NCT02836717|593282084|FG000|Test Phase|Lack of Efficacy|14|||
164249975|NCT02836717|593282085|FG001|Test Phase|Lack of Efficacy|8|||
164249976|NCT02836717|593282086|FG002|Test Phase|Lack of Efficacy|0|||
164249977|NCT02836717|593282084|FG000|Study Phase|Adverse Event|2|||
164249978|NCT02836717|593282085|FG001|Study Phase|Adverse Event|0|||
164249979|NCT02836717|593282086|FG002|Study Phase|Adverse Event|0|||
164249980|NCT02836717|593282084|FG000|Study Phase|Lack of Efficacy|8|||
164249981|NCT02836717|593282085|FG001|Study Phase|Lack of Efficacy|6|||
164249982|NCT02836717|593282086|FG002|Study Phase|Lack of Efficacy|1|||
164249983|NCT02836717|593282084|FG000|Study Phase|Withdrawal by Subject|1|||
164249984|NCT02836717|593282085|FG001|Study Phase|Withdrawal by Subject|0|||
164249985|NCT02836717|593282086|FG002|Study Phase|Withdrawal by Subject|0|||
164249986|NCT02836717|593282084|FG000|Study Phase|Death|1|||
164249987|NCT02836717|593282085|FG001|Study Phase|Death|0|||
164249988|NCT02836717|593282086|FG002|Study Phase|Death|0|||
164249989|NCT02836717|593282084|FG000|Study Phase|abdominal surgeries|2|||
164249990|NCT02836717|593282085|FG001|Study Phase|abdominal surgeries|1|||
164249991|NCT02836717|593282086|FG002|Study Phase|abdominal surgeries|0|||
164249992|NCT00104416|593282087|FG000|Double-Blind Phase|Adverse Event|2|||
164249993|NCT00104416|593282088|FG001|Double-Blind Phase|Adverse Event|1|||
164249994|NCT00104416|593282089|FG002|Double-Blind Phase|Adverse Event|0|||
164249995|NCT00104416|593282090|FG003|Double-Blind Phase|Adverse Event|0|||
164249996|NCT00104416|593282091|FG004|Double-Blind Phase|Adverse Event|0|||
164249997|NCT00104416|593282087|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164249998|NCT00104416|593282088|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164249999|NCT00104416|593282089|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164250000|NCT00104416|593282090|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164250001|NCT00104416|593282091|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164250002|NCT00104416|593282087|FG000|Double-Blind Phase|Protocol Violation|0|||
164250003|NCT00104416|593282088|FG001|Double-Blind Phase|Protocol Violation|1|||
164250004|NCT00104416|593282089|FG002|Double-Blind Phase|Protocol Violation|0|||
164250005|NCT00104416|593282090|FG003|Double-Blind Phase|Protocol Violation|0|||
164250006|NCT00104416|593282091|FG004|Double-Blind Phase|Protocol Violation|0|||
164250007|NCT00104416|593282087|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164250008|NCT00104416|593282088|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
164250009|NCT00104416|593282089|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164250010|NCT00104416|593282090|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164250011|NCT00104416|593282091|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164250012|NCT00104416|593282087|FG000|Double-Blind Phase|Pregnancy|1|||
164250013|NCT00104416|593282088|FG001|Double-Blind Phase|Pregnancy|0|||
164250014|NCT00104416|593282089|FG002|Double-Blind Phase|Pregnancy|0|||
164250015|NCT00104416|593282090|FG003|Double-Blind Phase|Pregnancy|0|||
164250016|NCT00104416|593282091|FG004|Double-Blind Phase|Pregnancy|0|||
164250017|NCT00104416|593282087|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
164250018|NCT00104416|593282088|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
164250019|NCT00104416|593282089|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
164250020|NCT00104416|593282090|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
164250021|NCT00104416|593282091|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
164250022|NCT00104416|593282087|FG000|Continuation Phase|Adverse Event|0|||
164250023|NCT00104416|593282088|FG001|Continuation Phase|Adverse Event|0|||
164250024|NCT00104416|593282089|FG002|Continuation Phase|Adverse Event|2|||
164250025|NCT00104416|593282090|FG003|Continuation Phase|Adverse Event|0|||
164250026|NCT00104416|593282091|FG004|Continuation Phase|Adverse Event|2|||
164250027|NCT00104416|593282087|FG000|Continuation Phase|Lost to Follow-up|0|||
164250028|NCT00104416|593282088|FG001|Continuation Phase|Lost to Follow-up|0|||
164250029|NCT00104416|593282089|FG002|Continuation Phase|Lost to Follow-up|1|||
164250030|NCT00104416|593282090|FG003|Continuation Phase|Lost to Follow-up|0|||
164250031|NCT00104416|593282091|FG004|Continuation Phase|Lost to Follow-up|1|||
164250032|NCT00104416|593282087|FG000|Continuation Phase|Withdrawal by Subject|0|||
164250033|NCT00104416|593282088|FG001|Continuation Phase|Withdrawal by Subject|0|||
164250034|NCT00104416|593282089|FG002|Continuation Phase|Withdrawal by Subject|2|||
164250035|NCT00104416|593282090|FG003|Continuation Phase|Withdrawal by Subject|1|||
164250036|NCT00104416|593282091|FG004|Continuation Phase|Withdrawal by Subject|1|||
164250037|NCT00104416|593282087|FG000|Continuation Phase|Pregnancy|0|||
164250038|NCT00104416|593282088|FG001|Continuation Phase|Pregnancy|0|||
164250039|NCT00104416|593282089|FG002|Continuation Phase|Pregnancy|1|||
164250040|NCT00104416|593282090|FG003|Continuation Phase|Pregnancy|1|||
164250041|NCT00104416|593282091|FG004|Continuation Phase|Pregnancy|0|||
164250042|NCT00104416|593282087|FG000|Continuation Phase|Non-compliance|0|||
164250043|NCT00104416|593282088|FG001|Continuation Phase|Non-compliance|0|||
164250044|NCT00104416|593282089|FG002|Continuation Phase|Non-compliance|0|||
164250045|NCT00104416|593282090|FG003|Continuation Phase|Non-compliance|0|||
164250046|NCT00104416|593282091|FG004|Continuation Phase|Non-compliance|1|||
164250047|NCT00438360|593282092|FG000|Overall Study|Adverse Event|6|||
164250048|NCT00438360|593282093|FG001|Overall Study|Adverse Event|1|||
164250049|NCT00438360|593282092|FG000|Overall Study|Lack of Efficacy|42|||
164250050|NCT00438360|593282093|FG001|Overall Study|Lack of Efficacy|27|||
164250051|NCT00438360|593282092|FG000|Overall Study|Other|24|||
164250052|NCT00438360|593282093|FG001|Overall Study|Other|15|||
164250053|NCT00070109|593282094|FG000|Overall Study|Death|1|||
164250054|NCT00070109|593282095|FG001|Overall Study|Death|1|||
164250055|NCT00070109|593282096|FG002|Overall Study|Death|0|||
164250056|NCT00070109|593282097|FG003|Overall Study|Death|0|||
164250057|NCT00070109|593282098|FG004|Overall Study|Death|1|||
164250058|NCT00070109|593282094|FG000|Overall Study|Lack of Efficacy|6|||
164250059|NCT00070109|593282095|FG001|Overall Study|Lack of Efficacy|4|||
164250060|NCT00070109|593282096|FG002|Overall Study|Lack of Efficacy|5|||
164250061|NCT00070109|593282097|FG003|Overall Study|Lack of Efficacy|15|||
164250062|NCT00070109|593282098|FG004|Overall Study|Lack of Efficacy|5|||
164250063|NCT00070109|593282094|FG000|Overall Study|Physician Decision|1|||
164250064|NCT00070109|593282095|FG001|Overall Study|Physician Decision|0|||
164250065|NCT00070109|593282096|FG002|Overall Study|Physician Decision|0|||
164250066|NCT00070109|593282097|FG003|Overall Study|Physician Decision|0|||
164250067|NCT00070109|593282098|FG004|Overall Study|Physician Decision|0|||
164250068|NCT00070109|593282094|FG000|Overall Study|Withdrawal by Subject|0|||
164250069|NCT00070109|593282095|FG001|Overall Study|Withdrawal by Subject|1|||
164250070|NCT00070109|593282096|FG002|Overall Study|Withdrawal by Subject|1|||
164250071|NCT00070109|593282097|FG003|Overall Study|Withdrawal by Subject|0|||
164250072|NCT00070109|593282098|FG004|Overall Study|Withdrawal by Subject|0|||
164250073|NCT00070109|593282094|FG000|Overall Study|Adverse Event|0|||
164250074|NCT00070109|593282095|FG001|Overall Study|Adverse Event|0|||
164250075|NCT00070109|593282096|FG002|Overall Study|Adverse Event|2|||
164250076|NCT00070109|593282097|FG003|Overall Study|Adverse Event|4|||
164250077|NCT00070109|593282098|FG004|Overall Study|Adverse Event|2|||
164250078|NCT00070109|593282094|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
164250079|NCT00070109|593282095|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
164250080|NCT00070109|593282096|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
164250081|NCT00070109|593282097|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
164250082|NCT00070109|593282098|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
164250083|NCT01164891|593282109|FG000|Overall Study|Disease Progression|5|||
164250084|NCT01164891|593282109|FG000|Overall Study|Adverse Event|1|||
164250085|NCT00441142|593282110|FG000|Overall Study|Adverse Event|2|||
164250086|NCT00441142|593282111|FG001|Overall Study|Adverse Event|3|||
164250087|NCT00441142|593282112|FG002|Overall Study|Adverse Event|3|||
164250088|NCT00441142|593282113|FG003|Overall Study|Adverse Event|22|||
164250089|NCT00441142|593282110|FG000|Overall Study|Lack of Efficacy|3|||
164250090|NCT00441142|593282111|FG001|Overall Study|Lack of Efficacy|3|||
164250091|NCT00441142|593282112|FG002|Overall Study|Lack of Efficacy|17|||
164250092|NCT00441142|593282113|FG003|Overall Study|Lack of Efficacy|32|||
164250093|NCT00441142|593282110|FG000|Overall Study|Withdrawal by Subject|0|||
164250094|NCT00441142|593282111|FG001|Overall Study|Withdrawal by Subject|0|||
164250095|NCT00441142|593282112|FG002|Overall Study|Withdrawal by Subject|2|||
164250096|NCT00441142|593282113|FG003|Overall Study|Withdrawal by Subject|10|||
164250097|NCT00441142|593282110|FG000|Overall Study|Patient still receiving active study tx|1|||
164250098|NCT00441142|593282111|FG001|Overall Study|Patient still receiving active study tx|0|||
164250099|NCT00441142|593282112|FG002|Overall Study|Patient still receiving active study tx|0|||
164250100|NCT00441142|593282113|FG003|Overall Study|Patient still receiving active study tx|2|||
164250101|NCT00441142|593282110|FG000|Overall Study|Physician Decision|0|||
164250102|NCT00441142|593282111|FG001|Overall Study|Physician Decision|1|||
164250103|NCT00441142|593282112|FG002|Overall Study|Physician Decision|0|||
164250104|NCT00441142|593282113|FG003|Overall Study|Physician Decision|1|||
163886698|NCT04492722|591956528|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
163886699|NCT04492722|591956529|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
163886700|NCT04492722|591956530|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
163886701|NCT04492722|591956531|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
163886702|NCT04492722|591956528|FG000|Overall Study|Due to Covid-19 pandemic|7|||
164250105|NCT00441142|593282110|FG000|Overall Study|Death|0|||
163886703|NCT04492722|591956529|FG001|Overall Study|Due to Covid-19 pandemic|3|||
163886704|NCT04492722|591956530|FG002|Overall Study|Due to Covid-19 pandemic|7|||
163886705|NCT04492722|591956531|FG003|Overall Study|Due to Covid-19 pandemic|6|||
163886706|NCT04492722|591956528|FG000|Overall Study|Failure to meet randomisation criteria|2|||
163886707|NCT04492722|591956529|FG001|Overall Study|Failure to meet randomisation criteria|3|||
164250106|NCT00441142|593282111|FG001|Overall Study|Death|0|||
164250107|NCT00441142|593282112|FG002|Overall Study|Death|0|||
164250108|NCT00441142|593282113|FG003|Overall Study|Death|1|||
164250109|NCT00338286|593282114|FG000|Overall Study|Withdrawal by Subject|50|||
164250110|NCT00338286|593282115|FG001|Overall Study|Withdrawal by Subject|54|||
163886708|NCT04492722|591956530|FG002|Overall Study|Failure to meet randomisation criteria|4|||
163886709|NCT04492722|591956531|FG003|Overall Study|Failure to meet randomisation criteria|2|||
164250111|NCT00338286|593282114|FG000|Overall Study|Lost to Follow-up|80|||
164250112|NCT00338286|593282115|FG001|Overall Study|Lost to Follow-up|66|||
164250113|NCT00338286|593282114|FG000|Overall Study|Other|103|||
164250114|NCT00338286|593282115|FG001|Overall Study|Other|93|||
164250115|NCT00022763|593282116|FG000|Overall Study|Adverse Event|1|||
164250116|NCT00022763|593282117|FG001|Overall Study|Adverse Event|2|||
164250117|NCT00022763|593282116|FG000|Overall Study|Injection Site Reactions|0|||
164250118|NCT00022763|593282117|FG001|Overall Study|Injection Site Reactions|2|||
164250119|NCT00022763|593282116|FG000|Overall Study|Death|0|||
164250120|NCT00022763|593282117|FG001|Overall Study|Death|1|||
164250121|NCT00022763|593282116|FG000|Overall Study|Lost to Follow-up|0|||
164250122|NCT00022763|593282117|FG001|Overall Study|Lost to Follow-up|3|||
164250123|NCT00022763|593282116|FG000|Overall Study|Withdrawal by Subject|4|||
164250124|NCT00022763|593282117|FG001|Overall Study|Withdrawal by Subject|7|||
164250125|NCT00022763|593282116|FG000|Overall Study|Insufficient Therapy|1|||
164250126|NCT00022763|593282117|FG001|Overall Study|Insufficient Therapy|0|||
164250127|NCT00022763|593282116|FG000|Overall Study|Admin|3|||
164250128|NCT00022763|593282117|FG001|Overall Study|Admin|2|||
164250129|NCT03248531|593282118|FG000|Overall Study|Adverse Event|0|||
164250130|NCT03248531|593282119|FG001|Overall Study|Adverse Event|0|||
164250131|NCT03248531|593282120|FG002|Overall Study|Adverse Event|1|||
164250132|NCT03248531|593282118|FG000|Overall Study|Lost to Follow-up|1|||
164250133|NCT03248531|593282119|FG001|Overall Study|Lost to Follow-up|0|||
164250134|NCT03248531|593282120|FG002|Overall Study|Lost to Follow-up|5|||
164250135|NCT03248531|593282118|FG000|Overall Study|Withdrawal by Subject|3|||
164250136|NCT03248531|593282119|FG001|Overall Study|Withdrawal by Subject|3|||
164250137|NCT03248531|593282120|FG002|Overall Study|Withdrawal by Subject|2|||
164250138|NCT03248531|593282118|FG000|Overall Study|Sponsor Request|0|||
164250139|NCT03248531|593282119|FG001|Overall Study|Sponsor Request|2|||
164250140|NCT03248531|593282120|FG002|Overall Study|Sponsor Request|0|||
164250141|NCT04908865|593282121|FG000|Overall Study|Adverse Event|2|||
164250142|NCT04908865|593282121|FG000|Overall Study|Lack of Efficacy|5|||
164250143|NCT04908865|593282121|FG000|Overall Study|Lost to Follow-up|1|||
164250144|NCT05286658|593282122|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
164250145|NCT05286658|593282122|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
164250146|NCT00470262|593282123|FG000|Overall Study|Withdrawal by Subject|2|||
164250147|NCT00470262|593282124|FG001|Overall Study|Withdrawal by Subject|0|||
164250148|NCT00851552|593282127|FG000|Overall Study|Death|2|||
164250149|NCT00851552|593282127|FG000|Overall Study|Adverse Event|1|||
164250150|NCT00851552|593282127|FG000|Overall Study|Disease Progression|4|||
164250151|NCT01558596|593282130|FG000|Overall Study|Withdrawal by Subject|1|||
164250152|NCT01558596|593282131|FG001|Overall Study|Withdrawal by Subject|0|||
164250153|NCT01558596|593282130|FG000|Overall Study|surgery elsewhere or cancelled|1|||
164250154|NCT01558596|593282131|FG001|Overall Study|surgery elsewhere or cancelled|1|||
164250155|NCT01558596|593282130|FG000|Overall Study|Protocol Violation|1|||
164250156|NCT01558596|593282131|FG001|Overall Study|Protocol Violation|0|||
164250157|NCT01437111|593282132|FG000|Overall Study|Adverse Event|2|||
164250158|NCT01437111|593282132|FG000|Overall Study|Withdrawal by Subject|4|||
164250159|NCT01437111|593282132|FG000|Overall Study|Not reported|5|||
164250160|NCT01437111|593282132|FG000|Overall Study|Physician Decision|1|||
164250161|NCT01437111|593282132|FG000|Overall Study|Lost to Follow-up|5|||
164250162|NCT01437111|593282132|FG000|Overall Study|Protocol Violation|1|||
164250163|NCT02473471|593282134|FG000|Overall Study|poor oral hygiene|2|||
164250164|NCT02473471|593282134|FG000|Overall Study|Lost to Follow-up|1|||
164250165|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
164250166|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
164250167|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
164250168|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
164250169|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
164250170|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
164250171|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
164250172|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
164250173|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
164250174|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
164250175|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
164250176|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
163886710|NCT04492722|591956528|FG000|Overall Study|Early termination from the study|54|||
163886711|NCT04492722|591956529|FG001|Overall Study|Early termination from the study|51|||
164250177|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250178|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
163886712|NCT04492722|591956530|FG002|Overall Study|Early termination from the study|50|||
163886713|NCT04492722|591956531|FG003|Overall Study|Early termination from the study|50|||
164250179|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
164250180|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250181|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250182|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250183|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250184|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250185|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250186|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250187|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250188|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
164250189|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
164250190|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
164250191|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
164250192|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
164250193|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
164250194|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
164250195|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
164250196|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
164250197|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
164250198|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
164250199|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
164250200|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
164250201|NCT01667133|593282135|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250202|NCT01667133|593282136|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250203|NCT01667133|593282137|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250204|NCT01667133|593282138|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
164250205|NCT01667133|593282139|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250206|NCT01667133|593282140|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250207|NCT01667133|593282141|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250208|NCT01667133|593282142|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250209|NCT01667133|593282143|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250210|NCT01667133|593282144|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250211|NCT01667133|593282145|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250212|NCT01667133|593282146|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
164250213|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
164250214|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
164250215|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
164250216|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
164250217|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
164250218|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
164250219|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
164250220|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
163886714|NCT04492722|591956528|FG000|Overall Study|Missing|3|||
163886715|NCT04492722|591956529|FG001|Overall Study|Missing|0|||
163886716|NCT04492722|591956530|FG002|Overall Study|Missing|0|||
163886717|NCT04492722|591956531|FG003|Overall Study|Missing|5|||
163886718|NCT04492722|591956528|FG000|Overall Study|Participants who did not receive treatment|0|||
163886719|NCT04492722|591956529|FG001|Overall Study|Participants who did not receive treatment|1|||
163886720|NCT04492722|591956530|FG002|Overall Study|Participants who did not receive treatment|4|||
163886721|NCT04492722|591956531|FG003|Overall Study|Participants who did not receive treatment|0|||
163886722|NCT04074759|591956532|FG000|Overall Study|Withdrawal by Subject|0|||
163886723|NCT04074759|591956533|FG001|Overall Study|Withdrawal by Subject|0|||
163886724|NCT04074759|591956534|FG002|Overall Study|Withdrawal by Subject|0|||
163886725|NCT04074759|591956535|FG003|Overall Study|Withdrawal by Subject|0|||
163886726|NCT04074759|591956536|FG004|Overall Study|Withdrawal by Subject|0|||
163886727|NCT04074759|591956537|FG005|Overall Study|Withdrawal by Subject|2|||
163886728|NCT04074759|591956538|FG006|Overall Study|Withdrawal by Subject|0|||
163886729|NCT04074759|591956539|FG007|Overall Study|Withdrawal by Subject|2|||
163886730|NCT04074759|591956540|FG008|Overall Study|Withdrawal by Subject|1|||
163886731|NCT04074759|591956541|FG009|Overall Study|Withdrawal by Subject|2|||
163886732|NCT04074759|591956542|FG010|Overall Study|Withdrawal by Subject|9|||
163886733|NCT04074759|591956543|FG011|Overall Study|Withdrawal by Subject|2|||
163886734|NCT04074759|591956544|FG012|Overall Study|Withdrawal by Subject|1|||
163886735|NCT04074759|591956545|FG013|Overall Study|Withdrawal by Subject|3|||
163886736|NCT04074759|591956546|FG014|Overall Study|Withdrawal by Subject|2|||
163886737|NCT04074759|591956547|FG015|Overall Study|Withdrawal by Subject|0|||
163886738|NCT04074759|591956548|FG016|Overall Study|Withdrawal by Subject|0|||
163886739|NCT04074759|591956549|FG017|Overall Study|Withdrawal by Subject|3|||
163886740|NCT04074759|591956550|FG018|Overall Study|Withdrawal by Subject|1|||
163886741|NCT04074759|591956532|FG000|Overall Study|Death|1|||
163886742|NCT04074759|591956533|FG001|Overall Study|Death|0|||
164084038|NCT01628120|592672231|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
164084039|NCT01628120|592672231|FG000|Overall Study|Moved or Relocated|5|||
164250221|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
164250222|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
163886743|NCT04074759|591956534|FG002|Overall Study|Death|1|||
163886744|NCT04074759|591956535|FG003|Overall Study|Death|1|||
163886745|NCT04074759|591956536|FG004|Overall Study|Death|2|||
163886746|NCT04074759|591956537|FG005|Overall Study|Death|0|||
163886747|NCT04074759|591956538|FG006|Overall Study|Death|1|||
163886748|NCT04074759|591956539|FG007|Overall Study|Death|0|||
163886749|NCT04074759|591956540|FG008|Overall Study|Death|3|||
164250223|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
164250224|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
164250225|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250226|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250227|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250228|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250229|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250230|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250231|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250232|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250233|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250234|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
164250235|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250236|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
164250237|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
164250238|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
164250239|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
164250240|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
164250241|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
164250242|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
164250243|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
164250244|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
164250245|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
164250246|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
164250247|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
164250248|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
164250249|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250250|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250251|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250252|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250253|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250254|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250255|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250256|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250257|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250258|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
164250259|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250260|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
164250261|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Death|0|||
164250262|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Death|0|||
164250263|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Death|0|||
163886750|NCT04074759|591956541|FG009|Overall Study|Death|2|||
163886751|NCT04074759|591956542|FG010|Overall Study|Death|4|||
163991527|NCT01925209|592337195|FG003|Treatment Epoch|Physician Decision|0|||
163991528|NCT01925209|592337192|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
163991529|NCT01925209|592337193|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
163991530|NCT01925209|592337194|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
164250264|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Death|0|||
164250265|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Death|0|||
163886752|NCT04074759|591956543|FG011|Overall Study|Death|1|||
163886753|NCT04074759|591956544|FG012|Overall Study|Death|0|||
163886754|NCT04074759|591956545|FG013|Overall Study|Death|2|||
163886755|NCT04074759|591956546|FG014|Overall Study|Death|1|||
163886756|NCT04074759|591956547|FG015|Overall Study|Death|0|||
163886757|NCT04074759|591956548|FG016|Overall Study|Death|1|||
163886758|NCT04074759|591956549|FG017|Overall Study|Death|0|||
163886759|NCT04074759|591956550|FG018|Overall Study|Death|1|||
163886760|NCT04074759|591956532|FG000|Overall Study|Lost to Follow-up|0|||
163886761|NCT04074759|591956533|FG001|Overall Study|Lost to Follow-up|0|||
163886762|NCT04074759|591956534|FG002|Overall Study|Lost to Follow-up|0|||
164250266|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Death|0|||
164250267|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Death|0|||
164250268|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Death|0|||
164250269|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Death|0|||
164250270|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Death|1|||
164250271|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Death|0|||
164250272|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Death|0|||
164250273|NCT01667133|593282135|FG000|Phase 2: Dose-expansion|Other|0|||
164250274|NCT01667133|593282136|FG001|Phase 2: Dose-expansion|Other|0|||
164250275|NCT01667133|593282137|FG002|Phase 2: Dose-expansion|Other|0|||
164250276|NCT01667133|593282138|FG003|Phase 2: Dose-expansion|Other|0|||
164250277|NCT01667133|593282139|FG004|Phase 2: Dose-expansion|Other|0|||
163886763|NCT04074759|591956535|FG003|Overall Study|Lost to Follow-up|0|||
163886764|NCT04074759|591956536|FG004|Overall Study|Lost to Follow-up|0|||
163886765|NCT04074759|591956537|FG005|Overall Study|Lost to Follow-up|0|||
163886766|NCT04074759|591956538|FG006|Overall Study|Lost to Follow-up|0|||
163886767|NCT04074759|591956539|FG007|Overall Study|Lost to Follow-up|0|||
163886768|NCT04074759|591956540|FG008|Overall Study|Lost to Follow-up|0|||
163886769|NCT04074759|591956541|FG009|Overall Study|Lost to Follow-up|0|||
163886770|NCT04074759|591956542|FG010|Overall Study|Lost to Follow-up|1|||
163886771|NCT04074759|591956543|FG011|Overall Study|Lost to Follow-up|0|||
163886772|NCT04074759|591956544|FG012|Overall Study|Lost to Follow-up|0|||
163886773|NCT04074759|591956545|FG013|Overall Study|Lost to Follow-up|0|||
163886774|NCT04074759|591956546|FG014|Overall Study|Lost to Follow-up|0|||
163886775|NCT04074759|591956547|FG015|Overall Study|Lost to Follow-up|0|||
163886776|NCT04074759|591956548|FG016|Overall Study|Lost to Follow-up|1|||
163886777|NCT04074759|591956549|FG017|Overall Study|Lost to Follow-up|0|||
163886778|NCT04074759|591956550|FG018|Overall Study|Lost to Follow-up|1|||
163886779|NCT04074759|591956532|FG000|Overall Study|Other|0|||
163886780|NCT04074759|591956533|FG001|Overall Study|Other|1|||
163886781|NCT04074759|591956534|FG002|Overall Study|Other|1|||
163886782|NCT04074759|591956535|FG003|Overall Study|Other|0|||
163886783|NCT04074759|591956536|FG004|Overall Study|Other|2|||
163886784|NCT04074759|591956537|FG005|Overall Study|Other|1|||
163886785|NCT04074759|591956538|FG006|Overall Study|Other|2|||
163886786|NCT04074759|591956539|FG007|Overall Study|Other|1|||
163886787|NCT04074759|591956540|FG008|Overall Study|Other|1|||
163886788|NCT04074759|591956541|FG009|Overall Study|Other|4|||
163886789|NCT04074759|591956542|FG010|Overall Study|Other|4|||
163886790|NCT04074759|591956543|FG011|Overall Study|Other|2|||
163886791|NCT04074759|591956544|FG012|Overall Study|Other|0|||
164084040|NCT01628120|592672231|FG000|Overall Study|Kidney Transplant|2|||
164084041|NCT01628120|592672231|FG000|Overall Study|Use of Standard of Care|1|||
164084042|NCT01165996|592672236|FG000|Overall Study|Death|1|||
164084043|NCT01165996|592672236|FG000|Overall Study|Physician Decision|1|||
164084044|NCT00096265|592672237|FG000|Overall Study|Ineligible|1|||
164084045|NCT00096265|592672238|FG001|Overall Study|Ineligible|0|||
164084046|NCT00096265|592672239|FG002|Overall Study|Ineligible|0|||
164084047|NCT02232074|592672242|FG000|Overall Study|Withdrawal by Subject|5|||
164084048|NCT02232074|592672243|FG001|Overall Study|Withdrawal by Subject|3|||
164084049|NCT02232074|592672242|FG000|Overall Study|No legal concerns at baseline|36|||
164084050|NCT02232074|592672243|FG001|Overall Study|No legal concerns at baseline|41|||
164084051|NCT02232074|592672242|FG000|Overall Study|deemed ineligible|0|||
164084052|NCT02232074|592672243|FG001|Overall Study|deemed ineligible|1|||
164084053|NCT01927757|592672244|FG000|Overall Study|Withdrawal by Subject|14|||
164084054|NCT01927757|592672244|FG000|Overall Study|Lost to Follow-up|2|||
164084055|NCT01927757|592672244|FG000|Overall Study|Decision by Sponsor|2|||
164084056|NCT01927757|592672244|FG000|Overall Study|Other|1|||
164084057|NCT01927757|592672244|FG000|Overall Study|Ethical Reasons|4|||
164084058|NCT00444795|592672246|FG000|Overall Study|Not Treated|1|||
164084059|NCT00444795|592672246|FG000|Overall Study|Treated Prior to the Contract Date|2|||
164084060|NCT00988169|592672247|FG000|Overall Study|Withdrawal by Subject|1|||
164084061|NCT00704418|592672248|FG000|Overall Study|Withdrawal by Subject|2|||
164084062|NCT00704418|592672249|FG001|Overall Study|Withdrawal by Subject|0|||
164084063|NCT00704418|592672248|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
164084064|NCT00704418|592672249|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
164084065|NCT01464827|592672250|FG000|Overall Study|Adverse Event|0|||
164084066|NCT01464827|592672251|FG001|Overall Study|Adverse Event|0|||
164084067|NCT01464827|592672252|FG002|Overall Study|Adverse Event|0|||
164084068|NCT01464827|592672253|FG003|Overall Study|Adverse Event|0|||
164084069|NCT01464827|592672254|FG004|Overall Study|Adverse Event|0|||
164084070|NCT01464827|592672255|FG005|Overall Study|Adverse Event|0|||
164084071|NCT01464827|592672256|FG006|Overall Study|Adverse Event|0|||
164084072|NCT01464827|592672257|FG007|Overall Study|Adverse Event|0|||
164084073|NCT01464827|592672258|FG008|Overall Study|Adverse Event|0|||
164084074|NCT01464827|592672259|FG009|Overall Study|Adverse Event|0|||
164084075|NCT01464827|592672260|FG010|Overall Study|Adverse Event|0|||
164084076|NCT01464827|592672261|FG011|Overall Study|Adverse Event|0|||
164084077|NCT01464827|592672262|FG012|Overall Study|Adverse Event|1|||
164084078|NCT01464827|592672263|FG013|Overall Study|Adverse Event|0|||
164084079|NCT01464827|592672250|FG000|Overall Study|Withdrawal by Subject|1|||
164084080|NCT01464827|592672251|FG001|Overall Study|Withdrawal by Subject|0|||
164084081|NCT01464827|592672252|FG002|Overall Study|Withdrawal by Subject|0|||
164084082|NCT01464827|592672253|FG003|Overall Study|Withdrawal by Subject|0|||
164084083|NCT01464827|592672254|FG004|Overall Study|Withdrawal by Subject|1|||
164084084|NCT01464827|592672255|FG005|Overall Study|Withdrawal by Subject|0|||
164084085|NCT01464827|592672256|FG006|Overall Study|Withdrawal by Subject|0|||
163886792|NCT04074759|591956545|FG013|Overall Study|Other|0|||
163886793|NCT04074759|591956546|FG014|Overall Study|Other|0|||
163886794|NCT04074759|591956547|FG015|Overall Study|Other|1|||
163886795|NCT04074759|591956548|FG016|Overall Study|Other|0|||
163886796|NCT04074759|591956549|FG017|Overall Study|Other|0|||
163886797|NCT04074759|591956550|FG018|Overall Study|Other|0|||
163886798|NCT04074759|591956532|FG000|Overall Study|Missing end of study status|0|||
163886799|NCT04074759|591956533|FG001|Overall Study|Missing end of study status|0|||
163886800|NCT04074759|591956534|FG002|Overall Study|Missing end of study status|0|||
164084086|NCT01464827|592672257|FG007|Overall Study|Withdrawal by Subject|1|||
164250278|NCT01667133|593282140|FG005|Phase 2: Dose-expansion|Other|0|||
164250279|NCT01667133|593282141|FG006|Phase 2: Dose-expansion|Other|0|||
164250280|NCT01667133|593282142|FG007|Phase 2: Dose-expansion|Other|0|||
164250281|NCT01667133|593282143|FG008|Phase 2: Dose-expansion|Other|0|||
164250282|NCT01667133|593282144|FG009|Phase 2: Dose-expansion|Other|0|||
164250283|NCT01667133|593282145|FG010|Phase 2: Dose-expansion|Other|0|||
164250284|NCT01667133|593282146|FG011|Phase 2: Dose-expansion|Other|1|||
164250285|NCT01916824|593282151|FG000|Overall Study|Lost to Follow-up|3|||
164250286|NCT01916824|593282152|FG001|Overall Study|Lost to Follow-up|6|||
164250287|NCT01916824|593282151|FG000|Overall Study|Physician Decision|2|||
164250288|NCT01916824|593282152|FG001|Overall Study|Physician Decision|0|||
164250289|NCT01916824|593282151|FG000|Overall Study|Withdrawal by Subject|2|||
164250290|NCT01916824|593282152|FG001|Overall Study|Withdrawal by Subject|3|||
164250291|NCT03835481|593282157|FG000|Double-blind Period|Other not stated below|0|||
164250292|NCT03835481|593282158|FG001|Double-blind Period|Other not stated below|0|||
164250293|NCT03835481|593282159|FG002|Double-blind Period|Other not stated below|0|||
164250294|NCT03835481|593282160|FG003|Double-blind Period|Other not stated below|1|||
164250295|NCT03835481|593282161|FG004|Double-blind Period|Other not stated below|1|||
164250296|NCT03835481|593282157|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
164250297|NCT03835481|593282158|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
164250298|NCT03835481|593282159|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
164250299|NCT03835481|593282160|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
164250300|NCT03835481|593282161|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
163886801|NCT04074759|591956535|FG003|Overall Study|Missing end of study status|0|||
163886802|NCT04074759|591956536|FG004|Overall Study|Missing end of study status|0|||
163886803|NCT04074759|591956537|FG005|Overall Study|Missing end of study status|0|||
163886804|NCT04074759|591956538|FG006|Overall Study|Missing end of study status|0|||
163886805|NCT04074759|591956539|FG007|Overall Study|Missing end of study status|0|||
163886806|NCT04074759|591956540|FG008|Overall Study|Missing end of study status|0|||
163886807|NCT04074759|591956541|FG009|Overall Study|Missing end of study status|0|||
163886808|NCT04074759|591956542|FG010|Overall Study|Missing end of study status|2|||
163886809|NCT04074759|591956543|FG011|Overall Study|Missing end of study status|0|||
163886810|NCT04074759|591956544|FG012|Overall Study|Missing end of study status|0|||
163886811|NCT04074759|591956545|FG013|Overall Study|Missing end of study status|0|||
163886812|NCT04074759|591956546|FG014|Overall Study|Missing end of study status|0|||
163886813|NCT04074759|591956547|FG015|Overall Study|Missing end of study status|0|||
163886814|NCT04074759|591956548|FG016|Overall Study|Missing end of study status|1|||
163886815|NCT04074759|591956549|FG017|Overall Study|Missing end of study status|0|||
163886816|NCT04074759|591956550|FG018|Overall Study|Missing end of study status|0|||
163886817|NCT05329220|591956554|FG000|Active Trial Period|Adverse Event|0|||
163886818|NCT05329220|591956555|FG001|Active Trial Period|Adverse Event|0|||
163886819|NCT05329220|591956556|FG002|Active Trial Period|Adverse Event|0|||
163886820|NCT05329220|591956557|FG003|Active Trial Period|Adverse Event|0|||
163886821|NCT05329220|591956558|FG004|Active Trial Period|Adverse Event|1|||
163886822|NCT05329220|591956559|FG005|Active Trial Period|Adverse Event|0|||
163886823|NCT05329220|591956554|FG000|Active Trial Period|Lost to Follow-up|0|||
163886824|NCT05329220|591956555|FG001|Active Trial Period|Lost to Follow-up|0|||
163886825|NCT05329220|591956556|FG002|Active Trial Period|Lost to Follow-up|0|||
163886826|NCT05329220|591956557|FG003|Active Trial Period|Lost to Follow-up|0|||
163886827|NCT05329220|591956558|FG004|Active Trial Period|Lost to Follow-up|32|||
163886828|NCT05329220|591956559|FG005|Active Trial Period|Lost to Follow-up|28|||
163886829|NCT05329220|591956554|FG000|Active Trial Period|Physician Decision|0|||
163886830|NCT05329220|591956555|FG001|Active Trial Period|Physician Decision|0|||
163886831|NCT05329220|591956556|FG002|Active Trial Period|Physician Decision|0|||
163886832|NCT05329220|591956557|FG003|Active Trial Period|Physician Decision|0|||
163886833|NCT05329220|591956558|FG004|Active Trial Period|Physician Decision|2|||
163886834|NCT05329220|591956559|FG005|Active Trial Period|Physician Decision|0|||
163886835|NCT05329220|591956554|FG000|Active Trial Period|Protocol Violation|0|||
163886836|NCT05329220|591956555|FG001|Active Trial Period|Protocol Violation|0|||
163886837|NCT05329220|591956556|FG002|Active Trial Period|Protocol Violation|0|||
163886838|NCT05329220|591956557|FG003|Active Trial Period|Protocol Violation|0|||
164250301|NCT03835481|593282157|FG000|Double-blind Period|Withdrawal by Subject|0|||
164250302|NCT03835481|593282158|FG001|Double-blind Period|Withdrawal by Subject|0|||
164250303|NCT03835481|593282159|FG002|Double-blind Period|Withdrawal by Subject|1|||
163886839|NCT05329220|591956558|FG004|Active Trial Period|Protocol Violation|1|||
163886840|NCT05329220|591956559|FG005|Active Trial Period|Protocol Violation|3|||
163886841|NCT05329220|591956554|FG000|Active Trial Period|Withdrawal by Subject|0|||
163886842|NCT05329220|591956555|FG001|Active Trial Period|Withdrawal by Subject|0|||
163886843|NCT05329220|591956556|FG002|Active Trial Period|Withdrawal by Subject|0|||
163886844|NCT05329220|591956557|FG003|Active Trial Period|Withdrawal by Subject|1|||
163886845|NCT05329220|591956558|FG004|Active Trial Period|Withdrawal by Subject|12|||
164250304|NCT03835481|593282160|FG003|Double-blind Period|Withdrawal by Subject|0|||
164250305|NCT03835481|593282161|FG004|Double-blind Period|Withdrawal by Subject|5|||
164250306|NCT03835481|593282157|FG000|Double-blind Period|Lost to Follow-up|0|||
164250307|NCT03835481|593282158|FG001|Double-blind Period|Lost to Follow-up|0|||
164250308|NCT03835481|593282159|FG002|Double-blind Period|Lost to Follow-up|0|||
164250309|NCT03835481|593282160|FG003|Double-blind Period|Lost to Follow-up|1|||
164250310|NCT03835481|593282161|FG004|Double-blind Period|Lost to Follow-up|0|||
164250311|NCT03835481|593282157|FG000|Double-blind Period|Protocol Violation|0|||
164250312|NCT03835481|593282158|FG001|Double-blind Period|Protocol Violation|2|||
164250313|NCT03835481|593282159|FG002|Double-blind Period|Protocol Violation|0|||
164250314|NCT03835481|593282160|FG003|Double-blind Period|Protocol Violation|1|||
164250315|NCT03835481|593282161|FG004|Double-blind Period|Protocol Violation|0|||
164250316|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
164250317|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
164250318|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
164250319|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
164250320|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
164250321|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
164250322|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
164250323|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
164250324|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
164250325|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
163991531|NCT01925209|592337195|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
163991532|NCT01925209|592337192|FG000|Treatment Epoch|Death|1|||
163991533|NCT01925209|592337193|FG001|Treatment Epoch|Death|0|||
163991534|NCT01925209|592337194|FG002|Treatment Epoch|Death|0|||
163991535|NCT01925209|592337195|FG003|Treatment Epoch|Death|0|||
163991536|NCT01925209|592337192|FG000|Treatment Epoch|Protocol deviation|0|||
163991537|NCT01925209|592337193|FG001|Treatment Epoch|Protocol deviation|0|||
163991538|NCT01925209|592337194|FG002|Treatment Epoch|Protocol deviation|1|||
163991539|NCT01925209|592337195|FG003|Treatment Epoch|Protocol deviation|1|||
163991540|NCT01925209|592337192|FG000|Treatment Epoch|Withdrawal by Subject|4|||
163991541|NCT01925209|592337193|FG001|Treatment Epoch|Withdrawal by Subject|3|||
163991542|NCT01925209|592337194|FG002|Treatment Epoch|Withdrawal by Subject|3|||
163991543|NCT01925209|592337195|FG003|Treatment Epoch|Withdrawal by Subject|2|||
163991544|NCT01925209|592337192|FG000|Treatment Epoch|Adverse Event|3|||
163991545|NCT01925209|592337193|FG001|Treatment Epoch|Adverse Event|5|||
163991546|NCT01925209|592337194|FG002|Treatment Epoch|Adverse Event|3|||
163991547|NCT01925209|592337195|FG003|Treatment Epoch|Adverse Event|1|||
163991548|NCT01925209|592337192|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
163991549|NCT01925209|592337193|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
163991550|NCT01925209|592337194|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
163991551|NCT01925209|592337195|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
163991552|NCT01925209|592337192|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
163991553|NCT01925209|592337193|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
163991554|NCT01925209|592337194|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
163991555|NCT01925209|592337195|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
163991556|NCT01925209|592337192|FG000|Follow-up|Adverse Event|1|||
163991557|NCT01925209|592337193|FG001|Follow-up|Adverse Event|4|||
163991558|NCT01925209|592337194|FG002|Follow-up|Adverse Event|0|||
163991559|NCT01925209|592337195|FG003|Follow-up|Adverse Event|1|||
163991560|NCT01925209|592337192|FG000|Follow-up|Physician Decision|0|||
163991561|NCT01925209|592337193|FG001|Follow-up|Physician Decision|0|||
163991562|NCT01925209|592337194|FG002|Follow-up|Physician Decision|1|||
163991563|NCT01925209|592337195|FG003|Follow-up|Physician Decision|0|||
163991564|NCT01925209|592337192|FG000|Follow-up|Non-compliance with study treatment|0|||
163991565|NCT01925209|592337193|FG001|Follow-up|Non-compliance with study treatment|0|||
163991566|NCT01925209|592337194|FG002|Follow-up|Non-compliance with study treatment|0|||
163991567|NCT01925209|592337195|FG003|Follow-up|Non-compliance with study treatment|1|||
163991568|NCT01925209|592337192|FG000|Follow-up|Withdrawal by Subject|0|||
163991569|NCT01925209|592337193|FG001|Follow-up|Withdrawal by Subject|2|||
163991570|NCT01925209|592337194|FG002|Follow-up|Withdrawal by Subject|0|||
163991571|NCT01925209|592337195|FG003|Follow-up|Withdrawal by Subject|2|||
163991572|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Adverse Event|21|||
164250326|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
164250327|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
163991573|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Adverse Event|6|||
163991574|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
163991575|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
163991576|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
163991577|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
163991578|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
163991579|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
163991580|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Physician Decision|0|||
163991581|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Physician Decision|3|||
164084087|NCT01464827|592672258|FG008|Overall Study|Withdrawal by Subject|0|||
164084088|NCT01464827|592672259|FG009|Overall Study|Withdrawal by Subject|0|||
164084089|NCT01464827|592672260|FG010|Overall Study|Withdrawal by Subject|0|||
164084090|NCT01464827|592672261|FG011|Overall Study|Withdrawal by Subject|0|||
164084091|NCT01464827|592672262|FG012|Overall Study|Withdrawal by Subject|0|||
164084092|NCT01464827|592672263|FG013|Overall Study|Withdrawal by Subject|0|||
164084093|NCT01464827|592672250|FG000|Overall Study|Lost to Follow-up|0|||
164084094|NCT01464827|592672251|FG001|Overall Study|Lost to Follow-up|2|||
164084095|NCT01464827|592672252|FG002|Overall Study|Lost to Follow-up|0|||
164084096|NCT01464827|592672253|FG003|Overall Study|Lost to Follow-up|2|||
164084097|NCT01464827|592672254|FG004|Overall Study|Lost to Follow-up|3|||
164084098|NCT01464827|592672255|FG005|Overall Study|Lost to Follow-up|1|||
164084099|NCT01464827|592672256|FG006|Overall Study|Lost to Follow-up|2|||
164084100|NCT01464827|592672257|FG007|Overall Study|Lost to Follow-up|2|||
164084101|NCT01464827|592672258|FG008|Overall Study|Lost to Follow-up|0|||
164084102|NCT01464827|592672259|FG009|Overall Study|Lost to Follow-up|0|||
164084103|NCT01464827|592672260|FG010|Overall Study|Lost to Follow-up|0|||
164084104|NCT01464827|592672261|FG011|Overall Study|Lost to Follow-up|1|||
164084105|NCT01464827|592672262|FG012|Overall Study|Lost to Follow-up|0|||
164084106|NCT01464827|592672263|FG013|Overall Study|Lost to Follow-up|1|||
164084107|NCT01464827|592672250|FG000|Overall Study|Other|2|||
164084108|NCT01464827|592672251|FG001|Overall Study|Other|3|||
164084109|NCT01464827|592672252|FG002|Overall Study|Other|0|||
164084110|NCT01464827|592672253|FG003|Overall Study|Other|2|||
164084111|NCT01464827|592672254|FG004|Overall Study|Other|3|||
164084112|NCT01464827|592672255|FG005|Overall Study|Other|0|||
164084113|NCT01464827|592672256|FG006|Overall Study|Other|1|||
164084114|NCT01464827|592672257|FG007|Overall Study|Other|0|||
164084115|NCT01464827|592672258|FG008|Overall Study|Other|3|||
164084116|NCT01464827|592672259|FG009|Overall Study|Other|1|||
164084117|NCT01464827|592672260|FG010|Overall Study|Other|2|||
164084118|NCT01464827|592672261|FG011|Overall Study|Other|0|||
164084119|NCT01464827|592672262|FG012|Overall Study|Other|1|||
164084120|NCT01464827|592672263|FG013|Overall Study|Other|0|||
164084121|NCT01464827|592672250|FG000|Overall Study|Not Treated|0|||
164084122|NCT01464827|592672251|FG001|Overall Study|Not Treated|2|||
164084123|NCT01464827|592672252|FG002|Overall Study|Not Treated|0|||
164084124|NCT01464827|592672253|FG003|Overall Study|Not Treated|0|||
164084125|NCT01464827|592672254|FG004|Overall Study|Not Treated|1|||
164084126|NCT01464827|592672255|FG005|Overall Study|Not Treated|0|||
164084127|NCT01464827|592672256|FG006|Overall Study|Not Treated|1|||
164084128|NCT01464827|592672257|FG007|Overall Study|Not Treated|0|||
164250328|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
164250329|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
164250330|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
164250331|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
164250332|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
164250333|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
164250334|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
164250335|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
164250336|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250337|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250338|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250339|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
164250340|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
164250341|NCT03835481|593282157|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
164250342|NCT03835481|593282158|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
164250343|NCT03835481|593282159|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
164250344|NCT03835481|593282160|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
164250345|NCT03835481|593282161|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
164250346|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
164084129|NCT01464827|592672258|FG008|Overall Study|Not Treated|0|||
164084130|NCT01464827|592672259|FG009|Overall Study|Not Treated|2|||
164084131|NCT01464827|592672260|FG010|Overall Study|Not Treated|0|||
164084132|NCT01464827|592672261|FG011|Overall Study|Not Treated|1|||
164084133|NCT01464827|592672262|FG012|Overall Study|Not Treated|0|||
164084134|NCT01464827|592672263|FG013|Overall Study|Not Treated|2|||
164084135|NCT01075763|592672264|FG000|Overall Study|Lost to Follow-up|2|||
164084136|NCT01075763|592672265|FG001|Overall Study|Lost to Follow-up|1|||
164250347|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
164250348|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
164084137|NCT01075763|592672264|FG000|Overall Study|Lack of Efficacy|0|||
164084138|NCT01075763|592672265|FG001|Overall Study|Lack of Efficacy|1|||
164084139|NCT01075763|592672264|FG000|Overall Study|Withdrawal by Subject|2|||
164084140|NCT01075763|592672265|FG001|Overall Study|Withdrawal by Subject|2|||
164084141|NCT00586521|592672266|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
164250349|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
164250350|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
164250351|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
164250352|NCT00191945|593282162|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
164250353|NCT00191945|593282163|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
164250354|NCT02063984|593282168|FG000|Overall Study|Lost to Follow-up|6|||
164250355|NCT02063984|593282169|FG001|Overall Study|Lost to Follow-up|5|||
164250356|NCT04222699|593282172|FG000|Overall Study|Lost to Follow-up|2|||
164250357|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
164250358|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
164250359|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
164250360|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
164250361|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
164250362|NCT01536561|593282175|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
164250363|NCT03583359|593282196|FG000|Overall Study|Withdrawal by Subject|15|||
164250364|NCT03583359|593282197|FG001|Overall Study|Withdrawal by Subject|6|||
164250365|NCT03583359|593282196|FG000|Overall Study|Lost to Follow-up|12|||
164250366|NCT03583359|593282197|FG001|Overall Study|Lost to Follow-up|3|||
164250367|NCT03583359|593282196|FG000|Overall Study|Adverse Event|0|||
164250368|NCT03583359|593282197|FG001|Overall Study|Adverse Event|1|||
164338656|NCT00319501|593615220|FG000|Double-blind Period|Withdrawal by Subject|0|||
164338657|NCT00319501|593615221|FG001|Double-blind Period|Withdrawal by Subject|3|||
163886846|NCT05329220|591956559|FG005|Active Trial Period|Withdrawal by Subject|13|||
163886847|NCT05329220|591956554|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163886848|NCT05329220|591956555|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163886849|NCT05329220|591956556|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163886850|NCT05329220|591956557|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163886851|NCT05329220|591956558|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
163886852|NCT05329220|591956559|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
163886853|NCT05329220|591956554|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163886854|NCT05329220|591956555|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163886855|NCT05329220|591956556|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163886856|NCT05329220|591956557|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163886857|NCT05329220|591956558|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
163886858|NCT05329220|591956559|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
163886859|NCT05329220|591956554|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
163886860|NCT05329220|591956555|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
163886861|NCT05329220|591956556|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
163886862|NCT05329220|591956557|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
163886863|NCT05329220|591956558|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
163886864|NCT05329220|591956559|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
163886865|NCT05329220|591956554|FG000|Follow-up Period|Adverse Event|0|||
163886866|NCT05329220|591956555|FG001|Follow-up Period|Adverse Event|0|||
163886867|NCT05329220|591956556|FG002|Follow-up Period|Adverse Event|0|||
163886868|NCT05329220|591956557|FG003|Follow-up Period|Adverse Event|0|||
163886869|NCT05329220|591956558|FG004|Follow-up Period|Adverse Event|2|||
163886870|NCT05329220|591956559|FG005|Follow-up Period|Adverse Event|1|||
163886871|NCT05329220|591956554|FG000|Follow-up Period|Death|0|||
163886872|NCT05329220|591956555|FG001|Follow-up Period|Death|0|||
163886873|NCT05329220|591956556|FG002|Follow-up Period|Death|1|||
163886874|NCT05329220|591956557|FG003|Follow-up Period|Death|1|||
163886875|NCT05329220|591956558|FG004|Follow-up Period|Death|0|||
163886876|NCT05329220|591956559|FG005|Follow-up Period|Death|1|||
163886877|NCT05329220|591956554|FG000|Follow-up Period|Lost to Follow-up|0|||
163886878|NCT05329220|591956555|FG001|Follow-up Period|Lost to Follow-up|1|||
163886879|NCT05329220|591956556|FG002|Follow-up Period|Lost to Follow-up|2|||
163886880|NCT05329220|591956557|FG003|Follow-up Period|Lost to Follow-up|2|||
163886881|NCT05329220|591956558|FG004|Follow-up Period|Lost to Follow-up|113|||
163886882|NCT05329220|591956559|FG005|Follow-up Period|Lost to Follow-up|89|||
163886883|NCT05329220|591956554|FG000|Follow-up Period|Physician Decision|0|||
163886884|NCT05329220|591956555|FG001|Follow-up Period|Physician Decision|0|||
163886885|NCT05329220|591956556|FG002|Follow-up Period|Physician Decision|0|||
163886886|NCT05329220|591956557|FG003|Follow-up Period|Physician Decision|0|||
163886887|NCT05329220|591956558|FG004|Follow-up Period|Physician Decision|2|||
164250369|NCT03583359|593282196|FG000|Overall Study|Protocol Violation|0|||
164250370|NCT03583359|593282197|FG001|Overall Study|Protocol Violation|1|||
164250371|NCT03583359|593282196|FG000|Overall Study|Other|2|||
164338658|NCT00319501|593615220|FG000|Double-blind Period|Sponsor Request|1|||
164250372|NCT03583359|593282197|FG001|Overall Study|Other|1|||
164250373|NCT01831466|593282202|FG000|Overall Study|Protocol Violation|1|||
164250374|NCT01831466|593282203|FG001|Overall Study|Protocol Violation|1|||
164250375|NCT01831466|593282204|FG002|Overall Study|Protocol Violation|2|||
164250376|NCT01831466|593282205|FG003|Overall Study|Protocol Violation|0|||
164250377|NCT01831466|593282206|FG004|Overall Study|Protocol Violation|0|||
164250378|NCT01831466|593282207|FG005|Overall Study|Protocol Violation|1|||
164250379|NCT01831466|593282208|FG006|Overall Study|Protocol Violation|0|||
163991582|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
163991583|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
163991584|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
163991585|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
163991586|NCT00510276|592337205|FG000|Acute Double-Blind Phase|Subject Decision|26|||
163991587|NCT00510276|592337206|FG001|Acute Double-Blind Phase|Subject Decision|28|||
163991588|NCT00510276|592337205|FG000|Extension Open-Label Phase|Adverse Event|9|||
163991589|NCT00510276|592337206|FG001|Extension Open-Label Phase|Adverse Event|18|||
163991590|NCT00510276|592337205|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
163991591|NCT00510276|592337206|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
163991592|NCT00510276|592337205|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
163991593|NCT00510276|592337206|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
163991594|NCT00510276|592337205|FG000|Extension Open-Label Phase|Physician Decision|2|||
163991595|NCT00510276|592337206|FG001|Extension Open-Label Phase|Physician Decision|3|||
163991596|NCT00510276|592337205|FG000|Extension Open-Label Phase|Protocol Violation|0|||
163991597|NCT00510276|592337206|FG001|Extension Open-Label Phase|Protocol Violation|1|||
163991598|NCT00510276|592337205|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
163991599|NCT00510276|592337206|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
163991600|NCT00510276|592337205|FG000|Extension Open-Label Phase|Subject Decision|7|||
163991601|NCT00510276|592337206|FG001|Extension Open-Label Phase|Subject Decision|9|||
163991602|NCT04025632|592339576|FG000|Overall Study|Adverse Event|1|||
163991603|NCT04025632|592339577|FG001|Overall Study|Adverse Event|1|||
163991604|NCT04025632|592339576|FG000|Overall Study|Withdrawal by Subject|1|||
163991605|NCT04025632|592339577|FG001|Overall Study|Withdrawal by Subject|1|||
164250380|NCT01831466|593282209|FG007|Overall Study|Protocol Violation|0|||
164250381|NCT01831466|593282210|FG008|Overall Study|Protocol Violation|0|||
164250382|NCT01831466|593282211|FG009|Overall Study|Protocol Violation|0|||
164250383|NCT01831466|593282212|FG010|Overall Study|Protocol Violation|0|||
164250384|NCT01831466|593282213|FG011|Overall Study|Protocol Violation|0|||
164250385|NCT01831466|593282202|FG000|Overall Study|Other|2|||
164250386|NCT01831466|593282203|FG001|Overall Study|Other|3|||
164250387|NCT01831466|593282204|FG002|Overall Study|Other|2|||
164250388|NCT01831466|593282205|FG003|Overall Study|Other|2|||
164250389|NCT01831466|593282206|FG004|Overall Study|Other|2|||
164250390|NCT01831466|593282207|FG005|Overall Study|Other|1|||
164250391|NCT01831466|593282208|FG006|Overall Study|Other|0|||
164250392|NCT01831466|593282209|FG007|Overall Study|Other|0|||
164250393|NCT01831466|593282210|FG008|Overall Study|Other|0|||
164250394|NCT01831466|593282211|FG009|Overall Study|Other|0|||
164250395|NCT01831466|593282212|FG010|Overall Study|Other|0|||
164250396|NCT01831466|593282213|FG011|Overall Study|Other|0|||
164250397|NCT01831466|593282202|FG000|Overall Study|Non-compliance with study treatment|2|||
164250398|NCT01831466|593282203|FG001|Overall Study|Non-compliance with study treatment|1|||
164250399|NCT01831466|593282204|FG002|Overall Study|Non-compliance with study treatment|1|||
164250400|NCT01831466|593282205|FG003|Overall Study|Non-compliance with study treatment|0|||
164250401|NCT01831466|593282206|FG004|Overall Study|Non-compliance with study treatment|0|||
164250402|NCT01831466|593282207|FG005|Overall Study|Non-compliance with study treatment|1|||
164250403|NCT01831466|593282208|FG006|Overall Study|Non-compliance with study treatment|0|||
164250404|NCT01831466|593282209|FG007|Overall Study|Non-compliance with study treatment|0|||
163991606|NCT04025632|592339576|FG000|Overall Study|Study Terminated by Sponsor|10|||
163991607|NCT04025632|592339577|FG001|Overall Study|Study Terminated by Sponsor|9|||
163991608|NCT04025632|592339576|FG000|Overall Study|Physician Decision|3|||
164250405|NCT01831466|593282210|FG008|Overall Study|Non-compliance with study treatment|0|||
163991609|NCT04025632|592339577|FG001|Overall Study|Physician Decision|1|||
163991610|NCT00376961|592339578|FG000|Initial Registration|Adverse Event|1|||
163991611|NCT00376961|592339579|FG001|Initial Registration|Adverse Event|0|||
164084142|NCT03083483|592672270|FG000|Overall Study|Adverse Event|1|||
164250406|NCT01831466|593282211|FG009|Overall Study|Non-compliance with study treatment|0|||
164250407|NCT01831466|593282212|FG010|Overall Study|Non-compliance with study treatment|0|||
164250408|NCT01831466|593282213|FG011|Overall Study|Non-compliance with study treatment|0|||
164338659|NCT00319501|593615221|FG001|Double-blind Period|Sponsor Request|0|||
163991612|NCT00376961|592339578|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
163991613|NCT00376961|592339579|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
164084143|NCT03083483|592672271|FG001|Overall Study|Adverse Event|1|||
164084144|NCT03083483|592672272|FG002|Overall Study|Adverse Event|1|||
164250409|NCT01831466|593282202|FG000|Overall Study|Death|0|||
164250410|NCT01831466|593282203|FG001|Overall Study|Death|1|||
164250411|NCT01831466|593282204|FG002|Overall Study|Death|0|||
164250412|NCT01831466|593282205|FG003|Overall Study|Death|0|||
164250413|NCT01831466|593282206|FG004|Overall Study|Death|0|||
164250414|NCT01831466|593282207|FG005|Overall Study|Death|0|||
164250415|NCT01831466|593282208|FG006|Overall Study|Death|0|||
164250416|NCT01831466|593282209|FG007|Overall Study|Death|0|||
164250417|NCT01831466|593282210|FG008|Overall Study|Death|0|||
164250418|NCT01831466|593282211|FG009|Overall Study|Death|0|||
164250419|NCT01831466|593282212|FG010|Overall Study|Death|0|||
164250420|NCT01831466|593282213|FG011|Overall Study|Death|0|||
164250421|NCT01831466|593282202|FG000|Overall Study|Withdrawal by Subject|6|||
164250422|NCT01831466|593282203|FG001|Overall Study|Withdrawal by Subject|3|||
164250423|NCT01831466|593282204|FG002|Overall Study|Withdrawal by Subject|3|||
164250424|NCT01831466|593282205|FG003|Overall Study|Withdrawal by Subject|3|||
164250425|NCT01831466|593282206|FG004|Overall Study|Withdrawal by Subject|3|||
164250426|NCT01831466|593282207|FG005|Overall Study|Withdrawal by Subject|5|||
164250427|NCT01831466|593282208|FG006|Overall Study|Withdrawal by Subject|0|||
164250428|NCT01831466|593282209|FG007|Overall Study|Withdrawal by Subject|0|||
164250429|NCT01831466|593282210|FG008|Overall Study|Withdrawal by Subject|0|||
164250430|NCT01831466|593282211|FG009|Overall Study|Withdrawal by Subject|1|||
164250431|NCT01831466|593282212|FG010|Overall Study|Withdrawal by Subject|0|||
164250432|NCT01831466|593282213|FG011|Overall Study|Withdrawal by Subject|1|||
164250433|NCT01831466|593282202|FG000|Overall Study|Lost to Follow-up|0|||
164250434|NCT01831466|593282203|FG001|Overall Study|Lost to Follow-up|1|||
164250435|NCT01831466|593282204|FG002|Overall Study|Lost to Follow-up|4|||
164250436|NCT01831466|593282205|FG003|Overall Study|Lost to Follow-up|2|||
164250437|NCT01831466|593282206|FG004|Overall Study|Lost to Follow-up|0|||
164250438|NCT01831466|593282207|FG005|Overall Study|Lost to Follow-up|3|||
164250439|NCT01831466|593282208|FG006|Overall Study|Lost to Follow-up|0|||
164250440|NCT01831466|593282209|FG007|Overall Study|Lost to Follow-up|0|||
164250441|NCT01831466|593282210|FG008|Overall Study|Lost to Follow-up|0|||
164250442|NCT01831466|593282211|FG009|Overall Study|Lost to Follow-up|1|||
164250443|NCT01831466|593282212|FG010|Overall Study|Lost to Follow-up|0|||
164250444|NCT01831466|593282213|FG011|Overall Study|Lost to Follow-up|1|||
164250445|NCT01831466|593282202|FG000|Overall Study|Lack of Efficacy|5|||
164250446|NCT01831466|593282203|FG001|Overall Study|Lack of Efficacy|8|||
164250447|NCT01831466|593282204|FG002|Overall Study|Lack of Efficacy|7|||
164250448|NCT01831466|593282205|FG003|Overall Study|Lack of Efficacy|6|||
164250449|NCT01831466|593282206|FG004|Overall Study|Lack of Efficacy|9|||
164250450|NCT01831466|593282207|FG005|Overall Study|Lack of Efficacy|8|||
164250451|NCT01831466|593282208|FG006|Overall Study|Lack of Efficacy|1|||
164250452|NCT01831466|593282209|FG007|Overall Study|Lack of Efficacy|1|||
164250453|NCT01831466|593282210|FG008|Overall Study|Lack of Efficacy|2|||
164250454|NCT01831466|593282211|FG009|Overall Study|Lack of Efficacy|2|||
164250455|NCT01831466|593282212|FG010|Overall Study|Lack of Efficacy|2|||
164250456|NCT01831466|593282213|FG011|Overall Study|Lack of Efficacy|0|||
164250457|NCT01831466|593282202|FG000|Overall Study|Adverse Event|0|||
164250458|NCT01831466|593282203|FG001|Overall Study|Adverse Event|0|||
164250459|NCT01831466|593282204|FG002|Overall Study|Adverse Event|4|||
164250460|NCT01831466|593282205|FG003|Overall Study|Adverse Event|6|||
164250461|NCT01831466|593282206|FG004|Overall Study|Adverse Event|3|||
164250462|NCT01831466|593282207|FG005|Overall Study|Adverse Event|7|||
164250463|NCT01831466|593282208|FG006|Overall Study|Adverse Event|0|||
164250464|NCT01831466|593282209|FG007|Overall Study|Adverse Event|1|||
164250465|NCT01831466|593282210|FG008|Overall Study|Adverse Event|1|||
164250466|NCT01831466|593282211|FG009|Overall Study|Adverse Event|1|||
163886888|NCT05329220|591956559|FG005|Follow-up Period|Physician Decision|2|||
163886889|NCT05329220|591956554|FG000|Follow-up Period|Protocol Violation|0|||
163886890|NCT05329220|591956555|FG001|Follow-up Period|Protocol Violation|0|||
163886891|NCT05329220|591956556|FG002|Follow-up Period|Protocol Violation|0|||
163886892|NCT05329220|591956557|FG003|Follow-up Period|Protocol Violation|0|||
163886893|NCT05329220|591956558|FG004|Follow-up Period|Protocol Violation|0|||
164338660|NCT00319501|593615220|FG000|Double-blind Period|Did not receive treatment|42|||
164338661|NCT00319501|593615221|FG001|Double-blind Period|Did not receive treatment|29|||
164250467|NCT01831466|593282212|FG010|Overall Study|Adverse Event|0|||
164250468|NCT01831466|593282213|FG011|Overall Study|Adverse Event|2|||
164250469|NCT03497039|593282215|FG000|Overall Study|Withdrawal by Subject|1|||
164250470|NCT03497039|593282216|FG001|Overall Study|Withdrawal by Subject|0|||
164250471|NCT03497039|593282215|FG000|Overall Study|Protocol Violation|0|||
164250472|NCT03497039|593282216|FG001|Overall Study|Protocol Violation|1|||
164250473|NCT02567799|593282217|FG000|Concurrent Chemoradiotherapy|Death|1|||
164250474|NCT02567799|593282218|FG001|Concurrent Chemoradiotherapy|Death|0|||
164250475|NCT02567799|593282219|FG002|Concurrent Chemoradiotherapy|Death|0|||
164338662|NCT00319501|593615220|FG000|Open-label Period|Adverse Event|5|||
164250476|NCT02567799|593282217|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
164250477|NCT02567799|593282218|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
164250478|NCT02567799|593282219|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
164250479|NCT02567799|593282217|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
164338663|NCT00319501|593615221|FG001|Open-label Period|Adverse Event|0|||
164250480|NCT02567799|593282218|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
164250481|NCT02567799|593282219|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
164084145|NCT03083483|592672270|FG000|Overall Study|Lost to Follow-up|2|||
164250482|NCT02567799|593282217|FG000|Follow-up|Death|1|||
164250483|NCT02567799|593282218|FG001|Follow-up|Death|0|||
164250484|NCT02567799|593282219|FG002|Follow-up|Death|1|||
164250485|NCT02567799|593282217|FG000|Follow-up|Progressive Disease|1|||
164250486|NCT02567799|593282218|FG001|Follow-up|Progressive Disease|1|||
164250487|NCT02567799|593282219|FG002|Follow-up|Progressive Disease|3|||
164250488|NCT02131662|593282220|FG000|Overall Study|Protocol Violation|1|||
164250489|NCT02131662|593282221|FG001|Overall Study|Protocol Violation|0|||
164250490|NCT02131662|593282222|FG002|Overall Study|Protocol Violation|0|||
164250491|NCT02131662|593282223|FG003|Overall Study|Protocol Violation|0|||
164250492|NCT02131662|593282224|FG004|Overall Study|Protocol Violation|0|||
164250493|NCT02131662|593282220|FG000|Overall Study|Other|2|||
164250494|NCT02131662|593282221|FG001|Overall Study|Other|4|||
164250495|NCT02131662|593282222|FG002|Overall Study|Other|3|||
164250496|NCT02131662|593282223|FG003|Overall Study|Other|3|||
164250497|NCT02131662|593282224|FG004|Overall Study|Other|4|||
164250498|NCT02131662|593282220|FG000|Overall Study|Adverse Event|0|||
164250499|NCT02131662|593282221|FG001|Overall Study|Adverse Event|1|||
164250500|NCT02131662|593282222|FG002|Overall Study|Adverse Event|1|||
164250501|NCT02131662|593282223|FG003|Overall Study|Adverse Event|1|||
164250502|NCT02131662|593282224|FG004|Overall Study|Adverse Event|3|||
164250503|NCT02131662|593282220|FG000|Overall Study|Pregnancy|0|||
164250504|NCT02131662|593282221|FG001|Overall Study|Pregnancy|1|||
164250505|NCT02131662|593282222|FG002|Overall Study|Pregnancy|0|||
164250506|NCT02131662|593282223|FG003|Overall Study|Pregnancy|1|||
164250507|NCT02131662|593282224|FG004|Overall Study|Pregnancy|0|||
164250508|NCT02131662|593282220|FG000|Overall Study|Wish for pregnancy|0|||
164250509|NCT02131662|593282221|FG001|Overall Study|Wish for pregnancy|0|||
164250510|NCT02131662|593282222|FG002|Overall Study|Wish for pregnancy|0|||
164250511|NCT02131662|593282223|FG003|Overall Study|Wish for pregnancy|0|||
164250512|NCT02131662|593282224|FG004|Overall Study|Wish for pregnancy|1|||
164250513|NCT02131662|593282220|FG000|Overall Study|Lack of Efficacy|1|||
164250514|NCT02131662|593282221|FG001|Overall Study|Lack of Efficacy|0|||
164250515|NCT02131662|593282222|FG002|Overall Study|Lack of Efficacy|0|||
164250516|NCT02131662|593282223|FG003|Overall Study|Lack of Efficacy|0|||
164250517|NCT02131662|593282224|FG004|Overall Study|Lack of Efficacy|1|||
164250518|NCT02131662|593282220|FG000|Overall Study|Withdrawal by Subject|1|||
164250519|NCT02131662|593282221|FG001|Overall Study|Withdrawal by Subject|5|||
164250520|NCT02131662|593282222|FG002|Overall Study|Withdrawal by Subject|1|||
164250521|NCT02131662|593282223|FG003|Overall Study|Withdrawal by Subject|5|||
163886894|NCT05329220|591956559|FG005|Follow-up Period|Protocol Violation|1|||
163886895|NCT05329220|591956554|FG000|Follow-up Period|Withdrawal by Subject|0|||
163886896|NCT05329220|591956555|FG001|Follow-up Period|Withdrawal by Subject|0|||
163886897|NCT05329220|591956556|FG002|Follow-up Period|Withdrawal by Subject|1|||
163886898|NCT05329220|591956557|FG003|Follow-up Period|Withdrawal by Subject|1|||
163886899|NCT05329220|591956558|FG004|Follow-up Period|Withdrawal by Subject|34|||
163886900|NCT05329220|591956559|FG005|Follow-up Period|Withdrawal by Subject|35|||
163886901|NCT05329220|591956554|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163886902|NCT05329220|591956555|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163886903|NCT05329220|591956556|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
163886904|NCT05329220|591956557|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163886905|NCT05329220|591956558|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163886906|NCT05329220|591956559|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
163886907|NCT05329220|591956554|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163886908|NCT05329220|591956555|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163886909|NCT05329220|591956556|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163886910|NCT05329220|591956557|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163886911|NCT05329220|591956558|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
163886912|NCT05329220|591956559|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
163886913|NCT05329220|591956554|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
164084146|NCT03083483|592672271|FG001|Overall Study|Lost to Follow-up|1|||
164250522|NCT02131662|593282224|FG004|Overall Study|Withdrawal by Subject|6|||
164250523|NCT02131662|593282220|FG000|Overall Study|Lost to Follow-up|1|||
164250524|NCT02131662|593282221|FG001|Overall Study|Lost to Follow-up|3|||
164250525|NCT02131662|593282222|FG002|Overall Study|Lost to Follow-up|0|||
164250526|NCT02131662|593282223|FG003|Overall Study|Lost to Follow-up|9|||
164250527|NCT02131662|593282224|FG004|Overall Study|Lost to Follow-up|0|||
164250528|NCT02131662|593282220|FG000|Overall Study|Not treated|2|||
164250529|NCT02131662|593282221|FG001|Overall Study|Not treated|0|||
164250530|NCT02131662|593282222|FG002|Overall Study|Not treated|2|||
164250531|NCT02131662|593282223|FG003|Overall Study|Not treated|2|||
164250532|NCT02131662|593282224|FG004|Overall Study|Not treated|3|||
164250533|NCT01016132|593282247|FG000|Overall Study|Discomfort|1|||
164250534|NCT00790582|593282250|FG000|Overall Study|Death|14|||
164250535|NCT00790582|593282251|FG001|Overall Study|Death|32|||
164250536|NCT00790582|593282250|FG000|Overall Study|Physician Decision|7|||
164250537|NCT00790582|593282251|FG001|Overall Study|Physician Decision|1|||
164250538|NCT00790582|593282250|FG000|Overall Study|Lost to Follow-up|3|||
164250539|NCT00790582|593282251|FG001|Overall Study|Lost to Follow-up|3|||
164250540|NCT00790582|593282250|FG000|Overall Study|Withdrawal by Subject|7|||
164250541|NCT00790582|593282251|FG001|Overall Study|Withdrawal by Subject|51|||
164250542|NCT00803595|593282252|FG000|Overall Study|Adverse Event|3|||
164084147|NCT03083483|592672272|FG002|Overall Study|Lost to Follow-up|1|||
164084148|NCT03083483|592672270|FG000|Overall Study|technological issues|1|||
164084149|NCT03083483|592672271|FG001|Overall Study|technological issues|0|||
164084150|NCT03083483|592672272|FG002|Overall Study|technological issues|1|||
164084151|NCT02710071|592672273|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
164084152|NCT02710071|592672274|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
164084153|NCT02710071|592672273|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
164084154|NCT02710071|592672274|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
164084155|NCT05487456|592672277|FG000|Overall Study|Withdrawal by Subject|0|||
164084156|NCT05487456|592672278|FG001|Overall Study|Withdrawal by Subject|0|||
164084157|NCT05487456|592672279|FG002|Overall Study|Withdrawal by Subject|1|||
164084158|NCT05487456|592672280|FG003|Overall Study|Withdrawal by Subject|0|||
164084159|NCT00958256|592672282|FG000|Overall Study|Adverse Event|3|||
164084160|NCT05431153|592672283|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164084161|NCT05431153|592672284|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164084162|NCT05431153|592672285|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164084163|NCT05431153|592672286|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164084164|NCT05431153|592672287|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
164084165|NCT05431153|592672288|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164084166|NCT00678392|592672289|FG000|Overall Study|Adverse Event|0|||
164084167|NCT00678392|592672290|FG001|Overall Study|Adverse Event|6|||
164084168|NCT00678392|592672289|FG000|Overall Study|Death|280|||
164084169|NCT00678392|592672290|FG001|Overall Study|Death|269|||
164250543|NCT00803595|593282253|FG001|Overall Study|Adverse Event|4|||
164250544|NCT00803595|593282254|FG002|Overall Study|Adverse Event|1|||
164250545|NCT00803595|593282252|FG000|Overall Study|Protocol Violation|7|||
164250546|NCT00803595|593282253|FG001|Overall Study|Protocol Violation|2|||
163991614|NCT00376961|592339578|FG000|Initial Registration|Progression/relapse|1|||
163991615|NCT00376961|592339579|FG001|Initial Registration|Progression/relapse|0|||
163991616|NCT00376961|592339578|FG000|Initial Registration|Ineligible|3|||
163991617|NCT00376961|592339579|FG001|Initial Registration|Ineligible|0|||
163991618|NCT00376961|592339578|FG000|Maintenance|Adverse Event|0|||
163991619|NCT00376961|592339579|FG001|Maintenance|Adverse Event|1|||
163991620|NCT00376961|592339578|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
163991621|NCT00376961|592339579|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
163991622|NCT00376961|592339578|FG000|Maintenance|Progression/relapse|0|||
163991623|NCT00376961|592339579|FG001|Maintenance|Progression/relapse|18|||
163991624|NCT00376961|592339578|FG000|Maintenance|Ineligible|0|||
163991625|NCT00376961|592339579|FG001|Maintenance|Ineligible|3|||
163991626|NCT02591615|592339581|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
163991627|NCT02591615|592339582|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
163991628|NCT02591615|592339583|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
163991629|NCT02591615|592339584|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
163991630|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
163991631|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
163991632|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
163991633|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
163991634|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
163991635|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
163991636|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
163991637|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
163991638|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
163991639|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
163991640|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
163991641|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
163991642|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
163991643|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
164084170|NCT00678392|592672289|FG000|Overall Study|Lost to Follow-up|15|||
164084171|NCT00678392|592672290|FG001|Overall Study|Lost to Follow-up|13|||
164084172|NCT00678392|592672289|FG000|Overall Study|Objective Progression or Relapse|3|||
164250547|NCT00803595|593282254|FG002|Overall Study|Protocol Violation|12|||
164250548|NCT00803595|593282252|FG000|Overall Study|Withdrawal by Subject|5|||
164250549|NCT00803595|593282253|FG001|Overall Study|Withdrawal by Subject|2|||
164250550|NCT00803595|593282254|FG002|Overall Study|Withdrawal by Subject|3|||
163991644|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
163991645|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
164250551|NCT02566785|593282255|FG000|Overall Study|Lost to Follow-up|0|||
164250552|NCT02566785|593282256|FG001|Overall Study|Lost to Follow-up|2|||
163991646|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
163991647|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
163991648|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
163991649|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
163991650|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
163991651|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
163991652|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
163991653|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
163991654|NCT02591615|592339581|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
163991655|NCT02591615|592339582|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
163991656|NCT02591615|592339583|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
163991657|NCT02591615|592339584|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
163991658|NCT02591615|592339581|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
163991659|NCT02591615|592339582|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
163991660|NCT02591615|592339583|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
163991661|NCT02591615|592339584|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
163991662|NCT02591615|592339581|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
163991663|NCT02591615|592339582|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
163991664|NCT02591615|592339583|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
163991665|NCT02591615|592339584|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
163991666|NCT02591615|592339581|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
163991667|NCT02591615|592339582|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
163991668|NCT02591615|592339583|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
163991669|NCT02591615|592339584|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
163991670|NCT02591615|592339581|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
163991671|NCT02591615|592339582|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
163991672|NCT02591615|592339583|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
163991673|NCT02591615|592339584|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
163991674|NCT02591615|592339581|FG000|Maintenance MK-3475|Adverse Event|0|||
163991675|NCT02591615|592339582|FG001|Maintenance MK-3475|Adverse Event|3|||
163991676|NCT02591615|592339583|FG002|Maintenance MK-3475|Adverse Event|1|||
163991677|NCT02591615|592339584|FG003|Maintenance MK-3475|Adverse Event|2|||
164142040|NCT02968849|592880887|FG000|Overall Study|Death|8|||
163991678|NCT02591615|592339581|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
164142041|NCT02968849|592880888|FG001|Overall Study|Death|10|||
164142042|NCT02968849|592880887|FG000|Overall Study|Lost to Follow-up|31|||
164142043|NCT02968849|592880888|FG001|Overall Study|Lost to Follow-up|29|||
164142044|NCT02968849|592880887|FG000|Overall Study|Withdrawal by Subject|73|||
164142045|NCT02968849|592880888|FG001|Overall Study|Withdrawal by Subject|64|||
164142046|NCT02968849|592880887|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
164142047|NCT02968849|592880888|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
164142048|NCT02968849|592880887|FG000|Overall Study|Physician Decision|6|||
164142049|NCT02968849|592880888|FG001|Overall Study|Physician Decision|9|||
164142050|NCT02968849|592880887|FG000|Overall Study|Other|16|||
164142051|NCT02968849|592880888|FG001|Overall Study|Other|10|||
164142052|NCT05292183|592882535|FG000|Overall Study|Adverse Event|1|||
164142053|NCT02017015|592882540|FG000|Overall Study|Adverse Event|9|||
164142054|NCT02017015|592882540|FG000|Overall Study|Withdrawal by Subject|21|||
164142055|NCT02017015|592882540|FG000|Overall Study|Death|4|||
164142056|NCT02017015|592882540|FG000|Overall Study|Progressive Disease|31|||
164142057|NCT02017015|592882540|FG000|Overall Study|Non-compliance with study drug|2|||
164142058|NCT02017015|592882540|FG000|Overall Study|Physician Decision|2|||
164142059|NCT01277601|592882543|FG000|Overall Study|Adverse Event|5|||
164142060|NCT01277601|592882544|FG001|Overall Study|Adverse Event|3|||
164142061|NCT01277601|592882545|FG002|Overall Study|Adverse Event|0|||
164142062|NCT01277601|592882546|FG003|Overall Study|Adverse Event|7|||
164142063|NCT01277601|592882543|FG000|Overall Study|Withdrawal by Subject|18|||
164142064|NCT01277601|592882544|FG001|Overall Study|Withdrawal by Subject|21|||
164142065|NCT01277601|592882545|FG002|Overall Study|Withdrawal by Subject|8|||
164142066|NCT01277601|592882546|FG003|Overall Study|Withdrawal by Subject|17|||
164142067|NCT01277601|592882543|FG000|Overall Study|Lost to Follow-up|7|||
164142068|NCT01277601|592882544|FG001|Overall Study|Lost to Follow-up|9|||
164142069|NCT01277601|592882545|FG002|Overall Study|Lost to Follow-up|4|||
164142070|NCT01277601|592882546|FG003|Overall Study|Lost to Follow-up|2|||
164142071|NCT01277601|592882543|FG000|Overall Study|Physician Decision|3|||
164142072|NCT01277601|592882544|FG001|Overall Study|Physician Decision|5|||
164142073|NCT01277601|592882545|FG002|Overall Study|Physician Decision|1|||
164142074|NCT01277601|592882546|FG003|Overall Study|Physician Decision|6|||
164142075|NCT01277601|592882543|FG000|Overall Study|Pregnancy|2|||
164142076|NCT01277601|592882544|FG001|Overall Study|Pregnancy|2|||
164142077|NCT01277601|592882545|FG002|Overall Study|Pregnancy|4|||
164142078|NCT01277601|592882546|FG003|Overall Study|Pregnancy|1|||
163991679|NCT02591615|592339582|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
163991680|NCT02591615|592339583|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
163991681|NCT02591615|592339584|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
163991682|NCT02591615|592339581|FG000|Maintenance MK-3475|Death|0|||
163991683|NCT02591615|592339582|FG001|Maintenance MK-3475|Death|1|||
163991684|NCT02591615|592339583|FG002|Maintenance MK-3475|Death|1|||
163991685|NCT02591615|592339584|FG003|Maintenance MK-3475|Death|0|||
163991686|NCT02591615|592339581|FG000|Maintenance MK-3475|Physician discretion|0|||
163991687|NCT02591615|592339582|FG001|Maintenance MK-3475|Physician discretion|0|||
163991688|NCT02591615|592339583|FG002|Maintenance MK-3475|Physician discretion|1|||
163991689|NCT02591615|592339584|FG003|Maintenance MK-3475|Physician discretion|0|||
163991690|NCT02591615|592339581|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
164250553|NCT02566785|593282255|FG000|Overall Study|Worsening condition|1|||
164250554|NCT02566785|593282256|FG001|Overall Study|Worsening condition|1|||
164250555|NCT01597908|593282257|FG000|Randomized Phase|Death|217|||
164250556|NCT01597908|593282258|FG001|Randomized Phase|Death|238|||
164250557|NCT01597908|593282259|FG002|Randomized Phase|Death|0|||
164250558|NCT01597908|593282257|FG000|Randomized Phase|Sponsor Decision|93|||
164250559|NCT01597908|593282258|FG001|Randomized Phase|Sponsor Decision|39|||
164250560|NCT01597908|593282259|FG002|Randomized Phase|Sponsor Decision|0|||
164250561|NCT01597908|593282257|FG000|Randomized Phase|Lost to Follow-up|9|||
164250562|NCT01597908|593282258|FG001|Randomized Phase|Lost to Follow-up|16|||
164250563|NCT01597908|593282259|FG002|Randomized Phase|Lost to Follow-up|0|||
164250564|NCT01597908|593282257|FG000|Randomized Phase|Physician Decision|6|||
164250565|NCT01597908|593282258|FG001|Randomized Phase|Physician Decision|3|||
164250566|NCT01597908|593282259|FG002|Randomized Phase|Physician Decision|0|||
164250567|NCT01597908|593282257|FG000|Randomized Phase|Withdrawal by Subject|26|||
164250568|NCT01597908|593282258|FG001|Randomized Phase|Withdrawal by Subject|22|||
164250569|NCT01597908|593282259|FG002|Randomized Phase|Withdrawal by Subject|0|||
164250570|NCT01597908|593282257|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
164250571|NCT01597908|593282258|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
164250572|NCT01597908|593282259|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
164250573|NCT01597908|593282257|FG000|Crossover Phase|Death|0|||
164250574|NCT01597908|593282258|FG001|Crossover Phase|Death|0|||
164250575|NCT01597908|593282259|FG002|Crossover Phase|Death|11|||
164250576|NCT01597908|593282257|FG000|Crossover Phase|Withdrawal by Subject|0|||
163991691|NCT02591615|592339582|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
163991692|NCT02591615|592339583|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
163991693|NCT02591615|592339584|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
163991694|NCT02591615|592339581|FG000|Maintenance MK-3475|In active treatment|2|||
163991695|NCT02591615|592339582|FG001|Maintenance MK-3475|In active treatment|0|||
163991696|NCT02591615|592339583|FG002|Maintenance MK-3475|In active treatment|0|||
163991697|NCT02591615|592339584|FG003|Maintenance MK-3475|In active treatment|1|||
163991698|NCT00686127|592339587|FG000|Overall Study|Withdrawal by Subject|14|||
163991699|NCT00686127|592339588|FG001|Overall Study|Withdrawal by Subject|6|||
163991700|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
163991701|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
163991702|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
163991703|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
164250577|NCT01597908|593282258|FG001|Crossover Phase|Withdrawal by Subject|0|||
164250578|NCT01597908|593282259|FG002|Crossover Phase|Withdrawal by Subject|3|||
164250579|NCT01597908|593282257|FG000|Crossover Phase|Sponsor Decision|0|||
164250580|NCT01597908|593282258|FG001|Crossover Phase|Sponsor Decision|0|||
164250581|NCT01597908|593282259|FG002|Crossover Phase|Sponsor Decision|20|||
164250582|NCT02949024|593282262|FG000|Overall Study|Withdrawal by Subject|0|||
163991704|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
163991705|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
163991706|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
164006718|NCT03519178|592391057|FG008|PF-06873600 Treatment|Physician Decision|0|||
164006719|NCT03519178|592391058|FG009|PF-06873600 Treatment|Physician Decision|0|||
164006720|NCT03519178|592391059|FG010|PF-06873600 Treatment|Physician Decision|1|||
164006721|NCT03519178|592391060|FG011|PF-06873600 Treatment|Physician Decision|0|||
164006722|NCT03519178|592391061|FG012|PF-06873600 Treatment|Physician Decision|0|||
164006723|NCT03519178|592391062|FG013|PF-06873600 Treatment|Physician Decision|4|||
164006724|NCT03519178|592391063|FG014|PF-06873600 Treatment|Physician Decision|1|||
164006725|NCT03519178|592391049|FG000|PF-06873600 Treatment|Progressive disease|1|||
164006726|NCT03519178|592391050|FG001|PF-06873600 Treatment|Progressive disease|1|||
164006727|NCT03519178|592391051|FG002|PF-06873600 Treatment|Progressive disease|1|||
164006728|NCT03519178|592391052|FG003|PF-06873600 Treatment|Progressive disease|1|||
164006729|NCT03519178|592391053|FG004|PF-06873600 Treatment|Progressive disease|6|||
164006730|NCT03519178|592391054|FG005|PF-06873600 Treatment|Progressive disease|7|||
164006731|NCT03519178|592391055|FG006|PF-06873600 Treatment|Progressive disease|3|||
164006732|NCT03519178|592391056|FG007|PF-06873600 Treatment|Progressive disease|7|||
164006733|NCT03519178|592391057|FG008|PF-06873600 Treatment|Progressive disease|3|||
164250583|NCT02949024|593282263|FG001|Overall Study|Withdrawal by Subject|1|||
164250584|NCT01027650|593282264|FG000|Overall Study|Personal Reasons|0|||
164250585|NCT01027650|593282265|FG001|Overall Study|Personal Reasons|0|||
164250586|NCT01027650|593282266|FG002|Overall Study|Personal Reasons|0|||
164250587|NCT01027650|593282267|FG003|Overall Study|Personal Reasons|0|||
164250588|NCT01027650|593282268|FG004|Overall Study|Personal Reasons|2|||
164250589|NCT01027650|593282269|FG005|Overall Study|Personal Reasons|1|||
163991707|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
164250590|NCT01027650|593282270|FG006|Overall Study|Personal Reasons|0|||
164250591|NCT01027650|593282271|FG007|Overall Study|Personal Reasons|0|||
164250592|NCT01027650|593282264|FG000|Overall Study|Lost to Follow-up|0|||
164250593|NCT01027650|593282265|FG001|Overall Study|Lost to Follow-up|0|||
164250594|NCT01027650|593282266|FG002|Overall Study|Lost to Follow-up|0|||
164250595|NCT01027650|593282267|FG003|Overall Study|Lost to Follow-up|0|||
164250596|NCT01027650|593282268|FG004|Overall Study|Lost to Follow-up|0|||
164250597|NCT01027650|593282269|FG005|Overall Study|Lost to Follow-up|0|||
164250598|NCT01027650|593282270|FG006|Overall Study|Lost to Follow-up|1|||
164250599|NCT01027650|593282271|FG007|Overall Study|Lost to Follow-up|0|||
164250600|NCT01027650|593282264|FG000|Overall Study|Lack of Efficacy|0|||
164338664|NCT00319501|593615220|FG000|Open-label Period|Protocol Violation|6|||
164338665|NCT00319501|593615221|FG001|Open-label Period|Protocol Violation|0|||
163991708|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163991709|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163991710|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163991711|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
163991712|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
163991713|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164250601|NCT01027650|593282265|FG001|Overall Study|Lack of Efficacy|0|||
164338666|NCT00319501|593615220|FG000|Open-label Period|Withdrawal by Subject|38|||
164338667|NCT00319501|593615221|FG001|Open-label Period|Withdrawal by Subject|0|||
164338668|NCT00319501|593615220|FG000|Open-label Period|Principal Investigator decision|6|||
164338669|NCT00319501|593615221|FG001|Open-label Period|Principal Investigator decision|0|||
164338670|NCT00319501|593615220|FG000|Open-label Period|Sponsor request|12|||
164338671|NCT00319501|593615221|FG001|Open-label Period|Sponsor request|0|||
163886914|NCT05329220|591956555|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163886915|NCT05329220|591956556|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163886916|NCT05329220|591956557|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163886917|NCT05329220|591956558|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
163886918|NCT05329220|591956559|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
163886919|NCT05329220|591956554|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163886920|NCT05329220|591956555|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163886921|NCT05329220|591956556|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163886922|NCT05329220|591956557|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163886923|NCT05329220|591956558|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
163886924|NCT05329220|591956559|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
163886925|NCT05329220|591956554|FG000|Follow-up Period|EARLY TERMINATION|0|||
163886926|NCT05329220|591956555|FG001|Follow-up Period|EARLY TERMINATION|0|||
163886927|NCT05329220|591956556|FG002|Follow-up Period|EARLY TERMINATION|0|||
163886928|NCT05329220|591956557|FG003|Follow-up Period|EARLY TERMINATION|0|||
163886929|NCT05329220|591956558|FG004|Follow-up Period|EARLY TERMINATION|0|||
163886930|NCT05329220|591956559|FG005|Follow-up Period|EARLY TERMINATION|1|||
163886931|NCT05329220|591956554|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163886932|NCT05329220|591956555|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163886933|NCT05329220|591956556|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163886934|NCT05329220|591956557|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163886935|NCT05329220|591956558|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
163886936|NCT05329220|591956559|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
163886937|NCT05329220|591956554|FG000|Follow-up Period|DROPPED|0|||
163886938|NCT05329220|591956555|FG001|Follow-up Period|DROPPED|0|||
163886939|NCT05329220|591956556|FG002|Follow-up Period|DROPPED|0|||
163886940|NCT05329220|591956557|FG003|Follow-up Period|DROPPED|0|||
163886941|NCT05329220|591956558|FG004|Follow-up Period|DROPPED|0|||
163886942|NCT05329220|591956559|FG005|Follow-up Period|DROPPED|1|||
164250602|NCT01027650|593282266|FG002|Overall Study|Lack of Efficacy|0|||
164250603|NCT01027650|593282267|FG003|Overall Study|Lack of Efficacy|0|||
164250604|NCT01027650|593282268|FG004|Overall Study|Lack of Efficacy|0|||
164338672|NCT00319501|593615220|FG000|Open-label Period|Lost to Follow-up|5|||
164338673|NCT00319501|593615221|FG001|Open-label Period|Lost to Follow-up|0|||
164338674|NCT00319501|593615220|FG000|Open-label Period|Did not receive treatment|33|||
163886943|NCT05329220|591956554|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
164250605|NCT01027650|593282269|FG005|Overall Study|Lack of Efficacy|1|||
164250606|NCT01027650|593282270|FG006|Overall Study|Lack of Efficacy|0|||
164250607|NCT01027650|593282271|FG007|Overall Study|Lack of Efficacy|0|||
164250608|NCT05160415|593283962|FG000|Overall Study|Withdrawal by Subject|3|||
164250609|NCT00933608|593283963|FG000|Overall Study|Adverse Event|4|||
164250610|NCT00933608|593283964|FG001|Overall Study|Adverse Event|2|||
164250611|NCT00933608|593283963|FG000|Overall Study|Physician Decision|1|||
164250612|NCT00933608|593283964|FG001|Overall Study|Physician Decision|0|||
164250613|NCT00623233|593283967|FG000|Overall Study|Adverse Event|10|||
164250614|NCT00623233|593283967|FG000|Overall Study|Physician Decision|10|||
164250615|NCT00623233|593283967|FG000|Overall Study|Lost to Follow-up|1|||
164250616|NCT00623233|593283967|FG000|Overall Study|Withdrawal by Subject|3|||
164250617|NCT00559845|593283968|FG000|Overall Study|Withdrew Consent|1|||
164250618|NCT00559845|593283968|FG000|Overall Study|Disease Progression|1|||
164250619|NCT00559845|593283968|FG000|Overall Study|Adverse Event|3|||
164250620|NCT00559845|593283968|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
164250621|NCT00559845|593283968|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
164250622|NCT03206970|593283969|FG000|Overall Study|Death|21|||
164250623|NCT03206970|593283969|FG000|Overall Study|Withdrawal by Subject|13|||
164250624|NCT03206970|593283969|FG000|Overall Study|Lost to Follow-up|3|||
164250625|NCT03206970|593283969|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
164250626|NCT03654040|593283970|FG000|Overall Study|Death|1|||
164250627|NCT03654040|593283971|FG001|Overall Study|Death|0|||
164250628|NCT03654040|593283970|FG000|Overall Study|Withdrawal by Subject|1|||
164250629|NCT03654040|593283971|FG001|Overall Study|Withdrawal by Subject|0|||
164250630|NCT03654040|593283970|FG000|Overall Study|Study terminated by sponsor|8|||
164250631|NCT03654040|593283971|FG001|Overall Study|Study terminated by sponsor|2|||
164250632|NCT03654040|593283970|FG000|Overall Study|Failure to initiate study therapy|2|||
164250633|NCT03654040|593283971|FG001|Overall Study|Failure to initiate study therapy|0|||
164250634|NCT03654040|593283970|FG000|Overall Study|Transplanted at another center|2|||
164250635|NCT03654040|593283971|FG001|Overall Study|Transplanted at another center|0|||
164250636|NCT03654040|593283970|FG000|Overall Study|Failure to meet eligibility criteria|14|||
164250637|NCT03654040|593283971|FG001|Overall Study|Failure to meet eligibility criteria|2|||
164250638|NCT03654040|593283970|FG000|Overall Study|No longer transplant candidate|1|||
164250639|NCT03654040|593283971|FG001|Overall Study|No longer transplant candidate|0|||
164250640|NCT03654040|593283970|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
164250641|NCT03654040|593283971|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
164250642|NCT03654040|593283970|FG000|Overall Study|Recipient ineligible|0|||
164250643|NCT03654040|593283971|FG001|Overall Study|Recipient ineligible|2|||
164250644|NCT03654040|593283970|FG000|Overall Study|Received deceased liver|0|||
164250645|NCT03654040|593283971|FG001|Overall Study|Received deceased liver|1|||
163886944|NCT05329220|591956555|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163886945|NCT05329220|591956556|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163886946|NCT05329220|591956557|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163886947|NCT05329220|591956558|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
163886948|NCT05329220|591956559|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
163886949|NCT04313972|591956566|FG000|Overall Study|Withdrawal by Subject|0|||
163886950|NCT04313972|591956567|FG001|Overall Study|Withdrawal by Subject|1|||
163886951|NCT05201079|591956581|FG000|Overall Study|Adverse Event|7|||
163886952|NCT05201079|591956582|FG001|Overall Study|Adverse Event|11|||
163886953|NCT05201079|591956581|FG000|Overall Study|Death|1|||
163886954|NCT05201079|591956582|FG001|Overall Study|Death|1|||
163886955|NCT05201079|591956581|FG000|Overall Study|Lack of Efficacy|0|||
163886956|NCT05201079|591956582|FG001|Overall Study|Lack of Efficacy|2|||
163886957|NCT05201079|591956581|FG000|Overall Study|Lost to Follow-up|0|||
163886958|NCT05201079|591956582|FG001|Overall Study|Lost to Follow-up|1|||
163886959|NCT05201079|591956581|FG000|Overall Study|Physician Decision|1|||
163886960|NCT05201079|591956582|FG001|Overall Study|Physician Decision|1|||
163886961|NCT05201079|591956581|FG000|Overall Study|Protocol Violation|1|||
163886962|NCT05201079|591956582|FG001|Overall Study|Protocol Violation|0|||
163886963|NCT05201079|591956581|FG000|Overall Study|Withdrawal by Subject|1|||
163886964|NCT05201079|591956582|FG001|Overall Study|Withdrawal by Subject|0|||
163886965|NCT05201079|591956581|FG000|Overall Study|Forbidden medication|9|||
163886966|NCT05201079|591956582|FG001|Overall Study|Forbidden medication|5|||
163886967|NCT05201079|591956581|FG000|Overall Study|Transfer to another hospital|0|||
163886968|NCT05201079|591956582|FG001|Overall Study|Transfer to another hospital|1|||
163886969|NCT05201079|591956581|FG000|Overall Study|Clinical condition|1|||
163886970|NCT05201079|591956582|FG001|Overall Study|Clinical condition|0|||
163886971|NCT05201079|591956581|FG000|Overall Study|SAE and sepsis|1|||
163886972|NCT05201079|591956582|FG001|Overall Study|SAE and sepsis|0|||
163886973|NCT04719832|591956591|FG000|Overall Study|Adverse Event|2|||
163886974|NCT04719832|591956592|FG001|Overall Study|Adverse Event|0|||
163886975|NCT04719832|591956591|FG000|Overall Study|Lack of Efficacy|2|||
163886976|NCT04719832|591956592|FG001|Overall Study|Lack of Efficacy|4|||
163886977|NCT04719832|591956591|FG000|Overall Study|Lost to Follow-up|0|||
164250646|NCT01951586|593283972|FG000|Overall Study|Death|61|||
164250647|NCT01951586|593283973|FG001|Overall Study|Death|120|||
164250648|NCT01951586|593283972|FG000|Overall Study|Withdrawal by Subject|8|||
164250649|NCT01951586|593283973|FG001|Overall Study|Withdrawal by Subject|17|||
164250650|NCT01951586|593283972|FG000|Overall Study|Lost to Follow-up|0|||
164250651|NCT01951586|593283973|FG001|Overall Study|Lost to Follow-up|1|||
164250652|NCT01951586|593283972|FG000|Overall Study|Sponsor Decision|9|||
164250653|NCT01951586|593283973|FG001|Overall Study|Sponsor Decision|10|||
164250654|NCT02120781|593283979|FG000|Overall Study|Physician Decision|2|||
164250655|NCT02120781|593283980|FG001|Overall Study|Physician Decision|0|||
164250656|NCT02120781|593283979|FG000|Overall Study|Completion not documented|2|||
164250657|NCT02120781|593283980|FG001|Overall Study|Completion not documented|1|||
164250658|NCT01977729|593283986|FG000|Overall Study|Study terminated|1|||
164250659|NCT05332392|593283987|FG000|Overall Study|Did not meet inclusion criteria|25|||
164250660|NCT05332392|593283987|FG000|Overall Study|Principal Investigator's decision|17|||
164250661|NCT05332392|593283987|FG000|Overall Study|Adverse Event|1|||
164250662|NCT05332392|593283987|FG000|Overall Study|Subject's decision|1|||
164250663|NCT01268046|593283988|FG000|Overall Study|Withdrawal by Subject|1|||
164250664|NCT01268046|593283989|FG001|Overall Study|Withdrawal by Subject|0|||
164250665|NCT01268046|593283990|FG002|Overall Study|Withdrawal by Subject|0|||
164250666|NCT01268046|593283991|FG003|Overall Study|Withdrawal by Subject|1|||
164250667|NCT01268046|593283988|FG000|Overall Study|Lost to Follow-up|0|||
164250668|NCT01268046|593283989|FG001|Overall Study|Lost to Follow-up|0|||
164250669|NCT01268046|593283990|FG002|Overall Study|Lost to Follow-up|1|||
164250670|NCT01268046|593283991|FG003|Overall Study|Lost to Follow-up|0|||
164250671|NCT03850093|593283992|FG000|Overall Study|Withdrawal by Subject|1|||
164250672|NCT03850093|593283993|FG001|Overall Study|Withdrawal by Subject|0|||
164250673|NCT03850093|593283994|FG002|Overall Study|Withdrawal by Subject|2|||
164250674|NCT03636893|593283997|FG000|Overall Study|Death|0|||
164250675|NCT03636893|593283998|FG001|Overall Study|Death|1|||
164250676|NCT03636893|593283997|FG000|Overall Study|Protocol Violation|0|||
164250677|NCT03636893|593283998|FG001|Overall Study|Protocol Violation|3|||
164250678|NCT03636893|593283997|FG000|Overall Study|Withdrawal by Subject|1|||
164250679|NCT03636893|593283998|FG001|Overall Study|Withdrawal by Subject|2|||
164250680|NCT03636893|593283997|FG000|Overall Study|Refusal to surgery|4|||
164250681|NCT03636893|593283998|FG001|Overall Study|Refusal to surgery|3|||
164250682|NCT03636893|593283997|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
164250683|NCT03636893|593283998|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
164250684|NCT03636893|593283997|FG000|Overall Study|Adverse Event|1|||
164250685|NCT03636893|593283998|FG001|Overall Study|Adverse Event|1|||
164250686|NCT02314156|593283999|FG000|Overall Study|Adverse Event|1|||
164250687|NCT02314156|593284000|FG001|Overall Study|Adverse Event|0|||
164250688|NCT02314156|593283999|FG000|Overall Study|Withdrawal by Subject|1|||
164250689|NCT02314156|593284000|FG001|Overall Study|Withdrawal by Subject|0|||
164250690|NCT00224120|593284001|FG000|Overall Study|Adverse Event|10|||
164250691|NCT00224120|593284002|FG001|Overall Study|Adverse Event|4|||
164250692|NCT00224120|593284001|FG000|Overall Study|Protocol Violation|1|||
164250693|NCT00224120|593284002|FG001|Overall Study|Protocol Violation|0|||
164250694|NCT00224120|593284001|FG000|Overall Study|Withdrawal by Subject|5|||
164250695|NCT00224120|593284002|FG001|Overall Study|Withdrawal by Subject|10|||
164250696|NCT00224120|593284001|FG000|Overall Study|Lack of Efficacy|0|||
164250697|NCT00224120|593284002|FG001|Overall Study|Lack of Efficacy|2|||
164250698|NCT00224120|593284001|FG000|Overall Study|Lost to Follow-up|2|||
164250699|NCT00224120|593284002|FG001|Overall Study|Lost to Follow-up|3|||
164250700|NCT00224120|593284001|FG000|Overall Study|Other|4|||
164250701|NCT00224120|593284002|FG001|Overall Study|Other|5|||
164250702|NCT00758069|593284007|FG000|Overall Study|Lack of Efficacy|0|||
164250703|NCT00758069|593284008|FG001|Overall Study|Lack of Efficacy|0|||
164250704|NCT00758069|593284009|FG002|Overall Study|Lack of Efficacy|1|||
164250705|NCT00758069|593284007|FG000|Overall Study|Incorrect Study Drug|1|||
164250706|NCT00758069|593284008|FG001|Overall Study|Incorrect Study Drug|0|||
164250707|NCT00758069|593284009|FG002|Overall Study|Incorrect Study Drug|0|||
164250708|NCT04560816|593284010|FG000|Overall Study|Withdrawal by Subject|1|||
164250709|NCT04560816|593284011|FG001|Overall Study|Withdrawal by Subject|1|||
164250710|NCT04560816|593284012|FG002|Overall Study|Withdrawal by Subject|1|||
164250711|NCT04560816|593284013|FG003|Overall Study|Withdrawal by Subject|0|||
164250712|NCT04560816|593284014|FG004|Overall Study|Withdrawal by Subject|3|||
164250713|NCT04560816|593284015|FG005|Overall Study|Withdrawal by Subject|0|||
164250714|NCT04560816|593284010|FG000|Overall Study|Lost to Follow-up|1|||
164250715|NCT04560816|593284011|FG001|Overall Study|Lost to Follow-up|0|||
164250716|NCT04560816|593284012|FG002|Overall Study|Lost to Follow-up|0|||
164250717|NCT04560816|593284013|FG003|Overall Study|Lost to Follow-up|0|||
164250718|NCT04560816|593284014|FG004|Overall Study|Lost to Follow-up|0|||
164250719|NCT04560816|593284015|FG005|Overall Study|Lost to Follow-up|0|||
164250720|NCT04560816|593284010|FG000|Overall Study|Protocol Violation|1|||
164084173|NCT00678392|592672290|FG001|Overall Study|Objective Progression or Relapse|8|||
164250721|NCT04560816|593284011|FG001|Overall Study|Protocol Violation|0|||
164250722|NCT04560816|593284012|FG002|Overall Study|Protocol Violation|0|||
164250723|NCT04560816|593284013|FG003|Overall Study|Protocol Violation|0|||
164250724|NCT04560816|593284014|FG004|Overall Study|Protocol Violation|0|||
164250725|NCT04560816|593284015|FG005|Overall Study|Protocol Violation|0|||
164250726|NCT03226249|593284016|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
164250727|NCT03226249|593284016|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
164250728|NCT03226249|593284016|FG000|Survival Follow-up|Patients still in follow-up.|30|||
164250729|NCT02277691|593284017|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
164250730|NCT02277691|593284017|FG000|Overall Study|Voluntary Withdrawal|7|||
164250731|NCT02277691|593284017|FG000|Overall Study|Lack of Efficacy|5|||
164250732|NCT02277691|593284017|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
164250733|NCT02846389|593284020|FG000|Overall Study|Withdrawal by Subject|1|||
164250734|NCT02846389|593284021|FG001|Overall Study|Withdrawal by Subject|1|||
164250735|NCT01804049|593284024|FG000|Overall Study|Adverse Event|2|||
164250736|NCT01804049|593284025|FG001|Overall Study|Adverse Event|10|||
164250737|NCT01804049|593284024|FG000|Overall Study|Lost to Follow-up|2|||
163991714|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
163991715|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
163991716|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
163991717|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
163991718|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
163991719|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
163991720|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
163991721|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163991722|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163991723|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163991724|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
163991725|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
163991726|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
163991727|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
163991728|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
163991729|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
163991730|NCT05195528|592339589|FG000|Placebo-controlled Treatment Period|Other|0|||
163991731|NCT05195528|592339590|FG001|Placebo-controlled Treatment Period|Other|0|||
163991732|NCT05195528|592339591|FG002|Placebo-controlled Treatment Period|Other|1|||
163991733|NCT05195528|592339592|FG003|Placebo-controlled Treatment Period|Other|0|||
163991734|NCT05195528|592339593|FG004|Placebo-controlled Treatment Period|Other|0|||
163991735|NCT05195528|592339589|FG000|Extension Period|PTE or AE or SAE|0|||
164084174|NCT00678392|592672289|FG000|Overall Study|Sponsor's Decision|1|||
164084175|NCT00678392|592672290|FG001|Overall Study|Sponsor's Decision|2|||
164250738|NCT01804049|593284025|FG001|Overall Study|Lost to Follow-up|1|||
164250739|NCT01804049|593284024|FG000|Overall Study|Decreased interest/personal|4|||
164250740|NCT01804049|593284025|FG001|Overall Study|Decreased interest/personal|5|||
164250741|NCT01804049|593284024|FG000|Overall Study|Other health concerns|2|||
164250742|NCT01804049|593284025|FG001|Overall Study|Other health concerns|7|||
164250743|NCT01804049|593284024|FG000|Overall Study|Moved out of area|0|||
164250744|NCT01804049|593284025|FG001|Overall Study|Moved out of area|7|||
164250745|NCT01804049|593284024|FG000|Overall Study|other MD recommended|1|||
164250746|NCT01804049|593284025|FG001|Overall Study|other MD recommended|1|||
164250747|NCT01804049|593284024|FG000|Overall Study|Enrollment in dual studies|0|||
164250748|NCT01804049|593284025|FG001|Overall Study|Enrollment in dual studies|1|||
164250749|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250750|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
164250751|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250752|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250753|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250754|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
164250755|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
164250756|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
164250757|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250758|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250759|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164250760|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164084176|NCT00678392|592672289|FG000|Overall Study|Withdrawal by Subject|4|||
164250761|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
164250762|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
164338675|NCT00319501|593615221|FG001|Open-label Period|Did not receive treatment|0|||
163991736|NCT05195528|592339590|FG001|Extension Period|PTE or AE or SAE|4|||
163991737|NCT05195528|592339591|FG002|Extension Period|PTE or AE or SAE|5|||
163991738|NCT05195528|592339592|FG003|Extension Period|PTE or AE or SAE|4|||
163991739|NCT05195528|592339593|FG004|Extension Period|PTE or AE or SAE|4|||
163991740|NCT05195528|592339589|FG000|Extension Period|Protocol Violation|0|||
164250763|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164338676|NCT00319501|593615220|FG000|Open-label Period|Other|11|||
164250764|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164250765|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164250766|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164250767|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
163886978|NCT04719832|591956592|FG001|Overall Study|Lost to Follow-up|2|||
164250768|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
164250769|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250770|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250771|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250772|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
164250773|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250774|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
164250775|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250776|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250777|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164250778|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164338677|NCT00319501|593615221|FG001|Open-label Period|Other|0|||
164338678|NCT00319501|593615220|FG000|Open-label Extension Period|Adverse Event|2|||
164338679|NCT00319501|593615221|FG001|Open-label Extension Period|Adverse Event|0|||
164338680|NCT00319501|593615220|FG000|Open-label Extension Period|Did not receive treatment|18|||
164338681|NCT00319501|593615221|FG001|Open-label Extension Period|Did not receive treatment|0|||
164338682|NCT00319501|593615220|FG000|Open-label Extension Period|Other|1|||
164338683|NCT00319501|593615221|FG001|Open-label Extension Period|Other|0|||
164338684|NCT00319501|593615220|FG000|Open-label Extension Period|Principal investigator decision|2|||
164338685|NCT00319501|593615221|FG001|Open-label Extension Period|Principal investigator decision|0|||
164338686|NCT00319501|593615220|FG000|Open-label Extension Period|Sponsor request|26|||
164338687|NCT00319501|593615221|FG001|Open-label Extension Period|Sponsor request|0|||
164338688|NCT00319501|593615220|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
164338689|NCT00319501|593615221|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164338690|NCT02764697|593615223|FG000|Overall Study|Lack of Efficacy|3|||
164338691|NCT00302107|593615226|FG000|Overall Study|Lost to Follow-up|6|||
164338692|NCT00302107|593615227|FG001|Overall Study|Lost to Follow-up|5|||
164338693|NCT00302107|593615226|FG000|Overall Study|Protocol Violation|1|||
163886979|NCT04719832|591956591|FG000|Overall Study|Physician Decision|0|||
163886980|NCT04719832|591956592|FG001|Overall Study|Physician Decision|1|||
163886981|NCT04719832|591956591|FG000|Overall Study|Pregnancy|1|||
163886982|NCT04719832|591956592|FG001|Overall Study|Pregnancy|1|||
163886983|NCT04719832|591956591|FG000|Overall Study|Withdrawal by Subject|5|||
163886984|NCT04719832|591956592|FG001|Overall Study|Withdrawal by Subject|5|||
163886985|NCT04719832|591956591|FG000|Overall Study|Randomized, not treated|0|||
163886986|NCT04719832|591956592|FG001|Overall Study|Randomized, not treated|2|||
163886987|NCT04719832|591956591|FG000|Overall Study|GCP violations|4|||
163886988|NCT04719832|591956592|FG001|Overall Study|GCP violations|7|||
163886989|NCT05239455|591956593|FG000|Overall Study|Adverse Event|1|||
163886990|NCT05239455|591956593|FG000|Overall Study|Sponsor Decision|5|||
163886991|NCT05239455|591956593|FG000|Overall Study|Incomplete Blood Collection|1|||
163886992|NCT03701763|591956594|FG000|Placebo-controlled Phase|Adverse Event|1|||
163886993|NCT03701763|591956595|FG001|Placebo-controlled Phase|Adverse Event|5|||
163886994|NCT03701763|591956596|FG002|Placebo-controlled Phase|Adverse Event|0|||
163886995|NCT03701763|591956597|FG003|Placebo-controlled Phase|Adverse Event|0|||
163886996|NCT03701763|591956594|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
163886997|NCT03701763|591956595|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
163886998|NCT03701763|591956596|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
163886999|NCT03701763|591956597|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
163887000|NCT03701763|591956594|FG000|Placebo-controlled Phase|Miscellaneous|2|||
163887001|NCT03701763|591956595|FG001|Placebo-controlled Phase|Miscellaneous|0|||
163887002|NCT03701763|591956596|FG002|Placebo-controlled Phase|Miscellaneous|0|||
163887003|NCT03701763|591956597|FG003|Placebo-controlled Phase|Miscellaneous|0|||
163887004|NCT03701763|591956594|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
163887005|NCT03701763|591956595|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
163887006|NCT03701763|591956596|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
163887007|NCT03701763|591956597|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
163991741|NCT05195528|592339590|FG001|Extension Period|Protocol Violation|2|||
164338694|NCT00302107|593615227|FG001|Overall Study|Protocol Violation|0|||
164338695|NCT00302107|593615226|FG000|Overall Study|Relocation|0|||
164338696|NCT00302107|593615227|FG001|Overall Study|Relocation|1|||
164338697|NCT00302107|593615226|FG000|Overall Study|Withdrawal by Subject|0|||
164338698|NCT00302107|593615227|FG001|Overall Study|Withdrawal by Subject|3|||
163887008|NCT03701763|591956594|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
163887009|NCT03701763|591956595|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
163887010|NCT03701763|591956596|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
163887011|NCT03701763|591956597|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
164250779|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
164250780|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
164250781|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164250782|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164250783|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
164250784|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
163991742|NCT05195528|592339591|FG002|Extension Period|Protocol Violation|1|||
163991743|NCT05195528|592339592|FG003|Extension Period|Protocol Violation|0|||
164250785|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250786|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
164250787|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250788|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250789|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250790|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
164250791|NCT03985943|593284034|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250792|NCT03985943|593284035|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
164250793|NCT03985943|593284036|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250794|NCT03985943|593284037|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250795|NCT03985943|593284038|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250796|NCT03985943|593284039|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
164250797|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164250798|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164250799|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
163887012|NCT03701763|591956594|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
163887013|NCT03701763|591956595|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
163887014|NCT03701763|591956596|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
163887015|NCT03701763|591956597|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
163887016|NCT03701763|591956594|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
163887017|NCT03701763|591956595|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
163887018|NCT03701763|591956596|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
163887019|NCT03701763|591956597|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
163887020|NCT03701763|591956594|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
163887021|NCT03701763|591956595|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
163887022|NCT03701763|591956596|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
163887023|NCT03701763|591956597|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
163887024|NCT03701763|591956594|FG000|Apremilast Extension Phase|Adverse Event|0|||
163887025|NCT03701763|591956595|FG001|Apremilast Extension Phase|Adverse Event|0|||
163887026|NCT03701763|591956596|FG002|Apremilast Extension Phase|Adverse Event|3|||
163887027|NCT03701763|591956597|FG003|Apremilast Extension Phase|Adverse Event|1|||
163887028|NCT03701763|591956594|FG000|Apremilast Extension Phase|Miscellaneous|0|||
163887029|NCT03701763|591956595|FG001|Apremilast Extension Phase|Miscellaneous|0|||
163887030|NCT03701763|591956596|FG002|Apremilast Extension Phase|Miscellaneous|2|||
163991744|NCT05195528|592339593|FG004|Extension Period|Protocol Violation|1|||
163991745|NCT05195528|592339589|FG000|Extension Period|Lost to Follow-up|0|||
163991746|NCT05195528|592339590|FG001|Extension Period|Lost to Follow-up|6|||
163991747|NCT05195528|592339591|FG002|Extension Period|Lost to Follow-up|13|||
163991748|NCT05195528|592339592|FG003|Extension Period|Lost to Follow-up|3|||
164250800|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
164250801|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
164250802|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
164250803|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164250804|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164250805|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
164250806|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
164250807|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
164250808|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
164250809|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
164250810|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
163991749|NCT05195528|592339593|FG004|Extension Period|Lost to Follow-up|7|||
163991750|NCT05195528|592339589|FG000|Extension Period|Withdrawal by Subject|0|||
163887031|NCT03701763|591956597|FG003|Apremilast Extension Phase|Miscellaneous|1|||
163991751|NCT05195528|592339590|FG001|Extension Period|Withdrawal by Subject|12|||
163887032|NCT03701763|591956594|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
163991752|NCT05195528|592339591|FG002|Extension Period|Withdrawal by Subject|9|||
163991753|NCT05195528|592339592|FG003|Extension Period|Withdrawal by Subject|6|||
164250811|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
164250812|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
164250813|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
164250814|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
164250815|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164250816|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164250817|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164250818|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164250819|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164250820|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164250821|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250822|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250823|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
164250824|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250825|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
164250826|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
164250827|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
164250828|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
164250829|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
164250830|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
164250831|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
164250832|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
164250833|NCT03985943|593284034|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
164250834|NCT03985943|593284035|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
164250835|NCT03985943|593284036|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
164250836|NCT03985943|593284037|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
164250837|NCT03985943|593284038|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
164250838|NCT03985943|593284039|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
164250839|NCT01265563|593284040|FG000|Overall Study|Withdrawal by Subject|0|||
164250840|NCT01265563|593284041|FG001|Overall Study|Withdrawal by Subject|1|||
164250841|NCT01265563|593284042|FG002|Overall Study|Withdrawal by Subject|1|||
164250842|NCT01265563|593284043|FG003|Overall Study|Withdrawal by Subject|0|||
164250843|NCT01265563|593284044|FG004|Overall Study|Withdrawal by Subject|2|||
164250844|NCT04075513|593284050|FG000|Overall Study|Withdrawal by Subject|2|||
164250845|NCT04075513|593284051|FG001|Overall Study|Withdrawal by Subject|2|||
164250846|NCT04075513|593284050|FG000|Overall Study|Lack of Efficacy|1|||
164250847|NCT04075513|593284051|FG001|Overall Study|Lack of Efficacy|0|||
164250848|NCT04075513|593284050|FG000|Overall Study|Lost to Follow-up|4|||
164250849|NCT04075513|593284051|FG001|Overall Study|Lost to Follow-up|2|||
164250850|NCT04075513|593284050|FG000|Overall Study|Switch to insulin pump|1|||
164250851|NCT04075513|593284051|FG001|Overall Study|Switch to insulin pump|0|||
164250852|NCT05730335|593284052|FG000|Overall Study|Lost to Follow-up|8|||
164250853|NCT05730335|593284052|FG000|Overall Study|Withdrawal by Subject|6|||
164250854|NCT01534351|593284055|FG000|Overall Study|Study Terminated Early|1|||
164250855|NCT01534351|593284056|FG001|Overall Study|Study Terminated Early|0|||
164250856|NCT01534351|593284057|FG002|Overall Study|Study Terminated Early|0|||
164250857|NCT01369199|593284060|FG000|Overall Study|Withdrawal by Subject|1|||
164250858|NCT01369199|593284060|FG000|Overall Study|Lost to Follow-up|2|||
164250859|NCT03248167|593284065|FG000|Overall Study|Withdrawal by Subject|2|||
164250860|NCT03248167|593284066|FG001|Overall Study|Withdrawal by Subject|2|||
164250861|NCT03248167|593284065|FG000|Overall Study|Physician Decision|0|||
164250862|NCT03248167|593284066|FG001|Overall Study|Physician Decision|1|||
164250863|NCT03248167|593284065|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
164250864|NCT03248167|593284066|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
164250865|NCT03248167|593284065|FG000|Overall Study|Lost to Follow-up|1|||
164250866|NCT03248167|593284066|FG001|Overall Study|Lost to Follow-up|0|||
164338699|NCT00302107|593615226|FG000|Overall Study|Adverse Event|1|||
164338700|NCT00302107|593615227|FG001|Overall Study|Adverse Event|0|||
164338701|NCT00437983|593615228|FG000|Overall Study|Adverse Event|6|||
163991754|NCT05195528|592339593|FG004|Extension Period|Withdrawal by Subject|5|||
163991755|NCT05195528|592339589|FG000|Extension Period|Lack of Efficacy|0|||
163991756|NCT05195528|592339590|FG001|Extension Period|Lack of Efficacy|3|||
163991757|NCT05195528|592339591|FG002|Extension Period|Lack of Efficacy|0|||
163991758|NCT05195528|592339592|FG003|Extension Period|Lack of Efficacy|0|||
163991759|NCT05195528|592339593|FG004|Extension Period|Lack of Efficacy|2|||
163991760|NCT05195528|592339589|FG000|Extension Period|Not Treated|0|||
164250867|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Death|0|||
164250868|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Death|1|||
164338702|NCT00437983|593615229|FG001|Overall Study|Adverse Event|6|||
163991761|NCT05195528|592339590|FG001|Extension Period|Not Treated|0|||
164250869|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Death|1|||
164338703|NCT00437983|593615228|FG000|Overall Study|Protocol Violation|2|||
163991762|NCT05195528|592339591|FG002|Extension Period|Not Treated|2|||
163991763|NCT05195528|592339592|FG003|Extension Period|Not Treated|3|||
163991764|NCT05195528|592339593|FG004|Extension Period|Not Treated|0|||
163991765|NCT05195528|592339589|FG000|Extension Period|Other|0|||
163991766|NCT05195528|592339590|FG001|Extension Period|Other|1|||
163991767|NCT05195528|592339591|FG002|Extension Period|Other|1|||
163991768|NCT05195528|592339592|FG003|Extension Period|Other|0|||
163991769|NCT05195528|592339593|FG004|Extension Period|Other|0|||
163991770|NCT01552902|592339594|FG000|Overall Study|Adverse Event|1|||
163991771|NCT01552902|592339595|FG001|Overall Study|Adverse Event|15|||
163991772|NCT01552902|592339596|FG002|Overall Study|Adverse Event|14|||
163991773|NCT01552902|592339594|FG000|Overall Study|Protocol Violation|3|||
163991774|NCT01552902|592339595|FG001|Overall Study|Protocol Violation|3|||
163991775|NCT01552902|592339596|FG002|Overall Study|Protocol Violation|3|||
163991776|NCT01552902|592339594|FG000|Overall Study|Lack of Efficacy|4|||
163991777|NCT01552902|592339595|FG001|Overall Study|Lack of Efficacy|3|||
163991778|NCT01552902|592339596|FG002|Overall Study|Lack of Efficacy|1|||
163991779|NCT01552902|592339594|FG000|Overall Study|Withdrawal by Subject|1|||
163991780|NCT01552902|592339595|FG001|Overall Study|Withdrawal by Subject|9|||
163991781|NCT01552902|592339596|FG002|Overall Study|Withdrawal by Subject|6|||
163991782|NCT01552902|592339594|FG000|Overall Study|Lost to Follow-up|1|||
163991783|NCT01552902|592339595|FG001|Overall Study|Lost to Follow-up|3|||
163991784|NCT01552902|592339596|FG002|Overall Study|Lost to Follow-up|6|||
163991785|NCT01552902|592339594|FG000|Overall Study|Other|3|||
163991786|NCT01552902|592339595|FG001|Overall Study|Other|4|||
163991787|NCT01552902|592339596|FG002|Overall Study|Other|3|||
163991788|NCT02720757|592339597|FG000|Overall Study|Other reason|5|||
163991789|NCT02720757|592339597|FG000|Overall Study|Loss of contact|4|||
163991790|NCT02720757|592339597|FG000|Overall Study|Informed consent withdrawal|1|||
163991791|NCT02720757|592339597|FG000|Overall Study|Patients wish to withdraw|2|||
163991792|NCT02720757|592339597|FG000|Overall Study|Missing|3|||
164250870|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Death|0|||
164250871|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Death|0|||
164250872|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Death|0|||
164250873|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Death|0|||
164250874|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Death|0|||
164250875|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250876|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250877|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
164250878|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250879|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
164250880|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250881|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250882|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
164250883|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250884|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250885|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250886|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164250887|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250888|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250889|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250890|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164250891|NCT02122146|593284067|FG000|Part 1: Dose Escalation|Other|1|||
164250892|NCT02122146|593284068|FG001|Part 1: Dose Escalation|Other|0|||
164250893|NCT02122146|593284069|FG002|Part 1: Dose Escalation|Other|0|||
164250894|NCT02122146|593284070|FG003|Part 1: Dose Escalation|Other|0|||
164250895|NCT02122146|593284071|FG004|Part 1: Dose Escalation|Other|0|||
164250896|NCT02122146|593284072|FG005|Part 1: Dose Escalation|Other|1|||
164250897|NCT02122146|593284073|FG006|Part 1: Dose Escalation|Other|1|||
164250898|NCT02122146|593284074|FG007|Part 1: Dose Escalation|Other|2|||
164250899|NCT03472495|593284075|FG000|Overall Study|Treatment no longer indicated|1|||
164250900|NCT03472495|593284076|FG001|Overall Study|Treatment no longer indicated|2|||
164250901|NCT03472495|593284075|FG000|Overall Study|Physician Decision|0|||
163991793|NCT02720757|592339597|FG000|Overall Study|General exclusion|3|||
164250902|NCT03472495|593284076|FG001|Overall Study|Physician Decision|2|||
164338704|NCT00437983|593615229|FG001|Overall Study|Protocol Violation|1|||
163991794|NCT00168831|592339599|FG000|Overall Study|Adverse Event|36|||
163991795|NCT00168831|592339600|FG001|Overall Study|Adverse Event|47|||
163991796|NCT00168831|592339601|FG002|Overall Study|Adverse Event|74|||
164338705|NCT00437983|593615228|FG000|Overall Study|Withdrawal by Subject|5|||
164338706|NCT00437983|593615229|FG001|Overall Study|Withdrawal by Subject|6|||
164338707|NCT02612129|593615230|FG000|Single Dose Treatment Period|Screening Failure|1|||
164338708|NCT02612129|593615231|FG001|Single Dose Treatment Period|Screening Failure|0|||
164338709|NCT02612129|593615232|FG002|Single Dose Treatment Period|Screening Failure|0|||
164338710|NCT02612129|593615230|FG000|Continuous Treatment Period|Early Escape|0|||
163991797|NCT00168831|592339599|FG000|Overall Study|Lost to Follow-up|5|||
163991798|NCT00168831|592339600|FG001|Overall Study|Lost to Follow-up|6|||
163991799|NCT00168831|592339601|FG002|Overall Study|Lost to Follow-up|4|||
164250903|NCT02584452|593284079|FG000|Overall Study|Physician Decision|1|||
164250904|NCT02584452|593284080|FG001|Overall Study|Physician Decision|1|||
164250905|NCT02584452|593284079|FG000|Overall Study|Lost to Follow-up|1|||
164250906|NCT02584452|593284080|FG001|Overall Study|Lost to Follow-up|1|||
164250907|NCT02998671|593284081|FG000|Period 1|Study Terminated By Sponsor|2|||
164250908|NCT02998671|593284082|FG001|Period 1|Study Terminated By Sponsor|1|||
164250909|NCT02998671|593284083|FG002|Period 1|Study Terminated By Sponsor|0|||
164250910|NCT02998671|593284084|FG003|Period 1|Study Terminated By Sponsor|0|||
164250911|NCT02998671|593284085|FG004|Period 1|Study Terminated By Sponsor|1|||
164250912|NCT02998671|593284081|FG000|Period 1|Withdrawal by Subject|1|||
164250913|NCT02998671|593284082|FG001|Period 1|Withdrawal by Subject|2|||
164250914|NCT02998671|593284083|FG002|Period 1|Withdrawal by Subject|0|||
164250915|NCT02998671|593284084|FG003|Period 1|Withdrawal by Subject|0|||
164250916|NCT02998671|593284085|FG004|Period 1|Withdrawal by Subject|2|||
164250917|NCT02998671|593284081|FG000|Period 1|Pregnancy|1|||
164250918|NCT02998671|593284082|FG001|Period 1|Pregnancy|0|||
164250919|NCT02998671|593284083|FG002|Period 1|Pregnancy|0|||
164250920|NCT02998671|593284084|FG003|Period 1|Pregnancy|0|||
164250921|NCT02998671|593284085|FG004|Period 1|Pregnancy|0|||
164250922|NCT02998671|593284081|FG000|Period 1|Adverse Event|0|||
164250923|NCT02998671|593284082|FG001|Period 1|Adverse Event|0|||
164250924|NCT02998671|593284083|FG002|Period 1|Adverse Event|0|||
164250925|NCT02998671|593284084|FG003|Period 1|Adverse Event|0|||
164250926|NCT02998671|593284085|FG004|Period 1|Adverse Event|1|||
164250927|NCT02998671|593284081|FG000|Period 2|Adverse Event|0|||
164250928|NCT02998671|593284082|FG001|Period 2|Adverse Event|1|||
164250929|NCT02998671|593284083|FG002|Period 2|Adverse Event|0|||
164250930|NCT02998671|593284084|FG003|Period 2|Adverse Event|0|||
164250931|NCT02998671|593284085|FG004|Period 2|Adverse Event|0|||
164250932|NCT02998671|593284081|FG000|Period 2|Study Terminated By Sponsor|3|||
164250933|NCT02998671|593284082|FG001|Period 2|Study Terminated By Sponsor|5|||
164250934|NCT02998671|593284083|FG002|Period 2|Study Terminated By Sponsor|1|||
164250935|NCT02998671|593284084|FG003|Period 2|Study Terminated By Sponsor|3|||
164250936|NCT02998671|593284085|FG004|Period 2|Study Terminated By Sponsor|0|||
164250937|NCT02998671|593284081|FG000|Period 2|Withdrawal by Subject|0|||
164250938|NCT02998671|593284082|FG001|Period 2|Withdrawal by Subject|1|||
164250939|NCT02998671|593284083|FG002|Period 2|Withdrawal by Subject|0|||
164250940|NCT02998671|593284084|FG003|Period 2|Withdrawal by Subject|0|||
164250941|NCT02998671|593284085|FG004|Period 2|Withdrawal by Subject|0|||
164250942|NCT02998671|593284081|FG000|Period 2|Lost to Follow-up|0|||
164250943|NCT02998671|593284082|FG001|Period 2|Lost to Follow-up|0|||
164250944|NCT02998671|593284083|FG002|Period 2|Lost to Follow-up|0|||
164250945|NCT02998671|593284084|FG003|Period 2|Lost to Follow-up|1|||
164250946|NCT02998671|593284085|FG004|Period 2|Lost to Follow-up|0|||
164250947|NCT02038946|593284086|FG000|Overall Study|Death|5|||
164250948|NCT02038946|593284086|FG000|Overall Study|Withdrawal by Subject|3|||
164250949|NCT02038946|593284086|FG000|Overall Study|Lost to Follow-up|2|||
164250950|NCT02038946|593284086|FG000|Overall Study|Other reasons|2|||
164250951|NCT00771927|593284090|FG000|Overall Study|Adverse Event|100|||
164250952|NCT00771927|593284091|FG001|Overall Study|Adverse Event|105|||
164250953|NCT00771927|593284090|FG000|Overall Study|Lack of Efficacy|70|||
164250954|NCT00771927|593284091|FG001|Overall Study|Lack of Efficacy|42|||
164250955|NCT00771927|593284090|FG000|Overall Study|Lost to Follow-up|46|||
164250956|NCT00771927|593284091|FG001|Overall Study|Lost to Follow-up|46|||
164250957|NCT00771927|593284090|FG000|Overall Study|Withdrawal by Subject|16|||
164250958|NCT00771927|593284091|FG001|Overall Study|Withdrawal by Subject|17|||
164250959|NCT00771927|593284090|FG000|Overall Study|Other reason|23|||
164250960|NCT00771927|593284091|FG001|Overall Study|Other reason|27|||
164250961|NCT02467192|593284095|FG000|Overall Study|Death|1|||
164250962|NCT02467192|593284095|FG000|Overall Study|revealed to have pneumonia before|2|||
164250963|NCT03213938|593284096|FG000|Overall Study|Lost to Follow-up|4|||
164250964|NCT03213938|593284097|FG001|Overall Study|Lost to Follow-up|3|||
164250965|NCT03213938|593284096|FG000|Overall Study|Lack of Efficacy|1|||
164250966|NCT03213938|593284097|FG001|Overall Study|Lack of Efficacy|0|||
164250967|NCT03213938|593284096|FG000|Overall Study|Decline to participate|5|||
164250968|NCT03213938|593284097|FG001|Overall Study|Decline to participate|4|||
164250969|NCT03213938|593284096|FG000|Overall Study|Without reason|4|||
164250970|NCT03213938|593284097|FG001|Overall Study|Without reason|5|||
164250971|NCT01814046|593284098|FG000|Drug Administration|Death due to complications of RSV|1|||
164250972|NCT01814046|593284099|FG001|Drug Administration|Death due to complications of RSV|0|||
164250973|NCT01814046|593284100|FG002|Drug Administration|Death due to complications of RSV|0|||
164250974|NCT00429182|593284101|FG000|Overall Study|Not evaluable, Disease Progression|2|||
164250975|NCT00429182|593284101|FG000|Overall Study|Not eligible|5|||
164250976|NCT03335150|593284104|FG000|Overall Study|Withdrawal by Subject|10|||
164250977|NCT03335150|593284105|FG001|Overall Study|Withdrawal by Subject|4|||
164250978|NCT03335150|593284104|FG000|Overall Study|Adverse Event|0|||
164250979|NCT03335150|593284105|FG001|Overall Study|Adverse Event|1|||
164250980|NCT02218697|593284110|FG000|Overall Study|Adverse Event|0|||
164250981|NCT02218697|593284111|FG001|Overall Study|Adverse Event|2|||
164250982|NCT02218697|593284110|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
164250983|NCT02218697|593284111|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
164250984|NCT02218697|593284110|FG000|Overall Study|Withdrawal by Subject|2|||
164250985|NCT02218697|593284111|FG001|Overall Study|Withdrawal by Subject|3|||
164250986|NCT02142803|593284114|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
164250987|NCT02142803|593284115|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
164250988|NCT02142803|593284116|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
164250989|NCT02142803|593284117|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
164250990|NCT05111002|593284120|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
164250991|NCT05111002|593284121|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
164250992|NCT05111002|593284120|FG000|Secondary Outcome|Lost to Follow-up|1|||
164250993|NCT05111002|593284121|FG001|Secondary Outcome|Lost to Follow-up|0|||
164250994|NCT04380753|593284122|FG000|Overall Study|Participants continuing study|4|||
164250995|NCT04380753|593284122|FG000|Overall Study|Death|2|||
164250996|NCT04776720|593284123|FG000|Overall Study|COVID Related|4|||
164250997|NCT04776720|593284124|FG001|Overall Study|COVID Related|2|||
164250998|NCT04776720|593284123|FG000|Overall Study|Adverse Event|2|||
164250999|NCT04776720|593284124|FG001|Overall Study|Adverse Event|0|||
164251000|NCT04776720|593284123|FG000|Overall Study|Serious Adverse Event|0|||
163887033|NCT03701763|591956595|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
163887034|NCT03701763|591956596|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
164251001|NCT04776720|593284124|FG001|Overall Study|Serious Adverse Event|1|||
164251002|NCT04776720|593284123|FG000|Overall Study|Too Busy|3|||
164251003|NCT04776720|593284124|FG001|Overall Study|Too Busy|1|||
164251004|NCT04776720|593284123|FG000|Overall Study|Lost to Follow-up|1|||
164251005|NCT04776720|593284124|FG001|Overall Study|Lost to Follow-up|2|||
164251006|NCT04776720|593284123|FG000|Overall Study|Family|2|||
164251007|NCT04776720|593284124|FG001|Overall Study|Family|2|||
164251008|NCT04776720|593284123|FG000|Overall Study|No remote technology access|0|||
164251009|NCT04776720|593284124|FG001|Overall Study|No remote technology access|1|||
164251010|NCT04776720|593284123|FG000|Overall Study|Withdrawal by Subject|1|||
164251011|NCT04776720|593284124|FG001|Overall Study|Withdrawal by Subject|0|||
164251012|NCT04776720|593284123|FG000|Overall Study|Cannot tolerate intervention|1|||
164251013|NCT04776720|593284124|FG001|Overall Study|Cannot tolerate intervention|0|||
164251014|NCT04776720|593284123|FG000|Overall Study|Incomplete outcome data|6|||
164251015|NCT04776720|593284124|FG001|Overall Study|Incomplete outcome data|1|||
164251016|NCT02311881|593284125|FG000|Overall Study|Did not meet the study criteria|2|||
164251017|NCT02311881|593284126|FG001|Overall Study|Did not meet the study criteria|2|||
164251018|NCT02311881|593284127|FG002|Overall Study|Did not meet the study criteria|0|||
164251019|NCT02311881|593284125|FG000|Overall Study|Adverse Event|7|||
164251020|NCT02311881|593284126|FG001|Overall Study|Adverse Event|15|||
164338711|NCT02612129|593615231|FG001|Continuous Treatment Period|Early Escape|2|||
164338712|NCT02612129|593615232|FG002|Continuous Treatment Period|Early Escape|0|||
164338713|NCT02612129|593615230|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
164338714|NCT02612129|593615231|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
164338715|NCT02612129|593615232|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
164338716|NCT02612129|593615230|FG000|Continuous Treatment Period|Safety Reasons|0|||
164338717|NCT02612129|593615231|FG001|Continuous Treatment Period|Safety Reasons|3|||
164338718|NCT02612129|593615232|FG002|Continuous Treatment Period|Safety Reasons|0|||
164338719|NCT02612129|593615230|FG000|Continuous Treatment Period|Death|0|||
164338720|NCT02612129|593615231|FG001|Continuous Treatment Period|Death|1|||
164338721|NCT02612129|593615232|FG002|Continuous Treatment Period|Death|0|||
164338722|NCT02612129|593615230|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
164338723|NCT02612129|593615231|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
164338724|NCT02612129|593615232|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
164338725|NCT02557295|593615233|FG000|Overall Study|Withdrawal by Subject|9|||
164338726|NCT02557295|593615234|FG001|Overall Study|Withdrawal by Subject|2|||
164338727|NCT02557295|593615235|FG002|Overall Study|Withdrawal by Subject|4|||
163887035|NCT03701763|591956597|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
163887036|NCT03701763|591956594|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
163887037|NCT03701763|591956595|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
164251021|NCT02311881|593284127|FG002|Overall Study|Adverse Event|8|||
164251022|NCT02311881|593284125|FG000|Overall Study|Lost to Follow-up|3|||
164251023|NCT02311881|593284126|FG001|Overall Study|Lost to Follow-up|3|||
164251024|NCT02311881|593284127|FG002|Overall Study|Lost to Follow-up|2|||
164251025|NCT02311881|593284125|FG000|Overall Study|Protocol Violation|1|||
164251026|NCT02311881|593284126|FG001|Overall Study|Protocol Violation|2|||
164251027|NCT02311881|593284127|FG002|Overall Study|Protocol Violation|3|||
164251028|NCT02311881|593284125|FG000|Overall Study|Withdrawal of consent|14|||
164251029|NCT02311881|593284126|FG001|Overall Study|Withdrawal of consent|16|||
164251030|NCT02311881|593284127|FG002|Overall Study|Withdrawal of consent|17|||
164251031|NCT02311881|593284125|FG000|Overall Study|Other|0|||
164251032|NCT02311881|593284126|FG001|Overall Study|Other|0|||
164251033|NCT02311881|593284127|FG002|Overall Study|Other|1|||
164251034|NCT02311881|593284125|FG000|Overall Study|Lack of Efficacy|1|||
164251035|NCT02311881|593284126|FG001|Overall Study|Lack of Efficacy|2|||
164251036|NCT02311881|593284127|FG002|Overall Study|Lack of Efficacy|0|||
164251037|NCT02311881|593284125|FG000|Overall Study|Subject has border line pregnancy test|1|||
164251038|NCT02311881|593284126|FG001|Overall Study|Subject has border line pregnancy test|0|||
164251039|NCT02311881|593284127|FG002|Overall Study|Subject has border line pregnancy test|0|||
164251040|NCT02311881|593284125|FG000|Overall Study|Withdrawal by Subject|3|||
164251041|NCT02311881|593284126|FG001|Overall Study|Withdrawal by Subject|1|||
164251042|NCT02311881|593284127|FG002|Overall Study|Withdrawal by Subject|4|||
164251043|NCT02311881|593284125|FG000|Overall Study|Sponsor Decision|1|||
164251044|NCT02311881|593284126|FG001|Overall Study|Sponsor Decision|1|||
164251045|NCT02311881|593284127|FG002|Overall Study|Sponsor Decision|1|||
164251046|NCT02311881|593284125|FG000|Overall Study|Protocol Deviation|1|||
164251047|NCT02311881|593284126|FG001|Overall Study|Protocol Deviation|0|||
164251048|NCT02311881|593284127|FG002|Overall Study|Protocol Deviation|0|||
164251049|NCT02311881|593284125|FG000|Overall Study|Non-Compliance|1|||
164251050|NCT02311881|593284126|FG001|Overall Study|Non-Compliance|0|||
164251051|NCT02311881|593284127|FG002|Overall Study|Non-Compliance|2|||
164251052|NCT02311881|593284125|FG000|Overall Study|Physician Decision|0|||
164251053|NCT02311881|593284126|FG001|Overall Study|Physician Decision|0|||
164251054|NCT02311881|593284127|FG002|Overall Study|Physician Decision|1|||
164251055|NCT02311881|593284125|FG000|Overall Study|Medical Monitor Discretion|0|||
164251056|NCT02311881|593284126|FG001|Overall Study|Medical Monitor Discretion|0|||
164251057|NCT02311881|593284127|FG002|Overall Study|Medical Monitor Discretion|1|||
164251058|NCT02311881|593284125|FG000|Overall Study|Participant taking another medication|0|||
164251059|NCT02311881|593284126|FG001|Overall Study|Participant taking another medication|0|||
164251060|NCT02311881|593284127|FG002|Overall Study|Participant taking another medication|1|||
164251061|NCT02311881|593284125|FG000|Overall Study|Serious Adverse Event|0|||
164251062|NCT02311881|593284126|FG001|Overall Study|Serious Adverse Event|1|||
164251063|NCT02311881|593284127|FG002|Overall Study|Serious Adverse Event|0|||
164251064|NCT03306433|593284128|FG000|Overall Study|Lost to Follow-up|3|||
164251065|NCT03306433|593284128|FG000|Overall Study|Patient did not have teeth extracted|1|||
164251066|NCT03306433|593284128|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
164251067|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Adverse Event|21|||
164251068|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Adverse Event|34|||
164251069|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Adverse Event|14|||
164251070|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Adverse Event|17|||
164251071|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Adverse Event|0|||
164251072|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
164251073|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
164251074|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
164251075|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
164251076|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
164251077|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
164251078|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
164251079|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
164251080|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
164251081|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
164251082|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Physician Decision|2|||
164251083|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Physician Decision|4|||
164251084|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Physician Decision|4|||
164251085|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Physician Decision|4|||
164251086|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Physician Decision|0|||
164251087|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
164251088|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
164251089|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
164251090|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
164251091|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
164251092|NCT00451958|593284129|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
164251093|NCT00451958|593284130|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
164251094|NCT00451958|593284131|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
164251095|NCT00451958|593284132|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
164251096|NCT00451958|593284133|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
164251097|NCT01042158|593284136|FG000|Overall Study|Physician Decision|1|||
164251098|NCT01575808|593284137|FG000|Overall Study|Death|2|||
164251099|NCT01575808|593284138|FG001|Overall Study|Death|0|||
164251100|NCT01575808|593284137|FG000|Overall Study|Withdrawal by Subject|1|||
164251101|NCT01575808|593284138|FG001|Overall Study|Withdrawal by Subject|0|||
164251102|NCT00875485|593286206|FG000|Challenge Dose Epoch|Pregnancy|1|||
164251103|NCT00875485|593286207|FG001|Challenge Dose Epoch|Pregnancy|0|||
164251104|NCT01271010|593286208|FG000|Overall Study|Reason not specified|11|||
164251105|NCT01271010|593286208|FG000|Overall Study|Start of new CLL therapy|1|||
164251106|NCT01271010|593286208|FG000|Overall Study|Protocol Violation|1|||
164251107|NCT01271010|593286208|FG000|Overall Study|Death|2|||
164251108|NCT01271010|593286208|FG000|Overall Study|Progression and relapse of disease|1|||
164251109|NCT01271010|593286208|FG000|Overall Study|Withdrawal by Subject|18|||
164251110|NCT01271010|593286208|FG000|Overall Study|Disease progression|27|||
164251111|NCT01631747|593286209|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
164251112|NCT01631747|593286210|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
164251113|NCT01631747|593286209|FG000|Live Birth|Pregnancy Termination|1|||
164251114|NCT01631747|593286210|FG001|Live Birth|Pregnancy Termination|0|||
164251115|NCT01631747|593286209|FG000|Live Birth|MIscarriage|2|||
164251116|NCT01631747|593286210|FG001|Live Birth|MIscarriage|0|||
164251117|NCT01631747|593286209|FG000|Live Birth|Stillbirth|1|||
164251118|NCT01631747|593286210|FG001|Live Birth|Stillbirth|1|||
164251119|NCT01631747|593286209|FG000|One Year Infant Outcomes|Patient Refused|13|||
164251120|NCT01631747|593286210|FG001|One Year Infant Outcomes|Patient Refused|9|||
164251121|NCT02908685|593286211|FG000|Part 1 OLE|Withdrawal by Subject|0|||
164251122|NCT02908685|593286212|FG001|Part 1 OLE|Withdrawal by Subject|0|||
164251123|NCT02908685|593286213|FG002|Part 1 OLE|Withdrawal by Subject|0|||
164251124|NCT02908685|593286214|FG003|Part 1 OLE|Withdrawal by Subject|0|||
164338728|NCT02557295|593615236|FG003|Overall Study|Withdrawal by Subject|0|||
164338729|NCT02557295|593615237|FG004|Overall Study|Withdrawal by Subject|0|||
164338730|NCT02557295|593615238|FG005|Overall Study|Withdrawal by Subject|0|||
164251125|NCT02908685|593286215|FG004|Part 1 OLE|Withdrawal by Subject|0|||
164251126|NCT02908685|593286216|FG005|Part 1 OLE|Withdrawal by Subject|0|||
164251127|NCT02908685|593286217|FG006|Part 1 OLE|Withdrawal by Subject|0|||
164251128|NCT02908685|593286218|FG007|Part 1 OLE|Withdrawal by Subject|0|||
164251129|NCT02908685|593286219|FG008|Part 1 OLE|Withdrawal by Subject|0|||
164251130|NCT02908685|593286220|FG009|Part 1 OLE|Withdrawal by Subject|0|||
164251131|NCT02908685|593286221|FG010|Part 1 OLE|Withdrawal by Subject|2|||
164251132|NCT02908685|593286222|FG011|Part 1 OLE|Withdrawal by Subject|1|||
164251133|NCT02908685|593286223|FG012|Part 1 OLE|Withdrawal by Subject|0|||
164251134|NCT02908685|593286224|FG013|Part 1 OLE|Withdrawal by Subject|0|||
164251135|NCT02908685|593286211|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251136|NCT02908685|593286212|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251137|NCT02908685|593286213|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251138|NCT02908685|593286214|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251139|NCT02908685|593286215|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251140|NCT02908685|593286216|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251141|NCT02908685|593286217|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251142|NCT02908685|593286218|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251143|NCT02908685|593286219|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251144|NCT02908685|593286220|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251145|NCT02908685|593286221|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251146|NCT02908685|593286222|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
164251147|NCT02908685|593286223|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
164251148|NCT02908685|593286224|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
164251149|NCT02908685|593286211|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251150|NCT02908685|593286212|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251151|NCT02908685|593286213|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251152|NCT02908685|593286214|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251153|NCT02908685|593286215|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251154|NCT02908685|593286216|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251155|NCT02908685|593286217|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251156|NCT02908685|593286218|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251157|NCT02908685|593286219|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251158|NCT02908685|593286220|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251159|NCT02908685|593286221|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251160|NCT02908685|593286222|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251161|NCT02908685|593286223|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
164251162|NCT02908685|593286224|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
164251163|NCT02908685|593286211|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251164|NCT02908685|593286212|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251165|NCT02908685|593286213|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251166|NCT02908685|593286214|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251167|NCT02908685|593286215|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251168|NCT02908685|593286216|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251169|NCT02908685|593286217|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251170|NCT02908685|593286218|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251171|NCT02908685|593286219|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251172|NCT02908685|593286220|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251173|NCT02908685|593286221|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251174|NCT02908685|593286222|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251175|NCT02908685|593286223|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
164251176|NCT02908685|593286224|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
164251177|NCT02908685|593286211|FG000|Part 2 OLE: > Month 24|Death|0|||
164251178|NCT02908685|593286212|FG001|Part 2 OLE: > Month 24|Death|0|||
164251179|NCT02908685|593286213|FG002|Part 2 OLE: > Month 24|Death|0|||
164251180|NCT02908685|593286214|FG003|Part 2 OLE: > Month 24|Death|0|||
164251181|NCT02908685|593286215|FG004|Part 2 OLE: > Month 24|Death|0|||
164251182|NCT02908685|593286216|FG005|Part 2 OLE: > Month 24|Death|0|||
164251183|NCT02908685|593286217|FG006|Part 2 OLE: > Month 24|Death|0|||
164251184|NCT02908685|593286218|FG007|Part 2 OLE: > Month 24|Death|0|||
164251185|NCT02908685|593286219|FG008|Part 2 OLE: > Month 24|Death|0|||
164251186|NCT02908685|593286220|FG009|Part 2 OLE: > Month 24|Death|0|||
164251187|NCT02908685|593286221|FG010|Part 2 OLE: > Month 24|Death|0|||
164251188|NCT02908685|593286222|FG011|Part 2 OLE: > Month 24|Death|0|||
164251189|NCT02908685|593286223|FG012|Part 2 OLE: > Month 24|Death|1|||
164251190|NCT02908685|593286224|FG013|Part 2 OLE: > Month 24|Death|0|||
164251191|NCT02908685|593286211|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
164251192|NCT02908685|593286212|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
164251193|NCT02908685|593286213|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
164251194|NCT02908685|593286214|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
164251195|NCT02908685|593286215|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
164251196|NCT02908685|593286216|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
164251197|NCT02908685|593286217|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
164338731|NCT02557295|593615239|FG006|Overall Study|Withdrawal by Subject|15|||
164338732|NCT02557295|593615240|FG007|Overall Study|Withdrawal by Subject|1|||
164338733|NCT02557295|593615241|FG008|Overall Study|Withdrawal by Subject|3|||
164251198|NCT02908685|593286218|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
164251199|NCT02908685|593286219|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
164251200|NCT02908685|593286220|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
164251201|NCT02908685|593286221|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
164251202|NCT02908685|593286222|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
164251203|NCT02908685|593286223|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
164251204|NCT02908685|593286224|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
164251205|NCT02908685|593286211|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251206|NCT02908685|593286212|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251207|NCT02908685|593286213|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251208|NCT02908685|593286214|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251209|NCT02908685|593286215|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251210|NCT02908685|593286216|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251211|NCT02908685|593286217|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251212|NCT02908685|593286218|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251213|NCT02908685|593286219|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251214|NCT02908685|593286220|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251215|NCT02908685|593286221|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251216|NCT02908685|593286222|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
164251217|NCT02908685|593286223|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
164251218|NCT02908685|593286224|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
164251219|NCT02954406|593286225|FG000|Overall Study|Adverse Event|0|||
164251220|NCT02954406|593286226|FG001|Overall Study|Adverse Event|1|||
164251221|NCT02954406|593286227|FG002|Overall Study|Adverse Event|0|||
164251222|NCT02954406|593286228|FG003|Overall Study|Adverse Event|0|||
164251223|NCT02954406|593286229|FG004|Overall Study|Adverse Event|1|||
164251224|NCT02954406|593286230|FG005|Overall Study|Adverse Event|0|||
164251225|NCT02954406|593286231|FG006|Overall Study|Adverse Event|0|||
164251226|NCT02954406|593286232|FG007|Overall Study|Adverse Event|0|||
164251227|NCT02954406|593286233|FG008|Overall Study|Adverse Event|1|||
164251228|NCT02954406|593286234|FG009|Overall Study|Adverse Event|1|||
164251229|NCT02954406|593286235|FG010|Overall Study|Adverse Event|0|||
164251230|NCT02954406|593286225|FG000|Overall Study|Progressive Disease|3|||
164251231|NCT02954406|593286226|FG001|Overall Study|Progressive Disease|4|||
164251232|NCT02954406|593286227|FG002|Overall Study|Progressive Disease|3|||
164251233|NCT02954406|593286228|FG003|Overall Study|Progressive Disease|4|||
164251234|NCT02954406|593286229|FG004|Overall Study|Progressive Disease|3|||
164251235|NCT02954406|593286230|FG005|Overall Study|Progressive Disease|3|||
164251236|NCT02954406|593286231|FG006|Overall Study|Progressive Disease|2|||
164251237|NCT02954406|593286232|FG007|Overall Study|Progressive Disease|2|||
164251238|NCT02954406|593286233|FG008|Overall Study|Progressive Disease|1|||
164251239|NCT02954406|593286234|FG009|Overall Study|Progressive Disease|1|||
164251240|NCT02954406|593286235|FG010|Overall Study|Progressive Disease|0|||
164251241|NCT02954406|593286225|FG000|Overall Study|Symptomatic Deterioration|0|||
164251242|NCT02954406|593286226|FG001|Overall Study|Symptomatic Deterioration|1|||
164251243|NCT02954406|593286227|FG002|Overall Study|Symptomatic Deterioration|0|||
164251244|NCT02954406|593286228|FG003|Overall Study|Symptomatic Deterioration|0|||
164251245|NCT02954406|593286229|FG004|Overall Study|Symptomatic Deterioration|0|||
164251246|NCT02954406|593286230|FG005|Overall Study|Symptomatic Deterioration|0|||
164251247|NCT02954406|593286231|FG006|Overall Study|Symptomatic Deterioration|0|||
164251248|NCT02954406|593286232|FG007|Overall Study|Symptomatic Deterioration|0|||
164251249|NCT02954406|593286233|FG008|Overall Study|Symptomatic Deterioration|0|||
164251250|NCT02954406|593286234|FG009|Overall Study|Symptomatic Deterioration|0|||
164251251|NCT02954406|593286235|FG010|Overall Study|Symptomatic Deterioration|0|||
164251252|NCT02954406|593286225|FG000|Overall Study|Death|0|||
164251253|NCT02954406|593286226|FG001|Overall Study|Death|0|||
164251254|NCT02954406|593286227|FG002|Overall Study|Death|0|||
164251255|NCT02954406|593286228|FG003|Overall Study|Death|0|||
164251256|NCT02954406|593286229|FG004|Overall Study|Death|1|||
164251257|NCT02954406|593286230|FG005|Overall Study|Death|0|||
164251258|NCT02954406|593286231|FG006|Overall Study|Death|0|||
164251259|NCT02954406|593286232|FG007|Overall Study|Death|0|||
164251260|NCT02954406|593286233|FG008|Overall Study|Death|1|||
164251261|NCT02954406|593286234|FG009|Overall Study|Death|1|||
164251262|NCT02954406|593286235|FG010|Overall Study|Death|0|||
164251263|NCT02954406|593286225|FG000|Overall Study|Reason Not Specified|0|||
164251264|NCT02954406|593286226|FG001|Overall Study|Reason Not Specified|0|||
164338734|NCT02557295|593615233|FG000|Overall Study|Disease Progression|0|||
164338735|NCT02557295|593615234|FG001|Overall Study|Disease Progression|0|||
164338736|NCT02557295|593615235|FG002|Overall Study|Disease Progression|0|||
164251265|NCT02954406|593286227|FG002|Overall Study|Reason Not Specified|3|||
164251266|NCT02954406|593286228|FG003|Overall Study|Reason Not Specified|2|||
164251267|NCT02954406|593286229|FG004|Overall Study|Reason Not Specified|2|||
164251268|NCT02954406|593286230|FG005|Overall Study|Reason Not Specified|0|||
164251269|NCT02954406|593286231|FG006|Overall Study|Reason Not Specified|1|||
164251270|NCT02954406|593286232|FG007|Overall Study|Reason Not Specified|0|||
164251271|NCT02954406|593286233|FG008|Overall Study|Reason Not Specified|1|||
164251272|NCT02954406|593286234|FG009|Overall Study|Reason Not Specified|0|||
164251273|NCT02954406|593286235|FG010|Overall Study|Reason Not Specified|0|||
164251274|NCT00782171|593286236|FG000|Overall Study|Lost to Follow-up|2|||
164251275|NCT00782171|593286237|FG001|Overall Study|Lost to Follow-up|2|||
164251276|NCT00782171|593286236|FG000|Overall Study|Withdrawal by Subject|2|||
164251277|NCT00782171|593286237|FG001|Overall Study|Withdrawal by Subject|1|||
164251278|NCT00782171|593286236|FG000|Overall Study|complications|3|||
163887038|NCT03701763|591956596|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
164142159|NCT00287586|592882564|FG000|Overall Study|Lost to Follow-up|5|||
164142160|NCT00287586|592882565|FG001|Overall Study|Lost to Follow-up|4|||
164142161|NCT00287586|592882564|FG000|Overall Study|Death|2|||
164142162|NCT00287586|592882565|FG001|Overall Study|Death|3|||
164142163|NCT00287586|592882564|FG000|Overall Study|Elevated Hematocrit|3|||
164142164|NCT00287586|592882565|FG001|Overall Study|Elevated Hematocrit|0|||
164142165|NCT00287586|592882564|FG000|Overall Study|Rash|3|||
164142166|NCT00287586|592882565|FG001|Overall Study|Rash|0|||
164142167|NCT00287586|592882564|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
164142168|NCT00287586|592882565|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
164142169|NCT00287586|592882564|FG000|Overall Study|Stroke|2|||
164142170|NCT00287586|592882565|FG001|Overall Study|Stroke|0|||
164142171|NCT00287586|592882564|FG000|Overall Study|Myocardial Infarction|1|||
164142172|NCT00287586|592882565|FG001|Overall Study|Myocardial Infarction|0|||
164142173|NCT00287586|592882564|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
164142174|NCT00287586|592882565|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
164142175|NCT00287586|592882564|FG000|Overall Study|Cognitive Impairment|1|||
164142176|NCT00287586|592882565|FG001|Overall Study|Cognitive Impairment|0|||
164142177|NCT00287586|592882564|FG000|Overall Study|Pancreatic Cancer|1|||
164142178|NCT00287586|592882565|FG001|Overall Study|Pancreatic Cancer|3|||
164142179|NCT00287586|592882564|FG000|Overall Study|Sleep Apnea|1|||
164142180|NCT00287586|592882565|FG001|Overall Study|Sleep Apnea|0|||
164142181|NCT00287586|592882564|FG000|Overall Study|Shoulder Pain|1|||
164142182|NCT00287586|592882565|FG001|Overall Study|Shoulder Pain|0|||
164142183|NCT00287586|592882564|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
164142184|NCT00287586|592882565|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
164142185|NCT00287586|592882564|FG000|Overall Study|Nonadherence|1|||
164142186|NCT00287586|592882565|FG001|Overall Study|Nonadherence|1|||
164142187|NCT00287586|592882564|FG000|Overall Study|Enrolled in Another Study|1|||
164142188|NCT00287586|592882565|FG001|Overall Study|Enrolled in Another Study|0|||
164142189|NCT00287586|592882564|FG000|Overall Study|Major Depression|0|||
164142190|NCT00287586|592882565|FG001|Overall Study|Major Depression|2|||
164142191|NCT00287586|592882564|FG000|Overall Study|Lung Cancer|0|||
164142192|NCT00287586|592882565|FG001|Overall Study|Lung Cancer|2|||
164142193|NCT00287586|592882564|FG000|Overall Study|Elevated IPSS Score|0|||
164142194|NCT00287586|592882565|FG001|Overall Study|Elevated IPSS Score|1|||
164142195|NCT00287586|592882564|FG000|Overall Study|Retroperitoneal Cancer|0|||
164142196|NCT00287586|592882565|FG001|Overall Study|Retroperitoneal Cancer|1|||
164142197|NCT00287586|592882564|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
164142198|NCT00287586|592882565|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
164142199|NCT00287586|592882564|FG000|Overall Study|Mood Swings and Irritability|0|||
164142200|NCT00287586|592882565|FG001|Overall Study|Mood Swings and Irritability|1|||
164142201|NCT00287586|592882564|FG000|Overall Study|Bradycardia|0|||
164142202|NCT00287586|592882565|FG001|Overall Study|Bradycardia|1|||
164142203|NCT00287586|592882564|FG000|Overall Study|Itchy Swollen Eyes|0|||
164142204|NCT00287586|592882565|FG001|Overall Study|Itchy Swollen Eyes|1|||
164142205|NCT00287586|592882564|FG000|Overall Study|Recurrent Melanoma|0|||
164142206|NCT00287586|592882565|FG001|Overall Study|Recurrent Melanoma|1|||
164142207|NCT00113763|592882567|FG000|Overall Study|Adverse Event|5|||
164142208|NCT00113763|592882568|FG001|Overall Study|Adverse Event|2|||
164142209|NCT00113763|592882567|FG000|Overall Study|Disease Progression|28|||
164142210|NCT00113763|592882568|FG001|Overall Study|Disease Progression|14|||
164142211|NCT00113763|592882567|FG000|Overall Study|Lost to Follow-up|10|||
164251279|NCT00782171|593286237|FG001|Overall Study|complications|1|||
164251280|NCT00782171|593286236|FG000|Overall Study|others|7|||
164251281|NCT00782171|593286237|FG001|Overall Study|others|9|||
164251282|NCT00782171|593286236|FG000|Overall Study|not eligible|8|||
164251283|NCT00782171|593286237|FG001|Overall Study|not eligible|6|||
164251284|NCT01691014|593286238|FG000|Overall Study|Premature Termination|1|||
164338737|NCT02557295|593615236|FG003|Overall Study|Disease Progression|0|||
164338738|NCT02557295|593615237|FG004|Overall Study|Disease Progression|0|||
163887039|NCT03701763|591956597|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
163887040|NCT03701763|591956594|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
163887041|NCT03701763|591956595|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
163887042|NCT03701763|591956596|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
163887043|NCT03701763|591956597|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
163887044|NCT03701763|591956594|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
163887045|NCT03701763|591956595|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
163887046|NCT03701763|591956596|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
163887047|NCT03701763|591956597|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
163887048|NCT03701763|591956594|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
163887049|NCT03701763|591956595|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
163887050|NCT03701763|591956596|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
163887051|NCT03701763|591956597|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
163887052|NCT03701763|591956594|FG000|14-Week Observational Follow-up Phase|Other|0|||
163991800|NCT00168831|592339599|FG000|Overall Study|Withdrawal by Subject|7|||
163991801|NCT00168831|592339600|FG001|Overall Study|Withdrawal by Subject|14|||
163991802|NCT00168831|592339601|FG002|Overall Study|Withdrawal by Subject|19|||
163991803|NCT00168831|592339599|FG000|Overall Study|Protocol Violation|6|||
163991804|NCT00168831|592339600|FG001|Overall Study|Protocol Violation|11|||
163991805|NCT00168831|592339601|FG002|Overall Study|Protocol Violation|11|||
163991806|NCT00168831|592339599|FG000|Overall Study|Other|6|||
163991807|NCT00168831|592339600|FG001|Overall Study|Other|3|||
163991808|NCT00168831|592339601|FG002|Overall Study|Other|6|||
163991809|NCT04173741|592339603|FG000|Overall Study|IVC measurement cannot be done|1|||
163991810|NCT04173741|592339604|FG001|Overall Study|IVC measurement cannot be done|1|||
163991811|NCT02357420|592339605|FG000|Overall Study|Adverse Event|3|||
163991812|NCT02357420|592339606|FG001|Overall Study|Adverse Event|3|||
163991813|NCT02357420|592339607|FG002|Overall Study|Adverse Event|8|||
164338739|NCT02557295|593615238|FG005|Overall Study|Disease Progression|0|||
164338740|NCT02557295|593615239|FG006|Overall Study|Disease Progression|1|||
164338741|NCT02557295|593615240|FG007|Overall Study|Disease Progression|0|||
164338742|NCT02557295|593615241|FG008|Overall Study|Disease Progression|0|||
164338743|NCT02557295|593615233|FG000|Overall Study|Lack of Efficacy|24|||
164338744|NCT02557295|593615234|FG001|Overall Study|Lack of Efficacy|1|||
164338745|NCT02557295|593615235|FG002|Overall Study|Lack of Efficacy|3|||
164338746|NCT02557295|593615236|FG003|Overall Study|Lack of Efficacy|0|||
164338747|NCT02557295|593615237|FG004|Overall Study|Lack of Efficacy|0|||
164338748|NCT02557295|593615238|FG005|Overall Study|Lack of Efficacy|0|||
164338749|NCT02557295|593615239|FG006|Overall Study|Lack of Efficacy|12|||
164338750|NCT02557295|593615240|FG007|Overall Study|Lack of Efficacy|1|||
164338751|NCT02557295|593615241|FG008|Overall Study|Lack of Efficacy|0|||
164338752|NCT02557295|593615233|FG000|Overall Study|Adverse Event|16|||
164338753|NCT02557295|593615234|FG001|Overall Study|Adverse Event|2|||
164338754|NCT02557295|593615235|FG002|Overall Study|Adverse Event|3|||
164338755|NCT02557295|593615236|FG003|Overall Study|Adverse Event|0|||
164338756|NCT02557295|593615237|FG004|Overall Study|Adverse Event|0|||
164338757|NCT02557295|593615238|FG005|Overall Study|Adverse Event|0|||
164338758|NCT02557295|593615239|FG006|Overall Study|Adverse Event|2|||
164338759|NCT02557295|593615240|FG007|Overall Study|Adverse Event|1|||
164338760|NCT02557295|593615241|FG008|Overall Study|Adverse Event|1|||
164338761|NCT02557295|593615233|FG000|Overall Study|Lost to Follow-up|4|||
164338762|NCT02557295|593615234|FG001|Overall Study|Lost to Follow-up|0|||
164338763|NCT02557295|593615235|FG002|Overall Study|Lost to Follow-up|0|||
164338764|NCT02557295|593615236|FG003|Overall Study|Lost to Follow-up|0|||
164338765|NCT02557295|593615237|FG004|Overall Study|Lost to Follow-up|0|||
164338766|NCT02557295|593615238|FG005|Overall Study|Lost to Follow-up|0|||
164338767|NCT02557295|593615239|FG006|Overall Study|Lost to Follow-up|9|||
164338768|NCT02557295|593615240|FG007|Overall Study|Lost to Follow-up|0|||
164338769|NCT02557295|593615241|FG008|Overall Study|Lost to Follow-up|0|||
164338770|NCT02557295|593615233|FG000|Overall Study|Study Close|54|||
164338771|NCT02557295|593615234|FG001|Overall Study|Study Close|3|||
164338772|NCT02557295|593615235|FG002|Overall Study|Study Close|5|||
164338773|NCT02557295|593615236|FG003|Overall Study|Study Close|3|||
164338774|NCT02557295|593615237|FG004|Overall Study|Study Close|0|||
164338775|NCT02557295|593615238|FG005|Overall Study|Study Close|0|||
164338776|NCT02557295|593615239|FG006|Overall Study|Study Close|37|||
163887053|NCT03701763|591956595|FG001|14-Week Observational Follow-up Phase|Other|0|||
164251285|NCT01691014|593286239|FG001|Overall Study|Premature Termination|6|||
164251286|NCT01691014|593286240|FG002|Overall Study|Premature Termination|0|||
163991814|NCT02357420|592339608|FG003|Overall Study|Adverse Event|9|||
163991815|NCT02357420|592339605|FG000|Overall Study|Investigator Decision|1|||
163991816|NCT02357420|592339606|FG001|Overall Study|Investigator Decision|0|||
163991817|NCT02357420|592339607|FG002|Overall Study|Investigator Decision|0|||
163887054|NCT03701763|591956596|FG002|14-Week Observational Follow-up Phase|Other|1|||
163887055|NCT03701763|591956597|FG003|14-Week Observational Follow-up Phase|Other|0|||
163887056|NCT03701763|591956594|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
163887057|NCT03701763|591956595|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
163887058|NCT03701763|591956596|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
163887059|NCT03701763|591956597|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
163887060|NCT03701763|591956594|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
163887061|NCT03701763|591956595|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
163887062|NCT03701763|591956596|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
163887063|NCT03701763|591956597|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
163887064|NCT04489771|591959307|FG000|Overall Study|Death|27|||
163887065|NCT04489771|591959308|FG001|Overall Study|Death|25|||
163887066|NCT04489771|591959307|FG000|Overall Study|Withdrawal by Subject|1|||
164251287|NCT01691014|593286241|FG003|Overall Study|Premature Termination|3|||
164251288|NCT01691014|593286238|FG000|Overall Study|Other|0|||
164251289|NCT01691014|593286239|FG001|Overall Study|Other|0|||
164251290|NCT01691014|593286240|FG002|Overall Study|Other|2|||
163887067|NCT04489771|591959308|FG001|Overall Study|Withdrawal by Subject|0|||
163887068|NCT04489771|591959307|FG000|Overall Study|Participants Ongoing in Study|50|||
163887069|NCT04489771|591959308|FG001|Overall Study|Participants Ongoing in Study|51|||
163887070|NCT06516705|591959316|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
163887071|NCT06516705|591959317|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
163887072|NCT06516705|591959316|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
163887073|NCT06516705|591959317|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
163887074|NCT06516705|591959316|FG000|T3 ( 3 Month After Education)|covid-19|1|||
163887075|NCT06516705|591959317|FG001|T3 ( 3 Month After Education)|covid-19|2|||
163887076|NCT06516705|591959316|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
163887077|NCT06516705|591959317|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
163887078|NCT06516705|591959316|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
163887079|NCT06516705|591959317|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
163887080|NCT06516705|591959316|FG000|T4 ( 6 Month After Education)|covid-19|3|||
163887081|NCT06516705|591959317|FG001|T4 ( 6 Month After Education)|covid-19|2|||
163887082|NCT06516705|591959316|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
163887083|NCT06516705|591959317|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
163887084|NCT05579899|591959318|FG000|Overall Study|Lost to Follow-up|3|||
163887085|NCT05579899|591959319|FG001|Overall Study|Lost to Follow-up|1|||
163887086|NCT05579899|591959318|FG000|Overall Study|Adverse Event|0|||
163887087|NCT05579899|591959319|FG001|Overall Study|Adverse Event|3|||
163887088|NCT05579899|591959318|FG000|Overall Study|Pregnancy|0|||
163887089|NCT05579899|591959319|FG001|Overall Study|Pregnancy|1|||
163887090|NCT05579899|591959318|FG000|Overall Study|Withdrawal by Subject|0|||
163887091|NCT05579899|591959319|FG001|Overall Study|Withdrawal by Subject|3|||
163887092|NCT04059484|591959321|FG000|Overall Study|Adverse Event|2|||
163887093|NCT04059484|591959322|FG001|Overall Study|Adverse Event|5|||
163887094|NCT04059484|591959321|FG000|Overall Study|Withdrawal by Subject|5|||
163887095|NCT04059484|591959322|FG001|Overall Study|Withdrawal by Subject|3|||
164251291|NCT01691014|593286241|FG003|Overall Study|Other|0|||
164251292|NCT01691014|593286238|FG000|Overall Study|Withdrawal by Subject|0|||
164251293|NCT01691014|593286239|FG001|Overall Study|Withdrawal by Subject|1|||
164251294|NCT01691014|593286240|FG002|Overall Study|Withdrawal by Subject|1|||
164251295|NCT01691014|593286241|FG003|Overall Study|Withdrawal by Subject|1|||
164251296|NCT01691014|593286238|FG000|Overall Study|Adverse Event|0|||
164251297|NCT01691014|593286239|FG001|Overall Study|Adverse Event|5|||
164251298|NCT01691014|593286240|FG002|Overall Study|Adverse Event|1|||
164251299|NCT01691014|593286241|FG003|Overall Study|Adverse Event|1|||
164251300|NCT01691014|593286238|FG000|Overall Study|Lack of Efficacy|2|||
164251301|NCT01691014|593286239|FG001|Overall Study|Lack of Efficacy|3|||
164251302|NCT01691014|593286240|FG002|Overall Study|Lack of Efficacy|7|||
164338777|NCT02557295|593615240|FG007|Overall Study|Study Close|3|||
164338778|NCT02557295|593615241|FG008|Overall Study|Study Close|19|||
163887096|NCT04059484|591959321|FG000|Overall Study|Progressive disease|112|||
163887097|NCT04059484|591959322|FG001|Overall Study|Progressive disease|112|||
163887098|NCT04059484|591959321|FG000|Overall Study|Other|8|||
163887099|NCT04059484|591959322|FG001|Overall Study|Other|3|||
163887100|NCT04059484|591959321|FG000|Overall Study|Ongoing|20|||
163887101|NCT04059484|591959322|FG001|Overall Study|Ongoing|20|||
164251303|NCT01691014|593286241|FG003|Overall Study|Lack of Efficacy|0|||
164251304|NCT05897242|593286244|FG000|Overall Study|Lost to Follow-up|6|||
164251305|NCT05897242|593286245|FG001|Overall Study|Lost to Follow-up|1|||
164251306|NCT05897242|593286244|FG000|Overall Study|Incomplete|1|||
164251307|NCT05897242|593286245|FG001|Overall Study|Incomplete|0|||
164251308|NCT05897242|593286244|FG000|Overall Study|Withdrawal by Subject|1|||
164251309|NCT05897242|593286245|FG001|Overall Study|Withdrawal by Subject|0|||
164251310|NCT03522246|593286246|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
164251311|NCT03522246|593286247|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
164251312|NCT03522246|593286248|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
164251313|NCT03522246|593286249|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
164251314|NCT03522246|593286250|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
164251315|NCT00814580|593286251|FG000|Overall Study|Adverse Event|6|||
164251316|NCT00814580|593286252|FG001|Overall Study|Adverse Event|15|||
164251317|NCT00814580|593286251|FG000|Overall Study|Lack of Efficacy|18|||
164251318|NCT00814580|593286252|FG001|Overall Study|Lack of Efficacy|25|||
164251319|NCT00814580|593286251|FG000|Overall Study|Protocol Violation|2|||
164251320|NCT00814580|593286252|FG001|Overall Study|Protocol Violation|0|||
164251321|NCT00814580|593286251|FG000|Overall Study|Withdrawal by Subject|2|||
164251322|NCT00814580|593286252|FG001|Overall Study|Withdrawal by Subject|2|||
164251323|NCT00814580|593286251|FG000|Overall Study|Other|1|||
164251324|NCT00814580|593286252|FG001|Overall Study|Other|3|||
164251325|NCT00814580|593286251|FG000|Overall Study|Did Not Take Drug|2|||
164338779|NCT02557295|593615233|FG000|Overall Study|except for study close|4|||
164338780|NCT02557295|593615234|FG001|Overall Study|except for study close|0|||
164338781|NCT02557295|593615235|FG002|Overall Study|except for study close|0|||
164338782|NCT02557295|593615236|FG003|Overall Study|except for study close|0|||
164338783|NCT02557295|593615237|FG004|Overall Study|except for study close|0|||
164338784|NCT02557295|593615238|FG005|Overall Study|except for study close|0|||
164338785|NCT02557295|593615239|FG006|Overall Study|except for study close|5|||
163991818|NCT02357420|592339608|FG003|Overall Study|Investigator Decision|0|||
164338786|NCT02557295|593615240|FG007|Overall Study|except for study close|1|||
164338787|NCT02557295|593615241|FG008|Overall Study|except for study close|0|||
164338788|NCT01798004|593617042|FG000|Overall Study|Death|2|||
164251326|NCT00814580|593286252|FG001|Overall Study|Did Not Take Drug|2|||
164251327|NCT02482428|593286253|FG000|Overall Study|Lost to Follow-up|4|||
164251328|NCT02482428|593286254|FG001|Overall Study|Lost to Follow-up|9|||
164251329|NCT02482428|593286255|FG002|Overall Study|Lost to Follow-up|1|||
164251330|NCT02482428|593286256|FG003|Overall Study|Lost to Follow-up|2|||
164251331|NCT02482428|593286257|FG004|Overall Study|Lost to Follow-up|4|||
164338789|NCT01798004|593617042|FG000|Overall Study|Lack of Efficacy|8|||
164338790|NCT01798004|593617042|FG000|Overall Study|Physician Decision|25|||
164338791|NCT01798004|593617042|FG000|Overall Study|Withdrawal by Subject|4|||
164338792|NCT01798004|593617042|FG000|Overall Study|Ineligible|4|||
164338793|NCT01798004|593617042|FG000|Overall Study|Patient/parent refusal|7|||
164338794|NCT01798004|593617042|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
164338795|NCT01798004|593617042|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
164338796|NCT03320057|593617043|FG000|Overall Study|Lost to Follow-up|4|||
164338797|NCT03320057|593617044|FG001|Overall Study|Lost to Follow-up|17|||
164338798|NCT03320057|593617043|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
164338799|NCT03320057|593617044|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
164338800|NCT06956170|593617045|FG000|Overall Study|Death|2|||
164338801|NCT06956170|593617046|FG001|Overall Study|Death|1|||
164338802|NCT06956170|593617045|FG000|Overall Study|Withdrawal by Subject|1|||
164338803|NCT06956170|593617046|FG001|Overall Study|Withdrawal by Subject|0|||
164338804|NCT06956170|593617045|FG000|Overall Study|Ongoing|7|||
164338805|NCT06956170|593617046|FG001|Overall Study|Ongoing|10|||
164338806|NCT02323113|593617047|FG000|Overall Study|Adverse Event|3|||
164338807|NCT02323113|593617048|FG001|Overall Study|Adverse Event|3|||
164338808|NCT02323113|593617049|FG002|Overall Study|Adverse Event|2|||
164338809|NCT02323113|593617050|FG003|Overall Study|Adverse Event|5|||
164338810|NCT02323113|593617051|FG004|Overall Study|Adverse Event|8|||
164338811|NCT02323113|593617052|FG005|Overall Study|Adverse Event|3|||
164338812|NCT02323113|593617053|FG006|Overall Study|Adverse Event|6|||
164338813|NCT02323113|593617054|FG007|Overall Study|Adverse Event|0|||
164338814|NCT02323113|593617047|FG000|Overall Study|Progressive Disease|0|||
164338815|NCT02323113|593617048|FG001|Overall Study|Progressive Disease|1|||
164338816|NCT02323113|593617049|FG002|Overall Study|Progressive Disease|1|||
164338817|NCT02323113|593617050|FG003|Overall Study|Progressive Disease|0|||
164338818|NCT02323113|593617051|FG004|Overall Study|Progressive Disease|0|||
164338819|NCT02323113|593617052|FG005|Overall Study|Progressive Disease|3|||
164338820|NCT02323113|593617053|FG006|Overall Study|Progressive Disease|0|||
164338821|NCT02323113|593617054|FG007|Overall Study|Progressive Disease|0|||
164338822|NCT02323113|593617047|FG000|Overall Study|Symptomatic Deterioration|0|||
164338823|NCT02323113|593617048|FG001|Overall Study|Symptomatic Deterioration|0|||
164338824|NCT02323113|593617049|FG002|Overall Study|Symptomatic Deterioration|1|||
164338825|NCT02323113|593617050|FG003|Overall Study|Symptomatic Deterioration|0|||
164338826|NCT02323113|593617051|FG004|Overall Study|Symptomatic Deterioration|1|||
164338827|NCT02323113|593617052|FG005|Overall Study|Symptomatic Deterioration|0|||
164338828|NCT02323113|593617053|FG006|Overall Study|Symptomatic Deterioration|0|||
164338829|NCT02323113|593617054|FG007|Overall Study|Symptomatic Deterioration|0|||
164338830|NCT02323113|593617047|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
164251332|NCT02482428|593286253|FG000|Overall Study|Physician Decision|0|||
164251333|NCT02482428|593286254|FG001|Overall Study|Physician Decision|0|||
164251334|NCT02482428|593286255|FG002|Overall Study|Physician Decision|0|||
164251335|NCT02482428|593286256|FG003|Overall Study|Physician Decision|0|||
164251336|NCT02482428|593286257|FG004|Overall Study|Physician Decision|1|||
164251337|NCT02482428|593286253|FG000|Overall Study|protocol deviation|1|||
164251338|NCT02482428|593286254|FG001|Overall Study|protocol deviation|1|||
164251339|NCT02482428|593286255|FG002|Overall Study|protocol deviation|0|||
164251340|NCT02482428|593286256|FG003|Overall Study|protocol deviation|0|||
164251341|NCT02482428|593286257|FG004|Overall Study|protocol deviation|0|||
164251342|NCT02482428|593286253|FG000|Overall Study|subject/guardian decision|4|||
164251343|NCT02482428|593286254|FG001|Overall Study|subject/guardian decision|2|||
164084177|NCT00678392|592672290|FG001|Overall Study|Withdrawal by Subject|4|||
164084178|NCT00678392|592672289|FG000|Overall Study|Randomized But Not Treated|2|||
164084179|NCT00678392|592672290|FG001|Overall Study|Randomized But Not Treated|7|||
164084180|NCT00678392|592672289|FG000|Overall Study|Other|56|||
164084181|NCT00678392|592672290|FG001|Overall Study|Other|53|||
164084182|NCT03341507|592672291|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
164084183|NCT00989261|592672293|FG000|Overall Study|Still in follow up|12|||
164084184|NCT00989261|592672294|FG001|Overall Study|Still in follow up|21|||
164084185|NCT00989261|592672293|FG000|Overall Study|Withdrawal by Subject|0|||
164084186|NCT00989261|592672294|FG001|Overall Study|Withdrawal by Subject|1|||
164084187|NCT00989261|592672293|FG000|Overall Study|Lost to Follow-up|3|||
164084188|NCT00989261|592672294|FG001|Overall Study|Lost to Follow-up|0|||
164084189|NCT00782509|592672295|FG000|Overall Study|Adverse Event|20|||
164084190|NCT00782509|592672296|FG001|Overall Study|Adverse Event|10|||
164084191|NCT00782509|592672297|FG002|Overall Study|Adverse Event|20|||
164084192|NCT00782509|592672295|FG000|Overall Study|Lost to Follow-up|1|||
164084193|NCT00782509|592672296|FG001|Overall Study|Lost to Follow-up|2|||
164084194|NCT00782509|592672297|FG002|Overall Study|Lost to Follow-up|3|||
164084195|NCT00782509|592672295|FG000|Overall Study|Withdrawal by Subject|3|||
164251344|NCT02482428|593286255|FG002|Overall Study|subject/guardian decision|0|||
164251345|NCT02482428|593286256|FG003|Overall Study|subject/guardian decision|0|||
164251346|NCT02482428|593286257|FG004|Overall Study|subject/guardian decision|2|||
164251347|NCT00809835|593286260|FG000|Overall Study|Lost to Follow-up|7|||
164251348|NCT00809835|593286261|FG001|Overall Study|Lost to Follow-up|6|||
164251349|NCT00809835|593286262|FG002|Overall Study|Lost to Follow-up|10|||
164251350|NCT00809835|593286263|FG003|Overall Study|Lost to Follow-up|2|||
164251351|NCT00809835|593286260|FG000|Overall Study|Withdrawal by Subject|1|||
164251352|NCT00809835|593286261|FG001|Overall Study|Withdrawal by Subject|1|||
164251353|NCT00809835|593286262|FG002|Overall Study|Withdrawal by Subject|1|||
164251354|NCT00809835|593286263|FG003|Overall Study|Withdrawal by Subject|0|||
164251355|NCT02547038|593286264|FG000|Overall Study|Lost to Follow-up|3|||
164251356|NCT02547038|593286265|FG001|Overall Study|Lost to Follow-up|2|||
164251357|NCT00516893|593286266|FG000|Overall Study|Lost to Follow-up|4|||
164251358|NCT00516893|593286266|FG000|Overall Study|Adverse Event|3|||
164251359|NCT00516893|593286266|FG000|Overall Study|Withdrawal by Subject|2|||
164251360|NCT00516893|593286266|FG000|Overall Study|Noncompliance|2|||
164251361|NCT00516893|593286266|FG000|Overall Study|Death|1|||
164251362|NCT00516893|593286266|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
164251363|NCT00516893|593286266|FG000|Overall Study|Relocated|1|||
164251364|NCT00516893|593286266|FG000|Overall Study|Pregnancy|1|||
164251365|NCT00516893|593286266|FG000|Overall Study|Received Medication From Another Study|1|||
164251366|NCT05924165|593286273|FG000|Overall Study|Physician Decision|2|||
164251367|NCT05924165|593286274|FG001|Overall Study|Physician Decision|3|||
164251368|NCT01681186|593286275|FG000|Washout Period From Second Intervention|Adverse Event|0|||
164251369|NCT01681186|593286276|FG001|Washout Period From Second Intervention|Adverse Event|0|||
164251370|NCT01681186|593286277|FG002|Washout Period From Second Intervention|Adverse Event|0|||
164251371|NCT01681186|593286278|FG003|Washout Period From Second Intervention|Adverse Event|0|||
164251372|NCT01681186|593286279|FG004|Washout Period From Second Intervention|Adverse Event|0|||
164251373|NCT01681186|593286280|FG005|Washout Period From Second Intervention|Adverse Event|0|||
164251374|NCT01681186|593286281|FG006|Washout Period From Second Intervention|Adverse Event|1|||
164251375|NCT01681186|593286282|FG007|Washout Period From Second Intervention|Adverse Event|0|||
164251376|NCT01681186|593286275|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
164084196|NCT00782509|592672296|FG001|Overall Study|Withdrawal by Subject|5|||
164084197|NCT00782509|592672297|FG002|Overall Study|Withdrawal by Subject|8|||
164084198|NCT00782509|592672295|FG000|Overall Study|Non compliance with protocol|2|||
164084199|NCT00782509|592672296|FG001|Overall Study|Non compliance with protocol|0|||
164251377|NCT01681186|593286276|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
164251378|NCT01681186|593286277|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
164251379|NCT01681186|593286278|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
164251380|NCT01681186|593286279|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
164251381|NCT01681186|593286280|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
164251382|NCT01681186|593286281|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
163991819|NCT02357420|592339605|FG000|Overall Study|Prohibited Medication|1|||
163991820|NCT02357420|592339606|FG001|Overall Study|Prohibited Medication|1|||
164251383|NCT01681186|593286282|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
164251384|NCT01681186|593286275|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251385|NCT01681186|593286276|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251386|NCT01681186|593286277|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251387|NCT01681186|593286278|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251388|NCT01681186|593286279|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251389|NCT01681186|593286280|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251390|NCT01681186|593286281|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
164251391|NCT01681186|593286282|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
164251392|NCT01681186|593286275|FG000|Fourth Intervention|Protocol Violation|0|||
163991821|NCT02357420|592339607|FG002|Overall Study|Prohibited Medication|0|||
164251393|NCT01681186|593286276|FG001|Fourth Intervention|Protocol Violation|0|||
164251394|NCT01681186|593286277|FG002|Fourth Intervention|Protocol Violation|0|||
164251395|NCT01681186|593286278|FG003|Fourth Intervention|Protocol Violation|0|||
164251396|NCT01681186|593286279|FG004|Fourth Intervention|Protocol Violation|0|||
164251397|NCT01681186|593286280|FG005|Fourth Intervention|Protocol Violation|0|||
164251398|NCT01681186|593286281|FG006|Fourth Intervention|Protocol Violation|0|||
164251399|NCT01681186|593286282|FG007|Fourth Intervention|Protocol Violation|1|||
164251400|NCT04308239|593286283|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
164251401|NCT04308239|593286284|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
164251402|NCT04308239|593286283|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
164251403|NCT04308239|593286284|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
164251404|NCT04308239|593286283|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
164251405|NCT04308239|593286284|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
164251406|NCT04308239|593286283|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
164251407|NCT04308239|593286284|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
164251408|NCT05791565|593286287|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
164251409|NCT05791565|593286288|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
163991822|NCT02357420|592339608|FG003|Overall Study|Prohibited Medication|0|||
164251410|NCT00880269|593286289|FG000|Overall Study|Protocol Violation|1|||
164251411|NCT00880269|593286290|FG001|Overall Study|Protocol Violation|0|||
164251412|NCT00880269|593286289|FG000|Overall Study|Disease Progression|13|||
164251413|NCT00880269|593286290|FG001|Overall Study|Disease Progression|11|||
164251414|NCT00880269|593286289|FG000|Overall Study|New Cancer Therapy|1|||
164251415|NCT00880269|593286290|FG001|Overall Study|New Cancer Therapy|0|||
164251416|NCT00880269|593286289|FG000|Overall Study|Death|4|||
164251417|NCT00880269|593286290|FG001|Overall Study|Death|2|||
164251418|NCT00880269|593286289|FG000|Overall Study|Lost to Follow-up|0|||
164251419|NCT00880269|593286290|FG001|Overall Study|Lost to Follow-up|1|||
164251420|NCT00880269|593286289|FG000|Overall Study|Withdrawal by Subject|3|||
164251421|NCT00880269|593286290|FG001|Overall Study|Withdrawal by Subject|4|||
164251422|NCT00880269|593286289|FG000|Overall Study|Adverse Event|10|||
164251423|NCT00880269|593286290|FG001|Overall Study|Adverse Event|9|||
164251424|NCT02516982|593286292|FG000|Overall Study|Called in to antenatal appointment|32|||
164251425|NCT02516982|593286293|FG001|Overall Study|Called in to antenatal appointment|35|||
164251426|NCT02516982|593286294|FG002|Overall Study|Called in to antenatal appointment|0|||
164251427|NCT02516982|593286295|FG003|Overall Study|Called in to antenatal appointment|0|||
164251428|NCT02516982|593286292|FG000|Overall Study|Withdrawal by Subject|0|||
164251429|NCT02516982|593286293|FG001|Overall Study|Withdrawal by Subject|0|||
164251430|NCT02516982|593286294|FG002|Overall Study|Withdrawal by Subject|1|||
164251431|NCT02516982|593286295|FG003|Overall Study|Withdrawal by Subject|2|||
164251432|NCT02516982|593286292|FG000|Overall Study|Protocol Violation|0|||
164251433|NCT02516982|593286293|FG001|Overall Study|Protocol Violation|0|||
164251434|NCT02516982|593286294|FG002|Overall Study|Protocol Violation|1|||
164251435|NCT02516982|593286295|FG003|Overall Study|Protocol Violation|1|||
164251436|NCT02516982|593286292|FG000|Overall Study|Did not install the app|0|||
164251437|NCT02516982|593286293|FG001|Overall Study|Did not install the app|0|||
164251438|NCT02516982|593286294|FG002|Overall Study|Did not install the app|46|||
164251439|NCT02516982|593286295|FG003|Overall Study|Did not install the app|47|||
164251440|NCT03645421|593286300|FG000|Overall Study|Adverse Event|0|||
164251441|NCT03645421|593286301|FG001|Overall Study|Adverse Event|0|||
164251442|NCT03645421|593286302|FG002|Overall Study|Adverse Event|4|||
164251443|NCT03645421|593286303|FG003|Overall Study|Adverse Event|1|||
164251444|NCT03645421|593286300|FG000|Overall Study|Withdrawal by patient|0|||
164251445|NCT03645421|593286301|FG001|Overall Study|Withdrawal by patient|0|||
164251446|NCT03645421|593286302|FG002|Overall Study|Withdrawal by patient|0|||
164251447|NCT03645421|593286303|FG003|Overall Study|Withdrawal by patient|3|||
164251448|NCT03645421|593286300|FG000|Overall Study|Study specific withdrawal criteria|0|||
164251449|NCT03645421|593286301|FG001|Overall Study|Study specific withdrawal criteria|0|||
163887102|NCT04292223|591959323|FG000|Overall Study|Adverse Event|1|||
164251450|NCT03645421|593286302|FG002|Overall Study|Study specific withdrawal criteria|1|||
164251451|NCT03645421|593286303|FG003|Overall Study|Study specific withdrawal criteria|0|||
164251452|NCT03379259|593286304|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
164251453|NCT03379259|593286305|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
164251454|NCT03379259|593286306|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
163887103|NCT04292223|591959323|FG000|Overall Study|Lost to Follow-up|1|||
163887104|NCT04292223|591959323|FG000|Overall Study|Noncompliance with study drug|2|||
163887105|NCT04292223|591959323|FG000|Overall Study|Patient moved out of the state|1|||
163887106|NCT00753545|591959324|FG000|Overall Study|Death|98|||
163887107|NCT00753545|591959325|FG001|Overall Study|Death|112|||
163887108|NCT00753545|591959324|FG000|Overall Study|Lost to Follow-up|2|||
163887109|NCT00753545|591959325|FG001|Overall Study|Lost to Follow-up|3|||
163887110|NCT00753545|591959324|FG000|Overall Study|Protocol Violation|1|||
163887111|NCT00753545|591959325|FG001|Overall Study|Protocol Violation|0|||
163887112|NCT00753545|591959324|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
163887113|NCT00753545|591959325|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
163887114|NCT05453773|591959326|FG000|Overall Study|Withdrawal by Subject|3|||
163887115|NCT05453773|591959326|FG000|Overall Study|Lost to Follow-up|3|||
163887116|NCT05453773|591959326|FG000|Overall Study|Difficult Blood Draw|3|||
163887117|NCT02485938|591959329|FG000|Overall Study|Withdrawal of consent|2|||
163887118|NCT02485938|591959330|FG001|Overall Study|Withdrawal of consent|0|||
163887119|NCT03839940|591959331|FG000|Overall Study|Withdrawal by Subject|3|||
163887120|NCT03839940|591959332|FG001|Overall Study|Withdrawal by Subject|0|||
164251455|NCT03379259|593286307|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
164251456|NCT03379259|593286308|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
164251457|NCT03379259|593286309|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
163887121|NCT03839940|591959331|FG000|Overall Study|Protocol Violation|0|||
163887122|NCT03839940|591959332|FG001|Overall Study|Protocol Violation|1|||
163887123|NCT03839940|591959331|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
163887124|NCT03839940|591959332|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
163887125|NCT00470704|591959333|FG000|Overall Study|Withdrawal by Subject|4|||
164251458|NCT03379259|593286304|FG000|Overall Study|Death|0|||
163991823|NCT02357420|592339605|FG000|Overall Study|Protocol Non-compliance|0|||
163991824|NCT02357420|592339606|FG001|Overall Study|Protocol Non-compliance|0|||
163991825|NCT02357420|592339607|FG002|Overall Study|Protocol Non-compliance|0|||
163991826|NCT02357420|592339608|FG003|Overall Study|Protocol Non-compliance|1|||
164251459|NCT03379259|593286305|FG001|Overall Study|Death|1|||
164251460|NCT03379259|593286306|FG002|Overall Study|Death|2|||
164251461|NCT03379259|593286307|FG003|Overall Study|Death|1|||
164251462|NCT03379259|593286308|FG004|Overall Study|Death|4|||
164251463|NCT03379259|593286309|FG005|Overall Study|Death|2|||
164251464|NCT03379259|593286304|FG000|Overall Study|Withdrawal by Subject|0|||
164251465|NCT03379259|593286305|FG001|Overall Study|Withdrawal by Subject|0|||
164251466|NCT03379259|593286306|FG002|Overall Study|Withdrawal by Subject|1|||
164251467|NCT03379259|593286307|FG003|Overall Study|Withdrawal by Subject|0|||
164251468|NCT03379259|593286308|FG004|Overall Study|Withdrawal by Subject|2|||
164251469|NCT03379259|593286309|FG005|Overall Study|Withdrawal by Subject|0|||
164251470|NCT03379259|593286304|FG000|Overall Study|Study terminated by sponsor|0|||
164251471|NCT03379259|593286305|FG001|Overall Study|Study terminated by sponsor|0|||
163887126|NCT00470704|591959334|FG001|Overall Study|Withdrawal by Subject|3|||
163887127|NCT00470704|591959333|FG000|Overall Study|Relapse/Progression|37|||
163887128|NCT00470704|591959334|FG001|Overall Study|Relapse/Progression|42|||
163887129|NCT00470704|591959333|FG000|Overall Study|toxicity|0|||
163887130|NCT00470704|591959334|FG001|Overall Study|toxicity|1|||
163887131|NCT04963270|591959335|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
163887132|NCT04963270|591959336|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
163887133|NCT04963270|591959337|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
163887134|NCT04963270|591959338|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
163887135|NCT04963270|591959335|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163887136|NCT04963270|591959336|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
163887137|NCT04963270|591959337|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
163887138|NCT04963270|591959338|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164251472|NCT03379259|593286306|FG002|Overall Study|Study terminated by sponsor|0|||
164251473|NCT03379259|593286307|FG003|Overall Study|Study terminated by sponsor|1|||
164251474|NCT03379259|593286308|FG004|Overall Study|Study terminated by sponsor|1|||
163887139|NCT04963270|591959335|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
163887140|NCT04963270|591959336|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164251475|NCT03379259|593286309|FG005|Overall Study|Study terminated by sponsor|4|||
163991827|NCT02357420|592339605|FG000|Overall Study|Withdrawn Consent|4|||
163991828|NCT02357420|592339606|FG001|Overall Study|Withdrawn Consent|8|||
163991829|NCT02357420|592339607|FG002|Overall Study|Withdrawn Consent|6|||
163991830|NCT02357420|592339608|FG003|Overall Study|Withdrawn Consent|6|||
163991831|NCT02357420|592339605|FG000|Overall Study|Lost to Follow-up|3|||
163991832|NCT02357420|592339606|FG001|Overall Study|Lost to Follow-up|0|||
164251476|NCT03379259|593286304|FG000|Overall Study|Disease progression|0|||
164251477|NCT03379259|593286305|FG001|Overall Study|Disease progression|0|||
164251478|NCT03379259|593286306|FG002|Overall Study|Disease progression|0|||
164251479|NCT03379259|593286307|FG003|Overall Study|Disease progression|1|||
164251480|NCT03379259|593286308|FG004|Overall Study|Disease progression|0|||
164251481|NCT03379259|593286309|FG005|Overall Study|Disease progression|1|||
164251482|NCT03379259|593286304|FG000|Overall Study|Lost to Follow-up|0|||
164251483|NCT03379259|593286305|FG001|Overall Study|Lost to Follow-up|0|||
164251484|NCT03379259|593286306|FG002|Overall Study|Lost to Follow-up|0|||
164251485|NCT03379259|593286307|FG003|Overall Study|Lost to Follow-up|0|||
164251486|NCT03379259|593286308|FG004|Overall Study|Lost to Follow-up|1|||
164251487|NCT03379259|593286309|FG005|Overall Study|Lost to Follow-up|0|||
164251488|NCT03379259|593286304|FG000|Overall Study|Deteriorating condition|0|||
164251489|NCT03379259|593286305|FG001|Overall Study|Deteriorating condition|0|||
164251490|NCT03379259|593286306|FG002|Overall Study|Deteriorating condition|0|||
164251491|NCT03379259|593286307|FG003|Overall Study|Deteriorating condition|0|||
164251492|NCT03379259|593286308|FG004|Overall Study|Deteriorating condition|1|||
164251493|NCT03379259|593286309|FG005|Overall Study|Deteriorating condition|0|||
164251494|NCT03195660|593286310|FG000|Overall Study|The study was terminated|2|||
164251495|NCT00375427|593286311|FG000|Overall Study|Adverse Event|21|||
164251496|NCT00375427|593286312|FG001|Overall Study|Adverse Event|27|||
164251497|NCT00375427|593286311|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164251498|NCT00375427|593286312|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164251499|NCT00375427|593286311|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164251500|NCT00375427|593286312|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164251501|NCT00375427|593286311|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164251502|NCT00375427|593286312|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164251503|NCT00375427|593286311|FG000|Overall Study|Patient no longer requires study drug|3|||
164251504|NCT00375427|593286312|FG001|Overall Study|Patient no longer requires study drug|7|||
164251505|NCT00375427|593286311|FG000|Overall Study|Protocol Violation|10|||
164251506|NCT00375427|593286312|FG001|Overall Study|Protocol Violation|8|||
164251507|NCT00375427|593286311|FG000|Overall Study|Withdrawal by Subject|9|||
164251508|NCT00375427|593286312|FG001|Overall Study|Withdrawal by Subject|13|||
164251509|NCT00375427|593286311|FG000|Overall Study|Lost to Follow-up|1|||
164251510|NCT00375427|593286312|FG001|Overall Study|Lost to Follow-up|1|||
164251511|NCT00375427|593286311|FG000|Overall Study|Administrative reasons|0|||
164251512|NCT00375427|593286312|FG001|Overall Study|Administrative reasons|1|||
164251513|NCT00375427|593286311|FG000|Overall Study|Death|11|||
164251514|NCT00375427|593286312|FG001|Overall Study|Death|10|||
164251515|NCT03249909|593286318|FG000|Overall Study|Withdrawal by Subject|3|||
164251516|NCT03249909|593286319|FG001|Overall Study|Withdrawal by Subject|0|||
164251517|NCT03249909|593286320|FG002|Overall Study|Withdrawal by Subject|0|||
164251518|NCT03249909|593286318|FG000|Overall Study|Adverse Event|3|||
164251519|NCT03249909|593286319|FG001|Overall Study|Adverse Event|0|||
164251520|NCT03249909|593286320|FG002|Overall Study|Adverse Event|0|||
164251521|NCT03249909|593286318|FG000|Overall Study|Lost to Follow-up|0|||
164251522|NCT03249909|593286319|FG001|Overall Study|Lost to Follow-up|1|||
163991833|NCT02357420|592339607|FG002|Overall Study|Lost to Follow-up|2|||
163991834|NCT02357420|592339608|FG003|Overall Study|Lost to Follow-up|3|||
163991835|NCT03617705|592339609|FG000|Overall Study|Withdrawal by Subject|2|||
164251523|NCT03249909|593286320|FG002|Overall Study|Lost to Follow-up|0|||
164251524|NCT03517371|593286321|FG000|Overall Study|Adverse Event|8|||
164251525|NCT03517371|593286322|FG001|Overall Study|Adverse Event|9|||
164251526|NCT03517371|593286321|FG000|Overall Study|Lost to Follow-up|1|||
164251527|NCT03517371|593286322|FG001|Overall Study|Lost to Follow-up|2|||
164251528|NCT03517371|593286321|FG000|Overall Study|Withdrawal by Subject|4|||
164251529|NCT03517371|593286322|FG001|Overall Study|Withdrawal by Subject|4|||
164251530|NCT03517371|593286321|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
164251531|NCT03517371|593286322|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
164251532|NCT03517371|593286321|FG000|Overall Study|COVID restrictions|2|||
164251533|NCT03517371|593286322|FG001|Overall Study|COVID restrictions|0|||
164251534|NCT03517371|593286321|FG000|Overall Study|Receiving DBS Surgery|0|||
164251535|NCT03517371|593286322|FG001|Overall Study|Receiving DBS Surgery|1|||
164251536|NCT05411822|593286323|FG000|Overall Study|Withdrawal by Subject|2|||
164251537|NCT05411822|593286324|FG001|Overall Study|Withdrawal by Subject|1|||
164251538|NCT01345929|593286325|FG000|Overall Study|Withdrawal by Subject|9|||
164251539|NCT01345929|593286326|FG001|Overall Study|Withdrawal by Subject|8|||
164251540|NCT01345929|593286325|FG000|Overall Study|Lost to Follow-up|9|||
164251541|NCT01345929|593286326|FG001|Overall Study|Lost to Follow-up|9|||
164251542|NCT01345929|593286325|FG000|Overall Study|Adverse Event|0|||
164251543|NCT01345929|593286326|FG001|Overall Study|Adverse Event|1|||
164251544|NCT01345929|593286325|FG000|Overall Study|Didn't meet eligibility criteria|2|||
164251545|NCT01345929|593286326|FG001|Overall Study|Didn't meet eligibility criteria|0|||
164251546|NCT01345929|593286325|FG000|Overall Study|40,000 CFU/ML|1|||
164251547|NCT01345929|593286326|FG001|Overall Study|40,000 CFU/ML|0|||
164251548|NCT01345929|593286325|FG000|Overall Study|Patient withdrawal|0|||
164251549|NCT01345929|593286326|FG001|Overall Study|Patient withdrawal|1|||
164251550|NCT02819297|593286327|FG000|Overall Study|Withdrawal by Subject|25|||
164251551|NCT02819297|593286328|FG001|Overall Study|Withdrawal by Subject|13|||
164251552|NCT02819297|593286327|FG000|Overall Study|Lost to Follow-up|12|||
164251553|NCT02819297|593286328|FG001|Overall Study|Lost to Follow-up|14|||
164251554|NCT02819297|593286327|FG000|Overall Study|Adverse Event|12|||
164251555|NCT02819297|593286328|FG001|Overall Study|Adverse Event|10|||
164251556|NCT02819297|593286327|FG000|Overall Study|Physician Decision|5|||
164251557|NCT02819297|593286328|FG001|Overall Study|Physician Decision|5|||
164251558|NCT02819297|593286327|FG000|Overall Study|Lack of Efficacy|5|||
164251559|NCT02819297|593286328|FG001|Overall Study|Lack of Efficacy|8|||
164251560|NCT02819297|593286327|FG000|Overall Study|Protocol Violation|1|||
164251561|NCT02819297|593286328|FG001|Overall Study|Protocol Violation|2|||
164251562|NCT01670279|593286329|FG000|Overall Study|Adverse Event|0|||
164251563|NCT01670279|593286330|FG001|Overall Study|Adverse Event|1|||
164251564|NCT01670279|593286331|FG002|Overall Study|Adverse Event|0|||
164251565|NCT01670279|593286332|FG003|Overall Study|Adverse Event|0|||
164251566|NCT01670279|593286329|FG000|Overall Study|Physician Decision|0|||
164251567|NCT01670279|593286330|FG001|Overall Study|Physician Decision|1|||
164251568|NCT01670279|593286331|FG002|Overall Study|Physician Decision|0|||
164251569|NCT01670279|593286332|FG003|Overall Study|Physician Decision|0|||
164251570|NCT01670279|593286329|FG000|Overall Study|Participant met withdrawal criteria|0|||
164251571|NCT01670279|593286330|FG001|Overall Study|Participant met withdrawal criteria|0|||
164251572|NCT01670279|593286331|FG002|Overall Study|Participant met withdrawal criteria|0|||
164251573|NCT01670279|593286332|FG003|Overall Study|Participant met withdrawal criteria|1|||
164251574|NCT02318368|593286333|FG000|Overall Study|Withdrawal by Subject|2|||
164251575|NCT02318368|593286334|FG001|Overall Study|Withdrawal by Subject|0|||
164251576|NCT02318368|593286333|FG000|Overall Study|Study terminated by the sponsor|5|||
164251577|NCT02318368|593286334|FG001|Overall Study|Study terminated by the sponsor|2|||
164251578|NCT02318368|593286333|FG000|Overall Study|Death|0|||
164251579|NCT02318368|593286334|FG001|Overall Study|Death|1|||
164338831|NCT02323113|593617048|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
164338832|NCT02323113|593617049|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338833|NCT02323113|593617050|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338834|NCT02323113|593617051|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338835|NCT02323113|593617052|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
164338836|NCT02323113|593617053|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338837|NCT02323113|593617054|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
164338838|NCT02323113|593617047|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338839|NCT02323113|593617048|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
164338840|NCT02323113|593617049|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338841|NCT02323113|593617050|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164251580|NCT01901614|593286335|FG000|Overall Study|Adverse Event|0|||
164251581|NCT01901614|593286336|FG001|Overall Study|Adverse Event|1|||
164251582|NCT01901614|593286335|FG000|Overall Study|Lost to Follow-up|1|||
164251583|NCT01901614|593286336|FG001|Overall Study|Lost to Follow-up|0|||
164251584|NCT01901614|593286335|FG000|Overall Study|Screen Fail|1|||
164251585|NCT01901614|593286336|FG001|Overall Study|Screen Fail|0|||
164251586|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251587|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251588|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251589|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
164251590|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
164251591|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
163887141|NCT04963270|591959337|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
163887142|NCT04963270|591959338|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164084200|NCT00782509|592672297|FG002|Overall Study|Non compliance with protocol|0|||
164084201|NCT00782509|592672295|FG000|Overall Study|Other reasons not stated above|5|||
164084202|NCT00782509|592672296|FG001|Overall Study|Other reasons not stated above|2|||
164084203|NCT00782509|592672297|FG002|Overall Study|Other reasons not stated above|3|||
164084204|NCT00782509|592672295|FG000|Overall Study|Lack of Efficacy|10|||
164084205|NCT00782509|592672296|FG001|Overall Study|Lack of Efficacy|5|||
164084206|NCT00782509|592672297|FG002|Overall Study|Lack of Efficacy|2|||
164084207|NCT01401478|592672308|FG000|Overall Study|Study drug not available|6|||
164084208|NCT01401478|592672308|FG000|Overall Study|Adverse Event|5|||
164084209|NCT01401478|592672308|FG000|Overall Study|Hyperphosphatemia|5|||
164084210|NCT01401478|592672308|FG000|Overall Study|Lost to Follow-up|5|||
164084211|NCT01401478|592672308|FG000|Overall Study|Kidney transplantation|3|||
164084212|NCT01401478|592672308|FG000|Overall Study|Withdrawal by Subject|3|||
164084213|NCT01401478|592672308|FG000|Overall Study|Blood samples not available|1|||
164084214|NCT01401478|592672308|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
164084215|NCT01401478|592672308|FG000|Overall Study|Low intact parathyroid hormone|1|||
164084216|NCT01401478|592672308|FG000|Overall Study|Serious adverse event|1|||
164084217|NCT01814137|592672310|FG000|Overall Study|Adverse Event|0|||
164084218|NCT01814137|592672311|FG001|Overall Study|Adverse Event|1|||
164084219|NCT01814137|592672310|FG000|Overall Study|Withdrawal by Subject|2|||
164084220|NCT01814137|592672311|FG001|Overall Study|Withdrawal by Subject|2|||
164084221|NCT01814137|592672310|FG000|Overall Study|Physician Decision|1|||
164084222|NCT01814137|592672311|FG001|Overall Study|Physician Decision|1|||
164084223|NCT01814137|592672310|FG000|Overall Study|Unclassified|2|||
164084224|NCT01814137|592672311|FG001|Overall Study|Unclassified|1|||
164084225|NCT02536378|592672316|FG000|Overall Study|Physician Decision|0|||
164084226|NCT02536378|592672317|FG001|Overall Study|Physician Decision|2|||
164084227|NCT02536378|592672316|FG000|Overall Study|Withdrawal by Subject|0|||
164084228|NCT02536378|592672317|FG001|Overall Study|Withdrawal by Subject|1|||
164084229|NCT02536378|592672316|FG000|Overall Study|Death|1|||
164084230|NCT02536378|592672317|FG001|Overall Study|Death|2|||
164084231|NCT02536378|592672316|FG000|Overall Study|Patient refused further follow up|6|||
164084232|NCT02536378|592672317|FG001|Overall Study|Patient refused further follow up|2|||
164084233|NCT02418910|592672318|FG000|Overall Study|Lost to Follow-up|3|||
164084234|NCT02418910|592672318|FG000|Overall Study|Withdrawal by Subject|4|||
164084235|NCT02472977|592672319|FG000|Overall Study|Disease progression|4|||
164084236|NCT02472977|592672320|FG001|Overall Study|Disease progression|25|||
164084237|NCT02472977|592672321|FG002|Overall Study|Disease progression|6|||
164084238|NCT02472977|592672319|FG000|Overall Study|Withdrawal by Subject|0|||
164084239|NCT02472977|592672320|FG001|Overall Study|Withdrawal by Subject|1|||
164084240|NCT02472977|592672321|FG002|Overall Study|Withdrawal by Subject|0|||
164084241|NCT02472977|592672319|FG000|Overall Study|Study drug toxicity|2|||
164084242|NCT02472977|592672320|FG001|Overall Study|Study drug toxicity|0|||
164084243|NCT02472977|592672321|FG002|Overall Study|Study drug toxicity|2|||
164084244|NCT02472977|592672319|FG000|Overall Study|Subject request to discontinue treatment|0|||
164084245|NCT02472977|592672320|FG001|Overall Study|Subject request to discontinue treatment|1|||
164084246|NCT02472977|592672321|FG002|Overall Study|Subject request to discontinue treatment|0|||
164084247|NCT01829295|592672322|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
164084248|NCT01829295|592672323|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
164084249|NCT01829295|592672324|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
164084250|NCT01829295|592672325|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
164084251|NCT01829295|592672322|FG000|6-12 Months|Adverse Event|0|||
164084252|NCT01829295|592672323|FG001|6-12 Months|Adverse Event|0|||
164084253|NCT01829295|592672324|FG002|6-12 Months|Adverse Event|3|||
164084254|NCT01829295|592672325|FG003|6-12 Months|Adverse Event|2|||
164084255|NCT01829295|592672322|FG000|6-12 Months|Lost to Follow-up|2|||
164084256|NCT01829295|592672323|FG001|6-12 Months|Lost to Follow-up|0|||
164084257|NCT01829295|592672324|FG002|6-12 Months|Lost to Follow-up|0|||
164084258|NCT01829295|592672325|FG003|6-12 Months|Lost to Follow-up|0|||
164084259|NCT01829295|592672322|FG000|6-12 Months|Withdrawal by Subject|2|||
163887143|NCT04963270|591959335|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
164084260|NCT01829295|592672323|FG001|6-12 Months|Withdrawal by Subject|2|||
164084261|NCT01829295|592672324|FG002|6-12 Months|Withdrawal by Subject|0|||
164084262|NCT01829295|592672325|FG003|6-12 Months|Withdrawal by Subject|0|||
164084263|NCT02629965|592672328|FG000|Period 1|Adverse Event|1|||
164084264|NCT02629965|592672329|FG001|Period 1|Adverse Event|0|||
164084265|NCT02629965|592672328|FG000|Period 1|Unexpected worsening of disease|2|||
164084266|NCT02629965|592672329|FG001|Period 1|Unexpected worsening of disease|0|||
164084267|NCT02629965|592672328|FG000|Period 1|Other than listed above|1|||
164338842|NCT02323113|593617051|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338843|NCT02323113|593617052|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338844|NCT02323113|593617053|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338845|NCT02323113|593617054|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
164338846|NCT02280304|593617059|FG000|Overall Study|Lost to Follow-up|7|||
164338847|NCT02280304|593617060|FG001|Overall Study|Lost to Follow-up|8|||
164338848|NCT04805541|593617061|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
164338849|NCT00713323|593617072|FG000|Overall Study|Adverse Event|75|||
164338850|NCT00713323|593617072|FG000|Overall Study|Withdrawal by Subject|15|||
164338851|NCT00713323|593617072|FG000|Overall Study|Lost to Follow-up|11|||
164338852|NCT00713323|593617072|FG000|Overall Study|Lack of Efficacy|36|||
164338853|NCT00713323|593617072|FG000|Overall Study|Low creatine clearance at screening|1|||
164338854|NCT00713323|593617072|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
164338855|NCT00713323|593617072|FG000|Overall Study|Surgery cured allodynic pain|1|||
164338856|NCT00713323|593617072|FG000|Overall Study|Pain free|1|||
164338857|NCT00713323|593617072|FG000|Overall Study|Non-compliance|1|||
164338858|NCT00713323|593617072|FG000|Overall Study|Pain resolved|1|||
164338859|NCT00713323|593617072|FG000|Overall Study|Subject travelling to USA|1|||
164338860|NCT00713323|593617072|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
164338861|NCT00713323|593617072|FG000|Overall Study|Treatment that may interact with Sativex|1|||
163887144|NCT04963270|591959336|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
163887145|NCT04963270|591959337|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
163887146|NCT04963270|591959338|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
163887147|NCT04963270|591959335|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
163887148|NCT04963270|591959336|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
163887149|NCT04963270|591959337|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
163887150|NCT04963270|591959338|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
163887151|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
163887152|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
163887153|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
163887154|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
163887155|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
163887156|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
163887157|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
163887158|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
163887159|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
163887160|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
163887161|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
163887162|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
163887163|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
163887164|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
163887165|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
163887166|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
163887167|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
163887168|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
163887169|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
163887170|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
163887171|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
163887172|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
163887173|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
163887174|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
163887175|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
163887176|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
163887177|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
163887178|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
163887179|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
164251592|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251593|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251594|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251595|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
164084268|NCT02629965|592672329|FG001|Period 1|Other than listed above|2|||
163887180|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
163887181|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
163887182|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
163887183|NCT04963270|591959335|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
163887184|NCT04963270|591959336|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
163887185|NCT04963270|591959337|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
163887186|NCT04963270|591959338|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
163887187|NCT05540665|591959339|FG000|Overall Study|Study terminated by sponsor|6|||
163887188|NCT05540665|591959340|FG001|Overall Study|Study terminated by sponsor|6|||
163887189|NCT05540665|591959341|FG002|Overall Study|Study terminated by sponsor|7|||
163887190|NCT03462030|591959342|FG000|Overall Study|Withdrawal by Subject|1|||
163887191|NCT03462030|591959343|FG001|Overall Study|Withdrawal by Subject|1|||
163887192|NCT03381196|591959344|FG000|Overall Study|Withdrawal by Subject|7|||
163887193|NCT03381196|591959345|FG001|Overall Study|Withdrawal by Subject|7|||
163887194|NCT03381196|591959344|FG000|Overall Study|Other|0|||
163887195|NCT03381196|591959345|FG001|Overall Study|Other|1|||
164084269|NCT02629965|592672328|FG000|Period 2|Adverse Event|1|||
164084270|NCT02629965|592672329|FG001|Period 2|Adverse Event|0|||
164084271|NCT03387059|592672333|FG000|Overall Study|Study termination|5|||
164084272|NCT03387059|592672334|FG001|Overall Study|Study termination|4|||
164084273|NCT01606137|592672335|FG000|Overall Study|Adverse Event|85|||
164084274|NCT01606137|592672335|FG000|Overall Study|Withdrawal by Subject|74|||
164084275|NCT01606137|592672335|FG000|Overall Study|Lack of Efficacy|56|||
164084276|NCT01606137|592672335|FG000|Overall Study|Lost to Follow-up|15|||
164084277|NCT01606137|592672335|FG000|Overall Study|Protocol Violation|1|||
164084278|NCT01606137|592672335|FG000|Overall Study|Patient non-compliance|9|||
164084279|NCT01606137|592672335|FG000|Overall Study|Death|1|||
164084280|NCT01606137|592672335|FG000|Overall Study|Decreased/no pain|4|||
164084281|NCT01606137|592672335|FG000|Overall Study|Issues with driving|4|||
164084282|NCT01606137|592672335|FG000|Overall Study|multiple sclerosis less stable|1|||
164084283|NCT01606137|592672335|FG000|Overall Study|Increased bilirubin|1|||
164084284|NCT01606137|592672335|FG000|Overall Study|Spray causes nausea|1|||
164084285|NCT01606137|592672335|FG000|Overall Study|Not enough improvement|4|||
164084286|NCT01606137|592672335|FG000|Overall Study|Wanted to try another treatment|1|||
164084287|NCT01606137|592672335|FG000|Overall Study|Patient leaving country|1|||
164084288|NCT01606137|592672335|FG000|Overall Study|Personal reasons|1|||
164084289|NCT01606137|592672335|FG000|Overall Study|Unable to tolerate study med. taste|1|||
164084290|NCT01606137|592672335|FG000|Overall Study|Patient moving|1|||
164084291|NCT01606137|592672335|FG000|Overall Study|Unable to collect consistent data|1|||
164084292|NCT03586830|592672346|FG000|Overall Study|Site terminated by Sponsor|1|||
164084293|NCT03586830|592672347|FG001|Overall Study|Site terminated by Sponsor|4|||
164084294|NCT03586830|592672348|FG002|Overall Study|Site terminated by Sponsor|3|||
164084295|NCT03586830|592672349|FG003|Overall Study|Site terminated by Sponsor|3|||
164084296|NCT03586830|592672346|FG000|Overall Study|Lost to Follow-up|0|||
164084297|NCT03586830|592672347|FG001|Overall Study|Lost to Follow-up|2|||
164084298|NCT03586830|592672348|FG002|Overall Study|Lost to Follow-up|2|||
164084299|NCT03586830|592672349|FG003|Overall Study|Lost to Follow-up|1|||
164251596|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251597|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
164251598|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251599|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
164251600|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251601|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251602|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251603|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
164251604|NCT03629223|593286337|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251605|NCT03629223|593286338|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
164251606|NCT03629223|593286339|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251607|NCT03629223|593286340|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251608|NCT03629223|593286341|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251609|NCT03629223|593286342|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
164251610|NCT03629223|593286337|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
164251611|NCT03629223|593286338|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251612|NCT03629223|593286339|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251613|NCT03629223|593286340|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251614|NCT03629223|593286341|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251615|NCT03629223|593286342|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
164251616|NCT02702609|593286343|FG000|Overall Study|Lost to Follow-up|8|||
164251617|NCT02702609|593286344|FG001|Overall Study|Lost to Follow-up|4|||
164251618|NCT02702609|593286343|FG000|Overall Study|Physician Decision|1|||
164251619|NCT02702609|593286344|FG001|Overall Study|Physician Decision|0|||
164251620|NCT02674464|593286345|FG000|Overall Study|Death|10|||
164251621|NCT02674464|593286346|FG001|Overall Study|Death|21|||
164251622|NCT02674464|593286345|FG000|Overall Study|Withdrawal by Subject|24|||
164251623|NCT02674464|593286346|FG001|Overall Study|Withdrawal by Subject|44|||
164251624|NCT02674464|593286345|FG000|Overall Study|Lost to Follow-up|97|||
164084300|NCT03586830|592672346|FG000|Overall Study|Withdrawal by Subject|1|||
164084301|NCT03586830|592672347|FG001|Overall Study|Withdrawal by Subject|0|||
164251625|NCT02674464|593286346|FG001|Overall Study|Lost to Follow-up|92|||
164251626|NCT02674464|593286345|FG000|Overall Study|Outside survey window|6|||
164251627|NCT02674464|593286346|FG001|Overall Study|Outside survey window|3|||
164084302|NCT03586830|592672348|FG002|Overall Study|Withdrawal by Subject|3|||
164084303|NCT03586830|592672349|FG003|Overall Study|Withdrawal by Subject|1|||
164084304|NCT00395083|592672350|FG000|Overall Study|Withdrawal by Subject|6|||
164084305|NCT00395083|592672351|FG001|Overall Study|Withdrawal by Subject|5|||
164084306|NCT00395083|592672350|FG000|Overall Study|Developed another disease|4|||
164084307|NCT00395083|592672351|FG001|Overall Study|Developed another disease|3|||
164084308|NCT00628745|592672352|FG000|Overall Study|Withdrawal by Subject|63|||
164084309|NCT00628745|592672353|FG001|Overall Study|Withdrawal by Subject|3|||
164084310|NCT00628745|592672354|FG002|Overall Study|Withdrawal by Subject|9|||
164251628|NCT04153981|593286347|FG000|Overall Study|Death|1|||
164251629|NCT04153981|593286347|FG000|Overall Study|Withdrawal by Subject|24|||
164251630|NCT04153981|593286347|FG000|Overall Study|Lost to Follow-up|1|||
164251631|NCT04153981|593286347|FG000|Overall Study|Physician Decision|1|||
164251632|NCT04153981|593286347|FG000|Overall Study|Due to Unavailable Glucometer|1|||
164251633|NCT04153981|593286347|FG000|Overall Study|Covid 19|52|||
164251634|NCT04153981|593286347|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
164251635|NCT04153981|593286347|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
164251636|NCT01555073|593286348|FG000|Overall Study|Lost to Follow-up|1|||
164251637|NCT01555073|593286349|FG001|Overall Study|Lost to Follow-up|2|||
164251638|NCT01555073|593286350|FG002|Overall Study|Lost to Follow-up|0|||
164251639|NCT01555073|593286351|FG003|Overall Study|Lost to Follow-up|5|||
164251640|NCT01262638|593286352|FG000|Overall Study|Adverse Event|3|||
164251641|NCT01262638|593286353|FG001|Overall Study|Adverse Event|4|||
164251642|NCT01262638|593286354|FG002|Overall Study|Adverse Event|3|||
164251643|NCT01262638|593286355|FG003|Overall Study|Adverse Event|4|||
164251644|NCT01262638|593286352|FG000|Overall Study|Protocol Violation|1|||
164251645|NCT01262638|593286353|FG001|Overall Study|Protocol Violation|0|||
164251646|NCT01262638|593286354|FG002|Overall Study|Protocol Violation|0|||
164251647|NCT01262638|593286355|FG003|Overall Study|Protocol Violation|1|||
164251648|NCT01262638|593286352|FG000|Overall Study|Withdrawal by Subject|2|||
164251649|NCT01262638|593286353|FG001|Overall Study|Withdrawal by Subject|1|||
164251650|NCT01262638|593286354|FG002|Overall Study|Withdrawal by Subject|0|||
164251651|NCT01262638|593286355|FG003|Overall Study|Withdrawal by Subject|1|||
164251652|NCT01262638|593286352|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164251653|NCT01262638|593286353|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164251654|NCT01262638|593286354|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
164251655|NCT01262638|593286355|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164251656|NCT01262638|593286352|FG000|Overall Study|Lost to Follow-up|1|||
164251657|NCT01262638|593286353|FG001|Overall Study|Lost to Follow-up|1|||
164251658|NCT01262638|593286354|FG002|Overall Study|Lost to Follow-up|1|||
164251659|NCT01262638|593286355|FG003|Overall Study|Lost to Follow-up|1|||
164251660|NCT01262638|593286352|FG000|Overall Study|Participant Went Out of Town|0|||
164251661|NCT01262638|593286353|FG001|Overall Study|Participant Went Out of Town|0|||
164251662|NCT01262638|593286354|FG002|Overall Study|Participant Went Out of Town|1|||
164251663|NCT01262638|593286355|FG003|Overall Study|Participant Went Out of Town|0|||
164251664|NCT01071252|593286356|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
164251665|NCT01071252|593286357|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
164251666|NCT01071252|593286358|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
164251667|NCT01071252|593286359|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
164251668|NCT01071252|593286360|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
164251669|NCT01071252|593286356|FG000|Overall Study|Withdrawal by Subject|8|||
164251670|NCT01071252|593286357|FG001|Overall Study|Withdrawal by Subject|2|||
164251671|NCT01071252|593286358|FG002|Overall Study|Withdrawal by Subject|1|||
164251672|NCT01071252|593286359|FG003|Overall Study|Withdrawal by Subject|2|||
164251673|NCT01071252|593286360|FG004|Overall Study|Withdrawal by Subject|3|||
164251674|NCT01071252|593286356|FG000|Overall Study|administrative problems|1|||
164251675|NCT01071252|593286357|FG001|Overall Study|administrative problems|1|||
164251676|NCT01071252|593286358|FG002|Overall Study|administrative problems|0|||
164251677|NCT01071252|593286359|FG003|Overall Study|administrative problems|2|||
163887196|NCT03381196|591959344|FG000|Overall Study|Lost to Follow-up|5|||
164251678|NCT01071252|593286360|FG004|Overall Study|administrative problems|1|||
164251679|NCT01071252|593286356|FG000|Overall Study|Lost to Follow-up|1|||
164251680|NCT01071252|593286357|FG001|Overall Study|Lost to Follow-up|0|||
163887197|NCT03381196|591959345|FG001|Overall Study|Lost to Follow-up|4|||
163887198|NCT03381196|591959344|FG000|Overall Study|Death|0|||
163887199|NCT03381196|591959345|FG001|Overall Study|Death|1|||
163991836|NCT03617705|592339609|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
163991837|NCT03617705|592339609|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
163991838|NCT03502187|592339610|FG000|Overall Study|Withdrawal by Subject|4|||
163991839|NCT03502187|592339611|FG001|Overall Study|Withdrawal by Subject|3|||
163991840|NCT03502187|592339612|FG002|Overall Study|Withdrawal by Subject|3|||
163991841|NCT03502187|592339610|FG000|Overall Study|Lost to Follow-up|5|||
163991842|NCT03502187|592339611|FG001|Overall Study|Lost to Follow-up|4|||
163991843|NCT03502187|592339612|FG002|Overall Study|Lost to Follow-up|5|||
163991844|NCT00214461|592339613|FG000|Overall Study|Adverse Event|0|||
163991845|NCT00214461|592339614|FG001|Overall Study|Adverse Event|0|||
163991846|NCT00214461|592339615|FG002|Overall Study|Adverse Event|1|||
164251681|NCT01071252|593286358|FG002|Overall Study|Lost to Follow-up|1|||
164251682|NCT01071252|593286359|FG003|Overall Study|Lost to Follow-up|2|||
164251683|NCT01071252|593286360|FG004|Overall Study|Lost to Follow-up|0|||
164251684|NCT01071252|593286356|FG000|Overall Study|Adverse Event|1|||
164251685|NCT01071252|593286357|FG001|Overall Study|Adverse Event|1|||
164251686|NCT01071252|593286358|FG002|Overall Study|Adverse Event|0|||
164251687|NCT01071252|593286359|FG003|Overall Study|Adverse Event|1|||
164251688|NCT01071252|593286360|FG004|Overall Study|Adverse Event|0|||
164251689|NCT01071252|593286356|FG000|Overall Study|Death|0|||
164251690|NCT01071252|593286357|FG001|Overall Study|Death|0|||
164251691|NCT01071252|593286358|FG002|Overall Study|Death|0|||
164251692|NCT01071252|593286359|FG003|Overall Study|Death|0|||
164251693|NCT01071252|593286360|FG004|Overall Study|Death|1|||
163991847|NCT00214461|592339616|FG003|Overall Study|Adverse Event|1|||
164251694|NCT01066104|593286361|FG000|Overall Study|Adverse Event|1|||
164251695|NCT01066104|593286362|FG001|Overall Study|Adverse Event|1|||
164251696|NCT01066104|593286361|FG000|Overall Study|Protocol Violation|1|||
164251697|NCT01066104|593286362|FG001|Overall Study|Protocol Violation|0|||
164251698|NCT03902392|593286365|FG000|Overall Study|Lost to Follow-up|7|||
164251699|NCT03902392|593286366|FG001|Overall Study|Lost to Follow-up|7|||
164251700|NCT00260832|593286367|FG000|Overall Study|Adverse Event|26|||
164251701|NCT00260832|593286368|FG001|Overall Study|Adverse Event|19|||
164251702|NCT00260832|593286367|FG000|Overall Study|Progression|116|||
164251703|NCT00260832|593286368|FG001|Overall Study|Progression|96|||
164251704|NCT00260832|593286367|FG000|Overall Study|Withdrawal by Subject|15|||
164251705|NCT00260832|593286368|FG001|Overall Study|Withdrawal by Subject|17|||
164251706|NCT00260832|593286367|FG000|Overall Study|Physician Decision|15|||
164251707|NCT00260832|593286368|FG001|Overall Study|Physician Decision|9|||
164251708|NCT00260832|593286367|FG000|Overall Study|Death|43|||
164251709|NCT00260832|593286368|FG001|Overall Study|Death|62|||
164251710|NCT00260832|593286367|FG000|Overall Study|Other|10|||
164251711|NCT00260832|593286368|FG001|Overall Study|Other|7|||
164251712|NCT00260832|593286367|FG000|Overall Study|Protocol Violation|3|||
164251713|NCT00260832|593286368|FG001|Overall Study|Protocol Violation|1|||
164251714|NCT01104545|593286369|FG000|Overall Study|Adverse Event|0|||
164251715|NCT01104545|593286370|FG001|Overall Study|Adverse Event|1|||
164251716|NCT01104545|593286371|FG002|Overall Study|Adverse Event|2|||
164251717|NCT00564902|593286373|FG000|Overall Study|Withdrawal by Subject|0|||
164251718|NCT00564902|593286374|FG001|Overall Study|Withdrawal by Subject|3|||
164251719|NCT00564902|593286375|FG002|Overall Study|Withdrawal by Subject|4|||
164251720|NCT00564902|593286373|FG000|Overall Study|Death|1|||
164251721|NCT00564902|593286374|FG001|Overall Study|Death|1|||
164251722|NCT00564902|593286375|FG002|Overall Study|Death|0|||
164251723|NCT00958347|593286376|FG000|Overall Study|Death|43|||
164251724|NCT00958347|593286376|FG000|Overall Study|Withdrawal by Subject|23|||
164251725|NCT00958347|593286376|FG000|Overall Study|Lost to Follow-up|15|||
164251726|NCT00958347|593286376|FG000|Overall Study|revision/removal|10|||
164251727|NCT00958347|593286376|FG000|Overall Study|study termination|135|||
164338862|NCT04015336|593617073|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
164338863|NCT00246753|593617074|FG000|Overall Study|Withdrawal by Subject|2|||
164338864|NCT00246753|593617074|FG000|Overall Study|Physician Decision|2|||
163991848|NCT00214461|592339613|FG000|Overall Study|Withdrawal by Subject|0|||
163991849|NCT00214461|592339614|FG001|Overall Study|Withdrawal by Subject|0|||
164084311|NCT00628745|592672355|FG003|Overall Study|Withdrawal by Subject|2|||
164251728|NCT04552288|593286379|FG000|Overall Study|Death|3|||
163991850|NCT00214461|592339615|FG002|Overall Study|Withdrawal by Subject|1|||
164251729|NCT04552288|593286379|FG000|Overall Study|Lost to Follow-up|6|||
164251730|NCT04552288|593286379|FG000|Overall Study|Physician Decision|3|||
163991851|NCT00214461|592339616|FG003|Overall Study|Withdrawal by Subject|0|||
163991852|NCT06118385|592339617|FG000|Overall Study|Protocol Violation|0|||
164251731|NCT04552288|593286379|FG000|Overall Study|Protocol Violation|9|||
164251732|NCT04552288|593286379|FG000|Overall Study|Withdrawal by Subject|6|||
164251733|NCT04552288|593286379|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
164251734|NCT04532294|593286380|FG000|Overall Study|Withdrawal by Subject|0|||
164251735|NCT04532294|593286381|FG001|Overall Study|Withdrawal by Subject|0|||
164251736|NCT04532294|593286382|FG002|Overall Study|Withdrawal by Subject|1|||
164251737|NCT04532294|593286380|FG000|Overall Study|Participants Not Dosed|0|||
164251738|NCT04532294|593286381|FG001|Overall Study|Participants Not Dosed|0|||
164251739|NCT04532294|593286382|FG002|Overall Study|Participants Not Dosed|2|||
164251740|NCT03089047|593286383|FG000|Overall Study|Lost to Follow-up|1|||
164251741|NCT03089047|593286384|FG001|Overall Study|Lost to Follow-up|0|||
164251742|NCT00375505|593286385|FG000|Overall Study|Adverse Event|1|||
164251743|NCT00375505|593286386|FG001|Overall Study|Adverse Event|2|||
164251744|NCT02146131|593286387|FG000|Overall Study|Physician Decision|61|||
164251745|NCT02146131|593286388|FG001|Overall Study|Physician Decision|56|||
164251746|NCT02097719|593286389|FG000|Overall Study|Subject Withdrew Consent|1|||
164251747|NCT02097719|593286390|FG001|Overall Study|Subject Withdrew Consent|0|||
164251748|NCT02097719|593286389|FG000|Overall Study|Lost to Follow-up|0|||
164251749|NCT02097719|593286390|FG001|Overall Study|Lost to Follow-up|1|||
164251750|NCT02097719|593286389|FG000|Overall Study|Adverse Event|2|||
164251751|NCT02097719|593286390|FG001|Overall Study|Adverse Event|0|||
164251752|NCT00809926|593286392|FG000|Overall Study|Adverse Event|18|||
164251753|NCT00809926|593286393|FG001|Overall Study|Adverse Event|10|||
164251754|NCT00809926|593286392|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164251755|NCT00809926|593286393|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164251756|NCT00809926|593286392|FG000|Overall Study|Patient withdrew consent|8|||
164251757|NCT00809926|593286393|FG001|Overall Study|Patient withdrew consent|6|||
164251758|NCT00809926|593286392|FG000|Overall Study|Lost to Follow-up|2|||
164251759|NCT00809926|593286393|FG001|Overall Study|Lost to Follow-up|1|||
164251760|NCT00809926|593286392|FG000|Overall Study|Administrative Problems|0|||
164251761|NCT00809926|593286393|FG001|Overall Study|Administrative Problems|1|||
164251762|NCT00809926|593286392|FG000|Overall Study|Protocol deviation|0|||
164251763|NCT00809926|593286393|FG001|Overall Study|Protocol deviation|2|||
164251764|NCT01108731|593286400|FG000|Overall Study|Withdrawal by Subject|1|||
164251765|NCT01108731|593286401|FG001|Overall Study|Withdrawal by Subject|1|||
164251766|NCT01108731|593286400|FG000|Overall Study|Adverse Event|3|||
164251767|NCT01108731|593286401|FG001|Overall Study|Adverse Event|3|||
164251768|NCT01451749|593286407|FG000|Overall Study|Protocol Violation|14|||
164251769|NCT01451749|593286408|FG001|Overall Study|Protocol Violation|7|||
164251770|NCT01451749|593286407|FG000|Overall Study|Lost to Follow-up|15|||
164251771|NCT01451749|593286408|FG001|Overall Study|Lost to Follow-up|5|||
164251772|NCT01451749|593286407|FG000|Overall Study|Meet the exclusion criteria,and|1|||
164251773|NCT01451749|593286408|FG001|Overall Study|Meet the exclusion criteria,and|1|||
164251774|NCT01451749|593286407|FG000|Overall Study|Adverse Event|2|||
164251775|NCT01451749|593286408|FG001|Overall Study|Adverse Event|0|||
164251776|NCT01451749|593286407|FG000|Overall Study|Withdrawal by Subject|0|||
164251777|NCT01451749|593286408|FG001|Overall Study|Withdrawal by Subject|1|||
164251778|NCT01063062|593286409|FG000|Overall Study|Patient withdrew consent|0|||
164251779|NCT01063062|593286410|FG001|Overall Study|Patient withdrew consent|1|||
164251780|NCT01063062|593286409|FG000|Overall Study|Adverse Event|2|||
164251781|NCT01063062|593286410|FG001|Overall Study|Adverse Event|4|||
164251782|NCT01063062|593286409|FG000|Overall Study|Protocol Violation|5|||
164251783|NCT01063062|593286410|FG001|Overall Study|Protocol Violation|4|||
164338865|NCT00246753|593617074|FG000|Overall Study|Adverse Event|2|||
164338866|NCT00246753|593617074|FG000|Overall Study|Unacceptable toxicity|2|||
163991853|NCT06118385|592339618|FG001|Overall Study|Protocol Violation|0|||
163991854|NCT06118385|592339619|FG002|Overall Study|Protocol Violation|0|||
163991855|NCT06118385|592339620|FG003|Overall Study|Protocol Violation|0|||
163991856|NCT06118385|592339621|FG004|Overall Study|Protocol Violation|0|||
163991857|NCT06118385|592339622|FG005|Overall Study|Protocol Violation|0|||
163991858|NCT06118385|592339623|FG006|Overall Study|Protocol Violation|0|||
164251784|NCT01063062|593286409|FG000|Overall Study|Investigator's request|1|||
164251785|NCT01063062|593286410|FG001|Overall Study|Investigator's request|0|||
164251786|NCT01063062|593286409|FG000|Overall Study|Lost to Follow-up|0|||
164251787|NCT01063062|593286410|FG001|Overall Study|Lost to Follow-up|2|||
164338867|NCT05154578|593617075|FG000|Overall Study|Withdrawal by Subject|2|||
164338868|NCT05154578|593617076|FG001|Overall Study|Withdrawal by Subject|3|||
164338869|NCT05154578|593617077|FG002|Overall Study|Withdrawal by Subject|2|||
164338870|NCT05154578|593617078|FG003|Overall Study|Withdrawal by Subject|4|||
164338871|NCT05154578|593617079|FG004|Overall Study|Withdrawal by Subject|0|||
164338872|NCT05154578|593617075|FG000|Overall Study|Lost to Follow-up|0|||
163991859|NCT06118385|592339624|FG007|Overall Study|Protocol Violation|0|||
163991860|NCT06118385|592339625|FG008|Overall Study|Protocol Violation|1|||
164251788|NCT01063062|593286409|FG000|Overall Study|Miscellaneous reason|0|||
164251789|NCT01063062|593286410|FG001|Overall Study|Miscellaneous reason|1|||
164251790|NCT02175277|593286411|FG000|Overall Study|Protocol-specified Criteria|1|||
164251791|NCT03818607|593288207|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
164251792|NCT03818607|593288208|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
164251793|NCT03818607|593288207|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
164251794|NCT03818607|593288208|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
164251795|NCT03818607|593288207|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
164251796|NCT03818607|593288208|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
164251797|NCT01147250|593288212|FG000|Overall Study|Lost to Follow-up|14|||
164251798|NCT01147250|593288213|FG001|Overall Study|Lost to Follow-up|11|||
164338873|NCT05154578|593617076|FG001|Overall Study|Lost to Follow-up|1|||
164084312|NCT00628745|592672356|FG004|Overall Study|Withdrawal by Subject|69|||
164084313|NCT00628745|592672352|FG000|Overall Study|Does not meet inclusion criteria|0|||
164084314|NCT00628745|592672353|FG001|Overall Study|Does not meet inclusion criteria|12|||
164084315|NCT00628745|592672354|FG002|Overall Study|Does not meet inclusion criteria|0|||
164084316|NCT00628745|592672355|FG003|Overall Study|Does not meet inclusion criteria|0|||
164084317|NCT00628745|592672356|FG004|Overall Study|Does not meet inclusion criteria|18|||
164084318|NCT00628745|592672352|FG000|Overall Study|Participation in an interventional clinical trial|81|||
164084319|NCT00628745|592672353|FG001|Overall Study|Participation in an interventional clinical trial|4|||
164338874|NCT05154578|593617077|FG002|Overall Study|Lost to Follow-up|0|||
164338875|NCT05154578|593617078|FG003|Overall Study|Lost to Follow-up|3|||
164338876|NCT05154578|593617079|FG004|Overall Study|Lost to Follow-up|0|||
164338877|NCT05154578|593617075|FG000|Overall Study|Adverse Event|0|||
164084320|NCT00628745|592672354|FG002|Overall Study|Participation in an interventional clinical trial|7|||
164084321|NCT00628745|592672355|FG003|Overall Study|Participation in an interventional clinical trial|0|||
164084322|NCT00628745|592672356|FG004|Overall Study|Participation in an interventional clinical trial|63|||
164084323|NCT00628745|592672352|FG000|Overall Study|Physician Decision|8|||
164084324|NCT00628745|592672353|FG001|Overall Study|Physician Decision|4|||
164084325|NCT00628745|592672354|FG002|Overall Study|Physician Decision|3|||
164084326|NCT00628745|592672355|FG003|Overall Study|Physician Decision|0|||
164084327|NCT00628745|592672356|FG004|Overall Study|Physician Decision|30|||
164084328|NCT00628745|592672352|FG000|Overall Study|Lost to Follow-up|109|||
164084329|NCT00628745|592672353|FG001|Overall Study|Lost to Follow-up|7|||
164084330|NCT00628745|592672354|FG002|Overall Study|Lost to Follow-up|7|||
164084331|NCT00628745|592672355|FG003|Overall Study|Lost to Follow-up|0|||
164084332|NCT00628745|592672356|FG004|Overall Study|Lost to Follow-up|498|||
164338878|NCT05154578|593617076|FG001|Overall Study|Adverse Event|0|||
164338879|NCT05154578|593617077|FG002|Overall Study|Adverse Event|0|||
164338880|NCT05154578|593617078|FG003|Overall Study|Adverse Event|1|||
164338881|NCT05154578|593617079|FG004|Overall Study|Adverse Event|0|||
164338882|NCT05154578|593617075|FG000|Overall Study|Relocated to another province|0|||
164338883|NCT05154578|593617076|FG001|Overall Study|Relocated to another province|0|||
164338884|NCT05154578|593617077|FG002|Overall Study|Relocated to another province|1|||
164338885|NCT05154578|593617078|FG003|Overall Study|Relocated to another province|0|||
164338886|NCT05154578|593617079|FG004|Overall Study|Relocated to another province|1|||
164338887|NCT05154578|593617075|FG000|Overall Study|Baby loss|0|||
164338888|NCT05154578|593617076|FG001|Overall Study|Baby loss|1|||
164338889|NCT05154578|593617077|FG002|Overall Study|Baby loss|0|||
164338890|NCT05154578|593617078|FG003|Overall Study|Baby loss|0|||
164338891|NCT05154578|593617079|FG004|Overall Study|Baby loss|0|||
164338892|NCT01419626|593617080|FG000|Overall Study|Protocol Violation|3|||
164338893|NCT01419626|593617081|FG001|Overall Study|Protocol Violation|2|||
164338894|NCT01419626|593617082|FG002|Overall Study|Protocol Violation|2|||
164338895|NCT01419626|593617080|FG000|Overall Study|Withdrawal by Subject|1|||
164338896|NCT01419626|593617081|FG001|Overall Study|Withdrawal by Subject|0|||
164338897|NCT01419626|593617082|FG002|Overall Study|Withdrawal by Subject|0|||
164338898|NCT01419626|593617080|FG000|Overall Study|Lost to Follow-up|0|||
164338899|NCT01419626|593617081|FG001|Overall Study|Lost to Follow-up|1|||
164338900|NCT01419626|593617082|FG002|Overall Study|Lost to Follow-up|1|||
164338901|NCT01146912|593617083|FG000|Overall Study|Already received influenza vaccination|817|||
164338902|NCT01146912|593617084|FG001|Overall Study|Already received influenza vaccination|822|||
164338903|NCT01146912|593617085|FG002|Overall Study|Already received influenza vaccination|13|||
164338904|NCT01146912|593617086|FG003|Overall Study|Already received influenza vaccination|15|||
164338905|NCT01146912|593617087|FG004|Overall Study|Already received influenza vaccination|41|||
164338906|NCT01146912|593617088|FG005|Overall Study|Already received influenza vaccination|61|||
164338907|NCT01146912|593617089|FG006|Overall Study|Already received influenza vaccination|56|||
164338908|NCT01146912|593617090|FG007|Overall Study|Already received influenza vaccination|0|||
164338909|NCT01146912|593617083|FG000|Overall Study|< 14 weeks gestational age|0|||
164338910|NCT01146912|593617084|FG001|Overall Study|< 14 weeks gestational age|0|||
164338911|NCT01146912|593617085|FG002|Overall Study|< 14 weeks gestational age|3|||
164338912|NCT01146912|593617086|FG003|Overall Study|< 14 weeks gestational age|2|||
164338913|NCT01146912|593617087|FG004|Overall Study|< 14 weeks gestational age|0|||
164338914|NCT01146912|593617088|FG005|Overall Study|< 14 weeks gestational age|0|||
164338915|NCT01146912|593617089|FG006|Overall Study|< 14 weeks gestational age|0|||
164338916|NCT01146912|593617090|FG007|Overall Study|< 14 weeks gestational age|0|||
164338917|NCT01146912|593617083|FG000|Overall Study|Duplicate patient|0|||
164338918|NCT01146912|593617084|FG001|Overall Study|Duplicate patient|0|||
164338919|NCT01146912|593617085|FG002|Overall Study|Duplicate patient|1|||
164084333|NCT00628745|592672352|FG000|Overall Study|Death|197|||
164084334|NCT00628745|592672353|FG001|Overall Study|Death|81|||
164084335|NCT00628745|592672354|FG002|Overall Study|Death|12|||
164338920|NCT01146912|593617086|FG003|Overall Study|Duplicate patient|0|||
164338921|NCT01146912|593617087|FG004|Overall Study|Duplicate patient|0|||
164338922|NCT01146912|593617088|FG005|Overall Study|Duplicate patient|0|||
164084336|NCT00628745|592672355|FG003|Overall Study|Death|4|||
164084337|NCT00628745|592672356|FG004|Overall Study|Death|939|||
164338923|NCT01146912|593617089|FG006|Overall Study|Duplicate patient|0|||
164251799|NCT01147250|593288212|FG000|Overall Study|Withdrawal by Subject|83|||
164251800|NCT01147250|593288213|FG001|Overall Study|Withdrawal by Subject|88|||
164251801|NCT01147250|593288212|FG000|Overall Study|Site termination by sponsor|13|||
164251802|NCT01147250|593288213|FG001|Overall Study|Site termination by sponsor|5|||
164251803|NCT01147250|593288212|FG000|Overall Study|Other than specified|0|||
164251804|NCT01147250|593288213|FG001|Overall Study|Other than specified|1|||
164251805|NCT02249091|593288215|FG000|Overall Study|Lack of Efficacy|8|||
164251806|NCT02249091|593288216|FG001|Overall Study|Lack of Efficacy|3|||
164251807|NCT02249091|593288215|FG000|Overall Study|Physician Decision|4|||
164251808|NCT02249091|593288216|FG001|Overall Study|Physician Decision|1|||
164251809|NCT02249091|593288215|FG000|Overall Study|Withdrawal by Subject|2|||
164251810|NCT02249091|593288216|FG001|Overall Study|Withdrawal by Subject|2|||
164251811|NCT02249091|593288215|FG000|Overall Study|Death|3|||
164251812|NCT02249091|593288216|FG001|Overall Study|Death|4|||
164251813|NCT02249091|593288215|FG000|Overall Study|Adverse Event|1|||
164251814|NCT02249091|593288216|FG001|Overall Study|Adverse Event|0|||
164251815|NCT02249091|593288215|FG000|Overall Study|Stable disease with following SCT|0|||
164251816|NCT02249091|593288216|FG001|Overall Study|Stable disease with following SCT|1|||
164251817|NCT02249091|593288215|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
164251818|NCT02249091|593288216|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
164251819|NCT02249091|593288215|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
164251820|NCT02249091|593288216|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
164251821|NCT02249091|593288215|FG000|Overall Study|Refractory AML|1|||
164251822|NCT02249091|593288216|FG001|Overall Study|Refractory AML|1|||
164251823|NCT00716482|593288220|FG000|Overall Study|Lost to Follow-up|6|||
164251824|NCT00716482|593288220|FG000|Overall Study|Inadequate acquisition or analysis|50|||
164251825|NCT00716482|593288220|FG000|Overall Study|no pathology obtained|10|||
164251826|NCT00716482|593288220|FG000|Overall Study|technical/machine error|28|||
164251827|NCT00716482|593288220|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
164251828|NCT00765037|593288221|FG000|Overall Study|Lost to Follow-up|5|||
164251829|NCT00765037|593288221|FG000|Overall Study|Adverse Event|1|||
164251830|NCT02125838|593288224|FG000|Overall Study|Lost to Follow-up|4|||
164251831|NCT02125838|593288225|FG001|Overall Study|Lost to Follow-up|4|||
164251832|NCT00244725|593288233|FG000|Overall Study|Lost to Follow-up|3|||
163991861|NCT06118385|592339626|FG009|Overall Study|Protocol Violation|0|||
163991862|NCT06118385|592339627|FG010|Overall Study|Protocol Violation|0|||
164251833|NCT00244725|593288234|FG001|Overall Study|Lost to Follow-up|4|||
164251834|NCT00244725|593288235|FG002|Overall Study|Lost to Follow-up|9|||
164251835|NCT00244725|593288236|FG003|Overall Study|Lost to Follow-up|2|||
164251836|NCT00244725|593288233|FG000|Overall Study|Withdrawal by Subject|9|||
164251837|NCT00244725|593288234|FG001|Overall Study|Withdrawal by Subject|7|||
164251838|NCT00244725|593288235|FG002|Overall Study|Withdrawal by Subject|7|||
164251839|NCT00244725|593288236|FG003|Overall Study|Withdrawal by Subject|8|||
164251840|NCT00244725|593288233|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
164251841|NCT00244725|593288234|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
164251842|NCT00244725|593288235|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
164251843|NCT00244725|593288236|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
164251844|NCT00244725|593288233|FG000|Overall Study|Physician Decision|3|||
164251845|NCT00244725|593288234|FG001|Overall Study|Physician Decision|0|||
164251846|NCT00244725|593288235|FG002|Overall Study|Physician Decision|1|||
164251847|NCT00244725|593288236|FG003|Overall Study|Physician Decision|2|||
164338924|NCT01146912|593617090|FG007|Overall Study|Duplicate patient|0|||
164338925|NCT02980783|593617091|FG000|Overall Study|Lost to Follow-up|1|||
164338926|NCT00880542|593617092|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
164338927|NCT00880542|593617092|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
164338928|NCT00880542|593617092|FG000|REP: Surgical Resection|progressive disease|1|||
164338929|NCT05047770|593617093|FG000|Overall Study|Withdrawal by Subject|15|||
164338930|NCT05047770|593617094|FG001|Overall Study|Withdrawal by Subject|10|||
164338931|NCT05047770|593617095|FG002|Overall Study|Withdrawal by Subject|6|||
164338932|NCT05047770|593617096|FG003|Overall Study|Withdrawal by Subject|12|||
164338933|NCT05047770|593617093|FG000|Overall Study|Lost to Follow-up|7|||
164338934|NCT05047770|593617094|FG001|Overall Study|Lost to Follow-up|5|||
163991863|NCT06118385|592339628|FG011|Overall Study|Protocol Violation|0|||
164251848|NCT00244725|593288233|FG000|Overall Study|Adverse Events|3|||
164251849|NCT00244725|593288234|FG001|Overall Study|Adverse Events|1|||
164251850|NCT00244725|593288235|FG002|Overall Study|Adverse Events|4|||
164251851|NCT00244725|593288236|FG003|Overall Study|Adverse Events|4|||
164251852|NCT00244725|593288233|FG000|Overall Study|Withdrwal by participant|1|||
164251853|NCT00244725|593288234|FG001|Overall Study|Withdrwal by participant|0|||
164251854|NCT00244725|593288235|FG002|Overall Study|Withdrwal by participant|0|||
164338935|NCT05047770|593617095|FG002|Overall Study|Lost to Follow-up|12|||
164338936|NCT05047770|593617096|FG003|Overall Study|Lost to Follow-up|13|||
164338937|NCT05047770|593617093|FG000|Overall Study|Other|1|||
164338938|NCT05047770|593617094|FG001|Overall Study|Other|0|||
164084338|NCT00628745|592672352|FG000|Overall Study|Participant transferred to another THAOS site|6|||
164084339|NCT00628745|592672353|FG001|Overall Study|Participant transferred to another THAOS site|0|||
164084340|NCT00628745|592672354|FG002|Overall Study|Participant transferred to another THAOS site|0|||
164084341|NCT00628745|592672355|FG003|Overall Study|Participant transferred to another THAOS site|0|||
164084342|NCT00628745|592672356|FG004|Overall Study|Participant transferred to another THAOS site|7|||
164084343|NCT00628745|592672352|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
164084344|NCT00628745|592672353|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
164084345|NCT00628745|592672354|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
164084346|NCT00628745|592672355|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
164084347|NCT00628745|592672356|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
164084348|NCT00628745|592672352|FG000|Overall Study|Site closure|152|||
164084349|NCT00628745|592672353|FG001|Overall Study|Site closure|146|||
164084350|NCT00628745|592672354|FG002|Overall Study|Site closure|6|||
164084351|NCT00628745|592672355|FG003|Overall Study|Site closure|8|||
164084352|NCT00628745|592672356|FG004|Overall Study|Site closure|691|||
164084353|NCT00628745|592672352|FG000|Overall Study|Duplicate participant|0|||
164084354|NCT00628745|592672353|FG001|Overall Study|Duplicate participant|0|||
164084355|NCT00628745|592672354|FG002|Overall Study|Duplicate participant|0|||
164084356|NCT00628745|592672355|FG003|Overall Study|Duplicate participant|0|||
164084357|NCT00628745|592672356|FG004|Overall Study|Duplicate participant|1|||
164084358|NCT00628745|592672352|FG000|Overall Study|Missing|4|||
164084359|NCT00628745|592672353|FG001|Overall Study|Missing|3|||
164084360|NCT00628745|592672354|FG002|Overall Study|Missing|0|||
164084361|NCT00628745|592672355|FG003|Overall Study|Missing|0|||
164084362|NCT00628745|592672356|FG004|Overall Study|Missing|10|||
164084363|NCT00628745|592672352|FG000|Overall Study|Othe reasons|987|||
164084364|NCT00628745|592672353|FG001|Overall Study|Othe reasons|373|||
164084365|NCT00628745|592672354|FG002|Overall Study|Othe reasons|105|||
164084366|NCT00628745|592672355|FG003|Overall Study|Othe reasons|1|||
164084367|NCT00628745|592672356|FG004|Overall Study|Othe reasons|1772|||
164084368|NCT05188521|592673888|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
164084369|NCT05188521|592673889|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
164084370|NCT01132118|592673890|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
164084371|NCT01132118|592673891|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
164084372|NCT01132118|592673890|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164084373|NCT01132118|592673891|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
164084374|NCT01132118|592673890|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
164084375|NCT01132118|592673891|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
164084376|NCT01644890|592673892|FG000|Overall Study|Adverse Event|7|||
164084377|NCT01644890|592673893|FG001|Overall Study|Adverse Event|20|||
164084378|NCT01644890|592673892|FG000|Overall Study|Death|1|||
164084379|NCT01644890|592673893|FG001|Overall Study|Death|3|||
164084380|NCT01644890|592673892|FG000|Overall Study|Physician Decision|3|||
164084381|NCT01644890|592673893|FG001|Overall Study|Physician Decision|9|||
164084382|NCT01644890|592673892|FG000|Overall Study|Protocol Violation|6|||
164084383|NCT01644890|592673893|FG001|Overall Study|Protocol Violation|7|||
164084384|NCT01644890|592673892|FG000|Overall Study|Withdrawal by Subject|19|||
164084385|NCT01644890|592673893|FG001|Overall Study|Withdrawal by Subject|27|||
164084386|NCT01644890|592673892|FG000|Overall Study|Progression Disease|160|||
164338939|NCT05047770|593617095|FG002|Overall Study|Other|1|||
164338940|NCT05047770|593617096|FG003|Overall Study|Other|0|||
164084387|NCT01644890|592673893|FG001|Overall Study|Progression Disease|131|||
164084388|NCT01644890|592673892|FG000|Overall Study|Clinical Progression|6|||
164084389|NCT01644890|592673893|FG001|Overall Study|Clinical Progression|6|||
164084390|NCT01644890|592673892|FG000|Overall Study|> 28 days since last dose of study drug|6|||
164084391|NCT01644890|592673893|FG001|Overall Study|> 28 days since last dose of study drug|3|||
164084392|NCT01644890|592673892|FG000|Overall Study|Other|8|||
164084393|NCT01644890|592673893|FG001|Overall Study|Other|9|||
164084394|NCT01413204|592673896|FG000|Overall Study|Adverse Event|1|||
164084395|NCT01413204|592673897|FG001|Overall Study|Adverse Event|2|||
164084396|NCT01413204|592673898|FG002|Overall Study|Adverse Event|2|||
164084397|NCT01413204|592673896|FG000|Overall Study|Physician Decision|3|||
164084398|NCT01413204|592673897|FG001|Overall Study|Physician Decision|0|||
164084399|NCT01413204|592673898|FG002|Overall Study|Physician Decision|2|||
164084400|NCT01413204|592673896|FG000|Overall Study|Withdrawal by Subject|1|||
164084401|NCT01413204|592673897|FG001|Overall Study|Withdrawal by Subject|4|||
164084402|NCT01413204|592673898|FG002|Overall Study|Withdrawal by Subject|4|||
164084403|NCT01413204|592673896|FG000|Overall Study|Clearly not eligible for the study|0|||
164084404|NCT01413204|592673897|FG001|Overall Study|Clearly not eligible for the study|0|||
164084405|NCT01413204|592673898|FG002|Overall Study|Clearly not eligible for the study|1|||
164084406|NCT01413204|592673896|FG000|Overall Study|Fasting plasma glucose level increased|1|||
164338941|NCT01772160|593617097|FG000|Overall Study|Death|3|||
164251855|NCT00244725|593288236|FG003|Overall Study|Withdrwal by participant|1|||
164251856|NCT00244725|593288233|FG000|Overall Study|Liver function test abnormality|2|||
164251857|NCT00244725|593288234|FG001|Overall Study|Liver function test abnormality|0|||
164251858|NCT00244725|593288235|FG002|Overall Study|Liver function test abnormality|0|||
164251859|NCT00244725|593288236|FG003|Overall Study|Liver function test abnormality|1|||
164251860|NCT00244725|593288233|FG000|Overall Study|Sponsor withdrew the participant|1|||
164251861|NCT00244725|593288234|FG001|Overall Study|Sponsor withdrew the participant|0|||
164251862|NCT00244725|593288235|FG002|Overall Study|Sponsor withdrew the participant|0|||
164251863|NCT00244725|593288236|FG003|Overall Study|Sponsor withdrew the participant|1|||
164251864|NCT00244725|593288233|FG000|Overall Study|Mediciation Error|0|||
164251865|NCT00244725|593288234|FG001|Overall Study|Mediciation Error|1|||
164251866|NCT00244725|593288235|FG002|Overall Study|Mediciation Error|0|||
164251867|NCT00244725|593288236|FG003|Overall Study|Mediciation Error|0|||
164251868|NCT00244725|593288233|FG000|Overall Study|Rehab Refused to allow participantion|0|||
164251869|NCT00244725|593288234|FG001|Overall Study|Rehab Refused to allow participantion|1|||
164251870|NCT00244725|593288235|FG002|Overall Study|Rehab Refused to allow participantion|0|||
164251871|NCT00244725|593288236|FG003|Overall Study|Rehab Refused to allow participantion|0|||
164251872|NCT00244725|593288233|FG000|Overall Study|Headache|0|||
164251873|NCT00244725|593288234|FG001|Overall Study|Headache|1|||
164251874|NCT00244725|593288235|FG002|Overall Study|Headache|0|||
164251875|NCT00244725|593288236|FG003|Overall Study|Headache|0|||
164251876|NCT00244725|593288233|FG000|Overall Study|Received prohibited medication|0|||
164251877|NCT00244725|593288234|FG001|Overall Study|Received prohibited medication|1|||
164251878|NCT00244725|593288235|FG002|Overall Study|Received prohibited medication|0|||
164251879|NCT00244725|593288236|FG003|Overall Study|Received prohibited medication|1|||
164251880|NCT00244725|593288233|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
164251881|NCT00244725|593288234|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
164251882|NCT00244725|593288235|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
164251883|NCT00244725|593288236|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
164251884|NCT00244725|593288233|FG000|Overall Study|Administrative reason|0|||
164251885|NCT00244725|593288234|FG001|Overall Study|Administrative reason|0|||
164251886|NCT00244725|593288235|FG002|Overall Study|Administrative reason|1|||
164251887|NCT00244725|593288236|FG003|Overall Study|Administrative reason|0|||
164251888|NCT00244725|593288233|FG000|Overall Study|Vomit|0|||
164251889|NCT00244725|593288234|FG001|Overall Study|Vomit|0|||
164251890|NCT00244725|593288235|FG002|Overall Study|Vomit|1|||
164251891|NCT00244725|593288236|FG003|Overall Study|Vomit|0|||
164251892|NCT00244725|593288233|FG000|Overall Study|Failed to follow-up|0|||
164251893|NCT00244725|593288234|FG001|Overall Study|Failed to follow-up|0|||
164251894|NCT00244725|593288235|FG002|Overall Study|Failed to follow-up|1|||
164251895|NCT00244725|593288236|FG003|Overall Study|Failed to follow-up|1|||
164251896|NCT04004221|593288241|FG000|Overall Study|Death|89|||
164251897|NCT04004221|593288241|FG000|Overall Study|Withdrawal by Subject|5|||
164251898|NCT04004221|593288241|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
164251899|NCT04004221|593288241|FG000|Overall Study|Sponsor Decision|9|||
164251900|NCT04004221|593288241|FG000|Overall Study|Participant refused to enter LTE|1|||
164251901|NCT03423238|593288242|FG000|Overall Study|Lost to Follow-up|1|||
164251902|NCT03423238|593288243|FG001|Overall Study|Lost to Follow-up|0|||
164251903|NCT03423238|593288242|FG000|Overall Study|Withdrawal by Subject|1|||
164251904|NCT03423238|593288243|FG001|Overall Study|Withdrawal by Subject|0|||
164251905|NCT00506454|593288245|FG000|Overall Study|Withdrawal by Subject|1|||
164251906|NCT00506454|593288246|FG001|Overall Study|Withdrawal by Subject|1|||
164251907|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
164251908|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
164251909|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
164251910|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163887200|NCT03381196|591959344|FG000|Overall Study|Adverse Event|1|||
163887201|NCT03381196|591959345|FG001|Overall Study|Adverse Event|0|||
163887202|NCT03381196|591959344|FG000|Overall Study|Randomized, not treated|3|||
163887203|NCT03381196|591959345|FG001|Overall Study|Randomized, not treated|6|||
163887204|NCT00227344|591959346|FG000|Overall Study|study terminated early|12|||
163887205|NCT00227344|591959347|FG001|Overall Study|study terminated early|5|||
163887206|NCT03371381|591959348|FG000|Overall Study|Death|5|||
164251911|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164251912|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164251913|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
164251914|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
164251915|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251916|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251917|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251918|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163887207|NCT03371381|591959348|FG000|Overall Study|Study terminated by sponsor|3|||
163887208|NCT03371381|591959348|FG000|Overall Study|Other|4|||
164251919|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251920|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
164251921|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
164251922|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
164251923|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
164251924|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251925|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251926|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251927|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
164251928|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
164251929|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
164251930|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251931|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251932|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251933|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251934|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
164251935|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
164251936|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251937|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251938|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251939|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251940|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251941|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
164251942|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251943|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
164251944|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251945|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251946|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251947|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251948|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
164251949|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
164251950|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
164251951|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
164251952|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251953|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251954|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251955|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
164251956|NCT03745638|593288247|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
164251957|NCT03745638|593288248|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
164251958|NCT03745638|593288249|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251959|NCT03745638|593288250|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251960|NCT03745638|593288251|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251961|NCT03745638|593288252|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251962|NCT03745638|593288253|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
164251963|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164251964|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164251965|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164251966|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164338942|NCT01772160|593617097|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
164338943|NCT01772160|593617097|FG000|Overall Study|Consent withdrawal|3|||
164338944|NCT01772160|593617097|FG000|Overall Study|Migrated / moved from the study area|4|||
164338945|NCT01772160|593617097|FG000|Overall Study|Lost to Follow-up|30|||
164338946|NCT01772160|593617097|FG000|Overall Study|Other|5|||
164338947|NCT02202980|593617098|FG000|Overall Study|Lack of Efficacy|1|||
164338948|NCT02202980|593617099|FG001|Overall Study|Lack of Efficacy|0|||
164338949|NCT02202980|593617100|FG002|Overall Study|Lack of Efficacy|7|||
164338950|NCT02202980|593617101|FG003|Overall Study|Lack of Efficacy|0|||
164338951|NCT02202980|593617102|FG004|Overall Study|Lack of Efficacy|3|||
163887209|NCT01073566|591959354|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
163887210|NCT01073566|591959355|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
163887211|NCT05780437|591959356|FG000|Overall Study|Withdrawal by Subject|22|||
163887212|NCT05780437|591959357|FG001|Overall Study|Withdrawal by Subject|16|||
163887213|NCT03544281|591959362|FG000|Main Study Phase|Death|3|||
163887214|NCT03544281|591959363|FG001|Main Study Phase|Death|2|||
163887215|NCT03544281|591959364|FG002|Main Study Phase|Death|6|||
164084407|NCT01413204|592673897|FG001|Overall Study|Fasting plasma glucose level increased|0|||
163887216|NCT03544281|591959365|FG003|Main Study Phase|Death|8|||
163887217|NCT03544281|591959366|FG004|Main Study Phase|Death|4|||
163887218|NCT03544281|591959367|FG005|Main Study Phase|Death|2|||
163887219|NCT03544281|591959368|FG006|Main Study Phase|Death|4|||
164084408|NCT01413204|592673898|FG002|Overall Study|Fasting plasma glucose level increased|10|||
164084409|NCT00313703|592673900|FG000|Overall Study|Lost to Follow-up|11|||
164084410|NCT00313703|592673901|FG001|Overall Study|Lost to Follow-up|2|||
164084411|NCT00313703|592673902|FG002|Overall Study|Lost to Follow-up|5|||
164084412|NCT00313703|592673903|FG003|Overall Study|Lost to Follow-up|12|||
164084413|NCT02497391|592673904|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
164084414|NCT02497391|592673905|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
164084415|NCT02497391|592673906|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
164084416|NCT02497391|592673907|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
164084417|NCT02497391|592673908|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
164084418|NCT02497391|592673909|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
164084419|NCT02497391|592673904|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
164084420|NCT02497391|592673905|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
164084421|NCT02497391|592673906|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
164084422|NCT02497391|592673907|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
164084423|NCT02497391|592673908|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
164084424|NCT02497391|592673909|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
164084425|NCT02497391|592673904|FG000|Period 3 (14 Days)|Adverse Event|0|||
164084426|NCT02497391|592673905|FG001|Period 3 (14 Days)|Adverse Event|1|||
164084427|NCT02497391|592673906|FG002|Period 3 (14 Days)|Adverse Event|0|||
164084428|NCT02497391|592673907|FG003|Period 3 (14 Days)|Adverse Event|0|||
164084429|NCT02497391|592673908|FG004|Period 3 (14 Days)|Adverse Event|0|||
164084430|NCT02497391|592673909|FG005|Period 3 (14 Days)|Adverse Event|0|||
164084431|NCT02497391|592673904|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
164084432|NCT02497391|592673905|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
164084433|NCT02497391|592673906|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
164084434|NCT02497391|592673907|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
164084435|NCT02497391|592673908|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
164084436|NCT02497391|592673909|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
164084437|NCT02497391|592673904|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
164084438|NCT02497391|592673905|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
164084439|NCT02497391|592673906|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
164084440|NCT02497391|592673907|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
164084441|NCT02497391|592673908|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
164084442|NCT02497391|592673909|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
164084443|NCT03031899|592673912|FG000|Overall Study|Protocol Violation|1|||
164084444|NCT03031899|592673912|FG000|Overall Study|lesion disappeared after stopping habit|1|||
164084445|NCT01664052|592673913|FG000|Phase 1|No device placement|6|||
164084446|NCT01664052|592673914|FG001|Phase 1|No device placement|0|||
164084447|NCT01664052|592673913|FG000|Phase 1|No HSG 1 hr post placement|1|||
164084448|NCT01664052|592673914|FG001|Phase 1|No HSG 1 hr post placement|0|||
164084449|NCT01664052|592673913|FG000|Phase 2|No device placement|0|||
164084450|NCT01664052|592673914|FG001|Phase 2|No device placement|4|||
164084451|NCT01060670|592673915|FG000|Run In|screen failure|0|||
164084452|NCT01060670|592673916|FG001|Run In|screen failure|238|||
164084453|NCT03705351|592673919|FG000|Overall Study|Study termination|3|||
164084454|NCT03705351|592673919|FG000|Overall Study|Death|1|||
164084455|NCT03705351|592673919|FG000|Overall Study|Lack of Efficacy|2|||
164251967|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163887220|NCT03544281|591959369|FG007|Main Study Phase|Death|5|||
163887221|NCT03544281|591959370|FG008|Main Study Phase|Death|5|||
163887222|NCT03544281|591959371|FG009|Main Study Phase|Death|8|||
163887223|NCT03544281|591959372|FG010|Main Study Phase|Death|6|||
163887224|NCT03544281|591959373|FG011|Main Study Phase|Death|4|||
163887225|NCT03544281|591959374|FG012|Main Study Phase|Death|0|||
163887226|NCT03544281|591959375|FG013|Main Study Phase|Death|0|||
163887227|NCT03544281|591959376|FG014|Main Study Phase|Death|0|||
163887228|NCT03544281|591959377|FG015|Main Study Phase|Death|0|||
163887229|NCT03544281|591959378|FG016|Main Study Phase|Death|0|||
163887230|NCT03544281|591959379|FG017|Main Study Phase|Death|0|||
163887231|NCT03544281|591959380|FG018|Main Study Phase|Death|0|||
163887232|NCT03544281|591959381|FG019|Main Study Phase|Death|0|||
164084456|NCT03705351|592673919|FG000|Overall Study|Withdrawal by Subject|1|||
164084457|NCT00633152|592673922|FG000|Overall Study|Adverse Event|1|||
164084458|NCT00633152|592673923|FG001|Overall Study|Adverse Event|0|||
164084459|NCT00633152|592673922|FG000|Overall Study|Randomized, did not receive study drug|5|||
164251968|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
163887233|NCT03544281|591959382|FG020|Main Study Phase|Death|0|||
163887234|NCT03544281|591959383|FG021|Main Study Phase|Death|0|||
163887235|NCT03544281|591959362|FG000|Main Study Phase|Lost to Follow-up|0|||
163887236|NCT03544281|591959363|FG001|Main Study Phase|Lost to Follow-up|0|||
163887237|NCT03544281|591959364|FG002|Main Study Phase|Lost to Follow-up|0|||
164084460|NCT00633152|592673923|FG001|Overall Study|Randomized, did not receive study drug|2|||
164084461|NCT00633152|592673922|FG000|Overall Study|Withdrawal by Subject|1|||
164084462|NCT00633152|592673923|FG001|Overall Study|Withdrawal by Subject|1|||
164251969|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
164251970|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251971|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251972|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251973|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
164251974|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164251975|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
164251976|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
164251977|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164251978|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164251979|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
164251980|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
164251981|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
164251982|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
164251983|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
164251984|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251985|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251986|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251987|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251988|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
164251989|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
164251990|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
164251991|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251992|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251993|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251994|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251995|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251996|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
164251997|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
164251998|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164251999|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164252000|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
164252001|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
164252002|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
164252003|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
164252004|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
164252005|NCT03745638|593288247|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252006|NCT03745638|593288248|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252007|NCT03745638|593288249|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252008|NCT03745638|593288250|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252009|NCT03745638|593288251|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
164252010|NCT03745638|593288252|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
164252011|NCT03745638|593288253|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
164252012|NCT00976716|593288254|FG000|Overall Study|Adverse Event|1|||
164252013|NCT02993822|593288262|FG000|Overall Study|Lack of Efficacy|1|||
164252014|NCT02993822|593288263|FG001|Overall Study|Lack of Efficacy|1|||
164252015|NCT02993822|593288264|FG002|Overall Study|Lack of Efficacy|0|||
164252016|NCT02993822|593288265|FG003|Overall Study|Lack of Efficacy|0|||
164252017|NCT02993822|593288262|FG000|Overall Study|Protocol Violation|1|||
164252018|NCT02993822|593288263|FG001|Overall Study|Protocol Violation|0|||
164252019|NCT02993822|593288264|FG002|Overall Study|Protocol Violation|0|||
164252020|NCT02993822|593288265|FG003|Overall Study|Protocol Violation|0|||
164252021|NCT02993822|593288262|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
164252022|NCT02993822|593288263|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
164252023|NCT02993822|593288264|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
164084463|NCT00633152|592673922|FG000|Overall Study|Lost to Follow-up|4|||
164252024|NCT02993822|593288265|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
164252025|NCT02993822|593288262|FG000|Overall Study|Adverse Event|3|||
164252026|NCT02993822|593288263|FG001|Overall Study|Adverse Event|1|||
164252027|NCT02993822|593288264|FG002|Overall Study|Adverse Event|7|||
164252028|NCT02993822|593288265|FG003|Overall Study|Adverse Event|0|||
164252029|NCT02993822|593288262|FG000|Overall Study|Withdrawal by Subject|4|||
164252030|NCT02993822|593288263|FG001|Overall Study|Withdrawal by Subject|2|||
164252031|NCT02993822|593288264|FG002|Overall Study|Withdrawal by Subject|2|||
164252032|NCT02993822|593288265|FG003|Overall Study|Withdrawal by Subject|3|||
164252033|NCT02993822|593288262|FG000|Overall Study|Lost to Follow-up|1|||
164252034|NCT02993822|593288263|FG001|Overall Study|Lost to Follow-up|0|||
164252035|NCT02993822|593288264|FG002|Overall Study|Lost to Follow-up|1|||
164252036|NCT02993822|593288265|FG003|Overall Study|Lost to Follow-up|0|||
164252037|NCT01221753|593288269|FG000|Overall Study|Adverse Event|1|||
164252038|NCT01939977|593288273|FG000|Overall Study|Adverse Event|4|||
164252039|NCT01939977|593288274|FG001|Overall Study|Adverse Event|3|||
164252040|NCT01939977|593288273|FG000|Overall Study|Lack of Efficacy|3|||
164252041|NCT01939977|593288274|FG001|Overall Study|Lack of Efficacy|0|||
164252042|NCT01939977|593288273|FG000|Overall Study|Physician Decision|1|||
164252043|NCT01939977|593288274|FG001|Overall Study|Physician Decision|1|||
164252044|NCT01939977|593288273|FG000|Overall Study|Withdrawal by Subject|0|||
164252045|NCT01939977|593288274|FG001|Overall Study|Withdrawal by Subject|2|||
164252046|NCT01939977|593288273|FG000|Overall Study|Did not meet inclusion criteria|1|||
164252047|NCT01939977|593288274|FG001|Overall Study|Did not meet inclusion criteria|0|||
164252048|NCT01939977|593288273|FG000|Overall Study|Did not receive study medication|0|||
164252049|NCT01939977|593288274|FG001|Overall Study|Did not receive study medication|1|||
164252050|NCT01603043|593288278|FG000|Overall Study|Study Futility|7|||
164252051|NCT01603043|593288279|FG001|Overall Study|Study Futility|3|||
164252052|NCT01917929|593288280|FG000|Overall Study|Death|8|||
164252053|NCT01917929|593288280|FG000|Overall Study|Lost to Follow-up|19|||
164252054|NCT01917929|593288280|FG000|Overall Study|Withdrawal by Subject|33|||
164252055|NCT01917929|593288280|FG000|Overall Study|Adverse Event|6|||
164252056|NCT01917929|593288280|FG000|Overall Study|Investigative Site Terminated|35|||
164252057|NCT01917929|593288280|FG000|Overall Study|Censored because study device not implanted|6|||
164252058|NCT01917929|593288280|FG000|Overall Study|Censored because surgery not performed|3|||
164252059|NCT01917929|593288280|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
164252060|NCT01917929|593288280|FG000|Overall Study|Sponsor terminated study|175|||
164252061|NCT01696981|593288281|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
164252062|NCT01696981|593288282|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
164252063|NCT01696981|593288281|FG000|Overall Study|Died Before Randomization|3|||
164252064|NCT01696981|593288282|FG001|Overall Study|Died Before Randomization|8|||
164252065|NCT01696981|593288281|FG000|Overall Study|Died Before ASU (Control)|278|||
164252066|NCT01696981|593288282|FG001|Overall Study|Died Before ASU (Control)|0|||
164252067|NCT01696981|593288281|FG000|Overall Study|Refused ASU (Control)|920|||
164252068|NCT01696981|593288282|FG001|Overall Study|Refused ASU (Control)|0|||
164252069|NCT01696981|593288281|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
164252070|NCT01696981|593288282|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
164252071|NCT03599518|593288283|FG000|Overall Study|Clinical progression|0|||
164252072|NCT03599518|593288284|FG001|Overall Study|Clinical progression|0|||
164252073|NCT03599518|593288285|FG002|Overall Study|Clinical progression|0|||
164252074|NCT03599518|593288286|FG003|Overall Study|Clinical progression|0|||
164252075|NCT03599518|593288287|FG004|Overall Study|Clinical progression|1|||
164252076|NCT03599518|593288283|FG000|Overall Study|Adverse Event|0|||
164252077|NCT03599518|593288284|FG001|Overall Study|Adverse Event|0|||
164252078|NCT03599518|593288285|FG002|Overall Study|Adverse Event|0|||
164252079|NCT03599518|593288286|FG003|Overall Study|Adverse Event|0|||
164252080|NCT03599518|593288287|FG004|Overall Study|Adverse Event|1|||
164252081|NCT03599518|593288283|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
164252082|NCT03599518|593288284|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
164252083|NCT03599518|593288285|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
164252084|NCT03599518|593288286|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
164252085|NCT03599518|593288287|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
164252086|NCT03599518|593288283|FG000|Overall Study|Participant withdrawal from study treatment|0|||
164252087|NCT03599518|593288284|FG001|Overall Study|Participant withdrawal from study treatment|0|||
164252088|NCT03599518|593288285|FG002|Overall Study|Participant withdrawal from study treatment|1|||
164252089|NCT03599518|593288286|FG003|Overall Study|Participant withdrawal from study treatment|0|||
164252090|NCT03599518|593288287|FG004|Overall Study|Participant withdrawal from study treatment|0|||
164252091|NCT02798315|593288290|FG000|Overall Study|Failure to return|1|||
164252092|NCT00005947|593288291|FG000|Overall Study|Death|54|||
164252093|NCT00005947|593288292|FG001|Overall Study|Death|40|||
164252094|NCT00005947|593288291|FG000|Overall Study|Patient Refused to Continue|2|||
164252095|NCT00005947|593288292|FG001|Overall Study|Patient Refused to Continue|1|||
164252096|NCT00005947|593288291|FG000|Overall Study|Site Closure|1|||
164252097|NCT00005947|593288292|FG001|Overall Study|Site Closure|0|||
164252098|NCT00465972|593288293|FG000|Overall Study|Withdrawal by Subject|2|||
164252099|NCT00465972|593288294|FG001|Overall Study|Withdrawal by Subject|1|||
164252100|NCT05356910|593288299|FG000|Overall Study|Lost to Follow-up|10|||
164252101|NCT05356910|593288300|FG001|Overall Study|Lost to Follow-up|19|||
164252102|NCT05356910|593288301|FG002|Overall Study|Lost to Follow-up|0|||
164252103|NCT05356910|593288302|FG003|Overall Study|Lost to Follow-up|0|||
164252104|NCT05356910|593288299|FG000|Overall Study|Withdrawal by Subject|4|||
164252105|NCT05356910|593288300|FG001|Overall Study|Withdrawal by Subject|2|||
164252106|NCT05356910|593288301|FG002|Overall Study|Withdrawal by Subject|0|||
164252107|NCT05356910|593288302|FG003|Overall Study|Withdrawal by Subject|0|||
164252108|NCT02712996|593288303|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
164252109|NCT02712996|593288304|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
164252110|NCT00972517|593288305|FG000|Overall Study|Adverse Event|0|||
164252111|NCT00972517|593288306|FG001|Overall Study|Adverse Event|0|||
164252112|NCT00972517|593288307|FG002|Overall Study|Adverse Event|0|||
164252113|NCT00972517|593288308|FG003|Overall Study|Adverse Event|1|||
164252114|NCT00972517|593288309|FG004|Overall Study|Adverse Event|0|||
164252115|NCT00972517|593288310|FG005|Overall Study|Adverse Event|0|||
164252116|NCT00972517|593288305|FG000|Overall Study|Withdrawal by Subject|0|||
164252117|NCT00972517|593288306|FG001|Overall Study|Withdrawal by Subject|1|||
164252118|NCT00972517|593288307|FG002|Overall Study|Withdrawal by Subject|0|||
164252119|NCT00972517|593288308|FG003|Overall Study|Withdrawal by Subject|2|||
164252120|NCT00972517|593288309|FG004|Overall Study|Withdrawal by Subject|1|||
164252121|NCT00972517|593288310|FG005|Overall Study|Withdrawal by Subject|0|||
164252122|NCT00819156|593288311|FG000|Overall Study|Adverse Event|1|||
164252123|NCT00819156|593288312|FG001|Overall Study|Adverse Event|4|||
164252124|NCT00819156|593288313|FG002|Overall Study|Adverse Event|2|||
164252125|NCT00819156|593288314|FG003|Overall Study|Adverse Event|1|||
164252126|NCT00819156|593288315|FG004|Overall Study|Adverse Event|2|||
164252127|NCT00819156|593288316|FG005|Overall Study|Adverse Event|3|||
164252128|NCT00819156|593288311|FG000|Overall Study|Withdrawal by Subject|0|||
164252129|NCT00819156|593288312|FG001|Overall Study|Withdrawal by Subject|3|||
164252130|NCT00819156|593288313|FG002|Overall Study|Withdrawal by Subject|2|||
164252131|NCT00819156|593288314|FG003|Overall Study|Withdrawal by Subject|0|||
164252132|NCT00819156|593288315|FG004|Overall Study|Withdrawal by Subject|1|||
164252133|NCT00819156|593288316|FG005|Overall Study|Withdrawal by Subject|0|||
164252134|NCT00819156|593288311|FG000|Overall Study|Protocol Violation|1|||
164252135|NCT00819156|593288312|FG001|Overall Study|Protocol Violation|0|||
164252136|NCT00819156|593288313|FG002|Overall Study|Protocol Violation|1|||
164252137|NCT00819156|593288314|FG003|Overall Study|Protocol Violation|0|||
164252138|NCT00819156|593288315|FG004|Overall Study|Protocol Violation|0|||
164252139|NCT00819156|593288316|FG005|Overall Study|Protocol Violation|1|||
164252140|NCT00819156|593288311|FG000|Overall Study|Lost to Follow-up|0|||
164252141|NCT00819156|593288312|FG001|Overall Study|Lost to Follow-up|1|||
164252142|NCT00819156|593288313|FG002|Overall Study|Lost to Follow-up|0|||
164252143|NCT00819156|593288314|FG003|Overall Study|Lost to Follow-up|0|||
164252144|NCT00819156|593288315|FG004|Overall Study|Lost to Follow-up|0|||
164338952|NCT02202980|593617103|FG005|Overall Study|Lack of Efficacy|1|||
164338953|NCT02202980|593617104|FG006|Overall Study|Lack of Efficacy|11|||
164338954|NCT02202980|593617105|FG007|Overall Study|Lack of Efficacy|2|||
164338955|NCT02202980|593617106|FG008|Overall Study|Lack of Efficacy|2|||
163887238|NCT03544281|591959365|FG003|Main Study Phase|Lost to Follow-up|0|||
164084464|NCT00633152|592673923|FG001|Overall Study|Lost to Follow-up|1|||
164252145|NCT00819156|593288316|FG005|Overall Study|Lost to Follow-up|2|||
164252146|NCT00819156|593288311|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
164252147|NCT00819156|593288312|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
164252148|NCT00819156|593288313|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
164252149|NCT00819156|593288314|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
164338956|NCT02202980|593617107|FG009|Overall Study|Lack of Efficacy|0|||
164252150|NCT00819156|593288315|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
164338957|NCT02202980|593617108|FG010|Overall Study|Lack of Efficacy|0|||
164252151|NCT00819156|593288316|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
164252152|NCT00819156|593288311|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
164252153|NCT00819156|593288312|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252154|NCT00819156|593288313|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252155|NCT00819156|593288314|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252156|NCT00819156|593288315|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
164338958|NCT02202980|593617109|FG011|Overall Study|Lack of Efficacy|3|||
163991864|NCT06118385|592339617|FG000|Overall Study|Out-of-range blood tests|0|||
163991865|NCT06118385|592339618|FG001|Overall Study|Out-of-range blood tests|0|||
163991866|NCT06118385|592339619|FG002|Overall Study|Out-of-range blood tests|0|||
163991867|NCT06118385|592339620|FG003|Overall Study|Out-of-range blood tests|0|||
163991868|NCT06118385|592339621|FG004|Overall Study|Out-of-range blood tests|0|||
163991869|NCT06118385|592339622|FG005|Overall Study|Out-of-range blood tests|0|||
163991870|NCT06118385|592339623|FG006|Overall Study|Out-of-range blood tests|0|||
163991871|NCT06118385|592339624|FG007|Overall Study|Out-of-range blood tests|0|||
164084465|NCT00633152|592673922|FG000|Overall Study|Miscellaneous Other|3|||
164084466|NCT00633152|592673923|FG001|Overall Study|Miscellaneous Other|2|||
163991872|NCT06118385|592339625|FG008|Overall Study|Out-of-range blood tests|1|||
164084467|NCT02180061|592673924|FG000|Overall Study|Adverse Event|4|||
164084468|NCT02180061|592673925|FG001|Overall Study|Adverse Event|2|||
164084469|NCT02180061|592673924|FG000|Overall Study|Clinical Progression|5|||
164084470|NCT02180061|592673925|FG001|Overall Study|Clinical Progression|1|||
164084471|NCT02180061|592673924|FG000|Overall Study|Progressive Disease|15|||
164084472|NCT02180061|592673925|FG001|Overall Study|Progressive Disease|5|||
164084473|NCT02180061|592673924|FG000|Overall Study|Physician Decision|1|||
164084474|NCT02180061|592673925|FG001|Overall Study|Physician Decision|0|||
164084475|NCT00056160|592673928|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
164084476|NCT00056160|592673929|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
164084477|NCT00056160|592673928|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
164084478|NCT00056160|592673929|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
164084479|NCT00056160|592673928|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
164084480|NCT00056160|592673929|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
164084481|NCT00056160|592673928|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
164084482|NCT00056160|592673929|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
164084483|NCT00056160|592673928|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
164084484|NCT00056160|592673929|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
164084485|NCT00056160|592673928|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
164084486|NCT00056160|592673929|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
164084487|NCT00056160|592673928|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
164084488|NCT00056160|592673929|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
164084489|NCT00056160|592673928|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
164084490|NCT00056160|592673929|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
164084491|NCT00056160|592673928|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
164084492|NCT00056160|592673929|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
164084493|NCT00056160|592673928|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
164084494|NCT00056160|592673929|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
164084495|NCT00056160|592673928|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
164084496|NCT00056160|592673929|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
164084497|NCT00056160|592673928|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
164084498|NCT00056160|592673929|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
164084499|NCT00056160|592673928|FG000|Final Follow-up|Transferred into expanded access study.|3|||
164084500|NCT00056160|592673929|FG001|Final Follow-up|Transferred into expanded access study.|0|||
164084501|NCT00056160|592673928|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
164084502|NCT00056160|592673929|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
164084503|NCT00056160|592673928|FG000|Final Follow-up|Adverse Event|1|||
164084504|NCT00056160|592673929|FG001|Final Follow-up|Adverse Event|0|||
164084505|NCT01469364|592673930|FG000|Overall Study|Adverse Event|1|||
164084506|NCT01469364|592673930|FG000|Overall Study|Withdrawal by Subject|1|||
164084507|NCT01579474|592673931|FG000|Overall Study|Adverse Event|1|||
164084508|NCT01579474|592673932|FG001|Overall Study|Adverse Event|13|||
164084509|NCT01579474|592673933|FG002|Overall Study|Adverse Event|2|||
164084510|NCT01579474|592673934|FG003|Overall Study|Adverse Event|0|||
164084511|NCT01579474|592673935|FG004|Overall Study|Adverse Event|0|||
164084512|NCT01579474|592673936|FG005|Overall Study|Adverse Event|1|||
164084513|NCT01579474|592673931|FG000|Overall Study|Lack of Efficacy|1|||
164084514|NCT01579474|592673932|FG001|Overall Study|Lack of Efficacy|0|||
164084515|NCT01579474|592673933|FG002|Overall Study|Lack of Efficacy|0|||
164084516|NCT01579474|592673934|FG003|Overall Study|Lack of Efficacy|0|||
164084517|NCT01579474|592673935|FG004|Overall Study|Lack of Efficacy|1|||
164084518|NCT01579474|592673936|FG005|Overall Study|Lack of Efficacy|0|||
164084519|NCT01579474|592673931|FG000|Overall Study|Withdrawal by Subject|1|||
164084520|NCT01579474|592673932|FG001|Overall Study|Withdrawal by Subject|0|||
164084521|NCT01579474|592673933|FG002|Overall Study|Withdrawal by Subject|0|||
164084522|NCT01579474|592673934|FG003|Overall Study|Withdrawal by Subject|0|||
164084523|NCT01579474|592673935|FG004|Overall Study|Withdrawal by Subject|0|||
164084524|NCT01579474|592673936|FG005|Overall Study|Withdrawal by Subject|0|||
164084525|NCT02295774|592673937|FG000|Overall Study|Physician Decision|1|||
164084526|NCT02295774|592673937|FG000|Overall Study|Withdrawal by Subject|2|||
164084527|NCT03532009|592673941|FG000|Overall Study|Other|1|||
164084528|NCT03532009|592673942|FG001|Overall Study|Other|1|||
164252157|NCT00819156|593288316|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
164252158|NCT00819156|593288311|FG000|Overall Study|Prostate-specific antigen progression|0|||
164252159|NCT00819156|593288312|FG001|Overall Study|Prostate-specific antigen progression|0|||
164252160|NCT00819156|593288313|FG002|Overall Study|Prostate-specific antigen progression|0|||
164084529|NCT03532009|592673941|FG000|Overall Study|Death|1|||
164084530|NCT03532009|592673942|FG001|Overall Study|Death|1|||
164084531|NCT03532009|592673941|FG000|Overall Study|Withdrawal by Patient|0|||
164084532|NCT03532009|592673942|FG001|Overall Study|Withdrawal by Patient|2|||
163991873|NCT06118385|592339626|FG009|Overall Study|Out-of-range blood tests|0|||
163991874|NCT06118385|592339627|FG010|Overall Study|Out-of-range blood tests|0|||
163991875|NCT06118385|592339628|FG011|Overall Study|Out-of-range blood tests|0|||
163991876|NCT01554579|592339629|FG000|Overall Study|Adverse Event|6|||
163991877|NCT01554579|592339630|FG001|Overall Study|Adverse Event|25|||
163991878|NCT01554579|592339629|FG000|Overall Study|Lack of Efficacy|2|||
163991879|NCT01554579|592339630|FG001|Overall Study|Lack of Efficacy|1|||
163991880|NCT01554579|592339629|FG000|Overall Study|Withdrawal by Subject|2|||
163991881|NCT01554579|592339630|FG001|Overall Study|Withdrawal by Subject|1|||
163991882|NCT00234039|592339631|FG000|Overall Study|Adverse Event|2|||
163991883|NCT00234039|592339631|FG000|Overall Study|Progression/relapse|34|||
163991884|NCT00234039|592339631|FG000|Overall Study|Other - Not Protocol Specified|3|||
163991885|NCT00234039|592339631|FG000|Overall Study|Ineligible|9|||
163991886|NCT00234039|592339631|FG000|Overall Study|No Protocol Treatment Received|2|||
163991887|NCT01808612|592339632|FG000|Treatment Period|Adverse Event|8|||
163991888|NCT01808612|592339633|FG001|Treatment Period|Adverse Event|4|||
163991889|NCT01808612|592339634|FG002|Treatment Period|Adverse Event|3|||
163991890|NCT01808612|592339632|FG000|Treatment Period|Lost to Follow-up|2|||
163991891|NCT01808612|592339633|FG001|Treatment Period|Lost to Follow-up|2|||
163991892|NCT01808612|592339634|FG002|Treatment Period|Lost to Follow-up|1|||
163991893|NCT01808612|592339632|FG000|Treatment Period|Protocol Violation|1|||
163991894|NCT01808612|592339633|FG001|Treatment Period|Protocol Violation|0|||
163991895|NCT01808612|592339634|FG002|Treatment Period|Protocol Violation|0|||
163991896|NCT01808612|592339632|FG000|Treatment Period|Withdrawal by Subject|1|||
163991897|NCT01808612|592339633|FG001|Treatment Period|Withdrawal by Subject|0|||
163991898|NCT01808612|592339634|FG002|Treatment Period|Withdrawal by Subject|4|||
163991899|NCT01808612|592339632|FG000|Treatment Period|Physician Decision|1|||
163991900|NCT01808612|592339633|FG001|Treatment Period|Physician Decision|0|||
163991901|NCT01808612|592339634|FG002|Treatment Period|Physician Decision|4|||
163991902|NCT01808612|592339632|FG000|Treatment Period|Sponsor Decision|1|||
163991903|NCT01808612|592339633|FG001|Treatment Period|Sponsor Decision|0|||
163991904|NCT01808612|592339634|FG002|Treatment Period|Sponsor Decision|0|||
163991905|NCT01808612|592339632|FG000|Treatment Period|Lack of Efficacy|1|||
163991906|NCT01808612|592339633|FG001|Treatment Period|Lack of Efficacy|1|||
163991907|NCT01808612|592339634|FG002|Treatment Period|Lack of Efficacy|2|||
163991908|NCT01808612|592339632|FG000|Discontinuation Period|Adverse Event|1|||
163991909|NCT01808612|592339633|FG001|Discontinuation Period|Adverse Event|0|||
164084533|NCT00368966|592673943|FG000|Infant Series|Withdrawal by Subject|11|||
164084534|NCT00368966|592673944|FG001|Infant Series|Withdrawal by Subject|6|||
164084535|NCT00368966|592673943|FG000|Infant Series|Protocol Violation|2|||
164084536|NCT00368966|592673944|FG001|Infant Series|Protocol Violation|1|||
164084537|NCT00368966|592673943|FG000|Infant Series|Lost to Follow-up|2|||
164084538|NCT00368966|592673944|FG001|Infant Series|Lost to Follow-up|0|||
164084539|NCT00368966|592673943|FG000|Infant Series|Randomization error|0|||
164084540|NCT00368966|592673944|FG001|Infant Series|Randomization error|1|||
164084541|NCT00368966|592673943|FG000|Infant Series|Failed to meet eligibility criteria|0|||
164084542|NCT00368966|592673944|FG001|Infant Series|Failed to meet eligibility criteria|1|||
164084543|NCT00368966|592673943|FG000|Infant Series|Adverse Event|0|||
164084544|NCT00368966|592673944|FG001|Infant Series|Adverse Event|1|||
164084545|NCT00368966|592673943|FG000|Infant Series|Failed to return|1|||
164084546|NCT00368966|592673944|FG001|Infant Series|Failed to return|0|||
164084547|NCT00368966|592673943|FG000|After Infant|Failed to return|3|||
164084548|NCT00368966|592673944|FG001|After Infant|Failed to return|1|||
164084549|NCT00368966|592673943|FG000|After Infant|Adverse Event|1|||
164084550|NCT00368966|592673944|FG001|After Infant|Adverse Event|2|||
164084551|NCT00368966|592673943|FG000|After Infant|Withdrawal by Subject|1|||
164084552|NCT00368966|592673944|FG001|After Infant|Withdrawal by Subject|1|||
164084553|NCT00368966|592673943|FG000|After Infant|Death|1|||
164084554|NCT00368966|592673944|FG001|After Infant|Death|0|||
164084555|NCT00368966|592673943|FG000|After Infant|Lost to Follow-up|0|||
164084556|NCT00368966|592673944|FG001|After Infant|Lost to Follow-up|1|||
164084557|NCT00368966|592673943|FG000|Toddler Dose|Withdrawal by Subject|1|||
164084558|NCT00368966|592673944|FG001|Toddler Dose|Withdrawal by Subject|1|||
164084559|NCT00368966|592673943|FG000|Toddler Dose|Lost to Follow-up|0|||
164084560|NCT00368966|592673944|FG001|Toddler Dose|Lost to Follow-up|2|||
164084561|NCT02866175|592673945|FG000|Overall Study|Adverse Event|56|||
164084562|NCT02866175|592673946|FG001|Overall Study|Adverse Event|54|||
164084563|NCT02866175|592673945|FG000|Overall Study|Withdrawal by Subject|31|||
164084564|NCT02866175|592673946|FG001|Overall Study|Withdrawal by Subject|52|||
164084565|NCT02866175|592673945|FG000|Overall Study|Death|30|||
164084566|NCT02866175|592673946|FG001|Overall Study|Death|23|||
164084567|NCT02866175|592673945|FG000|Overall Study|Other|7|||
164084568|NCT02866175|592673946|FG001|Overall Study|Other|14|||
164084569|NCT02866175|592673945|FG000|Overall Study|Progressive disease|1|||
164084570|NCT02866175|592673946|FG001|Overall Study|Progressive disease|1|||
164084571|NCT02866175|592673945|FG000|Overall Study|Lost to Follow-up|2|||
164084572|NCT02866175|592673946|FG001|Overall Study|Lost to Follow-up|0|||
164084573|NCT02866175|592673945|FG000|Overall Study|Lack of Efficacy|0|||
164084574|NCT02866175|592673946|FG001|Overall Study|Lack of Efficacy|1|||
164084575|NCT02866175|592673945|FG000|Overall Study|Physician Decision|3|||
164084576|NCT02866175|592673946|FG001|Overall Study|Physician Decision|15|||
164084577|NCT02866175|592673945|FG000|Overall Study|Did not receive treatment|5|||
164084578|NCT02866175|592673946|FG001|Overall Study|Did not receive treatment|15|||
164084579|NCT01694485|592673953|FG000|Overall Study|Withdrawal by Subject|20|||
164084580|NCT01694485|592673954|FG001|Overall Study|Withdrawal by Subject|6|||
164084581|NCT01694485|592673955|FG002|Overall Study|Withdrawal by Subject|7|||
164084582|NCT01694485|592673956|FG003|Overall Study|Withdrawal by Subject|25|||
164084583|NCT01694485|592673957|FG004|Overall Study|Withdrawal by Subject|18|||
164084584|NCT01694485|592673953|FG000|Overall Study|Sponsor Decision|3|||
164084585|NCT01694485|592673954|FG001|Overall Study|Sponsor Decision|0|||
164084586|NCT01694485|592673955|FG002|Overall Study|Sponsor Decision|0|||
164084587|NCT01694485|592673956|FG003|Overall Study|Sponsor Decision|2|||
164084588|NCT01694485|592673957|FG004|Overall Study|Sponsor Decision|0|||
164084589|NCT01694485|592673953|FG000|Overall Study|Lost to Follow-up|9|||
164084590|NCT01694485|592673954|FG001|Overall Study|Lost to Follow-up|1|||
164084591|NCT01694485|592673955|FG002|Overall Study|Lost to Follow-up|6|||
164084592|NCT01694485|592673956|FG003|Overall Study|Lost to Follow-up|10|||
164084593|NCT01694485|592673957|FG004|Overall Study|Lost to Follow-up|7|||
164084594|NCT01694485|592673953|FG000|Overall Study|Death|1|||
164084595|NCT01694485|592673954|FG001|Overall Study|Death|0|||
164084596|NCT01694485|592673955|FG002|Overall Study|Death|0|||
164084597|NCT01694485|592673956|FG003|Overall Study|Death|1|||
164084598|NCT01694485|592673957|FG004|Overall Study|Death|0|||
164084599|NCT02907203|592673958|FG000|Overall Study|Death|1|||
164084600|NCT02907203|592673958|FG000|Overall Study|Lost to Follow-up|3|||
164084601|NCT02907203|592673958|FG000|Overall Study|Withdrawal by Subject|3|||
164084602|NCT02907203|592673958|FG000|Overall Study|Surgical bypass|1|||
164252161|NCT00819156|593288314|FG003|Overall Study|Prostate-specific antigen progression|0|||
164252162|NCT00819156|593288315|FG004|Overall Study|Prostate-specific antigen progression|1|||
164252163|NCT00819156|593288316|FG005|Overall Study|Prostate-specific antigen progression|0|||
164252164|NCT00984594|593288317|FG000|Overall Study|Lost to Follow-up|1|||
164252165|NCT00984594|593288318|FG001|Overall Study|Lost to Follow-up|0|||
164252166|NCT00984594|593288317|FG000|Overall Study|Withdrawal by Subject|0|||
164252167|NCT00984594|593288318|FG001|Overall Study|Withdrawal by Subject|1|||
164252168|NCT00851890|593288319|FG000|Overall Study|Lost to Follow-up|0|||
164252169|NCT00851890|593288320|FG001|Overall Study|Lost to Follow-up|1|||
164252170|NCT00851890|593288321|FG002|Overall Study|Lost to Follow-up|0|||
164252171|NCT00851890|593288322|FG003|Overall Study|Lost to Follow-up|1|||
164252172|NCT03135431|593288323|FG000|Overall Study|Study Surgeon not available|2|||
164252173|NCT03135431|593288324|FG001|Overall Study|Study Surgeon not available|0|||
164252174|NCT00281099|593288327|FG000|Overall Study|Death|46|||
164252175|NCT00281099|593288328|FG001|Overall Study|Death|57|||
164252176|NCT00281099|593288327|FG000|Overall Study|Lost to Follow-up|10|||
164252177|NCT00281099|593288328|FG001|Overall Study|Lost to Follow-up|19|||
164252178|NCT00281099|593288327|FG000|Overall Study|Withdrawal by Subject|65|||
164252179|NCT00281099|593288328|FG001|Overall Study|Withdrawal by Subject|70|||
164252180|NCT00281099|593288327|FG000|Overall Study|Physician Decision|79|||
164252181|NCT00281099|593288328|FG001|Overall Study|Physician Decision|72|||
164252182|NCT00281099|593288327|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
164252183|NCT00281099|593288328|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
164252184|NCT00104728|593288329|FG000|Overall Study|screen failures|19|||
164252185|NCT03206918|593288330|FG000|Overall Study|Death|11|||
164252186|NCT03206918|593288330|FG000|Overall Study|Withdrawal by Subject|5|||
164252187|NCT03206918|593288330|FG000|Overall Study|Study terminated by sponsor|12|||
164252188|NCT03206918|593288330|FG000|Overall Study|Lost to Follow-up|3|||
164252189|NCT03206918|593288330|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
164252190|NCT02701764|593288331|FG000|Overall Study|Lost to Follow-up|0|||
164252191|NCT02701764|593288332|FG001|Overall Study|Lost to Follow-up|1|||
164252192|NCT06899737|593288338|FG000|Overall Study|Lost to Follow-up|19|||
164252193|NCT06899737|593288339|FG001|Overall Study|Lost to Follow-up|7|||
164252194|NCT01082081|593288340|FG000|Overall Study|Lost to Follow-up|0|||
164252195|NCT01082081|593288341|FG001|Overall Study|Lost to Follow-up|0|||
164252196|NCT01082081|593288342|FG002|Overall Study|Lost to Follow-up|1|||
164252197|NCT01082081|593288340|FG000|Overall Study|Withdrawal by Subject|0|||
164252198|NCT01082081|593288341|FG001|Overall Study|Withdrawal by Subject|0|||
164252199|NCT01082081|593288342|FG002|Overall Study|Withdrawal by Subject|1|||
164252200|NCT01082081|593288340|FG000|Overall Study|Other Reason|0|||
164252201|NCT01082081|593288341|FG001|Overall Study|Other Reason|1|||
164252202|NCT01082081|593288342|FG002|Overall Study|Other Reason|0|||
164252203|NCT01170273|593288343|FG000|Overall Study|Lost to Follow-up|6|||
164252204|NCT01170273|593288344|FG001|Overall Study|Lost to Follow-up|8|||
164252205|NCT01170273|593288343|FG000|Overall Study|Protocol Violation|1|||
164252206|NCT01170273|593288344|FG001|Overall Study|Protocol Violation|0|||
163991910|NCT01808612|592339634|FG002|Discontinuation Period|Adverse Event|0|||
163991911|NCT01808612|592339632|FG000|Discontinuation Period|Physician Decision|1|||
163991912|NCT01808612|592339633|FG001|Discontinuation Period|Physician Decision|0|||
163991913|NCT01808612|592339634|FG002|Discontinuation Period|Physician Decision|0|||
163991914|NCT01808612|592339632|FG000|Discontinuation Period|Lost to Follow-up|0|||
163991915|NCT01808612|592339633|FG001|Discontinuation Period|Lost to Follow-up|1|||
163991916|NCT01808612|592339634|FG002|Discontinuation Period|Lost to Follow-up|0|||
163991917|NCT03072160|592339637|FG000|Overall Study|Adverse Event|3|||
163991918|NCT03072160|592339638|FG001|Overall Study|Adverse Event|1|||
163991919|NCT03072160|592339637|FG000|Overall Study|Refused further treatment|6|||
163991920|NCT03072160|592339638|FG001|Overall Study|Refused further treatment|1|||
163991921|NCT03072160|592339637|FG000|Overall Study|Physician Decision|1|||
163991922|NCT03072160|592339638|FG001|Overall Study|Physician Decision|0|||
164252207|NCT01170273|593288343|FG000|Overall Study|Death|1|||
164252208|NCT01170273|593288344|FG001|Overall Study|Death|0|||
164252209|NCT01170273|593288343|FG000|Overall Study|Adverse Event|0|||
164252210|NCT01170273|593288344|FG001|Overall Study|Adverse Event|1|||
164252211|NCT03159468|593288345|FG000|Overall Study|Withdrawal by Subject|0|||
164252212|NCT03159468|593288346|FG001|Overall Study|Withdrawal by Subject|0|||
163991923|NCT03072160|592339637|FG000|Overall Study|Disease progression on study|1|||
164252213|NCT03159468|593288347|FG002|Overall Study|Withdrawal by Subject|3|||
164252214|NCT03159468|593288348|FG003|Overall Study|Withdrawal by Subject|0|||
164252215|NCT03159468|593288349|FG004|Overall Study|Withdrawal by Subject|0|||
164252216|NCT03159468|593288350|FG005|Overall Study|Withdrawal by Subject|0|||
164252217|NCT00375674|593288351|FG000|Overall Study|Other|26|||
164252218|NCT00375674|593288352|FG001|Overall Study|Other|18|||
164252219|NCT00375674|593288351|FG000|Overall Study|Death|67|||
164252220|NCT00375674|593288352|FG001|Overall Study|Death|76|||
164252221|NCT00375674|593288351|FG000|Overall Study|Participants refused further follow-up|31|||
164252222|NCT00375674|593288352|FG001|Overall Study|Participants refused further follow-up|30|||
164252223|NCT00375674|593288351|FG000|Overall Study|Lost to Follow-up|17|||
164252224|NCT00375674|593288352|FG001|Overall Study|Lost to Follow-up|15|||
164252225|NCT00375674|593288351|FG000|Overall Study|Enrolled but not treated|3|||
164252226|NCT00375674|593288352|FG001|Overall Study|Enrolled but not treated|2|||
164252227|NCT00912782|593288353|FG000|Overall Study|Death|2|||
164252228|NCT00912782|593288354|FG001|Overall Study|Death|1|||
164252229|NCT00912782|593288353|FG000|Overall Study|Lost to Follow-up|0|||
164252230|NCT00912782|593288354|FG001|Overall Study|Lost to Follow-up|1|||
164252231|NCT00912782|593288353|FG000|Overall Study|Did not receive vascular access type|1|||
164252232|NCT00912782|593288354|FG001|Overall Study|Did not receive vascular access type|2|||
164252233|NCT00912782|593288353|FG000|Overall Study|Relocated before study completion|0|||
164252234|NCT00912782|593288354|FG001|Overall Study|Relocated before study completion|1|||
164252235|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Adverse Event|1|||
164252236|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Adverse Event|0|||
164252237|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
164252238|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
164252239|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
164252240|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
164252241|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
164252242|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
164252243|NCT00301262|593289992|FG000|Double Blind Phase (DB)|Other|1|||
164252244|NCT00301262|593289993|FG001|Double Blind Phase (DB)|Other|4|||
164252245|NCT00301262|593289992|FG000|Open Label Phase (OL)|Adverse Event|1|||
164252246|NCT00301262|593289993|FG001|Open Label Phase (OL)|Adverse Event|0|||
164252247|NCT00301262|593289992|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
164252248|NCT00301262|593289993|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
164252249|NCT00301262|593289992|FG000|Open Label Phase (OL)|Other|2|||
164252250|NCT00301262|593289993|FG001|Open Label Phase (OL)|Other|0|||
164252251|NCT03530995|593289994|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
164252252|NCT03530995|593289995|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
164252253|NCT03530995|593289994|FG000|Part 1 Period 3|Protocol Violation|1|||
164252254|NCT03530995|593289995|FG001|Part 1 Period 3|Protocol Violation|0|||
164252255|NCT03530995|593289994|FG000|Part 1 Period 4|Physician Decision|1|||
164252256|NCT03530995|593289995|FG001|Part 1 Period 4|Physician Decision|0|||
164252257|NCT03530995|593289994|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
164252258|NCT03530995|593289995|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
164252259|NCT01443364|593290003|FG000|Overall Study|Lack of Efficacy|14|||
164252260|NCT01443364|593290003|FG000|Overall Study|Lost to Follow-up|3|||
164252261|NCT01443364|593290003|FG000|Overall Study|Withdrawal by Subject|5|||
164252262|NCT01443364|593290003|FG000|Overall Study|Other Reason|4|||
164252263|NCT01443364|593290003|FG000|Overall Study|SAE, non-fatal|6|||
164252264|NCT01443364|593290003|FG000|Overall Study|AE, non-serious non-fatal|8|||
164252265|NCT01443364|593290003|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164252266|NCT02650804|593290004|FG000|Overall Study|Adverse Event|3|||
164252267|NCT02650804|593290005|FG001|Overall Study|Adverse Event|2|||
164252268|NCT02650804|593290004|FG000|Overall Study|Death|1|||
164252269|NCT02650804|593290005|FG001|Overall Study|Death|2|||
164252270|NCT02650804|593290004|FG000|Overall Study|Progressive Disease|7|||
164252271|NCT02650804|593290005|FG001|Overall Study|Progressive Disease|10|||
164252272|NCT02650804|593290004|FG000|Overall Study|Physician Decision|0|||
164252273|NCT02650804|593290005|FG001|Overall Study|Physician Decision|2|||
164252274|NCT02650804|593290004|FG000|Overall Study|Withdrawal by Subject|1|||
164252275|NCT02650804|593290005|FG001|Overall Study|Withdrawal by Subject|4|||
164252276|NCT02650804|593290004|FG000|Overall Study|Symptomatic deterioration|5|||
164252277|NCT02650804|593290005|FG001|Overall Study|Symptomatic deterioration|7|||
164252278|NCT02650804|593290004|FG000|Overall Study|Protocol Violation|0|||
164252279|NCT02650804|593290005|FG001|Overall Study|Protocol Violation|1|||
164252280|NCT01986231|593290010|FG000|Overall Study|Adverse Event|1|||
164252281|NCT02150057|593290011|FG000|Overall Study|Lost to Follow-up|6|||
163887239|NCT03544281|591959366|FG004|Main Study Phase|Lost to Follow-up|0|||
163887240|NCT03544281|591959367|FG005|Main Study Phase|Lost to Follow-up|0|||
164252282|NCT02150057|593290012|FG001|Overall Study|Lost to Follow-up|4|||
164252283|NCT02388165|593290013|FG000|Overall Study|Study terminated by sponsor|5|||
164252284|NCT02388165|593290014|FG001|Overall Study|Study terminated by sponsor|5|||
164252285|NCT02388165|593290013|FG000|Overall Study|Other|11|||
164252286|NCT02388165|593290014|FG001|Overall Study|Other|13|||
164252287|NCT02388165|593290013|FG000|Overall Study|No longer meet eligibility criteria|40|||
164252288|NCT02388165|593290014|FG001|Overall Study|No longer meet eligibility criteria|43|||
164252289|NCT02388165|593290013|FG000|Overall Study|Withdrawal of consent|31|||
164252290|NCT02388165|593290014|FG001|Overall Study|Withdrawal of consent|32|||
164252291|NCT02388165|593290013|FG000|Overall Study|Lost to Follow-up|19|||
164252292|NCT02388165|593290014|FG001|Overall Study|Lost to Follow-up|20|||
164252293|NCT02388165|593290013|FG000|Overall Study|Death|13|||
164252294|NCT02388165|593290014|FG001|Overall Study|Death|10|||
164252295|NCT02388165|593290013|FG000|Overall Study|Adverse Event|3|||
164252296|NCT02388165|593290014|FG001|Overall Study|Adverse Event|5|||
164252297|NCT02388165|593290013|FG000|Overall Study|Did not meet entrance criteria|5|||
164252298|NCT02388165|593290014|FG001|Overall Study|Did not meet entrance criteria|2|||
164252299|NCT04551963|593290018|FG000|Overall Study|Physician Decision|1|||
164252300|NCT04551963|593290019|FG001|Overall Study|Physician Decision|1|||
164252301|NCT04551963|593290018|FG000|Overall Study|Death|1|||
164252302|NCT04551963|593290019|FG001|Overall Study|Death|0|||
164252303|NCT02974855|593290020|FG000|Overall Study|Adverse Event|0|||
164252304|NCT02974855|593290021|FG001|Overall Study|Adverse Event|1|||
164252305|NCT02974855|593290022|FG002|Overall Study|Adverse Event|0|||
164252306|NCT02974855|593290023|FG003|Overall Study|Adverse Event|1|||
164252307|NCT01474772|593290024|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
164252308|NCT01474772|593290025|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
164252309|NCT01474772|593290024|FG000|Period 1|AE not Related to Study Drug|1|||
164252310|NCT01474772|593290025|FG001|Period 1|AE not Related to Study Drug|0|||
164252311|NCT01474772|593290024|FG000|Period 1|Withdrawal by Subject|3|||
164252312|NCT01474772|593290025|FG001|Period 1|Withdrawal by Subject|1|||
164252313|NCT01474772|593290024|FG000|Period 1|Lost to Follow-up|1|||
164252314|NCT01474772|593290025|FG001|Period 1|Lost to Follow-up|0|||
164252315|NCT01474772|593290024|FG000|Period 1|Reason not Specified|1|||
164252316|NCT01474772|593290025|FG001|Period 1|Reason not Specified|1|||
164252317|NCT01474772|593290024|FG000|Washout|AE not Related to Study Drug|2|||
164252318|NCT01474772|593290025|FG001|Washout|AE not Related to Study Drug|0|||
164252319|NCT01474772|593290024|FG000|Washout|Withdrawal by Subject|1|||
164252320|NCT01474772|593290025|FG001|Washout|Withdrawal by Subject|0|||
164252321|NCT01474772|593290024|FG000|Washout|Lost to Follow-up|0|||
164252322|NCT01474772|593290025|FG001|Washout|Lost to Follow-up|1|||
164252323|NCT01474772|593290024|FG000|Washout|Reason not Specified|0|||
164252324|NCT01474772|593290025|FG001|Washout|Reason not Specified|1|||
164252325|NCT01474772|593290024|FG000|Period 2|Death|0|||
164252326|NCT01474772|593290025|FG001|Period 2|Death|1|||
164252327|NCT01474772|593290024|FG000|Period 2|AE Related to Study Drug|0|||
164252328|NCT01474772|593290025|FG001|Period 2|AE Related to Study Drug|1|||
164252329|NCT01474772|593290024|FG000|Period 2|AE not Related to Study Drug|4|||
164252330|NCT01474772|593290025|FG001|Period 2|AE not Related to Study Drug|1|||
164252331|NCT01474772|593290024|FG000|Period 2|Lack of Efficacy|1|||
164252332|NCT01474772|593290025|FG001|Period 2|Lack of Efficacy|0|||
164252333|NCT01474772|593290024|FG000|Period 2|Withdrawal by Subject|3|||
164252334|NCT01474772|593290025|FG001|Period 2|Withdrawal by Subject|4|||
164252335|NCT01474772|593290024|FG000|Period 2|Lost to Follow-up|1|||
164252336|NCT01474772|593290025|FG001|Period 2|Lost to Follow-up|1|||
164252337|NCT01474772|593290024|FG000|Period 2|Reason not Specified|0|||
164252338|NCT01474772|593290025|FG001|Period 2|Reason not Specified|2|||
164252339|NCT01474772|593290024|FG000|Follow-up|AE not Related to Study Drug|0|||
164252340|NCT01474772|593290025|FG001|Follow-up|AE not Related to Study Drug|1|||
164252341|NCT00633074|593290026|FG000|Overall Study|Adverse Event|1|||
164252342|NCT00633074|593290027|FG001|Overall Study|Adverse Event|0|||
164252343|NCT00365105|593290028|FG000|Overall Study|Protocol Violation|5|||
164252344|NCT00365105|593290029|FG001|Overall Study|Protocol Violation|8|||
164252345|NCT00748618|593290030|FG000|Overall Study|Adverse Event|1|||
164252346|NCT00748618|593290031|FG001|Overall Study|Adverse Event|0|||
164252347|NCT06004895|593290032|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
164252348|NCT06004895|593290032|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
164252349|NCT00466947|593290033|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
164252350|NCT00466947|593290034|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
164252351|NCT00466947|593290033|FG000|Study End Analysis Period|Adverse Event|35|||
164252352|NCT00466947|593290034|FG001|Study End Analysis Period|Adverse Event|43|||
164252353|NCT00466947|593290033|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
164252354|NCT00466947|593290034|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
164252355|NCT00466947|593290033|FG000|Study End Analysis Period|Physician Decision|29|||
164252356|NCT00466947|593290034|FG001|Study End Analysis Period|Physician Decision|29|||
164252357|NCT00466947|593290033|FG000|Study End Analysis Period|Protocol Violation|9|||
163887241|NCT03544281|591959368|FG006|Main Study Phase|Lost to Follow-up|0|||
164252358|NCT00466947|593290034|FG001|Study End Analysis Period|Protocol Violation|17|||
164252359|NCT00466947|593290033|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
164252360|NCT00466947|593290034|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
164252361|NCT00466947|593290033|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
164252362|NCT00466947|593290034|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
164252363|NCT00466947|593290033|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
164252364|NCT00466947|593290034|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
164252365|NCT00466947|593290033|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
164252366|NCT00466947|593290034|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
164252367|NCT00878254|593290035|FG000|Overall Study|Physician Decision|1|||
164252368|NCT00878254|593290035|FG000|Overall Study|Death|1|||
164252369|NCT00878254|593290035|FG000|Overall Study|Withdrawal by Subject|1|||
164252370|NCT01995526|593290036|FG000|Overall Study|Physician Decision|1|||
164252371|NCT03367403|593290041|FG000|Overall Study|Adverse Event|20|||
164252372|NCT03367403|593290042|FG001|Overall Study|Adverse Event|6|||
164252373|NCT03367403|593290043|FG002|Overall Study|Adverse Event|2|||
164252374|NCT03367403|593290041|FG000|Overall Study|Withdrawal by Subject|12|||
164252375|NCT03367403|593290042|FG001|Overall Study|Withdrawal by Subject|13|||
164252376|NCT03367403|593290043|FG002|Overall Study|Withdrawal by Subject|1|||
164252377|NCT03367403|593290041|FG000|Overall Study|Death|1|||
164252378|NCT03367403|593290042|FG001|Overall Study|Death|2|||
164252379|NCT03367403|593290043|FG002|Overall Study|Death|0|||
164252380|NCT03367403|593290041|FG000|Overall Study|Physician Decision|0|||
164252381|NCT03367403|593290042|FG001|Overall Study|Physician Decision|1|||
164252382|NCT03367403|593290043|FG002|Overall Study|Physician Decision|0|||
163887242|NCT03544281|591959369|FG007|Main Study Phase|Lost to Follow-up|0|||
163887243|NCT03544281|591959370|FG008|Main Study Phase|Lost to Follow-up|0|||
163887244|NCT03544281|591959371|FG009|Main Study Phase|Lost to Follow-up|0|||
163887245|NCT03544281|591959372|FG010|Main Study Phase|Lost to Follow-up|1|||
163887246|NCT03544281|591959373|FG011|Main Study Phase|Lost to Follow-up|0|||
163887247|NCT03544281|591959374|FG012|Main Study Phase|Lost to Follow-up|0|||
163887248|NCT03544281|591959375|FG013|Main Study Phase|Lost to Follow-up|0|||
163887249|NCT03544281|591959376|FG014|Main Study Phase|Lost to Follow-up|0|||
163887250|NCT03544281|591959377|FG015|Main Study Phase|Lost to Follow-up|0|||
163887251|NCT03544281|591959378|FG016|Main Study Phase|Lost to Follow-up|0|||
163887252|NCT03544281|591959379|FG017|Main Study Phase|Lost to Follow-up|0|||
163887253|NCT03544281|591959380|FG018|Main Study Phase|Lost to Follow-up|0|||
163887254|NCT03544281|591959381|FG019|Main Study Phase|Lost to Follow-up|0|||
163887255|NCT03544281|591959382|FG020|Main Study Phase|Lost to Follow-up|0|||
163887256|NCT03544281|591959383|FG021|Main Study Phase|Lost to Follow-up|0|||
163887257|NCT03544281|591959362|FG000|Main Study Phase|Physician Decision|0|||
163887258|NCT03544281|591959363|FG001|Main Study Phase|Physician Decision|0|||
163887259|NCT03544281|591959364|FG002|Main Study Phase|Physician Decision|0|||
164084603|NCT01798485|592673959|FG000|Overall Study|Adverse Event|32|||
164084604|NCT01798485|592673960|FG001|Overall Study|Adverse Event|40|||
164084605|NCT01798485|592673959|FG000|Overall Study|Withdrawal by Subject|27|||
164084606|NCT01798485|592673960|FG001|Overall Study|Withdrawal by Subject|31|||
164084607|NCT01798485|592673959|FG000|Overall Study|Lost to Follow-up|0|||
164084608|NCT01798485|592673960|FG001|Overall Study|Lost to Follow-up|3|||
164084609|NCT01798485|592673959|FG000|Overall Study|Physician Decision|14|||
164084610|NCT01798485|592673960|FG001|Overall Study|Physician Decision|10|||
164084611|NCT01798485|592673959|FG000|Overall Study|Objective Disease Progression|152|||
164084612|NCT01798485|592673960|FG001|Overall Study|Objective Disease Progression|106|||
164084613|NCT01798485|592673959|FG000|Overall Study|Death|25|||
164084614|NCT01798485|592673960|FG001|Overall Study|Death|22|||
164084615|NCT01798485|592673959|FG000|Overall Study|Sponsor Decision|61|||
164084616|NCT01798485|592673960|FG001|Overall Study|Sponsor Decision|54|||
164084617|NCT01798485|592673959|FG000|Overall Study|Clinical Progression|35|||
164084618|NCT01798485|592673960|FG001|Overall Study|Clinical Progression|24|||
164084619|NCT03687125|592673961|FG000|Overall Study|Progressive Disease|2|||
164084620|NCT03687125|592673962|FG001|Overall Study|Progressive Disease|1|||
164084621|NCT03687125|592673961|FG000|Overall Study|Protocol Violation|1|||
164084622|NCT03687125|592673962|FG001|Overall Study|Protocol Violation|0|||
164084623|NCT00770991|592673963|FG000|Overall Study|Physician Decision|2|||
164084624|NCT00770991|592673964|FG001|Overall Study|Physician Decision|0|||
164252383|NCT03367403|593290041|FG000|Overall Study|Protocol Violation|1|||
164252384|NCT03367403|593290042|FG001|Overall Study|Protocol Violation|1|||
164252385|NCT03367403|593290043|FG002|Overall Study|Protocol Violation|0|||
164252386|NCT03367403|593290041|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164252387|NCT03367403|593290042|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
164252388|NCT03367403|593290043|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164252389|NCT03367403|593290041|FG000|Overall Study|COVID-19|3|||
164252390|NCT03367403|593290042|FG001|Overall Study|COVID-19|6|||
164252391|NCT03367403|593290043|FG002|Overall Study|COVID-19|0|||
164252392|NCT03367403|593290041|FG000|Overall Study|Abuse of Alcohol Intake|0|||
164252393|NCT03367403|593290042|FG001|Overall Study|Abuse of Alcohol Intake|1|||
164252394|NCT03367403|593290043|FG002|Overall Study|Abuse of Alcohol Intake|0|||
164252395|NCT03367403|593290041|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
164252396|NCT03367403|593290042|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
164252397|NCT03367403|593290043|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
164252398|NCT02321319|593290048|FG000|Overall Study|Product discontinued|5|||
164252399|NCT03497975|593290051|FG000|Overall Study|Withdrew Consent|34|||
164252400|NCT03497975|593290052|FG001|Overall Study|Withdrew Consent|35|||
164252401|NCT03497975|593290051|FG000|Overall Study|Lost to Follow-up|7|||
164252402|NCT03497975|593290052|FG001|Overall Study|Lost to Follow-up|7|||
164252403|NCT03497975|593290051|FG000|Overall Study|Physician Decision|4|||
163887260|NCT03544281|591959365|FG003|Main Study Phase|Physician Decision|0|||
164084625|NCT00770991|592673963|FG000|Overall Study|Withdrawal by Subject|1|||
164084626|NCT00770991|592673964|FG001|Overall Study|Withdrawal by Subject|0|||
164084627|NCT00770991|592673963|FG000|Overall Study|Adverse Event|1|||
164252404|NCT03497975|593290052|FG001|Overall Study|Physician Decision|5|||
164252405|NCT03497975|593290051|FG000|Overall Study|Discontinued|42|||
164252406|NCT03497975|593290052|FG001|Overall Study|Discontinued|39|||
164252407|NCT03497975|593290051|FG000|Overall Study|Reason Not Specified|15|||
164252408|NCT03497975|593290052|FG001|Overall Study|Reason Not Specified|14|||
164252409|NCT02141399|593290053|FG000|Overall Study|Adverse Event|158|||
164252410|NCT02141399|593290053|FG000|Overall Study|Lack of Efficacy|62|||
164252411|NCT02141399|593290053|FG000|Overall Study|Lost to Follow-up|151|||
164252412|NCT02141399|593290053|FG000|Overall Study|Non-compliance with study drug|18|||
164252413|NCT02141399|593290053|FG000|Overall Study|Other|45|||
164252414|NCT02141399|593290053|FG000|Overall Study|Physician Decision|17|||
164252415|NCT02141399|593290053|FG000|Overall Study|Pregnancy|3|||
164252416|NCT02141399|593290053|FG000|Overall Study|Protocol Violation|38|||
164252417|NCT02141399|593290053|FG000|Overall Study|Withdrawal by Subject|238|||
164252418|NCT02141399|593290053|FG000|Overall Study|Failure to meet eligibility criteria|14|||
164252419|NCT00606034|593290056|FG000|Overall Study|incarceration|1|||
164252420|NCT01734395|593290057|FG000|Overall Study|Other|65|||
164252421|NCT01734395|593290057|FG000|Overall Study|Lost to Follow-up|287|||
164252422|NCT01734395|593290057|FG000|Overall Study|Lack of Efficacy|5|||
164252423|NCT01734395|593290057|FG000|Overall Study|Adverse Event|40|||
164252424|NCT01734395|593290057|FG000|Overall Study|Withdrawal by Subject|10|||
164252425|NCT01734395|593290057|FG000|Overall Study|Missing the reasons for not completed|3|||
164252426|NCT00935493|593290063|FG000|Overall Study|Lost to Follow-up|1|||
164252427|NCT00935493|593290064|FG001|Overall Study|Lost to Follow-up|1|||
164252428|NCT00935493|593290065|FG002|Overall Study|Lost to Follow-up|1|||
164252429|NCT00935493|593290063|FG000|Overall Study|Treatment Discontinued|0|||
164252430|NCT00935493|593290064|FG001|Overall Study|Treatment Discontinued|1|||
164252431|NCT00935493|593290065|FG002|Overall Study|Treatment Discontinued|0|||
164252432|NCT01355679|593290067|FG000|Overall Study|benign tumor types found at biopsy|2|||
164252433|NCT02027311|593290068|FG000|Overall Study|Protocol Violation|3|||
164252434|NCT02027311|593290069|FG001|Overall Study|Protocol Violation|2|||
164252435|NCT00964002|593290071|FG000|Overall Study|Protocol Violation|8|||
164252436|NCT03768089|593290074|FG000|Part A|Lost to Follow-up|0|||
164252437|NCT03768089|593290075|FG001|Part A|Lost to Follow-up|0|||
164252438|NCT03768089|593290076|FG002|Part A|Lost to Follow-up|0|||
164252439|NCT03768089|593290077|FG003|Part A|Lost to Follow-up|0|||
164252440|NCT03768089|593290078|FG004|Part A|Lost to Follow-up|1|||
164252441|NCT03768089|593290079|FG005|Part A|Lost to Follow-up|0|||
164252442|NCT03768089|593290080|FG006|Part A|Lost to Follow-up|0|||
164252443|NCT03768089|593290081|FG007|Part A|Lost to Follow-up|0|||
164252444|NCT03768089|593290082|FG008|Part A|Lost to Follow-up|0|||
164252445|NCT03768089|593290083|FG009|Part A|Lost to Follow-up|0|||
164252446|NCT03768089|593290084|FG010|Part A|Lost to Follow-up|0|||
164252447|NCT03768089|593290085|FG011|Part A|Lost to Follow-up|0|||
164252448|NCT03768089|593290086|FG012|Part A|Lost to Follow-up|0|||
164252449|NCT03768089|593290087|FG013|Part A|Lost to Follow-up|0|||
164252450|NCT03768089|593290088|FG014|Part A|Lost to Follow-up|0|||
163887261|NCT03544281|591959366|FG004|Main Study Phase|Physician Decision|0|||
164252451|NCT03768089|593290089|FG015|Part A|Lost to Follow-up|0|||
164252452|NCT03768089|593290090|FG016|Part A|Lost to Follow-up|0|||
164252453|NCT03768089|593290091|FG017|Part A|Lost to Follow-up|0|||
164252454|NCT03768089|593290074|FG000|Part C|Randomized, Never Dosed|0|||
164252455|NCT03768089|593290075|FG001|Part C|Randomized, Never Dosed|0|||
164252456|NCT03768089|593290076|FG002|Part C|Randomized, Never Dosed|0|||
164252457|NCT03768089|593290077|FG003|Part C|Randomized, Never Dosed|0|||
164252458|NCT03768089|593290078|FG004|Part C|Randomized, Never Dosed|0|||
164252459|NCT03768089|593290079|FG005|Part C|Randomized, Never Dosed|0|||
164252460|NCT03768089|593290080|FG006|Part C|Randomized, Never Dosed|0|||
164252461|NCT03768089|593290081|FG007|Part C|Randomized, Never Dosed|0|||
164252462|NCT03768089|593290082|FG008|Part C|Randomized, Never Dosed|0|||
164252463|NCT03768089|593290083|FG009|Part C|Randomized, Never Dosed|0|||
164252464|NCT03768089|593290084|FG010|Part C|Randomized, Never Dosed|0|||
164252465|NCT03768089|593290085|FG011|Part C|Randomized, Never Dosed|0|||
164252466|NCT03768089|593290086|FG012|Part C|Randomized, Never Dosed|0|||
164252467|NCT03768089|593290087|FG013|Part C|Randomized, Never Dosed|0|||
164252468|NCT03768089|593290088|FG014|Part C|Randomized, Never Dosed|1|||
164252469|NCT03768089|593290089|FG015|Part C|Randomized, Never Dosed|0|||
164252470|NCT03768089|593290090|FG016|Part C|Randomized, Never Dosed|0|||
164252471|NCT03768089|593290091|FG017|Part C|Randomized, Never Dosed|0|||
164252472|NCT02091362|593290094|FG000|Period 1|Protocol Violation|1|||
164252473|NCT02091362|593290095|FG001|Period 1|Protocol Violation|0|||
164252474|NCT02091362|593290094|FG000|Period 1|Withdrawal by Subject|2|||
164252475|NCT02091362|593290095|FG001|Period 1|Withdrawal by Subject|3|||
164252476|NCT02091362|593290094|FG000|Period 1|Lost to Follow-up|0|||
164252477|NCT02091362|593290095|FG001|Period 1|Lost to Follow-up|1|||
164252478|NCT02091362|593290094|FG000|Period 1|Adverse Event|2|||
164252479|NCT02091362|593290095|FG001|Period 1|Adverse Event|0|||
164252480|NCT02091362|593290094|FG000|Wash-out|Lost to Follow-up|1|||
164252481|NCT02091362|593290095|FG001|Wash-out|Lost to Follow-up|1|||
164252482|NCT02091362|593290094|FG000|Wash-out|Withdrawal by Subject|0|||
164252483|NCT02091362|593290095|FG001|Wash-out|Withdrawal by Subject|2|||
164252484|NCT02091362|593290094|FG000|Period 2|Adverse Event|1|||
164252485|NCT02091362|593290095|FG001|Period 2|Adverse Event|0|||
164252486|NCT02091362|593290094|FG000|Period 2|Lost to Follow-up|0|||
164252487|NCT02091362|593290095|FG001|Period 2|Lost to Follow-up|1|||
164252488|NCT02091362|593290094|FG000|Period 2|Withdrawal by Subject|1|||
164252489|NCT02091362|593290095|FG001|Period 2|Withdrawal by Subject|1|||
164252490|NCT02565147|593290096|FG000|Overall Study|Withdrawal by Subject|5|||
164252491|NCT02565147|593290097|FG001|Overall Study|Withdrawal by Subject|1|||
164252492|NCT02565147|593290096|FG000|Overall Study|Lost to Follow-up|0|||
164252493|NCT02565147|593290097|FG001|Overall Study|Lost to Follow-up|1|||
164252494|NCT02565147|593290096|FG000|Overall Study|Death|1|||
164252495|NCT02565147|593290097|FG001|Overall Study|Death|1|||
164252496|NCT00787839|593290098|FG000|Overall Study|Failure to have the OGTT was most common|404|||
164252497|NCT03799952|593290101|FG000|Overall Study|Program was too easy, discontinued|1|||
164252498|NCT03799952|593290102|FG001|Overall Study|Program was too easy, discontinued|0|||
164252499|NCT03799952|593290101|FG000|Overall Study|Lost to Follow-up|0|||
164252500|NCT03799952|593290102|FG001|Overall Study|Lost to Follow-up|2|||
164252501|NCT00902850|593290103|FG000|Overall Study|Physician Decision|2|||
164252502|NCT00902850|593290104|FG001|Overall Study|Physician Decision|2|||
164252503|NCT03292640|593290107|FG000|Overall Study|Withdrawal by Subject|17|||
164252504|NCT03292640|593290108|FG001|Overall Study|Withdrawal by Subject|16|||
164252505|NCT03292640|593290107|FG000|Overall Study|Adverse Event|20|||
164252506|NCT03292640|593290108|FG001|Overall Study|Adverse Event|2|||
164252507|NCT03292640|593290107|FG000|Overall Study|Lost to Follow-up|24|||
164252508|NCT03292640|593290108|FG001|Overall Study|Lost to Follow-up|24|||
164252509|NCT02015481|593290109|FG000|Overall Study|Death|1|||
164252510|NCT03122145|593290111|FG000|Overall Study|Concurrent respiratory disease|3|||
164252511|NCT03122145|593290112|FG001|Overall Study|Concurrent respiratory disease|0|||
164252512|NCT00079391|593290113|FG000|Overall Study|Withdrawal by Subject|1|||
164252513|NCT00837161|593290114|FG000|Overall Study|refused hysterectomy|2|||
164252514|NCT01456195|593292141|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164252515|NCT01456195|593292142|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
164252516|NCT01456195|593292143|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164252517|NCT01456195|593292141|FG000|Overall Study|Lost to Follow-up|3|||
164252518|NCT01456195|593292142|FG001|Overall Study|Lost to Follow-up|1|||
163887262|NCT03544281|591959367|FG005|Main Study Phase|Physician Decision|0|||
163887263|NCT03544281|591959368|FG006|Main Study Phase|Physician Decision|0|||
163887264|NCT03544281|591959369|FG007|Main Study Phase|Physician Decision|1|||
163887265|NCT03544281|591959370|FG008|Main Study Phase|Physician Decision|0|||
163887266|NCT03544281|591959371|FG009|Main Study Phase|Physician Decision|0|||
163887267|NCT03544281|591959372|FG010|Main Study Phase|Physician Decision|0|||
163887268|NCT03544281|591959373|FG011|Main Study Phase|Physician Decision|0|||
164252519|NCT01456195|593292143|FG002|Overall Study|Lost to Follow-up|3|||
163887269|NCT03544281|591959374|FG012|Main Study Phase|Physician Decision|0|||
164084628|NCT00770991|592673964|FG001|Overall Study|Adverse Event|5|||
164252520|NCT01456195|593292141|FG000|Overall Study|Voluntary Withdrawal|5|||
164252521|NCT01456195|593292142|FG001|Overall Study|Voluntary Withdrawal|3|||
164252522|NCT01456195|593292143|FG002|Overall Study|Voluntary Withdrawal|7|||
164252523|NCT01456195|593292141|FG000|Overall Study|Lack of Efficacy|0|||
164338959|NCT02202980|593617110|FG012|Overall Study|Lack of Efficacy|10|||
164338960|NCT02202980|593617111|FG013|Overall Study|Lack of Efficacy|0|||
164338961|NCT02202980|593617098|FG000|Overall Study|Protocol Violation|0|||
164084629|NCT00770991|592673963|FG000|Overall Study|Pregnancy|1|||
164252524|NCT01456195|593292142|FG001|Overall Study|Lack of Efficacy|1|||
164252525|NCT01456195|593292143|FG002|Overall Study|Lack of Efficacy|0|||
164338962|NCT02202980|593617099|FG001|Overall Study|Protocol Violation|0|||
164252526|NCT01456195|593292141|FG000|Overall Study|Other Reasons|2|||
164252527|NCT01456195|593292142|FG001|Overall Study|Other Reasons|1|||
164252528|NCT01456195|593292143|FG002|Overall Study|Other Reasons|3|||
164252529|NCT02109432|593292144|FG000|Overall Study|Withdrawal by Subject|1|||
164252530|NCT03372551|593292151|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
164252531|NCT03372551|593292152|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
164252532|NCT04683029|593292162|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
164252533|NCT04683029|593292163|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
164252534|NCT04683029|593292164|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
164252535|NCT04683029|593292165|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
164252536|NCT04683029|593292162|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
164252537|NCT04683029|593292163|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
164252538|NCT04683029|593292164|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
164252539|NCT04683029|593292165|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
164252540|NCT04683029|593292162|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
164252541|NCT04683029|593292163|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
164252542|NCT04683029|593292164|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
164252543|NCT04683029|593292165|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
164252544|NCT04299308|593292169|FG000|Overall Study|Withdrawal by Subject|1|||
164252545|NCT04299308|593292170|FG001|Overall Study|Withdrawal by Subject|0|||
164252546|NCT04299308|593292169|FG000|Overall Study|issue with PET image (1)|1|||
164252547|NCT04299308|593292170|FG001|Overall Study|issue with PET image (1)|0|||
164252548|NCT02920528|593292173|FG000|Overall Study|Incomplete Data|1|||
164252549|NCT02920528|593292174|FG001|Overall Study|Incomplete Data|1|||
164252550|NCT02920528|593292175|FG002|Overall Study|Incomplete Data|1|||
164252551|NCT02920528|593292173|FG000|Overall Study|Adverse Event|0|||
164252552|NCT02920528|593292174|FG001|Overall Study|Adverse Event|0|||
164252553|NCT02920528|593292175|FG002|Overall Study|Adverse Event|3|||
164252554|NCT02920528|593292173|FG000|Overall Study|Did not meet inclusion criteria|2|||
163991924|NCT03072160|592339638|FG001|Overall Study|Disease progression on study|1|||
163991925|NCT03072160|592339637|FG000|Overall Study|No contact|0|||
163991926|NCT03072160|592339638|FG001|Overall Study|No contact|1|||
163991927|NCT01046695|592339639|FG000|Overall Study|Subject had a pacemaker|0|||
163991928|NCT01046695|592339640|FG001|Overall Study|Subject had a pacemaker|1|||
163991929|NCT01046695|592339639|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
163991930|NCT01046695|592339640|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
163991931|NCT04426695|592339641|FG000|Overall Study|Death|2|||
163991932|NCT04426695|592339642|FG001|Overall Study|Death|0|||
163991933|NCT04426695|592339643|FG002|Overall Study|Death|1|||
163991934|NCT04426695|592339644|FG003|Overall Study|Death|27|||
163991935|NCT04426695|592339645|FG004|Overall Study|Death|25|||
163991936|NCT04426695|592339646|FG005|Overall Study|Death|21|||
163991937|NCT04426695|592339647|FG006|Overall Study|Death|42|||
163991938|NCT04426695|592339648|FG007|Overall Study|Death|23|||
163991939|NCT04426695|592339649|FG008|Overall Study|Death|37|||
163991940|NCT04426695|592339650|FG009|Overall Study|Death|14|||
163991941|NCT04426695|592339651|FG010|Overall Study|Death|8|||
163991942|NCT04426695|592339652|FG011|Overall Study|Death|7|||
163991943|NCT04426695|592339653|FG012|Overall Study|Death|13|||
164252555|NCT02920528|593292174|FG001|Overall Study|Did not meet inclusion criteria|0|||
164252556|NCT02920528|593292175|FG002|Overall Study|Did not meet inclusion criteria|1|||
164252557|NCT03596047|593292177|FG000|Overall Study|Withdrawal by Subject|7|||
164252558|NCT03596047|593292178|FG001|Overall Study|Withdrawal by Subject|4|||
164252559|NCT03596047|593292177|FG000|Overall Study|Lost to Follow-up|0|||
164252560|NCT03596047|593292178|FG001|Overall Study|Lost to Follow-up|2|||
164252561|NCT00066703|593292179|FG000|Overall Study|Adverse Event|80|||
164252562|NCT00066703|593292180|FG001|Overall Study|Adverse Event|111|||
164338963|NCT02202980|593617100|FG002|Overall Study|Protocol Violation|0|||
164338964|NCT02202980|593617101|FG003|Overall Study|Protocol Violation|3|||
164338965|NCT02202980|593617102|FG004|Overall Study|Protocol Violation|3|||
164338966|NCT02202980|593617103|FG005|Overall Study|Protocol Violation|0|||
164338967|NCT02202980|593617104|FG006|Overall Study|Protocol Violation|0|||
164338968|NCT02202980|593617105|FG007|Overall Study|Protocol Violation|0|||
164338969|NCT02202980|593617106|FG008|Overall Study|Protocol Violation|0|||
164338970|NCT02202980|593617107|FG009|Overall Study|Protocol Violation|0|||
164338971|NCT02202980|593617108|FG010|Overall Study|Protocol Violation|0|||
164338972|NCT02202980|593617109|FG011|Overall Study|Protocol Violation|0|||
164338973|NCT02202980|593617110|FG012|Overall Study|Protocol Violation|0|||
164338974|NCT02202980|593617111|FG013|Overall Study|Protocol Violation|0|||
164338975|NCT02202980|593617098|FG000|Overall Study|Lost to Follow-up|0|||
164338976|NCT02202980|593617099|FG001|Overall Study|Lost to Follow-up|1|||
164338977|NCT02202980|593617100|FG002|Overall Study|Lost to Follow-up|1|||
164338978|NCT02202980|593617101|FG003|Overall Study|Lost to Follow-up|1|||
164252563|NCT00066703|593292179|FG000|Overall Study|Death|3|||
164338979|NCT02202980|593617102|FG004|Overall Study|Lost to Follow-up|0|||
164338980|NCT02202980|593617103|FG005|Overall Study|Lost to Follow-up|0|||
164338981|NCT02202980|593617104|FG006|Overall Study|Lost to Follow-up|0|||
164338982|NCT02202980|593617105|FG007|Overall Study|Lost to Follow-up|1|||
164338983|NCT02202980|593617106|FG008|Overall Study|Lost to Follow-up|1|||
164338984|NCT02202980|593617107|FG009|Overall Study|Lost to Follow-up|0|||
163991944|NCT04426695|592339654|FG013|Overall Study|Death|25|||
164252564|NCT00066703|593292180|FG001|Overall Study|Death|0|||
164252565|NCT00066703|593292179|FG000|Overall Study|Lack of Efficacy|114|||
164252566|NCT00066703|593292180|FG001|Overall Study|Lack of Efficacy|69|||
164252567|NCT00066703|593292179|FG000|Overall Study|Lost to Follow-up|31|||
164084630|NCT00770991|592673964|FG001|Overall Study|Pregnancy|0|||
164084631|NCT00490061|592673966|FG000|Overall Study|Physician Decision|1|||
164084632|NCT00952484|592673967|FG000|Overall Study|Withdrawal by Subject|0|||
164084633|NCT00952484|592673968|FG001|Overall Study|Withdrawal by Subject|1|||
164084634|NCT00952484|592673969|FG002|Overall Study|Withdrawal by Subject|0|||
164084635|NCT02750306|592673970|FG000|Overall Study|Withdrawal by Subject|5|||
164084636|NCT02750306|592673971|FG001|Overall Study|Withdrawal by Subject|2|||
164084637|NCT02750306|592673970|FG000|Overall Study|Protocol Violation|1|||
164084638|NCT02750306|592673971|FG001|Overall Study|Protocol Violation|0|||
164084639|NCT00585351|592673975|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
164084640|NCT00585351|592673976|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
164084641|NCT00585351|592673977|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
164084642|NCT00585351|592673978|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
164084643|NCT00585351|592673979|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
164084644|NCT00585351|592673980|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
164084645|NCT00585351|592673981|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
164084646|NCT00585351|592673982|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
164084647|NCT00585351|592673975|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
164084648|NCT00585351|592673976|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
164084649|NCT00585351|592673977|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
164084650|NCT00585351|592673978|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
164084651|NCT00585351|592673979|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
164084652|NCT00585351|592673980|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
164084653|NCT00585351|592673981|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
164084654|NCT00585351|592673982|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
164084655|NCT00585351|592673975|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
164084656|NCT00585351|592673976|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
164084657|NCT00585351|592673977|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
164084658|NCT00585351|592673978|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
164084659|NCT00585351|592673979|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
164084660|NCT00585351|592673980|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
164252568|NCT00066703|593292180|FG001|Overall Study|Lost to Follow-up|28|||
164252569|NCT00066703|593292179|FG000|Overall Study|Withdrawal by Subject|38|||
164252570|NCT00066703|593292180|FG001|Overall Study|Withdrawal by Subject|63|||
164252571|NCT00066703|593292179|FG000|Overall Study|Treatment ongoing|346|||
164252572|NCT00066703|593292180|FG001|Overall Study|Treatment ongoing|311|||
164252573|NCT01696968|593292181|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
164252574|NCT01696968|593292182|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
164252575|NCT01696968|593292181|FG000|Overall Study|Died Before Randomization|3|||
164252576|NCT01696968|593292182|FG001|Overall Study|Died Before Randomization|8|||
164252577|NCT01696968|593292181|FG000|Overall Study|Died Before ASU (Control)|278|||
164252578|NCT01696968|593292182|FG001|Overall Study|Died Before ASU (Control)|0|||
164252579|NCT01696968|593292181|FG000|Overall Study|Refused ASU (Control)|920|||
164252580|NCT01696968|593292182|FG001|Overall Study|Refused ASU (Control)|0|||
164252581|NCT01696968|593292181|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
164252582|NCT01696968|593292182|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
164252583|NCT00734604|593292183|FG000|Overall Study|Adverse Event|0|||
164252584|NCT00734604|593292184|FG001|Overall Study|Adverse Event|2|||
164252585|NCT00734604|593292185|FG002|Overall Study|Adverse Event|0|||
164252586|NCT00734604|593292186|FG003|Overall Study|Adverse Event|2|||
164252587|NCT00734604|593292187|FG004|Overall Study|Adverse Event|1|||
164252588|NCT00734604|593292188|FG005|Overall Study|Adverse Event|1|||
164252589|NCT00734604|593292183|FG000|Overall Study|Serious Adverse Event|1|||
164252590|NCT00734604|593292184|FG001|Overall Study|Serious Adverse Event|0|||
164252591|NCT00734604|593292185|FG002|Overall Study|Serious Adverse Event|1|||
164252592|NCT00734604|593292186|FG003|Overall Study|Serious Adverse Event|2|||
164252593|NCT00734604|593292187|FG004|Overall Study|Serious Adverse Event|0|||
164252594|NCT00734604|593292188|FG005|Overall Study|Serious Adverse Event|1|||
164252595|NCT00734604|593292183|FG000|Overall Study|Lost to Follow-up|1|||
164252596|NCT00734604|593292184|FG001|Overall Study|Lost to Follow-up|2|||
164252597|NCT00734604|593292185|FG002|Overall Study|Lost to Follow-up|2|||
164252598|NCT00734604|593292186|FG003|Overall Study|Lost to Follow-up|4|||
164252599|NCT00734604|593292187|FG004|Overall Study|Lost to Follow-up|2|||
164252600|NCT00734604|593292188|FG005|Overall Study|Lost to Follow-up|3|||
164252601|NCT00734604|593292183|FG000|Overall Study|Physician Decision|0|||
164252602|NCT00734604|593292184|FG001|Overall Study|Physician Decision|1|||
164252603|NCT00734604|593292185|FG002|Overall Study|Physician Decision|1|||
164252604|NCT00734604|593292186|FG003|Overall Study|Physician Decision|0|||
164252605|NCT00734604|593292187|FG004|Overall Study|Physician Decision|0|||
164252606|NCT00734604|593292188|FG005|Overall Study|Physician Decision|0|||
164252607|NCT00734604|593292183|FG000|Overall Study|Protocol Violation|0|||
164252608|NCT00734604|593292184|FG001|Overall Study|Protocol Violation|2|||
164252609|NCT00734604|593292185|FG002|Overall Study|Protocol Violation|0|||
164252610|NCT00734604|593292186|FG003|Overall Study|Protocol Violation|0|||
164252611|NCT00734604|593292187|FG004|Overall Study|Protocol Violation|1|||
164252612|NCT00734604|593292188|FG005|Overall Study|Protocol Violation|0|||
164252613|NCT00734604|593292183|FG000|Overall Study|Sponsor Decision|1|||
164252614|NCT00734604|593292184|FG001|Overall Study|Sponsor Decision|2|||
164252615|NCT00734604|593292185|FG002|Overall Study|Sponsor Decision|1|||
164252616|NCT00734604|593292186|FG003|Overall Study|Sponsor Decision|0|||
164252617|NCT00734604|593292187|FG004|Overall Study|Sponsor Decision|2|||
164252618|NCT00734604|593292188|FG005|Overall Study|Sponsor Decision|0|||
164252619|NCT00734604|593292183|FG000|Overall Study|Withdrawal by Subject|0|||
164252620|NCT00734604|593292184|FG001|Overall Study|Withdrawal by Subject|2|||
164252621|NCT00734604|593292185|FG002|Overall Study|Withdrawal by Subject|0|||
164252622|NCT00734604|593292186|FG003|Overall Study|Withdrawal by Subject|1|||
164252623|NCT00734604|593292187|FG004|Overall Study|Withdrawal by Subject|2|||
164252624|NCT00734604|593292188|FG005|Overall Study|Withdrawal by Subject|1|||
164252625|NCT00734604|593292183|FG000|Overall Study|Lack of Efficacy|0|||
164252626|NCT00734604|593292184|FG001|Overall Study|Lack of Efficacy|1|||
164252627|NCT00734604|593292185|FG002|Overall Study|Lack of Efficacy|1|||
164252628|NCT00734604|593292186|FG003|Overall Study|Lack of Efficacy|0|||
164252629|NCT00734604|593292187|FG004|Overall Study|Lack of Efficacy|0|||
164252630|NCT00734604|593292188|FG005|Overall Study|Lack of Efficacy|0|||
164252631|NCT02199314|593292189|FG000|Overall Study|Withdrawal by Subject|6|||
164252632|NCT02199314|593292189|FG000|Overall Study|Physician Decision|10|||
164252633|NCT04848220|593292190|FG000|Overall Study|Unable to proceed to study procedure|0|||
164252634|NCT04848220|593292191|FG001|Overall Study|Unable to proceed to study procedure|1|||
164252635|NCT04848220|593292192|FG002|Overall Study|Unable to proceed to study procedure|0|||
164252636|NCT04848220|593292190|FG000|Overall Study|Fractional flow not significant|0|||
164252637|NCT04848220|593292191|FG001|Overall Study|Fractional flow not significant|1|||
164252638|NCT04848220|593292192|FG002|Overall Study|Fractional flow not significant|0|||
164252639|NCT02557100|593292197|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
164252640|NCT02557100|593292198|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
164252641|NCT02557100|593292199|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
164252642|NCT02557100|593292197|FG000|Single Blind Treatment Period|Death|0|||
164252643|NCT02557100|593292198|FG001|Single Blind Treatment Period|Death|1|||
164252644|NCT02557100|593292199|FG002|Single Blind Treatment Period|Death|0|||
164252645|NCT02557100|593292197|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
164252646|NCT02557100|593292198|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
164252647|NCT02557100|593292199|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
164252648|NCT02557100|593292197|FG000|Single Blind Treatment Period|Adverse Event|0|||
164252649|NCT02557100|593292198|FG001|Single Blind Treatment Period|Adverse Event|1|||
164252650|NCT02557100|593292199|FG002|Single Blind Treatment Period|Adverse Event|0|||
164252651|NCT02557100|593292197|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
164252652|NCT02557100|593292198|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
164252653|NCT02557100|593292199|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
164252654|NCT02557100|593292197|FG000|Cumulative Abatacept Period|Other Reasons|0|||
164252655|NCT02557100|593292198|FG001|Cumulative Abatacept Period|Other Reasons|0|||
164252656|NCT02557100|593292199|FG002|Cumulative Abatacept Period|Other Reasons|1|||
164252657|NCT02557100|593292197|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
164252658|NCT02557100|593292198|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
164252659|NCT02557100|593292199|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
164338985|NCT02202980|593617108|FG010|Overall Study|Lost to Follow-up|0|||
164338986|NCT02202980|593617109|FG011|Overall Study|Lost to Follow-up|0|||
164252660|NCT02557100|593292197|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
164252661|NCT02557100|593292198|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
164338987|NCT02202980|593617110|FG012|Overall Study|Lost to Follow-up|1|||
164252662|NCT02557100|593292199|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
164338988|NCT02202980|593617111|FG013|Overall Study|Lost to Follow-up|0|||
164252663|NCT02513485|593292203|FG000|Overall Study|Adverse Event|1|||
164252664|NCT02513485|593292204|FG001|Overall Study|Adverse Event|0|||
164252665|NCT01436656|593292220|FG000|Dose Escalation|Death|1|||
164252666|NCT01436656|593292221|FG001|Dose Escalation|Death|3|||
163991945|NCT04426695|592339655|FG014|Overall Study|Death|19|||
163991946|NCT04426695|592339656|FG015|Overall Study|Death|7|||
163991947|NCT04426695|592339657|FG016|Overall Study|Death|8|||
163991948|NCT04426695|592339658|FG017|Overall Study|Death|4|||
163991949|NCT04426695|592339641|FG000|Overall Study|Lost to Follow-up|2|||
163991950|NCT04426695|592339642|FG001|Overall Study|Lost to Follow-up|4|||
163991951|NCT04426695|592339643|FG002|Overall Study|Lost to Follow-up|1|||
164084661|NCT00585351|592673981|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
164084662|NCT00585351|592673982|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
164084663|NCT00585351|592673975|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
164084664|NCT00585351|592673976|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
164084665|NCT00585351|592673977|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164084666|NCT00585351|592673978|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164084667|NCT00585351|592673979|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164252667|NCT01436656|593292222|FG002|Dose Escalation|Death|1|||
164252668|NCT01436656|593292223|FG003|Dose Escalation|Death|0|||
163991952|NCT04426695|592339644|FG003|Overall Study|Lost to Follow-up|19|||
163991953|NCT04426695|592339645|FG004|Overall Study|Lost to Follow-up|10|||
163991954|NCT04426695|592339646|FG005|Overall Study|Lost to Follow-up|14|||
163991955|NCT04426695|592339647|FG006|Overall Study|Lost to Follow-up|5|||
163991956|NCT04426695|592339648|FG007|Overall Study|Lost to Follow-up|14|||
163991957|NCT04426695|592339649|FG008|Overall Study|Lost to Follow-up|10|||
163991958|NCT04426695|592339650|FG009|Overall Study|Lost to Follow-up|11|||
163991959|NCT04426695|592339651|FG010|Overall Study|Lost to Follow-up|12|||
163991960|NCT04426695|592339652|FG011|Overall Study|Lost to Follow-up|6|||
163991961|NCT04426695|592339653|FG012|Overall Study|Lost to Follow-up|2|||
163991962|NCT04426695|592339654|FG013|Overall Study|Lost to Follow-up|2|||
163991963|NCT04426695|592339655|FG014|Overall Study|Lost to Follow-up|2|||
163991964|NCT04426695|592339656|FG015|Overall Study|Lost to Follow-up|0|||
163991965|NCT04426695|592339657|FG016|Overall Study|Lost to Follow-up|0|||
163991966|NCT04426695|592339658|FG017|Overall Study|Lost to Follow-up|0|||
163991967|NCT04426695|592339641|FG000|Overall Study|Participant Decision|1|||
163991968|NCT04426695|592339642|FG001|Overall Study|Participant Decision|2|||
163991969|NCT04426695|592339643|FG002|Overall Study|Participant Decision|2|||
163991970|NCT04426695|592339644|FG003|Overall Study|Participant Decision|12|||
163991971|NCT04426695|592339645|FG004|Overall Study|Participant Decision|18|||
163991972|NCT04426695|592339646|FG005|Overall Study|Participant Decision|22|||
163991973|NCT04426695|592339647|FG006|Overall Study|Participant Decision|13|||
163991974|NCT04426695|592339648|FG007|Overall Study|Participant Decision|13|||
163991975|NCT04426695|592339649|FG008|Overall Study|Participant Decision|10|||
163991976|NCT04426695|592339650|FG009|Overall Study|Participant Decision|15|||
163991977|NCT04426695|592339651|FG010|Overall Study|Participant Decision|16|||
163991978|NCT04426695|592339652|FG011|Overall Study|Participant Decision|17|||
163991979|NCT04426695|592339653|FG012|Overall Study|Participant Decision|2|||
163991980|NCT04426695|592339654|FG013|Overall Study|Participant Decision|1|||
163991981|NCT04426695|592339655|FG014|Overall Study|Participant Decision|2|||
163991982|NCT04426695|592339656|FG015|Overall Study|Participant Decision|0|||
164252669|NCT01436656|593292224|FG004|Dose Escalation|Death|2|||
164252670|NCT01436656|593292225|FG005|Dose Escalation|Death|1|||
164252671|NCT01436656|593292226|FG006|Dose Escalation|Death|1|||
164252672|NCT01436656|593292227|FG007|Dose Escalation|Death|1|||
164252673|NCT01436656|593292228|FG008|Dose Escalation|Death|1|||
164252674|NCT01436656|593292229|FG009|Dose Escalation|Death|0|||
164252675|NCT01436656|593292230|FG010|Dose Escalation|Death|0|||
164252676|NCT01436656|593292231|FG011|Dose Escalation|Death|0|||
164252677|NCT01436656|593292232|FG012|Dose Escalation|Death|0|||
164252678|NCT01436656|593292233|FG013|Dose Escalation|Death|0|||
164252679|NCT01436656|593292234|FG014|Dose Escalation|Death|0|||
164252680|NCT01436656|593292235|FG015|Dose Escalation|Death|0|||
164252681|NCT01436656|593292236|FG016|Dose Escalation|Death|0|||
164252682|NCT01436656|593292237|FG017|Dose Escalation|Death|0|||
164252683|NCT01436656|593292220|FG000|Dose Escalation|Protocol Violation|0|||
164252684|NCT01436656|593292221|FG001|Dose Escalation|Protocol Violation|0|||
164252685|NCT01436656|593292222|FG002|Dose Escalation|Protocol Violation|0|||
164252686|NCT01436656|593292223|FG003|Dose Escalation|Protocol Violation|0|||
164252687|NCT01436656|593292224|FG004|Dose Escalation|Protocol Violation|0|||
164252688|NCT01436656|593292225|FG005|Dose Escalation|Protocol Violation|1|||
164252689|NCT01436656|593292226|FG006|Dose Escalation|Protocol Violation|0|||
164252690|NCT01436656|593292227|FG007|Dose Escalation|Protocol Violation|0|||
164252691|NCT01436656|593292228|FG008|Dose Escalation|Protocol Violation|0|||
164252692|NCT01436656|593292229|FG009|Dose Escalation|Protocol Violation|0|||
164252693|NCT01436656|593292230|FG010|Dose Escalation|Protocol Violation|0|||
164252694|NCT01436656|593292231|FG011|Dose Escalation|Protocol Violation|0|||
164252695|NCT01436656|593292232|FG012|Dose Escalation|Protocol Violation|0|||
164252696|NCT01436656|593292233|FG013|Dose Escalation|Protocol Violation|0|||
164252697|NCT01436656|593292234|FG014|Dose Escalation|Protocol Violation|0|||
164252698|NCT01436656|593292235|FG015|Dose Escalation|Protocol Violation|0|||
164252699|NCT01436656|593292236|FG016|Dose Escalation|Protocol Violation|0|||
164252700|NCT01436656|593292237|FG017|Dose Escalation|Protocol Violation|0|||
164252701|NCT01436656|593292220|FG000|Dose Escalation|Withdrawal by Subject|0|||
164252702|NCT01436656|593292221|FG001|Dose Escalation|Withdrawal by Subject|0|||
164252703|NCT01436656|593292222|FG002|Dose Escalation|Withdrawal by Subject|0|||
164252704|NCT01436656|593292223|FG003|Dose Escalation|Withdrawal by Subject|0|||
164252705|NCT01436656|593292224|FG004|Dose Escalation|Withdrawal by Subject|1|||
164252706|NCT01436656|593292225|FG005|Dose Escalation|Withdrawal by Subject|0|||
164252707|NCT01436656|593292226|FG006|Dose Escalation|Withdrawal by Subject|0|||
164252708|NCT01436656|593292227|FG007|Dose Escalation|Withdrawal by Subject|2|||
164252709|NCT01436656|593292228|FG008|Dose Escalation|Withdrawal by Subject|0|||
164252710|NCT01436656|593292229|FG009|Dose Escalation|Withdrawal by Subject|1|||
164252711|NCT01436656|593292230|FG010|Dose Escalation|Withdrawal by Subject|1|||
164252712|NCT01436656|593292231|FG011|Dose Escalation|Withdrawal by Subject|0|||
164252713|NCT01436656|593292232|FG012|Dose Escalation|Withdrawal by Subject|0|||
164252714|NCT01436656|593292233|FG013|Dose Escalation|Withdrawal by Subject|0|||
164252715|NCT01436656|593292234|FG014|Dose Escalation|Withdrawal by Subject|0|||
164252716|NCT01436656|593292235|FG015|Dose Escalation|Withdrawal by Subject|0|||
164252717|NCT01436656|593292236|FG016|Dose Escalation|Withdrawal by Subject|0|||
164252718|NCT01436656|593292237|FG017|Dose Escalation|Withdrawal by Subject|0|||
164252719|NCT01436656|593292220|FG000|Dose Escalation|Administrative problems|0|||
164252720|NCT01436656|593292221|FG001|Dose Escalation|Administrative problems|1|||
164252721|NCT01436656|593292222|FG002|Dose Escalation|Administrative problems|0|||
164252722|NCT01436656|593292223|FG003|Dose Escalation|Administrative problems|0|||
164252723|NCT01436656|593292224|FG004|Dose Escalation|Administrative problems|0|||
164252724|NCT01436656|593292225|FG005|Dose Escalation|Administrative problems|0|||
164252725|NCT01436656|593292226|FG006|Dose Escalation|Administrative problems|0|||
164252726|NCT01436656|593292227|FG007|Dose Escalation|Administrative problems|0|||
164252727|NCT01436656|593292228|FG008|Dose Escalation|Administrative problems|0|||
164252728|NCT01436656|593292229|FG009|Dose Escalation|Administrative problems|0|||
164252729|NCT01436656|593292230|FG010|Dose Escalation|Administrative problems|0|||
164252730|NCT01436656|593292231|FG011|Dose Escalation|Administrative problems|0|||
164252731|NCT01436656|593292232|FG012|Dose Escalation|Administrative problems|0|||
164252732|NCT01436656|593292233|FG013|Dose Escalation|Administrative problems|0|||
164252733|NCT01436656|593292234|FG014|Dose Escalation|Administrative problems|0|||
164252734|NCT01436656|593292235|FG015|Dose Escalation|Administrative problems|0|||
164252735|NCT01436656|593292236|FG016|Dose Escalation|Administrative problems|0|||
164252736|NCT01436656|593292237|FG017|Dose Escalation|Administrative problems|0|||
164252737|NCT01436656|593292220|FG000|Dose Escalation|Lost to Follow-up|1|||
164252738|NCT01436656|593292221|FG001|Dose Escalation|Lost to Follow-up|0|||
164252739|NCT01436656|593292222|FG002|Dose Escalation|Lost to Follow-up|0|||
164252740|NCT01436656|593292223|FG003|Dose Escalation|Lost to Follow-up|0|||
164252741|NCT01436656|593292224|FG004|Dose Escalation|Lost to Follow-up|1|||
164252742|NCT01436656|593292225|FG005|Dose Escalation|Lost to Follow-up|0|||
164252743|NCT01436656|593292226|FG006|Dose Escalation|Lost to Follow-up|0|||
164252744|NCT01436656|593292227|FG007|Dose Escalation|Lost to Follow-up|0|||
164252745|NCT01436656|593292228|FG008|Dose Escalation|Lost to Follow-up|0|||
164252746|NCT01436656|593292229|FG009|Dose Escalation|Lost to Follow-up|0|||
164252747|NCT01436656|593292230|FG010|Dose Escalation|Lost to Follow-up|0|||
164252748|NCT01436656|593292231|FG011|Dose Escalation|Lost to Follow-up|0|||
164252749|NCT01436656|593292232|FG012|Dose Escalation|Lost to Follow-up|0|||
164252750|NCT01436656|593292233|FG013|Dose Escalation|Lost to Follow-up|0|||
164252751|NCT01436656|593292234|FG014|Dose Escalation|Lost to Follow-up|0|||
164252752|NCT01436656|593292235|FG015|Dose Escalation|Lost to Follow-up|0|||
164252753|NCT01436656|593292236|FG016|Dose Escalation|Lost to Follow-up|0|||
164252754|NCT01436656|593292237|FG017|Dose Escalation|Lost to Follow-up|0|||
164252755|NCT01436656|593292220|FG000|Dose Escalation|New anti-cancer therapy|1|||
164252756|NCT01436656|593292221|FG001|Dose Escalation|New anti-cancer therapy|0|||
164252757|NCT01436656|593292222|FG002|Dose Escalation|New anti-cancer therapy|0|||
164252758|NCT01436656|593292223|FG003|Dose Escalation|New anti-cancer therapy|0|||
164252759|NCT01436656|593292224|FG004|Dose Escalation|New anti-cancer therapy|0|||
164252760|NCT01436656|593292225|FG005|Dose Escalation|New anti-cancer therapy|0|||
164252761|NCT01436656|593292226|FG006|Dose Escalation|New anti-cancer therapy|0|||
164252762|NCT01436656|593292227|FG007|Dose Escalation|New anti-cancer therapy|0|||
164252763|NCT01436656|593292228|FG008|Dose Escalation|New anti-cancer therapy|1|||
164252764|NCT01436656|593292229|FG009|Dose Escalation|New anti-cancer therapy|1|||
164252765|NCT01436656|593292230|FG010|Dose Escalation|New anti-cancer therapy|0|||
164252766|NCT01436656|593292231|FG011|Dose Escalation|New anti-cancer therapy|0|||
164252767|NCT01436656|593292232|FG012|Dose Escalation|New anti-cancer therapy|0|||
164252768|NCT01436656|593292233|FG013|Dose Escalation|New anti-cancer therapy|0|||
164252769|NCT01436656|593292234|FG014|Dose Escalation|New anti-cancer therapy|0|||
164252770|NCT01436656|593292235|FG015|Dose Escalation|New anti-cancer therapy|0|||
164252771|NCT01436656|593292236|FG016|Dose Escalation|New anti-cancer therapy|0|||
164252772|NCT01436656|593292237|FG017|Dose Escalation|New anti-cancer therapy|0|||
164252773|NCT01436656|593292220|FG000|Dose Expansion|Adverse Event|0|||
164252774|NCT01436656|593292221|FG001|Dose Expansion|Adverse Event|0|||
164252775|NCT01436656|593292222|FG002|Dose Expansion|Adverse Event|0|||
164252776|NCT01436656|593292223|FG003|Dose Expansion|Adverse Event|0|||
164252777|NCT01436656|593292224|FG004|Dose Expansion|Adverse Event|0|||
164252778|NCT01436656|593292225|FG005|Dose Expansion|Adverse Event|0|||
164252779|NCT01436656|593292226|FG006|Dose Expansion|Adverse Event|0|||
164252780|NCT01436656|593292227|FG007|Dose Expansion|Adverse Event|0|||
164252781|NCT01436656|593292228|FG008|Dose Expansion|Adverse Event|0|||
164252782|NCT01436656|593292229|FG009|Dose Expansion|Adverse Event|0|||
164252783|NCT01436656|593292230|FG010|Dose Expansion|Adverse Event|0|||
164252784|NCT01436656|593292231|FG011|Dose Expansion|Adverse Event|1|||
164252785|NCT01436656|593292232|FG012|Dose Expansion|Adverse Event|0|||
164252786|NCT01436656|593292233|FG013|Dose Expansion|Adverse Event|0|||
164252787|NCT01436656|593292234|FG014|Dose Expansion|Adverse Event|0|||
164252788|NCT01436656|593292235|FG015|Dose Expansion|Adverse Event|0|||
164252789|NCT01436656|593292236|FG016|Dose Expansion|Adverse Event|0|||
164252790|NCT01436656|593292237|FG017|Dose Expansion|Adverse Event|0|||
164252791|NCT01436656|593292220|FG000|Dose Expansion|Withdrawal by Subject|0|||
164252792|NCT01436656|593292221|FG001|Dose Expansion|Withdrawal by Subject|0|||
164252793|NCT01436656|593292222|FG002|Dose Expansion|Withdrawal by Subject|0|||
164252794|NCT01436656|593292223|FG003|Dose Expansion|Withdrawal by Subject|0|||
164252795|NCT01436656|593292224|FG004|Dose Expansion|Withdrawal by Subject|0|||
164252796|NCT01436656|593292225|FG005|Dose Expansion|Withdrawal by Subject|0|||
164252797|NCT01436656|593292226|FG006|Dose Expansion|Withdrawal by Subject|0|||
164252798|NCT01436656|593292227|FG007|Dose Expansion|Withdrawal by Subject|0|||
164252799|NCT01436656|593292228|FG008|Dose Expansion|Withdrawal by Subject|0|||
164252800|NCT01436656|593292229|FG009|Dose Expansion|Withdrawal by Subject|0|||
164252801|NCT01436656|593292230|FG010|Dose Expansion|Withdrawal by Subject|0|||
164252802|NCT01436656|593292231|FG011|Dose Expansion|Withdrawal by Subject|1|||
164252803|NCT01436656|593292232|FG012|Dose Expansion|Withdrawal by Subject|3|||
164252804|NCT01436656|593292233|FG013|Dose Expansion|Withdrawal by Subject|1|||
164252805|NCT01436656|593292234|FG014|Dose Expansion|Withdrawal by Subject|2|||
164252806|NCT01436656|593292235|FG015|Dose Expansion|Withdrawal by Subject|0|||
164252807|NCT01436656|593292236|FG016|Dose Expansion|Withdrawal by Subject|1|||
164252808|NCT01436656|593292237|FG017|Dose Expansion|Withdrawal by Subject|1|||
164252809|NCT01436656|593292220|FG000|Dose Expansion|Death|0|||
164338989|NCT02202980|593617098|FG000|Overall Study|Withdrew Consent|0|||
164252810|NCT01436656|593292221|FG001|Dose Expansion|Death|0|||
164252811|NCT01436656|593292222|FG002|Dose Expansion|Death|0|||
164338990|NCT02202980|593617099|FG001|Overall Study|Withdrew Consent|1|||
164338991|NCT02202980|593617100|FG002|Overall Study|Withdrew Consent|2|||
164338992|NCT02202980|593617101|FG003|Overall Study|Withdrew Consent|0|||
164338993|NCT02202980|593617102|FG004|Overall Study|Withdrew Consent|0|||
164338994|NCT02202980|593617103|FG005|Overall Study|Withdrew Consent|0|||
164338995|NCT02202980|593617104|FG006|Overall Study|Withdrew Consent|0|||
164338996|NCT02202980|593617105|FG007|Overall Study|Withdrew Consent|0|||
164252812|NCT01436656|593292223|FG003|Dose Expansion|Death|0|||
164252813|NCT01436656|593292224|FG004|Dose Expansion|Death|0|||
164252814|NCT01436656|593292225|FG005|Dose Expansion|Death|0|||
164252815|NCT01436656|593292226|FG006|Dose Expansion|Death|0|||
164252816|NCT01436656|593292227|FG007|Dose Expansion|Death|0|||
164252817|NCT01436656|593292228|FG008|Dose Expansion|Death|0|||
164252818|NCT01436656|593292229|FG009|Dose Expansion|Death|0|||
164252819|NCT01436656|593292230|FG010|Dose Expansion|Death|0|||
164252820|NCT01436656|593292231|FG011|Dose Expansion|Death|0|||
164252821|NCT01436656|593292232|FG012|Dose Expansion|Death|1|||
164252822|NCT01436656|593292233|FG013|Dose Expansion|Death|0|||
164252823|NCT01436656|593292234|FG014|Dose Expansion|Death|3|||
164252824|NCT01436656|593292235|FG015|Dose Expansion|Death|0|||
164252825|NCT01436656|593292236|FG016|Dose Expansion|Death|3|||
164252826|NCT01436656|593292237|FG017|Dose Expansion|Death|3|||
164252827|NCT01436656|593292220|FG000|Dose Expansion|Lost to Follow-up|0|||
164252828|NCT01436656|593292221|FG001|Dose Expansion|Lost to Follow-up|0|||
164252829|NCT01436656|593292222|FG002|Dose Expansion|Lost to Follow-up|0|||
164252830|NCT01436656|593292223|FG003|Dose Expansion|Lost to Follow-up|0|||
164252831|NCT01436656|593292224|FG004|Dose Expansion|Lost to Follow-up|0|||
164252832|NCT01436656|593292225|FG005|Dose Expansion|Lost to Follow-up|0|||
164252833|NCT01436656|593292226|FG006|Dose Expansion|Lost to Follow-up|0|||
164252834|NCT01436656|593292227|FG007|Dose Expansion|Lost to Follow-up|0|||
164252835|NCT01436656|593292228|FG008|Dose Expansion|Lost to Follow-up|0|||
164252836|NCT01436656|593292229|FG009|Dose Expansion|Lost to Follow-up|0|||
164252837|NCT01436656|593292230|FG010|Dose Expansion|Lost to Follow-up|0|||
164252838|NCT01436656|593292231|FG011|Dose Expansion|Lost to Follow-up|0|||
164252839|NCT01436656|593292232|FG012|Dose Expansion|Lost to Follow-up|0|||
164252840|NCT01436656|593292233|FG013|Dose Expansion|Lost to Follow-up|0|||
164252841|NCT01436656|593292234|FG014|Dose Expansion|Lost to Follow-up|0|||
164252842|NCT01436656|593292235|FG015|Dose Expansion|Lost to Follow-up|0|||
164252843|NCT01436656|593292236|FG016|Dose Expansion|Lost to Follow-up|0|||
164252844|NCT01436656|593292237|FG017|Dose Expansion|Lost to Follow-up|3|||
164252845|NCT01436656|593292220|FG000|Dose Expansion|Disease progression|0|||
164252846|NCT01436656|593292221|FG001|Dose Expansion|Disease progression|0|||
164252847|NCT01436656|593292222|FG002|Dose Expansion|Disease progression|0|||
164252848|NCT01436656|593292223|FG003|Dose Expansion|Disease progression|0|||
164252849|NCT01436656|593292224|FG004|Dose Expansion|Disease progression|0|||
164252850|NCT01436656|593292225|FG005|Dose Expansion|Disease progression|0|||
164252851|NCT01436656|593292226|FG006|Dose Expansion|Disease progression|0|||
164252852|NCT01436656|593292227|FG007|Dose Expansion|Disease progression|0|||
164252853|NCT01436656|593292228|FG008|Dose Expansion|Disease progression|0|||
164252854|NCT01436656|593292229|FG009|Dose Expansion|Disease progression|0|||
164252855|NCT01436656|593292230|FG010|Dose Expansion|Disease progression|0|||
164252856|NCT01436656|593292231|FG011|Dose Expansion|Disease progression|3|||
164252857|NCT01436656|593292232|FG012|Dose Expansion|Disease progression|1|||
164252858|NCT01436656|593292233|FG013|Dose Expansion|Disease progression|0|||
164252859|NCT01436656|593292234|FG014|Dose Expansion|Disease progression|1|||
164252860|NCT01436656|593292235|FG015|Dose Expansion|Disease progression|0|||
164252861|NCT01436656|593292236|FG016|Dose Expansion|Disease progression|0|||
164252862|NCT01436656|593292237|FG017|Dose Expansion|Disease progression|1|||
164252863|NCT01436656|593292220|FG000|Dose Expansion|New cancer therapy|0|||
164252864|NCT01436656|593292221|FG001|Dose Expansion|New cancer therapy|0|||
164252865|NCT01436656|593292222|FG002|Dose Expansion|New cancer therapy|0|||
164252866|NCT01436656|593292223|FG003|Dose Expansion|New cancer therapy|0|||
164252867|NCT01436656|593292224|FG004|Dose Expansion|New cancer therapy|0|||
164252868|NCT01436656|593292225|FG005|Dose Expansion|New cancer therapy|0|||
164252869|NCT01436656|593292226|FG006|Dose Expansion|New cancer therapy|0|||
164252870|NCT01436656|593292227|FG007|Dose Expansion|New cancer therapy|0|||
164252871|NCT01436656|593292228|FG008|Dose Expansion|New cancer therapy|0|||
164252872|NCT01436656|593292229|FG009|Dose Expansion|New cancer therapy|0|||
164252873|NCT01436656|593292230|FG010|Dose Expansion|New cancer therapy|0|||
164252874|NCT01436656|593292231|FG011|Dose Expansion|New cancer therapy|1|||
164252875|NCT01436656|593292232|FG012|Dose Expansion|New cancer therapy|1|||
164252876|NCT01436656|593292233|FG013|Dose Expansion|New cancer therapy|0|||
164252877|NCT01436656|593292234|FG014|Dose Expansion|New cancer therapy|2|||
164252878|NCT01436656|593292235|FG015|Dose Expansion|New cancer therapy|0|||
164252879|NCT01436656|593292236|FG016|Dose Expansion|New cancer therapy|0|||
164252880|NCT01436656|593292237|FG017|Dose Expansion|New cancer therapy|0|||
164252881|NCT01406938|593292238|FG000|Induction Period|Subject/guardian decision|6|||
164252882|NCT01406938|593292239|FG001|Induction Period|Subject/guardian decision|8|||
164252883|NCT01406938|593292240|FG002|Induction Period|Subject/guardian decision|0|||
164252884|NCT01406938|593292241|FG003|Induction Period|Subject/guardian decision|0|||
164252885|NCT01406938|593292242|FG004|Induction Period|Subject/guardian decision|0|||
164252886|NCT01406938|593292243|FG005|Induction Period|Subject/guardian decision|0|||
164252887|NCT01406938|593292238|FG000|Induction Period|Protocol deviation|1|||
164252888|NCT01406938|593292239|FG001|Induction Period|Protocol deviation|0|||
164252889|NCT01406938|593292240|FG002|Induction Period|Protocol deviation|0|||
164252890|NCT01406938|593292241|FG003|Induction Period|Protocol deviation|0|||
164252891|NCT01406938|593292242|FG004|Induction Period|Protocol deviation|0|||
164252892|NCT01406938|593292243|FG005|Induction Period|Protocol deviation|0|||
164252893|NCT01406938|593292238|FG000|Induction Period|Adverse Event|8|||
164252894|NCT01406938|593292239|FG001|Induction Period|Adverse Event|9|||
164252895|NCT01406938|593292240|FG002|Induction Period|Adverse Event|0|||
164252896|NCT01406938|593292241|FG003|Induction Period|Adverse Event|0|||
164252897|NCT01406938|593292242|FG004|Induction Period|Adverse Event|0|||
164252898|NCT01406938|593292243|FG005|Induction Period|Adverse Event|0|||
164252899|NCT01406938|593292238|FG000|Induction Period|Lack of Efficacy|1|||
164252900|NCT01406938|593292239|FG001|Induction Period|Lack of Efficacy|0|||
164252901|NCT01406938|593292240|FG002|Induction Period|Lack of Efficacy|0|||
164252902|NCT01406938|593292241|FG003|Induction Period|Lack of Efficacy|0|||
164252903|NCT01406938|593292242|FG004|Induction Period|Lack of Efficacy|0|||
164252904|NCT01406938|593292243|FG005|Induction Period|Lack of Efficacy|0|||
164252905|NCT01406938|593292238|FG000|Induction Period|Lost to Follow-up|2|||
164252906|NCT01406938|593292239|FG001|Induction Period|Lost to Follow-up|3|||
164252907|NCT01406938|593292240|FG002|Induction Period|Lost to Follow-up|0|||
164252908|NCT01406938|593292241|FG003|Induction Period|Lost to Follow-up|0|||
164252909|NCT01406938|593292242|FG004|Induction Period|Lost to Follow-up|0|||
164252910|NCT01406938|593292243|FG005|Induction Period|Lost to Follow-up|0|||
164252911|NCT01406938|593292238|FG000|Maintenance Period|Adverse Event|0|||
164252912|NCT01406938|593292239|FG001|Maintenance Period|Adverse Event|0|||
164252913|NCT01406938|593292240|FG002|Maintenance Period|Adverse Event|2|||
164252914|NCT01406938|593292241|FG003|Maintenance Period|Adverse Event|8|||
164252915|NCT01406938|593292242|FG004|Maintenance Period|Adverse Event|4|||
164252916|NCT01406938|593292243|FG005|Maintenance Period|Adverse Event|2|||
164252917|NCT01406938|593292238|FG000|Maintenance Period|Death|0|||
164252918|NCT01406938|593292239|FG001|Maintenance Period|Death|0|||
164252919|NCT01406938|593292240|FG002|Maintenance Period|Death|0|||
164252920|NCT01406938|593292241|FG003|Maintenance Period|Death|0|||
164252921|NCT01406938|593292242|FG004|Maintenance Period|Death|1|||
164252922|NCT01406938|593292243|FG005|Maintenance Period|Death|0|||
164252923|NCT01406938|593292238|FG000|Maintenance Period|Subject/guardian decision|0|||
164252924|NCT01406938|593292239|FG001|Maintenance Period|Subject/guardian decision|0|||
164252925|NCT01406938|593292240|FG002|Maintenance Period|Subject/guardian decision|11|||
164252926|NCT01406938|593292241|FG003|Maintenance Period|Subject/guardian decision|7|||
164252927|NCT01406938|593292242|FG004|Maintenance Period|Subject/guardian decision|10|||
164252928|NCT01406938|593292243|FG005|Maintenance Period|Subject/guardian decision|7|||
164252929|NCT01406938|593292238|FG000|Maintenance Period|Protocol Violation|0|||
164252930|NCT01406938|593292239|FG001|Maintenance Period|Protocol Violation|0|||
164252931|NCT01406938|593292240|FG002|Maintenance Period|Protocol Violation|2|||
164252932|NCT01406938|593292241|FG003|Maintenance Period|Protocol Violation|2|||
164252933|NCT01406938|593292242|FG004|Maintenance Period|Protocol Violation|2|||
164252934|NCT01406938|593292243|FG005|Maintenance Period|Protocol Violation|2|||
164252935|NCT01406938|593292238|FG000|Maintenance Period|Pregnancy|0|||
164252936|NCT01406938|593292239|FG001|Maintenance Period|Pregnancy|0|||
164252937|NCT01406938|593292240|FG002|Maintenance Period|Pregnancy|0|||
164252938|NCT01406938|593292241|FG003|Maintenance Period|Pregnancy|0|||
164252939|NCT01406938|593292242|FG004|Maintenance Period|Pregnancy|1|||
164252940|NCT01406938|593292243|FG005|Maintenance Period|Pregnancy|0|||
164252941|NCT01406938|593292238|FG000|Maintenance Period|Lost to Follow-up|0|||
164252942|NCT01406938|593292239|FG001|Maintenance Period|Lost to Follow-up|0|||
164252943|NCT01406938|593292240|FG002|Maintenance Period|Lost to Follow-up|0|||
164252944|NCT01406938|593292241|FG003|Maintenance Period|Lost to Follow-up|0|||
164252945|NCT01406938|593292242|FG004|Maintenance Period|Lost to Follow-up|4|||
164252946|NCT01406938|593292243|FG005|Maintenance Period|Lost to Follow-up|0|||
164252947|NCT01406938|593292238|FG000|Maintenance Period|Lack of Efficacy|0|||
164252948|NCT01406938|593292239|FG001|Maintenance Period|Lack of Efficacy|0|||
163887270|NCT03544281|591959375|FG013|Main Study Phase|Physician Decision|0|||
163887271|NCT03544281|591959376|FG014|Main Study Phase|Physician Decision|0|||
164252949|NCT01406938|593292240|FG002|Maintenance Period|Lack of Efficacy|2|||
164252950|NCT01406938|593292241|FG003|Maintenance Period|Lack of Efficacy|1|||
164252951|NCT01406938|593292242|FG004|Maintenance Period|Lack of Efficacy|3|||
164252952|NCT01406938|593292243|FG005|Maintenance Period|Lack of Efficacy|5|||
164252953|NCT01406938|593292238|FG000|Follow up|Lack of Efficacy|3|||
164252954|NCT01406938|593292239|FG001|Follow up|Lack of Efficacy|2|||
164252955|NCT01406938|593292240|FG002|Follow up|Lack of Efficacy|1|||
164252956|NCT01406938|593292241|FG003|Follow up|Lack of Efficacy|0|||
164252957|NCT01406938|593292242|FG004|Follow up|Lack of Efficacy|0|||
164252958|NCT01406938|593292243|FG005|Follow up|Lack of Efficacy|0|||
164252959|NCT01406938|593292238|FG000|Follow up|Patient/guardian decision|4|||
164252960|NCT01406938|593292239|FG001|Follow up|Patient/guardian decision|2|||
164252961|NCT01406938|593292240|FG002|Follow up|Patient/guardian decision|4|||
164252962|NCT01406938|593292241|FG003|Follow up|Patient/guardian decision|2|||
164252963|NCT01406938|593292242|FG004|Follow up|Patient/guardian decision|4|||
164252964|NCT01406938|593292243|FG005|Follow up|Patient/guardian decision|1|||
164252965|NCT01406938|593292238|FG000|Follow up|Protocol Violation|0|||
164252966|NCT01406938|593292239|FG001|Follow up|Protocol Violation|0|||
164252967|NCT01406938|593292240|FG002|Follow up|Protocol Violation|1|||
164252968|NCT01406938|593292241|FG003|Follow up|Protocol Violation|0|||
164252969|NCT01406938|593292242|FG004|Follow up|Protocol Violation|0|||
164252970|NCT01406938|593292243|FG005|Follow up|Protocol Violation|0|||
164252971|NCT01406938|593292238|FG000|Follow up|Physician Decision|0|||
164252972|NCT01406938|593292239|FG001|Follow up|Physician Decision|0|||
164252973|NCT01406938|593292240|FG002|Follow up|Physician Decision|2|||
164252974|NCT01406938|593292241|FG003|Follow up|Physician Decision|0|||
164252975|NCT01406938|593292242|FG004|Follow up|Physician Decision|3|||
164252976|NCT01406938|593292243|FG005|Follow up|Physician Decision|1|||
164252977|NCT01406938|593292238|FG000|Follow up|Lost to Follow-up|1|||
164252978|NCT01406938|593292239|FG001|Follow up|Lost to Follow-up|1|||
164252979|NCT01406938|593292240|FG002|Follow up|Lost to Follow-up|0|||
164252980|NCT01406938|593292241|FG003|Follow up|Lost to Follow-up|1|||
164252981|NCT01406938|593292242|FG004|Follow up|Lost to Follow-up|2|||
164252982|NCT01406938|593292243|FG005|Follow up|Lost to Follow-up|1|||
164252983|NCT01576146|593292246|FG000|Extension Period 1|Adverse Event|2|||
164252984|NCT01576146|593292246|FG000|Extension Period 1|Death|2|||
164252985|NCT01576146|593292246|FG000|Extension Period 1|Physician Decision|2|||
164252986|NCT01576146|593292246|FG000|Extension Period 1|Withdrawal by Subject|1|||
164252987|NCT01576146|593292246|FG000|Extension Period 1|Lost to Follow-up|1|||
164252988|NCT01576146|593292246|FG000|Extension Period 1|Parathyroidectomy|1|||
164252989|NCT01576146|593292246|FG000|Extension Period 1|Renal Transplant|1|||
164252990|NCT01576146|593292246|FG000|Extension Period 2|Sponsor Decision|13|||
164252991|NCT01576146|593292246|FG000|Extension Period 2|Death|1|||
164252992|NCT01576146|593292246|FG000|Extension Period 2|Adverse Event|1|||
164252993|NCT01576146|593292246|FG000|Extension Period 2|Renal Transplant|1|||
164252994|NCT01576146|593292246|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
164252995|NCT03654404|593292248|FG000|Overall Study|Death|1|||
164252996|NCT03654404|593292248|FG000|Overall Study|Lost to Follow-up|2|||
164252997|NCT03654404|593292248|FG000|Overall Study|Withdrawal by Subject|5|||
164252998|NCT00654745|593292249|FG000|Overall Study|Adverse Event|12|||
164252999|NCT00654745|593292249|FG000|Overall Study|Lost to Follow-up|7|||
164253000|NCT00654745|593292249|FG000|Overall Study|Protocol Violation|11|||
164253001|NCT00654745|593292249|FG000|Overall Study|Withdrawal by Subject|10|||
164253002|NCT00654745|593292249|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
164253003|NCT00194077|593292252|FG000|Overall Study|Lack of Efficacy|22|||
164253004|NCT00194077|593292253|FG001|Overall Study|Lack of Efficacy|29|||
164253005|NCT00194077|593292252|FG000|Overall Study|Study nonadherence|1|||
164253006|NCT00194077|593292253|FG001|Overall Study|Study nonadherence|0|||
164253007|NCT00194077|593292252|FG000|Overall Study|Withdrawal by Subject|1|||
164253008|NCT00194077|593292253|FG001|Overall Study|Withdrawal by Subject|1|||
164253009|NCT03470194|593292254|FG000|Overall Study|Lost to Follow-up|11|||
164253010|NCT03470194|593292255|FG001|Overall Study|Lost to Follow-up|17|||
164253011|NCT01822899|593292256|FG000|Overall Study|Adverse Event|6|||
164253012|NCT01822899|593292257|FG001|Overall Study|Adverse Event|5|||
164253013|NCT01822899|593292256|FG000|Overall Study|Lack of Efficacy|6|||
164253014|NCT01822899|593292257|FG001|Overall Study|Lack of Efficacy|3|||
164338997|NCT02202980|593617106|FG008|Overall Study|Withdrew Consent|1|||
164338998|NCT02202980|593617107|FG009|Overall Study|Withdrew Consent|0|||
164338999|NCT02202980|593617108|FG010|Overall Study|Withdrew Consent|0|||
164339000|NCT02202980|593617109|FG011|Overall Study|Withdrew Consent|0|||
164253015|NCT01822899|593292256|FG000|Overall Study|Protocol Violation|6|||
164253016|NCT01822899|593292257|FG001|Overall Study|Protocol Violation|3|||
164253017|NCT01822899|593292256|FG000|Overall Study|Lost to Follow-up|1|||
164253018|NCT01822899|593292257|FG001|Overall Study|Lost to Follow-up|0|||
164339001|NCT02202980|593617110|FG012|Overall Study|Withdrew Consent|0|||
164339002|NCT02202980|593617111|FG013|Overall Study|Withdrew Consent|0|||
164339003|NCT01952145|593617112|FG000|Overall Study|Protocol Violation|2|||
164339004|NCT01952145|593617113|FG001|Overall Study|Protocol Violation|1|||
164339005|NCT01952145|593617112|FG000|Overall Study|Death|0|||
164339006|NCT01952145|593617113|FG001|Overall Study|Death|1|||
164339007|NCT01952145|593617112|FG000|Overall Study|Adverse Event|9|||
164253019|NCT01822899|593292256|FG000|Overall Study|Withdrawal by Subject|5|||
164253020|NCT01822899|593292257|FG001|Overall Study|Withdrawal by Subject|7|||
164253021|NCT00759876|593292259|FG000|Overall Study|Sponsor terminated study early|36|||
164253022|NCT01450696|593292260|FG000|Overall Study|Never Treated|1|||
164253023|NCT01450696|593292261|FG001|Overall Study|Never Treated|1|||
164253024|NCT01450696|593292260|FG000|Overall Study|Death|77|||
164253025|NCT01450696|593292261|FG001|Overall Study|Death|84|||
164253026|NCT01450696|593292260|FG000|Overall Study|Lost to Follow-up|3|||
164339008|NCT01952145|593617113|FG001|Overall Study|Adverse Event|0|||
164253027|NCT01450696|593292261|FG001|Overall Study|Lost to Follow-up|3|||
164339009|NCT01952145|593617112|FG000|Overall Study|Withdrawal Criteria|16|||
164142212|NCT00113763|592882568|FG001|Overall Study|Lost to Follow-up|0|||
164142213|NCT00113763|592882567|FG000|Overall Study|Withdrawal by Subject|1|||
164142214|NCT00113763|592882568|FG001|Overall Study|Withdrawal by Subject|4|||
164142215|NCT00113763|592882567|FG000|Overall Study|Other|27|||
164142216|NCT00113763|592882568|FG001|Overall Study|Other|6|||
164142217|NCT00113763|592882567|FG000|Overall Study|Non-compliance|1|||
164142218|NCT00113763|592882568|FG001|Overall Study|Non-compliance|0|||
164142219|NCT00113763|592882567|FG000|Overall Study|Ongoing|1|||
164142220|NCT00113763|592882568|FG001|Overall Study|Ongoing|0|||
164142221|NCT03743415|592882569|FG000|Overall Study|Death|5|||
164142222|NCT03743415|592882570|FG001|Overall Study|Death|3|||
164142223|NCT03743415|592882571|FG002|Overall Study|Death|1|||
164142224|NCT03743415|592882572|FG003|Overall Study|Death|4|||
164142225|NCT03743415|592882573|FG004|Overall Study|Death|0|||
164142226|NCT03743415|592882574|FG005|Overall Study|Death|0|||
164142227|NCT03743415|592882575|FG006|Overall Study|Death|0|||
164142228|NCT03743415|592882576|FG007|Overall Study|Death|0|||
164142229|NCT03743415|592882577|FG008|Overall Study|Death|1|||
164142230|NCT03743415|592882578|FG009|Overall Study|Death|0|||
164142231|NCT03743415|592882569|FG000|Overall Study|Withdrawal by Subject|1|||
164142232|NCT03743415|592882570|FG001|Overall Study|Withdrawal by Subject|0|||
164142233|NCT03743415|592882571|FG002|Overall Study|Withdrawal by Subject|4|||
164142234|NCT03743415|592882572|FG003|Overall Study|Withdrawal by Subject|5|||
164142235|NCT03743415|592882573|FG004|Overall Study|Withdrawal by Subject|5|||
164142236|NCT03743415|592882574|FG005|Overall Study|Withdrawal by Subject|2|||
164142237|NCT03743415|592882575|FG006|Overall Study|Withdrawal by Subject|2|||
164142238|NCT03743415|592882576|FG007|Overall Study|Withdrawal by Subject|5|||
164142239|NCT03743415|592882577|FG008|Overall Study|Withdrawal by Subject|9|||
164142240|NCT03743415|592882578|FG009|Overall Study|Withdrawal by Subject|10|||
164142241|NCT03743415|592882569|FG000|Overall Study|Lost to Follow-up|2|||
164142242|NCT03743415|592882570|FG001|Overall Study|Lost to Follow-up|0|||
164142243|NCT03743415|592882571|FG002|Overall Study|Lost to Follow-up|2|||
164142244|NCT03743415|592882572|FG003|Overall Study|Lost to Follow-up|1|||
164142245|NCT03743415|592882573|FG004|Overall Study|Lost to Follow-up|1|||
164142246|NCT03743415|592882574|FG005|Overall Study|Lost to Follow-up|0|||
164142247|NCT03743415|592882575|FG006|Overall Study|Lost to Follow-up|1|||
164142248|NCT03743415|592882576|FG007|Overall Study|Lost to Follow-up|4|||
164142249|NCT03743415|592882577|FG008|Overall Study|Lost to Follow-up|13|||
164142250|NCT03743415|592882578|FG009|Overall Study|Lost to Follow-up|13|||
164142251|NCT00094861|592882579|FG000|Overall Study|Adverse Event|5|||
164142252|NCT00094861|592882580|FG001|Overall Study|Adverse Event|2|||
164142253|NCT00094861|592882579|FG000|Overall Study|Withdrawal by Subject|5|||
164142254|NCT00094861|592882580|FG001|Overall Study|Withdrawal by Subject|3|||
164142255|NCT00094861|592882579|FG000|Overall Study|Physician Decision|1|||
164142256|NCT00094861|592882580|FG001|Overall Study|Physician Decision|1|||
164142257|NCT00094861|592882579|FG000|Overall Study|Lost to Follow-up|0|||
164142258|NCT00094861|592882580|FG001|Overall Study|Lost to Follow-up|1|||
164142259|NCT00094861|592882579|FG000|Overall Study|Death|4|||
164142260|NCT00094861|592882580|FG001|Overall Study|Death|2|||
164142261|NCT00094861|592882579|FG000|Overall Study|Other|3|||
164142262|NCT00094861|592882580|FG001|Overall Study|Other|0|||
164142263|NCT00451204|592882582|FG000|Overall Study|Adverse Event|4|||
164142264|NCT00451204|592882583|FG001|Overall Study|Adverse Event|6|||
164142265|NCT00451204|592882582|FG000|Overall Study|Lack of Efficacy|4|||
164142266|NCT00451204|592882583|FG001|Overall Study|Lack of Efficacy|4|||
164253028|NCT01450696|593292260|FG000|Overall Study|Non-Compliance|1|||
164253029|NCT01450696|593292261|FG001|Overall Study|Non-Compliance|0|||
164253030|NCT01450696|593292260|FG000|Overall Study|Withdrawal by Subject|13|||
164253031|NCT01450696|593292261|FG001|Overall Study|Withdrawal by Subject|2|||
164253032|NCT01450696|593292260|FG000|Overall Study|Study Terminated by Sponsor|53|||
164253033|NCT01450696|593292261|FG001|Overall Study|Study Terminated by Sponsor|58|||
164253034|NCT02570152|593292262|FG000|Overall Study|Protocol Violation|2|||
164253035|NCT02570152|593292262|FG000|Overall Study|Migrated/moved from study area|13|||
164253036|NCT02684617|593292263|FG000|Overall Study|Adverse Event|1|||
164253037|NCT02684617|593292264|FG001|Overall Study|Adverse Event|0|||
164253038|NCT02684617|593292265|FG002|Overall Study|Adverse Event|1|||
164253039|NCT02684617|593292263|FG000|Overall Study|Death|8|||
164253040|NCT02684617|593292264|FG001|Overall Study|Death|16|||
164253041|NCT02684617|593292265|FG002|Overall Study|Death|28|||
164253042|NCT02684617|593292263|FG000|Overall Study|Withdrawal by Subject|2|||
164253043|NCT02684617|593292264|FG001|Overall Study|Withdrawal by Subject|0|||
164253044|NCT02684617|593292265|FG002|Overall Study|Withdrawal by Subject|4|||
164253045|NCT02684617|593292263|FG000|Overall Study|Screen Failure|1|||
164253046|NCT02684617|593292264|FG001|Overall Study|Screen Failure|0|||
164253047|NCT02684617|593292265|FG002|Overall Study|Screen Failure|2|||
164253048|NCT02684617|593292263|FG000|Overall Study|Study Terminated by Sponsor|6|||
164253049|NCT02684617|593292264|FG001|Overall Study|Study Terminated by Sponsor|1|||
164253050|NCT02684617|593292265|FG002|Overall Study|Study Terminated by Sponsor|5|||
164253051|NCT00853242|593292266|FG000|Overall Study|Adverse Event|0|||
164253052|NCT00853242|593292267|FG001|Overall Study|Adverse Event|1|||
164253053|NCT00853242|593292268|FG002|Overall Study|Adverse Event|1|||
164253054|NCT00853242|593292269|FG003|Overall Study|Adverse Event|0|||
164253055|NCT00853242|593292270|FG004|Overall Study|Adverse Event|3|||
164253056|NCT00853242|593292271|FG005|Overall Study|Adverse Event|1|||
164253057|NCT00853242|593292272|FG006|Overall Study|Adverse Event|1|||
164253058|NCT00853242|593292266|FG000|Overall Study|Noncompliant|0|||
164253059|NCT00853242|593292267|FG001|Overall Study|Noncompliant|0|||
164253060|NCT00853242|593292268|FG002|Overall Study|Noncompliant|0|||
164253061|NCT00853242|593292269|FG003|Overall Study|Noncompliant|0|||
164253062|NCT00853242|593292270|FG004|Overall Study|Noncompliant|1|||
164253063|NCT00853242|593292271|FG005|Overall Study|Noncompliant|0|||
164253064|NCT00853242|593292272|FG006|Overall Study|Noncompliant|0|||
164253065|NCT00853242|593292266|FG000|Overall Study|Withdrawal by Subject|1|||
164253066|NCT00853242|593292267|FG001|Overall Study|Withdrawal by Subject|2|||
164253067|NCT00853242|593292268|FG002|Overall Study|Withdrawal by Subject|0|||
164253068|NCT00853242|593292269|FG003|Overall Study|Withdrawal by Subject|4|||
164253069|NCT00853242|593292270|FG004|Overall Study|Withdrawal by Subject|0|||
164253070|NCT00853242|593292271|FG005|Overall Study|Withdrawal by Subject|0|||
164253071|NCT00853242|593292272|FG006|Overall Study|Withdrawal by Subject|2|||
164253072|NCT00853242|593292266|FG000|Overall Study|Other|2|||
164253073|NCT00853242|593292267|FG001|Overall Study|Other|0|||
163991983|NCT04426695|592339657|FG016|Overall Study|Participant Decision|0|||
163991984|NCT04426695|592339658|FG017|Overall Study|Participant Decision|0|||
163991985|NCT04426695|592339641|FG000|Overall Study|Adverse Event|0|||
163991986|NCT04426695|592339642|FG001|Overall Study|Adverse Event|0|||
163991987|NCT04426695|592339643|FG002|Overall Study|Adverse Event|0|||
163991988|NCT04426695|592339644|FG003|Overall Study|Adverse Event|0|||
163991989|NCT04426695|592339645|FG004|Overall Study|Adverse Event|0|||
163991990|NCT04426695|592339646|FG005|Overall Study|Adverse Event|0|||
163991991|NCT04426695|592339647|FG006|Overall Study|Adverse Event|0|||
163991992|NCT04426695|592339648|FG007|Overall Study|Adverse Event|1|||
164253074|NCT00853242|593292268|FG002|Overall Study|Other|2|||
164253075|NCT00853242|593292269|FG003|Overall Study|Other|0|||
164253076|NCT00853242|593292270|FG004|Overall Study|Other|0|||
164253077|NCT00853242|593292271|FG005|Overall Study|Other|1|||
164253078|NCT00853242|593292272|FG006|Overall Study|Other|2|||
164253079|NCT02516098|593292280|FG000|Period 1|Protocol Violation|1|||
164253080|NCT02516098|593292281|FG001|Period 1|Protocol Violation|0|||
164253081|NCT02516098|593292280|FG000|Washout After Period 1|Adverse Event|0|||
164253082|NCT02516098|593292281|FG001|Washout After Period 1|Adverse Event|1|||
164253083|NCT02516098|593292280|FG000|Period 2|Withdrawal by Subject|0|||
164253084|NCT02516098|593292281|FG001|Period 2|Withdrawal by Subject|1|||
164253085|NCT01092780|593292282|FG000|Washout Period 1|Adverse Event|0|||
164253086|NCT01092780|593292283|FG001|Washout Period 1|Adverse Event|1|||
164253087|NCT01092780|593292284|FG002|Washout Period 1|Adverse Event|0|||
164253088|NCT01092780|593292285|FG003|Washout Period 1|Adverse Event|0|||
164253089|NCT01092780|593292282|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
164253090|NCT01092780|593292283|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
164253091|NCT01092780|593292284|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
164253092|NCT01092780|593292285|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
164253093|NCT01092780|593292282|FG000|Washout Period 2|Adverse Event|0|||
164253094|NCT01092780|593292283|FG001|Washout Period 2|Adverse Event|1|||
164253095|NCT01092780|593292284|FG002|Washout Period 2|Adverse Event|1|||
164253096|NCT01092780|593292285|FG003|Washout Period 2|Adverse Event|0|||
164253097|NCT01257230|593292286|FG000|Overall Study|Not Treated|0|||
164253098|NCT01257230|593292287|FG001|Overall Study|Not Treated|0|||
164253099|NCT01257230|593292288|FG002|Overall Study|Not Treated|1|||
164253100|NCT01257230|593292286|FG000|Overall Study|Adverse Event|2|||
164253101|NCT01257230|593292287|FG001|Overall Study|Adverse Event|0|||
164253102|NCT01257230|593292288|FG002|Overall Study|Adverse Event|0|||
164253103|NCT01257230|593292286|FG000|Overall Study|Lack of Efficacy|0|||
164253104|NCT01257230|593292287|FG001|Overall Study|Lack of Efficacy|1|||
164253105|NCT01257230|593292288|FG002|Overall Study|Lack of Efficacy|0|||
164253106|NCT01257230|593292286|FG000|Overall Study|Protocol Violation|3|||
164253107|NCT01257230|593292287|FG001|Overall Study|Protocol Violation|0|||
164253108|NCT01257230|593292288|FG002|Overall Study|Protocol Violation|1|||
164253109|NCT01257230|593292286|FG000|Overall Study|Withdrawal by Subject|0|||
164253110|NCT01257230|593292287|FG001|Overall Study|Withdrawal by Subject|4|||
164253111|NCT01257230|593292288|FG002|Overall Study|Withdrawal by Subject|1|||
164253112|NCT01257230|593292286|FG000|Overall Study|Other reason not defined above|1|||
164253113|NCT01257230|593292287|FG001|Overall Study|Other reason not defined above|5|||
164253114|NCT01257230|593292288|FG002|Overall Study|Other reason not defined above|3|||
164253115|NCT01205061|593292291|FG000|Overall Study|Adverse Event|4|||
164253116|NCT01205061|593292291|FG000|Overall Study|Withdrawal by Subject|11|||
164253117|NCT01205061|593292291|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
164253118|NCT01205061|593292291|FG000|Overall Study|Lost to Follow-up|9|||
164253119|NCT01205061|593292291|FG000|Overall Study|Other|1|||
164253120|NCT04026009|593292292|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164253121|NCT04026009|593292293|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164253122|NCT04026009|593292294|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164253123|NCT04026009|593292295|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164253124|NCT04026009|593292296|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164253125|NCT04026009|593292292|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253126|NCT04026009|593292293|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253127|NCT04026009|593292294|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253128|NCT04026009|593292295|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
164253129|NCT04026009|593292296|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
164253130|NCT01988662|593292297|FG000|Overall Study|Subject/guardian decision|1|||
164253131|NCT01988662|593292298|FG001|Overall Study|Subject/guardian decision|1|||
164253132|NCT01988662|593292297|FG000|Overall Study|Adverse Event|3|||
164253133|NCT01988662|593292298|FG001|Overall Study|Adverse Event|1|||
164253134|NCT00615719|593292299|FG000|Overall Study|Physician Decision|5|||
164253135|NCT02300558|593292300|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
164253136|NCT02300558|593292300|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
164253137|NCT02300558|593292300|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
164253138|NCT02300558|593292300|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
164253139|NCT01471028|593292301|FG000|VTI-208|Adverse Event|39|||
164253140|NCT01471028|593292302|FG001|VTI-208|Adverse Event|41|||
164253141|NCT01471028|593292301|FG000|VTI-208|Withdrawal by Subject|0|||
164253142|NCT01471028|593292302|FG001|VTI-208|Withdrawal by Subject|2|||
164253143|NCT01471028|593292301|FG000|VTI-208|Lost to Follow-up|1|||
164253144|NCT01471028|593292302|FG001|VTI-208|Lost to Follow-up|1|||
164253145|NCT01471028|593292301|FG000|VTI-208E|Death|7|||
164253146|NCT01471028|593292302|FG001|VTI-208E|Death|10|||
164253147|NCT01471028|593292301|FG000|VTI-208E|Withdrawal by Subject|1|||
164253148|NCT01471028|593292302|FG001|VTI-208E|Withdrawal by Subject|0|||
164253149|NCT01471028|593292301|FG000|VTI-208E|Lost to Follow-up|0|||
164253150|NCT01471028|593292302|FG001|VTI-208E|Lost to Follow-up|2|||
164253151|NCT02957747|593292303|FG000|Overall Study|Withdrawal by Subject|0|||
164253152|NCT02957747|593292304|FG001|Overall Study|Withdrawal by Subject|3|||
164253153|NCT02957747|593292303|FG000|Overall Study|Lost to Follow-up|10|||
164253154|NCT02957747|593292304|FG001|Overall Study|Lost to Follow-up|5|||
164253155|NCT02016716|593292313|FG000|Overall Study|Withdrawal by Subject|5|||
164253156|NCT02016716|593292314|FG001|Overall Study|Withdrawal by Subject|5|||
164253157|NCT02016716|593292315|FG002|Overall Study|Withdrawal by Subject|5|||
164253158|NCT02016716|593292313|FG000|Overall Study|Protocol-specified Criteria|0|||
164253159|NCT02016716|593292314|FG001|Overall Study|Protocol-specified Criteria|1|||
164253160|NCT02016716|593292315|FG002|Overall Study|Protocol-specified Criteria|0|||
164253161|NCT02016716|593292313|FG000|Overall Study|Lost to Follow-up|1|||
164253162|NCT02016716|593292314|FG001|Overall Study|Lost to Follow-up|2|||
164253163|NCT02016716|593292315|FG002|Overall Study|Lost to Follow-up|1|||
164253164|NCT02931838|593292316|FG000|Overall Study|Reason not provided by investigator|1|||
164253165|NCT02931838|593292317|FG001|Overall Study|Reason not provided by investigator|0|||
164253166|NCT02931838|593292318|FG002|Overall Study|Reason not provided by investigator|1|||
164253167|NCT02931838|593292319|FG003|Overall Study|Reason not provided by investigator|0|||
164253168|NCT02931838|593292320|FG004|Overall Study|Reason not provided by investigator|0|||
164253169|NCT02931838|593292321|FG005|Overall Study|Reason not provided by investigator|0|||
164253170|NCT02931838|593292316|FG000|Overall Study|Poor/non-compliance|0|||
164253171|NCT02931838|593292317|FG001|Overall Study|Poor/non-compliance|0|||
164253172|NCT02931838|593292318|FG002|Overall Study|Poor/non-compliance|1|||
164253173|NCT02931838|593292319|FG003|Overall Study|Poor/non-compliance|0|||
164253174|NCT02931838|593292320|FG004|Overall Study|Poor/non-compliance|0|||
164253175|NCT02931838|593292321|FG005|Overall Study|Poor/non-compliance|0|||
164253176|NCT02931838|593292316|FG000|Overall Study|Lack of Efficacy|5|||
164253177|NCT02931838|593292317|FG001|Overall Study|Lack of Efficacy|4|||
164253178|NCT02931838|593292318|FG002|Overall Study|Lack of Efficacy|0|||
164253179|NCT02931838|593292319|FG003|Overall Study|Lack of Efficacy|0|||
164253180|NCT02931838|593292320|FG004|Overall Study|Lack of Efficacy|0|||
164253181|NCT02931838|593292321|FG005|Overall Study|Lack of Efficacy|1|||
164253182|NCT02931838|593292316|FG000|Overall Study|Lost to Follow-up|1|||
164253183|NCT02931838|593292317|FG001|Overall Study|Lost to Follow-up|0|||
164253184|NCT02931838|593292318|FG002|Overall Study|Lost to Follow-up|1|||
164253185|NCT02931838|593292319|FG003|Overall Study|Lost to Follow-up|1|||
164253186|NCT02931838|593292320|FG004|Overall Study|Lost to Follow-up|2|||
164253187|NCT02931838|593292321|FG005|Overall Study|Lost to Follow-up|0|||
164253188|NCT02931838|593292316|FG000|Overall Study|Subject request to discontinue treatment|4|||
164253189|NCT02931838|593292317|FG001|Overall Study|Subject request to discontinue treatment|3|||
164253190|NCT02931838|593292318|FG002|Overall Study|Subject request to discontinue treatment|3|||
164253191|NCT02931838|593292319|FG003|Overall Study|Subject request to discontinue treatment|0|||
164253192|NCT02931838|593292320|FG004|Overall Study|Subject request to discontinue treatment|1|||
164253193|NCT02931838|593292321|FG005|Overall Study|Subject request to discontinue treatment|0|||
164253194|NCT02931838|593292316|FG000|Overall Study|Withdrawal by Subject|1|||
164253195|NCT02931838|593292317|FG001|Overall Study|Withdrawal by Subject|2|||
164253196|NCT02931838|593292318|FG002|Overall Study|Withdrawal by Subject|0|||
164253197|NCT02931838|593292319|FG003|Overall Study|Withdrawal by Subject|1|||
164253198|NCT02931838|593292320|FG004|Overall Study|Withdrawal by Subject|0|||
164253199|NCT02931838|593292321|FG005|Overall Study|Withdrawal by Subject|0|||
164253200|NCT02931838|593292316|FG000|Overall Study|Adverse Event|2|||
164253201|NCT02931838|593292317|FG001|Overall Study|Adverse Event|1|||
164253202|NCT02931838|593292318|FG002|Overall Study|Adverse Event|2|||
164253203|NCT02931838|593292319|FG003|Overall Study|Adverse Event|1|||
164253204|NCT02931838|593292320|FG004|Overall Study|Adverse Event|3|||
164253205|NCT02931838|593292321|FG005|Overall Study|Adverse Event|1|||
164253206|NCT01963767|593292322|FG000|Overall Study|Withdrawal by Subject|4|||
163887272|NCT03544281|591959377|FG015|Main Study Phase|Physician Decision|0|||
163887273|NCT03544281|591959378|FG016|Main Study Phase|Physician Decision|0|||
163887274|NCT03544281|591959379|FG017|Main Study Phase|Physician Decision|0|||
163887275|NCT03544281|591959380|FG018|Main Study Phase|Physician Decision|0|||
163887276|NCT03544281|591959381|FG019|Main Study Phase|Physician Decision|0|||
163887277|NCT03544281|591959382|FG020|Main Study Phase|Physician Decision|0|||
163887278|NCT03544281|591959383|FG021|Main Study Phase|Physician Decision|0|||
163887279|NCT03544281|591959362|FG000|Main Study Phase|Withdrawal by Subject|2|||
163991993|NCT04426695|592339649|FG008|Overall Study|Adverse Event|0|||
164253207|NCT01963767|593292323|FG001|Overall Study|Withdrawal by Subject|2|||
164253208|NCT01963767|593292322|FG000|Overall Study|Adverse Event|2|||
164253209|NCT01963767|593292323|FG001|Overall Study|Adverse Event|0|||
164253210|NCT01659996|593292324|FG000|Overall Study|Protocol Violation|3|||
164253211|NCT01659996|593292325|FG001|Overall Study|Protocol Violation|3|||
164253212|NCT01659996|593292326|FG002|Overall Study|Protocol Violation|3|||
164253213|NCT01659996|593292324|FG000|Overall Study|Lost to Follow-up|1|||
164253214|NCT01659996|593292325|FG001|Overall Study|Lost to Follow-up|3|||
164253215|NCT01659996|593292326|FG002|Overall Study|Lost to Follow-up|2|||
164253216|NCT01659996|593292324|FG000|Overall Study|Adverse Event|0|||
164253217|NCT01659996|593292325|FG001|Overall Study|Adverse Event|0|||
164253218|NCT01659996|593292326|FG002|Overall Study|Adverse Event|1|||
164253219|NCT01659996|593292324|FG000|Overall Study|Withdrawal by Subject|4|||
164253220|NCT01659996|593292325|FG001|Overall Study|Withdrawal by Subject|1|||
164253221|NCT01659996|593292326|FG002|Overall Study|Withdrawal by Subject|5|||
164253222|NCT02709577|593292327|FG000|Overall Study|non-accommodating anatomy|0|||
164253223|NCT02709577|593292328|FG001|Overall Study|non-accommodating anatomy|1|||
164253224|NCT02709577|593292329|FG002|Overall Study|non-accommodating anatomy|0|||
164253225|NCT02709577|593292330|FG003|Overall Study|non-accommodating anatomy|0|||
164253226|NCT02709577|593292327|FG000|Overall Study|procedural complication|0|||
164253227|NCT02709577|593292328|FG001|Overall Study|procedural complication|1|||
164253228|NCT02709577|593292329|FG002|Overall Study|procedural complication|0|||
164253229|NCT02709577|593292330|FG003|Overall Study|procedural complication|0|||
164253230|NCT02709577|593292327|FG000|Overall Study|Withdrawal by Subject|2|||
164253231|NCT02709577|593292328|FG001|Overall Study|Withdrawal by Subject|3|||
164253232|NCT02709577|593292329|FG002|Overall Study|Withdrawal by Subject|2|||
164253233|NCT02709577|593292330|FG003|Overall Study|Withdrawal by Subject|0|||
164253234|NCT03823287|593292331|FG000|Overall Study|Withdrawal by Subject|25|||
164253235|NCT03823287|593292332|FG001|Overall Study|Withdrawal by Subject|17|||
164253236|NCT03823287|593292331|FG000|Overall Study|Death|13|||
164253237|NCT03823287|593292332|FG001|Overall Study|Death|7|||
164253238|NCT03823287|593292331|FG000|Overall Study|Lost to Follow-up|7|||
164253239|NCT03823287|593292332|FG001|Overall Study|Lost to Follow-up|8|||
164253240|NCT03823287|593292331|FG000|Overall Study|Adverse Event|6|||
164253241|NCT03823287|593292332|FG001|Overall Study|Adverse Event|8|||
164253242|NCT03823287|593292331|FG000|Overall Study|Physician Decision|5|||
164253243|NCT03823287|593292332|FG001|Overall Study|Physician Decision|2|||
164253244|NCT03823287|593292331|FG000|Overall Study|Lack of Efficacy|2|||
164253245|NCT03823287|593292332|FG001|Overall Study|Lack of Efficacy|0|||
164253246|NCT03823287|593292331|FG000|Overall Study|Other|2|||
164253247|NCT03823287|593292332|FG001|Overall Study|Other|4|||
164253248|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Adverse Event|7|||
163887280|NCT03544281|591959363|FG001|Main Study Phase|Withdrawal by Subject|0|||
163887281|NCT03544281|591959364|FG002|Main Study Phase|Withdrawal by Subject|1|||
164253249|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Adverse Event|0|||
164253250|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Adverse Event|0|||
164253251|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
164253252|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
164253253|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
163887282|NCT03544281|591959365|FG003|Main Study Phase|Withdrawal by Subject|2|||
163887283|NCT03544281|591959366|FG004|Main Study Phase|Withdrawal by Subject|0|||
163887284|NCT03544281|591959367|FG005|Main Study Phase|Withdrawal by Subject|0|||
163887285|NCT03544281|591959368|FG006|Main Study Phase|Withdrawal by Subject|0|||
163887286|NCT03544281|591959369|FG007|Main Study Phase|Withdrawal by Subject|0|||
163887287|NCT03544281|591959370|FG008|Main Study Phase|Withdrawal by Subject|2|||
163887288|NCT03544281|591959371|FG009|Main Study Phase|Withdrawal by Subject|3|||
163887289|NCT03544281|591959372|FG010|Main Study Phase|Withdrawal by Subject|0|||
163887290|NCT03544281|591959373|FG011|Main Study Phase|Withdrawal by Subject|4|||
163887291|NCT03544281|591959374|FG012|Main Study Phase|Withdrawal by Subject|0|||
163887292|NCT03544281|591959375|FG013|Main Study Phase|Withdrawal by Subject|0|||
163887293|NCT03544281|591959376|FG014|Main Study Phase|Withdrawal by Subject|0|||
163887294|NCT03544281|591959377|FG015|Main Study Phase|Withdrawal by Subject|0|||
163887295|NCT03544281|591959378|FG016|Main Study Phase|Withdrawal by Subject|0|||
163887296|NCT03544281|591959379|FG017|Main Study Phase|Withdrawal by Subject|0|||
163887297|NCT03544281|591959380|FG018|Main Study Phase|Withdrawal by Subject|0|||
163887298|NCT03544281|591959381|FG019|Main Study Phase|Withdrawal by Subject|0|||
163887299|NCT03544281|591959382|FG020|Main Study Phase|Withdrawal by Subject|0|||
163887300|NCT03544281|591959383|FG021|Main Study Phase|Withdrawal by Subject|0|||
163887301|NCT03544281|591959362|FG000|Main Study Phase|Ongoing|3|||
163887302|NCT03544281|591959363|FG001|Main Study Phase|Ongoing|1|||
164253254|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
163887303|NCT03544281|591959364|FG002|Main Study Phase|Ongoing|2|||
163887304|NCT03544281|591959365|FG003|Main Study Phase|Ongoing|4|||
163887305|NCT03544281|591959366|FG004|Main Study Phase|Ongoing|2|||
163887306|NCT03544281|591959367|FG005|Main Study Phase|Ongoing|4|||
163887307|NCT03544281|591959368|FG006|Main Study Phase|Ongoing|4|||
164253255|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
164253256|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
164253257|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
164253258|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
163887308|NCT03544281|591959369|FG007|Main Study Phase|Ongoing|0|||
163887309|NCT03544281|591959370|FG008|Main Study Phase|Ongoing|2|||
163887310|NCT03544281|591959371|FG009|Main Study Phase|Ongoing|2|||
164253259|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
164253260|NCT01059864|593292335|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
164253261|NCT01059864|593292336|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
164253262|NCT01059864|593292337|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
164253263|NCT01059864|593292335|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164253264|NCT01059864|593292336|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164253265|NCT01059864|593292337|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
164253266|NCT03108521|593292338|FG000|Overall Study|Lost to Follow-up|3|||
164253267|NCT03108521|593292339|FG001|Overall Study|Lost to Follow-up|0|||
164253268|NCT03108521|593292338|FG000|Overall Study|Lack of Efficacy|2|||
164253269|NCT03108521|593292339|FG001|Overall Study|Lack of Efficacy|0|||
164253270|NCT03108521|593292338|FG000|Overall Study|Physician Decision|4|||
164253271|NCT03108521|593292339|FG001|Overall Study|Physician Decision|0|||
164253272|NCT03108521|593292338|FG000|Overall Study|Adverse Event|3|||
164253273|NCT03108521|593292339|FG001|Overall Study|Adverse Event|0|||
164253274|NCT03281629|593292345|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
164253275|NCT03281629|593292346|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
164253276|NCT03281629|593292345|FG000|Overall Study|Death|0|||
164253277|NCT03281629|593292346|FG001|Overall Study|Death|1|||
164253278|NCT03281629|593292345|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
164253279|NCT03281629|593292346|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
164253280|NCT01380535|593294136|FG000|Overall Study|Adverse Event|3|||
164253281|NCT01380535|593294137|FG001|Overall Study|Adverse Event|3|||
164253282|NCT01380535|593294136|FG000|Overall Study|Death|3|||
164253283|NCT01380535|593294137|FG001|Overall Study|Death|0|||
164253284|NCT01380535|593294136|FG000|Overall Study|Study site closed|0|||
164253285|NCT01380535|593294137|FG001|Overall Study|Study site closed|5|||
164253286|NCT01380535|593294136|FG000|Overall Study|Withdrawal by Subject|1|||
164253287|NCT01380535|593294137|FG001|Overall Study|Withdrawal by Subject|2|||
164253288|NCT01380535|593294136|FG000|Overall Study|Protocol Violation|0|||
164253289|NCT01380535|593294137|FG001|Overall Study|Protocol Violation|2|||
164253290|NCT01380535|593294136|FG000|Overall Study|Lack of Efficacy|0|||
164253291|NCT01380535|593294137|FG001|Overall Study|Lack of Efficacy|3|||
164253292|NCT00489424|593294138|FG000|Overall Study|Adverse Event|3|||
164253293|NCT00489424|593294139|FG001|Overall Study|Adverse Event|3|||
164253294|NCT00489424|593294140|FG002|Overall Study|Adverse Event|4|||
164253295|NCT00489424|593294138|FG000|Overall Study|Lack of Efficacy|1|||
164253296|NCT00489424|593294139|FG001|Overall Study|Lack of Efficacy|0|||
164253297|NCT00489424|593294140|FG002|Overall Study|Lack of Efficacy|0|||
164253298|NCT00489424|593294138|FG000|Overall Study|Administrative problems|0|||
164253299|NCT00489424|593294139|FG001|Overall Study|Administrative problems|2|||
164253300|NCT00489424|593294140|FG002|Overall Study|Administrative problems|1|||
164253301|NCT00394251|593294141|FG000|Overall Study|Adverse Event|7|||
164253302|NCT00394251|593294142|FG001|Overall Study|Adverse Event|5|||
164253303|NCT00394251|593294141|FG000|Overall Study|Unacceptable Toxicity|20|||
164253304|NCT00394251|593294142|FG001|Overall Study|Unacceptable Toxicity|18|||
164253305|NCT00394251|593294141|FG000|Overall Study|Physician Decision|1|||
164253306|NCT00394251|593294142|FG001|Overall Study|Physician Decision|1|||
164253307|NCT00394251|593294141|FG000|Overall Study|Protocol Violation|0|||
164253308|NCT00394251|593294142|FG001|Overall Study|Protocol Violation|1|||
164253309|NCT00394251|593294141|FG000|Overall Study|Withdrawal by Subject|7|||
164253310|NCT00394251|593294142|FG001|Overall Study|Withdrawal by Subject|11|||
164253311|NCT00394251|593294141|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
164253312|NCT00394251|593294142|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
164253313|NCT00962741|593294143|FG000|Overall Study|Failed to return|3|||
164253314|NCT00962741|593294143|FG000|Overall Study|Lost to Follow-up|2|||
164253315|NCT00962741|593294143|FG000|Overall Study|Withdrawal by Subject|1|||
164253316|NCT00962741|593294143|FG000|Overall Study|Lack of Efficacy|1|||
164253317|NCT00962741|593294143|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
164253318|NCT01545934|593294144|FG000|Overall Study|Withdrawal by Subject|4|||
164253319|NCT01545934|593294145|FG001|Overall Study|Withdrawal by Subject|3|||
164253320|NCT01545934|593294144|FG000|Overall Study|Lost to Follow-up|1|||
164253321|NCT01545934|593294145|FG001|Overall Study|Lost to Follow-up|0|||
164253322|NCT01843673|593294150|FG000|Overall Study|Lack of Efficacy|2|||
164253323|NCT01843673|593294150|FG000|Overall Study|Withdrawal by Subject|4|||
164253324|NCT00695955|593294155|FG000|Cohort 1|Adverse Event|26|||
164253325|NCT00695955|593294155|FG000|Cohort 1|Protocol Violation|2|||
164253326|NCT00695955|593294155|FG000|Cohort 1|Lost to Follow-up|30|||
164253327|NCT00695955|593294155|FG000|Cohort 1|Withdrawal by Subject|25|||
164253328|NCT00695955|593294155|FG000|Cohort 1|Lack of Efficacy|3|||
164253329|NCT00695955|593294155|FG000|Cohort 1|Other|16|||
164253330|NCT00695955|593294155|FG000|Cohort 2|Adverse Event|24|||
164253331|NCT00695955|593294155|FG000|Cohort 2|Protocol Violation|5|||
164253332|NCT00695955|593294155|FG000|Cohort 2|Lost to Follow-up|38|||
164253333|NCT00695955|593294155|FG000|Cohort 2|Withdrawal by Subject|28|||
164253334|NCT00695955|593294155|FG000|Cohort 2|Lack of Efficacy|4|||
164253335|NCT00695955|593294155|FG000|Cohort 2|Other|5|||
164253336|NCT00888329|593294156|FG000|Overall Study|Physician Decision|6|||
164253337|NCT00888329|593294157|FG001|Overall Study|Physician Decision|9|||
164253338|NCT04826094|593294158|FG000|Overall Study|Lost to Follow-up|2|||
164253339|NCT04826094|593294159|FG001|Overall Study|Lost to Follow-up|1|||
164253340|NCT04826094|593294160|FG002|Overall Study|Lost to Follow-up|0|||
164253341|NCT04826094|593294161|FG003|Overall Study|Lost to Follow-up|0|||
164253342|NCT04826094|593294162|FG004|Overall Study|Lost to Follow-up|1|||
164253343|NCT04826094|593294163|FG005|Overall Study|Lost to Follow-up|3|||
164253344|NCT04826094|593294164|FG006|Overall Study|Lost to Follow-up|1|||
164253345|NCT04826094|593294165|FG007|Overall Study|Lost to Follow-up|1|||
164253346|NCT04826094|593294158|FG000|Overall Study|Participant withdrew consent|1|||
164253347|NCT04826094|593294159|FG001|Overall Study|Participant withdrew consent|0|||
164253348|NCT04826094|593294160|FG002|Overall Study|Participant withdrew consent|0|||
164253349|NCT04826094|593294161|FG003|Overall Study|Participant withdrew consent|1|||
164253350|NCT04826094|593294162|FG004|Overall Study|Participant withdrew consent|1|||
164253351|NCT04826094|593294163|FG005|Overall Study|Participant withdrew consent|1|||
164253352|NCT04826094|593294164|FG006|Overall Study|Participant withdrew consent|0|||
164253353|NCT04826094|593294165|FG007|Overall Study|Participant withdrew consent|1|||
164253354|NCT04826094|593294158|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
164253355|NCT04826094|593294159|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
164253356|NCT04826094|593294160|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
164253357|NCT04826094|593294161|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
164253358|NCT04826094|593294162|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
164253359|NCT04826094|593294163|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
164253360|NCT04826094|593294164|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
164253361|NCT04826094|593294165|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
164253362|NCT04826094|593294158|FG000|Overall Study|Withdrawn by Investigator|0|||
164253363|NCT04826094|593294159|FG001|Overall Study|Withdrawn by Investigator|0|||
164253364|NCT04826094|593294160|FG002|Overall Study|Withdrawn by Investigator|0|||
163887311|NCT03544281|591959372|FG010|Main Study Phase|Ongoing|1|||
163887312|NCT03544281|591959373|FG011|Main Study Phase|Ongoing|0|||
163887313|NCT03544281|591959374|FG012|Main Study Phase|Ongoing|0|||
163887314|NCT03544281|591959375|FG013|Main Study Phase|Ongoing|0|||
163887315|NCT03544281|591959376|FG014|Main Study Phase|Ongoing|0|||
163887316|NCT03544281|591959377|FG015|Main Study Phase|Ongoing|0|||
163887317|NCT03544281|591959378|FG016|Main Study Phase|Ongoing|0|||
163887318|NCT03544281|591959379|FG017|Main Study Phase|Ongoing|0|||
163887319|NCT03544281|591959380|FG018|Main Study Phase|Ongoing|0|||
163887320|NCT03544281|591959381|FG019|Main Study Phase|Ongoing|0|||
163887321|NCT03544281|591959382|FG020|Main Study Phase|Ongoing|0|||
163887322|NCT03544281|591959383|FG021|Main Study Phase|Ongoing|0|||
163887323|NCT03544281|591959362|FG000|Main Study Phase|Investigator Site Closed|0|||
163887324|NCT03544281|591959363|FG001|Main Study Phase|Investigator Site Closed|0|||
163887325|NCT03544281|591959364|FG002|Main Study Phase|Investigator Site Closed|0|||
163887326|NCT03544281|591959365|FG003|Main Study Phase|Investigator Site Closed|0|||
163887327|NCT03544281|591959366|FG004|Main Study Phase|Investigator Site Closed|0|||
163887328|NCT03544281|591959367|FG005|Main Study Phase|Investigator Site Closed|0|||
163887329|NCT03544281|591959368|FG006|Main Study Phase|Investigator Site Closed|0|||
163887330|NCT03544281|591959369|FG007|Main Study Phase|Investigator Site Closed|0|||
163887331|NCT03544281|591959370|FG008|Main Study Phase|Investigator Site Closed|0|||
163887332|NCT03544281|591959371|FG009|Main Study Phase|Investigator Site Closed|1|||
163887333|NCT03544281|591959372|FG010|Main Study Phase|Investigator Site Closed|0|||
163887334|NCT03544281|591959373|FG011|Main Study Phase|Investigator Site Closed|0|||
163887335|NCT03544281|591959374|FG012|Main Study Phase|Investigator Site Closed|0|||
163887336|NCT03544281|591959375|FG013|Main Study Phase|Investigator Site Closed|0|||
163887337|NCT03544281|591959376|FG014|Main Study Phase|Investigator Site Closed|0|||
163887338|NCT03544281|591959377|FG015|Main Study Phase|Investigator Site Closed|0|||
163887339|NCT03544281|591959378|FG016|Main Study Phase|Investigator Site Closed|0|||
163887340|NCT03544281|591959379|FG017|Main Study Phase|Investigator Site Closed|0|||
164253365|NCT04826094|593294161|FG003|Overall Study|Withdrawn by Investigator|0|||
164253366|NCT04826094|593294162|FG004|Overall Study|Withdrawn by Investigator|0|||
164253367|NCT04826094|593294163|FG005|Overall Study|Withdrawn by Investigator|1|||
164253368|NCT04826094|593294164|FG006|Overall Study|Withdrawn by Investigator|0|||
164253369|NCT04826094|593294165|FG007|Overall Study|Withdrawn by Investigator|1|||
164253370|NCT04826094|593294158|FG000|Overall Study|Other: Moved from area|1|||
164253371|NCT04826094|593294159|FG001|Overall Study|Other: Moved from area|1|||
163887341|NCT03544281|591959380|FG018|Main Study Phase|Investigator Site Closed|0|||
163887342|NCT03544281|591959381|FG019|Main Study Phase|Investigator Site Closed|0|||
164253372|NCT04826094|593294160|FG002|Overall Study|Other: Moved from area|1|||
164253373|NCT04826094|593294161|FG003|Overall Study|Other: Moved from area|0|||
164253374|NCT04826094|593294162|FG004|Overall Study|Other: Moved from area|0|||
164253375|NCT04826094|593294163|FG005|Overall Study|Other: Moved from area|0|||
164253376|NCT04826094|593294164|FG006|Overall Study|Other: Moved from area|0|||
164253377|NCT04826094|593294165|FG007|Overall Study|Other: Moved from area|0|||
164253378|NCT04826094|593294158|FG000|Overall Study|Other: Declined|0|||
164253379|NCT04826094|593294159|FG001|Overall Study|Other: Declined|0|||
164253380|NCT04826094|593294160|FG002|Overall Study|Other: Declined|0|||
164253381|NCT04826094|593294161|FG003|Overall Study|Other: Declined|0|||
164253382|NCT04826094|593294162|FG004|Overall Study|Other: Declined|1|||
164253383|NCT04826094|593294163|FG005|Overall Study|Other: Declined|0|||
164253384|NCT04826094|593294164|FG006|Overall Study|Other: Declined|0|||
164253385|NCT04826094|593294165|FG007|Overall Study|Other: Declined|0|||
164253386|NCT04826094|593294158|FG000|Overall Study|Other: Vaccine not administered|0|||
164253387|NCT04826094|593294159|FG001|Overall Study|Other: Vaccine not administered|0|||
164253388|NCT04826094|593294160|FG002|Overall Study|Other: Vaccine not administered|1|||
164253389|NCT04826094|593294161|FG003|Overall Study|Other: Vaccine not administered|0|||
164253390|NCT04826094|593294162|FG004|Overall Study|Other: Vaccine not administered|0|||
164253391|NCT04826094|593294163|FG005|Overall Study|Other: Vaccine not administered|1|||
164253392|NCT04826094|593294164|FG006|Overall Study|Other: Vaccine not administered|1|||
164253393|NCT04826094|593294165|FG007|Overall Study|Other: Vaccine not administered|3|||
164253394|NCT03928418|593294172|FG000|Overall Study|Lost to Follow-up|5|||
164253395|NCT03928418|593294173|FG001|Overall Study|Lost to Follow-up|3|||
164253396|NCT03928418|593294174|FG002|Overall Study|Lost to Follow-up|5|||
164253397|NCT03928418|593294172|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
164253398|NCT03928418|593294173|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
164253399|NCT03928418|593294174|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
164253400|NCT05319600|593294175|FG000|Overall Study|Withdrawal by Subject|1|||
164253401|NCT05319600|593294176|FG001|Overall Study|Withdrawal by Subject|0|||
164253402|NCT05319600|593294175|FG000|Overall Study|Lost to Follow-up|0|||
164253403|NCT05319600|593294176|FG001|Overall Study|Lost to Follow-up|4|||
164253404|NCT00904670|593294177|FG000|Open Label Phase|Withdrawal by Subject|2|||
164253405|NCT00904670|593294178|FG001|Open Label Phase|Withdrawal by Subject|0|||
164253406|NCT00904670|593294177|FG000|Open Label Phase|Adverse Event|2|||
164253407|NCT00904670|593294178|FG001|Open Label Phase|Adverse Event|0|||
164253408|NCT00904670|593294177|FG000|Open Label Phase|Lack of Efficacy|1|||
164253409|NCT00904670|593294178|FG001|Open Label Phase|Lack of Efficacy|0|||
164253410|NCT00904670|593294177|FG000|Open Label Phase|Lost to Follow-up|1|||
164253411|NCT00904670|593294178|FG001|Open Label Phase|Lost to Follow-up|0|||
164253412|NCT00690430|593294186|FG000|Core Phase|Abnormal Laboratory value|0|||
164253413|NCT00690430|593294187|FG001|Core Phase|Abnormal Laboratory value|1|||
164253414|NCT00690430|593294188|FG002|Core Phase|Abnormal Laboratory value|0|||
164253415|NCT00690430|593294186|FG000|Core Phase|Adverse Event|5|||
164253416|NCT00690430|593294187|FG001|Core Phase|Adverse Event|1|||
164253417|NCT00690430|593294188|FG002|Core Phase|Adverse Event|0|||
164253418|NCT00690430|593294186|FG000|Core Phase|Death|0|||
164253419|NCT00690430|593294187|FG001|Core Phase|Death|2|||
164253420|NCT00690430|593294188|FG002|Core Phase|Death|0|||
164253421|NCT00690430|593294186|FG000|Core Phase|Protocol Violation|1|||
164253422|NCT00690430|593294187|FG001|Core Phase|Protocol Violation|0|||
164253423|NCT00690430|593294188|FG002|Core Phase|Protocol Violation|0|||
164253424|NCT00690430|593294186|FG000|Core Phase|Withdrawal by Subject|3|||
164253425|NCT00690430|593294187|FG001|Core Phase|Withdrawal by Subject|3|||
164253426|NCT00690430|593294188|FG002|Core Phase|Withdrawal by Subject|0|||
164253427|NCT00690430|593294186|FG000|Core Phase|Subject no longer requires study drug|1|||
164253428|NCT00690430|593294187|FG001|Core Phase|Subject no longer requires study drug|0|||
164253429|NCT00690430|593294188|FG002|Core Phase|Subject no longer requires study drug|0|||
164253430|NCT00690430|593294186|FG000|Core Phase|Lack of Efficacy|8|||
164253431|NCT00690430|593294187|FG001|Core Phase|Lack of Efficacy|10|||
163887343|NCT03544281|591959382|FG020|Main Study Phase|Investigator Site Closed|0|||
163887344|NCT03544281|591959383|FG021|Main Study Phase|Investigator Site Closed|0|||
163887345|NCT03544281|591959362|FG000|Main Study Phase|Did not receive study treatment|0|||
163887346|NCT03544281|591959363|FG001|Main Study Phase|Did not receive study treatment|0|||
164090462|NCT03384745|592693438|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
164253432|NCT00690430|593294188|FG002|Core Phase|Lack of Efficacy|0|||
164253433|NCT00690430|593294186|FG000|Core Phase|Administrative Problems|0|||
164253434|NCT00690430|593294187|FG001|Core Phase|Administrative Problems|1|||
164253435|NCT00690430|593294188|FG002|Core Phase|Administrative Problems|0|||
164253436|NCT00690430|593294186|FG000|Core Phase|Early Termination|0|||
164253437|NCT00690430|593294187|FG001|Core Phase|Early Termination|5|||
164253438|NCT00690430|593294188|FG002|Core Phase|Early Termination|0|||
164253439|NCT00690430|593294186|FG000|Extension Phase|Lack of Efficacy|3|||
164253440|NCT00690430|593294187|FG001|Extension Phase|Lack of Efficacy|1|||
164253441|NCT00690430|593294188|FG002|Extension Phase|Lack of Efficacy|4|||
164253442|NCT00690430|593294186|FG000|Extension Phase|Abnormal Lab Values|1|||
164253443|NCT00690430|593294187|FG001|Extension Phase|Abnormal Lab Values|0|||
164253444|NCT00690430|593294188|FG002|Extension Phase|Abnormal Lab Values|0|||
164253445|NCT00690430|593294186|FG000|Extension Phase|Abnormal test procedure results|1|||
164253446|NCT00690430|593294187|FG001|Extension Phase|Abnormal test procedure results|0|||
163887347|NCT03544281|591959364|FG002|Main Study Phase|Did not receive study treatment|0|||
163887348|NCT03544281|591959365|FG003|Main Study Phase|Did not receive study treatment|0|||
163887349|NCT03544281|591959366|FG004|Main Study Phase|Did not receive study treatment|0|||
163887350|NCT03544281|591959367|FG005|Main Study Phase|Did not receive study treatment|0|||
163887351|NCT03544281|591959368|FG006|Main Study Phase|Did not receive study treatment|1|||
163887352|NCT03544281|591959369|FG007|Main Study Phase|Did not receive study treatment|0|||
163887353|NCT03544281|591959370|FG008|Main Study Phase|Did not receive study treatment|0|||
163887354|NCT03544281|591959371|FG009|Main Study Phase|Did not receive study treatment|0|||
163887355|NCT03544281|591959372|FG010|Main Study Phase|Did not receive study treatment|0|||
163887356|NCT03544281|591959373|FG011|Main Study Phase|Did not receive study treatment|0|||
163887357|NCT03544281|591959374|FG012|Main Study Phase|Did not receive study treatment|0|||
163887358|NCT03544281|591959375|FG013|Main Study Phase|Did not receive study treatment|0|||
164253447|NCT00690430|593294188|FG002|Extension Phase|Abnormal test procedure results|0|||
164253448|NCT00690430|593294186|FG000|Extension Phase|Administrative Problems|0|||
164253449|NCT00690430|593294187|FG001|Extension Phase|Administrative Problems|1|||
164253450|NCT00690430|593294188|FG002|Extension Phase|Administrative Problems|1|||
164253451|NCT00690430|593294186|FG000|Extension Phase|Adverse Event|2|||
164253452|NCT00690430|593294187|FG001|Extension Phase|Adverse Event|1|||
164253453|NCT00690430|593294188|FG002|Extension Phase|Adverse Event|2|||
164253454|NCT00690430|593294186|FG000|Extension Phase|Death|1|||
164253455|NCT00690430|593294187|FG001|Extension Phase|Death|1|||
164253456|NCT00690430|593294188|FG002|Extension Phase|Death|1|||
164253457|NCT00690430|593294186|FG000|Extension Phase|Withdrawal by Subject|0|||
164253458|NCT00690430|593294187|FG001|Extension Phase|Withdrawal by Subject|0|||
164253459|NCT00690430|593294188|FG002|Extension Phase|Withdrawal by Subject|2|||
164253460|NCT00690430|593294186|FG000|Extension Phase|Early Termination|10|||
164253461|NCT00690430|593294187|FG001|Extension Phase|Early Termination|1|||
164253462|NCT00690430|593294188|FG002|Extension Phase|Early Termination|3|||
164253463|NCT02120300|593294189|FG000|Overall Study|Enrolled but Never Treated|2|||
164253464|NCT02120300|593294190|FG001|Overall Study|Enrolled but Never Treated|0|||
164253465|NCT02120300|593294191|FG002|Overall Study|Enrolled but Never Treated|0|||
164253466|NCT02120300|593294192|FG003|Overall Study|Enrolled but Never Treated|0|||
164253467|NCT02120300|593294189|FG000|Overall Study|Lack of Efficacy|0|||
164253468|NCT02120300|593294190|FG001|Overall Study|Lack of Efficacy|0|||
164253469|NCT02120300|593294191|FG002|Overall Study|Lack of Efficacy|0|||
164253470|NCT02120300|593294192|FG003|Overall Study|Lack of Efficacy|1|||
164253471|NCT02120300|593294189|FG000|Overall Study|Lost to Follow-up|1|||
164253472|NCT02120300|593294190|FG001|Overall Study|Lost to Follow-up|0|||
164253473|NCT02120300|593294191|FG002|Overall Study|Lost to Follow-up|0|||
164253474|NCT02120300|593294192|FG003|Overall Study|Lost to Follow-up|0|||
164253475|NCT01721486|593294195|FG000|Overall Study|Protocol Violation|1|||
164253476|NCT01721486|593294196|FG001|Overall Study|Protocol Violation|0|||
164253477|NCT01721486|593294195|FG000|Overall Study|Physician Decision|0|||
164253478|NCT01721486|593294196|FG001|Overall Study|Physician Decision|1|||
164253479|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
164253480|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
164253481|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
164253482|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
164253483|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Death|58|||
164253484|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Death|65|||
163887359|NCT03544281|591959376|FG014|Main Study Phase|Did not receive study treatment|0|||
163887360|NCT03544281|591959377|FG015|Main Study Phase|Did not receive study treatment|0|||
163887361|NCT03544281|591959378|FG016|Main Study Phase|Did not receive study treatment|0|||
163887362|NCT03544281|591959379|FG017|Main Study Phase|Did not receive study treatment|0|||
163887363|NCT03544281|591959380|FG018|Main Study Phase|Did not receive study treatment|0|||
163887364|NCT03544281|591959381|FG019|Main Study Phase|Did not receive study treatment|0|||
163887365|NCT03544281|591959382|FG020|Main Study Phase|Did not receive study treatment|0|||
163887366|NCT03544281|591959383|FG021|Main Study Phase|Did not receive study treatment|0|||
163887367|NCT03544281|591959362|FG000|PACT Phase|Adverse Event|0|||
164253485|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Adverse Event|28|||
164253486|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Adverse Event|40|||
164253487|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Disease Progression|22|||
164253488|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Disease Progression|35|||
164253489|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Other|25|||
164253490|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Other|33|||
163887368|NCT03544281|591959363|FG001|PACT Phase|Adverse Event|0|||
163887369|NCT03544281|591959364|FG002|PACT Phase|Adverse Event|0|||
164253491|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
164253492|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
164253493|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Noncompliance|8|||
164253494|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Noncompliance|8|||
164253495|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
164253496|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
164253497|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
164253498|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
164253499|NCT00286091|593294203|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
164253500|NCT00286091|593294204|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
164253501|NCT00286091|593294203|FG000|Open-label Treatment Phase|Physician Decision|24|||
164253502|NCT00286091|593294204|FG001|Open-label Treatment Phase|Physician Decision|21|||
164253503|NCT00286091|593294203|FG000|Open-label Treatment Phase|Adverse Event|5|||
164253504|NCT00286091|593294204|FG001|Open-label Treatment Phase|Adverse Event|16|||
164253505|NCT00286091|593294203|FG000|Open-label Treatment Phase|Other|11|||
164253506|NCT00286091|593294204|FG001|Open-label Treatment Phase|Other|11|||
164253507|NCT00286091|593294203|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
164253508|NCT00286091|593294204|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
164253509|NCT00286091|593294203|FG000|Open-label Treatment Phase|Death|10|||
164253510|NCT00286091|593294204|FG001|Open-label Treatment Phase|Death|7|||
164253511|NCT00286091|593294203|FG000|Open-label Treatment Phase|Disease Progression|9|||
164253512|NCT00286091|593294204|FG001|Open-label Treatment Phase|Disease Progression|3|||
164253513|NCT00286091|593294203|FG000|Open-label Treatment Phase|Noncompliance|3|||
164253514|NCT00286091|593294204|FG001|Open-label Treatment Phase|Noncompliance|1|||
164253515|NCT00286091|593294203|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
164253516|NCT00286091|593294204|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
164253517|NCT00286091|593294203|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
164253518|NCT00286091|593294204|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
164253519|NCT00286091|593294203|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
164253520|NCT00286091|593294204|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
164253521|NCT02936869|593294205|FG000|Overall Study|Lost to Follow-up|1|||
164253522|NCT02936869|593294206|FG001|Overall Study|Lost to Follow-up|3|||
164253523|NCT02936869|593294205|FG000|Overall Study|Death|0|||
164253524|NCT02936869|593294206|FG001|Overall Study|Death|1|||
164253525|NCT02936869|593294205|FG000|Overall Study|Legal Case|0|||
164253526|NCT02936869|593294206|FG001|Overall Study|Legal Case|1|||
164253527|NCT02936869|593294205|FG000|Overall Study|Protocol Violation|1|||
164253528|NCT02936869|593294206|FG001|Overall Study|Protocol Violation|0|||
164253529|NCT00335738|593294207|FG000|Overall Study|Physician Decision|6|||
164253530|NCT00335738|593294208|FG001|Overall Study|Physician Decision|0|||
164253531|NCT00335738|593294207|FG000|Overall Study|Withdrawal by Subject|2|||
164253532|NCT00335738|593294208|FG001|Overall Study|Withdrawal by Subject|0|||
164253533|NCT00335738|593294207|FG000|Overall Study|Ineligible|3|||
164253534|NCT00335738|593294208|FG001|Overall Study|Ineligible|4|||
164253535|NCT05141175|593294211|FG000|Overall Study|Withdrawal by Subject|1|||
164253536|NCT02036580|593294212|FG000|Overall Study|Withdrawal by Subject|0|||
164253537|NCT02036580|593294213|FG001|Overall Study|Withdrawal by Subject|1|||
164253538|NCT02036580|593294214|FG002|Overall Study|Withdrawal by Subject|0|||
164253539|NCT02036580|593294212|FG000|Overall Study|Adverse Event|1|||
164253540|NCT02036580|593294213|FG001|Overall Study|Adverse Event|0|||
164253541|NCT02036580|593294214|FG002|Overall Study|Adverse Event|0|||
164253542|NCT03098433|593294221|FG000|Overall Study|Withdrawal by Subject|10|||
164253543|NCT04470050|593294222|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164253544|NCT04470050|593294223|FG001|Double-blind Treatment Phase|Adverse Event|0|||
164253545|NCT04470050|593294224|FG002|Double-blind Treatment Phase|Adverse Event|0|||
164253546|NCT04470050|593294225|FG003|Double-blind Treatment Phase|Adverse Event|1|||
164253547|NCT04470050|593294226|FG004|Double-blind Treatment Phase|Adverse Event|0|||
164253548|NCT04470050|593294227|FG005|Double-blind Treatment Phase|Adverse Event|0|||
164253549|NCT04470050|593294228|FG006|Double-blind Treatment Phase|Adverse Event|0|||
164253550|NCT04470050|593294222|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253551|NCT04470050|593294223|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253552|NCT04470050|593294224|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253553|NCT04470050|593294225|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253554|NCT04470050|593294226|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
164253555|NCT04470050|593294227|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
164253556|NCT04470050|593294228|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
163887370|NCT03544281|591959365|FG003|PACT Phase|Adverse Event|0|||
164253557|NCT04470050|593294222|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
164253558|NCT04470050|593294223|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
164253559|NCT04470050|593294224|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
164253560|NCT04470050|593294225|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
164253561|NCT04470050|593294226|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
164253562|NCT04470050|593294227|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
164253563|NCT04470050|593294228|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
164253564|NCT01813058|593294229|FG000|Overall Study|Withdrawal by Subject|5|||
164253565|NCT01813058|593294230|FG001|Overall Study|Withdrawal by Subject|4|||
164253566|NCT03585764|593294231|FG000|Overall Study|Death|3|||
164253567|NCT03585764|593294232|FG001|Overall Study|Death|2|||
164253568|NCT03585764|593294233|FG002|Overall Study|Death|3|||
164253569|NCT03585764|593294234|FG003|Overall Study|Death|0|||
164253570|NCT03585764|593294231|FG000|Overall Study|Lost to Follow-up|0|||
164253571|NCT03585764|593294232|FG001|Overall Study|Lost to Follow-up|1|||
164253572|NCT03585764|593294233|FG002|Overall Study|Lost to Follow-up|0|||
164253573|NCT03585764|593294234|FG003|Overall Study|Lost to Follow-up|0|||
164253574|NCT03585764|593294231|FG000|Overall Study|Physician Decision|0|||
164253575|NCT03585764|593294232|FG001|Overall Study|Physician Decision|0|||
164253576|NCT03585764|593294233|FG002|Overall Study|Physician Decision|2|||
164253577|NCT03585764|593294234|FG003|Overall Study|Physician Decision|0|||
164253578|NCT01581021|593294236|FG000|Overall Study|Lost to Follow-up|4|||
164253579|NCT01581021|593294237|FG001|Overall Study|Lost to Follow-up|6|||
164253580|NCT01581021|593294236|FG000|Overall Study|More than 2 hooks in thoracic|3|||
164253581|NCT01581021|593294237|FG001|Overall Study|More than 2 hooks in thoracic|0|||
164253582|NCT01581021|593294236|FG000|Overall Study|Neuromuscular|2|||
164253583|NCT01581021|593294237|FG001|Overall Study|Neuromuscular|1|||
164253584|NCT01581021|593294236|FG000|Overall Study|Not Randomized|1|||
164253585|NCT01581021|593294237|FG001|Overall Study|Not Randomized|2|||
164253586|NCT01581021|593294236|FG000|Overall Study|Lenke 6 Classification|0|||
164253587|NCT01581021|593294237|FG001|Overall Study|Lenke 6 Classification|1|||
164253588|NCT01581021|593294236|FG000|Overall Study|Lack of Efficacy|0|||
164253589|NCT01581021|593294237|FG001|Overall Study|Lack of Efficacy|1|||
164253590|NCT03604172|593294238|FG000|Overall Study|Lost to Follow-up|1|||
164253591|NCT03604172|593294239|FG001|Overall Study|Lost to Follow-up|2|||
164253592|NCT00054327|593294240|FG000|Overall Study|Engraftment failure|1|||
164253593|NCT00054327|593294241|FG001|Overall Study|Engraftment failure|0|||
164253594|NCT00054327|593294242|FG002|Overall Study|Engraftment failure|0|||
164253595|NCT00054327|593294243|FG003|Overall Study|Engraftment failure|0|||
164253596|NCT00054327|593294244|FG004|Overall Study|Engraftment failure|0|||
164253597|NCT00054327|593294245|FG005|Overall Study|Engraftment failure|0|||
164253598|NCT03028129|593294248|FG000|Overall Study|Adverse Event|13|||
164253599|NCT03028129|593294249|FG001|Overall Study|Adverse Event|2|||
164253600|NCT03028129|593294248|FG000|Overall Study|Lost to Follow-up|50|||
164253601|NCT03028129|593294249|FG001|Overall Study|Lost to Follow-up|38|||
164253602|NCT03028129|593294248|FG000|Overall Study|Physician Decision|0|||
164253603|NCT03028129|593294249|FG001|Overall Study|Physician Decision|1|||
164253604|NCT03028129|593294248|FG000|Overall Study|Protocol Violation|1|||
164253605|NCT03028129|593294249|FG001|Overall Study|Protocol Violation|1|||
164339010|NCT01952145|593617113|FG001|Overall Study|Withdrawal Criteria|11|||
164339011|NCT01952145|593617112|FG000|Overall Study|Unclassified|1|||
163887371|NCT03544281|591959366|FG004|PACT Phase|Adverse Event|0|||
163887372|NCT03544281|591959367|FG005|PACT Phase|Adverse Event|0|||
164339012|NCT01952145|593617113|FG001|Overall Study|Unclassified|1|||
164339013|NCT01540838|593617117|FG000|Overall Study|Open nasogastric tube|9|||
164253606|NCT03028129|593294248|FG000|Overall Study|Withdrawal by Subject|62|||
164253607|NCT03028129|593294249|FG001|Overall Study|Withdrawal by Subject|45|||
164253608|NCT00923351|593294250|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
164253609|NCT00923351|593294251|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
164253610|NCT00923351|593294252|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
164253611|NCT00182078|593294253|FG000|Overall Study|Withdrawal by Subject|1|||
164253612|NCT00182078|593294254|FG001|Overall Study|Withdrawal by Subject|0|||
164253613|NCT01076205|593294255|FG000|Overall Study|Adverse Drug Reaction|299|||
164253614|NCT01076205|593294255|FG000|Overall Study|Lack of Effectiveness|1423|||
164253615|NCT01076205|593294255|FG000|Overall Study|Other Reason|1075|||
163887373|NCT03544281|591959368|FG006|PACT Phase|Adverse Event|0|||
163887374|NCT03544281|591959369|FG007|PACT Phase|Adverse Event|0|||
163887375|NCT03544281|591959370|FG008|PACT Phase|Adverse Event|0|||
164253616|NCT01076205|593294255|FG000|Overall Study|Unknown Reason|71|||
164253617|NCT01076205|593294255|FG000|Overall Study|Lost to Follow-up|3151|||
164253618|NCT00361231|593294256|FG000|Overall Study|Physician Decision|3|||
164253619|NCT00361231|593294256|FG000|Overall Study|Symptomatic deterioration|5|||
164253620|NCT00361231|593294256|FG000|Overall Study|Radiographic disease progression|16|||
164253621|NCT00361231|593294256|FG000|Overall Study|Withdrawal by Subject|4|||
164253622|NCT00361231|593294256|FG000|Overall Study|Adverse Event|6|||
164253623|NCT01732510|593294258|FG000|Overall Study|Adverse Event|0|||
164253624|NCT01732510|593294259|FG001|Overall Study|Adverse Event|1|||
164253625|NCT01732510|593294260|FG002|Overall Study|Adverse Event|1|||
164253626|NCT01732510|593294261|FG003|Overall Study|Adverse Event|0|||
164253627|NCT01732510|593294262|FG004|Overall Study|Adverse Event|0|||
164253628|NCT01732510|593294263|FG005|Overall Study|Adverse Event|0|||
164253629|NCT01732510|593294264|FG006|Overall Study|Adverse Event|1|||
164253630|NCT01732510|593294258|FG000|Overall Study|Protocol Violation|0|||
164253631|NCT01732510|593294259|FG001|Overall Study|Protocol Violation|0|||
164253632|NCT01732510|593294260|FG002|Overall Study|Protocol Violation|0|||
164253633|NCT01732510|593294261|FG003|Overall Study|Protocol Violation|1|||
164253634|NCT01732510|593294262|FG004|Overall Study|Protocol Violation|0|||
164253635|NCT01732510|593294263|FG005|Overall Study|Protocol Violation|0|||
164253636|NCT01732510|593294264|FG006|Overall Study|Protocol Violation|0|||
164253637|NCT01732510|593294258|FG000|Overall Study|Withdrawal by Subject|1|||
164253638|NCT01732510|593294259|FG001|Overall Study|Withdrawal by Subject|3|||
164253639|NCT01732510|593294260|FG002|Overall Study|Withdrawal by Subject|2|||
164253640|NCT01732510|593294261|FG003|Overall Study|Withdrawal by Subject|1|||
164253641|NCT01732510|593294262|FG004|Overall Study|Withdrawal by Subject|5|||
164253642|NCT01732510|593294263|FG005|Overall Study|Withdrawal by Subject|0|||
164253643|NCT01732510|593294264|FG006|Overall Study|Withdrawal by Subject|1|||
164253644|NCT01732510|593294258|FG000|Overall Study|Lost to Follow-up|0|||
164253645|NCT01732510|593294259|FG001|Overall Study|Lost to Follow-up|0|||
164253646|NCT01732510|593294260|FG002|Overall Study|Lost to Follow-up|1|||
164253647|NCT01732510|593294261|FG003|Overall Study|Lost to Follow-up|1|||
164253648|NCT01732510|593294262|FG004|Overall Study|Lost to Follow-up|0|||
164253649|NCT01732510|593294263|FG005|Overall Study|Lost to Follow-up|1|||
164253650|NCT01732510|593294264|FG006|Overall Study|Lost to Follow-up|0|||
164253651|NCT01732510|593294258|FG000|Overall Study|Physician Decision|0|||
164253652|NCT01732510|593294259|FG001|Overall Study|Physician Decision|1|||
164253653|NCT01732510|593294260|FG002|Overall Study|Physician Decision|0|||
164253654|NCT01732510|593294261|FG003|Overall Study|Physician Decision|0|||
164253655|NCT01732510|593294262|FG004|Overall Study|Physician Decision|0|||
164253656|NCT01732510|593294263|FG005|Overall Study|Physician Decision|0|||
164253657|NCT01732510|593294264|FG006|Overall Study|Physician Decision|0|||
164253658|NCT01732510|593294258|FG000|Overall Study|Pregnancy|0|||
164253659|NCT01732510|593294259|FG001|Overall Study|Pregnancy|0|||
164253660|NCT01732510|593294260|FG002|Overall Study|Pregnancy|0|||
164253661|NCT01732510|593294261|FG003|Overall Study|Pregnancy|1|||
164253662|NCT01732510|593294262|FG004|Overall Study|Pregnancy|0|||
164253663|NCT01732510|593294263|FG005|Overall Study|Pregnancy|0|||
164253664|NCT01732510|593294264|FG006|Overall Study|Pregnancy|0|||
164253665|NCT01732510|593294258|FG000|Overall Study|Study Terminated By Sponsor|0|||
164253666|NCT01732510|593294259|FG001|Overall Study|Study Terminated By Sponsor|0|||
164253667|NCT01732510|593294260|FG002|Overall Study|Study Terminated By Sponsor|0|||
164253668|NCT01732510|593294261|FG003|Overall Study|Study Terminated By Sponsor|1|||
164253669|NCT01732510|593294262|FG004|Overall Study|Study Terminated By Sponsor|0|||
164253670|NCT01732510|593294263|FG005|Overall Study|Study Terminated By Sponsor|12|||
164253671|NCT01732510|593294264|FG006|Overall Study|Study Terminated By Sponsor|6|||
164253672|NCT00313144|593294265|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
164253673|NCT00313144|593294265|FG000|Overall Study|Death|7|||
164253674|NCT00313144|593294265|FG000|Overall Study|Lost to Follow-up|5|||
164253675|NCT00313144|593294265|FG000|Overall Study|Withdrawal by Subject|4|||
164253676|NCT00313144|593294265|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
164253677|NCT00313144|593294265|FG000|Overall Study|Physician Decision|4|||
164253678|NCT00313144|593294265|FG000|Overall Study|Adverse event - transient|5|||
164253679|NCT00313144|593294265|FG000|Overall Study|Liver transplant|1|||
164253680|NCT00313144|593294265|FG000|Overall Study|Insurance (homecare provider) change|1|||
164253681|NCT00313144|593294265|FG000|Overall Study|Change to different product|1|||
164253682|NCT00313144|593294265|FG000|Overall Study|Due to termination of the study|66|||
164253683|NCT03403361|593294266|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
164253684|NCT02487654|593294268|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
164253685|NCT02487654|593294269|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
164253686|NCT02487654|593294268|FG000|Overall Study|Withdrawal by Subject|3|||
164253687|NCT02487654|593294269|FG001|Overall Study|Withdrawal by Subject|7|||
164253688|NCT02443116|593294270|FG000|Part 1|Adverse Event|2|||
163887376|NCT03544281|591959371|FG009|PACT Phase|Adverse Event|0|||
164253689|NCT02443116|593294271|FG001|Part 1|Adverse Event|3|||
164253690|NCT02443116|593294272|FG002|Part 1|Adverse Event|0|||
164253691|NCT02443116|593294273|FG003|Part 1|Adverse Event|0|||
163887377|NCT03544281|591959372|FG010|PACT Phase|Adverse Event|0|||
164253692|NCT02443116|593294274|FG004|Part 1|Adverse Event|0|||
164253693|NCT02443116|593294275|FG005|Part 1|Adverse Event|0|||
164253694|NCT02443116|593294276|FG006|Part 1|Adverse Event|0|||
164253695|NCT02443116|593294277|FG007|Part 1|Adverse Event|0|||
164253696|NCT02443116|593294278|FG008|Part 1|Adverse Event|0|||
164253697|NCT02443116|593294270|FG000|Part 1|Withdrew informed consent|0|||
164253698|NCT02443116|593294271|FG001|Part 1|Withdrew informed consent|1|||
164253699|NCT02443116|593294272|FG002|Part 1|Withdrew informed consent|0|||
164253700|NCT02443116|593294273|FG003|Part 1|Withdrew informed consent|0|||
164253701|NCT02443116|593294274|FG004|Part 1|Withdrew informed consent|0|||
164253702|NCT02443116|593294275|FG005|Part 1|Withdrew informed consent|0|||
164253703|NCT02443116|593294276|FG006|Part 1|Withdrew informed consent|0|||
164253704|NCT02443116|593294277|FG007|Part 1|Withdrew informed consent|0|||
164253705|NCT02443116|593294278|FG008|Part 1|Withdrew informed consent|0|||
164253706|NCT02443116|593294270|FG000|Part 1|Lost to Follow-up|0|||
164253707|NCT02443116|593294271|FG001|Part 1|Lost to Follow-up|0|||
164253708|NCT02443116|593294272|FG002|Part 1|Lost to Follow-up|2|||
164253709|NCT02443116|593294273|FG003|Part 1|Lost to Follow-up|0|||
164253710|NCT02443116|593294274|FG004|Part 1|Lost to Follow-up|0|||
164253711|NCT02443116|593294275|FG005|Part 1|Lost to Follow-up|0|||
164253712|NCT02443116|593294276|FG006|Part 1|Lost to Follow-up|0|||
164253713|NCT02443116|593294277|FG007|Part 1|Lost to Follow-up|0|||
164253714|NCT02443116|593294278|FG008|Part 1|Lost to Follow-up|0|||
164253715|NCT02443116|593294270|FG000|Part 1|Participant moved out of state|0|||
164253716|NCT02443116|593294271|FG001|Part 1|Participant moved out of state|0|||
164253717|NCT02443116|593294272|FG002|Part 1|Participant moved out of state|1|||
164253718|NCT02443116|593294273|FG003|Part 1|Participant moved out of state|0|||
164253719|NCT02443116|593294274|FG004|Part 1|Participant moved out of state|0|||
164253720|NCT02443116|593294275|FG005|Part 1|Participant moved out of state|0|||
164253721|NCT02443116|593294276|FG006|Part 1|Participant moved out of state|0|||
164253722|NCT02443116|593294277|FG007|Part 1|Participant moved out of state|0|||
164253723|NCT02443116|593294278|FG008|Part 1|Participant moved out of state|0|||
164253724|NCT02443116|593294270|FG000|Part 1|Participant enrolled in another clinical trial|0|||
164253725|NCT02443116|593294271|FG001|Part 1|Participant enrolled in another clinical trial|0|||
164253726|NCT02443116|593294272|FG002|Part 1|Participant enrolled in another clinical trial|1|||
164253727|NCT02443116|593294273|FG003|Part 1|Participant enrolled in another clinical trial|0|||
164253728|NCT02443116|593294274|FG004|Part 1|Participant enrolled in another clinical trial|0|||
164253729|NCT02443116|593294275|FG005|Part 1|Participant enrolled in another clinical trial|0|||
164253730|NCT02443116|593294276|FG006|Part 1|Participant enrolled in another clinical trial|0|||
164253731|NCT02443116|593294277|FG007|Part 1|Participant enrolled in another clinical trial|0|||
164253732|NCT02443116|593294278|FG008|Part 1|Participant enrolled in another clinical trial|0|||
164253733|NCT02443116|593294270|FG000|Part 2|Adverse Event|0|||
164253734|NCT02443116|593294271|FG001|Part 2|Adverse Event|0|||
164253735|NCT02443116|593294272|FG002|Part 2|Adverse Event|0|||
164253736|NCT02443116|593294273|FG003|Part 2|Adverse Event|0|||
164253737|NCT02443116|593294274|FG004|Part 2|Adverse Event|1|||
164253738|NCT02443116|593294275|FG005|Part 2|Adverse Event|1|||
164253739|NCT02443116|593294276|FG006|Part 2|Adverse Event|2|||
164253740|NCT02443116|593294277|FG007|Part 2|Adverse Event|0|||
164253741|NCT02443116|593294278|FG008|Part 2|Adverse Event|0|||
164253742|NCT02443116|593294270|FG000|Part 2|Withdrew informed consent|0|||
164253743|NCT02443116|593294271|FG001|Part 2|Withdrew informed consent|0|||
164253744|NCT02443116|593294272|FG002|Part 2|Withdrew informed consent|0|||
164253745|NCT02443116|593294273|FG003|Part 2|Withdrew informed consent|0|||
164253746|NCT02443116|593294274|FG004|Part 2|Withdrew informed consent|0|||
164253747|NCT02443116|593294275|FG005|Part 2|Withdrew informed consent|1|||
164253748|NCT02443116|593294276|FG006|Part 2|Withdrew informed consent|1|||
164253749|NCT02443116|593294277|FG007|Part 2|Withdrew informed consent|0|||
164253750|NCT02443116|593294278|FG008|Part 2|Withdrew informed consent|0|||
164253751|NCT02443116|593294270|FG000|Part 2|Inability to comply with protocol|0|||
164253752|NCT02443116|593294271|FG001|Part 2|Inability to comply with protocol|0|||
164253753|NCT02443116|593294272|FG002|Part 2|Inability to comply with protocol|0|||
164253754|NCT02443116|593294273|FG003|Part 2|Inability to comply with protocol|1|||
164253755|NCT02443116|593294274|FG004|Part 2|Inability to comply with protocol|0|||
164253756|NCT02443116|593294275|FG005|Part 2|Inability to comply with protocol|0|||
164253757|NCT02443116|593294276|FG006|Part 2|Inability to comply with protocol|0|||
164253758|NCT02443116|593294277|FG007|Part 2|Inability to comply with protocol|0|||
164253759|NCT02443116|593294278|FG008|Part 2|Inability to comply with protocol|0|||
164253760|NCT02443116|593294270|FG000|Part 2|Lost to Follow-up|0|||
164253761|NCT02443116|593294271|FG001|Part 2|Lost to Follow-up|0|||
164253762|NCT02443116|593294272|FG002|Part 2|Lost to Follow-up|0|||
164253763|NCT02443116|593294273|FG003|Part 2|Lost to Follow-up|1|||
164253764|NCT02443116|593294274|FG004|Part 2|Lost to Follow-up|0|||
164253765|NCT02443116|593294275|FG005|Part 2|Lost to Follow-up|0|||
164253766|NCT02443116|593294276|FG006|Part 2|Lost to Follow-up|0|||
164253767|NCT02443116|593294277|FG007|Part 2|Lost to Follow-up|0|||
164253768|NCT02443116|593294278|FG008|Part 2|Lost to Follow-up|0|||
164253769|NCT02443116|593294270|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253770|NCT02443116|593294271|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253771|NCT02443116|593294272|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253772|NCT02443116|593294273|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253773|NCT02443116|593294274|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253774|NCT02443116|593294275|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
164253775|NCT02443116|593294276|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253776|NCT02443116|593294277|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253777|NCT02443116|593294278|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
164253778|NCT02443116|593294270|FG000|Part 3|Adverse Event|0|||
164253779|NCT02443116|593294271|FG001|Part 3|Adverse Event|0|||
164253780|NCT02443116|593294272|FG002|Part 3|Adverse Event|0|||
164253781|NCT02443116|593294273|FG003|Part 3|Adverse Event|0|||
164253782|NCT02443116|593294274|FG004|Part 3|Adverse Event|0|||
164253783|NCT02443116|593294275|FG005|Part 3|Adverse Event|0|||
164253784|NCT02443116|593294276|FG006|Part 3|Adverse Event|0|||
164253785|NCT02443116|593294277|FG007|Part 3|Adverse Event|0|||
164253786|NCT02443116|593294278|FG008|Part 3|Adverse Event|1|||
164253787|NCT02443116|593294270|FG000|Part 3|Withdrew informed consent|0|||
164253788|NCT02443116|593294271|FG001|Part 3|Withdrew informed consent|0|||
164253789|NCT02443116|593294272|FG002|Part 3|Withdrew informed consent|0|||
164253790|NCT02443116|593294273|FG003|Part 3|Withdrew informed consent|0|||
164253791|NCT02443116|593294274|FG004|Part 3|Withdrew informed consent|0|||
164253792|NCT02443116|593294275|FG005|Part 3|Withdrew informed consent|0|||
164253793|NCT02443116|593294276|FG006|Part 3|Withdrew informed consent|0|||
164253794|NCT02443116|593294277|FG007|Part 3|Withdrew informed consent|3|||
164253795|NCT02443116|593294278|FG008|Part 3|Withdrew informed consent|2|||
164253796|NCT02443116|593294270|FG000|Part 3|Lost to Follow-up|0|||
164253797|NCT02443116|593294271|FG001|Part 3|Lost to Follow-up|0|||
164253798|NCT02443116|593294272|FG002|Part 3|Lost to Follow-up|0|||
164253799|NCT02443116|593294273|FG003|Part 3|Lost to Follow-up|0|||
164253800|NCT02443116|593294274|FG004|Part 3|Lost to Follow-up|0|||
164253801|NCT02443116|593294275|FG005|Part 3|Lost to Follow-up|0|||
164253802|NCT02443116|593294276|FG006|Part 3|Lost to Follow-up|0|||
164253803|NCT02443116|593294277|FG007|Part 3|Lost to Follow-up|1|||
164253804|NCT02443116|593294278|FG008|Part 3|Lost to Follow-up|2|||
164253805|NCT01932372|593294279|FG000|Overall Study|Not meeting eligibility criteria|33|||
164253806|NCT01932372|593294280|FG001|Overall Study|Not meeting eligibility criteria|179|||
164253807|NCT03594747|593294285|FG000|Overall Study|Death|78|||
164253808|NCT03594747|593294286|FG001|Overall Study|Death|86|||
164253809|NCT03594747|593294287|FG002|Overall Study|Death|87|||
164253810|NCT03594747|593294285|FG000|Overall Study|Withdrawal by Subject|5|||
164253811|NCT03594747|593294286|FG001|Overall Study|Withdrawal by Subject|2|||
164253812|NCT03594747|593294287|FG002|Overall Study|Withdrawal by Subject|11|||
164253813|NCT03594747|593294285|FG000|Overall Study|Lost to Follow-up|4|||
164253814|NCT03594747|593294286|FG001|Overall Study|Lost to Follow-up|1|||
164253815|NCT03594747|593294287|FG002|Overall Study|Lost to Follow-up|1|||
164253816|NCT03594747|593294285|FG000|Overall Study|Physician Decision|0|||
164253817|NCT03594747|593294286|FG001|Overall Study|Physician Decision|1|||
164253818|NCT03594747|593294287|FG002|Overall Study|Physician Decision|0|||
164253819|NCT03594747|593294285|FG000|Overall Study|Sponsor decision|23|||
164253820|NCT03594747|593294286|FG001|Overall Study|Sponsor decision|17|||
164253821|NCT03594747|593294287|FG002|Overall Study|Sponsor decision|16|||
164253822|NCT03594747|593294285|FG000|Overall Study|Did not meet inclusion criteria|0|||
164253823|NCT03594747|593294286|FG001|Overall Study|Did not meet inclusion criteria|0|||
164253824|NCT03594747|593294287|FG002|Overall Study|Did not meet inclusion criteria|1|||
164253825|NCT03594747|593294285|FG000|Overall Study|Transfer to long term extension study|10|||
164253826|NCT03594747|593294286|FG001|Overall Study|Transfer to long term extension study|12|||
164253827|NCT03594747|593294287|FG002|Overall Study|Transfer to long term extension study|5|||
164253828|NCT04382586|593294288|FG000|Overall Study|Death|3|||
164253829|NCT04382586|593294289|FG001|Overall Study|Death|4|||
164253830|NCT04382586|593294288|FG000|Overall Study|Lost to Follow-up|11|||
164253831|NCT04382586|593294289|FG001|Overall Study|Lost to Follow-up|8|||
164253832|NCT04382586|593294288|FG000|Overall Study|Withdrawal by Subject|3|||
164253833|NCT04382586|593294289|FG001|Overall Study|Withdrawal by Subject|1|||
164253834|NCT04382586|593294288|FG000|Overall Study|Physician Decision|0|||
164253835|NCT04382586|593294289|FG001|Overall Study|Physician Decision|3|||
164253836|NCT02265536|593294297|FG000|Overall Study|Adverse Event|1|||
163887378|NCT03544281|591959373|FG011|PACT Phase|Adverse Event|0|||
164253837|NCT02265536|593294298|FG001|Overall Study|Adverse Event|0|||
164253838|NCT02265536|593294299|FG002|Overall Study|Adverse Event|0|||
164253839|NCT02265536|593294300|FG003|Overall Study|Adverse Event|0|||
164253840|NCT02265536|593294301|FG004|Overall Study|Adverse Event|1|||
164253841|NCT02265536|593294302|FG005|Overall Study|Adverse Event|0|||
163887379|NCT03544281|591959374|FG012|PACT Phase|Adverse Event|1|||
164253842|NCT02265536|593294297|FG000|Overall Study|Physician Decision|0|||
163887380|NCT03544281|591959375|FG013|PACT Phase|Adverse Event|0|||
164253843|NCT02265536|593294298|FG001|Overall Study|Physician Decision|0|||
164253844|NCT02265536|593294299|FG002|Overall Study|Physician Decision|0|||
164253845|NCT02265536|593294300|FG003|Overall Study|Physician Decision|0|||
164253846|NCT02265536|593294301|FG004|Overall Study|Physician Decision|2|||
163887381|NCT03544281|591959376|FG014|PACT Phase|Adverse Event|0|||
163887382|NCT03544281|591959377|FG015|PACT Phase|Adverse Event|0|||
164253847|NCT02265536|593294302|FG005|Overall Study|Physician Decision|0|||
164253848|NCT02265536|593294297|FG000|Overall Study|Withdrawal by Subject|0|||
164253849|NCT02265536|593294298|FG001|Overall Study|Withdrawal by Subject|3|||
164253850|NCT02265536|593294299|FG002|Overall Study|Withdrawal by Subject|0|||
164253851|NCT02265536|593294300|FG003|Overall Study|Withdrawal by Subject|0|||
164253852|NCT02265536|593294301|FG004|Overall Study|Withdrawal by Subject|0|||
164253853|NCT02265536|593294302|FG005|Overall Study|Withdrawal by Subject|0|||
164253854|NCT00349349|593294305|FG000|Overall Study|Adverse Event|5|||
164253855|NCT00349349|593294306|FG001|Overall Study|Adverse Event|6|||
164253856|NCT00349349|593294307|FG002|Overall Study|Adverse Event|2|||
164253857|NCT00349349|593294305|FG000|Overall Study|Withdrawal by Subject|5|||
164253858|NCT00349349|593294306|FG001|Overall Study|Withdrawal by Subject|2|||
164253859|NCT00349349|593294307|FG002|Overall Study|Withdrawal by Subject|1|||
164253860|NCT00349349|593294305|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
164253861|NCT00349349|593294306|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
164253862|NCT00349349|593294307|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
164253863|NCT00349349|593294305|FG000|Overall Study|Death|13|||
164253864|NCT00349349|593294306|FG001|Overall Study|Death|10|||
164253865|NCT00349349|593294307|FG002|Overall Study|Death|1|||
164253866|NCT00349349|593294305|FG000|Overall Study|Other Treatment Selected|2|||
164253867|NCT00349349|593294306|FG001|Overall Study|Other Treatment Selected|0|||
164253868|NCT00349349|593294307|FG002|Overall Study|Other Treatment Selected|0|||
164253869|NCT00349349|593294305|FG000|Overall Study|Participant Reduced General Condition|0|||
164253870|NCT00349349|593294306|FG001|Overall Study|Participant Reduced General Condition|1|||
164253871|NCT00349349|593294307|FG002|Overall Study|Participant Reduced General Condition|0|||
164253872|NCT00349349|593294305|FG000|Overall Study|Physician Decision|1|||
164253873|NCT00349349|593294306|FG001|Overall Study|Physician Decision|2|||
164253874|NCT00349349|593294307|FG002|Overall Study|Physician Decision|1|||
164253875|NCT00349349|593294305|FG000|Overall Study|No Response|0|||
164253876|NCT00349349|593294306|FG001|Overall Study|No Response|3|||
164253877|NCT00349349|593294307|FG002|Overall Study|No Response|0|||
164253878|NCT00349349|593294305|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
164253879|NCT00349349|593294306|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
164253880|NCT00349349|593294307|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
164253881|NCT02907216|593294308|FG000|Overall Study|No benefit to be obtained by continuing|0|||
164253882|NCT02907216|593294309|FG001|Overall Study|No benefit to be obtained by continuing|1|||
163887383|NCT03544281|591959378|FG016|PACT Phase|Adverse Event|0|||
164253883|NCT02907216|593294308|FG000|Overall Study|Withdrawal by Subject|1|||
164253884|NCT02907216|593294309|FG001|Overall Study|Withdrawal by Subject|0|||
164253885|NCT02485639|593294314|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
164253886|NCT02485639|593294314|FG000|Overall Study|Early termination|4|||
164253887|NCT02485639|593294314|FG000|Overall Study|Withdrawal by Subject|4|||
164253888|NCT02597452|593294315|FG000|Overall Study|testing incomplete|30|||
164253889|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
164253890|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
164253891|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
164253892|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
164253893|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
164253894|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
164253895|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
164253896|NCT01673854|593294317|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
163887384|NCT03544281|591959379|FG017|PACT Phase|Adverse Event|1|||
164253897|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
164253898|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
163887385|NCT03544281|591959380|FG018|PACT Phase|Adverse Event|1|||
163887386|NCT03544281|591959381|FG019|PACT Phase|Adverse Event|0|||
163887387|NCT03544281|591959382|FG020|PACT Phase|Adverse Event|0|||
163887388|NCT03544281|591959383|FG021|PACT Phase|Adverse Event|0|||
164253899|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
164253900|NCT01673854|593294317|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
164253901|NCT00334737|593294318|FG000|Hospital Phase|Death|1|||
164253902|NCT00334737|593294319|FG001|Hospital Phase|Death|2|||
164253903|NCT00334737|593294320|FG002|Hospital Phase|Death|3|||
164339014|NCT01540838|593617118|FG001|Overall Study|Open nasogastric tube|7|||
163887389|NCT02547233|591959384|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
163887390|NCT02547233|591959385|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
164253904|NCT00334737|593294318|FG000|Hospital Phase|Withdrawal by Subject|0|||
164253905|NCT00334737|593294319|FG001|Hospital Phase|Withdrawal by Subject|0|||
164253906|NCT00334737|593294320|FG002|Hospital Phase|Withdrawal by Subject|1|||
164253907|NCT00334737|593294318|FG000|Hospital Phase|Did not receive study drug|1|||
164253908|NCT00334737|593294319|FG001|Hospital Phase|Did not receive study drug|0|||
164253909|NCT00334737|593294320|FG002|Hospital Phase|Did not receive study drug|0|||
164253910|NCT00334737|593294318|FG000|Follow up Phase|Lost to Follow-up|5|||
164253911|NCT00334737|593294319|FG001|Follow up Phase|Lost to Follow-up|3|||
164253912|NCT00334737|593294320|FG002|Follow up Phase|Lost to Follow-up|6|||
164253913|NCT02640625|593296016|FG000|Overall Study|Adverse Event|1|||
164253914|NCT01579565|593296017|FG000|Randomized|Adverse Event|1|||
164253915|NCT01579565|593296018|FG001|Randomized|Adverse Event|3|||
164253916|NCT01579565|593296017|FG000|Randomized|Withdrawal by Subject|3|||
164084668|NCT00585351|592673980|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164084669|NCT00585351|592673981|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164253917|NCT01579565|593296018|FG001|Randomized|Withdrawal by Subject|0|||
164253918|NCT01579565|593296017|FG000|Randomized|inadequate preoperative pupil dilation|0|||
164253919|NCT01579565|593296018|FG001|Randomized|inadequate preoperative pupil dilation|1|||
164253920|NCT01579565|593296017|FG000|Randomized|prohibited preoperative eating|1|||
164253921|NCT01579565|593296018|FG001|Randomized|prohibited preoperative eating|0|||
164253922|NCT01579565|593296017|FG000|Randomized|prohibited preoperative medication|0|||
164253923|NCT01579565|593296018|FG001|Randomized|prohibited preoperative medication|1|||
164253924|NCT01579565|593296017|FG000|Treated|Physician Decision|0|||
164253925|NCT01579565|593296018|FG001|Treated|Physician Decision|1|||
164253926|NCT01579565|593296017|FG000|Treated|Lost to Follow-up|2|||
164253927|NCT01579565|593296018|FG001|Treated|Lost to Follow-up|1|||
164253928|NCT01579565|593296017|FG000|Treated|declined to return for final visit|0|||
164253929|NCT01579565|593296018|FG001|Treated|declined to return for final visit|1|||
164253930|NCT02013206|593296019|FG000|Overall Study|Progressive disease (PD)|14|||
164253931|NCT02013206|593296020|FG001|Overall Study|Progressive disease (PD)|17|||
164253932|NCT02013206|593296019|FG000|Overall Study|Symptomatic deterioration|3|||
164253933|NCT02013206|593296020|FG001|Overall Study|Symptomatic deterioration|1|||
164253934|NCT02013206|593296019|FG000|Overall Study|Adverse Event|1|||
164253935|NCT02013206|593296020|FG001|Overall Study|Adverse Event|0|||
164253936|NCT02013206|593296019|FG000|Overall Study|Patient refusal|2|||
164253937|NCT02013206|593296020|FG001|Overall Study|Patient refusal|0|||
164253938|NCT02013206|593296019|FG000|Overall Study|Patient non-compliance|1|||
164253939|NCT02013206|593296020|FG001|Overall Study|Patient non-compliance|0|||
164253940|NCT02013206|593296019|FG000|Overall Study|Death|1|||
164253941|NCT02013206|593296020|FG001|Overall Study|Death|2|||
164253942|NCT02013206|593296019|FG000|Overall Study|Other reasons off treatment|5|||
164253943|NCT02013206|593296020|FG001|Overall Study|Other reasons off treatment|2|||
164253944|NCT05425732|593296023|FG000|Overall Study|Death|4|||
164253945|NCT05425732|593296024|FG001|Overall Study|Death|2|||
164253946|NCT05425732|593296025|FG002|Overall Study|Death|0|||
164253947|NCT05425732|593296026|FG003|Overall Study|Death|0|||
164253948|NCT05425732|593296023|FG000|Overall Study|Lost to Follow-up|10|||
164253949|NCT05425732|593296024|FG001|Overall Study|Lost to Follow-up|15|||
164253950|NCT05425732|593296025|FG002|Overall Study|Lost to Follow-up|5|||
164253951|NCT05425732|593296026|FG003|Overall Study|Lost to Follow-up|3|||
164253952|NCT05425732|593296023|FG000|Overall Study|Physician Decision|0|||
164253953|NCT05425732|593296024|FG001|Overall Study|Physician Decision|2|||
164253954|NCT05425732|593296025|FG002|Overall Study|Physician Decision|0|||
164253955|NCT05425732|593296026|FG003|Overall Study|Physician Decision|0|||
164253956|NCT05425732|593296023|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164253957|NCT05425732|593296024|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
164253958|NCT05425732|593296025|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164253959|NCT05425732|593296026|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164253960|NCT05425732|593296023|FG000|Overall Study|Withdrawal by Subject|4|||
164253961|NCT05425732|593296024|FG001|Overall Study|Withdrawal by Subject|8|||
164253962|NCT05425732|593296025|FG002|Overall Study|Withdrawal by Subject|1|||
164253963|NCT05425732|593296026|FG003|Overall Study|Withdrawal by Subject|1|||
164253964|NCT05425732|593296023|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
164253965|NCT05425732|593296024|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
164253966|NCT05425732|593296025|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
164253967|NCT05425732|593296026|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
164253968|NCT02582814|593296027|FG000|Overall Study|Study-specific withdrawal criteria|1|||
164253969|NCT02582814|593296028|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164253970|NCT02582814|593296027|FG000|Overall Study|Withdrawal by Subject|4|||
164253971|NCT02582814|593296028|FG001|Overall Study|Withdrawal by Subject|3|||
164253972|NCT02582814|593296027|FG000|Overall Study|Adverse Event|4|||
164253973|NCT02582814|593296028|FG001|Overall Study|Adverse Event|4|||
164253974|NCT01558115|593296032|FG000|Overall Study|Withdrawal by Subject|3|||
164253975|NCT01558115|593296032|FG000|Overall Study|Study closed due to poor enrollment|4|||
164253976|NCT01696994|593296033|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
164253977|NCT01696994|593296034|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
164253978|NCT01696994|593296033|FG000|Overall Study|Died Before Randomization|1|||
164253979|NCT01696994|593296034|FG001|Overall Study|Died Before Randomization|2|||
164253980|NCT01696994|593296033|FG000|Overall Study|Died Before ASU (Control)|73|||
164253981|NCT01696994|593296034|FG001|Overall Study|Died Before ASU (Control)|0|||
164253982|NCT01696994|593296033|FG000|Overall Study|No Ovaries at Baseline|4807|||
164253983|NCT01696994|593296034|FG001|Overall Study|No Ovaries at Baseline|4851|||
164253984|NCT01696994|593296033|FG000|Overall Study|Refused ASU (Control)|311|||
164253985|NCT01696994|593296034|FG001|Overall Study|Refused ASU (Control)|0|||
164253986|NCT01696994|593296033|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
164253987|NCT01696994|593296034|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
164253988|NCT04644276|593296035|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
164253989|NCT04644276|593296036|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
164253990|NCT04644276|593296037|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
164253991|NCT00705250|593296038|FG000|Overall Study|Withdrawal by Subject|1|||
164253992|NCT00705250|593296038|FG000|Overall Study|Patient died in car accident|1|||
164253993|NCT01667224|593296040|FG000|Overall Study|Withdrawal by Subject|3|||
164253994|NCT01667224|593296041|FG001|Overall Study|Withdrawal by Subject|1|||
164253995|NCT01667224|593296040|FG000|Overall Study|Protocol Violation|1|||
164253996|NCT01667224|593296041|FG001|Overall Study|Protocol Violation|1|||
163887391|NCT02547233|591959384|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
163991994|NCT04426695|592339650|FG009|Overall Study|Adverse Event|0|||
163991995|NCT04426695|592339651|FG010|Overall Study|Adverse Event|1|||
163991996|NCT04426695|592339652|FG011|Overall Study|Adverse Event|1|||
163991997|NCT04426695|592339653|FG012|Overall Study|Adverse Event|0|||
163991998|NCT04426695|592339654|FG013|Overall Study|Adverse Event|0|||
163991999|NCT04426695|592339655|FG014|Overall Study|Adverse Event|0|||
163992000|NCT04426695|592339656|FG015|Overall Study|Adverse Event|0|||
163992001|NCT04426695|592339657|FG016|Overall Study|Adverse Event|0|||
163992002|NCT04426695|592339658|FG017|Overall Study|Adverse Event|0|||
163992003|NCT04426695|592339641|FG000|Overall Study|Sponsor Request|0|||
163992004|NCT04426695|592339642|FG001|Overall Study|Sponsor Request|0|||
163992005|NCT04426695|592339643|FG002|Overall Study|Sponsor Request|0|||
163992006|NCT04426695|592339644|FG003|Overall Study|Sponsor Request|0|||
163992007|NCT04426695|592339645|FG004|Overall Study|Sponsor Request|0|||
163992008|NCT04426695|592339646|FG005|Overall Study|Sponsor Request|0|||
163992009|NCT04426695|592339647|FG006|Overall Study|Sponsor Request|1|||
163992010|NCT04426695|592339648|FG007|Overall Study|Sponsor Request|0|||
163992011|NCT04426695|592339649|FG008|Overall Study|Sponsor Request|0|||
163992012|NCT04426695|592339650|FG009|Overall Study|Sponsor Request|0|||
163992013|NCT04426695|592339651|FG010|Overall Study|Sponsor Request|0|||
163992014|NCT04426695|592339652|FG011|Overall Study|Sponsor Request|0|||
163992015|NCT04426695|592339653|FG012|Overall Study|Sponsor Request|0|||
163992016|NCT04426695|592339654|FG013|Overall Study|Sponsor Request|0|||
163992017|NCT04426695|592339655|FG014|Overall Study|Sponsor Request|0|||
163992018|NCT04426695|592339656|FG015|Overall Study|Sponsor Request|0|||
163992019|NCT04426695|592339657|FG016|Overall Study|Sponsor Request|0|||
163992020|NCT04426695|592339658|FG017|Overall Study|Sponsor Request|0|||
163992021|NCT04426695|592339641|FG000|Overall Study|Physician Decision|0|||
163992022|NCT04426695|592339642|FG001|Overall Study|Physician Decision|0|||
163992023|NCT04426695|592339643|FG002|Overall Study|Physician Decision|0|||
163992024|NCT04426695|592339644|FG003|Overall Study|Physician Decision|0|||
163992025|NCT04426695|592339645|FG004|Overall Study|Physician Decision|0|||
163992026|NCT04426695|592339646|FG005|Overall Study|Physician Decision|0|||
163992027|NCT04426695|592339647|FG006|Overall Study|Physician Decision|0|||
163992028|NCT04426695|592339648|FG007|Overall Study|Physician Decision|0|||
163992029|NCT04426695|592339649|FG008|Overall Study|Physician Decision|0|||
163992030|NCT04426695|592339650|FG009|Overall Study|Physician Decision|1|||
163992031|NCT04426695|592339651|FG010|Overall Study|Physician Decision|0|||
163992032|NCT04426695|592339652|FG011|Overall Study|Physician Decision|0|||
163992033|NCT04426695|592339653|FG012|Overall Study|Physician Decision|1|||
163992034|NCT04426695|592339654|FG013|Overall Study|Physician Decision|0|||
163992035|NCT04426695|592339655|FG014|Overall Study|Physician Decision|0|||
163992036|NCT04426695|592339656|FG015|Overall Study|Physician Decision|0|||
163992037|NCT04426695|592339657|FG016|Overall Study|Physician Decision|0|||
163992038|NCT04426695|592339658|FG017|Overall Study|Physician Decision|0|||
163992039|NCT04426695|592339641|FG000|Overall Study|Randomized but Never Treated|3|||
163992040|NCT04426695|592339642|FG001|Overall Study|Randomized but Never Treated|1|||
163992041|NCT04426695|592339643|FG002|Overall Study|Randomized but Never Treated|0|||
163992042|NCT04426695|592339644|FG003|Overall Study|Randomized but Never Treated|4|||
163992043|NCT04426695|592339645|FG004|Overall Study|Randomized but Never Treated|5|||
163992044|NCT04426695|592339646|FG005|Overall Study|Randomized but Never Treated|5|||
163992045|NCT04426695|592339647|FG006|Overall Study|Randomized but Never Treated|4|||
164253997|NCT03350035|593296042|FG000|Overall Study|Lack of Efficacy|2|||
164253998|NCT03350035|593296043|FG001|Overall Study|Lack of Efficacy|0|||
164253999|NCT03350035|593296044|FG002|Overall Study|Lack of Efficacy|0|||
164254000|NCT03350035|593296042|FG000|Overall Study|Subject discharged to hospice|0|||
164254001|NCT03350035|593296043|FG001|Overall Study|Subject discharged to hospice|0|||
164254002|NCT03350035|593296044|FG002|Overall Study|Subject discharged to hospice|1|||
164254003|NCT00316225|593296045|FG000|Overall Study|Adverse Event|2|||
164254004|NCT00316225|593296045|FG000|Overall Study|Physician Decision|3|||
164254005|NCT00316225|593296045|FG000|Overall Study|Progressive Disease|15|||
164254006|NCT00316225|593296045|FG000|Overall Study|Withdrawal by Subject|3|||
163887392|NCT02547233|591959385|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
163887393|NCT02547233|591959384|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
163887394|NCT02547233|591959385|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
163887395|NCT02547233|591959384|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
163887396|NCT02547233|591959385|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
164254007|NCT00316225|593296045|FG000|Overall Study|Death|2|||
164254008|NCT01811485|593296046|FG000|Overall Study|Adverse Event|1|||
164254009|NCT01811485|593296047|FG001|Overall Study|Adverse Event|3|||
164254010|NCT01811485|593296048|FG002|Overall Study|Adverse Event|2|||
164254011|NCT01811485|593296046|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164254012|NCT01811485|593296047|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164254013|NCT01811485|593296048|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
164254014|NCT01811485|593296046|FG000|Overall Study|Administrative problems|1|||
164254015|NCT01811485|593296047|FG001|Overall Study|Administrative problems|0|||
164254016|NCT01811485|593296048|FG002|Overall Study|Administrative problems|0|||
164254017|NCT01811485|593296046|FG000|Overall Study|Protocol Deviation|0|||
164254018|NCT01811485|593296047|FG001|Overall Study|Protocol Deviation|1|||
164254019|NCT01811485|593296048|FG002|Overall Study|Protocol Deviation|0|||
164254020|NCT00425698|593296049|FG000|Overall Study|Adverse Event|3|||
164254021|NCT00425698|593296050|FG001|Overall Study|Adverse Event|1|||
164254022|NCT00425698|593296049|FG000|Overall Study|Withdrawal by Subject|0|||
164254023|NCT00425698|593296050|FG001|Overall Study|Withdrawal by Subject|1|||
164254024|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
164254025|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
164254026|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
164254027|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
164254028|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164254029|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
164254030|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
164254031|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
164254032|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
164254033|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
164254034|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
164254035|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
164254036|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
164254037|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
164254038|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
164254039|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
164254040|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
164254041|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254042|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254043|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254044|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254045|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254046|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254047|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254048|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254049|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
163887397|NCT02547233|591959384|FG000|12-month Follow-up|Withdrawal by Subject|10|||
164254050|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254051|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254052|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254053|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
164254054|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
164254055|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
164254056|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
164254057|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
164254058|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
164254059|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
164254060|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
164254061|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
164254062|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
164254063|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
164254064|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
164254065|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
164254066|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
164254067|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
164254068|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
164254069|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
164254070|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
164254071|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
164254072|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
164254073|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
164254074|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
164254075|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
164254076|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
164254077|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
164254078|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
164254079|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
164254080|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
164254081|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
164254082|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
164254083|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
164254084|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
164254085|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
164254086|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
164254087|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
164254088|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254089|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254090|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254091|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254092|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254093|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254094|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254095|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254096|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254097|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254098|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164254099|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
164254100|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
164254101|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
164254102|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
164254103|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254104|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164339015|NCT01540838|593617117|FG000|Overall Study|Treatment doses missing|8|||
164339016|NCT01540838|593617118|FG001|Overall Study|Treatment doses missing|12|||
164339017|NCT01540838|593617117|FG000|Overall Study|Additional antibiotic treatment|1|||
164339018|NCT01540838|593617118|FG001|Overall Study|Additional antibiotic treatment|2|||
164339019|NCT01540838|593617117|FG000|Overall Study|Died before treatment initiation|1|||
164339020|NCT01540838|593617118|FG001|Overall Study|Died before treatment initiation|1|||
164339021|NCT01540838|593617117|FG000|Overall Study|Not BM. Other treatment|3|||
164339022|NCT01540838|593617118|FG001|Overall Study|Not BM. Other treatment|1|||
164339023|NCT02130570|593617119|FG000|Overall Study|Death|3|||
164339024|NCT02130570|593617120|FG001|Overall Study|Death|5|||
163887398|NCT02547233|591959385|FG001|12-month Follow-up|Withdrawal by Subject|10|||
163887399|NCT02547233|591959384|FG000|12-month Follow-up|Lost to Follow-up|3|||
163887400|NCT02547233|591959385|FG001|12-month Follow-up|Lost to Follow-up|3|||
164254105|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254106|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254107|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254108|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164339025|NCT02130570|593617119|FG000|Overall Study|Withdrawal by Subject|6|||
164339026|NCT02130570|593617120|FG001|Overall Study|Withdrawal by Subject|3|||
163887401|NCT02547233|591959384|FG000|12-month Follow-up|Lack of Efficacy|1|||
164254109|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163887402|NCT02547233|591959385|FG001|12-month Follow-up|Lack of Efficacy|2|||
163887403|NCT02547233|591959384|FG000|12-month Follow-up|Protocol Violation|0|||
163887404|NCT02547233|591959385|FG001|12-month Follow-up|Protocol Violation|1|||
163887405|NCT02547233|591959384|FG000|12-month Follow-up|Other|0|||
163887406|NCT02547233|591959385|FG001|12-month Follow-up|Other|1|||
163887407|NCT03603600|591959387|FG000|Overall Study|Withdrawal by Subject|5|||
163887408|NCT03603600|591959388|FG001|Overall Study|Withdrawal by Subject|7|||
163887409|NCT03603600|591959387|FG000|Overall Study|Lost to Follow-up|2|||
163887410|NCT03603600|591959388|FG001|Overall Study|Lost to Follow-up|3|||
163887411|NCT03603600|591959387|FG000|Overall Study|Death|3|||
163887412|NCT03603600|591959388|FG001|Overall Study|Death|1|||
163887413|NCT03603600|591959387|FG000|Overall Study|Physician Decision|2|||
163887414|NCT03603600|591959388|FG001|Overall Study|Physician Decision|1|||
163887415|NCT03603600|591959387|FG000|Overall Study|Other reason|1|||
163887416|NCT03603600|591959388|FG001|Overall Study|Other reason|0|||
163887417|NCT03461276|591959393|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
163887418|NCT03461276|591959394|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
163887419|NCT03461276|591959393|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
163887420|NCT03461276|591959394|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
163887421|NCT03461276|591959393|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
163887422|NCT03461276|591959394|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
163887423|NCT03461276|591959393|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
163887424|NCT03461276|591959394|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
163887425|NCT03461276|591959393|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
163887426|NCT03461276|591959394|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
163887427|NCT03461276|591959393|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
163887428|NCT03461276|591959394|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
163887429|NCT03461276|591959393|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
163887430|NCT03461276|591959394|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
163887431|NCT03461276|591959393|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
163887432|NCT03461276|591959394|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
163887433|NCT03461276|591959393|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
163887434|NCT03461276|591959394|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
163887435|NCT03461276|591959393|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
163887436|NCT03461276|591959394|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
163887437|NCT02310646|591959395|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
163887438|NCT02310646|591959396|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
163887439|NCT02310646|591959395|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
163887440|NCT02310646|591959396|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
163887441|NCT02043678|591959401|FG000|Overall Study|Never treated|11|||
163887442|NCT02043678|591959402|FG001|Overall Study|Never treated|9|||
163887443|NCT02043678|591959401|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
163887444|NCT02043678|591959402|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
163887445|NCT02043678|591959401|FG000|Overall Study|AE without clinical PD|54|||
163887446|NCT02043678|591959402|FG001|Overall Study|AE without clinical PD|36|||
163887447|NCT02043678|591959401|FG000|Overall Study|Lost to Follow-up|1|||
163887448|NCT02043678|591959402|FG001|Overall Study|Lost to Follow-up|1|||
163887449|NCT02043678|591959401|FG000|Overall Study|Other|10|||
163887450|NCT02043678|591959402|FG001|Overall Study|Other|14|||
163887451|NCT02043678|591959401|FG000|Overall Study|Clinical PD|114|||
163887452|NCT02043678|591959402|FG001|Overall Study|Clinical PD|148|||
163887453|NCT02043678|591959401|FG000|Overall Study|Radiological PD|100|||
163887454|NCT02043678|591959402|FG001|Overall Study|Radiological PD|90|||
163887455|NCT02043678|591959401|FG000|Overall Study|Protocol-driven decision point|59|||
163887456|NCT02043678|591959402|FG001|Overall Study|Protocol-driven decision point|58|||
163887457|NCT02043678|591959401|FG000|Overall Study|Withdrawal by Subject|16|||
163887458|NCT02043678|591959402|FG001|Overall Study|Withdrawal by Subject|20|||
163887459|NCT02043678|591959401|FG000|Overall Study|Protocol Violation|1|||
163887460|NCT02043678|591959402|FG001|Overall Study|Protocol Violation|0|||
163887461|NCT02043678|591959401|FG000|Overall Study|Deterioration of general conditions|1|||
163887462|NCT02043678|591959402|FG001|Overall Study|Deterioration of general conditions|1|||
163887463|NCT02043678|591959401|FG000|Overall Study|Logistical difficulties|2|||
164254110|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254111|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254112|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
164254113|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
163887464|NCT02043678|591959402|FG001|Overall Study|Logistical difficulties|0|||
163887465|NCT02043678|591959401|FG000|Overall Study|Non-compliance with study drug|3|||
163887466|NCT02043678|591959402|FG001|Overall Study|Non-compliance with study drug|1|||
163887467|NCT02043678|591959401|FG000|Overall Study|Physician Decision|4|||
163887468|NCT02043678|591959402|FG001|Overall Study|Physician Decision|3|||
163887469|NCT02043678|591959401|FG000|Overall Study|Subject decision|0|||
164254114|NCT03831191|593296056|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254115|NCT03831191|593296057|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254116|NCT03831191|593296058|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254117|NCT03831191|593296059|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
164254118|NCT03831191|593296060|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254119|NCT03831191|593296061|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254120|NCT03831191|593296062|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254121|NCT03831191|593296063|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254122|NCT03831191|593296064|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254123|NCT03831191|593296065|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254124|NCT03831191|593296066|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254125|NCT03831191|593296067|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254126|NCT03831191|593296068|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254127|NCT03831191|593296069|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254128|NCT03831191|593296070|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
164254129|NCT03831191|593296056|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254130|NCT03831191|593296057|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254131|NCT03831191|593296058|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254132|NCT03831191|593296059|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
164254133|NCT03831191|593296060|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
164254134|NCT03831191|593296061|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
164254135|NCT03831191|593296062|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
164254136|NCT03831191|593296063|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
164254137|NCT03831191|593296064|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
164254138|NCT03831191|593296065|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
164254139|NCT03831191|593296066|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
164254140|NCT03831191|593296067|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
164254141|NCT03831191|593296068|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
164254142|NCT03831191|593296069|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
164254143|NCT03831191|593296070|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
164254144|NCT03831191|593296056|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254145|NCT03831191|593296057|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254146|NCT03831191|593296058|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254147|NCT03831191|593296059|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254148|NCT03831191|593296060|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254149|NCT03831191|593296061|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254150|NCT03831191|593296062|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254151|NCT03831191|593296063|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254152|NCT03831191|593296064|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254153|NCT03831191|593296065|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254154|NCT03831191|593296066|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254155|NCT03831191|593296067|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254156|NCT03831191|593296068|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254157|NCT03831191|593296069|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164254158|NCT03831191|593296070|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
164254159|NCT03831191|593296056|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254160|NCT03831191|593296057|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254161|NCT03831191|593296058|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254162|NCT03831191|593296059|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254163|NCT03831191|593296060|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254164|NCT03831191|593296061|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254165|NCT03831191|593296062|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254166|NCT03831191|593296063|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254167|NCT03831191|593296064|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254168|NCT03831191|593296065|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254169|NCT03831191|593296066|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254170|NCT03831191|593296067|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254171|NCT03831191|593296068|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254172|NCT03831191|593296069|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164254173|NCT03831191|593296070|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
164254174|NCT01177553|593296071|FG000|Overall Study|babies not yet 6 months of age|1|||
164254175|NCT01177553|593296072|FG001|Overall Study|babies not yet 6 months of age|0|||
164254176|NCT01421303|593296074|FG000|Overall Study|Lost to Follow-up|13|||
164254177|NCT01421303|593296074|FG000|Overall Study|Non compliance with study procedure|1|||
164339027|NCT02130570|593617119|FG000|Overall Study|Part of practice that discontinued study|0|||
164339028|NCT02130570|593617120|FG001|Overall Study|Part of practice that discontinued study|5|||
164254178|NCT01421303|593296074|FG000|Overall Study|Other|7|||
164254179|NCT01421303|593296074|FG000|Overall Study|Withdrawal by Subject|1|||
164254180|NCT03640507|593296075|FG000|Overall Study|Withdrawal by Subject|0|||
164254181|NCT03640507|593296076|FG001|Overall Study|Withdrawal by Subject|0|||
164254182|NCT03640507|593296077|FG002|Overall Study|Withdrawal by Subject|1|||
164254183|NCT03525600|593296078|FG000|Overall Study|Adverse Event|9|||
164254184|NCT03525600|593296079|FG001|Overall Study|Adverse Event|6|||
164254185|NCT03525600|593296080|FG002|Overall Study|Adverse Event|5|||
164254186|NCT03525600|593296081|FG003|Overall Study|Adverse Event|3|||
164254187|NCT03525600|593296078|FG000|Overall Study|Lost to Follow-up|2|||
164254188|NCT03525600|593296079|FG001|Overall Study|Lost to Follow-up|4|||
164254189|NCT03525600|593296080|FG002|Overall Study|Lost to Follow-up|4|||
164254190|NCT03525600|593296081|FG003|Overall Study|Lost to Follow-up|0|||
164254191|NCT03525600|593296078|FG000|Overall Study|Physician Decision|1|||
164254192|NCT03525600|593296079|FG001|Overall Study|Physician Decision|0|||
164254193|NCT03525600|593296080|FG002|Overall Study|Physician Decision|2|||
164254194|NCT03525600|593296081|FG003|Overall Study|Physician Decision|0|||
164254195|NCT03525600|593296078|FG000|Overall Study|Consent withdrawal|36|||
164254196|NCT03525600|593296079|FG001|Overall Study|Consent withdrawal|20|||
164254197|NCT03525600|593296080|FG002|Overall Study|Consent withdrawal|6|||
164254198|NCT03525600|593296081|FG003|Overall Study|Consent withdrawal|13|||
164254199|NCT03525600|593296078|FG000|Overall Study|Death|7|||
164254200|NCT03525600|593296079|FG001|Overall Study|Death|6|||
164254201|NCT03525600|593296080|FG002|Overall Study|Death|4|||
164254202|NCT03525600|593296081|FG003|Overall Study|Death|3|||
164254203|NCT03525600|593296078|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
164254204|NCT03525600|593296079|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
164254205|NCT03525600|593296080|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
164254206|NCT03525600|593296081|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
164254207|NCT03525600|593296078|FG000|Overall Study|Other|0|||
164254208|NCT03525600|593296079|FG001|Overall Study|Other|1|||
164254209|NCT03525600|593296080|FG002|Overall Study|Other|0|||
164254210|NCT03525600|593296081|FG003|Overall Study|Other|0|||
164254211|NCT02676895|593296082|FG000|Overall Study|Administrative reason|1|||
164254212|NCT02676895|593296083|FG001|Overall Study|Administrative reason|0|||
164254213|NCT02676895|593296084|FG002|Overall Study|Administrative reason|0|||
164254214|NCT02676895|593296082|FG000|Overall Study|Protocol Violation|1|||
164254215|NCT02676895|593296083|FG001|Overall Study|Protocol Violation|0|||
164254216|NCT02676895|593296084|FG002|Overall Study|Protocol Violation|0|||
164254217|NCT02676895|593296082|FG000|Overall Study|Adverse Event|0|||
164254218|NCT02676895|593296083|FG001|Overall Study|Adverse Event|3|||
164254219|NCT02676895|593296084|FG002|Overall Study|Adverse Event|1|||
164254220|NCT02676895|593296082|FG000|Overall Study|Lost to Follow-up|0|||
164254221|NCT02676895|593296083|FG001|Overall Study|Lost to Follow-up|0|||
164254222|NCT02676895|593296084|FG002|Overall Study|Lost to Follow-up|1|||
164254223|NCT02676895|593296082|FG000|Overall Study|Withdrawal by Subject|0|||
164254224|NCT02676895|593296083|FG001|Overall Study|Withdrawal by Subject|0|||
164254225|NCT02676895|593296084|FG002|Overall Study|Withdrawal by Subject|1|||
164254226|NCT01270880|593296088|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
164254227|NCT00613327|593296089|FG000|Overall Study|Adverse Event|38|||
164254228|NCT00613327|593296089|FG000|Overall Study|Lost to Follow-up|8|||
164254229|NCT00613327|593296089|FG000|Overall Study|Withdrawal by Subject|6|||
164254230|NCT00613327|593296089|FG000|Overall Study|Protocol Violation|2|||
164254231|NCT00613327|593296089|FG000|Overall Study|Other|47|||
164254232|NCT00344318|593296090|FG000|Overall Study|Adverse Event|0|||
164254233|NCT00344318|593296091|FG001|Overall Study|Adverse Event|3|||
164254234|NCT00344318|593296092|FG002|Overall Study|Adverse Event|0|||
164254235|NCT00344318|593296093|FG003|Overall Study|Adverse Event|1|||
164254236|NCT00344318|593296090|FG000|Overall Study|Withdrawal by Subject|2|||
164254237|NCT00344318|593296091|FG001|Overall Study|Withdrawal by Subject|2|||
164254238|NCT00344318|593296092|FG002|Overall Study|Withdrawal by Subject|0|||
164254239|NCT00344318|593296093|FG003|Overall Study|Withdrawal by Subject|2|||
164254240|NCT00344318|593296090|FG000|Overall Study|Lost to Follow-up|2|||
164254241|NCT00344318|593296091|FG001|Overall Study|Lost to Follow-up|0|||
164254242|NCT00344318|593296092|FG002|Overall Study|Lost to Follow-up|1|||
164254243|NCT00344318|593296093|FG003|Overall Study|Lost to Follow-up|0|||
164254244|NCT00395486|593296099|FG000|Overall Study|Adverse Event|1|||
164254245|NCT00395486|593296100|FG001|Overall Study|Adverse Event|2|||
164254246|NCT00395486|593296099|FG000|Overall Study|Withdrawal by Subject|5|||
164254247|NCT00395486|593296100|FG001|Overall Study|Withdrawal by Subject|2|||
164254248|NCT00395486|593296099|FG000|Overall Study|Lost to Follow-up|0|||
164254249|NCT00395486|593296100|FG001|Overall Study|Lost to Follow-up|1|||
164254250|NCT00290771|593296107|FG000|Overall Study|Disease progression|95|||
164254251|NCT00290771|593296108|FG001|Overall Study|Disease progression|73|||
164254252|NCT00290771|593296107|FG000|Overall Study|Death|11|||
164254253|NCT00290771|593296108|FG001|Overall Study|Death|10|||
164254254|NCT00290771|593296107|FG000|Overall Study|Adverse Event|12|||
164254255|NCT00290771|593296108|FG001|Overall Study|Adverse Event|6|||
164254256|NCT00290771|593296107|FG000|Overall Study|Withdrawal by Subject|5|||
164254257|NCT00290771|593296108|FG001|Overall Study|Withdrawal by Subject|6|||
164254258|NCT00290771|593296107|FG000|Overall Study|Administrative problems|2|||
164254259|NCT00290771|593296108|FG001|Overall Study|Administrative problems|1|||
164254260|NCT00290771|593296107|FG000|Overall Study|Protocol Violation|2|||
164254261|NCT00290771|593296108|FG001|Overall Study|Protocol Violation|0|||
164254262|NCT00290771|593296107|FG000|Overall Study|Lost to Follow-up|0|||
164254263|NCT00290771|593296108|FG001|Overall Study|Lost to Follow-up|1|||
164254264|NCT04154293|593296111|FG000|Overall Study|Withdrawal by Subject|2|||
164254265|NCT04154293|593296112|FG001|Overall Study|Withdrawal by Subject|3|||
164254266|NCT04154293|593296113|FG002|Overall Study|Withdrawal by Subject|1|||
164254267|NCT04154293|593296111|FG000|Overall Study|Physician Decision|0|||
164254268|NCT04154293|593296112|FG001|Overall Study|Physician Decision|0|||
164254269|NCT04154293|593296113|FG002|Overall Study|Physician Decision|1|||
164254270|NCT04731298|593296114|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
164254271|NCT04731298|593296115|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
164254272|NCT01208961|593296116|FG000|High-Fat Period III|Protocol Violation|1|||
164254273|NCT01208961|593296117|FG001|High-Fat Period III|Protocol Violation|0|||
164254274|NCT01262560|593296118|FG000|Overall Study|Protocol Violation|0|||
164254275|NCT01262560|593296119|FG001|Overall Study|Protocol Violation|1|||
164254276|NCT01262560|593296120|FG002|Overall Study|Protocol Violation|2|||
164254277|NCT00350870|593296125|FG000|Overall Study|Withdrawal by Subject|21|||
164254278|NCT00350870|593296126|FG001|Overall Study|Withdrawal by Subject|17|||
164254279|NCT00350870|593296127|FG002|Overall Study|Withdrawal by Subject|15|||
164254280|NCT00350870|593296128|FG003|Overall Study|Withdrawal by Subject|14|||
164254281|NCT00350870|593296125|FG000|Overall Study|Physician Decision|1|||
164254282|NCT00350870|593296126|FG001|Overall Study|Physician Decision|0|||
164254283|NCT00350870|593296127|FG002|Overall Study|Physician Decision|1|||
164254284|NCT00350870|593296128|FG003|Overall Study|Physician Decision|1|||
164254285|NCT02095873|593296133|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164254286|NCT02095873|593296134|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164254287|NCT02095873|593296133|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
164254288|NCT02095873|593296134|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
164254289|NCT02095873|593296133|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
164254290|NCT02095873|593296134|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
164254291|NCT00792740|593296138|FG000|Overall Study|Disease Worsening|3|||
164254292|NCT00792740|593296139|FG001|Overall Study|Disease Worsening|2|||
164254293|NCT00792740|593296138|FG000|Overall Study|Personal Reason|1|||
164254294|NCT00792740|593296139|FG001|Overall Study|Personal Reason|0|||
164254295|NCT00792740|593296138|FG000|Overall Study|Adverse Event|1|||
164254296|NCT00792740|593296139|FG001|Overall Study|Adverse Event|3|||
164254297|NCT00792740|593296138|FG000|Overall Study|Patient's withdrawal of consent|0|||
164254298|NCT00792740|593296139|FG001|Overall Study|Patient's withdrawal of consent|1|||
164254299|NCT00792740|593296138|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
164254300|NCT00792740|593296139|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
164254301|NCT00792740|593296138|FG000|Overall Study|Other reasons|0|||
164254302|NCT00792740|593296139|FG001|Overall Study|Other reasons|1|||
164254303|NCT02791516|593296140|FG000|Overall Study|Withdrawal by Subject|1|||
164254304|NCT02791516|593296141|FG001|Overall Study|Withdrawal by Subject|1|||
164254305|NCT02524275|593296142|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
164254306|NCT01439971|593296143|FG000|Overall Study|Required number in cohort dosed|0|||
164254307|NCT01439971|593296144|FG001|Overall Study|Required number in cohort dosed|1|||
164254308|NCT01439971|593296145|FG002|Overall Study|Required number in cohort dosed|2|||
164339029|NCT01065597|593617130|FG000|Overall Study|Adverse Event|1|||
163887470|NCT02043678|591959402|FG001|Overall Study|Subject decision|1|||
164254309|NCT01439971|593296146|FG003|Overall Study|Required number in cohort dosed|0|||
164254310|NCT01439971|593296147|FG004|Overall Study|Required number in cohort dosed|1|||
164254311|NCT02628600|593296148|FG000|Overall Study|Death|2|||
164254312|NCT02628600|593296149|FG001|Overall Study|Death|1|||
164254313|NCT02628600|593296148|FG000|Overall Study|Adverse Event|3|||
164254314|NCT02628600|593296149|FG001|Overall Study|Adverse Event|20|||
164339030|NCT00386607|593617134|FG000|Core|Adverse Event|40|||
164254315|NCT02628600|593296148|FG000|Overall Study|Protocol Violation|0|||
164254316|NCT02628600|593296149|FG001|Overall Study|Protocol Violation|1|||
164254317|NCT02628600|593296148|FG000|Overall Study|Lack of Efficacy|2|||
164254318|NCT02628600|593296149|FG001|Overall Study|Lack of Efficacy|0|||
164254319|NCT02628600|593296148|FG000|Overall Study|Withdrawal by Subject|13|||
164254320|NCT02628600|593296149|FG001|Overall Study|Withdrawal by Subject|8|||
164339031|NCT00386607|593617135|FG001|Core|Adverse Event|0|||
163887471|NCT02043678|591959401|FG000|Overall Study|Switching to other therapy|3|||
164254321|NCT02628600|593296148|FG000|Overall Study|Lost to Follow-up|1|||
164254322|NCT02628600|593296149|FG001|Overall Study|Lost to Follow-up|0|||
164254323|NCT02628600|593296148|FG000|Overall Study|Physician Decision|2|||
164254324|NCT02628600|593296149|FG001|Overall Study|Physician Decision|2|||
164254325|NCT02628600|593296148|FG000|Overall Study|Other not specified|1|||
164254326|NCT02628600|593296149|FG001|Overall Study|Other not specified|0|||
164254327|NCT03763656|593296150|FG000|Overall Study|Physician Decision|1|||
164254328|NCT03763656|593296150|FG000|Overall Study|Protocol Violation|1|||
164254329|NCT03763656|593296150|FG000|Overall Study|Withdrawal by Subject|7|||
164254330|NCT03479541|593296151|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
164254331|NCT03479541|593296152|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
164254332|NCT03479541|593296153|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
164254333|NCT03479541|593296154|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
164254334|NCT03479541|593296151|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
164254335|NCT03479541|593296152|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
164254336|NCT03479541|593296153|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
164254337|NCT03479541|593296154|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
164254338|NCT03479541|593296151|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
164254339|NCT03479541|593296152|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
164254340|NCT03479541|593296153|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
164254341|NCT03479541|593296154|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
163887472|NCT02043678|591959402|FG001|Overall Study|Switching to other therapy|2|||
163887473|NCT02043678|591959401|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
164254342|NCT03479541|593296151|FG000|Home Monitoring|Lost to Follow-up|0|||
164254343|NCT03479541|593296152|FG001|Home Monitoring|Lost to Follow-up|0|||
164254344|NCT03479541|593296153|FG002|Home Monitoring|Lost to Follow-up|8|||
164254345|NCT03479541|593296154|FG003|Home Monitoring|Lost to Follow-up|12|||
164254346|NCT03479541|593296151|FG000|Home Monitoring|Withdrawal by Subject|0|||
164254347|NCT03479541|593296152|FG001|Home Monitoring|Withdrawal by Subject|0|||
164254348|NCT03479541|593296153|FG002|Home Monitoring|Withdrawal by Subject|17|||
164254349|NCT03479541|593296154|FG003|Home Monitoring|Withdrawal by Subject|30|||
164254350|NCT03479541|593296151|FG000|Home Monitoring|Early Termination - PI Decision|0|||
164254351|NCT03479541|593296152|FG001|Home Monitoring|Early Termination - PI Decision|0|||
164254352|NCT03479541|593296153|FG002|Home Monitoring|Early Termination - PI Decision|4|||
164254353|NCT03479541|593296154|FG003|Home Monitoring|Early Termination - PI Decision|6|||
164254354|NCT03110029|593296158|FG000|Overall Study|Withdrawal by Subject|1|||
164254355|NCT03110029|593296159|FG001|Overall Study|Withdrawal by Subject|1|||
164254356|NCT02316353|593296162|FG000|Overall Study|Pregnancy|1|||
164254357|NCT02316353|593296163|FG001|Overall Study|Pregnancy|3|||
164254358|NCT02316353|593296162|FG000|Overall Study|Adverse Event|1|||
164254359|NCT02316353|593296163|FG001|Overall Study|Adverse Event|3|||
164254360|NCT02316353|593296162|FG000|Overall Study|Withdrawal by Subject|6|||
164254361|NCT02316353|593296163|FG001|Overall Study|Withdrawal by Subject|2|||
164254362|NCT03724981|593298722|FG000|First Device|Protocol Violation|1|||
164254363|NCT03724981|593298723|FG001|First Device|Protocol Violation|1|||
164254364|NCT00511433|593298725|FG000|Overall Study|Adverse Event|5|||
164254365|NCT00511433|593298726|FG001|Overall Study|Adverse Event|0|||
164254366|NCT00511433|593298725|FG000|Overall Study|Other Reason|1|||
164254367|NCT00511433|593298726|FG001|Overall Study|Other Reason|1|||
164254368|NCT00197145|593298727|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
164254369|NCT00197145|593298728|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
164254370|NCT00197145|593298727|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
164254371|NCT00197145|593298728|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
164254372|NCT00197145|593298727|FG000|Period 1: Randomized Treatment Phase|Other|2|||
164254373|NCT00197145|593298728|FG001|Period 1: Randomized Treatment Phase|Other|2|||
164254374|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
164254375|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
164254376|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
164254377|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
164254378|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
164254379|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
164254380|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
164254381|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
164254382|NCT00197145|593298727|FG000|Period 2 : Open Label Phase|Other|1|||
164254383|NCT00197145|593298728|FG001|Period 2 : Open Label Phase|Other|0|||
164254384|NCT01740089|593298729|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
164254385|NCT01740089|593298730|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
164254386|NCT01740089|593298731|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
164254387|NCT01740089|593298729|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
164254388|NCT01740089|593298730|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
164254389|NCT01740089|593298731|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
164254390|NCT01740089|593298729|FG000|After 12 Weeks|Lack of Efficacy|3|||
164254391|NCT01740089|593298730|FG001|After 12 Weeks|Lack of Efficacy|1|||
164254392|NCT01740089|593298731|FG002|After 12 Weeks|Lack of Efficacy|4|||
164254393|NCT01740089|593298729|FG000|After 12 Weeks|Adverse Event|2|||
164254394|NCT01740089|593298730|FG001|After 12 Weeks|Adverse Event|0|||
164254395|NCT01740089|593298731|FG002|After 12 Weeks|Adverse Event|5|||
164254396|NCT01740089|593298729|FG000|After 12 Weeks|Protocol Violation|1|||
164254397|NCT01740089|593298730|FG001|After 12 Weeks|Protocol Violation|1|||
164254398|NCT01740089|593298731|FG002|After 12 Weeks|Protocol Violation|1|||
164254399|NCT01740089|593298729|FG000|After 12 Weeks|Withdrawal by Subject|1|||
164254400|NCT01740089|593298730|FG001|After 12 Weeks|Withdrawal by Subject|1|||
164254401|NCT01740089|593298731|FG002|After 12 Weeks|Withdrawal by Subject|1|||
164254402|NCT00790868|593298734|FG000|Overall Study|Withdrawal by Subject|4|||
164254403|NCT00790868|593298735|FG001|Overall Study|Withdrawal by Subject|5|||
164254404|NCT00790868|593298734|FG000|Overall Study|Lost to Follow-up|2|||
164254405|NCT00790868|593298735|FG001|Overall Study|Lost to Follow-up|12|||
164254406|NCT02867813|593298739|FG000|Overall Study|Withdrawal by Subject|57|||
164254407|NCT02867813|593298740|FG001|Overall Study|Withdrawal by Subject|56|||
164254408|NCT02867813|593298739|FG000|Overall Study|Decision by Sponsor|7|||
164254409|NCT02867813|593298740|FG001|Overall Study|Decision by Sponsor|7|||
164254410|NCT02867813|593298739|FG000|Overall Study|Lost to Follow-up|91|||
164254411|NCT02867813|593298740|FG001|Overall Study|Lost to Follow-up|78|||
164254412|NCT02867813|593298739|FG000|Overall Study|Missing|2|||
164254413|NCT02867813|593298740|FG001|Overall Study|Missing|1|||
164254414|NCT02867813|593298739|FG000|Overall Study|Death|294|||
164254415|NCT02867813|593298740|FG001|Overall Study|Death|268|||
164254416|NCT02791191|593298741|FG000|Overall Study|Adverse Event|2|||
164254417|NCT02791191|593298742|FG001|Overall Study|Adverse Event|4|||
164254418|NCT02791191|593298743|FG002|Overall Study|Adverse Event|5|||
164254419|NCT02791191|593298741|FG000|Overall Study|Lack of Efficacy|0|||
164254420|NCT02791191|593298742|FG001|Overall Study|Lack of Efficacy|1|||
164254421|NCT02791191|593298743|FG002|Overall Study|Lack of Efficacy|0|||
164254422|NCT02791191|593298741|FG000|Overall Study|Study Drug Non-Compliance|0|||
164254423|NCT02791191|593298742|FG001|Overall Study|Study Drug Non-Compliance|2|||
164254424|NCT02791191|593298743|FG002|Overall Study|Study Drug Non-Compliance|0|||
164254425|NCT02791191|593298741|FG000|Overall Study|Site Closed by Sponsor|1|||
164254426|NCT02791191|593298742|FG001|Overall Study|Site Closed by Sponsor|1|||
164254427|NCT02791191|593298743|FG002|Overall Study|Site Closed by Sponsor|3|||
164254428|NCT02791191|593298741|FG000|Overall Study|Progressive Disease|1|||
164254429|NCT02791191|593298742|FG001|Overall Study|Progressive Disease|0|||
164254430|NCT02791191|593298743|FG002|Overall Study|Progressive Disease|0|||
164254431|NCT02791191|593298741|FG000|Overall Study|Study Terminated by Sponsor|29|||
164254432|NCT02791191|593298742|FG001|Overall Study|Study Terminated by Sponsor|101|||
164254433|NCT02791191|593298743|FG002|Overall Study|Study Terminated by Sponsor|109|||
164254434|NCT02791191|593298741|FG000|Overall Study|Withdrawal by Subject|3|||
164254435|NCT02791191|593298742|FG001|Overall Study|Withdrawal by Subject|1|||
164254436|NCT02791191|593298743|FG002|Overall Study|Withdrawal by Subject|3|||
164254437|NCT02791191|593298741|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
164254438|NCT02791191|593298742|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
164254439|NCT02791191|593298743|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
164254440|NCT02370537|593298744|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
164254441|NCT02370537|593298745|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
164254442|NCT02370537|593298746|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
164254443|NCT02370537|593298744|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
164254444|NCT02370537|593298745|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
164254445|NCT02370537|593298746|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
164254446|NCT02370537|593298744|FG000|Part B|Not randomised to receive treatment|1|||
164254447|NCT02370537|593298745|FG001|Part B|Not randomised to receive treatment|2|||
164254448|NCT02370537|593298746|FG002|Part B|Not randomised to receive treatment|259|||
164339032|NCT00386607|593617134|FG000|Core|Abnormal laboratory value(s)|3|||
164339033|NCT00386607|593617135|FG001|Core|Abnormal laboratory value(s)|0|||
164339034|NCT00386607|593617134|FG000|Core|Unsatisfactory therapeutic effect|23|||
164339035|NCT00386607|593617135|FG001|Core|Unsatisfactory therapeutic effect|0|||
164339036|NCT00386607|593617134|FG000|Core|Condition no longer requires study drug|4|||
164339037|NCT00386607|593617135|FG001|Core|Condition no longer requires study drug|0|||
164339038|NCT00386607|593617134|FG000|Core|Patient withdrew consent|15|||
164254449|NCT02370537|593298744|FG000|Part B|Withdrawal by Subject|0|||
164254450|NCT02370537|593298745|FG001|Part B|Withdrawal by Subject|1|||
164254451|NCT02370537|593298746|FG002|Part B|Withdrawal by Subject|0|||
164254452|NCT01952665|593298747|FG000|Overall Study|Physician Decision|3|||
164254453|NCT01952665|593298748|FG001|Overall Study|Physician Decision|2|||
164254454|NCT01952665|593298747|FG000|Overall Study|Lost to Follow-up|1|||
164339039|NCT00386607|593617135|FG001|Core|Patient withdrew consent|0|||
164339040|NCT00386607|593617134|FG000|Core|Lost to Follow-up|23|||
164254455|NCT01952665|593298748|FG001|Overall Study|Lost to Follow-up|2|||
164254456|NCT01952665|593298747|FG000|Overall Study|Adverse Event|2|||
164254457|NCT01952665|593298748|FG001|Overall Study|Adverse Event|1|||
164339041|NCT00386607|593617135|FG001|Core|Lost to Follow-up|0|||
164339042|NCT00386607|593617134|FG000|Core|Administrative problems|1|||
164254458|NCT01952665|593298747|FG000|Overall Study|Protocol Violation|0|||
164254459|NCT01952665|593298748|FG001|Overall Study|Protocol Violation|1|||
164254460|NCT02578680|593298749|FG000|Overall Study|Death|329|||
164254461|NCT02578680|593298750|FG001|Overall Study|Death|181|||
164254462|NCT02578680|593298749|FG000|Overall Study|Lost to Follow-up|3|||
164254463|NCT02578680|593298750|FG001|Overall Study|Lost to Follow-up|1|||
164254464|NCT02578680|593298749|FG000|Overall Study|Physician Decision|0|||
164254465|NCT02578680|593298750|FG001|Overall Study|Physician Decision|1|||
164254466|NCT02578680|593298749|FG000|Overall Study|Protocol Violation|1|||
164254467|NCT02578680|593298750|FG001|Overall Study|Protocol Violation|1|||
164254468|NCT02578680|593298749|FG000|Overall Study|Sponsor Decision|64|||
164254469|NCT02578680|593298750|FG001|Overall Study|Sponsor Decision|13|||
164254470|NCT02578680|593298749|FG000|Overall Study|Withdrawal by Subject|13|||
164254471|NCT02578680|593298750|FG001|Overall Study|Withdrawal by Subject|9|||
164254472|NCT01559259|593298752|FG000|Overall Study|Withdrawal by Subject|0|||
164254473|NCT01559259|593298753|FG001|Overall Study|Withdrawal by Subject|0|||
164254474|NCT01559259|593298754|FG002|Overall Study|Withdrawal by Subject|0|||
164254475|NCT01559259|593298755|FG003|Overall Study|Withdrawal by Subject|1|||
164254476|NCT01559259|593298756|FG004|Overall Study|Withdrawal by Subject|0|||
164254477|NCT01559259|593298752|FG000|Overall Study|Adverse Event|0|||
164254478|NCT01559259|593298753|FG001|Overall Study|Adverse Event|1|||
164254479|NCT01559259|593298754|FG002|Overall Study|Adverse Event|1|||
164254480|NCT01559259|593298755|FG003|Overall Study|Adverse Event|0|||
164254481|NCT01559259|593298756|FG004|Overall Study|Adverse Event|0|||
164254482|NCT03727646|593298757|FG000|Overall Study|Adverse Event|1|||
164254483|NCT03727646|593298758|FG001|Overall Study|Adverse Event|0|||
164339043|NCT00386607|593617135|FG001|Core|Administrative problems|0|||
164339044|NCT00386607|593617134|FG000|Core|Protocol Deviation|6|||
164339045|NCT00386607|593617135|FG001|Core|Protocol Deviation|0|||
164339046|NCT00386607|593617134|FG000|Extension|Adverse Event|0|||
164339047|NCT00386607|593617135|FG001|Extension|Adverse Event|6|||
164339048|NCT00386607|593617134|FG000|Extension|Abnormal laboratory value(s)|0|||
164339049|NCT00386607|593617135|FG001|Extension|Abnormal laboratory value(s)|1|||
164339050|NCT00386607|593617134|FG000|Extension|Administrative problems|0|||
164339051|NCT00386607|593617135|FG001|Extension|Administrative problems|1|||
164254484|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
164254485|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
164339052|NCT00386607|593617134|FG000|Extension|Lost to Follow-up|0|||
164339053|NCT00386607|593617135|FG001|Extension|Lost to Follow-up|3|||
164339054|NCT00386607|593617134|FG000|Extension|Patient withdrew consent|0|||
164339055|NCT00386607|593617135|FG001|Extension|Patient withdrew consent|5|||
164339056|NCT00386607|593617134|FG000|Extension|Unsatisfactory therapeutic effect|0|||
164339057|NCT00386607|593617135|FG001|Extension|Unsatisfactory therapeutic effect|1|||
164339058|NCT02713204|593617136|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
163887474|NCT02043678|591959402|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
163887475|NCT02043678|591959401|FG000|Overall Study|Missing|1|||
163887476|NCT02043678|591959402|FG001|Overall Study|Missing|0|||
163887477|NCT02043678|591959401|FG000|Overall Study|Adverse Event|0|||
163887478|NCT02043678|591959402|FG001|Overall Study|Adverse Event|1|||
163887479|NCT04307355|591959411|FG000|Overall Study|Non-Compliance|3|||
163887480|NCT04307355|591959412|FG001|Overall Study|Non-Compliance|3|||
163887481|NCT04307355|591959413|FG002|Overall Study|Non-Compliance|0|||
163887482|NCT04065841|591959414|FG000|Overall Study|Adverse Event|4|||
163887483|NCT04065841|591959415|FG001|Overall Study|Adverse Event|2|||
163887484|NCT04065841|591959416|FG002|Overall Study|Adverse Event|10|||
163887485|NCT04065841|591959417|FG003|Overall Study|Adverse Event|1|||
163887486|NCT04065841|591959414|FG000|Overall Study|Lost to Follow-up|1|||
163887487|NCT04065841|591959415|FG001|Overall Study|Lost to Follow-up|2|||
163887488|NCT04065841|591959416|FG002|Overall Study|Lost to Follow-up|2|||
163887489|NCT04065841|591959417|FG003|Overall Study|Lost to Follow-up|2|||
163887490|NCT04065841|591959414|FG000|Overall Study|Physician Decision|1|||
163887491|NCT04065841|591959415|FG001|Overall Study|Physician Decision|0|||
163887492|NCT04065841|591959416|FG002|Overall Study|Physician Decision|0|||
163887493|NCT04065841|591959417|FG003|Overall Study|Physician Decision|0|||
163887494|NCT04065841|591959414|FG000|Overall Study|Protocol Violation|0|||
164254486|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
164339059|NCT02713204|593617137|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163887495|NCT04065841|591959415|FG001|Overall Study|Protocol Violation|1|||
163887496|NCT04065841|591959416|FG002|Overall Study|Protocol Violation|0|||
163887497|NCT04065841|591959417|FG003|Overall Study|Protocol Violation|0|||
164254487|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
164254488|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
164339060|NCT02713204|593617138|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
164339061|NCT02713204|593617139|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164339062|NCT02713204|593617140|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
163887498|NCT04065841|591959414|FG000|Overall Study|Study terminated by Sponsor|22|||
163887499|NCT04065841|591959415|FG001|Overall Study|Study terminated by Sponsor|16|||
163887500|NCT04065841|591959416|FG002|Overall Study|Study terminated by Sponsor|28|||
164254489|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
164254490|NCT00306293|593298762|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
164254491|NCT00306293|593298763|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
164254492|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
164254493|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
164254494|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
164254495|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
164254496|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
164254497|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
164254498|NCT00306293|593298762|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
164254499|NCT00306293|593298763|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
164254500|NCT01089413|593298766|FG000|Overall Study|Lost to Follow-up|1|||
164254501|NCT01089413|593298766|FG000|Overall Study|Progressive Disease|93|||
164254502|NCT01089413|593298766|FG000|Overall Study|Participant Withdrew Consent|1|||
164254503|NCT01089413|593298766|FG000|Overall Study|Unacceptable Toxicity|12|||
164254504|NCT01089413|593298766|FG000|Overall Study|Death|10|||
164254505|NCT01089413|593298766|FG000|Overall Study|Metastasectomy|13|||
164254506|NCT01089413|593298766|FG000|Overall Study|Other|71|||
164254507|NCT01814878|593298768|FG000|Overall Study|Adverse Event|16|||
164254508|NCT01814878|593298769|FG001|Overall Study|Adverse Event|5|||
164254509|NCT01814878|593298768|FG000|Overall Study|Withdrawal by Subject|20|||
164254510|NCT01814878|593298769|FG001|Overall Study|Withdrawal by Subject|16|||
164254511|NCT01814878|593298768|FG000|Overall Study|Protocol Violation|5|||
164254512|NCT01814878|593298769|FG001|Overall Study|Protocol Violation|5|||
164254513|NCT01814878|593298768|FG000|Overall Study|Physician Decision|3|||
164254514|NCT01814878|593298769|FG001|Overall Study|Physician Decision|1|||
164254515|NCT01814878|593298768|FG000|Overall Study|Screening failure (drop-out)|0|||
164254516|NCT01814878|593298769|FG001|Overall Study|Screening failure (drop-out)|3|||
164254517|NCT01814878|593298768|FG000|Overall Study|Other|2|||
164254518|NCT01814878|593298769|FG001|Overall Study|Other|0|||
164254519|NCT04115748|593298774|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
164254520|NCT04115748|593298775|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
164254521|NCT04115748|593298776|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
164254522|NCT04115748|593298777|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
164254523|NCT04115748|593298778|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254524|NCT04115748|593298779|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254525|NCT04115748|593298780|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254526|NCT04115748|593298781|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254527|NCT04115748|593298782|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254528|NCT04115748|593298783|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
164254529|NCT04115748|593298774|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254530|NCT04115748|593298775|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254531|NCT04115748|593298776|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254532|NCT04115748|593298777|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
164254533|NCT04115748|593298778|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254534|NCT04115748|593298779|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254535|NCT04115748|593298780|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254536|NCT04115748|593298781|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254537|NCT04115748|593298782|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254538|NCT04115748|593298783|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
164254539|NCT04115748|593298774|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254540|NCT04115748|593298775|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254541|NCT04115748|593298776|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254542|NCT04115748|593298777|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
164254543|NCT04115748|593298778|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
164254544|NCT04115748|593298779|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
164254545|NCT04115748|593298780|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
164254546|NCT04115748|593298781|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
164254547|NCT04115748|593298782|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
164254548|NCT04115748|593298783|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
164254549|NCT04115748|593298774|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254550|NCT04115748|593298775|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254551|NCT04115748|593298776|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254552|NCT04115748|593298777|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254553|NCT04115748|593298778|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254554|NCT04115748|593298779|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254555|NCT04115748|593298780|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254556|NCT04115748|593298781|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254557|NCT04115748|593298782|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
164254558|NCT04115748|593298783|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
164254559|NCT01200407|593298784|FG000|Overall Study|Lost to Follow-up|56|||
164254560|NCT01200407|593298784|FG000|Overall Study|Adverse Event|3|||
164254561|NCT01200407|593298784|FG000|Overall Study|Withdrawal by Subject|4|||
164254562|NCT01200407|593298784|FG000|Overall Study|Other|19|||
164254563|NCT00152477|593298785|FG000|Chemotherapy Period|Adverse Event|9|||
164254564|NCT00152477|593298786|FG001|Chemotherapy Period|Adverse Event|4|||
164254565|NCT00152477|593298787|FG002|Chemotherapy Period|Adverse Event|5|||
164254566|NCT00152477|593298785|FG000|Chemotherapy Period|Death|1|||
164254567|NCT00152477|593298786|FG001|Chemotherapy Period|Death|3|||
164254568|NCT00152477|593298787|FG002|Chemotherapy Period|Death|3|||
164254569|NCT00152477|593298785|FG000|Chemotherapy Period|Lack of Efficacy|4|||
164254570|NCT00152477|593298786|FG001|Chemotherapy Period|Lack of Efficacy|5|||
164254571|NCT00152477|593298787|FG002|Chemotherapy Period|Lack of Efficacy|6|||
164254572|NCT00152477|593298785|FG000|Chemotherapy Period|Lost to Follow-up|1|||
164254573|NCT00152477|593298786|FG001|Chemotherapy Period|Lost to Follow-up|0|||
164254574|NCT00152477|593298787|FG002|Chemotherapy Period|Lost to Follow-up|1|||
164254575|NCT00152477|593298785|FG000|Chemotherapy Period|Protocol Violation|1|||
164254576|NCT00152477|593298786|FG001|Chemotherapy Period|Protocol Violation|1|||
164254577|NCT00152477|593298787|FG002|Chemotherapy Period|Protocol Violation|0|||
164254578|NCT00152477|593298785|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
164254579|NCT00152477|593298786|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
164254580|NCT00152477|593298787|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
164254581|NCT00152477|593298785|FG000|Chemotherapy Period|Progression of Disease|6|||
164254582|NCT00152477|593298786|FG001|Chemotherapy Period|Progression of Disease|8|||
164254583|NCT00152477|593298787|FG002|Chemotherapy Period|Progression of Disease|4|||
164254584|NCT00152477|593298785|FG000|Chemotherapy Period|Investigator decision|0|||
164254585|NCT00152477|593298786|FG001|Chemotherapy Period|Investigator decision|0|||
164254586|NCT00152477|593298787|FG002|Chemotherapy Period|Investigator decision|1|||
164254587|NCT00152477|593298785|FG000|Chemotherapy Period|Patient condition worsened|1|||
164254588|NCT00152477|593298786|FG001|Chemotherapy Period|Patient condition worsened|0|||
164254589|NCT00152477|593298787|FG002|Chemotherapy Period|Patient condition worsened|0|||
164254590|NCT00152477|593298785|FG000|Monotherapy Period|Adverse Event|1|||
164254591|NCT00152477|593298786|FG001|Monotherapy Period|Adverse Event|0|||
164254592|NCT00152477|593298787|FG002|Monotherapy Period|Adverse Event|5|||
164254593|NCT00152477|593298785|FG000|Monotherapy Period|Death|2|||
164254594|NCT00152477|593298786|FG001|Monotherapy Period|Death|0|||
164254595|NCT00152477|593298787|FG002|Monotherapy Period|Death|1|||
164254596|NCT00152477|593298785|FG000|Monotherapy Period|Lack of Efficacy|7|||
164254597|NCT00152477|593298786|FG001|Monotherapy Period|Lack of Efficacy|16|||
164254598|NCT00152477|593298787|FG002|Monotherapy Period|Lack of Efficacy|10|||
164254599|NCT00152477|593298785|FG000|Monotherapy Period|Protocol Violation|0|||
164254600|NCT00152477|593298786|FG001|Monotherapy Period|Protocol Violation|1|||
164254601|NCT00152477|593298787|FG002|Monotherapy Period|Protocol Violation|0|||
164254602|NCT00152477|593298785|FG000|Monotherapy Period|Withdrawal by Subject|0|||
164254603|NCT00152477|593298786|FG001|Monotherapy Period|Withdrawal by Subject|0|||
164254604|NCT00152477|593298787|FG002|Monotherapy Period|Withdrawal by Subject|4|||
164254605|NCT00152477|593298785|FG000|Monotherapy Period|Progression of Disease|5|||
164254606|NCT00152477|593298786|FG001|Monotherapy Period|Progression of Disease|11|||
164254607|NCT00152477|593298787|FG002|Monotherapy Period|Progression of Disease|12|||
164254608|NCT00152477|593298785|FG000|Monotherapy Period|Patient decision|0|||
164254609|NCT00152477|593298786|FG001|Monotherapy Period|Patient decision|1|||
164254610|NCT00152477|593298787|FG002|Monotherapy Period|Patient decision|1|||
164254611|NCT00152477|593298785|FG000|Monotherapy Period|Study personel decision|0|||
164254612|NCT00152477|593298786|FG001|Monotherapy Period|Study personel decision|0|||
164254613|NCT00152477|593298787|FG002|Monotherapy Period|Study personel decision|1|||
164254614|NCT00730041|593298790|FG000|Overall Study|Lost to Follow-up|0|||
164254615|NCT00730041|593298791|FG001|Overall Study|Lost to Follow-up|2|||
164254616|NCT00433966|593298794|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
164254617|NCT00433966|593298795|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
164254618|NCT00433966|593298796|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
164254619|NCT00433966|593298797|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
164254620|NCT00433966|593298794|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
164254621|NCT00433966|593298795|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
164254622|NCT00433966|593298796|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
164254623|NCT00433966|593298797|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
164254624|NCT00433966|593298794|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
164254625|NCT00433966|593298795|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
164254626|NCT00433966|593298796|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
164254627|NCT00433966|593298797|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
164254628|NCT00433966|593298794|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
164254629|NCT00433966|593298795|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
164254630|NCT00433966|593298796|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
164084670|NCT00585351|592673982|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
164084671|NCT00585351|592673975|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164084672|NCT00585351|592673976|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164084673|NCT00585351|592673977|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164084674|NCT00585351|592673978|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164084675|NCT00585351|592673979|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164084676|NCT00585351|592673980|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
164339063|NCT02713204|593617141|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164339064|NCT02713204|593617142|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164339065|NCT02713204|593617143|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
164084677|NCT00585351|592673981|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
164084678|NCT00585351|592673982|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
164084679|NCT00585351|592673975|FG000|Enrollment Period (Intervention)|Death|0|||
164084680|NCT00585351|592673976|FG001|Enrollment Period (Intervention)|Death|0|||
164084681|NCT00585351|592673977|FG002|Enrollment Period (Intervention)|Death|0|||
164084682|NCT00585351|592673978|FG003|Enrollment Period (Intervention)|Death|0|||
164084683|NCT00585351|592673979|FG004|Enrollment Period (Intervention)|Death|1|||
164084684|NCT00585351|592673980|FG005|Enrollment Period (Intervention)|Death|0|||
164254631|NCT00433966|593298797|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
164254632|NCT00433966|593298794|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
164254633|NCT00433966|593298795|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
164254634|NCT00433966|593298796|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
164254635|NCT00433966|593298797|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
164254636|NCT01296711|593298798|FG000|Overall Study|Adverse Event|3|||
164254637|NCT01296711|593298799|FG001|Overall Study|Adverse Event|1|||
164254638|NCT01296711|593298800|FG002|Overall Study|Adverse Event|4|||
164254639|NCT01296711|593298801|FG003|Overall Study|Adverse Event|3|||
164254640|NCT01296711|593298802|FG004|Overall Study|Adverse Event|1|||
164254641|NCT01296711|593298803|FG005|Overall Study|Adverse Event|6|||
164254642|NCT01296711|593298804|FG006|Overall Study|Adverse Event|11|||
164254643|NCT01296711|593298805|FG007|Overall Study|Adverse Event|3|||
164254644|NCT01296711|593298798|FG000|Overall Study|Lack of Efficacy|1|||
164254645|NCT01296711|593298799|FG001|Overall Study|Lack of Efficacy|4|||
164254646|NCT01296711|593298800|FG002|Overall Study|Lack of Efficacy|1|||
164254647|NCT01296711|593298801|FG003|Overall Study|Lack of Efficacy|1|||
164254648|NCT01296711|593298802|FG004|Overall Study|Lack of Efficacy|1|||
164254649|NCT01296711|593298803|FG005|Overall Study|Lack of Efficacy|0|||
164254650|NCT01296711|593298804|FG006|Overall Study|Lack of Efficacy|2|||
164254651|NCT01296711|593298805|FG007|Overall Study|Lack of Efficacy|3|||
164254652|NCT01296711|593298798|FG000|Overall Study|Lost to Follow-up|0|||
164254653|NCT01296711|593298799|FG001|Overall Study|Lost to Follow-up|0|||
164254654|NCT01296711|593298800|FG002|Overall Study|Lost to Follow-up|1|||
164254655|NCT01296711|593298801|FG003|Overall Study|Lost to Follow-up|1|||
164254656|NCT01296711|593298802|FG004|Overall Study|Lost to Follow-up|2|||
164254657|NCT01296711|593298803|FG005|Overall Study|Lost to Follow-up|0|||
164084685|NCT00585351|592673981|FG006|Enrollment Period (Intervention)|Death|1|||
164084686|NCT00585351|592673982|FG007|Enrollment Period (Intervention)|Death|0|||
164254658|NCT01296711|593298804|FG006|Overall Study|Lost to Follow-up|4|||
164254659|NCT01296711|593298805|FG007|Overall Study|Lost to Follow-up|2|||
164254660|NCT01296711|593298798|FG000|Overall Study|Protocol Violation|0|||
164254661|NCT01296711|593298799|FG001|Overall Study|Protocol Violation|0|||
164254662|NCT01296711|593298800|FG002|Overall Study|Protocol Violation|0|||
164254663|NCT01296711|593298801|FG003|Overall Study|Protocol Violation|1|||
164254664|NCT01296711|593298802|FG004|Overall Study|Protocol Violation|1|||
164254665|NCT01296711|593298803|FG005|Overall Study|Protocol Violation|0|||
164254666|NCT01296711|593298804|FG006|Overall Study|Protocol Violation|0|||
164254667|NCT01296711|593298805|FG007|Overall Study|Protocol Violation|0|||
164254668|NCT01296711|593298798|FG000|Overall Study|Withdrawal by Subject|4|||
164339066|NCT02713204|593617136|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339067|NCT02713204|593617137|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
163887501|NCT04065841|591959417|FG003|Overall Study|Study terminated by Sponsor|17|||
164084687|NCT00585351|592673975|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164084688|NCT00585351|592673976|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164339068|NCT02713204|593617138|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
164084689|NCT00585351|592673977|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164339069|NCT02713204|593617139|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164254669|NCT01296711|593298799|FG001|Overall Study|Withdrawal by Subject|2|||
164254670|NCT01296711|593298800|FG002|Overall Study|Withdrawal by Subject|2|||
164084690|NCT00585351|592673978|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164084691|NCT00585351|592673979|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
164254671|NCT01296711|593298801|FG003|Overall Study|Withdrawal by Subject|1|||
164254672|NCT01296711|593298802|FG004|Overall Study|Withdrawal by Subject|1|||
164254673|NCT01296711|593298803|FG005|Overall Study|Withdrawal by Subject|1|||
164254674|NCT01296711|593298804|FG006|Overall Study|Withdrawal by Subject|2|||
164254675|NCT01296711|593298805|FG007|Overall Study|Withdrawal by Subject|1|||
164254676|NCT01296711|593298798|FG000|Overall Study|Study termination|8|||
164254677|NCT01296711|593298799|FG001|Overall Study|Study termination|1|||
164254678|NCT01296711|593298800|FG002|Overall Study|Study termination|5|||
164254679|NCT01296711|593298801|FG003|Overall Study|Study termination|4|||
164254680|NCT01296711|593298802|FG004|Overall Study|Study termination|4|||
164254681|NCT01296711|593298803|FG005|Overall Study|Study termination|4|||
164254682|NCT01296711|593298804|FG006|Overall Study|Study termination|8|||
164254683|NCT01296711|593298805|FG007|Overall Study|Study termination|10|||
164254684|NCT01296711|593298798|FG000|Overall Study|Continued elevated liver enzymes|0|||
164254685|NCT01296711|593298799|FG001|Overall Study|Continued elevated liver enzymes|0|||
164254686|NCT01296711|593298800|FG002|Overall Study|Continued elevated liver enzymes|0|||
164254687|NCT01296711|593298801|FG003|Overall Study|Continued elevated liver enzymes|1|||
164254688|NCT01296711|593298802|FG004|Overall Study|Continued elevated liver enzymes|0|||
164254689|NCT01296711|593298803|FG005|Overall Study|Continued elevated liver enzymes|0|||
164254690|NCT01296711|593298804|FG006|Overall Study|Continued elevated liver enzymes|0|||
164254691|NCT01296711|593298805|FG007|Overall Study|Continued elevated liver enzymes|0|||
164254692|NCT01296711|593298798|FG000|Overall Study|Methotrexate discontinued|0|||
164254693|NCT01296711|593298799|FG001|Overall Study|Methotrexate discontinued|0|||
164254694|NCT01296711|593298800|FG002|Overall Study|Methotrexate discontinued|0|||
164254695|NCT01296711|593298801|FG003|Overall Study|Methotrexate discontinued|1|||
164254696|NCT01296711|593298802|FG004|Overall Study|Methotrexate discontinued|0|||
164254697|NCT01296711|593298803|FG005|Overall Study|Methotrexate discontinued|0|||
164254698|NCT01296711|593298804|FG006|Overall Study|Methotrexate discontinued|0|||
163992046|NCT04426695|592339648|FG007|Overall Study|Randomized but Never Treated|6|||
163992047|NCT04426695|592339649|FG008|Overall Study|Randomized but Never Treated|6|||
163992048|NCT04426695|592339650|FG009|Overall Study|Randomized but Never Treated|3|||
163992049|NCT04426695|592339651|FG010|Overall Study|Randomized but Never Treated|3|||
163992050|NCT04426695|592339652|FG011|Overall Study|Randomized but Never Treated|6|||
163992051|NCT04426695|592339653|FG012|Overall Study|Randomized but Never Treated|1|||
163992052|NCT04426695|592339654|FG013|Overall Study|Randomized but Never Treated|2|||
163992053|NCT04426695|592339655|FG014|Overall Study|Randomized but Never Treated|0|||
163992054|NCT04426695|592339656|FG015|Overall Study|Randomized but Never Treated|0|||
163992055|NCT04426695|592339657|FG016|Overall Study|Randomized but Never Treated|0|||
164084692|NCT00585351|592673980|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
164084693|NCT00585351|592673981|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164254699|NCT01296711|593298805|FG007|Overall Study|Methotrexate discontinued|0|||
164254700|NCT01296711|593298798|FG000|Overall Study|Investigator discretion|0|||
164254701|NCT01296711|593298799|FG001|Overall Study|Investigator discretion|0|||
164254702|NCT01296711|593298800|FG002|Overall Study|Investigator discretion|0|||
164254703|NCT01296711|593298801|FG003|Overall Study|Investigator discretion|0|||
164254704|NCT01296711|593298802|FG004|Overall Study|Investigator discretion|0|||
164254705|NCT01296711|593298803|FG005|Overall Study|Investigator discretion|0|||
164254706|NCT01296711|593298804|FG006|Overall Study|Investigator discretion|1|||
164254707|NCT01296711|593298805|FG007|Overall Study|Investigator discretion|0|||
164254708|NCT01296711|593298798|FG000|Overall Study|Other|0|||
164339070|NCT02713204|593617140|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339071|NCT02713204|593617141|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339072|NCT02713204|593617142|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339073|NCT02713204|593617143|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164339074|NCT02713204|593617136|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339075|NCT02713204|593617137|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
164339076|NCT02713204|593617138|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339077|NCT02713204|593617139|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339078|NCT02713204|593617140|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339079|NCT02713204|593617141|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339080|NCT02713204|593617142|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339081|NCT02713204|593617143|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164339082|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Adverse Event|1|||
164339083|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Adverse Event|0|||
164339084|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Adverse Event|0|||
164339085|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Adverse Event|1|||
164339086|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Adverse Event|1|||
164339087|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Adverse Event|0|||
164339088|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Adverse Event|2|||
164339089|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Adverse Event|1|||
164339090|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Death|0|||
164339091|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Death|0|||
164339092|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Death|0|||
164339093|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Death|1|||
164339094|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Death|0|||
164339095|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Death|1|||
164254709|NCT01296711|593298799|FG001|Overall Study|Other|0|||
163992056|NCT04426695|592339658|FG017|Overall Study|Randomized but Never Treated|0|||
163992057|NCT00559273|592339659|FG000|Correction Period (20 Weeks)|Death|3|||
163992058|NCT00559273|592339660|FG001|Correction Period (20 Weeks)|Death|4|||
163992059|NCT00559273|592339659|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
163992060|NCT00559273|592339660|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
163992061|NCT00559273|592339659|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
163992062|NCT00559273|592339660|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
163887502|NCT04065841|591959414|FG000|Overall Study|Withdrawal by Subject|1|||
163887503|NCT04065841|591959415|FG001|Overall Study|Withdrawal by Subject|1|||
163887504|NCT04065841|591959416|FG002|Overall Study|Withdrawal by Subject|2|||
163887505|NCT04065841|591959417|FG003|Overall Study|Withdrawal by Subject|0|||
163992063|NCT00559273|592339659|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
163992064|NCT00559273|592339660|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
163887506|NCT01420237|591959422|FG000|Overall Study|Death|13|||
163887507|NCT01420237|591959422|FG000|Overall Study|Withdrawal by Subject|41|||
163887508|NCT01420237|591959422|FG000|Overall Study|Lost to Follow-up|32|||
163887509|NCT01420237|591959422|FG000|Overall Study|Adverse Event|10|||
163887510|NCT01420237|591959422|FG000|Overall Study|Investigative Site Termination|43|||
163887511|NCT01420237|591959422|FG000|Overall Study|Censored because study device not implanted|21|||
163887512|NCT01420237|591959422|FG000|Overall Study|Censored because surgery not performed|2|||
163887513|NCT01420237|591959422|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
163887514|NCT01420237|591959422|FG000|Overall Study|Sponsor terminated study early|127|||
163887515|NCT05269667|591959423|FG000|Overall Study|Study Terminated by Sponsor|4|||
163887516|NCT03768505|591959425|FG000|Overall Study|sponsor decision|76|||
163887517|NCT03768505|591959425|FG000|Overall Study|Death|35|||
164254710|NCT01296711|593298800|FG002|Overall Study|Other|0|||
163887518|NCT03768505|591959425|FG000|Overall Study|Other -Various|30|||
163887519|NCT03768505|591959425|FG000|Overall Study|Withdrawal by Subject|22|||
163887520|NCT03768505|591959425|FG000|Overall Study|Lost to Follow-up|6|||
163887521|NCT02815566|591959430|FG000|Overall Study|Adverse Event|1|||
163887522|NCT02815566|591959431|FG001|Overall Study|Adverse Event|1|||
163887523|NCT02815566|591959430|FG000|Overall Study|Withdrawal by Subject|1|||
163887524|NCT02815566|591959431|FG001|Overall Study|Withdrawal by Subject|0|||
163887525|NCT02815566|591959430|FG000|Overall Study|Lost to Follow-up|0|||
163887526|NCT02815566|591959431|FG001|Overall Study|Lost to Follow-up|1|||
163887527|NCT02993159|591959432|FG000|Overall Study|Withdrawal by Subject|1|||
163887528|NCT02993159|591959433|FG001|Overall Study|Withdrawal by Subject|3|||
163887529|NCT02993159|591959432|FG000|Overall Study|Protocol Violation|1|||
163887530|NCT02993159|591959433|FG001|Overall Study|Protocol Violation|0|||
163887531|NCT02993159|591959432|FG000|Overall Study|Opted out of surgery|2|||
163887532|NCT02993159|591959433|FG001|Overall Study|Opted out of surgery|0|||
163887533|NCT02993159|591959432|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
163887534|NCT02993159|591959433|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
163887535|NCT02993159|591959432|FG000|Overall Study|Physician Decision|0|||
163887536|NCT02993159|591959433|FG001|Overall Study|Physician Decision|1|||
163887537|NCT02231164|591959434|FG000|Overall Study|Adverse Event|1|||
163887538|NCT02231164|591959435|FG001|Overall Study|Adverse Event|1|||
163887539|NCT02231164|591959434|FG000|Overall Study|Lack of Efficacy|4|||
163887540|NCT02231164|591959435|FG001|Overall Study|Lack of Efficacy|3|||
163887541|NCT02231164|591959434|FG000|Overall Study|Withdrawal by Subject|1|||
163887542|NCT02231164|591959435|FG001|Overall Study|Withdrawal by Subject|2|||
163992065|NCT00559273|592339659|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
163992066|NCT00559273|592339660|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
164254711|NCT01296711|593298801|FG003|Overall Study|Other|0|||
164254712|NCT01296711|593298802|FG004|Overall Study|Other|0|||
164254713|NCT01296711|593298803|FG005|Overall Study|Other|0|||
164254714|NCT01296711|593298804|FG006|Overall Study|Other|1|||
164254715|NCT01296711|593298805|FG007|Overall Study|Other|0|||
164254716|NCT01296711|593298798|FG000|Overall Study|Required restricted steroid injections|0|||
164254717|NCT01296711|593298799|FG001|Overall Study|Required restricted steroid injections|0|||
164254718|NCT01296711|593298800|FG002|Overall Study|Required restricted steroid injections|0|||
164254719|NCT01296711|593298801|FG003|Overall Study|Required restricted steroid injections|0|||
164254720|NCT01296711|593298802|FG004|Overall Study|Required restricted steroid injections|0|||
164254721|NCT01296711|593298803|FG005|Overall Study|Required restricted steroid injections|0|||
164254722|NCT01296711|593298804|FG006|Overall Study|Required restricted steroid injections|1|||
164254723|NCT01296711|593298805|FG007|Overall Study|Required restricted steroid injections|0|||
164254724|NCT01296711|593298798|FG000|Overall Study|Ongoing missed appointments|0|||
164254725|NCT01296711|593298799|FG001|Overall Study|Ongoing missed appointments|0|||
164254726|NCT01296711|593298800|FG002|Overall Study|Ongoing missed appointments|0|||
164254727|NCT01296711|593298801|FG003|Overall Study|Ongoing missed appointments|0|||
164254728|NCT01296711|593298802|FG004|Overall Study|Ongoing missed appointments|0|||
164254729|NCT01296711|593298803|FG005|Overall Study|Ongoing missed appointments|0|||
164254730|NCT01296711|593298804|FG006|Overall Study|Ongoing missed appointments|1|||
164254731|NCT01296711|593298805|FG007|Overall Study|Ongoing missed appointments|0|||
164254732|NCT01296711|593298798|FG000|Overall Study|Failure to comply with visits|0|||
164254733|NCT01296711|593298799|FG001|Overall Study|Failure to comply with visits|0|||
164254734|NCT01296711|593298800|FG002|Overall Study|Failure to comply with visits|0|||
164254735|NCT01296711|593298801|FG003|Overall Study|Failure to comply with visits|0|||
164254736|NCT01296711|593298802|FG004|Overall Study|Failure to comply with visits|0|||
164254737|NCT01296711|593298803|FG005|Overall Study|Failure to comply with visits|0|||
164254738|NCT01296711|593298804|FG006|Overall Study|Failure to comply with visits|0|||
164254739|NCT01296711|593298805|FG007|Overall Study|Failure to comply with visits|1|||
164254740|NCT01296711|593298798|FG000|Overall Study|Patient decision due to transport|0|||
164254741|NCT01296711|593298799|FG001|Overall Study|Patient decision due to transport|0|||
164254742|NCT01296711|593298800|FG002|Overall Study|Patient decision due to transport|0|||
164254743|NCT01296711|593298801|FG003|Overall Study|Patient decision due to transport|0|||
164254744|NCT01296711|593298802|FG004|Overall Study|Patient decision due to transport|0|||
164254745|NCT01296711|593298803|FG005|Overall Study|Patient decision due to transport|0|||
164254746|NCT01296711|593298804|FG006|Overall Study|Patient decision due to transport|0|||
164254747|NCT01296711|593298805|FG007|Overall Study|Patient decision due to transport|1|||
164254748|NCT01328535|593298807|FG000|Overall Study|Ineligible|1|||
164254749|NCT01035463|593298808|FG000|Overall Study|Adverse Event|0|||
164254750|NCT01035463|593298809|FG001|Overall Study|Adverse Event|0|||
164254751|NCT01035463|593298810|FG002|Overall Study|Adverse Event|4|||
164254752|NCT01035463|593298811|FG003|Overall Study|Adverse Event|1|||
164254753|NCT01035463|593298812|FG004|Overall Study|Adverse Event|5|||
164254754|NCT01035463|593298813|FG005|Overall Study|Adverse Event|7|||
164254755|NCT01035463|593298808|FG000|Overall Study|Withdrawal by Subject|0|||
164254756|NCT01035463|593298809|FG001|Overall Study|Withdrawal by Subject|2|||
164254757|NCT01035463|593298810|FG002|Overall Study|Withdrawal by Subject|1|||
164254758|NCT01035463|593298811|FG003|Overall Study|Withdrawal by Subject|0|||
164254759|NCT01035463|593298812|FG004|Overall Study|Withdrawal by Subject|1|||
164254760|NCT01035463|593298813|FG005|Overall Study|Withdrawal by Subject|4|||
164254761|NCT01035463|593298808|FG000|Overall Study|Disease progression|0|||
164254762|NCT01035463|593298809|FG001|Overall Study|Disease progression|0|||
164254763|NCT01035463|593298810|FG002|Overall Study|Disease progression|0|||
164254764|NCT01035463|593298811|FG003|Overall Study|Disease progression|0|||
164254765|NCT01035463|593298812|FG004|Overall Study|Disease progression|0|||
164254766|NCT01035463|593298813|FG005|Overall Study|Disease progression|3|||
164254767|NCT01035463|593298808|FG000|Overall Study|Other Malignancy|0|||
164254768|NCT01035463|593298809|FG001|Overall Study|Other Malignancy|0|||
164254769|NCT01035463|593298810|FG002|Overall Study|Other Malignancy|0|||
164254770|NCT01035463|593298811|FG003|Overall Study|Other Malignancy|0|||
164254771|NCT01035463|593298812|FG004|Overall Study|Other Malignancy|0|||
164254772|NCT01035463|593298813|FG005|Overall Study|Other Malignancy|2|||
164254773|NCT01035463|593298808|FG000|Overall Study|Other|0|||
164254774|NCT01035463|593298809|FG001|Overall Study|Other|0|||
164254775|NCT01035463|593298810|FG002|Overall Study|Other|0|||
164254776|NCT01035463|593298811|FG003|Overall Study|Other|1|||
164254777|NCT01035463|593298812|FG004|Overall Study|Other|0|||
164254778|NCT01035463|593298813|FG005|Overall Study|Other|2|||
164254779|NCT01126268|593298816|FG000|Overall Study|Adverse Event|1|||
164254780|NCT03425006|593298817|FG000|Overall Study|Withdrawal by Subject|1|||
164254781|NCT03425006|593298817|FG000|Overall Study|Physician Decision|1|||
164254782|NCT03425006|593298817|FG000|Overall Study|Death|1|||
164254783|NCT03748706|593298823|FG000|Overall Study|Lost to Follow-up|1|||
164254784|NCT03070171|593298826|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
164339096|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Death|0|||
164339097|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Death|3|||
164339098|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339099|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339100|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339101|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
164339102|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339103|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339104|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339105|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
164339106|NCT02713204|593617136|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
164339107|NCT02713204|593617137|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
164339108|NCT02713204|593617138|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
164339109|NCT02713204|593617139|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
164254785|NCT03070171|593298827|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
164254786|NCT03070171|593298826|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
164339110|NCT02713204|593617140|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
164254787|NCT03070171|593298827|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
164254788|NCT00610857|593298833|FG000|Overall Study|Not evaluable for response|2|||
164254789|NCT03655054|593298836|FG000|Overall Study|Lost to Follow-up|1|||
164254790|NCT01626118|593298837|FG000|Overall Study|Lack of Efficacy|1|||
164254791|NCT01626118|593298838|FG001|Overall Study|Lack of Efficacy|0|||
164254792|NCT01626118|593298839|FG002|Overall Study|Lack of Efficacy|1|||
164254793|NCT01626118|593298840|FG003|Overall Study|Lack of Efficacy|3|||
164254794|NCT01626118|593298837|FG000|Overall Study|Lost to Follow-up|1|||
164254795|NCT01626118|593298838|FG001|Overall Study|Lost to Follow-up|0|||
164254796|NCT01626118|593298839|FG002|Overall Study|Lost to Follow-up|0|||
164254797|NCT01626118|593298840|FG003|Overall Study|Lost to Follow-up|0|||
164254798|NCT01626118|593298837|FG000|Overall Study|Adverse Event|0|||
164254799|NCT01626118|593298838|FG001|Overall Study|Adverse Event|1|||
164254800|NCT01626118|593298839|FG002|Overall Study|Adverse Event|1|||
164254801|NCT01626118|593298840|FG003|Overall Study|Adverse Event|0|||
164254802|NCT01626118|593298837|FG000|Overall Study|Investigator Decision|0|||
164254803|NCT01626118|593298838|FG001|Overall Study|Investigator Decision|1|||
164254804|NCT01626118|593298839|FG002|Overall Study|Investigator Decision|0|||
164254805|NCT01626118|593298840|FG003|Overall Study|Investigator Decision|0|||
164254806|NCT00002540|593298841|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
164254807|NCT00002540|593298842|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
164254808|NCT00002540|593298841|FG000|Overall Study|Died Before Randomization|2|||
164254809|NCT00002540|593298842|FG001|Overall Study|Died Before Randomization|6|||
164254810|NCT00002540|593298841|FG000|Overall Study|Died Before ASU (Control)|202|||
164254811|NCT00002540|593298842|FG001|Overall Study|Died Before ASU (Control)|0|||
164254812|NCT00002540|593298841|FG000|Overall Study|Refused ASU (Control)|597|||
164254813|NCT00002540|593298842|FG001|Overall Study|Refused ASU (Control)|0|||
164254814|NCT00002540|593298841|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
164254815|NCT00002540|593298842|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
164254816|NCT03931382|593298843|FG000|Overall Study|Equipment malfunction|2|||
164254817|NCT03931382|593298844|FG001|Overall Study|Equipment malfunction|0|||
164254818|NCT03931382|593298845|FG002|Overall Study|Equipment malfunction|2|||
164254819|NCT03931382|593298843|FG000|Overall Study|Withdrawal by Subject|0|||
164254820|NCT03931382|593298844|FG001|Overall Study|Withdrawal by Subject|1|||
164254821|NCT03931382|593298845|FG002|Overall Study|Withdrawal by Subject|0|||
164254822|NCT02151903|593298846|FG000|Overall Study|Withdrawal by Subject|1|||
164254823|NCT02151903|593298847|FG001|Overall Study|Withdrawal by Subject|0|||
164254824|NCT02151903|593298846|FG000|Overall Study|Progressive disease|2|||
164254825|NCT02151903|593298847|FG001|Overall Study|Progressive disease|1|||
164254826|NCT01864148|593298848|FG000|Overall Study|Other|2|||
164254827|NCT01864148|593298849|FG001|Overall Study|Other|1|||
164254828|NCT01864148|593298850|FG002|Overall Study|Other|1|||
164254829|NCT01864148|593298851|FG003|Overall Study|Other|3|||
164254830|NCT01864148|593298852|FG004|Overall Study|Other|1|||
164254831|NCT01864148|593298848|FG000|Overall Study|Death|0|||
164254832|NCT01864148|593298849|FG001|Overall Study|Death|0|||
164254833|NCT01864148|593298850|FG002|Overall Study|Death|0|||
164254834|NCT01864148|593298851|FG003|Overall Study|Death|1|||
164254835|NCT01864148|593298852|FG004|Overall Study|Death|0|||
164254836|NCT01864148|593298848|FG000|Overall Study|Investigator Decision|5|||
164254837|NCT01864148|593298849|FG001|Overall Study|Investigator Decision|0|||
164254838|NCT01864148|593298850|FG002|Overall Study|Investigator Decision|0|||
164254839|NCT01864148|593298851|FG003|Overall Study|Investigator Decision|4|||
164254840|NCT01864148|593298852|FG004|Overall Study|Investigator Decision|6|||
164254841|NCT01864148|593298848|FG000|Overall Study|Withdrawal by Subject|9|||
164254842|NCT01864148|593298849|FG001|Overall Study|Withdrawal by Subject|2|||
164254843|NCT01864148|593298850|FG002|Overall Study|Withdrawal by Subject|6|||
164254844|NCT01864148|593298851|FG003|Overall Study|Withdrawal by Subject|8|||
164254845|NCT01864148|593298852|FG004|Overall Study|Withdrawal by Subject|8|||
164254846|NCT01864148|593298848|FG000|Overall Study|Lost to Follow-up|0|||
164254847|NCT01864148|593298849|FG001|Overall Study|Lost to Follow-up|0|||
164254848|NCT01864148|593298850|FG002|Overall Study|Lost to Follow-up|0|||
164254849|NCT01864148|593298851|FG003|Overall Study|Lost to Follow-up|2|||
164254850|NCT01864148|593298852|FG004|Overall Study|Lost to Follow-up|1|||
164254851|NCT01864148|593298848|FG000|Overall Study|Adverse Event|4|||
164254852|NCT01864148|593298849|FG001|Overall Study|Adverse Event|2|||
164254853|NCT01864148|593298850|FG002|Overall Study|Adverse Event|4|||
164254854|NCT01864148|593298851|FG003|Overall Study|Adverse Event|7|||
164254855|NCT01864148|593298852|FG004|Overall Study|Adverse Event|7|||
164254856|NCT01864148|593298848|FG000|Overall Study|Not Dosed|0|||
164254857|NCT01864148|593298849|FG001|Overall Study|Not Dosed|0|||
164254858|NCT01864148|593298850|FG002|Overall Study|Not Dosed|0|||
164254859|NCT01864148|593298851|FG003|Overall Study|Not Dosed|1|||
164254860|NCT01864148|593298852|FG004|Overall Study|Not Dosed|0|||
164254861|NCT01500252|593298855|FG000|Overall Study|Death|4|||
164254862|NCT01500252|593298856|FG001|Overall Study|Death|2|||
164254863|NCT01500252|593298855|FG000|Overall Study|Lost to Follow-up|5|||
164254864|NCT01500252|593298856|FG001|Overall Study|Lost to Follow-up|4|||
164254865|NCT00778375|593298857|FG000|Overall Study|Ineligible|3|||
164254866|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
164254867|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
164254868|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
164254869|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
164254870|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
164254871|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
164254872|NCT03490292|593298858|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
164254873|NCT03490292|593298859|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
164254874|NCT03490292|593298858|FG000|1 Year Follow Up Post Last Dose|Death|1|||
164254875|NCT03490292|593298859|FG001|1 Year Follow Up Post Last Dose|Death|1|||
164254876|NCT06003777|593298860|FG000|Period 1|Adverse Event|0|||
164254877|NCT06003777|593298861|FG001|Period 1|Adverse Event|0|||
164254878|NCT06003777|593298862|FG002|Period 1|Adverse Event|1|||
164254879|NCT06003777|593298863|FG003|Period 1|Adverse Event|0|||
164254880|NCT06003777|593298864|FG004|Period 1|Adverse Event|0|||
164254881|NCT06003777|593298865|FG005|Period 1|Adverse Event|0|||
164254882|NCT06003777|593298866|FG006|Period 1|Adverse Event|0|||
164254883|NCT06003777|593298867|FG007|Period 1|Adverse Event|0|||
164254884|NCT06003777|593298868|FG008|Period 1|Adverse Event|0|||
164254885|NCT06003777|593298869|FG009|Period 1|Adverse Event|0|||
164254886|NCT06003777|593298870|FG010|Period 1|Adverse Event|0|||
164254887|NCT06003777|593298871|FG011|Period 1|Adverse Event|0|||
164254888|NCT06003777|593298860|FG000|Period 1|Withdrawal by Subject|0|||
164254889|NCT06003777|593298861|FG001|Period 1|Withdrawal by Subject|0|||
164254890|NCT06003777|593298862|FG002|Period 1|Withdrawal by Subject|0|||
164254891|NCT06003777|593298863|FG003|Period 1|Withdrawal by Subject|0|||
164254892|NCT06003777|593298864|FG004|Period 1|Withdrawal by Subject|1|||
164254893|NCT06003777|593298865|FG005|Period 1|Withdrawal by Subject|0|||
164254894|NCT06003777|593298866|FG006|Period 1|Withdrawal by Subject|0|||
164254895|NCT06003777|593298867|FG007|Period 1|Withdrawal by Subject|0|||
164254896|NCT06003777|593298868|FG008|Period 1|Withdrawal by Subject|0|||
164254897|NCT06003777|593298869|FG009|Period 1|Withdrawal by Subject|0|||
164254898|NCT06003777|593298870|FG010|Period 1|Withdrawal by Subject|0|||
164254899|NCT06003777|593298871|FG011|Period 1|Withdrawal by Subject|0|||
164254900|NCT06003777|593298860|FG000|Period 2|Withdrawal by Subject|0|||
164254901|NCT06003777|593298861|FG001|Period 2|Withdrawal by Subject|0|||
164254902|NCT06003777|593298862|FG002|Period 2|Withdrawal by Subject|0|||
164254903|NCT06003777|593298863|FG003|Period 2|Withdrawal by Subject|0|||
164254904|NCT06003777|593298864|FG004|Period 2|Withdrawal by Subject|0|||
164254905|NCT06003777|593298865|FG005|Period 2|Withdrawal by Subject|0|||
164254906|NCT06003777|593298866|FG006|Period 2|Withdrawal by Subject|0|||
164254907|NCT06003777|593298867|FG007|Period 2|Withdrawal by Subject|0|||
164254908|NCT06003777|593298868|FG008|Period 2|Withdrawal by Subject|1|||
164254909|NCT06003777|593298869|FG009|Period 2|Withdrawal by Subject|0|||
164254910|NCT06003777|593298870|FG010|Period 2|Withdrawal by Subject|0|||
164254911|NCT06003777|593298871|FG011|Period 2|Withdrawal by Subject|0|||
164254912|NCT06003777|593298860|FG000|Period 3|Adverse Event|0|||
164254913|NCT06003777|593298861|FG001|Period 3|Adverse Event|0|||
164254914|NCT06003777|593298862|FG002|Period 3|Adverse Event|0|||
164254915|NCT06003777|593298863|FG003|Period 3|Adverse Event|0|||
164254916|NCT06003777|593298864|FG004|Period 3|Adverse Event|0|||
164254917|NCT06003777|593298865|FG005|Period 3|Adverse Event|0|||
164254918|NCT06003777|593298866|FG006|Period 3|Adverse Event|1|||
164254919|NCT06003777|593298867|FG007|Period 3|Adverse Event|0|||
164254920|NCT06003777|593298868|FG008|Period 3|Adverse Event|0|||
164254921|NCT06003777|593298869|FG009|Period 3|Adverse Event|0|||
164254922|NCT06003777|593298870|FG010|Period 3|Adverse Event|0|||
164254923|NCT06003777|593298871|FG011|Period 3|Adverse Event|0|||
164254924|NCT06003777|593298860|FG000|Period 4|No longer met eligibility criteria|0|||
164254925|NCT06003777|593298861|FG001|Period 4|No longer met eligibility criteria|0|||
164254926|NCT06003777|593298862|FG002|Period 4|No longer met eligibility criteria|1|||
164254927|NCT06003777|593298863|FG003|Period 4|No longer met eligibility criteria|0|||
164254928|NCT06003777|593298864|FG004|Period 4|No longer met eligibility criteria|0|||
164254929|NCT06003777|593298865|FG005|Period 4|No longer met eligibility criteria|0|||
164254930|NCT06003777|593298866|FG006|Period 4|No longer met eligibility criteria|0|||
164254931|NCT06003777|593298867|FG007|Period 4|No longer met eligibility criteria|0|||
164254932|NCT06003777|593298868|FG008|Period 4|No longer met eligibility criteria|0|||
164254933|NCT06003777|593298869|FG009|Period 4|No longer met eligibility criteria|0|||
164254934|NCT06003777|593298870|FG010|Period 4|No longer met eligibility criteria|0|||
164254935|NCT06003777|593298871|FG011|Period 4|No longer met eligibility criteria|0|||
164254936|NCT06003777|593298860|FG000|Period 4|Withdrawal by Subject|0|||
164254937|NCT06003777|593298861|FG001|Period 4|Withdrawal by Subject|1|||
164254938|NCT06003777|593298862|FG002|Period 4|Withdrawal by Subject|0|||
164254939|NCT06003777|593298863|FG003|Period 4|Withdrawal by Subject|0|||
164254940|NCT06003777|593298864|FG004|Period 4|Withdrawal by Subject|0|||
164254941|NCT06003777|593298865|FG005|Period 4|Withdrawal by Subject|0|||
164254942|NCT06003777|593298866|FG006|Period 4|Withdrawal by Subject|0|||
164254943|NCT06003777|593298867|FG007|Period 4|Withdrawal by Subject|0|||
164254944|NCT06003777|593298868|FG008|Period 4|Withdrawal by Subject|0|||
164254945|NCT06003777|593298869|FG009|Period 4|Withdrawal by Subject|0|||
164254946|NCT06003777|593298870|FG010|Period 4|Withdrawal by Subject|0|||
164254947|NCT06003777|593298871|FG011|Period 4|Withdrawal by Subject|0|||
164254948|NCT00712725|593298876|FG000|Overall Study|Adverse Event|1|||
164254949|NCT00712725|593298877|FG001|Overall Study|Adverse Event|0|||
164254950|NCT00712725|593298878|FG002|Overall Study|Adverse Event|0|||
164254951|NCT00712725|593298879|FG003|Overall Study|Adverse Event|1|||
164254952|NCT00712725|593298880|FG004|Overall Study|Adverse Event|0|||
164254953|NCT00712725|593298881|FG005|Overall Study|Adverse Event|0|||
164254954|NCT00712725|593298882|FG006|Overall Study|Adverse Event|0|||
164254955|NCT00712725|593298883|FG007|Overall Study|Adverse Event|0|||
164254956|NCT00712725|593298876|FG000|Overall Study|Lost to Follow-up|3|||
164254957|NCT00712725|593298877|FG001|Overall Study|Lost to Follow-up|2|||
164254958|NCT00712725|593298878|FG002|Overall Study|Lost to Follow-up|1|||
164254959|NCT00712725|593298879|FG003|Overall Study|Lost to Follow-up|1|||
164254960|NCT00712725|593298880|FG004|Overall Study|Lost to Follow-up|2|||
164254961|NCT00712725|593298881|FG005|Overall Study|Lost to Follow-up|2|||
164254962|NCT00712725|593298882|FG006|Overall Study|Lost to Follow-up|3|||
164254963|NCT00712725|593298883|FG007|Overall Study|Lost to Follow-up|1|||
164254964|NCT00712725|593298876|FG000|Overall Study|Physician Decision|2|||
164254965|NCT00712725|593298877|FG001|Overall Study|Physician Decision|0|||
164254966|NCT00712725|593298878|FG002|Overall Study|Physician Decision|0|||
164254967|NCT00712725|593298879|FG003|Overall Study|Physician Decision|0|||
164254968|NCT00712725|593298880|FG004|Overall Study|Physician Decision|1|||
164254969|NCT00712725|593298881|FG005|Overall Study|Physician Decision|0|||
164254970|NCT00712725|593298882|FG006|Overall Study|Physician Decision|2|||
164254971|NCT00712725|593298883|FG007|Overall Study|Physician Decision|0|||
164254972|NCT00712725|593298876|FG000|Overall Study|Pregnancy|0|||
164254973|NCT00712725|593298877|FG001|Overall Study|Pregnancy|1|||
164254974|NCT00712725|593298878|FG002|Overall Study|Pregnancy|0|||
164254975|NCT00712725|593298879|FG003|Overall Study|Pregnancy|0|||
164254976|NCT00712725|593298880|FG004|Overall Study|Pregnancy|1|||
164254977|NCT00712725|593298881|FG005|Overall Study|Pregnancy|0|||
164254978|NCT00712725|593298882|FG006|Overall Study|Pregnancy|2|||
164254979|NCT00712725|593298883|FG007|Overall Study|Pregnancy|0|||
164254980|NCT00712725|593298876|FG000|Overall Study|Protocol Violation|2|||
164254981|NCT00712725|593298877|FG001|Overall Study|Protocol Violation|0|||
164254982|NCT00712725|593298878|FG002|Overall Study|Protocol Violation|1|||
164254983|NCT00712725|593298879|FG003|Overall Study|Protocol Violation|3|||
164254984|NCT00712725|593298880|FG004|Overall Study|Protocol Violation|2|||
164254985|NCT00712725|593298881|FG005|Overall Study|Protocol Violation|0|||
164254986|NCT00712725|593298882|FG006|Overall Study|Protocol Violation|1|||
164254987|NCT00712725|593298883|FG007|Overall Study|Protocol Violation|1|||
164339111|NCT02713204|593617141|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
164339112|NCT02713204|593617142|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
164339113|NCT02713204|593617143|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
164339114|NCT00474760|593617147|FG000|Overall Study|Death|0|||
164339115|NCT00474760|593617148|FG001|Overall Study|Death|0|||
164339116|NCT00474760|593617149|FG002|Overall Study|Death|0|||
164254988|NCT00712725|593298876|FG000|Overall Study|Withdrawal by Subject|2|||
164254989|NCT00712725|593298877|FG001|Overall Study|Withdrawal by Subject|1|||
164254990|NCT00712725|593298878|FG002|Overall Study|Withdrawal by Subject|1|||
164254991|NCT00712725|593298879|FG003|Overall Study|Withdrawal by Subject|2|||
164254992|NCT00712725|593298880|FG004|Overall Study|Withdrawal by Subject|1|||
164254993|NCT00712725|593298881|FG005|Overall Study|Withdrawal by Subject|1|||
164254994|NCT00712725|593298882|FG006|Overall Study|Withdrawal by Subject|1|||
164254995|NCT00712725|593298883|FG007|Overall Study|Withdrawal by Subject|2|||
164339117|NCT00474760|593617150|FG003|Overall Study|Death|0|||
164254996|NCT00712725|593298876|FG000|Overall Study|Lack of Qualifying Event|16|||
164254997|NCT00712725|593298877|FG001|Overall Study|Lack of Qualifying Event|2|||
164254998|NCT00712725|593298878|FG002|Overall Study|Lack of Qualifying Event|6|||
164254999|NCT00712725|593298879|FG003|Overall Study|Lack of Qualifying Event|8|||
164255000|NCT00712725|593298880|FG004|Overall Study|Lack of Qualifying Event|11|||
164339118|NCT00474760|593617151|FG004|Overall Study|Death|2|||
164339119|NCT00474760|593617152|FG005|Overall Study|Death|0|||
164339120|NCT00474760|593617153|FG006|Overall Study|Death|0|||
164255001|NCT00712725|593298881|FG005|Overall Study|Lack of Qualifying Event|13|||
164255002|NCT00712725|593298882|FG006|Overall Study|Lack of Qualifying Event|11|||
164255003|NCT00712725|593298883|FG007|Overall Study|Lack of Qualifying Event|6|||
164255004|NCT00712725|593298876|FG000|Overall Study|Protocol Specified Criteria|3|||
164255005|NCT00712725|593298877|FG001|Overall Study|Protocol Specified Criteria|0|||
164255006|NCT00712725|593298878|FG002|Overall Study|Protocol Specified Criteria|1|||
164255007|NCT00712725|593298879|FG003|Overall Study|Protocol Specified Criteria|2|||
164255008|NCT00712725|593298880|FG004|Overall Study|Protocol Specified Criteria|1|||
164255009|NCT00712725|593298881|FG005|Overall Study|Protocol Specified Criteria|0|||
164255010|NCT00712725|593298882|FG006|Overall Study|Protocol Specified Criteria|2|||
164255011|NCT00712725|593298883|FG007|Overall Study|Protocol Specified Criteria|1|||
164255012|NCT00582712|593298890|FG000|Overall Study|Adverse Event|1|||
164255013|NCT00582712|593298890|FG000|Overall Study|Lack of Efficacy|1|||
164255014|NCT00582712|593298890|FG000|Overall Study|Withdrawal by Subject|1|||
164255015|NCT00582712|593298890|FG000|Overall Study|Complicating disease requiring treatment|1|||
164255016|NCT01901289|593298891|FG000|Overall Study|Death|32|||
164255017|NCT01901289|593298891|FG000|Overall Study|Lost to Follow-up|16|||
164255018|NCT01901289|593298891|FG000|Overall Study|Withdrawal by Subject|35|||
164255019|NCT01901289|593298891|FG000|Overall Study|Other type of endpoint met|2|||
164255020|NCT00700882|593298898|FG000|Overall Study|Never received treatment|6|||
164255021|NCT00700882|593298898|FG000|Overall Study|Ineligible|2|||
164255022|NCT00700882|593298898|FG000|Overall Study|No KIT mutation|51|||
164255023|NCT01606176|593298899|FG000|Overall Study|Adverse Event|2|||
164255024|NCT01606176|593298900|FG001|Overall Study|Adverse Event|3|||
164255025|NCT01606176|593298899|FG000|Overall Study|Disease progression|1|||
164255026|NCT01606176|593298900|FG001|Overall Study|Disease progression|0|||
164255027|NCT01606176|593298899|FG000|Overall Study|Withdrawal by Subject|1|||
164255028|NCT01606176|593298900|FG001|Overall Study|Withdrawal by Subject|0|||
164255029|NCT01818258|593298902|FG000|Overall Study|Death|3|||
164255030|NCT01818258|593298903|FG001|Overall Study|Death|0|||
164255031|NCT01818258|593298902|FG000|Overall Study|Withdrawal by Subject|0|||
164255032|NCT01818258|593298903|FG001|Overall Study|Withdrawal by Subject|1|||
164255033|NCT01818258|593298902|FG000|Overall Study|Lost to Follow-up|0|||
164255034|NCT01818258|593298903|FG001|Overall Study|Lost to Follow-up|1|||
164255035|NCT01818258|593298902|FG000|Overall Study|Unable to Travel to Clinic|0|||
164255036|NCT01818258|593298903|FG001|Overall Study|Unable to Travel to Clinic|1|||
164255037|NCT02839720|593298904|FG000|Overall Study|Adverse Event|2|||
164255038|NCT02839720|593298904|FG000|Overall Study|Non-compliance|2|||
164255039|NCT02839720|593298904|FG000|Overall Study|Intercurrent Illness|1|||
164255040|NCT02839720|593298904|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
164255041|NCT00107900|593298907|FG000|Overall Study|Adverse Event|3|||
164255042|NCT00107900|593298908|FG001|Overall Study|Adverse Event|2|||
164255043|NCT00107900|593298909|FG002|Overall Study|Adverse Event|10|||
164255044|NCT00107900|593298910|FG003|Overall Study|Adverse Event|3|||
164255045|NCT00107900|593298911|FG004|Overall Study|Adverse Event|5|||
164255046|NCT00107900|593298912|FG005|Overall Study|Adverse Event|3|||
164255047|NCT00107900|593298907|FG000|Overall Study|Death|0|||
164255048|NCT00107900|593298908|FG001|Overall Study|Death|0|||
164255049|NCT00107900|593298909|FG002|Overall Study|Death|0|||
164084694|NCT00585351|592673982|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
164255050|NCT00107900|593298910|FG003|Overall Study|Death|0|||
164255051|NCT00107900|593298911|FG004|Overall Study|Death|1|||
164255052|NCT00107900|593298912|FG005|Overall Study|Death|0|||
164255053|NCT00107900|593298907|FG000|Overall Study|Lost to Follow-up|4|||
164255054|NCT00107900|593298908|FG001|Overall Study|Lost to Follow-up|1|||
164255055|NCT00107900|593298909|FG002|Overall Study|Lost to Follow-up|3|||
164255056|NCT00107900|593298910|FG003|Overall Study|Lost to Follow-up|2|||
164255057|NCT00107900|593298911|FG004|Overall Study|Lost to Follow-up|5|||
164255058|NCT00107900|593298912|FG005|Overall Study|Lost to Follow-up|5|||
164255059|NCT00107900|593298907|FG000|Overall Study|Protocol Violation|1|||
164255060|NCT00107900|593298908|FG001|Overall Study|Protocol Violation|0|||
164255061|NCT00107900|593298909|FG002|Overall Study|Protocol Violation|5|||
164255062|NCT00107900|593298910|FG003|Overall Study|Protocol Violation|5|||
164255063|NCT00107900|593298911|FG004|Overall Study|Protocol Violation|7|||
164255064|NCT00107900|593298912|FG005|Overall Study|Protocol Violation|0|||
164255065|NCT00107900|593298907|FG000|Overall Study|Withdrawal by Subject|1|||
164255066|NCT00107900|593298908|FG001|Overall Study|Withdrawal by Subject|0|||
164255067|NCT00107900|593298909|FG002|Overall Study|Withdrawal by Subject|5|||
164255068|NCT00107900|593298910|FG003|Overall Study|Withdrawal by Subject|0|||
164255069|NCT00107900|593298911|FG004|Overall Study|Withdrawal by Subject|1|||
164255070|NCT00107900|593298912|FG005|Overall Study|Withdrawal by Subject|1|||
164255071|NCT00107900|593298907|FG000|Overall Study|Administrative Reasons|1|||
164255072|NCT00107900|593298908|FG001|Overall Study|Administrative Reasons|0|||
164255073|NCT00107900|593298909|FG002|Overall Study|Administrative Reasons|2|||
164255074|NCT00107900|593298910|FG003|Overall Study|Administrative Reasons|2|||
164255075|NCT00107900|593298911|FG004|Overall Study|Administrative Reasons|2|||
164255076|NCT00107900|593298912|FG005|Overall Study|Administrative Reasons|0|||
164255077|NCT03100539|593302225|FG000|Overall Study|Lost to Follow-up|60|||
164255078|NCT03100539|593302226|FG001|Overall Study|Lost to Follow-up|54|||
164255079|NCT03100539|593302227|FG002|Overall Study|Lost to Follow-up|17|||
164255080|NCT03100539|593302225|FG000|Overall Study|Uncollected|8|||
164255081|NCT03100539|593302226|FG001|Overall Study|Uncollected|8|||
164255082|NCT03100539|593302227|FG002|Overall Study|Uncollected|0|||
164255083|NCT03100539|593302225|FG000|Overall Study|Ally Health|0|||
164255084|NCT03100539|593302226|FG001|Overall Study|Ally Health|0|||
164255085|NCT03100539|593302227|FG002|Overall Study|Ally Health|3|||
164255086|NCT03100539|593302225|FG000|Overall Study|Disinterest|0|||
164255087|NCT03100539|593302226|FG001|Overall Study|Disinterest|0|||
164255088|NCT03100539|593302227|FG002|Overall Study|Disinterest|22|||
164255089|NCT03100539|593302225|FG000|Overall Study|Veteran Health|0|||
164255090|NCT03100539|593302226|FG001|Overall Study|Veteran Health|0|||
164255091|NCT03100539|593302227|FG002|Overall Study|Veteran Health|8|||
164255092|NCT03100539|593302225|FG000|Overall Study|Moved|0|||
164255093|NCT03100539|593302226|FG001|Overall Study|Moved|0|||
164255094|NCT03100539|593302227|FG002|Overall Study|Moved|1|||
163887554|NCT05808257|591959441|FG000|Overall Study|Lost to Follow-up|8|||
163887555|NCT05808257|591959442|FG001|Overall Study|Lost to Follow-up|8|||
163887556|NCT04568486|591959443|FG000|Overall Study|Withdrawal by Subject|26|||
163887557|NCT04568486|591959443|FG000|Overall Study|Lost to Follow-up|7|||
163887558|NCT04042233|591959444|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
163887559|NCT04042233|591959445|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
163887560|NCT04042233|591959444|FG000|Overall Study|Protocol Violation|0|||
163887561|NCT04042233|591959445|FG001|Overall Study|Protocol Violation|2|||
163887562|NCT04907851|591959448|FG000|Overall Study|Consent withdrawn|1|||
163887563|NCT04907851|591959449|FG001|Overall Study|Consent withdrawn|2|||
163887564|NCT04907851|591959450|FG002|Overall Study|Consent withdrawn|0|||
163887565|NCT04907851|591959448|FG000|Overall Study|Death|5|||
163887566|NCT04907851|591959449|FG001|Overall Study|Death|15|||
163887567|NCT04907851|591959450|FG002|Overall Study|Death|10|||
163887568|NCT05281562|591959453|FG000|Overall Study|Ineligible patient|1|||
163887569|NCT05281562|591959454|FG001|Overall Study|Ineligible patient|0|||
163887570|NCT00324805|591959460|FG000|Overall Study|Adverse Event|62|||
163887571|NCT00324805|591959461|FG001|Overall Study|Adverse Event|203|||
163887572|NCT00324805|591959460|FG000|Overall Study|Progression|7|||
163887573|NCT00324805|591959461|FG001|Overall Study|Progression|35|||
163887574|NCT00324805|591959460|FG000|Overall Study|Withdrawal by Subject|51|||
163887575|NCT00324805|591959461|FG001|Overall Study|Withdrawal by Subject|174|||
163887576|NCT00324805|591959460|FG000|Overall Study|Death|6|||
163887577|NCT00324805|591959461|FG001|Overall Study|Death|9|||
163887578|NCT00324805|591959460|FG000|Overall Study|Alternative therapy|4|||
163887579|NCT00324805|591959461|FG001|Overall Study|Alternative therapy|8|||
163887580|NCT00324805|591959460|FG000|Overall Study|Other complicating disease|1|||
163887581|NCT00324805|591959461|FG001|Overall Study|Other complicating disease|9|||
163887582|NCT00324805|591959460|FG000|Overall Study|Other reasons|7|||
163887583|NCT00324805|591959461|FG001|Overall Study|Other reasons|26|||
163887584|NCT00324805|591959460|FG000|Overall Study|Other|0|||
164255095|NCT03100539|593302225|FG000|Overall Study|Scheduling Conflicts|0|||
164255096|NCT03100539|593302226|FG001|Overall Study|Scheduling Conflicts|0|||
164255097|NCT03100539|593302227|FG002|Overall Study|Scheduling Conflicts|12|||
164255098|NCT02596958|593302237|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
164255099|NCT02596958|593302237|FG000|Overall Study|Cancer Progression|441|||
164255100|NCT02596958|593302237|FG000|Overall Study|Death From Cancer|112|||
164255101|NCT02596958|593302237|FG000|Overall Study|Death From Other Cause|33|||
164255102|NCT02596958|593302237|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
164255103|NCT02596958|593302237|FG000|Overall Study|Administrative Reasons/Other|231|||
164255104|NCT02596958|593302237|FG000|Overall Study|Lost to Follow-up|33|||
164255105|NCT02596958|593302237|FG000|Overall Study|Missing|32|||
164255106|NCT02596958|593302237|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
164255107|NCT00983515|593302238|FG000|Ritonavir Alone|liver panel out of range|6|||
164255108|NCT00983515|593302238|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
164255109|NCT01995669|593302239|FG000|Overall Study|Progression|2|||
164255110|NCT01995669|593302240|FG001|Overall Study|Progression|1|||
164255111|NCT01995669|593302241|FG002|Overall Study|Progression|1|||
164255112|NCT01995669|593302242|FG003|Overall Study|Progression|13|||
164255113|NCT01995669|593302239|FG000|Overall Study|Adverse Event|0|||
164255114|NCT01995669|593302240|FG001|Overall Study|Adverse Event|0|||
164255115|NCT01995669|593302241|FG002|Overall Study|Adverse Event|0|||
164255116|NCT01995669|593302242|FG003|Overall Study|Adverse Event|3|||
164255117|NCT01995669|593302239|FG000|Overall Study|Death|0|||
164255118|NCT01995669|593302240|FG001|Overall Study|Death|0|||
164255119|NCT01995669|593302241|FG002|Overall Study|Death|0|||
164255120|NCT01995669|593302242|FG003|Overall Study|Death|6|||
164255121|NCT01995669|593302239|FG000|Overall Study|Withdrawal by Subject|0|||
164255122|NCT01995669|593302240|FG001|Overall Study|Withdrawal by Subject|0|||
164255123|NCT01995669|593302241|FG002|Overall Study|Withdrawal by Subject|0|||
164255124|NCT01995669|593302242|FG003|Overall Study|Withdrawal by Subject|6|||
164255125|NCT01995669|593302239|FG000|Overall Study|Insurance Expired|0|||
164255126|NCT01995669|593302240|FG001|Overall Study|Insurance Expired|0|||
164255127|NCT01995669|593302241|FG002|Overall Study|Insurance Expired|0|||
164255128|NCT01995669|593302242|FG003|Overall Study|Insurance Expired|1|||
164255129|NCT04753658|593302243|FG000|Overall Study|Progressive disease|7|||
164255130|NCT04753658|593302243|FG000|Overall Study|Other|7|||
164255131|NCT04753658|593302243|FG000|Overall Study|Adverse Event|1|||
164255132|NCT05659719|593302244|FG000|Overall Study|At sponsor's request|0|||
164255133|NCT05659719|593302245|FG001|Overall Study|At sponsor's request|0|||
164255134|NCT05659719|593302246|FG002|Overall Study|At sponsor's request|0|||
164255135|NCT05659719|593302247|FG003|Overall Study|At sponsor's request|95|||
164255136|NCT05659719|593302244|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
164255137|NCT05659719|593302245|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
164255138|NCT05659719|593302246|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
164255139|NCT05659719|593302247|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
164255140|NCT05659719|593302244|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
164255141|NCT05659719|593302245|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
164255142|NCT05659719|593302246|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
164255143|NCT05659719|593302247|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
164255144|NCT05659719|593302244|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
164255145|NCT05659719|593302245|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
164255146|NCT05659719|593302246|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
164255147|NCT05659719|593302247|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
164255148|NCT05659719|593302244|FG000|Overall Study|Lost to Follow-up|0|||
164255149|NCT05659719|593302245|FG001|Overall Study|Lost to Follow-up|0|||
164255150|NCT05659719|593302246|FG002|Overall Study|Lost to Follow-up|0|||
164255151|NCT05659719|593302247|FG003|Overall Study|Lost to Follow-up|2|||
164255152|NCT05659719|593302244|FG000|Overall Study|Moved to another observational study|0|||
164255153|NCT05659719|593302245|FG001|Overall Study|Moved to another observational study|0|||
164255154|NCT05659719|593302246|FG002|Overall Study|Moved to another observational study|0|||
164255155|NCT05659719|593302247|FG003|Overall Study|Moved to another observational study|1|||
164255156|NCT05659719|593302244|FG000|Overall Study|The child was enrolled in an interventional study|0|||
164255157|NCT05659719|593302245|FG001|Overall Study|The child was enrolled in an interventional study|0|||
164255158|NCT05659719|593302246|FG002|Overall Study|The child was enrolled in an interventional study|0|||
163887585|NCT00324805|591959461|FG001|Overall Study|Other|2|||
163887586|NCT00324805|591959460|FG000|Overall Study|Did not start therapy|12|||
163887587|NCT00324805|591959461|FG001|Overall Study|Did not start therapy|17|||
163887588|NCT05792085|591959463|FG000|Overall Study|Death|0|||
163887589|NCT05792085|591959464|FG001|Overall Study|Death|0|||
163887590|NCT05792085|591959465|FG002|Overall Study|Death|0|||
163887591|NCT05792085|591959466|FG003|Overall Study|Death|0|||
163887592|NCT05792085|591959467|FG004|Overall Study|Death|1|||
163887593|NCT04524442|591959470|FG000|Overall Study|Subject Decision|1|||
163887594|NCT03819153|591959471|FG000|Overall Study|Withdrawal by Subject|20|||
164084695|NCT00192296|592673983|FG000|Overall Study|Withdrawal by Subject|0|||
164255159|NCT05659719|593302247|FG003|Overall Study|The child was enrolled in an interventional study|55|||
164255160|NCT05659719|593302244|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
163887595|NCT03819153|591959472|FG001|Overall Study|Withdrawal by Subject|28|||
164255161|NCT05659719|593302245|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
164255162|NCT05659719|593302246|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
164255163|NCT05659719|593302247|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
164255164|NCT05659719|593302244|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
164255165|NCT05659719|593302245|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
164255166|NCT05659719|593302246|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
164255167|NCT05659719|593302247|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
164255168|NCT02290691|593302248|FG000|Overall Study|Noncompliance|0|||
164255169|NCT02290691|593302249|FG001|Overall Study|Noncompliance|1|||
164255170|NCT02290691|593302248|FG000|Overall Study|Withdrawal by Subject|1|||
164255171|NCT02290691|593302249|FG001|Overall Study|Withdrawal by Subject|1|||
164255172|NCT02290691|593302248|FG000|Overall Study|Lost to Follow-up|7|||
164255173|NCT02290691|593302249|FG001|Overall Study|Lost to Follow-up|7|||
164255174|NCT00185380|593302251|FG000|Overall Study|Adverse Event|41|||
164255175|NCT00185380|593302252|FG001|Overall Study|Adverse Event|43|||
164255176|NCT00185380|593302253|FG002|Overall Study|Adverse Event|48|||
164255177|NCT00185380|593302251|FG000|Overall Study|Lost to Follow-up|0|||
164255178|NCT00185380|593302252|FG001|Overall Study|Lost to Follow-up|4|||
164255179|NCT00185380|593302253|FG002|Overall Study|Lost to Follow-up|3|||
164255180|NCT00185380|593302251|FG000|Overall Study|Pregnancy|1|||
164255181|NCT00185380|593302252|FG001|Overall Study|Pregnancy|4|||
164255182|NCT00185380|593302253|FG002|Overall Study|Pregnancy|0|||
164255183|NCT00185380|593302251|FG000|Overall Study|Protocol Violation|2|||
164255184|NCT00185380|593302252|FG001|Overall Study|Protocol Violation|2|||
164255185|NCT00185380|593302253|FG002|Overall Study|Protocol Violation|1|||
164255186|NCT00185380|593302251|FG000|Overall Study|Withdrawal by Subject|1|||
164255187|NCT00185380|593302252|FG001|Overall Study|Withdrawal by Subject|2|||
164255188|NCT00185380|593302253|FG002|Overall Study|Withdrawal by Subject|0|||
164255189|NCT00185380|593302251|FG000|Overall Study|Failed insertion|1|||
164255190|NCT00185380|593302252|FG001|Overall Study|Failed insertion|1|||
164255191|NCT00185380|593302253|FG002|Overall Study|Failed insertion|2|||
164255192|NCT00185380|593302251|FG000|Overall Study|Planned pregnancy|9|||
164255193|NCT00185380|593302252|FG001|Overall Study|Planned pregnancy|12|||
164255194|NCT00185380|593302253|FG002|Overall Study|Planned pregnancy|12|||
164255195|NCT00185380|593302251|FG000|Overall Study|No need for contraception|3|||
164255196|NCT00185380|593302252|FG001|Overall Study|No need for contraception|3|||
164255197|NCT00185380|593302253|FG002|Overall Study|No need for contraception|3|||
164255198|NCT00185380|593302251|FG000|Overall Study|Could not attend visits|2|||
164255199|NCT00185380|593302252|FG001|Overall Study|Could not attend visits|0|||
164255200|NCT00185380|593302253|FG002|Overall Study|Could not attend visits|4|||
164255201|NCT00185380|593302251|FG000|Overall Study|personal reason|6|||
164255202|NCT00185380|593302252|FG001|Overall Study|personal reason|1|||
164255203|NCT00185380|593302253|FG002|Overall Study|personal reason|1|||
164255204|NCT00218634|593302254|FG000|Overall Study|Lost to Follow-up|8|||
164255205|NCT00218634|593302255|FG001|Overall Study|Lost to Follow-up|15|||
164255206|NCT02589665|593302256|FG000|Induction Period|Did not receive drug|0|||
164255207|NCT02589665|593302257|FG001|Induction Period|Did not receive drug|0|||
164255208|NCT02589665|593302258|FG002|Induction Period|Did not receive drug|0|||
164255209|NCT02589665|593302259|FG003|Induction Period|Did not receive drug|1|||
164255210|NCT02589665|593302260|FG004|Induction Period|Did not receive drug|0|||
164255211|NCT02589665|593302261|FG005|Induction Period|Did not receive drug|0|||
164255212|NCT02589665|593302262|FG006|Induction Period|Did not receive drug|0|||
164255213|NCT02589665|593302263|FG007|Induction Period|Did not receive drug|0|||
164255214|NCT02589665|593302264|FG008|Induction Period|Did not receive drug|0|||
164255215|NCT02589665|593302265|FG009|Induction Period|Did not receive drug|0|||
164255216|NCT02589665|593302256|FG000|Induction Period|Adverse Event|3|||
164255217|NCT02589665|593302257|FG001|Induction Period|Adverse Event|0|||
164255218|NCT02589665|593302258|FG002|Induction Period|Adverse Event|2|||
164255219|NCT02589665|593302259|FG003|Induction Period|Adverse Event|2|||
164255220|NCT02589665|593302260|FG004|Induction Period|Adverse Event|0|||
164255221|NCT02589665|593302261|FG005|Induction Period|Adverse Event|0|||
164255222|NCT02589665|593302262|FG006|Induction Period|Adverse Event|0|||
164255223|NCT02589665|593302263|FG007|Induction Period|Adverse Event|0|||
164255224|NCT02589665|593302264|FG008|Induction Period|Adverse Event|0|||
164255225|NCT02589665|593302265|FG009|Induction Period|Adverse Event|0|||
164255226|NCT02589665|593302256|FG000|Induction Period|Withdrawal by Subject|0|||
164255227|NCT02589665|593302257|FG001|Induction Period|Withdrawal by Subject|1|||
164255228|NCT02589665|593302258|FG002|Induction Period|Withdrawal by Subject|0|||
164255229|NCT02589665|593302259|FG003|Induction Period|Withdrawal by Subject|1|||
164255230|NCT02589665|593302260|FG004|Induction Period|Withdrawal by Subject|0|||
164255231|NCT02589665|593302261|FG005|Induction Period|Withdrawal by Subject|0|||
164255232|NCT02589665|593302262|FG006|Induction Period|Withdrawal by Subject|0|||
164255233|NCT02589665|593302263|FG007|Induction Period|Withdrawal by Subject|0|||
164255234|NCT02589665|593302264|FG008|Induction Period|Withdrawal by Subject|0|||
164255235|NCT02589665|593302265|FG009|Induction Period|Withdrawal by Subject|0|||
164255236|NCT02589665|593302256|FG000|Induction Period|Protocol Violation|0|||
164255237|NCT02589665|593302257|FG001|Induction Period|Protocol Violation|1|||
164255238|NCT02589665|593302258|FG002|Induction Period|Protocol Violation|0|||
164255239|NCT02589665|593302259|FG003|Induction Period|Protocol Violation|0|||
164255240|NCT02589665|593302260|FG004|Induction Period|Protocol Violation|0|||
164255241|NCT02589665|593302261|FG005|Induction Period|Protocol Violation|0|||
164255242|NCT02589665|593302262|FG006|Induction Period|Protocol Violation|0|||
164255243|NCT02589665|593302263|FG007|Induction Period|Protocol Violation|0|||
164255244|NCT02589665|593302264|FG008|Induction Period|Protocol Violation|0|||
164255245|NCT02589665|593302265|FG009|Induction Period|Protocol Violation|0|||
164255246|NCT02589665|593302256|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255247|NCT02589665|593302257|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255248|NCT02589665|593302258|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255249|NCT02589665|593302259|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255250|NCT02589665|593302260|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
164255251|NCT02589665|593302261|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
164255252|NCT02589665|593302262|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
164255253|NCT02589665|593302263|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255254|NCT02589665|593302264|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255255|NCT02589665|593302265|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255256|NCT02589665|593302256|FG000|Maintenance Period|Withdrawal by Subject|0|||
164255257|NCT02589665|593302257|FG001|Maintenance Period|Withdrawal by Subject|0|||
164255258|NCT02589665|593302258|FG002|Maintenance Period|Withdrawal by Subject|0|||
164255259|NCT02589665|593302259|FG003|Maintenance Period|Withdrawal by Subject|0|||
164255260|NCT02589665|593302260|FG004|Maintenance Period|Withdrawal by Subject|4|||
164255261|NCT02589665|593302261|FG005|Maintenance Period|Withdrawal by Subject|2|||
164255262|NCT02589665|593302262|FG006|Maintenance Period|Withdrawal by Subject|4|||
164255263|NCT02589665|593302263|FG007|Maintenance Period|Withdrawal by Subject|0|||
164255264|NCT02589665|593302264|FG008|Maintenance Period|Withdrawal by Subject|0|||
164255265|NCT02589665|593302265|FG009|Maintenance Period|Withdrawal by Subject|0|||
164255266|NCT02589665|593302256|FG000|Maintenance Period|Lack of Efficacy|0|||
164255267|NCT02589665|593302257|FG001|Maintenance Period|Lack of Efficacy|0|||
164255268|NCT02589665|593302258|FG002|Maintenance Period|Lack of Efficacy|0|||
164255269|NCT02589665|593302259|FG003|Maintenance Period|Lack of Efficacy|0|||
164255270|NCT02589665|593302260|FG004|Maintenance Period|Lack of Efficacy|2|||
164255271|NCT02589665|593302261|FG005|Maintenance Period|Lack of Efficacy|1|||
164255272|NCT02589665|593302262|FG006|Maintenance Period|Lack of Efficacy|0|||
164255273|NCT02589665|593302263|FG007|Maintenance Period|Lack of Efficacy|0|||
164255274|NCT02589665|593302264|FG008|Maintenance Period|Lack of Efficacy|0|||
164255275|NCT02589665|593302265|FG009|Maintenance Period|Lack of Efficacy|0|||
164255276|NCT02589665|593302256|FG000|Maintenance Period|Adverse Event|0|||
164255277|NCT02589665|593302257|FG001|Maintenance Period|Adverse Event|0|||
164255278|NCT02589665|593302258|FG002|Maintenance Period|Adverse Event|0|||
164255279|NCT02589665|593302259|FG003|Maintenance Period|Adverse Event|0|||
164255280|NCT02589665|593302260|FG004|Maintenance Period|Adverse Event|0|||
164255281|NCT02589665|593302261|FG005|Maintenance Period|Adverse Event|0|||
164255282|NCT02589665|593302262|FG006|Maintenance Period|Adverse Event|2|||
164255283|NCT02589665|593302263|FG007|Maintenance Period|Adverse Event|0|||
164255284|NCT02589665|593302264|FG008|Maintenance Period|Adverse Event|0|||
164255285|NCT02589665|593302265|FG009|Maintenance Period|Adverse Event|0|||
164255286|NCT02589665|593302256|FG000|Maintenance Period|Lost to Follow-up|0|||
164255287|NCT02589665|593302257|FG001|Maintenance Period|Lost to Follow-up|0|||
164255288|NCT02589665|593302258|FG002|Maintenance Period|Lost to Follow-up|0|||
164255289|NCT02589665|593302259|FG003|Maintenance Period|Lost to Follow-up|0|||
164255290|NCT02589665|593302260|FG004|Maintenance Period|Lost to Follow-up|0|||
164255291|NCT02589665|593302261|FG005|Maintenance Period|Lost to Follow-up|1|||
164255292|NCT02589665|593302262|FG006|Maintenance Period|Lost to Follow-up|0|||
164255293|NCT02589665|593302263|FG007|Maintenance Period|Lost to Follow-up|0|||
164255294|NCT02589665|593302264|FG008|Maintenance Period|Lost to Follow-up|0|||
164255295|NCT02589665|593302265|FG009|Maintenance Period|Lost to Follow-up|0|||
164255296|NCT02589665|593302256|FG000|Maintenance Period|Physician Decision|0|||
164255297|NCT02589665|593302257|FG001|Maintenance Period|Physician Decision|0|||
164255298|NCT02589665|593302258|FG002|Maintenance Period|Physician Decision|0|||
164255299|NCT02589665|593302259|FG003|Maintenance Period|Physician Decision|0|||
164255300|NCT02589665|593302260|FG004|Maintenance Period|Physician Decision|0|||
164255301|NCT02589665|593302261|FG005|Maintenance Period|Physician Decision|1|||
164255302|NCT02589665|593302262|FG006|Maintenance Period|Physician Decision|0|||
164255303|NCT02589665|593302263|FG007|Maintenance Period|Physician Decision|0|||
164255304|NCT02589665|593302264|FG008|Maintenance Period|Physician Decision|0|||
164255305|NCT02589665|593302265|FG009|Maintenance Period|Physician Decision|0|||
164084696|NCT00192296|592673984|FG001|Overall Study|Withdrawal by Subject|1|||
164084697|NCT00192296|592673985|FG002|Overall Study|Withdrawal by Subject|0|||
164084698|NCT00192296|592673986|FG003|Overall Study|Withdrawal by Subject|0|||
164084699|NCT02227849|592673991|FG000|Overall Study|Adverse Event|4|||
164084700|NCT02227849|592673991|FG000|Overall Study|Physician Decision|1|||
164084701|NCT02227849|592673991|FG000|Overall Study|Withdrawal by Subject|3|||
164084702|NCT00457665|592673994|FG000|12 Months|Drug allergy|1|||
164255306|NCT02589665|593302256|FG000|Maintenance Period|Reason Not Collected|0|||
164255307|NCT02589665|593302257|FG001|Maintenance Period|Reason Not Collected|0|||
164255308|NCT02589665|593302258|FG002|Maintenance Period|Reason Not Collected|0|||
164255309|NCT02589665|593302259|FG003|Maintenance Period|Reason Not Collected|0|||
164255310|NCT02589665|593302260|FG004|Maintenance Period|Reason Not Collected|0|||
164255311|NCT02589665|593302261|FG005|Maintenance Period|Reason Not Collected|1|||
164255312|NCT02589665|593302262|FG006|Maintenance Period|Reason Not Collected|1|||
164255313|NCT02589665|593302263|FG007|Maintenance Period|Reason Not Collected|0|||
164255314|NCT02589665|593302264|FG008|Maintenance Period|Reason Not Collected|0|||
164255315|NCT02589665|593302265|FG009|Maintenance Period|Reason Not Collected|0|||
164255316|NCT02589665|593302256|FG000|Induction Extension Period|Adverse Event|0|||
164255317|NCT02589665|593302257|FG001|Induction Extension Period|Adverse Event|0|||
164255318|NCT02589665|593302258|FG002|Induction Extension Period|Adverse Event|0|||
164255319|NCT02589665|593302259|FG003|Induction Extension Period|Adverse Event|0|||
164255320|NCT02589665|593302260|FG004|Induction Extension Period|Adverse Event|0|||
164255321|NCT02589665|593302261|FG005|Induction Extension Period|Adverse Event|0|||
164255322|NCT02589665|593302262|FG006|Induction Extension Period|Adverse Event|0|||
164255323|NCT02589665|593302263|FG007|Induction Extension Period|Adverse Event|0|||
164255324|NCT02589665|593302264|FG008|Induction Extension Period|Adverse Event|4|||
164255325|NCT02589665|593302265|FG009|Induction Extension Period|Adverse Event|0|||
164255326|NCT02589665|593302256|FG000|Induction Extension Period|Lack of Efficacy|0|||
164255327|NCT02589665|593302257|FG001|Induction Extension Period|Lack of Efficacy|0|||
164255328|NCT02589665|593302258|FG002|Induction Extension Period|Lack of Efficacy|0|||
164255329|NCT02589665|593302259|FG003|Induction Extension Period|Lack of Efficacy|0|||
164255330|NCT02589665|593302260|FG004|Induction Extension Period|Lack of Efficacy|0|||
164255331|NCT02589665|593302261|FG005|Induction Extension Period|Lack of Efficacy|0|||
164255332|NCT02589665|593302262|FG006|Induction Extension Period|Lack of Efficacy|0|||
164255333|NCT02589665|593302263|FG007|Induction Extension Period|Lack of Efficacy|0|||
164255334|NCT02589665|593302264|FG008|Induction Extension Period|Lack of Efficacy|3|||
164255335|NCT02589665|593302265|FG009|Induction Extension Period|Lack of Efficacy|0|||
164255336|NCT02589665|593302256|FG000|Induction Extension Period|Withdrawal by Subject|0|||
164255337|NCT02589665|593302257|FG001|Induction Extension Period|Withdrawal by Subject|0|||
164255338|NCT02589665|593302258|FG002|Induction Extension Period|Withdrawal by Subject|0|||
164255339|NCT02589665|593302259|FG003|Induction Extension Period|Withdrawal by Subject|0|||
164255340|NCT02589665|593302260|FG004|Induction Extension Period|Withdrawal by Subject|0|||
164255341|NCT02589665|593302261|FG005|Induction Extension Period|Withdrawal by Subject|0|||
164255342|NCT02589665|593302262|FG006|Induction Extension Period|Withdrawal by Subject|0|||
164255343|NCT02589665|593302263|FG007|Induction Extension Period|Withdrawal by Subject|2|||
164255344|NCT02589665|593302264|FG008|Induction Extension Period|Withdrawal by Subject|3|||
164255345|NCT02589665|593302265|FG009|Induction Extension Period|Withdrawal by Subject|0|||
164255346|NCT02589665|593302256|FG000|Induction Extension Period|Physician Decision|0|||
164255347|NCT02589665|593302257|FG001|Induction Extension Period|Physician Decision|0|||
164255348|NCT02589665|593302258|FG002|Induction Extension Period|Physician Decision|0|||
164255349|NCT02589665|593302259|FG003|Induction Extension Period|Physician Decision|0|||
164255350|NCT02589665|593302260|FG004|Induction Extension Period|Physician Decision|0|||
164255351|NCT02589665|593302261|FG005|Induction Extension Period|Physician Decision|0|||
164255352|NCT02589665|593302262|FG006|Induction Extension Period|Physician Decision|0|||
164255353|NCT02589665|593302263|FG007|Induction Extension Period|Physician Decision|0|||
164255354|NCT02589665|593302264|FG008|Induction Extension Period|Physician Decision|1|||
164255355|NCT02589665|593302265|FG009|Induction Extension Period|Physician Decision|0|||
164255356|NCT02589665|593302256|FG000|Induction Extension Period|Reason Not Collected|0|||
164255357|NCT02589665|593302257|FG001|Induction Extension Period|Reason Not Collected|0|||
164255358|NCT02589665|593302258|FG002|Induction Extension Period|Reason Not Collected|0|||
164255359|NCT02589665|593302259|FG003|Induction Extension Period|Reason Not Collected|0|||
164255360|NCT02589665|593302260|FG004|Induction Extension Period|Reason Not Collected|0|||
164255361|NCT02589665|593302261|FG005|Induction Extension Period|Reason Not Collected|0|||
164084703|NCT00457665|592673995|FG001|12 Months|Drug allergy|1|||
164084704|NCT00457665|592673994|FG000|12 Months|High HIV viral load|5|||
164084705|NCT00457665|592673995|FG001|12 Months|High HIV viral load|1|||
164084706|NCT00457665|592673994|FG000|12 Months|Lipodystrophy|2|||
164084707|NCT00457665|592673995|FG001|12 Months|Lipodystrophy|0|||
164084708|NCT00457665|592673994|FG000|12 Months|Withdrawal by Subject|0|||
164255362|NCT02589665|593302262|FG006|Induction Extension Period|Reason Not Collected|0|||
164255363|NCT02589665|593302263|FG007|Induction Extension Period|Reason Not Collected|0|||
164255364|NCT02589665|593302264|FG008|Induction Extension Period|Reason Not Collected|1|||
164255365|NCT02589665|593302265|FG009|Induction Extension Period|Reason Not Collected|0|||
164339121|NCT00474760|593617147|FG000|Overall Study|Adverse Event|0|||
163887596|NCT03819153|591959471|FG000|Overall Study|Lost to Follow-up|23|||
164255366|NCT02589665|593302256|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255367|NCT02589665|593302257|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255368|NCT02589665|593302258|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255369|NCT02589665|593302259|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255370|NCT02589665|593302260|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255371|NCT02589665|593302261|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255372|NCT02589665|593302262|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255373|NCT02589665|593302263|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255374|NCT02589665|593302264|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
164255375|NCT02589665|593302265|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
164255376|NCT02589665|593302256|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
164255377|NCT02589665|593302257|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
164255378|NCT02589665|593302258|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
164255379|NCT02589665|593302259|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
164255380|NCT02589665|593302260|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
164255381|NCT02589665|593302261|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
164255382|NCT02589665|593302262|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
164255383|NCT02589665|593302263|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
164255384|NCT02589665|593302264|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
164255385|NCT02589665|593302265|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
164255386|NCT02589665|593302256|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
164255387|NCT02589665|593302257|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
164255388|NCT02589665|593302258|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
164255389|NCT02589665|593302259|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
164255390|NCT02589665|593302260|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
164255391|NCT02589665|593302261|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
164255392|NCT02589665|593302262|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
164255393|NCT02589665|593302263|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
164255394|NCT02589665|593302264|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
164255395|NCT02589665|593302265|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
164255396|NCT02589665|593302256|FG000|Maintenance Extension Period|Adverse Event|0|||
164255397|NCT02589665|593302257|FG001|Maintenance Extension Period|Adverse Event|0|||
164255398|NCT02589665|593302258|FG002|Maintenance Extension Period|Adverse Event|0|||
164255399|NCT02589665|593302259|FG003|Maintenance Extension Period|Adverse Event|0|||
164255400|NCT02589665|593302260|FG004|Maintenance Extension Period|Adverse Event|0|||
164255401|NCT02589665|593302261|FG005|Maintenance Extension Period|Adverse Event|0|||
164255402|NCT02589665|593302262|FG006|Maintenance Extension Period|Adverse Event|0|||
164255403|NCT02589665|593302263|FG007|Maintenance Extension Period|Adverse Event|0|||
164255404|NCT02589665|593302264|FG008|Maintenance Extension Period|Adverse Event|0|||
164255405|NCT02589665|593302265|FG009|Maintenance Extension Period|Adverse Event|2|||
164255406|NCT02589665|593302256|FG000|Maintenance Extension Period|Non-responder|0|||
164255407|NCT02589665|593302257|FG001|Maintenance Extension Period|Non-responder|0|||
164255408|NCT02589665|593302258|FG002|Maintenance Extension Period|Non-responder|0|||
164255409|NCT02589665|593302259|FG003|Maintenance Extension Period|Non-responder|0|||
164255410|NCT02589665|593302260|FG004|Maintenance Extension Period|Non-responder|0|||
164255411|NCT02589665|593302261|FG005|Maintenance Extension Period|Non-responder|0|||
164255412|NCT02589665|593302262|FG006|Maintenance Extension Period|Non-responder|0|||
164255413|NCT02589665|593302263|FG007|Maintenance Extension Period|Non-responder|0|||
164255414|NCT02589665|593302264|FG008|Maintenance Extension Period|Non-responder|0|||
164255415|NCT02589665|593302265|FG009|Maintenance Extension Period|Non-responder|1|||
164255416|NCT00978380|593302266|FG000|Overall Study|Protocol Violation|2|||
164255417|NCT00978380|593302266|FG000|Overall Study|Withdrawal criteria|9|||
164255418|NCT00978380|593302266|FG000|Overall Study|Unclassified|8|||
164255419|NCT00176488|593302269|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
164255420|NCT00327015|593302270|FG000|Overall Study|Lack of Efficacy|18|||
164255421|NCT00327015|593302271|FG001|Overall Study|Lack of Efficacy|18|||
164255422|NCT00327015|593302272|FG002|Overall Study|Lack of Efficacy|35|||
164339122|NCT00474760|593617148|FG001|Overall Study|Adverse Event|0|||
164339123|NCT00474760|593617149|FG002|Overall Study|Adverse Event|0|||
164339124|NCT00474760|593617150|FG003|Overall Study|Adverse Event|0|||
163887597|NCT03819153|591959472|FG001|Overall Study|Lost to Follow-up|30|||
163887598|NCT05526430|591959477|FG000|Overall Study|Withdrawal by Subject|0|||
163887599|NCT05526430|591959478|FG001|Overall Study|Withdrawal by Subject|2|||
163887600|NCT05526430|591959479|FG002|Overall Study|Withdrawal by Subject|0|||
163887601|NCT05526430|591959480|FG003|Overall Study|Withdrawal by Subject|0|||
163887602|NCT03058289|591959481|FG000|Overall Study|Radiographic Deterioration|0|||
163887603|NCT03058289|591959482|FG001|Overall Study|Radiographic Deterioration|3|||
164255423|NCT00327015|593302273|FG003|Overall Study|Lack of Efficacy|29|||
164255424|NCT00327015|593302270|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
164255425|NCT00327015|593302271|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
164255426|NCT00327015|593302272|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
164255427|NCT00327015|593302273|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
164255428|NCT00327015|593302270|FG000|Overall Study|Lost to Follow-up|22|||
164255429|NCT00327015|593302271|FG001|Overall Study|Lost to Follow-up|23|||
164255430|NCT00327015|593302272|FG002|Overall Study|Lost to Follow-up|29|||
164255431|NCT00327015|593302273|FG003|Overall Study|Lost to Follow-up|22|||
164255432|NCT00327015|593302270|FG000|Overall Study|Adverse Event|14|||
164255433|NCT00327015|593302271|FG001|Overall Study|Adverse Event|10|||
164255434|NCT00327015|593302272|FG002|Overall Study|Adverse Event|14|||
164255435|NCT00327015|593302273|FG003|Overall Study|Adverse Event|14|||
164255436|NCT00327015|593302270|FG000|Overall Study|Subject no longer meets study criteria|4|||
164255437|NCT00327015|593302271|FG001|Overall Study|Subject no longer meets study criteria|2|||
164255438|NCT00327015|593302272|FG002|Overall Study|Subject no longer meets study criteria|8|||
164255439|NCT00327015|593302273|FG003|Overall Study|Subject no longer meets study criteria|7|||
164255440|NCT00327015|593302270|FG000|Overall Study|Poor/Noncompliance|11|||
164255441|NCT00327015|593302271|FG001|Overall Study|Poor/Noncompliance|8|||
164255442|NCT00327015|593302272|FG002|Overall Study|Poor/Noncompliance|4|||
164255443|NCT00327015|593302273|FG003|Overall Study|Poor/Noncompliance|5|||
164255444|NCT00327015|593302270|FG000|Overall Study|Physician Decision|0|||
164255445|NCT00327015|593302271|FG001|Overall Study|Physician Decision|1|||
164255446|NCT00327015|593302272|FG002|Overall Study|Physician Decision|3|||
164255447|NCT00327015|593302273|FG003|Overall Study|Physician Decision|2|||
164255448|NCT00327015|593302270|FG000|Overall Study|Death|1|||
164255449|NCT00327015|593302271|FG001|Overall Study|Death|2|||
164255450|NCT00327015|593302272|FG002|Overall Study|Death|2|||
164255451|NCT00327015|593302273|FG003|Overall Study|Death|3|||
164255452|NCT00327015|593302270|FG000|Overall Study|Pregnancy|0|||
164255453|NCT00327015|593302271|FG001|Overall Study|Pregnancy|2|||
164255454|NCT00327015|593302272|FG002|Overall Study|Pregnancy|1|||
164255455|NCT00327015|593302273|FG003|Overall Study|Pregnancy|1|||
164255456|NCT00327015|593302270|FG000|Overall Study|Administrative Reason by Sponsor|1|||
164255457|NCT00327015|593302271|FG001|Overall Study|Administrative Reason by Sponsor|2|||
164255458|NCT00327015|593302272|FG002|Overall Study|Administrative Reason by Sponsor|2|||
164255459|NCT00327015|593302273|FG003|Overall Study|Administrative Reason by Sponsor|1|||
164255460|NCT01892436|593302274|FG000|Overall Study|Withdrawal by Subject|8|||
164255461|NCT01892436|593302275|FG001|Overall Study|Withdrawal by Subject|15|||
164255462|NCT01892436|593302276|FG002|Overall Study|Withdrawal by Subject|4|||
164255463|NCT01892436|593302277|FG003|Overall Study|Withdrawal by Subject|4|||
164255464|NCT01892436|593302274|FG000|Overall Study|Death|1|||
164255465|NCT01892436|593302275|FG001|Overall Study|Death|1|||
164255466|NCT01892436|593302276|FG002|Overall Study|Death|0|||
164255467|NCT01892436|593302277|FG003|Overall Study|Death|0|||
164255468|NCT01892436|593302274|FG000|Overall Study|Physician Decision|2|||
164255469|NCT01892436|593302275|FG001|Overall Study|Physician Decision|1|||
164255470|NCT01892436|593302276|FG002|Overall Study|Physician Decision|0|||
164255471|NCT01892436|593302277|FG003|Overall Study|Physician Decision|1|||
164255472|NCT01892436|593302274|FG000|Overall Study|Pregnancy|0|||
164255473|NCT01892436|593302275|FG001|Overall Study|Pregnancy|2|||
164255474|NCT01892436|593302276|FG002|Overall Study|Pregnancy|1|||
164255475|NCT01892436|593302277|FG003|Overall Study|Pregnancy|0|||
164255476|NCT01892436|593302274|FG000|Overall Study|Technical problems|2|||
164255477|NCT01892436|593302275|FG001|Overall Study|Technical problems|1|||
164255478|NCT01892436|593302276|FG002|Overall Study|Technical problems|1|||
164255479|NCT01892436|593302277|FG003|Overall Study|Technical problems|1|||
164255480|NCT01892436|593302274|FG000|Overall Study|Lack of Efficacy|1|||
164255481|NCT01892436|593302275|FG001|Overall Study|Lack of Efficacy|2|||
164255482|NCT01892436|593302276|FG002|Overall Study|Lack of Efficacy|2|||
164255483|NCT01892436|593302277|FG003|Overall Study|Lack of Efficacy|2|||
164255484|NCT01892436|593302274|FG000|Overall Study|Lost to Follow-up|1|||
164255485|NCT01892436|593302275|FG001|Overall Study|Lost to Follow-up|1|||
164255486|NCT01892436|593302276|FG002|Overall Study|Lost to Follow-up|1|||
164255487|NCT01892436|593302277|FG003|Overall Study|Lost to Follow-up|3|||
164255488|NCT01892436|593302274|FG000|Overall Study|non-compliance with treatment|1|||
164255489|NCT01892436|593302275|FG001|Overall Study|non-compliance with treatment|0|||
164255490|NCT01892436|593302276|FG002|Overall Study|non-compliance with treatment|0|||
164255491|NCT01892436|593302277|FG003|Overall Study|non-compliance with treatment|0|||
164255492|NCT01892436|593302274|FG000|Overall Study|Adverse Event|7|||
164255493|NCT01892436|593302275|FG001|Overall Study|Adverse Event|6|||
164255494|NCT01892436|593302276|FG002|Overall Study|Adverse Event|2|||
164255495|NCT01892436|593302277|FG003|Overall Study|Adverse Event|3|||
164255496|NCT02923830|593302281|FG000|Overall Study|Physician Decision|13|||
164255497|NCT02923830|593302282|FG001|Overall Study|Physician Decision|15|||
164255498|NCT00837265|593302283|FG000|Pilot Phase|Withdrawal by Subject|0|||
164255499|NCT00837265|593302284|FG001|Pilot Phase|Withdrawal by Subject|2|||
164255500|NCT00837265|593302285|FG002|Pilot Phase|Withdrawal by Subject|3|||
164255501|NCT00837265|593302286|FG003|Pilot Phase|Withdrawal by Subject|2|||
164255502|NCT00837265|593302287|FG004|Pilot Phase|Withdrawal by Subject|0|||
164255503|NCT00837265|593302288|FG005|Pilot Phase|Withdrawal by Subject|0|||
164255504|NCT00837265|593302289|FG006|Pilot Phase|Withdrawal by Subject|0|||
164255505|NCT00837265|593302283|FG000|Pilot Phase|Decision of the investigator|2|||
164255506|NCT00837265|593302284|FG001|Pilot Phase|Decision of the investigator|1|||
164255507|NCT00837265|593302285|FG002|Pilot Phase|Decision of the investigator|0|||
164255508|NCT00837265|593302286|FG003|Pilot Phase|Decision of the investigator|0|||
164255509|NCT00837265|593302287|FG004|Pilot Phase|Decision of the investigator|0|||
164255510|NCT00837265|593302288|FG005|Pilot Phase|Decision of the investigator|0|||
164255511|NCT00837265|593302289|FG006|Pilot Phase|Decision of the investigator|0|||
164255512|NCT00837265|593302283|FG000|Pilot Phase|Adverse Event|1|||
164255513|NCT00837265|593302284|FG001|Pilot Phase|Adverse Event|0|||
164255514|NCT00837265|593302285|FG002|Pilot Phase|Adverse Event|0|||
164255515|NCT00837265|593302286|FG003|Pilot Phase|Adverse Event|0|||
164255516|NCT00837265|593302287|FG004|Pilot Phase|Adverse Event|0|||
164255517|NCT00837265|593302288|FG005|Pilot Phase|Adverse Event|0|||
164255518|NCT00837265|593302289|FG006|Pilot Phase|Adverse Event|0|||
164255519|NCT00837265|593302283|FG000|Pilot Phase|Disease progression|0|||
164255520|NCT00837265|593302284|FG001|Pilot Phase|Disease progression|0|||
164255521|NCT00837265|593302285|FG002|Pilot Phase|Disease progression|0|||
164255522|NCT00837265|593302286|FG003|Pilot Phase|Disease progression|1|||
164255523|NCT00837265|593302287|FG004|Pilot Phase|Disease progression|0|||
164255524|NCT00837265|593302288|FG005|Pilot Phase|Disease progression|0|||
164255525|NCT00837265|593302289|FG006|Pilot Phase|Disease progression|0|||
164255526|NCT00837265|593302283|FG000|Pilot Phase|Participant left the city|0|||
164255527|NCT00837265|593302284|FG001|Pilot Phase|Participant left the city|0|||
164255528|NCT00837265|593302285|FG002|Pilot Phase|Participant left the city|0|||
164255529|NCT00837265|593302286|FG003|Pilot Phase|Participant left the city|1|||
164255530|NCT00837265|593302287|FG004|Pilot Phase|Participant left the city|0|||
164255531|NCT00837265|593302288|FG005|Pilot Phase|Participant left the city|0|||
164255532|NCT00837265|593302289|FG006|Pilot Phase|Participant left the city|0|||
164255533|NCT00837265|593302283|FG000|Main Phase|Withdrawal by Subject|0|||
164255534|NCT00837265|593302284|FG001|Main Phase|Withdrawal by Subject|0|||
164255535|NCT00837265|593302285|FG002|Main Phase|Withdrawal by Subject|0|||
164255536|NCT00837265|593302286|FG003|Main Phase|Withdrawal by Subject|0|||
164255537|NCT00837265|593302287|FG004|Main Phase|Withdrawal by Subject|4|||
164255538|NCT00837265|593302288|FG005|Main Phase|Withdrawal by Subject|2|||
164255539|NCT00837265|593302289|FG006|Main Phase|Withdrawal by Subject|1|||
164255540|NCT00837265|593302283|FG000|Main Phase|Decision of the investigator|0|||
164255541|NCT00837265|593302284|FG001|Main Phase|Decision of the investigator|0|||
164255542|NCT00837265|593302285|FG002|Main Phase|Decision of the investigator|0|||
164255543|NCT00837265|593302286|FG003|Main Phase|Decision of the investigator|0|||
164255544|NCT00837265|593302287|FG004|Main Phase|Decision of the investigator|0|||
164255545|NCT00837265|593302288|FG005|Main Phase|Decision of the investigator|2|||
164255546|NCT00837265|593302289|FG006|Main Phase|Decision of the investigator|1|||
164255547|NCT00837265|593302283|FG000|Main Phase|Adverse Event|0|||
164255548|NCT00837265|593302284|FG001|Main Phase|Adverse Event|0|||
164255549|NCT00837265|593302285|FG002|Main Phase|Adverse Event|0|||
164255550|NCT00837265|593302286|FG003|Main Phase|Adverse Event|0|||
164255551|NCT00837265|593302287|FG004|Main Phase|Adverse Event|0|||
164255552|NCT00837265|593302288|FG005|Main Phase|Adverse Event|1|||
164255553|NCT00837265|593302289|FG006|Main Phase|Adverse Event|0|||
164255554|NCT00837265|593302283|FG000|Main Phase|Death|0|||
164255555|NCT00837265|593302284|FG001|Main Phase|Death|0|||
164255556|NCT00837265|593302285|FG002|Main Phase|Death|0|||
164255557|NCT00837265|593302286|FG003|Main Phase|Death|0|||
164255558|NCT00837265|593302287|FG004|Main Phase|Death|2|||
164255559|NCT00837265|593302288|FG005|Main Phase|Death|0|||
164255560|NCT00837265|593302289|FG006|Main Phase|Death|1|||
164255561|NCT00837265|593302283|FG000|Main Phase|Lost to Follow-up|0|||
164255562|NCT00837265|593302284|FG001|Main Phase|Lost to Follow-up|0|||
164255563|NCT00837265|593302285|FG002|Main Phase|Lost to Follow-up|0|||
164255564|NCT00837265|593302286|FG003|Main Phase|Lost to Follow-up|0|||
164255565|NCT00837265|593302287|FG004|Main Phase|Lost to Follow-up|1|||
164255566|NCT00837265|593302288|FG005|Main Phase|Lost to Follow-up|0|||
164255567|NCT00837265|593302289|FG006|Main Phase|Lost to Follow-up|0|||
164255568|NCT00837265|593302283|FG000|Main Phase|Principal investigator resignation|0|||
164255569|NCT00837265|593302284|FG001|Main Phase|Principal investigator resignation|0|||
164255570|NCT00837265|593302285|FG002|Main Phase|Principal investigator resignation|0|||
164255571|NCT00837265|593302286|FG003|Main Phase|Principal investigator resignation|0|||
164255572|NCT00837265|593302287|FG004|Main Phase|Principal investigator resignation|2|||
164255573|NCT00837265|593302288|FG005|Main Phase|Principal investigator resignation|0|||
164255574|NCT00837265|593302289|FG006|Main Phase|Principal investigator resignation|0|||
164255575|NCT00837265|593302283|FG000|Main Phase|Participant's personal reason|0|||
164255576|NCT00837265|593302284|FG001|Main Phase|Participant's personal reason|0|||
164255577|NCT00837265|593302285|FG002|Main Phase|Participant's personal reason|0|||
164255578|NCT00837265|593302286|FG003|Main Phase|Participant's personal reason|0|||
164255579|NCT00837265|593302287|FG004|Main Phase|Participant's personal reason|1|||
164255580|NCT00837265|593302288|FG005|Main Phase|Participant's personal reason|0|||
164255581|NCT00837265|593302289|FG006|Main Phase|Participant's personal reason|0|||
164255582|NCT01751906|593302291|FG000|Overall Study|Lost to Follow-up|151|||
164255583|NCT01751906|593302292|FG001|Overall Study|Lost to Follow-up|68|||
164255584|NCT01751906|593302291|FG000|Overall Study|Withdrawal by Subject|22|||
164255585|NCT01751906|593302292|FG001|Overall Study|Withdrawal by Subject|18|||
164255586|NCT01751906|593302291|FG000|Overall Study|Physician Decision|5|||
164255587|NCT01751906|593302292|FG001|Overall Study|Physician Decision|2|||
164255588|NCT01751906|593302291|FG000|Overall Study|Death|84|||
164255589|NCT01751906|593302292|FG001|Overall Study|Death|43|||
164255590|NCT01751906|593302291|FG000|Overall Study|Denied on premises for follow-up by law|1|||
164255591|NCT01751906|593302292|FG001|Overall Study|Denied on premises for follow-up by law|0|||
164255592|NCT00733291|593302293|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
164255593|NCT00733291|593302294|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
164255594|NCT00733291|593302295|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
164255595|NCT00733291|593302296|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
164255596|NCT02242435|593302303|FG000|Overall Study|Lost to Follow-up|3|||
164255597|NCT02242435|593302304|FG001|Overall Study|Lost to Follow-up|4|||
164255598|NCT02242435|593302303|FG000|Overall Study|Adverse Event|3|||
164255599|NCT02242435|593302304|FG001|Overall Study|Adverse Event|2|||
164255600|NCT02242435|593302303|FG000|Overall Study|Withdrawal by Subject|13|||
164255601|NCT02242435|593302304|FG001|Overall Study|Withdrawal by Subject|8|||
164255602|NCT02242435|593302303|FG000|Overall Study|Death|0|||
164255603|NCT02242435|593302304|FG001|Overall Study|Death|1|||
164255604|NCT02242435|593302303|FG000|Overall Study|Protocol Violation|1|||
164255605|NCT02242435|593302304|FG001|Overall Study|Protocol Violation|0|||
164255606|NCT02242435|593302303|FG000|Overall Study|Physician Decision|0|||
164255607|NCT02242435|593302304|FG001|Overall Study|Physician Decision|1|||
164255608|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
164255609|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
164255610|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
164255611|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
164255612|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
164255613|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
164255614|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
164255615|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
164255616|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
164255617|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
164255618|NCT00510718|593302313|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
164255619|NCT00510718|593302314|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
164255620|NCT00420004|593302320|FG000|Overall Study|Adverse Event|4|||
164255621|NCT00420004|593302321|FG001|Overall Study|Adverse Event|1|||
164255622|NCT00420004|593302322|FG002|Overall Study|Adverse Event|1|||
164255623|NCT00420004|593302320|FG000|Overall Study|Lack of Efficacy|5|||
164255624|NCT00420004|593302321|FG001|Overall Study|Lack of Efficacy|4|||
164255625|NCT00420004|593302322|FG002|Overall Study|Lack of Efficacy|1|||
164255626|NCT00420004|593302320|FG000|Overall Study|Lost to Follow-up|31|||
164255627|NCT00420004|593302321|FG001|Overall Study|Lost to Follow-up|12|||
164255628|NCT00420004|593302322|FG002|Overall Study|Lost to Follow-up|10|||
164255629|NCT00420004|593302320|FG000|Overall Study|Entry Criteria Not Met|0|||
164255630|NCT00420004|593302321|FG001|Overall Study|Entry Criteria Not Met|1|||
164255631|NCT00420004|593302322|FG002|Overall Study|Entry Criteria Not Met|0|||
164255632|NCT00420004|593302320|FG000|Overall Study|Physician Decision|14|||
164255633|NCT00420004|593302321|FG001|Overall Study|Physician Decision|4|||
164255634|NCT00420004|593302322|FG002|Overall Study|Physician Decision|2|||
164255635|NCT00420004|593302320|FG000|Overall Study|Protocol Violation|5|||
164255636|NCT00420004|593302321|FG001|Overall Study|Protocol Violation|4|||
164255637|NCT00420004|593302322|FG002|Overall Study|Protocol Violation|3|||
164255638|NCT00420004|593302320|FG000|Overall Study|Withdrawal by Subject|67|||
164255639|NCT00420004|593302321|FG001|Overall Study|Withdrawal by Subject|42|||
164255640|NCT00420004|593302322|FG002|Overall Study|Withdrawal by Subject|14|||
164255641|NCT00420004|593302320|FG000|Overall Study|Sponsor Decision|3|||
164255642|NCT00420004|593302321|FG001|Overall Study|Sponsor Decision|3|||
164255643|NCT00420004|593302322|FG002|Overall Study|Sponsor Decision|1|||
164255644|NCT00591149|593302323|FG000|Overall Study|Adverse Event|4|||
164255645|NCT00591149|593302323|FG000|Overall Study|Withdrawal by Subject|1|||
164255646|NCT01606787|593302324|FG000|Overall Study|Withdrawal by Subject|4|||
164255647|NCT01606787|593302325|FG001|Overall Study|Withdrawal by Subject|5|||
164255648|NCT01606787|593302324|FG000|Overall Study|Surgery canceled|0|||
164255649|NCT01606787|593302325|FG001|Overall Study|Surgery canceled|2|||
164255650|NCT01610557|593302327|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255651|NCT01610557|593302328|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
164255652|NCT01610557|593302329|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255653|NCT01610557|593302330|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255654|NCT01610557|593302331|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
164255655|NCT01610557|593302327|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255656|NCT01610557|593302328|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255657|NCT01610557|593302329|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255658|NCT01610557|593302330|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
164255659|NCT01610557|593302331|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
164255660|NCT02003638|593302337|FG000|Overall Study|Withdrawal by Subject|1|||
164255661|NCT02003638|593302338|FG001|Overall Study|Withdrawal by Subject|0|||
164255662|NCT00713349|593302339|FG000|Overall Study|Protocol Violation|1|||
164255663|NCT03299881|593302340|FG000|Overall Study|Study Termination|17|||
164255664|NCT03299881|593302341|FG001|Overall Study|Study Termination|13|||
164255665|NCT01289353|593302342|FG000|Overall Study|Lost to Follow-up|2|||
164255666|NCT00129701|593302345|FG000|Overall Study|Withdrawal by Subject|33|||
164255667|NCT00006164|593302346|FG000|Overall Study|Withdrew or lost to follow-up|70|||
164255668|NCT00006164|593302347|FG001|Overall Study|Withdrew or lost to follow-up|81|||
164255669|NCT02750345|593302348|FG000|Intervention 1|Adverse Event|0|||
164255670|NCT02750345|593302349|FG001|Intervention 1|Adverse Event|0|||
164255671|NCT02750345|593302350|FG002|Intervention 1|Adverse Event|0|||
164255672|NCT02750345|593302351|FG003|Intervention 1|Adverse Event|0|||
164255673|NCT02750345|593302352|FG004|Intervention 1|Adverse Event|1|||
164255674|NCT02750345|593302353|FG005|Intervention 1|Adverse Event|0|||
164255675|NCT00223808|593302354|FG000|Overall Study|<5 hrs therapy before discharge|3|||
164255676|NCT00223808|593302355|FG001|Overall Study|<5 hrs therapy before discharge|5|||
164255677|NCT00223808|593302356|FG002|Overall Study|<5 hrs therapy before discharge|5|||
164255678|NCT00191724|593302359|FG000|Overall Study|Adverse Event|0|||
164255679|NCT00191724|593302360|FG001|Overall Study|Adverse Event|0|||
164255680|NCT00191724|593302361|FG002|Overall Study|Adverse Event|1|||
164255681|NCT00191724|593302362|FG003|Overall Study|Adverse Event|0|||
164255682|NCT00191724|593302363|FG004|Overall Study|Adverse Event|0|||
164255683|NCT00191724|593302359|FG000|Overall Study|Lost to Follow-up|1|||
164255684|NCT00191724|593302360|FG001|Overall Study|Lost to Follow-up|1|||
164255685|NCT00191724|593302361|FG002|Overall Study|Lost to Follow-up|0|||
164255686|NCT00191724|593302362|FG003|Overall Study|Lost to Follow-up|2|||
164255687|NCT00191724|593302363|FG004|Overall Study|Lost to Follow-up|3|||
164255688|NCT00191724|593302359|FG000|Overall Study|Withdrawal by Subject|0|||
164255689|NCT00191724|593302360|FG001|Overall Study|Withdrawal by Subject|0|||
164255690|NCT00191724|593302361|FG002|Overall Study|Withdrawal by Subject|0|||
164255691|NCT00191724|593302362|FG003|Overall Study|Withdrawal by Subject|1|||
164255692|NCT00191724|593302363|FG004|Overall Study|Withdrawal by Subject|0|||
164255693|NCT01231321|593302366|FG000|Overall Study|Adverse Event|3|||
164255694|NCT01231321|593302366|FG000|Overall Study|Lack of Efficacy|2|||
164255695|NCT00489736|593302367|FG000|Overall Study|Lack of Efficacy|53|||
164255696|NCT00489736|593302368|FG001|Overall Study|Lack of Efficacy|14|||
164255697|NCT00489736|593302367|FG000|Overall Study|Adverse Event|32|||
164255698|NCT00489736|593302368|FG001|Overall Study|Adverse Event|45|||
164255699|NCT00489736|593302367|FG000|Overall Study|Poor compliance|6|||
164255700|NCT00489736|593302368|FG001|Overall Study|Poor compliance|2|||
164255701|NCT00489736|593302367|FG000|Overall Study|Not coded/ Not pre-specified|5|||
164255702|NCT00489736|593302368|FG001|Overall Study|Not coded/ Not pre-specified|8|||
164255703|NCT04021524|593302369|FG000|Overall Study|Change in surgical intervention|0|||
164255704|NCT04021524|593302370|FG001|Overall Study|Change in surgical intervention|1|||
164255705|NCT06422364|593302371|FG000|Overall Study|Withdrawn due to study closure|0|||
164255706|NCT06422364|593302372|FG001|Overall Study|Withdrawn due to study closure|2|||
164255707|NCT05260073|593302374|FG000|Overall Study|Physician Decision|1|||
164255708|NCT05260073|593302374|FG000|Overall Study|Withdrawal by Subject|6|||
164255709|NCT05260073|593302374|FG000|Overall Study|Lost to Follow-up|14|||
164255710|NCT03458910|593302375|FG000|Overall Study|Withdrawal by Subject|7|||
164255711|NCT03458910|593302376|FG001|Overall Study|Withdrawal by Subject|8|||
164255712|NCT03458910|593302377|FG002|Overall Study|Withdrawal by Subject|6|||
164255713|NCT03458910|593302378|FG003|Overall Study|Withdrawal by Subject|4|||
164255714|NCT03458910|593302375|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
164255715|NCT03458910|593302376|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
164255716|NCT03458910|593302377|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
164255717|NCT03458910|593302378|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
164255718|NCT02752633|593302379|FG000|Overall Study|Withdrawal by Subject|1|||
164255719|NCT05059301|593302385|FG000|Overall Study|Adverse Event|0|||
164255720|NCT05059301|593302386|FG001|Overall Study|Adverse Event|2|||
164255721|NCT05059301|593302387|FG002|Overall Study|Adverse Event|2|||
164255722|NCT05059301|593302385|FG000|Overall Study|Lost to Follow-up|2|||
164255723|NCT05059301|593302386|FG001|Overall Study|Lost to Follow-up|3|||
164255724|NCT05059301|593302387|FG002|Overall Study|Lost to Follow-up|3|||
164255725|NCT01106651|593302388|FG000|Overall Study|Adverse Event|17|||
164255726|NCT01106651|593302389|FG001|Overall Study|Adverse Event|9|||
164255727|NCT01106651|593302390|FG002|Overall Study|Adverse Event|23|||
164255728|NCT01106651|593302388|FG000|Overall Study|Lost to Follow-up|8|||
164255729|NCT01106651|593302389|FG001|Overall Study|Lost to Follow-up|2|||
164255730|NCT01106651|593302390|FG002|Overall Study|Lost to Follow-up|6|||
164255731|NCT01106651|593302388|FG000|Overall Study|Physician Decision|4|||
164255732|NCT01106651|593302389|FG001|Overall Study|Physician Decision|3|||
164255733|NCT01106651|593302390|FG002|Overall Study|Physician Decision|1|||
164255734|NCT01106651|593302388|FG000|Overall Study|Protocol Violation|1|||
164255735|NCT01106651|593302389|FG001|Overall Study|Protocol Violation|2|||
164255736|NCT01106651|593302390|FG002|Overall Study|Protocol Violation|1|||
164255737|NCT01106651|593302388|FG000|Overall Study|Withdrawal by Subject|14|||
164255738|NCT01106651|593302389|FG001|Overall Study|Withdrawal by Subject|7|||
164255739|NCT01106651|593302390|FG002|Overall Study|Withdrawal by Subject|4|||
164255740|NCT01106651|593302388|FG000|Overall Study|Noncompliance with study drug|1|||
164255741|NCT01106651|593302389|FG001|Overall Study|Noncompliance with study drug|0|||
164255742|NCT01106651|593302390|FG002|Overall Study|Noncompliance with study drug|2|||
164255743|NCT01106651|593302388|FG000|Overall Study|Other|34|||
164255744|NCT01106651|593302389|FG001|Overall Study|Other|31|||
164255745|NCT01106651|593302390|FG002|Overall Study|Other|21|||
164255746|NCT01106651|593302388|FG000|Overall Study|Death|0|||
164255747|NCT01106651|593302389|FG001|Overall Study|Death|3|||
164255748|NCT01106651|593302390|FG002|Overall Study|Death|0|||
164255749|NCT02466425|593302394|FG000|Overall Study|Adverse Event|3|||
164255750|NCT02466425|593302395|FG001|Overall Study|Adverse Event|11|||
164255751|NCT02466425|593302394|FG000|Overall Study|Lack of Efficacy|4|||
164255752|NCT02466425|593302395|FG001|Overall Study|Lack of Efficacy|1|||
164255753|NCT02466425|593302394|FG000|Overall Study|Lost to Follow-up|3|||
164255754|NCT02466425|593302395|FG001|Overall Study|Lost to Follow-up|0|||
164255755|NCT02466425|593302394|FG000|Overall Study|Protocol Violation|1|||
164255756|NCT02466425|593302395|FG001|Overall Study|Protocol Violation|0|||
164255757|NCT02466425|593302394|FG000|Overall Study|Withdrawal by Subject|0|||
164255758|NCT02466425|593302395|FG001|Overall Study|Withdrawal by Subject|1|||
164255759|NCT02466425|593302394|FG000|Overall Study|Other|1|||
164255760|NCT02466425|593302395|FG001|Overall Study|Other|3|||
164255761|NCT02466425|593302394|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164255762|NCT02466425|593302395|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164255763|NCT00889603|593302396|FG000|Overall Study|Adverse Event|7|||
164255764|NCT00889603|593302396|FG000|Overall Study|Death|3|||
164255765|NCT00889603|593302396|FG000|Overall Study|Lost to Follow-up|19|||
164255766|NCT00889603|593302396|FG000|Overall Study|No longer willing to participant in stud|4|||
164255767|NCT00889603|593302396|FG000|Overall Study|Other|4|||
164255768|NCT01832493|593302398|FG000|Overall Study|Physician Decision|2|||
164255769|NCT01832493|593302398|FG000|Overall Study|Protocol Violation|4|||
164255770|NCT01832493|593302398|FG000|Overall Study|Unable to place LV lead|2|||
164255771|NCT01814397|593302401|FG000|Overall Study|Adverse Event|7|||
164255772|NCT01814397|593302401|FG000|Overall Study|Withdrawal by Subject|7|||
164255773|NCT04238481|593302413|FG000|Overall Study|Miscellaneous|0|||
164255774|NCT04238481|593302414|FG001|Overall Study|Miscellaneous|1|||
164255775|NCT04238481|593302415|FG002|Overall Study|Miscellaneous|0|||
164255776|NCT04238481|593302416|FG003|Overall Study|Miscellaneous|0|||
164255777|NCT02247011|593302417|FG000|Overall Study|Poor quality of radiological results|125|||
164255778|NCT02152371|593302418|FG000|Overall Study|Adverse Event|6|||
164255779|NCT02152371|593302419|FG001|Overall Study|Adverse Event|2|||
164255780|NCT02152371|593302418|FG000|Overall Study|Withdrawal by Subject|3|||
164255781|NCT02152371|593302419|FG001|Overall Study|Withdrawal by Subject|7|||
164255782|NCT02152371|593302418|FG000|Overall Study|Protocol Violation|2|||
164255783|NCT02152371|593302419|FG001|Overall Study|Protocol Violation|3|||
164255784|NCT02152371|593302418|FG000|Overall Study|Lost to Follow-up|1|||
164255785|NCT02152371|593302419|FG001|Overall Study|Lost to Follow-up|0|||
164255786|NCT02152371|593302418|FG000|Overall Study|Lack of Efficacy|0|||
164255787|NCT02152371|593302419|FG001|Overall Study|Lack of Efficacy|1|||
164255788|NCT02152371|593302418|FG000|Overall Study|Physician Decision|0|||
164255789|NCT02152371|593302419|FG001|Overall Study|Physician Decision|2|||
164255790|NCT02152371|593302418|FG000|Overall Study|Reason Not Given|0|||
164255791|NCT02152371|593302419|FG001|Overall Study|Reason Not Given|1|||
164255792|NCT00656058|593302421|FG000|Overall Study|Withdrawal by Subject|2|||
164255793|NCT00656058|593302421|FG000|Overall Study|Withdrawal by Subject|4|||
164255794|NCT00349921|593302423|FG000|First Spinal Injection|Physician Decision|1|||
164255795|NCT00349921|593302424|FG001|First Spinal Injection|Physician Decision|0|||
164255796|NCT00349921|593302425|FG002|First Spinal Injection|Physician Decision|0|||
164255797|NCT00349921|593302426|FG003|First Spinal Injection|Physician Decision|0|||
164255798|NCT00349921|593302423|FG000|First Spinal Injection|Adverse Event|0|||
164255799|NCT00349921|593302424|FG001|First Spinal Injection|Adverse Event|0|||
164255800|NCT00349921|593302425|FG002|First Spinal Injection|Adverse Event|1|||
164255801|NCT00349921|593302426|FG003|First Spinal Injection|Adverse Event|0|||
164255802|NCT03194568|593302427|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
164255803|NCT05285644|593302428|FG000|Overall Study|Adverse Event|3|||
164255804|NCT05285644|593302429|FG001|Overall Study|Adverse Event|3|||
164255805|NCT05285644|593302428|FG000|Overall Study|Withdrawal of Consent|2|||
164255806|NCT05285644|593302429|FG001|Overall Study|Withdrawal of Consent|5|||
164255807|NCT05285644|593302428|FG000|Overall Study|Noncompliance|0|||
164255808|NCT05285644|593302429|FG001|Overall Study|Noncompliance|4|||
164255809|NCT05285644|593302428|FG000|Overall Study|Lost to Follow-up|4|||
164255810|NCT05285644|593302429|FG001|Overall Study|Lost to Follow-up|6|||
164255811|NCT05285644|593302428|FG000|Overall Study|Disallowed Concurrent Medication|1|||
164255812|NCT05285644|593302429|FG001|Overall Study|Disallowed Concurrent Medication|1|||
164255813|NCT05285644|593302428|FG000|Overall Study|Investigator Decision|2|||
164255814|NCT05285644|593302429|FG001|Overall Study|Investigator Decision|0|||
164255815|NCT05285644|593302428|FG000|Overall Study|Protocol Deviation|1|||
164255816|NCT05285644|593302429|FG001|Overall Study|Protocol Deviation|0|||
164255817|NCT05285644|593302428|FG000|Overall Study|As specified in the Clinical Study Report|7|||
164255818|NCT05285644|593302429|FG001|Overall Study|As specified in the Clinical Study Report|3|||
164255819|NCT00920387|593302432|FG000|Stage 1|Adverse Event|1|||
164255820|NCT00920387|593302433|FG001|Stage 1|Adverse Event|0|||
164255821|NCT00920387|593302434|FG002|Stage 1|Adverse Event|0|||
164255822|NCT01448824|593303993|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255823|NCT01448824|593303994|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255824|NCT01448824|593303995|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255825|NCT01448824|593303996|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255826|NCT01448824|593303997|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255827|NCT01448824|593303998|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255828|NCT01448824|593303999|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
164255829|NCT01448824|593304000|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
164255830|NCT01448824|593303993|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255831|NCT01448824|593303994|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255832|NCT01448824|593303995|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255833|NCT01448824|593303996|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
164255834|NCT01448824|593303997|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
164255835|NCT01448824|593303998|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
164255836|NCT01448824|593303999|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255837|NCT01448824|593304000|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
164255838|NCT01448824|593303993|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255839|NCT01448824|593303994|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255840|NCT01448824|593303995|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255841|NCT01448824|593303996|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255842|NCT01448824|593303997|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255843|NCT01448824|593303998|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
164255844|NCT01448824|593303999|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255845|NCT01448824|593304000|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
164255846|NCT01448824|593303993|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
164255847|NCT01448824|593303994|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
164255848|NCT01448824|593303995|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
164255849|NCT01448824|593303996|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
164255850|NCT01448824|593303997|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
163887604|NCT03058289|591959483|FG002|Overall Study|Radiographic Deterioration|1|||
164255851|NCT01448824|593303998|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
164255852|NCT01448824|593303999|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
164255853|NCT01448824|593304000|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
164255854|NCT01448824|593303993|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163887605|NCT03058289|591959484|FG003|Overall Study|Radiographic Deterioration|2|||
164255855|NCT01448824|593303994|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255856|NCT01448824|593303995|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
163887606|NCT03058289|591959485|FG004|Overall Study|Radiographic Deterioration|6|||
164255857|NCT01448824|593303996|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255858|NCT01448824|593303997|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255859|NCT01448824|593303998|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255860|NCT01448824|593303999|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
164255861|NCT01448824|593304000|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
164255862|NCT01448824|593303993|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255863|NCT01448824|593303994|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255864|NCT01448824|593303995|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255865|NCT01448824|593303996|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255866|NCT01448824|593303997|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255867|NCT01448824|593303998|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255868|NCT01448824|593303999|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
164255869|NCT01448824|593304000|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
164255870|NCT01448824|593303993|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255871|NCT01448824|593303994|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255872|NCT01448824|593303995|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255873|NCT01448824|593303996|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255874|NCT01448824|593303997|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255875|NCT01448824|593303998|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255876|NCT01448824|593303999|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
164255877|NCT01448824|593304000|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
164255878|NCT01448824|593303993|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255879|NCT01448824|593303994|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255880|NCT01448824|593303995|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255881|NCT01448824|593303996|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255882|NCT01448824|593303997|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255883|NCT01448824|593303998|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255884|NCT01448824|593303999|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
164255885|NCT01448824|593304000|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
164255886|NCT01537081|593304003|FG000|Overall Study|Adverse Event|5|||
164255887|NCT01537081|593304004|FG001|Overall Study|Adverse Event|2|||
164255888|NCT01537081|593304005|FG002|Overall Study|Adverse Event|2|||
164255889|NCT01537081|593304003|FG000|Overall Study|Lack of Efficacy|2|||
164255890|NCT01537081|593304004|FG001|Overall Study|Lack of Efficacy|1|||
164255891|NCT01537081|593304005|FG002|Overall Study|Lack of Efficacy|0|||
164255892|NCT01537081|593304003|FG000|Overall Study|Lost to Follow-up|17|||
164255893|NCT01537081|593304004|FG001|Overall Study|Lost to Follow-up|15|||
164255894|NCT01537081|593304005|FG002|Overall Study|Lost to Follow-up|9|||
164255895|NCT01537081|593304003|FG000|Overall Study|Protocol Violation|3|||
164255896|NCT01537081|593304004|FG001|Overall Study|Protocol Violation|2|||
164255897|NCT01537081|593304005|FG002|Overall Study|Protocol Violation|2|||
164255898|NCT01537081|593304003|FG000|Overall Study|Withdrawal by Subject|6|||
164255899|NCT01537081|593304004|FG001|Overall Study|Withdrawal by Subject|11|||
164255900|NCT01537081|593304005|FG002|Overall Study|Withdrawal by Subject|3|||
164255901|NCT01537081|593304003|FG000|Overall Study|Physician Decision|5|||
164255902|NCT01537081|593304004|FG001|Overall Study|Physician Decision|6|||
164255903|NCT01537081|593304005|FG002|Overall Study|Physician Decision|0|||
164255904|NCT01537081|593304003|FG000|Overall Study|Sponsor decision|0|||
164255905|NCT01537081|593304004|FG001|Overall Study|Sponsor decision|1|||
164255906|NCT01537081|593304005|FG002|Overall Study|Sponsor decision|0|||
164255907|NCT01537081|593304003|FG000|Overall Study|Assigned but never dosed|1|||
164255908|NCT01537081|593304004|FG001|Overall Study|Assigned but never dosed|0|||
164255909|NCT01537081|593304005|FG002|Overall Study|Assigned but never dosed|0|||
164255910|NCT01110330|593304010|FG000|Overall Study|Adverse Event|0|||
164255911|NCT01110330|593304011|FG001|Overall Study|Adverse Event|4|||
164255912|NCT01110330|593304012|FG002|Overall Study|Adverse Event|3|||
164255913|NCT01110330|593304010|FG000|Overall Study|Lack of Efficacy|3|||
164255914|NCT01110330|593304011|FG001|Overall Study|Lack of Efficacy|1|||
164255915|NCT01110330|593304012|FG002|Overall Study|Lack of Efficacy|1|||
164255916|NCT01110330|593304010|FG000|Overall Study|Lost to Follow-up|9|||
164255917|NCT01110330|593304011|FG001|Overall Study|Lost to Follow-up|10|||
164255918|NCT01110330|593304012|FG002|Overall Study|Lost to Follow-up|15|||
164255919|NCT01110330|593304010|FG000|Overall Study|Physician Decision|0|||
164255920|NCT01110330|593304011|FG001|Overall Study|Physician Decision|1|||
163887607|NCT03058289|591959486|FG005|Overall Study|Radiographic Deterioration|3|||
164255921|NCT01110330|593304012|FG002|Overall Study|Physician Decision|0|||
164255922|NCT01110330|593304010|FG000|Overall Study|Protocol Violation|2|||
164255923|NCT01110330|593304011|FG001|Overall Study|Protocol Violation|0|||
164255924|NCT01110330|593304012|FG002|Overall Study|Protocol Violation|4|||
164255925|NCT01110330|593304010|FG000|Overall Study|Withdrawal by Subject|0|||
164255926|NCT01110330|593304011|FG001|Overall Study|Withdrawal by Subject|6|||
164255927|NCT01110330|593304012|FG002|Overall Study|Withdrawal by Subject|2|||
164255928|NCT01110330|593304010|FG000|Overall Study|Other|1|||
163992067|NCT00559273|592339659|FG000|Evaluation Period (8 Weeks)|Death|1|||
163992068|NCT00559273|592339660|FG001|Evaluation Period (8 Weeks)|Death|3|||
163992069|NCT00559273|592339659|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
163992070|NCT00559273|592339660|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
163992071|NCT00559273|592339659|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
163992072|NCT00559273|592339660|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
163992073|NCT00559273|592339659|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
163992074|NCT00559273|592339660|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
163992075|NCT03653390|592339664|FG000|Overall Study|Lost to Follow-up|12|||
163992076|NCT03653390|592339665|FG001|Overall Study|Lost to Follow-up|8|||
163992077|NCT03653390|592339666|FG002|Overall Study|Lost to Follow-up|7|||
163992078|NCT03653390|592339664|FG000|Overall Study|Withdrawal by Subject|6|||
163992079|NCT03653390|592339665|FG001|Overall Study|Withdrawal by Subject|1|||
163992080|NCT03653390|592339666|FG002|Overall Study|Withdrawal by Subject|1|||
163992081|NCT03653390|592339664|FG000|Overall Study|Death|1|||
163992082|NCT03653390|592339665|FG001|Overall Study|Death|0|||
163992083|NCT03653390|592339666|FG002|Overall Study|Death|0|||
163992084|NCT03653390|592339664|FG000|Overall Study|Paper Survey Lost|1|||
163992085|NCT03653390|592339665|FG001|Overall Study|Paper Survey Lost|0|||
163992086|NCT03653390|592339666|FG002|Overall Study|Paper Survey Lost|0|||
164255929|NCT01110330|593304011|FG001|Overall Study|Other|1|||
164255930|NCT01110330|593304012|FG002|Overall Study|Other|1|||
164255931|NCT02759107|593304013|FG000|Overall Study|Adverse Event|0|||
164255932|NCT02759107|593304014|FG001|Overall Study|Adverse Event|0|||
164255933|NCT02759107|593304015|FG002|Overall Study|Adverse Event|0|||
164255934|NCT02759107|593304016|FG003|Overall Study|Adverse Event|0|||
164255935|NCT02759107|593304017|FG004|Overall Study|Adverse Event|0|||
164255936|NCT02759107|593304018|FG005|Overall Study|Adverse Event|0|||
164255937|NCT02759107|593304019|FG006|Overall Study|Adverse Event|0|||
164255938|NCT02759107|593304020|FG007|Overall Study|Adverse Event|0|||
164255939|NCT02759107|593304021|FG008|Overall Study|Adverse Event|0|||
164255940|NCT02759107|593304022|FG009|Overall Study|Adverse Event|0|||
164255941|NCT02759107|593304023|FG010|Overall Study|Adverse Event|0|||
164255942|NCT02759107|593304024|FG011|Overall Study|Adverse Event|0|||
164255943|NCT02759107|593304025|FG012|Overall Study|Adverse Event|2|||
164255944|NCT02759107|593304026|FG013|Overall Study|Adverse Event|0|||
164255945|NCT02759107|593304027|FG014|Overall Study|Adverse Event|0|||
164255946|NCT02759107|593304028|FG015|Overall Study|Adverse Event|1|||
164255947|NCT02759107|593304029|FG016|Overall Study|Adverse Event|0|||
164255948|NCT02759107|593304030|FG017|Overall Study|Adverse Event|2|||
164255949|NCT02759107|593304013|FG000|Overall Study|Scheduling Conflict|0|||
164255950|NCT02759107|593304014|FG001|Overall Study|Scheduling Conflict|0|||
164255951|NCT02759107|593304015|FG002|Overall Study|Scheduling Conflict|0|||
164255952|NCT02759107|593304016|FG003|Overall Study|Scheduling Conflict|0|||
164255953|NCT02759107|593304017|FG004|Overall Study|Scheduling Conflict|0|||
164255954|NCT02759107|593304018|FG005|Overall Study|Scheduling Conflict|0|||
164255955|NCT02759107|593304019|FG006|Overall Study|Scheduling Conflict|0|||
164255956|NCT02759107|593304020|FG007|Overall Study|Scheduling Conflict|0|||
164255957|NCT02759107|593304021|FG008|Overall Study|Scheduling Conflict|0|||
164255958|NCT02759107|593304022|FG009|Overall Study|Scheduling Conflict|1|||
164255959|NCT02759107|593304023|FG010|Overall Study|Scheduling Conflict|0|||
164255960|NCT02759107|593304024|FG011|Overall Study|Scheduling Conflict|0|||
164255961|NCT02759107|593304025|FG012|Overall Study|Scheduling Conflict|0|||
164255962|NCT02759107|593304026|FG013|Overall Study|Scheduling Conflict|0|||
164255963|NCT02759107|593304027|FG014|Overall Study|Scheduling Conflict|0|||
164255964|NCT02759107|593304028|FG015|Overall Study|Scheduling Conflict|0|||
164255965|NCT02759107|593304029|FG016|Overall Study|Scheduling Conflict|0|||
164255966|NCT02759107|593304030|FG017|Overall Study|Scheduling Conflict|0|||
164255967|NCT02526524|593304036|FG000|Overall Study|Withdrawal by Subject|3|||
164255968|NCT02526524|593304037|FG001|Overall Study|Withdrawal by Subject|3|||
164255969|NCT02526524|593304038|FG002|Overall Study|Withdrawal by Subject|6|||
164255970|NCT02526524|593304039|FG003|Overall Study|Withdrawal by Subject|1|||
164255971|NCT02526524|593304040|FG004|Overall Study|Withdrawal by Subject|9|||
164255972|NCT02526524|593304041|FG005|Overall Study|Withdrawal by Subject|5|||
164255973|NCT02526524|593304036|FG000|Overall Study|Adverse Event|3|||
164255974|NCT02526524|593304037|FG001|Overall Study|Adverse Event|2|||
164255975|NCT02526524|593304038|FG002|Overall Study|Adverse Event|4|||
164255976|NCT02526524|593304039|FG003|Overall Study|Adverse Event|2|||
164255977|NCT02526524|593304040|FG004|Overall Study|Adverse Event|6|||
164255978|NCT02526524|593304041|FG005|Overall Study|Adverse Event|8|||
164255979|NCT02526524|593304036|FG000|Overall Study|Lost to Follow-up|2|||
164255980|NCT02526524|593304037|FG001|Overall Study|Lost to Follow-up|3|||
164255981|NCT02526524|593304038|FG002|Overall Study|Lost to Follow-up|8|||
164255982|NCT02526524|593304039|FG003|Overall Study|Lost to Follow-up|1|||
164255983|NCT02526524|593304040|FG004|Overall Study|Lost to Follow-up|2|||
164339125|NCT00474760|593617151|FG004|Overall Study|Adverse Event|1|||
164339126|NCT00474760|593617152|FG005|Overall Study|Adverse Event|7|||
164339127|NCT00474760|593617153|FG006|Overall Study|Adverse Event|0|||
164339128|NCT00474760|593617147|FG000|Overall Study|Laboratory abnormality|0|||
164339129|NCT00474760|593617148|FG001|Overall Study|Laboratory abnormality|0|||
164339130|NCT00474760|593617149|FG002|Overall Study|Laboratory abnormality|0|||
164339131|NCT00474760|593617150|FG003|Overall Study|Laboratory abnormality|0|||
164339132|NCT00474760|593617151|FG004|Overall Study|Laboratory abnormality|0|||
164339133|NCT00474760|593617152|FG005|Overall Study|Laboratory abnormality|1|||
163887608|NCT03058289|591959487|FG006|Overall Study|Radiographic Deterioration|0|||
164084709|NCT00457665|592673995|FG001|12 Months|Withdrawal by Subject|2|||
164084710|NCT00457665|592673994|FG000|12 Months|Abnormal Liver function tests|0|||
164255984|NCT02526524|593304041|FG005|Overall Study|Lost to Follow-up|5|||
164255985|NCT02526524|593304036|FG000|Overall Study|Protocol Violation|3|||
164255986|NCT02526524|593304037|FG001|Overall Study|Protocol Violation|1|||
164255987|NCT02526524|593304038|FG002|Overall Study|Protocol Violation|5|||
164255988|NCT02526524|593304039|FG003|Overall Study|Protocol Violation|3|||
163887609|NCT03058289|591959488|FG007|Overall Study|Radiographic Deterioration|4|||
164255989|NCT02526524|593304040|FG004|Overall Study|Protocol Violation|4|||
164255990|NCT02526524|593304041|FG005|Overall Study|Protocol Violation|3|||
164255991|NCT02526524|593304036|FG000|Overall Study|Loss of Glucose Control|0|||
164255992|NCT02526524|593304037|FG001|Overall Study|Loss of Glucose Control|0|||
164255993|NCT02526524|593304038|FG002|Overall Study|Loss of Glucose Control|3|||
164339134|NCT00474760|593617153|FG006|Overall Study|Laboratory abnormality|0|||
164339135|NCT00474760|593617147|FG000|Overall Study|Withdrawal by Subject|0|||
164255994|NCT02526524|593304039|FG003|Overall Study|Loss of Glucose Control|0|||
164255995|NCT02526524|593304040|FG004|Overall Study|Loss of Glucose Control|2|||
164255996|NCT02526524|593304041|FG005|Overall Study|Loss of Glucose Control|0|||
164255997|NCT02526524|593304036|FG000|Overall Study|Physician Decision|0|||
164255998|NCT02526524|593304037|FG001|Overall Study|Physician Decision|0|||
164255999|NCT02526524|593304038|FG002|Overall Study|Physician Decision|0|||
164256000|NCT02526524|593304039|FG003|Overall Study|Physician Decision|0|||
164256001|NCT02526524|593304040|FG004|Overall Study|Physician Decision|1|||
164256002|NCT02526524|593304041|FG005|Overall Study|Physician Decision|0|||
164256003|NCT02526524|593304036|FG000|Overall Study|Sponsor Decision|1|||
164256004|NCT02526524|593304037|FG001|Overall Study|Sponsor Decision|0|||
164256005|NCT02526524|593304038|FG002|Overall Study|Sponsor Decision|0|||
164256006|NCT02526524|593304039|FG003|Overall Study|Sponsor Decision|0|||
164256007|NCT02526524|593304040|FG004|Overall Study|Sponsor Decision|0|||
164256008|NCT02526524|593304041|FG005|Overall Study|Sponsor Decision|0|||
164256009|NCT03002818|593304042|FG000|Overall Study|Decision of the investigator|1|||
164256010|NCT03764631|593304044|FG000|Overall Study|Personal Reasons|3|||
164256011|NCT03764631|593304045|FG001|Overall Study|Personal Reasons|2|||
164256012|NCT03764631|593304044|FG000|Overall Study|Switching Therapy|3|||
164256013|NCT03764631|593304045|FG001|Overall Study|Switching Therapy|3|||
164256014|NCT03764631|593304044|FG000|Overall Study|Adverse Event|0|||
164256015|NCT03764631|593304045|FG001|Overall Study|Adverse Event|1|||
164256016|NCT03764631|593304044|FG000|Overall Study|Lost to Follow-up|33|||
164256017|NCT03764631|593304045|FG001|Overall Study|Lost to Follow-up|41|||
164256018|NCT03764631|593304044|FG000|Overall Study|No data as study site was closed|2|||
164256019|NCT03764631|593304045|FG001|Overall Study|No data as study site was closed|6|||
164256020|NCT01549886|593304046|FG000|Overall Study|Sponsor's decision|2|||
164256021|NCT01549886|593304047|FG001|Overall Study|Sponsor's decision|3|||
164256022|NCT00473668|593304048|FG000|Overall Study|Withdrawal by Subject|0|||
164256023|NCT00473668|593304049|FG001|Overall Study|Withdrawal by Subject|2|||
164256024|NCT00473668|593304050|FG002|Overall Study|Withdrawal by Subject|0|||
164256025|NCT00473668|593304048|FG000|Overall Study|Migrated/moved from study area|3|||
164256026|NCT00473668|593304049|FG001|Overall Study|Migrated/moved from study area|2|||
164256027|NCT00473668|593304050|FG002|Overall Study|Migrated/moved from study area|0|||
164256028|NCT00473668|593304048|FG000|Overall Study|Lost to Follow-up|0|||
164256029|NCT00473668|593304049|FG001|Overall Study|Lost to Follow-up|4|||
164256030|NCT00473668|593304050|FG002|Overall Study|Lost to Follow-up|6|||
164256031|NCT00473668|593304048|FG000|Overall Study|Other|2|||
164256032|NCT00473668|593304049|FG001|Overall Study|Other|3|||
164256033|NCT00473668|593304050|FG002|Overall Study|Other|4|||
164256034|NCT02039219|593304051|FG000|Treatment|Withdrawal by Subject|1|||
164256035|NCT02039219|593304052|FG001|Treatment|Withdrawal by Subject|0|||
164256036|NCT02039219|593304051|FG000|Treatment|Adverse Event|0|||
164256037|NCT02039219|593304052|FG001|Treatment|Adverse Event|1|||
164256038|NCT02039219|593304051|FG000|Treatment|Physician Decision|1|||
164256039|NCT02039219|593304052|FG001|Treatment|Physician Decision|0|||
164256040|NCT02039219|593304051|FG000|Treatment|Lost to Follow-up|0|||
164256041|NCT02039219|593304052|FG001|Treatment|Lost to Follow-up|1|||
164256042|NCT02039219|593304051|FG000|Treatment|Protocol Violation|1|||
164256043|NCT02039219|593304052|FG001|Treatment|Protocol Violation|0|||
164256044|NCT02039219|593304051|FG000|Treatment|Death|1|||
164256045|NCT02039219|593304052|FG001|Treatment|Death|0|||
164256046|NCT02039219|593304051|FG000|Follow up|Adverse Event|0|||
164256047|NCT02039219|593304052|FG001|Follow up|Adverse Event|1|||
164256048|NCT02226562|593304058|FG000|Overall Study|Lost to Follow-up|0|||
164256049|NCT02226562|593304059|FG001|Overall Study|Lost to Follow-up|1|||
164256050|NCT04569136|593304060|FG000|Overall Study|Lost to Follow-up|2|||
164256051|NCT04569136|593304061|FG001|Overall Study|Lost to Follow-up|0|||
164256052|NCT04569136|593304062|FG002|Overall Study|Lost to Follow-up|1|||
164256053|NCT01466660|593304068|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
164256054|NCT01466660|593304069|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
164256055|NCT01466660|593304068|FG000|Overall Study|Worsening of underlying cancer disease|5|||
164256056|NCT01466660|593304069|FG001|Overall Study|Worsening of underlying cancer disease|2|||
164339136|NCT00474760|593617148|FG001|Overall Study|Withdrawal by Subject|0|||
164256057|NCT01466660|593304068|FG000|Overall Study|Other adverse event|19|||
164256058|NCT01466660|593304069|FG001|Overall Study|Other adverse event|18|||
164256059|NCT01466660|593304068|FG000|Overall Study|Protocol Violation|2|||
164256060|NCT01466660|593304069|FG001|Overall Study|Protocol Violation|1|||
164256061|NCT01466660|593304068|FG000|Overall Study|Refused continuation of trial medication|4|||
164339137|NCT00474760|593617149|FG002|Overall Study|Withdrawal by Subject|0|||
164256062|NCT01466660|593304069|FG001|Overall Study|Refused continuation of trial medication|3|||
164256063|NCT01466660|593304068|FG000|Overall Study|Other reason not defined above|10|||
164256064|NCT01466660|593304069|FG001|Overall Study|Other reason not defined above|8|||
164256065|NCT03576066|593304070|FG000|Overall Study|Noncompliance with study drug|0|||
164256066|NCT03576066|593304071|FG001|Overall Study|Noncompliance with study drug|1|||
164339138|NCT00474760|593617150|FG003|Overall Study|Withdrawal by Subject|1|||
164256067|NCT00608023|593304072|FG000|Overall Study|Withdrawal by Subject|8|||
164256068|NCT00608023|593304073|FG001|Overall Study|Withdrawal by Subject|10|||
164256069|NCT00608023|593304074|FG002|Overall Study|Withdrawal by Subject|7|||
164256070|NCT00608023|593304072|FG000|Overall Study|Adverse Event|1|||
164256071|NCT00608023|593304073|FG001|Overall Study|Adverse Event|4|||
164256072|NCT00608023|593304074|FG002|Overall Study|Adverse Event|5|||
164256073|NCT00608023|593304072|FG000|Overall Study|Lost to Follow-up|2|||
164256074|NCT00608023|593304073|FG001|Overall Study|Lost to Follow-up|2|||
164256075|NCT00608023|593304074|FG002|Overall Study|Lost to Follow-up|1|||
164256076|NCT00608023|593304072|FG000|Overall Study|Protocol Violation|1|||
164256077|NCT00608023|593304073|FG001|Overall Study|Protocol Violation|3|||
164256078|NCT00608023|593304074|FG002|Overall Study|Protocol Violation|1|||
164256079|NCT00608023|593304072|FG000|Overall Study|Unknown reason|0|||
164256080|NCT00608023|593304073|FG001|Overall Study|Unknown reason|3|||
164256081|NCT00608023|593304074|FG002|Overall Study|Unknown reason|0|||
164256082|NCT05275010|593304078|FG000|Overall Study|Reason Not Specified|4|||
164256083|NCT05275010|593304079|FG001|Overall Study|Reason Not Specified|1|||
164256084|NCT05275010|593304078|FG000|Overall Study|Withdrawal by Subject|1|||
164256085|NCT05275010|593304079|FG001|Overall Study|Withdrawal by Subject|0|||
164256086|NCT05275010|593304078|FG000|Overall Study|Lost to Follow-up|0|||
164256087|NCT05275010|593304079|FG001|Overall Study|Lost to Follow-up|1|||
164256088|NCT04484649|593304082|FG000|Overall Study|Lost to Follow-up|2|||
164256089|NCT04484649|593304083|FG001|Overall Study|Lost to Follow-up|1|||
164256090|NCT04484649|593304082|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
164256091|NCT04484649|593304083|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
164256092|NCT01681069|593304084|FG000|Overall Study|Withdrawal by Subject|4|||
164256093|NCT01681069|593304085|FG001|Overall Study|Withdrawal by Subject|5|||
164256094|NCT01681069|593304084|FG000|Overall Study|Protocol Violation|1|||
164256095|NCT01681069|593304085|FG001|Overall Study|Protocol Violation|1|||
164256096|NCT01681069|593304084|FG000|Overall Study|Adverse Event|0|||
164256097|NCT01681069|593304085|FG001|Overall Study|Adverse Event|1|||
164256098|NCT01463696|593304086|FG000|Overall Study|Adverse Event|0|||
164256099|NCT01463696|593304087|FG001|Overall Study|Adverse Event|1|||
164256100|NCT01463696|593304088|FG002|Overall Study|Adverse Event|0|||
164256101|NCT01463696|593304089|FG003|Overall Study|Adverse Event|2|||
164256102|NCT01463696|593304090|FG004|Overall Study|Adverse Event|0|||
164256103|NCT01463696|593304091|FG005|Overall Study|Adverse Event|1|||
164256104|NCT01463696|593304092|FG006|Overall Study|Adverse Event|3|||
164256105|NCT01463696|593304093|FG007|Overall Study|Adverse Event|2|||
164256106|NCT01463696|593304086|FG000|Overall Study|Lost to Follow-up|0|||
164256107|NCT01463696|593304087|FG001|Overall Study|Lost to Follow-up|0|||
164256108|NCT01463696|593304088|FG002|Overall Study|Lost to Follow-up|1|||
164256109|NCT01463696|593304089|FG003|Overall Study|Lost to Follow-up|0|||
164256110|NCT01463696|593304090|FG004|Overall Study|Lost to Follow-up|0|||
164256111|NCT01463696|593304091|FG005|Overall Study|Lost to Follow-up|0|||
164256112|NCT01463696|593304092|FG006|Overall Study|Lost to Follow-up|0|||
164256113|NCT01463696|593304093|FG007|Overall Study|Lost to Follow-up|0|||
164256114|NCT01463696|593304086|FG000|Overall Study|Progressive Disease|0|||
164256115|NCT01463696|593304087|FG001|Overall Study|Progressive Disease|1|||
164256116|NCT01463696|593304088|FG002|Overall Study|Progressive Disease|0|||
164256117|NCT01463696|593304089|FG003|Overall Study|Progressive Disease|1|||
164339139|NCT00474760|593617151|FG004|Overall Study|Withdrawal by Subject|0|||
164339140|NCT00474760|593617152|FG005|Overall Study|Withdrawal by Subject|1|||
164339141|NCT00474760|593617153|FG006|Overall Study|Withdrawal by Subject|1|||
164339142|NCT00474760|593617147|FG000|Overall Study|Other|0|||
164339143|NCT00474760|593617148|FG001|Overall Study|Other|1|||
164339144|NCT00474760|593617149|FG002|Overall Study|Other|0|||
164339145|NCT00474760|593617150|FG003|Overall Study|Other|0|||
164339146|NCT00474760|593617151|FG004|Overall Study|Other|1|||
164339147|NCT00474760|593617152|FG005|Overall Study|Other|0|||
164339148|NCT00474760|593617153|FG006|Overall Study|Other|0|||
164339149|NCT00474760|593617147|FG000|Overall Study|Progressive disease|3|||
164339150|NCT00474760|593617148|FG001|Overall Study|Progressive disease|2|||
164339151|NCT00474760|593617149|FG002|Overall Study|Progressive disease|3|||
164256118|NCT01463696|593304090|FG004|Overall Study|Progressive Disease|0|||
164256119|NCT01463696|593304091|FG005|Overall Study|Progressive Disease|1|||
164256120|NCT01463696|593304092|FG006|Overall Study|Progressive Disease|4|||
164256121|NCT01463696|593304093|FG007|Overall Study|Progressive Disease|2|||
164339152|NCT00474760|593617150|FG003|Overall Study|Progressive disease|2|||
164256122|NCT01463696|593304086|FG000|Overall Study|Withdrawal by Subject|0|||
164256123|NCT01463696|593304087|FG001|Overall Study|Withdrawal by Subject|0|||
164256124|NCT01463696|593304088|FG002|Overall Study|Withdrawal by Subject|0|||
164256125|NCT01463696|593304089|FG003|Overall Study|Withdrawal by Subject|1|||
164256126|NCT01463696|593304090|FG004|Overall Study|Withdrawal by Subject|1|||
164339153|NCT00474760|593617151|FG004|Overall Study|Progressive disease|8|||
164339154|NCT00474760|593617152|FG005|Overall Study|Progressive disease|20|||
164256127|NCT01463696|593304091|FG005|Overall Study|Withdrawal by Subject|1|||
164339155|NCT00474760|593617153|FG006|Overall Study|Progressive disease|7|||
164339156|NCT00474760|593617147|FG000|Overall Study|Terminated by sponsor|0|||
164084711|NCT00457665|592673995|FG001|12 Months|Abnormal Liver function tests|5|||
164084712|NCT00457665|592673994|FG000|24 Months|Withdrawal by Subject|3|||
164084713|NCT00457665|592673995|FG001|24 Months|Withdrawal by Subject|2|||
164084714|NCT00457665|592673994|FG000|24 Months|Lipodystrophy|1|||
163887610|NCT03058289|591959489|FG008|Overall Study|Radiographic Deterioration|2|||
164084715|NCT00457665|592673995|FG001|24 Months|Lipodystrophy|1|||
164084716|NCT00457665|592673994|FG000|24 Months|Abnormal liver function tests|1|||
164084717|NCT00457665|592673995|FG001|24 Months|Abnormal liver function tests|5|||
164084718|NCT02535000|592673996|FG000|Overall Study|Cancellation of surgery.|1|||
164084719|NCT02535000|592673997|FG001|Overall Study|Cancellation of surgery.|2|||
164084720|NCT04317781|592673999|FG000|Overall Study|Adverse Event|1|||
164084721|NCT04317781|592673999|FG000|Overall Study|Disease relapse|1|||
164084722|NCT04317781|592673999|FG000|Overall Study|Withdrawal by Subject|1|||
164084723|NCT00706706|592674002|FG000|Overall Study|Death|53|||
164084724|NCT00706706|592674002|FG000|Overall Study|Lost to Follow-up|7|||
164084725|NCT00706706|592674002|FG000|Overall Study|Study endpoint had reached|45|||
164084726|NCT02175966|592674007|FG000|Follow-up Period|Lack of Efficacy|10|||
164084727|NCT02175966|592674008|FG001|Follow-up Period|Lack of Efficacy|6|||
164084728|NCT00210626|592674009|FG000|Overall Study|Adverse Event|1|||
164084729|NCT00210626|592674010|FG001|Overall Study|Adverse Event|2|||
164084730|NCT00210626|592674009|FG000|Overall Study|Protocol Violation|1|||
164084731|NCT00210626|592674010|FG001|Overall Study|Protocol Violation|5|||
163887611|NCT03058289|591959481|FG000|Overall Study|Adverse Event|2|||
163887612|NCT03058289|591959482|FG001|Overall Study|Adverse Event|0|||
163887613|NCT03058289|591959483|FG002|Overall Study|Adverse Event|1|||
163887614|NCT03058289|591959484|FG003|Overall Study|Adverse Event|3|||
163887615|NCT03058289|591959485|FG004|Overall Study|Adverse Event|1|||
163887616|NCT03058289|591959486|FG005|Overall Study|Adverse Event|0|||
163887617|NCT03058289|591959487|FG006|Overall Study|Adverse Event|1|||
163887618|NCT03058289|591959488|FG007|Overall Study|Adverse Event|3|||
163887619|NCT03058289|591959489|FG008|Overall Study|Adverse Event|0|||
163887620|NCT03058289|591959481|FG000|Overall Study|Withdrawal by Subject|0|||
163887621|NCT03058289|591959482|FG001|Overall Study|Withdrawal by Subject|0|||
163887622|NCT03058289|591959483|FG002|Overall Study|Withdrawal by Subject|0|||
163887623|NCT03058289|591959484|FG003|Overall Study|Withdrawal by Subject|2|||
163887624|NCT03058289|591959485|FG004|Overall Study|Withdrawal by Subject|0|||
163887625|NCT03058289|591959486|FG005|Overall Study|Withdrawal by Subject|2|||
163887626|NCT03058289|591959487|FG006|Overall Study|Withdrawal by Subject|0|||
163887627|NCT03058289|591959488|FG007|Overall Study|Withdrawal by Subject|4|||
163887628|NCT03058289|591959489|FG008|Overall Study|Withdrawal by Subject|1|||
163887629|NCT03058289|591959481|FG000|Overall Study|Physician Decision|1|||
163887630|NCT03058289|591959482|FG001|Overall Study|Physician Decision|0|||
163887631|NCT03058289|591959483|FG002|Overall Study|Physician Decision|0|||
164084732|NCT00210626|592674009|FG000|Overall Study|Lost to Follow-up|11|||
164084733|NCT00210626|592674010|FG001|Overall Study|Lost to Follow-up|11|||
164084734|NCT00210626|592674009|FG000|Overall Study|Death|1|||
164084735|NCT00210626|592674010|FG001|Overall Study|Death|0|||
164084736|NCT00210626|592674009|FG000|Overall Study|Withdrawal by Subject|29|||
164084737|NCT00210626|592674010|FG001|Overall Study|Withdrawal by Subject|20|||
164084738|NCT00210626|592674009|FG000|Overall Study|Physician Decision|0|||
164084739|NCT00210626|592674010|FG001|Overall Study|Physician Decision|2|||
163887632|NCT03058289|591959484|FG003|Overall Study|Physician Decision|2|||
163887633|NCT03058289|591959485|FG004|Overall Study|Physician Decision|1|||
163887634|NCT03058289|591959486|FG005|Overall Study|Physician Decision|0|||
163887635|NCT03058289|591959487|FG006|Overall Study|Physician Decision|2|||
164084740|NCT00210626|592674009|FG000|Overall Study|Sponser Request|1|||
164084741|NCT00210626|592674010|FG001|Overall Study|Sponser Request|0|||
164084742|NCT00210626|592674009|FG000|Overall Study|Other|4|||
164084743|NCT00210626|592674010|FG001|Overall Study|Other|5|||
164084744|NCT03361956|592674011|FG000|Overall Study|Adverse Event|1|||
164084745|NCT03361956|592674012|FG001|Overall Study|Adverse Event|0|||
164084746|NCT03361956|592674013|FG002|Overall Study|Adverse Event|1|||
164084747|NCT03361956|592674014|FG003|Overall Study|Adverse Event|1|||
163887636|NCT03058289|591959488|FG007|Overall Study|Physician Decision|3|||
163887637|NCT03058289|591959489|FG008|Overall Study|Physician Decision|0|||
163887638|NCT03058289|591959481|FG000|Overall Study|Clinical Deterioration|2|||
163887639|NCT03058289|591959482|FG001|Overall Study|Clinical Deterioration|0|||
163887640|NCT03058289|591959483|FG002|Overall Study|Clinical Deterioration|0|||
163887641|NCT03058289|591959484|FG003|Overall Study|Clinical Deterioration|2|||
163887642|NCT03058289|591959485|FG004|Overall Study|Clinical Deterioration|1|||
163887643|NCT03058289|591959486|FG005|Overall Study|Clinical Deterioration|1|||
163887644|NCT03058289|591959487|FG006|Overall Study|Clinical Deterioration|0|||
163887645|NCT03058289|591959488|FG007|Overall Study|Clinical Deterioration|3|||
163887646|NCT03058289|591959489|FG008|Overall Study|Clinical Deterioration|2|||
163887647|NCT03058289|591959481|FG000|Overall Study|Lost to Follow-up|0|||
163887648|NCT03058289|591959482|FG001|Overall Study|Lost to Follow-up|0|||
163887649|NCT03058289|591959483|FG002|Overall Study|Lost to Follow-up|0|||
163887650|NCT03058289|591959484|FG003|Overall Study|Lost to Follow-up|0|||
163887651|NCT03058289|591959485|FG004|Overall Study|Lost to Follow-up|1|||
163887652|NCT03058289|591959486|FG005|Overall Study|Lost to Follow-up|0|||
163887653|NCT03058289|591959487|FG006|Overall Study|Lost to Follow-up|0|||
163887654|NCT03058289|591959488|FG007|Overall Study|Lost to Follow-up|0|||
163887655|NCT03058289|591959489|FG008|Overall Study|Lost to Follow-up|0|||
163887656|NCT03058289|591959481|FG000|Overall Study|Refused Further Treatment|0|||
163887657|NCT03058289|591959482|FG001|Overall Study|Refused Further Treatment|0|||
163887658|NCT03058289|591959483|FG002|Overall Study|Refused Further Treatment|1|||
163887659|NCT03058289|591959484|FG003|Overall Study|Refused Further Treatment|0|||
163887660|NCT03058289|591959485|FG004|Overall Study|Refused Further Treatment|1|||
164084748|NCT03361956|592674015|FG004|Overall Study|Adverse Event|0|||
164084749|NCT03361956|592674011|FG000|Overall Study|Other|0|||
164084750|NCT03361956|592674012|FG001|Overall Study|Other|0|||
164084751|NCT03361956|592674013|FG002|Overall Study|Other|0|||
164084752|NCT03361956|592674014|FG003|Overall Study|Other|1|||
164256128|NCT01463696|593304092|FG006|Overall Study|Withdrawal by Subject|2|||
164256129|NCT01463696|593304093|FG007|Overall Study|Withdrawal by Subject|0|||
164256130|NCT01463696|593304086|FG000|Overall Study|Not Treated|0|||
164256131|NCT01463696|593304087|FG001|Overall Study|Not Treated|0|||
164256132|NCT01463696|593304088|FG002|Overall Study|Not Treated|0|||
164256133|NCT01463696|593304089|FG003|Overall Study|Not Treated|0|||
164256134|NCT01463696|593304090|FG004|Overall Study|Not Treated|0|||
164256135|NCT01463696|593304091|FG005|Overall Study|Not Treated|0|||
164256136|NCT01463696|593304092|FG006|Overall Study|Not Treated|1|||
164256137|NCT01463696|593304093|FG007|Overall Study|Not Treated|0|||
164256138|NCT03883165|593304095|FG000|Overall Study|Withdrawal by Subject|4|||
164256139|NCT03883165|593304096|FG001|Overall Study|Withdrawal by Subject|3|||
164256140|NCT00967694|593304097|FG000|Overall Study|Withdrawal by Subject|6|||
164256141|NCT00245050|593304098|FG000|Overall Study|Adverse Event|3|||
164256142|NCT00245050|593304099|FG001|Overall Study|Adverse Event|2|||
164256143|NCT03275246|593304102|FG000|Overall Study|Protocol Violation|5|||
164256144|NCT03275246|593304102|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
164256145|NCT02301546|593304103|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
164256146|NCT02301546|593304104|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
164256147|NCT02301546|593304103|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
163992087|NCT00849667|592339669|FG000|Overall Study|Withdrawal by Subject|16|||
164256148|NCT02301546|593304104|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
164256149|NCT02301546|593304103|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
164256150|NCT02301546|593304104|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
164256151|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
164256152|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
164256153|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
164256154|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
164256155|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
164256156|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
164256157|NCT02301546|593304103|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
164256158|NCT02301546|593304104|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
164256159|NCT05526781|593304107|FG000|Overall Study|Lost to Follow-up|1|||
164256160|NCT03905265|593304108|FG000|Overall Study|Withdrawal by Subject|1|||
164256161|NCT03905265|593304109|FG001|Overall Study|Withdrawal by Subject|1|||
164256162|NCT03905265|593304110|FG002|Overall Study|Withdrawal by Subject|0|||
164256163|NCT03905265|593304111|FG003|Overall Study|Withdrawal by Subject|0|||
164256164|NCT04952597|593304114|FG000|Overall Study|Death|12|||
164256165|NCT04952597|593304115|FG001|Overall Study|Death|13|||
164256166|NCT04952597|593304116|FG002|Overall Study|Death|14|||
164256167|NCT04952597|593304114|FG000|Overall Study|Withdrawal by Subject|1|||
164256168|NCT04952597|593304115|FG001|Overall Study|Withdrawal by Subject|0|||
164256169|NCT04952597|593304116|FG002|Overall Study|Withdrawal by Subject|3|||
164256170|NCT04952597|593304114|FG000|Overall Study|Lost to Follow-up|0|||
164256171|NCT04952597|593304115|FG001|Overall Study|Lost to Follow-up|1|||
164256172|NCT04952597|593304116|FG002|Overall Study|Lost to Follow-up|1|||
164256173|NCT03632993|593304117|FG000|Overall Study|Withdrawal by Subject|1|||
164256174|NCT03632993|593304118|FG001|Overall Study|Withdrawal by Subject|0|||
164256175|NCT03632993|593304119|FG002|Overall Study|Withdrawal by Subject|0|||
164256176|NCT03632993|593304120|FG003|Overall Study|Withdrawal by Subject|0|||
164256177|NCT03632993|593304121|FG004|Overall Study|Withdrawal by Subject|0|||
164256178|NCT03632993|593304122|FG005|Overall Study|Withdrawal by Subject|0|||
164256179|NCT03632993|593304123|FG006|Overall Study|Withdrawal by Subject|0|||
164256180|NCT03632993|593304124|FG007|Overall Study|Withdrawal by Subject|0|||
164256181|NCT03632993|593304125|FG008|Overall Study|Withdrawal by Subject|0|||
164256182|NCT03632993|593304126|FG009|Overall Study|Withdrawal by Subject|1|||
164256183|NCT03632993|593304117|FG000|Overall Study|Protocol Non-compliance|0|||
164256184|NCT03632993|593304118|FG001|Overall Study|Protocol Non-compliance|1|||
164256185|NCT03632993|593304119|FG002|Overall Study|Protocol Non-compliance|0|||
164256186|NCT03632993|593304120|FG003|Overall Study|Protocol Non-compliance|0|||
164256187|NCT03632993|593304121|FG004|Overall Study|Protocol Non-compliance|0|||
164256188|NCT03632993|593304122|FG005|Overall Study|Protocol Non-compliance|0|||
164256189|NCT03632993|593304123|FG006|Overall Study|Protocol Non-compliance|0|||
164256190|NCT03632993|593304124|FG007|Overall Study|Protocol Non-compliance|0|||
164256191|NCT03632993|593304125|FG008|Overall Study|Protocol Non-compliance|0|||
164256192|NCT03632993|593304126|FG009|Overall Study|Protocol Non-compliance|0|||
164256193|NCT03632993|593304117|FG000|Overall Study|Lost to Follow-up|0|||
164256194|NCT03632993|593304118|FG001|Overall Study|Lost to Follow-up|0|||
164256195|NCT03632993|593304119|FG002|Overall Study|Lost to Follow-up|0|||
164256196|NCT03632993|593304120|FG003|Overall Study|Lost to Follow-up|0|||
164256197|NCT03632993|593304121|FG004|Overall Study|Lost to Follow-up|0|||
164256198|NCT03632993|593304122|FG005|Overall Study|Lost to Follow-up|1|||
164256199|NCT03632993|593304123|FG006|Overall Study|Lost to Follow-up|0|||
164256200|NCT03632993|593304124|FG007|Overall Study|Lost to Follow-up|1|||
164256201|NCT03632993|593304125|FG008|Overall Study|Lost to Follow-up|0|||
163992088|NCT00849667|592339670|FG001|Overall Study|Withdrawal by Subject|33|||
164256202|NCT03632993|593304126|FG009|Overall Study|Lost to Follow-up|0|||
164256203|NCT03632993|593304117|FG000|Overall Study|Adverse Event|0|||
164256204|NCT03632993|593304118|FG001|Overall Study|Adverse Event|0|||
163992089|NCT00849667|592339671|FG002|Overall Study|Withdrawal by Subject|35|||
164256205|NCT03632993|593304119|FG002|Overall Study|Adverse Event|0|||
164256206|NCT03632993|593304120|FG003|Overall Study|Adverse Event|0|||
164256207|NCT03632993|593304121|FG004|Overall Study|Adverse Event|0|||
164256208|NCT03632993|593304122|FG005|Overall Study|Adverse Event|1|||
164256209|NCT03632993|593304123|FG006|Overall Study|Adverse Event|0|||
164256210|NCT03632993|593304124|FG007|Overall Study|Adverse Event|1|||
164256211|NCT03632993|593304125|FG008|Overall Study|Adverse Event|0|||
164256212|NCT03632993|593304126|FG009|Overall Study|Adverse Event|0|||
164256213|NCT01005316|593304127|FG000|Overall Study|Adverse Event|0|||
164256214|NCT01005316|593304128|FG001|Overall Study|Adverse Event|0|||
164256215|NCT01005316|593304129|FG002|Overall Study|Adverse Event|0|||
164256216|NCT01005316|593304130|FG003|Overall Study|Adverse Event|1|||
164256217|NCT01005316|593304127|FG000|Overall Study|Death|20|||
164256218|NCT01005316|593304128|FG001|Overall Study|Death|5|||
164256219|NCT01005316|593304129|FG002|Overall Study|Death|1|||
164256220|NCT01005316|593304130|FG003|Overall Study|Death|15|||
164256221|NCT01005316|593304127|FG000|Overall Study|Study Termination|5|||
164256222|NCT01005316|593304128|FG001|Overall Study|Study Termination|63|||
164256223|NCT01005316|593304129|FG002|Overall Study|Study Termination|9|||
164256224|NCT01005316|593304130|FG003|Overall Study|Study Termination|85|||
164256225|NCT01005316|593304127|FG000|Overall Study|Lost to Follow-up|1|||
164256226|NCT01005316|593304128|FG001|Overall Study|Lost to Follow-up|3|||
164256227|NCT01005316|593304129|FG002|Overall Study|Lost to Follow-up|0|||
164256228|NCT01005316|593304130|FG003|Overall Study|Lost to Follow-up|2|||
164256229|NCT01005316|593304127|FG000|Overall Study|Physician Decision|6|||
164256230|NCT01005316|593304128|FG001|Overall Study|Physician Decision|0|||
164256231|NCT01005316|593304129|FG002|Overall Study|Physician Decision|0|||
164256232|NCT01005316|593304130|FG003|Overall Study|Physician Decision|0|||
164256233|NCT01005316|593304127|FG000|Overall Study|Sponsor Decision|6|||
164256234|NCT01005316|593304128|FG001|Overall Study|Sponsor Decision|3|||
164256235|NCT01005316|593304129|FG002|Overall Study|Sponsor Decision|0|||
164256236|NCT01005316|593304130|FG003|Overall Study|Sponsor Decision|0|||
164256237|NCT01005316|593304127|FG000|Overall Study|Withdrawal by Subject|1|||
164256238|NCT01005316|593304128|FG001|Overall Study|Withdrawal by Subject|1|||
164256239|NCT01005316|593304129|FG002|Overall Study|Withdrawal by Subject|0|||
164256240|NCT01005316|593304130|FG003|Overall Study|Withdrawal by Subject|2|||
164256241|NCT01005316|593304127|FG000|Overall Study|Consented to Another Study|2|||
164256242|NCT01005316|593304128|FG001|Overall Study|Consented to Another Study|0|||
164256243|NCT01005316|593304129|FG002|Overall Study|Consented to Another Study|0|||
164256244|NCT01005316|593304130|FG003|Overall Study|Consented to Another Study|0|||
164256245|NCT01005316|593304127|FG000|Overall Study|Delisted|8|||
164256246|NCT01005316|593304128|FG001|Overall Study|Delisted|0|||
164256247|NCT01005316|593304129|FG002|Overall Study|Delisted|0|||
164256248|NCT01005316|593304130|FG003|Overall Study|Delisted|0|||
164256249|NCT01005316|593304127|FG000|Overall Study|Transferred Care|1|||
164256250|NCT01005316|593304128|FG001|Overall Study|Transferred Care|0|||
164256251|NCT01005316|593304129|FG002|Overall Study|Transferred Care|1|||
164256252|NCT01005316|593304130|FG003|Overall Study|Transferred Care|3|||
164256253|NCT01005316|593304127|FG000|Overall Study|Retransplanted|0|||
164256254|NCT01005316|593304128|FG001|Overall Study|Retransplanted|1|||
164256255|NCT01005316|593304129|FG002|Overall Study|Retransplanted|0|||
164256256|NCT01005316|593304130|FG003|Overall Study|Retransplanted|0|||
164256257|NCT00632827|593304131|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
164256258|NCT00632827|593304131|FG000|Overall Study|Death|2|||
164256259|NCT00632827|593304131|FG000|Overall Study|Adverse Event|5|||
164256260|NCT00632827|593304131|FG000|Overall Study|Lost to Follow-up|1|||
164256261|NCT00368836|593304134|FG000|Phase II|Screen Failure|1|||
164256262|NCT00368836|593304134|FG000|Phase II|Withdrawal by Subject|1|||
164256263|NCT00368836|593304134|FG000|Phase II|unable to collect blood and/or breath|17|||
164256264|NCT00368836|593304134|FG000|Phase II|Protocol Violation|2|||
164256265|NCT03272828|593304137|FG000|Overall Study|Lost to Follow-up|7|||
164256266|NCT03272828|593304138|FG001|Overall Study|Lost to Follow-up|7|||
164256267|NCT03272828|593304137|FG000|Overall Study|Withdrawal by Subject|2|||
164256268|NCT03272828|593304138|FG001|Overall Study|Withdrawal by Subject|0|||
164256269|NCT03272828|593304137|FG000|Overall Study|Deceased|1|||
164256270|NCT03272828|593304138|FG001|Overall Study|Deceased|1|||
164256271|NCT03272828|593304137|FG000|Overall Study|Failed implant|1|||
164256272|NCT03272828|593304138|FG001|Overall Study|Failed implant|2|||
164256273|NCT03888235|593304142|FG000|Overall Study|Lost to Follow-up|1|||
164256274|NCT03888235|593304143|FG001|Overall Study|Lost to Follow-up|1|||
164256275|NCT03888235|593304144|FG002|Overall Study|Lost to Follow-up|0|||
164256276|NCT01054560|593304145|FG000|Overall Study|Death|10|||
164256277|NCT01054560|593304146|FG001|Overall Study|Death|21|||
164256278|NCT01054560|593304145|FG000|Overall Study|Lost to Follow-up|2|||
164256279|NCT01054560|593304146|FG001|Overall Study|Lost to Follow-up|5|||
164256280|NCT01054560|593304145|FG000|Overall Study|Withdrawal by Subject|0|||
164256281|NCT01054560|593304146|FG001|Overall Study|Withdrawal by Subject|2|||
164256282|NCT01054560|593304145|FG000|Overall Study|Physician Decision|1|||
164256283|NCT01054560|593304146|FG001|Overall Study|Physician Decision|0|||
164256284|NCT01923363|593304152|FG000|Overall Study|Protocol Violation|1|||
164256285|NCT00244933|593304156|FG000|Overall Study|Not response evaluable|2|||
164256286|NCT00866047|593304157|FG000|Treatment Period|Progressive disease|13|||
164256287|NCT00866047|593304157|FG000|Treatment Period|Adverse Event|16|||
164256288|NCT00866047|593304157|FG000|Treatment Period|Physician Decision|14|||
164256289|NCT00866047|593304157|FG000|Treatment Period|Withdrawal by Subject|5|||
164256290|NCT00866047|593304157|FG000|Follow-up Period|Lost to Follow-up|5|||
164256291|NCT02928029|593304158|FG000|Overall Study|Withdrawal by Subject|0|||
164256292|NCT02928029|593304159|FG001|Overall Study|Withdrawal by Subject|1|||
164256293|NCT02928029|593304158|FG000|Overall Study|Radiological progression|1|||
164256294|NCT02928029|593304159|FG001|Overall Study|Radiological progression|0|||
164256295|NCT02928029|593304158|FG000|Overall Study|Clinical progression|1|||
164256296|NCT02928029|593304159|FG001|Overall Study|Clinical progression|2|||
164256297|NCT02928029|593304158|FG000|Overall Study|AE not related to clinical progression|1|||
164256298|NCT02928029|593304159|FG001|Overall Study|AE not related to clinical progression|1|||
164256299|NCT03703817|593304160|FG000|Overall Study|Not meeting eligibility criteria|7|||
164256300|NCT03703817|593304161|FG001|Overall Study|Not meeting eligibility criteria|4|||
164256301|NCT00616018|593304163|FG000|Overall Study|Protocol Violation|3|||
164256302|NCT03315793|593304164|FG000|Overall Study|Adverse Event|4|||
164256303|NCT03315793|593304165|FG001|Overall Study|Adverse Event|2|||
164256304|NCT03315793|593304164|FG000|Overall Study|Protocol Deviation|1|||
164256305|NCT03315793|593304165|FG001|Overall Study|Protocol Deviation|0|||
164256306|NCT03315793|593304164|FG000|Overall Study|Difficult for regular visit|0|||
164256307|NCT03315793|593304165|FG001|Overall Study|Difficult for regular visit|1|||
164256308|NCT01463111|593306121|FG000|Overall Study|Withdrawal by Subject|2|||
164256309|NCT01463111|593306121|FG000|Overall Study|Lost to Follow-up|5|||
164256310|NCT01463111|593306121|FG000|Overall Study|Physician Decision|2|||
164256311|NCT00882583|593306122|FG000|Overall Study|Physician Decision|1|||
164256312|NCT00882583|593306123|FG001|Overall Study|Physician Decision|0|||
164256313|NCT00882583|593306122|FG000|Overall Study|Adverse Event|0|||
164256314|NCT00882583|593306123|FG001|Overall Study|Adverse Event|1|||
164256315|NCT03389555|593306132|FG000|Overall Study|Protocol Violation|1|||
164256316|NCT03389555|593306133|FG001|Overall Study|Protocol Violation|3|||
164256317|NCT03389555|593306132|FG000|Overall Study|Death|1|||
164256318|NCT03389555|593306133|FG001|Overall Study|Death|0|||
164256319|NCT01885208|593306134|FG000|Overall Study|Unclassified|32|||
164256320|NCT01885208|593306135|FG001|Overall Study|Unclassified|38|||
164256321|NCT00920218|593306140|FG000|Overall Study|Serious Adverse Event|2|||
164256322|NCT00920218|593306141|FG001|Overall Study|Serious Adverse Event|0|||
164256323|NCT00920218|593306142|FG002|Overall Study|Serious Adverse Event|2|||
164256324|NCT00920218|593306143|FG003|Overall Study|Serious Adverse Event|1|||
164256325|NCT00920218|593306140|FG000|Overall Study|Withdrawal by Subject|0|||
164256326|NCT00920218|593306141|FG001|Overall Study|Withdrawal by Subject|3|||
164256327|NCT00920218|593306142|FG002|Overall Study|Withdrawal by Subject|2|||
164256328|NCT00920218|593306143|FG003|Overall Study|Withdrawal by Subject|0|||
164256329|NCT00920218|593306140|FG000|Overall Study|Migrated/moved from study area|0|||
164256330|NCT00920218|593306141|FG001|Overall Study|Migrated/moved from study area|0|||
164256331|NCT00920218|593306142|FG002|Overall Study|Migrated/moved from study area|1|||
164256332|NCT00920218|593306143|FG003|Overall Study|Migrated/moved from study area|0|||
164256333|NCT00920218|593306140|FG000|Overall Study|Lost to Follow-up|0|||
164256334|NCT00920218|593306141|FG001|Overall Study|Lost to Follow-up|1|||
164256335|NCT00920218|593306142|FG002|Overall Study|Lost to Follow-up|0|||
164256336|NCT00920218|593306143|FG003|Overall Study|Lost to Follow-up|3|||
164256337|NCT00920218|593306140|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
164256338|NCT00920218|593306141|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
163887661|NCT03058289|591959486|FG005|Overall Study|Refused Further Treatment|0|||
163887662|NCT03058289|591959487|FG006|Overall Study|Refused Further Treatment|0|||
163887663|NCT03058289|591959488|FG007|Overall Study|Refused Further Treatment|0|||
163887664|NCT03058289|591959489|FG008|Overall Study|Refused Further Treatment|0|||
163887665|NCT03058289|591959481|FG000|Overall Study|Rapid Progression of Disease|0|||
163887666|NCT03058289|591959482|FG001|Overall Study|Rapid Progression of Disease|0|||
163887667|NCT03058289|591959483|FG002|Overall Study|Rapid Progression of Disease|0|||
163887668|NCT03058289|591959484|FG003|Overall Study|Rapid Progression of Disease|1|||
163992090|NCT00849667|592339669|FG000|Overall Study|Lost to Follow-up|8|||
164256339|NCT00920218|593306142|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
164256340|NCT00920218|593306143|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
164256341|NCT00920218|593306140|FG000|Overall Study|Other|0|||
164256342|NCT00920218|593306141|FG001|Overall Study|Other|0|||
164256343|NCT00920218|593306142|FG002|Overall Study|Other|1|||
164256344|NCT00920218|593306143|FG003|Overall Study|Other|0|||
164256345|NCT00923975|593306144|FG000|Overall Study|Did not meet inclusion criteria|1|||
163992091|NCT00849667|592339670|FG001|Overall Study|Lost to Follow-up|8|||
164256346|NCT04417218|593306150|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
164256347|NCT04417218|593306151|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
164256348|NCT00873041|593306152|FG000|Core Study|Adverse Event|2|||
163887669|NCT03058289|591959485|FG004|Overall Study|Rapid Progression of Disease|0|||
163887670|NCT03058289|591959486|FG005|Overall Study|Rapid Progression of Disease|0|||
163887671|NCT03058289|591959487|FG006|Overall Study|Rapid Progression of Disease|0|||
163887672|NCT03058289|591959488|FG007|Overall Study|Rapid Progression of Disease|0|||
163887673|NCT03058289|591959489|FG008|Overall Study|Rapid Progression of Disease|0|||
163887674|NCT03085810|591959490|FG000|Main Study|Withdrawal by Subject|77|||
163887675|NCT03085810|591959491|FG001|Main Study|Withdrawal by Subject|0|||
163887676|NCT03085810|591959492|FG002|Main Study|Withdrawal by Subject|0|||
163887677|NCT03085810|591959490|FG000|Main Study|Terminated By Sponsor|14|||
164256349|NCT00873041|593306153|FG001|Core Study|Adverse Event|3|||
164256350|NCT00873041|593306154|FG002|Core Study|Adverse Event|1|||
164256351|NCT00873041|593306152|FG000|Core Study|Withdrawal by Subject|1|||
164256352|NCT00873041|593306153|FG001|Core Study|Withdrawal by Subject|2|||
164256353|NCT00873041|593306154|FG002|Core Study|Withdrawal by Subject|2|||
164256354|NCT00873041|593306152|FG000|Core Study|Lost to Follow-up|3|||
164256355|NCT00873041|593306153|FG001|Core Study|Lost to Follow-up|1|||
164256356|NCT00873041|593306154|FG002|Core Study|Lost to Follow-up|0|||
164256357|NCT00873041|593306152|FG000|Core Study|Abnormal laboratory value|0|||
164256358|NCT00873041|593306153|FG001|Core Study|Abnormal laboratory value|0|||
164256359|NCT00873041|593306154|FG002|Core Study|Abnormal laboratory value|1|||
164339157|NCT00474760|593617148|FG001|Overall Study|Terminated by sponsor|0|||
164339158|NCT00474760|593617149|FG002|Overall Study|Terminated by sponsor|0|||
164339159|NCT00474760|593617150|FG003|Overall Study|Terminated by sponsor|0|||
164084753|NCT03361956|592674015|FG004|Overall Study|Other|0|||
164256360|NCT00873041|593306152|FG000|Core Study|Protocol deviation|1|||
164339160|NCT00474760|593617151|FG004|Overall Study|Terminated by sponsor|0|||
164339161|NCT00474760|593617152|FG005|Overall Study|Terminated by sponsor|0|||
164339162|NCT00474760|593617153|FG006|Overall Study|Terminated by sponsor|2|||
164339163|NCT01927627|593617155|FG000|Overall Study|Adverse Event|3|||
164339164|NCT01927627|593617155|FG000|Overall Study|Lack of Efficacy|1|||
164339165|NCT01927627|593617155|FG000|Overall Study|Financial Concerns|1|||
164339166|NCT02635776|593617156|FG000|Overall Study|Physician Decision|1|||
164339167|NCT02635776|593617157|FG001|Overall Study|Physician Decision|0|||
164339168|NCT02635776|593617156|FG000|Overall Study|Adverse Event|51|||
164339169|NCT02635776|593617157|FG001|Overall Study|Adverse Event|3|||
164339170|NCT02635776|593617156|FG000|Overall Study|Withdrawal by Subject|41|||
164339171|NCT02635776|593617157|FG001|Overall Study|Withdrawal by Subject|7|||
164339172|NCT02635776|593617156|FG000|Overall Study|Lost to Follow-up|4|||
164339173|NCT02635776|593617157|FG001|Overall Study|Lost to Follow-up|0|||
164339174|NCT02635776|593617156|FG000|Overall Study|Other reasons|5|||
164339175|NCT02635776|593617157|FG001|Overall Study|Other reasons|1|||
164339176|NCT00660673|593617158|FG000|Overall Study|Adverse Event|84|||
164339177|NCT00660673|593617158|FG000|Overall Study|Lack of Efficacy|7|||
164339178|NCT00660673|593617158|FG000|Overall Study|Withdrawal by Subject|22|||
164339179|NCT00660673|593617158|FG000|Overall Study|Administrative|2|||
164339180|NCT00660673|593617158|FG000|Overall Study|Protocol Violation|2|||
164339181|NCT00579098|593617159|FG000|Overall Study|Lost to Follow-up|2|||
164339182|NCT00579098|593617160|FG001|Overall Study|Lost to Follow-up|0|||
164339183|NCT00579098|593617159|FG000|Overall Study|Adverse Event|2|||
164339184|NCT00579098|593617160|FG001|Overall Study|Adverse Event|3|||
164339185|NCT00579098|593617159|FG000|Overall Study|Withdrawal by Subject|2|||
164339186|NCT00579098|593617160|FG001|Overall Study|Withdrawal by Subject|3|||
164339187|NCT00579098|593617159|FG000|Overall Study|AF returned after ablation|3|||
164339188|NCT00579098|593617160|FG001|Overall Study|AF returned after ablation|2|||
164339189|NCT00633750|593617167|FG000|Overall Study|Adverse Event|2|||
164339190|NCT00633750|593617167|FG000|Overall Study|Withdrawal by Subject|3|||
164339191|NCT01903031|593617168|FG000|Overall Study|Not Able to Attend Clinic|1|||
164339192|NCT01903031|593617169|FG001|Overall Study|Not Able to Attend Clinic|1|||
164339193|NCT01903031|593617170|FG002|Overall Study|Not Able to Attend Clinic|0|||
164339194|NCT01903031|593617168|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
164339195|NCT01903031|593617169|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
164339196|NCT01903031|593617170|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
164339197|NCT01903031|593617168|FG000|Overall Study|Adverse Event|0|||
164339198|NCT01903031|593617169|FG001|Overall Study|Adverse Event|1|||
164339199|NCT01903031|593617170|FG002|Overall Study|Adverse Event|0|||
164339200|NCT01903031|593617168|FG000|Overall Study|Withdrawal by Subject|0|||
164339201|NCT01903031|593617169|FG001|Overall Study|Withdrawal by Subject|1|||
164339202|NCT01903031|593617170|FG002|Overall Study|Withdrawal by Subject|1|||
164339203|NCT01903031|593617168|FG000|Overall Study|Protocol Violation|0|||
164339204|NCT01903031|593617169|FG001|Overall Study|Protocol Violation|0|||
164339205|NCT01903031|593617170|FG002|Overall Study|Protocol Violation|2|||
164339206|NCT01903031|593617168|FG000|Overall Study|Lost to Follow-up|0|||
164339207|NCT01903031|593617169|FG001|Overall Study|Lost to Follow-up|0|||
164339208|NCT01903031|593617170|FG002|Overall Study|Lost to Follow-up|1|||
164084754|NCT03361956|592674011|FG000|Overall Study|Withdrawal by Subject|2|||
164256361|NCT00873041|593306153|FG001|Core Study|Protocol deviation|0|||
164256362|NCT00873041|593306154|FG002|Core Study|Protocol deviation|1|||
164339209|NCT01903031|593617168|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
164339210|NCT01903031|593617169|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
164339211|NCT01903031|593617170|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
164339212|NCT01811225|593617171|FG000|Treatment Period 1|Adverse Event|2|||
164339213|NCT01811225|593617172|FG001|Treatment Period 1|Adverse Event|3|||
164339214|NCT01811225|593617171|FG000|Treatment Period 1|Lost to Follow-up|12|||
164339215|NCT01811225|593617172|FG001|Treatment Period 1|Lost to Follow-up|8|||
164339216|NCT01811225|593617171|FG000|Treatment Period 1|transporation|1|||
164339217|NCT01811225|593617172|FG001|Treatment Period 1|transporation|0|||
164256363|NCT00873041|593306152|FG000|Extension Study|Adverse Event|1|||
164256364|NCT00873041|593306153|FG001|Extension Study|Adverse Event|0|||
164256365|NCT00873041|593306154|FG002|Extension Study|Adverse Event|1|||
164256366|NCT00873041|593306152|FG000|Extension Study|Administrative reasons|0|||
164256367|NCT00873041|593306153|FG001|Extension Study|Administrative reasons|0|||
164256368|NCT00873041|593306154|FG002|Extension Study|Administrative reasons|1|||
164256369|NCT02449889|593306157|FG000|Overall Study|Adverse Event|1|||
164256370|NCT02449889|593306158|FG001|Overall Study|Adverse Event|2|||
164256371|NCT02449889|593306159|FG002|Overall Study|Adverse Event|0|||
164256372|NCT02449889|593306157|FG000|Overall Study|Protocol Violation|0|||
164256373|NCT02449889|593306158|FG001|Overall Study|Protocol Violation|4|||
164256374|NCT02449889|593306159|FG002|Overall Study|Protocol Violation|1|||
164256375|NCT00758264|593306160|FG000|Active Phase|Withdrawal by Subject|0|||
164256376|NCT00758264|593306161|FG001|Active Phase|Withdrawal by Subject|0|||
164256377|NCT00758264|593306162|FG002|Active Phase|Withdrawal by Subject|1|||
164256378|NCT00758264|593306160|FG000|Active Phase|Lost to Follow-up|1|||
164256379|NCT00758264|593306161|FG001|Active Phase|Lost to Follow-up|0|||
164256380|NCT00758264|593306162|FG002|Active Phase|Lost to Follow-up|0|||
164256381|NCT00758264|593306160|FG000|Active Phase|Other|0|||
164256382|NCT00758264|593306161|FG001|Active Phase|Other|0|||
164256383|NCT00758264|593306162|FG002|Active Phase|Other|4|||
164256384|NCT01082874|593306164|FG000|Overall Study|Lost to Follow-up|10|||
164256385|NCT01082874|593306165|FG001|Overall Study|Lost to Follow-up|10|||
163887678|NCT03085810|591959491|FG001|Main Study|Terminated By Sponsor|0|||
163887679|NCT03085810|591959492|FG002|Main Study|Terminated By Sponsor|0|||
163887680|NCT03085810|591959490|FG000|Main Study|Protocol Violation|15|||
163887681|NCT03085810|591959491|FG001|Main Study|Protocol Violation|0|||
163887682|NCT03085810|591959492|FG002|Main Study|Protocol Violation|0|||
163887683|NCT03085810|591959490|FG000|Main Study|Physician Decision|13|||
163887684|NCT03085810|591959491|FG001|Main Study|Physician Decision|0|||
164256386|NCT01082874|593306166|FG002|Overall Study|Lost to Follow-up|6|||
164256387|NCT01082874|593306167|FG003|Overall Study|Lost to Follow-up|10|||
164256388|NCT01082874|593306164|FG000|Overall Study|Withdrawal by Subject|1|||
164256389|NCT01082874|593306165|FG001|Overall Study|Withdrawal by Subject|2|||
164256390|NCT01082874|593306166|FG002|Overall Study|Withdrawal by Subject|5|||
164256391|NCT01082874|593306167|FG003|Overall Study|Withdrawal by Subject|3|||
164256392|NCT03176472|593306178|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
164256393|NCT03176472|593306179|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
164256394|NCT03176472|593306178|FG000|Double Blind Treatment Period|Adverse Event|0|||
164256395|NCT03176472|593306179|FG001|Double Blind Treatment Period|Adverse Event|5|||
164256396|NCT03176472|593306178|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
164256397|NCT03176472|593306179|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164256398|NCT03176472|593306178|FG000|Double Blind Treatment Period|Physician Decision|0|||
164256399|NCT03176472|593306179|FG001|Double Blind Treatment Period|Physician Decision|1|||
164256400|NCT03176472|593306178|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164256401|NCT03176472|593306179|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164256402|NCT03176472|593306178|FG000|Double Blind Treatment Period|Not Provided|1|||
164256403|NCT03176472|593306179|FG001|Double Blind Treatment Period|Not Provided|0|||
164256404|NCT03176472|593306178|FG000|Open Label Extension|Withdrawal by Subject|3|||
164256405|NCT03176472|593306179|FG001|Open Label Extension|Withdrawal by Subject|4|||
164256406|NCT03176472|593306178|FG000|Open Label Extension|Adverse Event|2|||
164256407|NCT03176472|593306179|FG001|Open Label Extension|Adverse Event|4|||
164256408|NCT03176472|593306178|FG000|Open Label Extension|Lost to Follow-up|1|||
164256409|NCT03176472|593306179|FG001|Open Label Extension|Lost to Follow-up|2|||
164256410|NCT03176472|593306178|FG000|Open Label Extension|Protocol Violation|0|||
164256411|NCT03176472|593306179|FG001|Open Label Extension|Protocol Violation|1|||
164256412|NCT03176472|593306178|FG000|Open Label Extension|Not Provided|2|||
164256413|NCT03176472|593306179|FG001|Open Label Extension|Not Provided|1|||
164256414|NCT01846663|593306180|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
164256415|NCT01846663|593306181|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
164256416|NCT01846663|593306180|FG000|Overall Study|Withdrawal by Subject|1|||
164256417|NCT01846663|593306181|FG001|Overall Study|Withdrawal by Subject|0|||
164256418|NCT01846663|593306180|FG000|Overall Study|Adverse Event|1|||
164256419|NCT01846663|593306181|FG001|Overall Study|Adverse Event|2|||
164256420|NCT04295681|593306195|FG000|Overall Study|Eligibility error|1|||
164256421|NCT04295681|593306196|FG001|Overall Study|Eligibility error|3|||
164339218|NCT01811225|593617171|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
163887685|NCT03085810|591959492|FG002|Main Study|Physician Decision|0|||
164256422|NCT02210689|593306203|FG000|Overall Study|Withdrawal by Subject|7|||
164256423|NCT02210689|593306204|FG001|Overall Study|Withdrawal by Subject|4|||
164256424|NCT02210689|593306205|FG002|Overall Study|Withdrawal by Subject|2|||
164339219|NCT01811225|593617172|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
163887686|NCT03085810|591959490|FG000|Main Study|Lost to Follow-up|17|||
164256425|NCT02210689|593306203|FG000|Overall Study|Adverse Event|0|||
164256426|NCT02210689|593306204|FG001|Overall Study|Adverse Event|1|||
164256427|NCT02210689|593306205|FG002|Overall Study|Adverse Event|0|||
163887687|NCT03085810|591959491|FG001|Main Study|Lost to Follow-up|0|||
164256428|NCT02210689|593306203|FG000|Overall Study|Protocol Violation|1|||
164256429|NCT02210689|593306204|FG001|Overall Study|Protocol Violation|0|||
164256430|NCT02210689|593306205|FG002|Overall Study|Protocol Violation|0|||
164256431|NCT02210689|593306203|FG000|Overall Study|Lost to Follow-up|11|||
164256432|NCT02210689|593306204|FG001|Overall Study|Lost to Follow-up|9|||
164256433|NCT02210689|593306205|FG002|Overall Study|Lost to Follow-up|5|||
164256434|NCT02210689|593306203|FG000|Overall Study|Pregnancy|0|||
164256435|NCT02210689|593306204|FG001|Overall Study|Pregnancy|1|||
164256436|NCT02210689|593306205|FG002|Overall Study|Pregnancy|0|||
164256437|NCT02210689|593306203|FG000|Overall Study|Lack of Efficacy|0|||
164256438|NCT02210689|593306204|FG001|Overall Study|Lack of Efficacy|1|||
164256439|NCT02210689|593306205|FG002|Overall Study|Lack of Efficacy|5|||
164256440|NCT02210689|593306203|FG000|Overall Study|Prohibited medication|2|||
164256441|NCT02210689|593306204|FG001|Overall Study|Prohibited medication|8|||
164256442|NCT02210689|593306205|FG002|Overall Study|Prohibited medication|1|||
164256443|NCT02210689|593306203|FG000|Overall Study|Negative Nugent score at baseline|6|||
164256444|NCT02210689|593306204|FG001|Overall Study|Negative Nugent score at baseline|2|||
164256445|NCT02210689|593306205|FG002|Overall Study|Negative Nugent score at baseline|2|||
164256446|NCT02210689|593306203|FG000|Overall Study|Other|25|||
164256447|NCT02210689|593306204|FG001|Overall Study|Other|21|||
164256448|NCT02210689|593306205|FG002|Overall Study|Other|8|||
164256449|NCT00675441|593306206|FG000|Overall Study|Withdrawal by Subject|2|||
164256450|NCT00675441|593306206|FG000|Overall Study|Death|1|||
164256451|NCT05427539|593306208|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164256452|NCT05427539|593306209|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164256453|NCT05427539|593306208|FG000|Period 1|Withdrawal by Subject|1|||
164256454|NCT05427539|593306209|FG001|Period 1|Withdrawal by Subject|0|||
164256455|NCT05129449|593306212|FG000|Overall Study|Protocol Violation|1|||
164256456|NCT02901054|593306216|FG000|Overall Study|Physician Decision|1|||
164256457|NCT02901054|593306216|FG000|Overall Study|Withdrawal by Subject|3|||
164256458|NCT03718884|593306219|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
164256459|NCT03718884|593306220|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
164256460|NCT03718884|593306219|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
164256461|NCT03718884|593306220|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
164256462|NCT02099344|593306223|FG000|Overall Study|Physician Decision|1|||
164256463|NCT02099344|593306224|FG001|Overall Study|Physician Decision|0|||
164256464|NCT00404755|593306225|FG000|Phase I (Bupropion)|Adverse Event|3|||
164256465|NCT00404755|593306225|FG000|Phase I (Bupropion)|Other|1|||
164256466|NCT00404755|593306225|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
164256467|NCT05145322|593306226|FG000|Overall Study|Lost to Follow-up|4|||
164256468|NCT05145322|593306227|FG001|Overall Study|Lost to Follow-up|5|||
164256469|NCT06359028|593306228|FG000|Overall Study|Adverse Event|1|||
164256470|NCT06359028|593306229|FG001|Overall Study|Adverse Event|0|||
164256471|NCT06359028|593306228|FG000|Overall Study|Withdrawal by Subject|1|||
164256472|NCT06359028|593306229|FG001|Overall Study|Withdrawal by Subject|0|||
164256473|NCT04700540|593306230|FG000|Overall Study|Withdrawal by Subject|12|||
164256474|NCT04700540|593306231|FG001|Overall Study|Withdrawal by Subject|8|||
164256475|NCT04700540|593306230|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
164256476|NCT04700540|593306231|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
164256477|NCT05248997|593306232|FG000|Overall Study|Lost to Follow-up|1|||
164256478|NCT05248997|593306233|FG001|Overall Study|Lost to Follow-up|1|||
164256479|NCT05248997|593306232|FG000|Overall Study|Randomized but not treated|32|||
164256480|NCT05248997|593306233|FG001|Overall Study|Randomized but not treated|25|||
164256481|NCT03515551|593306234|FG000|Overall Study|Death|4|||
164256482|NCT03515551|593306235|FG001|Overall Study|Death|1|||
164256483|NCT03515551|593306236|FG002|Overall Study|Death|2|||
164256484|NCT03515551|593306237|FG003|Overall Study|Death|2|||
164256485|NCT03515551|593306238|FG004|Overall Study|Death|2|||
164256486|NCT03515551|593306239|FG005|Overall Study|Death|4|||
164256487|NCT03515551|593306240|FG006|Overall Study|Death|1|||
164256488|NCT03515551|593306234|FG000|Overall Study|Lost to Follow-up|0|||
164256489|NCT03515551|593306235|FG001|Overall Study|Lost to Follow-up|0|||
164256490|NCT03515551|593306236|FG002|Overall Study|Lost to Follow-up|1|||
164256491|NCT03515551|593306237|FG003|Overall Study|Lost to Follow-up|0|||
164256492|NCT03515551|593306238|FG004|Overall Study|Lost to Follow-up|0|||
164256493|NCT03515551|593306239|FG005|Overall Study|Lost to Follow-up|0|||
164256494|NCT03515551|593306240|FG006|Overall Study|Lost to Follow-up|0|||
164256495|NCT03515551|593306234|FG000|Overall Study|Withdrawal by Subject|0|||
164256496|NCT03515551|593306235|FG001|Overall Study|Withdrawal by Subject|1|||
163887688|NCT03085810|591959492|FG002|Main Study|Lost to Follow-up|0|||
164256497|NCT03515551|593306236|FG002|Overall Study|Withdrawal by Subject|0|||
164339220|NCT01811225|593617171|FG000|Treatment Period 2|Lost to Follow-up|1|||
164339221|NCT01811225|593617172|FG001|Treatment Period 2|Lost to Follow-up|2|||
164339222|NCT01811225|593617171|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
164339223|NCT01811225|593617172|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
164339224|NCT03000569|593617173|FG000|Overall Study|Withdrawal by Subject|1|||
164256498|NCT03515551|593306237|FG003|Overall Study|Withdrawal by Subject|0|||
164256499|NCT03515551|593306238|FG004|Overall Study|Withdrawal by Subject|0|||
164256500|NCT03515551|593306239|FG005|Overall Study|Withdrawal by Subject|0|||
164256501|NCT03515551|593306240|FG006|Overall Study|Withdrawal by Subject|1|||
164256502|NCT03515551|593306234|FG000|Overall Study|Study ended by sponsor|0|||
164256503|NCT03515551|593306235|FG001|Overall Study|Study ended by sponsor|0|||
164256504|NCT03515551|593306236|FG002|Overall Study|Study ended by sponsor|2|||
164256505|NCT03515551|593306237|FG003|Overall Study|Study ended by sponsor|1|||
164256506|NCT03515551|593306238|FG004|Overall Study|Study ended by sponsor|3|||
164256507|NCT03515551|593306239|FG005|Overall Study|Study ended by sponsor|0|||
164256508|NCT03515551|593306240|FG006|Overall Study|Study ended by sponsor|3|||
164256509|NCT03515551|593306234|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256510|NCT03515551|593306235|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
164256511|NCT03515551|593306236|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256512|NCT03515551|593306237|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256513|NCT03515551|593306238|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256514|NCT03515551|593306239|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256515|NCT03515551|593306240|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
164256516|NCT00673231|593306241|FG000|Overall Study|Withdrawal by Subject|14|||
164256517|NCT00673231|593306242|FG001|Overall Study|Withdrawal by Subject|10|||
164256518|NCT00673231|593306243|FG002|Overall Study|Withdrawal by Subject|8|||
164256519|NCT00673231|593306244|FG003|Overall Study|Withdrawal by Subject|6|||
164256520|NCT00673231|593306241|FG000|Overall Study|Adverse Event|6|||
164256521|NCT00673231|593306242|FG001|Overall Study|Adverse Event|5|||
164256522|NCT00673231|593306243|FG002|Overall Study|Adverse Event|9|||
164256523|NCT00673231|593306244|FG003|Overall Study|Adverse Event|6|||
164256524|NCT00673231|593306241|FG000|Overall Study|Lost to Follow-up|1|||
164256525|NCT00673231|593306242|FG001|Overall Study|Lost to Follow-up|2|||
164256526|NCT00673231|593306243|FG002|Overall Study|Lost to Follow-up|1|||
164256527|NCT00673231|593306244|FG003|Overall Study|Lost to Follow-up|2|||
164339225|NCT03000569|593617174|FG001|Overall Study|Withdrawal by Subject|0|||
164339226|NCT02298023|593617175|FG000|Overall Study|Withdrawal by Subject|1|||
164339227|NCT02298023|593617176|FG001|Overall Study|Withdrawal by Subject|0|||
164339228|NCT02298023|593617177|FG002|Overall Study|Withdrawal by Subject|0|||
164339229|NCT00492531|593617185|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
164339230|NCT00492531|593617186|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
164339231|NCT04122534|593617192|FG000|Overall Study|Lost to Follow-up|4|||
164339232|NCT01790932|593617193|FG000|Overall Study|Disease Progression|41|||
164256528|NCT00673231|593306241|FG000|Overall Study|Death|0|||
164256529|NCT00673231|593306242|FG001|Overall Study|Death|0|||
164256530|NCT00673231|593306243|FG002|Overall Study|Death|1|||
164256531|NCT00673231|593306244|FG003|Overall Study|Death|0|||
164256532|NCT00673231|593306241|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
164256533|NCT00673231|593306242|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
164256534|NCT00673231|593306243|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
164256535|NCT00673231|593306244|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
164256536|NCT02952313|593306245|FG000|Primary Endpoint|Lost to Follow-up|4|||
164256537|NCT02952313|593306245|FG000|Primary Endpoint|Withdrawal by Subject|1|||
164256538|NCT02952313|593306245|FG000|Primary Endpoint|Lack of Efficacy|1|||
164256539|NCT02952313|593306245|FG000|Primary Endpoint|Missed visit|1|||
164256540|NCT02952313|593306245|FG000|Long-term Follow-up|Lost to Follow-up|12|||
164256541|NCT02952313|593306245|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
164256542|NCT02952313|593306245|FG000|Long-term Follow-up|Lack of Efficacy|6|||
164256543|NCT02952313|593306245|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
164256544|NCT02952313|593306245|FG000|Long-term Follow-up|Physician Decision|1|||
164256545|NCT02952313|593306245|FG000|Long-term Follow-up|Death|1|||
164256546|NCT04470908|593306250|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
164256547|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
164256548|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
164256549|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
164256550|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
164256551|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
164256552|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
164256553|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
164256554|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
164256555|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
164256556|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
164256557|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
164256558|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
164256559|NCT04376684|593306251|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
164256560|NCT04376684|593306252|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
164256561|NCT04376684|593306253|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
164256562|NCT04376684|593306254|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
164256563|NCT04376684|593306251|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
164256564|NCT04376684|593306252|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
164256565|NCT04376684|593306253|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
164256566|NCT04376684|593306254|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
164256567|NCT04376684|593306251|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
164256568|NCT04376684|593306252|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
164256569|NCT04376684|593306253|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
163887689|NCT03085810|591959490|FG000|Main Study|Adverse Event|25|||
163887690|NCT03085810|591959491|FG001|Main Study|Adverse Event|0|||
163887691|NCT03085810|591959492|FG002|Main Study|Adverse Event|0|||
163887692|NCT03085810|591959490|FG000|Main Study|Pregnancy|7|||
163887693|NCT03085810|591959491|FG001|Main Study|Pregnancy|0|||
163887694|NCT03085810|591959492|FG002|Main Study|Pregnancy|0|||
163887695|NCT03085810|591959490|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
163887696|NCT03085810|591959491|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
163887697|NCT03085810|591959492|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
163887698|NCT03085810|591959490|FG000|Main Study|Lack of Efficacy|10|||
163887699|NCT03085810|591959491|FG001|Main Study|Lack of Efficacy|0|||
163887700|NCT03085810|591959492|FG002|Main Study|Lack of Efficacy|0|||
163887701|NCT03085810|591959490|FG000|Main Study|Death|12|||
163887702|NCT03085810|591959491|FG001|Main Study|Death|0|||
163887703|NCT03085810|591959492|FG002|Main Study|Death|0|||
163887704|NCT03085810|591959490|FG000|Main Study|Disease progression|1|||
163887705|NCT03085810|591959491|FG001|Main Study|Disease progression|0|||
163887706|NCT03085810|591959492|FG002|Main Study|Disease progression|0|||
163887707|NCT03085810|591959490|FG000|Main Study|Site Closure|3|||
163887708|NCT03085810|591959491|FG001|Main Study|Site Closure|0|||
163887709|NCT03085810|591959492|FG002|Main Study|Site Closure|0|||
163887710|NCT03085810|591959490|FG000|Main Study|Planned pregnancy|17|||
163887711|NCT03085810|591959491|FG001|Main Study|Planned pregnancy|0|||
163887712|NCT03085810|591959492|FG002|Main Study|Planned pregnancy|0|||
163887713|NCT03085810|591959490|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
163887714|NCT03085810|591959491|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
163887715|NCT03085810|591959492|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
163887716|NCT03085810|591959490|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
163887717|NCT03085810|591959491|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
163887718|NCT03085810|591959492|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
163887719|NCT03085810|591959490|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
164256570|NCT04376684|593306254|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
163887720|NCT03085810|591959491|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
163887721|NCT03085810|591959492|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
164256571|NCT04376684|593306251|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
164256572|NCT04376684|593306252|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
163887722|NCT03085810|591959490|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
164256573|NCT04376684|593306253|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
164256574|NCT04376684|593306254|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
164256575|NCT01666119|593306255|FG000|Overall Study|Adverse Event|6|||
164256576|NCT01666119|593306255|FG000|Overall Study|Withdrawal by Subject|16|||
164256577|NCT01666119|593306255|FG000|Overall Study|Lost to Follow-up|7|||
164256578|NCT01666119|593306255|FG000|Overall Study|non compliance with study medication, pa|18|||
164256579|NCT01666119|593306255|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
164256580|NCT02470585|593306271|FG000|Overall Study|Death|224|||
164256581|NCT02470585|593306272|FG001|Overall Study|Death|227|||
164256582|NCT02470585|593306273|FG002|Overall Study|Death|199|||
164256583|NCT02470585|593306271|FG000|Overall Study|Withdrew consent|21|||
164256584|NCT02470585|593306272|FG001|Overall Study|Withdrew consent|22|||
164256585|NCT02470585|593306273|FG002|Overall Study|Withdrew consent|31|||
164256586|NCT02470585|593306271|FG000|Overall Study|Lost to Follow-up|8|||
164256587|NCT02470585|593306272|FG001|Overall Study|Lost to Follow-up|15|||
164256588|NCT02470585|593306273|FG002|Overall Study|Lost to Follow-up|13|||
164256589|NCT02470585|593306271|FG000|Overall Study|Sponsor discontinued study|117|||
164256590|NCT02470585|593306272|FG001|Overall Study|Sponsor discontinued study|110|||
164256591|NCT02470585|593306273|FG002|Overall Study|Sponsor discontinued study|122|||
164256592|NCT02470585|593306271|FG000|Overall Study|Other, not specified|5|||
164256593|NCT02470585|593306272|FG001|Overall Study|Other, not specified|7|||
164256594|NCT02470585|593306273|FG002|Overall Study|Other, not specified|14|||
164256595|NCT02470585|593306271|FG000|Overall Study|Missing due to site non-compliance|0|||
164256596|NCT02470585|593306272|FG001|Overall Study|Missing due to site non-compliance|2|||
164256597|NCT02470585|593306273|FG002|Overall Study|Missing due to site non-compliance|3|||
164256598|NCT02602275|593306274|FG000|Day 1|Physician Decision|0|||
164256599|NCT02602275|593306275|FG001|Day 1|Physician Decision|1|||
164256600|NCT03028415|593306277|FG000|Overall Study|Lost to Follow-up|6|||
164256601|NCT03028415|593306278|FG001|Overall Study|Lost to Follow-up|3|||
164256602|NCT03028415|593306277|FG000|Overall Study|Withdrawal by Subject|1|||
164256603|NCT03028415|593306278|FG001|Overall Study|Withdrawal by Subject|0|||
164339233|NCT01790932|593617193|FG000|Overall Study|Adverse Event|7|||
164339234|NCT01790932|593617193|FG000|Overall Study|Physician Decision|1|||
164339235|NCT01790932|593617193|FG000|Overall Study|Withdrawal by Subject|1|||
164339236|NCT01441180|593617199|FG000|Overall Study|Lost to Follow-up|1|||
164339237|NCT01441180|593617200|FG001|Overall Study|Lost to Follow-up|1|||
164339238|NCT01441180|593617201|FG002|Overall Study|Lost to Follow-up|1|||
164339239|NCT01441180|593617199|FG000|Overall Study|Discontinued|0|||
164339240|NCT01441180|593617200|FG001|Overall Study|Discontinued|0|||
164339241|NCT01441180|593617201|FG002|Overall Study|Discontinued|2|||
164339242|NCT01558739|593617204|FG000|Overall Study|Adverse Event|7|||
164339243|NCT01558739|593617204|FG000|Overall Study|Withdrawal by Subject|2|||
164339244|NCT01558739|593617204|FG000|Overall Study|Death|3|||
164339245|NCT01558739|593617204|FG000|Overall Study|Disease Progression|4|||
164339246|NCT01558739|593617204|FG000|Overall Study|Protocol Violation|1|||
164339247|NCT01402011|593617209|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
164339248|NCT01402011|593617210|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
164339249|NCT01402011|593617211|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
164339250|NCT01402011|593617209|FG000|Active Treatment Period|Withdrawal by Subject|1|||
164339251|NCT01402011|593617210|FG001|Active Treatment Period|Withdrawal by Subject|3|||
164339252|NCT01402011|593617211|FG002|Active Treatment Period|Withdrawal by Subject|0|||
164339253|NCT01402011|593617209|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
164339254|NCT01402011|593617210|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
164339255|NCT01402011|593617211|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
164339256|NCT01066000|593617212|FG000|Overall Study|Protocol Violation|4|||
164339257|NCT01066000|593617212|FG000|Overall Study|Death|3|||
164339258|NCT01066000|593617212|FG000|Overall Study|Withdrawal by Subject|1|||
164339259|NCT01066000|593617212|FG000|Overall Study|Adverse Event|1|||
164339260|NCT01386008|593617213|FG000|Overall Study|exited w/o incident /study discontinued|17|||
164339261|NCT01386008|593617213|FG000|Overall Study|Adverse Event|3|||
164339262|NCT01067976|593617214|FG000|Overall Study|Study drug never administered|20|||
164339263|NCT01067976|593617214|FG000|Overall Study|Study prematurely discontinued|2|||
164339264|NCT04449861|593617215|FG000|Overall Study|Withdrawal by Subject|4|||
164339265|NCT04449861|593617215|FG000|Overall Study|Lost to Follow-up|5|||
164256604|NCT03028415|593306277|FG000|Overall Study|Discontinued due to COVID-19|1|||
164256605|NCT03028415|593306278|FG001|Overall Study|Discontinued due to COVID-19|0|||
164256606|NCT02241733|593306279|FG000|Overall Study|Lost to Follow-up|9|||
164256607|NCT02241733|593306280|FG001|Overall Study|Lost to Follow-up|4|||
164256608|NCT02241733|593306279|FG000|Overall Study|Physician Decision|6|||
164256609|NCT02241733|593306280|FG001|Overall Study|Physician Decision|2|||
164339266|NCT04449861|593617215|FG000|Overall Study|Death|112|||
164339267|NCT00976677|593617216|FG000|Overall Study|Adverse Event|1|||
164339268|NCT00976677|593617217|FG001|Overall Study|Adverse Event|0|||
164256610|NCT02241733|593306279|FG000|Overall Study|Withdrawal by Subject|0|||
164256611|NCT02241733|593306280|FG001|Overall Study|Withdrawal by Subject|2|||
164256612|NCT02241733|593306279|FG000|Overall Study|Death|0|||
164256613|NCT02241733|593306280|FG001|Overall Study|Death|2|||
164256614|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
164256615|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
164256616|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
164256617|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
164256618|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
164256619|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
164256620|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
164256621|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
164256622|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
164256623|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
164256624|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
164256625|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
164256626|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
164256627|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
164256628|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
164256629|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
164256630|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
164256631|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
164256632|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
164256633|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
164256634|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
164256635|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
164256636|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
164256637|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
164256638|NCT01866111|593306285|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
164256639|NCT01866111|593306286|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
164256640|NCT01866111|593306287|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
164256641|NCT01866111|593306288|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
164256642|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
164256643|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
164256644|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
164256645|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
164256646|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
164256647|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
164256648|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
164256649|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
164256650|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
164256651|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
164256652|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
164256653|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
164256654|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
164256655|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
164256656|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
164256657|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
164256658|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Death|1|||
164256659|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Death|1|||
164256660|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Death|3|||
164256661|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Death|2|||
164256662|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
164256663|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
164256664|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
164256665|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
164256666|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
164256667|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
164256668|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
164256669|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
164256670|NCT01866111|593306285|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
164256671|NCT01866111|593306286|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
164256672|NCT01866111|593306287|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
164256673|NCT01866111|593306288|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
164256674|NCT04113018|593306293|FG000|Overall Study|Death|2|||
164256675|NCT04113018|593306293|FG000|Overall Study|Lost to Follow-up|1|||
164256676|NCT04113018|593306293|FG000|Overall Study|Still On Study (on study treatment)|24|||
164256677|NCT04113018|593306293|FG000|Overall Study|Still On Study (in follow up)|12|||
164256678|NCT03802630|593306294|FG000|Overall Study|Study terminated by sponsor|130|||
164256679|NCT03802630|593306295|FG001|Overall Study|Study terminated by sponsor|134|||
164256680|NCT03802630|593306294|FG000|Overall Study|Subject decision|16|||
164256681|NCT03802630|593306295|FG001|Overall Study|Subject decision|9|||
164256682|NCT03802630|593306294|FG000|Overall Study|Adverse Event|3|||
164256683|NCT03802630|593306295|FG001|Overall Study|Adverse Event|1|||
164256684|NCT03802630|593306294|FG000|Overall Study|Lost to Follow-up|2|||
164256685|NCT03802630|593306295|FG001|Overall Study|Lost to Follow-up|2|||
164256686|NCT03802630|593306294|FG000|Overall Study|Physician Decision|2|||
164256687|NCT03802630|593306295|FG001|Overall Study|Physician Decision|0|||
164256688|NCT03802630|593306294|FG000|Overall Study|Death|0|||
164256689|NCT03802630|593306295|FG001|Overall Study|Death|2|||
164256690|NCT00157196|593306296|FG000|Overall Study|Ongoing at data cut-off|9|||
164256691|NCT05005013|593306297|FG000|Overall Study|Withdrawal by Subject|5|||
164256692|NCT05005013|593306298|FG001|Overall Study|Withdrawal by Subject|1|||
164256693|NCT05005013|593306297|FG000|Overall Study|Lost to Follow-up|3|||
164256694|NCT05005013|593306298|FG001|Overall Study|Lost to Follow-up|1|||
164256695|NCT05005013|593306297|FG000|Overall Study|Ineligibility|1|||
164256696|NCT05005013|593306298|FG001|Overall Study|Ineligibility|1|||
164256697|NCT06099223|593306299|FG000|Overall Study|Preoperative surveys missed|0|||
164256698|NCT06099223|593306300|FG001|Overall Study|Preoperative surveys missed|1|||
164256699|NCT04283994|593306303|FG000|Overall Study|Death|11|||
164256700|NCT04283994|593306304|FG001|Overall Study|Death|20|||
164339269|NCT00976677|593617216|FG000|Overall Study|Withdrawal by Subject|0|||
164339270|NCT00976677|593617217|FG001|Overall Study|Withdrawal by Subject|2|||
164339271|NCT00976677|593617216|FG000|Overall Study|Disease progression|1|||
164339272|NCT00976677|593617217|FG001|Overall Study|Disease progression|1|||
164339273|NCT00976677|593617216|FG000|Overall Study|Trial unblinded|2|||
164339274|NCT00976677|593617217|FG001|Overall Study|Trial unblinded|2|||
164256701|NCT04283994|593306305|FG002|Overall Study|Death|11|||
164256702|NCT04283994|593306306|FG003|Overall Study|Death|0|||
164256703|NCT04283994|593306307|FG004|Overall Study|Death|0|||
164256704|NCT04283994|593306308|FG005|Overall Study|Death|0|||
164256705|NCT04283994|593306309|FG006|Overall Study|Death|0|||
164256706|NCT04283994|593306303|FG000|Overall Study|Withdrawal by Subject|16|||
164256707|NCT04283994|593306304|FG001|Overall Study|Withdrawal by Subject|4|||
164256708|NCT04283994|593306305|FG002|Overall Study|Withdrawal by Subject|6|||
164256709|NCT04283994|593306306|FG003|Overall Study|Withdrawal by Subject|1|||
164339275|NCT00976677|593617216|FG000|Overall Study|Unknown/Missing|1|||
164339276|NCT00976677|593617217|FG001|Overall Study|Unknown/Missing|0|||
164339277|NCT06238362|593617222|FG000|Overall Study|Insufficient total sleep time|1|||
164339278|NCT06238362|593617223|FG001|Overall Study|Insufficient total sleep time|0|||
164339279|NCT06238362|593617222|FG000|Overall Study|Inadequate signal quality|1|||
164339280|NCT06238362|593617223|FG001|Overall Study|Inadequate signal quality|0|||
164339281|NCT01313858|593618867|FG000|Overall Study|Premature Treatment Termination|251|||
164339282|NCT01313858|593618868|FG001|Overall Study|Premature Treatment Termination|219|||
164339283|NCT01313858|593618869|FG002|Overall Study|Premature Treatment Termination|191|||
164339284|NCT01313858|593618867|FG000|Overall Study|Lost to Follow-up|35|||
164339285|NCT01313858|593618868|FG001|Overall Study|Lost to Follow-up|51|||
164339286|NCT01313858|593618869|FG002|Overall Study|Lost to Follow-up|47|||
164339287|NCT03689530|593618873|FG000|Overall Study|Withdrawal by Subject|53|||
164339288|NCT03689530|593618874|FG001|Overall Study|Withdrawal by Subject|16|||
164339289|NCT01392443|593618875|FG000|Overall Study|Disease progression|30|||
164256710|NCT04283994|593306307|FG004|Overall Study|Withdrawal by Subject|0|||
164256711|NCT04283994|593306308|FG005|Overall Study|Withdrawal by Subject|1|||
164339290|NCT01392443|593618875|FG000|Overall Study|Adverse Event|24|||
164339291|NCT01392443|593618875|FG000|Overall Study|Death|7|||
164339292|NCT01392443|593618875|FG000|Overall Study|Withdrawal by Subject|5|||
164339293|NCT01392443|593618875|FG000|Overall Study|Lost to Follow-up|1|||
164256712|NCT04283994|593306309|FG006|Overall Study|Withdrawal by Subject|0|||
164256713|NCT00583752|593306310|FG000|Overall Study|Lost to Follow-up|5|||
164256714|NCT00583752|593306311|FG001|Overall Study|Lost to Follow-up|5|||
164256715|NCT00526656|593306312|FG000|Overall Study|Death|1|||
164256716|NCT00526656|593306312|FG000|Overall Study|Refused surgery|1|||
164256717|NCT04091581|593306313|FG000|Overall Study|Lost to Follow-up|0|||
164256718|NCT04091581|593306314|FG001|Overall Study|Lost to Follow-up|1|||
164256719|NCT01795495|593306315|FG000|Overall Study|Protocol Violation|1|||
164256720|NCT01795495|593306316|FG001|Overall Study|Protocol Violation|0|||
164256721|NCT01795495|593306317|FG002|Overall Study|Protocol Violation|1|||
164256722|NCT01795495|593306315|FG000|Overall Study|Physician Decision|0|||
164256723|NCT01795495|593306316|FG001|Overall Study|Physician Decision|0|||
164256724|NCT01795495|593306317|FG002|Overall Study|Physician Decision|1|||
164256725|NCT01331837|593306318|FG000|Overall Study|Death|30|||
164256726|NCT01331837|593306319|FG001|Overall Study|Death|34|||
164256727|NCT01331837|593306318|FG000|Overall Study|Lost to Follow-up|3|||
164256728|NCT01331837|593306319|FG001|Overall Study|Lost to Follow-up|1|||
164256729|NCT01331837|593306318|FG000|Overall Study|Info not recorded|10|||
164256730|NCT01331837|593306319|FG001|Overall Study|Info not recorded|16|||
164256731|NCT01331837|593306318|FG000|Overall Study|Withdrawal by Subject|13|||
164256732|NCT01331837|593306319|FG001|Overall Study|Withdrawal by Subject|16|||
164256733|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
164256734|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
164256735|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
164256736|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
164256737|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
164256738|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
164256739|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
164256740|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
164256741|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
164256742|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
164256743|NCT01263015|593307946|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
164256744|NCT01263015|593307947|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
164256745|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
164256746|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
164256747|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
164256748|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
164256749|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
164256750|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
164256751|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
164256752|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
164256753|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
164256754|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
164256755|NCT01263015|593307946|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
164256756|NCT01263015|593307947|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
164256757|NCT05599451|593307948|FG000|Overall Study|Not randomized|11|||
164256758|NCT05599451|593307949|FG001|Overall Study|Not randomized|0|||
164256759|NCT05599451|593307950|FG002|Overall Study|Not randomized|0|||
164256760|NCT05599451|593307951|FG003|Overall Study|Not randomized|0|||
164256761|NCT05599451|593307952|FG004|Overall Study|Not randomized|0|||
164256762|NCT05599451|593307948|FG000|Overall Study|Physician Decision|0|||
164256763|NCT05599451|593307949|FG001|Overall Study|Physician Decision|0|||
164256764|NCT05599451|593307950|FG002|Overall Study|Physician Decision|0|||
164256765|NCT05599451|593307951|FG003|Overall Study|Physician Decision|1|||
164256766|NCT05599451|593307952|FG004|Overall Study|Physician Decision|0|||
164256767|NCT02723006|593307953|FG000|Overall Study|Withdrawal by Subject|0|||
164256768|NCT02723006|593307954|FG001|Overall Study|Withdrawal by Subject|1|||
164256769|NCT02723006|593307955|FG002|Overall Study|Withdrawal by Subject|1|||
164256770|NCT02723006|593307953|FG000|Overall Study|Study Terminated by Sponsor|1|||
164256771|NCT02723006|593307954|FG001|Overall Study|Study Terminated by Sponsor|6|||
164256772|NCT02723006|593307955|FG002|Overall Study|Study Terminated by Sponsor|6|||
164256773|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Adverse Event|76|||
164256774|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Adverse Event|0|||
164256775|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Adverse Event|0|||
164256776|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Death|3|||
164256777|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Death|0|||
164256778|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Death|0|||
164256779|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
164256780|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
164256781|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
164256782|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Physician Decision|9|||
164256783|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Physician Decision|0|||
164256784|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Physician Decision|0|||
164256785|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
164256786|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
164256787|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
164256788|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Disease progression|45|||
164256789|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Disease progression|0|||
164256790|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Disease progression|0|||
164256791|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
164339294|NCT01392443|593618875|FG000|Overall Study|Protocol Violation|1|||
164256792|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
164256793|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
164256794|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
164256795|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
164256796|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
164256797|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
164256798|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
164256799|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
164256800|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
164256801|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
164256802|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
164256803|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
164256804|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
164256805|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
164256806|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
164256807|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
164256808|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
164256809|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
164256810|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
164256811|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
164256812|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
164256813|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
164256814|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
164256815|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
164256816|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
164256817|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
164256818|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Promotor request|1|||
164256819|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Promotor request|0|||
164256820|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Promotor request|0|||
164256821|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
164256822|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
164256823|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
164256824|NCT01461928|593307956|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
164256825|NCT01461928|593307957|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
164256826|NCT01461928|593307958|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
164256827|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Death|3|||
164256828|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Death|0|||
164256829|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Death|0|||
164256830|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
164256831|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
164256832|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
164256833|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
164256834|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
164256835|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
164256836|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Diseases progression|91|||
164256837|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Diseases progression|0|||
164256838|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Diseases progression|0|||
164256839|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Adverse Event|70|||
164256840|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Adverse Event|0|||
164256841|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Adverse Event|0|||
164256842|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Physician Decision|9|||
164256843|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Physician Decision|0|||
164256844|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Physician Decision|0|||
164256845|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
164256846|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
164256847|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
164256848|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
164256849|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
164256850|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
164256851|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
164256852|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
164256853|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
164256854|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Not compliant|1|||
164256855|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Not compliant|0|||
164256856|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Not compliant|0|||
164256857|NCT01461928|593307956|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
164256858|NCT01461928|593307957|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
164256859|NCT01461928|593307958|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
164256860|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Adverse Event|0|||
164256861|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Adverse Event|2|||
164256862|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Adverse Event|0|||
164256863|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Death|0|||
164256864|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Death|10|||
164256865|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Death|8|||
164256866|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Physician Decision|0|||
164256867|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Physician Decision|0|||
164256868|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Physician Decision|4|||
164256869|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
164256870|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
163887723|NCT03085810|591959491|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
163887724|NCT03085810|591959492|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
163887725|NCT02601313|591959493|FG000|Overall Study|Death|2|||
164256871|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
164256872|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Moved to another town|0|||
164256873|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Moved to another town|1|||
164256874|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Moved to another town|0|||
164256875|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Disease progression|0|||
164256876|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Disease progression|0|||
164256877|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Disease progression|3|||
164256878|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
164256879|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
164256880|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
164256881|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
164256882|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
164256883|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
164256884|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
164256885|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
164256886|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
164256887|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
164256888|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
164256889|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
164256890|NCT01461928|593307956|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
163887726|NCT02601313|591959494|FG001|Overall Study|Death|41|||
164256891|NCT01461928|593307957|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
164256892|NCT01461928|593307958|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
163887727|NCT02601313|591959495|FG002|Overall Study|Death|6|||
164256893|NCT00539513|593307966|FG000|Overall Study|Withdrawal by Subject|2|||
164256894|NCT00539513|593307967|FG001|Overall Study|Withdrawal by Subject|1|||
164256895|NCT00539513|593307966|FG000|Overall Study|Lost to Follow-up|0|||
164256896|NCT00539513|593307967|FG001|Overall Study|Lost to Follow-up|1|||
164256897|NCT00711113|593307968|FG000|Overall Study|Lost to Follow-up|9|||
164256898|NCT00711113|593307968|FG000|Overall Study|Implant lost|2|||
164256899|NCT02456636|593307969|FG000|Overall Study|Death|0|||
164256900|NCT02456636|593307970|FG001|Overall Study|Death|3|||
164256901|NCT02456636|593307971|FG002|Overall Study|Death|0|||
164256902|NCT02456636|593307969|FG000|Overall Study|Pregnancy|1|||
164256903|NCT02456636|593307970|FG001|Overall Study|Pregnancy|3|||
164256904|NCT02456636|593307971|FG002|Overall Study|Pregnancy|5|||
164256905|NCT02456636|593307969|FG000|Overall Study|Physician Decision|4|||
164256906|NCT02456636|593307970|FG001|Overall Study|Physician Decision|5|||
164256907|NCT02456636|593307971|FG002|Overall Study|Physician Decision|4|||
164256908|NCT02456636|593307969|FG000|Overall Study|Withdrawal by Subject|13|||
164256909|NCT02456636|593307970|FG001|Overall Study|Withdrawal by Subject|14|||
164256910|NCT02456636|593307971|FG002|Overall Study|Withdrawal by Subject|16|||
164256911|NCT02456636|593307969|FG000|Overall Study|Lost to Follow-up|50|||
164256912|NCT02456636|593307970|FG001|Overall Study|Lost to Follow-up|44|||
164256913|NCT02456636|593307971|FG002|Overall Study|Lost to Follow-up|50|||
164256914|NCT05312632|593307974|FG000|Overall Study|Adverse Event|12|||
164256915|NCT05312632|593307974|FG000|Overall Study|Withdrawal by Subject|10|||
164256916|NCT05312632|593307974|FG000|Overall Study|Lack of Efficacy|4|||
164256917|NCT05312632|593307974|FG000|Overall Study|Non-compliance with study procedures|9|||
164256918|NCT05312632|593307974|FG000|Overall Study|Other|4|||
164256919|NCT02379221|593307975|FG000|Overall Study|Lost to Follow-up|1|||
164256920|NCT00519376|593307976|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256921|NCT00519376|593307977|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256922|NCT00519376|593307978|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256923|NCT00519376|593307979|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256924|NCT00519376|593307980|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256925|NCT00519376|593307981|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256926|NCT00519376|593307982|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256927|NCT00519376|593307983|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256928|NCT00519376|593307984|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256929|NCT00519376|593307985|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256930|NCT00519376|593307986|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256931|NCT00519376|593307987|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256932|NCT00519376|593307988|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
164256933|NCT00519376|593307989|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256934|NCT00519376|593307990|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256935|NCT00519376|593307991|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
164256936|NCT00519376|593307976|FG000|Treatment Period 4|Lost to Follow-up|0|||
164256937|NCT00519376|593307977|FG001|Treatment Period 4|Lost to Follow-up|0|||
164256938|NCT00519376|593307978|FG002|Treatment Period 4|Lost to Follow-up|1|||
164256939|NCT00519376|593307979|FG003|Treatment Period 4|Lost to Follow-up|0|||
164256940|NCT00519376|593307980|FG004|Treatment Period 4|Lost to Follow-up|0|||
164256941|NCT00519376|593307981|FG005|Treatment Period 4|Lost to Follow-up|0|||
164256942|NCT00519376|593307982|FG006|Treatment Period 4|Lost to Follow-up|0|||
164256943|NCT00519376|593307983|FG007|Treatment Period 4|Lost to Follow-up|0|||
164256944|NCT00519376|593307984|FG008|Treatment Period 4|Lost to Follow-up|0|||
164256945|NCT00519376|593307985|FG009|Treatment Period 4|Lost to Follow-up|0|||
164256946|NCT00519376|593307986|FG010|Treatment Period 4|Lost to Follow-up|0|||
164256947|NCT00519376|593307987|FG011|Treatment Period 4|Lost to Follow-up|0|||
164256948|NCT00519376|593307988|FG012|Treatment Period 4|Lost to Follow-up|0|||
164256949|NCT00519376|593307989|FG013|Treatment Period 4|Lost to Follow-up|0|||
164256950|NCT00519376|593307990|FG014|Treatment Period 4|Lost to Follow-up|0|||
164256951|NCT00519376|593307991|FG015|Treatment Period 4|Lost to Follow-up|0|||
164256952|NCT03812185|593307995|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
164256953|NCT01801436|593308009|FG000|Overall Study|Withdrawal by Subject|3|||
164256954|NCT01801436|593308009|FG000|Overall Study|Adverse Event|2|||
164256955|NCT01801436|593308009|FG000|Overall Study|Progressive disease|4|||
164256956|NCT04085458|593308012|FG000|Overall Study|Other|1|||
164256957|NCT04085458|593308012|FG000|Overall Study|Withdrawal by Subject|2|||
164256958|NCT04085458|593308012|FG000|Overall Study|Adverse Event|2|||
164256959|NCT02447250|593308013|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
164256960|NCT02447250|593308013|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
164256961|NCT02447250|593308013|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
163992092|NCT00849667|592339671|FG002|Overall Study|Lost to Follow-up|8|||
163992093|NCT00849667|592339669|FG000|Overall Study|Adverse Event|1|||
163992094|NCT00849667|592339670|FG001|Overall Study|Adverse Event|2|||
163992095|NCT00849667|592339671|FG002|Overall Study|Adverse Event|0|||
163992096|NCT00849667|592339669|FG000|Overall Study|Other|18|||
163992097|NCT00849667|592339670|FG001|Overall Study|Other|19|||
163992098|NCT00849667|592339671|FG002|Overall Study|Other|18|||
163992099|NCT00849667|592339669|FG000|Overall Study|Progressive disease|119|||
163992100|NCT00849667|592339670|FG001|Overall Study|Progressive disease|100|||
163992101|NCT00849667|592339671|FG002|Overall Study|Progressive disease|112|||
164084755|NCT03361956|592674012|FG001|Overall Study|Withdrawal by Subject|2|||
164256962|NCT02743949|593308014|FG000|Overall Study|Adverse Event|0|||
164256963|NCT02743949|593308015|FG001|Overall Study|Adverse Event|0|||
164256964|NCT02743949|593308016|FG002|Overall Study|Adverse Event|2|||
164256965|NCT02743949|593308014|FG000|Overall Study|Significant Protocol Deviation|2|||
164256966|NCT02743949|593308015|FG001|Overall Study|Significant Protocol Deviation|0|||
164256967|NCT02743949|593308016|FG002|Overall Study|Significant Protocol Deviation|1|||
164256968|NCT02743949|593308014|FG000|Overall Study|Voluntary Withdrawal|2|||
164256969|NCT02743949|593308015|FG001|Overall Study|Voluntary Withdrawal|1|||
164256970|NCT02743949|593308016|FG002|Overall Study|Voluntary Withdrawal|0|||
164339295|NCT01977794|593618878|FG000|Overall Study|Adverse Event|2|||
164339296|NCT01977794|593618879|FG001|Overall Study|Adverse Event|2|||
164339297|NCT01977794|593618878|FG000|Overall Study|Lost to Follow-up|2|||
164339298|NCT01977794|593618879|FG001|Overall Study|Lost to Follow-up|1|||
164339299|NCT01977794|593618878|FG000|Overall Study|Protocol Violation|1|||
164339300|NCT01977794|593618879|FG001|Overall Study|Protocol Violation|0|||
164339301|NCT01977794|593618878|FG000|Overall Study|Death|1|||
164339302|NCT01977794|593618879|FG001|Overall Study|Death|1|||
164339303|NCT01977794|593618878|FG000|Overall Study|Withdrew consent|2|||
164339304|NCT01977794|593618879|FG001|Overall Study|Withdrew consent|1|||
164339305|NCT01977794|593618878|FG000|Overall Study|Other|0|||
164339306|NCT01977794|593618879|FG001|Overall Study|Other|1|||
164339307|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
164339308|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
164339309|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
164339310|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
164339311|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
164339312|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
164339313|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
164339314|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
164339315|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
164339316|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339317|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339318|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339319|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339320|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339321|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339322|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
164339323|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
164339324|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339325|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339326|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339327|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339328|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339329|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
164339330|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
163992102|NCT00849667|592339669|FG000|Overall Study|Sponsor decision|208|||
163992103|NCT00849667|592339670|FG001|Overall Study|Sponsor decision|204|||
164339331|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
164339332|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339333|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
163992104|NCT00849667|592339671|FG002|Overall Study|Sponsor decision|190|||
163992105|NCT00849667|592339669|FG000|Overall Study|Investigator discretion|0|||
163992106|NCT00849667|592339670|FG001|Overall Study|Investigator discretion|0|||
163992107|NCT00849667|592339671|FG002|Overall Study|Investigator discretion|1|||
163992108|NCT00189462|592339672|FG000|Overall Study|Lack of Efficacy|5|||
163992109|NCT00189462|592339673|FG001|Overall Study|Lack of Efficacy|1|||
163992110|NCT00189462|592339672|FG000|Overall Study|Lost to Follow-up|18|||
164256971|NCT01921218|593308017|FG000|Overall Study|Death|2|||
164256972|NCT01921218|593308018|FG001|Overall Study|Death|1|||
164256973|NCT01921218|593308017|FG000|Overall Study|Withdrawal by Subject|0|||
164256974|NCT01921218|593308018|FG001|Overall Study|Withdrawal by Subject|2|||
164256975|NCT01921218|593308017|FG000|Overall Study|Kidney transplant|1|||
164256976|NCT01921218|593308018|FG001|Overall Study|Kidney transplant|1|||
164256977|NCT00960011|593308019|FG000|Overall Study|Death|5|||
164256978|NCT00960011|593308020|FG001|Overall Study|Death|0|||
164256979|NCT00960011|593308019|FG000|Overall Study|Lost to Follow-up|6|||
164256980|NCT00960011|593308020|FG001|Overall Study|Lost to Follow-up|2|||
164256981|NCT01498575|593308021|FG000|Overall Sample|Withdrawal by Subject|60|||
164339334|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339335|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339336|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339337|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339338|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
164339339|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
164339340|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339341|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339342|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339343|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339344|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339345|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339346|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
164339347|NCT00533897|593618880|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
164339348|NCT00533897|593618881|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339349|NCT00533897|593618882|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339350|NCT00533897|593618883|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339351|NCT00533897|593618884|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339352|NCT00533897|593618885|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339353|NCT00533897|593618886|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339354|NCT00533897|593618887|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
164339355|NCT00533897|593618880|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339356|NCT00533897|593618881|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
164339357|NCT00533897|593618882|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
164339358|NCT00533897|593618883|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339359|NCT00533897|593618884|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339360|NCT00533897|593618885|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339361|NCT00533897|593618886|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339362|NCT00533897|593618887|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
164339363|NCT00533897|593618880|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339364|NCT00533897|593618881|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339365|NCT00533897|593618882|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
164339366|NCT00533897|593618883|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339367|NCT00533897|593618884|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339368|NCT00533897|593618885|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339369|NCT00533897|593618886|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339370|NCT00533897|593618887|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
164339371|NCT00533897|593618880|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339372|NCT00533897|593618881|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339373|NCT00533897|593618882|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339374|NCT00533897|593618883|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339375|NCT00533897|593618884|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339376|NCT00533897|593618885|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
164339377|NCT00533897|593618886|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
164339378|NCT00533897|593618887|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
163992111|NCT00189462|592339673|FG001|Overall Study|Lost to Follow-up|20|||
164142267|NCT00451204|592882582|FG000|Overall Study|Lost to Follow-up|4|||
164256982|NCT01498575|593308022|FG001|Overall Sample|Withdrawal by Subject|14|||
163992112|NCT00553462|592339674|FG000|Overall Study|Adverse Event|4|||
163992113|NCT00553462|592339674|FG000|Overall Study|Progression|4|||
163992114|NCT00553462|592339674|FG000|Overall Study|Withdrawal by Subject|5|||
163992115|NCT00553462|592339674|FG000|Overall Study|Physician Decision|1|||
164256983|NCT01498575|593308021|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
164256984|NCT01498575|593308022|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
164256985|NCT01498575|593308021|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
164256986|NCT01498575|593308022|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
164256987|NCT00090142|593308026|FG000|Treatment Period I|Lost to Follow-up|1|||
164256988|NCT00090142|593308027|FG001|Treatment Period I|Lost to Follow-up|2|||
164256989|NCT00090142|593308026|FG000|Treatment Period I|Protocol Violation|2|||
164256990|NCT00090142|593308027|FG001|Treatment Period I|Protocol Violation|0|||
164256991|NCT00090142|593308026|FG000|Treatment Period I|Withdrawal by Subject|2|||
164256992|NCT00090142|593308027|FG001|Treatment Period I|Withdrawal by Subject|0|||
164256993|NCT00090142|593308026|FG000|Treatment Period I|Other|0|||
164256994|NCT00090142|593308027|FG001|Treatment Period I|Other|1|||
164256995|NCT00090142|593308026|FG000|Treatment Period II|Other|1|||
164256996|NCT00090142|593308027|FG001|Treatment Period II|Other|0|||
164256997|NCT01126437|593308028|FG000|Overall Study|Not treated|11|||
164256998|NCT01126437|593308029|FG001|Overall Study|Not treated|18|||
164256999|NCT01126437|593308030|FG002|Overall Study|Not treated|19|||
164257000|NCT01126437|593308028|FG000|Overall Study|Sites with data irregularities/fraud|6|||
164257001|NCT01126437|593308029|FG001|Overall Study|Sites with data irregularities/fraud|6|||
164257002|NCT01126437|593308030|FG002|Overall Study|Sites with data irregularities/fraud|7|||
164257003|NCT01126437|593308028|FG000|Overall Study|Adverse Event|602|||
164257004|NCT01126437|593308029|FG001|Overall Study|Adverse Event|606|||
164257005|NCT01126437|593308030|FG002|Overall Study|Adverse Event|635|||
164257006|NCT01126437|593308028|FG000|Overall Study|Lack of Efficacy|65|||
163992116|NCT01262625|592339677|FG000|Overall Study|Administrative Error|1|||
164257007|NCT01126437|593308029|FG001|Overall Study|Lack of Efficacy|60|||
164257008|NCT01126437|593308030|FG002|Overall Study|Lack of Efficacy|59|||
164257009|NCT01126437|593308028|FG000|Overall Study|Protocol Violation|64|||
164257010|NCT01126437|593308029|FG001|Overall Study|Protocol Violation|66|||
164257011|NCT01126437|593308030|FG002|Overall Study|Protocol Violation|41|||
164257012|NCT01126437|593308028|FG000|Overall Study|Lost to Follow-up|52|||
164257013|NCT01126437|593308029|FG001|Overall Study|Lost to Follow-up|63|||
164257014|NCT01126437|593308030|FG002|Overall Study|Lost to Follow-up|55|||
164257015|NCT01126437|593308028|FG000|Overall Study|Withdrawal by Subject|331|||
164257016|NCT01126437|593308029|FG001|Overall Study|Withdrawal by Subject|335|||
164257017|NCT01126437|593308030|FG002|Overall Study|Withdrawal by Subject|319|||
164257018|NCT01126437|593308028|FG000|Overall Study|Other reason not specified|210|||
164257019|NCT01126437|593308029|FG001|Overall Study|Other reason not specified|176|||
164257020|NCT01126437|593308030|FG002|Overall Study|Other reason not specified|178|||
164257021|NCT00006046|593308036|FG000|Overall Study|Adverse Event|3|||
164257022|NCT00006046|593308037|FG001|Overall Study|Adverse Event|0|||
164257023|NCT00006046|593308038|FG002|Overall Study|Adverse Event|0|||
164257024|NCT00006046|593308039|FG003|Overall Study|Adverse Event|0|||
164257025|NCT00006046|593308040|FG004|Overall Study|Adverse Event|0|||
164257026|NCT00006046|593308036|FG000|Overall Study|Disease Progression|2|||
164257027|NCT00006046|593308037|FG001|Overall Study|Disease Progression|0|||
164257028|NCT00006046|593308038|FG002|Overall Study|Disease Progression|0|||
164257029|NCT00006046|593308039|FG003|Overall Study|Disease Progression|0|||
164257030|NCT00006046|593308040|FG004|Overall Study|Disease Progression|0|||
164257031|NCT00596154|593308041|FG000|Overall Study|Not Evaluable|2|||
164257032|NCT00642369|593308047|FG000|Overall Study|Adverse Event|2|||
164257033|NCT00642369|593308048|FG001|Overall Study|Adverse Event|3|||
164257034|NCT00642369|593308047|FG000|Overall Study|Withdrawal by Subject|1|||
164257035|NCT00642369|593308048|FG001|Overall Study|Withdrawal by Subject|0|||
164257036|NCT00642369|593308047|FG000|Overall Study|misdiagnosis|0|||
164257037|NCT00642369|593308048|FG001|Overall Study|misdiagnosis|1|||
164257038|NCT00642369|593308047|FG000|Overall Study|Lack of Efficacy|2|||
164257039|NCT00642369|593308048|FG001|Overall Study|Lack of Efficacy|2|||
164257040|NCT00996281|593308055|FG000|Overall Study|Adverse Event|75|||
164257041|NCT00996281|593308056|FG001|Overall Study|Adverse Event|37|||
164257042|NCT00996281|593308055|FG000|Overall Study|Major Protocol Deviation|6|||
163992117|NCT01262625|592339678|FG001|Overall Study|Administrative Error|1|||
164257043|NCT00996281|593308056|FG001|Overall Study|Major Protocol Deviation|7|||
164257044|NCT00996281|593308055|FG000|Overall Study|Lost to Follow-up|14|||
164257045|NCT00996281|593308056|FG001|Overall Study|Lost to Follow-up|16|||
164257046|NCT00996281|593308055|FG000|Overall Study|Withdrawal by Subject|31|||
164257047|NCT00996281|593308056|FG001|Overall Study|Withdrawal by Subject|20|||
164257048|NCT00996281|593308055|FG000|Overall Study|Lack of Efficacy|0|||
164257049|NCT00996281|593308056|FG001|Overall Study|Lack of Efficacy|2|||
164339379|NCT00533897|593618880|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339380|NCT00533897|593618881|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339381|NCT00533897|593618882|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
163992118|NCT01262625|592339677|FG000|Overall Study|Site Closed|1|||
164257050|NCT00996281|593308055|FG000|Overall Study|Other|5|||
164257051|NCT00996281|593308056|FG001|Overall Study|Other|7|||
164257052|NCT05593913|593308061|FG000|Overall Study|Insufficient image quality|39|||
164257053|NCT04934800|593308064|FG000|Overall Study|Other|1|||
164257054|NCT04934800|593308064|FG000|Overall Study|Withdrawal by Subject|5|||
164257055|NCT04934800|593308064|FG000|Overall Study|Lack of Efficacy|1|||
164257056|NCT04934800|593308064|FG000|Overall Study|Adverse Event|9|||
164257057|NCT04934800|593308064|FG000|Overall Study|Lost to Follow-up|5|||
164257058|NCT04934800|593308064|FG000|Overall Study|Enrolled but not treated|1|||
164257059|NCT00516906|593308065|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
164257060|NCT00516906|593308066|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
164257061|NCT01974206|593308067|FG000|Overall Study|Did Not Take Study Drug|0|||
163887728|NCT02601313|591959493|FG000|Overall Study|Enrolled but never treated|0|||
163887729|NCT02601313|591959494|FG001|Overall Study|Enrolled but never treated|6|||
163887730|NCT02601313|591959495|FG002|Overall Study|Enrolled but never treated|3|||
163887731|NCT02601313|591959493|FG000|Overall Study|Enrolled, did not initiate AC|4|||
163992119|NCT01262625|592339678|FG001|Overall Study|Site Closed|0|||
163887732|NCT02601313|591959494|FG001|Overall Study|Enrolled, did not initiate AC|0|||
163887733|NCT02601313|591959495|FG002|Overall Study|Enrolled, did not initiate AC|0|||
164339382|NCT00533897|593618883|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339383|NCT00533897|593618884|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339384|NCT00533897|593618885|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
164339385|NCT00533897|593618886|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339386|NCT00533897|593618887|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
164339387|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339388|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339389|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339390|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339391|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339392|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
164339393|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
164339394|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
164339395|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Death|0|||
164339396|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Death|0|||
164339397|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Death|0|||
164339398|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Death|0|||
164339399|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Death|0|||
164339400|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Death|0|||
164339401|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Death|1|||
164339402|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Death|3|||
164339403|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339404|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339405|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339406|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339407|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339408|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
164339409|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
164339410|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
164339411|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339412|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339413|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339414|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339415|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339416|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339417|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
164339418|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
164339419|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Adverse Event|0|||
164339420|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Adverse Event|0|||
164339421|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Adverse Event|0|||
164339422|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Adverse Event|0|||
164339423|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Adverse Event|0|||
164339424|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Adverse Event|0|||
164339425|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Adverse Event|2|||
164339426|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Adverse Event|5|||
164339427|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Pregnancy|0|||
164339428|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Pregnancy|0|||
164339429|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Pregnancy|0|||
164339430|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Pregnancy|0|||
164339431|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Pregnancy|0|||
164339432|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Pregnancy|0|||
164339433|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Pregnancy|0|||
164339434|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Pregnancy|2|||
164339435|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339436|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339437|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339438|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339439|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339440|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
164339441|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
164339442|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
164339443|NCT00533897|593618880|FG000|Long Term Extension (LTE)|Other|0|||
164339444|NCT00533897|593618881|FG001|Long Term Extension (LTE)|Other|0|||
164339445|NCT00533897|593618882|FG002|Long Term Extension (LTE)|Other|0|||
164339446|NCT00533897|593618883|FG003|Long Term Extension (LTE)|Other|0|||
164339447|NCT00533897|593618884|FG004|Long Term Extension (LTE)|Other|0|||
164339448|NCT00533897|593618885|FG005|Long Term Extension (LTE)|Other|0|||
164339449|NCT00533897|593618886|FG006|Long Term Extension (LTE)|Other|1|||
164339450|NCT00533897|593618887|FG007|Long Term Extension (LTE)|Other|6|||
164339451|NCT01546207|593618890|FG000|Overall Study|Death|1|||
164339452|NCT01626456|593618891|FG000|Overall Study|Withdrawal by Subject|21|||
164339453|NCT01626456|593618892|FG001|Overall Study|Withdrawal by Subject|46|||
164339454|NCT01626456|593618891|FG000|Overall Study|Adverse Event|2|||
164339455|NCT01626456|593618892|FG001|Overall Study|Adverse Event|27|||
164339456|NCT01626456|593618891|FG000|Overall Study|Lost to Follow-up|2|||
164339457|NCT01626456|593618892|FG001|Overall Study|Lost to Follow-up|27|||
164339458|NCT01626456|593618891|FG000|Overall Study|Lack of Efficacy|6|||
164339459|NCT01626456|593618892|FG001|Overall Study|Lack of Efficacy|7|||
164339460|NCT01626456|593618891|FG000|Overall Study|Physician Decision|1|||
164339461|NCT01626456|593618892|FG001|Overall Study|Physician Decision|4|||
164339462|NCT01626456|593618891|FG000|Overall Study|Protocol Violation|1|||
164339463|NCT01626456|593618892|FG001|Overall Study|Protocol Violation|1|||
164339464|NCT01626456|593618891|FG000|Overall Study|Site Closure|2|||
164339465|NCT01626456|593618892|FG001|Overall Study|Site Closure|3|||
164339466|NCT01626456|593618891|FG000|Overall Study|Incarceration|0|||
164339467|NCT01626456|593618892|FG001|Overall Study|Incarceration|2|||
164339468|NCT00506662|593618893|FG000|Overall Study|Adverse Event|0|||
164339469|NCT00506662|593618894|FG001|Overall Study|Adverse Event|2|||
164339470|NCT00506662|593618893|FG000|Overall Study|Lack of Efficacy|1|||
164339471|NCT00506662|593618894|FG001|Overall Study|Lack of Efficacy|0|||
164339472|NCT00506662|593618893|FG000|Overall Study|Protocol Violation|2|||
164339473|NCT00506662|593618894|FG001|Overall Study|Protocol Violation|4|||
164339474|NCT00506662|593618893|FG000|Overall Study|Trial terminated|10|||
164339475|NCT00506662|593618894|FG001|Overall Study|Trial terminated|16|||
164339476|NCT00506662|593618893|FG000|Overall Study|Not recorded|4|||
164339477|NCT00506662|593618894|FG001|Overall Study|Not recorded|6|||
164339478|NCT00491075|593618896|FG000|Overall Study|Withdrawal by Subject|1|||
164339479|NCT00491075|593618896|FG000|Overall Study|Physician Decision|1|||
164339480|NCT01603355|593618897|FG000|Overall Study|Lack of Efficacy|2|||
164339481|NCT03750955|593618900|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
164339482|NCT03750955|593618901|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
164339483|NCT03750955|593618900|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
164339484|NCT03750955|593618901|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
164339485|NCT00697788|593618904|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339486|NCT00697788|593618905|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
164339487|NCT00697788|593618906|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339488|NCT00697788|593618907|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339489|NCT00697788|593618908|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339490|NCT00697788|593618909|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339491|NCT00697788|593618910|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339492|NCT00697788|593618911|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
164339493|NCT00697788|593618904|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339494|NCT00697788|593618905|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339495|NCT00697788|593618906|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339496|NCT00697788|593618907|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339497|NCT00697788|593618908|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
164339498|NCT00697788|593618909|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339499|NCT00697788|593618910|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339500|NCT00697788|593618911|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
164339501|NCT00142935|593618912|FG000|Overall Study|Other reason|1|||
164339502|NCT00142935|593618913|FG001|Overall Study|Other reason|1|||
164339503|NCT00142935|593618914|FG002|Overall Study|Other reason|1|||
164084756|NCT03361956|592674013|FG002|Overall Study|Withdrawal by Subject|2|||
164339504|NCT00142935|593618912|FG000|Overall Study|Lost to Follow-up|2|||
164339505|NCT00142935|593618913|FG001|Overall Study|Lost to Follow-up|5|||
164084757|NCT03361956|592674014|FG003|Overall Study|Withdrawal by Subject|0|||
164339506|NCT00142935|593618914|FG002|Overall Study|Lost to Follow-up|5|||
164339507|NCT00142935|593618912|FG000|Overall Study|Death|0|||
163887734|NCT02601313|591959493|FG000|Overall Study|Full consent withdrawal|0|||
163887735|NCT02601313|591959494|FG001|Overall Study|Full consent withdrawal|3|||
163887736|NCT02601313|591959495|FG002|Overall Study|Full consent withdrawal|2|||
163887737|NCT02601313|591959493|FG000|Overall Study|Lost to Follow-up|0|||
163887738|NCT02601313|591959494|FG001|Overall Study|Lost to Follow-up|1|||
163887739|NCT02601313|591959495|FG002|Overall Study|Lost to Follow-up|1|||
163887740|NCT05192109|591959500|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163887741|NCT05192109|591959501|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163887742|NCT05192109|591959502|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163887743|NCT05192109|591959503|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163887744|NCT05192109|591959500|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
163887745|NCT05192109|591959501|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
163887746|NCT05192109|591959502|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163887747|NCT05192109|591959503|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
163887748|NCT05623228|591959506|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
163887749|NCT05623228|591959507|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887750|NCT05623228|591959508|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887751|NCT05623228|591959509|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887752|NCT05623228|591959510|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887753|NCT05623228|591959511|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887754|NCT05623228|591959512|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887755|NCT05623228|591959513|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
163887756|NCT05623228|591959506|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
163887757|NCT05623228|591959507|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163887758|NCT05623228|591959508|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
163887759|NCT05623228|591959509|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
163887760|NCT05623228|591959510|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163887761|NCT05623228|591959511|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163887762|NCT05623228|591959512|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163887763|NCT05623228|591959513|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
163887764|NCT04802967|591960963|FG000|Part B|Withdrawal by Subject|0|||
163887765|NCT04802967|591960964|FG001|Part B|Withdrawal by Subject|0|||
163887766|NCT04802967|591960965|FG002|Part B|Withdrawal by Subject|0|||
163887767|NCT04802967|591960966|FG003|Part B|Withdrawal by Subject|0|||
163887768|NCT04802967|591960967|FG004|Part B|Withdrawal by Subject|0|||
163887769|NCT04802967|591960968|FG005|Part B|Withdrawal by Subject|1|||
163887770|NCT04802967|591960969|FG006|Part B|Withdrawal by Subject|0|||
163887771|NCT04802967|591960970|FG007|Part B|Withdrawal by Subject|0|||
163887772|NCT04802967|591960971|FG008|Part B|Withdrawal by Subject|0|||
163887773|NCT04802967|591960972|FG009|Part B|Withdrawal by Subject|0|||
163887774|NCT03560609|591960977|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
163887775|NCT03560609|591960978|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
164257062|NCT01974206|593308068|FG001|Overall Study|Did Not Take Study Drug|1|||
164257063|NCT01974206|593308067|FG000|Overall Study|Physician Decision|1|||
164257064|NCT01974206|593308068|FG001|Overall Study|Physician Decision|0|||
164257065|NCT01974206|593308067|FG000|Overall Study|Withdrawal by Subject|3|||
164257066|NCT01974206|593308068|FG001|Overall Study|Withdrawal by Subject|0|||
164257067|NCT01974206|593308067|FG000|Overall Study|Lost to Follow-up|1|||
164257068|NCT01974206|593308068|FG001|Overall Study|Lost to Follow-up|0|||
164257069|NCT01974206|593308067|FG000|Overall Study|Death|1|||
164257070|NCT01974206|593308068|FG001|Overall Study|Death|0|||
164257071|NCT02059499|593308070|FG000|Upto Week 20|Lost to Follow-up|2|||
164339508|NCT00142935|593618913|FG001|Overall Study|Death|2|||
163887776|NCT02268253|591960981|FG000|Stage 1|Withdrawal by Subject|1|||
163887777|NCT02268253|591960982|FG001|Stage 1|Withdrawal by Subject|0|||
163887778|NCT02268253|591960983|FG002|Stage 1|Withdrawal by Subject|0|||
163887779|NCT02268253|591960984|FG003|Stage 1|Withdrawal by Subject|0|||
163887780|NCT02268253|591960985|FG004|Stage 1|Withdrawal by Subject|0|||
163887781|NCT02268253|591960986|FG005|Stage 1|Withdrawal by Subject|0|||
163887782|NCT02268253|591960987|FG006|Stage 1|Withdrawal by Subject|0|||
163887783|NCT02268253|591960981|FG000|Stage 1|Death|0|||
163887784|NCT02268253|591960982|FG001|Stage 1|Death|2|||
163887785|NCT02268253|591960983|FG002|Stage 1|Death|2|||
163887786|NCT02268253|591960984|FG003|Stage 1|Death|2|||
163887787|NCT02268253|591960985|FG004|Stage 1|Death|1|||
163887788|NCT02268253|591960986|FG005|Stage 1|Death|1|||
164084758|NCT03361956|592674015|FG004|Overall Study|Withdrawal by Subject|3|||
164084759|NCT03361956|592674011|FG000|Overall Study|Disease Relapse|0|||
164339509|NCT00142935|593618914|FG002|Overall Study|Death|1|||
163887789|NCT02268253|591960987|FG006|Stage 1|Death|0|||
163887790|NCT02268253|591960981|FG000|Stage 2|Disease Recurrence/ Progression|0|||
163887791|NCT02268253|591960982|FG001|Stage 2|Disease Recurrence/ Progression|0|||
163887792|NCT02268253|591960983|FG002|Stage 2|Disease Recurrence/ Progression|1|||
163887793|NCT02268253|591960984|FG003|Stage 2|Disease Recurrence/ Progression|0|||
163887794|NCT02268253|591960985|FG004|Stage 2|Disease Recurrence/ Progression|0|||
163887795|NCT02268253|591960986|FG005|Stage 2|Disease Recurrence/ Progression|0|||
164257072|NCT02059499|593308071|FG001|Upto Week 20|Lost to Follow-up|6|||
164257073|NCT02059499|593308072|FG002|Upto Week 20|Lost to Follow-up|0|||
164257074|NCT02059499|593308070|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
164257075|NCT02059499|593308071|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
164257076|NCT02059499|593308072|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
164257077|NCT02059499|593308070|FG000|Upto Week 20|Withdrawal by Subject|1|||
164257078|NCT02059499|593308071|FG001|Upto Week 20|Withdrawal by Subject|1|||
164257079|NCT02059499|593308072|FG002|Upto Week 20|Withdrawal by Subject|0|||
164257080|NCT02059499|593308070|FG000|Upto Week 20|No treatment per protocol criteria|0|||
164257081|NCT02059499|593308071|FG001|Upto Week 20|No treatment per protocol criteria|0|||
164257082|NCT02059499|593308072|FG002|Upto Week 20|No treatment per protocol criteria|5|||
164257083|NCT02059499|593308070|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
164257084|NCT02059499|593308071|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
164257085|NCT02059499|593308072|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
164257086|NCT02059499|593308070|FG000|Post-week 20|Lost to Follow-up|0|||
164257087|NCT02059499|593308071|FG001|Post-week 20|Lost to Follow-up|2|||
164257088|NCT02059499|593308072|FG002|Post-week 20|Lost to Follow-up|0|||
164257089|NCT02059499|593308070|FG000|Post-week 20|Withdrawal by Subject|0|||
164257090|NCT02059499|593308071|FG001|Post-week 20|Withdrawal by Subject|1|||
164257091|NCT02059499|593308072|FG002|Post-week 20|Withdrawal by Subject|0|||
164257092|NCT02059499|593308070|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
164257093|NCT02059499|593308071|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
164257094|NCT02059499|593308072|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
164257095|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
164257096|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257097|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257098|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257099|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257100|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
164257101|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
164257102|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
164257103|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257104|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257105|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257106|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
164257107|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
164257108|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
164257109|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257110|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257111|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257112|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
164257113|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
164257114|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
164257115|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257116|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257117|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257118|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
164257119|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
164257120|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
164257121|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257122|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257123|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257124|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
164257125|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
164257126|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257127|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257128|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257129|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257130|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
164257131|NCT03989349|593308077|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
164257132|NCT03989349|593308078|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
164257133|NCT03989349|593308079|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257134|NCT03989349|593308080|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257135|NCT03989349|593308081|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257136|NCT03989349|593308082|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
164257137|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164257138|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164257139|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
164257140|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
164257141|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
164257142|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
164257143|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164257144|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164257145|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
164257146|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
164257147|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
164257148|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
164257149|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164257150|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164257151|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
164257152|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
164257153|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
164257154|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
164339510|NCT01180985|593618919|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
164339511|NCT01180985|593618920|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
164339512|NCT00705289|593618921|FG000|Overall Study|Subject or treating physician's choice|131|||
164339513|NCT00619177|593618927|FG000|Overall Study|Adverse Event|18|||
164339514|NCT00619177|593618927|FG000|Overall Study|Lost to Follow-up|2|||
164339515|NCT00619177|593618927|FG000|Overall Study|Lack of Efficacy|1|||
164339516|NCT00619177|593618927|FG000|Overall Study|Missing termination information|481|||
164339517|NCT00619177|593618927|FG000|Overall Study|Not specified reasons|6|||
164339518|NCT01281137|593618932|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
164339519|NCT01281137|593618933|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
164339520|NCT01281137|593618932|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
164339521|NCT01281137|593618933|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
164339522|NCT01281137|593618932|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
164339523|NCT01281137|593618933|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
164339524|NCT01281137|593618932|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
164339525|NCT01281137|593618933|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
164339526|NCT01281137|593618932|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
164339527|NCT01281137|593618933|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
164339528|NCT00788073|593618934|FG000|STX209 Then Placebo|Adverse Event|1|||
164339529|NCT00788073|593618935|FG001|STX209 Then Placebo|Adverse Event|0|||
164339530|NCT00788073|593618934|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
164339531|NCT00788073|593618935|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
164339532|NCT00788073|593618934|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
164339533|NCT00788073|593618935|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
164339534|NCT00788073|593618934|FG000|STX209 Then Placebo|unable to return due to travel|0|||
164339535|NCT00788073|593618935|FG001|STX209 Then Placebo|unable to return due to travel|1|||
164339536|NCT00788073|593618934|FG000|Placebo Then STX209|Adverse Event|2|||
164339537|NCT00788073|593618935|FG001|Placebo Then STX209|Adverse Event|0|||
164339538|NCT00788073|593618934|FG000|Placebo Then STX209|Protocol Violation|0|||
164339539|NCT00788073|593618935|FG001|Placebo Then STX209|Protocol Violation|1|||
164339540|NCT03608254|593618936|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
164339541|NCT03608254|593618936|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
164339542|NCT00910273|593618937|FG000|Overall Study|Lack of Efficacy|6|||
164339543|NCT00910273|593618938|FG001|Overall Study|Lack of Efficacy|9|||
164339544|NCT00910273|593618937|FG000|Overall Study|Adverse Event|1|||
163887796|NCT02268253|591960987|FG006|Stage 2|Disease Recurrence/ Progression|0|||
163887797|NCT02268253|591960981|FG000|Stage 2|Withdrawal by Subject|0|||
164257155|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257156|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257157|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164257158|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257159|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
164257160|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164257161|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164257162|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164257163|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164257164|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164257165|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164257166|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164257167|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
164257168|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
164257169|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
164257170|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
164257171|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
164257172|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
164257173|NCT03989349|593308077|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
164257174|NCT03989349|593308078|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
164257175|NCT03989349|593308079|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
164257176|NCT03989349|593308080|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
164257177|NCT03989349|593308081|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
164257178|NCT03989349|593308082|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
164257179|NCT02684058|593308083|FG000|Treatment Period|Progressive disease|4|||
164257180|NCT02684058|593308084|FG001|Treatment Period|Progressive disease|10|||
164257181|NCT02684058|593308085|FG002|Treatment Period|Progressive disease|19|||
164257182|NCT02684058|593308083|FG000|Treatment Period|Adverse Event|3|||
164257183|NCT02684058|593308084|FG001|Treatment Period|Adverse Event|8|||
164257184|NCT02684058|593308085|FG002|Treatment Period|Adverse Event|1|||
164257185|NCT02684058|593308083|FG000|Treatment Period|Physician Decision|5|||
164257186|NCT02684058|593308084|FG001|Treatment Period|Physician Decision|1|||
164257187|NCT02684058|593308085|FG002|Treatment Period|Physician Decision|2|||
164257188|NCT02684058|593308083|FG000|Treatment Period|New therapy for study indication|1|||
164257189|NCT02684058|593308084|FG001|Treatment Period|New therapy for study indication|0|||
164257190|NCT02684058|593308085|FG002|Treatment Period|New therapy for study indication|0|||
164257191|NCT02684058|593308083|FG000|Treatment Period|Protocol deviation|0|||
164257192|NCT02684058|593308084|FG001|Treatment Period|Protocol deviation|1|||
164339545|NCT00910273|593618938|FG001|Overall Study|Adverse Event|1|||
164339546|NCT00910273|593618937|FG000|Overall Study|Withdrawal by Subject|1|||
164339547|NCT00910273|593618938|FG001|Overall Study|Withdrawal by Subject|0|||
164339548|NCT00910273|593618937|FG000|Overall Study|Discontinuation of study by sponsor|8|||
164339549|NCT00910273|593618938|FG001|Overall Study|Discontinuation of study by sponsor|2|||
164339550|NCT00910273|593618937|FG000|Overall Study|Protocol Violation|1|||
164339551|NCT00910273|593618938|FG001|Overall Study|Protocol Violation|0|||
164339552|NCT00910273|593618937|FG000|Overall Study|Lost to Follow-up|1|||
164339553|NCT00910273|593618938|FG001|Overall Study|Lost to Follow-up|1|||
164339554|NCT03540030|593618939|FG000|Overall Study|Withdrawal by Subject|2|||
164339555|NCT03540030|593618940|FG001|Overall Study|Withdrawal by Subject|1|||
164339556|NCT03540030|593618939|FG000|Overall Study|screen fail|7|||
164339557|NCT03540030|593618940|FG001|Overall Study|screen fail|1|||
164339558|NCT03540030|593618939|FG000|Overall Study|never had surgery after signing consent|9|||
164339559|NCT03540030|593618940|FG001|Overall Study|never had surgery after signing consent|1|||
164339560|NCT00569270|593618941|FG000|Period: First Intervention|Protocol Violation|0|||
164339561|NCT00569270|593618942|FG001|Period: First Intervention|Protocol Violation|1|||
164339562|NCT04729621|593618947|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
164339563|NCT04729621|593618948|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
164339564|NCT04729621|593618949|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
164339565|NCT04729621|593618950|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
164339566|NCT04729621|593618951|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
164339567|NCT04729621|593618947|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
164339568|NCT04729621|593618948|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
164339569|NCT04729621|593618949|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
164339570|NCT04729621|593618950|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
164339571|NCT04729621|593618951|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
164339572|NCT04729621|593618947|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
163887798|NCT02268253|591960982|FG001|Stage 2|Withdrawal by Subject|0|||
163887799|NCT02268253|591960983|FG002|Stage 2|Withdrawal by Subject|2|||
163887800|NCT02268253|591960984|FG003|Stage 2|Withdrawal by Subject|0|||
163887801|NCT02268253|591960985|FG004|Stage 2|Withdrawal by Subject|0|||
163887802|NCT02268253|591960986|FG005|Stage 2|Withdrawal by Subject|2|||
163887803|NCT02268253|591960987|FG006|Stage 2|Withdrawal by Subject|0|||
163887804|NCT02268253|591960981|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163887805|NCT02268253|591960982|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163887806|NCT02268253|591960983|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
163887807|NCT02268253|591960984|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163887808|NCT02268253|591960985|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163887809|NCT02268253|591960986|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
163887810|NCT02268253|591960987|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
163887811|NCT02268253|591960981|FG000|Stage 2|Death|0|||
163887812|NCT02268253|591960982|FG001|Stage 2|Death|0|||
163887813|NCT02268253|591960983|FG002|Stage 2|Death|19|||
163887814|NCT02268253|591960984|FG003|Stage 2|Death|0|||
163887815|NCT02268253|591960985|FG004|Stage 2|Death|0|||
163887816|NCT02268253|591960986|FG005|Stage 2|Death|20|||
163887817|NCT02268253|591960987|FG006|Stage 2|Death|1|||
163887818|NCT02268253|591960981|FG000|Stage 2|Lost to Follow-up|0|||
163887819|NCT02268253|591960982|FG001|Stage 2|Lost to Follow-up|0|||
163887820|NCT02268253|591960983|FG002|Stage 2|Lost to Follow-up|0|||
163887821|NCT02268253|591960984|FG003|Stage 2|Lost to Follow-up|0|||
163887822|NCT02268253|591960985|FG004|Stage 2|Lost to Follow-up|0|||
163887823|NCT02268253|591960986|FG005|Stage 2|Lost to Follow-up|4|||
163887824|NCT02268253|591960987|FG006|Stage 2|Lost to Follow-up|0|||
163887825|NCT02268253|591960981|FG000|Stage 2|Transferred to Hospice|0|||
163887826|NCT02268253|591960982|FG001|Stage 2|Transferred to Hospice|0|||
163887827|NCT02268253|591960983|FG002|Stage 2|Transferred to Hospice|0|||
163887828|NCT02268253|591960984|FG003|Stage 2|Transferred to Hospice|0|||
163887829|NCT02268253|591960985|FG004|Stage 2|Transferred to Hospice|0|||
164257193|NCT02684058|593308085|FG002|Treatment Period|Protocol deviation|0|||
164257194|NCT02684058|593308083|FG000|Treatment Period|Subject/guardian decision|4|||
164257195|NCT02684058|593308084|FG001|Treatment Period|Subject/guardian decision|3|||
164257196|NCT02684058|593308085|FG002|Treatment Period|Subject/guardian decision|0|||
163887830|NCT02268253|591960986|FG005|Stage 2|Transferred to Hospice|2|||
163887831|NCT02268253|591960987|FG006|Stage 2|Transferred to Hospice|0|||
163887832|NCT02268253|591960981|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
163887833|NCT02268253|591960982|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
163887834|NCT02268253|591960983|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
163887835|NCT02268253|591960984|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
163887836|NCT02268253|591960985|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
163887837|NCT02268253|591960986|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
163887838|NCT02268253|591960987|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
163887839|NCT02268253|591960981|FG000|Stage 3A|Withdrawal by Subject|0|||
164084760|NCT03361956|592674012|FG001|Overall Study|Disease Relapse|0|||
163887840|NCT02268253|591960982|FG001|Stage 3A|Withdrawal by Subject|0|||
163887841|NCT02268253|591960983|FG002|Stage 3A|Withdrawal by Subject|2|||
163887842|NCT02268253|591960984|FG003|Stage 3A|Withdrawal by Subject|0|||
163887843|NCT02268253|591960985|FG004|Stage 3A|Withdrawal by Subject|0|||
164257197|NCT02684058|593308083|FG000|Treatment Period|Death|0|||
164257198|NCT02684058|593308084|FG001|Treatment Period|Death|0|||
164257199|NCT02684058|593308085|FG002|Treatment Period|Death|2|||
164257200|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163887844|NCT02268253|591960986|FG005|Stage 3A|Withdrawal by Subject|0|||
163887845|NCT02268253|591960987|FG006|Stage 3A|Withdrawal by Subject|0|||
163887846|NCT02268253|591960981|FG000|Stage 3A|Physician Decision|0|||
163887847|NCT02268253|591960982|FG001|Stage 3A|Physician Decision|0|||
163887848|NCT02268253|591960983|FG002|Stage 3A|Physician Decision|2|||
163887849|NCT02268253|591960984|FG003|Stage 3A|Physician Decision|0|||
163887850|NCT02268253|591960985|FG004|Stage 3A|Physician Decision|0|||
163887851|NCT02268253|591960986|FG005|Stage 3A|Physician Decision|0|||
163887852|NCT02268253|591960987|FG006|Stage 3A|Physician Decision|0|||
163887853|NCT02268253|591960981|FG000|Stage 3A|Study Terminated by Sponsor|0|||
163887854|NCT02268253|591960982|FG001|Stage 3A|Study Terminated by Sponsor|0|||
163887855|NCT02268253|591960983|FG002|Stage 3A|Study Terminated by Sponsor|2|||
163887856|NCT02268253|591960984|FG003|Stage 3A|Study Terminated by Sponsor|0|||
163887857|NCT02268253|591960985|FG004|Stage 3A|Study Terminated by Sponsor|0|||
163887858|NCT02268253|591960986|FG005|Stage 3A|Study Terminated by Sponsor|0|||
163887859|NCT02268253|591960987|FG006|Stage 3A|Study Terminated by Sponsor|0|||
163887860|NCT02268253|591960981|FG000|Stage 3A|Lost to Follow-up|0|||
163887861|NCT02268253|591960982|FG001|Stage 3A|Lost to Follow-up|0|||
163887862|NCT02268253|591960983|FG002|Stage 3A|Lost to Follow-up|1|||
163887863|NCT02268253|591960984|FG003|Stage 3A|Lost to Follow-up|0|||
163887864|NCT02268253|591960985|FG004|Stage 3A|Lost to Follow-up|0|||
163887865|NCT02268253|591960986|FG005|Stage 3A|Lost to Follow-up|0|||
163887866|NCT02268253|591960987|FG006|Stage 3A|Lost to Follow-up|0|||
163887867|NCT02268253|591960981|FG000|Stage 3A|Death|0|||
163887868|NCT02268253|591960982|FG001|Stage 3A|Death|0|||
163887869|NCT02268253|591960983|FG002|Stage 3A|Death|5|||
163887870|NCT02268253|591960984|FG003|Stage 3A|Death|0|||
163887871|NCT02268253|591960985|FG004|Stage 3A|Death|0|||
163887872|NCT02268253|591960986|FG005|Stage 3A|Death|0|||
163887873|NCT02268253|591960987|FG006|Stage 3A|Death|0|||
163887874|NCT05672069|591960988|FG000|Overall Study|Implant removal|1|||
163887875|NCT05672069|591960988|FG000|Overall Study|Lost to Follow-up|2|||
164257201|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164257202|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
164257203|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
164257204|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
164257205|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
164257206|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164257207|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164257208|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
164257209|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|Death|0|||
164257210|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|Death|0|||
164257211|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|Death|3|||
164257212|NCT02684058|593308083|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
164257213|NCT02684058|593308084|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
164257214|NCT02684058|593308085|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
164257215|NCT02684058|593308083|FG000|Post-treatment Survival Follow-up|Death|0|||
164257216|NCT02684058|593308084|FG001|Post-treatment Survival Follow-up|Death|0|||
164257217|NCT02684058|593308085|FG002|Post-treatment Survival Follow-up|Death|7|||
164257218|NCT02684058|593308083|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
164257219|NCT02684058|593308084|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
164257220|NCT02684058|593308085|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
164257221|NCT02684058|593308083|FG000|Crossover Treatment Period|Progressive disease|0|||
164257222|NCT02684058|593308084|FG001|Crossover Treatment Period|Progressive disease|1|||
164257223|NCT02684058|593308085|FG002|Crossover Treatment Period|Progressive disease|0|||
164257224|NCT01802580|593308086|FG000|Overall Study|Physician Decision|1|||
164257225|NCT01802580|593308087|FG001|Overall Study|Physician Decision|0|||
164257226|NCT01802580|593308086|FG000|Overall Study|Protocol Violation|2|||
164257227|NCT01802580|593308087|FG001|Overall Study|Protocol Violation|0|||
164257228|NCT01802580|593308086|FG000|Overall Study|Withdrawal by Subject|5|||
164257229|NCT01802580|593308087|FG001|Overall Study|Withdrawal by Subject|6|||
164257230|NCT01802580|593308086|FG000|Overall Study|Other|1|||
164257231|NCT01802580|593308087|FG001|Overall Study|Other|3|||
164257232|NCT01802580|593308086|FG000|Overall Study|Lack of Efficacy|0|||
164257233|NCT01802580|593308087|FG001|Overall Study|Lack of Efficacy|2|||
164257234|NCT03255967|593308088|FG000|Overall Study|Adverse Event|26|||
164257235|NCT03255967|593308089|FG001|Overall Study|Adverse Event|30|||
164257236|NCT03255967|593308088|FG000|Overall Study|Withdrawal by Subject|6|||
164257237|NCT03255967|593308089|FG001|Overall Study|Withdrawal by Subject|6|||
164257238|NCT03255967|593308088|FG000|Overall Study|Schedule conflict|6|||
164257239|NCT03255967|593308089|FG001|Overall Study|Schedule conflict|4|||
164257240|NCT03255967|593308088|FG000|Overall Study|POA did not sign consent form|2|||
164257241|NCT03255967|593308089|FG001|Overall Study|POA did not sign consent form|0|||
164257242|NCT01252186|593308090|FG000|Overall Study|Adverse Event|9|||
164257243|NCT01252186|593308091|FG001|Overall Study|Adverse Event|6|||
164257244|NCT01252186|593308092|FG002|Overall Study|Adverse Event|8|||
164257245|NCT01252186|593308090|FG000|Overall Study|Withdrawal by Subject|2|||
164257246|NCT01252186|593308091|FG001|Overall Study|Withdrawal by Subject|5|||
164257247|NCT01252186|593308092|FG002|Overall Study|Withdrawal by Subject|2|||
164257248|NCT01252186|593308090|FG000|Overall Study|Physician Decision|0|||
164257249|NCT01252186|593308091|FG001|Overall Study|Physician Decision|0|||
164257250|NCT01252186|593308092|FG002|Overall Study|Physician Decision|1|||
164257251|NCT01252186|593308090|FG000|Overall Study|Non-compliance|0|||
164257252|NCT01252186|593308091|FG001|Overall Study|Non-compliance|3|||
164257253|NCT01252186|593308092|FG002|Overall Study|Non-compliance|4|||
164257254|NCT01252186|593308090|FG000|Overall Study|Protocol Violation|0|||
164257255|NCT01252186|593308091|FG001|Overall Study|Protocol Violation|0|||
164257256|NCT01252186|593308092|FG002|Overall Study|Protocol Violation|1|||
164257257|NCT01252186|593308090|FG000|Overall Study|Pregnancy|2|||
164257258|NCT01252186|593308091|FG001|Overall Study|Pregnancy|2|||
164257259|NCT01252186|593308092|FG002|Overall Study|Pregnancy|0|||
164257260|NCT01252186|593308090|FG000|Overall Study|Sponsor Request|2|||
164257261|NCT01252186|593308091|FG001|Overall Study|Sponsor Request|1|||
164257262|NCT01252186|593308092|FG002|Overall Study|Sponsor Request|0|||
164257263|NCT01252186|593308090|FG000|Overall Study|Lost to Follow-up|10|||
164257264|NCT01252186|593308091|FG001|Overall Study|Lost to Follow-up|10|||
164257265|NCT01252186|593308092|FG002|Overall Study|Lost to Follow-up|11|||
164257266|NCT01252186|593308090|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
164257267|NCT01252186|593308091|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
164257268|NCT01252186|593308092|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
164257269|NCT01327053|593308097|FG000|Overall Study|Adverse Event|23|||
164257270|NCT01327053|593308098|FG001|Overall Study|Adverse Event|57|||
164257271|NCT01327053|593308097|FG000|Overall Study|Patient/guardian decision|11|||
164257272|NCT01327053|593308098|FG001|Overall Study|Patient/guardian decision|35|||
164257273|NCT01327053|593308097|FG000|Overall Study|Physician Decision|10|||
164257274|NCT01327053|593308098|FG001|Overall Study|Physician Decision|14|||
164257275|NCT01327053|593308097|FG000|Overall Study|Death|1|||
164257276|NCT01327053|593308098|FG001|Overall Study|Death|5|||
164257277|NCT01327053|593308097|FG000|Overall Study|Lost to Follow-up|2|||
164257278|NCT01327053|593308098|FG001|Overall Study|Lost to Follow-up|4|||
164257279|NCT01327053|593308097|FG000|Overall Study|Non-compliance with study treatment|0|||
164257280|NCT01327053|593308098|FG001|Overall Study|Non-compliance with study treatment|5|||
164257281|NCT01327053|593308097|FG000|Overall Study|Study terminated by Sponsor|1|||
164257282|NCT01327053|593308098|FG001|Overall Study|Study terminated by Sponsor|3|||
164257283|NCT01327053|593308097|FG000|Overall Study|Progressive disease|31|||
164257284|NCT01327053|593308098|FG001|Overall Study|Progressive disease|26|||
164257285|NCT01327053|593308097|FG000|Overall Study|Protocol Violation|0|||
164257286|NCT01327053|593308098|FG001|Overall Study|Protocol Violation|1|||
164257287|NCT01327053|593308097|FG000|Overall Study|Untreated|0|||
164257288|NCT01327053|593308098|FG001|Overall Study|Untreated|1|||
164257289|NCT00778258|593308099|FG000|Overall Study|Adverse Event|1|||
164257290|NCT00778258|593308100|FG001|Overall Study|Adverse Event|0|||
164257291|NCT00778258|593308101|FG002|Overall Study|Adverse Event|0|||
164257292|NCT00778258|593308102|FG003|Overall Study|Adverse Event|0|||
164257293|NCT00778258|593308103|FG004|Overall Study|Adverse Event|0|||
164257294|NCT00778258|593308104|FG005|Overall Study|Adverse Event|1|||
164257295|NCT00778258|593308105|FG006|Overall Study|Adverse Event|0|||
164257296|NCT00778258|593308106|FG007|Overall Study|Adverse Event|0|||
164257297|NCT00778258|593308107|FG008|Overall Study|Adverse Event|0|||
164257298|NCT00778258|593308099|FG000|Overall Study|Lost to Follow-up|0|||
164257299|NCT00778258|593308100|FG001|Overall Study|Lost to Follow-up|0|||
164257300|NCT00778258|593308101|FG002|Overall Study|Lost to Follow-up|2|||
164257301|NCT00778258|593308102|FG003|Overall Study|Lost to Follow-up|0|||
164257302|NCT00778258|593308103|FG004|Overall Study|Lost to Follow-up|0|||
164257303|NCT00778258|593308104|FG005|Overall Study|Lost to Follow-up|3|||
164257304|NCT00778258|593308105|FG006|Overall Study|Lost to Follow-up|2|||
164257305|NCT00778258|593308106|FG007|Overall Study|Lost to Follow-up|2|||
164257306|NCT00778258|593308107|FG008|Overall Study|Lost to Follow-up|0|||
164257307|NCT00778258|593308099|FG000|Overall Study|Withdrawal by Subject|6|||
164257308|NCT00778258|593308100|FG001|Overall Study|Withdrawal by Subject|2|||
164257309|NCT00778258|593308101|FG002|Overall Study|Withdrawal by Subject|8|||
164257310|NCT00778258|593308102|FG003|Overall Study|Withdrawal by Subject|2|||
164257311|NCT00778258|593308103|FG004|Overall Study|Withdrawal by Subject|0|||
164257312|NCT00778258|593308104|FG005|Overall Study|Withdrawal by Subject|6|||
164257313|NCT00778258|593308105|FG006|Overall Study|Withdrawal by Subject|12|||
164257314|NCT00778258|593308106|FG007|Overall Study|Withdrawal by Subject|12|||
164257315|NCT00778258|593308107|FG008|Overall Study|Withdrawal by Subject|4|||
164257316|NCT00778258|593308099|FG000|Overall Study|New Contraindication|0|||
164257317|NCT00778258|593308100|FG001|Overall Study|New Contraindication|0|||
164257318|NCT00778258|593308101|FG002|Overall Study|New Contraindication|0|||
164257319|NCT00778258|593308102|FG003|Overall Study|New Contraindication|0|||
164257320|NCT00778258|593308103|FG004|Overall Study|New Contraindication|0|||
164257321|NCT00778258|593308104|FG005|Overall Study|New Contraindication|0|||
164257322|NCT00778258|593308105|FG006|Overall Study|New Contraindication|0|||
164257323|NCT00778258|593308106|FG007|Overall Study|New Contraindication|1|||
164339573|NCT04729621|593618948|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
164339574|NCT04729621|593618949|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
164257324|NCT00778258|593308107|FG008|Overall Study|New Contraindication|0|||
164257325|NCT00778258|593308099|FG000|Overall Study|Non-compliance|0|||
164257326|NCT00778258|593308100|FG001|Overall Study|Non-compliance|0|||
164257327|NCT00778258|593308101|FG002|Overall Study|Non-compliance|0|||
164257328|NCT00778258|593308102|FG003|Overall Study|Non-compliance|1|||
164257329|NCT00778258|593308103|FG004|Overall Study|Non-compliance|0|||
164257330|NCT00778258|593308104|FG005|Overall Study|Non-compliance|0|||
164257331|NCT00778258|593308105|FG006|Overall Study|Non-compliance|0|||
164257332|NCT00778258|593308106|FG007|Overall Study|Non-compliance|0|||
164257333|NCT00778258|593308107|FG008|Overall Study|Non-compliance|0|||
164257334|NCT00778258|593308099|FG000|Overall Study|Other|0|||
164257335|NCT00778258|593308100|FG001|Overall Study|Other|0|||
164257336|NCT00778258|593308101|FG002|Overall Study|Other|0|||
164257337|NCT00778258|593308102|FG003|Overall Study|Other|0|||
164257338|NCT00778258|593308103|FG004|Overall Study|Other|0|||
164257339|NCT00778258|593308104|FG005|Overall Study|Other|0|||
164257340|NCT00778258|593308105|FG006|Overall Study|Other|1|||
164257341|NCT00778258|593308106|FG007|Overall Study|Other|0|||
164257342|NCT00778258|593308107|FG008|Overall Study|Other|0|||
164257343|NCT00661726|593308108|FG000|Overall Study|Adverse Event|1|||
164257344|NCT02147197|593308109|FG000|Overall Study|Adverse Event|1|||
164257345|NCT02147197|593308110|FG001|Overall Study|Adverse Event|0|||
163887876|NCT04016662|591960991|FG000|Run-In Phase|Death|1|||
163887877|NCT04016662|591960991|FG000|Run-In Phase|Withdrawal by Subject|11|||
163887878|NCT04016662|591960991|FG000|Run-In Phase|Not meeting screening eligibility|9|||
163887879|NCT04016662|591960991|FG000|Run-In Phase|Physician Decision|3|||
163887880|NCT04016662|591960991|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
163887881|NCT04016662|591960991|FG000|PLGS (12 Weeks)|Death|1|||
163887882|NCT04016662|591960991|FG000|SAP (12 Weeks)|Death|1|||
163887883|NCT03021096|591960992|FG000|Overall Study|Lost to Follow-up|4|||
163887884|NCT03021096|591960992|FG000|Overall Study|Protocol Violation|2|||
163887885|NCT03216057|591960993|FG000|Overall Study|Lost to Follow-up|2|||
163887886|NCT03216057|591960994|FG001|Overall Study|Lost to Follow-up|2|||
163887887|NCT05126433|591960995|FG000|Overall Study|Withdrawal by Subject|3|||
163887888|NCT05126433|591960996|FG001|Overall Study|Withdrawal by Subject|0|||
164257346|NCT02147197|593308111|FG002|Overall Study|Adverse Event|0|||
164257347|NCT02147197|593308109|FG000|Overall Study|Withdrawal of Consent|4|||
163887889|NCT05126433|591960997|FG002|Overall Study|Withdrawal by Subject|4|||
163887890|NCT05126433|591960995|FG000|Overall Study|Death|9|||
163887891|NCT05126433|591960996|FG001|Overall Study|Death|3|||
163887892|NCT05126433|591960997|FG002|Overall Study|Death|5|||
164257348|NCT02147197|593308110|FG001|Overall Study|Withdrawal of Consent|3|||
163887893|NCT05126433|591960995|FG000|Overall Study|Study Terminated by sponsor|0|||
164257349|NCT02147197|593308111|FG002|Overall Study|Withdrawal of Consent|2|||
164257350|NCT02147197|593308109|FG000|Overall Study|Lost to Follow-up|2|||
163992120|NCT00110994|592339679|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
163992121|NCT00110994|592339680|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
163992122|NCT00110994|592339679|FG000|Double-blind (DB) Treatment|Death|1|||
163992123|NCT00110994|592339680|FG001|Double-blind (DB) Treatment|Death|0|||
163992124|NCT00110994|592339679|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
163992125|NCT00110994|592339680|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
163992126|NCT00110994|592339679|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
163992127|NCT00110994|592339680|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
163992128|NCT00110994|592339679|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
163992129|NCT00110994|592339680|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
163992130|NCT00110994|592339679|FG000|Double-blind (DB) Treatment|other reasons|2|||
163992131|NCT00110994|592339680|FG001|Double-blind (DB) Treatment|other reasons|3|||
163992132|NCT00110994|592339679|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
163992133|NCT00110994|592339680|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
163992134|NCT00110994|592339679|FG000|Active Follow-up|Other reasons|0|||
163992135|NCT00110994|592339680|FG001|Active Follow-up|Other reasons|2|||
163992136|NCT00110994|592339679|FG000|Long Term Follow-up|Death|19|||
163992137|NCT00110994|592339680|FG001|Long Term Follow-up|Death|17|||
163992138|NCT04398732|592339681|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
163992139|NCT01500057|592339689|FG000|Overall Study|Lost to Follow-up|6|||
163992140|NCT01500057|592339690|FG001|Overall Study|Lost to Follow-up|4|||
163992141|NCT02318784|592339693|FG000|Overall Study|Adverse Event|13|||
163992142|NCT02318784|592339693|FG000|Overall Study|Death|2|||
163992143|NCT02318784|592339693|FG000|Overall Study|Progressive Disease|37|||
163992144|NCT02318784|592339693|FG000|Overall Study|Withdrawal by Subject|10|||
163992145|NCT00354601|592339696|FG000|Overall Study|Protocol Violation|1|||
163992146|NCT00354601|592339696|FG000|Overall Study|progression|1|||
163992147|NCT02471716|592339697|FG000|Overall Study|Withdrawal by Subject|0|||
163992148|NCT02471716|592339698|FG001|Overall Study|Withdrawal by Subject|1|||
163992149|NCT02471716|592339699|FG002|Overall Study|Withdrawal by Subject|0|||
163992150|NCT02471716|592339700|FG003|Overall Study|Withdrawal by Subject|2|||
163992151|NCT02471716|592339701|FG004|Overall Study|Withdrawal by Subject|5|||
163992152|NCT02471716|592339697|FG000|Overall Study|Study Terminiated by sponsor|0|||
163992153|NCT02471716|592339698|FG001|Overall Study|Study Terminiated by sponsor|0|||
163992154|NCT02471716|592339699|FG002|Overall Study|Study Terminiated by sponsor|0|||
163992155|NCT02471716|592339700|FG003|Overall Study|Study Terminiated by sponsor|1|||
163992156|NCT02471716|592339701|FG004|Overall Study|Study Terminiated by sponsor|0|||
163992157|NCT02471716|592339697|FG000|Overall Study|Lost to Follow-up|0|||
163992158|NCT02471716|592339698|FG001|Overall Study|Lost to Follow-up|0|||
163992159|NCT02471716|592339699|FG002|Overall Study|Lost to Follow-up|0|||
163992160|NCT02471716|592339700|FG003|Overall Study|Lost to Follow-up|3|||
163992161|NCT02471716|592339701|FG004|Overall Study|Lost to Follow-up|2|||
163992162|NCT02471716|592339697|FG000|Overall Study|Death|0|||
163992163|NCT02471716|592339698|FG001|Overall Study|Death|0|||
163992164|NCT02471716|592339699|FG002|Overall Study|Death|0|||
163992165|NCT02471716|592339700|FG003|Overall Study|Death|1|||
163992166|NCT02471716|592339701|FG004|Overall Study|Death|0|||
163992167|NCT02471716|592339697|FG000|Overall Study|Other|0|||
163992168|NCT02471716|592339698|FG001|Overall Study|Other|0|||
163992169|NCT02471716|592339699|FG002|Overall Study|Other|0|||
163992170|NCT02471716|592339700|FG003|Overall Study|Other|8|||
163992171|NCT02471716|592339701|FG004|Overall Study|Other|9|||
163992172|NCT01838044|592339717|FG000|Overall Study|Adverse Event|4|||
163992173|NCT01838044|592339718|FG001|Overall Study|Adverse Event|6|||
163992174|NCT01838044|592339717|FG000|Overall Study|Protocol Violation|3|||
163992175|NCT01838044|592339718|FG001|Overall Study|Protocol Violation|3|||
164084761|NCT03361956|592674013|FG002|Overall Study|Disease Relapse|1|||
163992176|NCT01838044|592339717|FG000|Overall Study|Withdrawal by Subject|0|||
164084762|NCT03361956|592674014|FG003|Overall Study|Disease Relapse|0|||
164084763|NCT03361956|592674015|FG004|Overall Study|Disease Relapse|0|||
164084764|NCT03361956|592674011|FG000|Overall Study|Physician Decision|0|||
164084765|NCT03361956|592674012|FG001|Overall Study|Physician Decision|2|||
164084766|NCT03361956|592674013|FG002|Overall Study|Physician Decision|0|||
163992177|NCT01838044|592339718|FG001|Overall Study|Withdrawal by Subject|2|||
163992178|NCT01838044|592339717|FG000|Overall Study|Insufficient clinical response|1|||
163992179|NCT01838044|592339718|FG001|Overall Study|Insufficient clinical response|2|||
163992180|NCT01838044|592339717|FG000|Overall Study|Medication error without associated AE|0|||
163992181|NCT01838044|592339718|FG001|Overall Study|Medication error without associated AE|1|||
163992182|NCT01838044|592339717|FG000|Overall Study|Lost to Follow-up|0|||
163887894|NCT05126433|591960996|FG001|Overall Study|Study Terminated by sponsor|1|||
163887895|NCT05126433|591960997|FG002|Overall Study|Study Terminated by sponsor|2|||
164257351|NCT02147197|593308110|FG001|Overall Study|Lost to Follow-up|3|||
164257352|NCT02147197|593308111|FG002|Overall Study|Lost to Follow-up|1|||
164257353|NCT02147197|593308109|FG000|Overall Study|Protocol Violation|1|||
164257354|NCT02147197|593308110|FG001|Overall Study|Protocol Violation|0|||
163887896|NCT05126433|591960995|FG000|Overall Study|Progressive Disease|1|||
163887897|NCT05126433|591960996|FG001|Overall Study|Progressive Disease|4|||
164257355|NCT02147197|593308111|FG002|Overall Study|Protocol Violation|3|||
164257356|NCT02147197|593308109|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164257357|NCT02147197|593308110|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164257358|NCT02147197|593308111|FG002|Overall Study|Other Miscellaneous Reasons|3|||
164257359|NCT02644096|593308112|FG000|Overall Study|Withdrawal by Subject|28|||
164257360|NCT02644096|593308113|FG001|Overall Study|Withdrawal by Subject|25|||
164257361|NCT00322452|593308114|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164257362|NCT00322452|593308115|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164257363|NCT00322452|593308114|FG000|Overall Study|Lost to Follow-up|5|||
164257364|NCT00322452|593308115|FG001|Overall Study|Lost to Follow-up|2|||
164257365|NCT00322452|593308114|FG000|Overall Study|Withdrawal by Subject|19|||
164257366|NCT00322452|593308115|FG001|Overall Study|Withdrawal by Subject|46|||
164257367|NCT00322452|593308114|FG000|Overall Study|Death|223|||
164257368|NCT00322452|593308115|FG001|Overall Study|Death|227|||
164257369|NCT02438384|593308116|FG000|Overall Study|Lost to Follow-up|8|||
164257370|NCT02438384|593308117|FG001|Overall Study|Lost to Follow-up|6|||
164257371|NCT02438384|593308118|FG002|Overall Study|Lost to Follow-up|4|||
164257372|NCT02650128|593308119|FG000|Overall Study|Death|2|||
164257373|NCT00303446|593309858|FG000|Overall Study|Withdrawal by Subject|2|||
164257374|NCT00303446|593309859|FG001|Overall Study|Withdrawal by Subject|2|||
164257375|NCT00303446|593309858|FG000|Overall Study|Death|0|||
164257376|NCT00303446|593309859|FG001|Overall Study|Death|1|||
164257377|NCT00303446|593309858|FG000|Overall Study|Physician Decision|0|||
164257378|NCT00303446|593309859|FG001|Overall Study|Physician Decision|1|||
164257379|NCT03116828|593309861|FG000|Overall Study|Adverse Event|1|||
164257380|NCT03116828|593309862|FG001|Overall Study|Adverse Event|10|||
164339575|NCT04729621|593618950|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
164339576|NCT04729621|593618951|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
164339577|NCT04729621|593618947|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164339578|NCT04729621|593618948|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164339579|NCT04729621|593618949|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
164339580|NCT04729621|593618950|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
164339581|NCT04729621|593618951|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
164339582|NCT04729621|593618947|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339583|NCT04729621|593618948|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339584|NCT04729621|593618949|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339585|NCT04729621|593618950|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
164339586|NCT04729621|593618951|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
164339587|NCT04729621|593618947|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
164339588|NCT04729621|593618948|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
164339589|NCT04729621|593618949|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
164339590|NCT04729621|593618950|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
164339591|NCT04729621|593618951|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
164339592|NCT00347360|593618953|FG000|Overall Study|Adverse Event|1|||
164339593|NCT00347360|593618954|FG001|Overall Study|Adverse Event|2|||
164339594|NCT00347360|593618955|FG002|Overall Study|Adverse Event|0|||
164339595|NCT00347360|593618956|FG003|Overall Study|Adverse Event|4|||
164339596|NCT00347360|593618957|FG004|Overall Study|Adverse Event|1|||
164339597|NCT00347360|593618958|FG005|Overall Study|Adverse Event|2|||
164339598|NCT00347360|593618959|FG006|Overall Study|Adverse Event|2|||
164339599|NCT00347360|593618960|FG007|Overall Study|Adverse Event|0|||
164339600|NCT00347360|593618961|FG008|Overall Study|Adverse Event|2|||
164339601|NCT00347360|593618962|FG009|Overall Study|Adverse Event|3|||
164339602|NCT00347360|593618963|FG010|Overall Study|Adverse Event|3|||
164339603|NCT00347360|593618964|FG011|Overall Study|Adverse Event|1|||
164339604|NCT00347360|593618965|FG012|Overall Study|Adverse Event|3|||
164339605|NCT00347360|593618966|FG013|Overall Study|Adverse Event|2|||
164339606|NCT00347360|593618967|FG014|Overall Study|Adverse Event|2|||
164339607|NCT00347360|593618953|FG000|Overall Study|Lost to Follow-up|0|||
164339608|NCT00347360|593618954|FG001|Overall Study|Lost to Follow-up|0|||
164339609|NCT00347360|593618955|FG002|Overall Study|Lost to Follow-up|0|||
164339610|NCT00347360|593618956|FG003|Overall Study|Lost to Follow-up|2|||
164339611|NCT00347360|593618957|FG004|Overall Study|Lost to Follow-up|1|||
164339612|NCT00347360|593618958|FG005|Overall Study|Lost to Follow-up|1|||
164339613|NCT00347360|593618959|FG006|Overall Study|Lost to Follow-up|0|||
163887898|NCT05126433|591960997|FG002|Overall Study|Progressive Disease|3|||
164257381|NCT03116828|593309861|FG000|Overall Study|Withdrawal by Subject|4|||
164257382|NCT03116828|593309862|FG001|Overall Study|Withdrawal by Subject|8|||
164257383|NCT03116828|593309861|FG000|Overall Study|OTHER|3|||
164257384|NCT03116828|593309862|FG001|Overall Study|OTHER|3|||
163992183|NCT01838044|592339718|FG001|Overall Study|Lost to Follow-up|2|||
163992184|NCT00330187|592339719|FG000|Overall Study|Lost to Follow-up|12|||
164339614|NCT00347360|593618960|FG007|Overall Study|Lost to Follow-up|1|||
164339615|NCT00347360|593618961|FG008|Overall Study|Lost to Follow-up|1|||
164339616|NCT00347360|593618962|FG009|Overall Study|Lost to Follow-up|2|||
164339617|NCT00347360|593618963|FG010|Overall Study|Lost to Follow-up|0|||
164339618|NCT00347360|593618964|FG011|Overall Study|Lost to Follow-up|0|||
164339619|NCT00347360|593618965|FG012|Overall Study|Lost to Follow-up|1|||
164339620|NCT00347360|593618966|FG013|Overall Study|Lost to Follow-up|0|||
164339621|NCT00347360|593618967|FG014|Overall Study|Lost to Follow-up|0|||
164339622|NCT00347360|593618953|FG000|Overall Study|Protocol Violation|2|||
163992185|NCT00330187|592339720|FG001|Overall Study|Lost to Follow-up|13|||
163992186|NCT00330187|592339721|FG002|Overall Study|Lost to Follow-up|14|||
163992187|NCT00330187|592339722|FG003|Overall Study|Lost to Follow-up|10|||
163992188|NCT00330187|592339719|FG000|Overall Study|Withdrawal by Subject|8|||
164339623|NCT00347360|593618954|FG001|Overall Study|Protocol Violation|3|||
164084767|NCT03361956|592674014|FG003|Overall Study|Physician Decision|1|||
164084768|NCT03361956|592674015|FG004|Overall Study|Physician Decision|0|||
164257385|NCT05243745|593309865|FG000|Overall Study|Withdrawal by Subject|0|||
164257386|NCT05243745|593309866|FG001|Overall Study|Withdrawal by Subject|0|||
164257387|NCT05243745|593309867|FG002|Overall Study|Withdrawal by Subject|0|||
164257388|NCT05243745|593309868|FG003|Overall Study|Withdrawal by Subject|1|||
164257389|NCT05243745|593309865|FG000|Overall Study|Unable to Attend Visit 6|0|||
164257390|NCT05243745|593309866|FG001|Overall Study|Unable to Attend Visit 6|0|||
164257391|NCT05243745|593309867|FG002|Overall Study|Unable to Attend Visit 6|1|||
164257392|NCT05243745|593309868|FG003|Overall Study|Unable to Attend Visit 6|0|||
164257393|NCT04187144|593309881|FG000|Overall Study|Lost to Follow-up|12|||
164257394|NCT04187144|593309882|FG001|Overall Study|Lost to Follow-up|11|||
164257395|NCT04187144|593309881|FG000|Overall Study|Withdrawal by Subject|20|||
164257396|NCT04187144|593309882|FG001|Overall Study|Withdrawal by Subject|18|||
164257397|NCT04187144|593309881|FG000|Overall Study|Adverse Event|19|||
164257398|NCT04187144|593309882|FG001|Overall Study|Adverse Event|4|||
164257399|NCT04187144|593309881|FG000|Overall Study|Physician Decision|5|||
164257400|NCT04187144|593309882|FG001|Overall Study|Physician Decision|3|||
164257401|NCT04187144|593309881|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
164257402|NCT04187144|593309882|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
164257403|NCT04187144|593309881|FG000|Overall Study|Protocol Deviation|1|||
164257404|NCT04187144|593309882|FG001|Overall Study|Protocol Deviation|4|||
164257405|NCT03842969|593309883|FG000|Overall Study|Participant declined follow-up visit|0|||
164257406|NCT03842969|593309884|FG001|Overall Study|Participant declined follow-up visit|1|||
164257407|NCT03842969|593309885|FG002|Overall Study|Participant declined follow-up visit|0|||
164257408|NCT03842969|593309883|FG000|Overall Study|Sponsor's decision|12|||
164257409|NCT03842969|593309884|FG001|Overall Study|Sponsor's decision|99|||
164257410|NCT03842969|593309885|FG002|Overall Study|Sponsor's decision|61|||
164257411|NCT03842969|593309883|FG000|Overall Study|Pregnancy|0|||
164257412|NCT03842969|593309884|FG001|Overall Study|Pregnancy|0|||
164257413|NCT03842969|593309885|FG002|Overall Study|Pregnancy|1|||
164257414|NCT03842969|593309883|FG000|Overall Study|Death|1|||
164257415|NCT03842969|593309884|FG001|Overall Study|Death|0|||
164257416|NCT03842969|593309885|FG002|Overall Study|Death|1|||
164257417|NCT03842969|593309883|FG000|Overall Study|Withdrawal by Subject|3|||
164257418|NCT03842969|593309884|FG001|Overall Study|Withdrawal by Subject|30|||
164257419|NCT03842969|593309885|FG002|Overall Study|Withdrawal by Subject|18|||
164257420|NCT03842969|593309883|FG000|Overall Study|Protocol Violation|1|||
164257421|NCT03842969|593309884|FG001|Overall Study|Protocol Violation|1|||
164257422|NCT03842969|593309885|FG002|Overall Study|Protocol Violation|0|||
164257423|NCT03842969|593309883|FG000|Overall Study|Physician Decision|0|||
164257424|NCT03842969|593309884|FG001|Overall Study|Physician Decision|3|||
164257425|NCT03842969|593309885|FG002|Overall Study|Physician Decision|0|||
164257426|NCT03842969|593309883|FG000|Overall Study|Lost to Follow-up|0|||
164257427|NCT03842969|593309884|FG001|Overall Study|Lost to Follow-up|2|||
164257428|NCT03842969|593309885|FG002|Overall Study|Lost to Follow-up|0|||
164257429|NCT03842969|593309883|FG000|Overall Study|Adverse Event|0|||
164257430|NCT03842969|593309884|FG001|Overall Study|Adverse Event|2|||
164257431|NCT03842969|593309885|FG002|Overall Study|Adverse Event|0|||
164257432|NCT01044745|593309886|FG000|Overall Study|Ineiligible|2|||
164257433|NCT01159171|593309889|FG000|Overall Study|Adverse Event|11|||
164257434|NCT01159171|593309889|FG000|Overall Study|Progression of Disease|28|||
164257435|NCT01159171|593309889|FG000|Overall Study|Protocol Violation|1|||
164257436|NCT01159171|593309889|FG000|Overall Study|Need for Surgery|5|||
164257437|NCT01159171|593309889|FG000|Overall Study|Medical Decision|4|||
164257438|NCT01159171|593309889|FG000|Overall Study|Death|1|||
164257439|NCT02264665|593309890|FG000|Overall Study|Other|0|||
164257440|NCT02264665|593309891|FG001|Overall Study|Other|0|||
164257441|NCT02264665|593309892|FG002|Overall Study|Other|3|||
164257442|NCT02264665|593309893|FG003|Overall Study|Other|0|||
164257443|NCT02264665|593309894|FG004|Overall Study|Other|0|||
164257444|NCT02264665|593309895|FG005|Overall Study|Other|0|||
164257445|NCT02264665|593309896|FG006|Overall Study|Other|0|||
164257446|NCT02264665|593309890|FG000|Overall Study|Death|9|||
164257447|NCT02264665|593309891|FG001|Overall Study|Death|8|||
164257448|NCT02264665|593309892|FG002|Overall Study|Death|13|||
164257449|NCT02264665|593309893|FG003|Overall Study|Death|5|||
164257450|NCT02264665|593309894|FG004|Overall Study|Death|0|||
164257451|NCT02264665|593309895|FG005|Overall Study|Death|0|||
164257452|NCT02264665|593309896|FG006|Overall Study|Death|1|||
164257453|NCT02264665|593309890|FG000|Overall Study|Lost to Follow-up|1|||
164257454|NCT02264665|593309891|FG001|Overall Study|Lost to Follow-up|0|||
164257455|NCT02264665|593309892|FG002|Overall Study|Lost to Follow-up|2|||
164257456|NCT02264665|593309893|FG003|Overall Study|Lost to Follow-up|1|||
164257457|NCT02264665|593309894|FG004|Overall Study|Lost to Follow-up|0|||
164257458|NCT02264665|593309895|FG005|Overall Study|Lost to Follow-up|0|||
164257459|NCT02264665|593309896|FG006|Overall Study|Lost to Follow-up|0|||
164339624|NCT00347360|593618955|FG002|Overall Study|Protocol Violation|1|||
164339625|NCT00347360|593618956|FG003|Overall Study|Protocol Violation|2|||
164339626|NCT00347360|593618957|FG004|Overall Study|Protocol Violation|1|||
164339627|NCT00347360|593618958|FG005|Overall Study|Protocol Violation|2|||
164339628|NCT00347360|593618959|FG006|Overall Study|Protocol Violation|0|||
164339629|NCT00347360|593618960|FG007|Overall Study|Protocol Violation|0|||
164339630|NCT00347360|593618961|FG008|Overall Study|Protocol Violation|1|||
164339631|NCT00347360|593618962|FG009|Overall Study|Protocol Violation|2|||
164339632|NCT00347360|593618963|FG010|Overall Study|Protocol Violation|0|||
164339633|NCT00347360|593618964|FG011|Overall Study|Protocol Violation|0|||
164339634|NCT00347360|593618965|FG012|Overall Study|Protocol Violation|0|||
164339635|NCT00347360|593618966|FG013|Overall Study|Protocol Violation|1|||
164339636|NCT00347360|593618967|FG014|Overall Study|Protocol Violation|0|||
164339637|NCT00347360|593618953|FG000|Overall Study|Withdrawal by Subject|0|||
164339638|NCT00347360|593618954|FG001|Overall Study|Withdrawal by Subject|1|||
164339639|NCT00347360|593618955|FG002|Overall Study|Withdrawal by Subject|2|||
164339640|NCT00347360|593618956|FG003|Overall Study|Withdrawal by Subject|4|||
164339641|NCT00347360|593618957|FG004|Overall Study|Withdrawal by Subject|1|||
164339642|NCT00347360|593618958|FG005|Overall Study|Withdrawal by Subject|2|||
164339643|NCT00347360|593618959|FG006|Overall Study|Withdrawal by Subject|1|||
164339644|NCT00347360|593618960|FG007|Overall Study|Withdrawal by Subject|1|||
164339645|NCT00347360|593618961|FG008|Overall Study|Withdrawal by Subject|1|||
164339646|NCT00347360|593618962|FG009|Overall Study|Withdrawal by Subject|1|||
164339647|NCT00347360|593618963|FG010|Overall Study|Withdrawal by Subject|0|||
164339648|NCT00347360|593618964|FG011|Overall Study|Withdrawal by Subject|3|||
164339649|NCT00347360|593618965|FG012|Overall Study|Withdrawal by Subject|4|||
164339650|NCT00347360|593618966|FG013|Overall Study|Withdrawal by Subject|2|||
164257460|NCT02264665|593309890|FG000|Overall Study|Participant decision|0|||
164257461|NCT02264665|593309891|FG001|Overall Study|Participant decision|0|||
164339651|NCT00347360|593618967|FG014|Overall Study|Withdrawal by Subject|1|||
164339652|NCT00347360|593618953|FG000|Overall Study|Lack of Efficacy|1|||
164257462|NCT02264665|593309892|FG002|Overall Study|Participant decision|0|||
164257463|NCT02264665|593309893|FG003|Overall Study|Participant decision|1|||
164257464|NCT02264665|593309894|FG004|Overall Study|Participant decision|0|||
164257465|NCT02264665|593309895|FG005|Overall Study|Participant decision|0|||
164257466|NCT02264665|593309896|FG006|Overall Study|Participant decision|0|||
164257467|NCT02264665|593309890|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
164257468|NCT02264665|593309891|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
164257469|NCT02264665|593309892|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
164339653|NCT00347360|593618954|FG001|Overall Study|Lack of Efficacy|1|||
164339654|NCT00347360|593618955|FG002|Overall Study|Lack of Efficacy|3|||
164339655|NCT00347360|593618956|FG003|Overall Study|Lack of Efficacy|1|||
163887899|NCT05126433|591960995|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
163887900|NCT05126433|591960996|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
163887901|NCT05126433|591960997|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
163887902|NCT03907878|591960998|FG000|Treatment Period|Withdrawal by Subject|5|||
163887903|NCT03907878|591960998|FG000|Treatment Period|Adverse Event|4|||
163887904|NCT03907878|591960998|FG000|Treatment Period|Lack of Efficacy|1|||
163887905|NCT03907878|591960998|FG000|Treatment Period|Protocol Violation|1|||
163887906|NCT03907878|591960998|FG000|Follow-up Period|Adverse Event|3|||
163887907|NCT03907878|591960998|FG000|Follow-up Period|Withdrawal by Subject|3|||
163887908|NCT02861300|591960999|FG000|Overall Study|Death|0|||
163887909|NCT02861300|591961000|FG001|Overall Study|Death|0|||
163887910|NCT02861300|591961001|FG002|Overall Study|Death|0|||
163887911|NCT02861300|591961002|FG003|Overall Study|Death|0|||
163887912|NCT02861300|591961003|FG004|Overall Study|Death|0|||
163887913|NCT02861300|591961004|FG005|Overall Study|Death|0|||
163887914|NCT02861300|591961005|FG006|Overall Study|Death|24|||
163887915|NCT02861300|591960999|FG000|Overall Study|Delay in treatment|0|||
163887916|NCT02861300|591961000|FG001|Overall Study|Delay in treatment|0|||
163887917|NCT02861300|591961001|FG002|Overall Study|Delay in treatment|0|||
163887918|NCT02861300|591961002|FG003|Overall Study|Delay in treatment|0|||
163887919|NCT02861300|591961003|FG004|Overall Study|Delay in treatment|0|||
163887920|NCT02861300|591961004|FG005|Overall Study|Delay in treatment|1|||
163887921|NCT02861300|591961005|FG006|Overall Study|Delay in treatment|0|||
164257470|NCT02264665|593309893|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
164257471|NCT02264665|593309894|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
164257472|NCT02264665|593309895|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
164257473|NCT02264665|593309896|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
164257474|NCT02264665|593309890|FG000|Overall Study|Data Missing|0|||
164257475|NCT02264665|593309891|FG001|Overall Study|Data Missing|0|||
164257476|NCT02264665|593309892|FG002|Overall Study|Data Missing|1|||
164257477|NCT02264665|593309893|FG003|Overall Study|Data Missing|0|||
164257478|NCT02264665|593309894|FG004|Overall Study|Data Missing|0|||
164257479|NCT02264665|593309895|FG005|Overall Study|Data Missing|0|||
164257480|NCT02264665|593309896|FG006|Overall Study|Data Missing|0|||
164257481|NCT01962987|593309897|FG000|Overall Study|Adverse Event|4|||
164257482|NCT01962987|593309898|FG001|Overall Study|Adverse Event|4|||
164257483|NCT01962987|593309899|FG002|Overall Study|Adverse Event|0|||
164257484|NCT01962987|593309897|FG000|Overall Study|Lost to Follow-up|0|||
164257485|NCT01962987|593309898|FG001|Overall Study|Lost to Follow-up|0|||
164257486|NCT01962987|593309899|FG002|Overall Study|Lost to Follow-up|1|||
164257487|NCT01962987|593309897|FG000|Overall Study|Non compliance with dosing requirements|4|||
164257488|NCT01962987|593309898|FG001|Overall Study|Non compliance with dosing requirements|2|||
164257489|NCT01962987|593309899|FG002|Overall Study|Non compliance with dosing requirements|0|||
164257490|NCT01962987|593309897|FG000|Overall Study|Miscellaneous|1|||
164257491|NCT01962987|593309898|FG001|Overall Study|Miscellaneous|9|||
164257492|NCT01962987|593309899|FG002|Overall Study|Miscellaneous|2|||
164257493|NCT01962987|593309897|FG000|Overall Study|Restricted medication|5|||
164257494|NCT01962987|593309898|FG001|Overall Study|Restricted medication|1|||
164257495|NCT01962987|593309899|FG002|Overall Study|Restricted medication|1|||
164257496|NCT01962987|593309897|FG000|Overall Study|Serious Adverse Event|1|||
164257497|NCT01962987|593309898|FG001|Overall Study|Serious Adverse Event|0|||
164257498|NCT01962987|593309899|FG002|Overall Study|Serious Adverse Event|0|||
164257499|NCT01962987|593309897|FG000|Overall Study|Withdrawal by Subject|11|||
164257500|NCT01962987|593309898|FG001|Overall Study|Withdrawal by Subject|10|||
164257501|NCT01962987|593309899|FG002|Overall Study|Withdrawal by Subject|6|||
164257502|NCT01962987|593309897|FG000|Overall Study|Randomized in Error|4|||
164257503|NCT01962987|593309898|FG001|Overall Study|Randomized in Error|2|||
164257504|NCT01962987|593309899|FG002|Overall Study|Randomized in Error|2|||
164257505|NCT00789581|593309900|FG000|AC Therapy|Adverse Event|2|||
164257506|NCT00789581|593309901|FG001|AC Therapy|Adverse Event|3|||
163887922|NCT02861300|591960999|FG000|Overall Study|Disease Progression|0|||
163887923|NCT02861300|591961000|FG001|Overall Study|Disease Progression|1|||
163887924|NCT02861300|591961001|FG002|Overall Study|Disease Progression|0|||
163887925|NCT02861300|591961002|FG003|Overall Study|Disease Progression|0|||
163887926|NCT02861300|591961003|FG004|Overall Study|Disease Progression|0|||
163887927|NCT02861300|591961004|FG005|Overall Study|Disease Progression|0|||
164257507|NCT00789581|593309900|FG000|AC Therapy|Withdrawal by Subject|4|||
164257508|NCT00789581|593309901|FG001|AC Therapy|Withdrawal by Subject|7|||
163887928|NCT02861300|591961005|FG006|Overall Study|Disease Progression|2|||
164257509|NCT00789581|593309900|FG000|AC Therapy|Disease recurrence|3|||
163887929|NCT02861300|591960999|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
163887930|NCT02861300|591961000|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
163887931|NCT02861300|591961001|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
163887932|NCT02861300|591961002|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
163887933|NCT02861300|591961003|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
163887934|NCT02861300|591961004|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
164257510|NCT00789581|593309901|FG001|AC Therapy|Disease recurrence|1|||
164339656|NCT00347360|593618957|FG004|Overall Study|Lack of Efficacy|0|||
164339657|NCT00347360|593618958|FG005|Overall Study|Lack of Efficacy|1|||
164339658|NCT00347360|593618959|FG006|Overall Study|Lack of Efficacy|0|||
164339659|NCT00347360|593618960|FG007|Overall Study|Lack of Efficacy|1|||
164339660|NCT00347360|593618961|FG008|Overall Study|Lack of Efficacy|1|||
164339661|NCT00347360|593618962|FG009|Overall Study|Lack of Efficacy|0|||
164339662|NCT00347360|593618963|FG010|Overall Study|Lack of Efficacy|0|||
164339663|NCT00347360|593618964|FG011|Overall Study|Lack of Efficacy|0|||
164339664|NCT00347360|593618965|FG012|Overall Study|Lack of Efficacy|0|||
164339665|NCT00347360|593618966|FG013|Overall Study|Lack of Efficacy|0|||
164339666|NCT00347360|593618967|FG014|Overall Study|Lack of Efficacy|0|||
164339667|NCT00347360|593618953|FG000|Overall Study|Reason not listed/blank|1|||
164339668|NCT00347360|593618954|FG001|Overall Study|Reason not listed/blank|0|||
164339669|NCT00347360|593618955|FG002|Overall Study|Reason not listed/blank|0|||
164339670|NCT00347360|593618956|FG003|Overall Study|Reason not listed/blank|0|||
164339671|NCT00347360|593618957|FG004|Overall Study|Reason not listed/blank|0|||
164339672|NCT00347360|593618958|FG005|Overall Study|Reason not listed/blank|0|||
164339673|NCT00347360|593618959|FG006|Overall Study|Reason not listed/blank|1|||
164339674|NCT00347360|593618960|FG007|Overall Study|Reason not listed/blank|0|||
164339675|NCT00347360|593618961|FG008|Overall Study|Reason not listed/blank|0|||
164339676|NCT00347360|593618962|FG009|Overall Study|Reason not listed/blank|0|||
164339677|NCT00347360|593618963|FG010|Overall Study|Reason not listed/blank|0|||
164339678|NCT00347360|593618964|FG011|Overall Study|Reason not listed/blank|0|||
164339679|NCT00347360|593618965|FG012|Overall Study|Reason not listed/blank|0|||
164339680|NCT00347360|593618966|FG013|Overall Study|Reason not listed/blank|1|||
164339681|NCT00347360|593618967|FG014|Overall Study|Reason not listed/blank|0|||
164339682|NCT00347360|593618953|FG000|Overall Study|Per sponsors instruction|0|||
164339683|NCT00347360|593618954|FG001|Overall Study|Per sponsors instruction|1|||
164339684|NCT00347360|593618955|FG002|Overall Study|Per sponsors instruction|0|||
164339685|NCT00347360|593618956|FG003|Overall Study|Per sponsors instruction|0|||
164339686|NCT00347360|593618957|FG004|Overall Study|Per sponsors instruction|0|||
164339687|NCT00347360|593618958|FG005|Overall Study|Per sponsors instruction|0|||
164339688|NCT00347360|593618959|FG006|Overall Study|Per sponsors instruction|0|||
164339689|NCT00347360|593618960|FG007|Overall Study|Per sponsors instruction|0|||
164339690|NCT00347360|593618961|FG008|Overall Study|Per sponsors instruction|0|||
164339691|NCT00347360|593618962|FG009|Overall Study|Per sponsors instruction|0|||
164339692|NCT00347360|593618963|FG010|Overall Study|Per sponsors instruction|0|||
164339693|NCT00347360|593618964|FG011|Overall Study|Per sponsors instruction|0|||
164339694|NCT00347360|593618965|FG012|Overall Study|Per sponsors instruction|0|||
164339695|NCT00347360|593618966|FG013|Overall Study|Per sponsors instruction|0|||
164339696|NCT00347360|593618967|FG014|Overall Study|Per sponsors instruction|0|||
164339697|NCT00347360|593618953|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
164339698|NCT00347360|593618954|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
164339699|NCT00347360|593618955|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
164339700|NCT00347360|593618956|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
164339701|NCT00347360|593618957|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
164339702|NCT00347360|593618958|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
164339703|NCT00347360|593618959|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
164339704|NCT00347360|593618960|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
164339705|NCT00347360|593618961|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
164339706|NCT00347360|593618962|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
164339707|NCT00347360|593618963|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
164339708|NCT00347360|593618964|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
164339709|NCT00347360|593618965|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
164339710|NCT00347360|593618966|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
164339711|NCT00347360|593618967|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
164339712|NCT00347360|593618953|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
164339713|NCT00347360|593618954|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
164339714|NCT00347360|593618955|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
164339715|NCT00347360|593618956|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
164339716|NCT00347360|593618957|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
164339717|NCT00347360|593618958|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
164339718|NCT00347360|593618959|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
164339719|NCT00347360|593618960|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
164339720|NCT00347360|593618961|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
164339721|NCT00347360|593618962|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
164339722|NCT00347360|593618963|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
164339723|NCT00347360|593618964|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
164339724|NCT00347360|593618965|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
164339725|NCT00347360|593618966|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
164339726|NCT00347360|593618967|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
163992189|NCT00330187|592339720|FG001|Overall Study|Withdrawal by Subject|5|||
163992190|NCT00330187|592339721|FG002|Overall Study|Withdrawal by Subject|4|||
163992191|NCT00330187|592339722|FG003|Overall Study|Withdrawal by Subject|4|||
164257511|NCT00789581|593309900|FG000|AC Therapy|Intercurrent Illness|1|||
164257512|NCT00789581|593309901|FG001|AC Therapy|Intercurrent Illness|0|||
164257513|NCT00789581|593309900|FG000|AC Therapy|Never Treated|1|||
164257514|NCT00789581|593309901|FG001|AC Therapy|Never Treated|4|||
164257515|NCT00789581|593309900|FG000|AC Therapy|Other|0|||
164257516|NCT00789581|593309901|FG001|AC Therapy|Other|2|||
164257517|NCT00789581|593309900|FG000|Adjuvant Therapy|Never treated|2|||
164257518|NCT00789581|593309901|FG001|Adjuvant Therapy|Never treated|2|||
164257519|NCT00789581|593309900|FG000|Adjuvant Therapy|Adverse Event|20|||
164257520|NCT00789581|593309901|FG001|Adjuvant Therapy|Adverse Event|44|||
164257521|NCT00789581|593309900|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
164257522|NCT00789581|593309901|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
164257523|NCT00789581|593309900|FG000|Adjuvant Therapy|Disease recurrence|2|||
164257524|NCT00789581|593309901|FG001|Adjuvant Therapy|Disease recurrence|1|||
164257525|NCT00789581|593309900|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
164257526|NCT00789581|593309901|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
164257527|NCT00789581|593309900|FG000|Adjuvant Therapy|Protocol Violation|1|||
164257528|NCT00789581|593309901|FG001|Adjuvant Therapy|Protocol Violation|1|||
164257529|NCT00789581|593309900|FG000|Adjuvant Therapy|Other|0|||
164257530|NCT00789581|593309901|FG001|Adjuvant Therapy|Other|1|||
164257531|NCT01468207|593309902|FG000|Treatment Period 1|Adverse Event|1|||
164257532|NCT01468207|593309903|FG001|Treatment Period 1|Adverse Event|0|||
164257533|NCT01468207|593309904|FG002|Treatment Period 1|Adverse Event|0|||
164257534|NCT01468207|593309905|FG003|Treatment Period 1|Adverse Event|0|||
164257535|NCT01468207|593309906|FG004|Treatment Period 1|Adverse Event|0|||
164257536|NCT01468207|593309907|FG005|Treatment Period 1|Adverse Event|0|||
164257537|NCT01468207|593309902|FG000|Treatment Period 1|Protocol Violation|1|||
164339727|NCT00347360|593618953|FG000|Overall Study|Abnormal lab values|0|||
164339728|NCT00347360|593618954|FG001|Overall Study|Abnormal lab values|0|||
163992192|NCT01162421|592339730|FG000|Overall Study|Did not receive study drug|2|||
163992193|NCT01162421|592339731|FG001|Overall Study|Did not receive study drug|1|||
163992194|NCT01162421|592339730|FG000|Overall Study|Adverse Event|2|||
163992195|NCT01162421|592339731|FG001|Overall Study|Adverse Event|5|||
163992196|NCT01162421|592339730|FG000|Overall Study|Lost to Follow-up|0|||
163992197|NCT01162421|592339731|FG001|Overall Study|Lost to Follow-up|2|||
163992198|NCT01162421|592339730|FG000|Overall Study|Lack of Efficacy|2|||
163992199|NCT01162421|592339731|FG001|Overall Study|Lack of Efficacy|2|||
163992200|NCT01162421|592339730|FG000|Overall Study|Other|2|||
163992201|NCT01162421|592339731|FG001|Overall Study|Other|3|||
163992202|NCT01133171|592339737|FG000|Overall Study|Withdrawal by Subject|1|||
163992203|NCT01133171|592339738|FG001|Overall Study|Withdrawal by Subject|2|||
163992204|NCT01133171|592339739|FG002|Overall Study|Withdrawal by Subject|0|||
163992205|NCT02526550|592339740|FG000|Overall Study|Lost to Follow-up|1|||
163992206|NCT00091832|592339742|FG000|Overall Study|Physician Decision|1|||
163992207|NCT00091832|592339743|FG001|Overall Study|Physician Decision|0|||
163992208|NCT00091832|592339744|FG002|Overall Study|Physician Decision|0|||
163992209|NCT00091832|592339745|FG003|Overall Study|Physician Decision|0|||
163992210|NCT00091832|592339746|FG004|Overall Study|Physician Decision|0|||
163992211|NCT00091832|592339747|FG005|Overall Study|Physician Decision|0|||
163992212|NCT00091832|592339742|FG000|Overall Study|Adverse Event|0|||
163992213|NCT00091832|592339743|FG001|Overall Study|Adverse Event|0|||
163992214|NCT00091832|592339744|FG002|Overall Study|Adverse Event|0|||
163992215|NCT00091832|592339745|FG003|Overall Study|Adverse Event|1|||
163992216|NCT00091832|592339746|FG004|Overall Study|Adverse Event|3|||
163992217|NCT00091832|592339747|FG005|Overall Study|Adverse Event|0|||
163992218|NCT00091832|592339742|FG000|Overall Study|Withdrawal by Subject|4|||
164257538|NCT01468207|593309903|FG001|Treatment Period 1|Protocol Violation|1|||
164339729|NCT00347360|593618955|FG002|Overall Study|Abnormal lab values|0|||
164339730|NCT00347360|593618956|FG003|Overall Study|Abnormal lab values|0|||
164339731|NCT00347360|593618957|FG004|Overall Study|Abnormal lab values|0|||
164339732|NCT00347360|593618958|FG005|Overall Study|Abnormal lab values|0|||
164339733|NCT00347360|593618959|FG006|Overall Study|Abnormal lab values|1|||
164339734|NCT00347360|593618960|FG007|Overall Study|Abnormal lab values|0|||
164339735|NCT00347360|593618961|FG008|Overall Study|Abnormal lab values|0|||
164339736|NCT00347360|593618962|FG009|Overall Study|Abnormal lab values|0|||
164339737|NCT00347360|593618963|FG010|Overall Study|Abnormal lab values|0|||
164257539|NCT01468207|593309904|FG002|Treatment Period 1|Protocol Violation|0|||
164257540|NCT01468207|593309905|FG003|Treatment Period 1|Protocol Violation|0|||
164257541|NCT01468207|593309906|FG004|Treatment Period 1|Protocol Violation|0|||
164257542|NCT01468207|593309907|FG005|Treatment Period 1|Protocol Violation|0|||
164257543|NCT01468207|593309902|FG000|Treatment Period 1|Withdrawal by Subject|5|||
164339738|NCT00347360|593618964|FG011|Overall Study|Abnormal lab values|0|||
164339739|NCT00347360|593618965|FG012|Overall Study|Abnormal lab values|0|||
163992219|NCT00091832|592339743|FG001|Overall Study|Withdrawal by Subject|5|||
164257544|NCT01468207|593309903|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164257545|NCT01468207|593309904|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164339740|NCT00347360|593618966|FG013|Overall Study|Abnormal lab values|0|||
163992220|NCT00091832|592339744|FG002|Overall Study|Withdrawal by Subject|0|||
163992221|NCT00091832|592339745|FG003|Overall Study|Withdrawal by Subject|1|||
163992222|NCT00091832|592339746|FG004|Overall Study|Withdrawal by Subject|3|||
163992223|NCT00091832|592339747|FG005|Overall Study|Withdrawal by Subject|1|||
164257546|NCT01468207|593309905|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164257547|NCT01468207|593309906|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164257548|NCT01468207|593309907|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164257549|NCT01468207|593309902|FG000|Treatment Period 1|Lost to Follow-up|2|||
164257550|NCT01468207|593309903|FG001|Treatment Period 1|Lost to Follow-up|1|||
164257551|NCT01468207|593309904|FG002|Treatment Period 1|Lost to Follow-up|0|||
164257552|NCT01468207|593309905|FG003|Treatment Period 1|Lost to Follow-up|0|||
164257553|NCT01468207|593309906|FG004|Treatment Period 1|Lost to Follow-up|0|||
164257554|NCT01468207|593309907|FG005|Treatment Period 1|Lost to Follow-up|0|||
164257555|NCT01468207|593309902|FG000|Treatment Period 1|Other|0|||
164257556|NCT01468207|593309903|FG001|Treatment Period 1|Other|2|||
164257557|NCT01468207|593309904|FG002|Treatment Period 1|Other|0|||
164257558|NCT01468207|593309905|FG003|Treatment Period 1|Other|0|||
164257559|NCT01468207|593309906|FG004|Treatment Period 1|Other|0|||
164257560|NCT01468207|593309907|FG005|Treatment Period 1|Other|0|||
164257561|NCT01468207|593309902|FG000|Treatment Period 2|Adverse Event|0|||
164257562|NCT01468207|593309903|FG001|Treatment Period 2|Adverse Event|0|||
164257563|NCT01468207|593309904|FG002|Treatment Period 2|Adverse Event|6|||
164257564|NCT01468207|593309905|FG003|Treatment Period 2|Adverse Event|1|||
164257565|NCT01468207|593309906|FG004|Treatment Period 2|Adverse Event|2|||
164257566|NCT01468207|593309907|FG005|Treatment Period 2|Adverse Event|1|||
164257567|NCT01468207|593309902|FG000|Treatment Period 2|Lack of Efficacy|0|||
164257568|NCT01468207|593309903|FG001|Treatment Period 2|Lack of Efficacy|0|||
164257569|NCT01468207|593309904|FG002|Treatment Period 2|Lack of Efficacy|1|||
164257570|NCT01468207|593309905|FG003|Treatment Period 2|Lack of Efficacy|1|||
164257571|NCT01468207|593309906|FG004|Treatment Period 2|Lack of Efficacy|0|||
164257572|NCT01468207|593309907|FG005|Treatment Period 2|Lack of Efficacy|2|||
164257573|NCT01468207|593309902|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164257574|NCT01468207|593309903|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164257575|NCT01468207|593309904|FG002|Treatment Period 2|Withdrawal by Subject|5|||
164257576|NCT01468207|593309905|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164257577|NCT01468207|593309906|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164257578|NCT01468207|593309907|FG005|Treatment Period 2|Withdrawal by Subject|2|||
164257579|NCT01468207|593309902|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
164257580|NCT01468207|593309903|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
164257581|NCT01468207|593309904|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
164257582|NCT01468207|593309905|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
164257583|NCT01468207|593309906|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
164257584|NCT01468207|593309907|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
163992224|NCT00091832|592339742|FG000|Overall Study|Death|6|||
163992225|NCT00091832|592339743|FG001|Overall Study|Death|4|||
164257585|NCT01468207|593309902|FG000|Treatment Period 2|Lost to Follow-up|0|||
164257586|NCT01468207|593309903|FG001|Treatment Period 2|Lost to Follow-up|0|||
164257587|NCT01468207|593309904|FG002|Treatment Period 2|Lost to Follow-up|5|||
164257588|NCT01468207|593309905|FG003|Treatment Period 2|Lost to Follow-up|1|||
163992226|NCT00091832|592339744|FG002|Overall Study|Death|5|||
164257589|NCT01468207|593309906|FG004|Treatment Period 2|Lost to Follow-up|0|||
164257590|NCT01468207|593309907|FG005|Treatment Period 2|Lost to Follow-up|0|||
164257591|NCT01468207|593309902|FG000|Treatment Period 2|Other|0|||
164257592|NCT01468207|593309903|FG001|Treatment Period 2|Other|0|||
164257593|NCT01468207|593309904|FG002|Treatment Period 2|Other|5|||
164257594|NCT01468207|593309905|FG003|Treatment Period 2|Other|1|||
164257595|NCT01468207|593309906|FG004|Treatment Period 2|Other|1|||
164257596|NCT01468207|593309907|FG005|Treatment Period 2|Other|2|||
164257597|NCT00470093|593309908|FG000|Overall Study|Adverse Event|2|||
164257598|NCT00664560|593309909|FG000|Overall Study|Adverse Event|19|||
163992227|NCT00091832|592339745|FG003|Overall Study|Death|8|||
164257599|NCT00664560|593309910|FG001|Overall Study|Adverse Event|16|||
164257600|NCT00664560|593309911|FG002|Overall Study|Adverse Event|7|||
164257601|NCT00664560|593309909|FG000|Overall Study|Withdrawal by Subject|9|||
164257602|NCT00664560|593309910|FG001|Overall Study|Withdrawal by Subject|13|||
164257603|NCT00664560|593309911|FG002|Overall Study|Withdrawal by Subject|7|||
164257604|NCT00664560|593309909|FG000|Overall Study|Lost to Follow-up|0|||
164257605|NCT00664560|593309910|FG001|Overall Study|Lost to Follow-up|2|||
164257606|NCT00664560|593309911|FG002|Overall Study|Lost to Follow-up|0|||
164257607|NCT00664560|593309909|FG000|Overall Study|Other|11|||
164257608|NCT00664560|593309910|FG001|Overall Study|Other|4|||
164257609|NCT00664560|593309911|FG002|Overall Study|Other|5|||
164257610|NCT01328041|593309912|FG000|Overall Study|Adverse Event|7|||
164257611|NCT01328041|593309912|FG000|Overall Study|Lack of Efficacy|27|||
164257612|NCT01328041|593309912|FG000|Overall Study|Protocol Violation|7|||
164257613|NCT01328041|593309912|FG000|Overall Study|Lost to Follow-up|7|||
164257614|NCT01328041|593309912|FG000|Overall Study|Physician Decision|2|||
164257615|NCT01328041|593309912|FG000|Overall Study|Withdrawal by Subject|7|||
164257616|NCT03392883|593309915|FG000|Overall Study|Lost to Follow-up|122|||
164257617|NCT03392883|593309916|FG001|Overall Study|Lost to Follow-up|13|||
164257618|NCT03392883|593309917|FG002|Overall Study|Lost to Follow-up|9|||
164257619|NCT03392883|593309915|FG000|Overall Study|Death|4|||
164257620|NCT03392883|593309916|FG001|Overall Study|Death|0|||
164257621|NCT03392883|593309917|FG002|Overall Study|Death|0|||
164257622|NCT03392883|593309915|FG000|Overall Study|Lack of Efficacy|29|||
164257623|NCT03392883|593309916|FG001|Overall Study|Lack of Efficacy|0|||
164257624|NCT03392883|593309917|FG002|Overall Study|Lack of Efficacy|0|||
164257625|NCT03392883|593309915|FG000|Overall Study|Withdrawal by Subject|180|||
164257626|NCT03392883|593309916|FG001|Overall Study|Withdrawal by Subject|0|||
164257627|NCT03392883|593309917|FG002|Overall Study|Withdrawal by Subject|0|||
164257628|NCT03392883|593309915|FG000|Overall Study|Adverse Event|1|||
164257629|NCT03392883|593309916|FG001|Overall Study|Adverse Event|0|||
164257630|NCT03392883|593309917|FG002|Overall Study|Adverse Event|0|||
164257631|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257632|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
164257633|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257634|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257635|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
164257636|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257637|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
164257638|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257639|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257640|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
164257641|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257642|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
164257643|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257644|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257645|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
164257646|NCT02688088|593309919|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257647|NCT02688088|593309920|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
164257648|NCT02688088|593309921|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257649|NCT02688088|593309922|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257650|NCT02688088|593309923|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
164257651|NCT02688088|593309919|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257652|NCT02688088|593309920|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257653|NCT02688088|593309921|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
164084769|NCT03361956|592674011|FG000|Overall Study|Lost to Follow-up|0|||
164084770|NCT03361956|592674012|FG001|Overall Study|Lost to Follow-up|0|||
164084771|NCT03361956|592674013|FG002|Overall Study|Lost to Follow-up|1|||
164257654|NCT02688088|593309922|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257655|NCT02688088|593309923|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
164257656|NCT02688088|593309919|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257657|NCT02688088|593309920|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257658|NCT02688088|593309921|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
164257659|NCT02688088|593309922|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257660|NCT02688088|593309923|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
164257661|NCT02688088|593309919|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164084772|NCT03361956|592674014|FG003|Overall Study|Lost to Follow-up|1|||
164257662|NCT02688088|593309920|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164257663|NCT02688088|593309921|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164084773|NCT03361956|592674015|FG004|Overall Study|Lost to Follow-up|2|||
164257664|NCT02688088|593309922|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
164257665|NCT02688088|593309923|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
164257666|NCT02688088|593309919|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257667|NCT02688088|593309920|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257668|NCT02688088|593309921|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257669|NCT02688088|593309922|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
164257670|NCT02688088|593309923|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
164257671|NCT02688088|593309919|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257672|NCT02688088|593309920|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257673|NCT02688088|593309921|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257674|NCT02688088|593309922|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
164257675|NCT02688088|593309923|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
164257676|NCT00515294|593309935|FG000|Overall Study|Lost to Follow-up|3|||
164257677|NCT00515294|593309936|FG001|Overall Study|Lost to Follow-up|2|||
164257678|NCT00515294|593309937|FG002|Overall Study|Lost to Follow-up|3|||
164257679|NCT00515294|593309938|FG003|Overall Study|Lost to Follow-up|1|||
164257680|NCT00515294|593309935|FG000|Overall Study|Driver simulator problems|1|||
164257681|NCT00515294|593309936|FG001|Overall Study|Driver simulator problems|1|||
164257682|NCT00515294|593309937|FG002|Overall Study|Driver simulator problems|1|||
164257683|NCT00515294|593309938|FG003|Overall Study|Driver simulator problems|3|||
164257684|NCT00515294|593309935|FG000|Overall Study|Caffeine amount inaccurate|5|||
164257685|NCT00515294|593309936|FG001|Overall Study|Caffeine amount inaccurate|0|||
164257686|NCT00515294|593309937|FG002|Overall Study|Caffeine amount inaccurate|7|||
164257687|NCT00515294|593309938|FG003|Overall Study|Caffeine amount inaccurate|0|||
164257688|NCT01453205|593309939|FG000|Overall Study|Lost to Follow-up|3|||
164257689|NCT01453205|593309940|FG001|Overall Study|Lost to Follow-up|0|||
164257690|NCT01453205|593309941|FG002|Overall Study|Lost to Follow-up|1|||
164257691|NCT01453205|593309939|FG000|Overall Study|Withdrawal by Subject|8|||
164257692|NCT01453205|593309940|FG001|Overall Study|Withdrawal by Subject|3|||
164257693|NCT01453205|593309941|FG002|Overall Study|Withdrawal by Subject|0|||
164257694|NCT01453205|593309939|FG000|Overall Study|Death|24|||
164257695|NCT01453205|593309940|FG001|Overall Study|Death|22|||
164257696|NCT01453205|593309941|FG002|Overall Study|Death|18|||
164257697|NCT01453205|593309939|FG000|Overall Study|Other|45|||
164257698|NCT01453205|593309940|FG001|Overall Study|Other|27|||
164257699|NCT01453205|593309941|FG002|Overall Study|Other|35|||
164257700|NCT05596734|593309942|FG000|Substudy A|Withdrawal by Subject|1|||
164257701|NCT05596734|593309943|FG001|Substudy A|Withdrawal by Subject|0|||
164257702|NCT05596734|593309944|FG002|Substudy A|Withdrawal by Subject|0|||
164257703|NCT05596734|593309945|FG003|Substudy A|Withdrawal by Subject|0|||
164257704|NCT05596734|593309946|FG004|Substudy A|Withdrawal by Subject|0|||
164257705|NCT05596734|593309947|FG005|Substudy A|Withdrawal by Subject|0|||
164257706|NCT05596734|593309948|FG006|Substudy A|Withdrawal by Subject|1|||
164257707|NCT05596734|593309949|FG007|Substudy A|Withdrawal by Subject|0|||
164257708|NCT05596734|593309950|FG008|Substudy A|Withdrawal by Subject|0|||
164257709|NCT05596734|593309951|FG009|Substudy A|Withdrawal by Subject|0|||
164257710|NCT05596734|593309952|FG010|Substudy A|Withdrawal by Subject|0|||
164257711|NCT05596734|593309953|FG011|Substudy A|Withdrawal by Subject|0|||
164257712|NCT05596734|593309954|FG012|Substudy A|Withdrawal by Subject|0|||
164257713|NCT05596734|593309955|FG013|Substudy A|Withdrawal by Subject|0|||
164257714|NCT05596734|593309956|FG014|Substudy A|Withdrawal by Subject|0|||
164257715|NCT05596734|593309957|FG015|Substudy A|Withdrawal by Subject|0|||
164257716|NCT05596734|593309958|FG016|Substudy A|Withdrawal by Subject|0|||
164257717|NCT05596734|593309959|FG017|Substudy A|Withdrawal by Subject|0|||
164257718|NCT05596734|593309960|FG018|Substudy A|Withdrawal by Subject|0|||
164257719|NCT05596734|593309961|FG019|Substudy A|Withdrawal by Subject|0|||
164257720|NCT05596734|593309962|FG020|Substudy A|Withdrawal by Subject|0|||
164257721|NCT05596734|593309963|FG021|Substudy A|Withdrawal by Subject|0|||
164257722|NCT05596734|593309964|FG022|Substudy A|Withdrawal by Subject|0|||
164257723|NCT05596734|593309965|FG023|Substudy A|Withdrawal by Subject|0|||
164257724|NCT05596734|593309942|FG000|Substudy A|Lost to Follow-up|1|||
164257725|NCT05596734|593309943|FG001|Substudy A|Lost to Follow-up|0|||
164257726|NCT05596734|593309944|FG002|Substudy A|Lost to Follow-up|1|||
164257727|NCT05596734|593309945|FG003|Substudy A|Lost to Follow-up|0|||
164257728|NCT05596734|593309946|FG004|Substudy A|Lost to Follow-up|0|||
164257729|NCT05596734|593309947|FG005|Substudy A|Lost to Follow-up|0|||
164257730|NCT05596734|593309948|FG006|Substudy A|Lost to Follow-up|0|||
164257731|NCT05596734|593309949|FG007|Substudy A|Lost to Follow-up|0|||
164257732|NCT05596734|593309950|FG008|Substudy A|Lost to Follow-up|0|||
164339741|NCT00347360|593618967|FG014|Overall Study|Abnormal lab values|0|||
164084774|NCT02330081|592674018|FG000|Overall Study|Adverse Event|1|||
164339742|NCT00347360|593618953|FG000|Overall Study|PI recommended early withdrawal|0|||
164084775|NCT02330081|592674018|FG000|Overall Study|Donation did not meet criteria|1|||
164339743|NCT00347360|593618954|FG001|Overall Study|PI recommended early withdrawal|0|||
164257733|NCT05596734|593309951|FG009|Substudy A|Lost to Follow-up|0|||
164257734|NCT05596734|593309952|FG010|Substudy A|Lost to Follow-up|0|||
164257735|NCT05596734|593309953|FG011|Substudy A|Lost to Follow-up|0|||
164257736|NCT05596734|593309954|FG012|Substudy A|Lost to Follow-up|0|||
163992228|NCT00091832|592339746|FG004|Overall Study|Death|5|||
163992229|NCT00091832|592339747|FG005|Overall Study|Death|6|||
163992230|NCT00091832|592339742|FG000|Overall Study|Disease Progression|2|||
163992231|NCT00091832|592339743|FG001|Overall Study|Disease Progression|0|||
163992232|NCT00091832|592339744|FG002|Overall Study|Disease Progression|0|||
163992233|NCT00091832|592339745|FG003|Overall Study|Disease Progression|1|||
163992234|NCT00091832|592339746|FG004|Overall Study|Disease Progression|1|||
163992235|NCT00091832|592339747|FG005|Overall Study|Disease Progression|2|||
163992236|NCT00091832|592339742|FG000|Overall Study|Ineligibility Determined|0|||
163992237|NCT00091832|592339743|FG001|Overall Study|Ineligibility Determined|0|||
164257737|NCT05596734|593309955|FG013|Substudy A|Lost to Follow-up|0|||
164257738|NCT05596734|593309956|FG014|Substudy A|Lost to Follow-up|0|||
164257739|NCT05596734|593309957|FG015|Substudy A|Lost to Follow-up|0|||
164257740|NCT05596734|593309958|FG016|Substudy A|Lost to Follow-up|0|||
164257741|NCT05596734|593309959|FG017|Substudy A|Lost to Follow-up|0|||
164257742|NCT05596734|593309960|FG018|Substudy A|Lost to Follow-up|0|||
164257743|NCT05596734|593309961|FG019|Substudy A|Lost to Follow-up|0|||
164257744|NCT05596734|593309962|FG020|Substudy A|Lost to Follow-up|0|||
164257745|NCT05596734|593309963|FG021|Substudy A|Lost to Follow-up|0|||
164257746|NCT05596734|593309964|FG022|Substudy A|Lost to Follow-up|0|||
164257747|NCT05596734|593309965|FG023|Substudy A|Lost to Follow-up|0|||
164257748|NCT05596734|593309942|FG000|Substudy B|Withdrawal by Subject|0|||
164257749|NCT05596734|593309943|FG001|Substudy B|Withdrawal by Subject|0|||
164257750|NCT05596734|593309944|FG002|Substudy B|Withdrawal by Subject|0|||
164257751|NCT05596734|593309945|FG003|Substudy B|Withdrawal by Subject|0|||
164257752|NCT05596734|593309946|FG004|Substudy B|Withdrawal by Subject|0|||
164257753|NCT05596734|593309947|FG005|Substudy B|Withdrawal by Subject|0|||
164257754|NCT05596734|593309948|FG006|Substudy B|Withdrawal by Subject|0|||
164257755|NCT05596734|593309949|FG007|Substudy B|Withdrawal by Subject|0|||
164257756|NCT05596734|593309950|FG008|Substudy B|Withdrawal by Subject|0|||
164257757|NCT05596734|593309951|FG009|Substudy B|Withdrawal by Subject|0|||
164257758|NCT05596734|593309952|FG010|Substudy B|Withdrawal by Subject|0|||
164257759|NCT05596734|593309953|FG011|Substudy B|Withdrawal by Subject|0|||
164339744|NCT00347360|593618955|FG002|Overall Study|PI recommended early withdrawal|0|||
164339745|NCT00347360|593618956|FG003|Overall Study|PI recommended early withdrawal|0|||
164339746|NCT00347360|593618957|FG004|Overall Study|PI recommended early withdrawal|0|||
164339747|NCT00347360|593618958|FG005|Overall Study|PI recommended early withdrawal|0|||
164339748|NCT00347360|593618959|FG006|Overall Study|PI recommended early withdrawal|0|||
164339749|NCT00347360|593618960|FG007|Overall Study|PI recommended early withdrawal|0|||
164339750|NCT00347360|593618961|FG008|Overall Study|PI recommended early withdrawal|0|||
164339751|NCT00347360|593618962|FG009|Overall Study|PI recommended early withdrawal|1|||
164339752|NCT00347360|593618963|FG010|Overall Study|PI recommended early withdrawal|0|||
164339753|NCT00347360|593618964|FG011|Overall Study|PI recommended early withdrawal|0|||
164339754|NCT00347360|593618965|FG012|Overall Study|PI recommended early withdrawal|0|||
164339755|NCT00347360|593618966|FG013|Overall Study|PI recommended early withdrawal|0|||
164339756|NCT00347360|593618967|FG014|Overall Study|PI recommended early withdrawal|0|||
164339757|NCT00347360|593618953|FG000|Overall Study|Did not meet criteria before ABPM|0|||
164339758|NCT00347360|593618954|FG001|Overall Study|Did not meet criteria before ABPM|0|||
164339759|NCT00347360|593618955|FG002|Overall Study|Did not meet criteria before ABPM|0|||
164339760|NCT00347360|593618956|FG003|Overall Study|Did not meet criteria before ABPM|0|||
164339761|NCT00347360|593618957|FG004|Overall Study|Did not meet criteria before ABPM|0|||
164339762|NCT00347360|593618958|FG005|Overall Study|Did not meet criteria before ABPM|0|||
164339763|NCT00347360|593618959|FG006|Overall Study|Did not meet criteria before ABPM|0|||
164339764|NCT00347360|593618960|FG007|Overall Study|Did not meet criteria before ABPM|0|||
164339765|NCT00347360|593618961|FG008|Overall Study|Did not meet criteria before ABPM|0|||
164339766|NCT00347360|593618962|FG009|Overall Study|Did not meet criteria before ABPM|0|||
164339767|NCT00347360|593618963|FG010|Overall Study|Did not meet criteria before ABPM|1|||
164339768|NCT00347360|593618964|FG011|Overall Study|Did not meet criteria before ABPM|0|||
164339769|NCT00347360|593618965|FG012|Overall Study|Did not meet criteria before ABPM|0|||
164339770|NCT00347360|593618966|FG013|Overall Study|Did not meet criteria before ABPM|0|||
164339771|NCT00347360|593618967|FG014|Overall Study|Did not meet criteria before ABPM|0|||
164339772|NCT00347360|593618953|FG000|Overall Study|Randomized in error|0|||
163992238|NCT00091832|592339744|FG002|Overall Study|Ineligibility Determined|1|||
163992239|NCT00091832|592339745|FG003|Overall Study|Ineligibility Determined|0|||
164084776|NCT02330081|592674018|FG000|Overall Study|Protocol Violation|6|||
164257760|NCT05596734|593309954|FG012|Substudy B|Withdrawal by Subject|1|||
164257761|NCT05596734|593309955|FG013|Substudy B|Withdrawal by Subject|0|||
164257762|NCT05596734|593309956|FG014|Substudy B|Withdrawal by Subject|1|||
164257763|NCT05596734|593309957|FG015|Substudy B|Withdrawal by Subject|2|||
164339773|NCT00347360|593618954|FG001|Overall Study|Randomized in error|0|||
164339774|NCT00347360|593618955|FG002|Overall Study|Randomized in error|0|||
164339775|NCT00347360|593618956|FG003|Overall Study|Randomized in error|0|||
164339776|NCT00347360|593618957|FG004|Overall Study|Randomized in error|0|||
164257764|NCT05596734|593309958|FG016|Substudy B|Withdrawal by Subject|2|||
164257765|NCT05596734|593309959|FG017|Substudy B|Withdrawal by Subject|1|||
164257766|NCT05596734|593309960|FG018|Substudy B|Withdrawal by Subject|2|||
164257767|NCT05596734|593309961|FG019|Substudy B|Withdrawal by Subject|0|||
164257768|NCT05596734|593309962|FG020|Substudy B|Withdrawal by Subject|0|||
164257769|NCT05596734|593309963|FG021|Substudy B|Withdrawal by Subject|0|||
164257770|NCT05596734|593309964|FG022|Substudy B|Withdrawal by Subject|0|||
164257771|NCT05596734|593309965|FG023|Substudy B|Withdrawal by Subject|1|||
164257772|NCT05596734|593309942|FG000|Substudy B|Physician Decision|0|||
163887935|NCT02861300|591961005|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
163887936|NCT02861300|591960999|FG000|Overall Study|Clinical Complications|0|||
163887937|NCT02861300|591961000|FG001|Overall Study|Clinical Complications|0|||
163887938|NCT02861300|591961001|FG002|Overall Study|Clinical Complications|0|||
163887939|NCT02861300|591961002|FG003|Overall Study|Clinical Complications|0|||
163887940|NCT02861300|591961003|FG004|Overall Study|Clinical Complications|0|||
163887941|NCT02861300|591961004|FG005|Overall Study|Clinical Complications|0|||
163887942|NCT02861300|591961005|FG006|Overall Study|Clinical Complications|1|||
163887943|NCT03133546|591961012|FG000|Overall Study|Death|46|||
163887944|NCT03133546|591961013|FG001|Overall Study|Death|43|||
163887945|NCT03133546|591961012|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
164257773|NCT05596734|593309943|FG001|Substudy B|Physician Decision|0|||
164257774|NCT05596734|593309944|FG002|Substudy B|Physician Decision|0|||
163887946|NCT03133546|591961013|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
163887947|NCT05034328|591961014|FG000|Overall Study|Protocol Violation|1|||
163992240|NCT00091832|592339746|FG004|Overall Study|Ineligibility Determined|1|||
163992241|NCT00091832|592339747|FG005|Overall Study|Ineligibility Determined|0|||
163992242|NCT00091832|592339742|FG000|Overall Study|Lost to Follow-up|1|||
163992243|NCT00091832|592339743|FG001|Overall Study|Lost to Follow-up|0|||
163992244|NCT00091832|592339744|FG002|Overall Study|Lost to Follow-up|3|||
163992245|NCT00091832|592339745|FG003|Overall Study|Lost to Follow-up|3|||
163992246|NCT00091832|592339746|FG004|Overall Study|Lost to Follow-up|2|||
163992247|NCT00091832|592339747|FG005|Overall Study|Lost to Follow-up|1|||
163992248|NCT00091832|592339742|FG000|Overall Study|Noncompliance|0|||
163992249|NCT00091832|592339743|FG001|Overall Study|Noncompliance|1|||
163992250|NCT00091832|592339744|FG002|Overall Study|Noncompliance|0|||
163992251|NCT00091832|592339745|FG003|Overall Study|Noncompliance|0|||
163992252|NCT00091832|592339746|FG004|Overall Study|Noncompliance|0|||
163992253|NCT00091832|592339747|FG005|Overall Study|Noncompliance|0|||
163992254|NCT00091832|592339742|FG000|Overall Study|Other|0|||
163992255|NCT00091832|592339743|FG001|Overall Study|Other|1|||
163992256|NCT00091832|592339744|FG002|Overall Study|Other|2|||
163992257|NCT00091832|592339745|FG003|Overall Study|Other|0|||
164257775|NCT05596734|593309945|FG003|Substudy B|Physician Decision|0|||
164257776|NCT05596734|593309946|FG004|Substudy B|Physician Decision|0|||
164257777|NCT05596734|593309947|FG005|Substudy B|Physician Decision|0|||
164257778|NCT05596734|593309948|FG006|Substudy B|Physician Decision|0|||
163992258|NCT00091832|592339746|FG004|Overall Study|Other|0|||
163992259|NCT00091832|592339747|FG005|Overall Study|Other|0|||
163992260|NCT00091832|592339742|FG000|Overall Study|Protocol Violation|0|||
163992261|NCT00091832|592339743|FG001|Overall Study|Protocol Violation|0|||
163992262|NCT00091832|592339744|FG002|Overall Study|Protocol Violation|1|||
163992263|NCT00091832|592339745|FG003|Overall Study|Protocol Violation|0|||
163992264|NCT00091832|592339746|FG004|Overall Study|Protocol Violation|0|||
163992265|NCT00091832|592339747|FG005|Overall Study|Protocol Violation|1|||
163992266|NCT03434379|592339750|FG000|Global Period|Lost to Follow-up|3|||
163992267|NCT03434379|592339751|FG001|Global Period|Lost to Follow-up|6|||
163992268|NCT03434379|592339752|FG002|Global Period|Lost to Follow-up|0|||
163992269|NCT03434379|592339753|FG003|Global Period|Lost to Follow-up|0|||
163992270|NCT03434379|592339750|FG000|Global Period|Death|115|||
163992271|NCT03434379|592339751|FG001|Global Period|Death|228|||
163992272|NCT03434379|592339752|FG002|Global Period|Death|0|||
163992273|NCT03434379|592339753|FG003|Global Period|Death|0|||
163992274|NCT03434379|592339750|FG000|Global Period|Withdrawal by Subject|20|||
163992275|NCT03434379|592339751|FG001|Global Period|Withdrawal by Subject|21|||
163992276|NCT03434379|592339752|FG002|Global Period|Withdrawal by Subject|0|||
163992277|NCT03434379|592339753|FG003|Global Period|Withdrawal by Subject|0|||
163992278|NCT03434379|592339750|FG000|Global Period|Reason Unspecified|0|||
163992279|NCT03434379|592339751|FG001|Global Period|Reason Unspecified|1|||
163992280|NCT03434379|592339752|FG002|Global Period|Reason Unspecified|0|||
163992281|NCT03434379|592339753|FG003|Global Period|Reason Unspecified|0|||
163992282|NCT03434379|592339750|FG000|Global Period|Study Ended by Sponsor|26|||
163992283|NCT03434379|592339751|FG001|Global Period|Study Ended by Sponsor|80|||
163992284|NCT03434379|592339752|FG002|Global Period|Study Ended by Sponsor|0|||
163992285|NCT03434379|592339753|FG003|Global Period|Study Ended by Sponsor|0|||
163992286|NCT03434379|592339750|FG000|Global Period|Physician Decision|1|||
163992287|NCT03434379|592339751|FG001|Global Period|Physician Decision|0|||
163992288|NCT03434379|592339752|FG002|Global Period|Physician Decision|0|||
163992289|NCT03434379|592339753|FG003|Global Period|Physician Decision|0|||
163992290|NCT03434379|592339750|FG000|China Extension Period|Lost to Follow-up|0|||
163992291|NCT03434379|592339751|FG001|China Extension Period|Lost to Follow-up|0|||
163992292|NCT03434379|592339752|FG002|China Extension Period|Lost to Follow-up|2|||
163992293|NCT03434379|592339753|FG003|China Extension Period|Lost to Follow-up|3|||
163992294|NCT03434379|592339750|FG000|China Extension Period|Death|0|||
163992295|NCT03434379|592339751|FG001|China Extension Period|Death|0|||
163992296|NCT03434379|592339752|FG002|China Extension Period|Death|46|||
163992297|NCT03434379|592339753|FG003|China Extension Period|Death|88|||
163992298|NCT03434379|592339750|FG000|China Extension Period|Withdrawal by Subject|0|||
163992299|NCT03434379|592339751|FG001|China Extension Period|Withdrawal by Subject|0|||
163992300|NCT03434379|592339752|FG002|China Extension Period|Withdrawal by Subject|8|||
163992301|NCT03434379|592339753|FG003|China Extension Period|Withdrawal by Subject|6|||
163992302|NCT03434379|592339750|FG000|China Extension Period|Study Ended by Sponsor|0|||
163992303|NCT03434379|592339751|FG001|China Extension Period|Study Ended by Sponsor|0|||
163992304|NCT03434379|592339752|FG002|China Extension Period|Study Ended by Sponsor|5|||
163992305|NCT03434379|592339753|FG003|China Extension Period|Study Ended by Sponsor|36|||
163992306|NCT00686647|592339757|FG000|Overall Study|Lost to Follow-up|1|||
163992307|NCT00686647|592339757|FG000|Overall Study|Death|1|||
163992308|NCT00578643|592339758|FG000|Overall Study|Death|1|||
163992309|NCT00578643|592339758|FG000|Overall Study|Lost to Follow-up|1|||
163992310|NCT01725750|592339759|FG000|Overall Study|Adverse Event|1|||
163992311|NCT01725750|592339760|FG001|Overall Study|Adverse Event|0|||
163992312|NCT01725750|592339759|FG000|Overall Study|Lost to Follow-up|1|||
163992313|NCT01725750|592339760|FG001|Overall Study|Lost to Follow-up|1|||
163992314|NCT01725750|592339759|FG000|Overall Study|Withdrawal by Subject|0|||
163992315|NCT01725750|592339760|FG001|Overall Study|Withdrawal by Subject|9|||
163992316|NCT03179436|592339762|FG000|Overall Study|Withdrawal by Subject|1|||
163992317|NCT03179436|592339763|FG001|Overall Study|Withdrawal by Subject|0|||
163992318|NCT03179436|592339764|FG002|Overall Study|Withdrawal by Subject|0|||
163992319|NCT03179436|592339765|FG003|Overall Study|Withdrawal by Subject|4|||
163992320|NCT03179436|592339766|FG004|Overall Study|Withdrawal by Subject|2|||
163992321|NCT03179436|592339767|FG005|Overall Study|Withdrawal by Subject|2|||
163992322|NCT03179436|592339768|FG006|Overall Study|Withdrawal by Subject|5|||
164257779|NCT05596734|593309949|FG007|Substudy B|Physician Decision|0|||
163992323|NCT03179436|592339769|FG007|Overall Study|Withdrawal by Subject|0|||
163992324|NCT03179436|592339770|FG008|Overall Study|Withdrawal by Subject|3|||
163992325|NCT03179436|592339771|FG009|Overall Study|Withdrawal by Subject|0|||
163992326|NCT03179436|592339772|FG010|Overall Study|Withdrawal by Subject|0|||
163992327|NCT03179436|592339773|FG011|Overall Study|Withdrawal by Subject|0|||
163992328|NCT03179436|592339762|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164257780|NCT05596734|593309950|FG008|Substudy B|Physician Decision|0|||
164257781|NCT05596734|593309951|FG009|Substudy B|Physician Decision|0|||
163992329|NCT03179436|592339763|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163992330|NCT03179436|592339764|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163992331|NCT03179436|592339765|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
163992332|NCT03179436|592339766|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
163992333|NCT03179436|592339767|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
163992334|NCT03179436|592339768|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
163992335|NCT03179436|592339769|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
163992336|NCT03179436|592339770|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
163992337|NCT03179436|592339771|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
163992338|NCT03179436|592339772|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
163992339|NCT03179436|592339773|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
163992340|NCT03179436|592339762|FG000|Overall Study|Sponsor Decision|0|||
163992341|NCT03179436|592339763|FG001|Overall Study|Sponsor Decision|0|||
163992342|NCT03179436|592339764|FG002|Overall Study|Sponsor Decision|1|||
163992343|NCT03179436|592339765|FG003|Overall Study|Sponsor Decision|3|||
163992344|NCT03179436|592339766|FG004|Overall Study|Sponsor Decision|9|||
163992345|NCT03179436|592339767|FG005|Overall Study|Sponsor Decision|7|||
163992346|NCT03179436|592339768|FG006|Overall Study|Sponsor Decision|2|||
163992347|NCT03179436|592339769|FG007|Overall Study|Sponsor Decision|4|||
163992348|NCT03179436|592339770|FG008|Overall Study|Sponsor Decision|23|||
163992349|NCT03179436|592339771|FG009|Overall Study|Sponsor Decision|6|||
164257782|NCT05596734|593309952|FG010|Substudy B|Physician Decision|0|||
164257783|NCT05596734|593309953|FG011|Substudy B|Physician Decision|0|||
164257784|NCT05596734|593309954|FG012|Substudy B|Physician Decision|0|||
164257785|NCT05596734|593309955|FG013|Substudy B|Physician Decision|0|||
164257786|NCT05596734|593309956|FG014|Substudy B|Physician Decision|0|||
164257787|NCT05596734|593309957|FG015|Substudy B|Physician Decision|1|||
164257788|NCT05596734|593309958|FG016|Substudy B|Physician Decision|0|||
164257789|NCT05596734|593309959|FG017|Substudy B|Physician Decision|0|||
164257790|NCT05596734|593309960|FG018|Substudy B|Physician Decision|0|||
163992350|NCT03179436|592339772|FG010|Overall Study|Sponsor Decision|7|||
163992351|NCT03179436|592339773|FG011|Overall Study|Sponsor Decision|5|||
164084777|NCT02277769|592674019|FG000|Overall Study|Protocol Violation|3|||
164257791|NCT05596734|593309961|FG019|Substudy B|Physician Decision|0|||
164084778|NCT02277769|592674020|FG001|Overall Study|Protocol Violation|3|||
164084779|NCT02277769|592674021|FG002|Overall Study|Protocol Violation|5|||
164084780|NCT02277769|592674019|FG000|Overall Study|Lack of Efficacy|17|||
164084781|NCT02277769|592674020|FG001|Overall Study|Lack of Efficacy|0|||
164084782|NCT02277769|592674021|FG002|Overall Study|Lack of Efficacy|4|||
164084783|NCT02277769|592674019|FG000|Overall Study|Adverse Event|14|||
164084784|NCT02277769|592674020|FG001|Overall Study|Adverse Event|2|||
164084785|NCT02277769|592674021|FG002|Overall Study|Adverse Event|4|||
164084786|NCT02277769|592674019|FG000|Overall Study|Other than specified above|12|||
164084787|NCT02277769|592674020|FG001|Overall Study|Other than specified above|8|||
164257792|NCT05596734|593309962|FG020|Substudy B|Physician Decision|0|||
164257793|NCT05596734|593309963|FG021|Substudy B|Physician Decision|0|||
164257794|NCT05596734|593309964|FG022|Substudy B|Physician Decision|0|||
164257795|NCT05596734|593309965|FG023|Substudy B|Physician Decision|0|||
164257796|NCT05596734|593309942|FG000|Substudy B|Lost to Follow-up|0|||
164257797|NCT05596734|593309943|FG001|Substudy B|Lost to Follow-up|0|||
164257798|NCT05596734|593309944|FG002|Substudy B|Lost to Follow-up|0|||
164084788|NCT02277769|592674021|FG002|Overall Study|Other than specified above|5|||
164084789|NCT03775681|592674025|FG000|Overall Study|Physician Decision|3|||
164084790|NCT02123459|592674028|FG000|Washout Period (1 Day)|Adverse Event|1|||
164084791|NCT02123459|592674029|FG001|Washout Period (1 Day)|Adverse Event|0|||
164084792|NCT02196506|592674030|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
164084793|NCT02196506|592674031|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
164084794|NCT02196506|592674032|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
164084795|NCT02196506|592674033|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
164084796|NCT02196506|592674030|FG000|Phase A|Withdrawal by Subject|34|||
164084797|NCT02196506|592674031|FG001|Phase A|Withdrawal by Subject|0|||
164084798|NCT02196506|592674032|FG002|Phase A|Withdrawal by Subject|0|||
164084799|NCT02196506|592674033|FG003|Phase A|Withdrawal by Subject|0|||
164084800|NCT02196506|592674030|FG000|Phase A|Adverse Event|22|||
164084801|NCT02196506|592674031|FG001|Phase A|Adverse Event|0|||
164084802|NCT02196506|592674032|FG002|Phase A|Adverse Event|0|||
164084803|NCT02196506|592674033|FG003|Phase A|Adverse Event|0|||
163887948|NCT05034328|591961015|FG001|Overall Study|Protocol Violation|0|||
164084804|NCT02196506|592674030|FG000|Phase A|Lost to Follow-up|9|||
164084805|NCT02196506|592674031|FG001|Phase A|Lost to Follow-up|0|||
164084806|NCT02196506|592674032|FG002|Phase A|Lost to Follow-up|0|||
164084807|NCT02196506|592674033|FG003|Phase A|Lost to Follow-up|0|||
164084808|NCT02196506|592674030|FG000|Phase A|Protocol deviation|12|||
164084809|NCT02196506|592674031|FG001|Phase A|Protocol deviation|0|||
164084810|NCT02196506|592674032|FG002|Phase A|Protocol deviation|0|||
164084811|NCT02196506|592674033|FG003|Phase A|Protocol deviation|0|||
164084812|NCT02196506|592674030|FG000|Phase A|Participant withdrawn by investigator|10|||
164084813|NCT02196506|592674031|FG001|Phase A|Participant withdrawn by investigator|0|||
164084814|NCT02196506|592674032|FG002|Phase A|Participant withdrawn by investigator|0|||
164084815|NCT02196506|592674033|FG003|Phase A|Participant withdrawn by investigator|0|||
164084816|NCT02196506|592674030|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
164084817|NCT02196506|592674031|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
164084818|NCT02196506|592674032|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
164084819|NCT02196506|592674033|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
164084820|NCT02196506|592674030|FG000|Phase B|Lack of Efficacy|0|||
164084821|NCT02196506|592674031|FG001|Phase B|Lack of Efficacy|1|||
164084822|NCT02196506|592674032|FG002|Phase B|Lack of Efficacy|2|||
164084823|NCT02196506|592674033|FG003|Phase B|Lack of Efficacy|0|||
164084824|NCT02196506|592674030|FG000|Phase B|Withdrawal by Participant|0|||
164084825|NCT02196506|592674031|FG001|Phase B|Withdrawal by Participant|8|||
164084826|NCT02196506|592674032|FG002|Phase B|Withdrawal by Participant|1|||
164257799|NCT05596734|593309945|FG003|Substudy B|Lost to Follow-up|0|||
164257800|NCT05596734|593309946|FG004|Substudy B|Lost to Follow-up|0|||
164257801|NCT05596734|593309947|FG005|Substudy B|Lost to Follow-up|0|||
164084827|NCT02196506|592674033|FG003|Phase B|Withdrawal by Participant|0|||
164084828|NCT02196506|592674030|FG000|Phase B|Adverse Event|0|||
164084829|NCT02196506|592674031|FG001|Phase B|Adverse Event|4|||
164257802|NCT05596734|593309948|FG006|Substudy B|Lost to Follow-up|0|||
164257803|NCT05596734|593309949|FG007|Substudy B|Lost to Follow-up|0|||
163992352|NCT03179436|592339762|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992353|NCT03179436|592339763|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
164257804|NCT05596734|593309950|FG008|Substudy B|Lost to Follow-up|0|||
164257805|NCT05596734|593309951|FG009|Substudy B|Lost to Follow-up|0|||
164257806|NCT05596734|593309952|FG010|Substudy B|Lost to Follow-up|0|||
164257807|NCT05596734|593309953|FG011|Substudy B|Lost to Follow-up|0|||
164257808|NCT05596734|593309954|FG012|Substudy B|Lost to Follow-up|1|||
164257809|NCT05596734|593309955|FG013|Substudy B|Lost to Follow-up|0|||
164257810|NCT05596734|593309956|FG014|Substudy B|Lost to Follow-up|1|||
164257811|NCT05596734|593309957|FG015|Substudy B|Lost to Follow-up|1|||
164257812|NCT05596734|593309958|FG016|Substudy B|Lost to Follow-up|0|||
164257813|NCT05596734|593309959|FG017|Substudy B|Lost to Follow-up|0|||
164257814|NCT05596734|593309960|FG018|Substudy B|Lost to Follow-up|0|||
164257815|NCT05596734|593309961|FG019|Substudy B|Lost to Follow-up|0|||
164257816|NCT05596734|593309962|FG020|Substudy B|Lost to Follow-up|0|||
164257817|NCT05596734|593309963|FG021|Substudy B|Lost to Follow-up|0|||
164257818|NCT05596734|593309964|FG022|Substudy B|Lost to Follow-up|0|||
164257819|NCT05596734|593309965|FG023|Substudy B|Lost to Follow-up|0|||
164257820|NCT02118766|593309970|FG000|Overall Study|Adverse Event|7|||
164257821|NCT02118766|593309971|FG001|Overall Study|Adverse Event|2|||
164257822|NCT02118766|593309970|FG000|Overall Study|Withdrawal by Subject|3|||
164257823|NCT02118766|593309971|FG001|Overall Study|Withdrawal by Subject|6|||
164257824|NCT02118766|593309970|FG000|Overall Study|Lost to Follow-up|5|||
164339777|NCT00347360|593618958|FG005|Overall Study|Randomized in error|0|||
164339778|NCT00347360|593618959|FG006|Overall Study|Randomized in error|0|||
164339779|NCT00347360|593618960|FG007|Overall Study|Randomized in error|0|||
163992354|NCT03179436|592339764|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992355|NCT03179436|592339765|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
164257825|NCT02118766|593309971|FG001|Overall Study|Lost to Follow-up|4|||
164257826|NCT02118766|593309970|FG000|Overall Study|Withdrawal by parent/guardian|12|||
164339780|NCT00347360|593618961|FG008|Overall Study|Randomized in error|0|||
164339781|NCT00347360|593618962|FG009|Overall Study|Randomized in error|0|||
164339782|NCT00347360|593618963|FG010|Overall Study|Randomized in error|0|||
164339783|NCT00347360|593618964|FG011|Overall Study|Randomized in error|1|||
164339784|NCT00347360|593618965|FG012|Overall Study|Randomized in error|0|||
164339785|NCT00347360|593618966|FG013|Overall Study|Randomized in error|0|||
164339786|NCT00347360|593618967|FG014|Overall Study|Randomized in error|0|||
164339787|NCT00347360|593618953|FG000|Overall Study|Failed inclusion criteria #4|0|||
164339788|NCT00347360|593618954|FG001|Overall Study|Failed inclusion criteria #4|0|||
164339789|NCT00347360|593618955|FG002|Overall Study|Failed inclusion criteria #4|0|||
164339790|NCT00347360|593618956|FG003|Overall Study|Failed inclusion criteria #4|0|||
164339791|NCT00347360|593618957|FG004|Overall Study|Failed inclusion criteria #4|0|||
164339792|NCT00347360|593618958|FG005|Overall Study|Failed inclusion criteria #4|0|||
164339793|NCT00347360|593618959|FG006|Overall Study|Failed inclusion criteria #4|0|||
164339794|NCT00347360|593618960|FG007|Overall Study|Failed inclusion criteria #4|0|||
164339795|NCT00347360|593618961|FG008|Overall Study|Failed inclusion criteria #4|0|||
164339796|NCT00347360|593618962|FG009|Overall Study|Failed inclusion criteria #4|0|||
164339797|NCT00347360|593618963|FG010|Overall Study|Failed inclusion criteria #4|0|||
164339798|NCT00347360|593618964|FG011|Overall Study|Failed inclusion criteria #4|1|||
164339799|NCT00347360|593618965|FG012|Overall Study|Failed inclusion criteria #4|0|||
164339800|NCT00347360|593618966|FG013|Overall Study|Failed inclusion criteria #4|0|||
164339801|NCT00347360|593618967|FG014|Overall Study|Failed inclusion criteria #4|0|||
164339802|NCT00347360|593618953|FG000|Overall Study|Prolonged duration between visits|0|||
164339803|NCT00347360|593618954|FG001|Overall Study|Prolonged duration between visits|0|||
164339804|NCT00347360|593618955|FG002|Overall Study|Prolonged duration between visits|0|||
164339805|NCT00347360|593618956|FG003|Overall Study|Prolonged duration between visits|0|||
164339806|NCT00347360|593618957|FG004|Overall Study|Prolonged duration between visits|0|||
164339807|NCT00347360|593618958|FG005|Overall Study|Prolonged duration between visits|0|||
164339808|NCT00347360|593618959|FG006|Overall Study|Prolonged duration between visits|0|||
164339809|NCT00347360|593618960|FG007|Overall Study|Prolonged duration between visits|0|||
164339810|NCT00347360|593618961|FG008|Overall Study|Prolonged duration between visits|0|||
164339811|NCT00347360|593618962|FG009|Overall Study|Prolonged duration between visits|0|||
164339812|NCT00347360|593618963|FG010|Overall Study|Prolonged duration between visits|0|||
164339813|NCT00347360|593618964|FG011|Overall Study|Prolonged duration between visits|0|||
164339814|NCT00347360|593618965|FG012|Overall Study|Prolonged duration between visits|1|||
164339815|NCT00347360|593618966|FG013|Overall Study|Prolonged duration between visits|0|||
164339816|NCT00347360|593618967|FG014|Overall Study|Prolonged duration between visits|0|||
164257827|NCT02118766|593309971|FG001|Overall Study|Withdrawal by parent/guardian|18|||
164257828|NCT02118766|593309970|FG000|Overall Study|Other|3|||
164339817|NCT00347360|593618953|FG000|Overall Study|Subject left town, ran out of study drug|0|||
164339818|NCT00347360|593618954|FG001|Overall Study|Subject left town, ran out of study drug|0|||
164339819|NCT00347360|593618955|FG002|Overall Study|Subject left town, ran out of study drug|0|||
164339820|NCT00347360|593618956|FG003|Overall Study|Subject left town, ran out of study drug|0|||
164339821|NCT00347360|593618957|FG004|Overall Study|Subject left town, ran out of study drug|0|||
164084830|NCT02196506|592674032|FG002|Phase B|Adverse Event|1|||
164257829|NCT02118766|593309971|FG001|Overall Study|Other|1|||
164257830|NCT04210245|593309972|FG000|Overall Study|Adverse Event|0|||
164257831|NCT04210245|593309973|FG001|Overall Study|Adverse Event|3|||
164257832|NCT04210245|593309974|FG002|Overall Study|Adverse Event|6|||
164257833|NCT04210245|593309975|FG003|Overall Study|Adverse Event|0|||
164257834|NCT04210245|593309972|FG000|Overall Study|Withdrawal by Subject|0|||
164257835|NCT04210245|593309973|FG001|Overall Study|Withdrawal by Subject|1|||
164257836|NCT04210245|593309974|FG002|Overall Study|Withdrawal by Subject|4|||
164257837|NCT04210245|593309975|FG003|Overall Study|Withdrawal by Subject|4|||
164084831|NCT02196506|592674033|FG003|Phase B|Adverse Event|0|||
164257838|NCT04210245|593309972|FG000|Overall Study|Lost to Follow-up|0|||
164257839|NCT04210245|593309973|FG001|Overall Study|Lost to Follow-up|1|||
164257840|NCT04210245|593309974|FG002|Overall Study|Lost to Follow-up|1|||
164257841|NCT04210245|593309975|FG003|Overall Study|Lost to Follow-up|1|||
164257842|NCT04210245|593309972|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
164257843|NCT04210245|593309973|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
164257844|NCT04210245|593309974|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
164257845|NCT04210245|593309975|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
164257846|NCT02248649|593309976|FG000|Overall Study|Death|7|||
164257847|NCT02248649|593309977|FG001|Overall Study|Death|11|||
164257848|NCT02248649|593309976|FG000|Overall Study|Lost to Follow-up|14|||
164257849|NCT02248649|593309977|FG001|Overall Study|Lost to Follow-up|10|||
164257850|NCT04621240|593309983|FG000|Overall Study|Withdrawal by Subject|36|||
164257851|NCT01221623|593309984|FG000|Overall Study|Withdrawal by Subject|19|||
163887949|NCT05034328|591961014|FG000|Overall Study|Lost to Follow-up|0|||
163887950|NCT05034328|591961015|FG001|Overall Study|Lost to Follow-up|10|||
163887951|NCT05399459|591961016|FG000|Overall Study|Randomized but not treated|29|||
163887952|NCT05399459|591961017|FG001|Overall Study|Randomized but not treated|30|||
163887953|NCT05399459|591961018|FG002|Overall Study|Randomized but not treated|38|||
163887954|NCT05399459|591961016|FG000|Overall Study|Lost to Follow-up|1|||
163887955|NCT05399459|591961017|FG001|Overall Study|Lost to Follow-up|0|||
163887956|NCT05399459|591961018|FG002|Overall Study|Lost to Follow-up|0|||
163887957|NCT04992520|591961019|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
163887958|NCT04992520|591961020|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
163887959|NCT04992520|591961021|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
163887960|NCT04992520|591961022|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
163887961|NCT04992520|591961023|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
163887962|NCT04992520|591961024|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
163887963|NCT04992520|591961019|FG000|Part A: First Challenge|Non-compliance|0|||
163887964|NCT04992520|591961020|FG001|Part A: First Challenge|Non-compliance|0|||
163887965|NCT04992520|591961021|FG002|Part A: First Challenge|Non-compliance|0|||
163887966|NCT04992520|591961022|FG003|Part A: First Challenge|Non-compliance|1|||
163887967|NCT04992520|591961023|FG004|Part A: First Challenge|Non-compliance|0|||
163887968|NCT04992520|591961024|FG005|Part A: First Challenge|Non-compliance|0|||
163887969|NCT04992520|591961019|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163887970|NCT04992520|591961020|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163887971|NCT04992520|591961021|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
163887972|NCT04992520|591961022|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
163887973|NCT04992520|591961023|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
164257852|NCT01221623|593309985|FG001|Overall Study|Withdrawal by Subject|8|||
164257853|NCT01221623|593309984|FG000|Overall Study|Lost to Follow-up|7|||
163887974|NCT04992520|591961024|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
163887975|NCT04992520|591961019|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163887976|NCT04992520|591961020|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163887977|NCT04992520|591961021|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
164084832|NCT02196506|592674030|FG000|Phase B|Lost to Follow-up|0|||
164257854|NCT01221623|593309985|FG001|Overall Study|Lost to Follow-up|1|||
164257855|NCT01221623|593309984|FG000|Overall Study|Adverse Event|6|||
164257856|NCT01221623|593309985|FG001|Overall Study|Adverse Event|3|||
164257857|NCT01221623|593309984|FG000|Overall Study|Death|1|||
164257858|NCT01221623|593309985|FG001|Overall Study|Death|0|||
164257859|NCT01221623|593309984|FG000|Overall Study|Other|5|||
164257860|NCT01221623|593309985|FG001|Overall Study|Other|2|||
164257861|NCT00780143|593309986|FG000|Overall Study|Progressive disease|1|||
164257862|NCT00780143|593309986|FG000|Overall Study|Toxicity|1|||
164257863|NCT00780143|593309986|FG000|Overall Study|Adverse Event|1|||
164257864|NCT00830375|593309991|FG000|Overall Study|Lost to Follow-up|1|||
164257865|NCT01700959|593309992|FG000|Overall Study|Adverse Event|0|||
164257866|NCT01700959|593309993|FG001|Overall Study|Adverse Event|1|||
164257867|NCT01700959|593309994|FG002|Overall Study|Adverse Event|1|||
164257868|NCT01700959|593309995|FG003|Overall Study|Adverse Event|2|||
164257869|NCT01700959|593309996|FG004|Overall Study|Adverse Event|0|||
164257870|NCT01700959|593309997|FG005|Overall Study|Adverse Event|2|||
163992356|NCT03179436|592339766|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992357|NCT03179436|592339767|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
163992358|NCT03179436|592339768|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992359|NCT03179436|592339769|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992360|NCT03179436|592339770|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992361|NCT03179436|592339771|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992362|NCT03179436|592339772|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992363|NCT03179436|592339773|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
163992364|NCT03179436|592339762|FG000|Overall Study|Lost to Follow-up|1|||
163992365|NCT03179436|592339763|FG001|Overall Study|Lost to Follow-up|0|||
163992366|NCT03179436|592339764|FG002|Overall Study|Lost to Follow-up|0|||
164257871|NCT01700959|593309992|FG000|Overall Study|Withdrawal by Subject|15|||
164257872|NCT01700959|593309993|FG001|Overall Study|Withdrawal by Subject|9|||
164257873|NCT01700959|593309994|FG002|Overall Study|Withdrawal by Subject|12|||
163887978|NCT04992520|591961022|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163887979|NCT04992520|591961023|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163887980|NCT04992520|591961024|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
163887981|NCT03625167|591961025|FG000|Overall Study|Protocol Violation|5|||
163887982|NCT05583578|591961026|FG000|Overall Study|Withdrawal by Subject|2|||
163887983|NCT05583578|591961027|FG001|Overall Study|Withdrawal by Subject|0|||
163887984|NCT05877976|591961028|FG000|Overall Study|Lost to Follow-up|31|||
163887985|NCT00248287|591961029|FG000|Overall Study|Adverse Event|11|||
164339822|NCT00347360|593618958|FG005|Overall Study|Subject left town, ran out of study drug|0|||
163887986|NCT00248287|591961030|FG001|Overall Study|Adverse Event|10|||
163887987|NCT00248287|591961029|FG000|Overall Study|Death|1|||
163887988|NCT00248287|591961030|FG001|Overall Study|Death|0|||
163887989|NCT00248287|591961029|FG000|Overall Study|Lost to Follow-up|0|||
163887990|NCT00248287|591961030|FG001|Overall Study|Lost to Follow-up|1|||
163887991|NCT00248287|591961029|FG000|Overall Study|Investigator Request|4|||
163887992|NCT00248287|591961030|FG001|Overall Study|Investigator Request|3|||
163887993|NCT00248287|591961029|FG000|Overall Study|Patient Request|5|||
163887994|NCT00248287|591961030|FG001|Overall Study|Patient Request|3|||
163887995|NCT00248287|591961029|FG000|Overall Study|Other|3|||
163887996|NCT00248287|591961030|FG001|Overall Study|Other|2|||
164257874|NCT01700959|593309995|FG003|Overall Study|Withdrawal by Subject|11|||
164257875|NCT01700959|593309996|FG004|Overall Study|Withdrawal by Subject|8|||
164257876|NCT01700959|593309997|FG005|Overall Study|Withdrawal by Subject|12|||
164339823|NCT00347360|593618959|FG006|Overall Study|Subject left town, ran out of study drug|0|||
164339824|NCT00347360|593618960|FG007|Overall Study|Subject left town, ran out of study drug|0|||
164339825|NCT00347360|593618961|FG008|Overall Study|Subject left town, ran out of study drug|0|||
164339826|NCT00347360|593618962|FG009|Overall Study|Subject left town, ran out of study drug|0|||
164339827|NCT00347360|593618963|FG010|Overall Study|Subject left town, ran out of study drug|0|||
164339828|NCT00347360|593618964|FG011|Overall Study|Subject left town, ran out of study drug|0|||
164339829|NCT00347360|593618965|FG012|Overall Study|Subject left town, ran out of study drug|0|||
164257877|NCT01700959|593309992|FG000|Overall Study|Ineligible|2|||
164257878|NCT01700959|593309993|FG001|Overall Study|Ineligible|1|||
164257879|NCT01700959|593309994|FG002|Overall Study|Ineligible|2|||
164257880|NCT01700959|593309995|FG003|Overall Study|Ineligible|0|||
164257881|NCT01700959|593309996|FG004|Overall Study|Ineligible|0|||
164257882|NCT01700959|593309997|FG005|Overall Study|Ineligible|1|||
164257883|NCT01700959|593309992|FG000|Overall Study|Noncompliant|9|||
164257884|NCT01700959|593309993|FG001|Overall Study|Noncompliant|9|||
164257885|NCT01700959|593309994|FG002|Overall Study|Noncompliant|17|||
163992367|NCT03179436|592339765|FG003|Overall Study|Lost to Follow-up|1|||
163992368|NCT03179436|592339766|FG004|Overall Study|Lost to Follow-up|0|||
163992369|NCT03179436|592339767|FG005|Overall Study|Lost to Follow-up|1|||
163992370|NCT03179436|592339768|FG006|Overall Study|Lost to Follow-up|0|||
163992371|NCT03179436|592339769|FG007|Overall Study|Lost to Follow-up|0|||
163992372|NCT03179436|592339770|FG008|Overall Study|Lost to Follow-up|1|||
163992373|NCT03179436|592339771|FG009|Overall Study|Lost to Follow-up|1|||
163992374|NCT03179436|592339772|FG010|Overall Study|Lost to Follow-up|0|||
163992375|NCT03179436|592339773|FG011|Overall Study|Lost to Follow-up|0|||
163992376|NCT03179436|592339762|FG000|Overall Study|Death|12|||
163992377|NCT03179436|592339763|FG001|Overall Study|Death|17|||
163992378|NCT03179436|592339764|FG002|Overall Study|Death|7|||
163992379|NCT03179436|592339765|FG003|Overall Study|Death|32|||
163992380|NCT03179436|592339766|FG004|Overall Study|Death|29|||
163992381|NCT03179436|592339767|FG005|Overall Study|Death|30|||
163992382|NCT03179436|592339768|FG006|Overall Study|Death|33|||
163992383|NCT03179436|592339769|FG007|Overall Study|Death|9|||
163992384|NCT03179436|592339770|FG008|Overall Study|Death|84|||
163992385|NCT03179436|592339771|FG009|Overall Study|Death|33|||
163992386|NCT03179436|592339772|FG010|Overall Study|Death|22|||
163992387|NCT03179436|592339773|FG011|Overall Study|Death|15|||
163992388|NCT01634555|592339774|FG000|Overall Study|Adverse Event|3|||
163992389|NCT01634555|592339774|FG000|Overall Study|Physician Decision|1|||
164084833|NCT02196506|592674031|FG001|Phase B|Lost to Follow-up|2|||
164084834|NCT02196506|592674032|FG002|Phase B|Lost to Follow-up|1|||
164084835|NCT02196506|592674033|FG003|Phase B|Lost to Follow-up|0|||
164257886|NCT01700959|593309995|FG003|Overall Study|Noncompliant|18|||
163992390|NCT01506882|592339775|FG000|Overall Study|Lack of Efficacy|4|||
163992391|NCT01506882|592339776|FG001|Overall Study|Lack of Efficacy|3|||
163992392|NCT01506882|592339775|FG000|Overall Study|Lost to Follow-up|1|||
164257887|NCT01700959|593309996|FG004|Overall Study|Noncompliant|15|||
164257888|NCT01700959|593309997|FG005|Overall Study|Noncompliant|9|||
163992393|NCT01506882|592339776|FG001|Overall Study|Lost to Follow-up|0|||
163992394|NCT01506882|592339775|FG000|Overall Study|Withdrawal by Subject|9|||
163992395|NCT01506882|592339776|FG001|Overall Study|Withdrawal by Subject|3|||
163992396|NCT01506882|592339775|FG000|Overall Study|SAE, non-fatal|2|||
163992397|NCT01506882|592339776|FG001|Overall Study|SAE, non-fatal|0|||
163992398|NCT01506882|592339775|FG000|Overall Study|AE, non-serious non-fatal|3|||
164257889|NCT01700959|593309992|FG000|Overall Study|Side effects|1|||
164084836|NCT02196506|592674030|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
164084837|NCT02196506|592674031|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
164084838|NCT02196506|592674032|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
164084839|NCT02196506|592674033|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
164084840|NCT02196506|592674030|FG000|Phase A+|Withdrawal by Participant|0|||
164084841|NCT02196506|592674031|FG001|Phase A+|Withdrawal by Participant|0|||
164339830|NCT00347360|593618966|FG013|Overall Study|Subject left town, ran out of study drug|1|||
164339831|NCT00347360|593618967|FG014|Overall Study|Subject left town, ran out of study drug|0|||
164339832|NCT00347360|593618953|FG000|Overall Study|Subject refuse to sign updated consent|0|||
164339833|NCT00347360|593618954|FG001|Overall Study|Subject refuse to sign updated consent|0|||
164339834|NCT00347360|593618955|FG002|Overall Study|Subject refuse to sign updated consent|0|||
164339835|NCT00347360|593618956|FG003|Overall Study|Subject refuse to sign updated consent|0|||
164339836|NCT00347360|593618957|FG004|Overall Study|Subject refuse to sign updated consent|0|||
164339837|NCT00347360|593618958|FG005|Overall Study|Subject refuse to sign updated consent|0|||
164339838|NCT00347360|593618959|FG006|Overall Study|Subject refuse to sign updated consent|0|||
164339839|NCT00347360|593618960|FG007|Overall Study|Subject refuse to sign updated consent|0|||
164339840|NCT00347360|593618961|FG008|Overall Study|Subject refuse to sign updated consent|0|||
164339841|NCT00347360|593618962|FG009|Overall Study|Subject refuse to sign updated consent|0|||
164339842|NCT00347360|593618963|FG010|Overall Study|Subject refuse to sign updated consent|0|||
164339843|NCT00347360|593618964|FG011|Overall Study|Subject refuse to sign updated consent|0|||
164339844|NCT00347360|593618965|FG012|Overall Study|Subject refuse to sign updated consent|0|||
164339845|NCT00347360|593618966|FG013|Overall Study|Subject refuse to sign updated consent|0|||
164339846|NCT00347360|593618967|FG014|Overall Study|Subject refuse to sign updated consent|1|||
164339847|NCT00347360|593618953|FG000|Overall Study|Visits conflicted with new job|0|||
164339848|NCT00347360|593618954|FG001|Overall Study|Visits conflicted with new job|0|||
164339849|NCT00347360|593618955|FG002|Overall Study|Visits conflicted with new job|0|||
164339850|NCT00347360|593618956|FG003|Overall Study|Visits conflicted with new job|0|||
164339851|NCT00347360|593618957|FG004|Overall Study|Visits conflicted with new job|0|||
164339852|NCT00347360|593618958|FG005|Overall Study|Visits conflicted with new job|0|||
164339853|NCT00347360|593618959|FG006|Overall Study|Visits conflicted with new job|1|||
164339854|NCT00347360|593618960|FG007|Overall Study|Visits conflicted with new job|0|||
164339855|NCT00347360|593618961|FG008|Overall Study|Visits conflicted with new job|0|||
164339856|NCT00347360|593618962|FG009|Overall Study|Visits conflicted with new job|0|||
164339857|NCT00347360|593618963|FG010|Overall Study|Visits conflicted with new job|0|||
164339858|NCT00347360|593618964|FG011|Overall Study|Visits conflicted with new job|0|||
164339859|NCT00347360|593618965|FG012|Overall Study|Visits conflicted with new job|0|||
164339860|NCT00347360|593618966|FG013|Overall Study|Visits conflicted with new job|0|||
164339861|NCT00347360|593618967|FG014|Overall Study|Visits conflicted with new job|0|||
164339862|NCT01387789|593618970|FG000|Overall Study|Adverse Event|5|||
164339863|NCT01387789|593618970|FG000|Overall Study|Lack of Efficacy|2|||
164339864|NCT01387789|593618970|FG000|Overall Study|Lost to Follow-up|1|||
164339865|NCT00913380|593618971|FG000|Clinical Outcomes|Lost to Follow-up|6|||
164339866|NCT00913380|593618972|FG001|Clinical Outcomes|Lost to Follow-up|6|||
164339867|NCT02187744|593618973|FG000|Study|Participant refused further follow-up|1|||
164339868|NCT02187744|593618974|FG001|Study|Participant refused further follow-up|0|||
164339869|NCT02187744|593618973|FG000|Study|Other|2|||
164339870|NCT02187744|593618974|FG001|Study|Other|1|||
164339871|NCT02187744|593618973|FG000|Study|Lost to Follow-up|0|||
164339872|NCT02187744|593618974|FG001|Study|Lost to Follow-up|2|||
164339873|NCT02187744|593618973|FG000|Study|Related adverse event, not serious|0|||
164339874|NCT02187744|593618974|FG001|Study|Related adverse event, not serious|2|||
164339875|NCT02187744|593618973|FG000|Study|Death|1|||
164339876|NCT02187744|593618974|FG001|Study|Death|0|||
164339877|NCT02187744|593618973|FG000|Study|Related adverse event, serious non-fatal|0|||
164339878|NCT02187744|593618974|FG001|Study|Related adverse event, serious non-fatal|1|||
163887997|NCT04103580|591961033|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
163887998|NCT04103580|591961034|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
163887999|NCT04103580|591961033|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
163888000|NCT04103580|591961034|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
163888001|NCT04103580|591961033|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
163888002|NCT04103580|591961034|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
163888003|NCT04103580|591961033|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
164084842|NCT02196506|592674032|FG002|Phase A+|Withdrawal by Participant|0|||
164339879|NCT02187744|593618973|FG000|Treatment|Death|1|||
164339880|NCT02187744|593618974|FG001|Treatment|Death|0|||
164339881|NCT02187744|593618973|FG000|Treatment|Related adverse event, serious non-fatal|0|||
164339882|NCT02187744|593618974|FG001|Treatment|Related adverse event, serious non-fatal|1|||
164339883|NCT02187744|593618973|FG000|Treatment|Related adverse event, not serious|0|||
164339884|NCT02187744|593618974|FG001|Treatment|Related adverse event, not serious|2|||
164339885|NCT02187744|593618973|FG000|Treatment|Lost to Follow-up|0|||
164084843|NCT02196506|592674033|FG003|Phase A+|Withdrawal by Participant|5|||
164257890|NCT01700959|593309993|FG001|Overall Study|Side effects|4|||
164257891|NCT01700959|593309994|FG002|Overall Study|Side effects|8|||
164257892|NCT01700959|593309995|FG003|Overall Study|Side effects|4|||
164257893|NCT01700959|593309996|FG004|Overall Study|Side effects|4|||
164257894|NCT01700959|593309997|FG005|Overall Study|Side effects|1|||
164257895|NCT01457014|593309998|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
163888004|NCT04103580|591961034|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
163888005|NCT04103580|591961033|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
163888006|NCT04103580|591961034|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
163888007|NCT04103580|591961033|FG000|Phase 1 Active Caregiving|Other|3|||
163888008|NCT04103580|591961034|FG001|Phase 1 Active Caregiving|Other|3|||
163888009|NCT04103580|591961033|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
163888010|NCT04103580|591961034|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
163888011|NCT04103580|591961033|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
163888012|NCT04103580|591961034|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
163888013|NCT04103580|591961033|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
164257896|NCT01457014|593309999|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
164257897|NCT01457014|593310000|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
164257898|NCT01457014|593310001|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
164257899|NCT01457014|593309998|FG000|First Night|Withdrawal by Subject|3|||
164257900|NCT01457014|593309999|FG001|First Night|Withdrawal by Subject|0|||
164257901|NCT01457014|593310000|FG002|First Night|Withdrawal by Subject|0|||
164257902|NCT01457014|593310001|FG003|First Night|Withdrawal by Subject|0|||
164257903|NCT02461290|593310002|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
164257904|NCT02461290|593310002|FG000|Overall Study|Lost to Follow-up|3|||
164257905|NCT03319953|593310003|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
164257906|NCT03319953|593310004|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
164257907|NCT03319953|593310005|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
164257908|NCT03319953|593310006|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
164339886|NCT02187744|593618974|FG001|Treatment|Lost to Follow-up|1|||
164339887|NCT02187744|593618973|FG000|Treatment|Other|2|||
164339888|NCT02187744|593618974|FG001|Treatment|Other|0|||
164339889|NCT02187744|593618973|FG000|Treatment|Participant refused continued treatment|1|||
164339890|NCT02187744|593618974|FG001|Treatment|Participant refused continued treatment|1|||
164339891|NCT01788228|593618975|FG000|Overall Study|Migrated/moved from study area|1|||
164339892|NCT01788228|593618976|FG001|Overall Study|Migrated/moved from study area|0|||
164339893|NCT01972568|593618981|FG000|Overall Study|Other events|3|||
164339894|NCT01972568|593618982|FG001|Overall Study|Other events|0|||
164339895|NCT01972568|593618983|FG002|Overall Study|Other events|0|||
164339896|NCT01972568|593618981|FG000|Overall Study|Lack of Efficacy|0|||
164339897|NCT01972568|593618982|FG001|Overall Study|Lack of Efficacy|1|||
164339898|NCT01972568|593618983|FG002|Overall Study|Lack of Efficacy|2|||
164339899|NCT01972568|593618981|FG000|Overall Study|Protocol Violation|1|||
164339900|NCT01972568|593618982|FG001|Overall Study|Protocol Violation|2|||
164339901|NCT01972568|593618983|FG002|Overall Study|Protocol Violation|2|||
164339902|NCT01972568|593618981|FG000|Overall Study|Withdrawal by Subject|6|||
164339903|NCT01972568|593618982|FG001|Overall Study|Withdrawal by Subject|3|||
164339904|NCT01972568|593618983|FG002|Overall Study|Withdrawal by Subject|7|||
164339905|NCT01972568|593618981|FG000|Overall Study|Lost to Follow-up|1|||
164339906|NCT01972568|593618982|FG001|Overall Study|Lost to Follow-up|0|||
164339907|NCT01972568|593618983|FG002|Overall Study|Lost to Follow-up|0|||
164339908|NCT01972568|593618981|FG000|Overall Study|Adverse Event|5|||
164339909|NCT01972568|593618982|FG001|Overall Study|Adverse Event|6|||
164339910|NCT01972568|593618983|FG002|Overall Study|Adverse Event|5|||
164339911|NCT02059408|593618987|FG000|Overall Study|Did not get tested|0|||
164339912|NCT02059408|593618988|FG001|Overall Study|Did not get tested|330|||
164339913|NCT02059408|593618989|FG002|Overall Study|Did not get tested|358|||
164339914|NCT04223973|593618995|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
164339915|NCT04223973|593618996|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
164339916|NCT04223973|593618995|FG000|Overall Study|Adverse Event|4|||
164339917|NCT04223973|593618996|FG001|Overall Study|Adverse Event|0|||
163888014|NCT04103580|591961034|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
163888015|NCT04103580|591961033|FG000|Phase 2 Bereavement|Other|8|||
164257909|NCT03319953|593310003|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
164257910|NCT03319953|593310004|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
164257911|NCT03319953|593310005|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
164257912|NCT03319953|593310006|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
164257913|NCT04027049|593310010|FG000|Overall Study|Withdrawn by family|1|||
164339918|NCT04223973|593618995|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
164339919|NCT04223973|593618996|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
164339920|NCT04223973|593618995|FG000|Overall Study|Physician Decision|1|||
164339921|NCT04223973|593618996|FG001|Overall Study|Physician Decision|1|||
164339922|NCT04223973|593618995|FG000|Overall Study|Withdrawal by Subject|0|||
163888016|NCT04103580|591961034|FG001|Phase 2 Bereavement|Other|6|||
163888017|NCT04145440|591961035|FG000|Overall Study|Physician Decision|3|||
163888018|NCT04145440|591961036|FG001|Overall Study|Physician Decision|0|||
163888019|NCT04145440|591961035|FG000|Overall Study|Use of prohibited therapy|2|||
163888020|NCT04145440|591961036|FG001|Overall Study|Use of prohibited therapy|3|||
163888021|NCT04248725|591961050|FG000|Post-Treatment|Lost to Follow-up|6|||
163888022|NCT04248725|591961051|FG001|Post-Treatment|Lost to Follow-up|5|||
163888023|NCT04248725|591961050|FG000|6-Month Follow Up|Lost to Follow-up|9|||
163888024|NCT04248725|591961051|FG001|6-Month Follow Up|Lost to Follow-up|8|||
163888025|NCT01210807|591961058|FG000|Overall Study|Lost to Follow-up|1|||
163888026|NCT01210807|591961059|FG001|Overall Study|Lost to Follow-up|2|||
163888027|NCT01210807|591961058|FG000|Overall Study|Not implanted bilaterally|2|||
163888028|NCT01210807|591961059|FG001|Overall Study|Not implanted bilaterally|1|||
163888029|NCT05977530|591961060|FG000|Overall Study|Withdrawal by Subject|1|||
163888030|NCT05977530|591961060|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
163888031|NCT05496231|591961061|FG000|Overall Study|Adverse Event|1|||
163888032|NCT05496231|591961062|FG001|Overall Study|Adverse Event|1|||
163888033|NCT05496231|591961063|FG002|Overall Study|Adverse Event|0|||
163888034|NCT05496231|591961064|FG003|Overall Study|Adverse Event|4|||
163992399|NCT01506882|592339776|FG001|Overall Study|AE, non-serious non-fatal|1|||
163992400|NCT01506882|592339775|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
163992401|NCT01506882|592339776|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
163992402|NCT01506882|592339775|FG000|Overall Study|Other Reason|2|||
163992403|NCT01506882|592339776|FG001|Overall Study|Other Reason|0|||
163992404|NCT02663895|592341987|FG000|Overall Study|Adverse Event|3|||
163992405|NCT02663895|592341987|FG000|Overall Study|Physician Decision|2|||
163992406|NCT02663895|592341987|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
163992407|NCT02663895|592341987|FG000|Overall Study|Withdrawal by Subject|1|||
163992408|NCT00809328|592341988|FG000|Overall Study|Lack of Efficacy|18|||
163992409|NCT00809328|592341988|FG000|Overall Study|Adverse Event|6|||
163992410|NCT00809328|592341988|FG000|Overall Study|Protocol Violation|3|||
163992411|NCT00809328|592341988|FG000|Overall Study|Withdrawal by Subject|2|||
163992412|NCT00008385|592341989|FG000|Overall Study|Off treatment reasons not reported|79|||
163992413|NCT00008385|592341990|FG001|Overall Study|Off treatment reasons not reported|70|||
163992414|NCT00008385|592341989|FG000|Overall Study|Progressive disease|52|||
163992415|NCT00008385|592341990|FG001|Overall Study|Progressive disease|117|||
163992416|NCT00008385|592341989|FG000|Overall Study|Adverse Event|8|||
163992417|NCT00008385|592341990|FG001|Overall Study|Adverse Event|20|||
163992418|NCT00008385|592341989|FG000|Overall Study|Death|12|||
163992419|NCT00008385|592341990|FG001|Overall Study|Death|18|||
163992420|NCT00008385|592341989|FG000|Overall Study|Withdrawal by Subject|67|||
163992421|NCT00008385|592341990|FG001|Overall Study|Withdrawal by Subject|157|||
163992422|NCT00008385|592341989|FG000|Overall Study|Start non-protocol therapy|3|||
163992423|NCT00008385|592341990|FG001|Overall Study|Start non-protocol therapy|1|||
163992424|NCT00008385|592341989|FG000|Overall Study|Other complicating disease|17|||
164339923|NCT04223973|593618996|FG001|Overall Study|Withdrawal by Subject|1|||
164339924|NCT00594659|593618997|FG000|Overall Study|Lost to Follow-up|13|||
164339925|NCT00594659|593618998|FG001|Overall Study|Lost to Follow-up|9|||
164339926|NCT00594659|593618999|FG002|Overall Study|Lost to Follow-up|7|||
164339927|NCT00142298|593619001|FG000|Overall Study|Adverse Event|10|||
164339928|NCT00142298|593619002|FG001|Overall Study|Adverse Event|10|||
164339929|NCT00142298|593619003|FG002|Overall Study|Adverse Event|1|||
164339930|NCT00142298|593619004|FG003|Overall Study|Adverse Event|5|||
164339931|NCT00142298|593619005|FG004|Overall Study|Adverse Event|2|||
164339932|NCT00142298|593619006|FG005|Overall Study|Adverse Event|2|||
164339933|NCT00142298|593619007|FG006|Overall Study|Adverse Event|0|||
164339934|NCT00142298|593619008|FG007|Overall Study|Adverse Event|0|||
164339935|NCT00142298|593619009|FG008|Overall Study|Adverse Event|0|||
164339936|NCT00142298|593619010|FG009|Overall Study|Adverse Event|0|||
164339937|NCT00142298|593619001|FG000|Overall Study|Clinical disease progression|1|||
164339938|NCT00142298|593619002|FG001|Overall Study|Clinical disease progression|0|||
164339939|NCT00142298|593619003|FG002|Overall Study|Clinical disease progression|0|||
164339940|NCT00142298|593619004|FG003|Overall Study|Clinical disease progression|0|||
164339941|NCT00142298|593619005|FG004|Overall Study|Clinical disease progression|0|||
164339942|NCT00142298|593619006|FG005|Overall Study|Clinical disease progression|0|||
164339943|NCT00142298|593619007|FG006|Overall Study|Clinical disease progression|0|||
164339944|NCT00142298|593619008|FG007|Overall Study|Clinical disease progression|0|||
164339945|NCT00142298|593619009|FG008|Overall Study|Clinical disease progression|0|||
164339946|NCT00142298|593619010|FG009|Overall Study|Clinical disease progression|0|||
164339947|NCT00142298|593619001|FG000|Overall Study|Death|1|||
164339948|NCT00142298|593619002|FG001|Overall Study|Death|1|||
164339949|NCT00142298|593619003|FG002|Overall Study|Death|1|||
163992425|NCT00008385|592341990|FG001|Overall Study|Other complicating disease|30|||
164339950|NCT00142298|593619004|FG003|Overall Study|Death|0|||
164339951|NCT00142298|593619005|FG004|Overall Study|Death|0|||
164339952|NCT00142298|593619006|FG005|Overall Study|Death|6|||
164339953|NCT00142298|593619007|FG006|Overall Study|Death|0|||
163992426|NCT00008385|592341989|FG000|Overall Study|Maximum dose reached|0|||
163992427|NCT00008385|592341990|FG001|Overall Study|Maximum dose reached|2|||
163992428|NCT00008385|592341989|FG000|Overall Study|Other|105|||
163992429|NCT00008385|592341990|FG001|Overall Study|Other|212|||
163992430|NCT00008385|592341989|FG000|Overall Study|Not start protocol therapy|44|||
163992431|NCT00008385|592341990|FG001|Overall Study|Not start protocol therapy|175|||
163992432|NCT00365989|592341993|FG000|Overall Study|Withdrawal by Subject|1|||
163992433|NCT00365989|592341993|FG000|Overall Study|Non-compliance|1|||
163992434|NCT00317044|592341994|FG000|Overall Study|Protocol Violation|28|||
163992435|NCT00317044|592341995|FG001|Overall Study|Protocol Violation|22|||
164084844|NCT02196506|592674030|FG000|Phase A+|Adverse Event|0|||
164084845|NCT02196506|592674031|FG001|Phase A+|Adverse Event|0|||
164084846|NCT02196506|592674032|FG002|Phase A+|Adverse Event|0|||
164084847|NCT02196506|592674033|FG003|Phase A+|Adverse Event|1|||
164084848|NCT02196506|592674030|FG000|Phase A+|Lost to Follow-up|0|||
164084849|NCT02196506|592674031|FG001|Phase A+|Lost to Follow-up|0|||
164084850|NCT02196506|592674032|FG002|Phase A+|Lost to Follow-up|0|||
164084851|NCT02196506|592674033|FG003|Phase A+|Lost to Follow-up|6|||
164084852|NCT02196506|592674030|FG000|Phase A+|Participant withdrawn by investigator|0|||
164084853|NCT02196506|592674031|FG001|Phase A+|Participant withdrawn by investigator|0|||
164084854|NCT02196506|592674032|FG002|Phase A+|Participant withdrawn by investigator|0|||
164084855|NCT02196506|592674033|FG003|Phase A+|Participant withdrawn by investigator|1|||
164084856|NCT01098240|592674034|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
164084857|NCT01098240|592674035|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
164084858|NCT01098240|592674036|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
164084859|NCT01098240|592674034|FG000|Open-Label Phase|Protocol Violation|4|||
164084860|NCT01098240|592674035|FG001|Open-Label Phase|Protocol Violation|0|||
164084861|NCT01098240|592674036|FG002|Open-Label Phase|Protocol Violation|0|||
164084862|NCT01098240|592674034|FG000|Open-Label Phase|Lost to Follow-up|13|||
164084863|NCT01098240|592674035|FG001|Open-Label Phase|Lost to Follow-up|0|||
164084864|NCT01098240|592674036|FG002|Open-Label Phase|Lost to Follow-up|0|||
164084865|NCT01098240|592674034|FG000|Open-Label Phase|Other|19|||
164084866|NCT01098240|592674035|FG001|Open-Label Phase|Other|0|||
164084867|NCT01098240|592674036|FG002|Open-Label Phase|Other|0|||
164084868|NCT01098240|592674034|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
164084869|NCT01098240|592674035|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164084870|NCT01098240|592674036|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164084871|NCT01098240|592674034|FG000|Open-Label Phase|Pregnancy|1|||
164084872|NCT01098240|592674035|FG001|Open-Label Phase|Pregnancy|0|||
164084873|NCT01098240|592674036|FG002|Open-Label Phase|Pregnancy|0|||
164084874|NCT01098240|592674034|FG000|Open-Label Phase|Withdrawal by Subject|9|||
164084875|NCT01098240|592674035|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164084876|NCT01098240|592674036|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164084877|NCT01098240|592674034|FG000|Open-Label Phase|Adverse Event|12|||
164084878|NCT01098240|592674035|FG001|Open-Label Phase|Adverse Event|0|||
163992436|NCT00317044|592341996|FG002|Overall Study|Protocol Violation|20|||
163992437|NCT00317044|592341994|FG000|Overall Study|Adverse Event|4|||
164084879|NCT01098240|592674036|FG002|Open-Label Phase|Adverse Event|0|||
164084880|NCT01098240|592674034|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
164084881|NCT01098240|592674035|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
164084882|NCT01098240|592674036|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
164084883|NCT01098240|592674034|FG000|Double-Blind Phase|Protocol Violation|0|||
164084884|NCT01098240|592674035|FG001|Double-Blind Phase|Protocol Violation|2|||
164257914|NCT04027049|593310011|FG001|Overall Study|Withdrawn by family|0|||
164257915|NCT04027049|593310010|FG000|Overall Study|Participant safety|1|||
164257916|NCT04027049|593310011|FG001|Overall Study|Participant safety|0|||
164257917|NCT00871923|593311634|FG000|Overall Study|Death|1|||
164257918|NCT00871923|593311634|FG000|Overall Study|Withdrawal by Subject|1|||
164257919|NCT00496483|593311640|FG000|Overall Study|Not dosed|9|||
164257920|NCT00496483|593311640|FG000|Overall Study|Adverse Event|2|||
164257921|NCT00496483|593311640|FG000|Overall Study|Lack of Efficacy|1|||
164257922|NCT04258995|593311642|FG000|Overall Study|Lost to Follow-up|1|||
164257923|NCT04258995|593311643|FG001|Overall Study|Lost to Follow-up|1|||
164257924|NCT03285958|593311645|FG000|Overall Study|Lost to Follow-up|1|||
164257925|NCT03285958|593311646|FG001|Overall Study|Lost to Follow-up|1|||
164257926|NCT03285958|593311645|FG000|Overall Study|Withdrawal by Subject|1|||
164257927|NCT03285958|593311646|FG001|Overall Study|Withdrawal by Subject|0|||
164257928|NCT03285958|593311645|FG000|Overall Study|Not able to attend required orientation|3|||
164257929|NCT03285958|593311646|FG001|Overall Study|Not able to attend required orientation|0|||
164257930|NCT02998203|593311647|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
164257931|NCT02998203|593311648|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
164257932|NCT02998203|593311647|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
164257933|NCT02998203|593311648|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
164257934|NCT01145352|593311651|FG000|Overall Study|Found to have been registered twice|6|||
164257935|NCT01145352|593311651|FG000|Overall Study|Treated before marketing approval|4|||
164257936|NCT01145352|593311651|FG000|Overall Study|Syringe formulation was used|1|||
163992438|NCT00317044|592341995|FG001|Overall Study|Adverse Event|7|||
163992439|NCT00317044|592341996|FG002|Overall Study|Adverse Event|4|||
163992440|NCT00317044|592341994|FG000|Overall Study|Withdrawal by Subject|10|||
163992441|NCT00317044|592341995|FG001|Overall Study|Withdrawal by Subject|7|||
163992442|NCT00317044|592341996|FG002|Overall Study|Withdrawal by Subject|12|||
163992443|NCT00317044|592341994|FG000|Overall Study|Lost to Follow-up|0|||
163992444|NCT00317044|592341995|FG001|Overall Study|Lost to Follow-up|2|||
164257937|NCT00316693|593311654|FG000|Overall Study|Adverse Event|6|||
164257938|NCT00316693|593311655|FG001|Overall Study|Adverse Event|1|||
164257939|NCT00316693|593311654|FG000|Overall Study|Protocol Violation|1|||
163992445|NCT00317044|592341996|FG002|Overall Study|Lost to Follow-up|3|||
163992446|NCT00317044|592341994|FG000|Overall Study|Multiple Reasons|6|||
163992447|NCT00317044|592341995|FG001|Overall Study|Multiple Reasons|2|||
164084885|NCT01098240|592674036|FG002|Double-Blind Phase|Protocol Violation|4|||
164084886|NCT01098240|592674034|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164084887|NCT01098240|592674035|FG001|Double-Blind Phase|Lost to Follow-up|2|||
163992448|NCT00317044|592341996|FG002|Overall Study|Multiple Reasons|6|||
163992449|NCT04317690|592341999|FG000|Overall Study|did not have complete information for primary outcome|0|||
163992450|NCT04317690|592342000|FG001|Overall Study|did not have complete information for primary outcome|4|||
163992451|NCT04317690|592342001|FG002|Overall Study|did not have complete information for primary outcome|0|||
163992452|NCT04317690|592342002|FG003|Overall Study|did not have complete information for primary outcome|2|||
163992453|NCT04317690|592342003|FG004|Overall Study|did not have complete information for primary outcome|0|||
163992454|NCT02318095|592342004|FG000|Overall Study|Adverse Event|1|||
163992455|NCT00600171|592342007|FG000|Overall Study|Adverse Event|0|||
163992456|NCT00600171|592342008|FG001|Overall Study|Adverse Event|1|||
163992457|NCT00600171|592342009|FG002|Overall Study|Adverse Event|0|||
163992458|NCT00600171|592342010|FG003|Overall Study|Adverse Event|0|||
163992459|NCT00600171|592342011|FG004|Overall Study|Adverse Event|1|||
163992460|NCT00600171|592342012|FG005|Overall Study|Adverse Event|0|||
163992461|NCT00600171|592342007|FG000|Overall Study|Lack of Efficacy|9|||
163992462|NCT00600171|592342008|FG001|Overall Study|Lack of Efficacy|12|||
163992463|NCT00600171|592342009|FG002|Overall Study|Lack of Efficacy|3|||
163992464|NCT00600171|592342010|FG003|Overall Study|Lack of Efficacy|5|||
163992465|NCT00600171|592342011|FG004|Overall Study|Lack of Efficacy|4|||
163992466|NCT00600171|592342012|FG005|Overall Study|Lack of Efficacy|0|||
163992467|NCT00600171|592342007|FG000|Overall Study|Protocol Violation|1|||
163992468|NCT00600171|592342008|FG001|Overall Study|Protocol Violation|2|||
163992469|NCT00600171|592342009|FG002|Overall Study|Protocol Violation|0|||
163992470|NCT00600171|592342010|FG003|Overall Study|Protocol Violation|1|||
163992471|NCT00600171|592342011|FG004|Overall Study|Protocol Violation|0|||
163992472|NCT00600171|592342012|FG005|Overall Study|Protocol Violation|0|||
164084888|NCT01098240|592674036|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164084889|NCT01098240|592674034|FG000|Double-Blind Phase|Other|0|||
164084890|NCT01098240|592674035|FG001|Double-Blind Phase|Other|2|||
164339954|NCT00142298|593619008|FG007|Overall Study|Death|0|||
164339955|NCT00142298|593619009|FG008|Overall Study|Death|0|||
164339956|NCT00142298|593619010|FG009|Overall Study|Death|0|||
164339957|NCT00142298|593619001|FG000|Overall Study|Lack of Efficacy|44|||
164339958|NCT00142298|593619002|FG001|Overall Study|Lack of Efficacy|62|||
164339959|NCT00142298|593619003|FG002|Overall Study|Lack of Efficacy|9|||
164339960|NCT00142298|593619004|FG003|Overall Study|Lack of Efficacy|12|||
164339961|NCT00142298|593619005|FG004|Overall Study|Lack of Efficacy|1|||
164339962|NCT00142298|593619006|FG005|Overall Study|Lack of Efficacy|0|||
164339963|NCT00142298|593619007|FG006|Overall Study|Lack of Efficacy|0|||
164339964|NCT00142298|593619008|FG007|Overall Study|Lack of Efficacy|1|||
164339965|NCT00142298|593619009|FG008|Overall Study|Lack of Efficacy|0|||
164339966|NCT00142298|593619010|FG009|Overall Study|Lack of Efficacy|0|||
164339967|NCT00142298|593619001|FG000|Overall Study|Non-compliance|15|||
164339968|NCT00142298|593619002|FG001|Overall Study|Non-compliance|13|||
164339969|NCT00142298|593619003|FG002|Overall Study|Non-compliance|0|||
164339970|NCT00142298|593619004|FG003|Overall Study|Non-compliance|6|||
164339971|NCT00142298|593619005|FG004|Overall Study|Non-compliance|1|||
164339972|NCT00142298|593619006|FG005|Overall Study|Non-compliance|0|||
164339973|NCT00142298|593619007|FG006|Overall Study|Non-compliance|0|||
164339974|NCT00142298|593619008|FG007|Overall Study|Non-compliance|3|||
164339975|NCT00142298|593619009|FG008|Overall Study|Non-compliance|3|||
164339976|NCT00142298|593619010|FG009|Overall Study|Non-compliance|0|||
164339977|NCT00142298|593619001|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
164339978|NCT00142298|593619002|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
163992473|NCT00600171|592342007|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
163992474|NCT00600171|592342008|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164084891|NCT01098240|592674036|FG002|Double-Blind Phase|Other|2|||
164339979|NCT00142298|593619003|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
164084892|NCT01098240|592674034|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
163992475|NCT00600171|592342009|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
163992476|NCT00600171|592342010|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
164084893|NCT01098240|592674035|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
163992477|NCT00600171|592342011|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163992478|NCT00600171|592342012|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
163992479|NCT00600171|592342007|FG000|Overall Study|Withdrawal by Subject|3|||
164084894|NCT01098240|592674036|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
164084895|NCT01098240|592674034|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
164084896|NCT01098240|592674035|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
164339980|NCT00142298|593619004|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
164339981|NCT00142298|593619005|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
164339982|NCT00142298|593619006|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
163992480|NCT00600171|592342008|FG001|Overall Study|Withdrawal by Subject|0|||
163992481|NCT00600171|592342009|FG002|Overall Study|Withdrawal by Subject|0|||
163992482|NCT00600171|592342010|FG003|Overall Study|Withdrawal by Subject|1|||
163992483|NCT00600171|592342011|FG004|Overall Study|Withdrawal by Subject|1|||
163992484|NCT00600171|592342012|FG005|Overall Study|Withdrawal by Subject|1|||
163992485|NCT00600171|592342007|FG000|Overall Study|Physician Decision|0|||
163992486|NCT00600171|592342008|FG001|Overall Study|Physician Decision|1|||
163992487|NCT00600171|592342009|FG002|Overall Study|Physician Decision|0|||
163992488|NCT00600171|592342010|FG003|Overall Study|Physician Decision|1|||
163992489|NCT00600171|592342011|FG004|Overall Study|Physician Decision|0|||
163992490|NCT00600171|592342012|FG005|Overall Study|Physician Decision|2|||
163992491|NCT00600171|592342007|FG000|Overall Study|Lost to Follow-up|0|||
163992492|NCT00600171|592342008|FG001|Overall Study|Lost to Follow-up|0|||
163992493|NCT00600171|592342009|FG002|Overall Study|Lost to Follow-up|0|||
163992494|NCT00600171|592342010|FG003|Overall Study|Lost to Follow-up|1|||
163992495|NCT00600171|592342011|FG004|Overall Study|Lost to Follow-up|0|||
163992496|NCT00600171|592342012|FG005|Overall Study|Lost to Follow-up|0|||
163992497|NCT02367521|592342013|FG000|Overall Study|severe headache after intervention|2|||
163992498|NCT02367521|592342014|FG001|Overall Study|severe headache after intervention|0|||
163992499|NCT02367521|592342013|FG000|Overall Study|unable to find transportation|2|||
163992500|NCT02367521|592342014|FG001|Overall Study|unable to find transportation|0|||
163992501|NCT00542191|592342015|FG000|Overall Study|Death|3|||
163992502|NCT03603652|592342024|FG000|Overall Study|Death|2|||
163992503|NCT03213366|592342029|FG000|Overall Study|Lost to Follow-up|9|||
163992504|NCT03213366|592342030|FG001|Overall Study|Lost to Follow-up|4|||
163992505|NCT02532855|592342034|FG000|Overall Study|Lost to Follow-up|4|||
163992506|NCT02532855|592342035|FG001|Overall Study|Lost to Follow-up|3|||
163992507|NCT02532855|592342034|FG000|Overall Study|Withdrawal by Subject|4|||
163992508|NCT02532855|592342035|FG001|Overall Study|Withdrawal by Subject|8|||
163992509|NCT00666926|592342036|FG000|Overall Study|Adverse Event|0|||
163992510|NCT00666926|592342037|FG001|Overall Study|Adverse Event|0|||
163992511|NCT00666926|592342038|FG002|Overall Study|Adverse Event|0|||
163992512|NCT00666926|592342039|FG003|Overall Study|Adverse Event|0|||
163992513|NCT00666926|592342040|FG004|Overall Study|Adverse Event|0|||
163992514|NCT00666926|592342041|FG005|Overall Study|Adverse Event|0|||
163992515|NCT00666926|592342042|FG006|Overall Study|Adverse Event|0|||
163992516|NCT00666926|592342043|FG007|Overall Study|Adverse Event|0|||
163992517|NCT00666926|592342044|FG008|Overall Study|Adverse Event|0|||
163992518|NCT00666926|592342045|FG009|Overall Study|Adverse Event|2|||
163992519|NCT00666926|592342046|FG010|Overall Study|Adverse Event|2|||
163992520|NCT00666926|592342047|FG011|Overall Study|Adverse Event|2|||
163992521|NCT00666926|592342048|FG012|Overall Study|Adverse Event|0|||
163992522|NCT00666926|592342049|FG013|Overall Study|Adverse Event|1|||
163992523|NCT00666926|592342050|FG014|Overall Study|Adverse Event|0|||
163992524|NCT00666926|592342051|FG015|Overall Study|Adverse Event|0|||
163992525|NCT00666926|592342036|FG000|Overall Study|Laboratory abnormality|0|||
163992526|NCT00666926|592342037|FG001|Overall Study|Laboratory abnormality|0|||
163992527|NCT00666926|592342038|FG002|Overall Study|Laboratory abnormality|0|||
163992528|NCT00666926|592342039|FG003|Overall Study|Laboratory abnormality|0|||
163992529|NCT00666926|592342040|FG004|Overall Study|Laboratory abnormality|0|||
163992530|NCT00666926|592342041|FG005|Overall Study|Laboratory abnormality|0|||
163992531|NCT00666926|592342042|FG006|Overall Study|Laboratory abnormality|0|||
163992532|NCT00666926|592342043|FG007|Overall Study|Laboratory abnormality|0|||
164257940|NCT00316693|593311655|FG001|Overall Study|Protocol Violation|0|||
164257941|NCT00316693|593311654|FG000|Overall Study|Withdrawal by Subject|6|||
164257942|NCT00316693|593311655|FG001|Overall Study|Withdrawal by Subject|6|||
164257943|NCT00316693|593311654|FG000|Overall Study|Lost to Follow-up|26|||
164257944|NCT00316693|593311655|FG001|Overall Study|Lost to Follow-up|34|||
164257945|NCT00316693|593311654|FG000|Overall Study|Other|38|||
164257946|NCT00316693|593311655|FG001|Overall Study|Other|44|||
164257947|NCT01967823|593311656|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
164257948|NCT00413894|593311663|FG000|Overall Study|Withdrawal by Subject|10|||
164257949|NCT00413894|593311663|FG000|Overall Study|Administrative Reasons|1|||
164257950|NCT00413894|593311663|FG000|Overall Study|Hb <10 grams/deciliter|12|||
164257951|NCT00413894|593311663|FG000|Overall Study|Adverse Event|28|||
163992533|NCT00666926|592342044|FG008|Overall Study|Laboratory abnormality|0|||
163992534|NCT00666926|592342045|FG009|Overall Study|Laboratory abnormality|0|||
163992535|NCT00666926|592342046|FG010|Overall Study|Laboratory abnormality|1|||
163992536|NCT00666926|592342047|FG011|Overall Study|Laboratory abnormality|0|||
163992537|NCT00666926|592342048|FG012|Overall Study|Laboratory abnormality|0|||
163992538|NCT00666926|592342049|FG013|Overall Study|Laboratory abnormality|0|||
163992539|NCT00666926|592342050|FG014|Overall Study|Laboratory abnormality|0|||
163992540|NCT00666926|592342051|FG015|Overall Study|Laboratory abnormality|1|||
163992541|NCT00666926|592342036|FG000|Overall Study|Lack of Efficacy|0|||
163992542|NCT00666926|592342037|FG001|Overall Study|Lack of Efficacy|0|||
163992543|NCT00666926|592342038|FG002|Overall Study|Lack of Efficacy|0|||
163992544|NCT00666926|592342039|FG003|Overall Study|Lack of Efficacy|0|||
163992545|NCT00666926|592342040|FG004|Overall Study|Lack of Efficacy|0|||
164084897|NCT01098240|592674036|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
164084898|NCT01098240|592674034|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164257952|NCT00413894|593311663|FG000|Overall Study|Protocol Violation|11|||
164257953|NCT00413894|593311663|FG000|Overall Study|Other|18|||
164257954|NCT04225676|593311664|FG000|Overall Study|Physician Decision|1|||
164257955|NCT04225676|593311664|FG000|Overall Study|Lack of Efficacy|1|||
164257956|NCT04225676|593311664|FG000|Overall Study|Study terminated by sponsor|3|||
164257957|NCT05289271|593311667|FG000|Overall Study|Mistakenly allocated, untreated|1|||
164257958|NCT05289271|593311668|FG001|Overall Study|Mistakenly allocated, untreated|0|||
164257959|NCT02019108|593311669|FG000|Overall Study|Lost to Follow-up|5|||
164257960|NCT02019108|593311670|FG001|Overall Study|Lost to Follow-up|7|||
164257961|NCT00908115|593311673|FG000|Overall Study|Other|14|||
164257962|NCT00313313|593311680|FG000|Overall Study|Lack of Efficacy|14|||
164257963|NCT00313313|593311681|FG001|Overall Study|Lack of Efficacy|9|||
164257964|NCT00313313|593311682|FG002|Overall Study|Lack of Efficacy|20|||
164257965|NCT00313313|593311680|FG000|Overall Study|Withdrawal of consent by subject|18|||
164257966|NCT00313313|593311681|FG001|Overall Study|Withdrawal of consent by subject|17|||
164257967|NCT00313313|593311682|FG002|Overall Study|Withdrawal of consent by subject|31|||
164257968|NCT00313313|593311680|FG000|Overall Study|Lost to Follow-up|10|||
164257969|NCT00313313|593311681|FG001|Overall Study|Lost to Follow-up|7|||
164257970|NCT00313313|593311682|FG002|Overall Study|Lost to Follow-up|9|||
164257971|NCT00313313|593311680|FG000|Overall Study|Adverse Event|15|||
164257972|NCT00313313|593311681|FG001|Overall Study|Adverse Event|16|||
164257973|NCT00313313|593311682|FG002|Overall Study|Adverse Event|12|||
164257974|NCT00313313|593311680|FG000|Overall Study|Physician Decision|2|||
164257975|NCT00313313|593311681|FG001|Overall Study|Physician Decision|6|||
164257976|NCT00313313|593311682|FG002|Overall Study|Physician Decision|4|||
164257977|NCT00313313|593311680|FG000|Overall Study|Poor/Noncompliance|3|||
164257978|NCT00313313|593311681|FG001|Overall Study|Poor/Noncompliance|6|||
164257979|NCT00313313|593311682|FG002|Overall Study|Poor/Noncompliance|2|||
164257980|NCT00313313|593311680|FG000|Overall Study|Pregnancy|1|||
164339983|NCT00142298|593619007|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
164339984|NCT00142298|593619008|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
164339985|NCT00142298|593619009|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
164339986|NCT00142298|593619010|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
164339987|NCT00142298|593619001|FG000|Overall Study|Pregnancy|4|||
164339988|NCT00142298|593619002|FG001|Overall Study|Pregnancy|4|||
164339989|NCT00142298|593619003|FG002|Overall Study|Pregnancy|2|||
164339990|NCT00142298|593619004|FG003|Overall Study|Pregnancy|3|||
164339991|NCT00142298|593619005|FG004|Overall Study|Pregnancy|0|||
164339992|NCT00142298|593619006|FG005|Overall Study|Pregnancy|0|||
164339993|NCT00142298|593619007|FG006|Overall Study|Pregnancy|0|||
164339994|NCT00142298|593619008|FG007|Overall Study|Pregnancy|0|||
164339995|NCT00142298|593619009|FG008|Overall Study|Pregnancy|1|||
164339996|NCT00142298|593619010|FG009|Overall Study|Pregnancy|0|||
164339997|NCT00142298|593619001|FG000|Overall Study|Virologic breakthrough|19|||
164339998|NCT00142298|593619002|FG001|Overall Study|Virologic breakthrough|23|||
164339999|NCT00142298|593619003|FG002|Overall Study|Virologic breakthrough|9|||
164340000|NCT00142298|593619004|FG003|Overall Study|Virologic breakthrough|7|||
164340001|NCT00142298|593619005|FG004|Overall Study|Virologic breakthrough|2|||
164340002|NCT00142298|593619006|FG005|Overall Study|Virologic breakthrough|3|||
164340003|NCT00142298|593619007|FG006|Overall Study|Virologic breakthrough|3|||
163888035|NCT05496231|591961061|FG000|Overall Study|Withdrawal by Subject|5|||
163888036|NCT05496231|591961062|FG001|Overall Study|Withdrawal by Subject|5|||
163888037|NCT05496231|591961063|FG002|Overall Study|Withdrawal by Subject|4|||
163888038|NCT05496231|591961064|FG003|Overall Study|Withdrawal by Subject|11|||
163888039|NCT05496231|591961061|FG000|Overall Study|Migrated/moved from the study area|3|||
163888040|NCT05496231|591961062|FG001|Overall Study|Migrated/moved from the study area|5|||
163888041|NCT05496231|591961063|FG002|Overall Study|Migrated/moved from the study area|3|||
163888042|NCT05496231|591961064|FG003|Overall Study|Migrated/moved from the study area|3|||
163888043|NCT05496231|591961061|FG000|Overall Study|Lost to Follow-up|13|||
163888044|NCT05496231|591961062|FG001|Overall Study|Lost to Follow-up|6|||
163888045|NCT05496231|591961063|FG002|Overall Study|Lost to Follow-up|11|||
163888046|NCT05496231|591961064|FG003|Overall Study|Lost to Follow-up|6|||
163888047|NCT05496231|591961061|FG000|Overall Study|Other|9|||
163888048|NCT05496231|591961062|FG001|Overall Study|Other|7|||
164257981|NCT00313313|593311681|FG001|Overall Study|Pregnancy|2|||
164257982|NCT00313313|593311682|FG002|Overall Study|Pregnancy|0|||
163888049|NCT05496231|591961063|FG002|Overall Study|Other|7|||
163888050|NCT05496231|591961064|FG003|Overall Study|Other|8|||
163888051|NCT04898673|591961079|FG000|Overall Study|Screenfail|1|||
163888052|NCT04898673|591961080|FG001|Overall Study|Screenfail|0|||
164257983|NCT00313313|593311680|FG000|Overall Study|Death|0|||
164257984|NCT00313313|593311681|FG001|Overall Study|Death|0|||
164257985|NCT00313313|593311682|FG002|Overall Study|Death|2|||
163888053|NCT04797897|591961081|FG000|Overall Study|Study Termination by Sponsor|1|||
164257986|NCT00313313|593311680|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164340004|NCT00142298|593619008|FG007|Overall Study|Virologic breakthrough|0|||
164340005|NCT00142298|593619009|FG008|Overall Study|Virologic breakthrough|0|||
164257987|NCT00313313|593311681|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
163992546|NCT00666926|592342041|FG005|Overall Study|Lack of Efficacy|1|||
163992547|NCT00666926|592342042|FG006|Overall Study|Lack of Efficacy|0|||
163992548|NCT00666926|592342043|FG007|Overall Study|Lack of Efficacy|0|||
163992549|NCT00666926|592342044|FG008|Overall Study|Lack of Efficacy|0|||
164257988|NCT00313313|593311682|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
164257989|NCT01973387|593311683|FG000|Overall Study|Adverse Event|14|||
164257990|NCT01973387|593311684|FG001|Overall Study|Adverse Event|4|||
164257991|NCT01973387|593311683|FG000|Overall Study|Withdrawal by Subject|7|||
164257992|NCT01973387|593311684|FG001|Overall Study|Withdrawal by Subject|4|||
164257993|NCT01973387|593311683|FG000|Overall Study|Study terminated by sponsor|63|||
164257994|NCT01973387|593311684|FG001|Overall Study|Study terminated by sponsor|0|||
164257995|NCT01973387|593311683|FG000|Overall Study|Progressive disease or relapse|16|||
163992550|NCT00666926|592342045|FG009|Overall Study|Lack of Efficacy|0|||
163992551|NCT00666926|592342046|FG010|Overall Study|Lack of Efficacy|0|||
163992552|NCT00666926|592342047|FG011|Overall Study|Lack of Efficacy|1|||
163992553|NCT00666926|592342048|FG012|Overall Study|Lack of Efficacy|0|||
163992554|NCT00666926|592342049|FG013|Overall Study|Lack of Efficacy|0|||
163992555|NCT00666926|592342050|FG014|Overall Study|Lack of Efficacy|0|||
163992556|NCT00666926|592342051|FG015|Overall Study|Lack of Efficacy|0|||
163992557|NCT00666926|592342036|FG000|Overall Study|Lost to Follow-up|0|||
163992558|NCT00666926|592342037|FG001|Overall Study|Lost to Follow-up|0|||
163992559|NCT00666926|592342038|FG002|Overall Study|Lost to Follow-up|0|||
163992560|NCT00666926|592342039|FG003|Overall Study|Lost to Follow-up|1|||
163992561|NCT00666926|592342040|FG004|Overall Study|Lost to Follow-up|0|||
163992562|NCT00666926|592342041|FG005|Overall Study|Lost to Follow-up|0|||
163992563|NCT00666926|592342042|FG006|Overall Study|Lost to Follow-up|0|||
163992564|NCT00666926|592342043|FG007|Overall Study|Lost to Follow-up|0|||
163992565|NCT00666926|592342044|FG008|Overall Study|Lost to Follow-up|0|||
163992566|NCT00666926|592342045|FG009|Overall Study|Lost to Follow-up|0|||
163992567|NCT00666926|592342046|FG010|Overall Study|Lost to Follow-up|0|||
163992568|NCT00666926|592342047|FG011|Overall Study|Lost to Follow-up|0|||
164257996|NCT01973387|593311684|FG001|Overall Study|Progressive disease or relapse|5|||
164340006|NCT00142298|593619010|FG009|Overall Study|Virologic breakthrough|0|||
164340007|NCT00142298|593619001|FG000|Overall Study|Other- not specified|0|||
164340008|NCT00142298|593619002|FG001|Overall Study|Other- not specified|3|||
164340009|NCT00142298|593619003|FG002|Overall Study|Other- not specified|0|||
164340010|NCT00142298|593619004|FG003|Overall Study|Other- not specified|1|||
164340011|NCT00142298|593619005|FG004|Overall Study|Other- not specified|0|||
164340012|NCT00142298|593619006|FG005|Overall Study|Other- not specified|0|||
164340013|NCT00142298|593619007|FG006|Overall Study|Other- not specified|0|||
164340014|NCT00142298|593619008|FG007|Overall Study|Other- not specified|0|||
164340015|NCT00142298|593619009|FG008|Overall Study|Other- not specified|0|||
164340016|NCT00142298|593619010|FG009|Overall Study|Other- not specified|0|||
164340017|NCT00142298|593619001|FG000|Overall Study|Lost to Follow-up|0|||
164340018|NCT00142298|593619002|FG001|Overall Study|Lost to Follow-up|0|||
164340019|NCT00142298|593619003|FG002|Overall Study|Lost to Follow-up|0|||
164340020|NCT00142298|593619004|FG003|Overall Study|Lost to Follow-up|0|||
164340021|NCT00142298|593619005|FG004|Overall Study|Lost to Follow-up|0|||
164340022|NCT00142298|593619006|FG005|Overall Study|Lost to Follow-up|0|||
164340023|NCT00142298|593619007|FG006|Overall Study|Lost to Follow-up|2|||
164340024|NCT00142298|593619008|FG007|Overall Study|Lost to Follow-up|0|||
164340025|NCT00142298|593619009|FG008|Overall Study|Lost to Follow-up|0|||
164340026|NCT00142298|593619010|FG009|Overall Study|Lost to Follow-up|0|||
164340027|NCT00142298|593619001|FG000|Overall Study|Treatment Failure|0|||
164340028|NCT00142298|593619002|FG001|Overall Study|Treatment Failure|0|||
164340029|NCT00142298|593619003|FG002|Overall Study|Treatment Failure|0|||
164340030|NCT00142298|593619004|FG003|Overall Study|Treatment Failure|0|||
164340031|NCT00142298|593619005|FG004|Overall Study|Treatment Failure|0|||
164340032|NCT00142298|593619006|FG005|Overall Study|Treatment Failure|2|||
164340033|NCT00142298|593619007|FG006|Overall Study|Treatment Failure|2|||
164340034|NCT00142298|593619008|FG007|Overall Study|Treatment Failure|0|||
164340035|NCT00142298|593619009|FG008|Overall Study|Treatment Failure|0|||
164340036|NCT00142298|593619010|FG009|Overall Study|Treatment Failure|0|||
164340037|NCT02423772|593619013|FG000|Overall Study|Lost to Follow-up|3|||
163992569|NCT00666926|592342048|FG012|Overall Study|Lost to Follow-up|0|||
163992570|NCT00666926|592342049|FG013|Overall Study|Lost to Follow-up|0|||
164340038|NCT02423772|593619014|FG001|Overall Study|Lost to Follow-up|3|||
164340039|NCT02423772|593619013|FG000|Overall Study|Did not begin intervention|2|||
164340040|NCT02423772|593619014|FG001|Overall Study|Did not begin intervention|5|||
163992571|NCT00666926|592342050|FG014|Overall Study|Lost to Follow-up|0|||
163992572|NCT00666926|592342051|FG015|Overall Study|Lost to Follow-up|0|||
163992573|NCT00666926|592342036|FG000|Overall Study|Other|2|||
163992574|NCT00666926|592342037|FG001|Overall Study|Other|4|||
163992575|NCT00666926|592342038|FG002|Overall Study|Other|3|||
163992576|NCT00666926|592342039|FG003|Overall Study|Other|3|||
163992577|NCT00666926|592342040|FG004|Overall Study|Other|3|||
164340041|NCT01193842|593619015|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
163888054|NCT04797897|591961082|FG001|Overall Study|Study Termination by Sponsor|1|||
163888055|NCT04568434|591961097|FG000|Overall Study|Voluntary Withdrawal|0|||
164084899|NCT01098240|592674035|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
164084900|NCT01098240|592674036|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
164084901|NCT01098240|592674034|FG000|Double-Blind Phase|Adverse Event|0|||
164084902|NCT01098240|592674035|FG001|Double-Blind Phase|Adverse Event|3|||
164084903|NCT01098240|592674036|FG002|Double-Blind Phase|Adverse Event|3|||
164084904|NCT01070394|592674037|FG000|Overall Study|Adverse Event|6|||
164084905|NCT01070394|592674037|FG000|Overall Study|Withdrawal by Subject|1|||
164084906|NCT00066807|592674038|FG000|Overall Study|Study was terminated early|14|||
164084907|NCT00066807|592674039|FG001|Overall Study|Study was terminated early|15|||
164084908|NCT03507439|592674040|FG000|Overall Study|Other|2|||
164084909|NCT03507439|592674041|FG001|Overall Study|Other|1|||
164084910|NCT03507439|592674040|FG000|Overall Study|Withdrawal by Subject|1|||
164084911|NCT03507439|592674041|FG001|Overall Study|Withdrawal by Subject|0|||
164084912|NCT03507439|592674040|FG000|Overall Study|Death|1|||
164084913|NCT03507439|592674041|FG001|Overall Study|Death|1|||
164084914|NCT00874757|592674042|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
164084915|NCT03346538|592675789|FG000|Overall Study|Physician Decision|0|||
164084916|NCT03346538|592675790|FG001|Overall Study|Physician Decision|1|||
164084917|NCT03346538|592675791|FG002|Overall Study|Physician Decision|0|||
164084918|NCT03346538|592675789|FG000|Overall Study|Withdrawal by Subject|3|||
164084919|NCT03346538|592675790|FG001|Overall Study|Withdrawal by Subject|2|||
164084920|NCT03346538|592675791|FG002|Overall Study|Withdrawal by Subject|0|||
164084921|NCT03346538|592675789|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
164084922|NCT03346538|592675790|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
164084923|NCT03346538|592675791|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
164084924|NCT04014959|592675793|FG000|Baseline MRI and Assessments|Physician Decision|2|||
164084925|NCT04014959|592675793|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
164084926|NCT04014959|592675793|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
164084927|NCT02004847|592675795|FG000|Overall Study|Protocol Violation|1|||
164084928|NCT02004847|592675796|FG001|Overall Study|Protocol Violation|1|||
164084929|NCT02220920|592675797|FG000|Overall Study|Adverse Event|1|||
164084930|NCT02220920|592675798|FG001|Overall Study|Adverse Event|0|||
164084931|NCT02220920|592675797|FG000|Overall Study|Lack of Efficacy|0|||
164084932|NCT02220920|592675798|FG001|Overall Study|Lack of Efficacy|1|||
164084933|NCT02220920|592675797|FG000|Overall Study|Withdrawal by Subject|1|||
164084934|NCT02220920|592675798|FG001|Overall Study|Withdrawal by Subject|0|||
164084935|NCT02220920|592675797|FG000|Overall Study|Conflict with the stopping criteria|1|||
164084936|NCT02220920|592675798|FG001|Overall Study|Conflict with the stopping criteria|2|||
164084937|NCT02811861|592675812|FG000|Overall Study|Radiological Disease Progression|123|||
164084938|NCT02811861|592675813|FG001|Overall Study|Radiological Disease Progression|97|||
164084939|NCT02811861|592675814|FG002|Overall Study|Radiological Disease Progression|174|||
164084940|NCT02811861|592675812|FG000|Overall Study|Clinical Disease Progression|20|||
164084941|NCT02811861|592675813|FG001|Overall Study|Clinical Disease Progression|19|||
164084942|NCT02811861|592675814|FG002|Overall Study|Clinical Disease Progression|22|||
164084943|NCT02811861|592675812|FG000|Overall Study|Adverse Event|63|||
164084944|NCT02811861|592675813|FG001|Overall Study|Adverse Event|60|||
164084945|NCT02811861|592675814|FG002|Overall Study|Adverse Event|41|||
164084946|NCT02811861|592675812|FG000|Overall Study|Lost to Follow-up|0|||
164084947|NCT02811861|592675813|FG001|Overall Study|Lost to Follow-up|0|||
164084948|NCT02811861|592675814|FG002|Overall Study|Lost to Follow-up|1|||
164084949|NCT02811861|592675812|FG000|Overall Study|Subject Choice|29|||
164084950|NCT02811861|592675813|FG001|Overall Study|Subject Choice|17|||
164084951|NCT02811861|592675814|FG002|Overall Study|Subject Choice|23|||
164084952|NCT02811861|592675812|FG000|Overall Study|Withdrawal by Subject|4|||
164084953|NCT02811861|592675813|FG001|Overall Study|Withdrawal by Subject|4|||
164084954|NCT02811861|592675814|FG002|Overall Study|Withdrawal by Subject|9|||
164084955|NCT02811861|592675812|FG000|Overall Study|Other|4|||
164084956|NCT02811861|592675813|FG001|Overall Study|Other|13|||
164084957|NCT02811861|592675814|FG002|Overall Study|Other|3|||
164084958|NCT02811861|592675812|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
164084959|NCT02811861|592675813|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
164084960|NCT02811861|592675814|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
164084961|NCT02811861|592675812|FG000|Overall Study|Randomized but not treated|2|||
164084962|NCT02811861|592675813|FG001|Overall Study|Randomized but not treated|3|||
164084963|NCT02811861|592675814|FG002|Overall Study|Randomized but not treated|17|||
164084964|NCT04081337|592675818|FG000|Overall Study|Adverse Event|0|||
164084965|NCT04081337|592675819|FG001|Overall Study|Adverse Event|1|||
164084966|NCT04081337|592675818|FG000|Overall Study|Withdrawal by Subject|2|||
164084967|NCT04081337|592675819|FG001|Overall Study|Withdrawal by Subject|0|||
164084968|NCT04081337|592675818|FG000|Overall Study|Physician Decision|1|||
164084969|NCT04081337|592675819|FG001|Overall Study|Physician Decision|2|||
164084970|NCT04081337|592675818|FG000|Overall Study|Lost to Follow-up|1|||
164084971|NCT04081337|592675819|FG001|Overall Study|Lost to Follow-up|0|||
164084972|NCT06624072|592675820|FG000|Washout Period 1 (7 days)|Adverse Event|0|||
164084973|NCT06624072|592675821|FG001|Washout Period 1 (7 days)|Adverse Event|0|||
164084974|NCT06624072|592675822|FG002|Washout Period 1 (7 days)|Adverse Event|1|||
164084975|NCT01387737|592675835|FG000|Overall Study|Adverse Event|20|||
164084976|NCT01387737|592675836|FG001|Overall Study|Adverse Event|30|||
164084977|NCT01387737|592675835|FG000|Overall Study|Lack of Efficacy|1|||
164084978|NCT01387737|592675836|FG001|Overall Study|Lack of Efficacy|0|||
164084979|NCT01387737|592675835|FG000|Overall Study|Physician Decision|3|||
164084980|NCT01387737|592675836|FG001|Overall Study|Physician Decision|10|||
164084981|NCT01387737|592675835|FG000|Overall Study|Withdrawal by Subject|27|||
164084982|NCT01387737|592675836|FG001|Overall Study|Withdrawal by Subject|31|||
164084983|NCT01387737|592675835|FG000|Overall Study|Clearly not eligible for the study|1|||
164084984|NCT01387737|592675836|FG001|Overall Study|Clearly not eligible for the study|3|||
164084985|NCT00707954|592675838|FG000|Overall Study|Physician Decision|0|||
164084986|NCT00707954|592675839|FG001|Overall Study|Physician Decision|0|||
164084987|NCT00707954|592675840|FG002|Overall Study|Physician Decision|0|||
164084988|NCT00707954|592675841|FG003|Overall Study|Physician Decision|0|||
164084989|NCT00707954|592675842|FG004|Overall Study|Physician Decision|1|||
164257997|NCT01973387|593311683|FG000|Overall Study|Death|4|||
164257998|NCT01973387|593311684|FG001|Overall Study|Death|3|||
164257999|NCT01973387|593311683|FG000|Overall Study|Randomized, not treated|2|||
164084990|NCT06509100|592675845|FG000|Overall Study|Withdrawal by Subject|1|||
164084991|NCT06509100|592675845|FG000|Overall Study|Lost to Follow-up|1|||
164084992|NCT05002569|592675846|FG000|Randomized|Withdrew Consent|3|||
164084993|NCT05002569|592675847|FG001|Randomized|Withdrew Consent|0|||
164084994|NCT05002569|592675846|FG000|Randomized|No longer meets study criteria|0|||
164258000|NCT01973387|593311684|FG001|Overall Study|Randomized, not treated|2|||
164258001|NCT01345591|593311685|FG000|Overall Study|Lost to Follow-up|1|||
164258002|NCT02851797|593311686|FG000|Overall Study|Withdrawal by Subject|4|||
164258003|NCT02851797|593311687|FG001|Overall Study|Withdrawal by Subject|2|||
164084995|NCT05002569|592675847|FG001|Randomized|No longer meets study criteria|1|||
164084996|NCT05002569|592675846|FG000|Randomized|AE unrelated to study drug|1|||
164084997|NCT05002569|592675847|FG001|Randomized|AE unrelated to study drug|0|||
164084998|NCT05002569|592675846|FG000|Treatment Period|Requested to Discontinue|26|||
164084999|NCT05002569|592675847|FG001|Treatment Period|Requested to Discontinue|5|||
164085000|NCT05002569|592675846|FG000|Treatment Period|Withdrew Consent|7|||
164258004|NCT02851797|593311686|FG000|Overall Study|Adverse Event|3|||
164258005|NCT02851797|593311687|FG001|Overall Study|Adverse Event|0|||
164258006|NCT03622112|593311689|FG000|Overall Study|Withdrawal by Subject|6|||
164258007|NCT03622112|593311690|FG001|Overall Study|Withdrawal by Subject|2|||
164258008|NCT03622112|593311691|FG002|Overall Study|Withdrawal by Subject|4|||
164258009|NCT03622112|593311692|FG003|Overall Study|Withdrawal by Subject|2|||
164258010|NCT03622112|593311693|FG004|Overall Study|Withdrawal by Subject|1|||
164258011|NCT03622112|593311694|FG005|Overall Study|Withdrawal by Subject|2|||
164258012|NCT03622112|593311695|FG006|Overall Study|Withdrawal by Subject|2|||
164258013|NCT03622112|593311689|FG000|Overall Study|Death|0|||
164258014|NCT03622112|593311690|FG001|Overall Study|Death|0|||
164258015|NCT03622112|593311691|FG002|Overall Study|Death|0|||
164258016|NCT03622112|593311692|FG003|Overall Study|Death|1|||
164258017|NCT03622112|593311693|FG004|Overall Study|Death|0|||
164258018|NCT03622112|593311694|FG005|Overall Study|Death|0|||
164258019|NCT03622112|593311695|FG006|Overall Study|Death|0|||
164258020|NCT03622112|593311689|FG000|Overall Study|Lost to Follow-up|1|||
164258021|NCT03622112|593311690|FG001|Overall Study|Lost to Follow-up|1|||
164258022|NCT03622112|593311691|FG002|Overall Study|Lost to Follow-up|0|||
164258023|NCT03622112|593311692|FG003|Overall Study|Lost to Follow-up|0|||
164340042|NCT01193842|593619016|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
164340043|NCT01193842|593619017|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164340044|NCT01193842|593619018|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164340045|NCT01193842|593619019|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
164340046|NCT01193842|593619015|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
164340047|NCT01193842|593619016|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340048|NCT01193842|593619017|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340049|NCT01193842|593619018|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340050|NCT01193842|593619019|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
164340051|NCT01193842|593619015|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
163992578|NCT00666926|592342041|FG005|Overall Study|Other|3|||
163992579|NCT00666926|592342042|FG006|Overall Study|Other|4|||
163992580|NCT00666926|592342043|FG007|Overall Study|Other|0|||
163992581|NCT00666926|592342044|FG008|Overall Study|Other|3|||
163992582|NCT00666926|592342045|FG009|Overall Study|Other|5|||
163992583|NCT00666926|592342046|FG010|Overall Study|Other|3|||
163992584|NCT00666926|592342047|FG011|Overall Study|Other|26|||
163992585|NCT00666926|592342048|FG012|Overall Study|Other|3|||
163992586|NCT00666926|592342049|FG013|Overall Study|Other|2|||
163992587|NCT00666926|592342050|FG014|Overall Study|Other|4|||
163992588|NCT00666926|592342051|FG015|Overall Study|Other|4|||
163992589|NCT00666926|592342036|FG000|Overall Study|Withdrawal by Subject|0|||
163992590|NCT00666926|592342037|FG001|Overall Study|Withdrawal by Subject|0|||
163992591|NCT00666926|592342038|FG002|Overall Study|Withdrawal by Subject|0|||
163992592|NCT00666926|592342039|FG003|Overall Study|Withdrawal by Subject|0|||
163992593|NCT00666926|592342040|FG004|Overall Study|Withdrawal by Subject|0|||
163992594|NCT00666926|592342041|FG005|Overall Study|Withdrawal by Subject|0|||
163992595|NCT00666926|592342042|FG006|Overall Study|Withdrawal by Subject|0|||
163992596|NCT00666926|592342043|FG007|Overall Study|Withdrawal by Subject|1|||
163992597|NCT00666926|592342044|FG008|Overall Study|Withdrawal by Subject|0|||
163992598|NCT00666926|592342045|FG009|Overall Study|Withdrawal by Subject|3|||
163992599|NCT00666926|592342046|FG010|Overall Study|Withdrawal by Subject|0|||
163992600|NCT00666926|592342047|FG011|Overall Study|Withdrawal by Subject|3|||
163992601|NCT00666926|592342048|FG012|Overall Study|Withdrawal by Subject|0|||
163992602|NCT00666926|592342049|FG013|Overall Study|Withdrawal by Subject|1|||
163992603|NCT00666926|592342050|FG014|Overall Study|Withdrawal by Subject|3|||
163992604|NCT00666926|592342051|FG015|Overall Study|Withdrawal by Subject|3|||
163992605|NCT00666926|592342036|FG000|Overall Study|Death|0|||
163992606|NCT00666926|592342037|FG001|Overall Study|Death|0|||
163992607|NCT00666926|592342038|FG002|Overall Study|Death|0|||
163992608|NCT00666926|592342039|FG003|Overall Study|Death|0|||
163992609|NCT00666926|592342040|FG004|Overall Study|Death|0|||
163992610|NCT00666926|592342041|FG005|Overall Study|Death|0|||
163992611|NCT00666926|592342042|FG006|Overall Study|Death|0|||
163992612|NCT00666926|592342043|FG007|Overall Study|Death|0|||
163992613|NCT00666926|592342044|FG008|Overall Study|Death|0|||
163992614|NCT00666926|592342045|FG009|Overall Study|Death|0|||
163992615|NCT00666926|592342046|FG010|Overall Study|Death|0|||
164258024|NCT03622112|593311693|FG004|Overall Study|Lost to Follow-up|0|||
164258025|NCT03622112|593311694|FG005|Overall Study|Lost to Follow-up|0|||
164258026|NCT03622112|593311695|FG006|Overall Study|Lost to Follow-up|0|||
163992616|NCT00666926|592342047|FG011|Overall Study|Death|1|||
163992617|NCT00666926|592342048|FG012|Overall Study|Death|0|||
164258027|NCT03622112|593311689|FG000|Overall Study|Study-specific withdrawal criteria|10|||
164258028|NCT03622112|593311690|FG001|Overall Study|Study-specific withdrawal criteria|8|||
164258029|NCT03622112|593311691|FG002|Overall Study|Study-specific withdrawal criteria|7|||
164258030|NCT03622112|593311692|FG003|Overall Study|Study-specific withdrawal criteria|6|||
164258031|NCT03622112|593311693|FG004|Overall Study|Study-specific withdrawal criteria|4|||
164258032|NCT03622112|593311694|FG005|Overall Study|Study-specific withdrawal criteria|18|||
164258033|NCT03622112|593311695|FG006|Overall Study|Study-specific withdrawal criteria|4|||
164258034|NCT03622112|593311689|FG000|Overall Study|Protocol Violation|2|||
164258035|NCT03622112|593311690|FG001|Overall Study|Protocol Violation|0|||
163992618|NCT00666926|592342049|FG013|Overall Study|Death|0|||
163992619|NCT00666926|592342050|FG014|Overall Study|Death|0|||
164258036|NCT03622112|593311691|FG002|Overall Study|Protocol Violation|1|||
163992620|NCT00666926|592342051|FG015|Overall Study|Death|0|||
163992621|NCT01960855|592342054|FG000|Overall Study|Subject noncompliant|1|||
163992622|NCT01960855|592342055|FG001|Overall Study|Subject noncompliant|0|||
163992623|NCT01960855|592342056|FG002|Overall Study|Subject noncompliant|0|||
163992624|NCT01960855|592342057|FG003|Overall Study|Subject noncompliant|0|||
163992625|NCT01960855|592342058|FG004|Overall Study|Subject noncompliant|0|||
163992626|NCT01960855|592342054|FG000|Overall Study|Adverse Event|2|||
163992627|NCT01960855|592342055|FG001|Overall Study|Adverse Event|0|||
163992628|NCT01960855|592342056|FG002|Overall Study|Adverse Event|6|||
163992629|NCT01960855|592342057|FG003|Overall Study|Adverse Event|2|||
163992630|NCT01960855|592342058|FG004|Overall Study|Adverse Event|2|||
163992631|NCT01960855|592342054|FG000|Overall Study|Lack of Efficacy|1|||
163992632|NCT01960855|592342055|FG001|Overall Study|Lack of Efficacy|1|||
163992633|NCT01960855|592342056|FG002|Overall Study|Lack of Efficacy|0|||
163992634|NCT01960855|592342057|FG003|Overall Study|Lack of Efficacy|0|||
163992635|NCT01960855|592342058|FG004|Overall Study|Lack of Efficacy|0|||
163992636|NCT01960855|592342054|FG000|Overall Study|Other|2|||
163992637|NCT01960855|592342055|FG001|Overall Study|Other|1|||
163992638|NCT01960855|592342056|FG002|Overall Study|Other|1|||
163992639|NCT01960855|592342057|FG003|Overall Study|Other|1|||
163992640|NCT01960855|592342058|FG004|Overall Study|Other|0|||
163992641|NCT01960855|592342054|FG000|Overall Study|Consent withdrawn by subject|3|||
163992642|NCT01960855|592342055|FG001|Overall Study|Consent withdrawn by subject|1|||
164258037|NCT03622112|593311692|FG003|Overall Study|Protocol Violation|1|||
164258038|NCT03622112|593311693|FG004|Overall Study|Protocol Violation|0|||
164258039|NCT03622112|593311694|FG005|Overall Study|Protocol Violation|0|||
164258040|NCT03622112|593311695|FG006|Overall Study|Protocol Violation|0|||
164258041|NCT03622112|593311689|FG000|Overall Study|Adverse Event|6|||
164258042|NCT03622112|593311690|FG001|Overall Study|Adverse Event|8|||
164258043|NCT03622112|593311691|FG002|Overall Study|Adverse Event|4|||
164258044|NCT03622112|593311692|FG003|Overall Study|Adverse Event|11|||
164258045|NCT03622112|593311693|FG004|Overall Study|Adverse Event|4|||
164258046|NCT03622112|593311694|FG005|Overall Study|Adverse Event|20|||
164258047|NCT03622112|593311695|FG006|Overall Study|Adverse Event|2|||
163992643|NCT01960855|592342056|FG002|Overall Study|Consent withdrawn by subject|2|||
163992644|NCT01960855|592342057|FG003|Overall Study|Consent withdrawn by subject|1|||
163992645|NCT01960855|592342058|FG004|Overall Study|Consent withdrawn by subject|1|||
163992646|NCT01960855|592342054|FG000|Overall Study|Lost to Follow-up|2|||
164258048|NCT03622112|593311689|FG000|Overall Study|Reason not specified|0|||
164258049|NCT03622112|593311690|FG001|Overall Study|Reason not specified|1|||
164258050|NCT03622112|593311691|FG002|Overall Study|Reason not specified|0|||
164258051|NCT03622112|593311692|FG003|Overall Study|Reason not specified|1|||
164258052|NCT03622112|593311693|FG004|Overall Study|Reason not specified|1|||
164258053|NCT03622112|593311694|FG005|Overall Study|Reason not specified|2|||
164258054|NCT03622112|593311695|FG006|Overall Study|Reason not specified|1|||
164258055|NCT01165320|593311698|FG000|Overall Study|Clinical adverse experience|2|||
164258056|NCT01165320|593311699|FG001|Overall Study|Clinical adverse experience|1|||
164258057|NCT01165320|593311700|FG002|Overall Study|Clinical adverse experience|0|||
164258058|NCT01165320|593311698|FG000|Overall Study|Laboratory adverse experience|1|||
164258059|NCT01165320|593311699|FG001|Overall Study|Laboratory adverse experience|0|||
164258060|NCT01165320|593311700|FG002|Overall Study|Laboratory adverse experience|0|||
164258061|NCT01165320|593311698|FG000|Overall Study|Lack of Efficacy|0|||
164258062|NCT01165320|593311699|FG001|Overall Study|Lack of Efficacy|2|||
164258063|NCT01165320|593311700|FG002|Overall Study|Lack of Efficacy|0|||
164258064|NCT01165320|593311698|FG000|Overall Study|Reason unknown|0|||
164258065|NCT01165320|593311699|FG001|Overall Study|Reason unknown|1|||
164085001|NCT05002569|592675847|FG001|Treatment Period|Withdrew Consent|1|||
164085002|NCT05002569|592675846|FG000|Treatment Period|Study Drug Toxicity|114|||
164085003|NCT05002569|592675847|FG001|Treatment Period|Study Drug Toxicity|64|||
164085004|NCT05002569|592675846|FG000|Treatment Period|AE unrelated to study drug|6|||
164085005|NCT05002569|592675847|FG001|Treatment Period|AE unrelated to study drug|12|||
164085006|NCT05002569|592675846|FG000|Treatment Period|Disease Recurrence|102|||
164085007|NCT05002569|592675847|FG001|Treatment Period|Disease Recurrence|128|||
164085008|NCT05002569|592675846|FG000|Treatment Period|Other Reasons|4|||
164085009|NCT05002569|592675847|FG001|Treatment Period|Other Reasons|7|||
164085010|NCT05002569|592675846|FG000|Treatment Period|Death|1|||
164085011|NCT05002569|592675847|FG001|Treatment Period|Death|1|||
164085012|NCT05002569|592675846|FG000|Follow Up|Death|78|||
164085013|NCT05002569|592675847|FG001|Follow Up|Death|69|||
164085014|NCT05002569|592675846|FG000|Follow Up|Lost to Follow-up|3|||
164085015|NCT05002569|592675847|FG001|Follow Up|Lost to Follow-up|3|||
164085016|NCT05002569|592675846|FG000|Follow Up|Withdrew consent|17|||
164085017|NCT05002569|592675847|FG001|Follow Up|Withdrew consent|16|||
164085018|NCT05002569|592675846|FG000|Follow Up|Other Reasons|444|||
164085019|NCT05002569|592675847|FG001|Follow Up|Other Reasons|452|||
164085020|NCT00220701|592675853|FG000|Overall Study|Lost to Follow-up|5|||
164085021|NCT00220701|592675854|FG001|Overall Study|Lost to Follow-up|4|||
164085022|NCT04041570|592675856|FG000|Overall Study|Moved from Area|0|||
164085023|NCT04041570|592675857|FG001|Overall Study|Moved from Area|2|||
164085024|NCT05211336|592675858|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
164085025|NCT05211336|592675859|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
164085026|NCT05211336|592675858|FG000|Overall Study|Progressive disease|0|||
164085027|NCT05211336|592675859|FG001|Overall Study|Progressive disease|4|||
164085028|NCT05211336|592675858|FG000|Overall Study|Death due to myocardial infarction|0|||
164085029|NCT05211336|592675859|FG001|Overall Study|Death due to myocardial infarction|1|||
164085030|NCT05211336|592675858|FG000|Overall Study|Death due to unknown cause|0|||
164085031|NCT05211336|592675859|FG001|Overall Study|Death due to unknown cause|1|||
164085032|NCT05211336|592675858|FG000|Overall Study|Worsening kidney function and quality of response|0|||
164085033|NCT05211336|592675859|FG001|Overall Study|Worsening kidney function and quality of response|1|||
164085034|NCT02337829|592675860|FG000|Overall Study|Death|0|||
164085035|NCT02337829|592675861|FG001|Overall Study|Death|1|||
164085036|NCT02337829|592675862|FG002|Overall Study|Death|0|||
164085037|NCT02337829|592675863|FG003|Overall Study|Death|0|||
164085038|NCT02337829|592675860|FG000|Overall Study|Study terminated by sponsor|12|||
164085039|NCT02337829|592675861|FG001|Overall Study|Study terminated by sponsor|10|||
164258066|NCT01165320|593311700|FG002|Overall Study|Reason unknown|0|||
164258067|NCT03305419|593311701|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163888056|NCT04568434|591961098|FG001|Overall Study|Voluntary Withdrawal|1|||
163888057|NCT04568434|591961099|FG002|Overall Study|Voluntary Withdrawal|1|||
164258068|NCT03305419|593311702|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
164258069|NCT03305419|593311703|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
163888058|NCT04568434|591961097|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
164085040|NCT02337829|592675862|FG002|Overall Study|Study terminated by sponsor|5|||
164085041|NCT02337829|592675863|FG003|Overall Study|Study terminated by sponsor|6|||
164258070|NCT03305419|593311704|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258071|NCT03305419|593311705|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258072|NCT03305419|593311706|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164085042|NCT02337829|592675860|FG000|Overall Study|discontinued for other reasons|6|||
164085043|NCT02337829|592675861|FG001|Overall Study|discontinued for other reasons|3|||
164085044|NCT02337829|592675862|FG002|Overall Study|discontinued for other reasons|1|||
164085045|NCT02337829|592675863|FG003|Overall Study|discontinued for other reasons|4|||
164085046|NCT01418352|592675864|FG000|Overall Study|Lost to Follow-up|2|||
164085047|NCT01418352|592675865|FG001|Overall Study|Lost to Follow-up|0|||
164085048|NCT01418352|592675866|FG002|Overall Study|Lost to Follow-up|0|||
164085049|NCT01418352|592675867|FG003|Overall Study|Lost to Follow-up|0|||
164258073|NCT03305419|593311707|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258074|NCT03305419|593311708|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
164258075|NCT03305419|593311701|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
164258076|NCT03305419|593311702|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258077|NCT03305419|593311703|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258078|NCT03305419|593311704|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258079|NCT03305419|593311705|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258080|NCT03305419|593311706|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258081|NCT03305419|593311707|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258082|NCT03305419|593311708|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
164258083|NCT03305419|593311701|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
164258084|NCT03305419|593311702|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258085|NCT03305419|593311703|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258086|NCT03305419|593311704|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258087|NCT03305419|593311705|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258088|NCT03305419|593311706|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
163888059|NCT04568434|591961098|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
163888060|NCT04568434|591961099|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
163888061|NCT04568434|591961097|FG000|Overall Study|Investigator Judgement|1|||
163888062|NCT04568434|591961098|FG001|Overall Study|Investigator Judgement|0|||
163888063|NCT04568434|591961099|FG002|Overall Study|Investigator Judgement|0|||
163888064|NCT04049643|591961106|FG000|Overall Study|Lack of Efficacy|1|||
163888065|NCT04049643|591961107|FG001|Overall Study|Lack of Efficacy|1|||
163888066|NCT04049643|591961108|FG002|Overall Study|Lack of Efficacy|0|||
163888067|NCT04049643|591961106|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
163888068|NCT04049643|591961107|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
163888069|NCT04049643|591961108|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
163888070|NCT04081103|591961109|FG000|Overall Study|Adverse Event|1|||
163888071|NCT04081103|591961110|FG001|Overall Study|Adverse Event|1|||
163888072|NCT04081103|591961111|FG002|Overall Study|Adverse Event|1|||
163888073|NCT04081103|591961109|FG000|Overall Study|Physician Decision|0|||
163888074|NCT04081103|591961110|FG001|Overall Study|Physician Decision|0|||
163888075|NCT04081103|591961111|FG002|Overall Study|Physician Decision|1|||
163888076|NCT03365882|591961114|FG000|Randomization|Still Receiving Protocol Treatment|2|||
163888077|NCT03365882|591961115|FG001|Randomization|Still Receiving Protocol Treatment|0|||
163888078|NCT03365882|591961114|FG000|Randomization|Adverse Event|1|||
163888079|NCT03365882|591961115|FG001|Randomization|Adverse Event|2|||
163888080|NCT03365882|591961114|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
163888081|NCT03365882|591961115|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
163888082|NCT03365882|591961114|FG000|Randomization|Progression/Relapse|21|||
163888083|NCT03365882|591961115|FG001|Randomization|Progression/Relapse|3|||
163888084|NCT03365882|591961114|FG000|Randomization|Death|1|||
163888085|NCT03365882|591961115|FG001|Randomization|Death|0|||
163888086|NCT03365882|591961114|FG000|Randomization|Other - Not Protocol Specified|1|||
164258089|NCT03305419|593311707|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258090|NCT03305419|593311708|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
164258091|NCT03305419|593311701|FG000|Part B (14 Days)|Adverse Event|0|||
164258092|NCT03305419|593311702|FG001|Part B (14 Days)|Adverse Event|0|||
164258093|NCT03305419|593311703|FG002|Part B (14 Days)|Adverse Event|0|||
164258094|NCT03305419|593311704|FG003|Part B (14 Days)|Adverse Event|0|||
164258095|NCT03305419|593311705|FG004|Part B (14 Days)|Adverse Event|1|||
164258096|NCT03305419|593311706|FG005|Part B (14 Days)|Adverse Event|2|||
164258097|NCT03305419|593311707|FG006|Part B (14 Days)|Adverse Event|4|||
164258098|NCT03305419|593311708|FG007|Part B (14 Days)|Adverse Event|0|||
164258099|NCT03305419|593311701|FG000|Part B (14 Days)|Physician Decision|0|||
164258100|NCT03305419|593311702|FG001|Part B (14 Days)|Physician Decision|0|||
164258101|NCT03305419|593311703|FG002|Part B (14 Days)|Physician Decision|0|||
164258102|NCT03305419|593311704|FG003|Part B (14 Days)|Physician Decision|0|||
164258103|NCT03305419|593311705|FG004|Part B (14 Days)|Physician Decision|2|||
164258104|NCT03305419|593311706|FG005|Part B (14 Days)|Physician Decision|8|||
164258105|NCT03305419|593311707|FG006|Part B (14 Days)|Physician Decision|1|||
164258106|NCT03305419|593311708|FG007|Part B (14 Days)|Physician Decision|0|||
164258107|NCT01155466|593311709|FG000|Overall Study|Adverse Event|13|||
164258108|NCT01155466|593311710|FG001|Overall Study|Adverse Event|15|||
164258109|NCT01155466|593311711|FG002|Overall Study|Adverse Event|6|||
164258110|NCT01155466|593311712|FG003|Overall Study|Adverse Event|17|||
164258111|NCT01155466|593311713|FG004|Overall Study|Adverse Event|18|||
164258112|NCT01155466|593311709|FG000|Overall Study|Lost to Follow-up|0|||
163888087|NCT03365882|591961115|FG001|Randomization|Other - Not Protocol Specified|1|||
163888088|NCT03365882|591961114|FG000|Randomization|Major Protocol Deviation|0|||
163888089|NCT03365882|591961115|FG001|Randomization|Major Protocol Deviation|1|||
163888090|NCT03365882|591961114|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
164258113|NCT01155466|593311710|FG001|Overall Study|Lost to Follow-up|0|||
164258114|NCT01155466|593311711|FG002|Overall Study|Lost to Follow-up|0|||
164258115|NCT01155466|593311712|FG003|Overall Study|Lost to Follow-up|0|||
164258116|NCT01155466|593311713|FG004|Overall Study|Lost to Follow-up|2|||
164258117|NCT01155466|593311709|FG000|Overall Study|Withdrawal by Subject|7|||
164258118|NCT01155466|593311710|FG001|Overall Study|Withdrawal by Subject|5|||
164258119|NCT01155466|593311711|FG002|Overall Study|Withdrawal by Subject|9|||
164258120|NCT01155466|593311712|FG003|Overall Study|Withdrawal by Subject|4|||
163992647|NCT01960855|592342055|FG001|Overall Study|Lost to Follow-up|1|||
163992648|NCT01960855|592342056|FG002|Overall Study|Lost to Follow-up|0|||
163992649|NCT01960855|592342057|FG003|Overall Study|Lost to Follow-up|0|||
163992650|NCT01960855|592342058|FG004|Overall Study|Lost to Follow-up|2|||
163992651|NCT01879410|592342059|FG000|Overall Study|Adverse Event|9|||
163992652|NCT01879410|592342060|FG001|Overall Study|Adverse Event|14|||
163992653|NCT01879410|592342059|FG000|Overall Study|Lack of Efficacy|4|||
163992654|NCT01879410|592342060|FG001|Overall Study|Lack of Efficacy|6|||
163992655|NCT01879410|592342059|FG000|Overall Study|Protocol Violation|1|||
163992656|NCT01879410|592342060|FG001|Overall Study|Protocol Violation|7|||
163992657|NCT01879410|592342059|FG000|Overall Study|Lost to Follow-up|2|||
163992658|NCT01879410|592342060|FG001|Overall Study|Lost to Follow-up|1|||
163992659|NCT01879410|592342059|FG000|Overall Study|Withdrawal by Subject|7|||
163992660|NCT01879410|592342060|FG001|Overall Study|Withdrawal by Subject|8|||
163992661|NCT01879410|592342059|FG000|Overall Study|Randomised in Error|1|||
163992662|NCT01879410|592342060|FG001|Overall Study|Randomised in Error|2|||
163992663|NCT02058147|592342061|FG000|Overall Study|Randomized but not treated|0|||
163992664|NCT02058147|592342062|FG001|Overall Study|Randomized but not treated|0|||
163992665|NCT02058147|592342063|FG002|Overall Study|Randomized but not treated|1|||
163992666|NCT02058147|592342061|FG000|Overall Study|Adverse Event|12|||
163992667|NCT02058147|592342062|FG001|Overall Study|Adverse Event|9|||
163992668|NCT02058147|592342063|FG002|Overall Study|Adverse Event|21|||
163992669|NCT02058147|592342061|FG000|Overall Study|Lack of Efficacy|1|||
163992670|NCT02058147|592342062|FG001|Overall Study|Lack of Efficacy|0|||
163992671|NCT02058147|592342063|FG002|Overall Study|Lack of Efficacy|3|||
163992672|NCT02058147|592342061|FG000|Overall Study|Poor compliance to protocol|8|||
163992673|NCT02058147|592342062|FG001|Overall Study|Poor compliance to protocol|9|||
163992674|NCT02058147|592342063|FG002|Overall Study|Poor compliance to protocol|4|||
163992675|NCT02058147|592342061|FG000|Overall Study|Other than specified|8|||
163992676|NCT02058147|592342062|FG001|Overall Study|Other than specified|9|||
163992677|NCT02058147|592342063|FG002|Overall Study|Other than specified|0|||
163992678|NCT00773279|592342068|FG000|Period 1|Adverse Event|2|||
163992679|NCT00773279|592342069|FG001|Period 1|Adverse Event|1|||
163992680|NCT00773279|592342068|FG000|Period 1|Lack of Efficacy|0|||
163992681|NCT00773279|592342069|FG001|Period 1|Lack of Efficacy|2|||
163992682|NCT00773279|592342068|FG000|Period 1|Unclassified|5|||
163992683|NCT00773279|592342069|FG001|Period 1|Unclassified|1|||
163992684|NCT00773279|592342068|FG000|Period 2|Adverse Event|0|||
163992685|NCT00773279|592342069|FG001|Period 2|Adverse Event|1|||
163992686|NCT00773279|592342068|FG000|Period 2|Lack of Efficacy|1|||
163992687|NCT00773279|592342069|FG001|Period 2|Lack of Efficacy|0|||
163992688|NCT00773279|592342068|FG000|Period 2|Protocol Violation|0|||
164085050|NCT01418352|592675864|FG000|Overall Study|Adverse Event|0|||
164258121|NCT01155466|593311713|FG004|Overall Study|Withdrawal by Subject|4|||
164258122|NCT01155466|593311709|FG000|Overall Study|Protocol Violation|0|||
164340052|NCT01193842|593619016|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164340053|NCT01193842|593619017|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
164340054|NCT01193842|593619018|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164340055|NCT01193842|593619019|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
164340056|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Death|0|||
164340057|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Death|0|||
164340058|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Death|0|||
164340059|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Death|1|||
164340060|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Death|1|||
164340061|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Adverse Event|0|||
164340062|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Adverse Event|0|||
164340063|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Adverse Event|0|||
164340064|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Adverse Event|5|||
163992689|NCT00773279|592342069|FG001|Period 2|Protocol Violation|3|||
163992690|NCT00773279|592342068|FG000|Period 2|Unclassified|2|||
163992691|NCT00773279|592342069|FG001|Period 2|Unclassified|2|||
163992692|NCT04178772|592342070|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
163992693|NCT04178772|592342070|FG000|Overall Study|study terminated early due to COVID-19|7|||
164258123|NCT01155466|593311710|FG001|Overall Study|Protocol Violation|0|||
164258124|NCT01155466|593311711|FG002|Overall Study|Protocol Violation|2|||
164340065|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Adverse Event|3|||
164340066|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
163992694|NCT01737931|592342071|FG000|Overall Study|Withdrawal by Subject|0|||
163992695|NCT01737931|592342072|FG001|Overall Study|Withdrawal by Subject|1|||
164085051|NCT01418352|592675865|FG001|Overall Study|Adverse Event|1|||
164258125|NCT01155466|593311712|FG003|Overall Study|Protocol Violation|0|||
163888091|NCT03365882|591961115|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
163888092|NCT03365882|591961114|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
163888093|NCT03365882|591961115|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
163888094|NCT03365882|591961114|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
163888095|NCT03365882|591961115|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
163888096|NCT03365882|591961114|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
163888097|NCT03365882|591961115|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
163888098|NCT04437615|591961116|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
163888099|NCT04828005|591961117|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
164085052|NCT01418352|592675866|FG002|Overall Study|Adverse Event|0|||
164258126|NCT01155466|593311713|FG004|Overall Study|Protocol Violation|1|||
164340067|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
164340068|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
164340069|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
164340070|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
164340071|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Ineligible|0|||
164340072|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Ineligible|0|||
164340073|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Ineligible|0|||
164340074|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Ineligible|0|||
164340075|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Ineligible|1|||
164340076|NCT01193842|593619015|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
164340077|NCT01193842|593619016|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
164340078|NCT01193842|593619017|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
164340079|NCT01193842|593619018|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
164340080|NCT01193842|593619019|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
164340081|NCT03487549|593619021|FG000|Overall Study|Protocol Violation|0|||
164340082|NCT03487549|593619022|FG001|Overall Study|Protocol Violation|1|||
164340083|NCT03487549|593619021|FG000|Overall Study|Lost to Follow-up|2|||
164340084|NCT03487549|593619022|FG001|Overall Study|Lost to Follow-up|1|||
164340085|NCT03487549|593619021|FG000|Overall Study|Withdrawal by Subject|2|||
164340086|NCT03487549|593619022|FG001|Overall Study|Withdrawal by Subject|0|||
164340087|NCT01995825|593620475|FG000|Overall Study|Withdrawal by Subject|1|||
164340088|NCT01995825|593620476|FG001|Overall Study|Withdrawal by Subject|0|||
164340089|NCT00354744|593620479|FG000|Overall Study|Adverse Event|2|||
164340090|NCT00354744|593620479|FG000|Overall Study|Death|2|||
163888100|NCT04828005|591961118|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
163888101|NCT04828005|591961119|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
163888102|NCT04828005|591961120|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
163888103|NCT04828005|591961117|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
163888104|NCT04828005|591961118|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
163888105|NCT04828005|591961119|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
163888106|NCT04828005|591961120|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
164340091|NCT00354744|593620479|FG000|Overall Study|Lack of Efficacy|11|||
164340092|NCT00354744|593620479|FG000|Overall Study|Lost to Follow-up|2|||
164340093|NCT00354744|593620479|FG000|Overall Study|Physician Decision|11|||
164340094|NCT00354744|593620479|FG000|Overall Study|Withdrawal by Subject|14|||
163888107|NCT04828005|591961117|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
164085053|NCT01418352|592675867|FG003|Overall Study|Adverse Event|0|||
164258127|NCT01155466|593311709|FG000|Overall Study|Administrative|0|||
164258128|NCT01155466|593311710|FG001|Overall Study|Administrative|3|||
164258129|NCT01155466|593311711|FG002|Overall Study|Administrative|0|||
164258130|NCT01155466|593311712|FG003|Overall Study|Administrative|0|||
164258131|NCT01155466|593311713|FG004|Overall Study|Administrative|0|||
164258132|NCT01155466|593311709|FG000|Overall Study|Randomized not treated|2|||
164258133|NCT01155466|593311710|FG001|Overall Study|Randomized not treated|2|||
164258134|NCT01155466|593311711|FG002|Overall Study|Randomized not treated|3|||
164258135|NCT01155466|593311712|FG003|Overall Study|Randomized not treated|0|||
164258136|NCT01155466|593311713|FG004|Overall Study|Randomized not treated|2|||
164258137|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
164258138|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
164258139|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
164258140|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
164340095|NCT00541931|593620480|FG000|Overall Study|Adverse Event|1|||
164340096|NCT00541931|593620481|FG001|Overall Study|Adverse Event|0|||
164340097|NCT00541931|593620480|FG000|Overall Study|Lost to Follow-up|3|||
164340098|NCT00541931|593620481|FG001|Overall Study|Lost to Follow-up|3|||
164340099|NCT00541931|593620480|FG000|Overall Study|Withdrawal by Subject|1|||
164340100|NCT00541931|593620481|FG001|Overall Study|Withdrawal by Subject|0|||
164340101|NCT00541931|593620480|FG000|Overall Study|Transportation Issue|0|||
164340102|NCT00541931|593620481|FG001|Overall Study|Transportation Issue|1|||
164340103|NCT03094169|593620482|FG000|Overall Study|Lack of Efficacy|0|||
164340104|NCT03094169|593620483|FG001|Overall Study|Lack of Efficacy|0|||
164340105|NCT03094169|593620484|FG002|Overall Study|Lack of Efficacy|0|||
164340106|NCT03094169|593620485|FG003|Overall Study|Lack of Efficacy|0|||
164340107|NCT03094169|593620486|FG004|Overall Study|Lack of Efficacy|0|||
164340108|NCT03094169|593620487|FG005|Overall Study|Lack of Efficacy|0|||
164340109|NCT03094169|593620488|FG006|Overall Study|Lack of Efficacy|0|||
164340110|NCT03094169|593620489|FG007|Overall Study|Lack of Efficacy|21|||
164340111|NCT03094169|593620482|FG000|Overall Study|Adverse Event|0|||
163888108|NCT04828005|591961118|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
163888109|NCT04828005|591961119|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
163888110|NCT04828005|591961120|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
163888111|NCT04828005|591961117|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
163888112|NCT04828005|591961118|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
163888113|NCT04828005|591961119|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
163888114|NCT04828005|591961120|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
163888115|NCT04828005|591961117|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
163888116|NCT04828005|591961118|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
163888117|NCT04828005|591961119|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
163888118|NCT04828005|591961120|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
163888119|NCT04828005|591961117|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
163888120|NCT04828005|591961118|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
163888121|NCT04828005|591961119|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
163888122|NCT04828005|591961120|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
163888123|NCT04828005|591961117|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
163888124|NCT04828005|591961118|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
163888125|NCT04828005|591961119|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
163888126|NCT04828005|591961120|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
163888127|NCT04828005|591961117|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
163888128|NCT04828005|591961118|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
163888129|NCT04828005|591961119|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
163888130|NCT04828005|591961120|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
163888131|NCT04828005|591961117|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
163888132|NCT04828005|591961118|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
163888133|NCT04828005|591961119|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
163888134|NCT04828005|591961120|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
163888135|NCT03023410|591963243|FG000|Overall Study|study termination|0|||
163888136|NCT03023410|591963244|FG001|Overall Study|study termination|1|||
163888137|NCT04799899|591963245|FG000|Overall Study|Lost to Follow-up|2|||
163888138|NCT04799899|591963246|FG001|Overall Study|Lost to Follow-up|4|||
163888139|NCT05459688|591963249|FG000|Overall Study|Lost to Follow-up|6|||
163888140|NCT05459688|591963249|FG000|Overall Study|Physician Decision|1|||
163888141|NCT05459688|591963249|FG000|Overall Study|Withdrawal by Subject|19|||
163888142|NCT05459688|591963249|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
163888143|NCT03379675|591963252|FG000|Overall Study|Lost to Follow-up|0|||
164258141|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
164258142|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
164340112|NCT03094169|593620483|FG001|Overall Study|Adverse Event|0|||
164340113|NCT03094169|593620484|FG002|Overall Study|Adverse Event|0|||
164340114|NCT03094169|593620485|FG003|Overall Study|Adverse Event|0|||
164340115|NCT03094169|593620486|FG004|Overall Study|Adverse Event|0|||
163992696|NCT01737931|592342073|FG002|Overall Study|Withdrawal by Subject|1|||
163992697|NCT01737931|592342071|FG000|Overall Study|Physician Decision|0|||
163992698|NCT01737931|592342072|FG001|Overall Study|Physician Decision|1|||
163992699|NCT01737931|592342073|FG002|Overall Study|Physician Decision|0|||
163992700|NCT04897867|592342074|FG000|Overall Study|Withdrawal of Consent|1|||
163992701|NCT04897867|592342074|FG000|Overall Study|Pregnancy|1|||
163992702|NCT04897867|592342074|FG000|Overall Study|Lost to Follow-up|7|||
163992703|NCT04897867|592342074|FG000|Overall Study|Reason not Specified|2|||
163992704|NCT00508391|592342075|FG000|First Treatment|Withdrawal by Subject|6|||
163992705|NCT00508391|592342076|FG001|First Treatment|Withdrawal by Subject|3|||
163992706|NCT00508391|592342075|FG000|Second Treatment|Withdrawal by Subject|2|||
163992707|NCT00508391|592342076|FG001|Second Treatment|Withdrawal by Subject|0|||
164085054|NCT01418352|592675864|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
164258143|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
164258144|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
164258145|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
164258146|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
164258147|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Other|1|||
164258148|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Other|1|||
164258149|NCT02075047|593311714|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
164258150|NCT02075047|593311715|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
164258151|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
164258152|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
164258153|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
164258154|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
164258155|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
164258156|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
164258157|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
164258158|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
164258159|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
164258160|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
164258161|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Other|1|||
164258162|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Other|2|||
164258163|NCT02075047|593311714|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
164258164|NCT02075047|593311715|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
164258165|NCT00075946|593311716|FG000|Overall Study|Path ineligible: undetermined histology|0|||
164258166|NCT00075946|593311717|FG001|Overall Study|Path ineligible: undetermined histology|0|||
164258167|NCT00075946|593311718|FG002|Overall Study|Path ineligible: undetermined histology|0|||
164258168|NCT00075946|593311719|FG003|Overall Study|Path ineligible: undetermined histology|0|||
164258169|NCT00075946|593311720|FG004|Overall Study|Path ineligible: undetermined histology|6|||
164258170|NCT00075946|593311716|FG000|Overall Study|Did not achieve response after induction|0|||
164258171|NCT00075946|593311717|FG001|Overall Study|Did not achieve response after induction|0|||
164258172|NCT00075946|593311718|FG002|Overall Study|Did not achieve response after induction|0|||
164258173|NCT00075946|593311719|FG003|Overall Study|Did not achieve response after induction|0|||
164258174|NCT00075946|593311720|FG004|Overall Study|Did not achieve response after induction|182|||
164258175|NCT00075946|593311716|FG000|Overall Study|Incorrectly randomized (no response)|5|||
164258176|NCT00075946|593311717|FG001|Overall Study|Incorrectly randomized (no response)|5|||
164258177|NCT00075946|593311718|FG002|Overall Study|Incorrectly randomized (no response)|5|||
164258178|NCT00075946|593311719|FG003|Overall Study|Incorrectly randomized (no response)|1|||
164340116|NCT03094169|593620487|FG005|Overall Study|Adverse Event|0|||
164340117|NCT03094169|593620488|FG006|Overall Study|Adverse Event|0|||
164340118|NCT03094169|593620489|FG007|Overall Study|Adverse Event|2|||
164340119|NCT03094169|593620482|FG000|Overall Study|Withdrawal by Subject|0|||
164340120|NCT03094169|593620483|FG001|Overall Study|Withdrawal by Subject|0|||
164340121|NCT03094169|593620484|FG002|Overall Study|Withdrawal by Subject|0|||
164340122|NCT03094169|593620485|FG003|Overall Study|Withdrawal by Subject|0|||
164340123|NCT03094169|593620486|FG004|Overall Study|Withdrawal by Subject|0|||
164340124|NCT03094169|593620487|FG005|Overall Study|Withdrawal by Subject|0|||
164340125|NCT03094169|593620488|FG006|Overall Study|Withdrawal by Subject|1|||
164340126|NCT03094169|593620489|FG007|Overall Study|Withdrawal by Subject|1|||
164340127|NCT03094169|593620482|FG000|Overall Study|Trial Termination|0|||
164340128|NCT03094169|593620483|FG001|Overall Study|Trial Termination|0|||
164340129|NCT03094169|593620484|FG002|Overall Study|Trial Termination|0|||
164340130|NCT03094169|593620485|FG003|Overall Study|Trial Termination|0|||
164340131|NCT03094169|593620486|FG004|Overall Study|Trial Termination|0|||
164340132|NCT03094169|593620487|FG005|Overall Study|Trial Termination|0|||
164340133|NCT03094169|593620488|FG006|Overall Study|Trial Termination|0|||
164340134|NCT03094169|593620489|FG007|Overall Study|Trial Termination|1|||
164340135|NCT00617851|593620490|FG000|Overall Study|Death|0|||
164340136|NCT00617851|593620491|FG001|Overall Study|Death|0|||
164340137|NCT00617851|593620492|FG002|Overall Study|Death|0|||
163992708|NCT00880256|592342077|FG000|Overall Study|Lost to Follow-up|28|||
163992709|NCT02041962|592342081|FG000|Overall Study|Lost Aetna Coverage|43|||
163888144|NCT03379675|591963253|FG001|Overall Study|Lost to Follow-up|1|||
164258179|NCT00075946|593311720|FG004|Overall Study|Incorrectly randomized (no response)|0|||
164340138|NCT00617851|593620493|FG003|Overall Study|Death|1|||
164340139|NCT00617851|593620490|FG000|Overall Study|Withdrawal by Subject|14|||
164340140|NCT00617851|593620491|FG001|Overall Study|Withdrawal by Subject|7|||
164340141|NCT00617851|593620492|FG002|Overall Study|Withdrawal by Subject|12|||
164340142|NCT00617851|593620493|FG003|Overall Study|Withdrawal by Subject|4|||
164340143|NCT00617851|593620490|FG000|Overall Study|Lost to Follow-up|27|||
164258180|NCT00075946|593311716|FG000|Overall Study|Adverse Event|2|||
164258181|NCT00075946|593311717|FG001|Overall Study|Adverse Event|10|||
164258182|NCT00075946|593311718|FG002|Overall Study|Adverse Event|0|||
164258183|NCT00075946|593311719|FG003|Overall Study|Adverse Event|2|||
164258184|NCT00075946|593311720|FG004|Overall Study|Adverse Event|0|||
164258185|NCT00075946|593311716|FG000|Overall Study|Death|0|||
164258186|NCT00075946|593311717|FG001|Overall Study|Death|1|||
164258187|NCT00075946|593311718|FG002|Overall Study|Death|0|||
164258188|NCT00075946|593311719|FG003|Overall Study|Death|0|||
164258189|NCT00075946|593311720|FG004|Overall Study|Death|0|||
164258190|NCT00075946|593311716|FG000|Overall Study|Withdrawal by Subject|23|||
164258191|NCT00075946|593311717|FG001|Overall Study|Withdrawal by Subject|58|||
164258192|NCT00075946|593311718|FG002|Overall Study|Withdrawal by Subject|4|||
164258193|NCT00075946|593311719|FG003|Overall Study|Withdrawal by Subject|9|||
164258194|NCT00075946|593311720|FG004|Overall Study|Withdrawal by Subject|0|||
164258195|NCT00075946|593311716|FG000|Overall Study|Alternative therapy|16|||
164258196|NCT00075946|593311717|FG001|Overall Study|Alternative therapy|2|||
164258197|NCT00075946|593311718|FG002|Overall Study|Alternative therapy|5|||
164258198|NCT00075946|593311719|FG003|Overall Study|Alternative therapy|0|||
164258199|NCT00075946|593311720|FG004|Overall Study|Alternative therapy|0|||
164258200|NCT00075946|593311716|FG000|Overall Study|Other complicating disease|7|||
164258201|NCT00075946|593311717|FG001|Overall Study|Other complicating disease|13|||
164258202|NCT00075946|593311718|FG002|Overall Study|Other complicating disease|1|||
164258203|NCT00075946|593311719|FG003|Overall Study|Other complicating disease|4|||
164258204|NCT00075946|593311720|FG004|Overall Study|Other complicating disease|0|||
164258205|NCT00075946|593311716|FG000|Overall Study|No response to retreatment|23|||
164258206|NCT00075946|593311717|FG001|Overall Study|No response to retreatment|0|||
164258207|NCT00075946|593311718|FG002|Overall Study|No response to retreatment|2|||
164258208|NCT00075946|593311719|FG003|Overall Study|No response to retreatment|0|||
164258209|NCT00075946|593311720|FG004|Overall Study|No response to retreatment|0|||
164258210|NCT00075946|593311716|FG000|Overall Study|Time to progression less than 6 months|15|||
164258211|NCT00075946|593311717|FG001|Overall Study|Time to progression less than 6 months|30|||
164258212|NCT00075946|593311718|FG002|Overall Study|Time to progression less than 6 months|8|||
164258213|NCT00075946|593311719|FG003|Overall Study|Time to progression less than 6 months|3|||
164258214|NCT00075946|593311720|FG004|Overall Study|Time to progression less than 6 months|0|||
164258215|NCT00075946|593311716|FG000|Overall Study|Other|57|||
164258216|NCT00075946|593311717|FG001|Overall Study|Other|32|||
164258217|NCT00075946|593311718|FG002|Overall Study|Other|3|||
164258218|NCT00075946|593311719|FG003|Overall Study|Other|11|||
164258219|NCT00075946|593311720|FG004|Overall Study|Other|0|||
164258220|NCT04154605|593311725|FG000|Overall Study|Procedure Canceled|1|||
164258221|NCT04154605|593311726|FG001|Overall Study|Procedure Canceled|1|||
164258222|NCT04154605|593311725|FG000|Overall Study|Missed follow up|1|||
164258223|NCT04154605|593311726|FG001|Overall Study|Missed follow up|1|||
164258224|NCT04154605|593311725|FG000|Overall Study|Withdrawal by Subject|1|||
164258225|NCT04154605|593311726|FG001|Overall Study|Withdrawal by Subject|0|||
164258226|NCT01229254|593311729|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
164258227|NCT01229254|593311730|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
164258228|NCT01229254|593311731|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
164258229|NCT01229254|593311729|FG000|Overall Study|Adverse Event|4|||
164258230|NCT01229254|593311730|FG001|Overall Study|Adverse Event|5|||
164258231|NCT01229254|593311731|FG002|Overall Study|Adverse Event|3|||
164258232|NCT01229254|593311729|FG000|Overall Study|Lost to Follow-up|3|||
164258233|NCT01229254|593311730|FG001|Overall Study|Lost to Follow-up|0|||
164258234|NCT01229254|593311731|FG002|Overall Study|Lost to Follow-up|1|||
164258235|NCT01229254|593311729|FG000|Overall Study|Physician Decision|0|||
164258236|NCT01229254|593311730|FG001|Overall Study|Physician Decision|3|||
164258237|NCT01229254|593311731|FG002|Overall Study|Physician Decision|0|||
164340144|NCT00617851|593620491|FG001|Overall Study|Lost to Follow-up|29|||
164340145|NCT00617851|593620492|FG002|Overall Study|Lost to Follow-up|31|||
164258238|NCT01229254|593311729|FG000|Overall Study|Protocol Violation|4|||
164258239|NCT01229254|593311730|FG001|Overall Study|Protocol Violation|6|||
164258240|NCT01229254|593311731|FG002|Overall Study|Protocol Violation|5|||
164258241|NCT01229254|593311729|FG000|Overall Study|Withdrawal by Subject|1|||
163888145|NCT03379675|591963254|FG002|Overall Study|Lost to Follow-up|0|||
164258242|NCT01229254|593311730|FG001|Overall Study|Withdrawal by Subject|0|||
164340146|NCT00617851|593620493|FG003|Overall Study|Lost to Follow-up|19|||
164340147|NCT00617851|593620490|FG000|Overall Study|Inappropriate Enrollment|5|||
164258243|NCT01229254|593311731|FG002|Overall Study|Withdrawal by Subject|1|||
164340148|NCT00617851|593620491|FG001|Overall Study|Inappropriate Enrollment|4|||
164258244|NCT01229254|593311729|FG000|Overall Study|Non-compliance with Study Drug|0|||
164258245|NCT01229254|593311730|FG001|Overall Study|Non-compliance with Study Drug|1|||
163888146|NCT03379675|591963252|FG000|Overall Study|Adverse Event|2|||
163888147|NCT03379675|591963253|FG001|Overall Study|Adverse Event|0|||
163888148|NCT03379675|591963254|FG002|Overall Study|Adverse Event|0|||
163888149|NCT03379675|591963252|FG000|Overall Study|Withdrawal by Subject|2|||
164085055|NCT01418352|592675865|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
164085056|NCT01418352|592675866|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
164085057|NCT01418352|592675867|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
164085058|NCT01418352|592675864|FG000|Overall Study|Subject Withdrew Consent|0|||
164085059|NCT01418352|592675865|FG001|Overall Study|Subject Withdrew Consent|1|||
164085060|NCT01418352|592675866|FG002|Overall Study|Subject Withdrew Consent|2|||
164085061|NCT01418352|592675867|FG003|Overall Study|Subject Withdrew Consent|1|||
164085062|NCT01418352|592675864|FG000|Overall Study|Protocol Deviation|0|||
164085063|NCT01418352|592675865|FG001|Overall Study|Protocol Deviation|0|||
164258246|NCT01229254|593311731|FG002|Overall Study|Non-compliance with Study Drug|1|||
164258247|NCT02231892|593311732|FG000|Overall Study|Lost to Follow-up|1|||
164258248|NCT02231892|593311733|FG001|Overall Study|Lost to Follow-up|0|||
163888150|NCT03379675|591963253|FG001|Overall Study|Withdrawal by Subject|1|||
163888151|NCT03379675|591963254|FG002|Overall Study|Withdrawal by Subject|2|||
163888152|NCT02817776|591963255|FG000|Overall Study|Excluded|33|||
163888153|NCT02817776|591963255|FG000|Overall Study|Lost to Follow-up|20|||
163888154|NCT02817776|591963255|FG000|Overall Study|Withdrawal by Subject|33|||
163888155|NCT02817776|591963255|FG000|Overall Study|Death|2|||
163888156|NCT02675751|591963258|FG000|Overall Study|Lost to Follow-up|16|||
163888157|NCT02359890|591963259|FG000|Overall Study|Not meeting eligibility|4|||
163888158|NCT02359890|591963259|FG000|Overall Study|Never treated with study catheter|6|||
164258249|NCT02231892|593311734|FG002|Overall Study|Lost to Follow-up|3|||
164258250|NCT02231892|593311732|FG000|Overall Study|Withdrawal by Subject|4|||
164258251|NCT02231892|593311733|FG001|Overall Study|Withdrawal by Subject|3|||
164258252|NCT02231892|593311734|FG002|Overall Study|Withdrawal by Subject|15|||
164258253|NCT02231892|593311732|FG000|Overall Study|Physician Decision|0|||
164258254|NCT02231892|593311733|FG001|Overall Study|Physician Decision|2|||
164258255|NCT02231892|593311734|FG002|Overall Study|Physician Decision|4|||
164258256|NCT02231892|593311732|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
164258257|NCT02231892|593311733|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
164258258|NCT02231892|593311734|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
164258259|NCT02231892|593311732|FG000|Overall Study|Participant motor threshold was >83%|0|||
164258260|NCT02231892|593311733|FG001|Overall Study|Participant motor threshold was >83%|0|||
164258261|NCT02231892|593311734|FG002|Overall Study|Participant motor threshold was >83%|9|||
164258262|NCT02231892|593311732|FG000|Overall Study|Could not find motor threshold|2|||
164258263|NCT02231892|593311733|FG001|Overall Study|Could not find motor threshold|0|||
164258264|NCT02231892|593311734|FG002|Overall Study|Could not find motor threshold|1|||
164258265|NCT02231892|593311732|FG000|Overall Study|Could not find reliable motor hotspot|0|||
164258266|NCT02231892|593311733|FG001|Overall Study|Could not find reliable motor hotspot|0|||
164258267|NCT02231892|593311734|FG002|Overall Study|Could not find reliable motor hotspot|1|||
164258268|NCT00223977|593311744|FG000|Overall Study|Adverse Event|7|||
164258269|NCT00223977|593311745|FG001|Overall Study|Adverse Event|10|||
164258270|NCT00223977|593311746|FG002|Overall Study|Adverse Event|0|||
164258271|NCT00223977|593311744|FG000|Overall Study|Protocol Violation|0|||
163888159|NCT05714761|591963263|FG000|Overall Study|Lost to Follow-up|3|||
163888160|NCT05714761|591963263|FG000|Overall Study|Withdrawal by Subject|3|||
163888161|NCT05714761|591963263|FG000|Overall Study|unblinding of sensor data|1|||
163888162|NCT05714761|591963263|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
163888163|NCT05714761|591963263|FG000|Overall Study|did not return second CGM sensor|4|||
164258272|NCT00223977|593311745|FG001|Overall Study|Protocol Violation|0|||
164258273|NCT00223977|593311746|FG002|Overall Study|Protocol Violation|1|||
164258274|NCT00223977|593311744|FG000|Overall Study|Withdrawal by Subject|1|||
164258275|NCT00223977|593311745|FG001|Overall Study|Withdrawal by Subject|1|||
164258276|NCT00223977|593311746|FG002|Overall Study|Withdrawal by Subject|2|||
164258277|NCT00223977|593311744|FG000|Overall Study|Other|1|||
164258278|NCT00223977|593311745|FG001|Overall Study|Other|0|||
164258279|NCT00223977|593311746|FG002|Overall Study|Other|0|||
164258280|NCT01534260|593311749|FG000|Overall Study|Adverse Event|1|||
164258281|NCT01534260|593311750|FG001|Overall Study|Adverse Event|8|||
163888164|NCT05213390|591963264|FG000|Overall Study|Withdrawal by Subject|2|||
163888165|NCT05213390|591963264|FG000|Overall Study|Lost to Follow-up|12|||
163888166|NCT05213390|591963264|FG000|Overall Study|Protocol Violation|9|||
163888167|NCT03031470|591963268|FG000|Overall Study|Adverse Event|3|||
163888168|NCT03031470|591963269|FG001|Overall Study|Adverse Event|0|||
163888169|NCT03031470|591963268|FG000|Overall Study|Death|3|||
164258282|NCT01534260|593311749|FG000|Overall Study|Death|2|||
164258283|NCT01534260|593311750|FG001|Overall Study|Death|0|||
164258284|NCT01534260|593311749|FG000|Overall Study|Lack of Efficacy|1|||
164258285|NCT01534260|593311750|FG001|Overall Study|Lack of Efficacy|1|||
164085064|NCT01418352|592675866|FG002|Overall Study|Protocol Deviation|1|||
164258286|NCT01534260|593311749|FG000|Overall Study|Withdrawal by Subject|1|||
164258287|NCT01534260|593311750|FG001|Overall Study|Withdrawal by Subject|3|||
164258288|NCT01534260|593311749|FG000|Overall Study|Disease Progression|8|||
164258289|NCT01534260|593311750|FG001|Overall Study|Disease Progression|6|||
164258290|NCT01534260|593311749|FG000|Overall Study|Physician Decision|3|||
164258291|NCT01534260|593311750|FG001|Overall Study|Physician Decision|1|||
164258292|NCT01534260|593311749|FG000|Overall Study|No treatment, per protocol|0|||
163888170|NCT03031470|591963269|FG001|Overall Study|Death|1|||
164258293|NCT01534260|593311750|FG001|Overall Study|No treatment, per protocol|1|||
164258294|NCT02359045|593311751|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
164258295|NCT02359045|593311752|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164258296|NCT02359045|593311751|FG000|Overall Study|Lost to Follow-up|1|||
164258297|NCT02359045|593311752|FG001|Overall Study|Lost to Follow-up|1|||
164258298|NCT02359045|593311751|FG000|Overall Study|Adverse Event|0|||
164258299|NCT02359045|593311752|FG001|Overall Study|Adverse Event|1|||
164258300|NCT01342965|593311761|FG000|Overall Study|Death|58|||
164258301|NCT01342965|593311762|FG001|Overall Study|Death|57|||
164258302|NCT01342965|593311761|FG000|Overall Study|Lost to Follow-up|5|||
164258303|NCT01342965|593311762|FG001|Overall Study|Lost to Follow-up|3|||
164258304|NCT01342965|593311761|FG000|Overall Study|Other Reasons- Unspecified|44|||
164258305|NCT01342965|593311762|FG001|Overall Study|Other Reasons- Unspecified|38|||
164258306|NCT01342965|593311761|FG000|Overall Study|Withdrawal by Subject|2|||
164258307|NCT01342965|593311762|FG001|Overall Study|Withdrawal by Subject|9|||
164258308|NCT00856206|593311763|FG000|Overall Study|Protocol Violation|6|||
164258309|NCT00856206|593311764|FG001|Overall Study|Protocol Violation|18|||
164258310|NCT00856206|593311763|FG000|Overall Study|Adverse Event|10|||
164258311|NCT00856206|593311764|FG001|Overall Study|Adverse Event|46|||
164258312|NCT00856206|593311763|FG000|Overall Study|Lack of Efficacy|1|||
164258313|NCT00856206|593311764|FG001|Overall Study|Lack of Efficacy|2|||
164258314|NCT00856206|593311763|FG000|Overall Study|Withdrawal by Subject|15|||
164258315|NCT00856206|593311764|FG001|Overall Study|Withdrawal by Subject|36|||
164258316|NCT00856206|593311763|FG000|Overall Study|Lost to Follow-up|13|||
164258317|NCT00856206|593311764|FG001|Overall Study|Lost to Follow-up|39|||
164258318|NCT00856206|593311763|FG000|Overall Study|Death|2|||
164258319|NCT00856206|593311764|FG001|Overall Study|Death|2|||
164258320|NCT00856206|593311763|FG000|Overall Study|Decision by the Sponsor|4|||
164258321|NCT00856206|593311764|FG001|Overall Study|Decision by the Sponsor|8|||
164258322|NCT00856206|593311763|FG000|Overall Study|Other than specified above|3|||
164258323|NCT00856206|593311764|FG001|Overall Study|Other than specified above|10|||
164258324|NCT02780856|593311769|FG000|Overall Study|Lost to Follow-up|1|||
164258325|NCT02226198|593313668|FG000|Lead-in Phase|Protocol Violation|1|||
164258326|NCT02226198|593313669|FG001|Lead-in Phase|Protocol Violation|0|||
164258327|NCT02226198|593313670|FG002|Lead-in Phase|Protocol Violation|0|||
164258328|NCT02226198|593313668|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
164258329|NCT02226198|593313669|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
164258330|NCT02226198|593313670|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
164258331|NCT01440517|593313673|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
164258332|NCT01288612|593313675|FG000|Overall Study|Unable to contact|11|||
164258333|NCT01288612|593313676|FG001|Overall Study|Unable to contact|16|||
164258334|NCT01288612|593313677|FG002|Overall Study|Unable to contact|20|||
164258335|NCT01288612|593313675|FG000|Overall Study|Declined|78|||
164258336|NCT01288612|593313676|FG001|Overall Study|Declined|63|||
164258337|NCT01288612|593313677|FG002|Overall Study|Declined|62|||
164258338|NCT01288612|593313675|FG000|Overall Study|Unable to intubate|0|||
164258339|NCT01288612|593313676|FG001|Overall Study|Unable to intubate|3|||
164258340|NCT01288612|593313677|FG002|Overall Study|Unable to intubate|0|||
164258341|NCT00642174|593313678|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
164258342|NCT00642174|593313679|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
164258343|NCT00896363|593313680|FG000|Overall Study|Adverse Event|3|||
164258344|NCT00896363|593313681|FG001|Overall Study|Adverse Event|4|||
164258345|NCT00896363|593313682|FG002|Overall Study|Adverse Event|2|||
164258346|NCT00896363|593313680|FG000|Overall Study|Lack of Efficacy|0|||
164258347|NCT00896363|593313681|FG001|Overall Study|Lack of Efficacy|2|||
164258348|NCT00896363|593313682|FG002|Overall Study|Lack of Efficacy|1|||
164258349|NCT00896363|593313680|FG000|Overall Study|Withdrawal by Subject|3|||
164258350|NCT00896363|593313681|FG001|Overall Study|Withdrawal by Subject|5|||
164258351|NCT00896363|593313682|FG002|Overall Study|Withdrawal by Subject|5|||
164258352|NCT01730339|593313683|FG000|Overall Study|Withdrawal by Subject|3|||
164258353|NCT01730339|593313684|FG001|Overall Study|Withdrawal by Subject|2|||
164258354|NCT01730339|593313683|FG000|Overall Study|Lost to Follow-up|1|||
164258355|NCT01730339|593313684|FG001|Overall Study|Lost to Follow-up|1|||
164258356|NCT01730339|593313683|FG000|Overall Study|Un-specified|1|||
164258357|NCT01730339|593313684|FG001|Overall Study|Un-specified|0|||
164258358|NCT01739933|593313687|FG000|Overall Study|Death|89|||
164258359|NCT01739933|593313688|FG001|Overall Study|Death|86|||
164258360|NCT01739933|593313687|FG000|Overall Study|Withdrawal by Subject|10|||
164258361|NCT01739933|593313688|FG001|Overall Study|Withdrawal by Subject|8|||
164258362|NCT01739933|593313687|FG000|Overall Study|Lost to Follow-up|3|||
164258363|NCT01739933|593313688|FG001|Overall Study|Lost to Follow-up|10|||
164258364|NCT01739933|593313687|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
164258365|NCT01739933|593313688|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
164258366|NCT03356977|593313691|FG000|Overall Study|Lost to Follow-up|3|||
164258367|NCT03356977|593313691|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164258368|NCT02442310|593313697|FG000|Overall Study|Adverse Event|2|||
164258369|NCT02442310|593313697|FG000|Overall Study|Withdrawal by Subject|1|||
164258370|NCT01562314|593313698|FG000|Overall Study|Adverse Event|10|||
164258371|NCT01562314|593313699|FG001|Overall Study|Adverse Event|5|||
164258372|NCT01562314|593313698|FG000|Overall Study|Met Withdrawal Criteria|3|||
164258373|NCT01562314|593313699|FG001|Overall Study|Met Withdrawal Criteria|2|||
164258374|NCT01562314|593313698|FG000|Overall Study|Withdrawal by Subject|0|||
164258375|NCT01562314|593313699|FG001|Overall Study|Withdrawal by Subject|1|||
164258376|NCT00585546|593313700|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
164258377|NCT00585546|593313700|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
164258378|NCT03077438|593313707|FG000|Overall Study|Protocol Violation|3|||
164258379|NCT03077438|593313708|FG001|Overall Study|Protocol Violation|5|||
164258380|NCT03077438|593313707|FG000|Overall Study|Withdrawal by Subject|3|||
164258381|NCT03077438|593313708|FG001|Overall Study|Withdrawal by Subject|6|||
164258382|NCT03077438|593313707|FG000|Overall Study|Lost to Follow-up|6|||
164258383|NCT03077438|593313708|FG001|Overall Study|Lost to Follow-up|3|||
164258384|NCT00813865|593313709|FG000|Overall Study|Failure to Respond|3|||
164258385|NCT00813865|593313709|FG000|Overall Study|Lost to Follow-up|3|||
164258386|NCT00813865|593313709|FG000|Overall Study|Withdrawal by Subject|1|||
164258387|NCT00543803|593313711|FG000|Overall Study|Adverse Event|14|||
164258388|NCT00543803|593313711|FG000|Overall Study|Lack of Efficacy|22|||
164258389|NCT00543803|593313711|FG000|Overall Study|Lost to Follow-up|20|||
164258390|NCT00543803|593313711|FG000|Overall Study|Other|86|||
164258391|NCT01190475|593313712|FG000|Overall Study|Withdrawal by Subject|0|||
164258392|NCT01190475|593313713|FG001|Overall Study|Withdrawal by Subject|0|||
164258393|NCT01190475|593313714|FG002|Overall Study|Withdrawal by Subject|1|||
164258394|NCT00624585|593313715|FG000|Overall Study|Death|3|||
164258395|NCT00624585|593313715|FG000|Overall Study|Disease Progression|6|||
164258396|NCT00624585|593313715|FG000|Overall Study|Adverse Event|3|||
164258397|NCT04154345|593313721|FG000|Overall Study|Covid-19 pandemic|4|||
164258398|NCT03505788|593313722|FG000|Overall Study|Lost to Follow-up|2|||
164258399|NCT03505788|593313723|FG001|Overall Study|Lost to Follow-up|1|||
164258400|NCT03505788|593313722|FG000|Overall Study|Withdrawal by Subject|1|||
164258401|NCT03505788|593313723|FG001|Overall Study|Withdrawal by Subject|3|||
164258402|NCT03505788|593313722|FG000|Overall Study|Physician Decision|0|||
164258403|NCT03505788|593313723|FG001|Overall Study|Physician Decision|1|||
164258404|NCT01535599|593313725|FG000|Overall Study|Adverse Event|6|||
164258405|NCT01535599|593313726|FG001|Overall Study|Adverse Event|15|||
164258406|NCT01535599|593313725|FG000|Overall Study|Lost to Follow-up|3|||
164258407|NCT01535599|593313726|FG001|Overall Study|Lost to Follow-up|4|||
164258408|NCT01535599|593313725|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
164258409|NCT01535599|593313726|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
164258410|NCT01535599|593313725|FG000|Overall Study|Treatment Failure|33|||
164258411|NCT01535599|593313726|FG001|Overall Study|Treatment Failure|66|||
164258412|NCT01535599|593313725|FG000|Overall Study|BL Culture + for Group A Strep|0|||
164258413|NCT01535599|593313726|FG001|Overall Study|BL Culture + for Group A Strep|1|||
164258414|NCT01535599|593313725|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
164258415|NCT01535599|593313726|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
164258416|NCT01535599|593313725|FG000|Overall Study|Randomized in Error|2|||
164258417|NCT01535599|593313726|FG001|Overall Study|Randomized in Error|4|||
164258418|NCT01535599|593313725|FG000|Overall Study|Did not use product|1|||
164258419|NCT01535599|593313726|FG001|Overall Study|Did not use product|0|||
164258420|NCT01535599|593313725|FG000|Overall Study|Other|1|||
164258421|NCT01535599|593313726|FG001|Overall Study|Other|0|||
164258422|NCT01535599|593313725|FG000|Overall Study|Stopped medication|0|||
164258423|NCT01535599|593313726|FG001|Overall Study|Stopped medication|1|||
164258424|NCT01535599|593313725|FG000|Overall Study|Noncompliance|0|||
164258425|NCT01535599|593313726|FG001|Overall Study|Noncompliance|1|||
164258426|NCT00676520|593313727|FG000|Overall Study|Withdrawal by Subject|163|||
164258427|NCT00676520|593313727|FG000|Overall Study|Lost to Follow-up|162|||
164258428|NCT00676520|593313727|FG000|Overall Study|Death|159|||
164258429|NCT00676520|593313727|FG000|Overall Study|Physician Decision|20|||
164258430|NCT00676520|593313727|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
164258431|NCT00676520|593313727|FG000|Overall Study|Other Reason|18|||
164258432|NCT03466099|593313738|FG000|Overall Study|Adverse Event|1|||
164258433|NCT03466099|593313739|FG001|Overall Study|Adverse Event|1|||
164258434|NCT03466099|593313740|FG002|Overall Study|Adverse Event|1|||
164340149|NCT00617851|593620492|FG002|Overall Study|Inappropriate Enrollment|1|||
164340150|NCT00617851|593620493|FG003|Overall Study|Inappropriate Enrollment|1|||
164340151|NCT00617851|593620490|FG000|Overall Study|Unable to classify|1|||
164340152|NCT00617851|593620491|FG001|Overall Study|Unable to classify|0|||
164340153|NCT00617851|593620492|FG002|Overall Study|Unable to classify|1|||
164340154|NCT00617851|593620493|FG003|Overall Study|Unable to classify|0|||
164340155|NCT05350410|593620496|FG000|Overall Study|Withdrawal by Subject|1|||
164340156|NCT01030536|593620507|FG000|Overall Study|Withdrawal by Subject|0|||
164340157|NCT01030536|593620508|FG001|Overall Study|Withdrawal by Subject|0|||
164340158|NCT01030536|593620509|FG002|Overall Study|Withdrawal by Subject|1|||
164340159|NCT01030536|593620510|FG003|Overall Study|Withdrawal by Subject|0|||
164340160|NCT01030536|593620511|FG004|Overall Study|Withdrawal by Subject|0|||
164340161|NCT01030536|593620507|FG000|Overall Study|undefined|1|||
164340162|NCT01030536|593620508|FG001|Overall Study|undefined|0|||
164340163|NCT01030536|593620509|FG002|Overall Study|undefined|1|||
164340164|NCT01030536|593620510|FG003|Overall Study|undefined|1|||
164340165|NCT01030536|593620511|FG004|Overall Study|undefined|0|||
164340166|NCT01030536|593620507|FG000|Overall Study|Adverse Event|0|||
164340167|NCT01030536|593620508|FG001|Overall Study|Adverse Event|3|||
164340168|NCT01030536|593620509|FG002|Overall Study|Adverse Event|1|||
164340169|NCT01030536|593620510|FG003|Overall Study|Adverse Event|0|||
164340170|NCT01030536|593620511|FG004|Overall Study|Adverse Event|1|||
164340171|NCT01030536|593620507|FG000|Overall Study|Progressive disease|6|||
164340172|NCT01030536|593620508|FG001|Overall Study|Progressive disease|2|||
164340173|NCT01030536|593620509|FG002|Overall Study|Progressive disease|3|||
164340174|NCT01030536|593620510|FG003|Overall Study|Progressive disease|2|||
164340175|NCT01030536|593620511|FG004|Overall Study|Progressive disease|0|||
164340176|NCT01030536|593620507|FG000|Overall Study|Death|0|||
164340177|NCT01030536|593620508|FG001|Overall Study|Death|1|||
164258435|NCT03466099|593313738|FG000|Overall Study|Withdrawal by Subject|2|||
164258436|NCT03466099|593313739|FG001|Overall Study|Withdrawal by Subject|3|||
164258437|NCT03466099|593313740|FG002|Overall Study|Withdrawal by Subject|1|||
164340178|NCT01030536|593620509|FG002|Overall Study|Death|0|||
164340179|NCT01030536|593620510|FG003|Overall Study|Death|0|||
164340180|NCT01030536|593620511|FG004|Overall Study|Death|0|||
164340181|NCT03345914|593620512|FG000|Overall Study|Transition to another study at week 16|80|||
164340182|NCT03345914|593620513|FG001|Overall Study|Transition to another study at week 16|86|||
164258438|NCT03466099|593313738|FG000|Overall Study|Use of rescue medication|8|||
164258439|NCT03466099|593313739|FG001|Overall Study|Use of rescue medication|9|||
164258440|NCT03466099|593313740|FG002|Overall Study|Use of rescue medication|13|||
164258441|NCT03466099|593313738|FG000|Overall Study|Rescued without meeting criteria|4|||
164340183|NCT03345914|593620514|FG002|Overall Study|Transition to another study at week 16|78|||
164258442|NCT03466099|593313739|FG001|Overall Study|Rescued without meeting criteria|1|||
164258443|NCT03466099|593313740|FG002|Overall Study|Rescued without meeting criteria|1|||
164258444|NCT03466099|593313738|FG000|Overall Study|Subject compliance|2|||
164258445|NCT03466099|593313739|FG001|Overall Study|Subject compliance|0|||
164258446|NCT03466099|593313740|FG002|Overall Study|Subject compliance|0|||
164258447|NCT03466099|593313738|FG000|Overall Study|Worsening disease|0|||
164258448|NCT03466099|593313739|FG001|Overall Study|Worsening disease|0|||
164258449|NCT03466099|593313740|FG002|Overall Study|Worsening disease|1|||
164258450|NCT00590824|593313745|FG000|Overall Study|Disease could not be resected|0|||
164258451|NCT00590824|593313746|FG001|Overall Study|Disease could not be resected|2|||
164258452|NCT00590824|593313747|FG002|Overall Study|Disease could not be resected|1|||
164258453|NCT00590824|593313748|FG003|Overall Study|Disease could not be resected|0|||
164258454|NCT00590824|593313745|FG000|Overall Study|Adverse Event|0|||
164258455|NCT00590824|593313746|FG001|Overall Study|Adverse Event|0|||
164258456|NCT00590824|593313747|FG002|Overall Study|Adverse Event|0|||
164258457|NCT00590824|593313748|FG003|Overall Study|Adverse Event|1|||
164258458|NCT00744978|593313751|FG000|Period 1|Lost to Follow-up|1|||
164258459|NCT00744978|593313752|FG001|Period 1|Lost to Follow-up|0|||
164258460|NCT00744978|593313751|FG000|Period 1|Withdrawal by Subject|0|||
164258461|NCT00744978|593313752|FG001|Period 1|Withdrawal by Subject|2|||
164258462|NCT00744978|593313751|FG000|Period 1|Other|0|||
164258463|NCT00744978|593313752|FG001|Period 1|Other|2|||
164258464|NCT00744978|593313751|FG000|Period 1|Adverse Event|4|||
164258465|NCT00744978|593313752|FG001|Period 1|Adverse Event|0|||
164258466|NCT00744978|593313751|FG000|Period 1|Randomized but not Treated|1|||
164258467|NCT00744978|593313752|FG001|Period 1|Randomized but not Treated|1|||
164258468|NCT00744978|593313751|FG000|Period 2|Adverse Event|0|||
164258469|NCT00744978|593313752|FG001|Period 2|Adverse Event|1|||
164258470|NCT03773133|593313753|FG000|Overall Study|Screen Failure|8|||
164258471|NCT03770728|593313754|FG000|Overall Study|Adverse Event|1|||
164258472|NCT03770728|593313755|FG001|Overall Study|Adverse Event|0|||
164258473|NCT03770728|593313756|FG002|Overall Study|Adverse Event|1|||
164258474|NCT03770728|593313757|FG003|Overall Study|Adverse Event|0|||
164258475|NCT03770728|593313754|FG000|Overall Study|Poor compliance to protocol|0|||
164258476|NCT03770728|593313755|FG001|Overall Study|Poor compliance to protocol|0|||
164258477|NCT03770728|593313756|FG002|Overall Study|Poor compliance to protocol|1|||
164258478|NCT03770728|593313757|FG003|Overall Study|Poor compliance to protocol|0|||
164258479|NCT03770728|593313754|FG000|Overall Study|Withdrawal by Subject|13|||
164258480|NCT03770728|593313755|FG001|Overall Study|Withdrawal by Subject|8|||
164258481|NCT03770728|593313756|FG002|Overall Study|Withdrawal by Subject|9|||
164258482|NCT03770728|593313757|FG003|Overall Study|Withdrawal by Subject|13|||
164258483|NCT03770728|593313754|FG000|Overall Study|Other than specified|24|||
164258484|NCT03770728|593313755|FG001|Overall Study|Other than specified|23|||
164258485|NCT03770728|593313756|FG002|Overall Study|Other than specified|21|||
164258486|NCT03770728|593313757|FG003|Overall Study|Other than specified|22|||
164258487|NCT02778555|593313758|FG000|Overall Study|Withdrawal by Subject|55|||
164258488|NCT02778555|593313759|FG001|Overall Study|Withdrawal by Subject|32|||
164258489|NCT02778555|593313760|FG002|Overall Study|Withdrawal by Subject|107|||
164258490|NCT02379988|593313761|FG000|Overall Study|Not eligible|1|||
164258491|NCT01895543|593313766|FG000|Overall Study|Withdrawal by Subject|43|||
164258492|NCT01895543|593313766|FG000|Overall Study|Lost to Follow-up|25|||
164258493|NCT01895543|593313766|FG000|Overall Study|Adverse Event|28|||
164258494|NCT01895543|593313766|FG000|Overall Study|Subject's substantial non-compliance|6|||
164258495|NCT01895543|593313766|FG000|Overall Study|Protocol Violation|1|||
164258496|NCT01895543|593313766|FG000|Overall Study|Physician Decision|2|||
164258497|NCT01895543|593313766|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
164258498|NCT00503581|593313767|FG000|Overall Study|Study closed|3|||
164258499|NCT00503581|593313768|FG001|Overall Study|Study closed|4|||
164258500|NCT00503581|593313769|FG002|Overall Study|Study closed|2|||
164258501|NCT04262882|593313770|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
164258502|NCT04262882|593313771|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
164340184|NCT03345914|593620512|FG000|Overall Study|Transition to OLE during follow-up|37|||
164340185|NCT03345914|593620513|FG001|Overall Study|Transition to OLE during follow-up|33|||
164340186|NCT03345914|593620514|FG002|Overall Study|Transition to OLE during follow-up|39|||
163992710|NCT02041962|592342082|FG001|Overall Study|Lost Aetna Coverage|40|||
164258503|NCT04262882|593313770|FG000|Overall Study|Lost to Follow-up|1|||
164258504|NCT04262882|593313771|FG001|Overall Study|Lost to Follow-up|0|||
164258505|NCT01301066|593313772|FG000|Overall Study|Lost to Follow-up|5|||
164258506|NCT01301066|593313773|FG001|Overall Study|Lost to Follow-up|11|||
164258507|NCT01301066|593313772|FG000|Overall Study|Protocol Violation|8|||
164258508|NCT01301066|593313773|FG001|Overall Study|Protocol Violation|7|||
164258509|NCT01301066|593313772|FG000|Overall Study|Withdrawal by Subject|4|||
164258510|NCT01301066|593313773|FG001|Overall Study|Withdrawal by Subject|9|||
164258511|NCT01301066|593313772|FG000|Overall Study|Adverse Event|6|||
164258512|NCT01301066|593313773|FG001|Overall Study|Adverse Event|6|||
164258513|NCT01301066|593313772|FG000|Overall Study|Sponsor Decision|2|||
164340187|NCT03345914|593620512|FG000|Overall Study|Physician Decision|0|||
164258514|NCT01301066|593313773|FG001|Overall Study|Sponsor Decision|1|||
164258515|NCT01301066|593313772|FG000|Overall Study|Physician Decision|0|||
164258516|NCT01301066|593313773|FG001|Overall Study|Physician Decision|1|||
164258517|NCT01301066|593313772|FG000|Overall Study|Other|2|||
164258518|NCT01301066|593313773|FG001|Overall Study|Other|0|||
164258519|NCT04003207|593313776|FG000|Overall Study|Protocol Violation|1|||
163888171|NCT03031470|591963268|FG000|Overall Study|Lost to Follow-up|1|||
163888172|NCT03031470|591963269|FG001|Overall Study|Lost to Follow-up|1|||
163888173|NCT03031470|591963268|FG000|Overall Study|Withdrawal by Subject|1|||
163888174|NCT03031470|591963269|FG001|Overall Study|Withdrawal by Subject|0|||
163888175|NCT03031470|591963268|FG000|Overall Study|Protocol entry criteria not met|0|||
163888176|NCT03031470|591963269|FG001|Overall Study|Protocol entry criteria not met|1|||
164258520|NCT00468676|593313781|FG000|Overall Study|Lost to Follow-up|14|||
164258521|NCT00468676|593313782|FG001|Overall Study|Lost to Follow-up|11|||
164258522|NCT00468676|593313781|FG000|Overall Study|Death|2|||
164258523|NCT00468676|593313782|FG001|Overall Study|Death|1|||
164258524|NCT00721578|593313788|FG000|Overall Study|Death|1|||
164258525|NCT00721578|593313789|FG001|Overall Study|Death|1|||
164258526|NCT00721578|593313788|FG000|Overall Study|Withdrawal by Subject|1|||
164258527|NCT00721578|593313789|FG001|Overall Study|Withdrawal by Subject|1|||
164258528|NCT02256384|593313803|FG000|Overall Study|Withdrawal by Subject|12|||
164258529|NCT02256384|593313803|FG000|Overall Study|Equipment not capturing data|2|||
164258530|NCT05032690|593313810|FG000|Period 1|Adverse Event|0|||
164258531|NCT05032690|593313811|FG001|Period 1|Adverse Event|1|||
164258532|NCT05032690|593313812|FG002|Period 1|Adverse Event|0|||
164258533|NCT05032690|593313813|FG003|Period 1|Adverse Event|0|||
164258534|NCT05032690|593313810|FG000|Period 1|Withdrawal by Subject|1|||
164258535|NCT05032690|593313811|FG001|Period 1|Withdrawal by Subject|0|||
164258536|NCT05032690|593313812|FG002|Period 1|Withdrawal by Subject|0|||
164258537|NCT05032690|593313813|FG003|Period 1|Withdrawal by Subject|0|||
164258538|NCT05032690|593313810|FG000|Period 1|No longer meets eligibility criteria|0|||
164258539|NCT05032690|593313811|FG001|Period 1|No longer meets eligibility criteria|1|||
164258540|NCT05032690|593313812|FG002|Period 1|No longer meets eligibility criteria|0|||
164258541|NCT05032690|593313813|FG003|Period 1|No longer meets eligibility criteria|0|||
164258542|NCT05032690|593313810|FG000|Period 2|Adverse Event|1|||
164258543|NCT05032690|593313811|FG001|Period 2|Adverse Event|0|||
164258544|NCT05032690|593313812|FG002|Period 2|Adverse Event|0|||
164258545|NCT05032690|593313813|FG003|Period 2|Adverse Event|0|||
164258546|NCT05032690|593313810|FG000|Period 2|Withdrawal by Subject|0|||
164258547|NCT05032690|593313811|FG001|Period 2|Withdrawal by Subject|1|||
164258548|NCT05032690|593313812|FG002|Period 2|Withdrawal by Subject|0|||
164258549|NCT05032690|593313813|FG003|Period 2|Withdrawal by Subject|0|||
164258550|NCT05032690|593313810|FG000|Period 2|No longer meets eligibility criteria|0|||
164258551|NCT05032690|593313811|FG001|Period 2|No longer meets eligibility criteria|1|||
164258552|NCT05032690|593313812|FG002|Period 2|No longer meets eligibility criteria|0|||
164258553|NCT05032690|593313813|FG003|Period 2|No longer meets eligibility criteria|0|||
164258554|NCT05032690|593313810|FG000|Period 3|Adverse Event|0|||
164258555|NCT05032690|593313811|FG001|Period 3|Adverse Event|1|||
164258556|NCT05032690|593313812|FG002|Period 3|Adverse Event|0|||
164258557|NCT05032690|593313813|FG003|Period 3|Adverse Event|0|||
164258558|NCT00487942|593313814|FG000|Overall Study|Adverse Event|1|||
164258559|NCT00487942|593313815|FG001|Overall Study|Adverse Event|1|||
164258560|NCT00487942|593313816|FG002|Overall Study|Adverse Event|1|||
164258561|NCT00487942|593313817|FG003|Overall Study|Adverse Event|1|||
164258562|NCT00487942|593313814|FG000|Overall Study|Lost to Follow-up|1|||
164258563|NCT00487942|593313815|FG001|Overall Study|Lost to Follow-up|0|||
164258564|NCT00487942|593313816|FG002|Overall Study|Lost to Follow-up|0|||
164258565|NCT00487942|593313817|FG003|Overall Study|Lost to Follow-up|1|||
164258566|NCT00487942|593313814|FG000|Overall Study|Protocol Violation|1|||
164258567|NCT00487942|593313815|FG001|Overall Study|Protocol Violation|1|||
164258568|NCT00487942|593313816|FG002|Overall Study|Protocol Violation|0|||
163888177|NCT03031470|591963268|FG000|Overall Study|Cancel the operation|0|||
163888178|NCT03031470|591963269|FG001|Overall Study|Cancel the operation|1|||
164258569|NCT00487942|593313817|FG003|Overall Study|Protocol Violation|0|||
164258570|NCT00487942|593313814|FG000|Overall Study|Withdrawal by Subject|0|||
164258571|NCT00487942|593313815|FG001|Overall Study|Withdrawal by Subject|1|||
164258572|NCT00487942|593313816|FG002|Overall Study|Withdrawal by Subject|2|||
164258573|NCT00487942|593313817|FG003|Overall Study|Withdrawal by Subject|0|||
164258574|NCT00211757|593313818|FG000|Overall Study|Withdrawal by Subject|1|||
164258575|NCT00211757|593313819|FG001|Overall Study|Withdrawal by Subject|1|||
164258576|NCT00211757|593313818|FG000|Overall Study|Lack of Efficacy|0|||
164258577|NCT00211757|593313819|FG001|Overall Study|Lack of Efficacy|1|||
164258578|NCT05151445|593313820|FG000|Overall Study|Withdrawal by Subject|3|||
164258579|NCT02298179|593313821|FG000|Overall Study|Lost to Follow-up|0|||
163888179|NCT01593917|591963270|FG000|Overall Study|Death|67|||
163900158|NCT02397096|592005614|FG000|Study Extension 3|Withdrawal by Subject|2|||
164258580|NCT02298179|593313822|FG001|Overall Study|Lost to Follow-up|0|||
164258581|NCT02298179|593313823|FG002|Overall Study|Lost to Follow-up|1|||
164258582|NCT02298179|593313824|FG003|Overall Study|Lost to Follow-up|0|||
164258583|NCT02298179|593313825|FG004|Overall Study|Lost to Follow-up|0|||
164258584|NCT02298179|593313826|FG005|Overall Study|Lost to Follow-up|0|||
164258585|NCT02298179|593313827|FG006|Overall Study|Lost to Follow-up|0|||
164258586|NCT02298179|593313828|FG007|Overall Study|Lost to Follow-up|1|||
164258587|NCT02298179|593313829|FG008|Overall Study|Lost to Follow-up|0|||
164258588|NCT02298179|593313830|FG009|Overall Study|Lost to Follow-up|0|||
164258589|NCT02298179|593313831|FG010|Overall Study|Lost to Follow-up|0|||
164258590|NCT02298179|593313832|FG011|Overall Study|Lost to Follow-up|0|||
164258591|NCT04098367|593316008|FG000|Overall Study|Adverse Event|0|||
164258592|NCT04098367|593316009|FG001|Overall Study|Adverse Event|0|||
164258593|NCT04098367|593316010|FG002|Overall Study|Adverse Event|1|||
164258594|NCT04098367|593316008|FG000|Overall Study|Lost to Follow-up|1|||
164258595|NCT04098367|593316009|FG001|Overall Study|Lost to Follow-up|5|||
164258596|NCT04098367|593316010|FG002|Overall Study|Lost to Follow-up|2|||
164258597|NCT04098367|593316008|FG000|Overall Study|Withdrawal by Subject|0|||
164258598|NCT04098367|593316009|FG001|Overall Study|Withdrawal by Subject|0|||
164258599|NCT04098367|593316010|FG002|Overall Study|Withdrawal by Subject|1|||
164258600|NCT04098367|593316008|FG000|Overall Study|Sick . Could not attend visit|1|||
164258601|NCT04098367|593316009|FG001|Overall Study|Sick . Could not attend visit|0|||
164258602|NCT04098367|593316010|FG002|Overall Study|Sick . Could not attend visit|0|||
164258603|NCT01728077|593316011|FG000|Overall Study|Lack of Efficacy|3|||
164258604|NCT01728077|593316012|FG001|Overall Study|Lack of Efficacy|1|||
164258605|NCT01728077|593316011|FG000|Overall Study|Lost to Follow-up|1|||
164258606|NCT01728077|593316012|FG001|Overall Study|Lost to Follow-up|0|||
164340188|NCT03345914|593620513|FG001|Overall Study|Physician Decision|1|||
164340189|NCT03345914|593620514|FG002|Overall Study|Physician Decision|1|||
164340190|NCT03345914|593620512|FG000|Overall Study|Withdrawal by Subject|5|||
164340191|NCT03345914|593620513|FG001|Overall Study|Withdrawal by Subject|1|||
164340192|NCT03345914|593620514|FG002|Overall Study|Withdrawal by Subject|2|||
164340193|NCT03345914|593620512|FG000|Overall Study|Other|1|||
164340194|NCT03345914|593620513|FG001|Overall Study|Other|1|||
164340195|NCT03345914|593620514|FG002|Overall Study|Other|1|||
164340196|NCT03345914|593620512|FG000|Overall Study|Ongoing|0|||
164340197|NCT03345914|593620513|FG001|Overall Study|Ongoing|0|||
164340198|NCT03345914|593620514|FG002|Overall Study|Ongoing|1|||
164340199|NCT02601027|593620517|FG000|Registration to Surgery|Withdrawal by Subject|20|||
164340200|NCT02601027|593620518|FG001|Registration to Surgery|Withdrawal by Subject|10|||
164340201|NCT01330030|593620519|FG000|Overall Study|Lost to Follow-up|16|||
164340202|NCT01330030|593620520|FG001|Overall Study|Lost to Follow-up|17|||
164340203|NCT01365052|593620521|FG000|Overall Study|Adverse Event|4|||
164340204|NCT01365052|593620522|FG001|Overall Study|Adverse Event|4|||
164340205|NCT02248701|593620525|FG000|Overall Study|Withdrawal by Subject|2|||
164340206|NCT02248701|593620526|FG001|Overall Study|Withdrawal by Subject|1|||
164340207|NCT02248701|593620525|FG000|Overall Study|Physician Decision|0|||
164340208|NCT02248701|593620526|FG001|Overall Study|Physician Decision|1|||
164340209|NCT02248701|593620525|FG000|Overall Study|Adverse Event|1|||
164340210|NCT02248701|593620526|FG001|Overall Study|Adverse Event|0|||
164340211|NCT02248701|593620525|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
164340212|NCT02248701|593620526|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
164340213|NCT00885846|593620529|FG000|Overall Study|Withdrawal by Subject|2|||
164340214|NCT00885846|593620530|FG001|Overall Study|Withdrawal by Subject|5|||
164340215|NCT00885846|593620531|FG002|Overall Study|Withdrawal by Subject|2|||
164340216|NCT00074984|593620532|FG000|Overall Study|Death|1|||
164340217|NCT00074984|593620533|FG001|Overall Study|Death|2|||
164340218|NCT00074984|593620532|FG000|Overall Study|Withdrawal by Subject|2|||
164340219|NCT00074984|593620533|FG001|Overall Study|Withdrawal by Subject|3|||
164340220|NCT00074984|593620532|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
164340221|NCT00074984|593620533|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
164258607|NCT01728077|593316011|FG000|Overall Study|Subject choice|2|||
164340222|NCT03758443|593620534|FG000|Induction Period|Adverse Event|2|||
164340223|NCT03758443|593620535|FG001|Induction Period|Adverse Event|4|||
164340224|NCT03758443|593620536|FG002|Induction Period|Adverse Event|2|||
164340225|NCT03758443|593620537|FG003|Induction Period|Adverse Event|3|||
164340226|NCT03758443|593620534|FG000|Induction Period|Physician Decision|1|||
164340227|NCT03758443|593620535|FG001|Induction Period|Physician Decision|1|||
164340228|NCT03758443|593620536|FG002|Induction Period|Physician Decision|3|||
164258608|NCT01728077|593316012|FG001|Overall Study|Subject choice|3|||
164258609|NCT01728077|593316011|FG000|Overall Study|Death|0|||
164258610|NCT01728077|593316012|FG001|Overall Study|Death|1|||
164258611|NCT01728077|593316011|FG000|Overall Study|Patient moving|1|||
164258612|NCT01728077|593316012|FG001|Overall Study|Patient moving|0|||
164340229|NCT03758443|593620537|FG003|Induction Period|Physician Decision|0|||
164340230|NCT03758443|593620534|FG000|Induction Period|Protocol Violation|0|||
164340231|NCT03758443|593620535|FG001|Induction Period|Protocol Violation|0|||
164258613|NCT01728077|593316011|FG000|Overall Study|Non compliance|1|||
164258614|NCT01728077|593316012|FG001|Overall Study|Non compliance|0|||
164258615|NCT00378599|593316015|FG000|Overall Study|Adverse Event|38|||
164258616|NCT00378599|593316015|FG000|Overall Study|Protocol Violation|2|||
164258617|NCT00378599|593316015|FG000|Overall Study|Treatment failure|7|||
164258618|NCT00378599|593316015|FG000|Overall Study|Withdrawal by Subject|5|||
164258619|NCT03224507|593316025|FG000|Overall Study|Death|3|||
164258620|NCT03224507|593316026|FG001|Overall Study|Death|0|||
164258621|NCT03224507|593316025|FG000|Overall Study|Lack of Efficacy|6|||
164258622|NCT03224507|593316026|FG001|Overall Study|Lack of Efficacy|0|||
164258623|NCT03224507|593316025|FG000|Overall Study|Withdrawal by Subject|6|||
164258624|NCT03224507|593316026|FG001|Overall Study|Withdrawal by Subject|0|||
164258625|NCT01032291|593316027|FG000|Safety Lead-in|Adverse Event|1|||
164258626|NCT01032291|593316028|FG001|Safety Lead-in|Adverse Event|0|||
164258627|NCT01032291|593316029|FG002|Safety Lead-in|Adverse Event|0|||
164340232|NCT03758443|593620536|FG002|Induction Period|Protocol Violation|0|||
164340233|NCT03758443|593620537|FG003|Induction Period|Protocol Violation|1|||
164340234|NCT03758443|593620534|FG000|Induction Period|Withdrawal by Subject|3|||
164340235|NCT03758443|593620535|FG001|Induction Period|Withdrawal by Subject|2|||
164340236|NCT03758443|593620536|FG002|Induction Period|Withdrawal by Subject|2|||
164340237|NCT03758443|593620537|FG003|Induction Period|Withdrawal by Subject|4|||
164340238|NCT03758443|593620534|FG000|Extended Induction Period|Adverse Event|1|||
164340239|NCT03758443|593620535|FG001|Extended Induction Period|Adverse Event|1|||
164340240|NCT03758443|593620536|FG002|Extended Induction Period|Adverse Event|0|||
164340241|NCT03758443|593620537|FG003|Extended Induction Period|Adverse Event|1|||
164340242|NCT03758443|593620534|FG000|Extended Induction Period|Lost to Follow-up|1|||
164340243|NCT03758443|593620535|FG001|Extended Induction Period|Lost to Follow-up|0|||
164340244|NCT03758443|593620536|FG002|Extended Induction Period|Lost to Follow-up|0|||
164340245|NCT03758443|593620537|FG003|Extended Induction Period|Lost to Follow-up|0|||
164340246|NCT03758443|593620534|FG000|Extended Induction Period|Physician Decision|2|||
164340247|NCT03758443|593620535|FG001|Extended Induction Period|Physician Decision|1|||
164340248|NCT03758443|593620536|FG002|Extended Induction Period|Physician Decision|2|||
164340249|NCT03758443|593620537|FG003|Extended Induction Period|Physician Decision|2|||
164340250|NCT03758443|593620534|FG000|Extended Induction Period|Protocol Violation|0|||
164340251|NCT03758443|593620535|FG001|Extended Induction Period|Protocol Violation|0|||
164340252|NCT03758443|593620536|FG002|Extended Induction Period|Protocol Violation|0|||
164340253|NCT03758443|593620537|FG003|Extended Induction Period|Protocol Violation|1|||
164340254|NCT03758443|593620534|FG000|Extended Induction Period|Withdrawal by Subject|8|||
164340255|NCT03758443|593620535|FG001|Extended Induction Period|Withdrawal by Subject|1|||
164340256|NCT03758443|593620536|FG002|Extended Induction Period|Withdrawal by Subject|7|||
164340257|NCT03758443|593620537|FG003|Extended Induction Period|Withdrawal by Subject|3|||
164340258|NCT03758443|593620534|FG000|Extended Induction Period|Miscellaneous|1|||
164340259|NCT03758443|593620535|FG001|Extended Induction Period|Miscellaneous|0|||
164340260|NCT03758443|593620536|FG002|Extended Induction Period|Miscellaneous|0|||
164340261|NCT03758443|593620537|FG003|Extended Induction Period|Miscellaneous|0|||
164340262|NCT03758443|593620534|FG000|Maintenance Period|Adverse Event|1|||
164340263|NCT03758443|593620535|FG001|Maintenance Period|Adverse Event|2|||
164340264|NCT03758443|593620536|FG002|Maintenance Period|Adverse Event|0|||
164340265|NCT03758443|593620537|FG003|Maintenance Period|Adverse Event|0|||
164340266|NCT03758443|593620534|FG000|Maintenance Period|Lost to Follow-up|0|||
164340267|NCT03758443|593620535|FG001|Maintenance Period|Lost to Follow-up|0|||
164340268|NCT03758443|593620536|FG002|Maintenance Period|Lost to Follow-up|0|||
164340269|NCT03758443|593620537|FG003|Maintenance Period|Lost to Follow-up|1|||
164340270|NCT03758443|593620534|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
164340271|NCT03758443|593620535|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
164340272|NCT03758443|593620536|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
164340273|NCT03758443|593620537|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
164340274|NCT03758443|593620534|FG000|Maintenance Period|Protocol Violation|0|||
164340275|NCT03758443|593620535|FG001|Maintenance Period|Protocol Violation|1|||
164340276|NCT03758443|593620536|FG002|Maintenance Period|Protocol Violation|0|||
164340277|NCT03758443|593620537|FG003|Maintenance Period|Protocol Violation|0|||
164340278|NCT03758443|593620534|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
164340279|NCT03758443|593620535|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
164340280|NCT03758443|593620536|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
164340281|NCT03758443|593620537|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
164258628|NCT01032291|593316027|FG000|Safety Lead-in|Death|1|||
164258629|NCT01032291|593316028|FG001|Safety Lead-in|Death|0|||
164340282|NCT03758443|593620534|FG000|Maintenance Period|Withdrawal by Subject|1|||
164258630|NCT01032291|593316029|FG002|Safety Lead-in|Death|0|||
163888180|NCT01593917|591963270|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
164258631|NCT01032291|593316027|FG000|Proof of Concept|Adverse Event|0|||
164258632|NCT01032291|593316028|FG001|Proof of Concept|Adverse Event|5|||
164258633|NCT01032291|593316029|FG002|Proof of Concept|Adverse Event|1|||
164258634|NCT01032291|593316027|FG000|Proof of Concept|Death|0|||
164258635|NCT01032291|593316028|FG001|Proof of Concept|Death|1|||
164258636|NCT01032291|593316029|FG002|Proof of Concept|Death|2|||
164258637|NCT01032291|593316027|FG000|Proof of Concept|Lack of Efficacy|0|||
164258638|NCT01032291|593316028|FG001|Proof of Concept|Lack of Efficacy|1|||
164258639|NCT01032291|593316029|FG002|Proof of Concept|Lack of Efficacy|0|||
164258640|NCT01032291|593316027|FG000|Proof of Concept|Never Received Study Drug|0|||
164258641|NCT01032291|593316028|FG001|Proof of Concept|Never Received Study Drug|1|||
164258642|NCT01032291|593316029|FG002|Proof of Concept|Never Received Study Drug|0|||
164258643|NCT00347438|593316030|FG000|Overall Study|Withdrawal by Subject|1|||
164258644|NCT00347438|593316030|FG000|Overall Study|Physician Decision|1|||
164258645|NCT01529515|593316033|FG000|TRANSITION PHASE|Adverse Event|16|||
164258646|NCT01529515|593316034|FG001|TRANSITION PHASE|Adverse Event|0|||
164258647|NCT01529515|593316035|FG002|TRANSITION PHASE|Adverse Event|0|||
164258648|NCT01529515|593316036|FG003|TRANSITION PHASE|Adverse Event|0|||
164258649|NCT01529515|593316033|FG000|TRANSITION PHASE|Death|1|||
164258650|NCT01529515|593316034|FG001|TRANSITION PHASE|Death|0|||
164258651|NCT01529515|593316035|FG002|TRANSITION PHASE|Death|0|||
164258652|NCT01529515|593316036|FG003|TRANSITION PHASE|Death|0|||
164258653|NCT01529515|593316033|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
164258654|NCT01529515|593316034|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
164258655|NCT01529515|593316035|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
164258656|NCT01529515|593316036|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
164258657|NCT01529515|593316033|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
164258658|NCT01529515|593316034|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
164258659|NCT01529515|593316035|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
164258660|NCT01529515|593316036|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
164258661|NCT01529515|593316033|FG000|TRANSITION PHASE|Protocol Violation|4|||
164258662|NCT01529515|593316034|FG001|TRANSITION PHASE|Protocol Violation|0|||
164258663|NCT01529515|593316035|FG002|TRANSITION PHASE|Protocol Violation|0|||
164258664|NCT01529515|593316036|FG003|TRANSITION PHASE|Protocol Violation|0|||
164258665|NCT01529515|593316033|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
164258666|NCT01529515|593316034|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
164258667|NCT01529515|593316035|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
164258668|NCT01529515|593316036|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
164258669|NCT01529515|593316033|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
164258670|NCT01529515|593316034|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
164258671|NCT01529515|593316035|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
164258672|NCT01529515|593316036|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
164258673|NCT01529515|593316033|FG000|TRANSITION PHASE|Other|9|||
164258674|NCT01529515|593316034|FG001|TRANSITION PHASE|Other|0|||
164258675|NCT01529515|593316035|FG002|TRANSITION PHASE|Other|0|||
164258676|NCT01529515|593316036|FG003|TRANSITION PHASE|Other|0|||
164258677|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Adverse Event|0|||
164258678|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Adverse Event|10|||
164258679|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Adverse Event|0|||
164258680|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Adverse Event|0|||
164258681|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
164258682|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
164258683|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
164258684|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
164258685|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
164258686|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
164258687|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
164258688|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
164258689|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
164258690|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
164258691|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
164258692|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
163888181|NCT01593917|591963270|FG000|Overall Study|Withdrawal by Subject|23|||
163888182|NCT01593917|591963270|FG000|Overall Study|Lost to Follow-up|12|||
163888183|NCT01593917|591963270|FG000|Overall Study|Protocol Violation|5|||
163888184|NCT01593917|591963270|FG000|Overall Study|Physician Decision|3|||
163888185|NCT02683447|591963274|FG000|Overall Study|Lost to Follow-up|2|||
164340283|NCT03758443|593620535|FG001|Maintenance Period|Withdrawal by Subject|0|||
164258693|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
164258694|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
164258695|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
164258696|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
164258697|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
164258698|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
164258699|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
164258700|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
164258701|NCT01529515|593316033|FG000|MAINTENANCE PHASE|Other|0|||
164258702|NCT01529515|593316034|FG001|MAINTENANCE PHASE|Other|10|||
163992711|NCT02041962|592342081|FG000|Overall Study|Death|1|||
164258703|NCT01529515|593316035|FG002|MAINTENANCE PHASE|Other|0|||
164258704|NCT01529515|593316036|FG003|MAINTENANCE PHASE|Other|0|||
164258705|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
164258706|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
164258707|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
164258708|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
164258709|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
164258710|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
164258711|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
164258712|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
164258713|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
164258714|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
164258715|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
164258716|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
164258717|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
163888186|NCT04663737|591963275|FG000|Overall Study|Withdrawal by Subject|2|||
164258718|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
164258719|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
164258720|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
164258721|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
164258722|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
164258723|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
164258724|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
164258725|NCT01529515|593316033|FG000|DOUBLE BLIND PHASE|Other|0|||
164258726|NCT01529515|593316034|FG001|DOUBLE BLIND PHASE|Other|0|||
164258727|NCT01529515|593316035|FG002|DOUBLE BLIND PHASE|Other|9|||
164258728|NCT01529515|593316036|FG003|DOUBLE BLIND PHASE|Other|2|||
164258729|NCT00322023|593316038|FG000|Overall Study|various|0|||
164258730|NCT00322023|593316039|FG001|Overall Study|various|2|||
164258731|NCT00322023|593316040|FG002|Overall Study|various|6|||
164258732|NCT03327220|593316041|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
164258733|NCT03327220|593316042|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
164258734|NCT03327220|593316041|FG000|Overall Study|Investigator Decision|2|||
164258735|NCT03327220|593316042|FG001|Overall Study|Investigator Decision|0|||
164258736|NCT03327220|593316041|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
164258737|NCT03327220|593316042|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
164258738|NCT03327220|593316041|FG000|Overall Study|Fungal infection|1|||
164258739|NCT03327220|593316042|FG001|Overall Study|Fungal infection|0|||
164258740|NCT03327220|593316041|FG000|Overall Study|Discharged to Rehabilitation|0|||
164258741|NCT03327220|593316042|FG001|Overall Study|Discharged to Rehabilitation|1|||
164258742|NCT03327220|593316041|FG000|Overall Study|Missing|1|||
164258743|NCT03327220|593316042|FG001|Overall Study|Missing|0|||
164258744|NCT03920293|593316043|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
164258745|NCT03920293|593316044|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
164258746|NCT03920293|593316043|FG000|Randomized-Controlled Period|Physician Decision|1|||
164258747|NCT03920293|593316044|FG001|Randomized-Controlled Period|Physician Decision|2|||
164258748|NCT03920293|593316043|FG000|Randomized-Controlled Period|Adverse Event|0|||
164258749|NCT03920293|593316044|FG001|Randomized-Controlled Period|Adverse Event|2|||
164258750|NCT03920293|593316043|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
164258751|NCT03920293|593316044|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
164258752|NCT03920293|593316043|FG000|Randomized-Controlled Period|Death|2|||
164258753|NCT03920293|593316044|FG001|Randomized-Controlled Period|Death|0|||
164258754|NCT03920293|593316043|FG000|Randomized-Controlled Period|Protocol Violation|1|||
164258755|NCT03920293|593316044|FG001|Randomized-Controlled Period|Protocol Violation|0|||
164258756|NCT03920293|593316043|FG000|Randomized-Controlled Period|Noncompliance|1|||
164258757|NCT03920293|593316044|FG001|Randomized-Controlled Period|Noncompliance|0|||
164258758|NCT03920293|593316043|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
164258759|NCT03920293|593316044|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
164258760|NCT03920293|593316043|FG000|Open- Label Extension Period|Death|3|||
164258761|NCT03920293|593316044|FG001|Open- Label Extension Period|Death|3|||
163888187|NCT04663737|591963276|FG001|Overall Study|Withdrawal by Subject|0|||
164258762|NCT03920293|593316043|FG000|Open- Label Extension Period|Physician Decision|5|||
164258763|NCT03920293|593316044|FG001|Open- Label Extension Period|Physician Decision|3|||
164258764|NCT03920293|593316043|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
164258765|NCT03920293|593316044|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
164258766|NCT00523705|593316045|FG000|Overall Study|No time for study.|0|||
164258767|NCT00523705|593316046|FG001|Overall Study|No time for study.|1|||
164258768|NCT00693017|593316047|FG000|Overall Study|Sponsor Decision|2|||
164258769|NCT00693017|593316048|FG001|Overall Study|Sponsor Decision|1|||
164258770|NCT00693017|593316047|FG000|Overall Study|Death|0|||
164258771|NCT00693017|593316048|FG001|Overall Study|Death|1|||
164258772|NCT01691885|593316052|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
164258773|NCT01691885|593316053|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
164258774|NCT01691885|593316052|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
164258775|NCT01691885|593316053|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
164258776|NCT03555981|593316054|FG000|Overall Study|Lost to Follow-up|0|||
164258777|NCT03555981|593316055|FG001|Overall Study|Lost to Follow-up|2|||
164258778|NCT00688324|593316057|FG000|Overall Study|Withdrawal by Subject|2|||
164258779|NCT00688324|593316057|FG000|Overall Study|Physician Decision|5|||
164258780|NCT00688324|593316057|FG000|Overall Study|Lost to Follow-up|1|||
164258781|NCT01972308|593316060|FG000|Overall Study|Withdrawal by Subject|0|||
164258782|NCT01972308|593316061|FG001|Overall Study|Withdrawal by Subject|1|||
164258783|NCT01972308|593316060|FG000|Overall Study|Lost to Follow-up|4|||
164258784|NCT01972308|593316061|FG001|Overall Study|Lost to Follow-up|6|||
164258785|NCT01972308|593316060|FG000|Overall Study|Death|4|||
164258786|NCT01972308|593316061|FG001|Overall Study|Death|1|||
164258787|NCT00847665|593316063|FG000|Overall Study|Withdrawal by Subject|1|||
164258788|NCT00847665|593316064|FG001|Overall Study|Withdrawal by Subject|0|||
164258789|NCT04035564|593316065|FG000|Overall Study|Protocol Violation|1|||
164258790|NCT04035564|593316066|FG001|Overall Study|Protocol Violation|2|||
164258791|NCT04035564|593316065|FG000|Overall Study|No laboratory available|2|||
164258792|NCT04035564|593316066|FG001|Overall Study|No laboratory available|2|||
164258793|NCT04035564|593316065|FG000|Overall Study|Guardian declined consent|1|||
164258794|NCT04035564|593316066|FG001|Overall Study|Guardian declined consent|2|||
164258795|NCT03333252|593316071|FG000|Overall Study|Adverse Event|10|||
164258796|NCT03333252|593316072|FG001|Overall Study|Adverse Event|6|||
164258797|NCT03333252|593316073|FG002|Overall Study|Adverse Event|5|||
164258798|NCT03333252|593316074|FG003|Overall Study|Adverse Event|2|||
164258799|NCT03333252|593316071|FG000|Overall Study|Death|1|||
164258800|NCT03333252|593316072|FG001|Overall Study|Death|3|||
164258801|NCT03333252|593316073|FG002|Overall Study|Death|0|||
164258802|NCT03333252|593316074|FG003|Overall Study|Death|0|||
164258803|NCT03333252|593316071|FG000|Overall Study|Lack of Efficacy|8|||
164258804|NCT03333252|593316072|FG001|Overall Study|Lack of Efficacy|4|||
164258805|NCT03333252|593316073|FG002|Overall Study|Lack of Efficacy|0|||
164258806|NCT03333252|593316074|FG003|Overall Study|Lack of Efficacy|7|||
164258807|NCT03333252|593316071|FG000|Overall Study|Lost to Follow-up|0|||
164258808|NCT03333252|593316072|FG001|Overall Study|Lost to Follow-up|5|||
164258809|NCT03333252|593316073|FG002|Overall Study|Lost to Follow-up|9|||
164258810|NCT03333252|593316074|FG003|Overall Study|Lost to Follow-up|3|||
164258811|NCT03333252|593316071|FG000|Overall Study|Withdrawal by Subject|14|||
164258812|NCT03333252|593316072|FG001|Overall Study|Withdrawal by Subject|24|||
164258813|NCT03333252|593316073|FG002|Overall Study|Withdrawal by Subject|11|||
164258814|NCT03333252|593316074|FG003|Overall Study|Withdrawal by Subject|17|||
164258815|NCT00939029|593316075|FG000|Overall Study|Withdrawal by Subject|3|||
164258816|NCT00939029|593316076|FG001|Overall Study|Withdrawal by Subject|7|||
164258817|NCT00939029|593316075|FG000|Overall Study|Lost to Follow-up|3|||
164258818|NCT00939029|593316076|FG001|Overall Study|Lost to Follow-up|4|||
164258819|NCT00939029|593316075|FG000|Overall Study|Adverse Event|0|||
164258820|NCT00939029|593316076|FG001|Overall Study|Adverse Event|1|||
164258821|NCT04686084|593316077|FG000|Overall Study|Lost to Follow-up|1|||
164258822|NCT01779856|593316079|FG000|Overall Study|Withdrawal by Subject|15|||
164258823|NCT01779856|593316079|FG000|Overall Study|Death|3|||
164258824|NCT01779856|593316079|FG000|Overall Study|Physician Decision|1|||
164258825|NCT01779856|593316079|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
164258826|NCT01779856|593316079|FG000|Overall Study|Delays in scheduling implant|1|||
164258827|NCT01779856|593316079|FG000|Overall Study|Subject ineligible for Implant|2|||
164258828|NCT01425359|593316083|FG000|Overall Study|Randomized but Not Treated|2|||
164258829|NCT01425359|593316084|FG001|Overall Study|Randomized but Not Treated|3|||
164258830|NCT01425359|593316083|FG000|Overall Study|Adverse Event|9|||
164258831|NCT01425359|593316084|FG001|Overall Study|Adverse Event|8|||
164258832|NCT01425359|593316083|FG000|Overall Study|Revascularization|0|||
164258833|NCT01425359|593316084|FG001|Overall Study|Revascularization|1|||
164258834|NCT01425359|593316083|FG000|Overall Study|Death|0|||
164258835|NCT01425359|593316084|FG001|Overall Study|Death|1|||
164258836|NCT01425359|593316083|FG000|Overall Study|Unsatisfactory Response|1|||
164258837|NCT01425359|593316084|FG001|Overall Study|Unsatisfactory Response|0|||
164258838|NCT01425359|593316083|FG000|Overall Study|Protocol Violation|1|||
164258839|NCT01425359|593316084|FG001|Overall Study|Protocol Violation|2|||
164258840|NCT01425359|593316083|FG000|Overall Study|Subject Withdrew Consent|1|||
164258841|NCT01425359|593316084|FG001|Overall Study|Subject Withdrew Consent|2|||
164258842|NCT01425359|593316083|FG000|Overall Study|Investigator's Discretion|2|||
164258843|NCT01425359|593316084|FG001|Overall Study|Investigator's Discretion|0|||
164258844|NCT01425359|593316083|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
164258845|NCT01425359|593316084|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
164258846|NCT03960580|593316085|FG000|Overall Study|Adverse Event|2|||
164258847|NCT03960580|593316086|FG001|Overall Study|Adverse Event|1|||
164258848|NCT03960580|593316087|FG002|Overall Study|Adverse Event|1|||
164258849|NCT03960580|593316085|FG000|Overall Study|Lost to Follow-up|1|||
164258850|NCT03960580|593316086|FG001|Overall Study|Lost to Follow-up|0|||
164258851|NCT03960580|593316087|FG002|Overall Study|Lost to Follow-up|0|||
164258852|NCT03960580|593316085|FG000|Overall Study|Lack of Efficacy|2|||
164258853|NCT03960580|593316086|FG001|Overall Study|Lack of Efficacy|1|||
164258854|NCT03960580|593316087|FG002|Overall Study|Lack of Efficacy|0|||
164258855|NCT03960580|593316085|FG000|Overall Study|Protocol Violation|0|||
164258856|NCT03960580|593316086|FG001|Overall Study|Protocol Violation|0|||
164258857|NCT03960580|593316087|FG002|Overall Study|Protocol Violation|1|||
164258858|NCT03960580|593316085|FG000|Overall Study|Withdrawal by Subject|1|||
164258859|NCT03960580|593316086|FG001|Overall Study|Withdrawal by Subject|1|||
164258860|NCT03960580|593316087|FG002|Overall Study|Withdrawal by Subject|1|||
164258861|NCT03960580|593316085|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
164258862|NCT03960580|593316086|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
164258863|NCT03960580|593316087|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
164258864|NCT02135029|593316092|FG000|Overall Study|Adverse Event|2|||
164258865|NCT02135029|593316093|FG001|Overall Study|Adverse Event|2|||
164258866|NCT02135029|593316094|FG002|Overall Study|Adverse Event|2|||
164258867|NCT02135029|593316092|FG000|Overall Study|Lost to Follow-up|0|||
164258868|NCT02135029|593316093|FG001|Overall Study|Lost to Follow-up|1|||
164258869|NCT02135029|593316094|FG002|Overall Study|Lost to Follow-up|0|||
164258870|NCT02135029|593316092|FG000|Overall Study|Withdrawal by Subject|2|||
164258871|NCT02135029|593316093|FG001|Overall Study|Withdrawal by Subject|0|||
164258872|NCT02135029|593316094|FG002|Overall Study|Withdrawal by Subject|1|||
164258873|NCT02135029|593316092|FG000|Overall Study|Other|0|||
164258874|NCT02135029|593316093|FG001|Overall Study|Other|1|||
164258875|NCT02135029|593316094|FG002|Overall Study|Other|0|||
164258876|NCT02135029|593316092|FG000|Overall Study|Death|0|||
164258877|NCT02135029|593316093|FG001|Overall Study|Death|1|||
164258878|NCT02135029|593316094|FG002|Overall Study|Death|0|||
164258879|NCT03832322|593316097|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
164258880|NCT03832322|593316098|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
164258881|NCT01778049|593316100|FG000|Open Label Treatment Period|Adverse Event|5|||
164258882|NCT01778049|593316101|FG001|Open Label Treatment Period|Adverse Event|15|||
164258883|NCT01778049|593316102|FG002|Open Label Treatment Period|Adverse Event|0|||
164258884|NCT01778049|593316103|FG003|Open Label Treatment Period|Adverse Event|0|||
164258885|NCT01778049|593316104|FG004|Open Label Treatment Period|Adverse Event|0|||
164258886|NCT01778049|593316105|FG005|Open Label Treatment Period|Adverse Event|0|||
164258887|NCT01778049|593316100|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
164258888|NCT01778049|593316101|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
164258889|NCT01778049|593316102|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
164258890|NCT01778049|593316103|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
164340284|NCT03758443|593620536|FG002|Maintenance Period|Withdrawal by Subject|1|||
164340285|NCT03758443|593620537|FG003|Maintenance Period|Withdrawal by Subject|1|||
164340286|NCT03758443|593620534|FG000|Maintenance Period|Miscellaneous|0|||
164340287|NCT03758443|593620535|FG001|Maintenance Period|Miscellaneous|0|||
164340288|NCT03758443|593620536|FG002|Maintenance Period|Miscellaneous|1|||
164340289|NCT03758443|593620537|FG003|Maintenance Period|Miscellaneous|0|||
164258891|NCT01778049|593316104|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
164258892|NCT01778049|593316105|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
164258893|NCT01778049|593316100|FG000|Open Label Treatment Period|Protocol Violation|5|||
164258894|NCT01778049|593316101|FG001|Open Label Treatment Period|Protocol Violation|5|||
164258895|NCT01778049|593316102|FG002|Open Label Treatment Period|Protocol Violation|0|||
164258896|NCT01778049|593316103|FG003|Open Label Treatment Period|Protocol Violation|0|||
164258897|NCT01778049|593316104|FG004|Open Label Treatment Period|Protocol Violation|0|||
164258898|NCT01778049|593316105|FG005|Open Label Treatment Period|Protocol Violation|0|||
164258899|NCT01778049|593316100|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
164258900|NCT01778049|593316101|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
164258901|NCT01778049|593316102|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
164258902|NCT01778049|593316103|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
164258903|NCT01778049|593316104|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
164258904|NCT01778049|593316105|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
164258905|NCT01778049|593316100|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
164258906|NCT01778049|593316101|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
163888188|NCT02489903|591963277|FG000|Screening|Screen Failure|24|||
164258907|NCT01778049|593316102|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
164258908|NCT01778049|593316103|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
164258909|NCT01778049|593316104|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
164258910|NCT01778049|593316105|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
164258911|NCT01778049|593316100|FG000|Open Label Treatment Period|Not treated|2|||
164258912|NCT01778049|593316101|FG001|Open Label Treatment Period|Not treated|1|||
164258913|NCT01778049|593316102|FG002|Open Label Treatment Period|Not treated|0|||
164258914|NCT01778049|593316103|FG003|Open Label Treatment Period|Not treated|0|||
164258915|NCT01778049|593316104|FG004|Open Label Treatment Period|Not treated|0|||
164258916|NCT01778049|593316105|FG005|Open Label Treatment Period|Not treated|0|||
164258917|NCT01778049|593316100|FG000|Open Label Treatment Period|Other reason not defined above|77|||
164258918|NCT01778049|593316101|FG001|Open Label Treatment Period|Other reason not defined above|94|||
164258919|NCT01778049|593316102|FG002|Open Label Treatment Period|Other reason not defined above|0|||
164258920|NCT01778049|593316103|FG003|Open Label Treatment Period|Other reason not defined above|0|||
164258921|NCT01778049|593316104|FG004|Open Label Treatment Period|Other reason not defined above|0|||
164258922|NCT01778049|593316105|FG005|Open Label Treatment Period|Other reason not defined above|0|||
164258923|NCT01778049|593316100|FG000|Double Blind Treatment Period|Adverse Event|0|||
164258924|NCT01778049|593316101|FG001|Double Blind Treatment Period|Adverse Event|0|||
164258925|NCT01778049|593316102|FG002|Double Blind Treatment Period|Adverse Event|4|||
164258926|NCT01778049|593316103|FG003|Double Blind Treatment Period|Adverse Event|5|||
164258927|NCT01778049|593316104|FG004|Double Blind Treatment Period|Adverse Event|3|||
164258928|NCT01778049|593316105|FG005|Double Blind Treatment Period|Adverse Event|2|||
164258929|NCT01778049|593316100|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
164258930|NCT01778049|593316101|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164258931|NCT01778049|593316102|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164258932|NCT01778049|593316103|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
164258933|NCT01778049|593316104|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
164258934|NCT01778049|593316105|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
164258935|NCT01778049|593316100|FG000|Double Blind Treatment Period|Protocol Violation|0|||
164258936|NCT01778049|593316101|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164258937|NCT01778049|593316102|FG002|Double Blind Treatment Period|Protocol Violation|2|||
164258938|NCT01778049|593316103|FG003|Double Blind Treatment Period|Protocol Violation|0|||
164258939|NCT01778049|593316104|FG004|Double Blind Treatment Period|Protocol Violation|0|||
164258940|NCT01778049|593316105|FG005|Double Blind Treatment Period|Protocol Violation|0|||
164258941|NCT01778049|593316100|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
164258942|NCT01778049|593316101|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164258943|NCT01778049|593316102|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
164258944|NCT01778049|593316103|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
164258945|NCT01778049|593316104|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
164258946|NCT01778049|593316105|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
164258947|NCT01778049|593316100|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
164258948|NCT01778049|593316101|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
164258949|NCT01778049|593316102|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
164258950|NCT01778049|593316103|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
164258951|NCT01778049|593316104|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164258952|NCT01778049|593316105|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
164258953|NCT01778049|593316100|FG000|Double Blind Treatment Period|Not treated|0|||
164258954|NCT01778049|593316101|FG001|Double Blind Treatment Period|Not treated|0|||
164258955|NCT01778049|593316102|FG002|Double Blind Treatment Period|Not treated|0|||
164258956|NCT01778049|593316103|FG003|Double Blind Treatment Period|Not treated|2|||
163888189|NCT02489903|591963278|FG001|Screening|Screen Failure|0|||
164258957|NCT01778049|593316104|FG004|Double Blind Treatment Period|Not treated|2|||
164258958|NCT01778049|593316105|FG005|Double Blind Treatment Period|Not treated|0|||
164258959|NCT01778049|593316100|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
164258960|NCT01778049|593316101|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
164258961|NCT01778049|593316102|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
164258962|NCT01778049|593316103|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
163888190|NCT02489903|591963279|FG002|Screening|Screen Failure|0|||
163888191|NCT02489903|591963280|FG003|Screening|Screen Failure|8|||
164258963|NCT01778049|593316104|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
164258964|NCT01778049|593316105|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
164258965|NCT02186652|593316106|FG000|Overall Study|Lost to Follow-up|2|||
164258966|NCT02186652|593316107|FG001|Overall Study|Lost to Follow-up|0|||
164258967|NCT00503776|593316111|FG000|Overall Study|Withdrawal by Subject|1|||
164258968|NCT00503776|593316112|FG001|Overall Study|Withdrawal by Subject|0|||
164258969|NCT00503776|593316113|FG002|Overall Study|Withdrawal by Subject|1|||
164258970|NCT00503776|593316114|FG003|Overall Study|Withdrawal by Subject|1|||
163888192|NCT02489903|591963277|FG000|Randomized and Received Treatment|Protocol Violation|0|||
164258971|NCT00503776|593316111|FG000|Overall Study|Physician Decision|0|||
164258972|NCT00503776|593316112|FG001|Overall Study|Physician Decision|0|||
164258973|NCT00503776|593316113|FG002|Overall Study|Physician Decision|1|||
164258974|NCT00503776|593316114|FG003|Overall Study|Physician Decision|1|||
164258975|NCT00107315|593316115|FG000|Overall Study|Disease Progression|9|||
164258976|NCT00107315|593316115|FG000|Overall Study|Adverse Event|4|||
164258977|NCT00107315|593316115|FG000|Overall Study|Withdrawal by Subject|2|||
164258978|NCT02509039|593316120|FG000|Overall Study|Adverse Event|0|||
164258979|NCT02509039|593316121|FG001|Overall Study|Adverse Event|1|||
164258980|NCT02509039|593316122|FG002|Overall Study|Adverse Event|1|||
164258981|NCT02509039|593316123|FG003|Overall Study|Adverse Event|1|||
164258982|NCT02509039|593316120|FG000|Overall Study|Withdrawal by Subject|0|||
164258983|NCT02509039|593316121|FG001|Overall Study|Withdrawal by Subject|0|||
164258984|NCT02509039|593316122|FG002|Overall Study|Withdrawal by Subject|1|||
164258985|NCT02509039|593316123|FG003|Overall Study|Withdrawal by Subject|0|||
164258986|NCT02509039|593316120|FG000|Overall Study|Progressive disease|2|||
164258987|NCT02509039|593316121|FG001|Overall Study|Progressive disease|2|||
164258988|NCT02509039|593316122|FG002|Overall Study|Progressive disease|1|||
164340290|NCT03080454|593620538|FG000|Baseline|Adverse Event|2|||
164340291|NCT03080454|593620538|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
164340292|NCT03080454|593620538|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
164340293|NCT02747875|593620539|FG000|Overall Study|Physician Decision|1|||
164340294|NCT02747875|593620540|FG001|Overall Study|Physician Decision|0|||
164340295|NCT02747875|593620539|FG000|Overall Study|Adverse Event|0|||
164340296|NCT02747875|593620540|FG001|Overall Study|Adverse Event|1|||
164340297|NCT03863197|593620541|FG000|Overall Study|Lost to Follow-up|2|||
164340298|NCT03863197|593620542|FG001|Overall Study|Lost to Follow-up|3|||
164340299|NCT03863197|593620541|FG000|Overall Study|Withdrawal by Subject|4|||
164340300|NCT03863197|593620542|FG001|Overall Study|Withdrawal by Subject|0|||
164340301|NCT03863197|593620541|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
164340302|NCT03863197|593620542|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
164340303|NCT01781975|593620543|FG000|Overall Study|Death|1|||
164340304|NCT01781975|593620544|FG001|Overall Study|Death|0|||
164340305|NCT01781975|593620543|FG000|Overall Study|Withdrawal by Subject|1|||
163992712|NCT02041962|592342082|FG001|Overall Study|Death|1|||
163992713|NCT02041962|592342081|FG000|Overall Study|Lost to Follow-up|37|||
163992714|NCT02041962|592342082|FG001|Overall Study|Lost to Follow-up|32|||
164258989|NCT02509039|593316123|FG003|Overall Study|Progressive disease|5|||
164258990|NCT02509039|593316120|FG000|Overall Study|Study terminated by Sponsor|1|||
164258991|NCT02509039|593316121|FG001|Overall Study|Study terminated by Sponsor|0|||
164258992|NCT02509039|593316122|FG002|Overall Study|Study terminated by Sponsor|0|||
164258993|NCT02509039|593316123|FG003|Overall Study|Study terminated by Sponsor|0|||
164258994|NCT03359785|593316124|FG000|Overall Study|Protocol Violation|0|||
164258995|NCT03359785|593316125|FG001|Overall Study|Protocol Violation|1|||
164258996|NCT03359785|593316126|FG002|Overall Study|Protocol Violation|0|||
164258997|NCT03359785|593316127|FG003|Overall Study|Protocol Violation|0|||
164258998|NCT03359785|593316124|FG000|Overall Study|Early study termination due to study pause|0|||
164258999|NCT03359785|593316125|FG001|Overall Study|Early study termination due to study pause|0|||
164259000|NCT03359785|593316126|FG002|Overall Study|Early study termination due to study pause|2|||
164259001|NCT03359785|593316127|FG003|Overall Study|Early study termination due to study pause|0|||
164259002|NCT03359785|593316124|FG000|Overall Study|Withdrawal by Subject|2|||
164259003|NCT03359785|593316125|FG001|Overall Study|Withdrawal by Subject|2|||
164259004|NCT03359785|593316126|FG002|Overall Study|Withdrawal by Subject|0|||
164259005|NCT03359785|593316127|FG003|Overall Study|Withdrawal by Subject|0|||
164259006|NCT03276026|593316131|FG000|Overall Study|Protocol Violation|1|||
164259007|NCT03276026|593316132|FG001|Overall Study|Protocol Violation|0|||
164259008|NCT03650803|593316133|FG000|Overall Study|Lost to Follow-up|6|||
164340306|NCT01781975|593620544|FG001|Overall Study|Withdrawal by Subject|1|||
164340307|NCT01622231|593620545|FG000|Overall Study|Physician Decision|1|||
164340308|NCT01622231|593620545|FG000|Overall Study|Withdrawal by Subject|1|||
164340309|NCT01058655|593620546|FG000|Overall Study|Withdrawal by Subject|1|||
163992715|NCT02041962|592342081|FG000|Overall Study|Withdrawal by Subject|0|||
164259009|NCT00252694|593316137|FG000|Overall Study|Withdrawal by Subject|83|||
164259010|NCT00252694|593316138|FG001|Overall Study|Withdrawal by Subject|91|||
164259011|NCT00252694|593316137|FG000|Overall Study|Death|36|||
164259012|NCT00252694|593316138|FG001|Overall Study|Death|34|||
164259013|NCT00252694|593316137|FG000|Overall Study|Mostly Lost to Follow Up|8|||
164259014|NCT00252694|593316138|FG001|Overall Study|Mostly Lost to Follow Up|13|||
164259015|NCT00252694|593316137|FG000|Overall Study|Patient Moving|17|||
163992716|NCT02041962|592342082|FG001|Overall Study|Withdrawal by Subject|11|||
163992717|NCT01686568|592342083|FG000|Main Study|Withdrawal by Subject|1|||
163992718|NCT01686568|592342084|FG001|Main Study|Withdrawal by Subject|3|||
163992719|NCT01686568|592342083|FG000|Main Study|Noncompliance with protocol|0|||
163992720|NCT01686568|592342084|FG001|Main Study|Noncompliance with protocol|1|||
163992721|NCT01686568|592342083|FG000|Main Study|Liver enzymes above range of exclusion|1|||
164259016|NCT00252694|593316138|FG001|Overall Study|Patient Moving|16|||
164259017|NCT00367744|593316140|FG000|Overall Study|Lost to Follow-up|4|||
164259018|NCT00367744|593316141|FG001|Overall Study|Lost to Follow-up|5|||
164259019|NCT03664674|593316142|FG000|Overall Study|Adverse Event|1|||
164259020|NCT03664674|593316143|FG001|Overall Study|Adverse Event|1|||
164259021|NCT03664674|593316142|FG000|Overall Study|Physician Decision|0|||
163992722|NCT01686568|592342084|FG001|Main Study|Liver enzymes above range of exclusion|0|||
163992723|NCT01686568|592342083|FG000|Sub-Study|Not consented for sub-study|2|||
163992724|NCT01686568|592342084|FG001|Sub-Study|Not consented for sub-study|2|||
164259022|NCT03664674|593316143|FG001|Overall Study|Physician Decision|1|||
164259023|NCT03664674|593316142|FG000|Overall Study|Withdrawal by Subject|2|||
163992725|NCT02928952|592342085|FG000|Overall Study|Lost to Follow-up|5|||
163992726|NCT02928952|592342086|FG001|Overall Study|Lost to Follow-up|5|||
164259024|NCT03664674|593316143|FG001|Overall Study|Withdrawal by Subject|0|||
164259025|NCT04584346|593316150|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
164259026|NCT04584346|593316151|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
164259027|NCT03894969|593316160|FG000|Overall Study|Adverse Event|0|||
164259028|NCT03894969|593316161|FG001|Overall Study|Adverse Event|2|||
164259029|NCT03894969|593316162|FG002|Overall Study|Adverse Event|0|||
164259030|NCT03894969|593316163|FG003|Overall Study|Adverse Event|1|||
164259031|NCT03894969|593316164|FG004|Overall Study|Adverse Event|2|||
164259032|NCT03894969|593316160|FG000|Overall Study|Lost to Follow-up|3|||
164259033|NCT03894969|593316161|FG001|Overall Study|Lost to Follow-up|1|||
164259034|NCT03894969|593316162|FG002|Overall Study|Lost to Follow-up|1|||
164259035|NCT03894969|593316163|FG003|Overall Study|Lost to Follow-up|0|||
164259036|NCT03894969|593316164|FG004|Overall Study|Lost to Follow-up|0|||
163888193|NCT02489903|591963278|FG001|Randomized and Received Treatment|Protocol Violation|1|||
163888194|NCT02489903|591963279|FG002|Randomized and Received Treatment|Protocol Violation|0|||
163888195|NCT02489903|591963280|FG003|Randomized and Received Treatment|Protocol Violation|0|||
164259037|NCT03894969|593316160|FG000|Overall Study|Withdrawal by Subject|2|||
164259038|NCT03894969|593316161|FG001|Overall Study|Withdrawal by Subject|1|||
163888196|NCT02489903|591963277|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
163888197|NCT02489903|591963278|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
164259039|NCT03894969|593316162|FG002|Overall Study|Withdrawal by Subject|3|||
164259040|NCT03894969|593316163|FG003|Overall Study|Withdrawal by Subject|4|||
164259041|NCT03894969|593316164|FG004|Overall Study|Withdrawal by Subject|8|||
164259042|NCT03894969|593316160|FG000|Overall Study|Other|0|||
164259043|NCT03894969|593316161|FG001|Overall Study|Other|0|||
164259044|NCT03894969|593316162|FG002|Overall Study|Other|0|||
164259045|NCT03894969|593316163|FG003|Overall Study|Other|0|||
164259046|NCT03894969|593316164|FG004|Overall Study|Other|3|||
163888198|NCT02489903|591963279|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
163888199|NCT02489903|591963280|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
163888200|NCT02489903|591963277|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
163888201|NCT02489903|591963278|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
163888202|NCT02489903|591963279|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
163888203|NCT02489903|591963280|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
163888204|NCT02489903|591963277|FG000|Randomized and Received Treatment|Death|10|||
163888205|NCT02489903|591963278|FG001|Randomized and Received Treatment|Death|1|||
163888206|NCT02489903|591963279|FG002|Randomized and Received Treatment|Death|0|||
163888207|NCT02489903|591963280|FG003|Randomized and Received Treatment|Death|0|||
163888208|NCT03904147|591963285|FG000|Overall Study|Death|15|||
163888209|NCT03904147|591963286|FG001|Overall Study|Death|13|||
163888210|NCT03904147|591963287|FG002|Overall Study|Death|15|||
163888211|NCT03904147|591963285|FG000|Overall Study|Withdrawal by Subject|7|||
163888212|NCT03904147|591963286|FG001|Overall Study|Withdrawal by Subject|12|||
163888213|NCT03904147|591963287|FG002|Overall Study|Withdrawal by Subject|1|||
163888214|NCT03904147|591963285|FG000|Overall Study|1Y visit completed after 365 days|1|||
163888215|NCT03904147|591963286|FG001|Overall Study|1Y visit completed after 365 days|1|||
164259047|NCT03894969|593316160|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
164259048|NCT03894969|593316161|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
164259049|NCT03894969|593316162|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
164259050|NCT03894969|593316163|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
164259051|NCT03894969|593316164|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
163888216|NCT03904147|591963287|FG002|Overall Study|1Y visit completed after 365 days|0|||
163888217|NCT04413708|591963288|FG000|Overall Study|Lost to Follow-up|1|||
163888218|NCT04413708|591963289|FG001|Overall Study|Lost to Follow-up|2|||
164259052|NCT03894969|593316160|FG000|Overall Study|Solicited Adverse Event|0|||
164259053|NCT03894969|593316161|FG001|Overall Study|Solicited Adverse Event|1|||
164259054|NCT03894969|593316162|FG002|Overall Study|Solicited Adverse Event|0|||
164259055|NCT03894969|593316163|FG003|Overall Study|Solicited Adverse Event|0|||
164259056|NCT03894969|593316164|FG004|Overall Study|Solicited Adverse Event|0|||
164259057|NCT02979093|593316165|FG000|First Scan Session|Scanning data problems|1|||
164259058|NCT02979093|593316166|FG001|First Scan Session|Scanning data problems|2|||
164259059|NCT02979093|593316167|FG002|First Scan Session|Scanning data problems|2|||
164259060|NCT02979093|593316168|FG003|First Scan Session|Scanning data problems|0|||
164259061|NCT02979093|593316165|FG000|Second Scan Session|Scanning data problems|3|||
164259062|NCT02979093|593316166|FG001|Second Scan Session|Scanning data problems|0|||
164259063|NCT02979093|593316167|FG002|Second Scan Session|Scanning data problems|1|||
164259064|NCT02979093|593316168|FG003|Second Scan Session|Scanning data problems|3|||
164340310|NCT01058655|593620547|FG001|Overall Study|Withdrawal by Subject|0|||
164340311|NCT01058655|593620548|FG002|Overall Study|Withdrawal by Subject|3|||
164340312|NCT01058655|593620549|FG003|Overall Study|Withdrawal by Subject|4|||
164340313|NCT01058655|593620546|FG000|Overall Study|Prolonged Treatment Delay|0|||
164340314|NCT01058655|593620547|FG001|Overall Study|Prolonged Treatment Delay|0|||
164340315|NCT01058655|593620548|FG002|Overall Study|Prolonged Treatment Delay|0|||
164340316|NCT01058655|593620549|FG003|Overall Study|Prolonged Treatment Delay|2|||
164340317|NCT01058655|593620546|FG000|Overall Study|Symptomatic Deterioration|0|||
164340318|NCT01058655|593620547|FG001|Overall Study|Symptomatic Deterioration|0|||
164340319|NCT01058655|593620548|FG002|Overall Study|Symptomatic Deterioration|0|||
164340320|NCT01058655|593620549|FG003|Overall Study|Symptomatic Deterioration|1|||
164340321|NCT01058655|593620546|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
164340322|NCT01058655|593620547|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
164340323|NCT01058655|593620548|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
164340324|NCT01058655|593620549|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
164340325|NCT01058655|593620546|FG000|Overall Study|Death|0|||
164340326|NCT01058655|593620547|FG001|Overall Study|Death|1|||
164340327|NCT01058655|593620548|FG002|Overall Study|Death|1|||
164340328|NCT01058655|593620549|FG003|Overall Study|Death|0|||
164340329|NCT01058655|593620546|FG000|Overall Study|Disease Progression|1|||
164340330|NCT01058655|593620547|FG001|Overall Study|Disease Progression|2|||
164340331|NCT01058655|593620548|FG002|Overall Study|Disease Progression|4|||
164340332|NCT01058655|593620549|FG003|Overall Study|Disease Progression|24|||
164340333|NCT01058655|593620546|FG000|Overall Study|Other|0|||
164340334|NCT01058655|593620547|FG001|Overall Study|Other|0|||
164340335|NCT01058655|593620548|FG002|Overall Study|Other|0|||
164340336|NCT01058655|593620549|FG003|Overall Study|Other|4|||
164340337|NCT04545060|593620550|FG000|Overall Study|Adverse Event|0|||
164340338|NCT04545060|593620551|FG001|Overall Study|Adverse Event|1|||
164340339|NCT04545060|593620550|FG000|Overall Study|Death|0|||
164340340|NCT04545060|593620551|FG001|Overall Study|Death|5|||
164340341|NCT04545060|593620550|FG000|Overall Study|Lost to Follow-up|10|||
164340342|NCT04545060|593620551|FG001|Overall Study|Lost to Follow-up|13|||
164340343|NCT04545060|593620550|FG000|Overall Study|Physician Decision|3|||
164340344|NCT04545060|593620551|FG001|Overall Study|Physician Decision|0|||
164340345|NCT04545060|593620550|FG000|Overall Study|Withdrawal by Subject|17|||
164340346|NCT04545060|593620551|FG001|Overall Study|Withdrawal by Subject|22|||
164340347|NCT02939079|593620552|FG000|Overall Study|Adverse Event|2|||
164340348|NCT02939079|593620553|FG001|Overall Study|Adverse Event|1|||
164340349|NCT02939079|593620552|FG000|Overall Study|Lost to Follow-up|0|||
164340350|NCT02939079|593620553|FG001|Overall Study|Lost to Follow-up|2|||
164340351|NCT02939079|593620552|FG000|Overall Study|Protocol Violation|1|||
164340352|NCT02939079|593620553|FG001|Overall Study|Protocol Violation|0|||
164340353|NCT02939079|593620552|FG000|Overall Study|Withdrawal by Subject|0|||
164340354|NCT02939079|593620553|FG001|Overall Study|Withdrawal by Subject|1|||
164340355|NCT02939079|593620552|FG000|Overall Study|relapse during the study|1|||
164340356|NCT02939079|593620553|FG001|Overall Study|relapse during the study|1|||
164340357|NCT00973674|593620554|FG000|Overall Study|Protocol Violation|2|||
164340358|NCT00973674|593620555|FG001|Overall Study|Protocol Violation|0|||
164340359|NCT02846324|593620565|FG000|Overall Study|Other|1|||
164340360|NCT02846324|593620566|FG001|Overall Study|Other|0|||
164340361|NCT02846324|593620567|FG002|Overall Study|Other|0|||
164340362|NCT02846324|593620568|FG003|Overall Study|Other|0|||
163888219|NCT04599062|591963290|FG000|Overall Study|Physician Decision|1|||
163888220|NCT04599062|591963291|FG001|Overall Study|Physician Decision|0|||
163888221|NCT06103188|591963298|FG000|Overall Study|Lost to Follow-up|1|||
164259065|NCT02308163|593316169|FG000|Overall Study|Not fulfill eligible criteria|1|||
164259066|NCT02308163|593316170|FG001|Overall Study|Not fulfill eligible criteria|2|||
164340363|NCT02846324|593620565|FG000|Overall Study|Withdrawal by Subject|1|||
164340364|NCT02846324|593620566|FG001|Overall Study|Withdrawal by Subject|0|||
164340365|NCT02846324|593620567|FG002|Overall Study|Withdrawal by Subject|4|||
164340366|NCT02846324|593620568|FG003|Overall Study|Withdrawal by Subject|0|||
163992727|NCT02928952|592342085|FG000|Overall Study|Withdrawal by Subject|5|||
164259067|NCT02308163|593316171|FG002|Overall Study|Not fulfill eligible criteria|0|||
164259068|NCT02308163|593316172|FG003|Overall Study|Not fulfill eligible criteria|1|||
164259069|NCT02308163|593316173|FG004|Overall Study|Not fulfill eligible criteria|1|||
164259070|NCT02308163|593316169|FG000|Overall Study|Adverse Event|9|||
164259071|NCT02308163|593316170|FG001|Overall Study|Adverse Event|5|||
164259072|NCT02308163|593316171|FG002|Overall Study|Adverse Event|2|||
164259073|NCT02308163|593316172|FG003|Overall Study|Adverse Event|2|||
164259074|NCT02308163|593316173|FG004|Overall Study|Adverse Event|11|||
164259075|NCT02308163|593316169|FG000|Overall Study|Lack of Efficacy|11|||
164259076|NCT02308163|593316170|FG001|Overall Study|Lack of Efficacy|3|||
164259077|NCT02308163|593316171|FG002|Overall Study|Lack of Efficacy|8|||
164259078|NCT02308163|593316172|FG003|Overall Study|Lack of Efficacy|4|||
164259079|NCT02308163|593316173|FG004|Overall Study|Lack of Efficacy|6|||
164259080|NCT02308163|593316169|FG000|Overall Study|Withdrawal of consent|2|||
164259081|NCT02308163|593316170|FG001|Overall Study|Withdrawal of consent|3|||
164259082|NCT02308163|593316171|FG002|Overall Study|Withdrawal of consent|0|||
164259083|NCT02308163|593316172|FG003|Overall Study|Withdrawal of consent|2|||
164259084|NCT02308163|593316173|FG004|Overall Study|Withdrawal of consent|6|||
164259085|NCT02308163|593316169|FG000|Overall Study|Protocol Violation|3|||
164259086|NCT02308163|593316170|FG001|Overall Study|Protocol Violation|3|||
164259087|NCT02308163|593316171|FG002|Overall Study|Protocol Violation|3|||
164259088|NCT02308163|593316172|FG003|Overall Study|Protocol Violation|2|||
164259089|NCT02308163|593316173|FG004|Overall Study|Protocol Violation|5|||
164259090|NCT02308163|593316169|FG000|Overall Study|Lab data met discontinuation criteria|3|||
164259091|NCT02308163|593316170|FG001|Overall Study|Lab data met discontinuation criteria|0|||
164259092|NCT02308163|593316171|FG002|Overall Study|Lab data met discontinuation criteria|0|||
164259093|NCT02308163|593316172|FG003|Overall Study|Lab data met discontinuation criteria|2|||
164259094|NCT02308163|593316173|FG004|Overall Study|Lab data met discontinuation criteria|0|||
164259095|NCT02308163|593316169|FG000|Overall Study|Miscellaneous|2|||
164259096|NCT02308163|593316170|FG001|Overall Study|Miscellaneous|2|||
164259097|NCT02308163|593316171|FG002|Overall Study|Miscellaneous|1|||
164259098|NCT02308163|593316172|FG003|Overall Study|Miscellaneous|0|||
164259099|NCT02308163|593316173|FG004|Overall Study|Miscellaneous|5|||
164259100|NCT00443053|593316175|FG000|Overall Study|Adverse Event|2|||
164259101|NCT00443053|593316176|FG001|Overall Study|Adverse Event|1|||
164259102|NCT00443053|593316175|FG000|Overall Study|Withdrawal by Subject|9|||
164259103|NCT00443053|593316176|FG001|Overall Study|Withdrawal by Subject|18|||
164259104|NCT00443053|593316175|FG000|Overall Study|Lost to Follow-up|4|||
164259105|NCT00443053|593316176|FG001|Overall Study|Lost to Follow-up|5|||
164259106|NCT00443053|593316175|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
164259107|NCT00443053|593316176|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164259108|NCT00443053|593316175|FG000|Overall Study|Noncompliance|2|||
164259109|NCT00443053|593316176|FG001|Overall Study|Noncompliance|1|||
164259110|NCT00443053|593316175|FG000|Overall Study|Other|3|||
164259111|NCT00443053|593316176|FG001|Overall Study|Other|4|||
164259112|NCT00443053|593316175|FG000|Overall Study|Physician Decision|0|||
164259113|NCT00443053|593316176|FG001|Overall Study|Physician Decision|4|||
164259114|NCT00541866|593316177|FG000|Overall Study|Adverse Event|3|||
164259115|NCT00541866|593316178|FG001|Overall Study|Adverse Event|0|||
164259116|NCT00541866|593316179|FG002|Overall Study|Adverse Event|0|||
164259117|NCT00541866|593316180|FG003|Overall Study|Adverse Event|0|||
164259118|NCT00541866|593316181|FG004|Overall Study|Adverse Event|0|||
164259119|NCT00541866|593316177|FG000|Overall Study|Death|1|||
164259120|NCT00541866|593316178|FG001|Overall Study|Death|0|||
164259121|NCT00541866|593316179|FG002|Overall Study|Death|0|||
164259122|NCT00541866|593316180|FG003|Overall Study|Death|0|||
164259123|NCT00541866|593316181|FG004|Overall Study|Death|0|||
164340367|NCT00516074|593620575|FG000|Overall Study|Adverse Event|0|||
164340368|NCT00516074|593620576|FG001|Overall Study|Adverse Event|1|||
164340369|NCT00516074|593620575|FG000|Overall Study|Subject Decision|4|||
164340370|NCT00516074|593620576|FG001|Overall Study|Subject Decision|2|||
163992728|NCT02928952|592342086|FG001|Overall Study|Withdrawal by Subject|1|||
164259124|NCT00541866|593316177|FG000|Overall Study|Lack of Efficacy|19|||
164259125|NCT00541866|593316178|FG001|Overall Study|Lack of Efficacy|15|||
164259126|NCT00541866|593316179|FG002|Overall Study|Lack of Efficacy|10|||
164259127|NCT00541866|593316180|FG003|Overall Study|Lack of Efficacy|12|||
164259128|NCT00541866|593316181|FG004|Overall Study|Lack of Efficacy|14|||
164259129|NCT00541866|593316177|FG000|Overall Study|Not Reported or Other|11|||
164259130|NCT00541866|593316178|FG001|Overall Study|Not Reported or Other|3|||
164259131|NCT00541866|593316179|FG002|Overall Study|Not Reported or Other|3|||
164340371|NCT00516074|593620575|FG000|Overall Study|Loss of Glucose Control|2|||
164340372|NCT00516074|593620576|FG001|Overall Study|Loss of Glucose Control|0|||
164259132|NCT00541866|593316180|FG003|Overall Study|Not Reported or Other|3|||
164259133|NCT00541866|593316181|FG004|Overall Study|Not Reported or Other|1|||
164259134|NCT00541866|593316177|FG000|Overall Study|Physician Decision|0|||
164259135|NCT00541866|593316178|FG001|Overall Study|Physician Decision|0|||
164259136|NCT00541866|593316179|FG002|Overall Study|Physician Decision|2|||
164259137|NCT00541866|593316180|FG003|Overall Study|Physician Decision|1|||
164259138|NCT00541866|593316181|FG004|Overall Study|Physician Decision|0|||
164259139|NCT00522418|593316182|FG000|Overall Study|Local IRB Consent Violation|5|||
164259140|NCT00522418|593316183|FG001|Overall Study|Local IRB Consent Violation|5|||
163888222|NCT06103188|591963299|FG001|Overall Study|Lost to Follow-up|6|||
163888223|NCT06103188|591963300|FG002|Overall Study|Lost to Follow-up|4|||
163888224|NCT04436276|591963310|FG000|Overall Study|Adverse Event|0|||
163888225|NCT04436276|591963311|FG001|Overall Study|Adverse Event|0|||
163888226|NCT04436276|591963312|FG002|Overall Study|Adverse Event|0|||
164259141|NCT00522418|593316182|FG000|Overall Study|Early Study Termination|46|||
164259142|NCT00522418|593316183|FG001|Overall Study|Early Study Termination|47|||
164259143|NCT00522418|593316182|FG000|Overall Study|Noncompliance|2|||
164259144|NCT00522418|593316183|FG001|Overall Study|Noncompliance|2|||
163888227|NCT04436276|591963313|FG003|Overall Study|Adverse Event|0|||
163888228|NCT04436276|591963314|FG004|Overall Study|Adverse Event|0|||
163888229|NCT04436276|591963315|FG005|Overall Study|Adverse Event|0|||
164259145|NCT00522418|593316182|FG000|Overall Study|Reason Not Specified|3|||
164259146|NCT00522418|593316183|FG001|Overall Study|Reason Not Specified|1|||
164259147|NCT00522418|593316182|FG000|Overall Study|Consent Withdraw|1|||
163888230|NCT04436276|591963316|FG006|Overall Study|Adverse Event|0|||
164259148|NCT00522418|593316183|FG001|Overall Study|Consent Withdraw|2|||
164259149|NCT00522418|593316182|FG000|Overall Study|Lack of Efficacy|0|||
164259150|NCT00522418|593316183|FG001|Overall Study|Lack of Efficacy|1|||
163888231|NCT04436276|591963317|FG007|Overall Study|Adverse Event|0|||
163888232|NCT04436276|591963318|FG008|Overall Study|Adverse Event|0|||
163888233|NCT04436276|591963319|FG009|Overall Study|Adverse Event|0|||
164259151|NCT02438683|593316184|FG000|Overall Study|Adverse Event|1|||
164259152|NCT02438683|593316185|FG001|Overall Study|Adverse Event|0|||
164259153|NCT02438683|593316186|FG002|Overall Study|Adverse Event|0|||
164259154|NCT02438683|593316187|FG003|Overall Study|Adverse Event|0|||
164259155|NCT02438683|593316188|FG004|Overall Study|Adverse Event|0|||
164259156|NCT02438683|593316189|FG005|Overall Study|Adverse Event|0|||
164259157|NCT00082368|593316194|FG000|Overall Study|Not treated-pt had poor IV access|1|||
164259158|NCT02825420|593316196|FG000|Overall Study|Death|30|||
164259159|NCT02825420|593316197|FG001|Overall Study|Death|12|||
164259160|NCT02825420|593316196|FG000|Overall Study|Progressive disease|6|||
164259161|NCT02825420|593316197|FG001|Overall Study|Progressive disease|1|||
164259162|NCT02825420|593316196|FG000|Overall Study|Lost to Follow-up|2|||
164259163|NCT02825420|593316197|FG001|Overall Study|Lost to Follow-up|2|||
164259164|NCT02825420|593316196|FG000|Overall Study|Withdrawal by Subject|1|||
164259165|NCT02825420|593316197|FG001|Overall Study|Withdrawal by Subject|1|||
164259166|NCT02825420|593316196|FG000|Overall Study|Protocol amendment not signed|1|||
164259167|NCT02825420|593316197|FG001|Overall Study|Protocol amendment not signed|1|||
164259168|NCT02825420|593316196|FG000|Overall Study|Physician Decision|1|||
164259169|NCT02825420|593316197|FG001|Overall Study|Physician Decision|0|||
164259170|NCT02825420|593316196|FG000|Overall Study|Did not receive PLD|2|||
164259171|NCT02825420|593316197|FG001|Overall Study|Did not receive PLD|0|||
164259172|NCT00445939|593318374|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
164259173|NCT00445939|593318375|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
164259174|NCT00445939|593318376|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
164259175|NCT00445939|593318377|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
164259176|NCT00445939|593318374|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
164259177|NCT00445939|593318375|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
164259178|NCT00445939|593318376|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
164259179|NCT00445939|593318377|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
164259180|NCT00416715|593318378|FG000|Overall Study|Not evaluable for joint aches|7|||
164259181|NCT00416715|593318378|FG000|Overall Study|Vitamin D levels not evaluable|8|||
164259182|NCT01007435|593318380|FG000|Overall Study|Adverse Event|16|||
164259183|NCT01007435|593318381|FG001|Overall Study|Adverse Event|25|||
164259184|NCT01007435|593318382|FG002|Overall Study|Adverse Event|47|||
164259185|NCT01007435|593318383|FG003|Overall Study|Adverse Event|31|||
164259186|NCT01007435|593318380|FG000|Overall Study|Death|2|||
164259187|NCT01007435|593318381|FG001|Overall Study|Death|4|||
164259188|NCT01007435|593318382|FG002|Overall Study|Death|2|||
164259189|NCT01007435|593318383|FG003|Overall Study|Death|1|||
164259190|NCT01007435|593318380|FG000|Overall Study|Insufficient Therapeutic Response|21|||
164259191|NCT01007435|593318381|FG001|Overall Study|Insufficient Therapeutic Response|7|||
164259192|NCT01007435|593318382|FG002|Overall Study|Insufficient Therapeutic Response|2|||
164259193|NCT01007435|593318383|FG003|Overall Study|Insufficient Therapeutic Response|9|||
164259194|NCT01007435|593318380|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
164259195|NCT01007435|593318381|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
164259196|NCT01007435|593318382|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
164259197|NCT01007435|593318383|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
164259198|NCT01007435|593318380|FG000|Overall Study|Other Protocol Violation|2|||
164259199|NCT01007435|593318381|FG001|Overall Study|Other Protocol Violation|0|||
164259200|NCT01007435|593318382|FG002|Overall Study|Other Protocol Violation|1|||
164259201|NCT01007435|593318383|FG003|Overall Study|Other Protocol Violation|0|||
164259202|NCT01007435|593318380|FG000|Overall Study|Refused Treatment|13|||
164259203|NCT01007435|593318381|FG001|Overall Study|Refused Treatment|13|||
164259204|NCT01007435|593318382|FG002|Overall Study|Refused Treatment|5|||
164259205|NCT01007435|593318383|FG003|Overall Study|Refused Treatment|8|||
164259206|NCT01007435|593318380|FG000|Overall Study|Failure to Return|5|||
164259207|NCT01007435|593318381|FG001|Overall Study|Failure to Return|4|||
164259208|NCT01007435|593318382|FG002|Overall Study|Failure to Return|3|||
164259209|NCT01007435|593318383|FG003|Overall Study|Failure to Return|6|||
164259210|NCT01007435|593318380|FG000|Overall Study|Reason not Specified|1|||
164259211|NCT01007435|593318381|FG001|Overall Study|Reason not Specified|1|||
164259212|NCT01007435|593318382|FG002|Overall Study|Reason not Specified|2|||
164259213|NCT01007435|593318383|FG003|Overall Study|Reason not Specified|1|||
164259214|NCT02576535|593318384|FG000|Overall Study|Withdrawal by Subject|2|||
164340373|NCT00810355|593620578|FG000|Overall Study|Lost to Follow-up|13|||
164340374|NCT00810355|593620579|FG001|Overall Study|Lost to Follow-up|17|||
164340375|NCT00810355|593620580|FG002|Overall Study|Lost to Follow-up|11|||
164340376|NCT00810355|593620578|FG000|Overall Study|Withdrawal by Subject|1|||
164340377|NCT00810355|593620579|FG001|Overall Study|Withdrawal by Subject|0|||
164259215|NCT02545517|593318385|FG000|Overall Study|Death|2|||
164259216|NCT02545517|593318386|FG001|Overall Study|Death|2|||
164259217|NCT02545517|593318387|FG002|Overall Study|Death|1|||
164259218|NCT02545517|593318385|FG000|Overall Study|Lost to Follow-up|14|||
164259219|NCT02545517|593318386|FG001|Overall Study|Lost to Follow-up|13|||
164259220|NCT02545517|593318387|FG002|Overall Study|Lost to Follow-up|17|||
164259221|NCT02545517|593318385|FG000|Overall Study|Protocol Violation|0|||
164259222|NCT02545517|593318386|FG001|Overall Study|Protocol Violation|1|||
164259223|NCT02545517|593318387|FG002|Overall Study|Protocol Violation|1|||
164259224|NCT02545517|593318385|FG000|Overall Study|Withdrawal by Subject|5|||
164259225|NCT02545517|593318386|FG001|Overall Study|Withdrawal by Subject|8|||
164259226|NCT02545517|593318387|FG002|Overall Study|Withdrawal by Subject|9|||
164259227|NCT02545517|593318385|FG000|Overall Study|Administrative reason|5|||
164259228|NCT02545517|593318386|FG001|Overall Study|Administrative reason|6|||
164259229|NCT02545517|593318387|FG002|Overall Study|Administrative reason|10|||
164259230|NCT02545517|593318385|FG000|Overall Study|Other|2|||
164259231|NCT02545517|593318386|FG001|Overall Study|Other|4|||
164259232|NCT02545517|593318387|FG002|Overall Study|Other|3|||
164259233|NCT03334851|593318388|FG000|Overall Study|Other|0|||
164259234|NCT03334851|593318389|FG001|Overall Study|Other|0|||
164259235|NCT03334851|593318390|FG002|Overall Study|Other|0|||
164259236|NCT03334851|593318391|FG003|Overall Study|Other|0|||
164259237|NCT03334851|593318392|FG004|Overall Study|Other|0|||
164259238|NCT03334851|593318393|FG005|Overall Study|Other|0|||
164259239|NCT03334851|593318394|FG006|Overall Study|Other|0|||
164259240|NCT03334851|593318395|FG007|Overall Study|Other|1|||
164259241|NCT03334851|593318396|FG008|Overall Study|Other|0|||
164259242|NCT03334851|593318397|FG009|Overall Study|Other|0|||
164259243|NCT03334851|593318398|FG010|Overall Study|Other|0|||
164259244|NCT03334851|593318399|FG011|Overall Study|Other|0|||
164259245|NCT03334851|593318400|FG012|Overall Study|Other|0|||
164259246|NCT03334851|593318388|FG000|Overall Study|Adverse Event|0|||
164259247|NCT03334851|593318389|FG001|Overall Study|Adverse Event|0|||
164259248|NCT03334851|593318390|FG002|Overall Study|Adverse Event|0|||
164259249|NCT03334851|593318391|FG003|Overall Study|Adverse Event|0|||
164259250|NCT03334851|593318392|FG004|Overall Study|Adverse Event|0|||
164259251|NCT03334851|593318393|FG005|Overall Study|Adverse Event|0|||
164259252|NCT03334851|593318394|FG006|Overall Study|Adverse Event|0|||
164259253|NCT03334851|593318395|FG007|Overall Study|Adverse Event|1|||
164259254|NCT03334851|593318396|FG008|Overall Study|Adverse Event|0|||
164259255|NCT03334851|593318397|FG009|Overall Study|Adverse Event|0|||
164259256|NCT03334851|593318398|FG010|Overall Study|Adverse Event|0|||
164259257|NCT03334851|593318399|FG011|Overall Study|Adverse Event|0|||
164259258|NCT03334851|593318400|FG012|Overall Study|Adverse Event|0|||
164259259|NCT03334851|593318388|FG000|Overall Study|Withdrawal by Subject|0|||
164259260|NCT03334851|593318389|FG001|Overall Study|Withdrawal by Subject|0|||
164259261|NCT03334851|593318390|FG002|Overall Study|Withdrawal by Subject|0|||
164259262|NCT03334851|593318391|FG003|Overall Study|Withdrawal by Subject|0|||
164259263|NCT03334851|593318392|FG004|Overall Study|Withdrawal by Subject|0|||
164259264|NCT03334851|593318393|FG005|Overall Study|Withdrawal by Subject|0|||
164259265|NCT03334851|593318394|FG006|Overall Study|Withdrawal by Subject|0|||
164259266|NCT03334851|593318395|FG007|Overall Study|Withdrawal by Subject|0|||
164259267|NCT03334851|593318396|FG008|Overall Study|Withdrawal by Subject|0|||
164259268|NCT03334851|593318397|FG009|Overall Study|Withdrawal by Subject|0|||
164259269|NCT03334851|593318398|FG010|Overall Study|Withdrawal by Subject|1|||
164259270|NCT03334851|593318399|FG011|Overall Study|Withdrawal by Subject|0|||
164259271|NCT03334851|593318400|FG012|Overall Study|Withdrawal by Subject|1|||
164259272|NCT03334851|593318388|FG000|Overall Study|Lost to Follow-up|0|||
164259273|NCT03334851|593318389|FG001|Overall Study|Lost to Follow-up|0|||
164259274|NCT03334851|593318390|FG002|Overall Study|Lost to Follow-up|0|||
164259275|NCT03334851|593318391|FG003|Overall Study|Lost to Follow-up|0|||
164259276|NCT03334851|593318392|FG004|Overall Study|Lost to Follow-up|0|||
164259277|NCT03334851|593318393|FG005|Overall Study|Lost to Follow-up|0|||
164259278|NCT03334851|593318394|FG006|Overall Study|Lost to Follow-up|0|||
164259279|NCT03334851|593318395|FG007|Overall Study|Lost to Follow-up|0|||
164259280|NCT03334851|593318396|FG008|Overall Study|Lost to Follow-up|0|||
164259281|NCT03334851|593318397|FG009|Overall Study|Lost to Follow-up|0|||
164259282|NCT03334851|593318398|FG010|Overall Study|Lost to Follow-up|2|||
164259283|NCT03334851|593318399|FG011|Overall Study|Lost to Follow-up|1|||
164259284|NCT03334851|593318400|FG012|Overall Study|Lost to Follow-up|0|||
164340378|NCT00810355|593620580|FG002|Overall Study|Withdrawal by Subject|0|||
164340379|NCT04154930|593620588|FG000|Overall Study|Withdrawal by Subject|15|||
164340380|NCT04154930|593620589|FG001|Overall Study|Withdrawal by Subject|6|||
163888234|NCT04436276|591963320|FG010|Overall Study|Adverse Event|0|||
163888235|NCT04436276|591963321|FG011|Overall Study|Adverse Event|0|||
163888236|NCT04436276|591963322|FG012|Overall Study|Adverse Event|0|||
163888237|NCT04436276|591963323|FG013|Overall Study|Adverse Event|0|||
163888238|NCT04436276|591963324|FG014|Overall Study|Adverse Event|0|||
163888239|NCT04436276|591963325|FG015|Overall Study|Adverse Event|0|||
163888240|NCT04436276|591963326|FG016|Overall Study|Adverse Event|1|||
164259285|NCT00396136|593318404|FG000|Overall Study|Death|43|||
163888241|NCT04436276|591963327|FG017|Overall Study|Adverse Event|0|||
164259286|NCT00396136|593318404|FG000|Overall Study|Withdrawal by Subject|59|||
164259287|NCT00396136|593318404|FG000|Overall Study|Lost to Follow-up|15|||
164259288|NCT00396136|593318404|FG000|Overall Study|Study device explanted|8|||
164259289|NCT03172325|593318408|FG000|Overall Study|Adverse Event|2|||
164259290|NCT03172325|593318409|FG001|Overall Study|Adverse Event|3|||
164259291|NCT03172325|593318408|FG000|Overall Study|Positive PPD|1|||
164259292|NCT03172325|593318409|FG001|Overall Study|Positive PPD|0|||
164259293|NCT03172325|593318408|FG000|Overall Study|Poor Compliance|1|||
164259294|NCT03172325|593318409|FG001|Overall Study|Poor Compliance|1|||
164259295|NCT00385944|593318415|FG000|1st Maintenance Dose Period|Physician Decision|1|||
164259296|NCT00385944|593318416|FG001|1st Maintenance Dose Period|Physician Decision|0|||
164259297|NCT00385944|593318417|FG002|1st Maintenance Dose Period|Physician Decision|0|||
164259298|NCT00385944|593318415|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
164259299|NCT00385944|593318416|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
164259300|NCT00385944|593318417|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
164259301|NCT00385944|593318415|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
164259302|NCT00385944|593318416|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
164259303|NCT00385944|593318417|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
164259304|NCT00385944|593318415|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
164259305|NCT00385944|593318416|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
164259306|NCT00385944|593318417|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
164259307|NCT00823212|593318418|FG000|Overall Study|Death|8|||
164259308|NCT00823212|593318419|FG001|Overall Study|Death|10|||
164259309|NCT00823212|593318418|FG000|Overall Study|Withdrawal by Subject|6|||
164259310|NCT00823212|593318419|FG001|Overall Study|Withdrawal by Subject|1|||
164259311|NCT00823212|593318418|FG000|Overall Study|Incarcerated|0|||
164259312|NCT00823212|593318419|FG001|Overall Study|Incarcerated|1|||
164259313|NCT00823212|593318418|FG000|Overall Study|Missed 12-month visit|21|||
164259314|NCT00823212|593318419|FG001|Overall Study|Missed 12-month visit|21|||
164259315|NCT01694121|593318420|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
164259316|NCT01694121|593318421|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
164259317|NCT00521599|593318422|FG000|Overall Study|Adverse Event|5|||
164259318|NCT00521599|593318423|FG001|Overall Study|Adverse Event|7|||
164259319|NCT00521599|593318424|FG002|Overall Study|Adverse Event|6|||
164259320|NCT00521599|593318422|FG000|Overall Study|Treatment Failure|8|||
164259321|NCT00521599|593318423|FG001|Overall Study|Treatment Failure|9|||
164259322|NCT00521599|593318424|FG002|Overall Study|Treatment Failure|22|||
164259323|NCT00521599|593318422|FG000|Overall Study|Lost to Follow-up|2|||
164259324|NCT00521599|593318423|FG001|Overall Study|Lost to Follow-up|1|||
164259325|NCT00521599|593318424|FG002|Overall Study|Lost to Follow-up|2|||
164259326|NCT00521599|593318422|FG000|Overall Study|Withdrawal by Subject|3|||
164259327|NCT00521599|593318423|FG001|Overall Study|Withdrawal by Subject|5|||
164259328|NCT00521599|593318424|FG002|Overall Study|Withdrawal by Subject|1|||
164259329|NCT00521599|593318422|FG000|Overall Study|Withdrawal by subject treatment related|3|||
164259330|NCT00521599|593318423|FG001|Overall Study|Withdrawal by subject treatment related|1|||
164259331|NCT00521599|593318424|FG002|Overall Study|Withdrawal by subject treatment related|2|||
164259332|NCT00521599|593318422|FG000|Overall Study|Protocol Violation|2|||
164259333|NCT00521599|593318423|FG001|Overall Study|Protocol Violation|4|||
164259334|NCT00521599|593318424|FG002|Overall Study|Protocol Violation|2|||
164259335|NCT00521599|593318422|FG000|Overall Study|Did not meet protocol eligibility|2|||
164259336|NCT00521599|593318423|FG001|Overall Study|Did not meet protocol eligibility|2|||
164259337|NCT00521599|593318424|FG002|Overall Study|Did not meet protocol eligibility|1|||
164259338|NCT00496197|593318428|FG000|Overall Study|Discontinued study due to death|43|||
164259339|NCT00496197|593318428|FG000|Overall Study|Adverse Event|13|||
164259340|NCT00496197|593318428|FG000|Overall Study|Does not meet entrance criteria|5|||
164259341|NCT00496197|593318428|FG000|Overall Study|Insufficient clinical response|3|||
164259342|NCT00496197|593318428|FG000|Overall Study|Insufficient bacteriological response|10|||
164259343|NCT00496197|593318428|FG000|Overall Study|Lost to Follow-up|11|||
164259344|NCT00496197|593318428|FG000|Overall Study|Withdrawal by Subject|11|||
164259345|NCT00496197|593318428|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
164259346|NCT00496197|593318428|FG000|Overall Study|Other|14|||
164259347|NCT00496197|593318428|FG000|Overall Study|Protocol Violation|8|||
164259348|NCT00149994|593318429|FG000|Overall Study|Administrative problems:|1|||
164259349|NCT00149994|593318430|FG001|Overall Study|Administrative problems:|0|||
164259350|NCT00149994|593318429|FG000|Overall Study|Protocol Violation|0|||
164259351|NCT00149994|593318430|FG001|Overall Study|Protocol Violation|1|||
164259352|NCT01610713|593318431|FG000|Overall Study|Adverse Event|3|||
164259353|NCT01610713|593318432|FG001|Overall Study|Adverse Event|0|||
164259354|NCT01610713|593318431|FG000|Overall Study|Lack of Efficacy|1|||
164259355|NCT01610713|593318432|FG001|Overall Study|Lack of Efficacy|0|||
164259356|NCT01610713|593318431|FG000|Overall Study|low mood and poor motivation|1|||
164259357|NCT01610713|593318432|FG001|Overall Study|low mood and poor motivation|0|||
164259358|NCT01610713|593318431|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
164085065|NCT01418352|592675867|FG003|Overall Study|Protocol Deviation|0|||
164259359|NCT01610713|593318432|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
164259360|NCT01610713|593318431|FG000|Overall Study|Lost to Follow-up|0|||
164259361|NCT01610713|593318432|FG001|Overall Study|Lost to Follow-up|1|||
164259362|NCT03943550|593318437|FG000|Overall Study|Adverse Event|0|||
164259363|NCT03943550|593318438|FG001|Overall Study|Adverse Event|0|||
164259364|NCT03943550|593318439|FG002|Overall Study|Adverse Event|1|||
164259365|NCT03943550|593318437|FG000|Overall Study|Lost to Follow-up|0|||
164259366|NCT03943550|593318438|FG001|Overall Study|Lost to Follow-up|0|||
164259367|NCT03943550|593318439|FG002|Overall Study|Lost to Follow-up|1|||
164259368|NCT03943550|593318437|FG000|Overall Study|Progressive Disease|0|||
164259369|NCT03943550|593318438|FG001|Overall Study|Progressive Disease|0|||
164259370|NCT03943550|593318439|FG002|Overall Study|Progressive Disease|2|||
164259371|NCT03943550|593318437|FG000|Overall Study|Participant Moved Out of the Country|0|||
164259372|NCT03943550|593318438|FG001|Overall Study|Participant Moved Out of the Country|1|||
164259373|NCT03943550|593318439|FG002|Overall Study|Participant Moved Out of the Country|0|||
164259374|NCT00543296|593318440|FG000|Overall Study|Physician Decision|7|||
164259375|NCT00934947|593318441|FG000|Overall Study|Adverse Event|0|||
164259376|NCT00934947|593318442|FG001|Overall Study|Adverse Event|2|||
164259377|NCT00096226|593318445|FG000|Overall Study|Ineligible|2|||
164259378|NCT00096226|593318445|FG000|Overall Study|Protocol treatment not started|1|||
164259379|NCT06107803|593318446|FG000|Overall Study|Adverse Event|1|||
164259380|NCT06107803|593318446|FG000|Overall Study|Withdrawal by Subject|2|||
164259381|NCT06107803|593318446|FG000|Overall Study|Protocol Violation|1|||
164259382|NCT03099174|593318448|FG000|Overall Study|Withdrawal by Subject|0|||
164259383|NCT03099174|593318449|FG001|Overall Study|Withdrawal by Subject|0|||
164259384|NCT03099174|593318450|FG002|Overall Study|Withdrawal by Subject|1|||
164259385|NCT03099174|593318451|FG003|Overall Study|Withdrawal by Subject|0|||
164259386|NCT03099174|593318452|FG004|Overall Study|Withdrawal by Subject|2|||
164259387|NCT03099174|593318453|FG005|Overall Study|Withdrawal by Subject|2|||
164259388|NCT03099174|593318454|FG006|Overall Study|Withdrawal by Subject|1|||
164259389|NCT03099174|593318455|FG007|Overall Study|Withdrawal by Subject|4|||
164259390|NCT03099174|593318448|FG000|Overall Study|Adverse Event|0|||
164259391|NCT03099174|593318449|FG001|Overall Study|Adverse Event|1|||
164259392|NCT03099174|593318450|FG002|Overall Study|Adverse Event|1|||
164259393|NCT03099174|593318451|FG003|Overall Study|Adverse Event|2|||
164259394|NCT03099174|593318452|FG004|Overall Study|Adverse Event|5|||
164259395|NCT03099174|593318453|FG005|Overall Study|Adverse Event|3|||
164259396|NCT03099174|593318454|FG006|Overall Study|Adverse Event|6|||
164259397|NCT03099174|593318455|FG007|Overall Study|Adverse Event|4|||
164259398|NCT03099174|593318448|FG000|Overall Study|Other than listed|6|||
163888242|NCT04436276|591963328|FG018|Overall Study|Adverse Event|0|||
163888243|NCT04436276|591963329|FG019|Overall Study|Adverse Event|0|||
163888244|NCT04436276|591963330|FG020|Overall Study|Adverse Event|0|||
163888245|NCT04436276|591963331|FG021|Overall Study|Adverse Event|0|||
163888246|NCT04436276|591963332|FG022|Overall Study|Adverse Event|0|||
163888247|NCT04436276|591963310|FG000|Overall Study|Death|0|||
163888248|NCT04436276|591963311|FG001|Overall Study|Death|0|||
163888249|NCT04436276|591963312|FG002|Overall Study|Death|0|||
163888250|NCT04436276|591963313|FG003|Overall Study|Death|0|||
163888251|NCT04436276|591963314|FG004|Overall Study|Death|0|||
163888252|NCT04436276|591963315|FG005|Overall Study|Death|0|||
163888253|NCT04436276|591963316|FG006|Overall Study|Death|0|||
163888254|NCT04436276|591963317|FG007|Overall Study|Death|0|||
163888255|NCT04436276|591963318|FG008|Overall Study|Death|0|||
163888256|NCT04436276|591963319|FG009|Overall Study|Death|0|||
163888257|NCT04436276|591963320|FG010|Overall Study|Death|0|||
163888258|NCT04436276|591963321|FG011|Overall Study|Death|0|||
163888259|NCT04436276|591963322|FG012|Overall Study|Death|1|||
163888260|NCT04436276|591963323|FG013|Overall Study|Death|0|||
163888261|NCT04436276|591963324|FG014|Overall Study|Death|1|||
163888262|NCT04436276|591963325|FG015|Overall Study|Death|0|||
163888263|NCT04436276|591963326|FG016|Overall Study|Death|0|||
163888264|NCT04436276|591963327|FG017|Overall Study|Death|0|||
163888265|NCT04436276|591963328|FG018|Overall Study|Death|0|||
163888266|NCT04436276|591963329|FG019|Overall Study|Death|2|||
163888267|NCT04436276|591963330|FG020|Overall Study|Death|0|||
163888268|NCT04436276|591963331|FG021|Overall Study|Death|1|||
163888269|NCT04436276|591963332|FG022|Overall Study|Death|0|||
163888270|NCT04436276|591963310|FG000|Overall Study|Lost to Follow-up|0|||
163888271|NCT04436276|591963311|FG001|Overall Study|Lost to Follow-up|2|||
163888272|NCT04436276|591963312|FG002|Overall Study|Lost to Follow-up|2|||
163888273|NCT04436276|591963313|FG003|Overall Study|Lost to Follow-up|1|||
163888274|NCT04436276|591963314|FG004|Overall Study|Lost to Follow-up|4|||
163888275|NCT04436276|591963315|FG005|Overall Study|Lost to Follow-up|1|||
163888276|NCT04436276|591963316|FG006|Overall Study|Lost to Follow-up|0|||
163888277|NCT04436276|591963317|FG007|Overall Study|Lost to Follow-up|0|||
163888278|NCT04436276|591963318|FG008|Overall Study|Lost to Follow-up|1|||
163888279|NCT04436276|591963319|FG009|Overall Study|Lost to Follow-up|0|||
163888280|NCT04436276|591963320|FG010|Overall Study|Lost to Follow-up|5|||
163888281|NCT04436276|591963321|FG011|Overall Study|Lost to Follow-up|5|||
163888282|NCT04436276|591963322|FG012|Overall Study|Lost to Follow-up|4|||
163888283|NCT04436276|591963323|FG013|Overall Study|Lost to Follow-up|1|||
163888284|NCT04436276|591963324|FG014|Overall Study|Lost to Follow-up|7|||
163888285|NCT04436276|591963325|FG015|Overall Study|Lost to Follow-up|7|||
164259399|NCT03099174|593318449|FG001|Overall Study|Other than listed|6|||
164259400|NCT03099174|593318450|FG002|Overall Study|Other than listed|5|||
164259401|NCT03099174|593318451|FG003|Overall Study|Other than listed|6|||
164259402|NCT03099174|593318452|FG004|Overall Study|Other than listed|19|||
163888286|NCT04436276|591963326|FG016|Overall Study|Lost to Follow-up|1|||
164259403|NCT03099174|593318453|FG005|Overall Study|Other than listed|10|||
164259404|NCT03099174|593318454|FG006|Overall Study|Other than listed|26|||
164259405|NCT03099174|593318455|FG007|Overall Study|Other than listed|23|||
164259406|NCT02378298|593318457|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
164259407|NCT02378298|593318458|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
164259408|NCT02378298|593318459|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
164259409|NCT02378298|593318457|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
164259410|NCT02378298|593318458|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
164259411|NCT02378298|593318459|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
164259412|NCT02378298|593318457|FG000|Surveillance (19-68 Weeks)|Death|1|||
164259413|NCT02378298|593318458|FG001|Surveillance (19-68 Weeks)|Death|0|||
164259414|NCT02378298|593318459|FG002|Surveillance (19-68 Weeks)|Death|0|||
164259415|NCT04173260|593318460|FG000|Overall Study|Early termination|4|||
164259416|NCT04730635|593318461|FG000|Overall Study|Lost to Follow-up|1|||
164259417|NCT04730635|593318462|FG001|Overall Study|Lost to Follow-up|0|||
164259418|NCT04730635|593318461|FG000|Overall Study|Withdrawal by Subject|0|||
164259419|NCT04730635|593318462|FG001|Overall Study|Withdrawal by Subject|1|||
164259420|NCT03070223|593318465|FG000|Overall Study|Lost to Follow-up|34|||
164259421|NCT03070223|593318466|FG001|Overall Study|Lost to Follow-up|27|||
164259422|NCT03070223|593318465|FG000|Overall Study|Withdrawal by Subject|12|||
164259423|NCT03070223|593318466|FG001|Overall Study|Withdrawal by Subject|22|||
164259424|NCT03070223|593318465|FG000|Overall Study|Protocol Violation|0|||
164259425|NCT03070223|593318466|FG001|Overall Study|Protocol Violation|1|||
164259426|NCT03006458|593318472|FG000|First Intervention|Unsatisfied Vision|0|||
164259427|NCT03006458|593318473|FG001|First Intervention|Unsatisfied Vision|3|||
164259428|NCT03219034|593318474|FG000|Overall Study|Lost to Follow-up|9|||
164259429|NCT03219034|593318475|FG001|Overall Study|Lost to Follow-up|13|||
164259430|NCT03219034|593318474|FG000|Overall Study|Additional dental work needed|1|||
164259431|NCT03219034|593318475|FG001|Overall Study|Additional dental work needed|0|||
164259432|NCT03219034|593318474|FG000|Overall Study|UPPP Surgery|1|||
164259433|NCT03219034|593318475|FG001|Overall Study|UPPP Surgery|0|||
164259434|NCT03219034|593318474|FG000|Overall Study|Dental sensitivity|0|||
164259435|NCT03219034|593318475|FG001|Overall Study|Dental sensitivity|1|||
164259436|NCT03219034|593318474|FG000|Overall Study|Death in family|0|||
164259437|NCT03219034|593318475|FG001|Overall Study|Death in family|1|||
164259438|NCT00118846|593318476|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
164259439|NCT00118846|593318477|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
164259440|NCT00118846|593318476|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
164259441|NCT00118846|593318477|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
164259442|NCT00118846|593318476|FG000|Overall Study|Physician Decision|1|||
164259443|NCT00118846|593318477|FG001|Overall Study|Physician Decision|0|||
164259444|NCT00118846|593318476|FG000|Overall Study|Medical condition|2|||
164259445|NCT00118846|593318477|FG001|Overall Study|Medical condition|2|||
164259446|NCT00118846|593318476|FG000|Overall Study|Lost to Follow-up|0|||
164259447|NCT00118846|593318477|FG001|Overall Study|Lost to Follow-up|2|||
164340381|NCT04154930|593620588|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
164340382|NCT04154930|593620589|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
163888287|NCT04436276|591963327|FG017|Overall Study|Lost to Follow-up|0|||
164259448|NCT00118846|593318476|FG000|Overall Study|Personal reason|4|||
164259449|NCT00118846|593318477|FG001|Overall Study|Personal reason|5|||
164259450|NCT01468233|593318479|FG000|Treatment Period 1|Adverse Event|5|||
163888288|NCT04436276|591963328|FG018|Overall Study|Lost to Follow-up|1|||
163888289|NCT04436276|591963329|FG019|Overall Study|Lost to Follow-up|1|||
163888290|NCT04436276|591963330|FG020|Overall Study|Lost to Follow-up|2|||
163888291|NCT04436276|591963331|FG021|Overall Study|Lost to Follow-up|1|||
163888292|NCT04436276|591963332|FG022|Overall Study|Lost to Follow-up|1|||
163888293|NCT04436276|591963310|FG000|Overall Study|Physician Decision|1|||
163888294|NCT04436276|591963311|FG001|Overall Study|Physician Decision|0|||
163888295|NCT04436276|591963312|FG002|Overall Study|Physician Decision|2|||
164259451|NCT01468233|593318480|FG001|Treatment Period 1|Adverse Event|3|||
164259452|NCT01468233|593318481|FG002|Treatment Period 1|Adverse Event|0|||
164259453|NCT01468233|593318482|FG003|Treatment Period 1|Adverse Event|0|||
164259454|NCT01468233|593318483|FG004|Treatment Period 1|Adverse Event|0|||
164259455|NCT01468233|593318484|FG005|Treatment Period 1|Adverse Event|0|||
164259456|NCT01468233|593318479|FG000|Treatment Period 1|Withdrawal by Subject|3|||
163888296|NCT04436276|591963313|FG003|Overall Study|Physician Decision|1|||
163888297|NCT04436276|591963314|FG004|Overall Study|Physician Decision|0|||
163888298|NCT04436276|591963315|FG005|Overall Study|Physician Decision|0|||
164340383|NCT04154930|593620588|FG000|Overall Study|Lost to Follow-up|14|||
164259457|NCT01468233|593318480|FG001|Treatment Period 1|Withdrawal by Subject|4|||
164259458|NCT01468233|593318481|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164259459|NCT01468233|593318482|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164259460|NCT01468233|593318483|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164259461|NCT01468233|593318484|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164259462|NCT01468233|593318479|FG000|Treatment Period 1|Lost to Follow-up|3|||
164259463|NCT01468233|593318480|FG001|Treatment Period 1|Lost to Follow-up|0|||
164259464|NCT01468233|593318481|FG002|Treatment Period 1|Lost to Follow-up|0|||
164259465|NCT01468233|593318482|FG003|Treatment Period 1|Lost to Follow-up|0|||
164259466|NCT01468233|593318483|FG004|Treatment Period 1|Lost to Follow-up|0|||
164259467|NCT01468233|593318484|FG005|Treatment Period 1|Lost to Follow-up|0|||
164259468|NCT01468233|593318479|FG000|Treatment Period 1|Other|1|||
164259469|NCT01468233|593318480|FG001|Treatment Period 1|Other|1|||
164259470|NCT01468233|593318481|FG002|Treatment Period 1|Other|0|||
164259471|NCT01468233|593318482|FG003|Treatment Period 1|Other|0|||
164259472|NCT01468233|593318483|FG004|Treatment Period 1|Other|0|||
164259473|NCT01468233|593318484|FG005|Treatment Period 1|Other|0|||
164259474|NCT01468233|593318479|FG000|Treatment Period 2|Adverse Event|0|||
164259475|NCT01468233|593318480|FG001|Treatment Period 2|Adverse Event|0|||
164259476|NCT01468233|593318481|FG002|Treatment Period 2|Adverse Event|3|||
164259477|NCT01468233|593318482|FG003|Treatment Period 2|Adverse Event|0|||
164259478|NCT01468233|593318483|FG004|Treatment Period 2|Adverse Event|2|||
164259479|NCT01468233|593318484|FG005|Treatment Period 2|Adverse Event|1|||
164259480|NCT01468233|593318479|FG000|Treatment Period 2|Lack of Efficacy|0|||
164259481|NCT01468233|593318480|FG001|Treatment Period 2|Lack of Efficacy|0|||
164259482|NCT01468233|593318481|FG002|Treatment Period 2|Lack of Efficacy|9|||
164259483|NCT01468233|593318482|FG003|Treatment Period 2|Lack of Efficacy|2|||
164259484|NCT01468233|593318483|FG004|Treatment Period 2|Lack of Efficacy|0|||
164259485|NCT01468233|593318484|FG005|Treatment Period 2|Lack of Efficacy|1|||
164259486|NCT01468233|593318479|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164259487|NCT01468233|593318480|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164259488|NCT01468233|593318481|FG002|Treatment Period 2|Withdrawal by Subject|9|||
164259489|NCT01468233|593318482|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164259490|NCT01468233|593318483|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164259491|NCT01468233|593318484|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164259492|NCT01468233|593318479|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
164259493|NCT01468233|593318480|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
164259494|NCT01468233|593318481|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
164259495|NCT01468233|593318482|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
164259496|NCT01468233|593318483|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
164259497|NCT01468233|593318484|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
164259498|NCT01468233|593318479|FG000|Treatment Period 2|Lost to Follow-up|0|||
164259499|NCT01468233|593318480|FG001|Treatment Period 2|Lost to Follow-up|0|||
164259500|NCT01468233|593318481|FG002|Treatment Period 2|Lost to Follow-up|3|||
164259501|NCT01468233|593318482|FG003|Treatment Period 2|Lost to Follow-up|0|||
164259502|NCT01468233|593318483|FG004|Treatment Period 2|Lost to Follow-up|2|||
164259503|NCT01468233|593318484|FG005|Treatment Period 2|Lost to Follow-up|0|||
164259504|NCT01468233|593318479|FG000|Treatment Period 2|Other|0|||
164259505|NCT01468233|593318480|FG001|Treatment Period 2|Other|0|||
164259506|NCT01468233|593318481|FG002|Treatment Period 2|Other|3|||
164259507|NCT01468233|593318482|FG003|Treatment Period 2|Other|0|||
164259508|NCT01468233|593318483|FG004|Treatment Period 2|Other|1|||
164259509|NCT01468233|593318484|FG005|Treatment Period 2|Other|0|||
164259510|NCT01574157|593318488|FG000|Overall Study|Withdrawal by Subject|4|||
164259511|NCT01574157|593318489|FG001|Overall Study|Withdrawal by Subject|5|||
164259512|NCT01574157|593318488|FG000|Overall Study|Lost to Follow-up|0|||
164259513|NCT01574157|593318489|FG001|Overall Study|Lost to Follow-up|3|||
164259514|NCT00578877|593318490|FG000|Overall Study|Lost to Follow-up|8|||
164259515|NCT00578877|593318491|FG001|Overall Study|Lost to Follow-up|10|||
164259516|NCT00578877|593318490|FG000|Overall Study|early discontinue|61|||
164259517|NCT00578877|593318491|FG001|Overall Study|early discontinue|101|||
164259518|NCT00578877|593318490|FG000|Overall Study|did not provide follow-up data|12|||
164259519|NCT00578877|593318491|FG001|Overall Study|did not provide follow-up data|17|||
164259520|NCT01202188|593318493|FG000|Overall Study|Protocol deviation|14|||
164259521|NCT01202188|593318494|FG001|Overall Study|Protocol deviation|8|||
164259522|NCT01202188|593318495|FG002|Overall Study|Protocol deviation|12|||
164259523|NCT01202188|593318496|FG003|Overall Study|Protocol deviation|10|||
164259524|NCT01202188|593318497|FG004|Overall Study|Protocol deviation|11|||
164259525|NCT01202188|593318493|FG000|Overall Study|Subject withdrew consent|12|||
164259526|NCT01202188|593318494|FG001|Overall Study|Subject withdrew consent|13|||
164259527|NCT01202188|593318495|FG002|Overall Study|Subject withdrew consent|22|||
164259528|NCT01202188|593318496|FG003|Overall Study|Subject withdrew consent|11|||
164259529|NCT01202188|593318497|FG004|Overall Study|Subject withdrew consent|13|||
164259530|NCT01202188|593318493|FG000|Overall Study|Adverse Event|5|||
164259531|NCT01202188|593318494|FG001|Overall Study|Adverse Event|23|||
164259532|NCT01202188|593318495|FG002|Overall Study|Adverse Event|13|||
164259533|NCT01202188|593318496|FG003|Overall Study|Adverse Event|10|||
164259534|NCT01202188|593318497|FG004|Overall Study|Adverse Event|10|||
164259535|NCT01202188|593318493|FG000|Overall Study|Administrative problems|3|||
164259536|NCT01202188|593318494|FG001|Overall Study|Administrative problems|2|||
164259537|NCT01202188|593318495|FG002|Overall Study|Administrative problems|1|||
164259538|NCT01202188|593318496|FG003|Overall Study|Administrative problems|1|||
164259539|NCT01202188|593318497|FG004|Overall Study|Administrative problems|2|||
164259540|NCT01202188|593318493|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164259541|NCT01202188|593318494|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164259542|NCT01202188|593318495|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164259543|NCT01202188|593318496|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
164259544|NCT01202188|593318497|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
164259545|NCT01202188|593318493|FG000|Overall Study|Lost to Follow-up|1|||
164259546|NCT01202188|593318494|FG001|Overall Study|Lost to Follow-up|1|||
164259547|NCT01202188|593318495|FG002|Overall Study|Lost to Follow-up|0|||
164259548|NCT01202188|593318496|FG003|Overall Study|Lost to Follow-up|4|||
164259549|NCT01202188|593318497|FG004|Overall Study|Lost to Follow-up|1|||
164259550|NCT01202188|593318493|FG000|Overall Study|Death|1|||
164259551|NCT01202188|593318494|FG001|Overall Study|Death|1|||
164259552|NCT01202188|593318495|FG002|Overall Study|Death|1|||
164259553|NCT01202188|593318496|FG003|Overall Study|Death|1|||
164259554|NCT01202188|593318497|FG004|Overall Study|Death|0|||
164259555|NCT01202188|593318493|FG000|Overall Study|Abnormal test procedure result (s)|0|||
164259556|NCT01202188|593318494|FG001|Overall Study|Abnormal test procedure result (s)|0|||
164259557|NCT01202188|593318495|FG002|Overall Study|Abnormal test procedure result (s)|2|||
164259558|NCT01202188|593318496|FG003|Overall Study|Abnormal test procedure result (s)|0|||
164259559|NCT01202188|593318497|FG004|Overall Study|Abnormal test procedure result (s)|0|||
164259560|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
164259561|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
164259562|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
164259563|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
164259564|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
164259565|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
164259566|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
164259567|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
164259568|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
164259569|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
164259570|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
164259571|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
164259572|NCT01632241|593318498|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
164259573|NCT01632241|593318499|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
164259574|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
164259575|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
164259576|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
164259577|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
164259578|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
164259579|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
164259580|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
164259581|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
164259582|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
164259583|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
164259584|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
164259585|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
164259586|NCT01632241|593318498|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
164259587|NCT01632241|593318499|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
164259588|NCT01846299|593318508|FG000|Overall Study|Physician Decision|4|||
164259589|NCT01846299|593318509|FG001|Overall Study|Physician Decision|2|||
164259590|NCT01846299|593318508|FG000|Overall Study|Protocol deviation|1|||
164259591|NCT01846299|593318509|FG001|Overall Study|Protocol deviation|0|||
164259592|NCT01846299|593318508|FG000|Overall Study|Death|1|||
164259593|NCT01846299|593318509|FG001|Overall Study|Death|2|||
164259594|NCT01846299|593318508|FG000|Overall Study|Lost to Follow-up|3|||
164259595|NCT01846299|593318509|FG001|Overall Study|Lost to Follow-up|0|||
164259596|NCT01846299|593318508|FG000|Overall Study|Withdrawal by Subject|1|||
163888299|NCT04436276|591963316|FG006|Overall Study|Physician Decision|0|||
163888300|NCT04436276|591963317|FG007|Overall Study|Physician Decision|0|||
164142268|NCT00451204|592882583|FG001|Overall Study|Lost to Follow-up|4|||
164259597|NCT01846299|593318509|FG001|Overall Study|Withdrawal by Subject|6|||
164259598|NCT01846299|593318508|FG000|Overall Study|Adverse Event|2|||
164259599|NCT01846299|593318509|FG001|Overall Study|Adverse Event|0|||
164259600|NCT03559517|593318510|FG000|Overall Study|Withdrawal by Subject|1|||
164259601|NCT03559517|593318511|FG001|Overall Study|Withdrawal by Subject|0|||
163888301|NCT04436276|591963318|FG008|Overall Study|Physician Decision|0|||
163888302|NCT04436276|591963319|FG009|Overall Study|Physician Decision|0|||
163888303|NCT04436276|591963320|FG010|Overall Study|Physician Decision|0|||
164259602|NCT03559517|593318512|FG002|Overall Study|Withdrawal by Subject|0|||
164259603|NCT01330628|593318513|FG000|Overall Study|Death|2|||
164259604|NCT01330628|593318514|FG001|Overall Study|Death|3|||
164259605|NCT01330628|593318513|FG000|Overall Study|Lost to Follow-up|5|||
164259606|NCT01330628|593318514|FG001|Overall Study|Lost to Follow-up|6|||
164259607|NCT01330628|593318513|FG000|Overall Study|Adverse Event|44|||
164259608|NCT01330628|593318514|FG001|Overall Study|Adverse Event|25|||
164259609|NCT01330628|593318513|FG000|Overall Study|Withdrawn|18|||
164259610|NCT01330628|593318514|FG001|Overall Study|Withdrawn|6|||
164259611|NCT01330628|593318513|FG000|Overall Study|Didn't receive study treatment|1|||
164259612|NCT01330628|593318514|FG001|Overall Study|Didn't receive study treatment|0|||
164259613|NCT03761394|593318515|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
164340384|NCT04154930|593620589|FG001|Overall Study|Lost to Follow-up|6|||
164340385|NCT04154930|593620588|FG000|Overall Study|Other|6|||
164340386|NCT04154930|593620589|FG001|Overall Study|Other|0|||
164340387|NCT00657358|593620590|FG000|Overall Study|Lack of Efficacy|6|||
164340388|NCT00400764|593620594|FG000|Phase Ib|Adverse Event|1|||
164340389|NCT00400764|593620595|FG001|Phase Ib|Adverse Event|0|||
164340390|NCT00400764|593620596|FG002|Phase Ib|Adverse Event|0|||
164340391|NCT00400764|593620597|FG003|Phase Ib|Adverse Event|0|||
164340392|NCT00400764|593620598|FG004|Phase Ib|Adverse Event|0|||
164340393|NCT00400764|593620594|FG000|Phase Ib|Death|1|||
164340394|NCT00400764|593620595|FG001|Phase Ib|Death|0|||
164340395|NCT00400764|593620596|FG002|Phase Ib|Death|0|||
164340396|NCT00400764|593620597|FG003|Phase Ib|Death|0|||
164340397|NCT00400764|593620598|FG004|Phase Ib|Death|0|||
164340398|NCT00400764|593620594|FG000|Phase Ib|Disease Progression|4|||
164340399|NCT00400764|593620595|FG001|Phase Ib|Disease Progression|4|||
164340400|NCT00400764|593620596|FG002|Phase Ib|Disease Progression|0|||
164340401|NCT00400764|593620597|FG003|Phase Ib|Disease Progression|0|||
164340402|NCT00400764|593620598|FG004|Phase Ib|Disease Progression|0|||
164340403|NCT00400764|593620594|FG000|Phase II|Death|0|||
164340404|NCT00400764|593620595|FG001|Phase II|Death|0|||
164340405|NCT00400764|593620596|FG002|Phase II|Death|1|||
164340406|NCT00400764|593620597|FG003|Phase II|Death|2|||
164340407|NCT00400764|593620598|FG004|Phase II|Death|0|||
164340408|NCT00400764|593620594|FG000|Phase II|Lost to Follow-up|0|||
164340409|NCT00400764|593620595|FG001|Phase II|Lost to Follow-up|0|||
164340410|NCT00400764|593620596|FG002|Phase II|Lost to Follow-up|1|||
164340411|NCT00400764|593620597|FG003|Phase II|Lost to Follow-up|0|||
164340412|NCT00400764|593620598|FG004|Phase II|Lost to Follow-up|0|||
164340413|NCT00400764|593620594|FG000|Phase II|Physician Decision|0|||
164340414|NCT00400764|593620595|FG001|Phase II|Physician Decision|0|||
164340415|NCT00400764|593620596|FG002|Phase II|Physician Decision|1|||
164340416|NCT00400764|593620597|FG003|Phase II|Physician Decision|1|||
164340417|NCT00400764|593620598|FG004|Phase II|Physician Decision|0|||
164340418|NCT00400764|593620594|FG000|Phase II|Sponsor's decision to terminate|0|||
164340419|NCT00400764|593620595|FG001|Phase II|Sponsor's decision to terminate|0|||
164340420|NCT00400764|593620596|FG002|Phase II|Sponsor's decision to terminate|18|||
164340421|NCT00400764|593620597|FG003|Phase II|Sponsor's decision to terminate|22|||
164340422|NCT00400764|593620598|FG004|Phase II|Sponsor's decision to terminate|11|||
164340423|NCT00400764|593620594|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
164340424|NCT00400764|593620595|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
164340425|NCT00400764|593620596|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
164340426|NCT00400764|593620597|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
164340427|NCT00400764|593620598|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
164340428|NCT00400764|593620594|FG000|Phase II|Withdrawal by Subject|0|||
164340429|NCT00400764|593620595|FG001|Phase II|Withdrawal by Subject|0|||
164340430|NCT00400764|593620596|FG002|Phase II|Withdrawal by Subject|1|||
164340431|NCT00400764|593620597|FG003|Phase II|Withdrawal by Subject|1|||
164340432|NCT00400764|593620598|FG004|Phase II|Withdrawal by Subject|0|||
164340433|NCT01449539|593620603|FG000|Overall Study|Withdrawal by Subject|3|||
164340434|NCT01449539|593620603|FG000|Overall Study|Toxicity not study related|1|||
164340435|NCT03113071|593620604|FG000|Overall Study|Withdrawal by Subject|1|||
163888304|NCT04436276|591963321|FG011|Overall Study|Physician Decision|1|||
164340436|NCT03113071|593620605|FG001|Overall Study|Withdrawal by Subject|0|||
164340437|NCT02369016|593620608|FG000|Overall Study|AE associated with clinical disease progression|2|||
164259614|NCT03761394|593318516|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
164340438|NCT02369016|593620609|FG001|Overall Study|AE associated with clinical disease progression|1|||
164259615|NCT03761394|593318517|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
164259616|NCT03761394|593318518|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
164259617|NCT03761394|593318515|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
164259618|NCT03761394|593318516|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
164259619|NCT03761394|593318517|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
164259620|NCT03761394|593318518|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
164259621|NCT03761394|593318515|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
164259622|NCT03761394|593318516|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
164259623|NCT03761394|593318517|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
164259624|NCT03761394|593318518|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
164259625|NCT03761394|593318515|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
164259626|NCT03761394|593318516|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
164259627|NCT03761394|593318517|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
164259628|NCT03761394|593318518|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
164259629|NCT01080768|593318528|FG000|Overall Study|Protocol Deviation|2|||
164259630|NCT01080768|593318529|FG001|Overall Study|Protocol Deviation|1|||
164259631|NCT00580034|593318540|FG000|Overall Study|Toxicity|10|||
164259632|NCT00580034|593318541|FG001|Overall Study|Toxicity|0|||
164259633|NCT01939002|593318542|FG000|Overall Study|Adverse Event|13|||
164259634|NCT01939002|593318543|FG001|Overall Study|Adverse Event|13|||
164259635|NCT01939002|593318542|FG000|Overall Study|Withdrawal by Subject|5|||
164259636|NCT01939002|593318543|FG001|Overall Study|Withdrawal by Subject|3|||
164259637|NCT01939002|593318542|FG000|Overall Study|Other|1|||
164259638|NCT01939002|593318543|FG001|Overall Study|Other|2|||
164259639|NCT00098748|593318547|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
164259640|NCT00098748|593318548|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
164259641|NCT00098748|593318549|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
164259642|NCT00098748|593318547|FG000|Received Study Treatment|Death|2|||
164259643|NCT00098748|593318548|FG001|Received Study Treatment|Death|1|||
164259644|NCT00098748|593318549|FG002|Received Study Treatment|Death|2|||
164259645|NCT00098748|593318547|FG000|Received Study Treatment|Adverse Event|1|||
164259646|NCT00098748|593318548|FG001|Received Study Treatment|Adverse Event|2|||
164259647|NCT00098748|593318549|FG002|Received Study Treatment|Adverse Event|5|||
164259648|NCT00098748|593318547|FG000|Received Study Treatment|Lack of Efficacy|40|||
164259649|NCT00098748|593318548|FG001|Received Study Treatment|Lack of Efficacy|27|||
164259650|NCT00098748|593318549|FG002|Received Study Treatment|Lack of Efficacy|27|||
164259651|NCT00098748|593318547|FG000|Received Study Treatment|Other|2|||
164259652|NCT00098748|593318548|FG001|Received Study Treatment|Other|2|||
164259653|NCT00098748|593318549|FG002|Received Study Treatment|Other|6|||
164259654|NCT00098748|593318547|FG000|Received Study Treatment|Subject defaulted|3|||
164259655|NCT00098748|593318548|FG001|Received Study Treatment|Subject defaulted|4|||
164259656|NCT00098748|593318549|FG002|Received Study Treatment|Subject defaulted|4|||
164259657|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
164259658|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
164259659|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
164259660|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
164259661|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
164259662|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
164259663|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
164259664|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
164259665|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
164259666|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
164259667|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
164259668|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
164259669|NCT00098748|593318547|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
164259670|NCT00098748|593318548|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
164259671|NCT00098748|593318549|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
164259672|NCT03095027|593320199|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
164259673|NCT03095027|593320200|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
164259674|NCT02982018|593320201|FG000|Overall Study|Incorrect Lens Dispensed|1|||
164259675|NCT02982018|593320202|FG001|Overall Study|Incorrect Lens Dispensed|0|||
164259676|NCT02982018|593320201|FG000|Overall Study|Protocol Violation|1|||
164259677|NCT02982018|593320202|FG001|Overall Study|Protocol Violation|1|||
164259678|NCT02982018|593320201|FG000|Overall Study|Adverse Event|1|||
164259679|NCT02982018|593320202|FG001|Overall Study|Adverse Event|1|||
164340439|NCT02369016|593620608|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
164340440|NCT02369016|593620609|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
164340441|NCT02369016|593620608|FG000|Overall Study|Progressive disease - clinical progression|1|||
164340442|NCT02369016|593620609|FG001|Overall Study|Progressive disease - clinical progression|4|||
164340443|NCT02369016|593620608|FG000|Overall Study|withdrawal by patient|4|||
163888305|NCT04436276|591963322|FG012|Overall Study|Physician Decision|2|||
163888306|NCT04436276|591963323|FG013|Overall Study|Physician Decision|0|||
163888307|NCT04436276|591963324|FG014|Overall Study|Physician Decision|0|||
163888308|NCT04436276|591963325|FG015|Overall Study|Physician Decision|0|||
164259680|NCT02982018|593320201|FG000|Overall Study|Lens Discomfort|2|||
164259681|NCT02982018|593320202|FG001|Overall Study|Lens Discomfort|0|||
164259682|NCT02982018|593320201|FG000|Overall Study|Withdrawal by Subject|0|||
164259683|NCT02982018|593320202|FG001|Overall Study|Withdrawal by Subject|1|||
164259684|NCT03245736|593320203|FG000|Overall Study|Adverse Event|1|||
164259685|NCT03245736|593320203|FG000|Overall Study|Progressive Disease|4|||
164259686|NCT01942161|593320204|FG000|Overall Study|Adverse Event|1|||
164259687|NCT01942161|593320205|FG001|Overall Study|Adverse Event|2|||
164259688|NCT01942161|593320206|FG002|Overall Study|Adverse Event|5|||
164259689|NCT01942161|593320204|FG000|Overall Study|Physician Decision|3|||
164259690|NCT01942161|593320205|FG001|Overall Study|Physician Decision|1|||
164259691|NCT01942161|593320206|FG002|Overall Study|Physician Decision|0|||
164259692|NCT01942161|593320204|FG000|Overall Study|Protocol Violation|1|||
164259693|NCT01942161|593320205|FG001|Overall Study|Protocol Violation|0|||
164259694|NCT01942161|593320206|FG002|Overall Study|Protocol Violation|0|||
164259695|NCT01942161|593320204|FG000|Overall Study|Withdrawal by Subject|3|||
164259696|NCT01942161|593320205|FG001|Overall Study|Withdrawal by Subject|3|||
164259697|NCT01942161|593320206|FG002|Overall Study|Withdrawal by Subject|1|||
164259698|NCT01257568|593320209|FG000|Overall Study|Lost to Follow-up|2|||
164259699|NCT01257568|593320209|FG000|Overall Study|Withdrawal by Subject|6|||
164259700|NCT01257568|593320209|FG000|Overall Study|Terminated|1|||
164259701|NCT01257568|593320209|FG000|Overall Study|Component Revision|24|||
164259702|NCT00132691|593320211|FG000|Overall Study|Lost to Follow-up|5|||
164259703|NCT00132691|593320212|FG001|Overall Study|Lost to Follow-up|8|||
164259704|NCT00132691|593320211|FG000|Overall Study|Missed 2-year visit|4|||
164259705|NCT00132691|593320212|FG001|Overall Study|Missed 2-year visit|4|||
164259706|NCT00132691|593320211|FG000|Overall Study|Death|2|||
164259707|NCT00132691|593320212|FG001|Overall Study|Death|0|||
164259708|NCT02251717|593320213|FG000|Overall Study|Adverse Event|0|||
164259709|NCT02251717|593320214|FG001|Overall Study|Adverse Event|1|||
164259710|NCT02251717|593320213|FG000|Overall Study|Withdrew Consent|1|||
164259711|NCT02251717|593320214|FG001|Overall Study|Withdrew Consent|0|||
164259712|NCT00798317|593320217|FG000|Overall Study|Physician Decision|0|||
164259713|NCT00798317|593320218|FG001|Overall Study|Physician Decision|1|||
164259714|NCT00798317|593320217|FG000|Overall Study|Withdrawal by Subject|5|||
164259715|NCT00798317|593320218|FG001|Overall Study|Withdrawal by Subject|4|||
164259716|NCT00798317|593320217|FG000|Overall Study|Lost to Follow-up|2|||
164259717|NCT00798317|593320218|FG001|Overall Study|Lost to Follow-up|2|||
164259718|NCT00798317|593320217|FG000|Overall Study|Adverse Event|2|||
164259719|NCT00798317|593320218|FG001|Overall Study|Adverse Event|0|||
164259720|NCT00798317|593320217|FG000|Overall Study|Death|1|||
163888309|NCT04436276|591963326|FG016|Overall Study|Physician Decision|0|||
163888310|NCT04436276|591963327|FG017|Overall Study|Physician Decision|0|||
163888311|NCT04436276|591963328|FG018|Overall Study|Physician Decision|0|||
164259721|NCT00798317|593320218|FG001|Overall Study|Death|0|||
164259722|NCT00919867|593320219|FG000|First Intervention|Withdrawal by Subject|0|||
164259723|NCT00919867|593320220|FG001|First Intervention|Withdrawal by Subject|0|||
164259724|NCT00919867|593320221|FG002|First Intervention|Withdrawal by Subject|1|||
164259725|NCT00919867|593320222|FG003|First Intervention|Withdrawal by Subject|0|||
164259726|NCT00919867|593320223|FG004|First Intervention|Withdrawal by Subject|0|||
164259727|NCT00919867|593320224|FG005|First Intervention|Withdrawal by Subject|0|||
164259728|NCT00919867|593320219|FG000|First Intervention|Physician Decision|0|||
164340444|NCT02369016|593620609|FG001|Overall Study|withdrawal by patient|0|||
164340445|NCT02369016|593620608|FG000|Overall Study|Progressive disease - radiological progression|6|||
164340446|NCT02369016|593620609|FG001|Overall Study|Progressive disease - radiological progression|2|||
164340447|NCT01187433|593620610|FG000|Overall Study|Protocol Violation|6|||
164340448|NCT01187433|593620611|FG001|Overall Study|Protocol Violation|2|||
164340449|NCT01187433|593620610|FG000|Overall Study|Withdrawal by Subject|5|||
164340450|NCT01187433|593620611|FG001|Overall Study|Withdrawal by Subject|2|||
164340451|NCT04203797|593620612|FG000|Overall Study|Adverse Event|1|||
164340452|NCT04203797|593620613|FG001|Overall Study|Adverse Event|0|||
164340453|NCT04203797|593620612|FG000|Overall Study|Did not complete End of Study follow-up|1|||
164340454|NCT04203797|593620613|FG001|Overall Study|Did not complete End of Study follow-up|0|||
164340455|NCT00621959|593620614|FG000|Overall Study|Adverse Event|4|||
164340456|NCT00621959|593620615|FG001|Overall Study|Adverse Event|2|||
163888312|NCT04436276|591963329|FG019|Overall Study|Physician Decision|0|||
164259729|NCT00919867|593320220|FG001|First Intervention|Physician Decision|0|||
164259730|NCT00919867|593320221|FG002|First Intervention|Physician Decision|0|||
164259731|NCT00919867|593320222|FG003|First Intervention|Physician Decision|0|||
164259732|NCT00919867|593320223|FG004|First Intervention|Physician Decision|0|||
164259733|NCT00919867|593320224|FG005|First Intervention|Physician Decision|1|||
164259734|NCT03361189|593320234|FG000|Overall Study|Received heart transplant|1|||
164259735|NCT03361189|593320235|FG001|Overall Study|Received heart transplant|0|||
163888313|NCT04436276|591963330|FG020|Overall Study|Physician Decision|1|||
164259736|NCT03361189|593320234|FG000|Overall Study|Pacemake replacement|0|||
164259737|NCT03361189|593320235|FG001|Overall Study|Pacemake replacement|1|||
164259738|NCT03575065|593320236|FG000|Overall Study|Death|31|||
164259739|NCT03575065|593320237|FG001|Overall Study|Death|12|||
164259740|NCT03575065|593320236|FG000|Overall Study|Sponsor's Decision|28|||
164259741|NCT03575065|593320237|FG001|Overall Study|Sponsor's Decision|13|||
164259742|NCT03575065|593320236|FG000|Overall Study|Withdrawal by Subject|2|||
164259743|NCT03575065|593320237|FG001|Overall Study|Withdrawal by Subject|1|||
164259744|NCT03575065|593320236|FG000|Overall Study|Lost to Follow-up|1|||
164259745|NCT03575065|593320237|FG001|Overall Study|Lost to Follow-up|0|||
164259746|NCT03344549|593320238|FG000|Overall Study|Withdrawal by Subject|3|||
164259747|NCT03344549|593320239|FG001|Overall Study|Withdrawal by Subject|2|||
164259748|NCT03344549|593320238|FG000|Overall Study|Dialysis|2|||
164259749|NCT03344549|593320239|FG001|Overall Study|Dialysis|0|||
164259750|NCT03344549|593320238|FG000|Overall Study|Cancer|1|||
164259751|NCT03344549|593320239|FG001|Overall Study|Cancer|0|||
164259752|NCT03344549|593320238|FG000|Overall Study|Lack of electronic device|1|||
164259753|NCT03344549|593320239|FG001|Overall Study|Lack of electronic device|0|||
164259754|NCT03344549|593320238|FG000|Overall Study|Transportation difficulty|0|||
164259755|NCT03344549|593320239|FG001|Overall Study|Transportation difficulty|13|||
164259756|NCT02323126|593320240|FG000|Overall Study|Patient / guardian decision|0|||
164259757|NCT02323126|593320241|FG001|Overall Study|Patient / guardian decision|1|||
164259758|NCT02323126|593320242|FG002|Overall Study|Patient / guardian decision|2|||
164259759|NCT02323126|593320240|FG000|Overall Study|Progressive disease|14|||
164259760|NCT02323126|593320241|FG001|Overall Study|Progressive disease|8|||
164259761|NCT02323126|593320242|FG002|Overall Study|Progressive disease|14|||
164259762|NCT02323126|593320240|FG000|Overall Study|Physician Decision|0|||
164259763|NCT02323126|593320241|FG001|Overall Study|Physician Decision|1|||
164259764|NCT02323126|593320242|FG002|Overall Study|Physician Decision|3|||
164259765|NCT02323126|593320240|FG000|Overall Study|Death|1|||
164259766|NCT02323126|593320241|FG001|Overall Study|Death|1|||
164259767|NCT02323126|593320242|FG002|Overall Study|Death|4|||
164259768|NCT02323126|593320240|FG000|Overall Study|Adverse Event|3|||
164259769|NCT02323126|593320241|FG001|Overall Study|Adverse Event|5|||
164259770|NCT02323126|593320242|FG002|Overall Study|Adverse Event|7|||
164259771|NCT01685801|593320248|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
164259772|NCT01685801|593320249|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
164259773|NCT01685801|593320250|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
164259774|NCT01685801|593320251|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
164259775|NCT01685801|593320248|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
164259776|NCT01685801|593320249|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
164259777|NCT01685801|593320250|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
164259778|NCT01685801|593320251|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
164259779|NCT00113399|593320252|FG000|Overall Study|Death|1|||
164259780|NCT00113399|593320253|FG001|Overall Study|Death|1|||
164259781|NCT00113399|593320252|FG000|Overall Study|Withdrawal by Subject|1|||
164259782|NCT00113399|593320253|FG001|Overall Study|Withdrawal by Subject|2|||
164259783|NCT00113399|593320252|FG000|Overall Study|Complete Response|0|||
164259784|NCT00113399|593320253|FG001|Overall Study|Complete Response|1|||
164259785|NCT00113399|593320252|FG000|Overall Study|Other|0|||
164259786|NCT00113399|593320253|FG001|Overall Study|Other|1|||
164259787|NCT03350256|593320254|FG000|Overall Study|Inclusion/exclusion violation|4|||
164259788|NCT03350256|593320254|FG000|Overall Study|Recommended for other therapies|2|||
164259789|NCT03350256|593320254|FG000|Overall Study|Protocol Violation|3|||
164259790|NCT03350256|593320254|FG000|Overall Study|Non compliance|2|||
164259791|NCT03350256|593320254|FG000|Overall Study|Denial by insurance|1|||
164259792|NCT03350256|593320254|FG000|Overall Study|Adverse Event|2|||
164259793|NCT03350256|593320254|FG000|Overall Study|Trial failure|12|||
164259794|NCT03350256|593320254|FG000|Overall Study|Did not proceed to permanent implant|3|||
164259795|NCT03350256|593320254|FG000|Overall Study|Withdrawal by Subject|3|||
164259796|NCT03350256|593320254|FG000|Overall Study|Subject moving out of state|1|||
164259797|NCT03350256|593320254|FG000|Overall Study|Lost to Follow-up|1|||
164259798|NCT03350256|593320254|FG000|Overall Study|Lack of Efficacy|2|||
164259799|NCT00666588|593320255|FG000|Overall Study|ineligible|2|||
163888314|NCT04436276|591963331|FG021|Overall Study|Physician Decision|2|||
164259800|NCT00666588|593320256|FG001|Overall Study|ineligible|0|||
164259801|NCT00666588|593320257|FG002|Overall Study|ineligible|0|||
164259802|NCT00666588|593320258|FG003|Overall Study|ineligible|2|||
164259803|NCT00666588|593320255|FG000|Overall Study|inevaluable|2|||
164259804|NCT00666588|593320256|FG001|Overall Study|inevaluable|0|||
164259805|NCT00666588|593320257|FG002|Overall Study|inevaluable|0|||
164259806|NCT00666588|593320258|FG003|Overall Study|inevaluable|0|||
164259807|NCT04043234|593320259|FG000|Overall Study|Lost to Follow-up|1|||
164259808|NCT04043234|593320259|FG000|Overall Study|Withdrawal by Subject|1|||
164259809|NCT01187446|593320261|FG000|Overall Study|Patient started non-protocol therapy|0|||
164259810|NCT01187446|593320262|FG001|Overall Study|Patient started non-protocol therapy|1|||
164259811|NCT00791479|593320268|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259812|NCT00791479|593320269|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259813|NCT00791479|593320270|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259814|NCT00791479|593320271|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259815|NCT00791479|593320272|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
164259816|NCT00791479|593320273|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
164259817|NCT00791479|593320268|FG000|Overall Study|Adverse Event|0|||
164259818|NCT00791479|593320269|FG001|Overall Study|Adverse Event|1|||
164259819|NCT00791479|593320270|FG002|Overall Study|Adverse Event|0|||
164259820|NCT00791479|593320271|FG003|Overall Study|Adverse Event|2|||
164259821|NCT00791479|593320272|FG004|Overall Study|Adverse Event|0|||
164259822|NCT00791479|593320273|FG005|Overall Study|Adverse Event|1|||
164259823|NCT00791479|593320268|FG000|Overall Study|Lost to Follow-up|0|||
164259824|NCT00791479|593320269|FG001|Overall Study|Lost to Follow-up|1|||
164259825|NCT00791479|593320270|FG002|Overall Study|Lost to Follow-up|0|||
164259826|NCT00791479|593320271|FG003|Overall Study|Lost to Follow-up|0|||
164259827|NCT00791479|593320272|FG004|Overall Study|Lost to Follow-up|0|||
164259828|NCT00791479|593320273|FG005|Overall Study|Lost to Follow-up|1|||
164085066|NCT01418352|592675864|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
164085067|NCT01418352|592675865|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
164259829|NCT00791479|593320268|FG000|Overall Study|Protocol Violation|2|||
164259830|NCT00791479|593320269|FG001|Overall Study|Protocol Violation|1|||
164259831|NCT00791479|593320270|FG002|Overall Study|Protocol Violation|0|||
164259832|NCT00791479|593320271|FG003|Overall Study|Protocol Violation|1|||
164259833|NCT00791479|593320272|FG004|Overall Study|Protocol Violation|0|||
164259834|NCT00791479|593320273|FG005|Overall Study|Protocol Violation|0|||
164259835|NCT00791479|593320268|FG000|Overall Study|Withdrawal by Subject|0|||
164259836|NCT00791479|593320269|FG001|Overall Study|Withdrawal by Subject|0|||
164259837|NCT00791479|593320270|FG002|Overall Study|Withdrawal by Subject|0|||
164259838|NCT00791479|593320271|FG003|Overall Study|Withdrawal by Subject|1|||
164259839|NCT00791479|593320272|FG004|Overall Study|Withdrawal by Subject|0|||
164259840|NCT00791479|593320273|FG005|Overall Study|Withdrawal by Subject|1|||
164259841|NCT03405935|593320276|FG000|Overall Study|Adverse Event|3|||
164259842|NCT03405935|593320276|FG000|Overall Study|Death|2|||
164259843|NCT03405935|593320276|FG000|Overall Study|Withdrawal by Subject|1|||
164259844|NCT03405935|593320276|FG000|Overall Study|Lost to Follow-up|2|||
164259845|NCT04979897|593320277|FG000|Overall Study|Death|1|||
164259846|NCT04979897|593320278|FG001|Overall Study|Death|8|||
164259847|NCT04979897|593320277|FG000|Overall Study|Lost to Follow-up|111|||
164259848|NCT04979897|593320278|FG001|Overall Study|Lost to Follow-up|56|||
164259849|NCT04979897|593320277|FG000|Overall Study|Withdrawal by Subject|7|||
164259850|NCT04979897|593320278|FG001|Overall Study|Withdrawal by Subject|2|||
164259851|NCT01774097|593320279|FG000|Overall Study|Withdrawal by Subject|1|||
164259852|NCT01774097|593320280|FG001|Overall Study|Withdrawal by Subject|1|||
164259853|NCT01774097|593320279|FG000|Overall Study|Adverse Event|1|||
164259854|NCT01774097|593320280|FG001|Overall Study|Adverse Event|1|||
164259855|NCT04659174|593320286|FG000|Overall Study|Sponsor decision to discontinue study|0|||
164259856|NCT04659174|593320287|FG001|Overall Study|Sponsor decision to discontinue study|2|||
164259857|NCT04659174|593320286|FG000|Overall Study|Lost to Follow-up|9|||
164259858|NCT04659174|593320287|FG001|Overall Study|Lost to Follow-up|11|||
164259859|NCT04659174|593320286|FG000|Overall Study|Adverse Event|8|||
164259860|NCT04659174|593320287|FG001|Overall Study|Adverse Event|5|||
164259861|NCT04659174|593320286|FG000|Overall Study|Withdrawal by Subject|17|||
164259862|NCT04659174|593320287|FG001|Overall Study|Withdrawal by Subject|33|||
164259863|NCT04659174|593320286|FG000|Overall Study|Progressive disease|0|||
164259864|NCT04659174|593320287|FG001|Overall Study|Progressive disease|2|||
164259865|NCT04659174|593320286|FG000|Overall Study|Other reasons|0|||
164259866|NCT04659174|593320287|FG001|Overall Study|Other reasons|2|||
164259867|NCT04659174|593320286|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
164259868|NCT04659174|593320287|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
164259869|NCT04659174|593320286|FG000|Overall Study|Alcohol or illegal drug use|0|||
164259870|NCT04659174|593320287|FG001|Overall Study|Alcohol or illegal drug use|3|||
164259871|NCT04659174|593320286|FG000|Overall Study|Violation of entry criteria|1|||
164259872|NCT04659174|593320287|FG001|Overall Study|Violation of entry criteria|0|||
164259873|NCT04659174|593320286|FG000|Overall Study|Death|0|||
164259874|NCT04659174|593320287|FG001|Overall Study|Death|1|||
164259875|NCT02781792|593320288|FG000|Overall Study|Adverse Event|1|||
164259876|NCT02781792|593320289|FG001|Overall Study|Adverse Event|2|||
164259877|NCT02781792|593320288|FG000|Overall Study|Withdrawal by Subject|3|||
164259878|NCT02781792|593320289|FG001|Overall Study|Withdrawal by Subject|1|||
164259879|NCT02781792|593320288|FG000|Overall Study|Lack of Efficacy|1|||
164259880|NCT02781792|593320289|FG001|Overall Study|Lack of Efficacy|1|||
164259881|NCT02781792|593320288|FG000|Overall Study|Hospice|0|||
164259882|NCT02781792|593320289|FG001|Overall Study|Hospice|1|||
164259883|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
164259884|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
164259885|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
164259886|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
164340457|NCT00621959|593620614|FG000|Overall Study|Lack of Efficacy|1|||
164340458|NCT00621959|593620615|FG001|Overall Study|Lack of Efficacy|1|||
164340459|NCT00621959|593620614|FG000|Overall Study|Lost to Follow-up|0|||
164340460|NCT00621959|593620615|FG001|Overall Study|Lost to Follow-up|2|||
164340461|NCT00621959|593620614|FG000|Overall Study|Withdrawal by Subject|1|||
164340462|NCT00621959|593620615|FG001|Overall Study|Withdrawal by Subject|1|||
164340463|NCT00621959|593620614|FG000|Overall Study|Other|1|||
164340464|NCT00621959|593620615|FG001|Overall Study|Other|3|||
164340465|NCT00242216|593620616|FG000|Overall Study|Lost to Follow-up|12|||
164340466|NCT00242216|593620617|FG001|Overall Study|Lost to Follow-up|17|||
164340467|NCT00242216|593620616|FG000|Overall Study|Death|4|||
164340468|NCT00242216|593620617|FG001|Overall Study|Death|2|||
164340469|NCT00242216|593620616|FG000|Overall Study|Lack of Efficacy|1|||
164340470|NCT00242216|593620617|FG001|Overall Study|Lack of Efficacy|2|||
164340471|NCT00242216|593620616|FG000|Overall Study|no medicaiton dispensed|1|||
164340472|NCT00242216|593620617|FG001|Overall Study|no medicaiton dispensed|1|||
164340473|NCT02484690|593620618|FG000|Overall Study|Adverse Event|1|||
164340474|NCT02484690|593620619|FG001|Overall Study|Adverse Event|3|||
164340475|NCT02484690|593620620|FG002|Overall Study|Adverse Event|0|||
164340476|NCT02484690|593620621|FG003|Overall Study|Adverse Event|0|||
164259887|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
164340477|NCT02484690|593620622|FG004|Overall Study|Adverse Event|5|||
164340478|NCT02484690|593620618|FG000|Overall Study|Death|0|||
164340479|NCT02484690|593620619|FG001|Overall Study|Death|0|||
164340480|NCT02484690|593620620|FG002|Overall Study|Death|0|||
164340481|NCT02484690|593620621|FG003|Overall Study|Death|0|||
164340482|NCT02484690|593620622|FG004|Overall Study|Death|1|||
164259888|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
164259889|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
164259890|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259891|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259892|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259893|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
164259894|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
164259895|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259896|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259897|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259898|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259899|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259900|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
164259901|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259902|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259903|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259904|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259905|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259906|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259907|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
164259908|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259909|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259910|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259911|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259912|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259913|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259914|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259915|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259916|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259917|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259918|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
164259919|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259920|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164085068|NCT01418352|592675866|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
164259921|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
164259922|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259923|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259924|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259925|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259926|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259927|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259928|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259929|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259930|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259931|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259932|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259933|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259934|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259935|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259936|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
164259937|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259938|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259939|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
164259940|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259941|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259942|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259943|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259944|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259945|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259946|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259947|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259948|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259949|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259950|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259951|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259952|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259953|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259954|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
164259955|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259956|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259957|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259958|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259959|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259960|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259961|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259962|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259963|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259964|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259965|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
164259966|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259967|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259968|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259969|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259970|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259971|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259972|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
164259973|NCT03447314|593320294|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259974|NCT03447314|593320295|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259975|NCT03447314|593320296|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164340483|NCT02484690|593620618|FG000|Overall Study|Withdrawal by Subject|1|||
164340484|NCT02484690|593620619|FG001|Overall Study|Withdrawal by Subject|3|||
164340485|NCT02484690|593620620|FG002|Overall Study|Withdrawal by Subject|1|||
164340486|NCT02484690|593620621|FG003|Overall Study|Withdrawal by Subject|2|||
164340487|NCT02484690|593620622|FG004|Overall Study|Withdrawal by Subject|0|||
164340488|NCT02484690|593620618|FG000|Overall Study|Physician Decision|2|||
164340489|NCT02484690|593620619|FG001|Overall Study|Physician Decision|0|||
164340490|NCT02484690|593620620|FG002|Overall Study|Physician Decision|1|||
164340491|NCT02484690|593620621|FG003|Overall Study|Physician Decision|0|||
164259976|NCT03447314|593320297|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
164259977|NCT03447314|593320298|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259978|NCT03447314|593320299|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
164259979|NCT03447314|593320300|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259980|NCT03447314|593320301|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259981|NCT03447314|593320302|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259982|NCT03447314|593320303|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164340492|NCT02484690|593620622|FG004|Overall Study|Physician Decision|0|||
164340493|NCT02484690|593620618|FG000|Overall Study|Lost to Follow-up|0|||
164340494|NCT02484690|593620619|FG001|Overall Study|Lost to Follow-up|0|||
164340495|NCT02484690|593620620|FG002|Overall Study|Lost to Follow-up|1|||
164340496|NCT02484690|593620621|FG003|Overall Study|Lost to Follow-up|0|||
164340497|NCT02484690|593620622|FG004|Overall Study|Lost to Follow-up|0|||
164340498|NCT03360747|593620623|FG000|Overall Study|Voluntary Withdrawal|1|||
164340499|NCT01759511|593620624|FG000|Overall Study|Adverse Event|4|||
164340500|NCT01759511|593620624|FG000|Overall Study|Death|2|||
164340501|NCT01759511|593620624|FG000|Overall Study|Lack of Efficacy|2|||
164340502|NCT01759511|593620624|FG000|Overall Study|Physician Decision|1|||
164340503|NCT01759511|593620624|FG000|Overall Study|Progressive Disease|5|||
164340504|NCT01759511|593620624|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
164340505|NCT01759511|593620624|FG000|Overall Study|Study Terminated by Sponsor|13|||
164340506|NCT01759511|593620624|FG000|Overall Study|Withdrawal by Subject|3|||
164259983|NCT03447314|593320304|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259984|NCT03447314|593320305|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259985|NCT03447314|593320306|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259986|NCT03447314|593320307|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259987|NCT03447314|593320308|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259988|NCT03447314|593320309|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259989|NCT03447314|593320310|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259990|NCT03447314|593320311|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
164259991|NCT01920568|593320313|FG000|Overall Study|Adverse Event|27|||
164259992|NCT01920568|593320314|FG001|Overall Study|Adverse Event|8|||
164259993|NCT01920568|593320313|FG000|Overall Study|Protocol Violation|5|||
164259994|NCT01920568|593320314|FG001|Overall Study|Protocol Violation|3|||
164259995|NCT01920568|593320313|FG000|Overall Study|Lost to Follow-up|2|||
164259996|NCT01920568|593320314|FG001|Overall Study|Lost to Follow-up|2|||
164259997|NCT01920568|593320313|FG000|Overall Study|Physician Decision|13|||
164259998|NCT01920568|593320314|FG001|Overall Study|Physician Decision|4|||
164259999|NCT01920568|593320313|FG000|Overall Study|Withdrawal by Subject|79|||
164260000|NCT01920568|593320314|FG001|Overall Study|Withdrawal by Subject|55|||
164260001|NCT01920568|593320313|FG000|Overall Study|Death due to disease progression|25|||
164260002|NCT01920568|593320314|FG001|Overall Study|Death due to disease progression|12|||
164260003|NCT04049266|593320318|FG000|Overall Study|Adverse Event|16|||
164260004|NCT04049266|593320319|FG001|Overall Study|Adverse Event|9|||
164260005|NCT04049266|593320318|FG000|Overall Study|Non-compliance with study drug|0|||
164260006|NCT04049266|593320319|FG001|Overall Study|Non-compliance with study drug|3|||
164260007|NCT04049266|593320318|FG000|Overall Study|Withdrawal by Subject|6|||
164260008|NCT04049266|593320319|FG001|Overall Study|Withdrawal by Subject|10|||
164260009|NCT04049266|593320318|FG000|Overall Study|Lost to Follow-up|2|||
164260010|NCT04049266|593320319|FG001|Overall Study|Lost to Follow-up|2|||
164260011|NCT04049266|593320318|FG000|Overall Study|Progressive disease|11|||
164260012|NCT04049266|593320319|FG001|Overall Study|Progressive disease|2|||
164260013|NCT04049266|593320318|FG000|Overall Study|Physician Decision|1|||
164260014|NCT04049266|593320319|FG001|Overall Study|Physician Decision|0|||
164260015|NCT04049266|593320318|FG000|Overall Study|Patient moved out of state|1|||
164260016|NCT04049266|593320319|FG001|Overall Study|Patient moved out of state|0|||
164260017|NCT01703208|593320320|FG000|Overall Study|Death|61|||
164260018|NCT01703208|593320321|FG001|Overall Study|Death|48|||
164260019|NCT01703208|593320320|FG000|Overall Study|Lack of Efficacy|1|||
164260020|NCT01703208|593320321|FG001|Overall Study|Lack of Efficacy|2|||
164260021|NCT01703208|593320320|FG000|Overall Study|Lost to Follow-up|68|||
164260022|NCT01703208|593320321|FG001|Overall Study|Lost to Follow-up|62|||
164260023|NCT01703208|593320320|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164260024|NCT01703208|593320321|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164340507|NCT02569671|593620632|FG000|Overall Study|Lost to Follow-up|2|||
164340508|NCT02569671|593620633|FG001|Overall Study|Lost to Follow-up|1|||
163992729|NCT02928952|592342085|FG000|Overall Study|Physician Decision|0|||
163992730|NCT02928952|592342086|FG001|Overall Study|Physician Decision|1|||
163992731|NCT02601573|592342087|FG000|Overall Study|Lost to Follow-up|0|||
163992732|NCT02601573|592342088|FG001|Overall Study|Lost to Follow-up|3|||
163992733|NCT02601573|592342089|FG002|Overall Study|Lost to Follow-up|1|||
163992734|NCT02601573|592342090|FG003|Overall Study|Lost to Follow-up|0|||
163992735|NCT02601573|592342091|FG004|Overall Study|Lost to Follow-up|2|||
163992736|NCT02601573|592342087|FG000|Overall Study|Withdrawal by Subject|0|||
163992737|NCT02601573|592342088|FG001|Overall Study|Withdrawal by Subject|1|||
163992738|NCT02601573|592342089|FG002|Overall Study|Withdrawal by Subject|0|||
163992739|NCT02601573|592342090|FG003|Overall Study|Withdrawal by Subject|1|||
163992740|NCT02601573|592342091|FG004|Overall Study|Withdrawal by Subject|0|||
163992741|NCT00974220|592342092|FG000|Treatment Period 1|Adverse Event|2|||
163992742|NCT00974220|592342093|FG001|Treatment Period 1|Adverse Event|1|||
163992743|NCT00974220|592342092|FG000|Treatment Period 1|noncompliant subjects|0|||
163992744|NCT00974220|592342093|FG001|Treatment Period 1|noncompliant subjects|1|||
163992745|NCT01850615|592342094|FG000|Overall Study|Protocol Violation|4|||
163992746|NCT01850615|592342095|FG001|Overall Study|Protocol Violation|1|||
163992747|NCT01850615|592342094|FG000|Overall Study|Adverse Event|2|||
163992748|NCT01850615|592342095|FG001|Overall Study|Adverse Event|1|||
163992749|NCT01850615|592342094|FG000|Overall Study|Withdrawal by Subject|3|||
163992750|NCT01850615|592342095|FG001|Overall Study|Withdrawal by Subject|1|||
163992751|NCT01850615|592342094|FG000|Overall Study|Lost to Follow-up|0|||
163992752|NCT01850615|592342095|FG001|Overall Study|Lost to Follow-up|1|||
164260025|NCT01703208|593320320|FG000|Overall Study|Excluded Medication|1|||
164260026|NCT01703208|593320321|FG001|Overall Study|Excluded Medication|2|||
164260027|NCT01703208|593320320|FG000|Overall Study|Site Discontinued Study Participation|23|||
164260028|NCT01703208|593320321|FG001|Overall Study|Site Discontinued Study Participation|27|||
164260029|NCT01703208|593320320|FG000|Overall Study|Physician Decision|11|||
164260030|NCT01703208|593320321|FG001|Overall Study|Physician Decision|13|||
164260031|NCT01703208|593320320|FG000|Overall Study|Progressive disease|2|||
164260032|NCT01703208|593320321|FG001|Overall Study|Progressive disease|2|||
164260033|NCT01703208|593320320|FG000|Overall Study|Protocol Violation|1|||
164260034|NCT01703208|593320321|FG001|Overall Study|Protocol Violation|1|||
164260035|NCT01703208|593320320|FG000|Overall Study|Study Terminated by Sponsor|1710|||
164260036|NCT01703208|593320321|FG001|Overall Study|Study Terminated by Sponsor|1716|||
164260037|NCT01703208|593320320|FG000|Overall Study|Withdrawal by Subject|205|||
164260038|NCT01703208|593320321|FG001|Overall Study|Withdrawal by Subject|209|||
164260039|NCT01703208|593320320|FG000|Overall Study|Adverse Event|14|||
164260040|NCT01703208|593320321|FG001|Overall Study|Adverse Event|19|||
164260041|NCT01703208|593320320|FG000|Overall Study|Technical Problems|0|||
164260042|NCT01703208|593320321|FG001|Overall Study|Technical Problems|1|||
164260043|NCT01703208|593320320|FG000|Overall Study|Protocol Deviation|2|||
164260044|NCT01703208|593320321|FG001|Overall Study|Protocol Deviation|0|||
164260045|NCT04600076|593320325|FG000|Overall Study|Lost to Follow-up|3|||
164260046|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
164260047|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
164260048|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
164260049|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
164260050|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
164260051|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
164260052|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
164260053|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
164260054|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
164260055|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
164260056|NCT01639339|593320326|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
164260057|NCT01639339|593320327|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
164260058|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
164260059|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
164260060|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
164260061|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
164260062|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
164260063|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
164260064|NCT01639339|593320326|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
164260065|NCT01639339|593320327|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
163888315|NCT04436276|591963332|FG022|Overall Study|Physician Decision|0|||
163888316|NCT04436276|591963310|FG000|Overall Study|Protocol Violation|0|||
163888317|NCT04436276|591963311|FG001|Overall Study|Protocol Violation|0|||
163888318|NCT04436276|591963312|FG002|Overall Study|Protocol Violation|0|||
163888319|NCT04436276|591963313|FG003|Overall Study|Protocol Violation|0|||
163888320|NCT04436276|591963314|FG004|Overall Study|Protocol Violation|0|||
163888321|NCT04436276|591963315|FG005|Overall Study|Protocol Violation|0|||
163888322|NCT04436276|591963316|FG006|Overall Study|Protocol Violation|0|||
163888323|NCT04436276|591963317|FG007|Overall Study|Protocol Violation|0|||
163888324|NCT04436276|591963318|FG008|Overall Study|Protocol Violation|0|||
163888325|NCT04436276|591963319|FG009|Overall Study|Protocol Violation|0|||
163888326|NCT04436276|591963320|FG010|Overall Study|Protocol Violation|0|||
163888327|NCT04436276|591963321|FG011|Overall Study|Protocol Violation|0|||
163888328|NCT04436276|591963322|FG012|Overall Study|Protocol Violation|0|||
163888329|NCT04436276|591963323|FG013|Overall Study|Protocol Violation|1|||
163888330|NCT04436276|591963324|FG014|Overall Study|Protocol Violation|0|||
163888331|NCT04436276|591963325|FG015|Overall Study|Protocol Violation|1|||
163888332|NCT04436276|591963326|FG016|Overall Study|Protocol Violation|0|||
163888333|NCT04436276|591963327|FG017|Overall Study|Protocol Violation|0|||
163888334|NCT04436276|591963328|FG018|Overall Study|Protocol Violation|0|||
163888335|NCT04436276|591963329|FG019|Overall Study|Protocol Violation|0|||
163888336|NCT04436276|591963330|FG020|Overall Study|Protocol Violation|0|||
163888337|NCT04436276|591963331|FG021|Overall Study|Protocol Violation|0|||
163888338|NCT04436276|591963332|FG022|Overall Study|Protocol Violation|0|||
163888339|NCT04436276|591963310|FG000|Overall Study|Withdrawal by Subject|25|||
163888340|NCT04436276|591963311|FG001|Overall Study|Withdrawal by Subject|22|||
163888341|NCT04436276|591963312|FG002|Overall Study|Withdrawal by Subject|24|||
163888342|NCT04436276|591963313|FG003|Overall Study|Withdrawal by Subject|23|||
163888343|NCT04436276|591963314|FG004|Overall Study|Withdrawal by Subject|14|||
163888344|NCT04436276|591963315|FG005|Overall Study|Withdrawal by Subject|0|||
163888345|NCT04436276|591963316|FG006|Overall Study|Withdrawal by Subject|0|||
163888346|NCT04436276|591963317|FG007|Overall Study|Withdrawal by Subject|1|||
163888347|NCT04436276|591963318|FG008|Overall Study|Withdrawal by Subject|0|||
163888348|NCT04436276|591963319|FG009|Overall Study|Withdrawal by Subject|1|||
163888349|NCT04436276|591963320|FG010|Overall Study|Withdrawal by Subject|17|||
163888350|NCT04436276|591963321|FG011|Overall Study|Withdrawal by Subject|7|||
163888351|NCT04436276|591963322|FG012|Overall Study|Withdrawal by Subject|10|||
163888352|NCT04436276|591963323|FG013|Overall Study|Withdrawal by Subject|6|||
164260066|NCT02891681|593320328|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
164260067|NCT02891681|593320329|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
164260068|NCT02891681|593320330|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
164260069|NCT02891681|593320328|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
164260070|NCT02891681|593320329|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
164260071|NCT02891681|593320330|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
164260072|NCT02891681|593320328|FG000|Overall Study|Taken off study after first imaging appointment|1|||
164260073|NCT02891681|593320329|FG001|Overall Study|Taken off study after first imaging appointment|0|||
164260074|NCT02891681|593320330|FG002|Overall Study|Taken off study after first imaging appointment|0|||
164260075|NCT01170598|593320331|FG000|Overall Study|Withdrawal by Subject|1|||
164260076|NCT01170598|593320331|FG000|Overall Study|Death|3|||
164260077|NCT01170598|593320331|FG000|Overall Study|Lost to Follow-up|1|||
164260078|NCT01170598|593320331|FG000|Overall Study|Refused|1|||
164260079|NCT01271712|593320332|FG000|Double Blind Treatment|Death|2|||
164260080|NCT01271712|593320333|FG001|Double Blind Treatment|Death|0|||
164260081|NCT01271712|593320332|FG000|Double Blind Treatment|Lack of Efficacy|1|||
164260082|NCT01271712|593320333|FG001|Double Blind Treatment|Lack of Efficacy|0|||
164260083|NCT01271712|593320332|FG000|Double Blind Treatment|Adverse Event|9|||
164260084|NCT01271712|593320333|FG001|Double Blind Treatment|Adverse Event|4|||
164260085|NCT01271712|593320332|FG000|Double Blind Treatment|Progressive disease|23|||
164260086|NCT01271712|593320333|FG001|Double Blind Treatment|Progressive disease|3|||
164260087|NCT01271712|593320332|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
164260088|NCT01271712|593320333|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
164260089|NCT01271712|593320332|FG000|Double Blind Treatment|Non compliance with study drug|2|||
164260090|NCT01271712|593320333|FG001|Double Blind Treatment|Non compliance with study drug|0|||
164260091|NCT01271712|593320332|FG000|Double Blind Treatment|receive no study drug|1|||
164260092|NCT01271712|593320333|FG001|Double Blind Treatment|receive no study drug|0|||
164260093|NCT01271712|593320332|FG000|Open Label Treatment|Death|6|||
164260094|NCT01271712|593320333|FG001|Open Label Treatment|Death|5|||
164260095|NCT01271712|593320332|FG000|Open Label Treatment|Withdrawal by Subject|6|||
164260096|NCT01271712|593320333|FG001|Open Label Treatment|Withdrawal by Subject|11|||
164260097|NCT01271712|593320332|FG000|Open Label Treatment|Physician Decision|2|||
164260098|NCT01271712|593320333|FG001|Open Label Treatment|Physician Decision|0|||
164260099|NCT01271712|593320332|FG000|Open Label Treatment|Adverse Event|14|||
164260100|NCT01271712|593320333|FG001|Open Label Treatment|Adverse Event|8|||
164260101|NCT01271712|593320332|FG000|Open Label Treatment|Progressive disease|59|||
164260102|NCT01271712|593320333|FG001|Open Label Treatment|Progressive disease|32|||
164260103|NCT01271712|593320332|FG000|Open Label Treatment|transferred to rollover study|1|||
164260104|NCT01271712|593320333|FG001|Open Label Treatment|transferred to rollover study|0|||
164260105|NCT01271712|593320332|FG000|Open Label Treatment|Non-compliance with study drug|1|||
164260106|NCT01271712|593320333|FG001|Open Label Treatment|Non-compliance with study drug|0|||
164260107|NCT01271712|593320332|FG000|Open Label Treatment|Protocol Violation|0|||
163992753|NCT01850615|592342094|FG000|Overall Study|Unclassified|0|||
164260108|NCT01271712|593320333|FG001|Open Label Treatment|Protocol Violation|1|||
164260109|NCT01271712|593320332|FG000|Open Label Treatment|Switching to other therapy|2|||
164260110|NCT01271712|593320333|FG001|Open Label Treatment|Switching to other therapy|1|||
164260111|NCT01271712|593320332|FG000|Safety Follow-up|Death|11|||
164260112|NCT01271712|593320333|FG001|Safety Follow-up|Death|7|||
164260113|NCT01271712|593320332|FG000|Safety Follow-up|Withdrawal by Subject|4|||
163992754|NCT01850615|592342095|FG001|Overall Study|Unclassified|1|||
163992755|NCT00706628|592342096|FG000|Overall Study|Other Adverse Event|16|||
163992756|NCT00706628|592342097|FG001|Overall Study|Other Adverse Event|5|||
163992757|NCT00706628|592342098|FG002|Overall Study|Other Adverse Event|5|||
163992758|NCT00706628|592342099|FG003|Overall Study|Other Adverse Event|2|||
163992759|NCT00706628|592342096|FG000|Overall Study|Non compliant with protocol|0|||
163992760|NCT00706628|592342097|FG001|Overall Study|Non compliant with protocol|1|||
163992761|NCT00706628|592342098|FG002|Overall Study|Non compliant with protocol|0|||
164260114|NCT01271712|593320333|FG001|Safety Follow-up|Withdrawal by Subject|2|||
164260115|NCT01271712|593320332|FG000|Safety Follow-up|Protocol Violation|1|||
164260116|NCT01271712|593320333|FG001|Safety Follow-up|Protocol Violation|1|||
164260117|NCT01271712|593320332|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
164260118|NCT01271712|593320333|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
164260119|NCT01271712|593320332|FG000|Safety Follow-up|No follow-up|1|||
164260120|NCT01271712|593320333|FG001|Safety Follow-up|No follow-up|1|||
164260121|NCT01271712|593320332|FG000|Safety Follow-up|Progressive disease|1|||
164260122|NCT01271712|593320333|FG001|Safety Follow-up|Progressive disease|0|||
164260123|NCT01271712|593320332|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
164260124|NCT01271712|593320333|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
164260125|NCT02685748|593320336|FG000|Overall Study|Withdrawal by Subject|3|||
164260126|NCT02685748|593320337|FG001|Overall Study|Withdrawal by Subject|2|||
164260127|NCT01944098|593320340|FG000|Overall Study|Physician Decision|1|||
164260128|NCT01944098|593320341|FG001|Overall Study|Physician Decision|0|||
164260129|NCT02136680|593320342|FG000|Overall Study|No Longer Interested|1|||
164260130|NCT02136680|593320343|FG001|Overall Study|No Longer Interested|1|||
164260131|NCT02136680|593320342|FG000|Overall Study|No longer receiving care at clinic|3|||
164260132|NCT02136680|593320343|FG001|Overall Study|No longer receiving care at clinic|5|||
164260133|NCT02136680|593320342|FG000|Overall Study|Moved away|5|||
164260134|NCT02136680|593320343|FG001|Overall Study|Moved away|4|||
164260135|NCT02136680|593320342|FG000|Overall Study|Unable to schedule|17|||
164260136|NCT02136680|593320343|FG001|Overall Study|Unable to schedule|16|||
164260137|NCT02136680|593320342|FG000|Overall Study|Study ended before interview due|6|||
163992762|NCT00706628|592342099|FG003|Overall Study|Non compliant with protocol|0|||
163992763|NCT00706628|592342096|FG000|Overall Study|Consent withdrawn|6|||
163992764|NCT00706628|592342097|FG001|Overall Study|Consent withdrawn|1|||
163992765|NCT00706628|592342098|FG002|Overall Study|Consent withdrawn|3|||
163992766|NCT00706628|592342099|FG003|Overall Study|Consent withdrawn|0|||
163992767|NCT00706628|592342096|FG000|Overall Study|Progressive disease|20|||
163992768|NCT00706628|592342097|FG001|Overall Study|Progressive disease|13|||
163992769|NCT00706628|592342098|FG002|Overall Study|Progressive disease|8|||
163992770|NCT00706628|592342099|FG003|Overall Study|Progressive disease|1|||
163992771|NCT00706628|592342096|FG000|Overall Study|Other than those stated above|4|||
163992772|NCT00706628|592342097|FG001|Overall Study|Other than those stated above|0|||
163992773|NCT00706628|592342098|FG002|Overall Study|Other than those stated above|0|||
163992774|NCT00706628|592342099|FG003|Overall Study|Other than those stated above|0|||
163992775|NCT00706628|592342096|FG000|Overall Study|Not treated|1|||
163992776|NCT00706628|592342097|FG001|Overall Study|Not treated|1|||
163992777|NCT00706628|592342098|FG002|Overall Study|Not treated|0|||
163992778|NCT00706628|592342099|FG003|Overall Study|Not treated|0|||
163992779|NCT02921425|592342100|FG000|Overall Study|Protocol Violation|9|||
163992780|NCT01227967|592342101|FG000|Overall Study|Protocol Violation|3|||
163992781|NCT01227967|592342102|FG001|Overall Study|Protocol Violation|1|||
163992782|NCT01227967|592342101|FG000|Overall Study|Death|0|||
163992783|NCT01227967|592342102|FG001|Overall Study|Death|1|||
163992784|NCT01227967|592342101|FG000|Overall Study|Lost to Follow-up|8|||
163992785|NCT01227967|592342102|FG001|Overall Study|Lost to Follow-up|3|||
163992786|NCT01227967|592342101|FG000|Overall Study|Withdrawal by Subject|4|||
163992787|NCT01227967|592342102|FG001|Overall Study|Withdrawal by Subject|3|||
163992788|NCT01227967|592342101|FG000|Overall Study|Physician Decision|0|||
163992789|NCT01227967|592342102|FG001|Overall Study|Physician Decision|1|||
163992790|NCT01227967|592342101|FG000|Overall Study|Never Started Treatment|0|||
163992791|NCT01227967|592342102|FG001|Overall Study|Never Started Treatment|4|||
163992792|NCT01227967|592342101|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
163992793|NCT01227967|592342102|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
163992794|NCT03403400|592342103|FG000|Overall Study|Lost to Follow-up|1|||
163992795|NCT03403400|592342104|FG001|Overall Study|Lost to Follow-up|0|||
164260138|NCT02136680|593320343|FG001|Overall Study|Study ended before interview due|3|||
164260139|NCT03136497|593321952|FG000|Overall Study|Screen Failure|1|||
164260140|NCT03136497|593321953|FG001|Overall Study|Screen Failure|0|||
164260141|NCT03136497|593321954|FG002|Overall Study|Screen Failure|0|||
164260142|NCT00557310|593321956|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
164260143|NCT00557310|593321956|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
163992796|NCT03403400|592342105|FG002|Overall Study|Lost to Follow-up|1|||
163992797|NCT03403400|592342103|FG000|Overall Study|Hospitalization|1|||
163992798|NCT03403400|592342104|FG001|Overall Study|Hospitalization|0|||
163992799|NCT03403400|592342105|FG002|Overall Study|Hospitalization|0|||
163992800|NCT03403400|592342103|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
164085069|NCT01418352|592675867|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
164085070|NCT00619619|592675868|FG000|Overall Study|Physician Decision|0|||
164085071|NCT00619619|592675869|FG001|Overall Study|Physician Decision|0|||
164085072|NCT00619619|592675870|FG002|Overall Study|Physician Decision|1|||
164085073|NCT00619619|592675871|FG003|Overall Study|Physician Decision|0|||
164085074|NCT00619619|592675872|FG004|Overall Study|Physician Decision|0|||
164085075|NCT00619619|592675873|FG005|Overall Study|Physician Decision|0|||
164085076|NCT00619619|592675874|FG006|Overall Study|Physician Decision|0|||
164085077|NCT00619619|592675875|FG007|Overall Study|Physician Decision|0|||
164085078|NCT00619619|592675868|FG000|Overall Study|Protocol Violation|0|||
164085079|NCT00619619|592675869|FG001|Overall Study|Protocol Violation|0|||
164085080|NCT00619619|592675870|FG002|Overall Study|Protocol Violation|0|||
164260144|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
164260145|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
164260146|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
164260147|NCT00557310|593321956|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
164260148|NCT02351349|593321957|FG000|Overall Study|Withdrawal by Subject|2|||
164085081|NCT00619619|592675871|FG003|Overall Study|Protocol Violation|1|||
164260149|NCT02351349|593321958|FG001|Overall Study|Withdrawal by Subject|3|||
164260150|NCT02649218|593321959|FG000|Overall Study|Adverse Event|8|||
164260151|NCT02649218|593321959|FG000|Overall Study|Lack of Efficacy|8|||
164260152|NCT02649218|593321959|FG000|Overall Study|Pregnancy|3|||
164260153|NCT02649218|593321959|FG000|Overall Study|Protocol Violation|3|||
164260154|NCT02649218|593321959|FG000|Overall Study|Physician Decision|1|||
164260155|NCT02649218|593321959|FG000|Overall Study|Withdrawal by Subject|2|||
164260156|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
164260157|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
164260158|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
164260159|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
164260160|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
164260161|NCT01224821|593321960|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
164260162|NCT01224821|593321960|FG000|Long-Term Follow-Up|Death|2|||
164260163|NCT01224821|593321960|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
164260164|NCT02174523|593321961|FG000|Overall Study|Withdrawal by Subject|1|||
164260165|NCT02174523|593321962|FG001|Overall Study|Withdrawal by Subject|0|||
164260166|NCT00794365|593321963|FG000|Overall Study|Lost to Follow-up|38|||
164260167|NCT00794365|593321963|FG000|Overall Study|Other|17|||
164260168|NCT00794365|593321963|FG000|Overall Study|Poor Compliance|11|||
164260169|NCT00794365|593321963|FG000|Overall Study|Adverse Event|10|||
164260170|NCT00794365|593321963|FG000|Overall Study|Lack of Efficacy|3|||
164260171|NCT01451931|593321966|FG000|Overall Study|Lost to Follow-up|17|||
164260172|NCT01451931|593321967|FG001|Overall Study|Lost to Follow-up|36|||
164260173|NCT01451931|593321968|FG002|Overall Study|Lost to Follow-up|21|||
164260174|NCT01451931|593321966|FG000|Overall Study|Withdrawal by Subject|16|||
164260175|NCT01451931|593321967|FG001|Overall Study|Withdrawal by Subject|22|||
164260176|NCT01451931|593321968|FG002|Overall Study|Withdrawal by Subject|22|||
164260177|NCT04422561|593321969|FG000|Overall Study|Lost to Follow-up|25|||
164340509|NCT02569671|593620632|FG000|Overall Study|Withdrawal by Subject|1|||
164340510|NCT02569671|593620633|FG001|Overall Study|Withdrawal by Subject|3|||
164340511|NCT01757535|593620634|FG000|Overall Study|Disease Relapse|151|||
163888353|NCT04436276|591963324|FG014|Overall Study|Withdrawal by Subject|20|||
163888354|NCT04436276|591963325|FG015|Overall Study|Withdrawal by Subject|6|||
163888355|NCT04436276|591963326|FG016|Overall Study|Withdrawal by Subject|11|||
163888356|NCT04436276|591963327|FG017|Overall Study|Withdrawal by Subject|4|||
163888357|NCT04436276|591963328|FG018|Overall Study|Withdrawal by Subject|14|||
163888358|NCT04436276|591963329|FG019|Overall Study|Withdrawal by Subject|24|||
163888359|NCT04436276|591963330|FG020|Overall Study|Withdrawal by Subject|24|||
163888360|NCT04436276|591963331|FG021|Overall Study|Withdrawal by Subject|16|||
163888361|NCT04436276|591963332|FG022|Overall Study|Withdrawal by Subject|14|||
163888362|NCT04436276|591963310|FG000|Overall Study|Other|3|||
163888363|NCT04436276|591963311|FG001|Overall Study|Other|2|||
164085082|NCT00619619|592675872|FG004|Overall Study|Protocol Violation|0|||
164085083|NCT00619619|592675873|FG005|Overall Study|Protocol Violation|0|||
164085084|NCT00619619|592675874|FG006|Overall Study|Protocol Violation|1|||
164260178|NCT04422561|593321970|FG001|Overall Study|Lost to Follow-up|11|||
164260179|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
164260180|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
164260181|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
164260182|NCT00230282|593321976|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
164260183|NCT04669262|593321986|FG000|Overall Study|Withdrawal by Subject|0|||
164260184|NCT04669262|593321987|FG001|Overall Study|Withdrawal by Subject|0|||
164340512|NCT01757535|593620635|FG001|Overall Study|Disease Relapse|181|||
163888364|NCT04436276|591963312|FG002|Overall Study|Other|5|||
163888365|NCT04436276|591963313|FG003|Overall Study|Other|9|||
163888366|NCT04436276|591963314|FG004|Overall Study|Other|23|||
164085085|NCT00619619|592675875|FG007|Overall Study|Protocol Violation|1|||
164085086|NCT00619619|592675868|FG000|Overall Study|Adverse Event|0|||
164085087|NCT00619619|592675869|FG001|Overall Study|Adverse Event|0|||
164085088|NCT00619619|592675870|FG002|Overall Study|Adverse Event|0|||
164085089|NCT00619619|592675871|FG003|Overall Study|Adverse Event|0|||
164260185|NCT04669262|593321988|FG002|Overall Study|Withdrawal by Subject|0|||
164260186|NCT04669262|593321989|FG003|Overall Study|Withdrawal by Subject|1|||
164260187|NCT04669262|593321986|FG000|Overall Study|Randomized but Not Treated|0|||
164260188|NCT04669262|593321987|FG001|Overall Study|Randomized but Not Treated|1|||
164260189|NCT04669262|593321988|FG002|Overall Study|Randomized but Not Treated|0|||
164260190|NCT04669262|593321989|FG003|Overall Study|Randomized but Not Treated|0|||
164260191|NCT01638013|593321990|FG000|Overall Study|Adverse Event|36|||
164260192|NCT01638013|593321991|FG001|Overall Study|Adverse Event|29|||
164260193|NCT01638013|593321992|FG002|Overall Study|Adverse Event|48|||
164260194|NCT01638013|593321990|FG000|Overall Study|Lack of Efficacy|39|||
164260195|NCT01638013|593321991|FG001|Overall Study|Lack of Efficacy|11|||
164260196|NCT01638013|593321992|FG002|Overall Study|Lack of Efficacy|14|||
164260197|NCT01638013|593321990|FG000|Overall Study|Protocol Violation|10|||
164260198|NCT01638013|593321991|FG001|Overall Study|Protocol Violation|7|||
164260199|NCT01638013|593321992|FG002|Overall Study|Protocol Violation|11|||
164260200|NCT01638013|593321990|FG000|Overall Study|Met discontinuation criteria|4|||
164260201|NCT01638013|593321991|FG001|Overall Study|Met discontinuation criteria|0|||
164260202|NCT01638013|593321992|FG002|Overall Study|Met discontinuation criteria|7|||
164260203|NCT01638013|593321990|FG000|Overall Study|Subject Lost to Follow up|1|||
164260204|NCT01638013|593321991|FG001|Overall Study|Subject Lost to Follow up|0|||
164260205|NCT01638013|593321992|FG002|Overall Study|Subject Lost to Follow up|1|||
164260206|NCT01638013|593321990|FG000|Overall Study|Miscellaneous|25|||
164260207|NCT01638013|593321991|FG001|Overall Study|Miscellaneous|19|||
164260208|NCT01638013|593321992|FG002|Overall Study|Miscellaneous|23|||
164260209|NCT01638013|593321990|FG000|Overall Study|Withdrawal of Consent|16|||
164260210|NCT01638013|593321991|FG001|Overall Study|Withdrawal of Consent|12|||
164260211|NCT01638013|593321992|FG002|Overall Study|Withdrawal of Consent|16|||
164260212|NCT01638013|593321990|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
164260213|NCT01638013|593321991|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
164260214|NCT01638013|593321992|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
164260215|NCT02701777|593321993|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
164260216|NCT02701777|593321994|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
164260217|NCT02701777|593321995|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
164260218|NCT02701777|593321996|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
164340513|NCT01757535|593620634|FG000|Overall Study|Other Reasons|28|||
164340514|NCT01757535|593620635|FG001|Overall Study|Other Reasons|27|||
164340515|NCT01757535|593620634|FG000|Overall Study|Adverse Event|31|||
164340516|NCT01757535|593620635|FG001|Overall Study|Adverse Event|11|||
164340517|NCT01757535|593620634|FG000|Overall Study|Withdrew Consent|19|||
164340518|NCT01757535|593620635|FG001|Overall Study|Withdrew Consent|13|||
164340519|NCT01757535|593620634|FG000|Overall Study|Physician Decision|7|||
164340520|NCT01757535|593620635|FG001|Overall Study|Physician Decision|0|||
164340521|NCT01757535|593620634|FG000|Overall Study|Death|2|||
164340522|NCT01757535|593620635|FG001|Overall Study|Death|2|||
164340523|NCT00589290|593620636|FG000|Overall Study|Withdrawal by Subject|1|||
164340524|NCT03730012|593620638|FG000|Overall Study|Adverse Event|0|||
164340525|NCT03730012|593620639|FG001|Overall Study|Adverse Event|1|||
164340526|NCT03730012|593620638|FG000|Overall Study|Lack of Efficacy|1|||
164340527|NCT03730012|593620639|FG001|Overall Study|Lack of Efficacy|5|||
164340528|NCT03730012|593620638|FG000|Overall Study|Withdrawal by Subject|0|||
164340529|NCT03730012|593620639|FG001|Overall Study|Withdrawal by Subject|1|||
164340530|NCT03730012|593620638|FG000|Overall Study|Miscellaneous|2|||
164340531|NCT03730012|593620639|FG001|Overall Study|Miscellaneous|1|||
164340532|NCT01367002|593622197|FG000|Overall Study|Withdrawal by Subject|1|||
164340533|NCT01367002|593622198|FG001|Overall Study|Withdrawal by Subject|0|||
164340534|NCT01367002|593622197|FG000|Overall Study|Physician Decision|0|||
164340535|NCT01367002|593622198|FG001|Overall Study|Physician Decision|2|||
164340536|NCT00403234|593622199|FG000|Overall Study|Withdrawal by Subject|0|||
164340537|NCT00403234|593622200|FG001|Overall Study|Withdrawal by Subject|1|||
164340538|NCT00403234|593622201|FG002|Overall Study|Withdrawal by Subject|0|||
164340539|NCT00403234|593622202|FG003|Overall Study|Withdrawal by Subject|0|||
164340540|NCT00403234|593622199|FG000|Overall Study|Adverse Event|1|||
164340541|NCT00403234|593622200|FG001|Overall Study|Adverse Event|0|||
164085090|NCT00619619|592675872|FG004|Overall Study|Adverse Event|2|||
164085091|NCT00619619|592675873|FG005|Overall Study|Adverse Event|0|||
164260219|NCT02701777|593321993|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
164260220|NCT02701777|593321994|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
164260221|NCT02701777|593321995|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
164260222|NCT02701777|593321996|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
164260223|NCT01960998|593322001|FG000|Overall Study|Lost to Follow-up|3|||
164085092|NCT00619619|592675874|FG006|Overall Study|Adverse Event|0|||
164085093|NCT00619619|592675875|FG007|Overall Study|Adverse Event|2|||
164260224|NCT01960998|593322002|FG001|Overall Study|Lost to Follow-up|7|||
164260225|NCT01960998|593322001|FG000|Overall Study|Death|0|||
164260226|NCT01960998|593322002|FG001|Overall Study|Death|1|||
164260227|NCT01960998|593322001|FG000|Overall Study|Withdrawal by Subject|8|||
164260228|NCT01960998|593322002|FG001|Overall Study|Withdrawal by Subject|2|||
164260229|NCT01960998|593322001|FG000|Overall Study|lost computer access|0|||
164260230|NCT01960998|593322002|FG001|Overall Study|lost computer access|1|||
163888367|NCT04436276|591963315|FG005|Overall Study|Other|1|||
164085094|NCT01992107|592675878|FG000|Overall Study|Administrative reasons|2|||
164260231|NCT01904149|593322005|FG000|Overall Study|Adverse Event|3|||
164260232|NCT01904149|593322006|FG001|Overall Study|Adverse Event|4|||
164260233|NCT01904149|593322007|FG002|Overall Study|Adverse Event|0|||
164260234|NCT01904149|593322008|FG003|Overall Study|Adverse Event|1|||
164260235|NCT01904149|593322009|FG004|Overall Study|Adverse Event|1|||
164260236|NCT01904149|593322010|FG005|Overall Study|Adverse Event|2|||
164260237|NCT01904149|593322005|FG000|Overall Study|Lack of Efficacy|0|||
164260238|NCT01904149|593322006|FG001|Overall Study|Lack of Efficacy|3|||
164260239|NCT01904149|593322007|FG002|Overall Study|Lack of Efficacy|1|||
164260240|NCT01904149|593322008|FG003|Overall Study|Lack of Efficacy|3|||
164260241|NCT01904149|593322009|FG004|Overall Study|Lack of Efficacy|3|||
164260242|NCT01904149|593322010|FG005|Overall Study|Lack of Efficacy|1|||
164260243|NCT01904149|593322005|FG000|Overall Study|Withdrawal by Subject|1|||
164260244|NCT01904149|593322006|FG001|Overall Study|Withdrawal by Subject|3|||
164260245|NCT01904149|593322007|FG002|Overall Study|Withdrawal by Subject|1|||
164260246|NCT01904149|593322008|FG003|Overall Study|Withdrawal by Subject|0|||
164260247|NCT01904149|593322009|FG004|Overall Study|Withdrawal by Subject|1|||
164260248|NCT01904149|593322010|FG005|Overall Study|Withdrawal by Subject|0|||
164260249|NCT01904149|593322005|FG000|Overall Study|Protocol Violation|0|||
164260250|NCT01904149|593322006|FG001|Overall Study|Protocol Violation|1|||
164260251|NCT01904149|593322007|FG002|Overall Study|Protocol Violation|0|||
164260252|NCT01904149|593322008|FG003|Overall Study|Protocol Violation|0|||
164260253|NCT01904149|593322009|FG004|Overall Study|Protocol Violation|0|||
164260254|NCT01904149|593322010|FG005|Overall Study|Protocol Violation|0|||
164260255|NCT01904149|593322005|FG000|Overall Study|non compliance with study drug|1|||
164260256|NCT01904149|593322006|FG001|Overall Study|non compliance with study drug|0|||
164260257|NCT01904149|593322007|FG002|Overall Study|non compliance with study drug|0|||
164260258|NCT01904149|593322008|FG003|Overall Study|non compliance with study drug|0|||
164260259|NCT01904149|593322009|FG004|Overall Study|non compliance with study drug|0|||
164260260|NCT01904149|593322010|FG005|Overall Study|non compliance with study drug|0|||
164260261|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Death|5|||
164260262|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Death|0|||
164260263|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Death|0|||
164260264|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
164260265|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
164260266|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
164260267|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
164260268|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
164260269|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
164260270|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
164260271|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
164260272|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
164260273|NCT01357161|593322011|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
164260274|NCT01357161|593322012|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
164260275|NCT01357161|593322013|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
164260276|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
164260277|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
164260278|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
164260279|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
164260280|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
164260281|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
164260282|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
164260283|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
164260284|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
164260285|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
164260286|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
164260287|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
164260288|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
164085095|NCT01992107|592675879|FG001|Overall Study|Administrative reasons|0|||
164085096|NCT01992107|592675880|FG002|Overall Study|Administrative reasons|0|||
164085097|NCT01992107|592675878|FG000|Overall Study|Adverse Event|0|||
164085098|NCT01992107|592675879|FG001|Overall Study|Adverse Event|1|||
164085099|NCT01992107|592675880|FG002|Overall Study|Adverse Event|0|||
164260289|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
164340542|NCT00403234|593622201|FG002|Overall Study|Adverse Event|1|||
164260290|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
164260291|NCT01357161|593322011|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
164260292|NCT01357161|593322012|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
164260293|NCT01357161|593322013|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
164260294|NCT01824823|593322014|FG000|Overall Study|Lack of Efficacy|1|||
164260295|NCT01824823|593322015|FG001|Overall Study|Lack of Efficacy|1|||
164260296|NCT01824823|593322014|FG000|Overall Study|Off-treatment reason not submitted|1|||
164260297|NCT01824823|593322015|FG001|Overall Study|Off-treatment reason not submitted|0|||
164260298|NCT03349645|593322016|FG000|Overall Study|Sponsor Terminated Study|75|||
164260299|NCT03349645|593322016|FG000|Overall Study|Withdrawal by Subject|4|||
164260300|NCT03349645|593322016|FG000|Overall Study|Protocol Violation|1|||
164260301|NCT03349645|593322016|FG000|Overall Study|Other|2|||
164260302|NCT02910401|593322017|FG000|Overall Study|Study closure Study closure|0|||
164260303|NCT02910401|593322018|FG001|Overall Study|Study closure Study closure|0|||
164260304|NCT02910401|593322019|FG002|Overall Study|Study closure Study closure|2|||
164260305|NCT02910401|593322017|FG000|Overall Study|Physician Decision|1|||
164260306|NCT02910401|593322018|FG001|Overall Study|Physician Decision|0|||
164260307|NCT02910401|593322019|FG002|Overall Study|Physician Decision|0|||
164260308|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
164260309|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
164260310|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Death|0|||
164260311|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Death|0|||
164260312|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
164260313|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
164260314|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
164260315|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
164260316|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
164260317|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
164260318|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
164260319|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
164260320|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
164260321|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
164260322|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
164260323|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
164260324|NCT00433160|593322022|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
164260325|NCT00433160|593322023|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
164260326|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
164260327|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
164260328|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
164260329|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
164260330|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
164260331|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
164260332|NCT00433160|593322022|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
164260333|NCT00433160|593322023|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
164260334|NCT00433160|593322022|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
164260335|NCT00433160|593322023|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
164260336|NCT00433160|593322022|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
164260337|NCT00433160|593322023|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
164260338|NCT00433160|593322022|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
164260339|NCT00433160|593322023|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
164260340|NCT01774253|593322024|FG000|Overall Study|Lack of Efficacy|4|||
164260341|NCT01774253|593322024|FG000|Overall Study|Physician Decision|2|||
164260342|NCT01774253|593322024|FG000|Overall Study|Withdrawal by Subject|2|||
164260343|NCT01774253|593322024|FG000|Overall Study|Death|1|||
164260344|NCT00772369|593322025|FG000|Overall Study|Did not return record release form|1|||
164260345|NCT02240368|593322029|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
164260346|NCT02240368|593322030|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
164260347|NCT02240368|593322031|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
164260348|NCT02240368|593322029|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
164260349|NCT02240368|593322030|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
164260350|NCT02240368|593322031|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
164260351|NCT03510468|593322032|FG000|Overall Study|Lost to Follow-up|1|||
164260352|NCT03510468|593322032|FG000|Overall Study|Adverse Event|5|||
164260353|NCT03510468|593322032|FG000|Overall Study|Physician Decision|1|||
164260354|NCT03510468|593322032|FG000|Overall Study|non-compliant with treatment|2|||
164340543|NCT00403234|593622202|FG003|Overall Study|Adverse Event|0|||
164340544|NCT00560105|593622205|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
164340545|NCT00560105|593622206|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
164260355|NCT03510468|593322032|FG000|Overall Study|Missed visit|1|||
164260356|NCT03372460|593322034|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
163992801|NCT03403400|592342104|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
163992802|NCT03403400|592342105|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
163992803|NCT01107444|592342109|FG000|Overall Study|Withdrawal by Subject|8|||
163992804|NCT01107444|592342110|FG001|Overall Study|Withdrawal by Subject|12|||
163992805|NCT01107444|592342109|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
163992806|NCT01107444|592342110|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
163992807|NCT02266433|592342114|FG000|Overall Study|Lost to Follow-up|54|||
163992808|NCT02266433|592342115|FG001|Overall Study|Lost to Follow-up|46|||
163992809|NCT02266433|592342114|FG000|Overall Study|Withdrawal by Subject|5|||
163992810|NCT02266433|592342115|FG001|Overall Study|Withdrawal by Subject|7|||
163992811|NCT00737529|592342119|FG000|Overall Study|Disease Progression|95|||
163992812|NCT00737529|592342119|FG000|Overall Study|Adverse Event|24|||
163992813|NCT00737529|592342119|FG000|Overall Study|Withdrawal by Subject|5|||
163992814|NCT00737529|592342119|FG000|Overall Study|Death|4|||
163992815|NCT00737529|592342119|FG000|Overall Study|Protocol Violation|1|||
164260357|NCT03372460|593322035|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
164260358|NCT00916058|593322043|FG000|Phase 1|Screen Failure|0|||
164260359|NCT00916058|593322044|FG001|Phase 1|Screen Failure|0|||
164260360|NCT00916058|593322045|FG002|Phase 1|Screen Failure|0|||
164260361|NCT00916058|593322046|FG003|Phase 1|Screen Failure|0|||
164260362|NCT00916058|593322047|FG004|Phase 1|Screen Failure|0|||
163992816|NCT00737529|592342119|FG000|Overall Study|Other|4|||
163992817|NCT01948830|592342120|FG000|Overall Study|Physician Decision|1|||
164260363|NCT00916058|593322048|FG005|Phase 1|Screen Failure|1|||
164260364|NCT00916058|593322049|FG006|Phase 1|Screen Failure|0|||
164260365|NCT00916058|593322043|FG000|Phase 2|Screen Failure|0|||
164260366|NCT00916058|593322044|FG001|Phase 2|Screen Failure|0|||
164260367|NCT00916058|593322045|FG002|Phase 2|Screen Failure|0|||
164260368|NCT00916058|593322046|FG003|Phase 2|Screen Failure|0|||
164260369|NCT00916058|593322047|FG004|Phase 2|Screen Failure|0|||
164260370|NCT00916058|593322048|FG005|Phase 2|Screen Failure|0|||
164260371|NCT00916058|593322049|FG006|Phase 2|Screen Failure|3|||
164260372|NCT00871117|593322050|FG000|Overall Study|Lost to Follow-up|5|||
164260373|NCT00871117|593322051|FG001|Overall Study|Lost to Follow-up|6|||
164260374|NCT00871117|593322050|FG000|Overall Study|Other|0|||
164260375|NCT00871117|593322051|FG001|Overall Study|Other|4|||
164260376|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
164260377|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
164260378|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
164260379|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
164260380|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
164260381|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
164260382|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
164260383|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
164260384|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
164260385|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
164260386|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
164260387|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
164260388|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
164260389|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
164260390|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
164260391|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
164260392|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
164260393|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
164260394|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
164260395|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
164260396|NCT03222973|593322052|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
164260397|NCT03222973|593322053|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
164260398|NCT03222973|593322054|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
164260399|NCT03222973|593322055|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
164260400|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
164260401|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
164260402|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
164260403|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
163992818|NCT01948830|592342121|FG001|Overall Study|Physician Decision|3|||
163992819|NCT01948830|592342120|FG000|Overall Study|Protocol deviation|1|||
164085100|NCT01992107|592675878|FG000|Overall Study|Lost to Follow-up|46|||
164260404|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
164260405|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
164260406|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
164260407|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
164260408|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
164260409|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
164260410|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
163992820|NCT01948830|592342121|FG001|Overall Study|Protocol deviation|2|||
163992821|NCT01948830|592342120|FG000|Overall Study|Lost to Follow-up|5|||
163992822|NCT01948830|592342121|FG001|Overall Study|Lost to Follow-up|4|||
164260411|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
164260412|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
164260413|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
164260414|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
164260415|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
164260416|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
164260417|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
164260418|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
164260419|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
164260420|NCT03222973|593322052|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
164260421|NCT03222973|593322053|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
164260422|NCT03222973|593322054|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
164260423|NCT03222973|593322055|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
164260424|NCT02080481|593322056|FG000|Overall Study|Never received a block.|1|||
164260425|NCT02080481|593322057|FG001|Overall Study|Never received a block.|0|||
164260426|NCT02439450|593322059|FG000|Overall Study|Adverse Event|4|||
164260427|NCT02439450|593322060|FG001|Overall Study|Adverse Event|1|||
164260428|NCT02439450|593322061|FG002|Overall Study|Adverse Event|0|||
164260429|NCT02439450|593322062|FG003|Overall Study|Adverse Event|0|||
164260430|NCT02439450|593322059|FG000|Overall Study|Withdrawal by Subject|1|||
164260431|NCT02439450|593322060|FG001|Overall Study|Withdrawal by Subject|2|||
164260432|NCT02439450|593322061|FG002|Overall Study|Withdrawal by Subject|0|||
164260433|NCT02439450|593322062|FG003|Overall Study|Withdrawal by Subject|0|||
164260434|NCT02439450|593322059|FG000|Overall Study|Death|3|||
164260435|NCT02439450|593322060|FG001|Overall Study|Death|0|||
164260436|NCT02439450|593322061|FG002|Overall Study|Death|0|||
164260437|NCT02439450|593322062|FG003|Overall Study|Death|1|||
164260438|NCT02439450|593322059|FG000|Overall Study|Progressive Disease|18|||
164260439|NCT02439450|593322060|FG001|Overall Study|Progressive Disease|41|||
164260440|NCT02439450|593322061|FG002|Overall Study|Progressive Disease|2|||
164260441|NCT02439450|593322062|FG003|Overall Study|Progressive Disease|3|||
164260442|NCT03730961|593322067|FG000|Overall Study|Adverse Event|0|||
164260443|NCT03730961|593322068|FG001|Overall Study|Adverse Event|1|||
164260444|NCT04508751|593322071|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
164260445|NCT04508751|593322072|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
164260446|NCT04508751|593322073|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
164340546|NCT01550289|593622207|FG000|Overall Study|Protocol Violation|1|||
164340547|NCT01550289|593622208|FG001|Overall Study|Protocol Violation|0|||
164340548|NCT01550289|593622207|FG000|Overall Study|Lost to Follow-up|1|||
163992823|NCT01948830|592342120|FG000|Overall Study|Withdrawal by Subject|14|||
163992824|NCT01948830|592342121|FG001|Overall Study|Withdrawal by Subject|17|||
163992825|NCT01948830|592342120|FG000|Overall Study|Adverse Event|9|||
163992826|NCT01948830|592342121|FG001|Overall Study|Adverse Event|2|||
163992827|NCT01948830|592342120|FG000|Overall Study|Death|3|||
163992828|NCT01948830|592342121|FG001|Overall Study|Death|4|||
163992829|NCT01145560|592342122|FG000|Overall Study|Withdrawal by Subject|2|||
163992830|NCT01145560|592342123|FG001|Overall Study|Withdrawal by Subject|1|||
163992831|NCT01145560|592342124|FG002|Overall Study|Withdrawal by Subject|0|||
163992832|NCT01145560|592342122|FG000|Overall Study|Lost to Follow-up|1|||
163992833|NCT01145560|592342123|FG001|Overall Study|Lost to Follow-up|1|||
163992834|NCT01145560|592342124|FG002|Overall Study|Lost to Follow-up|1|||
163992835|NCT01145560|592342122|FG000|Overall Study|No study drug by 24h after organ failure|1|||
163992836|NCT01145560|592342123|FG001|Overall Study|No study drug by 24h after organ failure|0|||
163992837|NCT01145560|592342124|FG002|Overall Study|No study drug by 24h after organ failure|0|||
164260447|NCT01444027|593322084|FG000|Overall Study|Withdrawal by Subject|4|||
164260448|NCT01444027|593322085|FG001|Overall Study|Withdrawal by Subject|10|||
164260449|NCT01444027|593322086|FG002|Overall Study|Withdrawal by Subject|24|||
164260450|NCT01444027|593322084|FG000|Overall Study|Lost to Follow-up|26|||
164260451|NCT01444027|593322085|FG001|Overall Study|Lost to Follow-up|20|||
164260452|NCT01444027|593322086|FG002|Overall Study|Lost to Follow-up|14|||
164260453|NCT03551665|593322088|FG000|Overall Study|Lost to Follow-up|11|||
164260454|NCT03551665|593322089|FG001|Overall Study|Lost to Follow-up|2|||
164260455|NCT03966885|593323541|FG000|Overall Study|Death|1|||
164260456|NCT03966885|593323542|FG001|Overall Study|Death|0|||
164260457|NCT03966885|593323541|FG000|Overall Study|Lost to Follow-up|1|||
164260458|NCT03966885|593323542|FG001|Overall Study|Lost to Follow-up|2|||
164260459|NCT03966885|593323541|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
164260460|NCT03966885|593323542|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
164260461|NCT03966885|593323541|FG000|Overall Study|Moved from study area.|0|||
164260462|NCT03966885|593323542|FG001|Overall Study|Moved from study area.|2|||
164340549|NCT01550289|593622208|FG001|Overall Study|Lost to Follow-up|1|||
164340550|NCT01550289|593622207|FG000|Overall Study|Withdrawal by Subject|11|||
164260463|NCT00840060|593323543|FG000|Overall Study|Withdrawal by Subject|1|||
164260464|NCT00840060|593323544|FG001|Overall Study|Withdrawal by Subject|0|||
164260465|NCT00840060|593323543|FG000|Overall Study|Change in emotional/behavioral status|0|||
164340551|NCT01550289|593622208|FG001|Overall Study|Withdrawal by Subject|3|||
163992838|NCT01145560|592342122|FG000|Overall Study|Accidental unblinding of study treatment|0|||
163992839|NCT01145560|592342123|FG001|Overall Study|Accidental unblinding of study treatment|1|||
163992840|NCT01145560|592342124|FG002|Overall Study|Accidental unblinding of study treatment|0|||
163992841|NCT01145560|592342122|FG000|Overall Study|False insurance information|0|||
163992842|NCT01145560|592342123|FG001|Overall Study|False insurance information|1|||
163992843|NCT01145560|592342124|FG002|Overall Study|False insurance information|0|||
163992844|NCT01145560|592342122|FG000|Overall Study|Withdrawal of therapy|0|||
163992845|NCT01145560|592342123|FG001|Overall Study|Withdrawal of therapy|0|||
163992846|NCT01145560|592342124|FG002|Overall Study|Withdrawal of therapy|1|||
163992847|NCT00712348|592342125|FG000|Overall Study|Withdrawal by Subject|1|||
163992848|NCT03310970|592342127|FG000|Overall Study|Withdrawal by Subject|0|||
163992849|NCT03310970|592342128|FG001|Overall Study|Withdrawal by Subject|1|||
163992850|NCT01446419|592342133|FG000|Overall Study|Death|1|||
163992851|NCT01446419|592342134|FG001|Overall Study|Death|0|||
163992852|NCT01446419|592342133|FG000|Overall Study|Withdrawal by Subject|1|||
163992853|NCT01446419|592342134|FG001|Overall Study|Withdrawal by Subject|1|||
163992854|NCT01446419|592342133|FG000|Overall Study|Terminated per protocol|3|||
163992855|NCT01446419|592342134|FG001|Overall Study|Terminated per protocol|0|||
163992856|NCT01557166|592342135|FG000|Overall Study|Adverse Event|20|||
163992857|NCT01557166|592342136|FG001|Overall Study|Adverse Event|6|||
163992858|NCT01557166|592342135|FG000|Overall Study|Lack of Efficacy|2|||
163992859|NCT01557166|592342136|FG001|Overall Study|Lack of Efficacy|1|||
163992860|NCT01557166|592342135|FG000|Overall Study|Protocol Violation|8|||
163992861|NCT01557166|592342136|FG001|Overall Study|Protocol Violation|5|||
163992862|NCT01557166|592342135|FG000|Overall Study|Withdrawn consent|12|||
163992863|NCT01557166|592342136|FG001|Overall Study|Withdrawn consent|20|||
163992864|NCT01557166|592342135|FG000|Overall Study|Target dose not tolerated|1|||
163992865|NCT01557166|592342136|FG001|Overall Study|Target dose not tolerated|0|||
163992866|NCT01557166|592342135|FG000|Overall Study|Psychiatric disorder|1|||
163992867|NCT01557166|592342136|FG001|Overall Study|Psychiatric disorder|0|||
163992868|NCT01557166|592342135|FG000|Overall Study|Unclassified|2|||
163992869|NCT01557166|592342136|FG001|Overall Study|Unclassified|5|||
163992870|NCT00946309|592342137|FG000|Overall Study|Protocol Violation|1|||
163992871|NCT00946309|592342138|FG001|Overall Study|Protocol Violation|0|||
163992872|NCT00946309|592342137|FG000|Overall Study|Lost to Follow-up|0|||
163992873|NCT00946309|592342138|FG001|Overall Study|Lost to Follow-up|1|||
163992874|NCT00946309|592342137|FG000|Overall Study|Procedure cancelled/discontinued|0|||
163992875|NCT00946309|592342138|FG001|Overall Study|Procedure cancelled/discontinued|3|||
163992876|NCT01465659|592342139|FG000|Completed 1 Cycle of Treatment|Death|0|||
163992877|NCT01465659|592342140|FG001|Completed 1 Cycle of Treatment|Death|1|||
163992878|NCT01465659|592342141|FG002|Completed 1 Cycle of Treatment|Death|0|||
163992879|NCT01465659|592342142|FG003|Completed 1 Cycle of Treatment|Death|0|||
163992880|NCT01465659|592342139|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
163992881|NCT01465659|592342140|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
163992882|NCT01465659|592342141|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
163992883|NCT01465659|592342142|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
163992884|NCT01465659|592342139|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
163992885|NCT01465659|592342140|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
163992886|NCT01465659|592342141|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
163992887|NCT01465659|592342142|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
163992888|NCT01465659|592342139|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
164260466|NCT00840060|593323544|FG001|Overall Study|Change in emotional/behavioral status|1|||
164260467|NCT01514240|593323545|FG000|Overall Study|Adverse Event|4|||
164260468|NCT01514240|593323546|FG001|Overall Study|Adverse Event|4|||
164260469|NCT01514240|593323545|FG000|Overall Study|Subject Decision|2|||
163992889|NCT01465659|592342140|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
164260470|NCT01514240|593323546|FG001|Overall Study|Subject Decision|7|||
164260471|NCT00509093|593323547|FG000|Overall Study|Adverse Event|10|||
164260472|NCT00509093|593323547|FG000|Overall Study|Disease Progression|9|||
164260473|NCT00509093|593323547|FG000|Overall Study|Transformed into MDS|1|||
164260474|NCT00509093|593323547|FG000|Overall Study|Withdrawal by Subject|3|||
164340552|NCT03539081|593622209|FG000|Overall Study|Withdrawal by Subject|2|||
163992890|NCT01465659|592342141|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
163992891|NCT01465659|592342142|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
164260475|NCT00509093|593323547|FG000|Overall Study|Physician Decision|1|||
163992892|NCT01465659|592342139|FG000|Completed Follow for 1 Year|Death|6|||
163992893|NCT01465659|592342140|FG001|Completed Follow for 1 Year|Death|3|||
163992894|NCT01465659|592342141|FG002|Completed Follow for 1 Year|Death|2|||
163992895|NCT01465659|592342142|FG003|Completed Follow for 1 Year|Death|4|||
163992896|NCT02411747|592342145|FG000|Overall Study|Withdrawal by Subject|1|||
163992897|NCT02411747|592342146|FG001|Overall Study|Withdrawal by Subject|0|||
163992898|NCT02411747|592342145|FG000|Overall Study|Protocol Violation|2|||
164260476|NCT05013424|593323548|FG000|Overall Study|Lost to Follow-up|1|||
164260477|NCT05013424|593323549|FG001|Overall Study|Lost to Follow-up|1|||
164260478|NCT05013424|593323550|FG002|Overall Study|Lost to Follow-up|1|||
164260479|NCT05013424|593323548|FG000|Overall Study|Withdrawal by Subject|0|||
164260480|NCT05013424|593323549|FG001|Overall Study|Withdrawal by Subject|1|||
164260481|NCT05013424|593323550|FG002|Overall Study|Withdrawal by Subject|0|||
164260482|NCT01103063|593323551|FG000|Overall Study|Adverse Event|3|||
164260483|NCT01103063|593323552|FG001|Overall Study|Adverse Event|1|||
164260484|NCT01103063|593323551|FG000|Overall Study|Lost to Follow-up|68|||
164260485|NCT01103063|593323552|FG001|Overall Study|Lost to Follow-up|51|||
164260486|NCT01103063|593323551|FG000|Overall Study|Withdrawal by Subject|60|||
164260487|NCT01103063|593323552|FG001|Overall Study|Withdrawal by Subject|15|||
164260488|NCT01103063|593323551|FG000|Overall Study|Other|16|||
164260489|NCT01103063|593323552|FG001|Overall Study|Other|11|||
164260490|NCT01103063|593323551|FG000|Overall Study|Protocol Violation|1|||
164260491|NCT01103063|593323552|FG001|Overall Study|Protocol Violation|0|||
164260492|NCT01103063|593323551|FG000|Overall Study|Study terminated by Sponsor|326|||
164260493|NCT01103063|593323552|FG001|Overall Study|Study terminated by Sponsor|342|||
164260494|NCT01103063|593323551|FG000|Overall Study|Death|3|||
164260495|NCT01103063|593323552|FG001|Overall Study|Death|1|||
164260496|NCT03899064|593323561|FG000|Overall Study|Lost to Follow-up|1|||
164260497|NCT03899064|593323561|FG000|Overall Study|Protocol Violation|2|||
164260498|NCT03899064|593323561|FG000|Overall Study|Withdrawal by Subject|2|||
164260499|NCT03899064|593323561|FG000|Overall Study|Other|2|||
164260500|NCT03283098|593323562|FG000|Overall Study|Withdrawal by Subject|0|||
164260501|NCT03283098|593323563|FG001|Overall Study|Withdrawal by Subject|1|||
164260502|NCT01069861|593323567|FG000|Overall Study|Death|1|||
164260503|NCT01069861|593323567|FG000|Overall Study|Adverse Event|1|||
164260504|NCT01069861|593323567|FG000|Overall Study|Did not meet entrance criteria|1|||
164260505|NCT00354107|593323568|FG000|Overall Study|Adverse Event|2|||
164260506|NCT00354107|593323568|FG000|Overall Study|Physician Decision|2|||
164260507|NCT00354107|593323568|FG000|Overall Study|Withdrawal by Subject|1|||
164260508|NCT03538444|593323577|FG000|Overall Study|opioid withdrawal|1|||
164260509|NCT03538444|593323578|FG001|Overall Study|opioid withdrawal|0|||
164260510|NCT00457821|593323584|FG000|Part 2|Withdrawal by Subject|0|||
164260511|NCT00457821|593323585|FG001|Part 2|Withdrawal by Subject|0|||
164260512|NCT00457821|593323586|FG002|Part 2|Withdrawal by Subject|0|||
164260513|NCT00457821|593323587|FG003|Part 2|Withdrawal by Subject|0|||
164260514|NCT00457821|593323588|FG004|Part 2|Withdrawal by Subject|0|||
164260515|NCT00457821|593323589|FG005|Part 2|Withdrawal by Subject|0|||
164260516|NCT00457821|593323590|FG006|Part 2|Withdrawal by Subject|0|||
164260517|NCT00457821|593323591|FG007|Part 2|Withdrawal by Subject|1|||
164260518|NCT00790647|593323596|FG000|Overall Study|Adverse Event|1|||
164260519|NCT02437409|593323601|FG000|Overall Study|Withdrawal by Subject|3|||
164260520|NCT02437409|593323601|FG000|Overall Study|Screening failure|12|||
164260521|NCT00027378|593323602|FG000|Overall Study|Physician Decision|0|||
164260522|NCT00027378|593323603|FG001|Overall Study|Physician Decision|3|||
164260523|NCT01369680|593323605|FG000|Overall Study|Lost to Follow-up|0|||
164260524|NCT01369680|593323606|FG001|Overall Study|Lost to Follow-up|0|||
163992899|NCT02411747|592342146|FG001|Overall Study|Protocol Violation|4|||
163992900|NCT02149810|592342147|FG000|Overall Study|Physician Decision|1|||
163992901|NCT02149810|592342148|FG001|Overall Study|Physician Decision|2|||
163992902|NCT02149810|592342147|FG000|Overall Study|Lost to Follow-up|2|||
163992903|NCT02149810|592342148|FG001|Overall Study|Lost to Follow-up|1|||
163992904|NCT02149810|592342147|FG000|Overall Study|Withdrawal by Subject|5|||
163992905|NCT02149810|592342148|FG001|Overall Study|Withdrawal by Subject|1|||
164260525|NCT01369680|593323607|FG002|Overall Study|Lost to Follow-up|1|||
164260526|NCT01369680|593323608|FG003|Overall Study|Lost to Follow-up|2|||
164260527|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
164260528|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
164260529|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
164260530|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
164260531|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
164260532|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
164260533|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
164260534|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
164260535|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
164260536|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
164260537|NCT03549871|593323609|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
163992906|NCT00428597|592342149|FG000|Overall Study|Randomized but not treated|3|||
163992907|NCT00428597|592342150|FG001|Overall Study|Randomized but not treated|3|||
164260538|NCT03549871|593323610|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
164260539|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
164260540|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
164260541|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
164260542|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
164260543|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
164260544|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
164260545|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
164260546|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
164260547|NCT03549871|593323609|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
164260548|NCT03549871|593323610|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
164260549|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
164260550|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
164260551|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
164260552|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
164260553|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
164260554|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
164260555|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
164260556|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
164260557|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
164260558|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
164260559|NCT00737568|593323613|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
164260560|NCT00737568|593323614|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
164260561|NCT00737568|593323613|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
164260562|NCT00737568|593323614|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
164260563|NCT00737568|593323613|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
164260564|NCT00737568|593323614|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
164260565|NCT00737568|593323613|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
164260566|NCT00737568|593323614|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
164260567|NCT01133626|593323615|FG000|Overall Study|Adverse Event|0|||
164260568|NCT01133626|593323616|FG001|Overall Study|Adverse Event|1|||
164260569|NCT01133626|593323617|FG002|Overall Study|Adverse Event|0|||
164260570|NCT01133626|593323615|FG000|Overall Study|Withdrawal by Subject|1|||
164260571|NCT01133626|593323616|FG001|Overall Study|Withdrawal by Subject|2|||
164260572|NCT01133626|593323617|FG002|Overall Study|Withdrawal by Subject|2|||
164260573|NCT01133626|593323615|FG000|Overall Study|Other|0|||
164260574|NCT01133626|593323616|FG001|Overall Study|Other|2|||
164260575|NCT01133626|593323617|FG002|Overall Study|Other|0|||
164260576|NCT00951080|593323618|FG000|Overall Study|Adverse Event|3|||
164260577|NCT00951080|593323619|FG001|Overall Study|Adverse Event|3|||
164260578|NCT00951080|593323618|FG000|Overall Study|Lost to Follow-up|0|||
164260579|NCT00951080|593323619|FG001|Overall Study|Lost to Follow-up|1|||
164260580|NCT00951080|593323618|FG000|Overall Study|Physician Decision|4|||
164260581|NCT00951080|593323619|FG001|Overall Study|Physician Decision|1|||
164260582|NCT00951080|593323618|FG000|Overall Study|Other|19|||
164260583|NCT00951080|593323619|FG001|Overall Study|Other|22|||
164260584|NCT01713283|593323620|FG000|Overall Study|Lack of Efficacy|10|||
164260585|NCT01713283|593323621|FG001|Overall Study|Lack of Efficacy|2|||
163888368|NCT04436276|591963316|FG006|Overall Study|Other|0|||
164260586|NCT01713283|593323620|FG000|Overall Study|Lost to Follow-up|1|||
164260587|NCT01713283|593323621|FG001|Overall Study|Lost to Follow-up|1|||
164260588|NCT00835640|593323622|FG000|Second Intervention|Protocol Violation|1|||
164260589|NCT00835640|593323623|FG001|Second Intervention|Protocol Violation|0|||
164260590|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
164260591|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
164260592|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Death|1|||
164260593|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Death|0|||
164260594|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
164260595|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
163888369|NCT04436276|591963317|FG007|Overall Study|Other|0|||
163888370|NCT04436276|591963318|FG008|Overall Study|Other|0|||
163888371|NCT04436276|591963319|FG009|Overall Study|Other|0|||
164260596|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
164260597|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
164260598|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
164260599|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
163888372|NCT04436276|591963320|FG010|Overall Study|Other|3|||
164085101|NCT01992107|592675879|FG001|Overall Study|Lost to Follow-up|22|||
164260600|NCT00350272|593323624|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
164260601|NCT00350272|593323625|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
164260602|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
164260603|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
164260604|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
164260605|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
164260606|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
163888373|NCT04436276|591963321|FG011|Overall Study|Other|1|||
163888374|NCT04436276|591963322|FG012|Overall Study|Other|1|||
164260607|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
164260608|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
164260609|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
164260610|NCT00350272|593323624|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
164260611|NCT00350272|593323625|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
164260612|NCT00235391|593323627|FG000|Overall Study|Adverse Event|4|||
164260613|NCT00235391|593323628|FG001|Overall Study|Adverse Event|5|||
164260614|NCT00235391|593323629|FG002|Overall Study|Adverse Event|10|||
164260615|NCT00235391|593323630|FG003|Overall Study|Adverse Event|72|||
164260616|NCT00235391|593323631|FG004|Overall Study|Adverse Event|5|||
164260617|NCT00235391|593323632|FG005|Overall Study|Adverse Event|2|||
164260618|NCT00235391|593323627|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164260619|NCT00235391|593323628|FG001|Overall Study|Abnormal laboratory value(s)|5|||
164260620|NCT00235391|593323629|FG002|Overall Study|Abnormal laboratory value(s)|4|||
164260621|NCT00235391|593323630|FG003|Overall Study|Abnormal laboratory value(s)|27|||
164260622|NCT00235391|593323631|FG004|Overall Study|Abnormal laboratory value(s)|1|||
164260623|NCT00235391|593323632|FG005|Overall Study|Abnormal laboratory value(s)|2|||
164260624|NCT00235391|593323627|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164260625|NCT00235391|593323628|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164260626|NCT00235391|593323629|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164260627|NCT00235391|593323630|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
164260628|NCT00235391|593323631|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
164260629|NCT00235391|593323632|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
164260630|NCT00235391|593323627|FG000|Overall Study|Condition no longer requires treatment|3|||
164260631|NCT00235391|593323628|FG001|Overall Study|Condition no longer requires treatment|0|||
164260632|NCT00235391|593323629|FG002|Overall Study|Condition no longer requires treatment|0|||
164260633|NCT00235391|593323630|FG003|Overall Study|Condition no longer requires treatment|11|||
164260634|NCT00235391|593323631|FG004|Overall Study|Condition no longer requires treatment|1|||
164260635|NCT00235391|593323632|FG005|Overall Study|Condition no longer requires treatment|0|||
164260636|NCT00235391|593323627|FG000|Overall Study|Protocol deviation|0|||
164340553|NCT03539081|593622210|FG001|Overall Study|Withdrawal by Subject|3|||
164340554|NCT03539081|593622211|FG002|Overall Study|Withdrawal by Subject|0|||
164340555|NCT03539081|593622209|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
164340556|NCT03539081|593622210|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
164340557|NCT03539081|593622211|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
164340558|NCT02555683|593622218|FG000|Overall Study|Physician Decision|1|||
164340559|NCT02555683|593622219|FG001|Overall Study|Physician Decision|0|||
164340560|NCT02555683|593622220|FG002|Overall Study|Physician Decision|2|||
164340561|NCT02555683|593622218|FG000|Overall Study|Lost to Follow-up|2|||
164340562|NCT02555683|593622219|FG001|Overall Study|Lost to Follow-up|1|||
164340563|NCT02555683|593622220|FG002|Overall Study|Lost to Follow-up|2|||
164340564|NCT02555683|593622218|FG000|Overall Study|Technical Problems|1|||
164340565|NCT02555683|593622219|FG001|Overall Study|Technical Problems|1|||
163992908|NCT00428597|592342149|FG000|Overall Study|Objective Progression or Relapse|19|||
163992909|NCT00428597|592342150|FG001|Overall Study|Objective Progression or Relapse|47|||
163992910|NCT00428597|592342149|FG000|Overall Study|Study Terminated by Sponsor|41|||
163992911|NCT00428597|592342150|FG001|Overall Study|Study Terminated by Sponsor|16|||
163992912|NCT00428597|592342149|FG000|Overall Study|Adverse Event|15|||
163992913|NCT00428597|592342150|FG001|Overall Study|Adverse Event|7|||
163992914|NCT00428597|592342149|FG000|Overall Study|Global Deterioration of Health Status|1|||
163992915|NCT00428597|592342150|FG001|Overall Study|Global Deterioration of Health Status|5|||
163992916|NCT00428597|592342149|FG000|Overall Study|Protocol Violation|2|||
163992917|NCT00428597|592342150|FG001|Overall Study|Protocol Violation|1|||
163992918|NCT00428597|592342149|FG000|Overall Study|Withdrawal by Subject|2|||
163992919|NCT00428597|592342150|FG001|Overall Study|Withdrawal by Subject|1|||
163992920|NCT00428597|592342149|FG000|Overall Study|Other|1|||
163992921|NCT00428597|592342150|FG001|Overall Study|Other|1|||
163992922|NCT00428597|592342149|FG000|Overall Study|Lost to Follow-up|0|||
163992923|NCT00428597|592342150|FG001|Overall Study|Lost to Follow-up|1|||
163992924|NCT00428597|592342149|FG000|Overall Study|Pregnancy|1|||
163992925|NCT00428597|592342150|FG001|Overall Study|Pregnancy|0|||
163992926|NCT00428597|592342149|FG000|Overall Study|Death|1|||
163992927|NCT00428597|592342150|FG001|Overall Study|Death|3|||
163992928|NCT00675597|592342151|FG000|Overall Study|Withdrawal by Subject|3|||
164260637|NCT00235391|593323628|FG001|Overall Study|Protocol deviation|0|||
164260638|NCT00235391|593323629|FG002|Overall Study|Protocol deviation|1|||
164260639|NCT00235391|593323630|FG003|Overall Study|Protocol deviation|11|||
164260640|NCT00235391|593323631|FG004|Overall Study|Protocol deviation|0|||
164260641|NCT00235391|593323632|FG005|Overall Study|Protocol deviation|0|||
163992929|NCT00560755|592342153|FG000|Overall Study|Protocol Violation|15|||
163992930|NCT00560755|592342153|FG000|Overall Study|Withdrawal by Subject|26|||
164085102|NCT01992107|592675880|FG002|Overall Study|Lost to Follow-up|26|||
163992931|NCT00560755|592342153|FG000|Overall Study|Lost to Follow-up|9|||
163992932|NCT00560755|592342153|FG000|Overall Study|Adverse Event|8|||
163992933|NCT00560755|592342153|FG000|Overall Study|Physician Decision|2|||
163992934|NCT03828487|592342156|FG000|Overall Study|Physician Decision|1|||
163992935|NCT02474329|592342161|FG000|Overall Study|Withdraw or did not contribute data.|13|||
163992936|NCT01356589|592342162|FG000|Overall Study|Enrolled, but not treated|3|||
163992937|NCT01356589|592342162|FG000|Overall Study|Dose data not recorded|2|||
163992938|NCT02447848|592342163|FG000|Overall Study|Patient discharged|3|||
163992939|NCT02447848|592342163|FG000|Overall Study|Lack of Efficacy|4|||
163992940|NCT02447848|592342163|FG000|Overall Study|Withdrawal by Subject|4|||
163992941|NCT03219164|592343864|FG000|Overall Study|Study Terminated by Sponsor|16|||
163992942|NCT03219164|592343865|FG001|Overall Study|Study Terminated by Sponsor|12|||
163992943|NCT03219164|592343864|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
163992944|NCT03219164|592343865|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
163992945|NCT03219164|592343864|FG000|Overall Study|Lost to Follow-up|1|||
163992946|NCT03219164|592343865|FG001|Overall Study|Lost to Follow-up|1|||
163992947|NCT03219164|592343864|FG000|Overall Study|Adverse Event|1|||
163992948|NCT03219164|592343865|FG001|Overall Study|Adverse Event|0|||
163992949|NCT03219164|592343864|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163992950|NCT03219164|592343865|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163992951|NCT03219164|592343864|FG000|Overall Study|Protocol Violation|0|||
163992952|NCT03219164|592343865|FG001|Overall Study|Protocol Violation|1|||
163992953|NCT03219164|592343864|FG000|Overall Study|Withdrew Assent|1|||
163992954|NCT03219164|592343865|FG001|Overall Study|Withdrew Assent|0|||
163992955|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
163992956|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
163992957|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
163992958|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163992959|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163992960|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163992961|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163992962|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
163992963|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
163992964|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
163992965|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
163992966|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163992967|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163992968|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163992969|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163992970|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
163992971|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
163992972|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
163992973|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
163992974|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164260642|NCT00235391|593323627|FG000|Overall Study|Withdrawal by Subject|2|||
164260643|NCT00235391|593323628|FG001|Overall Study|Withdrawal by Subject|3|||
163992975|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163992976|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163992977|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163992978|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
163992979|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
163992980|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
163992981|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
163992982|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163992983|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163992984|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163992985|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163992986|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
163992987|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
163992988|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
163992989|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
163992990|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163992991|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163992992|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164260644|NCT00235391|593323629|FG002|Overall Study|Withdrawal by Subject|3|||
164260645|NCT00235391|593323630|FG003|Overall Study|Withdrawal by Subject|61|||
163992993|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163992994|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
163992995|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
163992996|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
163992997|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163992998|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163992999|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163993000|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163993001|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163993002|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
163993003|NCT01097629|592343873|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
163993004|NCT01097629|592343874|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
163993005|NCT01097629|592343875|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
163993006|NCT01097629|592343876|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163993007|NCT01097629|592343877|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163993008|NCT01097629|592343878|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163993009|NCT01097629|592343879|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163993010|NCT01097629|592343880|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
163993011|NCT01097629|592343873|FG000|DB RO Phase|Withdrawal by Subject|0|||
163993012|NCT01097629|592343874|FG001|DB RO Phase|Withdrawal by Subject|0|||
163993013|NCT01097629|592343875|FG002|DB RO Phase|Withdrawal by Subject|0|||
163993014|NCT01097629|592343876|FG003|DB RO Phase|Withdrawal by Subject|0|||
163993015|NCT01097629|592343877|FG004|DB RO Phase|Withdrawal by Subject|0|||
163993016|NCT01097629|592343878|FG005|DB RO Phase|Withdrawal by Subject|0|||
163993017|NCT01097629|592343879|FG006|DB RO Phase|Withdrawal by Subject|0|||
163993018|NCT01097629|592343880|FG007|DB RO Phase|Withdrawal by Subject|1|||
163993019|NCT01097629|592343873|FG000|DB RO Phase|Protocol Violation|0|||
163993020|NCT01097629|592343874|FG001|DB RO Phase|Protocol Violation|0|||
163993021|NCT01097629|592343875|FG002|DB RO Phase|Protocol Violation|0|||
163993022|NCT01097629|592343876|FG003|DB RO Phase|Protocol Violation|1|||
163993023|NCT01097629|592343877|FG004|DB RO Phase|Protocol Violation|0|||
163993024|NCT01097629|592343878|FG005|DB RO Phase|Protocol Violation|1|||
163993025|NCT01097629|592343879|FG006|DB RO Phase|Protocol Violation|1|||
163993026|NCT01097629|592343880|FG007|DB RO Phase|Protocol Violation|0|||
163993027|NCT01097629|592343873|FG000|DB RO Phase|Lost to Follow-up|0|||
163993028|NCT01097629|592343874|FG001|DB RO Phase|Lost to Follow-up|0|||
163993029|NCT01097629|592343875|FG002|DB RO Phase|Lost to Follow-up|0|||
163993030|NCT01097629|592343876|FG003|DB RO Phase|Lost to Follow-up|0|||
163993031|NCT01097629|592343877|FG004|DB RO Phase|Lost to Follow-up|0|||
163993032|NCT01097629|592343878|FG005|DB RO Phase|Lost to Follow-up|0|||
163993033|NCT01097629|592343879|FG006|DB RO Phase|Lost to Follow-up|2|||
163993034|NCT01097629|592343880|FG007|DB RO Phase|Lost to Follow-up|0|||
163993035|NCT00956943|592343881|FG000|Overall Study|Lost to Follow-up|9|||
163993036|NCT00956943|592343882|FG001|Overall Study|Lost to Follow-up|10|||
163993037|NCT02613208|592343883|FG000|Overall Study|Withdrawal by Subject|1|||
163993038|NCT02613208|592343883|FG000|Overall Study|Change of address|2|||
163993039|NCT02613208|592343883|FG000|Overall Study|Physician Decision|2|||
163993040|NCT02613208|592343883|FG000|Overall Study|Lost to Follow-up|5|||
163993041|NCT02613208|592343883|FG000|Overall Study|Death|37|||
163993042|NCT01524991|592343884|FG000|Overall Study|Adverse Event|12|||
163993043|NCT01524991|592343884|FG000|Overall Study|Death|1|||
164260646|NCT00235391|593323631|FG004|Overall Study|Withdrawal by Subject|5|||
164260647|NCT00235391|593323632|FG005|Overall Study|Withdrawal by Subject|0|||
164260648|NCT00235391|593323627|FG000|Overall Study|Lost to Follow-up|0|||
164260649|NCT00235391|593323628|FG001|Overall Study|Lost to Follow-up|3|||
163993044|NCT01524991|592343884|FG000|Overall Study|Disease ProgressionDu|17|||
163993045|NCT01524991|592343884|FG000|Overall Study|Other complicating disease|1|||
164260650|NCT00235391|593323629|FG002|Overall Study|Lost to Follow-up|3|||
163993046|NCT01524991|592343884|FG000|Overall Study|Withdrawal by Subject|2|||
163993047|NCT01524991|592343884|FG000|Overall Study|Symptomatic Deterioration|1|||
163993048|NCT04574999|592343887|FG000|Overall Study|Adverse Event|1|||
163993049|NCT04574999|592343888|FG001|Overall Study|Adverse Event|0|||
163993050|NCT04574999|592343887|FG000|Overall Study|Lack of Efficacy|2|||
163993051|NCT04574999|592343888|FG001|Overall Study|Lack of Efficacy|3|||
163993052|NCT04574999|592343887|FG000|Overall Study|Protocol Violation|1|||
163993053|NCT04574999|592343888|FG001|Overall Study|Protocol Violation|0|||
163993054|NCT04574999|592343887|FG000|Overall Study|Withdrawal by Subject|2|||
163993055|NCT04574999|592343888|FG001|Overall Study|Withdrawal by Subject|2|||
163993056|NCT04574999|592343887|FG000|Overall Study|Lost to Follow-up|1|||
163993057|NCT04574999|592343888|FG001|Overall Study|Lost to Follow-up|0|||
163993058|NCT04574999|592343887|FG000|Overall Study|Personal problems|1|||
163993059|NCT04574999|592343888|FG001|Overall Study|Personal problems|0|||
164260651|NCT00235391|593323630|FG003|Overall Study|Lost to Follow-up|16|||
164260652|NCT00235391|593323631|FG004|Overall Study|Lost to Follow-up|0|||
164260653|NCT00235391|593323632|FG005|Overall Study|Lost to Follow-up|0|||
163993060|NCT04574999|592343887|FG000|Overall Study|Previous planned surgery|1|||
163993061|NCT04574999|592343888|FG001|Overall Study|Previous planned surgery|0|||
163993062|NCT00206726|592343890|FG000|Overall Study|Delayed recovery of blood counts|1|||
163993063|NCT00206726|592343890|FG000|Overall Study|Progressive disease or relapsed disease|18|||
164260654|NCT00235391|593323627|FG000|Overall Study|Administrative problems|0|||
164260655|NCT00235391|593323628|FG001|Overall Study|Administrative problems|0|||
164260656|NCT00235391|593323629|FG002|Overall Study|Administrative problems|0|||
164260657|NCT00235391|593323630|FG003|Overall Study|Administrative problems|1|||
164260658|NCT00235391|593323631|FG004|Overall Study|Administrative problems|0|||
164260659|NCT00235391|593323632|FG005|Overall Study|Administrative problems|0|||
164260660|NCT00235391|593323627|FG000|Overall Study|Death|0|||
164260661|NCT00235391|593323628|FG001|Overall Study|Death|0|||
164260662|NCT00235391|593323629|FG002|Overall Study|Death|1|||
164260663|NCT00235391|593323630|FG003|Overall Study|Death|4|||
164260664|NCT00235391|593323631|FG004|Overall Study|Death|0|||
164260665|NCT00235391|593323632|FG005|Overall Study|Death|0|||
164260666|NCT02927925|593323635|FG000|Overall Study|Death|16|||
164260667|NCT02927925|593323635|FG000|Overall Study|Physician Decision|1|||
164260668|NCT02927925|593323635|FG000|Overall Study|Withdrawal by Subject|11|||
164260669|NCT02927925|593323635|FG000|Overall Study|Other|3|||
164260670|NCT02927925|593323635|FG000|Overall Study|Disease progression at clinical cutoff|1|||
164260671|NCT00075725|593323638|FG000|Overall Study|Adverse Event|6|||
164260672|NCT00075725|593323639|FG001|Overall Study|Adverse Event|6|||
164260673|NCT00075725|593323640|FG002|Overall Study|Adverse Event|20|||
164260674|NCT00075725|593323641|FG003|Overall Study|Adverse Event|8|||
164260675|NCT00075725|593323642|FG004|Overall Study|Adverse Event|4|||
164260676|NCT00075725|593323643|FG005|Overall Study|Adverse Event|38|||
164260677|NCT00075725|593323644|FG006|Overall Study|Adverse Event|3|||
164260678|NCT00075725|593323645|FG007|Overall Study|Adverse Event|51|||
164260679|NCT00075725|593323646|FG008|Overall Study|Adverse Event|15|||
164260680|NCT00075725|593323647|FG009|Overall Study|Adverse Event|4|||
164260681|NCT00075725|593323648|FG010|Overall Study|Adverse Event|2|||
164260682|NCT00075725|593323649|FG011|Overall Study|Adverse Event|2|||
164260683|NCT00075725|593323638|FG000|Overall Study|Death|3|||
164260684|NCT00075725|593323639|FG001|Overall Study|Death|5|||
164260685|NCT00075725|593323640|FG002|Overall Study|Death|10|||
164260686|NCT00075725|593323641|FG003|Overall Study|Death|2|||
164260687|NCT00075725|593323642|FG004|Overall Study|Death|3|||
164260688|NCT00075725|593323643|FG005|Overall Study|Death|25|||
164260689|NCT00075725|593323644|FG006|Overall Study|Death|4|||
164260690|NCT00075725|593323645|FG007|Overall Study|Death|22|||
164260691|NCT00075725|593323646|FG008|Overall Study|Death|14|||
164260692|NCT00075725|593323647|FG009|Overall Study|Death|4|||
164260693|NCT00075725|593323648|FG010|Overall Study|Death|3|||
164260694|NCT00075725|593323649|FG011|Overall Study|Death|0|||
164260695|NCT00075725|593323638|FG000|Overall Study|Lost to Follow-up|1|||
164260696|NCT00075725|593323639|FG001|Overall Study|Lost to Follow-up|1|||
164260697|NCT00075725|593323640|FG002|Overall Study|Lost to Follow-up|4|||
164260698|NCT00075725|593323641|FG003|Overall Study|Lost to Follow-up|1|||
164260699|NCT00075725|593323642|FG004|Overall Study|Lost to Follow-up|0|||
164260700|NCT00075725|593323643|FG005|Overall Study|Lost to Follow-up|13|||
164260701|NCT00075725|593323644|FG006|Overall Study|Lost to Follow-up|2|||
164260702|NCT00075725|593323645|FG007|Overall Study|Lost to Follow-up|4|||
164260703|NCT00075725|593323646|FG008|Overall Study|Lost to Follow-up|1|||
164260704|NCT00075725|593323647|FG009|Overall Study|Lost to Follow-up|0|||
164260705|NCT00075725|593323648|FG010|Overall Study|Lost to Follow-up|0|||
163888375|NCT04436276|591963323|FG013|Overall Study|Other|2|||
163888376|NCT04436276|591963324|FG014|Overall Study|Other|3|||
164085103|NCT01992107|592675878|FG000|Overall Study|noncompliance and were unavailable|7|||
164142269|NCT00451204|592882582|FG000|Overall Study|Protocol Violation|1|||
164260706|NCT00075725|593323649|FG011|Overall Study|Lost to Follow-up|0|||
164260707|NCT00075725|593323638|FG000|Overall Study|Physician Decision|2|||
164260708|NCT00075725|593323639|FG001|Overall Study|Physician Decision|6|||
164260709|NCT00075725|593323640|FG002|Overall Study|Physician Decision|5|||
164260710|NCT00075725|593323641|FG003|Overall Study|Physician Decision|8|||
164260711|NCT00075725|593323642|FG004|Overall Study|Physician Decision|4|||
164260712|NCT00075725|593323643|FG005|Overall Study|Physician Decision|19|||
164260713|NCT00075725|593323644|FG006|Overall Study|Physician Decision|3|||
164260714|NCT00075725|593323645|FG007|Overall Study|Physician Decision|17|||
164260715|NCT00075725|593323646|FG008|Overall Study|Physician Decision|5|||
164260716|NCT00075725|593323647|FG009|Overall Study|Physician Decision|0|||
164260717|NCT00075725|593323648|FG010|Overall Study|Physician Decision|1|||
164260718|NCT00075725|593323649|FG011|Overall Study|Physician Decision|0|||
164260719|NCT00075725|593323638|FG000|Overall Study|Pregnancy|0|||
164260720|NCT00075725|593323639|FG001|Overall Study|Pregnancy|0|||
164260721|NCT00075725|593323640|FG002|Overall Study|Pregnancy|0|||
164260722|NCT00075725|593323641|FG003|Overall Study|Pregnancy|0|||
164260723|NCT00075725|593323642|FG004|Overall Study|Pregnancy|0|||
163888377|NCT04436276|591963325|FG015|Overall Study|Other|0|||
164260724|NCT00075725|593323643|FG005|Overall Study|Pregnancy|1|||
164260725|NCT00075725|593323644|FG006|Overall Study|Pregnancy|0|||
164260726|NCT00075725|593323645|FG007|Overall Study|Pregnancy|1|||
164260727|NCT00075725|593323646|FG008|Overall Study|Pregnancy|0|||
164260728|NCT00075725|593323647|FG009|Overall Study|Pregnancy|0|||
164260729|NCT00075725|593323648|FG010|Overall Study|Pregnancy|0|||
164260730|NCT00075725|593323649|FG011|Overall Study|Pregnancy|0|||
164260731|NCT00075725|593323638|FG000|Overall Study|Protocol Violation|1|||
164260732|NCT00075725|593323639|FG001|Overall Study|Protocol Violation|1|||
164260733|NCT00075725|593323640|FG002|Overall Study|Protocol Violation|0|||
164260734|NCT00075725|593323641|FG003|Overall Study|Protocol Violation|3|||
164260735|NCT00075725|593323642|FG004|Overall Study|Protocol Violation|3|||
164260736|NCT00075725|593323643|FG005|Overall Study|Protocol Violation|2|||
164260737|NCT00075725|593323644|FG006|Overall Study|Protocol Violation|1|||
164260738|NCT00075725|593323645|FG007|Overall Study|Protocol Violation|2|||
164260739|NCT00075725|593323646|FG008|Overall Study|Protocol Violation|3|||
164260740|NCT00075725|593323647|FG009|Overall Study|Protocol Violation|0|||
164260741|NCT00075725|593323648|FG010|Overall Study|Protocol Violation|0|||
164260742|NCT00075725|593323649|FG011|Overall Study|Protocol Violation|1|||
164260743|NCT00075725|593323638|FG000|Overall Study|Withdrawal by Subject|12|||
164260744|NCT00075725|593323639|FG001|Overall Study|Withdrawal by Subject|3|||
164260745|NCT00075725|593323640|FG002|Overall Study|Withdrawal by Subject|6|||
164260746|NCT00075725|593323641|FG003|Overall Study|Withdrawal by Subject|10|||
164260747|NCT00075725|593323642|FG004|Overall Study|Withdrawal by Subject|6|||
164260748|NCT00075725|593323643|FG005|Overall Study|Withdrawal by Subject|27|||
164260749|NCT00075725|593323644|FG006|Overall Study|Withdrawal by Subject|7|||
164260750|NCT00075725|593323645|FG007|Overall Study|Withdrawal by Subject|31|||
164260751|NCT00075725|593323646|FG008|Overall Study|Withdrawal by Subject|10|||
164260752|NCT00075725|593323647|FG009|Overall Study|Withdrawal by Subject|2|||
164260753|NCT00075725|593323648|FG010|Overall Study|Withdrawal by Subject|0|||
164260754|NCT00075725|593323649|FG011|Overall Study|Withdrawal by Subject|0|||
164260755|NCT00075725|593323638|FG000|Overall Study|Disease Progression, all other reasons|17|||
164260756|NCT00075725|593323639|FG001|Overall Study|Disease Progression, all other reasons|5|||
164260757|NCT00075725|593323640|FG002|Overall Study|Disease Progression, all other reasons|33|||
164260758|NCT00075725|593323641|FG003|Overall Study|Disease Progression, all other reasons|6|||
164260759|NCT00075725|593323642|FG004|Overall Study|Disease Progression, all other reasons|21|||
164260760|NCT00075725|593323643|FG005|Overall Study|Disease Progression, all other reasons|59|||
164260761|NCT00075725|593323644|FG006|Overall Study|Disease Progression, all other reasons|20|||
164260762|NCT00075725|593323645|FG007|Overall Study|Disease Progression, all other reasons|46|||
164260763|NCT00075725|593323646|FG008|Overall Study|Disease Progression, all other reasons|21|||
164260764|NCT00075725|593323647|FG009|Overall Study|Disease Progression, all other reasons|4|||
164260765|NCT00075725|593323648|FG010|Overall Study|Disease Progression, all other reasons|0|||
164260766|NCT00075725|593323649|FG011|Overall Study|Disease Progression, all other reasons|5|||
164260767|NCT00075725|593323638|FG000|Overall Study|Patient off treatment|0|||
164260768|NCT00075725|593323639|FG001|Overall Study|Patient off treatment|0|||
164260769|NCT00075725|593323640|FG002|Overall Study|Patient off treatment|1|||
164260770|NCT00075725|593323641|FG003|Overall Study|Patient off treatment|2|||
164260771|NCT00075725|593323642|FG004|Overall Study|Patient off treatment|1|||
164260772|NCT00075725|593323643|FG005|Overall Study|Patient off treatment|0|||
164260773|NCT00075725|593323644|FG006|Overall Study|Patient off treatment|0|||
164260774|NCT00075725|593323645|FG007|Overall Study|Patient off treatment|2|||
164260775|NCT00075725|593323646|FG008|Overall Study|Patient off treatment|1|||
164260776|NCT00075725|593323647|FG009|Overall Study|Patient off treatment|0|||
164260777|NCT00075725|593323648|FG010|Overall Study|Patient off treatment|0|||
164260778|NCT00075725|593323649|FG011|Overall Study|Patient off treatment|0|||
164260779|NCT00075725|593323638|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
164260780|NCT00075725|593323639|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
164260781|NCT00075725|593323640|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
164260782|NCT00075725|593323641|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
164260783|NCT00075725|593323642|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
164260784|NCT00075725|593323643|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
164260785|NCT00075725|593323644|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
164260786|NCT00075725|593323645|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
164260787|NCT00075725|593323646|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
164260788|NCT00075725|593323647|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
164260789|NCT00075725|593323648|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
164260790|NCT00075725|593323649|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
164340566|NCT02555683|593622220|FG002|Overall Study|Technical Problems|0|||
163993064|NCT00206726|592343890|FG000|Overall Study|Placed on new protocol|1|||
164340567|NCT02555683|593622218|FG000|Overall Study|Protocol deviation|0|||
163993065|NCT00206726|592343890|FG000|Overall Study|Bone marrow transplant|1|||
163993066|NCT00206726|592343890|FG000|Overall Study|Adverse Event|17|||
163993067|NCT00206726|592343890|FG000|Overall Study|Death|4|||
163993068|NCT00206726|592343890|FG000|Overall Study|Protocol Violation|1|||
164260791|NCT00075725|593323638|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
164260792|NCT00075725|593323639|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
164260793|NCT00075725|593323640|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
164260794|NCT00075725|593323641|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
163993069|NCT00206726|592343890|FG000|Overall Study|Withdrawal by Subject|8|||
164260795|NCT00075725|593323642|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
164260796|NCT00075725|593323643|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
164260797|NCT00075725|593323644|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
164260798|NCT00075725|593323645|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
164260799|NCT00075725|593323646|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
164260800|NCT00075725|593323647|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
164260801|NCT00075725|593323648|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
164260802|NCT00075725|593323649|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
164260803|NCT00075725|593323638|FG000|Overall Study|Pt non compliant with therapy|2|||
164260804|NCT00075725|593323639|FG001|Overall Study|Pt non compliant with therapy|1|||
164260805|NCT00075725|593323640|FG002|Overall Study|Pt non compliant with therapy|1|||
164260806|NCT00075725|593323641|FG003|Overall Study|Pt non compliant with therapy|0|||
164260807|NCT00075725|593323642|FG004|Overall Study|Pt non compliant with therapy|2|||
164260808|NCT00075725|593323643|FG005|Overall Study|Pt non compliant with therapy|14|||
164260809|NCT00075725|593323644|FG006|Overall Study|Pt non compliant with therapy|2|||
164260810|NCT00075725|593323645|FG007|Overall Study|Pt non compliant with therapy|5|||
164260811|NCT00075725|593323646|FG008|Overall Study|Pt non compliant with therapy|3|||
164260812|NCT00075725|593323647|FG009|Overall Study|Pt non compliant with therapy|0|||
164260813|NCT00075725|593323648|FG010|Overall Study|Pt non compliant with therapy|0|||
164260814|NCT00075725|593323649|FG011|Overall Study|Pt non compliant with therapy|0|||
164260815|NCT00075725|593323638|FG000|Overall Study|Pt age out of range for treatment|0|||
164260816|NCT00075725|593323639|FG001|Overall Study|Pt age out of range for treatment|1|||
164260817|NCT00075725|593323640|FG002|Overall Study|Pt age out of range for treatment|0|||
164260818|NCT00075725|593323641|FG003|Overall Study|Pt age out of range for treatment|0|||
164260819|NCT00075725|593323642|FG004|Overall Study|Pt age out of range for treatment|0|||
164260820|NCT00075725|593323643|FG005|Overall Study|Pt age out of range for treatment|1|||
164260821|NCT00075725|593323644|FG006|Overall Study|Pt age out of range for treatment|0|||
164260822|NCT00075725|593323645|FG007|Overall Study|Pt age out of range for treatment|1|||
164260823|NCT00075725|593323646|FG008|Overall Study|Pt age out of range for treatment|0|||
164260824|NCT00075725|593323647|FG009|Overall Study|Pt age out of range for treatment|0|||
164260825|NCT00075725|593323648|FG010|Overall Study|Pt age out of range for treatment|0|||
164260826|NCT00075725|593323649|FG011|Overall Study|Pt age out of range for treatment|0|||
164260827|NCT00075725|593323638|FG000|Overall Study|Insurance issues|0|||
164260828|NCT00075725|593323639|FG001|Overall Study|Insurance issues|1|||
164260829|NCT00075725|593323640|FG002|Overall Study|Insurance issues|0|||
164260830|NCT00075725|593323641|FG003|Overall Study|Insurance issues|1|||
164260831|NCT00075725|593323642|FG004|Overall Study|Insurance issues|1|||
164260832|NCT00075725|593323643|FG005|Overall Study|Insurance issues|1|||
164260833|NCT00075725|593323644|FG006|Overall Study|Insurance issues|0|||
164260834|NCT00075725|593323645|FG007|Overall Study|Insurance issues|1|||
164260835|NCT00075725|593323646|FG008|Overall Study|Insurance issues|0|||
164260836|NCT00075725|593323647|FG009|Overall Study|Insurance issues|0|||
164260837|NCT00075725|593323648|FG010|Overall Study|Insurance issues|0|||
164260838|NCT00075725|593323649|FG011|Overall Study|Insurance issues|0|||
164260839|NCT00075725|593323638|FG000|Overall Study|MRD positive after extended ind|0|||
164260840|NCT00075725|593323639|FG001|Overall Study|MRD positive after extended ind|1|||
164260841|NCT00075725|593323640|FG002|Overall Study|MRD positive after extended ind|1|||
164260842|NCT00075725|593323641|FG003|Overall Study|MRD positive after extended ind|0|||
164260843|NCT00075725|593323642|FG004|Overall Study|MRD positive after extended ind|1|||
164260844|NCT00075725|593323643|FG005|Overall Study|MRD positive after extended ind|2|||
164260845|NCT00075725|593323644|FG006|Overall Study|MRD positive after extended ind|0|||
164260846|NCT00075725|593323645|FG007|Overall Study|MRD positive after extended ind|1|||
164260847|NCT00075725|593323646|FG008|Overall Study|MRD positive after extended ind|0|||
164260848|NCT00075725|593323647|FG009|Overall Study|MRD positive after extended ind|0|||
164260849|NCT00075725|593323648|FG010|Overall Study|MRD positive after extended ind|0|||
164260850|NCT00075725|593323649|FG011|Overall Study|MRD positive after extended ind|0|||
164260851|NCT00075725|593323638|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
164260852|NCT00075725|593323639|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
164260853|NCT00075725|593323640|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
164260854|NCT00075725|593323641|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
164340568|NCT02555683|593622219|FG001|Overall Study|Protocol deviation|1|||
163993070|NCT05148884|592343891|FG000|Overall Study|Withdrawal by Subject|3|||
163993071|NCT05148884|592343892|FG001|Overall Study|Withdrawal by Subject|0|||
163993072|NCT05148884|592343891|FG000|Overall Study|Deep brain stimulation operation|0|||
163993073|NCT05148884|592343892|FG001|Overall Study|Deep brain stimulation operation|1|||
163993074|NCT01341457|592343893|FG000|Overall Study|Adverse Event|2|||
163993075|NCT01341457|592343894|FG001|Overall Study|Adverse Event|0|||
164340569|NCT02555683|593622220|FG002|Overall Study|Protocol deviation|0|||
164340570|NCT02555683|593622218|FG000|Overall Study|Lack of Efficacy|2|||
164260855|NCT00075725|593323642|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
164260856|NCT00075725|593323643|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
164260857|NCT00075725|593323644|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
164260858|NCT00075725|593323645|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
164260859|NCT00075725|593323646|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
164260860|NCT00075725|593323647|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
164260861|NCT00075725|593323648|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
164260862|NCT00075725|593323649|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
164260863|NCT00075725|593323638|FG000|Overall Study|Inevaluable|1|||
164260864|NCT00075725|593323639|FG001|Overall Study|Inevaluable|1|||
164260865|NCT00075725|593323640|FG002|Overall Study|Inevaluable|4|||
164260866|NCT00075725|593323641|FG003|Overall Study|Inevaluable|2|||
164260867|NCT00075725|593323642|FG004|Overall Study|Inevaluable|2|||
164260868|NCT00075725|593323643|FG005|Overall Study|Inevaluable|9|||
164260869|NCT00075725|593323644|FG006|Overall Study|Inevaluable|1|||
164260870|NCT00075725|593323645|FG007|Overall Study|Inevaluable|11|||
164260871|NCT00075725|593323646|FG008|Overall Study|Inevaluable|2|||
164260872|NCT00075725|593323647|FG009|Overall Study|Inevaluable|0|||
164260873|NCT00075725|593323648|FG010|Overall Study|Inevaluable|1|||
164260874|NCT00075725|593323649|FG011|Overall Study|Inevaluable|0|||
164260875|NCT00075725|593323638|FG000|Overall Study|Other|4|||
164260876|NCT00075725|593323639|FG001|Overall Study|Other|2|||
164260877|NCT00075725|593323640|FG002|Overall Study|Other|1|||
164260878|NCT00075725|593323641|FG003|Overall Study|Other|1|||
164260879|NCT00075725|593323642|FG004|Overall Study|Other|1|||
164260880|NCT00075725|593323643|FG005|Overall Study|Other|4|||
164260881|NCT00075725|593323644|FG006|Overall Study|Other|2|||
164260882|NCT00075725|593323645|FG007|Overall Study|Other|9|||
164260883|NCT00075725|593323646|FG008|Overall Study|Other|2|||
164260884|NCT00075725|593323647|FG009|Overall Study|Other|1|||
164260885|NCT00075725|593323648|FG010|Overall Study|Other|0|||
164260886|NCT00075725|593323649|FG011|Overall Study|Other|3|||
164260887|NCT00075725|593323638|FG000|Overall Study|Pt trying to find a BM donor|0|||
164260888|NCT00075725|593323639|FG001|Overall Study|Pt trying to find a BM donor|1|||
164260889|NCT00075725|593323640|FG002|Overall Study|Pt trying to find a BM donor|0|||
164260890|NCT00075725|593323641|FG003|Overall Study|Pt trying to find a BM donor|0|||
164260891|NCT00075725|593323642|FG004|Overall Study|Pt trying to find a BM donor|0|||
164260892|NCT00075725|593323643|FG005|Overall Study|Pt trying to find a BM donor|0|||
164260893|NCT00075725|593323644|FG006|Overall Study|Pt trying to find a BM donor|0|||
164260894|NCT00075725|593323645|FG007|Overall Study|Pt trying to find a BM donor|0|||
164260895|NCT00075725|593323646|FG008|Overall Study|Pt trying to find a BM donor|0|||
164260896|NCT00075725|593323647|FG009|Overall Study|Pt trying to find a BM donor|0|||
164260897|NCT00075725|593323648|FG010|Overall Study|Pt trying to find a BM donor|0|||
164260898|NCT00075725|593323649|FG011|Overall Study|Pt trying to find a BM donor|0|||
164260899|NCT00075725|593323638|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
164260900|NCT00075725|593323639|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
164260901|NCT00075725|593323640|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
164260902|NCT00075725|593323641|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
164260903|NCT00075725|593323642|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
164260904|NCT00075725|593323643|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
164260905|NCT00075725|593323644|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
164260906|NCT00075725|593323645|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
164260907|NCT00075725|593323646|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
164260908|NCT00075725|593323647|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
164260909|NCT00075725|593323648|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
164260910|NCT00075725|593323649|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
164260911|NCT00075725|593323638|FG000|Overall Study|Unsuccessful institutional transfer|0|||
164260912|NCT00075725|593323639|FG001|Overall Study|Unsuccessful institutional transfer|0|||
164260913|NCT00075725|593323640|FG002|Overall Study|Unsuccessful institutional transfer|2|||
164260914|NCT00075725|593323641|FG003|Overall Study|Unsuccessful institutional transfer|0|||
164260915|NCT00075725|593323642|FG004|Overall Study|Unsuccessful institutional transfer|0|||
164260916|NCT00075725|593323643|FG005|Overall Study|Unsuccessful institutional transfer|0|||
164260917|NCT00075725|593323644|FG006|Overall Study|Unsuccessful institutional transfer|0|||
164260918|NCT00075725|593323645|FG007|Overall Study|Unsuccessful institutional transfer|0|||
163888378|NCT04436276|591963326|FG016|Overall Study|Other|0|||
164260919|NCT00075725|593323646|FG008|Overall Study|Unsuccessful institutional transfer|0|||
164260920|NCT00075725|593323647|FG009|Overall Study|Unsuccessful institutional transfer|1|||
164260921|NCT00075725|593323648|FG010|Overall Study|Unsuccessful institutional transfer|0|||
164260922|NCT00075725|593323649|FG011|Overall Study|Unsuccessful institutional transfer|0|||
164260923|NCT00075725|593323638|FG000|Overall Study|specimen(s) not submitted|0|||
164260924|NCT00075725|593323639|FG001|Overall Study|specimen(s) not submitted|0|||
163888379|NCT04436276|591963327|FG017|Overall Study|Other|6|||
164260925|NCT00075725|593323640|FG002|Overall Study|specimen(s) not submitted|2|||
164260926|NCT00075725|593323641|FG003|Overall Study|specimen(s) not submitted|0|||
164260927|NCT00075725|593323642|FG004|Overall Study|specimen(s) not submitted|0|||
164260928|NCT00075725|593323643|FG005|Overall Study|specimen(s) not submitted|0|||
164260929|NCT00075725|593323644|FG006|Overall Study|specimen(s) not submitted|0|||
164260930|NCT00075725|593323645|FG007|Overall Study|specimen(s) not submitted|0|||
164260931|NCT00075725|593323646|FG008|Overall Study|specimen(s) not submitted|0|||
164260932|NCT00075725|593323647|FG009|Overall Study|specimen(s) not submitted|0|||
164260933|NCT00075725|593323648|FG010|Overall Study|specimen(s) not submitted|0|||
164260934|NCT00075725|593323649|FG011|Overall Study|specimen(s) not submitted|0|||
164260935|NCT00075725|593323638|FG000|Overall Study|Pt went to transplant|0|||
163993076|NCT00832819|592343897|FG000|Overall Study|Adverse Event|0|||
163993077|NCT00832819|592343898|FG001|Overall Study|Adverse Event|1|||
163993078|NCT00832819|592343899|FG002|Overall Study|Adverse Event|0|||
163993079|NCT00832819|592343897|FG000|Overall Study|Protocol Violation|0|||
163993080|NCT00832819|592343898|FG001|Overall Study|Protocol Violation|0|||
163993081|NCT00832819|592343899|FG002|Overall Study|Protocol Violation|1|||
163993082|NCT01717638|592343900|FG000|Overall Study|Lost to Follow-up|0|||
163993083|NCT01717638|592343901|FG001|Overall Study|Lost to Follow-up|0|||
163993084|NCT01717638|592343902|FG002|Overall Study|Lost to Follow-up|0|||
164085104|NCT01992107|592675879|FG001|Overall Study|noncompliance and were unavailable|3|||
164260936|NCT00075725|593323639|FG001|Overall Study|Pt went to transplant|0|||
164260937|NCT00075725|593323640|FG002|Overall Study|Pt went to transplant|0|||
164260938|NCT00075725|593323641|FG003|Overall Study|Pt went to transplant|1|||
163888380|NCT04436276|591963328|FG018|Overall Study|Other|1|||
163888381|NCT04436276|591963329|FG019|Overall Study|Other|0|||
163888382|NCT04436276|591963330|FG020|Overall Study|Other|2|||
163888383|NCT04436276|591963331|FG021|Overall Study|Other|2|||
163888384|NCT04436276|591963332|FG022|Overall Study|Other|60|||
163888385|NCT03656510|591963334|FG000|Overall Study|Lost to Follow-up|1|||
163888386|NCT03656510|591963335|FG001|Overall Study|Lost to Follow-up|0|||
163888387|NCT03656510|591963336|FG002|Overall Study|Lost to Follow-up|0|||
163888388|NCT03656510|591963337|FG003|Overall Study|Lost to Follow-up|0|||
163888389|NCT03656510|591963338|FG004|Overall Study|Lost to Follow-up|0|||
163888390|NCT03656510|591963339|FG005|Overall Study|Lost to Follow-up|0|||
163888391|NCT03656510|591963334|FG000|Overall Study|Withdrawal by Subject|1|||
163888392|NCT03656510|591963335|FG001|Overall Study|Withdrawal by Subject|1|||
163888393|NCT03656510|591963336|FG002|Overall Study|Withdrawal by Subject|0|||
163888394|NCT03656510|591963337|FG003|Overall Study|Withdrawal by Subject|1|||
163888395|NCT03656510|591963338|FG004|Overall Study|Withdrawal by Subject|0|||
163888396|NCT03656510|591963339|FG005|Overall Study|Withdrawal by Subject|0|||
163888397|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
163888398|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
163888399|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
163888400|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
163888401|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
163888402|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
163888403|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
163888404|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
163888405|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
163888406|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
163888407|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
163888408|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
163888409|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
163888410|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
163888411|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
163888412|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
163888413|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
163888414|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
163888415|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
163888416|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
163888417|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163888418|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
163888419|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163888420|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163888421|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
163888422|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
163888423|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
163888424|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
163888425|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
163888426|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
163888427|NCT03852472|591963346|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
163888428|NCT03852472|591963347|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
163888429|NCT03852472|591963348|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
163888430|NCT03852472|591963349|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
163888431|NCT03852472|591963350|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
163888432|NCT03852472|591963346|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
163888433|NCT03852472|591963347|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
163888434|NCT03852472|591963348|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
163888435|NCT03852472|591963349|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
163888436|NCT03852472|591963350|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
163993085|NCT01717638|592343903|FG003|Overall Study|Lost to Follow-up|0|||
164085105|NCT01992107|592675880|FG002|Overall Study|noncompliance and were unavailable|2|||
164085106|NCT01992107|592675878|FG000|Overall Study|Withdrawal by Subject|13|||
164085107|NCT01992107|592675879|FG001|Overall Study|Withdrawal by Subject|7|||
164085108|NCT01992107|592675880|FG002|Overall Study|Withdrawal by Subject|8|||
164085109|NCT02022007|592675881|FG000|Overall Study|Withdrawal by Subject|1|||
164085110|NCT02022007|592675882|FG001|Overall Study|Withdrawal by Subject|1|||
164085111|NCT02022007|592675883|FG002|Overall Study|Withdrawal by Subject|1|||
164085112|NCT02022007|592675881|FG000|Overall Study|Noncompliant|0|||
164085113|NCT02022007|592675882|FG001|Overall Study|Noncompliant|0|||
164085114|NCT02022007|592675883|FG002|Overall Study|Noncompliant|1|||
164085115|NCT01214603|592675884|FG000|Overall Study|Adverse Event|0|||
164260939|NCT00075725|593323642|FG004|Overall Study|Pt went to transplant|0|||
164260940|NCT00075725|593323643|FG005|Overall Study|Pt went to transplant|1|||
164260941|NCT00075725|593323644|FG006|Overall Study|Pt went to transplant|0|||
164260942|NCT00075725|593323645|FG007|Overall Study|Pt went to transplant|0|||
164260943|NCT00075725|593323646|FG008|Overall Study|Pt went to transplant|0|||
164260944|NCT00075725|593323647|FG009|Overall Study|Pt went to transplant|0|||
164260945|NCT00075725|593323648|FG010|Overall Study|Pt went to transplant|0|||
164260946|NCT00075725|593323649|FG011|Overall Study|Pt went to transplant|0|||
164260947|NCT00075725|593323638|FG000|Overall Study|Pt received additional steroids|0|||
164260948|NCT00075725|593323639|FG001|Overall Study|Pt received additional steroids|0|||
164260949|NCT00075725|593323640|FG002|Overall Study|Pt received additional steroids|0|||
164260950|NCT00075725|593323641|FG003|Overall Study|Pt received additional steroids|1|||
164260951|NCT00075725|593323642|FG004|Overall Study|Pt received additional steroids|0|||
164260952|NCT00075725|593323643|FG005|Overall Study|Pt received additional steroids|0|||
164260953|NCT00075725|593323644|FG006|Overall Study|Pt received additional steroids|0|||
164260954|NCT00075725|593323645|FG007|Overall Study|Pt received additional steroids|0|||
164260955|NCT00075725|593323646|FG008|Overall Study|Pt received additional steroids|0|||
164260956|NCT00075725|593323647|FG009|Overall Study|Pt received additional steroids|0|||
164260957|NCT00075725|593323648|FG010|Overall Study|Pt received additional steroids|0|||
164260958|NCT00075725|593323649|FG011|Overall Study|Pt received additional steroids|0|||
163993086|NCT01717638|592343904|FG004|Overall Study|Lost to Follow-up|0|||
163993087|NCT01717638|592343905|FG005|Overall Study|Lost to Follow-up|1|||
163993088|NCT01717638|592343906|FG006|Overall Study|Lost to Follow-up|0|||
163993089|NCT01717638|592343907|FG007|Overall Study|Lost to Follow-up|0|||
163993090|NCT01717638|592343908|FG008|Overall Study|Lost to Follow-up|0|||
163993091|NCT01717638|592343909|FG009|Overall Study|Lost to Follow-up|0|||
163993092|NCT01717638|592343910|FG010|Overall Study|Lost to Follow-up|0|||
163993093|NCT01717638|592343911|FG011|Overall Study|Lost to Follow-up|0|||
163993094|NCT01717638|592343912|FG012|Overall Study|Lost to Follow-up|0|||
163993095|NCT01717638|592343900|FG000|Overall Study|Father in hospital|0|||
163993096|NCT01717638|592343901|FG001|Overall Study|Father in hospital|0|||
163993097|NCT01717638|592343902|FG002|Overall Study|Father in hospital|0|||
163993098|NCT01717638|592343903|FG003|Overall Study|Father in hospital|0|||
163993099|NCT01717638|592343904|FG004|Overall Study|Father in hospital|0|||
163993100|NCT01717638|592343905|FG005|Overall Study|Father in hospital|0|||
164260959|NCT00075725|593323638|FG000|Overall Study|Pt relocated|0|||
164260960|NCT00075725|593323639|FG001|Overall Study|Pt relocated|0|||
164260961|NCT00075725|593323640|FG002|Overall Study|Pt relocated|0|||
164260962|NCT00075725|593323641|FG003|Overall Study|Pt relocated|2|||
164260963|NCT00075725|593323642|FG004|Overall Study|Pt relocated|0|||
164260964|NCT00075725|593323643|FG005|Overall Study|Pt relocated|1|||
164260965|NCT00075725|593323644|FG006|Overall Study|Pt relocated|1|||
164260966|NCT00075725|593323645|FG007|Overall Study|Pt relocated|2|||
164260967|NCT00075725|593323646|FG008|Overall Study|Pt relocated|1|||
164260968|NCT00075725|593323647|FG009|Overall Study|Pt relocated|0|||
164260969|NCT00075725|593323648|FG010|Overall Study|Pt relocated|0|||
164260970|NCT00075725|593323649|FG011|Overall Study|Pt relocated|0|||
164260971|NCT00075725|593323638|FG000|Overall Study|Institution Terminated|0|||
164260972|NCT00075725|593323639|FG001|Overall Study|Institution Terminated|0|||
164260973|NCT00075725|593323640|FG002|Overall Study|Institution Terminated|0|||
164260974|NCT00075725|593323641|FG003|Overall Study|Institution Terminated|0|||
164260975|NCT00075725|593323642|FG004|Overall Study|Institution Terminated|1|||
164260976|NCT00075725|593323643|FG005|Overall Study|Institution Terminated|0|||
164260977|NCT00075725|593323644|FG006|Overall Study|Institution Terminated|0|||
164260978|NCT00075725|593323645|FG007|Overall Study|Institution Terminated|3|||
164260979|NCT00075725|593323646|FG008|Overall Study|Institution Terminated|0|||
164260980|NCT00075725|593323647|FG009|Overall Study|Institution Terminated|0|||
164260981|NCT00075725|593323648|FG010|Overall Study|Institution Terminated|0|||
163993101|NCT01717638|592343906|FG006|Overall Study|Father in hospital|0|||
164085116|NCT01214603|592675885|FG001|Overall Study|Adverse Event|0|||
164085117|NCT01214603|592675886|FG002|Overall Study|Adverse Event|1|||
164085118|NCT01214603|592675884|FG000|Overall Study|Death|1|||
164085119|NCT01214603|592675885|FG001|Overall Study|Death|0|||
164085120|NCT01214603|592675886|FG002|Overall Study|Death|0|||
163993102|NCT01717638|592343907|FG007|Overall Study|Father in hospital|0|||
164085121|NCT01214603|592675884|FG000|Overall Study|Progressive Disease|4|||
164260982|NCT00075725|593323649|FG011|Overall Study|Institution Terminated|0|||
164260983|NCT00075725|593323638|FG000|Overall Study|Study Closure|1|||
164260984|NCT00075725|593323639|FG001|Overall Study|Study Closure|0|||
164260985|NCT00075725|593323640|FG002|Overall Study|Study Closure|0|||
164260986|NCT00075725|593323641|FG003|Overall Study|Study Closure|0|||
164260987|NCT00075725|593323642|FG004|Overall Study|Study Closure|1|||
164260988|NCT00075725|593323643|FG005|Overall Study|Study Closure|3|||
164260989|NCT00075725|593323644|FG006|Overall Study|Study Closure|0|||
164260990|NCT00075725|593323645|FG007|Overall Study|Study Closure|1|||
164260991|NCT00075725|593323646|FG008|Overall Study|Study Closure|0|||
164260992|NCT00075725|593323647|FG009|Overall Study|Study Closure|0|||
164260993|NCT00075725|593323648|FG010|Overall Study|Study Closure|0|||
164260994|NCT00075725|593323649|FG011|Overall Study|Study Closure|0|||
164260995|NCT00075725|593323638|FG000|Overall Study|Other complications|0|||
164260996|NCT00075725|593323639|FG001|Overall Study|Other complications|0|||
164260997|NCT00075725|593323640|FG002|Overall Study|Other complications|0|||
164260998|NCT00075725|593323641|FG003|Overall Study|Other complications|0|||
164260999|NCT00075725|593323642|FG004|Overall Study|Other complications|0|||
164261000|NCT00075725|593323643|FG005|Overall Study|Other complications|1|||
164261001|NCT00075725|593323644|FG006|Overall Study|Other complications|0|||
164261002|NCT00075725|593323645|FG007|Overall Study|Other complications|0|||
164261003|NCT00075725|593323646|FG008|Overall Study|Other complications|0|||
164261004|NCT00075725|593323647|FG009|Overall Study|Other complications|0|||
164261005|NCT00075725|593323648|FG010|Overall Study|Other complications|0|||
164261006|NCT00075725|593323649|FG011|Overall Study|Other complications|0|||
164261007|NCT00075725|593323638|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
164261008|NCT00075725|593323639|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
164261009|NCT00075725|593323640|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
164261010|NCT00075725|593323641|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
164261011|NCT00075725|593323642|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
164261012|NCT00075725|593323643|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
164261013|NCT00075725|593323644|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
164261014|NCT00075725|593323645|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
164261015|NCT00075725|593323646|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
164340571|NCT02555683|593622219|FG001|Overall Study|Lack of Efficacy|0|||
164340572|NCT02555683|593622220|FG002|Overall Study|Lack of Efficacy|0|||
164340573|NCT02555683|593622218|FG000|Overall Study|Death|0|||
164340574|NCT02555683|593622219|FG001|Overall Study|Death|1|||
164340575|NCT02555683|593622220|FG002|Overall Study|Death|2|||
164340576|NCT02555683|593622218|FG000|Overall Study|Adverse Event|1|||
163993103|NCT01717638|592343908|FG008|Overall Study|Father in hospital|0|||
163993104|NCT01717638|592343909|FG009|Overall Study|Father in hospital|0|||
163993105|NCT01717638|592343910|FG010|Overall Study|Father in hospital|0|||
163993106|NCT01717638|592343911|FG011|Overall Study|Father in hospital|0|||
163993107|NCT01717638|592343912|FG012|Overall Study|Father in hospital|1|||
163993108|NCT01717638|592343900|FG000|Overall Study|Withdrawal by Subject|0|||
163993109|NCT01717638|592343901|FG001|Overall Study|Withdrawal by Subject|1|||
163993110|NCT01717638|592343902|FG002|Overall Study|Withdrawal by Subject|1|||
164261016|NCT00075725|593323647|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
164261017|NCT00075725|593323648|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
164340577|NCT02555683|593622219|FG001|Overall Study|Adverse Event|0|||
164340578|NCT02555683|593622220|FG002|Overall Study|Adverse Event|1|||
164340579|NCT02555683|593622218|FG000|Overall Study|Subject/guardian decision|12|||
164340580|NCT02555683|593622219|FG001|Overall Study|Subject/guardian decision|12|||
163888437|NCT03852472|591963346|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
163888438|NCT03852472|591963347|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
163888439|NCT03852472|591963348|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
163888440|NCT03852472|591963349|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
163888441|NCT03852472|591963350|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
163888442|NCT03852472|591963346|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
163888443|NCT03852472|591963347|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
163888444|NCT03852472|591963348|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
163888445|NCT03852472|591963349|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
163888446|NCT03852472|591963350|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
163888447|NCT03852472|591963346|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
163993111|NCT01717638|592343903|FG003|Overall Study|Withdrawal by Subject|0|||
164085122|NCT01214603|592675885|FG001|Overall Study|Progressive Disease|1|||
164085123|NCT01214603|592675886|FG002|Overall Study|Progressive Disease|3|||
164340581|NCT02555683|593622220|FG002|Overall Study|Subject/guardian decision|22|||
164340582|NCT02555683|593622218|FG000|Overall Study|Death post Treatment/safety period|0|||
163993112|NCT01717638|592343904|FG004|Overall Study|Withdrawal by Subject|1|||
164085124|NCT01507896|592675887|FG000|Overall Study|Withdrawal by Subject|1|||
164142270|NCT00451204|592882583|FG001|Overall Study|Protocol Violation|0|||
164261018|NCT00075725|593323649|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
164340583|NCT02555683|593622219|FG001|Overall Study|Death post Treatment/safety period|1|||
164261019|NCT00075725|593323638|FG000|Overall Study|Pt incarcerated|0|||
164261020|NCT00075725|593323639|FG001|Overall Study|Pt incarcerated|0|||
164261021|NCT00075725|593323640|FG002|Overall Study|Pt incarcerated|0|||
164261022|NCT00075725|593323641|FG003|Overall Study|Pt incarcerated|0|||
164261023|NCT00075725|593323642|FG004|Overall Study|Pt incarcerated|0|||
164261024|NCT00075725|593323643|FG005|Overall Study|Pt incarcerated|0|||
164261025|NCT00075725|593323644|FG006|Overall Study|Pt incarcerated|0|||
164261026|NCT00075725|593323645|FG007|Overall Study|Pt incarcerated|1|||
164261027|NCT00075725|593323646|FG008|Overall Study|Pt incarcerated|0|||
164261028|NCT00075725|593323647|FG009|Overall Study|Pt incarcerated|0|||
164261029|NCT00075725|593323648|FG010|Overall Study|Pt incarcerated|0|||
164261030|NCT00075725|593323649|FG011|Overall Study|Pt incarcerated|0|||
164261031|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Death|1|||
164261032|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Death|1|||
164261033|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Death|0|||
164261034|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Death|0|||
164261035|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Death|1|||
164261036|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Death|0|||
164261037|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Death|0|||
164261038|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Death|0|||
164261039|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Death|0|||
164261040|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Death|0|||
164261041|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
164261042|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
164261043|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
164261044|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261045|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
164261046|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261047|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261048|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261049|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261050|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
164261051|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261052|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261053|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261054|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261055|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
164261056|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261057|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261058|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261059|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261060|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
164261061|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
164261062|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261063|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261064|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261065|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261066|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261067|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261068|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261069|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261070|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
164261071|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
164261072|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261073|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261074|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
164261075|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
164261076|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261077|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261078|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261079|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164261080|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
164340584|NCT02555683|593622220|FG002|Overall Study|Death post Treatment/safety period|0|||
164340585|NCT04622306|593622224|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
164340586|NCT04622306|593622225|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
164261081|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
164261082|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261083|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261084|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
164261085|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261086|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164340587|NCT04622306|593622226|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
164261087|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261088|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261089|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261090|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
164261091|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
164261092|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
164261093|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
164261094|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
164261095|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
164261096|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261097|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261098|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261099|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261100|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
164261101|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
164261102|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
164261103|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
164261104|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261105|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
164261106|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261107|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261108|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261109|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261110|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261111|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
164261112|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261113|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261114|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
164261115|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
164261116|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261117|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261118|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261119|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261120|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
164261121|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261122|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261123|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261124|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261125|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261126|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164340588|NCT04622306|593622227|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
164340589|NCT04622306|593622228|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
164340590|NCT04622306|593622229|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
164340591|NCT04622306|593622224|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340592|NCT04622306|593622225|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340593|NCT04622306|593622226|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
164340594|NCT04622306|593622227|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
164340595|NCT04622306|593622228|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340596|NCT04622306|593622229|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
164340597|NCT01896102|593622233|FG000|Overall Study|Death|1|||
164340598|NCT01896102|593622233|FG000|Overall Study|Participant to receive allogenic transplant|2|||
164340599|NCT00696800|593622239|FG000|Overall Study|Adverse Event|16|||
164340600|NCT00696800|593622240|FG001|Overall Study|Adverse Event|3|||
164340601|NCT00696800|593622239|FG000|Overall Study|Insufficient compliance with medication|2|||
164340602|NCT00696800|593622240|FG001|Overall Study|Insufficient compliance with medication|1|||
164340603|NCT00696800|593622239|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
164085125|NCT01507896|592675887|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
164085126|NCT00446654|592675895|FG000|Overall Study|Withdrawal by Subject|1|||
164085127|NCT00446654|592675896|FG001|Overall Study|Withdrawal by Subject|0|||
164085128|NCT00446654|592675895|FG000|Overall Study|Adverse Event|1|||
164085129|NCT00446654|592675896|FG001|Overall Study|Adverse Event|0|||
164085130|NCT01102777|592675900|FG000|Overall Study|Death|2|||
164085131|NCT01102777|592675901|FG001|Overall Study|Death|6|||
164085132|NCT01102777|592675900|FG000|Overall Study|Lost to Follow-up|7|||
164085133|NCT01102777|592675901|FG001|Overall Study|Lost to Follow-up|10|||
164085134|NCT01875445|592675902|FG000|Overall Study|Lost to Follow-up|5|||
164085135|NCT01875445|592675903|FG001|Overall Study|Lost to Follow-up|0|||
164085136|NCT01875445|592675902|FG000|Overall Study|Withdrawal by Subject|2|||
164085137|NCT01875445|592675903|FG001|Overall Study|Withdrawal by Subject|0|||
164085138|NCT04029090|592675904|FG000|Overall Study|Protocol Violation|1|||
164085139|NCT04029090|592675905|FG001|Overall Study|Protocol Violation|0|||
164085140|NCT04029090|592675906|FG002|Overall Study|Protocol Violation|0|||
164085141|NCT04029090|592675904|FG000|Overall Study|Withdrawal by Subject|0|||
164085142|NCT04029090|592675905|FG001|Overall Study|Withdrawal by Subject|1|||
164085143|NCT04029090|592675906|FG002|Overall Study|Withdrawal by Subject|0|||
164085144|NCT00501046|592675907|FG000|Overall Study|Adverse Event|21|||
164085145|NCT00501046|592675908|FG001|Overall Study|Adverse Event|25|||
164085146|NCT00501046|592675907|FG000|Overall Study|Death|23|||
164085147|NCT00501046|592675908|FG001|Overall Study|Death|30|||
164085148|NCT00501046|592675907|FG000|Overall Study|Lost to Follow-up|14|||
164085149|NCT00501046|592675908|FG001|Overall Study|Lost to Follow-up|13|||
164085150|NCT00501046|592675907|FG000|Overall Study|Physician Decision|7|||
164085151|NCT00501046|592675908|FG001|Overall Study|Physician Decision|2|||
164085152|NCT00501046|592675907|FG000|Overall Study|Pregnancy|0|||
164085153|NCT00501046|592675908|FG001|Overall Study|Pregnancy|3|||
164085154|NCT00501046|592675907|FG000|Overall Study|Protocol Violation|2|||
164085155|NCT00501046|592675908|FG001|Overall Study|Protocol Violation|1|||
164085156|NCT00501046|592675907|FG000|Overall Study|Withdrawal by Subject|84|||
164085157|NCT00501046|592675908|FG001|Overall Study|Withdrawal by Subject|83|||
164085158|NCT00501046|592675907|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
164085159|NCT00501046|592675908|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
164085160|NCT05056727|592675909|FG000|Initiation Phase|Lost to Follow-up|1|||
164085161|NCT05056727|592675910|FG001|Initiation Phase|Lost to Follow-up|0|||
164261127|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261128|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261129|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261130|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261131|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261132|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261133|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261134|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261135|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261136|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261137|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261138|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261139|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261140|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261141|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
164261142|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
164261143|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
164261144|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
164261145|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
164261146|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261147|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164085162|NCT05056727|592675911|FG002|Initiation Phase|Lost to Follow-up|0|||
164085163|NCT05056727|592675912|FG003|Initiation Phase|Lost to Follow-up|0|||
164085164|NCT05056727|592675909|FG000|Initiation Phase|Study-specific; Study terminated; Other|20|||
164085165|NCT05056727|592675910|FG001|Initiation Phase|Study-specific; Study terminated; Other|0|||
164085166|NCT05056727|592675911|FG002|Initiation Phase|Study-specific; Study terminated; Other|0|||
164085167|NCT05056727|592675912|FG003|Initiation Phase|Study-specific; Study terminated; Other|0|||
164085168|NCT05056727|592675909|FG000|Initiation Phase|Withdrawal by Subject|9|||
164261148|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261149|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261150|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
164261151|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261152|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261153|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261154|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
164261155|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
164261156|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261157|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261158|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261159|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261160|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261161|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261162|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261163|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261164|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261165|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261166|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261167|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261168|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261169|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261170|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261171|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261172|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261173|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261174|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261175|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
164261176|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261177|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261178|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261179|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261180|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
164261181|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261182|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261183|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261184|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261185|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
164261186|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261187|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261188|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261189|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261190|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261191|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261192|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
164261193|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261194|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261195|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
163993113|NCT01717638|592343905|FG005|Overall Study|Withdrawal by Subject|0|||
163993114|NCT01717638|592343906|FG006|Overall Study|Withdrawal by Subject|2|||
163993115|NCT01717638|592343907|FG007|Overall Study|Withdrawal by Subject|1|||
163993116|NCT01717638|592343908|FG008|Overall Study|Withdrawal by Subject|2|||
164340604|NCT00696800|593622240|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
163993117|NCT01717638|592343909|FG009|Overall Study|Withdrawal by Subject|1|||
163993118|NCT01717638|592343910|FG010|Overall Study|Withdrawal by Subject|0|||
163993119|NCT01717638|592343911|FG011|Overall Study|Withdrawal by Subject|0|||
163993120|NCT01717638|592343912|FG012|Overall Study|Withdrawal by Subject|18|||
163993121|NCT01719757|592343913|FG000|Overall Study|Adverse Event|38|||
163993122|NCT01719757|592343913|FG000|Overall Study|Withdrawal by Subject|15|||
163993123|NCT01719757|592343913|FG000|Overall Study|Lost to Follow-up|20|||
163993124|NCT01719757|592343913|FG000|Overall Study|Protocol Violation|1|||
163993125|NCT01719757|592343913|FG000|Overall Study|well controlled pain|27|||
163993126|NCT02626338|592343914|FG000|Overall Study|Lack of Efficacy|3|||
163993127|NCT02626338|592343915|FG001|Overall Study|Lack of Efficacy|2|||
163993128|NCT02626338|592343916|FG002|Overall Study|Lack of Efficacy|0|||
163993129|NCT03312218|592343922|FG000|Overall Study|Never signed in to access the app|54|||
163993130|NCT03312218|592343923|FG001|Overall Study|Never signed in to access the app|58|||
163993131|NCT01901224|592343924|FG000|Overall Study|study was not funded and terminated|2|||
163993132|NCT06441877|592343925|FG000|Overall Study|Withdrawal by Subject|0|||
163993133|NCT06441877|592343926|FG001|Overall Study|Withdrawal by Subject|2|||
163993134|NCT06441877|592343927|FG002|Overall Study|Withdrawal by Subject|0|||
163993135|NCT06441877|592343928|FG003|Overall Study|Withdrawal by Subject|0|||
163993136|NCT05742984|592343929|FG000|Overall Study|Adverse Event|0|||
163993137|NCT05742984|592343930|FG001|Overall Study|Adverse Event|0|||
163993138|NCT05742984|592343931|FG002|Overall Study|Adverse Event|1|||
163993139|NCT05742984|592343932|FG003|Overall Study|Adverse Event|0|||
163993140|NCT05742984|592343933|FG004|Overall Study|Adverse Event|1|||
163993141|NCT05742984|592343934|FG005|Overall Study|Adverse Event|1|||
163993142|NCT05742984|592343929|FG000|Overall Study|Withdrawal by Subject|0|||
163993143|NCT05742984|592343930|FG001|Overall Study|Withdrawal by Subject|1|||
163993144|NCT05742984|592343931|FG002|Overall Study|Withdrawal by Subject|0|||
163993145|NCT05742984|592343932|FG003|Overall Study|Withdrawal by Subject|0|||
163993146|NCT05742984|592343933|FG004|Overall Study|Withdrawal by Subject|0|||
163993147|NCT05742984|592343934|FG005|Overall Study|Withdrawal by Subject|2|||
163993148|NCT02162862|592343935|FG000|Overall Study|Lost to Follow-up|0|||
163993149|NCT02162862|592343936|FG001|Overall Study|Lost to Follow-up|11|||
163993150|NCT02162862|592343937|FG002|Overall Study|Lost to Follow-up|0|||
163993151|NCT02162862|592343935|FG000|Overall Study|Subject did not feel the med was needed|0|||
163993152|NCT02162862|592343936|FG001|Overall Study|Subject did not feel the med was needed|0|||
163993153|NCT02162862|592343937|FG002|Overall Study|Subject did not feel the med was needed|4|||
163993154|NCT03116113|592343938|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993155|NCT03116113|592343939|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993156|NCT03116113|592343940|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993157|NCT03116113|592343941|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993158|NCT03116113|592343942|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993159|NCT03116113|592343943|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993160|NCT03116113|592343944|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
163993161|NCT03116113|592343945|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
163993162|NCT03116113|592343946|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
163993163|NCT02159807|592343947|FG000|Overall Study|Adverse Event|0|||
163993164|NCT02159807|592343948|FG001|Overall Study|Adverse Event|0|||
163993165|NCT02159807|592343949|FG002|Overall Study|Adverse Event|1|||
163993166|NCT02159807|592343947|FG000|Overall Study|No CSF|1|||
163993167|NCT02159807|592343948|FG001|Overall Study|No CSF|1|||
163993168|NCT02159807|592343949|FG002|Overall Study|No CSF|1|||
163993169|NCT02159807|592343947|FG000|Overall Study|elevated blood pressure|0|||
163993170|NCT02159807|592343948|FG001|Overall Study|elevated blood pressure|0|||
163993171|NCT02159807|592343949|FG002|Overall Study|elevated blood pressure|1|||
163993172|NCT00950170|592343950|FG000|Overall Study|Parent/Legal Guardian Request|1|||
163993173|NCT00950170|592343950|FG000|Overall Study|Adverse Event|2|||
164340605|NCT00696800|593622239|FG000|Overall Study|Insufficient ovarian response|4|||
164340606|NCT00696800|593622240|FG001|Overall Study|Insufficient ovarian response|1|||
164340607|NCT00696800|593622239|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
164340608|NCT00696800|593622240|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
164340609|NCT00696800|593622239|FG000|Overall Study|Too high ovarian response|6|||
164340610|NCT00696800|593622240|FG001|Overall Study|Too high ovarian response|1|||
163993174|NCT00950170|592343950|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
163993175|NCT01254669|592343953|FG000|Overall Study|Withdrawal by Subject|0|||
164340611|NCT00696800|593622239|FG000|Overall Study|No/too few/bad quality oocytes|4|||
164340612|NCT00696800|593622240|FG001|Overall Study|No/too few/bad quality oocytes|3|||
163993176|NCT01254669|592343954|FG001|Overall Study|Withdrawal by Subject|1|||
163993177|NCT01254669|592343953|FG000|Overall Study|time constraint|2|||
163993178|NCT01254669|592343954|FG001|Overall Study|time constraint|2|||
163993179|NCT01254669|592343953|FG000|Overall Study|called to clinic during intervention|1|||
164142271|NCT00451204|592882582|FG000|Overall Study|Patient refusal|8|||
164340613|NCT00696800|593622239|FG000|Overall Study|No/abnormal fertilization|11|||
164340614|NCT00696800|593622240|FG001|Overall Study|No/abnormal fertilization|13|||
164340615|NCT00696800|593622239|FG000|Overall Study|No/too few/bad quality embryos|24|||
164340616|NCT00696800|593622240|FG001|Overall Study|No/too few/bad quality embryos|18|||
164340617|NCT00696800|593622239|FG000|Overall Study|Other Reasons|5|||
164340618|NCT00696800|593622240|FG001|Overall Study|Other Reasons|3|||
164340619|NCT00696800|593622239|FG000|Overall Study|Not treated|1|||
164085169|NCT05056727|592675910|FG001|Initiation Phase|Withdrawal by Subject|0|||
164085170|NCT05056727|592675911|FG002|Initiation Phase|Withdrawal by Subject|0|||
164085171|NCT05056727|592675912|FG003|Initiation Phase|Withdrawal by Subject|0|||
164261196|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261197|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261198|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261199|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261200|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
164261201|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
164261202|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261203|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261204|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261205|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
164261206|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261207|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261208|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261209|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261210|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
164261211|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
164261212|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261213|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
164261214|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261215|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
164261216|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261217|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261218|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261219|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261220|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
164261221|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Other|5|||
164261222|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Other|1|||
164261223|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Other|0|||
164261224|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Other|3|||
164261225|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Other|0|||
164261226|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Other|0|||
164261227|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Other|0|||
164261228|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Other|0|||
164261229|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Other|0|||
164261230|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Other|0|||
164261231|NCT03352557|593323650|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261232|NCT03352557|593323651|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261233|NCT03352557|593323652|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261234|NCT03352557|593323653|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261235|NCT03352557|593323654|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
164340620|NCT00696800|593622240|FG001|Overall Study|Not treated|2|||
164340621|NCT00762385|593622242|FG000|First Intervention|Lens Issue|1|||
164340622|NCT00762385|593622243|FG001|First Intervention|Lens Issue|1|||
164085172|NCT05056727|592675909|FG000|Initiation Phase|Physician Decision|4|||
164261236|NCT03352557|593323655|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261237|NCT03352557|593323656|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261238|NCT03352557|593323657|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261239|NCT03352557|593323658|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261240|NCT03352557|593323659|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
164261241|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Death|0|||
164261242|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Death|0|||
164340623|NCT00762385|593622242|FG000|First Intervention|Lost to Follow-up|0|||
164340624|NCT00762385|593622243|FG001|First Intervention|Lost to Follow-up|2|||
164340625|NCT00762385|593622242|FG000|First Intervention|Ineligible|1|||
163888448|NCT03852472|591963347|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
163888449|NCT03852472|591963348|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
163888450|NCT03852472|591963349|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
163888451|NCT03852472|591963350|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
163888452|NCT03852472|591963346|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
163888453|NCT03852472|591963347|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
163888454|NCT03852472|591963348|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
164261243|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Death|0|||
164261244|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Death|0|||
164261245|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Death|0|||
164261246|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Death|1|||
164261247|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Death|0|||
164261248|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Death|1|||
163993180|NCT01254669|592343954|FG001|Overall Study|called to clinic during intervention|1|||
163993181|NCT00103012|592343958|FG000|Overall Study|Withdrawal by Subject|2|||
163993182|NCT00103012|592343959|FG001|Overall Study|Withdrawal by Subject|1|||
163993183|NCT00103012|592343960|FG002|Overall Study|Withdrawal by Subject|2|||
163993184|NCT00103012|592343958|FG000|Overall Study|Pregnancy|1|||
163993185|NCT00103012|592343959|FG001|Overall Study|Pregnancy|0|||
163993186|NCT00103012|592343960|FG002|Overall Study|Pregnancy|0|||
163993187|NCT00103012|592343958|FG000|Overall Study|Adverse Event|0|||
163993188|NCT00103012|592343959|FG001|Overall Study|Adverse Event|0|||
164261249|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Death|1|||
164261250|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Death|1|||
164261251|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261252|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261253|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261254|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261255|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261256|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
164261257|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261258|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261259|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261260|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
164261261|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261262|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261263|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164340626|NCT00762385|593622243|FG001|First Intervention|Ineligible|0|||
163993189|NCT00103012|592343960|FG002|Overall Study|Adverse Event|1|||
163993190|NCT00103012|592343958|FG000|Overall Study|Subject non-compliant with medications|0|||
164340627|NCT00762385|593622242|FG000|First Intervention|Protocol Violation|0|||
164340628|NCT00762385|593622243|FG001|First Intervention|Protocol Violation|1|||
164340629|NCT00762385|593622242|FG000|Second Intervention|Protocol Violation|3|||
164340630|NCT00762385|593622243|FG001|Second Intervention|Protocol Violation|3|||
164340631|NCT00591344|593622246|FG000|Overall Study|Transportation issues|1|||
164340632|NCT00591344|593622247|FG001|Overall Study|Transportation issues|0|||
164340633|NCT00591344|593622246|FG000|Overall Study|Moved out of state|1|||
164340634|NCT00591344|593622247|FG001|Overall Study|Moved out of state|0|||
164340635|NCT00591344|593622246|FG000|Overall Study|Medical complications|1|||
164340636|NCT00591344|593622247|FG001|Overall Study|Medical complications|3|||
164340637|NCT00591344|593622246|FG000|Overall Study|Underwent DBS|2|||
164340638|NCT00591344|593622247|FG001|Overall Study|Underwent DBS|2|||
164340639|NCT00591344|593622246|FG000|Overall Study|Death|0|||
164340640|NCT00591344|593622247|FG001|Overall Study|Death|1|||
164340641|NCT00591344|593622246|FG000|Overall Study|Lost to Follow-up|0|||
164340642|NCT00591344|593622247|FG001|Overall Study|Lost to Follow-up|1|||
164340643|NCT00591344|593622246|FG000|Overall Study|Did not want to come off medication|0|||
164340644|NCT00591344|593622247|FG001|Overall Study|Did not want to come off medication|1|||
163993191|NCT00103012|592343959|FG001|Overall Study|Subject non-compliant with medications|0|||
163993192|NCT00103012|592343960|FG002|Overall Study|Subject non-compliant with medications|1|||
164085173|NCT05056727|592675910|FG001|Initiation Phase|Physician Decision|0|||
164261264|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164340645|NCT00493025|593622248|FG000|Overall Study|Physician Decision|19|||
164340646|NCT01609231|593622255|FG000|Overall Study|Adverse Event|1|||
164340647|NCT01609231|593622256|FG001|Overall Study|Adverse Event|3|||
164340648|NCT01609231|593622255|FG000|Overall Study|Physician Decision|1|||
164340649|NCT01609231|593622256|FG001|Overall Study|Physician Decision|0|||
164340650|NCT01609231|593622255|FG000|Overall Study|Withdrawal by Subject|1|||
164340651|NCT01609231|593622256|FG001|Overall Study|Withdrawal by Subject|0|||
164340652|NCT00494299|593622257|FG000|Overall Study|Adverse Event|93|||
164340653|NCT00494299|593622258|FG001|Overall Study|Adverse Event|13|||
164340654|NCT00494299|593622257|FG000|Overall Study|Lost to Follow-up|1|||
164340655|NCT00494299|593622258|FG001|Overall Study|Lost to Follow-up|0|||
164340656|NCT00494299|593622257|FG000|Overall Study|Physician Decision|0|||
164340657|NCT00494299|593622258|FG001|Overall Study|Physician Decision|2|||
164340658|NCT00494299|593622257|FG000|Overall Study|Protocol Violation|1|||
164340659|NCT00494299|593622258|FG001|Overall Study|Protocol Violation|2|||
164340660|NCT00494299|593622257|FG000|Overall Study|Withdrawal by Subject|8|||
164340661|NCT00494299|593622258|FG001|Overall Study|Withdrawal by Subject|3|||
164340662|NCT00494299|593622257|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
164340663|NCT00494299|593622258|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
164340664|NCT00494299|593622257|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
163993193|NCT00393718|592343967|FG000|Overall Study|Adverse Event|20|||
163993194|NCT00393718|592343968|FG001|Overall Study|Adverse Event|8|||
163993195|NCT00393718|592343967|FG000|Overall Study|Protocol Violation|1|||
163993196|NCT00393718|592343968|FG001|Overall Study|Protocol Violation|2|||
163993197|NCT00393718|592343967|FG000|Overall Study|Lack of Efficacy|10|||
163993198|NCT00393718|592343968|FG001|Overall Study|Lack of Efficacy|9|||
163993199|NCT00393718|592343967|FG000|Overall Study|Hypoglycaemia|3|||
164261265|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261266|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261267|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261268|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261269|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
164261270|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
164261271|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261272|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261273|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261274|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261275|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
164261276|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
164261277|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
164261278|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
164261279|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
164261280|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
164261281|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261282|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261283|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261284|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261285|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261286|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
164261287|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
164261288|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
164261289|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
164261290|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
164261291|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261292|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164340665|NCT00494299|593622258|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
164340666|NCT00494299|593622257|FG000|Overall Study|Site Closed by Sponsor|6|||
163993200|NCT00393718|592343968|FG001|Overall Study|Hypoglycaemia|2|||
163993201|NCT00393718|592343967|FG000|Overall Study|Subject decision|5|||
163993202|NCT00393718|592343968|FG001|Overall Study|Subject decision|0|||
163993203|NCT00393718|592343967|FG000|Overall Study|Withdrawal of consent|2|||
163993204|NCT00393718|592343968|FG001|Overall Study|Withdrawal of consent|1|||
163993205|NCT00393718|592343967|FG000|Overall Study|Missed measurement|1|||
163993206|NCT00393718|592343968|FG001|Overall Study|Missed measurement|0|||
163993207|NCT00393718|592343967|FG000|Overall Study|Move|1|||
163993208|NCT00393718|592343968|FG001|Overall Study|Move|0|||
163993209|NCT01084551|592343973|FG000|Overall Study|Adverse Event|2|||
163993210|NCT01084551|592343974|FG001|Overall Study|Adverse Event|9|||
163993211|NCT01084551|592343975|FG002|Overall Study|Adverse Event|4|||
163993212|NCT01084551|592343973|FG000|Overall Study|Lack of Efficacy|2|||
163993213|NCT01084551|592343974|FG001|Overall Study|Lack of Efficacy|0|||
163993214|NCT01084551|592343975|FG002|Overall Study|Lack of Efficacy|1|||
163993215|NCT01084551|592343973|FG000|Overall Study|Withdrawal by Subject|2|||
163993216|NCT01084551|592343974|FG001|Overall Study|Withdrawal by Subject|1|||
163993217|NCT01084551|592343975|FG002|Overall Study|Withdrawal by Subject|0|||
163993218|NCT01084551|592343973|FG000|Overall Study|Protocol Violation|2|||
163993219|NCT01084551|592343974|FG001|Overall Study|Protocol Violation|4|||
163993220|NCT01084551|592343975|FG002|Overall Study|Protocol Violation|0|||
163993221|NCT01084551|592343973|FG000|Overall Study|Lost to Follow-up|0|||
163993222|NCT01084551|592343974|FG001|Overall Study|Lost to Follow-up|0|||
163993223|NCT01084551|592343975|FG002|Overall Study|Lost to Follow-up|3|||
163993224|NCT01084551|592343973|FG000|Overall Study|Physician Decision|1|||
163993225|NCT01084551|592343974|FG001|Overall Study|Physician Decision|0|||
163993226|NCT01084551|592343975|FG002|Overall Study|Physician Decision|0|||
163993227|NCT03902080|592343976|FG000|Overall Study|Adverse Event|17|||
163993228|NCT03902080|592343977|FG001|Overall Study|Adverse Event|15|||
163993229|NCT03902080|592343976|FG000|Overall Study|Withdrawal by Subject|28|||
164261293|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261294|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261295|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261296|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261297|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261298|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261299|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
164261300|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
164261301|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261302|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261303|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261304|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261305|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261306|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
164261307|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
164261308|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
164261309|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
164261310|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
164261311|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261312|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261313|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261314|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261315|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261316|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261317|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261318|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
164261319|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
164261320|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
164261321|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261322|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261323|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261324|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261325|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261326|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261327|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261328|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
164261329|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
163888455|NCT03852472|591963349|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
163888456|NCT03852472|591963350|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
163993230|NCT03902080|592343977|FG001|Overall Study|Withdrawal by Subject|35|||
163993231|NCT03902080|592343976|FG000|Overall Study|Lost to Follow-up|6|||
163993232|NCT03902080|592343977|FG001|Overall Study|Lost to Follow-up|7|||
163993233|NCT03902080|592343976|FG000|Overall Study|Other|3|||
163993234|NCT03902080|592343977|FG001|Overall Study|Other|5|||
163993235|NCT03902080|592343976|FG000|Overall Study|Non compliance|4|||
163993236|NCT03902080|592343977|FG001|Overall Study|Non compliance|3|||
163993237|NCT03902080|592343976|FG000|Overall Study|Physician Decision|5|||
163993238|NCT03902080|592343977|FG001|Overall Study|Physician Decision|1|||
163993239|NCT03902080|592343976|FG000|Overall Study|Protocol Violation|3|||
163993240|NCT03902080|592343977|FG001|Overall Study|Protocol Violation|3|||
163993241|NCT03902080|592343976|FG000|Overall Study|Lack of Efficacy|1|||
163993242|NCT03902080|592343977|FG001|Overall Study|Lack of Efficacy|3|||
163993243|NCT03902080|592343976|FG000|Overall Study|Withdrawn prior to dosing|0|||
163993244|NCT03902080|592343977|FG001|Overall Study|Withdrawn prior to dosing|1|||
163993245|NCT01703000|592343978|FG000|Overall Study|Death|1|||
163993246|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993247|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
163993248|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993249|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993250|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993251|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
163993252|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
163993253|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
163993254|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
163993255|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
163993256|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163993257|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163993258|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163993259|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163993260|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163993261|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163993262|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163993263|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163993264|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
163993265|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
163993266|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993267|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993268|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993269|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163993270|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993271|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
163993272|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
163993273|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163993274|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163993275|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163993276|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
163993277|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
163993278|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
163993279|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
163993280|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
163993281|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163993282|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
163993283|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
163993284|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
163993285|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
164261330|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
164261331|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261332|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261333|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
163993286|NCT00289913|592343979|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
163993287|NCT00289913|592343980|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163993288|NCT00289913|592343981|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
163993289|NCT00289913|592343982|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
164142272|NCT00451204|592882583|FG001|Overall Study|Patient refusal|4|||
164261334|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261335|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261336|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261337|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261338|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
164261339|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261340|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
164261341|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261342|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261343|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261344|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261345|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261346|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261347|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261348|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
164261349|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
164261350|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
164261351|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261352|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261353|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261354|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261355|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261356|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
164261357|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261358|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261359|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
164261360|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
164261361|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261362|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261363|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261364|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261365|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261366|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261367|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261368|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261369|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
164261370|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
164261371|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261372|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164340667|NCT00494299|593622258|FG001|Overall Study|Site Closed by Sponsor|0|||
164340668|NCT00494299|593622257|FG000|Overall Study|Protocol Driven Decision Point|11|||
164340669|NCT00494299|593622258|FG001|Overall Study|Protocol Driven Decision Point|22|||
164340670|NCT03822182|593622264|FG000|Overall Study|Protocol Violation|0|||
164340671|NCT03822182|593622265|FG001|Overall Study|Protocol Violation|1|||
164340672|NCT03822182|593622266|FG002|Overall Study|Protocol Violation|1|||
164340673|NCT01484275|593622267|FG000|Overall Study|Study terminated by sponsor|28|||
164340674|NCT01484275|593622268|FG001|Overall Study|Study terminated by sponsor|32|||
164340675|NCT01484275|593622267|FG000|Overall Study|Other|10|||
164340676|NCT01484275|593622268|FG001|Overall Study|Other|0|||
164340677|NCT01484275|593622267|FG000|Overall Study|Death|3|||
164340678|NCT01484275|593622268|FG001|Overall Study|Death|4|||
164340679|NCT01484275|593622267|FG000|Overall Study|Withdrawal by Subject|1|||
164340680|NCT01484275|593622268|FG001|Overall Study|Withdrawal by Subject|5|||
164340681|NCT01484275|593622267|FG000|Overall Study|Lost to Follow-up|1|||
164340682|NCT01484275|593622268|FG001|Overall Study|Lost to Follow-up|1|||
164340683|NCT03113916|593622271|FG000|Overall Study|Withdrawal by Subject|9|||
164340684|NCT03113916|593622272|FG001|Overall Study|Withdrawal by Subject|7|||
164340685|NCT03113916|593622271|FG000|Overall Study|Pregnancy|1|||
164340686|NCT03113916|593622272|FG001|Overall Study|Pregnancy|3|||
164340687|NCT03113916|593622271|FG000|Overall Study|Lost to Follow-up|1|||
164340688|NCT03113916|593622272|FG001|Overall Study|Lost to Follow-up|2|||
164340689|NCT00241358|593622273|FG000|Overall Study|Determined to be not ineligible|0|||
163888457|NCT03852472|591963346|FG000|Period 2 - Week 44|Adverse Event|0|||
164085174|NCT05056727|592675911|FG002|Initiation Phase|Physician Decision|0|||
164261373|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261374|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261375|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261376|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261377|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261378|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
164261379|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
164261380|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
164261381|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261382|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261383|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261384|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261385|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261386|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261387|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261388|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
164261389|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
164261390|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
164261391|NCT03352557|593323650|FG000|LTE Period: Week 80 to Week 173|Other|0|||
164261392|NCT03352557|593323651|FG001|LTE Period: Week 80 to Week 173|Other|0|||
164261393|NCT03352557|593323652|FG002|LTE Period: Week 80 to Week 173|Other|0|||
164261394|NCT03352557|593323653|FG003|LTE Period: Week 80 to Week 173|Other|0|||
164261395|NCT03352557|593323654|FG004|LTE Period: Week 80 to Week 173|Other|0|||
164261396|NCT03352557|593323655|FG005|LTE Period: Week 80 to Week 173|Other|0|||
164261397|NCT03352557|593323656|FG006|LTE Period: Week 80 to Week 173|Other|0|||
164261398|NCT03352557|593323657|FG007|LTE Period: Week 80 to Week 173|Other|1|||
164261399|NCT03352557|593323658|FG008|LTE Period: Week 80 to Week 173|Other|0|||
164261400|NCT03352557|593323659|FG009|LTE Period: Week 80 to Week 173|Other|0|||
164261401|NCT01560637|593323660|FG000|Overall Study|Adverse Event|63|||
164261402|NCT01560637|593323660|FG000|Overall Study|Death|69|||
164261403|NCT01560637|593323660|FG000|Overall Study|Lost to Follow-up|8|||
164261404|NCT01560637|593323660|FG000|Overall Study|Protocol Violation|8|||
164261405|NCT01560637|593323660|FG000|Overall Study|Withdrawal by Subject|24|||
164261406|NCT01560637|593323660|FG000|Overall Study|Progressive Disease|20|||
164261407|NCT01560637|593323660|FG000|Overall Study|Other Reason Not Specified|6|||
164261408|NCT04962230|593323669|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
164261409|NCT04962230|593323669|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
164261410|NCT02275117|593323672|FG000|Overall Study|Adverse Event|0|||
164261411|NCT02275117|593323673|FG001|Overall Study|Adverse Event|0|||
164261412|NCT02275117|593323674|FG002|Overall Study|Adverse Event|0|||
164261413|NCT02275117|593323675|FG003|Overall Study|Adverse Event|0|||
164261414|NCT02275117|593323676|FG004|Overall Study|Adverse Event|1|||
164261415|NCT02275117|593323672|FG000|Overall Study|Lack of Efficacy|6|||
164261416|NCT02275117|593323673|FG001|Overall Study|Lack of Efficacy|7|||
164261417|NCT02275117|593323674|FG002|Overall Study|Lack of Efficacy|5|||
164261418|NCT02275117|593323675|FG003|Overall Study|Lack of Efficacy|2|||
164261419|NCT02275117|593323676|FG004|Overall Study|Lack of Efficacy|10|||
164261420|NCT02275117|593323672|FG000|Overall Study|Lost to Follow-up|11|||
164261421|NCT02275117|593323673|FG001|Overall Study|Lost to Follow-up|16|||
164261422|NCT02275117|593323674|FG002|Overall Study|Lost to Follow-up|15|||
164261423|NCT02275117|593323675|FG003|Overall Study|Lost to Follow-up|16|||
164261424|NCT02275117|593323676|FG004|Overall Study|Lost to Follow-up|8|||
164261425|NCT02275117|593323672|FG000|Overall Study|Physician Decision|0|||
164261426|NCT02275117|593323673|FG001|Overall Study|Physician Decision|1|||
164261427|NCT02275117|593323674|FG002|Overall Study|Physician Decision|1|||
164261428|NCT02275117|593323675|FG003|Overall Study|Physician Decision|0|||
164261429|NCT02275117|593323676|FG004|Overall Study|Physician Decision|1|||
164340690|NCT00241358|593622274|FG001|Overall Study|Determined to be not ineligible|1|||
164340691|NCT00241358|593622275|FG002|Overall Study|Determined to be not ineligible|1|||
164340692|NCT01893203|593622277|FG000|Overall Study|Withdrawal by Subject|1|||
164261430|NCT02275117|593323672|FG000|Overall Study|Protocol Violation|1|||
164261431|NCT02275117|593323673|FG001|Overall Study|Protocol Violation|0|||
164261432|NCT02275117|593323674|FG002|Overall Study|Protocol Violation|1|||
164261433|NCT02275117|593323675|FG003|Overall Study|Protocol Violation|1|||
164261434|NCT02275117|593323676|FG004|Overall Study|Protocol Violation|0|||
164261435|NCT02275117|593323672|FG000|Overall Study|Withdrawal by Subject|6|||
164261436|NCT02275117|593323673|FG001|Overall Study|Withdrawal by Subject|4|||
164261437|NCT02275117|593323674|FG002|Overall Study|Withdrawal by Subject|7|||
164261438|NCT02275117|593323675|FG003|Overall Study|Withdrawal by Subject|3|||
164261439|NCT02275117|593323676|FG004|Overall Study|Withdrawal by Subject|3|||
164261440|NCT02275117|593323672|FG000|Overall Study|Terminated by Sponsor|4|||
164261441|NCT02275117|593323673|FG001|Overall Study|Terminated by Sponsor|4|||
164261442|NCT02275117|593323674|FG002|Overall Study|Terminated by Sponsor|4|||
164340693|NCT01758523|593622278|FG000|Overall Study|Adverse Event|2|||
164340694|NCT01758523|593622279|FG001|Overall Study|Adverse Event|1|||
164261443|NCT02275117|593323675|FG003|Overall Study|Terminated by Sponsor|6|||
164261444|NCT02275117|593323676|FG004|Overall Study|Terminated by Sponsor|4|||
164261445|NCT02275117|593323672|FG000|Overall Study|Worsening of Study Indication|0|||
164261446|NCT02275117|593323673|FG001|Overall Study|Worsening of Study Indication|1|||
164261447|NCT02275117|593323674|FG002|Overall Study|Worsening of Study Indication|2|||
164261448|NCT02275117|593323675|FG003|Overall Study|Worsening of Study Indication|0|||
164261449|NCT02275117|593323676|FG004|Overall Study|Worsening of Study Indication|0|||
164261450|NCT02275117|593323672|FG000|Overall Study|Study Burden|5|||
164261451|NCT02275117|593323673|FG001|Overall Study|Study Burden|4|||
164261452|NCT02275117|593323674|FG002|Overall Study|Study Burden|7|||
164261453|NCT02275117|593323675|FG003|Overall Study|Study Burden|5|||
164261454|NCT02275117|593323676|FG004|Overall Study|Study Burden|7|||
164261455|NCT02275117|593323672|FG000|Overall Study|Other|1|||
164261456|NCT02275117|593323673|FG001|Overall Study|Other|0|||
164261457|NCT02275117|593323674|FG002|Overall Study|Other|0|||
164261458|NCT02275117|593323675|FG003|Overall Study|Other|0|||
164261459|NCT02275117|593323676|FG004|Overall Study|Other|2|||
164261460|NCT01081301|593323680|FG000|Overall Study|Bereaved|3|||
164261461|NCT01081301|593323680|FG000|Overall Study|Too busy|5|||
164261462|NCT01081301|593323680|FG000|Overall Study|Patient too ill|2|||
164261463|NCT01081301|593323680|FG000|Overall Study|Lost to Follow-up|4|||
164261464|NCT01646645|593323687|FG000|Overall Study|No Treated|1|||
164261465|NCT01646645|593323687|FG000|Overall Study|Inevaluable Donor|29|||
164261466|NCT00717522|593323688|FG000|Overall Study|Disease Progression|5|||
164261467|NCT00717522|593323688|FG000|Overall Study|Adverse Event|1|||
164261468|NCT00717522|593323688|FG000|Overall Study|Death|1|||
164261469|NCT01799239|593323689|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
164261470|NCT01799239|593323690|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
164261471|NCT01799239|593323689|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
164261472|NCT01799239|593323690|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
164261473|NCT01799239|593323689|FG000|Period 1 (7 Days)|Protocol Violation|0|||
164261474|NCT01799239|593323690|FG001|Period 1 (7 Days)|Protocol Violation|1|||
164261475|NCT01799239|593323689|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
164261476|NCT01799239|593323690|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
164261477|NCT01799239|593323689|FG000|Period 2 (7 Days)|Protocol Violation|1|||
164261478|NCT01799239|593323690|FG001|Period 2 (7 Days)|Protocol Violation|0|||
164261479|NCT04209114|593323691|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
164261480|NCT04209114|593323692|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
164261481|NCT04209114|593323693|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
164261482|NCT04209114|593323691|FG000|Pre-Treatment Phase|Other reasons|0|||
164261483|NCT04209114|593323692|FG001|Pre-Treatment Phase|Other reasons|0|||
164261484|NCT04209114|593323693|FG002|Pre-Treatment Phase|Other reasons|1|||
164261485|NCT04209114|593323691|FG000|Pre-Treatment Phase|Death|0|||
164261486|NCT04209114|593323692|FG001|Pre-Treatment Phase|Death|0|||
164261487|NCT04209114|593323693|FG002|Pre-Treatment Phase|Death|1|||
164261488|NCT04209114|593323691|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
164261489|NCT04209114|593323692|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
164261490|NCT04209114|593323693|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
164261491|NCT04209114|593323691|FG000|Treatment Phase|Other reasons|5|||
164261492|NCT04209114|593323692|FG001|Treatment Phase|Other reasons|3|||
164261493|NCT04209114|593323693|FG002|Treatment Phase|Other reasons|0|||
164261494|NCT04209114|593323691|FG000|Treatment Phase|Lost to Follow-up|1|||
164261495|NCT04209114|593323692|FG001|Treatment Phase|Lost to Follow-up|0|||
164261496|NCT04209114|593323693|FG002|Treatment Phase|Lost to Follow-up|0|||
164261497|NCT04209114|593323691|FG000|Treatment Phase|Participant withdrew consent|1|||
164261498|NCT04209114|593323692|FG001|Treatment Phase|Participant withdrew consent|0|||
164261499|NCT04209114|593323693|FG002|Treatment Phase|Participant withdrew consent|0|||
164261500|NCT04209114|593323691|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
164261501|NCT04209114|593323692|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
164261502|NCT04209114|593323693|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
164261503|NCT04209114|593323691|FG000|Treatment Phase|Death|4|||
164261504|NCT04209114|593323692|FG001|Treatment Phase|Death|1|||
164261505|NCT04209114|593323693|FG002|Treatment Phase|Death|0|||
164261506|NCT04209114|593323691|FG000|Treatment Phase|Study drug toxicity|4|||
164261507|NCT04209114|593323692|FG001|Treatment Phase|Study drug toxicity|6|||
164261508|NCT04209114|593323693|FG002|Treatment Phase|Study drug toxicity|0|||
164261509|NCT04209114|593323691|FG000|Treatment Phase|Disease progression|6|||
164261510|NCT04209114|593323692|FG001|Treatment Phase|Disease progression|9|||
164261511|NCT04209114|593323693|FG002|Treatment Phase|Disease progression|0|||
164261512|NCT04143217|593325489|FG000|Overall Study|Withdrawal by Subject|42|||
164261513|NCT04143217|593325489|FG000|Overall Study|Adverse Event|29|||
164261514|NCT04143217|593325489|FG000|Overall Study|Lost to Follow-up|29|||
164261515|NCT04143217|593325489|FG000|Overall Study|Lack of Efficacy|15|||
164261516|NCT04143217|593325489|FG000|Overall Study|Physician Decision|1|||
164261517|NCT04143217|593325489|FG000|Overall Study|Non-Compliance With Study Drug|6|||
164261518|NCT04143217|593325489|FG000|Overall Study|Other, Multiple Categories|11|||
164261519|NCT02210832|593325492|FG000|Overall Study|Pregnancy termination .|3|||
164261520|NCT02210832|593325493|FG001|Overall Study|Pregnancy termination .|4|||
164261521|NCT02210832|593325494|FG002|Overall Study|Pregnancy termination .|1|||
164261522|NCT02210832|593325492|FG000|Overall Study|Lost to Follow-up|26|||
164261523|NCT02210832|593325493|FG001|Overall Study|Lost to Follow-up|32|||
164261524|NCT02210832|593325494|FG002|Overall Study|Lost to Follow-up|17|||
164261525|NCT00471887|593325497|FG000|Overall Study|Adverse Event|9|||
164261526|NCT01278407|593325505|FG000|Confirmatory Phase|Adverse Event|5|||
164261527|NCT01278407|593325506|FG001|Confirmatory Phase|Adverse Event|10|||
164261528|NCT01278407|593325507|FG002|Confirmatory Phase|Adverse Event|1|||
164261529|NCT01278407|593325508|FG003|Confirmatory Phase|Adverse Event|0|||
164261530|NCT01278407|593325509|FG004|Confirmatory Phase|Adverse Event|0|||
164261531|NCT01278407|593325505|FG000|Confirmatory Phase|Participant's Choice|3|||
164261532|NCT01278407|593325506|FG001|Confirmatory Phase|Participant's Choice|5|||
164261533|NCT01278407|593325507|FG002|Confirmatory Phase|Participant's Choice|3|||
164261534|NCT01278407|593325508|FG003|Confirmatory Phase|Participant's Choice|0|||
164261535|NCT01278407|593325509|FG004|Confirmatory Phase|Participant's Choice|0|||
164261536|NCT01278407|593325505|FG000|Confirmatory Phase|Other|1|||
164261537|NCT01278407|593325506|FG001|Confirmatory Phase|Other|1|||
164261538|NCT01278407|593325507|FG002|Confirmatory Phase|Other|2|||
164261539|NCT01278407|593325508|FG003|Confirmatory Phase|Other|0|||
164261540|NCT01278407|593325509|FG004|Confirmatory Phase|Other|0|||
164261541|NCT01278407|593325505|FG000|Extension Phase|Adverse Event|0|||
164261542|NCT01278407|593325506|FG001|Extension Phase|Adverse Event|0|||
164261543|NCT01278407|593325507|FG002|Extension Phase|Adverse Event|0|||
164261544|NCT01278407|593325508|FG003|Extension Phase|Adverse Event|7|||
164261545|NCT01278407|593325509|FG004|Extension Phase|Adverse Event|16|||
164261546|NCT01278407|593325505|FG000|Extension Phase|Participant's Choice|0|||
164261547|NCT01278407|593325506|FG001|Extension Phase|Participant's Choice|0|||
164261548|NCT01278407|593325507|FG002|Extension Phase|Participant's Choice|0|||
164261549|NCT01278407|593325508|FG003|Extension Phase|Participant's Choice|4|||
164261550|NCT01278407|593325509|FG004|Extension Phase|Participant's Choice|11|||
164261551|NCT01278407|593325505|FG000|Extension Phase|Other|0|||
164261552|NCT01278407|593325506|FG001|Extension Phase|Other|0|||
164261553|NCT01278407|593325507|FG002|Extension Phase|Other|0|||
164261554|NCT01278407|593325508|FG003|Extension Phase|Other|1|||
164261555|NCT01278407|593325509|FG004|Extension Phase|Other|3|||
164261556|NCT03710876|593325510|FG000|Overall Study|Death|0|||
164261557|NCT03710876|593325511|FG001|Overall Study|Death|2|||
164261558|NCT03710876|593325510|FG000|Overall Study|Withdrawal by Subject|0|||
164261559|NCT03710876|593325511|FG001|Overall Study|Withdrawal by Subject|2|||
164261560|NCT02534935|593325512|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
164261561|NCT02534935|593325513|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
164261562|NCT02534935|593325514|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
164261563|NCT02534935|593325512|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
164261564|NCT02534935|593325513|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
164261565|NCT02534935|593325514|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
164261566|NCT02534935|593325512|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
164261567|NCT02534935|593325513|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
164261568|NCT02534935|593325514|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
164261569|NCT02534935|593325512|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
164261570|NCT02534935|593325513|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
164261571|NCT02534935|593325514|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
164261572|NCT02534935|593325512|FG000|Stage 1: 24 Months|Adverse Event|0|||
164261573|NCT02534935|593325513|FG001|Stage 1: 24 Months|Adverse Event|2|||
164261574|NCT02534935|593325514|FG002|Stage 1: 24 Months|Adverse Event|0|||
164261575|NCT02534935|593325512|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
164261576|NCT02534935|593325513|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
164261577|NCT02534935|593325514|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
164261578|NCT02534935|593325512|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
164085175|NCT05056727|592675912|FG003|Initiation Phase|Physician Decision|0|||
164261579|NCT02534935|593325513|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
164261580|NCT02534935|593325514|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
164261581|NCT01460719|593325515|FG000|Overall Study|Adverse Event|1|||
164142273|NCT00451204|592882582|FG000|Overall Study|Other|1|||
164261582|NCT01460719|593325515|FG000|Overall Study|Withdrawal by Subject|1|||
164261583|NCT03602885|593325521|FG000|Overall Study|Lost to Follow-up|3|||
164261584|NCT03602885|593325522|FG001|Overall Study|Lost to Follow-up|0|||
164261585|NCT02838901|593325527|FG000|Overall Study|Withdrawal by Subject|1|||
164261586|NCT02838901|593325528|FG001|Overall Study|Withdrawal by Subject|1|||
164261587|NCT02838901|593325527|FG000|Overall Study|Lost to Follow-up|1|||
164261588|NCT02838901|593325528|FG001|Overall Study|Lost to Follow-up|1|||
164261589|NCT01007123|593325529|FG000|Overall Study|Adverse Event|3|||
164261590|NCT01007123|593325530|FG001|Overall Study|Adverse Event|4|||
164261591|NCT01007123|593325531|FG002|Overall Study|Adverse Event|7|||
164261592|NCT01007123|593325532|FG003|Overall Study|Adverse Event|1|||
164261593|NCT01007123|593325529|FG000|Overall Study|Lack of Efficacy|1|||
164261594|NCT01007123|593325530|FG001|Overall Study|Lack of Efficacy|0|||
163888458|NCT03852472|591963347|FG001|Period 2 - Week 44|Adverse Event|3|||
163888459|NCT03852472|591963348|FG002|Period 2 - Week 44|Adverse Event|1|||
164085176|NCT05056727|592675909|FG000|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
164085177|NCT05056727|592675910|FG001|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|237|||
164085178|NCT05056727|592675911|FG002|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
164085179|NCT05056727|592675912|FG003|Run-in Phase|Study-specific; Site terminated; Screen failure; Study terminated; Other|0|||
164085180|NCT05056727|592675909|FG000|Run-in Phase|Death|0|||
164085181|NCT05056727|592675910|FG001|Run-in Phase|Death|3|||
164085182|NCT05056727|592675911|FG002|Run-in Phase|Death|0|||
164085183|NCT05056727|592675912|FG003|Run-in Phase|Death|0|||
164085184|NCT05056727|592675909|FG000|Run-in Phase|Withdrawal by Subject|0|||
164085185|NCT05056727|592675910|FG001|Run-in Phase|Withdrawal by Subject|25|||
164085186|NCT05056727|592675911|FG002|Run-in Phase|Withdrawal by Subject|0|||
164085187|NCT05056727|592675912|FG003|Run-in Phase|Withdrawal by Subject|0|||
164085188|NCT05056727|592675909|FG000|Run-in Phase|Physician Decision|0|||
164085189|NCT05056727|592675910|FG001|Run-in Phase|Physician Decision|20|||
164085190|NCT05056727|592675911|FG002|Run-in Phase|Physician Decision|0|||
164085191|NCT05056727|592675912|FG003|Run-in Phase|Physician Decision|0|||
164085192|NCT05056727|592675909|FG000|Run-in Phase|Lost to Follow-up|0|||
164085193|NCT05056727|592675910|FG001|Run-in Phase|Lost to Follow-up|1|||
164085194|NCT05056727|592675911|FG002|Run-in Phase|Lost to Follow-up|0|||
164085195|NCT05056727|592675912|FG003|Run-in Phase|Lost to Follow-up|0|||
164085196|NCT05056727|592675909|FG000|Maintenance Phase|Site terminated; Study terminated; Other|0|||
164085197|NCT05056727|592675910|FG001|Maintenance Phase|Site terminated; Study terminated; Other|0|||
164085198|NCT05056727|592675911|FG002|Maintenance Phase|Site terminated; Study terminated; Other|332|||
164085199|NCT05056727|592675912|FG003|Maintenance Phase|Site terminated; Study terminated; Other|314|||
164085200|NCT05056727|592675909|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164085201|NCT05056727|592675910|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164085202|NCT05056727|592675911|FG002|Maintenance Phase|Withdrawal by Subject|19|||
164085203|NCT05056727|592675912|FG003|Maintenance Phase|Withdrawal by Subject|21|||
164085204|NCT05056727|592675909|FG000|Maintenance Phase|Physician Decision|0|||
163888460|NCT03852472|591963349|FG003|Period 2 - Week 44|Adverse Event|2|||
163888461|NCT03852472|591963350|FG004|Period 2 - Week 44|Adverse Event|2|||
163888462|NCT03852472|591963346|FG000|Period 2 - Week 44|COVID-19 Related|0|||
164085205|NCT05056727|592675910|FG001|Maintenance Phase|Physician Decision|0|||
164085206|NCT05056727|592675911|FG002|Maintenance Phase|Physician Decision|4|||
164085207|NCT05056727|592675912|FG003|Maintenance Phase|Physician Decision|16|||
164261595|NCT01007123|593325531|FG002|Overall Study|Lack of Efficacy|1|||
164261596|NCT01007123|593325532|FG003|Overall Study|Lack of Efficacy|4|||
164261597|NCT01007123|593325529|FG000|Overall Study|Protocol Violation|1|||
164261598|NCT01007123|593325530|FG001|Overall Study|Protocol Violation|1|||
164261599|NCT01007123|593325531|FG002|Overall Study|Protocol Violation|2|||
164261600|NCT01007123|593325532|FG003|Overall Study|Protocol Violation|1|||
164261601|NCT01007123|593325529|FG000|Overall Study|Withdrawal by Subject|1|||
164261602|NCT01007123|593325530|FG001|Overall Study|Withdrawal by Subject|0|||
164261603|NCT01007123|593325531|FG002|Overall Study|Withdrawal by Subject|1|||
164261604|NCT01007123|593325532|FG003|Overall Study|Withdrawal by Subject|0|||
164261605|NCT01007123|593325529|FG000|Overall Study|Lost to Follow-up|0|||
164261606|NCT01007123|593325530|FG001|Overall Study|Lost to Follow-up|1|||
164261607|NCT01007123|593325531|FG002|Overall Study|Lost to Follow-up|0|||
164261608|NCT01007123|593325532|FG003|Overall Study|Lost to Follow-up|0|||
164261609|NCT04431713|593325533|FG000|Overall Study|Withdrawal by Subject|2|||
164261610|NCT04431713|593325534|FG001|Overall Study|Withdrawal by Subject|0|||
164261611|NCT04431713|593325533|FG000|Overall Study|Death|2|||
164085208|NCT05056727|592675909|FG000|Maintenance Phase|Lost to Follow-up|0|||
164085209|NCT05056727|592675910|FG001|Maintenance Phase|Lost to Follow-up|0|||
164085210|NCT05056727|592675911|FG002|Maintenance Phase|Lost to Follow-up|2|||
164085211|NCT05056727|592675912|FG003|Maintenance Phase|Lost to Follow-up|2|||
164261612|NCT04431713|593325534|FG001|Overall Study|Death|2|||
163888463|NCT03852472|591963347|FG001|Period 2 - Week 44|COVID-19 Related|0|||
164261613|NCT02285114|593325536|FG000|Main Phase|Investigator's Discretion|0|||
164261614|NCT02285114|593325537|FG001|Main Phase|Investigator's Discretion|2|||
164261615|NCT02285114|593325538|FG002|Main Phase|Investigator's Discretion|0|||
164261616|NCT02285114|593325539|FG003|Main Phase|Investigator's Discretion|0|||
164261617|NCT02285114|593325540|FG004|Main Phase|Investigator's Discretion|0|||
163993290|NCT00289913|592343983|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163993291|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993292|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993293|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
163993294|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993295|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993296|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
163993297|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
163993298|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
163993299|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
163993300|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
163993301|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163993302|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
163993303|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163993304|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163993305|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
163993306|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
163993307|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
163993308|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
163993309|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163993310|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163993311|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163993312|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993313|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
163993314|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993315|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993316|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163993317|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
163993318|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
163993319|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
163993320|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
163993321|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
163993322|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
163993323|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
163993324|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
163993325|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
163993326|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
163993327|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
163993328|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
163993329|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
163993330|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
163993331|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
163993332|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163993333|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163993334|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163993335|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
163993336|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163993337|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163993338|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163993339|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
163993340|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
163993341|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163993342|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163993343|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163993344|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
163993345|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
163993346|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163993347|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163993348|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163993349|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
163993350|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
164085212|NCT05056727|592675909|FG000|Maintenance Phase|Death|0|||
164085213|NCT05056727|592675910|FG001|Maintenance Phase|Death|0|||
164085214|NCT05056727|592675911|FG002|Maintenance Phase|Death|4|||
164085215|NCT05056727|592675912|FG003|Maintenance Phase|Death|2|||
164085216|NCT02622113|592675913|FG000|Overall Study|Adverse Event|4|||
164085217|NCT02622113|592675914|FG001|Overall Study|Adverse Event|4|||
164085218|NCT02622113|592675913|FG000|Overall Study|Physician Decision|0|||
164085219|NCT02622113|592675914|FG001|Overall Study|Physician Decision|1|||
164085220|NCT02622113|592675913|FG000|Overall Study|Withdrawal by Subject|0|||
164085221|NCT02622113|592675914|FG001|Overall Study|Withdrawal by Subject|2|||
164085222|NCT02622113|592675913|FG000|Overall Study|Stopping Criteria|1|||
164085223|NCT02622113|592675914|FG001|Overall Study|Stopping Criteria|3|||
164085224|NCT03289208|592675916|FG000|Overall Study|Adverse Event|1|||
164085225|NCT03289208|592675917|FG001|Overall Study|Adverse Event|0|||
164085226|NCT03289208|592675918|FG002|Overall Study|Adverse Event|0|||
164085227|NCT01840605|592675920|FG000|Overall Study|Adverse Event|0|||
164085228|NCT01840605|592675921|FG001|Overall Study|Adverse Event|1|||
164085229|NCT01840605|592675920|FG000|Overall Study|Physician Decision|2|||
164085230|NCT01840605|592675921|FG001|Overall Study|Physician Decision|1|||
164085231|NCT05308472|592675922|FG000|Overall Study|Adverse Event|0|||
164085232|NCT05308472|592675923|FG001|Overall Study|Adverse Event|0|||
164085233|NCT05308472|592675924|FG002|Overall Study|Adverse Event|3|||
164085234|NCT03469271|592675925|FG000|Overall Study|Withdrawal by Subject|2|||
164085235|NCT03469271|592675926|FG001|Overall Study|Withdrawal by Subject|0|||
164085236|NCT03469271|592675927|FG002|Overall Study|Withdrawal by Subject|0|||
164085237|NCT03469271|592675928|FG003|Overall Study|Withdrawal by Subject|1|||
163888464|NCT03852472|591963348|FG002|Period 2 - Week 44|COVID-19 Related|0|||
163888465|NCT03852472|591963349|FG003|Period 2 - Week 44|COVID-19 Related|1|||
163888466|NCT03852472|591963350|FG004|Period 2 - Week 44|COVID-19 Related|0|||
163888467|NCT03852472|591963346|FG000|Period 2 - Week 44|Reason not stated|0|||
163888468|NCT03852472|591963347|FG001|Period 2 - Week 44|Reason not stated|0|||
163888469|NCT03852472|591963348|FG002|Period 2 - Week 44|Reason not stated|0|||
163888470|NCT03852472|591963349|FG003|Period 2 - Week 44|Reason not stated|0|||
163888471|NCT03852472|591963350|FG004|Period 2 - Week 44|Reason not stated|1|||
163888472|NCT06457802|591963351|FG000|Overall Study|Early termination of study prior to participant completion|2|||
163888473|NCT06457802|591963352|FG001|Overall Study|Early termination of study prior to participant completion|2|||
163888474|NCT03974178|591963358|FG000|Overall Study|Death|0|||
163888475|NCT03974178|591963359|FG001|Overall Study|Death|1|||
163888476|NCT04880863|591963360|FG000|Overall Study|Adverse Event|1|||
163888477|NCT04880863|591963360|FG000|Overall Study|Patient decision|2|||
163888478|NCT04880863|591963360|FG000|Overall Study|Confirmed Disease Progression|15|||
163888479|NCT04880863|591963360|FG000|Overall Study|Death|3|||
163888480|NCT04880863|591963360|FG000|Overall Study|Physician Decision|4|||
163888481|NCT04880863|591963360|FG000|Overall Study|Unconfirmed Disease Progression|4|||
163888482|NCT04880863|591963360|FG000|Overall Study|Withdrawal by Subject|2|||
163888483|NCT04880863|591963360|FG000|Overall Study|Study discontinuation by the sponsor|4|||
163888484|NCT04880863|591963360|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
163888485|NCT04880863|591963360|FG000|Overall Study|Not received study drug NAP|2|||
163888486|NCT03899259|591963361|FG000|Overall Study|Adverse Event|5|||
163888487|NCT03899259|591963362|FG001|Overall Study|Adverse Event|4|||
163888488|NCT03899259|591963363|FG002|Overall Study|Adverse Event|6|||
163888489|NCT03899259|591963361|FG000|Overall Study|Lack of Efficacy|5|||
163888490|NCT03899259|591963362|FG001|Overall Study|Lack of Efficacy|0|||
163888491|NCT03899259|591963363|FG002|Overall Study|Lack of Efficacy|2|||
163888492|NCT03899259|591963361|FG000|Overall Study|Pregnancy|3|||
163888493|NCT03899259|591963362|FG001|Overall Study|Pregnancy|0|||
163888494|NCT03899259|591963363|FG002|Overall Study|Pregnancy|1|||
163888495|NCT03899259|591963361|FG000|Overall Study|Physician Decision|0|||
163888496|NCT03899259|591963362|FG001|Overall Study|Physician Decision|1|||
163888497|NCT03899259|591963363|FG002|Overall Study|Physician Decision|0|||
163888498|NCT03899259|591963361|FG000|Overall Study|Protocol Deviation|1|||
163888499|NCT03899259|591963362|FG001|Overall Study|Protocol Deviation|1|||
163888500|NCT03899259|591963363|FG002|Overall Study|Protocol Deviation|1|||
163888501|NCT03899259|591963361|FG000|Overall Study|Withdrawal by Subject|8|||
163888502|NCT03899259|591963362|FG001|Overall Study|Withdrawal by Subject|10|||
163888503|NCT03899259|591963363|FG002|Overall Study|Withdrawal by Subject|12|||
163888504|NCT03899259|591963361|FG000|Overall Study|Lost to Follow-up|5|||
163888505|NCT03899259|591963362|FG001|Overall Study|Lost to Follow-up|6|||
164085238|NCT03760510|592675930|FG000|Overall Study|Not ventilated for 24 hours|105|||
164085239|NCT03760510|592675931|FG001|Overall Study|Not ventilated for 24 hours|97|||
164085240|NCT00871728|592675933|FG000|Overall Study|Adverse Event|1|||
163888506|NCT03899259|591963363|FG002|Overall Study|Lost to Follow-up|2|||
163888507|NCT03899259|591963361|FG000|Overall Study|Lack of Adherence|1|||
163888508|NCT03899259|591963362|FG001|Overall Study|Lack of Adherence|0|||
163888509|NCT03899259|591963363|FG002|Overall Study|Lack of Adherence|0|||
163888510|NCT03899259|591963361|FG000|Overall Study|Screen Failure|1|||
163888511|NCT03899259|591963362|FG001|Overall Study|Screen Failure|0|||
163888512|NCT03899259|591963363|FG002|Overall Study|Screen Failure|0|||
163888513|NCT03899259|591963361|FG000|Overall Study|Ongoing Study Participation|127|||
163888514|NCT03899259|591963362|FG001|Overall Study|Ongoing Study Participation|134|||
163888515|NCT03899259|591963363|FG002|Overall Study|Ongoing Study Participation|210|||
164085241|NCT00871728|592675933|FG000|Overall Study|Protocol Violation|7|||
164085242|NCT00871728|592675933|FG000|Overall Study|Lost to Follow-up|2|||
164261618|NCT02285114|593325541|FG005|Main Phase|Investigator's Discretion|0|||
164261619|NCT02285114|593325536|FG000|Main Phase|Enrolled but Never Treated|1|||
164261620|NCT02285114|593325537|FG001|Main Phase|Enrolled but Never Treated|0|||
164261621|NCT02285114|593325538|FG002|Main Phase|Enrolled but Never Treated|0|||
164261622|NCT02285114|593325539|FG003|Main Phase|Enrolled but Never Treated|0|||
164261623|NCT02285114|593325540|FG004|Main Phase|Enrolled but Never Treated|0|||
164261624|NCT02285114|593325541|FG005|Main Phase|Enrolled but Never Treated|0|||
164261625|NCT02285114|593325536|FG000|Main Phase|Withdrew Consent|0|||
164261626|NCT02285114|593325537|FG001|Main Phase|Withdrew Consent|0|||
164261627|NCT02285114|593325538|FG002|Main Phase|Withdrew Consent|1|||
164261628|NCT02285114|593325539|FG003|Main Phase|Withdrew Consent|0|||
164261629|NCT02285114|593325540|FG004|Main Phase|Withdrew Consent|0|||
164261630|NCT02285114|593325541|FG005|Main Phase|Withdrew Consent|0|||
164261631|NCT02285114|593325536|FG000|Extension Phase|Investigator's Discretion|0|||
164261632|NCT02285114|593325537|FG001|Extension Phase|Investigator's Discretion|0|||
164261633|NCT02285114|593325538|FG002|Extension Phase|Investigator's Discretion|0|||
164261634|NCT02285114|593325539|FG003|Extension Phase|Investigator's Discretion|14|||
164261635|NCT02285114|593325540|FG004|Extension Phase|Investigator's Discretion|1|||
164261636|NCT02285114|593325541|FG005|Extension Phase|Investigator's Discretion|0|||
164261637|NCT02285114|593325536|FG000|Extension Phase|Lost to Follow-up|0|||
164261638|NCT02285114|593325537|FG001|Extension Phase|Lost to Follow-up|0|||
164261639|NCT02285114|593325538|FG002|Extension Phase|Lost to Follow-up|0|||
164261640|NCT02285114|593325539|FG003|Extension Phase|Lost to Follow-up|1|||
164261641|NCT02285114|593325540|FG004|Extension Phase|Lost to Follow-up|1|||
164261642|NCT02285114|593325541|FG005|Extension Phase|Lost to Follow-up|0|||
164261643|NCT02285114|593325536|FG000|Extension Phase|Non-compliance with Study Drug|0|||
164261644|NCT02285114|593325537|FG001|Extension Phase|Non-compliance with Study Drug|0|||
164261645|NCT02285114|593325538|FG002|Extension Phase|Non-compliance with Study Drug|0|||
164261646|NCT02285114|593325539|FG003|Extension Phase|Non-compliance with Study Drug|2|||
164261647|NCT02285114|593325540|FG004|Extension Phase|Non-compliance with Study Drug|0|||
164261648|NCT02285114|593325541|FG005|Extension Phase|Non-compliance with Study Drug|0|||
164261649|NCT02285114|593325536|FG000|Extension Phase|Pregnancy|0|||
164261650|NCT02285114|593325537|FG001|Extension Phase|Pregnancy|0|||
164261651|NCT02285114|593325538|FG002|Extension Phase|Pregnancy|0|||
164261652|NCT02285114|593325539|FG003|Extension Phase|Pregnancy|1|||
164261653|NCT02285114|593325540|FG004|Extension Phase|Pregnancy|0|||
164261654|NCT02285114|593325541|FG005|Extension Phase|Pregnancy|0|||
164261655|NCT00320255|593325542|FG000|Overall Study|Lack of Efficacy|1|||
164261656|NCT00320255|593325543|FG001|Overall Study|Lack of Efficacy|0|||
164261657|NCT00320255|593325544|FG002|Overall Study|Lack of Efficacy|0|||
164261658|NCT00320255|593325545|FG003|Overall Study|Lack of Efficacy|0|||
164085243|NCT00871728|592675933|FG000|Overall Study|Failed to Visit Hospital|4|||
164085244|NCT00871728|592675933|FG000|Overall Study|Participant Non-compliance|1|||
164085245|NCT00871728|592675933|FG000|Overall Study|Withdrawal of Informed Consent|5|||
164085246|NCT04147715|592675934|FG000|Overall Study|Adverse Event|0|||
164261659|NCT00320255|593325546|FG004|Overall Study|Lack of Efficacy|0|||
164261660|NCT00320255|593325547|FG005|Overall Study|Lack of Efficacy|0|||
164261661|NCT00320255|593325542|FG000|Overall Study|Adverse Event|5|||
164261662|NCT00320255|593325543|FG001|Overall Study|Adverse Event|2|||
164261663|NCT00320255|593325544|FG002|Overall Study|Adverse Event|3|||
164261664|NCT00320255|593325545|FG003|Overall Study|Adverse Event|2|||
164261665|NCT00320255|593325546|FG004|Overall Study|Adverse Event|0|||
164261666|NCT00320255|593325547|FG005|Overall Study|Adverse Event|0|||
164261667|NCT00320255|593325542|FG000|Overall Study|Withdrawal by Subject|1|||
164261668|NCT00320255|593325543|FG001|Overall Study|Withdrawal by Subject|2|||
164261669|NCT00320255|593325544|FG002|Overall Study|Withdrawal by Subject|2|||
164261670|NCT00320255|593325545|FG003|Overall Study|Withdrawal by Subject|4|||
164261671|NCT00320255|593325546|FG004|Overall Study|Withdrawal by Subject|0|||
164085247|NCT04147715|592675935|FG001|Overall Study|Adverse Event|0|||
164261672|NCT00320255|593325547|FG005|Overall Study|Withdrawal by Subject|0|||
164085248|NCT04147715|592675936|FG002|Overall Study|Adverse Event|0|||
164261673|NCT00320255|593325542|FG000|Overall Study|Poor compliance/noncompliance|1|||
164261674|NCT00320255|593325543|FG001|Overall Study|Poor compliance/noncompliance|1|||
164261675|NCT00320255|593325544|FG002|Overall Study|Poor compliance/noncompliance|0|||
164261676|NCT00320255|593325545|FG003|Overall Study|Poor compliance/noncompliance|1|||
164261677|NCT00320255|593325546|FG004|Overall Study|Poor compliance/noncompliance|0|||
164261678|NCT00320255|593325547|FG005|Overall Study|Poor compliance/noncompliance|0|||
164261679|NCT00320255|593325542|FG000|Overall Study|No longer meets study criteria|0|||
164261680|NCT00320255|593325543|FG001|Overall Study|No longer meets study criteria|0|||
164261681|NCT00320255|593325544|FG002|Overall Study|No longer meets study criteria|0|||
164261682|NCT00320255|593325545|FG003|Overall Study|No longer meets study criteria|1|||
164261683|NCT00320255|593325546|FG004|Overall Study|No longer meets study criteria|0|||
164261684|NCT00320255|593325547|FG005|Overall Study|No longer meets study criteria|0|||
164261685|NCT00320255|593325542|FG000|Overall Study|Other|3|||
164261686|NCT00320255|593325543|FG001|Overall Study|Other|2|||
163993351|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163993352|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163993353|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163993354|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
163993355|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
163993356|NCT00289913|592343979|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163993357|NCT00289913|592343980|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163993358|NCT00289913|592343981|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163993359|NCT00289913|592343982|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
163993360|NCT00289913|592343983|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
163993361|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993362|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
163993363|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993364|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993365|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
163993366|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
163993367|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
163993368|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
163993369|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
163993370|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
163993371|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163993372|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163993373|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
164340695|NCT01758523|593622278|FG000|Overall Study|Lack of Efficacy|4|||
164340696|NCT01758523|593622279|FG001|Overall Study|Lack of Efficacy|2|||
164340697|NCT01758523|593622278|FG000|Overall Study|Lost to Follow-up|3|||
164340698|NCT01758523|593622279|FG001|Overall Study|Lost to Follow-up|4|||
164340699|NCT01758523|593622278|FG000|Overall Study|Withdrawal by Subject|12|||
164340700|NCT01758523|593622279|FG001|Overall Study|Withdrawal by Subject|7|||
164340701|NCT00722800|593622280|FG000|Overall Study|Withdrawal by Subject|1|||
164340702|NCT00722800|593622281|FG001|Overall Study|Withdrawal by Subject|0|||
164340703|NCT00722800|593622280|FG000|Overall Study|Physician Decision|1|||
164340704|NCT00722800|593622281|FG001|Overall Study|Physician Decision|0|||
164340705|NCT00590135|593622282|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
164340706|NCT02130297|593622287|FG000|Overall Study|Lost to Follow-up|4|||
164340707|NCT00508755|593622296|FG000|Overall Study|Withdrawal by Subject|1|||
164340708|NCT00957580|593622297|FG000|Overall Study|Ongoing at data cut-off|0|||
164340709|NCT00957580|593622298|FG001|Overall Study|Ongoing at data cut-off|1|||
164340710|NCT00957580|593622299|FG002|Overall Study|Ongoing at data cut-off|0|||
164340711|NCT00957580|593622297|FG000|Overall Study|Enrolled but not treated|0|||
164340712|NCT00957580|593622298|FG001|Overall Study|Enrolled but not treated|1|||
164340713|NCT00957580|593622299|FG002|Overall Study|Enrolled but not treated|0|||
164340714|NCT00945893|593622300|FG000|Overall Study|Lost to Follow-up|2|||
164340715|NCT00945893|593622301|FG001|Overall Study|Lost to Follow-up|8|||
164340716|NCT00945893|593622300|FG000|Overall Study|Withdrawal of consent|1|||
164340717|NCT00945893|593622301|FG001|Overall Study|Withdrawal of consent|2|||
164340718|NCT01611155|593622302|FG000|Overall Study|Adverse Event|1|||
164340719|NCT01611155|593622303|FG001|Overall Study|Adverse Event|1|||
164340720|NCT01611155|593622302|FG000|Overall Study|Refused further treatment|6|||
163888516|NCT01152450|591963364|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
163888517|NCT01152450|591963365|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
163888518|NCT01152450|591963366|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
163888519|NCT01152450|591963367|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
163888520|NCT01152450|591963368|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
163888521|NCT01152450|591963369|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
163888522|NCT01152450|591963364|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
163888523|NCT01152450|591963365|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
163888524|NCT01152450|591963366|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
163888525|NCT01152450|591963367|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
163888526|NCT01152450|591963368|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
163888527|NCT01152450|591963369|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
163888528|NCT01152450|591963364|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163888529|NCT01152450|591963365|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
164340721|NCT01611155|593622303|FG001|Overall Study|Refused further treatment|4|||
164340722|NCT01611155|593622302|FG000|Overall Study|Disease progression|1|||
164340723|NCT01611155|593622303|FG001|Overall Study|Disease progression|0|||
164340724|NCT01611155|593622302|FG000|Overall Study|Withdrawal by Subject|1|||
164340725|NCT01611155|593622303|FG001|Overall Study|Withdrawal by Subject|0|||
164340726|NCT01611155|593622302|FG000|Overall Study|Alternative treatment|0|||
164340727|NCT01611155|593622303|FG001|Overall Study|Alternative treatment|1|||
163888530|NCT01152450|591963366|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
163888531|NCT01152450|591963367|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163888532|NCT01152450|591963368|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163888533|NCT01152450|591963369|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
163888534|NCT05670587|591963370|FG000|Overall Study|Withdrawal by Subject|3|||
163888535|NCT01544114|591963374|FG000|Overall Study|Withdrawal by Subject|0|||
163888536|NCT01544114|591963375|FG001|Overall Study|Withdrawal by Subject|0|||
163888537|NCT01544114|591963376|FG002|Overall Study|Withdrawal by Subject|3|||
163888538|NCT01544114|591963374|FG000|Overall Study|Lost to Follow-up|0|||
163888539|NCT01544114|591963375|FG001|Overall Study|Lost to Follow-up|2|||
163888540|NCT01544114|591963376|FG002|Overall Study|Lost to Follow-up|0|||
163888541|NCT01544114|591963374|FG000|Overall Study|Adverse Event|1|||
163888542|NCT01544114|591963375|FG001|Overall Study|Adverse Event|1|||
163888543|NCT01544114|591963376|FG002|Overall Study|Adverse Event|2|||
163888544|NCT01544114|591963374|FG000|Overall Study|Protocol Violation|0|||
163888545|NCT01544114|591963375|FG001|Overall Study|Protocol Violation|1|||
163888546|NCT01544114|591963376|FG002|Overall Study|Protocol Violation|0|||
163888547|NCT04508309|591963381|FG000|Overall Study|Death|0|||
163888548|NCT04508309|591963382|FG001|Overall Study|Death|0|||
163888549|NCT04508309|591963383|FG002|Overall Study|Death|0|||
163888550|NCT04508309|591963384|FG003|Overall Study|Death|0|||
163888551|NCT04508309|591963385|FG004|Overall Study|Death|1|||
163888552|NCT04508309|591963381|FG000|Overall Study|Lost to Follow-up|0|||
163888553|NCT04508309|591963382|FG001|Overall Study|Lost to Follow-up|0|||
163888554|NCT04508309|591963383|FG002|Overall Study|Lost to Follow-up|1|||
163888555|NCT04508309|591963384|FG003|Overall Study|Lost to Follow-up|1|||
163888556|NCT04508309|591963385|FG004|Overall Study|Lost to Follow-up|0|||
163888557|NCT04508309|591963381|FG000|Overall Study|Withdrawal by Subject|0|||
163888558|NCT04508309|591963382|FG001|Overall Study|Withdrawal by Subject|0|||
163888559|NCT04508309|591963383|FG002|Overall Study|Withdrawal by Subject|0|||
163888560|NCT04508309|591963384|FG003|Overall Study|Withdrawal by Subject|0|||
163888561|NCT04508309|591963385|FG004|Overall Study|Withdrawal by Subject|1|||
163888562|NCT02305888|591963390|FG000|Overall Study|Lost to Follow-up|0|||
163888563|NCT02305888|591963391|FG001|Overall Study|Lost to Follow-up|0|||
163888564|NCT02305888|591963392|FG002|Overall Study|Lost to Follow-up|1|||
163888565|NCT02305888|591963390|FG000|Overall Study|Adverse Event|0|||
163888566|NCT02305888|591963391|FG001|Overall Study|Adverse Event|1|||
163993374|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
163993375|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
163888567|NCT02305888|591963392|FG002|Overall Study|Adverse Event|0|||
163888568|NCT05139810|591963393|FG000|Overall Study|Voluntary Withdrawal|2|||
163888569|NCT05139810|591963394|FG001|Overall Study|Voluntary Withdrawal|1|||
164261687|NCT00320255|593325544|FG002|Overall Study|Other|1|||
164261688|NCT00320255|593325545|FG003|Overall Study|Other|0|||
164261689|NCT00320255|593325546|FG004|Overall Study|Other|0|||
164261690|NCT00320255|593325547|FG005|Overall Study|Other|0|||
164261691|NCT00683917|593325550|FG000|Overall Study|Study prematurely terminated|10|||
164261692|NCT03022097|593325556|FG000|Overall Study|Adverse Event|3|||
164261693|NCT03022097|593325557|FG001|Overall Study|Adverse Event|4|||
164261694|NCT03022097|593325558|FG002|Overall Study|Adverse Event|1|||
164261695|NCT03022097|593325559|FG003|Overall Study|Adverse Event|3|||
164261696|NCT03022097|593325556|FG000|Overall Study|Progressive Disease|2|||
164261697|NCT03022097|593325557|FG001|Overall Study|Progressive Disease|0|||
164261698|NCT03022097|593325558|FG002|Overall Study|Progressive Disease|5|||
164261699|NCT03022097|593325559|FG003|Overall Study|Progressive Disease|2|||
164261700|NCT03022097|593325556|FG000|Overall Study|Lack of Efficacy|0|||
163888570|NCT05139810|591963395|FG002|Overall Study|Voluntary Withdrawal|0|||
163888571|NCT05139810|591963393|FG000|Overall Study|Pregnancy|1|||
163993376|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993377|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993378|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993379|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
163993380|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
164085249|NCT04147715|592675937|FG003|Overall Study|Adverse Event|0|||
163888572|NCT05139810|591963394|FG001|Overall Study|Pregnancy|0|||
164085250|NCT04147715|592675938|FG004|Overall Study|Adverse Event|0|||
164261701|NCT03022097|593325557|FG001|Overall Study|Lack of Efficacy|0|||
164261702|NCT03022097|593325558|FG002|Overall Study|Lack of Efficacy|3|||
164261703|NCT03022097|593325559|FG003|Overall Study|Lack of Efficacy|3|||
163888573|NCT05139810|591963395|FG002|Overall Study|Pregnancy|0|||
164261704|NCT03022097|593325556|FG000|Overall Study|Protocol Violation|1|||
164261705|NCT03022097|593325557|FG001|Overall Study|Protocol Violation|0|||
163888574|NCT05139810|591963393|FG000|Overall Study|Roll Over to CS7|19|||
163888575|NCT05139810|591963394|FG001|Overall Study|Roll Over to CS7|44|||
163888576|NCT05139810|591963395|FG002|Overall Study|Roll Over to CS7|20|||
163888577|NCT05940194|591963396|FG000|Overall Study|Adverse Event|0|||
163888578|NCT05940194|591963397|FG001|Overall Study|Adverse Event|1|||
163888579|NCT05940194|591963398|FG002|Overall Study|Adverse Event|0|||
163888580|NCT05940194|591963396|FG000|Overall Study|Migrated/Moved from the study area|2|||
163888581|NCT05940194|591963397|FG001|Overall Study|Migrated/Moved from the study area|2|||
163993381|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
164261706|NCT03022097|593325558|FG002|Overall Study|Protocol Violation|1|||
164261707|NCT03022097|593325559|FG003|Overall Study|Protocol Violation|0|||
164261708|NCT03022097|593325556|FG000|Overall Study|Withdrawal by Subject|11|||
164261709|NCT03022097|593325557|FG001|Overall Study|Withdrawal by Subject|13|||
164261710|NCT03022097|593325558|FG002|Overall Study|Withdrawal by Subject|15|||
164261711|NCT03022097|593325559|FG003|Overall Study|Withdrawal by Subject|21|||
164261712|NCT03022097|593325556|FG000|Overall Study|Lost to Follow-up|0|||
164261713|NCT03022097|593325557|FG001|Overall Study|Lost to Follow-up|0|||
164261714|NCT03022097|593325558|FG002|Overall Study|Lost to Follow-up|1|||
164261715|NCT03022097|593325559|FG003|Overall Study|Lost to Follow-up|1|||
164261716|NCT03022097|593325556|FG000|Overall Study|Other|4|||
164261717|NCT03022097|593325557|FG001|Overall Study|Other|1|||
164261718|NCT03022097|593325558|FG002|Overall Study|Other|6|||
164261719|NCT03022097|593325559|FG003|Overall Study|Other|4|||
164261720|NCT03022097|593325556|FG000|Overall Study|Due to COVID-19 pandemic|0|||
164261721|NCT03022097|593325557|FG001|Overall Study|Due to COVID-19 pandemic|1|||
164261722|NCT03022097|593325558|FG002|Overall Study|Due to COVID-19 pandemic|0|||
164261723|NCT03022097|593325559|FG003|Overall Study|Due to COVID-19 pandemic|0|||
164261724|NCT03640052|593325565|FG000|Overall Study|Lost to Follow-up|0|||
164261725|NCT03640052|593325566|FG001|Overall Study|Lost to Follow-up|1|||
164261726|NCT03640052|593325567|FG002|Overall Study|Lost to Follow-up|0|||
164261727|NCT03640052|593325568|FG003|Overall Study|Lost to Follow-up|0|||
164261728|NCT03640052|593325569|FG004|Overall Study|Lost to Follow-up|0|||
164261729|NCT00623545|593325570|FG000|Overall Study|Adverse Event|6|||
164261730|NCT00623545|593325570|FG000|Overall Study|Withdrawal by Subject|4|||
164261731|NCT05479097|593325573|FG000|Overall Study|Withdrawal by Subject|2|||
164261732|NCT04126564|593325574|FG000|Overall Study|Withdrawal by Subject|0|||
164261733|NCT04126564|593325575|FG001|Overall Study|Withdrawal by Subject|2|||
164261734|NCT04126564|593325574|FG000|Overall Study|Lost to Follow-up|0|||
164261735|NCT04126564|593325575|FG001|Overall Study|Lost to Follow-up|1|||
164261736|NCT03941964|593325579|FG000|Overall Study|Adverse Event|1|||
164261737|NCT03941964|593325580|FG001|Overall Study|Adverse Event|8|||
163993382|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
163993383|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
164261738|NCT03941964|593325579|FG000|Overall Study|Progressive disease|7|||
164261739|NCT03941964|593325580|FG001|Overall Study|Progressive disease|3|||
164261740|NCT03941964|593325579|FG000|Overall Study|Lack of Efficacy|0|||
164261741|NCT03941964|593325580|FG001|Overall Study|Lack of Efficacy|1|||
164261742|NCT03941964|593325579|FG000|Overall Study|Death|3|||
164261743|NCT03941964|593325580|FG001|Overall Study|Death|1|||
164261744|NCT03941964|593325579|FG000|Overall Study|Withdrew consent|1|||
164261745|NCT03941964|593325580|FG001|Overall Study|Withdrew consent|3|||
164261746|NCT03941964|593325579|FG000|Overall Study|Physician Decision|9|||
164261747|NCT03941964|593325580|FG001|Overall Study|Physician Decision|2|||
164261748|NCT03941964|593325579|FG000|Overall Study|Other, not specified|2|||
164261749|NCT03941964|593325580|FG001|Overall Study|Other, not specified|1|||
164261750|NCT00445848|593325581|FG000|Overall Study|Adverse Event|14|||
164261751|NCT00445848|593325581|FG000|Overall Study|Withdrawal by Subject|4|||
164261752|NCT00445848|593325581|FG000|Overall Study|Progression|62|||
164261753|NCT00445848|593325581|FG000|Overall Study|Other-Not protocol specified|5|||
164261754|NCT05605691|593325582|FG000|Overall Study|Lost to Follow-up|1|||
164261755|NCT00855933|593325584|FG000|Overall Study|Withdrawal by Subject|0|||
164261756|NCT00855933|593325585|FG001|Overall Study|Withdrawal by Subject|1|||
164261757|NCT05463744|593325586|FG000|Treatment Period|Withdrawal by Subject|19|||
164261758|NCT05463744|593325587|FG001|Treatment Period|Withdrawal by Subject|16|||
164261759|NCT05463744|593325586|FG000|Treatment Period|Adverse Event|4|||
164261760|NCT05463744|593325587|FG001|Treatment Period|Adverse Event|4|||
164261761|NCT05463744|593325586|FG000|Treatment Period|Pregnancy|0|||
164261762|NCT05463744|593325587|FG001|Treatment Period|Pregnancy|3|||
164261763|NCT05463744|593325586|FG000|Treatment Period|Lost to Follow-up|1|||
164261764|NCT05463744|593325587|FG001|Treatment Period|Lost to Follow-up|3|||
164261765|NCT05463744|593325586|FG000|Treatment Period|Inadvertent enrollment|2|||
164261766|NCT05463744|593325587|FG001|Treatment Period|Inadvertent enrollment|1|||
164261767|NCT05463744|593325586|FG000|Treatment Period|Death|0|||
164261768|NCT05463744|593325587|FG001|Treatment Period|Death|1|||
164261769|NCT05463744|593325586|FG000|Treatment Period|Non-compliance with Study Drug|1|||
164261770|NCT05463744|593325587|FG001|Treatment Period|Non-compliance with Study Drug|0|||
164261771|NCT05463744|593325586|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
164261772|NCT05463744|593325587|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
164261773|NCT05463744|593325586|FG000|Treatment Period|Physician Decision|0|||
164261774|NCT05463744|593325587|FG001|Treatment Period|Physician Decision|1|||
164261775|NCT05463744|593325586|FG000|Follow-Up Period|Withdrawal by Subject|3|||
164261776|NCT05463744|593325587|FG001|Follow-Up Period|Withdrawal by Subject|1|||
164261777|NCT05463744|593325586|FG000|Follow-Up Period|Lost to Follow-up|1|||
164261778|NCT05463744|593325587|FG001|Follow-Up Period|Lost to Follow-up|1|||
164261779|NCT02851407|593325588|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164261780|NCT02851407|593325589|FG001|Overall Study|Withdrawal by parent/guardian|7|||
164261781|NCT02851407|593325588|FG000|Overall Study|Protocol deviation|0|||
164261782|NCT02851407|593325589|FG001|Overall Study|Protocol deviation|1|||
164261783|NCT02851407|593325588|FG000|Overall Study|Transferred to another hospital to continue|1|||
164261784|NCT02851407|593325589|FG001|Overall Study|Transferred to another hospital to continue|0|||
164261785|NCT02851407|593325588|FG000|Overall Study|Other Death|30|||
164261786|NCT02851407|593325589|FG001|Overall Study|Other Death|20|||
164261787|NCT02851407|593325588|FG000|Overall Study|Adverse event, serious fatal|6|||
163993384|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
163993385|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
163993386|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163993387|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
163993388|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
163993389|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163993390|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
163993391|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163993392|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163993393|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163993394|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
163993395|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
163993396|NCT00289913|592343979|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163993397|NCT00289913|592343980|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
163993398|NCT00289913|592343981|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163993399|NCT00289913|592343982|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163993400|NCT00289913|592343983|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
163993401|NCT03822884|592343984|FG000|Overall Study|Withdrawal by Subject|0|||
163993402|NCT03822884|592343985|FG001|Overall Study|Withdrawal by Subject|0|||
163993403|NCT03822884|592343986|FG002|Overall Study|Withdrawal by Subject|0|||
163993404|NCT03822884|592343987|FG003|Overall Study|Withdrawal by Subject|0|||
163993405|NCT03822884|592343988|FG004|Overall Study|Withdrawal by Subject|1|||
163993406|NCT03822884|592343989|FG005|Overall Study|Withdrawal by Subject|0|||
163993407|NCT00434967|592343992|FG000|Overall Study|Adverse Event|2|||
163993408|NCT00434967|592343993|FG001|Overall Study|Adverse Event|4|||
163993409|NCT00434967|592343994|FG002|Overall Study|Adverse Event|3|||
163993410|NCT00434967|592343995|FG003|Overall Study|Adverse Event|3|||
163993411|NCT00434967|592343992|FG000|Overall Study|Lost to Follow-up|0|||
163993412|NCT00434967|592343993|FG001|Overall Study|Lost to Follow-up|0|||
163993413|NCT00434967|592343994|FG002|Overall Study|Lost to Follow-up|1|||
163993414|NCT00434967|592343995|FG003|Overall Study|Lost to Follow-up|0|||
163993415|NCT00434967|592343992|FG000|Overall Study|Withdrawal by Subject|2|||
163993416|NCT00434967|592343993|FG001|Overall Study|Withdrawal by Subject|2|||
163993417|NCT00434967|592343994|FG002|Overall Study|Withdrawal by Subject|4|||
163993418|NCT00434967|592343995|FG003|Overall Study|Withdrawal by Subject|6|||
163993419|NCT00434967|592343992|FG000|Overall Study|Randomized in error|0|||
163993420|NCT00434967|592343993|FG001|Overall Study|Randomized in error|0|||
163993421|NCT00434967|592343994|FG002|Overall Study|Randomized in error|0|||
163993422|NCT00434967|592343995|FG003|Overall Study|Randomized in error|1|||
163993423|NCT00434967|592343992|FG000|Overall Study|Protocol Violation|0|||
163993424|NCT00434967|592343993|FG001|Overall Study|Protocol Violation|1|||
164261788|NCT02851407|593325589|FG001|Overall Study|Adverse event, serious fatal|8|||
164261789|NCT02851407|593325588|FG000|Overall Study|Consent withdrawn by participant|5|||
164261790|NCT02851407|593325589|FG001|Overall Study|Consent withdrawn by participant|3|||
164340728|NCT01611155|593622302|FG000|Overall Study|Ineligible patient|0|||
164340729|NCT01611155|593622303|FG001|Overall Study|Ineligible patient|1|||
164340730|NCT01602120|593622306|FG000|Overall Study|Adverse Event|3|||
164340731|NCT01602120|593622307|FG001|Overall Study|Adverse Event|6|||
164340732|NCT01602120|593622308|FG002|Overall Study|Adverse Event|0|||
163993425|NCT00434967|592343994|FG002|Overall Study|Protocol Violation|0|||
163993426|NCT00434967|592343995|FG003|Overall Study|Protocol Violation|1|||
163993427|NCT00434967|592343992|FG000|Overall Study|Physician Decision|1|||
163993428|NCT00434967|592343993|FG001|Overall Study|Physician Decision|1|||
163993429|NCT00434967|592343994|FG002|Overall Study|Physician Decision|1|||
163993430|NCT00434967|592343995|FG003|Overall Study|Physician Decision|0|||
163993431|NCT00434967|592343992|FG000|Overall Study|Patient Disposition Challenges|2|||
163993432|NCT00434967|592343993|FG001|Overall Study|Patient Disposition Challenges|0|||
163993433|NCT00434967|592343994|FG002|Overall Study|Patient Disposition Challenges|0|||
163993434|NCT00434967|592343995|FG003|Overall Study|Patient Disposition Challenges|3|||
164261791|NCT02851407|593325588|FG000|Overall Study|Screen failure|2|||
164340733|NCT01602120|593622309|FG003|Overall Study|Adverse Event|2|||
164340734|NCT01602120|593622306|FG000|Overall Study|Death|0|||
164340735|NCT01602120|593622307|FG001|Overall Study|Death|4|||
164340736|NCT01602120|593622308|FG002|Overall Study|Death|0|||
164340737|NCT01602120|593622309|FG003|Overall Study|Death|0|||
163993435|NCT01279057|592343996|FG000|Overall Study|Adverse Event|1|||
163993436|NCT01279057|592343997|FG001|Overall Study|Adverse Event|0|||
164261792|NCT02851407|593325589|FG001|Overall Study|Screen failure|1|||
164261793|NCT02851407|593325588|FG000|Overall Study|Disease relapse|9|||
164261794|NCT02851407|593325589|FG001|Overall Study|Disease relapse|6|||
164261795|NCT02851407|593325588|FG000|Overall Study|Physician Decision|7|||
164261796|NCT02851407|593325589|FG001|Overall Study|Physician Decision|6|||
164261797|NCT02851407|593325588|FG000|Overall Study|Transferred to hospital closer to home|0|||
164261798|NCT02851407|593325589|FG001|Overall Study|Transferred to hospital closer to home|1|||
164261799|NCT02851407|593325588|FG000|Overall Study|Enrolled in an investigational study|0|||
164261800|NCT02851407|593325589|FG001|Overall Study|Enrolled in an investigational study|1|||
164261801|NCT02851407|593325588|FG000|Overall Study|Early recovery|1|||
164261802|NCT02851407|593325589|FG001|Overall Study|Early recovery|0|||
164261803|NCT02851407|593325588|FG000|Overall Study|Adverse event, non-fatal|7|||
164261804|NCT02851407|593325589|FG001|Overall Study|Adverse event, non-fatal|5|||
164261805|NCT02851407|593325588|FG000|Overall Study|Lost to Follow-up|0|||
164261806|NCT02851407|593325589|FG001|Overall Study|Lost to Follow-up|2|||
164261807|NCT02585830|593325595|FG000|Overall Study|Withdrawal by Subject|3|||
164261808|NCT00812006|593325596|FG000|Overall Study|Lost to Follow-up|0|||
164261809|NCT00812006|593325597|FG001|Overall Study|Lost to Follow-up|0|||
164261810|NCT00812006|593325598|FG002|Overall Study|Lost to Follow-up|2|||
164261811|NCT00812006|593325596|FG000|Overall Study|Physician Decision|0|||
164261812|NCT00812006|593325597|FG001|Overall Study|Physician Decision|0|||
164261813|NCT00812006|593325598|FG002|Overall Study|Physician Decision|1|||
164261814|NCT00812006|593325596|FG000|Overall Study|Withdrawal by Subject|2|||
164261815|NCT00812006|593325597|FG001|Overall Study|Withdrawal by Subject|1|||
164261816|NCT00812006|593325598|FG002|Overall Study|Withdrawal by Subject|1|||
164261817|NCT00812006|593325596|FG000|Overall Study|Lack of Qualifying Event|4|||
164261818|NCT00812006|593325597|FG001|Overall Study|Lack of Qualifying Event|2|||
164261819|NCT00812006|593325598|FG002|Overall Study|Lack of Qualifying Event|2|||
164261820|NCT00068250|593325599|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
164261821|NCT00068250|593325600|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
164261822|NCT00068250|593325601|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
164261823|NCT00068250|593325602|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
164261824|NCT03242772|593325603|FG000|Overall Study|Lost to Follow-up|2|||
164261825|NCT03242772|593325604|FG001|Overall Study|Lost to Follow-up|0|||
164261826|NCT03242772|593325603|FG000|Overall Study|Physician Decision|0|||
164261827|NCT03242772|593325604|FG001|Overall Study|Physician Decision|1|||
164261828|NCT03242772|593325603|FG000|Overall Study|Withdrawal by Subject|1|||
164261829|NCT03242772|593325604|FG001|Overall Study|Withdrawal by Subject|0|||
164261830|NCT04677660|593325605|FG000|Overall Study|Lost to Follow-up|0|||
164261831|NCT04677660|593325606|FG001|Overall Study|Lost to Follow-up|2|||
164261832|NCT04677660|593325605|FG000|Overall Study|Withdrawal by Subject|0|||
164261833|NCT04677660|593325606|FG001|Overall Study|Withdrawal by Subject|1|||
164261834|NCT04677660|593325605|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
164261835|NCT04677660|593325606|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
164261836|NCT02499900|593325607|FG000|Core Study Period|Other|1|||
164261837|NCT02499900|593325608|FG001|Core Study Period|Other|4|||
164261838|NCT02499900|593325607|FG000|Core Study Period|Lost to Follow-up|1|||
164261839|NCT02499900|593325608|FG001|Core Study Period|Lost to Follow-up|2|||
164261840|NCT02499900|593325607|FG000|Core Study Period|Per sponsor request|0|||
164261841|NCT02499900|593325608|FG001|Core Study Period|Per sponsor request|1|||
164261842|NCT02499900|593325607|FG000|Core Study Period|Pregnancy|1|||
164261843|NCT02499900|593325608|FG001|Core Study Period|Pregnancy|0|||
163888582|NCT05940194|591963398|FG002|Overall Study|Migrated/Moved from the study area|4|||
163888583|NCT06182033|591963399|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
163888584|NCT06182033|591963400|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
163888585|NCT06182033|591963399|FG000|Overall Study|Target child relocation|1|||
163888586|NCT06182033|591963400|FG001|Overall Study|Target child relocation|1|||
164261844|NCT02499900|593325607|FG000|Core Study Period|Protocol Violation|3|||
164261845|NCT02499900|593325608|FG001|Core Study Period|Protocol Violation|0|||
163888587|NCT06182033|591963399|FG000|Overall Study|Withdrawal by Subject|1|||
163888588|NCT06182033|591963400|FG001|Overall Study|Withdrawal by Subject|0|||
163888589|NCT05576155|591963401|FG000|Overall Study|Withdrawal by Subject|1|||
163888590|NCT05576155|591963402|FG001|Overall Study|Withdrawal by Subject|1|||
163888591|NCT04515849|591963403|FG000|Overall Study|Adverse Event|0|||
163888592|NCT04515849|591963404|FG001|Overall Study|Adverse Event|0|||
164261846|NCT02499900|593325607|FG000|Core Study Period|Withdrawal by Subject|11|||
164261847|NCT02499900|593325608|FG001|Core Study Period|Withdrawal by Subject|10|||
164261848|NCT02499900|593325607|FG000|Core Study Period|Adverse Event|18|||
164261849|NCT02499900|593325608|FG001|Core Study Period|Adverse Event|14|||
164261850|NCT02499900|593325607|FG000|Core Study Period|Death|0|||
163888593|NCT04515849|591963405|FG002|Overall Study|Adverse Event|0|||
163888594|NCT04515849|591963406|FG003|Overall Study|Adverse Event|1|||
164261851|NCT02499900|593325608|FG001|Core Study Period|Death|1|||
164261852|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
164261853|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
163888595|NCT04515849|591963407|FG004|Overall Study|Adverse Event|2|||
164085251|NCT04147715|592675939|FG005|Overall Study|Adverse Event|0|||
164261854|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
164261855|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
164261856|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
164261857|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
164261858|NCT02499900|593325607|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
164261859|NCT02499900|593325608|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
164261860|NCT02499900|593325607|FG000|Extension Study Period|Adverse Event|2|||
164261861|NCT02499900|593325608|FG001|Extension Study Period|Adverse Event|4|||
164261862|NCT02499900|593325607|FG000|Extension Study Period|Withdrawal by Subject|5|||
164261863|NCT02499900|593325608|FG001|Extension Study Period|Withdrawal by Subject|2|||
164261864|NCT02499900|593325607|FG000|Extension Study Period|Physician Decision|2|||
164261865|NCT02499900|593325608|FG001|Extension Study Period|Physician Decision|5|||
164261866|NCT02499900|593325607|FG000|Extension Study Period|Pregnancy|1|||
164261867|NCT02499900|593325608|FG001|Extension Study Period|Pregnancy|2|||
164261868|NCT02499900|593325607|FG000|Extension Study Period|Lost to Follow-up|2|||
164261869|NCT02499900|593325608|FG001|Extension Study Period|Lost to Follow-up|5|||
164261870|NCT02499900|593325607|FG000|Extension Study Period|Other|0|||
164261871|NCT02499900|593325608|FG001|Extension Study Period|Other|2|||
164261872|NCT03385265|593325612|FG000|Overall Study|Withdrawal by Subject|5|||
164261873|NCT03385265|593325613|FG001|Overall Study|Withdrawal by Subject|2|||
164261874|NCT03385265|593325614|FG002|Overall Study|Withdrawal by Subject|5|||
164261875|NCT03385265|593325615|FG003|Overall Study|Withdrawal by Subject|2|||
164261876|NCT01089023|593325616|FG000|Overall Study|Lost to Follow-up|3|||
164261877|NCT01089023|593325616|FG000|Overall Study|Adverse Event|1|||
164261878|NCT01089023|593325616|FG000|Overall Study|Withdrawal by Subject|1|||
164261879|NCT01089023|593325616|FG000|Overall Study|Protocol Violation|1|||
164261880|NCT01089023|593325616|FG000|Overall Study|Lack of Efficacy|1|||
164261881|NCT02434354|593325617|FG000|Overall Study|screen fail|3|||
164261882|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
164261883|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
164261884|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
164261885|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
164261886|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
164261887|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
164261888|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
164261889|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
164261890|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
164261891|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
164261892|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
164261893|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
164261894|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Adverse Event|1|||
164261895|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Adverse Event|0|||
164261896|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Adverse Event|2|||
163888596|NCT04515849|591963403|FG000|Overall Study|Death|2|||
163888597|NCT04515849|591963404|FG001|Overall Study|Death|0|||
163888598|NCT04515849|591963405|FG002|Overall Study|Death|0|||
163888599|NCT04515849|591963406|FG003|Overall Study|Death|0|||
163888600|NCT04515849|591963407|FG004|Overall Study|Death|0|||
163888601|NCT04515849|591963403|FG000|Overall Study|Other:family emergency|0|||
163888602|NCT04515849|591963404|FG001|Overall Study|Other:family emergency|0|||
163888603|NCT04515849|591963405|FG002|Overall Study|Other:family emergency|0|||
163888604|NCT04515849|591963406|FG003|Overall Study|Other:family emergency|1|||
163888605|NCT04515849|591963407|FG004|Overall Study|Other:family emergency|0|||
163888606|NCT04515849|591963403|FG000|Overall Study|Other:randomised by error|0|||
163888607|NCT04515849|591963404|FG001|Overall Study|Other:randomised by error|1|||
163888608|NCT04515849|591963405|FG002|Overall Study|Other:randomised by error|0|||
163888609|NCT04515849|591963406|FG003|Overall Study|Other:randomised by error|0|||
163888610|NCT04515849|591963407|FG004|Overall Study|Other:randomised by error|0|||
163888611|NCT04515849|591963403|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
163888612|NCT04515849|591963404|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
164261897|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Adverse Event|0|||
164261898|NCT01185964|593325619|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
164261899|NCT01185964|593325620|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
164261900|NCT01185964|593325621|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
164261901|NCT01185964|593325622|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
164261902|NCT01185964|593325619|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
164340738|NCT01602120|593622306|FG000|Overall Study|Lost to Follow-up|0|||
164340739|NCT01602120|593622307|FG001|Overall Study|Lost to Follow-up|1|||
163888613|NCT04515849|591963405|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
164340740|NCT01602120|593622308|FG002|Overall Study|Lost to Follow-up|0|||
164261903|NCT01185964|593325620|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
164261904|NCT01185964|593325621|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
164261905|NCT01185964|593325622|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
164261906|NCT01185964|593325619|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
164261907|NCT01185964|593325620|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
164261908|NCT01185964|593325621|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
164261909|NCT01185964|593325622|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
164261910|NCT01185964|593325619|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
164261911|NCT01185964|593325620|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
164261912|NCT01185964|593325621|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
164261913|NCT01185964|593325622|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
164261914|NCT04465877|593325623|FG000|Overall Study|Noncompliant with study requirements|0|||
164261915|NCT04465877|593325624|FG001|Overall Study|Noncompliant with study requirements|0|||
164261916|NCT04465877|593325625|FG002|Overall Study|Noncompliant with study requirements|1|||
164261917|NCT04465877|593325626|FG003|Overall Study|Noncompliant with study requirements|0|||
164261918|NCT03440918|593325639|FG000|Overall Study|Protocol Violation|0|||
164261919|NCT03440918|593325640|FG001|Overall Study|Protocol Violation|16|||
164261920|NCT03576755|593325641|FG000|Overall Study|Withdrawal by Subject|1|||
164261921|NCT03576755|593325642|FG001|Overall Study|Withdrawal by Subject|0|||
164261922|NCT03576755|593325643|FG002|Overall Study|Withdrawal by Subject|0|||
164261923|NCT03576755|593325644|FG003|Overall Study|Withdrawal by Subject|0|||
164261924|NCT04346108|593325645|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
164261925|NCT04346108|593325646|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
164261926|NCT04346108|593325647|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
164261927|NCT04346108|593325645|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
164261928|NCT04346108|593325646|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
164261929|NCT04346108|593325647|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
164261930|NCT01598753|593325648|FG000|Overall Study|Adverse Event|1|||
164261931|NCT01598753|593325649|FG001|Overall Study|Adverse Event|9|||
164261932|NCT01598753|593325650|FG002|Overall Study|Adverse Event|1|||
164261933|NCT01598753|593325651|FG003|Overall Study|Adverse Event|7|||
164261934|NCT01598753|593325648|FG000|Overall Study|Lost to Follow-up|4|||
164261935|NCT01598753|593325649|FG001|Overall Study|Lost to Follow-up|3|||
164261936|NCT01598753|593325650|FG002|Overall Study|Lost to Follow-up|7|||
164261937|NCT01598753|593325651|FG003|Overall Study|Lost to Follow-up|5|||
164261938|NCT01598753|593325648|FG000|Overall Study|Physician Decision|0|||
164261939|NCT01598753|593325649|FG001|Overall Study|Physician Decision|1|||
164261940|NCT01598753|593325650|FG002|Overall Study|Physician Decision|0|||
164261941|NCT01598753|593325651|FG003|Overall Study|Physician Decision|2|||
164261942|NCT01598753|593325648|FG000|Overall Study|Withdrawal by Subject|7|||
164261943|NCT01598753|593325649|FG001|Overall Study|Withdrawal by Subject|2|||
164261944|NCT01598753|593325650|FG002|Overall Study|Withdrawal by Subject|0|||
164261945|NCT01598753|593325651|FG003|Overall Study|Withdrawal by Subject|1|||
164261946|NCT02014480|593325652|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261947|NCT02014480|593325653|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261948|NCT02014480|593325654|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
164261949|NCT02014480|593325655|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261950|NCT02014480|593325656|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261951|NCT02014480|593325657|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164261952|NCT02014480|593325652|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164261953|NCT02014480|593325653|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164261954|NCT02014480|593325654|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164261955|NCT02014480|593325655|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
164261956|NCT02014480|593325656|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164261957|NCT02014480|593325657|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164261958|NCT02014480|593325652|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
163993437|NCT01279057|592343998|FG002|Overall Study|Adverse Event|1|||
164085252|NCT04147715|592675940|FG006|Overall Study|Adverse Event|0|||
164261959|NCT02014480|593325653|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261960|NCT02014480|593325654|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
164261961|NCT02014480|593325655|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261962|NCT02014480|593325656|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261963|NCT02014480|593325657|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164261964|NCT02014480|593325652|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164261965|NCT02014480|593325653|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164261966|NCT02014480|593325654|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
164261967|NCT02014480|593325655|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164261968|NCT02014480|593325656|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164261969|NCT02014480|593325657|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164085253|NCT04147715|592675941|FG007|Overall Study|Adverse Event|2|||
164085254|NCT04147715|592675942|FG008|Overall Study|Adverse Event|1|||
164085255|NCT04147715|592675943|FG009|Overall Study|Adverse Event|0|||
164085256|NCT04147715|592675944|FG010|Overall Study|Adverse Event|0|||
164085257|NCT04147715|592675945|FG011|Overall Study|Adverse Event|0|||
164085258|NCT00895583|592675955|FG000|Overall Study|Adverse Event|28|||
164085259|NCT00895583|592675956|FG001|Overall Study|Adverse Event|4|||
164085260|NCT00895583|592675955|FG000|Overall Study|Death|2|||
164085261|NCT00895583|592675956|FG001|Overall Study|Death|1|||
164085262|NCT00895583|592675955|FG000|Overall Study|Physician Decision|3|||
164085263|NCT00895583|592675956|FG001|Overall Study|Physician Decision|1|||
164085264|NCT00895583|592675955|FG000|Overall Study|Lost to Follow-up|1|||
164085265|NCT00895583|592675956|FG001|Overall Study|Lost to Follow-up|3|||
164085266|NCT00895583|592675955|FG000|Overall Study|Protocol Violation|1|||
164085267|NCT00895583|592675956|FG001|Overall Study|Protocol Violation|0|||
164085268|NCT00895583|592675955|FG000|Overall Study|Withdrawal by Subject|4|||
164085269|NCT00895583|592675956|FG001|Overall Study|Withdrawal by Subject|2|||
164085270|NCT00895583|592675955|FG000|Overall Study|Lack of Efficacy|5|||
164085271|NCT00895583|592675956|FG001|Overall Study|Lack of Efficacy|0|||
164085272|NCT00895583|592675955|FG000|Overall Study|Other|0|||
164085273|NCT00895583|592675956|FG001|Overall Study|Other|1|||
164085274|NCT01078090|592675959|FG000|Overall Study|Lost to Follow-up|2363|||
164085275|NCT01078090|592675959|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
164085276|NCT01078090|592675959|FG000|Overall Study|Lack of Efficacy|1193|||
164085277|NCT01078090|592675959|FG000|Overall Study|ADR and lack of efficacy|61|||
164085278|NCT01078090|592675959|FG000|Overall Study|Other|523|||
164085279|NCT04535583|592675960|FG000|Overall Study|Lost to Follow-up|1|||
164085280|NCT04535583|592675960|FG000|Overall Study|Physician Decision|1|||
164085281|NCT04535583|592675960|FG000|Overall Study|Withdrawal by Subject|1|||
164085282|NCT01748890|592675962|FG000|Overall Study|Insufficient recruitment for analysis|4|||
164085283|NCT03035227|592675963|FG000|Overall Study|study stopped due to PI leaving institut|1|||
164340741|NCT01602120|593622309|FG003|Overall Study|Lost to Follow-up|1|||
164340742|NCT01602120|593622306|FG000|Overall Study|Protocol Violation|1|||
164340743|NCT01602120|593622307|FG001|Overall Study|Protocol Violation|1|||
163888614|NCT04515849|591963406|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
164340744|NCT01602120|593622308|FG002|Overall Study|Protocol Violation|0|||
164340745|NCT01602120|593622309|FG003|Overall Study|Protocol Violation|0|||
164340746|NCT01602120|593622306|FG000|Overall Study|Non-compliance|0|||
164340747|NCT01602120|593622307|FG001|Overall Study|Non-compliance|3|||
164340748|NCT01602120|593622308|FG002|Overall Study|Non-compliance|0|||
164340749|NCT01602120|593622309|FG003|Overall Study|Non-compliance|1|||
164340750|NCT01602120|593622306|FG000|Overall Study|Withdrawal by Subject|8|||
163888615|NCT04515849|591963407|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
163888616|NCT04515849|591963403|FG000|Overall Study|Physician Decision|0|||
163888617|NCT04515849|591963404|FG001|Overall Study|Physician Decision|1|||
163888618|NCT04515849|591963405|FG002|Overall Study|Physician Decision|0|||
163888619|NCT04515849|591963406|FG003|Overall Study|Physician Decision|0|||
163888620|NCT04515849|591963407|FG004|Overall Study|Physician Decision|0|||
163888621|NCT04515849|591963403|FG000|Overall Study|Withdrawal by Subject|1|||
163888622|NCT04515849|591963404|FG001|Overall Study|Withdrawal by Subject|2|||
163888623|NCT04515849|591963405|FG002|Overall Study|Withdrawal by Subject|1|||
163888624|NCT04515849|591963406|FG003|Overall Study|Withdrawal by Subject|0|||
163888625|NCT04515849|591963407|FG004|Overall Study|Withdrawal by Subject|0|||
163888626|NCT05693935|591965153|FG000|Double-blind Period (8 Weeks)|Adverse Event|5|||
163888627|NCT05693935|591965154|FG001|Double-blind Period (8 Weeks)|Adverse Event|4|||
163888628|NCT05693935|591965155|FG002|Double-blind Period (8 Weeks)|Adverse Event|2|||
163888629|NCT05693935|591965156|FG003|Double-blind Period (8 Weeks)|Adverse Event|3|||
163888630|NCT05693935|591965157|FG004|Double-blind Period (8 Weeks)|Adverse Event|0|||
163888631|NCT05693935|591965158|FG005|Double-blind Period (8 Weeks)|Adverse Event|0|||
163888632|NCT05693935|591965159|FG006|Double-blind Period (8 Weeks)|Adverse Event|0|||
163888633|NCT05693935|591965153|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|26|||
163888634|NCT05693935|591965154|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|35|||
163888635|NCT05693935|591965155|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|31|||
163888636|NCT05693935|591965156|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|33|||
164085284|NCT03035227|592675964|FG001|Overall Study|study stopped due to PI leaving institut|1|||
164085285|NCT02100956|592675965|FG000|At Least One Week Between Injections|Adverse Event|0|||
164085286|NCT02100956|592675966|FG001|At Least One Week Between Injections|Adverse Event|1|||
164085287|NCT03529955|592675967|FG000|Overall Study|Adverse Event|1|||
164085288|NCT03529955|592675967|FG000|Overall Study|Lack of Efficacy|1|||
164340751|NCT01602120|593622307|FG001|Overall Study|Withdrawal by Subject|17|||
164340752|NCT01602120|593622308|FG002|Overall Study|Withdrawal by Subject|0|||
164340753|NCT01602120|593622309|FG003|Overall Study|Withdrawal by Subject|3|||
164340754|NCT01602120|593622306|FG000|Overall Study|Study Terminated by Sponsor|12|||
164340755|NCT01602120|593622307|FG001|Overall Study|Study Terminated by Sponsor|24|||
164340756|NCT01602120|593622308|FG002|Overall Study|Study Terminated by Sponsor|17|||
164261970|NCT02014480|593325652|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261971|NCT02014480|593325653|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
164261972|NCT02014480|593325654|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261973|NCT02014480|593325655|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261974|NCT02014480|593325656|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261975|NCT02014480|593325657|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164261976|NCT02014480|593325652|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261977|NCT02014480|593325653|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261978|NCT02014480|593325654|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
164261979|NCT02014480|593325655|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261980|NCT02014480|593325656|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
164261981|NCT02014480|593325657|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
164261982|NCT02014480|593325652|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261983|NCT02014480|593325653|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261984|NCT02014480|593325654|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261985|NCT02014480|593325655|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261986|NCT02014480|593325656|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164261987|NCT02014480|593325657|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
164261988|NCT00724854|593325658|FG000|Overall Study|Lack of Efficacy|187|||
164261989|NCT00724854|593325659|FG001|Overall Study|Lack of Efficacy|13|||
164261990|NCT00724854|593325658|FG000|Overall Study|Lost to Follow-up|87|||
164261991|NCT00724854|593325659|FG001|Overall Study|Lost to Follow-up|10|||
164261992|NCT00724854|593325658|FG000|Overall Study|Adverse Event|62|||
164261993|NCT00724854|593325659|FG001|Overall Study|Adverse Event|4|||
164261994|NCT00724854|593325658|FG000|Overall Study|Other|42|||
164261995|NCT00724854|593325659|FG001|Overall Study|Other|3|||
164261996|NCT00724854|593325658|FG000|Overall Study|Death|11|||
164261997|NCT00724854|593325659|FG001|Overall Study|Death|0|||
164261998|NCT00724854|593325658|FG000|Overall Study|Change of treatment|7|||
164261999|NCT00724854|593325659|FG001|Overall Study|Change of treatment|0|||
164262000|NCT00724854|593325658|FG000|Overall Study|Withdrawal by Subject|5|||
164262001|NCT00724854|593325659|FG001|Overall Study|Withdrawal by Subject|0|||
164262002|NCT00724854|593325658|FG000|Overall Study|Adverse event + lack of efficacy|2|||
164262003|NCT00724854|593325659|FG001|Overall Study|Adverse event + lack of efficacy|1|||
164262004|NCT01338610|593325660|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
164262005|NCT01338610|593325661|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
164262006|NCT01338610|593325662|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
164262007|NCT01338610|593325660|FG000|Overall Study|Protocol Violation|1|||
164262008|NCT01338610|593325661|FG001|Overall Study|Protocol Violation|0|||
164262009|NCT01338610|593325662|FG002|Overall Study|Protocol Violation|1|||
164262010|NCT01338610|593325660|FG000|Overall Study|Adverse Event|3|||
164262011|NCT01338610|593325661|FG001|Overall Study|Adverse Event|0|||
164262012|NCT01338610|593325662|FG002|Overall Study|Adverse Event|0|||
164262013|NCT01865812|593325663|FG000|Primary Treatment Phase|Adverse Event|2|||
164262014|NCT01865812|593325664|FG001|Primary Treatment Phase|Adverse Event|0|||
164262015|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
164262016|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
164262017|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Pruritus|0|||
164262018|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Pruritus|3|||
164262019|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
164262020|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
164262021|NCT01865812|593325663|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
164262022|NCT01865812|593325664|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
164262023|NCT02032407|593327952|FG000|Overall Study|Lost to Follow-up|2|||
164262024|NCT02032407|593327952|FG000|Overall Study|Pregnancy|1|||
164262025|NCT02032407|593327952|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164262026|NCT02324205|593327954|FG000|Overall Study|Withdrawal by Subject|37|||
164262027|NCT00090233|593327957|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
164262028|NCT00090233|593327958|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
164262029|NCT00090233|593327957|FG000|Overall Study|Adverse Event|214|||
164262030|NCT00090233|593327958|FG001|Overall Study|Adverse Event|198|||
164262031|NCT00090233|593327957|FG000|Overall Study|Lost to Follow-up|68|||
164262032|NCT00090233|593327958|FG001|Overall Study|Lost to Follow-up|95|||
164262033|NCT00090233|593327957|FG000|Overall Study|Protocol Violation|960|||
163888637|NCT05693935|591965157|FG004|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163888638|NCT05693935|591965158|FG005|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164262034|NCT00090233|593327958|FG001|Overall Study|Protocol Violation|1022|||
164262035|NCT00090233|593327957|FG000|Overall Study|Withdrawal by Subject|182|||
164262036|NCT00090233|593327958|FG001|Overall Study|Withdrawal by Subject|211|||
164262037|NCT00090233|593327957|FG000|Overall Study|Moved|203|||
164262038|NCT00090233|593327958|FG001|Overall Study|Moved|189|||
164262039|NCT00090233|593327957|FG000|Overall Study|Other|1211|||
164262040|NCT00090233|593327958|FG001|Overall Study|Other|1160|||
164262041|NCT00090233|593327957|FG000|Overall Study|Data not available at data cut-off point|1552|||
164262042|NCT00090233|593327958|FG001|Overall Study|Data not available at data cut-off point|1563|||
164262043|NCT04863248|593327959|FG000|Overall Study|Sponsor Terminated|4|||
164262044|NCT04863248|593327960|FG001|Overall Study|Sponsor Terminated|1|||
164262045|NCT04863248|593327959|FG000|Overall Study|Death|0|||
164262046|NCT04863248|593327960|FG001|Overall Study|Death|1|||
164262047|NCT04863248|593327959|FG000|Overall Study|Withdrawal by Subject|0|||
164262048|NCT04863248|593327960|FG001|Overall Study|Withdrawal by Subject|1|||
164262049|NCT02536300|593327961|FG000|Overall Study|Investigator's Discretion|17|||
164262050|NCT02536300|593327962|FG001|Overall Study|Investigator's Discretion|11|||
164262051|NCT02536300|593327963|FG002|Overall Study|Investigator's Discretion|2|||
164262052|NCT02536300|593327961|FG000|Overall Study|Progressive Disease|11|||
163993438|NCT01279057|592343996|FG000|Overall Study|Insufficient therapeutic response|0|||
163993439|NCT01279057|592343997|FG001|Overall Study|Insufficient therapeutic response|0|||
163993440|NCT01279057|592343998|FG002|Overall Study|Insufficient therapeutic response|1|||
163993441|NCT01279057|592343996|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163993442|NCT01279057|592343997|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
163993443|NCT01279057|592343998|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163993444|NCT01279057|592343996|FG000|Overall Study|Withdrew consent|2|||
163993445|NCT01279057|592343997|FG001|Overall Study|Withdrew consent|0|||
163993446|NCT01279057|592343998|FG002|Overall Study|Withdrew consent|1|||
163993447|NCT01279057|592343996|FG000|Overall Study|Pregnancy|0|||
163993448|NCT01279057|592343997|FG001|Overall Study|Pregnancy|1|||
163993449|NCT01279057|592343998|FG002|Overall Study|Pregnancy|0|||
163993450|NCT01279057|592343996|FG000|Overall Study|Other|3|||
163993451|NCT01279057|592343997|FG001|Overall Study|Other|3|||
163993452|NCT01279057|592343998|FG002|Overall Study|Other|0|||
163993453|NCT01014585|592344001|FG000|Overall Study|Adverse Event|0|||
163993454|NCT01014585|592344002|FG001|Overall Study|Adverse Event|2|||
163993455|NCT01014585|592344003|FG002|Overall Study|Adverse Event|0|||
163993456|NCT01014585|592344004|FG003|Overall Study|Adverse Event|3|||
164262053|NCT02536300|593327962|FG001|Overall Study|Progressive Disease|7|||
164262054|NCT02536300|593327963|FG002|Overall Study|Progressive Disease|6|||
164262055|NCT02536300|593327961|FG000|Overall Study|Study Terminated by Sponsor|6|||
164262056|NCT02536300|593327962|FG001|Overall Study|Study Terminated by Sponsor|4|||
164262057|NCT02536300|593327963|FG002|Overall Study|Study Terminated by Sponsor|7|||
164262058|NCT02536300|593327961|FG000|Overall Study|Death|7|||
164262059|NCT02536300|593327962|FG001|Overall Study|Death|0|||
164262060|NCT02536300|593327963|FG002|Overall Study|Death|5|||
164262061|NCT02536300|593327961|FG000|Overall Study|Withdrew Consent|4|||
164262062|NCT02536300|593327962|FG001|Overall Study|Withdrew Consent|2|||
164262063|NCT02536300|593327963|FG002|Overall Study|Withdrew Consent|0|||
164262064|NCT02536300|593327961|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
164262065|NCT02536300|593327962|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
164262066|NCT02536300|593327963|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
164262067|NCT02536300|593327961|FG000|Overall Study|Enrolled but Never Treated|0|||
164262068|NCT02536300|593327962|FG001|Overall Study|Enrolled but Never Treated|0|||
164262069|NCT02536300|593327963|FG002|Overall Study|Enrolled but Never Treated|1|||
164262070|NCT02536300|593327961|FG000|Overall Study|Non-compliance With Study Drug|1|||
164262071|NCT02536300|593327962|FG001|Overall Study|Non-compliance With Study Drug|0|||
164262072|NCT02536300|593327963|FG002|Overall Study|Non-compliance With Study Drug|0|||
164262073|NCT02536300|593327961|FG000|Overall Study|Protocol Violation|0|||
164262074|NCT02536300|593327962|FG001|Overall Study|Protocol Violation|1|||
164262075|NCT02536300|593327963|FG002|Overall Study|Protocol Violation|0|||
164262076|NCT01482169|593327966|FG000|Overall Study|Physician Decision|2|||
163993457|NCT01014585|592344001|FG000|Overall Study|Withdrawal by Subject|2|||
163993458|NCT01014585|592344002|FG001|Overall Study|Withdrawal by Subject|0|||
163993459|NCT01014585|592344003|FG002|Overall Study|Withdrawal by Subject|1|||
163993460|NCT01014585|592344004|FG003|Overall Study|Withdrawal by Subject|3|||
163993461|NCT01014585|592344001|FG000|Overall Study|Lost to Follow-up|0|||
163993462|NCT01014585|592344002|FG001|Overall Study|Lost to Follow-up|0|||
163993463|NCT01014585|592344003|FG002|Overall Study|Lost to Follow-up|0|||
163993464|NCT01014585|592344004|FG003|Overall Study|Lost to Follow-up|2|||
164262077|NCT01777542|593327967|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
164262078|NCT01777542|593327968|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
164262079|NCT01030874|593327971|FG000|Overall Study|Withdrawal by Subject|1|||
164262080|NCT01030874|593327972|FG001|Overall Study|Withdrawal by Subject|0|||
164340757|NCT01602120|593622309|FG003|Overall Study|Study Terminated by Sponsor|44|||
164340758|NCT01602120|593622306|FG000|Overall Study|Physician Decision|2|||
164340759|NCT01602120|593622307|FG001|Overall Study|Physician Decision|3|||
163993465|NCT01014585|592344001|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
163993466|NCT01014585|592344002|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
164262081|NCT01030874|593327971|FG000|Overall Study|Discharged in first 2 weeks|17|||
164262082|NCT01030874|593327972|FG001|Overall Study|Discharged in first 2 weeks|16|||
164262083|NCT02279719|593327975|FG000|Overall Study|Patients randomized but never treated|0|||
164340760|NCT01602120|593622308|FG002|Overall Study|Physician Decision|0|||
164262084|NCT02279719|593327976|FG001|Overall Study|Patients randomized but never treated|0|||
164262085|NCT02279719|593327977|FG002|Overall Study|Patients randomized but never treated|0|||
164262086|NCT02279719|593327978|FG003|Overall Study|Patients randomized but never treated|0|||
164262087|NCT02279719|593327979|FG004|Overall Study|Patients randomized but never treated|3|||
164262088|NCT02279719|593327980|FG005|Overall Study|Patients randomized but never treated|0|||
164262089|NCT02279719|593327981|FG006|Overall Study|Patients randomized but never treated|3|||
164262090|NCT03541187|593327984|FG000|Overall Study|Lost to Follow-up|2|||
164262091|NCT03541187|593327985|FG001|Overall Study|Lost to Follow-up|6|||
164262092|NCT03541187|593327984|FG000|Overall Study|Pregnancy|0|||
164262093|NCT03541187|593327985|FG001|Overall Study|Pregnancy|1|||
164262094|NCT03541187|593327984|FG000|Overall Study|Withdrawal by Subject|6|||
164262095|NCT03541187|593327985|FG001|Overall Study|Withdrawal by Subject|2|||
164262096|NCT03541187|593327984|FG000|Overall Study|Moved out of town|1|||
164262097|NCT03541187|593327985|FG001|Overall Study|Moved out of town|0|||
164262098|NCT03541187|593327984|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
164262099|NCT03541187|593327985|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
164262100|NCT03541187|593327984|FG000|Overall Study|Did not meet randomization criteria|1|||
164262101|NCT03541187|593327985|FG001|Overall Study|Did not meet randomization criteria|1|||
164340761|NCT01602120|593622309|FG003|Overall Study|Physician Decision|0|||
163993467|NCT01014585|592344003|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
163993468|NCT01014585|592344004|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
163993469|NCT01481896|592344007|FG000|Overall Study|Lost to Follow-up|12|||
163993470|NCT00364182|592344009|FG000|First Intervention|Secondary prophylaxis|1|||
163993471|NCT00364182|592344010|FG001|First Intervention|Secondary prophylaxis|0|||
163993472|NCT00364182|592344011|FG002|First Intervention|Secondary prophylaxis|0|||
163993473|NCT00364182|592344009|FG000|First Intervention|Withdrawal by Subject|2|||
163993474|NCT00364182|592344010|FG001|First Intervention|Withdrawal by Subject|0|||
163993475|NCT00364182|592344011|FG002|First Intervention|Withdrawal by Subject|0|||
163993476|NCT00364182|592344009|FG000|Second Intervention|non-compliance|0|||
163993477|NCT00364182|592344010|FG001|Second Intervention|non-compliance|1|||
163993478|NCT00364182|592344011|FG002|Second Intervention|non-compliance|1|||
163993479|NCT00364182|592344009|FG000|Second Intervention|Protocol Violation|0|||
163993480|NCT00364182|592344010|FG001|Second Intervention|Protocol Violation|1|||
163993481|NCT00364182|592344011|FG002|Second Intervention|Protocol Violation|0|||
164085289|NCT03016078|592675974|FG000|Overall Study|Protocol Violation|1|||
164085290|NCT03016078|592675974|FG000|Overall Study|Protocol Violation|1|||
164340762|NCT01602120|593622306|FG000|Overall Study|Unspecified Reason|3|||
164340763|NCT01602120|593622307|FG001|Overall Study|Unspecified Reason|1|||
164340764|NCT01602120|593622308|FG002|Overall Study|Unspecified Reason|0|||
164340765|NCT01602120|593622309|FG003|Overall Study|Unspecified Reason|2|||
164340766|NCT04502433|593622310|FG000|Overall Study|Death|2|||
164340767|NCT04502433|593622311|FG001|Overall Study|Death|4|||
164340768|NCT04502433|593622310|FG000|Overall Study|Lost to Follow-up|1|||
164340769|NCT04502433|593622311|FG001|Overall Study|Lost to Follow-up|0|||
164340770|NCT04502433|593622310|FG000|Overall Study|Physician Decision|0|||
164340771|NCT04502433|593622311|FG001|Overall Study|Physician Decision|1|||
164340772|NCT01681472|593622314|FG000|Overall Study|Adverse Event|0|||
164340773|NCT01681472|593622315|FG001|Overall Study|Adverse Event|1|||
164340774|NCT01681472|593622316|FG002|Overall Study|Adverse Event|0|||
164340775|NCT01681472|593622317|FG003|Overall Study|Adverse Event|0|||
164340776|NCT01696071|593622330|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
164340777|NCT01696071|593622331|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
164340778|NCT00678080|593622335|FG000|Overall Study|Physician Decision|2|||
164340779|NCT00678080|593622336|FG001|Overall Study|Physician Decision|0|||
164085291|NCT04526899|592675975|FG000|Overall Study|Withdrawal by Subject|3|||
164262102|NCT03541187|593327984|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
164262103|NCT03541187|593327985|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
164262104|NCT03541187|593327984|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
164340780|NCT00678080|593622335|FG000|Overall Study|Lost to Follow-up|1|||
164340781|NCT00678080|593622336|FG001|Overall Study|Lost to Follow-up|0|||
164340782|NCT00678080|593622335|FG000|Overall Study|Withdrawal by Subject|0|||
164340783|NCT00678080|593622336|FG001|Overall Study|Withdrawal by Subject|1|||
164340784|NCT04439201|593622339|FG000|Overall Study|Ineligible|2|||
164340785|NCT04439201|593622339|FG000|Overall Study|Never start protocol therapy|1|||
164340786|NCT04439201|593622339|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
164340787|NCT04439201|593622339|FG000|Overall Study|Mutation status not confirmed|4|||
164340788|NCT04439201|593622339|FG000|Overall Study|Adverse Event|1|||
164340789|NCT04439201|593622339|FG000|Overall Study|Death|7|||
164340790|NCT04439201|593622339|FG000|Overall Study|Withdrawal by Subject|2|||
164340791|NCT04439201|593622339|FG000|Overall Study|Disease progression|20|||
163993482|NCT00364182|592344009|FG000|Second Intervention|Adverse Event|0|||
163993483|NCT00364182|592344010|FG001|Second Intervention|Adverse Event|0|||
164142274|NCT00451204|592882583|FG001|Overall Study|Other|2|||
164340792|NCT04439201|593622339|FG000|Overall Study|Alternative therapy|1|||
164262105|NCT03541187|593327985|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
164262106|NCT00869050|593327989|FG000|Overall Study|Screen Failure|3|||
164262107|NCT03199053|593327996|FG000|ST Period|Withdrawal by Subject|2|||
164262108|NCT03199053|593327997|FG001|ST Period|Withdrawal by Subject|4|||
164262109|NCT03199053|593327998|FG002|ST Period|Withdrawal by Subject|6|||
164262110|NCT03199053|593327996|FG000|ST Period|Withdrawal by parent/guardian|1|||
164262111|NCT03199053|593327997|FG001|ST Period|Withdrawal by parent/guardian|1|||
164262112|NCT03199053|593327998|FG002|ST Period|Withdrawal by parent/guardian|1|||
164262113|NCT03199053|593327996|FG000|ST Period|Lost to Follow-up|2|||
164262114|NCT03199053|593327997|FG001|ST Period|Lost to Follow-up|0|||
164262115|NCT03199053|593327998|FG002|ST Period|Lost to Follow-up|1|||
164262116|NCT03199053|593327996|FG000|LT Period|Withdrawal by Subject|1|||
164262117|NCT03199053|593327997|FG001|LT Period|Withdrawal by Subject|3|||
164262118|NCT03199053|593327998|FG002|LT Period|Withdrawal by Subject|3|||
164262119|NCT03199053|593327996|FG000|LT Period|Withdrawal by parent/guardian|0|||
164262120|NCT03199053|593327997|FG001|LT Period|Withdrawal by parent/guardian|0|||
164262121|NCT03199053|593327998|FG002|LT Period|Withdrawal by parent/guardian|1|||
164262122|NCT03199053|593327996|FG000|LT Period|Lost to Follow-up|0|||
164262123|NCT03199053|593327997|FG001|LT Period|Lost to Follow-up|1|||
164262124|NCT03199053|593327998|FG002|LT Period|Lost to Follow-up|1|||
164262125|NCT03199053|593327996|FG000|LT Period|Miscellaneous|0|||
164262126|NCT03199053|593327997|FG001|LT Period|Miscellaneous|0|||
164262127|NCT03199053|593327998|FG002|LT Period|Miscellaneous|2|||
164262128|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
164262129|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
164262130|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
164262131|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
164262132|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
164262133|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
164262134|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
164262135|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
164262136|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
164262137|NCT03199053|593327996|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
164262138|NCT03199053|593327997|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
164262139|NCT03199053|593327998|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
164262140|NCT03298984|593328003|FG000|Overall Study|Physician Decision|1|||
164262141|NCT03298984|593328004|FG001|Overall Study|Physician Decision|0|||
164262142|NCT03298984|593328005|FG002|Overall Study|Physician Decision|0|||
164262143|NCT03298984|593328006|FG003|Overall Study|Physician Decision|6|||
164262144|NCT03298984|593328003|FG000|Overall Study|Lack of Efficacy|0|||
164262145|NCT03298984|593328004|FG001|Overall Study|Lack of Efficacy|1|||
164262146|NCT03298984|593328005|FG002|Overall Study|Lack of Efficacy|1|||
164262147|NCT03298984|593328006|FG003|Overall Study|Lack of Efficacy|4|||
164262148|NCT03298984|593328003|FG000|Overall Study|Relapsed disease (following remission)|0|||
164262149|NCT03298984|593328004|FG001|Overall Study|Relapsed disease (following remission)|0|||
164262150|NCT03298984|593328005|FG002|Overall Study|Relapsed disease (following remission)|1|||
164262151|NCT03298984|593328006|FG003|Overall Study|Relapsed disease (following remission)|1|||
164262152|NCT03298984|593328003|FG000|Overall Study|Adverse Event|0|||
164340793|NCT04439201|593622339|FG000|Overall Study|Physician Decision|1|||
164340794|NCT05136690|593622340|FG000|Period 1|Withdrawal by Subject|0|||
164340795|NCT05136690|593622341|FG001|Period 1|Withdrawal by Subject|1|||
164340796|NCT05136690|593622340|FG000|Period 2|Lost to Follow-up|0|||
164340797|NCT05136690|593622341|FG001|Period 2|Lost to Follow-up|3|||
164340798|NCT05136690|593622340|FG000|Period 2|Withdrawal by Subject|0|||
164340799|NCT05136690|593622341|FG001|Period 2|Withdrawal by Subject|1|||
164340800|NCT02020577|593622342|FG000|Overall Study|Progressive disease|3|||
163888639|NCT05693935|591965159|FG006|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163888640|NCT05693935|591965153|FG000|Double-blind Period (8 Weeks)|Lost to Follow-up|5|||
163888641|NCT05693935|591965154|FG001|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
164262153|NCT03298984|593328004|FG001|Overall Study|Adverse Event|0|||
164262154|NCT03298984|593328005|FG002|Overall Study|Adverse Event|0|||
164262155|NCT03298984|593328006|FG003|Overall Study|Adverse Event|1|||
164262156|NCT03298984|593328003|FG000|Overall Study|Death|0|||
164262157|NCT03298984|593328004|FG001|Overall Study|Death|0|||
164262158|NCT03298984|593328005|FG002|Overall Study|Death|0|||
164262159|NCT03298984|593328006|FG003|Overall Study|Death|2|||
164262160|NCT03298984|593328003|FG000|Overall Study|Insurance Company Decision|0|||
164262161|NCT03298984|593328004|FG001|Overall Study|Insurance Company Decision|0|||
164262162|NCT03298984|593328005|FG002|Overall Study|Insurance Company Decision|0|||
164340801|NCT02020577|593622343|FG001|Overall Study|Progressive disease|38|||
164340802|NCT02020577|593622342|FG000|Overall Study|Other AE or clinical progression|0|||
164340803|NCT02020577|593622343|FG001|Overall Study|Other AE or clinical progression|15|||
164340804|NCT02020577|593622342|FG000|Overall Study|Withdrawal by Subject|0|||
164340805|NCT02020577|593622343|FG001|Overall Study|Withdrawal by Subject|1|||
163888642|NCT05693935|591965155|FG002|Double-blind Period (8 Weeks)|Lost to Follow-up|6|||
164340806|NCT02020577|593622342|FG000|Overall Study|Other than stated above|0|||
164085292|NCT04526899|592675976|FG001|Overall Study|Withdrawal by Subject|2|||
164262163|NCT03298984|593328006|FG003|Overall Study|Insurance Company Decision|1|||
164262164|NCT01571284|593328007|FG000|Overall Study|Participant's decision|84|||
164262165|NCT01571284|593328007|FG000|Overall Study|Lost to Follow-up|3|||
164262166|NCT01571284|593328007|FG000|Overall Study|Enrolled but not treated|2|||
164262167|NCT01571284|593328007|FG000|Overall Study|Other than specified above|80|||
164262168|NCT03883113|593328026|FG000|Overall Study|Physician Decision|4|||
164085293|NCT04526899|592675977|FG002|Overall Study|Withdrawal by Subject|2|||
164262169|NCT03883113|593328027|FG001|Overall Study|Physician Decision|2|||
164262170|NCT03883113|593328026|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
164262171|NCT03883113|593328027|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
164262172|NCT03883113|593328026|FG000|Overall Study|Pregnancy|1|||
164262173|NCT03883113|593328027|FG001|Overall Study|Pregnancy|0|||
164262174|NCT03883113|593328026|FG000|Overall Study|Adverse Event|0|||
164262175|NCT03883113|593328027|FG001|Overall Study|Adverse Event|1|||
164262176|NCT03883113|593328026|FG000|Overall Study|Withdrawal by Subject|1|||
164262177|NCT03883113|593328027|FG001|Overall Study|Withdrawal by Subject|2|||
164262178|NCT03883113|593328026|FG000|Overall Study|Lost to Follow-up|1|||
164262179|NCT03883113|593328027|FG001|Overall Study|Lost to Follow-up|0|||
164262180|NCT02323204|593328028|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
164262181|NCT02323204|593328029|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
164262182|NCT02323204|593328030|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
164262183|NCT02323204|593328031|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
164262184|NCT02323204|593328028|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
164262185|NCT02323204|593328029|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
164262186|NCT02323204|593328030|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
164262187|NCT02323204|593328031|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
164262188|NCT02323204|593328028|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
164262189|NCT02323204|593328029|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
164262190|NCT02323204|593328030|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
164262191|NCT02323204|593328031|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
164262192|NCT02323204|593328028|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
164262193|NCT02323204|593328029|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
164262194|NCT02323204|593328030|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
164262195|NCT02323204|593328031|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
164262196|NCT02323204|593328028|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
164262197|NCT02323204|593328029|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
164262198|NCT02323204|593328030|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
164262199|NCT02323204|593328031|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
164262200|NCT02323204|593328028|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
164262201|NCT02323204|593328029|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
164262202|NCT02323204|593328030|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
164262203|NCT02323204|593328031|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
164340807|NCT02020577|593622343|FG001|Overall Study|Other than stated above|1|||
164340808|NCT01453361|593622344|FG000|Overall Study|Disease Progression|6|||
164340809|NCT01453361|593622344|FG000|Overall Study|Screen-Failures|10|||
164340810|NCT01752985|593622345|FG000|Treatment Period|Subject request to discontinue treatment|1|||
164340811|NCT01752985|593622346|FG001|Treatment Period|Subject request to discontinue treatment|0|||
164340812|NCT01752985|593622347|FG002|Treatment Period|Subject request to discontinue treatment|1|||
164340813|NCT01752985|593622345|FG000|Treatment Period|Subject no longer meets study criteria|0|||
164340814|NCT01752985|593622346|FG001|Treatment Period|Subject no longer meets study criteria|1|||
164340815|NCT01752985|593622347|FG002|Treatment Period|Subject no longer meets study criteria|1|||
164340816|NCT01752985|593622345|FG000|Treatment Period|Adverse Event|2|||
164340817|NCT01752985|593622346|FG001|Treatment Period|Adverse Event|1|||
164340818|NCT01752985|593622347|FG002|Treatment Period|Adverse Event|2|||
164340819|NCT01752985|593622345|FG000|Treatment Period|Withdrawal by Subject|1|||
164340820|NCT01752985|593622346|FG001|Treatment Period|Withdrawal by Subject|1|||
164340821|NCT01752985|593622347|FG002|Treatment Period|Withdrawal by Subject|0|||
164340822|NCT01752985|593622345|FG000|Treatment Period|Lost to Follow-up|0|||
164340823|NCT01752985|593622346|FG001|Treatment Period|Lost to Follow-up|0|||
163888643|NCT05693935|591965156|FG003|Double-blind Period (8 Weeks)|Lost to Follow-up|4|||
163888644|NCT05693935|591965157|FG004|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
163888645|NCT05693935|591965158|FG005|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
163888646|NCT05693935|591965159|FG006|Double-blind Period (8 Weeks)|Lost to Follow-up|0|||
163888647|NCT05693935|591965153|FG000|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
163888648|NCT05693935|591965154|FG001|Double-blind Period (8 Weeks)|Lack of Efficacy|1|||
163888649|NCT05693935|591965155|FG002|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163888650|NCT05693935|591965156|FG003|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163888651|NCT05693935|591965157|FG004|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163888652|NCT05693935|591965158|FG005|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
163888653|NCT05693935|591965159|FG006|Double-blind Period (8 Weeks)|Lack of Efficacy|0|||
164262204|NCT02323204|593328028|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262205|NCT02323204|593328029|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
164262206|NCT02323204|593328030|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262207|NCT02323204|593328031|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
164262208|NCT02323204|593328028|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
164262209|NCT02323204|593328029|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
164262210|NCT02323204|593328030|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
164262211|NCT02323204|593328031|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
164262212|NCT02323204|593328028|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262213|NCT02323204|593328029|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
164262214|NCT02323204|593328030|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
164262215|NCT02323204|593328031|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
164262216|NCT02046226|593328037|FG000|Overall Study|Lost to Follow-up|7|||
164262217|NCT01095653|593328038|FG000|Overall Study|Lack of Efficacy|3|||
164262218|NCT01095653|593328039|FG001|Overall Study|Lack of Efficacy|0|||
164262219|NCT01095653|593328040|FG002|Overall Study|Lack of Efficacy|0|||
164262220|NCT01095653|593328038|FG000|Overall Study|Adverse Event|1|||
164262221|NCT01095653|593328039|FG001|Overall Study|Adverse Event|4|||
164262222|NCT01095653|593328040|FG002|Overall Study|Adverse Event|4|||
164262223|NCT01095653|593328038|FG000|Overall Study|Lost to Follow-up|1|||
164262224|NCT01095653|593328039|FG001|Overall Study|Lost to Follow-up|0|||
164262225|NCT01095653|593328040|FG002|Overall Study|Lost to Follow-up|4|||
164262226|NCT01095653|593328038|FG000|Overall Study|Withdrawal by Subject|4|||
164262227|NCT01095653|593328039|FG001|Overall Study|Withdrawal by Subject|5|||
164262228|NCT01095653|593328040|FG002|Overall Study|Withdrawal by Subject|3|||
164262229|NCT01095653|593328038|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
164262230|NCT01095653|593328039|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
164262231|NCT01095653|593328040|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
164262232|NCT00171925|593328041|FG000|Overall Study|Adverse Event|10|||
164262233|NCT00171925|593328042|FG001|Overall Study|Adverse Event|6|||
164262234|NCT00171925|593328041|FG000|Overall Study|Protocol Violation|1|||
164262235|NCT00171925|593328042|FG001|Overall Study|Protocol Violation|1|||
164262236|NCT00171925|593328041|FG000|Overall Study|Withdrawal by Subject|6|||
164262237|NCT00171925|593328042|FG001|Overall Study|Withdrawal by Subject|9|||
164262238|NCT00171925|593328041|FG000|Overall Study|Lost to Follow-up|2|||
164262239|NCT00171925|593328042|FG001|Overall Study|Lost to Follow-up|2|||
164262240|NCT00171925|593328041|FG000|Overall Study|Administrative problems|10|||
164262241|NCT00171925|593328042|FG001|Overall Study|Administrative problems|11|||
164262242|NCT00171925|593328041|FG000|Overall Study|Death|1|||
164262243|NCT00171925|593328042|FG001|Overall Study|Death|2|||
164262244|NCT02692040|593328043|FG000|Overall Study|Protocol Violation|0|||
164262245|NCT02692040|593328044|FG001|Overall Study|Protocol Violation|0|||
164262246|NCT02692040|593328045|FG002|Overall Study|Protocol Violation|0|||
164262247|NCT02692040|593328046|FG003|Overall Study|Protocol Violation|0|||
164262248|NCT02692040|593328047|FG004|Overall Study|Protocol Violation|0|||
164262249|NCT02692040|593328048|FG005|Overall Study|Protocol Violation|0|||
164262250|NCT02692040|593328049|FG006|Overall Study|Protocol Violation|0|||
164262251|NCT02692040|593328050|FG007|Overall Study|Protocol Violation|0|||
164262252|NCT02692040|593328051|FG008|Overall Study|Protocol Violation|0|||
164262253|NCT02692040|593328052|FG009|Overall Study|Protocol Violation|0|||
164262254|NCT02692040|593328053|FG010|Overall Study|Protocol Violation|0|||
164262255|NCT02692040|593328054|FG011|Overall Study|Protocol Violation|0|||
164262256|NCT02692040|593328055|FG012|Overall Study|Protocol Violation|1|||
164262257|NCT02692040|593328056|FG013|Overall Study|Protocol Violation|0|||
164262258|NCT02692040|593328057|FG014|Overall Study|Protocol Violation|0|||
164262259|NCT02692040|593328058|FG015|Overall Study|Protocol Violation|0|||
164262260|NCT02692040|593328059|FG016|Overall Study|Protocol Violation|0|||
164262261|NCT02692040|593328043|FG000|Overall Study|Adverse Event|0|||
164262262|NCT02692040|593328044|FG001|Overall Study|Adverse Event|0|||
164262263|NCT02692040|593328045|FG002|Overall Study|Adverse Event|0|||
164262264|NCT02692040|593328046|FG003|Overall Study|Adverse Event|0|||
164262265|NCT02692040|593328047|FG004|Overall Study|Adverse Event|0|||
164262266|NCT02692040|593328048|FG005|Overall Study|Adverse Event|0|||
164262267|NCT02692040|593328049|FG006|Overall Study|Adverse Event|0|||
164262268|NCT02692040|593328050|FG007|Overall Study|Adverse Event|0|||
164262269|NCT02692040|593328051|FG008|Overall Study|Adverse Event|0|||
164262270|NCT02692040|593328052|FG009|Overall Study|Adverse Event|0|||
164262271|NCT02692040|593328053|FG010|Overall Study|Adverse Event|0|||
164262272|NCT02692040|593328054|FG011|Overall Study|Adverse Event|0|||
164262273|NCT02692040|593328055|FG012|Overall Study|Adverse Event|0|||
164262274|NCT02692040|593328056|FG013|Overall Study|Adverse Event|3|||
164262275|NCT02692040|593328057|FG014|Overall Study|Adverse Event|1|||
164262276|NCT02692040|593328058|FG015|Overall Study|Adverse Event|1|||
164262277|NCT02692040|593328059|FG016|Overall Study|Adverse Event|0|||
164262278|NCT01819129|593328065|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
164262279|NCT01819129|593328066|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
164262280|NCT01819129|593328065|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
164262281|NCT01819129|593328066|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
164262282|NCT01819129|593328065|FG000|Overall Study|Other, Subject moved out of the country|0|||
164262283|NCT01819129|593328066|FG001|Overall Study|Other, Subject moved out of the country|1|||
164262284|NCT01819129|593328065|FG000|Overall Study|Withdrawal by Subject|15|||
164262285|NCT01819129|593328066|FG001|Overall Study|Withdrawal by Subject|15|||
164262286|NCT01819129|593328065|FG000|Overall Study|Lost to Follow-up|5|||
164262287|NCT01819129|593328066|FG001|Overall Study|Lost to Follow-up|2|||
164262288|NCT01819129|593328065|FG000|Overall Study|Lack of Efficacy|0|||
164262289|NCT01819129|593328066|FG001|Overall Study|Lack of Efficacy|1|||
164262290|NCT01819129|593328065|FG000|Overall Study|Adverse Event|1|||
164262291|NCT01819129|593328066|FG001|Overall Study|Adverse Event|4|||
164262292|NCT01819129|593328065|FG000|Overall Study|Death|1|||
164262293|NCT01819129|593328066|FG001|Overall Study|Death|1|||
164262294|NCT01819129|593328065|FG000|Overall Study|Withdrawal Criteria|20|||
164262295|NCT01819129|593328066|FG001|Overall Study|Withdrawal Criteria|15|||
164262296|NCT02752958|593328068|FG000|Overall Study|Adverse Event|3|||
164262297|NCT02752958|593328068|FG000|Overall Study|Lost to Follow-up|1|||
164262298|NCT02752958|593328068|FG000|Overall Study|Protocol Violation|1|||
164262299|NCT02752958|593328068|FG000|Overall Study|Withdrawal by Subject|2|||
164262300|NCT02752958|593328068|FG000|Overall Study|Other (Reason not specified)|2|||
164262301|NCT00054691|593328071|FG000|Overall Study|Unmeasurable Disease|2|||
164262302|NCT00054691|593328071|FG000|Overall Study|Noncompliant|1|||
164262303|NCT02836873|593328072|FG000|Overall Study|Protocol Violation|0|||
164262304|NCT02836873|593328073|FG001|Overall Study|Protocol Violation|1|||
164262305|NCT02836873|593328072|FG000|Overall Study|Adverse Event|1|||
164262306|NCT02836873|593328073|FG001|Overall Study|Adverse Event|4|||
164262307|NCT02836873|593328072|FG000|Overall Study|Withdrawal by Subject|2|||
164262308|NCT02836873|593328073|FG001|Overall Study|Withdrawal by Subject|2|||
164262309|NCT02836873|593328072|FG000|Overall Study|Lost to Follow-up|1|||
164262310|NCT02836873|593328073|FG001|Overall Study|Lost to Follow-up|3|||
164262311|NCT02836873|593328072|FG000|Overall Study|Physician Decision|0|||
164262312|NCT02836873|593328073|FG001|Overall Study|Physician Decision|1|||
164262313|NCT02836873|593328072|FG000|Overall Study|Other|1|||
164262314|NCT02836873|593328073|FG001|Overall Study|Other|0|||
164262315|NCT00853125|593328076|FG000|Overall Study|Study participant's donor was CMV +|1|||
164262316|NCT02914548|593328077|FG000|Overall Study|Adverse Event|15|||
164262317|NCT02914548|593328078|FG001|Overall Study|Adverse Event|7|||
164262318|NCT02914548|593328079|FG002|Overall Study|Adverse Event|15|||
164262319|NCT02914548|593328077|FG000|Overall Study|Physician Decision|2|||
164262320|NCT02914548|593328078|FG001|Overall Study|Physician Decision|2|||
164262321|NCT02914548|593328079|FG002|Overall Study|Physician Decision|0|||
164262322|NCT02914548|593328077|FG000|Overall Study|Protocol Violation|1|||
164262323|NCT02914548|593328078|FG001|Overall Study|Protocol Violation|0|||
164262324|NCT02914548|593328079|FG002|Overall Study|Protocol Violation|0|||
164262325|NCT02914548|593328077|FG000|Overall Study|Withdrawal by Subject|3|||
164262326|NCT02914548|593328078|FG001|Overall Study|Withdrawal by Subject|4|||
164262327|NCT02914548|593328079|FG002|Overall Study|Withdrawal by Subject|4|||
164262328|NCT02914548|593328077|FG000|Overall Study|>40% of body surface area|0|||
164262329|NCT02914548|593328078|FG001|Overall Study|>40% of body surface area|1|||
164262330|NCT02914548|593328079|FG002|Overall Study|>40% of body surface area|1|||
164262331|NCT03746600|593328085|FG000|Overall Study|Withdrawal by Subject|3|||
164262332|NCT03746600|593328086|FG001|Overall Study|Withdrawal by Subject|3|||
164262333|NCT03746600|593328085|FG000|Overall Study|dismissed from study|1|||
164262334|NCT03746600|593328086|FG001|Overall Study|dismissed from study|0|||
164262335|NCT03746600|593328085|FG000|Overall Study|Lost to Follow-up|1|||
164262336|NCT03746600|593328086|FG001|Overall Study|Lost to Follow-up|0|||
164262337|NCT03023826|593328087|FG000|Period 1|Withdrawal by Subject|0|||
164262338|NCT03023826|593328088|FG001|Period 1|Withdrawal by Subject|0|||
164262339|NCT03023826|593328089|FG002|Period 1|Withdrawal by Subject|0|||
164262340|NCT03023826|593328090|FG003|Period 1|Withdrawal by Subject|0|||
164085294|NCT04526899|592675975|FG000|Overall Study|Lost to Follow-up|3|||
164262341|NCT03023826|593328091|FG004|Period 1|Withdrawal by Subject|1|||
164262342|NCT03023826|593328092|FG005|Period 1|Withdrawal by Subject|0|||
164262343|NCT00977938|593328098|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
164262344|NCT00977938|593328099|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
164262345|NCT00977938|593328100|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
164262346|NCT00977938|593328101|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
164262347|NCT00977938|593328098|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
164262348|NCT00977938|593328099|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
164262349|NCT00977938|593328100|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
164262350|NCT00977938|593328101|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
164262351|NCT00977938|593328098|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
164262352|NCT00977938|593328099|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
164262353|NCT00977938|593328100|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
164262354|NCT00977938|593328101|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
164262355|NCT00977938|593328098|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
164262356|NCT00977938|593328099|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
164262357|NCT00977938|593328100|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
164262358|NCT00977938|593328101|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
164262359|NCT00977938|593328098|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
164262360|NCT00977938|593328099|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
164262361|NCT00977938|593328100|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
164262362|NCT00977938|593328101|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
164262363|NCT00977938|593328098|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
164262364|NCT00977938|593328099|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
164262365|NCT00977938|593328100|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
164262366|NCT00977938|593328101|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
164262367|NCT02142283|593328105|FG000|Overall Study|Death|20|||
164262368|NCT02142283|593328106|FG001|Overall Study|Death|18|||
164262369|NCT02142283|593328105|FG000|Overall Study|Withdrawal by Subject|1|||
164262370|NCT02142283|593328106|FG001|Overall Study|Withdrawal by Subject|3|||
164262371|NCT02460783|593328107|FG000|Overall Study|Withdrawal by Subject|1|||
164262372|NCT02460783|593328108|FG001|Overall Study|Withdrawal by Subject|3|||
164262373|NCT02460783|593328107|FG000|Overall Study|Lost to Follow-up|1|||
164262374|NCT02460783|593328108|FG001|Overall Study|Lost to Follow-up|1|||
164262375|NCT01484834|593328109|FG000|Overall Study|Lost to Follow-up|5|||
164262376|NCT01484834|593328110|FG001|Overall Study|Lost to Follow-up|8|||
164262377|NCT01484834|593328111|FG002|Overall Study|Lost to Follow-up|1|||
164262378|NCT01484834|593328112|FG003|Overall Study|Lost to Follow-up|4|||
164262379|NCT00747344|593328113|FG000|Controlled Period|Adverse Event|3|||
164262380|NCT00747344|593328114|FG001|Controlled Period|Adverse Event|0|||
164262381|NCT00747344|593328115|FG002|Controlled Period|Adverse Event|0|||
164262382|NCT00747344|593328116|FG003|Controlled Period|Adverse Event|0|||
164262383|NCT00747344|593328113|FG000|Controlled Period|Lack of Efficacy|2|||
164262384|NCT00747344|593328114|FG001|Controlled Period|Lack of Efficacy|1|||
164262385|NCT00747344|593328115|FG002|Controlled Period|Lack of Efficacy|0|||
164262386|NCT00747344|593328116|FG003|Controlled Period|Lack of Efficacy|0|||
164262387|NCT00747344|593328113|FG000|Controlled Period|Other|0|||
164262388|NCT00747344|593328114|FG001|Controlled Period|Other|3|||
164262389|NCT00747344|593328115|FG002|Controlled Period|Other|0|||
164262390|NCT00747344|593328116|FG003|Controlled Period|Other|0|||
164262391|NCT00747344|593328113|FG000|After Controlled Period|Adverse Event|0|||
164262392|NCT00747344|593328114|FG001|After Controlled Period|Adverse Event|0|||
164262393|NCT00747344|593328115|FG002|After Controlled Period|Adverse Event|0|||
164262394|NCT00747344|593328116|FG003|After Controlled Period|Adverse Event|1|||
164262395|NCT01371643|593328117|FG000|Overall Study|Withdrawal by Subject|3|||
164262396|NCT01371643|593328118|FG001|Overall Study|Withdrawal by Subject|0|||
164262397|NCT02374814|593328122|FG000|Overall Study|Lost to Follow-up|1|||
164262398|NCT02374814|593328123|FG001|Overall Study|Lost to Follow-up|1|||
164262399|NCT02374814|593328124|FG002|Overall Study|Lost to Follow-up|0|||
164262400|NCT02374814|593328125|FG003|Overall Study|Lost to Follow-up|1|||
164262401|NCT02374814|593328126|FG004|Overall Study|Lost to Follow-up|0|||
164262402|NCT02374814|593328127|FG005|Overall Study|Lost to Follow-up|0|||
164262403|NCT02374814|593328122|FG000|Overall Study|Withdrawal by Subject|0|||
164262404|NCT02374814|593328123|FG001|Overall Study|Withdrawal by Subject|0|||
164262405|NCT02374814|593328124|FG002|Overall Study|Withdrawal by Subject|1|||
164085295|NCT04526899|592675976|FG001|Overall Study|Lost to Follow-up|3|||
164262406|NCT02374814|593328125|FG003|Overall Study|Withdrawal by Subject|1|||
164262407|NCT02374814|593328126|FG004|Overall Study|Withdrawal by Subject|0|||
164262408|NCT02374814|593328127|FG005|Overall Study|Withdrawal by Subject|0|||
164262409|NCT00884039|593328128|FG000|Overall Study|Withdrawal by Subject|0|||
164262410|NCT00884039|593328129|FG001|Overall Study|Withdrawal by Subject|1|||
164262411|NCT00884039|593328128|FG000|Overall Study|Lack of Efficacy|2|||
164262412|NCT00884039|593328129|FG001|Overall Study|Lack of Efficacy|0|||
164262413|NCT02182440|593328136|FG000|Overall Study|Adverse Event|0|||
164262414|NCT02182440|593328137|FG001|Overall Study|Adverse Event|1|||
164262415|NCT02182440|593328138|FG002|Overall Study|Adverse Event|0|||
164262416|NCT02182440|593328139|FG003|Overall Study|Adverse Event|0|||
164262417|NCT02182440|593328136|FG000|Overall Study|Death|31|||
164262418|NCT02182440|593328137|FG001|Overall Study|Death|8|||
164262419|NCT02182440|593328138|FG002|Overall Study|Death|5|||
164262420|NCT02182440|593328139|FG003|Overall Study|Death|16|||
164262421|NCT02182440|593328136|FG000|Overall Study|Protocol Violation|0|||
164262422|NCT02182440|593328137|FG001|Overall Study|Protocol Violation|1|||
164262423|NCT02182440|593328138|FG002|Overall Study|Protocol Violation|0|||
164262424|NCT02182440|593328139|FG003|Overall Study|Protocol Violation|0|||
164262425|NCT02182440|593328136|FG000|Overall Study|Physician Decision|1|||
164262426|NCT02182440|593328137|FG001|Overall Study|Physician Decision|0|||
164262427|NCT02182440|593328138|FG002|Overall Study|Physician Decision|0|||
164262428|NCT02182440|593328139|FG003|Overall Study|Physician Decision|0|||
164262429|NCT02182440|593328136|FG000|Overall Study|Withdrawal by Subject|1|||
164262430|NCT02182440|593328137|FG001|Overall Study|Withdrawal by Subject|1|||
164262431|NCT02182440|593328138|FG002|Overall Study|Withdrawal by Subject|3|||
164262432|NCT02182440|593328139|FG003|Overall Study|Withdrawal by Subject|4|||
164262433|NCT02182440|593328136|FG000|Overall Study|different, e.g adm other hospital|12|||
164262434|NCT02182440|593328137|FG001|Overall Study|different, e.g adm other hospital|3|||
164262435|NCT02182440|593328138|FG002|Overall Study|different, e.g adm other hospital|3|||
164262436|NCT02182440|593328139|FG003|Overall Study|different, e.g adm other hospital|10|||
164262437|NCT03754582|593328140|FG000|Treatment Phase|Adverse Event|0|||
164262438|NCT03754582|593328141|FG001|Treatment Phase|Adverse Event|1|||
164262439|NCT03754582|593328142|FG002|Treatment Phase|Adverse Event|0|||
164262440|NCT03754582|593328140|FG000|Follow-up Phase|Other|0|||
164262441|NCT03754582|593328141|FG001|Follow-up Phase|Other|0|||
164262442|NCT03754582|593328142|FG002|Follow-up Phase|Other|1|||
164262443|NCT00072293|593328145|FG000|Overall Study|Lost to Follow-up|1|||
164262444|NCT00072293|593328146|FG001|Overall Study|Lost to Follow-up|1|||
164262445|NCT00072293|593328145|FG000|Overall Study|Withdrawal by Subject|0|||
164262446|NCT00072293|593328146|FG001|Overall Study|Withdrawal by Subject|1|||
164262447|NCT01561755|593328147|FG000|Overall Study|Lost to Follow-up|0|||
164262448|NCT01561755|593328148|FG001|Overall Study|Lost to Follow-up|1|||
164262449|NCT01166958|593328149|FG000|Overall Study|Withdrawal by Subject|1|||
164262450|NCT01166958|593328150|FG001|Overall Study|Withdrawal by Subject|0|||
164262451|NCT01605227|593328151|FG000|Overall Study|Did not receive study treatment|2|||
164262452|NCT01605227|593328152|FG001|Overall Study|Did not receive study treatment|3|||
164262453|NCT01605227|593328151|FG000|Overall Study|Adverse Event|228|||
164262454|NCT01605227|593328152|FG001|Overall Study|Adverse Event|42|||
164262455|NCT01605227|593328151|FG000|Overall Study|Progressive Disease|132|||
164262456|NCT01605227|593328152|FG001|Overall Study|Progressive Disease|128|||
164262457|NCT01605227|593328151|FG000|Overall Study|Clinical Deterioration|227|||
164262458|NCT01605227|593328152|FG001|Overall Study|Clinical Deterioration|133|||
164262459|NCT01605227|593328151|FG000|Overall Study|Lost to Follow-up|1|||
164262460|NCT01605227|593328152|FG001|Overall Study|Lost to Follow-up|0|||
164262461|NCT01605227|593328151|FG000|Overall Study|Protocol Violation|1|||
164262462|NCT01605227|593328152|FG001|Overall Study|Protocol Violation|0|||
164262463|NCT01605227|593328151|FG000|Overall Study|Physician Decision|9|||
164262464|NCT01605227|593328152|FG001|Overall Study|Physician Decision|7|||
164262465|NCT01605227|593328151|FG000|Overall Study|Withdrawal by Subject|18|||
164340824|NCT01752985|593622347|FG002|Treatment Period|Lost to Follow-up|1|||
164340825|NCT01516437|593623785|FG000|Overall Study|Reason not specified|0|||
164340826|NCT01516437|593623786|FG001|Overall Study|Reason not specified|0|||
163888654|NCT05693935|591965153|FG000|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
163888655|NCT05693935|591965154|FG001|Double-blind Period (8 Weeks)|Randomized But Not Treated|5|||
163888656|NCT05693935|591965155|FG002|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
163888657|NCT05693935|591965156|FG003|Double-blind Period (8 Weeks)|Randomized But Not Treated|1|||
163888658|NCT05693935|591965157|FG004|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
163888659|NCT05693935|591965158|FG005|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
163888660|NCT05693935|591965159|FG006|Double-blind Period (8 Weeks)|Randomized But Not Treated|0|||
163888661|NCT05693935|591965153|FG000|Double-blind Period (8 Weeks)|Other Than Specified|11|||
163993484|NCT00364182|592344011|FG002|Second Intervention|Adverse Event|1|||
164262466|NCT01605227|593328152|FG001|Overall Study|Withdrawal by Subject|14|||
164340827|NCT01516437|593623787|FG002|Overall Study|Reason not specified|1|||
164340828|NCT01516437|593623788|FG003|Overall Study|Reason not specified|1|||
164340829|NCT02025621|593623789|FG000|Overall Study|Withdrawal by Subject|1|||
164262467|NCT01605227|593328151|FG000|Overall Study|Sponsor Decision|2|||
164262468|NCT01605227|593328152|FG001|Overall Study|Sponsor Decision|0|||
164262469|NCT01605227|593328151|FG000|Overall Study|Started New Therapy|1|||
164262470|NCT01605227|593328152|FG001|Overall Study|Started New Therapy|0|||
164262471|NCT01605227|593328151|FG000|Overall Study|Subject Decision|0|||
164262472|NCT01605227|593328152|FG001|Overall Study|Subject Decision|1|||
164262473|NCT01605227|593328151|FG000|Overall Study|Dose Held >6 weeks|0|||
164262474|NCT01605227|593328152|FG001|Overall Study|Dose Held >6 weeks|1|||
164262475|NCT02847858|593328153|FG000|Overall Study|Lost to Follow-up|401|||
164262476|NCT02847858|593328154|FG001|Overall Study|Lost to Follow-up|269|||
164262477|NCT00624819|593328155|FG000|Follow-up Period: Year 4|Parents decision|0|||
164262478|NCT00624819|593328156|FG001|Follow-up Period: Year 4|Parents decision|0|||
164262479|NCT00624819|593328157|FG002|Follow-up Period: Year 4|Parents decision|1|||
164262480|NCT00624819|593328158|FG003|Follow-up Period: Year 4|Parents decision|0|||
164262481|NCT00624819|593328155|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
164262482|NCT00624819|593328156|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
164262483|NCT00624819|593328157|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
164262484|NCT00624819|593328158|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
164262485|NCT02826421|593328161|FG000|Overall Study|Adverse Event|1|||
164262486|NCT02826421|593328162|FG001|Overall Study|Adverse Event|0|||
164262487|NCT02826421|593328163|FG002|Overall Study|Adverse Event|0|||
164262488|NCT02826421|593328164|FG003|Overall Study|Adverse Event|1|||
164262489|NCT02826421|593328161|FG000|Overall Study|Withdrawal by Subject|1|||
164262490|NCT02826421|593328162|FG001|Overall Study|Withdrawal by Subject|3|||
164262491|NCT02826421|593328163|FG002|Overall Study|Withdrawal by Subject|1|||
164262492|NCT02826421|593328164|FG003|Overall Study|Withdrawal by Subject|1|||
164262493|NCT02826421|593328161|FG000|Overall Study|Reason not given|1|||
164262494|NCT02826421|593328162|FG001|Overall Study|Reason not given|0|||
164262495|NCT02826421|593328163|FG002|Overall Study|Reason not given|1|||
164262496|NCT02826421|593328164|FG003|Overall Study|Reason not given|0|||
164262497|NCT02210221|593328167|FG000|Overall Study|Lack of Efficacy|7|||
164262498|NCT02210221|593328167|FG000|Overall Study|Withdrawal by Subject|43|||
164262499|NCT00405964|593328170|FG000|Overall Study|Treatment Failure|17|||
164262500|NCT00405964|593328171|FG001|Overall Study|Treatment Failure|45|||
164262501|NCT00405964|593328170|FG000|Overall Study|Adverse Event|7|||
164262502|NCT00405964|593328171|FG001|Overall Study|Adverse Event|16|||
164262503|NCT00405964|593328170|FG000|Overall Study|Lost to Follow-up|5|||
164262504|NCT00405964|593328171|FG001|Overall Study|Lost to Follow-up|5|||
164262505|NCT00405964|593328170|FG000|Overall Study|Withdrawal by Subject|19|||
164262506|NCT00405964|593328171|FG001|Overall Study|Withdrawal by Subject|23|||
164262507|NCT00405964|593328170|FG000|Overall Study|Protocol Violation|11|||
164262508|NCT00405964|593328171|FG001|Overall Study|Protocol Violation|6|||
164262509|NCT05291936|593328172|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
164262510|NCT05291936|593328173|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
164262511|NCT05291936|593328172|FG000|Period 1|Withdrew Consent during study|1|||
164262512|NCT05291936|593328173|FG001|Period 1|Withdrew Consent during study|0|||
164262513|NCT05291936|593328172|FG000|Period 2|Adverse Event|0|||
164262514|NCT05291936|593328173|FG001|Period 2|Adverse Event|1|||
164262515|NCT05291936|593328172|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
164262516|NCT05291936|593328173|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164262517|NCT00391391|593328174|FG000|Overall Study|Adverse Event|0|||
164262518|NCT00391391|593328175|FG001|Overall Study|Adverse Event|0|||
164262519|NCT00391391|593328176|FG002|Overall Study|Adverse Event|0|||
164262520|NCT00391391|593328177|FG003|Overall Study|Adverse Event|1|||
164262521|NCT00391391|593328174|FG000|Overall Study|Lost to Follow-up|1|||
164262522|NCT00391391|593328175|FG001|Overall Study|Lost to Follow-up|3|||
164262523|NCT00391391|593328176|FG002|Overall Study|Lost to Follow-up|7|||
164262524|NCT00391391|593328177|FG003|Overall Study|Lost to Follow-up|4|||
164262525|NCT00391391|593328174|FG000|Overall Study|Protocol Violation|2|||
164262526|NCT00391391|593328175|FG001|Overall Study|Protocol Violation|3|||
164262527|NCT00391391|593328176|FG002|Overall Study|Protocol Violation|6|||
164262528|NCT00391391|593328177|FG003|Overall Study|Protocol Violation|7|||
164262529|NCT00391391|593328174|FG000|Overall Study|Withdrawal by Subject|6|||
164262530|NCT00391391|593328175|FG001|Overall Study|Withdrawal by Subject|4|||
164262531|NCT00391391|593328176|FG002|Overall Study|Withdrawal by Subject|10|||
164262532|NCT00391391|593328177|FG003|Overall Study|Withdrawal by Subject|7|||
164262533|NCT01300819|593328178|FG000|Overall Study|Adverse Event|9|||
164262534|NCT01300819|593328179|FG001|Overall Study|Adverse Event|27|||
164340830|NCT02025621|593623790|FG001|Overall Study|Withdrawal by Subject|0|||
164340831|NCT02025621|593623789|FG000|Overall Study|Death|0|||
164340832|NCT02025621|593623790|FG001|Overall Study|Death|1|||
164262535|NCT01300819|593328178|FG000|Overall Study|Lack of Efficacy|2|||
164262536|NCT01300819|593328179|FG001|Overall Study|Lack of Efficacy|1|||
164262537|NCT01300819|593328178|FG000|Overall Study|Withdrawal by Subject|10|||
164262538|NCT01300819|593328179|FG001|Overall Study|Withdrawal by Subject|12|||
164262539|NCT01300819|593328178|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
164262540|NCT01300819|593328179|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
164262541|NCT01300819|593328178|FG000|Overall Study|Refusal to down titrate study drug|0|||
164262542|NCT01300819|593328179|FG001|Overall Study|Refusal to down titrate study drug|1|||
164262543|NCT01300819|593328178|FG000|Overall Study|Administrative reason|0|||
164262544|NCT01300819|593328179|FG001|Overall Study|Administrative reason|1|||
164262545|NCT01300819|593328178|FG000|Overall Study|Safety follow up not done by mistake|0|||
164262546|NCT01300819|593328179|FG001|Overall Study|Safety follow up not done by mistake|1|||
164340833|NCT02025621|593623789|FG000|Overall Study|No longer eligible|10|||
164340834|NCT02025621|593623790|FG001|Overall Study|No longer eligible|15|||
164262547|NCT01300819|593328178|FG000|Overall Study|Follow up call was not done|1|||
164262548|NCT01300819|593328179|FG001|Overall Study|Follow up call was not done|0|||
164262549|NCT02649855|593328180|FG000|Overall Study|Refused further treatment|2|||
164262550|NCT02649855|593328181|FG001|Overall Study|Refused further treatment|1|||
164262551|NCT02649855|593328182|FG002|Overall Study|Refused further treatment|1|||
164262552|NCT02649855|593328180|FG000|Overall Study|Withdrew consent|0|||
164262553|NCT02649855|593328181|FG001|Overall Study|Withdrew consent|1|||
164262554|NCT02649855|593328182|FG002|Overall Study|Withdrew consent|0|||
164262555|NCT02649855|593328180|FG000|Overall Study|Switched to alternative treatment|0|||
164262556|NCT02649855|593328181|FG001|Overall Study|Switched to alternative treatment|1|||
164262557|NCT02649855|593328182|FG002|Overall Study|Switched to alternative treatment|1|||
164262558|NCT02649855|593328180|FG000|Overall Study|Principal investigator discretion|0|||
164262559|NCT02649855|593328181|FG001|Overall Study|Principal investigator discretion|1|||
164262560|NCT02649855|593328182|FG002|Overall Study|Principal investigator discretion|1|||
164262561|NCT02649855|593328180|FG000|Overall Study|No treatment, per protocol|1|||
164262562|NCT02649855|593328181|FG001|Overall Study|No treatment, per protocol|0|||
164262563|NCT02649855|593328182|FG002|Overall Study|No treatment, per protocol|0|||
164262564|NCT02649855|593328180|FG000|Overall Study|Initiate new treatment|1|||
164262565|NCT02649855|593328181|FG001|Overall Study|Initiate new treatment|0|||
164262566|NCT02649855|593328182|FG002|Overall Study|Initiate new treatment|0|||
164262567|NCT00428220|593330215|FG000|Overall Study|Participant died|8|||
164262568|NCT00428220|593330215|FG000|Overall Study|Global deterioration of health status|7|||
164262569|NCT00428220|593330215|FG000|Overall Study|Lost to Follow-up|4|||
164262570|NCT00428220|593330215|FG000|Overall Study|Objective progression or relapse|123|||
164262571|NCT00428220|593330215|FG000|Overall Study|Participant refused continued treatment|7|||
164262572|NCT00428220|593330215|FG000|Overall Study|Adverse Event|51|||
164262573|NCT00428220|593330215|FG000|Overall Study|Other|23|||
164262574|NCT03131596|593330218|FG000|Overall Study|Protocol Violation|3|||
164262575|NCT03131596|593330219|FG001|Overall Study|Protocol Violation|3|||
164262576|NCT03131596|593330218|FG000|Overall Study|Lost to Follow-up|3|||
164262577|NCT03131596|593330219|FG001|Overall Study|Lost to Follow-up|0|||
164262578|NCT00734071|593330220|FG000|Overall Study|Adverse Event|4|||
164262579|NCT00734071|593330221|FG001|Overall Study|Adverse Event|3|||
164262580|NCT00734071|593330220|FG000|Overall Study|Lack of Efficacy|3|||
164262581|NCT00734071|593330221|FG001|Overall Study|Lack of Efficacy|1|||
164262582|NCT00734071|593330220|FG000|Overall Study|Noncompliance|2|||
164262583|NCT00734071|593330221|FG001|Overall Study|Noncompliance|2|||
164262584|NCT00734071|593330220|FG000|Overall Study|Protocol Deviations|3|||
164262585|NCT00734071|593330221|FG001|Overall Study|Protocol Deviations|4|||
164262586|NCT00734071|593330220|FG000|Overall Study|Voluntary Withdrawal|9|||
164262587|NCT00734071|593330221|FG001|Overall Study|Voluntary Withdrawal|7|||
164262588|NCT00734071|593330220|FG000|Overall Study|Lost to Follow-up|16|||
164262589|NCT00734071|593330221|FG001|Overall Study|Lost to Follow-up|8|||
164262590|NCT00734071|593330220|FG000|Overall Study|Other|1|||
164262591|NCT00734071|593330221|FG001|Overall Study|Other|2|||
164262592|NCT03654885|593330222|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
164262593|NCT03654885|593330223|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
164262594|NCT03654885|593330222|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
164262595|NCT03654885|593330223|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
164262596|NCT03654885|593330222|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
164262597|NCT03654885|593330223|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
164262598|NCT03654885|593330222|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
164262599|NCT03654885|593330223|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
164262600|NCT03654885|593330222|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
164262601|NCT03654885|593330223|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
164262602|NCT03654885|593330222|FG000|Overall Study|Adverse Event in Study Eye|3|||
164262603|NCT03654885|593330223|FG001|Overall Study|Adverse Event in Study Eye|0|||
164262604|NCT03654885|593330222|FG000|Overall Study|Consent Withdrawn|1|||
164262605|NCT03654885|593330223|FG001|Overall Study|Consent Withdrawn|0|||
164262606|NCT03654885|593330222|FG000|Overall Study|Death|3|||
164262607|NCT03654885|593330223|FG001|Overall Study|Death|1|||
164262608|NCT03654885|593330222|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
164262609|NCT03654885|593330223|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
164262610|NCT03654885|593330222|FG000|Overall Study|Lost to Follow-up|3|||
164262611|NCT03654885|593330223|FG001|Overall Study|Lost to Follow-up|3|||
164262612|NCT05275582|593330224|FG000|Overall Study|Lost to Follow-up|1|||
164262613|NCT05275582|593330225|FG001|Overall Study|Lost to Follow-up|0|||
164262614|NCT05275582|593330224|FG000|Overall Study|Withdrawal by Subject|0|||
164262615|NCT05275582|593330225|FG001|Overall Study|Withdrawal by Subject|2|||
164262616|NCT05275582|593330224|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
164262617|NCT05275582|593330225|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
164262618|NCT05275582|593330224|FG000|Overall Study|Death|1|||
164262619|NCT05275582|593330225|FG001|Overall Study|Death|0|||
164262620|NCT05275582|593330224|FG000|Overall Study|Protocol Violation|1|||
164262621|NCT05275582|593330225|FG001|Overall Study|Protocol Violation|0|||
164262622|NCT00549900|593330227|FG000|Overall Study|Adverse Event|1|||
164262623|NCT01176565|593330235|FG000|Overall Study|Lost to Follow-up|12|||
164262624|NCT01176565|593330236|FG001|Overall Study|Lost to Follow-up|16|||
164262625|NCT01176565|593330235|FG000|Overall Study|Withdrawal by Subject|7|||
164262626|NCT01176565|593330236|FG001|Overall Study|Withdrawal by Subject|1|||
164262627|NCT01176565|593330235|FG000|Overall Study|Not Analyzed (any other reason)|1|||
164262628|NCT01176565|593330236|FG001|Overall Study|Not Analyzed (any other reason)|2|||
164262629|NCT02754141|593330237|FG000|Overall Study|Disease progression|11|||
164262630|NCT02754141|593330238|FG001|Overall Study|Disease progression|7|||
164262631|NCT02754141|593330239|FG002|Overall Study|Disease progression|8|||
164262632|NCT02754141|593330240|FG003|Overall Study|Disease progression|5|||
164262633|NCT02754141|593330241|FG004|Overall Study|Disease progression|7|||
164262634|NCT02754141|593330242|FG005|Overall Study|Disease progression|7|||
164262635|NCT02754141|593330243|FG006|Overall Study|Disease progression|7|||
164262636|NCT02754141|593330244|FG007|Overall Study|Disease progression|6|||
164262637|NCT02754141|593330245|FG008|Overall Study|Disease progression|11|||
164262638|NCT02754141|593330246|FG009|Overall Study|Disease progression|16|||
164262639|NCT02754141|593330247|FG010|Overall Study|Disease progression|18|||
164262640|NCT02754141|593330248|FG011|Overall Study|Disease progression|13|||
164262641|NCT02754141|593330249|FG012|Overall Study|Disease progression|10|||
164262642|NCT02754141|593330250|FG013|Overall Study|Disease progression|12|||
164262643|NCT02754141|593330251|FG014|Overall Study|Disease progression|12|||
164262644|NCT02754141|593330252|FG015|Overall Study|Disease progression|14|||
164262645|NCT02754141|593330253|FG016|Overall Study|Disease progression|0|||
164262646|NCT02754141|593330254|FG017|Overall Study|Disease progression|1|||
164262647|NCT02754141|593330237|FG000|Overall Study|Study drug toxicity|1|||
164262648|NCT02754141|593330238|FG001|Overall Study|Study drug toxicity|1|||
164262649|NCT02754141|593330239|FG002|Overall Study|Study drug toxicity|0|||
164262650|NCT02754141|593330240|FG003|Overall Study|Study drug toxicity|0|||
164262651|NCT02754141|593330241|FG004|Overall Study|Study drug toxicity|0|||
164262652|NCT02754141|593330242|FG005|Overall Study|Study drug toxicity|0|||
164262653|NCT02754141|593330243|FG006|Overall Study|Study drug toxicity|0|||
164262654|NCT02754141|593330244|FG007|Overall Study|Study drug toxicity|0|||
164262655|NCT02754141|593330245|FG008|Overall Study|Study drug toxicity|0|||
164262656|NCT02754141|593330246|FG009|Overall Study|Study drug toxicity|0|||
164262657|NCT02754141|593330247|FG010|Overall Study|Study drug toxicity|2|||
164262658|NCT02754141|593330248|FG011|Overall Study|Study drug toxicity|1|||
164262659|NCT02754141|593330249|FG012|Overall Study|Study drug toxicity|1|||
164262660|NCT02754141|593330250|FG013|Overall Study|Study drug toxicity|0|||
164262661|NCT02754141|593330251|FG014|Overall Study|Study drug toxicity|0|||
164262662|NCT02754141|593330252|FG015|Overall Study|Study drug toxicity|0|||
164262663|NCT02754141|593330253|FG016|Overall Study|Study drug toxicity|0|||
164262664|NCT02754141|593330254|FG017|Overall Study|Study drug toxicity|0|||
164262665|NCT02754141|593330237|FG000|Overall Study|AE unrelated to study drug|1|||
164262666|NCT02754141|593330238|FG001|Overall Study|AE unrelated to study drug|1|||
164262667|NCT02754141|593330239|FG002|Overall Study|AE unrelated to study drug|0|||
164262668|NCT02754141|593330240|FG003|Overall Study|AE unrelated to study drug|1|||
164262669|NCT02754141|593330241|FG004|Overall Study|AE unrelated to study drug|3|||
164262670|NCT02754141|593330242|FG005|Overall Study|AE unrelated to study drug|2|||
164262671|NCT02754141|593330243|FG006|Overall Study|AE unrelated to study drug|1|||
164262672|NCT02754141|593330244|FG007|Overall Study|AE unrelated to study drug|0|||
164262673|NCT02754141|593330245|FG008|Overall Study|AE unrelated to study drug|0|||
164262674|NCT02754141|593330246|FG009|Overall Study|AE unrelated to study drug|0|||
164262675|NCT02754141|593330247|FG010|Overall Study|AE unrelated to study drug|0|||
164262676|NCT02754141|593330248|FG011|Overall Study|AE unrelated to study drug|0|||
164262677|NCT02754141|593330249|FG012|Overall Study|AE unrelated to study drug|0|||
164262678|NCT02754141|593330250|FG013|Overall Study|AE unrelated to study drug|0|||
164262679|NCT02754141|593330251|FG014|Overall Study|AE unrelated to study drug|0|||
164262680|NCT02754141|593330252|FG015|Overall Study|AE unrelated to study drug|0|||
164262681|NCT02754141|593330253|FG016|Overall Study|AE unrelated to study drug|0|||
164262682|NCT02754141|593330254|FG017|Overall Study|AE unrelated to study drug|0|||
164262683|NCT02754141|593330237|FG000|Overall Study|Request to discontinue|0|||
164262684|NCT02754141|593330238|FG001|Overall Study|Request to discontinue|0|||
164262685|NCT02754141|593330239|FG002|Overall Study|Request to discontinue|0|||
164262686|NCT02754141|593330240|FG003|Overall Study|Request to discontinue|0|||
164262687|NCT02754141|593330241|FG004|Overall Study|Request to discontinue|0|||
164262688|NCT02754141|593330242|FG005|Overall Study|Request to discontinue|0|||
164262689|NCT02754141|593330243|FG006|Overall Study|Request to discontinue|0|||
164262690|NCT02754141|593330244|FG007|Overall Study|Request to discontinue|0|||
164262691|NCT02754141|593330245|FG008|Overall Study|Request to discontinue|1|||
164262692|NCT02754141|593330246|FG009|Overall Study|Request to discontinue|0|||
164262693|NCT02754141|593330247|FG010|Overall Study|Request to discontinue|0|||
164262694|NCT02754141|593330248|FG011|Overall Study|Request to discontinue|0|||
164262695|NCT02754141|593330249|FG012|Overall Study|Request to discontinue|0|||
164262696|NCT02754141|593330250|FG013|Overall Study|Request to discontinue|1|||
164262697|NCT02754141|593330251|FG014|Overall Study|Request to discontinue|1|||
164262698|NCT02754141|593330252|FG015|Overall Study|Request to discontinue|0|||
164262699|NCT02754141|593330253|FG016|Overall Study|Request to discontinue|0|||
164262700|NCT02754141|593330254|FG017|Overall Study|Request to discontinue|0|||
164262701|NCT02754141|593330237|FG000|Overall Study|Withdrew consent|0|||
164262702|NCT02754141|593330238|FG001|Overall Study|Withdrew consent|0|||
164262703|NCT02754141|593330239|FG002|Overall Study|Withdrew consent|0|||
164262704|NCT02754141|593330240|FG003|Overall Study|Withdrew consent|0|||
164262705|NCT02754141|593330241|FG004|Overall Study|Withdrew consent|0|||
164262706|NCT02754141|593330242|FG005|Overall Study|Withdrew consent|0|||
164262707|NCT02754141|593330243|FG006|Overall Study|Withdrew consent|0|||
164262708|NCT02754141|593330244|FG007|Overall Study|Withdrew consent|0|||
164262709|NCT02754141|593330245|FG008|Overall Study|Withdrew consent|0|||
164262710|NCT02754141|593330246|FG009|Overall Study|Withdrew consent|1|||
164262711|NCT02754141|593330247|FG010|Overall Study|Withdrew consent|0|||
164262712|NCT02754141|593330248|FG011|Overall Study|Withdrew consent|0|||
164262713|NCT02754141|593330249|FG012|Overall Study|Withdrew consent|0|||
164262714|NCT02754141|593330250|FG013|Overall Study|Withdrew consent|0|||
164262715|NCT02754141|593330251|FG014|Overall Study|Withdrew consent|0|||
164262716|NCT02754141|593330252|FG015|Overall Study|Withdrew consent|0|||
164262717|NCT02754141|593330253|FG016|Overall Study|Withdrew consent|0|||
164262718|NCT02754141|593330254|FG017|Overall Study|Withdrew consent|0|||
164262719|NCT02754141|593330237|FG000|Overall Study|Maximum clinical benefit|0|||
164262720|NCT02754141|593330238|FG001|Overall Study|Maximum clinical benefit|0|||
164262721|NCT02754141|593330239|FG002|Overall Study|Maximum clinical benefit|0|||
164262722|NCT02754141|593330240|FG003|Overall Study|Maximum clinical benefit|1|||
164262723|NCT02754141|593330241|FG004|Overall Study|Maximum clinical benefit|0|||
164262724|NCT02754141|593330242|FG005|Overall Study|Maximum clinical benefit|0|||
164262725|NCT02754141|593330243|FG006|Overall Study|Maximum clinical benefit|0|||
164262726|NCT02754141|593330244|FG007|Overall Study|Maximum clinical benefit|0|||
164262727|NCT02754141|593330245|FG008|Overall Study|Maximum clinical benefit|0|||
164262728|NCT02754141|593330246|FG009|Overall Study|Maximum clinical benefit|0|||
164262729|NCT02754141|593330247|FG010|Overall Study|Maximum clinical benefit|0|||
164262730|NCT02754141|593330248|FG011|Overall Study|Maximum clinical benefit|0|||
163993485|NCT00364182|592344009|FG000|Third Intervention|non-compliance|0|||
163993486|NCT00364182|592344010|FG001|Third Intervention|non-compliance|1|||
163993487|NCT00364182|592344011|FG002|Third Intervention|non-compliance|0|||
163993488|NCT00364182|592344009|FG000|Third Intervention|Lost to Follow-up|0|||
163993489|NCT00364182|592344010|FG001|Third Intervention|Lost to Follow-up|0|||
163993490|NCT00364182|592344011|FG002|Third Intervention|Lost to Follow-up|1|||
163993491|NCT03336502|592344012|FG000|Overall Study|Physician Decision|0|||
163993492|NCT03336502|592344013|FG001|Overall Study|Physician Decision|1|||
163993493|NCT03336502|592344012|FG000|Overall Study|Prohibited Drugs|1|||
163993494|NCT03336502|592344013|FG001|Overall Study|Prohibited Drugs|1|||
163993495|NCT03336502|592344012|FG000|Overall Study|Death|1|||
163993496|NCT03336502|592344013|FG001|Overall Study|Death|2|||
163993497|NCT03336502|592344012|FG000|Overall Study|Adverse Event|2|||
163993498|NCT03336502|592344013|FG001|Overall Study|Adverse Event|5|||
163993499|NCT05032950|592344029|FG000|Overall Study|Adverse Event|0|||
163993500|NCT05032950|592344030|FG001|Overall Study|Adverse Event|0|||
163993501|NCT05032950|592344031|FG002|Overall Study|Adverse Event|1|||
163993502|NCT05032950|592344032|FG003|Overall Study|Adverse Event|1|||
163993503|NCT05032950|592344033|FG004|Overall Study|Adverse Event|0|||
163993504|NCT05032950|592344034|FG005|Overall Study|Adverse Event|0|||
163993505|NCT02959814|592344035|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
163993506|NCT02959814|592344035|FG000|Overall Study|Excluded based on anatomical criteria|2|||
163993507|NCT02959814|592344035|FG000|Overall Study|Protocol Violation|7|||
163993508|NCT02959814|592344035|FG000|Overall Study|FFR not measured|2|||
163993509|NCT02959814|592344035|FG000|Overall Study|In-procedure QFR not computed|6|||
163993510|NCT02959814|592344035|FG000|Overall Study|Excluded by FFR core-lab|24|||
163993511|NCT04343651|592344039|FG000|Overall Study|Physician Decision|2|||
164085296|NCT04526899|592675977|FG002|Overall Study|Lost to Follow-up|1|||
164262731|NCT02754141|593330249|FG012|Overall Study|Maximum clinical benefit|0|||
164262732|NCT02754141|593330250|FG013|Overall Study|Maximum clinical benefit|0|||
164262733|NCT02754141|593330251|FG014|Overall Study|Maximum clinical benefit|0|||
164262734|NCT02754141|593330252|FG015|Overall Study|Maximum clinical benefit|0|||
164262735|NCT02754141|593330253|FG016|Overall Study|Maximum clinical benefit|0|||
164262736|NCT02754141|593330254|FG017|Overall Study|Maximum clinical benefit|0|||
164262737|NCT02754141|593330237|FG000|Overall Study|No longer meets study criteria|0|||
164262738|NCT02754141|593330238|FG001|Overall Study|No longer meets study criteria|0|||
163993512|NCT04343651|592344040|FG001|Overall Study|Physician Decision|1|||
163993513|NCT04343651|592344039|FG000|Overall Study|Lost to Follow-up|2|||
163993514|NCT04343651|592344040|FG001|Overall Study|Lost to Follow-up|1|||
163993515|NCT04343651|592344039|FG000|Overall Study|Protocol Violation|4|||
164262739|NCT02754141|593330239|FG002|Overall Study|No longer meets study criteria|0|||
164262740|NCT02754141|593330240|FG003|Overall Study|No longer meets study criteria|1|||
163993516|NCT04343651|592344040|FG001|Overall Study|Protocol Violation|6|||
163993517|NCT04343651|592344039|FG000|Overall Study|Missing|3|||
163993518|NCT04343651|592344040|FG001|Overall Study|Missing|9|||
163993519|NCT04343651|592344039|FG000|Overall Study|Withdrawal by Subject|0|||
163993520|NCT04343651|592344040|FG001|Overall Study|Withdrawal by Subject|4|||
163993521|NCT04343651|592344039|FG000|Overall Study|Death|0|||
163993522|NCT04343651|592344040|FG001|Overall Study|Death|1|||
163993523|NCT04343651|592344039|FG000|Overall Study|Did not start treatment|1|||
163993524|NCT04343651|592344040|FG001|Overall Study|Did not start treatment|1|||
163993525|NCT04343651|592344039|FG000|Overall Study|Patient did not complete visits 3-6|0|||
163993526|NCT04343651|592344040|FG001|Overall Study|Patient did not complete visits 3-6|1|||
163993527|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
163993528|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
163993529|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
163993530|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163993531|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163993532|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163993533|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164085297|NCT04526899|592675975|FG000|Overall Study|Investigator's decision|1|||
164085298|NCT04526899|592675976|FG001|Overall Study|Investigator's decision|0|||
164085299|NCT04526899|592675977|FG002|Overall Study|Investigator's decision|0|||
163993534|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164085300|NCT04526899|592675975|FG000|Overall Study|Death|33|||
164262741|NCT02754141|593330241|FG004|Overall Study|No longer meets study criteria|0|||
164262742|NCT02754141|593330242|FG005|Overall Study|No longer meets study criteria|0|||
164085301|NCT04526899|592675976|FG001|Overall Study|Death|17|||
164085302|NCT04526899|592675977|FG002|Overall Study|Death|13|||
164085303|NCT04526899|592675975|FG000|Overall Study|Other|1|||
164085304|NCT04526899|592675976|FG001|Overall Study|Other|0|||
164085305|NCT04526899|592675977|FG002|Overall Study|Other|0|||
164085306|NCT04526899|592675975|FG000|Overall Study|On-Treatment|19|||
164085307|NCT04526899|592675976|FG001|Overall Study|On-Treatment|10|||
164085308|NCT04526899|592675977|FG002|Overall Study|On-Treatment|12|||
164085309|NCT04526899|592675975|FG000|Overall Study|Survival Follow-up|34|||
164085310|NCT04526899|592675976|FG001|Overall Study|Survival Follow-up|14|||
164085311|NCT04526899|592675977|FG002|Overall Study|Survival Follow-up|16|||
164085312|NCT00416520|592677218|FG000|Open-label Period|Adverse Event|28|||
164085313|NCT00416520|592677219|FG001|Open-label Period|Adverse Event|10|||
164085314|NCT00416520|592677220|FG002|Open-label Period|Adverse Event|0|||
164085315|NCT00416520|592677221|FG003|Open-label Period|Adverse Event|0|||
164085316|NCT00416520|592677218|FG000|Open-label Period|Death|2|||
164085317|NCT00416520|592677219|FG001|Open-label Period|Death|1|||
164085318|NCT00416520|592677220|FG002|Open-label Period|Death|0|||
164085319|NCT00416520|592677221|FG003|Open-label Period|Death|0|||
164262743|NCT02754141|593330243|FG006|Overall Study|No longer meets study criteria|0|||
164262744|NCT02754141|593330244|FG007|Overall Study|No longer meets study criteria|0|||
164262745|NCT02754141|593330245|FG008|Overall Study|No longer meets study criteria|0|||
164262746|NCT02754141|593330246|FG009|Overall Study|No longer meets study criteria|0|||
164262747|NCT02754141|593330247|FG010|Overall Study|No longer meets study criteria|0|||
164262748|NCT02754141|593330248|FG011|Overall Study|No longer meets study criteria|0|||
164262749|NCT02754141|593330249|FG012|Overall Study|No longer meets study criteria|0|||
164262750|NCT02754141|593330250|FG013|Overall Study|No longer meets study criteria|0|||
164262751|NCT02754141|593330251|FG014|Overall Study|No longer meets study criteria|0|||
164262752|NCT02754141|593330252|FG015|Overall Study|No longer meets study criteria|0|||
164262753|NCT02754141|593330253|FG016|Overall Study|No longer meets study criteria|0|||
164262754|NCT02754141|593330254|FG017|Overall Study|No longer meets study criteria|0|||
164262755|NCT02754141|593330237|FG000|Overall Study|Other reasons|0|||
164262756|NCT02754141|593330238|FG001|Overall Study|Other reasons|0|||
164262757|NCT02754141|593330239|FG002|Overall Study|Other reasons|0|||
164262758|NCT02754141|593330240|FG003|Overall Study|Other reasons|0|||
163993535|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
163993536|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
163993537|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
163993538|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
163993539|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163993540|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163993541|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163993542|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163993543|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163993544|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
163993545|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
163993546|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
163993547|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993548|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993549|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993550|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993551|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993552|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993553|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
163993554|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
163993555|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
163993556|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
163993557|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163993558|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164085320|NCT00416520|592677218|FG000|Open-label Period|Lack of Efficacy|8|||
164085321|NCT00416520|592677219|FG001|Open-label Period|Lack of Efficacy|1|||
164085322|NCT00416520|592677220|FG002|Open-label Period|Lack of Efficacy|0|||
164262759|NCT02754141|593330241|FG004|Overall Study|Other reasons|0|||
164085323|NCT00416520|592677221|FG003|Open-label Period|Lack of Efficacy|0|||
164085324|NCT00416520|592677218|FG000|Open-label Period|Protocol Violation|3|||
164085325|NCT00416520|592677219|FG001|Open-label Period|Protocol Violation|3|||
164085326|NCT00416520|592677220|FG002|Open-label Period|Protocol Violation|0|||
164085327|NCT00416520|592677221|FG003|Open-label Period|Protocol Violation|0|||
164085328|NCT00416520|592677218|FG000|Open-label Period|Withdrawal by Subject|16|||
164085329|NCT00416520|592677219|FG001|Open-label Period|Withdrawal by Subject|5|||
164085330|NCT00416520|592677220|FG002|Open-label Period|Withdrawal by Subject|0|||
164085331|NCT00416520|592677221|FG003|Open-label Period|Withdrawal by Subject|0|||
164085332|NCT00416520|592677218|FG000|Open-label Period|Other Reasons|3|||
164085333|NCT00416520|592677219|FG001|Open-label Period|Other Reasons|12|||
164085334|NCT00416520|592677220|FG002|Open-label Period|Other Reasons|0|||
164085335|NCT00416520|592677221|FG003|Open-label Period|Other Reasons|0|||
164085336|NCT00416520|592677218|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
164085337|NCT00416520|592677219|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
164085338|NCT00416520|592677220|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
164085339|NCT00416520|592677221|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
164085340|NCT00416520|592677218|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
164085341|NCT00416520|592677219|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
164085342|NCT00416520|592677220|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
164085343|NCT00416520|592677221|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
164085344|NCT00416520|592677218|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
164085345|NCT00416520|592677219|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
164085346|NCT00416520|592677220|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
164085347|NCT00416520|592677221|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
164085348|NCT00449072|592677222|FG000|Overall Study|Adverse Event|3|||
164085349|NCT00449072|592677223|FG001|Overall Study|Adverse Event|1|||
164085350|NCT00449072|592677222|FG000|Overall Study|Protocol Violation|14|||
164085351|NCT00449072|592677223|FG001|Overall Study|Protocol Violation|12|||
164085352|NCT00449072|592677222|FG000|Overall Study|Lost to Follow-up|5|||
164085353|NCT00449072|592677223|FG001|Overall Study|Lost to Follow-up|7|||
164085354|NCT00449072|592677222|FG000|Overall Study|Withdrawal by Subject|11|||
164262760|NCT02754141|593330242|FG005|Overall Study|Other reasons|0|||
164262761|NCT02754141|593330243|FG006|Overall Study|Other reasons|0|||
164262762|NCT02754141|593330244|FG007|Overall Study|Other reasons|1|||
164262763|NCT02754141|593330245|FG008|Overall Study|Other reasons|0|||
164262764|NCT02754141|593330246|FG009|Overall Study|Other reasons|0|||
164262765|NCT02754141|593330247|FG010|Overall Study|Other reasons|0|||
164262766|NCT02754141|593330248|FG011|Overall Study|Other reasons|0|||
164262767|NCT02754141|593330249|FG012|Overall Study|Other reasons|2|||
164262768|NCT02754141|593330250|FG013|Overall Study|Other reasons|0|||
164262769|NCT02754141|593330251|FG014|Overall Study|Other reasons|0|||
164262770|NCT02754141|593330252|FG015|Overall Study|Other reasons|0|||
164262771|NCT02754141|593330253|FG016|Overall Study|Other reasons|0|||
164262772|NCT02754141|593330254|FG017|Overall Study|Other reasons|0|||
164262773|NCT02754141|593330237|FG000|Overall Study|Completed treatment as per protocol|0|||
164262774|NCT02754141|593330238|FG001|Overall Study|Completed treatment as per protocol|1|||
164262775|NCT02754141|593330239|FG002|Overall Study|Completed treatment as per protocol|0|||
164262776|NCT02754141|593330240|FG003|Overall Study|Completed treatment as per protocol|0|||
164262777|NCT02754141|593330241|FG004|Overall Study|Completed treatment as per protocol|0|||
164262778|NCT02754141|593330242|FG005|Overall Study|Completed treatment as per protocol|0|||
164262779|NCT02754141|593330243|FG006|Overall Study|Completed treatment as per protocol|0|||
164262780|NCT02754141|593330244|FG007|Overall Study|Completed treatment as per protocol|0|||
164262781|NCT02754141|593330245|FG008|Overall Study|Completed treatment as per protocol|0|||
164262782|NCT02754141|593330246|FG009|Overall Study|Completed treatment as per protocol|0|||
164262783|NCT02754141|593330247|FG010|Overall Study|Completed treatment as per protocol|0|||
164262784|NCT02754141|593330248|FG011|Overall Study|Completed treatment as per protocol|0|||
164262785|NCT02754141|593330249|FG012|Overall Study|Completed treatment as per protocol|1|||
164262786|NCT02754141|593330250|FG013|Overall Study|Completed treatment as per protocol|0|||
164262787|NCT02754141|593330251|FG014|Overall Study|Completed treatment as per protocol|0|||
164085355|NCT00449072|592677223|FG001|Overall Study|Withdrawal by Subject|8|||
164085356|NCT00449072|592677222|FG000|Overall Study|Lack of Efficacy|1|||
164085357|NCT00449072|592677223|FG001|Overall Study|Lack of Efficacy|1|||
164085358|NCT00449072|592677222|FG000|Overall Study|Physician Decision|1|||
164262788|NCT02754141|593330252|FG015|Overall Study|Completed treatment as per protocol|0|||
164262789|NCT02754141|593330253|FG016|Overall Study|Completed treatment as per protocol|0|||
164262790|NCT02754141|593330254|FG017|Overall Study|Completed treatment as per protocol|0|||
164262791|NCT02754141|593330237|FG000|Overall Study|Not completing monotherapy|0|||
164262792|NCT02754141|593330238|FG001|Overall Study|Not completing monotherapy|0|||
164262793|NCT02754141|593330239|FG002|Overall Study|Not completing monotherapy|0|||
164262794|NCT02754141|593330240|FG003|Overall Study|Not completing monotherapy|0|||
164262795|NCT02754141|593330241|FG004|Overall Study|Not completing monotherapy|0|||
164262796|NCT02754141|593330242|FG005|Overall Study|Not completing monotherapy|0|||
164085359|NCT00449072|592677223|FG001|Overall Study|Physician Decision|0|||
164085360|NCT00449072|592677222|FG000|Overall Study|Not treated|0|||
164085361|NCT00449072|592677223|FG001|Overall Study|Not treated|1|||
164262797|NCT02754141|593330243|FG006|Overall Study|Not completing monotherapy|0|||
164262798|NCT02754141|593330244|FG007|Overall Study|Not completing monotherapy|0|||
164262799|NCT02754141|593330245|FG008|Overall Study|Not completing monotherapy|0|||
164262800|NCT02754141|593330246|FG009|Overall Study|Not completing monotherapy|0|||
164262801|NCT02754141|593330247|FG010|Overall Study|Not completing monotherapy|0|||
164262802|NCT02754141|593330248|FG011|Overall Study|Not completing monotherapy|0|||
164262803|NCT02754141|593330249|FG012|Overall Study|Not completing monotherapy|0|||
164262804|NCT02754141|593330250|FG013|Overall Study|Not completing monotherapy|1|||
164262805|NCT02754141|593330251|FG014|Overall Study|Not completing monotherapy|0|||
164262806|NCT02754141|593330252|FG015|Overall Study|Not completing monotherapy|0|||
164262807|NCT02754141|593330253|FG016|Overall Study|Not completing monotherapy|0|||
164262808|NCT02754141|593330254|FG017|Overall Study|Not completing monotherapy|0|||
164262809|NCT02680041|593330255|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
164262810|NCT02680041|593330255|FG000|Overall Study|Lost to Follow-up|2|||
164262811|NCT04239222|593330256|FG000|Baseline|Withdrawal by Subject|0|||
164262812|NCT04239222|593330257|FG001|Baseline|Withdrawal by Subject|0|||
164262813|NCT04239222|593330258|FG002|Baseline|Withdrawal by Subject|1|||
164262814|NCT04239222|593330259|FG003|Baseline|Withdrawal by Subject|1|||
164262815|NCT04239222|593330256|FG000|First Foot Assignment|Withdrawal by Subject|0|||
164262816|NCT04239222|593330257|FG001|First Foot Assignment|Withdrawal by Subject|0|||
164262817|NCT04239222|593330258|FG002|First Foot Assignment|Withdrawal by Subject|1|||
164262818|NCT04239222|593330259|FG003|First Foot Assignment|Withdrawal by Subject|0|||
164262819|NCT04239222|593330256|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
164262820|NCT04239222|593330257|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
164262821|NCT04239222|593330258|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
164262822|NCT04239222|593330259|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
164262823|NCT00937404|593330260|FG000|Overall Study|Protocol Violation|1|||
164262824|NCT00937404|593330260|FG000|Overall Study|Withdrawal by Subject|1|||
164262825|NCT01779869|593330261|FG000|Overall Study|Physician Decision|2|||
164262826|NCT01691105|593330267|FG000|1 Month Follow-up|Lost to Follow-up|41|||
164262827|NCT01691105|593330268|FG001|1 Month Follow-up|Lost to Follow-up|38|||
164262828|NCT01691105|593330267|FG000|1 Month Follow-up|Death|2|||
164262829|NCT01691105|593330268|FG001|1 Month Follow-up|Death|3|||
164262830|NCT01691105|593330267|FG000|6 Month Follow-up|Lost to Follow-up|39|||
164262831|NCT01691105|593330268|FG001|6 Month Follow-up|Lost to Follow-up|58|||
164262832|NCT01691105|593330267|FG000|6 Month Follow-up|Death|13|||
164262833|NCT01691105|593330268|FG001|6 Month Follow-up|Death|13|||
164262834|NCT01691105|593330267|FG000|12 Month Follow-up|Lost to Follow-up|50|||
164262835|NCT01691105|593330268|FG001|12 Month Follow-up|Lost to Follow-up|71|||
164262836|NCT01691105|593330267|FG000|12 Month Follow-up|Death|22|||
164262837|NCT01691105|593330268|FG001|12 Month Follow-up|Death|30|||
164262838|NCT01691105|593330267|FG000|12 Month Biochemical Verification|Death|22|||
164262839|NCT01691105|593330268|FG001|12 Month Biochemical Verification|Death|30|||
164262840|NCT01691105|593330267|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
164262841|NCT01691105|593330268|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
164262842|NCT01691105|593330267|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
164262843|NCT01691105|593330268|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
164262844|NCT00957944|593330269|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
164262845|NCT00957944|593330270|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
164262846|NCT01323270|593330274|FG000|Overall Study|Withdrawal by Subject|19|||
164262847|NCT01323270|593330275|FG001|Overall Study|Withdrawal by Subject|10|||
164262848|NCT01323270|593330274|FG000|Overall Study|Protocol Violation|9|||
164262849|NCT01323270|593330275|FG001|Overall Study|Protocol Violation|7|||
164262850|NCT01323270|593330274|FG000|Overall Study|Lost to Follow-up|4|||
164262851|NCT01323270|593330275|FG001|Overall Study|Lost to Follow-up|6|||
164262852|NCT01323270|593330274|FG000|Overall Study|Adverse Event|8|||
164262853|NCT01323270|593330275|FG001|Overall Study|Adverse Event|0|||
164262854|NCT01323270|593330274|FG000|Overall Study|Other|0|||
164262855|NCT01323270|593330275|FG001|Overall Study|Other|3|||
164340835|NCT02025621|593623789|FG000|Overall Study|Surgery initiated before infusion|3|||
164340836|NCT02025621|593623790|FG001|Overall Study|Surgery initiated before infusion|3|||
164340837|NCT00739674|593623791|FG000|Overall Study|Screening failures|19|||
164340838|NCT00739674|593623792|FG001|Overall Study|Screening failures|17|||
164340839|NCT00739674|593623791|FG000|Overall Study|Site 212 removal|19|||
164340840|NCT00739674|593623792|FG001|Overall Study|Site 212 removal|13|||
164340841|NCT00739674|593623791|FG000|Overall Study|No follow-up data|33|||
164262856|NCT01323270|593330274|FG000|Overall Study|Physician Decision|0|||
164262857|NCT01323270|593330275|FG001|Overall Study|Physician Decision|2|||
164262858|NCT01323270|593330274|FG000|Overall Study|Not eligible|1|||
164340842|NCT00739674|593623792|FG001|Overall Study|No follow-up data|18|||
164262859|NCT01323270|593330275|FG001|Overall Study|Not eligible|1|||
164262860|NCT01323270|593330274|FG000|Overall Study|Death|1|||
164262861|NCT01323270|593330275|FG001|Overall Study|Death|0|||
164262862|NCT01323270|593330274|FG000|Overall Study|Randomized, but not vaccinated|1|||
164340843|NCT00739674|593623791|FG000|Overall Study|Dietician consultation >30 days|1|||
164340844|NCT00739674|593623792|FG001|Overall Study|Dietician consultation >30 days|9|||
164262863|NCT01323270|593330275|FG001|Overall Study|Randomized, but not vaccinated|0|||
164262864|NCT02229214|593330278|FG000|Overall Study|Adverse Event|2|||
164262865|NCT02229214|593330279|FG001|Overall Study|Adverse Event|0|||
164262866|NCT02229214|593330278|FG000|Overall Study|Withdrawal by Subject|4|||
164262867|NCT02229214|593330279|FG001|Overall Study|Withdrawal by Subject|0|||
164262868|NCT00246025|593330286|FG000|Overall Study|Adverse Event|7|||
164262869|NCT00246025|593330287|FG001|Overall Study|Adverse Event|9|||
164262870|NCT00246025|593330288|FG002|Overall Study|Adverse Event|9|||
164262871|NCT00246025|593330289|FG003|Overall Study|Adverse Event|10|||
164262872|NCT00246025|593330286|FG000|Overall Study|Withdrawal by Subject|3|||
164262873|NCT00246025|593330287|FG001|Overall Study|Withdrawal by Subject|0|||
164262874|NCT00246025|593330288|FG002|Overall Study|Withdrawal by Subject|1|||
164262875|NCT00246025|593330289|FG003|Overall Study|Withdrawal by Subject|2|||
164262876|NCT00246025|593330286|FG000|Overall Study|unsuitable medical history was found|0|||
164262877|NCT00246025|593330287|FG001|Overall Study|unsuitable medical history was found|0|||
164262878|NCT00246025|593330288|FG002|Overall Study|unsuitable medical history was found|0|||
164262879|NCT00246025|593330289|FG003|Overall Study|unsuitable medical history was found|1|||
164262880|NCT03305081|593330292|FG000|Overall Study|Lost to Follow-up|10|||
164262881|NCT03305081|593330293|FG001|Overall Study|Lost to Follow-up|15|||
164262882|NCT01218100|593330294|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
164262883|NCT01218100|593330295|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
164262884|NCT01218100|593330296|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
164262885|NCT01218100|593330297|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
164262886|NCT01218100|593330294|FG000|Overall Study|Adverse Event|4|||
164262887|NCT01218100|593330295|FG001|Overall Study|Adverse Event|6|||
164262888|NCT01218100|593330296|FG002|Overall Study|Adverse Event|6|||
164262889|NCT01218100|593330297|FG003|Overall Study|Adverse Event|7|||
164262890|NCT01218100|593330294|FG000|Overall Study|Lack of Efficacy|9|||
164262891|NCT01218100|593330295|FG001|Overall Study|Lack of Efficacy|6|||
164262892|NCT01218100|593330296|FG002|Overall Study|Lack of Efficacy|5|||
164262893|NCT01218100|593330297|FG003|Overall Study|Lack of Efficacy|12|||
164262894|NCT01218100|593330294|FG000|Overall Study|Protocol Violation|0|||
164262895|NCT01218100|593330295|FG001|Overall Study|Protocol Violation|0|||
164262896|NCT01218100|593330296|FG002|Overall Study|Protocol Violation|1|||
164262897|NCT01218100|593330297|FG003|Overall Study|Protocol Violation|1|||
164262898|NCT01218100|593330294|FG000|Overall Study|Withdrawal by Subject|5|||
164262899|NCT01218100|593330295|FG001|Overall Study|Withdrawal by Subject|2|||
164262900|NCT01218100|593330296|FG002|Overall Study|Withdrawal by Subject|6|||
164262901|NCT01218100|593330297|FG003|Overall Study|Withdrawal by Subject|7|||
164262902|NCT01218100|593330294|FG000|Overall Study|Lost to Follow-up|3|||
164262903|NCT01218100|593330295|FG001|Overall Study|Lost to Follow-up|8|||
164262904|NCT01218100|593330296|FG002|Overall Study|Lost to Follow-up|2|||
164340845|NCT00739674|593623791|FG000|Overall Study|Adverse Event|22|||
164340846|NCT00739674|593623792|FG001|Overall Study|Adverse Event|13|||
164340847|NCT00739674|593623791|FG000|Overall Study|Death|1|||
164340848|NCT00739674|593623792|FG001|Overall Study|Death|0|||
164340849|NCT00739674|593623791|FG000|Overall Study|Lack of Efficacy|1|||
164340850|NCT00739674|593623792|FG001|Overall Study|Lack of Efficacy|0|||
164340851|NCT00739674|593623791|FG000|Overall Study|Lost to Follow-up|52|||
164340852|NCT00739674|593623792|FG001|Overall Study|Lost to Follow-up|30|||
164340853|NCT00739674|593623791|FG000|Overall Study|Protocol Violation|5|||
164340854|NCT00739674|593623792|FG001|Overall Study|Protocol Violation|5|||
164262905|NCT01218100|593330297|FG003|Overall Study|Lost to Follow-up|1|||
163888662|NCT05693935|591965154|FG001|Double-blind Period (8 Weeks)|Other Than Specified|5|||
163888663|NCT05693935|591965155|FG002|Double-blind Period (8 Weeks)|Other Than Specified|8|||
163888664|NCT05693935|591965156|FG003|Double-blind Period (8 Weeks)|Other Than Specified|7|||
164262906|NCT01218100|593330294|FG000|Overall Study|Other Reason|2|||
164262907|NCT01218100|593330295|FG001|Overall Study|Other Reason|2|||
164262908|NCT01218100|593330296|FG002|Overall Study|Other Reason|6|||
164262909|NCT01218100|593330297|FG003|Overall Study|Other Reason|4|||
164262910|NCT02437305|593330298|FG000|Overall Study|Lost to Follow-up|18|||
164262911|NCT02437305|593330299|FG001|Overall Study|Lost to Follow-up|12|||
164262912|NCT01118520|593330300|FG000|Overall Study|AAA repair|9|||
164262913|NCT01118520|593330301|FG001|Overall Study|AAA repair|7|||
164340855|NCT00739674|593623791|FG000|Overall Study|Withdrawal by Subject|9|||
164340856|NCT00739674|593623792|FG001|Overall Study|Withdrawal by Subject|9|||
164340857|NCT00739674|593623791|FG000|Overall Study|Reason missing|2|||
164340858|NCT00739674|593623792|FG001|Overall Study|Reason missing|0|||
163888665|NCT05693935|591965157|FG004|Double-blind Period (8 Weeks)|Other Than Specified|0|||
164262914|NCT01118520|593330302|FG002|Overall Study|AAA repair|9|||
164262915|NCT01118520|593330300|FG000|Overall Study|Adverse Event|3|||
164340859|NCT00739674|593623791|FG000|Overall Study|Clinic closed|6|||
164262916|NCT01118520|593330301|FG001|Overall Study|Adverse Event|3|||
164262917|NCT01118520|593330302|FG002|Overall Study|Adverse Event|3|||
164262918|NCT01118520|593330300|FG000|Overall Study|Withdrawal by Subject|8|||
164262919|NCT01118520|593330301|FG001|Overall Study|Withdrawal by Subject|13|||
164340860|NCT00739674|593623792|FG001|Overall Study|Clinic closed|4|||
164262920|NCT01118520|593330302|FG002|Overall Study|Withdrawal by Subject|8|||
164262921|NCT01170065|593330303|FG000|Overall Study|Adverse Event|17|||
164262922|NCT01170065|593330304|FG001|Overall Study|Adverse Event|50|||
164262923|NCT01170065|593330305|FG002|Overall Study|Adverse Event|10|||
164262924|NCT01170065|593330303|FG000|Overall Study|Lost to Follow-up|1|||
164262925|NCT01170065|593330304|FG001|Overall Study|Lost to Follow-up|4|||
164262926|NCT01170065|593330305|FG002|Overall Study|Lost to Follow-up|1|||
164262927|NCT01170065|593330303|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
164262928|NCT01170065|593330304|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
164262929|NCT01170065|593330305|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
164262930|NCT01170065|593330303|FG000|Overall Study|Reason other than specified|3|||
164262931|NCT01170065|593330304|FG001|Overall Study|Reason other than specified|8|||
164262932|NCT01170065|593330305|FG002|Overall Study|Reason other than specified|3|||
164262933|NCT01170065|593330303|FG000|Overall Study|Ongoing after planned observation time|5|||
164262934|NCT01170065|593330304|FG001|Overall Study|Ongoing after planned observation time|26|||
164262935|NCT01170065|593330305|FG002|Overall Study|Ongoing after planned observation time|10|||
164262936|NCT03220581|593330306|FG000|Overall Study|Withdrawal by Subject|0|||
164262937|NCT03220581|593330307|FG001|Overall Study|Withdrawal by Subject|1|||
164262938|NCT03220581|593330306|FG000|Overall Study|Lost to Follow-up|3|||
164262939|NCT03220581|593330307|FG001|Overall Study|Lost to Follow-up|6|||
164262940|NCT01071200|593330308|FG000|Overall Study|Lack of ovarian response|1|||
164262941|NCT01071200|593330309|FG001|Overall Study|Lack of ovarian response|1|||
164262942|NCT01071200|593330308|FG000|Overall Study|No fertilization|4|||
164262943|NCT01071200|593330309|FG001|Overall Study|No fertilization|0|||
164262944|NCT01071200|593330308|FG000|Overall Study|No oocytes retrieved|1|||
164262945|NCT01071200|593330309|FG001|Overall Study|No oocytes retrieved|1|||
164262946|NCT01071200|593330308|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
164262947|NCT01071200|593330309|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
164262948|NCT01071200|593330308|FG000|Overall Study|No viable embryos|0|||
164262949|NCT01071200|593330309|FG001|Overall Study|No viable embryos|1|||
164262950|NCT01920893|593330312|FG000|Overall Study|Adverse Event|5|||
164262951|NCT01920893|593330313|FG001|Overall Study|Adverse Event|2|||
164262952|NCT01920893|593330312|FG000|Overall Study|Lack of Efficacy|2|||
164262953|NCT01920893|593330313|FG001|Overall Study|Lack of Efficacy|0|||
164262954|NCT01396265|593330314|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
164262955|NCT01767493|593330315|FG000|Overall Study|screen failures|3|||
164262956|NCT02446418|593330316|FG000|Overall Study|Adverse Event|4|||
164262957|NCT02446418|593330317|FG001|Overall Study|Adverse Event|8|||
164262958|NCT02446418|593330316|FG000|Overall Study|Physician Decision|5|||
164262959|NCT02446418|593330317|FG001|Overall Study|Physician Decision|1|||
164262960|NCT02446418|593330316|FG000|Overall Study|Withdrawal by Subject|3|||
164262961|NCT02446418|593330317|FG001|Overall Study|Withdrawal by Subject|3|||
164262962|NCT02446418|593330316|FG000|Overall Study|Lost to Follow-up|2|||
164262963|NCT02446418|593330317|FG001|Overall Study|Lost to Follow-up|2|||
164262964|NCT02446418|593330316|FG000|Overall Study|Protocol Violation|1|||
164262965|NCT02446418|593330317|FG001|Overall Study|Protocol Violation|2|||
164262966|NCT02446418|593330316|FG000|Overall Study|Lack of Efficacy|2|||
164262967|NCT02446418|593330317|FG001|Overall Study|Lack of Efficacy|0|||
164262968|NCT02446418|593330316|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
164262969|NCT02446418|593330317|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
164262970|NCT01286987|593330318|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
164262971|NCT01286987|593330319|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
164262972|NCT01286987|593330320|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
164262973|NCT01286987|593330321|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
163993559|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164262974|NCT01286987|593330322|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
164262975|NCT01286987|593330323|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
164262976|NCT01286987|593330324|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
164262977|NCT01286987|593330325|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
164262978|NCT01286987|593330326|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
164262979|NCT01286987|593330327|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
164262980|NCT01286987|593330328|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
164262981|NCT01286987|593330329|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
164262982|NCT01286987|593330330|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
164262983|NCT01286987|593330331|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
163993560|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164262984|NCT01286987|593330332|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
164262985|NCT01286987|593330318|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
164262986|NCT01286987|593330319|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
164262987|NCT01286987|593330320|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
164262988|NCT01286987|593330321|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
164262989|NCT01286987|593330322|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
164340861|NCT00739674|593623791|FG000|Overall Study|Patient moved|3|||
164085362|NCT00449072|592677222|FG000|Overall Study|Excluded medication|0|||
164262990|NCT01286987|593330323|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
164262991|NCT01286987|593330324|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
164262992|NCT01286987|593330325|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
164262993|NCT01286987|593330326|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
164262994|NCT01286987|593330327|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
164262995|NCT01286987|593330328|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
164262996|NCT01286987|593330329|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
164262997|NCT01286987|593330330|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
164262998|NCT01286987|593330331|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
164262999|NCT01286987|593330332|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
164263000|NCT01286987|593330318|FG000|Part 1: Dose Escalation|Physician Decision|0|||
164263001|NCT01286987|593330319|FG001|Part 1: Dose Escalation|Physician Decision|0|||
164263002|NCT01286987|593330320|FG002|Part 1: Dose Escalation|Physician Decision|0|||
164263003|NCT01286987|593330321|FG003|Part 1: Dose Escalation|Physician Decision|0|||
164263004|NCT01286987|593330322|FG004|Part 1: Dose Escalation|Physician Decision|1|||
164263005|NCT01286987|593330323|FG005|Part 1: Dose Escalation|Physician Decision|0|||
164263006|NCT01286987|593330324|FG006|Part 1: Dose Escalation|Physician Decision|0|||
164263007|NCT01286987|593330325|FG007|Part 1: Dose Escalation|Physician Decision|0|||
164263008|NCT01286987|593330326|FG008|Part 1: Dose Escalation|Physician Decision|0|||
164263009|NCT01286987|593330327|FG009|Part 1: Dose Escalation|Physician Decision|0|||
164263010|NCT01286987|593330328|FG010|Part 1: Dose Escalation|Physician Decision|0|||
164263011|NCT01286987|593330329|FG011|Part 1: Dose Escalation|Physician Decision|0|||
164263012|NCT01286987|593330330|FG012|Part 1: Dose Escalation|Physician Decision|0|||
164263013|NCT01286987|593330331|FG013|Part 1: Dose Escalation|Physician Decision|0|||
164263014|NCT01286987|593330332|FG014|Part 1: Dose Escalation|Physician Decision|0|||
164263015|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Death|0|||
164263016|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Death|0|||
164263017|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Death|0|||
164263018|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Death|0|||
164263019|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Death|0|||
164263020|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Death|0|||
164263021|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Death|0|||
164263022|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Death|0|||
164263023|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Death|0|||
164263024|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Death|0|||
164263025|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Death|0|||
164263026|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Death|0|||
164263027|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Death|1|||
164263028|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Death|1|||
164263029|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Death|0|||
164263030|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Physician Decision|0|||
164263031|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Physician Decision|0|||
164263032|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Physician Decision|0|||
164263033|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Physician Decision|0|||
164263034|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Physician Decision|0|||
164263035|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Physician Decision|0|||
164263036|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Physician Decision|0|||
164263037|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Physician Decision|0|||
164263038|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Physician Decision|0|||
164263039|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Physician Decision|0|||
164263040|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Physician Decision|1|||
164263041|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Physician Decision|1|||
164263042|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Physician Decision|0|||
164263043|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Physician Decision|1|||
164263044|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Physician Decision|0|||
164263045|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Other|0|||
164263046|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Other|0|||
164263047|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Other|0|||
164263048|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Other|0|||
164263049|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Other|0|||
164263050|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Other|0|||
164263051|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Other|0|||
164263052|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Other|0|||
164263053|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Other|0|||
164263054|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Other|0|||
164263055|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Other|0|||
164263056|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Other|0|||
164263057|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Other|0|||
164263058|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Other|1|||
164263059|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Other|0|||
164263060|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
164263061|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
164263062|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
164263063|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
164263064|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
164263065|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
164263066|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
164263067|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
164263068|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
164263069|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
164263070|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
164263071|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
164263072|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
164263073|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
164263074|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
164263075|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
164263076|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
164263077|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
164263078|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
164263079|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
164263080|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
164263081|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
164263082|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
164263083|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
164263084|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
164263085|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
164263086|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
164263087|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
164263088|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
164263089|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
164263090|NCT01286987|593330318|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263091|NCT01286987|593330319|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263092|NCT01286987|593330320|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263093|NCT01286987|593330321|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263094|NCT01286987|593330322|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263095|NCT01286987|593330323|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263096|NCT01286987|593330324|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263097|NCT01286987|593330325|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263098|NCT01286987|593330326|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263099|NCT01286987|593330327|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263100|NCT01286987|593330328|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
164263101|NCT01286987|593330329|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263102|NCT01286987|593330330|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263103|NCT01286987|593330331|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263104|NCT01286987|593330332|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
164263105|NCT03093974|593330337|FG000|Overall Study|Withdrawal by Subject|32|||
164263106|NCT03093974|593330338|FG001|Overall Study|Withdrawal by Subject|27|||
164263107|NCT03093974|593330337|FG000|Overall Study|Adverse Event|17|||
164263108|NCT03093974|593330338|FG001|Overall Study|Adverse Event|24|||
164263109|NCT03093974|593330337|FG000|Overall Study|Death|0|||
164263110|NCT03093974|593330338|FG001|Overall Study|Death|1|||
164263111|NCT03093974|593330337|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164263112|NCT03093974|593330338|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164263113|NCT03093974|593330337|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
164263114|NCT03093974|593330338|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
164263115|NCT03093974|593330337|FG000|Overall Study|Lost to Follow-up|0|||
164263116|NCT03093974|593330338|FG001|Overall Study|Lost to Follow-up|1|||
164263117|NCT03093974|593330337|FG000|Overall Study|Other|1|||
164263118|NCT03093974|593330338|FG001|Overall Study|Other|2|||
164263119|NCT01009346|593330343|FG000|Overall Study|Adverse Event|4|||
164263120|NCT00033540|593330344|FG000|Overall Study|Adverse Event|14|||
164263121|NCT00033540|593330344|FG000|Overall Study|Death|1|||
164263122|NCT00033540|593330344|FG000|Overall Study|Progression|26|||
164263123|NCT00033540|593330344|FG000|Overall Study|Withdrawal by Subject|6|||
163888666|NCT05693935|591965158|FG005|Double-blind Period (8 Weeks)|Other Than Specified|0|||
163888667|NCT05693935|591965159|FG006|Double-blind Period (8 Weeks)|Other Than Specified|0|||
163888668|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Adverse Event|0|||
163888669|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Adverse Event|5|||
163888670|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Adverse Event|6|||
164085363|NCT00449072|592677223|FG001|Overall Study|Excluded medication|2|||
164263124|NCT00033540|593330344|FG000|Overall Study|Other|5|||
164263125|NCT00033540|593330344|FG000|Overall Study|Ineligible|3|||
164263126|NCT00033540|593330344|FG000|Overall Study|Never received treatment|2|||
164263127|NCT01253265|593330347|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
164263128|NCT01253265|593330348|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263129|NCT01253265|593330349|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263130|NCT01253265|593330350|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263131|NCT01253265|593330351|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
164263132|NCT01253265|593330347|FG000|Overall Study|Withdrawal by Subject|0|||
164263133|NCT01253265|593330348|FG001|Overall Study|Withdrawal by Subject|0|||
164263134|NCT01253265|593330349|FG002|Overall Study|Withdrawal by Subject|0|||
164263135|NCT01253265|593330350|FG003|Overall Study|Withdrawal by Subject|0|||
164263136|NCT01253265|593330351|FG004|Overall Study|Withdrawal by Subject|1|||
164263137|NCT00066469|593330354|FG000|Overall Study|Death|3|||
164263138|NCT00066469|593330354|FG000|Overall Study|Lack of Efficacy|9|||
164263139|NCT00066469|593330354|FG000|Overall Study|Lost to Follow-up|1|||
164263140|NCT00066469|593330354|FG000|Overall Study|Physician Decision|1|||
164263141|NCT00066469|593330354|FG000|Overall Study|Withdrawal by Subject|1|||
164263142|NCT00066469|593330354|FG000|Overall Study|ineligible|1|||
164263143|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Death|8|||
164263144|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Death|8|||
164263145|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Death|0|||
164263146|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Death|0|||
164263147|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
164263148|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
164263149|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
164263150|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
164263151|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
164263152|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
164263153|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
164263154|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
164263155|NCT03271047|593330355|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
164263156|NCT03271047|593330356|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
164263157|NCT03271047|593330357|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
164263158|NCT03271047|593330358|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
164263159|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Other|0|||
164263160|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Other|0|||
164263161|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Other|0|||
164263162|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Other|1|||
164263163|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Death|0|||
164263164|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Death|0|||
164263165|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Death|20|||
164263166|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Death|21|||
164263167|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
164263168|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
164263169|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
164263170|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
164263171|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
164263172|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
164263173|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
164263174|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
164263175|NCT03271047|593330355|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
164263176|NCT03271047|593330356|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
164263177|NCT03271047|593330357|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
164263178|NCT03271047|593330358|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
164263179|NCT00711802|593330359|FG000|Overall Study|Not treated (no further detail)|2|||
164263180|NCT00711802|593330360|FG001|Overall Study|Not treated (no further detail)|1|||
164263181|NCT00711802|593330361|FG002|Overall Study|Not treated (no further detail)|2|||
164263182|NCT00711802|593330362|FG003|Overall Study|Not treated (no further detail)|0|||
164263183|NCT00711802|593330363|FG004|Overall Study|Not treated (no further detail)|2|||
164263184|NCT00711802|593330364|FG005|Overall Study|Not treated (no further detail)|0|||
163993561|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163993562|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
163993563|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
163993564|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
163993565|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
164263185|NCT00711802|593330365|FG006|Overall Study|Not treated (no further detail)|0|||
164263186|NCT00711802|593330366|FG007|Overall Study|Not treated (no further detail)|0|||
164263187|NCT00711802|593330359|FG000|Overall Study|Adverse Event|0|||
164263188|NCT00711802|593330360|FG001|Overall Study|Adverse Event|0|||
164263189|NCT00711802|593330361|FG002|Overall Study|Adverse Event|0|||
164263190|NCT00711802|593330362|FG003|Overall Study|Adverse Event|0|||
164263191|NCT00711802|593330363|FG004|Overall Study|Adverse Event|1|||
164263192|NCT00711802|593330364|FG005|Overall Study|Adverse Event|1|||
164263193|NCT00711802|593330365|FG006|Overall Study|Adverse Event|0|||
164263194|NCT00711802|593330366|FG007|Overall Study|Adverse Event|0|||
164263195|NCT00711802|593330359|FG000|Overall Study|Microbiological failure|0|||
164263196|NCT00711802|593330360|FG001|Overall Study|Microbiological failure|1|||
164263197|NCT00711802|593330361|FG002|Overall Study|Microbiological failure|0|||
164263198|NCT00711802|593330362|FG003|Overall Study|Microbiological failure|0|||
164263199|NCT00711802|593330363|FG004|Overall Study|Microbiological failure|0|||
164263200|NCT00711802|593330364|FG005|Overall Study|Microbiological failure|1|||
164263201|NCT00711802|593330365|FG006|Overall Study|Microbiological failure|0|||
164263202|NCT00711802|593330366|FG007|Overall Study|Microbiological failure|0|||
164263203|NCT00711802|593330359|FG000|Overall Study|Protocol Violation|0|||
164263204|NCT00711802|593330360|FG001|Overall Study|Protocol Violation|0|||
164263205|NCT00711802|593330361|FG002|Overall Study|Protocol Violation|0|||
164263206|NCT00711802|593330362|FG003|Overall Study|Protocol Violation|1|||
164263207|NCT00711802|593330363|FG004|Overall Study|Protocol Violation|0|||
164263208|NCT00711802|593330364|FG005|Overall Study|Protocol Violation|0|||
164263209|NCT00711802|593330365|FG006|Overall Study|Protocol Violation|0|||
164263210|NCT00711802|593330366|FG007|Overall Study|Protocol Violation|0|||
164263211|NCT00711802|593330359|FG000|Overall Study|Physician Decision|0|||
164263212|NCT00711802|593330360|FG001|Overall Study|Physician Decision|2|||
164263213|NCT00711802|593330361|FG002|Overall Study|Physician Decision|0|||
164263214|NCT00711802|593330362|FG003|Overall Study|Physician Decision|0|||
164263215|NCT00711802|593330363|FG004|Overall Study|Physician Decision|0|||
164263216|NCT00711802|593330364|FG005|Overall Study|Physician Decision|0|||
164263217|NCT00711802|593330365|FG006|Overall Study|Physician Decision|0|||
164263218|NCT00711802|593330366|FG007|Overall Study|Physician Decision|0|||
164263219|NCT00711802|593330359|FG000|Overall Study|Withdrawal by Subject|0|||
164263220|NCT00711802|593330360|FG001|Overall Study|Withdrawal by Subject|1|||
164263221|NCT00711802|593330361|FG002|Overall Study|Withdrawal by Subject|0|||
164263222|NCT00711802|593330362|FG003|Overall Study|Withdrawal by Subject|1|||
164263223|NCT00711802|593330363|FG004|Overall Study|Withdrawal by Subject|0|||
164263224|NCT00711802|593330364|FG005|Overall Study|Withdrawal by Subject|0|||
164263225|NCT00711802|593330365|FG006|Overall Study|Withdrawal by Subject|0|||
164263226|NCT00711802|593330366|FG007|Overall Study|Withdrawal by Subject|0|||
164263227|NCT00711802|593330359|FG000|Overall Study|Lost to Follow-up|0|||
164263228|NCT00711802|593330360|FG001|Overall Study|Lost to Follow-up|0|||
164263229|NCT00711802|593330361|FG002|Overall Study|Lost to Follow-up|3|||
164263230|NCT00711802|593330362|FG003|Overall Study|Lost to Follow-up|1|||
164263231|NCT00711802|593330363|FG004|Overall Study|Lost to Follow-up|10|||
164263232|NCT00711802|593330364|FG005|Overall Study|Lost to Follow-up|6|||
164263233|NCT00711802|593330365|FG006|Overall Study|Lost to Follow-up|4|||
164263234|NCT00711802|593330366|FG007|Overall Study|Lost to Follow-up|2|||
164263235|NCT00711802|593330359|FG000|Overall Study|Reason not reported|0|||
164263236|NCT00711802|593330360|FG001|Overall Study|Reason not reported|1|||
164263237|NCT00711802|593330361|FG002|Overall Study|Reason not reported|1|||
164263238|NCT00711802|593330362|FG003|Overall Study|Reason not reported|0|||
164263239|NCT00711802|593330363|FG004|Overall Study|Reason not reported|1|||
164263240|NCT00711802|593330364|FG005|Overall Study|Reason not reported|0|||
164263241|NCT00711802|593330365|FG006|Overall Study|Reason not reported|1|||
164263242|NCT00711802|593330366|FG007|Overall Study|Reason not reported|0|||
164263243|NCT00882908|593330368|FG000|Overall Study|Adverse Event|0|||
164263244|NCT00882908|593330369|FG001|Overall Study|Adverse Event|0|||
164263245|NCT00882908|593330370|FG002|Overall Study|Adverse Event|1|||
164263246|NCT00882908|593330371|FG003|Overall Study|Adverse Event|0|||
164263247|NCT00882908|593330372|FG004|Overall Study|Adverse Event|1|||
164263248|NCT00882908|593330368|FG000|Overall Study|Lost to Follow-up|3|||
164263249|NCT00882908|593330369|FG001|Overall Study|Lost to Follow-up|5|||
164263250|NCT00882908|593330370|FG002|Overall Study|Lost to Follow-up|3|||
164263251|NCT00882908|593330371|FG003|Overall Study|Lost to Follow-up|1|||
164263252|NCT00882908|593330372|FG004|Overall Study|Lost to Follow-up|2|||
164263253|NCT00882908|593330368|FG000|Overall Study|Protocol Violation|0|||
164263254|NCT00882908|593330369|FG001|Overall Study|Protocol Violation|1|||
164263255|NCT00882908|593330370|FG002|Overall Study|Protocol Violation|0|||
164263256|NCT00882908|593330371|FG003|Overall Study|Protocol Violation|0|||
164263257|NCT00882908|593330372|FG004|Overall Study|Protocol Violation|0|||
164263258|NCT00882908|593330368|FG000|Overall Study|Withdrawal by Subject|0|||
164263259|NCT00882908|593330369|FG001|Overall Study|Withdrawal by Subject|0|||
164263260|NCT00882908|593330370|FG002|Overall Study|Withdrawal by Subject|3|||
164263261|NCT00882908|593330371|FG003|Overall Study|Withdrawal by Subject|5|||
164263262|NCT00882908|593330372|FG004|Overall Study|Withdrawal by Subject|2|||
164263263|NCT00882908|593330368|FG000|Overall Study|Subject reached a virologic endpoint|0|||
164263264|NCT00882908|593330369|FG001|Overall Study|Subject reached a virologic endpoint|0|||
164263265|NCT00882908|593330370|FG002|Overall Study|Subject reached a virologic endpoint|0|||
164263266|NCT00882908|593330371|FG003|Overall Study|Subject reached a virologic endpoint|0|||
164263267|NCT00882908|593330372|FG004|Overall Study|Subject reached a virologic endpoint|1|||
164340862|NCT00739674|593623792|FG001|Overall Study|Patient moved|2|||
164263268|NCT00882908|593330368|FG000|Overall Study|Study terminated in error|0|||
164263269|NCT00882908|593330369|FG001|Overall Study|Study terminated in error|0|||
164263270|NCT00882908|593330370|FG002|Overall Study|Study terminated in error|0|||
164263271|NCT00882908|593330371|FG003|Overall Study|Study terminated in error|1|||
164263272|NCT00882908|593330372|FG004|Overall Study|Study terminated in error|0|||
164263273|NCT03283150|593330373|FG000|Overall Study|Withdrawal by Subject|6|||
164263274|NCT03283150|593330374|FG001|Overall Study|Withdrawal by Subject|0|||
164263275|NCT03283150|593330375|FG002|Overall Study|Withdrawal by Subject|0|||
164263276|NCT00581828|593330376|FG000|Overall Study|Protocol Violation|1|||
164263277|NCT02981407|593330377|FG000|Overall Study|Withdrawal by Subject|2|||
164263278|NCT02981407|593330378|FG001|Overall Study|Withdrawal by Subject|0|||
164263279|NCT02410824|593330381|FG000|First Intervention (One Week)|Headache|0|||
164263280|NCT02410824|593330382|FG001|First Intervention (One Week)|Headache|1|||
164263281|NCT02436408|593330383|FG000|Overall Study|Death|1|||
164263282|NCT00392808|593330384|FG000|Overall Study|Lost to Follow-up|3|||
164263283|NCT00392808|593330385|FG001|Overall Study|Lost to Follow-up|2|||
164263284|NCT00392808|593330386|FG002|Overall Study|Lost to Follow-up|1|||
164263285|NCT00392808|593330387|FG003|Overall Study|Lost to Follow-up|2|||
164263286|NCT00392808|593330384|FG000|Overall Study|Unable to withdraw blood|3|||
164263287|NCT00392808|593330385|FG001|Overall Study|Unable to withdraw blood|1|||
164263288|NCT00392808|593330386|FG002|Overall Study|Unable to withdraw blood|1|||
164263289|NCT00392808|593330387|FG003|Overall Study|Unable to withdraw blood|2|||
164263290|NCT02084238|593330388|FG000|Overall Study|Lost to Follow-up|2|||
164263291|NCT02818036|593330389|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
164263292|NCT02818036|593330390|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
164263293|NCT02818036|593330389|FG000|Overall Study|Withdrawal by Subject|1|||
164263294|NCT02818036|593330390|FG001|Overall Study|Withdrawal by Subject|0|||
164263295|NCT01038713|593330391|FG000|Overall Study|Patient to hospice|1|||
164263296|NCT01038713|593330392|FG001|Overall Study|Patient to hospice|1|||
164263297|NCT01038713|593330393|FG002|Overall Study|Patient to hospice|1|||
164263298|NCT01038713|593330391|FG000|Overall Study|Lost to Follow-up|3|||
164263299|NCT01038713|593330392|FG001|Overall Study|Lost to Follow-up|0|||
164263300|NCT01038713|593330393|FG002|Overall Study|Lost to Follow-up|0|||
164263301|NCT01038713|593330391|FG000|Overall Study|Neuroendocrine Tumor|0|||
164263302|NCT01038713|593330392|FG001|Overall Study|Neuroendocrine Tumor|1|||
164263303|NCT01038713|593330393|FG002|Overall Study|Neuroendocrine Tumor|0|||
164263304|NCT01038713|593330391|FG000|Overall Study|died from PEP|0|||
164263305|NCT01038713|593330392|FG001|Overall Study|died from PEP|1|||
164263306|NCT01038713|593330393|FG002|Overall Study|died from PEP|0|||
164263307|NCT01038713|593330391|FG000|Overall Study|Autoimmune Pancreatitis|1|||
164263308|NCT01038713|593330392|FG001|Overall Study|Autoimmune Pancreatitis|0|||
164263309|NCT01038713|593330393|FG002|Overall Study|Autoimmune Pancreatitis|0|||
164263310|NCT03777917|593330394|FG000|Overall Study|Withdrawal by Subject|1|||
164263311|NCT03777917|593330395|FG001|Overall Study|Withdrawal by Subject|0|||
164263312|NCT03777917|593330394|FG000|Overall Study|Physician Decision|1|||
164263313|NCT03777917|593330395|FG001|Overall Study|Physician Decision|0|||
164263314|NCT03777917|593330394|FG000|Overall Study|Lost to Follow-up|6|||
164263315|NCT03777917|593330395|FG001|Overall Study|Lost to Follow-up|2|||
164263316|NCT03777917|593330394|FG000|Overall Study|Other|1|||
164263317|NCT03777917|593330395|FG001|Overall Study|Other|0|||
164263318|NCT01154283|593330396|FG000|0-6 Weeks|Withdrawal by Subject|7|||
164263319|NCT01154283|593330397|FG001|0-6 Weeks|Withdrawal by Subject|2|||
164263320|NCT01154283|593330396|FG000|0-6 Weeks|Death|0|||
164263321|NCT01154283|593330397|FG001|0-6 Weeks|Death|1|||
164263322|NCT01154283|593330396|FG000|7-12 Weeks|Death|1|||
164263323|NCT01154283|593330397|FG001|7-12 Weeks|Death|0|||
164263324|NCT01154283|593330396|FG000|7-12 Weeks|Withdrawal by Subject|0|||
164263325|NCT01154283|593330397|FG001|7-12 Weeks|Withdrawal by Subject|1|||
164263326|NCT04063787|593330398|FG000|Overall Study|Inadequate Doppler data|4|||
164263327|NCT04063787|593330398|FG000|Overall Study|Lost to Follow-up|2|||
164263328|NCT04063787|593330398|FG000|Overall Study|Death|3|||
164263329|NCT00320372|593330399|FG000|Overall Study|Physician Decision|4|||
164263330|NCT00320372|593330400|FG001|Overall Study|Physician Decision|7|||
164263331|NCT00320372|593330399|FG000|Overall Study|Death|7|||
164263332|NCT00320372|593330400|FG001|Overall Study|Death|8|||
164263333|NCT00320372|593330399|FG000|Overall Study|Withdrawal by Subject|55|||
164263334|NCT00320372|593330400|FG001|Overall Study|Withdrawal by Subject|37|||
164340863|NCT00739674|593623791|FG000|Overall Study|Non compliant|4|||
164340864|NCT00739674|593623792|FG001|Overall Study|Non compliant|0|||
164340865|NCT00739674|593623791|FG000|Overall Study|Unable to attend visit|3|||
164340866|NCT00739674|593623792|FG001|Overall Study|Unable to attend visit|1|||
164340867|NCT00739674|593623791|FG000|Overall Study|Home monitoring off meds|1|||
164340868|NCT00739674|593623792|FG001|Overall Study|Home monitoring off meds|0|||
164340869|NCT00739674|593623791|FG000|Overall Study|Erectile dysfunction|0|||
164263335|NCT00320372|593330399|FG000|Overall Study|Non-Compliance|40|||
164263336|NCT00320372|593330400|FG001|Overall Study|Non-Compliance|39|||
164263337|NCT00320372|593330399|FG000|Overall Study|Did not Meet (I/E)|3|||
164263338|NCT00320372|593330400|FG001|Overall Study|Did not Meet (I/E)|1|||
164340870|NCT00739674|593623792|FG001|Overall Study|Erectile dysfunction|1|||
164263339|NCT00320372|593330399|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
164263340|NCT00320372|593330400|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
164263341|NCT01416441|593330401|FG000|Overall Study|Lost to Follow-up|5|||
164263342|NCT01416441|593330401|FG000|Overall Study|Adverse Event|6|||
164263343|NCT01416441|593330401|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
164340871|NCT01897454|593623794|FG000|Overall Study|Withdrawal by Subject|1|||
164263344|NCT01416441|593330401|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
164263345|NCT01416441|593330401|FG000|Overall Study|Investigator Withdrew Subject|2|||
164263346|NCT01416441|593330401|FG000|Overall Study|Subject Withdrew Consent|12|||
164263347|NCT01416441|593330401|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
164263348|NCT03959982|593331776|FG000|Overall Study|Withdrawal by Subject|1|||
164263349|NCT03959982|593331777|FG001|Overall Study|Withdrawal by Subject|0|||
164263350|NCT03959982|593331776|FG000|Overall Study|Physician Decision|2|||
164263351|NCT03959982|593331777|FG001|Overall Study|Physician Decision|0|||
164263352|NCT03959982|593331776|FG000|Overall Study|Lost to Follow-up|1|||
164263353|NCT03959982|593331777|FG001|Overall Study|Lost to Follow-up|0|||
164263354|NCT04030247|593331778|FG000|Overall Study|Withdrawal by Subject|4|||
164263355|NCT04030247|593331778|FG000|Overall Study|Lost to Follow-up|13|||
164263356|NCT02191605|593331779|FG000|Overall Study|Lost to Follow-up|9|||
164263357|NCT02191605|593331780|FG001|Overall Study|Lost to Follow-up|4|||
164263358|NCT02191605|593331781|FG002|Overall Study|Lost to Follow-up|7|||
164263359|NCT02191605|593331782|FG003|Overall Study|Lost to Follow-up|3|||
164263360|NCT02191605|593331783|FG004|Overall Study|Lost to Follow-up|4|||
164263361|NCT01309269|593331786|FG000|Overall Study|Adverse Event|56|||
164263362|NCT01309269|593331786|FG000|Overall Study|Withdrawal by Subject|25|||
164263363|NCT01309269|593331786|FG000|Overall Study|Lack of Acceptance|15|||
164263364|NCT01309269|593331786|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
164263365|NCT01309269|593331786|FG000|Overall Study|Kidney Transplant|25|||
164263366|NCT01309269|593331786|FG000|Overall Study|Administrative Problems|141|||
164263367|NCT01309269|593331786|FG000|Overall Study|Other|256|||
164263368|NCT01309269|593331786|FG000|Overall Study|Other|1|||
164263369|NCT01309269|593331786|FG000|Overall Study|Study Completion Data Not Recorded|95|||
164263370|NCT01309269|593331786|FG000|Overall Study|Enrolled but not Treated|107|||
164263371|NCT03647267|593331803|FG000|Overall Study|Lost to Follow-up|1|||
164263372|NCT03647267|593331804|FG001|Overall Study|Lost to Follow-up|0|||
164263373|NCT05079477|593331805|FG000|Overall Study|Lost to Follow-up|2|||
164263374|NCT05079477|593331806|FG001|Overall Study|Lost to Follow-up|0|||
164263375|NCT05079477|593331805|FG000|Overall Study|Withdrawal by Subject|1|||
164263376|NCT05079477|593331806|FG001|Overall Study|Withdrawal by Subject|0|||
164263377|NCT05079477|593331805|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
164263378|NCT05079477|593331806|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
164263379|NCT05079477|593331805|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
164263380|NCT05079477|593331806|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
164263381|NCT05320393|593331809|FG000|Overall Study|Withdrawal by Subject|1|||
164263382|NCT05320393|593331810|FG001|Overall Study|Withdrawal by Subject|0|||
164263383|NCT05320393|593331811|FG002|Overall Study|Withdrawal by Subject|2|||
164263384|NCT05320393|593331809|FG000|Overall Study|Lost to Follow-up|1|||
164263385|NCT05320393|593331810|FG001|Overall Study|Lost to Follow-up|2|||
164263386|NCT05320393|593331811|FG002|Overall Study|Lost to Follow-up|1|||
164263387|NCT05320393|593331809|FG000|Overall Study|Moved; too much driving|0|||
164263388|NCT05320393|593331810|FG001|Overall Study|Moved; too much driving|0|||
164263389|NCT05320393|593331811|FG002|Overall Study|Moved; too much driving|2|||
164263390|NCT05320393|593331809|FG000|Overall Study|Did not receive treatment|0|||
164263391|NCT05320393|593331810|FG001|Overall Study|Did not receive treatment|0|||
164263392|NCT05320393|593331811|FG002|Overall Study|Did not receive treatment|1|||
164263393|NCT04411420|593331813|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
164263394|NCT04411420|593331814|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
164263395|NCT04411420|593331813|FG000|Survey Subset|Lost to Follow-up|134|||
164263396|NCT04411420|593331814|FG001|Survey Subset|Lost to Follow-up|120|||
164263397|NCT03187834|593331815|FG000|Overall Study|Lost to Follow-up|0|||
164263398|NCT03187834|593331816|FG001|Overall Study|Lost to Follow-up|1|||
164263399|NCT03187834|593331817|FG002|Overall Study|Lost to Follow-up|2|||
164263400|NCT03187834|593331818|FG003|Overall Study|Lost to Follow-up|2|||
164263401|NCT03187834|593331815|FG000|Overall Study|Had invalid anthropometric measurements|5|||
164263402|NCT03187834|593331816|FG001|Overall Study|Had invalid anthropometric measurements|3|||
164263403|NCT03187834|593331817|FG002|Overall Study|Had invalid anthropometric measurements|4|||
164263404|NCT03187834|593331818|FG003|Overall Study|Had invalid anthropometric measurements|2|||
164263405|NCT00240110|593331819|FG000|Overall Study|Lost to Follow-up|6|||
164263406|NCT00240110|593331820|FG001|Overall Study|Lost to Follow-up|7|||
164263407|NCT01344538|593331822|FG000|Overall Study|Adverse Event|1|||
164263408|NCT01344538|593331823|FG001|Overall Study|Adverse Event|1|||
164263409|NCT01344538|593331822|FG000|Overall Study|Lost to Follow-up|1|||
164263410|NCT01344538|593331823|FG001|Overall Study|Lost to Follow-up|0|||
164263411|NCT01655381|593331824|FG000|Overall Study|Investigator Decision|1|||
163888671|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Adverse Event|14|||
163888672|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Adverse Event|4|||
164263412|NCT01655381|593331824|FG000|Overall Study|Moved to Another City|1|||
164340872|NCT02195583|593623796|FG000|Overall Study|Lost to Follow-up|1|||
164263413|NCT01655381|593331824|FG000|Overall Study|Insufficient Treatment Response|1|||
164263414|NCT04195438|593331825|FG000|Overall Study|Withdrawal by Subject|1|||
164263415|NCT00613925|593331826|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
164263416|NCT00613925|593331827|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
164263417|NCT01156389|593331830|FG000|Overall Study|Elevated liver enzymes|4|||
164263418|NCT01156389|593331831|FG001|Overall Study|Elevated liver enzymes|0|||
164263419|NCT01156389|593331830|FG000|Overall Study|Vomiting|0|||
164263420|NCT01156389|593331831|FG001|Overall Study|Vomiting|1|||
164263421|NCT01703117|593331832|FG000|Overall Study|Adverse Event|4|||
164263422|NCT01703117|593331833|FG001|Overall Study|Adverse Event|3|||
164263423|NCT01703117|593331832|FG000|Overall Study|Withdrawal by Subject|0|||
164263424|NCT01703117|593331833|FG001|Overall Study|Withdrawal by Subject|1|||
164263425|NCT00350623|593331834|FG000|Overall Study|Lost to Follow-up|8|||
164263426|NCT00350623|593331835|FG001|Overall Study|Lost to Follow-up|3|||
164263427|NCT00350623|593331836|FG002|Overall Study|Lost to Follow-up|4|||
164263428|NCT00350623|593331834|FG000|Overall Study|Withdrawal by Subject|0|||
164263429|NCT00350623|593331835|FG001|Overall Study|Withdrawal by Subject|1|||
164263430|NCT00350623|593331836|FG002|Overall Study|Withdrawal by Subject|1|||
164263431|NCT00350623|593331834|FG000|Overall Study|patient traveling outside the country|0|||
164263432|NCT00350623|593331835|FG001|Overall Study|patient traveling outside the country|0|||
164263433|NCT00350623|593331836|FG002|Overall Study|patient traveling outside the country|1|||
164340873|NCT02195583|593623796|FG000|Overall Study|Withdrawal by Subject|4|||
164340874|NCT02195583|593623796|FG000|Overall Study|Adverse Event|2|||
164340875|NCT02195583|593623796|FG000|Overall Study|Other Reason|2|||
164340876|NCT01560403|593623797|FG000|Overall Study|Lost to Follow-up|0|||
164340877|NCT01560403|593623798|FG001|Overall Study|Lost to Follow-up|1|||
164340878|NCT00983437|593623800|FG000|Overall Study|Adverse Event|9|||
164340879|NCT00983437|593623800|FG000|Overall Study|Lack of Efficacy|1|||
164340880|NCT00983437|593623800|FG000|Overall Study|Withdrawal by Subject|8|||
164340881|NCT00983437|593623800|FG000|Overall Study|Noncompliance to Study Procedures|1|||
164340882|NCT00983437|593623800|FG000|Overall Study|Lost to Follow-up|2|||
164340883|NCT00983437|593623800|FG000|Overall Study|Other Reason|26|||
164340884|NCT04019288|593623801|FG000|Overall Study|Death|1|||
164340885|NCT04019288|593623802|FG001|Overall Study|Death|0|||
163888673|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Adverse Event|1|||
163888674|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Adverse Event|3|||
163888675|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Withdrawal by Subject|0|||
163888676|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Withdrawal by Subject|32|||
163888677|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Withdrawal by Subject|29|||
163888678|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Withdrawal by Subject|39|||
163888679|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Withdrawal by Subject|14|||
163888680|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Withdrawal by Subject|15|||
163888681|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Withdrawal by Subject|8|||
163888682|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Protocol Violation|0|||
163888683|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Protocol Violation|1|||
163888684|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Protocol Violation|1|||
163888685|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Protocol Violation|1|||
163888686|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Protocol Violation|0|||
163888687|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Protocol Violation|0|||
163888688|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Protocol Violation|0|||
163888689|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Lost to Follow-up|0|||
163888690|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
163888691|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Lost to Follow-up|19|||
163888692|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Lost to Follow-up|17|||
163888693|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Lost to Follow-up|3|||
163888694|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Lost to Follow-up|5|||
163888695|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Lost to Follow-up|4|||
163888696|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
163888697|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
163888698|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
163888699|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
163888700|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Lack of Efficacy|0|||
163888701|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Lack of Efficacy|1|||
163888702|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Lack of Efficacy|2|||
163888703|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163888704|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163888705|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Randomized But Not Treated|1|||
163993566|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163993567|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163993568|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163993569|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163888706|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
164263434|NCT00330928|593331853|FG000|Overall Study|Lost to Follow-up|6|||
164263435|NCT00330928|593331853|FG000|Overall Study|Physician Decision|9|||
164263436|NCT00330928|593331853|FG000|Overall Study|Death|1|||
164340886|NCT04019288|593623803|FG002|Overall Study|Death|0|||
164263437|NCT00330928|593331853|FG000|Overall Study|IVUS could not be performed.|1|||
164263438|NCT03028480|593331854|FG000|Overall Study|No revisit after the first prescription date|2|||
164263439|NCT03028480|593331854|FG000|Overall Study|Did not use the drug|1|||
163888707|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163888708|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163888709|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Randomized But Not Treated|0|||
163888710|NCT05693935|591965153|FG000|Open-label Period (48 Weeks)|Other Than Specified|0|||
163888711|NCT05693935|591965154|FG001|Open-label Period (48 Weeks)|Other Than Specified|12|||
163888712|NCT05693935|591965155|FG002|Open-label Period (48 Weeks)|Other Than Specified|9|||
163888713|NCT05693935|591965156|FG003|Open-label Period (48 Weeks)|Other Than Specified|10|||
163888714|NCT05693935|591965157|FG004|Open-label Period (48 Weeks)|Other Than Specified|4|||
163888715|NCT05693935|591965158|FG005|Open-label Period (48 Weeks)|Other Than Specified|3|||
163888716|NCT05693935|591965159|FG006|Open-label Period (48 Weeks)|Other Than Specified|4|||
163888717|NCT00085735|591965168|FG000|Overall Study|Adverse Event|1|||
163888718|NCT00085735|591965169|FG001|Overall Study|Adverse Event|0|||
163888719|NCT00085735|591965170|FG002|Overall Study|Adverse Event|0|||
163888720|NCT00085735|591965171|FG003|Overall Study|Adverse Event|0|||
163888721|NCT00085735|591965172|FG004|Overall Study|Adverse Event|0|||
163888722|NCT00085735|591965173|FG005|Overall Study|Adverse Event|0|||
163888723|NCT00085735|591965168|FG000|Overall Study|Lack of Efficacy|2|||
163888724|NCT00085735|591965169|FG001|Overall Study|Lack of Efficacy|4|||
163888725|NCT00085735|591965170|FG002|Overall Study|Lack of Efficacy|6|||
163888726|NCT00085735|591965171|FG003|Overall Study|Lack of Efficacy|3|||
163888727|NCT00085735|591965172|FG004|Overall Study|Lack of Efficacy|4|||
163888728|NCT00085735|591965173|FG005|Overall Study|Lack of Efficacy|3|||
163888729|NCT00085735|591965168|FG000|Overall Study|Lost to Follow-up|0|||
163888730|NCT00085735|591965169|FG001|Overall Study|Lost to Follow-up|1|||
163888731|NCT00085735|591965170|FG002|Overall Study|Lost to Follow-up|0|||
163888732|NCT00085735|591965171|FG003|Overall Study|Lost to Follow-up|0|||
163888733|NCT00085735|591965172|FG004|Overall Study|Lost to Follow-up|1|||
163888734|NCT00085735|591965173|FG005|Overall Study|Lost to Follow-up|0|||
163888735|NCT00085735|591965168|FG000|Overall Study|Physician Decision|2|||
163888736|NCT00085735|591965169|FG001|Overall Study|Physician Decision|3|||
163888737|NCT00085735|591965170|FG002|Overall Study|Physician Decision|2|||
163888738|NCT00085735|591965171|FG003|Overall Study|Physician Decision|3|||
163888739|NCT00085735|591965172|FG004|Overall Study|Physician Decision|11|||
163888740|NCT00085735|591965173|FG005|Overall Study|Physician Decision|8|||
163888741|NCT00085735|591965168|FG000|Overall Study|Protocol Violation|1|||
163888742|NCT00085735|591965169|FG001|Overall Study|Protocol Violation|0|||
163888743|NCT00085735|591965170|FG002|Overall Study|Protocol Violation|0|||
163888744|NCT00085735|591965171|FG003|Overall Study|Protocol Violation|0|||
163888745|NCT00085735|591965172|FG004|Overall Study|Protocol Violation|0|||
163888746|NCT00085735|591965173|FG005|Overall Study|Protocol Violation|0|||
163888747|NCT00085735|591965168|FG000|Overall Study|Withdrawal by Subject|1|||
163888748|NCT00085735|591965169|FG001|Overall Study|Withdrawal by Subject|0|||
163888749|NCT00085735|591965170|FG002|Overall Study|Withdrawal by Subject|4|||
163888750|NCT00085735|591965171|FG003|Overall Study|Withdrawal by Subject|5|||
163888751|NCT00085735|591965172|FG004|Overall Study|Withdrawal by Subject|7|||
163888752|NCT00085735|591965173|FG005|Overall Study|Withdrawal by Subject|8|||
163888753|NCT00085735|591965168|FG000|Overall Study|Patient ineligible|1|||
163888754|NCT00085735|591965169|FG001|Overall Study|Patient ineligible|0|||
163888755|NCT00085735|591965170|FG002|Overall Study|Patient ineligible|3|||
163888756|NCT00085735|591965171|FG003|Overall Study|Patient ineligible|7|||
163888757|NCT00085735|591965172|FG004|Overall Study|Patient ineligible|17|||
163888758|NCT00085735|591965173|FG005|Overall Study|Patient ineligible|8|||
163888759|NCT00085735|591965168|FG000|Overall Study|Excess residual disease|2|||
163888760|NCT00085735|591965169|FG001|Overall Study|Excess residual disease|2|||
163888761|NCT00085735|591965170|FG002|Overall Study|Excess residual disease|1|||
163888762|NCT00085735|591965171|FG003|Overall Study|Excess residual disease|1|||
163888763|NCT00085735|591965172|FG004|Overall Study|Excess residual disease|1|||
163888764|NCT00085735|591965173|FG005|Overall Study|Excess residual disease|4|||
163888765|NCT00085735|591965168|FG000|Overall Study|Reason not documented|1|||
163888766|NCT00085735|591965169|FG001|Overall Study|Reason not documented|0|||
163888767|NCT00085735|591965170|FG002|Overall Study|Reason not documented|1|||
163888768|NCT00085735|591965171|FG003|Overall Study|Reason not documented|0|||
163888769|NCT00085735|591965172|FG004|Overall Study|Reason not documented|1|||
163888770|NCT00085735|591965173|FG005|Overall Study|Reason not documented|0|||
163888771|NCT00085735|591965168|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
163888772|NCT00085735|591965169|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
163888773|NCT00085735|591965170|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
163888774|NCT00085735|591965171|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
163888775|NCT00085735|591965172|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
163888776|NCT00085735|591965173|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
163888777|NCT06504862|591965174|FG000|Transition period|Adverse Event|1|||
163888778|NCT06504862|591965175|FG001|Transition period|Adverse Event|0|||
163888779|NCT05949788|591965176|FG000|Overall Study|severe birth deformity|2|||
163993570|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163993571|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
163993572|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993573|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993574|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
163993575|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993576|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993577|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993578|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993579|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993580|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
163993581|NCT01583374|592344044|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993582|NCT01583374|592344045|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
163993583|NCT01583374|592344046|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993584|NCT01583374|592344047|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993585|NCT01583374|592344048|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993586|NCT01583374|592344049|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993587|NCT01583374|592344050|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993588|NCT01583374|592344051|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993589|NCT01583374|592344052|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
163993590|NCT01583374|592344044|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993591|NCT01583374|592344045|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993592|NCT01583374|592344046|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993593|NCT01583374|592344047|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993594|NCT01583374|592344048|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993595|NCT01583374|592344049|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993596|NCT01583374|592344050|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993597|NCT01583374|592344051|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
163993598|NCT01583374|592344052|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163993599|NCT01583374|592344044|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163993600|NCT01583374|592344045|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163993601|NCT01583374|592344046|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
163993602|NCT01583374|592344047|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163993603|NCT01583374|592344048|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163993604|NCT01583374|592344049|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163993605|NCT01583374|592344050|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163993606|NCT01583374|592344051|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163993607|NCT01583374|592344052|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
163993608|NCT01583374|592344044|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
163993609|NCT01583374|592344045|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
163993610|NCT01583374|592344046|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
163993611|NCT01583374|592344047|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
163993612|NCT01583374|592344048|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
163993613|NCT01583374|592344049|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
163993614|NCT01583374|592344050|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
163993615|NCT01583374|592344051|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
163993616|NCT01583374|592344052|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
163993617|NCT01583374|592344044|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163993618|NCT01583374|592344045|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
163993619|NCT01583374|592344046|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
163993620|NCT01583374|592344047|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163993621|NCT01583374|592344048|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
163993622|NCT01583374|592344049|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163993623|NCT01583374|592344050|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
164263440|NCT03028480|593331854|FG000|Overall Study|Violation of the enrollment deadline|10|||
164263441|NCT03028480|593331854|FG000|Overall Study|Case report forms were not collected|21|||
164263442|NCT04706273|593331857|FG000|Overall Study|Withdrawal by Subject|27|||
164263443|NCT04706273|593331857|FG000|Overall Study|Physician Decision|1|||
164263444|NCT04706273|593331857|FG000|Overall Study|Lost to Follow-up|42|||
164263445|NCT04706273|593331857|FG000|Overall Study|Death|85|||
164263446|NCT04706273|593331857|FG000|Overall Study|Amputation that removes study device|2|||
163993624|NCT01583374|592344051|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163993625|NCT01583374|592344052|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
163993626|NCT01583374|592344044|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163993627|NCT01583374|592344045|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163993628|NCT01583374|592344046|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
164263447|NCT04706273|593331857|FG000|Overall Study|Surgical bypass|3|||
164263448|NCT04706273|593331857|FG000|Overall Study|Changing hospital|23|||
163993629|NCT01583374|592344047|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163993630|NCT01583374|592344048|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
163993631|NCT01583374|592344049|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
163993632|NCT01583374|592344050|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163993633|NCT01583374|592344051|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163993634|NCT01583374|592344052|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163993635|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
163993636|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
163993637|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163993638|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163993639|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
163993640|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163993641|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
163993642|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
163993643|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
163993644|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
163993645|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
163993646|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
163993647|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
163993648|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
163993649|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
163993650|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
163993651|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
163993652|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
163993653|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163993654|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163993655|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163993656|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163993657|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
163993658|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163993659|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
163993660|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
163993661|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
163993662|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
163993663|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
163993664|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
163993665|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
163993666|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
163888780|NCT05949788|591965177|FG001|Overall Study|severe birth deformity|7|||
163888781|NCT05949788|591965176|FG000|Overall Study|twin-twin transfusion syndrome|2|||
163888782|NCT05949788|591965177|FG001|Overall Study|twin-twin transfusion syndrome|7|||
163888783|NCT05949788|591965176|FG000|Overall Study|neonatal hemolytic disease|3|||
163888784|NCT05949788|591965177|FG001|Overall Study|neonatal hemolytic disease|8|||
163888785|NCT05949788|591965176|FG000|Overall Study|death within 14 days after birth|2|||
163888786|NCT05949788|591965177|FG001|Overall Study|death within 14 days after birth|6|||
163888787|NCT05949788|591965176|FG000|Overall Study|transfer to another hospital|2|||
163888788|NCT05949788|591965177|FG001|Overall Study|transfer to another hospital|6|||
163888789|NCT01574274|591965178|FG000|Overall Study|Ineligible|0|||
163888790|NCT01574274|591965179|FG001|Overall Study|Ineligible|1|||
163888791|NCT01574274|591965178|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
163993667|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
163993668|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
163993669|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
164263449|NCT04706273|593331857|FG000|Overall Study|Unable to attend hospital|2|||
164263450|NCT00759356|593331860|FG000|Overall Study|Adverse Event|0|||
164263451|NCT00759356|593331861|FG001|Overall Study|Adverse Event|1|||
164263452|NCT00759356|593331860|FG000|Overall Study|Withdrawal by Subject|0|||
164263453|NCT00759356|593331861|FG001|Overall Study|Withdrawal by Subject|2|||
164263454|NCT00759356|593331860|FG000|Overall Study|Subject was unable to return|1|||
164263455|NCT00759356|593331861|FG001|Overall Study|Subject was unable to return|0|||
164263456|NCT02403635|593331866|FG000|Overall Study|Not eligible|9|||
164263457|NCT00585221|593331870|FG000|Overall Study|Protocol Violation|8|||
164263458|NCT02509052|593331871|FG000|Overall Study|Non compliance|0|||
163888792|NCT01574274|591965179|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
163888793|NCT01574274|591965178|FG000|Overall Study|Ph+ B-ALL|3|||
163888794|NCT01574274|591965179|FG001|Overall Study|Ph+ B-ALL|4|||
164085364|NCT00449072|592677222|FG000|Overall Study|Non-compliance|2|||
164263459|NCT02509052|593331872|FG001|Overall Study|Non compliance|0|||
164263460|NCT02509052|593331873|FG002|Overall Study|Non compliance|1|||
164263461|NCT03554772|593331877|FG000|Overall Study|Lost to Follow-up|0|||
164263462|NCT03554772|593331878|FG001|Overall Study|Lost to Follow-up|0|||
164263463|NCT03554772|593331879|FG002|Overall Study|Lost to Follow-up|0|||
164263464|NCT03554772|593331880|FG003|Overall Study|Lost to Follow-up|2|||
164263465|NCT03263923|593331881|FG000|Overall Study|Withdrawal by Subject|10|||
164263466|NCT03263923|593331882|FG001|Overall Study|Withdrawal by Subject|8|||
164263467|NCT03263923|593331881|FG000|Overall Study|Lost to Follow-up|15|||
164263468|NCT03263923|593331882|FG001|Overall Study|Lost to Follow-up|13|||
164263469|NCT00241631|593331889|FG000|Run in (2 Weeks)|Physician Decision|3|||
164263470|NCT00241631|593331890|FG001|Run in (2 Weeks)|Physician Decision|3|||
164263471|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|sore throat|1|||
164263472|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|sore throat|0|||
164263473|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
164263474|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
164263475|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
164263476|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
164263477|NCT00241631|593331889|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
164263478|NCT00241631|593331890|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
164263479|NCT00435162|593331893|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
164263480|NCT00435162|593331894|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
164340887|NCT00094172|593623804|FG000|Overall Study|Adverse Event|0|||
164340888|NCT00094172|593623805|FG001|Overall Study|Adverse Event|1|||
164340889|NCT00094172|593623804|FG000|Overall Study|Lost to Follow-up|2|||
164340890|NCT00094172|593623805|FG001|Overall Study|Lost to Follow-up|0|||
164340891|NCT00094172|593623804|FG000|Overall Study|Protocol Violation|0|||
164340892|NCT00094172|593623805|FG001|Overall Study|Protocol Violation|1|||
164340893|NCT00094172|593623804|FG000|Overall Study|Withdrawal by Subject|10|||
164340894|NCT00094172|593623805|FG001|Overall Study|Withdrawal by Subject|5|||
164340895|NCT00094172|593623804|FG000|Overall Study|Primary endpoint met.|1|||
164340896|NCT00094172|593623805|FG001|Overall Study|Primary endpoint met.|0|||
164340897|NCT00094172|593623804|FG000|Overall Study|Started other MS therapy due to disease|1|||
164340898|NCT00094172|593623805|FG001|Overall Study|Started other MS therapy due to disease|0|||
164340899|NCT00289133|593623813|FG000|Overall Study|Non-study device implanted|12|||
164340900|NCT00289133|593623814|FG001|Overall Study|Non-study device implanted|0|||
164340901|NCT00289133|593623813|FG000|Overall Study|Protocol Violation|32|||
164340902|NCT00289133|593623814|FG001|Overall Study|Protocol Violation|38|||
164340903|NCT00289133|593623813|FG000|Overall Study|Withdrawal by Subject|9|||
164340904|NCT00289133|593623814|FG001|Overall Study|Withdrawal by Subject|10|||
164340905|NCT00289133|593623813|FG000|Overall Study|Death|5|||
164340906|NCT00289133|593623814|FG001|Overall Study|Death|10|||
164340907|NCT00289133|593623813|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
164340908|NCT00289133|593623814|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
164340909|NCT00289133|593623813|FG000|Overall Study|Physician Decision|41|||
164340910|NCT00289133|593623814|FG001|Overall Study|Physician Decision|45|||
164340911|NCT00289133|593623813|FG000|Overall Study|Revision|8|||
164340912|NCT00289133|593623814|FG001|Overall Study|Revision|6|||
164340913|NCT00289133|593623813|FG000|Overall Study|Lost to Follow-up|92|||
164340914|NCT00289133|593623814|FG001|Overall Study|Lost to Follow-up|115|||
164340915|NCT03372096|593623819|FG000|Overall Study|Study Closed|8|||
164340916|NCT00040365|593623820|FG000|Overall Study|Death|1|||
164340917|NCT00040365|593623820|FG000|Overall Study|Progressive disease|7|||
164340918|NCT00040365|593623820|FG000|Overall Study|Lost to Follow-up|3|||
164340919|NCT01397890|593623829|FG000|Overall Study|Withdrawal by Subject|7|||
164340920|NCT01397890|593623830|FG001|Overall Study|Withdrawal by Subject|11|||
163888795|NCT01574274|591965178|FG000|Overall Study|Induction Death|2|||
163888796|NCT01574274|591965179|FG001|Overall Study|Induction Death|0|||
163888797|NCT01574274|591965178|FG000|Overall Study|Induction Failure|4|||
163888798|NCT01574274|591965179|FG001|Overall Study|Induction Failure|1|||
163888799|NCT01574274|591965178|FG000|Overall Study|Adverse Event|16|||
163888800|NCT01574274|591965179|FG001|Overall Study|Adverse Event|13|||
163888801|NCT01574274|591965178|FG000|Overall Study|Remission Death|1|||
163888802|NCT01574274|591965179|FG001|Overall Study|Remission Death|0|||
163888803|NCT01574274|591965178|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
163888804|NCT01574274|591965179|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
163888805|NCT01574274|591965178|FG000|Overall Study|Other, unknown|3|||
163888806|NCT01574274|591965179|FG001|Overall Study|Other, unknown|2|||
163888807|NCT02191618|591965189|FG000|Overall Study|Withdrawal by Subject|3|||
163888808|NCT02191618|591965189|FG000|Overall Study|Missed Visit|4|||
163888809|NCT01943409|591965193|FG000|Overall Study|resumed oral/entral|24|||
163888810|NCT01943409|591965194|FG001|Overall Study|resumed oral/entral|20|||
163888811|NCT01943409|591965193|FG000|Overall Study|Protocol Violation|14|||
163888812|NCT01943409|591965194|FG001|Overall Study|Protocol Violation|24|||
163888813|NCT01943409|591965193|FG000|Overall Study|Death|3|||
164263481|NCT00435162|593331895|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
164263482|NCT00435162|593331896|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
164340921|NCT01397890|593623829|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
163993670|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
163993671|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993672|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993673|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993674|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993675|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
163993676|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993677|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
163993678|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993679|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
163993680|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163993681|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163993682|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163993683|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163993684|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163993685|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163993686|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
163993687|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163993688|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
163993689|NCT01583374|592344044|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
163993690|NCT01583374|592344045|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
163993691|NCT01583374|592344046|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163993692|NCT01583374|592344047|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
163993693|NCT01583374|592344048|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
163993694|NCT01583374|592344049|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163993695|NCT01583374|592344050|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
163993696|NCT01583374|592344051|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
163993697|NCT01583374|592344052|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
163993698|NCT01292057|592344055|FG000|Overall Study|Protocol Violation|1|||
163993699|NCT01292057|592344056|FG001|Overall Study|Protocol Violation|1|||
163993700|NCT01292057|592344055|FG000|Overall Study|Lost to Follow-up|1|||
163993701|NCT01292057|592344056|FG001|Overall Study|Lost to Follow-up|1|||
163993702|NCT02307370|592344057|FG000|Overall Study|Death|5|||
163993703|NCT02307370|592344057|FG000|Overall Study|Lost to Follow-up|1|||
163993704|NCT02307370|592344057|FG000|Overall Study|Withdrawal by Subject|1|||
163993705|NCT02307370|592344057|FG000|Overall Study|Declined Addendum ICF|6|||
163993706|NCT02307370|592344057|FG000|Overall Study|No response during telephone contact|5|||
163993707|NCT02307370|592344057|FG000|Overall Study|Protocol Violation|1|||
163993708|NCT02732951|592345866|FG000|Overall Study|Other than listed|1|||
163993709|NCT02732951|592345867|FG001|Overall Study|Other than listed|0|||
163993710|NCT02732951|592345866|FG000|Overall Study|Lost to Follow-up|0|||
163993711|NCT02732951|592345867|FG001|Overall Study|Lost to Follow-up|1|||
163993712|NCT02732951|592345866|FG000|Overall Study|Adverse Event|4|||
163993713|NCT02732951|592345867|FG001|Overall Study|Adverse Event|4|||
163993714|NCT02732951|592345866|FG000|Overall Study|Protocol Violation|0|||
163993715|NCT02732951|592345867|FG001|Overall Study|Protocol Violation|1|||
163993716|NCT01805180|592345868|FG000|Lead-in Donor Phase|screen failure|1|||
163993717|NCT01805180|592345869|FG001|Lead-in Donor Phase|screen failure|0|||
163993718|NCT01805180|592345870|FG002|Lead-in Donor Phase|screen failure|0|||
163993719|NCT01427309|592345873|FG000|Overall Study|Lost to Follow-up|130|||
163993720|NCT01427309|592345874|FG001|Overall Study|Lost to Follow-up|145|||
163993721|NCT01427309|592345875|FG002|Overall Study|Lost to Follow-up|122|||
163993722|NCT01427309|592345876|FG003|Overall Study|Lost to Follow-up|135|||
163993723|NCT01427309|592345873|FG000|Overall Study|Protocol Violation|42|||
163993724|NCT01427309|592345874|FG001|Overall Study|Protocol Violation|69|||
163993725|NCT01427309|592345875|FG002|Overall Study|Protocol Violation|125|||
163993726|NCT01427309|592345876|FG003|Overall Study|Protocol Violation|124|||
163993727|NCT01427309|592345873|FG000|Overall Study|Adverse Event|0|||
163993728|NCT01427309|592345874|FG001|Overall Study|Adverse Event|0|||
163993729|NCT01427309|592345875|FG002|Overall Study|Adverse Event|3|||
163993730|NCT01427309|592345876|FG003|Overall Study|Adverse Event|1|||
164085365|NCT00449072|592677223|FG001|Overall Study|Non-compliance|5|||
163993731|NCT01427309|592345873|FG000|Overall Study|Serious adverse event|52|||
163993732|NCT01427309|592345874|FG001|Overall Study|Serious adverse event|45|||
163993733|NCT01427309|592345875|FG002|Overall Study|Serious adverse event|50|||
163993734|NCT01427309|592345876|FG003|Overall Study|Serious adverse event|61|||
163993735|NCT01427309|592345873|FG000|Overall Study|Withdrawal by Subject|148|||
163993736|NCT01427309|592345874|FG001|Overall Study|Withdrawal by Subject|148|||
163993737|NCT01427309|592345875|FG002|Overall Study|Withdrawal by Subject|61|||
164085366|NCT00449072|592677222|FG000|Overall Study|Sponsor decision|1|||
164085367|NCT00449072|592677223|FG001|Overall Study|Sponsor decision|3|||
164085368|NCT00449072|592677222|FG000|Overall Study|Relocation|3|||
164085369|NCT00449072|592677223|FG001|Overall Study|Relocation|2|||
164085370|NCT01612000|592677231|FG000|Overall Study|Lost to Follow-up|6|||
163993738|NCT01427309|592345876|FG003|Overall Study|Withdrawal by Subject|55|||
163993739|NCT00928070|592345879|FG000|Overall Study|Lost to Follow-up|1|||
163993740|NCT00928070|592345880|FG001|Overall Study|Lost to Follow-up|2|||
163993741|NCT00928070|592345879|FG000|Overall Study|Withdrawal by Subject|10|||
163993742|NCT00928070|592345880|FG001|Overall Study|Withdrawal by Subject|3|||
163993743|NCT00928070|592345879|FG000|Overall Study|Adverse Event|14|||
163993744|NCT00928070|592345880|FG001|Overall Study|Adverse Event|26|||
163993745|NCT00928070|592345879|FG000|Overall Study|Lack of Efficacy|9|||
163993746|NCT00928070|592345880|FG001|Overall Study|Lack of Efficacy|5|||
163993747|NCT00928070|592345879|FG000|Overall Study|Did not meet entrance criteria|16|||
163993748|NCT00928070|592345880|FG001|Overall Study|Did not meet entrance criteria|9|||
163993749|NCT00928070|592345879|FG000|Overall Study|Protocol Violation|6|||
163993750|NCT00928070|592345880|FG001|Overall Study|Protocol Violation|5|||
163993751|NCT00928070|592345879|FG000|Overall Study|Randomized but not treated|2|||
163993752|NCT00928070|592345880|FG001|Overall Study|Randomized but not treated|2|||
163993753|NCT00928070|592345879|FG000|Overall Study|Other|5|||
163993754|NCT00928070|592345880|FG001|Overall Study|Other|5|||
164263483|NCT00435162|593331897|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
164263484|NCT00435162|593331898|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
164263485|NCT00694096|593331899|FG000|Overall Study|Withdrawal by Subject|5|||
164263486|NCT02078102|593331905|FG000|Overall Study|Adverse Event|1|||
164263487|NCT02078102|593331906|FG001|Overall Study|Adverse Event|0|||
164263488|NCT02078102|593331905|FG000|Overall Study|Withdrawal by Subject|1|||
164263489|NCT02078102|593331906|FG001|Overall Study|Withdrawal by Subject|0|||
164263490|NCT02078102|593331905|FG000|Overall Study|Physician Decision|0|||
164263491|NCT02078102|593331906|FG001|Overall Study|Physician Decision|1|||
164263492|NCT02185014|593331907|FG000|Overall Study|Adverse Event|18|||
164263493|NCT02185014|593331907|FG000|Overall Study|Withdrew Consent|8|||
164263494|NCT02185014|593331907|FG000|Overall Study|Lost to Follow-up|4|||
164263495|NCT02185014|593331907|FG000|Overall Study|Lack of Efficacy|14|||
164263496|NCT02185014|593331907|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
164263497|NCT02185014|593331907|FG000|Overall Study|Subject Noncompliance|1|||
164263498|NCT02185014|593331907|FG000|Overall Study|Other|4|||
164263499|NCT02141490|593331908|FG000|Overall Study|Screening failures|4|||
164263500|NCT02141490|593331909|FG001|Overall Study|Screening failures|0|||
164263501|NCT02141490|593331910|FG002|Overall Study|Screening failures|0|||
164263502|NCT01813721|593331911|FG000|Overall Study|Ineligibility determined|63|||
164263503|NCT01813721|593331911|FG000|Overall Study|Withdrawal by Subject|1|||
164263504|NCT02133664|593331912|FG000|Overall Study|Lost to Follow-up|2|||
164263505|NCT02133664|593331913|FG001|Overall Study|Lost to Follow-up|1|||
164263506|NCT02133664|593331912|FG000|Overall Study|Adverse Event|3|||
164263507|NCT02133664|593331913|FG001|Overall Study|Adverse Event|6|||
164263508|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
164263509|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
164263510|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
164263511|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
164263512|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
164263513|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
164263514|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
164263515|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
163993755|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
163993756|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
163993757|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
163993758|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
163993759|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
163993760|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
163993761|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
163993762|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
163993763|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
163993764|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
163993765|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
163993766|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
163993767|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
163993768|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
163993769|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
163993770|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
163993771|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
163993772|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
163993773|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
164263516|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
164263517|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
164263518|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
164263519|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
164085371|NCT01612000|592677232|FG001|Overall Study|Lost to Follow-up|4|||
164085372|NCT01612000|592677233|FG002|Overall Study|Lost to Follow-up|4|||
164085373|NCT01612000|592677234|FG003|Overall Study|Lost to Follow-up|8|||
164085374|NCT01612000|592677231|FG000|Overall Study|Physician Decision|0|||
163888814|NCT01943409|591965194|FG001|Overall Study|Death|1|||
163888815|NCT01943409|591965193|FG000|Overall Study|Withdrawal by Subject|4|||
163888816|NCT01943409|591965194|FG001|Overall Study|Withdrawal by Subject|3|||
163888817|NCT02969707|591965197|FG000|Overall Study|Withdrawal by Subject|6|||
163888818|NCT02969707|591965198|FG001|Overall Study|Withdrawal by Subject|5|||
163888819|NCT02969707|591965197|FG000|Overall Study|Severe anxiety|0|||
163888820|NCT02969707|591965198|FG001|Overall Study|Severe anxiety|1|||
163888821|NCT02969707|591965197|FG000|Overall Study|Positive toxicology screen|0|||
163888822|NCT02969707|591965198|FG001|Overall Study|Positive toxicology screen|2|||
163888823|NCT02969707|591965197|FG000|Overall Study|Claustrophobia|2|||
163888824|NCT02969707|591965198|FG001|Overall Study|Claustrophobia|2|||
163888825|NCT02969707|591965197|FG000|Overall Study|Non-compliance|1|||
163888826|NCT02969707|591965198|FG001|Overall Study|Non-compliance|2|||
163888827|NCT03020199|591965199|FG000|Treatment Period|Adverse Event|0|||
163888828|NCT03020199|591965200|FG001|Treatment Period|Adverse Event|2|||
163888829|NCT03020199|591965199|FG000|Treatment Period|Lack of Efficacy|1|||
163888830|NCT03020199|591965200|FG001|Treatment Period|Lack of Efficacy|6|||
163888831|NCT03020199|591965199|FG000|Treatment Period|Lost to Follow-up|1|||
163888832|NCT03020199|591965200|FG001|Treatment Period|Lost to Follow-up|6|||
163888833|NCT03020199|591965199|FG000|Treatment Period|Physician Decision|0|||
163888834|NCT03020199|591965200|FG001|Treatment Period|Physician Decision|1|||
163888835|NCT03020199|591965199|FG000|Treatment Period|Subject/guardian decision|8|||
163888836|NCT03020199|591965200|FG001|Treatment Period|Subject/guardian decision|15|||
163888837|NCT03020199|591965199|FG000|Treatment Period|Subjects not treated|3|||
163888838|NCT03020199|591965200|FG001|Treatment Period|Subjects not treated|4|||
163888839|NCT03020199|591965199|FG000|Follow-up Period|Disease relapse|32|||
163888840|NCT03020199|591965200|FG001|Follow-up Period|Disease relapse|7|||
163888841|NCT03020199|591965199|FG000|Follow-up Period|Lack of Efficacy|1|||
163888842|NCT03020199|591965200|FG001|Follow-up Period|Lack of Efficacy|2|||
163888843|NCT03020199|591965199|FG000|Follow-up Period|Lost to Follow-up|4|||
163888844|NCT03020199|591965200|FG001|Follow-up Period|Lost to Follow-up|6|||
163888845|NCT03020199|591965199|FG000|Follow-up Period|Physician Decision|2|||
163888846|NCT03020199|591965200|FG001|Follow-up Period|Physician Decision|2|||
163888847|NCT03020199|591965199|FG000|Follow-up Period|Protocol Violation|1|||
163888848|NCT03020199|591965200|FG001|Follow-up Period|Protocol Violation|2|||
163888849|NCT03020199|591965199|FG000|Follow-up Period|Study terminated by Sponsor|6|||
163888850|NCT03020199|591965200|FG001|Follow-up Period|Study terminated by Sponsor|3|||
163888851|NCT03020199|591965199|FG000|Follow-up Period|Subject/guardian decision|14|||
163888852|NCT03020199|591965200|FG001|Follow-up Period|Subject/guardian decision|9|||
163888853|NCT04314713|591965201|FG000|Overall Study|Lost to Follow-up|0|||
163888854|NCT04314713|591965202|FG001|Overall Study|Lost to Follow-up|0|||
163888855|NCT04314713|591965203|FG002|Overall Study|Lost to Follow-up|0|||
163888856|NCT04314713|591965204|FG003|Overall Study|Lost to Follow-up|1|||
163888857|NCT04314713|591965205|FG004|Overall Study|Lost to Follow-up|0|||
163888858|NCT04314713|591965206|FG005|Overall Study|Lost to Follow-up|0|||
163888859|NCT02714257|591965207|FG000|Overall Study|Withdrawal by Subject|6|||
163888860|NCT02714257|591965208|FG001|Overall Study|Withdrawal by Subject|11|||
163888861|NCT02714257|591965207|FG000|Overall Study|Death|3|||
163888862|NCT02714257|591965208|FG001|Overall Study|Death|4|||
163888863|NCT02714257|591965207|FG000|Overall Study|Lost to Follow-up|1|||
163888864|NCT02714257|591965208|FG001|Overall Study|Lost to Follow-up|6|||
163888865|NCT03800654|591965217|FG000|Overall Study|Time constraints|3|||
163888866|NCT03800654|591965218|FG001|Overall Study|Time constraints|3|||
164085375|NCT01612000|592677232|FG001|Overall Study|Physician Decision|0|||
163888867|NCT03800654|591965219|FG002|Overall Study|Time constraints|3|||
164085376|NCT01612000|592677233|FG002|Overall Study|Physician Decision|1|||
164085377|NCT01612000|592677234|FG003|Overall Study|Physician Decision|0|||
164085378|NCT01612000|592677231|FG000|Overall Study|Withdrawal by Subject|3|||
164085379|NCT01612000|592677232|FG001|Overall Study|Withdrawal by Subject|1|||
164085380|NCT01612000|592677233|FG002|Overall Study|Withdrawal by Subject|2|||
164085381|NCT01612000|592677234|FG003|Overall Study|Withdrawal by Subject|2|||
164085382|NCT03425331|592677235|FG000|Overall Study|Withdrawal by Subject|1|||
164085383|NCT03425331|592677235|FG000|Overall Study|Death|1|||
164085384|NCT03425331|592677235|FG000|Overall Study|Adverse Event|1|||
164085385|NCT03425331|592677235|FG000|Overall Study|Disease Progression|2|||
164085386|NCT03433274|592677236|FG000|Overall Study|Withdrawal by Subject|2|||
164085387|NCT03433274|592677236|FG000|Overall Study|Missed visit|5|||
164085388|NCT03433274|592677236|FG000|Overall Study|Death|23|||
164085389|NCT00441584|592677237|FG000|Overall Study|Lack of Efficacy|79|||
164085390|NCT00441584|592677237|FG000|Overall Study|Withdrawal by Subject|8|||
164085391|NCT00441584|592677237|FG000|Overall Study|Adverse Event|6|||
164085392|NCT00441584|592677237|FG000|Overall Study|Protocol Violation|5|||
164085393|NCT00441584|592677237|FG000|Overall Study|Lost to Follow-up|4|||
164085394|NCT00441584|592677237|FG000|Overall Study|Failure to meet eligibility criteria|3|||
163993774|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
163993775|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
163993776|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
163993777|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
163993778|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
163993779|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
163993780|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
163993781|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
163993782|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
163993783|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
163993784|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
163993785|NCT00849017|592345881|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
163993786|NCT00849017|592345882|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
163993787|NCT00849017|592345883|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
163993788|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
163993789|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
163993790|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
163993791|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
163993792|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
163993793|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
163993794|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
163993795|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
163993796|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
163993797|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
163993798|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
163993799|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
163993800|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
163993801|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
163993802|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
163993803|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
163993804|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
163993805|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
163993806|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
163993807|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
163993808|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
163993809|NCT00849017|592345881|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
163993810|NCT00849017|592345882|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
163993811|NCT00849017|592345883|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
163993812|NCT02913313|592345884|FG000|Overall Study|DISEASE PROGRESSION|1|||
163993813|NCT02913313|592345885|FG001|Overall Study|DISEASE PROGRESSION|2|||
163993814|NCT02913313|592345886|FG002|Overall Study|DISEASE PROGRESSION|2|||
163993815|NCT02913313|592345887|FG003|Overall Study|DISEASE PROGRESSION|4|||
163993816|NCT02913313|592345888|FG004|Overall Study|DISEASE PROGRESSION|6|||
163993817|NCT02913313|592345889|FG005|Overall Study|DISEASE PROGRESSION|4|||
163993818|NCT02913313|592345890|FG006|Overall Study|DISEASE PROGRESSION|19|||
163993819|NCT02913313|592345891|FG007|Overall Study|DISEASE PROGRESSION|3|||
163993820|NCT02913313|592345892|FG008|Overall Study|DISEASE PROGRESSION|4|||
163993821|NCT02913313|592345893|FG009|Overall Study|DISEASE PROGRESSION|4|||
163993822|NCT02913313|592345894|FG010|Overall Study|DISEASE PROGRESSION|11|||
163993823|NCT02913313|592345895|FG011|Overall Study|DISEASE PROGRESSION|5|||
163993824|NCT02913313|592345896|FG012|Overall Study|DISEASE PROGRESSION|14|||
163993825|NCT02913313|592345897|FG013|Overall Study|DISEASE PROGRESSION|3|||
163993826|NCT02913313|592345884|FG000|Overall Study|Not Reported|0|||
163993827|NCT02913313|592345885|FG001|Overall Study|Not Reported|0|||
163993828|NCT02913313|592345886|FG002|Overall Study|Not Reported|0|||
163993829|NCT02913313|592345887|FG003|Overall Study|Not Reported|0|||
164263520|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
164263521|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
164263522|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
164263523|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
164263524|NCT03906656|593331914|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
164263525|NCT03906656|593331915|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
163993830|NCT02913313|592345888|FG004|Overall Study|Not Reported|1|||
163993831|NCT02913313|592345889|FG005|Overall Study|Not Reported|0|||
163993832|NCT02913313|592345890|FG006|Overall Study|Not Reported|0|||
163993833|NCT02913313|592345891|FG007|Overall Study|Not Reported|0|||
163993834|NCT02913313|592345892|FG008|Overall Study|Not Reported|0|||
163993835|NCT02913313|592345893|FG009|Overall Study|Not Reported|0|||
163993836|NCT02913313|592345894|FG010|Overall Study|Not Reported|4|||
163993837|NCT02913313|592345895|FG011|Overall Study|Not Reported|0|||
163993838|NCT02913313|592345896|FG012|Overall Study|Not Reported|0|||
164263526|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
163993839|NCT02913313|592345897|FG013|Overall Study|Not Reported|0|||
163993840|NCT02913313|592345884|FG000|Overall Study|Other reasons|0|||
163993841|NCT02913313|592345885|FG001|Overall Study|Other reasons|0|||
163993842|NCT02913313|592345886|FG002|Overall Study|Other reasons|0|||
163993843|NCT02913313|592345887|FG003|Overall Study|Other reasons|0|||
163993844|NCT02913313|592345888|FG004|Overall Study|Other reasons|1|||
163993845|NCT02913313|592345889|FG005|Overall Study|Other reasons|0|||
163993846|NCT02913313|592345890|FG006|Overall Study|Other reasons|0|||
163993847|NCT02913313|592345891|FG007|Overall Study|Other reasons|0|||
163993848|NCT02913313|592345892|FG008|Overall Study|Other reasons|0|||
163993849|NCT02913313|592345893|FG009|Overall Study|Other reasons|0|||
163993850|NCT02913313|592345894|FG010|Overall Study|Other reasons|1|||
163993851|NCT02913313|592345895|FG011|Overall Study|Other reasons|0|||
163993852|NCT02913313|592345896|FG012|Overall Study|Other reasons|0|||
163993853|NCT02913313|592345897|FG013|Overall Study|Other reasons|0|||
163993854|NCT02913313|592345884|FG000|Overall Study|Withdrawal by Subject|0|||
163993855|NCT02913313|592345885|FG001|Overall Study|Withdrawal by Subject|0|||
163993856|NCT02913313|592345886|FG002|Overall Study|Withdrawal by Subject|1|||
163993857|NCT02913313|592345887|FG003|Overall Study|Withdrawal by Subject|0|||
163993858|NCT02913313|592345888|FG004|Overall Study|Withdrawal by Subject|0|||
163993859|NCT02913313|592345889|FG005|Overall Study|Withdrawal by Subject|0|||
163993860|NCT02913313|592345890|FG006|Overall Study|Withdrawal by Subject|1|||
163993861|NCT02913313|592345891|FG007|Overall Study|Withdrawal by Subject|1|||
163993862|NCT02913313|592345892|FG008|Overall Study|Withdrawal by Subject|0|||
163993863|NCT02913313|592345893|FG009|Overall Study|Withdrawal by Subject|0|||
163993864|NCT02913313|592345894|FG010|Overall Study|Withdrawal by Subject|1|||
163993865|NCT02913313|592345895|FG011|Overall Study|Withdrawal by Subject|0|||
163993866|NCT02913313|592345896|FG012|Overall Study|Withdrawal by Subject|0|||
163993867|NCT02913313|592345897|FG013|Overall Study|Withdrawal by Subject|0|||
163993868|NCT02913313|592345884|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993869|NCT02913313|592345885|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993870|NCT02913313|592345886|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993871|NCT02913313|592345887|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993872|NCT02913313|592345888|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993873|NCT02913313|592345889|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993874|NCT02913313|592345890|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993875|NCT02913313|592345891|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993876|NCT02913313|592345892|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993877|NCT02913313|592345893|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993878|NCT02913313|592345894|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163993879|NCT02913313|592345895|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
163993880|NCT02913313|592345896|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163993881|NCT02913313|592345897|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
163993882|NCT02913313|592345884|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
163993883|NCT02913313|592345885|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
163993884|NCT02913313|592345886|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
163993885|NCT02913313|592345887|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
163993886|NCT02913313|592345888|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
163993887|NCT02913313|592345889|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
163993888|NCT02913313|592345890|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
163993889|NCT02913313|592345891|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
163993890|NCT02913313|592345892|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
163993891|NCT02913313|592345893|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
163993892|NCT02913313|592345894|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
163993893|NCT02913313|592345895|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
163993894|NCT02913313|592345896|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
163993895|NCT02913313|592345897|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
163993896|NCT01061008|592345898|FG000|Overall Study|Badiocephalic fistula failed|3|||
163993897|NCT01061008|592345899|FG001|Overall Study|Badiocephalic fistula failed|2|||
163993898|NCT01061008|592345898|FG000|Overall Study|Death|1|||
164263527|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
164263528|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
163993899|NCT01061008|592345899|FG001|Overall Study|Death|0|||
163993900|NCT01061008|592345898|FG000|Overall Study|Withdrawal by Subject|1|||
163993901|NCT01061008|592345899|FG001|Overall Study|Withdrawal by Subject|3|||
163993902|NCT01061008|592345898|FG000|Overall Study|Unable to exercise following surgery|1|||
163993903|NCT01061008|592345899|FG001|Overall Study|Unable to exercise following surgery|0|||
164263529|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
164263530|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
164263531|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
164263532|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
164263533|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
164263534|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
163993904|NCT01061008|592345898|FG000|Overall Study|Adverse Event|0|||
163993905|NCT01061008|592345899|FG001|Overall Study|Adverse Event|1|||
163993906|NCT02908100|592345902|FG000|Overall Study|Adverse Event|7|||
163993907|NCT02908100|592345903|FG001|Overall Study|Adverse Event|6|||
163993908|NCT02908100|592345904|FG002|Overall Study|Adverse Event|9|||
163993909|NCT02908100|592345902|FG000|Overall Study|Death|2|||
163993910|NCT02908100|592345903|FG001|Overall Study|Death|0|||
163993911|NCT02908100|592345904|FG002|Overall Study|Death|0|||
163993912|NCT02908100|592345902|FG000|Overall Study|Lack of Efficacy|2|||
163993913|NCT02908100|592345903|FG001|Overall Study|Lack of Efficacy|3|||
163993914|NCT02908100|592345904|FG002|Overall Study|Lack of Efficacy|3|||
163993915|NCT02908100|592345902|FG000|Overall Study|Lost to Follow-up|0|||
163993916|NCT02908100|592345903|FG001|Overall Study|Lost to Follow-up|1|||
163993917|NCT02908100|592345904|FG002|Overall Study|Lost to Follow-up|2|||
163993918|NCT02908100|592345902|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163993919|NCT02908100|592345903|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163993920|NCT02908100|592345904|FG002|Overall Study|Non-Compliance With Study Drug|2|||
163993921|NCT02908100|592345902|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
163993922|NCT02908100|592345903|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
163993923|NCT02908100|592345904|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
163993924|NCT02908100|592345902|FG000|Overall Study|Physician Decision|0|||
163993925|NCT02908100|592345903|FG001|Overall Study|Physician Decision|1|||
163993926|NCT02908100|592345904|FG002|Overall Study|Physician Decision|0|||
163993927|NCT02908100|592345902|FG000|Overall Study|Pregnancy|1|||
163993928|NCT02908100|592345903|FG001|Overall Study|Pregnancy|2|||
163993929|NCT02908100|592345904|FG002|Overall Study|Pregnancy|0|||
163993930|NCT02908100|592345902|FG000|Overall Study|Withdrawal by Subject|8|||
163993931|NCT02908100|592345903|FG001|Overall Study|Withdrawal by Subject|7|||
163993932|NCT02908100|592345904|FG002|Overall Study|Withdrawal by Subject|5|||
163993933|NCT02908100|592345902|FG000|Overall Study|Randomised in Error|1|||
163993934|NCT02908100|592345903|FG001|Overall Study|Randomised in Error|0|||
163993935|NCT02908100|592345904|FG002|Overall Study|Randomised in Error|0|||
163993936|NCT02024971|592345905|FG000|Overall Study|Data Not Available|30|||
163993937|NCT02024971|592345905|FG000|Overall Study|Lost to Follow-up|6|||
163993938|NCT05254418|592345908|FG000|Overall Study|Adverse Event|2|||
163993939|NCT02631538|592345910|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
163993940|NCT02631538|592345911|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
163993941|NCT02631538|592345912|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
163993942|NCT02631538|592345913|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
163993943|NCT02631538|592345910|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
163993944|NCT02631538|592345911|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
163993945|NCT02631538|592345912|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
163993946|NCT02631538|592345913|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
163993947|NCT02631538|592345910|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
163993948|NCT02631538|592345911|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
163993949|NCT02631538|592345912|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
163993950|NCT02631538|592345913|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
163993951|NCT02631538|592345910|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
163993952|NCT02631538|592345911|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
163993953|NCT02631538|592345912|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
163993954|NCT02631538|592345913|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
163993955|NCT02631538|592345910|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
163993956|NCT02631538|592345911|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
163993957|NCT02631538|592345912|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
163993958|NCT02631538|592345913|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
164085395|NCT00542386|592677238|FG000|Overall Study|Adverse Event|1|||
164085396|NCT00542386|592677239|FG001|Overall Study|Adverse Event|7|||
164340922|NCT01397890|593623830|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
164340923|NCT01397890|593623829|FG000|Overall Study|Death|2|||
164340924|NCT01397890|593623830|FG001|Overall Study|Death|3|||
164340925|NCT01397890|593623829|FG000|Overall Study|Lost to Follow-up|1|||
164340926|NCT01397890|593623830|FG001|Overall Study|Lost to Follow-up|4|||
164340927|NCT01397890|593623829|FG000|Overall Study|Condition under Investigation Worsened|1|||
164340928|NCT01397890|593623830|FG001|Overall Study|Condition under Investigation Worsened|3|||
164340929|NCT01397890|593623829|FG000|Overall Study|Adverse Event|1|||
163993959|NCT02631538|592345910|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
163993960|NCT02631538|592345911|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
163993961|NCT02631538|592345912|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
163993962|NCT02631538|592345913|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
163993963|NCT00440726|592345916|FG000|Phase 1|Dose-Limiting Toxicity|0|||
163993964|NCT00440726|592345917|FG001|Phase 1|Dose-Limiting Toxicity|1|||
163993965|NCT00440726|592345918|FG002|Phase 1|Dose-Limiting Toxicity|0|||
164085397|NCT00542386|592677240|FG002|Overall Study|Adverse Event|7|||
164085398|NCT00542386|592677241|FG003|Overall Study|Adverse Event|8|||
163993966|NCT00440726|592345916|FG000|Phase 1|Physician Decision|1|||
163993967|NCT00440726|592345917|FG001|Phase 1|Physician Decision|0|||
163993968|NCT00440726|592345918|FG002|Phase 1|Physician Decision|0|||
163993969|NCT00440726|592345916|FG000|Phase 2|Death|0|||
163993970|NCT00440726|592345917|FG001|Phase 2|Death|0|||
163993971|NCT00440726|592345918|FG002|Phase 2|Death|1|||
163993972|NCT00440726|592345916|FG000|Phase 2|Adverse Event|0|||
163993973|NCT00440726|592345917|FG001|Phase 2|Adverse Event|0|||
163993974|NCT00440726|592345918|FG002|Phase 2|Adverse Event|1|||
163993975|NCT04067518|592345919|FG000|Overall Study|Adverse Event|1|||
163993976|NCT04067518|592345920|FG001|Overall Study|Adverse Event|3|||
164340930|NCT01397890|593623830|FG001|Overall Study|Adverse Event|2|||
164340931|NCT01397890|593623829|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
164340932|NCT01397890|593623830|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
164340933|NCT01397890|593623829|FG000|Overall Study|Others|2|||
164340934|NCT01397890|593623830|FG001|Overall Study|Others|1|||
164340935|NCT02763462|593623834|FG000|Overall Study|Protocol Violation|6|||
164340936|NCT00129272|593623835|FG000|Overall Study|Lost to Follow-up|12|||
163993977|NCT04067518|592345919|FG000|Overall Study|Screen failures|0|||
163993978|NCT04067518|592345920|FG001|Overall Study|Screen failures|1|||
163993979|NCT04067518|592345919|FG000|Overall Study|Enrolled but not treated|0|||
163993980|NCT04067518|592345920|FG001|Overall Study|Enrolled but not treated|1|||
163993981|NCT00110019|592345921|FG000|Overall Study|Lack of Efficacy|253|||
163993982|NCT00110019|592345922|FG001|Overall Study|Lack of Efficacy|285|||
163993983|NCT00110019|592345921|FG000|Overall Study|Adverse Event|61|||
163993984|NCT00110019|592345922|FG001|Overall Study|Adverse Event|40|||
163993985|NCT00110019|592345921|FG000|Overall Study|Death|13|||
163993986|NCT00110019|592345922|FG001|Overall Study|Death|15|||
163993987|NCT00110019|592345921|FG000|Overall Study|Withdrawal by Subject|21|||
163993988|NCT00110019|592345922|FG001|Overall Study|Withdrawal by Subject|9|||
163993989|NCT00110019|592345921|FG000|Overall Study|alternative therapy|5|||
163888868|NCT03800654|591965217|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
163888869|NCT03800654|591965218|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
163888870|NCT03800654|591965219|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
163888871|NCT03800654|591965217|FG000|Overall Study|Lost to Follow-up|2|||
163993990|NCT00110019|592345922|FG001|Overall Study|alternative therapy|1|||
163993991|NCT00110019|592345921|FG000|Overall Study|complicating disease|1|||
163993992|NCT00110019|592345922|FG001|Overall Study|complicating disease|1|||
163993993|NCT00110019|592345921|FG000|Overall Study|symptom deterioration|13|||
163993994|NCT00110019|592345922|FG001|Overall Study|symptom deterioration|16|||
163993995|NCT00110019|592345921|FG000|Overall Study|Not start protocol therapy|17|||
164340937|NCT00129272|593623836|FG001|Overall Study|Lost to Follow-up|11|||
164340938|NCT00129272|593623835|FG000|Overall Study|Withdrawal by Subject|5|||
164340939|NCT00129272|593623836|FG001|Overall Study|Withdrawal by Subject|11|||
163888872|NCT03800654|591965218|FG001|Overall Study|Lost to Follow-up|1|||
163888873|NCT03800654|591965219|FG002|Overall Study|Lost to Follow-up|6|||
163888874|NCT03800654|591965217|FG000|Overall Study|Medical Health Issue|0|||
163888875|NCT03800654|591965218|FG001|Overall Study|Medical Health Issue|0|||
163888876|NCT03800654|591965219|FG002|Overall Study|Medical Health Issue|1|||
163888877|NCT03800654|591965217|FG000|Overall Study|Personal Issues|0|||
163888878|NCT03800654|591965218|FG001|Overall Study|Personal Issues|2|||
163888879|NCT03800654|591965219|FG002|Overall Study|Personal Issues|0|||
163888880|NCT03800654|591965217|FG000|Overall Study|Protocol Violation|0|||
163888881|NCT03800654|591965218|FG001|Overall Study|Protocol Violation|1|||
163888882|NCT03800654|591965219|FG002|Overall Study|Protocol Violation|0|||
163888883|NCT03459729|591965220|FG000|Overall Study|Physician Decision|2|||
163888884|NCT02626533|591965227|FG000|Overall Study|Protocol Violation|14|||
163888885|NCT02626533|591965227|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
163888886|NCT02626533|591965227|FG000|Overall Study|Withdrawal by Subject|1|||
163888887|NCT04068181|591965228|FG000|Overall Study|Death|17|||
163888888|NCT04068181|591965229|FG001|Overall Study|Death|12|||
163888889|NCT04068181|591965230|FG002|Overall Study|Death|4|||
163993996|NCT00110019|592345922|FG001|Overall Study|Not start protocol therapy|16|||
164340940|NCT00675948|593623838|FG000|Overall Study|Adverse Event|23|||
164340941|NCT00675948|593623839|FG001|Overall Study|Adverse Event|1|||
164340942|NCT00675948|593623838|FG000|Overall Study|Lack of Efficacy|3|||
164340943|NCT00675948|593623839|FG001|Overall Study|Lack of Efficacy|0|||
164340944|NCT00675948|593623838|FG000|Overall Study|Withdrawal by Subject|7|||
164340945|NCT00675948|593623839|FG001|Overall Study|Withdrawal by Subject|0|||
163888890|NCT04068181|591965231|FG003|Overall Study|Death|7|||
163888891|NCT04068181|591965228|FG000|Overall Study|Lost to Follow-up|1|||
163993997|NCT00110019|592345921|FG000|Overall Study|other reasons|22|||
163993998|NCT00110019|592345922|FG001|Overall Study|other reasons|30|||
164340946|NCT00675948|593623838|FG000|Overall Study|Lost to Follow-up|2|||
163888892|NCT04068181|591965229|FG001|Overall Study|Lost to Follow-up|0|||
163993999|NCT04276207|592345926|FG000|Period 1|Withdrawal by Subject|0|||
163994000|NCT04276207|592345927|FG001|Period 1|Withdrawal by Subject|1|||
163994001|NCT01256177|592345928|FG000|Overall Study|Withdrawal by Subject|23|||
163994002|NCT01256177|592345929|FG001|Overall Study|Withdrawal by Subject|22|||
163994003|NCT01256177|592345928|FG000|Overall Study|Lost to Follow-up|2|||
164340947|NCT00675948|593623839|FG001|Overall Study|Lost to Follow-up|0|||
164340948|NCT00675948|593623838|FG000|Overall Study|Protocol Violation|1|||
164340949|NCT00675948|593623839|FG001|Overall Study|Protocol Violation|0|||
164340950|NCT00675948|593623838|FG000|Overall Study|Pain under control|1|||
164340951|NCT00675948|593623839|FG001|Overall Study|Pain under control|0|||
164340952|NCT00675948|593623838|FG000|Overall Study|Sponsor decision|0|||
164340953|NCT00675948|593623839|FG001|Overall Study|Sponsor decision|1|||
164340954|NCT00675948|593623838|FG000|Overall Study|Patient died|1|||
164340955|NCT00675948|593623839|FG001|Overall Study|Patient died|0|||
164340956|NCT00675948|593623838|FG000|Overall Study|Patient unable to comply with diaries|1|||
164340957|NCT00675948|593623839|FG001|Overall Study|Patient unable to comply with diaries|0|||
164340958|NCT00675948|593623838|FG000|Overall Study|Patient feels unable to take medication|0|||
164340959|NCT00675948|593623839|FG001|Overall Study|Patient feels unable to take medication|1|||
164340960|NCT02100514|593623840|FG000|Treatment Period|Adverse Event|0|||
164340961|NCT02100514|593623841|FG001|Treatment Period|Adverse Event|5|||
164340962|NCT02100514|593623842|FG002|Treatment Period|Adverse Event|0|||
164340963|NCT02100514|593623843|FG003|Treatment Period|Adverse Event|0|||
164340964|NCT02100514|593623844|FG004|Treatment Period|Adverse Event|0|||
164340965|NCT02100514|593623840|FG000|Treatment Period|Death|2|||
164340966|NCT02100514|593623841|FG001|Treatment Period|Death|2|||
164340967|NCT02100514|593623842|FG002|Treatment Period|Death|0|||
164340968|NCT02100514|593623843|FG003|Treatment Period|Death|0|||
164340969|NCT02100514|593623844|FG004|Treatment Period|Death|0|||
164340970|NCT02100514|593623840|FG000|Treatment Period|Lost to Follow-up|5|||
164340971|NCT02100514|593623841|FG001|Treatment Period|Lost to Follow-up|17|||
164340972|NCT02100514|593623842|FG002|Treatment Period|Lost to Follow-up|0|||
164340973|NCT02100514|593623843|FG003|Treatment Period|Lost to Follow-up|0|||
164340974|NCT02100514|593623844|FG004|Treatment Period|Lost to Follow-up|0|||
164340975|NCT02100514|593623840|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340976|NCT02100514|593623841|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
164340977|NCT02100514|593623842|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340978|NCT02100514|593623843|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340979|NCT02100514|593623844|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
164340980|NCT02100514|593623840|FG000|Treatment Period|Protocol Violation|1|||
164340981|NCT02100514|593623841|FG001|Treatment Period|Protocol Violation|1|||
164340982|NCT02100514|593623842|FG002|Treatment Period|Protocol Violation|0|||
164340983|NCT02100514|593623843|FG003|Treatment Period|Protocol Violation|0|||
164340984|NCT02100514|593623844|FG004|Treatment Period|Protocol Violation|0|||
164340985|NCT02100514|593623840|FG000|Treatment Period|Withdrawal by Subject|12|||
164340986|NCT02100514|593623841|FG001|Treatment Period|Withdrawal by Subject|37|||
164340987|NCT02100514|593623842|FG002|Treatment Period|Withdrawal by Subject|0|||
164340988|NCT02100514|593623843|FG003|Treatment Period|Withdrawal by Subject|0|||
164340989|NCT02100514|593623844|FG004|Treatment Period|Withdrawal by Subject|0|||
164340990|NCT02100514|593623840|FG000|Treatment Period|Other|9|||
164340991|NCT02100514|593623841|FG001|Treatment Period|Other|11|||
164340992|NCT02100514|593623842|FG002|Treatment Period|Other|0|||
164340993|NCT02100514|593623843|FG003|Treatment Period|Other|0|||
164340994|NCT02100514|593623844|FG004|Treatment Period|Other|0|||
164340995|NCT02100514|593623840|FG000|Extension Period|Withdrew consent|0|||
164340996|NCT02100514|593623841|FG001|Extension Period|Withdrew consent|0|||
164340997|NCT02100514|593623842|FG002|Extension Period|Withdrew consent|2|||
164340998|NCT02100514|593623843|FG003|Extension Period|Withdrew consent|0|||
164340999|NCT02100514|593623844|FG004|Extension Period|Withdrew consent|0|||
164341000|NCT00319553|593623845|FG000|Overall Study|Protocol Violation|1|||
164341001|NCT00319553|593623846|FG001|Overall Study|Protocol Violation|2|||
164341002|NCT00319553|593623845|FG000|Overall Study|Lost to Follow-up|2|||
164341003|NCT00319553|593623846|FG001|Overall Study|Lost to Follow-up|1|||
164341004|NCT00319553|593623845|FG000|Overall Study|Withdrawal by Subject|1|||
164341005|NCT00319553|593623846|FG001|Overall Study|Withdrawal by Subject|1|||
164341006|NCT01145625|593623847|FG000|Overall Study|Lost to Follow-up|8|||
164341007|NCT01145625|593623848|FG001|Overall Study|Lost to Follow-up|9|||
164341008|NCT01145625|593623847|FG000|Overall Study|Adverse Event|6|||
164341009|NCT01145625|593623848|FG001|Overall Study|Adverse Event|4|||
163888893|NCT04068181|591965230|FG002|Overall Study|Lost to Follow-up|0|||
163888894|NCT04068181|591965231|FG003|Overall Study|Lost to Follow-up|0|||
163888895|NCT04068181|591965228|FG000|Overall Study|Withdrawal of consent from study|3|||
163888896|NCT04068181|591965229|FG001|Overall Study|Withdrawal of consent from study|0|||
163888897|NCT04068181|591965230|FG002|Overall Study|Withdrawal of consent from study|0|||
163888898|NCT04068181|591965231|FG003|Overall Study|Withdrawal of consent from study|0|||
163888899|NCT03785964|591965234|FG000|Overall Study|Adverse Event|14|||
163888900|NCT03785964|591965235|FG001|Overall Study|Adverse Event|1|||
163888901|NCT03785964|591965234|FG000|Overall Study|Unqualified Clinical Progression|1|||
163888902|NCT03785964|591965235|FG001|Overall Study|Unqualified Clinical Progression|1|||
163888903|NCT03785964|591965234|FG000|Overall Study|Participant non-compliance|1|||
163888904|NCT03785964|591965235|FG001|Overall Study|Participant non-compliance|1|||
163888905|NCT03785964|591965234|FG000|Overall Study|Not treated|1|||
163888906|NCT03785964|591965235|FG001|Overall Study|Not treated|0|||
163994004|NCT01256177|592345929|FG001|Overall Study|Lost to Follow-up|2|||
163994005|NCT01256177|592345928|FG000|Overall Study|Adverse Event|8|||
163994006|NCT01256177|592345929|FG001|Overall Study|Adverse Event|9|||
163994007|NCT01256177|592345928|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
163994008|NCT01256177|592345929|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
163994009|NCT01256177|592345928|FG000|Overall Study|Condition under Investigation Worsened|1|||
163994010|NCT01256177|592345929|FG001|Overall Study|Condition under Investigation Worsened|0|||
163994011|NCT01256177|592345928|FG000|Overall Study|Lack of Efficacy|11|||
163994012|NCT01256177|592345929|FG001|Overall Study|Lack of Efficacy|2|||
163994013|NCT01256177|592345928|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
163994014|NCT01256177|592345929|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
163994015|NCT02690194|592345930|FG000|Overall Study|Withdrawal by Subject|1|||
163994016|NCT02690194|592345931|FG001|Overall Study|Withdrawal by Subject|4|||
163994017|NCT02690194|592345932|FG002|Overall Study|Withdrawal by Subject|0|||
163994018|NCT03624946|592345933|FG000|Overall Study|Lost to Follow-up|0|||
163994019|NCT03624946|592345934|FG001|Overall Study|Lost to Follow-up|1|||
163994020|NCT00862251|592345938|FG000|Overall Study|Adverse Event|8|||
163994021|NCT00862251|592345939|FG001|Overall Study|Adverse Event|3|||
163994022|NCT00862251|592345940|FG002|Overall Study|Adverse Event|1|||
163994023|NCT00862251|592345938|FG000|Overall Study|Lost to Follow-up|0|||
163994024|NCT00862251|592345939|FG001|Overall Study|Lost to Follow-up|0|||
163994025|NCT00862251|592345940|FG002|Overall Study|Lost to Follow-up|1|||
163994026|NCT00862251|592345938|FG000|Overall Study|Protocol Violation|2|||
163994027|NCT00862251|592345939|FG001|Overall Study|Protocol Violation|0|||
163994028|NCT00862251|592345940|FG002|Overall Study|Protocol Violation|1|||
163994029|NCT00862251|592345938|FG000|Overall Study|Withdrawal by Subject|9|||
163994030|NCT00862251|592345939|FG001|Overall Study|Withdrawal by Subject|2|||
163994031|NCT00862251|592345940|FG002|Overall Study|Withdrawal by Subject|6|||
163994032|NCT00624520|592345941|FG000|Overall Study|Withdrawal by Subject|12|||
163994033|NCT00624520|592345942|FG001|Overall Study|Withdrawal by Subject|7|||
163994034|NCT00624520|592345941|FG000|Overall Study|Death|0|||
163994035|NCT00624520|592345942|FG001|Overall Study|Death|1|||
163994036|NCT02796755|592345943|FG000|Overall Study|Adverse Event|2|||
163994037|NCT02796755|592345944|FG001|Overall Study|Adverse Event|0|||
163994038|NCT00675025|592345945|FG000|Overall Study|Study Terminated by Sponsor|38|||
163994039|NCT00675025|592345946|FG001|Overall Study|Study Terminated by Sponsor|42|||
163994040|NCT00675025|592345945|FG000|Overall Study|Adverse Event|6|||
163994041|NCT00675025|592345946|FG001|Overall Study|Adverse Event|11|||
163994042|NCT00675025|592345945|FG000|Overall Study|Lost to Follow-up|6|||
163994043|NCT00675025|592345946|FG001|Overall Study|Lost to Follow-up|4|||
163994044|NCT00675025|592345945|FG000|Overall Study|Withdrawal by Subject|4|||
163994045|NCT00675025|592345946|FG001|Overall Study|Withdrawal by Subject|6|||
163994046|NCT00556426|592345950|FG000|Overall Study|Withdrawal by Subject|3|||
163994047|NCT00556426|592345950|FG000|Overall Study|Death|6|||
163994048|NCT00944034|592345952|FG000|Overall Study|Inappropriate enrollment|0|||
163994049|NCT00944034|592345953|FG001|Overall Study|Inappropriate enrollment|1|||
163994050|NCT00944034|592345954|FG002|Overall Study|Inappropriate enrollment|0|||
163994051|NCT00944034|592345955|FG003|Overall Study|Inappropriate enrollment|1|||
163994052|NCT00944034|592345956|FG004|Overall Study|Inappropriate enrollment|2|||
163994053|NCT00944034|592345957|FG005|Overall Study|Inappropriate enrollment|1|||
163994054|NCT00944034|592345958|FG006|Overall Study|Inappropriate enrollment|0|||
163994055|NCT00944034|592345959|FG007|Overall Study|Inappropriate enrollment|0|||
163994056|NCT00944034|592345960|FG008|Overall Study|Inappropriate enrollment|1|||
163994057|NCT00944034|592345961|FG009|Overall Study|Inappropriate enrollment|1|||
163994058|NCT00944034|592345962|FG010|Overall Study|Inappropriate enrollment|0|||
163994059|NCT00944034|592345963|FG011|Overall Study|Inappropriate enrollment|0|||
163994060|NCT00944034|592345952|FG000|Overall Study|Withdrawal by Subject|3|||
163994061|NCT00944034|592345953|FG001|Overall Study|Withdrawal by Subject|2|||
163994062|NCT00944034|592345954|FG002|Overall Study|Withdrawal by Subject|6|||
163994063|NCT00944034|592345955|FG003|Overall Study|Withdrawal by Subject|2|||
163994064|NCT00944034|592345956|FG004|Overall Study|Withdrawal by Subject|5|||
163994065|NCT00944034|592345957|FG005|Overall Study|Withdrawal by Subject|8|||
163994066|NCT00944034|592345958|FG006|Overall Study|Withdrawal by Subject|2|||
163994067|NCT00944034|592345959|FG007|Overall Study|Withdrawal by Subject|2|||
163994068|NCT00944034|592345960|FG008|Overall Study|Withdrawal by Subject|3|||
163994069|NCT00944034|592345961|FG009|Overall Study|Withdrawal by Subject|4|||
163994070|NCT00944034|592345962|FG010|Overall Study|Withdrawal by Subject|0|||
163994071|NCT00944034|592345963|FG011|Overall Study|Withdrawal by Subject|4|||
163994072|NCT00944034|592345952|FG000|Overall Study|Lost to Follow-up|0|||
163994073|NCT00944034|592345953|FG001|Overall Study|Lost to Follow-up|4|||
163994074|NCT00944034|592345954|FG002|Overall Study|Lost to Follow-up|2|||
163994075|NCT00944034|592345955|FG003|Overall Study|Lost to Follow-up|0|||
163994076|NCT00944034|592345956|FG004|Overall Study|Lost to Follow-up|5|||
163994077|NCT00944034|592345957|FG005|Overall Study|Lost to Follow-up|7|||
163994078|NCT00944034|592345958|FG006|Overall Study|Lost to Follow-up|0|||
163994079|NCT00944034|592345959|FG007|Overall Study|Lost to Follow-up|1|||
164263535|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
163994080|NCT00944034|592345960|FG008|Overall Study|Lost to Follow-up|5|||
163994081|NCT00944034|592345961|FG009|Overall Study|Lost to Follow-up|1|||
163994082|NCT00944034|592345962|FG010|Overall Study|Lost to Follow-up|1|||
163994083|NCT00944034|592345963|FG011|Overall Study|Lost to Follow-up|0|||
163994084|NCT00944034|592345952|FG000|Overall Study|Death|0|||
163994085|NCT00944034|592345953|FG001|Overall Study|Death|0|||
163994086|NCT00944034|592345954|FG002|Overall Study|Death|1|||
163994087|NCT00944034|592345955|FG003|Overall Study|Death|0|||
163994088|NCT00944034|592345956|FG004|Overall Study|Death|0|||
163994089|NCT00944034|592345957|FG005|Overall Study|Death|0|||
163888907|NCT03785964|591965234|FG000|Overall Study|Other reason|5|||
163994090|NCT00944034|592345958|FG006|Overall Study|Death|0|||
163994091|NCT00944034|592345959|FG007|Overall Study|Death|0|||
163994092|NCT00944034|592345960|FG008|Overall Study|Death|0|||
163994093|NCT00944034|592345961|FG009|Overall Study|Death|0|||
163994094|NCT00944034|592345962|FG010|Overall Study|Death|0|||
163888908|NCT03785964|591965235|FG001|Overall Study|Other reason|11|||
163888909|NCT03785964|591965234|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
163888910|NCT03785964|591965235|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
163888911|NCT02723591|591965236|FG000|Overall Study|Adverse Event|48|||
163888912|NCT02723591|591965237|FG001|Overall Study|Adverse Event|40|||
163888913|NCT02723591|591965236|FG000|Overall Study|Death|2|||
163888914|NCT02723591|591965237|FG001|Overall Study|Death|2|||
163888915|NCT02723591|591965236|FG000|Overall Study|Lack of Efficacy|4|||
163888916|NCT02723591|591965237|FG001|Overall Study|Lack of Efficacy|3|||
163888917|NCT02723591|591965236|FG000|Overall Study|Lost to Follow-up|1|||
163888918|NCT02723591|591965237|FG001|Overall Study|Lost to Follow-up|7|||
163888919|NCT02723591|591965236|FG000|Overall Study|Protocol Violation|20|||
163888920|NCT02723591|591965237|FG001|Overall Study|Protocol Violation|23|||
163888921|NCT02723591|591965236|FG000|Overall Study|Withdrawal by Subject|4|||
163888922|NCT02723591|591965237|FG001|Overall Study|Withdrawal by Subject|8|||
163888923|NCT02723591|591965236|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
163888924|NCT02723591|591965237|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
163888925|NCT02723591|591965236|FG000|Overall Study|Miscellaneous|5|||
163888926|NCT02723591|591965237|FG001|Overall Study|Miscellaneous|6|||
163888927|NCT05070728|591965238|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
163888928|NCT05070728|591965239|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
163888929|NCT02151981|591965240|FG000|Overall Study|Death|184|||
163888930|NCT02151981|591965241|FG001|Overall Study|Death|88|||
163888931|NCT02151981|591965240|FG000|Overall Study|Lost to Follow-up|7|||
163888932|NCT02151981|591965241|FG001|Overall Study|Lost to Follow-up|1|||
163888933|NCT02151981|591965240|FG000|Overall Study|Withdrawal by Subject|27|||
163888934|NCT02151981|591965241|FG001|Overall Study|Withdrawal by Subject|21|||
163888935|NCT02151981|591965240|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163888936|NCT02151981|591965241|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163994095|NCT00944034|592345963|FG011|Overall Study|Death|0|||
163994096|NCT00944034|592345952|FG000|Overall Study|Protocol Violation|2|||
163994097|NCT00944034|592345953|FG001|Overall Study|Protocol Violation|0|||
163994098|NCT00944034|592345954|FG002|Overall Study|Protocol Violation|0|||
163994099|NCT00944034|592345955|FG003|Overall Study|Protocol Violation|1|||
163994100|NCT00944034|592345956|FG004|Overall Study|Protocol Violation|2|||
163994101|NCT00944034|592345957|FG005|Overall Study|Protocol Violation|3|||
163994102|NCT00944034|592345958|FG006|Overall Study|Protocol Violation|0|||
163994103|NCT00944034|592345959|FG007|Overall Study|Protocol Violation|1|||
163994104|NCT00944034|592345960|FG008|Overall Study|Protocol Violation|1|||
163994105|NCT00944034|592345961|FG009|Overall Study|Protocol Violation|4|||
163994106|NCT00944034|592345962|FG010|Overall Study|Protocol Violation|0|||
163994107|NCT00944034|592345963|FG011|Overall Study|Protocol Violation|0|||
163994108|NCT00944034|592345952|FG000|Overall Study|Unable to classify|0|||
163994109|NCT00944034|592345953|FG001|Overall Study|Unable to classify|0|||
163994110|NCT00944034|592345954|FG002|Overall Study|Unable to classify|0|||
163994111|NCT00944034|592345955|FG003|Overall Study|Unable to classify|0|||
163994112|NCT00944034|592345956|FG004|Overall Study|Unable to classify|0|||
163994113|NCT00944034|592345957|FG005|Overall Study|Unable to classify|1|||
163994114|NCT00944034|592345958|FG006|Overall Study|Unable to classify|1|||
163888937|NCT02151981|591965240|FG000|Overall Study|Other reasons|1|||
163888938|NCT02151981|591965241|FG001|Overall Study|Other reasons|2|||
163888939|NCT05645757|591965261|FG000|Overall Study|Enrolled but treatment not administered|0|||
163888940|NCT05645757|591965262|FG001|Overall Study|Enrolled but treatment not administered|0|||
163994115|NCT00944034|592345959|FG007|Overall Study|Unable to classify|1|||
163994116|NCT00944034|592345960|FG008|Overall Study|Unable to classify|0|||
163994117|NCT00944034|592345961|FG009|Overall Study|Unable to classify|0|||
163994118|NCT00944034|592345962|FG010|Overall Study|Unable to classify|0|||
163994119|NCT00944034|592345963|FG011|Overall Study|Unable to classify|0|||
163994120|NCT00944034|592345952|FG000|Overall Study|Administrative reason|0|||
163994121|NCT00944034|592345953|FG001|Overall Study|Administrative reason|0|||
163994122|NCT00944034|592345954|FG002|Overall Study|Administrative reason|0|||
163994123|NCT00944034|592345955|FG003|Overall Study|Administrative reason|0|||
163994124|NCT00944034|592345956|FG004|Overall Study|Administrative reason|0|||
163994125|NCT00944034|592345957|FG005|Overall Study|Administrative reason|0|||
163994126|NCT00944034|592345958|FG006|Overall Study|Administrative reason|1|||
163994127|NCT00944034|592345959|FG007|Overall Study|Administrative reason|0|||
163994128|NCT00944034|592345960|FG008|Overall Study|Administrative reason|0|||
163994129|NCT00944034|592345961|FG009|Overall Study|Administrative reason|0|||
163994130|NCT00944034|592345962|FG010|Overall Study|Administrative reason|0|||
163994131|NCT00944034|592345963|FG011|Overall Study|Administrative reason|0|||
163994132|NCT01596257|592345964|FG000|Overall Study|Inadequate Collection|23|||
163994133|NCT01596257|592345965|FG001|Overall Study|Inadequate Collection|19|||
163994134|NCT01570244|592345969|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
163994135|NCT00531960|592345972|FG000|Overall Study|Adverse Event|5|||
163994136|NCT00531960|592345973|FG001|Overall Study|Adverse Event|4|||
164085399|NCT00542386|592677242|FG004|Overall Study|Adverse Event|13|||
164085400|NCT00542386|592677243|FG005|Overall Study|Adverse Event|4|||
164085401|NCT00542386|592677238|FG000|Overall Study|Death|0|||
164085402|NCT00542386|592677239|FG001|Overall Study|Death|0|||
163888941|NCT05645757|591965263|FG002|Overall Study|Enrolled but treatment not administered|0|||
163888942|NCT05645757|591965264|FG003|Overall Study|Enrolled but treatment not administered|0|||
163888943|NCT05645757|591965265|FG004|Overall Study|Enrolled but treatment not administered|1|||
163888944|NCT05645757|591965266|FG005|Overall Study|Enrolled but treatment not administered|1|||
163888945|NCT05645757|591965267|FG006|Overall Study|Enrolled but treatment not administered|0|||
163888946|NCT05645757|591965268|FG007|Overall Study|Enrolled but treatment not administered|0|||
163888947|NCT03905798|591965269|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
163888948|NCT03463044|591965270|FG000|Overall Study|Lost to Follow-up|0|||
163888949|NCT03463044|591965271|FG001|Overall Study|Lost to Follow-up|0|||
163888950|NCT03463044|591965272|FG002|Overall Study|Lost to Follow-up|0|||
163888951|NCT03463044|591965273|FG003|Overall Study|Lost to Follow-up|0|||
163888952|NCT03463044|591965274|FG004|Overall Study|Lost to Follow-up|0|||
163888953|NCT03463044|591965275|FG005|Overall Study|Lost to Follow-up|0|||
163888954|NCT03463044|591965276|FG006|Overall Study|Lost to Follow-up|0|||
163888955|NCT03463044|591965277|FG007|Overall Study|Lost to Follow-up|1|||
163888956|NCT03463044|591965278|FG008|Overall Study|Lost to Follow-up|0|||
163888957|NCT03334630|591965279|FG000|Overall Study|Withdrawal by Subject|7|||
163888958|NCT03334630|591965280|FG001|Overall Study|Withdrawal by Subject|7|||
163888959|NCT03334630|591965279|FG000|Overall Study|Lost to Follow-up|3|||
163888960|NCT03334630|591965280|FG001|Overall Study|Lost to Follow-up|1|||
163888961|NCT03334630|591965279|FG000|Overall Study|Adverse Event|0|||
163888962|NCT03334630|591965280|FG001|Overall Study|Adverse Event|1|||
163888963|NCT03334630|591965279|FG000|Overall Study|Physician Decision|1|||
163888964|NCT03334630|591965280|FG001|Overall Study|Physician Decision|1|||
163888965|NCT03334630|591965279|FG000|Overall Study|Enrollment closed|2|||
163888966|NCT03334630|591965280|FG001|Overall Study|Enrollment closed|1|||
163888967|NCT03334630|591965279|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
163888968|NCT03334630|591965280|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
163888969|NCT03334630|591965279|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
163888970|NCT03334630|591965280|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
163888971|NCT04498390|591965281|FG000|Overall Study|Adverse Event|0|||
163888972|NCT04498390|591965282|FG001|Overall Study|Adverse Event|0|||
163888973|NCT04498390|591965283|FG002|Overall Study|Adverse Event|1|||
163888974|NCT04498390|591965284|FG003|Overall Study|Adverse Event|0|||
163888975|NCT04498390|591965285|FG004|Overall Study|Adverse Event|0|||
163888976|NCT04498390|591965281|FG000|Overall Study|Withdrawal by Subject|0|||
163888977|NCT04498390|591965282|FG001|Overall Study|Withdrawal by Subject|0|||
163888978|NCT04498390|591965283|FG002|Overall Study|Withdrawal by Subject|0|||
163888979|NCT04498390|591965284|FG003|Overall Study|Withdrawal by Subject|1|||
163888980|NCT04498390|591965285|FG004|Overall Study|Withdrawal by Subject|0|||
163888981|NCT02068885|591965286|FG000|Overall Study|Withdrew|3|||
163888982|NCT02068885|591965287|FG001|Overall Study|Withdrew|5|||
163888983|NCT02068885|591965288|FG002|Overall Study|Withdrew|8|||
163888984|NCT04721977|591965293|FG000|Overall Study|Death|15|||
163888985|NCT04721977|591965293|FG000|Overall Study|Ongoing|51|||
163888986|NCT04304820|591967429|FG000|Overall Study|Death|1|||
163888987|NCT04304820|591967429|FG000|Overall Study|Lost to Follow-up|1|||
163888988|NCT04304820|591967429|FG000|Overall Study|Pursuing Stem Cell Transplant|4|||
163888989|NCT04304820|591967429|FG000|Overall Study|Pursuing Additional Immunosuppressive therapy|4|||
163888990|NCT04304820|591967429|FG000|Overall Study|Evolution to Myeloid Malignancy|1|||
163888991|NCT03873818|591967430|FG000|Overall Study|Death|9|||
163888992|NCT03873818|591967431|FG001|Overall Study|Death|3|||
163888993|NCT03873818|591967430|FG000|Overall Study|Lost to Follow-up|1|||
163888994|NCT03873818|591967431|FG001|Overall Study|Lost to Follow-up|0|||
163888995|NCT05171855|591967432|FG000|Overall Study|Death|1|||
163888996|NCT05171855|591967433|FG001|Overall Study|Death|0|||
163888997|NCT05171855|591967434|FG002|Overall Study|Death|0|||
163888998|NCT05171855|591967432|FG000|Overall Study|Withdrawal by Subject|2|||
163888999|NCT05171855|591967433|FG001|Overall Study|Withdrawal by Subject|0|||
163994137|NCT00531960|592345972|FG000|Overall Study|Death|3|||
163994138|NCT00531960|592345973|FG001|Overall Study|Death|2|||
163994139|NCT00531960|592345972|FG000|Overall Study|Lack of Efficacy|42|||
163994140|NCT00531960|592345973|FG001|Overall Study|Lack of Efficacy|41|||
163994141|NCT00531960|592345972|FG000|Overall Study|Violation of Selection Criteria|2|||
163994142|NCT00531960|592345973|FG001|Overall Study|Violation of Selection Criteria|0|||
163994143|NCT00531960|592345972|FG000|Overall Study|Refused Treatment|5|||
163994144|NCT00531960|592345973|FG001|Overall Study|Refused Treatment|6|||
163994145|NCT00531960|592345972|FG000|Overall Study|Other|4|||
163994146|NCT00531960|592345973|FG001|Overall Study|Other|10|||
163994147|NCT04258579|592345975|FG000|Overall Study|Withdrawal by Subject|7|||
163994148|NCT04258579|592345975|FG000|Overall Study|Lost to Follow-up|3|||
163994149|NCT04258579|592345975|FG000|Overall Study|Protocol Violation|2|||
163994150|NCT04258579|592345975|FG000|Overall Study|Adverse Event|1|||
163994151|NCT04007159|592345976|FG000|Induction Phase|(missed study visits)|16|||
163994152|NCT04007159|592345976|FG000|Induction Phase|Withdrawal by Subject|4|||
163994153|NCT04007159|592345976|FG000|Induction Phase|Adverse Event|2|||
163994154|NCT04007159|592345976|FG000|Challenge Phase|missed study visits|3|||
163994155|NCT00331006|592345978|FG000|Screening Phase|Withdrawal by Subject|1|||
163994156|NCT00331006|592345978|FG000|Screening Phase|enrollment halted|1|||
163994157|NCT00331006|592345978|FG000|Screening Phase|Lost to Follow-up|1|||
163994158|NCT00331006|592345978|FG000|Screening Phase|Ineligible for treatment phase|4|||
163994159|NCT00331006|592345978|FG000|Treatment Phase|Withdrawal by Subject|1|||
163994160|NCT00331006|592345978|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
163994161|NCT00331006|592345978|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
163994162|NCT03804684|592345979|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
163994163|NCT03804684|592345980|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
163994164|NCT00238264|592345981|FG000|Overall Study|Death|7|||
163994165|NCT00238264|592345981|FG000|Overall Study|Lost to Follow-up|18|||
163994166|NCT00238264|592345981|FG000|Overall Study|Withdrawal by Subject|4|||
163994167|NCT00238264|592345981|FG000|Overall Study|Ineligible|7|||
163994168|NCT00713219|592345982|FG000|Overall Study|Death|1|||
163994169|NCT00713219|592345982|FG000|Overall Study|Protocol Violation|1|||
163994170|NCT03183128|592345983|FG000|Overall Study|Adverse Event|1|||
163994171|NCT03183128|592345984|FG001|Overall Study|Adverse Event|2|||
163994172|NCT03183128|592345983|FG000|Overall Study|Withdrawal by Subject|1|||
163994173|NCT03183128|592345984|FG001|Overall Study|Withdrawal by Subject|8|||
163994174|NCT03183128|592345983|FG000|Overall Study|Protocol Violation|2|||
163994175|NCT03183128|592345984|FG001|Overall Study|Protocol Violation|0|||
163994176|NCT03183128|592345983|FG000|Overall Study|Lack of Efficacy|4|||
163994177|NCT03183128|592345984|FG001|Overall Study|Lack of Efficacy|27|||
163994178|NCT03183128|592345983|FG000|Overall Study|Lost to Follow-up|1|||
163994179|NCT03183128|592345984|FG001|Overall Study|Lost to Follow-up|0|||
163994180|NCT03183128|592345983|FG000|Overall Study|Death|2|||
163994181|NCT03183128|592345984|FG001|Overall Study|Death|0|||
163994182|NCT03183128|592345983|FG000|Overall Study|Physician Decision|1|||
163994183|NCT03183128|592345984|FG001|Overall Study|Physician Decision|0|||
163994184|NCT02978222|592345985|FG000|Overall Study|Withdrawal by Subject|2|||
163994185|NCT02978222|592345986|FG001|Overall Study|Withdrawal by Subject|2|||
163994186|NCT02978222|592345985|FG000|Overall Study|Physician Decision|2|||
163994187|NCT02978222|592345986|FG001|Overall Study|Physician Decision|0|||
163994188|NCT02978222|592345985|FG000|Overall Study|Adverse Event|0|||
163994189|NCT02978222|592345986|FG001|Overall Study|Adverse Event|1|||
163994190|NCT02978222|592345985|FG000|Overall Study|Death|1|||
163994191|NCT02978222|592345986|FG001|Overall Study|Death|0|||
163994192|NCT02978222|592345985|FG000|Overall Study|Disease Progression|32|||
163994193|NCT02978222|592345986|FG001|Overall Study|Disease Progression|32|||
163994194|NCT02978222|592345985|FG000|Overall Study|Early Study Termination|24|||
163994195|NCT02978222|592345986|FG001|Overall Study|Early Study Termination|21|||
163994196|NCT03258814|592345987|FG000|Overall Study|Early Termination|4|||
163994197|NCT03258814|592345988|FG001|Overall Study|Early Termination|3|||
163994198|NCT03258814|592345989|FG002|Overall Study|Early Termination|10|||
163994199|NCT01413958|592345990|FG000|Overall Study|Lost to Follow-up|0|||
163994200|NCT01413958|592345991|FG001|Overall Study|Lost to Follow-up|1|||
163994201|NCT02908516|592345992|FG000|Overall Study|Study Terminated|3|||
163994202|NCT02908516|592345993|FG001|Overall Study|Study Terminated|3|||
163994203|NCT01225562|592345996|FG000|Overall Study|Withdrawal by Subject|52|||
163994204|NCT01225562|592345997|FG001|Overall Study|Withdrawal by Subject|50|||
163994205|NCT01225562|592345998|FG002|Overall Study|Withdrawal by Subject|52|||
163994206|NCT01225562|592345996|FG000|Overall Study|Lost to Follow-up|3|||
163994207|NCT01225562|592345997|FG001|Overall Study|Lost to Follow-up|6|||
163994208|NCT01225562|592345998|FG002|Overall Study|Lost to Follow-up|1|||
163994209|NCT00348140|592345999|FG000|Overall Study|Adverse Event|46|||
163994210|NCT00348140|592346000|FG001|Overall Study|Adverse Event|49|||
163994211|NCT00348140|592346001|FG002|Overall Study|Adverse Event|78|||
163994212|NCT00348140|592345999|FG000|Overall Study|Lost to Follow-up|4|||
163994213|NCT00348140|592346000|FG001|Overall Study|Lost to Follow-up|4|||
163994214|NCT00348140|592346001|FG002|Overall Study|Lost to Follow-up|4|||
163994215|NCT00348140|592345999|FG000|Overall Study|Protocol Violation|12|||
163994216|NCT00348140|592346000|FG001|Overall Study|Protocol Violation|13|||
163994217|NCT00348140|592346001|FG002|Overall Study|Protocol Violation|14|||
163994218|NCT00348140|592345999|FG000|Overall Study|Withdrawal by Subject|32|||
163994219|NCT00348140|592346000|FG001|Overall Study|Withdrawal by Subject|40|||
163994220|NCT00348140|592346001|FG002|Overall Study|Withdrawal by Subject|40|||
163994221|NCT00348140|592345999|FG000|Overall Study|Non-compliance|8|||
163994222|NCT00348140|592346000|FG001|Overall Study|Non-compliance|13|||
163994223|NCT00348140|592346001|FG002|Overall Study|Non-compliance|5|||
163994224|NCT00348140|592345999|FG000|Overall Study|Participant at risk due to study drug|2|||
163994225|NCT00348140|592346000|FG001|Overall Study|Participant at risk due to study drug|0|||
163994226|NCT00348140|592346001|FG002|Overall Study|Participant at risk due to study drug|0|||
163994227|NCT00348140|592345999|FG000|Overall Study|Conditional medication increased dose|1|||
163994228|NCT00348140|592346000|FG001|Overall Study|Conditional medication increased dose|0|||
163994229|NCT00348140|592346001|FG002|Overall Study|Conditional medication increased dose|0|||
163994230|NCT00348140|592345999|FG000|Overall Study|Caregiver related|4|||
163994231|NCT00348140|592346000|FG001|Overall Study|Caregiver related|7|||
163994232|NCT00348140|592346001|FG002|Overall Study|Caregiver related|3|||
163994233|NCT00348140|592345999|FG000|Overall Study|Participant hospitalised|3|||
163994234|NCT00348140|592346000|FG001|Overall Study|Participant hospitalised|0|||
163994235|NCT00348140|592346001|FG002|Overall Study|Participant hospitalised|0|||
163994236|NCT00348140|592345999|FG000|Overall Study|Efficacy related|1|||
163994237|NCT00348140|592346000|FG001|Overall Study|Efficacy related|1|||
163994238|NCT00348140|592346001|FG002|Overall Study|Efficacy related|0|||
163994239|NCT00348140|592345999|FG000|Overall Study|Administration related|3|||
163994240|NCT00348140|592346000|FG001|Overall Study|Administration related|1|||
163994241|NCT00348140|592346001|FG002|Overall Study|Administration related|1|||
163994242|NCT00348140|592345999|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
163994243|NCT00348140|592346000|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
163994244|NCT00348140|592346001|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
163994245|NCT00348140|592345999|FG000|Overall Study|Participant unwell|1|||
163994246|NCT00348140|592346000|FG001|Overall Study|Participant unwell|0|||
163994247|NCT00348140|592346001|FG002|Overall Study|Participant unwell|0|||
163994248|NCT00348140|592345999|FG000|Overall Study|Screen failure|1|||
163994249|NCT00348140|592346000|FG001|Overall Study|Screen failure|0|||
163994250|NCT00348140|592346001|FG002|Overall Study|Screen failure|0|||
163889000|NCT05171855|591967434|FG002|Overall Study|Withdrawal by Subject|5|||
163889001|NCT05171855|591967432|FG000|Overall Study|Physician Decision|1|||
163889002|NCT05171855|591967433|FG001|Overall Study|Physician Decision|0|||
163889003|NCT05171855|591967434|FG002|Overall Study|Physician Decision|0|||
163889004|NCT05171855|591967432|FG000|Overall Study|Adverse Event|2|||
163889005|NCT05171855|591967433|FG001|Overall Study|Adverse Event|4|||
163889006|NCT05171855|591967434|FG002|Overall Study|Adverse Event|2|||
163889007|NCT05171855|591967432|FG000|Overall Study|Other|0|||
163889008|NCT05171855|591967433|FG001|Overall Study|Other|0|||
163994251|NCT00348140|592345999|FG000|Overall Study|Investigator decided to discontinue|4|||
163994252|NCT00348140|592346000|FG001|Overall Study|Investigator decided to discontinue|1|||
163994253|NCT00348140|592346001|FG002|Overall Study|Investigator decided to discontinue|4|||
163994254|NCT00348140|592345999|FG000|Overall Study|Decided to discontinue on their own|1|||
163994255|NCT00348140|592346000|FG001|Overall Study|Decided to discontinue on their own|4|||
163994256|NCT00348140|592346001|FG002|Overall Study|Decided to discontinue on their own|1|||
163994257|NCT00348140|592345999|FG000|Overall Study|Use of prohibited drug|1|||
163994258|NCT00348140|592346000|FG001|Overall Study|Use of prohibited drug|0|||
163994259|NCT00348140|592346001|FG002|Overall Study|Use of prohibited drug|2|||
163994260|NCT00348140|592345999|FG000|Overall Study|Disease progression|1|||
163994261|NCT00348140|592346000|FG001|Overall Study|Disease progression|2|||
163994262|NCT00348140|592346001|FG002|Overall Study|Disease progression|5|||
163889009|NCT05171855|591967434|FG002|Overall Study|Other|1|||
163994263|NCT00348140|592345999|FG000|Overall Study|Increased risk of cardiac infarction|0|||
163994264|NCT00348140|592346000|FG001|Overall Study|Increased risk of cardiac infarction|1|||
163994265|NCT00348140|592346001|FG002|Overall Study|Increased risk of cardiac infarction|0|||
163994266|NCT00348140|592345999|FG000|Overall Study|Serious adverse event|0|||
163994267|NCT00348140|592346000|FG001|Overall Study|Serious adverse event|1|||
163994268|NCT00348140|592346001|FG002|Overall Study|Serious adverse event|0|||
163994269|NCT00348140|592345999|FG000|Overall Study|Abnormal ECG|0|||
163994270|NCT00348140|592346000|FG001|Overall Study|Abnormal ECG|1|||
163994271|NCT00348140|592346001|FG002|Overall Study|Abnormal ECG|3|||
163994272|NCT00348140|592345999|FG000|Overall Study|Participant died|0|||
163994273|NCT00348140|592346000|FG001|Overall Study|Participant died|1|||
163994274|NCT00348140|592346001|FG002|Overall Study|Participant died|0|||
163994275|NCT00348140|592345999|FG000|Overall Study|Exclusion criteria met|0|||
163994276|NCT00348140|592346000|FG001|Overall Study|Exclusion criteria met|0|||
163994277|NCT00348140|592346001|FG002|Overall Study|Exclusion criteria met|1|||
163994278|NCT00348140|592345999|FG000|Overall Study|Memory declined|0|||
163889010|NCT04221490|591967437|FG000|At 30 Days Follow-up|Death|7|||
163994279|NCT00348140|592346000|FG001|Overall Study|Memory declined|0|||
163994280|NCT00348140|592346001|FG002|Overall Study|Memory declined|1|||
163994281|NCT01375764|592346002|FG000|Overall Study|Lost to Follow-up|0|||
163994282|NCT01375764|592346003|FG001|Overall Study|Lost to Follow-up|1|||
163994283|NCT01375764|592346004|FG002|Overall Study|Lost to Follow-up|0|||
163994284|NCT01375764|592346005|FG003|Overall Study|Lost to Follow-up|0|||
163994285|NCT01375764|592346006|FG004|Overall Study|Lost to Follow-up|0|||
163994286|NCT01375764|592346002|FG000|Overall Study|Withdrawal by Subject|2|||
163994287|NCT01375764|592346003|FG001|Overall Study|Withdrawal by Subject|0|||
163994288|NCT01375764|592346004|FG002|Overall Study|Withdrawal by Subject|0|||
163994289|NCT01375764|592346005|FG003|Overall Study|Withdrawal by Subject|0|||
163994290|NCT01375764|592346006|FG004|Overall Study|Withdrawal by Subject|1|||
163994291|NCT01375764|592346002|FG000|Overall Study|Other|0|||
163994292|NCT01375764|592346003|FG001|Overall Study|Other|0|||
163994293|NCT01375764|592346004|FG002|Overall Study|Other|0|||
163994294|NCT01375764|592346005|FG003|Overall Study|Other|1|||
163994295|NCT01375764|592346006|FG004|Overall Study|Other|0|||
163994296|NCT03887130|592346007|FG000|Overall Study|Progressive disease|23|||
163994297|NCT03887130|592346008|FG001|Overall Study|Progressive disease|14|||
163994298|NCT03887130|592346009|FG002|Overall Study|Progressive disease|7|||
163994299|NCT03887130|592346007|FG000|Overall Study|Protocol Violation|3|||
164085403|NCT00542386|592677240|FG002|Overall Study|Death|1|||
164085404|NCT00542386|592677241|FG003|Overall Study|Death|2|||
164085405|NCT00542386|592677242|FG004|Overall Study|Death|1|||
164085406|NCT00542386|592677243|FG005|Overall Study|Death|2|||
164085407|NCT00542386|592677238|FG000|Overall Study|Lack of Efficacy|32|||
164085408|NCT00542386|592677239|FG001|Overall Study|Lack of Efficacy|12|||
164085409|NCT00542386|592677240|FG002|Overall Study|Lack of Efficacy|10|||
164085410|NCT00542386|592677241|FG003|Overall Study|Lack of Efficacy|13|||
164085411|NCT00542386|592677242|FG004|Overall Study|Lack of Efficacy|7|||
164085412|NCT00542386|592677243|FG005|Overall Study|Lack of Efficacy|31|||
164085413|NCT00542386|592677238|FG000|Overall Study|Physician Decision|1|||
164085414|NCT00542386|592677239|FG001|Overall Study|Physician Decision|0|||
164085415|NCT00542386|592677240|FG002|Overall Study|Physician Decision|0|||
164085416|NCT00542386|592677241|FG003|Overall Study|Physician Decision|1|||
164085417|NCT00542386|592677242|FG004|Overall Study|Physician Decision|0|||
164085418|NCT00542386|592677243|FG005|Overall Study|Physician Decision|0|||
164085419|NCT00542386|592677238|FG000|Overall Study|Protocol Violation|0|||
164085420|NCT00542386|592677239|FG001|Overall Study|Protocol Violation|0|||
164085421|NCT00542386|592677240|FG002|Overall Study|Protocol Violation|1|||
164085422|NCT00542386|592677241|FG003|Overall Study|Protocol Violation|0|||
164085423|NCT00542386|592677242|FG004|Overall Study|Protocol Violation|0|||
164085424|NCT00542386|592677243|FG005|Overall Study|Protocol Violation|4|||
164085425|NCT00542386|592677238|FG000|Overall Study|Withdrawal by Subject|5|||
164085426|NCT00542386|592677239|FG001|Overall Study|Withdrawal by Subject|8|||
164085427|NCT00542386|592677240|FG002|Overall Study|Withdrawal by Subject|10|||
164085428|NCT00542386|592677241|FG003|Overall Study|Withdrawal by Subject|11|||
164085429|NCT00542386|592677242|FG004|Overall Study|Withdrawal by Subject|15|||
164085430|NCT00542386|592677243|FG005|Overall Study|Withdrawal by Subject|7|||
164085431|NCT00542386|592677238|FG000|Overall Study|Other Reasons|4|||
164085432|NCT00542386|592677239|FG001|Overall Study|Other Reasons|1|||
164085433|NCT00542386|592677240|FG002|Overall Study|Other Reasons|4|||
164085434|NCT00542386|592677241|FG003|Overall Study|Other Reasons|3|||
164085435|NCT00542386|592677242|FG004|Overall Study|Other Reasons|4|||
164085436|NCT00542386|592677243|FG005|Overall Study|Other Reasons|2|||
164085437|NCT04864405|592677244|FG000|Overall Study|Withdrawal by Subject|4|||
164085438|NCT04864405|592677245|FG001|Overall Study|Withdrawal by Subject|6|||
164085439|NCT04864405|592677244|FG000|Overall Study|Did not want endocrine therapy|3|||
164085440|NCT04864405|592677245|FG001|Overall Study|Did not want endocrine therapy|5|||
164085441|NCT00506441|592677246|FG000|Period 1; Open-label Period|Adverse Event|21|||
164085442|NCT00506441|592677247|FG001|Period 1; Open-label Period|Adverse Event|0|||
164085443|NCT00506441|592677246|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
164085444|NCT00506441|592677247|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
164085445|NCT00506441|592677246|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
164085446|NCT00506441|592677247|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
164085447|NCT00506441|592677246|FG000|Period 1; Open-label Period|Physician Decision|5|||
164085448|NCT00506441|592677247|FG001|Period 1; Open-label Period|Physician Decision|0|||
164085449|NCT00506441|592677246|FG000|Period 1; Open-label Period|Protocol Violation|9|||
164085450|NCT00506441|592677247|FG001|Period 1; Open-label Period|Protocol Violation|0|||
164085451|NCT00506441|592677246|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
164263536|NCT03906656|593331914|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
163994300|NCT03887130|592346008|FG001|Overall Study|Protocol Violation|1|||
163994301|NCT03887130|592346009|FG002|Overall Study|Protocol Violation|2|||
163994302|NCT03887130|592346007|FG000|Overall Study|Drug related toxicity|7|||
163994303|NCT03887130|592346008|FG001|Overall Study|Drug related toxicity|7|||
164085452|NCT00506441|592677247|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
164085453|NCT00506441|592677246|FG000|Period 1; Open-label Period|Other Reasons|13|||
164085454|NCT00506441|592677247|FG001|Period 1; Open-label Period|Other Reasons|0|||
163994304|NCT03887130|592346009|FG002|Overall Study|Drug related toxicity|13|||
163994305|NCT03887130|592346007|FG000|Overall Study|Non drug related toxicity|3|||
163994306|NCT03887130|592346008|FG001|Overall Study|Non drug related toxicity|0|||
163994307|NCT03887130|592346009|FG002|Overall Study|Non drug related toxicity|0|||
163994308|NCT03887130|592346007|FG000|Overall Study|Death|2|||
163994309|NCT03887130|592346008|FG001|Overall Study|Death|2|||
163994310|NCT03887130|592346009|FG002|Overall Study|Death|1|||
163994311|NCT03887130|592346007|FG000|Overall Study|Withdrawal by Subject|7|||
163994312|NCT03887130|592346008|FG001|Overall Study|Withdrawal by Subject|6|||
163994313|NCT03887130|592346009|FG002|Overall Study|Withdrawal by Subject|11|||
163994314|NCT03887130|592346007|FG000|Overall Study|other reason|6|||
163994315|NCT03887130|592346008|FG001|Overall Study|other reason|20|||
163994316|NCT03887130|592346009|FG002|Overall Study|other reason|17|||
163994317|NCT00484315|592346010|FG000|12-Month Clinical Follow-up|Death|6|||
163994318|NCT00484315|592346011|FG001|12-Month Clinical Follow-up|Death|2|||
163994319|NCT00484315|592346010|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
163994320|NCT00484315|592346011|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
163994321|NCT00484315|592346010|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
163994322|NCT00484315|592346011|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
163994323|NCT00484315|592346010|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
163994324|NCT00484315|592346011|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
163994325|NCT00484315|592346010|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
163994326|NCT00484315|592346011|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
163994327|NCT00484315|592346010|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
163994328|NCT00484315|592346011|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
163994329|NCT00484315|592346010|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
163994330|NCT00484315|592346011|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
163994331|NCT01990261|592346012|FG000|Overall Study|Death Before Treatment Start|2|||
163994332|NCT01990261|592346012|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
163994333|NCT01990261|592346012|FG000|Overall Study|Death From other Causes|1|||
163994334|NCT01990261|592346012|FG000|Overall Study|Disease Progression (PD)|8|||
163994335|NCT01990261|592346012|FG000|Overall Study|PD Before Treatment Start|1|||
163994336|NCT01990261|592346012|FG000|Overall Study|Dossier not Approved|1|||
163994337|NCT01990261|592346012|FG000|Overall Study|Lost to Follow-up|2|||
163994338|NCT01078805|592346015|FG000|Overall Study|Clinically significant abnormal lab|5|||
163994339|NCT01078805|592346015|FG000|Overall Study|Death|134|||
163994340|NCT01078805|592346015|FG000|Overall Study|Lost to Follow-up|676|||
163994341|NCT01078805|592346015|FG000|Overall Study|Physician Decision|169|||
163994342|NCT01078805|592346015|FG000|Overall Study|Serious adverse event|26|||
163994343|NCT01078805|592346015|FG000|Overall Study|Sponsor decision|46|||
163994344|NCT01078805|592346015|FG000|Overall Study|Withdrawal by Subject|739|||
163994345|NCT01078805|592346015|FG000|Overall Study|Other|173|||
163994346|NCT01078805|592346015|FG000|Overall Study|Didn't take study drug|82|||
163994347|NCT01609842|592346016|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
163994348|NCT01609842|592346017|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
163994349|NCT04722991|592346018|FG000|Overall Study|Adverse Event|12|||
163994350|NCT04722991|592346019|FG001|Overall Study|Adverse Event|4|||
163994351|NCT04722991|592346018|FG000|Overall Study|Death|2|||
163994352|NCT04722991|592346019|FG001|Overall Study|Death|0|||
163994353|NCT04722991|592346018|FG000|Overall Study|Lost to Follow-up|1|||
163994354|NCT04722991|592346019|FG001|Overall Study|Lost to Follow-up|1|||
163994355|NCT04722991|592346018|FG000|Overall Study|Withdrawal cirterion met|2|||
163994356|NCT04722991|592346019|FG001|Overall Study|Withdrawal cirterion met|2|||
163994357|NCT04722991|592346018|FG000|Overall Study|Other|1|||
163994358|NCT04722991|592346019|FG001|Overall Study|Other|0|||
163994359|NCT04722991|592346018|FG000|Overall Study|Non-compliance|0|||
163994360|NCT04722991|592346019|FG001|Overall Study|Non-compliance|1|||
163994361|NCT04722991|592346018|FG000|Overall Study|Withdrawal by Subject|0|||
163994362|NCT04722991|592346019|FG001|Overall Study|Withdrawal by Subject|1|||
163994363|NCT03186989|592346020|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163994364|NCT03186989|592346021|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163994365|NCT03186989|592346022|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
163994366|NCT03186989|592346023|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
163994367|NCT03186989|592346024|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
163994368|NCT03186989|592346025|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163994369|NCT03186989|592346026|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164263537|NCT03906656|593331915|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
163994370|NCT03186989|592346027|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
164263538|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
164085455|NCT00506441|592677246|FG000|Period 2; Double-blind Period|Adverse Event|0|||
164085456|NCT00506441|592677247|FG001|Period 2; Double-blind Period|Adverse Event|1|||
164263539|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
164263540|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
164263541|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
164263542|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Death|2|||
163994371|NCT03186989|592346028|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163994372|NCT03186989|592346029|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163994373|NCT03186989|592346030|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
163994374|NCT03186989|592346020|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994375|NCT03186989|592346021|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994376|NCT03186989|592346022|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994377|NCT03186989|592346023|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994378|NCT03186989|592346024|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994379|NCT03186989|592346025|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
163994380|NCT03186989|592346026|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994381|NCT03186989|592346027|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994382|NCT03186989|592346028|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994383|NCT03186989|592346029|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994384|NCT03186989|592346030|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
163994385|NCT03186989|592346020|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994386|NCT03186989|592346021|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994387|NCT03186989|592346022|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994388|NCT03186989|592346023|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994389|NCT03186989|592346024|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994390|NCT03186989|592346025|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994391|NCT03186989|592346026|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
163994392|NCT03186989|592346027|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994393|NCT03186989|592346028|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994394|NCT03186989|592346029|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994395|NCT03186989|592346030|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
163994396|NCT03186989|592346020|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994397|NCT03186989|592346021|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994398|NCT03186989|592346022|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994399|NCT03186989|592346023|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994400|NCT03186989|592346024|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
164142275|NCT01696058|592882584|FG000|Overall Study|Adverse Event|21|||
164142276|NCT01696058|592882585|FG001|Overall Study|Adverse Event|11|||
164142277|NCT01696058|592882584|FG000|Overall Study|Lack of Efficacy|2|||
164142278|NCT01696058|592882585|FG001|Overall Study|Lack of Efficacy|3|||
163889011|NCT04221490|591967437|FG000|At 30 Days Follow-up|Physician Decision|1|||
163889012|NCT04221490|591967437|FG000|At 30 Days Follow-up|Missed Visit|4|||
163889013|NCT04221490|591967437|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
163889014|NCT04221490|591967437|FG000|At 6 Months Follow-up|Death|9|||
163889015|NCT04221490|591967437|FG000|At 6 Months Follow-up|Missed Visit|8|||
163889016|NCT04221490|591967437|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
163889017|NCT04221490|591967437|FG000|At 1 Year Follow-up|Death|7|||
163889018|NCT04221490|591967437|FG000|At 1 Year Follow-up|Withdrawal by Subject|2|||
163889019|NCT04221490|591967437|FG000|At 1 Year Follow-up|Missed Visit|9|||
163889020|NCT04221490|591967437|FG000|At 1 Year Follow-up|Exited for Other Reasons|1|||
164142279|NCT01696058|592882584|FG000|Overall Study|Protocol Violation|9|||
164142280|NCT01696058|592882585|FG001|Overall Study|Protocol Violation|3|||
164142281|NCT01696058|592882584|FG000|Overall Study|Lost to Follow-up|2|||
164142282|NCT01696058|592882585|FG001|Overall Study|Lost to Follow-up|5|||
164142283|NCT01696058|592882584|FG000|Overall Study|Withdrawal by Subject|4|||
164142284|NCT01696058|592882585|FG001|Overall Study|Withdrawal by Subject|6|||
164142285|NCT01696058|592882584|FG000|Overall Study|Other reason prematurely discontinued|5|||
164142286|NCT01696058|592882585|FG001|Overall Study|Other reason prematurely discontinued|3|||
163994401|NCT03186989|592346025|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
163994402|NCT03186989|592346026|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
163994403|NCT03186989|592346027|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994404|NCT03186989|592346028|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
163994405|NCT03186989|592346029|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994406|NCT03186989|592346030|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
163994407|NCT02246621|592346034|FG000|Overall Study|Withdrawal by Subject|28|||
163994408|NCT02246621|592346035|FG001|Overall Study|Withdrawal by Subject|16|||
163994409|NCT02246621|592346034|FG000|Overall Study|Lost to Follow-up|1|||
163994410|NCT02246621|592346035|FG001|Overall Study|Lost to Follow-up|0|||
163994411|NCT02246621|592346034|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
163994412|NCT02246621|592346035|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
163994413|NCT00821678|592346036|FG000|Overall Study|Withdrawal by Subject|8|||
163994414|NCT00821678|592346037|FG001|Overall Study|Withdrawal by Subject|0|||
163994415|NCT00821678|592346036|FG000|Overall Study|Lost to Follow-up|13|||
163994416|NCT00821678|592346037|FG001|Overall Study|Lost to Follow-up|12|||
163994417|NCT00821678|592346036|FG000|Overall Study|Death|0|||
163994418|NCT00821678|592346037|FG001|Overall Study|Death|2|||
163994419|NCT03641560|592346038|FG000|Overall Study|Withdrawal by Subject|6|||
163994420|NCT03641560|592346038|FG000|Overall Study|Progressive disease|40|||
163994421|NCT03641560|592346038|FG000|Overall Study|Death|6|||
163994422|NCT04439279|592347828|FG000|Overall Study|Adverse Event|7|||
163994423|NCT04439279|592347828|FG000|Overall Study|Death|4|||
163994424|NCT04439279|592347828|FG000|Overall Study|Disease progression|17|||
163994425|NCT04439279|592347828|FG000|Overall Study|Complicating disease|3|||
163994426|NCT04439279|592347828|FG000|Overall Study|Withdrawal by Subject|2|||
163994427|NCT04439279|592347828|FG000|Overall Study|Ineligible|1|||
163994428|NCT04439279|592347828|FG000|Overall Study|Treatment still ongoing|1|||
163994429|NCT02031679|592347829|FG000|Overall Study|Protocol Violation|0|||
163994430|NCT02031679|592347830|FG001|Overall Study|Protocol Violation|1|||
163994431|NCT02031679|592347829|FG000|Overall Study|Lack of Efficacy|0|||
163994432|NCT02031679|592347830|FG001|Overall Study|Lack of Efficacy|1|||
163994433|NCT01974817|592347831|FG000|Overall Study|Death|4|||
163994434|NCT01974817|592347831|FG000|Overall Study|Lost to Follow-up|2|||
163994435|NCT01974817|592347831|FG000|Overall Study|Protocol Violation|2|||
163994436|NCT00110305|592347836|FG000|Overall Study|Adverse Event|46|||
163994437|NCT00110305|592347837|FG001|Overall Study|Adverse Event|13|||
163994438|NCT00110305|592347836|FG000|Overall Study|Sponsors Decision|1|||
163994439|NCT00110305|592347837|FG001|Overall Study|Sponsors Decision|0|||
163994440|NCT00110305|592347836|FG000|Overall Study|Subject Non-Compliant|9|||
164263543|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Death|0|||
163994441|NCT00110305|592347837|FG001|Overall Study|Subject Non-Compliant|2|||
163994442|NCT00110305|592347836|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
163994443|NCT00110305|592347837|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
164263544|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
164263545|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
164263546|NCT03906656|593331914|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
164263547|NCT03906656|593331915|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
164263548|NCT00343915|593331917|FG000|Primary Study|Withdrawal by Subject|1|||
164263549|NCT00343915|593331918|FG001|Primary Study|Withdrawal by Subject|0|||
164263550|NCT00343915|593331917|FG000|Primary Study|Lost to Follow-up|2|||
164263551|NCT00343915|593331918|FG001|Primary Study|Lost to Follow-up|3|||
164263552|NCT00343915|593331917|FG000|Primary Study|Other|1|||
164263553|NCT00343915|593331918|FG001|Primary Study|Other|0|||
164263554|NCT00536874|593331920|FG000|Overall Study|Adverse Event|1|||
164263555|NCT00536874|593331920|FG000|Overall Study|Death|2|||
164263556|NCT00536874|593331920|FG000|Overall Study|Withdrawal by Subject|1|||
164263557|NCT01853072|593331921|FG000|Overall Study|Adverse event prior to treatment|0|||
164263558|NCT01853072|593331922|FG001|Overall Study|Adverse event prior to treatment|1|||
164263559|NCT01853072|593331921|FG000|Overall Study|Adverse Event|0|||
164263560|NCT01853072|593331922|FG001|Overall Study|Adverse Event|3|||
164263561|NCT01853072|593331921|FG000|Overall Study|Death|1|||
164263562|NCT01853072|593331922|FG001|Overall Study|Death|4|||
164263563|NCT01853072|593331921|FG000|Overall Study|Lost to Follow-up|0|||
164263564|NCT01853072|593331922|FG001|Overall Study|Lost to Follow-up|3|||
164263565|NCT01853072|593331921|FG000|Overall Study|Non-compliance with study drug|0|||
164263566|NCT01853072|593331922|FG001|Overall Study|Non-compliance with study drug|1|||
164263567|NCT01853072|593331921|FG000|Overall Study|Physician Decision|1|||
164263568|NCT01853072|593331922|FG001|Overall Study|Physician Decision|1|||
164263569|NCT01853072|593331921|FG000|Overall Study|Withdrawal by Subject|1|||
163994444|NCT00110305|592347836|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
163994445|NCT00110305|592347837|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
163994446|NCT00110305|592347836|FG000|Overall Study|Protocol Violation|0|||
164263570|NCT01853072|593331922|FG001|Overall Study|Withdrawal by Subject|2|||
164263571|NCT01853072|593331921|FG000|Overall Study|Reason not specified|9|||
164263572|NCT01853072|593331922|FG001|Overall Study|Reason not specified|6|||
164263573|NCT00930969|593331923|FG000|Overall Study|Death|5|||
163889021|NCT04987320|591967438|FG000|Overall Study|Withdrawal by Subject|0|||
163889022|NCT04987320|591967439|FG001|Overall Study|Withdrawal by Subject|1|||
163889023|NCT01824875|591967440|FG000|Overall Study|Disease progression|22|||
163889024|NCT01824875|591967441|FG001|Overall Study|Disease progression|15|||
163889025|NCT01824875|591967440|FG000|Overall Study|Withdrawal by Subject|5|||
163889026|NCT01824875|591967441|FG001|Overall Study|Withdrawal by Subject|4|||
163889027|NCT01824875|591967440|FG000|Overall Study|Adverse Event|4|||
163889028|NCT01824875|591967441|FG001|Overall Study|Adverse Event|10|||
163889029|NCT01824875|591967440|FG000|Overall Study|Alternative therapy|3|||
163889030|NCT01824875|591967441|FG001|Overall Study|Alternative therapy|0|||
163889031|NCT01824875|591967440|FG000|Overall Study|Complicating disease|1|||
163889032|NCT01824875|591967441|FG001|Overall Study|Complicating disease|0|||
163889033|NCT01824875|591967440|FG000|Overall Study|Physician Decision|0|||
163889034|NCT01824875|591967441|FG001|Overall Study|Physician Decision|1|||
163889035|NCT01824875|591967440|FG000|Overall Study|Non-compliance|1|||
163889036|NCT01824875|591967441|FG001|Overall Study|Non-compliance|1|||
163889037|NCT01824875|591967440|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
163889038|NCT01824875|591967441|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
163889039|NCT01824875|591967440|FG000|Overall Study|Administrative issues|0|||
163889040|NCT01824875|591967441|FG001|Overall Study|Administrative issues|2|||
163889041|NCT01824875|591967440|FG000|Overall Study|Ineligible or never started treatment|9|||
163889042|NCT01824875|591967441|FG001|Overall Study|Ineligible or never started treatment|5|||
163889043|NCT01824875|591967440|FG000|Overall Study|Other|0|||
163889044|NCT01824875|591967441|FG001|Overall Study|Other|2|||
163889045|NCT04195698|591967442|FG000|Overall Study|Adverse Event|4|||
163889046|NCT04195698|591967443|FG001|Overall Study|Adverse Event|11|||
163889047|NCT04195698|591967442|FG000|Overall Study|Withdrawal by Subject|9|||
163889048|NCT04195698|591967443|FG001|Overall Study|Withdrawal by Subject|10|||
163889049|NCT04195698|591967442|FG000|Overall Study|Lost to Follow-up|5|||
163889050|NCT04195698|591967443|FG001|Overall Study|Lost to Follow-up|4|||
163889051|NCT04195698|591967442|FG000|Overall Study|Lack of Efficacy|2|||
163889052|NCT04195698|591967443|FG001|Overall Study|Lack of Efficacy|10|||
163889053|NCT04195698|591967442|FG000|Overall Study|Other|5|||
163889054|NCT04195698|591967443|FG001|Overall Study|Other|4|||
163889055|NCT00433329|591967444|FG000|Overall Study|Adverse Event|9|||
163889056|NCT00433329|591967444|FG000|Overall Study|Death|4|||
163889057|NCT00433329|591967444|FG000|Overall Study|Withdrew consent|3|||
163889058|NCT00433329|591967444|FG000|Overall Study|Discontinued sildenafil|2|||
163889059|NCT00433329|591967444|FG000|Overall Study|Moved out of state|1|||
163889060|NCT00433329|591967444|FG000|Overall Study|Lost to Follow-up|1|||
163889061|NCT00433329|591967444|FG000|Overall Study|Physician Decision|1|||
163889062|NCT01129102|591967445|FG000|Overall Study|No study drug treatment|2|||
163889063|NCT01129102|591967446|FG001|Overall Study|No study drug treatment|3|||
163889064|NCT01129102|591967447|FG002|Overall Study|No study drug treatment|1|||
163889065|NCT01129102|591967445|FG000|Overall Study|Withdrawal by Subject|2|||
163889066|NCT01129102|591967446|FG001|Overall Study|Withdrawal by Subject|0|||
163889067|NCT01129102|591967447|FG002|Overall Study|Withdrawal by Subject|3|||
163889068|NCT01129102|591967445|FG000|Overall Study|Protocol Violation|0|||
163889069|NCT01129102|591967446|FG001|Overall Study|Protocol Violation|1|||
163889070|NCT01129102|591967447|FG002|Overall Study|Protocol Violation|1|||
163889071|NCT01129102|591967445|FG000|Overall Study|Pregnancy|0|||
163889072|NCT01129102|591967446|FG001|Overall Study|Pregnancy|0|||
163889073|NCT01129102|591967447|FG002|Overall Study|Pregnancy|1|||
163889074|NCT01129102|591967445|FG000|Overall Study|Adverse Event|2|||
163889075|NCT01129102|591967446|FG001|Overall Study|Adverse Event|2|||
163889076|NCT01129102|591967447|FG002|Overall Study|Adverse Event|1|||
163889077|NCT01129102|591967445|FG000|Overall Study|Lost to Follow-up|2|||
163889078|NCT01129102|591967446|FG001|Overall Study|Lost to Follow-up|0|||
163889079|NCT01129102|591967447|FG002|Overall Study|Lost to Follow-up|0|||
163889080|NCT05256017|591967450|FG000|Treatment Period|Withdrawal by Subject|1|||
163889081|NCT05256017|591967451|FG001|Treatment Period|Withdrawal by Subject|1|||
163889082|NCT05256017|591967450|FG000|Follow-up|Lost to Follow-up|7|||
163889083|NCT05256017|591967451|FG001|Follow-up|Lost to Follow-up|1|||
163889084|NCT05256017|591967450|FG000|Follow-up|Withdrawal by Subject|1|||
163889085|NCT05256017|591967451|FG001|Follow-up|Withdrawal by Subject|0|||
163889086|NCT05256017|591967450|FG000|Follow-up|Death|0|||
163889087|NCT05256017|591967451|FG001|Follow-up|Death|1|||
163889088|NCT05082025|591967454|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
163889089|NCT03854227|591967456|FG000|Overall Study|Adverse Event|0|||
163889090|NCT03854227|591967457|FG001|Overall Study|Adverse Event|0|||
163889091|NCT03854227|591967458|FG002|Overall Study|Adverse Event|0|||
163889092|NCT03854227|591967459|FG003|Overall Study|Adverse Event|1|||
163889093|NCT03854227|591967460|FG004|Overall Study|Adverse Event|0|||
163889094|NCT03854227|591967461|FG005|Overall Study|Adverse Event|0|||
164263574|NCT00930969|593331923|FG000|Overall Study|Lost to Follow-up|1|||
163889095|NCT03854227|591967462|FG006|Overall Study|Adverse Event|1|||
164263575|NCT00930969|593331923|FG000|Overall Study|Physician Decision|13|||
164263576|NCT00930969|593331923|FG000|Overall Study|Withdrawal by Subject|19|||
164263577|NCT01287221|593331924|FG000|Overall Study|Lack of Perceived Benefit|1|||
164263578|NCT01287221|593331925|FG001|Overall Study|Lack of Perceived Benefit|1|||
164263579|NCT01287221|593331924|FG000|Overall Study|Adverse Event|3|||
164263580|NCT01287221|593331925|FG001|Overall Study|Adverse Event|3|||
164263581|NCT01287221|593331924|FG000|Overall Study|Withdrawal by Subject|0|||
164263582|NCT01287221|593331925|FG001|Overall Study|Withdrawal by Subject|1|||
164263583|NCT03515941|593331928|FG000|Overall Study|Adverse Event|1|||
164263584|NCT03515941|593331929|FG001|Overall Study|Adverse Event|0|||
164263585|NCT03559699|593333964|FG000|Overall Study|Withdrawal by Subject|6|||
163889096|NCT03854227|591967463|FG007|Overall Study|Adverse Event|0|||
164263586|NCT03559699|593333964|FG000|Overall Study|Lost to Follow-up|1|||
164263587|NCT00031460|593333965|FG000|Overall Study|Lost to Follow-up|0|||
163889097|NCT03854227|591967464|FG008|Overall Study|Adverse Event|0|||
163889098|NCT03854227|591967465|FG009|Overall Study|Adverse Event|3|||
163889099|NCT03854227|591967466|FG010|Overall Study|Adverse Event|0|||
163889100|NCT03854227|591967467|FG011|Overall Study|Adverse Event|1|||
163889101|NCT03854227|591967456|FG000|Overall Study|Death|0|||
163889102|NCT03854227|591967457|FG001|Overall Study|Death|0|||
163889103|NCT03854227|591967458|FG002|Overall Study|Death|0|||
163889104|NCT03854227|591967459|FG003|Overall Study|Death|0|||
163889105|NCT03854227|591967460|FG004|Overall Study|Death|0|||
163889106|NCT03854227|591967461|FG005|Overall Study|Death|1|||
163889107|NCT03854227|591967462|FG006|Overall Study|Death|0|||
163889108|NCT03854227|591967463|FG007|Overall Study|Death|0|||
163889109|NCT03854227|591967464|FG008|Overall Study|Death|0|||
163889110|NCT03854227|591967465|FG009|Overall Study|Death|1|||
163889111|NCT03854227|591967466|FG010|Overall Study|Death|0|||
163889112|NCT03854227|591967467|FG011|Overall Study|Death|1|||
163889113|NCT03854227|591967456|FG000|Overall Study|Physician Decision|0|||
163889114|NCT03854227|591967457|FG001|Overall Study|Physician Decision|0|||
163889115|NCT03854227|591967458|FG002|Overall Study|Physician Decision|0|||
163889116|NCT03854227|591967459|FG003|Overall Study|Physician Decision|0|||
163889117|NCT03854227|591967460|FG004|Overall Study|Physician Decision|0|||
163889118|NCT03854227|591967461|FG005|Overall Study|Physician Decision|1|||
163889119|NCT03854227|591967462|FG006|Overall Study|Physician Decision|0|||
163889120|NCT03854227|591967463|FG007|Overall Study|Physician Decision|0|||
163889121|NCT03854227|591967464|FG008|Overall Study|Physician Decision|1|||
163889122|NCT03854227|591967465|FG009|Overall Study|Physician Decision|1|||
163889123|NCT03854227|591967466|FG010|Overall Study|Physician Decision|0|||
163889124|NCT03854227|591967467|FG011|Overall Study|Physician Decision|1|||
163889125|NCT03854227|591967456|FG000|Overall Study|Progressive disease|1|||
163889126|NCT03854227|591967457|FG001|Overall Study|Progressive disease|1|||
163889127|NCT03854227|591967458|FG002|Overall Study|Progressive disease|1|||
163889128|NCT03854227|591967459|FG003|Overall Study|Progressive disease|2|||
163889129|NCT03854227|591967460|FG004|Overall Study|Progressive disease|3|||
163889130|NCT03854227|591967461|FG005|Overall Study|Progressive disease|1|||
163889131|NCT03854227|591967462|FG006|Overall Study|Progressive disease|2|||
163889132|NCT03854227|591967463|FG007|Overall Study|Progressive disease|5|||
163889133|NCT03854227|591967464|FG008|Overall Study|Progressive disease|2|||
163889134|NCT03854227|591967465|FG009|Overall Study|Progressive disease|5|||
163889135|NCT03854227|591967466|FG010|Overall Study|Progressive disease|1|||
163889136|NCT03854227|591967467|FG011|Overall Study|Progressive disease|6|||
163889137|NCT03854227|591967456|FG000|Overall Study|Study terminated by sponsor|0|||
163889138|NCT03854227|591967457|FG001|Overall Study|Study terminated by sponsor|0|||
163889139|NCT03854227|591967458|FG002|Overall Study|Study terminated by sponsor|0|||
163889140|NCT03854227|591967459|FG003|Overall Study|Study terminated by sponsor|0|||
164263588|NCT00031460|593333966|FG001|Overall Study|Lost to Follow-up|1|||
163889141|NCT03854227|591967460|FG004|Overall Study|Study terminated by sponsor|0|||
163889142|NCT03854227|591967461|FG005|Overall Study|Study terminated by sponsor|0|||
163889143|NCT03854227|591967462|FG006|Overall Study|Study terminated by sponsor|0|||
163889144|NCT03854227|591967463|FG007|Overall Study|Study terminated by sponsor|0|||
163889145|NCT03854227|591967464|FG008|Overall Study|Study terminated by sponsor|0|||
163889146|NCT03854227|591967465|FG009|Overall Study|Study terminated by sponsor|1|||
163889147|NCT03854227|591967466|FG010|Overall Study|Study terminated by sponsor|0|||
163889148|NCT03854227|591967467|FG011|Overall Study|Study terminated by sponsor|0|||
163889149|NCT03854227|591967456|FG000|Overall Study|Withdrawal by Subject|0|||
163889150|NCT03854227|591967457|FG001|Overall Study|Withdrawal by Subject|0|||
163889151|NCT03854227|591967458|FG002|Overall Study|Withdrawal by Subject|1|||
163889152|NCT03854227|591967459|FG003|Overall Study|Withdrawal by Subject|0|||
163889153|NCT03854227|591967460|FG004|Overall Study|Withdrawal by Subject|0|||
163889154|NCT03854227|591967461|FG005|Overall Study|Withdrawal by Subject|0|||
163889155|NCT03854227|591967462|FG006|Overall Study|Withdrawal by Subject|0|||
163889156|NCT03854227|591967463|FG007|Overall Study|Withdrawal by Subject|0|||
163889157|NCT03854227|591967464|FG008|Overall Study|Withdrawal by Subject|0|||
163889158|NCT03854227|591967465|FG009|Overall Study|Withdrawal by Subject|1|||
163889159|NCT03854227|591967466|FG010|Overall Study|Withdrawal by Subject|1|||
163889160|NCT03854227|591967467|FG011|Overall Study|Withdrawal by Subject|0|||
163889161|NCT03854227|591967456|FG000|Overall Study|Disease relapse|0|||
163889162|NCT03854227|591967457|FG001|Overall Study|Disease relapse|0|||
163889163|NCT03854227|591967458|FG002|Overall Study|Disease relapse|0|||
163889164|NCT03854227|591967459|FG003|Overall Study|Disease relapse|0|||
163889165|NCT03854227|591967460|FG004|Overall Study|Disease relapse|0|||
163889166|NCT03854227|591967461|FG005|Overall Study|Disease relapse|0|||
163889167|NCT03854227|591967462|FG006|Overall Study|Disease relapse|0|||
163889168|NCT03854227|591967463|FG007|Overall Study|Disease relapse|0|||
163889169|NCT03854227|591967464|FG008|Overall Study|Disease relapse|1|||
163889170|NCT03854227|591967465|FG009|Overall Study|Disease relapse|0|||
163889171|NCT03854227|591967466|FG010|Overall Study|Disease relapse|0|||
163889172|NCT03854227|591967467|FG011|Overall Study|Disease relapse|0|||
163889173|NCT03854227|591967456|FG000|Overall Study|Global deterioration of health status|0|||
163889174|NCT03854227|591967457|FG001|Overall Study|Global deterioration of health status|0|||
163889175|NCT03854227|591967458|FG002|Overall Study|Global deterioration of health status|0|||
163889176|NCT03854227|591967459|FG003|Overall Study|Global deterioration of health status|0|||
163889177|NCT03854227|591967460|FG004|Overall Study|Global deterioration of health status|0|||
163889178|NCT03854227|591967461|FG005|Overall Study|Global deterioration of health status|1|||
163889179|NCT03854227|591967462|FG006|Overall Study|Global deterioration of health status|0|||
163889180|NCT03854227|591967463|FG007|Overall Study|Global deterioration of health status|1|||
163889181|NCT03854227|591967464|FG008|Overall Study|Global deterioration of health status|0|||
163889182|NCT03854227|591967465|FG009|Overall Study|Global deterioration of health status|0|||
163889183|NCT03854227|591967466|FG010|Overall Study|Global deterioration of health status|0|||
163889184|NCT03854227|591967467|FG011|Overall Study|Global deterioration of health status|0|||
163889185|NCT03854227|591967456|FG000|Overall Study|Refused further treatment|0|||
163889186|NCT03854227|591967457|FG001|Overall Study|Refused further treatment|0|||
163889187|NCT03854227|591967458|FG002|Overall Study|Refused further treatment|0|||
163889188|NCT03854227|591967459|FG003|Overall Study|Refused further treatment|0|||
163889189|NCT03854227|591967460|FG004|Overall Study|Refused further treatment|0|||
163889190|NCT03854227|591967461|FG005|Overall Study|Refused further treatment|0|||
163889191|NCT03854227|591967462|FG006|Overall Study|Refused further treatment|0|||
163889192|NCT03854227|591967463|FG007|Overall Study|Refused further treatment|0|||
163889193|NCT03854227|591967464|FG008|Overall Study|Refused further treatment|0|||
163889194|NCT03854227|591967465|FG009|Overall Study|Refused further treatment|1|||
163889195|NCT03854227|591967466|FG010|Overall Study|Refused further treatment|0|||
163889196|NCT03854227|591967467|FG011|Overall Study|Refused further treatment|1|||
163889197|NCT03854227|591967456|FG000|Overall Study|Other|0|||
163889198|NCT03854227|591967457|FG001|Overall Study|Other|0|||
163889199|NCT03854227|591967458|FG002|Overall Study|Other|0|||
163889200|NCT03854227|591967459|FG003|Overall Study|Other|0|||
163889201|NCT03854227|591967460|FG004|Overall Study|Other|0|||
163889202|NCT03854227|591967461|FG005|Overall Study|Other|0|||
163889203|NCT03854227|591967462|FG006|Overall Study|Other|0|||
163889204|NCT03854227|591967463|FG007|Overall Study|Other|0|||
163889205|NCT03854227|591967464|FG008|Overall Study|Other|1|||
163889206|NCT03854227|591967465|FG009|Overall Study|Other|1|||
163889207|NCT03854227|591967466|FG010|Overall Study|Other|0|||
163889208|NCT03854227|591967467|FG011|Overall Study|Other|0|||
163889209|NCT04192266|591967468|FG000|Overall Study|Withdrawal by Subject|3|||
163889210|NCT04192266|591967469|FG001|Overall Study|Withdrawal by Subject|2|||
163889211|NCT04948697|591967470|FG000|Overall Study|Progressive disease|27|||
163889212|NCT04948697|591967471|FG001|Overall Study|Progressive disease|18|||
163889213|NCT04948697|591967470|FG000|Overall Study|Adverse Event|14|||
163889214|NCT04948697|591967471|FG001|Overall Study|Adverse Event|4|||
163889215|NCT04948697|591967470|FG000|Overall Study|Participant moved to long term extension study|7|||
163889216|NCT04948697|591967471|FG001|Overall Study|Participant moved to long term extension study|4|||
163889217|NCT04948697|591967470|FG000|Overall Study|Withdrawal by Subject|10|||
163889218|NCT04948697|591967471|FG001|Overall Study|Withdrawal by Subject|0|||
163994447|NCT00110305|592347837|FG001|Overall Study|Protocol Violation|1|||
163889219|NCT04948697|591967470|FG000|Overall Study|Closed by Sponsor|3|||
163889220|NCT04948697|591967471|FG001|Overall Study|Closed by Sponsor|2|||
163889221|NCT04948697|591967470|FG000|Overall Study|Physician Decision|0|||
163889222|NCT04948697|591967471|FG001|Overall Study|Physician Decision|2|||
163889223|NCT04948697|591967470|FG000|Overall Study|Lost to Follow-up|0|||
163994448|NCT00110305|592347836|FG000|Overall Study|Withdrawal by Subject|7|||
163994449|NCT00110305|592347837|FG001|Overall Study|Withdrawal by Subject|7|||
163994450|NCT00110305|592347836|FG000|Overall Study|Lost to Follow-up|20|||
163994451|NCT00110305|592347837|FG001|Overall Study|Lost to Follow-up|3|||
163994452|NCT00110305|592347836|FG000|Overall Study|Other|8|||
163994453|NCT00110305|592347837|FG001|Overall Study|Other|2|||
163994454|NCT05047523|592347838|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163994455|NCT05047523|592347839|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163889224|NCT04948697|591967471|FG001|Overall Study|Lost to Follow-up|1|||
163889225|NCT04948697|591967470|FG000|Overall Study|Other-Miscellaneous|1|||
163889226|NCT04948697|591967471|FG001|Overall Study|Other-Miscellaneous|0|||
163889227|NCT04948697|591967470|FG000|Overall Study|Randomized but not treated|0|||
163889228|NCT04948697|591967471|FG001|Overall Study|Randomized but not treated|1|||
163889229|NCT04870515|591967472|FG000|Overall Study|Lost to Follow-up|0|||
163889230|NCT04870515|591967473|FG001|Overall Study|Lost to Follow-up|2|||
163889231|NCT04870515|591967472|FG000|Overall Study|Withdrawal by Subject|0|||
163889232|NCT04870515|591967473|FG001|Overall Study|Withdrawal by Subject|1|||
163889233|NCT04870515|591967472|FG000|Overall Study|Withdrawal due to complications with standard of care treatment|2|||
163889234|NCT04870515|591967473|FG001|Overall Study|Withdrawal due to complications with standard of care treatment|0|||
163889235|NCT04032704|591967474|FG000|Part A|Withdrawal by Subject|0|||
163889236|NCT04032704|591967475|FG001|Part A|Withdrawal by Subject|0|||
163889237|NCT04032704|591967476|FG002|Part A|Withdrawal by Subject|3|||
163889238|NCT04032704|591967477|FG003|Part A|Withdrawal by Subject|0|||
163889239|NCT04032704|591967478|FG004|Part A|Withdrawal by Subject|1|||
163889240|NCT04032704|591967479|FG005|Part A|Withdrawal by Subject|7|||
163889241|NCT04032704|591967480|FG006|Part A|Withdrawal by Subject|0|||
163889242|NCT04032704|591967481|FG007|Part A|Withdrawal by Subject|0|||
163889243|NCT04032704|591967482|FG008|Part A|Withdrawal by Subject|0|||
163889244|NCT04032704|591967483|FG009|Part A|Withdrawal by Subject|0|||
163889245|NCT04032704|591967484|FG010|Part A|Withdrawal by Subject|0|||
163889246|NCT04032704|591967485|FG011|Part A|Withdrawal by Subject|0|||
163889247|NCT04032704|591967486|FG012|Part A|Withdrawal by Subject|0|||
163889248|NCT04032704|591967487|FG013|Part A|Withdrawal by Subject|0|||
163889249|NCT04032704|591967488|FG014|Part A|Withdrawal by Subject|0|||
163889250|NCT04032704|591967489|FG015|Part A|Withdrawal by Subject|0|||
163889251|NCT04032704|591967490|FG016|Part A|Withdrawal by Subject|0|||
163889252|NCT04032704|591967491|FG017|Part A|Withdrawal by Subject|0|||
163889253|NCT04032704|591967474|FG000|Part A|Lost to Follow-up|1|||
163889254|NCT04032704|591967475|FG001|Part A|Lost to Follow-up|0|||
163889255|NCT04032704|591967476|FG002|Part A|Lost to Follow-up|0|||
163889256|NCT04032704|591967477|FG003|Part A|Lost to Follow-up|0|||
163889257|NCT04032704|591967478|FG004|Part A|Lost to Follow-up|0|||
163889258|NCT04032704|591967479|FG005|Part A|Lost to Follow-up|0|||
163889259|NCT04032704|591967480|FG006|Part A|Lost to Follow-up|0|||
163889260|NCT04032704|591967481|FG007|Part A|Lost to Follow-up|0|||
163889261|NCT04032704|591967482|FG008|Part A|Lost to Follow-up|0|||
163889262|NCT04032704|591967483|FG009|Part A|Lost to Follow-up|0|||
163889263|NCT04032704|591967484|FG010|Part A|Lost to Follow-up|0|||
163889264|NCT04032704|591967485|FG011|Part A|Lost to Follow-up|0|||
163889265|NCT04032704|591967486|FG012|Part A|Lost to Follow-up|0|||
163889266|NCT04032704|591967487|FG013|Part A|Lost to Follow-up|0|||
163889267|NCT04032704|591967488|FG014|Part A|Lost to Follow-up|0|||
163889268|NCT04032704|591967489|FG015|Part A|Lost to Follow-up|0|||
163889269|NCT04032704|591967490|FG016|Part A|Lost to Follow-up|0|||
163889270|NCT04032704|591967491|FG017|Part A|Lost to Follow-up|0|||
163889271|NCT04032704|591967474|FG000|Part A|Death|9|||
163889272|NCT04032704|591967475|FG001|Part A|Death|2|||
163889273|NCT04032704|591967476|FG002|Part A|Death|10|||
163889274|NCT04032704|591967477|FG003|Part A|Death|7|||
163889275|NCT04032704|591967478|FG004|Part A|Death|4|||
163889276|NCT04032704|591967479|FG005|Part A|Death|5|||
163889277|NCT04032704|591967480|FG006|Part A|Death|0|||
163889278|NCT04032704|591967481|FG007|Part A|Death|0|||
163889279|NCT04032704|591967482|FG008|Part A|Death|0|||
163889280|NCT04032704|591967483|FG009|Part A|Death|0|||
163889281|NCT04032704|591967484|FG010|Part A|Death|0|||
163889282|NCT04032704|591967485|FG011|Part A|Death|0|||
163889283|NCT04032704|591967486|FG012|Part A|Death|0|||
163889284|NCT04032704|591967487|FG013|Part A|Death|0|||
163889285|NCT04032704|591967488|FG014|Part A|Death|0|||
163889286|NCT04032704|591967489|FG015|Part A|Death|0|||
163889287|NCT04032704|591967490|FG016|Part A|Death|0|||
163889288|NCT04032704|591967491|FG017|Part A|Death|0|||
163889289|NCT04032704|591967474|FG000|Part B|Other|0|||
163889290|NCT04032704|591967475|FG001|Part B|Other|0|||
163889291|NCT04032704|591967476|FG002|Part B|Other|0|||
163889292|NCT04032704|591967477|FG003|Part B|Other|0|||
163889293|NCT04032704|591967478|FG004|Part B|Other|0|||
163889294|NCT04032704|591967479|FG005|Part B|Other|0|||
163889295|NCT04032704|591967480|FG006|Part B|Other|0|||
163889296|NCT04032704|591967481|FG007|Part B|Other|1|||
163889297|NCT04032704|591967482|FG008|Part B|Other|2|||
163889298|NCT04032704|591967483|FG009|Part B|Other|1|||
163889299|NCT04032704|591967484|FG010|Part B|Other|1|||
163889300|NCT04032704|591967485|FG011|Part B|Other|1|||
163889301|NCT04032704|591967486|FG012|Part B|Other|5|||
163889302|NCT04032704|591967487|FG013|Part B|Other|13|||
163889303|NCT04032704|591967488|FG014|Part B|Other|0|||
163889304|NCT04032704|591967489|FG015|Part B|Other|0|||
163889305|NCT04032704|591967490|FG016|Part B|Other|0|||
163889306|NCT04032704|591967491|FG017|Part B|Other|0|||
163889307|NCT04032704|591967474|FG000|Part B|Study termination by Sponsor|0|||
163889308|NCT04032704|591967475|FG001|Part B|Study termination by Sponsor|0|||
163889309|NCT04032704|591967476|FG002|Part B|Study termination by Sponsor|0|||
163889310|NCT04032704|591967477|FG003|Part B|Study termination by Sponsor|0|||
163889311|NCT04032704|591967478|FG004|Part B|Study termination by Sponsor|0|||
163889312|NCT04032704|591967479|FG005|Part B|Study termination by Sponsor|0|||
163889313|NCT04032704|591967480|FG006|Part B|Study termination by Sponsor|0|||
163889314|NCT04032704|591967481|FG007|Part B|Study termination by Sponsor|0|||
163889315|NCT04032704|591967482|FG008|Part B|Study termination by Sponsor|1|||
163889316|NCT04032704|591967483|FG009|Part B|Study termination by Sponsor|0|||
163889317|NCT04032704|591967484|FG010|Part B|Study termination by Sponsor|0|||
163889318|NCT04032704|591967485|FG011|Part B|Study termination by Sponsor|0|||
163889319|NCT04032704|591967486|FG012|Part B|Study termination by Sponsor|0|||
163889320|NCT04032704|591967487|FG013|Part B|Study termination by Sponsor|0|||
163889321|NCT04032704|591967488|FG014|Part B|Study termination by Sponsor|0|||
163889322|NCT04032704|591967489|FG015|Part B|Study termination by Sponsor|0|||
163889323|NCT04032704|591967490|FG016|Part B|Study termination by Sponsor|0|||
163889324|NCT04032704|591967491|FG017|Part B|Study termination by Sponsor|0|||
163889325|NCT04032704|591967474|FG000|Part B|Withdrawal by Subject|0|||
163889326|NCT04032704|591967475|FG001|Part B|Withdrawal by Subject|0|||
163889327|NCT04032704|591967476|FG002|Part B|Withdrawal by Subject|0|||
163889328|NCT04032704|591967477|FG003|Part B|Withdrawal by Subject|0|||
163889329|NCT04032704|591967478|FG004|Part B|Withdrawal by Subject|0|||
163889330|NCT04032704|591967479|FG005|Part B|Withdrawal by Subject|0|||
163889331|NCT04032704|591967480|FG006|Part B|Withdrawal by Subject|3|||
163889332|NCT04032704|591967481|FG007|Part B|Withdrawal by Subject|2|||
163889333|NCT04032704|591967482|FG008|Part B|Withdrawal by Subject|2|||
163889334|NCT04032704|591967483|FG009|Part B|Withdrawal by Subject|1|||
163889335|NCT04032704|591967484|FG010|Part B|Withdrawal by Subject|4|||
163889336|NCT04032704|591967485|FG011|Part B|Withdrawal by Subject|6|||
163889337|NCT04032704|591967486|FG012|Part B|Withdrawal by Subject|2|||
163889338|NCT04032704|591967487|FG013|Part B|Withdrawal by Subject|1|||
163889339|NCT04032704|591967488|FG014|Part B|Withdrawal by Subject|0|||
163889340|NCT04032704|591967489|FG015|Part B|Withdrawal by Subject|1|||
163889341|NCT04032704|591967490|FG016|Part B|Withdrawal by Subject|0|||
163889342|NCT04032704|591967491|FG017|Part B|Withdrawal by Subject|0|||
163889343|NCT04032704|591967474|FG000|Part B|Lost to Follow-up|0|||
163889344|NCT04032704|591967475|FG001|Part B|Lost to Follow-up|0|||
163889345|NCT04032704|591967476|FG002|Part B|Lost to Follow-up|0|||
163889346|NCT04032704|591967477|FG003|Part B|Lost to Follow-up|0|||
163889347|NCT04032704|591967478|FG004|Part B|Lost to Follow-up|0|||
163889348|NCT04032704|591967479|FG005|Part B|Lost to Follow-up|0|||
163889349|NCT04032704|591967480|FG006|Part B|Lost to Follow-up|0|||
163889350|NCT04032704|591967481|FG007|Part B|Lost to Follow-up|0|||
163889351|NCT04032704|591967482|FG008|Part B|Lost to Follow-up|0|||
163889352|NCT04032704|591967483|FG009|Part B|Lost to Follow-up|0|||
163889353|NCT04032704|591967484|FG010|Part B|Lost to Follow-up|0|||
163889354|NCT04032704|591967485|FG011|Part B|Lost to Follow-up|1|||
163889355|NCT04032704|591967486|FG012|Part B|Lost to Follow-up|0|||
163889356|NCT04032704|591967487|FG013|Part B|Lost to Follow-up|0|||
163994456|NCT05047523|592347840|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
163889357|NCT04032704|591967488|FG014|Part B|Lost to Follow-up|0|||
163889358|NCT04032704|591967489|FG015|Part B|Lost to Follow-up|0|||
163889359|NCT04032704|591967490|FG016|Part B|Lost to Follow-up|0|||
163889360|NCT04032704|591967491|FG017|Part B|Lost to Follow-up|0|||
163889361|NCT04032704|591967474|FG000|Part B|Death|0|||
163889362|NCT04032704|591967475|FG001|Part B|Death|0|||
163889363|NCT04032704|591967476|FG002|Part B|Death|0|||
163889364|NCT04032704|591967477|FG003|Part B|Death|0|||
163889365|NCT04032704|591967478|FG004|Part B|Death|0|||
163994457|NCT05047523|592347841|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163994458|NCT05047523|592347842|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163994459|NCT05047523|592347843|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
163994460|NCT05047523|592347838|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163994461|NCT05047523|592347839|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
163994462|NCT05047523|592347840|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163994463|NCT05047523|592347841|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163994464|NCT05047523|592347842|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163994465|NCT05047523|592347843|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
163994466|NCT05047523|592347838|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
163994467|NCT05047523|592347839|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
163994468|NCT05047523|592347840|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
163994469|NCT05047523|592347841|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
163994470|NCT05047523|592347842|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
163994471|NCT05047523|592347843|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
163994472|NCT05047523|592347838|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
163994473|NCT05047523|592347839|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163994474|NCT05047523|592347840|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163994475|NCT05047523|592347841|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163994476|NCT05047523|592347842|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163994477|NCT05047523|592347843|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
163994478|NCT05047523|592347838|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163994479|NCT05047523|592347839|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163994480|NCT05047523|592347840|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163994481|NCT05047523|592347841|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
163994482|NCT05047523|592347842|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
163994483|NCT05047523|592347843|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
163994484|NCT05047523|592347838|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
163994485|NCT05047523|592347839|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
163994486|NCT05047523|592347840|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
163994487|NCT05047523|592347841|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
163994488|NCT05047523|592347842|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
163994489|NCT05047523|592347843|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
163994490|NCT03658889|592347844|FG000|Overall Study|Protocol Violation|2|||
163994491|NCT03658889|592347845|FG001|Overall Study|Protocol Violation|0|||
164263589|NCT00031460|593333965|FG000|Overall Study|Withdrawal by Subject|1|||
164263590|NCT00031460|593333966|FG001|Overall Study|Withdrawal by Subject|1|||
164263591|NCT00031460|593333965|FG000|Overall Study|Non-Compliant|1|||
164263592|NCT00031460|593333966|FG001|Overall Study|Non-Compliant|1|||
163994492|NCT01609933|592347849|FG000|Overall Study|Adverse Event|1|||
163994493|NCT01609933|592347849|FG000|Overall Study|Withdrawal by Subject|3|||
163994494|NCT00224016|592347850|FG000|Titration Period|Withdrawal by Subject|0|||
163994495|NCT00224016|592347851|FG001|Titration Period|Withdrawal by Subject|1|||
163994496|NCT00224016|592347850|FG000|Titration Period|Lost to Follow-up|1|||
163994497|NCT00224016|592347851|FG001|Titration Period|Lost to Follow-up|0|||
163994498|NCT00224016|592347850|FG000|Maintenance Period|Withdrawal by Subject|2|||
163994499|NCT00224016|592347851|FG001|Maintenance Period|Withdrawal by Subject|0|||
163994500|NCT00224016|592347850|FG000|Maintenance Period|Lost to Follow-up|0|||
163994501|NCT00224016|592347851|FG001|Maintenance Period|Lost to Follow-up|1|||
163994502|NCT01252966|592347852|FG000|Overall Study|Lost to Follow-up|16|||
163994503|NCT01252966|592347853|FG001|Overall Study|Lost to Follow-up|10|||
163994504|NCT01252966|592347852|FG000|Overall Study|Withdrawal by Subject|7|||
163994505|NCT01252966|592347853|FG001|Overall Study|Withdrawal by Subject|3|||
163994506|NCT04188197|592347856|FG000|Overall Study|Lost to Follow-up|4|||
163994507|NCT04188197|592347857|FG001|Overall Study|Lost to Follow-up|1|||
163994508|NCT04188197|592347856|FG000|Overall Study|Withdrawal by Subject|1|||
163994509|NCT04188197|592347857|FG001|Overall Study|Withdrawal by Subject|1|||
163994510|NCT04188197|592347856|FG000|Overall Study|Pregnancy|0|||
163994511|NCT04188197|592347857|FG001|Overall Study|Pregnancy|1|||
163994512|NCT04684420|592347863|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163994513|NCT04684420|592347864|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163994514|NCT04684420|592347865|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
163994515|NCT04684420|592347866|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
163994516|NCT04684420|592347863|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
163994517|NCT04684420|592347864|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
163994518|NCT04684420|592347865|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
163994519|NCT04684420|592347866|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
163994520|NCT00463476|592347867|FG000|Overall Study|Withdrawal by Subject|1|||
163994521|NCT00463476|592347868|FG001|Overall Study|Withdrawal by Subject|2|||
163994522|NCT00463476|592347867|FG000|Overall Study|Lost to Follow-up|1|||
163994523|NCT00463476|592347868|FG001|Overall Study|Lost to Follow-up|1|||
163994524|NCT03371355|592347880|FG000|Overall Study|Investigator judgment|0|||
163994525|NCT03371355|592347881|FG001|Overall Study|Investigator judgment|0|||
163994526|NCT03371355|592347882|FG002|Overall Study|Investigator judgment|1|||
163994527|NCT03371355|592347883|FG003|Overall Study|Investigator judgment|1|||
163994528|NCT03371355|592347880|FG000|Overall Study|Voluntary withdrawal|1|||
163994529|NCT03371355|592347881|FG001|Overall Study|Voluntary withdrawal|0|||
163994530|NCT03371355|592347882|FG002|Overall Study|Voluntary withdrawal|1|||
163994531|NCT03371355|592347883|FG003|Overall Study|Voluntary withdrawal|2|||
163994532|NCT03371355|592347880|FG000|Overall Study|Adverse Event|0|||
163994533|NCT03371355|592347881|FG001|Overall Study|Adverse Event|1|||
163994534|NCT03371355|592347882|FG002|Overall Study|Adverse Event|2|||
163994535|NCT03371355|592347883|FG003|Overall Study|Adverse Event|3|||
163994536|NCT03371355|592347880|FG000|Overall Study|Reason not Specified|0|||
163994537|NCT03371355|592347881|FG001|Overall Study|Reason not Specified|1|||
163994538|NCT03371355|592347882|FG002|Overall Study|Reason not Specified|0|||
163994539|NCT03371355|592347883|FG003|Overall Study|Reason not Specified|1|||
163994540|NCT00868790|592347884|FG000|Period 1|Adverse Event|1|||
163994541|NCT00868790|592347885|FG001|Period 1|Adverse Event|0|||
163994542|NCT00868790|592347886|FG002|Period 1|Adverse Event|0|||
163994543|NCT00868790|592347887|FG003|Period 1|Adverse Event|0|||
163994544|NCT00868790|592347888|FG004|Period 1|Adverse Event|0|||
163994545|NCT00868790|592347889|FG005|Period 1|Adverse Event|0|||
163994546|NCT00868790|592347890|FG006|Period 1|Adverse Event|0|||
163994547|NCT00868790|592347891|FG007|Period 1|Adverse Event|3|||
163994548|NCT00868790|592347892|FG008|Period 1|Adverse Event|1|||
164263593|NCT00031460|593333965|FG000|Overall Study|Death|0|||
163994549|NCT00868790|592347893|FG009|Period 1|Adverse Event|0|||
163994550|NCT00868790|592347894|FG010|Period 1|Adverse Event|0|||
163994551|NCT00868790|592347895|FG011|Period 1|Adverse Event|0|||
163994552|NCT00868790|592347896|FG012|Period 1|Adverse Event|0|||
163994553|NCT00868790|592347897|FG013|Period 1|Adverse Event|1|||
163994554|NCT00868790|592347884|FG000|Period 1|Protocol Violation|1|||
163994555|NCT00868790|592347885|FG001|Period 1|Protocol Violation|0|||
163994556|NCT00868790|592347886|FG002|Period 1|Protocol Violation|0|||
163994557|NCT00868790|592347887|FG003|Period 1|Protocol Violation|0|||
163994558|NCT00868790|592347888|FG004|Period 1|Protocol Violation|0|||
163994559|NCT00868790|592347889|FG005|Period 1|Protocol Violation|0|||
163994560|NCT00868790|592347890|FG006|Period 1|Protocol Violation|0|||
163994561|NCT00868790|592347891|FG007|Period 1|Protocol Violation|0|||
163994562|NCT00868790|592347892|FG008|Period 1|Protocol Violation|0|||
163994563|NCT00868790|592347893|FG009|Period 1|Protocol Violation|0|||
163994564|NCT00868790|592347894|FG010|Period 1|Protocol Violation|0|||
163994565|NCT00868790|592347895|FG011|Period 1|Protocol Violation|0|||
163889366|NCT04032704|591967479|FG005|Part B|Death|0|||
163889367|NCT04032704|591967480|FG006|Part B|Death|13|||
163889368|NCT04032704|591967481|FG007|Part B|Death|13|||
163889369|NCT04032704|591967482|FG008|Part B|Death|14|||
163889370|NCT04032704|591967483|FG009|Part B|Death|12|||
163889371|NCT04032704|591967484|FG010|Part B|Death|12|||
163994566|NCT00868790|592347896|FG012|Period 1|Protocol Violation|0|||
163994567|NCT00868790|592347897|FG013|Period 1|Protocol Violation|0|||
163994568|NCT00868790|592347884|FG000|Period 1|Withdrawal by Subject|0|||
163994569|NCT00868790|592347885|FG001|Period 1|Withdrawal by Subject|1|||
163994570|NCT00868790|592347886|FG002|Period 1|Withdrawal by Subject|0|||
163994571|NCT00868790|592347887|FG003|Period 1|Withdrawal by Subject|0|||
163994572|NCT00868790|592347888|FG004|Period 1|Withdrawal by Subject|0|||
163994573|NCT00868790|592347889|FG005|Period 1|Withdrawal by Subject|0|||
163994574|NCT00868790|592347890|FG006|Period 1|Withdrawal by Subject|0|||
163994575|NCT00868790|592347891|FG007|Period 1|Withdrawal by Subject|0|||
163994576|NCT00868790|592347892|FG008|Period 1|Withdrawal by Subject|0|||
163994577|NCT00868790|592347893|FG009|Period 1|Withdrawal by Subject|0|||
163994578|NCT00868790|592347894|FG010|Period 1|Withdrawal by Subject|0|||
163994579|NCT00868790|592347895|FG011|Period 1|Withdrawal by Subject|0|||
163994580|NCT00868790|592347896|FG012|Period 1|Withdrawal by Subject|0|||
163994581|NCT00868790|592347897|FG013|Period 1|Withdrawal by Subject|1|||
163994582|NCT00868790|592347884|FG000|Period 1|Abnormal Triglycerides|0|||
163994583|NCT00868790|592347885|FG001|Period 1|Abnormal Triglycerides|0|||
163994584|NCT00868790|592347886|FG002|Period 1|Abnormal Triglycerides|0|||
163994585|NCT00868790|592347887|FG003|Period 1|Abnormal Triglycerides|0|||
163994586|NCT00868790|592347888|FG004|Period 1|Abnormal Triglycerides|1|||
163994587|NCT00868790|592347889|FG005|Period 1|Abnormal Triglycerides|0|||
163994588|NCT00868790|592347890|FG006|Period 1|Abnormal Triglycerides|0|||
163994589|NCT00868790|592347891|FG007|Period 1|Abnormal Triglycerides|0|||
163994590|NCT00868790|592347892|FG008|Period 1|Abnormal Triglycerides|0|||
163994591|NCT00868790|592347893|FG009|Period 1|Abnormal Triglycerides|0|||
163994592|NCT00868790|592347894|FG010|Period 1|Abnormal Triglycerides|0|||
163994593|NCT00868790|592347895|FG011|Period 1|Abnormal Triglycerides|0|||
163994594|NCT00868790|592347896|FG012|Period 1|Abnormal Triglycerides|0|||
163994595|NCT00868790|592347897|FG013|Period 1|Abnormal Triglycerides|0|||
163994596|NCT00868790|592347884|FG000|Period 1|Lost to Follow-up|0|||
163994597|NCT00868790|592347885|FG001|Period 1|Lost to Follow-up|0|||
164085457|NCT00506441|592677246|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
164085458|NCT00506441|592677247|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
164341010|NCT01145625|593623847|FG000|Overall Study|Protocol Violation|3|||
164341011|NCT01145625|593623848|FG001|Overall Study|Protocol Violation|1|||
164341012|NCT01145625|593623847|FG000|Overall Study|Withdrawal by Subject|7|||
164341013|NCT01145625|593623848|FG001|Overall Study|Withdrawal by Subject|16|||
164341014|NCT01145625|593623847|FG000|Overall Study|Pregnancy|0|||
163889372|NCT04032704|591967485|FG011|Part B|Death|13|||
163889373|NCT04032704|591967486|FG012|Part B|Death|7|||
164341015|NCT01145625|593623848|FG001|Overall Study|Pregnancy|1|||
164341016|NCT01751178|593623849|FG000|Overall Study|Adverse Event|2|||
164341017|NCT01751178|593623850|FG001|Overall Study|Adverse Event|0|||
164341018|NCT01751178|593623851|FG002|Overall Study|Adverse Event|0|||
164341019|NCT01751178|593623849|FG000|Overall Study|Other Reason (unknown)|1|||
164341020|NCT01751178|593623850|FG001|Overall Study|Other Reason (unknown)|0|||
163889374|NCT04032704|591967487|FG013|Part B|Death|17|||
163889375|NCT04032704|591967488|FG014|Part B|Death|2|||
163889376|NCT04032704|591967489|FG015|Part B|Death|1|||
163889377|NCT04032704|591967490|FG016|Part B|Death|2|||
163889378|NCT04032704|591967491|FG017|Part B|Death|2|||
163889379|NCT01501955|591967492|FG000|Overall Study|Withdrawal by Subject|1|||
163994598|NCT00868790|592347886|FG002|Period 1|Lost to Follow-up|0|||
163994599|NCT00868790|592347887|FG003|Period 1|Lost to Follow-up|0|||
163994600|NCT00868790|592347888|FG004|Period 1|Lost to Follow-up|0|||
163994601|NCT00868790|592347889|FG005|Period 1|Lost to Follow-up|1|||
163994602|NCT00868790|592347890|FG006|Period 1|Lost to Follow-up|0|||
163994603|NCT00868790|592347891|FG007|Period 1|Lost to Follow-up|0|||
163994604|NCT00868790|592347892|FG008|Period 1|Lost to Follow-up|0|||
163994605|NCT00868790|592347893|FG009|Period 1|Lost to Follow-up|0|||
163994606|NCT00868790|592347894|FG010|Period 1|Lost to Follow-up|0|||
163994607|NCT00868790|592347895|FG011|Period 1|Lost to Follow-up|0|||
163994608|NCT00868790|592347896|FG012|Period 1|Lost to Follow-up|0|||
163994609|NCT00868790|592347897|FG013|Period 1|Lost to Follow-up|0|||
163994610|NCT00868790|592347884|FG000|Period 2|Adverse Event|0|||
163994611|NCT00868790|592347885|FG001|Period 2|Adverse Event|0|||
163994612|NCT00868790|592347886|FG002|Period 2|Adverse Event|0|||
163994613|NCT00868790|592347887|FG003|Period 2|Adverse Event|0|||
163994614|NCT00868790|592347888|FG004|Period 2|Adverse Event|0|||
163994615|NCT00868790|592347889|FG005|Period 2|Adverse Event|0|||
163994616|NCT00868790|592347890|FG006|Period 2|Adverse Event|0|||
163994617|NCT00868790|592347891|FG007|Period 2|Adverse Event|0|||
163994618|NCT00868790|592347892|FG008|Period 2|Adverse Event|1|||
163994619|NCT00868790|592347893|FG009|Period 2|Adverse Event|0|||
163994620|NCT00868790|592347894|FG010|Period 2|Adverse Event|0|||
163994621|NCT00868790|592347895|FG011|Period 2|Adverse Event|0|||
164341021|NCT01751178|593623851|FG002|Overall Study|Other Reason (unknown)|2|||
164341022|NCT04289623|593623852|FG000|Wave 1 Emails|Email was not delivered|268|||
164341023|NCT04289623|593623853|FG001|Wave 1 Emails|Email was not delivered|257|||
164341024|NCT04289623|593623854|FG002|Wave 1 Emails|Email was not delivered|0|||
164341025|NCT04289623|593623855|FG003|Wave 1 Emails|Email was not delivered|0|||
163889380|NCT01501955|591967493|FG001|Overall Study|Withdrawal by Subject|0|||
163889381|NCT01501955|591967492|FG000|Overall Study|Adverse Event|1|||
163889382|NCT01501955|591967493|FG001|Overall Study|Adverse Event|3|||
163889383|NCT04298983|591967494|FG000|Overall Study|Adverse Event|4|||
163889384|NCT04298983|591967494|FG000|Overall Study|Lack of Efficacy|3|||
163889385|NCT02927236|591967495|FG000|Characterization Phase|Physician Decision|0|||
163889386|NCT02927236|591967496|FG001|Characterization Phase|Physician Decision|3|||
163889387|NCT02927236|591967497|FG002|Characterization Phase|Physician Decision|0|||
163889388|NCT02927236|591967498|FG003|Characterization Phase|Physician Decision|2|||
163889389|NCT02927236|591967495|FG000|Characterization Phase|Lost to Follow-up|0|||
163889390|NCT02927236|591967496|FG001|Characterization Phase|Lost to Follow-up|0|||
163889391|NCT02927236|591967497|FG002|Characterization Phase|Lost to Follow-up|0|||
163889392|NCT02927236|591967498|FG003|Characterization Phase|Lost to Follow-up|3|||
163889393|NCT02927236|591967495|FG000|Characterization Phase|Withdrawal by Subject|1|||
163889394|NCT02927236|591967496|FG001|Characterization Phase|Withdrawal by Subject|0|||
163889395|NCT02927236|591967497|FG002|Characterization Phase|Withdrawal by Subject|0|||
163889396|NCT02927236|591967498|FG003|Characterization Phase|Withdrawal by Subject|1|||
163889397|NCT02927236|591967495|FG000|Treatment Phase|Adverse Event|1|||
163889398|NCT02927236|591967496|FG001|Treatment Phase|Adverse Event|0|||
163889399|NCT02927236|591967497|FG002|Treatment Phase|Adverse Event|1|||
163889400|NCT02927236|591967498|FG003|Treatment Phase|Adverse Event|1|||
163889401|NCT02927236|591967495|FG000|Treatment Phase|Protocol Violation|3|||
163889402|NCT02927236|591967496|FG001|Treatment Phase|Protocol Violation|0|||
163889403|NCT02927236|591967497|FG002|Treatment Phase|Protocol Violation|0|||
163889404|NCT02927236|591967498|FG003|Treatment Phase|Protocol Violation|1|||
163889405|NCT02927236|591967495|FG000|Treatment Phase|Lost to Follow-up|1|||
163889406|NCT02927236|591967496|FG001|Treatment Phase|Lost to Follow-up|0|||
163889407|NCT02927236|591967497|FG002|Treatment Phase|Lost to Follow-up|0|||
163889408|NCT02927236|591967498|FG003|Treatment Phase|Lost to Follow-up|0|||
163889409|NCT02927236|591967495|FG000|Follow-up Phase|Lost to Follow-up|1|||
163889410|NCT02927236|591967496|FG001|Follow-up Phase|Lost to Follow-up|0|||
163889411|NCT02927236|591967497|FG002|Follow-up Phase|Lost to Follow-up|1|||
163889412|NCT02927236|591967498|FG003|Follow-up Phase|Lost to Follow-up|0|||
163889413|NCT05477186|591967499|FG000|Overall Study|Vaccine not administered|0|||
163889414|NCT05477186|591967500|FG001|Overall Study|Vaccine not administered|2|||
163889415|NCT05477186|591967501|FG002|Overall Study|Vaccine not administered|1|||
163889416|NCT05477186|591967502|FG003|Overall Study|Vaccine not administered|0|||
163889417|NCT05477186|591967503|FG004|Overall Study|Vaccine not administered|1|||
163889418|NCT05477186|591967504|FG005|Overall Study|Vaccine not administered|0|||
163889419|NCT05477186|591967505|FG006|Overall Study|Vaccine not administered|0|||
163889420|NCT05477186|591967499|FG000|Overall Study|Withdrawal by Subject|1|||
163889421|NCT05477186|591967500|FG001|Overall Study|Withdrawal by Subject|0|||
163889422|NCT05477186|591967501|FG002|Overall Study|Withdrawal by Subject|0|||
163889423|NCT05477186|591967502|FG003|Overall Study|Withdrawal by Subject|0|||
163889424|NCT05477186|591967503|FG004|Overall Study|Withdrawal by Subject|0|||
163889425|NCT05477186|591967504|FG005|Overall Study|Withdrawal by Subject|1|||
163889426|NCT05477186|591967505|FG006|Overall Study|Withdrawal by Subject|0|||
163889427|NCT05477186|591967499|FG000|Overall Study|Lost to Follow-up|1|||
163889428|NCT05477186|591967500|FG001|Overall Study|Lost to Follow-up|0|||
163889429|NCT05477186|591967501|FG002|Overall Study|Lost to Follow-up|2|||
163889430|NCT05477186|591967502|FG003|Overall Study|Lost to Follow-up|1|||
163889431|NCT05477186|591967503|FG004|Overall Study|Lost to Follow-up|1|||
163889432|NCT05477186|591967504|FG005|Overall Study|Lost to Follow-up|0|||
163889433|NCT05477186|591967505|FG006|Overall Study|Lost to Follow-up|2|||
163889434|NCT01919554|591967507|FG000|Overall Study|Withdrawal by Subject|0|||
163889435|NCT01919554|591967508|FG001|Overall Study|Withdrawal by Subject|0|||
163889436|NCT01919554|591967509|FG002|Overall Study|Withdrawal by Subject|1|||
163889437|NCT01919554|591967510|FG003|Overall Study|Withdrawal by Subject|1|||
163889438|NCT01733316|591967513|FG000|RP103 Phase|Non-compliance|1|||
163889439|NCT01733316|591967513|FG000|Long Term Extension Phase|Adverse Event|1|||
163889440|NCT01733316|591967513|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
163889441|NCT01733316|591967513|FG000|Long Term Extension Phase|Sponsor Decision|2|||
163889442|NCT02838420|591967518|FG000|Overall Study|Ongoing in Study|113|||
163889443|NCT02838420|591967519|FG001|Overall Study|Ongoing in Study|45|||
163889444|NCT02838420|591967518|FG000|Overall Study|Lost to Follow-up|1|||
163889445|NCT02838420|591967519|FG001|Overall Study|Lost to Follow-up|0|||
163889446|NCT02838420|591967518|FG000|Overall Study|Withdrawal by Subject|3|||
163889447|NCT02838420|591967519|FG001|Overall Study|Withdrawal by Subject|4|||
163889448|NCT02838420|591967518|FG000|Overall Study|Death|8|||
163889449|NCT02838420|591967519|FG001|Overall Study|Death|13|||
163889450|NCT03024437|591967520|FG000|Overall Study|Adverse Event|0|||
163889451|NCT03024437|591967521|FG001|Overall Study|Adverse Event|1|||
164341026|NCT04289623|593623856|FG004|Wave 1 Emails|Email was not delivered|0|||
163889452|NCT03024437|591967522|FG002|Overall Study|Adverse Event|3|||
163889453|NCT03024437|591967523|FG003|Overall Study|Adverse Event|5|||
163889454|NCT03024437|591967524|FG004|Overall Study|Adverse Event|0|||
163889455|NCT03024437|591967520|FG000|Overall Study|Physician Decision|1|||
163889456|NCT03024437|591967521|FG001|Overall Study|Physician Decision|0|||
163889457|NCT03024437|591967522|FG002|Overall Study|Physician Decision|0|||
163889458|NCT03024437|591967523|FG003|Overall Study|Physician Decision|1|||
163889459|NCT03024437|591967524|FG004|Overall Study|Physician Decision|0|||
163889460|NCT03024437|591967520|FG000|Overall Study|Disease progression, relapse|1|||
163889461|NCT03024437|591967521|FG001|Overall Study|Disease progression, relapse|0|||
163889462|NCT03024437|591967522|FG002|Overall Study|Disease progression, relapse|0|||
163889463|NCT03024437|591967523|FG003|Overall Study|Disease progression, relapse|3|||
163889464|NCT03024437|591967524|FG004|Overall Study|Disease progression, relapse|0|||
163889465|NCT03024437|591967520|FG000|Overall Study|Disease progression, refractory disease|4|||
163889466|NCT03024437|591967521|FG001|Overall Study|Disease progression, refractory disease|4|||
163889467|NCT03024437|591967522|FG002|Overall Study|Disease progression, refractory disease|2|||
163889468|NCT03024437|591967523|FG003|Overall Study|Disease progression, refractory disease|2|||
163889469|NCT03024437|591967524|FG004|Overall Study|Disease progression, refractory disease|1|||
163889470|NCT03024437|591967520|FG000|Overall Study|Newly diagnosed cancer|0|||
163889471|NCT03024437|591967521|FG001|Overall Study|Newly diagnosed cancer|0|||
163889472|NCT03024437|591967522|FG002|Overall Study|Newly diagnosed cancer|0|||
163889473|NCT03024437|591967523|FG003|Overall Study|Newly diagnosed cancer|1|||
163889474|NCT03024437|591967524|FG004|Overall Study|Newly diagnosed cancer|0|||
163889475|NCT03024437|591967520|FG000|Overall Study|Moved out of state|0|||
163889476|NCT03024437|591967521|FG001|Overall Study|Moved out of state|1|||
163889477|NCT03024437|591967522|FG002|Overall Study|Moved out of state|0|||
163889478|NCT03024437|591967523|FG003|Overall Study|Moved out of state|0|||
163889479|NCT03024437|591967524|FG004|Overall Study|Moved out of state|0|||
163889480|NCT03024437|591967520|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163889481|NCT03024437|591967521|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163889482|NCT03024437|591967522|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
163889483|NCT03024437|591967523|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163889484|NCT03024437|591967524|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
163889485|NCT03240016|591967527|FG000|Overall Study|Adverse Event|9|||
163889486|NCT03240016|591967527|FG000|Overall Study|Withdrawal by Subject|7|||
163994622|NCT00868790|592347896|FG012|Period 2|Adverse Event|0|||
163994623|NCT00868790|592347897|FG013|Period 2|Adverse Event|0|||
163994624|NCT00868790|592347884|FG000|Period 2|Lost to Follow-up|0|||
163994625|NCT00868790|592347885|FG001|Period 2|Lost to Follow-up|1|||
163994626|NCT00868790|592347886|FG002|Period 2|Lost to Follow-up|0|||
163994627|NCT00868790|592347887|FG003|Period 2|Lost to Follow-up|0|||
163889487|NCT03240016|591967527|FG000|Overall Study|Death|1|||
163889488|NCT03240016|591967527|FG000|Overall Study|Physician Decision|2|||
163889489|NCT05200403|591967528|FG000|Overall Study|Withdrawal by Subject|4|||
163889490|NCT05200403|591967529|FG001|Overall Study|Withdrawal by Subject|2|||
163889491|NCT05200403|591967530|FG002|Overall Study|Withdrawal by Subject|6|||
163889492|NCT05546411|591967531|FG000|Overall Study|Progressive Disease|1|||
163889493|NCT05546411|591967532|FG001|Overall Study|Progressive Disease|0|||
163994628|NCT00868790|592347888|FG004|Period 2|Lost to Follow-up|0|||
163994629|NCT00868790|592347889|FG005|Period 2|Lost to Follow-up|1|||
163994630|NCT00868790|592347890|FG006|Period 2|Lost to Follow-up|0|||
163994631|NCT00868790|592347891|FG007|Period 2|Lost to Follow-up|0|||
163994632|NCT00868790|592347892|FG008|Period 2|Lost to Follow-up|0|||
163994633|NCT00868790|592347893|FG009|Period 2|Lost to Follow-up|0|||
163994634|NCT00868790|592347894|FG010|Period 2|Lost to Follow-up|0|||
163994635|NCT00868790|592347895|FG011|Period 2|Lost to Follow-up|0|||
163994636|NCT00868790|592347896|FG012|Period 2|Lost to Follow-up|0|||
163994637|NCT00868790|592347897|FG013|Period 2|Lost to Follow-up|0|||
163994638|NCT00868790|592347884|FG000|Period 2|Withdrawal by Subject|0|||
163994639|NCT00868790|592347885|FG001|Period 2|Withdrawal by Subject|0|||
163994640|NCT00868790|592347886|FG002|Period 2|Withdrawal by Subject|0|||
163994641|NCT00868790|592347887|FG003|Period 2|Withdrawal by Subject|0|||
163994642|NCT00868790|592347888|FG004|Period 2|Withdrawal by Subject|0|||
163994643|NCT00868790|592347889|FG005|Period 2|Withdrawal by Subject|0|||
163994644|NCT00868790|592347890|FG006|Period 2|Withdrawal by Subject|0|||
163994645|NCT00868790|592347891|FG007|Period 2|Withdrawal by Subject|0|||
163994646|NCT00868790|592347892|FG008|Period 2|Withdrawal by Subject|1|||
163994647|NCT00868790|592347893|FG009|Period 2|Withdrawal by Subject|0|||
163994648|NCT00868790|592347894|FG010|Period 2|Withdrawal by Subject|0|||
163994649|NCT00868790|592347895|FG011|Period 2|Withdrawal by Subject|0|||
163994650|NCT00868790|592347896|FG012|Period 2|Withdrawal by Subject|0|||
163994651|NCT00868790|592347897|FG013|Period 2|Withdrawal by Subject|1|||
163994652|NCT00868790|592347884|FG000|Period 3|Adverse Event|0|||
163994653|NCT00868790|592347885|FG001|Period 3|Adverse Event|0|||
163994654|NCT00868790|592347886|FG002|Period 3|Adverse Event|0|||
163994655|NCT00868790|592347887|FG003|Period 3|Adverse Event|0|||
163994656|NCT00868790|592347888|FG004|Period 3|Adverse Event|0|||
163994657|NCT00868790|592347889|FG005|Period 3|Adverse Event|0|||
163994658|NCT00868790|592347890|FG006|Period 3|Adverse Event|0|||
163994659|NCT00868790|592347891|FG007|Period 3|Adverse Event|0|||
163994660|NCT00868790|592347892|FG008|Period 3|Adverse Event|0|||
163994661|NCT00868790|592347893|FG009|Period 3|Adverse Event|1|||
163994662|NCT00868790|592347894|FG010|Period 3|Adverse Event|0|||
163994663|NCT00868790|592347895|FG011|Period 3|Adverse Event|0|||
163994664|NCT00868790|592347896|FG012|Period 3|Adverse Event|0|||
163994665|NCT00868790|592347897|FG013|Period 3|Adverse Event|0|||
163994666|NCT00868790|592347884|FG000|Period 3|Protocol Violation|0|||
163994667|NCT00868790|592347885|FG001|Period 3|Protocol Violation|0|||
163994668|NCT00868790|592347886|FG002|Period 3|Protocol Violation|0|||
163994669|NCT00868790|592347887|FG003|Period 3|Protocol Violation|0|||
163994670|NCT00868790|592347888|FG004|Period 3|Protocol Violation|0|||
163994671|NCT00868790|592347889|FG005|Period 3|Protocol Violation|0|||
163994672|NCT00868790|592347890|FG006|Period 3|Protocol Violation|0|||
164085459|NCT00506441|592677246|FG000|Period 2; Double-blind Period|Physician Decision|1|||
164263594|NCT00031460|593333966|FG001|Overall Study|Death|1|||
164263595|NCT00031460|593333965|FG000|Overall Study|Reactivation of Disease|5|||
164263596|NCT00031460|593333966|FG001|Overall Study|Reactivation of Disease|9|||
164263597|NCT00031460|593333965|FG000|Overall Study|Disruption of blinded drug supply|2|||
164263598|NCT00031460|593333966|FG001|Overall Study|Disruption of blinded drug supply|0|||
164263599|NCT00031460|593333965|FG000|Overall Study|Confirmed unevaluable|0|||
164263600|NCT00031460|593333966|FG001|Overall Study|Confirmed unevaluable|1|||
164263601|NCT02080260|593333968|FG000|Overall Study|Death|18|||
164263602|NCT02080260|593333968|FG000|Overall Study|Withdrawal by Subject|1|||
164263603|NCT05438602|593333969|FG000|Treatment (15 Days)|Adverse Event|2|||
164263604|NCT05438602|593333970|FG001|Treatment (15 Days)|Adverse Event|1|||
164263605|NCT05438602|593333971|FG002|Treatment (15 Days)|Adverse Event|3|||
164263606|NCT05438602|593333969|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
164263607|NCT05438602|593333970|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
164263608|NCT05438602|593333971|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
164263609|NCT05438602|593333969|FG000|Treatment (15 Days)|Other|0|||
164263610|NCT05438602|593333970|FG001|Treatment (15 Days)|Other|0|||
164263611|NCT05438602|593333971|FG002|Treatment (15 Days)|Other|1|||
164263612|NCT05438602|593333969|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
164263613|NCT05438602|593333970|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
164263614|NCT05438602|593333971|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
164263615|NCT05438602|593333969|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
163994673|NCT00868790|592347891|FG007|Period 3|Protocol Violation|0|||
163994674|NCT00868790|592347892|FG008|Period 3|Protocol Violation|0|||
163994675|NCT00868790|592347893|FG009|Period 3|Protocol Violation|0|||
163994676|NCT00868790|592347894|FG010|Period 3|Protocol Violation|1|||
163994677|NCT00868790|592347895|FG011|Period 3|Protocol Violation|0|||
163994678|NCT00868790|592347896|FG012|Period 3|Protocol Violation|0|||
163994679|NCT00868790|592347897|FG013|Period 3|Protocol Violation|0|||
163994680|NCT00868790|592347884|FG000|Period 3|Study Terminated by Sponsor|0|||
163994681|NCT00868790|592347885|FG001|Period 3|Study Terminated by Sponsor|0|||
163994682|NCT00868790|592347886|FG002|Period 3|Study Terminated by Sponsor|0|||
163994683|NCT00868790|592347887|FG003|Period 3|Study Terminated by Sponsor|1|||
163994684|NCT00868790|592347888|FG004|Period 3|Study Terminated by Sponsor|0|||
163994685|NCT00868790|592347889|FG005|Period 3|Study Terminated by Sponsor|0|||
164263616|NCT05438602|593333970|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
164263617|NCT05438602|593333971|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
164263618|NCT05438602|593333969|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
163889494|NCT05546411|591967531|FG000|Overall Study|Adverse Event|0|||
163889495|NCT05546411|591967532|FG001|Overall Study|Adverse Event|1|||
163889496|NCT05546411|591967531|FG000|Overall Study|Metastatic disease|1|||
163889497|NCT05546411|591967532|FG001|Overall Study|Metastatic disease|0|||
163889498|NCT02606422|591967533|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
163889499|NCT02606422|591967534|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
164085460|NCT00506441|592677247|FG001|Period 2; Double-blind Period|Physician Decision|1|||
164341027|NCT04289623|593623857|FG005|Wave 1 Emails|Email was not delivered|0|||
163889500|NCT02606422|591967533|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
163889501|NCT02606422|591967534|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
163889502|NCT02606422|591967533|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
163889503|NCT02606422|591967534|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
163889504|NCT02606422|591967533|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
163889505|NCT02606422|591967534|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
163889506|NCT04625465|591967535|FG000|Overall Study|Lost to Follow-up|2|||
163889507|NCT04625465|591967536|FG001|Overall Study|Lost to Follow-up|2|||
163889508|NCT04625465|591967537|FG002|Overall Study|Lost to Follow-up|1|||
164341028|NCT04138810|593623860|FG000|Overall Study|Withdrawal by Subject|0|||
164341029|NCT04138810|593623861|FG001|Overall Study|Withdrawal by Subject|1|||
164341030|NCT04138810|593623860|FG000|Overall Study|Subject cancelled surgery|1|||
164341031|NCT04138810|593623861|FG001|Overall Study|Subject cancelled surgery|0|||
164341032|NCT03641339|593623864|FG000|Overall Study|Physician Decision|1|||
164341033|NCT03641339|593623865|FG001|Overall Study|Physician Decision|0|||
164341034|NCT03641339|593623866|FG002|Overall Study|Physician Decision|0|||
164341035|NCT03641339|593623867|FG003|Overall Study|Physician Decision|0|||
164341036|NCT03641339|593623868|FG004|Overall Study|Physician Decision|0|||
164341037|NCT03641339|593623869|FG005|Overall Study|Physician Decision|0|||
164341038|NCT03641339|593623864|FG000|Overall Study|Withdrawal by Subject|0|||
164341039|NCT03641339|593623865|FG001|Overall Study|Withdrawal by Subject|2|||
164341040|NCT03641339|593623866|FG002|Overall Study|Withdrawal by Subject|0|||
164341041|NCT03641339|593623867|FG003|Overall Study|Withdrawal by Subject|2|||
164341042|NCT03641339|593623868|FG004|Overall Study|Withdrawal by Subject|0|||
164341043|NCT03641339|593623869|FG005|Overall Study|Withdrawal by Subject|1|||
164341044|NCT02329080|593623870|FG000|Overall Study|Adverse Event|1|||
164341045|NCT02329080|593623870|FG000|Overall Study|Death|4|||
164341046|NCT02329080|593623870|FG000|Overall Study|Lack of Efficacy|22|||
164341047|NCT02329080|593623870|FG000|Overall Study|Lost to Follow-up|1|||
164341048|NCT02329080|593623870|FG000|Overall Study|Physician Decision|2|||
164341049|NCT02329080|593623870|FG000|Overall Study|Partial response|4|||
164341050|NCT02329080|593623870|FG000|Overall Study|Complete response|4|||
164341051|NCT00413244|593623872|FG000|Overall Study|Withdrawal by Subject|10|||
164341052|NCT00413244|593623873|FG001|Overall Study|Withdrawal by Subject|1|||
164341053|NCT02319837|593623876|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
164341054|NCT02319837|593623877|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
164341055|NCT02319837|593623878|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
164341056|NCT02319837|593623876|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
164341057|NCT02319837|593623877|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
164341058|NCT02319837|593623878|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
164341059|NCT02319837|593623876|FG000|Study Treatment Phase|Adverse Event|73|||
164341060|NCT02319837|593623877|FG001|Study Treatment Phase|Adverse Event|36|||
164341061|NCT02319837|593623878|FG002|Study Treatment Phase|Adverse Event|63|||
164341062|NCT02319837|593623876|FG000|Study Treatment Phase|Development of castration resistance|0|||
164341063|NCT02319837|593623877|FG001|Study Treatment Phase|Development of castration resistance|2|||
164341064|NCT02319837|593623878|FG002|Study Treatment Phase|Development of castration resistance|0|||
164341065|NCT02319837|593623876|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
164341066|NCT02319837|593623877|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
164341067|NCT02319837|593623878|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
164341068|NCT02319837|593623876|FG000|Study Treatment Phase|Protocol Violation|2|||
164341069|NCT02319837|593623877|FG001|Study Treatment Phase|Protocol Violation|2|||
164341070|NCT02319837|593623878|FG002|Study Treatment Phase|Protocol Violation|1|||
164341071|NCT02319837|593623876|FG000|Study Treatment Phase|Lost to Follow-up|0|||
164341072|NCT02319837|593623877|FG001|Study Treatment Phase|Lost to Follow-up|1|||
164341073|NCT02319837|593623878|FG002|Study Treatment Phase|Lost to Follow-up|0|||
164341074|NCT02319837|593623876|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
164341075|NCT02319837|593623877|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
164341076|NCT02319837|593623878|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
164341077|NCT02319837|593623876|FG000|Study Treatment Phase|Other|0|||
164341078|NCT02319837|593623877|FG001|Study Treatment Phase|Other|1|||
164341079|NCT02319837|593623878|FG002|Study Treatment Phase|Other|0|||
164341080|NCT02319837|593623876|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
164341081|NCT02319837|593623877|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
164341082|NCT02319837|593623878|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
164341083|NCT02319837|593623876|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
164341084|NCT02319837|593623877|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
163994686|NCT00868790|592347890|FG006|Period 3|Study Terminated by Sponsor|0|||
163994687|NCT00868790|592347891|FG007|Period 3|Study Terminated by Sponsor|0|||
163994688|NCT00868790|592347892|FG008|Period 3|Study Terminated by Sponsor|0|||
163994689|NCT00868790|592347893|FG009|Period 3|Study Terminated by Sponsor|0|||
163994690|NCT00868790|592347894|FG010|Period 3|Study Terminated by Sponsor|0|||
163994691|NCT00868790|592347895|FG011|Period 3|Study Terminated by Sponsor|0|||
163994692|NCT00868790|592347896|FG012|Period 3|Study Terminated by Sponsor|0|||
163994693|NCT00868790|592347897|FG013|Period 3|Study Terminated by Sponsor|0|||
163994694|NCT00868790|592347884|FG000|Period 4|Adverse Event|0|||
163994695|NCT00868790|592347885|FG001|Period 4|Adverse Event|0|||
163994696|NCT00868790|592347886|FG002|Period 4|Adverse Event|0|||
163994697|NCT00868790|592347887|FG003|Period 4|Adverse Event|0|||
163994698|NCT00868790|592347888|FG004|Period 4|Adverse Event|0|||
163994699|NCT00868790|592347889|FG005|Period 4|Adverse Event|0|||
163994700|NCT00868790|592347890|FG006|Period 4|Adverse Event|0|||
163994701|NCT00868790|592347891|FG007|Period 4|Adverse Event|1|||
163994702|NCT00868790|592347892|FG008|Period 4|Adverse Event|0|||
163994703|NCT00868790|592347893|FG009|Period 4|Adverse Event|0|||
163994704|NCT00868790|592347894|FG010|Period 4|Adverse Event|1|||
163994705|NCT00868790|592347895|FG011|Period 4|Adverse Event|0|||
163994706|NCT00868790|592347896|FG012|Period 4|Adverse Event|1|||
163994707|NCT00868790|592347897|FG013|Period 4|Adverse Event|0|||
163994708|NCT00868790|592347884|FG000|Period 4|Lost to Follow-up|0|||
163994709|NCT00868790|592347885|FG001|Period 4|Lost to Follow-up|0|||
163994710|NCT00868790|592347886|FG002|Period 4|Lost to Follow-up|0|||
163994711|NCT00868790|592347887|FG003|Period 4|Lost to Follow-up|0|||
163994712|NCT00868790|592347888|FG004|Period 4|Lost to Follow-up|0|||
163994713|NCT00868790|592347889|FG005|Period 4|Lost to Follow-up|0|||
163994714|NCT00868790|592347890|FG006|Period 4|Lost to Follow-up|0|||
163994715|NCT00868790|592347891|FG007|Period 4|Lost to Follow-up|1|||
163994716|NCT00868790|592347892|FG008|Period 4|Lost to Follow-up|0|||
163994717|NCT00868790|592347893|FG009|Period 4|Lost to Follow-up|0|||
163994718|NCT00868790|592347894|FG010|Period 4|Lost to Follow-up|0|||
163994719|NCT00868790|592347895|FG011|Period 4|Lost to Follow-up|0|||
163994720|NCT00868790|592347896|FG012|Period 4|Lost to Follow-up|0|||
163994721|NCT00868790|592347897|FG013|Period 4|Lost to Follow-up|0|||
163994722|NCT00868790|592347884|FG000|Period 4|Study Terminated by Sponsor|2|||
163994723|NCT00868790|592347885|FG001|Period 4|Study Terminated by Sponsor|0|||
163994724|NCT00868790|592347886|FG002|Period 4|Study Terminated by Sponsor|0|||
163994725|NCT00868790|592347887|FG003|Period 4|Study Terminated by Sponsor|0|||
163994726|NCT00868790|592347888|FG004|Period 4|Study Terminated by Sponsor|0|||
163994727|NCT00868790|592347889|FG005|Period 4|Study Terminated by Sponsor|0|||
163994728|NCT00868790|592347890|FG006|Period 4|Study Terminated by Sponsor|0|||
163994729|NCT00868790|592347891|FG007|Period 4|Study Terminated by Sponsor|1|||
163994730|NCT00868790|592347892|FG008|Period 4|Study Terminated by Sponsor|2|||
163994731|NCT00868790|592347893|FG009|Period 4|Study Terminated by Sponsor|0|||
163994732|NCT00868790|592347894|FG010|Period 4|Study Terminated by Sponsor|2|||
163994733|NCT00868790|592347895|FG011|Period 4|Study Terminated by Sponsor|1|||
164085461|NCT00506441|592677246|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
163889509|NCT04625465|591967538|FG003|Overall Study|Lost to Follow-up|0|||
163889510|NCT04625465|591967539|FG004|Overall Study|Lost to Follow-up|0|||
163889511|NCT04625465|591967540|FG005|Overall Study|Lost to Follow-up|2|||
163889512|NCT04625465|591967541|FG006|Overall Study|Lost to Follow-up|0|||
163889513|NCT04625465|591967542|FG007|Overall Study|Lost to Follow-up|0|||
163889514|NCT04625465|591967535|FG000|Overall Study|Death|1|||
163889515|NCT04625465|591967536|FG001|Overall Study|Death|0|||
163889516|NCT04625465|591967537|FG002|Overall Study|Death|0|||
163889517|NCT04625465|591967538|FG003|Overall Study|Death|0|||
163889518|NCT04625465|591967539|FG004|Overall Study|Death|0|||
163889519|NCT04625465|591967540|FG005|Overall Study|Death|0|||
163889520|NCT04625465|591967541|FG006|Overall Study|Death|0|||
163889521|NCT04625465|591967542|FG007|Overall Study|Death|0|||
163889522|NCT04625465|591967535|FG000|Overall Study|Withdrawal by Subject|1|||
163889523|NCT04625465|591967536|FG001|Overall Study|Withdrawal by Subject|0|||
163889524|NCT04625465|591967537|FG002|Overall Study|Withdrawal by Subject|4|||
163889525|NCT04625465|591967538|FG003|Overall Study|Withdrawal by Subject|4|||
163994734|NCT00868790|592347896|FG012|Period 4|Study Terminated by Sponsor|0|||
163994735|NCT00868790|592347897|FG013|Period 4|Study Terminated by Sponsor|1|||
163994736|NCT00868790|592347884|FG000|Period 4|Abnormal ALT/AST|0|||
163994737|NCT00868790|592347885|FG001|Period 4|Abnormal ALT/AST|0|||
163994738|NCT00868790|592347886|FG002|Period 4|Abnormal ALT/AST|1|||
163994739|NCT00868790|592347887|FG003|Period 4|Abnormal ALT/AST|0|||
163994740|NCT00868790|592347888|FG004|Period 4|Abnormal ALT/AST|0|||
163994741|NCT00868790|592347889|FG005|Period 4|Abnormal ALT/AST|0|||
163994742|NCT00868790|592347890|FG006|Period 4|Abnormal ALT/AST|0|||
163994743|NCT00868790|592347891|FG007|Period 4|Abnormal ALT/AST|0|||
163994744|NCT00868790|592347892|FG008|Period 4|Abnormal ALT/AST|0|||
163994745|NCT00868790|592347893|FG009|Period 4|Abnormal ALT/AST|0|||
163994746|NCT00868790|592347894|FG010|Period 4|Abnormal ALT/AST|0|||
163994747|NCT00868790|592347895|FG011|Period 4|Abnormal ALT/AST|0|||
163994748|NCT00868790|592347896|FG012|Period 4|Abnormal ALT/AST|0|||
163994749|NCT00868790|592347897|FG013|Period 4|Abnormal ALT/AST|0|||
164263619|NCT05438602|593333970|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
164263620|NCT05438602|593333971|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
164263621|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
164263622|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
164263623|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
164263624|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
164263625|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
164263626|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
164263627|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
164263628|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
164263629|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
164263630|NCT05438602|593333969|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
163889526|NCT04625465|591967539|FG004|Overall Study|Withdrawal by Subject|4|||
163889527|NCT04625465|591967540|FG005|Overall Study|Withdrawal by Subject|0|||
163889528|NCT04625465|591967541|FG006|Overall Study|Withdrawal by Subject|0|||
163889529|NCT04625465|591967542|FG007|Overall Study|Withdrawal by Subject|0|||
163889530|NCT05566639|591967546|FG000|Overall Study|Adverse Event|1|||
163889531|NCT05566639|591967547|FG001|Overall Study|Adverse Event|1|||
163889532|NCT05566639|591967546|FG000|Overall Study|Serious Adverse Event|1|||
163889533|NCT05566639|591967547|FG001|Overall Study|Serious Adverse Event|3|||
163889534|NCT05566639|591967546|FG000|Overall Study|Death|44|||
163889535|NCT05566639|591967547|FG001|Overall Study|Death|45|||
163889536|NCT05566639|591967546|FG000|Overall Study|Lost to Follow-up|467|||
163889537|NCT05566639|591967547|FG001|Overall Study|Lost to Follow-up|461|||
163889538|NCT05566639|591967546|FG000|Overall Study|Physician Decision|45|||
163889539|NCT05566639|591967547|FG001|Overall Study|Physician Decision|44|||
163889540|NCT05566639|591967546|FG000|Overall Study|Protocol Deviation|4|||
163889541|NCT05566639|591967547|FG001|Overall Study|Protocol Deviation|4|||
163889542|NCT05566639|591967546|FG000|Overall Study|Withdrawal by Subject|277|||
163889543|NCT05566639|591967547|FG001|Overall Study|Withdrawal by Subject|271|||
163889544|NCT05566639|591967546|FG000|Overall Study|Other Than Specified|52|||
163889545|NCT05566639|591967547|FG001|Overall Study|Other Than Specified|64|||
163889546|NCT04054193|591967555|FG000|Cycle 1|Physician Decision|1|||
163889547|NCT04054193|591967555|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
163889548|NCT04054193|591967555|FG000|Cycle 1|Allocated but not treated|3|||
163889549|NCT04054193|591967555|FG000|Cycles 2-3|Physician Decision|2|||
163889550|NCT04054193|591967555|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
163889551|NCT04054193|591967555|FG000|Cycles 2-3|Various reasons|17|||
163889552|NCT05436262|591967558|FG000|Pre-Randomization|Withdrawal by Subject|1|||
163889553|NCT05436262|591967559|FG001|Pre-Randomization|Withdrawal by Subject|0|||
163889554|NCT05436262|591967560|FG002|Pre-Randomization|Withdrawal by Subject|0|||
163889555|NCT05436262|591967558|FG000|Randomization|Withdrawal by Subject|0|||
163889556|NCT05436262|591967559|FG001|Randomization|Withdrawal by Subject|1|||
163889557|NCT05436262|591967560|FG002|Randomization|Withdrawal by Subject|0|||
163889558|NCT05299073|591967561|FG000|Overall Study|Withdrawal by Subject|0|||
163889559|NCT05299073|591967562|FG001|Overall Study|Withdrawal by Subject|0|||
163889560|NCT05299073|591967563|FG002|Overall Study|Withdrawal by Subject|1|||
163889561|NCT05299073|591967561|FG000|Overall Study|Adverse Event|0|||
163889562|NCT05299073|591967562|FG001|Overall Study|Adverse Event|1|||
163889563|NCT05299073|591967563|FG002|Overall Study|Adverse Event|0|||
163889564|NCT05299073|591967561|FG000|Overall Study|Lost to Follow-up|0|||
163889565|NCT05299073|591967562|FG001|Overall Study|Lost to Follow-up|1|||
163889566|NCT05299073|591967563|FG002|Overall Study|Lost to Follow-up|0|||
163889567|NCT03952338|591967564|FG000|Overall Study|Lost to Follow-up|11|||
163889568|NCT03952338|591967565|FG001|Overall Study|Lost to Follow-up|17|||
163889569|NCT03952338|591967564|FG000|Overall Study|Withdrawal by Subject|1|||
163889570|NCT03952338|591967565|FG001|Overall Study|Withdrawal by Subject|1|||
163889571|NCT03952338|591967564|FG000|Overall Study|Protocol Violation|1|||
163889572|NCT03952338|591967565|FG001|Overall Study|Protocol Violation|0|||
163889573|NCT05934942|591967566|FG000|Run-in Period|Not treated|1|||
163889574|NCT05934942|591967566|FG000|Run-in Period|Withdrawal by Subject|1|||
163889575|NCT03924635|591967567|FG000|Overall Study|Withdrawal by Subject|2|||
163889576|NCT03924635|591967568|FG001|Overall Study|Withdrawal by Subject|4|||
163889577|NCT05469464|591967569|FG000|Overall Study|Withdrawal by Subject|8|||
163889578|NCT05469464|591967570|FG001|Overall Study|Withdrawal by Subject|7|||
164263631|NCT05438602|593333970|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
163889579|NCT05469464|591967571|FG002|Overall Study|Withdrawal by Subject|4|||
163889580|NCT05469464|591967572|FG003|Overall Study|Withdrawal by Subject|5|||
163889581|NCT05469464|591967569|FG000|Overall Study|Adverse Event|8|||
163889582|NCT05469464|591967570|FG001|Overall Study|Adverse Event|14|||
163889583|NCT05469464|591967571|FG002|Overall Study|Adverse Event|13|||
163889584|NCT05469464|591967572|FG003|Overall Study|Adverse Event|2|||
163889585|NCT05469464|591967569|FG000|Overall Study|Lost to Follow-up|2|||
163889586|NCT05469464|591967570|FG001|Overall Study|Lost to Follow-up|5|||
163889587|NCT05469464|591967571|FG002|Overall Study|Lost to Follow-up|3|||
163889588|NCT05469464|591967572|FG003|Overall Study|Lost to Follow-up|3|||
163889589|NCT05469464|591967569|FG000|Overall Study|Lack of Efficacy|4|||
163889590|NCT05469464|591967570|FG001|Overall Study|Lack of Efficacy|1|||
163889591|NCT05469464|591967571|FG002|Overall Study|Lack of Efficacy|2|||
163889592|NCT05469464|591967572|FG003|Overall Study|Lack of Efficacy|2|||
163889593|NCT05469464|591967569|FG000|Overall Study|Physician Decision|0|||
163889594|NCT05469464|591967570|FG001|Overall Study|Physician Decision|0|||
163994750|NCT00868790|592347884|FG000|Post-study|Withdrawal by Subject|0|||
163994751|NCT00868790|592347885|FG001|Post-study|Withdrawal by Subject|0|||
163994752|NCT00868790|592347886|FG002|Post-study|Withdrawal by Subject|0|||
163994753|NCT00868790|592347887|FG003|Post-study|Withdrawal by Subject|0|||
163994754|NCT00868790|592347888|FG004|Post-study|Withdrawal by Subject|1|||
163994755|NCT00868790|592347889|FG005|Post-study|Withdrawal by Subject|0|||
163994756|NCT00868790|592347890|FG006|Post-study|Withdrawal by Subject|0|||
163994757|NCT00868790|592347891|FG007|Post-study|Withdrawal by Subject|0|||
163994758|NCT00868790|592347892|FG008|Post-study|Withdrawal by Subject|0|||
163994759|NCT00868790|592347893|FG009|Post-study|Withdrawal by Subject|0|||
163994760|NCT00868790|592347894|FG010|Post-study|Withdrawal by Subject|0|||
163994761|NCT00868790|592347895|FG011|Post-study|Withdrawal by Subject|0|||
163994762|NCT00868790|592347896|FG012|Post-study|Withdrawal by Subject|0|||
163994763|NCT00868790|592347897|FG013|Post-study|Withdrawal by Subject|0|||
163994764|NCT00868790|592347884|FG000|Post-study|Excluded Medication|0|||
163994765|NCT00868790|592347885|FG001|Post-study|Excluded Medication|0|||
163994766|NCT00868790|592347886|FG002|Post-study|Excluded Medication|0|||
163994767|NCT00868790|592347887|FG003|Post-study|Excluded Medication|0|||
163994768|NCT00868790|592347888|FG004|Post-study|Excluded Medication|0|||
163994769|NCT00868790|592347889|FG005|Post-study|Excluded Medication|0|||
163994770|NCT00868790|592347890|FG006|Post-study|Excluded Medication|0|||
163994771|NCT00868790|592347891|FG007|Post-study|Excluded Medication|2|||
163994772|NCT00868790|592347892|FG008|Post-study|Excluded Medication|0|||
163994773|NCT00868790|592347893|FG009|Post-study|Excluded Medication|1|||
163994774|NCT00868790|592347894|FG010|Post-study|Excluded Medication|0|||
163994775|NCT00868790|592347895|FG011|Post-study|Excluded Medication|0|||
163994776|NCT00868790|592347896|FG012|Post-study|Excluded Medication|0|||
163994777|NCT00868790|592347897|FG013|Post-study|Excluded Medication|0|||
163994778|NCT02909153|592347903|FG000|Overall Study|Withdrawal by Subject|0|||
163994779|NCT02909153|592347904|FG001|Overall Study|Withdrawal by Subject|1|||
163994780|NCT02909153|592347905|FG002|Overall Study|Withdrawal by Subject|0|||
163994781|NCT02909153|592347906|FG003|Overall Study|Withdrawal by Subject|0|||
163994782|NCT02909153|592347907|FG004|Overall Study|Withdrawal by Subject|0|||
163994783|NCT01273064|592347908|FG000|Overall Study|Adverse Event|5|||
163994784|NCT01273064|592347909|FG001|Overall Study|Adverse Event|1|||
163994785|NCT01273064|592347910|FG002|Overall Study|Adverse Event|3|||
163994786|NCT01273064|592347911|FG003|Overall Study|Adverse Event|2|||
163994787|NCT01273064|592347912|FG004|Overall Study|Adverse Event|1|||
163994788|NCT01273064|592347908|FG000|Overall Study|Withdrawal by Subject|4|||
163994789|NCT01273064|592347909|FG001|Overall Study|Withdrawal by Subject|2|||
163994790|NCT01273064|592347910|FG002|Overall Study|Withdrawal by Subject|2|||
163994791|NCT01273064|592347911|FG003|Overall Study|Withdrawal by Subject|2|||
163994792|NCT01273064|592347912|FG004|Overall Study|Withdrawal by Subject|0|||
163994793|NCT01273064|592347908|FG000|Overall Study|Study Termination|13|||
163994794|NCT01273064|592347909|FG001|Overall Study|Study Termination|27|||
164263632|NCT05438602|593333971|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
164263633|NCT01930890|593333972|FG000|Overall Study|Study Termination|14|||
163889595|NCT05469464|591967571|FG002|Overall Study|Physician Decision|0|||
163994795|NCT01273064|592347910|FG002|Overall Study|Study Termination|26|||
163994796|NCT01273064|592347911|FG003|Overall Study|Study Termination|16|||
163994797|NCT01273064|592347912|FG004|Overall Study|Study Termination|8|||
163994798|NCT01273064|592347908|FG000|Overall Study|Lost to Follow-up|1|||
163994799|NCT01273064|592347909|FG001|Overall Study|Lost to Follow-up|0|||
163994800|NCT01273064|592347910|FG002|Overall Study|Lost to Follow-up|0|||
163994801|NCT01273064|592347911|FG003|Overall Study|Lost to Follow-up|0|||
163994802|NCT01273064|592347912|FG004|Overall Study|Lost to Follow-up|0|||
163994803|NCT01273064|592347908|FG000|Overall Study|Physician Decision|0|||
164263634|NCT01930890|593333973|FG001|Overall Study|Study Termination|28|||
163889596|NCT05469464|591967572|FG003|Overall Study|Physician Decision|1|||
163889597|NCT05374798|591967575|FG000|Overall Study|Lost to Follow-up|2|||
163889598|NCT05374798|591967575|FG000|Overall Study|Withdrawal by Subject|2|||
163889599|NCT05374798|591967575|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
163889600|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Adverse Event|1|||
163889601|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Adverse Event|4|||
163994804|NCT01273064|592347909|FG001|Overall Study|Physician Decision|0|||
163994805|NCT01273064|592347910|FG002|Overall Study|Physician Decision|0|||
163994806|NCT01273064|592347911|FG003|Overall Study|Physician Decision|0|||
163994807|NCT01273064|592347912|FG004|Overall Study|Physician Decision|1|||
163994808|NCT04666038|592347913|FG000|Overall Study|Progressive Disease|2|||
163994809|NCT04666038|592347914|FG001|Overall Study|Progressive Disease|0|||
163994810|NCT04666038|592347913|FG000|Overall Study|Death|38|||
163994811|NCT04666038|592347914|FG001|Overall Study|Death|32|||
163994812|NCT04666038|592347913|FG000|Overall Study|Withdrawal by Subject|10|||
164263635|NCT01930890|593333974|FG002|Overall Study|Study Termination|13|||
163889602|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
163889603|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
163889604|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
163889605|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
163889606|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
163889607|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Death|0|||
163889608|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Death|2|||
163889609|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Death|0|||
163889610|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Death|0|||
163889611|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Death|0|||
163889612|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Death|0|||
163889613|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Death|0|||
163889614|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
163889615|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163889616|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163889617|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
164263636|NCT01930890|593333975|FG003|Overall Study|Study Termination|25|||
164263637|NCT01930890|593333972|FG000|Overall Study|Death|0|||
164263638|NCT01930890|593333973|FG001|Overall Study|Death|0|||
164263639|NCT01930890|593333974|FG002|Overall Study|Death|0|||
163889618|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163889619|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163889620|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
163889621|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163889622|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
163889623|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163889624|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163889625|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163889626|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163889627|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
163889628|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Progressive disease|0|||
163889629|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Progressive disease|1|||
163889630|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Progressive disease|0|||
163889631|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Progressive disease|0|||
163889632|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Progressive disease|0|||
163889633|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Progressive disease|0|||
163889634|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Progressive disease|0|||
163889635|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
163889636|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Study terminated by sponsor|1|||
163889637|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163889638|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163889639|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163889640|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163889641|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Study terminated by sponsor|0|||
163889642|NCT04585815|591967582|FG000|Sub-study A- Treatment Phase|Other|1|||
163889643|NCT04585815|591967583|FG001|Sub-study A- Treatment Phase|Other|0|||
163889644|NCT04585815|591967584|FG002|Sub-study A- Treatment Phase|Other|0|||
163889645|NCT04585815|591967585|FG003|Sub-study A- Treatment Phase|Other|0|||
163889646|NCT04585815|591967586|FG004|Sub-study A- Treatment Phase|Other|0|||
163889647|NCT04585815|591967587|FG005|Sub-study A- Treatment Phase|Other|0|||
163889648|NCT04585815|591967588|FG006|Sub-study A- Treatment Phase|Other|0|||
163889649|NCT04585815|591967582|FG000|Sub-study A- Follow-up Phase|Death|0|||
163889650|NCT04585815|591967583|FG001|Sub-study A- Follow-up Phase|Death|1|||
163889651|NCT04585815|591967584|FG002|Sub-study A- Follow-up Phase|Death|0|||
163889652|NCT04585815|591967585|FG003|Sub-study A- Follow-up Phase|Death|0|||
163889653|NCT04585815|591967586|FG004|Sub-study A- Follow-up Phase|Death|0|||
163889654|NCT04585815|591967587|FG005|Sub-study A- Follow-up Phase|Death|0|||
163889655|NCT04585815|591967588|FG006|Sub-study A- Follow-up Phase|Death|0|||
163889656|NCT04585815|591967582|FG000|Sub-study A- Follow-up Phase|Study terminated by sponsor|1|||
163889657|NCT04585815|591967583|FG001|Sub-study A- Follow-up Phase|Study terminated by sponsor|3|||
163889658|NCT04585815|591967584|FG002|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163889659|NCT04585815|591967585|FG003|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163889660|NCT04585815|591967586|FG004|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163889661|NCT04585815|591967587|FG005|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163889662|NCT04585815|591967588|FG006|Sub-study A- Follow-up Phase|Study terminated by sponsor|0|||
163889663|NCT04585815|591967582|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
163889664|NCT04585815|591967583|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
163889665|NCT04585815|591967584|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
164142287|NCT02186834|592882587|FG000|Dose Escalation|Death|0|||
164263640|NCT01930890|593333975|FG003|Overall Study|Death|1|||
163994813|NCT04666038|592347914|FG001|Overall Study|Withdrawal by Subject|19|||
163994814|NCT04666038|592347913|FG000|Overall Study|Lost to Follow-up|0|||
163994815|NCT04666038|592347914|FG001|Overall Study|Lost to Follow-up|2|||
163994816|NCT04666038|592347913|FG000|Overall Study|On Study Treatment|46|||
163994817|NCT04666038|592347914|FG001|Overall Study|On Study Treatment|5|||
163994818|NCT04666038|592347913|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
163994819|NCT04666038|592347914|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
163994820|NCT02867761|592347921|FG000|Overall Study|Participant withdrawn by investigator|0|||
163994821|NCT02867761|592347922|FG001|Overall Study|Participant withdrawn by investigator|1|||
163994822|NCT02867761|592347921|FG000|Overall Study|Lost to Follow-up|25|||
163994823|NCT02867761|592347922|FG001|Overall Study|Lost to Follow-up|18|||
163994824|NCT02867761|592347921|FG000|Overall Study|Unable to complete protocol|3|||
163994825|NCT02867761|592347922|FG001|Overall Study|Unable to complete protocol|7|||
163994826|NCT03595280|592347923|FG000|Overall Study|Lost to Follow-up|6|||
163994827|NCT03595280|592347924|FG001|Overall Study|Lost to Follow-up|9|||
163994828|NCT03595280|592347925|FG002|Overall Study|Lost to Follow-up|15|||
163994829|NCT02658812|592347928|FG000|Overall Study|Disease Progression|7|||
163994830|NCT02658812|592347928|FG000|Overall Study|Unrelated to study treatment|1|||
163994831|NCT02658812|592347928|FG000|Overall Study|Adverse Event|1|||
163994832|NCT02445586|592347931|FG000|Overall Study|Death|14|||
163994833|NCT02445586|592347931|FG000|Overall Study|Withdrawal by Subject|13|||
163994834|NCT02445586|592347931|FG000|Overall Study|Disease Progression|10|||
163994835|NCT02445586|592347931|FG000|Overall Study|Protocol Violation|1|||
163994836|NCT02445586|592347931|FG000|Overall Study|Medical Condition|1|||
163994837|NCT01512264|592347932|FG000|Overall Study|Lost to Follow-up|0|||
163994838|NCT01512264|592347933|FG001|Overall Study|Lost to Follow-up|0|||
163994839|NCT01512264|592347934|FG002|Overall Study|Lost to Follow-up|0|||
163994840|NCT01512264|592347935|FG003|Overall Study|Lost to Follow-up|1|||
164263641|NCT01930890|593333972|FG000|Overall Study|Investigator Decision|0|||
164263642|NCT01930890|593333973|FG001|Overall Study|Investigator Decision|1|||
164263643|NCT01930890|593333974|FG002|Overall Study|Investigator Decision|0|||
164263644|NCT01930890|593333975|FG003|Overall Study|Investigator Decision|0|||
164263645|NCT01930890|593333972|FG000|Overall Study|Consent Withdrawn|0|||
164263646|NCT01930890|593333973|FG001|Overall Study|Consent Withdrawn|3|||
164263647|NCT01930890|593333974|FG002|Overall Study|Consent Withdrawn|0|||
164263648|NCT01930890|593333975|FG003|Overall Study|Consent Withdrawn|1|||
164263649|NCT01930890|593333972|FG000|Overall Study|Adverse Event|0|||
164263650|NCT01930890|593333973|FG001|Overall Study|Adverse Event|1|||
164263651|NCT01930890|593333974|FG002|Overall Study|Adverse Event|0|||
164263652|NCT01930890|593333975|FG003|Overall Study|Adverse Event|0|||
164263653|NCT02091284|593333976|FG000|Overall Study|Withdrawal by Subject|2|||
164263654|NCT02091284|593333977|FG001|Overall Study|Withdrawal by Subject|1|||
164263655|NCT02091284|593333976|FG000|Overall Study|unreliable data|1|||
164263656|NCT02091284|593333977|FG001|Overall Study|unreliable data|0|||
164263657|NCT02853435|593333978|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164263658|NCT02853435|593333979|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164263659|NCT02853435|593333980|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164341085|NCT02319837|593623878|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
164263660|NCT02853435|593333981|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164263661|NCT02853435|593333982|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
164263662|NCT02853435|593333983|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
164341086|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
164341087|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
164341088|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
164341089|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
163994841|NCT01194440|592347936|FG000|Baseline (First Dose)|Reason not specified|4|||
163994842|NCT01194440|592347936|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
163994843|NCT01194440|592347936|FG000|Baseline (First Dose)|Change in therapy|1|||
163994844|NCT01194440|592347936|FG000|Baseline (First Dose)|Adverse Event|1|||
163994845|NCT01194440|592347936|FG000|6-months (2nd Dose)|Change in therapy|4|||
163994846|NCT00854828|592347937|FG000|Overall Study|Death|1|||
163994847|NCT00854828|592347938|FG001|Overall Study|Death|0|||
163994848|NCT00854828|592347939|FG002|Overall Study|Death|0|||
164355671|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
164263663|NCT03747120|593333984|FG000|Overall Study|treatment related toxicity|3|||
164263664|NCT03747120|593333985|FG001|Overall Study|treatment related toxicity|0|||
163994849|NCT00854828|592347940|FG003|Overall Study|Death|0|||
163994850|NCT00854828|592347937|FG000|Overall Study|Withdrawal by Subject|1|||
163994851|NCT00854828|592347938|FG001|Overall Study|Withdrawal by Subject|1|||
163994852|NCT00854828|592347939|FG002|Overall Study|Withdrawal by Subject|0|||
163994853|NCT00854828|592347940|FG003|Overall Study|Withdrawal by Subject|9|||
163994854|NCT00854828|592347937|FG000|Overall Study|Missed 24mo visit|1|||
164263665|NCT03747120|593333986|FG002|Overall Study|treatment related toxicity|0|||
164263666|NCT03747120|593333984|FG000|Overall Study|Withdrawal by Subject|0|||
163994855|NCT00854828|592347938|FG001|Overall Study|Missed 24mo visit|1|||
163994856|NCT00854828|592347939|FG002|Overall Study|Missed 24mo visit|8|||
163994857|NCT00854828|592347940|FG003|Overall Study|Missed 24mo visit|8|||
163994858|NCT01931059|592347941|FG000|Day 1|Pregnancy|0|||
163994859|NCT01931059|592347942|FG001|Day 1|Pregnancy|1|||
163994860|NCT01931059|592347941|FG000|Day3|Lost to Follow-up|1|||
163994861|NCT01931059|592347942|FG001|Day3|Lost to Follow-up|0|||
163994862|NCT02675075|592347944|FG000|Overall Study|Lost to Follow-up|3|||
163994863|NCT02675075|592347945|FG001|Overall Study|Lost to Follow-up|0|||
163994864|NCT02292212|592347946|FG000|ViE Phase|Withdrawal by Subject|1|||
163994865|NCT02292212|592347946|FG000|ViE Phase|Protocol Violation|2|||
163994866|NCT04957290|592347955|FG000|Overall Study|Progressive disease|3|||
163994867|NCT04957290|592347956|FG001|Overall Study|Progressive disease|3|||
163994868|NCT04957290|592347957|FG002|Overall Study|Progressive disease|2|||
163994869|NCT04957290|592347958|FG003|Overall Study|Progressive disease|0|||
163994870|NCT04957290|592347959|FG004|Overall Study|Progressive disease|0|||
163994871|NCT04957290|592347960|FG005|Overall Study|Progressive disease|0|||
163994872|NCT04957290|592347955|FG000|Overall Study|Withdrawal by Subject|1|||
163994873|NCT04957290|592347956|FG001|Overall Study|Withdrawal by Subject|0|||
163994874|NCT04957290|592347957|FG002|Overall Study|Withdrawal by Subject|1|||
163994875|NCT04957290|592347958|FG003|Overall Study|Withdrawal by Subject|0|||
163994876|NCT04957290|592347959|FG004|Overall Study|Withdrawal by Subject|0|||
163994877|NCT04957290|592347960|FG005|Overall Study|Withdrawal by Subject|0|||
163994878|NCT04957290|592347955|FG000|Overall Study|Death|0|||
163994879|NCT04957290|592347956|FG001|Overall Study|Death|2|||
163994880|NCT04957290|592347957|FG002|Overall Study|Death|1|||
163994881|NCT04957290|592347958|FG003|Overall Study|Death|0|||
163994882|NCT04957290|592347959|FG004|Overall Study|Death|0|||
163994883|NCT04957290|592347960|FG005|Overall Study|Death|0|||
163994884|NCT04957290|592347955|FG000|Overall Study|non compliance with study drug|0|||
163994885|NCT04957290|592347956|FG001|Overall Study|non compliance with study drug|1|||
163994886|NCT04957290|592347957|FG002|Overall Study|non compliance with study drug|0|||
163994887|NCT04957290|592347958|FG003|Overall Study|non compliance with study drug|0|||
163994888|NCT04957290|592347959|FG004|Overall Study|non compliance with study drug|0|||
163994889|NCT04957290|592347960|FG005|Overall Study|non compliance with study drug|0|||
163994890|NCT04957290|592347955|FG000|Overall Study|none specified.|0|||
163994891|NCT04957290|592347956|FG001|Overall Study|none specified.|1|||
163994892|NCT04957290|592347957|FG002|Overall Study|none specified.|2|||
163994893|NCT04957290|592347958|FG003|Overall Study|none specified.|0|||
163994894|NCT04957290|592347959|FG004|Overall Study|none specified.|0|||
163994895|NCT04957290|592347960|FG005|Overall Study|none specified.|0|||
163994896|NCT04957290|592347955|FG000|Overall Study|unacceptable toxicity|0|||
163994897|NCT04957290|592347956|FG001|Overall Study|unacceptable toxicity|0|||
163994898|NCT04957290|592347957|FG002|Overall Study|unacceptable toxicity|1|||
163994899|NCT04957290|592347958|FG003|Overall Study|unacceptable toxicity|0|||
163994900|NCT04957290|592347959|FG004|Overall Study|unacceptable toxicity|0|||
163994901|NCT04957290|592347960|FG005|Overall Study|unacceptable toxicity|0|||
163994902|NCT04957290|592347955|FG000|Overall Study|Adverse Event|0|||
163994903|NCT04957290|592347956|FG001|Overall Study|Adverse Event|0|||
163994904|NCT04957290|592347957|FG002|Overall Study|Adverse Event|1|||
164085462|NCT00506441|592677247|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
164085463|NCT00506441|592677246|FG000|Period 2; Double-blind Period|Other Reason|1|||
164263667|NCT03747120|593333985|FG001|Overall Study|Withdrawal by Subject|1|||
164263668|NCT03747120|593333986|FG002|Overall Study|Withdrawal by Subject|2|||
164263669|NCT03362931|593334002|FG000|Overall Study|Adverse Event|1|||
164263670|NCT03362931|593334002|FG000|Overall Study|Death|2|||
163994905|NCT04957290|592347958|FG003|Overall Study|Adverse Event|0|||
163994906|NCT04957290|592347959|FG004|Overall Study|Adverse Event|0|||
163994907|NCT04957290|592347960|FG005|Overall Study|Adverse Event|0|||
163994908|NCT04957290|592347955|FG000|Overall Study|study terminated by sponsor|0|||
163994909|NCT04957290|592347956|FG001|Overall Study|study terminated by sponsor|0|||
164085464|NCT00506441|592677247|FG001|Period 2; Double-blind Period|Other Reason|1|||
164085465|NCT04969939|592677248|FG000|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
163994910|NCT04957290|592347957|FG002|Overall Study|study terminated by sponsor|2|||
163994911|NCT04957290|592347958|FG003|Overall Study|study terminated by sponsor|0|||
163994912|NCT04957290|592347959|FG004|Overall Study|study terminated by sponsor|0|||
163994913|NCT04957290|592347960|FG005|Overall Study|study terminated by sponsor|0|||
163994914|NCT01282229|592347961|FG000|Overall Study|Protocol Violation|2|||
163994915|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994916|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164085466|NCT04969939|592677249|FG001|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164085467|NCT04969939|592677250|FG002|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164085468|NCT04969939|592677251|FG003|Part 2a: Run in Period (32 Weeks)|Adverse Event|4|||
164085469|NCT04969939|592677252|FG004|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164085470|NCT04969939|592677253|FG005|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164085471|NCT04969939|592677254|FG006|Part 2a: Run in Period (32 Weeks)|Adverse Event|0|||
164085472|NCT04969939|592677248|FG000|Part 2a: Run in Period (32 Weeks)|Other|0|||
164085473|NCT04969939|592677249|FG001|Part 2a: Run in Period (32 Weeks)|Other|0|||
164085474|NCT04969939|592677250|FG002|Part 2a: Run in Period (32 Weeks)|Other|0|||
164085475|NCT04969939|592677251|FG003|Part 2a: Run in Period (32 Weeks)|Other|5|||
164085476|NCT04969939|592677252|FG004|Part 2a: Run in Period (32 Weeks)|Other|0|||
164085477|NCT04969939|592677253|FG005|Part 2a: Run in Period (32 Weeks)|Other|0|||
164085478|NCT04969939|592677254|FG006|Part 2a: Run in Period (32 Weeks)|Other|0|||
164263671|NCT01998893|593334003|FG000|Overall Study|Adverse Event|2|||
164263672|NCT01998893|593334003|FG000|Overall Study|Death|1|||
164263673|NCT01998893|593334003|FG000|Overall Study|Lost to Follow-up|8|||
164263674|NCT01998893|593334003|FG000|Overall Study|Physician Decision|2|||
164263675|NCT01998893|593334003|FG000|Overall Study|Protocol Violation|2|||
164263676|NCT01998893|593334003|FG000|Overall Study|Withdrawal by Subject|1|||
164263677|NCT01998893|593334003|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
164263678|NCT03276052|593334004|FG000|Overall Study|Withdrawal by Subject|5|||
164263679|NCT03276052|593334004|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
164263680|NCT05136898|593334009|FG000|Overall Study|Adverse Event|2|||
164263681|NCT01994863|593334010|FG000|Period 1|Adverse Event|4|||
164263682|NCT01994863|593334011|FG001|Period 1|Adverse Event|0|||
164263683|NCT01994863|593334010|FG000|Period 1|Withdrawal by Subject|1|||
164263684|NCT01994863|593334011|FG001|Period 1|Withdrawal by Subject|0|||
164263685|NCT01994863|593334010|FG000|Period 1|Trial stopped by sponsor|1|||
164263686|NCT01994863|593334011|FG001|Period 1|Trial stopped by sponsor|3|||
164263687|NCT01994863|593334010|FG000|Period 1|Lack of Efficacy|1|||
164263688|NCT01994863|593334011|FG001|Period 1|Lack of Efficacy|0|||
164263689|NCT01994863|593334010|FG000|Period 2|Adverse Event|0|||
164263690|NCT01994863|593334011|FG001|Period 2|Adverse Event|1|||
164263691|NCT01994863|593334010|FG000|Period 2|Lack of Efficacy|0|||
164263692|NCT01994863|593334011|FG001|Period 2|Lack of Efficacy|2|||
164263693|NCT01994863|593334010|FG000|Period 2|Withdrawal by Subject|1|||
164263694|NCT01994863|593334011|FG001|Period 2|Withdrawal by Subject|1|||
164263695|NCT03784846|593334014|FG000|Pre-COVID Study|Lost to Follow-up|3|||
164263696|NCT03784846|593334015|FG001|Pre-COVID Study|Lost to Follow-up|3|||
164263697|NCT03784846|593334016|FG002|Pre-COVID Study|Lost to Follow-up|2|||
164263698|NCT03784846|593334014|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
164263699|NCT03784846|593334015|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
164263700|NCT03784846|593334016|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
164263701|NCT03784846|593334014|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
164263702|NCT03784846|593334015|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
164263703|NCT03784846|593334016|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
164263704|NCT03784846|593334014|FG000|Post-COVID Study|Lost to Follow-up|3|||
164263705|NCT03784846|593334015|FG001|Post-COVID Study|Lost to Follow-up|5|||
164263706|NCT03784846|593334016|FG002|Post-COVID Study|Lost to Follow-up|1|||
164263707|NCT03784846|593334014|FG000|Post-COVID Study|Withdrawal by Subject|1|||
164263708|NCT03784846|593334015|FG001|Post-COVID Study|Withdrawal by Subject|2|||
164263709|NCT03784846|593334016|FG002|Post-COVID Study|Withdrawal by Subject|0|||
164263710|NCT00931723|593334017|FG000|Overall Study|Withdrawal by Subject|11|||
164263711|NCT00931723|593334018|FG001|Overall Study|Withdrawal by Subject|13|||
164263712|NCT00931723|593334017|FG000|Overall Study|Adverse Event|6|||
164263713|NCT00931723|593334018|FG001|Overall Study|Adverse Event|13|||
164263714|NCT00931723|593334017|FG000|Overall Study|Lithium found in blood|0|||
164263715|NCT00931723|593334018|FG001|Overall Study|Lithium found in blood|1|||
164263716|NCT00931723|593334017|FG000|Overall Study|Condition under investigation worsened|1|||
163889666|NCT04585815|591967585|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
164085479|NCT04969939|592677248|FG000|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164263717|NCT00931723|593334018|FG001|Overall Study|Condition under investigation worsened|2|||
164263718|NCT00931723|593334017|FG000|Overall Study|Lost to Follow-up|1|||
164263719|NCT00931723|593334018|FG001|Overall Study|Lost to Follow-up|2|||
164085480|NCT04969939|592677249|FG001|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164263720|NCT00931723|593334017|FG000|Overall Study|Study-specific discontinuation criteria|1|||
164263721|NCT00931723|593334018|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164263722|NCT00931723|593334017|FG000|Overall Study|Severe non-compliance to protocol|2|||
164263723|NCT00931723|593334018|FG001|Overall Study|Severe non-compliance to protocol|0|||
164263724|NCT00931723|593334017|FG000|Overall Study|Safety reasons|0|||
164085481|NCT04969939|592677250|FG002|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164263725|NCT00931723|593334018|FG001|Overall Study|Safety reasons|1|||
164263726|NCT00931723|593334017|FG000|Overall Study|Took prohibited concomitant medication|0|||
164263727|NCT00931723|593334018|FG001|Overall Study|Took prohibited concomitant medication|1|||
164263728|NCT00931723|593334017|FG000|Overall Study|Lack or insufficient theraputic response|2|||
164263729|NCT00931723|593334018|FG001|Overall Study|Lack or insufficient theraputic response|5|||
164263730|NCT00931723|593334017|FG000|Overall Study|Sponsor decision|1|||
164263731|NCT00931723|593334018|FG001|Overall Study|Sponsor decision|0|||
164263732|NCT00931723|593334017|FG000|Overall Study|Late hospital discharge|1|||
164263733|NCT00931723|593334018|FG001|Overall Study|Late hospital discharge|0|||
164263734|NCT03054350|593334019|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
164263735|NCT03054350|593334020|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
164263736|NCT03054350|593334021|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
164263737|NCT03054350|593334022|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
164263738|NCT03054350|593334023|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
164263739|NCT03054350|593334024|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
164263740|NCT03054350|593334019|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263741|NCT03054350|593334020|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263742|NCT03054350|593334021|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
164263743|NCT03054350|593334022|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263744|NCT03054350|593334023|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263745|NCT03054350|593334024|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
164263746|NCT03054350|593334019|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
164263747|NCT03054350|593334020|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263748|NCT03054350|593334021|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263749|NCT03054350|593334022|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
164263750|NCT03054350|593334023|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263751|NCT03054350|593334024|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
164263752|NCT03054350|593334019|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263753|NCT03054350|593334020|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263754|NCT03054350|593334021|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
164263755|NCT03054350|593334022|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263756|NCT03054350|593334023|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263757|NCT03054350|593334024|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
164263758|NCT01643850|593334025|FG000|Overall Study|Withdrawal by Subject|0|||
164263759|NCT01643850|593334026|FG001|Overall Study|Withdrawal by Subject|0|||
164263760|NCT01643850|593334027|FG002|Overall Study|Withdrawal by Subject|0|||
164263761|NCT01643850|593334028|FG003|Overall Study|Withdrawal by Subject|0|||
164263762|NCT01643850|593334029|FG004|Overall Study|Withdrawal by Subject|1|||
164263763|NCT01643850|593334030|FG005|Overall Study|Withdrawal by Subject|0|||
164263764|NCT01643850|593334031|FG006|Overall Study|Withdrawal by Subject|0|||
164263765|NCT01643850|593334032|FG007|Overall Study|Withdrawal by Subject|0|||
164263766|NCT01643850|593334033|FG008|Overall Study|Withdrawal by Subject|0|||
164263767|NCT01643850|593334025|FG000|Overall Study|Lost to Follow-up|0|||
164263768|NCT01643850|593334026|FG001|Overall Study|Lost to Follow-up|0|||
164263769|NCT01643850|593334027|FG002|Overall Study|Lost to Follow-up|0|||
164263770|NCT01643850|593334028|FG003|Overall Study|Lost to Follow-up|0|||
164263771|NCT01643850|593334029|FG004|Overall Study|Lost to Follow-up|0|||
164263772|NCT01643850|593334030|FG005|Overall Study|Lost to Follow-up|0|||
164263773|NCT01643850|593334031|FG006|Overall Study|Lost to Follow-up|1|||
164263774|NCT01643850|593334032|FG007|Overall Study|Lost to Follow-up|0|||
164263775|NCT01643850|593334033|FG008|Overall Study|Lost to Follow-up|1|||
164263776|NCT01643850|593334025|FG000|Overall Study|Adverse Event|0|||
164263777|NCT01643850|593334026|FG001|Overall Study|Adverse Event|0|||
164263778|NCT01643850|593334027|FG002|Overall Study|Adverse Event|0|||
164263779|NCT01643850|593334028|FG003|Overall Study|Adverse Event|0|||
164263780|NCT01643850|593334029|FG004|Overall Study|Adverse Event|1|||
164263781|NCT01643850|593334030|FG005|Overall Study|Adverse Event|0|||
164263782|NCT01643850|593334031|FG006|Overall Study|Adverse Event|0|||
164263783|NCT01643850|593334032|FG007|Overall Study|Adverse Event|0|||
164341090|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
164341091|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
164341092|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
164341093|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
164341094|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
164341095|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
164341096|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
164263784|NCT01643850|593334033|FG008|Overall Study|Adverse Event|0|||
164263785|NCT01643850|593334025|FG000|Overall Study|Administrative Problems|0|||
164341097|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
164341098|NCT02319837|593623876|FG000|Long-Term Follow-Up Phase|Death|33|||
163889667|NCT04585815|591967586|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
164263786|NCT01643850|593334026|FG001|Overall Study|Administrative Problems|0|||
164263787|NCT01643850|593334027|FG002|Overall Study|Administrative Problems|1|||
164263788|NCT01643850|593334028|FG003|Overall Study|Administrative Problems|0|||
164263789|NCT01643850|593334029|FG004|Overall Study|Administrative Problems|1|||
164263790|NCT01643850|593334030|FG005|Overall Study|Administrative Problems|0|||
164263791|NCT01643850|593334031|FG006|Overall Study|Administrative Problems|0|||
164263792|NCT01643850|593334032|FG007|Overall Study|Administrative Problems|0|||
164263793|NCT01643850|593334033|FG008|Overall Study|Administrative Problems|0|||
164263794|NCT01133405|593334034|FG000|Period 1|Withdrawal by Subject|0|||
164263795|NCT01133405|593334035|FG001|Period 1|Withdrawal by Subject|1|||
164263796|NCT01133405|593334036|FG002|Period 1|Withdrawal by Subject|0|||
164263797|NCT01133405|593334037|FG003|Period 1|Withdrawal by Subject|1|||
164263798|NCT01133405|593334038|FG004|Period 1|Withdrawal by Subject|0|||
164263799|NCT01133405|593334039|FG005|Period 1|Withdrawal by Subject|1|||
164263800|NCT01133405|593334040|FG006|Period 1|Withdrawal by Subject|0|||
164263801|NCT01133405|593334041|FG007|Period 1|Withdrawal by Subject|0|||
164263802|NCT01133405|593334042|FG008|Period 1|Withdrawal by Subject|0|||
164263803|NCT01133405|593334043|FG009|Period 1|Withdrawal by Subject|0|||
164263804|NCT01133405|593334034|FG000|Period 1|Physician Decision|0|||
164263805|NCT01133405|593334035|FG001|Period 1|Physician Decision|0|||
164263806|NCT01133405|593334036|FG002|Period 1|Physician Decision|0|||
164263807|NCT01133405|593334037|FG003|Period 1|Physician Decision|1|||
164263808|NCT01133405|593334038|FG004|Period 1|Physician Decision|0|||
164263809|NCT01133405|593334039|FG005|Period 1|Physician Decision|0|||
164263810|NCT01133405|593334040|FG006|Period 1|Physician Decision|0|||
164263811|NCT01133405|593334041|FG007|Period 1|Physician Decision|0|||
164263812|NCT01133405|593334042|FG008|Period 1|Physician Decision|0|||
164263813|NCT01133405|593334043|FG009|Period 1|Physician Decision|0|||
164263814|NCT01133405|593334034|FG000|Period 1|Discontinued after randomization|1|||
164263815|NCT01133405|593334035|FG001|Period 1|Discontinued after randomization|0|||
164263816|NCT01133405|593334036|FG002|Period 1|Discontinued after randomization|0|||
164263817|NCT01133405|593334037|FG003|Period 1|Discontinued after randomization|0|||
164263818|NCT01133405|593334038|FG004|Period 1|Discontinued after randomization|0|||
164263819|NCT01133405|593334039|FG005|Period 1|Discontinued after randomization|0|||
164263820|NCT01133405|593334040|FG006|Period 1|Discontinued after randomization|1|||
164263821|NCT01133405|593334041|FG007|Period 1|Discontinued after randomization|0|||
164263822|NCT01133405|593334042|FG008|Period 1|Discontinued after randomization|0|||
164263823|NCT01133405|593334043|FG009|Period 1|Discontinued after randomization|0|||
164263824|NCT01133405|593334034|FG000|Period 1|Received drug only in period 2|0|||
164263825|NCT01133405|593334035|FG001|Period 1|Received drug only in period 2|1|||
164263826|NCT01133405|593334036|FG002|Period 1|Received drug only in period 2|0|||
164263827|NCT01133405|593334037|FG003|Period 1|Received drug only in period 2|2|||
164263828|NCT01133405|593334038|FG004|Period 1|Received drug only in period 2|0|||
164263829|NCT01133405|593334039|FG005|Period 1|Received drug only in period 2|1|||
164263830|NCT01133405|593334040|FG006|Period 1|Received drug only in period 2|0|||
164263831|NCT01133405|593334041|FG007|Period 1|Received drug only in period 2|0|||
164263832|NCT01133405|593334042|FG008|Period 1|Received drug only in period 2|0|||
164263833|NCT01133405|593334043|FG009|Period 1|Received drug only in period 2|0|||
164263834|NCT01133405|593334034|FG000|Period 1|Received drug only in period 3|0|||
164263835|NCT01133405|593334035|FG001|Period 1|Received drug only in period 3|1|||
164263836|NCT01133405|593334036|FG002|Period 1|Received drug only in period 3|1|||
164263837|NCT01133405|593334037|FG003|Period 1|Received drug only in period 3|0|||
164263838|NCT01133405|593334038|FG004|Period 1|Received drug only in period 3|0|||
164263839|NCT01133405|593334039|FG005|Period 1|Received drug only in period 3|0|||
164263840|NCT01133405|593334040|FG006|Period 1|Received drug only in period 3|0|||
164263841|NCT01133405|593334041|FG007|Period 1|Received drug only in period 3|0|||
164263842|NCT01133405|593334042|FG008|Period 1|Received drug only in period 3|0|||
164263843|NCT01133405|593334043|FG009|Period 1|Received drug only in period 3|0|||
164263844|NCT01133405|593334034|FG000|Period 2|Adverse Event|0|||
164263845|NCT01133405|593334035|FG001|Period 2|Adverse Event|0|||
164263846|NCT01133405|593334036|FG002|Period 2|Adverse Event|1|||
164263847|NCT01133405|593334037|FG003|Period 2|Adverse Event|0|||
164263848|NCT01133405|593334038|FG004|Period 2|Adverse Event|0|||
164263849|NCT01133405|593334039|FG005|Period 2|Adverse Event|0|||
164263850|NCT01133405|593334040|FG006|Period 2|Adverse Event|0|||
164263851|NCT01133405|593334041|FG007|Period 2|Adverse Event|0|||
164263852|NCT01133405|593334042|FG008|Period 2|Adverse Event|0|||
164263853|NCT01133405|593334043|FG009|Period 2|Adverse Event|0|||
164263854|NCT01133405|593334034|FG000|Period 2|Withdrawal by Subject|0|||
164263855|NCT01133405|593334035|FG001|Period 2|Withdrawal by Subject|0|||
164263856|NCT01133405|593334036|FG002|Period 2|Withdrawal by Subject|0|||
164263857|NCT01133405|593334037|FG003|Period 2|Withdrawal by Subject|1|||
164263858|NCT01133405|593334038|FG004|Period 2|Withdrawal by Subject|0|||
164263859|NCT01133405|593334039|FG005|Period 2|Withdrawal by Subject|1|||
164263860|NCT01133405|593334040|FG006|Period 2|Withdrawal by Subject|0|||
164263861|NCT01133405|593334041|FG007|Period 2|Withdrawal by Subject|0|||
164263862|NCT01133405|593334042|FG008|Period 2|Withdrawal by Subject|0|||
164263863|NCT01133405|593334043|FG009|Period 2|Withdrawal by Subject|0|||
164263864|NCT01133405|593334034|FG000|Period 2|Entry Criteria Not Met|0|||
164263865|NCT01133405|593334035|FG001|Period 2|Entry Criteria Not Met|1|||
164263866|NCT01133405|593334036|FG002|Period 2|Entry Criteria Not Met|0|||
164263867|NCT01133405|593334037|FG003|Period 2|Entry Criteria Not Met|0|||
164263868|NCT01133405|593334038|FG004|Period 2|Entry Criteria Not Met|0|||
164263869|NCT01133405|593334039|FG005|Period 2|Entry Criteria Not Met|0|||
164263870|NCT01133405|593334040|FG006|Period 2|Entry Criteria Not Met|0|||
164263871|NCT01133405|593334041|FG007|Period 2|Entry Criteria Not Met|0|||
164263872|NCT01133405|593334042|FG008|Period 2|Entry Criteria Not Met|0|||
164263873|NCT01133405|593334043|FG009|Period 2|Entry Criteria Not Met|0|||
164263874|NCT01133405|593334034|FG000|Period 2|Physician Decision|0|||
164263875|NCT01133405|593334035|FG001|Period 2|Physician Decision|0|||
164263876|NCT01133405|593334036|FG002|Period 2|Physician Decision|0|||
164263877|NCT01133405|593334037|FG003|Period 2|Physician Decision|0|||
164263878|NCT01133405|593334038|FG004|Period 2|Physician Decision|0|||
164263879|NCT01133405|593334039|FG005|Period 2|Physician Decision|1|||
164263880|NCT01133405|593334040|FG006|Period 2|Physician Decision|0|||
164263881|NCT01133405|593334041|FG007|Period 2|Physician Decision|0|||
164085482|NCT04969939|592677251|FG003|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|2|||
164085483|NCT04969939|592677252|FG004|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164085484|NCT04969939|592677253|FG005|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164085485|NCT04969939|592677254|FG006|Part 2a: Run in Period (32 Weeks)|Lost to Follow-up|0|||
164085486|NCT04969939|592677248|FG000|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164085487|NCT04969939|592677249|FG001|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164085488|NCT04969939|592677250|FG002|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164085489|NCT04969939|592677251|FG003|Part 2a: Run in Period (32 Weeks)|Pregnancy|1|||
164085490|NCT04969939|592677252|FG004|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164085491|NCT04969939|592677253|FG005|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164085492|NCT04969939|592677254|FG006|Part 2a: Run in Period (32 Weeks)|Pregnancy|0|||
164085493|NCT04969939|592677248|FG000|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164085494|NCT04969939|592677249|FG001|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164085495|NCT04969939|592677250|FG002|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164085496|NCT04969939|592677251|FG003|Part 2a: Run in Period (32 Weeks)|Protocol Violation|1|||
164085497|NCT04969939|592677252|FG004|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164085498|NCT04969939|592677253|FG005|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164085499|NCT04969939|592677254|FG006|Part 2a: Run in Period (32 Weeks)|Protocol Violation|0|||
164085500|NCT04969939|592677248|FG000|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164085501|NCT04969939|592677249|FG001|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164085502|NCT04969939|592677250|FG002|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164085503|NCT04969939|592677251|FG003|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164085504|NCT04969939|592677252|FG004|Part 2b (16 Weeks)|Withdrawal by Subject|3|||
164085505|NCT04969939|592677253|FG005|Part 2b (16 Weeks)|Withdrawal by Subject|1|||
164085506|NCT04969939|592677254|FG006|Part 2b (16 Weeks)|Withdrawal by Subject|0|||
164085507|NCT03843359|592677255|FG000|Escalation Phase|Lost to Follow-up|0|||
164085508|NCT03843359|592677256|FG001|Escalation Phase|Lost to Follow-up|0|||
164085509|NCT03843359|592677257|FG002|Escalation Phase|Lost to Follow-up|0|||
164085510|NCT03843359|592677258|FG003|Escalation Phase|Lost to Follow-up|0|||
164085511|NCT03843359|592677259|FG004|Escalation Phase|Lost to Follow-up|0|||
164085512|NCT03843359|592677260|FG005|Escalation Phase|Lost to Follow-up|0|||
164263882|NCT01133405|593334042|FG008|Period 2|Physician Decision|0|||
164263883|NCT01133405|593334043|FG009|Period 2|Physician Decision|0|||
164263884|NCT00867087|593334046|FG000|Overall Study|Other|1|||
164263885|NCT00867087|593334046|FG000|Overall Study|Withdrawal by Subject|4|||
164263886|NCT00867087|593334046|FG000|Overall Study|Death|37|||
164263887|NCT03300024|593334047|FG000|Overall Study|Physician Decision|4|||
164263888|NCT03300024|593334048|FG001|Overall Study|Physician Decision|6|||
164263889|NCT01238835|593334049|FG000|Overall Study|Death|124|||
164263890|NCT01238835|593334049|FG000|Overall Study|Withdrawal by Subject|9|||
164263891|NCT01238835|593334049|FG000|Overall Study|Lost to Follow-up|1|||
164263892|NCT01238835|593334049|FG000|Overall Study|Site early discontinuation|2|||
164263893|NCT02088073|593334050|FG000|Acute Phase|Withdrawal by Subject|5|||
164263894|NCT02088073|593334051|FG001|Acute Phase|Withdrawal by Subject|0|||
164263895|NCT02088073|593334052|FG002|Acute Phase|Withdrawal by Subject|0|||
164263896|NCT02088073|593334053|FG003|Acute Phase|Withdrawal by Subject|0|||
164263897|NCT02088073|593334054|FG004|Acute Phase|Withdrawal by Subject|0|||
164341099|NCT02319837|593623877|FG001|Long-Term Follow-Up Phase|Death|54|||
164341100|NCT02319837|593623878|FG002|Long-Term Follow-Up Phase|Death|42|||
163889668|NCT04585815|591967587|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
164341101|NCT02435147|593623879|FG000|Overall Study|non-evaluable DXA scan|11|||
164341102|NCT00839852|593623882|FG000|Overall Study|Adverse Event|10|||
164341103|NCT00839852|593623882|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164085513|NCT03843359|592677261|FG006|Escalation Phase|Lost to Follow-up|0|||
164085514|NCT03843359|592677262|FG007|Escalation Phase|Lost to Follow-up|0|||
164085515|NCT03843359|592677263|FG008|Escalation Phase|Lost to Follow-up|1|||
164263898|NCT02088073|593334050|FG000|Acute Phase|Hyperkalemia|2|||
164263899|NCT02088073|593334051|FG001|Acute Phase|Hyperkalemia|0|||
164263900|NCT02088073|593334052|FG002|Acute Phase|Hyperkalemia|0|||
164263901|NCT02088073|593334053|FG003|Acute Phase|Hyperkalemia|0|||
164263902|NCT02088073|593334054|FG004|Acute Phase|Hyperkalemia|0|||
164263903|NCT02088073|593334050|FG000|Maintanance Phase|Withdrawal by Subject|0|||
164263904|NCT02088073|593334051|FG001|Maintanance Phase|Withdrawal by Subject|2|||
164263905|NCT02088073|593334052|FG002|Maintanance Phase|Withdrawal by Subject|0|||
164263906|NCT02088073|593334053|FG003|Maintanance Phase|Withdrawal by Subject|0|||
164263907|NCT02088073|593334054|FG004|Maintanance Phase|Withdrawal by Subject|0|||
164263908|NCT02088073|593334050|FG000|Maintanance Phase|Adverse Event|0|||
164263909|NCT02088073|593334051|FG001|Maintanance Phase|Adverse Event|0|||
164263910|NCT02088073|593334052|FG002|Maintanance Phase|Adverse Event|3|||
164263911|NCT02088073|593334053|FG003|Maintanance Phase|Adverse Event|0|||
164263912|NCT02088073|593334054|FG004|Maintanance Phase|Adverse Event|1|||
164263913|NCT02088073|593334050|FG000|Maintanance Phase|Physician Decision|0|||
164263914|NCT02088073|593334051|FG001|Maintanance Phase|Physician Decision|0|||
164263915|NCT02088073|593334052|FG002|Maintanance Phase|Physician Decision|0|||
164263916|NCT02088073|593334053|FG003|Maintanance Phase|Physician Decision|0|||
164263917|NCT02088073|593334054|FG004|Maintanance Phase|Physician Decision|1|||
164263918|NCT02088073|593334050|FG000|Maintanance Phase|Sponsor's decision|0|||
164263919|NCT02088073|593334051|FG001|Maintanance Phase|Sponsor's decision|2|||
164263920|NCT02088073|593334052|FG002|Maintanance Phase|Sponsor's decision|0|||
164263921|NCT02088073|593334053|FG003|Maintanance Phase|Sponsor's decision|2|||
164263922|NCT02088073|593334054|FG004|Maintanance Phase|Sponsor's decision|1|||
164263923|NCT02088073|593334050|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
164263924|NCT02088073|593334051|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
164263925|NCT02088073|593334052|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
164263926|NCT02088073|593334053|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
164263927|NCT02088073|593334054|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
164263928|NCT02088073|593334050|FG000|Maintanance Phase|Miscellaneous|0|||
164263929|NCT02088073|593334051|FG001|Maintanance Phase|Miscellaneous|2|||
164263930|NCT02088073|593334052|FG002|Maintanance Phase|Miscellaneous|1|||
164263931|NCT02088073|593334053|FG003|Maintanance Phase|Miscellaneous|2|||
164263932|NCT02088073|593334054|FG004|Maintanance Phase|Miscellaneous|1|||
164263933|NCT02088073|593334050|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
164263934|NCT02088073|593334051|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
164263935|NCT02088073|593334052|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
164263936|NCT02088073|593334053|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
164263937|NCT02088073|593334054|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
164263938|NCT02088073|593334050|FG000|Maintanance Phase|Subject compliance|0|||
164263939|NCT02088073|593334051|FG001|Maintanance Phase|Subject compliance|1|||
164263940|NCT02088073|593334052|FG002|Maintanance Phase|Subject compliance|0|||
164341104|NCT00839852|593623882|FG000|Overall Study|Protocol Violation|9|||
164341105|NCT00839852|593623882|FG000|Overall Study|Withdrawal of Consent|16|||
164341106|NCT00839852|593623882|FG000|Overall Study|Lost to Follow-up|7|||
164341107|NCT00839852|593623882|FG000|Overall Study|Lack of Compliance While in Jail|1|||
164341108|NCT00839852|593623882|FG000|Overall Study|Pregnancy|1|||
164341109|NCT03082261|593623883|FG000|Overall Study|Death|4|||
164341110|NCT03082261|593623883|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
164341111|NCT03082261|593623883|FG000|Overall Study|Insurance denial|1|||
164341112|NCT03082261|593623883|FG000|Overall Study|Peripheral lead added|1|||
164341113|NCT03082261|593623883|FG000|Overall Study|Withdrawal by Subject|40|||
164341114|NCT03082261|593623883|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
164341115|NCT03082261|593623883|FG000|Overall Study|Subject implanted with device other than study device|1|||
164341116|NCT03082261|593623883|FG000|Overall Study|Lost to Follow-up|14|||
164341117|NCT03082261|593623883|FG000|Overall Study|Subject moved to a different state|1|||
164341118|NCT03082261|593623883|FG000|Overall Study|Subject non-compliance|2|||
164341119|NCT03082261|593623883|FG000|Overall Study|Subject participation terminated by investigator|9|||
164341120|NCT03082261|593623883|FG000|Overall Study|Subject participation terminated by sponsor|4|||
164341121|NCT03082261|593623883|FG000|Overall Study|System explant|19|||
164341122|NCT03082261|593623883|FG000|Overall Study|Unable to place lead(s)|2|||
164341123|NCT03082261|593623883|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
164341124|NCT01313312|593623887|FG000|Overall Study|Adverse Event|5|||
163889669|NCT04585815|591967588|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
163889670|NCT04585815|591967582|FG000|Sub-study B- Treatment Phase|Death|0|||
164263941|NCT02088073|593334053|FG003|Maintanance Phase|Subject compliance|0|||
164263942|NCT02088073|593334054|FG004|Maintanance Phase|Subject compliance|0|||
164263943|NCT04612842|593334055|FG000|Overall Study|Lost to Follow-up|20|||
164263944|NCT04612842|593334056|FG001|Overall Study|Lost to Follow-up|11|||
164263945|NCT04612842|593334055|FG000|Overall Study|Withdrawal by Subject|26|||
164263946|NCT04612842|593334056|FG001|Overall Study|Withdrawal by Subject|15|||
164341125|NCT01313312|593623887|FG000|Overall Study|Withdrawal by Subject|18|||
164263947|NCT04612842|593334055|FG000|Overall Study|Death|2|||
164341126|NCT01313312|593623887|FG000|Overall Study|Lack of Efficacy|3|||
164341127|NCT01313312|593623887|FG000|Overall Study|Investigator Decision|1|||
164341128|NCT01313312|593623887|FG000|Overall Study|Observational Phase|1|||
164341129|NCT01313312|593623887|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
164341130|NCT01313312|593623887|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
164341131|NCT01206166|593623895|FG000|Overall Study|No evaluable data|2|||
164341132|NCT01206166|593623896|FG001|Overall Study|No evaluable data|3|||
164341133|NCT02716805|593623897|FG000|Overall Study|Progressive disease|2|||
164341134|NCT02716805|593623898|FG001|Overall Study|Progressive disease|0|||
164341135|NCT02716805|593623899|FG002|Overall Study|Progressive disease|0|||
164341136|NCT02716805|593623900|FG003|Overall Study|Progressive disease|0|||
164341137|NCT00066365|593623901|FG000|Overall Study|Adverse Event|1|||
164341138|NCT00066365|593623902|FG001|Overall Study|Adverse Event|0|||
164341139|NCT00066365|593623901|FG000|Overall Study|Lack of Efficacy|15|||
164341140|NCT00066365|593623902|FG001|Overall Study|Lack of Efficacy|12|||
164341141|NCT00066365|593623901|FG000|Overall Study|Physician Decision|1|||
164341142|NCT00066365|593623902|FG001|Overall Study|Physician Decision|0|||
164341143|NCT00066365|593623901|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
164341144|NCT00066365|593623902|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
164341145|NCT00066365|593623901|FG000|Overall Study|Ineligible|4|||
164341146|NCT00066365|593623902|FG001|Overall Study|Ineligible|2|||
164341147|NCT00467857|593623905|FG000|Overall Study|Adverse Event|1|||
164341148|NCT00467857|593623906|FG001|Overall Study|Adverse Event|0|||
164341149|NCT00467857|593623905|FG000|Overall Study|Withdrew consent|2|||
164341150|NCT00467857|593623906|FG001|Overall Study|Withdrew consent|0|||
164341151|NCT00467857|593623905|FG000|Overall Study|Death|0|||
164341152|NCT00467857|593623906|FG001|Overall Study|Death|1|||
164341153|NCT00467857|593623905|FG000|Overall Study|Discharged from court service|0|||
164341154|NCT00467857|593623906|FG001|Overall Study|Discharged from court service|1|||
164341155|NCT00467857|593623905|FG000|Overall Study|Emergency care required|0|||
164341156|NCT00467857|593623906|FG001|Overall Study|Emergency care required|1|||
164341157|NCT00467857|593623905|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
164341158|NCT00467857|593623906|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
164341159|NCT00467857|593623905|FG000|Overall Study|Discontinuation reason missing|0|||
164341160|NCT00467857|593623906|FG001|Overall Study|Discontinuation reason missing|3|||
164341161|NCT03576495|593623908|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
164341162|NCT03576495|593623909|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
164341163|NCT05306977|593623911|FG000|Overall Study|Withdrawal by Subject|1|||
164341164|NCT02628938|593623912|FG000|Overall Study|Did not attend the follow up recall|2|||
164341165|NCT02628938|593623913|FG001|Overall Study|Did not attend the follow up recall|2|||
163889671|NCT04585815|591967583|FG001|Sub-study B- Treatment Phase|Death|0|||
163889672|NCT04585815|591967584|FG002|Sub-study B- Treatment Phase|Death|0|||
163889673|NCT04585815|591967585|FG003|Sub-study B- Treatment Phase|Death|1|||
163889674|NCT04585815|591967586|FG004|Sub-study B- Treatment Phase|Death|0|||
163889675|NCT04585815|591967587|FG005|Sub-study B- Treatment Phase|Death|0|||
163889676|NCT04585815|591967588|FG006|Sub-study B- Treatment Phase|Death|0|||
163889677|NCT04585815|591967582|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
163889678|NCT04585815|591967583|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
163889679|NCT04585815|591967584|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
163889680|NCT04585815|591967585|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
163889681|NCT04585815|591967586|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
163889682|NCT04585815|591967587|FG005|Sub-study B- Treatment Phase|Progressive disease|1|||
163889683|NCT04585815|591967588|FG006|Sub-study B- Treatment Phase|Progressive disease|5|||
163889684|NCT04585815|591967582|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163889685|NCT04585815|591967583|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163889686|NCT04585815|591967584|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163889687|NCT04585815|591967585|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
163889688|NCT04585815|591967586|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163889689|NCT04585815|591967587|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
163889690|NCT04585815|591967588|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
163889691|NCT04585815|591967582|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163889692|NCT04585815|591967583|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163889693|NCT04585815|591967584|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163889694|NCT04585815|591967585|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
163889695|NCT04585815|591967586|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163889696|NCT04585815|591967587|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163889697|NCT04585815|591967588|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
163889698|NCT04585815|591967582|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
163889699|NCT04585815|591967583|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
163889700|NCT04585815|591967584|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
163889701|NCT04585815|591967585|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
163889702|NCT04585815|591967586|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
164263948|NCT04612842|593334056|FG001|Overall Study|Death|2|||
164263949|NCT02419131|593334057|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
164263950|NCT02419131|593334058|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
164263951|NCT02419131|593334059|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
164263952|NCT02419131|593334057|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
164263953|NCT02419131|593334058|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
164263954|NCT02419131|593334059|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
164263955|NCT03060512|593334060|FG000|Overall Study|Adverse Event|4|||
164263956|NCT03060512|593334061|FG001|Overall Study|Adverse Event|6|||
164263957|NCT03060512|593334060|FG000|Overall Study|Lost to Follow-up|1|||
164263958|NCT03060512|593334061|FG001|Overall Study|Lost to Follow-up|1|||
164263959|NCT03060512|593334060|FG000|Overall Study|Withdrawal by Subject|1|||
164263960|NCT03060512|593334061|FG001|Overall Study|Withdrawal by Subject|0|||
164263961|NCT03060512|593334060|FG000|Overall Study|Non-compliance with study medication|1|||
164263962|NCT03060512|593334061|FG001|Overall Study|Non-compliance with study medication|2|||
164263963|NCT03444766|593334065|FG000|Overall Study|Other Reasons|2|||
164263964|NCT03444766|593334065|FG000|Overall Study|Participant Withdrew Consent|5|||
164263965|NCT03444766|593334065|FG000|Overall Study|Lost to Follow-up|2|||
164263966|NCT03444766|593334065|FG000|Overall Study|Death|2|||
164263967|NCT03444766|593334065|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
164263968|NCT03444766|593334065|FG000|Overall Study|Disease Progression|49|||
164263969|NCT02969590|593334069|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
164263970|NCT02969590|593334070|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
164263971|NCT02969590|593334071|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
164263972|NCT03421743|593334072|FG000|Overall Study|Lack of Efficacy|1|||
164263973|NCT03421743|593334073|FG001|Overall Study|Lack of Efficacy|0|||
164263974|NCT03421743|593334072|FG000|Overall Study|Adverse Event|2|||
164263975|NCT03421743|593334073|FG001|Overall Study|Adverse Event|1|||
164263976|NCT03421743|593334072|FG000|Overall Study|Withdrawal by Subject|0|||
164263977|NCT03421743|593334073|FG001|Overall Study|Withdrawal by Subject|1|||
164263978|NCT02680574|593334080|FG000|Overall Study|Death|137|||
164263979|NCT02680574|593334081|FG001|Overall Study|Death|137|||
164263980|NCT02680574|593334080|FG000|Overall Study|Withdrawal by Subject|17|||
164263981|NCT02680574|593334081|FG001|Overall Study|Withdrawal by Subject|9|||
164263982|NCT02680574|593334080|FG000|Overall Study|Lost to Follow-up|4|||
164263983|NCT02680574|593334081|FG001|Overall Study|Lost to Follow-up|6|||
164263984|NCT02387164|593334084|FG000|Overall Study|Lost to Follow-up|2|||
164263985|NCT02387164|593334085|FG001|Overall Study|Lost to Follow-up|0|||
164263986|NCT02387164|593334084|FG000|Overall Study|Diagnosed|1|||
164263987|NCT02387164|593334085|FG001|Overall Study|Diagnosed|2|||
164263988|NCT02370641|593334086|FG000|Overall Study|dropped study|4|||
164263989|NCT02370641|593334087|FG001|Overall Study|dropped study|2|||
164263990|NCT01036529|593334090|FG000|Overall Study|Adverse Event|0|||
164263991|NCT01036529|593334091|FG001|Overall Study|Adverse Event|1|||
164263992|NCT01036529|593334090|FG000|Overall Study|Lost to Follow-up|0|||
164263993|NCT01036529|593334091|FG001|Overall Study|Lost to Follow-up|1|||
164263994|NCT01036529|593334090|FG000|Overall Study|Physician Decision|1|||
164263995|NCT01036529|593334091|FG001|Overall Study|Physician Decision|0|||
164263996|NCT01036529|593334090|FG000|Overall Study|Withdrawal by Subject|1|||
164263997|NCT01036529|593334091|FG001|Overall Study|Withdrawal by Subject|1|||
164263998|NCT01036529|593334090|FG000|Overall Study|Sponsor study termination|11|||
164263999|NCT01036529|593334091|FG001|Overall Study|Sponsor study termination|12|||
164264000|NCT01719003|593334092|FG000|Overall Study|Non compliant with protocol|1|||
164264001|NCT01719003|593334093|FG001|Overall Study|Non compliant with protocol|1|||
164264002|NCT01719003|593334094|FG002|Overall Study|Non compliant with protocol|0|||
164264003|NCT01719003|593334095|FG003|Overall Study|Non compliant with protocol|1|||
164264004|NCT01719003|593334096|FG004|Overall Study|Non compliant with protocol|2|||
164264005|NCT01719003|593334097|FG005|Overall Study|Non compliant with protocol|1|||
164264006|NCT01719003|593334098|FG006|Overall Study|Non compliant with protocol|2|||
164264007|NCT01719003|593334099|FG007|Overall Study|Non compliant with protocol|3|||
164264008|NCT01719003|593334100|FG008|Overall Study|Non compliant with protocol|0|||
163889703|NCT04585815|591967587|FG005|Sub-study B- Treatment Phase|Physician Decision|0|||
163889704|NCT04585815|591967588|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
163889705|NCT04585815|591967582|FG000|Sub-study B- Follow-up Phase|Death|0|||
163889706|NCT04585815|591967583|FG001|Sub-study B- Follow-up Phase|Death|0|||
163889707|NCT04585815|591967584|FG002|Sub-study B- Follow-up Phase|Death|1|||
164264009|NCT01719003|593334092|FG000|Overall Study|Adverse Event|6|||
164264010|NCT01719003|593334093|FG001|Overall Study|Adverse Event|5|||
164264011|NCT01719003|593334094|FG002|Overall Study|Adverse Event|4|||
164264012|NCT01719003|593334095|FG003|Overall Study|Adverse Event|3|||
164264013|NCT01719003|593334096|FG004|Overall Study|Adverse Event|4|||
164264014|NCT01719003|593334097|FG005|Overall Study|Adverse Event|3|||
164264015|NCT01719003|593334098|FG006|Overall Study|Adverse Event|6|||
164264016|NCT01719003|593334099|FG007|Overall Study|Adverse Event|5|||
164264017|NCT01719003|593334100|FG008|Overall Study|Adverse Event|0|||
164264018|NCT01719003|593334092|FG000|Overall Study|Lost to Follow-up|0|||
164264019|NCT01719003|593334093|FG001|Overall Study|Lost to Follow-up|6|||
164264020|NCT01719003|593334094|FG002|Overall Study|Lost to Follow-up|7|||
164264021|NCT01719003|593334095|FG003|Overall Study|Lost to Follow-up|2|||
164264022|NCT01719003|593334096|FG004|Overall Study|Lost to Follow-up|3|||
164264023|NCT01719003|593334097|FG005|Overall Study|Lost to Follow-up|4|||
164264024|NCT01719003|593334098|FG006|Overall Study|Lost to Follow-up|3|||
164264025|NCT01719003|593334099|FG007|Overall Study|Lost to Follow-up|2|||
164264026|NCT01719003|593334100|FG008|Overall Study|Lost to Follow-up|2|||
164264027|NCT01719003|593334092|FG000|Overall Study|Refusal to continue, not due to AE|2|||
164264028|NCT01719003|593334093|FG001|Overall Study|Refusal to continue, not due to AE|5|||
164264029|NCT01719003|593334094|FG002|Overall Study|Refusal to continue, not due to AE|4|||
164264030|NCT01719003|593334095|FG003|Overall Study|Refusal to continue, not due to AE|4|||
164264031|NCT01719003|593334096|FG004|Overall Study|Refusal to continue, not due to AE|4|||
164264032|NCT01719003|593334097|FG005|Overall Study|Refusal to continue, not due to AE|3|||
164264033|NCT01719003|593334098|FG006|Overall Study|Refusal to continue, not due to AE|8|||
164264034|NCT01719003|593334099|FG007|Overall Study|Refusal to continue, not due to AE|7|||
164264035|NCT01719003|593334100|FG008|Overall Study|Refusal to continue, not due to AE|1|||
164264036|NCT01719003|593334092|FG000|Overall Study|Reason other than those specified|0|||
164264037|NCT01719003|593334093|FG001|Overall Study|Reason other than those specified|0|||
164264038|NCT01719003|593334094|FG002|Overall Study|Reason other than those specified|2|||
164264039|NCT01719003|593334095|FG003|Overall Study|Reason other than those specified|3|||
164264040|NCT01719003|593334096|FG004|Overall Study|Reason other than those specified|4|||
164264041|NCT01719003|593334097|FG005|Overall Study|Reason other than those specified|1|||
164264042|NCT01719003|593334098|FG006|Overall Study|Reason other than those specified|0|||
164264043|NCT01719003|593334099|FG007|Overall Study|Reason other than those specified|3|||
164264044|NCT01719003|593334100|FG008|Overall Study|Reason other than those specified|1|||
164264045|NCT01719003|593334092|FG000|Overall Study|Lack of Efficacy|0|||
164264046|NCT01719003|593334093|FG001|Overall Study|Lack of Efficacy|0|||
164264047|NCT01719003|593334094|FG002|Overall Study|Lack of Efficacy|0|||
164264048|NCT01719003|593334095|FG003|Overall Study|Lack of Efficacy|0|||
164264049|NCT01719003|593334096|FG004|Overall Study|Lack of Efficacy|0|||
164264050|NCT01719003|593334097|FG005|Overall Study|Lack of Efficacy|0|||
164264051|NCT01719003|593334098|FG006|Overall Study|Lack of Efficacy|1|||
164264052|NCT01719003|593334099|FG007|Overall Study|Lack of Efficacy|0|||
164264053|NCT01719003|593334100|FG008|Overall Study|Lack of Efficacy|0|||
164264054|NCT02370095|593334101|FG000|Overall Study|Withdrawal by Subject|0|||
164264055|NCT02370095|593334102|FG001|Overall Study|Withdrawal by Subject|1|||
164264056|NCT00700102|593334103|FG000|Overall Study|Died|394|||
164264057|NCT00700102|593334104|FG001|Overall Study|Died|385|||
164264058|NCT00700102|593334103|FG000|Overall Study|Lost to Follow-up|8|||
164264059|NCT00700102|593334104|FG001|Overall Study|Lost to Follow-up|10|||
164264060|NCT01667562|593334105|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
164264061|NCT01667562|593334106|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
163889708|NCT04585815|591967585|FG003|Sub-study B- Follow-up Phase|Death|3|||
163889709|NCT04585815|591967586|FG004|Sub-study B- Follow-up Phase|Death|1|||
163889710|NCT04585815|591967587|FG005|Sub-study B- Follow-up Phase|Death|0|||
163889711|NCT04585815|591967588|FG006|Sub-study B- Follow-up Phase|Death|3|||
163889712|NCT04585815|591967582|FG000|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163889713|NCT04585815|591967583|FG001|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
164264062|NCT01667562|593334105|FG000|Erlotinib Phase|Lost to Follow-up|0|||
164264063|NCT01667562|593334106|FG001|Erlotinib Phase|Lost to Follow-up|1|||
164264064|NCT01667562|593334105|FG000|Erlotinib Phase|Adverse Event|0|||
164264065|NCT01667562|593334106|FG001|Erlotinib Phase|Adverse Event|1|||
164264066|NCT01667562|593334105|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
164264067|NCT01667562|593334106|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
164264068|NCT02525939|593334107|FG000|Overall Study|Lost to Follow-up|27|||
164264069|NCT02525939|593334108|FG001|Overall Study|Lost to Follow-up|24|||
164264070|NCT02525939|593334107|FG000|Overall Study|Physician Decision|0|||
164264071|NCT02525939|593334108|FG001|Overall Study|Physician Decision|1|||
164264072|NCT02525939|593334107|FG000|Overall Study|Withdrawal by Subject|24|||
164264073|NCT02525939|593334108|FG001|Overall Study|Withdrawal by Subject|39|||
164264074|NCT02525939|593334107|FG000|Overall Study|Death|180|||
164264075|NCT02525939|593334108|FG001|Overall Study|Death|179|||
164264076|NCT01028716|593334109|FG000|Overall Study|Physician Decision|1|||
164264077|NCT02130986|593334110|FG000|Overall Study|Withdrawal by Subject|4|||
164264078|NCT02130986|593334111|FG001|Overall Study|Withdrawal by Subject|4|||
164264079|NCT02130986|593334110|FG000|Overall Study|Lost to Follow-up|151|||
164264080|NCT02130986|593334111|FG001|Overall Study|Lost to Follow-up|160|||
164264081|NCT01129882|593334112|FG000|Overall Study|Adverse Event|39|||
164264082|NCT01129882|593334112|FG000|Overall Study|Death|6|||
164264083|NCT01129882|593334112|FG000|Overall Study|Lack of Efficacy|5|||
164264084|NCT01129882|593334112|FG000|Overall Study|Lost to Follow-up|13|||
164264085|NCT01129882|593334112|FG000|Overall Study|Physician Decision|27|||
164264086|NCT01129882|593334112|FG000|Overall Study|Protocol Deviation|3|||
164264087|NCT01129882|593334112|FG000|Overall Study|Withdrawal Criteria Met|19|||
164264088|NCT01129882|593334112|FG000|Overall Study|Trial Termination by Sponsor|6|||
164264089|NCT01129882|593334112|FG000|Overall Study|Withdrawal by Subject|160|||
164264090|NCT01319721|593334115|FG000|Overall Study|Lost to Follow-up|1|||
164264091|NCT01319721|593334116|FG001|Overall Study|Lost to Follow-up|6|||
164264092|NCT02653495|593334117|FG000|Overall Study|Lost to Follow-up|2|||
164264093|NCT02653495|593334118|FG001|Overall Study|Lost to Follow-up|0|||
164264094|NCT02653495|593334117|FG000|Overall Study|Screening Failure|10|||
164264095|NCT02653495|593334118|FG001|Overall Study|Screening Failure|0|||
164264096|NCT02761694|593334122|FG000|Overall Study|Lack of Efficacy|0|||
164264097|NCT02761694|593334123|FG001|Overall Study|Lack of Efficacy|0|||
164264098|NCT02761694|593334124|FG002|Overall Study|Lack of Efficacy|0|||
164264099|NCT02761694|593334125|FG003|Overall Study|Lack of Efficacy|0|||
164264100|NCT02761694|593334126|FG004|Overall Study|Lack of Efficacy|0|||
164264101|NCT02761694|593334127|FG005|Overall Study|Lack of Efficacy|0|||
164264102|NCT02761694|593334128|FG006|Overall Study|Lack of Efficacy|6|||
164264103|NCT02761694|593334129|FG007|Overall Study|Lack of Efficacy|0|||
164264104|NCT02761694|593334130|FG008|Overall Study|Lack of Efficacy|0|||
164264105|NCT02761694|593334131|FG009|Overall Study|Lack of Efficacy|1|||
164264106|NCT02761694|593334132|FG010|Overall Study|Lack of Efficacy|1|||
164264107|NCT02761694|593334133|FG011|Overall Study|Lack of Efficacy|4|||
164264108|NCT02761694|593334122|FG000|Overall Study|Death|0|||
164264109|NCT02761694|593334123|FG001|Overall Study|Death|0|||
164264110|NCT02761694|593334124|FG002|Overall Study|Death|0|||
164264111|NCT02761694|593334125|FG003|Overall Study|Death|0|||
164264112|NCT02761694|593334126|FG004|Overall Study|Death|0|||
164264113|NCT02761694|593334127|FG005|Overall Study|Death|0|||
164264114|NCT02761694|593334128|FG006|Overall Study|Death|2|||
164264115|NCT02761694|593334129|FG007|Overall Study|Death|0|||
164264116|NCT02761694|593334130|FG008|Overall Study|Death|2|||
164264117|NCT02761694|593334131|FG009|Overall Study|Death|2|||
164264118|NCT02761694|593334132|FG010|Overall Study|Death|1|||
164264119|NCT02761694|593334133|FG011|Overall Study|Death|0|||
164264120|NCT02761694|593334122|FG000|Overall Study|Physician Decision|0|||
164264121|NCT02761694|593334123|FG001|Overall Study|Physician Decision|0|||
164264122|NCT02761694|593334124|FG002|Overall Study|Physician Decision|0|||
164264123|NCT02761694|593334125|FG003|Overall Study|Physician Decision|0|||
164264124|NCT02761694|593334126|FG004|Overall Study|Physician Decision|0|||
164264125|NCT02761694|593334127|FG005|Overall Study|Physician Decision|0|||
164341166|NCT02628938|593623914|FG002|Overall Study|Did not attend the follow up recall|1|||
164341167|NCT02628938|593623912|FG000|Overall Study|Failure to comply with the instructions|3|||
164341168|NCT02628938|593623913|FG001|Overall Study|Failure to comply with the instructions|0|||
164341169|NCT02628938|593623914|FG002|Overall Study|Failure to comply with the instructions|3|||
164341170|NCT02058693|593623915|FG000|Phase 1|Withdrawal by Subject|3|||
164341171|NCT02058693|593623916|FG001|Phase 1|Withdrawal by Subject|2|||
164341172|NCT02058693|593623915|FG000|Phase 1|Adverse Event|0|||
164341173|NCT02058693|593623916|FG001|Phase 1|Adverse Event|1|||
164341174|NCT02058693|593623915|FG000|Phase 1|Lack of Efficacy|1|||
164264126|NCT02761694|593334128|FG006|Overall Study|Physician Decision|1|||
164341175|NCT02058693|593623916|FG001|Phase 1|Lack of Efficacy|0|||
164264127|NCT02761694|593334129|FG007|Overall Study|Physician Decision|0|||
164264128|NCT02761694|593334130|FG008|Overall Study|Physician Decision|0|||
164341176|NCT02058693|593623915|FG000|Phase 1|Physician Decision|1|||
164341177|NCT02058693|593623916|FG001|Phase 1|Physician Decision|1|||
164341178|NCT02058693|593623915|FG000|Phase 2|Withdrawal by Subject|0|||
164264129|NCT02761694|593334131|FG009|Overall Study|Physician Decision|0|||
164264130|NCT02761694|593334132|FG010|Overall Study|Physician Decision|0|||
164264131|NCT02761694|593334133|FG011|Overall Study|Physician Decision|0|||
164264132|NCT02761694|593334122|FG000|Overall Study|Withdrawal by Subject|0|||
164264133|NCT02761694|593334123|FG001|Overall Study|Withdrawal by Subject|0|||
164264134|NCT02761694|593334124|FG002|Overall Study|Withdrawal by Subject|0|||
164264135|NCT02761694|593334125|FG003|Overall Study|Withdrawal by Subject|1|||
164264136|NCT02761694|593334126|FG004|Overall Study|Withdrawal by Subject|0|||
164264137|NCT02761694|593334127|FG005|Overall Study|Withdrawal by Subject|0|||
164264138|NCT02761694|593334128|FG006|Overall Study|Withdrawal by Subject|4|||
164264139|NCT02761694|593334129|FG007|Overall Study|Withdrawal by Subject|0|||
164264140|NCT02761694|593334130|FG008|Overall Study|Withdrawal by Subject|2|||
164264141|NCT02761694|593334131|FG009|Overall Study|Withdrawal by Subject|1|||
164264142|NCT02761694|593334132|FG010|Overall Study|Withdrawal by Subject|0|||
164264143|NCT02761694|593334133|FG011|Overall Study|Withdrawal by Subject|0|||
164264144|NCT02761694|593334122|FG000|Overall Study|Lost to Follow-up|0|||
164264145|NCT02761694|593334123|FG001|Overall Study|Lost to Follow-up|0|||
164264146|NCT02761694|593334124|FG002|Overall Study|Lost to Follow-up|0|||
164264147|NCT02761694|593334125|FG003|Overall Study|Lost to Follow-up|0|||
164264148|NCT02761694|593334126|FG004|Overall Study|Lost to Follow-up|0|||
164264149|NCT02761694|593334127|FG005|Overall Study|Lost to Follow-up|0|||
164264150|NCT02761694|593334128|FG006|Overall Study|Lost to Follow-up|1|||
164264151|NCT02761694|593334129|FG007|Overall Study|Lost to Follow-up|0|||
164264152|NCT02761694|593334130|FG008|Overall Study|Lost to Follow-up|0|||
164264153|NCT02761694|593334131|FG009|Overall Study|Lost to Follow-up|0|||
164264154|NCT02761694|593334132|FG010|Overall Study|Lost to Follow-up|0|||
164264155|NCT02761694|593334133|FG011|Overall Study|Lost to Follow-up|1|||
164264156|NCT02761694|593334122|FG000|Overall Study|Adverse Event|0|||
164264157|NCT02761694|593334123|FG001|Overall Study|Adverse Event|0|||
164264158|NCT02761694|593334124|FG002|Overall Study|Adverse Event|0|||
164264159|NCT02761694|593334125|FG003|Overall Study|Adverse Event|0|||
164264160|NCT02761694|593334126|FG004|Overall Study|Adverse Event|0|||
164264161|NCT02761694|593334127|FG005|Overall Study|Adverse Event|0|||
164264162|NCT02761694|593334128|FG006|Overall Study|Adverse Event|1|||
164264163|NCT02761694|593334129|FG007|Overall Study|Adverse Event|0|||
164264164|NCT02761694|593334130|FG008|Overall Study|Adverse Event|1|||
164264165|NCT02761694|593334131|FG009|Overall Study|Adverse Event|0|||
164264166|NCT02761694|593334132|FG010|Overall Study|Adverse Event|0|||
164264167|NCT02761694|593334133|FG011|Overall Study|Adverse Event|1|||
164264168|NCT02761694|593334122|FG000|Overall Study|Other|4|||
164264169|NCT02761694|593334123|FG001|Overall Study|Other|4|||
164264170|NCT02761694|593334124|FG002|Overall Study|Other|1|||
164264171|NCT02761694|593334125|FG003|Overall Study|Other|2|||
164264172|NCT02761694|593334126|FG004|Overall Study|Other|3|||
164264173|NCT02761694|593334127|FG005|Overall Study|Other|3|||
164264174|NCT02761694|593334128|FG006|Overall Study|Other|18|||
164264175|NCT02761694|593334129|FG007|Overall Study|Other|8|||
164264176|NCT02761694|593334130|FG008|Overall Study|Other|0|||
164264177|NCT02761694|593334131|FG009|Overall Study|Other|1|||
164264178|NCT02761694|593334132|FG010|Overall Study|Other|1|||
164264179|NCT02761694|593334133|FG011|Overall Study|Other|0|||
164264180|NCT02395055|593334139|FG000|Overall Study|Withdrawal by Subject|7|||
164264181|NCT02395055|593334140|FG001|Overall Study|Withdrawal by Subject|3|||
164264182|NCT01896271|593334141|FG000|Overall Study|Physician Decision|10|||
164264183|NCT03002623|593334145|FG000|Overall Study|Lost to Follow-up|1|||
164264184|NCT03002623|593334146|FG001|Overall Study|Lost to Follow-up|0|||
164264185|NCT03002623|593334145|FG000|Overall Study|Physician Decision|1|||
164264186|NCT03002623|593334146|FG001|Overall Study|Physician Decision|1|||
164264187|NCT00526110|593334149|FG000|Overall Study|Adverse Event|2|||
164264188|NCT00526110|593334150|FG001|Overall Study|Adverse Event|9|||
164264189|NCT00526110|593334149|FG000|Overall Study|Disease Progression|0|||
164264190|NCT00526110|593334150|FG001|Overall Study|Disease Progression|19|||
164264191|NCT00526110|593334149|FG000|Overall Study|Maximal Response|0|||
164264192|NCT00526110|593334150|FG001|Overall Study|Maximal Response|6|||
163889714|NCT04585815|591967584|FG002|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163889715|NCT04585815|591967585|FG003|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163889716|NCT04585815|591967586|FG004|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163889717|NCT04585815|591967587|FG005|Sub-study B- Follow-up Phase|Study terminated by sponsor|1|||
163889718|NCT04585815|591967588|FG006|Sub-study B- Follow-up Phase|Study terminated by sponsor|0|||
163889719|NCT01854775|591967589|FG000|Treatment Phase (48 Weeks)|Withdrew consent|1|||
163889720|NCT01854775|591967590|FG001|Treatment Phase (48 Weeks)|Withdrew consent|1|||
163889721|NCT01854775|591967591|FG002|Treatment Phase (48 Weeks)|Withdrew consent|0|||
163889722|NCT01854775|591967589|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
164264193|NCT00526110|593334149|FG000|Overall Study|Withdrawal by Subject|0|||
163889723|NCT01854775|591967590|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
163889724|NCT01854775|591967591|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
164264194|NCT00526110|593334150|FG001|Overall Study|Withdrawal by Subject|2|||
164264195|NCT00526110|593334149|FG000|Overall Study|Poor Tolerance|0|||
164264196|NCT00526110|593334150|FG001|Overall Study|Poor Tolerance|5|||
164264197|NCT00953680|593334151|FG000|Period 1|Withdrawal by Subject|0|||
163889725|NCT01854775|591967589|FG000|Extension Phase|Pregnancy|1|||
164264198|NCT00953680|593334152|FG001|Period 1|Withdrawal by Subject|1|||
164264199|NCT03762616|593334154|FG000|Overall Study|Protocol Violation|2|||
164264200|NCT00758589|593336404|FG000|Overall Study|Adverse Event|3|||
164264201|NCT00758589|593336405|FG001|Overall Study|Adverse Event|2|||
164264202|NCT00758589|593336406|FG002|Overall Study|Adverse Event|5|||
164264203|NCT00758589|593336407|FG003|Overall Study|Adverse Event|4|||
164264204|NCT00758589|593336404|FG000|Overall Study|Withdrawal by Subject|0|||
164264205|NCT00758589|593336405|FG001|Overall Study|Withdrawal by Subject|1|||
164264206|NCT00758589|593336406|FG002|Overall Study|Withdrawal by Subject|1|||
164264207|NCT00758589|593336407|FG003|Overall Study|Withdrawal by Subject|1|||
164264208|NCT00758589|593336404|FG000|Overall Study|Palm stopped to work|0|||
164264209|NCT00758589|593336405|FG001|Overall Study|Palm stopped to work|0|||
164264210|NCT00758589|593336406|FG002|Overall Study|Palm stopped to work|0|||
164264211|NCT00758589|593336407|FG003|Overall Study|Palm stopped to work|1|||
164264212|NCT00583791|593336409|FG000|Overall Study|Other|67|||
164264213|NCT00583791|593336409|FG000|Overall Study|Death|6|||
164264214|NCT00203021|593336410|FG000|Overall Study|Death|4|||
164264215|NCT00203021|593336411|FG001|Overall Study|Death|1|||
164264216|NCT00203021|593336410|FG000|Overall Study|Adverse Event|10|||
164264217|NCT00203021|593336411|FG001|Overall Study|Adverse Event|5|||
164264218|NCT00203021|593336410|FG000|Overall Study|Withdrawal by Subject|45|||
164264219|NCT00203021|593336411|FG001|Overall Study|Withdrawal by Subject|48|||
164264220|NCT00203021|593336410|FG000|Overall Study|Lost to Follow-up|9|||
164264221|NCT00203021|593336411|FG001|Overall Study|Lost to Follow-up|7|||
164264222|NCT00203021|593336410|FG000|Overall Study|Other than specified|11|||
164264223|NCT00203021|593336411|FG001|Overall Study|Other than specified|16|||
164264224|NCT03204890|593336416|FG000|Overall Study|Withdrawal by Subject|1|||
164264225|NCT04524455|593336429|FG000|Overall Study|Death|3|||
164264226|NCT04524455|593336430|FG001|Overall Study|Death|3|||
164264227|NCT04524455|593336429|FG000|Overall Study|Decision by Sponsor|0|||
164264228|NCT04524455|593336430|FG001|Overall Study|Decision by Sponsor|2|||
164264229|NCT04524455|593336429|FG000|Overall Study|Withdrawal of Consent From Study|1|||
164264230|NCT04524455|593336430|FG001|Overall Study|Withdrawal of Consent From Study|0|||
164264231|NCT04524455|593336429|FG000|Overall Study|Lost to Follow-up|0|||
164264232|NCT04524455|593336430|FG001|Overall Study|Lost to Follow-up|1|||
164264233|NCT01688739|593336431|FG000|Overall Study|Administrative Decision|1|||
164264234|NCT01688739|593336432|FG001|Overall Study|Administrative Decision|0|||
164264235|NCT01688739|593336433|FG002|Overall Study|Administrative Decision|0|||
164264236|NCT01688739|593336434|FG003|Overall Study|Administrative Decision|0|||
164264237|NCT01688739|593336435|FG004|Overall Study|Administrative Decision|0|||
164264238|NCT01688739|593336436|FG005|Overall Study|Administrative Decision|0|||
164264239|NCT01688739|593336437|FG006|Overall Study|Administrative Decision|0|||
164264240|NCT01688739|593336438|FG007|Overall Study|Administrative Decision|0|||
164264241|NCT01688739|593336439|FG008|Overall Study|Administrative Decision|0|||
164264242|NCT01688739|593336440|FG009|Overall Study|Administrative Decision|0|||
164264243|NCT00490776|593336443|FG000|Overall Study|Withdrawal by Subject|1|||
164264244|NCT00490776|593336443|FG000|Overall Study|Administrative Problems|1|||
164264245|NCT00490776|593336443|FG000|Overall Study|Death|1|||
164264246|NCT00490776|593336443|FG000|Overall Study|New Cancer Therapy|1|||
164264247|NCT00490776|593336443|FG000|Overall Study|Disease Progression|5|||
164264248|NCT03383783|593336444|FG000|Overall Study|Withdrawal by Subject|2|||
164264249|NCT01340937|593336452|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
164264250|NCT01340937|593336453|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
164264251|NCT01340937|593336454|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
164264252|NCT01340937|593336455|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
164264253|NCT01340937|593336452|FG000|Period 1: Infant Series|Adverse Event|0|||
164264254|NCT01340937|593336453|FG001|Period 1: Infant Series|Adverse Event|1|||
164264255|NCT01340937|593336454|FG002|Period 1: Infant Series|Adverse Event|4|||
163994917|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994918|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
163994919|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994920|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
163994921|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994922|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994923|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994924|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994925|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994926|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994927|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994928|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164264256|NCT01340937|593336455|FG003|Period 1: Infant Series|Adverse Event|0|||
164264257|NCT01340937|593336452|FG000|Period 1: Infant Series|Death|2|||
164264258|NCT01340937|593336453|FG001|Period 1: Infant Series|Death|0|||
164264259|NCT01340937|593336454|FG002|Period 1: Infant Series|Death|2|||
164264260|NCT01340937|593336455|FG003|Period 1: Infant Series|Death|0|||
164264261|NCT01340937|593336452|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
163994929|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
164264262|NCT01340937|593336453|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
164264263|NCT01340937|593336454|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
164264264|NCT01340937|593336455|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
164264265|NCT01340937|593336452|FG000|Period 1: Infant Series|Physician Decision|2|||
164264266|NCT01340937|593336453|FG001|Period 1: Infant Series|Physician Decision|3|||
164264267|NCT01340937|593336454|FG002|Period 1: Infant Series|Physician Decision|1|||
164264268|NCT01340937|593336455|FG003|Period 1: Infant Series|Physician Decision|0|||
164264269|NCT01340937|593336452|FG000|Period 1: Infant Series|Protocol Violation|1|||
164264270|NCT01340937|593336453|FG001|Period 1: Infant Series|Protocol Violation|4|||
164264271|NCT01340937|593336454|FG002|Period 1: Infant Series|Protocol Violation|4|||
164264272|NCT01340937|593336455|FG003|Period 1: Infant Series|Protocol Violation|3|||
164264273|NCT01340937|593336452|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
164264274|NCT01340937|593336453|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
164264275|NCT01340937|593336454|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
164264276|NCT01340937|593336455|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
164264277|NCT01340937|593336452|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
164264278|NCT01340937|593336453|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
164264279|NCT01340937|593336454|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
164264280|NCT01340937|593336455|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
164264281|NCT01340937|593336452|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
164264282|NCT01340937|593336453|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
164264283|NCT01340937|593336454|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
164264284|NCT01340937|593336455|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
164264285|NCT01340937|593336452|FG000|Period 2: Interim Period|Adverse Event|1|||
164264286|NCT01340937|593336453|FG001|Period 2: Interim Period|Adverse Event|0|||
164264287|NCT01340937|593336454|FG002|Period 2: Interim Period|Adverse Event|1|||
164264288|NCT01340937|593336455|FG003|Period 2: Interim Period|Adverse Event|0|||
164264289|NCT01340937|593336452|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
164264290|NCT01340937|593336453|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
164264291|NCT01340937|593336454|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
164264292|NCT01340937|593336455|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
164264293|NCT01340937|593336452|FG000|Period 2: Interim Period|Physician Decision|0|||
164264294|NCT01340937|593336453|FG001|Period 2: Interim Period|Physician Decision|1|||
164264295|NCT01340937|593336454|FG002|Period 2: Interim Period|Physician Decision|1|||
164264296|NCT01340937|593336455|FG003|Period 2: Interim Period|Physician Decision|0|||
164264297|NCT01340937|593336452|FG000|Period 2: Interim Period|Protocol Violation|5|||
164264298|NCT01340937|593336453|FG001|Period 2: Interim Period|Protocol Violation|3|||
164264299|NCT01340937|593336454|FG002|Period 2: Interim Period|Protocol Violation|6|||
164264300|NCT01340937|593336455|FG003|Period 2: Interim Period|Protocol Violation|3|||
164264301|NCT01340937|593336452|FG000|Period 2: Interim Period|Technical problems|4|||
164264302|NCT01340937|593336453|FG001|Period 2: Interim Period|Technical problems|4|||
164264303|NCT01340937|593336454|FG002|Period 2: Interim Period|Technical problems|6|||
164264304|NCT01340937|593336455|FG003|Period 2: Interim Period|Technical problems|3|||
164264305|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
164264306|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
164264307|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
164264308|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
164264309|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
164264310|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
164264311|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
164264312|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
164264313|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
164264314|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
164264315|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
164264316|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
164264317|NCT01340937|593336452|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
164264318|NCT01340937|593336453|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
164264319|NCT01340937|593336454|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
164264320|NCT01340937|593336455|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
164264321|NCT00046930|593336456|FG000|Overall Study|Ineligible|12|||
164341179|NCT02058693|593623916|FG001|Phase 2|Withdrawal by Subject|2|||
164341180|NCT03855228|593623918|FG000|Overall Study|Adverse Event|2|||
164341181|NCT03855228|593623919|FG001|Overall Study|Adverse Event|4|||
164341182|NCT03855228|593623920|FG002|Overall Study|Adverse Event|4|||
164341183|NCT03855228|593623921|FG003|Overall Study|Adverse Event|8|||
164341184|NCT03855228|593623918|FG000|Overall Study|Treatment Failure|1|||
164264322|NCT00046930|593336457|FG001|Overall Study|Ineligible|4|||
164264323|NCT00440310|593336458|FG000|Overall Study|Lost to Follow-up|4|||
164264324|NCT00440310|593336459|FG001|Overall Study|Lost to Follow-up|5|||
164264325|NCT00440310|593336458|FG000|Overall Study|Protocol Violation|0|||
164264326|NCT00440310|593336459|FG001|Overall Study|Protocol Violation|1|||
164264327|NCT00440310|593336458|FG000|Overall Study|Withdrawal by Subject|15|||
164341185|NCT03855228|593623919|FG001|Overall Study|Treatment Failure|2|||
164341186|NCT03855228|593623920|FG002|Overall Study|Treatment Failure|1|||
164341187|NCT03855228|593623921|FG003|Overall Study|Treatment Failure|8|||
164085516|NCT03843359|592677264|FG009|Escalation Phase|Lost to Follow-up|0|||
164085517|NCT03843359|592677265|FG010|Escalation Phase|Lost to Follow-up|0|||
164085518|NCT03843359|592677266|FG011|Escalation Phase|Lost to Follow-up|0|||
164085519|NCT03843359|592677267|FG012|Escalation Phase|Lost to Follow-up|0|||
164085520|NCT03843359|592677268|FG013|Escalation Phase|Lost to Follow-up|0|||
164085521|NCT03843359|592677269|FG014|Escalation Phase|Lost to Follow-up|0|||
164085522|NCT03843359|592677270|FG015|Escalation Phase|Lost to Follow-up|0|||
164085523|NCT03843359|592677255|FG000|Escalation Phase|Physician Decision|0|||
164085524|NCT03843359|592677256|FG001|Escalation Phase|Physician Decision|0|||
164085525|NCT03843359|592677257|FG002|Escalation Phase|Physician Decision|1|||
164085526|NCT03843359|592677258|FG003|Escalation Phase|Physician Decision|0|||
164085527|NCT03843359|592677259|FG004|Escalation Phase|Physician Decision|0|||
164085528|NCT03843359|592677260|FG005|Escalation Phase|Physician Decision|1|||
164085529|NCT03843359|592677261|FG006|Escalation Phase|Physician Decision|0|||
164085530|NCT03843359|592677262|FG007|Escalation Phase|Physician Decision|0|||
164085531|NCT03843359|592677263|FG008|Escalation Phase|Physician Decision|0|||
164085532|NCT03843359|592677264|FG009|Escalation Phase|Physician Decision|0|||
164085533|NCT03843359|592677265|FG010|Escalation Phase|Physician Decision|0|||
164085534|NCT03843359|592677266|FG011|Escalation Phase|Physician Decision|0|||
164085535|NCT03843359|592677267|FG012|Escalation Phase|Physician Decision|0|||
164085536|NCT03843359|592677268|FG013|Escalation Phase|Physician Decision|0|||
164085537|NCT03843359|592677269|FG014|Escalation Phase|Physician Decision|0|||
164085538|NCT03843359|592677270|FG015|Escalation Phase|Physician Decision|0|||
164085539|NCT03843359|592677255|FG000|Escalation Phase|Investigator site closed|0|||
164085540|NCT03843359|592677256|FG001|Escalation Phase|Investigator site closed|1|||
164085541|NCT03843359|592677257|FG002|Escalation Phase|Investigator site closed|0|||
164085542|NCT03843359|592677258|FG003|Escalation Phase|Investigator site closed|1|||
164085543|NCT03843359|592677259|FG004|Escalation Phase|Investigator site closed|1|||
164085544|NCT03843359|592677260|FG005|Escalation Phase|Investigator site closed|0|||
164085545|NCT03843359|592677261|FG006|Escalation Phase|Investigator site closed|1|||
164085546|NCT03843359|592677262|FG007|Escalation Phase|Investigator site closed|0|||
164085547|NCT03843359|592677263|FG008|Escalation Phase|Investigator site closed|2|||
164085548|NCT03843359|592677264|FG009|Escalation Phase|Investigator site closed|0|||
164085549|NCT03843359|592677265|FG010|Escalation Phase|Investigator site closed|0|||
164085550|NCT03843359|592677266|FG011|Escalation Phase|Investigator site closed|0|||
164085551|NCT03843359|592677267|FG012|Escalation Phase|Investigator site closed|0|||
164085552|NCT03843359|592677268|FG013|Escalation Phase|Investigator site closed|0|||
164085553|NCT03843359|592677269|FG014|Escalation Phase|Investigator site closed|0|||
164085554|NCT03843359|592677270|FG015|Escalation Phase|Investigator site closed|0|||
164085555|NCT03843359|592677255|FG000|Escalation Phase|Ongoing at the time of analysis|0|||
164085556|NCT03843359|592677256|FG001|Escalation Phase|Ongoing at the time of analysis|0|||
164085557|NCT03843359|592677257|FG002|Escalation Phase|Ongoing at the time of analysis|0|||
164085558|NCT03843359|592677258|FG003|Escalation Phase|Ongoing at the time of analysis|0|||
164085559|NCT03843359|592677259|FG004|Escalation Phase|Ongoing at the time of analysis|0|||
164085560|NCT03843359|592677260|FG005|Escalation Phase|Ongoing at the time of analysis|0|||
164264328|NCT00440310|593336459|FG001|Overall Study|Withdrawal by Subject|14|||
164264329|NCT00440310|593336458|FG000|Overall Study|No Reply at EOS|7|||
164264330|NCT00440310|593336459|FG001|Overall Study|No Reply at EOS|7|||
164264331|NCT00440310|593336458|FG000|Overall Study|Other|1|||
164264332|NCT00440310|593336459|FG001|Overall Study|Other|0|||
164264333|NCT00440310|593336458|FG000|Overall Study|Status Unknown|1|||
164264334|NCT00440310|593336459|FG001|Overall Study|Status Unknown|3|||
164264335|NCT01657760|593336462|FG000|Overall Study|Withdrawal by Subject|0|||
164264336|NCT01657760|593336463|FG001|Overall Study|Withdrawal by Subject|0|||
164264337|NCT01657760|593336464|FG002|Overall Study|Withdrawal by Subject|0|||
164264338|NCT01657760|593336465|FG003|Overall Study|Withdrawal by Subject|1|||
164264339|NCT01657760|593336462|FG000|Overall Study|Physician Decision|1|||
164264340|NCT01657760|593336463|FG001|Overall Study|Physician Decision|1|||
164264341|NCT01657760|593336464|FG002|Overall Study|Physician Decision|1|||
164341188|NCT03855228|593623918|FG000|Overall Study|Lost to Follow-up|0|||
164341189|NCT03855228|593623919|FG001|Overall Study|Lost to Follow-up|0|||
164341190|NCT03855228|593623920|FG002|Overall Study|Lost to Follow-up|0|||
164341191|NCT03855228|593623921|FG003|Overall Study|Lost to Follow-up|1|||
164341192|NCT03855228|593623918|FG000|Overall Study|Protocol Violation|0|||
164085561|NCT03843359|592677261|FG006|Escalation Phase|Ongoing at the time of analysis|0|||
164085562|NCT03843359|592677262|FG007|Escalation Phase|Ongoing at the time of analysis|0|||
164085563|NCT03843359|592677263|FG008|Escalation Phase|Ongoing at the time of analysis|1|||
164341193|NCT03855228|593623919|FG001|Overall Study|Protocol Violation|1|||
164085564|NCT03843359|592677264|FG009|Escalation Phase|Ongoing at the time of analysis|0|||
164264342|NCT01657760|593336465|FG003|Overall Study|Physician Decision|2|||
164341194|NCT03855228|593623920|FG002|Overall Study|Protocol Violation|2|||
164341195|NCT03855228|593623921|FG003|Overall Study|Protocol Violation|1|||
164341196|NCT03855228|593623918|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
164142288|NCT02186834|592882588|FG001|Dose Escalation|Death|0|||
164264343|NCT02469415|593336466|FG000|Overall Study|Withdrawal by Subject|1|||
164264344|NCT02469415|593336466|FG000|Overall Study|Investigational agent placed on hold|2|||
164085565|NCT03843359|592677265|FG010|Escalation Phase|Ongoing at the time of analysis|0|||
164264345|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
164264346|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
164264347|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
164264348|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
164264349|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
164264350|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
164264351|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
164264352|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
164264353|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
164264354|NCT02119156|593336467|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
164264355|NCT02119156|593336468|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
164264356|NCT02119156|593336469|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
164264357|NCT02119156|593336467|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
164264358|NCT02119156|593336468|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
164264359|NCT02119156|593336469|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
164264360|NCT00940485|593336477|FG000|Overall Study|HBeAb positive at Baseline|3|||
164264361|NCT00940485|593336478|FG001|Overall Study|HBeAb positive at Baseline|2|||
164264362|NCT00940485|593336477|FG000|Overall Study|Lost to Follow-up|2|||
164264363|NCT00940485|593336478|FG001|Overall Study|Lost to Follow-up|3|||
164264364|NCT00940485|593336477|FG000|Overall Study|Adverse Event|8|||
164264365|NCT00940485|593336478|FG001|Overall Study|Adverse Event|0|||
164264366|NCT00940485|593336477|FG000|Overall Study|Withdrawal by Subject|1|||
164264367|NCT00940485|593336478|FG001|Overall Study|Withdrawal by Subject|1|||
164264368|NCT00940485|593336477|FG000|Overall Study|Others|1|||
164264369|NCT00940485|593336478|FG001|Overall Study|Others|1|||
164264370|NCT01113580|593336479|FG000|Overall Study|Protocol Violation|1|||
164264371|NCT01113580|593336480|FG001|Overall Study|Protocol Violation|0|||
164264372|NCT04599166|593336492|FG000|Overall Study|Technological failure connecting to study app|80|||
164264373|NCT01974752|593336493|FG000|Overall Study|Death|33|||
164264374|NCT01974752|593336494|FG001|Overall Study|Death|11|||
164264375|NCT01974752|593336493|FG000|Overall Study|Lost to Follow-up|2|||
164264376|NCT01974752|593336494|FG001|Overall Study|Lost to Follow-up|0|||
164264377|NCT01974752|593336493|FG000|Overall Study|Withdrawal by Subject|2|||
164264378|NCT01974752|593336494|FG001|Overall Study|Withdrawal by Subject|3|||
164264379|NCT01974752|593336493|FG000|Overall Study|Other Eligibility Criteria|0|||
164264380|NCT01974752|593336494|FG001|Overall Study|Other Eligibility Criteria|1|||
163994930|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994931|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994932|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994933|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994934|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994935|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994936|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994937|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
163994938|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163994939|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
163994940|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163994941|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
163994942|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163994943|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163994944|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
163994945|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994946|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994947|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994948|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994949|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994950|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994951|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164085566|NCT03843359|592677266|FG011|Escalation Phase|Ongoing at the time of analysis|1|||
164085567|NCT03843359|592677267|FG012|Escalation Phase|Ongoing at the time of analysis|1|||
164264381|NCT02317809|593336495|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
164264382|NCT02317809|593336496|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
164264383|NCT02317809|593336495|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
164264384|NCT02317809|593336496|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
164341197|NCT03855228|593623919|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
164264385|NCT02435680|593336497|FG000|Overall Study|Physician Decision|3|||
163994952|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164264386|NCT02435680|593336498|FG001|Overall Study|Physician Decision|0|||
164264387|NCT02435680|593336499|FG002|Overall Study|Physician Decision|0|||
164264388|NCT02435680|593336497|FG000|Overall Study|subject / guardian decision|0|||
164264389|NCT02435680|593336498|FG001|Overall Study|subject / guardian decision|3|||
164264390|NCT02435680|593336499|FG002|Overall Study|subject / guardian decision|2|||
164264391|NCT02435680|593336497|FG000|Overall Study|Adverse Event|8|||
164264392|NCT02435680|593336498|FG001|Overall Study|Adverse Event|3|||
164264393|NCT02435680|593336499|FG002|Overall Study|Adverse Event|2|||
164264394|NCT02435680|593336497|FG000|Overall Study|progressive disease|10|||
164264395|NCT02435680|593336498|FG001|Overall Study|progressive disease|7|||
164264396|NCT02435680|593336499|FG002|Overall Study|progressive disease|11|||
164264397|NCT02435680|593336497|FG000|Overall Study|not treated|0|||
164264398|NCT02435680|593336498|FG001|Overall Study|not treated|0|||
164264399|NCT02435680|593336499|FG002|Overall Study|not treated|1|||
164264400|NCT02233738|593336500|FG000|Overall Study|Lost to Follow-up|5|||
164264401|NCT02233738|593336501|FG001|Overall Study|Lost to Follow-up|12|||
164264402|NCT02233738|593336500|FG000|Overall Study|Death|0|||
164264403|NCT02233738|593336501|FG001|Overall Study|Death|1|||
164264404|NCT02233738|593336500|FG000|Overall Study|Withdrawal by Subject|0|||
164264405|NCT02233738|593336501|FG001|Overall Study|Withdrawal by Subject|1|||
164264406|NCT02233738|593336500|FG000|Overall Study|Did not return after Baseline|3|||
164264407|NCT02233738|593336501|FG001|Overall Study|Did not return after Baseline|2|||
164264408|NCT00096174|593336502|FG000|Overall Study|Lack of Efficacy|9|||
164264409|NCT00096174|593336502|FG000|Overall Study|Adverse Event|15|||
164264410|NCT00096174|593336502|FG000|Overall Study|Death|6|||
164264411|NCT00096174|593336502|FG000|Overall Study|Withdrawal by Subject|15|||
164264412|NCT00096174|593336502|FG000|Overall Study|Not started protocol therapy|3|||
164264413|NCT00096174|593336502|FG000|Overall Study|Ineligible|6|||
164264414|NCT00096174|593336502|FG000|Overall Study|other reason|8|||
164264415|NCT00953524|593336503|FG000|Overall Study|Adverse Event|2|||
164264416|NCT00953524|593336504|FG001|Overall Study|Adverse Event|0|||
164264417|NCT00953524|593336505|FG002|Overall Study|Adverse Event|1|||
164264418|NCT00953524|593336506|FG003|Overall Study|Adverse Event|2|||
164264419|NCT00953524|593336503|FG000|Overall Study|Protocol Violation|18|||
164264420|NCT00953524|593336504|FG001|Overall Study|Protocol Violation|10|||
164264421|NCT00953524|593336505|FG002|Overall Study|Protocol Violation|11|||
164264422|NCT00953524|593336506|FG003|Overall Study|Protocol Violation|6|||
164264423|NCT00953524|593336503|FG000|Overall Study|Lost to Follow-up|0|||
164264424|NCT00953524|593336504|FG001|Overall Study|Lost to Follow-up|1|||
164264425|NCT00953524|593336505|FG002|Overall Study|Lost to Follow-up|1|||
164264426|NCT00953524|593336506|FG003|Overall Study|Lost to Follow-up|0|||
164264427|NCT00953524|593336503|FG000|Overall Study|Withdrawal by Subject|2|||
164264428|NCT00953524|593336504|FG001|Overall Study|Withdrawal by Subject|4|||
164264429|NCT00953524|593336505|FG002|Overall Study|Withdrawal by Subject|1|||
164264430|NCT00953524|593336506|FG003|Overall Study|Withdrawal by Subject|0|||
164264431|NCT00294645|593336507|FG000|Overall Study|Death|10|||
164264432|NCT00294645|593336508|FG001|Overall Study|Death|18|||
164264433|NCT00294645|593336507|FG000|Overall Study|Lost to Follow-up|1|||
164264434|NCT00294645|593336508|FG001|Overall Study|Lost to Follow-up|10|||
164264435|NCT00294645|593336507|FG000|Overall Study|Withdrawal by Subject|18|||
164264436|NCT00294645|593336508|FG001|Overall Study|Withdrawal by Subject|34|||
164264437|NCT00294645|593336507|FG000|Overall Study|Physician Decision|15|||
164264438|NCT00294645|593336508|FG001|Overall Study|Physician Decision|20|||
164264439|NCT00294645|593336507|FG000|Overall Study|Other|4|||
164264440|NCT00294645|593336508|FG001|Overall Study|Other|10|||
164264441|NCT00554619|593336511|FG000|Overall Study|Adverse Event|1|||
164264442|NCT00554619|593336511|FG000|Overall Study|Physician Decision|1|||
164085568|NCT03843359|592677268|FG013|Escalation Phase|Ongoing at the time of analysis|0|||
164142289|NCT02186834|592882589|FG002|Dose Escalation|Death|0|||
164264443|NCT00554619|593336511|FG000|Overall Study|Liver Function Test Abnormality|1|||
164264444|NCT00907803|593336513|FG000|Overall Study|Withdrawal of consent - long commute|1|||
164264445|NCT00907803|593336514|FG001|Overall Study|Withdrawal of consent - long commute|0|||
164264446|NCT00907803|593336515|FG002|Overall Study|Withdrawal of consent - long commute|0|||
164264447|NCT00907803|593336513|FG000|Overall Study|Adverse Event|2|||
164264448|NCT00907803|593336514|FG001|Overall Study|Adverse Event|0|||
163889726|NCT01854775|591967590|FG001|Extension Phase|Pregnancy|0|||
164264449|NCT00907803|593336515|FG002|Overall Study|Adverse Event|0|||
164264450|NCT00907803|593336513|FG000|Overall Study|Withdrawal by Subject|0|||
164264451|NCT00907803|593336514|FG001|Overall Study|Withdrawal by Subject|1|||
164264452|NCT00907803|593336515|FG002|Overall Study|Withdrawal by Subject|0|||
164264453|NCT00907803|593336513|FG000|Overall Study|Lost to Follow-up|0|||
164264454|NCT00907803|593336514|FG001|Overall Study|Lost to Follow-up|1|||
164264455|NCT00907803|593336515|FG002|Overall Study|Lost to Follow-up|0|||
164264456|NCT00907803|593336513|FG000|Overall Study|Protocol Violation|0|||
164264457|NCT00907803|593336514|FG001|Overall Study|Protocol Violation|1|||
164264458|NCT00907803|593336515|FG002|Overall Study|Protocol Violation|0|||
164264459|NCT05426031|593336520|FG000|Overall Study|Circulatory Arrest|3|||
164264460|NCT05426031|593336521|FG001|Overall Study|Circulatory Arrest|2|||
164264461|NCT00089986|593336522|FG000|Overall Study|Adverse Event|6|||
164264462|NCT00089986|593336523|FG001|Overall Study|Adverse Event|9|||
164264463|NCT00089986|593336524|FG002|Overall Study|Adverse Event|6|||
164264464|NCT00089986|593336522|FG000|Overall Study|Lost to Follow-up|3|||
164264465|NCT00089986|593336523|FG001|Overall Study|Lost to Follow-up|1|||
164264466|NCT00089986|593336524|FG002|Overall Study|Lost to Follow-up|1|||
164264467|NCT00089986|593336522|FG000|Overall Study|Protocol Violation|0|||
164264468|NCT00089986|593336523|FG001|Overall Study|Protocol Violation|1|||
164264469|NCT00089986|593336524|FG002|Overall Study|Protocol Violation|0|||
164264470|NCT00089986|593336522|FG000|Overall Study|Patient transferred to another hospital|2|||
164264471|NCT00089986|593336523|FG001|Overall Study|Patient transferred to another hospital|1|||
164264472|NCT00089986|593336524|FG002|Overall Study|Patient transferred to another hospital|0|||
164264473|NCT00089986|593336522|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
164264474|NCT00089986|593336523|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
164264475|NCT00089986|593336524|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
164264476|NCT00089986|593336522|FG000|Overall Study|Hemohlobin stopping rule|0|||
164264477|NCT00089986|593336523|FG001|Overall Study|Hemohlobin stopping rule|1|||
164085569|NCT03843359|592677269|FG014|Escalation Phase|Ongoing at the time of analysis|0|||
164085570|NCT03843359|592677270|FG015|Escalation Phase|Ongoing at the time of analysis|0|||
164085571|NCT03843359|592677255|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085572|NCT03843359|592677256|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085573|NCT03843359|592677257|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|7|||
164085574|NCT03843359|592677258|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164264478|NCT00089986|593336524|FG002|Overall Study|Hemohlobin stopping rule|0|||
163889727|NCT01854775|591967591|FG002|Extension Phase|Pregnancy|0|||
164264479|NCT00089986|593336522|FG000|Overall Study|Investigator decision to withdrew|0|||
164264480|NCT00089986|593336523|FG001|Overall Study|Investigator decision to withdrew|1|||
164264481|NCT00089986|593336524|FG002|Overall Study|Investigator decision to withdrew|0|||
164264482|NCT00089986|593336522|FG000|Overall Study|Enrollment in another study|0|||
163994953|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164264483|NCT00089986|593336523|FG001|Overall Study|Enrollment in another study|1|||
164264484|NCT00089986|593336524|FG002|Overall Study|Enrollment in another study|0|||
164264485|NCT00089986|593336522|FG000|Overall Study|Family decision|0|||
164264486|NCT00089986|593336523|FG001|Overall Study|Family decision|1|||
164264487|NCT00089986|593336524|FG002|Overall Study|Family decision|0|||
164264488|NCT00089986|593336522|FG000|Overall Study|Do not resuscitate (DNR)|0|||
164264489|NCT00089986|593336523|FG001|Overall Study|Do not resuscitate (DNR)|0|||
164264490|NCT00089986|593336524|FG002|Overall Study|Do not resuscitate (DNR)|1|||
164264491|NCT00089986|593336522|FG000|Overall Study|Withdrawal by Subject|3|||
164264492|NCT00089986|593336523|FG001|Overall Study|Withdrawal by Subject|6|||
164264493|NCT00089986|593336524|FG002|Overall Study|Withdrawal by Subject|2|||
164264494|NCT04065074|593336528|FG000|Overall Study|Adverse Event|1|||
164264495|NCT04065074|593336528|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
164264496|NCT02334683|593336529|FG000|First 12 Week Period|Lost to Follow-up|1|||
164264497|NCT02334683|593336530|FG001|First 12 Week Period|Lost to Follow-up|0|||
164264498|NCT02334683|593336529|FG000|Second 12 Week Period|Adverse Event|0|||
164264499|NCT02334683|593336530|FG001|Second 12 Week Period|Adverse Event|1|||
164264500|NCT01062841|593336531|FG000|Overall Study|Indwelling Device Removed|41|||
164264501|NCT01062841|593336532|FG001|Overall Study|Indwelling Device Removed|48|||
164264502|NCT01062841|593336531|FG000|Overall Study|Death|3|||
164264503|NCT01062841|593336532|FG001|Overall Study|Death|5|||
164264504|NCT01062841|593336531|FG000|Overall Study|Withdrawal by Subject|2|||
164264505|NCT01062841|593336532|FG001|Overall Study|Withdrawal by Subject|0|||
164264506|NCT01062841|593336531|FG000|Overall Study|Withdrawal by Study|3|||
164264507|NCT01062841|593336532|FG001|Overall Study|Withdrawal by Study|0|||
164264508|NCT03958656|593336533|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
164264509|NCT03958656|593336534|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
164264510|NCT03958656|593336535|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
164264511|NCT03958656|593336536|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
163994954|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994955|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994956|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994957|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994958|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994959|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
164264512|NCT03958656|593336533|FG000|Overall Study|No longer meets eligibility criteria|0|||
164264513|NCT03958656|593336534|FG001|Overall Study|No longer meets eligibility criteria|0|||
164264514|NCT03958656|593336535|FG002|Overall Study|No longer meets eligibility criteria|1|||
164264515|NCT03958656|593336536|FG003|Overall Study|No longer meets eligibility criteria|0|||
164264516|NCT03958656|593336533|FG000|Overall Study|Started anti-cancer treatment|0|||
164264517|NCT03958656|593336534|FG001|Overall Study|Started anti-cancer treatment|0|||
164264518|NCT03958656|593336535|FG002|Overall Study|Started anti-cancer treatment|1|||
164264519|NCT03958656|593336536|FG003|Overall Study|Started anti-cancer treatment|0|||
164264520|NCT03831880|593336537|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
164264521|NCT03831880|593336538|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
164264522|NCT03831880|593336537|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
164264523|NCT03831880|593336538|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
164264524|NCT03158012|593336541|FG000|Overall Study|Withdrawal by Subject|0|||
164264525|NCT03158012|593336542|FG001|Overall Study|Withdrawal by Subject|1|||
164264526|NCT02788201|593336543|FG000|Overall Study|Death|1|||
164264527|NCT02788201|593336544|FG001|Overall Study|Death|1|||
164264528|NCT02788201|593336545|FG002|Overall Study|Death|1|||
164264529|NCT02788201|593336546|FG003|Overall Study|Death|1|||
164264530|NCT02788201|593336547|FG004|Overall Study|Death|0|||
164264531|NCT02788201|593336548|FG005|Overall Study|Death|1|||
164264532|NCT02788201|593336543|FG000|Overall Study|Ineligible|0|||
164264533|NCT02788201|593336544|FG001|Overall Study|Ineligible|0|||
164264534|NCT02788201|593336545|FG002|Overall Study|Ineligible|0|||
164264535|NCT02788201|593336546|FG003|Overall Study|Ineligible|0|||
164264536|NCT02788201|593336547|FG004|Overall Study|Ineligible|0|||
164264537|NCT02788201|593336548|FG005|Overall Study|Ineligible|1|||
164341198|NCT03855228|593623920|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
164341199|NCT03855228|593623921|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
164341200|NCT02993757|593623922|FG000|Overall Study|Non compliance with the protocol|155|||
164341201|NCT02993757|593623923|FG001|Overall Study|Non compliance with the protocol|170|||
164341202|NCT02993757|593623922|FG000|Overall Study|Lost to Follow-up|1|||
164341203|NCT02993757|593623923|FG001|Overall Study|Lost to Follow-up|0|||
164341204|NCT02993757|593623922|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
164341205|NCT02993757|593623923|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
164341206|NCT00190671|593623924|FG000|Overall Study|Satisfactory Response|4|||
164341207|NCT00190671|593623925|FG001|Overall Study|Satisfactory Response|7|||
164341208|NCT00190671|593623924|FG000|Overall Study|Lack of Efficacy|19|||
164341209|NCT00190671|593623925|FG001|Overall Study|Lack of Efficacy|24|||
164341210|NCT00190671|593623924|FG000|Overall Study|Death from Study Disease|1|||
164085575|NCT03843359|592677259|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
164085576|NCT03843359|592677260|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164142290|NCT02186834|592882590|FG003|Dose Escalation|Death|1|||
164264538|NCT02788201|593336543|FG000|Overall Study|Withdrawal by Subject|0|||
164264539|NCT02788201|593336544|FG001|Overall Study|Withdrawal by Subject|0|||
164264540|NCT02788201|593336545|FG002|Overall Study|Withdrawal by Subject|0|||
164341211|NCT00190671|593623925|FG001|Overall Study|Death from Study Disease|1|||
164341212|NCT00190671|593623924|FG000|Overall Study|Adverse Event|3|||
164341213|NCT00190671|593623925|FG001|Overall Study|Adverse Event|2|||
164341214|NCT00190671|593623924|FG000|Overall Study|Clinical Relapse|0|||
164341215|NCT00190671|593623925|FG001|Overall Study|Clinical Relapse|1|||
164341216|NCT00190671|593623924|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
164341217|NCT00190671|593623925|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
164341218|NCT00190671|593623924|FG000|Overall Study|Death from Other Causes|0|||
164341219|NCT00190671|593623925|FG001|Overall Study|Death from Other Causes|2|||
164341220|NCT00190671|593623924|FG000|Overall Study|Protocol Violation|0|||
164341221|NCT00190671|593623925|FG001|Overall Study|Protocol Violation|1|||
164341222|NCT00190671|593623924|FG000|Overall Study|Withdrawal by Subject|0|||
164264541|NCT02788201|593336546|FG003|Overall Study|Withdrawal by Subject|0|||
164264542|NCT02788201|593336547|FG004|Overall Study|Withdrawal by Subject|0|||
164264543|NCT02788201|593336548|FG005|Overall Study|Withdrawal by Subject|1|||
164264544|NCT01874275|593336549|FG000|Overall Study|Lost to Follow-up|1|||
164264545|NCT01874275|593336550|FG001|Overall Study|Lost to Follow-up|0|||
164264546|NCT04662073|593336551|FG000|Overall Study|Withdrawal by Subject|1|||
164341223|NCT00190671|593623925|FG001|Overall Study|Withdrawal by Subject|2|||
164341224|NCT00087607|593623926|FG000|Overall Study|Adverse Event|14|||
164341225|NCT00087607|593623927|FG001|Overall Study|Adverse Event|24|||
163889728|NCT01854775|591967589|FG000|Extension Phase|Investigator's Discretion|1|||
163889729|NCT01854775|591967590|FG001|Extension Phase|Investigator's Discretion|0|||
163889730|NCT01854775|591967591|FG002|Extension Phase|Investigator's Discretion|0|||
163889731|NCT01854775|591967589|FG000|Extension Phase|Non-Compliance with study drug|1|||
163889732|NCT01854775|591967590|FG001|Extension Phase|Non-Compliance with study drug|0|||
163889733|NCT01854775|591967591|FG002|Extension Phase|Non-Compliance with study drug|0|||
163889734|NCT01854775|591967589|FG000|Extension Phase|Lost to Follow-up|1|||
163889735|NCT01854775|591967590|FG001|Extension Phase|Lost to Follow-up|0|||
163889736|NCT01854775|591967591|FG002|Extension Phase|Lost to Follow-up|0|||
163889737|NCT01854775|591967589|FG000|Extension Phase|Withdrew consent|0|||
163889738|NCT01854775|591967590|FG001|Extension Phase|Withdrew consent|1|||
163889739|NCT01854775|591967591|FG002|Extension Phase|Withdrew consent|0|||
163889740|NCT04068311|591967592|FG000|Overall Study|Death|3|||
163889741|NCT04068311|591967593|FG001|Overall Study|Death|3|||
163889742|NCT04068311|591967592|FG000|Overall Study|Lost to Follow-up|24|||
163889743|NCT04068311|591967593|FG001|Overall Study|Lost to Follow-up|68|||
163889744|NCT04068311|591967592|FG000|Overall Study|Withdrawal by Subject|5|||
163889745|NCT04068311|591967593|FG001|Overall Study|Withdrawal by Subject|0|||
163889746|NCT03100149|591967594|FG000|Overall Study|Adverse Event|0|||
163889747|NCT03100149|591967595|FG001|Overall Study|Adverse Event|1|||
163889748|NCT03100149|591967596|FG002|Overall Study|Adverse Event|0|||
163889749|NCT03100149|591967594|FG000|Overall Study|Participant Moved out of Country|0|||
163889750|NCT03100149|591967595|FG001|Overall Study|Participant Moved out of Country|0|||
163889751|NCT03100149|591967596|FG002|Overall Study|Participant Moved out of Country|1|||
163889752|NCT03100149|591967594|FG000|Overall Study|Withdrawal by Subject|0|||
163889753|NCT03100149|591967595|FG001|Overall Study|Withdrawal by Subject|3|||
163889754|NCT03100149|591967596|FG002|Overall Study|Withdrawal by Subject|1|||
163889755|NCT02670525|591967597|FG000|Overall Study|Death|94|||
163889756|NCT02670525|591967598|FG001|Overall Study|Death|14|||
163889757|NCT02670525|591967597|FG000|Overall Study|Lost to Follow-up|4|||
163889758|NCT02670525|591967598|FG001|Overall Study|Lost to Follow-up|1|||
163889759|NCT02670525|591967597|FG000|Overall Study|Subject withdrew consent|1|||
163889760|NCT02670525|591967598|FG001|Overall Study|Subject withdrew consent|0|||
163889761|NCT02670525|591967597|FG000|Overall Study|Unknown, data entry delayed|123|||
163889762|NCT02670525|591967598|FG001|Overall Study|Unknown, data entry delayed|78|||
163889763|NCT03474107|591969055|FG000|Overall Study|Adverse Event|42|||
163889764|NCT03474107|591969056|FG001|Overall Study|Adverse Event|46|||
164264547|NCT04662073|593336552|FG001|Overall Study|Withdrawal by Subject|0|||
164341226|NCT00087607|593623926|FG000|Overall Study|Death|0|||
164341227|NCT00087607|593623927|FG001|Overall Study|Death|1|||
164264548|NCT00681564|593336553|FG000|Overall Study|Lost to Follow-up|6|||
164264549|NCT00681564|593336554|FG001|Overall Study|Lost to Follow-up|6|||
163889765|NCT03474107|591969055|FG000|Overall Study|Death|2|||
163889766|NCT03474107|591969056|FG001|Overall Study|Death|2|||
163889767|NCT03474107|591969055|FG000|Overall Study|Lost to Follow-up|0|||
163889768|NCT03474107|591969056|FG001|Overall Study|Lost to Follow-up|1|||
163889769|NCT03474107|591969055|FG000|Overall Study|Progressive Disease|177|||
163889770|NCT03474107|591969056|FG001|Overall Study|Progressive Disease|180|||
163889771|NCT03474107|591969055|FG000|Overall Study|Protocol Violation|1|||
163889772|NCT03474107|591969056|FG001|Overall Study|Protocol Violation|1|||
164264550|NCT00681564|593336553|FG000|Overall Study|Withdrawal by Subject|0|||
164264551|NCT00681564|593336554|FG001|Overall Study|Withdrawal by Subject|1|||
164264552|NCT00681564|593336553|FG000|Overall Study|Death|0|||
164341228|NCT00087607|593623926|FG000|Overall Study|Insufficient Therapeutic Response|53|||
164264553|NCT00681564|593336554|FG001|Overall Study|Death|1|||
164264554|NCT00762996|593336556|FG000|Period One|Protocol Violation|0|||
164264555|NCT00762996|593336557|FG001|Period One|Protocol Violation|0|||
164264556|NCT00762996|593336558|FG002|Period One|Protocol Violation|1|||
164264557|NCT00762996|593336559|FG003|Period One|Protocol Violation|0|||
164264558|NCT00762996|593336556|FG000|Period One|ineligible|0|||
164264559|NCT00762996|593336557|FG001|Period One|ineligible|0|||
164264560|NCT00762996|593336558|FG002|Period One|ineligible|1|||
164264561|NCT00762996|593336559|FG003|Period One|ineligible|1|||
164264562|NCT00762996|593336556|FG000|Period One|Adverse Event|0|||
164264563|NCT00762996|593336557|FG001|Period One|Adverse Event|0|||
164264564|NCT00762996|593336558|FG002|Period One|Adverse Event|1|||
164264565|NCT00762996|593336559|FG003|Period One|Adverse Event|0|||
164264566|NCT00762996|593336556|FG000|Period One|Withdrawal by Subject|0|||
164264567|NCT00762996|593336557|FG001|Period One|Withdrawal by Subject|0|||
164264568|NCT00762996|593336558|FG002|Period One|Withdrawal by Subject|1|||
164341229|NCT00087607|593623927|FG001|Overall Study|Insufficient Therapeutic Response|42|||
164341230|NCT00087607|593623926|FG000|Overall Study|Failure to return|21|||
164341231|NCT00087607|593623927|FG001|Overall Study|Failure to return|17|||
164341232|NCT00087607|593623926|FG000|Overall Study|Withdrew Consent|12|||
164341233|NCT00087607|593623927|FG001|Overall Study|Withdrew Consent|16|||
164341234|NCT00087607|593623926|FG000|Overall Study|Administrative|12|||
164341235|NCT00087607|593623927|FG001|Overall Study|Administrative|12|||
164341236|NCT00087607|593623926|FG000|Overall Study|Refused Treatment|5|||
164341237|NCT00087607|593623927|FG001|Overall Study|Refused Treatment|7|||
164341238|NCT00087607|593623926|FG000|Overall Study|Other Protocol Violation|5|||
164341239|NCT00087607|593623927|FG001|Overall Study|Other Protocol Violation|2|||
164341240|NCT00087607|593623926|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164341241|NCT00087607|593623927|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164341242|NCT02699593|593623928|FG000|Period 1|Unsatisfactory Visual Response|0|||
164341243|NCT02699593|593623929|FG001|Period 1|Unsatisfactory Visual Response|1|||
164341244|NCT02699593|593623928|FG000|Period 1|Torn Contact Len|4|||
164341245|NCT02699593|593623929|FG001|Period 1|Torn Contact Len|3|||
164341246|NCT02699593|593623928|FG000|Period 1|Protocol Violation|0|||
164341247|NCT02699593|593623929|FG001|Period 1|Protocol Violation|1|||
164341248|NCT02699593|593623928|FG000|Period 1|Withdrawal by Subject|0|||
164341249|NCT02699593|593623929|FG001|Period 1|Withdrawal by Subject|1|||
164341250|NCT02699593|593623928|FG000|Period 1|Adverse Event|1|||
164341251|NCT02699593|593623929|FG001|Period 1|Adverse Event|1|||
164341252|NCT02699593|593623928|FG000|Period 2|Adverse Event|1|||
163994960|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
163994961|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163994962|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
163994963|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163994964|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
163994965|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
163994966|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
163994967|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
163994968|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
164085577|NCT03843359|592677261|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085578|NCT03843359|592677262|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085579|NCT03843359|592677263|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085580|NCT03843359|592677264|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085581|NCT03843359|592677265|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085582|NCT03843359|592677266|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085583|NCT03843359|592677267|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085584|NCT03843359|592677268|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164264569|NCT00762996|593336559|FG003|Period One|Withdrawal by Subject|0|||
164264570|NCT00657150|593336560|FG000|Overall Study|Adverse Event|19|||
164341253|NCT02699593|593623929|FG001|Period 2|Adverse Event|1|||
164341254|NCT02699593|593623928|FG000|Period 2|Lost Contact Lens|0|||
164341255|NCT02699593|593623929|FG001|Period 2|Lost Contact Lens|1|||
164264571|NCT00657150|593336561|FG001|Overall Study|Adverse Event|10|||
164341256|NCT02699593|593623928|FG000|Period 2|Torn Contact Lens|1|||
164341257|NCT02699593|593623929|FG001|Period 2|Torn Contact Lens|0|||
164341258|NCT02015754|593623930|FG000|Overall Study|Disease progression|5|||
164341259|NCT02015754|593623930|FG000|Overall Study|Change in treatment modality|5|||
164264572|NCT00657150|593336560|FG000|Overall Study|Non-compliant with protocol|5|||
164264573|NCT00657150|593336561|FG001|Overall Study|Non-compliant with protocol|9|||
164341260|NCT02015754|593623930|FG000|Overall Study|Lost to Follow-up|1|||
164264574|NCT00657150|593336560|FG000|Overall Study|Lost to Follow-up|2|||
164264575|NCT00657150|593336561|FG001|Overall Study|Lost to Follow-up|0|||
164264576|NCT00657150|593336560|FG000|Overall Study|Withdrawal by Subject|51|||
164264577|NCT00657150|593336561|FG001|Overall Study|Withdrawal by Subject|36|||
164264578|NCT00657150|593336560|FG000|Overall Study|Other|38|||
164264579|NCT00657150|593336561|FG001|Overall Study|Other|38|||
164264580|NCT00657150|593336560|FG000|Treatment|Adverse Event|60|||
164264581|NCT00657150|593336561|FG001|Treatment|Adverse Event|53|||
164264582|NCT00657150|593336560|FG000|Treatment|Non-compliant with protocol|10|||
164264583|NCT00657150|593336561|FG001|Treatment|Non-compliant with protocol|9|||
164264584|NCT00657150|593336560|FG000|Treatment|Lost to Follow-up|1|||
164264585|NCT00657150|593336561|FG001|Treatment|Lost to Follow-up|0|||
164264586|NCT00657150|593336560|FG000|Treatment|Withdrawal by Subject|23|||
164264587|NCT00657150|593336561|FG001|Treatment|Withdrawal by Subject|20|||
164264588|NCT00657150|593336560|FG000|Treatment|Other|13|||
164264589|NCT00657150|593336561|FG001|Treatment|Other|15|||
164264590|NCT00468845|593336568|FG000|Overall Study|Adverse Event|9|||
164264591|NCT00468845|593336569|FG001|Overall Study|Adverse Event|14|||
164264592|NCT00468845|593336570|FG002|Overall Study|Adverse Event|11|||
164264593|NCT00468845|593336568|FG000|Overall Study|Lost to Follow-up|2|||
164264594|NCT00468845|593336569|FG001|Overall Study|Lost to Follow-up|1|||
164264595|NCT00468845|593336570|FG002|Overall Study|Lost to Follow-up|2|||
164264596|NCT00468845|593336568|FG000|Overall Study|Other|4|||
164264597|NCT00468845|593336569|FG001|Overall Study|Other|9|||
164264598|NCT00468845|593336570|FG002|Overall Study|Other|5|||
164264599|NCT00468845|593336568|FG000|Overall Study|No longer willing to participate|5|||
164264600|NCT00468845|593336569|FG001|Overall Study|No longer willing to participate|6|||
164264601|NCT00468845|593336570|FG002|Overall Study|No longer willing to participate|10|||
164264602|NCT00468845|593336568|FG000|Overall Study|Randomized, not treated|1|||
164264603|NCT00468845|593336569|FG001|Overall Study|Randomized, not treated|4|||
164341261|NCT02229383|593623931|FG000|Overall Study|Adverse Event|7|||
164341262|NCT02229383|593623932|FG001|Overall Study|Adverse Event|4|||
164341263|NCT02229383|593623931|FG000|Overall Study|Death|0|||
163889773|NCT03474107|591969055|FG000|Overall Study|Withdrawal by Subject|15|||
163889774|NCT03474107|591969056|FG001|Overall Study|Withdrawal by Subject|27|||
163889775|NCT03474107|591969055|FG000|Overall Study|Physician Decision|7|||
163889776|NCT03474107|591969056|FG001|Overall Study|Physician Decision|22|||
163889777|NCT03474107|591969055|FG000|Overall Study|Miscellaneous|1|||
163889778|NCT03474107|591969056|FG001|Overall Study|Miscellaneous|6|||
163889779|NCT05041257|591969057|FG000|Overall Study|Death|37|||
163889780|NCT05041257|591969057|FG000|Overall Study|Lost to Follow-up|3|||
163889781|NCT05041257|591969057|FG000|Overall Study|Sponsor decision|39|||
163889782|NCT03067480|591969058|FG000|Overall Study|Lost to Follow-up|2|||
163889783|NCT03067480|591969059|FG001|Overall Study|Lost to Follow-up|4|||
163889784|NCT03067480|591969058|FG000|Overall Study|started insulin|1|||
163889785|NCT03067480|591969059|FG001|Overall Study|started insulin|1|||
163889786|NCT05782816|591969060|FG000|Overall Study|Withdrawal by Subject|1|||
163889787|NCT05782816|591969061|FG001|Overall Study|Withdrawal by Subject|0|||
163889788|NCT02442349|591969062|FG000|Overall Study|Death|95|||
163889789|NCT02442349|591969062|FG000|Overall Study|Withdrawal by Subject|27|||
163889790|NCT02442349|591969062|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
163889791|NCT02442349|591969062|FG000|Overall Study|Lost to Follow-up|1|||
163889792|NCT03748953|591969066|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
163889793|NCT03748953|591969067|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
163889794|NCT03748953|591969066|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
163889795|NCT03748953|591969067|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
163889796|NCT03748953|591969066|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
163889797|NCT03748953|591969067|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
163889798|NCT03748953|591969066|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
163889799|NCT03748953|591969067|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
163889800|NCT03748953|591969066|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
163889801|NCT03748953|591969067|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
163889802|NCT04676763|591969068|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
163889803|NCT04676763|591969069|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
163889804|NCT04676763|591969070|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
163889805|NCT04676763|591969068|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
163889806|NCT04676763|591969069|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
163889807|NCT04676763|591969070|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
163889808|NCT04676763|591969068|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
164264604|NCT00468845|593336570|FG002|Overall Study|Randomized, not treated|2|||
164264605|NCT00787930|593336571|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
164264606|NCT01400243|593336572|FG000|Overall Study|Protocol Violation|8|||
164264607|NCT01400243|593336573|FG001|Overall Study|Protocol Violation|11|||
164264608|NCT04316741|593336574|FG000|Baseline Enrollment|Lost to Follow-up|1|||
164264609|NCT04316741|593336575|FG001|Baseline Enrollment|Lost to Follow-up|1|||
163889809|NCT04676763|591969069|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
164264610|NCT04316741|593336574|FG000|Immediate Post-Test|Lost to Follow-up|5|||
163994969|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994970|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994971|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994972|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994973|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994974|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994975|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994976|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994977|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994978|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994979|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994980|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994981|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994982|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994983|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
163994984|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994985|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994986|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
163994987|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994988|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
163994989|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994990|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994991|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994992|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994993|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
164085585|NCT03843359|592677269|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164090463|NCT03384745|592693439|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
164264611|NCT04316741|593336575|FG001|Immediate Post-Test|Lost to Follow-up|1|||
164264612|NCT04316741|593336574|FG000|1-month Post-test|Lost to Follow-up|7|||
164341264|NCT02229383|593623932|FG001|Overall Study|Death|1|||
163889810|NCT04676763|591969070|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
163889811|NCT02296125|591969071|FG000|Overall Study|Withdrawal by Subject|18|||
163889812|NCT02296125|591969072|FG001|Overall Study|Withdrawal by Subject|8|||
163889813|NCT02296125|591969073|FG002|Overall Study|Withdrawal by Subject|6|||
163889814|NCT02296125|591969074|FG003|Overall Study|Withdrawal by Subject|2|||
163889815|NCT02296125|591969071|FG000|Overall Study|Adverse Event|41|||
163889816|NCT02296125|591969072|FG001|Overall Study|Adverse Event|52|||
163889817|NCT02296125|591969073|FG002|Overall Study|Adverse Event|9|||
163889818|NCT02296125|591969074|FG003|Overall Study|Adverse Event|4|||
163889819|NCT02296125|591969071|FG000|Overall Study|Severe non-compliance to protocol|0|||
163889820|NCT02296125|591969072|FG001|Overall Study|Severe non-compliance to protocol|1|||
163889821|NCT02296125|591969073|FG002|Overall Study|Severe non-compliance to protocol|0|||
163889822|NCT02296125|591969074|FG003|Overall Study|Severe non-compliance to protocol|0|||
163889823|NCT02296125|591969071|FG000|Overall Study|Condition under investigation worsened|153|||
163889824|NCT02296125|591969072|FG001|Overall Study|Condition under investigation worsened|199|||
163889825|NCT02296125|591969073|FG002|Overall Study|Condition under investigation worsened|39|||
163889826|NCT02296125|591969074|FG003|Overall Study|Condition under investigation worsened|56|||
163889827|NCT02296125|591969071|FG000|Overall Study|Any reason not specifically recorded|6|||
163889828|NCT02296125|591969072|FG001|Overall Study|Any reason not specifically recorded|4|||
163889829|NCT02296125|591969073|FG002|Overall Study|Any reason not specifically recorded|2|||
163889830|NCT02296125|591969074|FG003|Overall Study|Any reason not specifically recorded|0|||
163889831|NCT04858451|591969079|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
163889832|NCT04858451|591969080|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889833|NCT04858451|591969081|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889834|NCT04858451|591969082|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889835|NCT04858451|591969083|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889836|NCT04858451|591969084|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889837|NCT04858451|591969085|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889838|NCT04858451|591969086|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889839|NCT04858451|591969087|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
163889840|NCT04858451|591969079|FG000|Part 2|Discontinued|0|||
163889841|NCT04858451|591969080|FG001|Part 2|Discontinued|0|||
163889842|NCT04858451|591969081|FG002|Part 2|Discontinued|0|||
163889843|NCT04858451|591969082|FG003|Part 2|Discontinued|0|||
163889844|NCT04858451|591969083|FG004|Part 2|Discontinued|0|||
163889845|NCT04858451|591969084|FG005|Part 2|Discontinued|0|||
163889846|NCT04858451|591969085|FG006|Part 2|Discontinued|0|||
163889847|NCT04858451|591969086|FG007|Part 2|Discontinued|0|||
163889848|NCT04858451|591969087|FG008|Part 2|Discontinued|63|||
163889849|NCT02998268|591969088|FG000|Overall Study|Adverse Event|0|||
163889850|NCT02998268|591969089|FG001|Overall Study|Adverse Event|2|||
163889851|NCT02998268|591969088|FG000|Overall Study|Withdrawal by Subject|0|||
163889852|NCT02998268|591969089|FG001|Overall Study|Withdrawal by Subject|1|||
163889853|NCT04225273|591969090|FG000|Overall Study|Lost to Follow-up|3|||
163889854|NCT02966873|591969091|FG000|Overall Study|Lost to Follow-up|16|||
163889855|NCT02966873|591969092|FG001|Overall Study|Lost to Follow-up|15|||
163889856|NCT00950742|591969094|FG000|Overall Study|Other Adverse Event|1|||
163889857|NCT00950742|591969095|FG001|Overall Study|Other Adverse Event|0|||
163889858|NCT00950742|591969094|FG000|Overall Study|Withdrawal by Subject|3|||
163889859|NCT00950742|591969095|FG001|Overall Study|Withdrawal by Subject|0|||
164264613|NCT04316741|593336575|FG001|1-month Post-test|Lost to Follow-up|2|||
164264614|NCT04316741|593336574|FG000|3-month Follow-up|Lost to Follow-up|10|||
164264615|NCT04316741|593336575|FG001|3-month Follow-up|Lost to Follow-up|2|||
164264616|NCT01442064|593336576|FG000|Overall Study|Adverse Event|2|||
164264617|NCT01442064|593336577|FG001|Overall Study|Adverse Event|2|||
164264618|NCT01442064|593336578|FG002|Overall Study|Adverse Event|2|||
164264619|NCT01442064|593336579|FG003|Overall Study|Adverse Event|1|||
164264620|NCT01442064|593336580|FG004|Overall Study|Adverse Event|2|||
164264621|NCT01442064|593336581|FG005|Overall Study|Adverse Event|0|||
164264622|NCT01442064|593336576|FG000|Overall Study|Death|0|||
164341265|NCT02229383|593623931|FG000|Overall Study|Lost to Follow-up|5|||
164341266|NCT02229383|593623932|FG001|Overall Study|Lost to Follow-up|3|||
164341267|NCT02229383|593623931|FG000|Overall Study|Withdrawal by Subject|4|||
164341268|NCT02229383|593623932|FG001|Overall Study|Withdrawal by Subject|6|||
163889860|NCT00950742|591969094|FG000|Overall Study|Progressive Disease|6|||
163889861|NCT00950742|591969095|FG001|Overall Study|Progressive Disease|2|||
163889862|NCT00950742|591969094|FG000|Overall Study|Dose limiting toxicity|6|||
164341269|NCT02229383|593623931|FG000|Overall Study|Did not receive treatment|1|||
163889863|NCT00950742|591969095|FG001|Overall Study|Dose limiting toxicity|0|||
163889864|NCT01456949|591969097|FG000|Enrollment|PI death- incomplete data|6|||
163889865|NCT01456949|591969097|FG000|Enrollment|Death|1|||
163889866|NCT01456949|591969097|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
163889867|NCT01456949|591969097|FG000|Enrollment|Physician Decision|10|||
163889868|NCT01456949|591969097|FG000|Enrollment|Withdrawal by Subject|7|||
163889869|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
163994994|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994995|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994996|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994997|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994998|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163994999|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995000|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995001|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995002|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995003|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995004|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995005|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995006|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
163995007|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
163995008|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995009|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995010|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
163995011|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995012|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995013|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995014|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995015|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995016|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995017|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163889870|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
163995018|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995019|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995020|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164090464|NCT02984683|592693440|FG000|Overall Study|Adverse Event|3|||
164264623|NCT01442064|593336577|FG001|Overall Study|Death|1|||
164264624|NCT01442064|593336578|FG002|Overall Study|Death|3|||
164264625|NCT01442064|593336579|FG003|Overall Study|Death|3|||
164264626|NCT01442064|593336580|FG004|Overall Study|Death|1|||
164264627|NCT01442064|593336581|FG005|Overall Study|Death|3|||
164341270|NCT02229383|593623932|FG001|Overall Study|Did not receive treatment|0|||
163889871|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
163889872|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
164264628|NCT01442064|593336576|FG000|Overall Study|Lost to Follow-up|5|||
164264629|NCT01442064|593336577|FG001|Overall Study|Lost to Follow-up|5|||
164264630|NCT01442064|593336578|FG002|Overall Study|Lost to Follow-up|1|||
164264631|NCT01442064|593336579|FG003|Overall Study|Lost to Follow-up|1|||
164264632|NCT01442064|593336580|FG004|Overall Study|Lost to Follow-up|3|||
164264633|NCT01442064|593336581|FG005|Overall Study|Lost to Follow-up|3|||
164264634|NCT01442064|593336576|FG000|Overall Study|Physician Decision|1|||
164264635|NCT01442064|593336577|FG001|Overall Study|Physician Decision|1|||
164264636|NCT01442064|593336578|FG002|Overall Study|Physician Decision|2|||
164264637|NCT01442064|593336579|FG003|Overall Study|Physician Decision|3|||
164264638|NCT01442064|593336580|FG004|Overall Study|Physician Decision|3|||
164264639|NCT01442064|593336581|FG005|Overall Study|Physician Decision|1|||
164264640|NCT01442064|593336576|FG000|Overall Study|Withdrawal by Subject|6|||
164264641|NCT01442064|593336577|FG001|Overall Study|Withdrawal by Subject|3|||
164264642|NCT01442064|593336578|FG002|Overall Study|Withdrawal by Subject|2|||
164264643|NCT01442064|593336579|FG003|Overall Study|Withdrawal by Subject|2|||
164264644|NCT01442064|593336580|FG004|Overall Study|Withdrawal by Subject|2|||
164264645|NCT01442064|593336581|FG005|Overall Study|Withdrawal by Subject|1|||
164264646|NCT01442064|593336576|FG000|Overall Study|Sponsor decision|82|||
164264647|NCT01442064|593336577|FG001|Overall Study|Sponsor decision|88|||
164264648|NCT01442064|593336578|FG002|Overall Study|Sponsor decision|92|||
164264649|NCT01442064|593336579|FG003|Overall Study|Sponsor decision|88|||
164264650|NCT01442064|593336580|FG004|Overall Study|Sponsor decision|95|||
164264651|NCT01442064|593336581|FG005|Overall Study|Sponsor decision|87|||
164264652|NCT01442064|593336576|FG000|Overall Study|Subject non-compliance|0|||
164264653|NCT01442064|593336577|FG001|Overall Study|Subject non-compliance|0|||
164264654|NCT01442064|593336578|FG002|Overall Study|Subject non-compliance|0|||
164264655|NCT01442064|593336579|FG003|Overall Study|Subject non-compliance|0|||
164264656|NCT01442064|593336580|FG004|Overall Study|Subject non-compliance|0|||
164264657|NCT01442064|593336581|FG005|Overall Study|Subject non-compliance|2|||
164264658|NCT01442064|593336576|FG000|Overall Study|Condition mandated other intervention|1|||
164264659|NCT01442064|593336577|FG001|Overall Study|Condition mandated other intervention|1|||
163889873|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
163889874|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
164264660|NCT01442064|593336578|FG002|Overall Study|Condition mandated other intervention|2|||
163889875|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
163889876|NCT01456949|591969097|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
163889877|NCT04753697|591969098|FG000|Induction Phase|Withdrawal by Subject|12|||
163889878|NCT04753697|591969099|FG001|Induction Phase|Withdrawal by Subject|5|||
163889879|NCT04753697|591969100|FG002|Induction Phase|Withdrawal by Subject|6|||
163889880|NCT04753697|591969098|FG000|Induction Phase|Physician Decision|1|||
163889881|NCT04753697|591969099|FG001|Induction Phase|Physician Decision|0|||
163889882|NCT04753697|591969100|FG002|Induction Phase|Physician Decision|0|||
163889883|NCT04753697|591969098|FG000|Induction Phase|Lost to Follow-up|2|||
163889884|NCT04753697|591969099|FG001|Induction Phase|Lost to Follow-up|2|||
163889885|NCT04753697|591969100|FG002|Induction Phase|Lost to Follow-up|1|||
163889886|NCT04753697|591969098|FG000|Induction Phase|Lack of Efficacy|1|||
163889887|NCT04753697|591969099|FG001|Induction Phase|Lack of Efficacy|0|||
163889888|NCT04753697|591969100|FG002|Induction Phase|Lack of Efficacy|0|||
163889889|NCT04753697|591969098|FG000|Maintenance Phase|Physician Decision|0|||
163889890|NCT04753697|591969099|FG001|Maintenance Phase|Physician Decision|0|||
163889891|NCT04753697|591969100|FG002|Maintenance Phase|Physician Decision|1|||
163889892|NCT04753697|591969098|FG000|Maintenance Phase|Withdrawal by Subject|3|||
163889893|NCT04753697|591969099|FG001|Maintenance Phase|Withdrawal by Subject|4|||
163889894|NCT04753697|591969100|FG002|Maintenance Phase|Withdrawal by Subject|6|||
163889895|NCT04753697|591969098|FG000|Maintenance Phase|Lost to Follow-up|2|||
163889896|NCT04753697|591969099|FG001|Maintenance Phase|Lost to Follow-up|2|||
163889897|NCT04753697|591969100|FG002|Maintenance Phase|Lost to Follow-up|0|||
163889898|NCT04753697|591969098|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
163889899|NCT04753697|591969099|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
163889900|NCT04753697|591969100|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
163889901|NCT04753697|591969098|FG000|Maintenance Phase|Adverse Event|0|||
163889902|NCT04753697|591969099|FG001|Maintenance Phase|Adverse Event|1|||
163889903|NCT04753697|591969100|FG002|Maintenance Phase|Adverse Event|1|||
163889904|NCT04753697|591969098|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
163889905|NCT04753697|591969099|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
163889906|NCT04753697|591969100|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
164090465|NCT02984683|592693441|FG001|Overall Study|Adverse Event|3|||
164264661|NCT01442064|593336579|FG003|Overall Study|Condition mandated other intervention|0|||
164264662|NCT01442064|593336580|FG004|Overall Study|Condition mandated other intervention|0|||
164341271|NCT02229383|593623931|FG000|Overall Study|Other|3|||
164341272|NCT02229383|593623932|FG001|Overall Study|Other|8|||
164341273|NCT00873015|593623938|FG000|Overall Study|Withdrawal by Subject|0|||
164341274|NCT00873015|593623939|FG001|Overall Study|Withdrawal by Subject|1|||
164341275|NCT00873015|593623940|FG002|Overall Study|Withdrawal by Subject|0|||
164341276|NCT00873015|593623941|FG003|Overall Study|Withdrawal by Subject|0|||
164341277|NCT02400333|593625292|FG000|Overall Study|Withdrawal by Subject|0|||
163995021|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
164341278|NCT02400333|593625293|FG001|Overall Study|Withdrawal by Subject|1|||
164341279|NCT02400333|593625294|FG002|Overall Study|Withdrawal by Subject|0|||
164341280|NCT02400333|593625295|FG003|Overall Study|Withdrawal by Subject|1|||
164341281|NCT02400333|593625292|FG000|Overall Study|Protocol Violation|1|||
164341282|NCT02400333|593625293|FG001|Overall Study|Protocol Violation|0|||
164341283|NCT02400333|593625294|FG002|Overall Study|Protocol Violation|2|||
164341284|NCT02400333|593625295|FG003|Overall Study|Protocol Violation|1|||
164341285|NCT01687998|593625299|FG000|Overall Study|Withdrawal by Subject|49|||
164341286|NCT01687998|593625300|FG001|Overall Study|Withdrawal by Subject|51|||
164341287|NCT01687998|593625299|FG000|Overall Study|Known to be Alive at Study End|54|||
164341288|NCT01687998|593625300|FG001|Overall Study|Known to be Alive at Study End|62|||
164341289|NCT01687998|593625299|FG000|Overall Study|Lost to Follow-up|9|||
164341290|NCT01687998|593625300|FG001|Overall Study|Lost to Follow-up|7|||
164341291|NCT01663532|593625303|FG000|Overall Study|Lost to Follow-up|9|||
164341292|NCT01663532|593625304|FG001|Overall Study|Lost to Follow-up|10|||
163995022|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995023|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995024|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995025|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995026|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995027|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995028|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995029|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
163995030|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995031|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995032|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
163995033|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995034|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995035|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995036|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995037|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995038|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995039|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995040|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995041|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995042|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995043|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995044|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995045|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995046|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995047|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995048|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995049|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995050|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995051|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995052|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
163995053|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995054|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995055|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
163995056|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995057|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995058|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995059|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995060|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995061|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995062|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995063|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995064|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995065|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
164341293|NCT01663532|593625303|FG000|Overall Study|Adverse Event|7|||
164264663|NCT01442064|593336581|FG005|Overall Study|Condition mandated other intervention|2|||
164264664|NCT01360398|593336582|FG000|Overall Study|Withdrawal by Subject|14|||
164264665|NCT01360398|593336582|FG000|Overall Study|Other|7|||
164264666|NCT01360398|593336582|FG000|Overall Study|Migrated/moved from study area|1|||
164264667|NCT02153346|593336583|FG000|Overall Study|Lost to Follow-up|11|||
164264668|NCT01710527|593336584|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
164264669|NCT01710527|593336585|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
164264670|NCT03946124|593338669|FG000|Overall Study|Withdrawal by Subject|19|||
164264671|NCT02118597|593338678|FG000|Overall Study|Sponsor terminated the study|14|||
164264672|NCT02118597|593338678|FG000|Overall Study|Serious Adverse Event|1|||
164264673|NCT02118597|593338678|FG000|Overall Study|Investigator's decision|1|||
164264674|NCT01891344|593338679|FG000|Overall Study|Ongoing|6|||
164264675|NCT01891344|593338680|FG001|Overall Study|Ongoing|2|||
164264676|NCT01891344|593338681|FG002|Overall Study|Ongoing|0|||
164264677|NCT01891344|593338682|FG003|Overall Study|Ongoing|1|||
164264678|NCT01891344|593338683|FG004|Overall Study|Ongoing|4|||
164264679|NCT01891344|593338684|FG005|Overall Study|Ongoing|1|||
164264680|NCT01891344|593338685|FG006|Overall Study|Ongoing|0|||
164264681|NCT01891344|593338686|FG007|Overall Study|Ongoing|0|||
164264682|NCT01852825|593338687|FG000|Overall Study|Withdrawal by Subject|2|||
164264683|NCT01852825|593338688|FG001|Overall Study|Withdrawal by Subject|0|||
164264684|NCT01852825|593338689|FG002|Overall Study|Withdrawal by Subject|0|||
164264685|NCT01414205|593338690|FG000|Overall Study|Death|5|||
164264686|NCT01414205|593338691|FG001|Overall Study|Death|1|||
164264687|NCT01414205|593338690|FG000|Overall Study|Lost to Follow-up|1|||
164264688|NCT01414205|593338691|FG001|Overall Study|Lost to Follow-up|4|||
164264689|NCT01414205|593338690|FG000|Overall Study|Physician Decision|0|||
164264690|NCT01414205|593338691|FG001|Overall Study|Physician Decision|1|||
164264691|NCT01414205|593338690|FG000|Overall Study|Randomized but not Treated|1|||
164264692|NCT01414205|593338691|FG001|Overall Study|Randomized but not Treated|1|||
164264693|NCT01166373|593338692|FG000|Overall Study|Lost to Follow-up|3|||
164264694|NCT01166373|593338693|FG001|Overall Study|Lost to Follow-up|2|||
164264695|NCT01166373|593338694|FG002|Overall Study|Lost to Follow-up|2|||
164264696|NCT01166373|593338695|FG003|Overall Study|Lost to Follow-up|2|||
164264697|NCT01166373|593338692|FG000|Overall Study|Withdrawal by Subject|1|||
164264698|NCT01166373|593338693|FG001|Overall Study|Withdrawal by Subject|2|||
164264699|NCT01166373|593338694|FG002|Overall Study|Withdrawal by Subject|2|||
164264700|NCT01166373|593338695|FG003|Overall Study|Withdrawal by Subject|3|||
164264701|NCT01166373|593338692|FG000|Overall Study|Physician Decision|1|||
164264702|NCT01166373|593338693|FG001|Overall Study|Physician Decision|0|||
164341294|NCT01663532|593625304|FG001|Overall Study|Adverse Event|13|||
164341295|NCT01663532|593625303|FG000|Overall Study|Met Withdrawal Criteria|7|||
164341296|NCT01663532|593625304|FG001|Overall Study|Met Withdrawal Criteria|6|||
164341297|NCT01663532|593625303|FG000|Overall Study|Physician Decision|1|||
164341298|NCT01663532|593625304|FG001|Overall Study|Physician Decision|1|||
164341299|NCT01663532|593625303|FG000|Overall Study|Withdrawal by Subject|35|||
164341300|NCT01663532|593625304|FG001|Overall Study|Withdrawal by Subject|17|||
164341301|NCT01663532|593625303|FG000|Overall Study|Lack of Efficacy|15|||
164341302|NCT01663532|593625304|FG001|Overall Study|Lack of Efficacy|60|||
164341303|NCT01871532|593625310|FG000|Overall Study|Withdrawal by Subject|1|||
164341304|NCT01871532|593625311|FG001|Overall Study|Withdrawal by Subject|2|||
164341305|NCT00283400|593625312|FG000|Overall Study|Withdrawal by Subject|1|||
164341306|NCT00283400|593625313|FG001|Overall Study|Withdrawal by Subject|1|||
164341307|NCT00283400|593625314|FG002|Overall Study|Withdrawal by Subject|0|||
164341308|NCT00283400|593625315|FG003|Overall Study|Withdrawal by Subject|0|||
164341309|NCT00283400|593625312|FG000|Overall Study|Death|1|||
164341310|NCT00283400|593625313|FG001|Overall Study|Death|0|||
164341311|NCT00283400|593625314|FG002|Overall Study|Death|1|||
164341312|NCT00283400|593625315|FG003|Overall Study|Death|0|||
164341313|NCT00934089|593625319|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
164341314|NCT00934089|593625320|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
164264703|NCT01166373|593338694|FG002|Overall Study|Physician Decision|0|||
164264704|NCT01166373|593338695|FG003|Overall Study|Physician Decision|0|||
164264705|NCT02498067|593338696|FG000|Overall Study|Lost to Follow-up|22|||
164264706|NCT02498067|593338696|FG000|Overall Study|Did not meet inclusion criteria|11|||
164264707|NCT02214225|593338701|FG000|Overall Study|Lost to Follow-up|46|||
164341315|NCT00934089|593625319|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
164341316|NCT00934089|593625320|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
164341317|NCT01020981|593625321|FG000|Overall Study|Did not return mailed survey|74|||
164341318|NCT01020981|593625322|FG001|Overall Study|Did not return mailed survey|58|||
164264708|NCT02214225|593338702|FG001|Overall Study|Lost to Follow-up|18|||
164264709|NCT02214225|593338703|FG002|Overall Study|Lost to Follow-up|18|||
164264710|NCT02214225|593338701|FG000|Overall Study|Withdrawal by Subject|2|||
164264711|NCT02214225|593338702|FG001|Overall Study|Withdrawal by Subject|0|||
164264712|NCT02214225|593338703|FG002|Overall Study|Withdrawal by Subject|2|||
164264713|NCT02214225|593338701|FG000|Overall Study|Death|5|||
164264714|NCT02214225|593338702|FG001|Overall Study|Death|0|||
164264715|NCT02214225|593338703|FG002|Overall Study|Death|1|||
164264716|NCT02214225|593338701|FG000|Overall Study|randomized in error, not vaccinated|2|||
164264717|NCT02214225|593338702|FG001|Overall Study|randomized in error, not vaccinated|1|||
164264718|NCT02214225|593338703|FG002|Overall Study|randomized in error, not vaccinated|1|||
164264719|NCT03987932|593338704|FG000|Overall Study|Lost to Follow-up|2|||
164264720|NCT03987932|593338705|FG001|Overall Study|Lost to Follow-up|1|||
164264721|NCT03987932|593338706|FG002|Overall Study|Lost to Follow-up|1|||
164264722|NCT03987932|593338704|FG000|Overall Study|Non-study related elective surgery|0|||
164264723|NCT03987932|593338705|FG001|Overall Study|Non-study related elective surgery|0|||
164264724|NCT03987932|593338706|FG002|Overall Study|Non-study related elective surgery|1|||
164264725|NCT01669421|593338709|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
164264726|NCT01669421|593338709|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
164264727|NCT02813668|593338715|FG000|Overall Study|Death|4|||
164264728|NCT02813668|593338715|FG000|Overall Study|Lost to Follow-up|509|||
164264729|NCT02813668|593338715|FG000|Overall Study|Withdrawal by Subject|148|||
164264730|NCT02813668|593338715|FG000|Overall Study|No longer at worksite|85|||
164264731|NCT02813668|593338715|FG000|Overall Study|Medical reasons not related to the study|4|||
164264732|NCT02961790|593338716|FG000|Overall Study|Canceled|4|||
164264733|NCT02961790|593338717|FG001|Overall Study|Canceled|5|||
163995066|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995067|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995068|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995069|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995070|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995071|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995072|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995073|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995074|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995075|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
163995076|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995077|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995078|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995079|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
163995080|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995081|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995082|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995083|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995084|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995085|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995086|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995087|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995088|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995089|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995090|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995091|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995092|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995093|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995094|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995095|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995096|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995097|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
164142291|NCT02186834|592882591|FG004|Dose Escalation|Death|0|||
164264734|NCT02961790|593338718|FG002|Overall Study|Canceled|1|||
164264735|NCT02961790|593338719|FG003|Overall Study|Canceled|4|||
164264736|NCT02961790|593338716|FG000|Overall Study|without baseline data|4|||
164264737|NCT02961790|593338717|FG001|Overall Study|without baseline data|0|||
164264738|NCT02961790|593338718|FG002|Overall Study|without baseline data|1|||
164264739|NCT02961790|593338719|FG003|Overall Study|without baseline data|0|||
164264740|NCT02961790|593338716|FG000|Overall Study|without post baseline data|7|||
164264741|NCT02961790|593338717|FG001|Overall Study|without post baseline data|6|||
164264742|NCT02961790|593338718|FG002|Overall Study|without post baseline data|4|||
164264743|NCT02961790|593338719|FG003|Overall Study|without post baseline data|1|||
164264744|NCT02594098|593338724|FG000|Overall Study|Lack of Efficacy|17|||
164264745|NCT02594098|593338725|FG001|Overall Study|Lack of Efficacy|6|||
164264746|NCT02594098|593338724|FG000|Overall Study|Withdrawal by Subject|1|||
164264747|NCT02594098|593338725|FG001|Overall Study|Withdrawal by Subject|3|||
163995098|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
163995099|NCT00896532|592347962|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995100|NCT00896532|592347963|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
163995101|NCT00896532|592347964|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995102|NCT00896532|592347965|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
163995103|NCT00896532|592347966|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
163995104|NCT00896532|592347967|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995105|NCT00896532|592347968|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995106|NCT00896532|592347969|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995107|NCT00896532|592347970|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995108|NCT00896532|592347971|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995109|NCT00896532|592347972|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995110|NCT00896532|592347973|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995111|NCT00896532|592347974|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995112|NCT00896532|592347975|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995113|NCT00896532|592347976|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995114|NCT00896532|592347977|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995115|NCT00896532|592347978|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995116|NCT00896532|592347979|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995117|NCT00896532|592347980|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995118|NCT00896532|592347981|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995119|NCT00896532|592347982|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995120|NCT00896532|592347983|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995121|NCT00896532|592347984|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
163995122|NCT00896532|592347962|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995123|NCT00896532|592347963|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995124|NCT00896532|592347964|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995125|NCT00896532|592347965|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995126|NCT00896532|592347966|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995127|NCT00896532|592347967|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995128|NCT00896532|592347968|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995129|NCT00896532|592347969|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995130|NCT00896532|592347970|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
163995131|NCT00896532|592347971|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995132|NCT00896532|592347972|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995133|NCT00896532|592347973|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995134|NCT00896532|592347974|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995135|NCT00896532|592347975|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995136|NCT00896532|592347976|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995137|NCT00896532|592347977|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995138|NCT00896532|592347978|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995139|NCT00896532|592347979|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995140|NCT00896532|592347980|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995141|NCT00896532|592347981|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995142|NCT00896532|592347982|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995143|NCT00896532|592347983|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995144|NCT00896532|592347984|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
163995145|NCT00896532|592347962|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995146|NCT00896532|592347963|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995147|NCT00896532|592347964|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995148|NCT00896532|592347965|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
164090466|NCT02984683|592693440|FG000|Overall Study|Withdrawal by Subject|1|||
164264748|NCT02594098|593338724|FG000|Overall Study|Terminated participation|6|||
164264749|NCT02594098|593338725|FG001|Overall Study|Terminated participation|2|||
164264750|NCT02594098|593338724|FG000|Overall Study|Seek alternative treatment|2|||
164264751|NCT02594098|593338725|FG001|Overall Study|Seek alternative treatment|1|||
164264752|NCT02594098|593338724|FG000|Overall Study|Other|0|||
164264753|NCT02594098|593338725|FG001|Overall Study|Other|1|||
164264754|NCT01866423|593338727|FG000|Overall Study|Lack of Efficacy|3|||
164264755|NCT01866423|593338727|FG000|Overall Study|Sponsor Decision|1|||
164264756|NCT03366103|593338728|FG000|Overall Study|Disease Progression|3|||
164264757|NCT03366103|593338729|FG001|Overall Study|Disease Progression|1|||
164264758|NCT03366103|593338730|FG002|Overall Study|Disease Progression|0|||
164264759|NCT03366103|593338728|FG000|Overall Study|Adverse Event|0|||
164264760|NCT03366103|593338729|FG001|Overall Study|Adverse Event|1|||
164264761|NCT03366103|593338730|FG002|Overall Study|Adverse Event|0|||
164264762|NCT00541099|593338737|FG000|Overall Study|Ineligible|3|||
164341319|NCT01020981|593625321|FG000|Overall Study|Survey returned undeliverable|8|||
163995149|NCT00896532|592347966|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995150|NCT00896532|592347967|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995151|NCT00896532|592347968|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995152|NCT00896532|592347969|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995153|NCT00896532|592347970|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995154|NCT00896532|592347971|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995155|NCT00896532|592347972|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995156|NCT00896532|592347973|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995157|NCT00896532|592347974|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
163995158|NCT00896532|592347975|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995159|NCT00896532|592347976|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995160|NCT00896532|592347977|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995161|NCT00896532|592347978|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995162|NCT00896532|592347979|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995163|NCT00896532|592347980|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995164|NCT00896532|592347981|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995165|NCT00896532|592347982|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995166|NCT00896532|592347983|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995167|NCT00896532|592347984|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
163995168|NCT00896532|592347962|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995169|NCT00896532|592347963|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995170|NCT00896532|592347964|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995171|NCT00896532|592347965|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995172|NCT00896532|592347966|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995173|NCT00896532|592347967|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995174|NCT00896532|592347968|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995175|NCT00896532|592347969|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995176|NCT00896532|592347970|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995177|NCT00896532|592347971|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995178|NCT00896532|592347972|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
163995179|NCT00896532|592347973|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995180|NCT00896532|592347974|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
163995181|NCT00896532|592347975|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995182|NCT00896532|592347976|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995183|NCT00896532|592347977|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995184|NCT00896532|592347978|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995185|NCT00896532|592347979|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995186|NCT00896532|592347980|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995187|NCT00896532|592347981|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995188|NCT00896532|592347982|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995189|NCT00896532|592347983|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995190|NCT00896532|592347984|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
163995191|NCT00896532|592347962|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995192|NCT00896532|592347963|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995193|NCT00896532|592347964|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995194|NCT00896532|592347965|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995195|NCT00896532|592347966|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995196|NCT00896532|592347967|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995197|NCT00896532|592347968|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995198|NCT00896532|592347969|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995199|NCT00896532|592347970|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995200|NCT00896532|592347971|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995201|NCT00896532|592347972|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995202|NCT00896532|592347973|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995203|NCT00896532|592347974|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
163995204|NCT00896532|592347975|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
163995205|NCT00896532|592347976|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995206|NCT00896532|592347977|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995207|NCT00896532|592347978|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995208|NCT00896532|592347979|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995209|NCT00896532|592347980|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
164264763|NCT05590000|593338744|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
164264764|NCT01174004|593338745|FG000|Overall Study|Adverse Event|2|||
164264765|NCT01174004|593338746|FG001|Overall Study|Adverse Event|10|||
164264766|NCT01174004|593338745|FG000|Overall Study|Withdrawal by Subject|2|||
164264767|NCT01174004|593338746|FG001|Overall Study|Withdrawal by Subject|3|||
164264768|NCT01174004|593338745|FG000|Overall Study|At Discretion of Sponsor|2|||
164264769|NCT01174004|593338746|FG001|Overall Study|At Discretion of Sponsor|2|||
164264770|NCT01174004|593338745|FG000|Overall Study|Protocol Violation|0|||
164264771|NCT01174004|593338746|FG001|Overall Study|Protocol Violation|1|||
164264772|NCT01174004|593338745|FG000|Overall Study|Physician Decision|1|||
164264773|NCT01174004|593338746|FG001|Overall Study|Physician Decision|0|||
164264774|NCT00434759|593338753|FG000|Overall Study|Lack of Efficacy|5|||
164264775|NCT00434759|593338754|FG001|Overall Study|Lack of Efficacy|4|||
164264776|NCT00434759|593338753|FG000|Overall Study|Withdrawal by Subject|17|||
164264777|NCT00434759|593338754|FG001|Overall Study|Withdrawal by Subject|1|||
164264778|NCT00434759|593338753|FG000|Overall Study|family affairs|2|||
164264779|NCT00434759|593338754|FG001|Overall Study|family affairs|0|||
164264780|NCT01143896|593338756|FG000|Overall Study|Did not complete Baseline Interview|5|||
164264781|NCT01143896|593338757|FG001|Overall Study|Did not complete Baseline Interview|4|||
164264782|NCT01143896|593338756|FG000|Overall Study|Lost to Follow-up|18|||
164264783|NCT01143896|593338757|FG001|Overall Study|Lost to Follow-up|13|||
164264784|NCT01143896|593338756|FG000|Overall Study|Withdrawal by Subject|13|||
164264785|NCT01143896|593338757|FG001|Overall Study|Withdrawal by Subject|5|||
164264786|NCT01143896|593338756|FG000|Overall Study|Death|6|||
164264787|NCT01143896|593338757|FG001|Overall Study|Death|3|||
164264788|NCT01318070|593338758|FG000|Overall Study|Adverse Event|1|||
164264789|NCT01318070|593338759|FG001|Overall Study|Adverse Event|1|||
164264790|NCT01318070|593338760|FG002|Overall Study|Adverse Event|5|||
164264791|NCT01318070|593338758|FG000|Overall Study|Withdrawal by Subject|0|||
164264792|NCT01318070|593338759|FG001|Overall Study|Withdrawal by Subject|1|||
164264793|NCT01318070|593338760|FG002|Overall Study|Withdrawal by Subject|1|||
164264794|NCT01318070|593338758|FG000|Overall Study|Lack of Efficacy|0|||
164264795|NCT01318070|593338759|FG001|Overall Study|Lack of Efficacy|0|||
164264796|NCT01318070|593338760|FG002|Overall Study|Lack of Efficacy|1|||
164264797|NCT01318070|593338758|FG000|Overall Study|Principal Investigator Discretion|1|||
164264798|NCT01318070|593338759|FG001|Overall Study|Principal Investigator Discretion|0|||
164264799|NCT01318070|593338760|FG002|Overall Study|Principal Investigator Discretion|0|||
164264800|NCT00042432|593338761|FG000|Overall Study|Adverse Event|4|||
164264801|NCT00042432|593338762|FG001|Overall Study|Adverse Event|1|||
164264802|NCT00042432|593338761|FG000|Overall Study|Withdrawal by Subject|1|||
164264803|NCT00042432|593338762|FG001|Overall Study|Withdrawal by Subject|3|||
164264804|NCT00042432|593338761|FG000|Overall Study|Death|0|||
164264805|NCT00042432|593338762|FG001|Overall Study|Death|2|||
164264806|NCT00042432|593338761|FG000|Overall Study|Ineligibility determined|1|||
164264807|NCT00042432|593338762|FG001|Overall Study|Ineligibility determined|0|||
164264808|NCT00042432|593338761|FG000|Overall Study|Initiation of maintenance dialysis|1|||
164264809|NCT00042432|593338762|FG001|Overall Study|Initiation of maintenance dialysis|1|||
164264810|NCT00042432|593338761|FG000|Overall Study|Other|2|||
164264811|NCT00042432|593338762|FG001|Overall Study|Other|0|||
164264812|NCT02966795|593338764|FG000|Overall Study|Patient Left the Country|0|||
164264813|NCT02966795|593338765|FG001|Overall Study|Patient Left the Country|1|||
164264814|NCT00432744|593338766|FG000|Months 0-6|Withdrawal by Subject|4|||
164264815|NCT00432744|593338767|FG001|Months 0-6|Withdrawal by Subject|4|||
164264816|NCT00432744|593338766|FG000|Months 0-6|Too disabled to score|1|||
164264817|NCT00432744|593338767|FG001|Months 0-6|Too disabled to score|0|||
164264818|NCT00432744|593338766|FG000|Months 7 - 12|Withdrawal by Subject|1|||
164264819|NCT00432744|593338767|FG001|Months 7 - 12|Withdrawal by Subject|0|||
164264820|NCT00432744|593338766|FG000|Months 7 - 12|Too disabled to score|0|||
164264821|NCT00432744|593338767|FG001|Months 7 - 12|Too disabled to score|1|||
163995210|NCT00896532|592347981|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995211|NCT00896532|592347982|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995212|NCT00896532|592347983|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995213|NCT00896532|592347984|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
163995214|NCT00896532|592347962|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
164264822|NCT00461305|593338770|FG000|Treatment|Adverse Event|26|||
164264823|NCT00461305|593338771|FG001|Treatment|Adverse Event|3|||
164341320|NCT01020981|593625322|FG001|Overall Study|Survey returned undeliverable|32|||
164341321|NCT01020981|593625321|FG000|Overall Study|Participant declined to complete survey|2|||
164341322|NCT01020981|593625322|FG001|Overall Study|Participant declined to complete survey|0|||
164341323|NCT00680017|593625326|FG000|Overall Study|Adverse Event|13|||
164341324|NCT00680017|593625327|FG001|Overall Study|Adverse Event|7|||
164341325|NCT00680017|593625326|FG000|Overall Study|Withdrawal by Subject|2|||
163995215|NCT00896532|592347963|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
164142292|NCT02186834|592882592|FG005|Dose Escalation|Death|0|||
164264824|NCT00461305|593338770|FG000|Treatment|Lost to Follow-up|4|||
164264825|NCT00461305|593338771|FG001|Treatment|Lost to Follow-up|2|||
164264826|NCT00461305|593338770|FG000|Treatment|Protocol Violation|13|||
164264827|NCT00461305|593338771|FG001|Treatment|Protocol Violation|2|||
164264828|NCT00461305|593338770|FG000|Treatment|Withdrawal by Subject|48|||
164264829|NCT00461305|593338771|FG001|Treatment|Withdrawal by Subject|2|||
164264830|NCT00461305|593338770|FG000|Treatment|Never dispensed|5|||
163995216|NCT00896532|592347964|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
163995217|NCT00896532|592347965|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
163995218|NCT00896532|592347966|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
163995219|NCT00896532|592347967|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
163995220|NCT00896532|592347968|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
163995221|NCT00896532|592347969|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
163995222|NCT00896532|592347970|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
163995223|NCT00896532|592347971|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
164341326|NCT00680017|593625327|FG001|Overall Study|Withdrawal by Subject|5|||
163995224|NCT00896532|592347972|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
163995225|NCT00896532|592347973|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
163995226|NCT00896532|592347974|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
163995227|NCT00896532|592347975|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
163995228|NCT00896532|592347976|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
163995229|NCT00896532|592347977|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
163995230|NCT00896532|592347978|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
163995231|NCT00896532|592347979|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
163995232|NCT00896532|592347980|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
163995233|NCT00896532|592347981|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
163995234|NCT00896532|592347982|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
163995235|NCT00896532|592347983|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
163995236|NCT00896532|592347984|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
163995237|NCT00896532|592347962|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995238|NCT00896532|592347963|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995239|NCT00896532|592347964|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995240|NCT00896532|592347965|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995241|NCT00896532|592347966|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995242|NCT00896532|592347967|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995243|NCT00896532|592347968|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164341327|NCT00680017|593625326|FG000|Overall Study|Lost to Follow-up|2|||
164341328|NCT00680017|593625327|FG001|Overall Study|Lost to Follow-up|0|||
164341329|NCT01434667|593625328|FG000|Overall Study|Lost to Follow-up|5|||
164341330|NCT01434667|593625329|FG001|Overall Study|Lost to Follow-up|10|||
164341331|NCT02034110|593625330|FG000|Overall Study|Physician Decision|0|||
164341332|NCT02034110|593625331|FG001|Overall Study|Physician Decision|0|||
164341333|NCT02034110|593625332|FG002|Overall Study|Physician Decision|0|||
164341334|NCT02034110|593625333|FG003|Overall Study|Physician Decision|0|||
164341335|NCT02034110|593625334|FG004|Overall Study|Physician Decision|2|||
164341336|NCT02034110|593625335|FG005|Overall Study|Physician Decision|0|||
164341337|NCT02034110|593625336|FG006|Overall Study|Physician Decision|1|||
164341338|NCT02034110|593625337|FG007|Overall Study|Physician Decision|0|||
164341339|NCT02034110|593625330|FG000|Overall Study|Lost to Follow-up|1|||
164341340|NCT02034110|593625331|FG001|Overall Study|Lost to Follow-up|0|||
164341341|NCT02034110|593625332|FG002|Overall Study|Lost to Follow-up|0|||
164341342|NCT02034110|593625333|FG003|Overall Study|Lost to Follow-up|0|||
164341343|NCT02034110|593625334|FG004|Overall Study|Lost to Follow-up|1|||
164341344|NCT02034110|593625335|FG005|Overall Study|Lost to Follow-up|0|||
164341345|NCT02034110|593625336|FG006|Overall Study|Lost to Follow-up|1|||
164341346|NCT02034110|593625337|FG007|Overall Study|Lost to Follow-up|0|||
164341347|NCT02034110|593625330|FG000|Overall Study|Withdrawal by Subject|5|||
164341348|NCT02034110|593625331|FG001|Overall Study|Withdrawal by Subject|7|||
164341349|NCT02034110|593625332|FG002|Overall Study|Withdrawal by Subject|0|||
164341350|NCT02034110|593625333|FG003|Overall Study|Withdrawal by Subject|3|||
164341351|NCT02034110|593625334|FG004|Overall Study|Withdrawal by Subject|7|||
164341352|NCT02034110|593625335|FG005|Overall Study|Withdrawal by Subject|0|||
164341353|NCT02034110|593625336|FG006|Overall Study|Withdrawal by Subject|3|||
164341354|NCT02034110|593625337|FG007|Overall Study|Withdrawal by Subject|1|||
164341355|NCT02034110|593625330|FG000|Overall Study|Study closed by sponsor|6|||
164341356|NCT02034110|593625331|FG001|Overall Study|Study closed by sponsor|2|||
164341357|NCT02034110|593625332|FG002|Overall Study|Study closed by sponsor|0|||
164085586|NCT03843359|592677270|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
164085587|NCT03843359|592677255|FG000|Crossover|Withdrawal by Subject|0|||
164085588|NCT03843359|592677256|FG001|Crossover|Withdrawal by Subject|0|||
164085589|NCT03843359|592677257|FG002|Crossover|Withdrawal by Subject|0|||
164085590|NCT03843359|592677258|FG003|Crossover|Withdrawal by Subject|0|||
164341358|NCT02034110|593625333|FG003|Overall Study|Study closed by sponsor|6|||
164341359|NCT02034110|593625334|FG004|Overall Study|Study closed by sponsor|7|||
164341360|NCT02034110|593625335|FG005|Overall Study|Study closed by sponsor|0|||
163995244|NCT00896532|592347969|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995245|NCT00896532|592347970|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
164341361|NCT02034110|593625336|FG006|Overall Study|Study closed by sponsor|42|||
164341362|NCT02034110|593625337|FG007|Overall Study|Study closed by sponsor|0|||
164341363|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
164341364|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
164085591|NCT03843359|592677259|FG004|Crossover|Withdrawal by Subject|0|||
164085592|NCT03843359|592677260|FG005|Crossover|Withdrawal by Subject|0|||
164085593|NCT03843359|592677261|FG006|Crossover|Withdrawal by Subject|0|||
164085594|NCT03843359|592677262|FG007|Crossover|Withdrawal by Subject|0|||
164085595|NCT03843359|592677263|FG008|Crossover|Withdrawal by Subject|0|||
164085596|NCT03843359|592677264|FG009|Crossover|Withdrawal by Subject|0|||
164085597|NCT03843359|592677265|FG010|Crossover|Withdrawal by Subject|0|||
164085598|NCT03843359|592677266|FG011|Crossover|Withdrawal by Subject|0|||
164085599|NCT03843359|592677267|FG012|Crossover|Withdrawal by Subject|0|||
164085600|NCT03843359|592677268|FG013|Crossover|Withdrawal by Subject|0|||
164085601|NCT03843359|592677269|FG014|Crossover|Withdrawal by Subject|0|||
164085602|NCT03843359|592677270|FG015|Crossover|Withdrawal by Subject|1|||
164085603|NCT03843359|592677255|FG000|Crossover|Investigator site closed|0|||
164085604|NCT03843359|592677256|FG001|Crossover|Investigator site closed|0|||
164085605|NCT03843359|592677257|FG002|Crossover|Investigator site closed|0|||
164085606|NCT03843359|592677258|FG003|Crossover|Investigator site closed|0|||
164085607|NCT03843359|592677259|FG004|Crossover|Investigator site closed|0|||
164085608|NCT03843359|592677260|FG005|Crossover|Investigator site closed|0|||
164085609|NCT03843359|592677261|FG006|Crossover|Investigator site closed|0|||
164085610|NCT03843359|592677262|FG007|Crossover|Investigator site closed|0|||
164085611|NCT03843359|592677263|FG008|Crossover|Investigator site closed|0|||
164085612|NCT03843359|592677264|FG009|Crossover|Investigator site closed|0|||
164085613|NCT03843359|592677265|FG010|Crossover|Investigator site closed|0|||
164085614|NCT03843359|592677266|FG011|Crossover|Investigator site closed|0|||
164085615|NCT03843359|592677267|FG012|Crossover|Investigator site closed|0|||
164085616|NCT03843359|592677268|FG013|Crossover|Investigator site closed|0|||
164085617|NCT03843359|592677269|FG014|Crossover|Investigator site closed|2|||
164085618|NCT03843359|592677270|FG015|Crossover|Investigator site closed|2|||
164085619|NCT03843359|592677255|FG000|Crossover|Ongoing at the time of analysis|0|||
164085620|NCT03843359|592677256|FG001|Crossover|Ongoing at the time of analysis|0|||
164085621|NCT03843359|592677257|FG002|Crossover|Ongoing at the time of analysis|0|||
164085622|NCT03843359|592677258|FG003|Crossover|Ongoing at the time of analysis|0|||
164085623|NCT03843359|592677259|FG004|Crossover|Ongoing at the time of analysis|0|||
164085624|NCT03843359|592677260|FG005|Crossover|Ongoing at the time of analysis|0|||
164085625|NCT03843359|592677261|FG006|Crossover|Ongoing at the time of analysis|0|||
164085626|NCT03843359|592677262|FG007|Crossover|Ongoing at the time of analysis|0|||
164085627|NCT03843359|592677263|FG008|Crossover|Ongoing at the time of analysis|0|||
164085628|NCT03843359|592677264|FG009|Crossover|Ongoing at the time of analysis|0|||
164085629|NCT03843359|592677265|FG010|Crossover|Ongoing at the time of analysis|0|||
164085630|NCT03843359|592677266|FG011|Crossover|Ongoing at the time of analysis|0|||
164085631|NCT03843359|592677267|FG012|Crossover|Ongoing at the time of analysis|0|||
164085632|NCT03843359|592677268|FG013|Crossover|Ongoing at the time of analysis|1|||
164085633|NCT03843359|592677269|FG014|Crossover|Ongoing at the time of analysis|0|||
164085634|NCT03843359|592677270|FG015|Crossover|Ongoing at the time of analysis|0|||
164085635|NCT03075527|592677271|FG000|Overall Study|Death|1|||
164085636|NCT03075527|592677271|FG000|Overall Study|Withdrawal by Subject|1|||
164085637|NCT03075527|592677271|FG000|Overall Study|Physician Decision|3|||
164085638|NCT03075527|592677271|FG000|Overall Study|Progression/Relapse|14|||
164085639|NCT05359003|592677276|FG000|Overall Study|Withdrawal by Subject|1|||
164085640|NCT05359003|592677277|FG001|Overall Study|Withdrawal by Subject|3|||
164085641|NCT06202521|592677280|FG000|Overall Study|Withdrawal by Subject|0|||
164085642|NCT06202521|592677281|FG001|Overall Study|Withdrawal by Subject|1|||
164085643|NCT06202521|592677282|FG002|Overall Study|Withdrawal by Subject|0|||
164264831|NCT00461305|593338771|FG001|Treatment|Never dispensed|0|||
164264832|NCT00461305|593338770|FG000|Treatment|Study drug not taken|1|||
164264833|NCT00461305|593338771|FG001|Treatment|Study drug not taken|0|||
164264834|NCT00461305|593338770|FG000|Treatment|Partially missing diary|2|||
164264835|NCT00461305|593338771|FG001|Treatment|Partially missing diary|0|||
164264836|NCT00461305|593338770|FG000|Treatment|Other (missing drug etc)|2|||
164264837|NCT00461305|593338771|FG001|Treatment|Other (missing drug etc)|0|||
164085644|NCT06202521|592677283|FG003|Overall Study|Withdrawal by Subject|1|||
164085645|NCT06202521|592677280|FG000|Overall Study|Adverse Event|0|||
164085646|NCT06202521|592677281|FG001|Overall Study|Adverse Event|0|||
164264838|NCT00461305|593338770|FG000|Continued Treatment|Adverse Event|26|||
164341365|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Progression|3|||
164085647|NCT06202521|592677282|FG002|Overall Study|Adverse Event|1|||
164085648|NCT06202521|592677283|FG003|Overall Study|Adverse Event|0|||
164085649|NCT02717611|592677286|FG000|Overall Study|Death|13|||
164085650|NCT02717611|592677286|FG000|Overall Study|Withdrawal by Subject|6|||
164341366|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
164341367|NCT00064337|593625338|FG000|PBSCC or Induction/PBSCC|Death|2|||
164341368|NCT00064337|593625338|FG000|Transplant|Adverse Event|9|||
164341369|NCT00064337|593625338|FG000|Transplant|Not protocol-specified|5|||
164341370|NCT00064337|593625338|FG000|Transplant|Death|3|||
164341371|NCT00064337|593625338|FG000|Transplant|Patient Refusal|2|||
164085651|NCT02717611|592677286|FG000|Overall Study|Active, not recruiting|40|||
164264839|NCT00461305|593338771|FG001|Continued Treatment|Adverse Event|0|||
164341372|NCT00064337|593625338|FG000|Transplant|Progression|2|||
163995246|NCT00896532|592347971|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995247|NCT00896532|592347972|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995248|NCT00896532|592347973|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995249|NCT00896532|592347974|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995250|NCT00896532|592347975|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995251|NCT00896532|592347976|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995252|NCT00896532|592347977|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
163995253|NCT00896532|592347978|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
163995254|NCT00896532|592347979|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995255|NCT00896532|592347980|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995256|NCT00896532|592347981|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995257|NCT00896532|592347982|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995258|NCT00896532|592347983|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995259|NCT00896532|592347984|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
163995260|NCT00896532|592347962|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995261|NCT00896532|592347963|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995262|NCT00896532|592347964|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995263|NCT00896532|592347965|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995264|NCT00896532|592347966|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995265|NCT00896532|592347967|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995266|NCT00896532|592347968|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995267|NCT00896532|592347969|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995268|NCT00896532|592347970|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995269|NCT00896532|592347971|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163889907|NCT05002088|591969103|FG000|Overall Study|Withdrawal by Subject|9|||
163889908|NCT05002088|591969104|FG001|Overall Study|Withdrawal by Subject|0|||
163889909|NCT05002088|591969103|FG000|Overall Study|Lost to Follow-up|0|||
163889910|NCT05002088|591969104|FG001|Overall Study|Lost to Follow-up|1|||
163889911|NCT05002088|591969103|FG000|Overall Study|Death|16|||
163889912|NCT05002088|591969104|FG001|Overall Study|Death|2|||
163889913|NCT05002088|591969103|FG000|Overall Study|Protocol Violation|25|||
163889914|NCT05002088|591969104|FG001|Overall Study|Protocol Violation|7|||
163889915|NCT04770402|591969106|FG000|Overall Study|Lost to Follow-up|1|||
163889916|NCT04770402|591969107|FG001|Overall Study|Lost to Follow-up|2|||
163889917|NCT04770402|591969106|FG000|Overall Study|Non-compliance|1|||
163889918|NCT04770402|591969107|FG001|Overall Study|Non-compliance|0|||
163889919|NCT04770402|591969106|FG000|Overall Study|Withdrawal by Subject|0|||
163889920|NCT04770402|591969107|FG001|Overall Study|Withdrawal by Subject|1|||
163889921|NCT03599661|591969108|FG000|Overall Study|Lost to Follow-up|9|||
163889922|NCT04811040|591969109|FG000|Overall Study|Lost to Follow-up|2|||
163889923|NCT04811040|591969110|FG001|Overall Study|Lost to Follow-up|0|||
163889924|NCT04811040|591969111|FG002|Overall Study|Lost to Follow-up|0|||
163889925|NCT04811040|591969112|FG003|Overall Study|Lost to Follow-up|0|||
163889926|NCT04811040|591969109|FG000|Overall Study|Withdrew consent|1|||
163889927|NCT04811040|591969110|FG001|Overall Study|Withdrew consent|1|||
163889928|NCT04811040|591969111|FG002|Overall Study|Withdrew consent|0|||
163889929|NCT04811040|591969112|FG003|Overall Study|Withdrew consent|0|||
163889930|NCT05446168|591969117|FG000|Overall Study|Physician Decision|0|||
163889931|NCT05446168|591969118|FG001|Overall Study|Physician Decision|1|||
163889932|NCT01828099|591969122|FG000|Treatment Period|Adverse Event|24|||
163889933|NCT01828099|591969123|FG001|Treatment Period|Adverse Event|23|||
163889934|NCT01828099|591969122|FG000|Treatment Period|Death|10|||
163889935|NCT01828099|591969123|FG001|Treatment Period|Death|12|||
163889936|NCT01828099|591969122|FG000|Treatment Period|Lost to Follow-up|2|||
163889937|NCT01828099|591969123|FG001|Treatment Period|Lost to Follow-up|1|||
163889938|NCT01828099|591969122|FG000|Treatment Period|Non-compliance with study treatment|1|||
163889939|NCT01828099|591969123|FG001|Treatment Period|Non-compliance with study treatment|0|||
163889940|NCT01828099|591969122|FG000|Treatment Period|Physician Decision|17|||
163889941|NCT01828099|591969123|FG001|Treatment Period|Physician Decision|16|||
163889942|NCT01828099|591969122|FG000|Treatment Period|Progressive disease|99|||
163889943|NCT01828099|591969123|FG001|Treatment Period|Progressive disease|107|||
163889944|NCT01828099|591969122|FG000|Treatment Period|Subject/guardian decision|22|||
163889945|NCT01828099|591969123|FG001|Treatment Period|Subject/guardian decision|26|||
163889946|NCT01828099|591969122|FG000|Treatment Period|Study terminated by Sponsor|13|||
163889947|NCT01828099|591969123|FG001|Treatment Period|Study terminated by Sponsor|1|||
163889948|NCT01828099|591969122|FG000|Treatment Period|Protocol deviation|1|||
163889949|NCT01828099|591969123|FG001|Treatment Period|Protocol deviation|0|||
163889950|NCT01828099|591969122|FG000|Treatment Period|No longer requires treatment|0|||
163889951|NCT01828099|591969123|FG001|Treatment Period|No longer requires treatment|1|||
163889952|NCT01828099|591969122|FG000|Extension-treatment Phase|Adverse Event|0|||
163889953|NCT01828099|591969123|FG001|Extension-treatment Phase|Adverse Event|17|||
163889954|NCT01828099|591969122|FG000|Extension-treatment Phase|Death|0|||
163889955|NCT01828099|591969123|FG001|Extension-treatment Phase|Death|11|||
163889956|NCT01828099|591969122|FG000|Extension-treatment Phase|Physician Decision|0|||
163889957|NCT01828099|591969123|FG001|Extension-treatment Phase|Physician Decision|5|||
163889958|NCT01828099|591969122|FG000|Extension-treatment Phase|Progressive disease|0|||
163889959|NCT01828099|591969123|FG001|Extension-treatment Phase|Progressive disease|54|||
163889960|NCT01828099|591969122|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
163889961|NCT01828099|591969123|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
163889962|NCT01828099|591969122|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
163889963|NCT01828099|591969123|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
163889964|NCT06473662|591969126|FG000|Overall Study|Withdrawal by Subject|1|||
163889965|NCT06473662|591969127|FG001|Overall Study|Withdrawal by Subject|6|||
163889966|NCT06473662|591969128|FG002|Overall Study|Withdrawal by Subject|5|||
163889967|NCT06473662|591969126|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
163889968|NCT06473662|591969127|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
163889969|NCT06473662|591969128|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
163889970|NCT06473662|591969126|FG000|Overall Study|Starting HbA1c below 7%|0|||
163889971|NCT06473662|591969127|FG001|Overall Study|Starting HbA1c below 7%|1|||
163889972|NCT06473662|591969128|FG002|Overall Study|Starting HbA1c below 7%|1|||
163889973|NCT06473662|591969126|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
163889974|NCT06473662|591969127|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
163889975|NCT06473662|591969128|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
163889976|NCT06473662|591969126|FG000|Overall Study|Did not take medication|2|||
163889977|NCT06473662|591969127|FG001|Overall Study|Did not take medication|3|||
163889978|NCT06473662|591969128|FG002|Overall Study|Did not take medication|2|||
163889979|NCT04471246|591969133|FG000|Overall Study|Lost to Follow-up|2|||
163889980|NCT04471246|591969134|FG001|Overall Study|Lost to Follow-up|2|||
163889981|NCT04826471|591969135|FG000|Overall Study|Lost to Follow-up|2|||
163889982|NCT04826471|591969135|FG000|Overall Study|Protocol Violation|3|||
163889983|NCT04826471|591969135|FG000|Overall Study|Withdrawal by Subject|1|||
163889984|NCT05764525|591969136|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
163889985|NCT05764525|591969137|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
163889986|NCT05764525|591969136|FG000|Overall Study|Withdrawal by Subject|4|||
163889987|NCT05764525|591969137|FG001|Overall Study|Withdrawal by Subject|8|||
163889988|NCT05764525|591969136|FG000|Overall Study|Physician Decision|1|||
163889989|NCT05764525|591969137|FG001|Overall Study|Physician Decision|0|||
163889990|NCT04079218|591969138|FG000|Overall Study|Death|1|||
163889991|NCT04079218|591969139|FG001|Overall Study|Death|0|||
163889992|NCT04079218|591969138|FG000|Overall Study|Withdrawal by Subject|3|||
163889993|NCT04079218|591969139|FG001|Overall Study|Withdrawal by Subject|0|||
163889994|NCT04079218|591969138|FG000|Overall Study|Physician Decision|4|||
163889995|NCT04079218|591969139|FG001|Overall Study|Physician Decision|0|||
163889996|NCT04079218|591969138|FG000|Overall Study|Lost to Follow-up|0|||
163889997|NCT04079218|591969139|FG001|Overall Study|Lost to Follow-up|1|||
163889998|NCT03910478|591969147|FG000|Overall Study|Death|13|||
163889999|NCT03910478|591969148|FG001|Overall Study|Death|6|||
164264840|NCT00461305|593338770|FG000|Continued Treatment|Lost to Follow-up|4|||
164264841|NCT00461305|593338771|FG001|Continued Treatment|Lost to Follow-up|0|||
164264842|NCT00461305|593338770|FG000|Continued Treatment|Protocol Violation|13|||
164264843|NCT00461305|593338771|FG001|Continued Treatment|Protocol Violation|0|||
164264844|NCT00461305|593338770|FG000|Continued Treatment|Withdrawal by Subject|48|||
164264845|NCT00461305|593338771|FG001|Continued Treatment|Withdrawal by Subject|0|||
164264846|NCT00461305|593338770|FG000|Continued Treatment|Partially missing diary|2|||
164264847|NCT00461305|593338771|FG001|Continued Treatment|Partially missing diary|0|||
164264848|NCT00461305|593338770|FG000|Continued Treatment|Other (missing drug etc)|2|||
164264849|NCT00461305|593338771|FG001|Continued Treatment|Other (missing drug etc)|0|||
164264850|NCT02513823|593338772|FG000|Overall Study|Lost to Follow-up|4|||
164264851|NCT02513823|593338772|FG000|Overall Study|Physician Decision|1|||
164264852|NCT02743780|593338773|FG000|Part 3 (7 Days)|Adverse Event|0|||
164264853|NCT02743780|593338774|FG001|Part 3 (7 Days)|Adverse Event|0|||
164264854|NCT02743780|593338775|FG002|Part 3 (7 Days)|Adverse Event|1|||
163890000|NCT03910478|591969147|FG000|Overall Study|Withdrawal by Subject|23|||
163890001|NCT03910478|591969148|FG001|Overall Study|Withdrawal by Subject|2|||
163890002|NCT03910478|591969147|FG000|Overall Study|Physician Decision|5|||
163890003|NCT03910478|591969148|FG001|Overall Study|Physician Decision|0|||
163890004|NCT03910478|591969147|FG000|Overall Study|Protocol Violation|1|||
163890005|NCT03910478|591969148|FG001|Overall Study|Protocol Violation|0|||
163890006|NCT03910478|591969147|FG000|Overall Study|Failure to meet continuation criteria|2|||
164142371|NCT00182325|592882692|FG000|Overall Study|Lost to Follow-up|7|||
163995270|NCT00896532|592347972|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995271|NCT00896532|592347973|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995272|NCT00896532|592347974|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995273|NCT00896532|592347975|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995274|NCT00896532|592347976|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995275|NCT00896532|592347977|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
163995276|NCT00896532|592347978|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
163995277|NCT00896532|592347979|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
163995278|NCT00896532|592347980|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995279|NCT00896532|592347981|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995280|NCT00896532|592347982|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995281|NCT00896532|592347983|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995282|NCT00896532|592347984|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
163995283|NCT00896532|592347962|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995284|NCT00896532|592347963|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995285|NCT00896532|592347964|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995286|NCT00896532|592347965|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995287|NCT00896532|592347966|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995288|NCT00896532|592347967|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995289|NCT00896532|592347968|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995290|NCT00896532|592347969|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995291|NCT00896532|592347970|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995292|NCT00896532|592347971|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995293|NCT00896532|592347972|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995294|NCT00896532|592347973|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995295|NCT00896532|592347974|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995296|NCT00896532|592347975|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995297|NCT00896532|592347976|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995298|NCT00896532|592347977|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995299|NCT00896532|592347978|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
163995300|NCT00896532|592347979|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995301|NCT00896532|592347980|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995302|NCT00896532|592347981|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995303|NCT00896532|592347982|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995304|NCT00896532|592347983|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995305|NCT00896532|592347984|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
163995306|NCT00896532|592347962|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
163995307|NCT00896532|592347963|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
163995308|NCT00896532|592347964|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
163995309|NCT00896532|592347965|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
163995310|NCT00896532|592347966|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
163995311|NCT00896532|592347967|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
163995312|NCT00896532|592347968|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
163995313|NCT00896532|592347969|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
163995314|NCT00896532|592347970|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
163995315|NCT00896532|592347971|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
163995316|NCT00896532|592347972|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
163995317|NCT00896532|592347973|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
163995318|NCT00896532|592347974|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
163995319|NCT00896532|592347975|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
163995320|NCT00896532|592347976|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
163995321|NCT00896532|592347977|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
163995322|NCT00896532|592347978|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
163995323|NCT00896532|592347979|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
163995324|NCT00896532|592347980|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
163995325|NCT00896532|592347981|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
163995326|NCT00896532|592347982|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
163995327|NCT00896532|592347983|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
163995328|NCT00896532|592347984|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
163995329|NCT00896532|592347962|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995330|NCT00896532|592347963|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995331|NCT00896532|592347964|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995332|NCT00896532|592347965|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995333|NCT00896532|592347966|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995334|NCT00896532|592347967|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995335|NCT00896532|592347968|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995336|NCT00896532|592347969|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995337|NCT00896532|592347970|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995338|NCT00896532|592347971|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995339|NCT00896532|592347972|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995340|NCT00896532|592347973|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995341|NCT00896532|592347974|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995342|NCT00896532|592347975|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995343|NCT00896532|592347976|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995344|NCT00896532|592347977|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995345|NCT00896532|592347978|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
163995346|NCT00896532|592347979|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995347|NCT00896532|592347980|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995348|NCT00896532|592347981|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995349|NCT00896532|592347982|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995350|NCT00896532|592347983|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
163995351|NCT00896532|592347984|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
164341373|NCT00064337|593625338|FG000|Maintenance|Adverse Event|3|||
164341374|NCT00064337|593625338|FG000|Maintenance|Progression|2|||
164341375|NCT00064337|593625338|FG000|Maintenance|On treatment at time of analysis|2|||
164341376|NCT00064337|593625338|FG000|Maintenance|Not protocol-specified|2|||
164341377|NCT00064337|593625338|FG000|Maintenance|Death|1|||
164341378|NCT02279420|593625339|FG000|Overall Study|Lost to Follow-up|23|||
164341379|NCT03535844|593625342|FG000|Overall Study|Withdrawal by Subject|0|||
164341380|NCT03535844|593625343|FG001|Overall Study|Withdrawal by Subject|1|||
164341381|NCT00612040|593625344|FG000|Overall Study|Adverse Event|0|||
164341382|NCT00612040|593625345|FG001|Overall Study|Adverse Event|2|||
164341383|NCT00612040|593625346|FG002|Overall Study|Adverse Event|1|||
164341384|NCT00612040|593625344|FG000|Overall Study|Protocol Violation|1|||
164341385|NCT00612040|593625345|FG001|Overall Study|Protocol Violation|2|||
164341386|NCT00612040|593625346|FG002|Overall Study|Protocol Violation|1|||
164341387|NCT00612040|593625344|FG000|Overall Study|Lack of Efficacy|2|||
164341388|NCT00612040|593625345|FG001|Overall Study|Lack of Efficacy|1|||
164341389|NCT00612040|593625346|FG002|Overall Study|Lack of Efficacy|0|||
164341390|NCT00612040|593625344|FG000|Overall Study|Unclassified|2|||
164341391|NCT00612040|593625345|FG001|Overall Study|Unclassified|2|||
164341392|NCT00612040|593625346|FG002|Overall Study|Unclassified|5|||
164341393|NCT00297830|593625347|FG000|6 Month Visit|Death|1|||
164341394|NCT00297830|593625348|FG001|6 Month Visit|Death|0|||
164341395|NCT00297830|593625349|FG002|6 Month Visit|Death|2|||
164341396|NCT00297830|593625347|FG000|6 Month Visit|Withdrawal by Subject|2|||
164341397|NCT00297830|593625348|FG001|6 Month Visit|Withdrawal by Subject|1|||
163995352|NCT00896532|592347962|FG000|Months 48-72: Follow-on Phase|Death|0|||
163995353|NCT00896532|592347963|FG001|Months 48-72: Follow-on Phase|Death|0|||
163995354|NCT00896532|592347964|FG002|Months 48-72: Follow-on Phase|Death|0|||
164341398|NCT00297830|593625349|FG002|6 Month Visit|Withdrawal by Subject|1|||
164341399|NCT00297830|593625347|FG000|6 Month Visit|Adverse Event|0|||
164341400|NCT00297830|593625348|FG001|6 Month Visit|Adverse Event|1|||
164341401|NCT00297830|593625349|FG002|6 Month Visit|Adverse Event|0|||
164341402|NCT00297830|593625347|FG000|12 Month Visit|Lost to Follow-up|1|||
164341403|NCT00297830|593625348|FG001|12 Month Visit|Lost to Follow-up|0|||
164341404|NCT00297830|593625349|FG002|12 Month Visit|Lost to Follow-up|0|||
164341405|NCT00297830|593625347|FG000|12 Month Visit|Adverse Event|0|||
163995355|NCT00896532|592347965|FG003|Months 48-72: Follow-on Phase|Death|0|||
163995356|NCT00896532|592347966|FG004|Months 48-72: Follow-on Phase|Death|0|||
163995357|NCT00896532|592347967|FG005|Months 48-72: Follow-on Phase|Death|0|||
163995358|NCT00896532|592347968|FG006|Months 48-72: Follow-on Phase|Death|0|||
163995359|NCT00896532|592347969|FG007|Months 48-72: Follow-on Phase|Death|0|||
163995360|NCT00896532|592347970|FG008|Months 48-72: Follow-on Phase|Death|0|||
163995361|NCT00896532|592347971|FG009|Months 48-72: Follow-on Phase|Death|0|||
163995362|NCT00896532|592347972|FG010|Months 48-72: Follow-on Phase|Death|0|||
163995363|NCT00896532|592347973|FG011|Months 48-72: Follow-on Phase|Death|0|||
163995364|NCT00896532|592347974|FG012|Months 48-72: Follow-on Phase|Death|0|||
163995365|NCT00896532|592347975|FG013|Months 48-72: Follow-on Phase|Death|0|||
163995366|NCT00896532|592347976|FG014|Months 48-72: Follow-on Phase|Death|0|||
163995367|NCT00896532|592347977|FG015|Months 48-72: Follow-on Phase|Death|0|||
163995368|NCT00896532|592347978|FG016|Months 48-72: Follow-on Phase|Death|0|||
163995369|NCT00896532|592347979|FG017|Months 48-72: Follow-on Phase|Death|0|||
163995370|NCT00896532|592347980|FG018|Months 48-72: Follow-on Phase|Death|1|||
163995371|NCT00896532|592347981|FG019|Months 48-72: Follow-on Phase|Death|0|||
163995372|NCT00896532|592347982|FG020|Months 48-72: Follow-on Phase|Death|0|||
163995373|NCT00896532|592347983|FG021|Months 48-72: Follow-on Phase|Death|0|||
163995374|NCT00896532|592347984|FG022|Months 48-72: Follow-on Phase|Death|0|||
163995375|NCT00896532|592347962|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995376|NCT00896532|592347963|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995377|NCT00896532|592347964|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995378|NCT00896532|592347965|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995379|NCT00896532|592347966|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995380|NCT00896532|592347967|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995381|NCT00896532|592347968|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995382|NCT00896532|592347969|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995383|NCT00896532|592347970|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995384|NCT00896532|592347971|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995385|NCT00896532|592347972|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995386|NCT00896532|592347973|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995387|NCT00896532|592347974|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995388|NCT00896532|592347975|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995389|NCT00896532|592347976|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995390|NCT00896532|592347977|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164264855|NCT02743780|593338776|FG003|Part 3 (7 Days)|Adverse Event|0|||
164264856|NCT02743780|593338777|FG004|Part 3 (7 Days)|Adverse Event|0|||
164264857|NCT01294462|593338778|FG000|Overall Study|Lost to Follow-up|1|||
164264858|NCT01294462|593338779|FG001|Overall Study|Lost to Follow-up|0|||
164264859|NCT01294462|593338778|FG000|Overall Study|Withdrawal by Subject|65|||
164264860|NCT01294462|593338779|FG001|Overall Study|Withdrawal by Subject|63|||
164264861|NCT04342689|593338783|FG000|Overall Study|Withdrawal by Subject|32|||
164264862|NCT04342689|593338784|FG001|Overall Study|Withdrawal by Subject|33|||
164264863|NCT04342689|593338783|FG000|Overall Study|Lost to Follow-up|10|||
164264864|NCT04342689|593338784|FG001|Overall Study|Lost to Follow-up|12|||
164264865|NCT01460407|593338785|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
164264866|NCT01460407|593338786|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
164264867|NCT00844805|593338788|FG000|Treatment Phase|Adverse Event|5|||
164264868|NCT00844805|593338789|FG001|Treatment Phase|Adverse Event|1|||
164264869|NCT00844805|593338790|FG002|Treatment Phase|Adverse Event|0|||
164264870|NCT00844805|593338791|FG003|Treatment Phase|Adverse Event|0|||
164264871|NCT00844805|593338788|FG000|Treatment Phase|Withdrawal by Subject|3|||
164264872|NCT00844805|593338789|FG001|Treatment Phase|Withdrawal by Subject|4|||
164264873|NCT00844805|593338790|FG002|Treatment Phase|Withdrawal by Subject|0|||
164264874|NCT00844805|593338791|FG003|Treatment Phase|Withdrawal by Subject|0|||
164264875|NCT00844805|593338788|FG000|Treatment Phase|Noncompliance With Protocol|1|||
164264876|NCT00844805|593338789|FG001|Treatment Phase|Noncompliance With Protocol|0|||
164264877|NCT00844805|593338790|FG002|Treatment Phase|Noncompliance With Protocol|0|||
163995391|NCT00896532|592347978|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995392|NCT00896532|592347979|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164264878|NCT00844805|593338791|FG003|Treatment Phase|Noncompliance With Protocol|0|||
164264879|NCT00844805|593338788|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
164264880|NCT00844805|593338789|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
164264881|NCT00844805|593338790|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
164264882|NCT00844805|593338791|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
164264883|NCT00844805|593338788|FG000|Follow-Up Phase|Adverse Event|0|||
164264884|NCT00844805|593338789|FG001|Follow-Up Phase|Adverse Event|0|||
164264885|NCT00844805|593338790|FG002|Follow-Up Phase|Adverse Event|1|||
163995393|NCT00896532|592347980|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995394|NCT00896532|592347981|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164264886|NCT00844805|593338791|FG003|Follow-Up Phase|Adverse Event|0|||
164264887|NCT00844805|593338788|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
164264888|NCT00844805|593338789|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
163890007|NCT03910478|591969148|FG001|Overall Study|Failure to meet continuation criteria|0|||
163890008|NCT03910478|591969147|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
163890009|NCT03910478|591969148|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
163890010|NCT05293171|591969149|FG000|Washout 5 to 7 Days|Adverse Event|1|||
164264889|NCT00844805|593338790|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
164264890|NCT00844805|593338791|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
164264891|NCT00844805|593338788|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
164264892|NCT00844805|593338789|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
164264893|NCT00844805|593338790|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
164264894|NCT00844805|593338791|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
164264895|NCT00844805|593338788|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
164264896|NCT00844805|593338789|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
164264897|NCT00844805|593338790|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
163890011|NCT05293171|591969150|FG001|Washout 5 to 7 Days|Adverse Event|1|||
163890012|NCT05293171|591969151|FG002|Washout 5 to 7 Days|Adverse Event|0|||
163890013|NCT05293171|591969152|FG003|Washout 5 to 7 Days|Adverse Event|0|||
163890014|NCT05293171|591969153|FG004|Washout 5 to 7 Days|Adverse Event|0|||
163890015|NCT05293171|591969154|FG005|Washout 5 to 7 Days|Adverse Event|0|||
163890016|NCT05293171|591969155|FG006|Washout 5 to 7 Days|Adverse Event|0|||
163890017|NCT05293171|591969156|FG007|Washout 5 to 7 Days|Adverse Event|0|||
163890018|NCT05293171|591969157|FG008|Washout 5 to 7 Days|Adverse Event|0|||
163890019|NCT05293171|591969158|FG009|Washout 5 to 7 Days|Adverse Event|0|||
163890020|NCT05293171|591969159|FG010|Washout 5 to 7 Days|Adverse Event|0|||
163890021|NCT05293171|591969160|FG011|Washout 5 to 7 Days|Adverse Event|0|||
163890022|NCT05293171|591969149|FG000|Washout 5 to 7 Days|Adverse Event|0|||
163890023|NCT05293171|591969150|FG001|Washout 5 to 7 Days|Adverse Event|0|||
163890024|NCT05293171|591969151|FG002|Washout 5 to 7 Days|Adverse Event|0|||
163890025|NCT05293171|591969152|FG003|Washout 5 to 7 Days|Adverse Event|0|||
163890026|NCT05293171|591969153|FG004|Washout 5 to 7 Days|Adverse Event|0|||
163890027|NCT05293171|591969154|FG005|Washout 5 to 7 Days|Adverse Event|1|||
163890028|NCT05293171|591969155|FG006|Washout 5 to 7 Days|Adverse Event|0|||
163890029|NCT05293171|591969156|FG007|Washout 5 to 7 Days|Adverse Event|0|||
163890030|NCT05293171|591969157|FG008|Washout 5 to 7 Days|Adverse Event|0|||
163890031|NCT05293171|591969158|FG009|Washout 5 to 7 Days|Adverse Event|0|||
163890032|NCT05293171|591969159|FG010|Washout 5 to 7 Days|Adverse Event|0|||
163890033|NCT05293171|591969160|FG011|Washout 5 to 7 Days|Adverse Event|0|||
163890034|NCT04066205|591969161|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
163890035|NCT04066205|591969162|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
163890036|NCT04066205|591969161|FG000|T2 Immediate Post-Intervention|did not respond|5|||
163890037|NCT04066205|591969162|FG001|T2 Immediate Post-Intervention|did not respond|3|||
163890038|NCT02052882|591969163|FG000|Overall Study|Not treated|11|||
163890039|NCT02052882|591969163|FG000|Overall Study|Protocol Violation|1|||
163890040|NCT02052882|591969163|FG000|Overall Study|Inadequate testing|1|||
163890041|NCT03734679|591969169|FG000|Overall Study|Missed Visit|1|||
163890042|NCT05218096|591969175|FG000|Primary Evaluation|Withdrawal by Subject|0|||
163890043|NCT05218096|591969176|FG001|Primary Evaluation|Withdrawal by Subject|0|||
163890044|NCT05218096|591969177|FG002|Primary Evaluation|Withdrawal by Subject|2|||
163890045|NCT05218096|591969178|FG003|Primary Evaluation|Withdrawal by Subject|0|||
163890046|NCT05218096|591969179|FG004|Primary Evaluation|Withdrawal by Subject|0|||
163890047|NCT05218096|591969175|FG000|Primary Evaluation|Physician Decision|1|||
163890048|NCT05218096|591969176|FG001|Primary Evaluation|Physician Decision|0|||
163890049|NCT05218096|591969177|FG002|Primary Evaluation|Physician Decision|0|||
163890050|NCT05218096|591969178|FG003|Primary Evaluation|Physician Decision|0|||
163890051|NCT05218096|591969179|FG004|Primary Evaluation|Physician Decision|0|||
163890052|NCT05218096|591969175|FG000|Extended Treatment|Clinical Deterioration|1|||
163890053|NCT05218096|591969176|FG001|Extended Treatment|Clinical Deterioration|1|||
163890054|NCT05218096|591969177|FG002|Extended Treatment|Clinical Deterioration|0|||
163890055|NCT05218096|591969178|FG003|Extended Treatment|Clinical Deterioration|0|||
163995395|NCT00896532|592347982|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
164264898|NCT00844805|593338791|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
164341406|NCT00297830|593625348|FG001|12 Month Visit|Adverse Event|3|||
164341407|NCT00297830|593625349|FG002|12 Month Visit|Adverse Event|0|||
164341408|NCT00297830|593625347|FG000|12 Month Visit|Withdrawal by Subject|0|||
164341409|NCT00297830|593625348|FG001|12 Month Visit|Withdrawal by Subject|3|||
163890056|NCT05218096|591969179|FG004|Extended Treatment|Clinical Deterioration|0|||
163890057|NCT05218096|591969175|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
163890058|NCT05218096|591969176|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
163890059|NCT05218096|591969177|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
163890060|NCT05218096|591969178|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
163890061|NCT05218096|591969179|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
163890062|NCT05218096|591969175|FG000|Extended Treatment|Withdrawal by Subject|1|||
163890063|NCT05218096|591969176|FG001|Extended Treatment|Withdrawal by Subject|3|||
164264899|NCT00844805|593338788|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
164341410|NCT00297830|593625349|FG002|12 Month Visit|Withdrawal by Subject|0|||
163995396|NCT00896532|592347983|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
163995397|NCT00896532|592347984|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
163995398|NCT00896532|592347962|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995399|NCT00896532|592347963|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995400|NCT00896532|592347964|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995401|NCT00896532|592347965|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995402|NCT00896532|592347966|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995403|NCT00896532|592347967|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995404|NCT00896532|592347968|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995405|NCT00896532|592347969|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995406|NCT00896532|592347970|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995407|NCT00896532|592347971|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995408|NCT00896532|592347972|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995409|NCT00896532|592347973|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995410|NCT00896532|592347974|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995411|NCT00896532|592347975|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995412|NCT00896532|592347976|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995413|NCT00896532|592347977|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995414|NCT00896532|592347978|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995415|NCT00896532|592347979|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995416|NCT00896532|592347980|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995417|NCT00896532|592347981|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995418|NCT00896532|592347982|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
164264900|NCT00844805|593338789|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
164264901|NCT00844805|593338790|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
163995419|NCT00896532|592347983|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
163995420|NCT00896532|592347984|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
163995421|NCT01176916|592347985|FG000|Overall Study|Adverse Event|61|||
163995422|NCT01176916|592347985|FG000|Overall Study|Death|1|||
163995423|NCT01176916|592347985|FG000|Overall Study|Lost to Follow-up|15|||
163995424|NCT01176916|592347985|FG000|Overall Study|Objective progression or relapse|17|||
163995425|NCT01176916|592347985|FG000|Overall Study|Protocol Violation|24|||
163995426|NCT01176916|592347985|FG000|Overall Study|Withdrawal by Subject|37|||
163995427|NCT01176916|592347985|FG000|Overall Study|Other|6|||
163995428|NCT01176916|592347985|FG000|Overall Study|Withdrawal prior to Treatment|6|||
163995429|NCT03158220|592347988|FG000|Overall Study|Screen Failure|0|||
163995430|NCT03158220|592347989|FG001|Overall Study|Screen Failure|1|||
163995431|NCT03158220|592347988|FG000|Overall Study|Withdrawal by Subject|8|||
163995432|NCT03158220|592347989|FG001|Overall Study|Withdrawal by Subject|9|||
163995433|NCT03158220|592347988|FG000|Overall Study|Status unknown|0|||
163995434|NCT03158220|592347989|FG001|Overall Study|Status unknown|1|||
163995435|NCT03158220|592347988|FG000|Overall Study|Lost to Follow-up|8|||
163995436|NCT03158220|592347989|FG001|Overall Study|Lost to Follow-up|5|||
163995437|NCT03158220|592347988|FG000|Overall Study|Physician Decision|1|||
163995438|NCT03158220|592347989|FG001|Overall Study|Physician Decision|0|||
163995439|NCT01671280|592347990|FG000|Overall Study|Withdrawal by Subject|2|||
163995440|NCT00996203|592347991|FG000|Overall Study|Adverse Event|3|||
163995441|NCT00996203|592347991|FG000|Overall Study|Lost to Follow-up|1|||
163995442|NCT00996203|592347991|FG000|Overall Study|Lack of Efficacy|1|||
163995443|NCT00996203|592347991|FG000|Overall Study|Protocol Violation|2|||
163995444|NCT01959165|592347992|FG000|Overall Study|Adverse Event|0|||
163995445|NCT01959165|592347993|FG001|Overall Study|Adverse Event|0|||
163995446|NCT01959165|592347994|FG002|Overall Study|Adverse Event|0|||
163995447|NCT01959165|592347995|FG003|Overall Study|Adverse Event|1|||
163995448|NCT01959165|592347992|FG000|Overall Study|Lack of Efficacy|1|||
163995449|NCT01959165|592347993|FG001|Overall Study|Lack of Efficacy|0|||
163995450|NCT01959165|592347994|FG002|Overall Study|Lack of Efficacy|0|||
164142372|NCT00182325|592882693|FG001|Overall Study|Lost to Follow-up|7|||
164264902|NCT00844805|593338791|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
164264903|NCT00259298|593338792|FG000|Overall Study|Withdrawal by Subject|1|||
164264904|NCT00259298|593338792|FG000|Overall Study|Physician Decision|2|||
164264905|NCT01011933|593338796|FG000|Overall Study|Wrong cell type|1|||
164264906|NCT01011933|593338796|FG000|Overall Study|Improper pre-protocol Rx|1|||
164264907|NCT01011933|593338796|FG000|Overall Study|Inadequate pathology|1|||
164264908|NCT01011933|593338796|FG000|Overall Study|Never treated|1|||
164264909|NCT00475865|593338798|FG000|Overall Study|Adverse Event|0|||
164264910|NCT00475865|593338799|FG001|Overall Study|Adverse Event|3|||
164264911|NCT00475865|593338800|FG002|Overall Study|Adverse Event|4|||
164264912|NCT00475865|593338798|FG000|Overall Study|Lack of Efficacy|1|||
164341411|NCT02835820|593625350|FG000|Overall Study|Baseline Screen Failure|0|||
164341412|NCT02835820|593625351|FG001|Overall Study|Baseline Screen Failure|3|||
163995451|NCT01959165|592347995|FG003|Overall Study|Lack of Efficacy|0|||
164264913|NCT00475865|593338799|FG001|Overall Study|Lack of Efficacy|0|||
164341413|NCT00827502|593625352|FG000|Overall Study|randomized but not treated|11|||
164085652|NCT02717611|592677286|FG000|Overall Study|Complicating disease|1|||
164085653|NCT00616928|592677289|FG000|Overall Study|Adverse Event|6|||
164085654|NCT00616928|592677290|FG001|Overall Study|Adverse Event|3|||
164085655|NCT00616928|592677291|FG002|Overall Study|Adverse Event|2|||
164264914|NCT00475865|593338800|FG002|Overall Study|Lack of Efficacy|0|||
164264915|NCT00475865|593338798|FG000|Overall Study|Progressive disease|0|||
164264916|NCT00475865|593338799|FG001|Overall Study|Progressive disease|1|||
164264917|NCT00475865|593338800|FG002|Overall Study|Progressive disease|2|||
164264918|NCT00475865|593338798|FG000|Overall Study|Participant did not wish to continue|1|||
164264919|NCT00475865|593338799|FG001|Overall Study|Participant did not wish to continue|0|||
164264920|NCT00475865|593338800|FG002|Overall Study|Participant did not wish to continue|0|||
164264921|NCT00475865|593338798|FG000|Overall Study|Other than above|0|||
164264922|NCT00475865|593338799|FG001|Overall Study|Other than above|1|||
164264923|NCT00475865|593338800|FG002|Overall Study|Other than above|0|||
164341414|NCT00827502|593625352|FG000|Overall Study|Adverse Event|1|||
164341415|NCT00827502|593625352|FG000|Overall Study|Lost to Follow-up|4|||
164341416|NCT00827502|593625352|FG000|Overall Study|Withdrawal by Subject|5|||
163890064|NCT05218096|591969177|FG002|Extended Treatment|Withdrawal by Subject|0|||
163890065|NCT05218096|591969178|FG003|Extended Treatment|Withdrawal by Subject|2|||
163890066|NCT05218096|591969179|FG004|Extended Treatment|Withdrawal by Subject|2|||
163890067|NCT05218096|591969175|FG000|Extended Treatment|Lack of Efficacy|3|||
163890068|NCT05218096|591969176|FG001|Extended Treatment|Lack of Efficacy|0|||
163890069|NCT05218096|591969177|FG002|Extended Treatment|Lack of Efficacy|0|||
163890070|NCT05218096|591969178|FG003|Extended Treatment|Lack of Efficacy|0|||
163890071|NCT05218096|591969179|FG004|Extended Treatment|Lack of Efficacy|0|||
163890072|NCT05218096|591969175|FG000|Extended Treatment|Physician Decision|0|||
163890073|NCT05218096|591969176|FG001|Extended Treatment|Physician Decision|1|||
163890074|NCT05218096|591969177|FG002|Extended Treatment|Physician Decision|0|||
163890075|NCT05218096|591969178|FG003|Extended Treatment|Physician Decision|0|||
163890076|NCT05218096|591969179|FG004|Extended Treatment|Physician Decision|0|||
163890077|NCT05218096|591969175|FG000|Open-label Extension|Adverse Event|1|||
163890078|NCT05218096|591969176|FG001|Open-label Extension|Adverse Event|0|||
163890079|NCT05218096|591969177|FG002|Open-label Extension|Adverse Event|0|||
163890080|NCT05218096|591969178|FG003|Open-label Extension|Adverse Event|0|||
163890081|NCT05218096|591969179|FG004|Open-label Extension|Adverse Event|1|||
163890082|NCT05218096|591969175|FG000|Open-label Extension|Pregnancy|0|||
163890083|NCT05218096|591969176|FG001|Open-label Extension|Pregnancy|0|||
163890084|NCT05218096|591969177|FG002|Open-label Extension|Pregnancy|0|||
163890085|NCT05218096|591969178|FG003|Open-label Extension|Pregnancy|0|||
163890086|NCT05218096|591969179|FG004|Open-label Extension|Pregnancy|1|||
163890087|NCT05218096|591969175|FG000|Open-label Extension|Lack of Efficacy|1|||
163890088|NCT05218096|591969176|FG001|Open-label Extension|Lack of Efficacy|2|||
163890089|NCT05218096|591969177|FG002|Open-label Extension|Lack of Efficacy|0|||
163890090|NCT05218096|591969178|FG003|Open-label Extension|Lack of Efficacy|0|||
163890091|NCT05218096|591969179|FG004|Open-label Extension|Lack of Efficacy|0|||
163890092|NCT05218096|591969175|FG000|Open-label Extension|Lost to Follow-up|1|||
163890093|NCT05218096|591969176|FG001|Open-label Extension|Lost to Follow-up|0|||
163890094|NCT05218096|591969177|FG002|Open-label Extension|Lost to Follow-up|0|||
163890095|NCT05218096|591969178|FG003|Open-label Extension|Lost to Follow-up|0|||
163890096|NCT05218096|591969179|FG004|Open-label Extension|Lost to Follow-up|0|||
163890097|NCT05218096|591969175|FG000|Open-label Extension|Death|0|||
163890098|NCT05218096|591969176|FG001|Open-label Extension|Death|0|||
163890099|NCT05218096|591969177|FG002|Open-label Extension|Death|0|||
163890100|NCT05218096|591969178|FG003|Open-label Extension|Death|1|||
163890101|NCT05218096|591969179|FG004|Open-label Extension|Death|0|||
163890102|NCT05218096|591969175|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
163890103|NCT05218096|591969176|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
163890104|NCT05218096|591969177|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
163890105|NCT05218096|591969178|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
163890106|NCT05218096|591969179|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
163890107|NCT04032847|591969194|FG000|Overall Study|Study termination by sponsor|8|||
163890108|NCT04032847|591969195|FG001|Overall Study|Study termination by sponsor|0|||
163890109|NCT04032847|591969196|FG002|Overall Study|Study termination by sponsor|4|||
163890110|NCT04032847|591969194|FG000|Overall Study|Death|12|||
163890111|NCT04032847|591969195|FG001|Overall Study|Death|0|||
163890112|NCT04032847|591969196|FG002|Overall Study|Death|0|||
163890113|NCT04032847|591969194|FG000|Overall Study|Progressive disease|2|||
163890114|NCT04032847|591969195|FG001|Overall Study|Progressive disease|0|||
163890115|NCT04032847|591969196|FG002|Overall Study|Progressive disease|1|||
163890116|NCT03056573|591969197|FG000|Overall Study|Death|2|||
163890117|NCT03056573|591969198|FG001|Overall Study|Death|4|||
163890118|NCT03056573|591969197|FG000|Overall Study|Withdrawal by Subject|2|||
163890119|NCT03056573|591969198|FG001|Overall Study|Withdrawal by Subject|0|||
163890120|NCT03056573|591969197|FG000|Overall Study|Lost to Follow-up|1|||
163890121|NCT03056573|591969198|FG001|Overall Study|Lost to Follow-up|1|||
163890122|NCT03697876|591969199|FG000|Overall Study|Lost to Follow-up|0|||
164264924|NCT02726880|593338801|FG000|Overall Study|Withdrawal by Subject|2|||
163995452|NCT01959165|592347992|FG000|Overall Study|overdose|0|||
163995453|NCT01959165|592347993|FG001|Overall Study|overdose|0|||
163995454|NCT01959165|592347994|FG002|Overall Study|overdose|0|||
163995455|NCT01959165|592347995|FG003|Overall Study|overdose|1|||
163995456|NCT01959165|592347992|FG000|Overall Study|Welfare recipient|0|||
163995457|NCT01959165|592347993|FG001|Overall Study|Welfare recipient|1|||
163995458|NCT01959165|592347994|FG002|Overall Study|Welfare recipient|0|||
163995459|NCT01959165|592347995|FG003|Overall Study|Welfare recipient|0|||
163995460|NCT03686969|592347996|FG000|Overall Study|Study terminated|1|||
163995461|NCT03686969|592347997|FG001|Overall Study|Study terminated|0|||
163995462|NCT00848120|592347999|FG000|Overall Study|Adverse Event|1|||
164264925|NCT02726880|593338802|FG001|Overall Study|Withdrawal by Subject|0|||
164264926|NCT02726880|593338801|FG000|Overall Study|Lost to Follow-up|1|||
164264927|NCT02726880|593338802|FG001|Overall Study|Lost to Follow-up|3|||
164264928|NCT00787202|593338803|FG000|Overall Study|Adverse Event|3|||
164264929|NCT00787202|593338804|FG001|Overall Study|Adverse Event|2|||
164264930|NCT00787202|593338805|FG002|Overall Study|Adverse Event|0|||
164264931|NCT00787202|593338806|FG003|Overall Study|Adverse Event|0|||
164264932|NCT00787202|593338807|FG004|Overall Study|Adverse Event|2|||
164264933|NCT00787202|593338803|FG000|Overall Study|Lack of Efficacy|5|||
164264934|NCT00787202|593338804|FG001|Overall Study|Lack of Efficacy|6|||
164264935|NCT00787202|593338805|FG002|Overall Study|Lack of Efficacy|5|||
164264936|NCT00787202|593338806|FG003|Overall Study|Lack of Efficacy|2|||
164264937|NCT00787202|593338807|FG004|Overall Study|Lack of Efficacy|1|||
164264938|NCT00787202|593338803|FG000|Overall Study|Lost to Follow-up|1|||
164264939|NCT00787202|593338804|FG001|Overall Study|Lost to Follow-up|0|||
164264940|NCT00787202|593338805|FG002|Overall Study|Lost to Follow-up|0|||
164264941|NCT00787202|593338806|FG003|Overall Study|Lost to Follow-up|0|||
164264942|NCT00787202|593338807|FG004|Overall Study|Lost to Follow-up|0|||
164264943|NCT00787202|593338803|FG000|Overall Study|Withdrawal by Subject|2|||
164264944|NCT00787202|593338804|FG001|Overall Study|Withdrawal by Subject|2|||
164264945|NCT00787202|593338805|FG002|Overall Study|Withdrawal by Subject|2|||
164264946|NCT00787202|593338806|FG003|Overall Study|Withdrawal by Subject|0|||
164264947|NCT00787202|593338807|FG004|Overall Study|Withdrawal by Subject|0|||
164264948|NCT00787202|593338803|FG000|Overall Study|Protocol Violation|2|||
164264949|NCT00787202|593338804|FG001|Overall Study|Protocol Violation|1|||
163995463|NCT01961115|592348003|FG000|Overall Study|Disease Progression|1|||
163995464|NCT01961115|592348004|FG001|Overall Study|Disease Progression|0|||
163995465|NCT01961115|592348005|FG002|Overall Study|Disease Progression|3|||
163995466|NCT01961115|592348003|FG000|Overall Study|Adverse Event|1|||
163995467|NCT01961115|592348004|FG001|Overall Study|Adverse Event|0|||
163995468|NCT01961115|592348005|FG002|Overall Study|Adverse Event|1|||
163995469|NCT02497001|592348006|FG000|Overall Study|Lost to Follow-up|10|||
163995470|NCT02497001|592348007|FG001|Overall Study|Lost to Follow-up|2|||
163995471|NCT02497001|592348008|FG002|Overall Study|Lost to Follow-up|0|||
163995472|NCT02497001|592348009|FG003|Overall Study|Lost to Follow-up|2|||
163995473|NCT02497001|592348006|FG000|Overall Study|Adverse Event|28|||
164264950|NCT00787202|593338805|FG002|Overall Study|Protocol Violation|0|||
164264951|NCT00787202|593338806|FG003|Overall Study|Protocol Violation|0|||
164264952|NCT00787202|593338807|FG004|Overall Study|Protocol Violation|1|||
164264953|NCT00787202|593338803|FG000|Overall Study|Randomized, not treated|1|||
164264954|NCT00787202|593338804|FG001|Overall Study|Randomized, not treated|0|||
164264955|NCT00787202|593338805|FG002|Overall Study|Randomized, not treated|0|||
164264956|NCT00787202|593338806|FG003|Overall Study|Randomized, not treated|0|||
164264957|NCT00787202|593338807|FG004|Overall Study|Randomized, not treated|0|||
164264958|NCT01510145|593338808|FG000|Overall Study|Adverse Event|6|||
164264959|NCT01510145|593338808|FG000|Overall Study|Lost to Follow-up|5|||
164264960|NCT01510145|593338808|FG000|Overall Study|Withdrawal by Subject|6|||
164264961|NCT01510145|593338808|FG000|Overall Study|Relative reported subject withdrew|1|||
164264962|NCT01822535|593338809|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
164264963|NCT01822535|593338810|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
164264964|NCT01822535|593338809|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
164264965|NCT01822535|593338810|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
164264966|NCT01822535|593338809|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
164264967|NCT01822535|593338810|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
164264968|NCT02278614|593338813|FG000|Overall Study|Withdrawal by Subject|3|||
164264969|NCT02278614|593338814|FG001|Overall Study|Withdrawal by Subject|5|||
164264970|NCT02278614|593338813|FG000|Overall Study|Adverse Event|1|||
164264971|NCT02278614|593338814|FG001|Overall Study|Adverse Event|0|||
164264972|NCT02278614|593338813|FG000|Overall Study|left eye was not eligible|1|||
164264973|NCT02278614|593338814|FG001|Overall Study|left eye was not eligible|0|||
164264974|NCT02279498|593338815|FG000|Overall Study|Adverse Event|3|||
164264975|NCT02279498|593338816|FG001|Overall Study|Adverse Event|0|||
164341417|NCT05096221|593625353|FG000|Part 2|Physician Decision|0|||
164341418|NCT05096221|593625354|FG001|Part 2|Physician Decision|1|||
163995474|NCT02497001|592348007|FG001|Overall Study|Adverse Event|30|||
164264976|NCT02279498|593338815|FG000|Overall Study|Lack of Efficacy|4|||
163995475|NCT02497001|592348008|FG002|Overall Study|Adverse Event|11|||
163995476|NCT02497001|592348009|FG003|Overall Study|Adverse Event|11|||
163995477|NCT02497001|592348006|FG000|Overall Study|Withdrawal by Subject|14|||
163995478|NCT02497001|592348007|FG001|Overall Study|Withdrawal by Subject|37|||
163995479|NCT02497001|592348008|FG002|Overall Study|Withdrawal by Subject|19|||
163995480|NCT02497001|592348009|FG003|Overall Study|Withdrawal by Subject|15|||
163995481|NCT02497001|592348006|FG000|Overall Study|Physician Decision|5|||
163995482|NCT02497001|592348007|FG001|Overall Study|Physician Decision|11|||
163995483|NCT02497001|592348008|FG002|Overall Study|Physician Decision|5|||
163995484|NCT02497001|592348009|FG003|Overall Study|Physician Decision|1|||
163995485|NCT02497001|592348006|FG000|Overall Study|subjects that were not treated|1|||
163995486|NCT02497001|592348007|FG001|Overall Study|subjects that were not treated|2|||
163995487|NCT02497001|592348008|FG002|Overall Study|subjects that were not treated|2|||
163995488|NCT02497001|592348009|FG003|Overall Study|subjects that were not treated|1|||
163995489|NCT02497001|592348006|FG000|Overall Study|Major Protocol Deviation|3|||
163995490|NCT02497001|592348007|FG001|Overall Study|Major Protocol Deviation|4|||
163995491|NCT02497001|592348008|FG002|Overall Study|Major Protocol Deviation|4|||
163995492|NCT02497001|592348009|FG003|Overall Study|Major Protocol Deviation|4|||
163995493|NCT02497001|592348006|FG000|Overall Study|Lack of Efficacy|10|||
163995494|NCT02497001|592348007|FG001|Overall Study|Lack of Efficacy|16|||
163995495|NCT02497001|592348008|FG002|Overall Study|Lack of Efficacy|6|||
163995496|NCT02497001|592348009|FG003|Overall Study|Lack of Efficacy|6|||
163995497|NCT02497001|592348006|FG000|Overall Study|Protocol Violation|3|||
163995498|NCT02497001|592348007|FG001|Overall Study|Protocol Violation|1|||
163995499|NCT02497001|592348008|FG002|Overall Study|Protocol Violation|3|||
163995500|NCT02497001|592348009|FG003|Overall Study|Protocol Violation|1|||
163995501|NCT00705263|592348010|FG000|Overall Study|Withdrawal by Subject|2|||
163995502|NCT02899156|592348011|FG000|Overall Study|Death|1|||
163995503|NCT02899156|592348012|FG001|Overall Study|Death|0|||
163995504|NCT02899156|592348011|FG000|Overall Study|Physician Decision|0|||
163995505|NCT02899156|592348012|FG001|Overall Study|Physician Decision|1|||
163995506|NCT01445678|592348014|FG000|Overall Study|Adverse Event|12|||
163995507|NCT01445678|592348015|FG001|Overall Study|Adverse Event|8|||
163995508|NCT01445678|592348014|FG000|Overall Study|Lack of Efficacy|0|||
163995509|NCT01445678|592348015|FG001|Overall Study|Lack of Efficacy|2|||
163995510|NCT01445678|592348014|FG000|Overall Study|Lost to Follow-up|8|||
163995511|NCT01445678|592348015|FG001|Overall Study|Lost to Follow-up|5|||
163995512|NCT01445678|592348014|FG000|Overall Study|Protocol Violation|1|||
163995513|NCT01445678|592348015|FG001|Overall Study|Protocol Violation|1|||
163995514|NCT01445678|592348014|FG000|Overall Study|Withdrawal by Subject|9|||
163995515|NCT01445678|592348015|FG001|Overall Study|Withdrawal by Subject|5|||
163995516|NCT01565980|592348016|FG000|Overall Study|Death|1|||
163995517|NCT01565980|592348017|FG001|Overall Study|Death|0|||
163995518|NCT01565980|592348016|FG000|Overall Study|Lost to Follow-up|1|||
163995519|NCT01565980|592348017|FG001|Overall Study|Lost to Follow-up|0|||
163995520|NCT01565980|592348016|FG000|Overall Study|health complications|1|||
163995521|NCT01565980|592348017|FG001|Overall Study|health complications|1|||
163995522|NCT01565980|592348016|FG000|Overall Study|stopped medical treatment|1|||
163995523|NCT01565980|592348017|FG001|Overall Study|stopped medical treatment|0|||
163995524|NCT01565980|592348016|FG000|Overall Study|Withdrawal by Subject|0|||
163995525|NCT01565980|592348017|FG001|Overall Study|Withdrawal by Subject|3|||
163995526|NCT02078219|592348018|FG000|Overall Study|Other|2|||
163995527|NCT02078219|592348019|FG001|Overall Study|Other|2|||
163995528|NCT02078219|592348020|FG002|Overall Study|Other|3|||
163995529|NCT02078219|592348021|FG003|Overall Study|Other|0|||
163995530|NCT02078219|592348022|FG004|Overall Study|Other|1|||
163995531|NCT02078219|592348018|FG000|Overall Study|Withdrawal by Subject|0|||
163995532|NCT02078219|592348019|FG001|Overall Study|Withdrawal by Subject|1|||
163995533|NCT02078219|592348020|FG002|Overall Study|Withdrawal by Subject|0|||
163995534|NCT02078219|592348021|FG003|Overall Study|Withdrawal by Subject|1|||
163995535|NCT02078219|592348022|FG004|Overall Study|Withdrawal by Subject|1|||
163995536|NCT02078219|592348018|FG000|Overall Study|Protocol Violation|0|||
163995537|NCT02078219|592348019|FG001|Overall Study|Protocol Violation|0|||
163995538|NCT02078219|592348020|FG002|Overall Study|Protocol Violation|0|||
163995539|NCT02078219|592348021|FG003|Overall Study|Protocol Violation|1|||
163995540|NCT02078219|592348022|FG004|Overall Study|Protocol Violation|0|||
163995541|NCT02078219|592348018|FG000|Overall Study|Death|0|||
163995542|NCT02078219|592348019|FG001|Overall Study|Death|0|||
163995543|NCT02078219|592348020|FG002|Overall Study|Death|0|||
163995544|NCT02078219|592348021|FG003|Overall Study|Death|1|||
163995545|NCT02078219|592348022|FG004|Overall Study|Death|0|||
163995546|NCT02078219|592348018|FG000|Overall Study|Adverse Event|1|||
163995547|NCT02078219|592348019|FG001|Overall Study|Adverse Event|1|||
163995548|NCT02078219|592348020|FG002|Overall Study|Adverse Event|3|||
163995549|NCT02078219|592348021|FG003|Overall Study|Adverse Event|1|||
163995550|NCT02078219|592348022|FG004|Overall Study|Adverse Event|0|||
163995551|NCT00891202|592348028|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
163995552|NCT00891202|592348029|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
163995553|NCT00891202|592348030|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
163995554|NCT00891202|592348031|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
163995555|NCT00891202|592348028|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
163995556|NCT00891202|592348029|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
163995557|NCT00891202|592348030|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
163995558|NCT00891202|592348031|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
163995559|NCT00891202|592348028|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
163995560|NCT00891202|592348029|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
163995561|NCT00891202|592348030|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
163995562|NCT00891202|592348031|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
163995563|NCT00891202|592348028|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
163995564|NCT00891202|592348029|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
163995565|NCT00891202|592348030|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
163995566|NCT00891202|592348031|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
163995567|NCT05019131|592349940|FG000|Overall Study|Lost to Follow-up|0|||
163995568|NCT05019131|592349941|FG001|Overall Study|Lost to Follow-up|3|||
163995569|NCT02360098|592349942|FG000|Overall Study|Physician Decision|7|||
163995570|NCT03293654|592349945|FG000|Overall Study|Lost to Follow-up|0|||
163995571|NCT03293654|592349946|FG001|Overall Study|Lost to Follow-up|1|||
163995572|NCT03293654|592349947|FG002|Overall Study|Lost to Follow-up|0|||
163995573|NCT01919307|592349948|FG000|Overall Study|Withdrawal by Subject|9|||
163995574|NCT05052723|592349950|FG000|Overall Study|Death|19|||
163995575|NCT02771522|592349954|FG000|Overall Study|Lost to Follow-up|3|||
163995576|NCT02771522|592349954|FG000|Overall Study|Withdrawal by Subject|2|||
163995577|NCT02771522|592349954|FG000|Overall Study|No white spot lesions|3|||
164264977|NCT02279498|593338816|FG001|Overall Study|Lack of Efficacy|0|||
163995578|NCT03049449|592349957|FG000|Overall Study|Did not receive treatment.|0|||
163995579|NCT03049449|592349958|FG001|Overall Study|Did not receive treatment.|0|||
163995580|NCT03049449|592349959|FG002|Overall Study|Did not receive treatment.|0|||
163995581|NCT03049449|592349960|FG003|Overall Study|Did not receive treatment.|0|||
163995582|NCT03049449|592349961|FG004|Overall Study|Did not receive treatment.|0|||
163995583|NCT03049449|592349962|FG005|Overall Study|Did not receive treatment.|0|||
163995584|NCT03049449|592349963|FG006|Overall Study|Did not receive treatment.|0|||
163995585|NCT03049449|592349964|FG007|Overall Study|Did not receive treatment.|0|||
163995586|NCT03049449|592349965|FG008|Overall Study|Did not receive treatment.|1|||
163995587|NCT03049449|592349966|FG009|Overall Study|Did not receive treatment.|0|||
163995588|NCT03049449|592349957|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
163995589|NCT03049449|592349958|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
163995590|NCT03049449|592349959|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
163995591|NCT03049449|592349960|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
163995592|NCT03049449|592349961|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
163995593|NCT03049449|592349962|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
163995594|NCT03049449|592349963|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
163995595|NCT03049449|592349964|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
163995596|NCT03049449|592349965|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
163995597|NCT03049449|592349966|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
163995598|NCT03049449|592349957|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163995599|NCT03049449|592349958|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163995600|NCT03049449|592349959|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164264978|NCT02279498|593338815|FG000|Overall Study|Lost to Follow-up|0|||
164264979|NCT02279498|593338816|FG001|Overall Study|Lost to Follow-up|1|||
164264980|NCT02279498|593338815|FG000|Overall Study|Withdrawal by Subject|9|||
164264981|NCT02279498|593338816|FG001|Overall Study|Withdrawal by Subject|2|||
164264982|NCT02279498|593338815|FG000|Overall Study|Undefined|2|||
163890123|NCT03697876|591969200|FG001|Overall Study|Lost to Follow-up|1|||
163890124|NCT03697876|591969199|FG000|Overall Study|Adverse Event|1|||
163890125|NCT03697876|591969200|FG001|Overall Study|Adverse Event|0|||
163890126|NCT05321082|591969201|FG000|Overall Study|Other than listed|40|||
164264983|NCT02279498|593338816|FG001|Overall Study|Undefined|1|||
164264984|NCT00737711|593338817|FG000|Overall Study|Adverse Event|2|||
164264985|NCT00737711|593338817|FG000|Overall Study|Death|8|||
164264986|NCT00737711|593338817|FG000|Overall Study|Failure to return|4|||
164264987|NCT00737711|593338817|FG000|Overall Study|Protocol Violation|1|||
164264988|NCT00737711|593338817|FG000|Overall Study|Withdrawal by Subject|5|||
164264989|NCT00737711|593338817|FG000|Overall Study|Blood transfusion|6|||
164264990|NCT00737711|593338817|FG000|Overall Study|Other|5|||
164264991|NCT02739321|593338818|FG000|Overall Study|Lack of Efficacy|1|||
164264992|NCT02739321|593338819|FG001|Overall Study|Lack of Efficacy|1|||
164264993|NCT02739321|593338818|FG000|Overall Study|Lost to Follow-up|1|||
164264994|NCT02739321|593338819|FG001|Overall Study|Lost to Follow-up|1|||
164264995|NCT02739321|593338818|FG000|Overall Study|Withdrawal by Subject|1|||
164264996|NCT02739321|593338819|FG001|Overall Study|Withdrawal by Subject|2|||
164264997|NCT02558400|593338820|FG000|Overall Study|Adverse Event|47|||
164264998|NCT02558400|593338821|FG001|Overall Study|Adverse Event|53|||
164264999|NCT02558400|593338822|FG002|Overall Study|Adverse Event|4|||
164265000|NCT02558400|593338820|FG000|Overall Study|Withdrawal by Subject|13|||
164265001|NCT02558400|593338821|FG001|Overall Study|Withdrawal by Subject|9|||
163995601|NCT03049449|592349960|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
164006734|NCT03519178|592391058|FG009|PF-06873600 Treatment|Progressive disease|5|||
164265002|NCT02558400|593338822|FG002|Overall Study|Withdrawal by Subject|8|||
164265003|NCT02558400|593338820|FG000|Overall Study|Non-Compliant|0|||
164265004|NCT02558400|593338821|FG001|Overall Study|Non-Compliant|1|||
164265005|NCT02558400|593338822|FG002|Overall Study|Non-Compliant|3|||
164265006|NCT02558400|593338820|FG000|Overall Study|Lost to Follow-up|5|||
164265007|NCT02558400|593338821|FG001|Overall Study|Lost to Follow-up|5|||
164265008|NCT02558400|593338822|FG002|Overall Study|Lost to Follow-up|4|||
164265009|NCT02558400|593338820|FG000|Overall Study|Lack of Efficacy|0|||
164265010|NCT02558400|593338821|FG001|Overall Study|Lack of Efficacy|13|||
164265011|NCT02558400|593338822|FG002|Overall Study|Lack of Efficacy|1|||
164265012|NCT02558400|593338820|FG000|Overall Study|Disallowed Concurrent Medication|6|||
164265013|NCT02558400|593338821|FG001|Overall Study|Disallowed Concurrent Medication|7|||
164265014|NCT02558400|593338822|FG002|Overall Study|Disallowed Concurrent Medication|5|||
164265015|NCT02558400|593338820|FG000|Overall Study|Physician Decision|2|||
164265016|NCT02558400|593338821|FG001|Overall Study|Physician Decision|2|||
164265017|NCT02558400|593338822|FG002|Overall Study|Physician Decision|0|||
164265018|NCT02558400|593338820|FG000|Overall Study|Protocol Violation|6|||
164265019|NCT02558400|593338821|FG001|Overall Study|Protocol Violation|3|||
164265020|NCT02558400|593338822|FG002|Overall Study|Protocol Violation|8|||
164265021|NCT02558400|593338820|FG000|Overall Study|Death|0|||
163890127|NCT05321082|591969202|FG001|Overall Study|Other than listed|26|||
163890128|NCT05321082|591969203|FG002|Overall Study|Other than listed|27|||
163890129|NCT05321082|591969201|FG000|Overall Study|Lost to Follow-up|0|||
163890130|NCT05321082|591969202|FG001|Overall Study|Lost to Follow-up|1|||
163890131|NCT05321082|591969203|FG002|Overall Study|Lost to Follow-up|0|||
163890132|NCT05321082|591969201|FG000|Overall Study|Withdrawal by Subject|30|||
163890133|NCT05321082|591969202|FG001|Overall Study|Withdrawal by Subject|34|||
163890134|NCT05321082|591969203|FG002|Overall Study|Withdrawal by Subject|42|||
163890135|NCT05321082|591969201|FG000|Overall Study|Protocol Violation|0|||
163890136|NCT05321082|591969202|FG001|Overall Study|Protocol Violation|0|||
163890137|NCT05321082|591969203|FG002|Overall Study|Protocol Violation|1|||
163890138|NCT05321082|591969201|FG000|Overall Study|Adverse Event|49|||
163890139|NCT05321082|591969202|FG001|Overall Study|Adverse Event|49|||
163890140|NCT05321082|591969203|FG002|Overall Study|Adverse Event|48|||
163890141|NCT05321082|591969201|FG000|Overall Study|Lack of Efficacy|2|||
163890142|NCT05321082|591969202|FG001|Overall Study|Lack of Efficacy|0|||
163890143|NCT05321082|591969203|FG002|Overall Study|Lack of Efficacy|1|||
164265022|NCT02558400|593338821|FG001|Overall Study|Death|1|||
164265023|NCT02558400|593338822|FG002|Overall Study|Death|0|||
164265024|NCT02558400|593338820|FG000|Overall Study|Ineligible for the study|0|||
164265025|NCT02558400|593338821|FG001|Overall Study|Ineligible for the study|2|||
163890144|NCT05321082|591969201|FG000|Overall Study|Not treated|1|||
163890145|NCT05321082|591969202|FG001|Overall Study|Not treated|0|||
164265026|NCT02558400|593338822|FG002|Overall Study|Ineligible for the study|0|||
164265027|NCT02230683|593338826|FG000|Overall Study|Adverse Event|1|||
164265028|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
163890146|NCT05321082|591969203|FG002|Overall Study|Not treated|1|||
163890147|NCT07147257|591969204|FG000|Overall Study|Pregnancy|1|||
163890148|NCT07147257|591969205|FG001|Overall Study|Pregnancy|0|||
163890149|NCT07147257|591969204|FG000|Overall Study|Physician Decision|0|||
163890150|NCT07147257|591969205|FG001|Overall Study|Physician Decision|1|||
163890151|NCT07147257|591969204|FG000|Overall Study|Withdrawal by Subject|0|||
163995602|NCT03049449|592349961|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163995603|NCT03049449|592349962|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163995604|NCT03049449|592349963|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163995605|NCT03049449|592349964|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
163995606|NCT03049449|592349965|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
163995607|NCT03049449|592349966|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
163995608|NCT02054702|592349970|FG000|Overall Study|Lost to Follow-up|3|||
163995609|NCT02054702|592349971|FG001|Overall Study|Lost to Follow-up|5|||
163995610|NCT02054702|592349970|FG000|Overall Study|Adverse Event|3|||
163995611|NCT02054702|592349971|FG001|Overall Study|Adverse Event|1|||
163995612|NCT02054702|592349970|FG000|Overall Study|Met Withdrawal Criteria|4|||
163995613|NCT02054702|592349971|FG001|Overall Study|Met Withdrawal Criteria|1|||
163995614|NCT02054702|592349970|FG000|Overall Study|Physician Decision|0|||
163995615|NCT02054702|592349971|FG001|Overall Study|Physician Decision|1|||
163995616|NCT02054702|592349970|FG000|Overall Study|Withdrawal by Subject|14|||
163995617|NCT02054702|592349971|FG001|Overall Study|Withdrawal by Subject|4|||
163995618|NCT03486392|592349972|FG000|Overall Study|Lost to Follow-up|0|||
163995619|NCT03486392|592349973|FG001|Overall Study|Lost to Follow-up|0|||
163995620|NCT03486392|592349974|FG002|Overall Study|Lost to Follow-up|8|||
163995621|NCT03486392|592349975|FG003|Overall Study|Lost to Follow-up|5|||
163995622|NCT03486392|592349976|FG004|Overall Study|Lost to Follow-up|2|||
164265029|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
164265030|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
164265031|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
164265032|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
164265033|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
164265034|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
164265035|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
164265036|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
164265037|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
164265038|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
164265039|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
164265040|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
164265041|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
164265042|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
164265043|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
164265044|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
164265045|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
164265046|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
163995623|NCT03486392|592349972|FG000|Overall Study|Withdrawal by Subject|3|||
163995624|NCT03486392|592349973|FG001|Overall Study|Withdrawal by Subject|0|||
163995625|NCT03486392|592349974|FG002|Overall Study|Withdrawal by Subject|6|||
163995626|NCT03486392|592349975|FG003|Overall Study|Withdrawal by Subject|4|||
163995627|NCT03486392|592349976|FG004|Overall Study|Withdrawal by Subject|1|||
163995628|NCT03486392|592349972|FG000|Overall Study|Death|0|||
163995629|NCT03486392|592349973|FG001|Overall Study|Death|0|||
163995630|NCT03486392|592349974|FG002|Overall Study|Death|0|||
163995631|NCT03486392|592349975|FG003|Overall Study|Death|0|||
163995632|NCT03486392|592349976|FG004|Overall Study|Death|1|||
163995633|NCT02347631|592349982|FG000|First Intervention (2 Months)|Adverse Event|1|||
163995634|NCT02347631|592349983|FG001|First Intervention (2 Months)|Adverse Event|1|||
163995635|NCT02347631|592349982|FG000|First Intervention (2 Months)|Pregnancy|1|||
163995636|NCT02347631|592349983|FG001|First Intervention (2 Months)|Pregnancy|0|||
163995637|NCT02347631|592349982|FG000|First Intervention (2 Months)|Moved out of area|0|||
163995638|NCT02347631|592349983|FG001|First Intervention (2 Months)|Moved out of area|2|||
163995639|NCT02347631|592349982|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
163995640|NCT02347631|592349983|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
163995641|NCT02347631|592349982|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
164085656|NCT00616928|592677292|FG003|Overall Study|Adverse Event|2|||
163995642|NCT02347631|592349983|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
163995643|NCT02347631|592349982|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
164085657|NCT00616928|592677289|FG000|Overall Study|Other|51|||
163995644|NCT02347631|592349983|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
163995645|NCT02347631|592349982|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
163995646|NCT02347631|592349983|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
163995647|NCT02347631|592349982|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
163995648|NCT02347631|592349983|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
164085658|NCT00616928|592677290|FG001|Overall Study|Other|8|||
164265047|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
164265048|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
164265049|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
164265050|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
164265051|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
164265052|NCT00624780|593338827|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
164265053|NCT00624780|593338828|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
164265054|NCT00624780|593338829|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
164265055|NCT00624780|593338830|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
164265056|NCT00624780|593338831|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
164265057|NCT00624780|593338832|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
164265058|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
164265059|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
164265060|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
164265061|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
164265062|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
164265063|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
164265064|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
164265065|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
164265066|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
163890152|NCT07147257|591969205|FG001|Overall Study|Withdrawal by Subject|1|||
163890153|NCT07147257|591969204|FG000|Overall Study|Drug administration failure|0|||
163890154|NCT07147257|591969205|FG001|Overall Study|Drug administration failure|1|||
163890155|NCT04231149|591970560|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163890156|NCT04231149|591970561|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
163890157|NCT04231149|591970562|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163890158|NCT04231149|591970563|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163890159|NCT04231149|591970564|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
163890160|NCT03252847|591970565|FG000|Overall Study|Withdrawal by Subject|0|||
163890161|NCT03252847|591970566|FG001|Overall Study|Withdrawal by Subject|0|||
163890162|NCT03252847|591970567|FG002|Overall Study|Withdrawal by Subject|1|||
163890163|NCT03252847|591970568|FG003|Overall Study|Withdrawal by Subject|0|||
163890164|NCT03252847|591970569|FG004|Overall Study|Withdrawal by Subject|0|||
163890165|NCT03252847|591970570|FG005|Overall Study|Withdrawal by Subject|0|||
163890166|NCT03252847|591970571|FG006|Overall Study|Withdrawal by Subject|0|||
163890167|NCT03252847|591970565|FG000|Overall Study|Other: Patient decision|0|||
163890168|NCT03252847|591970566|FG001|Overall Study|Other: Patient decision|0|||
163890169|NCT03252847|591970567|FG002|Overall Study|Other: Patient decision|0|||
163890170|NCT03252847|591970568|FG003|Overall Study|Other: Patient decision|0|||
163890171|NCT03252847|591970569|FG004|Overall Study|Other: Patient decision|1|||
163890172|NCT03252847|591970570|FG005|Overall Study|Other: Patient decision|0|||
163890173|NCT03252847|591970571|FG006|Overall Study|Other: Patient decision|0|||
163890174|NCT04914676|591970574|FG000|Overall Study|Study termination|3|||
163890175|NCT04914676|591970575|FG001|Overall Study|Study termination|0|||
163890176|NCT03235544|591970576|FG000|Overall Study|Death|11|||
163890177|NCT03235544|591970577|FG001|Overall Study|Death|31|||
163890178|NCT03235544|591970578|FG002|Overall Study|Death|19|||
163890179|NCT03235544|591970579|FG003|Overall Study|Death|34|||
163890180|NCT03235544|591970576|FG000|Overall Study|Lost to Follow-up|0|||
163890181|NCT03235544|591970577|FG001|Overall Study|Lost to Follow-up|1|||
163890182|NCT03235544|591970578|FG002|Overall Study|Lost to Follow-up|1|||
163890183|NCT03235544|591970579|FG003|Overall Study|Lost to Follow-up|1|||
163890184|NCT03235544|591970576|FG000|Overall Study|Withdrawal by Subject|0|||
163890185|NCT03235544|591970577|FG001|Overall Study|Withdrawal by Subject|3|||
163890186|NCT03235544|591970578|FG002|Overall Study|Withdrawal by Subject|1|||
163890187|NCT03235544|591970579|FG003|Overall Study|Withdrawal by Subject|5|||
163890188|NCT03235544|591970576|FG000|Overall Study|Disease Progression|0|||
163890189|NCT03235544|591970577|FG001|Overall Study|Disease Progression|1|||
163890190|NCT03235544|591970578|FG002|Overall Study|Disease Progression|0|||
163890191|NCT03235544|591970579|FG003|Overall Study|Disease Progression|2|||
163890192|NCT03235544|591970576|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
163995649|NCT01262898|592349985|FG000|Overall Study|Protocol Violation|1|||
163995650|NCT01262898|592349986|FG001|Overall Study|Protocol Violation|1|||
164341419|NCT03417219|593625358|FG000|Overall Study|Lost to Follow-up|0|||
163890193|NCT03235544|591970577|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
163890194|NCT03235544|591970578|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
163890195|NCT03235544|591970579|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
163890196|NCT03235544|591970576|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
163890197|NCT03235544|591970577|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
163890198|NCT03235544|591970578|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
163890199|NCT03235544|591970579|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
163890200|NCT02433379|591970580|FG000|Overall Study|Screen Failures|55|||
163890201|NCT02433379|591970580|FG000|Overall Study|Death|57|||
163890202|NCT02433379|591970580|FG000|Overall Study|Total Withdrawals|209|||
163995651|NCT01262898|592349987|FG002|Overall Study|Protocol Violation|0|||
163995652|NCT01262898|592349988|FG003|Overall Study|Protocol Violation|0|||
163995653|NCT01262898|592349985|FG000|Overall Study|Lost to Follow-up|1|||
163995654|NCT01262898|592349986|FG001|Overall Study|Lost to Follow-up|0|||
163995655|NCT01262898|592349987|FG002|Overall Study|Lost to Follow-up|0|||
163995656|NCT01262898|592349988|FG003|Overall Study|Lost to Follow-up|0|||
163995657|NCT01262898|592349985|FG000|Overall Study|Withdrawal by Subject|1|||
163995658|NCT01262898|592349986|FG001|Overall Study|Withdrawal by Subject|1|||
163995659|NCT01262898|592349987|FG002|Overall Study|Withdrawal by Subject|0|||
163995660|NCT01262898|592349988|FG003|Overall Study|Withdrawal by Subject|0|||
163995661|NCT02304926|592349989|FG000|Overall Study|Lost to Follow-up|2|||
163995662|NCT02304926|592349990|FG001|Overall Study|Lost to Follow-up|1|||
163995663|NCT02388295|592349997|FG000|Dose Escalation Week 1|Adverse Event|1|||
163995664|NCT02388295|592349998|FG001|Dose Escalation Week 1|Adverse Event|2|||
163995665|NCT02388295|592349999|FG002|Dose Escalation Week 1|Adverse Event|1|||
163995666|NCT02388295|592349997|FG000|Dose Escalation Week 1|Determined not eligible|1|||
163995667|NCT02388295|592349998|FG001|Dose Escalation Week 1|Determined not eligible|1|||
163995668|NCT02388295|592349999|FG002|Dose Escalation Week 1|Determined not eligible|1|||
163995669|NCT02388295|592349997|FG000|Dose Escalation Week 2|Protocol Violation|0|||
163995670|NCT02388295|592349998|FG001|Dose Escalation Week 2|Protocol Violation|1|||
163995671|NCT02388295|592349999|FG002|Dose Escalation Week 2|Protocol Violation|0|||
163995672|NCT02388295|592349997|FG000|Dose Escalation Week 2|Determined not eligible|1|||
163995673|NCT02388295|592349998|FG001|Dose Escalation Week 2|Determined not eligible|1|||
163995674|NCT02388295|592349999|FG002|Dose Escalation Week 2|Determined not eligible|1|||
163995675|NCT02388295|592349997|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
163995676|NCT02388295|592349998|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
163995677|NCT02388295|592349999|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
163995678|NCT02076165|592350000|FG000|Overall Study|Lost to Follow-up|7|||
163995679|NCT02076165|592350001|FG001|Overall Study|Lost to Follow-up|5|||
163995680|NCT02076165|592350000|FG000|Overall Study|Refused follow-up assessment|1|||
163995681|NCT02076165|592350001|FG001|Overall Study|Refused follow-up assessment|1|||
163995682|NCT01551693|592350002|FG000|Overall Study|Disease Progression|1|||
163995683|NCT01551693|592350003|FG001|Overall Study|Disease Progression|0|||
163995684|NCT01551693|592350002|FG000|Overall Study|Adverse Event|0|||
163995685|NCT01551693|592350003|FG001|Overall Study|Adverse Event|1|||
163995686|NCT01551693|592350002|FG000|Overall Study|Withdrawal by Subject|0|||
163995687|NCT01551693|592350003|FG001|Overall Study|Withdrawal by Subject|1|||
163995688|NCT02429856|592350004|FG000|Overall Study|Death|12|||
163995689|NCT02429856|592350005|FG001|Overall Study|Death|13|||
163995690|NCT02429856|592350004|FG000|Overall Study|Lost to Follow-up|6|||
163995691|NCT02429856|592350005|FG001|Overall Study|Lost to Follow-up|5|||
163995692|NCT02429856|592350004|FG000|Overall Study|Withdrawal by Subject|1|||
163995693|NCT02429856|592350005|FG001|Overall Study|Withdrawal by Subject|1|||
164341420|NCT03417219|593625359|FG001|Overall Study|Lost to Follow-up|3|||
164341421|NCT02264639|593625364|FG000|Overall Study|Death (after completing single-dose phase)|1|||
164341422|NCT02264639|593625365|FG001|Overall Study|Death (after completing single-dose phase)|0|||
163995694|NCT01950819|592350009|FG000|Overall Study|Graft Loss|35|||
163995695|NCT01950819|592350010|FG001|Overall Study|Graft Loss|30|||
163995696|NCT01950819|592350009|FG000|Overall Study|Death|29|||
163995697|NCT01950819|592350010|FG001|Overall Study|Death|34|||
163995698|NCT01950819|592350009|FG000|Overall Study|Subject / Gardian decision|54|||
163995699|NCT01950819|592350010|FG001|Overall Study|Subject / Gardian decision|51|||
163995700|NCT01950819|592350009|FG000|Overall Study|technical problems|2|||
163995701|NCT01950819|592350010|FG001|Overall Study|technical problems|0|||
163995702|NCT01950819|592350009|FG000|Overall Study|Pregnancy|0|||
163995703|NCT01950819|592350010|FG001|Overall Study|Pregnancy|2|||
163995704|NCT01950819|592350009|FG000|Overall Study|Lost to Follow-up|9|||
163995705|NCT01950819|592350010|FG001|Overall Study|Lost to Follow-up|17|||
163995706|NCT04134494|592350012|FG000|Overall Study|Lost to Follow-up|2|||
163995707|NCT00781365|592350013|FG000|Overall Study|Withdrawal by Subject|13|||
163995708|NCT00781365|592350014|FG001|Overall Study|Withdrawal by Subject|8|||
163995709|NCT00781365|592350013|FG000|Overall Study|Did Not Attend Visit|20|||
163995710|NCT00781365|592350014|FG001|Overall Study|Did Not Attend Visit|28|||
163995711|NCT00781365|592350013|FG000|Overall Study|Language barrier|1|||
163995712|NCT00781365|592350014|FG001|Overall Study|Language barrier|0|||
163995713|NCT01360645|592350015|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
164085659|NCT00616928|592677291|FG002|Overall Study|Other|15|||
164341423|NCT02264639|593625366|FG002|Overall Study|Death (after completing single-dose phase)|0|||
164341424|NCT02264639|593625367|FG003|Overall Study|Death (after completing single-dose phase)|0|||
163995714|NCT01360645|592350016|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
163995715|NCT01360645|592350017|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
163995716|NCT01360645|592350018|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
163995717|NCT01360645|592350015|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
163995718|NCT01360645|592350016|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
163995719|NCT01360645|592350017|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
164085660|NCT00616928|592677292|FG003|Overall Study|Other|5|||
163995720|NCT01360645|592350018|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
163995721|NCT01360645|592350015|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
163995722|NCT01360645|592350016|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
164085661|NCT00616928|592677289|FG000|Overall Study|Lost to Follow-up|5|||
164085662|NCT00616928|592677290|FG001|Overall Study|Lost to Follow-up|7|||
164085663|NCT00616928|592677291|FG002|Overall Study|Lost to Follow-up|0|||
164085664|NCT00616928|592677292|FG003|Overall Study|Lost to Follow-up|0|||
164085665|NCT05182606|592677295|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|29|||
164085666|NCT02669264|592677300|FG000|Overall Study|Death|5|||
164085667|NCT02669264|592677301|FG001|Overall Study|Death|5|||
164085668|NCT02669264|592677302|FG002|Overall Study|Death|3|||
164085669|NCT02669264|592677303|FG003|Overall Study|Death|3|||
164085670|NCT02669264|592677304|FG004|Overall Study|Death|3|||
164085671|NCT02669264|592677305|FG005|Overall Study|Death|6|||
164085672|NCT02669264|592677306|FG006|Overall Study|Death|3|||
164085673|NCT02669264|592677300|FG000|Overall Study|Withdrawal by Subject|0|||
164085674|NCT02669264|592677301|FG001|Overall Study|Withdrawal by Subject|1|||
164085675|NCT02669264|592677302|FG002|Overall Study|Withdrawal by Subject|0|||
164085676|NCT02669264|592677303|FG003|Overall Study|Withdrawal by Subject|0|||
164085677|NCT02669264|592677304|FG004|Overall Study|Withdrawal by Subject|1|||
164085678|NCT02669264|592677305|FG005|Overall Study|Withdrawal by Subject|0|||
164085679|NCT02669264|592677306|FG006|Overall Study|Withdrawal by Subject|0|||
164085680|NCT02669264|592677300|FG000|Overall Study|Lost to Follow-up|0|||
164085681|NCT02669264|592677301|FG001|Overall Study|Lost to Follow-up|0|||
164085682|NCT02669264|592677302|FG002|Overall Study|Lost to Follow-up|0|||
164085683|NCT02669264|592677303|FG003|Overall Study|Lost to Follow-up|0|||
164085684|NCT02669264|592677304|FG004|Overall Study|Lost to Follow-up|1|||
164085685|NCT02669264|592677305|FG005|Overall Study|Lost to Follow-up|0|||
164085686|NCT02669264|592677306|FG006|Overall Study|Lost to Follow-up|0|||
164085687|NCT02669264|592677300|FG000|Overall Study|Miscellaneous|0|||
164085688|NCT02669264|592677301|FG001|Overall Study|Miscellaneous|0|||
164085689|NCT02669264|592677302|FG002|Overall Study|Miscellaneous|0|||
164085690|NCT02669264|592677303|FG003|Overall Study|Miscellaneous|0|||
164085691|NCT02669264|592677304|FG004|Overall Study|Miscellaneous|0|||
164085692|NCT02669264|592677305|FG005|Overall Study|Miscellaneous|0|||
164085693|NCT02669264|592677306|FG006|Overall Study|Miscellaneous|2|||
164085694|NCT00500682|592677307|FG000|Overall Study|Adverse Event|37|||
164085695|NCT00500682|592677308|FG001|Overall Study|Adverse Event|29|||
164085696|NCT00500682|592677307|FG000|Overall Study|Death|25|||
164085697|NCT00500682|592677308|FG001|Overall Study|Death|16|||
164085698|NCT00500682|592677307|FG000|Overall Study|Lost to Follow-up|11|||
164085699|NCT00500682|592677308|FG001|Overall Study|Lost to Follow-up|11|||
164085700|NCT00500682|592677307|FG000|Overall Study|Physician Decision|6|||
164085701|NCT00500682|592677308|FG001|Overall Study|Physician Decision|10|||
164085702|NCT00500682|592677307|FG000|Overall Study|Pregnancy|2|||
164085703|NCT00500682|592677308|FG001|Overall Study|Pregnancy|0|||
164085704|NCT00500682|592677307|FG000|Overall Study|Protocol Violation|1|||
164085705|NCT00500682|592677308|FG001|Overall Study|Protocol Violation|3|||
164085706|NCT00500682|592677307|FG000|Overall Study|Withdrawal by Subject|80|||
164085707|NCT00500682|592677308|FG001|Overall Study|Withdrawal by Subject|74|||
163995723|NCT01360645|592350017|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
163995724|NCT01360645|592350018|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
163995725|NCT01360645|592350015|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
163995726|NCT01360645|592350016|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
163995727|NCT01360645|592350017|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
163995728|NCT01360645|592350018|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
163995729|NCT01360645|592350015|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
163995730|NCT01360645|592350016|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
163995731|NCT01360645|592350017|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
163995732|NCT01360645|592350018|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
164085708|NCT00500682|592677307|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
164085709|NCT00500682|592677308|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
164085710|NCT01680159|592677309|FG000|Screening Period|Not meet criteria for dose-up period|7|||
164085711|NCT01680159|592677309|FG000|Increased Dose Period|Adverse Event|6|||
164085712|NCT01680159|592677309|FG000|Increased Dose Period|Withdrawal by Subject|2|||
164085713|NCT04128696|592677310|FG000|Overall Study|Lost to Follow-up|3|||
164085714|NCT04128696|592677311|FG001|Overall Study|Lost to Follow-up|7|||
164085715|NCT04128696|592677310|FG000|Overall Study|Withdrawal by Subject|12|||
164085716|NCT04128696|592677311|FG001|Overall Study|Withdrawal by Subject|11|||
164085717|NCT04128696|592677310|FG000|Overall Study|Study Closed/Terminated|26|||
164085718|NCT04128696|592677311|FG001|Overall Study|Study Closed/Terminated|38|||
164085719|NCT04128696|592677310|FG000|Overall Study|Physician Decision|2|||
164085720|NCT04128696|592677311|FG001|Overall Study|Physician Decision|3|||
164085721|NCT00772382|592677312|FG000|Overall Study|Adverse Event|19|||
164341425|NCT02264639|593625368|FG004|Overall Study|Death (after completing single-dose phase)|0|||
163995733|NCT01360645|592350015|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
163995734|NCT01360645|592350016|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
163995735|NCT01360645|592350017|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
163995736|NCT01360645|592350018|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
163995737|NCT01360645|592350015|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
163995738|NCT01360645|592350016|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
163995739|NCT01360645|592350017|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
163995740|NCT01360645|592350018|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
163995741|NCT01360645|592350015|FG000|Phase B (6 Weeks)|Adverse Event|0|||
163995742|NCT01360645|592350016|FG001|Phase B (6 Weeks)|Adverse Event|6|||
163995743|NCT01360645|592350017|FG002|Phase B (6 Weeks)|Adverse Event|0|||
163995744|NCT01360645|592350018|FG003|Phase B (6 Weeks)|Adverse Event|0|||
163995745|NCT01360645|592350015|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
163995746|NCT01360645|592350016|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
163995747|NCT01360645|592350017|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
163995748|NCT01360645|592350018|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
163995749|NCT01360645|592350015|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
163995750|NCT01360645|592350016|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
163995751|NCT01360645|592350017|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
163995752|NCT01360645|592350018|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
163995753|NCT01360645|592350015|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
163995754|NCT01360645|592350016|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
163995755|NCT01360645|592350017|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
163995756|NCT01360645|592350018|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
163995757|NCT01360645|592350015|FG000|Phase A+|Lost to Follow-up|0|||
163995758|NCT01360645|592350016|FG001|Phase A+|Lost to Follow-up|0|||
163995759|NCT01360645|592350017|FG002|Phase A+|Lost to Follow-up|0|||
163995760|NCT01360645|592350018|FG003|Phase A+|Lost to Follow-up|7|||
163995761|NCT01360645|592350015|FG000|Phase A+|Adverse Event|0|||
163995762|NCT01360645|592350016|FG001|Phase A+|Adverse Event|0|||
163995763|NCT01360645|592350017|FG002|Phase A+|Adverse Event|0|||
163995764|NCT01360645|592350018|FG003|Phase A+|Adverse Event|2|||
163995765|NCT01360645|592350015|FG000|Phase A+|Met Withdrawal Criteria|0|||
163995766|NCT01360645|592350016|FG001|Phase A+|Met Withdrawal Criteria|0|||
163995767|NCT01360645|592350017|FG002|Phase A+|Met Withdrawal Criteria|0|||
163995768|NCT01360645|592350018|FG003|Phase A+|Met Withdrawal Criteria|4|||
163995769|NCT01360645|592350015|FG000|Phase A+|Physician Decision|0|||
163995770|NCT01360645|592350016|FG001|Phase A+|Physician Decision|0|||
163995771|NCT01360645|592350017|FG002|Phase A+|Physician Decision|0|||
163995772|NCT01360645|592350018|FG003|Phase A+|Physician Decision|2|||
163995773|NCT01360645|592350015|FG000|Phase A+|Withdrawal by Subject|0|||
163995774|NCT01360645|592350016|FG001|Phase A+|Withdrawal by Subject|0|||
163995775|NCT01360645|592350017|FG002|Phase A+|Withdrawal by Subject|0|||
163995776|NCT01360645|592350018|FG003|Phase A+|Withdrawal by Subject|5|||
163995777|NCT01360645|592350015|FG000|Phase A+|Protocol Deviation|0|||
163995778|NCT01360645|592350016|FG001|Phase A+|Protocol Deviation|0|||
163995779|NCT01360645|592350017|FG002|Phase A+|Protocol Deviation|0|||
163995780|NCT01360645|592350018|FG003|Phase A+|Protocol Deviation|4|||
164341426|NCT02264639|593625364|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
164341427|NCT02264639|593625365|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341428|NCT02264639|593625366|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341429|NCT02264639|593625367|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341430|NCT02264639|593625368|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
164341431|NCT02264639|593625364|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341432|NCT02264639|593625365|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341433|NCT02264639|593625366|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
164341434|NCT02264639|593625367|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341435|NCT02264639|593625368|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
164341436|NCT02264639|593625364|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341437|NCT02264639|593625365|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341438|NCT02264639|593625366|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341439|NCT02264639|593625367|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
164341440|NCT02264639|593625368|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
164341441|NCT00369824|593625372|FG000|Overall Study|Adverse Event|0|||
163995781|NCT01032629|592350023|FG000|Overall Study|Closed Site|21|||
163995782|NCT01032629|592350024|FG001|Overall Study|Closed Site|18|||
163995783|NCT01032629|592350025|FG002|Overall Study|Closed Site|16|||
163995784|NCT01032629|592350023|FG000|Overall Study|Withdrawal by Subject|50|||
163995785|NCT01032629|592350024|FG001|Overall Study|Withdrawal by Subject|36|||
163995786|NCT01032629|592350025|FG002|Overall Study|Withdrawal by Subject|35|||
163995787|NCT01032629|592350023|FG000|Overall Study|Lost to Follow-up|74|||
163995788|NCT01032629|592350024|FG001|Overall Study|Lost to Follow-up|47|||
163995789|NCT01032629|592350025|FG002|Overall Study|Lost to Follow-up|37|||
163995790|NCT01662648|592350026|FG000|Overall Study|Death|1|||
163995791|NCT01662648|592350027|FG001|Overall Study|Death|3|||
163995792|NCT01662648|592350026|FG000|Overall Study|Adverse Event|40|||
163995793|NCT01662648|592350027|FG001|Overall Study|Adverse Event|37|||
163995794|NCT01662648|592350026|FG000|Overall Study|Lack of Efficacy|17|||
163995795|NCT01662648|592350027|FG001|Overall Study|Lack of Efficacy|16|||
163995796|NCT01662648|592350026|FG000|Overall Study|Participant ineligible to continue trial|1|||
163995797|NCT01662648|592350027|FG001|Overall Study|Participant ineligible to continue trial|1|||
163995798|NCT01662648|592350026|FG000|Overall Study|Lost to Follow-up|24|||
163995799|NCT01662648|592350027|FG001|Overall Study|Lost to Follow-up|36|||
163995800|NCT01662648|592350026|FG000|Overall Study|Withdrawal by Subject|36|||
163995801|NCT01662648|592350027|FG001|Overall Study|Withdrawal by Subject|53|||
163995802|NCT01662648|592350026|FG000|Overall Study|Participant non-compliant|16|||
163995803|NCT01662648|592350027|FG001|Overall Study|Participant non-compliant|20|||
163995804|NCT01662648|592350026|FG000|Overall Study|Other|8|||
163995805|NCT01662648|592350027|FG001|Overall Study|Other|11|||
163995806|NCT01662648|592350026|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
163995807|NCT01662648|592350027|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
163995808|NCT01662648|592350026|FG000|Overall Study|LOE and other reason unspecified|1|||
163995809|NCT01662648|592350027|FG001|Overall Study|LOE and other reason unspecified|0|||
163995810|NCT01662648|592350026|FG000|Overall Study|LOE and Participant non-compliant|0|||
163995811|NCT01662648|592350027|FG001|Overall Study|LOE and Participant non-compliant|1|||
163995812|NCT00619957|592350029|FG000|Month 24 Double-Blind|Adverse Event|9|||
163995813|NCT00619957|592350030|FG001|Month 24 Double-Blind|Adverse Event|7|||
163995814|NCT00619957|592350029|FG000|Month 24 Double-Blind|Protocol Violation|1|||
163995815|NCT00619957|592350030|FG001|Month 24 Double-Blind|Protocol Violation|0|||
163995816|NCT00619957|592350029|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
163995817|NCT00619957|592350030|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
163995818|NCT00619957|592350029|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
163995819|NCT00619957|592350030|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
163995820|NCT00619957|592350029|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
163995821|NCT00619957|592350030|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
163995822|NCT00619957|592350029|FG000|Month 48 Open-Label|Adverse Event|4|||
163995823|NCT00619957|592350030|FG001|Month 48 Open-Label|Adverse Event|4|||
163995824|NCT00619957|592350029|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
163995825|NCT00619957|592350030|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
163995826|NCT00619957|592350029|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
163995827|NCT00619957|592350030|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
163995828|NCT00723957|592350031|FG000|Overall Study|Adverse event unrelated to study drug|1|||
163995829|NCT00723957|592350032|FG001|Overall Study|Adverse event unrelated to study drug|4|||
163995830|NCT00723957|592350031|FG000|Overall Study|Death|3|||
163995831|NCT00723957|592350032|FG001|Overall Study|Death|4|||
164085722|NCT00772382|592677312|FG000|Overall Study|Death|6|||
164341442|NCT00369824|593625373|FG001|Overall Study|Adverse Event|2|||
164341443|NCT00369824|593625374|FG002|Overall Study|Adverse Event|0|||
164341444|NCT00369824|593625375|FG003|Overall Study|Adverse Event|0|||
164341445|NCT00369824|593625376|FG004|Overall Study|Adverse Event|1|||
164341446|NCT00369824|593625377|FG005|Overall Study|Adverse Event|0|||
164341447|NCT00369824|593625372|FG000|Overall Study|Protocol Violation|0|||
164341448|NCT00369824|593625373|FG001|Overall Study|Protocol Violation|1|||
164341449|NCT00369824|593625374|FG002|Overall Study|Protocol Violation|0|||
164341450|NCT00369824|593625375|FG003|Overall Study|Protocol Violation|1|||
164341451|NCT00369824|593625376|FG004|Overall Study|Protocol Violation|1|||
164341452|NCT00369824|593625377|FG005|Overall Study|Protocol Violation|0|||
164341453|NCT00369824|593625372|FG000|Overall Study|Withdrawal by Subject|9|||
164341454|NCT00369824|593625373|FG001|Overall Study|Withdrawal by Subject|5|||
164341455|NCT00369824|593625374|FG002|Overall Study|Withdrawal by Subject|5|||
164341456|NCT00369824|593625375|FG003|Overall Study|Withdrawal by Subject|4|||
164341457|NCT00369824|593625376|FG004|Overall Study|Withdrawal by Subject|6|||
164341458|NCT00369824|593625377|FG005|Overall Study|Withdrawal by Subject|2|||
164341459|NCT00369824|593625372|FG000|Overall Study|Lost to Follow-up|6|||
164341460|NCT00369824|593625373|FG001|Overall Study|Lost to Follow-up|11|||
164341461|NCT00369824|593625374|FG002|Overall Study|Lost to Follow-up|7|||
164341462|NCT00369824|593625375|FG003|Overall Study|Lost to Follow-up|8|||
164341463|NCT00369824|593625376|FG004|Overall Study|Lost to Follow-up|9|||
164341464|NCT00369824|593625377|FG005|Overall Study|Lost to Follow-up|6|||
164341465|NCT00369824|593625372|FG000|Overall Study|Other|0|||
164341466|NCT00369824|593625373|FG001|Overall Study|Other|0|||
164341467|NCT00369824|593625374|FG002|Overall Study|Other|0|||
164341468|NCT00369824|593625375|FG003|Overall Study|Other|2|||
164341469|NCT00369824|593625376|FG004|Overall Study|Other|1|||
164341470|NCT00369824|593625377|FG005|Overall Study|Other|3|||
164341471|NCT01443078|593625378|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
164341472|NCT01443078|593625378|FG000|Overall Study|Withdrawal by Subject|1|||
164341473|NCT01443078|593625378|FG000|Overall Study|Patient had brain mets|1|||
164341474|NCT01390649|593625379|FG000|Overall Study|Physician Decision|1|||
164341475|NCT00415168|593625380|FG000|Overall Study|Death|26|||
164341476|NCT00415168|593625380|FG000|Overall Study|Lost to Follow-up|3|||
163890203|NCT04200456|591970581|FG000|Overall Study|Physician Decision|0|||
163890204|NCT04200456|591970582|FG001|Overall Study|Physician Decision|1|||
163890205|NCT04200456|591970581|FG000|Overall Study|Withdrawal by Subject|2|||
163890206|NCT04200456|591970582|FG001|Overall Study|Withdrawal by Subject|2|||
163890207|NCT04200456|591970581|FG000|Overall Study|Lack of Efficacy|1|||
163890208|NCT04200456|591970582|FG001|Overall Study|Lack of Efficacy|1|||
163890209|NCT04200456|591970581|FG000|Overall Study|Adverse event, non-fatal|0|||
163890210|NCT04200456|591970582|FG001|Overall Study|Adverse event, non-fatal|1|||
163890211|NCT04200456|591970581|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
163890212|NCT04200456|591970582|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
163890213|NCT00592852|591970583|FG000|Overall Study|Non-compliance|1|||
163890214|NCT00592852|591970583|FG000|Overall Study|Adverse Event|3|||
163890215|NCT00592852|591970583|FG000|Overall Study|Found ineligible|1|||
163890216|NCT00592852|591970583|FG000|Overall Study|Withdrawal by Subject|1|||
163890217|NCT02505984|591970586|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
163890218|NCT02505984|591970587|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
163890219|NCT02505984|591970586|FG000|Overall Study|Unreliable self-report data|1|||
163890220|NCT02505984|591970587|FG001|Overall Study|Unreliable self-report data|0|||
163890221|NCT02505984|591970586|FG000|Overall Study|Study blind opened during assessment|0|||
163890222|NCT02505984|591970587|FG001|Overall Study|Study blind opened during assessment|1|||
163890223|NCT02505984|591970586|FG000|Overall Study|Noncompliance with study protocol|0|||
163890224|NCT02505984|591970587|FG001|Overall Study|Noncompliance with study protocol|1|||
163890225|NCT04299464|591970598|FG000|Overall Study|Adverse Event|1|||
163890226|NCT04299464|591970599|FG001|Overall Study|Adverse Event|0|||
163890227|NCT04299464|591970600|FG002|Overall Study|Adverse Event|2|||
163890228|NCT04299464|591970598|FG000|Overall Study|Non-compliance with Study Drug|1|||
163890229|NCT04299464|591970599|FG001|Overall Study|Non-compliance with Study Drug|0|||
163890230|NCT04299464|591970600|FG002|Overall Study|Non-compliance with Study Drug|0|||
163890231|NCT04299464|591970598|FG000|Overall Study|Reason not Specified|0|||
163890232|NCT04299464|591970599|FG001|Overall Study|Reason not Specified|1|||
163890233|NCT04299464|591970600|FG002|Overall Study|Reason not Specified|3|||
163890234|NCT04299464|591970598|FG000|Overall Study|Physician Decision|0|||
163890235|NCT04299464|591970599|FG001|Overall Study|Physician Decision|1|||
163890236|NCT04299464|591970600|FG002|Overall Study|Physician Decision|1|||
163890237|NCT04299464|591970598|FG000|Overall Study|Withdrawal by Subject|0|||
163890238|NCT04299464|591970599|FG001|Overall Study|Withdrawal by Subject|2|||
163890239|NCT04299464|591970600|FG002|Overall Study|Withdrawal by Subject|1|||
163890240|NCT05907174|591970606|FG000|3-Month Assessment|Withdrawal by Subject|0|||
163890241|NCT05907174|591970607|FG001|3-Month Assessment|Withdrawal by Subject|0|||
163890242|NCT05907174|591970608|FG002|3-Month Assessment|Withdrawal by Subject|0|||
163890243|NCT05907174|591970609|FG003|3-Month Assessment|Withdrawal by Subject|1|||
163890244|NCT05907174|591970606|FG000|3-Month Assessment|Lost to Follow-up|1|||
163890245|NCT05907174|591970607|FG001|3-Month Assessment|Lost to Follow-up|1|||
163890246|NCT05907174|591970608|FG002|3-Month Assessment|Lost to Follow-up|1|||
163890247|NCT05907174|591970609|FG003|3-Month Assessment|Lost to Follow-up|1|||
163890248|NCT05907174|591970606|FG000|6-Month Assessment|Death|0|||
163890249|NCT05907174|591970607|FG001|6-Month Assessment|Death|0|||
163890250|NCT05907174|591970608|FG002|6-Month Assessment|Death|3|||
163890251|NCT05907174|591970609|FG003|6-Month Assessment|Death|0|||
163890252|NCT05907174|591970606|FG000|6-Month Assessment|Withdrawal by Subject|0|||
163890253|NCT05907174|591970607|FG001|6-Month Assessment|Withdrawal by Subject|0|||
163890254|NCT05907174|591970608|FG002|6-Month Assessment|Withdrawal by Subject|1|||
163890255|NCT05907174|591970609|FG003|6-Month Assessment|Withdrawal by Subject|1|||
163890256|NCT05907174|591970606|FG000|6-Month Assessment|Lost to Follow-up|0|||
163890257|NCT05907174|591970607|FG001|6-Month Assessment|Lost to Follow-up|1|||
163890258|NCT05907174|591970608|FG002|6-Month Assessment|Lost to Follow-up|1|||
163890259|NCT05907174|591970609|FG003|6-Month Assessment|Lost to Follow-up|1|||
163890260|NCT03209973|591970618|FG000|Overall Study|Withdrawal by Subject|7|||
163890261|NCT03209973|591970618|FG000|Overall Study|Lost to Follow-up|2|||
163890262|NCT03209973|591970618|FG000|Overall Study|Death|8|||
163890263|NCT03209973|591970618|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
163890264|NCT03209973|591970618|FG000|Overall Study|Sponsor Decision|18|||
163995832|NCT00723957|592350031|FG000|Overall Study|Disease progression|27|||
163995833|NCT00723957|592350032|FG001|Overall Study|Disease progression|25|||
163995834|NCT00723957|592350031|FG000|Overall Study|Maximum clinical benefit|4|||
163995835|NCT00723957|592350032|FG001|Overall Study|Maximum clinical benefit|5|||
163995836|NCT00723957|592350031|FG000|Overall Study|Investigator decision|1|||
163995837|NCT00723957|592350032|FG001|Overall Study|Investigator decision|1|||
163995838|NCT00723957|592350031|FG000|Overall Study|Study drug toxicity|4|||
163995839|NCT00723957|592350032|FG001|Overall Study|Study drug toxicity|6|||
163995840|NCT00723957|592350031|FG000|Overall Study|Withdrawal by Subject|7|||
163995841|NCT00723957|592350032|FG001|Overall Study|Withdrawal by Subject|5|||
163995842|NCT00723957|592350031|FG000|Overall Study|Reason not analyzed|1|||
163995843|NCT00723957|592350032|FG001|Overall Study|Reason not analyzed|0|||
163995844|NCT00723957|592350031|FG000|Overall Study|Never received treatment|3|||
163995845|NCT00723957|592350032|FG001|Overall Study|Never received treatment|3|||
163995846|NCT01763164|592350033|FG000|Treatment Phase|Participant/Guardian decision|26|||
163995847|NCT01763164|592350034|FG001|Treatment Phase|Participant/Guardian decision|14|||
163995848|NCT01763164|592350033|FG000|Treatment Phase|Protocol Violation|1|||
163995849|NCT01763164|592350034|FG001|Treatment Phase|Protocol Violation|1|||
163995850|NCT01763164|592350033|FG000|Treatment Phase|Progressive Disease|142|||
163995851|NCT01763164|592350034|FG001|Treatment Phase|Progressive Disease|76|||
163995852|NCT01763164|592350033|FG000|Treatment Phase|Physician Decision|24|||
163995853|NCT01763164|592350034|FG001|Treatment Phase|Physician Decision|13|||
163995854|NCT01763164|592350033|FG000|Treatment Phase|Death|10|||
163995855|NCT01763164|592350034|FG001|Treatment Phase|Death|1|||
163995856|NCT01763164|592350033|FG000|Treatment Phase|Adverse Event|66|||
163995857|NCT01763164|592350034|FG001|Treatment Phase|Adverse Event|8|||
163995858|NCT01763164|592350033|FG000|Treatment Phase|Randomized but not Treated|0|||
163995859|NCT01763164|592350034|FG001|Treatment Phase|Randomized but not Treated|19|||
163995860|NCT01763164|592350033|FG000|Treatment Phase|Other|0|||
163995861|NCT01763164|592350034|FG001|Treatment Phase|Other|1|||
163995862|NCT01763164|592350033|FG000|Follow up Phase|New therapy for study indication|12|||
163995863|NCT01763164|592350034|FG001|Follow up Phase|New therapy for study indication|3|||
163995864|NCT01763164|592350033|FG000|Follow up Phase|Death|21|||
163995865|NCT01763164|592350034|FG001|Follow up Phase|Death|4|||
163995866|NCT01763164|592350033|FG000|Follow up Phase|Subject/guardian decision|9|||
163995867|NCT01763164|592350034|FG001|Follow up Phase|Subject/guardian decision|2|||
163995868|NCT01763164|592350033|FG000|Follow up Phase|Progressive disease|127|||
163995869|NCT01763164|592350034|FG001|Follow up Phase|Progressive disease|62|||
163995870|NCT01763164|592350033|FG000|Follow up Phase|Physician Decision|10|||
163995871|NCT01763164|592350034|FG001|Follow up Phase|Physician Decision|3|||
163995872|NCT01763164|592350033|FG000|Follow up Phase|Lost to Follow-up|1|||
163995873|NCT01763164|592350034|FG001|Follow up Phase|Lost to Follow-up|0|||
163995874|NCT01763164|592350033|FG000|Follow up Phase|Adverse Event|17|||
163995875|NCT01763164|592350034|FG001|Follow up Phase|Adverse Event|1|||
163995876|NCT01264939|592350035|FG000|Overall Study|Adverse Event|1|||
163995877|NCT01264939|592350036|FG001|Overall Study|Adverse Event|3|||
163995878|NCT01264939|592350035|FG000|Overall Study|Lost to Follow-up|0|||
163995879|NCT01264939|592350036|FG001|Overall Study|Lost to Follow-up|3|||
163995880|NCT01264939|592350035|FG000|Overall Study|Physician Decision|1|||
163995881|NCT01264939|592350036|FG001|Overall Study|Physician Decision|1|||
163995882|NCT01264939|592350035|FG000|Overall Study|Patient/Guardian Decision|8|||
163995883|NCT01264939|592350036|FG001|Overall Study|Patient/Guardian Decision|10|||
163995884|NCT01264939|592350035|FG000|Overall Study|Disease Progression|8|||
163995885|NCT01264939|592350036|FG001|Overall Study|Disease Progression|11|||
163995886|NCT04964258|592350037|FG000|Overall Study|Lost to Follow-up|1|||
163995887|NCT04964258|592350038|FG001|Overall Study|Lost to Follow-up|0|||
163995888|NCT04964258|592350039|FG002|Overall Study|Lost to Follow-up|0|||
163995889|NCT04964258|592350040|FG003|Overall Study|Lost to Follow-up|0|||
163995890|NCT04964258|592350041|FG004|Overall Study|Lost to Follow-up|0|||
163995891|NCT04964258|592350042|FG005|Overall Study|Lost to Follow-up|1|||
163995892|NCT04964258|592350043|FG006|Overall Study|Lost to Follow-up|0|||
163995893|NCT04964258|592350044|FG007|Overall Study|Lost to Follow-up|0|||
164265067|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
163995894|NCT04964258|592350045|FG008|Overall Study|Lost to Follow-up|0|||
163995895|NCT04964258|592350046|FG009|Overall Study|Lost to Follow-up|0|||
163995896|NCT04964258|592350047|FG010|Overall Study|Lost to Follow-up|0|||
163995897|NCT02965378|592350048|FG000|Overall Study|Progression|16|||
163995898|NCT02965378|592350049|FG001|Overall Study|Progression|4|||
163995899|NCT02965378|592350048|FG000|Overall Study|Adverse Event|5|||
163995900|NCT02965378|592350049|FG001|Overall Study|Adverse Event|2|||
163995901|NCT02965378|592350048|FG000|Overall Study|Death|2|||
163995902|NCT02965378|592350049|FG001|Overall Study|Death|0|||
163995903|NCT02965378|592350048|FG000|Overall Study|Refusal|2|||
164265068|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
163995904|NCT02965378|592350049|FG001|Overall Study|Refusal|1|||
163995905|NCT02965378|592350048|FG000|Overall Study|Not protocol specified|0|||
163995906|NCT02965378|592350049|FG001|Overall Study|Not protocol specified|2|||
163995907|NCT01384292|592350052|FG000|Part B|Severe non-compliance to protocol|1|||
163995908|NCT01384292|592350053|FG001|Part B|Severe non-compliance to protocol|0|||
163995909|NCT01384292|592350054|FG002|Part B|Severe non-compliance to protocol|0|||
163995910|NCT01171612|592350056|FG000|Overall Study|Lost to Follow-up|51|||
163995911|NCT01285349|592350057|FG000|Overall Study|Lost to Follow-up|27|||
163995912|NCT01285349|592350058|FG001|Overall Study|Lost to Follow-up|20|||
163995913|NCT01285349|592350059|FG002|Overall Study|Lost to Follow-up|27|||
163995914|NCT00565617|592350060|FG000|Overall Study|Withdrawal by Subject|1|||
163995915|NCT03040024|592350061|FG000|Overall Study|Adverse Event|0|||
163995916|NCT03040024|592350062|FG001|Overall Study|Adverse Event|1|||
163995917|NCT03040024|592350063|FG002|Overall Study|Adverse Event|0|||
163995918|NCT03040024|592350061|FG000|Overall Study|Death|0|||
163995919|NCT03040024|592350062|FG001|Overall Study|Death|1|||
163995920|NCT03040024|592350063|FG002|Overall Study|Death|0|||
163995921|NCT03040024|592350061|FG000|Overall Study|Physician Decision|0|||
163995922|NCT03040024|592350062|FG001|Overall Study|Physician Decision|0|||
163995923|NCT03040024|592350063|FG002|Overall Study|Physician Decision|1|||
163995924|NCT01526148|592350065|FG000|Overall Study|Adverse Event|6|||
163995925|NCT01526148|592350066|FG001|Overall Study|Adverse Event|5|||
163995926|NCT01526148|592350065|FG000|Overall Study|Lost to Follow-up|3|||
163995927|NCT01526148|592350066|FG001|Overall Study|Lost to Follow-up|6|||
163995928|NCT01526148|592350065|FG000|Overall Study|Withdrawal by Subject|2|||
163995929|NCT01526148|592350066|FG001|Overall Study|Withdrawal by Subject|0|||
163995930|NCT01526148|592350065|FG000|Overall Study|Unstable Medical Condition|1|||
163995931|NCT01526148|592350066|FG001|Overall Study|Unstable Medical Condition|0|||
163995932|NCT01526148|592350065|FG000|Overall Study|Unable to discontinue concomitant med|1|||
163995933|NCT01526148|592350066|FG001|Overall Study|Unable to discontinue concomitant med|0|||
163995934|NCT01526148|592350065|FG000|Overall Study|Moved out of state|1|||
163995935|NCT01526148|592350066|FG001|Overall Study|Moved out of state|0|||
163995936|NCT01526148|592350065|FG000|Overall Study|Incarcerated|0|||
163995937|NCT01526148|592350066|FG001|Overall Study|Incarcerated|2|||
163995938|NCT01173653|592350067|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
163995939|NCT01173653|592350068|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
163995940|NCT01988090|592350083|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
163995941|NCT01988090|592350084|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
163995942|NCT01988090|592350083|FG000|Start Treament After Randomization|Protocol Violation|0|||
163995943|NCT01988090|592350084|FG001|Start Treament After Randomization|Protocol Violation|1|||
163995944|NCT01988090|592350083|FG000|Complete Study After Start|Withdrawal by Subject|2|||
163995945|NCT01988090|592350084|FG001|Complete Study After Start|Withdrawal by Subject|0|||
163995946|NCT01988090|592350083|FG000|Complete Study After Start|Protocol Violation|1|||
163995947|NCT01988090|592350084|FG001|Complete Study After Start|Protocol Violation|1|||
163995948|NCT01439945|592350097|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
163995949|NCT01439945|592350098|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
163995950|NCT01439945|592350099|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
163995951|NCT01439945|592350100|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
163995952|NCT01439945|592350097|FG000|Double-Blind Treatment Phase|Ineligible|1|||
163995953|NCT01439945|592350098|FG001|Double-Blind Treatment Phase|Ineligible|2|||
163995954|NCT01439945|592350099|FG002|Double-Blind Treatment Phase|Ineligible|0|||
163995955|NCT01439945|592350100|FG003|Double-Blind Treatment Phase|Ineligible|1|||
163995956|NCT04082663|592350101|FG000|Overall Study|Adverse Event|6|||
163995957|NCT04082663|592350101|FG000|Overall Study|Lost to Follow-up|1|||
163995958|NCT00927563|592350102|FG000|Overall Study|Lost to Follow-up|1|||
163995959|NCT00927563|592350102|FG000|Overall Study|Withdrawal by Subject|1|||
163995960|NCT03529409|592350105|FG000|Randomized|Lost to Follow-up|0|||
163995961|NCT03529409|592350106|FG001|Randomized|Lost to Follow-up|0|||
163995962|NCT03529409|592350107|FG002|Randomized|Lost to Follow-up|4|||
163995963|NCT03529409|592350105|FG000|Randomized|Excluded|0|||
163995964|NCT03529409|592350106|FG001|Randomized|Excluded|0|||
163995965|NCT03529409|592350107|FG002|Randomized|Excluded|1|||
163995966|NCT03529409|592350105|FG000|Post-treatment Assessment|Death|1|||
163995967|NCT03529409|592350106|FG001|Post-treatment Assessment|Death|0|||
164085723|NCT00772382|592677312|FG000|Overall Study|Lack of Efficacy|4|||
164265069|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
164265070|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265071|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
163995968|NCT03529409|592350107|FG002|Post-treatment Assessment|Death|0|||
163995969|NCT03529409|592350105|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
163995970|NCT03529409|592350106|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
163995971|NCT03529409|592350107|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
163995972|NCT03529409|592350105|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
163995973|NCT03529409|592350106|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
163995974|NCT03529409|592350107|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
163995975|NCT03529409|592350105|FG000|Follow-up Assessment|Death|1|||
163995976|NCT03529409|592350106|FG001|Follow-up Assessment|Death|0|||
163995977|NCT03529409|592350107|FG002|Follow-up Assessment|Death|0|||
163995978|NCT03529409|592350105|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
163995979|NCT03529409|592350106|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
163995980|NCT03529409|592350107|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
163995981|NCT01497262|592350110|FG000|Overall Study|Abnormal Lab Values|4|||
163995982|NCT01497262|592350110|FG000|Overall Study|Abnormal Test Procedure Result|1|||
163995983|NCT01497262|592350110|FG000|Overall Study|Physician Decision|1|||
163995984|NCT01497262|592350110|FG000|Overall Study|Withdrawal by Subject|2|||
163995985|NCT01497262|592350110|FG000|Overall Study|Adverse Event|2|||
163995986|NCT01497262|592350110|FG000|Overall Study|Protocol Violation|1|||
163995987|NCT05501119|592350111|FG000|Overall Study|Withdrawal by Subject|2|||
163995988|NCT05501119|592350111|FG000|Overall Study|Lost to Follow-up|5|||
163995989|NCT01752023|592350112|FG000|Overall Study|Physician Decision|2|||
163995990|NCT01752023|592350113|FG001|Overall Study|Physician Decision|1|||
163995991|NCT02542072|592350114|FG000|First Intervention (1 Month)|Adverse Event|1|||
163995992|NCT02542072|592350115|FG001|First Intervention (1 Month)|Adverse Event|1|||
163995993|NCT02542072|592350114|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
163995994|NCT02542072|592350115|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
163995995|NCT02542072|592350114|FG000|First Intervention (1 Month)|Lens discomfort|1|||
163995996|NCT02542072|592350115|FG001|First Intervention (1 Month)|Lens discomfort|2|||
163995997|NCT02542072|592350114|FG000|First Intervention (1 Month)|Protocol Violation|1|||
163995998|NCT02542072|592350115|FG001|First Intervention (1 Month)|Protocol Violation|0|||
163995999|NCT02542072|592350114|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
163996000|NCT02542072|592350115|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
163996001|NCT02542072|592350114|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
163996002|NCT02542072|592350115|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
163996003|NCT02440581|592350121|FG000|Overall Study|Death|0|||
163996004|NCT02440581|592350122|FG001|Overall Study|Death|0|||
163996005|NCT02440581|592350123|FG002|Overall Study|Death|7|||
164265072|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265073|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
164265074|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265075|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
164265076|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
164265077|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
164265078|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
164265079|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
164265080|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
164265081|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
164265082|NCT00624780|593338827|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
164265083|NCT00624780|593338828|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
164265084|NCT00624780|593338829|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
164265085|NCT00624780|593338830|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
164265086|NCT00624780|593338831|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
164265087|NCT00624780|593338832|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
164265088|NCT00624780|593338827|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
164265089|NCT00624780|593338828|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
164265090|NCT00624780|593338829|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
164265091|NCT00624780|593338830|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
164265092|NCT00624780|593338831|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
164265093|NCT00624780|593338832|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
164265094|NCT00624780|593338827|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
164265095|NCT00624780|593338828|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265096|NCT00624780|593338829|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265097|NCT00624780|593338830|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265098|NCT00624780|593338831|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265099|NCT00624780|593338832|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
164265100|NCT00624780|593338827|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265101|NCT00624780|593338828|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265102|NCT00624780|593338829|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
164265103|NCT00624780|593338830|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265104|NCT00624780|593338831|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265105|NCT00624780|593338832|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
164265106|NCT00624780|593338827|FG000|Follow-up (Week 26)|Death|0|||
164265107|NCT00624780|593338828|FG001|Follow-up (Week 26)|Death|0|||
164265108|NCT00624780|593338829|FG002|Follow-up (Week 26)|Death|1|||
164265109|NCT00624780|593338830|FG003|Follow-up (Week 26)|Death|0|||
164265110|NCT00624780|593338831|FG004|Follow-up (Week 26)|Death|0|||
164265111|NCT00624780|593338832|FG005|Follow-up (Week 26)|Death|0|||
164265112|NCT00624780|593338827|FG000|Follow-up (Week 26)|Adverse Event|0|||
164265113|NCT00624780|593338828|FG001|Follow-up (Week 26)|Adverse Event|0|||
163996006|NCT02440581|592350124|FG003|Overall Study|Death|5|||
163996007|NCT02440581|592350121|FG000|Overall Study|Transplanted|1|||
163996008|NCT02440581|592350122|FG001|Overall Study|Transplanted|0|||
163996009|NCT02440581|592350123|FG002|Overall Study|Transplanted|3|||
163996010|NCT02440581|592350124|FG003|Overall Study|Transplanted|2|||
163996011|NCT02440581|592350121|FG000|Overall Study|Withdrawal by Subject|4|||
163996012|NCT02440581|592350122|FG001|Overall Study|Withdrawal by Subject|11|||
163996013|NCT02440581|592350123|FG002|Overall Study|Withdrawal by Subject|3|||
163996014|NCT02440581|592350124|FG003|Overall Study|Withdrawal by Subject|7|||
163996015|NCT00654498|592350125|FG000|Overall Study|Not Treated|1|||
163996016|NCT00654498|592350126|FG001|Overall Study|Not Treated|0|||
163996017|NCT00654498|592350125|FG000|Overall Study|Adverse Event|6|||
163996018|NCT00654498|592350126|FG001|Overall Study|Adverse Event|1|||
163996019|NCT00654498|592350125|FG000|Overall Study|Protocol Violation|1|||
163996020|NCT00654498|592350126|FG001|Overall Study|Protocol Violation|1|||
163996021|NCT00654498|592350125|FG000|Overall Study|Lost to Follow-up|1|||
163996022|NCT00654498|592350126|FG001|Overall Study|Lost to Follow-up|5|||
163996023|NCT00654498|592350125|FG000|Overall Study|Withdrawal by Subject|1|||
163996024|NCT00654498|592350126|FG001|Overall Study|Withdrawal by Subject|0|||
163996025|NCT00654498|592350125|FG000|Overall Study|Other reason not defined above|4|||
163996026|NCT00654498|592350126|FG001|Overall Study|Other reason not defined above|5|||
163996027|NCT01468987|592350127|FG000|Overall Study|Adverse Event|12|||
163996028|NCT01468987|592350128|FG001|Overall Study|Adverse Event|9|||
163996029|NCT01468987|592350127|FG000|Overall Study|Death|4|||
163996030|NCT01468987|592350128|FG001|Overall Study|Death|1|||
163996031|NCT01468987|592350127|FG000|Overall Study|Lost to Follow-up|10|||
163996032|NCT01468987|592350128|FG001|Overall Study|Lost to Follow-up|5|||
163996033|NCT01468987|592350127|FG000|Overall Study|Protocol Violation|8|||
163996034|NCT01468987|592350128|FG001|Overall Study|Protocol Violation|2|||
163996035|NCT01468987|592350127|FG000|Overall Study|Withdrawal by Subject|28|||
163996036|NCT01468987|592350128|FG001|Overall Study|Withdrawal by Subject|28|||
163996037|NCT01468987|592350127|FG000|Overall Study|Physician Decision|8|||
163996038|NCT01468987|592350128|FG001|Overall Study|Physician Decision|15|||
163996039|NCT01468987|592350127|FG000|Overall Study|Sponsor Decision|1|||
163996040|NCT01468987|592350128|FG001|Overall Study|Sponsor Decision|0|||
163996041|NCT00787787|592350129|FG000|Overall Study|Lack of Efficacy|4|||
163996042|NCT00787787|592350129|FG000|Overall Study|Adverse Event|3|||
163996043|NCT00943683|592350130|FG000|Overall Study|Adverse Event|3|||
163996044|NCT00943683|592350131|FG001|Overall Study|Adverse Event|3|||
163996045|NCT00943683|592350130|FG000|Overall Study|Lost to Follow-up|1|||
163996046|NCT00943683|592350131|FG001|Overall Study|Lost to Follow-up|1|||
163996047|NCT00943683|592350130|FG000|Overall Study|Protocol Violation|1|||
163996048|NCT00943683|592350131|FG001|Overall Study|Protocol Violation|2|||
163996049|NCT00943683|592350130|FG000|Overall Study|Withdrawal by Subject|1|||
163996050|NCT00943683|592350131|FG001|Overall Study|Withdrawal by Subject|0|||
163996051|NCT00943683|592350130|FG000|Overall Study|Patient Moved|1|||
163996052|NCT00943683|592350131|FG001|Overall Study|Patient Moved|0|||
163996053|NCT01245673|592350132|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
163996054|NCT01459614|592350142|FG000|Overall Study|Adverse Event|1|||
163996055|NCT01459614|592350143|FG001|Overall Study|Adverse Event|0|||
163996056|NCT03283085|592350146|FG000|Overall Study|Adverse Event|18|||
163996057|NCT03283085|592350147|FG001|Overall Study|Adverse Event|3|||
163996058|NCT03283085|592350148|FG002|Overall Study|Adverse Event|13|||
163996059|NCT03283085|592350149|FG003|Overall Study|Adverse Event|0|||
163996060|NCT03283085|592350150|FG004|Overall Study|Adverse Event|0|||
163996061|NCT03283085|592350151|FG005|Overall Study|Adverse Event|5|||
163996062|NCT03283085|592350146|FG000|Overall Study|Death|0|||
163996063|NCT03283085|592350147|FG001|Overall Study|Death|0|||
163996064|NCT03283085|592350148|FG002|Overall Study|Death|3|||
163996065|NCT03283085|592350149|FG003|Overall Study|Death|1|||
163996066|NCT03283085|592350150|FG004|Overall Study|Death|0|||
163996067|NCT03283085|592350151|FG005|Overall Study|Death|0|||
163996068|NCT03283085|592350146|FG000|Overall Study|Withdrawal by Subject|42|||
163996069|NCT03283085|592350147|FG001|Overall Study|Withdrawal by Subject|21|||
163996070|NCT03283085|592350148|FG002|Overall Study|Withdrawal by Subject|66|||
163996071|NCT03283085|592350149|FG003|Overall Study|Withdrawal by Subject|3|||
163996072|NCT03283085|592350150|FG004|Overall Study|Withdrawal by Subject|3|||
163996073|NCT03283085|592350151|FG005|Overall Study|Withdrawal by Subject|5|||
163996074|NCT03283085|592350146|FG000|Overall Study|Physician Decision|14|||
163996075|NCT03283085|592350147|FG001|Overall Study|Physician Decision|8|||
163996076|NCT03283085|592350148|FG002|Overall Study|Physician Decision|19|||
163996077|NCT03283085|592350149|FG003|Overall Study|Physician Decision|0|||
163996078|NCT03283085|592350150|FG004|Overall Study|Physician Decision|0|||
163996079|NCT03283085|592350151|FG005|Overall Study|Physician Decision|2|||
163996080|NCT03283085|592350146|FG000|Overall Study|Site Terminated by Sponsor|1|||
163996081|NCT03283085|592350147|FG001|Overall Study|Site Terminated by Sponsor|0|||
163996082|NCT03283085|592350148|FG002|Overall Study|Site Terminated by Sponsor|3|||
163996083|NCT03283085|592350149|FG003|Overall Study|Site Terminated by Sponsor|0|||
163996084|NCT03283085|592350150|FG004|Overall Study|Site Terminated by Sponsor|0|||
163996085|NCT03283085|592350151|FG005|Overall Study|Site Terminated by Sponsor|0|||
163996086|NCT03283085|592350146|FG000|Overall Study|Lost to Follow-up|2|||
163996087|NCT03283085|592350147|FG001|Overall Study|Lost to Follow-up|0|||
163996088|NCT03283085|592350148|FG002|Overall Study|Lost to Follow-up|2|||
163996089|NCT03283085|592350149|FG003|Overall Study|Lost to Follow-up|0|||
163996090|NCT03283085|592350150|FG004|Overall Study|Lost to Follow-up|0|||
163996091|NCT03283085|592350151|FG005|Overall Study|Lost to Follow-up|1|||
163996092|NCT03283085|592350146|FG000|Overall Study|Pregnancy|0|||
163996093|NCT03283085|592350147|FG001|Overall Study|Pregnancy|0|||
163890265|NCT03209973|591970618|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
163890266|NCT03209973|591970618|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
163996094|NCT03283085|592350148|FG002|Overall Study|Pregnancy|1|||
163996095|NCT03283085|592350149|FG003|Overall Study|Pregnancy|0|||
163996096|NCT03283085|592350150|FG004|Overall Study|Pregnancy|0|||
163996097|NCT03283085|592350151|FG005|Overall Study|Pregnancy|0|||
163996098|NCT03283085|592350146|FG000|Overall Study|Lack of Efficacy|12|||
163996099|NCT03283085|592350147|FG001|Overall Study|Lack of Efficacy|6|||
163996100|NCT03283085|592350148|FG002|Overall Study|Lack of Efficacy|24|||
163996101|NCT03283085|592350149|FG003|Overall Study|Lack of Efficacy|1|||
163996102|NCT03283085|592350150|FG004|Overall Study|Lack of Efficacy|1|||
163996103|NCT03283085|592350151|FG005|Overall Study|Lack of Efficacy|0|||
163996104|NCT03283085|592350146|FG000|Overall Study|Reason not Specified|0|||
163996105|NCT03283085|592350147|FG001|Overall Study|Reason not Specified|4|||
163996106|NCT03283085|592350148|FG002|Overall Study|Reason not Specified|8|||
163996107|NCT03283085|592350149|FG003|Overall Study|Reason not Specified|0|||
163996108|NCT03283085|592350150|FG004|Overall Study|Reason not Specified|0|||
163890267|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
163890268|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
163890269|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
163890270|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
163890271|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
163890272|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
163890273|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
163890274|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
163890275|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
163890276|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
163890277|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
163890278|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
163890279|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
163890280|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
163890281|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
163890282|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
163890283|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
163890284|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
163890285|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
163890286|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
163890287|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
163890288|NCT04800211|591970623|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
163890289|NCT04800211|591970624|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
163890290|NCT04800211|591970625|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
163890291|NCT04800211|591970623|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
163890292|NCT04800211|591970624|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
163890293|NCT04800211|591970625|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
163890294|NCT04800211|591970623|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
163890295|NCT04800211|591970624|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
163890296|NCT04800211|591970625|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
163890297|NCT04800211|591970623|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
163890298|NCT04800211|591970624|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
163890299|NCT04800211|591970625|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
163890300|NCT05170841|591970626|FG000|Single Dose Phase|Adverse Event|1|||
163890301|NCT05170841|591970627|FG001|Single Dose Phase|Adverse Event|2|||
163996109|NCT03283085|592350151|FG005|Overall Study|Reason not Specified|1|||
163996110|NCT06001307|592351718|FG000|Overall Study|Lost to Follow-up|1|||
163996111|NCT06001307|592351719|FG001|Overall Study|Lost to Follow-up|2|||
163996112|NCT03532100|592351722|FG000|Overall Study|Intervention malfunction|1|||
163996113|NCT03896581|592351723|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
163996114|NCT03896581|592351724|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
163996115|NCT03896581|592351723|FG000|Overall Study|Withdrawal by Subject|4|||
163996116|NCT03896581|592351724|FG001|Overall Study|Withdrawal by Subject|1|||
163996117|NCT03896581|592351723|FG000|Overall Study|Lost to Follow-up|1|||
163996118|NCT03896581|592351724|FG001|Overall Study|Lost to Follow-up|0|||
163996119|NCT03896581|592351723|FG000|Overall Study|Lack of Efficacy|2|||
163996120|NCT03896581|592351724|FG001|Overall Study|Lack of Efficacy|1|||
163996121|NCT03896581|592351723|FG000|Overall Study|Adverse event, non-fatal|0|||
163890302|NCT05170841|591970628|FG002|Single Dose Phase|Adverse Event|0|||
163996122|NCT03896581|592351724|FG001|Overall Study|Adverse event, non-fatal|2|||
163996123|NCT02689492|592351727|FG000|Overall Study|Lost to Follow-up|61|||
163996124|NCT02689492|592351727|FG000|Overall Study|Withdrawal by Subject|11|||
163996125|NCT02689492|592351727|FG000|Overall Study|Death|9|||
163996126|NCT02689492|592351727|FG000|Overall Study|Physician Decision|2|||
163996127|NCT02689492|592351727|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
163996128|NCT02689492|592351727|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
163996129|NCT02689492|592351727|FG000|Overall Study|Other than listed|1|||
163996130|NCT01750918|592351728|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
163996131|NCT01750918|592351729|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
163996132|NCT01750918|592351730|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
163996133|NCT01750918|592351731|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
163996134|NCT01750918|592351732|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
163996135|NCT01750918|592351733|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
163996136|NCT01750918|592351734|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
163996137|NCT01750918|592351735|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
163996138|NCT01750918|592351728|FG000|Overall Study|Lost to Follow-up|0|||
163996139|NCT01750918|592351729|FG001|Overall Study|Lost to Follow-up|0|||
163996140|NCT01750918|592351730|FG002|Overall Study|Lost to Follow-up|2|||
163996141|NCT01750918|592351731|FG003|Overall Study|Lost to Follow-up|2|||
163996142|NCT01750918|592351732|FG004|Overall Study|Lost to Follow-up|0|||
163996143|NCT01750918|592351733|FG005|Overall Study|Lost to Follow-up|0|||
163996144|NCT01750918|592351734|FG006|Overall Study|Lost to Follow-up|0|||
163996145|NCT01750918|592351735|FG007|Overall Study|Lost to Follow-up|1|||
163996146|NCT01750918|592351728|FG000|Overall Study|Withdrawal by Subject|0|||
163996147|NCT01750918|592351729|FG001|Overall Study|Withdrawal by Subject|0|||
163996148|NCT01750918|592351730|FG002|Overall Study|Withdrawal by Subject|1|||
163996149|NCT01750918|592351731|FG003|Overall Study|Withdrawal by Subject|2|||
163996150|NCT01750918|592351732|FG004|Overall Study|Withdrawal by Subject|1|||
163996151|NCT01750918|592351733|FG005|Overall Study|Withdrawal by Subject|1|||
163996152|NCT01750918|592351734|FG006|Overall Study|Withdrawal by Subject|2|||
163996153|NCT01750918|592351735|FG007|Overall Study|Withdrawal by Subject|2|||
163996154|NCT00162773|592351744|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
163996155|NCT02338843|592351746|FG000|Overall Study|Adverse Event|2|||
163996156|NCT02338843|592351747|FG001|Overall Study|Adverse Event|1|||
163996157|NCT02338843|592351746|FG000|Overall Study|Death|40|||
163996158|NCT02338843|592351747|FG001|Overall Study|Death|53|||
163996159|NCT02338843|592351746|FG000|Overall Study|Physician Decision|1|||
163996160|NCT02338843|592351747|FG001|Overall Study|Physician Decision|0|||
163996161|NCT02338843|592351746|FG000|Overall Study|Withdrawal by Subject|0|||
163996162|NCT02338843|592351747|FG001|Overall Study|Withdrawal by Subject|2|||
163996163|NCT02338843|592351746|FG000|Overall Study|Subject Recovered|0|||
163996164|NCT02338843|592351747|FG001|Overall Study|Subject Recovered|2|||
163996165|NCT02338843|592351746|FG000|Overall Study|Discontinued prior to randomizat|1|||
163890303|NCT05170841|591970629|FG003|Single Dose Phase|Adverse Event|2|||
163890304|NCT05170841|591970626|FG000|Multiple Dose Phase|Adverse Event|1|||
163890305|NCT05170841|591970627|FG001|Multiple Dose Phase|Adverse Event|2|||
163890306|NCT05170841|591970628|FG002|Multiple Dose Phase|Adverse Event|1|||
163890307|NCT05170841|591970629|FG003|Multiple Dose Phase|Adverse Event|4|||
163890308|NCT05170841|591970626|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
163890309|NCT05170841|591970627|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
163890310|NCT05170841|591970628|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
163890311|NCT05170841|591970629|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
163890312|NCT05123586|591970632|FG000|Overall Study|Physician Decision|1|||
163890313|NCT05123586|591970633|FG001|Overall Study|Physician Decision|1|||
163890314|NCT05123586|591970632|FG000|Overall Study|Withdrawal by Subject|0|||
163890315|NCT05123586|591970633|FG001|Overall Study|Withdrawal by Subject|3|||
163890316|NCT06122194|591970652|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
163890317|NCT06122194|591970653|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
163890318|NCT06122194|591970654|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
163890319|NCT06122194|591970655|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
163890320|NCT03088878|591970663|FG000|Overall Study|Adverse Event|0|||
163890321|NCT03088878|591970664|FG001|Overall Study|Adverse Event|0|||
163890322|NCT03088878|591970665|FG002|Overall Study|Adverse Event|0|||
163890323|NCT03088878|591970666|FG003|Overall Study|Adverse Event|0|||
163890324|NCT03088878|591970667|FG004|Overall Study|Adverse Event|4|||
163890325|NCT03088878|591970668|FG005|Overall Study|Adverse Event|2|||
163890326|NCT03088878|591970669|FG006|Overall Study|Adverse Event|1|||
163890327|NCT03088878|591970670|FG007|Overall Study|Adverse Event|0|||
163890328|NCT03088878|591970671|FG008|Overall Study|Adverse Event|0|||
163890329|NCT03088878|591970672|FG009|Overall Study|Adverse Event|0|||
163890330|NCT03088878|591970673|FG010|Overall Study|Adverse Event|0|||
163890331|NCT03088878|591970674|FG011|Overall Study|Adverse Event|0|||
163890332|NCT03088878|591970675|FG012|Overall Study|Adverse Event|5|||
163890333|NCT03088878|591970676|FG013|Overall Study|Adverse Event|3|||
163890334|NCT03088878|591970663|FG000|Overall Study|Clinical Progression|0|||
163890335|NCT03088878|591970664|FG001|Overall Study|Clinical Progression|0|||
163890336|NCT03088878|591970665|FG002|Overall Study|Clinical Progression|0|||
163890337|NCT03088878|591970666|FG003|Overall Study|Clinical Progression|0|||
163890338|NCT03088878|591970667|FG004|Overall Study|Clinical Progression|2|||
163890339|NCT03088878|591970668|FG005|Overall Study|Clinical Progression|0|||
163890340|NCT03088878|591970669|FG006|Overall Study|Clinical Progression|0|||
163890341|NCT03088878|591970670|FG007|Overall Study|Clinical Progression|0|||
163890342|NCT03088878|591970671|FG008|Overall Study|Clinical Progression|0|||
163890343|NCT03088878|591970672|FG009|Overall Study|Clinical Progression|0|||
163890344|NCT03088878|591970673|FG010|Overall Study|Clinical Progression|0|||
163890345|NCT03088878|591970674|FG011|Overall Study|Clinical Progression|0|||
163890346|NCT03088878|591970675|FG012|Overall Study|Clinical Progression|0|||
163890347|NCT03088878|591970676|FG013|Overall Study|Clinical Progression|0|||
163890348|NCT03088878|591970663|FG000|Overall Study|Death|0|||
163890349|NCT03088878|591970664|FG001|Overall Study|Death|0|||
163890350|NCT03088878|591970665|FG002|Overall Study|Death|0|||
163890351|NCT03088878|591970666|FG003|Overall Study|Death|0|||
163890352|NCT03088878|591970667|FG004|Overall Study|Death|2|||
163890353|NCT03088878|591970668|FG005|Overall Study|Death|0|||
163890354|NCT03088878|591970669|FG006|Overall Study|Death|0|||
163890355|NCT03088878|591970670|FG007|Overall Study|Death|0|||
163890356|NCT03088878|591970671|FG008|Overall Study|Death|0|||
163890357|NCT03088878|591970672|FG009|Overall Study|Death|0|||
163890358|NCT03088878|591970673|FG010|Overall Study|Death|0|||
163890359|NCT03088878|591970674|FG011|Overall Study|Death|1|||
163890360|NCT03088878|591970675|FG012|Overall Study|Death|0|||
163890361|NCT03088878|591970676|FG013|Overall Study|Death|0|||
163890362|NCT03088878|591970663|FG000|Overall Study|Disease Progression|1|||
163890363|NCT03088878|591970664|FG001|Overall Study|Disease Progression|2|||
163890364|NCT03088878|591970665|FG002|Overall Study|Disease Progression|3|||
163890365|NCT03088878|591970666|FG003|Overall Study|Disease Progression|0|||
163890366|NCT03088878|591970667|FG004|Overall Study|Disease Progression|3|||
163890367|NCT03088878|591970668|FG005|Overall Study|Disease Progression|0|||
163890368|NCT03088878|591970669|FG006|Overall Study|Disease Progression|0|||
163890369|NCT03088878|591970670|FG007|Overall Study|Disease Progression|0|||
163890370|NCT03088878|591970671|FG008|Overall Study|Disease Progression|0|||
163890371|NCT03088878|591970672|FG009|Overall Study|Disease Progression|0|||
163996166|NCT02338843|592351747|FG001|Overall Study|Discontinued prior to randomizat|0|||
163890372|NCT03088878|591970673|FG010|Overall Study|Disease Progression|0|||
163890373|NCT03088878|591970674|FG011|Overall Study|Disease Progression|0|||
163890374|NCT03088878|591970675|FG012|Overall Study|Disease Progression|1|||
163996167|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
163890375|NCT03088878|591970676|FG013|Overall Study|Disease Progression|1|||
163890376|NCT03088878|591970663|FG000|Overall Study|Initiation of Alternative Treatment|0|||
163890377|NCT03088878|591970664|FG001|Overall Study|Initiation of Alternative Treatment|0|||
163890378|NCT03088878|591970665|FG002|Overall Study|Initiation of Alternative Treatment|0|||
163890379|NCT03088878|591970666|FG003|Overall Study|Initiation of Alternative Treatment|1|||
163890380|NCT03088878|591970667|FG004|Overall Study|Initiation of Alternative Treatment|0|||
163996168|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
163890381|NCT03088878|591970668|FG005|Overall Study|Initiation of Alternative Treatment|0|||
163996169|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
163996170|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
163996171|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
163996172|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
163996173|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
163996174|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
163996175|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
163996176|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
163996177|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
163996178|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163996179|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163996180|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163996181|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
163996182|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163996183|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
163996184|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163996185|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163996186|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
163996187|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
163996188|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
163996189|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
163996190|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
163996191|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
163996192|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
163996193|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
163996194|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
163996195|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
163996196|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
163996197|NCT02660580|592351754|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
163996198|NCT02660580|592351755|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
163996199|NCT02660580|592351756|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
163996200|NCT02660580|592351757|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
163996201|NCT02660580|592351758|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
163996202|NCT02660580|592351754|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
163996203|NCT02660580|592351755|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
163996204|NCT02660580|592351756|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
163996205|NCT02660580|592351757|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
163996206|NCT02660580|592351758|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
163996207|NCT02660580|592351754|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
163996208|NCT02660580|592351755|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
163996209|NCT02660580|592351756|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
163996210|NCT02660580|592351757|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
163996211|NCT02660580|592351758|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
163996212|NCT02660580|592351754|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
163996213|NCT02660580|592351755|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
163996214|NCT02660580|592351756|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
163996215|NCT02660580|592351757|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
163996216|NCT02660580|592351758|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
163996217|NCT02660580|592351754|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
163996218|NCT02660580|592351755|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
163890382|NCT03088878|591970669|FG006|Overall Study|Initiation of Alternative Treatment|0|||
163890383|NCT03088878|591970670|FG007|Overall Study|Initiation of Alternative Treatment|1|||
163890384|NCT03088878|591970671|FG008|Overall Study|Initiation of Alternative Treatment|1|||
163890385|NCT03088878|591970672|FG009|Overall Study|Initiation of Alternative Treatment|0|||
163890386|NCT03088878|591970673|FG010|Overall Study|Initiation of Alternative Treatment|0|||
163890387|NCT03088878|591970674|FG011|Overall Study|Initiation of Alternative Treatment|0|||
163890388|NCT03088878|591970675|FG012|Overall Study|Initiation of Alternative Treatment|0|||
163996219|NCT02660580|592351756|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
163996220|NCT02660580|592351757|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
164085724|NCT00772382|592677312|FG000|Overall Study|Physician Decision|5|||
164341477|NCT00415168|593625380|FG000|Overall Study|Physician Decision|13|||
163890389|NCT03088878|591970676|FG013|Overall Study|Initiation of Alternative Treatment|0|||
163890390|NCT03088878|591970663|FG000|Overall Study|Withdrawal by Subject|0|||
163890391|NCT03088878|591970664|FG001|Overall Study|Withdrawal by Subject|0|||
163890392|NCT03088878|591970665|FG002|Overall Study|Withdrawal by Subject|0|||
163890393|NCT03088878|591970666|FG003|Overall Study|Withdrawal by Subject|1|||
163890394|NCT03088878|591970667|FG004|Overall Study|Withdrawal by Subject|4|||
163890395|NCT03088878|591970668|FG005|Overall Study|Withdrawal by Subject|1|||
163890396|NCT03088878|591970669|FG006|Overall Study|Withdrawal by Subject|1|||
163890397|NCT03088878|591970670|FG007|Overall Study|Withdrawal by Subject|0|||
163890398|NCT03088878|591970671|FG008|Overall Study|Withdrawal by Subject|1|||
163890399|NCT03088878|591970672|FG009|Overall Study|Withdrawal by Subject|2|||
163890400|NCT03088878|591970673|FG010|Overall Study|Withdrawal by Subject|0|||
163890401|NCT03088878|591970674|FG011|Overall Study|Withdrawal by Subject|2|||
163890402|NCT03088878|591970675|FG012|Overall Study|Withdrawal by Subject|1|||
163890403|NCT03088878|591970676|FG013|Overall Study|Withdrawal by Subject|0|||
163890404|NCT03088878|591970663|FG000|Overall Study|Terminated by Sponsor|2|||
163890405|NCT03088878|591970664|FG001|Overall Study|Terminated by Sponsor|1|||
163890406|NCT03088878|591970665|FG002|Overall Study|Terminated by Sponsor|0|||
163890407|NCT03088878|591970666|FG003|Overall Study|Terminated by Sponsor|1|||
163890408|NCT03088878|591970667|FG004|Overall Study|Terminated by Sponsor|6|||
163890409|NCT03088878|591970668|FG005|Overall Study|Terminated by Sponsor|0|||
163890410|NCT03088878|591970669|FG006|Overall Study|Terminated by Sponsor|0|||
163890411|NCT03088878|591970670|FG007|Overall Study|Terminated by Sponsor|0|||
163890412|NCT03088878|591970671|FG008|Overall Study|Terminated by Sponsor|0|||
163890413|NCT03088878|591970672|FG009|Overall Study|Terminated by Sponsor|0|||
163890414|NCT03088878|591970673|FG010|Overall Study|Terminated by Sponsor|3|||
163890415|NCT03088878|591970674|FG011|Overall Study|Terminated by Sponsor|13|||
163890416|NCT03088878|591970675|FG012|Overall Study|Terminated by Sponsor|2|||
163890417|NCT03088878|591970676|FG013|Overall Study|Terminated by Sponsor|1|||
163890418|NCT03088878|591970663|FG000|Overall Study|Completed 2 years of Treatment|0|||
163890419|NCT03088878|591970664|FG001|Overall Study|Completed 2 years of Treatment|0|||
163890420|NCT03088878|591970665|FG002|Overall Study|Completed 2 years of Treatment|0|||
163890421|NCT03088878|591970666|FG003|Overall Study|Completed 2 years of Treatment|0|||
163890422|NCT03088878|591970667|FG004|Overall Study|Completed 2 years of Treatment|0|||
163890423|NCT03088878|591970668|FG005|Overall Study|Completed 2 years of Treatment|0|||
163890424|NCT03088878|591970669|FG006|Overall Study|Completed 2 years of Treatment|1|||
163890425|NCT03088878|591970670|FG007|Overall Study|Completed 2 years of Treatment|0|||
163890426|NCT03088878|591970671|FG008|Overall Study|Completed 2 years of Treatment|0|||
163890427|NCT03088878|591970672|FG009|Overall Study|Completed 2 years of Treatment|1|||
163890428|NCT03088878|591970673|FG010|Overall Study|Completed 2 years of Treatment|0|||
163890429|NCT03088878|591970674|FG011|Overall Study|Completed 2 years of Treatment|0|||
163890430|NCT03088878|591970675|FG012|Overall Study|Completed 2 years of Treatment|8|||
163890431|NCT03088878|591970676|FG013|Overall Study|Completed 2 years of Treatment|3|||
163890432|NCT03088878|591970663|FG000|Overall Study|Physician Decision|0|||
163890433|NCT03088878|591970664|FG001|Overall Study|Physician Decision|0|||
163890434|NCT03088878|591970665|FG002|Overall Study|Physician Decision|0|||
163890435|NCT03088878|591970666|FG003|Overall Study|Physician Decision|0|||
163890436|NCT03088878|591970667|FG004|Overall Study|Physician Decision|0|||
163890437|NCT03088878|591970668|FG005|Overall Study|Physician Decision|0|||
163890438|NCT03088878|591970669|FG006|Overall Study|Physician Decision|0|||
163890439|NCT03088878|591970670|FG007|Overall Study|Physician Decision|2|||
163890440|NCT03088878|591970671|FG008|Overall Study|Physician Decision|1|||
163890441|NCT03088878|591970672|FG009|Overall Study|Physician Decision|0|||
163890442|NCT03088878|591970673|FG010|Overall Study|Physician Decision|0|||
163890443|NCT03088878|591970674|FG011|Overall Study|Physician Decision|0|||
163890444|NCT03088878|591970675|FG012|Overall Study|Physician Decision|0|||
163890445|NCT03088878|591970676|FG013|Overall Study|Physician Decision|1|||
163890446|NCT03088878|591970663|FG000|Overall Study|COVID Related noncompliance|0|||
163890447|NCT03088878|591970664|FG001|Overall Study|COVID Related noncompliance|0|||
163890448|NCT03088878|591970665|FG002|Overall Study|COVID Related noncompliance|0|||
163890449|NCT03088878|591970666|FG003|Overall Study|COVID Related noncompliance|0|||
163890450|NCT03088878|591970667|FG004|Overall Study|COVID Related noncompliance|0|||
163890451|NCT03088878|591970668|FG005|Overall Study|COVID Related noncompliance|0|||
163890452|NCT03088878|591970669|FG006|Overall Study|COVID Related noncompliance|0|||
163890453|NCT03088878|591970670|FG007|Overall Study|COVID Related noncompliance|0|||
163890454|NCT03088878|591970671|FG008|Overall Study|COVID Related noncompliance|0|||
163890455|NCT03088878|591970672|FG009|Overall Study|COVID Related noncompliance|0|||
163890456|NCT03088878|591970673|FG010|Overall Study|COVID Related noncompliance|0|||
163890457|NCT03088878|591970674|FG011|Overall Study|COVID Related noncompliance|0|||
163890458|NCT03088878|591970675|FG012|Overall Study|COVID Related noncompliance|0|||
163890459|NCT03088878|591970676|FG013|Overall Study|COVID Related noncompliance|1|||
163890460|NCT03088878|591970663|FG000|Overall Study|Drug or Study Noncompliance|0|||
163890461|NCT03088878|591970664|FG001|Overall Study|Drug or Study Noncompliance|0|||
163890462|NCT03088878|591970665|FG002|Overall Study|Drug or Study Noncompliance|0|||
163890463|NCT03088878|591970666|FG003|Overall Study|Drug or Study Noncompliance|0|||
163890464|NCT03088878|591970667|FG004|Overall Study|Drug or Study Noncompliance|0|||
163996221|NCT02660580|592351758|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
163890465|NCT03088878|591970668|FG005|Overall Study|Drug or Study Noncompliance|0|||
163996222|NCT02660580|592351754|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
163996223|NCT02660580|592351755|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
163996224|NCT02660580|592351756|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
163996225|NCT02660580|592351757|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
163996226|NCT02660580|592351758|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
163996227|NCT02660580|592351754|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
163996228|NCT02660580|592351755|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
163996229|NCT02660580|592351756|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
163996230|NCT02660580|592351757|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
163996231|NCT02660580|592351758|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
163996232|NCT05415449|592351759|FG000|Overall Study|Lost to Follow-up|2|||
163996233|NCT05415449|592351759|FG000|Overall Study|Withdrawal by Subject|4|||
163996234|NCT02185521|592351762|FG000|Overall Study|Withdrawal by Subject|1|||
163996235|NCT02185521|592351762|FG000|Overall Study|Protocol Violation|1|||
163996236|NCT00398112|592351779|FG000|Overall Study|Adverse Event|4|||
163890466|NCT03088878|591970669|FG006|Overall Study|Drug or Study Noncompliance|0|||
163890467|NCT03088878|591970670|FG007|Overall Study|Drug or Study Noncompliance|0|||
163890468|NCT03088878|591970671|FG008|Overall Study|Drug or Study Noncompliance|0|||
163890469|NCT03088878|591970672|FG009|Overall Study|Drug or Study Noncompliance|0|||
163890470|NCT03088878|591970673|FG010|Overall Study|Drug or Study Noncompliance|0|||
163890471|NCT03088878|591970674|FG011|Overall Study|Drug or Study Noncompliance|0|||
163890472|NCT03088878|591970675|FG012|Overall Study|Drug or Study Noncompliance|1|||
163890473|NCT03088878|591970676|FG013|Overall Study|Drug or Study Noncompliance|0|||
163890474|NCT04690582|591970680|FG000|Overall Study|Withdrawal by Subject|6|||
163890475|NCT04690582|591970681|FG001|Overall Study|Withdrawal by Subject|4|||
163890476|NCT05104463|591970684|FG000|Overall Study|Adverse Event|1|||
163890477|NCT05104463|591970685|FG001|Overall Study|Adverse Event|1|||
163890478|NCT05104463|591970684|FG000|Overall Study|Lost to Follow-up|1|||
163890479|NCT05104463|591970685|FG001|Overall Study|Lost to Follow-up|1|||
163890480|NCT05104463|591970684|FG000|Overall Study|Physician Decision|1|||
163890481|NCT05104463|591970685|FG001|Overall Study|Physician Decision|0|||
163890482|NCT05104463|591970684|FG000|Overall Study|Protocol Violation|0|||
163890483|NCT05104463|591970685|FG001|Overall Study|Protocol Violation|2|||
163890484|NCT05104463|591970684|FG000|Overall Study|Withdrawal by Subject|1|||
163890485|NCT05104463|591970685|FG001|Overall Study|Withdrawal by Subject|1|||
163890486|NCT05267470|591970686|FG000|Overall Study|Decision by sponsor|0|||
163890487|NCT05267470|591970687|FG001|Overall Study|Decision by sponsor|3|||
163890488|NCT05267470|591970688|FG002|Overall Study|Decision by sponsor|19|||
163890489|NCT05267470|591970689|FG003|Overall Study|Decision by sponsor|7|||
163890490|NCT05267470|591970690|FG004|Overall Study|Decision by sponsor|3|||
163890491|NCT05267470|591970686|FG000|Overall Study|Withdrawal by Subject|1|||
163890492|NCT05267470|591970687|FG001|Overall Study|Withdrawal by Subject|1|||
163890493|NCT05267470|591970688|FG002|Overall Study|Withdrawal by Subject|2|||
163890494|NCT05267470|591970689|FG003|Overall Study|Withdrawal by Subject|2|||
163890495|NCT05267470|591970690|FG004|Overall Study|Withdrawal by Subject|0|||
163890496|NCT05267470|591970686|FG000|Overall Study|Death|3|||
163890497|NCT05267470|591970687|FG001|Overall Study|Death|5|||
163890498|NCT05267470|591970688|FG002|Overall Study|Death|8|||
163890499|NCT05267470|591970689|FG003|Overall Study|Death|18|||
163890500|NCT05267470|591970690|FG004|Overall Study|Death|1|||
163890501|NCT05267470|591970686|FG000|Overall Study|Lost to Follow-up|0|||
163890502|NCT05267470|591970687|FG001|Overall Study|Lost to Follow-up|0|||
163890503|NCT05267470|591970688|FG002|Overall Study|Lost to Follow-up|0|||
163890504|NCT05267470|591970689|FG003|Overall Study|Lost to Follow-up|1|||
163890505|NCT05267470|591970690|FG004|Overall Study|Lost to Follow-up|0|||
163890506|NCT04428203|591970691|FG000|Overall Study|Adverse Event|1|||
163996237|NCT00398112|592351779|FG000|Overall Study|Disease progression|9|||
163996238|NCT00398112|592351779|FG000|Overall Study|Alternative treatment|1|||
163996239|NCT00398112|592351779|FG000|Overall Study|Withdrawal by Subject|3|||
163996240|NCT00398112|592351779|FG000|Overall Study|Death|1|||
163996241|NCT00582556|592351780|FG000|Overall Study|Withdrawal by Subject|0|||
163890507|NCT04428203|591970692|FG001|Overall Study|Adverse Event|0|||
163890508|NCT04428203|591970693|FG002|Overall Study|Adverse Event|0|||
163890509|NCT04428203|591970691|FG000|Overall Study|Withdrawal by Subject|1|||
163890510|NCT04428203|591970692|FG001|Overall Study|Withdrawal by Subject|0|||
163996242|NCT00582556|592351781|FG001|Overall Study|Withdrawal by Subject|1|||
163996243|NCT00582556|592351782|FG002|Overall Study|Withdrawal by Subject|1|||
163996244|NCT00582556|592351780|FG000|Overall Study|Physician Decision|0|||
163890511|NCT04428203|591970693|FG002|Overall Study|Withdrawal by Subject|1|||
163890512|NCT02823145|591970694|FG000|Enrollment|Other|1|||
163890513|NCT02823145|591970695|FG001|Enrollment|Other|0|||
163890514|NCT02823145|591970694|FG000|Treatment|Adverse Event|0|||
163890515|NCT02823145|591970695|FG001|Treatment|Adverse Event|11|||
163890516|NCT02823145|591970694|FG000|Treatment|Death|0|||
163890517|NCT02823145|591970695|FG001|Treatment|Death|3|||
163996245|NCT00582556|592351781|FG001|Overall Study|Physician Decision|0|||
163996246|NCT00582556|592351782|FG002|Overall Study|Physician Decision|1|||
163996247|NCT01993888|592351783|FG000|Overall Study|Death|1|||
163996248|NCT01993888|592351784|FG001|Overall Study|Death|1|||
163996249|NCT01993888|592351783|FG000|Overall Study|Lost to Follow-up|1|||
163996250|NCT01993888|592351784|FG001|Overall Study|Lost to Follow-up|1|||
163996251|NCT01993888|592351783|FG000|Overall Study|Withdrawal by Subject|0|||
163996252|NCT01993888|592351784|FG001|Overall Study|Withdrawal by Subject|1|||
163996253|NCT03124459|592351788|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163996254|NCT03124459|592351789|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163996255|NCT03124459|592351790|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163996256|NCT03124459|592351791|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163996257|NCT03124459|592351792|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
163996258|NCT03124459|592351793|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
163996259|NCT03124459|592351788|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163996260|NCT03124459|592351789|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163996261|NCT03124459|592351790|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163996262|NCT03124459|592351791|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163996263|NCT03124459|592351792|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
163996264|NCT03124459|592351793|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
163996265|NCT03124459|592351788|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163996266|NCT03124459|592351789|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163996267|NCT03124459|592351790|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163996268|NCT03124459|592351791|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
163996269|NCT03124459|592351792|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
163996270|NCT03124459|592351793|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
163996271|NCT03124459|592351788|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163996272|NCT03124459|592351789|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163996273|NCT03124459|592351790|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163996274|NCT03124459|592351791|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
163996275|NCT03124459|592351792|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
163996276|NCT03124459|592351793|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
163996277|NCT03124459|592351788|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163996278|NCT03124459|592351789|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163996279|NCT03124459|592351790|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163996280|NCT03124459|592351791|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163996281|NCT03124459|592351792|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
163996282|NCT03124459|592351793|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
163996283|NCT03124459|592351788|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163996284|NCT03124459|592351789|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163996285|NCT03124459|592351790|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163996286|NCT03124459|592351791|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163996287|NCT03124459|592351792|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
163996288|NCT03124459|592351793|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
163996289|NCT01028352|592351794|FG000|Overall Study|Ineligible due to baseline average pain|5|||
163996290|NCT01028352|592351794|FG000|Overall Study|Withdrawal by Subject|1|||
163996291|NCT01903876|592351795|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
163996292|NCT01903876|592351796|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
163996293|NCT01903876|592351795|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
163996294|NCT01903876|592351796|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
163996295|NCT00826748|592351807|FG000|Overall Study|Withdrawal by Subject|0|||
163996296|NCT00826748|592351808|FG001|Overall Study|Withdrawal by Subject|0|||
163996297|NCT00826748|592351809|FG002|Overall Study|Withdrawal by Subject|2|||
163996298|NCT00826748|592351807|FG000|Overall Study|Physician Decision|0|||
163996299|NCT00826748|592351808|FG001|Overall Study|Physician Decision|0|||
163996300|NCT00826748|592351809|FG002|Overall Study|Physician Decision|1|||
163996301|NCT00826748|592351807|FG000|Overall Study|Samples Did Not pass QC|0|||
163996302|NCT00826748|592351808|FG001|Overall Study|Samples Did Not pass QC|0|||
163996303|NCT00826748|592351809|FG002|Overall Study|Samples Did Not pass QC|1|||
163996304|NCT02300129|592351811|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
163996305|NCT02300129|592351812|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
163996306|NCT02300129|592351813|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
163996307|NCT02300129|592351814|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
163996308|NCT02300129|592351811|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
163996309|NCT02300129|592351812|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
163996310|NCT02300129|592351813|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
163996311|NCT02300129|592351814|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
163996312|NCT02300129|592351811|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
163996313|NCT02300129|592351812|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
164085725|NCT00772382|592677312|FG000|Overall Study|Protocol Violation|1|||
163996314|NCT02300129|592351813|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
163996315|NCT02300129|592351814|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
163996316|NCT01887912|592351815|FG000|Overall Study|Serious adverse event|400|||
163996317|NCT01887912|592351816|FG001|Overall Study|Serious adverse event|198|||
163996318|NCT01887912|592351815|FG000|Overall Study|Other Adverse Event|34|||
163996319|NCT01887912|592351816|FG001|Overall Study|Other Adverse Event|15|||
163996320|NCT01887912|592351815|FG000|Overall Study|Protocol Violation|67|||
163996321|NCT01887912|592351816|FG001|Overall Study|Protocol Violation|37|||
163996322|NCT01887912|592351815|FG000|Overall Study|Lost to Follow-up|163|||
163996323|NCT01887912|592351816|FG001|Overall Study|Lost to Follow-up|74|||
163996324|NCT01887912|592351815|FG000|Overall Study|Withdrawal by Subject|606|||
163996325|NCT01887912|592351816|FG001|Overall Study|Withdrawal by Subject|349|||
163996326|NCT01887912|592351815|FG000|Overall Study|Other|122|||
163996327|NCT01887912|592351816|FG001|Overall Study|Other|58|||
163996328|NCT04462536|592351817|FG000|Overall Study|Withdrawal by Subject|3|||
163996329|NCT04462536|592351818|FG001|Overall Study|Withdrawal by Subject|9|||
163996330|NCT04462536|592351817|FG000|Overall Study|Lost to Follow-up|2|||
163996331|NCT04462536|592351818|FG001|Overall Study|Lost to Follow-up|4|||
163996332|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
163996333|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
163996334|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
163996335|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
163996336|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
163996337|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
163996338|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
163996339|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
163996340|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
163996341|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
163996342|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
163996343|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
163996344|NCT02747927|592351819|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
163996345|NCT02747927|592351820|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
163996346|NCT02747927|592351819|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
163996347|NCT02747927|592351820|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
163996348|NCT02747927|592351819|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
163996349|NCT02747927|592351820|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
163996350|NCT02747927|592351819|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
163996351|NCT02747927|592351820|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
163996352|NCT02747927|592351819|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
163996353|NCT02747927|592351820|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
163996354|NCT02747927|592351819|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
163996355|NCT02747927|592351820|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
163996356|NCT02747927|592351819|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
163996357|NCT02747927|592351820|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
163996358|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
163996359|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
163996360|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
163996361|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
163996362|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
163996363|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
163996364|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
163996365|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
163996366|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
163996367|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
163996368|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
163996369|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
163996370|NCT02747927|592351819|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
164265114|NCT00624780|593338829|FG002|Follow-up (Week 26)|Adverse Event|0|||
164265115|NCT00624780|593338830|FG003|Follow-up (Week 26)|Adverse Event|0|||
164265116|NCT00624780|593338831|FG004|Follow-up (Week 26)|Adverse Event|1|||
164265117|NCT00624780|593338832|FG005|Follow-up (Week 26)|Adverse Event|0|||
164265118|NCT00624780|593338827|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
164085726|NCT00772382|592677312|FG000|Overall Study|Withdrawal by Subject|10|||
164265119|NCT00624780|593338828|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
164085727|NCT00772382|592677312|FG000|Overall Study|Other Reasons|10|||
164085728|NCT05576012|592677317|FG000|Overall Study|Physician Decision|0|||
164085729|NCT05576012|592677318|FG001|Overall Study|Physician Decision|0|||
164085730|NCT05576012|592677319|FG002|Overall Study|Physician Decision|0|||
164085731|NCT05576012|592677320|FG003|Overall Study|Physician Decision|0|||
164085732|NCT05576012|592677321|FG004|Overall Study|Physician Decision|0|||
164085733|NCT05576012|592677322|FG005|Overall Study|Physician Decision|0|||
164085734|NCT05576012|592677323|FG006|Overall Study|Physician Decision|0|||
164085735|NCT05576012|592677324|FG007|Overall Study|Physician Decision|0|||
164085736|NCT05576012|592677325|FG008|Overall Study|Physician Decision|1|||
164085737|NCT05576012|592677326|FG009|Overall Study|Physician Decision|0|||
164085738|NCT03731182|592678513|FG000|Overall Study|Lost to Follow-up|2|||
164085739|NCT03731182|592678514|FG001|Overall Study|Lost to Follow-up|0|||
164085740|NCT03731182|592678513|FG000|Overall Study|Physician Decision|1|||
164085741|NCT03731182|592678514|FG001|Overall Study|Physician Decision|0|||
164085742|NCT03731182|592678513|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
164085743|NCT03731182|592678514|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164085744|NCT03036579|592678521|FG000|2 Years|Lost to Follow-up|1|||
164085745|NCT03036579|592678522|FG001|2 Years|Lost to Follow-up|0|||
164085746|NCT03036579|592678521|FG000|3 Years|Lost to Follow-up|0|||
163890518|NCT02823145|591970694|FG000|Treatment|Family Decision|0|||
163890519|NCT02823145|591970695|FG001|Treatment|Family Decision|1|||
163890520|NCT02823145|591970694|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
164085747|NCT03036579|592678522|FG001|3 Years|Lost to Follow-up|1|||
164085748|NCT02352337|592678523|FG000|Overall Study|Patients never treated|4|||
164085749|NCT02352337|592678524|FG001|Overall Study|Patients never treated|1|||
164085750|NCT02352337|592678525|FG002|Overall Study|Patients never treated|2|||
164085751|NCT02458638|592678528|FG000|Overall Study|Death|309|||
164085752|NCT02458638|592678528|FG000|Overall Study|End of Cohort/End of Study|67|||
164085753|NCT02458638|592678528|FG000|Overall Study|Lost to Follow-up|31|||
164085754|NCT02458638|592678528|FG000|Overall Study|Other Reasons|4|||
164085755|NCT02458638|592678528|FG000|Overall Study|Physician Decision|1|||
164085756|NCT02458638|592678528|FG000|Overall Study|Withdrawal by Subject|47|||
164085757|NCT00576901|592678540|FG000|Overall Study|Withdrawal by Subject|1|||
164085758|NCT00576901|592678540|FG000|Overall Study|Disease course|1|||
164085759|NCT00576901|592678540|FG000|Overall Study|Protocol Violation|1|||
164085760|NCT02398188|592678541|FG000|Overall Study|Adverse Event|2|||
163890521|NCT02823145|591970695|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
163890522|NCT02823145|591970694|FG000|Treatment|Lack of Efficacy|0|||
163890523|NCT02823145|591970695|FG001|Treatment|Lack of Efficacy|48|||
163890524|NCT02823145|591970694|FG000|Treatment|Non-Compliance With E-Diary|0|||
163890525|NCT02823145|591970695|FG001|Treatment|Non-Compliance With E-Diary|1|||
163890526|NCT02823145|591970694|FG000|Treatment|Physician Decision|0|||
163890527|NCT02823145|591970695|FG001|Treatment|Physician Decision|2|||
163890528|NCT02823145|591970694|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
163890529|NCT02823145|591970695|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
163890530|NCT02823145|591970694|FG000|Treatment|Subject needed to take prohibited medication|0|||
163890531|NCT02823145|591970695|FG001|Treatment|Subject needed to take prohibited medication|1|||
163890532|NCT02823145|591970694|FG000|Treatment|Subject transferred to direct access programme|0|||
163890533|NCT02823145|591970695|FG001|Treatment|Subject transferred to direct access programme|1|||
163890534|NCT02823145|591970694|FG000|Treatment|Switching to commercially available drug|0|||
163890535|NCT02823145|591970695|FG001|Treatment|Switching to commercially available drug|11|||
163890536|NCT02823145|591970694|FG000|Treatment|Transitioned to commercial supply of medication|0|||
163890537|NCT02823145|591970695|FG001|Treatment|Transitioned to commercial supply of medication|1|||
163890538|NCT02823145|591970694|FG000|Treatment|Withdrawal By Caregiver|0|||
163890539|NCT02823145|591970695|FG001|Treatment|Withdrawal By Caregiver|1|||
163890540|NCT02823145|591970694|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
163890541|NCT02823145|591970695|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
163890542|NCT02823145|591970694|FG000|Treatment|Withdrawal by Subject|0|||
163890543|NCT02823145|591970695|FG001|Treatment|Withdrawal by Subject|16|||
163890544|NCT02823145|591970694|FG000|Treatment|Reason unknown|0|||
163890545|NCT02823145|591970695|FG001|Treatment|Reason unknown|1|||
163890546|NCT04622046|591970696|FG000|Intervention Period|Adverse Event|1|||
163890547|NCT04622046|591970696|FG000|Intervention Period|Withdrawal by Subject|2|||
163890548|NCT04622046|591970696|FG000|Extension Period|Ongoing in the Extension Period|21|||
163890549|NCT04171141|591972673|FG000|Overall Study|Adverse Event|0|||
163890550|NCT04171141|591972674|FG001|Overall Study|Adverse Event|0|||
164265120|NCT00624780|593338829|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
163890551|NCT04171141|591972675|FG002|Overall Study|Adverse Event|2|||
163890552|NCT04171141|591972676|FG003|Overall Study|Adverse Event|0|||
163890553|NCT04171141|591972677|FG004|Overall Study|Adverse Event|0|||
163890554|NCT04171141|591972678|FG005|Overall Study|Adverse Event|0|||
164085761|NCT02398188|592678542|FG001|Overall Study|Adverse Event|3|||
164085762|NCT02398188|592678541|FG000|Overall Study|Lost to Follow-up|5|||
164085763|NCT02398188|592678542|FG001|Overall Study|Lost to Follow-up|0|||
164085764|NCT02398188|592678541|FG000|Overall Study|Non-compliance|4|||
164265121|NCT00624780|593338830|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
164265122|NCT00624780|593338831|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
164265123|NCT00624780|593338832|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
163890555|NCT04171141|591972679|FG006|Overall Study|Adverse Event|0|||
163890556|NCT04171141|591972680|FG007|Overall Study|Adverse Event|0|||
163890557|NCT04171141|591972681|FG008|Overall Study|Adverse Event|0|||
163890558|NCT04171141|591972682|FG009|Overall Study|Adverse Event|0|||
163890559|NCT04171141|591972683|FG010|Overall Study|Adverse Event|0|||
163890560|NCT04171141|591972684|FG011|Overall Study|Adverse Event|0|||
163890561|NCT04171141|591972685|FG012|Overall Study|Adverse Event|0|||
163890562|NCT04171141|591972686|FG013|Overall Study|Adverse Event|2|||
163890563|NCT04171141|591972687|FG014|Overall Study|Adverse Event|0|||
163890564|NCT04171141|591972688|FG015|Overall Study|Adverse Event|0|||
163890565|NCT04171141|591972673|FG000|Overall Study|Physician Decision|0|||
163890566|NCT04171141|591972674|FG001|Overall Study|Physician Decision|0|||
163890567|NCT04171141|591972675|FG002|Overall Study|Physician Decision|0|||
163890568|NCT04171141|591972676|FG003|Overall Study|Physician Decision|0|||
163890569|NCT04171141|591972677|FG004|Overall Study|Physician Decision|1|||
163890570|NCT04171141|591972678|FG005|Overall Study|Physician Decision|0|||
163890571|NCT04171141|591972679|FG006|Overall Study|Physician Decision|0|||
163890572|NCT04171141|591972680|FG007|Overall Study|Physician Decision|0|||
163890573|NCT04171141|591972681|FG008|Overall Study|Physician Decision|0|||
163890574|NCT04171141|591972682|FG009|Overall Study|Physician Decision|0|||
163890575|NCT04171141|591972683|FG010|Overall Study|Physician Decision|0|||
163890576|NCT04171141|591972684|FG011|Overall Study|Physician Decision|0|||
163890577|NCT04171141|591972685|FG012|Overall Study|Physician Decision|0|||
163890578|NCT04171141|591972686|FG013|Overall Study|Physician Decision|0|||
163890579|NCT04171141|591972687|FG014|Overall Study|Physician Decision|0|||
163890580|NCT04171141|591972688|FG015|Overall Study|Physician Decision|1|||
163890581|NCT04171141|591972673|FG000|Overall Study|Progressive disease|2|||
163890582|NCT04171141|591972674|FG001|Overall Study|Progressive disease|3|||
163890583|NCT04171141|591972675|FG002|Overall Study|Progressive disease|4|||
163890584|NCT04171141|591972676|FG003|Overall Study|Progressive disease|7|||
163890585|NCT04171141|591972677|FG004|Overall Study|Progressive disease|1|||
163890586|NCT04171141|591972678|FG005|Overall Study|Progressive disease|8|||
163890587|NCT04171141|591972679|FG006|Overall Study|Progressive disease|4|||
163890588|NCT04171141|591972680|FG007|Overall Study|Progressive disease|6|||
163890589|NCT04171141|591972681|FG008|Overall Study|Progressive disease|7|||
163890590|NCT04171141|591972682|FG009|Overall Study|Progressive disease|3|||
163890591|NCT04171141|591972683|FG010|Overall Study|Progressive disease|4|||
163890592|NCT04171141|591972684|FG011|Overall Study|Progressive disease|3|||
163890593|NCT04171141|591972685|FG012|Overall Study|Progressive disease|4|||
163890594|NCT04171141|591972686|FG013|Overall Study|Progressive disease|2|||
163890595|NCT04171141|591972687|FG014|Overall Study|Progressive disease|4|||
163890596|NCT04171141|591972688|FG015|Overall Study|Progressive disease|1|||
163890597|NCT04171141|591972673|FG000|Overall Study|Withdrawal by Subject|0|||
163890598|NCT04171141|591972674|FG001|Overall Study|Withdrawal by Subject|0|||
163890599|NCT04171141|591972675|FG002|Overall Study|Withdrawal by Subject|0|||
163890600|NCT04171141|591972676|FG003|Overall Study|Withdrawal by Subject|1|||
163890601|NCT04171141|591972677|FG004|Overall Study|Withdrawal by Subject|0|||
163890602|NCT04171141|591972678|FG005|Overall Study|Withdrawal by Subject|0|||
163890603|NCT04171141|591972679|FG006|Overall Study|Withdrawal by Subject|1|||
163890604|NCT04171141|591972680|FG007|Overall Study|Withdrawal by Subject|0|||
163890605|NCT04171141|591972681|FG008|Overall Study|Withdrawal by Subject|0|||
163890606|NCT04171141|591972682|FG009|Overall Study|Withdrawal by Subject|1|||
163890607|NCT04171141|591972683|FG010|Overall Study|Withdrawal by Subject|0|||
163890608|NCT04171141|591972684|FG011|Overall Study|Withdrawal by Subject|0|||
163890609|NCT04171141|591972685|FG012|Overall Study|Withdrawal by Subject|0|||
163890610|NCT04171141|591972686|FG013|Overall Study|Withdrawal by Subject|0|||
163890611|NCT04171141|591972687|FG014|Overall Study|Withdrawal by Subject|0|||
163890612|NCT04171141|591972688|FG015|Overall Study|Withdrawal by Subject|0|||
163890613|NCT04171141|591972673|FG000|Overall Study|Global deterioration of health status|0|||
163890614|NCT04171141|591972674|FG001|Overall Study|Global deterioration of health status|0|||
163996371|NCT02747927|592351820|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
163996372|NCT02747927|592351819|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
163890615|NCT04171141|591972675|FG002|Overall Study|Global deterioration of health status|0|||
163890616|NCT04171141|591972676|FG003|Overall Study|Global deterioration of health status|1|||
163890617|NCT04171141|591972677|FG004|Overall Study|Global deterioration of health status|0|||
163890618|NCT04171141|591972678|FG005|Overall Study|Global deterioration of health status|2|||
163890619|NCT04171141|591972679|FG006|Overall Study|Global deterioration of health status|1|||
163890620|NCT04171141|591972680|FG007|Overall Study|Global deterioration of health status|0|||
163890621|NCT04171141|591972681|FG008|Overall Study|Global deterioration of health status|1|||
163890622|NCT04171141|591972682|FG009|Overall Study|Global deterioration of health status|0|||
163890623|NCT04171141|591972683|FG010|Overall Study|Global deterioration of health status|0|||
163890624|NCT04171141|591972684|FG011|Overall Study|Global deterioration of health status|0|||
163890625|NCT04171141|591972685|FG012|Overall Study|Global deterioration of health status|0|||
163996373|NCT02747927|592351820|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
163996374|NCT02747927|592351819|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
163996375|NCT02747927|592351820|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
163996376|NCT02747927|592351819|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
163996377|NCT02747927|592351820|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
163996378|NCT02747927|592351819|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
163996379|NCT02747927|592351820|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
163996380|NCT02747927|592351819|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
163996381|NCT02747927|592351820|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
163996382|NCT02747927|592351819|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
163996383|NCT02747927|592351820|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
163996384|NCT02747927|592351819|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
163996385|NCT02747927|592351820|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
163996386|NCT02747927|592351819|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
163996387|NCT02747927|592351820|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
163996388|NCT02747927|592351819|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
163996389|NCT02747927|592351820|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
163996390|NCT02747927|592351819|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
163996391|NCT02747927|592351820|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
163996392|NCT02747927|592351819|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
163996393|NCT02747927|592351820|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
163996394|NCT02747927|592351819|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
163996395|NCT02747927|592351820|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
163996396|NCT00450580|592351823|FG000|Overall Study|Adverse Event|5|||
163996397|NCT00450580|592351824|FG001|Overall Study|Adverse Event|7|||
163996398|NCT00450580|592351823|FG000|Overall Study|Lost to Follow-up|4|||
163996399|NCT00450580|592351824|FG001|Overall Study|Lost to Follow-up|5|||
163996400|NCT00450580|592351823|FG000|Overall Study|Withdrawal by Subject|2|||
164085765|NCT02398188|592678542|FG001|Overall Study|Non-compliance|4|||
164085766|NCT02398188|592678541|FG000|Overall Study|Protocol Violation|6|||
164085767|NCT02398188|592678542|FG001|Overall Study|Protocol Violation|10|||
164085768|NCT02398188|592678541|FG000|Overall Study|Sponsor Decision|2|||
164085769|NCT02398188|592678542|FG001|Overall Study|Sponsor Decision|1|||
164085770|NCT02398188|592678541|FG000|Overall Study|Pregnancy|1|||
164085771|NCT02398188|592678542|FG001|Overall Study|Pregnancy|0|||
164085772|NCT02398188|592678541|FG000|Overall Study|Withdrawal by Subject|7|||
164085773|NCT02398188|592678542|FG001|Overall Study|Withdrawal by Subject|16|||
164341478|NCT00415168|593625380|FG000|Overall Study|Sponsor Decision|4|||
164341479|NCT00415168|593625380|FG000|Overall Study|Withdrawal by Subject|6|||
164341480|NCT01612858|593625382|FG000|Overall Study|Withdrawal by Subject|5|||
164341481|NCT01612858|593625383|FG001|Overall Study|Withdrawal by Subject|1|||
164341482|NCT00003487|593625384|FG000|Overall Study|Not evaluable|2|||
164085774|NCT01259869|592678543|FG000|Overall Study|Duplicated registration|1|||
164085775|NCT05245617|592678544|FG000|Overall Study|Withdrawal by Subject|1|||
164085776|NCT00620763|592678545|FG000|Period: First Intervention|Withdrawal by Subject|0|||
164085777|NCT00620763|592678546|FG001|Period: First Intervention|Withdrawal by Subject|2|||
164085778|NCT00620763|592678545|FG000|Period: First Intervention|Protocol Violation|0|||
164085779|NCT00620763|592678546|FG001|Period: First Intervention|Protocol Violation|3|||
164085780|NCT00620763|592678545|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
164085781|NCT00620763|592678546|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
164085782|NCT00729859|592678547|FG000|Overall Study|Adverse Event|0|||
164085783|NCT00729859|592678548|FG001|Overall Study|Adverse Event|1|||
164341483|NCT00005044|593625387|FG000|Overall Study|Protocol Violation|37|||
164341484|NCT00005044|593625388|FG001|Overall Study|Protocol Violation|46|||
164341485|NCT00005044|593625387|FG000|Overall Study|Withdrawal by Subject|1|||
164341486|NCT00005044|593625388|FG001|Overall Study|Withdrawal by Subject|5|||
164341487|NCT00005044|593625387|FG000|Overall Study|No protocol treatment|0|||
164341488|NCT00005044|593625388|FG001|Overall Study|No protocol treatment|1|||
163890626|NCT04171141|591972686|FG013|Overall Study|Global deterioration of health status|0|||
163890627|NCT04171141|591972687|FG014|Overall Study|Global deterioration of health status|1|||
163890628|NCT04171141|591972688|FG015|Overall Study|Global deterioration of health status|1|||
163890629|NCT03314454|591972689|FG000|Overall Study|Protocol Violation|1|||
163890630|NCT04119843|591972690|FG000|Overall Study|Adverse Event|3|||
163890631|NCT04119843|591972690|FG000|Overall Study|Death|1|||
163890632|NCT02841579|591972699|FG000|Overall Study|Death|1|||
163890633|NCT02841579|591972699|FG000|Overall Study|Adverse Event|1|||
164341489|NCT00843856|593625389|FG000|Overall Study|Lost to Follow-up|1|||
163890634|NCT02841579|591972699|FG000|Overall Study|Lack of Efficacy|9|||
163890635|NCT04233216|591972702|FG000|Overall Study|Lost to Follow-up|1|||
164085784|NCT00729859|592678549|FG002|Overall Study|Adverse Event|0|||
164085785|NCT00729859|592678547|FG000|Overall Study|Withdrawal by Subject|0|||
164341490|NCT00843856|593625390|FG001|Overall Study|Lost to Follow-up|2|||
163996401|NCT00450580|592351824|FG001|Overall Study|Withdrawal by Subject|2|||
163996402|NCT00450580|592351823|FG000|Overall Study|Protocol Violation|1|||
163996403|NCT00450580|592351824|FG001|Overall Study|Protocol Violation|1|||
163996404|NCT00450580|592351823|FG000|Overall Study|Protocol-defined virologic failure|1|||
163996405|NCT00450580|592351824|FG001|Overall Study|Protocol-defined virologic failure|0|||
163996406|NCT00450580|592351823|FG000|Overall Study|Could not comply with scheduled visits|1|||
163996407|NCT00450580|592351824|FG001|Overall Study|Could not comply with scheduled visits|0|||
164085786|NCT00729859|592678548|FG001|Overall Study|Withdrawal by Subject|1|||
163996408|NCT00450580|592351823|FG000|Overall Study|Patient went to Brazil|1|||
164085787|NCT00729859|592678549|FG002|Overall Study|Withdrawal by Subject|0|||
164085788|NCT00760383|592678550|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
164085789|NCT00760383|592678551|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
164085790|NCT01336894|592678552|FG000|Follow-up|Study terminated prematurely|2|||
164085791|NCT01336894|592678553|FG001|Follow-up|Study terminated prematurely|7|||
164085792|NCT05034731|592678554|FG000|Overall Study|Screen fail|1|||
164085793|NCT05034731|592678555|FG001|Overall Study|Screen fail|1|||
164085794|NCT01725451|592678563|FG000|Period 1|Withdrawal by Subject|1|||
164085795|NCT01725451|592678564|FG001|Period 1|Withdrawal by Subject|0|||
164085796|NCT01725451|592678565|FG002|Period 1|Withdrawal by Subject|0|||
164085797|NCT01725451|592678566|FG003|Period 1|Withdrawal by Subject|0|||
164085798|NCT01725451|592678563|FG000|Washout From Period 3|Protocol Violation|0|||
164085799|NCT01725451|592678564|FG001|Washout From Period 3|Protocol Violation|0|||
164085800|NCT01725451|592678565|FG002|Washout From Period 3|Protocol Violation|1|||
164085801|NCT01725451|592678566|FG003|Washout From Period 3|Protocol Violation|0|||
164085802|NCT01725451|592678563|FG000|Washout From Period 3|Adverse Event|0|||
164085803|NCT01725451|592678564|FG001|Washout From Period 3|Adverse Event|1|||
163996409|NCT00450580|592351824|FG001|Overall Study|Patient went to Brazil|0|||
163996410|NCT00450580|592351823|FG000|Overall Study|Patient could not swallow Norvir|1|||
163996411|NCT00450580|592351824|FG001|Overall Study|Patient could not swallow Norvir|0|||
163996412|NCT00450580|592351823|FG000|Overall Study|Withdrawal due to pregnancy|0|||
163996413|NCT00450580|592351824|FG001|Overall Study|Withdrawal due to pregnancy|1|||
163996414|NCT00522392|592351829|FG000|Overall Study|Disease progression|0|||
163996415|NCT00522392|592351830|FG001|Overall Study|Disease progression|3|||
163996416|NCT00522392|592351829|FG000|Overall Study|Adverse Event|7|||
163996417|NCT00522392|592351830|FG001|Overall Study|Adverse Event|7|||
163996418|NCT00522392|592351829|FG000|Overall Study|Withdrawal by Subject|1|||
164085804|NCT01725451|592678565|FG002|Washout From Period 3|Adverse Event|0|||
164085805|NCT01725451|592678566|FG003|Washout From Period 3|Adverse Event|0|||
164085806|NCT01725451|592678563|FG000|Period 4|Adverse Event|0|||
164085807|NCT01725451|592678564|FG001|Period 4|Adverse Event|0|||
164085808|NCT01725451|592678565|FG002|Period 4|Adverse Event|1|||
164085809|NCT01725451|592678566|FG003|Period 4|Adverse Event|0|||
164085810|NCT00358826|592678567|FG000|Core Study|Adverse Event|1|||
164085811|NCT00358826|592678568|FG001|Core Study|Adverse Event|3|||
164085812|NCT00358826|592678569|FG002|Core Study|Adverse Event|1|||
164085813|NCT00358826|592678570|FG003|Core Study|Adverse Event|1|||
164085814|NCT00358826|592678571|FG004|Core Study|Adverse Event|0|||
164085815|NCT00358826|592678572|FG005|Core Study|Adverse Event|0|||
164085816|NCT00358826|592678573|FG006|Core Study|Adverse Event|0|||
164085817|NCT00358826|592678574|FG007|Core Study|Adverse Event|0|||
164085818|NCT00358826|592678567|FG000|Core Study|Withdrawal by Subject|2|||
164085819|NCT00358826|592678568|FG001|Core Study|Withdrawal by Subject|2|||
163890636|NCT04233216|591972703|FG001|Overall Study|Lost to Follow-up|0|||
163890637|NCT04233216|591972704|FG002|Overall Study|Lost to Follow-up|2|||
163890638|NCT04233216|591972705|FG003|Overall Study|Lost to Follow-up|0|||
163890639|NCT04233216|591972702|FG000|Overall Study|Physician Decision|0|||
163890640|NCT04233216|591972703|FG001|Overall Study|Physician Decision|3|||
163890641|NCT04233216|591972704|FG002|Overall Study|Physician Decision|0|||
163890642|NCT04233216|591972705|FG003|Overall Study|Physician Decision|2|||
164265124|NCT00624780|593338827|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
164265125|NCT00624780|593338828|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265126|NCT00624780|593338829|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265127|NCT00624780|593338830|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265128|NCT00624780|593338831|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265129|NCT00624780|593338832|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
164265130|NCT00624780|593338827|FG000|Follow-up (Week 26)|Other|1|||
164265131|NCT00624780|593338828|FG001|Follow-up (Week 26)|Other|1|||
164341491|NCT00345839|593625403|FG000|Overall Study|Withdrawal by Subject|91|||
163890643|NCT04233216|591972702|FG000|Overall Study|Withdrawal by Subject|0|||
163890644|NCT04233216|591972703|FG001|Overall Study|Withdrawal by Subject|2|||
163996419|NCT00522392|592351830|FG001|Overall Study|Withdrawal by Subject|1|||
163996420|NCT00522392|592351829|FG000|Overall Study|Physician Decision|0|||
164265132|NCT00624780|593338829|FG002|Follow-up (Week 26)|Other|0|||
164265133|NCT00624780|593338830|FG003|Follow-up (Week 26)|Other|0|||
164341492|NCT00345839|593625404|FG001|Overall Study|Withdrawal by Subject|98|||
163890645|NCT04233216|591972704|FG002|Overall Study|Withdrawal by Subject|1|||
163890646|NCT04233216|591972705|FG003|Overall Study|Withdrawal by Subject|0|||
164085820|NCT00358826|592678569|FG002|Core Study|Withdrawal by Subject|0|||
164265134|NCT00624780|593338831|FG004|Follow-up (Week 26)|Other|0|||
163890647|NCT03652389|591972706|FG000|Overall Study|Lost to Follow-up|1|||
163890648|NCT03652389|591972707|FG001|Overall Study|Lost to Follow-up|5|||
163890649|NCT03652389|591972706|FG000|Overall Study|Withdrawal by Subject|5|||
163890650|NCT03652389|591972707|FG001|Overall Study|Withdrawal by Subject|1|||
163890651|NCT03652389|591972706|FG000|Overall Study|New diagnosis|2|||
163890652|NCT03652389|591972707|FG001|Overall Study|New diagnosis|0|||
163890653|NCT04979442|591972710|FG000|Overall Study|Death|43|||
163996421|NCT00522392|592351830|FG001|Overall Study|Physician Decision|1|||
163996422|NCT00522392|592351829|FG000|Overall Study|Non-compliance|0|||
163996423|NCT00522392|592351830|FG001|Overall Study|Non-compliance|1|||
163996424|NCT03932812|592351831|FG000|Overall Study|Lost to Follow-up|12|||
163996425|NCT03932812|592351832|FG001|Overall Study|Lost to Follow-up|14|||
163996426|NCT03932812|592351831|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
163996427|NCT03932812|592351832|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
163996428|NCT00430755|592351835|FG000|Overall Study|Withdrawal by Subject|53|||
163996429|NCT01154101|592351840|FG000|Overall Study|Adverse Event|0|||
163996430|NCT01154101|592351841|FG001|Overall Study|Adverse Event|2|||
163996431|NCT01154101|592351842|FG002|Overall Study|Adverse Event|1|||
163996432|NCT01154101|592351843|FG003|Overall Study|Adverse Event|1|||
163996433|NCT01154101|592351844|FG004|Overall Study|Adverse Event|0|||
163996434|NCT01154101|592351840|FG000|Overall Study|Lost to Follow-up|0|||
163996435|NCT01154101|592351841|FG001|Overall Study|Lost to Follow-up|1|||
163996436|NCT01154101|592351842|FG002|Overall Study|Lost to Follow-up|0|||
163996437|NCT01154101|592351843|FG003|Overall Study|Lost to Follow-up|1|||
163996438|NCT01154101|592351844|FG004|Overall Study|Lost to Follow-up|0|||
163996439|NCT01154101|592351840|FG000|Overall Study|Withdrawal by Subject|0|||
163890654|NCT04979442|591972711|FG001|Overall Study|Death|30|||
163890655|NCT04979442|591972710|FG000|Overall Study|Withdrawal by Subject|8|||
163890656|NCT04979442|591972711|FG001|Overall Study|Withdrawal by Subject|13|||
163890657|NCT04979442|591972710|FG000|Overall Study|Physician Decision|1|||
163890658|NCT04979442|591972711|FG001|Overall Study|Physician Decision|1|||
163890659|NCT04979442|591972710|FG000|Overall Study|Lost to Follow-up|0|||
163890660|NCT04979442|591972711|FG001|Overall Study|Lost to Follow-up|2|||
163890661|NCT04979442|591972710|FG000|Overall Study|do not want to continue|0|||
163890662|NCT04979442|591972711|FG001|Overall Study|do not want to continue|1|||
163890663|NCT04005794|591972712|FG000|Overall Study|Lost to Follow-up|0|||
163890664|NCT04005794|591972713|FG001|Overall Study|Lost to Follow-up|4|||
163890665|NCT04005794|591972714|FG002|Overall Study|Lost to Follow-up|0|||
163890666|NCT02116530|591972718|FG000|Overall Study|Withdrawal by Subject|1|||
163890667|NCT02116530|591972719|FG001|Overall Study|Withdrawal by Subject|2|||
163996440|NCT01154101|592351841|FG001|Overall Study|Withdrawal by Subject|1|||
163996441|NCT01154101|592351842|FG002|Overall Study|Withdrawal by Subject|2|||
163996442|NCT01154101|592351843|FG003|Overall Study|Withdrawal by Subject|0|||
163996443|NCT01154101|592351844|FG004|Overall Study|Withdrawal by Subject|1|||
163996444|NCT03575104|592351845|FG000|Overall Study|Adverse Event|4|||
163996445|NCT03575104|592351846|FG001|Overall Study|Adverse Event|3|||
163996446|NCT03575104|592351847|FG002|Overall Study|Adverse Event|4|||
163996447|NCT03575104|592351845|FG000|Overall Study|Withdrawal by Subject|13|||
163996448|NCT03575104|592351846|FG001|Overall Study|Withdrawal by Subject|16|||
163996449|NCT03575104|592351847|FG002|Overall Study|Withdrawal by Subject|11|||
163996450|NCT03575104|592351845|FG000|Overall Study|Other reasons|6|||
163996451|NCT03575104|592351846|FG001|Overall Study|Other reasons|8|||
163996452|NCT03575104|592351847|FG002|Overall Study|Other reasons|6|||
163996453|NCT03575104|592351845|FG000|Overall Study|Lost to Follow-up|1|||
163996454|NCT03575104|592351846|FG001|Overall Study|Lost to Follow-up|2|||
163996455|NCT03575104|592351847|FG002|Overall Study|Lost to Follow-up|1|||
163996456|NCT00332709|592351848|FG000|Overall Study|Adverse Event|11|||
163996457|NCT00332709|592351849|FG001|Overall Study|Adverse Event|14|||
163996458|NCT00332709|592351848|FG000|Overall Study|Withdrawal by Subject|2|||
163890668|NCT02116530|591972718|FG000|Overall Study|Adverse Event|4|||
163890669|NCT02116530|591972719|FG001|Overall Study|Adverse Event|0|||
163890670|NCT02116530|591972718|FG000|Overall Study|Physician Decision|1|||
163890671|NCT02116530|591972719|FG001|Overall Study|Physician Decision|0|||
163890672|NCT02116530|591972718|FG000|Overall Study|Lost to Follow-up|1|||
163890673|NCT02116530|591972719|FG001|Overall Study|Lost to Follow-up|0|||
163996459|NCT00332709|592351849|FG001|Overall Study|Withdrawal by Subject|3|||
163996460|NCT00332709|592351848|FG000|Overall Study|Lost to Follow-up|2|||
163996461|NCT00332709|592351849|FG001|Overall Study|Lost to Follow-up|0|||
163996462|NCT00332709|592351848|FG000|Overall Study|Administrative Problems|0|||
163996463|NCT00332709|592351849|FG001|Overall Study|Administrative Problems|3|||
163996464|NCT00332709|592351848|FG000|Overall Study|Abnormal test procedure result|1|||
163996465|NCT00332709|592351849|FG001|Overall Study|Abnormal test procedure result|0|||
163996466|NCT01295125|592351854|FG000|Overall Study|Study stopped prematurely|9|||
163890674|NCT02116530|591972718|FG000|Overall Study|Other Medical Problems|2|||
163890675|NCT02116530|591972719|FG001|Overall Study|Other Medical Problems|2|||
163890676|NCT03766685|591972720|FG000|Overall Study|Lost to Follow-up|1|||
163890677|NCT03766685|591972721|FG001|Overall Study|Lost to Follow-up|1|||
163890678|NCT03766685|591972722|FG002|Overall Study|Lost to Follow-up|0|||
163890679|NCT03766685|591972723|FG003|Overall Study|Lost to Follow-up|0|||
163890680|NCT03766685|591972720|FG000|Overall Study|Adverse Event, not fatal|0|||
163890681|NCT03766685|591972721|FG001|Overall Study|Adverse Event, not fatal|1|||
163890682|NCT03766685|591972722|FG002|Overall Study|Adverse Event, not fatal|0|||
163890683|NCT03766685|591972723|FG003|Overall Study|Adverse Event, not fatal|1|||
164085821|NCT00358826|592678570|FG003|Core Study|Withdrawal by Subject|0|||
164265135|NCT00624780|593338832|FG005|Follow-up (Week 26)|Other|0|||
164265136|NCT04068519|593338834|FG000|Dose Verification|Death|15|||
164265137|NCT04068519|593338834|FG000|Dose Verification|Withdrawal by Subject|1|||
163890684|NCT03766685|591972720|FG000|Overall Study|Withdrawal by Subject|0|||
163890685|NCT03766685|591972721|FG001|Overall Study|Withdrawal by Subject|2|||
163890686|NCT03766685|591972722|FG002|Overall Study|Withdrawal by Subject|0|||
163890687|NCT03766685|591972723|FG003|Overall Study|Withdrawal by Subject|0|||
163890688|NCT03766685|591972720|FG000|Overall Study|Protocol Violation|0|||
163890689|NCT03766685|591972721|FG001|Overall Study|Protocol Violation|1|||
163890690|NCT03766685|591972722|FG002|Overall Study|Protocol Violation|0|||
163890691|NCT03766685|591972723|FG003|Overall Study|Protocol Violation|0|||
163890692|NCT03766685|591972720|FG000|Overall Study|Non-compliance|0|||
163890693|NCT03766685|591972721|FG001|Overall Study|Non-compliance|2|||
163890694|NCT03766685|591972722|FG002|Overall Study|Non-compliance|0|||
163890695|NCT03766685|591972723|FG003|Overall Study|Non-compliance|0|||
163890696|NCT02844465|591972728|FG000|Overall Study|Screen Failure|36|||
163890697|NCT02844465|591972728|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
163890698|NCT02844465|591972728|FG000|Overall Study|Withdrawal by Subject|5|||
163890699|NCT02844465|591972728|FG000|Overall Study|Lost to Follow-up|1|||
163890700|NCT02844465|591972728|FG000|Overall Study|Retreatment|1|||
163890701|NCT05029622|591972729|FG000|Overall Study|Lost to Follow-up|1|||
163890702|NCT05671653|591972730|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
163890703|NCT05671653|591972731|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
163890704|NCT05671653|591972732|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
163890705|NCT05671653|591972733|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
163890706|NCT05671653|591972734|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
163890707|NCT05671653|591972735|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
163890708|NCT05671653|591972736|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
163890709|NCT05671653|591972737|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
163890710|NCT05671653|591972738|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
163890711|NCT05671653|591972739|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
163890712|NCT05671653|591972740|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
163890713|NCT05671653|591972741|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
163890714|NCT05671653|591972742|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
163890715|NCT05671653|591972730|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890716|NCT05671653|591972731|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890717|NCT05671653|591972732|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890718|NCT05671653|591972733|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890719|NCT05671653|591972734|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890720|NCT05671653|591972735|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
163890721|NCT05671653|591972736|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890722|NCT05671653|591972737|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890723|NCT05671653|591972738|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890724|NCT05671653|591972739|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890725|NCT05671653|591972740|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890726|NCT05671653|591972741|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890727|NCT05671653|591972742|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
163890728|NCT05671653|591972730|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890729|NCT05671653|591972731|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890730|NCT05671653|591972732|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890731|NCT05671653|591972733|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890732|NCT05671653|591972734|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890733|NCT05671653|591972735|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
163890734|NCT05671653|591972736|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890735|NCT05671653|591972737|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890736|NCT05671653|591972738|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890737|NCT05671653|591972739|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890738|NCT05671653|591972740|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890739|NCT05671653|591972741|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890740|NCT05671653|591972742|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
163890741|NCT05671653|591972730|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890742|NCT05671653|591972731|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890743|NCT05671653|591972732|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890744|NCT05671653|591972733|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890745|NCT05671653|591972734|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890746|NCT05671653|591972735|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890747|NCT05671653|591972736|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163996467|NCT00891735|592351855|FG000|Overall Study|Adverse Event|2|||
163996468|NCT00891735|592351856|FG001|Overall Study|Adverse Event|0|||
163996469|NCT00891735|592351857|FG002|Overall Study|Adverse Event|2|||
163996470|NCT00891735|592351858|FG003|Overall Study|Adverse Event|0|||
163996471|NCT00891735|592351855|FG000|Overall Study|Death|8|||
163996472|NCT00891735|592351856|FG001|Overall Study|Death|5|||
163890748|NCT05671653|591972737|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890749|NCT05671653|591972738|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
163890750|NCT05671653|591972739|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890751|NCT05671653|591972740|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890752|NCT05671653|591972741|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890753|NCT05671653|591972742|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
163890754|NCT05671653|591972730|FG000|Cohort 2 Period 2|Adverse Event|0|||
163890755|NCT05671653|591972731|FG001|Cohort 2 Period 2|Adverse Event|0|||
163890756|NCT05671653|591972732|FG002|Cohort 2 Period 2|Adverse Event|0|||
163890757|NCT05671653|591972733|FG003|Cohort 2 Period 2|Adverse Event|0|||
163890758|NCT05671653|591972734|FG004|Cohort 2 Period 2|Adverse Event|0|||
163890759|NCT05671653|591972735|FG005|Cohort 2 Period 2|Adverse Event|0|||
163890760|NCT05671653|591972736|FG006|Cohort 2 Period 2|Adverse Event|0|||
163890761|NCT05671653|591972737|FG007|Cohort 2 Period 2|Adverse Event|0|||
163890762|NCT05671653|591972738|FG008|Cohort 2 Period 2|Adverse Event|0|||
163890763|NCT05671653|591972739|FG009|Cohort 2 Period 2|Adverse Event|0|||
163890764|NCT05671653|591972740|FG010|Cohort 2 Period 2|Adverse Event|1|||
163890765|NCT05671653|591972741|FG011|Cohort 2 Period 2|Adverse Event|0|||
163890766|NCT05671653|591972742|FG012|Cohort 2 Period 2|Adverse Event|0|||
163890767|NCT05671653|591972730|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
163890768|NCT05671653|591972731|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
163890769|NCT05671653|591972732|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
163890770|NCT05671653|591972733|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
163890771|NCT05671653|591972734|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
163890772|NCT05671653|591972735|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
163890773|NCT05671653|591972736|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
163890774|NCT05671653|591972737|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
163890775|NCT05671653|591972738|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
163890776|NCT05671653|591972739|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
163890777|NCT05671653|591972740|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
163890778|NCT05671653|591972741|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
163890779|NCT05671653|591972742|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
163890780|NCT05671653|591972730|FG000|Cohort 2 Period 2|Pregnancy|0|||
163890781|NCT05671653|591972731|FG001|Cohort 2 Period 2|Pregnancy|0|||
163890782|NCT05671653|591972732|FG002|Cohort 2 Period 2|Pregnancy|0|||
163890783|NCT05671653|591972733|FG003|Cohort 2 Period 2|Pregnancy|0|||
163890784|NCT05671653|591972734|FG004|Cohort 2 Period 2|Pregnancy|0|||
163890785|NCT05671653|591972735|FG005|Cohort 2 Period 2|Pregnancy|0|||
163890786|NCT05671653|591972736|FG006|Cohort 2 Period 2|Pregnancy|0|||
163890787|NCT05671653|591972737|FG007|Cohort 2 Period 2|Pregnancy|0|||
163890788|NCT05671653|591972738|FG008|Cohort 2 Period 2|Pregnancy|0|||
164265138|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Death|35|||
164265139|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
164265140|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
163890789|NCT05671653|591972739|FG009|Cohort 2 Period 2|Pregnancy|0|||
163890790|NCT05671653|591972740|FG010|Cohort 2 Period 2|Pregnancy|1|||
163890791|NCT05671653|591972741|FG011|Cohort 2 Period 2|Pregnancy|0|||
163890792|NCT05671653|591972742|FG012|Cohort 2 Period 2|Pregnancy|0|||
163890793|NCT05671653|591972730|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890794|NCT05671653|591972731|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890795|NCT05671653|591972732|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890796|NCT05671653|591972733|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890797|NCT05671653|591972734|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890798|NCT05671653|591972735|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890799|NCT05671653|591972736|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890800|NCT05671653|591972737|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890801|NCT05671653|591972738|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890802|NCT05671653|591972739|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890803|NCT05671653|591972740|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
163890804|NCT05671653|591972741|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
163996473|NCT00891735|592351857|FG002|Overall Study|Death|4|||
163890805|NCT05671653|591972742|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
163890806|NCT05671653|591972730|FG000|Cohort 2 Period 2|Other|0|||
163890807|NCT05671653|591972731|FG001|Cohort 2 Period 2|Other|0|||
163890808|NCT05671653|591972732|FG002|Cohort 2 Period 2|Other|0|||
163890809|NCT05671653|591972733|FG003|Cohort 2 Period 2|Other|0|||
163890810|NCT05671653|591972734|FG004|Cohort 2 Period 2|Other|0|||
163890811|NCT05671653|591972735|FG005|Cohort 2 Period 2|Other|0|||
163890812|NCT05671653|591972736|FG006|Cohort 2 Period 2|Other|0|||
163890813|NCT05671653|591972737|FG007|Cohort 2 Period 2|Other|0|||
163996474|NCT00891735|592351858|FG003|Overall Study|Death|5|||
164265141|NCT04068519|593338834|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
164265142|NCT04068519|593338834|FG000|Indication Expansion|Death|152|||
164341493|NCT00345839|593625403|FG000|Overall Study|Lost to Follow-up|58|||
163890814|NCT05671653|591972738|FG008|Cohort 2 Period 2|Other|0|||
163890815|NCT05671653|591972739|FG009|Cohort 2 Period 2|Other|0|||
163890816|NCT05671653|591972740|FG010|Cohort 2 Period 2|Other|1|||
163890817|NCT05671653|591972741|FG011|Cohort 2 Period 2|Other|0|||
163890818|NCT05671653|591972742|FG012|Cohort 2 Period 2|Other|0|||
163890819|NCT05671653|591972730|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890820|NCT05671653|591972731|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890821|NCT05671653|591972732|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890822|NCT05671653|591972733|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890823|NCT05671653|591972734|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890824|NCT05671653|591972735|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890825|NCT05671653|591972736|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890826|NCT05671653|591972737|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890827|NCT05671653|591972738|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890828|NCT05671653|591972739|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890829|NCT05671653|591972740|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890830|NCT05671653|591972741|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
163890831|NCT05671653|591972742|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
163890832|NCT01197378|591972746|FG000|Overall Study|Adverse Event|3|||
163890833|NCT01197378|591972746|FG000|Overall Study|Withdrawal by Subject|1|||
163890834|NCT01197378|591972746|FG000|Overall Study|Physician Decision|1|||
163890835|NCT01197378|591972746|FG000|Overall Study|Other|2|||
163890836|NCT06232590|591972747|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
163890837|NCT06232590|591972748|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
163890838|NCT02460458|591972749|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
163890839|NCT02460458|591972749|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
163890840|NCT02460458|591972749|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
163890841|NCT02460458|591972749|FG000|First Prospective Phase|Lost to Follow-up|84|||
163890842|NCT02460458|591972749|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
163890843|NCT03710603|591972753|FG000|Overall Study|Adverse Event|1|||
163890844|NCT03710603|591972754|FG001|Overall Study|Adverse Event|0|||
163890845|NCT03710603|591972753|FG000|Overall Study|Death|44|||
163890846|NCT03710603|591972754|FG001|Overall Study|Death|34|||
163890847|NCT03710603|591972753|FG000|Overall Study|Lost to Follow-up|3|||
164341494|NCT00345839|593625404|FG001|Overall Study|Lost to Follow-up|61|||
164341495|NCT03298867|593625420|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
164341496|NCT03298867|593625421|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
164341497|NCT03298867|593625420|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
164341498|NCT03298867|593625421|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
164341499|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
164341500|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
164341501|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
163890848|NCT03710603|591972754|FG001|Overall Study|Lost to Follow-up|5|||
163890849|NCT03710603|591972753|FG000|Overall Study|Withdrawal by Subject|11|||
163890850|NCT03710603|591972754|FG001|Overall Study|Withdrawal by Subject|10|||
163890851|NCT02589795|591972758|FG000|Overall Study|Lost to Follow-up|1|||
163890852|NCT02589795|591972759|FG001|Overall Study|Lost to Follow-up|0|||
163890853|NCT02589795|591972760|FG002|Overall Study|Lost to Follow-up|0|||
163890854|NCT02589795|591972758|FG000|Overall Study|Withdrawal by Subject|0|||
163890855|NCT02589795|591972759|FG001|Overall Study|Withdrawal by Subject|0|||
163890856|NCT02589795|591972760|FG002|Overall Study|Withdrawal by Subject|2|||
163890857|NCT02589795|591972758|FG000|Overall Study|Protocol Violation|0|||
163890858|NCT02589795|591972759|FG001|Overall Study|Protocol Violation|0|||
163890859|NCT02589795|591972760|FG002|Overall Study|Protocol Violation|1|||
163890860|NCT03691935|591972762|FG000|Overall Study|Physician Decision|2|||
163890861|NCT03691935|591972763|FG001|Overall Study|Physician Decision|1|||
163890862|NCT03691935|591972762|FG000|Overall Study|Adverse Event|3|||
163890863|NCT03691935|591972763|FG001|Overall Study|Adverse Event|0|||
163890864|NCT03511664|591972764|FG000|Overall Study|Death|457|||
163890865|NCT03511664|591972765|FG001|Overall Study|Death|201|||
163890866|NCT03511664|591972766|FG002|Overall Study|Death|21|||
164341502|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
163890867|NCT03511664|591972764|FG000|Overall Study|Withdrew consent|40|||
163890868|NCT03511664|591972765|FG001|Overall Study|Withdrew consent|63|||
163890869|NCT03511664|591972766|FG002|Overall Study|Withdrew consent|3|||
163890870|NCT03511664|591972764|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
163890871|NCT03511664|591972765|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
163890872|NCT03511664|591972766|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
163890873|NCT03511664|591972764|FG000|Overall Study|Lost to Follow-up|8|||
163890874|NCT03511664|591972765|FG001|Overall Study|Lost to Follow-up|5|||
163890875|NCT03511664|591972766|FG002|Overall Study|Lost to Follow-up|0|||
163890876|NCT03511664|591972764|FG000|Overall Study|Physician Decision|2|||
163996475|NCT00891735|592351855|FG000|Overall Study|Lost to Follow-up|2|||
163996476|NCT00891735|592351856|FG001|Overall Study|Lost to Follow-up|2|||
163996477|NCT00891735|592351857|FG002|Overall Study|Lost to Follow-up|2|||
163890877|NCT03511664|591972765|FG001|Overall Study|Physician Decision|1|||
163890878|NCT03511664|591972766|FG002|Overall Study|Physician Decision|0|||
163890879|NCT03511664|591972764|FG000|Overall Study|Patient non-compliance|1|||
163890880|NCT03511664|591972765|FG001|Overall Study|Patient non-compliance|0|||
163996478|NCT00891735|592351858|FG003|Overall Study|Lost to Follow-up|2|||
163996479|NCT00891735|592351855|FG000|Overall Study|Physician's decision to withdraw patient|1|||
163996480|NCT00891735|592351856|FG001|Overall Study|Physician's decision to withdraw patient|0|||
163996481|NCT00891735|592351857|FG002|Overall Study|Physician's decision to withdraw patient|0|||
163996482|NCT00891735|592351858|FG003|Overall Study|Physician's decision to withdraw patient|0|||
163996483|NCT00891735|592351855|FG000|Overall Study|Patient's decision to withdraw|4|||
163996484|NCT00891735|592351856|FG001|Overall Study|Patient's decision to withdraw|9|||
163996485|NCT00891735|592351857|FG002|Overall Study|Patient's decision to withdraw|4|||
163996486|NCT00891735|592351858|FG003|Overall Study|Patient's decision to withdraw|8|||
163996487|NCT01355289|592351859|FG000|Core Study|Adverse Event, Non-Fatal|1|||
163996488|NCT01355289|592351860|FG001|Core Study|Adverse Event, Non-Fatal|0|||
163996489|NCT01355289|592351861|FG002|Core Study|Adverse Event, Non-Fatal|0|||
163996490|NCT01355289|592351862|FG003|Core Study|Adverse Event, Non-Fatal|0|||
163996491|NCT01355289|592351863|FG004|Core Study|Adverse Event, Non-Fatal|0|||
163996492|NCT01355289|592351859|FG000|Core Study|Inadequate Therapeutic Effect|0|||
163996493|NCT01355289|592351860|FG001|Core Study|Inadequate Therapeutic Effect|0|||
163996494|NCT01355289|592351861|FG002|Core Study|Inadequate Therapeutic Effect|0|||
163996495|NCT01355289|592351862|FG003|Core Study|Inadequate Therapeutic Effect|1|||
163996496|NCT01355289|592351863|FG004|Core Study|Inadequate Therapeutic Effect|0|||
163996497|NCT01355289|592351859|FG000|Core Study|Other|0|||
163996498|NCT01355289|592351860|FG001|Core Study|Other|0|||
163996499|NCT01355289|592351861|FG002|Core Study|Other|0|||
163996500|NCT01355289|592351862|FG003|Core Study|Other|1|||
163996501|NCT01355289|592351863|FG004|Core Study|Other|0|||
163996502|NCT01355289|592351859|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
163996503|NCT01355289|592351860|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
163996504|NCT01355289|592351861|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
163996505|NCT01355289|592351862|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
163996506|NCT01355289|592351863|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
163996507|NCT01355289|592351859|FG000|Open Label Extension|Lost to Follow-up|0|||
163996508|NCT01355289|592351860|FG001|Open Label Extension|Lost to Follow-up|0|||
163996509|NCT01355289|592351861|FG002|Open Label Extension|Lost to Follow-up|0|||
163996510|NCT01355289|592351862|FG003|Open Label Extension|Lost to Follow-up|0|||
163996511|NCT01355289|592351863|FG004|Open Label Extension|Lost to Follow-up|1|||
163996512|NCT01355289|592351859|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
163996513|NCT01355289|592351860|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
163996514|NCT01355289|592351861|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
163996515|NCT01355289|592351862|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
163996516|NCT01355289|592351863|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
163996517|NCT01355289|592351859|FG000|Open Label Extension|Other|0|||
163996518|NCT01355289|592351860|FG001|Open Label Extension|Other|0|||
164085822|NCT00358826|592678571|FG004|Core Study|Withdrawal by Subject|0|||
163890881|NCT03511664|591972766|FG002|Overall Study|Patient non-compliance|0|||
163890882|NCT01946789|591972767|FG000|Overall Study|Death|0|||
163890883|NCT01946789|591972768|FG001|Overall Study|Death|2|||
163890884|NCT01946789|591972769|FG002|Overall Study|Death|1|||
163890885|NCT01946789|591972770|FG003|Overall Study|Death|1|||
163890886|NCT01946789|591972771|FG004|Overall Study|Death|1|||
163890887|NCT01946789|591972772|FG005|Overall Study|Death|1|||
163890888|NCT01946789|591972773|FG006|Overall Study|Death|3|||
163890889|NCT01946789|591972774|FG007|Overall Study|Death|1|||
163890890|NCT01946789|591972775|FG008|Overall Study|Death|2|||
163890891|NCT01946789|591972767|FG000|Overall Study|Progressive Disease|0|||
163890892|NCT01946789|591972768|FG001|Overall Study|Progressive Disease|0|||
163890893|NCT01946789|591972769|FG002|Overall Study|Progressive Disease|1|||
163890894|NCT01946789|591972770|FG003|Overall Study|Progressive Disease|0|||
163890895|NCT01946789|591972771|FG004|Overall Study|Progressive Disease|0|||
163890896|NCT01946789|591972772|FG005|Overall Study|Progressive Disease|2|||
163890897|NCT01946789|591972773|FG006|Overall Study|Progressive Disease|0|||
163996519|NCT01355289|592351861|FG002|Open Label Extension|Other|0|||
163996520|NCT01355289|592351862|FG003|Open Label Extension|Other|0|||
163996521|NCT01355289|592351863|FG004|Open Label Extension|Other|3|||
163890898|NCT01946789|591972774|FG007|Overall Study|Progressive Disease|0|||
163890899|NCT01946789|591972775|FG008|Overall Study|Progressive Disease|0|||
163890900|NCT01946789|591972767|FG000|Overall Study|Withdrawal by Subject|0|||
163890901|NCT01946789|591972768|FG001|Overall Study|Withdrawal by Subject|0|||
163996522|NCT00802360|592351866|FG000|Overall Study|Stimulation failure|4|||
163996523|NCT00802360|592351867|FG001|Overall Study|Stimulation failure|0|||
163996524|NCT00802360|592351868|FG002|Overall Study|Stimulation failure|3|||
163996525|NCT00802360|592351869|FG003|Overall Study|Stimulation failure|3|||
164085823|NCT00358826|592678572|FG005|Core Study|Withdrawal by Subject|0|||
164341503|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
164341504|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
163890902|NCT01946789|591972769|FG002|Overall Study|Withdrawal by Subject|0|||
163890903|NCT01946789|591972770|FG003|Overall Study|Withdrawal by Subject|2|||
163890904|NCT01946789|591972771|FG004|Overall Study|Withdrawal by Subject|1|||
163890905|NCT01946789|591972772|FG005|Overall Study|Withdrawal by Subject|0|||
163890906|NCT01946789|591972773|FG006|Overall Study|Withdrawal by Subject|1|||
163890907|NCT01946789|591972774|FG007|Overall Study|Withdrawal by Subject|0|||
163890908|NCT01946789|591972775|FG008|Overall Study|Withdrawal by Subject|0|||
163890909|NCT04076618|591972776|FG000|Overall Study|Lost to Follow-up|2|||
163890910|NCT04076618|591972777|FG001|Overall Study|Lost to Follow-up|1|||
163890911|NCT04076618|591972778|FG002|Overall Study|Lost to Follow-up|3|||
163890912|NCT04076618|591972776|FG000|Overall Study|Withdrawal by Subject|3|||
163890913|NCT04076618|591972777|FG001|Overall Study|Withdrawal by Subject|1|||
163890914|NCT04076618|591972778|FG002|Overall Study|Withdrawal by Subject|2|||
163890915|NCT04076618|591972776|FG000|Overall Study|Relocated out of state|0|||
163890916|NCT04076618|591972777|FG001|Overall Study|Relocated out of state|2|||
163890917|NCT04076618|591972778|FG002|Overall Study|Relocated out of state|0|||
163890918|NCT04076618|591972776|FG000|Overall Study|COVID concerns|0|||
163890919|NCT04076618|591972777|FG001|Overall Study|COVID concerns|1|||
163890920|NCT04076618|591972778|FG002|Overall Study|COVID concerns|0|||
163890921|NCT04076618|591972776|FG000|Overall Study|Adverse Event|0|||
163890922|NCT04076618|591972777|FG001|Overall Study|Adverse Event|0|||
163890923|NCT04076618|591972778|FG002|Overall Study|Adverse Event|2|||
163890924|NCT01928394|591972779|FG000|Treatment Period|Disease progression|17|||
163890925|NCT01928394|591972780|FG001|Treatment Period|Disease progression|2|||
163890926|NCT01928394|591972781|FG002|Treatment Period|Disease progression|12|||
163890927|NCT01928394|591972782|FG003|Treatment Period|Disease progression|48|||
163890928|NCT01928394|591972783|FG004|Treatment Period|Disease progression|3|||
163890929|NCT01928394|591972784|FG005|Treatment Period|Disease progression|25|||
163890930|NCT01928394|591972785|FG006|Treatment Period|Disease progression|38|||
163890931|NCT01928394|591972786|FG007|Treatment Period|Disease progression|16|||
163890932|NCT01928394|591972787|FG008|Treatment Period|Disease progression|3|||
163890933|NCT01928394|591972788|FG009|Treatment Period|Disease progression|11|||
163890934|NCT01928394|591972789|FG010|Treatment Period|Disease progression|22|||
163890935|NCT01928394|591972790|FG011|Treatment Period|Disease progression|73|||
163890936|NCT01928394|591972791|FG012|Treatment Period|Disease progression|38|||
163890937|NCT01928394|591972792|FG013|Treatment Period|Disease progression|118|||
163890938|NCT01928394|591972793|FG014|Treatment Period|Disease progression|59|||
163890939|NCT01928394|591972794|FG015|Treatment Period|Disease progression|1|||
163890940|NCT01928394|591972795|FG016|Treatment Period|Disease progression|43|||
163890941|NCT01928394|591972796|FG017|Treatment Period|Disease progression|56|||
163890942|NCT01928394|591972797|FG018|Treatment Period|Disease progression|50|||
163890943|NCT01928394|591972798|FG019|Treatment Period|Disease progression|71|||
163890944|NCT01928394|591972799|FG020|Treatment Period|Disease progression|30|||
163890945|NCT01928394|591972800|FG021|Treatment Period|Disease progression|31|||
163890946|NCT01928394|591972801|FG022|Treatment Period|Disease progression|31|||
163890947|NCT01928394|591972779|FG000|Treatment Period|Study drug toxicity|1|||
163890948|NCT01928394|591972780|FG001|Treatment Period|Study drug toxicity|1|||
163890949|NCT01928394|591972781|FG002|Treatment Period|Study drug toxicity|3|||
163890950|NCT01928394|591972782|FG003|Treatment Period|Study drug toxicity|3|||
163890951|NCT01928394|591972783|FG004|Treatment Period|Study drug toxicity|0|||
163890952|NCT01928394|591972784|FG005|Treatment Period|Study drug toxicity|9|||
163890953|NCT01928394|591972785|FG006|Treatment Period|Study drug toxicity|7|||
163890954|NCT01928394|591972786|FG007|Treatment Period|Study drug toxicity|1|||
163890955|NCT01928394|591972787|FG008|Treatment Period|Study drug toxicity|0|||
163890956|NCT01928394|591972788|FG009|Treatment Period|Study drug toxicity|5|||
163890957|NCT01928394|591972789|FG010|Treatment Period|Study drug toxicity|2|||
163890958|NCT01928394|591972790|FG011|Treatment Period|Study drug toxicity|3|||
163890959|NCT01928394|591972791|FG012|Treatment Period|Study drug toxicity|7|||
163890960|NCT01928394|591972792|FG013|Treatment Period|Study drug toxicity|5|||
163890961|NCT01928394|591972793|FG014|Treatment Period|Study drug toxicity|12|||
163890962|NCT01928394|591972794|FG015|Treatment Period|Study drug toxicity|0|||
163890963|NCT01928394|591972795|FG016|Treatment Period|Study drug toxicity|3|||
163890964|NCT01928394|591972796|FG017|Treatment Period|Study drug toxicity|3|||
163890965|NCT01928394|591972797|FG018|Treatment Period|Study drug toxicity|12|||
163890966|NCT01928394|591972798|FG019|Treatment Period|Study drug toxicity|15|||
163890967|NCT01928394|591972799|FG020|Treatment Period|Study drug toxicity|4|||
163890968|NCT01928394|591972800|FG021|Treatment Period|Study drug toxicity|7|||
163890969|NCT01928394|591972801|FG022|Treatment Period|Study drug toxicity|4|||
163890970|NCT01928394|591972779|FG000|Treatment Period|AE unrelated to study drug|0|||
163890971|NCT01928394|591972780|FG001|Treatment Period|AE unrelated to study drug|0|||
163890972|NCT01928394|591972781|FG002|Treatment Period|AE unrelated to study drug|2|||
163890973|NCT01928394|591972782|FG003|Treatment Period|AE unrelated to study drug|3|||
164085824|NCT00358826|592678573|FG006|Core Study|Withdrawal by Subject|0|||
163996526|NCT00802360|592351866|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
163996527|NCT00802360|592351867|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
163996528|NCT00802360|592351868|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
163996529|NCT00802360|592351869|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
163996530|NCT00802360|592351866|FG000|Overall Study|Cycle cancelled|0|||
163996531|NCT00802360|592351867|FG001|Overall Study|Cycle cancelled|1|||
163890974|NCT01928394|591972783|FG004|Treatment Period|AE unrelated to study drug|0|||
163890975|NCT01928394|591972784|FG005|Treatment Period|AE unrelated to study drug|5|||
163890976|NCT01928394|591972785|FG006|Treatment Period|AE unrelated to study drug|1|||
163890977|NCT01928394|591972786|FG007|Treatment Period|AE unrelated to study drug|0|||
163890978|NCT01928394|591972787|FG008|Treatment Period|AE unrelated to study drug|0|||
163890979|NCT01928394|591972788|FG009|Treatment Period|AE unrelated to study drug|2|||
163890980|NCT01928394|591972789|FG010|Treatment Period|AE unrelated to study drug|0|||
163890981|NCT01928394|591972790|FG011|Treatment Period|AE unrelated to study drug|12|||
163890982|NCT01928394|591972791|FG012|Treatment Period|AE unrelated to study drug|6|||
163890983|NCT01928394|591972792|FG013|Treatment Period|AE unrelated to study drug|13|||
163890984|NCT01928394|591972793|FG014|Treatment Period|AE unrelated to study drug|6|||
163890985|NCT01928394|591972794|FG015|Treatment Period|AE unrelated to study drug|1|||
163890986|NCT01928394|591972795|FG016|Treatment Period|AE unrelated to study drug|1|||
163890987|NCT01928394|591972796|FG017|Treatment Period|AE unrelated to study drug|6|||
163890988|NCT01928394|591972797|FG018|Treatment Period|AE unrelated to study drug|3|||
163996532|NCT00802360|592351868|FG002|Overall Study|Cycle cancelled|1|||
163996533|NCT00802360|592351869|FG003|Overall Study|Cycle cancelled|1|||
163996534|NCT00802360|592351866|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
163890989|NCT01928394|591972798|FG019|Treatment Period|AE unrelated to study drug|5|||
163890990|NCT01928394|591972799|FG020|Treatment Period|AE unrelated to study drug|1|||
163890991|NCT01928394|591972800|FG021|Treatment Period|AE unrelated to study drug|1|||
163890992|NCT01928394|591972801|FG022|Treatment Period|AE unrelated to study drug|0|||
163890993|NCT01928394|591972779|FG000|Treatment Period|Participant request to stop therapy|0|||
163890994|NCT01928394|591972780|FG001|Treatment Period|Participant request to stop therapy|0|||
163890995|NCT01928394|591972781|FG002|Treatment Period|Participant request to stop therapy|0|||
163890996|NCT01928394|591972782|FG003|Treatment Period|Participant request to stop therapy|0|||
163890997|NCT01928394|591972783|FG004|Treatment Period|Participant request to stop therapy|0|||
163890998|NCT01928394|591972784|FG005|Treatment Period|Participant request to stop therapy|3|||
163890999|NCT01928394|591972785|FG006|Treatment Period|Participant request to stop therapy|3|||
163891000|NCT01928394|591972786|FG007|Treatment Period|Participant request to stop therapy|0|||
163891001|NCT01928394|591972787|FG008|Treatment Period|Participant request to stop therapy|0|||
163891002|NCT01928394|591972788|FG009|Treatment Period|Participant request to stop therapy|0|||
163891003|NCT01928394|591972789|FG010|Treatment Period|Participant request to stop therapy|3|||
163891004|NCT01928394|591972790|FG011|Treatment Period|Participant request to stop therapy|2|||
163891005|NCT01928394|591972791|FG012|Treatment Period|Participant request to stop therapy|1|||
163891006|NCT01928394|591972792|FG013|Treatment Period|Participant request to stop therapy|2|||
163891007|NCT01928394|591972793|FG014|Treatment Period|Participant request to stop therapy|4|||
163891008|NCT01928394|591972794|FG015|Treatment Period|Participant request to stop therapy|0|||
163891009|NCT01928394|591972795|FG016|Treatment Period|Participant request to stop therapy|1|||
163891010|NCT01928394|591972796|FG017|Treatment Period|Participant request to stop therapy|3|||
163891011|NCT01928394|591972797|FG018|Treatment Period|Participant request to stop therapy|1|||
163891012|NCT01928394|591972798|FG019|Treatment Period|Participant request to stop therapy|1|||
163891013|NCT01928394|591972799|FG020|Treatment Period|Participant request to stop therapy|3|||
163891014|NCT01928394|591972800|FG021|Treatment Period|Participant request to stop therapy|1|||
163891015|NCT01928394|591972801|FG022|Treatment Period|Participant request to stop therapy|3|||
163891016|NCT01928394|591972779|FG000|Treatment Period|Participant withdrew consent|0|||
163891017|NCT01928394|591972780|FG001|Treatment Period|Participant withdrew consent|0|||
163891018|NCT01928394|591972781|FG002|Treatment Period|Participant withdrew consent|1|||
163891019|NCT01928394|591972782|FG003|Treatment Period|Participant withdrew consent|1|||
163891020|NCT01928394|591972783|FG004|Treatment Period|Participant withdrew consent|0|||
163891021|NCT01928394|591972784|FG005|Treatment Period|Participant withdrew consent|1|||
163891022|NCT01928394|591972785|FG006|Treatment Period|Participant withdrew consent|0|||
163891023|NCT01928394|591972786|FG007|Treatment Period|Participant withdrew consent|1|||
163891024|NCT01928394|591972787|FG008|Treatment Period|Participant withdrew consent|0|||
163996535|NCT00802360|592351867|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
163996536|NCT00802360|592351868|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
163996537|NCT00802360|592351869|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
163891025|NCT01928394|591972788|FG009|Treatment Period|Participant withdrew consent|0|||
163891026|NCT01928394|591972789|FG010|Treatment Period|Participant withdrew consent|1|||
163891027|NCT01928394|591972790|FG011|Treatment Period|Participant withdrew consent|1|||
163996538|NCT00802360|592351866|FG000|Overall Study|No positive serum pregnancy|17|||
163996539|NCT00802360|592351867|FG001|Overall Study|No positive serum pregnancy|20|||
163996540|NCT00802360|592351868|FG002|Overall Study|No positive serum pregnancy|14|||
164265143|NCT04068519|593338834|FG000|Indication Expansion|Withdrawal by Subject|10|||
164265144|NCT04068519|593338834|FG000|Indication Expansion|Lost to Follow-up|7|||
164265145|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
163996541|NCT00802360|592351869|FG003|Overall Study|No positive serum pregnancy|10|||
163996542|NCT00802360|592351866|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
163996543|NCT00802360|592351867|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163996544|NCT00802360|592351868|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
163996545|NCT00802360|592351869|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
163996546|NCT00802360|592351866|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
163996547|NCT00802360|592351867|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
163996548|NCT00802360|592351868|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
163996549|NCT00802360|592351869|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
163996550|NCT00802360|592351866|FG000|Overall Study|Other|2|||
163996551|NCT00802360|592351867|FG001|Overall Study|Other|3|||
163996552|NCT00802360|592351868|FG002|Overall Study|Other|6|||
163996553|NCT00802360|592351869|FG003|Overall Study|Other|3|||
163996554|NCT03838484|592351876|FG000|Overall Study|Lost to Follow-up|0|||
163996555|NCT03838484|592351877|FG001|Overall Study|Lost to Follow-up|1|||
163996556|NCT03838484|592351878|FG002|Overall Study|Lost to Follow-up|0|||
163996557|NCT03838484|592351879|FG003|Overall Study|Lost to Follow-up|0|||
163996558|NCT01900002|592351880|FG000|Overall Study|Withdrawal by Subject|2|||
163996559|NCT01900002|592351880|FG000|Overall Study|ineligible for Y-90|4|||
163996560|NCT01614964|592351881|FG000|Overall Study|Withdrawal by Subject|2|||
163996561|NCT01614964|592351882|FG001|Overall Study|Withdrawal by Subject|0|||
163996562|NCT01614964|592351881|FG000|Overall Study|Lost to Follow-up|3|||
163996563|NCT01614964|592351882|FG001|Overall Study|Lost to Follow-up|0|||
163996564|NCT00860470|592351891|FG000|Overall Study|Death|6|||
163996565|NCT00860470|592351892|FG001|Overall Study|Death|10|||
163996566|NCT00860470|592351891|FG000|Overall Study|Moved away|8|||
163996567|NCT00860470|592351892|FG001|Overall Study|Moved away|10|||
163996568|NCT00860470|592351891|FG000|Overall Study|Lost to Follow-up|34|||
163996569|NCT00860470|592351892|FG001|Overall Study|Lost to Follow-up|39|||
163996570|NCT00888238|592351894|FG000|Washout Period After Period 2|Adverse Event|0|||
163996571|NCT00888238|592351895|FG001|Washout Period After Period 2|Adverse Event|0|||
163996572|NCT00888238|592351896|FG002|Washout Period After Period 2|Adverse Event|1|||
163996573|NCT03480802|592353620|FG000|Overall Study|Lost to Follow-up|5|||
163996574|NCT03480802|592353621|FG001|Overall Study|Lost to Follow-up|1|||
163996575|NCT03480802|592353620|FG000|Overall Study|Withdrawal by Subject|2|||
163996576|NCT03480802|592353621|FG001|Overall Study|Withdrawal by Subject|1|||
163996577|NCT03480802|592353620|FG000|Overall Study|Relocated|0|||
163996578|NCT03480802|592353621|FG001|Overall Study|Relocated|1|||
163996579|NCT00988247|592353622|FG000|Overall Study|Adverse Event|17|||
163996580|NCT00988247|592353623|FG001|Overall Study|Adverse Event|3|||
163996581|NCT00988247|592353622|FG000|Overall Study|Withdrawal by Subject|44|||
163996582|NCT00988247|592353623|FG001|Overall Study|Withdrawal by Subject|13|||
163996583|NCT00988247|592353622|FG000|Overall Study|Pregnancy|1|||
163996584|NCT00988247|592353623|FG001|Overall Study|Pregnancy|2|||
163996585|NCT00988247|592353622|FG000|Overall Study|Lost to Follow-up|11|||
163996586|NCT00988247|592353623|FG001|Overall Study|Lost to Follow-up|2|||
163996587|NCT00988247|592353622|FG000|Overall Study|Protocol Violation|4|||
163996588|NCT00988247|592353623|FG001|Overall Study|Protocol Violation|5|||
163996589|NCT00988247|592353622|FG000|Overall Study|Sponsor requested withdrawal|3|||
163996590|NCT00988247|592353623|FG001|Overall Study|Sponsor requested withdrawal|1|||
163996591|NCT00988247|592353622|FG000|Overall Study|Other|3|||
163996592|NCT00988247|592353623|FG001|Overall Study|Other|0|||
163996593|NCT01409928|592353624|FG000|Overall Study|Physician Decision|12|||
163996594|NCT02661594|592353625|FG000|Overall Study|Protocol Violation|1|||
163996595|NCT02661594|592353626|FG001|Overall Study|Protocol Violation|0|||
163996596|NCT02661594|592353627|FG002|Overall Study|Protocol Violation|1|||
163996597|NCT02661594|592353628|FG003|Overall Study|Protocol Violation|0|||
163996598|NCT01169779|592353633|FG000|Overall Study|Adverse Event|3|||
163996599|NCT01169779|592353634|FG001|Overall Study|Adverse Event|11|||
163996600|NCT01169779|592353633|FG000|Overall Study|Lack of Efficacy|1|||
163996601|NCT01169779|592353634|FG001|Overall Study|Lack of Efficacy|0|||
163996602|NCT01169779|592353633|FG000|Overall Study|Protocol Violation|1|||
163996603|NCT01169779|592353634|FG001|Overall Study|Protocol Violation|1|||
163996604|NCT01169779|592353633|FG000|Overall Study|Withdrawal by Subject|3|||
163996605|NCT01169779|592353634|FG001|Overall Study|Withdrawal by Subject|2|||
163996606|NCT01169779|592353633|FG000|Overall Study|Familial and personal reasons|3|||
163996607|NCT01169779|592353634|FG001|Overall Study|Familial and personal reasons|3|||
163996608|NCT00432237|592353637|FG000|Overall Study|Adverse Event|0|||
163996609|NCT00432237|592353638|FG001|Overall Study|Adverse Event|0|||
163996610|NCT00432237|592353639|FG002|Overall Study|Adverse Event|0|||
163996611|NCT00432237|592353640|FG003|Overall Study|Adverse Event|1|||
163996612|NCT00432237|592353637|FG000|Overall Study|Lack of Efficacy|0|||
163996613|NCT00432237|592353638|FG001|Overall Study|Lack of Efficacy|0|||
163996614|NCT00432237|592353639|FG002|Overall Study|Lack of Efficacy|0|||
163996615|NCT00432237|592353640|FG003|Overall Study|Lack of Efficacy|1|||
163996616|NCT00432237|592353637|FG000|Overall Study|Lost to Follow-up|10|||
163996617|NCT00432237|592353638|FG001|Overall Study|Lost to Follow-up|10|||
163996618|NCT00432237|592353639|FG002|Overall Study|Lost to Follow-up|18|||
163996619|NCT00432237|592353640|FG003|Overall Study|Lost to Follow-up|18|||
163996620|NCT00432237|592353637|FG000|Overall Study|Physician Decision|1|||
163996621|NCT00432237|592353638|FG001|Overall Study|Physician Decision|3|||
163996622|NCT00432237|592353639|FG002|Overall Study|Physician Decision|2|||
163996623|NCT00432237|592353640|FG003|Overall Study|Physician Decision|1|||
163996624|NCT00432237|592353637|FG000|Overall Study|Pregnancy|0|||
163996625|NCT00432237|592353638|FG001|Overall Study|Pregnancy|1|||
163996626|NCT00432237|592353639|FG002|Overall Study|Pregnancy|0|||
164265146|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265147|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265148|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164341505|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
164341506|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
164341507|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
164341508|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
164341509|NCT03298867|593625420|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
164341510|NCT03298867|593625421|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
164341511|NCT03298867|593625420|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
164341512|NCT03298867|593625421|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
164341513|NCT00300274|593625422|FG000|Overall Study|Withdrawal by Subject|12|||
164341514|NCT00300274|593625423|FG001|Overall Study|Withdrawal by Subject|3|||
164341515|NCT00300274|593625424|FG002|Overall Study|Withdrawal by Subject|14|||
164341516|NCT00300274|593625422|FG000|Overall Study|Lost to Follow-up|3|||
164341517|NCT00300274|593625423|FG001|Overall Study|Lost to Follow-up|4|||
164341518|NCT00300274|593625424|FG002|Overall Study|Lost to Follow-up|5|||
164341519|NCT00300274|593625422|FG000|Overall Study|Death|31|||
164341520|NCT00300274|593625423|FG001|Overall Study|Death|20|||
164341521|NCT00300274|593625424|FG002|Overall Study|Death|25|||
164341522|NCT00300274|593625422|FG000|Overall Study|Re-transplant|0|||
164341523|NCT00300274|593625423|FG001|Overall Study|Re-transplant|0|||
164341524|NCT00300274|593625424|FG002|Overall Study|Re-transplant|1|||
164341525|NCT06934993|593625439|FG000|Overall Study|Withdrawal by Subject|29|||
164341526|NCT06934993|593625439|FG000|Overall Study|elevated postoperative creatinine level|11|||
164341527|NCT06934993|593625439|FG000|Overall Study|Death|3|||
164341528|NCT01218113|593627424|FG000|Overall Study|Withdrawal by Subject|1|||
164341529|NCT01218113|593627425|FG001|Overall Study|Withdrawal by Subject|0|||
164341530|NCT01218113|593627426|FG002|Overall Study|Withdrawal by Subject|1|||
164341531|NCT01218113|593627424|FG000|Overall Study|Lost to Follow-up|4|||
164341532|NCT01218113|593627425|FG001|Overall Study|Lost to Follow-up|1|||
164341533|NCT01218113|593627426|FG002|Overall Study|Lost to Follow-up|4|||
164341534|NCT01218113|593627424|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
164341535|NCT01218113|593627425|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
164341536|NCT01218113|593627426|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
164341537|NCT01385566|593627430|FG000|Overall Study|Lost to Follow-up|1|||
164341538|NCT01385566|593627431|FG001|Overall Study|Lost to Follow-up|0|||
164341539|NCT01385566|593627432|FG002|Overall Study|Lost to Follow-up|0|||
164341540|NCT01385566|593627433|FG003|Overall Study|Lost to Follow-up|0|||
164341541|NCT01385566|593627434|FG004|Overall Study|Lost to Follow-up|0|||
163996627|NCT00432237|592353640|FG003|Overall Study|Pregnancy|0|||
163996628|NCT00432237|592353637|FG000|Overall Study|Protocol Violation|13|||
164265149|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265150|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265151|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265152|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265153|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164265154|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
164265155|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164265156|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
164341542|NCT01385566|593627435|FG005|Overall Study|Lost to Follow-up|0|||
164341543|NCT01385566|593627430|FG000|Overall Study|Withdrawal by Subject|0|||
164341544|NCT01385566|593627431|FG001|Overall Study|Withdrawal by Subject|0|||
164341545|NCT01385566|593627432|FG002|Overall Study|Withdrawal by Subject|0|||
164341546|NCT01385566|593627433|FG003|Overall Study|Withdrawal by Subject|1|||
163996629|NCT00432237|592353638|FG001|Overall Study|Protocol Violation|10|||
163996630|NCT00432237|592353639|FG002|Overall Study|Protocol Violation|11|||
163996631|NCT00432237|592353640|FG003|Overall Study|Protocol Violation|8|||
163996632|NCT00432237|592353637|FG000|Overall Study|Withdrawal by Subject|5|||
163996633|NCT00432237|592353638|FG001|Overall Study|Withdrawal by Subject|6|||
164085825|NCT00358826|592678574|FG007|Core Study|Withdrawal by Subject|0|||
164085826|NCT00358826|592678567|FG000|Core Study|Lost to Follow-up|0|||
163996634|NCT00432237|592353639|FG002|Overall Study|Withdrawal by Subject|9|||
163996635|NCT00432237|592353640|FG003|Overall Study|Withdrawal by Subject|11|||
163996636|NCT00432237|592353637|FG000|Overall Study|Lack of Qualifying Event|38|||
163996637|NCT00432237|592353638|FG001|Overall Study|Lack of Qualifying Event|71|||
163996638|NCT00432237|592353639|FG002|Overall Study|Lack of Qualifying Event|69|||
163996639|NCT00432237|592353640|FG003|Overall Study|Lack of Qualifying Event|84|||
163996640|NCT01354132|592353641|FG000|Randomization|Physician Decision|1|||
163996641|NCT01354132|592353642|FG001|Randomization|Physician Decision|0|||
163996642|NCT01354132|592353641|FG000|Randomization|Withdrawal by Subject|0|||
163996643|NCT01354132|592353642|FG001|Randomization|Withdrawal by Subject|1|||
163996644|NCT01354132|592353641|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
163996645|NCT01354132|592353642|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
163996646|NCT01354132|592353641|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
163996647|NCT01354132|592353642|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
163996648|NCT01354132|592353641|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
163996649|NCT01354132|592353642|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
163996650|NCT00191854|592353645|FG000|Overall Study|Death|26|||
163996651|NCT00191854|592353646|FG001|Overall Study|Death|23|||
163996652|NCT00191854|592353647|FG002|Overall Study|Death|29|||
163996653|NCT00191854|592353645|FG000|Overall Study|Lost to Follow-up|7|||
163996654|NCT00191854|592353646|FG001|Overall Study|Lost to Follow-up|5|||
163996655|NCT00191854|592353647|FG002|Overall Study|Lost to Follow-up|5|||
163996656|NCT00191854|592353645|FG000|Overall Study|Withdrawal by Subject|4|||
163996657|NCT00191854|592353646|FG001|Overall Study|Withdrawal by Subject|2|||
163996658|NCT00191854|592353647|FG002|Overall Study|Withdrawal by Subject|3|||
163996659|NCT00191854|592353645|FG000|Overall Study|Sponsor Decision|0|||
163996660|NCT00191854|592353646|FG001|Overall Study|Sponsor Decision|0|||
163996661|NCT00191854|592353647|FG002|Overall Study|Sponsor Decision|1|||
163996662|NCT00191854|592353645|FG000|Overall Study|Screen Failure|0|||
163996663|NCT00191854|592353646|FG001|Overall Study|Screen Failure|0|||
163996664|NCT00191854|592353647|FG002|Overall Study|Screen Failure|1|||
163996665|NCT01933932|592353652|FG000|Overall Study|Death|173|||
163891028|NCT01928394|591972791|FG012|Treatment Period|Participant withdrew consent|1|||
163891029|NCT01928394|591972792|FG013|Treatment Period|Participant withdrew consent|0|||
163891030|NCT01928394|591972793|FG014|Treatment Period|Participant withdrew consent|2|||
163891031|NCT01928394|591972794|FG015|Treatment Period|Participant withdrew consent|0|||
163891032|NCT01928394|591972795|FG016|Treatment Period|Participant withdrew consent|2|||
163891033|NCT01928394|591972796|FG017|Treatment Period|Participant withdrew consent|1|||
163891034|NCT01928394|591972797|FG018|Treatment Period|Participant withdrew consent|1|||
163891035|NCT01928394|591972798|FG019|Treatment Period|Participant withdrew consent|1|||
163891036|NCT01928394|591972799|FG020|Treatment Period|Participant withdrew consent|0|||
163891037|NCT01928394|591972800|FG021|Treatment Period|Participant withdrew consent|2|||
163891038|NCT01928394|591972801|FG022|Treatment Period|Participant withdrew consent|0|||
163996666|NCT01933932|592353653|FG001|Overall Study|Death|163|||
163996667|NCT01933932|592353652|FG000|Overall Study|Withdrawal by Subject|11|||
163996668|NCT01933932|592353653|FG001|Overall Study|Withdrawal by Subject|14|||
163996669|NCT01933932|592353652|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163996670|NCT01933932|592353653|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
163996671|NCT02601950|592353654|FG000|Overall Study|Participant enrolled in rollover study|0|||
163996672|NCT02601950|592353655|FG001|Overall Study|Participant enrolled in rollover study|0|||
163891039|NCT01928394|591972779|FG000|Treatment Period|Poor/non-compliance|0|||
163891040|NCT01928394|591972780|FG001|Treatment Period|Poor/non-compliance|0|||
163891041|NCT01928394|591972781|FG002|Treatment Period|Poor/non-compliance|0|||
163891042|NCT01928394|591972782|FG003|Treatment Period|Poor/non-compliance|1|||
163891043|NCT01928394|591972783|FG004|Treatment Period|Poor/non-compliance|0|||
163891044|NCT01928394|591972784|FG005|Treatment Period|Poor/non-compliance|0|||
163891045|NCT01928394|591972785|FG006|Treatment Period|Poor/non-compliance|0|||
163996673|NCT02601950|592353656|FG002|Overall Study|Participant enrolled in rollover study|1|||
164341547|NCT01385566|593627434|FG004|Overall Study|Withdrawal by Subject|0|||
164341548|NCT01385566|593627435|FG005|Overall Study|Withdrawal by Subject|0|||
163891046|NCT01928394|591972786|FG007|Treatment Period|Poor/non-compliance|0|||
163891047|NCT01928394|591972787|FG008|Treatment Period|Poor/non-compliance|0|||
163891048|NCT01928394|591972788|FG009|Treatment Period|Poor/non-compliance|0|||
163891049|NCT01928394|591972789|FG010|Treatment Period|Poor/non-compliance|0|||
163891050|NCT01928394|591972790|FG011|Treatment Period|Poor/non-compliance|0|||
164341549|NCT00967668|593627436|FG000|Overall Study|Withdrawal by Subject|13|||
163996674|NCT02601950|592353657|FG003|Overall Study|Participant enrolled in rollover study|0|||
163996675|NCT02601950|592353658|FG004|Overall Study|Participant enrolled in rollover study|1|||
163996676|NCT02601950|592353659|FG005|Overall Study|Participant enrolled in rollover study|1|||
163996677|NCT02601950|592353660|FG006|Overall Study|Participant enrolled in rollover study|1|||
163996678|NCT02601950|592353661|FG007|Overall Study|Participant enrolled in rollover study|0|||
163996679|NCT02601950|592353654|FG000|Overall Study|Disease progression - radiological|21|||
163996680|NCT02601950|592353655|FG001|Overall Study|Disease progression - radiological|26|||
163996681|NCT02601950|592353656|FG002|Overall Study|Disease progression - radiological|22|||
163996682|NCT02601950|592353657|FG003|Overall Study|Disease progression - radiological|11|||
163996683|NCT02601950|592353658|FG004|Overall Study|Disease progression - radiological|46|||
163996684|NCT02601950|592353659|FG005|Overall Study|Disease progression - radiological|52|||
163996685|NCT02601950|592353660|FG006|Overall Study|Disease progression - radiological|7|||
163996686|NCT02601950|592353661|FG007|Overall Study|Disease progression - radiological|5|||
163996687|NCT02601950|592353654|FG000|Overall Study|Disease progression - clinical|3|||
163996688|NCT02601950|592353655|FG001|Overall Study|Disease progression - clinical|5|||
163996689|NCT02601950|592353656|FG002|Overall Study|Disease progression - clinical|4|||
163996690|NCT02601950|592353657|FG003|Overall Study|Disease progression - clinical|2|||
163996691|NCT02601950|592353658|FG004|Overall Study|Disease progression - clinical|6|||
163996692|NCT02601950|592353659|FG005|Overall Study|Disease progression - clinical|6|||
163996693|NCT02601950|592353660|FG006|Overall Study|Disease progression - clinical|5|||
163996694|NCT02601950|592353661|FG007|Overall Study|Disease progression - clinical|1|||
163996695|NCT02601950|592353654|FG000|Overall Study|Death|6|||
163996696|NCT02601950|592353655|FG001|Overall Study|Death|0|||
163996697|NCT02601950|592353656|FG002|Overall Study|Death|3|||
163996698|NCT02601950|592353657|FG003|Overall Study|Death|1|||
163996699|NCT02601950|592353658|FG004|Overall Study|Death|4|||
163996700|NCT02601950|592353659|FG005|Overall Study|Death|1|||
163996701|NCT02601950|592353660|FG006|Overall Study|Death|0|||
163996702|NCT02601950|592353661|FG007|Overall Study|Death|0|||
163996703|NCT02601950|592353654|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996704|NCT02601950|592353655|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996705|NCT02601950|592353656|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996706|NCT02601950|592353657|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996707|NCT02601950|592353658|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996708|NCT02601950|592353659|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
163996709|NCT02601950|592353660|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996710|NCT02601950|592353661|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
163996711|NCT02601950|592353654|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
163996712|NCT02601950|592353655|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
163996713|NCT02601950|592353656|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
163996714|NCT02601950|592353657|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
163996715|NCT02601950|592353658|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
163996716|NCT02601950|592353659|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
163996717|NCT02601950|592353660|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
163996718|NCT02601950|592353661|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
163996719|NCT02601950|592353654|FG000|Overall Study|Non-compliance|0|||
163996720|NCT02601950|592353655|FG001|Overall Study|Non-compliance|1|||
163996721|NCT02601950|592353656|FG002|Overall Study|Non-compliance|0|||
163996722|NCT02601950|592353657|FG003|Overall Study|Non-compliance|0|||
163996723|NCT02601950|592353658|FG004|Overall Study|Non-compliance|0|||
163996724|NCT02601950|592353659|FG005|Overall Study|Non-compliance|1|||
163996725|NCT02601950|592353660|FG006|Overall Study|Non-compliance|1|||
163996726|NCT02601950|592353661|FG007|Overall Study|Non-compliance|0|||
163996727|NCT02601950|592353654|FG000|Overall Study|Participant refused further study treatment|0|||
163996728|NCT02601950|592353655|FG001|Overall Study|Participant refused further study treatment|1|||
163996729|NCT02601950|592353656|FG002|Overall Study|Participant refused further study treatment|1|||
163996730|NCT02601950|592353657|FG003|Overall Study|Participant refused further study treatment|0|||
163996731|NCT02601950|592353658|FG004|Overall Study|Participant refused further study treatment|2|||
163996732|NCT02601950|592353659|FG005|Overall Study|Participant refused further study treatment|2|||
163996733|NCT02601950|592353660|FG006|Overall Study|Participant refused further study treatment|2|||
163996734|NCT02601950|592353661|FG007|Overall Study|Participant refused further study treatment|1|||
163996735|NCT02601950|592353654|FG000|Overall Study|Investigator discretion|1|||
163996736|NCT02601950|592353655|FG001|Overall Study|Investigator discretion|0|||
163996737|NCT02601950|592353656|FG002|Overall Study|Investigator discretion|1|||
163996738|NCT02601950|592353657|FG003|Overall Study|Investigator discretion|0|||
163996739|NCT02601950|592353658|FG004|Overall Study|Investigator discretion|1|||
163996740|NCT02601950|592353659|FG005|Overall Study|Investigator discretion|1|||
163996741|NCT02601950|592353660|FG006|Overall Study|Investigator discretion|1|||
164341550|NCT00967668|593627437|FG001|Overall Study|Withdrawal by Subject|8|||
164341551|NCT00967668|593627438|FG002|Overall Study|Withdrawal by Subject|8|||
163996742|NCT02601950|592353661|FG007|Overall Study|Investigator discretion|0|||
163996743|NCT02601950|592353654|FG000|Overall Study|Other|0|||
163996744|NCT02601950|592353655|FG001|Overall Study|Other|0|||
163996745|NCT02601950|592353656|FG002|Overall Study|Other|0|||
163996746|NCT02601950|592353657|FG003|Overall Study|Other|0|||
163996747|NCT02601950|592353658|FG004|Overall Study|Other|2|||
163996748|NCT02601950|592353659|FG005|Overall Study|Other|2|||
163996749|NCT02601950|592353660|FG006|Overall Study|Other|1|||
163996750|NCT02601950|592353661|FG007|Overall Study|Other|0|||
164085827|NCT00358826|592678568|FG001|Core Study|Lost to Follow-up|0|||
164341552|NCT00967668|593627436|FG000|Overall Study|Death|0|||
163996751|NCT02157883|592353662|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
163996752|NCT02157883|592353662|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
163996753|NCT02157883|592353662|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
163996754|NCT02157883|592353662|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
163996755|NCT02157883|592353662|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
163996756|NCT01701258|592353663|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
163996757|NCT01701258|592353664|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
163996758|NCT01701258|592353665|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
163996759|NCT01701258|592353666|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
163996760|NCT01701258|592353667|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
163996761|NCT01701258|592353668|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
163996762|NCT01701258|592353669|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
163996763|NCT01701258|592353670|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
163996764|NCT01701258|592353671|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
163996765|NCT01701258|592353672|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
163996766|NCT01701258|592353673|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
163996767|NCT01701258|592353674|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
163996768|NCT01701258|592353675|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
163996769|NCT01701258|592353663|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
163996770|NCT01701258|592353664|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
163996771|NCT01701258|592353665|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
163996772|NCT01701258|592353666|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
163996773|NCT01701258|592353667|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
163996774|NCT01701258|592353668|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
163996775|NCT01701258|592353669|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
163996776|NCT01701258|592353670|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
163996777|NCT01701258|592353671|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
163996778|NCT01701258|592353672|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
163996779|NCT01701258|592353673|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
163996780|NCT01701258|592353674|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
163996781|NCT01701258|592353675|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
163996782|NCT01701258|592353663|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
163996783|NCT01701258|592353664|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
163996784|NCT01701258|592353665|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
163996785|NCT01701258|592353666|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
163996786|NCT01701258|592353667|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
163996787|NCT01701258|592353668|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
163996788|NCT01701258|592353669|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
163996789|NCT01701258|592353670|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
163996790|NCT01701258|592353671|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
164265157|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265158|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265159|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
164265160|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265161|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265162|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265163|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265164|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
163996791|NCT01701258|592353672|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
163996792|NCT01701258|592353673|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
163996793|NCT01701258|592353674|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
163996794|NCT01701258|592353675|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
163996795|NCT01701258|592353663|FG000|Assessment and Scheduling|Investigator Terminated|2|||
163996796|NCT01701258|592353664|FG001|Assessment and Scheduling|Investigator Terminated|0|||
163996797|NCT01701258|592353665|FG002|Assessment and Scheduling|Investigator Terminated|0|||
163996798|NCT01701258|592353666|FG003|Assessment and Scheduling|Investigator Terminated|0|||
163996799|NCT01701258|592353667|FG004|Assessment and Scheduling|Investigator Terminated|0|||
163996800|NCT01701258|592353668|FG005|Assessment and Scheduling|Investigator Terminated|0|||
163996801|NCT01701258|592353669|FG006|Assessment and Scheduling|Investigator Terminated|0|||
163996802|NCT01701258|592353670|FG007|Assessment and Scheduling|Investigator Terminated|0|||
163996803|NCT01701258|592353671|FG008|Assessment and Scheduling|Investigator Terminated|0|||
163996804|NCT01701258|592353672|FG009|Assessment and Scheduling|Investigator Terminated|0|||
163996805|NCT01701258|592353673|FG010|Assessment and Scheduling|Investigator Terminated|0|||
163996806|NCT01701258|592353674|FG011|Assessment and Scheduling|Investigator Terminated|0|||
163996807|NCT01701258|592353675|FG012|Assessment and Scheduling|Investigator Terminated|0|||
163996808|NCT01323478|592353676|FG000|Overall Study|Adverse Event|7|||
163996809|NCT01323478|592353676|FG000|Overall Study|Lack of Efficacy|4|||
163996810|NCT01323478|592353676|FG000|Overall Study|Non-compliance With Study Product|3|||
164265165|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265166|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265167|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265168|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
164265169|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265170|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265171|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
163891051|NCT01928394|591972791|FG012|Treatment Period|Poor/non-compliance|1|||
163891052|NCT01928394|591972792|FG013|Treatment Period|Poor/non-compliance|0|||
163891053|NCT01928394|591972793|FG014|Treatment Period|Poor/non-compliance|1|||
163891054|NCT01928394|591972794|FG015|Treatment Period|Poor/non-compliance|0|||
163891055|NCT01928394|591972795|FG016|Treatment Period|Poor/non-compliance|0|||
163891056|NCT01928394|591972796|FG017|Treatment Period|Poor/non-compliance|1|||
163891057|NCT01928394|591972797|FG018|Treatment Period|Poor/non-compliance|0|||
163891058|NCT01928394|591972798|FG019|Treatment Period|Poor/non-compliance|1|||
163891059|NCT01928394|591972799|FG020|Treatment Period|Poor/non-compliance|0|||
163891060|NCT01928394|591972800|FG021|Treatment Period|Poor/non-compliance|0|||
163891061|NCT01928394|591972801|FG022|Treatment Period|Poor/non-compliance|0|||
163891062|NCT01928394|591972779|FG000|Treatment Period|other reason|0|||
163891063|NCT01928394|591972780|FG001|Treatment Period|other reason|0|||
163891064|NCT01928394|591972781|FG002|Treatment Period|other reason|0|||
163891065|NCT01928394|591972782|FG003|Treatment Period|other reason|0|||
163891066|NCT01928394|591972783|FG004|Treatment Period|other reason|0|||
163891067|NCT01928394|591972784|FG005|Treatment Period|other reason|0|||
163891068|NCT01928394|591972785|FG006|Treatment Period|other reason|0|||
163891069|NCT01928394|591972786|FG007|Treatment Period|other reason|0|||
164265172|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265173|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265174|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265175|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265176|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265177|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265178|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265179|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265180|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
164265181|NCT00969761|593338835|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265182|NCT00969761|593338836|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265183|NCT00969761|593338837|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265184|NCT00969761|593338838|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265185|NCT00969761|593338839|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265186|NCT00969761|593338840|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265187|NCT00969761|593338841|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265188|NCT00969761|593338842|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265189|NCT00969761|593338843|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
164265190|NCT00969761|593338844|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265191|NCT00969761|593338845|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265192|NCT00969761|593338846|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
164265193|NCT00969761|593338835|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
164265194|NCT00969761|593338836|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265195|NCT00969761|593338837|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
164265196|NCT00969761|593338838|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265197|NCT00969761|593338839|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
164265198|NCT00969761|593338840|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265199|NCT00969761|593338841|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265200|NCT00969761|593338842|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
164265201|NCT00969761|593338843|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
164265202|NCT00969761|593338844|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
164265203|NCT00969761|593338845|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265204|NCT00969761|593338846|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
164265205|NCT00969761|593338835|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265206|NCT00969761|593338836|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265207|NCT00969761|593338837|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265208|NCT00969761|593338838|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
164341553|NCT00967668|593627437|FG001|Overall Study|Death|2|||
163891070|NCT01928394|591972787|FG008|Treatment Period|other reason|0|||
163891071|NCT01928394|591972788|FG009|Treatment Period|other reason|0|||
163891072|NCT01928394|591972789|FG010|Treatment Period|other reason|1|||
163891073|NCT01928394|591972790|FG011|Treatment Period|other reason|1|||
163891074|NCT01928394|591972791|FG012|Treatment Period|other reason|1|||
163891075|NCT01928394|591972792|FG013|Treatment Period|other reason|0|||
163891076|NCT01928394|591972793|FG014|Treatment Period|other reason|1|||
163891077|NCT01928394|591972794|FG015|Treatment Period|other reason|0|||
163891078|NCT01928394|591972795|FG016|Treatment Period|other reason|0|||
163891079|NCT01928394|591972796|FG017|Treatment Period|other reason|0|||
163891080|NCT01928394|591972797|FG018|Treatment Period|other reason|2|||
163891081|NCT01928394|591972798|FG019|Treatment Period|other reason|2|||
163891082|NCT01928394|591972799|FG020|Treatment Period|other reason|0|||
163891083|NCT01928394|591972800|FG021|Treatment Period|other reason|0|||
163891084|NCT01928394|591972801|FG022|Treatment Period|other reason|0|||
163891085|NCT01928394|591972779|FG000|Treatment Period|Maximum clinical benefit|0|||
163891086|NCT01928394|591972780|FG001|Treatment Period|Maximum clinical benefit|0|||
163891087|NCT01928394|591972781|FG002|Treatment Period|Maximum clinical benefit|0|||
163891088|NCT01928394|591972782|FG003|Treatment Period|Maximum clinical benefit|0|||
163891089|NCT01928394|591972783|FG004|Treatment Period|Maximum clinical benefit|0|||
163891090|NCT01928394|591972784|FG005|Treatment Period|Maximum clinical benefit|0|||
163891091|NCT01928394|591972785|FG006|Treatment Period|Maximum clinical benefit|0|||
163891092|NCT01928394|591972786|FG007|Treatment Period|Maximum clinical benefit|0|||
163891093|NCT01928394|591972787|FG008|Treatment Period|Maximum clinical benefit|0|||
163891094|NCT01928394|591972788|FG009|Treatment Period|Maximum clinical benefit|0|||
163891095|NCT01928394|591972789|FG010|Treatment Period|Maximum clinical benefit|1|||
163891096|NCT01928394|591972790|FG011|Treatment Period|Maximum clinical benefit|1|||
163891097|NCT01928394|591972791|FG012|Treatment Period|Maximum clinical benefit|0|||
163891098|NCT01928394|591972792|FG013|Treatment Period|Maximum clinical benefit|0|||
163891099|NCT01928394|591972793|FG014|Treatment Period|Maximum clinical benefit|1|||
163891100|NCT01928394|591972794|FG015|Treatment Period|Maximum clinical benefit|0|||
163891101|NCT01928394|591972795|FG016|Treatment Period|Maximum clinical benefit|0|||
163891102|NCT01928394|591972796|FG017|Treatment Period|Maximum clinical benefit|1|||
163891103|NCT01928394|591972797|FG018|Treatment Period|Maximum clinical benefit|1|||
163891104|NCT01928394|591972798|FG019|Treatment Period|Maximum clinical benefit|0|||
163891105|NCT01928394|591972799|FG020|Treatment Period|Maximum clinical benefit|2|||
163891106|NCT01928394|591972800|FG021|Treatment Period|Maximum clinical benefit|0|||
163891107|NCT01928394|591972801|FG022|Treatment Period|Maximum clinical benefit|0|||
163891108|NCT01928394|591972779|FG000|Treatment Period|Lost to Follow-up|0|||
163891109|NCT01928394|591972780|FG001|Treatment Period|Lost to Follow-up|0|||
163891110|NCT01928394|591972781|FG002|Treatment Period|Lost to Follow-up|0|||
163891111|NCT01928394|591972782|FG003|Treatment Period|Lost to Follow-up|0|||
163891112|NCT01928394|591972783|FG004|Treatment Period|Lost to Follow-up|0|||
163891113|NCT01928394|591972784|FG005|Treatment Period|Lost to Follow-up|0|||
163891114|NCT01928394|591972785|FG006|Treatment Period|Lost to Follow-up|0|||
163891115|NCT01928394|591972786|FG007|Treatment Period|Lost to Follow-up|0|||
163891116|NCT01928394|591972787|FG008|Treatment Period|Lost to Follow-up|0|||
163891117|NCT01928394|591972788|FG009|Treatment Period|Lost to Follow-up|0|||
163891118|NCT01928394|591972789|FG010|Treatment Period|Lost to Follow-up|0|||
163891119|NCT01928394|591972790|FG011|Treatment Period|Lost to Follow-up|0|||
163891120|NCT01928394|591972791|FG012|Treatment Period|Lost to Follow-up|0|||
163891121|NCT01928394|591972792|FG013|Treatment Period|Lost to Follow-up|0|||
163891122|NCT01928394|591972793|FG014|Treatment Period|Lost to Follow-up|0|||
163891123|NCT01928394|591972794|FG015|Treatment Period|Lost to Follow-up|0|||
163891124|NCT01928394|591972795|FG016|Treatment Period|Lost to Follow-up|0|||
163891125|NCT01928394|591972796|FG017|Treatment Period|Lost to Follow-up|0|||
163891126|NCT01928394|591972797|FG018|Treatment Period|Lost to Follow-up|0|||
163891127|NCT01928394|591972798|FG019|Treatment Period|Lost to Follow-up|0|||
163891128|NCT01928394|591972799|FG020|Treatment Period|Lost to Follow-up|0|||
163891129|NCT01928394|591972800|FG021|Treatment Period|Lost to Follow-up|0|||
163891130|NCT01928394|591972801|FG022|Treatment Period|Lost to Follow-up|1|||
163891131|NCT01928394|591972779|FG000|Treatment Period|Death|0|||
163891132|NCT01928394|591972780|FG001|Treatment Period|Death|0|||
163891133|NCT01928394|591972781|FG002|Treatment Period|Death|0|||
163891134|NCT01928394|591972782|FG003|Treatment Period|Death|0|||
163891135|NCT01928394|591972783|FG004|Treatment Period|Death|0|||
163891136|NCT01928394|591972784|FG005|Treatment Period|Death|0|||
163891137|NCT01928394|591972785|FG006|Treatment Period|Death|0|||
163891138|NCT01928394|591972786|FG007|Treatment Period|Death|0|||
163891139|NCT01928394|591972787|FG008|Treatment Period|Death|0|||
163891140|NCT01928394|591972788|FG009|Treatment Period|Death|0|||
163996811|NCT01323478|592353676|FG000|Overall Study|Protocol Violation|1|||
163891141|NCT01928394|591972789|FG010|Treatment Period|Death|0|||
163891142|NCT01928394|591972790|FG011|Treatment Period|Death|0|||
163891143|NCT01928394|591972791|FG012|Treatment Period|Death|0|||
163891144|NCT01928394|591972792|FG013|Treatment Period|Death|1|||
163891145|NCT01928394|591972793|FG014|Treatment Period|Death|2|||
163891146|NCT01928394|591972794|FG015|Treatment Period|Death|0|||
163891147|NCT01928394|591972795|FG016|Treatment Period|Death|0|||
163891148|NCT01928394|591972796|FG017|Treatment Period|Death|0|||
163891149|NCT01928394|591972797|FG018|Treatment Period|Death|0|||
163891150|NCT01928394|591972798|FG019|Treatment Period|Death|0|||
163996812|NCT01323478|592353676|FG000|Overall Study|Withdrawal of Consent|1|||
163996813|NCT01323478|592353676|FG000|Overall Study|Administrative or Other Reasons|8|||
163996814|NCT00934102|592353680|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
163891151|NCT01928394|591972799|FG020|Treatment Period|Death|0|||
163891152|NCT01928394|591972800|FG021|Treatment Period|Death|0|||
163891153|NCT01928394|591972801|FG022|Treatment Period|Death|0|||
163891154|NCT01928394|591972779|FG000|Follow-up Period|Participant withdrew consent|3|||
163891155|NCT01928394|591972780|FG001|Follow-up Period|Participant withdrew consent|0|||
163891156|NCT01928394|591972781|FG002|Follow-up Period|Participant withdrew consent|1|||
163891157|NCT01928394|591972782|FG003|Follow-up Period|Participant withdrew consent|4|||
163891158|NCT01928394|591972783|FG004|Follow-up Period|Participant withdrew consent|0|||
163891159|NCT01928394|591972784|FG005|Follow-up Period|Participant withdrew consent|2|||
163891160|NCT01928394|591972785|FG006|Follow-up Period|Participant withdrew consent|5|||
163891161|NCT01928394|591972786|FG007|Follow-up Period|Participant withdrew consent|1|||
163891162|NCT01928394|591972787|FG008|Follow-up Period|Participant withdrew consent|0|||
163996815|NCT00934102|592353681|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
163996816|NCT00934102|592353682|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
163996817|NCT00792298|592353683|FG000|Treatment Period 1|Adverse Event|0|||
163996818|NCT00792298|592353684|FG001|Treatment Period 1|Adverse Event|1|||
163996819|NCT00792298|592353685|FG002|Treatment Period 1|Adverse Event|0|||
163891163|NCT01928394|591972788|FG009|Follow-up Period|Participant withdrew consent|0|||
163891164|NCT01928394|591972789|FG010|Follow-up Period|Participant withdrew consent|5|||
163891165|NCT01928394|591972790|FG011|Follow-up Period|Participant withdrew consent|8|||
163891166|NCT01928394|591972791|FG012|Follow-up Period|Participant withdrew consent|2|||
163891167|NCT01928394|591972792|FG013|Follow-up Period|Participant withdrew consent|12|||
163891168|NCT01928394|591972793|FG014|Follow-up Period|Participant withdrew consent|7|||
163891169|NCT01928394|591972794|FG015|Follow-up Period|Participant withdrew consent|0|||
163891170|NCT01928394|591972795|FG016|Follow-up Period|Participant withdrew consent|5|||
163891171|NCT01928394|591972796|FG017|Follow-up Period|Participant withdrew consent|3|||
163891172|NCT01928394|591972797|FG018|Follow-up Period|Participant withdrew consent|2|||
163891173|NCT01928394|591972798|FG019|Follow-up Period|Participant withdrew consent|7|||
163891174|NCT01928394|591972799|FG020|Follow-up Period|Participant withdrew consent|4|||
163891175|NCT01928394|591972800|FG021|Follow-up Period|Participant withdrew consent|6|||
163891176|NCT01928394|591972801|FG022|Follow-up Period|Participant withdrew consent|2|||
163891177|NCT01928394|591972779|FG000|Follow-up Period|Death|0|||
163891178|NCT01928394|591972780|FG001|Follow-up Period|Death|0|||
163891179|NCT01928394|591972781|FG002|Follow-up Period|Death|2|||
163891180|NCT01928394|591972782|FG003|Follow-up Period|Death|6|||
163891181|NCT01928394|591972783|FG004|Follow-up Period|Death|0|||
163891182|NCT01928394|591972784|FG005|Follow-up Period|Death|6|||
163891183|NCT01928394|591972785|FG006|Follow-up Period|Death|6|||
163891184|NCT01928394|591972786|FG007|Follow-up Period|Death|2|||
163891185|NCT01928394|591972787|FG008|Follow-up Period|Death|1|||
163891186|NCT01928394|591972788|FG009|Follow-up Period|Death|2|||
163891187|NCT01928394|591972789|FG010|Follow-up Period|Death|4|||
163891188|NCT01928394|591972790|FG011|Follow-up Period|Death|12|||
163891189|NCT01928394|591972791|FG012|Follow-up Period|Death|11|||
163891190|NCT01928394|591972792|FG013|Follow-up Period|Death|25|||
163996820|NCT00792298|592353686|FG003|Treatment Period 1|Adverse Event|1|||
163996821|NCT00792298|592353687|FG004|Treatment Period 1|Adverse Event|0|||
163996822|NCT00792298|592353688|FG005|Treatment Period 1|Adverse Event|1|||
163996823|NCT00792298|592353689|FG006|Treatment Period 1|Adverse Event|1|||
163996824|NCT00792298|592353690|FG007|Treatment Period 1|Adverse Event|0|||
163996825|NCT00792298|592353683|FG000|Treatment Period 1|Lack of Efficacy|0|||
163996826|NCT00792298|592353684|FG001|Treatment Period 1|Lack of Efficacy|0|||
163996827|NCT00792298|592353685|FG002|Treatment Period 1|Lack of Efficacy|1|||
163996828|NCT00792298|592353686|FG003|Treatment Period 1|Lack of Efficacy|0|||
163996829|NCT00792298|592353687|FG004|Treatment Period 1|Lack of Efficacy|0|||
163996830|NCT00792298|592353688|FG005|Treatment Period 1|Lack of Efficacy|0|||
163996831|NCT00792298|592353689|FG006|Treatment Period 1|Lack of Efficacy|0|||
163996832|NCT00792298|592353690|FG007|Treatment Period 1|Lack of Efficacy|0|||
163891191|NCT01928394|591972793|FG014|Follow-up Period|Death|18|||
163891192|NCT01928394|591972794|FG015|Follow-up Period|Death|0|||
163996833|NCT00792298|592353683|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163996834|NCT00792298|592353684|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163996835|NCT00792298|592353685|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163891193|NCT01928394|591972795|FG016|Follow-up Period|Death|6|||
163891194|NCT01928394|591972796|FG017|Follow-up Period|Death|5|||
163891195|NCT01928394|591972797|FG018|Follow-up Period|Death|13|||
163891196|NCT01928394|591972798|FG019|Follow-up Period|Death|13|||
163996836|NCT00792298|592353686|FG003|Treatment Period 1|Withdrawal by Subject|2|||
163891197|NCT01928394|591972799|FG020|Follow-up Period|Death|5|||
163891198|NCT01928394|591972800|FG021|Follow-up Period|Death|3|||
163891199|NCT01928394|591972801|FG022|Follow-up Period|Death|2|||
163891200|NCT01928394|591972779|FG000|Follow-up Period|other reason|0|||
163891201|NCT01928394|591972780|FG001|Follow-up Period|other reason|0|||
163996837|NCT00792298|592353687|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163996838|NCT00792298|592353688|FG005|Treatment Period 1|Withdrawal by Subject|2|||
163996839|NCT00792298|592353689|FG006|Treatment Period 1|Withdrawal by Subject|1|||
163996840|NCT00792298|592353690|FG007|Treatment Period 1|Withdrawal by Subject|0|||
163996841|NCT00792298|592353683|FG000|Treatment Period 1|Lost to Follow-up|0|||
163996842|NCT00792298|592353684|FG001|Treatment Period 1|Lost to Follow-up|0|||
163996843|NCT00792298|592353685|FG002|Treatment Period 1|Lost to Follow-up|0|||
163996844|NCT00792298|592353686|FG003|Treatment Period 1|Lost to Follow-up|0|||
163996845|NCT00792298|592353687|FG004|Treatment Period 1|Lost to Follow-up|0|||
163996846|NCT00792298|592353688|FG005|Treatment Period 1|Lost to Follow-up|0|||
163996847|NCT00792298|592353689|FG006|Treatment Period 1|Lost to Follow-up|1|||
163996848|NCT00792298|592353690|FG007|Treatment Period 1|Lost to Follow-up|0|||
163996849|NCT00792298|592353683|FG000|Treatment Period 1|Physician Decision|0|||
163996850|NCT00792298|592353684|FG001|Treatment Period 1|Physician Decision|0|||
163996851|NCT00792298|592353685|FG002|Treatment Period 1|Physician Decision|0|||
163996852|NCT00792298|592353686|FG003|Treatment Period 1|Physician Decision|1|||
163996853|NCT00792298|592353687|FG004|Treatment Period 1|Physician Decision|0|||
163996854|NCT00792298|592353688|FG005|Treatment Period 1|Physician Decision|0|||
163996855|NCT00792298|592353689|FG006|Treatment Period 1|Physician Decision|1|||
163996856|NCT00792298|592353690|FG007|Treatment Period 1|Physician Decision|0|||
163996857|NCT00792298|592353683|FG000|Treatment Period 1|Protocol Violation|0|||
163996858|NCT00792298|592353684|FG001|Treatment Period 1|Protocol Violation|0|||
163996859|NCT00792298|592353685|FG002|Treatment Period 1|Protocol Violation|0|||
163996860|NCT00792298|592353686|FG003|Treatment Period 1|Protocol Violation|0|||
163996861|NCT00792298|592353687|FG004|Treatment Period 1|Protocol Violation|0|||
163996862|NCT00792298|592353688|FG005|Treatment Period 1|Protocol Violation|0|||
163996863|NCT00792298|592353689|FG006|Treatment Period 1|Protocol Violation|0|||
163996864|NCT00792298|592353690|FG007|Treatment Period 1|Protocol Violation|1|||
163996865|NCT00792298|592353683|FG000|Washout|Adverse Event|0|||
163996866|NCT00792298|592353684|FG001|Washout|Adverse Event|0|||
163996867|NCT00792298|592353685|FG002|Washout|Adverse Event|0|||
163996868|NCT00792298|592353686|FG003|Washout|Adverse Event|0|||
163996869|NCT00792298|592353687|FG004|Washout|Adverse Event|0|||
163996870|NCT00792298|592353688|FG005|Washout|Adverse Event|1|||
163996871|NCT00792298|592353689|FG006|Washout|Adverse Event|0|||
163996872|NCT00792298|592353690|FG007|Washout|Adverse Event|0|||
163996873|NCT00792298|592353683|FG000|Washout|Withdrawal by Subject|0|||
163996874|NCT00792298|592353684|FG001|Washout|Withdrawal by Subject|0|||
163996875|NCT00792298|592353685|FG002|Washout|Withdrawal by Subject|1|||
163996876|NCT00792298|592353686|FG003|Washout|Withdrawal by Subject|0|||
163996877|NCT00792298|592353687|FG004|Washout|Withdrawal by Subject|0|||
163996878|NCT00792298|592353688|FG005|Washout|Withdrawal by Subject|1|||
163996879|NCT00792298|592353689|FG006|Washout|Withdrawal by Subject|0|||
163996880|NCT00792298|592353690|FG007|Washout|Withdrawal by Subject|0|||
163996881|NCT00792298|592353683|FG000|Treatment Period 2|Lack of Efficacy|0|||
163996882|NCT00792298|592353684|FG001|Treatment Period 2|Lack of Efficacy|0|||
163996883|NCT00792298|592353685|FG002|Treatment Period 2|Lack of Efficacy|0|||
163996884|NCT00792298|592353686|FG003|Treatment Period 2|Lack of Efficacy|0|||
163996885|NCT00792298|592353687|FG004|Treatment Period 2|Lack of Efficacy|1|||
163996886|NCT00792298|592353688|FG005|Treatment Period 2|Lack of Efficacy|0|||
163996887|NCT00792298|592353689|FG006|Treatment Period 2|Lack of Efficacy|0|||
163996888|NCT00792298|592353690|FG007|Treatment Period 2|Lack of Efficacy|0|||
163996889|NCT00792298|592353683|FG000|Treatment Period 2|Physician Decision|0|||
163996890|NCT00792298|592353684|FG001|Treatment Period 2|Physician Decision|0|||
163996891|NCT00792298|592353685|FG002|Treatment Period 2|Physician Decision|0|||
163996892|NCT00792298|592353686|FG003|Treatment Period 2|Physician Decision|0|||
163996893|NCT00792298|592353687|FG004|Treatment Period 2|Physician Decision|0|||
163996894|NCT00792298|592353688|FG005|Treatment Period 2|Physician Decision|0|||
163996895|NCT00792298|592353689|FG006|Treatment Period 2|Physician Decision|1|||
163996896|NCT00792298|592353690|FG007|Treatment Period 2|Physician Decision|0|||
163996897|NCT00792298|592353683|FG000|Treatment Period 2|Pregnancy|0|||
163996898|NCT00792298|592353684|FG001|Treatment Period 2|Pregnancy|0|||
163996899|NCT00792298|592353685|FG002|Treatment Period 2|Pregnancy|1|||
163996900|NCT00792298|592353686|FG003|Treatment Period 2|Pregnancy|0|||
163996901|NCT00792298|592353687|FG004|Treatment Period 2|Pregnancy|0|||
163996902|NCT00792298|592353688|FG005|Treatment Period 2|Pregnancy|0|||
163996903|NCT00792298|592353689|FG006|Treatment Period 2|Pregnancy|0|||
163996904|NCT00792298|592353690|FG007|Treatment Period 2|Pregnancy|0|||
163996905|NCT00792298|592353683|FG000|Treatment Period 2|Withdrawal by Subject|1|||
163996906|NCT00792298|592353684|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163996907|NCT00792298|592353685|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163996908|NCT00792298|592353686|FG003|Treatment Period 2|Withdrawal by Subject|2|||
163996909|NCT00792298|592353687|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163996910|NCT00792298|592353688|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163996911|NCT00792298|592353689|FG006|Treatment Period 2|Withdrawal by Subject|0|||
163996912|NCT00792298|592353690|FG007|Treatment Period 2|Withdrawal by Subject|2|||
163996913|NCT00486603|592353696|FG000|Overall Study|Withdrawal by Subject|1|||
163996914|NCT00486603|592353697|FG001|Overall Study|Withdrawal by Subject|0|||
163996915|NCT00486603|592353698|FG002|Overall Study|Withdrawal by Subject|0|||
163996916|NCT00486603|592353699|FG003|Overall Study|Withdrawal by Subject|0|||
164341554|NCT00967668|593627438|FG002|Overall Study|Death|4|||
164341555|NCT00967668|593627436|FG000|Overall Study|Removed due to behavior|1|||
164341556|NCT00967668|593627437|FG001|Overall Study|Removed due to behavior|1|||
164341557|NCT00967668|593627438|FG002|Overall Study|Removed due to behavior|2|||
164341558|NCT00967668|593627436|FG000|Overall Study|Refused Year 2|11|||
164341559|NCT00967668|593627437|FG001|Overall Study|Refused Year 2|6|||
164341560|NCT00967668|593627438|FG002|Overall Study|Refused Year 2|4|||
164341561|NCT00967668|593627436|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
164341562|NCT00967668|593627437|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
164341563|NCT00967668|593627438|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
164341564|NCT00967668|593627436|FG000|Overall Study|Lost to Follow-up|15|||
164341565|NCT00967668|593627437|FG001|Overall Study|Lost to Follow-up|9|||
164341566|NCT00967668|593627438|FG002|Overall Study|Lost to Follow-up|16|||
164341567|NCT00967668|593627436|FG000|Overall Study|Refused 12-mo assessment|3|||
164341568|NCT00967668|593627437|FG001|Overall Study|Refused 12-mo assessment|1|||
164341569|NCT00967668|593627438|FG002|Overall Study|Refused 12-mo assessment|9|||
164341570|NCT00967668|593627436|FG000|Overall Study|Pregnancy|1|||
164341571|NCT00967668|593627437|FG001|Overall Study|Pregnancy|0|||
164341572|NCT00967668|593627438|FG002|Overall Study|Pregnancy|0|||
164341573|NCT00825682|593627439|FG000|Overall Study|personal reasons/ inconvenience|13|||
164341574|NCT00825682|593627440|FG001|Overall Study|personal reasons/ inconvenience|5|||
164341575|NCT02468674|593627441|FG000|Overall Study|Adverse Event|0|||
164341576|NCT02468674|593627442|FG001|Overall Study|Adverse Event|0|||
164341577|NCT02468674|593627443|FG002|Overall Study|Adverse Event|0|||
164341578|NCT02468674|593627444|FG003|Overall Study|Adverse Event|1|||
164341579|NCT02468674|593627445|FG004|Overall Study|Adverse Event|0|||
164341580|NCT02468674|593627446|FG005|Overall Study|Adverse Event|1|||
164341581|NCT02468674|593627447|FG006|Overall Study|Adverse Event|0|||
164341582|NCT02468674|593627448|FG007|Overall Study|Adverse Event|0|||
164341583|NCT02468674|593627449|FG008|Overall Study|Adverse Event|0|||
164341584|NCT02468674|593627441|FG000|Overall Study|Lost to Follow-up|1|||
164341585|NCT02468674|593627442|FG001|Overall Study|Lost to Follow-up|0|||
164341586|NCT02468674|593627443|FG002|Overall Study|Lost to Follow-up|0|||
164341587|NCT02468674|593627444|FG003|Overall Study|Lost to Follow-up|0|||
164341588|NCT02468674|593627445|FG004|Overall Study|Lost to Follow-up|0|||
164341589|NCT02468674|593627446|FG005|Overall Study|Lost to Follow-up|0|||
164341590|NCT02468674|593627447|FG006|Overall Study|Lost to Follow-up|0|||
164341591|NCT02468674|593627448|FG007|Overall Study|Lost to Follow-up|1|||
164341592|NCT02468674|593627449|FG008|Overall Study|Lost to Follow-up|1|||
164341593|NCT02468674|593627441|FG000|Overall Study|Physician Decision|0|||
164341594|NCT02468674|593627442|FG001|Overall Study|Physician Decision|0|||
164341595|NCT02468674|593627443|FG002|Overall Study|Physician Decision|0|||
164341596|NCT02468674|593627444|FG003|Overall Study|Physician Decision|0|||
164341597|NCT02468674|593627445|FG004|Overall Study|Physician Decision|0|||
164341598|NCT02468674|593627446|FG005|Overall Study|Physician Decision|0|||
164341599|NCT02468674|593627447|FG006|Overall Study|Physician Decision|1|||
164341600|NCT02468674|593627448|FG007|Overall Study|Physician Decision|0|||
164341601|NCT02468674|593627449|FG008|Overall Study|Physician Decision|0|||
163891202|NCT01928394|591972781|FG002|Follow-up Period|other reason|0|||
163891203|NCT01928394|591972782|FG003|Follow-up Period|other reason|0|||
163891204|NCT01928394|591972783|FG004|Follow-up Period|other reason|0|||
163891205|NCT01928394|591972784|FG005|Follow-up Period|other reason|0|||
163891206|NCT01928394|591972785|FG006|Follow-up Period|other reason|1|||
163891207|NCT01928394|591972786|FG007|Follow-up Period|other reason|3|||
163891208|NCT01928394|591972787|FG008|Follow-up Period|other reason|0|||
163891209|NCT01928394|591972788|FG009|Follow-up Period|other reason|0|||
163891210|NCT01928394|591972789|FG010|Follow-up Period|other reason|2|||
163891211|NCT01928394|591972790|FG011|Follow-up Period|other reason|1|||
163891212|NCT01928394|591972791|FG012|Follow-up Period|other reason|0|||
163891213|NCT01928394|591972792|FG013|Follow-up Period|other reason|1|||
163891214|NCT01928394|591972793|FG014|Follow-up Period|other reason|4|||
163891215|NCT01928394|591972794|FG015|Follow-up Period|other reason|0|||
163891216|NCT01928394|591972795|FG016|Follow-up Period|other reason|2|||
164085828|NCT00358826|592678569|FG002|Core Study|Lost to Follow-up|0|||
164341602|NCT02468674|593627441|FG000|Overall Study|Patient/Guardian Decision|0|||
164341603|NCT02468674|593627442|FG001|Overall Study|Patient/Guardian Decision|0|||
164341604|NCT02468674|593627443|FG002|Overall Study|Patient/Guardian Decision|0|||
164341605|NCT02468674|593627444|FG003|Overall Study|Patient/Guardian Decision|0|||
164341606|NCT02468674|593627445|FG004|Overall Study|Patient/Guardian Decision|1|||
164341607|NCT02468674|593627446|FG005|Overall Study|Patient/Guardian Decision|0|||
164341608|NCT02468674|593627447|FG006|Overall Study|Patient/Guardian Decision|0|||
164341609|NCT02468674|593627448|FG007|Overall Study|Patient/Guardian Decision|2|||
164341610|NCT02468674|593627449|FG008|Overall Study|Patient/Guardian Decision|1|||
164341611|NCT02468674|593627441|FG000|Overall Study|Protocol Deviation|0|||
164341612|NCT02468674|593627442|FG001|Overall Study|Protocol Deviation|0|||
164341613|NCT02468674|593627443|FG002|Overall Study|Protocol Deviation|0|||
163891217|NCT01928394|591972796|FG017|Follow-up Period|other reason|0|||
163891218|NCT01928394|591972797|FG018|Follow-up Period|other reason|1|||
163891219|NCT01928394|591972798|FG019|Follow-up Period|other reason|1|||
163891220|NCT01928394|591972799|FG020|Follow-up Period|other reason|0|||
164341614|NCT02468674|593627444|FG003|Overall Study|Protocol Deviation|0|||
164341615|NCT02468674|593627445|FG004|Overall Study|Protocol Deviation|0|||
163996917|NCT00486603|592353700|FG004|Overall Study|Withdrawal by Subject|0|||
163996918|NCT00486603|592353696|FG000|Overall Study|Physician Decision|0|||
163996919|NCT00486603|592353697|FG001|Overall Study|Physician Decision|1|||
163996920|NCT00486603|592353698|FG002|Overall Study|Physician Decision|0|||
163996921|NCT00486603|592353699|FG003|Overall Study|Physician Decision|0|||
163996922|NCT00486603|592353700|FG004|Overall Study|Physician Decision|0|||
163996923|NCT02649634|592353701|FG000|Overall Study|Withdrawal by Subject|3|||
163996924|NCT02649634|592353702|FG001|Overall Study|Withdrawal by Subject|5|||
163996925|NCT02649634|592353701|FG000|Overall Study|Lost to Follow-up|0|||
163996926|NCT02649634|592353702|FG001|Overall Study|Lost to Follow-up|1|||
163996927|NCT01670994|592353705|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
163996928|NCT01670994|592353706|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
163996929|NCT01670994|592353705|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
163996930|NCT01670994|592353706|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
163996931|NCT01670994|592353705|FG000|Overall Study|Patient experienced DLT|0|||
163996932|NCT01670994|592353706|FG001|Overall Study|Patient experienced DLT|1|||
163996933|NCT00763009|592353707|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
163996934|NCT01111604|592353708|FG000|Overall Study|Lost to Follow-up|0|||
163996935|NCT01111604|592353709|FG001|Overall Study|Lost to Follow-up|0|||
163891221|NCT01928394|591972800|FG021|Follow-up Period|other reason|0|||
163891222|NCT01928394|591972801|FG022|Follow-up Period|other reason|1|||
163891223|NCT01928394|591972779|FG000|Follow-up Period|Lost to Follow-up|0|||
163891224|NCT01928394|591972780|FG001|Follow-up Period|Lost to Follow-up|0|||
163996936|NCT01111604|592353710|FG002|Overall Study|Lost to Follow-up|1|||
163996937|NCT01111604|592353708|FG000|Overall Study|Withdrew Consent|3|||
163996938|NCT01111604|592353709|FG001|Overall Study|Withdrew Consent|0|||
163996939|NCT01111604|592353710|FG002|Overall Study|Withdrew Consent|2|||
163996940|NCT01111604|592353708|FG000|Overall Study|Withdrawal by Subject|2|||
163996941|NCT01111604|592353709|FG001|Overall Study|Withdrawal by Subject|0|||
163996942|NCT01111604|592353710|FG002|Overall Study|Withdrawal by Subject|0|||
163996943|NCT01111604|592353708|FG000|Overall Study|Death|1|||
163996944|NCT01111604|592353709|FG001|Overall Study|Death|0|||
163996945|NCT01111604|592353710|FG002|Overall Study|Death|0|||
163996946|NCT01111604|592353708|FG000|Overall Study|Met Exclusion Criteria|2|||
163996947|NCT01111604|592353709|FG001|Overall Study|Met Exclusion Criteria|0|||
163996948|NCT01111604|592353710|FG002|Overall Study|Met Exclusion Criteria|0|||
163996949|NCT01360996|592353715|FG000|Overall Study|Withdrawal by Subject|4|||
163996950|NCT01360996|592353716|FG001|Overall Study|Withdrawal by Subject|3|||
163996951|NCT01360996|592353717|FG002|Overall Study|Withdrawal by Subject|2|||
163996952|NCT01360996|592353715|FG000|Overall Study|Noncompliant|2|||
163996953|NCT01360996|592353716|FG001|Overall Study|Noncompliant|0|||
163996954|NCT01360996|592353717|FG002|Overall Study|Noncompliant|0|||
163996955|NCT03377634|592353718|FG000|Study Period|Adverse Event|1|||
163996956|NCT03377634|592353719|FG001|Study Period|Adverse Event|0|||
163996957|NCT03377634|592353718|FG000|Study Period|Withdrawal by Subject|1|||
163996958|NCT03377634|592353719|FG001|Study Period|Withdrawal by Subject|0|||
163996959|NCT01454076|592353720|FG000|Overall Study|Other|2|||
163996960|NCT01454076|592353721|FG001|Overall Study|Other|0|||
163996961|NCT01454076|592353722|FG002|Overall Study|Other|0|||
163996962|NCT01454076|592353723|FG003|Overall Study|Other|1|||
163996963|NCT01454076|592353724|FG004|Overall Study|Other|2|||
163996964|NCT01454076|592353720|FG000|Overall Study|Withdrawal by Subject|3|||
163996965|NCT01454076|592353721|FG001|Overall Study|Withdrawal by Subject|4|||
163996966|NCT01454076|592353722|FG002|Overall Study|Withdrawal by Subject|2|||
163996967|NCT01454076|592353723|FG003|Overall Study|Withdrawal by Subject|1|||
163996968|NCT01454076|592353724|FG004|Overall Study|Withdrawal by Subject|2|||
163996969|NCT01454076|592353720|FG000|Overall Study|Adverse Event|8|||
163996970|NCT01454076|592353721|FG001|Overall Study|Adverse Event|2|||
163996971|NCT01454076|592353722|FG002|Overall Study|Adverse Event|7|||
163996972|NCT01454076|592353723|FG003|Overall Study|Adverse Event|0|||
163996973|NCT01454076|592353724|FG004|Overall Study|Adverse Event|2|||
163996974|NCT00291551|592353730|FG000|Overall Study|Death|7|||
163996975|NCT00291551|592353730|FG000|Overall Study|Withdrawal by Subject|6|||
163996976|NCT02452762|592353731|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
164341616|NCT02468674|593627446|FG005|Overall Study|Protocol Deviation|0|||
163891225|NCT01928394|591972781|FG002|Follow-up Period|Lost to Follow-up|0|||
163891226|NCT01928394|591972782|FG003|Follow-up Period|Lost to Follow-up|0|||
163891227|NCT01928394|591972783|FG004|Follow-up Period|Lost to Follow-up|0|||
163891228|NCT01928394|591972784|FG005|Follow-up Period|Lost to Follow-up|0|||
163891229|NCT01928394|591972785|FG006|Follow-up Period|Lost to Follow-up|0|||
163996977|NCT02452762|592353732|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
163996978|NCT02452762|592353731|FG000|Overall Study|Withdrawal by Subject|1|||
163996979|NCT02452762|592353732|FG001|Overall Study|Withdrawal by Subject|0|||
163891230|NCT01928394|591972786|FG007|Follow-up Period|Lost to Follow-up|0|||
163996980|NCT00584870|592353733|FG000|Overall Study|Adverse Event|4|||
163996981|NCT00584870|592353734|FG001|Overall Study|Adverse Event|3|||
163996982|NCT00584870|592353735|FG002|Overall Study|Adverse Event|2|||
163996983|NCT00584870|592353733|FG000|Overall Study|Lost to Follow-up|4|||
163996984|NCT00584870|592353734|FG001|Overall Study|Lost to Follow-up|1|||
163996985|NCT00584870|592353735|FG002|Overall Study|Lost to Follow-up|1|||
163996986|NCT00584870|592353733|FG000|Overall Study|Lack of Efficacy|7|||
163996987|NCT00584870|592353734|FG001|Overall Study|Lack of Efficacy|14|||
163996988|NCT00584870|592353735|FG002|Overall Study|Lack of Efficacy|8|||
163996989|NCT00584870|592353733|FG000|Overall Study|Withdrawal by Subject|10|||
163996990|NCT00584870|592353734|FG001|Overall Study|Withdrawal by Subject|5|||
163996991|NCT00584870|592353735|FG002|Overall Study|Withdrawal by Subject|3|||
163996992|NCT00584870|592353733|FG000|Overall Study|Protocol Violation|1|||
163996993|NCT00584870|592353734|FG001|Overall Study|Protocol Violation|1|||
163996994|NCT00584870|592353735|FG002|Overall Study|Protocol Violation|2|||
163996995|NCT00584870|592353733|FG000|Overall Study|Did not met entrance criteria|1|||
163996996|NCT00584870|592353734|FG001|Overall Study|Did not met entrance criteria|0|||
163996997|NCT00584870|592353735|FG002|Overall Study|Did not met entrance criteria|0|||
163996998|NCT00584870|592353733|FG000|Overall Study|Other|2|||
163996999|NCT00584870|592353734|FG001|Overall Study|Other|0|||
163997000|NCT00584870|592353735|FG002|Overall Study|Other|0|||
163997001|NCT00584870|592353733|FG000|Overall Study|Randomized but not treated|0|||
163997002|NCT00584870|592353734|FG001|Overall Study|Randomized but not treated|1|||
163997003|NCT00584870|592353735|FG002|Overall Study|Randomized but not treated|2|||
163997004|NCT00631137|592353736|FG000|Overall Study|Withdrawal by Subject|1|||
163997005|NCT00631137|592353737|FG001|Overall Study|Withdrawal by Subject|0|||
163997006|NCT03682120|592353738|FG000|Overall Study|Lost to Follow-up|11|||
163997007|NCT03682120|592353739|FG001|Overall Study|Lost to Follow-up|4|||
163997008|NCT03682120|592353740|FG002|Overall Study|Lost to Follow-up|5|||
163997009|NCT03682120|592353741|FG003|Overall Study|Lost to Follow-up|2|||
163997010|NCT03682120|592353738|FG000|Overall Study|Physician Decision|1|||
163997011|NCT03682120|592353739|FG001|Overall Study|Physician Decision|0|||
163997012|NCT03682120|592353740|FG002|Overall Study|Physician Decision|0|||
163997013|NCT03682120|592353741|FG003|Overall Study|Physician Decision|0|||
164265209|NCT00969761|593338839|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
164265210|NCT00969761|593338840|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265211|NCT00969761|593338841|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265212|NCT00969761|593338842|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265213|NCT00969761|593338843|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
164265214|NCT00969761|593338844|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265215|NCT00969761|593338845|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164265216|NCT00969761|593338846|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
164299923|NCT02234843|593472944|FG000|Overall Study|Non-compliance with study drug|1|||
163997014|NCT03682120|592353738|FG000|Overall Study|Withdrawal by Subject|1|||
163997015|NCT03682120|592353739|FG001|Overall Study|Withdrawal by Subject|2|||
163997016|NCT03682120|592353740|FG002|Overall Study|Withdrawal by Subject|3|||
163997017|NCT03682120|592353741|FG003|Overall Study|Withdrawal by Subject|0|||
163997018|NCT03682120|592353738|FG000|Overall Study|Death|0|||
163997019|NCT03682120|592353739|FG001|Overall Study|Death|1|||
163997020|NCT03682120|592353740|FG002|Overall Study|Death|0|||
163997021|NCT03682120|592353741|FG003|Overall Study|Death|0|||
163997022|NCT03682120|592353738|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
163997023|NCT03682120|592353739|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
163997024|NCT03682120|592353740|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
163997025|NCT03682120|592353741|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
163997026|NCT01015833|592353742|FG000|Overall Study|Death|1|||
163997027|NCT01015833|592353743|FG001|Overall Study|Death|0|||
163997028|NCT01015833|592353742|FG000|Overall Study|Withdrawal by Subject|3|||
163997029|NCT01015833|592353743|FG001|Overall Study|Withdrawal by Subject|2|||
163997030|NCT01015833|592353742|FG000|Overall Study|Adverse Event|0|||
163997031|NCT01015833|592353743|FG001|Overall Study|Adverse Event|1|||
163997032|NCT01015833|592353742|FG000|Overall Study|Physician Decision|2|||
163997033|NCT01015833|592353743|FG001|Overall Study|Physician Decision|0|||
163997034|NCT01015833|592353742|FG000|Overall Study|Symptomatic deterioration|0|||
163997035|NCT01015833|592353743|FG001|Overall Study|Symptomatic deterioration|1|||
163997036|NCT01015833|592353742|FG000|Overall Study|Other|5|||
163997037|NCT01015833|592353743|FG001|Overall Study|Other|1|||
163997038|NCT01015833|592353742|FG000|Overall Study|Motor Vehicle Accidents|1|||
163997039|NCT01015833|592353743|FG001|Overall Study|Motor Vehicle Accidents|0|||
163997040|NCT01015833|592353742|FG000|Overall Study|Did not start treatment|1|||
163997041|NCT01015833|592353743|FG001|Overall Study|Did not start treatment|0|||
163997042|NCT03898063|592353744|FG000|Overall Study|Withdrawal by Subject|10|||
163997043|NCT03898063|592353745|FG001|Overall Study|Withdrawal by Subject|8|||
163997044|NCT03430986|592353748|FG000|24-week Control Period|Adverse Event|1|||
163997045|NCT03430986|592353749|FG001|24-week Control Period|Adverse Event|0|||
163997046|NCT03430986|592353748|FG000|24-week Control Period|Lost to Follow-up|2|||
163997047|NCT03430986|592353749|FG001|24-week Control Period|Lost to Follow-up|2|||
163997048|NCT03430986|592353748|FG000|24-week Control Period|Withdrawal by Participant|5|||
163997049|NCT03430986|592353749|FG001|24-week Control Period|Withdrawal by Participant|0|||
163997050|NCT03430986|592353748|FG000|24-week Control Period|Protocol Deviation|0|||
163997051|NCT03430986|592353749|FG001|24-week Control Period|Protocol Deviation|2|||
163997052|NCT03430986|592353748|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
163997053|NCT03430986|592353749|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
163997054|NCT03430986|592353748|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
163997055|NCT03430986|592353749|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
163997056|NCT01889602|592353753|FG000|First Intervention|Adverse Event|1|||
163997057|NCT01889602|592353754|FG001|First Intervention|Adverse Event|1|||
163997058|NCT01889602|592353755|FG002|First Intervention|Adverse Event|1|||
163997059|NCT01889602|592353753|FG000|First Intervention|Protocol Violation|0|||
163997060|NCT01889602|592353754|FG001|First Intervention|Protocol Violation|1|||
163997061|NCT01889602|592353755|FG002|First Intervention|Protocol Violation|1|||
163997062|NCT01889602|592353753|FG000|First Intervention|Study ending|0|||
163997063|NCT01889602|592353754|FG001|First Intervention|Study ending|1|||
163997064|NCT01889602|592353755|FG002|First Intervention|Study ending|0|||
163997065|NCT01889602|592353753|FG000|Second Intervention|Adverse Event|0|||
163997066|NCT01889602|592353754|FG001|Second Intervention|Adverse Event|0|||
163997067|NCT01889602|592353755|FG002|Second Intervention|Adverse Event|1|||
163997068|NCT01889602|592353753|FG000|Second Intervention|Study ending|1|||
163997069|NCT01889602|592353754|FG001|Second Intervention|Study ending|0|||
163997070|NCT01889602|592353755|FG002|Second Intervention|Study ending|0|||
163997071|NCT01889602|592353753|FG000|Second Intervention|Withdrawal by Subject|0|||
163997072|NCT01889602|592353754|FG001|Second Intervention|Withdrawal by Subject|0|||
163997073|NCT01889602|592353755|FG002|Second Intervention|Withdrawal by Subject|1|||
163997074|NCT01889602|592353753|FG000|Third Intervention|Protocol Violation|1|||
163997075|NCT01889602|592353754|FG001|Third Intervention|Protocol Violation|0|||
163997076|NCT01889602|592353755|FG002|Third Intervention|Protocol Violation|0|||
163997077|NCT01889602|592353753|FG000|Third Intervention|Withdrawal by Subject|2|||
163997078|NCT01889602|592353754|FG001|Third Intervention|Withdrawal by Subject|2|||
163997079|NCT01889602|592353755|FG002|Third Intervention|Withdrawal by Subject|0|||
163997080|NCT00961961|592353756|FG000|Phase I|Withdrawal by Subject|7|||
163997081|NCT00961961|592353757|FG001|Phase I|Withdrawal by Subject|0|||
163997082|NCT00961961|592353758|FG002|Phase I|Withdrawal by Subject|0|||
163997083|NCT00961961|592353759|FG003|Phase I|Withdrawal by Subject|0|||
163997084|NCT00961961|592353756|FG000|Phase I|Lost to Follow-up|10|||
163997085|NCT00961961|592353757|FG001|Phase I|Lost to Follow-up|0|||
163997086|NCT00961961|592353758|FG002|Phase I|Lost to Follow-up|0|||
163997087|NCT00961961|592353759|FG003|Phase I|Lost to Follow-up|0|||
163997088|NCT00961961|592353756|FG000|Phase I|Lack of Efficacy|94|||
163997089|NCT00961961|592353757|FG001|Phase I|Lack of Efficacy|0|||
163997090|NCT00961961|592353758|FG002|Phase I|Lack of Efficacy|0|||
163997091|NCT00961961|592353759|FG003|Phase I|Lack of Efficacy|0|||
163997092|NCT00961961|592353756|FG000|Phase I|Adverse Event|7|||
164341617|NCT02468674|593627447|FG006|Overall Study|Protocol Deviation|0|||
164341618|NCT02468674|593627448|FG007|Overall Study|Protocol Deviation|1|||
164341619|NCT02468674|593627449|FG008|Overall Study|Protocol Deviation|1|||
164341620|NCT03281577|593627450|FG000|Overall Study|Adverse Event|0|||
164341621|NCT03281577|593627451|FG001|Overall Study|Adverse Event|0|||
164341622|NCT03281577|593627452|FG002|Overall Study|Adverse Event|0|||
164341623|NCT03281577|593627453|FG003|Overall Study|Adverse Event|1|||
164341624|NCT03281577|593627450|FG000|Overall Study|Withdrawal by Subject|1|||
164341625|NCT03281577|593627451|FG001|Overall Study|Withdrawal by Subject|0|||
164341626|NCT03281577|593627452|FG002|Overall Study|Withdrawal by Subject|0|||
164341627|NCT03281577|593627453|FG003|Overall Study|Withdrawal by Subject|0|||
164341628|NCT01644565|593627458|FG000|Overall Study|Undisclosed Medical History|1|||
164341629|NCT01644565|593627459|FG001|Overall Study|Undisclosed Medical History|0|||
164341630|NCT01644565|593627460|FG002|Overall Study|Undisclosed Medical History|0|||
164341631|NCT01644565|593627461|FG003|Overall Study|Undisclosed Medical History|0|||
164341632|NCT01644565|593627462|FG004|Overall Study|Undisclosed Medical History|0|||
164341633|NCT01644565|593627463|FG005|Overall Study|Undisclosed Medical History|0|||
164341634|NCT01644565|593627464|FG006|Overall Study|Undisclosed Medical History|0|||
164341635|NCT01644565|593627465|FG007|Overall Study|Undisclosed Medical History|0|||
164341636|NCT01644565|593627466|FG008|Overall Study|Undisclosed Medical History|0|||
164341637|NCT01644565|593627458|FG000|Overall Study|Lost to Follow-up|0|||
164341638|NCT01644565|593627459|FG001|Overall Study|Lost to Follow-up|0|||
164341639|NCT01644565|593627460|FG002|Overall Study|Lost to Follow-up|0|||
164341640|NCT01644565|593627461|FG003|Overall Study|Lost to Follow-up|1|||
164341641|NCT01644565|593627462|FG004|Overall Study|Lost to Follow-up|0|||
164341642|NCT01644565|593627463|FG005|Overall Study|Lost to Follow-up|0|||
164341643|NCT01644565|593627464|FG006|Overall Study|Lost to Follow-up|0|||
164341644|NCT01644565|593627465|FG007|Overall Study|Lost to Follow-up|2|||
164341645|NCT01644565|593627466|FG008|Overall Study|Lost to Follow-up|0|||
164341646|NCT01644565|593627458|FG000|Overall Study|Family emergency|0|||
164341647|NCT01644565|593627459|FG001|Overall Study|Family emergency|0|||
164341648|NCT01644565|593627460|FG002|Overall Study|Family emergency|0|||
164341649|NCT01644565|593627461|FG003|Overall Study|Family emergency|0|||
164341650|NCT01644565|593627462|FG004|Overall Study|Family emergency|1|||
164341651|NCT01644565|593627463|FG005|Overall Study|Family emergency|0|||
164341652|NCT01644565|593627464|FG006|Overall Study|Family emergency|0|||
164341653|NCT01644565|593627465|FG007|Overall Study|Family emergency|0|||
164341654|NCT01644565|593627466|FG008|Overall Study|Family emergency|0|||
164341655|NCT01644565|593627458|FG000|Overall Study|Relocation|0|||
164341656|NCT01644565|593627459|FG001|Overall Study|Relocation|0|||
164341657|NCT01644565|593627460|FG002|Overall Study|Relocation|0|||
164341658|NCT01644565|593627461|FG003|Overall Study|Relocation|0|||
164341659|NCT01644565|593627462|FG004|Overall Study|Relocation|0|||
164341660|NCT01644565|593627463|FG005|Overall Study|Relocation|0|||
164341661|NCT01644565|593627464|FG006|Overall Study|Relocation|0|||
164341662|NCT01644565|593627465|FG007|Overall Study|Relocation|0|||
164341663|NCT01644565|593627466|FG008|Overall Study|Relocation|1|||
164341664|NCT00443261|593627467|FG000|Overall Study|Death|1|||
164341665|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
164341666|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
163891231|NCT01928394|591972787|FG008|Follow-up Period|Lost to Follow-up|0|||
163891232|NCT01928394|591972788|FG009|Follow-up Period|Lost to Follow-up|0|||
163891233|NCT01928394|591972789|FG010|Follow-up Period|Lost to Follow-up|0|||
163891234|NCT01928394|591972790|FG011|Follow-up Period|Lost to Follow-up|1|||
163891235|NCT01928394|591972791|FG012|Follow-up Period|Lost to Follow-up|1|||
163891236|NCT01928394|591972792|FG013|Follow-up Period|Lost to Follow-up|0|||
163891237|NCT01928394|591972793|FG014|Follow-up Period|Lost to Follow-up|1|||
163891238|NCT01928394|591972794|FG015|Follow-up Period|Lost to Follow-up|0|||
163891239|NCT01928394|591972795|FG016|Follow-up Period|Lost to Follow-up|1|||
163891240|NCT01928394|591972796|FG017|Follow-up Period|Lost to Follow-up|0|||
163891241|NCT01928394|591972797|FG018|Follow-up Period|Lost to Follow-up|0|||
163891242|NCT01928394|591972798|FG019|Follow-up Period|Lost to Follow-up|0|||
163891243|NCT01928394|591972799|FG020|Follow-up Period|Lost to Follow-up|0|||
163891244|NCT01928394|591972800|FG021|Follow-up Period|Lost to Follow-up|0|||
164341667|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
164341668|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
164341669|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
164341670|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
164341671|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
164341672|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
164341673|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
164341674|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
164341675|NCT00787891|593627468|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
164341676|NCT00787891|593627469|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
164341677|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
163891245|NCT01928394|591972801|FG022|Follow-up Period|Lost to Follow-up|1|||
163891246|NCT01868997|591972802|FG000|Overall Study|Adverse Event|2|||
163891247|NCT01868997|591972803|FG001|Overall Study|Adverse Event|5|||
163891248|NCT01868997|591972802|FG000|Overall Study|Lack of Efficacy|2|||
163891249|NCT01868997|591972803|FG001|Overall Study|Lack of Efficacy|0|||
163891250|NCT01868997|591972802|FG000|Overall Study|Other|3|||
163891251|NCT01868997|591972803|FG001|Overall Study|Other|1|||
163891252|NCT05093842|591972806|FG000|Overall Study|Pregnancy loss|1|||
163891253|NCT05093842|591972807|FG001|Overall Study|Pregnancy loss|1|||
163891254|NCT05093842|591972806|FG000|Overall Study|Lost to Follow-up|6|||
163891255|NCT05093842|591972807|FG001|Overall Study|Lost to Follow-up|0|||
163891256|NCT05093842|591972806|FG000|Overall Study|Physician Decision|0|||
163891257|NCT05093842|591972807|FG001|Overall Study|Physician Decision|1|||
163891258|NCT01275677|591972812|FG000|Overall Study|Not at risk for recurrence.|1|||
163891259|NCT01275677|591972813|FG001|Overall Study|Not at risk for recurrence.|1|||
163891260|NCT01275677|591972812|FG000|Overall Study|No follow-up|26|||
163891261|NCT01275677|591972813|FG001|Overall Study|No follow-up|37|||
163891262|NCT01275677|591972812|FG000|Overall Study|No clinical follow up.|1|||
163891263|NCT01275677|591972813|FG001|Overall Study|No clinical follow up.|4|||
163891264|NCT03478956|591972817|FG000|Randomized Treatment Period|Adverse Event|1|||
163891265|NCT03478956|591972818|FG001|Randomized Treatment Period|Adverse Event|0|||
163891266|NCT03478956|591972819|FG002|Randomized Treatment Period|Adverse Event|0|||
163891267|NCT03478956|591972820|FG003|Randomized Treatment Period|Adverse Event|0|||
163891268|NCT03478956|591972817|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
163891269|NCT03478956|591972818|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
163891270|NCT03478956|591972819|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
163891271|NCT03478956|591972820|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
163891272|NCT03478956|591972817|FG000|Open Label Extension Period|Adverse Event|0|||
163891273|NCT03478956|591972818|FG001|Open Label Extension Period|Adverse Event|0|||
163891274|NCT03478956|591972819|FG002|Open Label Extension Period|Adverse Event|4|||
163891275|NCT03478956|591972820|FG003|Open Label Extension Period|Adverse Event|0|||
163891276|NCT03478956|591972817|FG000|Open Label Extension Period|Lack of Efficacy|0|||
163891277|NCT03478956|591972818|FG001|Open Label Extension Period|Lack of Efficacy|0|||
163891278|NCT03478956|591972819|FG002|Open Label Extension Period|Lack of Efficacy|8|||
163891279|NCT03478956|591972820|FG003|Open Label Extension Period|Lack of Efficacy|0|||
163891280|NCT03478956|591972817|FG000|Open Label Extension Period|Reason Not Provided|0|||
163891281|NCT03478956|591972818|FG001|Open Label Extension Period|Reason Not Provided|0|||
163891282|NCT03478956|591972819|FG002|Open Label Extension Period|Reason Not Provided|1|||
163891283|NCT03478956|591972820|FG003|Open Label Extension Period|Reason Not Provided|0|||
163891284|NCT03478956|591972817|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
163891285|NCT03478956|591972818|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
163891286|NCT03478956|591972819|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
163891287|NCT03478956|591972820|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
163891288|NCT03478956|591972817|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
163891289|NCT03478956|591972818|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
163891290|NCT03478956|591972819|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
163891291|NCT03478956|591972820|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
163891292|NCT03478956|591972817|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163891293|NCT03478956|591972818|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163891294|NCT03478956|591972819|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
163891295|NCT03478956|591972820|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
163891296|NCT04730739|591972821|FG000|Overall Study|Death|1|||
163891297|NCT02733159|591972824|FG000|Overall Study|Adverse Event|1|||
163891298|NCT02733159|591972824|FG000|Overall Study|Lack of disease progression|1|||
163891299|NCT05646355|591972831|FG000|Overall Study|Lost to Follow-up|1|||
163891300|NCT05646355|591972832|FG001|Overall Study|Lost to Follow-up|0|||
163891301|NCT05646355|591972831|FG000|Overall Study|translated materials not available for pilot|2|||
163891302|NCT05646355|591972832|FG001|Overall Study|translated materials not available for pilot|0|||
163891303|NCT05646355|591972831|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
163891304|NCT05646355|591972832|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
163891305|NCT03362476|591972833|FG000|Overall Study|Withdrawal by Subject|0|||
163891306|NCT03362476|591972834|FG001|Overall Study|Withdrawal by Subject|1|||
163891307|NCT05216406|591972835|FG000|Overall Study|Lost to Follow-up|8|||
163891308|NCT05216406|591972836|FG001|Overall Study|Lost to Follow-up|9|||
163891309|NCT04270942|591972839|FG000|Overall Study|Death|1|||
163891310|NCT04059185|591972840|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
163891311|NCT04059185|591972841|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
163891312|NCT04059185|591972842|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
163891313|NCT04059185|591972840|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
163891314|NCT04059185|591972841|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
163891315|NCT04059185|591972842|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
163891316|NCT04059185|591972840|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
163891317|NCT04059185|591972841|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
163891318|NCT04059185|591972842|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
163891319|NCT04059185|591972840|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
163891320|NCT04059185|591972841|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
163891321|NCT04059185|591972842|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
163891322|NCT04059185|591972840|FG000|Longitudinal Assessment-Adults Only|Death|4|||
163891323|NCT04059185|591972841|FG001|Longitudinal Assessment-Adults Only|Death|4|||
163891324|NCT04059185|591972842|FG002|Longitudinal Assessment-Adults Only|Death|3|||
163891325|NCT01009788|591972849|FG000|Overall Study|Withdrawal by Subject|1|||
163891326|NCT01009788|591972850|FG001|Overall Study|Withdrawal by Subject|0|||
163891327|NCT04741776|591972853|FG000|Overall Study|Withdrawal by Subject|7|||
163891328|NCT04741776|591972854|FG001|Overall Study|Withdrawal by Subject|10|||
163891329|NCT04741776|591972855|FG002|Overall Study|Withdrawal by Subject|10|||
163891330|NCT04741776|591972856|FG003|Overall Study|Withdrawal by Subject|17|||
163891331|NCT04741776|591972853|FG000|Overall Study|Death|0|||
163891332|NCT04741776|591972854|FG001|Overall Study|Death|0|||
163891333|NCT04741776|591972855|FG002|Overall Study|Death|1|||
163891334|NCT04741776|591972856|FG003|Overall Study|Death|0|||
163891335|NCT02852655|591972872|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
163891336|NCT02852655|591972873|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
163891337|NCT02852655|591972874|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
163891338|NCT02852655|591972872|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
163891339|NCT02852655|591972873|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
163891340|NCT02852655|591972874|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
163891341|NCT02852655|591972872|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
163891342|NCT02852655|591972873|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
163891343|NCT02852655|591972874|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
163891344|NCT02852655|591972872|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
163891345|NCT02852655|591972873|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
163891346|NCT02852655|591972874|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
163891347|NCT02852655|591972872|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
163891348|NCT02852655|591972873|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
163891349|NCT02852655|591972874|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
163891350|NCT02852655|591972872|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
163891351|NCT02852655|591972873|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
163891352|NCT02852655|591972874|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
163891353|NCT02852655|591972872|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
163891354|NCT02852655|591972873|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
163891355|NCT02852655|591972874|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
163891356|NCT02852655|591972872|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
163891357|NCT02852655|591972873|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
163891358|NCT02852655|591972874|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
163891359|NCT02852655|591972872|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
163891360|NCT02852655|591972873|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
163891361|NCT02852655|591972874|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
163891362|NCT05809453|591974376|FG000|Overall Study|Withdrawal by Subject|1|||
163891363|NCT05809453|591974377|FG001|Overall Study|Withdrawal by Subject|0|||
163891364|NCT05809453|591974378|FG002|Overall Study|Withdrawal by Subject|0|||
163891365|NCT05809453|591974379|FG003|Overall Study|Withdrawal by Subject|0|||
163891366|NCT03257410|591974381|FG000|Overall Study|Adverse Event|2|||
163891367|NCT03257410|591974382|FG001|Overall Study|Adverse Event|3|||
163891368|NCT03257410|591974381|FG000|Overall Study|Protocol Violation|1|||
163891369|NCT03257410|591974382|FG001|Overall Study|Protocol Violation|2|||
163891370|NCT03257410|591974381|FG000|Overall Study|Lost to Follow-up|1|||
163891371|NCT03257410|591974382|FG001|Overall Study|Lost to Follow-up|0|||
163891372|NCT03257410|591974381|FG000|Overall Study|Withdrawal by Subject|1|||
163891373|NCT03257410|591974382|FG001|Overall Study|Withdrawal by Subject|2|||
163891374|NCT03257410|591974381|FG000|Overall Study|Physician Decision|1|||
163891375|NCT03257410|591974382|FG001|Overall Study|Physician Decision|1|||
163891376|NCT03257410|591974381|FG000|Overall Study|Renal transplantation|2|||
163891377|NCT03257410|591974382|FG001|Overall Study|Renal transplantation|0|||
163891378|NCT03257410|591974381|FG000|Overall Study|Switch to peritoneal dialysis|1|||
163891379|NCT03257410|591974382|FG001|Overall Study|Switch to peritoneal dialysis|0|||
163891380|NCT03257410|591974381|FG000|Overall Study|Death|3|||
163891381|NCT03257410|591974382|FG001|Overall Study|Death|2|||
163891382|NCT03257410|591974381|FG000|Overall Study|Change to another dialysis center|2|||
163891383|NCT03257410|591974382|FG001|Overall Study|Change to another dialysis center|2|||
163891384|NCT03257410|591974381|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
163891385|NCT03257410|591974382|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
163891386|NCT03257410|591974381|FG000|Overall Study|Miscellaneous|2|||
163891387|NCT03257410|591974382|FG001|Overall Study|Miscellaneous|2|||
163891388|NCT03257410|591974381|FG000|Overall Study|Other|0|||
163997093|NCT00961961|592353757|FG001|Phase I|Adverse Event|0|||
163997094|NCT00961961|592353758|FG002|Phase I|Adverse Event|0|||
163997095|NCT00961961|592353759|FG003|Phase I|Adverse Event|0|||
163997096|NCT00961961|592353756|FG000|Phase I|Physician Decision|8|||
163997097|NCT00961961|592353757|FG001|Phase I|Physician Decision|0|||
163997098|NCT00961961|592353758|FG002|Phase I|Physician Decision|0|||
163997099|NCT00961961|592353759|FG003|Phase I|Physician Decision|0|||
163997100|NCT00961961|592353756|FG000|Phase II|Lost to Follow-up|0|||
163997101|NCT00961961|592353757|FG001|Phase II|Lost to Follow-up|0|||
163997102|NCT00961961|592353758|FG002|Phase II|Lost to Follow-up|10|||
163997103|NCT00961961|592353759|FG003|Phase II|Lost to Follow-up|7|||
163997104|NCT00961961|592353756|FG000|Phase II|Adverse Event|0|||
163997105|NCT00961961|592353757|FG001|Phase II|Adverse Event|0|||
163997106|NCT00961961|592353758|FG002|Phase II|Adverse Event|0|||
163997107|NCT00961961|592353759|FG003|Phase II|Adverse Event|1|||
163997108|NCT00961961|592353756|FG000|Phase II|Physician Decision|0|||
163997109|NCT00961961|592353757|FG001|Phase II|Physician Decision|0|||
163997110|NCT00961961|592353758|FG002|Phase II|Physician Decision|1|||
163997111|NCT00961961|592353759|FG003|Phase II|Physician Decision|0|||
163997112|NCT00961961|592353756|FG000|Phase II|Withdrawal by Subject|0|||
163997113|NCT00961961|592353757|FG001|Phase II|Withdrawal by Subject|0|||
163997114|NCT00961961|592353758|FG002|Phase II|Withdrawal by Subject|1|||
163997115|NCT00961961|592353759|FG003|Phase II|Withdrawal by Subject|0|||
163997116|NCT01412957|592353760|FG000|Overall Study|Withdrawal by Subject|6|||
163997117|NCT01412957|592353761|FG001|Overall Study|Withdrawal by Subject|22|||
163997118|NCT01412957|592353760|FG000|Overall Study|Lost to Follow-up|7|||
163997119|NCT01412957|592353761|FG001|Overall Study|Lost to Follow-up|2|||
163997120|NCT01412957|592353760|FG000|Overall Study|Death|136|||
163997121|NCT01412957|592353761|FG001|Overall Study|Death|133|||
163997122|NCT02040142|592353767|FG000|Overall Study|Lost to Follow-up|5|||
163997123|NCT02040142|592353767|FG000|Overall Study|Death|17|||
163997124|NCT02040142|592353767|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
163997125|NCT01926626|592353788|FG000|Overall Study|Withdrawal by Subject|15|||
163997126|NCT01926626|592353788|FG000|Overall Study|Lost to Follow-up|7|||
163997127|NCT03636906|592353789|FG000|Overall Study|Adverse Event|0|||
163997128|NCT03636906|592353790|FG001|Overall Study|Adverse Event|0|||
163997129|NCT03636906|592353791|FG002|Overall Study|Adverse Event|1|||
163997130|NCT03636906|592353789|FG000|Overall Study|Lost to Follow-up|1|||
163997131|NCT03636906|592353790|FG001|Overall Study|Lost to Follow-up|0|||
163997132|NCT03636906|592353791|FG002|Overall Study|Lost to Follow-up|0|||
163997133|NCT03636906|592353789|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
163997134|NCT03636906|592353790|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
163997135|NCT03636906|592353791|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
163997136|NCT03636906|592353789|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163997137|NCT03636906|592353790|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163997138|NCT03636906|592353791|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
163997139|NCT03636906|592353789|FG000|Overall Study|Other|0|||
163997140|NCT03636906|592353790|FG001|Overall Study|Other|0|||
163997141|NCT03636906|592353791|FG002|Overall Study|Other|1|||
163997142|NCT02292771|592353797|FG000|Overall Study|Withdrawal by Subject|2|||
163997143|NCT02292771|592353798|FG001|Overall Study|Withdrawal by Subject|1|||
163997144|NCT02292771|592353797|FG000|Overall Study|Lost to Follow-up|2|||
163997145|NCT02292771|592353798|FG001|Overall Study|Lost to Follow-up|1|||
163997146|NCT04280081|592353800|FG000|Overall Study|Adverse Event|4|||
163997147|NCT04280081|592353800|FG000|Overall Study|Death|2|||
163997148|NCT04280081|592353800|FG000|Overall Study|Progressive Disease|6|||
163997149|NCT01468311|592353801|FG000|Overall Study|mobilization failure|1|||
163997150|NCT01468311|592353801|FG000|Overall Study|Withdrawal by Subject|1|||
163997151|NCT00023322|592355527|FG000|Overall Study|Lost to Follow-up|1|||
163997152|NCT05194345|592355537|FG000|Overall Study|Withdrawal by Subject|6|||
164265217|NCT03081858|593340407|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
164265218|NCT03081858|593340408|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
163997153|NCT05194345|592355538|FG001|Overall Study|Withdrawal by Subject|4|||
163997154|NCT05194345|592355539|FG002|Overall Study|Withdrawal by Subject|0|||
163997155|NCT05194345|592355537|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
163997156|NCT05194345|592355538|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
163997157|NCT05194345|592355539|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
163997158|NCT04854499|592355541|FG000|Overall Study|Study Terminated by Sponsor|5|||
163997159|NCT04854499|592355542|FG001|Overall Study|Study Terminated by Sponsor|27|||
163997160|NCT04854499|592355543|FG002|Overall Study|Study Terminated by Sponsor|28|||
163997161|NCT04854499|592355544|FG003|Overall Study|Study Terminated by Sponsor|19|||
163997162|NCT04854499|592355545|FG004|Overall Study|Study Terminated by Sponsor|1|||
163997163|NCT04854499|592355546|FG005|Overall Study|Study Terminated by Sponsor|10|||
163997164|NCT04854499|592355541|FG000|Overall Study|Death|1|||
163997165|NCT04854499|592355542|FG001|Overall Study|Death|23|||
163997166|NCT04854499|592355543|FG002|Overall Study|Death|21|||
163997167|NCT04854499|592355544|FG003|Overall Study|Death|7|||
163997168|NCT04854499|592355545|FG004|Overall Study|Death|6|||
163997169|NCT04854499|592355546|FG005|Overall Study|Death|24|||
163997170|NCT04854499|592355541|FG000|Overall Study|Investigator's Discretion|0|||
163997171|NCT04854499|592355542|FG001|Overall Study|Investigator's Discretion|1|||
163997172|NCT04854499|592355543|FG002|Overall Study|Investigator's Discretion|3|||
163997173|NCT04854499|592355544|FG003|Overall Study|Investigator's Discretion|4|||
163997174|NCT04854499|592355545|FG004|Overall Study|Investigator's Discretion|1|||
163997175|NCT04854499|592355546|FG005|Overall Study|Investigator's Discretion|5|||
163997176|NCT04854499|592355541|FG000|Overall Study|Withdrew Consent|0|||
163997177|NCT04854499|592355542|FG001|Overall Study|Withdrew Consent|1|||
163997178|NCT04854499|592355543|FG002|Overall Study|Withdrew Consent|2|||
163997179|NCT04854499|592355544|FG003|Overall Study|Withdrew Consent|2|||
163997180|NCT04854499|592355545|FG004|Overall Study|Withdrew Consent|0|||
163997181|NCT04854499|592355546|FG005|Overall Study|Withdrew Consent|1|||
163997182|NCT04854499|592355541|FG000|Overall Study|Lost to Follow-up|0|||
163997183|NCT04854499|592355542|FG001|Overall Study|Lost to Follow-up|0|||
163997184|NCT04854499|592355543|FG002|Overall Study|Lost to Follow-up|0|||
163997185|NCT04854499|592355544|FG003|Overall Study|Lost to Follow-up|0|||
163997186|NCT04854499|592355545|FG004|Overall Study|Lost to Follow-up|0|||
163997187|NCT04854499|592355546|FG005|Overall Study|Lost to Follow-up|1|||
163997188|NCT02612909|592355547|FG000|Phase 2|Withdrawal by Subject|2|||
163997189|NCT02612909|592355548|FG001|Phase 2|Withdrawal by Subject|5|||
163997190|NCT02612909|592355549|FG002|Phase 2|Withdrawal by Subject|0|||
163997191|NCT02612909|592355550|FG003|Phase 2|Withdrawal by Subject|0|||
163997192|NCT02612909|592355551|FG004|Phase 2|Withdrawal by Subject|0|||
163997193|NCT02612909|592355547|FG000|Phase 2|Pregnancy|0|||
163997194|NCT02612909|592355548|FG001|Phase 2|Pregnancy|0|||
163997195|NCT02612909|592355549|FG002|Phase 2|Pregnancy|1|||
163997196|NCT02612909|592355550|FG003|Phase 2|Pregnancy|0|||
163997197|NCT02612909|592355551|FG004|Phase 2|Pregnancy|0|||
163997198|NCT02612909|592355547|FG000|Phase 3|Withdrawal by Subject|0|||
163997199|NCT02612909|592355548|FG001|Phase 3|Withdrawal by Subject|0|||
163997200|NCT02612909|592355549|FG002|Phase 3|Withdrawal by Subject|0|||
163997201|NCT02612909|592355550|FG003|Phase 3|Withdrawal by Subject|1|||
163997202|NCT02612909|592355551|FG004|Phase 3|Withdrawal by Subject|0|||
163997203|NCT05067127|592355556|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
163997204|NCT05067127|592355557|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
163997205|NCT05067127|592355558|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
163997206|NCT05067127|592355559|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
163997207|NCT05067127|592355556|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163997208|NCT05067127|592355557|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
163997209|NCT05067127|592355558|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163997210|NCT05067127|592355559|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
163997211|NCT05067127|592355556|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
163997212|NCT05067127|592355557|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163997213|NCT05067127|592355558|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163997214|NCT05067127|592355559|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163997215|NCT05067127|592355556|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
163891389|NCT03257410|591974382|FG001|Overall Study|Other|1|||
163891390|NCT03011333|591974383|FG000|Overall Study|Lost to Follow-up|0|||
163891391|NCT03011333|591974384|FG001|Overall Study|Lost to Follow-up|1|||
163891392|NCT03011333|591974385|FG002|Overall Study|Lost to Follow-up|0|||
163891393|NCT03011333|591974386|FG003|Overall Study|Lost to Follow-up|1|||
163891394|NCT03011333|591974387|FG004|Overall Study|Lost to Follow-up|4|||
163891395|NCT03011333|591974388|FG005|Overall Study|Lost to Follow-up|4|||
163891396|NCT03011333|591974389|FG006|Overall Study|Lost to Follow-up|5|||
163891397|NCT03663569|591974390|FG000|Overall Study|Discontinuation of study|11|||
163997216|NCT05067127|592355557|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
163997217|NCT05067127|592355558|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
163997218|NCT05067127|592355559|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
163997219|NCT05067127|592355556|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
163997220|NCT05067127|592355557|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
163997221|NCT05067127|592355558|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
163997222|NCT05067127|592355559|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
163997223|NCT05067127|592355556|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
163997224|NCT05067127|592355557|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
164085829|NCT00358826|592678570|FG003|Core Study|Lost to Follow-up|1|||
163891398|NCT03663569|591974390|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
163891399|NCT03663569|591974390|FG000|Overall Study|Deceased patient|6|||
163891400|NCT03663569|591974390|FG000|Overall Study|Lost to Follow-up|18|||
163891401|NCT03663569|591974390|FG000|Overall Study|Withdrawal of consent|5|||
163891402|NCT03663569|591974390|FG000|Overall Study|Patient's request|11|||
163891403|NCT03663569|591974390|FG000|Overall Study|Adverse Event|4|||
163891404|NCT03663569|591974390|FG000|Overall Study|Not come to second visit|3|||
163891405|NCT03663569|591974390|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
163891406|NCT03663569|591974390|FG000|Overall Study|Serious adverse event|1|||
163891407|NCT04183283|591974391|FG000|Period 1|Withdrawal by Subject|0|||
163891408|NCT04183283|591974392|FG001|Period 1|Withdrawal by Subject|1|||
163891409|NCT04183283|591974393|FG002|Period 1|Withdrawal by Subject|0|||
163891410|NCT04183283|591974394|FG003|Period 1|Withdrawal by Subject|0|||
163891411|NCT04183283|591974391|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
163891412|NCT04183283|591974392|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
163891413|NCT04183283|591974393|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
163891414|NCT04183283|591974394|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
163891415|NCT00104676|591974399|FG000|Overall Study|Death|3|||
163891416|NCT00104676|591974400|FG001|Overall Study|Death|2|||
163891417|NCT00104676|591974399|FG000|Overall Study|Withdrawal by Subject|0|||
163891418|NCT00104676|591974400|FG001|Overall Study|Withdrawal by Subject|2|||
163891419|NCT00104676|591974399|FG000|Overall Study|treatment interruption|4|||
163891420|NCT00104676|591974400|FG001|Overall Study|treatment interruption|10|||
163891421|NCT05622812|591974401|FG000|Overall Study|Withdrawal by Subject|1|||
163891422|NCT05622812|591974402|FG001|Overall Study|Withdrawal by Subject|4|||
163891423|NCT05622812|591974401|FG000|Overall Study|Lost to Follow-up|2|||
163891424|NCT05622812|591974402|FG001|Overall Study|Lost to Follow-up|1|||
163891425|NCT03916185|591974403|FG000|Overall Study|Lost to Follow-up|0|||
163891426|NCT03916185|591974404|FG001|Overall Study|Lost to Follow-up|1|||
163891427|NCT03916185|591974405|FG002|Overall Study|Lost to Follow-up|0|||
163891428|NCT03916185|591974406|FG003|Overall Study|Lost to Follow-up|0|||
163891429|NCT03916185|591974403|FG000|Overall Study|Moved|1|||
163891430|NCT03916185|591974404|FG001|Overall Study|Moved|0|||
163891431|NCT03916185|591974405|FG002|Overall Study|Moved|0|||
163891432|NCT03916185|591974406|FG003|Overall Study|Moved|1|||
163891433|NCT03916185|591974403|FG000|Overall Study|Not Able to Get to Clinic|1|||
163891434|NCT03916185|591974404|FG001|Overall Study|Not Able to Get to Clinic|0|||
163891435|NCT03916185|591974405|FG002|Overall Study|Not Able to Get to Clinic|0|||
163891436|NCT03916185|591974406|FG003|Overall Study|Not Able to Get to Clinic|0|||
163891437|NCT05297565|591974408|FG000|Overall Study|Other Reasons|0|||
163891438|NCT05297565|591974409|FG001|Overall Study|Other Reasons|1|||
163891439|NCT05297565|591974408|FG000|Overall Study|Physician Decision|0|||
163891440|NCT05297565|591974409|FG001|Overall Study|Physician Decision|1|||
163891441|NCT05297565|591974408|FG000|Overall Study|Disease recurrence|1|||
163891442|NCT05297565|591974409|FG001|Overall Study|Disease recurrence|0|||
163891443|NCT05299723|591974419|FG000|Overall Study|Withdrawal by Subject|0|||
163891444|NCT05299723|591974420|FG001|Overall Study|Withdrawal by Subject|2|||
163891445|NCT05299723|591974421|FG002|Overall Study|Withdrawal by Subject|0|||
163891446|NCT01959607|591974422|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
163891447|NCT01959607|591974423|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
163891448|NCT01959607|591974424|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163891449|NCT01959607|591974425|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
163891450|NCT03913442|591974426|FG000|Overall Study|Adverse Event|0|||
163891451|NCT03913442|591974427|FG001|Overall Study|Adverse Event|3|||
163891452|NCT03913442|591974426|FG000|Overall Study|Withdrawal by Subject|5|||
163891453|NCT03913442|591974427|FG001|Overall Study|Withdrawal by Subject|5|||
163891454|NCT03913442|591974426|FG000|Overall Study|Terminations|2|||
163891455|NCT03913442|591974427|FG001|Overall Study|Terminations|1|||
163891456|NCT03913442|591974426|FG000|Overall Study|Lost to Follow-up|2|||
163891457|NCT03913442|591974427|FG001|Overall Study|Lost to Follow-up|2|||
163891458|NCT00696111|591974428|FG000|Overall Study|Withdrawal by Subject|17|||
163891459|NCT03687086|591974435|FG000|Overall Study|Withdrawal by Subject|3|||
163891460|NCT03687086|591974436|FG001|Overall Study|Withdrawal by Subject|4|||
163891461|NCT03687086|591974435|FG000|Overall Study|Lost to Follow-up|1|||
163891462|NCT03687086|591974436|FG001|Overall Study|Lost to Follow-up|1|||
163891463|NCT03687086|591974435|FG000|Overall Study|Death|1|||
163891464|NCT03687086|591974436|FG001|Overall Study|Death|0|||
163891465|NCT03687086|591974435|FG000|Overall Study|Incomplete assessment|0|||
163891466|NCT03687086|591974436|FG001|Overall Study|Incomplete assessment|2|||
163891467|NCT04362254|591974440|FG000|Overall Study|Adverse Event|1|||
163891468|NCT04362254|591974440|FG000|Overall Study|Protocol Violation|1|||
163891469|NCT04362254|591974440|FG000|Overall Study|Due to early termination of the trial|10|||
163891470|NCT04707625|591974441|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
163891471|NCT00321048|591974442|FG000|Overall Study|Withdrawal by Subject|6|||
163891472|NCT00321048|591974443|FG001|Overall Study|Withdrawal by Subject|8|||
163891473|NCT01627574|591974444|FG000|Overall Study|Withdrawal by Subject|8|||
163891474|NCT01627574|591974445|FG001|Overall Study|Withdrawal by Subject|5|||
163891475|NCT01627574|591974444|FG000|Overall Study|Lost to Follow-up|13|||
163997225|NCT05067127|592355558|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
163997226|NCT05067127|592355559|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
163997227|NCT05067127|592355556|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163997228|NCT05067127|592355557|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
163997229|NCT05067127|592355558|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
163997230|NCT05067127|592355559|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
163997231|NCT03615222|592355561|FG000|Overall Study|Ineligible|26|||
163997232|NCT03615222|592355561|FG000|Overall Study|Withdrawal by Subject|7|||
163997233|NCT03615222|592355561|FG000|Overall Study|Death|1|||
163997234|NCT03304522|592355564|FG000|Overall Study|Adverse Event|0|||
163997235|NCT03304522|592355565|FG001|Overall Study|Adverse Event|4|||
163997236|NCT03304522|592355564|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
163997237|NCT03304522|592355565|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
163997238|NCT03304522|592355564|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
163997239|NCT03304522|592355565|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
163997240|NCT03304522|592355564|FG000|Overall Study|Other|0|||
163997241|NCT03304522|592355565|FG001|Overall Study|Other|1|||
163997242|NCT03367871|592355566|FG000|Overall Study|Lost to Follow-up|1|||
163997243|NCT02013544|592355568|FG000|Overall Study|Adverse Event|5|||
163997244|NCT02013544|592355569|FG001|Overall Study|Adverse Event|5|||
163997245|NCT02013544|592355568|FG000|Overall Study|Lost to Follow-up|2|||
163997246|NCT02013544|592355569|FG001|Overall Study|Lost to Follow-up|3|||
163997247|NCT02013544|592355568|FG000|Overall Study|Withdrawal by Subject|2|||
163997248|NCT02013544|592355569|FG001|Overall Study|Withdrawal by Subject|8|||
163997249|NCT02013544|592355568|FG000|Overall Study|Physician Decision|0|||
163997250|NCT02013544|592355569|FG001|Overall Study|Physician Decision|1|||
163997251|NCT02013544|592355568|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
163997252|NCT02013544|592355569|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
163997253|NCT00885365|592355572|FG000|4 Weeks ON Treatment|Adverse Event|2|||
163997254|NCT00885365|592355573|FG001|4 Weeks ON Treatment|Adverse Event|4|||
163997255|NCT00885365|592355572|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
163997256|NCT00885365|592355573|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
163997257|NCT00885365|592355572|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
163997258|NCT00885365|592355573|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
163997259|NCT01824979|592355574|FG000|Overall Study|Withdrawal by Subject|5|||
163997260|NCT01824979|592355575|FG001|Overall Study|Withdrawal by Subject|0|||
163997261|NCT01824979|592355574|FG000|Overall Study|Physician Decision|2|||
163997262|NCT01824979|592355575|FG001|Overall Study|Physician Decision|0|||
163997263|NCT01824979|592355574|FG000|Overall Study|Protocol Violation|6|||
163997264|NCT01824979|592355575|FG001|Overall Study|Protocol Violation|13|||
163997265|NCT01756456|592355583|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
163997266|NCT01756456|592355584|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
163997267|NCT01756456|592355585|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
163997268|NCT01756456|592355586|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
163997269|NCT01756456|592355587|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
163997270|NCT01756456|592355588|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
163997271|NCT01756456|592355583|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163997272|NCT01756456|592355584|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163997273|NCT01756456|592355585|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163997274|NCT01756456|592355586|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
163997275|NCT01756456|592355587|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
163997276|NCT01756456|592355588|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
163997277|NCT01756456|592355583|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163997278|NCT01756456|592355584|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
163997279|NCT01756456|592355585|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163997280|NCT01756456|592355586|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163997281|NCT01756456|592355587|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163997282|NCT01756456|592355588|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
163997283|NCT01756456|592355583|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
163997284|NCT01756456|592355584|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
163997285|NCT01756456|592355585|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
163997286|NCT01756456|592355586|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
163997287|NCT01756456|592355587|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
163997288|NCT01756456|592355588|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
163997289|NCT01756456|592355583|FG000|Treatment Period: Phase I/II|Other causes|0|||
163997290|NCT01756456|592355584|FG001|Treatment Period: Phase I/II|Other causes|0|||
163997291|NCT01756456|592355585|FG002|Treatment Period: Phase I/II|Other causes|0|||
163997292|NCT01756456|592355586|FG003|Treatment Period: Phase I/II|Other causes|1|||
163997293|NCT01756456|592355587|FG004|Treatment Period: Phase I/II|Other causes|2|||
163997294|NCT01756456|592355588|FG005|Treatment Period: Phase I/II|Other causes|2|||
163997295|NCT01756456|592355583|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
163997296|NCT01756456|592355584|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
163997297|NCT01756456|592355585|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
163997298|NCT01756456|592355586|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
163997299|NCT01756456|592355587|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
163997300|NCT01756456|592355588|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
163997301|NCT01756456|592355583|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163891476|NCT01627574|591974445|FG001|Overall Study|Lost to Follow-up|13|||
163891477|NCT04314778|591974448|FG000|Overall Study|Lost to Follow-up|5|||
163891478|NCT04314778|591974449|FG001|Overall Study|Lost to Follow-up|3|||
163997302|NCT01756456|592355584|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
163997303|NCT01756456|592355585|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163997304|NCT01756456|592355586|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163997305|NCT01756456|592355587|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163997306|NCT01756456|592355588|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
163997307|NCT01756456|592355583|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163997308|NCT01756456|592355584|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163997309|NCT01756456|592355585|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163997310|NCT01756456|592355586|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163997311|NCT01756456|592355587|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
163997312|NCT01756456|592355588|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
163997313|NCT01756456|592355583|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
163997314|NCT01756456|592355584|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
163997315|NCT01756456|592355585|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
163997316|NCT01756456|592355586|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
163997317|NCT01756456|592355587|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
163997318|NCT01756456|592355588|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
163997319|NCT01756456|592355583|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
163997320|NCT01756456|592355584|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
163997321|NCT01756456|592355585|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
163997322|NCT01756456|592355586|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
163997323|NCT01756456|592355587|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
163997324|NCT01756456|592355588|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
163997325|NCT01756456|592355583|FG000|Follow Up Period Phase I/II|Other causes|0|||
163997326|NCT01756456|592355584|FG001|Follow Up Period Phase I/II|Other causes|0|||
163997327|NCT01756456|592355585|FG002|Follow Up Period Phase I/II|Other causes|0|||
163997328|NCT01756456|592355586|FG003|Follow Up Period Phase I/II|Other causes|1|||
163997329|NCT01756456|592355587|FG004|Follow Up Period Phase I/II|Other causes|3|||
163997330|NCT01756456|592355588|FG005|Follow Up Period Phase I/II|Other causes|5|||
163997331|NCT02706938|592355589|FG000|First Period, 6 Weeks|Adverse Event|8|||
163997332|NCT02706938|592355590|FG001|First Period, 6 Weeks|Adverse Event|0|||
163997333|NCT02706938|592355589|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
163997334|NCT02706938|592355590|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
163997335|NCT02706938|592355589|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
163997336|NCT02706938|592355590|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
164265219|NCT03081858|593340409|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
164265220|NCT03081858|593340410|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
164265221|NCT02936284|593340413|FG000|Overall Study|Withdrawal by Subject|3|||
164265222|NCT02936284|593340414|FG001|Overall Study|Withdrawal by Subject|1|||
164265223|NCT02936284|593340413|FG000|Overall Study|Lost to Follow-up|7|||
164265224|NCT02936284|593340414|FG001|Overall Study|Lost to Follow-up|8|||
164265225|NCT01610596|593340415|FG000|Overall Study|Lost to Follow-up|0|||
164265226|NCT01610596|593340416|FG001|Overall Study|Lost to Follow-up|1|||
164265227|NCT00799591|593340419|FG000|Overall Study|De-escalation of doses|20|||
164265228|NCT00799591|593340419|FG000|Overall Study|Death|14|||
164265229|NCT00799591|593340419|FG000|Overall Study|Technical failure|12|||
164341678|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
163891479|NCT02240238|591974450|FG000|Phase 1|Adverse Event|0|||
163891480|NCT02240238|591974451|FG001|Phase 1|Adverse Event|0|||
163891481|NCT02240238|591974452|FG002|Phase 1|Adverse Event|0|||
163891482|NCT02240238|591974453|FG003|Phase 1|Adverse Event|0|||
163891483|NCT02240238|591974454|FG004|Phase 1|Adverse Event|0|||
163891484|NCT02240238|591974455|FG005|Phase 1|Adverse Event|0|||
163891485|NCT02240238|591974456|FG006|Phase 1|Adverse Event|3|||
163997337|NCT02706938|592355589|FG000|Second Period, 6 Weeks|Adverse Event|0|||
163997338|NCT02706938|592355590|FG001|Second Period, 6 Weeks|Adverse Event|7|||
164265230|NCT00799591|593340419|FG000|Overall Study|Resistant germ|11|||
164265231|NCT00799591|593340419|FG000|Overall Study|New infection|4|||
164265232|NCT00799591|593340419|FG000|Overall Study|Resistance germ and technical failure|2|||
163891486|NCT02240238|591974457|FG007|Phase 1|Adverse Event|1|||
163891487|NCT02240238|591974458|FG008|Phase 1|Adverse Event|0|||
163891488|NCT02240238|591974459|FG009|Phase 1|Adverse Event|0|||
163891489|NCT02240238|591974460|FG010|Phase 1|Adverse Event|0|||
163891490|NCT02240238|591974461|FG011|Phase 1|Adverse Event|0|||
163891491|NCT02240238|591974450|FG000|Phase 1|Death|0|||
163891492|NCT02240238|591974451|FG001|Phase 1|Death|0|||
163891493|NCT02240238|591974452|FG002|Phase 1|Death|0|||
163891494|NCT02240238|591974453|FG003|Phase 1|Death|0|||
163891495|NCT02240238|591974454|FG004|Phase 1|Death|0|||
163891496|NCT02240238|591974455|FG005|Phase 1|Death|1|||
163891497|NCT02240238|591974456|FG006|Phase 1|Death|0|||
163891498|NCT02240238|591974457|FG007|Phase 1|Death|0|||
163891499|NCT02240238|591974458|FG008|Phase 1|Death|0|||
163891500|NCT02240238|591974459|FG009|Phase 1|Death|0|||
163891501|NCT02240238|591974460|FG010|Phase 1|Death|0|||
163891502|NCT02240238|591974461|FG011|Phase 1|Death|0|||
163891503|NCT02240238|591974450|FG000|Phase 1|Sponsor termination|0|||
163891504|NCT02240238|591974451|FG001|Phase 1|Sponsor termination|0|||
163891505|NCT02240238|591974452|FG002|Phase 1|Sponsor termination|0|||
163891506|NCT02240238|591974453|FG003|Phase 1|Sponsor termination|0|||
163891507|NCT02240238|591974454|FG004|Phase 1|Sponsor termination|0|||
163891508|NCT02240238|591974455|FG005|Phase 1|Sponsor termination|1|||
163891509|NCT02240238|591974456|FG006|Phase 1|Sponsor termination|0|||
163891510|NCT02240238|591974457|FG007|Phase 1|Sponsor termination|0|||
163891511|NCT02240238|591974458|FG008|Phase 1|Sponsor termination|0|||
163891512|NCT02240238|591974459|FG009|Phase 1|Sponsor termination|0|||
163891513|NCT02240238|591974460|FG010|Phase 1|Sponsor termination|0|||
163891514|NCT02240238|591974461|FG011|Phase 1|Sponsor termination|0|||
163891515|NCT02240238|591974450|FG000|Phase 1|Withdrawal by Subject|0|||
163891516|NCT02240238|591974451|FG001|Phase 1|Withdrawal by Subject|0|||
163891517|NCT02240238|591974452|FG002|Phase 1|Withdrawal by Subject|0|||
163891518|NCT02240238|591974453|FG003|Phase 1|Withdrawal by Subject|0|||
163891519|NCT02240238|591974454|FG004|Phase 1|Withdrawal by Subject|0|||
163891520|NCT02240238|591974455|FG005|Phase 1|Withdrawal by Subject|2|||
163891521|NCT02240238|591974456|FG006|Phase 1|Withdrawal by Subject|0|||
163891522|NCT02240238|591974457|FG007|Phase 1|Withdrawal by Subject|0|||
163891523|NCT02240238|591974458|FG008|Phase 1|Withdrawal by Subject|0|||
163891524|NCT02240238|591974459|FG009|Phase 1|Withdrawal by Subject|0|||
163891525|NCT02240238|591974460|FG010|Phase 1|Withdrawal by Subject|0|||
163891526|NCT02240238|591974461|FG011|Phase 1|Withdrawal by Subject|0|||
163891527|NCT02240238|591974450|FG000|Phase 1|Physician Decision|0|||
163891528|NCT02240238|591974451|FG001|Phase 1|Physician Decision|0|||
163891529|NCT02240238|591974452|FG002|Phase 1|Physician Decision|0|||
163891530|NCT02240238|591974453|FG003|Phase 1|Physician Decision|0|||
163891531|NCT02240238|591974454|FG004|Phase 1|Physician Decision|0|||
163891532|NCT02240238|591974455|FG005|Phase 1|Physician Decision|2|||
163891533|NCT02240238|591974456|FG006|Phase 1|Physician Decision|0|||
163891534|NCT02240238|591974457|FG007|Phase 1|Physician Decision|0|||
163891535|NCT02240238|591974458|FG008|Phase 1|Physician Decision|0|||
163891536|NCT02240238|591974459|FG009|Phase 1|Physician Decision|0|||
163891537|NCT02240238|591974460|FG010|Phase 1|Physician Decision|0|||
163891538|NCT02240238|591974461|FG011|Phase 1|Physician Decision|0|||
163891539|NCT02240238|591974450|FG000|Phase 2|Adverse Event|0|||
163891540|NCT02240238|591974451|FG001|Phase 2|Adverse Event|0|||
163891541|NCT02240238|591974452|FG002|Phase 2|Adverse Event|0|||
163891542|NCT02240238|591974453|FG003|Phase 2|Adverse Event|0|||
163891543|NCT02240238|591974454|FG004|Phase 2|Adverse Event|0|||
163891544|NCT02240238|591974455|FG005|Phase 2|Adverse Event|0|||
163891545|NCT02240238|591974456|FG006|Phase 2|Adverse Event|0|||
163891546|NCT02240238|591974457|FG007|Phase 2|Adverse Event|0|||
163891547|NCT02240238|591974458|FG008|Phase 2|Adverse Event|0|||
164265233|NCT00799591|593340419|FG000|Overall Study|Persistance of fever undetermined origin|1|||
163891548|NCT02240238|591974459|FG009|Phase 2|Adverse Event|7|||
163891549|NCT02240238|591974460|FG010|Phase 2|Adverse Event|14|||
163891550|NCT02240238|591974461|FG011|Phase 2|Adverse Event|2|||
163891551|NCT02240238|591974450|FG000|Phase 2|Death|0|||
163891552|NCT02240238|591974451|FG001|Phase 2|Death|0|||
163891553|NCT02240238|591974452|FG002|Phase 2|Death|0|||
163891554|NCT02240238|591974453|FG003|Phase 2|Death|0|||
163891555|NCT02240238|591974454|FG004|Phase 2|Death|0|||
163891556|NCT02240238|591974455|FG005|Phase 2|Death|0|||
163891557|NCT02240238|591974456|FG006|Phase 2|Death|0|||
163891558|NCT02240238|591974457|FG007|Phase 2|Death|0|||
163891559|NCT02240238|591974458|FG008|Phase 2|Death|0|||
163891560|NCT02240238|591974459|FG009|Phase 2|Death|3|||
163891561|NCT02240238|591974460|FG010|Phase 2|Death|2|||
163891562|NCT02240238|591974461|FG011|Phase 2|Death|1|||
163891563|NCT02240238|591974450|FG000|Phase 2|Disease progression|0|||
163891564|NCT02240238|591974451|FG001|Phase 2|Disease progression|0|||
163891565|NCT02240238|591974452|FG002|Phase 2|Disease progression|0|||
163891566|NCT02240238|591974453|FG003|Phase 2|Disease progression|0|||
163891567|NCT02240238|591974454|FG004|Phase 2|Disease progression|0|||
163891568|NCT02240238|591974455|FG005|Phase 2|Disease progression|0|||
163891569|NCT02240238|591974456|FG006|Phase 2|Disease progression|0|||
163891570|NCT02240238|591974457|FG007|Phase 2|Disease progression|0|||
163891571|NCT02240238|591974458|FG008|Phase 2|Disease progression|0|||
163891572|NCT02240238|591974459|FG009|Phase 2|Disease progression|5|||
163891573|NCT02240238|591974460|FG010|Phase 2|Disease progression|11|||
163891574|NCT02240238|591974461|FG011|Phase 2|Disease progression|1|||
163997339|NCT02706938|592355589|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
163997340|NCT02706938|592355590|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
163997341|NCT00813995|592355591|FG000|Overall Study|Clinical adverse event|9|||
163997342|NCT00813995|592355592|FG001|Overall Study|Clinical adverse event|3|||
163997343|NCT00813995|592355591|FG000|Overall Study|Laboratory adverse event|0|||
163997344|NCT00813995|592355592|FG001|Overall Study|Laboratory adverse event|2|||
163997345|NCT00813995|592355591|FG000|Overall Study|Lack of Efficacy|1|||
163997346|NCT00813995|592355592|FG001|Overall Study|Lack of Efficacy|0|||
163997347|NCT00813995|592355591|FG000|Overall Study|Lost to Follow-up|4|||
163997348|NCT00813995|592355592|FG001|Overall Study|Lost to Follow-up|2|||
163997349|NCT00813995|592355591|FG000|Overall Study|Other reason|2|||
163997350|NCT00813995|592355592|FG001|Overall Study|Other reason|2|||
163997351|NCT00813995|592355591|FG000|Overall Study|Protocol Violation|3|||
163997352|NCT00813995|592355592|FG001|Overall Study|Protocol Violation|2|||
163997353|NCT00813995|592355591|FG000|Overall Study|Subject moved|4|||
163997354|NCT00813995|592355592|FG001|Overall Study|Subject moved|0|||
163997355|NCT00813995|592355591|FG000|Overall Study|Withdrawal by Subject|0|||
164265234|NCT00799591|593340419|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
164265235|NCT00799591|593340419|FG000|Overall Study|Infectious origin not probable|1|||
164265236|NCT02098369|593340420|FG000|Overall Study|Withdrawal by Subject|1|||
164265237|NCT02098369|593340421|FG001|Overall Study|Withdrawal by Subject|5|||
164265238|NCT02098369|593340422|FG002|Overall Study|Withdrawal by Subject|0|||
164265239|NCT02098369|593340420|FG000|Overall Study|Lost to Follow-up|5|||
164265240|NCT02098369|593340421|FG001|Overall Study|Lost to Follow-up|1|||
164265241|NCT02098369|593340422|FG002|Overall Study|Lost to Follow-up|3|||
164265242|NCT02098369|593340420|FG000|Overall Study|Death|1|||
164265243|NCT02098369|593340421|FG001|Overall Study|Death|1|||
164265244|NCT02098369|593340422|FG002|Overall Study|Death|1|||
164265245|NCT02098369|593340420|FG000|Overall Study|Other|0|||
164341679|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
163891575|NCT02240238|591974450|FG000|Phase 2|Withdrawal by Subject|0|||
163891576|NCT02240238|591974451|FG001|Phase 2|Withdrawal by Subject|0|||
163891577|NCT02240238|591974452|FG002|Phase 2|Withdrawal by Subject|0|||
163891578|NCT02240238|591974453|FG003|Phase 2|Withdrawal by Subject|0|||
163891579|NCT02240238|591974454|FG004|Phase 2|Withdrawal by Subject|0|||
163891580|NCT02240238|591974455|FG005|Phase 2|Withdrawal by Subject|0|||
163891581|NCT02240238|591974456|FG006|Phase 2|Withdrawal by Subject|0|||
163891582|NCT02240238|591974457|FG007|Phase 2|Withdrawal by Subject|0|||
163891583|NCT02240238|591974458|FG008|Phase 2|Withdrawal by Subject|0|||
163891584|NCT02240238|591974459|FG009|Phase 2|Withdrawal by Subject|1|||
163891585|NCT02240238|591974460|FG010|Phase 2|Withdrawal by Subject|1|||
163891586|NCT02240238|591974461|FG011|Phase 2|Withdrawal by Subject|0|||
163891587|NCT02240238|591974450|FG000|Phase 2|Physician Decision|0|||
163891588|NCT02240238|591974451|FG001|Phase 2|Physician Decision|0|||
163891589|NCT02240238|591974452|FG002|Phase 2|Physician Decision|0|||
163891590|NCT02240238|591974453|FG003|Phase 2|Physician Decision|0|||
163891591|NCT02240238|591974454|FG004|Phase 2|Physician Decision|0|||
163891592|NCT02240238|591974455|FG005|Phase 2|Physician Decision|0|||
163891593|NCT02240238|591974456|FG006|Phase 2|Physician Decision|0|||
163891594|NCT02240238|591974457|FG007|Phase 2|Physician Decision|0|||
163891595|NCT02240238|591974458|FG008|Phase 2|Physician Decision|0|||
163891596|NCT02240238|591974459|FG009|Phase 2|Physician Decision|1|||
163891597|NCT02240238|591974460|FG010|Phase 2|Physician Decision|3|||
163891598|NCT02240238|591974461|FG011|Phase 2|Physician Decision|0|||
163891599|NCT02240238|591974450|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891600|NCT02240238|591974451|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891601|NCT02240238|591974452|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891602|NCT02240238|591974453|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891603|NCT02240238|591974454|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891604|NCT02240238|591974455|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891605|NCT02240238|591974456|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891606|NCT02240238|591974457|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891607|NCT02240238|591974458|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891608|NCT02240238|591974459|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
163891609|NCT02240238|591974460|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891610|NCT02240238|591974461|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
163891611|NCT02240238|591974450|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891612|NCT02240238|591974451|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163997356|NCT00813995|592355592|FG001|Overall Study|Withdrawal by Subject|5|||
163997357|NCT02868892|592355593|FG000|Overall Study|Investigator left site and no follow-up|6|||
163997358|NCT04525703|592355601|FG000|Overall Study|Lost to Follow-up|6|||
163997359|NCT04525703|592355602|FG001|Overall Study|Lost to Follow-up|15|||
163997360|NCT04525703|592355603|FG002|Overall Study|Lost to Follow-up|8|||
163997361|NCT04752384|592355606|FG000|Overall Study|Withdrawal by Subject|1|||
163997362|NCT04752384|592355606|FG000|Overall Study|Death|1|||
163997363|NCT04439331|592355607|FG000|Overall Study|Never Start Protocol Therapy|2|||
163997364|NCT04439331|592355607|FG000|Overall Study|Ineligible|2|||
163997365|NCT04439331|592355607|FG000|Overall Study|Mutation Status Not Confirmed|1|||
163997366|NCT04439331|592355607|FG000|Overall Study|Adverse Event|1|||
163997367|NCT04439331|592355607|FG000|Overall Study|Death|1|||
163997368|NCT04439331|592355607|FG000|Overall Study|Disease Progression|20|||
163997369|NCT04439331|592355607|FG000|Overall Study|Withdrawal by Subject|6|||
163997370|NCT04439331|592355607|FG000|Overall Study|Physician Decision|1|||
163997371|NCT04439331|592355607|FG000|Overall Study|Other Complicating Disease|1|||
163997372|NCT04370509|592355609|FG000|Overall Study|Adverse Event|1|||
163997373|NCT04370509|592355610|FG001|Overall Study|Adverse Event|0|||
163997374|NCT04370509|592355609|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
163997375|NCT04370509|592355610|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
163997376|NCT04743856|592355611|FG000|Overall Study|Lost to Follow-up|6|||
163997377|NCT04743856|592355612|FG001|Overall Study|Lost to Follow-up|7|||
163997378|NCT04743856|592355611|FG000|Overall Study|Withdrawal by Subject|1|||
163997379|NCT04743856|592355612|FG001|Overall Study|Withdrawal by Subject|0|||
163997380|NCT04696861|592355613|FG000|Overall Study|Death|1|||
163997381|NCT04696861|592355614|FG001|Overall Study|Death|0|||
163997382|NCT04696861|592355613|FG000|Overall Study|Lost to Follow-up|3|||
163997383|NCT04696861|592355614|FG001|Overall Study|Lost to Follow-up|0|||
163997384|NCT04439188|592355615|FG000|Overall Study|Ineligible|3|||
163997385|NCT04439188|592355615|FG000|Overall Study|Adverse Event|4|||
163997386|NCT04439188|592355615|FG000|Overall Study|Death|1|||
163997387|NCT04439188|592355615|FG000|Overall Study|Disease Progression|25|||
163997388|NCT04439188|592355615|FG000|Overall Study|Withdrawal by Subject|2|||
163997389|NCT00413959|592355616|FG000|Overall Study|Pt had only one cycle.|1|||
163997390|NCT01870739|592355619|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
163997391|NCT01870739|592355620|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
163997392|NCT01870739|592355619|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
163997393|NCT01870739|592355620|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
163997394|NCT01870739|592355619|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
163997395|NCT01870739|592355620|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
163997396|NCT01870739|592355619|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
163997397|NCT01870739|592355620|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
163997398|NCT01870739|592355619|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
163997399|NCT01870739|592355620|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
164265246|NCT02098369|593340421|FG001|Overall Study|Other|2|||
164265247|NCT02098369|593340422|FG002|Overall Study|Other|1|||
164265248|NCT00570037|593340423|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
164265249|NCT00570037|593340424|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
164265250|NCT00413920|593340426|FG000|Overall Study|Adverse Event|9|||
164265251|NCT00413920|593340427|FG001|Overall Study|Adverse Event|11|||
164265252|NCT00413920|593340426|FG000|Overall Study|Lack of Efficacy|11|||
164265253|NCT00413920|593340427|FG001|Overall Study|Lack of Efficacy|9|||
164265254|NCT00413920|593340426|FG000|Overall Study|Death|3|||
163891613|NCT02240238|591974452|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891614|NCT02240238|591974453|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891615|NCT02240238|591974454|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891616|NCT02240238|591974455|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891617|NCT02240238|591974456|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891618|NCT02240238|591974457|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891619|NCT02240238|591974458|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891620|NCT02240238|591974459|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
163891621|NCT02240238|591974460|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891622|NCT02240238|591974461|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
163891623|NCT02240238|591974450|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163997400|NCT01870739|592355619|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
163997401|NCT01870739|592355620|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
163997402|NCT01870739|592355619|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
163997403|NCT01870739|592355620|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
163997404|NCT01986062|592355621|FG000|Overall Study|Lost to Follow-up|1|||
163997405|NCT01986062|592355622|FG001|Overall Study|Lost to Follow-up|0|||
163997406|NCT01986062|592355621|FG000|Overall Study|Withdrawal by Subject|0|||
164265255|NCT00413920|593340427|FG001|Overall Study|Death|5|||
164341680|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
164341681|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
163997407|NCT01986062|592355622|FG001|Overall Study|Withdrawal by Subject|1|||
163997408|NCT03538743|592355623|FG000|Overall Study|Adverse Event|0|||
163997409|NCT03538743|592355624|FG001|Overall Study|Adverse Event|0|||
163997410|NCT03538743|592355625|FG002|Overall Study|Adverse Event|1|||
163997411|NCT03538743|592355626|FG003|Overall Study|Adverse Event|1|||
163997412|NCT03538743|592355627|FG004|Overall Study|Adverse Event|0|||
163997413|NCT03538743|592355628|FG005|Overall Study|Adverse Event|0|||
163997414|NCT03538743|592355629|FG006|Overall Study|Adverse Event|0|||
163997415|NCT03538743|592355630|FG007|Overall Study|Adverse Event|0|||
163997416|NCT03538743|592355631|FG008|Overall Study|Adverse Event|0|||
163997417|NCT03538743|592355623|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
163997418|NCT03538743|592355624|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
163997419|NCT03538743|592355625|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
163997420|NCT03538743|592355626|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
163997421|NCT03538743|592355627|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
163997422|NCT03538743|592355628|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
163997423|NCT03538743|592355629|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
163997424|NCT03538743|592355630|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
163997425|NCT03538743|592355631|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
163997426|NCT03538743|592355623|FG000|Overall Study|Withdrawal by Subject|0|||
163997427|NCT03538743|592355624|FG001|Overall Study|Withdrawal by Subject|0|||
163997428|NCT03538743|592355625|FG002|Overall Study|Withdrawal by Subject|0|||
163997429|NCT03538743|592355626|FG003|Overall Study|Withdrawal by Subject|1|||
163997430|NCT03538743|592355627|FG004|Overall Study|Withdrawal by Subject|0|||
163997431|NCT03538743|592355628|FG005|Overall Study|Withdrawal by Subject|0|||
163997432|NCT03538743|592355629|FG006|Overall Study|Withdrawal by Subject|0|||
163997433|NCT03538743|592355630|FG007|Overall Study|Withdrawal by Subject|0|||
163997434|NCT03538743|592355631|FG008|Overall Study|Withdrawal by Subject|0|||
163997435|NCT01827384|592355634|FG000|Overall Study|Switched to alternative treatment|0|||
163997436|NCT01827384|592355635|FG001|Overall Study|Switched to alternative treatment|0|||
163997437|NCT01827384|592355636|FG002|Overall Study|Switched to alternative treatment|0|||
163997438|NCT01827384|592355637|FG003|Overall Study|Switched to alternative treatment|0|||
163997439|NCT01827384|592355638|FG004|Overall Study|Switched to alternative treatment|0|||
163997440|NCT01827384|592355639|FG005|Overall Study|Switched to alternative treatment|0|||
163997441|NCT01827384|592355640|FG006|Overall Study|Switched to alternative treatment|0|||
163997442|NCT01827384|592355641|FG007|Overall Study|Switched to alternative treatment|0|||
163997443|NCT01827384|592355642|FG008|Overall Study|Switched to alternative treatment|0|||
163997444|NCT01827384|592355643|FG009|Overall Study|Switched to alternative treatment|0|||
164265256|NCT00413920|593340426|FG000|Overall Study|Graft Loss|5|||
164265257|NCT00413920|593340427|FG001|Overall Study|Graft Loss|3|||
164265258|NCT01765426|593340428|FG000|Overall Study|Lost to Follow-up|0|||
164265259|NCT01765426|593340429|FG001|Overall Study|Lost to Follow-up|1|||
164265260|NCT01765426|593340430|FG002|Overall Study|Lost to Follow-up|0|||
164265261|NCT01765426|593340431|FG003|Overall Study|Lost to Follow-up|0|||
164265262|NCT01665430|593340432|FG000|Overall Study|Adverse Event|1|||
164265263|NCT01665430|593340432|FG000|Overall Study|Withdrawal by Subject|6|||
164265264|NCT01665430|593340432|FG000|Overall Study|Other Unspecified|2|||
164265265|NCT02310230|593340433|FG000|Overall Study|Physician Decision|1|||
164265266|NCT02310230|593340434|FG001|Overall Study|Physician Decision|3|||
164265267|NCT02310230|593340433|FG000|Overall Study|monitor baseline taken after induction|2|||
164265268|NCT02310230|593340434|FG001|Overall Study|monitor baseline taken after induction|7|||
163997445|NCT01827384|592355644|FG010|Overall Study|Switched to alternative treatment|0|||
163997446|NCT01827384|592355645|FG011|Overall Study|Switched to alternative treatment|0|||
163997447|NCT01827384|592355646|FG012|Overall Study|Switched to alternative treatment|0|||
163997448|NCT01827384|592355647|FG013|Overall Study|Switched to alternative treatment|2|||
163997449|NCT01827384|592355634|FG000|Overall Study|Disease progression before treatment|0|||
163997450|NCT01827384|592355635|FG001|Overall Study|Disease progression before treatment|0|||
163997451|NCT01827384|592355636|FG002|Overall Study|Disease progression before treatment|0|||
163997452|NCT01827384|592355637|FG003|Overall Study|Disease progression before treatment|0|||
163997453|NCT01827384|592355638|FG004|Overall Study|Disease progression before treatment|0|||
163997454|NCT01827384|592355639|FG005|Overall Study|Disease progression before treatment|0|||
163997455|NCT01827384|592355640|FG006|Overall Study|Disease progression before treatment|0|||
163997456|NCT01827384|592355641|FG007|Overall Study|Disease progression before treatment|0|||
163997457|NCT01827384|592355642|FG008|Overall Study|Disease progression before treatment|0|||
163997458|NCT01827384|592355643|FG009|Overall Study|Disease progression before treatment|0|||
163997459|NCT01827384|592355644|FG010|Overall Study|Disease progression before treatment|0|||
164265269|NCT02310230|593340433|FG000|Overall Study|Poor signal quality|5|||
164265270|NCT02310230|593340434|FG001|Overall Study|Poor signal quality|8|||
164265271|NCT02310230|593340433|FG000|Overall Study|Case cancelled|1|||
164265272|NCT02310230|593340434|FG001|Overall Study|Case cancelled|0|||
164265273|NCT00545532|593340435|FG000|Overall Study|Withdrawal by Subject|1|||
163997460|NCT01827384|592355645|FG011|Overall Study|Disease progression before treatment|0|||
164085830|NCT00358826|592678571|FG004|Core Study|Lost to Follow-up|0|||
163997461|NCT01827384|592355646|FG012|Overall Study|Disease progression before treatment|0|||
163997462|NCT01827384|592355647|FG013|Overall Study|Disease progression before treatment|4|||
163997463|NCT01827384|592355634|FG000|Overall Study|Ineligible|0|||
163997464|NCT01827384|592355635|FG001|Overall Study|Ineligible|0|||
163997465|NCT01827384|592355636|FG002|Overall Study|Ineligible|0|||
163997466|NCT01827384|592355637|FG003|Overall Study|Ineligible|0|||
163997467|NCT01827384|592355638|FG004|Overall Study|Ineligible|0|||
163997468|NCT01827384|592355639|FG005|Overall Study|Ineligible|0|||
163997469|NCT01827384|592355640|FG006|Overall Study|Ineligible|0|||
163997470|NCT01827384|592355641|FG007|Overall Study|Ineligible|0|||
163997471|NCT01827384|592355642|FG008|Overall Study|Ineligible|0|||
163997472|NCT01827384|592355643|FG009|Overall Study|Ineligible|0|||
163997473|NCT01827384|592355644|FG010|Overall Study|Ineligible|0|||
163997474|NCT01827384|592355645|FG011|Overall Study|Ineligible|0|||
163997475|NCT01827384|592355646|FG012|Overall Study|Ineligible|0|||
163997476|NCT01827384|592355647|FG013|Overall Study|Ineligible|19|||
163997477|NCT01827384|592355634|FG000|Overall Study|Participant died before treatment|0|||
163997478|NCT01827384|592355635|FG001|Overall Study|Participant died before treatment|0|||
163997479|NCT01827384|592355636|FG002|Overall Study|Participant died before treatment|0|||
163997480|NCT01827384|592355637|FG003|Overall Study|Participant died before treatment|0|||
163997481|NCT01827384|592355638|FG004|Overall Study|Participant died before treatment|0|||
163997482|NCT01827384|592355639|FG005|Overall Study|Participant died before treatment|0|||
163997483|NCT01827384|592355640|FG006|Overall Study|Participant died before treatment|0|||
163997484|NCT01827384|592355641|FG007|Overall Study|Participant died before treatment|0|||
163997485|NCT01827384|592355642|FG008|Overall Study|Participant died before treatment|0|||
163997486|NCT01827384|592355643|FG009|Overall Study|Participant died before treatment|0|||
163997487|NCT01827384|592355644|FG010|Overall Study|Participant died before treatment|0|||
163997488|NCT01827384|592355645|FG011|Overall Study|Participant died before treatment|0|||
163997489|NCT01827384|592355646|FG012|Overall Study|Participant died before treatment|0|||
163997490|NCT01827384|592355647|FG013|Overall Study|Participant died before treatment|5|||
163997491|NCT01827384|592355634|FG000|Overall Study|Insufficient tumor cells|0|||
163997492|NCT01827384|592355635|FG001|Overall Study|Insufficient tumor cells|0|||
163997493|NCT01827384|592355636|FG002|Overall Study|Insufficient tumor cells|0|||
163997494|NCT01827384|592355637|FG003|Overall Study|Insufficient tumor cells|0|||
163997495|NCT01827384|592355638|FG004|Overall Study|Insufficient tumor cells|0|||
163997496|NCT01827384|592355639|FG005|Overall Study|Insufficient tumor cells|0|||
163997497|NCT01827384|592355640|FG006|Overall Study|Insufficient tumor cells|0|||
163997498|NCT01827384|592355641|FG007|Overall Study|Insufficient tumor cells|0|||
163997499|NCT01827384|592355642|FG008|Overall Study|Insufficient tumor cells|0|||
163997500|NCT01827384|592355643|FG009|Overall Study|Insufficient tumor cells|0|||
163997501|NCT01827384|592355644|FG010|Overall Study|Insufficient tumor cells|0|||
163997502|NCT01827384|592355645|FG011|Overall Study|Insufficient tumor cells|0|||
163997503|NCT01827384|592355646|FG012|Overall Study|Insufficient tumor cells|0|||
163997504|NCT01827384|592355647|FG013|Overall Study|Insufficient tumor cells|13|||
163997505|NCT01827384|592355634|FG000|Overall Study|No actionable mutation|0|||
163997506|NCT01827384|592355635|FG001|Overall Study|No actionable mutation|0|||
163997507|NCT01827384|592355636|FG002|Overall Study|No actionable mutation|0|||
163997508|NCT01827384|592355637|FG003|Overall Study|No actionable mutation|0|||
163997509|NCT01827384|592355638|FG004|Overall Study|No actionable mutation|0|||
163997510|NCT01827384|592355639|FG005|Overall Study|No actionable mutation|0|||
163997511|NCT01827384|592355640|FG006|Overall Study|No actionable mutation|0|||
163997512|NCT01827384|592355641|FG007|Overall Study|No actionable mutation|0|||
163997513|NCT01827384|592355642|FG008|Overall Study|No actionable mutation|0|||
163997514|NCT01827384|592355643|FG009|Overall Study|No actionable mutation|0|||
163997515|NCT01827384|592355644|FG010|Overall Study|No actionable mutation|0|||
163997516|NCT01827384|592355645|FG011|Overall Study|No actionable mutation|0|||
163997517|NCT01827384|592355646|FG012|Overall Study|No actionable mutation|0|||
163997518|NCT01827384|592355647|FG013|Overall Study|No actionable mutation|73|||
163997519|NCT01827384|592355634|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
163997520|NCT01827384|592355635|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
163997521|NCT01827384|592355636|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
163997522|NCT01827384|592355637|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
163997523|NCT01827384|592355638|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
163997524|NCT01827384|592355639|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
163997525|NCT01827384|592355640|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
163997526|NCT01827384|592355641|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
163997527|NCT01827384|592355642|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
163997528|NCT01827384|592355643|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
163997529|NCT01827384|592355644|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
163997530|NCT01827384|592355645|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
163997531|NCT01827384|592355646|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
164341682|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
164341683|NCT00787891|593627468|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
164341684|NCT00787891|593627469|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
164341685|NCT01594281|593627470|FG000|Interventional Core Phase|Protocol Deviation|1|||
164341686|NCT01594281|593627471|FG001|Interventional Core Phase|Protocol Deviation|0|||
163891624|NCT02240238|591974451|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891625|NCT02240238|591974452|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891626|NCT02240238|591974453|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891627|NCT02240238|591974454|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891628|NCT02240238|591974455|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891629|NCT02240238|591974456|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891630|NCT02240238|591974457|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891631|NCT02240238|591974458|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891632|NCT02240238|591974459|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891633|NCT02240238|591974460|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
163891634|NCT02240238|591974461|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
163891635|NCT02240238|591974450|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891636|NCT02240238|591974451|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891637|NCT02240238|591974452|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891638|NCT02240238|591974453|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891639|NCT02240238|591974454|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891640|NCT02240238|591974455|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891641|NCT02240238|591974456|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891642|NCT02240238|591974457|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891643|NCT02240238|591974458|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891644|NCT02240238|591974459|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891645|NCT02240238|591974460|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
163891646|NCT02240238|591974461|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
163891647|NCT02240238|591974450|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891648|NCT02240238|591974451|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891649|NCT02240238|591974452|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891650|NCT02240238|591974453|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891651|NCT02240238|591974454|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891652|NCT02240238|591974455|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891653|NCT02240238|591974456|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891654|NCT02240238|591974457|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891655|NCT02240238|591974458|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891656|NCT02240238|591974459|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891657|NCT02240238|591974460|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
163891658|NCT02240238|591974461|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
163891659|NCT02240238|591974450|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891660|NCT02240238|591974451|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891661|NCT02240238|591974452|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891662|NCT02240238|591974453|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891663|NCT02240238|591974454|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891664|NCT02240238|591974455|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891665|NCT02240238|591974456|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891666|NCT02240238|591974457|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891667|NCT02240238|591974458|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891668|NCT02240238|591974459|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891669|NCT02240238|591974460|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
163891670|NCT02240238|591974461|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
163891671|NCT02240238|591974450|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891672|NCT02240238|591974451|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891673|NCT02240238|591974452|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891674|NCT02240238|591974453|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891675|NCT02240238|591974454|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891676|NCT02240238|591974455|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891677|NCT02240238|591974456|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891678|NCT02240238|591974457|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891679|NCT02240238|591974458|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891680|NCT02240238|591974459|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163997532|NCT01827384|592355647|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
163997533|NCT00630331|592355648|FG000|Overall Study|Death|2|||
163997534|NCT00630331|592355649|FG001|Overall Study|Death|1|||
163997535|NCT00630331|592355650|FG002|Overall Study|Death|1|||
163997536|NCT00630331|592355648|FG000|Overall Study|Adverse Event|1|||
163997537|NCT00630331|592355649|FG001|Overall Study|Adverse Event|0|||
163997538|NCT00630331|592355650|FG002|Overall Study|Adverse Event|0|||
163997539|NCT00630331|592355648|FG000|Overall Study|Withdrawal by Subject|12|||
163997540|NCT00630331|592355649|FG001|Overall Study|Withdrawal by Subject|7|||
163997541|NCT00630331|592355650|FG002|Overall Study|Withdrawal by Subject|5|||
163997542|NCT00630331|592355648|FG000|Overall Study|Lost to Follow-up|175|||
163997543|NCT00630331|592355649|FG001|Overall Study|Lost to Follow-up|143|||
164265274|NCT00545532|593340436|FG001|Overall Study|Withdrawal by Subject|3|||
164265275|NCT00545532|593340435|FG000|Overall Study|Lost to Follow-up|5|||
164265276|NCT00545532|593340436|FG001|Overall Study|Lost to Follow-up|6|||
164265277|NCT00545532|593340435|FG000|Overall Study|Death|0|||
164265278|NCT00545532|593340436|FG001|Overall Study|Death|1|||
164265279|NCT03593681|593340437|FG000|Overall Study|Inadequate sample collected|12|||
164265280|NCT03593681|593340437|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
164265281|NCT03593681|593340437|FG000|Overall Study|Protocol Violation|3|||
164265282|NCT03593681|593340437|FG000|Overall Study|Withdrawal by Subject|3|||
164265283|NCT03593681|593340437|FG000|Overall Study|Procedure not attempted|3|||
164265284|NCT03593681|593340437|FG000|Overall Study|Adverse Event|2|||
164265285|NCT03593681|593340437|FG000|Overall Study|Physician Decision|1|||
164265286|NCT01149486|593340438|FG000|First Intervention|Adverse Event|0|||
164265287|NCT01149486|593340439|FG001|First Intervention|Adverse Event|1|||
164265288|NCT00598078|593340440|FG000|Period 2 (Day 2)|Adverse Event|1|||
164265289|NCT00598078|593340441|FG001|Period 2 (Day 2)|Adverse Event|0|||
164265290|NCT01479595|593340444|FG000|Overall Study|Protocol deviation|0|||
164265291|NCT01479595|593340445|FG001|Overall Study|Protocol deviation|1|||
164265292|NCT01479595|593340444|FG000|Overall Study|Adverse Event|2|||
164265293|NCT01479595|593340445|FG001|Overall Study|Adverse Event|1|||
163997544|NCT00630331|592355650|FG002|Overall Study|Lost to Follow-up|170|||
163997545|NCT00630331|592355648|FG000|Overall Study|Inappropriate enrollment|3|||
164265294|NCT02120365|593340446|FG000|Overall Study|Withdrawal by Subject|0|||
163997546|NCT00630331|592355649|FG001|Overall Study|Inappropriate enrollment|6|||
163997547|NCT00630331|592355650|FG002|Overall Study|Inappropriate enrollment|3|||
163997548|NCT00630331|592355648|FG000|Overall Study|Unable to classify|9|||
163997549|NCT00630331|592355649|FG001|Overall Study|Unable to classify|4|||
163997550|NCT00630331|592355650|FG002|Overall Study|Unable to classify|3|||
163997551|NCT00630331|592355648|FG000|Overall Study|Protocol Violation|4|||
163997552|NCT00630331|592355649|FG001|Overall Study|Protocol Violation|5|||
163997553|NCT00630331|592355650|FG002|Overall Study|Protocol Violation|6|||
163997554|NCT01929135|592355659|FG000|Overall Study|Lost to Follow-up|1|||
163997555|NCT01929135|592355660|FG001|Overall Study|Lost to Follow-up|1|||
163997556|NCT02425098|592355661|FG000|Overall Study|Lost to Follow-up|7|||
163997557|NCT02425098|592355662|FG001|Overall Study|Lost to Follow-up|7|||
163997558|NCT02425098|592355661|FG000|Overall Study|Withdrawal by Subject|4|||
163997559|NCT02425098|592355662|FG001|Overall Study|Withdrawal by Subject|8|||
163997560|NCT02425098|592355661|FG000|Overall Study|Pregnancy|2|||
163997561|NCT02425098|592355662|FG001|Overall Study|Pregnancy|0|||
163997562|NCT02425098|592355661|FG000|Overall Study|Reason not Specified|0|||
163997563|NCT02425098|592355662|FG001|Overall Study|Reason not Specified|1|||
163997564|NCT01955707|592355665|FG000|Overall Study|Adverse Event|1|||
163997565|NCT01955707|592355666|FG001|Overall Study|Adverse Event|2|||
163997566|NCT01955707|592355665|FG000|Overall Study|Lost to Follow-up|2|||
163997567|NCT01955707|592355666|FG001|Overall Study|Lost to Follow-up|1|||
163997568|NCT01955707|592355665|FG000|Overall Study|Withdrawal by Subject|0|||
163997569|NCT01955707|592355666|FG001|Overall Study|Withdrawal by Subject|3|||
163997570|NCT01955707|592355665|FG000|Overall Study|Death|13|||
163997571|NCT01955707|592355666|FG001|Overall Study|Death|14|||
163997572|NCT01955707|592355665|FG000|Overall Study|Other|4|||
163997573|NCT01955707|592355666|FG001|Overall Study|Other|2|||
163997574|NCT01817790|592355671|FG000|Overall Study|Adverse Event|0|||
163997575|NCT01817790|592355672|FG001|Overall Study|Adverse Event|2|||
163997576|NCT01817790|592355671|FG000|Overall Study|Lost to Follow-up|0|||
163997577|NCT01817790|592355672|FG001|Overall Study|Lost to Follow-up|1|||
163997578|NCT01817790|592355671|FG000|Overall Study|Protocol Violation|2|||
163997579|NCT01817790|592355672|FG001|Overall Study|Protocol Violation|1|||
163997580|NCT01817790|592355671|FG000|Overall Study|Withdrawal by Subject|1|||
163997581|NCT01817790|592355672|FG001|Overall Study|Withdrawal by Subject|3|||
164265295|NCT02120365|593340447|FG001|Overall Study|Withdrawal by Subject|0|||
164265296|NCT02120365|593340448|FG002|Overall Study|Withdrawal by Subject|2|||
164265297|NCT02120365|593340449|FG003|Overall Study|Withdrawal by Subject|4|||
164265298|NCT02120365|593340450|FG004|Overall Study|Withdrawal by Subject|0|||
164265299|NCT02120365|593340451|FG005|Overall Study|Withdrawal by Subject|2|||
164265300|NCT01344629|593340454|FG000|Crossover Period 2|Withdrawal by Subject|0|||
164265301|NCT01344629|593340455|FG001|Crossover Period 2|Withdrawal by Subject|1|||
164265302|NCT00900146|593340456|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
164265303|NCT00900146|593340457|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
164265304|NCT00900146|593340458|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
163997582|NCT01817790|592355671|FG000|Overall Study|Other: Could not attend appointment|1|||
163997583|NCT01817790|592355672|FG001|Overall Study|Other: Could not attend appointment|1|||
163997584|NCT01671345|592355673|FG000|Overall Study|Lost to Follow-up|10|||
163997585|NCT01671345|592355674|FG001|Overall Study|Lost to Follow-up|6|||
163997586|NCT01671345|592355673|FG000|Overall Study|visit with non-participating physician|3|||
163997587|NCT01671345|592355674|FG001|Overall Study|visit with non-participating physician|3|||
163997588|NCT02847598|592355677|FG000|Overall Study|Adverse Event|0|||
163997589|NCT02847598|592355678|FG001|Overall Study|Adverse Event|0|||
163997590|NCT02847598|592355679|FG002|Overall Study|Adverse Event|0|||
163997591|NCT02847598|592355680|FG003|Overall Study|Adverse Event|0|||
163997592|NCT02847598|592355681|FG004|Overall Study|Adverse Event|0|||
164265305|NCT00900146|593340459|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
164265306|NCT00900146|593340460|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
164265307|NCT00900146|593340456|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
164265308|NCT00900146|593340457|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
164265309|NCT00900146|593340458|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
164265310|NCT00900146|593340459|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
164265311|NCT00900146|593340460|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
164265312|NCT00900146|593340456|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
164265313|NCT00900146|593340457|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265314|NCT00900146|593340458|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265315|NCT00900146|593340459|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265316|NCT00900146|593340460|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
164265317|NCT00900146|593340456|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
164265318|NCT00900146|593340457|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
164265319|NCT00900146|593340458|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
164265320|NCT00900146|593340459|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
164265321|NCT00900146|593340460|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
164265322|NCT00900146|593340456|FG000|Intermediate: Period III|Lost to Follow-up|2|||
164265323|NCT00900146|593340457|FG001|Intermediate: Period III|Lost to Follow-up|0|||
164265324|NCT00900146|593340458|FG002|Intermediate: Period III|Lost to Follow-up|0|||
164265325|NCT00900146|593340459|FG003|Intermediate: Period III|Lost to Follow-up|0|||
164265326|NCT00900146|593340460|FG004|Intermediate: Period III|Lost to Follow-up|1|||
163891681|NCT02240238|591974460|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
163891682|NCT02240238|591974461|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
163891683|NCT02240238|591974450|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891684|NCT02240238|591974451|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891685|NCT02240238|591974452|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891686|NCT02240238|591974453|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891687|NCT02240238|591974454|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891688|NCT02240238|591974455|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891689|NCT02240238|591974456|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891690|NCT02240238|591974457|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891691|NCT02240238|591974458|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891692|NCT02240238|591974459|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891693|NCT02240238|591974460|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
163891694|NCT02240238|591974461|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
163891695|NCT05863156|591974473|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
163891696|NCT05863156|591974474|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
163891697|NCT05863156|591974475|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
163891698|NCT01346540|591974476|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
163891699|NCT01346540|591974477|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
163891700|NCT01346540|591974476|FG000|Overall Study|Adverse Event|0|||
163891701|NCT01346540|591974477|FG001|Overall Study|Adverse Event|4|||
163891702|NCT03625115|591974483|FG000|Overall Study|Withdrawal by Subject|4|||
163891703|NCT03625115|591974484|FG001|Overall Study|Withdrawal by Subject|7|||
163891704|NCT03625115|591974483|FG000|Overall Study|Lost to Follow-up|17|||
163891705|NCT03625115|591974484|FG001|Overall Study|Lost to Follow-up|24|||
163891706|NCT04797195|591974485|FG000|Overall Study|Death|8|||
163891707|NCT04797195|591974486|FG001|Overall Study|Death|15|||
163891708|NCT04797195|591974485|FG000|Overall Study|Change from PD|15|||
163891709|NCT04797195|591974486|FG001|Overall Study|Change from PD|15|||
163891710|NCT04797195|591974485|FG000|Overall Study|Withdrawal by Subject|3|||
163891711|NCT04797195|591974486|FG001|Overall Study|Withdrawal by Subject|2|||
163891712|NCT05868382|591974487|FG000|Overall Study|Lost to Follow-up|5|||
163891713|NCT05868382|591974488|FG001|Overall Study|Lost to Follow-up|0|||
163891714|NCT05868382|591974489|FG002|Overall Study|Lost to Follow-up|6|||
163891715|NCT05868382|591974490|FG003|Overall Study|Lost to Follow-up|4|||
163891716|NCT05868382|591974491|FG004|Overall Study|Lost to Follow-up|2|||
163891717|NCT05868382|591974492|FG005|Overall Study|Lost to Follow-up|6|||
163891718|NCT05868382|591974487|FG000|Overall Study|Withdrawal by Subject|1|||
163891719|NCT05868382|591974488|FG001|Overall Study|Withdrawal by Subject|0|||
163891720|NCT05868382|591974489|FG002|Overall Study|Withdrawal by Subject|0|||
163891721|NCT05868382|591974490|FG003|Overall Study|Withdrawal by Subject|0|||
163891722|NCT05868382|591974491|FG004|Overall Study|Withdrawal by Subject|1|||
163891723|NCT05868382|591974492|FG005|Overall Study|Withdrawal by Subject|0|||
163891724|NCT03655028|591974493|FG000|12-weeks Follow up|Death|1|||
163891725|NCT03655028|591974494|FG001|12-weeks Follow up|Death|0|||
163891726|NCT03655028|591974493|FG000|12-weeks Follow up|Physician Decision|3|||
163891727|NCT03655028|591974494|FG001|12-weeks Follow up|Physician Decision|3|||
163891728|NCT03655028|591974493|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
163997593|NCT02847598|592355682|FG005|Overall Study|Adverse Event|0|||
163997594|NCT02847598|592355683|FG006|Overall Study|Adverse Event|0|||
163997595|NCT02847598|592355684|FG007|Overall Study|Adverse Event|1|||
163997596|NCT02847598|592355677|FG000|Overall Study|Consent withdrawn|2|||
163997597|NCT02847598|592355678|FG001|Overall Study|Consent withdrawn|0|||
163997598|NCT02847598|592355679|FG002|Overall Study|Consent withdrawn|0|||
163997599|NCT02847598|592355680|FG003|Overall Study|Consent withdrawn|4|||
163997600|NCT02847598|592355681|FG004|Overall Study|Consent withdrawn|3|||
163997601|NCT02847598|592355682|FG005|Overall Study|Consent withdrawn|2|||
163997602|NCT02847598|592355683|FG006|Overall Study|Consent withdrawn|1|||
163997603|NCT02847598|592355684|FG007|Overall Study|Consent withdrawn|3|||
163997604|NCT02847598|592355677|FG000|Overall Study|Death|3|||
163997605|NCT02847598|592355678|FG001|Overall Study|Death|0|||
163997606|NCT02847598|592355679|FG002|Overall Study|Death|0|||
163997607|NCT02847598|592355680|FG003|Overall Study|Death|0|||
163997608|NCT02847598|592355681|FG004|Overall Study|Death|0|||
163997609|NCT02847598|592355682|FG005|Overall Study|Death|0|||
163997610|NCT02847598|592355683|FG006|Overall Study|Death|0|||
163997611|NCT02847598|592355684|FG007|Overall Study|Death|0|||
163997612|NCT02847598|592355677|FG000|Overall Study|Lost to Follow-up|0|||
163997613|NCT02847598|592355678|FG001|Overall Study|Lost to Follow-up|0|||
163997614|NCT02847598|592355679|FG002|Overall Study|Lost to Follow-up|0|||
163997615|NCT02847598|592355680|FG003|Overall Study|Lost to Follow-up|0|||
163997616|NCT02847598|592355681|FG004|Overall Study|Lost to Follow-up|0|||
163997617|NCT02847598|592355682|FG005|Overall Study|Lost to Follow-up|1|||
163997618|NCT02847598|592355683|FG006|Overall Study|Lost to Follow-up|1|||
163997619|NCT02847598|592355684|FG007|Overall Study|Lost to Follow-up|0|||
163997620|NCT03690869|592355685|FG000|Overall Study|Adverse Event|0|||
163997621|NCT03690869|592355686|FG001|Overall Study|Adverse Event|0|||
163997622|NCT03690869|592355687|FG002|Overall Study|Adverse Event|0|||
163997623|NCT03690869|592355688|FG003|Overall Study|Adverse Event|1|||
163997624|NCT03690869|592355689|FG004|Overall Study|Adverse Event|0|||
163997625|NCT03690869|592355690|FG005|Overall Study|Adverse Event|0|||
163997626|NCT03690869|592355691|FG006|Overall Study|Adverse Event|0|||
163997627|NCT03690869|592355692|FG007|Overall Study|Adverse Event|1|||
163997628|NCT03690869|592355693|FG008|Overall Study|Adverse Event|0|||
163997629|NCT03690869|592355694|FG009|Overall Study|Adverse Event|1|||
163997630|NCT03690869|592355685|FG000|Overall Study|Death|1|||
163997631|NCT03690869|592355686|FG001|Overall Study|Death|1|||
163997632|NCT03690869|592355687|FG002|Overall Study|Death|1|||
163997633|NCT03690869|592355688|FG003|Overall Study|Death|4|||
163997634|NCT03690869|592355689|FG004|Overall Study|Death|2|||
163997635|NCT03690869|592355690|FG005|Overall Study|Death|5|||
163997636|NCT03690869|592355691|FG006|Overall Study|Death|3|||
163997637|NCT03690869|592355692|FG007|Overall Study|Death|2|||
163997638|NCT03690869|592355693|FG008|Overall Study|Death|0|||
163997639|NCT03690869|592355694|FG009|Overall Study|Death|3|||
163997640|NCT03690869|592355685|FG000|Overall Study|Lost to Follow-up|0|||
163997641|NCT03690869|592355686|FG001|Overall Study|Lost to Follow-up|0|||
163997642|NCT03690869|592355687|FG002|Overall Study|Lost to Follow-up|1|||
163997643|NCT03690869|592355688|FG003|Overall Study|Lost to Follow-up|0|||
163997644|NCT03690869|592355689|FG004|Overall Study|Lost to Follow-up|0|||
163997645|NCT03690869|592355690|FG005|Overall Study|Lost to Follow-up|0|||
163997646|NCT03690869|592355691|FG006|Overall Study|Lost to Follow-up|0|||
163997647|NCT03690869|592355692|FG007|Overall Study|Lost to Follow-up|0|||
163997648|NCT03690869|592355693|FG008|Overall Study|Lost to Follow-up|0|||
163997649|NCT03690869|592355694|FG009|Overall Study|Lost to Follow-up|0|||
163997650|NCT03690869|592355685|FG000|Overall Study|Other Treatment|1|||
164265327|NCT00900146|593340456|FG000|Intermediate: Period III|Administrative problems|85|||
163997651|NCT03690869|592355686|FG001|Overall Study|Other Treatment|1|||
163997652|NCT03690869|592355687|FG002|Overall Study|Other Treatment|1|||
163997653|NCT03690869|592355688|FG003|Overall Study|Other Treatment|2|||
164265328|NCT00900146|593340457|FG001|Intermediate: Period III|Administrative problems|92|||
163997654|NCT03690869|592355689|FG004|Overall Study|Other Treatment|3|||
163997655|NCT03690869|592355690|FG005|Overall Study|Other Treatment|1|||
163997656|NCT03690869|592355691|FG006|Overall Study|Other Treatment|2|||
163997657|NCT03690869|592355692|FG007|Overall Study|Other Treatment|7|||
163997658|NCT03690869|592355693|FG008|Overall Study|Other Treatment|0|||
163997659|NCT03690869|592355694|FG009|Overall Study|Other Treatment|3|||
163997660|NCT03690869|592355685|FG000|Overall Study|Physician Decision|0|||
163997661|NCT03690869|592355686|FG001|Overall Study|Physician Decision|1|||
163997662|NCT03690869|592355687|FG002|Overall Study|Physician Decision|0|||
163997663|NCT03690869|592355688|FG003|Overall Study|Physician Decision|0|||
163997664|NCT03690869|592355689|FG004|Overall Study|Physician Decision|0|||
163997665|NCT03690869|592355690|FG005|Overall Study|Physician Decision|0|||
163997666|NCT03690869|592355691|FG006|Overall Study|Physician Decision|0|||
163997667|NCT03690869|592355692|FG007|Overall Study|Physician Decision|0|||
163997668|NCT03690869|592355693|FG008|Overall Study|Physician Decision|0|||
163997669|NCT03690869|592355694|FG009|Overall Study|Physician Decision|0|||
163997670|NCT03690869|592355685|FG000|Overall Study|Progressive Disease|1|||
163997671|NCT03690869|592355686|FG001|Overall Study|Progressive Disease|2|||
163997672|NCT03690869|592355687|FG002|Overall Study|Progressive Disease|0|||
163891729|NCT03655028|591974494|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
164341687|NCT01594281|593627472|FG002|Interventional Core Phase|Protocol Deviation|0|||
164341688|NCT01594281|593627470|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
164341689|NCT01594281|593627471|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
164341690|NCT01594281|593627472|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
164341691|NCT01594281|593627470|FG000|Interventional Core Phase|Death|1|||
164341692|NCT01594281|593627471|FG001|Interventional Core Phase|Death|1|||
163891730|NCT03655028|591974493|FG000|12-weeks Follow up|Lost to Follow-up|4|||
163891731|NCT03655028|591974494|FG001|12-weeks Follow up|Lost to Follow-up|4|||
163891732|NCT03655028|591974493|FG000|24-weeks|Lost to Follow-up|1|||
163891733|NCT03655028|591974494|FG001|24-weeks|Lost to Follow-up|1|||
163891734|NCT03655028|591974493|FG000|24-weeks|Death|0|||
163891735|NCT03655028|591974494|FG001|24-weeks|Death|1|||
163891736|NCT03513302|591974495|FG000|First Intervention (14 Days)|Screen failure|15|||
163891737|NCT03513302|591974496|FG001|First Intervention (14 Days)|Screen failure|16|||
163891738|NCT01236781|591974497|FG000|Overall Study|Ineligible|2|||
163891739|NCT01236781|591974498|FG001|Overall Study|Ineligible|1|||
163891740|NCT01236781|591974497|FG000|Overall Study|Did not complete study imaging|5|||
163891741|NCT01236781|591974498|FG001|Overall Study|Did not complete study imaging|0|||
163891742|NCT04577963|591974499|FG000|Part 2|Death|0|||
163891743|NCT04577963|591974500|FG001|Part 2|Death|1|||
163891744|NCT04577963|591974501|FG002|Part 2|Death|8|||
163891745|NCT04577963|591974502|FG003|Part 2|Death|0|||
163891746|NCT04577963|591974503|FG004|Part 2|Death|20|||
163891747|NCT04577963|591974499|FG000|Part 2|Lost to Follow-up|0|||
163891748|NCT04577963|591974500|FG001|Part 2|Lost to Follow-up|0|||
163891749|NCT04577963|591974501|FG002|Part 2|Lost to Follow-up|0|||
163891750|NCT04577963|591974502|FG003|Part 2|Lost to Follow-up|0|||
163891751|NCT04577963|591974503|FG004|Part 2|Lost to Follow-up|2|||
163891752|NCT04577963|591974499|FG000|Part 2|Withdrawal by Subject|0|||
163891753|NCT04577963|591974500|FG001|Part 2|Withdrawal by Subject|0|||
163891754|NCT04577963|591974501|FG002|Part 2|Withdrawal by Subject|0|||
163891755|NCT04577963|591974502|FG003|Part 2|Withdrawal by Subject|0|||
163891756|NCT04577963|591974503|FG004|Part 2|Withdrawal by Subject|10|||
163891757|NCT04577963|591974499|FG000|Part 2|Progressive disease|0|||
163891758|NCT04577963|591974500|FG001|Part 2|Progressive disease|0|||
163891759|NCT04577963|591974501|FG002|Part 2|Progressive disease|0|||
163891760|NCT04577963|591974502|FG003|Part 2|Progressive disease|0|||
163891761|NCT04577963|591974503|FG004|Part 2|Progressive disease|2|||
163891762|NCT04577963|591974499|FG000|Part 2|Investigator decision|0|||
163891763|NCT04577963|591974500|FG001|Part 2|Investigator decision|0|||
163891764|NCT04577963|591974501|FG002|Part 2|Investigator decision|0|||
163891765|NCT04577963|591974502|FG003|Part 2|Investigator decision|0|||
163891766|NCT04577963|591974503|FG004|Part 2|Investigator decision|1|||
163891767|NCT04577963|591974499|FG000|Part 2|Sponsor terminated study|0|||
163891768|NCT04577963|591974500|FG001|Part 2|Sponsor terminated study|0|||
163891769|NCT04577963|591974501|FG002|Part 2|Sponsor terminated study|3|||
163891770|NCT04577963|591974502|FG003|Part 2|Sponsor terminated study|1|||
163891771|NCT04577963|591974503|FG004|Part 2|Sponsor terminated study|4|||
163891772|NCT05256654|591974504|FG000|Overall Study|Adverse Event|0|||
163891773|NCT05256654|591974505|FG001|Overall Study|Adverse Event|0|||
163891774|NCT05256654|591974506|FG002|Overall Study|Adverse Event|1|||
163891775|NCT05256654|591974507|FG003|Overall Study|Adverse Event|0|||
163891776|NCT05256654|591974504|FG000|Overall Study|Lost to Follow-up|0|||
163891777|NCT05256654|591974505|FG001|Overall Study|Lost to Follow-up|0|||
163891778|NCT05256654|591974506|FG002|Overall Study|Lost to Follow-up|0|||
163891779|NCT05256654|591974507|FG003|Overall Study|Lost to Follow-up|1|||
163891780|NCT05256654|591974504|FG000|Overall Study|Withdrawal by Subject|1|||
163891781|NCT05256654|591974505|FG001|Overall Study|Withdrawal by Subject|2|||
163891782|NCT05256654|591974506|FG002|Overall Study|Withdrawal by Subject|1|||
163891783|NCT05256654|591974507|FG003|Overall Study|Withdrawal by Subject|3|||
163891784|NCT05256654|591974504|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
163891785|NCT05256654|591974505|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
163891786|NCT05256654|591974506|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
163891787|NCT05256654|591974507|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
163891788|NCT05256654|591974504|FG000|Overall Study|Other|0|||
163891789|NCT05256654|591974505|FG001|Overall Study|Other|0|||
163891790|NCT05256654|591974506|FG002|Overall Study|Other|0|||
163891791|NCT05256654|591974507|FG003|Overall Study|Other|1|||
163891792|NCT02709161|591974512|FG000|Overall Study|Withdrawal by Subject|1|||
163891793|NCT02709161|591974513|FG001|Overall Study|Withdrawal by Subject|0|||
163891794|NCT04862416|591974519|FG000|Overall Study|Withdrawal by Subject|0|||
163891795|NCT04862416|591974520|FG001|Overall Study|Withdrawal by Subject|1|||
163891796|NCT04862416|591974521|FG002|Overall Study|Withdrawal by Subject|0|||
163891797|NCT04862416|591974522|FG003|Overall Study|Withdrawal by Subject|1|||
163891798|NCT04862416|591974523|FG004|Overall Study|Withdrawal by Subject|0|||
163891799|NCT04862416|591974524|FG005|Overall Study|Withdrawal by Subject|0|||
163891800|NCT04862416|591974525|FG006|Overall Study|Withdrawal by Subject|0|||
163997673|NCT03690869|592355688|FG003|Overall Study|Progressive Disease|1|||
163997674|NCT03690869|592355689|FG004|Overall Study|Progressive Disease|0|||
163997675|NCT03690869|592355690|FG005|Overall Study|Progressive Disease|0|||
163997676|NCT03690869|592355691|FG006|Overall Study|Progressive Disease|0|||
163997677|NCT03690869|592355692|FG007|Overall Study|Progressive Disease|0|||
163997678|NCT03690869|592355693|FG008|Overall Study|Progressive Disease|1|||
163997679|NCT03690869|592355694|FG009|Overall Study|Progressive Disease|1|||
163997680|NCT03690869|592355685|FG000|Overall Study|Subject Decision|0|||
163997681|NCT03690869|592355686|FG001|Overall Study|Subject Decision|0|||
163997682|NCT03690869|592355687|FG002|Overall Study|Subject Decision|0|||
163997683|NCT03690869|592355688|FG003|Overall Study|Subject Decision|1|||
163997684|NCT03690869|592355689|FG004|Overall Study|Subject Decision|0|||
163997685|NCT03690869|592355690|FG005|Overall Study|Subject Decision|0|||
163997686|NCT03690869|592355691|FG006|Overall Study|Subject Decision|0|||
163997687|NCT03690869|592355692|FG007|Overall Study|Subject Decision|1|||
163997688|NCT03690869|592355693|FG008|Overall Study|Subject Decision|0|||
163997689|NCT03690869|592355694|FG009|Overall Study|Subject Decision|0|||
163997690|NCT03797001|592357171|FG000|Overall Study|Withdrawn due to COVID19|4|||
163997691|NCT03797001|592357172|FG001|Overall Study|Withdrawn due to COVID19|0|||
163997692|NCT03797001|592357171|FG000|Overall Study|Withdrawal by Subject|7|||
163997693|NCT03797001|592357172|FG001|Overall Study|Withdrawal by Subject|6|||
163997694|NCT03797001|592357171|FG000|Overall Study|Adverse Event|0|||
163997695|NCT03797001|592357172|FG001|Overall Study|Adverse Event|1|||
163997696|NCT00960076|592357173|FG000|Overall Study|Adverse Event|1|||
163997697|NCT00960076|592357174|FG001|Overall Study|Adverse Event|7|||
163997698|NCT00960076|592357173|FG000|Overall Study|No longer met study criteria|1|||
163997699|NCT00960076|592357174|FG001|Overall Study|No longer met study criteria|5|||
163997700|NCT00960076|592357173|FG000|Overall Study|Withdrawal by Subject|1|||
163997701|NCT00960076|592357174|FG001|Overall Study|Withdrawal by Subject|2|||
163997702|NCT00960076|592357173|FG000|Overall Study|Lost to Follow-up|3|||
163997703|NCT00960076|592357174|FG001|Overall Study|Lost to Follow-up|3|||
163997704|NCT00960076|592357173|FG000|Overall Study|Severe non-compliance to protocol|1|||
163997705|NCT00960076|592357174|FG001|Overall Study|Severe non-compliance to protocol|2|||
163997706|NCT00960076|592357173|FG000|Overall Study|Hyperglycemia|1|||
163997707|NCT00960076|592357174|FG001|Overall Study|Hyperglycemia|5|||
163997708|NCT00960076|592357173|FG000|Overall Study|Did not attend the termination visit|0|||
163997709|NCT00960076|592357174|FG001|Overall Study|Did not attend the termination visit|1|||
163997710|NCT00500266|592357175|FG000|Overall Study|Death|3|||
163997711|NCT00500266|592357175|FG000|Overall Study|Lost to Follow-up|3|||
163997712|NCT00500266|592357175|FG000|Overall Study|Withdrawal by Subject|3|||
163997713|NCT00500266|592357175|FG000|Overall Study|Assigned, not treated|4|||
163997714|NCT02029976|592357176|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
163997715|NCT02029976|592357177|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
163997716|NCT02029976|592357176|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
163997717|NCT02029976|592357177|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
163997718|NCT02029976|592357176|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
163997719|NCT02029976|592357177|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
163997720|NCT02029976|592357176|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
163997721|NCT02029976|592357177|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
163997722|NCT03263806|592357178|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
163997723|NCT03263806|592357179|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
163997724|NCT03263806|592357178|FG000|Overall Study|Withdrawal by Subject|0|||
163997725|NCT03263806|592357179|FG001|Overall Study|Withdrawal by Subject|1|||
163997726|NCT03263806|592357178|FG000|Overall Study|Study Termination|5|||
163997727|NCT03263806|592357179|FG001|Overall Study|Study Termination|6|||
163997728|NCT04840667|592357180|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
163997729|NCT01445171|592357181|FG000|Overall Study|Lost to Follow-up|11|||
163997730|NCT01445171|592357181|FG000|Overall Study|Withdrawal by Subject|16|||
164341693|NCT01594281|593627472|FG002|Interventional Core Phase|Death|2|||
163997731|NCT01445171|592357181|FG000|Overall Study|Death|51|||
163997732|NCT01445171|592357181|FG000|Overall Study|Subjects declined to return for followup|9|||
163997733|NCT01445171|592357181|FG000|Overall Study|Consented but did not receive device|8|||
163997734|NCT01552057|592357182|FG000|Overall Study|Adverse Event|14|||
163997735|NCT01552057|592357183|FG001|Overall Study|Adverse Event|15|||
163997736|NCT01552057|592357182|FG000|Overall Study|Lack of Efficacy|8|||
163997737|NCT01552057|592357183|FG001|Overall Study|Lack of Efficacy|23|||
163997738|NCT01552057|592357182|FG000|Overall Study|Withdrawal by Subject|5|||
163997739|NCT01552057|592357183|FG001|Overall Study|Withdrawal by Subject|8|||
163997740|NCT01552057|592357182|FG000|Overall Study|Entry Criteria Not Met|2|||
163997741|NCT01552057|592357183|FG001|Overall Study|Entry Criteria Not Met|2|||
163997742|NCT01552057|592357182|FG000|Overall Study|Physician Decision|1|||
163997743|NCT01552057|592357183|FG001|Overall Study|Physician Decision|0|||
163997744|NCT03895203|592357184|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
164341694|NCT01594281|593627470|FG000|Interventional Core Phase|Lost to Follow-up|1|||
164341695|NCT01594281|593627471|FG001|Interventional Core Phase|Lost to Follow-up|4|||
164341696|NCT01594281|593627472|FG002|Interventional Core Phase|Lost to Follow-up|1|||
163997745|NCT03895203|592357185|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
163997746|NCT03895203|592357186|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
163997747|NCT03895203|592357187|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
163997748|NCT03895203|592357188|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
163997749|NCT03895203|592357189|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
163997750|NCT03895203|592357184|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
163997751|NCT03895203|592357185|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163997752|NCT03895203|592357186|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163997753|NCT03895203|592357187|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163997754|NCT03895203|592357188|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163997755|NCT03895203|592357189|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
163891801|NCT04862416|591974526|FG007|Overall Study|Withdrawal by Subject|0|||
163891802|NCT03571581|591974532|FG000|Overall Study|Death|2|||
163891803|NCT03571581|591974532|FG000|Overall Study|Withdrawal by Subject|2|||
163997756|NCT03895203|592357184|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
163997757|NCT03895203|592357185|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163997758|NCT03895203|592357186|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163997759|NCT03895203|592357187|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163997760|NCT03895203|592357188|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163997761|NCT03895203|592357189|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
163997762|NCT03895203|592357184|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
163997763|NCT03895203|592357185|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
163997764|NCT03895203|592357186|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
163997765|NCT03895203|592357187|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
163997766|NCT03895203|592357188|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
163997767|NCT03895203|592357189|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
163997768|NCT03895203|592357184|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163997769|NCT03895203|592357185|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
163997770|NCT03895203|592357186|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163997771|NCT03895203|592357187|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163997772|NCT03895203|592357188|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163997773|NCT03895203|592357189|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
163997774|NCT03895203|592357184|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163891804|NCT01309672|591974533|FG000|Overall Study|Lack of Efficacy|20|||
163891805|NCT01309672|591974533|FG000|Overall Study|Other|9|||
163997775|NCT03895203|592357185|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
163997776|NCT03895203|592357186|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163997777|NCT03895203|592357187|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163997778|NCT03895203|592357188|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163997779|NCT03895203|592357189|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
163997780|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163997781|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163891806|NCT01309672|591974533|FG000|Overall Study|Adverse Event|5|||
163997782|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163891807|NCT01309672|591974533|FG000|Overall Study|Withdrawal by Subject|3|||
163891808|NCT04141891|591974536|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
163891809|NCT04141891|591974537|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
163891810|NCT04141891|591974536|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
163891811|NCT04141891|591974537|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
163997783|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
164265329|NCT00900146|593340458|FG002|Intermediate: Period III|Administrative problems|84|||
164265330|NCT00900146|593340459|FG003|Intermediate: Period III|Administrative problems|90|||
164265331|NCT00900146|593340460|FG004|Intermediate: Period III|Administrative problems|163|||
164265332|NCT02305849|593340461|FG000|Overall Study|Adverse Event|10|||
164265333|NCT02305849|593340462|FG001|Overall Study|Adverse Event|12|||
164265334|NCT02305849|593340463|FG002|Overall Study|Adverse Event|7|||
164265335|NCT02305849|593340464|FG003|Overall Study|Adverse Event|3|||
164265336|NCT02305849|593340461|FG000|Overall Study|Lack of Efficacy|10|||
163891812|NCT04141891|591974536|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
163891813|NCT04141891|591974537|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
163891814|NCT04141891|591974536|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
163891815|NCT04141891|591974537|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
163891816|NCT04141891|591974536|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
163891817|NCT04141891|591974537|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
163891818|NCT04141891|591974536|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
163891819|NCT04141891|591974537|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
163891820|NCT04141891|591974536|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
163891821|NCT04141891|591974537|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
163891822|NCT04141891|591974536|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
163891823|NCT04141891|591974537|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
163891824|NCT04141891|591974536|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
163891825|NCT04141891|591974537|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
163891826|NCT04141891|591974536|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
163891827|NCT04141891|591974537|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
163891828|NCT04141891|591974536|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
163891829|NCT04141891|591974537|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
163891830|NCT04141891|591974536|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
163891831|NCT04141891|591974537|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
163891832|NCT04141891|591974536|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
163891833|NCT04141891|591974537|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
163891834|NCT04141891|591974536|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
163891835|NCT04141891|591974537|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
163891836|NCT04737330|591974538|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
163891837|NCT04737330|591974539|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
163891838|NCT04737330|591974538|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
163891839|NCT04737330|591974539|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
163891840|NCT04737330|591974538|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
163891841|NCT04737330|591974539|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
163891842|NCT04737330|591974538|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
163891843|NCT04737330|591974539|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
163891844|NCT04737330|591974538|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
163891845|NCT04737330|591974539|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
163891846|NCT04737330|591974538|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
163891847|NCT04737330|591974539|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
163891848|NCT03295721|591974543|FG000|Overall Study|Adverse Event|1|||
163891849|NCT03295721|591974544|FG001|Overall Study|Adverse Event|0|||
163891850|NCT03295721|591974545|FG002|Overall Study|Adverse Event|0|||
163891851|NCT03295721|591974543|FG000|Overall Study|Lost to Follow-up|1|||
163891852|NCT03295721|591974544|FG001|Overall Study|Lost to Follow-up|1|||
163891853|NCT03295721|591974545|FG002|Overall Study|Lost to Follow-up|1|||
163891854|NCT03295721|591974543|FG000|Overall Study|Withdrawal by Subject|1|||
163891855|NCT03295721|591974544|FG001|Overall Study|Withdrawal by Subject|0|||
163891856|NCT03295721|591974545|FG002|Overall Study|Withdrawal by Subject|1|||
163891857|NCT03295721|591974543|FG000|Overall Study|Death|0|||
163891858|NCT03295721|591974544|FG001|Overall Study|Death|0|||
163891859|NCT03295721|591974545|FG002|Overall Study|Death|1|||
163891860|NCT02598388|591976641|FG000|Overall Study|Lost to Follow-up|1|||
163891861|NCT02598388|591976642|FG001|Overall Study|Lost to Follow-up|0|||
163891862|NCT02598388|591976643|FG002|Overall Study|Lost to Follow-up|1|||
163891863|NCT02598388|591976644|FG003|Overall Study|Lost to Follow-up|0|||
163891864|NCT02598388|591976645|FG004|Overall Study|Lost to Follow-up|5|||
163891865|NCT02598388|591976646|FG005|Overall Study|Lost to Follow-up|1|||
163891866|NCT02598388|591976647|FG006|Overall Study|Lost to Follow-up|2|||
163891867|NCT02598388|591976648|FG007|Overall Study|Lost to Follow-up|1|||
163891868|NCT02598388|591976649|FG008|Overall Study|Lost to Follow-up|0|||
163891869|NCT02598388|591976650|FG009|Overall Study|Lost to Follow-up|0|||
163891870|NCT02598388|591976651|FG010|Overall Study|Lost to Follow-up|1|||
163891871|NCT02598388|591976652|FG011|Overall Study|Lost to Follow-up|0|||
163891872|NCT02598388|591976641|FG000|Overall Study|Withdrawal by Subject|0|||
163891873|NCT02598388|591976642|FG001|Overall Study|Withdrawal by Subject|0|||
164341697|NCT01594281|593627470|FG000|Interventional Core Phase|Adverse Event|4|||
164341698|NCT01594281|593627471|FG001|Interventional Core Phase|Adverse Event|4|||
164341699|NCT01594281|593627472|FG002|Interventional Core Phase|Adverse Event|4|||
164341700|NCT01594281|593627470|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
164341701|NCT01594281|593627471|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
164341702|NCT01594281|593627472|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
164341703|NCT01594281|593627470|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
164341704|NCT01594281|593627471|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
164341705|NCT01594281|593627472|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
164341706|NCT01594281|593627470|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
164341707|NCT01594281|593627471|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
164341708|NCT01594281|593627472|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
164341709|NCT01193530|593627476|FG000|Overall Study|Withdrawal by Subject|2|||
164341710|NCT01193530|593627477|FG001|Overall Study|Withdrawal by Subject|2|||
164341711|NCT01193530|593627476|FG000|Overall Study|Began Contraindicated Therapy|1|||
164341712|NCT01193530|593627477|FG001|Overall Study|Began Contraindicated Therapy|0|||
164341713|NCT01193530|593627476|FG000|Overall Study|Lost Light Box|0|||
163997784|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163997785|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
163997786|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
163997787|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
163997788|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
163997789|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
163997790|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
163997791|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
163997792|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
163997793|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
163997794|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
163997795|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
163997796|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
163997797|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
164341714|NCT01193530|593627477|FG001|Overall Study|Lost Light Box|1|||
164341715|NCT01193530|593627476|FG000|Overall Study|Returned home - out of state|0|||
164341716|NCT01193530|593627477|FG001|Overall Study|Returned home - out of state|1|||
164341717|NCT01193530|593627476|FG000|Overall Study|Non-Compliance|0|||
164341718|NCT01193530|593627477|FG001|Overall Study|Non-Compliance|1|||
164341719|NCT01890473|593627478|FG000|Overall Study|Lost to Follow-up|1|||
163891874|NCT02598388|591976643|FG002|Overall Study|Withdrawal by Subject|0|||
163891875|NCT02598388|591976644|FG003|Overall Study|Withdrawal by Subject|0|||
163891876|NCT02598388|591976645|FG004|Overall Study|Withdrawal by Subject|2|||
163891877|NCT02598388|591976646|FG005|Overall Study|Withdrawal by Subject|0|||
163891878|NCT02598388|591976647|FG006|Overall Study|Withdrawal by Subject|2|||
163891879|NCT02598388|591976648|FG007|Overall Study|Withdrawal by Subject|0|||
163891880|NCT02598388|591976649|FG008|Overall Study|Withdrawal by Subject|0|||
163891881|NCT02598388|591976650|FG009|Overall Study|Withdrawal by Subject|1|||
163891882|NCT02598388|591976651|FG010|Overall Study|Withdrawal by Subject|0|||
163891883|NCT02598388|591976652|FG011|Overall Study|Withdrawal by Subject|0|||
163891884|NCT02598388|591976641|FG000|Overall Study|Other|0|||
163891885|NCT02598388|591976642|FG001|Overall Study|Other|0|||
163891886|NCT02598388|591976643|FG002|Overall Study|Other|1|||
163891887|NCT02598388|591976644|FG003|Overall Study|Other|0|||
163891888|NCT02598388|591976645|FG004|Overall Study|Other|3|||
163891889|NCT02598388|591976646|FG005|Overall Study|Other|0|||
163891890|NCT02598388|591976647|FG006|Overall Study|Other|1|||
163891891|NCT02598388|591976648|FG007|Overall Study|Other|0|||
163891892|NCT02598388|591976649|FG008|Overall Study|Other|0|||
163891893|NCT02598388|591976650|FG009|Overall Study|Other|0|||
163891894|NCT02598388|591976651|FG010|Overall Study|Other|0|||
163891895|NCT02598388|591976652|FG011|Overall Study|Other|0|||
163891896|NCT03668236|591976655|FG000|90-day Follow-up|Withdrawal by Subject|3|||
163891897|NCT03668236|591976656|FG001|90-day Follow-up|Withdrawal by Subject|2|||
163891898|NCT03668236|591976655|FG000|90-day Follow-up|Lost to Follow-up|3|||
163891899|NCT03668236|591976656|FG001|90-day Follow-up|Lost to Follow-up|1|||
163891900|NCT03668236|591976655|FG000|Baseline Characteristics|Lost to Follow-up|9|||
163891901|NCT03668236|591976656|FG001|Baseline Characteristics|Lost to Follow-up|5|||
163891902|NCT03668236|591976655|FG000|1-year Follow-up|Withdrawal by Subject|17|||
163891903|NCT03668236|591976656|FG001|1-year Follow-up|Withdrawal by Subject|15|||
163891904|NCT06132282|591976657|FG000|Overall Study|Lost to Follow-up|31|||
163891905|NCT04499924|591976660|FG000|Overall Study|Study termination by sponsor|4|||
163891906|NCT04499924|591976661|FG001|Overall Study|Study termination by sponsor|6|||
163891907|NCT04499924|591976660|FG000|Overall Study|Withdrawal by Subject|1|||
163891908|NCT04499924|591976661|FG001|Overall Study|Withdrawal by Subject|3|||
163997798|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
164265337|NCT02305849|593340462|FG001|Overall Study|Lack of Efficacy|6|||
164265338|NCT02305849|593340463|FG002|Overall Study|Lack of Efficacy|3|||
163891909|NCT04850898|591976662|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
163891910|NCT04850898|591976663|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
163891911|NCT04909801|591976672|FG000|Overall Study|Lack of Efficacy|2|||
163891912|NCT04909801|591976673|FG001|Overall Study|Lack of Efficacy|1|||
163891913|NCT04909801|591976672|FG000|Overall Study|Adverse Event|1|||
163891914|NCT04909801|591976673|FG001|Overall Study|Adverse Event|2|||
163891915|NCT04909801|591976672|FG000|Overall Study|Participant request to discontinue study treatment|1|||
163891916|NCT04909801|591976673|FG001|Overall Study|Participant request to discontinue study treatment|2|||
163891917|NCT04909801|591976672|FG000|Overall Study|Withdrawal by Subject|2|||
163891918|NCT04909801|591976673|FG001|Overall Study|Withdrawal by Subject|1|||
163891919|NCT04909801|591976672|FG000|Overall Study|other reasons|1|||
163891920|NCT04909801|591976673|FG001|Overall Study|other reasons|1|||
163891921|NCT04447040|591976674|FG000|Overall Study|Lost to Follow-up|2|||
163891922|NCT04447040|591976675|FG001|Overall Study|Lost to Follow-up|1|||
163891923|NCT04447040|591976676|FG002|Overall Study|Lost to Follow-up|3|||
163891924|NCT04447040|591976677|FG003|Overall Study|Lost to Follow-up|3|||
163891925|NCT04447040|591976678|FG004|Overall Study|Lost to Follow-up|1|||
163891926|NCT04447040|591976679|FG005|Overall Study|Lost to Follow-up|3|||
163891927|NCT04447040|591976674|FG000|Overall Study|Withdrawal by Subject|0|||
163891928|NCT04447040|591976675|FG001|Overall Study|Withdrawal by Subject|1|||
163891929|NCT04447040|591976676|FG002|Overall Study|Withdrawal by Subject|1|||
163891930|NCT04447040|591976677|FG003|Overall Study|Withdrawal by Subject|1|||
163891931|NCT04447040|591976678|FG004|Overall Study|Withdrawal by Subject|0|||
163891932|NCT04447040|591976679|FG005|Overall Study|Withdrawal by Subject|0|||
163891933|NCT04433208|591976680|FG000|Overall Study|Withdrawal by Subject|0|||
163891934|NCT04433208|591976681|FG001|Overall Study|Withdrawal by Subject|1|||
163891935|NCT04433208|591976682|FG002|Overall Study|Withdrawal by Subject|1|||
163891936|NCT04433208|591976683|FG003|Overall Study|Withdrawal by Subject|0|||
163891937|NCT04433208|591976684|FG004|Overall Study|Withdrawal by Subject|2|||
163891938|NCT04433208|591976685|FG005|Overall Study|Withdrawal by Subject|1|||
163891939|NCT04433208|591976680|FG000|Overall Study|Lost to Follow-up|0|||
163891940|NCT04433208|591976681|FG001|Overall Study|Lost to Follow-up|0|||
163891941|NCT04433208|591976682|FG002|Overall Study|Lost to Follow-up|0|||
163891942|NCT04433208|591976683|FG003|Overall Study|Lost to Follow-up|0|||
163891943|NCT04433208|591976684|FG004|Overall Study|Lost to Follow-up|0|||
163891944|NCT04433208|591976685|FG005|Overall Study|Lost to Follow-up|1|||
163891945|NCT05485779|591976688|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891946|NCT05485779|591976689|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891947|NCT05485779|591976690|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891948|NCT05485779|591976691|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891949|NCT05485779|591976692|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891950|NCT05485779|591976693|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891951|NCT05485779|591976694|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891952|NCT05485779|591976695|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
163891953|NCT05485779|591976696|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
163891954|NCT05485779|591976697|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891955|NCT05485779|591976698|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
163891956|NCT05485779|591976688|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891957|NCT05485779|591976689|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891958|NCT05485779|591976690|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891959|NCT05485779|591976691|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891960|NCT05485779|591976692|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891961|NCT05485779|591976693|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891962|NCT05485779|591976694|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891963|NCT05485779|591976695|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891964|NCT05485779|591976696|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891965|NCT05485779|591976697|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
163891966|NCT05485779|591976698|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
163891967|NCT05485779|591976688|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891968|NCT05485779|591976689|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891969|NCT05485779|591976690|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891970|NCT05485779|591976691|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
163891971|NCT05485779|591976692|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891972|NCT05485779|591976693|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891973|NCT05485779|591976694|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891974|NCT05485779|591976695|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
164085831|NCT00358826|592678572|FG005|Core Study|Lost to Follow-up|0|||
163997799|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163997800|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163997801|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
163997802|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
163997803|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
163997804|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
163997805|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
163997806|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
163997807|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
163997808|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
163997809|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
163997810|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163997811|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163997812|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163997813|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
163997814|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163997815|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
163997816|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163997817|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163997818|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163997819|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
163997820|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163997821|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
163997822|NCT03895203|592357184|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163997823|NCT03895203|592357185|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163997824|NCT03895203|592357186|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163997825|NCT03895203|592357187|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163997826|NCT03895203|592357188|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
163997827|NCT03895203|592357189|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
163997828|NCT04572633|592357190|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
163997829|NCT03155997|592357193|FG000|Overall Study|Withdrawal by Subject|119|||
163997830|NCT03155997|592357194|FG001|Overall Study|Withdrawal by Subject|134|||
163997831|NCT03155997|592357193|FG000|Overall Study|Lost to Follow-up|12|||
163997832|NCT03155997|592357194|FG001|Overall Study|Lost to Follow-up|13|||
163997833|NCT03155997|592357193|FG000|Overall Study|Missing disposition data|0|||
163997834|NCT03155997|592357194|FG001|Overall Study|Missing disposition data|1|||
163997835|NCT03155997|592357193|FG000|Overall Study|On study treatment|2027|||
163997836|NCT03155997|592357194|FG001|Overall Study|On study treatment|2074|||
163997837|NCT03514914|592357196|FG000|Overall Study|Death|3|||
163997838|NCT03514914|592357197|FG001|Overall Study|Death|3|||
163997839|NCT03514914|592357196|FG000|Overall Study|Lost to Follow-up|117|||
163997840|NCT03514914|592357197|FG001|Overall Study|Lost to Follow-up|89|||
163997841|NCT02507349|592357204|FG000|Overall Study|Death|12|||
163997842|NCT02507349|592357205|FG001|Overall Study|Death|16|||
163997843|NCT02507349|592357204|FG000|Overall Study|Withdrawal by Subject|1|||
163997844|NCT02507349|592357205|FG001|Overall Study|Withdrawal by Subject|1|||
163997845|NCT02507349|592357204|FG000|Overall Study|Lost to Follow-up|174|||
163997846|NCT02507349|592357205|FG001|Overall Study|Lost to Follow-up|144|||
163997847|NCT02700984|592357206|FG000|Overall Study|Death|2|||
163997848|NCT02700984|592357207|FG001|Overall Study|Death|1|||
163997849|NCT02700984|592357206|FG000|Overall Study|Lost to Follow-up|2|||
163997850|NCT02700984|592357207|FG001|Overall Study|Lost to Follow-up|1|||
163997851|NCT02700984|592357206|FG000|Overall Study|Physician Decision|0|||
163997852|NCT02700984|592357207|FG001|Overall Study|Physician Decision|1|||
163997853|NCT02700984|592357206|FG000|Overall Study|Withdrawal by Subject|8|||
163997854|NCT02700984|592357207|FG001|Overall Study|Withdrawal by Subject|9|||
163997855|NCT02700984|592357206|FG000|Overall Study|Reason not specified|3|||
163997856|NCT02700984|592357207|FG001|Overall Study|Reason not specified|2|||
163997857|NCT00473876|592357208|FG000|Overall Study|Lost to Follow-up|3|||
163997858|NCT00473876|592357209|FG001|Overall Study|Lost to Follow-up|1|||
163997859|NCT00727402|592357210|FG000|Overall Study|Physician Decision|116|||
163997860|NCT03094195|592357212|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
163997861|NCT03094195|592357213|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
163997862|NCT03094195|592357214|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
163997863|NCT03094195|592357215|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163997864|NCT03094195|592357216|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163997865|NCT03094195|592357217|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163997866|NCT03094195|592357218|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163891975|NCT05485779|591976696|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891976|NCT05485779|591976697|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163900159|NCT02397096|592005615|FG001|Study Extension 3|Withdrawal by Subject|1|||
164265339|NCT02305849|593340464|FG003|Overall Study|Lack of Efficacy|9|||
164265340|NCT02305849|593340461|FG000|Overall Study|Withdrawal by Subject|2|||
164265341|NCT02305849|593340462|FG001|Overall Study|Withdrawal by Subject|2|||
164265342|NCT02305849|593340463|FG002|Overall Study|Withdrawal by Subject|1|||
164265343|NCT02305849|593340464|FG003|Overall Study|Withdrawal by Subject|4|||
164265344|NCT02305849|593340461|FG000|Overall Study|Lost to Follow-up|0|||
164265345|NCT02305849|593340462|FG001|Overall Study|Lost to Follow-up|2|||
164265346|NCT02305849|593340463|FG002|Overall Study|Lost to Follow-up|0|||
164265347|NCT02305849|593340464|FG003|Overall Study|Lost to Follow-up|0|||
164265348|NCT02305849|593340461|FG000|Overall Study|Protocol Violation|3|||
164265349|NCT02305849|593340462|FG001|Overall Study|Protocol Violation|2|||
164265350|NCT02305849|593340463|FG002|Overall Study|Protocol Violation|1|||
164265351|NCT02305849|593340464|FG003|Overall Study|Protocol Violation|1|||
164265352|NCT02305849|593340461|FG000|Overall Study|Lab data met discontinuation criteria|0|||
164265353|NCT02305849|593340462|FG001|Overall Study|Lab data met discontinuation criteria|1|||
164265354|NCT02305849|593340463|FG002|Overall Study|Lab data met discontinuation criteria|2|||
164265355|NCT02305849|593340464|FG003|Overall Study|Lab data met discontinuation criteria|1|||
164265356|NCT02305849|593340461|FG000|Overall Study|Miscellaneous|1|||
164265357|NCT02305849|593340462|FG001|Overall Study|Miscellaneous|2|||
164265358|NCT02305849|593340463|FG002|Overall Study|Miscellaneous|4|||
164265359|NCT02305849|593340464|FG003|Overall Study|Miscellaneous|1|||
164265360|NCT02305849|593340461|FG000|Overall Study|Not fulfill eligibility criteria|1|||
164265361|NCT02305849|593340462|FG001|Overall Study|Not fulfill eligibility criteria|1|||
164265362|NCT02305849|593340463|FG002|Overall Study|Not fulfill eligibility criteria|0|||
164265363|NCT02305849|593340464|FG003|Overall Study|Not fulfill eligibility criteria|0|||
164265364|NCT00355342|593340465|FG000|Overall Study|Adverse Event|13|||
164265365|NCT00355342|593340466|FG001|Overall Study|Adverse Event|15|||
164265366|NCT00355342|593340465|FG000|Overall Study|Lost to Follow-up|4|||
164265367|NCT00355342|593340466|FG001|Overall Study|Lost to Follow-up|2|||
164265368|NCT00355342|593340465|FG000|Overall Study|Withdrawal by Subject|14|||
164265369|NCT00355342|593340466|FG001|Overall Study|Withdrawal by Subject|11|||
164265370|NCT00355342|593340465|FG000|Overall Study|Sponsor terminated study|2|||
164265371|NCT00355342|593340466|FG001|Overall Study|Sponsor terminated study|2|||
164265372|NCT00355342|593340465|FG000|Overall Study|Overcompliant-PI discretion|1|||
164265373|NCT00355342|593340466|FG001|Overall Study|Overcompliant-PI discretion|0|||
164265374|NCT00355342|593340465|FG000|Overall Study|Use of prohibited medication|1|||
164265375|NCT00355342|593340466|FG001|Overall Study|Use of prohibited medication|0|||
164265376|NCT00355342|593340465|FG000|Overall Study|COPD exacerbation|1|||
164265377|NCT00355342|593340466|FG001|Overall Study|COPD exacerbation|1|||
164265378|NCT00355342|593340465|FG000|Overall Study|Dispensed wrong study drug kit|1|||
164265379|NCT00355342|593340466|FG001|Overall Study|Dispensed wrong study drug kit|0|||
164265380|NCT00355342|593340465|FG000|Overall Study|Non-compliance with Dexa scans|1|||
164265381|NCT00355342|593340466|FG001|Overall Study|Non-compliance with Dexa scans|0|||
164265382|NCT00355342|593340465|FG000|Overall Study|Withdrawal by participant and physician|1|||
164265383|NCT00355342|593340466|FG001|Overall Study|Withdrawal by participant and physician|0|||
164265384|NCT00355342|593340465|FG000|Overall Study|Participant relocated|0|||
164265385|NCT00355342|593340466|FG001|Overall Study|Participant relocated|1|||
164265386|NCT00355342|593340465|FG000|Overall Study|Participant discontinued study drug|0|||
164265387|NCT00355342|593340466|FG001|Overall Study|Participant discontinued study drug|1|||
164265388|NCT00355342|593340465|FG000|Overall Study|Study management|0|||
164265389|NCT00355342|593340466|FG001|Overall Study|Study management|1|||
164265390|NCT00355342|593340465|FG000|Overall Study|Protocol Violation|0|||
164265391|NCT00355342|593340466|FG001|Overall Study|Protocol Violation|1|||
164265392|NCT00355342|593340465|FG000|Overall Study|Use of protocol excluded medication|0|||
164265393|NCT00355342|593340466|FG001|Overall Study|Use of protocol excluded medication|1|||
164265394|NCT02689076|593340467|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
164265395|NCT02689076|593340468|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
164265396|NCT02689076|593340469|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
164265397|NCT02689076|593340467|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
164265398|NCT02689076|593340468|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
164265399|NCT02689076|593340469|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
164265400|NCT02689076|593340467|FG000|Overall Study|Did not have an HIE match|2|||
164265401|NCT02689076|593340468|FG001|Overall Study|Did not have an HIE match|0|||
164265402|NCT02689076|593340469|FG002|Overall Study|Did not have an HIE match|0|||
164265403|NCT02689076|593340467|FG000|Overall Study|Death during non-VA encounter|2|||
164265404|NCT02689076|593340468|FG001|Overall Study|Death during non-VA encounter|5|||
164265405|NCT02689076|593340469|FG002|Overall Study|Death during non-VA encounter|0|||
164265406|NCT02689076|593340467|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
164265407|NCT02689076|593340468|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
164265408|NCT02689076|593340469|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
164265409|NCT02689076|593340467|FG000|Overall Study|Participant no longer active in VA system|1|||
164265410|NCT02689076|593340468|FG001|Overall Study|Participant no longer active in VA system|0|||
164265411|NCT02689076|593340469|FG002|Overall Study|Participant no longer active in VA system|0|||
164265412|NCT02689076|593340467|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
164265413|NCT02689076|593340468|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
164265414|NCT02689076|593340469|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
164265415|NCT00933244|593340470|FG000|Overall Study|Withdrawal by Subject|5|||
164265416|NCT00933244|593340471|FG001|Overall Study|Withdrawal by Subject|1|||
164265417|NCT00933244|593340472|FG002|Overall Study|Withdrawal by Subject|3|||
164265418|NCT00495521|593340475|FG000|Overall Study|Physician Decision|0|||
164265419|NCT00495521|593340476|FG001|Overall Study|Physician Decision|1|||
164265420|NCT00693472|593340479|FG000|Part 1|Adverse Event|1|||
164265421|NCT00693472|593340480|FG001|Part 1|Adverse Event|1|||
164265422|NCT00693472|593340481|FG002|Part 1|Adverse Event|0|||
164265423|NCT00693472|593340482|FG003|Part 1|Adverse Event|0|||
164265424|NCT00693472|593340479|FG000|Part 1|Lost to Follow-up|0|||
164265425|NCT00693472|593340480|FG001|Part 1|Lost to Follow-up|1|||
164265426|NCT00693472|593340481|FG002|Part 1|Lost to Follow-up|0|||
164265427|NCT00693472|593340482|FG003|Part 1|Lost to Follow-up|0|||
164265428|NCT00693472|593340479|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
164265429|NCT00693472|593340480|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
164265430|NCT00693472|593340481|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
164265431|NCT00693472|593340482|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
164265432|NCT00693472|593340479|FG000|Part 2|Adverse Event|0|||
164265433|NCT00693472|593340480|FG001|Part 2|Adverse Event|0|||
164265434|NCT00693472|593340481|FG002|Part 2|Adverse Event|1|||
164265435|NCT00693472|593340482|FG003|Part 2|Adverse Event|0|||
164265436|NCT00693472|593340479|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
164265437|NCT00693472|593340480|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
164265438|NCT00693472|593340481|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
164265439|NCT00693472|593340482|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
164265440|NCT02782325|593340483|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
164265441|NCT02782325|593340484|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
164265442|NCT02782325|593340485|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
164265443|NCT02782325|593340483|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
164265444|NCT02782325|593340484|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
164265445|NCT02782325|593340485|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
164265446|NCT01527383|593340488|FG000|Overall Study|Adverse Event|5|||
164265447|NCT01527383|593340489|FG001|Overall Study|Adverse Event|0|||
164265448|NCT01527383|593340488|FG000|Overall Study|Lost to Follow-up|3|||
164265449|NCT01527383|593340489|FG001|Overall Study|Lost to Follow-up|0|||
164265450|NCT01527383|593340488|FG000|Overall Study|Physician Decision|2|||
164265451|NCT01527383|593340489|FG001|Overall Study|Physician Decision|0|||
164265452|NCT01527383|593340488|FG000|Overall Study|Pregnancy|1|||
164265453|NCT01527383|593340489|FG001|Overall Study|Pregnancy|0|||
164265454|NCT01527383|593340488|FG000|Overall Study|Protocol Violation|1|||
164341720|NCT01890473|593627479|FG001|Overall Study|Lost to Follow-up|0|||
164341721|NCT01890473|593627478|FG000|Overall Study|Poor/non-compliance|1|||
164341722|NCT01890473|593627479|FG001|Overall Study|Poor/non-compliance|0|||
164341723|NCT01945281|593627480|FG000|Overall Study|Adverse Event|1|||
164341724|NCT01945281|593627481|FG001|Overall Study|Adverse Event|0|||
164341725|NCT01945281|593627480|FG000|Overall Study|Death|3|||
164341726|NCT01945281|593627481|FG001|Overall Study|Death|3|||
163997867|NCT03094195|592357219|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
163997868|NCT03094195|592357212|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
163997869|NCT03094195|592357213|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
163997870|NCT03094195|592357214|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
163997871|NCT03094195|592357215|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163997872|NCT03094195|592357216|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164265455|NCT01527383|593340489|FG001|Overall Study|Protocol Violation|0|||
164265456|NCT01527383|593340488|FG000|Overall Study|Screen failure|1|||
164265457|NCT01527383|593340489|FG001|Overall Study|Screen failure|0|||
164265458|NCT01527383|593340488|FG000|Overall Study|Participant moved|0|||
164265459|NCT01527383|593340489|FG001|Overall Study|Participant moved|1|||
164265460|NCT01527383|593340488|FG000|Overall Study|Withdrawal by Subject|2|||
164265461|NCT01527383|593340489|FG001|Overall Study|Withdrawal by Subject|3|||
164265462|NCT00849875|593340490|FG000|Overall Study|Death|28|||
164265463|NCT00849875|593340490|FG000|Overall Study|Ongoing (unknown completion status)|11|||
164341727|NCT01945281|593627480|FG000|Overall Study|Physician Decision|1|||
164341728|NCT01945281|593627481|FG001|Overall Study|Physician Decision|1|||
164265464|NCT00849875|593340490|FG000|Overall Study|Others|6|||
164341729|NCT01945281|593627480|FG000|Overall Study|Technical Problems|1|||
164265465|NCT00849875|593340490|FG000|Overall Study|Lost to Follow-up|2|||
164265466|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
164265467|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
164265468|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
164265469|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
164265470|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
164265471|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
164265472|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164265473|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164265474|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
164265475|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
164265476|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
164265477|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
164265478|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
164265479|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
164265480|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
164265481|NCT00554099|593340495|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164265482|NCT00554099|593340496|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164265483|NCT00554099|593340497|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
164265484|NCT00554099|593340495|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
164265485|NCT00554099|593340496|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
164265486|NCT00554099|593340497|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
164265487|NCT00554099|593340495|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
164265488|NCT00554099|593340496|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
164265489|NCT00554099|593340497|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
164265490|NCT00554099|593340495|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
164265491|NCT00554099|593340496|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
164265492|NCT00554099|593340497|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
164265493|NCT04957758|593340502|FG000|Overall Study|Adverse Event|1|||
164265494|NCT04957758|593340503|FG001|Overall Study|Adverse Event|0|||
164265495|NCT04957758|593340502|FG000|Overall Study|Lost to Follow-up|0|||
164265496|NCT04957758|593340503|FG001|Overall Study|Lost to Follow-up|2|||
164265497|NCT04957758|593340502|FG000|Overall Study|Withdrawal by Subject|4|||
164265498|NCT04957758|593340503|FG001|Overall Study|Withdrawal by Subject|2|||
164265499|NCT04957758|593340502|FG000|Overall Study|Protocol Violation|0|||
164265500|NCT04957758|593340503|FG001|Overall Study|Protocol Violation|1|||
164265501|NCT03353922|593340504|FG000|Overall Study|Withdrawal by Subject|1|||
164265502|NCT03353922|593340505|FG001|Overall Study|Withdrawal by Subject|0|||
164265503|NCT03353922|593340506|FG002|Overall Study|Withdrawal by Subject|1|||
164265504|NCT03353922|593340507|FG003|Overall Study|Withdrawal by Subject|1|||
164265505|NCT03353922|593340508|FG004|Overall Study|Withdrawal by Subject|0|||
164265506|NCT03353922|593340509|FG005|Overall Study|Withdrawal by Subject|0|||
164265507|NCT03353922|593340504|FG000|Overall Study|Adverse Event|0|||
164265508|NCT03353922|593340505|FG001|Overall Study|Adverse Event|1|||
164265509|NCT03353922|593340506|FG002|Overall Study|Adverse Event|0|||
164265510|NCT03353922|593340507|FG003|Overall Study|Adverse Event|0|||
164265511|NCT03353922|593340508|FG004|Overall Study|Adverse Event|0|||
164265512|NCT03353922|593340509|FG005|Overall Study|Adverse Event|0|||
164265513|NCT03688555|593340510|FG000|Treatment Period|Adverse Event|0|||
164265514|NCT03688555|593340511|FG001|Treatment Period|Adverse Event|0|||
164265515|NCT03688555|593340512|FG002|Treatment Period|Adverse Event|1|||
164265516|NCT00886119|593340513|FG000|Period 1|Did not meet inclusion criteria|1|||
164265517|NCT00886119|593340514|FG001|Period 1|Did not meet inclusion criteria|0|||
164265518|NCT03553498|593340516|FG000|Overall Study|Missing primary outcome|1|||
164265519|NCT03553498|593340517|FG001|Overall Study|Missing primary outcome|2|||
164265520|NCT01498185|593340518|FG000|Overall Study|Adverse Event|0|||
164265521|NCT01498185|593340519|FG001|Overall Study|Adverse Event|0|||
164265522|NCT01498185|593340520|FG002|Overall Study|Adverse Event|0|||
164265523|NCT01498185|593340521|FG003|Overall Study|Adverse Event|1|||
164265524|NCT01498185|593340522|FG004|Overall Study|Adverse Event|0|||
164265525|NCT01498185|593340518|FG000|Overall Study|Withdrawal by Subject|1|||
164265526|NCT01498185|593340519|FG001|Overall Study|Withdrawal by Subject|1|||
164265527|NCT01498185|593340520|FG002|Overall Study|Withdrawal by Subject|0|||
164265528|NCT01498185|593340521|FG003|Overall Study|Withdrawal by Subject|2|||
164265529|NCT01498185|593340522|FG004|Overall Study|Withdrawal by Subject|1|||
164265530|NCT01498185|593340518|FG000|Overall Study|No longer met criteria, etc|0|||
164265531|NCT01498185|593340519|FG001|Overall Study|No longer met criteria, etc|0|||
164265532|NCT01498185|593340520|FG002|Overall Study|No longer met criteria, etc|0|||
164341730|NCT01945281|593627481|FG001|Overall Study|Technical Problems|0|||
163900160|NCT03275285|592005620|FG000|Overall Study|Ongoing|45|||
164265533|NCT01498185|593340521|FG003|Overall Study|No longer met criteria, etc|0|||
164265534|NCT01498185|593340522|FG004|Overall Study|No longer met criteria, etc|2|||
164265535|NCT01453946|593340524|FG000|Overall Study|Did not receive drug for the taper phase|1|||
164265536|NCT01453946|593340524|FG000|Overall Study|Protocol Violation|2|||
164265537|NCT01453946|593340524|FG000|Overall Study|Lack of Efficacy|3|||
164265538|NCT01453946|593340524|FG000|Overall Study|Adverse Event|3|||
164265539|NCT00846040|593340525|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
164265540|NCT00846040|593340526|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
164265541|NCT00846040|593340527|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
164265542|NCT00846040|593340525|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
164265543|NCT00846040|593340526|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
164265544|NCT00846040|593340527|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
164265545|NCT02827500|593340529|FG000|Overall Study|Death|7|||
164265546|NCT02827500|593340530|FG001|Overall Study|Death|3|||
164265547|NCT02827500|593340529|FG000|Overall Study|Lost to Follow-up|1|||
164265548|NCT02827500|593340530|FG001|Overall Study|Lost to Follow-up|1|||
164265549|NCT02827500|593340529|FG000|Overall Study|Withdrawal by Subject|3|||
164265550|NCT02827500|593340530|FG001|Overall Study|Withdrawal by Subject|1|||
164265551|NCT02827500|593340529|FG000|Overall Study|Missing primary endpoint data|3|||
164265552|NCT02827500|593340530|FG001|Overall Study|Missing primary endpoint data|1|||
164265553|NCT02827500|593340529|FG000|Overall Study|Other|5|||
164265554|NCT02827500|593340530|FG001|Overall Study|Other|1|||
164265555|NCT03697993|593340533|FG000|Overall Study|Became Ineligible after Enrollment|1|||
164265556|NCT03697993|593340534|FG001|Overall Study|Became Ineligible after Enrollment|3|||
164265557|NCT03697993|593340533|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
164265558|NCT03697993|593340534|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
164265559|NCT03697993|593340533|FG000|Overall Study|Lost to Follow-up|3|||
164265560|NCT03697993|593340534|FG001|Overall Study|Lost to Follow-up|0|||
164265561|NCT03697993|593340533|FG000|Overall Study|Physician Decision|4|||
164265562|NCT03697993|593340534|FG001|Overall Study|Physician Decision|0|||
164265563|NCT03697993|593340533|FG000|Overall Study|Initial Urine Culture Negative|0|||
164265564|NCT03697993|593340534|FG001|Overall Study|Initial Urine Culture Negative|1|||
164265565|NCT04384107|593340535|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
164265566|NCT04384107|593340536|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
164265567|NCT04384107|593340535|FG000|Overall Study|Lost to Follow-up|1|||
164265568|NCT04384107|593340536|FG001|Overall Study|Lost to Follow-up|0|||
164265569|NCT01591863|593340539|FG000|Overall Study|Adverse Event|3|||
164265570|NCT01591863|593340539|FG000|Overall Study|Withdrawal by Subject|1|||
164265571|NCT01591863|593340539|FG000|Overall Study|recurrence|9|||
164265572|NCT01591863|593340539|FG000|Overall Study|Lack of Efficacy|1|||
164265573|NCT00160654|593340540|FG000|Overall Study|Adverse Event|14|||
164265574|NCT00160654|593340540|FG000|Overall Study|Lack of Efficacy|4|||
164265575|NCT00160654|593340540|FG000|Overall Study|Lost to Follow-up|2|||
164265576|NCT00160654|593340540|FG000|Overall Study|Intake of expired drug|7|||
164265577|NCT00160654|593340540|FG000|Overall Study|Psychological trauma|1|||
163891977|NCT05485779|591976698|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
163891978|NCT02038777|591976699|FG000|Overall Study|Death|0|||
164265578|NCT00160654|593340540|FG000|Overall Study|Sponsor decision|1|||
164265579|NCT00160654|593340540|FG000|Overall Study|Patient met exclusion criteria|1|||
163891979|NCT02038777|591976700|FG001|Overall Study|Death|2|||
163891980|NCT02038777|591976701|FG002|Overall Study|Death|0|||
163891981|NCT02038777|591976702|FG003|Overall Study|Death|1|||
163891982|NCT02038777|591976703|FG004|Overall Study|Death|2|||
163891983|NCT02038777|591976704|FG005|Overall Study|Death|4|||
163891984|NCT02038777|591976705|FG006|Overall Study|Death|0|||
163891985|NCT02038777|591976706|FG007|Overall Study|Death|11|||
163891986|NCT02038777|591976699|FG000|Overall Study|Lost to Follow-up|0|||
163891987|NCT02038777|591976700|FG001|Overall Study|Lost to Follow-up|0|||
163891988|NCT02038777|591976701|FG002|Overall Study|Lost to Follow-up|0|||
163891989|NCT02038777|591976702|FG003|Overall Study|Lost to Follow-up|1|||
163891990|NCT02038777|591976703|FG004|Overall Study|Lost to Follow-up|0|||
163891991|NCT02038777|591976704|FG005|Overall Study|Lost to Follow-up|0|||
163891992|NCT02038777|591976705|FG006|Overall Study|Lost to Follow-up|0|||
163891993|NCT02038777|591976706|FG007|Overall Study|Lost to Follow-up|0|||
163891994|NCT02038777|591976699|FG000|Overall Study|Other|0|||
163891995|NCT02038777|591976700|FG001|Overall Study|Other|1|||
163891996|NCT02038777|591976701|FG002|Overall Study|Other|0|||
163891997|NCT02038777|591976702|FG003|Overall Study|Other|2|||
163891998|NCT02038777|591976703|FG004|Overall Study|Other|1|||
163891999|NCT02038777|591976704|FG005|Overall Study|Other|0|||
163892000|NCT02038777|591976705|FG006|Overall Study|Other|0|||
163892001|NCT02038777|591976706|FG007|Overall Study|Other|0|||
163892002|NCT02038777|591976699|FG000|Overall Study|Randomized but not treated|0|||
163892003|NCT02038777|591976700|FG001|Overall Study|Randomized but not treated|1|||
163892004|NCT02038777|591976701|FG002|Overall Study|Randomized but not treated|0|||
163892005|NCT02038777|591976702|FG003|Overall Study|Randomized but not treated|0|||
164265580|NCT00160654|593340540|FG000|Overall Study|Patient decision|1|||
164265581|NCT00160654|593340540|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
164265582|NCT00160654|593340540|FG000|Overall Study|Met exclusion criteria|1|||
164265583|NCT00831701|593340541|FG000|Overall Study|Withdrawal by Subject|2|||
164265584|NCT00831701|593340542|FG001|Overall Study|Withdrawal by Subject|0|||
164265585|NCT00831701|593340541|FG000|Overall Study|Stone expulsion before first medication|2|||
164265586|NCT00831701|593340542|FG001|Overall Study|Stone expulsion before first medication|2|||
164265587|NCT00831701|593340541|FG000|Overall Study|Lost to Follow-up|1|||
164265588|NCT00831701|593340542|FG001|Overall Study|Lost to Follow-up|3|||
164265589|NCT02366767|593340543|FG000|Overall Study|left for home after 1 day at camp|1|||
164265590|NCT02366767|593340544|FG001|Overall Study|left for home after 1 day at camp|0|||
164265591|NCT02242981|593340545|FG000|Overall Study|Withdrawal by Subject|1|||
164265592|NCT03474081|593340548|FG000|Overall Study|Adverse Event|6|||
164265593|NCT03474081|593340549|FG001|Overall Study|Adverse Event|3|||
164265594|NCT03474081|593340548|FG000|Overall Study|Lost to Follow-up|2|||
164265595|NCT03474081|593340549|FG001|Overall Study|Lost to Follow-up|1|||
164265596|NCT03474081|593340548|FG000|Overall Study|Physician Decision|3|||
164265597|NCT03474081|593340549|FG001|Overall Study|Physician Decision|2|||
164265598|NCT03474081|593340548|FG000|Overall Study|Withdrawal by Subject|5|||
164265599|NCT03474081|593340549|FG001|Overall Study|Withdrawal by Subject|7|||
164265600|NCT03474081|593340548|FG000|Overall Study|Investigator site closed|1|||
164265601|NCT03474081|593340549|FG001|Overall Study|Investigator site closed|0|||
164265602|NCT00459537|593340553|FG000|Overall Study|Adverse Event|1|||
164265603|NCT00459537|593340554|FG001|Overall Study|Adverse Event|6|||
164265604|NCT00459537|593340553|FG000|Overall Study|Lack of Efficacy|10|||
164265605|NCT00459537|593340554|FG001|Overall Study|Lack of Efficacy|11|||
164265606|NCT00459537|593340553|FG000|Overall Study|Withdrawal by Subject|20|||
164265607|NCT00459537|593340554|FG001|Overall Study|Withdrawal by Subject|26|||
164265608|NCT00459537|593340553|FG000|Overall Study|Lost to Follow-up|27|||
164265609|NCT00459537|593340554|FG001|Overall Study|Lost to Follow-up|30|||
164265610|NCT00459537|593340553|FG000|Overall Study|Administrative problems|3|||
164265611|NCT00459537|593340554|FG001|Overall Study|Administrative problems|0|||
164265612|NCT00459537|593340553|FG000|Overall Study|Protocol Violation|4|||
164265613|NCT00459537|593340554|FG001|Overall Study|Protocol Violation|3|||
164265614|NCT00459537|593340553|FG000|Overall Study|Missing|1|||
164265615|NCT00459537|593340554|FG001|Overall Study|Missing|0|||
164265616|NCT00546260|593340555|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
164265617|NCT00546260|593340556|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
164265618|NCT00664326|593342604|FG000|Overall Study|Adverse Event|14|||
164265619|NCT00664326|593342604|FG000|Overall Study|Noncompliance with study medication|3|||
164265620|NCT00664326|593342604|FG000|Overall Study|Withdrawal by Subject|1|||
164265621|NCT00664326|593342604|FG000|Overall Study|Physician Decision|1|||
164265622|NCT00664326|593342604|FG000|Overall Study|Other Reasons|3|||
164265623|NCT00664326|593342604|FG000|Overall Study|Death|2|||
164265624|NCT00664326|593342604|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
164265625|NCT01161537|593342606|FG000|Part B|Withdrawal by Subject|2|||
164265626|NCT00996801|593342607|FG000|Overall Study|Adverse Event|6|||
164265627|NCT00996801|593342608|FG001|Overall Study|Adverse Event|4|||
164265628|NCT00996801|593342609|FG002|Overall Study|Adverse Event|12|||
164265629|NCT00996801|593342610|FG003|Overall Study|Adverse Event|17|||
164265630|NCT00996801|593342611|FG004|Overall Study|Adverse Event|31|||
164265631|NCT00996801|593342612|FG005|Overall Study|Adverse Event|3|||
164265632|NCT00996801|593342607|FG000|Overall Study|Lack of Efficacy|3|||
164265633|NCT00996801|593342608|FG001|Overall Study|Lack of Efficacy|0|||
164265634|NCT00996801|593342609|FG002|Overall Study|Lack of Efficacy|1|||
164265635|NCT00996801|593342610|FG003|Overall Study|Lack of Efficacy|3|||
164265636|NCT00996801|593342611|FG004|Overall Study|Lack of Efficacy|0|||
164265637|NCT00996801|593342612|FG005|Overall Study|Lack of Efficacy|1|||
164265638|NCT00996801|593342607|FG000|Overall Study|Lost to Follow-up|0|||
164265639|NCT00996801|593342608|FG001|Overall Study|Lost to Follow-up|0|||
164265640|NCT00996801|593342609|FG002|Overall Study|Lost to Follow-up|0|||
164265641|NCT00996801|593342610|FG003|Overall Study|Lost to Follow-up|3|||
164265642|NCT00996801|593342611|FG004|Overall Study|Lost to Follow-up|3|||
164265643|NCT00996801|593342612|FG005|Overall Study|Lost to Follow-up|2|||
164265644|NCT00996801|593342607|FG000|Overall Study|Physician Decision|0|||
164265645|NCT00996801|593342608|FG001|Overall Study|Physician Decision|0|||
164265646|NCT00996801|593342609|FG002|Overall Study|Physician Decision|0|||
164265647|NCT00996801|593342610|FG003|Overall Study|Physician Decision|1|||
164265648|NCT00996801|593342611|FG004|Overall Study|Physician Decision|0|||
164265649|NCT00996801|593342612|FG005|Overall Study|Physician Decision|0|||
164265650|NCT00996801|593342607|FG000|Overall Study|Progressive Disease|0|||
164265651|NCT00996801|593342608|FG001|Overall Study|Progressive Disease|1|||
164265652|NCT00996801|593342609|FG002|Overall Study|Progressive Disease|0|||
164265653|NCT00996801|593342610|FG003|Overall Study|Progressive Disease|0|||
164265654|NCT00996801|593342611|FG004|Overall Study|Progressive Disease|0|||
164265655|NCT00996801|593342612|FG005|Overall Study|Progressive Disease|0|||
164265656|NCT00996801|593342607|FG000|Overall Study|Protocol Violation|3|||
163900161|NCT03275285|592005621|FG001|Overall Study|Ongoing|69|||
164265657|NCT00996801|593342608|FG001|Overall Study|Protocol Violation|4|||
164265658|NCT00996801|593342609|FG002|Overall Study|Protocol Violation|1|||
164265659|NCT00996801|593342610|FG003|Overall Study|Protocol Violation|2|||
164265660|NCT00996801|593342611|FG004|Overall Study|Protocol Violation|3|||
164265661|NCT00996801|593342612|FG005|Overall Study|Protocol Violation|4|||
164265662|NCT00996801|593342607|FG000|Overall Study|Study Terminated by Sponsor|0|||
164265663|NCT00996801|593342608|FG001|Overall Study|Study Terminated by Sponsor|1|||
164265664|NCT00996801|593342609|FG002|Overall Study|Study Terminated by Sponsor|0|||
164265665|NCT00996801|593342610|FG003|Overall Study|Study Terminated by Sponsor|0|||
164265666|NCT00996801|593342611|FG004|Overall Study|Study Terminated by Sponsor|46|||
164265667|NCT00996801|593342612|FG005|Overall Study|Study Terminated by Sponsor|0|||
164265668|NCT00996801|593342607|FG000|Overall Study|Withdrawal by Subject|8|||
164265669|NCT00996801|593342608|FG001|Overall Study|Withdrawal by Subject|6|||
164265670|NCT00996801|593342609|FG002|Overall Study|Withdrawal by Subject|9|||
164265671|NCT00996801|593342610|FG003|Overall Study|Withdrawal by Subject|5|||
164265672|NCT00996801|593342611|FG004|Overall Study|Withdrawal by Subject|5|||
164265673|NCT00996801|593342612|FG005|Overall Study|Withdrawal by Subject|9|||
164265674|NCT00289198|593342613|FG000|Overall Study|Adverse Event|0|||
164265675|NCT00289198|593342614|FG001|Overall Study|Adverse Event|2|||
164265676|NCT00289198|593342613|FG000|Overall Study|Protocol Violation|2|||
164265677|NCT00289198|593342614|FG001|Overall Study|Protocol Violation|1|||
164265678|NCT00289198|593342613|FG000|Overall Study|Withdrawal by Subject|4|||
164265679|NCT00289198|593342614|FG001|Overall Study|Withdrawal by Subject|1|||
164265680|NCT00289198|593342613|FG000|Overall Study|Lack of Efficacy|2|||
164265681|NCT00289198|593342614|FG001|Overall Study|Lack of Efficacy|0|||
163997873|NCT03094195|592357217|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163997874|NCT03094195|592357218|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164265682|NCT00289198|593342613|FG000|Overall Study|Other: Low compliance|0|||
164265683|NCT00289198|593342614|FG001|Overall Study|Other: Low compliance|1|||
164265684|NCT00289198|593342613|FG000|Overall Study|Other: Physician's decision|0|||
164265685|NCT00289198|593342614|FG001|Overall Study|Other: Physician's decision|1|||
164265686|NCT00289198|593342613|FG000|Overall Study|Other: Unable to attend on schedule|2|||
164265687|NCT00289198|593342614|FG001|Overall Study|Other: Unable to attend on schedule|1|||
164265688|NCT00289198|593342613|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
164265689|NCT00289198|593342614|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
164265690|NCT00289198|593342613|FG000|Overall Study|Other: Impossible to come on visit|0|||
164265691|NCT00289198|593342614|FG001|Overall Study|Other: Impossible to come on visit|1|||
164265692|NCT02559414|593342621|FG000|Overall Study|Lost to Follow-up|0|||
164265693|NCT02559414|593342622|FG001|Overall Study|Lost to Follow-up|1|||
164265694|NCT02559414|593342623|FG002|Overall Study|Lost to Follow-up|0|||
164265695|NCT02559414|593342621|FG000|Overall Study|Withdrawal by Subject|1|||
164265696|NCT02559414|593342622|FG001|Overall Study|Withdrawal by Subject|0|||
164265697|NCT02559414|593342623|FG002|Overall Study|Withdrawal by Subject|1|||
164265698|NCT02559414|593342621|FG000|Overall Study|Other|0|||
164265699|NCT02559414|593342622|FG001|Overall Study|Other|1|||
164265700|NCT02559414|593342623|FG002|Overall Study|Other|1|||
164265701|NCT03369431|593342624|FG000|Overall Study|Lost to Follow-up|1|||
164265702|NCT03369431|593342625|FG001|Overall Study|Lost to Follow-up|3|||
164265703|NCT03369431|593342624|FG000|Overall Study|Withdrawal by Subject|2|||
164265704|NCT03369431|593342625|FG001|Overall Study|Withdrawal by Subject|3|||
164265705|NCT03369431|593342624|FG000|Overall Study|Protocol Violation|1|||
164265706|NCT03369431|593342625|FG001|Overall Study|Protocol Violation|1|||
164265707|NCT00004445|593342626|FG000|Overall Study|Physician Decision|2|||
164265708|NCT00004445|593342626|FG000|Overall Study|Withdrawal by Subject|1|||
164265709|NCT00076336|593342627|FG000|Overall Study|Death|13|||
164265710|NCT00076336|593342628|FG001|Overall Study|Death|17|||
164265711|NCT00076336|593342627|FG000|Overall Study|Adverse Event|4|||
164265712|NCT00076336|593342628|FG001|Overall Study|Adverse Event|4|||
164265713|NCT00076336|593342627|FG000|Overall Study|Lost to Follow-up|4|||
164265714|NCT00076336|593342628|FG001|Overall Study|Lost to Follow-up|4|||
164265715|NCT00076336|593342627|FG000|Overall Study|Non-Compliance|2|||
164265716|NCT00076336|593342628|FG001|Overall Study|Non-Compliance|0|||
164265717|NCT00076336|593342627|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
164265718|NCT00076336|593342628|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
164265719|NCT00076336|593342627|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
164265720|NCT00076336|593342628|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
164265721|NCT00076336|593342627|FG000|Overall Study|Liver Transplantation|3|||
164265722|NCT00076336|593342628|FG001|Overall Study|Liver Transplantation|3|||
164265723|NCT00076336|593342627|FG000|Overall Study|Virologic Breakthrough|14|||
164341731|NCT01819831|593627484|FG000|Overall Study|Withdrawal by Subject|1|||
164341732|NCT05074667|593627487|FG000|Overall Study|Death|1|||
164341733|NCT05074667|593627487|FG000|Overall Study|Withdrawal by Subject|4|||
164341734|NCT05074667|593627487|FG000|Overall Study|Lost to Follow-up|10|||
164341735|NCT02478632|593627492|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
164341736|NCT02478632|593627493|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
164341737|NCT02478632|593627492|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
164341738|NCT02478632|593627493|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
164341739|NCT02478632|593627492|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
164341740|NCT02478632|593627493|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
164341741|NCT01867424|593627494|FG000|Overall Study|Patient noncompliance|2|||
164341742|NCT01867424|593627495|FG001|Overall Study|Patient noncompliance|1|||
163997875|NCT03094195|592357219|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
163892006|NCT02038777|591976703|FG004|Overall Study|Randomized but not treated|0|||
163892007|NCT02038777|591976704|FG005|Overall Study|Randomized but not treated|0|||
163892008|NCT02038777|591976705|FG006|Overall Study|Randomized but not treated|0|||
163892009|NCT02038777|591976706|FG007|Overall Study|Randomized but not treated|0|||
163892010|NCT02038777|591976699|FG000|Overall Study|Started Chemotherapy|1|||
164265724|NCT00076336|593342628|FG001|Overall Study|Virologic Breakthrough|16|||
164265725|NCT00076336|593342627|FG000|Overall Study|Treatment failure|4|||
164265726|NCT00076336|593342628|FG001|Overall Study|Treatment failure|5|||
164265727|NCT02753127|593342634|FG000|Overall Study|Lost to Follow-up|13|||
164265728|NCT02753127|593342635|FG001|Overall Study|Lost to Follow-up|11|||
164265729|NCT02753127|593342634|FG000|Overall Study|Withdrawal by Subject|37|||
164265730|NCT02753127|593342635|FG001|Overall Study|Withdrawal by Subject|47|||
164265731|NCT02753127|593342634|FG000|Overall Study|Other|3|||
164265732|NCT02753127|593342635|FG001|Overall Study|Other|8|||
164265733|NCT02753127|593342634|FG000|Overall Study|Hospice|0|||
164265734|NCT02753127|593342635|FG001|Overall Study|Hospice|2|||
164265735|NCT01519674|593342640|FG000|Overall Study|Adverse Event|3|||
164265736|NCT01519674|593342641|FG001|Overall Study|Adverse Event|3|||
164265737|NCT01519674|593342642|FG002|Overall Study|Adverse Event|0|||
164265738|NCT01519674|593342640|FG000|Overall Study|Lack of Efficacy|1|||
164265739|NCT01519674|593342641|FG001|Overall Study|Lack of Efficacy|1|||
164265740|NCT01519674|593342642|FG002|Overall Study|Lack of Efficacy|1|||
164265741|NCT01519674|593342640|FG000|Overall Study|Protocol Violation|0|||
164265742|NCT01519674|593342641|FG001|Overall Study|Protocol Violation|3|||
164265743|NCT01519674|593342642|FG002|Overall Study|Protocol Violation|1|||
164265744|NCT01519674|593342640|FG000|Overall Study|Withdrawal Criteria|7|||
164265745|NCT01519674|593342641|FG001|Overall Study|Withdrawal Criteria|2|||
164265746|NCT01519674|593342642|FG002|Overall Study|Withdrawal Criteria|7|||
164265747|NCT01519674|593342640|FG000|Overall Study|Unsclassified|10|||
164265748|NCT01519674|593342641|FG001|Overall Study|Unsclassified|4|||
164265749|NCT01519674|593342642|FG002|Overall Study|Unsclassified|3|||
164265750|NCT02046174|593342646|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
164265751|NCT02046174|593342647|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
164265752|NCT00186537|593342649|FG000|Overall Study|Withdrawal by Subject|4|||
164265753|NCT00186537|593342650|FG001|Overall Study|Withdrawal by Subject|0|||
164265754|NCT00186537|593342651|FG002|Overall Study|Withdrawal by Subject|3|||
164265755|NCT00186537|593342649|FG000|Overall Study|ALT > 1.5 x ULN|3|||
164265756|NCT00186537|593342650|FG001|Overall Study|ALT > 1.5 x ULN|0|||
164265757|NCT00186537|593342651|FG002|Overall Study|ALT > 1.5 x ULN|0|||
164265758|NCT01146288|593342655|FG000|First Intervention(1 Day)|Adverse Event|0|||
164265759|NCT01146288|593342656|FG001|First Intervention(1 Day)|Adverse Event|1|||
164265760|NCT03630302|593342657|FG000|Surgery|hardware issue prevented LFP recordings|1|||
164265761|NCT03630302|593342657|FG000|3 Month Visit|Adverse Event|2|||
164265762|NCT03630302|593342657|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
164265763|NCT01135914|593342658|FG000|Overall Study|Withdrawal by Subject|1|||
164265764|NCT01135914|593342659|FG001|Overall Study|Withdrawal by Subject|3|||
164265765|NCT01135914|593342660|FG002|Overall Study|Withdrawal by Subject|6|||
164265766|NCT01135914|593342658|FG000|Overall Study|Lost to Follow-up|1|||
164265767|NCT01135914|593342659|FG001|Overall Study|Lost to Follow-up|0|||
164265768|NCT01135914|593342660|FG002|Overall Study|Lost to Follow-up|1|||
164265769|NCT01135914|593342658|FG000|Overall Study|Protocol Violation|0|||
164265770|NCT01135914|593342659|FG001|Overall Study|Protocol Violation|0|||
164265771|NCT01135914|593342660|FG002|Overall Study|Protocol Violation|3|||
164265772|NCT01135914|593342658|FG000|Overall Study|Lack of Efficacy|2|||
164265773|NCT01135914|593342659|FG001|Overall Study|Lack of Efficacy|1|||
164265774|NCT01135914|593342660|FG002|Overall Study|Lack of Efficacy|10|||
164265775|NCT01135914|593342658|FG000|Overall Study|Adverse Event|0|||
164265776|NCT01135914|593342659|FG001|Overall Study|Adverse Event|1|||
164265777|NCT01135914|593342660|FG002|Overall Study|Adverse Event|2|||
164265778|NCT00931801|593342663|FG000|Overall Study|Adverse Event|0|||
164265779|NCT00931801|593342664|FG001|Overall Study|Adverse Event|0|||
164265780|NCT00931801|593342665|FG002|Overall Study|Adverse Event|1|||
164265781|NCT00931801|593342663|FG000|Overall Study|Lost to Follow-up|0|||
164265782|NCT00931801|593342664|FG001|Overall Study|Lost to Follow-up|1|||
164265783|NCT00931801|593342665|FG002|Overall Study|Lost to Follow-up|0|||
164265784|NCT00931801|593342663|FG000|Overall Study|Withdrawal by Subject|1|||
164265785|NCT00931801|593342664|FG001|Overall Study|Withdrawal by Subject|0|||
164265786|NCT00931801|593342665|FG002|Overall Study|Withdrawal by Subject|0|||
164265787|NCT00931801|593342663|FG000|Overall Study|Confirmed Virologic Failure|0|||
164265788|NCT00931801|593342664|FG001|Overall Study|Confirmed Virologic Failure|0|||
164265789|NCT00931801|593342665|FG002|Overall Study|Confirmed Virologic Failure|3|||
164265790|NCT00746733|593342666|FG000|Second Intervention|Adverse Event|1|||
164265791|NCT00746733|593342667|FG001|Second Intervention|Adverse Event|0|||
164265792|NCT00746733|593342666|FG000|Third Intervention|Withdrawal by Subject|1|||
164265793|NCT00746733|593342667|FG001|Third Intervention|Withdrawal by Subject|1|||
164265794|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
164265795|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
164265796|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
164265797|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
164265798|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
164265799|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
164265800|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
164265801|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
164265802|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
164265803|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
164265804|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
164265805|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
164265806|NCT00610441|593342668|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
164265807|NCT00610441|593342669|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
164265808|NCT00610441|593342670|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
164265809|NCT00610441|593342671|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
164265810|NCT00610441|593342668|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
164265811|NCT00610441|593342669|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
164265812|NCT00610441|593342670|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
164265813|NCT00610441|593342671|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
164265814|NCT00610441|593342668|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
163892011|NCT02038777|591976700|FG001|Overall Study|Started Chemotherapy|0|||
163892012|NCT02038777|591976701|FG002|Overall Study|Started Chemotherapy|3|||
164265815|NCT00610441|593342669|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
164265816|NCT00610441|593342670|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
164265817|NCT00610441|593342671|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
164265818|NCT00610441|593342668|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
164265819|NCT00610441|593342669|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
164265820|NCT00610441|593342670|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
164265821|NCT00610441|593342671|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
164265822|NCT00610441|593342668|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
164265823|NCT00610441|593342669|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
164265824|NCT00610441|593342670|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
164265825|NCT00610441|593342671|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
164265826|NCT00610441|593342668|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
164265827|NCT00610441|593342669|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
164265828|NCT00610441|593342670|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
164265829|NCT00610441|593342671|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
164265830|NCT00334282|593342672|FG000|Overall Study|Lost to Follow-up|11|||
164265831|NCT00334282|593342673|FG001|Overall Study|Lost to Follow-up|5|||
164265832|NCT00334282|593342672|FG000|Overall Study|Withdrawal by Subject|17|||
164265833|NCT00334282|593342673|FG001|Overall Study|Withdrawal by Subject|3|||
164265834|NCT00334282|593342672|FG000|Overall Study|Death|194|||
164265835|NCT00334282|593342673|FG001|Overall Study|Death|100|||
164265836|NCT00837876|593342678|FG000|Overall Study|Death|2|||
164265837|NCT00837876|593342678|FG000|Overall Study|Adverse Event|7|||
164265838|NCT00837876|593342678|FG000|Overall Study|Physician Decision|1|||
164265839|NCT00837876|593342678|FG000|Overall Study|Withdrawal by Subject|3|||
164265840|NCT00837876|593342678|FG000|Overall Study|disease progression|24|||
164265841|NCT00276094|593342680|FG000|Overall Study|Adverse Event|15|||
164265842|NCT00276094|593342681|FG001|Overall Study|Adverse Event|13|||
164265843|NCT00276094|593342682|FG002|Overall Study|Adverse Event|11|||
163892013|NCT02038777|591976702|FG003|Overall Study|Started Chemotherapy|0|||
163892014|NCT02038777|591976703|FG004|Overall Study|Started Chemotherapy|0|||
163892015|NCT02038777|591976704|FG005|Overall Study|Started Chemotherapy|0|||
163892016|NCT02038777|591976705|FG006|Overall Study|Started Chemotherapy|0|||
163892017|NCT02038777|591976706|FG007|Overall Study|Started Chemotherapy|0|||
163892018|NCT02038777|591976699|FG000|Overall Study|participation terminated by sponsor|0|||
163892019|NCT02038777|591976700|FG001|Overall Study|participation terminated by sponsor|0|||
163892020|NCT02038777|591976701|FG002|Overall Study|participation terminated by sponsor|0|||
163892021|NCT02038777|591976702|FG003|Overall Study|participation terminated by sponsor|0|||
163892022|NCT02038777|591976703|FG004|Overall Study|participation terminated by sponsor|0|||
163892023|NCT02038777|591976704|FG005|Overall Study|participation terminated by sponsor|0|||
163892024|NCT02038777|591976705|FG006|Overall Study|participation terminated by sponsor|1|||
163892025|NCT02038777|591976706|FG007|Overall Study|participation terminated by sponsor|1|||
163892026|NCT03676192|591976711|FG000|Induction Study Period|Adverse Event|21|||
163892027|NCT03676192|591976712|FG001|Induction Study Period|Adverse Event|20|||
163892028|NCT03676192|591976711|FG000|Induction Study Period|Death|23|||
163892029|NCT03676192|591976712|FG001|Induction Study Period|Death|20|||
163892030|NCT03676192|591976711|FG000|Induction Study Period|Lost to Follow-up|3|||
163900162|NCT00115934|592005622|FG000|Overall Study|Lost to Follow-up|1|||
164265844|NCT00276094|593342680|FG000|Overall Study|Withdrawal by Subject|14|||
164265845|NCT00276094|593342681|FG001|Overall Study|Withdrawal by Subject|14|||
164265846|NCT00276094|593342682|FG002|Overall Study|Withdrawal by Subject|12|||
164265847|NCT00276094|593342680|FG000|Overall Study|Protocol Violation|16|||
164265848|NCT00276094|593342681|FG001|Overall Study|Protocol Violation|7|||
164265849|NCT00276094|593342682|FG002|Overall Study|Protocol Violation|10|||
164265850|NCT00276094|593342680|FG000|Overall Study|Lost to Follow-up|8|||
164265851|NCT00276094|593342681|FG001|Overall Study|Lost to Follow-up|6|||
164265852|NCT00276094|593342682|FG002|Overall Study|Lost to Follow-up|4|||
164265853|NCT00276094|593342680|FG000|Overall Study|Other-Subject moved out of country|1|||
164265854|NCT00276094|593342681|FG001|Overall Study|Other-Subject moved out of country|0|||
164265855|NCT00276094|593342682|FG002|Overall Study|Other-Subject moved out of country|0|||
164265856|NCT00276094|593342680|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
164265857|NCT00276094|593342681|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
164265858|NCT00276094|593342682|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
164265859|NCT00276094|593342680|FG000|Overall Study|Other-Lack of efficacy|1|||
164265860|NCT00276094|593342681|FG001|Overall Study|Other-Lack of efficacy|0|||
164265861|NCT00276094|593342682|FG002|Overall Study|Other-Lack of efficacy|0|||
164265862|NCT00276094|593342680|FG000|Overall Study|Other-Refused follow-up visit|1|||
164265863|NCT00276094|593342681|FG001|Overall Study|Other-Refused follow-up visit|0|||
164265864|NCT00276094|593342682|FG002|Overall Study|Other-Refused follow-up visit|0|||
164265865|NCT00276094|593342680|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
164265866|NCT00276094|593342681|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
164265867|NCT00276094|593342682|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
164265868|NCT00276094|593342680|FG000|Overall Study|Other-Relocation|0|||
164265869|NCT00276094|593342681|FG001|Overall Study|Other-Relocation|1|||
164265870|NCT00276094|593342682|FG002|Overall Study|Other-Relocation|0|||
164341743|NCT04645953|593627496|FG000|Overall Study|Lost to Follow-up|2|||
164341744|NCT04645953|593627497|FG001|Overall Study|Lost to Follow-up|1|||
164341745|NCT04645953|593627498|FG002|Overall Study|Lost to Follow-up|1|||
164341746|NCT04645953|593627496|FG000|Overall Study|Withdrawal by Subject|0|||
164341747|NCT04645953|593627497|FG001|Overall Study|Withdrawal by Subject|1|||
164341748|NCT04645953|593627498|FG002|Overall Study|Withdrawal by Subject|0|||
164341749|NCT04645953|593627496|FG000|Overall Study|Physician Decision|0|||
164341750|NCT04645953|593627497|FG001|Overall Study|Physician Decision|1|||
164341751|NCT04645953|593627498|FG002|Overall Study|Physician Decision|0|||
164341752|NCT04645953|593627496|FG000|Overall Study|Discontinued Prior to Dosing|0|||
163997876|NCT03094195|592357212|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163997877|NCT03094195|592357213|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163997878|NCT03094195|592357214|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
163997879|NCT03094195|592357215|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163997880|NCT03094195|592357216|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163997881|NCT03094195|592357217|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163997882|NCT03094195|592357218|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164265871|NCT00276094|593342680|FG000|Overall Study|Other-Study medication lost|0|||
164265872|NCT00276094|593342681|FG001|Overall Study|Other-Study medication lost|0|||
164265873|NCT00276094|593342682|FG002|Overall Study|Other-Study medication lost|1|||
164265874|NCT00787137|593342683|FG000|Overall Study|Study Termination|0|||
164265875|NCT00787137|593342684|FG001|Overall Study|Study Termination|0|||
164341753|NCT04645953|593627497|FG001|Overall Study|Discontinued Prior to Dosing|0|||
164341754|NCT04645953|593627498|FG002|Overall Study|Discontinued Prior to Dosing|2|||
164265876|NCT00787137|593342685|FG002|Overall Study|Study Termination|1|||
164265877|NCT02075632|593342689|FG000|Overall Study|Adverse Event|1|||
164265878|NCT02075632|593342690|FG001|Overall Study|Adverse Event|1|||
164341755|NCT04613375|593627499|FG000|Overall Study|Death|198|||
164341756|NCT04613375|593627499|FG000|Overall Study|Withdrawal by Subject|3|||
164341757|NCT00434954|593627503|FG000|Overall Study|Adverse Event|17|||
164265879|NCT02075632|593342689|FG000|Overall Study|Lost to Follow-up|0|||
164265880|NCT02075632|593342690|FG001|Overall Study|Lost to Follow-up|3|||
164265881|NCT02075632|593342689|FG000|Overall Study|Withdrawal by Subject|0|||
164265882|NCT02075632|593342690|FG001|Overall Study|Withdrawal by Subject|1|||
164265883|NCT03464422|593342691|FG000|Overall Study|Lost to Follow-up|2|||
164265884|NCT03464422|593342691|FG000|Overall Study|Withdrawal by Subject|2|||
164265885|NCT01628367|593342695|FG000|Overall Study|Adverse Event|1|||
164265886|NCT01628367|593342696|FG001|Overall Study|Adverse Event|0|||
164265887|NCT00740714|593342697|FG000|Overall Study|Withdrawal by Subject|17|||
164265888|NCT00740714|593342698|FG001|Overall Study|Withdrawal by Subject|19|||
164265889|NCT00740714|593342699|FG002|Overall Study|Withdrawal by Subject|29|||
164265890|NCT00394901|593342703|FG000|Baseline Phase|Protocol Violation|0|||
164265891|NCT00394901|593342704|FG001|Baseline Phase|Protocol Violation|0|||
164265892|NCT00394901|593342705|FG002|Baseline Phase|Protocol Violation|1|||
164265893|NCT00394901|593342706|FG003|Baseline Phase|Protocol Violation|0|||
164265894|NCT00394901|593342703|FG000|Double-blind Phase|Adverse Event|5|||
164265895|NCT00394901|593342704|FG001|Double-blind Phase|Adverse Event|7|||
164265896|NCT00394901|593342705|FG002|Double-blind Phase|Adverse Event|16|||
164265897|NCT00394901|593342706|FG003|Double-blind Phase|Adverse Event|20|||
164265898|NCT00394901|593342703|FG000|Double-blind Phase|Lack of Efficacy|6|||
164265899|NCT00394901|593342704|FG001|Double-blind Phase|Lack of Efficacy|4|||
164265900|NCT00394901|593342705|FG002|Double-blind Phase|Lack of Efficacy|1|||
164265901|NCT00394901|593342706|FG003|Double-blind Phase|Lack of Efficacy|3|||
164265902|NCT00394901|593342703|FG000|Double-blind Phase|Withdrawal by Subject|2|||
164265903|NCT00394901|593342704|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164265904|NCT00394901|593342705|FG002|Double-blind Phase|Withdrawal by Subject|0|||
164265905|NCT00394901|593342706|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164265906|NCT00394901|593342703|FG000|Double-blind Phase|Lost to Follow-up|0|||
164265907|NCT00394901|593342704|FG001|Double-blind Phase|Lost to Follow-up|0|||
164265908|NCT00394901|593342705|FG002|Double-blind Phase|Lost to Follow-up|0|||
164265909|NCT00394901|593342706|FG003|Double-blind Phase|Lost to Follow-up|1|||
164265910|NCT00394901|593342703|FG000|Double-blind Phase|Protocol Violation|0|||
164265911|NCT00394901|593342704|FG001|Double-blind Phase|Protocol Violation|0|||
164265912|NCT00394901|593342705|FG002|Double-blind Phase|Protocol Violation|0|||
164265913|NCT00394901|593342706|FG003|Double-blind Phase|Protocol Violation|1|||
164265914|NCT00394901|593342703|FG000|Double-blind Phase|Death|1|||
164265915|NCT00394901|593342704|FG001|Double-blind Phase|Death|0|||
164265916|NCT00394901|593342705|FG002|Double-blind Phase|Death|0|||
164265917|NCT00394901|593342706|FG003|Double-blind Phase|Death|0|||
164265918|NCT00394901|593342703|FG000|Double-blind Phase|Subject's Personal Reason|1|||
164265919|NCT00394901|593342704|FG001|Double-blind Phase|Subject's Personal Reason|0|||
164265920|NCT00394901|593342705|FG002|Double-blind Phase|Subject's Personal Reason|0|||
164265921|NCT00394901|593342706|FG003|Double-blind Phase|Subject's Personal Reason|1|||
164265922|NCT00394901|593342703|FG000|Double-blind Phase|Lack of Compliance|0|||
164265923|NCT00394901|593342704|FG001|Double-blind Phase|Lack of Compliance|3|||
164265924|NCT00394901|593342705|FG002|Double-blind Phase|Lack of Compliance|0|||
164265925|NCT00394901|593342706|FG003|Double-blind Phase|Lack of Compliance|0|||
164265926|NCT00394901|593342703|FG000|Double-blind Phase|Entry into another study was found|0|||
164265927|NCT00394901|593342704|FG001|Double-blind Phase|Entry into another study was found|0|||
164265928|NCT00394901|593342705|FG002|Double-blind Phase|Entry into another study was found|1|||
164265929|NCT00394901|593342706|FG003|Double-blind Phase|Entry into another study was found|0|||
164265930|NCT00394901|593342703|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
164265931|NCT00394901|593342704|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
164265932|NCT00394901|593342705|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
164265933|NCT00394901|593342706|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
163892031|NCT03676192|591976712|FG001|Induction Study Period|Lost to Follow-up|3|||
163892032|NCT03676192|591976711|FG000|Induction Study Period|Physician Decision|6|||
164265934|NCT01886690|593342717|FG000|Overall Study|Protocol Violation|0|||
164265935|NCT01886690|593342718|FG001|Overall Study|Protocol Violation|1|||
164265936|NCT01886690|593342717|FG000|Overall Study|Personal Reasons|0|||
164265937|NCT01886690|593342718|FG001|Overall Study|Personal Reasons|1|||
164265938|NCT01439074|593342719|FG000|Overall Study|Lost to Follow-up|3|||
164265939|NCT01439074|593342720|FG001|Overall Study|Lost to Follow-up|4|||
164265940|NCT01439074|593342719|FG000|Overall Study|Subject shedding|1|||
164265941|NCT01439074|593342720|FG001|Overall Study|Subject shedding|0|||
164265942|NCT01439074|593342719|FG000|Overall Study|Withdrawal by Subject|1|||
164265943|NCT01439074|593342720|FG001|Overall Study|Withdrawal by Subject|5|||
164265944|NCT01439074|593342719|FG000|Overall Study|Other|4|||
164265945|NCT01439074|593342720|FG001|Overall Study|Other|4|||
164265946|NCT02463032|593342721|FG000|Overall Study|Lack of Efficacy|61|||
164265947|NCT02463032|593342722|FG001|Overall Study|Lack of Efficacy|50|||
164265948|NCT02463032|593342721|FG000|Overall Study|Death|8|||
164265949|NCT02463032|593342722|FG001|Overall Study|Death|8|||
164265950|NCT02463032|593342721|FG000|Overall Study|Adverse Event|2|||
164265951|NCT02463032|593342722|FG001|Overall Study|Adverse Event|6|||
164265952|NCT00612508|593342723|FG000|Overall Study|Withdrawal by Subject|3|||
164265953|NCT00612508|593342724|FG001|Overall Study|Withdrawal by Subject|4|||
164265954|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
164265955|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
164265956|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
164265957|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
164265958|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
164265959|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
164265960|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
164265961|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
164265962|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
164265963|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
164265964|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
164265965|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
164265966|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
164265967|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
164265968|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
164265969|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
164265970|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
164265971|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
164265972|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
164265973|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
164265974|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
164265975|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
164265976|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
164265977|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
164265978|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
164265979|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
164265980|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
164265981|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
164265982|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
164265983|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
164265984|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
164265985|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
164265986|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
164265987|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
164265988|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
164265989|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
164265990|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
164265991|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
164265992|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
164265993|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
164265994|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
164265995|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
164265996|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
163892033|NCT03676192|591976712|FG001|Induction Study Period|Physician Decision|3|||
163892034|NCT03676192|591976711|FG000|Induction Study Period|Progressive Disease|32|||
163892035|NCT03676192|591976712|FG001|Induction Study Period|Progressive Disease|21|||
163892036|NCT03676192|591976711|FG000|Induction Study Period|Protocol Violation|1|||
163892037|NCT03676192|591976712|FG001|Induction Study Period|Protocol Violation|2|||
163892038|NCT03676192|591976711|FG000|Induction Study Period|Withdrawal by Subject|20|||
163892039|NCT03676192|591976712|FG001|Induction Study Period|Withdrawal by Subject|15|||
163892040|NCT03386578|591976714|FG000|PK Component|Lost to Follow-up|0|||
163997883|NCT03094195|592357219|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
163997884|NCT03094195|592357212|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164265997|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
164265998|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
164265999|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
164266000|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
164266001|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
164266002|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
164266003|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
164266004|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
164266005|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
164266006|NCT02008357|593342725|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
164266007|NCT02008357|593342726|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
164266008|NCT02008357|593342725|FG000|Open-label Extension Period|Adverse Event|8|||
164266009|NCT02008357|593342726|FG001|Open-label Extension Period|Adverse Event|7|||
164266010|NCT02008357|593342725|FG000|Open-label Extension Period|Death|7|||
164266011|NCT02008357|593342726|FG001|Open-label Extension Period|Death|4|||
164266012|NCT02008357|593342725|FG000|Open-label Extension Period|Lack of Efficacy|9|||
164266013|NCT02008357|593342726|FG001|Open-label Extension Period|Lack of Efficacy|5|||
164266014|NCT02008357|593342725|FG000|Open-label Extension Period|Lost to Follow-up|2|||
164266015|NCT02008357|593342726|FG001|Open-label Extension Period|Lost to Follow-up|2|||
164266016|NCT02008357|593342725|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
164266017|NCT02008357|593342726|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
164266018|NCT02008357|593342725|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
164266019|NCT02008357|593342726|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
164266020|NCT02008357|593342725|FG000|Open-label Extension Period|Safety Risk|2|||
164266021|NCT02008357|593342726|FG001|Open-label Extension Period|Safety Risk|1|||
164266022|NCT02008357|593342725|FG000|Open-label Extension Period|Non-Compliance|0|||
164266023|NCT02008357|593342726|FG001|Open-label Extension Period|Non-Compliance|1|||
164266024|NCT02008357|593342725|FG000|Open-label Extension Period|Investigator Recommendation|0|||
163997885|NCT03094195|592357213|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
163997886|NCT03094195|592357214|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
164266025|NCT02008357|593342726|FG001|Open-label Extension Period|Investigator Recommendation|1|||
164266026|NCT02008357|593342725|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
164266027|NCT02008357|593342726|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
164266028|NCT02008357|593342725|FG000|Open-label Extension Period|Coordinating Center Request|2|||
164266029|NCT02008357|593342726|FG001|Open-label Extension Period|Coordinating Center Request|4|||
164266030|NCT02008357|593342725|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
164266031|NCT02008357|593342726|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
164266032|NCT02008357|593342725|FG000|Open-label Extension Period|Study Ended|20|||
164266033|NCT02008357|593342726|FG001|Open-label Extension Period|Study Ended|25|||
164266034|NCT02008357|593342725|FG000|Open-label Extension Period|Personal Reasons|0|||
164266035|NCT02008357|593342726|FG001|Open-label Extension Period|Personal Reasons|1|||
164266036|NCT02008357|593342725|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
164266037|NCT02008357|593342726|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
164266038|NCT02008357|593342725|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
164266039|NCT02008357|593342726|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
164266040|NCT02008357|593342725|FG000|Open-label Extension Period|Other|2|||
164266041|NCT02008357|593342726|FG001|Open-label Extension Period|Other|0|||
164266042|NCT02312219|593342727|FG000|Overall Study|Withdrawal by Subject|1|||
163997887|NCT03094195|592357215|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164266043|NCT02312219|593342728|FG001|Overall Study|Withdrawal by Subject|2|||
164266044|NCT02312219|593342727|FG000|Overall Study|could not schedule imaging in time|0|||
164266045|NCT02312219|593342728|FG001|Overall Study|could not schedule imaging in time|2|||
164266046|NCT02312219|593342727|FG000|Overall Study|Other|0|||
164266047|NCT02312219|593342728|FG001|Overall Study|Other|1|||
164266048|NCT02312219|593342727|FG000|Overall Study|Not randomized. Ineligible|0|||
164266049|NCT02312219|593342728|FG001|Overall Study|Not randomized. Ineligible|1|||
164266050|NCT04941807|593342729|FG000|Overall Study|Lost to Follow-up|1|||
164341758|NCT00434954|593627504|FG001|Overall Study|Adverse Event|2|||
163997888|NCT03094195|592357216|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164341759|NCT00434954|593627503|FG000|Overall Study|Entry criteria not met|14|||
164341760|NCT00434954|593627504|FG001|Overall Study|Entry criteria not met|16|||
164341761|NCT00434954|593627503|FG000|Overall Study|Lost to Follow-up|0|||
164341762|NCT00434954|593627504|FG001|Overall Study|Lost to Follow-up|1|||
164341763|NCT00434954|593627503|FG000|Overall Study|Physician Decision|6|||
164341764|NCT00434954|593627504|FG001|Overall Study|Physician Decision|3|||
164266051|NCT04941807|593342730|FG001|Overall Study|Lost to Follow-up|1|||
164266052|NCT01100567|593342731|FG000|Overall Study|Withdrawal by Subject|5|||
164266053|NCT01100567|593342732|FG001|Overall Study|Withdrawal by Subject|8|||
164266054|NCT01100567|593342731|FG000|Overall Study|Early Hospital Discharge|6|||
164266055|NCT01100567|593342732|FG001|Overall Study|Early Hospital Discharge|4|||
164266056|NCT01100567|593342731|FG000|Overall Study|Lost to Follow-up|1|||
164266057|NCT01100567|593342732|FG001|Overall Study|Lost to Follow-up|2|||
164266058|NCT01100567|593342731|FG000|Overall Study|Physician Decision|0|||
164266059|NCT01100567|593342732|FG001|Overall Study|Physician Decision|1|||
164266060|NCT01100567|593342731|FG000|Overall Study|Deemed ineligible after consent|0|||
164266061|NCT01100567|593342732|FG001|Overall Study|Deemed ineligible after consent|1|||
164266062|NCT02741570|593342733|FG000|Pre-Treatment Period|Other reasons|0|||
164266063|NCT02741570|593342734|FG001|Pre-Treatment Period|Other reasons|3|||
164266064|NCT02741570|593342733|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
164266065|NCT02741570|593342734|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
164266066|NCT02741570|593342733|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
164266067|NCT02741570|593342734|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
164266068|NCT02741570|593342733|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
164266069|NCT02741570|593342734|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
164266070|NCT02741570|593342733|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
164266071|NCT02741570|593342734|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
164266072|NCT02741570|593342733|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
164266073|NCT02741570|593342734|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
164266074|NCT02741570|593342733|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
164266075|NCT02741570|593342734|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164266076|NCT02741570|593342733|FG000|Pre-Treatment Period|Death|0|||
164266077|NCT02741570|593342734|FG001|Pre-Treatment Period|Death|1|||
164266078|NCT02741570|593342733|FG000|Pre-Treatment Period|Disease progression|0|||
164266079|NCT02741570|593342734|FG001|Pre-Treatment Period|Disease progression|1|||
164266080|NCT02741570|593342733|FG000|Treatment Period|Other reasons|47|||
164266081|NCT02741570|593342734|FG001|Treatment Period|Other reasons|12|||
164266082|NCT02741570|593342733|FG000|Treatment Period|Poor/non-compliance|0|||
164266083|NCT02741570|593342734|FG001|Treatment Period|Poor/non-compliance|2|||
164266084|NCT02741570|593342733|FG000|Treatment Period|Maximum clinical benefit|4|||
164266085|NCT02741570|593342734|FG001|Treatment Period|Maximum clinical benefit|6|||
164266086|NCT02741570|593342733|FG000|Treatment Period|Lost to Follow-up|1|||
164266087|NCT02741570|593342734|FG001|Treatment Period|Lost to Follow-up|3|||
164266088|NCT02741570|593342733|FG000|Treatment Period|Participant withdrew consent|9|||
164266089|NCT02741570|593342734|FG001|Treatment Period|Participant withdrew consent|13|||
164266090|NCT02741570|593342733|FG000|Treatment Period|Participant request to discontinue treatment|8|||
164266091|NCT02741570|593342734|FG001|Treatment Period|Participant request to discontinue treatment|23|||
164266092|NCT02741570|593342733|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
164266093|NCT02741570|593342734|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
164266094|NCT02741570|593342733|FG000|Treatment Period|Death|9|||
164266095|NCT02741570|593342734|FG001|Treatment Period|Death|7|||
164266096|NCT02741570|593342733|FG000|Treatment Period|Study drug toxicity|55|||
164266097|NCT02741570|593342734|FG001|Treatment Period|Study drug toxicity|47|||
164266098|NCT02741570|593342733|FG000|Treatment Period|Disease progression|294|||
164266099|NCT02741570|593342734|FG001|Treatment Period|Disease progression|301|||
164266100|NCT02741570|593342733|FG000|Treatment Period|Administrative reason by sponsor|0|||
164266101|NCT02741570|593342734|FG001|Treatment Period|Administrative reason by sponsor|1|||
164266102|NCT00946322|593342737|FG000|Pre-treatment|participant failure to follow up|1|||
164266103|NCT00946322|593342737|FG000|Post-treatment|participant failure to follow up|2|||
164266104|NCT03352453|593342741|FG000|Overall Study|Miscellaneous Reasons|1|||
164266105|NCT03352453|593342742|FG001|Overall Study|Miscellaneous Reasons|2|||
164266106|NCT03352453|593342741|FG000|Overall Study|Lack of Efficacy|1|||
164266107|NCT03352453|593342742|FG001|Overall Study|Lack of Efficacy|0|||
164266108|NCT03352453|593342741|FG000|Overall Study|Withdrawal by Subject|8|||
164266109|NCT03352453|593342742|FG001|Overall Study|Withdrawal by Subject|14|||
164266110|NCT03352453|593342741|FG000|Overall Study|Study Terminated by Sponsor|2|||
164266111|NCT03352453|593342742|FG001|Overall Study|Study Terminated by Sponsor|1|||
163997889|NCT03094195|592357217|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163997890|NCT03094195|592357218|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163997891|NCT03094195|592357219|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
163997892|NCT01651780|592357220|FG000|Overall Study|Physician decision: No 30-day visit|2|||
163997893|NCT01651780|592357221|FG001|Overall Study|Physician decision: No 30-day visit|1|||
163997894|NCT01651780|592357220|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
164266112|NCT03352453|593342741|FG000|Overall Study|Protocol Deviation|1|||
164266113|NCT03352453|593342742|FG001|Overall Study|Protocol Deviation|0|||
164266114|NCT03352453|593342741|FG000|Overall Study|Lost to Follow-up|7|||
164266115|NCT03352453|593342742|FG001|Overall Study|Lost to Follow-up|6|||
164266116|NCT03352453|593342741|FG000|Overall Study|Adverse Event|2|||
164266117|NCT03352453|593342742|FG001|Overall Study|Adverse Event|9|||
164266118|NCT03158272|593342745|FG000|Overall Study|Disease progression|3|||
164266119|NCT03158272|593342746|FG001|Overall Study|Disease progression|3|||
164266120|NCT03158272|593342747|FG002|Overall Study|Disease progression|4|||
164266121|NCT03158272|593342748|FG003|Overall Study|Disease progression|6|||
164266122|NCT03158272|593342745|FG000|Overall Study|Death|0|||
164266123|NCT03158272|593342746|FG001|Overall Study|Death|0|||
164266124|NCT03158272|593342747|FG002|Overall Study|Death|1|||
164266125|NCT03158272|593342748|FG003|Overall Study|Death|0|||
164266126|NCT03158272|593342745|FG000|Overall Study|Other reasons|0|||
164266127|NCT03158272|593342746|FG001|Overall Study|Other reasons|0|||
164266128|NCT03158272|593342747|FG002|Overall Study|Other reasons|1|||
164266129|NCT03158272|593342748|FG003|Overall Study|Other reasons|0|||
164266130|NCT03158272|593342745|FG000|Overall Study|Adverse event unrelated to the drug|0|||
164266131|NCT03158272|593342746|FG001|Overall Study|Adverse event unrelated to the drug|1|||
164266132|NCT03158272|593342747|FG002|Overall Study|Adverse event unrelated to the drug|0|||
164266133|NCT03158272|593342748|FG003|Overall Study|Adverse event unrelated to the drug|0|||
164266134|NCT00514020|593342749|FG000|Overall Study|Adverse Event|6|||
164266135|NCT00514020|593342749|FG000|Overall Study|Withdrawal by Subject|3|||
164266136|NCT00514020|593342749|FG000|Overall Study|Physician Decision|1|||
164266137|NCT00514020|593342749|FG000|Overall Study|disease progression|9|||
164266138|NCT00514020|593342749|FG000|Overall Study|other complicating disease|2|||
164266139|NCT00514020|593342749|FG000|Overall Study|patient went to radiation treatment|1|||
164266140|NCT00514020|593342749|FG000|Overall Study|"patients moved to the no tx group"|6|||
164266141|NCT01688921|593342750|FG000|Overall Study|Lost to Follow-up|7|||
164266142|NCT01688921|593342751|FG001|Overall Study|Lost to Follow-up|13|||
164266143|NCT01688921|593342750|FG000|Overall Study|Physician Decision|6|||
164266144|NCT01688921|593342751|FG001|Overall Study|Physician Decision|1|||
164266145|NCT01688921|593342750|FG000|Overall Study|Protocol Violation|0|||
164266146|NCT01688921|593342751|FG001|Overall Study|Protocol Violation|1|||
164266147|NCT01688921|593342750|FG000|Overall Study|informed consent|3|||
164266148|NCT01688921|593342751|FG001|Overall Study|informed consent|0|||
164266149|NCT01048866|593342759|FG000|Overall Study|Adverse Event|1|||
164266150|NCT01048866|593342760|FG001|Overall Study|Adverse Event|0|||
164266151|NCT01048866|593342759|FG000|Overall Study|Protocol Violation|1|||
164266152|NCT01048866|593342760|FG001|Overall Study|Protocol Violation|0|||
164266153|NCT01048866|593342759|FG000|Overall Study|Physician Decision|1|||
164266154|NCT01048866|593342760|FG001|Overall Study|Physician Decision|0|||
164266155|NCT01048866|593342759|FG000|Overall Study|Withdrawal by Subject|0|||
164266156|NCT01048866|593342760|FG001|Overall Study|Withdrawal by Subject|2|||
164266157|NCT01048866|593342759|FG000|Overall Study|Lost to Follow-up|0|||
164266158|NCT01048866|593342760|FG001|Overall Study|Lost to Follow-up|2|||
164266159|NCT01048866|593342759|FG000|Overall Study|Other|1|||
164266160|NCT01048866|593342760|FG001|Overall Study|Other|1|||
164266161|NCT03582813|593342761|FG000|Overall Study|Lost to Follow-up|18|||
164266162|NCT03582813|593342762|FG001|Overall Study|Lost to Follow-up|21|||
164266163|NCT03582813|593342761|FG000|Overall Study|Withdrawal by Subject|1|||
164266164|NCT03582813|593342762|FG001|Overall Study|Withdrawal by Subject|0|||
164266165|NCT02525094|593342767|FG000|Overall Study|Lost to Follow-up|2|||
164266166|NCT02525094|593342768|FG001|Overall Study|Lost to Follow-up|1|||
164266167|NCT02525094|593342767|FG000|Overall Study|Withdrawal by Subject|5|||
164266168|NCT02525094|593342768|FG001|Overall Study|Withdrawal by Subject|6|||
164266169|NCT02525094|593342767|FG000|Overall Study|Not Treated|1|||
164266170|NCT02525094|593342768|FG001|Overall Study|Not Treated|1|||
164266171|NCT01751776|593342771|FG000|Overall Study|Adverse Event|0|||
164341765|NCT00434954|593627503|FG000|Overall Study|Protocol Violation|36|||
164341766|NCT00434954|593627504|FG001|Overall Study|Protocol Violation|27|||
164341767|NCT00434954|593627503|FG000|Overall Study|Sponsor decision|1|||
164341768|NCT00434954|593627504|FG001|Overall Study|Sponsor decision|0|||
164341769|NCT00434954|593627503|FG000|Overall Study|Subject decision|8|||
164341770|NCT00434954|593627504|FG001|Overall Study|Subject decision|22|||
164341771|NCT00002651|593627505|FG000|Induction|Adverse Event|44|||
164341772|NCT00002651|593627506|FG001|Induction|Adverse Event|0|||
164341773|NCT00002651|593627507|FG002|Induction|Adverse Event|0|||
164266172|NCT01751776|593342772|FG001|Overall Study|Adverse Event|0|||
164266173|NCT01751776|593342773|FG002|Overall Study|Adverse Event|0|||
164266174|NCT01751776|593342774|FG003|Overall Study|Adverse Event|0|||
164266175|NCT01751776|593342775|FG004|Overall Study|Adverse Event|0|||
164266176|NCT01751776|593342776|FG005|Overall Study|Adverse Event|0|||
164266177|NCT01751776|593342777|FG006|Overall Study|Adverse Event|4|||
164266178|NCT01751776|593342778|FG007|Overall Study|Adverse Event|2|||
164266179|NCT01751776|593342771|FG000|Overall Study|Consent withdrawn|0|||
164266180|NCT01751776|593342772|FG001|Overall Study|Consent withdrawn|0|||
164266181|NCT01751776|593342773|FG002|Overall Study|Consent withdrawn|0|||
164266182|NCT01751776|593342774|FG003|Overall Study|Consent withdrawn|0|||
164266183|NCT01751776|593342775|FG004|Overall Study|Consent withdrawn|0|||
164266184|NCT01751776|593342776|FG005|Overall Study|Consent withdrawn|0|||
164266185|NCT01751776|593342777|FG006|Overall Study|Consent withdrawn|0|||
164266186|NCT01751776|593342778|FG007|Overall Study|Consent withdrawn|1|||
164341774|NCT00002651|593627505|FG000|Induction|Refusal unrelated to adverse event|50|||
164341775|NCT00002651|593627506|FG001|Induction|Refusal unrelated to adverse event|0|||
164266187|NCT01751776|593342771|FG000|Overall Study|Other reason not specified above|0|||
164266188|NCT01751776|593342772|FG001|Overall Study|Other reason not specified above|0|||
164266189|NCT01751776|593342773|FG002|Overall Study|Other reason not specified above|0|||
164266190|NCT01751776|593342774|FG003|Overall Study|Other reason not specified above|0|||
164266191|NCT01751776|593342775|FG004|Overall Study|Other reason not specified above|0|||
164266192|NCT01751776|593342776|FG005|Overall Study|Other reason not specified above|0|||
164266193|NCT01751776|593342777|FG006|Overall Study|Other reason not specified above|0|||
164266194|NCT01751776|593342778|FG007|Overall Study|Other reason not specified above|1|||
164266195|NCT03172130|593344409|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
164266196|NCT03172130|593344410|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
164266197|NCT00262847|593344421|FG000|Overall Study|Disease Progression|309|||
164266198|NCT00262847|593344422|FG001|Overall Study|Disease Progression|274|||
164266199|NCT00262847|593344423|FG002|Overall Study|Disease Progression|195|||
164266200|NCT00262847|593344421|FG000|Overall Study|Patient Refusal|41|||
164266201|NCT00262847|593344422|FG001|Overall Study|Patient Refusal|52|||
164266202|NCT00262847|593344423|FG002|Overall Study|Patient Refusal|47|||
164266203|NCT00262847|593344421|FG000|Overall Study|Adverse Event|74|||
164266204|NCT00262847|593344422|FG001|Overall Study|Adverse Event|88|||
164266205|NCT00262847|593344423|FG002|Overall Study|Adverse Event|108|||
164266206|NCT00262847|593344421|FG000|Overall Study|Death|8|||
164266207|NCT00262847|593344422|FG001|Overall Study|Death|8|||
164266208|NCT00262847|593344423|FG002|Overall Study|Death|11|||
164266209|NCT00262847|593344421|FG000|Overall Study|Concomitant disease|3|||
164266210|NCT00262847|593344422|FG001|Overall Study|Concomitant disease|2|||
164266211|NCT00262847|593344423|FG002|Overall Study|Concomitant disease|4|||
164266212|NCT00262847|593344421|FG000|Overall Study|Other Reasons|79|||
164266213|NCT00262847|593344422|FG001|Overall Study|Other Reasons|88|||
164266214|NCT00262847|593344423|FG002|Overall Study|Other Reasons|27|||
164266215|NCT00262847|593344421|FG000|Overall Study|Did not receive study treatment|4|||
164266216|NCT00262847|593344422|FG001|Overall Study|Did not receive study treatment|1|||
164266217|NCT00262847|593344423|FG002|Overall Study|Did not receive study treatment|4|||
164266218|NCT00387647|593344424|FG000|Overall Study|Death|18|||
164266219|NCT01825941|593344425|FG000|Overall Study|Lost to Follow-up|4|||
164266220|NCT01825941|593344426|FG001|Overall Study|Lost to Follow-up|1|||
164266221|NCT00528996|593344427|FG000|Overall Study|Other reasons than listing|6|||
164266222|NCT00528996|593344428|FG001|Overall Study|Other reasons than listing|7|||
164266223|NCT00528996|593344429|FG002|Overall Study|Other reasons than listing|14|||
164266224|NCT00528996|593344430|FG003|Overall Study|Other reasons than listing|11|||
164266225|NCT00528996|593344431|FG004|Overall Study|Other reasons than listing|5|||
164266226|NCT00528996|593344427|FG000|Overall Study|Refused continue medication|16|||
164266227|NCT00528996|593344428|FG001|Overall Study|Refused continue medication|0|||
164266228|NCT00528996|593344429|FG002|Overall Study|Refused continue medication|3|||
164266229|NCT00528996|593344430|FG003|Overall Study|Refused continue medication|3|||
164266230|NCT00528996|593344431|FG004|Overall Study|Refused continue medication|6|||
164266231|NCT00528996|593344427|FG000|Overall Study|Lost to Follow-up|2|||
164266232|NCT00528996|593344428|FG001|Overall Study|Lost to Follow-up|0|||
164266233|NCT00528996|593344429|FG002|Overall Study|Lost to Follow-up|4|||
164266234|NCT00528996|593344430|FG003|Overall Study|Lost to Follow-up|1|||
164266235|NCT00528996|593344431|FG004|Overall Study|Lost to Follow-up|3|||
164266236|NCT00528996|593344427|FG000|Overall Study|Protocol Violation|1|||
164266237|NCT00528996|593344428|FG001|Overall Study|Protocol Violation|2|||
164266238|NCT00528996|593344429|FG002|Overall Study|Protocol Violation|3|||
164266239|NCT00528996|593344430|FG003|Overall Study|Protocol Violation|3|||
164266240|NCT00528996|593344431|FG004|Overall Study|Protocol Violation|2|||
164266241|NCT00528996|593344427|FG000|Overall Study|Lack of Efficacy|7|||
164266242|NCT00528996|593344428|FG001|Overall Study|Lack of Efficacy|2|||
164266243|NCT00528996|593344429|FG002|Overall Study|Lack of Efficacy|1|||
164266244|NCT00528996|593344430|FG003|Overall Study|Lack of Efficacy|3|||
164266245|NCT00528996|593344431|FG004|Overall Study|Lack of Efficacy|3|||
164266246|NCT00528996|593344427|FG000|Overall Study|Adverse Event|32|||
164266247|NCT00528996|593344428|FG001|Overall Study|Adverse Event|13|||
164266248|NCT00528996|593344429|FG002|Overall Study|Adverse Event|18|||
164266249|NCT00528996|593344430|FG003|Overall Study|Adverse Event|29|||
164266250|NCT00528996|593344431|FG004|Overall Study|Adverse Event|18|||
164266251|NCT03495102|593344432|FG000|Overall Study|Adverse Event|5|||
164266252|NCT03495102|593344433|FG001|Overall Study|Adverse Event|7|||
164266253|NCT03495102|593344434|FG002|Overall Study|Adverse Event|10|||
164266254|NCT03495102|593344432|FG000|Overall Study|Death|3|||
164266255|NCT03495102|593344433|FG001|Overall Study|Death|4|||
164266256|NCT03495102|593344434|FG002|Overall Study|Death|4|||
164266257|NCT03495102|593344432|FG000|Overall Study|Lost to Follow-up|15|||
164266258|NCT03495102|593344433|FG001|Overall Study|Lost to Follow-up|16|||
164266259|NCT03495102|593344434|FG002|Overall Study|Lost to Follow-up|17|||
164266260|NCT03495102|593344432|FG000|Overall Study|Physician Decision|2|||
164266261|NCT03495102|593344433|FG001|Overall Study|Physician Decision|0|||
164266262|NCT03495102|593344434|FG002|Overall Study|Physician Decision|2|||
164266263|NCT03495102|593344432|FG000|Overall Study|Withdrawal by Subject|25|||
164266264|NCT03495102|593344433|FG001|Overall Study|Withdrawal by Subject|36|||
164266265|NCT03495102|593344434|FG002|Overall Study|Withdrawal by Subject|18|||
164266266|NCT03495102|593344432|FG000|Overall Study|Protocol Violation|1|||
164266267|NCT03495102|593344433|FG001|Overall Study|Protocol Violation|1|||
164266268|NCT03495102|593344434|FG002|Overall Study|Protocol Violation|0|||
164266269|NCT03495102|593344432|FG000|Overall Study|Site Closure|3|||
164266270|NCT03495102|593344433|FG001|Overall Study|Site Closure|1|||
164266271|NCT03495102|593344434|FG002|Overall Study|Site Closure|2|||
163892041|NCT03386578|591976715|FG001|PK Component|Lost to Follow-up|1|||
163892042|NCT03386578|591976716|FG002|PK Component|Lost to Follow-up|0|||
163892043|NCT03386578|591976717|FG003|PK Component|Lost to Follow-up|0|||
163892044|NCT03386578|591976718|FG004|PK Component|Lost to Follow-up|0|||
163892045|NCT03386578|591976719|FG005|PK Component|Lost to Follow-up|0|||
163892046|NCT03386578|591976720|FG006|PK Component|Lost to Follow-up|1|||
163892047|NCT03386578|591976721|FG007|PK Component|Lost to Follow-up|0|||
163892048|NCT03386578|591976722|FG008|PK Component|Lost to Follow-up|0|||
163892049|NCT03386578|591976723|FG009|PK Component|Lost to Follow-up|0|||
163892050|NCT03386578|591976714|FG000|PK Component|Stillbirth/Abortion|0|||
163892051|NCT03386578|591976715|FG001|PK Component|Stillbirth/Abortion|0|||
163892052|NCT03386578|591976716|FG002|PK Component|Stillbirth/Abortion|0|||
163892053|NCT03386578|591976717|FG003|PK Component|Stillbirth/Abortion|0|||
163892054|NCT03386578|591976718|FG004|PK Component|Stillbirth/Abortion|0|||
163892055|NCT03386578|591976719|FG005|PK Component|Stillbirth/Abortion|2|||
163892056|NCT03386578|591976720|FG006|PK Component|Stillbirth/Abortion|0|||
163892057|NCT03386578|591976721|FG007|PK Component|Stillbirth/Abortion|0|||
163892058|NCT03386578|591976722|FG008|PK Component|Stillbirth/Abortion|0|||
163892059|NCT03386578|591976723|FG009|PK Component|Stillbirth/Abortion|0|||
163892060|NCT03386578|591976714|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164266272|NCT03495102|593344432|FG000|Overall Study|Non-compliance|1|||
164266273|NCT03495102|593344433|FG001|Overall Study|Non-compliance|0|||
164266274|NCT03495102|593344434|FG002|Overall Study|Non-compliance|0|||
164266275|NCT03495102|593344432|FG000|Overall Study|Participant Duplicated at Another Site|0|||
164266276|NCT03495102|593344433|FG001|Overall Study|Participant Duplicated at Another Site|0|||
164266277|NCT03495102|593344434|FG002|Overall Study|Participant Duplicated at Another Site|1|||
164266278|NCT03495102|593344432|FG000|Overall Study|Primary Care Physician Recommendation|0|||
164266279|NCT03495102|593344433|FG001|Overall Study|Primary Care Physician Recommendation|1|||
164266280|NCT03495102|593344434|FG002|Overall Study|Primary Care Physician Recommendation|0|||
164266281|NCT03495102|593344432|FG000|Overall Study|Relocated to Another Country|0|||
164266282|NCT03495102|593344433|FG001|Overall Study|Relocated to Another Country|1|||
164266283|NCT03495102|593344434|FG002|Overall Study|Relocated to Another Country|0|||
164266284|NCT03495102|593344432|FG000|Overall Study|Participant was in Rehabilitation|1|||
164266285|NCT03495102|593344433|FG001|Overall Study|Participant was in Rehabilitation|0|||
164266286|NCT03495102|593344434|FG002|Overall Study|Participant was in Rehabilitation|0|||
164266287|NCT03938324|593344435|FG000|Overall Study|Lost to Follow-up|42|||
164266288|NCT03938324|593344436|FG001|Overall Study|Lost to Follow-up|21|||
164266289|NCT03938324|593344435|FG000|Overall Study|Withdrawal by Subject|6|||
164266290|NCT03938324|593344436|FG001|Overall Study|Withdrawal by Subject|1|||
164266291|NCT05160766|593344437|FG000|Overall Study|Adverse Event|0|||
164266292|NCT05160766|593344438|FG001|Overall Study|Adverse Event|1|||
164266293|NCT05160766|593344439|FG002|Overall Study|Adverse Event|0|||
164266294|NCT05160766|593344440|FG003|Overall Study|Adverse Event|0|||
164266295|NCT05160766|593344437|FG000|Overall Study|COVID-19 infection|0|||
164266296|NCT05160766|593344438|FG001|Overall Study|COVID-19 infection|1|||
164266297|NCT05160766|593344439|FG002|Overall Study|COVID-19 infection|0|||
164266298|NCT05160766|593344440|FG003|Overall Study|COVID-19 infection|0|||
164266299|NCT05160766|593344437|FG000|Overall Study|travel time|1|||
164266300|NCT05160766|593344438|FG001|Overall Study|travel time|0|||
164266301|NCT05160766|593344439|FG002|Overall Study|travel time|0|||
164266302|NCT05160766|593344440|FG003|Overall Study|travel time|1|||
164266303|NCT05160766|593344437|FG000|Overall Study|Withdrawal by Subject|3|||
164266304|NCT05160766|593344438|FG001|Overall Study|Withdrawal by Subject|5|||
164266305|NCT05160766|593344439|FG002|Overall Study|Withdrawal by Subject|4|||
164266306|NCT05160766|593344440|FG003|Overall Study|Withdrawal by Subject|2|||
164266307|NCT05160766|593344437|FG000|Overall Study|Death|0|||
164266308|NCT05160766|593344438|FG001|Overall Study|Death|0|||
164266309|NCT05160766|593344439|FG002|Overall Study|Death|2|||
164266310|NCT05160766|593344440|FG003|Overall Study|Death|5|||
163892061|NCT03386578|591976715|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163892062|NCT03386578|591976716|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
163892063|NCT03386578|591976717|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
163892064|NCT03386578|591976718|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
164266311|NCT05160766|593344437|FG000|Overall Study|Lost to Follow-up|0|||
164266312|NCT05160766|593344438|FG001|Overall Study|Lost to Follow-up|0|||
164266313|NCT05160766|593344439|FG002|Overall Study|Lost to Follow-up|1|||
164266314|NCT05160766|593344440|FG003|Overall Study|Lost to Follow-up|2|||
164266315|NCT05160766|593344437|FG000|Overall Study|No show|0|||
164266316|NCT05160766|593344438|FG001|Overall Study|No show|0|||
164266317|NCT05160766|593344439|FG002|Overall Study|No show|1|||
164266318|NCT05160766|593344440|FG003|Overall Study|No show|1|||
164266319|NCT05160766|593344437|FG000|Overall Study|Physician Decision|0|||
163997895|NCT01651780|592357221|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
163997896|NCT01651780|592357220|FG000|Overall Study|Withdrawal by Subject|2|||
163997897|NCT01651780|592357221|FG001|Overall Study|Withdrawal by Subject|0|||
163997898|NCT01651780|592357220|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
163997899|NCT01651780|592357221|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163997900|NCT01651780|592357220|FG000|Overall Study|Lost to Follow-up|1|||
163997901|NCT01651780|592357221|FG001|Overall Study|Lost to Follow-up|2|||
163997902|NCT01651780|592357220|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
163997903|NCT01651780|592357221|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
164266320|NCT05160766|593344438|FG001|Overall Study|Physician Decision|0|||
164266321|NCT05160766|593344439|FG002|Overall Study|Physician Decision|0|||
164266322|NCT05160766|593344440|FG003|Overall Study|Physician Decision|1|||
164266323|NCT05160766|593344437|FG000|Overall Study|Protocol Violation|0|||
164266324|NCT05160766|593344438|FG001|Overall Study|Protocol Violation|0|||
164266325|NCT05160766|593344439|FG002|Overall Study|Protocol Violation|1|||
163997904|NCT02949830|592357222|FG000|Overall Study|Adverse Event|1|||
164266326|NCT05160766|593344440|FG003|Overall Study|Protocol Violation|0|||
164266327|NCT01282294|593344441|FG000|Overall Study|Lost to Follow-up|14|||
164266328|NCT01282294|593344441|FG000|Overall Study|Screening failure|1|||
164266329|NCT01282294|593344441|FG000|Overall Study|Adverse Event|1|||
164266330|NCT01282294|593344441|FG000|Overall Study|Patient non-compliance|2|||
164266331|NCT01282294|593344441|FG000|Overall Study|Physician Decision|1|||
164266332|NCT02408523|593344442|FG000|Overall Study|Adverse Event|4|||
164266333|NCT02408523|593344443|FG001|Overall Study|Adverse Event|10|||
164266334|NCT02408523|593344442|FG000|Overall Study|Lack of Efficacy|0|||
164266335|NCT02408523|593344443|FG001|Overall Study|Lack of Efficacy|1|||
164266336|NCT02408523|593344442|FG000|Overall Study|Protocol Violation|1|||
164266337|NCT02408523|593344443|FG001|Overall Study|Protocol Violation|2|||
164266338|NCT02408523|593344442|FG000|Overall Study|Lost to Follow-up|2|||
164266339|NCT02408523|593344443|FG001|Overall Study|Lost to Follow-up|3|||
164341776|NCT00002651|593627507|FG002|Induction|Refusal unrelated to adverse event|0|||
163997905|NCT02949830|592357222|FG000|Overall Study|Withdrawal by Subject|1|||
163997906|NCT00054132|592357223|FG000|Overall Study|Not Treated|1|||
163997907|NCT01290887|592357224|FG000|Overall Study|Adverse Event|6|||
163997908|NCT01290887|592357225|FG001|Overall Study|Adverse Event|11|||
163997909|NCT01290887|592357224|FG000|Overall Study|Lack of Efficacy|4|||
163997910|NCT01290887|592357225|FG001|Overall Study|Lack of Efficacy|5|||
163997911|NCT01290887|592357224|FG000|Overall Study|Withdrawal by Subject|26|||
163997912|NCT01290887|592357225|FG001|Overall Study|Withdrawal by Subject|32|||
163997913|NCT01290887|592357224|FG000|Overall Study|Protocol Violation|2|||
163997914|NCT01290887|592357225|FG001|Overall Study|Protocol Violation|1|||
163997915|NCT01290887|592357224|FG000|Overall Study|Lost to Follow-up|4|||
163997916|NCT01290887|592357225|FG001|Overall Study|Lost to Follow-up|4|||
163997917|NCT01290887|592357224|FG000|Overall Study|Non-compliance to study procedures|0|||
163997918|NCT01290887|592357225|FG001|Overall Study|Non-compliance to study procedures|1|||
163997919|NCT01290887|592357224|FG000|Overall Study|Non-compliance to study medications|1|||
163997920|NCT01290887|592357225|FG001|Overall Study|Non-compliance to study medications|0|||
163997921|NCT01290887|592357224|FG000|Overall Study|Sponsor closure of study|420|||
163997922|NCT01290887|592357225|FG001|Overall Study|Sponsor closure of study|476|||
163997923|NCT01290887|592357224|FG000|Overall Study|Other|3|||
163997924|NCT01290887|592357225|FG001|Overall Study|Other|6|||
163997925|NCT01628926|592357226|FG000|Overall Study|Adverse Event|13|||
163997926|NCT01628926|592357227|FG001|Overall Study|Adverse Event|11|||
163997927|NCT01628926|592357228|FG002|Overall Study|Adverse Event|9|||
163997928|NCT01628926|592357226|FG000|Overall Study|Lack of Efficacy|2|||
163997929|NCT01628926|592357227|FG001|Overall Study|Lack of Efficacy|1|||
163997930|NCT01628926|592357228|FG002|Overall Study|Lack of Efficacy|5|||
163997931|NCT01628926|592357226|FG000|Overall Study|Withdrawal by Subject|6|||
163997932|NCT01628926|592357227|FG001|Overall Study|Withdrawal by Subject|4|||
164266340|NCT02408523|593344442|FG000|Overall Study|Withdrawal by Subject|3|||
164266341|NCT02408523|593344443|FG001|Overall Study|Withdrawal by Subject|1|||
164341777|NCT00002651|593627505|FG000|Induction|Progression/relapse|274|||
164341778|NCT00002651|593627506|FG001|Induction|Progression/relapse|0|||
164341779|NCT00002651|593627507|FG002|Induction|Progression/relapse|0|||
163997933|NCT01628926|592357228|FG002|Overall Study|Withdrawal by Subject|2|||
163997934|NCT01628926|592357226|FG000|Overall Study|Protocol Violation|0|||
163997935|NCT01628926|592357227|FG001|Overall Study|Protocol Violation|1|||
163997936|NCT01628926|592357228|FG002|Overall Study|Protocol Violation|0|||
163997937|NCT01628926|592357226|FG000|Overall Study|Discontinuation criteria|3|||
163997938|NCT01628926|592357227|FG001|Overall Study|Discontinuation criteria|4|||
163997939|NCT01628926|592357228|FG002|Overall Study|Discontinuation criteria|0|||
163997940|NCT01628926|592357226|FG000|Overall Study|Physician Decision|2|||
164266342|NCT02408523|593344442|FG000|Overall Study|Sponsor request|1|||
164266343|NCT02408523|593344443|FG001|Overall Study|Sponsor request|0|||
164266344|NCT02408523|593344442|FG000|Overall Study|Did not satisfy extension conditions|0|||
164266345|NCT02408523|593344443|FG001|Overall Study|Did not satisfy extension conditions|1|||
164266346|NCT02943915|593344444|FG000|Overall Study|Withdrawal by Subject|2|||
164341780|NCT00002651|593627505|FG000|Induction|Death|62|||
164266347|NCT02943915|593344445|FG001|Overall Study|Withdrawal by Subject|1|||
164266348|NCT02943915|593344446|FG002|Overall Study|Withdrawal by Subject|0|||
164266349|NCT02943915|593344447|FG003|Overall Study|Withdrawal by Subject|0|||
164266350|NCT02943915|593344444|FG000|Overall Study|Lost to Follow-up|3|||
164266351|NCT02943915|593344445|FG001|Overall Study|Lost to Follow-up|1|||
164266352|NCT02943915|593344446|FG002|Overall Study|Lost to Follow-up|0|||
164266353|NCT02943915|593344447|FG003|Overall Study|Lost to Follow-up|0|||
164266354|NCT02943915|593344444|FG000|Overall Study|excluded|0|||
164266355|NCT02943915|593344445|FG001|Overall Study|excluded|1|||
164266356|NCT02943915|593344446|FG002|Overall Study|excluded|0|||
164266357|NCT02943915|593344447|FG003|Overall Study|excluded|0|||
164266358|NCT03769311|593344448|FG000|Overall Study|Withdrawal by Subject|1|||
164266359|NCT01062061|593344451|FG000|Overall Study|Enrolled more than once|2|||
164266360|NCT01062061|593344451|FG000|Overall Study|Investigated before study start|13|||
164266361|NCT01062061|593344451|FG000|Overall Study|Outside chief indications|10|||
164266362|NCT01062061|593344451|FG000|Overall Study|Failed to meet inclusion criteria|2|||
164266363|NCT00524589|593344452|FG000|Overall Study|Withdrawal by Subject|2|||
164266364|NCT00524589|593344452|FG000|Overall Study|Disease Progression|16|||
164266365|NCT01266317|593344453|FG000|Overall Study|Withdrawal by Subject|2|||
164266366|NCT00098722|593344454|FG000|Double Blind Phase|Adverse Event|7|||
164266367|NCT00098722|593344455|FG001|Double Blind Phase|Adverse Event|7|||
164266368|NCT00098722|593344456|FG002|Double Blind Phase|Adverse Event|3|||
164266369|NCT00098722|593344457|FG003|Double Blind Phase|Adverse Event|0|||
164266370|NCT00098722|593344458|FG004|Double Blind Phase|Adverse Event|0|||
164266371|NCT00098722|593344459|FG005|Double Blind Phase|Adverse Event|0|||
163997941|NCT01628926|592357227|FG001|Overall Study|Physician Decision|2|||
163997942|NCT01628926|592357228|FG002|Overall Study|Physician Decision|1|||
163997943|NCT03029832|592357229|FG000|Overall Study|Safety Follow-Up Completed|2|||
163997944|NCT03029832|592357230|FG001|Overall Study|Safety Follow-Up Completed|0|||
163997945|NCT03029832|592357229|FG000|Overall Study|Death due to Disease Progression|1|||
163997946|NCT03029832|592357230|FG001|Overall Study|Death due to Disease Progression|0|||
163997947|NCT03029832|592357229|FG000|Overall Study|Study Terminated By Sponsor|1|||
163997948|NCT03029832|592357230|FG001|Overall Study|Study Terminated By Sponsor|1|||
163997949|NCT04373460|592357231|FG000|Overall Study|Did not receive tranfusion|18|||
163997950|NCT04373460|592357232|FG001|Overall Study|Did not receive tranfusion|26|||
163997951|NCT01412229|592357233|FG000|Overall Study|Physician Decision|1|||
163997952|NCT00454207|592357234|FG000|Overall Study|Adverse Event|3|||
163997953|NCT00454207|592357235|FG001|Overall Study|Adverse Event|1|||
163997954|NCT00454207|592357234|FG000|Overall Study|Lack of Efficacy|1|||
163997955|NCT00454207|592357235|FG001|Overall Study|Lack of Efficacy|0|||
163997956|NCT00454207|592357234|FG000|Overall Study|Protocol Violation|0|||
163997957|NCT00454207|592357235|FG001|Overall Study|Protocol Violation|1|||
163997958|NCT01672957|592357236|FG000|Overall Study|Protocol Violation|48|||
163997959|NCT01672957|592357236|FG000|Overall Study|Death|2|||
163997960|NCT01672957|592357236|FG000|Overall Study|ICF Signed After Transplantation|5|||
163997961|NCT01795547|592357241|FG000|Overall Study|Adverse Event|16|||
163997962|NCT01795547|592357242|FG001|Overall Study|Adverse Event|27|||
163997963|NCT01795547|592357241|FG000|Overall Study|Lack of Efficacy|8|||
163997964|NCT01795547|592357242|FG001|Overall Study|Lack of Efficacy|3|||
163997965|NCT01795547|592357241|FG000|Overall Study|Protocol Violation|6|||
163997966|NCT01795547|592357242|FG001|Overall Study|Protocol Violation|4|||
163997967|NCT01795547|592357241|FG000|Overall Study|Lost to Follow-up|2|||
163997968|NCT01795547|592357242|FG001|Overall Study|Lost to Follow-up|5|||
163997969|NCT01795547|592357241|FG000|Overall Study|Withdrawal of consent|7|||
163997970|NCT01795547|592357242|FG001|Overall Study|Withdrawal of consent|12|||
163997971|NCT01795547|592357241|FG000|Overall Study|Not Treated|4|||
163997972|NCT01795547|592357242|FG001|Overall Study|Not Treated|10|||
163997973|NCT01795547|592357241|FG000|Overall Study|Non-compliance with IMP|1|||
163997974|NCT01795547|592357242|FG001|Overall Study|Non-compliance with IMP|1|||
164266372|NCT00098722|593344460|FG006|Double Blind Phase|Adverse Event|0|||
164266373|NCT00098722|593344454|FG000|Double Blind Phase|Death|2|||
164266374|NCT00098722|593344455|FG001|Double Blind Phase|Death|5|||
164266375|NCT00098722|593344456|FG002|Double Blind Phase|Death|0|||
164266376|NCT00098722|593344457|FG003|Double Blind Phase|Death|0|||
163997975|NCT01795547|592357241|FG000|Overall Study|Others|4|||
164266377|NCT00098722|593344458|FG004|Double Blind Phase|Death|0|||
164266378|NCT00098722|593344459|FG005|Double Blind Phase|Death|0|||
163997976|NCT01795547|592357242|FG001|Overall Study|Others|1|||
163997977|NCT01795547|592357241|FG000|Overall Study|Not stated|0|||
163997978|NCT01795547|592357242|FG001|Overall Study|Not stated|1|||
163997979|NCT00642642|592357244|FG000|Treatment & Follow Up|Adverse Event|2|||
163997980|NCT00642642|592357244|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
163997981|NCT00642642|592357244|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
163997982|NCT02116621|592357245|FG000|Baseline|Withdrawal by Subject|0|||
164266379|NCT00098722|593344460|FG006|Double Blind Phase|Death|0|||
164266380|NCT00098722|593344454|FG000|Double Blind Phase|Lack of Efficacy|21|||
164266381|NCT00098722|593344455|FG001|Double Blind Phase|Lack of Efficacy|23|||
164266382|NCT00098722|593344456|FG002|Double Blind Phase|Lack of Efficacy|15|||
164266383|NCT00098722|593344457|FG003|Double Blind Phase|Lack of Efficacy|0|||
164266384|NCT00098722|593344458|FG004|Double Blind Phase|Lack of Efficacy|0|||
164266385|NCT00098722|593344459|FG005|Double Blind Phase|Lack of Efficacy|0|||
164266386|NCT00098722|593344460|FG006|Double Blind Phase|Lack of Efficacy|0|||
164266387|NCT00098722|593344454|FG000|Double Blind Phase|Participant defaulted|16|||
164266388|NCT00098722|593344455|FG001|Double Blind Phase|Participant defaulted|11|||
164266389|NCT00098722|593344456|FG002|Double Blind Phase|Participant defaulted|9|||
163997983|NCT02116621|592357246|FG001|Baseline|Withdrawal by Subject|4|||
163997984|NCT02116621|592357245|FG000|Three Month Follow-up|Death|1|||
163997985|NCT02116621|592357246|FG001|Three Month Follow-up|Death|1|||
163997986|NCT02116621|592357245|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
163997987|NCT02116621|592357246|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
163997988|NCT02116621|592357245|FG000|Three Month Follow-up|Lost to Follow-up|0|||
163997989|NCT02116621|592357246|FG001|Three Month Follow-up|Lost to Follow-up|1|||
163997990|NCT02116621|592357245|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
163997991|NCT02116621|592357246|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
163997992|NCT02116621|592357245|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
163997993|NCT02116621|592357246|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
163997994|NCT02116621|592357245|FG000|Six Month Follow-up|Lost to Follow-up|2|||
163997995|NCT02116621|592357246|FG001|Six Month Follow-up|Lost to Follow-up|1|||
163997996|NCT02116621|592357245|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
163997997|NCT02116621|592357246|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
163997998|NCT02116621|592357245|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
163997999|NCT02116621|592357246|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
163998000|NCT02116621|592357245|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
163998001|NCT02116621|592357246|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
163998002|NCT02116621|592357245|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
163998003|NCT02116621|592357246|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
163998004|NCT02116621|592357245|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
163998005|NCT02116621|592357246|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
163998006|NCT00151892|592357247|FG000|Overall Study|Lack of Efficacy|50|||
163998007|NCT00151892|592357248|FG001|Overall Study|Lack of Efficacy|57|||
163998008|NCT00151892|592357247|FG000|Overall Study|Patient request|10|||
163998009|NCT00151892|592357248|FG001|Overall Study|Patient request|7|||
163998010|NCT00151892|592357247|FG000|Overall Study|Lost to Follow-up|5|||
163998011|NCT00151892|592357248|FG001|Overall Study|Lost to Follow-up|10|||
163998012|NCT00151892|592357247|FG000|Overall Study|Adverse Event|6|||
163998013|NCT00151892|592357248|FG001|Overall Study|Adverse Event|3|||
163998014|NCT00151892|592357247|FG000|Overall Study|Protocol Violation|3|||
163998015|NCT00151892|592357248|FG001|Overall Study|Protocol Violation|3|||
163998016|NCT00151892|592357247|FG000|Overall Study|Non-compliance|0|||
163998017|NCT00151892|592357248|FG001|Overall Study|Non-compliance|1|||
163998018|NCT00151892|592357247|FG000|Overall Study|Pregnancy|0|||
163998019|NCT00151892|592357248|FG001|Overall Study|Pregnancy|1|||
163998020|NCT00151892|592357247|FG000|Overall Study|Did not return for a visit|1|||
163998021|NCT00151892|592357248|FG001|Overall Study|Did not return for a visit|0|||
163998022|NCT00151892|592357247|FG000|Overall Study|Used prohibited corticosteroids|1|||
163998023|NCT00151892|592357248|FG001|Overall Study|Used prohibited corticosteroids|0|||
163998024|NCT00151892|592357247|FG000|Overall Study|Lack of study medication at center|0|||
163998025|NCT00151892|592357248|FG001|Overall Study|Lack of study medication at center|1|||
163998026|NCT04223609|592357251|FG000|Overall Study|Adverse Event|0|||
163998027|NCT04223609|592357252|FG001|Overall Study|Adverse Event|1|||
163998028|NCT04223609|592357251|FG000|Overall Study|Missed last visit|0|||
163998029|NCT04223609|592357252|FG001|Overall Study|Missed last visit|1|||
163998030|NCT03437447|592357253|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163998031|NCT03437447|592357254|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163998032|NCT03437447|592357255|FG002|Treatment Period 1|Withdrawal by Subject|1|||
163998033|NCT03440944|592357258|FG000|Overall Study|Physician Decision|1|||
163998034|NCT03440944|592357259|FG001|Overall Study|Physician Decision|0|||
163998035|NCT03440944|592357258|FG000|Overall Study|No Acceptable Vasculature|0|||
163998036|NCT03440944|592357259|FG001|Overall Study|No Acceptable Vasculature|1|||
163998037|NCT00591734|592357260|FG000|Overall Study|Lack of Efficacy|35|||
163998038|NCT00591734|592357260|FG000|Overall Study|Adverse Event|5|||
163998039|NCT00591734|592357260|FG000|Overall Study|Physician Decision|5|||
164266390|NCT00098722|593344457|FG003|Double Blind Phase|Participant defaulted|0|||
164266391|NCT00098722|593344458|FG004|Double Blind Phase|Participant defaulted|0|||
164266392|NCT00098722|593344459|FG005|Double Blind Phase|Participant defaulted|0|||
163998040|NCT00591734|592357260|FG000|Overall Study|Intercurrent Illness|8|||
163998041|NCT04672083|592357261|FG000|Overall Study|Lost to Follow-up|1|||
163998042|NCT04672083|592357262|FG001|Overall Study|Lost to Follow-up|0|||
163998043|NCT04672083|592357263|FG002|Overall Study|Lost to Follow-up|0|||
163998044|NCT04672083|592357264|FG003|Overall Study|Lost to Follow-up|0|||
163998045|NCT04672083|592357265|FG004|Overall Study|Lost to Follow-up|0|||
163998046|NCT01551745|592357266|FG000|Overall Study|Withdrawal by Subject|1|||
163998047|NCT01551745|592357266|FG000|Overall Study|Disease Progression|2|||
163998048|NCT01661790|592357267|FG000|Overall Study|Lost to Follow-up|0|||
163998049|NCT01661790|592357268|FG001|Overall Study|Lost to Follow-up|2|||
164266393|NCT00098722|593344460|FG006|Double Blind Phase|Participant defaulted|0|||
164266394|NCT00098722|593344454|FG000|Double Blind Phase|Pregnancy|1|||
164266395|NCT00098722|593344455|FG001|Double Blind Phase|Pregnancy|0|||
164266396|NCT00098722|593344456|FG002|Double Blind Phase|Pregnancy|0|||
164266397|NCT00098722|593344457|FG003|Double Blind Phase|Pregnancy|0|||
164266398|NCT00098722|593344458|FG004|Double Blind Phase|Pregnancy|0|||
164266399|NCT00098722|593344459|FG005|Double Blind Phase|Pregnancy|0|||
164266400|NCT00098722|593344460|FG006|Double Blind Phase|Pregnancy|0|||
164266401|NCT00098722|593344454|FG000|Double Blind Phase|Randomized, not treated|4|||
164266402|NCT00098722|593344455|FG001|Double Blind Phase|Randomized, not treated|3|||
164266403|NCT00098722|593344456|FG002|Double Blind Phase|Randomized, not treated|3|||
164266404|NCT00098722|593344457|FG003|Double Blind Phase|Randomized, not treated|0|||
164266405|NCT00098722|593344458|FG004|Double Blind Phase|Randomized, not treated|0|||
164266406|NCT00098722|593344459|FG005|Double Blind Phase|Randomized, not treated|0|||
164266407|NCT00098722|593344460|FG006|Double Blind Phase|Randomized, not treated|0|||
164266408|NCT00098722|593344454|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
164266409|NCT00098722|593344455|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
164266410|NCT00098722|593344456|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
164266411|NCT00098722|593344457|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
164266412|NCT00098722|593344458|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
164266413|NCT00098722|593344459|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
164266414|NCT00098722|593344460|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
164266415|NCT00098722|593344454|FG000|Double Blind Phase|Other|7|||
164266416|NCT00098722|593344455|FG001|Double Blind Phase|Other|8|||
164266417|NCT00098722|593344456|FG002|Double Blind Phase|Other|7|||
164266418|NCT00098722|593344457|FG003|Double Blind Phase|Other|0|||
164266419|NCT00098722|593344458|FG004|Double Blind Phase|Other|0|||
164266420|NCT00098722|593344459|FG005|Double Blind Phase|Other|0|||
164266421|NCT00098722|593344460|FG006|Double Blind Phase|Other|0|||
164266422|NCT00098722|593344454|FG000|Open Label Phase|Adverse Event|0|||
164266423|NCT00098722|593344455|FG001|Open Label Phase|Adverse Event|0|||
164266424|NCT00098722|593344456|FG002|Open Label Phase|Adverse Event|0|||
164266425|NCT00098722|593344457|FG003|Open Label Phase|Adverse Event|5|||
164341781|NCT00002651|593627506|FG001|Induction|Death|0|||
164341782|NCT00002651|593627507|FG002|Induction|Death|0|||
164341783|NCT00002651|593627505|FG000|Induction|Other|823|||
164341784|NCT00002651|593627506|FG001|Induction|Other|0|||
164341785|NCT00002651|593627507|FG002|Induction|Other|0|||
164266426|NCT00098722|593344458|FG004|Open Label Phase|Adverse Event|0|||
164266427|NCT00098722|593344459|FG005|Open Label Phase|Adverse Event|0|||
164341786|NCT00002651|593627505|FG000|Induction|not eligible|90|||
164341787|NCT00002651|593627506|FG001|Induction|not eligible|0|||
164341788|NCT00002651|593627507|FG002|Induction|not eligible|0|||
163892065|NCT03386578|591976719|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163892066|NCT03386578|591976720|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163892067|NCT03386578|591976721|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
163892068|NCT03386578|591976722|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
163892069|NCT03386578|591976723|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
163892070|NCT03386578|591976714|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163892071|NCT03386578|591976715|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163892072|NCT03386578|591976716|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
163892073|NCT03386578|591976717|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
163892074|NCT03386578|591976718|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163892075|NCT03386578|591976719|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163892076|NCT03386578|591976720|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163892077|NCT03386578|591976721|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
163892078|NCT03386578|591976722|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
163892079|NCT03386578|591976723|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
163892080|NCT03386578|591976714|FG000|PrEP Comparison Component Step 1|Death|0|||
163892081|NCT03386578|591976715|FG001|PrEP Comparison Component Step 1|Death|0|||
163892082|NCT03386578|591976716|FG002|PrEP Comparison Component Step 1|Death|1|||
163892083|NCT03386578|591976717|FG003|PrEP Comparison Component Step 1|Death|0|||
163892084|NCT03386578|591976718|FG004|PrEP Comparison Component Step 1|Death|0|||
163892085|NCT03386578|591976719|FG005|PrEP Comparison Component Step 1|Death|0|||
163892086|NCT03386578|591976720|FG006|PrEP Comparison Component Step 1|Death|0|||
163892087|NCT03386578|591976721|FG007|PrEP Comparison Component Step 1|Death|9|||
163892088|NCT03386578|591976722|FG008|PrEP Comparison Component Step 1|Death|5|||
163892089|NCT03386578|591976723|FG009|PrEP Comparison Component Step 1|Death|0|||
163892090|NCT03386578|591976714|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892091|NCT03386578|591976715|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892092|NCT03386578|591976716|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
164266428|NCT00098722|593344460|FG006|Open Label Phase|Adverse Event|0|||
164266429|NCT00098722|593344454|FG000|Open Label Phase|Death|0|||
164266430|NCT00098722|593344455|FG001|Open Label Phase|Death|0|||
164341789|NCT00002651|593627505|FG000|Consolidation and Randomization|Adverse Event|0|||
164341790|NCT00002651|593627506|FG001|Consolidation and Randomization|Adverse Event|36|||
163892093|NCT03386578|591976717|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
163892094|NCT03386578|591976718|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892095|NCT03386578|591976719|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892096|NCT03386578|591976720|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892097|NCT03386578|591976721|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892098|NCT03386578|591976722|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
163892099|NCT03386578|591976723|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
163892100|NCT03386578|591976714|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892101|NCT03386578|591976715|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892102|NCT03386578|591976716|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892103|NCT03386578|591976717|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892104|NCT03386578|591976718|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163900163|NCT00115934|592005623|FG001|Overall Study|Lost to Follow-up|0|||
164085832|NCT00358826|592678573|FG006|Core Study|Lost to Follow-up|0|||
164266431|NCT00098722|593344456|FG002|Open Label Phase|Death|0|||
164266432|NCT00098722|593344457|FG003|Open Label Phase|Death|2|||
164266433|NCT00098722|593344458|FG004|Open Label Phase|Death|0|||
164266434|NCT00098722|593344459|FG005|Open Label Phase|Death|0|||
164266435|NCT00098722|593344460|FG006|Open Label Phase|Death|0|||
164266436|NCT00098722|593344454|FG000|Open Label Phase|Lack of Efficacy|0|||
164266437|NCT00098722|593344455|FG001|Open Label Phase|Lack of Efficacy|0|||
164266438|NCT00098722|593344456|FG002|Open Label Phase|Lack of Efficacy|0|||
164266439|NCT00098722|593344457|FG003|Open Label Phase|Lack of Efficacy|8|||
164266440|NCT00098722|593344458|FG004|Open Label Phase|Lack of Efficacy|0|||
164266441|NCT00098722|593344459|FG005|Open Label Phase|Lack of Efficacy|0|||
164341791|NCT00002651|593627507|FG002|Consolidation and Randomization|Adverse Event|14|||
164341792|NCT00002651|593627505|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
164341793|NCT00002651|593627506|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
164341794|NCT00002651|593627507|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
164341795|NCT00002651|593627505|FG000|Consolidation and Randomization|Progression/relapse|0|||
164341796|NCT00002651|593627506|FG001|Consolidation and Randomization|Progression/relapse|295|||
164341797|NCT00002651|593627507|FG002|Consolidation and Randomization|Progression/relapse|298|||
164341798|NCT00002651|593627505|FG000|Consolidation and Randomization|Death|0|||
164341799|NCT00002651|593627506|FG001|Consolidation and Randomization|Death|38|||
164341800|NCT00002651|593627507|FG002|Consolidation and Randomization|Death|48|||
164341801|NCT00002651|593627505|FG000|Consolidation and Randomization|Other|0|||
164341802|NCT00002651|593627506|FG001|Consolidation and Randomization|Other|314|||
164341803|NCT00002651|593627507|FG002|Consolidation and Randomization|Other|313|||
164341804|NCT00002651|593627505|FG000|Consolidation and Randomization|not eligible|0|||
164266442|NCT00098722|593344460|FG006|Open Label Phase|Lack of Efficacy|0|||
164266443|NCT00098722|593344454|FG000|Open Label Phase|Pregnancy|0|||
164266444|NCT00098722|593344455|FG001|Open Label Phase|Pregnancy|0|||
164266445|NCT00098722|593344456|FG002|Open Label Phase|Pregnancy|0|||
164266446|NCT00098722|593344457|FG003|Open Label Phase|Pregnancy|1|||
164266447|NCT00098722|593344458|FG004|Open Label Phase|Pregnancy|0|||
164266448|NCT00098722|593344459|FG005|Open Label Phase|Pregnancy|0|||
164266449|NCT00098722|593344460|FG006|Open Label Phase|Pregnancy|0|||
164266450|NCT00098722|593344454|FG000|Open Label Phase|Participant defaulted|0|||
164266451|NCT00098722|593344455|FG001|Open Label Phase|Participant defaulted|0|||
164266452|NCT00098722|593344456|FG002|Open Label Phase|Participant defaulted|0|||
164266453|NCT00098722|593344457|FG003|Open Label Phase|Participant defaulted|18|||
164266454|NCT00098722|593344458|FG004|Open Label Phase|Participant defaulted|0|||
164266455|NCT00098722|593344459|FG005|Open Label Phase|Participant defaulted|0|||
164266456|NCT00098722|593344460|FG006|Open Label Phase|Participant defaulted|0|||
164266457|NCT00098722|593344454|FG000|Open Label Phase|Ongoing at cut-off date|0|||
164266458|NCT00098722|593344455|FG001|Open Label Phase|Ongoing at cut-off date|0|||
164266459|NCT00098722|593344456|FG002|Open Label Phase|Ongoing at cut-off date|0|||
164266460|NCT00098722|593344457|FG003|Open Label Phase|Ongoing at cut-off date|220|||
164266461|NCT00098722|593344458|FG004|Open Label Phase|Ongoing at cut-off date|50|||
164266462|NCT00098722|593344459|FG005|Open Label Phase|Ongoing at cut-off date|0|||
164266463|NCT00098722|593344460|FG006|Open Label Phase|Ongoing at cut-off date|0|||
164266464|NCT00098722|593344454|FG000|Open Label Phase|Other|0|||
164266465|NCT00098722|593344455|FG001|Open Label Phase|Other|0|||
164341805|NCT00002651|593627506|FG001|Consolidation and Randomization|not eligible|102|||
164341806|NCT00002651|593627507|FG002|Consolidation and Randomization|not eligible|112|||
164266466|NCT00098722|593344456|FG002|Open Label Phase|Other|0|||
164266467|NCT00098722|593344457|FG003|Open Label Phase|Other|18|||
164266468|NCT00098722|593344458|FG004|Open Label Phase|Other|0|||
164266469|NCT00098722|593344459|FG005|Open Label Phase|Other|0|||
164266470|NCT00098722|593344460|FG006|Open Label Phase|Other|0|||
164266471|NCT00098722|593344454|FG000|Observation Phase|Death|0|||
164266472|NCT00098722|593344455|FG001|Observation Phase|Death|0|||
164266473|NCT00098722|593344456|FG002|Observation Phase|Death|0|||
164341807|NCT01705730|593627508|FG000|Overall Study|Lack of Efficacy|1|||
164341808|NCT01705730|593627508|FG000|Overall Study|Adverse Event|3|||
163998050|NCT02764541|592357271|FG000|Overall Study|Withdrawal by Subject|0|||
163998051|NCT02764541|592357272|FG001|Overall Study|Withdrawal by Subject|0|||
163998052|NCT02764541|592357273|FG002|Overall Study|Withdrawal by Subject|0|||
163998053|NCT02764541|592357274|FG003|Overall Study|Withdrawal by Subject|0|||
164266474|NCT00098722|593344457|FG003|Observation Phase|Death|0|||
164266475|NCT00098722|593344458|FG004|Observation Phase|Death|0|||
164266476|NCT00098722|593344459|FG005|Observation Phase|Death|5|||
164266477|NCT00098722|593344460|FG006|Observation Phase|Death|3|||
164266478|NCT00098722|593344454|FG000|Observation Phase|Lack of Efficacy|0|||
164266479|NCT00098722|593344455|FG001|Observation Phase|Lack of Efficacy|0|||
164266480|NCT00098722|593344456|FG002|Observation Phase|Lack of Efficacy|0|||
164266481|NCT00098722|593344457|FG003|Observation Phase|Lack of Efficacy|0|||
164266482|NCT00098722|593344458|FG004|Observation Phase|Lack of Efficacy|0|||
164266483|NCT00098722|593344459|FG005|Observation Phase|Lack of Efficacy|2|||
164266484|NCT00098722|593344460|FG006|Observation Phase|Lack of Efficacy|0|||
164266485|NCT00098722|593344454|FG000|Observation Phase|Participant defaulted|0|||
164266486|NCT00098722|593344455|FG001|Observation Phase|Participant defaulted|0|||
164266487|NCT00098722|593344456|FG002|Observation Phase|Participant defaulted|0|||
164266488|NCT00098722|593344457|FG003|Observation Phase|Participant defaulted|0|||
164266489|NCT00098722|593344458|FG004|Observation Phase|Participant defaulted|0|||
164266490|NCT00098722|593344459|FG005|Observation Phase|Participant defaulted|17|||
164266491|NCT00098722|593344460|FG006|Observation Phase|Participant defaulted|4|||
164266492|NCT00098722|593344454|FG000|Observation Phase|Other|0|||
164341809|NCT01705730|593627508|FG000|Overall Study|Lost to Follow-up|1|||
164341810|NCT01705730|593627508|FG000|Overall Study|Reason not Specified|4|||
164341811|NCT01921387|593627509|FG000|Overall Study|Adverse Event|1|||
164341812|NCT01773733|593627510|FG000|Overall Study|Adverse Event|3286|||
164341813|NCT01773733|593627511|FG001|Overall Study|Adverse Event|540|||
164341814|NCT01773733|593627510|FG000|Overall Study|Pregnancy|28|||
164341815|NCT01773733|593627511|FG001|Overall Study|Pregnancy|0|||
164341816|NCT01773733|593627510|FG000|Overall Study|Other different categories of not compl|55415|||
164341817|NCT01773733|593627511|FG001|Overall Study|Other different categories of not compl|7781|||
164341818|NCT00762229|593627514|FG000|Overall Study|Lost to Follow-up|1|||
164341819|NCT00762229|593627515|FG001|Overall Study|Lost to Follow-up|1|||
164341820|NCT00762229|593627514|FG000|Overall Study|did not recveive intervention|0|||
164341821|NCT00762229|593627515|FG001|Overall Study|did not recveive intervention|1|||
164341822|NCT01081678|593627519|FG000|Overall Study|Ineligibility Determined|0|||
164341823|NCT01081678|593627520|FG001|Overall Study|Ineligibility Determined|0|||
164341824|NCT01081678|593627521|FG002|Overall Study|Ineligibility Determined|1|||
164341825|NCT01081678|593627522|FG003|Overall Study|Ineligibility Determined|1|||
164341826|NCT01081678|593627519|FG000|Overall Study|Noncompliance|3|||
164341827|NCT01081678|593627520|FG001|Overall Study|Noncompliance|4|||
164341828|NCT01081678|593627521|FG002|Overall Study|Noncompliance|5|||
164341829|NCT01081678|593627522|FG003|Overall Study|Noncompliance|2|||
164341830|NCT01081678|593627519|FG000|Overall Study|Adverse Event|2|||
164341831|NCT01081678|593627520|FG001|Overall Study|Adverse Event|1|||
164341832|NCT01081678|593627521|FG002|Overall Study|Adverse Event|2|||
164341833|NCT01081678|593627522|FG003|Overall Study|Adverse Event|2|||
164341834|NCT01081678|593627519|FG000|Overall Study|Withdrawal by Subject|15|||
164341835|NCT01081678|593627520|FG001|Overall Study|Withdrawal by Subject|7|||
164341836|NCT01081678|593627521|FG002|Overall Study|Withdrawal by Subject|17|||
164341837|NCT01081678|593627522|FG003|Overall Study|Withdrawal by Subject|14|||
164341838|NCT01081678|593627519|FG000|Overall Study|Administrative Decision|1|||
164341839|NCT01081678|593627520|FG001|Overall Study|Administrative Decision|0|||
164341840|NCT01081678|593627521|FG002|Overall Study|Administrative Decision|0|||
164341841|NCT01081678|593627522|FG003|Overall Study|Administrative Decision|1|||
164341842|NCT01081678|593627519|FG000|Overall Study|Lost to Follow-up|4|||
164341843|NCT01081678|593627520|FG001|Overall Study|Lost to Follow-up|1|||
164341844|NCT01081678|593627521|FG002|Overall Study|Lost to Follow-up|4|||
164341845|NCT01081678|593627522|FG003|Overall Study|Lost to Follow-up|3|||
164341846|NCT01081678|593627519|FG000|Overall Study|Death|2|||
163998054|NCT02764541|592357275|FG004|Overall Study|Withdrawal by Subject|1|||
163998055|NCT02764541|592357276|FG005|Overall Study|Withdrawal by Subject|1|||
163998056|NCT02764541|592357277|FG006|Overall Study|Withdrawal by Subject|0|||
163998057|NCT02764541|592357278|FG007|Overall Study|Withdrawal by Subject|1|||
163998058|NCT02764541|592357271|FG000|Overall Study|Adverse Event|1|||
164266493|NCT00098722|593344455|FG001|Observation Phase|Other|0|||
164266494|NCT00098722|593344456|FG002|Observation Phase|Other|0|||
164266495|NCT00098722|593344457|FG003|Observation Phase|Other|0|||
164266496|NCT00098722|593344458|FG004|Observation Phase|Other|0|||
164341847|NCT01081678|593627520|FG001|Overall Study|Death|2|||
163998059|NCT02764541|592357272|FG001|Overall Study|Adverse Event|0|||
164341848|NCT01081678|593627521|FG002|Overall Study|Death|2|||
164341849|NCT01081678|593627522|FG003|Overall Study|Death|6|||
164341850|NCT01081678|593627519|FG000|Overall Study|Other|0|||
164341851|NCT01081678|593627520|FG001|Overall Study|Other|1|||
164341852|NCT01081678|593627521|FG002|Overall Study|Other|0|||
164341853|NCT01081678|593627522|FG003|Overall Study|Other|0|||
164341854|NCT01619423|593627525|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
163998060|NCT02764541|592357273|FG002|Overall Study|Adverse Event|0|||
163998061|NCT02764541|592357274|FG003|Overall Study|Adverse Event|0|||
163998062|NCT02764541|592357275|FG004|Overall Study|Adverse Event|0|||
163998063|NCT02764541|592357276|FG005|Overall Study|Adverse Event|0|||
164266497|NCT00098722|593344459|FG005|Observation Phase|Other|21|||
164266498|NCT00098722|593344460|FG006|Observation Phase|Other|10|||
164266499|NCT02046070|593344467|FG000|Overall Study|Progressive Disease|18|||
164266500|NCT02046070|593344468|FG001|Overall Study|Progressive Disease|11|||
164266501|NCT02046070|593344469|FG002|Overall Study|Progressive Disease|40|||
164266502|NCT02046070|593344467|FG000|Overall Study|Adverse Event|8|||
164266503|NCT02046070|593344468|FG001|Overall Study|Adverse Event|10|||
164266504|NCT02046070|593344469|FG002|Overall Study|Adverse Event|17|||
164266505|NCT02046070|593344467|FG000|Overall Study|Withdrawal by Subject|1|||
164266506|NCT02046070|593344468|FG001|Overall Study|Withdrawal by Subject|2|||
164266507|NCT02046070|593344469|FG002|Overall Study|Withdrawal by Subject|6|||
164266508|NCT02046070|593344467|FG000|Overall Study|Study Terminated by Sponsor|1|||
164266509|NCT02046070|593344468|FG001|Overall Study|Study Terminated by Sponsor|1|||
164266510|NCT02046070|593344469|FG002|Overall Study|Study Terminated by Sponsor|1|||
164266511|NCT02046070|593344467|FG000|Overall Study|Reason not Specified|4|||
164266512|NCT02046070|593344468|FG001|Overall Study|Reason not Specified|4|||
164266513|NCT02046070|593344469|FG002|Overall Study|Reason not Specified|6|||
164266514|NCT05601102|593344475|FG000|Overall Study|Death|1|||
164266515|NCT05601102|593344476|FG001|Overall Study|Death|2|||
164266516|NCT05601102|593344475|FG000|Overall Study|Withdrawal by Subject|1|||
164266517|NCT05601102|593344476|FG001|Overall Study|Withdrawal by Subject|1|||
164266518|NCT05601102|593344475|FG000|Overall Study|Lost to Follow-up|0|||
164266519|NCT05601102|593344476|FG001|Overall Study|Lost to Follow-up|2|||
164266520|NCT04284813|593344481|FG000|Overall Study|Withdrawal by Subject|1|||
164266521|NCT01145053|593344487|FG000|Overall Study|Adverse Event|22|||
164266522|NCT01145053|593344487|FG000|Overall Study|Lost to Follow-up|28|||
164266523|NCT01145053|593344487|FG000|Overall Study|Withdrawal by Subject|25|||
164266524|NCT01145053|593344487|FG000|Overall Study|Other|18|||
164266525|NCT00293709|593344488|FG000|Overall Study|Other|47|||
164266526|NCT02785458|593344489|FG000|1 Month|Withdrawal by Subject|2|||
164266527|NCT02785458|593344490|FG001|1 Month|Withdrawal by Subject|1|||
164266528|NCT02785458|593344489|FG000|1 Month|Lost to Follow-up|38|||
164266529|NCT02785458|593344490|FG001|1 Month|Lost to Follow-up|31|||
164266530|NCT02785458|593344489|FG000|1 Month|Deemed Ineligible|1|||
164266531|NCT02785458|593344490|FG001|1 Month|Deemed Ineligible|0|||
164266532|NCT02785458|593344489|FG000|1 Month|Completed Evaluation by Baseline|42|||
164266533|NCT02785458|593344490|FG001|1 Month|Completed Evaluation by Baseline|39|||
164266534|NCT02785458|593344489|FG000|1 Month|Partial Interview|0|||
164266535|NCT02785458|593344490|FG001|1 Month|Partial Interview|4|||
164266536|NCT02785458|593344489|FG000|3 Months|Withdrawal by Subject|3|||
164266537|NCT02785458|593344490|FG001|3 Months|Withdrawal by Subject|1|||
163892105|NCT03386578|591976719|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892106|NCT03386578|591976720|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892107|NCT03386578|591976721|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
163892108|NCT03386578|591976722|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
163892109|NCT03386578|591976723|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
163892110|NCT03386578|591976714|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892111|NCT03386578|591976715|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163998064|NCT02764541|592357277|FG006|Overall Study|Adverse Event|1|||
163998065|NCT02764541|592357278|FG007|Overall Study|Adverse Event|0|||
164266538|NCT02785458|593344489|FG000|3 Months|Lost to Follow-up|25|||
164266539|NCT02785458|593344490|FG001|3 Months|Lost to Follow-up|21|||
164266540|NCT02785458|593344489|FG000|3 Months|Completed Evaluation at 1 Month|100|||
164266541|NCT02785458|593344490|FG001|3 Months|Completed Evaluation at 1 Month|89|||
164266542|NCT01146652|593344491|FG000|Overall Study|Adverse Event|506|||
164266543|NCT01146652|593344492|FG001|Overall Study|Adverse Event|15|||
164266544|NCT01146652|593344491|FG000|Overall Study|Lack of Efficacy|91|||
164341855|NCT01619423|593627526|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
163998066|NCT02764541|592357271|FG000|Overall Study|Metastasis|1|||
164266545|NCT01146652|593344492|FG001|Overall Study|Lack of Efficacy|7|||
164266546|NCT01146652|593344491|FG000|Overall Study|Poor compliance to protocol|38|||
164266547|NCT01146652|593344492|FG001|Overall Study|Poor compliance to protocol|1|||
164266548|NCT01146652|593344491|FG000|Overall Study|Other unspecified reasons|314|||
164266549|NCT01146652|593344492|FG001|Overall Study|Other unspecified reasons|22|||
164266550|NCT01146652|593344491|FG000|Overall Study|Enrolled but not treated|2|||
164341856|NCT01619423|593627527|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
164266551|NCT01146652|593344492|FG001|Overall Study|Enrolled but not treated|0|||
164266552|NCT02590562|593344500|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
164341857|NCT01619423|593627528|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
164266553|NCT01457950|593344501|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
164266554|NCT01457950|593344502|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
164266555|NCT01457950|593344503|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
163998067|NCT02764541|592357272|FG001|Overall Study|Metastasis|0|||
164341858|NCT01281865|593627531|FG000|Overall Study|Adverse Event|1|||
164266556|NCT01457950|593344504|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
164266557|NCT01457950|593344501|FG000|Double-Blind Phase|Protocol Violation|2|||
164266558|NCT01457950|593344502|FG001|Double-Blind Phase|Protocol Violation|1|||
164266559|NCT01457950|593344503|FG002|Double-Blind Phase|Protocol Violation|0|||
164266560|NCT01457950|593344504|FG003|Double-Blind Phase|Protocol Violation|0|||
164266561|NCT01457950|593344501|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
164266562|NCT01457950|593344502|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
164266563|NCT01457950|593344503|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164266564|NCT01457950|593344504|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164266565|NCT01457950|593344501|FG000|Open-Label Phase|Adverse Event|0|||
164266566|NCT01457950|593344502|FG001|Open-Label Phase|Adverse Event|0|||
164266567|NCT01457950|593344503|FG002|Open-Label Phase|Adverse Event|0|||
164266568|NCT01457950|593344504|FG003|Open-Label Phase|Adverse Event|1|||
164266569|NCT01457950|593344501|FG000|Open-Label Phase|Protocol Violation|0|||
164266570|NCT01457950|593344502|FG001|Open-Label Phase|Protocol Violation|0|||
164266571|NCT01457950|593344503|FG002|Open-Label Phase|Protocol Violation|0|||
164266572|NCT01457950|593344504|FG003|Open-Label Phase|Protocol Violation|1|||
164266573|NCT01457950|593344501|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164266574|NCT01457950|593344502|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164266575|NCT01457950|593344503|FG002|Open-Label Phase|Withdrawal by Subject|2|||
164266576|NCT01457950|593344504|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164266577|NCT03351114|593344507|FG000|Overall Study|Withdrawal by Subject|1|||
164266578|NCT03249935|593344511|FG000|Overall Study|Discharged from facility early|36|||
164266579|NCT03249935|593344511|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
164266580|NCT03249935|593344511|FG000|Overall Study|Protocol Violation|5|||
164266581|NCT00989235|593344512|FG000|Overall Study|Death|0|||
164266582|NCT00989235|593344513|FG001|Overall Study|Death|1|||
163892112|NCT03386578|591976716|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892113|NCT03386578|591976717|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892114|NCT03386578|591976718|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892115|NCT03386578|591976719|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892116|NCT03386578|591976720|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892117|NCT03386578|591976721|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
163892118|NCT03386578|591976722|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
163892119|NCT03386578|591976723|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
163892120|NCT02424617|591976726|FG000|Overall Study|Adverse Event|0|||
163892121|NCT02424617|591976727|FG001|Overall Study|Adverse Event|1|||
163892122|NCT02424617|591976728|FG002|Overall Study|Adverse Event|0|||
164266583|NCT00989235|593344512|FG000|Overall Study|Adverse Event|0|||
164266584|NCT00989235|593344513|FG001|Overall Study|Adverse Event|1|||
164266585|NCT00989235|593344512|FG000|Overall Study|Lack of Efficacy|1|||
164266586|NCT00989235|593344513|FG001|Overall Study|Lack of Efficacy|0|||
164266587|NCT00989235|593344512|FG000|Overall Study|Withdrawal of Consent|1|||
164266588|NCT00989235|593344513|FG001|Overall Study|Withdrawal of Consent|1|||
164266589|NCT00989235|593344512|FG000|Overall Study|Desire to Become Pregnant|1|||
164266590|NCT00989235|593344513|FG001|Overall Study|Desire to Become Pregnant|0|||
164266591|NCT00989235|593344512|FG000|Overall Study|Randomized by Mistake|0|||
164266592|NCT00989235|593344513|FG001|Overall Study|Randomized by Mistake|2|||
164266593|NCT00989235|593344512|FG000|Overall Study|Lost to Follow-up|0|||
164266594|NCT00989235|593344513|FG001|Overall Study|Lost to Follow-up|1|||
164266595|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
164266596|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
164266597|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
164266598|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
164266599|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
164266600|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
164266601|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
164266602|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
164266603|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
164266604|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
164266605|NCT01352741|593344519|FG000|Open-label Tapentadol Titration Period|Other|4|||
164266606|NCT01352741|593344520|FG001|Open-label Tapentadol Titration Period|Other|0|||
164266607|NCT01352741|593344519|FG000|Double-blind Comparative Period|Protocol Violation|2|||
164266608|NCT01352741|593344520|FG001|Double-blind Comparative Period|Protocol Violation|0|||
164266609|NCT01352741|593344519|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
164266610|NCT01352741|593344520|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
164266611|NCT01352741|593344519|FG000|Double-blind Comparative Period|Adverse Event|16|||
164266612|NCT01352741|593344520|FG001|Double-blind Comparative Period|Adverse Event|17|||
164266613|NCT01352741|593344519|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
164266614|NCT01352741|593344520|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
164266615|NCT01352741|593344519|FG000|Double-blind Comparative Period|Death|0|||
164266616|NCT01352741|593344520|FG001|Double-blind Comparative Period|Death|1|||
164266617|NCT01352741|593344519|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
164266618|NCT01352741|593344520|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
164266619|NCT01352741|593344519|FG000|Double-blind Comparative Period|Other|1|||
164266620|NCT01352741|593344520|FG001|Double-blind Comparative Period|Other|2|||
164266621|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
164266622|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
164266623|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
164266624|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
164266625|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
164266626|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
164266627|NCT01352741|593344519|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
164266628|NCT01352741|593344520|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
164266629|NCT04070326|593344522|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
164266630|NCT04070326|593344523|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
164266631|NCT00645528|593344524|FG000|Overall Study|Did not show up for Visit 2|7|||
164266632|NCT01367704|593344525|FG000|Overall Study|Lost to Follow-up|47|||
164266633|NCT01367704|593344526|FG001|Overall Study|Lost to Follow-up|161|||
164266634|NCT03077698|593344529|FG000|Progestin Monotherapy|Stable Disease|8|||
164266635|NCT03077698|593344530|FG001|Progestin Monotherapy|Stable Disease|0|||
164266636|NCT03077698|593344529|FG000|Progestin Monotherapy|Adverse Event|1|||
164266637|NCT03077698|593344530|FG001|Progestin Monotherapy|Adverse Event|0|||
164266638|NCT03077698|593344529|FG000|Progestin Monotherapy|Death|1|||
163998068|NCT02764541|592357273|FG002|Overall Study|Metastasis|0|||
163998069|NCT02764541|592357274|FG003|Overall Study|Metastasis|0|||
163998070|NCT02764541|592357275|FG004|Overall Study|Metastasis|0|||
163998071|NCT02764541|592357276|FG005|Overall Study|Metastasis|0|||
163998072|NCT02764541|592357277|FG006|Overall Study|Metastasis|0|||
163998073|NCT02764541|592357278|FG007|Overall Study|Metastasis|0|||
163998074|NCT02764541|592357271|FG000|Overall Study|Disease progression|1|||
163998075|NCT02764541|592357272|FG001|Overall Study|Disease progression|1|||
164266639|NCT03077698|593344530|FG001|Progestin Monotherapy|Death|0|||
164266640|NCT03077698|593344529|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
164266641|NCT03077698|593344530|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
164266642|NCT03077698|593344529|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
164266643|NCT03077698|593344530|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
164266644|NCT03077698|593344529|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
164266645|NCT03077698|593344530|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
164266646|NCT03077698|593344529|FG000|Safety Follow Up|Withdrawal by Subject|2|||
164266647|NCT03077698|593344530|FG001|Safety Follow Up|Withdrawal by Subject|1|||
164266648|NCT03077698|593344529|FG000|Safety Follow Up|Transfer of care to hospice|1|||
164266649|NCT03077698|593344530|FG001|Safety Follow Up|Transfer of care to hospice|0|||
164266650|NCT03461406|593344532|FG000|Overall Study|Death|1|||
164266651|NCT03461406|593344533|FG001|Overall Study|Death|2|||
164266652|NCT03461406|593344532|FG000|Overall Study|Consent Withdrawn by Participant|0|||
164266653|NCT03461406|593344533|FG001|Overall Study|Consent Withdrawn by Participant|1|||
164266654|NCT03461406|593344532|FG000|Overall Study|Screen Failure|3|||
164266655|NCT03461406|593344533|FG001|Overall Study|Screen Failure|1|||
164266656|NCT03461406|593344532|FG000|Overall Study|Reason not Specified|1|||
164266657|NCT03461406|593344533|FG001|Overall Study|Reason not Specified|3|||
164266658|NCT03461406|593344532|FG000|Overall Study|Lost to Follow-up|3|||
164266659|NCT03461406|593344533|FG001|Overall Study|Lost to Follow-up|0|||
164266660|NCT01140568|593344534|FG000|Overall Study|disease progression|31|||
164266661|NCT01140568|593344534|FG000|Overall Study|Withdrawal by Subject|1|||
164266662|NCT01140568|593344534|FG000|Overall Study|Screen Fail|4|||
164266663|NCT03618628|593344535|FG000|Overall Study|Death|1|||
164266664|NCT03618628|593344535|FG000|Overall Study|Lost to Follow-up|1|||
164266665|NCT01969500|593344536|FG000|Overall Study|Death|0|||
164266666|NCT01969500|593344537|FG001|Overall Study|Death|1|||
164266667|NCT01969500|593344536|FG000|Overall Study|extended hospitalization|1|||
164266668|NCT01969500|593344537|FG001|Overall Study|extended hospitalization|1|||
163998076|NCT02764541|592357273|FG002|Overall Study|Disease progression|0|||
163998077|NCT02764541|592357274|FG003|Overall Study|Disease progression|0|||
163998078|NCT02764541|592357275|FG004|Overall Study|Disease progression|0|||
163998079|NCT02764541|592357276|FG005|Overall Study|Disease progression|0|||
163998080|NCT02764541|592357277|FG006|Overall Study|Disease progression|0|||
164266669|NCT02193087|593344538|FG000|Overall Study|Adverse Event|2|||
164266670|NCT02193087|593344539|FG001|Overall Study|Adverse Event|0|||
164266671|NCT02193087|593344540|FG002|Overall Study|Adverse Event|0|||
164266672|NCT02193087|593344541|FG003|Overall Study|Adverse Event|11|||
164266673|NCT02193087|593344538|FG000|Overall Study|Lost to Follow-up|14|||
164266674|NCT02193087|593344539|FG001|Overall Study|Lost to Follow-up|6|||
163998081|NCT02764541|592357278|FG007|Overall Study|Disease progression|1|||
163998082|NCT02764541|592357271|FG000|Overall Study|Protocol Violation|0|||
163998083|NCT02764541|592357272|FG001|Overall Study|Protocol Violation|0|||
164266675|NCT02193087|593344540|FG002|Overall Study|Lost to Follow-up|4|||
164266676|NCT02193087|593344541|FG003|Overall Study|Lost to Follow-up|37|||
164266677|NCT02193087|593344538|FG000|Overall Study|Protocol Violation|2|||
164266678|NCT02193087|593344539|FG001|Overall Study|Protocol Violation|0|||
164266679|NCT02193087|593344540|FG002|Overall Study|Protocol Violation|1|||
164266680|NCT02193087|593344541|FG003|Overall Study|Protocol Violation|2|||
164266681|NCT02193087|593344538|FG000|Overall Study|Withdrawal by Subject|10|||
164266682|NCT02193087|593344539|FG001|Overall Study|Withdrawal by Subject|3|||
164266683|NCT02193087|593344540|FG002|Overall Study|Withdrawal by Subject|1|||
164266684|NCT02193087|593344541|FG003|Overall Study|Withdrawal by Subject|19|||
164266685|NCT02193087|593344538|FG000|Overall Study|Other Reason Not Specified|7|||
164266686|NCT02193087|593344539|FG001|Overall Study|Other Reason Not Specified|2|||
164266687|NCT02193087|593344540|FG002|Overall Study|Other Reason Not Specified|1|||
164266688|NCT02193087|593344541|FG003|Overall Study|Other Reason Not Specified|9|||
164266689|NCT02193087|593344538|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
164266690|NCT02193087|593344539|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
164266691|NCT02193087|593344540|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
164266692|NCT02193087|593344541|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
164266693|NCT04096820|593344542|FG000|Overall Study|Did not return for intervention|2|||
164266694|NCT04096820|593344542|FG000|Overall Study|Death|1|||
164266695|NCT01241760|593344543|FG000|Overall Study|Adverse Event|1|||
164266696|NCT01241760|593344544|FG001|Overall Study|Adverse Event|0|||
164266697|NCT01241760|593344543|FG000|Overall Study|Lost to Follow-up|18|||
164266698|NCT01241760|593344544|FG001|Overall Study|Lost to Follow-up|22|||
164266699|NCT01241760|593344543|FG000|Overall Study|Withdrawal by Subject|13|||
164266700|NCT01241760|593344544|FG001|Overall Study|Withdrawal by Subject|13|||
164266701|NCT01241760|593344543|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
164266702|NCT01241760|593344544|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
164266703|NCT01241760|593344543|FG000|Overall Study|Other|1|||
164266704|NCT01241760|593344544|FG001|Overall Study|Other|1|||
164266705|NCT01636713|593344546|FG000|Overall Study|Adverse Event|16|||
164266706|NCT01636713|593344547|FG001|Overall Study|Adverse Event|16|||
164266707|NCT01636713|593344548|FG002|Overall Study|Adverse Event|7|||
164266708|NCT01636713|593344546|FG000|Overall Study|Lack of Efficacy|6|||
164266709|NCT01636713|593344547|FG001|Overall Study|Lack of Efficacy|6|||
164266710|NCT01636713|593344548|FG002|Overall Study|Lack of Efficacy|2|||
164266711|NCT01636713|593344546|FG000|Overall Study|Protocol Violation|3|||
164266712|NCT01636713|593344547|FG001|Overall Study|Protocol Violation|0|||
164266713|NCT01636713|593344548|FG002|Overall Study|Protocol Violation|1|||
164266714|NCT01636713|593344546|FG000|Overall Study|Lost to Follow-up|0|||
164266715|NCT01636713|593344547|FG001|Overall Study|Lost to Follow-up|0|||
164266716|NCT01636713|593344548|FG002|Overall Study|Lost to Follow-up|1|||
164266717|NCT01636713|593344546|FG000|Overall Study|Withdrawal by Subject|5|||
164266718|NCT01636713|593344547|FG001|Overall Study|Withdrawal by Subject|4|||
164266719|NCT01636713|593344548|FG002|Overall Study|Withdrawal by Subject|8|||
164266720|NCT01636713|593344546|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
164266721|NCT01636713|593344547|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
164266722|NCT01636713|593344548|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
164266723|NCT00276614|593344551|FG000|Overall Study|Progression of disease under study|3|||
164266724|NCT02117349|593344554|FG000|Overall Study|Withdrawal by Subject|1|||
164266725|NCT02117349|593344555|FG001|Overall Study|Withdrawal by Subject|0|||
164266726|NCT02117349|593344554|FG000|Overall Study|Lost to Follow-up|1|||
164266727|NCT02117349|593344555|FG001|Overall Study|Lost to Follow-up|1|||
164266728|NCT02117349|593344554|FG000|Overall Study|Death|1|||
164266729|NCT02117349|593344555|FG001|Overall Study|Death|0|||
164266730|NCT01977690|593344558|FG000|Overall Study|Withdrawal by Subject|0|||
164266731|NCT01977690|593344559|FG001|Overall Study|Withdrawal by Subject|4|||
164266732|NCT01711866|593344562|FG000|Overall Study|Noncompliant|3|||
164266733|NCT01711866|593344562|FG000|Overall Study|Withdrawal by Subject|3|||
164266734|NCT01711866|593344562|FG000|Overall Study|Adverse Event|2|||
164266735|NCT00456599|593344563|FG000|Overall Study|Non-compliance|1|||
164266736|NCT00456599|593344563|FG000|Overall Study|Withdrawal by Subject|2|||
164266737|NCT00260065|593344564|FG000|Overall Study|Progressive Disease|22|||
164266738|NCT00260065|593344564|FG000|Overall Study|Adverse Event|17|||
164266739|NCT00260065|593344564|FG000|Overall Study|Death|13|||
164266740|NCT00260065|593344564|FG000|Overall Study|Withdrawal by Subject|13|||
164266741|NCT00260065|593344564|FG000|Overall Study|Physician Decision|19|||
164266742|NCT00260065|593344564|FG000|Overall Study|Not otherwise specified|8|||
164266743|NCT00260065|593344564|FG000|Overall Study|Medication Noncompliance|1|||
164266744|NCT03780959|593344570|FG000|Part 1|Adverse Event|1|||
164266745|NCT03780959|593344571|FG001|Part 1|Adverse Event|0|||
164266746|NCT03780959|593344572|FG002|Part 1|Adverse Event|0|||
164266747|NCT03780959|593344570|FG000|Part 1|Withdrawal by Subject|1|||
164266748|NCT03780959|593344571|FG001|Part 1|Withdrawal by Subject|0|||
164266749|NCT03780959|593344572|FG002|Part 1|Withdrawal by Subject|0|||
164266750|NCT03780959|593344570|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
164266751|NCT03780959|593344571|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
164266752|NCT03780959|593344572|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
164266753|NCT03780959|593344570|FG000|Part 1|Response Status|2|||
164266754|NCT03780959|593344571|FG001|Part 1|Response Status|0|||
164266755|NCT03780959|593344572|FG002|Part 1|Response Status|0|||
164266756|NCT03780959|593344570|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
164266757|NCT03780959|593344571|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
164266758|NCT03780959|593344572|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
164266759|NCT03780959|593344570|FG000|Part 2|Response Status|0|||
164266760|NCT03780959|593344571|FG001|Part 2|Response Status|18|||
164266761|NCT03780959|593344572|FG002|Part 2|Response Status|6|||
164266762|NCT02831933|593346075|FG000|Overall Study|Physician Decision|11|||
164266763|NCT00358436|593346082|FG000|Overall Study|Adverse Event|29|||
164266764|NCT00358436|593346083|FG001|Overall Study|Adverse Event|13|||
164266765|NCT00358436|593346082|FG000|Overall Study|Lack of Efficacy|34|||
164266766|NCT00358436|593346083|FG001|Overall Study|Lack of Efficacy|36|||
164266767|NCT00358436|593346082|FG000|Overall Study|Lost to Follow-up|11|||
164266768|NCT00358436|593346083|FG001|Overall Study|Lost to Follow-up|6|||
164266769|NCT00358436|593346082|FG000|Overall Study|Protocol Violation|8|||
164266770|NCT00358436|593346083|FG001|Overall Study|Protocol Violation|3|||
164266771|NCT00358436|593346082|FG000|Overall Study|Withdrawal by Subject|40|||
164266772|NCT00358436|593346083|FG001|Overall Study|Withdrawal by Subject|17|||
164266773|NCT00358436|593346082|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
164266774|NCT00358436|593346083|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
164266775|NCT00358436|593346082|FG000|Overall Study|COPD exacerbation|22|||
164266776|NCT00358436|593346083|FG001|Overall Study|COPD exacerbation|10|||
164266777|NCT00358436|593346082|FG000|Overall Study|Other|6|||
164266778|NCT00358436|593346083|FG001|Overall Study|Other|1|||
164266779|NCT05065190|593346085|FG000|Overall Study|Other than listed|2|||
164266780|NCT05065190|593346086|FG001|Overall Study|Other than listed|12|||
163998084|NCT02764541|592357273|FG002|Overall Study|Protocol Violation|0|||
163998085|NCT02764541|592357274|FG003|Overall Study|Protocol Violation|1|||
163998086|NCT02764541|592357275|FG004|Overall Study|Protocol Violation|0|||
163998087|NCT02764541|592357276|FG005|Overall Study|Protocol Violation|1|||
163998088|NCT02764541|592357277|FG006|Overall Study|Protocol Violation|0|||
163998089|NCT02764541|592357278|FG007|Overall Study|Protocol Violation|0|||
163998090|NCT02764541|592357271|FG000|Overall Study|Physician Decision|0|||
163998091|NCT02764541|592357272|FG001|Overall Study|Physician Decision|0|||
163998092|NCT02764541|592357273|FG002|Overall Study|Physician Decision|0|||
163998093|NCT02764541|592357274|FG003|Overall Study|Physician Decision|1|||
163998094|NCT02764541|592357275|FG004|Overall Study|Physician Decision|0|||
163998095|NCT02764541|592357276|FG005|Overall Study|Physician Decision|0|||
163998096|NCT02764541|592357277|FG006|Overall Study|Physician Decision|0|||
163998097|NCT02764541|592357278|FG007|Overall Study|Physician Decision|1|||
163998098|NCT02764541|592357271|FG000|Overall Study|Three Cycles completed before surgery|0|||
163998099|NCT02764541|592357272|FG001|Overall Study|Three Cycles completed before surgery|0|||
163998100|NCT02764541|592357273|FG002|Overall Study|Three Cycles completed before surgery|0|||
163998101|NCT02764541|592357274|FG003|Overall Study|Three Cycles completed before surgery|1|||
163998102|NCT02764541|592357275|FG004|Overall Study|Three Cycles completed before surgery|0|||
163998103|NCT02764541|592357276|FG005|Overall Study|Three Cycles completed before surgery|0|||
163998104|NCT02764541|592357277|FG006|Overall Study|Three Cycles completed before surgery|0|||
163998105|NCT02764541|592357278|FG007|Overall Study|Three Cycles completed before surgery|0|||
163998106|NCT02764541|592357271|FG000|Overall Study|Patient Compliance|0|||
163998107|NCT02764541|592357272|FG001|Overall Study|Patient Compliance|0|||
163998108|NCT02764541|592357273|FG002|Overall Study|Patient Compliance|1|||
163998109|NCT02764541|592357274|FG003|Overall Study|Patient Compliance|0|||
163998110|NCT02764541|592357275|FG004|Overall Study|Patient Compliance|0|||
163998111|NCT02764541|592357276|FG005|Overall Study|Patient Compliance|0|||
163998112|NCT02764541|592357277|FG006|Overall Study|Patient Compliance|0|||
163998113|NCT02764541|592357278|FG007|Overall Study|Patient Compliance|0|||
163998114|NCT02764541|592357271|FG000|Overall Study|Death|0|||
163998115|NCT02764541|592357272|FG001|Overall Study|Death|0|||
163998116|NCT02764541|592357273|FG002|Overall Study|Death|0|||
163998117|NCT02764541|592357274|FG003|Overall Study|Death|0|||
163998118|NCT02764541|592357275|FG004|Overall Study|Death|0|||
163998119|NCT02764541|592357276|FG005|Overall Study|Death|0|||
164266781|NCT05065190|593346085|FG000|Overall Study|Lack of Efficacy|4|||
164266782|NCT05065190|593346086|FG001|Overall Study|Lack of Efficacy|0|||
164266783|NCT05065190|593346085|FG000|Overall Study|Adverse Event|1|||
164266784|NCT05065190|593346086|FG001|Overall Study|Adverse Event|10|||
164266785|NCT02769962|593346094|FG000|Overall Study|Physician Decision|0|||
164266786|NCT02769962|593346095|FG001|Overall Study|Physician Decision|0|||
164266787|NCT02769962|593346096|FG002|Overall Study|Physician Decision|0|||
164266788|NCT02769962|593346097|FG003|Overall Study|Physician Decision|0|||
164266789|NCT02769962|593346098|FG004|Overall Study|Physician Decision|0|||
163998120|NCT02764541|592357277|FG006|Overall Study|Death|1|||
163998121|NCT02764541|592357278|FG007|Overall Study|Death|0|||
163998122|NCT02764541|592357271|FG000|Overall Study|Insurance reasons|0|||
163998123|NCT02764541|592357272|FG001|Overall Study|Insurance reasons|0|||
163998124|NCT02764541|592357273|FG002|Overall Study|Insurance reasons|0|||
163998125|NCT02764541|592357274|FG003|Overall Study|Insurance reasons|0|||
164266790|NCT02769962|593346099|FG005|Overall Study|Physician Decision|1|||
163998126|NCT02764541|592357275|FG004|Overall Study|Insurance reasons|0|||
163998127|NCT02764541|592357276|FG005|Overall Study|Insurance reasons|0|||
163998128|NCT02764541|592357277|FG006|Overall Study|Insurance reasons|1|||
163998129|NCT02764541|592357278|FG007|Overall Study|Insurance reasons|0|||
163998130|NCT02048904|592357279|FG000|Overall Study|Withdrawal by Subject|7|||
163998131|NCT02048904|592357279|FG000|Overall Study|Physician Decision|70|||
163998132|NCT01813890|592357281|FG000|Overall Study|Adverse Event|0|||
163998133|NCT01813890|592357282|FG001|Overall Study|Adverse Event|3|||
163998134|NCT01813890|592357283|FG002|Overall Study|Adverse Event|4|||
163998135|NCT01813890|592357281|FG000|Overall Study|Lack of Efficacy|9|||
163998136|NCT01813890|592357282|FG001|Overall Study|Lack of Efficacy|1|||
163998137|NCT01813890|592357283|FG002|Overall Study|Lack of Efficacy|2|||
164266791|NCT02769962|593346100|FG006|Overall Study|Physician Decision|0|||
164266792|NCT02769962|593346101|FG007|Overall Study|Physician Decision|1|||
164266793|NCT02769962|593346094|FG000|Overall Study|Refused further treatment|0|||
164266794|NCT02769962|593346095|FG001|Overall Study|Refused further treatment|0|||
164266795|NCT02769962|593346096|FG002|Overall Study|Refused further treatment|0|||
164266796|NCT02769962|593346097|FG003|Overall Study|Refused further treatment|0|||
164266797|NCT02769962|593346098|FG004|Overall Study|Refused further treatment|0|||
164266798|NCT02769962|593346099|FG005|Overall Study|Refused further treatment|1|||
164266799|NCT02769962|593346100|FG006|Overall Study|Refused further treatment|1|||
164266800|NCT02769962|593346101|FG007|Overall Study|Refused further treatment|0|||
164266801|NCT05565937|593346102|FG000|Overall Study|Adverse Event|0|||
164266802|NCT05565937|593346103|FG001|Overall Study|Adverse Event|1|||
164266803|NCT05565937|593346102|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
164266804|NCT05565937|593346103|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
164266805|NCT05565937|593346102|FG000|Overall Study|Lost to Follow-up|2|||
164266806|NCT05565937|593346103|FG001|Overall Study|Lost to Follow-up|0|||
164266807|NCT05565937|593346102|FG000|Overall Study|Pregnancy|0|||
164266808|NCT05565937|593346103|FG001|Overall Study|Pregnancy|2|||
164266809|NCT05565937|593346102|FG000|Overall Study|Anisometropia|0|||
164266810|NCT05565937|593346103|FG001|Overall Study|Anisometropia|1|||
164266811|NCT04544683|593346104|FG000|Overall Study|Lost to Follow-up|2|||
164266812|NCT04544683|593346104|FG000|Overall Study|Underwent cervical spine surgery|6|||
164266813|NCT00151372|593346105|FG000|Overall Study|Death|12|||
164266814|NCT00151372|593346106|FG001|Overall Study|Death|11|||
164266815|NCT00151372|593346105|FG000|Overall Study|Lost to Follow-up|5|||
164266816|NCT00151372|593346106|FG001|Overall Study|Lost to Follow-up|5|||
164266817|NCT00151372|593346105|FG000|Overall Study|Too sick medically to continue|5|||
164266818|NCT00151372|593346106|FG001|Overall Study|Too sick medically to continue|6|||
164266819|NCT00151372|593346105|FG000|Overall Study|Withdrawal by Subject|7|||
164266820|NCT00151372|593346106|FG001|Overall Study|Withdrawal by Subject|7|||
164266821|NCT04732949|593346109|FG000|Overall Study|Withdrawal by Subject|23|||
164266822|NCT04732949|593346110|FG001|Overall Study|Withdrawal by Subject|27|||
164266823|NCT04732949|593346109|FG000|Overall Study|Protocol Violation|0|||
164266824|NCT04732949|593346110|FG001|Overall Study|Protocol Violation|1|||
164266825|NCT04732949|593346109|FG000|Overall Study|Non-compliance|0|||
164266826|NCT04732949|593346110|FG001|Overall Study|Non-compliance|2|||
164266827|NCT04732949|593346109|FG000|Overall Study|Physician Decision|2|||
164266828|NCT04732949|593346110|FG001|Overall Study|Physician Decision|1|||
164266829|NCT04732949|593346109|FG000|Overall Study|Serious adverse event (Fatal)|16|||
164266830|NCT04732949|593346110|FG001|Overall Study|Serious adverse event (Fatal)|18|||
164266831|NCT04732949|593346109|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
164266832|NCT04732949|593346110|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
164266833|NCT04732949|593346109|FG000|Overall Study|Non-serious adverse event|1|||
164266834|NCT04732949|593346110|FG001|Overall Study|Non-serious adverse event|3|||
164266835|NCT04732949|593346109|FG000|Overall Study|Lost to Follow-up|26|||
164266836|NCT04732949|593346110|FG001|Overall Study|Lost to Follow-up|27|||
164266837|NCT04732949|593346109|FG000|Overall Study|Other|6|||
164266838|NCT04732949|593346110|FG001|Overall Study|Other|3|||
164266839|NCT01023672|593346111|FG000|Overall Study|Worsening disease|2|||
164266840|NCT01023672|593346111|FG000|Overall Study|Death|1|||
164266841|NCT01286077|593346112|FG000|Overall Study|Adverse Event|2|||
164266842|NCT01286077|593346113|FG001|Overall Study|Adverse Event|0|||
164266843|NCT01286077|593346112|FG000|Overall Study|Death|1|||
164266844|NCT01286077|593346113|FG001|Overall Study|Death|0|||
164266845|NCT01286077|593346112|FG000|Overall Study|Protocol Violation|1|||
164266846|NCT01286077|593346113|FG001|Overall Study|Protocol Violation|1|||
163998138|NCT04482647|592357284|FG000|Overall Study|Time constraints|2|||
163998139|NCT04482647|592357284|FG000|Overall Study|Health issues|1|||
163998140|NCT04482647|592357284|FG000|Overall Study|Death in the family|1|||
164266847|NCT01286077|593346112|FG000|Overall Study|Withdrawal by Subject|0|||
164266848|NCT01286077|593346113|FG001|Overall Study|Withdrawal by Subject|2|||
163998141|NCT04482647|592357284|FG000|Overall Study|Disliked the intervention|1|||
163998142|NCT04482647|592357284|FG000|Overall Study|No reasons specified|7|||
163998143|NCT03952559|592357285|FG000|Double Blind Treatment Period|Adverse Event|0|||
164266849|NCT01286077|593346112|FG000|Overall Study|Intercurrent illness|1|||
164266850|NCT01286077|593346113|FG001|Overall Study|Intercurrent illness|0|||
163892123|NCT02424617|591976729|FG003|Overall Study|Adverse Event|0|||
163892124|NCT02424617|591976726|FG000|Overall Study|Investigator Decision|0|||
163892125|NCT02424617|591976727|FG001|Overall Study|Investigator Decision|0|||
163892126|NCT02424617|591976728|FG002|Overall Study|Investigator Decision|0|||
163892127|NCT02424617|591976729|FG003|Overall Study|Investigator Decision|1|||
163892128|NCT02424617|591976726|FG000|Overall Study|Withdrawal by Subject|1|||
163892129|NCT02424617|591976727|FG001|Overall Study|Withdrawal by Subject|1|||
163892130|NCT02424617|591976728|FG002|Overall Study|Withdrawal by Subject|0|||
163892131|NCT02424617|591976729|FG003|Overall Study|Withdrawal by Subject|1|||
163892132|NCT02424617|591976726|FG000|Overall Study|Progressive Disease|7|||
163892133|NCT02424617|591976727|FG001|Overall Study|Progressive Disease|6|||
163892134|NCT02424617|591976728|FG002|Overall Study|Progressive Disease|11|||
163892135|NCT02424617|591976729|FG003|Overall Study|Progressive Disease|10|||
163892136|NCT02424617|591976726|FG000|Overall Study|Other|0|||
163892137|NCT02424617|591976727|FG001|Overall Study|Other|0|||
163892138|NCT02424617|591976728|FG002|Overall Study|Other|0|||
163892139|NCT02424617|591976729|FG003|Overall Study|Other|1|||
163892140|NCT04971109|591976732|FG000|Overall Study|Adverse Event|4|||
163892141|NCT04971109|591976733|FG001|Overall Study|Adverse Event|3|||
163892142|NCT04971109|591976732|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
163892143|NCT04971109|591976733|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
163892144|NCT04971109|591976732|FG000|Overall Study|Lost to Follow-up|8|||
163892145|NCT04971109|591976733|FG001|Overall Study|Lost to Follow-up|2|||
163892146|NCT04971109|591976732|FG000|Overall Study|Physician Decision|5|||
163892147|NCT04971109|591976733|FG001|Overall Study|Physician Decision|0|||
163892148|NCT04971109|591976732|FG000|Overall Study|Protocol Violation|0|||
163892149|NCT04971109|591976733|FG001|Overall Study|Protocol Violation|1|||
163892150|NCT04971109|591976732|FG000|Overall Study|Withdrawal by Subject|18|||
163892151|NCT04971109|591976733|FG001|Overall Study|Withdrawal by Subject|3|||
163892152|NCT04971109|591976732|FG000|Overall Study|Subject was randomized in error|1|||
163892153|NCT04971109|591976733|FG001|Overall Study|Subject was randomized in error|0|||
163892154|NCT04778397|591976736|FG000|Overall Study|Death|59|||
163892155|NCT04778397|591976737|FG001|Overall Study|Death|54|||
163892156|NCT04778397|591976738|FG002|Overall Study|Death|11|||
163892157|NCT04778397|591976739|FG003|Overall Study|Death|9|||
163892158|NCT04778397|591976736|FG000|Overall Study|Study Terminated by Sponsor|34|||
163892159|NCT04778397|591976737|FG001|Overall Study|Study Terminated by Sponsor|42|||
163892160|NCT04778397|591976738|FG002|Overall Study|Study Terminated by Sponsor|15|||
163892161|NCT04778397|591976739|FG003|Overall Study|Study Terminated by Sponsor|12|||
163892162|NCT04778397|591976736|FG000|Overall Study|Withdrew Consent|5|||
163892163|NCT04778397|591976737|FG001|Overall Study|Withdrew Consent|4|||
163892164|NCT04778397|591976738|FG002|Overall Study|Withdrew Consent|1|||
163892165|NCT04778397|591976739|FG003|Overall Study|Withdrew Consent|1|||
163892166|NCT04778397|591976736|FG000|Overall Study|Reason Not Specified|1|||
163892167|NCT04778397|591976737|FG001|Overall Study|Reason Not Specified|3|||
163892168|NCT04778397|591976738|FG002|Overall Study|Reason Not Specified|0|||
163892169|NCT04778397|591976739|FG003|Overall Study|Reason Not Specified|2|||
163892170|NCT04778397|591976736|FG000|Overall Study|Lost to Follow-up|2|||
163892171|NCT04778397|591976737|FG001|Overall Study|Lost to Follow-up|1|||
163892172|NCT04778397|591976738|FG002|Overall Study|Lost to Follow-up|0|||
163892173|NCT04778397|591976739|FG003|Overall Study|Lost to Follow-up|1|||
163892174|NCT03987022|591976741|FG000|Overall Study|Lost to Follow-up|2|||
163892175|NCT03987022|591976742|FG001|Overall Study|Lost to Follow-up|2|||
163892176|NCT03987022|591976741|FG000|Overall Study|Withdrawal by Subject|1|||
163892177|NCT03987022|591976742|FG001|Overall Study|Withdrawal by Subject|0|||
163892178|NCT03308877|591976743|FG000|Overall Study|Lost to Follow-up|32|||
163892179|NCT03308877|591976744|FG001|Overall Study|Lost to Follow-up|28|||
163892180|NCT03523572|591976745|FG000|Dose Escalation|Progressive disease|1|||
163892181|NCT03523572|591976746|FG001|Dose Escalation|Progressive disease|0|||
163892182|NCT03523572|591976747|FG002|Dose Escalation|Progressive disease|0|||
163892183|NCT03523572|591976748|FG003|Dose Escalation|Progressive disease|0|||
163892184|NCT03523572|591976749|FG004|Dose Escalation|Progressive disease|0|||
163892185|NCT03523572|591976750|FG005|Dose Escalation|Progressive disease|0|||
163892186|NCT03523572|591976745|FG000|Dose Escalation|Clinical Progression|0|||
163892187|NCT03523572|591976746|FG001|Dose Escalation|Clinical Progression|1|||
163892188|NCT03523572|591976747|FG002|Dose Escalation|Clinical Progression|0|||
163892189|NCT03523572|591976748|FG003|Dose Escalation|Clinical Progression|0|||
163892190|NCT03523572|591976749|FG004|Dose Escalation|Clinical Progression|0|||
163892191|NCT03523572|591976750|FG005|Dose Escalation|Clinical Progression|0|||
163892192|NCT03523572|591976745|FG000|Dose Escalation|Adverse Event|2|||
163892193|NCT03523572|591976746|FG001|Dose Escalation|Adverse Event|0|||
163892194|NCT03523572|591976747|FG002|Dose Escalation|Adverse Event|0|||
163892195|NCT03523572|591976748|FG003|Dose Escalation|Adverse Event|0|||
163892196|NCT03523572|591976749|FG004|Dose Escalation|Adverse Event|0|||
163892197|NCT03523572|591976750|FG005|Dose Escalation|Adverse Event|0|||
163892198|NCT03523572|591976745|FG000|Dose Escalation|Physician Decision|1|||
163892199|NCT03523572|591976746|FG001|Dose Escalation|Physician Decision|1|||
163892200|NCT03523572|591976747|FG002|Dose Escalation|Physician Decision|0|||
163892201|NCT03523572|591976748|FG003|Dose Escalation|Physician Decision|0|||
163892202|NCT03523572|591976749|FG004|Dose Escalation|Physician Decision|0|||
163892203|NCT03523572|591976750|FG005|Dose Escalation|Physician Decision|0|||
163892204|NCT03523572|591976745|FG000|Dose Expansion|Progressive Disease|0|||
163892205|NCT03523572|591976746|FG001|Dose Expansion|Progressive Disease|0|||
163892206|NCT03523572|591976747|FG002|Dose Expansion|Progressive Disease|9|||
164266851|NCT01286077|593346112|FG000|Overall Study|Non-compliance|1|||
164266852|NCT01286077|593346113|FG001|Overall Study|Non-compliance|0|||
164266853|NCT01286077|593346112|FG000|Overall Study|The subject starts with alternative MMY|0|||
164266854|NCT01286077|593346113|FG001|Overall Study|The subject starts with alternative MMY|3|||
164266855|NCT01286077|593346112|FG000|Overall Study|Patient's decision to stop treatment|3|||
164266856|NCT01286077|593346113|FG001|Overall Study|Patient's decision to stop treatment|0|||
164266857|NCT01286077|593346112|FG000|Overall Study|Progression of disease|0|||
164266858|NCT01286077|593346113|FG001|Overall Study|Progression of disease|1|||
164266859|NCT01286077|593346112|FG000|Overall Study|refill medication not received in time|1|||
164266860|NCT01286077|593346113|FG001|Overall Study|refill medication not received in time|0|||
164266861|NCT02654236|593346114|FG000|Overall Study|Withdrawal by Subject|0|||
164266862|NCT02654236|593346115|FG001|Overall Study|Withdrawal by Subject|0|||
164266863|NCT02654236|593346116|FG002|Overall Study|Withdrawal by Subject|2|||
164266864|NCT01549873|593346117|FG000|Overall Study|Physician Decision|0|||
164266865|NCT01549873|593346118|FG001|Overall Study|Physician Decision|1|||
164266866|NCT02905006|593346119|FG000|Overall Study|Adverse Event|1|||
164266867|NCT02905006|593346120|FG001|Overall Study|Adverse Event|1|||
164266868|NCT02905006|593346121|FG002|Overall Study|Adverse Event|1|||
164266869|NCT02905006|593346122|FG003|Overall Study|Adverse Event|1|||
164266870|NCT02905006|593346123|FG004|Overall Study|Adverse Event|0|||
164266871|NCT02905006|593346124|FG005|Overall Study|Adverse Event|1|||
163892207|NCT03523572|591976748|FG003|Dose Expansion|Progressive Disease|11|||
163892208|NCT03523572|591976749|FG004|Dose Expansion|Progressive Disease|15|||
163892209|NCT03523572|591976750|FG005|Dose Expansion|Progressive Disease|2|||
163892210|NCT03523572|591976745|FG000|Dose Expansion|Clinical Progression|0|||
163892211|NCT03523572|591976746|FG001|Dose Expansion|Clinical Progression|0|||
163892212|NCT03523572|591976747|FG002|Dose Expansion|Clinical Progression|2|||
163892213|NCT03523572|591976748|FG003|Dose Expansion|Clinical Progression|2|||
163892214|NCT03523572|591976749|FG004|Dose Expansion|Clinical Progression|2|||
163892215|NCT03523572|591976750|FG005|Dose Expansion|Clinical Progression|0|||
163892216|NCT03523572|591976745|FG000|Dose Expansion|Adverse Event|0|||
163892217|NCT03523572|591976746|FG001|Dose Expansion|Adverse Event|0|||
163892218|NCT03523572|591976747|FG002|Dose Expansion|Adverse Event|10|||
163892219|NCT03523572|591976748|FG003|Dose Expansion|Adverse Event|1|||
163892220|NCT03523572|591976749|FG004|Dose Expansion|Adverse Event|5|||
163892221|NCT03523572|591976750|FG005|Dose Expansion|Adverse Event|2|||
163892222|NCT03523572|591976745|FG000|Dose Expansion|Withdrawal by Subject|0|||
163892223|NCT03523572|591976746|FG001|Dose Expansion|Withdrawal by Subject|0|||
163892224|NCT03523572|591976747|FG002|Dose Expansion|Withdrawal by Subject|1|||
163892225|NCT03523572|591976748|FG003|Dose Expansion|Withdrawal by Subject|1|||
163892226|NCT03523572|591976749|FG004|Dose Expansion|Withdrawal by Subject|0|||
163892227|NCT03523572|591976750|FG005|Dose Expansion|Withdrawal by Subject|0|||
163892228|NCT03523572|591976745|FG000|Dose Expansion|Physician Decision|0|||
163892229|NCT03523572|591976746|FG001|Dose Expansion|Physician Decision|0|||
163892230|NCT03523572|591976747|FG002|Dose Expansion|Physician Decision|1|||
163892231|NCT03523572|591976748|FG003|Dose Expansion|Physician Decision|0|||
163892232|NCT03523572|591976749|FG004|Dose Expansion|Physician Decision|1|||
163892233|NCT03523572|591976750|FG005|Dose Expansion|Physician Decision|0|||
164266872|NCT02905006|593346119|FG000|Overall Study|Lack of Efficacy|1|||
164266873|NCT02905006|593346120|FG001|Overall Study|Lack of Efficacy|0|||
164266874|NCT02905006|593346121|FG002|Overall Study|Lack of Efficacy|0|||
164266875|NCT02905006|593346122|FG003|Overall Study|Lack of Efficacy|0|||
164266876|NCT02905006|593346123|FG004|Overall Study|Lack of Efficacy|0|||
164266877|NCT02905006|593346124|FG005|Overall Study|Lack of Efficacy|0|||
164266878|NCT02905006|593346119|FG000|Overall Study|Protocol Violation|2|||
164266879|NCT02905006|593346120|FG001|Overall Study|Protocol Violation|0|||
163892234|NCT03523572|591976745|FG000|Dose Expansion|Miscellaneous|0|||
164266880|NCT02905006|593346121|FG002|Overall Study|Protocol Violation|0|||
164266881|NCT02905006|593346122|FG003|Overall Study|Protocol Violation|0|||
164266882|NCT02905006|593346123|FG004|Overall Study|Protocol Violation|0|||
164266883|NCT02905006|593346124|FG005|Overall Study|Protocol Violation|0|||
164266884|NCT02905006|593346119|FG000|Overall Study|Lost to Follow-up|0|||
163892235|NCT03523572|591976746|FG001|Dose Expansion|Miscellaneous|0|||
163892236|NCT03523572|591976747|FG002|Dose Expansion|Miscellaneous|0|||
163892237|NCT03523572|591976748|FG003|Dose Expansion|Miscellaneous|0|||
163892238|NCT03523572|591976749|FG004|Dose Expansion|Miscellaneous|3|||
163892239|NCT03523572|591976750|FG005|Dose Expansion|Miscellaneous|0|||
163892240|NCT04685135|591976756|FG000|Overall Study|Death|126|||
163892241|NCT04685135|591976757|FG001|Overall Study|Death|53|||
163892242|NCT04685135|591976756|FG000|Overall Study|Withdrawal by Subject|12|||
164266885|NCT02905006|593346120|FG001|Overall Study|Lost to Follow-up|0|||
164266886|NCT02905006|593346121|FG002|Overall Study|Lost to Follow-up|0|||
163998144|NCT03952559|592357286|FG001|Double Blind Treatment Period|Adverse Event|2|||
164266887|NCT02905006|593346122|FG003|Overall Study|Lost to Follow-up|1|||
164266888|NCT02905006|593346123|FG004|Overall Study|Lost to Follow-up|1|||
164266889|NCT02905006|593346124|FG005|Overall Study|Lost to Follow-up|0|||
164266890|NCT02905006|593346119|FG000|Overall Study|Withdrawal by Subject|0|||
164266891|NCT02905006|593346120|FG001|Overall Study|Withdrawal by Subject|0|||
164266892|NCT02905006|593346121|FG002|Overall Study|Withdrawal by Subject|1|||
164266893|NCT02905006|593346122|FG003|Overall Study|Withdrawal by Subject|1|||
164266894|NCT02905006|593346123|FG004|Overall Study|Withdrawal by Subject|0|||
164266895|NCT02905006|593346124|FG005|Overall Study|Withdrawal by Subject|1|||
164266896|NCT02905006|593346119|FG000|Overall Study|Screening exclusion criteria met|1|||
164266897|NCT02905006|593346120|FG001|Overall Study|Screening exclusion criteria met|0|||
164266898|NCT02905006|593346121|FG002|Overall Study|Screening exclusion criteria met|0|||
164266899|NCT02905006|593346122|FG003|Overall Study|Screening exclusion criteria met|0|||
164266900|NCT02905006|593346123|FG004|Overall Study|Screening exclusion criteria met|0|||
164266901|NCT02905006|593346124|FG005|Overall Study|Screening exclusion criteria met|0|||
164266902|NCT02905006|593346119|FG000|Overall Study|Lab withdrawal criterion met|0|||
164266903|NCT02905006|593346120|FG001|Overall Study|Lab withdrawal criterion met|1|||
164266904|NCT02905006|593346121|FG002|Overall Study|Lab withdrawal criterion met|2|||
164266905|NCT02905006|593346122|FG003|Overall Study|Lab withdrawal criterion met|2|||
164266906|NCT02905006|593346123|FG004|Overall Study|Lab withdrawal criterion met|2|||
164266907|NCT02905006|593346124|FG005|Overall Study|Lab withdrawal criterion met|1|||
164266908|NCT02905006|593346119|FG000|Overall Study|Positive for Tuberculosis|0|||
164266909|NCT02905006|593346120|FG001|Overall Study|Positive for Tuberculosis|1|||
164266910|NCT02905006|593346121|FG002|Overall Study|Positive for Tuberculosis|0|||
164266911|NCT02905006|593346122|FG003|Overall Study|Positive for Tuberculosis|0|||
164266912|NCT02905006|593346123|FG004|Overall Study|Positive for Tuberculosis|0|||
164266913|NCT02905006|593346124|FG005|Overall Study|Positive for Tuberculosis|0|||
164266914|NCT02905006|593346119|FG000|Overall Study|Subject positive for Hep B|0|||
164266915|NCT02905006|593346120|FG001|Overall Study|Subject positive for Hep B|0|||
164266916|NCT02905006|593346121|FG002|Overall Study|Subject positive for Hep B|1|||
164266917|NCT02905006|593346122|FG003|Overall Study|Subject positive for Hep B|0|||
164266918|NCT02905006|593346123|FG004|Overall Study|Subject positive for Hep B|0|||
164266919|NCT02905006|593346124|FG005|Overall Study|Subject positive for Hep B|0|||
164266920|NCT02905006|593346119|FG000|Overall Study|Patient moved abroad|0|||
164266921|NCT02905006|593346120|FG001|Overall Study|Patient moved abroad|0|||
164266922|NCT02905006|593346121|FG002|Overall Study|Patient moved abroad|0|||
164266923|NCT02905006|593346122|FG003|Overall Study|Patient moved abroad|1|||
164266924|NCT02905006|593346123|FG004|Overall Study|Patient moved abroad|0|||
164266925|NCT02905006|593346124|FG005|Overall Study|Patient moved abroad|0|||
164266926|NCT02905006|593346119|FG000|Overall Study|Patient randomized by mistake|0|||
164266927|NCT02905006|593346120|FG001|Overall Study|Patient randomized by mistake|0|||
164266928|NCT02905006|593346121|FG002|Overall Study|Patient randomized by mistake|0|||
164266929|NCT02905006|593346122|FG003|Overall Study|Patient randomized by mistake|0|||
164266930|NCT02905006|593346123|FG004|Overall Study|Patient randomized by mistake|0|||
164266931|NCT02905006|593346124|FG005|Overall Study|Patient randomized by mistake|1|||
164266932|NCT03627065|593346127|FG000|Overall Study|Study Terminated by sponsor|1|||
164266933|NCT03627065|593346127|FG000|Overall Study|Withdrawal by Subject|2|||
164266934|NCT02797184|593346128|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
164266935|NCT02797184|593346129|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
164266936|NCT06250738|593346130|FG000|Overall Study|Lost to Follow-up|1|||
164266937|NCT02677844|593346131|FG000|Period 3|Withdrawal by Subject|0|||
164266938|NCT02677844|593346132|FG001|Period 3|Withdrawal by Subject|0|||
164266939|NCT02677844|593346133|FG002|Period 3|Withdrawal by Subject|0|||
164266940|NCT02677844|593346134|FG003|Period 3|Withdrawal by Subject|1|||
164266941|NCT02677844|593346135|FG004|Period 3|Withdrawal by Subject|0|||
164266942|NCT02677844|593346136|FG005|Period 3|Withdrawal by Subject|0|||
164266943|NCT02677844|593346137|FG006|Period 3|Withdrawal by Subject|0|||
164266944|NCT01635764|593346138|FG000|Overall Study|Adverse Event|46|||
164266945|NCT01635764|593346138|FG000|Overall Study|Lack of Efficacy|76|||
164266946|NCT01635764|593346138|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
164266947|NCT01635764|593346138|FG000|Overall Study|Protocol Deviation|1|||
164266948|NCT01635764|593346138|FG000|Overall Study|Withdrew Consent|67|||
164266949|NCT01635764|593346138|FG000|Overall Study|Lost to Follow-up|53|||
164266950|NCT01635764|593346138|FG000|Overall Study|Other|28|||
164266951|NCT01816906|593346142|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
164266952|NCT01816906|593346143|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
164266953|NCT01816906|593346142|FG000|Six Months|Lost to Follow-up|14|||
164266954|NCT01816906|593346143|FG001|Six Months|Lost to Follow-up|16|||
164266955|NCT01816906|593346142|FG000|12 Months|Adverse Event|2|||
164266956|NCT01816906|593346143|FG001|12 Months|Adverse Event|2|||
164266957|NCT01816906|593346142|FG000|12 Months|Death|0|||
164266958|NCT01816906|593346143|FG001|12 Months|Death|2|||
163998145|NCT03952559|592357287|FG002|Double Blind Treatment Period|Adverse Event|1|||
164266959|NCT01816906|593346142|FG000|12 Months|Lost to Follow-up|2|||
164266960|NCT01816906|593346143|FG001|12 Months|Lost to Follow-up|1|||
164266961|NCT04375397|593346144|FG000|Overall Study|Death|1|||
164266962|NCT04375397|593346145|FG001|Overall Study|Death|1|||
163998146|NCT03952559|592357288|FG003|Double Blind Treatment Period|Adverse Event|0|||
163998147|NCT03952559|592357289|FG004|Double Blind Treatment Period|Adverse Event|1|||
163998148|NCT03952559|592357285|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
163998149|NCT03952559|592357286|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
163998150|NCT03952559|592357287|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
163998151|NCT03952559|592357288|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
163998152|NCT03952559|592357289|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
163998153|NCT03952559|592357285|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163998154|NCT03952559|592357286|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
163998155|NCT03952559|592357287|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
163998156|NCT03952559|592357288|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
163998157|NCT03952559|592357289|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
163998158|NCT03952559|592357285|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
163998159|NCT03952559|592357286|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
163998160|NCT03952559|592357287|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
163998161|NCT03952559|592357288|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
163998162|NCT03952559|592357289|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
163998163|NCT04980391|592357292|FG000|Overall Study|Death|0|||
163998164|NCT04980391|592357293|FG001|Overall Study|Death|0|||
163998165|NCT04980391|592357294|FG002|Overall Study|Death|1|||
163998166|NCT04980391|592357295|FG003|Overall Study|Death|1|||
163998167|NCT04980391|592357292|FG000|Overall Study|Lost to Follow-up|3|||
164266963|NCT04375397|593346144|FG000|Overall Study|Withdrew consent|2|||
164266964|NCT04375397|593346145|FG001|Overall Study|Withdrew consent|0|||
163998168|NCT04980391|592357293|FG001|Overall Study|Lost to Follow-up|3|||
163998169|NCT04980391|592357294|FG002|Overall Study|Lost to Follow-up|2|||
163998170|NCT04980391|592357295|FG003|Overall Study|Lost to Follow-up|3|||
163998171|NCT04980391|592357292|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
163998172|NCT04980391|592357293|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
163998173|NCT04980391|592357294|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
163998174|NCT04980391|592357295|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
163998175|NCT04980391|592357292|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163998176|NCT04980391|592357293|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163998177|NCT04980391|592357294|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
163998178|NCT04980391|592357295|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163998179|NCT04980391|592357292|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
163998180|NCT04980391|592357293|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
163998181|NCT04980391|592357294|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
163998182|NCT04980391|592357295|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
163998183|NCT04167345|592357296|FG000|Overall Study|Other|1|||
163998184|NCT04167345|592357297|FG001|Overall Study|Other|1|||
163998185|NCT04167345|592357298|FG002|Overall Study|Other|0|||
163998186|NCT04167345|592357299|FG003|Overall Study|Other|0|||
163998187|NCT04167345|592357300|FG004|Overall Study|Other|0|||
163998188|NCT01389245|592359050|FG000|Overall Study|Protocol Violation|10|||
163998189|NCT01389245|592359050|FG000|Overall Study|Lost to Follow-up|3|||
163998190|NCT01389245|592359050|FG000|Overall Study|Withdrawal by Subject|2|||
163998191|NCT05540652|592359051|FG000|Overall Study|Withdrawal by Subject|1|||
163998192|NCT04454489|592359052|FG000|Overall Study|Disease progression|12|||
163998193|NCT04454489|592359052|FG000|Overall Study|Death|4|||
163998194|NCT04454489|592359052|FG000|Overall Study|Adverse Event|1|||
163998195|NCT04454489|592359052|FG000|Overall Study|Physician Decision|1|||
164266965|NCT04375397|593346144|FG000|Overall Study|Lost to Follow-up|6|||
164266966|NCT04375397|593346145|FG001|Overall Study|Lost to Follow-up|4|||
163998198|NCT00442598|592359057|FG000|Overall Study|Adverse Event|1|||
163998199|NCT00442598|592359058|FG001|Overall Study|Adverse Event|0|||
163998200|NCT00442598|592359059|FG002|Overall Study|Adverse Event|0|||
163998201|NCT00442598|592359057|FG000|Overall Study|Tumor progression|3|||
163998202|NCT00442598|592359058|FG001|Overall Study|Tumor progression|4|||
163998203|NCT00442598|592359059|FG002|Overall Study|Tumor progression|0|||
163998204|NCT00442598|592359057|FG000|Overall Study|Clinical deterioration|1|||
163998205|NCT00442598|592359058|FG001|Overall Study|Clinical deterioration|2|||
163998206|NCT00442598|592359059|FG002|Overall Study|Clinical deterioration|0|||
163998207|NCT00442598|592359057|FG000|Overall Study|CA125 progression|0|||
163998208|NCT00442598|592359058|FG001|Overall Study|CA125 progression|1|||
164266967|NCT04375397|593346144|FG000|Overall Study|Other, not specified|0|||
163998209|NCT00442598|592359059|FG002|Overall Study|CA125 progression|0|||
163998210|NCT00442598|592359057|FG000|Overall Study|Reduced creatinine clearance|1|||
164085833|NCT00358826|592678574|FG007|Core Study|Lost to Follow-up|0|||
164085834|NCT00358826|592678567|FG000|Core Study|Physician Decision|0|||
164341859|NCT01281865|593627532|FG001|Overall Study|Adverse Event|1|||
164341860|NCT01281865|593627531|FG000|Overall Study|Withdrawal by Subject|1|||
164341861|NCT01281865|593627532|FG001|Overall Study|Withdrawal by Subject|0|||
164341862|NCT01281865|593627531|FG000|Overall Study|Lack of Efficacy|1|||
164341863|NCT01281865|593627532|FG001|Overall Study|Lack of Efficacy|0|||
164341864|NCT03478657|593627534|FG000|Overall Study|Withdrawal by Subject|0|||
164341865|NCT03478657|593627535|FG001|Overall Study|Withdrawal by Subject|1|||
164341866|NCT04891978|593627536|FG000|Baseline|Protocol Violation|2|||
164341867|NCT04891978|593627537|FG001|Baseline|Protocol Violation|1|||
164341868|NCT04891978|593627538|FG002|Baseline|Protocol Violation|0|||
164341869|NCT04891978|593627536|FG000|Baseline|Missing AIRQ|1|||
164341870|NCT04891978|593627537|FG001|Baseline|Missing AIRQ|0|||
164341871|NCT04891978|593627538|FG002|Baseline|Missing AIRQ|0|||
164341872|NCT04891978|593627536|FG000|Baseline|Did not attend a baseline visit|0|||
164341873|NCT04891978|593627537|FG001|Baseline|Did not attend a baseline visit|0|||
164341874|NCT04891978|593627538|FG002|Baseline|Did not attend a baseline visit|9|||
164341875|NCT01776840|593627539|FG000|Overall Study|Lost to Follow-up|12|||
164341876|NCT01776840|593627540|FG001|Overall Study|Lost to Follow-up|7|||
164341877|NCT01776840|593627539|FG000|Overall Study|Withdrawal by Subject|32|||
164341878|NCT01776840|593627540|FG001|Overall Study|Withdrawal by Subject|48|||
164341879|NCT01776840|593627539|FG000|Overall Study|Sponsor decision|89|||
164341880|NCT01776840|593627540|FG001|Overall Study|Sponsor decision|87|||
164341881|NCT05338216|593627541|FG000|Overall Study|Withdrawal by Subject|1|||
164341882|NCT05338216|593627542|FG001|Overall Study|Withdrawal by Subject|1|||
164341883|NCT02589405|593627546|FG000|Overall Study|Adverse Event|3|||
164341884|NCT02589405|593627546|FG000|Overall Study|Withdrawal by Subject|1|||
164341885|NCT02693119|593627547|FG000|Open-Label Period|Withdrawal by Subject|0|||
164341886|NCT02693119|593627548|FG001|Open-Label Period|Withdrawal by Subject|1|||
164341887|NCT01719783|593627549|FG000|Dose 2|Physician Decision|1|||
164341888|NCT01719783|593627550|FG001|Dose 2|Physician Decision|0|||
164341889|NCT01350492|593627551|FG000|Intervention|Lost to Follow-up|2|||
164341890|NCT01350492|593627552|FG001|Intervention|Lost to Follow-up|5|||
163998211|NCT00442598|592359058|FG001|Overall Study|Reduced creatinine clearance|0|||
163998212|NCT00442598|592359059|FG002|Overall Study|Reduced creatinine clearance|0|||
163998213|NCT00442598|592359057|FG000|Overall Study|Death|0|||
163998214|NCT00442598|592359058|FG001|Overall Study|Death|1|||
163998215|NCT00442598|592359059|FG002|Overall Study|Death|0|||
163998216|NCT02886702|592359060|FG000|Overall Study|Other|4|||
164341891|NCT01350492|593627551|FG000|Intervention|Withdrawal by Subject|3|||
164341892|NCT01350492|593627552|FG001|Intervention|Withdrawal by Subject|1|||
164341893|NCT01350492|593627551|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
164341894|NCT01350492|593627552|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
164341895|NCT01350492|593627551|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
164341896|NCT01350492|593627552|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
164341897|NCT00753766|593627553|FG000|Overall Study|Physician Decision|1|||
164341898|NCT00753766|593627554|FG001|Overall Study|Physician Decision|0|||
164341899|NCT03800173|593627557|FG000|Overall Study|Lost to Follow-up|0|||
164341900|NCT03800173|593627558|FG001|Overall Study|Lost to Follow-up|0|||
164341901|NCT03800173|593627559|FG002|Overall Study|Lost to Follow-up|0|||
164341902|NCT03800173|593627560|FG003|Overall Study|Lost to Follow-up|0|||
164341903|NCT03800173|593627561|FG004|Overall Study|Lost to Follow-up|1|||
164341904|NCT00932126|593627564|FG000|Overall Study|Adverse Event|0|||
164341905|NCT00932126|593627565|FG001|Overall Study|Adverse Event|0|||
164341906|NCT00932126|593627566|FG002|Overall Study|Adverse Event|0|||
164341907|NCT00932126|593627567|FG003|Overall Study|Adverse Event|0|||
164341908|NCT00932126|593627568|FG004|Overall Study|Adverse Event|0|||
164341909|NCT00932126|593627569|FG005|Overall Study|Adverse Event|0|||
164341910|NCT00932126|593627570|FG006|Overall Study|Adverse Event|1|||
163998217|NCT02886702|592359061|FG001|Overall Study|Other|3|||
163998218|NCT02886702|592359062|FG002|Overall Study|Other|9|||
163998219|NCT02886702|592359060|FG000|Overall Study|Withdrawal by Subject|24|||
163998220|NCT02886702|592359061|FG001|Overall Study|Withdrawal by Subject|18|||
164341911|NCT00932126|593627571|FG007|Overall Study|Adverse Event|2|||
164341912|NCT00932126|593627564|FG000|Overall Study|Protocol Violation|0|||
163998221|NCT02886702|592359062|FG002|Overall Study|Withdrawal by Subject|22|||
163998222|NCT02886702|592359060|FG000|Overall Study|Significant Worsening of Condition|0|||
163998223|NCT02886702|592359061|FG001|Overall Study|Significant Worsening of Condition|1|||
164341913|NCT00932126|593627565|FG001|Overall Study|Protocol Violation|0|||
164341914|NCT00932126|593627566|FG002|Overall Study|Protocol Violation|0|||
164341915|NCT00932126|593627567|FG003|Overall Study|Protocol Violation|0|||
164341916|NCT00932126|593627568|FG004|Overall Study|Protocol Violation|1|||
164341917|NCT00932126|593627569|FG005|Overall Study|Protocol Violation|0|||
164341918|NCT00932126|593627570|FG006|Overall Study|Protocol Violation|0|||
164341919|NCT00932126|593627571|FG007|Overall Study|Protocol Violation|0|||
164341920|NCT00932126|593627564|FG000|Overall Study|Withdrawal by Subject|0|||
164341921|NCT00932126|593627565|FG001|Overall Study|Withdrawal by Subject|0|||
164341922|NCT00932126|593627566|FG002|Overall Study|Withdrawal by Subject|1|||
164341923|NCT00932126|593627567|FG003|Overall Study|Withdrawal by Subject|0|||
164341924|NCT00932126|593627568|FG004|Overall Study|Withdrawal by Subject|0|||
163892243|NCT04685135|591976757|FG001|Overall Study|Withdrawal by Subject|16|||
163892244|NCT02315703|591976758|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163892245|NCT02315703|591976759|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163892246|NCT02315703|591976760|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163892247|NCT02315703|591976761|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
163892248|NCT02315703|591976762|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
163892249|NCT02315703|591976763|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163892250|NCT02315703|591976764|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
163892251|NCT02315703|591976765|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
163892252|NCT02315703|591976758|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
163892253|NCT02315703|591976759|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
163892254|NCT02315703|591976760|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
163892255|NCT02315703|591976761|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
163892256|NCT02315703|591976762|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
164085835|NCT00358826|592678568|FG001|Core Study|Physician Decision|0|||
164085836|NCT00358826|592678569|FG002|Core Study|Physician Decision|1|||
164085837|NCT00358826|592678570|FG003|Core Study|Physician Decision|0|||
164085838|NCT00358826|592678571|FG004|Core Study|Physician Decision|0|||
164085839|NCT00358826|592678572|FG005|Core Study|Physician Decision|0|||
164085840|NCT00358826|592678573|FG006|Core Study|Physician Decision|0|||
164085841|NCT00358826|592678574|FG007|Core Study|Physician Decision|0|||
164085842|NCT00358826|592678567|FG000|MDCT Substudy|Adverse Event|0|||
164085843|NCT00358826|592678568|FG001|MDCT Substudy|Adverse Event|0|||
163892257|NCT02315703|591976763|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
163892258|NCT02315703|591976764|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
163892259|NCT02315703|591976765|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
163892260|NCT02315703|591976758|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163892261|NCT02315703|591976759|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
164085844|NCT00358826|592678569|FG002|MDCT Substudy|Adverse Event|0|||
164085845|NCT00358826|592678570|FG003|MDCT Substudy|Adverse Event|0|||
164085846|NCT00358826|592678571|FG004|MDCT Substudy|Adverse Event|1|||
164085847|NCT00358826|592678572|FG005|MDCT Substudy|Adverse Event|0|||
164085848|NCT00358826|592678573|FG006|MDCT Substudy|Adverse Event|0|||
164085849|NCT00358826|592678574|FG007|MDCT Substudy|Adverse Event|0|||
164085850|NCT00358826|592678567|FG000|MDCT Substudy|Lost to Follow-up|0|||
164085851|NCT00358826|592678568|FG001|MDCT Substudy|Lost to Follow-up|0|||
163892262|NCT02315703|591976760|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163892263|NCT02315703|591976761|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163892264|NCT02315703|591976762|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163892265|NCT02315703|591976763|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
163892266|NCT02315703|591976764|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
163892267|NCT02315703|591976765|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
163892268|NCT02315703|591976758|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164085852|NCT00358826|592678569|FG002|MDCT Substudy|Lost to Follow-up|0|||
164085853|NCT00358826|592678570|FG003|MDCT Substudy|Lost to Follow-up|0|||
164085854|NCT00358826|592678571|FG004|MDCT Substudy|Lost to Follow-up|0|||
164085855|NCT00358826|592678572|FG005|MDCT Substudy|Lost to Follow-up|1|||
164085856|NCT00358826|592678573|FG006|MDCT Substudy|Lost to Follow-up|0|||
164085857|NCT00358826|592678574|FG007|MDCT Substudy|Lost to Follow-up|0|||
164085858|NCT00358826|592678567|FG000|MDCT Substudy|Withdrawal by Subject|0|||
164085859|NCT00358826|592678568|FG001|MDCT Substudy|Withdrawal by Subject|0|||
164085860|NCT00358826|592678569|FG002|MDCT Substudy|Withdrawal by Subject|0|||
164266968|NCT04375397|593346145|FG001|Overall Study|Other, not specified|1|||
164266969|NCT00086502|593346146|FG000|Overall Study|Adverse Event|11|||
164266970|NCT00086502|593346147|FG001|Overall Study|Adverse Event|2|||
164266971|NCT00086502|593346146|FG000|Overall Study|Lack of Efficacy|0|||
164266972|NCT00086502|593346147|FG001|Overall Study|Lack of Efficacy|2|||
164266973|NCT00086502|593346146|FG000|Overall Study|Lost to Follow-up|3|||
164266974|NCT00086502|593346147|FG001|Overall Study|Lost to Follow-up|1|||
164085861|NCT00358826|592678570|FG003|MDCT Substudy|Withdrawal by Subject|0|||
164085862|NCT00358826|592678571|FG004|MDCT Substudy|Withdrawal by Subject|0|||
164085863|NCT00358826|592678572|FG005|MDCT Substudy|Withdrawal by Subject|1|||
164085864|NCT00358826|592678573|FG006|MDCT Substudy|Withdrawal by Subject|0|||
164085865|NCT00358826|592678574|FG007|MDCT Substudy|Withdrawal by Subject|0|||
164085866|NCT00283686|592678575|FG000|Overall Study|Death|1|||
164085867|NCT00283686|592678576|FG001|Overall Study|Death|1|||
164085868|NCT00283686|592678577|FG002|Overall Study|Death|1|||
164085869|NCT00283686|592678578|FG003|Overall Study|Death|0|||
164085870|NCT00283686|592678575|FG000|Overall Study|Lost to Follow-up|21|||
164266975|NCT00086502|593346146|FG000|Overall Study|Physician Decision|1|||
164266976|NCT00086502|593346147|FG001|Overall Study|Physician Decision|1|||
164266977|NCT00086502|593346146|FG000|Overall Study|Pregnancy|0|||
164266978|NCT00086502|593346147|FG001|Overall Study|Pregnancy|1|||
163892269|NCT02315703|591976759|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
164085871|NCT00283686|592678576|FG001|Overall Study|Lost to Follow-up|31|||
164266979|NCT00086502|593346146|FG000|Overall Study|Protocol Violation|3|||
164266980|NCT00086502|593346147|FG001|Overall Study|Protocol Violation|3|||
164266981|NCT00086502|593346146|FG000|Overall Study|Withdrawal by Subject|5|||
164266982|NCT00086502|593346147|FG001|Overall Study|Withdrawal by Subject|6|||
164266983|NCT00086502|593346146|FG000|Overall Study|Patient Moved|1|||
164266984|NCT00086502|593346147|FG001|Overall Study|Patient Moved|1|||
164266985|NCT00086502|593346146|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
164266986|NCT00086502|593346147|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
164266987|NCT00086502|593346146|FG000|Overall Study|Patient Accidentally Unblinded|1|||
164266988|NCT00086502|593346147|FG001|Overall Study|Patient Accidentally Unblinded|0|||
164266989|NCT01304329|593346148|FG000|Third Intervention (3 Days)|Adverse Event|0|||
164266990|NCT01304329|593346149|FG001|Third Intervention (3 Days)|Adverse Event|1|||
164266991|NCT01304329|593346150|FG002|Third Intervention (3 Days)|Adverse Event|0|||
164266992|NCT01304329|593346151|FG003|Third Intervention (3 Days)|Adverse Event|0|||
164266993|NCT01304329|593346152|FG004|Third Intervention (3 Days)|Adverse Event|0|||
164266994|NCT01304329|593346153|FG005|Third Intervention (3 Days)|Adverse Event|0|||
164266995|NCT05545644|593346158|FG000|Overall Study|Lost to Follow-up|4|||
164266996|NCT05545644|593346159|FG001|Overall Study|Lost to Follow-up|3|||
164266997|NCT01945775|593346163|FG000|Overall Study|Death|214|||
163892270|NCT02315703|591976760|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163892271|NCT02315703|591976761|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163892272|NCT02315703|591976762|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163892273|NCT02315703|591976763|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163892274|NCT02315703|591976764|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
163892275|NCT02315703|591976765|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
163892276|NCT02315703|591976758|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
163892277|NCT02315703|591976759|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
163892278|NCT02315703|591976760|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
163892279|NCT02315703|591976761|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
163892280|NCT02315703|591976762|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
163892281|NCT02315703|591976763|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
163892282|NCT02315703|591976764|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
163892283|NCT02315703|591976765|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
163892284|NCT02315703|591976758|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
163892285|NCT02315703|591976759|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
163892286|NCT02315703|591976760|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
163892287|NCT02315703|591976761|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
163892288|NCT02315703|591976762|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
163892289|NCT02315703|591976763|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
163892290|NCT02315703|591976764|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
163892291|NCT02315703|591976765|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
163892292|NCT02315703|591976758|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
163892293|NCT02315703|591976759|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
163892294|NCT02315703|591976760|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163892295|NCT02315703|591976761|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163892296|NCT02315703|591976762|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163892297|NCT02315703|591976763|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163892298|NCT02315703|591976764|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163892299|NCT02315703|591976765|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
163892300|NCT02315703|591976758|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892301|NCT02315703|591976759|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
163892302|NCT02315703|591976760|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892303|NCT02315703|591976761|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892304|NCT02315703|591976762|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892305|NCT02315703|591976763|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892306|NCT02315703|591976764|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892307|NCT02315703|591976765|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
163892308|NCT02315703|591976758|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
163892309|NCT02315703|591976759|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
163892310|NCT02315703|591976760|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
163892311|NCT02315703|591976761|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
163892312|NCT02315703|591976762|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
163892313|NCT02315703|591976763|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
164266998|NCT01945775|593346164|FG001|Overall Study|Death|98|||
164266999|NCT01945775|593346163|FG000|Overall Study|Lost to Follow-up|12|||
164267000|NCT01945775|593346164|FG001|Overall Study|Lost to Follow-up|7|||
163892314|NCT02315703|591976764|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
163892315|NCT02315703|591976765|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
163892316|NCT02724969|591976769|FG000|Overall Study|Lost to Follow-up|12|||
163892317|NCT02724969|591976770|FG001|Overall Study|Lost to Follow-up|6|||
164267001|NCT01945775|593346163|FG000|Overall Study|Withdrawal by Subject|11|||
164267002|NCT01945775|593346164|FG001|Overall Study|Withdrawal by Subject|21|||
164267003|NCT01945775|593346163|FG000|Overall Study|Other|50|||
164267004|NCT01945775|593346164|FG001|Overall Study|Other|18|||
164267005|NCT02876328|593346165|FG000|Overall Study|Death|2|||
164267006|NCT02876328|593346166|FG001|Overall Study|Death|1|||
164267007|NCT02876328|593346167|FG002|Overall Study|Death|3|||
164267008|NCT02876328|593346168|FG003|Overall Study|Death|0|||
164267009|NCT02876328|593346169|FG004|Overall Study|Death|0|||
164267010|NCT02876328|593346170|FG005|Overall Study|Death|0|||
164267011|NCT02876328|593346171|FG006|Overall Study|Death|1|||
164267012|NCT02876328|593346172|FG007|Overall Study|Death|3|||
163998224|NCT02886702|592359062|FG002|Overall Study|Significant Worsening of Condition|0|||
163998225|NCT02886702|592359060|FG000|Overall Study|Protocol Violation|2|||
163998226|NCT02886702|592359061|FG001|Overall Study|Protocol Violation|2|||
163998227|NCT02886702|592359062|FG002|Overall Study|Protocol Violation|1|||
163998228|NCT02886702|592359060|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163998229|NCT02886702|592359061|FG001|Overall Study|Non-Compliance With Study Drug|1|||
163998230|NCT02886702|592359062|FG002|Overall Study|Non-Compliance With Study Drug|4|||
163998231|NCT02886702|592359060|FG000|Overall Study|Lost to Follow-up|11|||
163998232|NCT02886702|592359061|FG001|Overall Study|Lost to Follow-up|13|||
163998233|NCT02886702|592359062|FG002|Overall Study|Lost to Follow-up|8|||
163998234|NCT02886702|592359060|FG000|Overall Study|Lack of Efficacy|3|||
163998235|NCT02886702|592359061|FG001|Overall Study|Lack of Efficacy|4|||
163998236|NCT02886702|592359062|FG002|Overall Study|Lack of Efficacy|5|||
163998237|NCT02886702|592359060|FG000|Overall Study|Adverse Event|4|||
163998238|NCT02886702|592359061|FG001|Overall Study|Adverse Event|9|||
163998239|NCT02886702|592359062|FG002|Overall Study|Adverse Event|3|||
163998240|NCT02886702|592359060|FG000|Overall Study|Administrative Reasons|0|||
163998241|NCT02886702|592359061|FG001|Overall Study|Administrative Reasons|0|||
163998242|NCT02886702|592359062|FG002|Overall Study|Administrative Reasons|1|||
163998243|NCT01025635|592359075|FG000|Overall Study|Withdrawal by Subject|6|||
163998244|NCT01025635|592359076|FG001|Overall Study|Withdrawal by Subject|7|||
163998245|NCT01025635|592359075|FG000|Overall Study|Protocol Violation|4|||
163998246|NCT01025635|592359076|FG001|Overall Study|Protocol Violation|2|||
163998247|NCT01025635|592359075|FG000|Overall Study|Lack of Efficacy|0|||
163998248|NCT01025635|592359076|FG001|Overall Study|Lack of Efficacy|1|||
163998249|NCT01025635|592359075|FG000|Overall Study|Lost to Follow-up|9|||
163998250|NCT01025635|592359076|FG001|Overall Study|Lost to Follow-up|13|||
163998251|NCT01025635|592359075|FG000|Overall Study|Reason not known|4|||
163998252|NCT01025635|592359076|FG001|Overall Study|Reason not known|2|||
163998253|NCT02393209|592359077|FG000|Overall Study|Study Terminated by Sponsor|1|||
163998254|NCT02393209|592359078|FG001|Overall Study|Study Terminated by Sponsor|1|||
163998255|NCT02393209|592359079|FG002|Overall Study|Study Terminated by Sponsor|0|||
163998256|NCT02393209|592359080|FG003|Overall Study|Study Terminated by Sponsor|0|||
163998257|NCT02393209|592359077|FG000|Overall Study|Withdrawal by Patient|1|||
163998258|NCT02393209|592359078|FG001|Overall Study|Withdrawal by Patient|0|||
163998259|NCT02393209|592359079|FG002|Overall Study|Withdrawal by Patient|0|||
163998260|NCT02393209|592359080|FG003|Overall Study|Withdrawal by Patient|0|||
163998261|NCT02393209|592359077|FG000|Overall Study|Death|2|||
163998262|NCT02393209|592359078|FG001|Overall Study|Death|2|||
163998263|NCT02393209|592359079|FG002|Overall Study|Death|0|||
163998264|NCT02393209|592359080|FG003|Overall Study|Death|0|||
163998265|NCT02393209|592359077|FG000|Overall Study|Death due to Disease Progression|2|||
163998266|NCT02393209|592359078|FG001|Overall Study|Death due to Disease Progression|2|||
163998267|NCT02393209|592359079|FG002|Overall Study|Death due to Disease Progression|0|||
163998268|NCT02393209|592359080|FG003|Overall Study|Death due to Disease Progression|0|||
163998269|NCT02393209|592359077|FG000|Overall Study|Death from Legionella Infection|0|||
163998270|NCT02393209|592359078|FG001|Overall Study|Death from Legionella Infection|1|||
163998271|NCT02393209|592359079|FG002|Overall Study|Death from Legionella Infection|0|||
164267013|NCT02876328|593346173|FG008|Overall Study|Death|0|||
164267014|NCT02876328|593346174|FG009|Overall Study|Death|1|||
164267015|NCT02876328|593346175|FG010|Overall Study|Death|1|||
163998272|NCT02393209|592359080|FG003|Overall Study|Death from Legionella Infection|0|||
163998273|NCT02393209|592359077|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
163998274|NCT02393209|592359078|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
163998275|NCT02393209|592359079|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
163998276|NCT02393209|592359080|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
163998277|NCT02393209|592359077|FG000|Overall Study|Lost to Follow-up|0|||
164267016|NCT02876328|593346176|FG011|Overall Study|Death|0|||
164267017|NCT02876328|593346177|FG012|Overall Study|Death|0|||
164267018|NCT02876328|593346178|FG013|Overall Study|Death|0|||
163998278|NCT02393209|592359078|FG001|Overall Study|Lost to Follow-up|1|||
163892318|NCT02724969|591976769|FG000|Overall Study|Withdrawal by Subject|3|||
163892319|NCT02724969|591976770|FG001|Overall Study|Withdrawal by Subject|3|||
164267019|NCT02876328|593346179|FG014|Overall Study|Death|0|||
163998279|NCT02393209|592359079|FG002|Overall Study|Lost to Follow-up|0|||
163998280|NCT02393209|592359080|FG003|Overall Study|Lost to Follow-up|0|||
163998281|NCT03545282|592359081|FG000|Overall Study|Lost to Follow-up|15|||
163998282|NCT03545282|592359082|FG001|Overall Study|Lost to Follow-up|10|||
163998283|NCT03545282|592359081|FG000|Overall Study|Withdrawal by Subject|2|||
163998284|NCT03545282|592359082|FG001|Overall Study|Withdrawal by Subject|2|||
163998285|NCT00755079|592359083|FG000|Overall Study|Lost to Follow-up|1|||
164267020|NCT02876328|593346180|FG015|Overall Study|Death|0|||
164267021|NCT02876328|593346181|FG016|Overall Study|Death|1|||
164267022|NCT02876328|593346182|FG017|Overall Study|Death|1|||
164267023|NCT02876328|593346183|FG018|Overall Study|Death|0|||
164267024|NCT02876328|593346184|FG019|Overall Study|Death|0|||
164267025|NCT02876328|593346185|FG020|Overall Study|Death|0|||
164267026|NCT02876328|593346186|FG021|Overall Study|Death|1|||
164267027|NCT02876328|593346187|FG022|Overall Study|Death|0|||
164267028|NCT02876328|593346188|FG023|Overall Study|Death|0|||
164267029|NCT02876328|593346165|FG000|Overall Study|Withdrawal by Subject|0|||
164267030|NCT02876328|593346166|FG001|Overall Study|Withdrawal by Subject|2|||
164267031|NCT02876328|593346167|FG002|Overall Study|Withdrawal by Subject|3|||
163998286|NCT00755079|592359084|FG001|Overall Study|Lost to Follow-up|3|||
163998287|NCT00755079|592359083|FG000|Overall Study|Adverse Event|0|||
164267032|NCT02876328|593346168|FG003|Overall Study|Withdrawal by Subject|3|||
164267033|NCT02876328|593346169|FG004|Overall Study|Withdrawal by Subject|0|||
164267034|NCT02876328|593346170|FG005|Overall Study|Withdrawal by Subject|1|||
163998288|NCT00755079|592359084|FG001|Overall Study|Adverse Event|1|||
163998289|NCT00755079|592359083|FG000|Overall Study|Withdrawal by Subject|0|||
163998290|NCT00755079|592359084|FG001|Overall Study|Withdrawal by Subject|2|||
164267035|NCT02876328|593346171|FG006|Overall Study|Withdrawal by Subject|0|||
164267036|NCT02876328|593346172|FG007|Overall Study|Withdrawal by Subject|1|||
164267037|NCT02876328|593346173|FG008|Overall Study|Withdrawal by Subject|1|||
164267038|NCT02876328|593346174|FG009|Overall Study|Withdrawal by Subject|2|||
164267039|NCT02876328|593346175|FG010|Overall Study|Withdrawal by Subject|0|||
164267040|NCT02876328|593346176|FG011|Overall Study|Withdrawal by Subject|0|||
164267041|NCT02876328|593346177|FG012|Overall Study|Withdrawal by Subject|0|||
164267042|NCT02876328|593346178|FG013|Overall Study|Withdrawal by Subject|0|||
164267043|NCT02876328|593346179|FG014|Overall Study|Withdrawal by Subject|0|||
164267044|NCT02876328|593346180|FG015|Overall Study|Withdrawal by Subject|0|||
164267045|NCT02876328|593346181|FG016|Overall Study|Withdrawal by Subject|1|||
164267046|NCT02876328|593346182|FG017|Overall Study|Withdrawal by Subject|3|||
164267047|NCT02876328|593346183|FG018|Overall Study|Withdrawal by Subject|0|||
164267048|NCT02876328|593346184|FG019|Overall Study|Withdrawal by Subject|0|||
164267049|NCT02876328|593346185|FG020|Overall Study|Withdrawal by Subject|1|||
164267050|NCT02876328|593346186|FG021|Overall Study|Withdrawal by Subject|0|||
164267051|NCT02876328|593346187|FG022|Overall Study|Withdrawal by Subject|0|||
164267052|NCT02876328|593346188|FG023|Overall Study|Withdrawal by Subject|0|||
164267053|NCT02876328|593346165|FG000|Overall Study|Missed 12 Month Visit|15|||
164267054|NCT02876328|593346166|FG001|Overall Study|Missed 12 Month Visit|10|||
164267055|NCT02876328|593346167|FG002|Overall Study|Missed 12 Month Visit|11|||
164267056|NCT02876328|593346168|FG003|Overall Study|Missed 12 Month Visit|6|||
164267057|NCT02876328|593346169|FG004|Overall Study|Missed 12 Month Visit|10|||
164267058|NCT02876328|593346170|FG005|Overall Study|Missed 12 Month Visit|14|||
164267059|NCT02876328|593346171|FG006|Overall Study|Missed 12 Month Visit|3|||
164267060|NCT02876328|593346172|FG007|Overall Study|Missed 12 Month Visit|8|||
164267061|NCT02876328|593346173|FG008|Overall Study|Missed 12 Month Visit|9|||
164267062|NCT02876328|593346174|FG009|Overall Study|Missed 12 Month Visit|5|||
164267063|NCT02876328|593346175|FG010|Overall Study|Missed 12 Month Visit|4|||
164267064|NCT02876328|593346176|FG011|Overall Study|Missed 12 Month Visit|1|||
164267065|NCT02876328|593346177|FG012|Overall Study|Missed 12 Month Visit|5|||
164267066|NCT02876328|593346178|FG013|Overall Study|Missed 12 Month Visit|4|||
164267067|NCT02876328|593346179|FG014|Overall Study|Missed 12 Month Visit|4|||
164267068|NCT02876328|593346180|FG015|Overall Study|Missed 12 Month Visit|4|||
164267069|NCT02876328|593346181|FG016|Overall Study|Missed 12 Month Visit|3|||
164267070|NCT02876328|593346182|FG017|Overall Study|Missed 12 Month Visit|6|||
164267071|NCT02876328|593346183|FG018|Overall Study|Missed 12 Month Visit|2|||
164267072|NCT02876328|593346184|FG019|Overall Study|Missed 12 Month Visit|2|||
164267073|NCT02876328|593346185|FG020|Overall Study|Missed 12 Month Visit|11|||
164267074|NCT02876328|593346186|FG021|Overall Study|Missed 12 Month Visit|7|||
164267075|NCT02876328|593346187|FG022|Overall Study|Missed 12 Month Visit|1|||
164267076|NCT02876328|593346188|FG023|Overall Study|Missed 12 Month Visit|0|||
164267077|NCT01995552|593346189|FG000|Overall Study|Protocol Violation|1|||
164267078|NCT01995552|593346189|FG000|Overall Study|Lack of Efficacy|15|||
164267079|NCT01995552|593346189|FG000|Overall Study|Death|1|||
164267080|NCT02068118|593346191|FG000|18-month Comparative Study Period|Death|90|||
164267081|NCT02068118|593346192|FG001|18-month Comparative Study Period|Death|97|||
164267082|NCT02068118|593346191|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
164267083|NCT02068118|593346192|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
164267084|NCT02068118|593346191|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
163892320|NCT02724969|591976769|FG000|Overall Study|Infant demise|0|||
163892321|NCT02724969|591976770|FG001|Overall Study|Infant demise|2|||
163892322|NCT05974501|591976772|FG000|Overall Study|Physician Decision|0|||
163892323|NCT05974501|591976773|FG001|Overall Study|Physician Decision|1|||
163892324|NCT02497950|591976775|FG000|Overall Study|Death|209|||
163892325|NCT02497950|591976775|FG000|Overall Study|Transplanted|85|||
163892326|NCT02497950|591976775|FG000|Overall Study|Explanted|8|||
164267085|NCT02068118|593346192|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
164267086|NCT02068118|593346191|FG000|18-month Comparative Study Period|Heart transplant|9|||
164267087|NCT02068118|593346192|FG001|18-month Comparative Study Period|Heart transplant|15|||
164267088|NCT02068118|593346191|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
164267089|NCT02068118|593346192|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
164267090|NCT02068118|593346191|FG000|18-month Comparative Study Period|Hemiplegia|0|||
163892327|NCT02497950|591976775|FG000|Overall Study|Device Permanently Deactivated|4|||
164267091|NCT02068118|593346192|FG001|18-month Comparative Study Period|Hemiplegia|1|||
164267092|NCT02068118|593346191|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
164267093|NCT02068118|593346192|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
164267094|NCT02068118|593346191|FG000|18-month Comparative Study Period|Move|0|||
164267095|NCT02068118|593346192|FG001|18-month Comparative Study Period|Move|1|||
164267096|NCT02068118|593346191|FG000|18-month Comparative Study Period|Hearing loss|0|||
164267097|NCT02068118|593346192|FG001|18-month Comparative Study Period|Hearing loss|1|||
164267098|NCT02068118|593346191|FG000|Extension Period|Death|0|||
164267099|NCT02068118|593346192|FG001|Extension Period|Death|2|||
164267100|NCT02068118|593346191|FG000|Extension Period|Withdrawal by Subject|1|||
164267101|NCT02068118|593346192|FG001|Extension Period|Withdrawal by Subject|0|||
164267102|NCT02068118|593346191|FG000|Extension Period|Heart transplant|1|||
164267103|NCT02068118|593346192|FG001|Extension Period|Heart transplant|0|||
164267104|NCT02068118|593346191|FG000|Extension Period|Wrong device use|0|||
164267105|NCT02068118|593346192|FG001|Extension Period|Wrong device use|1|||
164267106|NCT00353873|593346195|FG000|Overall Study|Protocol Violation|1|||
164267107|NCT00353873|593346196|FG001|Overall Study|Protocol Violation|2|||
164267108|NCT00353873|593346195|FG000|Overall Study|Exacerbation|1|||
164267109|NCT00353873|593346196|FG001|Overall Study|Exacerbation|0|||
164267110|NCT00353873|593346195|FG000|Overall Study|Adverse Event|1|||
164267111|NCT00353873|593346196|FG001|Overall Study|Adverse Event|0|||
164267112|NCT00353873|593346195|FG000|Overall Study|Physician Decision|2|||
164267113|NCT00353873|593346196|FG001|Overall Study|Physician Decision|0|||
164267114|NCT00353873|593346195|FG000|Overall Study|Withdrawal by Subject|1|||
164267115|NCT00353873|593346196|FG001|Overall Study|Withdrawal by Subject|1|||
164267116|NCT01420627|593346197|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
164267117|NCT00453973|593346198|FG000|Overall Study|Adverse Event|4|||
164267118|NCT00453973|593346199|FG001|Overall Study|Adverse Event|9|||
164267119|NCT00453973|593346198|FG000|Overall Study|Withdrawal by Subject|7|||
164267120|NCT00453973|593346199|FG001|Overall Study|Withdrawal by Subject|6|||
164267121|NCT00453973|593346198|FG000|Overall Study|PI Decision|0|||
164267122|NCT00453973|593346199|FG001|Overall Study|PI Decision|2|||
164267123|NCT00453973|593346198|FG000|Overall Study|Relocation|1|||
164267124|NCT00453973|593346199|FG001|Overall Study|Relocation|0|||
164267125|NCT00453973|593346198|FG000|Overall Study|Renal transplant|1|||
164267126|NCT00453973|593346199|FG001|Overall Study|Renal transplant|1|||
164267127|NCT00453973|593346198|FG000|Overall Study|Site closed by sponsor|3|||
164267128|NCT00453973|593346199|FG001|Overall Study|Site closed by sponsor|0|||
164267129|NCT00453973|593346198|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
164267130|NCT00453973|593346199|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
164267131|NCT03743064|593346200|FG000|Overall Study|Adverse Event|7|||
164267132|NCT03743064|593346201|FG001|Overall Study|Adverse Event|9|||
164267133|NCT03743064|593346200|FG000|Overall Study|Death|25|||
164267134|NCT03743064|593346201|FG001|Overall Study|Death|28|||
164267135|NCT03743064|593346200|FG000|Overall Study|Lost to Follow-up|3|||
164267136|NCT03743064|593346201|FG001|Overall Study|Lost to Follow-up|6|||
164267137|NCT03743064|593346200|FG000|Overall Study|Withdrawal by Subject|28|||
164267138|NCT03743064|593346201|FG001|Overall Study|Withdrawal by Subject|25|||
164267139|NCT03743064|593346200|FG000|Overall Study|Physician Decision|2|||
164267140|NCT03743064|593346201|FG001|Overall Study|Physician Decision|4|||
164267141|NCT03743064|593346200|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
164267142|NCT03743064|593346201|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
164267143|NCT02759315|593346206|FG000|Overall Study|Adverse Event|0|||
164267144|NCT02759315|593346207|FG001|Overall Study|Adverse Event|0|||
164267145|NCT02759315|593346208|FG002|Overall Study|Adverse Event|0|||
164267146|NCT02759315|593346209|FG003|Overall Study|Adverse Event|1|||
163998291|NCT03751111|592359085|FG000|Overall Study|Lack of Efficacy|9|||
163998292|NCT03751111|592359086|FG001|Overall Study|Lack of Efficacy|30|||
163998293|NCT03751111|592359085|FG000|Overall Study|Adverse Event|3|||
163998294|NCT03751111|592359086|FG001|Overall Study|Adverse Event|2|||
163998295|NCT00929240|592359087|FG000|Initial Treatment Phase|Adverse Event|31|||
163998296|NCT00929240|592359088|FG001|Initial Treatment Phase|Adverse Event|0|||
163998297|NCT00929240|592359089|FG002|Initial Treatment Phase|Adverse Event|0|||
163998298|NCT00929240|592359087|FG000|Initial Treatment Phase|Disease progression|41|||
163998299|NCT00929240|592359088|FG001|Initial Treatment Phase|Disease progression|0|||
163998300|NCT00929240|592359089|FG002|Initial Treatment Phase|Disease progression|0|||
163998301|NCT00929240|592359087|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
164267147|NCT02759315|593346210|FG004|Overall Study|Adverse Event|0|||
164267148|NCT02759315|593346206|FG000|Overall Study|Death|0|||
164267149|NCT02759315|593346207|FG001|Overall Study|Death|0|||
163998302|NCT00929240|592359088|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
163998303|NCT00929240|592359089|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
164267150|NCT02759315|593346208|FG002|Overall Study|Death|1|||
164267151|NCT02759315|593346209|FG003|Overall Study|Death|0|||
164267152|NCT02759315|593346210|FG004|Overall Study|Death|0|||
164267153|NCT02759315|593346206|FG000|Overall Study|Lost to Follow-up|2|||
164267154|NCT02759315|593346207|FG001|Overall Study|Lost to Follow-up|0|||
164267155|NCT02759315|593346208|FG002|Overall Study|Lost to Follow-up|4|||
163998304|NCT00929240|592359087|FG000|Initial Treatment Phase|Protocol Violation|5|||
164267156|NCT02759315|593346209|FG003|Overall Study|Lost to Follow-up|0|||
164267157|NCT02759315|593346210|FG004|Overall Study|Lost to Follow-up|0|||
164267158|NCT02759315|593346206|FG000|Overall Study|Protocol Violation|0|||
164267159|NCT02759315|593346207|FG001|Overall Study|Protocol Violation|1|||
164267160|NCT02759315|593346208|FG002|Overall Study|Protocol Violation|0|||
164267161|NCT02759315|593346209|FG003|Overall Study|Protocol Violation|0|||
164267162|NCT02759315|593346210|FG004|Overall Study|Protocol Violation|0|||
164267163|NCT02759315|593346206|FG000|Overall Study|Study terminated prior to completion|2|||
164267164|NCT02759315|593346207|FG001|Overall Study|Study terminated prior to completion|0|||
164267165|NCT02759315|593346208|FG002|Overall Study|Study terminated prior to completion|5|||
164267166|NCT02759315|593346209|FG003|Overall Study|Study terminated prior to completion|0|||
164267167|NCT02759315|593346210|FG004|Overall Study|Study terminated prior to completion|1|||
164267168|NCT00870194|593346211|FG000|Overall Study|Adverse Event|10|||
164267169|NCT00870194|593346212|FG001|Overall Study|Adverse Event|5|||
164267170|NCT00870194|593346211|FG000|Overall Study|Lack of Efficacy|0|||
164267171|NCT00870194|593346212|FG001|Overall Study|Lack of Efficacy|1|||
164267172|NCT00870194|593346211|FG000|Overall Study|Lost to Follow-up|2|||
164267173|NCT00870194|593346212|FG001|Overall Study|Lost to Follow-up|0|||
164267174|NCT00870194|593346211|FG000|Overall Study|Physician Decision|3|||
164267175|NCT00870194|593346212|FG001|Overall Study|Physician Decision|1|||
164267176|NCT00870194|593346211|FG000|Overall Study|Protocol Violation|3|||
164267177|NCT00870194|593346212|FG001|Overall Study|Protocol Violation|3|||
164267178|NCT00870194|593346211|FG000|Overall Study|Entry Criteria Not Met|1|||
164267179|NCT00870194|593346212|FG001|Overall Study|Entry Criteria Not Met|2|||
164267180|NCT00870194|593346211|FG000|Overall Study|Subject Decision|7|||
164267181|NCT00870194|593346212|FG001|Overall Study|Subject Decision|2|||
164267182|NCT01219933|593346213|FG000|Overall Study|Adverse Event|8|||
164267183|NCT01219933|593346213|FG000|Overall Study|No LDA reached|5|||
164267184|NCT01219933|593346213|FG000|Overall Study|No LDA maintained|7|||
164267185|NCT01219933|593346213|FG000|Overall Study|Lost to Follow-up|3|||
164267186|NCT01219933|593346213|FG000|Overall Study|GC free|1|||
164267187|NCT01219933|593346213|FG000|Overall Study|Withdrawal by Subject|5|||
164267188|NCT01219933|593346213|FG000|Overall Study|Protocol Violation|8|||
164267189|NCT01219933|593346213|FG000|Overall Study|Lack of Efficacy|1|||
164267190|NCT00582738|593346214|FG000|Overall Study|Administrative Problems|7|||
164267191|NCT00582738|593346215|FG001|Overall Study|Administrative Problems|8|||
164267192|NCT00582738|593346214|FG000|Overall Study|Adverse Event|0|||
164267193|NCT00582738|593346215|FG001|Overall Study|Adverse Event|5|||
164267194|NCT00582738|593346214|FG000|Overall Study|Graft Lost|0|||
164267195|NCT00582738|593346215|FG001|Overall Study|Graft Lost|1|||
164267196|NCT00582738|593346214|FG000|Overall Study|Other|1|||
164267197|NCT00582738|593346215|FG001|Overall Study|Other|0|||
164267198|NCT00582738|593346214|FG000|Overall Study|Protocol Violation|1|||
164267199|NCT00582738|593346215|FG001|Overall Study|Protocol Violation|1|||
164267200|NCT00582738|593346214|FG000|Overall Study|Withdrawal by Subject|0|||
164267201|NCT00582738|593346215|FG001|Overall Study|Withdrawal by Subject|3|||
164267202|NCT02210091|593346219|FG000|Overall Study|Physician Decision|0|||
164267203|NCT02210091|593346220|FG001|Overall Study|Physician Decision|1|||
164267204|NCT02210091|593346219|FG000|Overall Study|Withdrawal by Sponsor|0|||
164267205|NCT02210091|593346220|FG001|Overall Study|Withdrawal by Sponsor|1|||
164267206|NCT01831817|593346221|FG000|Overall Study|Lost to Follow-up|1|||
164267207|NCT01831817|593346222|FG001|Overall Study|Lost to Follow-up|0|||
164267208|NCT01831817|593346223|FG002|Overall Study|Lost to Follow-up|0|||
164267209|NCT01831817|593346224|FG003|Overall Study|Lost to Follow-up|0|||
164267210|NCT01831817|593346221|FG000|Overall Study|Withdrawl of Consent|3|||
164267211|NCT01831817|593346222|FG001|Overall Study|Withdrawl of Consent|0|||
164267212|NCT01831817|593346223|FG002|Overall Study|Withdrawl of Consent|0|||
164267213|NCT01831817|593346224|FG003|Overall Study|Withdrawl of Consent|0|||
164267214|NCT00958217|593346225|FG000|Overall Study|Death|2|||
164267215|NCT00958217|593346226|FG001|Overall Study|Death|1|||
164267216|NCT00958217|593346225|FG000|Overall Study|Withdrawal by Subject|4|||
164267217|NCT00958217|593346226|FG001|Overall Study|Withdrawal by Subject|3|||
164267218|NCT00958217|593346225|FG000|Overall Study|Lost to Follow-up|17|||
164341925|NCT00932126|593627569|FG005|Overall Study|Withdrawal by Subject|0|||
163998305|NCT00929240|592359088|FG001|Initial Treatment Phase|Protocol Violation|0|||
163998306|NCT00929240|592359089|FG002|Initial Treatment Phase|Protocol Violation|0|||
163998307|NCT00929240|592359087|FG000|Initial Treatment Phase|Death|2|||
163998308|NCT00929240|592359088|FG001|Initial Treatment Phase|Death|0|||
163998309|NCT00929240|592359089|FG002|Initial Treatment Phase|Death|0|||
163998310|NCT00929240|592359087|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
164267219|NCT00958217|593346226|FG001|Overall Study|Lost to Follow-up|19|||
164267220|NCT00958217|593346225|FG000|Overall Study|Moved out of area|1|||
164267221|NCT00958217|593346226|FG001|Overall Study|Moved out of area|1|||
164267222|NCT00958217|593346225|FG000|Overall Study|Inpatient hospitalization|0|||
164267223|NCT00958217|593346226|FG001|Overall Study|Inpatient hospitalization|1|||
164267224|NCT02198235|593346228|FG000|Overall Study|Lost to Follow-up|3|||
164267225|NCT02198235|593346229|FG001|Overall Study|Lost to Follow-up|2|||
164267226|NCT02198235|593346230|FG002|Overall Study|Lost to Follow-up|2|||
164267227|NCT02440789|593346231|FG000|Overall Study|Withdrawal by Subject|3|||
164267228|NCT02440789|593346231|FG000|Overall Study|Not willing to adhere to reqs|1|||
164267229|NCT01999218|593346232|FG000|Overall Study|Hyperglycemia|18|||
164267230|NCT01999218|593346233|FG001|Overall Study|Hyperglycemia|17|||
164267231|NCT01999218|593346234|FG002|Overall Study|Hyperglycemia|17|||
164267232|NCT01999218|593346232|FG000|Overall Study|Lack of Efficacy|1|||
164267233|NCT01999218|593346233|FG001|Overall Study|Lack of Efficacy|0|||
164267234|NCT01999218|593346234|FG002|Overall Study|Lack of Efficacy|1|||
164267235|NCT01999218|593346232|FG000|Overall Study|Lost to Follow-up|22|||
164267236|NCT01999218|593346233|FG001|Overall Study|Lost to Follow-up|17|||
164267237|NCT01999218|593346234|FG002|Overall Study|Lost to Follow-up|18|||
164267238|NCT01999218|593346232|FG000|Overall Study|Non-Compliance With Study Drug|6|||
164267239|NCT01999218|593346233|FG001|Overall Study|Non-Compliance With Study Drug|4|||
164267240|NCT01999218|593346234|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164267241|NCT01999218|593346232|FG000|Overall Study|Physician Decision|1|||
164267242|NCT01999218|593346233|FG001|Overall Study|Physician Decision|4|||
164267243|NCT01999218|593346234|FG002|Overall Study|Physician Decision|6|||
164267244|NCT01999218|593346232|FG000|Overall Study|Protocol Violation|4|||
164267245|NCT01999218|593346233|FG001|Overall Study|Protocol Violation|5|||
164267246|NCT01999218|593346234|FG002|Overall Study|Protocol Violation|4|||
164267247|NCT01999218|593346232|FG000|Overall Study|Screen failure|0|||
164267248|NCT01999218|593346233|FG001|Overall Study|Screen failure|1|||
164267249|NCT01999218|593346234|FG002|Overall Study|Screen failure|0|||
164267250|NCT01999218|593346232|FG000|Overall Study|Study Terminated By Sponsor|7|||
164267251|NCT01999218|593346233|FG001|Overall Study|Study Terminated By Sponsor|5|||
164267252|NCT01999218|593346234|FG002|Overall Study|Study Terminated By Sponsor|12|||
164267253|NCT01999218|593346232|FG000|Overall Study|Participant moves|2|||
164267254|NCT01999218|593346233|FG001|Overall Study|Participant moves|5|||
164267255|NCT01999218|593346234|FG002|Overall Study|Participant moves|3|||
164267256|NCT01999218|593346232|FG000|Overall Study|Withdrawal by Subject|28|||
164267257|NCT01999218|593346233|FG001|Overall Study|Withdrawal by Subject|29|||
164267258|NCT01999218|593346234|FG002|Overall Study|Withdrawal by Subject|34|||
164267259|NCT01999218|593346232|FG000|Overall Study|Creatinine/eGFR|0|||
164267260|NCT01999218|593346233|FG001|Overall Study|Creatinine/eGFR|0|||
164267261|NCT01999218|593346234|FG002|Overall Study|Creatinine/eGFR|1|||
164267262|NCT01999218|593346232|FG000|Overall Study|Death|7|||
164267263|NCT01999218|593346233|FG001|Overall Study|Death|1|||
164267264|NCT01999218|593346234|FG002|Overall Study|Death|2|||
164267265|NCT01999218|593346232|FG000|Overall Study|Excluded Medication|1|||
164267266|NCT01999218|593346233|FG001|Overall Study|Excluded Medication|1|||
164267267|NCT01999218|593346234|FG002|Overall Study|Excluded Medication|2|||
164267268|NCT01999218|593346232|FG000|Overall Study|Adverse Event|9|||
164267269|NCT01999218|593346233|FG001|Overall Study|Adverse Event|7|||
164267270|NCT01999218|593346234|FG002|Overall Study|Adverse Event|7|||
164267271|NCT01999218|593346232|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
164267272|NCT01999218|593346233|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
164267273|NCT01999218|593346234|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
164267274|NCT01073930|593348516|FG000|Overall Study|Withdrawal by Subject|3|||
164267275|NCT01073930|593348517|FG001|Overall Study|Withdrawal by Subject|2|||
164267276|NCT01073930|593348516|FG000|Overall Study|Lost to Follow-up|0|||
164267277|NCT01073930|593348517|FG001|Overall Study|Lost to Follow-up|1|||
164267278|NCT01073930|593348516|FG000|Overall Study|Adverse Event|0|||
164267279|NCT01073930|593348517|FG001|Overall Study|Adverse Event|1|||
164267280|NCT01073930|593348516|FG000|Overall Study|Noncompliance with study drug|0|||
164267281|NCT01073930|593348517|FG001|Overall Study|Noncompliance with study drug|1|||
164267282|NCT01073930|593348516|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
164267283|NCT01073930|593348517|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
164267284|NCT04030962|593348519|FG000|Stage 2|Adverse Event|0|||
164267285|NCT04030962|593348520|FG001|Stage 2|Adverse Event|0|||
164267286|NCT04030962|593348521|FG002|Stage 2|Adverse Event|0|||
164267287|NCT04030962|593348522|FG003|Stage 2|Adverse Event|0|||
164267288|NCT04030962|593348523|FG004|Stage 2|Adverse Event|0|||
164267289|NCT04030962|593348524|FG005|Stage 2|Adverse Event|0|||
164267290|NCT04030962|593348525|FG006|Stage 2|Adverse Event|0|||
164267291|NCT04030962|593348526|FG007|Stage 2|Adverse Event|0|||
164267292|NCT04030962|593348527|FG008|Stage 2|Adverse Event|1|||
164267293|NCT04030962|593348528|FG009|Stage 2|Adverse Event|0|||
164267294|NCT04030962|593348529|FG010|Stage 2|Adverse Event|1|||
164267295|NCT04030962|593348530|FG011|Stage 2|Adverse Event|1|||
164267296|NCT04030962|593348531|FG012|Stage 2|Adverse Event|1|||
164267297|NCT04030962|593348519|FG000|Stage 2|Withdrawal by Subject|0|||
164267298|NCT04030962|593348520|FG001|Stage 2|Withdrawal by Subject|0|||
164267299|NCT04030962|593348521|FG002|Stage 2|Withdrawal by Subject|0|||
164267300|NCT04030962|593348522|FG003|Stage 2|Withdrawal by Subject|0|||
164267301|NCT04030962|593348523|FG004|Stage 2|Withdrawal by Subject|0|||
164267302|NCT04030962|593348524|FG005|Stage 2|Withdrawal by Subject|0|||
164267303|NCT04030962|593348525|FG006|Stage 2|Withdrawal by Subject|0|||
164267304|NCT04030962|593348526|FG007|Stage 2|Withdrawal by Subject|0|||
164267305|NCT04030962|593348527|FG008|Stage 2|Withdrawal by Subject|1|||
163998311|NCT00929240|592359088|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
163998312|NCT00929240|592359089|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
163998313|NCT00929240|592359087|FG000|Initial Treatment Phase|Physician Decision|4|||
163998314|NCT00929240|592359088|FG001|Initial Treatment Phase|Physician Decision|0|||
164267306|NCT04030962|593348528|FG009|Stage 2|Withdrawal by Subject|0|||
164267307|NCT04030962|593348529|FG010|Stage 2|Withdrawal by Subject|0|||
164267308|NCT04030962|593348530|FG011|Stage 2|Withdrawal by Subject|2|||
164267309|NCT04030962|593348531|FG012|Stage 2|Withdrawal by Subject|1|||
164267310|NCT04030962|593348519|FG000|Stage 2|Lost to Follow-up|0|||
164267311|NCT04030962|593348520|FG001|Stage 2|Lost to Follow-up|0|||
164267312|NCT04030962|593348521|FG002|Stage 2|Lost to Follow-up|0|||
164267313|NCT04030962|593348522|FG003|Stage 2|Lost to Follow-up|0|||
164267314|NCT04030962|593348523|FG004|Stage 2|Lost to Follow-up|0|||
164267315|NCT04030962|593348524|FG005|Stage 2|Lost to Follow-up|0|||
164267316|NCT04030962|593348525|FG006|Stage 2|Lost to Follow-up|0|||
164267317|NCT04030962|593348526|FG007|Stage 2|Lost to Follow-up|0|||
164267318|NCT04030962|593348527|FG008|Stage 2|Lost to Follow-up|1|||
164267319|NCT04030962|593348528|FG009|Stage 2|Lost to Follow-up|0|||
164267320|NCT04030962|593348529|FG010|Stage 2|Lost to Follow-up|0|||
164267321|NCT04030962|593348530|FG011|Stage 2|Lost to Follow-up|0|||
164267322|NCT04030962|593348531|FG012|Stage 2|Lost to Follow-up|0|||
164267323|NCT04030962|593348519|FG000|Stage 2|Technical Problems|0|||
164267324|NCT04030962|593348520|FG001|Stage 2|Technical Problems|0|||
164267325|NCT04030962|593348521|FG002|Stage 2|Technical Problems|0|||
164267326|NCT04030962|593348522|FG003|Stage 2|Technical Problems|0|||
164267327|NCT04030962|593348523|FG004|Stage 2|Technical Problems|0|||
164267328|NCT04030962|593348524|FG005|Stage 2|Technical Problems|0|||
164267329|NCT04030962|593348525|FG006|Stage 2|Technical Problems|0|||
164267330|NCT04030962|593348526|FG007|Stage 2|Technical Problems|0|||
164267331|NCT04030962|593348527|FG008|Stage 2|Technical Problems|0|||
164267332|NCT04030962|593348528|FG009|Stage 2|Technical Problems|0|||
164267333|NCT04030962|593348529|FG010|Stage 2|Technical Problems|0|||
164267334|NCT04030962|593348530|FG011|Stage 2|Technical Problems|1|||
164267335|NCT04030962|593348531|FG012|Stage 2|Technical Problems|0|||
164267336|NCT05288166|593348534|FG000|Overall Study|Adverse Event|1|||
164267337|NCT05288166|593348535|FG001|Overall Study|Adverse Event|0|||
164267338|NCT05288166|593348534|FG000|Overall Study|Lost to Follow-up|2|||
164267339|NCT05288166|593348535|FG001|Overall Study|Lost to Follow-up|0|||
164267340|NCT05288166|593348534|FG000|Overall Study|Physician Decision|0|||
164267341|NCT05288166|593348535|FG001|Overall Study|Physician Decision|2|||
164267342|NCT05288166|593348534|FG000|Overall Study|Screen Failure|1|||
164267343|NCT05288166|593348535|FG001|Overall Study|Screen Failure|1|||
164267344|NCT05288166|593348534|FG000|Overall Study|Withdrawal by Subject|4|||
164267345|NCT05288166|593348535|FG001|Overall Study|Withdrawal by Subject|2|||
164267346|NCT05288166|593348534|FG000|Overall Study|On Study Treatment|408|||
164267347|NCT05288166|593348535|FG001|Overall Study|On Study Treatment|418|||
164267348|NCT01114360|593348536|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
164267349|NCT01114360|593348537|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
164267350|NCT03007745|593348538|FG000|Overall Study|Sleep test negative for OSA|53|||
164267351|NCT03007745|593348539|FG001|Overall Study|Sleep test negative for OSA|49|||
164267352|NCT03007745|593348538|FG000|Overall Study|Physician Decision|6|||
164267353|NCT03007745|593348539|FG001|Overall Study|Physician Decision|9|||
164267354|NCT03007745|593348538|FG000|Overall Study|Withdrawal by Subject|38|||
164267355|NCT03007745|593348539|FG001|Overall Study|Withdrawal by Subject|16|||
164267356|NCT03007745|593348538|FG000|Overall Study|Lost to Follow-up|19|||
164267357|NCT03007745|593348539|FG001|Overall Study|Lost to Follow-up|25|||
164267358|NCT03007745|593348538|FG000|Overall Study|Unable to login to website|17|||
164267359|NCT03007745|593348539|FG001|Overall Study|Unable to login to website|4|||
164267360|NCT04912895|593348542|FG000|Overall Study|Unable to provide specimen|2|||
164267361|NCT04912895|593348543|FG001|Overall Study|Unable to provide specimen|0|||
164267362|NCT04912895|593348544|FG002|Overall Study|Unable to provide specimen|0|||
164267363|NCT02981524|593348545|FG000|Overall Study|Progressive Disease|14|||
164267364|NCT02981524|593348545|FG000|Overall Study|Death (unrelated)|1|||
164267365|NCT02981524|593348545|FG000|Overall Study|Treatment Related Toxicity|1|||
164267366|NCT02981524|593348545|FG000|Overall Study|Withdrawal by Subject|1|||
164267367|NCT00520013|593348546|FG000|Overall Study|Withdrawal by Subject|0|||
164267368|NCT00520013|593348547|FG001|Overall Study|Withdrawal by Subject|0|||
164267369|NCT00520013|593348548|FG002|Overall Study|Withdrawal by Subject|1|||
164267370|NCT00520013|593348546|FG000|Overall Study|Adverse Event|2|||
164267371|NCT00520013|593348547|FG001|Overall Study|Adverse Event|10|||
164267372|NCT00520013|593348548|FG002|Overall Study|Adverse Event|7|||
164267373|NCT00520013|593348546|FG000|Overall Study|Progressive Disease|7|||
164267374|NCT00520013|593348547|FG001|Overall Study|Progressive Disease|3|||
164267375|NCT00520013|593348548|FG002|Overall Study|Progressive Disease|0|||
164267376|NCT00520013|593348546|FG000|Overall Study|Clinical Progression|3|||
164267377|NCT00520013|593348547|FG001|Overall Study|Clinical Progression|1|||
164267378|NCT00520013|593348548|FG002|Overall Study|Clinical Progression|0|||
164267379|NCT00520013|593348546|FG000|Overall Study|Death|0|||
164267380|NCT00520013|593348547|FG001|Overall Study|Death|1|||
164267381|NCT00520013|593348548|FG002|Overall Study|Death|0|||
164267382|NCT00520013|593348546|FG000|Overall Study|Physician Decision|0|||
164267383|NCT00520013|593348547|FG001|Overall Study|Physician Decision|0|||
164267384|NCT00520013|593348548|FG002|Overall Study|Physician Decision|3|||
164267385|NCT00159913|593348549|FG000|Overall Study|Adverse Event|1|||
164267386|NCT00159913|593348550|FG001|Overall Study|Adverse Event|0|||
164267387|NCT00159913|593348551|FG002|Overall Study|Adverse Event|1|||
164267388|NCT00159913|593348552|FG003|Overall Study|Adverse Event|0|||
164267389|NCT00159913|593348549|FG000|Overall Study|Withdrawal by Subject|0|||
164267390|NCT00159913|593348550|FG001|Overall Study|Withdrawal by Subject|0|||
164267391|NCT00159913|593348551|FG002|Overall Study|Withdrawal by Subject|0|||
164267392|NCT00159913|593348552|FG003|Overall Study|Withdrawal by Subject|1|||
164267393|NCT00159913|593348549|FG000|Overall Study|Lost to Follow-up|0|||
164267394|NCT00159913|593348550|FG001|Overall Study|Lost to Follow-up|0|||
164267395|NCT00159913|593348551|FG002|Overall Study|Lost to Follow-up|0|||
164267396|NCT00159913|593348552|FG003|Overall Study|Lost to Follow-up|1|||
164267397|NCT00159913|593348549|FG000|Overall Study|Protocol Violation|1|||
164267398|NCT00159913|593348550|FG001|Overall Study|Protocol Violation|0|||
164267399|NCT00159913|593348551|FG002|Overall Study|Protocol Violation|1|||
164267400|NCT00159913|593348552|FG003|Overall Study|Protocol Violation|0|||
164267401|NCT03294135|593348553|FG000|Overall Study|Serious Adverse Event|1|||
164267402|NCT03294135|593348554|FG001|Overall Study|Serious Adverse Event|0|||
164267403|NCT03294135|593348555|FG002|Overall Study|Serious Adverse Event|0|||
164267404|NCT03294135|593348553|FG000|Overall Study|Lost to Follow-up|1|||
164267405|NCT03294135|593348554|FG001|Overall Study|Lost to Follow-up|0|||
164267406|NCT03294135|593348555|FG002|Overall Study|Lost to Follow-up|1|||
164267407|NCT03294135|593348553|FG000|Overall Study|Withdrawal by Subject|0|||
164267408|NCT03294135|593348554|FG001|Overall Study|Withdrawal by Subject|0|||
164267409|NCT03294135|593348555|FG002|Overall Study|Withdrawal by Subject|1|||
164267410|NCT03294135|593348553|FG000|Overall Study|Other|2|||
164267411|NCT03294135|593348554|FG001|Overall Study|Other|0|||
164267412|NCT03294135|593348555|FG002|Overall Study|Other|0|||
164267413|NCT02763254|593348556|FG000|Overall Study|Adverse Event|1|||
164267414|NCT03684304|593348558|FG000|Overall Study|Lost to Follow-up|19|||
164267415|NCT03684304|593348559|FG001|Overall Study|Lost to Follow-up|17|||
164267416|NCT00824005|593348560|FG000|Overall Study|Death|0|||
164267417|NCT00824005|593348561|FG001|Overall Study|Death|1|||
164267418|NCT00824005|593348560|FG000|Overall Study|Lost to Follow-up|0|||
164267419|NCT00824005|593348561|FG001|Overall Study|Lost to Follow-up|1|||
164267420|NCT01510184|593348562|FG000|Overall Study|Sponsor discretion|28|||
164267421|NCT01510184|593348563|FG001|Overall Study|Sponsor discretion|28|||
164267422|NCT01510184|593348562|FG000|Overall Study|Death|1|||
164267423|NCT01510184|593348563|FG001|Overall Study|Death|2|||
163998315|NCT00929240|592359089|FG002|Initial Treatment Phase|Physician Decision|0|||
164267424|NCT01510184|593348562|FG000|Overall Study|Withdrawal by Subject|1|||
164267425|NCT01510184|593348563|FG001|Overall Study|Withdrawal by Subject|4|||
164267426|NCT01510184|593348562|FG000|Overall Study|Other|0|||
164267427|NCT01510184|593348563|FG001|Overall Study|Other|1|||
164267428|NCT01143051|593348564|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
164267429|NCT01143051|593348565|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
164267430|NCT01143051|593348566|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
164267431|NCT01143051|593348567|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
164267432|NCT01143051|593348568|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
164267433|NCT01143051|593348569|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
164267434|NCT01143051|593348564|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
164267435|NCT01143051|593348565|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
164267436|NCT01143051|593348566|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
164267437|NCT01143051|593348567|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
164267438|NCT01143051|593348568|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
164267439|NCT01143051|593348569|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
164267440|NCT03458702|593348570|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
164267441|NCT03458702|593348571|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
164267442|NCT03458702|593348570|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
164267443|NCT03458702|593348571|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
164267444|NCT01390779|593348572|FG000|Overall Study|Physician Decision|1|||
163998316|NCT00929240|592359087|FG000|Maintenance Phase|Disease progression|0|||
164267445|NCT00765882|593348573|FG000|Overall Study|Adverse Event|10|||
164267446|NCT00765882|593348574|FG001|Overall Study|Adverse Event|21|||
164267447|NCT00765882|593348575|FG002|Overall Study|Adverse Event|20|||
164267448|NCT00765882|593348573|FG000|Overall Study|Lack of Efficacy|4|||
164267449|NCT00765882|593348574|FG001|Overall Study|Lack of Efficacy|0|||
164267450|NCT00765882|593348575|FG002|Overall Study|Lack of Efficacy|1|||
164267451|NCT00765882|593348573|FG000|Overall Study|Protocol Violation|4|||
164267452|NCT00765882|593348574|FG001|Overall Study|Protocol Violation|3|||
164267453|NCT00765882|593348575|FG002|Overall Study|Protocol Violation|1|||
164267454|NCT00765882|593348573|FG000|Overall Study|Withdrawal by Subject|2|||
164267455|NCT00765882|593348574|FG001|Overall Study|Withdrawal by Subject|6|||
164267456|NCT00765882|593348575|FG002|Overall Study|Withdrawal by Subject|6|||
164267457|NCT00765882|593348573|FG000|Overall Study|Lost to Follow-up|1|||
164267458|NCT00765882|593348574|FG001|Overall Study|Lost to Follow-up|9|||
164267459|NCT00765882|593348575|FG002|Overall Study|Lost to Follow-up|6|||
164267460|NCT00765882|593348573|FG000|Overall Study|Other Reason|3|||
164267461|NCT00765882|593348574|FG001|Overall Study|Other Reason|1|||
164267462|NCT00765882|593348575|FG002|Overall Study|Other Reason|2|||
164267463|NCT02231762|593348578|FG000|Combination Phase|Adverse Event|10|||
164267464|NCT02231762|593348579|FG001|Combination Phase|Adverse Event|0|||
164267465|NCT02231762|593348580|FG002|Combination Phase|Adverse Event|0|||
164267466|NCT02231762|593348581|FG003|Combination Phase|Adverse Event|0|||
164267467|NCT02231762|593348578|FG000|Combination Phase|Withdrawal by Subject|2|||
164267468|NCT02231762|593348579|FG001|Combination Phase|Withdrawal by Subject|0|||
164267469|NCT02231762|593348580|FG002|Combination Phase|Withdrawal by Subject|0|||
164267470|NCT02231762|593348581|FG003|Combination Phase|Withdrawal by Subject|0|||
164267471|NCT02231762|593348578|FG000|Combination Phase|Disease Progression|6|||
164267472|NCT02231762|593348579|FG001|Combination Phase|Disease Progression|0|||
164267473|NCT02231762|593348580|FG002|Combination Phase|Disease Progression|0|||
164267474|NCT02231762|593348581|FG003|Combination Phase|Disease Progression|0|||
164267475|NCT02231762|593348578|FG000|Combination Phase|Did not meet inclusion criteria|1|||
164267476|NCT02231762|593348579|FG001|Combination Phase|Did not meet inclusion criteria|0|||
164267477|NCT02231762|593348580|FG002|Combination Phase|Did not meet inclusion criteria|0|||
164267478|NCT02231762|593348581|FG003|Combination Phase|Did not meet inclusion criteria|0|||
164267479|NCT02231762|593348578|FG000|Combination Phase|Protocol Violation|1|||
164267480|NCT02231762|593348579|FG001|Combination Phase|Protocol Violation|0|||
164267481|NCT02231762|593348580|FG002|Combination Phase|Protocol Violation|0|||
164267482|NCT02231762|593348581|FG003|Combination Phase|Protocol Violation|0|||
164267483|NCT02231762|593348578|FG000|Maintenance Phase|Disease progression|0|||
164267484|NCT02231762|593348579|FG001|Maintenance Phase|Disease progression|3|||
164267485|NCT02231762|593348580|FG002|Maintenance Phase|Disease progression|4|||
164267486|NCT02231762|593348581|FG003|Maintenance Phase|Disease progression|3|||
164267487|NCT02231762|593348578|FG000|Maintenance Phase|Adverse Event|0|||
164267488|NCT02231762|593348579|FG001|Maintenance Phase|Adverse Event|0|||
164267489|NCT02231762|593348580|FG002|Maintenance Phase|Adverse Event|1|||
164267490|NCT02231762|593348581|FG003|Maintenance Phase|Adverse Event|2|||
164267491|NCT03455829|593348582|FG000|Overall Study|Death|2|||
164267492|NCT03455829|593348583|FG001|Overall Study|Death|3|||
164267493|NCT03455829|593348584|FG002|Overall Study|Death|2|||
164267494|NCT03455829|593348585|FG003|Overall Study|Death|4|||
164267495|NCT03455829|593348586|FG004|Overall Study|Death|2|||
164267496|NCT03455829|593348582|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
164267497|NCT03455829|593348583|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
164267498|NCT03455829|593348584|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
164267499|NCT03455829|593348585|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
164267500|NCT03455829|593348586|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
164267501|NCT03455829|593348582|FG000|Overall Study|Disease progression|0|||
164267502|NCT03455829|593348583|FG001|Overall Study|Disease progression|0|||
164267503|NCT03455829|593348584|FG002|Overall Study|Disease progression|0|||
164267504|NCT03455829|593348585|FG003|Overall Study|Disease progression|1|||
164267505|NCT03455829|593348586|FG004|Overall Study|Disease progression|1|||
164267506|NCT01697462|593348587|FG000|Overall Study|Disease Progression|1|||
164267507|NCT01697462|593348587|FG000|Overall Study|Adverse Event|6|||
164267508|NCT01697462|593348587|FG000|Overall Study|Lost to Follow-up|21|||
164267509|NCT01697462|593348587|FG000|Overall Study|Withdrawal by Subject|12|||
164267510|NCT01697462|593348587|FG000|Overall Study|Investigator Decision|21|||
164267511|NCT01697462|593348587|FG000|Overall Study|Death|1|||
164267512|NCT01697462|593348587|FG000|Overall Study|Other|10|||
164267513|NCT01697462|593348587|FG000|Overall Study|Missing|5|||
164267514|NCT00168103|593348588|FG000|Overall Study|Withdrawal by Subject|1|||
164267515|NCT00168103|593348589|FG001|Overall Study|Withdrawal by Subject|2|||
164267516|NCT00168103|593348590|FG002|Overall Study|Withdrawal by Subject|1|||
164267517|NCT00168103|593348591|FG003|Overall Study|Withdrawal by Subject|0|||
164267518|NCT00168103|593348588|FG000|Overall Study|Lost to Follow-up|1|||
164267519|NCT00168103|593348589|FG001|Overall Study|Lost to Follow-up|3|||
163892328|NCT02497950|591976775|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
163892329|NCT02497950|591976775|FG000|Overall Study|Lost to Follow-up|6|||
163892330|NCT02497950|591976775|FG000|Overall Study|Withdrawal by Subject|2|||
163892331|NCT02497950|591976775|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
164267520|NCT00168103|593348590|FG002|Overall Study|Lost to Follow-up|0|||
164267521|NCT00168103|593348591|FG003|Overall Study|Lost to Follow-up|0|||
164267522|NCT03532932|593348600|FG000|Overall Study|Protocol Deviation|33|||
164267523|NCT03532932|593348601|FG001|Overall Study|Protocol Deviation|31|||
164267524|NCT03532932|593348600|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
164267525|NCT03532932|593348601|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
164267526|NCT03532932|593348600|FG000|Overall Study|Withdrawal by Subject|2|||
164267527|NCT03532932|593348601|FG001|Overall Study|Withdrawal by Subject|0|||
164267528|NCT03532932|593348600|FG000|Overall Study|Lost to Follow-up|15|||
164267529|NCT03532932|593348601|FG001|Overall Study|Lost to Follow-up|9|||
164267530|NCT03532932|593348600|FG000|Overall Study|Adverse Event|4|||
164267531|NCT03532932|593348601|FG001|Overall Study|Adverse Event|3|||
164267532|NCT03532932|593348600|FG000|Overall Study|Death|0|||
164267533|NCT03532932|593348601|FG001|Overall Study|Death|2|||
164267534|NCT03532932|593348600|FG000|Overall Study|Other|11|||
164267535|NCT03532932|593348601|FG001|Overall Study|Other|16|||
164267536|NCT02255565|593348603|FG000|Overall Study|Withdrawal by Subject|0|||
164267537|NCT02255565|593348604|FG001|Overall Study|Withdrawal by Subject|1|||
164267538|NCT02255565|593348605|FG002|Overall Study|Withdrawal by Subject|0|||
164267539|NCT02699450|593348606|FG000|Overall Study|Death|2|||
164267540|NCT02699450|593348607|FG001|Overall Study|Death|1|||
164267541|NCT02699450|593348608|FG002|Overall Study|Death|2|||
164267542|NCT02699450|593348606|FG000|Overall Study|Met Criteria for Study Exit|0|||
164267543|NCT02699450|593348607|FG001|Overall Study|Met Criteria for Study Exit|0|||
164267544|NCT02699450|593348608|FG002|Overall Study|Met Criteria for Study Exit|1|||
164267545|NCT02699450|593348606|FG000|Overall Study|Protocol Violation|4|||
164267546|NCT02699450|593348607|FG001|Overall Study|Protocol Violation|3|||
164267547|NCT02699450|593348608|FG002|Overall Study|Protocol Violation|5|||
164267548|NCT02699450|593348606|FG000|Overall Study|Lost to Follow-up|3|||
164267549|NCT02699450|593348607|FG001|Overall Study|Lost to Follow-up|0|||
164267550|NCT02699450|593348608|FG002|Overall Study|Lost to Follow-up|5|||
164267551|NCT02699450|593348606|FG000|Overall Study|Physician Decision|2|||
164267552|NCT02699450|593348607|FG001|Overall Study|Physician Decision|0|||
164267553|NCT02699450|593348608|FG002|Overall Study|Physician Decision|0|||
164267554|NCT02699450|593348606|FG000|Overall Study|Withdrawal by Subject|3|||
164267555|NCT02699450|593348607|FG001|Overall Study|Withdrawal by Subject|1|||
164267556|NCT02699450|593348608|FG002|Overall Study|Withdrawal by Subject|2|||
164267557|NCT02699450|593348606|FG000|Overall Study|Adverse Event|1|||
164267558|NCT02699450|593348607|FG001|Overall Study|Adverse Event|0|||
164267559|NCT02699450|593348608|FG002|Overall Study|Adverse Event|0|||
164267560|NCT00810901|593348609|FG000|Overall Study|Lost to Follow-up|88|||
164267561|NCT00810901|593348610|FG001|Overall Study|Lost to Follow-up|58|||
164267562|NCT03689712|593348612|FG000|Overall Study|Adverse Event|1|||
164267563|NCT03689712|593348613|FG001|Overall Study|Adverse Event|0|||
164267564|NCT03689712|593348612|FG000|Overall Study|Death|20|||
164267565|NCT03689712|593348613|FG001|Overall Study|Death|10|||
164267566|NCT03689712|593348612|FG000|Overall Study|Lost to Follow-up|6|||
164267567|NCT03689712|593348613|FG001|Overall Study|Lost to Follow-up|6|||
164267568|NCT03689712|593348612|FG000|Overall Study|Other|1|||
164267569|NCT03689712|593348613|FG001|Overall Study|Other|0|||
164267570|NCT03689712|593348612|FG000|Overall Study|Patient Non-Compliance|0|||
164267571|NCT03689712|593348613|FG001|Overall Study|Patient Non-Compliance|1|||
164267572|NCT03689712|593348612|FG000|Overall Study|Withdrawal by Subject|20|||
164267573|NCT03689712|593348613|FG001|Overall Study|Withdrawal by Subject|4|||
164267574|NCT03689712|593348612|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
164267575|NCT03689712|593348613|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
164267576|NCT03689712|593348612|FG000|Overall Study|Randomized but not Treated|13|||
164267577|NCT03689712|593348613|FG001|Overall Study|Randomized but not Treated|7|||
164267578|NCT03689712|593348612|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
164267579|NCT03689712|593348613|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
164267580|NCT01133275|593348623|FG000|Overall Study|Withdrawal by Subject|1|||
164267581|NCT01133275|593348623|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
164267582|NCT02266875|593348628|FG000|Overall Study|Withdrawal by Subject|9|||
164267583|NCT02266875|593348629|FG001|Overall Study|Withdrawal by Subject|0|||
164267584|NCT02266875|593348628|FG000|Overall Study|Lost to Follow-up|2|||
164267585|NCT02266875|593348629|FG001|Overall Study|Lost to Follow-up|0|||
164267586|NCT00413010|593348630|FG000|Overall Study|Adverse Event|8|||
164267587|NCT00413010|593348631|FG001|Overall Study|Adverse Event|4|||
164267588|NCT00413010|593348630|FG000|Overall Study|Laboratory abnormality|0|||
164267589|NCT00413010|593348631|FG001|Overall Study|Laboratory abnormality|2|||
164267590|NCT00413010|593348630|FG000|Overall Study|Lack of Efficacy|0|||
164267591|NCT00413010|593348631|FG001|Overall Study|Lack of Efficacy|3|||
164267592|NCT00413010|593348630|FG000|Overall Study|Lost to Follow-up|3|||
164267593|NCT00413010|593348631|FG001|Overall Study|Lost to Follow-up|0|||
164267594|NCT00413010|593348630|FG000|Overall Study|Withdrawal by Subject|7|||
164267595|NCT00413010|593348631|FG001|Overall Study|Withdrawal by Subject|2|||
164267596|NCT00413010|593348630|FG000|Overall Study|Due to termination of the study|54|||
164267597|NCT00413010|593348631|FG001|Overall Study|Due to termination of the study|52|||
164267598|NCT02956850|593348632|FG000|Overall Study|Withdrawal by Subject|0|||
164267599|NCT02956850|593348633|FG001|Overall Study|Withdrawal by Subject|0|||
164267600|NCT02956850|593348634|FG002|Overall Study|Withdrawal by Subject|0|||
164267601|NCT02956850|593348635|FG003|Overall Study|Withdrawal by Subject|0|||
164267602|NCT02956850|593348636|FG004|Overall Study|Withdrawal by Subject|0|||
164267603|NCT02956850|593348637|FG005|Overall Study|Withdrawal by Subject|0|||
164267604|NCT02956850|593348638|FG006|Overall Study|Withdrawal by Subject|0|||
164267605|NCT02956850|593348639|FG007|Overall Study|Withdrawal by Subject|0|||
164267606|NCT02956850|593348640|FG008|Overall Study|Withdrawal by Subject|0|||
164267607|NCT02956850|593348641|FG009|Overall Study|Withdrawal by Subject|0|||
164267608|NCT02956850|593348642|FG010|Overall Study|Withdrawal by Subject|0|||
164267609|NCT02956850|593348643|FG011|Overall Study|Withdrawal by Subject|0|||
164267610|NCT02956850|593348644|FG012|Overall Study|Withdrawal by Subject|0|||
164267611|NCT02956850|593348645|FG013|Overall Study|Withdrawal by Subject|0|||
164267612|NCT02956850|593348646|FG014|Overall Study|Withdrawal by Subject|0|||
164267613|NCT02956850|593348647|FG015|Overall Study|Withdrawal by Subject|0|||
164267614|NCT02956850|593348648|FG016|Overall Study|Withdrawal by Subject|0|||
164267615|NCT02956850|593348649|FG017|Overall Study|Withdrawal by Subject|1|||
164267616|NCT00708734|593348650|FG000|Overall Study|scheduling conflict|2|||
164267617|NCT00708734|593348650|FG000|Overall Study|moved|1|||
164267618|NCT00708734|593348650|FG000|Overall Study|leg injury|1|||
164267619|NCT00708734|593348650|FG000|Overall Study|knee replacement|1|||
164267620|NCT00708734|593348650|FG000|Overall Study|vertigo|1|||
164267621|NCT00708734|593348650|FG000|Overall Study|leg fracture|1|||
164267622|NCT03412604|593348651|FG000|Overall Study|Withdrawal by Subject|1|||
164267623|NCT02634606|593348652|FG000|Overall Study|unable to obtain the drug at start|13|||
164267624|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Adverse Event|0|||
164267625|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Adverse Event|1|||
164267626|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Adverse Event|0|||
164267627|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Adverse Event|0|||
164267628|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Adverse Event|0|||
164267629|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Adverse Event|0|||
164267630|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
164267631|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267632|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267633|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267634|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267635|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
164267636|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
164267637|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
164267638|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
164267639|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
164267640|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
164267641|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
164267642|NCT00993499|593348660|FG000|Run-in Period (8 Days)|Progressive disease|0|||
164267643|NCT00993499|593348661|FG001|Run-in Period (8 Days)|Progressive disease|1|||
164267644|NCT00993499|593348662|FG002|Run-in Period (8 Days)|Progressive disease|1|||
164085872|NCT00283686|592678577|FG002|Overall Study|Lost to Follow-up|26|||
164267645|NCT00993499|593348663|FG003|Run-in Period (8 Days)|Progressive disease|0|||
164267646|NCT00993499|593348664|FG004|Run-in Period (8 Days)|Progressive disease|0|||
164267647|NCT00993499|593348665|FG005|Run-in Period (8 Days)|Progressive disease|0|||
164267648|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
164267649|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
164267650|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267651|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267652|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267653|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
164267654|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
164267655|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
164267656|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267657|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267658|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267659|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
164267660|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267661|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267662|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
164267663|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
164267664|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267665|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
164267666|NCT00993499|593348660|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267667|NCT00993499|593348661|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267668|NCT00993499|593348662|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
164267669|NCT00993499|593348663|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267670|NCT00993499|593348664|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267671|NCT00993499|593348665|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
164267672|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267673|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
164267674|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267675|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267676|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267677|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
164267678|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
164267679|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
164267680|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
164267681|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
164267682|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
164267683|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
164267684|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|DLT|1|||
164267685|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|DLT|0|||
164267686|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|DLT|2|||
164267687|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|DLT|1|||
164267688|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|DLT|0|||
164267689|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|DLT|0|||
164267690|NCT00993499|593348660|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
164267691|NCT00993499|593348661|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
164267692|NCT00993499|593348662|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
164267693|NCT00993499|593348663|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
164267694|NCT00993499|593348664|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
164267695|NCT00993499|593348665|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
164267696|NCT05432167|593348668|FG000|Overall Study|Adverse Event|0|||
164267697|NCT05432167|593348669|FG001|Overall Study|Adverse Event|2|||
164267698|NCT05432167|593348670|FG002|Overall Study|Adverse Event|1|||
164267699|NCT05432167|593348668|FG000|Overall Study|Lost to Follow-up|3|||
164267700|NCT05432167|593348669|FG001|Overall Study|Lost to Follow-up|3|||
164267701|NCT05432167|593348670|FG002|Overall Study|Lost to Follow-up|2|||
164267702|NCT05432167|593348668|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
164267703|NCT05432167|593348669|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
164267704|NCT05432167|593348670|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
164267705|NCT05432167|593348668|FG000|Overall Study|Physician Decision|1|||
164267706|NCT05432167|593348669|FG001|Overall Study|Physician Decision|0|||
164267707|NCT05432167|593348670|FG002|Overall Study|Physician Decision|0|||
164267708|NCT05432167|593348668|FG000|Overall Study|Withdrawal by Subject|7|||
164341926|NCT00932126|593627570|FG006|Overall Study|Withdrawal by Subject|0|||
164267709|NCT05432167|593348669|FG001|Overall Study|Withdrawal by Subject|4|||
164267710|NCT05432167|593348670|FG002|Overall Study|Withdrawal by Subject|11|||
164267711|NCT05432167|593348668|FG000|Overall Study|Other|0|||
164267712|NCT05432167|593348669|FG001|Overall Study|Other|0|||
164267713|NCT05432167|593348670|FG002|Overall Study|Other|1|||
164267714|NCT01287195|593348671|FG000|Overall Study|Withdrawal by Subject|2|||
164267715|NCT00283868|593348678|FG000|Overall Study|Lost to Follow-up|7|||
164267716|NCT00283868|593348679|FG001|Overall Study|Lost to Follow-up|8|||
164267717|NCT01515475|593348680|FG000|Overall Study|Lost to Follow-up|20|||
164267718|NCT01515475|593348681|FG001|Overall Study|Lost to Follow-up|15|||
164267719|NCT01515475|593348682|FG002|Overall Study|Lost to Follow-up|12|||
164267720|NCT01515475|593348683|FG003|Overall Study|Lost to Follow-up|12|||
164267721|NCT01996592|593348688|FG000|Overall Study|no response to text/no diary entry|32|||
164267722|NCT01996592|593348688|FG000|Overall Study|change in surgical date|4|||
164267723|NCT01996592|593348688|FG000|Overall Study|Withdrawal by Subject|5|||
164267724|NCT01996592|593348688|FG000|Overall Study|change in mode of delivery|4|||
164267725|NCT01406015|593348689|FG000|Overall Study|Withdrawal by Subject|3|||
164267726|NCT01406015|593348690|FG001|Overall Study|Withdrawal by Subject|3|||
164267727|NCT00707746|593348692|FG000|Treatment Period|Adverse Event|2|||
164267728|NCT00707746|593348693|FG001|Treatment Period|Adverse Event|4|||
164267729|NCT00707746|593348692|FG000|Treatment Period|Ineligibility|0|||
164267730|NCT00707746|593348693|FG001|Treatment Period|Ineligibility|1|||
164267731|NCT02573246|593348698|FG000|Overall Study|Lost to Follow-up|2|||
164267732|NCT02573246|593348699|FG001|Overall Study|Lost to Follow-up|0|||
164267733|NCT02573246|593348700|FG002|Overall Study|Lost to Follow-up|0|||
164267734|NCT02573246|593348701|FG003|Overall Study|Lost to Follow-up|0|||
164267735|NCT02573246|593348702|FG004|Overall Study|Lost to Follow-up|1|||
164267736|NCT02573246|593348698|FG000|Overall Study|Withdrawal by Subject|0|||
164267737|NCT02573246|593348699|FG001|Overall Study|Withdrawal by Subject|0|||
164267738|NCT02573246|593348700|FG002|Overall Study|Withdrawal by Subject|0|||
164267739|NCT02573246|593348701|FG003|Overall Study|Withdrawal by Subject|0|||
164267740|NCT02573246|593348702|FG004|Overall Study|Withdrawal by Subject|1|||
164267741|NCT02573246|593348698|FG000|Overall Study|Physician Decision|1|||
164267742|NCT02573246|593348699|FG001|Overall Study|Physician Decision|1|||
164267743|NCT02573246|593348700|FG002|Overall Study|Physician Decision|3|||
164267744|NCT02573246|593348701|FG003|Overall Study|Physician Decision|2|||
164267745|NCT02573246|593348702|FG004|Overall Study|Physician Decision|2|||
164267746|NCT01902888|593348703|FG000|Overall Study|Study Terminated|3|||
164267747|NCT02256267|593348704|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
164267748|NCT02256267|593348704|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
164267749|NCT03149003|593348705|FG000|Overall Study|Randomized but not treated|0|||
164267750|NCT03149003|593348706|FG001|Overall Study|Randomized but not treated|1|||
164267751|NCT03149003|593348707|FG002|Overall Study|Randomized but not treated|18|||
164267752|NCT01685983|593348708|FG000|Overall Study|Adverse Event|7|||
164267753|NCT01685983|593348708|FG000|Overall Study|Death|1|||
164267754|NCT01685983|593348708|FG000|Overall Study|Withdrawal by Subject|19|||
164267755|NCT01685983|593348708|FG000|Overall Study|Protocol Violation|2|||
164267756|NCT01685983|593348708|FG000|Overall Study|Physician Decision|13|||
164267757|NCT01685983|593348708|FG000|Overall Study|Other|7|||
164267758|NCT01685983|593348708|FG000|Overall Study|Progressive Disease|32|||
164267759|NCT01685983|593348708|FG000|Overall Study|Noncompliance with Study Drug|1|||
164267760|NCT01443130|593348709|FG000|Overall Study|Lost to Follow-up|44|||
164267761|NCT01443130|593348710|FG001|Overall Study|Lost to Follow-up|42|||
164267762|NCT01443130|593348711|FG002|Overall Study|Lost to Follow-up|50|||
164267763|NCT01443130|593348712|FG003|Overall Study|Lost to Follow-up|23|||
164267764|NCT01443130|593348713|FG004|Overall Study|Lost to Follow-up|25|||
164267765|NCT01443130|593348714|FG005|Overall Study|Lost to Follow-up|21|||
164267766|NCT01443130|593348709|FG000|Overall Study|Death|0|||
164267767|NCT01443130|593348710|FG001|Overall Study|Death|1|||
164267768|NCT01443130|593348711|FG002|Overall Study|Death|0|||
164267769|NCT01443130|593348712|FG003|Overall Study|Death|7|||
164267770|NCT01443130|593348713|FG004|Overall Study|Death|10|||
164267771|NCT01443130|593348714|FG005|Overall Study|Death|8|||
164267772|NCT01443130|593348709|FG000|Overall Study|Adverse Event|2|||
164267773|NCT01443130|593348710|FG001|Overall Study|Adverse Event|1|||
164267774|NCT01443130|593348711|FG002|Overall Study|Adverse Event|1|||
164267775|NCT01443130|593348712|FG003|Overall Study|Adverse Event|0|||
164341927|NCT00932126|593627571|FG007|Overall Study|Withdrawal by Subject|1|||
164341928|NCT00932126|593627564|FG000|Overall Study|Objective progression or relapse|3|||
164341929|NCT00932126|593627565|FG001|Overall Study|Objective progression or relapse|3|||
164341930|NCT00932126|593627566|FG002|Overall Study|Objective progression or relapse|2|||
164267776|NCT01443130|593348713|FG004|Overall Study|Adverse Event|0|||
164267777|NCT01443130|593348714|FG005|Overall Study|Adverse Event|0|||
164267778|NCT01443130|593348709|FG000|Overall Study|Protocol Violation|2|||
164267779|NCT01443130|593348710|FG001|Overall Study|Protocol Violation|1|||
164267780|NCT01443130|593348711|FG002|Overall Study|Protocol Violation|3|||
164341931|NCT00932126|593627567|FG003|Overall Study|Objective progression or relapse|3|||
164341932|NCT00932126|593627568|FG004|Overall Study|Objective progression or relapse|3|||
164267781|NCT01443130|593348712|FG003|Overall Study|Protocol Violation|2|||
164267782|NCT01443130|593348713|FG004|Overall Study|Protocol Violation|2|||
164267783|NCT01443130|593348714|FG005|Overall Study|Protocol Violation|3|||
164267784|NCT01443130|593348709|FG000|Overall Study|Withdrawal by Subject|15|||
164267785|NCT01443130|593348710|FG001|Overall Study|Withdrawal by Subject|14|||
164267786|NCT01443130|593348711|FG002|Overall Study|Withdrawal by Subject|12|||
164267787|NCT01443130|593348712|FG003|Overall Study|Withdrawal by Subject|7|||
164267788|NCT01443130|593348713|FG004|Overall Study|Withdrawal by Subject|7|||
164267789|NCT01443130|593348714|FG005|Overall Study|Withdrawal by Subject|2|||
164267790|NCT01443130|593348709|FG000|Overall Study|Death of Subject's Infant|5|||
164267791|NCT01443130|593348710|FG001|Overall Study|Death of Subject's Infant|10|||
164267792|NCT01443130|593348711|FG002|Overall Study|Death of Subject's Infant|11|||
163998317|NCT00929240|592359088|FG001|Maintenance Phase|Disease progression|73|||
163998318|NCT00929240|592359089|FG002|Maintenance Phase|Disease progression|60|||
163998319|NCT00929240|592359087|FG000|Maintenance Phase|Adverse Event|0|||
163998320|NCT00929240|592359088|FG001|Maintenance Phase|Adverse Event|9|||
163998321|NCT00929240|592359089|FG002|Maintenance Phase|Adverse Event|12|||
164267793|NCT01443130|593348712|FG003|Overall Study|Death of Subject's Infant|0|||
164267794|NCT01443130|593348713|FG004|Overall Study|Death of Subject's Infant|0|||
164267795|NCT01443130|593348714|FG005|Overall Study|Death of Subject's Infant|0|||
164267796|NCT02758301|593348715|FG000|Overall Study|Death|12|||
164267797|NCT02758301|593348716|FG001|Overall Study|Death|0|||
164267798|NCT02758301|593348715|FG000|Overall Study|Physician Decision|10|||
164267799|NCT02758301|593348716|FG001|Overall Study|Physician Decision|1|||
164267800|NCT02758301|593348715|FG000|Overall Study|Withdrawal by Subject|5|||
164267801|NCT02758301|593348716|FG001|Overall Study|Withdrawal by Subject|6|||
164267802|NCT02758301|593348715|FG000|Overall Study|Lost to Follow-up|7|||
164267803|NCT02758301|593348716|FG001|Overall Study|Lost to Follow-up|0|||
164267804|NCT02758301|593348715|FG000|Overall Study|Protocol Violation|0|||
164267805|NCT02758301|593348716|FG001|Overall Study|Protocol Violation|1|||
164267806|NCT00364533|593348717|FG000|Overall Study|Adverse Event|8|||
164267807|NCT00364533|593348718|FG001|Overall Study|Adverse Event|7|||
164267808|NCT00364533|593348719|FG002|Overall Study|Adverse Event|15|||
164267809|NCT00364533|593348720|FG003|Overall Study|Adverse Event|5|||
164267810|NCT00364533|593348721|FG004|Overall Study|Adverse Event|2|||
164267811|NCT00364533|593348717|FG000|Overall Study|Withdrawal by Subject|4|||
164267812|NCT00364533|593348718|FG001|Overall Study|Withdrawal by Subject|8|||
164267813|NCT00364533|593348719|FG002|Overall Study|Withdrawal by Subject|6|||
164267814|NCT00364533|593348720|FG003|Overall Study|Withdrawal by Subject|6|||
164267815|NCT00364533|593348721|FG004|Overall Study|Withdrawal by Subject|6|||
164267816|NCT00364533|593348717|FG000|Overall Study|Lack of Efficacy|22|||
164267817|NCT00364533|593348718|FG001|Overall Study|Lack of Efficacy|22|||
164267818|NCT00364533|593348719|FG002|Overall Study|Lack of Efficacy|21|||
164267819|NCT00364533|593348720|FG003|Overall Study|Lack of Efficacy|17|||
164267820|NCT00364533|593348721|FG004|Overall Study|Lack of Efficacy|42|||
164267821|NCT00364533|593348717|FG000|Overall Study|Subject discharged from hospital|4|||
164267822|NCT00364533|593348718|FG001|Overall Study|Subject discharged from hospital|1|||
164267823|NCT00364533|593348719|FG002|Overall Study|Subject discharged from hospital|2|||
164267824|NCT00364533|593348720|FG003|Overall Study|Subject discharged from hospital|3|||
164267825|NCT00364533|593348721|FG004|Overall Study|Subject discharged from hospital|1|||
164267826|NCT00364533|593348717|FG000|Overall Study|Variations in drug compliance|2|||
164267827|NCT00364533|593348718|FG001|Overall Study|Variations in drug compliance|1|||
164267828|NCT00364533|593348719|FG002|Overall Study|Variations in drug compliance|1|||
164267829|NCT00364533|593348720|FG003|Overall Study|Variations in drug compliance|0|||
164267830|NCT00364533|593348721|FG004|Overall Study|Variations in drug compliance|0|||
164267831|NCT00364533|593348717|FG000|Overall Study|Non-compliance|1|||
164267832|NCT00364533|593348718|FG001|Overall Study|Non-compliance|0|||
164267833|NCT00364533|593348719|FG002|Overall Study|Non-compliance|0|||
164267834|NCT00364533|593348720|FG003|Overall Study|Non-compliance|0|||
164267835|NCT00364533|593348721|FG004|Overall Study|Non-compliance|0|||
164267836|NCT00364533|593348717|FG000|Overall Study|Protocol Violation|1|||
164267837|NCT00364533|593348718|FG001|Overall Study|Protocol Violation|1|||
164267838|NCT00364533|593348719|FG002|Overall Study|Protocol Violation|0|||
164267839|NCT00364533|593348720|FG003|Overall Study|Protocol Violation|0|||
164267840|NCT00364533|593348721|FG004|Overall Study|Protocol Violation|0|||
164267841|NCT01490294|593348723|FG000|Overall Study|Prematurely discontinuation|4|||
164267842|NCT01490294|593348724|FG001|Overall Study|Prematurely discontinuation|0|||
164267843|NCT01490294|593348725|FG002|Overall Study|Prematurely discontinuation|1|||
164267844|NCT01490294|593348726|FG003|Overall Study|Prematurely discontinuation|1|||
164267845|NCT01490294|593348723|FG000|Overall Study|Adverse Event|1|||
164267846|NCT01490294|593348724|FG001|Overall Study|Adverse Event|0|||
164267847|NCT01490294|593348725|FG002|Overall Study|Adverse Event|0|||
164267848|NCT01490294|593348726|FG003|Overall Study|Adverse Event|0|||
163998322|NCT00929240|592359087|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163998323|NCT00929240|592359088|FG001|Maintenance Phase|Withdrawal by Subject|2|||
163998324|NCT00929240|592359089|FG002|Maintenance Phase|Withdrawal by Subject|6|||
163998325|NCT00929240|592359087|FG000|Maintenance Phase|Protocol Violation|0|||
164267849|NCT01266590|593349975|FG000|Overall Study|Adverse Event|3|||
164267850|NCT01266590|593349975|FG000|Overall Study|Lost to Follow-up|1|||
164267851|NCT01266590|593349975|FG000|Overall Study|Withdrawal by Subject|1|||
164267852|NCT01266590|593349975|FG000|Overall Study|Physician Decision|1|||
164267853|NCT00511134|593349976|FG000|Overall Study|Withdrawal by Subject|0|||
164267854|NCT00511134|593349977|FG001|Overall Study|Withdrawal by Subject|2|||
164267855|NCT01949090|593349978|FG000|Overall Study|Serious Adverse Event|0|||
164267856|NCT01949090|593349979|FG001|Overall Study|Serious Adverse Event|1|||
164267857|NCT01949090|593349980|FG002|Overall Study|Serious Adverse Event|2|||
164267858|NCT01949090|593349981|FG003|Overall Study|Serious Adverse Event|0|||
164267859|NCT01949090|593349982|FG004|Overall Study|Serious Adverse Event|1|||
164267860|NCT01949090|593349978|FG000|Overall Study|Withdrawal by Subject|2|||
164085873|NCT00283686|592678578|FG003|Overall Study|Lost to Follow-up|20|||
164085874|NCT00283686|592678575|FG000|Overall Study|Less than full participation|7|||
164267861|NCT01949090|593349979|FG001|Overall Study|Withdrawal by Subject|0|||
164267862|NCT01949090|593349980|FG002|Overall Study|Withdrawal by Subject|0|||
164267863|NCT01949090|593349981|FG003|Overall Study|Withdrawal by Subject|0|||
164267864|NCT01949090|593349982|FG004|Overall Study|Withdrawal by Subject|1|||
164267865|NCT01949090|593349978|FG000|Overall Study|Protocol non-compliance|0|||
164267866|NCT01949090|593349979|FG001|Overall Study|Protocol non-compliance|0|||
164267867|NCT01949090|593349980|FG002|Overall Study|Protocol non-compliance|0|||
164267868|NCT01949090|593349981|FG003|Overall Study|Protocol non-compliance|0|||
164267869|NCT01949090|593349982|FG004|Overall Study|Protocol non-compliance|1|||
164267870|NCT01949090|593349978|FG000|Overall Study|Lost to Follow-up|2|||
164267871|NCT01949090|593349979|FG001|Overall Study|Lost to Follow-up|1|||
164267872|NCT01949090|593349980|FG002|Overall Study|Lost to Follow-up|0|||
164267873|NCT01949090|593349981|FG003|Overall Study|Lost to Follow-up|1|||
164267874|NCT01949090|593349982|FG004|Overall Study|Lost to Follow-up|1|||
164267875|NCT00541346|593349983|FG000|Follow-up|Adverse Event|1|||
164267876|NCT02008773|593349984|FG000|Overall Study|Adverse Event|3|||
164267877|NCT02008773|593349985|FG001|Overall Study|Adverse Event|3|||
164267878|NCT02008773|593349986|FG002|Overall Study|Adverse Event|1|||
164267879|NCT02008773|593349987|FG003|Overall Study|Adverse Event|2|||
164267880|NCT02008773|593349984|FG000|Overall Study|Medication Non-compliance|2|||
164267881|NCT02008773|593349985|FG001|Overall Study|Medication Non-compliance|1|||
164267882|NCT02008773|593349986|FG002|Overall Study|Medication Non-compliance|3|||
164267883|NCT02008773|593349987|FG003|Overall Study|Medication Non-compliance|2|||
164267884|NCT02008773|593349984|FG000|Overall Study|Withdrawal by Subject|8|||
164267885|NCT02008773|593349985|FG001|Overall Study|Withdrawal by Subject|4|||
164267886|NCT02008773|593349986|FG002|Overall Study|Withdrawal by Subject|7|||
164267887|NCT02008773|593349987|FG003|Overall Study|Withdrawal by Subject|6|||
164267888|NCT02008773|593349984|FG000|Overall Study|Lost to Follow-up|0|||
164267889|NCT02008773|593349985|FG001|Overall Study|Lost to Follow-up|1|||
164267890|NCT02008773|593349986|FG002|Overall Study|Lost to Follow-up|3|||
164267891|NCT02008773|593349987|FG003|Overall Study|Lost to Follow-up|2|||
164267892|NCT02804750|593349993|FG000|Period 1|Adverse Event|0|||
164267893|NCT02804750|593349994|FG001|Period 1|Adverse Event|2|||
164267894|NCT02804750|593349993|FG000|Period 1|Withdrawal by Subject|0|||
164267895|NCT02804750|593349994|FG001|Period 1|Withdrawal by Subject|1|||
164267896|NCT02804750|593349993|FG000|Period 2|Adverse Event|1|||
164267897|NCT02804750|593349994|FG001|Period 2|Adverse Event|0|||
164267898|NCT02804750|593349993|FG000|Period 3|Adverse Event|0|||
164267899|NCT02804750|593349994|FG001|Period 3|Adverse Event|2|||
164267900|NCT02804750|593349993|FG000|Period 4|Adverse Event|0|||
164267901|NCT02804750|593349994|FG001|Period 4|Adverse Event|5|||
164267902|NCT04435600|593350000|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267903|NCT04435600|593350001|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267904|NCT04435600|593350002|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
164267905|NCT04435600|593350003|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267906|NCT04435600|593350004|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267907|NCT04435600|593350005|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267908|NCT04435600|593350006|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267909|NCT04435600|593350007|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267910|NCT04435600|593350008|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267911|NCT04435600|593350009|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164267912|NCT04435600|593350000|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267913|NCT04435600|593350001|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164341933|NCT00932126|593627569|FG005|Overall Study|Objective progression or relapse|3|||
164085875|NCT00283686|592678576|FG001|Overall Study|Less than full participation|9|||
164341934|NCT00932126|593627570|FG006|Overall Study|Objective progression or relapse|3|||
164341935|NCT00932126|593627571|FG007|Overall Study|Objective progression or relapse|5|||
164085876|NCT00283686|592678577|FG002|Overall Study|Less than full participation|6|||
164085877|NCT00283686|592678578|FG003|Overall Study|Less than full participation|12|||
164085878|NCT00696709|592678580|FG000|Overall Study|Withdrawal by Subject|1|||
164085879|NCT00696709|592678581|FG001|Overall Study|Withdrawal by Subject|2|||
164085880|NCT00696709|592678582|FG002|Overall Study|Withdrawal by Subject|1|||
164267914|NCT04435600|593350002|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267915|NCT04435600|593350003|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267916|NCT04435600|593350004|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267917|NCT04435600|593350005|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267918|NCT04435600|593350006|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267919|NCT04435600|593350007|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267920|NCT04435600|593350008|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
164267921|NCT04435600|593350009|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
164267922|NCT04435600|593350000|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267923|NCT04435600|593350001|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267924|NCT04435600|593350002|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267925|NCT04435600|593350003|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267926|NCT04435600|593350004|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267927|NCT04435600|593350005|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267928|NCT04435600|593350006|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267929|NCT04435600|593350007|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267930|NCT04435600|593350008|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
164267931|NCT04435600|593350009|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
164267932|NCT04435600|593350000|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267933|NCT04435600|593350001|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267934|NCT04435600|593350002|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267935|NCT04435600|593350003|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267936|NCT04435600|593350004|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267937|NCT04435600|593350005|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267938|NCT04435600|593350006|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267939|NCT04435600|593350007|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267940|NCT04435600|593350008|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
164267941|NCT04435600|593350009|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
164267942|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
164267943|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
164267944|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
164267945|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
164267946|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
164267947|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
164267948|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
164267949|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
164267950|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
164267951|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
164267952|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
164267953|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
164267954|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
164267955|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
164267956|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
164267957|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
164267958|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
164267959|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
164267960|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
164267961|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
164267962|NCT05149313|593350017|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
164267963|NCT05149313|593350018|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
164267964|NCT05149313|593350019|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
164267965|NCT05149313|593350020|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
164267966|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
164267967|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
164267968|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
164267969|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
164267970|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164267971|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
164267972|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
164267973|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
164267974|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164267975|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
164267976|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
164267977|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
164267978|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164267979|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164267980|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
164267981|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
164267982|NCT05149313|593350017|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
164267983|NCT05149313|593350018|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
164267984|NCT05149313|593350019|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
164267985|NCT05149313|593350020|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
164267986|NCT03826342|593350030|FG000|Overall Study|Withdrawal by Subject|8|||
164267987|NCT03826342|593350031|FG001|Overall Study|Withdrawal by Subject|1|||
164267988|NCT03826342|593350030|FG000|Overall Study|Lost to Follow-up|7|||
164267989|NCT03826342|593350031|FG001|Overall Study|Lost to Follow-up|7|||
164267990|NCT03826342|593350030|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
164267991|NCT03826342|593350031|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
164267992|NCT02212678|593350034|FG000|Overall Study|Adverse Event|1|||
164267993|NCT02337634|593350035|FG000|Overall Study|Protocol Violation|3|||
164267994|NCT02337634|593350036|FG001|Overall Study|Protocol Violation|1|||
164267995|NCT02337634|593350035|FG000|Overall Study|Lost to Follow-up|1|||
164267996|NCT02337634|593350036|FG001|Overall Study|Lost to Follow-up|0|||
164267997|NCT02428205|593350038|FG000|Overall Study|Lack of Efficacy|1|||
164267998|NCT02428205|593350039|FG001|Overall Study|Lack of Efficacy|0|||
164267999|NCT02428205|593350038|FG000|Overall Study|Lost to Follow-up|1|||
164268000|NCT02428205|593350039|FG001|Overall Study|Lost to Follow-up|1|||
164268001|NCT02428205|593350038|FG000|Overall Study|Worse behavior|0|||
164268002|NCT02428205|593350039|FG001|Overall Study|Worse behavior|1|||
164268003|NCT02888743|593350040|FG000|Overall Study|Withdrawal by Subject|1|||
164268004|NCT02888743|593350041|FG001|Overall Study|Withdrawal by Subject|2|||
164268005|NCT02888743|593350042|FG002|Overall Study|Withdrawal by Subject|2|||
164268006|NCT02888743|593350043|FG003|Overall Study|Withdrawal by Subject|0|||
164268007|NCT02888743|593350044|FG004|Overall Study|Withdrawal by Subject|1|||
164268008|NCT02888743|593350040|FG000|Overall Study|Disease progression before treatment|2|||
164268009|NCT02888743|593350041|FG001|Overall Study|Disease progression before treatment|0|||
164268010|NCT02888743|593350042|FG002|Overall Study|Disease progression before treatment|2|||
164268011|NCT02888743|593350043|FG003|Overall Study|Disease progression before treatment|0|||
164268012|NCT02888743|593350044|FG004|Overall Study|Disease progression before treatment|0|||
164268013|NCT02888743|593350040|FG000|Overall Study|Patient ineligible|1|||
164268014|NCT02888743|593350041|FG001|Overall Study|Patient ineligible|2|||
164268015|NCT02888743|593350042|FG002|Overall Study|Patient ineligible|0|||
164268016|NCT02888743|593350043|FG003|Overall Study|Patient ineligible|0|||
164268017|NCT02888743|593350044|FG004|Overall Study|Patient ineligible|0|||
164268018|NCT00527319|593350045|FG000|Overall Study|Withdrawal by Subject|5|||
164268019|NCT00527319|593350046|FG001|Overall Study|Withdrawal by Subject|0|||
164268020|NCT00527319|593350047|FG002|Overall Study|Withdrawal by Subject|1|||
164268021|NCT00527319|593350045|FG000|Overall Study|Lost to Follow-up|1|||
164268022|NCT00527319|593350046|FG001|Overall Study|Lost to Follow-up|0|||
164268023|NCT00527319|593350047|FG002|Overall Study|Lost to Follow-up|0|||
164268024|NCT00527319|593350045|FG000|Overall Study|Death|0|||
164268025|NCT00527319|593350046|FG001|Overall Study|Death|3|||
164268026|NCT00527319|593350047|FG002|Overall Study|Death|1|||
164268027|NCT00527319|593350045|FG000|Overall Study|Intercurrent Medical Illness|0|||
164268028|NCT00527319|593350046|FG001|Overall Study|Intercurrent Medical Illness|1|||
164268029|NCT00527319|593350047|FG002|Overall Study|Intercurrent Medical Illness|3|||
164268030|NCT00527319|593350045|FG000|Overall Study|Adverse Event|0|||
164268031|NCT00527319|593350046|FG001|Overall Study|Adverse Event|0|||
164268032|NCT00527319|593350047|FG002|Overall Study|Adverse Event|1|||
164268033|NCT01804582|593350050|FG000|Overall Study|Lost to Follow-up|47|||
164268034|NCT01804582|593350051|FG001|Overall Study|Lost to Follow-up|56|||
164268035|NCT01804582|593350050|FG000|Overall Study|Physician Decision|2|||
164268036|NCT01804582|593350051|FG001|Overall Study|Physician Decision|0|||
164268037|NCT00431951|593350054|FG000|Overall Study|Inability to follow study procedures|1|||
164268038|NCT00431951|593350055|FG001|Overall Study|Inability to follow study procedures|0|||
164268039|NCT00431951|593350056|FG002|Overall Study|Inability to follow study procedures|1|||
164268040|NCT00431951|593350057|FG003|Overall Study|Inability to follow study procedures|2|||
164268041|NCT00431951|593350054|FG000|Overall Study|Lost to Follow-up|0|||
164268042|NCT00431951|593350055|FG001|Overall Study|Lost to Follow-up|1|||
164268043|NCT00431951|593350056|FG002|Overall Study|Lost to Follow-up|0|||
164268044|NCT00431951|593350057|FG003|Overall Study|Lost to Follow-up|0|||
164268045|NCT00431951|593350054|FG000|Overall Study|Withdrawal by Subject|0|||
164268046|NCT00431951|593350055|FG001|Overall Study|Withdrawal by Subject|1|||
164268047|NCT00431951|593350056|FG002|Overall Study|Withdrawal by Subject|0|||
164268048|NCT00431951|593350057|FG003|Overall Study|Withdrawal by Subject|0|||
164268049|NCT00431951|593350054|FG000|Overall Study|Adverse Event|0|||
164268050|NCT00431951|593350055|FG001|Overall Study|Adverse Event|0|||
164268051|NCT00431951|593350056|FG002|Overall Study|Adverse Event|1|||
164268052|NCT00431951|593350057|FG003|Overall Study|Adverse Event|0|||
164268053|NCT00385723|593350058|FG000|Overall Study|Lost to Follow-up|1|||
164268054|NCT00385723|593350059|FG001|Overall Study|Lost to Follow-up|1|||
164268055|NCT00385723|593350060|FG002|Overall Study|Lost to Follow-up|0|||
164268056|NCT00385723|593350058|FG000|Overall Study|Withdrawal by Subject|1|||
164268057|NCT00385723|593350059|FG001|Overall Study|Withdrawal by Subject|0|||
164268058|NCT00385723|593350060|FG002|Overall Study|Withdrawal by Subject|2|||
164268059|NCT00689793|593350065|FG000|Overall Study|Lost to Follow-up|4|||
164268060|NCT00689793|593350066|FG001|Overall Study|Lost to Follow-up|5|||
164268061|NCT01920152|593350067|FG000|Overall Study|Withdrawal by Subject|1|||
164268062|NCT01920152|593350068|FG001|Overall Study|Withdrawal by Subject|2|||
164268063|NCT01167907|593350074|FG000|Overall Study|Protocol Violation|1|||
164268064|NCT01167907|593350075|FG001|Overall Study|Protocol Violation|0|||
164268065|NCT01167907|593350074|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
164341936|NCT00932126|593627564|FG000|Overall Study|Other|0|||
164268066|NCT01167907|593350075|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
164268067|NCT01814670|593350082|FG000|Overall Study|Protocol Violation|12|||
164268068|NCT00973102|593350083|FG000|Overall Study|Protocol Violation|1|||
164268069|NCT00973102|593350084|FG001|Overall Study|Protocol Violation|0|||
164268070|NCT00973102|593350083|FG000|Overall Study|Prisoner|0|||
164268071|NCT00973102|593350084|FG001|Overall Study|Prisoner|1|||
164268072|NCT01066780|593350085|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
164268073|NCT01066780|593350086|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
164268074|NCT02360293|593350087|FG000|Overall Study|Lost to Follow-up|73|||
164268075|NCT02360293|593350088|FG001|Overall Study|Lost to Follow-up|95|||
164268076|NCT02360293|593350087|FG000|Overall Study|Withdrawal by Subject|2|||
164268077|NCT02360293|593350088|FG001|Overall Study|Withdrawal by Subject|1|||
164268078|NCT02360293|593350087|FG000|Overall Study|Excluded|1|||
164268079|NCT02360293|593350088|FG001|Overall Study|Excluded|0|||
164268080|NCT02226549|593350089|FG000|Overall Study|Randomized but Never Treated|1|||
164268081|NCT02226549|593350090|FG001|Overall Study|Randomized but Never Treated|0|||
164268082|NCT02226549|593350089|FG000|Overall Study|Lost to Follow-up|0|||
164268083|NCT02226549|593350090|FG001|Overall Study|Lost to Follow-up|1|||
164268084|NCT03099148|593350091|FG000|Wash-out|scheduling conflict|0|||
164268085|NCT03099148|593350092|FG001|Wash-out|scheduling conflict|1|||
164268086|NCT03099148|593350093|FG002|Wash-out|scheduling conflict|0|||
164268087|NCT03099148|593350094|FG003|Wash-out|scheduling conflict|0|||
164268088|NCT03099148|593350091|FG000|Wash-out|Adverse Event|0|||
164268089|NCT03099148|593350092|FG001|Wash-out|Adverse Event|1|||
164268090|NCT03099148|593350093|FG002|Wash-out|Adverse Event|0|||
164268091|NCT03099148|593350094|FG003|Wash-out|Adverse Event|0|||
164268092|NCT01269385|593350095|FG000|Overall Study|Adverse Event|1|||
164268093|NCT01269385|593350096|FG001|Overall Study|Adverse Event|1|||
164268094|NCT01269385|593350097|FG002|Overall Study|Adverse Event|0|||
164268095|NCT01269385|593350098|FG003|Overall Study|Adverse Event|0|||
164268096|NCT00687609|593350103|FG000|Overall Study|Physician Decision|1|||
164268097|NCT00687609|593350103|FG000|Overall Study|Withdrawal by Subject|2|||
164268098|NCT02713529|593350104|FG000|Overall Study|Withdrawal by Subject|3|||
164268099|NCT02713529|593350105|FG001|Overall Study|Withdrawal by Subject|1|||
164268100|NCT02713529|593350106|FG002|Overall Study|Withdrawal by Subject|4|||
164268101|NCT02713529|593350107|FG003|Overall Study|Withdrawal by Subject|2|||
164268102|NCT02713529|593350108|FG004|Overall Study|Withdrawal by Subject|0|||
164268103|NCT02713529|593350109|FG005|Overall Study|Withdrawal by Subject|1|||
164268104|NCT02713529|593350110|FG006|Overall Study|Withdrawal by Subject|1|||
164268105|NCT02713529|593350104|FG000|Overall Study|Lost to Follow-up|1|||
164268106|NCT02713529|593350105|FG001|Overall Study|Lost to Follow-up|0|||
164268107|NCT02713529|593350106|FG002|Overall Study|Lost to Follow-up|1|||
164268108|NCT02713529|593350107|FG003|Overall Study|Lost to Follow-up|0|||
164268109|NCT02713529|593350108|FG004|Overall Study|Lost to Follow-up|0|||
164268110|NCT02713529|593350109|FG005|Overall Study|Lost to Follow-up|0|||
164268111|NCT02713529|593350110|FG006|Overall Study|Lost to Follow-up|0|||
164268112|NCT02713529|593350104|FG000|Overall Study|Death|3|||
164268113|NCT02713529|593350105|FG001|Overall Study|Death|3|||
164268114|NCT02713529|593350106|FG002|Overall Study|Death|26|||
164268115|NCT02713529|593350107|FG003|Overall Study|Death|27|||
164268116|NCT02713529|593350108|FG004|Overall Study|Death|3|||
164268117|NCT02713529|593350109|FG005|Overall Study|Death|13|||
164268118|NCT02713529|593350110|FG006|Overall Study|Death|3|||
164268119|NCT03667690|593351693|FG000|Overall Study|Adverse Event|0|||
164268120|NCT03667690|593351694|FG001|Overall Study|Adverse Event|3|||
164268121|NCT03667690|593351693|FG000|Overall Study|Death|22|||
164268122|NCT03667690|593351694|FG001|Overall Study|Death|21|||
164268123|NCT03667690|593351693|FG000|Overall Study|Lost to Follow-up|4|||
164268124|NCT03667690|593351694|FG001|Overall Study|Lost to Follow-up|5|||
164268125|NCT03667690|593351693|FG000|Overall Study|Withdrawal by Subject|7|||
164268126|NCT03667690|593351694|FG001|Overall Study|Withdrawal by Subject|8|||
164268127|NCT03667690|593351693|FG000|Overall Study|Subject could not return for additional investigational product|1|||
164268128|NCT03667690|593351694|FG001|Overall Study|Subject could not return for additional investigational product|0|||
164268129|NCT03667690|593351693|FG000|Overall Study|Subject discharged to hospice care|2|||
164268130|NCT03667690|593351694|FG001|Overall Study|Subject discharged to hospice care|0|||
164268131|NCT03667690|593351693|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
164268132|NCT03667690|593351694|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
164268133|NCT03667690|593351693|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
164268134|NCT03667690|593351694|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
164268135|NCT03667690|593351693|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
164268136|NCT03667690|593351694|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
164268137|NCT03667690|593351693|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
164268138|NCT03667690|593351694|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
164268139|NCT03667690|593351693|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
164268140|NCT03667690|593351694|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
164268141|NCT01192568|593351703|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
164268142|NCT01192568|593351704|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
164268143|NCT01192568|593351705|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
164268144|NCT01192568|593351706|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
164268145|NCT01192568|593351703|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
164268146|NCT01192568|593351704|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
164268147|NCT01192568|593351705|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
164268148|NCT01192568|593351706|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
164268149|NCT02593825|593351707|FG000|Intervention|Lost to Follow-up|10|||
164268150|NCT02593825|593351708|FG001|Intervention|Lost to Follow-up|12|||
164268151|NCT06359080|593351709|FG000|Overall Study|Withdrawal by Subject|3|||
164268152|NCT02783170|593351714|FG000|Overall Study|Randomized but not Vaccinated|1|||
164268153|NCT02783170|593351715|FG001|Overall Study|Randomized but not Vaccinated|0|||
164268154|NCT03323736|593351718|FG000|Overall Study|Screen Failure|14|||
164268155|NCT03323736|593351719|FG001|Overall Study|Screen Failure|9|||
164268156|NCT03323736|593351720|FG002|Overall Study|Screen Failure|1|||
164268157|NCT03323736|593351718|FG000|Overall Study|Withdrawal Before Treatment|3|||
164268158|NCT03323736|593351719|FG001|Overall Study|Withdrawal Before Treatment|1|||
164268159|NCT03323736|593351720|FG002|Overall Study|Withdrawal Before Treatment|1|||
164268160|NCT03323736|593351718|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
164268161|NCT03323736|593351719|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
164268162|NCT03323736|593351720|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
164268163|NCT01806064|593351721|FG000|Overall Study|Randomized Not Enrolled|0|||
164268164|NCT01806064|593351722|FG001|Overall Study|Randomized Not Enrolled|0|||
164268165|NCT01806064|593351723|FG002|Overall Study|Randomized Not Enrolled|0|||
164268166|NCT01806064|593351724|FG003|Overall Study|Randomized Not Enrolled|1|||
164268167|NCT01806064|593351725|FG004|Overall Study|Randomized Not Enrolled|2|||
164268168|NCT00701805|593351731|FG000|Overall Study|Withdrawal by Subject|3|||
164268169|NCT00701805|593351732|FG001|Overall Study|Withdrawal by Subject|1|||
164268170|NCT00701805|593351733|FG002|Overall Study|Withdrawal by Subject|4|||
164268171|NCT00701805|593351734|FG003|Overall Study|Withdrawal by Subject|3|||
164268172|NCT00701805|593351731|FG000|Overall Study|Adverse Event|0|||
164268173|NCT00701805|593351732|FG001|Overall Study|Adverse Event|1|||
164268174|NCT00701805|593351733|FG002|Overall Study|Adverse Event|1|||
164268175|NCT00701805|593351734|FG003|Overall Study|Adverse Event|0|||
164268176|NCT00701805|593351731|FG000|Overall Study|Missed 7 consecutive doses|0|||
164268177|NCT00701805|593351732|FG001|Overall Study|Missed 7 consecutive doses|1|||
164268178|NCT00701805|593351733|FG002|Overall Study|Missed 7 consecutive doses|0|||
164268179|NCT00701805|593351734|FG003|Overall Study|Missed 7 consecutive doses|0|||
164268180|NCT00701805|593351731|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
164268181|NCT00701805|593351732|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
164268182|NCT00701805|593351733|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
164268183|NCT00701805|593351734|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
164268184|NCT00701805|593351731|FG000|Overall Study|Physician decision, change of therapy|0|||
164268185|NCT00701805|593351732|FG001|Overall Study|Physician decision, change of therapy|0|||
164268186|NCT00701805|593351733|FG002|Overall Study|Physician decision, change of therapy|0|||
164268187|NCT00701805|593351734|FG003|Overall Study|Physician decision, change of therapy|1|||
164268188|NCT00701805|593351731|FG000|Overall Study|Difficult to travel to dialysis site|0|||
164268189|NCT00701805|593351732|FG001|Overall Study|Difficult to travel to dialysis site|0|||
164268190|NCT00701805|593351733|FG002|Overall Study|Difficult to travel to dialysis site|1|||
164268191|NCT00701805|593351734|FG003|Overall Study|Difficult to travel to dialysis site|0|||
164268192|NCT00701805|593351731|FG000|Overall Study|Resumption criteria were not met|0|||
164268193|NCT00701805|593351732|FG001|Overall Study|Resumption criteria were not met|1|||
163998326|NCT00929240|592359088|FG001|Maintenance Phase|Protocol Violation|1|||
163998327|NCT00929240|592359089|FG002|Maintenance Phase|Protocol Violation|0|||
163998328|NCT00929240|592359087|FG000|Maintenance Phase|Health authority/Study termination|0|||
163998329|NCT00929240|592359088|FG001|Maintenance Phase|Health authority/Study termination|1|||
163998330|NCT00929240|592359089|FG002|Maintenance Phase|Health authority/Study termination|2|||
163998331|NCT00929240|592359087|FG000|Maintenance Phase|Physician Decision|0|||
164268194|NCT00701805|593351733|FG002|Overall Study|Resumption criteria were not met|0|||
164268195|NCT00701805|593351734|FG003|Overall Study|Resumption criteria were not met|0|||
164268196|NCT05063539|593351735|FG000|Overall Study|Adverse Event|1|||
164268197|NCT05063539|593351736|FG001|Overall Study|Adverse Event|2|||
164268198|NCT05063539|593351737|FG002|Overall Study|Adverse Event|1|||
164268199|NCT05063539|593351735|FG000|Overall Study|Death|0|||
164268200|NCT05063539|593351736|FG001|Overall Study|Death|1|||
164268201|NCT05063539|593351737|FG002|Overall Study|Death|1|||
164268202|NCT05063539|593351735|FG000|Overall Study|Lost to Follow-up|0|||
164268203|NCT05063539|593351736|FG001|Overall Study|Lost to Follow-up|1|||
164268204|NCT05063539|593351737|FG002|Overall Study|Lost to Follow-up|0|||
164268205|NCT05063539|593351735|FG000|Overall Study|Physician Decision|4|||
164268206|NCT05063539|593351736|FG001|Overall Study|Physician Decision|3|||
164268207|NCT05063539|593351737|FG002|Overall Study|Physician Decision|1|||
164268208|NCT05063539|593351735|FG000|Overall Study|Progressive Disease|0|||
164268209|NCT05063539|593351736|FG001|Overall Study|Progressive Disease|2|||
164268210|NCT05063539|593351737|FG002|Overall Study|Progressive Disease|0|||
164268211|NCT05063539|593351735|FG000|Overall Study|Withdrawal by Subject|17|||
164268212|NCT05063539|593351736|FG001|Overall Study|Withdrawal by Subject|26|||
164268213|NCT05063539|593351737|FG002|Overall Study|Withdrawal by Subject|14|||
164268214|NCT05063539|593351735|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
164268215|NCT05063539|593351736|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
164268216|NCT05063539|593351737|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
164268217|NCT05063539|593351735|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
164268218|NCT05063539|593351736|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
164268219|NCT05063539|593351737|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
164268220|NCT05063539|593351735|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
164268221|NCT05063539|593351736|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
164268222|NCT05063539|593351737|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
164268223|NCT05063539|593351735|FG000|Overall Study|Discontinued due to Common Close Design|0|||
164268224|NCT05063539|593351736|FG001|Overall Study|Discontinued due to Common Close Design|1|||
164268225|NCT05063539|593351737|FG002|Overall Study|Discontinued due to Common Close Design|0|||
164268226|NCT05063539|593351735|FG000|Overall Study|Participant not co-operative|0|||
164268227|NCT05063539|593351736|FG001|Overall Study|Participant not co-operative|1|||
164268228|NCT05063539|593351737|FG002|Overall Study|Participant not co-operative|0|||
164268229|NCT05063539|593351735|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
164268230|NCT05063539|593351736|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
164268231|NCT05063539|593351737|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
164268232|NCT05063539|593351735|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
164268233|NCT05063539|593351736|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
164268234|NCT05063539|593351737|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
164268235|NCT04256512|593351738|FG000|Overall Study|Withdrawal by Subject|1|||
164268236|NCT03199469|593351739|FG000|Overall Study|Randomized, not treated|0|||
164268237|NCT03199469|593351740|FG001|Overall Study|Randomized, not treated|3|||
164268238|NCT03199469|593351739|FG000|Overall Study|Withdrawal by Subject|1|||
164268239|NCT03199469|593351740|FG001|Overall Study|Withdrawal by Subject|0|||
164268240|NCT03199469|593351739|FG000|Overall Study|Death|1|||
164268241|NCT03199469|593351740|FG001|Overall Study|Death|3|||
164268242|NCT03199469|593351739|FG000|Overall Study|Ongoing|5|||
164268243|NCT03199469|593351740|FG001|Overall Study|Ongoing|14|||
164268244|NCT04692077|593351743|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
164268245|NCT01751139|593351744|FG000|Overall Study|Other|135|||
164268246|NCT01751139|593351744|FG000|Overall Study|Sponsor study termination|1609|||
164268247|NCT01751139|593351744|FG000|Overall Study|Lost to Follow-up|240|||
164268248|NCT01751139|593351744|FG000|Overall Study|Withdrawal by Subject|251|||
164268249|NCT01751139|593351744|FG000|Overall Study|Adverse Event|1|||
164268250|NCT01751139|593351744|FG000|Overall Study|Death|31|||
164268251|NCT03344172|593351745|FG000|Overall Study|Received <1 dose of treatment|1|||
164268252|NCT03344172|593351746|FG001|Overall Study|Received <1 dose of treatment|0|||
164268253|NCT03106415|593351747|FG000|Phase 1|Withdrawal by Subject|1|||
164268254|NCT03106415|593351748|FG001|Phase 1|Withdrawal by Subject|0|||
164268255|NCT03106415|593351749|FG002|Phase 1|Withdrawal by Subject|0|||
164268256|NCT03106415|593351747|FG000|Phase 1|Adverse Event|1|||
164268257|NCT03106415|593351748|FG001|Phase 1|Adverse Event|1|||
164268258|NCT03106415|593351749|FG002|Phase 1|Adverse Event|0|||
164268259|NCT03106415|593351747|FG000|Phase 1|Protocol Violation|0|||
164268260|NCT03106415|593351748|FG001|Phase 1|Protocol Violation|1|||
164268261|NCT03106415|593351749|FG002|Phase 1|Protocol Violation|0|||
164268262|NCT01300351|593351751|FG000|Overall Study|Did not receive treatment|2|||
164268263|NCT01300351|593351752|FG001|Overall Study|Did not receive treatment|0|||
164268264|NCT01300351|593351751|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
164268265|NCT01300351|593351752|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
164268266|NCT01300351|593351751|FG000|Overall Study|Lost to Follow-up|0|||
164268267|NCT01300351|593351752|FG001|Overall Study|Lost to Follow-up|1|||
164268268|NCT01300351|593351751|FG000|Overall Study|Adverse Event|0|||
164268269|NCT01300351|593351752|FG001|Overall Study|Adverse Event|4|||
164341937|NCT00932126|593627565|FG001|Overall Study|Other|0|||
164341938|NCT00932126|593627566|FG002|Overall Study|Other|0|||
164341939|NCT00932126|593627567|FG003|Overall Study|Other|0|||
164341940|NCT00932126|593627568|FG004|Overall Study|Other|1|||
163998332|NCT00929240|592359088|FG001|Maintenance Phase|Physician Decision|2|||
163998333|NCT00929240|592359089|FG002|Maintenance Phase|Physician Decision|1|||
163998334|NCT00929240|592359087|FG000|Maintenance Phase|Change of treatment|0|||
163998335|NCT00929240|592359088|FG001|Maintenance Phase|Change of treatment|4|||
163998336|NCT00929240|592359089|FG002|Maintenance Phase|Change of treatment|0|||
164268270|NCT01300351|593351751|FG000|Overall Study|Withdrawal by Subject|7|||
164268271|NCT01300351|593351752|FG001|Overall Study|Withdrawal by Subject|10|||
164268272|NCT05824936|593351755|FG000|Overall Study|Lost to Follow-up|1|||
164268273|NCT00096018|593351756|FG000|Overall Study|Became Ineligible (not treated)|0|||
164268274|NCT00096018|593351757|FG001|Overall Study|Became Ineligible (not treated)|3|||
164268275|NCT00096018|593351756|FG000|Overall Study|Miscellaneous (not treated)|0|||
164268276|NCT00096018|593351757|FG001|Overall Study|Miscellaneous (not treated)|2|||
164268277|NCT00096018|593351756|FG000|Overall Study|Adverse Event|0|||
164268278|NCT00096018|593351757|FG001|Overall Study|Adverse Event|5|||
164268279|NCT00096018|593351756|FG000|Overall Study|Death|0|||
164268280|NCT00096018|593351757|FG001|Overall Study|Death|1|||
164268281|NCT00096018|593351756|FG000|Overall Study|Withdrawal by Subject|0|||
164268282|NCT00096018|593351757|FG001|Overall Study|Withdrawal by Subject|2|||
164268283|NCT00096018|593351756|FG000|Overall Study|Miscellaneous|2|||
164268284|NCT00096018|593351757|FG001|Overall Study|Miscellaneous|1|||
164268285|NCT00673881|593351758|FG000|Overall Study|Withdrawal by Subject|1|||
164268286|NCT00483041|593351759|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
164268287|NCT00483041|593351760|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
164268288|NCT02258529|593351761|FG000|Overall Study|Study Terminated by Sponsor|9|||
164268289|NCT02258529|593351761|FG000|Overall Study|Adverse Event|1|||
164268290|NCT00875056|593351764|FG000|Overall Study|Adverse Event|6|||
164268291|NCT00875056|593351765|FG001|Overall Study|Adverse Event|1|||
164268292|NCT00875056|593351766|FG002|Overall Study|Adverse Event|2|||
164268293|NCT00875056|593351764|FG000|Overall Study|Progressive Disease|14|||
164268294|NCT00875056|593351765|FG001|Overall Study|Progressive Disease|8|||
164268295|NCT00875056|593351766|FG002|Overall Study|Progressive Disease|3|||
164268296|NCT00875056|593351764|FG000|Overall Study|Withdrawal by Subject|3|||
164268297|NCT00875056|593351765|FG001|Overall Study|Withdrawal by Subject|0|||
164268298|NCT00875056|593351766|FG002|Overall Study|Withdrawal by Subject|1|||
164268299|NCT01842581|593351775|FG000|Overall Study|Adverse Event|6|||
164268300|NCT01842581|593351776|FG001|Overall Study|Adverse Event|4|||
164268301|NCT01842581|593351775|FG000|Overall Study|HE breakthrough|26|||
164268302|NCT01842581|593351776|FG001|Overall Study|HE breakthrough|13|||
164268303|NCT01842581|593351775|FG000|Overall Study|Liver transplant|2|||
164268304|NCT01842581|593351776|FG001|Overall Study|Liver transplant|0|||
164268305|NCT01842581|593351775|FG000|Overall Study|Lost to Follow-up|2|||
164268306|NCT01842581|593351776|FG001|Overall Study|Lost to Follow-up|5|||
164268307|NCT01842581|593351775|FG000|Overall Study|Withdrawal by Subject|5|||
164268308|NCT01842581|593351776|FG001|Overall Study|Withdrawal by Subject|7|||
164268309|NCT01842581|593351775|FG000|Overall Study|Other than specified|3|||
164268310|NCT01842581|593351776|FG001|Overall Study|Other than specified|1|||
164268311|NCT02648217|593351779|FG000|Overall Study|Adverse Event|0|||
164268312|NCT02648217|593351780|FG001|Overall Study|Adverse Event|1|||
164268313|NCT02648217|593351779|FG000|Overall Study|Lost to Follow-up|1|||
164268314|NCT02648217|593351780|FG001|Overall Study|Lost to Follow-up|1|||
164268315|NCT02648217|593351779|FG000|Overall Study|Withdrawal by Subject|4|||
164268316|NCT02648217|593351780|FG001|Overall Study|Withdrawal by Subject|3|||
164268317|NCT02648217|593351779|FG000|Overall Study|Unclassified|5|||
164268318|NCT02648217|593351780|FG001|Overall Study|Unclassified|0|||
164268319|NCT02553538|593351781|FG000|Overall Study|Could Not Reach by Telephone|133|||
164268320|NCT02553538|593351782|FG001|Overall Study|Could Not Reach by Telephone|0|||
164268321|NCT02553538|593351781|FG000|Overall Study|Died or Left Network|54|||
164268322|NCT02553538|593351782|FG001|Overall Study|Died or Left Network|56|||
164268323|NCT00815191|593351790|FG000|Overall Study|Protocol Violation|1|||
164268324|NCT00815191|593351791|FG001|Overall Study|Protocol Violation|1|||
164341941|NCT00932126|593627569|FG005|Overall Study|Other|0|||
164341942|NCT00932126|593627570|FG006|Overall Study|Other|1|||
164341943|NCT00932126|593627571|FG007|Overall Study|Other|2|||
164341944|NCT02121522|593627579|FG000|Overall Study|Adverse Event|1|||
164341945|NCT01235689|593627580|FG000|Overall Study|Adverse Event|12|||
164341946|NCT01235689|593627581|FG001|Overall Study|Adverse Event|16|||
163998337|NCT00929240|592359087|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
164142373|NCT00182325|592882692|FG000|Overall Study|Miscarriage|5|||
164268325|NCT02900170|593351792|FG000|Overall Study|Lost to Follow-up|8|||
164268326|NCT01873729|593351793|FG000|Overall Study|Withdrawal by Subject|1|||
164341947|NCT01235689|593627580|FG000|Overall Study|Lack of Efficacy|12|||
164341948|NCT01235689|593627581|FG001|Overall Study|Lack of Efficacy|5|||
164341949|NCT01235689|593627580|FG000|Overall Study|Withdrawal by Subject|3|||
164341950|NCT01235689|593627581|FG001|Overall Study|Withdrawal by Subject|4|||
164268327|NCT01741532|593351794|FG000|Overall Study|Adverse Event|4|||
164268328|NCT01741532|593351795|FG001|Overall Study|Adverse Event|0|||
164268329|NCT01741532|593351794|FG000|Overall Study|Withdrawal by Subject|1|||
164268330|NCT01741532|593351795|FG001|Overall Study|Withdrawal by Subject|1|||
164268331|NCT01741532|593351794|FG000|Overall Study|Protocol Violation|0|||
164268332|NCT01741532|593351795|FG001|Overall Study|Protocol Violation|1|||
164268333|NCT01741532|593351794|FG000|Overall Study|Worsening of the disease|3|||
164268334|NCT01741532|593351795|FG001|Overall Study|Worsening of the disease|1|||
164268335|NCT01741532|593351794|FG000|Overall Study|Sponsor decision|1|||
164268336|NCT01741532|593351795|FG001|Overall Study|Sponsor decision|0|||
164268337|NCT01741532|593351794|FG000|Overall Study|Medical event|1|||
164268338|NCT01741532|593351795|FG001|Overall Study|Medical event|0|||
164268339|NCT00613080|593351796|FG000|Overall Study|Ineligible / no protocol treatment|11|||
164268340|NCT02012686|593351798|FG000|Overall Study|muscle contraction|0|||
164268341|NCT02012686|593351799|FG001|Overall Study|muscle contraction|1|||
164268342|NCT02012686|593351798|FG000|Overall Study|electrocardiography monitoring noise|0|||
164268343|NCT02012686|593351799|FG001|Overall Study|electrocardiography monitoring noise|1|||
164268344|NCT01703065|593351800|FG000|Overall Study|Lack of Efficacy|1|||
164268345|NCT01703065|593351801|FG001|Overall Study|Lack of Efficacy|0|||
164268346|NCT02124772|593351802|FG000|Overall Study|Lack of Efficacy|2|||
164268347|NCT02124772|593351803|FG001|Overall Study|Lack of Efficacy|0|||
164268348|NCT02124772|593351804|FG002|Overall Study|Lack of Efficacy|0|||
164268349|NCT02124772|593351805|FG003|Overall Study|Lack of Efficacy|1|||
164268350|NCT02124772|593351806|FG004|Overall Study|Lack of Efficacy|2|||
164268351|NCT02124772|593351807|FG005|Overall Study|Lack of Efficacy|3|||
164268352|NCT02124772|593351808|FG006|Overall Study|Lack of Efficacy|0|||
164268353|NCT02124772|593351809|FG007|Overall Study|Lack of Efficacy|2|||
164268354|NCT02124772|593351810|FG008|Overall Study|Lack of Efficacy|0|||
164268355|NCT02124772|593351811|FG009|Overall Study|Lack of Efficacy|1|||
164268356|NCT02124772|593351812|FG010|Overall Study|Lack of Efficacy|0|||
164268357|NCT02124772|593351813|FG011|Overall Study|Lack of Efficacy|0|||
164268358|NCT02124772|593351814|FG012|Overall Study|Lack of Efficacy|1|||
164268359|NCT02124772|593351802|FG000|Overall Study|Adverse Event|1|||
164268360|NCT02124772|593351803|FG001|Overall Study|Adverse Event|4|||
164268361|NCT02124772|593351804|FG002|Overall Study|Adverse Event|1|||
164268362|NCT02124772|593351805|FG003|Overall Study|Adverse Event|5|||
164268363|NCT02124772|593351806|FG004|Overall Study|Adverse Event|2|||
164268364|NCT02124772|593351807|FG005|Overall Study|Adverse Event|1|||
164268365|NCT02124772|593351808|FG006|Overall Study|Adverse Event|1|||
164268366|NCT02124772|593351809|FG007|Overall Study|Adverse Event|5|||
164268367|NCT02124772|593351810|FG008|Overall Study|Adverse Event|0|||
164268368|NCT02124772|593351811|FG009|Overall Study|Adverse Event|3|||
164268369|NCT02124772|593351812|FG010|Overall Study|Adverse Event|1|||
164268370|NCT02124772|593351813|FG011|Overall Study|Adverse Event|3|||
164268371|NCT02124772|593351814|FG012|Overall Study|Adverse Event|1|||
164268372|NCT02124772|593351802|FG000|Overall Study|Withdrawal consent|0|||
164268373|NCT02124772|593351803|FG001|Overall Study|Withdrawal consent|1|||
164268374|NCT02124772|593351804|FG002|Overall Study|Withdrawal consent|1|||
164268375|NCT02124772|593351805|FG003|Overall Study|Withdrawal consent|1|||
164268376|NCT02124772|593351806|FG004|Overall Study|Withdrawal consent|0|||
164268377|NCT02124772|593351807|FG005|Overall Study|Withdrawal consent|1|||
164268378|NCT02124772|593351808|FG006|Overall Study|Withdrawal consent|1|||
164268379|NCT02124772|593351809|FG007|Overall Study|Withdrawal consent|0|||
164268380|NCT02124772|593351810|FG008|Overall Study|Withdrawal consent|0|||
164268381|NCT02124772|593351811|FG009|Overall Study|Withdrawal consent|1|||
164268382|NCT02124772|593351812|FG010|Overall Study|Withdrawal consent|0|||
164268383|NCT02124772|593351813|FG011|Overall Study|Withdrawal consent|1|||
164268384|NCT02124772|593351814|FG012|Overall Study|Withdrawal consent|0|||
164268385|NCT02124772|593351802|FG000|Overall Study|Investigator discretion|0|||
164268386|NCT02124772|593351803|FG001|Overall Study|Investigator discretion|2|||
164268387|NCT02124772|593351804|FG002|Overall Study|Investigator discretion|2|||
164268388|NCT02124772|593351805|FG003|Overall Study|Investigator discretion|1|||
164268389|NCT02124772|593351806|FG004|Overall Study|Investigator discretion|1|||
164268390|NCT02124772|593351807|FG005|Overall Study|Investigator discretion|0|||
164268391|NCT02124772|593351808|FG006|Overall Study|Investigator discretion|1|||
164268392|NCT02124772|593351809|FG007|Overall Study|Investigator discretion|0|||
164268393|NCT02124772|593351810|FG008|Overall Study|Investigator discretion|0|||
164268394|NCT02124772|593351811|FG009|Overall Study|Investigator discretion|1|||
164268395|NCT02124772|593351812|FG010|Overall Study|Investigator discretion|0|||
164268396|NCT02124772|593351813|FG011|Overall Study|Investigator discretion|1|||
164268397|NCT02124772|593351814|FG012|Overall Study|Investigator discretion|0|||
164268398|NCT02124772|593351802|FG000|Overall Study|Progressive disease|0|||
164268399|NCT02124772|593351803|FG001|Overall Study|Progressive disease|0|||
164268400|NCT02124772|593351804|FG002|Overall Study|Progressive disease|0|||
164268401|NCT02124772|593351805|FG003|Overall Study|Progressive disease|0|||
164268402|NCT02124772|593351806|FG004|Overall Study|Progressive disease|0|||
164268403|NCT02124772|593351807|FG005|Overall Study|Progressive disease|0|||
164268404|NCT02124772|593351808|FG006|Overall Study|Progressive disease|1|||
164268405|NCT02124772|593351809|FG007|Overall Study|Progressive disease|1|||
164341951|NCT01235689|593627580|FG000|Overall Study|Lost to Follow-up|1|||
164341952|NCT01235689|593627581|FG001|Overall Study|Lost to Follow-up|2|||
164341953|NCT01235689|593627580|FG000|Overall Study|Miscellaneous|1|||
164341954|NCT01235689|593627581|FG001|Overall Study|Miscellaneous|5|||
164268406|NCT02124772|593351810|FG008|Overall Study|Progressive disease|0|||
164268407|NCT02124772|593351811|FG009|Overall Study|Progressive disease|0|||
164268408|NCT02124772|593351812|FG010|Overall Study|Progressive disease|0|||
164268409|NCT02124772|593351813|FG011|Overall Study|Progressive disease|0|||
164268410|NCT02124772|593351814|FG012|Overall Study|Progressive disease|0|||
164268411|NCT02124772|593351802|FG000|Overall Study|Other|0|||
164268412|NCT02124772|593351803|FG001|Overall Study|Other|7|||
164268413|NCT02124772|593351804|FG002|Overall Study|Other|2|||
164268414|NCT02124772|593351805|FG003|Overall Study|Other|5|||
164268415|NCT02124772|593351806|FG004|Overall Study|Other|4|||
164268416|NCT02124772|593351807|FG005|Overall Study|Other|3|||
164268417|NCT02124772|593351808|FG006|Overall Study|Other|4|||
164268418|NCT02124772|593351809|FG007|Overall Study|Other|1|||
164268419|NCT02124772|593351810|FG008|Overall Study|Other|1|||
164268420|NCT02124772|593351811|FG009|Overall Study|Other|1|||
164268421|NCT02124772|593351812|FG010|Overall Study|Other|1|||
164268422|NCT02124772|593351813|FG011|Overall Study|Other|1|||
164268423|NCT02124772|593351814|FG012|Overall Study|Other|0|||
164268424|NCT01827332|593351815|FG000|Overall Study|Lost to Follow-up|2|||
164268425|NCT01827332|593351816|FG001|Overall Study|Lost to Follow-up|1|||
164268426|NCT01739803|593351817|FG000|Overall Study|Lost to Follow-up|9|||
164268427|NCT01739803|593351818|FG001|Overall Study|Lost to Follow-up|6|||
164268428|NCT03759041|593351822|FG000|Overall Study|Withdrawal by Subject|4|||
164268429|NCT03759041|593351823|FG001|Overall Study|Withdrawal by Subject|10|||
164268430|NCT03759041|593351824|FG002|Overall Study|Withdrawal by Subject|10|||
164268431|NCT03759041|593351822|FG000|Overall Study|Adverse Event|1|||
164268432|NCT03759041|593351823|FG001|Overall Study|Adverse Event|3|||
164268433|NCT03759041|593351824|FG002|Overall Study|Adverse Event|4|||
164268434|NCT03759041|593351822|FG000|Overall Study|Lack of Efficacy|0|||
164268435|NCT03759041|593351823|FG001|Overall Study|Lack of Efficacy|0|||
164268436|NCT03759041|593351824|FG002|Overall Study|Lack of Efficacy|1|||
164268437|NCT03759041|593351822|FG000|Overall Study|Study Terminated by Sponsor|15|||
164268438|NCT03759041|593351823|FG001|Overall Study|Study Terminated by Sponsor|16|||
164268439|NCT03759041|593351824|FG002|Overall Study|Study Terminated by Sponsor|10|||
164268440|NCT03759041|593351822|FG000|Overall Study|Other reason for discontinuation|0|||
164268441|NCT03759041|593351823|FG001|Overall Study|Other reason for discontinuation|2|||
164268442|NCT03759041|593351824|FG002|Overall Study|Other reason for discontinuation|1|||
164268443|NCT03759041|593351822|FG000|Overall Study|Lost to Follow-up|7|||
164268444|NCT03759041|593351823|FG001|Overall Study|Lost to Follow-up|2|||
164268445|NCT03759041|593351824|FG002|Overall Study|Lost to Follow-up|2|||
164268446|NCT03759041|593351822|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
164268447|NCT03759041|593351823|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
164268448|NCT03759041|593351824|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
164268449|NCT02449018|593351825|FG000|Overall Study|Abnormal laboratory value|0|||
164268450|NCT02449018|593351826|FG001|Overall Study|Abnormal laboratory value|1|||
164268451|NCT02449018|593351825|FG000|Overall Study|Administrative problems|1|||
164268452|NCT02449018|593351826|FG001|Overall Study|Administrative problems|0|||
164268453|NCT02449018|593351825|FG000|Overall Study|Adverse Event|5|||
164268454|NCT02449018|593351826|FG001|Overall Study|Adverse Event|1|||
164268455|NCT02449018|593351825|FG000|Overall Study|Protocol deviation|4|||
164268456|NCT02449018|593351826|FG001|Overall Study|Protocol deviation|0|||
164268457|NCT02449018|593351825|FG000|Overall Study|Patient decision|2|||
164268458|NCT02449018|593351826|FG001|Overall Study|Patient decision|0|||
164268459|NCT00525824|593351832|FG000|Overall Study|Adverse Event|7|||
164268460|NCT00525824|593351833|FG001|Overall Study|Adverse Event|11|||
164268461|NCT00525824|593351834|FG002|Overall Study|Adverse Event|6|||
164268462|NCT00525824|593351835|FG003|Overall Study|Adverse Event|7|||
164268463|NCT00525824|593351832|FG000|Overall Study|Withdrawal by Subject|5|||
164268464|NCT00525824|593351833|FG001|Overall Study|Withdrawal by Subject|9|||
164268465|NCT00525824|593351834|FG002|Overall Study|Withdrawal by Subject|3|||
164268466|NCT00525824|593351835|FG003|Overall Study|Withdrawal by Subject|4|||
164341955|NCT00806351|593627582|FG000|Overall Study|Death|5|||
164341956|NCT00806351|593627583|FG001|Overall Study|Death|4|||
164268467|NCT00525824|593351832|FG000|Overall Study|Lost to Follow-up|4|||
164268468|NCT00525824|593351833|FG001|Overall Study|Lost to Follow-up|2|||
164268469|NCT00525824|593351834|FG002|Overall Study|Lost to Follow-up|4|||
164268470|NCT00525824|593351835|FG003|Overall Study|Lost to Follow-up|0|||
164268471|NCT00525824|593351832|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
164268472|NCT00525824|593351833|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
164268473|NCT00525824|593351834|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
164268474|NCT00525824|593351835|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
164268475|NCT00525824|593351832|FG000|Overall Study|Severe non-compliance|0|||
164268476|NCT00525824|593351833|FG001|Overall Study|Severe non-compliance|1|||
164268477|NCT00525824|593351834|FG002|Overall Study|Severe non-compliance|1|||
164268478|NCT00525824|593351835|FG003|Overall Study|Severe non-compliance|1|||
164268479|NCT00525824|593351832|FG000|Overall Study|Safety reasons|1|||
164268480|NCT00525824|593351833|FG001|Overall Study|Safety reasons|0|||
164268481|NCT00525824|593351834|FG002|Overall Study|Safety reasons|1|||
164268482|NCT00525824|593351835|FG003|Overall Study|Safety reasons|0|||
164268483|NCT00525824|593351832|FG000|Overall Study|Other|1|||
164268484|NCT00525824|593351833|FG001|Overall Study|Other|3|||
164268485|NCT00525824|593351834|FG002|Overall Study|Other|3|||
164268486|NCT00525824|593351835|FG003|Overall Study|Other|1|||
164268487|NCT01522404|593351839|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
164268488|NCT01522404|593351840|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
164268489|NCT01522404|593351839|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
164268490|NCT01522404|593351840|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
164268491|NCT01522404|593351839|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
164268492|NCT01522404|593351840|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
164268493|NCT02698371|593351841|FG000|All Participants Flow|Lost to Follow-up|3|||
164268494|NCT02698371|593351841|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
164268495|NCT02698371|593351841|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
164268496|NCT02698371|593351841|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
164268497|NCT02698371|593351841|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
164268498|NCT02698371|593351841|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
164268499|NCT02698371|593351841|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
164268500|NCT01440881|593351844|FG000|Overall Study|Death|0|||
164268501|NCT01440881|593351845|FG001|Overall Study|Death|1|||
164268502|NCT02644356|593351847|FG000|Overall Study|Withdrawal by Subject|2|||
164268503|NCT02290938|593351848|FG000|Overall Study|Lost to Follow-up|14|||
164268504|NCT02290938|593351849|FG001|Overall Study|Lost to Follow-up|43|||
164268505|NCT00897390|593351850|FG000|Overall Study|Adverse Event|2|||
164268506|NCT00897390|593351850|FG000|Overall Study|No Longer Met Study Criteria|1|||
164268507|NCT00897390|593351850|FG000|Overall Study|Personal Reasons|1|||
164268508|NCT00897390|593351850|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
164268509|NCT04500769|593352807|FG000|Overall Study|Withdrawal by Subject|5|||
164268510|NCT05011513|593352808|FG000|Overall Study|Death|0|||
164268511|NCT05011513|593352809|FG001|Overall Study|Death|1|||
164268512|NCT05011513|593352808|FG000|Overall Study|Lost to Follow-up|4|||
164268513|NCT05011513|593352809|FG001|Overall Study|Lost to Follow-up|0|||
164268514|NCT05011513|593352808|FG000|Overall Study|Withdrawal by Subject|18|||
164268515|NCT05011513|593352809|FG001|Overall Study|Withdrawal by Subject|17|||
164268516|NCT05011513|593352808|FG000|Overall Study|Other|4|||
164268517|NCT05011513|593352809|FG001|Overall Study|Other|2|||
164268518|NCT01511562|593352810|FG000|Induction|Adverse Event|2|||
164268519|NCT01511562|593352811|FG001|Induction|Adverse Event|0|||
164268520|NCT01511562|593352810|FG000|Induction|Disease Progression|3|||
164268521|NCT01511562|593352811|FG001|Induction|Disease Progression|7|||
164268522|NCT01511562|593352810|FG000|Induction|Death|1|||
164268523|NCT01511562|593352811|FG001|Induction|Death|3|||
164268524|NCT01511562|593352810|FG000|Induction|Withdrawal by Subject|0|||
164268525|NCT01511562|593352811|FG001|Induction|Withdrawal by Subject|4|||
164268526|NCT01511562|593352810|FG000|Induction|Other|3|||
164268527|NCT01511562|593352811|FG001|Induction|Other|0|||
164268528|NCT01511562|593352810|FG000|Consolidation|Withdrawal by Subject|1|||
164268529|NCT01511562|593352811|FG001|Consolidation|Withdrawal by Subject|0|||
164268530|NCT01511562|593352810|FG000|Consolidation|Other|1|||
164268531|NCT01511562|593352811|FG001|Consolidation|Other|0|||
163892332|NCT02497950|591976775|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
163892333|NCT01221948|591976782|FG000|Overall Study|Physician Decision|5|||
163892334|NCT01221948|591976782|FG000|Overall Study|Withdrawal by Subject|2|||
163892335|NCT01221948|591976782|FG000|Overall Study|not disclosed|2|||
164085881|NCT00696709|592678583|FG003|Overall Study|Withdrawal by Subject|4|||
164085882|NCT00696709|592678584|FG004|Overall Study|Withdrawal by Subject|3|||
164085883|NCT00696709|592678580|FG000|Overall Study|Protocol Violation|1|||
164268532|NCT04736199|593352812|FG000|Overall Study|Adverse Event|28|||
164268533|NCT04736199|593352813|FG001|Overall Study|Adverse Event|22|||
164268534|NCT04736199|593352812|FG000|Overall Study|Death|9|||
164268535|NCT04736199|593352813|FG001|Overall Study|Death|3|||
164268536|NCT04736199|593352812|FG000|Overall Study|Lost to Follow-up|4|||
164268537|NCT04736199|593352813|FG001|Overall Study|Lost to Follow-up|1|||
164268538|NCT04736199|593352812|FG000|Overall Study|Physician Decision|5|||
164268539|NCT04736199|593352813|FG001|Overall Study|Physician Decision|9|||
164268540|NCT04736199|593352812|FG000|Overall Study|Withdrawal by Subject|21|||
164268541|NCT04736199|593352813|FG001|Overall Study|Withdrawal by Subject|9|||
164268542|NCT04736199|593352812|FG000|Overall Study|Progressive disease|120|||
164268543|NCT04736199|593352813|FG001|Overall Study|Progressive disease|101|||
164268544|NCT04736199|593352812|FG000|Overall Study|Subject decision|13|||
164268545|NCT04736199|593352813|FG001|Overall Study|Subject decision|13|||
164268546|NCT04736199|593352812|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
164268547|NCT04736199|593352813|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
163892336|NCT01221948|591976782|FG000|Overall Study|Death|1|||
164268548|NCT04736199|593352812|FG000|Overall Study|Additional primary malignancy|1|||
164268549|NCT04736199|593352813|FG001|Overall Study|Additional primary malignancy|0|||
164268550|NCT04736199|593352812|FG000|Overall Study|Non-compliance with study drug|0|||
164268551|NCT04736199|593352813|FG001|Overall Study|Non-compliance with study drug|1|||
164268552|NCT04736199|593352812|FG000|Overall Study|Other reason|0|||
164268553|NCT04736199|593352813|FG001|Overall Study|Other reason|1|||
164268554|NCT04736199|593352812|FG000|Overall Study|Ongoing with study drug|240|||
164268555|NCT04736199|593352813|FG001|Overall Study|Ongoing with study drug|63|||
164268556|NCT04736199|593352812|FG000|Overall Study|Study drug never administered|3|||
164268557|NCT04736199|593352813|FG001|Overall Study|Study drug never administered|0|||
164268558|NCT04744831|593352814|FG000|Overall Study|Adverse Event|6|||
164268559|NCT04744831|593352815|FG001|Overall Study|Adverse Event|4|||
164268560|NCT04744831|593352814|FG000|Overall Study|Clinical Progression|5|||
164268561|NCT04744831|593352815|FG001|Overall Study|Clinical Progression|5|||
164268562|NCT04744831|593352814|FG000|Overall Study|Death|2|||
164268563|NCT04744831|593352815|FG001|Overall Study|Death|1|||
164268564|NCT04744831|593352814|FG000|Overall Study|Other|5|||
164268565|NCT04744831|593352815|FG001|Overall Study|Other|1|||
164268566|NCT04744831|593352814|FG000|Overall Study|Progressive Disease|63|||
164268567|NCT04744831|593352815|FG001|Overall Study|Progressive Disease|29|||
164268568|NCT04744831|593352814|FG000|Overall Study|Withdrawal by Subject|1|||
164268569|NCT04744831|593352815|FG001|Overall Study|Withdrawal by Subject|0|||
164268570|NCT06024096|593352818|FG000|Overall Study|Lost to Follow-up|2|||
164268571|NCT06024096|593352819|FG001|Overall Study|Lost to Follow-up|5|||
164268572|NCT06024096|593352818|FG000|Overall Study|Physician Decision|0|||
164268573|NCT06024096|593352819|FG001|Overall Study|Physician Decision|1|||
164268574|NCT06024096|593352818|FG000|Overall Study|Withdrawal by Subject|2|||
164268575|NCT06024096|593352819|FG001|Overall Study|Withdrawal by Subject|3|||
164268576|NCT05818137|593352820|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
164268577|NCT05818137|593352820|FG000|Extension Treatment Period|Ongoing participants|44|||
164268578|NCT04938037|593352821|FG000|Overall Study|Lost to Follow-up|4|||
164268579|NCT04938037|593352822|FG001|Overall Study|Lost to Follow-up|3|||
164268580|NCT05925374|593352823|FG000|Overall Study|Lost to Follow-up|13|||
164268581|NCT03320330|593352826|FG000|Overall Study|Lack of Efficacy|5|||
164268582|NCT03320330|593352827|FG001|Overall Study|Lack of Efficacy|5|||
164268583|NCT03320330|593352828|FG002|Overall Study|Lack of Efficacy|14|||
164268584|NCT03320330|593352826|FG000|Overall Study|Physician Decision|1|||
164268585|NCT03320330|593352827|FG001|Overall Study|Physician Decision|0|||
164268586|NCT03320330|593352828|FG002|Overall Study|Physician Decision|0|||
164268587|NCT05206370|593352829|FG000|Overall Study|Adverse Event|3|||
164268588|NCT05206370|593352830|FG001|Overall Study|Adverse Event|4|||
164268589|NCT05206370|593352831|FG002|Overall Study|Adverse Event|5|||
164268590|NCT05206370|593352829|FG000|Overall Study|Withdrawal by Subject|27|||
164268591|NCT05206370|593352830|FG001|Overall Study|Withdrawal by Subject|30|||
164268592|NCT05206370|593352831|FG002|Overall Study|Withdrawal by Subject|24|||
164268593|NCT05206370|593352829|FG000|Overall Study|Physician Decision|1|||
164268594|NCT05206370|593352830|FG001|Overall Study|Physician Decision|3|||
164268595|NCT05206370|593352831|FG002|Overall Study|Physician Decision|2|||
164268596|NCT05206370|593352829|FG000|Overall Study|Death|0|||
164268597|NCT05206370|593352830|FG001|Overall Study|Death|1|||
164268598|NCT05206370|593352831|FG002|Overall Study|Death|3|||
164268599|NCT05206370|593352829|FG000|Overall Study|Lost to Follow-up|23|||
164268600|NCT05206370|593352830|FG001|Overall Study|Lost to Follow-up|16|||
164268601|NCT05206370|593352831|FG002|Overall Study|Lost to Follow-up|14|||
164268602|NCT05206370|593352829|FG000|Overall Study|Other, Nor Specified|2|||
164268603|NCT05206370|593352830|FG001|Overall Study|Other, Nor Specified|2|||
164268604|NCT05206370|593352831|FG002|Overall Study|Other, Nor Specified|4|||
164268605|NCT04998851|593352832|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
164268606|NCT04998851|593352833|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
164268607|NCT04998851|593352832|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
164268608|NCT04998851|593352833|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
164268609|NCT06038123|593352838|FG000|Overall Study|Withdrawal by Subject|1|||
164268610|NCT06038123|593352838|FG000|Overall Study|not return due to femur fracture|1|||
164268611|NCT05218499|593352839|FG000|Overall Study|Not treated|1|||
164268612|NCT05218499|593352840|FG001|Overall Study|Not treated|1|||
164268613|NCT05218499|593352841|FG002|Overall Study|Not treated|8|||
164268614|NCT05218499|593352839|FG000|Overall Study|Death|2|||
164268615|NCT05218499|593352840|FG001|Overall Study|Death|0|||
164268616|NCT05218499|593352841|FG002|Overall Study|Death|0|||
164268617|NCT05218499|593352839|FG000|Overall Study|Other than listed|3|||
164268618|NCT05218499|593352840|FG001|Overall Study|Other than listed|7|||
164268619|NCT05218499|593352841|FG002|Overall Study|Other than listed|10|||
164268620|NCT05218499|593352839|FG000|Overall Study|Protocol deviation|5|||
164268621|NCT05218499|593352840|FG001|Overall Study|Protocol deviation|6|||
164268622|NCT05218499|593352841|FG002|Overall Study|Protocol deviation|4|||
164268623|NCT05218499|593352839|FG000|Overall Study|Technical problems|0|||
164268624|NCT05218499|593352840|FG001|Overall Study|Technical problems|1|||
164268625|NCT05218499|593352841|FG002|Overall Study|Technical problems|0|||
164268626|NCT05218499|593352839|FG000|Overall Study|Burden of trial procedures|0|||
164268627|NCT05218499|593352840|FG001|Overall Study|Burden of trial procedures|1|||
164268628|NCT05218499|593352841|FG002|Overall Study|Burden of trial procedures|2|||
164268629|NCT05218499|593352839|FG000|Overall Study|Clinical disease progression|6|||
164268630|NCT05218499|593352840|FG001|Overall Study|Clinical disease progression|6|||
164268631|NCT05218499|593352841|FG002|Overall Study|Clinical disease progression|11|||
164268632|NCT05218499|593352839|FG000|Overall Study|Objective disease progression|44|||
164268633|NCT05218499|593352840|FG001|Overall Study|Objective disease progression|61|||
164268634|NCT05218499|593352841|FG002|Overall Study|Objective disease progression|42|||
164268635|NCT05218499|593352839|FG000|Overall Study|Adverse Event|11|||
164268636|NCT05218499|593352840|FG001|Overall Study|Adverse Event|36|||
164268637|NCT05218499|593352841|FG002|Overall Study|Adverse Event|9|||
164268638|NCT05218499|593352839|FG000|Overall Study|On treatment at time of snapshot|18|||
164268639|NCT05218499|593352840|FG001|Overall Study|On treatment at time of snapshot|29|||
164268640|NCT05218499|593352841|FG002|Overall Study|On treatment at time of snapshot|0|||
164268641|NCT05431387|593352850|FG000|Overall Study|Adverse Event|1|||
164268642|NCT05431387|593352851|FG001|Overall Study|Adverse Event|0|||
164268643|NCT05431387|593352850|FG000|Overall Study|Withdrawal by Subject|4|||
164268644|NCT05431387|593352851|FG001|Overall Study|Withdrawal by Subject|4|||
164268645|NCT05431387|593352850|FG000|Overall Study|Physician Decision|0|||
164268646|NCT05431387|593352851|FG001|Overall Study|Physician Decision|1|||
164268647|NCT05431387|593352850|FG000|Overall Study|Lost to Follow-up|5|||
164268648|NCT05431387|593352851|FG001|Overall Study|Lost to Follow-up|9|||
164268649|NCT05431387|593352850|FG000|Overall Study|Other, Not Specified|1|||
164268650|NCT05431387|593352851|FG001|Overall Study|Other, Not Specified|4|||
164268651|NCT03199391|593352852|FG000|Overall Study|Death|1|||
164268652|NCT03199391|593352852|FG000|Overall Study|Lost to Follow-up|3|||
164268653|NCT03199391|593352852|FG000|Overall Study|Adverse Event|2|||
164268654|NCT03199391|593352852|FG000|Overall Study|Withdrawal by Subject|10|||
164268655|NCT01867086|593352853|FG000|Overall Study|Disease Progression|1|||
164268656|NCT04257929|593352854|FG000|Overall Study|Adverse Event|1|||
164268657|NCT04257929|593352855|FG001|Overall Study|Adverse Event|0|||
164268658|NCT04257929|593352856|FG002|Overall Study|Adverse Event|1|||
164268659|NCT04257929|593352854|FG000|Overall Study|Withdrawal by Subject|1|||
164268660|NCT04257929|593352855|FG001|Overall Study|Withdrawal by Subject|0|||
164268661|NCT04257929|593352856|FG002|Overall Study|Withdrawal by Subject|0|||
164268662|NCT04257929|593352854|FG000|Overall Study|COVID-19|0|||
164268663|NCT04257929|593352855|FG001|Overall Study|COVID-19|1|||
164268664|NCT04257929|593352856|FG002|Overall Study|COVID-19|1|||
164268665|NCT04257929|593352854|FG000|Overall Study|Lost to Follow-up|0|||
164268666|NCT04257929|593352855|FG001|Overall Study|Lost to Follow-up|0|||
164268667|NCT04257929|593352856|FG002|Overall Study|Lost to Follow-up|1|||
164268668|NCT06036914|593352857|FG000|Overall Study|Withdrawal by Subject|1|||
164268669|NCT06036914|593352858|FG001|Overall Study|Withdrawal by Subject|0|||
164268670|NCT04697381|593352859|FG000|Extension Period|Adverse Event|0|||
164268671|NCT04697381|593352860|FG001|Extension Period|Adverse Event|0|||
164268672|NCT04697381|593352861|FG002|Extension Period|Adverse Event|3|||
164268673|NCT04697381|593352859|FG000|Extension Period|Physician Decision|0|||
164268674|NCT04697381|593352860|FG001|Extension Period|Physician Decision|0|||
164268675|NCT04697381|593352861|FG002|Extension Period|Physician Decision|2|||
164268676|NCT04697381|593352859|FG000|Extension Period|Other|0|||
164268677|NCT04697381|593352860|FG001|Extension Period|Other|0|||
164268678|NCT04697381|593352861|FG002|Extension Period|Other|1|||
164268679|NCT02486718|593352866|FG000|Enrollment Phase|Death|19|||
164268680|NCT02486718|593352867|FG001|Enrollment Phase|Death|0|||
164268681|NCT02486718|593352868|FG002|Enrollment Phase|Death|0|||
164268682|NCT02486718|593352866|FG000|Enrollment Phase|Symptomatic deterioration|1|||
164268683|NCT02486718|593352867|FG001|Enrollment Phase|Symptomatic deterioration|0|||
164268684|NCT02486718|593352868|FG002|Enrollment Phase|Symptomatic deterioration|0|||
164268685|NCT02486718|593352866|FG000|Enrollment Phase|Withdrawal by Subject|86|||
164268686|NCT02486718|593352867|FG001|Enrollment Phase|Withdrawal by Subject|0|||
164268687|NCT02486718|593352868|FG002|Enrollment Phase|Withdrawal by Subject|0|||
164341957|NCT00672646|593627587|FG000|Overall Study|Lost to Follow-up|0|||
164341958|NCT00672646|593627588|FG001|Overall Study|Lost to Follow-up|1|||
164341959|NCT00672646|593627589|FG002|Overall Study|Lost to Follow-up|2|||
164341960|NCT00672646|593627587|FG000|Overall Study|Withdrawal by Subject|0|||
164268688|NCT02486718|593352866|FG000|Enrollment Phase|Protocol Violation|18|||
164268689|NCT02486718|593352867|FG001|Enrollment Phase|Protocol Violation|0|||
164268690|NCT02486718|593352868|FG002|Enrollment Phase|Protocol Violation|0|||
164268691|NCT02486718|593352866|FG000|Enrollment Phase|Physician Decision|18|||
164268692|NCT02486718|593352867|FG001|Enrollment Phase|Physician Decision|0|||
164268693|NCT02486718|593352868|FG002|Enrollment Phase|Physician Decision|0|||
164268694|NCT02486718|593352866|FG000|Enrollment Phase|Reason not provided|41|||
164268695|NCT02486718|593352867|FG001|Enrollment Phase|Reason not provided|0|||
164268696|NCT02486718|593352868|FG002|Enrollment Phase|Reason not provided|0|||
164268697|NCT02486718|593352866|FG000|Enrollment Phase|Disease relapse|54|||
164268698|NCT02486718|593352867|FG001|Enrollment Phase|Disease relapse|0|||
164268699|NCT02486718|593352868|FG002|Enrollment Phase|Disease relapse|0|||
164341961|NCT00672646|593627588|FG001|Overall Study|Withdrawal by Subject|0|||
164268700|NCT02486718|593352866|FG000|Enrollment Phase|Lost to Follow-up|4|||
164268701|NCT02486718|593352867|FG001|Enrollment Phase|Lost to Follow-up|0|||
164268702|NCT02486718|593352868|FG002|Enrollment Phase|Lost to Follow-up|0|||
164268703|NCT02486718|593352866|FG000|Enrollment Phase|Adverse Event|34|||
164268704|NCT02486718|593352867|FG001|Enrollment Phase|Adverse Event|0|||
164268705|NCT02486718|593352868|FG002|Enrollment Phase|Adverse Event|0|||
164268706|NCT02486718|593352866|FG000|Randomized Phase|Withdrawal by Subject|0|||
164268707|NCT02486718|593352867|FG001|Randomized Phase|Withdrawal by Subject|44|||
164268708|NCT02486718|593352868|FG002|Randomized Phase|Withdrawal by Subject|47|||
164268709|NCT02486718|593352866|FG000|Randomized Phase|Protocol Violation|0|||
164268710|NCT02486718|593352867|FG001|Randomized Phase|Protocol Violation|2|||
164268711|NCT02486718|593352868|FG002|Randomized Phase|Protocol Violation|0|||
164268712|NCT02486718|593352866|FG000|Randomized Phase|Physician Decision|0|||
164268713|NCT02486718|593352867|FG001|Randomized Phase|Physician Decision|0|||
164268714|NCT02486718|593352868|FG002|Randomized Phase|Physician Decision|3|||
164268715|NCT02486718|593352866|FG000|Randomized Phase|Lost to Follow-up|0|||
164268716|NCT02486718|593352867|FG001|Randomized Phase|Lost to Follow-up|5|||
164268717|NCT02486718|593352868|FG002|Randomized Phase|Lost to Follow-up|11|||
164268718|NCT02486718|593352866|FG000|Randomized Phase|Disease Relapse|0|||
164268719|NCT02486718|593352867|FG001|Randomized Phase|Disease Relapse|1|||
164268720|NCT02486718|593352868|FG002|Randomized Phase|Disease Relapse|0|||
164268721|NCT02486718|593352866|FG000|Randomized Phase|Death|0|||
164268722|NCT02486718|593352867|FG001|Randomized Phase|Death|154|||
164268723|NCT02486718|593352868|FG002|Randomized Phase|Death|155|||
164268724|NCT02486718|593352866|FG000|Randomized Phase|Ongoing|0|||
164268725|NCT02486718|593352867|FG001|Randomized Phase|Ongoing|301|||
164268726|NCT02486718|593352868|FG002|Randomized Phase|Ongoing|282|||
164268727|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Death|1|||
164268728|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Death|0|||
164268729|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Death|0|||
164268730|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Death|0|||
164268731|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
164268732|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
164268733|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
164268734|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
164268735|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
164268736|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
164268737|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
164268738|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
164268739|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
164268740|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
164268741|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
164268742|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
164268743|NCT04271475|593352869|FG000|DB Period: Day 1 up to EODBT|Other|8|||
164268744|NCT04271475|593352870|FG001|DB Period: Day 1 up to EODBT|Other|5|||
164268745|NCT04271475|593352871|FG002|DB Period: Day 1 up to EODBT|Other|0|||
164268746|NCT04271475|593352872|FG003|DB Period: Day 1 up to EODBT|Other|0|||
164268747|NCT04271475|593352869|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
164268748|NCT04271475|593352870|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
164268749|NCT04271475|593352871|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
164268750|NCT04271475|593352872|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
164268751|NCT04271475|593352869|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
164268752|NCT04271475|593352870|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
164268753|NCT04271475|593352871|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
164268754|NCT04271475|593352872|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
164268755|NCT04088331|593352877|FG000|Overall Study|Lost to Follow-up|3|||
164268756|NCT04088331|593352877|FG000|Overall Study|Withdrawal by Subject|7|||
164268757|NCT04088331|593352877|FG000|Overall Study|Adverse Event|4|||
164268758|NCT01818284|593352878|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
164268759|NCT01818284|593352879|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
164268760|NCT01818284|593352878|FG000|Overall Study|Death|0|||
164268761|NCT01818284|593352879|FG001|Overall Study|Death|2|||
164268762|NCT03298451|593352880|FG000|Overall Study|Death|275|||
164268763|NCT03298451|593352881|FG001|Overall Study|Death|260|||
164268764|NCT03298451|593352882|FG002|Overall Study|Death|122|||
164341962|NCT00672646|593627589|FG002|Overall Study|Withdrawal by Subject|1|||
164268765|NCT03298451|593352883|FG003|Overall Study|Death|280|||
164341963|NCT00289783|593627590|FG000|Primary Phase|Adverse Event|10|||
164268766|NCT03298451|593352880|FG000|Overall Study|Lost to Follow-up|1|||
164268767|NCT03298451|593352881|FG001|Overall Study|Lost to Follow-up|1|||
164341964|NCT00289783|593627591|FG001|Primary Phase|Adverse Event|1|||
164341965|NCT00289783|593627590|FG000|Primary Phase|Protocol Violation|27|||
164341966|NCT00289783|593627591|FG001|Primary Phase|Protocol Violation|6|||
164268768|NCT03298451|593352882|FG002|Overall Study|Lost to Follow-up|0|||
164268769|NCT03298451|593352883|FG003|Overall Study|Lost to Follow-up|7|||
164268770|NCT03298451|593352880|FG000|Overall Study|Withdrawal by Subject|9|||
164268771|NCT03298451|593352881|FG001|Overall Study|Withdrawal by Subject|7|||
164268772|NCT03298451|593352882|FG002|Overall Study|Withdrawal by Subject|1|||
164341967|NCT00289783|593627590|FG000|Primary Phase|Withdrawal by Subject|93|||
164268773|NCT03298451|593352883|FG003|Overall Study|Withdrawal by Subject|20|||
164268774|NCT01299571|593352887|FG000|Overall Study|Protocol Violation|107|||
164268775|NCT00286221|593352889|FG000|Overall Study|Protocol Violation|2|||
164268776|NCT00286221|593352890|FG001|Overall Study|Protocol Violation|1|||
164268777|NCT00286221|593352891|FG002|Overall Study|Protocol Violation|6|||
164268778|NCT00286221|593352892|FG003|Overall Study|Protocol Violation|4|||
164268779|NCT00286221|593352889|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
164268780|NCT00286221|593352890|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
164268781|NCT00286221|593352891|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
164268782|NCT00286221|593352892|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
164268783|NCT00286221|593352889|FG000|Overall Study|Inability to trigger PCA|2|||
164268784|NCT00286221|593352890|FG001|Overall Study|Inability to trigger PCA|0|||
164268785|NCT00286221|593352891|FG002|Overall Study|Inability to trigger PCA|0|||
164268786|NCT00286221|593352892|FG003|Overall Study|Inability to trigger PCA|0|||
164268787|NCT00286221|593352889|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
164268788|NCT00286221|593352890|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
164268789|NCT00286221|593352891|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
164268790|NCT00286221|593352892|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
164268791|NCT00357656|593352893|FG000|Overall Study|Other, No surgery performed|0|||
164268792|NCT00357656|593352894|FG001|Overall Study|Other, No surgery performed|3|||
164268793|NCT02805725|593353667|FG000|Phase I (Dose escalation part)|Clinical progression|0|||
164268794|NCT02805725|593353668|FG001|Phase I (Dose escalation part)|Clinical progression|0|||
164268795|NCT02805725|593353669|FG002|Phase I (Dose escalation part)|Clinical progression|1|||
164268796|NCT02805725|593353670|FG003|Phase I (Dose escalation part)|Clinical progression|0|||
164268797|NCT02805725|593353671|FG004|Phase I (Dose escalation part)|Clinical progression|0|||
164268798|NCT02805725|593353667|FG000|Phase I (Dose escalation part)|Adverse Event|0|||
164268799|NCT02805725|593353668|FG001|Phase I (Dose escalation part)|Adverse Event|0|||
164268800|NCT02805725|593353669|FG002|Phase I (Dose escalation part)|Adverse Event|1|||
164268801|NCT02805725|593353670|FG003|Phase I (Dose escalation part)|Adverse Event|2|||
164268802|NCT02805725|593353671|FG004|Phase I (Dose escalation part)|Adverse Event|0|||
164268803|NCT02805725|593353667|FG000|Phase II|Protocol Violation|0|||
164268804|NCT02805725|593353668|FG001|Phase II|Protocol Violation|0|||
164268805|NCT02805725|593353669|FG002|Phase II|Protocol Violation|0|||
164268806|NCT02805725|593353670|FG003|Phase II|Protocol Violation|0|||
164268807|NCT02805725|593353671|FG004|Phase II|Protocol Violation|6|||
164268808|NCT05702918|593353675|FG000|Overall Study|Withdrawal by Subject|0|||
164268809|NCT05702918|593353676|FG001|Overall Study|Withdrawal by Subject|2|||
164268810|NCT05702918|593353675|FG000|Overall Study|Lost to Follow-up|0|||
164268811|NCT05702918|593353676|FG001|Overall Study|Lost to Follow-up|2|||
164268812|NCT05702918|593353675|FG000|Overall Study|Unrelated injury|2|||
164268813|NCT05702918|593353676|FG001|Overall Study|Unrelated injury|0|||
164268814|NCT03500172|593353682|FG000|Period 1: Baseline Randomization|Death|0|||
164268815|NCT03500172|593353683|FG001|Period 1: Baseline Randomization|Death|0|||
164268816|NCT03500172|593353684|FG002|Period 1: Baseline Randomization|Death|0|||
164268817|NCT03500172|593353685|FG003|Period 1: Baseline Randomization|Death|0|||
164268818|NCT03500172|593353686|FG004|Period 1: Baseline Randomization|Death|0|||
164268819|NCT03500172|593353687|FG005|Period 1: Baseline Randomization|Death|0|||
164268820|NCT03500172|593353688|FG006|Period 1: Baseline Randomization|Death|0|||
164268821|NCT03500172|593353689|FG007|Period 1: Baseline Randomization|Death|0|||
164268822|NCT03500172|593353690|FG008|Period 1: Baseline Randomization|Death|0|||
164268823|NCT03500172|593353691|FG009|Period 1: Baseline Randomization|Death|2|||
164268824|NCT03500172|593353692|FG010|Period 1: Baseline Randomization|Death|0|||
164268825|NCT03500172|593353682|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
164268826|NCT03500172|593353683|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
164268827|NCT03500172|593353684|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
164268828|NCT03500172|593353685|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
164268829|NCT03500172|593353686|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
164268830|NCT03500172|593353687|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
164268831|NCT03500172|593353688|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
164268832|NCT03500172|593353689|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
164268833|NCT03500172|593353690|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
164268834|NCT03500172|593353691|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
164268835|NCT03500172|593353692|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
164268836|NCT03500172|593353682|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
164268837|NCT03500172|593353683|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
164268838|NCT03500172|593353684|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
164268839|NCT03500172|593353685|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
164268840|NCT03500172|593353686|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
164268841|NCT03500172|593353687|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
164268842|NCT03500172|593353688|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
164268843|NCT03500172|593353689|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
164268844|NCT03500172|593353690|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
164268845|NCT03500172|593353691|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
164268846|NCT03500172|593353692|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
164268847|NCT03500172|593353682|FG000|Period 2: Re-Randomization|Death|0|||
164268848|NCT03500172|593353683|FG001|Period 2: Re-Randomization|Death|0|||
164268849|NCT03500172|593353684|FG002|Period 2: Re-Randomization|Death|0|||
164268850|NCT03500172|593353685|FG003|Period 2: Re-Randomization|Death|4|||
164268851|NCT03500172|593353686|FG004|Period 2: Re-Randomization|Death|2|||
164268852|NCT03500172|593353687|FG005|Period 2: Re-Randomization|Death|0|||
164268853|NCT03500172|593353688|FG006|Period 2: Re-Randomization|Death|5|||
164268854|NCT03500172|593353689|FG007|Period 2: Re-Randomization|Death|2|||
164268855|NCT03500172|593353690|FG008|Period 2: Re-Randomization|Death|0|||
164268856|NCT03500172|593353691|FG009|Period 2: Re-Randomization|Death|0|||
164268857|NCT03500172|593353692|FG010|Period 2: Re-Randomization|Death|0|||
164268858|NCT03171545|593353695|FG000|Baseline|Withdrawal by Subject|0|||
164268859|NCT03171545|593353696|FG001|Baseline|Withdrawal by Subject|0|||
164268860|NCT03171545|593353697|FG002|Baseline|Withdrawal by Subject|1|||
164268861|NCT03171545|593353698|FG003|Baseline|Withdrawal by Subject|2|||
164268862|NCT03171545|593353695|FG000|Baseline|Transferred out of clinic|4|||
164268863|NCT03171545|593353696|FG001|Baseline|Transferred out of clinic|0|||
164268864|NCT03171545|593353697|FG002|Baseline|Transferred out of clinic|2|||
164268865|NCT03171545|593353698|FG003|Baseline|Transferred out of clinic|0|||
164268866|NCT03171545|593353695|FG000|Baseline|Death|1|||
164268867|NCT03171545|593353696|FG001|Baseline|Death|2|||
164268868|NCT03171545|593353697|FG002|Baseline|Death|1|||
164268869|NCT03171545|593353698|FG003|Baseline|Death|5|||
164268870|NCT03171545|593353695|FG000|Baseline|Recovered renal function|0|||
164268871|NCT03171545|593353696|FG001|Baseline|Recovered renal function|0|||
164268872|NCT03171545|593353697|FG002|Baseline|Recovered renal function|1|||
164268873|NCT03171545|593353698|FG003|Baseline|Recovered renal function|0|||
164268874|NCT03171545|593353695|FG000|Baseline|Received transplant|0|||
164268875|NCT03171545|593353696|FG001|Baseline|Received transplant|0|||
164268876|NCT03171545|593353697|FG002|Baseline|Received transplant|1|||
164268877|NCT03171545|593353698|FG003|Baseline|Received transplant|0|||
164268878|NCT03171545|593353695|FG000|Baseline|No longer receiving in-center hemodialysis|0|||
164268879|NCT03171545|593353696|FG001|Baseline|No longer receiving in-center hemodialysis|2|||
164268880|NCT03171545|593353697|FG002|Baseline|No longer receiving in-center hemodialysis|3|||
164268881|NCT03171545|593353698|FG003|Baseline|No longer receiving in-center hemodialysis|0|||
164268882|NCT03171545|593353695|FG000|Intervention|Withdrawal by Subject|2|||
164268883|NCT03171545|593353696|FG001|Intervention|Withdrawal by Subject|0|||
164268884|NCT03171545|593353697|FG002|Intervention|Withdrawal by Subject|0|||
164268885|NCT03171545|593353698|FG003|Intervention|Withdrawal by Subject|4|||
164268886|NCT03171545|593353695|FG000|Intervention|Transferred out of clinic|12|||
164268887|NCT03171545|593353696|FG001|Intervention|Transferred out of clinic|9|||
164268888|NCT03171545|593353697|FG002|Intervention|Transferred out of clinic|17|||
164268889|NCT03171545|593353698|FG003|Intervention|Transferred out of clinic|9|||
164268890|NCT03171545|593353695|FG000|Intervention|Death|26|||
164268891|NCT03171545|593353696|FG001|Intervention|Death|16|||
164268892|NCT03171545|593353697|FG002|Intervention|Death|29|||
164268893|NCT03171545|593353698|FG003|Intervention|Death|14|||
164268894|NCT03171545|593353695|FG000|Intervention|Received transplant|7|||
164268895|NCT03171545|593353696|FG001|Intervention|Received transplant|5|||
164268896|NCT03171545|593353697|FG002|Intervention|Received transplant|3|||
164268897|NCT03171545|593353698|FG003|Intervention|Received transplant|6|||
164268898|NCT03171545|593353695|FG000|Intervention|No longer receiving in-center hemodialysis|7|||
164268899|NCT03171545|593353696|FG001|Intervention|No longer receiving in-center hemodialysis|4|||
164268900|NCT03171545|593353697|FG002|Intervention|No longer receiving in-center hemodialysis|4|||
164341968|NCT00289783|593627591|FG001|Primary Phase|Withdrawal by Subject|40|||
164341969|NCT00289783|593627590|FG000|Primary Phase|Lost to Follow-up|60|||
164341970|NCT00289783|593627591|FG001|Primary Phase|Lost to Follow-up|14|||
164341971|NCT00289783|593627590|FG000|Primary Phase|Migration from the study area|26|||
164341972|NCT00289783|593627591|FG001|Primary Phase|Migration from the study area|10|||
164341973|NCT00289783|593627590|FG000|Primary Phase|Other|32|||
164341974|NCT00289783|593627591|FG001|Primary Phase|Other|12|||
164341975|NCT00289783|593627590|FG000|Fourth Dose Phase|Adverse Event|1|||
164341976|NCT00289783|593627591|FG001|Fourth Dose Phase|Adverse Event|0|||
164341977|NCT00289783|593627590|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
164341978|NCT00289783|593627591|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
164341979|NCT00289783|593627590|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
164268901|NCT03171545|593353698|FG003|Intervention|No longer receiving in-center hemodialysis|6|||
164268902|NCT03171545|593353695|FG000|Intervention|Lost to Follow-up|0|||
164268903|NCT03171545|593353696|FG001|Intervention|Lost to Follow-up|1|||
164268904|NCT03171545|593353697|FG002|Intervention|Lost to Follow-up|0|||
164268905|NCT03171545|593353698|FG003|Intervention|Lost to Follow-up|0|||
164268906|NCT03171545|593353695|FG000|Follow up|Withdrawal by Subject|1|||
164268907|NCT03171545|593353696|FG001|Follow up|Withdrawal by Subject|1|||
164268908|NCT03171545|593353697|FG002|Follow up|Withdrawal by Subject|0|||
164268909|NCT03171545|593353698|FG003|Follow up|Withdrawal by Subject|0|||
164268910|NCT03171545|593353695|FG000|Follow up|Transferred out of clinic|4|||
164268911|NCT03171545|593353696|FG001|Follow up|Transferred out of clinic|4|||
164268912|NCT03171545|593353697|FG002|Follow up|Transferred out of clinic|12|||
164268913|NCT03171545|593353698|FG003|Follow up|Transferred out of clinic|7|||
164268914|NCT03171545|593353695|FG000|Follow up|Death|18|||
164268915|NCT03171545|593353696|FG001|Follow up|Death|12|||
164268916|NCT03171545|593353697|FG002|Follow up|Death|5|||
164268917|NCT03171545|593353698|FG003|Follow up|Death|8|||
164268918|NCT03171545|593353695|FG000|Follow up|Received transplant|4|||
164268919|NCT03171545|593353696|FG001|Follow up|Received transplant|1|||
164268920|NCT03171545|593353697|FG002|Follow up|Received transplant|0|||
164268921|NCT03171545|593353698|FG003|Follow up|Received transplant|1|||
164268922|NCT03171545|593353695|FG000|Follow up|No longer receiving in-center hemodialysis|4|||
164268923|NCT03171545|593353696|FG001|Follow up|No longer receiving in-center hemodialysis|2|||
164268924|NCT03171545|593353697|FG002|Follow up|No longer receiving in-center hemodialysis|1|||
164268925|NCT03171545|593353698|FG003|Follow up|No longer receiving in-center hemodialysis|0|||
164268926|NCT03171545|593353695|FG000|Follow up|Lost to Follow-up|1|||
164268927|NCT03171545|593353696|FG001|Follow up|Lost to Follow-up|2|||
164268928|NCT03171545|593353697|FG002|Follow up|Lost to Follow-up|3|||
164268929|NCT03171545|593353698|FG003|Follow up|Lost to Follow-up|1|||
164268930|NCT04409457|593353709|FG000|Screening Prior to Randomization|Screening fail prior to randomization|16|||
164268931|NCT04409457|593353710|FG001|Screening Prior to Randomization|Screening fail prior to randomization|13|||
164268932|NCT04409457|593353711|FG002|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268933|NCT04409457|593353712|FG003|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268934|NCT04409457|593353713|FG004|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268935|NCT04409457|593353714|FG005|Screening Prior to Randomization|Screening fail prior to randomization|0|||
164268936|NCT04409457|593353709|FG000|Screening Prior to Randomization|Withdrawal by Subject|2|||
164268937|NCT04409457|593353710|FG001|Screening Prior to Randomization|Withdrawal by Subject|1|||
164268938|NCT04409457|593353711|FG002|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268939|NCT04409457|593353712|FG003|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268940|NCT04409457|593353713|FG004|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268941|NCT04409457|593353714|FG005|Screening Prior to Randomization|Withdrawal by Subject|0|||
164268942|NCT04409457|593353709|FG000|Randomization|Withdrawal by Subject|0|||
164268943|NCT04409457|593353710|FG001|Randomization|Withdrawal by Subject|0|||
164268944|NCT04409457|593353711|FG002|Randomization|Withdrawal by Subject|0|||
164268945|NCT04409457|593353712|FG003|Randomization|Withdrawal by Subject|0|||
164268946|NCT04409457|593353713|FG004|Randomization|Withdrawal by Subject|1|||
164268947|NCT04409457|593353714|FG005|Randomization|Withdrawal by Subject|0|||
164268948|NCT04409457|593353709|FG000|Randomization|Incidental MRI finding at scan 1|0|||
164268949|NCT04409457|593353710|FG001|Randomization|Incidental MRI finding at scan 1|0|||
164268950|NCT04409457|593353711|FG002|Randomization|Incidental MRI finding at scan 1|0|||
164268951|NCT04409457|593353712|FG003|Randomization|Incidental MRI finding at scan 1|1|||
164268952|NCT04409457|593353713|FG004|Randomization|Incidental MRI finding at scan 1|0|||
164268953|NCT04409457|593353714|FG005|Randomization|Incidental MRI finding at scan 1|1|||
164268954|NCT04409457|593353709|FG000|Randomization|Technical/equipment error at scan 1|0|||
164268955|NCT04409457|593353710|FG001|Randomization|Technical/equipment error at scan 1|0|||
164268956|NCT04409457|593353711|FG002|Randomization|Technical/equipment error at scan 1|0|||
164268957|NCT04409457|593353712|FG003|Randomization|Technical/equipment error at scan 1|0|||
164268958|NCT04409457|593353713|FG004|Randomization|Technical/equipment error at scan 1|0|||
164268959|NCT04409457|593353714|FG005|Randomization|Technical/equipment error at scan 1|1|||
164268960|NCT04865770|593353715|FG000|Overall Study|Withdrawal by Subject|3|||
164268961|NCT04865770|593353716|FG001|Overall Study|Withdrawal by Subject|0|||
164341980|NCT00289783|593627591|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
164341981|NCT00289783|593627590|FG000|Fourth Dose Phase|Migration from the study area|1|||
164341982|NCT00289783|593627591|FG001|Fourth Dose Phase|Migration from the study area|1|||
164341983|NCT00289783|593627590|FG000|Fourth Dose Phase|Other|22|||
164341984|NCT00289783|593627591|FG001|Fourth Dose Phase|Other|10|||
164341985|NCT05248867|593627592|FG000|Double-blind Period|Lost to Follow-up|0|||
164341986|NCT05248867|593627593|FG001|Double-blind Period|Lost to Follow-up|3|||
163998338|NCT00929240|592359088|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
164268962|NCT04865770|593353715|FG000|Overall Study|Physician Decision|9|||
164268963|NCT04865770|593353716|FG001|Overall Study|Physician Decision|0|||
164268964|NCT04865770|593353715|FG000|Overall Study|Death|1|||
164268965|NCT04865770|593353716|FG001|Overall Study|Death|1|||
164268966|NCT04522973|593353722|FG000|Overall Study|Lost to Follow-up|4|||
164268967|NCT04522973|593353722|FG000|Overall Study|Could not adhere to study schedule|1|||
164268968|NCT04007796|593353723|FG000|Overall Study|Exclusion criterion met during the trial|1|||
164268969|NCT04007796|593353724|FG001|Overall Study|Exclusion criterion met during the trial|1|||
164268970|NCT04007796|593353723|FG000|Overall Study|Withdrawal by Subject|1|||
164268971|NCT04007796|593353724|FG001|Overall Study|Withdrawal by Subject|0|||
164268972|NCT03573401|593353725|FG000|Overall Study|Withdrawal by Subject|2|||
164268973|NCT03573401|593353726|FG001|Overall Study|Withdrawal by Subject|0|||
164268974|NCT03573401|593353725|FG000|Overall Study|Subject non-compliance with study schedule|1|||
163998339|NCT00929240|592359089|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
164268975|NCT03573401|593353726|FG001|Overall Study|Subject non-compliance with study schedule|0|||
164268976|NCT03573401|593353725|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
164268977|NCT03573401|593353726|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
164268978|NCT03573401|593353725|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
164268979|NCT03573401|593353726|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
164268980|NCT05579249|593353727|FG000|Overall Study|Withdrawal by Subject|1|||
164268981|NCT05579249|593353728|FG001|Overall Study|Withdrawal by Subject|3|||
164268982|NCT05579249|593353727|FG000|Overall Study|Lost to Follow-up|33|||
164268983|NCT05579249|593353728|FG001|Overall Study|Lost to Follow-up|52|||
164268984|NCT05579249|593353727|FG000|Overall Study|Physician Decision|2|||
164268985|NCT05579249|593353728|FG001|Overall Study|Physician Decision|2|||
164268986|NCT05579249|593353727|FG000|Overall Study|Death|0|||
164268987|NCT05579249|593353728|FG001|Overall Study|Death|2|||
164268988|NCT05028517|593353729|FG000|Overall Study|Lost to Follow-up|13|||
164268989|NCT05028517|593353730|FG001|Overall Study|Lost to Follow-up|20|||
164268990|NCT05028517|593353731|FG002|Overall Study|Lost to Follow-up|12|||
164268991|NCT05028517|593353729|FG000|Overall Study|Withdrawal by Subject|0|||
164268992|NCT05028517|593353730|FG001|Overall Study|Withdrawal by Subject|0|||
164268993|NCT05028517|593353731|FG002|Overall Study|Withdrawal by Subject|1|||
164268994|NCT00267150|593353732|FG000|Overall Study|Adverse Event|1|||
164268995|NCT00969436|593353736|FG000|Overall Study|Protocol Violation|1|||
164268996|NCT00969436|593353737|FG001|Overall Study|Protocol Violation|3|||
164268997|NCT00969436|593353738|FG002|Overall Study|Protocol Violation|0|||
164268998|NCT00969436|593353736|FG000|Overall Study|Migrated/moved from study area|12|||
164268999|NCT00969436|593353737|FG001|Overall Study|Migrated/moved from study area|10|||
164269000|NCT00969436|593353738|FG002|Overall Study|Migrated/moved from study area|2|||
164269001|NCT00969436|593353736|FG000|Overall Study|Father - serious health problem|0|||
164269002|NCT00969436|593353737|FG001|Overall Study|Father - serious health problem|0|||
164269003|NCT00969436|593353738|FG002|Overall Study|Father - serious health problem|1|||
164269004|NCT00969436|593353736|FG000|Overall Study|Parents personal problem|0|||
164269005|NCT00969436|593353737|FG001|Overall Study|Parents personal problem|0|||
164269006|NCT00969436|593353738|FG002|Overall Study|Parents personal problem|1|||
164269007|NCT00969436|593353736|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
164269008|NCT00969436|593353737|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
164269009|NCT00969436|593353738|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
164269010|NCT00969436|593353736|FG000|Overall Study|Withdrawal by Subject|3|||
164269011|NCT00969436|593353737|FG001|Overall Study|Withdrawal by Subject|0|||
164341987|NCT05248867|593627594|FG002|Double-blind Period|Lost to Follow-up|0|||
164341988|NCT05248867|593627595|FG003|Double-blind Period|Lost to Follow-up|0|||
164341989|NCT05248867|593627596|FG004|Double-blind Period|Lost to Follow-up|0|||
164341990|NCT05248867|593627597|FG005|Double-blind Period|Lost to Follow-up|0|||
164341991|NCT05248867|593627592|FG000|Double-blind Period|Withdrawal by Subject|5|||
164341992|NCT05248867|593627593|FG001|Double-blind Period|Withdrawal by Subject|14|||
164341993|NCT05248867|593627594|FG002|Double-blind Period|Withdrawal by Subject|0|||
164341994|NCT05248867|593627595|FG003|Double-blind Period|Withdrawal by Subject|0|||
164341995|NCT05248867|593627596|FG004|Double-blind Period|Withdrawal by Subject|0|||
164341996|NCT05248867|593627597|FG005|Double-blind Period|Withdrawal by Subject|0|||
164341997|NCT05248867|593627592|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164341998|NCT05248867|593627593|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
164341999|NCT05248867|593627594|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342000|NCT05248867|593627595|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342001|NCT05248867|593627596|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342002|NCT05248867|593627597|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
164342003|NCT05248867|593627592|FG000|Double-blind Period|Other, not specified|3|||
164342004|NCT05248867|593627593|FG001|Double-blind Period|Other, not specified|8|||
164342005|NCT05248867|593627594|FG002|Double-blind Period|Other, not specified|0|||
163998340|NCT00929240|592359087|FG000|Maintenance Phase|Participant not treated|0|||
163998341|NCT00929240|592359088|FG001|Maintenance Phase|Participant not treated|2|||
163998342|NCT00929240|592359089|FG002|Maintenance Phase|Participant not treated|0|||
163998343|NCT02582671|592359090|FG000|Overall Study|Failure to return|1|||
163998344|NCT02582671|592359090|FG000|Overall Study|Other, not specified|1|||
163998345|NCT01287104|592359095|FG000|Overall Study|Patient developed progressive disease|1|||
163998346|NCT01287104|592359096|FG001|Overall Study|Patient developed progressive disease|1|||
163998347|NCT01287104|592359097|FG002|Overall Study|Patient developed progressive disease|3|||
163998348|NCT01287104|592359098|FG003|Overall Study|Patient developed progressive disease|2|||
163998349|NCT01287104|592359095|FG000|Overall Study|Donor anaphylaxis|0|||
163998350|NCT01287104|592359096|FG001|Overall Study|Donor anaphylaxis|1|||
163998351|NCT01287104|592359097|FG002|Overall Study|Donor anaphylaxis|0|||
163998352|NCT01287104|592359098|FG003|Overall Study|Donor anaphylaxis|1|||
164269012|NCT00969436|593353738|FG002|Overall Study|Withdrawal by Subject|2|||
164269013|NCT00969436|593353736|FG000|Overall Study|Lost to Follow-up|8|||
164269014|NCT00969436|593353737|FG001|Overall Study|Lost to Follow-up|8|||
164269015|NCT00969436|593353738|FG002|Overall Study|Lost to Follow-up|5|||
164269016|NCT00351273|593353739|FG000|Overall Study|Lost to Follow-up|1|||
164269017|NCT00351273|593353740|FG001|Overall Study|Lost to Follow-up|2|||
164269018|NCT00351273|593353741|FG002|Overall Study|Lost to Follow-up|5|||
164269019|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
164269020|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
164269021|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
164269022|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
164269023|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
164269024|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
164269025|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
164269026|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
164269027|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
164269028|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
164269029|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
164269030|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
164269031|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
164269032|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
164269033|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
164269034|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
164269035|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
164269036|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
164269037|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
164269038|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
164269039|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
164269040|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
164269041|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
164269042|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
164269043|NCT01672866|593353742|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
164269044|NCT01672866|593353743|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
164269045|NCT01672866|593353744|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
164269046|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
164269047|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
164269048|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
164269049|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
164269050|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
164269051|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
164269052|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
164269053|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
164269054|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
164269055|NCT01672866|593353742|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
164269056|NCT01672866|593353743|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
164269057|NCT01672866|593353744|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
164269058|NCT02544373|593353747|FG000|Overall Study|Lost to Follow-up|5|||
164269059|NCT02544373|593353748|FG001|Overall Study|Lost to Follow-up|3|||
163998353|NCT01287104|592359095|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
163998354|NCT01287104|592359096|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
163998355|NCT01287104|592359097|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
163998356|NCT01287104|592359098|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
163998357|NCT01287104|592359095|FG000|Overall Study|Low donor chimerism|0|||
163998358|NCT01287104|592359096|FG001|Overall Study|Low donor chimerism|1|||
163998359|NCT01287104|592359097|FG002|Overall Study|Low donor chimerism|0|||
163998360|NCT01287104|592359098|FG003|Overall Study|Low donor chimerism|0|||
163998361|NCT01287104|592359095|FG000|Overall Study|NK cells did not meet release criteria|0|||
163998362|NCT01287104|592359096|FG001|Overall Study|NK cells did not meet release criteria|1|||
163998363|NCT01287104|592359097|FG002|Overall Study|NK cells did not meet release criteria|0|||
163998364|NCT01287104|592359098|FG003|Overall Study|NK cells did not meet release criteria|0|||
163998365|NCT01276288|592359105|FG000|Overall Study|Adverse Event|1|||
163998366|NCT01276288|592359106|FG001|Overall Study|Adverse Event|1|||
163998367|NCT01276288|592359107|FG002|Overall Study|Adverse Event|0|||
163998368|NCT01276288|592359108|FG003|Overall Study|Adverse Event|0|||
164269060|NCT02544373|593353747|FG000|Overall Study|Withdrawal by Subject|8|||
164269061|NCT02544373|593353748|FG001|Overall Study|Withdrawal by Subject|2|||
164269062|NCT04514341|593353749|FG000|Step 2 (Months 19-21)|In a 3-month delay period|0|||
164269063|NCT04514341|593353750|FG001|Step 2 (Months 19-21)|In a 3-month delay period|15725|||
163998369|NCT01276288|592359105|FG000|Overall Study|not treated|1|||
163998370|NCT01276288|592359106|FG001|Overall Study|not treated|0|||
163998371|NCT01276288|592359107|FG002|Overall Study|not treated|0|||
163998372|NCT01276288|592359108|FG003|Overall Study|not treated|0|||
163998373|NCT00629083|592359113|FG000|Overall Study|Adverse Event|0|||
163998374|NCT00629083|592359114|FG001|Overall Study|Adverse Event|2|||
164269064|NCT04514341|593353749|FG000|Step 4 (Months 31-33)|In a 3-month delay period|0|||
164269065|NCT04514341|593353750|FG001|Step 4 (Months 31-33)|In a 3-month delay period|15037|||
164269066|NCT01216683|593354689|FG000|Induction|Never started treatment|0|||
164269067|NCT01216683|593354690|FG001|Induction|Never started treatment|6|||
164269068|NCT01216683|593354691|FG002|Induction|Never started treatment|3|||
164269069|NCT01216683|593354689|FG000|Induction|Lack of Efficacy|4|||
164269070|NCT01216683|593354690|FG001|Induction|Lack of Efficacy|3|||
164269071|NCT01216683|593354691|FG002|Induction|Lack of Efficacy|7|||
164269072|NCT01216683|593354689|FG000|Induction|Adverse Event|0|||
164269073|NCT01216683|593354690|FG001|Induction|Adverse Event|5|||
164269074|NCT01216683|593354691|FG002|Induction|Adverse Event|5|||
164269075|NCT01216683|593354689|FG000|Induction|Death|0|||
164269076|NCT01216683|593354690|FG001|Induction|Death|0|||
164269077|NCT01216683|593354691|FG002|Induction|Death|2|||
164269078|NCT01216683|593354689|FG000|Induction|Withdrawal by Subject|0|||
164269079|NCT01216683|593354690|FG001|Induction|Withdrawal by Subject|4|||
164269080|NCT01216683|593354691|FG002|Induction|Withdrawal by Subject|2|||
164269081|NCT01216683|593354689|FG000|Induction|Other disease|0|||
164269082|NCT01216683|593354690|FG001|Induction|Other disease|1|||
164269083|NCT01216683|593354691|FG002|Induction|Other disease|2|||
164269084|NCT01216683|593354689|FG000|Continuation|Lack of Efficacy|3|||
164269085|NCT01216683|593354690|FG001|Continuation|Lack of Efficacy|2|||
164269086|NCT01216683|593354691|FG002|Continuation|Lack of Efficacy|7|||
164269087|NCT01216683|593354689|FG000|Continuation|Adverse Event|5|||
164269088|NCT01216683|593354690|FG001|Continuation|Adverse Event|3|||
164269089|NCT01216683|593354691|FG002|Continuation|Adverse Event|16|||
164269090|NCT01216683|593354689|FG000|Continuation|Death|1|||
164269091|NCT01216683|593354690|FG001|Continuation|Death|0|||
164269092|NCT01216683|593354691|FG002|Continuation|Death|2|||
164269093|NCT01216683|593354689|FG000|Continuation|Withdrawal by Subject|4|||
164269094|NCT01216683|593354690|FG001|Continuation|Withdrawal by Subject|5|||
164269095|NCT01216683|593354691|FG002|Continuation|Withdrawal by Subject|9|||
164269096|NCT01216683|593354689|FG000|Continuation|Other diseases|0|||
164269097|NCT01216683|593354690|FG001|Continuation|Other diseases|2|||
164269098|NCT01216683|593354691|FG002|Continuation|Other diseases|1|||
164269099|NCT01216683|593354689|FG000|Continuation|Physician Decision|1|||
164269100|NCT01216683|593354690|FG001|Continuation|Physician Decision|0|||
164269101|NCT01216683|593354691|FG002|Continuation|Physician Decision|1|||
164269102|NCT01216683|593354689|FG000|Continuation|Non-compliance|1|||
164269103|NCT01216683|593354690|FG001|Continuation|Non-compliance|0|||
164269104|NCT01216683|593354691|FG002|Continuation|Non-compliance|1|||
164269105|NCT01216683|593354689|FG000|Continuation|Insurance change|0|||
164269106|NCT01216683|593354690|FG001|Continuation|Insurance change|1|||
164269107|NCT01216683|593354691|FG002|Continuation|Insurance change|0|||
164269108|NCT01216683|593354689|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
164269109|NCT01216683|593354690|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
164269110|NCT01216683|593354691|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
164269111|NCT01216683|593354689|FG000|Continuation|Not reported|0|||
164269112|NCT01216683|593354690|FG001|Continuation|Not reported|0|||
164269113|NCT01216683|593354691|FG002|Continuation|Not reported|1|||
164269114|NCT01216683|593354689|FG000|Continuation|Never started treatment|0|||
163998375|NCT00629083|592359113|FG000|Overall Study|Lack of Efficacy|3|||
163998376|NCT00629083|592359114|FG001|Overall Study|Lack of Efficacy|1|||
163998377|NCT00629083|592359113|FG000|Overall Study|Withdrawal by Subject|10|||
163998378|NCT00629083|592359114|FG001|Overall Study|Withdrawal by Subject|2|||
164269115|NCT01216683|593354690|FG001|Continuation|Never started treatment|1|||
164269116|NCT01216683|593354691|FG002|Continuation|Never started treatment|5|||
164269117|NCT01350115|593354692|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
164269118|NCT01350115|593354693|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
164269119|NCT01350115|593354692|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
164269120|NCT01350115|593354693|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
164269121|NCT01350115|593354692|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
164269122|NCT01350115|593354693|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
164269123|NCT04327024|593354694|FG000|Overall Study|Death|1|||
164269124|NCT04327024|593354695|FG001|Overall Study|Death|2|||
163998379|NCT00629083|592359113|FG000|Overall Study|Lost to Follow-up|12|||
163998380|NCT00629083|592359114|FG001|Overall Study|Lost to Follow-up|8|||
164269125|NCT04327024|593354696|FG002|Overall Study|Death|1|||
163998381|NCT00629083|592359113|FG000|Overall Study|Moved out of country/state|2|||
164269126|NCT04327024|593354694|FG000|Overall Study|Non-compliance with study drug|0|||
164269127|NCT04327024|593354695|FG001|Overall Study|Non-compliance with study drug|1|||
164269128|NCT04327024|593354696|FG002|Overall Study|Non-compliance with study drug|0|||
164269129|NCT04327024|593354694|FG000|Overall Study|Withdrawal by Subject|1|||
164269130|NCT04327024|593354695|FG001|Overall Study|Withdrawal by Subject|1|||
164269131|NCT04327024|593354696|FG002|Overall Study|Withdrawal by Subject|2|||
164269132|NCT03968159|593354698|FG000|Overall Study|Adverse Event|4|||
164269133|NCT03968159|593354699|FG001|Overall Study|Adverse Event|4|||
164269134|NCT03968159|593354698|FG000|Overall Study|Lost to Follow-up|1|||
164269135|NCT03968159|593354699|FG001|Overall Study|Lost to Follow-up|1|||
164269136|NCT03968159|593354698|FG000|Overall Study|Use of prohibited medication|0|||
164269137|NCT03968159|593354699|FG001|Overall Study|Use of prohibited medication|1|||
164269138|NCT03968159|593354698|FG000|Overall Study|Protocol Violation|2|||
164269139|NCT03968159|593354699|FG001|Overall Study|Protocol Violation|2|||
164269140|NCT03968159|593354698|FG000|Overall Study|Withdrawal by Subject|4|||
164269141|NCT03968159|593354699|FG001|Overall Study|Withdrawal by Subject|6|||
164269142|NCT03968159|593354698|FG000|Overall Study|Lack of Efficacy|0|||
164269143|NCT03968159|593354699|FG001|Overall Study|Lack of Efficacy|1|||
164269144|NCT03968159|593354698|FG000|Overall Study|Not further specified|2|||
164269145|NCT03968159|593354699|FG001|Overall Study|Not further specified|0|||
164269146|NCT00864851|593354700|FG000|Overall Study|Withdrawal by Subject|0|||
164269147|NCT00864851|593354701|FG001|Overall Study|Withdrawal by Subject|1|||
164269148|NCT00864851|593354702|FG002|Overall Study|Withdrawal by Subject|0|||
164269149|NCT00864851|593354700|FG000|Overall Study|Physician Decision|1|||
164269150|NCT00864851|593354701|FG001|Overall Study|Physician Decision|0|||
164269151|NCT00864851|593354702|FG002|Overall Study|Physician Decision|0|||
164269152|NCT00864851|593354700|FG000|Overall Study|Death|1|||
164269153|NCT00864851|593354701|FG001|Overall Study|Death|0|||
164269154|NCT00864851|593354702|FG002|Overall Study|Death|0|||
164269155|NCT00864851|593354700|FG000|Overall Study|Patient uncooperative|1|||
164269156|NCT00864851|593354701|FG001|Overall Study|Patient uncooperative|0|||
164269157|NCT00864851|593354702|FG002|Overall Study|Patient uncooperative|0|||
164269158|NCT00443781|593354703|FG000|Overall Study|Lost to Follow-up|10|||
164269159|NCT00443781|593354703|FG000|Overall Study|Physician Decision|2|||
164269160|NCT00443781|593354703|FG000|Overall Study|Protocol Violation|1|||
164269161|NCT00443781|593354703|FG000|Overall Study|Withdrawal by Subject|6|||
164269162|NCT00443781|593354703|FG000|Overall Study|Unable to comply with study follow up|2|||
164269163|NCT00443781|593354703|FG000|Overall Study|Investigator terminated participation|1|||
164269164|NCT00443781|593354703|FG000|Overall Study|Insurance not covered|2|||
164269165|NCT00443781|593354703|FG000|Overall Study|PD/FAD not done|1|||
164269166|NCT00430937|593354704|FG000|Overall Study|Adverse Event|3|||
164269167|NCT00430937|593354705|FG001|Overall Study|Adverse Event|8|||
164269168|NCT00430937|593354704|FG000|Overall Study|Death|0|||
164269169|NCT00430937|593354705|FG001|Overall Study|Death|1|||
164269170|NCT00430937|593354704|FG000|Overall Study|Lost to Follow-up|6|||
164269171|NCT00430937|593354705|FG001|Overall Study|Lost to Follow-up|6|||
164269172|NCT00430937|593354704|FG000|Overall Study|Withdrawal by Subject|5|||
164269173|NCT00430937|593354705|FG001|Overall Study|Withdrawal by Subject|2|||
164269174|NCT00430937|593354704|FG000|Overall Study|Protocol Violation|3|||
164269175|NCT00430937|593354705|FG001|Overall Study|Protocol Violation|2|||
164269176|NCT00430937|593354704|FG000|Overall Study|Lack of Efficacy|6|||
164269177|NCT00430937|593354705|FG001|Overall Study|Lack of Efficacy|5|||
164269178|NCT00430937|593354704|FG000|Overall Study|Inappropriate enrollment|2|||
164269179|NCT00430937|593354705|FG001|Overall Study|Inappropriate enrollment|1|||
164269180|NCT00430937|593354704|FG000|Overall Study|Administrative reasons|1|||
164269181|NCT00430937|593354705|FG001|Overall Study|Administrative reasons|0|||
164269182|NCT00430937|593354704|FG000|Overall Study|Protocol discontinuation criteria met|1|||
164269183|NCT00430937|593354705|FG001|Overall Study|Protocol discontinuation criteria met|2|||
164269184|NCT00430937|593354704|FG000|Overall Study|Unable to classify|0|||
164269185|NCT00430937|593354705|FG001|Overall Study|Unable to classify|1|||
164269186|NCT01533922|593354706|FG000|Overall Study|Adverse Event|5|||
164269187|NCT01533922|593354707|FG001|Overall Study|Adverse Event|8|||
164269188|NCT01533922|593354708|FG002|Overall Study|Adverse Event|6|||
164269189|NCT01533922|593354709|FG003|Overall Study|Adverse Event|3|||
164269190|NCT01533922|593354710|FG004|Overall Study|Adverse Event|4|||
164269191|NCT01533922|593354706|FG000|Overall Study|Lack of Efficacy|0|||
164269192|NCT01533922|593354707|FG001|Overall Study|Lack of Efficacy|0|||
164269193|NCT01533922|593354708|FG002|Overall Study|Lack of Efficacy|1|||
164269194|NCT01533922|593354709|FG003|Overall Study|Lack of Efficacy|0|||
164269195|NCT01533922|593354710|FG004|Overall Study|Lack of Efficacy|0|||
164269196|NCT01533922|593354706|FG000|Overall Study|Protocol Violation|0|||
164269197|NCT01533922|593354707|FG001|Overall Study|Protocol Violation|3|||
164342006|NCT05248867|593627595|FG003|Double-blind Period|Other, not specified|0|||
164085884|NCT00696709|592678581|FG001|Overall Study|Protocol Violation|0|||
164269198|NCT01533922|593354708|FG002|Overall Study|Protocol Violation|0|||
164269199|NCT01533922|593354709|FG003|Overall Study|Protocol Violation|0|||
164269200|NCT01533922|593354710|FG004|Overall Study|Protocol Violation|1|||
164269201|NCT01533922|593354706|FG000|Overall Study|Withdrawal by Subject|3|||
164269202|NCT01533922|593354707|FG001|Overall Study|Withdrawal by Subject|1|||
164269203|NCT01533922|593354708|FG002|Overall Study|Withdrawal by Subject|2|||
164269204|NCT01533922|593354709|FG003|Overall Study|Withdrawal by Subject|2|||
164269205|NCT01533922|593354710|FG004|Overall Study|Withdrawal by Subject|1|||
164269206|NCT01533922|593354706|FG000|Overall Study|Other reason not defined above|2|||
164269207|NCT01533922|593354707|FG001|Overall Study|Other reason not defined above|0|||
164269208|NCT01533922|593354708|FG002|Overall Study|Other reason not defined above|1|||
164269209|NCT01533922|593354709|FG003|Overall Study|Other reason not defined above|0|||
164269210|NCT01533922|593354710|FG004|Overall Study|Other reason not defined above|0|||
164269211|NCT00895661|593354713|FG000|Overall Study|Death|1|||
164269212|NCT00895661|593354713|FG000|Overall Study|reason unknown|2|||
164269213|NCT02006069|593354714|FG000|Overall Study|MPP other programming|239|||
164269214|NCT02006069|593354715|FG001|Overall Study|MPP other programming|0|||
164269215|NCT02006069|593354714|FG000|Overall Study|RV only pacing|0|||
164269216|NCT02006069|593354715|FG001|Overall Study|RV only pacing|3|||
164269217|NCT02989805|593354718|FG000|Overall Study|invalid consent|6|||
164269218|NCT02989805|593354719|FG001|Overall Study|invalid consent|4|||
164269219|NCT02776033|593354720|FG000|Overall Study|Withdrawal by Subject|0|||
164269220|NCT02776033|593354721|FG001|Overall Study|Withdrawal by Subject|0|||
164269221|NCT02776033|593354722|FG002|Overall Study|Withdrawal by Subject|2|||
164269222|NCT02776033|593354720|FG000|Overall Study|Physician Decision|2|||
164269223|NCT02776033|593354721|FG001|Overall Study|Physician Decision|0|||
164269224|NCT02776033|593354722|FG002|Overall Study|Physician Decision|0|||
164269225|NCT02776033|593354720|FG000|Overall Study|Lost to Follow-up|1|||
164269226|NCT02776033|593354721|FG001|Overall Study|Lost to Follow-up|0|||
164269227|NCT02776033|593354722|FG002|Overall Study|Lost to Follow-up|0|||
164269228|NCT02776033|593354720|FG000|Overall Study|Adverse Event|1|||
164269229|NCT02776033|593354721|FG001|Overall Study|Adverse Event|2|||
164269230|NCT02776033|593354722|FG002|Overall Study|Adverse Event|0|||
164269231|NCT00685373|593354723|FG000|Overall Study|Adverse Event|3|||
164269232|NCT00685373|593354723|FG000|Overall Study|Withdrawal by Subject|5|||
164269233|NCT00685373|593354723|FG000|Overall Study|Lack of Efficacy|3|||
164269234|NCT00685373|593354723|FG000|Overall Study|Condition no longer requires study drug|1|||
164269235|NCT00685373|593354723|FG000|Overall Study|Lost to Follow-up|2|||
164269236|NCT00685373|593354723|FG000|Overall Study|Protocol Violation|1|||
164269237|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
164269238|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
164269239|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
164269240|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
164269241|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
164269242|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
164269243|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
164269244|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
164269245|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
164269246|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
164269247|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
164269248|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
164269249|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
164269250|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
164269251|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
164269252|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
164269253|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
164269254|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
164269255|NCT01302054|593354724|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
164269256|NCT01302054|593354725|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
164269257|NCT01302054|593354726|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
164269258|NCT01302054|593354724|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
164269259|NCT01302054|593354725|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
164269260|NCT01302054|593354726|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
164269261|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164269262|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
164269263|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
163892337|NCT01221948|591976782|FG000|Overall Study|Protocol Violation|4|||
164269264|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164269265|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
164269266|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164269267|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164269268|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
164269269|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
164269270|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
164269271|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
164269272|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
164269273|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164269274|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
164269275|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
164269276|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
164269277|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
164269278|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
164269279|NCT01302054|593354724|FG000|Double-Blind Treatment Phase|Other|0|||
164269280|NCT01302054|593354725|FG001|Double-Blind Treatment Phase|Other|4|||
164269281|NCT01302054|593354726|FG002|Double-Blind Treatment Phase|Other|9|||
164269282|NCT02639338|593354727|FG000|Overall Study|Lost to Follow-up|2|||
164269283|NCT02639338|593354728|FG001|Overall Study|Lost to Follow-up|2|||
164269284|NCT02639338|593354727|FG000|Overall Study|Withdrew Consent|1|||
164269285|NCT02639338|593354728|FG001|Overall Study|Withdrew Consent|2|||
164269286|NCT02639338|593354727|FG000|Overall Study|Death|1|||
164269287|NCT02639338|593354728|FG001|Overall Study|Death|0|||
164269288|NCT02639338|593354727|FG000|Overall Study|Randomized but Not Treated|0|||
164269289|NCT02639338|593354728|FG001|Overall Study|Randomized but Not Treated|1|||
164269290|NCT00966719|593354734|FG000|Overall Study|Lost to Follow-up|6|||
164269291|NCT00966719|593354735|FG001|Overall Study|Lost to Follow-up|11|||
164269292|NCT03242018|593354737|FG000|Overall Study|Adverse Event|7|||
164269293|NCT03242018|593354738|FG001|Overall Study|Adverse Event|7|||
164269294|NCT03242018|593354739|FG002|Overall Study|Adverse Event|6|||
164269295|NCT03242018|593354737|FG000|Overall Study|Lost to Follow-up|2|||
164269296|NCT03242018|593354738|FG001|Overall Study|Lost to Follow-up|2|||
164269297|NCT03242018|593354739|FG002|Overall Study|Lost to Follow-up|2|||
164269298|NCT03242018|593354737|FG000|Overall Study|At the Participant's Own Request|5|||
164269299|NCT03242018|593354738|FG001|Overall Study|At the Participant's Own Request|1|||
164269300|NCT03242018|593354739|FG002|Overall Study|At the Participant's Own Request|4|||
164269301|NCT03242018|593354737|FG000|Overall Study|Reason Not Specified|3|||
164269302|NCT03242018|593354738|FG001|Overall Study|Reason Not Specified|4|||
164269303|NCT03242018|593354739|FG002|Overall Study|Reason Not Specified|1|||
164269304|NCT03242018|593354737|FG000|Overall Study|Study Terminated by Sponsor|1|||
164269305|NCT03242018|593354738|FG001|Overall Study|Study Terminated by Sponsor|0|||
164269306|NCT03242018|593354739|FG002|Overall Study|Study Terminated by Sponsor|1|||
164269307|NCT02365285|593354741|FG000|Overall Study|Physician Decision|0|||
164269308|NCT02365285|593354742|FG001|Overall Study|Physician Decision|1|||
164269309|NCT02365285|593354743|FG002|Overall Study|Physician Decision|1|||
164269310|NCT02365285|593354744|FG003|Overall Study|Physician Decision|0|||
164269311|NCT02365285|593354741|FG000|Overall Study|Adverse Event|0|||
164269312|NCT02365285|593354742|FG001|Overall Study|Adverse Event|0|||
164269313|NCT02365285|593354743|FG002|Overall Study|Adverse Event|0|||
164269314|NCT02365285|593354744|FG003|Overall Study|Adverse Event|2|||
164269315|NCT00160199|593354745|FG000|Overall Study|Adverse Event|5|||
164269316|NCT00160199|593354746|FG001|Overall Study|Adverse Event|14|||
164269317|NCT00160199|593354745|FG000|Overall Study|Lack of Efficacy|0|||
164269318|NCT00160199|593354746|FG001|Overall Study|Lack of Efficacy|1|||
164269319|NCT00160199|593354745|FG000|Overall Study|Lost to Follow-up|7|||
164269320|NCT00160199|593354746|FG001|Overall Study|Lost to Follow-up|7|||
164269321|NCT00160199|593354745|FG000|Overall Study|Withdrawal by Subject|4|||
164269322|NCT00160199|593354746|FG001|Overall Study|Withdrawal by Subject|6|||
164269323|NCT00160199|593354745|FG000|Overall Study|Administrative|0|||
164269324|NCT00160199|593354746|FG001|Overall Study|Administrative|1|||
164269325|NCT00160199|593354745|FG000|Overall Study|Protocol Violation|8|||
164269326|NCT00160199|593354746|FG001|Overall Study|Protocol Violation|8|||
164269327|NCT03262116|593354747|FG000|Overall Study|Physician Decision|0|||
164269328|NCT03262116|593354748|FG001|Overall Study|Physician Decision|2|||
164269329|NCT03262116|593354749|FG002|Overall Study|Physician Decision|1|||
164269330|NCT03262116|593354750|FG003|Overall Study|Physician Decision|1|||
164269331|NCT03262116|593354751|FG004|Overall Study|Physician Decision|1|||
164269332|NCT03262116|593354752|FG005|Overall Study|Physician Decision|2|||
164342007|NCT05248867|593627596|FG004|Double-blind Period|Other, not specified|0|||
164342008|NCT05248867|593627597|FG005|Double-blind Period|Other, not specified|0|||
163998382|NCT00629083|592359114|FG001|Overall Study|Moved out of country/state|1|||
164269333|NCT02635347|593354755|FG000|Overall Study|Failed screening|20|||
164342009|NCT05248867|593627592|FG000|Open-label Period|Withdrawal by Subject|0|||
164342010|NCT05248867|593627593|FG001|Open-label Period|Withdrawal by Subject|0|||
164269334|NCT02635347|593354756|FG001|Overall Study|Failed screening|7|||
164269335|NCT00635089|593354761|FG000|Overall Study|Adverse Event|7|||
164269336|NCT00635089|593354761|FG000|Overall Study|Lack of Efficacy|28|||
164269337|NCT00635089|593354761|FG000|Overall Study|Protocol Deviation|4|||
164269338|NCT00635089|593354761|FG000|Overall Study|Lost to Follow-up|8|||
164269339|NCT00635089|593354761|FG000|Overall Study|Other|31|||
164269340|NCT01283542|593354763|FG000|Main Phase|Acute or progressive vision loss|1|||
164269341|NCT01283542|593354763|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
164269342|NCT01283542|593354763|FG000|Main Phase|abnormal laboratory values|5|||
164269343|NCT01283542|593354763|FG000|Extension Phase|Physician Decision|1|||
164269344|NCT01283542|593354763|FG000|Extension Phase|Adverse Event|1|||
164269345|NCT01283542|593354763|FG000|Extension Phase|Administrative problems|1|||
164342011|NCT05248867|593627594|FG002|Open-label Period|Withdrawal by Subject|3|||
164269346|NCT02725593|593354764|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
164269347|NCT02725593|593354765|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
164269348|NCT02725593|593354764|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
164269349|NCT02725593|593354765|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
164269350|NCT02725593|593354764|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
164269351|NCT02725593|593354765|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
164269352|NCT02725593|593354764|FG000|Long Term Extension|Withdrawal by Subject|1|||
164269353|NCT02725593|593354765|FG001|Long Term Extension|Withdrawal by Subject|3|||
164269354|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
164269355|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
164269356|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
164269357|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
164269358|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
164269359|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
164269360|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
164269361|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
164269362|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
164269363|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
164269364|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
164269365|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
164269366|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
164269367|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
164269368|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
164269369|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
164269370|NCT03689244|593354766|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
164269371|NCT03689244|593354767|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
164269372|NCT03689244|593354768|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
164269373|NCT03689244|593354769|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
164269374|NCT03689244|593354766|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
164269375|NCT03689244|593354767|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
164269376|NCT03689244|593354768|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
164269377|NCT03689244|593354769|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
164269378|NCT03689244|593354766|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
164269379|NCT03689244|593354767|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
164269380|NCT03689244|593354768|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
164269381|NCT03689244|593354769|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
164269382|NCT03689244|593354766|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
164269383|NCT03689244|593354767|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
164269384|NCT03689244|593354768|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
164269385|NCT03689244|593354769|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
164269386|NCT00444067|593354774|FG000|Overall Study|Lost to Follow-up|0|||
164269387|NCT00444067|593354775|FG001|Overall Study|Lost to Follow-up|1|||
164269388|NCT04208087|593354784|FG000|Overall Study|Adverse Event|1|||
164269389|NCT04208087|593354785|FG001|Overall Study|Adverse Event|0|||
164269390|NCT04208087|593354786|FG002|Overall Study|Adverse Event|0|||
164269391|NCT04208087|593354787|FG003|Overall Study|Adverse Event|0|||
164269392|NCT04208087|593354788|FG004|Overall Study|Adverse Event|0|||
164269393|NCT04208087|593354784|FG000|Overall Study|Withdrawal by Subject|0|||
164269394|NCT04208087|593354785|FG001|Overall Study|Withdrawal by Subject|0|||
164269395|NCT04208087|593354786|FG002|Overall Study|Withdrawal by Subject|1|||
164269396|NCT04208087|593354787|FG003|Overall Study|Withdrawal by Subject|0|||
164269397|NCT04208087|593354788|FG004|Overall Study|Withdrawal by Subject|0|||
164269398|NCT04208087|593354784|FG000|Overall Study|Other|0|||
164269399|NCT04208087|593354785|FG001|Overall Study|Other|0|||
164269400|NCT04208087|593354786|FG002|Overall Study|Other|0|||
164269401|NCT04208087|593354787|FG003|Overall Study|Other|0|||
163892338|NCT00746096|591976783|FG000|Overall Study|Adverse Event|1|||
163892339|NCT00746096|591976784|FG001|Overall Study|Adverse Event|0|||
164269402|NCT04208087|593354788|FG004|Overall Study|Other|1|||
164269403|NCT01198509|593354789|FG000|Overall Study|Withdrawal by Subject|1|||
164269404|NCT01198509|593354790|FG001|Overall Study|Withdrawal by Subject|0|||
164269405|NCT01198509|593354791|FG002|Overall Study|Withdrawal by Subject|0|||
164269406|NCT01198509|593354792|FG003|Overall Study|Withdrawal by Subject|0|||
164269407|NCT01198509|593354793|FG004|Overall Study|Withdrawal by Subject|0|||
164269408|NCT01198509|593354794|FG005|Overall Study|Withdrawal by Subject|0|||
164269409|NCT00837759|593356685|FG000|Overall Study|Protocol Violation|3|||
163892340|NCT00746096|591976783|FG000|Overall Study|Withdrawal by Subject|5|||
164269410|NCT00837759|593356685|FG000|Overall Study|Lost to Follow-up|1|||
164269411|NCT01597635|593356686|FG000|Part A|Adverse Event|3|||
164269412|NCT01597635|593356687|FG001|Part A|Adverse Event|0|||
164269413|NCT01597635|593356688|FG002|Part A|Adverse Event|0|||
164269414|NCT01597635|593356686|FG000|Part B|Adverse Event|0|||
164269415|NCT01597635|593356687|FG001|Part B|Adverse Event|0|||
164269416|NCT01597635|593356688|FG002|Part B|Adverse Event|1|||
164269417|NCT01597635|593356686|FG000|Part B|Protocol Violation|0|||
163998383|NCT00629083|592359113|FG000|Overall Study|Refused to return for 12 month visit|1|||
163998384|NCT00629083|592359114|FG001|Overall Study|Refused to return for 12 month visit|0|||
163998385|NCT01478958|592359115|FG000|Overall Study|Withdrawal by Subject|1|||
163998386|NCT01478958|592359116|FG001|Overall Study|Withdrawal by Subject|1|||
163998387|NCT01478958|592359117|FG002|Overall Study|Withdrawal by Subject|1|||
163998388|NCT01478958|592359115|FG000|Overall Study|Weight loss|1|||
163998389|NCT01478958|592359116|FG001|Overall Study|Weight loss|0|||
163998390|NCT01478958|592359117|FG002|Overall Study|Weight loss|0|||
163998391|NCT01478958|592359115|FG000|Overall Study|Re-located|0|||
163998392|NCT01478958|592359116|FG001|Overall Study|Re-located|1|||
163998393|NCT01478958|592359117|FG002|Overall Study|Re-located|0|||
163998394|NCT01478958|592359115|FG000|Overall Study|Unable to comply|0|||
163998395|NCT01478958|592359116|FG001|Overall Study|Unable to comply|0|||
163998396|NCT01478958|592359117|FG002|Overall Study|Unable to comply|2|||
163998397|NCT01193686|592359118|FG000|Overall Study|Withdrawal by Subject|4|||
163998398|NCT01193686|592359119|FG001|Overall Study|Withdrawal by Subject|1|||
163998399|NCT01193686|592359118|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
163998400|NCT01193686|592359119|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
163998401|NCT03401749|592359120|FG000|Overall Study|Lost to Follow-up|20|||
163998402|NCT03401749|592359121|FG001|Overall Study|Lost to Follow-up|16|||
163998403|NCT03401749|592359122|FG002|Overall Study|Lost to Follow-up|26|||
163998404|NCT01147809|592359125|FG000|Phase I (168 Days)|Adverse Event|0|||
163998405|NCT01147809|592359126|FG001|Phase I (168 Days)|Adverse Event|0|||
163998406|NCT01147809|592359127|FG002|Phase I (168 Days)|Adverse Event|0|||
164269418|NCT01597635|593356687|FG001|Part B|Protocol Violation|1|||
164269419|NCT01597635|593356688|FG002|Part B|Protocol Violation|0|||
164269420|NCT01597635|593356686|FG000|Part B|Protocol-defined stopping criteria|0|||
164269421|NCT01597635|593356687|FG001|Part B|Protocol-defined stopping criteria|4|||
164269422|NCT01597635|593356688|FG002|Part B|Protocol-defined stopping criteria|3|||
164269423|NCT01597635|593356686|FG000|Part B|Withdrawal by Subject|0|||
164269424|NCT01597635|593356687|FG001|Part B|Withdrawal by Subject|1|||
164269425|NCT01597635|593356688|FG002|Part B|Withdrawal by Subject|0|||
164269426|NCT01267175|593356691|FG000|Overall Study|Withdrawal by Subject|1|||
164269427|NCT01267175|593356691|FG000|Overall Study|Lost to Follow-up|1|||
164269428|NCT02690649|593356693|FG000|Overall Study|Withdrawal by Subject|1|||
164269429|NCT02690649|593356694|FG001|Overall Study|Withdrawal by Subject|1|||
164269430|NCT02690649|593356693|FG000|Overall Study|Protocol Violation|0|||
164269431|NCT02690649|593356694|FG001|Overall Study|Protocol Violation|3|||
164269432|NCT02066129|593356695|FG000|Overall Study|Lost to Follow-up|13|||
164269433|NCT02066129|593356696|FG001|Overall Study|Lost to Follow-up|12|||
164269434|NCT02066129|593356695|FG000|Overall Study|Withdrawal by Subject|7|||
164269435|NCT02066129|593356696|FG001|Overall Study|Withdrawal by Subject|10|||
164269436|NCT02066129|593356695|FG000|Overall Study|Lack of Efficacy|8|||
164269437|NCT02066129|593356696|FG001|Overall Study|Lack of Efficacy|10|||
164269438|NCT02066129|593356695|FG000|Overall Study|Physician Decision|1|||
164269439|NCT02066129|593356696|FG001|Overall Study|Physician Decision|1|||
164269440|NCT00316888|593356697|FG000|Overall Study|Adverse Event|4|||
164269441|NCT00316888|593356698|FG001|Overall Study|Adverse Event|5|||
164269442|NCT00316888|593356697|FG000|Overall Study|Withdrawal by Subject|2|||
164269443|NCT00316888|593356698|FG001|Overall Study|Withdrawal by Subject|2|||
164269444|NCT00316888|593356697|FG000|Overall Study|Not start protocol therapy|0|||
164269445|NCT00316888|593356698|FG001|Overall Study|Not start protocol therapy|1|||
164269446|NCT00857948|593356702|FG000|Overall Study|Withdrawal by Subject|2|||
164269447|NCT00857948|593356703|FG001|Overall Study|Withdrawal by Subject|0|||
163998407|NCT01147809|592359128|FG003|Phase I (168 Days)|Adverse Event|1|||
163998408|NCT01147809|592359129|FG004|Phase I (168 Days)|Adverse Event|0|||
163998409|NCT01147809|592359130|FG005|Phase I (168 Days)|Adverse Event|0|||
163998410|NCT01147809|592359125|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
163998411|NCT01147809|592359126|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
163998412|NCT01147809|592359127|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
163998413|NCT01147809|592359128|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
164269448|NCT00857948|593356704|FG002|Overall Study|Withdrawal by Subject|0|||
164269449|NCT00857948|593356705|FG003|Overall Study|Withdrawal by Subject|0|||
164269450|NCT00857948|593356702|FG000|Overall Study|Protocol Violation|1|||
164269451|NCT00857948|593356703|FG001|Overall Study|Protocol Violation|0|||
164269452|NCT00857948|593356704|FG002|Overall Study|Protocol Violation|1|||
164269453|NCT00857948|593356705|FG003|Overall Study|Protocol Violation|0|||
164269454|NCT00493636|593356708|FG000|Overall Study|Withdrawal by Subject|1|||
164269455|NCT00493636|593356709|FG001|Overall Study|Withdrawal by Subject|0|||
163998414|NCT01147809|592359129|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
163998415|NCT01147809|592359130|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
163998416|NCT01147809|592359125|FG000|Phase I (168 Days)|Physician Decision|0|||
163998417|NCT01147809|592359126|FG001|Phase I (168 Days)|Physician Decision|1|||
164269456|NCT00493636|593356708|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
164269457|NCT00493636|593356709|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
164269458|NCT00493636|593356708|FG000|Overall Study|Mis-randomization|1|||
164269459|NCT00493636|593356709|FG001|Overall Study|Mis-randomization|1|||
164269460|NCT01565941|593356710|FG000|Overall Study|Withdrawn by parent/guardian|3|||
164269461|NCT01565941|593356711|FG001|Overall Study|Withdrawn by parent/guardian|2|||
164269462|NCT01565941|593356710|FG000|Overall Study|Randomized; did not receive intevention|8|||
164269463|NCT01565941|593356711|FG001|Overall Study|Randomized; did not receive intevention|2|||
164269464|NCT03230292|593356712|FG000|Overall Study|Adverse Event|1|||
164269465|NCT03230292|593356712|FG000|Overall Study|Protocol Violation|1|||
164269466|NCT03230292|593356712|FG000|Overall Study|Lost to Follow-up|1|||
164269467|NCT03230292|593356712|FG000|Overall Study|Withdrawal by Subject|3|||
164269468|NCT02855944|593356713|FG000|Period 1: Treatment|Ongoing|14|||
164269469|NCT02855944|593356714|FG001|Period 1: Treatment|Ongoing|0|||
164269470|NCT02855944|593356713|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
164269471|NCT02855944|593356714|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
164269472|NCT02855944|593356713|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
164269473|NCT02855944|593356714|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
164269474|NCT03757130|593356715|FG000|Overall Study|Lost to Follow-up|0|||
164269475|NCT03757130|593356716|FG001|Overall Study|Lost to Follow-up|0|||
164269476|NCT03757130|593356717|FG002|Overall Study|Lost to Follow-up|0|||
164269477|NCT03757130|593356718|FG003|Overall Study|Lost to Follow-up|1|||
164269478|NCT03757130|593356719|FG004|Overall Study|Lost to Follow-up|0|||
164269479|NCT03757130|593356720|FG005|Overall Study|Lost to Follow-up|0|||
164269480|NCT03757130|593356721|FG006|Overall Study|Lost to Follow-up|0|||
164269481|NCT03757130|593356722|FG007|Overall Study|Lost to Follow-up|1|||
164269482|NCT03757130|593356715|FG000|Overall Study|Withdrawal by Subject|0|||
164269483|NCT03757130|593356716|FG001|Overall Study|Withdrawal by Subject|0|||
164269484|NCT03757130|593356717|FG002|Overall Study|Withdrawal by Subject|0|||
164269485|NCT03757130|593356718|FG003|Overall Study|Withdrawal by Subject|0|||
164269486|NCT03757130|593356719|FG004|Overall Study|Withdrawal by Subject|0|||
164269487|NCT03757130|593356720|FG005|Overall Study|Withdrawal by Subject|0|||
164269488|NCT03757130|593356721|FG006|Overall Study|Withdrawal by Subject|1|||
164269489|NCT03757130|593356722|FG007|Overall Study|Withdrawal by Subject|0|||
164269490|NCT01639755|593356723|FG000|Overall Study|Study Ongoing|15|||
164269491|NCT01639755|593356723|FG000|Overall Study|Patient had device explantation|4|||
164269492|NCT01439126|593356724|FG000|Overall Study|Adverse Event|2|||
164269493|NCT01439126|593356725|FG001|Overall Study|Adverse Event|0|||
164269494|NCT01439126|593356724|FG000|Overall Study|Withdrawal by Subject|5|||
164269495|NCT01439126|593356725|FG001|Overall Study|Withdrawal by Subject|21|||
164269496|NCT01439126|593356724|FG000|Overall Study|Protocol Violation|6|||
164269497|NCT01439126|593356725|FG001|Overall Study|Protocol Violation|4|||
164269498|NCT01439126|593356724|FG000|Overall Study|Lost to Follow-up|6|||
164269499|NCT01439126|593356725|FG001|Overall Study|Lost to Follow-up|3|||
164269500|NCT01439126|593356724|FG000|Overall Study|Other-Use of prohibited treatment|0|||
163892341|NCT00746096|591976784|FG001|Overall Study|Withdrawal by Subject|1|||
163892342|NCT00746096|591976783|FG000|Overall Study|Lost to Follow-up|2|||
163892343|NCT00746096|591976784|FG001|Overall Study|Lost to Follow-up|1|||
163892344|NCT00746096|591976783|FG000|Overall Study|Protocol Violation|1|||
163892345|NCT00746096|591976784|FG001|Overall Study|Protocol Violation|0|||
163892346|NCT00746096|591976783|FG000|Overall Study|No study drug treatment|1|||
163892347|NCT00746096|591976784|FG001|Overall Study|No study drug treatment|1|||
163892348|NCT03756662|591976785|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
163892349|NCT04295512|591976790|FG000|Overall Study|Lack of family response to schedule assessment|0|||
163892350|NCT04295512|591976791|FG001|Overall Study|Lack of family response to schedule assessment|0|||
163892351|NCT04295512|591976792|FG002|Overall Study|Lack of family response to schedule assessment|0|||
163892352|NCT04295512|591976793|FG003|Overall Study|Lack of family response to schedule assessment|2|||
163892353|NCT04295512|591976790|FG000|Overall Study|Therapist did not refer eligible family|7|||
163892354|NCT04295512|591976791|FG001|Overall Study|Therapist did not refer eligible family|7|||
163892355|NCT04295512|591976792|FG002|Overall Study|Therapist did not refer eligible family|0|||
163892356|NCT04295512|591976793|FG003|Overall Study|Therapist did not refer eligible family|0|||
163892357|NCT05207956|591976799|FG000|Overall Study|Lost to follow up|1|||
163892358|NCT05207956|591976800|FG001|Overall Study|Lost to follow up|2|||
163892359|NCT04587453|591976803|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
163892360|NCT04587453|591976804|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
163892361|NCT01254864|591976806|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
163892362|NCT01254864|591976807|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
164269501|NCT01439126|593356725|FG001|Overall Study|Other-Use of prohibited treatment|2|||
164269502|NCT01439126|593356724|FG000|Overall Study|Other-Miscellaneous|12|||
164269503|NCT01439126|593356725|FG001|Overall Study|Other-Miscellaneous|12|||
164269504|NCT01617447|593356727|FG000|Overall Study|Adverse Event|0|||
164269505|NCT01617447|593356728|FG001|Overall Study|Adverse Event|1|||
164269506|NCT01617447|593356727|FG000|Overall Study|Physician Decision|0|||
164269507|NCT01617447|593356728|FG001|Overall Study|Physician Decision|2|||
164269508|NCT05059977|593356729|FG000|Overall Study|Withdrawal by Subject|0|||
163892363|NCT01254864|591976808|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
163892364|NCT01254864|591976806|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
164269509|NCT05059977|593356730|FG001|Overall Study|Withdrawal by Subject|0|||
163998418|NCT01147809|592359127|FG002|Phase I (168 Days)|Physician Decision|2|||
163998419|NCT01147809|592359128|FG003|Phase I (168 Days)|Physician Decision|0|||
163998420|NCT01147809|592359129|FG004|Phase I (168 Days)|Physician Decision|0|||
163998421|NCT01147809|592359130|FG005|Phase I (168 Days)|Physician Decision|0|||
163998422|NCT01147809|592359125|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
163998423|NCT01147809|592359126|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
163998424|NCT01147809|592359127|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
163998425|NCT01147809|592359128|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
163998426|NCT01147809|592359129|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
163998427|NCT01147809|592359130|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
163998428|NCT01147809|592359125|FG000|Phase II (168 Days)|Adverse Event|0|||
163998429|NCT01147809|592359126|FG001|Phase II (168 Days)|Adverse Event|0|||
163998430|NCT01147809|592359127|FG002|Phase II (168 Days)|Adverse Event|0|||
163998431|NCT01147809|592359128|FG003|Phase II (168 Days)|Adverse Event|0|||
163998432|NCT01147809|592359129|FG004|Phase II (168 Days)|Adverse Event|3|||
164085885|NCT00696709|592678582|FG002|Overall Study|Protocol Violation|0|||
164085886|NCT00696709|592678583|FG003|Overall Study|Protocol Violation|0|||
164269510|NCT05059977|593356731|FG002|Overall Study|Withdrawal by Subject|1|||
164269511|NCT00576472|593356732|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269512|NCT00576472|593356733|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269513|NCT00576472|593356734|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269514|NCT00576472|593356735|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
164269515|NCT00576472|593356736|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269516|NCT00576472|593356737|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269517|NCT00576472|593356738|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269518|NCT00576472|593356739|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269519|NCT00576472|593356740|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269520|NCT00576472|593356741|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269521|NCT00576472|593356742|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269522|NCT00576472|593356743|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269523|NCT00576472|593356744|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269524|NCT00576472|593356745|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269525|NCT00576472|593356746|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
164269526|NCT00576472|593356732|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
164269527|NCT00576472|593356733|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
164269528|NCT00576472|593356734|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
164269529|NCT00576472|593356735|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
164269530|NCT00576472|593356736|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
164269531|NCT00576472|593356737|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
164269532|NCT00576472|593356738|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
164269533|NCT00576472|593356739|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
164269534|NCT00576472|593356740|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
164269535|NCT00576472|593356741|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
164269536|NCT00576472|593356742|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
164269537|NCT00576472|593356743|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
164269538|NCT00576472|593356744|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
164269539|NCT00576472|593356745|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
164269540|NCT00576472|593356746|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
164269541|NCT00576472|593356732|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269542|NCT00576472|593356733|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269543|NCT00576472|593356734|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269544|NCT00576472|593356735|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
164269545|NCT00576472|593356736|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269546|NCT00576472|593356737|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269547|NCT00576472|593356738|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269548|NCT00576472|593356739|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269549|NCT00576472|593356740|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164085887|NCT00696709|592678584|FG004|Overall Study|Protocol Violation|0|||
164085888|NCT00696709|592678580|FG000|Overall Study|Lost to Follow-up|1|||
164269550|NCT00576472|593356741|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269551|NCT00576472|593356742|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269552|NCT00576472|593356743|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269553|NCT00576472|593356744|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269554|NCT00576472|593356745|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269555|NCT00576472|593356746|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
164269556|NCT00576472|593356732|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
164269557|NCT00576472|593356733|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
163998433|NCT01147809|592359130|FG005|Phase II (168 Days)|Adverse Event|6|||
163998434|NCT01147809|592359125|FG000|Phase II (168 Days)|Protocol Violation|0|||
164085889|NCT00696709|592678581|FG001|Overall Study|Lost to Follow-up|1|||
164085890|NCT00696709|592678582|FG002|Overall Study|Lost to Follow-up|0|||
163998435|NCT01147809|592359126|FG001|Phase II (168 Days)|Protocol Violation|0|||
163998436|NCT01147809|592359127|FG002|Phase II (168 Days)|Protocol Violation|0|||
163998437|NCT01147809|592359128|FG003|Phase II (168 Days)|Protocol Violation|0|||
163998438|NCT01147809|592359129|FG004|Phase II (168 Days)|Protocol Violation|0|||
163998439|NCT01147809|592359130|FG005|Phase II (168 Days)|Protocol Violation|1|||
163998440|NCT01147809|592359125|FG000|Phase II (168 Days)|Physician Decision|0|||
163998441|NCT01147809|592359126|FG001|Phase II (168 Days)|Physician Decision|0|||
163998442|NCT01147809|592359127|FG002|Phase II (168 Days)|Physician Decision|0|||
163998443|NCT01147809|592359128|FG003|Phase II (168 Days)|Physician Decision|0|||
163998444|NCT01147809|592359129|FG004|Phase II (168 Days)|Physician Decision|5|||
163998445|NCT01147809|592359130|FG005|Phase II (168 Days)|Physician Decision|11|||
163998446|NCT01147809|592359125|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
163998447|NCT01147809|592359126|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
163998448|NCT01147809|592359127|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
163998449|NCT01147809|592359128|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
163998450|NCT01147809|592359129|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
163998451|NCT01147809|592359130|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
163998452|NCT01147809|592359125|FG000|Phase II (168 Days)|Ongoing|0|||
163998453|NCT01147809|592359126|FG001|Phase II (168 Days)|Ongoing|0|||
163998454|NCT01147809|592359127|FG002|Phase II (168 Days)|Ongoing|0|||
163998455|NCT01147809|592359128|FG003|Phase II (168 Days)|Ongoing|0|||
163998456|NCT01147809|592359129|FG004|Phase II (168 Days)|Ongoing|1|||
163998457|NCT01147809|592359130|FG005|Phase II (168 Days)|Ongoing|0|||
164269558|NCT00576472|593356734|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
164269559|NCT00576472|593356735|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
164269560|NCT00576472|593356736|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
164269561|NCT00576472|593356737|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
164269562|NCT00576472|593356738|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
164269563|NCT00576472|593356739|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
164269564|NCT00576472|593356740|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
164269565|NCT00576472|593356741|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
164269566|NCT00576472|593356742|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
164269567|NCT00576472|593356743|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
164269568|NCT00576472|593356744|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
164269569|NCT00576472|593356745|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
164269570|NCT00576472|593356746|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
164269571|NCT00576472|593356732|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
163892365|NCT01254864|591976807|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
163892366|NCT01254864|591976808|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
163892367|NCT01254864|591976806|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
163892368|NCT01254864|591976807|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
163892369|NCT01254864|591976808|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
163892370|NCT01254864|591976806|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
163892371|NCT01254864|591976807|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
163892372|NCT01254864|591976808|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
163892373|NCT01254864|591976806|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
163892374|NCT01254864|591976807|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
163892375|NCT01254864|591976808|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
163892376|NCT01254864|591976806|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
163892377|NCT01254864|591976807|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
163892378|NCT01254864|591976808|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
163892379|NCT01254864|591976806|FG000|Randomization Phase|Adverse Event|0|||
163892380|NCT01254864|591976807|FG001|Randomization Phase|Adverse Event|5|||
163892381|NCT01254864|591976808|FG002|Randomization Phase|Adverse Event|17|||
163892382|NCT01254864|591976806|FG000|Randomization Phase|Death|0|||
163892383|NCT01254864|591976807|FG001|Randomization Phase|Death|1|||
163892384|NCT01254864|591976808|FG002|Randomization Phase|Death|0|||
163892385|NCT01254864|591976806|FG000|Randomization Phase|Lost to Follow-up|0|||
163892386|NCT01254864|591976807|FG001|Randomization Phase|Lost to Follow-up|0|||
163892387|NCT01254864|591976808|FG002|Randomization Phase|Lost to Follow-up|1|||
163892388|NCT01254864|591976806|FG000|Randomization Phase|Physician Decision|0|||
163892389|NCT01254864|591976807|FG001|Randomization Phase|Physician Decision|20|||
163892390|NCT01254864|591976808|FG002|Randomization Phase|Physician Decision|25|||
163998458|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
163998459|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
164269572|NCT00576472|593356733|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269573|NCT00576472|593356734|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269574|NCT00576472|593356735|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
163892391|NCT01254864|591976806|FG000|Randomization Phase|Withdrawal by Subject|0|||
163892392|NCT01254864|591976807|FG001|Randomization Phase|Withdrawal by Subject|4|||
163892393|NCT01254864|591976808|FG002|Randomization Phase|Withdrawal by Subject|2|||
163892394|NCT01254864|591976806|FG000|Randomization Phase|Non-Compliance|0|||
164269575|NCT00576472|593356736|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269576|NCT00576472|593356737|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269577|NCT00576472|593356738|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269578|NCT00576472|593356739|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269579|NCT00576472|593356740|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269580|NCT00576472|593356741|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269581|NCT00576472|593356742|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269582|NCT00576472|593356743|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269583|NCT00576472|593356744|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269584|NCT00576472|593356745|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269585|NCT00576472|593356746|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
164269586|NCT00576472|593356732|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269587|NCT00576472|593356733|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269588|NCT00576472|593356734|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269589|NCT00576472|593356735|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
163892395|NCT01254864|591976807|FG001|Randomization Phase|Non-Compliance|1|||
163892396|NCT01254864|591976808|FG002|Randomization Phase|Non-Compliance|0|||
163892397|NCT01254864|591976806|FG000|Randomization Phase|Comorbidities|0|||
163892398|NCT01254864|591976807|FG001|Randomization Phase|Comorbidities|2|||
163892399|NCT01254864|591976808|FG002|Randomization Phase|Comorbidities|1|||
163892400|NCT03626220|591976809|FG000|Overall Study|Withdrawal by Subject|2|||
163892401|NCT03626220|591976810|FG001|Overall Study|Withdrawal by Subject|0|||
163892402|NCT01651403|591976816|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
163892403|NCT01651403|591976817|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
163892404|NCT01651403|591976816|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
163892405|NCT01651403|591976817|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
163892406|NCT01651403|591976816|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
163892407|NCT01651403|591976817|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
163892408|NCT01651403|591976816|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
163892409|NCT01651403|591976817|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
163892410|NCT01651403|591976816|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
163892411|NCT01651403|591976817|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
163892412|NCT01651403|591976816|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
163892413|NCT01651403|591976817|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
163892414|NCT05090683|591976818|FG000|Overall Study|Lost to Follow-up|10|||
163892415|NCT05090683|591976819|FG001|Overall Study|Lost to Follow-up|2|||
163892416|NCT05090683|591976818|FG000|Overall Study|Withdrawal by Subject|15|||
163892417|NCT05090683|591976819|FG001|Overall Study|Withdrawal by Subject|0|||
163892418|NCT03213665|591976820|FG000|Overall Study|Adverse Event|1|||
163892419|NCT03213665|591976820|FG000|Overall Study|Physician Decision|2|||
163892420|NCT03213665|591976820|FG000|Overall Study|Withdrawal by Subject|3|||
163892421|NCT03213665|591976820|FG000|Overall Study|Progressive Disease|13|||
163892422|NCT03325985|591976821|FG000|Overall Study|Lost to Follow-up|122|||
163892423|NCT03325985|591976822|FG001|Overall Study|Lost to Follow-up|26|||
163892424|NCT03325985|591976823|FG002|Overall Study|Lost to Follow-up|141|||
163892425|NCT03325985|591976824|FG003|Overall Study|Lost to Follow-up|28|||
163892426|NCT03325985|591976821|FG000|Overall Study|Death|99|||
163892427|NCT03325985|591976822|FG001|Overall Study|Death|36|||
163892428|NCT03325985|591976823|FG002|Overall Study|Death|94|||
163892429|NCT03325985|591976824|FG003|Overall Study|Death|32|||
163892430|NCT03034356|591976825|FG000|Baseline|Lost to Follow-up|2|||
163892431|NCT03034356|591976826|FG001|Baseline|Lost to Follow-up|4|||
163892432|NCT03034356|591976825|FG000|Baseline|Withdrawal by Subject|2|||
163892433|NCT03034356|591976826|FG001|Baseline|Withdrawal by Subject|0|||
163892434|NCT03034356|591976825|FG000|Baseline|Physician Decision|0|||
163892435|NCT03034356|591976826|FG001|Baseline|Physician Decision|1|||
163892436|NCT03034356|591976825|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
163892437|NCT03034356|591976826|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
163892438|NCT03034356|591976825|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
163892439|NCT03034356|591976826|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
163892440|NCT03034356|591976825|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
163892441|NCT03034356|591976826|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
163892442|NCT03034356|591976825|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
164085891|NCT00696709|592678583|FG003|Overall Study|Lost to Follow-up|0|||
164269590|NCT00576472|593356736|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
163892443|NCT03034356|591976826|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
163892444|NCT02684227|591976827|FG000|Overall Study|Adverse Event|1|||
163892445|NCT02684227|591976828|FG001|Overall Study|Adverse Event|7|||
163892446|NCT02684227|591976827|FG000|Overall Study|Death|0|||
163892447|NCT02684227|591976828|FG001|Overall Study|Death|2|||
163892448|NCT02684227|591976827|FG000|Overall Study|Withdrawal by Subject|0|||
163892449|NCT02684227|591976828|FG001|Overall Study|Withdrawal by Subject|1|||
163892450|NCT02684227|591976827|FG000|Overall Study|Progressive Disease|0|||
164085892|NCT00696709|592678584|FG004|Overall Study|Lost to Follow-up|0|||
163998460|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
163998461|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163998462|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163998463|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163998464|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163998465|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163998466|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164269591|NCT00576472|593356737|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269592|NCT00576472|593356738|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
164269593|NCT00576472|593356739|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269594|NCT00576472|593356740|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269595|NCT00576472|593356741|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269596|NCT00576472|593356742|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269597|NCT00576472|593356743|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269598|NCT00576472|593356744|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269599|NCT00576472|593356745|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269600|NCT00576472|593356746|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
164269601|NCT00576472|593356732|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
164269602|NCT00576472|593356733|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
164269603|NCT00576472|593356734|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
164269604|NCT00576472|593356735|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
164269605|NCT00576472|593356736|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
164269606|NCT00576472|593356737|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
164269607|NCT00576472|593356738|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
164269608|NCT00576472|593356739|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
164269609|NCT00576472|593356740|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
164269610|NCT00576472|593356741|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
164269611|NCT00576472|593356742|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
164269612|NCT00576472|593356743|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
164269613|NCT00576472|593356744|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
164269614|NCT00576472|593356745|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
164269615|NCT00576472|593356746|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
164269616|NCT00576472|593356732|FG000|MPH Cross Over Phase|Physician Decision|0|||
164269617|NCT00576472|593356733|FG001|MPH Cross Over Phase|Physician Decision|0|||
164269618|NCT00576472|593356734|FG002|MPH Cross Over Phase|Physician Decision|0|||
164269619|NCT00576472|593356735|FG003|MPH Cross Over Phase|Physician Decision|0|||
164269620|NCT00576472|593356736|FG004|MPH Cross Over Phase|Physician Decision|0|||
164269621|NCT00576472|593356737|FG005|MPH Cross Over Phase|Physician Decision|0|||
164269622|NCT00576472|593356738|FG006|MPH Cross Over Phase|Physician Decision|4|||
164269623|NCT00576472|593356739|FG007|MPH Cross Over Phase|Physician Decision|0|||
164269624|NCT00576472|593356740|FG008|MPH Cross Over Phase|Physician Decision|0|||
164269625|NCT00576472|593356741|FG009|MPH Cross Over Phase|Physician Decision|0|||
164269626|NCT00576472|593356742|FG010|MPH Cross Over Phase|Physician Decision|0|||
164269627|NCT00576472|593356743|FG011|MPH Cross Over Phase|Physician Decision|0|||
164269628|NCT00576472|593356744|FG012|MPH Cross Over Phase|Physician Decision|0|||
164269629|NCT00576472|593356745|FG013|MPH Cross Over Phase|Physician Decision|0|||
164269630|NCT00576472|593356746|FG014|MPH Cross Over Phase|Physician Decision|0|||
164269631|NCT00576472|593356732|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269632|NCT00576472|593356733|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269633|NCT00576472|593356734|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269634|NCT00576472|593356735|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269635|NCT00576472|593356736|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269636|NCT00576472|593356737|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269637|NCT00576472|593356738|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269638|NCT00576472|593356739|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269639|NCT00576472|593356740|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
164269640|NCT00576472|593356741|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269641|NCT00576472|593356742|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
164269642|NCT00576472|593356743|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
164269643|NCT00576472|593356744|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269644|NCT00576472|593356745|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269645|NCT00576472|593356746|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
164269646|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269647|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269648|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269649|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269650|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269651|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269652|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163998467|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
163998468|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
163998469|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
163998470|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163998471|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163998472|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163998473|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164269653|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269654|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269655|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269656|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
163998474|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163998475|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163998476|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
163998477|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
163998478|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
163998479|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163998480|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163998481|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163998482|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163998483|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163998484|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163998485|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998486|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998487|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
163998488|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998489|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998490|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998491|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998492|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998493|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
163998494|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
163998495|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163998496|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
163998497|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163998498|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163998499|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163998500|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163998501|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163998502|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163998503|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163998504|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998505|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998506|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998507|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998508|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998509|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998510|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998511|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163998512|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
163998513|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
163998514|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163998515|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163998516|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163998517|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163998518|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
163998519|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164269657|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269658|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269659|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
164269660|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
164269661|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
164269662|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
164269663|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
164342012|NCT05248867|593627595|FG003|Open-label Period|Withdrawal by Subject|1|||
163998520|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
164269664|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
164269665|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
164269666|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
164269667|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
164269668|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
163998521|NCT01307423|592359131|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998522|NCT01307423|592359132|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
163998523|NCT01307423|592359133|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
163998524|NCT01307423|592359134|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998525|NCT01307423|592359135|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998526|NCT01307423|592359136|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998527|NCT01307423|592359137|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998528|NCT01307423|592359138|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998529|NCT01307423|592359139|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
163998530|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163998531|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
163998532|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
163998533|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
163998534|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
163998535|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163998536|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163998537|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163998538|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
163998539|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163998540|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
163998541|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
163998542|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
163998543|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
163998544|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163998545|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163998546|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163998547|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
163998548|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998549|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998550|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998551|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998552|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998553|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
163998554|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998555|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998556|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
163998557|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163998558|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
163998559|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
163998560|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163998561|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163998562|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
163998563|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
163998564|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163998565|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
163998566|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998567|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998568|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998569|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
163998570|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998571|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998572|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998573|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998574|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
163998575|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
163998576|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
163998577|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
163998578|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
163998579|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
163998580|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
163998581|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
163998582|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
163998583|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
163998584|NCT01307423|592359131|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998585|NCT01307423|592359132|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998586|NCT01307423|592359133|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998587|NCT01307423|592359134|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998588|NCT01307423|592359135|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998589|NCT01307423|592359136|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
163998590|NCT01307423|592359137|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998591|NCT01307423|592359138|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998592|NCT01307423|592359139|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
163998593|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163998594|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
163998595|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
163998596|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163998597|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163998598|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163998599|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163998600|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
163998601|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
163998602|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163998603|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
163998604|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
163998605|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163998606|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163998607|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163998608|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163998609|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
163998610|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
163998611|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998612|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998613|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
163998614|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998615|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998616|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998617|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998618|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998619|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
163998620|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163998621|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
163998622|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
163998623|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163998624|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163998625|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163998626|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163998627|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
163998628|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
163998629|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163998630|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163998631|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163998632|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163998633|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163998634|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163998635|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163998636|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163998637|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163998638|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163998639|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
163998640|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163998641|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163998642|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163998643|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163998644|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163998645|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
163998646|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
163998647|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163998648|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163998649|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
163998650|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163998651|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163998652|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163998653|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163998654|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
163998655|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163998656|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998657|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
163998658|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
163998659|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998660|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998661|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998662|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998663|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998664|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
163998665|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163998666|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
163998667|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
163998668|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163998669|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163998670|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163998671|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163998672|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
163998673|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
163998674|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163998675|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
163998676|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
163998677|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163998678|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163998679|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163998680|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163998681|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
163998682|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
163998683|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998684|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163998685|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998686|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998687|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998688|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998689|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998690|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163998691|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163998692|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998693|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
163998694|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998695|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998696|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998697|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998698|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998699|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998700|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163998701|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998702|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
163998703|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998704|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998705|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998706|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998707|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998708|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163998709|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
163998710|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163998711|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
163998712|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
163998713|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163998714|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163998715|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163998716|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163998717|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
163998718|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
163998719|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998720|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998721|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
163998722|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998723|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998724|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998725|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998726|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998727|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163998728|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998729|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998730|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998731|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998732|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998733|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998734|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998735|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
163998736|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163998737|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163998738|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163998739|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163998740|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163998741|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163998742|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163998743|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163998744|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163998745|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163998746|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998747|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
163998748|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
163998749|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998750|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998751|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998752|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998753|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998754|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163998755|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163998756|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
163998757|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
163998758|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163998759|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163998760|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163998761|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163998762|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163998763|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163998764|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998765|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
163998766|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998767|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998768|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998769|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998770|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998771|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998772|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
163998773|NCT01307423|592359131|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163998774|NCT01307423|592359132|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163998775|NCT01307423|592359133|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
163998776|NCT01307423|592359134|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163998777|NCT01307423|592359135|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163998778|NCT01307423|592359136|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163998779|NCT01307423|592359137|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163998780|NCT01307423|592359138|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
163998781|NCT01307423|592359139|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
163998782|NCT03406962|592359142|FG000|Overall Study|Death|2|||
163998783|NCT03406962|592359142|FG000|Overall Study|Adverse Event|1|||
163998784|NCT03853694|592359143|FG000|Overall Study|Protocol Violation|3|||
163998785|NCT03853694|592359144|FG001|Overall Study|Protocol Violation|5|||
163998786|NCT03853694|592359145|FG002|Overall Study|Protocol Violation|3|||
163998787|NCT03853694|592359143|FG000|Overall Study|Delivered early|0|||
163998788|NCT03853694|592359144|FG001|Overall Study|Delivered early|1|||
163998789|NCT03853694|592359145|FG002|Overall Study|Delivered early|0|||
163998790|NCT03853694|592359143|FG000|Overall Study|not suitable to proceed|0|||
163998791|NCT03853694|592359144|FG001|Overall Study|not suitable to proceed|1|||
163998792|NCT03853694|592359145|FG002|Overall Study|not suitable to proceed|0|||
163998793|NCT03853694|592359143|FG000|Overall Study|difficult surgery|0|||
163998794|NCT03853694|592359144|FG001|Overall Study|difficult surgery|0|||
163998795|NCT03853694|592359145|FG002|Overall Study|difficult surgery|1|||
163998796|NCT03853694|592359143|FG000|Overall Study|Lost to Follow-up|0|||
163998797|NCT03853694|592359144|FG001|Overall Study|Lost to Follow-up|1|||
163998798|NCT03853694|592359145|FG002|Overall Study|Lost to Follow-up|0|||
163998799|NCT03853694|592359143|FG000|Overall Study|Withdrawal by Subject|0|||
163998800|NCT03853694|592359144|FG001|Overall Study|Withdrawal by Subject|1|||
163998801|NCT03853694|592359145|FG002|Overall Study|Withdrawal by Subject|0|||
163998802|NCT02209766|592359146|FG000|Overall Study|Withdrawal by Subject|0|||
163998803|NCT02209766|592359147|FG001|Overall Study|Withdrawal by Subject|0|||
163998804|NCT02209766|592359148|FG002|Overall Study|Withdrawal by Subject|0|||
163998805|NCT02209766|592359149|FG003|Overall Study|Withdrawal by Subject|1|||
163998806|NCT02209766|592359150|FG004|Overall Study|Withdrawal by Subject|0|||
164269669|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
164269670|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
164342013|NCT05248867|593627596|FG004|Open-label Period|Withdrawal by Subject|7|||
164342014|NCT05248867|593627597|FG005|Open-label Period|Withdrawal by Subject|9|||
164342015|NCT05248867|593627592|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342016|NCT05248867|593627593|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342017|NCT05248867|593627594|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342018|NCT05248867|593627595|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
164342019|NCT05248867|593627596|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342020|NCT05248867|593627597|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
164342021|NCT05248867|593627592|FG000|Open-label Period|Lost to Follow-up|0|||
164342022|NCT05248867|593627593|FG001|Open-label Period|Lost to Follow-up|0|||
164342023|NCT05248867|593627594|FG002|Open-label Period|Lost to Follow-up|0|||
163892451|NCT02684227|591976828|FG001|Overall Study|Progressive Disease|2|||
163892452|NCT04571619|591976831|FG000|Phase 1|Death|22|||
163892453|NCT04571619|591976832|FG001|Phase 1|Death|18|||
163892454|NCT04571619|591976831|FG000|Phase 1|Withdrawal by Subject|7|||
163892455|NCT04571619|591976832|FG001|Phase 1|Withdrawal by Subject|2|||
163892456|NCT04571619|591976831|FG000|Phase 2|Death|13|||
163892457|NCT04571619|591976832|FG001|Phase 2|Death|16|||
163892458|NCT04571619|591976831|FG000|Phase 2|Withdrawal by Subject|6|||
163892459|NCT04571619|591976832|FG001|Phase 2|Withdrawal by Subject|4|||
163892460|NCT04167553|591976835|FG000|Overall Study|Withdrawal by Subject|1|||
163892461|NCT04167553|591976836|FG001|Overall Study|Withdrawal by Subject|0|||
163892462|NCT04167553|591976837|FG002|Overall Study|Withdrawal by Subject|1|||
163892463|NCT04167553|591976838|FG003|Overall Study|Withdrawal by Subject|2|||
163892464|NCT04167553|591976839|FG004|Overall Study|Withdrawal by Subject|1|||
163892465|NCT04167553|591976840|FG005|Overall Study|Withdrawal by Subject|0|||
163892466|NCT04167553|591976841|FG006|Overall Study|Withdrawal by Subject|0|||
163892467|NCT04167553|591976835|FG000|Overall Study|Physician Decision|0|||
163998807|NCT00805207|592359151|FG000|Overall Study|Protocol Violation|0|||
163998808|NCT00805207|592359152|FG001|Overall Study|Protocol Violation|0|||
163998809|NCT00805207|592359153|FG002|Overall Study|Protocol Violation|1|||
163998810|NCT00805207|592359154|FG003|Overall Study|Protocol Violation|0|||
163998811|NCT00805207|592359155|FG004|Overall Study|Protocol Violation|0|||
164269671|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
164269672|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
164269673|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
164269674|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
164269675|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
164269676|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
164269677|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
164269678|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
164269679|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
164269680|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
164269681|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
163998812|NCT00805207|592359156|FG005|Overall Study|Protocol Violation|0|||
163998813|NCT00805207|592359157|FG006|Overall Study|Protocol Violation|0|||
163892468|NCT04167553|591976836|FG001|Overall Study|Physician Decision|0|||
163892469|NCT04167553|591976837|FG002|Overall Study|Physician Decision|0|||
163892470|NCT04167553|591976838|FG003|Overall Study|Physician Decision|0|||
163892471|NCT04167553|591976839|FG004|Overall Study|Physician Decision|2|||
163892472|NCT04167553|591976840|FG005|Overall Study|Physician Decision|2|||
163998814|NCT00805207|592359158|FG007|Overall Study|Protocol Violation|0|||
163998815|NCT00805207|592359159|FG008|Overall Study|Protocol Violation|0|||
163998816|NCT00805207|592359151|FG000|Overall Study|Physician Decision|0|||
163998817|NCT00805207|592359152|FG001|Overall Study|Physician Decision|1|||
163998818|NCT00805207|592359153|FG002|Overall Study|Physician Decision|0|||
163998819|NCT00805207|592359154|FG003|Overall Study|Physician Decision|0|||
163998820|NCT00805207|592359155|FG004|Overall Study|Physician Decision|0|||
163998821|NCT00805207|592359156|FG005|Overall Study|Physician Decision|1|||
163998822|NCT00805207|592359157|FG006|Overall Study|Physician Decision|0|||
163998823|NCT00805207|592359158|FG007|Overall Study|Physician Decision|0|||
164269682|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
164269683|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
164269684|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
164269685|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
164269686|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
164269687|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
164269688|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
164269689|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
164269690|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
164269691|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Side effects|0|||
164269692|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Side effects|0|||
164269693|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Side effects|0|||
164269694|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Side effects|0|||
164269695|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Side effects|0|||
164269696|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Side effects|0|||
164269697|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Side effects|0|||
164269698|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Side effects|0|||
164269699|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Side effects|0|||
164269700|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Side effects|0|||
164269701|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Side effects|0|||
164269702|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Side effects|0|||
164269703|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Side effects|0|||
164269704|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Side effects|0|||
164269705|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Side effects|8|||
164269706|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269707|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269708|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269709|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269710|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269711|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269712|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269713|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269714|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269715|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269716|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269717|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269718|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269719|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
164269720|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
164269721|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
164269722|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
164269723|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
164269724|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
164269725|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
163998824|NCT00805207|592359159|FG008|Overall Study|Physician Decision|0|||
163998825|NCT00805207|592359151|FG000|Overall Study|Withdrawal by Subject|0|||
163998826|NCT00805207|592359152|FG001|Overall Study|Withdrawal by Subject|1|||
163998827|NCT00805207|592359153|FG002|Overall Study|Withdrawal by Subject|0|||
163998828|NCT00805207|592359154|FG003|Overall Study|Withdrawal by Subject|0|||
163998829|NCT00805207|592359155|FG004|Overall Study|Withdrawal by Subject|1|||
163998830|NCT00805207|592359156|FG005|Overall Study|Withdrawal by Subject|2|||
163998831|NCT00805207|592359157|FG006|Overall Study|Withdrawal by Subject|0|||
163998832|NCT00805207|592359158|FG007|Overall Study|Withdrawal by Subject|0|||
163998833|NCT00805207|592359159|FG008|Overall Study|Withdrawal by Subject|0|||
163998834|NCT00064701|592359160|FG000|One Year Post-transplant|Did not receive study drug|7|||
163998835|NCT00064701|592359161|FG001|One Year Post-transplant|Did not receive study drug|12|||
163998836|NCT00064701|592359162|FG002|One Year Post-transplant|Did not receive study drug|11|||
163998837|NCT00064701|592359160|FG000|One Year Post-transplant|Adverse Event|23|||
163998838|NCT00064701|592359161|FG001|One Year Post-transplant|Adverse Event|19|||
163998839|NCT00064701|592359162|FG002|One Year Post-transplant|Adverse Event|37|||
163998840|NCT00064701|592359160|FG000|One Year Post-transplant|Rejection|0|||
163998841|NCT00064701|592359161|FG001|One Year Post-transplant|Rejection|1|||
163998842|NCT00064701|592359162|FG002|One Year Post-transplant|Rejection|16|||
163998843|NCT00064701|592359160|FG000|One Year Post-transplant|Non-compliance|4|||
163998844|NCT00064701|592359161|FG001|One Year Post-transplant|Non-compliance|2|||
163998845|NCT00064701|592359162|FG002|One Year Post-transplant|Non-compliance|5|||
163998846|NCT00064701|592359160|FG000|One Year Post-transplant|Graft Failure|3|||
163998847|NCT00064701|592359161|FG001|One Year Post-transplant|Graft Failure|2|||
163998848|NCT00064701|592359162|FG002|One Year Post-transplant|Graft Failure|1|||
163892473|NCT04167553|591976841|FG006|Overall Study|Physician Decision|0|||
163892474|NCT04167553|591976835|FG000|Overall Study|Lost to Follow-up|0|||
163892475|NCT04167553|591976836|FG001|Overall Study|Lost to Follow-up|0|||
163892476|NCT04167553|591976837|FG002|Overall Study|Lost to Follow-up|2|||
163892477|NCT04167553|591976838|FG003|Overall Study|Lost to Follow-up|0|||
163892478|NCT04167553|591976839|FG004|Overall Study|Lost to Follow-up|0|||
163892479|NCT04167553|591976840|FG005|Overall Study|Lost to Follow-up|0|||
163892480|NCT04167553|591976841|FG006|Overall Study|Lost to Follow-up|0|||
163892481|NCT04479761|591976844|FG000|Overall Study|could not perform the balance tasks|1|||
163892482|NCT04479761|591976845|FG001|Overall Study|could not perform the balance tasks|0|||
163892483|NCT04479761|591976846|FG002|Overall Study|could not perform the balance tasks|0|||
163892484|NCT04479761|591976844|FG000|Overall Study|Adverse Event|1|||
163892485|NCT04479761|591976845|FG001|Overall Study|Adverse Event|0|||
163892486|NCT04479761|591976846|FG002|Overall Study|Adverse Event|0|||
163892487|NCT04479761|591976844|FG000|Overall Study|one control did not meet screening criteria|0|||
163892488|NCT04479761|591976845|FG001|Overall Study|one control did not meet screening criteria|0|||
163892489|NCT04479761|591976846|FG002|Overall Study|one control did not meet screening criteria|1|||
163892490|NCT04479761|591976844|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
163892491|NCT04479761|591976845|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
163892492|NCT04479761|591976846|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
163892493|NCT05209152|591976847|FG000|Overall Study|Sponsor decision|1|||
163892494|NCT05209152|591976848|FG001|Overall Study|Sponsor decision|2|||
163892495|NCT05209152|591976847|FG000|Overall Study|Death|3|||
163892496|NCT05209152|591976848|FG001|Overall Study|Death|1|||
163892497|NCT04550221|591978902|FG000|Overall Study|Lost to Follow-up|0|||
163892498|NCT04550221|591978903|FG001|Overall Study|Lost to Follow-up|4|||
163892499|NCT04550221|591978902|FG000|Overall Study|Withdrawn|3|||
163892500|NCT04550221|591978903|FG001|Overall Study|Withdrawn|0|||
163892501|NCT04550221|591978902|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
163892502|NCT04550221|591978903|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
163892503|NCT05274074|591978904|FG000|Overall Study|Lost to Follow-up|2|||
163892504|NCT05274074|591978905|FG001|Overall Study|Lost to Follow-up|3|||
163892505|NCT05274074|591978904|FG000|Overall Study|Withdrawal by Subject|1|||
163892506|NCT05274074|591978905|FG001|Overall Study|Withdrawal by Subject|2|||
163892507|NCT04117347|591978906|FG000|Overall Study|Adverse Event|0|||
163892508|NCT04117347|591978907|FG001|Overall Study|Adverse Event|0|||
163892509|NCT04117347|591978908|FG002|Overall Study|Adverse Event|1|||
163892510|NCT04117347|591978906|FG000|Overall Study|No time for study|0|||
163892511|NCT04117347|591978907|FG001|Overall Study|No time for study|2|||
163998849|NCT00064701|592359160|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
163998850|NCT00064701|592359161|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
163892512|NCT04117347|591978908|FG002|Overall Study|No time for study|0|||
163892513|NCT04117347|591978906|FG000|Overall Study|Family emergency|1|||
163892514|NCT04117347|591978907|FG001|Overall Study|Family emergency|0|||
163892515|NCT04117347|591978908|FG002|Overall Study|Family emergency|0|||
163892516|NCT05194956|591978909|FG000|Washout Period|Withdrawal by Subject|0|||
163892517|NCT05194956|591978910|FG001|Washout Period|Withdrawal by Subject|2|||
163892518|NCT05452460|591978911|FG000|Overall Study|Lost to Follow-up|3|||
163892519|NCT05452460|591978912|FG001|Overall Study|Lost to Follow-up|3|||
164269726|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
164269727|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
164269728|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
164269729|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
164269730|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
164269731|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
164269732|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
164269733|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
164269734|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
164269735|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
164269736|NCT00576472|593356732|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269737|NCT00576472|593356733|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163892520|NCT05452460|591978911|FG000|Overall Study|Did not receive intervention|1|||
163892521|NCT05452460|591978912|FG001|Overall Study|Did not receive intervention|0|||
163892522|NCT02694822|591978914|FG000|Phase 1|Death|2|||
163892523|NCT02694822|591978915|FG001|Phase 1|Death|1|||
163892524|NCT02694822|591978916|FG002|Phase 1|Death|6|||
163892525|NCT02694822|591978917|FG003|Phase 1|Death|6|||
163892526|NCT02694822|591978918|FG004|Phase 1|Death|3|||
163892527|NCT02694822|591978919|FG005|Phase 1|Death|0|||
163892528|NCT02694822|591978914|FG000|Phase 1|Withdrawal by Subject|2|||
163892529|NCT02694822|591978915|FG001|Phase 1|Withdrawal by Subject|2|||
163892530|NCT02694822|591978916|FG002|Phase 1|Withdrawal by Subject|4|||
163892531|NCT02694822|591978917|FG003|Phase 1|Withdrawal by Subject|8|||
163892532|NCT02694822|591978918|FG004|Phase 1|Withdrawal by Subject|1|||
163892533|NCT02694822|591978919|FG005|Phase 1|Withdrawal by Subject|0|||
163892534|NCT02694822|591978914|FG000|Phase 2|Death|0|||
163892535|NCT02694822|591978915|FG001|Phase 2|Death|0|||
163892536|NCT02694822|591978916|FG002|Phase 2|Death|0|||
163892537|NCT02694822|591978917|FG003|Phase 2|Death|0|||
163892538|NCT02694822|591978918|FG004|Phase 2|Death|0|||
163892539|NCT02694822|591978919|FG005|Phase 2|Death|26|||
163892540|NCT02694822|591978914|FG000|Phase 2|Withdrawal by Subject|0|||
163892541|NCT02694822|591978915|FG001|Phase 2|Withdrawal by Subject|0|||
163892542|NCT02694822|591978916|FG002|Phase 2|Withdrawal by Subject|0|||
163892543|NCT02694822|591978917|FG003|Phase 2|Withdrawal by Subject|0|||
163892544|NCT02694822|591978918|FG004|Phase 2|Withdrawal by Subject|0|||
163892545|NCT02694822|591978919|FG005|Phase 2|Withdrawal by Subject|13|||
163892546|NCT02694822|591978914|FG000|Phase 2|Administrative Study Closure|0|||
163892547|NCT02694822|591978915|FG001|Phase 2|Administrative Study Closure|0|||
163892548|NCT02694822|591978916|FG002|Phase 2|Administrative Study Closure|0|||
163892549|NCT02694822|591978917|FG003|Phase 2|Administrative Study Closure|0|||
163892550|NCT02694822|591978918|FG004|Phase 2|Administrative Study Closure|0|||
163892551|NCT02694822|591978919|FG005|Phase 2|Administrative Study Closure|2|||
163892552|NCT02694822|591978914|FG000|Phase 2|Lost to Follow-up|0|||
163892553|NCT02694822|591978915|FG001|Phase 2|Lost to Follow-up|0|||
163892554|NCT02694822|591978916|FG002|Phase 2|Lost to Follow-up|0|||
163892555|NCT02694822|591978917|FG003|Phase 2|Lost to Follow-up|0|||
163892556|NCT02694822|591978918|FG004|Phase 2|Lost to Follow-up|0|||
163892557|NCT02694822|591978919|FG005|Phase 2|Lost to Follow-up|1|||
163892558|NCT02694822|591978914|FG000|Phase 2|Participant Transferred to Another Site|0|||
163892559|NCT02694822|591978915|FG001|Phase 2|Participant Transferred to Another Site|0|||
163892560|NCT02694822|591978916|FG002|Phase 2|Participant Transferred to Another Site|0|||
163892561|NCT02694822|591978917|FG003|Phase 2|Participant Transferred to Another Site|0|||
163892562|NCT02694822|591978918|FG004|Phase 2|Participant Transferred to Another Site|0|||
163892563|NCT02694822|591978919|FG005|Phase 2|Participant Transferred to Another Site|1|||
163892564|NCT05370040|591978920|FG000|Overall Study|Lost to Follow-up|0|||
163892565|NCT05370040|591978921|FG001|Overall Study|Lost to Follow-up|0|||
163892566|NCT05370040|591978922|FG002|Overall Study|Lost to Follow-up|1|||
163892567|NCT05370040|591978923|FG003|Overall Study|Lost to Follow-up|0|||
163892568|NCT05370040|591978924|FG004|Overall Study|Lost to Follow-up|1|||
164269738|NCT00576472|593356734|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269739|NCT00576472|593356735|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269740|NCT00576472|593356736|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269741|NCT00576472|593356737|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269742|NCT00576472|593356738|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
163892569|NCT05370040|591978925|FG005|Overall Study|Lost to Follow-up|0|||
163892571|NCT05906784|591978928|FG000|Overall Study|Lost to Follow-up|2|||
163892572|NCT05906784|591978929|FG001|Overall Study|Lost to Follow-up|1|||
163892573|NCT05906784|591978930|FG002|Overall Study|Lost to Follow-up|1|||
163892574|NCT05906784|591978931|FG003|Overall Study|Lost to Follow-up|1|||
163892575|NCT03249090|591978941|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
163892576|NCT03249090|591978942|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
163892577|NCT03249090|591978941|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
163892578|NCT03249090|591978942|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
163892579|NCT03249090|591978941|FG000|3 Month Time Point|Voluntary withdrawal|6|||
163892580|NCT03249090|591978942|FG001|3 Month Time Point|Voluntary withdrawal|3|||
163892581|NCT03249090|591978941|FG000|3 Month Time Point|Changed oncology practice|4|||
164085893|NCT00696709|592678580|FG000|Overall Study|Adverse Event|0|||
164085894|NCT00696709|592678581|FG001|Overall Study|Adverse Event|0|||
164085895|NCT00696709|592678582|FG002|Overall Study|Adverse Event|0|||
164269743|NCT00576472|593356739|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269744|NCT00576472|593356740|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269745|NCT00576472|593356741|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269746|NCT00576472|593356742|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269747|NCT00576472|593356743|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269748|NCT00576472|593356744|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269749|NCT00576472|593356745|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
164269750|NCT00576472|593356746|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
164269751|NCT03443427|593356747|FG000|Overall Study|Adverse Event|2|||
164269752|NCT03443427|593356748|FG001|Overall Study|Adverse Event|3|||
164269753|NCT03443427|593356747|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
164269754|NCT03443427|593356748|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164269755|NCT03443427|593356747|FG000|Overall Study|Other|4|||
164269756|NCT03443427|593356748|FG001|Overall Study|Other|6|||
164269757|NCT04405245|593356750|FG000|Overall Study|Adverse Event|0|||
164269758|NCT04405245|593356751|FG001|Overall Study|Adverse Event|1|||
164269759|NCT04405245|593356752|FG002|Overall Study|Adverse Event|0|||
164269760|NCT02576860|593356755|FG000|Overall Study|Adverse Event|6|||
164269761|NCT02576860|593356756|FG001|Overall Study|Adverse Event|6|||
164269762|NCT02576860|593356755|FG000|Overall Study|Lost to Follow-up|5|||
164269763|NCT02576860|593356756|FG001|Overall Study|Lost to Follow-up|7|||
164269764|NCT02576860|593356755|FG000|Overall Study|Physician Decision|0|||
164269765|NCT02576860|593356756|FG001|Overall Study|Physician Decision|1|||
164269766|NCT02576860|593356755|FG000|Overall Study|Protocol Violation|0|||
164269767|NCT02576860|593356756|FG001|Overall Study|Protocol Violation|2|||
163892582|NCT03249090|591978942|FG001|3 Month Time Point|Changed oncology practice|2|||
163892583|NCT03249090|591978941|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
163892584|NCT03249090|591978942|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
163892585|NCT03249090|591978941|FG000|12 Month Time Point|Voluntary withdrawal|35|||
163892586|NCT03249090|591978942|FG001|12 Month Time Point|Voluntary withdrawal|4|||
163892587|NCT03249090|591978941|FG000|12 Month Time Point|Changed oncology practice|20|||
163892588|NCT03249090|591978942|FG001|12 Month Time Point|Changed oncology practice|9|||
163892589|NCT03476343|591978946|FG000|Overall Study|Clinical exam moved to another scanner|7|||
163892590|NCT03476343|591978946|FG000|Overall Study|Clinical order cancelled|4|||
163892591|NCT03476343|591978946|FG000|Overall Study|Neonate did not settle down for the scan|1|||
163892592|NCT05147116|591978947|FG000|Overall Study|Withdrawal by Subject|0|||
163892593|NCT05147116|591978948|FG001|Overall Study|Withdrawal by Subject|1|||
163892594|NCT03672916|591978949|FG000|Overall Study|Death|6|||
163892595|NCT03672916|591978949|FG000|Overall Study|Lost to Follow-up|29|||
163892596|NCT03672916|591978949|FG000|Overall Study|Adverse Event|6|||
163892597|NCT03672916|591978949|FG000|Overall Study|Withdrawal by Subject|11|||
163892598|NCT04197336|591978950|FG000|Overall Study|Withdrawal by Subject|1|||
163892599|NCT04625725|591978954|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
163892600|NCT04625725|591978955|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163892601|NCT04625725|591978956|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163892602|NCT04625725|591978957|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163892603|NCT04625725|591978958|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163892604|NCT04625725|591978959|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
163892605|NCT04625725|591978954|FG000|Provent Main Study|Withdrawal by Subject|242|||
163892606|NCT04625725|591978955|FG001|Provent Main Study|Withdrawal by Subject|144|||
163892607|NCT04625725|591978956|FG002|Provent Main Study|Withdrawal by Subject|0|||
163892608|NCT04625725|591978957|FG003|Provent Main Study|Withdrawal by Subject|0|||
163892609|NCT04625725|591978958|FG004|Provent Main Study|Withdrawal by Subject|0|||
163892610|NCT04625725|591978959|FG005|Provent Main Study|Withdrawal by Subject|0|||
163892611|NCT04625725|591978954|FG000|Provent Main Study|Physician Decision|5|||
163892612|NCT04625725|591978955|FG001|Provent Main Study|Physician Decision|0|||
163892613|NCT04625725|591978956|FG002|Provent Main Study|Physician Decision|0|||
163892614|NCT04625725|591978957|FG003|Provent Main Study|Physician Decision|0|||
163892615|NCT04625725|591978958|FG004|Provent Main Study|Physician Decision|0|||
163892616|NCT04625725|591978959|FG005|Provent Main Study|Physician Decision|0|||
163892617|NCT04625725|591978954|FG000|Provent Main Study|Protocol Violation|1|||
163892618|NCT04625725|591978955|FG001|Provent Main Study|Protocol Violation|0|||
163892619|NCT04625725|591978956|FG002|Provent Main Study|Protocol Violation|0|||
163892620|NCT04625725|591978957|FG003|Provent Main Study|Protocol Violation|0|||
163892621|NCT04625725|591978958|FG004|Provent Main Study|Protocol Violation|0|||
163892622|NCT04625725|591978959|FG005|Provent Main Study|Protocol Violation|0|||
163892623|NCT04625725|591978954|FG000|Provent Main Study|Lost to Follow-up|357|||
164269768|NCT02576860|593356755|FG000|Overall Study|Withdrawal by Subject|13|||
164269769|NCT02576860|593356756|FG001|Overall Study|Withdrawal by Subject|8|||
164085896|NCT00696709|592678583|FG003|Overall Study|Adverse Event|1|||
164269770|NCT02576860|593356755|FG000|Overall Study|Disallowed medication|1|||
164269771|NCT02576860|593356756|FG001|Overall Study|Disallowed medication|0|||
164269772|NCT00780273|593356757|FG000|Overall Study|Death|1|||
164269773|NCT00780273|593356757|FG000|Overall Study|Lost to Follow-up|1|||
164269774|NCT02391961|593356758|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
164269775|NCT02391961|593356759|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
164269776|NCT02391961|593356758|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
164269777|NCT02391961|593356759|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
164269778|NCT02391961|593356758|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164269779|NCT02391961|593356759|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164269780|NCT00477269|593356760|FG000|Core Study|Adverse Event|6|||
163892624|NCT04625725|591978955|FG001|Provent Main Study|Lost to Follow-up|200|||
163892625|NCT04625725|591978956|FG002|Provent Main Study|Lost to Follow-up|0|||
163892626|NCT04625725|591978957|FG003|Provent Main Study|Lost to Follow-up|0|||
163892627|NCT04625725|591978958|FG004|Provent Main Study|Lost to Follow-up|0|||
163892628|NCT04625725|591978959|FG005|Provent Main Study|Lost to Follow-up|0|||
163892629|NCT04625725|591978954|FG000|Provent Main Study|Death|22|||
163892630|NCT04625725|591978955|FG001|Provent Main Study|Death|10|||
163892631|NCT04625725|591978956|FG002|Provent Main Study|Death|0|||
163892632|NCT04625725|591978957|FG003|Provent Main Study|Death|0|||
163892633|NCT04625725|591978958|FG004|Provent Main Study|Death|0|||
163892634|NCT04625725|591978959|FG005|Provent Main Study|Death|0|||
163892635|NCT04625725|591978954|FG000|Provent Main Study|Adverse Event|2|||
163892636|NCT04625725|591978955|FG001|Provent Main Study|Adverse Event|1|||
163892637|NCT04625725|591978956|FG002|Provent Main Study|Adverse Event|0|||
163892638|NCT04625725|591978957|FG003|Provent Main Study|Adverse Event|0|||
163892639|NCT04625725|591978958|FG004|Provent Main Study|Adverse Event|0|||
163892640|NCT04625725|591978959|FG005|Provent Main Study|Adverse Event|0|||
163892641|NCT04625725|591978954|FG000|Provent Main Study|Participants dosed in sub-study|310|||
163892642|NCT04625725|591978955|FG001|Provent Main Study|Participants dosed in sub-study|193|||
163892643|NCT04625725|591978956|FG002|Provent Main Study|Participants dosed in sub-study|0|||
163892644|NCT04625725|591978957|FG003|Provent Main Study|Participants dosed in sub-study|0|||
163892645|NCT04625725|591978958|FG004|Provent Main Study|Participants dosed in sub-study|0|||
163892646|NCT04625725|591978959|FG005|Provent Main Study|Participants dosed in sub-study|0|||
163892647|NCT04625725|591978954|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
163892648|NCT04625725|591978955|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
163892649|NCT04625725|591978956|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163892650|NCT04625725|591978957|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163892651|NCT04625725|591978958|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163892652|NCT04625725|591978959|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
163892653|NCT04625725|591978954|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
163892654|NCT04625725|591978955|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
163892655|NCT04625725|591978956|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163892656|NCT04625725|591978957|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163892657|NCT04625725|591978958|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163892658|NCT04625725|591978959|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
163892659|NCT04625725|591978954|FG000|Provent Main Study|INCARCERATION|3|||
163892660|NCT04625725|591978955|FG001|Provent Main Study|INCARCERATION|0|||
163892661|NCT04625725|591978956|FG002|Provent Main Study|INCARCERATION|0|||
163892662|NCT04625725|591978957|FG003|Provent Main Study|INCARCERATION|0|||
163892663|NCT04625725|591978958|FG004|Provent Main Study|INCARCERATION|0|||
163892664|NCT04625725|591978959|FG005|Provent Main Study|INCARCERATION|0|||
163892665|NCT04625725|591978954|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
163892666|NCT04625725|591978955|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
163892667|NCT04625725|591978956|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163892668|NCT04625725|591978957|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163892669|NCT04625725|591978958|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163892670|NCT04625725|591978959|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
163892671|NCT04625725|591978954|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
163892672|NCT04625725|591978955|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
163892673|NCT04625725|591978956|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163892674|NCT04625725|591978957|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163892675|NCT04625725|591978958|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163892676|NCT04625725|591978959|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
163892677|NCT04625725|591978954|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
163892678|NCT04625725|591978955|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
163892679|NCT04625725|591978956|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163892680|NCT04625725|591978957|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163892681|NCT04625725|591978958|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
163892682|NCT04625725|591978959|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
164269781|NCT00477269|593356761|FG001|Core Study|Adverse Event|4|||
163892683|NCT04625725|591978954|FG000|Provent Main Study|MISSING REASON|0|||
163892684|NCT04625725|591978955|FG001|Provent Main Study|MISSING REASON|1|||
164269782|NCT00477269|593356762|FG002|Core Study|Adverse Event|0|||
164269783|NCT00477269|593356760|FG000|Core Study|Death|3|||
164269784|NCT00477269|593356761|FG001|Core Study|Death|3|||
164269785|NCT00477269|593356762|FG002|Core Study|Death|0|||
164269786|NCT00477269|593356760|FG000|Core Study|Withdrawn Consent|0|||
164269787|NCT00477269|593356761|FG001|Core Study|Withdrawn Consent|1|||
164269788|NCT00477269|593356762|FG002|Core Study|Withdrawn Consent|0|||
164269789|NCT00477269|593356760|FG000|Open Label Extension|Adverse Event|0|||
164269790|NCT00477269|593356761|FG001|Open Label Extension|Adverse Event|0|||
164269791|NCT00477269|593356762|FG002|Open Label Extension|Adverse Event|4|||
164269792|NCT00477269|593356760|FG000|Open Label Extension|Abnormal laboratory values|0|||
164269793|NCT00477269|593356761|FG001|Open Label Extension|Abnormal laboratory values|0|||
164269794|NCT00477269|593356762|FG002|Open Label Extension|Abnormal laboratory values|1|||
164269795|NCT00477269|593356760|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
164269796|NCT00477269|593356761|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
164269797|NCT00477269|593356762|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
164269798|NCT00477269|593356760|FG000|Open Label Extension|Adminiatrative problems|0|||
164269799|NCT00477269|593356761|FG001|Open Label Extension|Adminiatrative problems|0|||
164269800|NCT00477269|593356762|FG002|Open Label Extension|Adminiatrative problems|2|||
164269801|NCT00477269|593356760|FG000|Open Label Extension|Death|0|||
164342024|NCT05248867|593627595|FG003|Open-label Period|Lost to Follow-up|0|||
164342025|NCT05248867|593627596|FG004|Open-label Period|Lost to Follow-up|5|||
164342026|NCT05248867|593627597|FG005|Open-label Period|Lost to Follow-up|2|||
164342027|NCT05248867|593627592|FG000|Open-label Period|COVID-19 Infection|0|||
164269802|NCT00477269|593356761|FG001|Open Label Extension|Death|0|||
164269803|NCT00477269|593356762|FG002|Open Label Extension|Death|4|||
164269804|NCT01541917|593356765|FG000|Overall Study|Lost to Follow-up|2|||
164269805|NCT01541917|593356766|FG001|Overall Study|Lost to Follow-up|2|||
163892685|NCT04625725|591978956|FG002|Provent Main Study|MISSING REASON|0|||
163892686|NCT04625725|591978957|FG003|Provent Main Study|MISSING REASON|0|||
163892687|NCT04625725|591978958|FG004|Provent Main Study|MISSING REASON|0|||
163892688|NCT04625725|591978959|FG005|Provent Main Study|MISSING REASON|0|||
163892689|NCT04625725|591978954|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163892690|NCT04625725|591978955|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163892691|NCT04625725|591978956|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163892692|NCT04625725|591978957|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
163892693|NCT04625725|591978958|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163892694|NCT04625725|591978959|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
163892695|NCT04625725|591978954|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163892696|NCT04625725|591978955|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163892697|NCT04625725|591978956|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
163892698|NCT04625725|591978957|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163892699|NCT04625725|591978958|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163892700|NCT04625725|591978959|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
163892701|NCT04625725|591978954|FG000|Provent Sub Study|Lost to Follow-up|0|||
163892702|NCT04625725|591978955|FG001|Provent Sub Study|Lost to Follow-up|0|||
163892703|NCT04625725|591978956|FG002|Provent Sub Study|Lost to Follow-up|20|||
163892704|NCT04625725|591978957|FG003|Provent Sub Study|Lost to Follow-up|10|||
163892705|NCT04625725|591978958|FG004|Provent Sub Study|Lost to Follow-up|6|||
164269806|NCT01541917|593356765|FG000|Overall Study|Withdrawal by Subject|13|||
164269807|NCT01541917|593356766|FG001|Overall Study|Withdrawal by Subject|7|||
164342028|NCT05248867|593627593|FG001|Open-label Period|COVID-19 Infection|0|||
164342029|NCT05248867|593627594|FG002|Open-label Period|COVID-19 Infection|0|||
164342030|NCT05248867|593627595|FG003|Open-label Period|COVID-19 Infection|0|||
164342031|NCT05248867|593627596|FG004|Open-label Period|COVID-19 Infection|1|||
164342032|NCT05248867|593627597|FG005|Open-label Period|COVID-19 Infection|0|||
164342033|NCT05248867|593627592|FG000|Open-label Period|Other, not specified|0|||
164342034|NCT05248867|593627593|FG001|Open-label Period|Other, not specified|0|||
164342035|NCT05248867|593627594|FG002|Open-label Period|Other, not specified|0|||
164342036|NCT05248867|593627595|FG003|Open-label Period|Other, not specified|0|||
164342037|NCT05248867|593627596|FG004|Open-label Period|Other, not specified|4|||
164342038|NCT05248867|593627597|FG005|Open-label Period|Other, not specified|0|||
164342039|NCT03128411|593627599|FG000|Treatment Phase|Adverse Event|21|||
164342040|NCT03128411|593627599|FG000|Treatment Phase|Physician Decision|1|||
163892706|NCT04625725|591978959|FG005|Provent Sub Study|Lost to Follow-up|4|||
163892707|NCT04625725|591978954|FG000|Provent Sub Study|Death|0|||
164269808|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
164342041|NCT03128411|593627599|FG000|Treatment Phase|Other|2|||
164342042|NCT03128411|593627599|FG000|Long Term Follow-up Phase|Death|2|||
164342043|NCT03749447|593629349|FG000|Overall Study|Adverse Event|11|||
164342044|NCT03749447|593629350|FG001|Overall Study|Adverse Event|3|||
164342045|NCT03749447|593629349|FG000|Overall Study|Death|1|||
164342046|NCT03749447|593629350|FG001|Overall Study|Death|1|||
164342047|NCT03749447|593629349|FG000|Overall Study|Lost to Follow-up|2|||
164342048|NCT03749447|593629350|FG001|Overall Study|Lost to Follow-up|2|||
163998851|NCT00064701|592359162|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
163998852|NCT00064701|592359160|FG000|One Year Post-transplant|Lost to Follow-up|1|||
164269809|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
164269810|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
164269811|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
164269812|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
164269813|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
164269814|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
164269815|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
164269816|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
164269817|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
164269818|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
164269819|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
164269820|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
164269821|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
164269822|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
164269823|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
164269824|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
164269825|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
164269826|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
164269827|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
164269828|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
164269829|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
164269830|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
164269831|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
164269832|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
164269833|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
164269834|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
164269835|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
164269836|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
164269837|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
164269838|NCT00121641|593356769|FG000|24-week Short-term Treatment Period|Other Reason|1|||
164269839|NCT00121641|593356770|FG001|24-week Short-term Treatment Period|Other Reason|0|||
164269840|NCT00121641|593356771|FG002|24-week Short-term Treatment Period|Other Reason|0|||
164269841|NCT00121641|593356772|FG003|24-week Short-term Treatment Period|Other Reason|0|||
164269842|NCT00121641|593356773|FG004|24-week Short-term Treatment Period|Other Reason|0|||
164269843|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
164269844|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
164269845|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
164269846|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
164269847|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
164269848|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
164269849|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
164269850|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
164269851|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
164269852|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
164269853|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
164269854|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
164269855|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
163998853|NCT00064701|592359161|FG001|One Year Post-transplant|Lost to Follow-up|0|||
163998854|NCT00064701|592359162|FG002|One Year Post-transplant|Lost to Follow-up|0|||
163998855|NCT00064701|592359160|FG000|One Year Post-transplant|Converted to rapamycin|1|||
163998856|NCT00064701|592359161|FG001|One Year Post-transplant|Converted to rapamycin|0|||
163998857|NCT00064701|592359162|FG002|One Year Post-transplant|Converted to rapamycin|0|||
163998858|NCT00064701|592359160|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
163998859|NCT00064701|592359161|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
163998860|NCT00064701|592359162|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
163998861|NCT00064701|592359160|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
163998862|NCT00064701|592359161|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
163998863|NCT00064701|592359162|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
164085897|NCT00696709|592678584|FG004|Overall Study|Adverse Event|0|||
164342049|NCT03749447|593629349|FG000|Overall Study|Reason Not Specified|0|||
163998864|NCT00064701|592359160|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
163998865|NCT00064701|592359161|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
163998866|NCT00064701|592359162|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
164342050|NCT03749447|593629350|FG001|Overall Study|Reason Not Specified|3|||
164342051|NCT03749447|593629349|FG000|Overall Study|Physician Decision|4|||
164342052|NCT03749447|593629350|FG001|Overall Study|Physician Decision|3|||
164342053|NCT03749447|593629349|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
164342054|NCT03749447|593629350|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
164342055|NCT03749447|593629349|FG000|Overall Study|Study Terminated By Sponsor|112|||
164342056|NCT03749447|593629350|FG001|Overall Study|Study Terminated By Sponsor|105|||
164342057|NCT03749447|593629349|FG000|Overall Study|Withdrawal by Subject|12|||
164342058|NCT03749447|593629350|FG001|Overall Study|Withdrawal by Subject|6|||
164342059|NCT03749447|593629349|FG000|Overall Study|Non-compliance With Study Drug|0|||
164342060|NCT03749447|593629350|FG001|Overall Study|Non-compliance With Study Drug|1|||
164342061|NCT01673867|593629352|FG000|Randomization|Adverse event unrelated to study drug|1|||
164342062|NCT01673867|593629353|FG001|Randomization|Adverse event unrelated to study drug|0|||
164342063|NCT01673867|593629352|FG000|Randomization|Participant request to discontinue study treatment|0|||
164342064|NCT01673867|593629353|FG001|Randomization|Participant request to discontinue study treatment|4|||
164342065|NCT01673867|593629352|FG000|Randomization|Withdrawal by participant|0|||
164342066|NCT01673867|593629353|FG001|Randomization|Withdrawal by participant|12|||
164342067|NCT01673867|593629352|FG000|Randomization|Lost to Follow-up|0|||
164342068|NCT01673867|593629353|FG001|Randomization|Lost to Follow-up|1|||
164342069|NCT01673867|593629352|FG000|Randomization|Participant no longer meets study criteria|4|||
164342070|NCT01673867|593629353|FG001|Randomization|Participant no longer meets study criteria|5|||
164342071|NCT01673867|593629352|FG000|Treatment|Disease Progression|208|||
164342072|NCT01673867|593629353|FG001|Treatment|Disease Progression|178|||
164342073|NCT01673867|593629352|FG000|Treatment|Study Drug Toxicity|23|||
164342074|NCT01673867|593629353|FG001|Treatment|Study Drug Toxicity|43|||
164342075|NCT01673867|593629352|FG000|Treatment|Death|2|||
164342076|NCT01673867|593629353|FG001|Treatment|Death|3|||
164342077|NCT01673867|593629352|FG000|Treatment|Adverse event unrelated to study drug|23|||
164342078|NCT01673867|593629353|FG001|Treatment|Adverse event unrelated to study drug|10|||
164342079|NCT01673867|593629352|FG000|Treatment|Participant request to discontinue study treatment|7|||
164342080|NCT01673867|593629353|FG001|Treatment|Participant request to discontinue study treatment|17|||
164342081|NCT01673867|593629352|FG000|Treatment|Withdrawal by participant|5|||
164342082|NCT01673867|593629353|FG001|Treatment|Withdrawal by participant|5|||
164342083|NCT01673867|593629352|FG000|Treatment|Maximum clinical benefit|1|||
164342084|NCT01673867|593629353|FG001|Treatment|Maximum clinical benefit|10|||
164342085|NCT01673867|593629352|FG000|Treatment|Participant no longer meets study criteria|2|||
164342086|NCT01673867|593629353|FG001|Treatment|Participant no longer meets study criteria|0|||
164342087|NCT01673867|593629352|FG000|Treatment|Administrative reason by sponsor|3|||
164342088|NCT01673867|593629353|FG001|Treatment|Administrative reason by sponsor|0|||
164342089|NCT01673867|593629352|FG000|Treatment|Other reason|11|||
164342090|NCT01673867|593629353|FG001|Treatment|Other reason|2|||
164342091|NCT02550106|593629354|FG000|Overall Study|Adverse Event|1|||
164342092|NCT02550106|593629354|FG000|Overall Study|Lack of Efficacy|3|||
164342093|NCT02550106|593629354|FG000|Overall Study|Protocol Violation|6|||
164342094|NCT02550106|593629354|FG000|Overall Study|Withdrawal by Subject|2|||
164342095|NCT01543958|593629355|FG000|Overall Study|Loss to follow-up|3|||
164342096|NCT01543958|593629355|FG000|Overall Study|ART initiation|1|||
164342097|NCT00926328|593629356|FG000|Overall Study|Lost to Follow-up|12|||
164342098|NCT00926328|593629357|FG001|Overall Study|Lost to Follow-up|14|||
164342099|NCT00726986|593629358|FG000|Induction Phase|Adverse Event|4|||
164342100|NCT00726986|593629358|FG000|Induction Phase|Withdrawal by Subject|2|||
164342101|NCT00726986|593629358|FG000|Induction Phase|Death|2|||
164342102|NCT00726986|593629358|FG000|Induction Phase|Lack of Efficacy|5|||
163892708|NCT04625725|591978955|FG001|Provent Sub Study|Death|0|||
163892709|NCT04625725|591978956|FG002|Provent Sub Study|Death|8|||
163892710|NCT04625725|591978957|FG003|Provent Sub Study|Death|5|||
163892711|NCT04625725|591978958|FG004|Provent Sub Study|Death|0|||
163892712|NCT04625725|591978959|FG005|Provent Sub Study|Death|1|||
164342103|NCT00726986|593629358|FG000|Induction Phase|Secondary Disease|2|||
164342104|NCT00726986|593629358|FG000|Maintenance Phase|Adverse Event|1|||
164342105|NCT00726986|593629358|FG000|Maintenance Phase|Lack of Efficacy|2|||
164342106|NCT01513343|593629361|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
164342107|NCT01513343|593629362|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
164342108|NCT01513343|593629361|FG000|Post Data Collection|Dropped/withdrew from study|7|||
164342109|NCT01513343|593629362|FG001|Post Data Collection|Dropped/withdrew from study|1|||
164342110|NCT01513343|593629361|FG000|Post Data Collection|Lost to Follow-up|10|||
164342111|NCT01513343|593629362|FG001|Post Data Collection|Lost to Follow-up|23|||
164342112|NCT01513343|593629361|FG000|6-month Follow-up|Lost to Follow-up|28|||
164342113|NCT01513343|593629362|FG001|6-month Follow-up|Lost to Follow-up|17|||
164342114|NCT01513343|593629361|FG000|12-month Follow-up|Lost to Follow-up|10|||
164342115|NCT01513343|593629362|FG001|12-month Follow-up|Lost to Follow-up|3|||
164342116|NCT00599924|593629363|FG000|Overall Study|Lack of Efficacy|3|||
164342117|NCT00599924|593629364|FG001|Overall Study|Lack of Efficacy|5|||
163892713|NCT04625725|591978954|FG000|Provent Sub Study|Adverse Event|0|||
163998867|NCT00064701|592359160|FG000|One Year Post-transplant|Poor absorption|0|||
163998868|NCT00064701|592359161|FG001|One Year Post-transplant|Poor absorption|1|||
163998869|NCT00064701|592359162|FG002|One Year Post-transplant|Poor absorption|0|||
163998870|NCT00064701|592359160|FG000|One Year Post-transplant|Pancreas transplant|0|||
163998871|NCT00064701|592359161|FG001|One Year Post-transplant|Pancreas transplant|0|||
163998872|NCT00064701|592359162|FG002|One Year Post-transplant|Pancreas transplant|1|||
163998873|NCT00064701|592359160|FG000|Clinical Continuation Phase|Adverse Event|12|||
163998874|NCT00064701|592359161|FG001|Clinical Continuation Phase|Adverse Event|21|||
163998875|NCT00064701|592359162|FG002|Clinical Continuation Phase|Adverse Event|14|||
163998876|NCT00064701|592359160|FG000|Clinical Continuation Phase|Non-compliance|8|||
163998877|NCT00064701|592359161|FG001|Clinical Continuation Phase|Non-compliance|6|||
163998878|NCT00064701|592359162|FG002|Clinical Continuation Phase|Non-compliance|7|||
163998879|NCT00064701|592359160|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
163998880|NCT00064701|592359161|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
163998881|NCT00064701|592359162|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
163998882|NCT00064701|592359160|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
163998883|NCT00064701|592359161|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
163998884|NCT00064701|592359162|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
163998885|NCT00064701|592359160|FG000|Clinical Continuation Phase|Graft Failure|5|||
163998886|NCT00064701|592359161|FG001|Clinical Continuation Phase|Graft Failure|5|||
163998887|NCT00064701|592359162|FG002|Clinical Continuation Phase|Graft Failure|2|||
163998888|NCT00064701|592359160|FG000|Clinical Continuation Phase|Rejection|1|||
163998889|NCT00064701|592359161|FG001|Clinical Continuation Phase|Rejection|2|||
163998890|NCT00064701|592359162|FG002|Clinical Continuation Phase|Rejection|2|||
163998891|NCT00064701|592359160|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
163998892|NCT00064701|592359161|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
163998893|NCT00064701|592359162|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
163998894|NCT00064701|592359160|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
163998895|NCT00064701|592359161|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
163998896|NCT00064701|592359162|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
163998897|NCT00064701|592359160|FG000|Clinical Continuation Phase|Physician Decision|1|||
163998898|NCT00064701|592359161|FG001|Clinical Continuation Phase|Physician Decision|3|||
163998899|NCT00064701|592359162|FG002|Clinical Continuation Phase|Physician Decision|0|||
163998900|NCT00064701|592359160|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
163998901|NCT00064701|592359161|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
163998902|NCT00064701|592359162|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
163998903|NCT00064701|592359160|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
164269856|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
164269857|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
164269858|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
164269859|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
164269860|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
164269861|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
164269862|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
164269863|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
164269864|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
164269865|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
164269866|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
164269867|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
164269868|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
164269869|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
164269870|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
164269871|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
164269872|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
164269873|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
164269874|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
164269875|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
164269876|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
164269877|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
163998904|NCT00064701|592359161|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
163998905|NCT00064701|592359162|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
163998906|NCT00064701|592359160|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
163998907|NCT00064701|592359161|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
163998908|NCT00064701|592359162|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
164085898|NCT00310856|592678585|FG000|Overall Study|Withdrawal by Subject|2|||
164085899|NCT00310856|592678586|FG001|Overall Study|Withdrawal by Subject|2|||
164342118|NCT00599924|593629365|FG002|Overall Study|Lack of Efficacy|1|||
164269878|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
164269879|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
164269880|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
164269881|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
164269882|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
164269883|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Death|0|||
164269884|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Death|0|||
164269885|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Death|0|||
164269886|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Death|1|||
164269887|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Death|0|||
164269888|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Missing|0|||
164269889|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Missing|0|||
164269890|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Missing|1|||
164269891|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Missing|0|||
164269892|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Missing|0|||
164269893|NCT00121641|593356769|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
164269894|NCT00121641|593356770|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
164269895|NCT00121641|593356771|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
164269896|NCT00121641|593356772|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
164269897|NCT00121641|593356773|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
164269898|NCT01792518|593356774|FG000|Overall Study|Adverse Event|3|||
164269899|NCT01792518|593356775|FG001|Overall Study|Adverse Event|4|||
164269900|NCT01792518|593356774|FG000|Overall Study|Protocol Violation|0|||
164269901|NCT01792518|593356775|FG001|Overall Study|Protocol Violation|1|||
164269902|NCT01792518|593356774|FG000|Overall Study|Lost to Follow-up|3|||
164269903|NCT01792518|593356775|FG001|Overall Study|Lost to Follow-up|1|||
164269904|NCT01792518|593356774|FG000|Overall Study|Withdrawal by Subject|2|||
163892714|NCT04625725|591978955|FG001|Provent Sub Study|Adverse Event|0|||
163892715|NCT04625725|591978956|FG002|Provent Sub Study|Adverse Event|0|||
163892716|NCT04625725|591978957|FG003|Provent Sub Study|Adverse Event|0|||
163892717|NCT04625725|591978958|FG004|Provent Sub Study|Adverse Event|0|||
164269905|NCT01792518|593356775|FG001|Overall Study|Withdrawal by Subject|0|||
164269906|NCT01792518|593356774|FG000|Overall Study|Other Reason|0|||
163892718|NCT04625725|591978959|FG005|Provent Sub Study|Adverse Event|1|||
163892719|NCT04625725|591978954|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163892720|NCT04625725|591978955|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163892721|NCT04625725|591978956|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163892722|NCT04625725|591978957|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163892723|NCT04625725|591978958|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
163892724|NCT04625725|591978959|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
163892725|NCT04625725|591978954|FG000|Provent Sub Study|Withdrawal by Subject|0|||
163892726|NCT04625725|591978955|FG001|Provent Sub Study|Withdrawal by Subject|0|||
163892727|NCT04625725|591978956|FG002|Provent Sub Study|Withdrawal by Subject|11|||
163892728|NCT04625725|591978957|FG003|Provent Sub Study|Withdrawal by Subject|13|||
163892729|NCT04625725|591978958|FG004|Provent Sub Study|Withdrawal by Subject|5|||
163892730|NCT04625725|591978959|FG005|Provent Sub Study|Withdrawal by Subject|6|||
163892731|NCT04625725|591978954|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163892732|NCT04625725|591978955|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163892733|NCT04625725|591978956|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163892734|NCT04625725|591978957|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163892735|NCT04625725|591978958|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
163892736|NCT04625725|591978959|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
163892737|NCT04308681|591978963|FG000|Pre-Treatment|Not reported|1|||
163892738|NCT04308681|591978964|FG001|Pre-Treatment|Not reported|1|||
163892739|NCT04308681|591978965|FG002|Pre-Treatment|Not reported|0|||
163892740|NCT04308681|591978966|FG003|Pre-Treatment|Not reported|0|||
163892741|NCT04308681|591978967|FG004|Pre-Treatment|Not reported|0|||
163892742|NCT04308681|591978968|FG005|Pre-Treatment|Not reported|2|||
163892743|NCT04308681|591978969|FG006|Pre-Treatment|Not reported|0|||
163892744|NCT04308681|591978970|FG007|Pre-Treatment|Not reported|0|||
163892745|NCT04308681|591978963|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
163892746|NCT04308681|591978964|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
163892747|NCT04308681|591978965|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
163892748|NCT04308681|591978966|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
163892749|NCT04308681|591978967|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
164269907|NCT01792518|593356775|FG001|Overall Study|Other Reason|1|||
164269908|NCT01565564|593356786|FG000|Overall Study|Lost to Follow-up|5|||
164269909|NCT01565564|593356787|FG001|Overall Study|Lost to Follow-up|1|||
164269910|NCT00249613|593356788|FG000|12 Month Follow-up|Death|1|||
163998909|NCT00064701|592359160|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
163998910|NCT00064701|592359161|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
164269911|NCT00249613|593356789|FG001|12 Month Follow-up|Death|1|||
164269912|NCT00249613|593356788|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
164269913|NCT00249613|593356789|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
164269914|NCT00249613|593356788|FG000|12 Month Follow-up|Lost to Follow-up|10|||
164269915|NCT00249613|593356789|FG001|12 Month Follow-up|Lost to Follow-up|8|||
164269916|NCT00806442|593356812|FG000|Overall Study|Lost to Follow-up|3|||
164269917|NCT00806442|593356813|FG001|Overall Study|Lost to Follow-up|2|||
164269918|NCT00806442|593356812|FG000|Overall Study|Withdrawal by Subject|1|||
164269919|NCT00806442|593356813|FG001|Overall Study|Withdrawal by Subject|5|||
164269920|NCT00654004|593356817|FG000|Overall Study|Lost to Follow-up|1|||
164269921|NCT00654004|593356818|FG001|Overall Study|Lost to Follow-up|0|||
164269922|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269923|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
164269924|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269925|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269926|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269927|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269928|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269929|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269930|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269931|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269932|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269933|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269934|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269935|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269936|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269937|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269938|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269939|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269940|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
164269941|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269942|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269943|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269944|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
164269945|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269946|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
164269947|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269948|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
164269949|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269950|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269951|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269952|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269953|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269954|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269955|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269956|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269957|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269958|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269959|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
164269960|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269961|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269962|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
164269963|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269964|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
164269965|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269966|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
164269967|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
164269968|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269969|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269970|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269971|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269972|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269973|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269974|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269975|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269976|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269977|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269978|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
164269979|NCT02528357|593356827|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269980|NCT02528357|593356828|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269981|NCT02528357|593356829|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269982|NCT02528357|593356830|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164342119|NCT00599924|593629366|FG003|Overall Study|Lack of Efficacy|2|||
164342120|NCT00599924|593629367|FG004|Overall Study|Lack of Efficacy|3|||
163998911|NCT00064701|592359162|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
163998912|NCT00064701|592359160|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
163998913|NCT00064701|592359161|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
163998914|NCT00064701|592359162|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
163998915|NCT00064701|592359160|FG000|Clinical Continuation Phase|Patient opted out|0|||
163998916|NCT00064701|592359161|FG001|Clinical Continuation Phase|Patient opted out|0|||
163998917|NCT00064701|592359162|FG002|Clinical Continuation Phase|Patient opted out|1|||
163998918|NCT01818297|592359163|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
163998919|NCT01818297|592359164|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
163998920|NCT01818297|592359163|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
163998921|NCT01818297|592359164|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
163998922|NCT01818297|592359163|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
163998923|NCT01818297|592359164|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
163998924|NCT00749190|592359167|FG000|Overall Study|Adverse Event|0|||
163998925|NCT00749190|592359168|FG001|Overall Study|Adverse Event|2|||
163998926|NCT00749190|592359169|FG002|Overall Study|Adverse Event|0|||
163998927|NCT00749190|592359170|FG003|Overall Study|Adverse Event|4|||
163998928|NCT00749190|592359171|FG004|Overall Study|Adverse Event|0|||
163998929|NCT00749190|592359172|FG005|Overall Study|Adverse Event|3|||
163998930|NCT00749190|592359173|FG006|Overall Study|Adverse Event|0|||
163998931|NCT00749190|592359167|FG000|Overall Study|Lack of Efficacy|3|||
163998932|NCT00749190|592359168|FG001|Overall Study|Lack of Efficacy|1|||
163998933|NCT00749190|592359169|FG002|Overall Study|Lack of Efficacy|1|||
163998934|NCT00749190|592359170|FG003|Overall Study|Lack of Efficacy|0|||
163998935|NCT00749190|592359171|FG004|Overall Study|Lack of Efficacy|0|||
163998936|NCT00749190|592359172|FG005|Overall Study|Lack of Efficacy|1|||
163998937|NCT00749190|592359173|FG006|Overall Study|Lack of Efficacy|0|||
163998938|NCT00749190|592359167|FG000|Overall Study|Withdrawal by Subject|2|||
163998939|NCT00749190|592359168|FG001|Overall Study|Withdrawal by Subject|1|||
163998940|NCT00749190|592359169|FG002|Overall Study|Withdrawal by Subject|0|||
163998941|NCT00749190|592359170|FG003|Overall Study|Withdrawal by Subject|0|||
163998942|NCT00749190|592359171|FG004|Overall Study|Withdrawal by Subject|0|||
163998943|NCT00749190|592359172|FG005|Overall Study|Withdrawal by Subject|1|||
163998944|NCT00749190|592359173|FG006|Overall Study|Withdrawal by Subject|0|||
163998945|NCT00749190|592359167|FG000|Overall Study|Protocol Violation|0|||
163998946|NCT00749190|592359168|FG001|Overall Study|Protocol Violation|1|||
163998947|NCT00749190|592359169|FG002|Overall Study|Protocol Violation|0|||
163998948|NCT00749190|592359170|FG003|Overall Study|Protocol Violation|0|||
163998949|NCT00749190|592359171|FG004|Overall Study|Protocol Violation|0|||
163998950|NCT00749190|592359172|FG005|Overall Study|Protocol Violation|0|||
163998951|NCT00749190|592359173|FG006|Overall Study|Protocol Violation|1|||
163998952|NCT00749190|592359167|FG000|Overall Study|Other reason not defined above|0|||
163998953|NCT00749190|592359168|FG001|Overall Study|Other reason not defined above|0|||
163998954|NCT00749190|592359169|FG002|Overall Study|Other reason not defined above|0|||
163998955|NCT00749190|592359170|FG003|Overall Study|Other reason not defined above|1|||
163998956|NCT00749190|592359171|FG004|Overall Study|Other reason not defined above|0|||
163998957|NCT00749190|592359172|FG005|Overall Study|Other reason not defined above|0|||
163998958|NCT00749190|592359173|FG006|Overall Study|Other reason not defined above|0|||
163998959|NCT00355121|592359174|FG000|Overall Study|Did not receive study vaccine|1|||
163998960|NCT00355121|592359175|FG001|Overall Study|Did not receive study vaccine|0|||
163998961|NCT00355121|592359176|FG002|Overall Study|Did not receive study vaccine|1|||
164342121|NCT00599924|593629368|FG005|Overall Study|Lack of Efficacy|2|||
164342122|NCT00599924|593629369|FG006|Overall Study|Lack of Efficacy|0|||
163998962|NCT00355121|592359174|FG000|Overall Study|Adverse Event|0|||
163998963|NCT00355121|592359175|FG001|Overall Study|Adverse Event|1|||
163998964|NCT00355121|592359176|FG002|Overall Study|Adverse Event|0|||
163998965|NCT00355121|592359174|FG000|Overall Study|Protocol Violation|7|||
163998966|NCT00355121|592359175|FG001|Overall Study|Protocol Violation|9|||
163998967|NCT00355121|592359176|FG002|Overall Study|Protocol Violation|1|||
163998968|NCT00355121|592359174|FG000|Overall Study|Lost to Follow-up|4|||
163998969|NCT00355121|592359175|FG001|Overall Study|Lost to Follow-up|7|||
163998970|NCT00355121|592359176|FG002|Overall Study|Lost to Follow-up|1|||
163998971|NCT00355121|592359174|FG000|Overall Study|Withdrawal by Subject|9|||
163998972|NCT00355121|592359175|FG001|Overall Study|Withdrawal by Subject|10|||
163998973|NCT00355121|592359176|FG002|Overall Study|Withdrawal by Subject|2|||
163998974|NCT00355121|592359174|FG000|Overall Study|Serious adverse events|0|||
163998975|NCT00355121|592359175|FG001|Overall Study|Serious adverse events|2|||
163998976|NCT00355121|592359176|FG002|Overall Study|Serious adverse events|0|||
163998977|NCT00784758|592359178|FG000|Overall Study|Withdrawal by Subject|3|||
163998978|NCT00784758|592359179|FG001|Overall Study|Withdrawal by Subject|0|||
163998979|NCT00784758|592359178|FG000|Overall Study|Adverse Event|1|||
163998980|NCT00784758|592359179|FG001|Overall Study|Adverse Event|0|||
164269983|NCT02528357|593356831|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164269984|NCT02528357|593356832|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
163998981|NCT03726268|592359180|FG000|Overall Study|Physician Decision|2|||
163998982|NCT03726268|592359181|FG001|Overall Study|Physician Decision|8|||
163998983|NCT03726268|592359182|FG002|Overall Study|Physician Decision|6|||
163998984|NCT03726268|592359183|FG003|Overall Study|Physician Decision|3|||
163998985|NCT03726268|592359180|FG000|Overall Study|Withdrawal by Subject|11|||
163998986|NCT03726268|592359181|FG001|Overall Study|Withdrawal by Subject|5|||
163998987|NCT03726268|592359182|FG002|Overall Study|Withdrawal by Subject|9|||
163998988|NCT03726268|592359183|FG003|Overall Study|Withdrawal by Subject|8|||
163998989|NCT00490542|592359184|FG000|Overall Study|Lost to Follow-up|3|||
163998990|NCT00490542|592359185|FG001|Overall Study|Lost to Follow-up|0|||
163998991|NCT00490542|592359184|FG000|Overall Study|Adverse Event|3|||
163998992|NCT00490542|592359185|FG001|Overall Study|Adverse Event|3|||
163998993|NCT00490542|592359184|FG000|Overall Study|Lack of Efficacy|1|||
163998994|NCT00490542|592359185|FG001|Overall Study|Lack of Efficacy|1|||
163998995|NCT02875223|592359186|FG000|Overall Study|Other reasons|0|||
163998996|NCT02875223|592359187|FG001|Overall Study|Other reasons|0|||
164269985|NCT02528357|593356833|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269986|NCT02528357|593356834|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269987|NCT02528357|593356835|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269988|NCT02528357|593356836|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269989|NCT02528357|593356837|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269990|NCT02528357|593356838|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269991|NCT02528357|593356839|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269992|NCT02528357|593356840|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269993|NCT02528357|593356841|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269994|NCT02528357|593356842|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269995|NCT02528357|593356843|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269996|NCT02528357|593356844|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269997|NCT02528357|593356845|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164269998|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164269999|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270000|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270001|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270002|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
163998997|NCT02875223|592359188|FG002|Overall Study|Other reasons|1|||
163998998|NCT02875223|592359189|FG003|Overall Study|Other reasons|0|||
164270003|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270004|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164342123|NCT00599924|593629363|FG000|Overall Study|Adverse Event|0|||
164342124|NCT00599924|593629364|FG001|Overall Study|Adverse Event|0|||
164342125|NCT00599924|593629365|FG002|Overall Study|Adverse Event|0|||
164342126|NCT00599924|593629366|FG003|Overall Study|Adverse Event|2|||
164342127|NCT00599924|593629367|FG004|Overall Study|Adverse Event|0|||
164342128|NCT00599924|593629368|FG005|Overall Study|Adverse Event|0|||
163998999|NCT02875223|592359190|FG004|Overall Study|Other reasons|1|||
163999000|NCT02875223|592359191|FG005|Overall Study|Other reasons|2|||
163999001|NCT02875223|592359192|FG006|Overall Study|Other reasons|0|||
163999002|NCT02875223|592359193|FG007|Overall Study|Other reasons|2|||
163999003|NCT02875223|592359194|FG008|Overall Study|Other reasons|0|||
163999004|NCT02875223|592359195|FG009|Overall Study|Other reasons|0|||
163999005|NCT02875223|592359196|FG010|Overall Study|Other reasons|0|||
163999006|NCT02875223|592359197|FG011|Overall Study|Other reasons|0|||
163999007|NCT02875223|592359198|FG012|Overall Study|Other reasons|0|||
164270005|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270006|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270007|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270008|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270009|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270010|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270011|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
164270012|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
164270013|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270014|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270015|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270016|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
164270017|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270018|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270019|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270020|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270021|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270022|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270023|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270024|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270025|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270026|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270027|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270028|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270029|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270030|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
164270031|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270032|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270033|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270034|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164342129|NCT00599924|593629369|FG006|Overall Study|Adverse Event|2|||
164342130|NCT00599924|593629363|FG000|Overall Study|Death|0|||
164342131|NCT00599924|593629364|FG001|Overall Study|Death|0|||
164342132|NCT00599924|593629365|FG002|Overall Study|Death|0|||
163892750|NCT04308681|591978968|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
163892751|NCT04308681|591978969|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
163892752|NCT04308681|591978970|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
163892753|NCT04308681|591978963|FG000|Treatment up to Week 26|Other reasons|2|||
163892754|NCT04308681|591978964|FG001|Treatment up to Week 26|Other reasons|0|||
163892755|NCT04308681|591978965|FG002|Treatment up to Week 26|Other reasons|0|||
163892756|NCT04308681|591978966|FG003|Treatment up to Week 26|Other reasons|0|||
163892757|NCT04308681|591978967|FG004|Treatment up to Week 26|Other reasons|1|||
163892758|NCT04308681|591978968|FG005|Treatment up to Week 26|Other reasons|1|||
163892759|NCT04308681|591978969|FG006|Treatment up to Week 26|Other reasons|0|||
163892760|NCT04308681|591978970|FG007|Treatment up to Week 26|Other reasons|0|||
163892761|NCT04308681|591978963|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163892762|NCT04308681|591978964|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
163892763|NCT04308681|591978965|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
163892764|NCT04308681|591978966|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163892765|NCT04308681|591978967|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
163892766|NCT04308681|591978968|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163892767|NCT04308681|591978969|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
163892768|NCT04308681|591978970|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
163892769|NCT04308681|591978963|FG000|Treatment up to Week 26|Adverse Event|6|||
163892770|NCT04308681|591978964|FG001|Treatment up to Week 26|Adverse Event|5|||
163892771|NCT04308681|591978965|FG002|Treatment up to Week 26|Adverse Event|5|||
163892772|NCT04308681|591978966|FG003|Treatment up to Week 26|Adverse Event|0|||
163892773|NCT04308681|591978967|FG004|Treatment up to Week 26|Adverse Event|6|||
164270035|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
164270036|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270037|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270038|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164342133|NCT00599924|593629366|FG003|Overall Study|Death|2|||
163892774|NCT04308681|591978968|FG005|Treatment up to Week 26|Adverse Event|1|||
163892775|NCT04308681|591978969|FG006|Treatment up to Week 26|Adverse Event|0|||
163892776|NCT04308681|591978970|FG007|Treatment up to Week 26|Adverse Event|0|||
163892777|NCT04308681|591978963|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163892778|NCT04308681|591978964|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
163892779|NCT04308681|591978965|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
163892780|NCT04308681|591978966|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163892781|NCT04308681|591978967|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163892782|NCT04308681|591978968|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163892783|NCT04308681|591978969|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163892784|NCT04308681|591978970|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
163892785|NCT04308681|591978963|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
163892786|NCT04308681|591978964|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
163892787|NCT04308681|591978965|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
163892788|NCT04308681|591978966|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
163892789|NCT04308681|591978967|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
163892790|NCT04308681|591978968|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
163892791|NCT04308681|591978969|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
163892792|NCT04308681|591978970|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
163892793|NCT04308681|591978963|FG000|OTE - 26 Weeks|Death|0|||
163892794|NCT04308681|591978964|FG001|OTE - 26 Weeks|Death|1|||
163892795|NCT04308681|591978965|FG002|OTE - 26 Weeks|Death|0|||
163892796|NCT04308681|591978966|FG003|OTE - 26 Weeks|Death|0|||
163892797|NCT04308681|591978967|FG004|OTE - 26 Weeks|Death|0|||
163892798|NCT04308681|591978968|FG005|OTE - 26 Weeks|Death|0|||
163892799|NCT04308681|591978969|FG006|OTE - 26 Weeks|Death|1|||
163892800|NCT04308681|591978970|FG007|OTE - 26 Weeks|Death|0|||
163892801|NCT04308681|591978963|FG000|OTE - 26 Weeks|Adverse Event|0|||
163892802|NCT04308681|591978964|FG001|OTE - 26 Weeks|Adverse Event|2|||
163892803|NCT04308681|591978965|FG002|OTE - 26 Weeks|Adverse Event|8|||
163892804|NCT04308681|591978966|FG003|OTE - 26 Weeks|Adverse Event|3|||
163892805|NCT04308681|591978967|FG004|OTE - 26 Weeks|Adverse Event|0|||
163892806|NCT04308681|591978968|FG005|OTE - 26 Weeks|Adverse Event|1|||
163892807|NCT04308681|591978969|FG006|OTE - 26 Weeks|Adverse Event|2|||
163892808|NCT04308681|591978970|FG007|OTE - 26 Weeks|Adverse Event|0|||
163892809|NCT04308681|591978963|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163892810|NCT04308681|591978964|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
163892811|NCT04308681|591978965|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
163892812|NCT04308681|591978966|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163892813|NCT04308681|591978967|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163892814|NCT04308681|591978968|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
163892815|NCT04308681|591978969|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163892816|NCT04308681|591978970|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
163892817|NCT00429364|591978973|FG000|Overall Study|Withdrawal by Subject|11|||
163892818|NCT00429364|591978974|FG001|Overall Study|Withdrawal by Subject|5|||
163892819|NCT00429364|591978973|FG000|Overall Study|Physician Decision|4|||
163892820|NCT00429364|591978974|FG001|Overall Study|Physician Decision|2|||
163892821|NCT00429364|591978973|FG000|Overall Study|Lost to Follow-up|7|||
163892822|NCT00429364|591978974|FG001|Overall Study|Lost to Follow-up|6|||
163892823|NCT00429364|591978973|FG000|Overall Study|Death|0|||
163892824|NCT00429364|591978974|FG001|Overall Study|Death|1|||
163892825|NCT00429364|591978973|FG000|Overall Study|Underwent aortic root surgery|10|||
163892826|NCT00429364|591978974|FG001|Overall Study|Underwent aortic root surgery|18|||
163892827|NCT00429364|591978973|FG000|Overall Study|Pregnancy|0|||
163892828|NCT00429364|591978974|FG001|Overall Study|Pregnancy|1|||
163892829|NCT05873556|591978975|FG000|Overall Study|Lost to Follow-up|4|||
163892830|NCT05873556|591978976|FG001|Overall Study|Lost to Follow-up|1|||
163892831|NCT04689256|591978978|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
164342134|NCT00599924|593629367|FG004|Overall Study|Death|0|||
164342135|NCT00599924|593629368|FG005|Overall Study|Death|2|||
164342136|NCT00599924|593629369|FG006|Overall Study|Death|1|||
164342137|NCT00599924|593629363|FG000|Overall Study|Protocol Violation|0|||
164342138|NCT00599924|593629364|FG001|Overall Study|Protocol Violation|0|||
164342139|NCT00599924|593629365|FG002|Overall Study|Protocol Violation|0|||
164342140|NCT00599924|593629366|FG003|Overall Study|Protocol Violation|1|||
163892832|NCT04689256|591978979|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
164342141|NCT00599924|593629367|FG004|Overall Study|Protocol Violation|0|||
164342142|NCT00599924|593629368|FG005|Overall Study|Protocol Violation|0|||
164342143|NCT00599924|593629369|FG006|Overall Study|Protocol Violation|0|||
163892833|NCT04862234|591978982|FG000|Overall Study|Surgery cancellation|1|||
163892834|NCT04862234|591978983|FG001|Overall Study|Surgery cancellation|2|||
163892835|NCT04862234|591978982|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
163892836|NCT04862234|591978983|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
163892837|NCT04862234|591978982|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
164342144|NCT00599924|593629363|FG000|Overall Study|Withdrawal by Subject|0|||
164342145|NCT00599924|593629364|FG001|Overall Study|Withdrawal by Subject|0|||
163892838|NCT04862234|591978983|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
163892839|NCT05828017|591978992|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
163892840|NCT04132518|591978993|FG000|Overall Study|Prematurely withdrawn from the study|0|||
163892841|NCT04132518|591978994|FG001|Overall Study|Prematurely withdrawn from the study|9|||
163892842|NCT04132518|591978995|FG002|Overall Study|Prematurely withdrawn from the study|1|||
163892843|NCT05425420|591978996|FG000|Overall Study|Physician Decision|1|||
163892844|NCT05425420|591978996|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
163892845|NCT04999111|591978997|FG000|Overall Study|Lost to Follow-up|21|||
163892846|NCT04999111|591978998|FG001|Overall Study|Lost to Follow-up|16|||
163892847|NCT04999111|591978999|FG002|Overall Study|Lost to Follow-up|2|||
163892848|NCT04999111|591979000|FG003|Overall Study|Lost to Follow-up|26|||
163892849|NCT04999111|591979001|FG004|Overall Study|Lost to Follow-up|30|||
163892850|NCT04999111|591979002|FG005|Overall Study|Lost to Follow-up|6|||
163892851|NCT04999111|591978997|FG000|Overall Study|Physician Decision|1|||
163892852|NCT04999111|591978998|FG001|Overall Study|Physician Decision|3|||
163892853|NCT04999111|591978999|FG002|Overall Study|Physician Decision|0|||
163892854|NCT04999111|591979000|FG003|Overall Study|Physician Decision|1|||
163892855|NCT04999111|591979001|FG004|Overall Study|Physician Decision|2|||
163892856|NCT04999111|591979002|FG005|Overall Study|Physician Decision|0|||
163892857|NCT04999111|591978997|FG000|Overall Study|Withdrawal by Subject|23|||
163892858|NCT04999111|591978998|FG001|Overall Study|Withdrawal by Subject|29|||
163892859|NCT04999111|591978999|FG002|Overall Study|Withdrawal by Subject|15|||
163892860|NCT04999111|591979000|FG003|Overall Study|Withdrawal by Subject|30|||
163892861|NCT04999111|591979001|FG004|Overall Study|Withdrawal by Subject|35|||
163892862|NCT04999111|591979002|FG005|Overall Study|Withdrawal by Subject|10|||
163892863|NCT04999111|591978997|FG000|Overall Study|Other|6|||
163892864|NCT04999111|591978998|FG001|Overall Study|Other|6|||
163892865|NCT04999111|591978999|FG002|Overall Study|Other|3|||
163892866|NCT04999111|591979000|FG003|Overall Study|Other|8|||
163892867|NCT04999111|591979001|FG004|Overall Study|Other|8|||
163892868|NCT04999111|591979002|FG005|Overall Study|Other|5|||
163892869|NCT04999111|591978997|FG000|Overall Study|Non-compliance with study schedule|1|||
163892870|NCT04999111|591978998|FG001|Overall Study|Non-compliance with study schedule|0|||
163892871|NCT04999111|591978999|FG002|Overall Study|Non-compliance with study schedule|0|||
163892872|NCT04999111|591979000|FG003|Overall Study|Non-compliance with study schedule|1|||
163892873|NCT04999111|591979001|FG004|Overall Study|Non-compliance with study schedule|1|||
163892874|NCT04999111|591979002|FG005|Overall Study|Non-compliance with study schedule|1|||
163892875|NCT04999111|591978997|FG000|Overall Study|Randomized but not vaccinated|1|||
163892876|NCT04999111|591978998|FG001|Overall Study|Randomized but not vaccinated|2|||
163892877|NCT04999111|591978999|FG002|Overall Study|Randomized but not vaccinated|0|||
163892878|NCT04999111|591979000|FG003|Overall Study|Randomized but not vaccinated|3|||
163892879|NCT04999111|591979001|FG004|Overall Study|Randomized but not vaccinated|3|||
163892880|NCT04999111|591979002|FG005|Overall Study|Randomized but not vaccinated|0|||
163892881|NCT04999111|591978997|FG000|Overall Study|Adverse Event|1|||
163892882|NCT04999111|591978998|FG001|Overall Study|Adverse Event|1|||
163892883|NCT04999111|591978999|FG002|Overall Study|Adverse Event|0|||
163892884|NCT04999111|591979000|FG003|Overall Study|Adverse Event|0|||
163892885|NCT04999111|591979001|FG004|Overall Study|Adverse Event|0|||
163892886|NCT04999111|591979002|FG005|Overall Study|Adverse Event|0|||
163892887|NCT04999111|591978997|FG000|Overall Study|Initiated prohibited medication|0|||
163892888|NCT04999111|591978998|FG001|Overall Study|Initiated prohibited medication|0|||
163892889|NCT04999111|591978999|FG002|Overall Study|Initiated prohibited medication|0|||
163892890|NCT04999111|591979000|FG003|Overall Study|Initiated prohibited medication|0|||
163892891|NCT04999111|591979001|FG004|Overall Study|Initiated prohibited medication|1|||
163892892|NCT04999111|591979002|FG005|Overall Study|Initiated prohibited medication|0|||
164085900|NCT00310856|592678587|FG002|Overall Study|Withdrawal by Subject|2|||
164085901|NCT00310856|592678585|FG000|Overall Study|Lost to Follow-up|1|||
164342146|NCT00599924|593629365|FG002|Overall Study|Withdrawal by Subject|1|||
164342147|NCT00599924|593629366|FG003|Overall Study|Withdrawal by Subject|0|||
164342148|NCT00599924|593629367|FG004|Overall Study|Withdrawal by Subject|1|||
164342149|NCT00599924|593629368|FG005|Overall Study|Withdrawal by Subject|0|||
164342150|NCT00599924|593629369|FG006|Overall Study|Withdrawal by Subject|0|||
164085902|NCT00310856|592678586|FG001|Overall Study|Lost to Follow-up|2|||
163892893|NCT03714815|591979003|FG000|Overall Study|Physician Decision|2|||
163892894|NCT03714815|591979003|FG000|Overall Study|Withdrawal by Subject|2|||
163892895|NCT03714815|591979003|FG000|Overall Study|Death|11|||
163892896|NCT04056611|591979010|FG000|Overall Study|Physician Decision|1|||
163892897|NCT03213873|591979013|FG000|Overall Study|Withdrawal by Subject|8|||
163892898|NCT03213873|591979014|FG001|Overall Study|Withdrawal by Subject|9|||
163892899|NCT03213873|591979013|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
163892900|NCT03213873|591979014|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
163892901|NCT03213873|591979013|FG000|Overall Study|Lost to Follow-up|0|||
164085903|NCT00310856|592678587|FG002|Overall Study|Lost to Follow-up|6|||
164342151|NCT00599924|593629363|FG000|Overall Study|Other|0|||
164342152|NCT00599924|593629364|FG001|Overall Study|Other|0|||
164270039|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270040|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270041|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270042|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270043|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270044|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270045|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270046|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
164270047|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270048|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
164270049|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
164270050|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
164270051|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270052|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270053|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270054|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
164270055|NCT02528357|593356827|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270056|NCT02528357|593356828|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270057|NCT02528357|593356829|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270058|NCT02528357|593356830|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270059|NCT02528357|593356831|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270060|NCT02528357|593356832|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270061|NCT02528357|593356833|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270062|NCT02528357|593356834|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270063|NCT02528357|593356835|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270064|NCT02528357|593356836|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270065|NCT02528357|593356837|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270066|NCT02528357|593356838|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
164270067|NCT02528357|593356839|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
164270068|NCT02528357|593356840|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270069|NCT02528357|593356841|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270070|NCT02528357|593356842|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270071|NCT02528357|593356843|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270072|NCT02528357|593356844|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270073|NCT02528357|593356845|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270074|NCT02528357|593356827|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270075|NCT02528357|593356828|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164342153|NCT00599924|593629365|FG002|Overall Study|Other|0|||
164342154|NCT00599924|593629366|FG003|Overall Study|Other|1|||
164342155|NCT00599924|593629367|FG004|Overall Study|Other|2|||
164342156|NCT00599924|593629368|FG005|Overall Study|Other|0|||
164342157|NCT00599924|593629369|FG006|Overall Study|Other|2|||
164342158|NCT02587234|593629370|FG000|Overall Study|Withdrawal by Subject|1|||
164342159|NCT02587234|593629371|FG001|Overall Study|Withdrawal by Subject|1|||
164342160|NCT02587234|593629370|FG000|Overall Study|Lost to Follow-up|0|||
164342161|NCT02587234|593629371|FG001|Overall Study|Lost to Follow-up|2|||
164342162|NCT02165215|593629372|FG000|Induction Phase|Adverse Event|1|||
164085904|NCT00310856|592678585|FG000|Overall Study|Inappropriate enrollment|1|||
164342163|NCT02165215|593629373|FG001|Induction Phase|Adverse Event|0|||
164342164|NCT02165215|593629374|FG002|Induction Phase|Adverse Event|0|||
164342165|NCT02165215|593629372|FG000|Induction Phase|Withdrawal by Subject|10|||
164342166|NCT02165215|593629373|FG001|Induction Phase|Withdrawal by Subject|0|||
164085905|NCT00310856|592678586|FG001|Overall Study|Inappropriate enrollment|1|||
164342167|NCT02165215|593629374|FG002|Induction Phase|Withdrawal by Subject|0|||
164342168|NCT02165215|593629372|FG000|Induction Phase|Protocol Violation|1|||
164342169|NCT02165215|593629373|FG001|Induction Phase|Protocol Violation|0|||
164342170|NCT02165215|593629374|FG002|Induction Phase|Protocol Violation|0|||
164342171|NCT02165215|593629372|FG000|Induction Phase|Physician Decision|1|||
164342172|NCT02165215|593629373|FG001|Induction Phase|Physician Decision|0|||
164342173|NCT02165215|593629374|FG002|Induction Phase|Physician Decision|0|||
164342174|NCT02165215|593629372|FG000|Induction Phase|Lack of Efficacy|2|||
164342175|NCT02165215|593629373|FG001|Induction Phase|Lack of Efficacy|0|||
164270076|NCT02528357|593356829|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270077|NCT02528357|593356830|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270078|NCT02528357|593356831|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270079|NCT02528357|593356832|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270080|NCT02528357|593356833|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270081|NCT02528357|593356834|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270082|NCT02528357|593356835|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270083|NCT02528357|593356836|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270084|NCT02528357|593356837|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270085|NCT02528357|593356838|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270086|NCT02528357|593356839|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270087|NCT02528357|593356840|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270088|NCT02528357|593356841|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270089|NCT02528357|593356842|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270090|NCT02528357|593356843|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
164270091|NCT02528357|593356844|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270092|NCT02528357|593356845|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
164270093|NCT02528357|593356827|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270094|NCT02528357|593356828|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270095|NCT02528357|593356829|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270096|NCT02528357|593356830|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270097|NCT02528357|593356831|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270098|NCT02528357|593356832|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270099|NCT02528357|593356833|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270100|NCT02528357|593356834|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270101|NCT02528357|593356835|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270102|NCT02528357|593356836|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270103|NCT02528357|593356837|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164342176|NCT02165215|593629374|FG002|Induction Phase|Lack of Efficacy|0|||
164342177|NCT02165215|593629372|FG000|Induction Phase|Non-Compliance|2|||
164342178|NCT02165215|593629373|FG001|Induction Phase|Non-Compliance|0|||
163892902|NCT03213873|591979014|FG001|Overall Study|Lost to Follow-up|2|||
163892903|NCT02631746|591979020|FG000|Overall Study|Lack of Efficacy|3|||
163892904|NCT04709419|591979021|FG000|Overall Study|Physician Decision|1|||
163892905|NCT04709419|591979022|FG001|Overall Study|Physician Decision|0|||
163892906|NCT02056834|591979023|FG000|Overall Study|Lost to Follow-up|7|||
163892907|NCT04580914|591979034|FG000|Overall Study|Withdrawal by Subject|6|||
163892908|NCT04580914|591979034|FG000|Overall Study|Lost to Follow-up|2|||
163892909|NCT02828358|591979036|FG000|Overall Study|Physician Decision|7|||
163892910|NCT02828358|591979037|FG001|Overall Study|Physician Decision|1|||
163892911|NCT02828358|591979036|FG000|Overall Study|Treatment Failure|6|||
163892912|NCT02828358|591979037|FG001|Overall Study|Treatment Failure|0|||
163892913|NCT02828358|591979036|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
163892914|NCT02828358|591979037|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
163892915|NCT02828358|591979036|FG000|Overall Study|Refusal of further protocol therapy|2|||
163892916|NCT02828358|591979037|FG001|Overall Study|Refusal of further protocol therapy|0|||
163892917|NCT02828358|591979036|FG000|Overall Study|Relapse|25|||
163892918|NCT02828358|591979037|FG001|Overall Study|Relapse|0|||
163892919|NCT02828358|591979036|FG000|Overall Study|Still on therapy|5|||
163892920|NCT02828358|591979037|FG001|Overall Study|Still on therapy|0|||
163892921|NCT05285137|591979052|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
163892922|NCT05285137|591979053|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
163892923|NCT05285137|591979054|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
163892924|NCT05285137|591979055|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
163892925|NCT05285137|591979056|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
163892926|NCT05285137|591979057|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
163892927|NCT05285137|591979058|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
163892928|NCT05285137|591979059|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
163892929|NCT05285137|591979060|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
163892930|NCT05285137|591979052|FG000|Overall Study|Lost to Follow-up|0|||
163892931|NCT05285137|591979053|FG001|Overall Study|Lost to Follow-up|0|||
163892932|NCT05285137|591979054|FG002|Overall Study|Lost to Follow-up|1|||
164342179|NCT02165215|593629374|FG002|Induction Phase|Non-Compliance|0|||
163892933|NCT05285137|591979055|FG003|Overall Study|Lost to Follow-up|3|||
163892934|NCT05285137|591979056|FG004|Overall Study|Lost to Follow-up|0|||
163999008|NCT02875223|592359186|FG000|Overall Study|Withdrawal by Subject|0|||
163999009|NCT02875223|592359187|FG001|Overall Study|Withdrawal by Subject|0|||
163999010|NCT02875223|592359188|FG002|Overall Study|Withdrawal by Subject|0|||
163999011|NCT02875223|592359189|FG003|Overall Study|Withdrawal by Subject|0|||
163999012|NCT02875223|592359190|FG004|Overall Study|Withdrawal by Subject|1|||
163999013|NCT02875223|592359191|FG005|Overall Study|Withdrawal by Subject|1|||
163999014|NCT02875223|592359192|FG006|Overall Study|Withdrawal by Subject|0|||
163999015|NCT02875223|592359193|FG007|Overall Study|Withdrawal by Subject|0|||
163999016|NCT02875223|592359194|FG008|Overall Study|Withdrawal by Subject|1|||
163999017|NCT02875223|592359195|FG009|Overall Study|Withdrawal by Subject|0|||
163999018|NCT02875223|592359196|FG010|Overall Study|Withdrawal by Subject|0|||
163999019|NCT02875223|592359197|FG011|Overall Study|Withdrawal by Subject|0|||
163999020|NCT02875223|592359198|FG012|Overall Study|Withdrawal by Subject|0|||
163999021|NCT02875223|592359186|FG000|Overall Study|Progressive disease|0|||
163999022|NCT02875223|592359187|FG001|Overall Study|Progressive disease|0|||
163999023|NCT02875223|592359188|FG002|Overall Study|Progressive disease|1|||
163999024|NCT02875223|592359189|FG003|Overall Study|Progressive disease|0|||
163999025|NCT02875223|592359190|FG004|Overall Study|Progressive disease|0|||
163999026|NCT02875223|592359191|FG005|Overall Study|Progressive disease|0|||
163999027|NCT02875223|592359192|FG006|Overall Study|Progressive disease|0|||
163999028|NCT02875223|592359193|FG007|Overall Study|Progressive disease|0|||
163999029|NCT02875223|592359194|FG008|Overall Study|Progressive disease|0|||
163999030|NCT02875223|592359195|FG009|Overall Study|Progressive disease|12|||
163999031|NCT02875223|592359196|FG010|Overall Study|Progressive disease|2|||
163999032|NCT02875223|592359197|FG011|Overall Study|Progressive disease|3|||
163999033|NCT02875223|592359198|FG012|Overall Study|Progressive disease|6|||
164270104|NCT02528357|593356838|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270105|NCT02528357|593356839|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270106|NCT02528357|593356840|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270107|NCT02528357|593356841|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270108|NCT02528357|593356842|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
164270109|NCT02528357|593356843|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
164270110|NCT02528357|593356844|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
164270111|NCT02528357|593356845|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
164270112|NCT01455220|593356847|FG000|Overall Study|screen fail|30|||
164270113|NCT02621073|593356848|FG000|Overall Study|Lost to Follow-up|0|||
164270114|NCT02621073|593356849|FG001|Overall Study|Lost to Follow-up|1|||
164270115|NCT02621073|593356848|FG000|Overall Study|Physician Decision|3|||
164270116|NCT02621073|593356849|FG001|Overall Study|Physician Decision|2|||
164270117|NCT01595581|593356850|FG000|Overall Study|Withdrawal by Subject|1|||
164270118|NCT01595581|593356851|FG001|Overall Study|Withdrawal by Subject|0|||
164270119|NCT01969721|593356853|FG000|Overall Study|Adverse Event|3|||
164270120|NCT01969721|593356854|FG001|Overall Study|Adverse Event|8|||
164270121|NCT01969721|593356855|FG002|Overall Study|Adverse Event|3|||
164270122|NCT01969721|593356856|FG003|Overall Study|Adverse Event|2|||
164270123|NCT01969721|593356853|FG000|Overall Study|Lack of Efficacy|0|||
164270124|NCT01969721|593356854|FG001|Overall Study|Lack of Efficacy|0|||
164270125|NCT01969721|593356855|FG002|Overall Study|Lack of Efficacy|1|||
164270126|NCT01969721|593356856|FG003|Overall Study|Lack of Efficacy|0|||
164270127|NCT01969721|593356853|FG000|Overall Study|Non compliant with protocol|1|||
164270128|NCT01969721|593356854|FG001|Overall Study|Non compliant with protocol|1|||
164270129|NCT01969721|593356855|FG002|Overall Study|Non compliant with protocol|0|||
164270130|NCT01969721|593356856|FG003|Overall Study|Non compliant with protocol|2|||
164270131|NCT01969721|593356853|FG000|Overall Study|Other not defined above|0|||
164342180|NCT02165215|593629372|FG000|Induction Phase|Lost to Follow-up|6|||
164342181|NCT02165215|593629373|FG001|Induction Phase|Lost to Follow-up|0|||
164342182|NCT02165215|593629374|FG002|Induction Phase|Lost to Follow-up|0|||
164342183|NCT02165215|593629372|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164342184|NCT02165215|593629373|FG001|Maintenance Phase|Withdrawal by Subject|7|||
164342185|NCT02165215|593629374|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164342186|NCT02165215|593629372|FG000|Maintenance Phase|Multiple reasons|0|||
164342187|NCT02165215|593629373|FG001|Maintenance Phase|Multiple reasons|2|||
164342188|NCT02165215|593629374|FG002|Maintenance Phase|Multiple reasons|1|||
163999034|NCT02875223|592359186|FG000|Overall Study|Death|4|||
164342189|NCT02165215|593629372|FG000|Maintenance Phase|Lost to Follow-up|0|||
163999035|NCT02875223|592359187|FG001|Overall Study|Death|4|||
163999036|NCT02875223|592359188|FG002|Overall Study|Death|3|||
163999037|NCT02875223|592359189|FG003|Overall Study|Death|4|||
163999038|NCT02875223|592359190|FG004|Overall Study|Death|2|||
163999039|NCT02875223|592359191|FG005|Overall Study|Death|3|||
163999040|NCT02875223|592359192|FG006|Overall Study|Death|5|||
163999041|NCT02875223|592359193|FG007|Overall Study|Death|7|||
163999042|NCT02875223|592359194|FG008|Overall Study|Death|3|||
163999043|NCT02875223|592359195|FG009|Overall Study|Death|2|||
163999044|NCT02875223|592359196|FG010|Overall Study|Death|0|||
163892935|NCT05285137|591979057|FG005|Overall Study|Lost to Follow-up|0|||
163892936|NCT05285137|591979058|FG006|Overall Study|Lost to Follow-up|1|||
163892937|NCT05285137|591979059|FG007|Overall Study|Lost to Follow-up|0|||
163892938|NCT05285137|591979060|FG008|Overall Study|Lost to Follow-up|0|||
163892939|NCT05285137|591979052|FG000|Overall Study|Physician Decision|0|||
163892940|NCT05285137|591979053|FG001|Overall Study|Physician Decision|1|||
163892941|NCT05285137|591979054|FG002|Overall Study|Physician Decision|0|||
163892942|NCT05285137|591979055|FG003|Overall Study|Physician Decision|0|||
163892943|NCT05285137|591979056|FG004|Overall Study|Physician Decision|0|||
163892944|NCT05285137|591979057|FG005|Overall Study|Physician Decision|0|||
163892945|NCT05285137|591979058|FG006|Overall Study|Physician Decision|0|||
163892946|NCT05285137|591979059|FG007|Overall Study|Physician Decision|0|||
163892947|NCT05285137|591979060|FG008|Overall Study|Physician Decision|0|||
163892948|NCT05285137|591979052|FG000|Overall Study|Pregnancy|0|||
163892949|NCT05285137|591979053|FG001|Overall Study|Pregnancy|0|||
163892950|NCT05285137|591979054|FG002|Overall Study|Pregnancy|0|||
163892951|NCT05285137|591979055|FG003|Overall Study|Pregnancy|0|||
163892952|NCT05285137|591979056|FG004|Overall Study|Pregnancy|0|||
163892953|NCT05285137|591979057|FG005|Overall Study|Pregnancy|0|||
163892954|NCT05285137|591979058|FG006|Overall Study|Pregnancy|1|||
163892955|NCT05285137|591979059|FG007|Overall Study|Pregnancy|0|||
163892956|NCT05285137|591979060|FG008|Overall Study|Pregnancy|0|||
163892957|NCT05285137|591979052|FG000|Overall Study|Withdrawal by Subject|0|||
163892958|NCT05285137|591979053|FG001|Overall Study|Withdrawal by Subject|1|||
163892959|NCT05285137|591979054|FG002|Overall Study|Withdrawal by Subject|2|||
163892960|NCT05285137|591979055|FG003|Overall Study|Withdrawal by Subject|1|||
163892961|NCT05285137|591979056|FG004|Overall Study|Withdrawal by Subject|0|||
163892962|NCT05285137|591979057|FG005|Overall Study|Withdrawal by Subject|0|||
163892963|NCT05285137|591979058|FG006|Overall Study|Withdrawal by Subject|0|||
163892964|NCT05285137|591979059|FG007|Overall Study|Withdrawal by Subject|0|||
163892965|NCT05285137|591979060|FG008|Overall Study|Withdrawal by Subject|1|||
163892966|NCT05309291|591979061|FG000|Overall Study|Adverse Event|0|||
163892967|NCT05309291|591979062|FG001|Overall Study|Adverse Event|1|||
163892968|NCT03221426|591979064|FG000|Overall Study|Ongoing in study|212|||
163892969|NCT03221426|591979065|FG001|Overall Study|Ongoing in study|193|||
163892970|NCT03221426|591979066|FG002|Overall Study|Ongoing in study|61|||
163892971|NCT03221426|591979067|FG003|Overall Study|Ongoing in study|55|||
163892972|NCT03221426|591979064|FG000|Overall Study|Withdrawal by Subject|12|||
163892973|NCT03221426|591979065|FG001|Overall Study|Withdrawal by Subject|4|||
163892974|NCT03221426|591979066|FG002|Overall Study|Withdrawal by Subject|2|||
163892975|NCT03221426|591979067|FG003|Overall Study|Withdrawal by Subject|3|||
163892976|NCT03221426|591979064|FG000|Overall Study|Lost to Follow-up|4|||
163892977|NCT03221426|591979065|FG001|Overall Study|Lost to Follow-up|1|||
163892978|NCT03221426|591979066|FG002|Overall Study|Lost to Follow-up|1|||
163892979|NCT03221426|591979067|FG003|Overall Study|Lost to Follow-up|0|||
163892980|NCT03221426|591979064|FG000|Overall Study|Death|174|||
163892981|NCT03221426|591979065|FG001|Overall Study|Death|204|||
163892982|NCT03221426|591979066|FG002|Overall Study|Death|36|||
163892983|NCT03221426|591979067|FG003|Overall Study|Death|45|||
163892984|NCT06262477|591980455|FG000|Overall Study|Withdrawal by Subject|1|||
163892985|NCT06262477|591980456|FG001|Overall Study|Withdrawal by Subject|0|||
163892986|NCT06262477|591980455|FG000|Overall Study|Adverse Event|0|||
163892987|NCT06262477|591980456|FG001|Overall Study|Adverse Event|1|||
163892988|NCT06262477|591980455|FG000|Overall Study|Lost to Follow-up|0|||
163892989|NCT06262477|591980456|FG001|Overall Study|Lost to Follow-up|1|||
163892990|NCT03220035|591980460|FG000|Overall Study|Adverse Event|1|||
163892991|NCT03220035|591980460|FG000|Overall Study|Protocol Violation|1|||
163892992|NCT03220035|591980460|FG000|Overall Study|Progressive Disease|2|||
163892993|NCT04024020|591980465|FG000|Overall Study|Withdrawal by Subject|2|||
163892994|NCT04024020|591980466|FG001|Overall Study|Withdrawal by Subject|2|||
163892995|NCT05269966|591980467|FG000|Overall Study|Adverse Event|4|||
163892996|NCT05269966|591980467|FG000|Overall Study|Withdrawal by Subject|1|||
163892997|NCT05269966|591980467|FG000|Overall Study|Lost to Follow-up|4|||
163892998|NCT05269966|591980467|FG000|Overall Study|Physician Decision|1|||
163892999|NCT06262347|591980470|FG000|Overall Study|Lost to Follow-up|4|||
163893000|NCT06262347|591980471|FG001|Overall Study|Lost to Follow-up|3|||
163893001|NCT06262347|591980470|FG000|Overall Study|Withdrawal by Subject|0|||
163893002|NCT06262347|591980471|FG001|Overall Study|Withdrawal by Subject|1|||
163893003|NCT04660539|591980486|FG000|Overall Study|Adverse Event|10|||
163893004|NCT04660539|591980486|FG000|Overall Study|Lack of Efficacy|4|||
163893005|NCT04660539|591980486|FG000|Overall Study|Lost to Follow-up|5|||
163893006|NCT04660539|591980486|FG000|Overall Study|Non-Compliance With Study Drug|3|||
163893007|NCT04660539|591980486|FG000|Overall Study|Reason not Specified|12|||
163999045|NCT02875223|592359197|FG011|Overall Study|Death|0|||
163999046|NCT02875223|592359198|FG012|Overall Study|Death|0|||
163893008|NCT04660539|591980486|FG000|Overall Study|Pregnancy|2|||
163893009|NCT04660539|591980486|FG000|Overall Study|Protocol Violation|2|||
163893010|NCT04660539|591980486|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
163893011|NCT04660539|591980486|FG000|Overall Study|Withdrawal by Subject|21|||
163999047|NCT02875223|592359186|FG000|Overall Study|Lost to Follow-up|0|||
163999048|NCT02875223|592359187|FG001|Overall Study|Lost to Follow-up|1|||
163999049|NCT02875223|592359188|FG002|Overall Study|Lost to Follow-up|1|||
163999050|NCT02875223|592359189|FG003|Overall Study|Lost to Follow-up|0|||
163999051|NCT02875223|592359190|FG004|Overall Study|Lost to Follow-up|1|||
163999052|NCT02875223|592359191|FG005|Overall Study|Lost to Follow-up|0|||
163999053|NCT02875223|592359192|FG006|Overall Study|Lost to Follow-up|1|||
163999054|NCT02875223|592359193|FG007|Overall Study|Lost to Follow-up|1|||
163999055|NCT02875223|592359194|FG008|Overall Study|Lost to Follow-up|0|||
163999056|NCT02875223|592359195|FG009|Overall Study|Lost to Follow-up|0|||
164085906|NCT00310856|592678587|FG002|Overall Study|Inappropriate enrollment|0|||
164085907|NCT00310856|592678585|FG000|Overall Study|Unable to classify|1|||
163893012|NCT05618587|591980487|FG000|Overall Study|Lost to Follow-up|2|||
163893013|NCT05618587|591980488|FG001|Overall Study|Lost to Follow-up|0|||
163893014|NCT05167864|591980489|FG000|Overall Study|Lost to Follow-up|7|||
163893015|NCT05167864|591980490|FG001|Overall Study|Lost to Follow-up|6|||
163893016|NCT05167864|591980491|FG002|Overall Study|Lost to Follow-up|7|||
163893017|NCT05167864|591980492|FG003|Overall Study|Lost to Follow-up|9|||
163893018|NCT03852550|591980495|FG000|Overall Study|Lost to Follow-up|4|||
163893019|NCT03852550|591980496|FG001|Overall Study|Lost to Follow-up|3|||
163893020|NCT03852550|591980495|FG000|Overall Study|Only parent outcomes completed|0|||
163893021|NCT03852550|591980496|FG001|Overall Study|Only parent outcomes completed|1|||
163893022|NCT03852550|591980495|FG000|Overall Study|Withdrawal by Subject|1|||
163893023|NCT03852550|591980496|FG001|Overall Study|Withdrawal by Subject|0|||
163893024|NCT05204654|591980497|FG000|Overall Study|Study terminated due to time restraint|2|||
163893025|NCT05204654|591980498|FG001|Overall Study|Study terminated due to time restraint|2|||
163893026|NCT01828112|591980506|FG000|Treatment Phase|Adverse Event|7|||
163893027|NCT01828112|591980507|FG001|Treatment Phase|Adverse Event|8|||
163893028|NCT01828112|591980508|FG002|Treatment Phase|Adverse Event|0|||
163893029|NCT01828112|591980506|FG000|Treatment Phase|Death|9|||
163893030|NCT01828112|591980507|FG001|Treatment Phase|Death|5|||
163893031|NCT01828112|591980508|FG002|Treatment Phase|Death|0|||
163893032|NCT01828112|591980506|FG000|Treatment Phase|No longer required treatment|0|||
163893033|NCT01828112|591980507|FG001|Treatment Phase|No longer required treatment|1|||
163893034|NCT01828112|591980508|FG002|Treatment Phase|No longer required treatment|0|||
163893035|NCT01828112|591980506|FG000|Treatment Phase|Physician Decision|6|||
163893036|NCT01828112|591980507|FG001|Treatment Phase|Physician Decision|7|||
163893037|NCT01828112|591980508|FG002|Treatment Phase|Physician Decision|0|||
163893038|NCT01828112|591980506|FG000|Treatment Phase|Pregnancy|1|||
163893039|NCT01828112|591980507|FG001|Treatment Phase|Pregnancy|0|||
163893040|NCT01828112|591980508|FG002|Treatment Phase|Pregnancy|0|||
163893041|NCT01828112|591980506|FG000|Treatment Phase|Progressive disease|79|||
163893042|NCT01828112|591980507|FG001|Treatment Phase|Progressive disease|87|||
163893043|NCT01828112|591980508|FG002|Treatment Phase|Progressive disease|0|||
163893044|NCT01828112|591980506|FG000|Treatment Phase|Study terminated by sponsor|1|||
163893045|NCT01828112|591980507|FG001|Treatment Phase|Study terminated by sponsor|0|||
163893046|NCT01828112|591980508|FG002|Treatment Phase|Study terminated by sponsor|0|||
163893047|NCT01828112|591980506|FG000|Treatment Phase|Subject/guardian decision|12|||
163893048|NCT01828112|591980507|FG001|Treatment Phase|Subject/guardian decision|8|||
163893049|NCT01828112|591980508|FG002|Treatment Phase|Subject/guardian decision|0|||
163893050|NCT01828112|591980506|FG000|Extension Treatment Phase|Adverse Event|0|||
163893051|NCT01828112|591980507|FG001|Extension Treatment Phase|Adverse Event|0|||
163893052|NCT01828112|591980508|FG002|Extension Treatment Phase|Adverse Event|6|||
163893053|NCT01828112|591980506|FG000|Extension Treatment Phase|Death|0|||
163893054|NCT01828112|591980507|FG001|Extension Treatment Phase|Death|0|||
163893055|NCT01828112|591980508|FG002|Extension Treatment Phase|Death|17|||
163893056|NCT01828112|591980506|FG000|Extension Treatment Phase|Physician Decision|0|||
163893057|NCT01828112|591980507|FG001|Extension Treatment Phase|Physician Decision|0|||
163893058|NCT01828112|591980508|FG002|Extension Treatment Phase|Physician Decision|5|||
163893059|NCT01828112|591980506|FG000|Extension Treatment Phase|Progressive disease|0|||
163893060|NCT01828112|591980507|FG001|Extension Treatment Phase|Progressive disease|0|||
163893061|NCT01828112|591980508|FG002|Extension Treatment Phase|Progressive disease|46|||
163893062|NCT01828112|591980506|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
163893063|NCT01828112|591980507|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
163893064|NCT01828112|591980508|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
163893065|NCT01828112|591980506|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
163893066|NCT01828112|591980507|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
163893067|NCT01828112|591980508|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
163893068|NCT05565820|591980519|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
163999057|NCT02875223|592359196|FG010|Overall Study|Lost to Follow-up|0|||
164085908|NCT00310856|592678586|FG001|Overall Study|Unable to classify|0|||
163893069|NCT05565820|591980520|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
163893070|NCT05565820|591980519|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
163893071|NCT05565820|591980520|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
163893072|NCT05586490|591980522|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163999058|NCT02875223|592359197|FG011|Overall Study|Lost to Follow-up|0|||
164270132|NCT01969721|593356854|FG001|Overall Study|Other not defined above|2|||
164270133|NCT01969721|593356855|FG002|Overall Study|Other not defined above|0|||
164270134|NCT01969721|593356856|FG003|Overall Study|Other not defined above|0|||
164270135|NCT01969721|593356853|FG000|Overall Study|Discontinued during washout periods.|0|||
164270136|NCT01969721|593356854|FG001|Overall Study|Discontinued during washout periods.|1|||
164270137|NCT01969721|593356855|FG002|Overall Study|Discontinued during washout periods.|1|||
164270138|NCT01969721|593356856|FG003|Overall Study|Discontinued during washout periods.|2|||
164270139|NCT00495755|593356857|FG000|Overall Study|Adverse Event|3|||
164270140|NCT02920957|593356858|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
164270141|NCT02920957|593356859|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
164270142|NCT02920957|593356858|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
164270143|NCT02920957|593356859|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
163893073|NCT05586490|591980523|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163893074|NCT05586490|591980524|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
163893075|NCT05586490|591980525|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163893076|NCT05586490|591980526|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
163893077|NCT05586490|591980522|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
163893078|NCT05586490|591980523|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163893079|NCT05586490|591980524|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163893080|NCT05586490|591980525|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163893081|NCT05586490|591980526|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
163893082|NCT05586490|591980522|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
163893083|NCT05586490|591980523|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163893084|NCT05586490|591980524|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163893085|NCT05586490|591980525|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163893086|NCT05586490|591980526|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
163893087|NCT04136912|591980527|FG000|Overall Study|Operational reasons|0|||
163893088|NCT04136912|591980528|FG001|Overall Study|Operational reasons|0|||
163893089|NCT04136912|591980529|FG002|Overall Study|Operational reasons|2|||
163893090|NCT03606408|591980530|FG000|Overall Study|Adverse Event|13|||
163893091|NCT03606408|591980530|FG000|Overall Study|Withdrawal by Subject|7|||
163893092|NCT03606408|591980530|FG000|Overall Study|Physician Decision|4|||
163893093|NCT03606408|591980530|FG000|Overall Study|Lack of Efficacy|2|||
163893094|NCT03606408|591980530|FG000|Overall Study|Death|1|||
163893095|NCT03606408|591980530|FG000|Overall Study|new therapy for study indication|1|||
163893096|NCT03556293|591980531|FG000|Overall Study|Ineligible for analysis|1904|||
163893097|NCT03556293|591980532|FG001|Overall Study|Ineligible for analysis|1471|||
163893098|NCT03556293|591980533|FG002|Overall Study|Ineligible for analysis|1091|||
163893099|NCT03556293|591980534|FG003|Overall Study|Ineligible for analysis|1269|||
163893100|NCT03292484|591980535|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
163893101|NCT03292484|591980535|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
163893102|NCT03292484|591980535|FG000|Overall Study|Protocol Violation|2|||
163893103|NCT03292484|591980535|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
163893104|NCT03292484|591980535|FG000|Overall Study|Sponsor decision|349|||
163893105|NCT03292484|591980535|FG000|Overall Study|Lost to Follow-up|7|||
163893106|NCT03292484|591980535|FG000|Overall Study|Coronavirus Disease 2019|1|||
163893107|NCT03292484|591980535|FG000|Overall Study|Other|20|||
163893108|NCT05012163|591980539|FG000|Overall Study|Protocol Violation|0|||
163893109|NCT05012163|591980540|FG001|Overall Study|Protocol Violation|0|||
163893110|NCT05012163|591980541|FG002|Overall Study|Protocol Violation|1|||
163893111|NCT05012163|591980542|FG003|Overall Study|Protocol Violation|1|||
163893112|NCT05524402|591980548|FG000|Overall Study|Withdrawal by Subject|3|||
163893113|NCT05524402|591980549|FG001|Overall Study|Withdrawal by Subject|1|||
163893114|NCT05524402|591980548|FG000|Overall Study|Lost to Follow-up|2|||
163893115|NCT05524402|591980549|FG001|Overall Study|Lost to Follow-up|1|||
163893116|NCT05976334|591980550|FG000|Part B|Death|0|||
163893117|NCT05976334|591980551|FG001|Part B|Death|1|||
163893118|NCT05976334|591980550|FG000|Part B|Study Terminated by Sponsor|0|||
163893119|NCT05976334|591980551|FG001|Part B|Study Terminated by Sponsor|1|||
163893120|NCT05976334|591980550|FG000|Part B|Reason Not Specified|0|||
163893121|NCT05976334|591980551|FG001|Part B|Reason Not Specified|1|||
163893122|NCT03381586|591980552|FG000|Overall Study|Adverse Event|1|||
163893123|NCT03381586|591980553|FG001|Overall Study|Adverse Event|1|||
163893124|NCT03381586|591980552|FG000|Overall Study|Protocol Violation|1|||
163893125|NCT03381586|591980553|FG001|Overall Study|Protocol Violation|0|||
163893126|NCT03381586|591980552|FG000|Overall Study|Withdrawal by Subject|1|||
163893127|NCT03381586|591980553|FG001|Overall Study|Withdrawal by Subject|2|||
163893128|NCT05280574|591980559|FG000|Overall Study|Withdrawal by Subject|0|||
163893129|NCT05280574|591980560|FG001|Overall Study|Withdrawal by Subject|2|||
163893130|NCT05280574|591980561|FG002|Overall Study|Withdrawal by Subject|0|||
163893131|NCT03733925|591980564|FG000|Overall Study|Lost to Follow-up|1|||
163893132|NCT03733925|591980564|FG000|Overall Study|Withdrawal by Subject|2|||
163893133|NCT03733925|591980564|FG000|Overall Study|Adverse Event|2|||
163999059|NCT02875223|592359198|FG012|Overall Study|Lost to Follow-up|0|||
163999060|NCT03136107|592359199|FG000|Overall Study|Other (Not specified)|1|||
163999061|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
163999062|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
163999063|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
163999064|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
163999065|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
163999066|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
163999067|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
163999068|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
163999069|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
163999070|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
163999071|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
163999072|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
163999073|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
163999074|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
163999075|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
163999076|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
163999077|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
163999078|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
163999079|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
163999080|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163999081|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163999082|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163999083|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163999084|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
163999085|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
163999086|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
163999087|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
163999088|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163999089|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163999090|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
163999091|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
163999092|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
163999093|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
163999094|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
163999095|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
163999096|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
163999097|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
163999098|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
163999099|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
163999100|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
163999101|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
163999102|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
163999103|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
163999104|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
163999105|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
163999106|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
163999107|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
163999108|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
163999109|NCT01707992|592359201|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
163999110|NCT01707992|592359202|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
163999111|NCT01707992|592359203|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
163999112|NCT01707992|592359204|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
163999113|NCT01707992|592359205|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
163999114|NCT01707992|592359206|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
163999115|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
163999116|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
163999117|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
163999118|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
163893134|NCT03733925|591980564|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163893135|NCT02361216|591980565|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
163893136|NCT02361216|591980566|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
163999119|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
163999120|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
163999121|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
164270144|NCT02920957|593356858|FG000|First Intervention : 1 Month|Adverse Event|1|||
164270145|NCT02920957|593356859|FG001|First Intervention : 1 Month|Adverse Event|0|||
164270146|NCT02920957|593356858|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
164270147|NCT02920957|593356859|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
164270148|NCT01789606|593356862|FG000|Overall Study|Participant not Purchased the Product|0|||
164270149|NCT01789606|593356863|FG001|Overall Study|Participant not Purchased the Product|20|||
164270150|NCT01789606|593356862|FG000|Overall Study|Withdrawal by Subject|0|||
164270151|NCT01789606|593356863|FG001|Overall Study|Withdrawal by Subject|1|||
164270152|NCT01789606|593356862|FG000|Overall Study|Ineligible|6|||
164270153|NCT01789606|593356863|FG001|Overall Study|Ineligible|2|||
164270154|NCT01789606|593356862|FG000|Overall Study|Administrative Reasons|17|||
164270155|NCT01789606|593356863|FG001|Overall Study|Administrative Reasons|6|||
164270156|NCT01789606|593356862|FG000|Overall Study|No Study Medication Taken|0|||
164270157|NCT01789606|593356863|FG001|Overall Study|No Study Medication Taken|1|||
164270158|NCT01789606|593356862|FG000|Overall Study|Protocol Violation|0|||
164270159|NCT01789606|593356863|FG001|Overall Study|Protocol Violation|55|||
164270160|NCT01789606|593356862|FG000|Overall Study|Adverse Event|0|||
164270161|NCT01789606|593356863|FG001|Overall Study|Adverse Event|3|||
164270162|NCT01789606|593356862|FG000|Overall Study|Lost to Follow-up|0|||
164270163|NCT01789606|593356863|FG001|Overall Study|Lost to Follow-up|14|||
164270164|NCT01789606|593356862|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
164270165|NCT01789606|593356863|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
164270166|NCT03180307|593356866|FG000|Overall Study|Lost to Follow-up|2|||
164270167|NCT03180307|593356867|FG001|Overall Study|Lost to Follow-up|0|||
164270168|NCT03180307|593356866|FG000|Overall Study|Death|1|||
164270169|NCT03180307|593356867|FG001|Overall Study|Death|0|||
164270170|NCT03180307|593356866|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
164270171|NCT03180307|593356867|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
164270172|NCT03159104|593356868|FG000|Overall Study|Violation of inclusion criteria|1|||
164270173|NCT03159104|593356869|FG001|Overall Study|Violation of inclusion criteria|2|||
164270174|NCT01563172|593356873|FG000|Overall Study|Adverse Event|5|||
163893137|NCT02361216|591980565|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
163893138|NCT02361216|591980566|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
163893139|NCT02361216|591980565|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
163893140|NCT02361216|591980566|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
163893141|NCT02361216|591980565|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
163893142|NCT02361216|591980566|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
163893143|NCT02361216|591980565|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
163893144|NCT02361216|591980566|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
163893145|NCT02361216|591980565|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
163893146|NCT02361216|591980566|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
163893147|NCT05683340|591980567|FG000|Overall Study|Adverse Event|1|||
163893148|NCT05683340|591980568|FG001|Overall Study|Adverse Event|1|||
163893149|NCT05683340|591980567|FG000|Overall Study|Protocol Violation|1|||
163893150|NCT05683340|591980568|FG001|Overall Study|Protocol Violation|0|||
163893151|NCT05683340|591980567|FG000|Overall Study|Withdrawal by Subject|0|||
163893152|NCT05683340|591980568|FG001|Overall Study|Withdrawal by Subject|2|||
163893153|NCT02224144|591980572|FG000|Overall Study|Lost to Follow-up|3|||
163893154|NCT02224144|591980573|FG001|Overall Study|Lost to Follow-up|1|||
163893155|NCT02224144|591980572|FG000|Overall Study|Death|2|||
163893156|NCT02224144|591980573|FG001|Overall Study|Death|0|||
163893157|NCT02224144|591980572|FG000|Overall Study|Withdrawal by Subject|0|||
163893158|NCT02224144|591980573|FG001|Overall Study|Withdrawal by Subject|1|||
163893159|NCT03505008|591980574|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
163893160|NCT03505008|591980575|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
163893161|NCT03505008|591980576|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
163893162|NCT03505008|591980577|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
163893163|NCT03505008|591980574|FG000|Before Week 24 Randomization|Adverse Event|10|||
163893164|NCT03505008|591980575|FG001|Before Week 24 Randomization|Adverse Event|0|||
164270175|NCT01563172|593356873|FG000|Overall Study|Lost to Follow-up|2|||
164270176|NCT01563172|593356873|FG000|Overall Study|Other (Protocol deviation)|5|||
164270177|NCT01563172|593356873|FG000|Overall Study|Other (Not specified)|1|||
164270178|NCT00720343|593358447|FG000|Overall Study|Lost to Follow-up|1|||
164270179|NCT00720343|593358448|FG001|Overall Study|Lost to Follow-up|0|||
164270180|NCT00720343|593358447|FG000|Overall Study|Protocol Violation|0|||
164270181|NCT00720343|593358448|FG001|Overall Study|Protocol Violation|2|||
163999122|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
163999123|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
163999124|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
163999125|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
163999126|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
163999127|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
163999128|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
163999129|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
163999130|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
163999131|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
163999132|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
163999133|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
163999134|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
163999135|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
163999136|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
163999137|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
163999138|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
163999139|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
163999140|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
163999141|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
163999142|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
163999143|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
163999144|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
163999145|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Death|0|||
164270182|NCT03459365|593358451|FG000|Overall Study|Withdrawal by Subject|6|||
163893165|NCT03505008|591980576|FG002|Before Week 24 Randomization|Adverse Event|0|||
163893166|NCT03505008|591980577|FG003|Before Week 24 Randomization|Adverse Event|0|||
163893167|NCT03505008|591980574|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
164270183|NCT03459365|593358451|FG000|Overall Study|Protocol Violation|8|||
163999146|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Death|0|||
163999147|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Death|0|||
163999148|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Death|2|||
163893168|NCT03505008|591980575|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
163893169|NCT03505008|591980576|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
163893170|NCT03505008|591980577|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
163893171|NCT03505008|591980574|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
164270184|NCT00344500|593358453|FG000|Overall Study|Adverse Event|6|||
164270185|NCT00344500|593358454|FG001|Overall Study|Adverse Event|2|||
163999149|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Death|0|||
163999150|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Death|0|||
163999151|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
163999152|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
163999153|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
163999154|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
163999155|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
163999156|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
163999157|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
163999158|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
163999159|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
163999160|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
163999161|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
163999162|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
163999163|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
163999164|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
163999165|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
164270186|NCT00344500|593358455|FG002|Overall Study|Adverse Event|0|||
164270187|NCT00344500|593358453|FG000|Overall Study|Lost to Follow-up|5|||
164270188|NCT00344500|593358454|FG001|Overall Study|Lost to Follow-up|13|||
164270189|NCT00344500|593358455|FG002|Overall Study|Lost to Follow-up|1|||
164270190|NCT00344500|593358453|FG000|Overall Study|Withdrawal by Subject|7|||
163999166|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
163999167|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
163999168|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
163999169|NCT01707992|592359201|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
164270191|NCT00344500|593358454|FG001|Overall Study|Withdrawal by Subject|10|||
164342190|NCT02165215|593629373|FG001|Maintenance Phase|Lost to Follow-up|2|||
164342191|NCT02165215|593629374|FG002|Maintenance Phase|Lost to Follow-up|0|||
164342192|NCT02165215|593629372|FG000|Maintenance Phase|Adverse Event|0|||
164342193|NCT02165215|593629373|FG001|Maintenance Phase|Adverse Event|1|||
163893172|NCT03505008|591980575|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
164270192|NCT00344500|593358455|FG002|Overall Study|Withdrawal by Subject|0|||
164270193|NCT00344500|593358453|FG000|Overall Study|Protocol Violation|4|||
164270194|NCT00344500|593358454|FG001|Overall Study|Protocol Violation|7|||
164270195|NCT00344500|593358455|FG002|Overall Study|Protocol Violation|1|||
164270196|NCT00344500|593358453|FG000|Overall Study|Not Noted|1|||
164270197|NCT00344500|593358454|FG001|Overall Study|Not Noted|3|||
164270198|NCT00344500|593358455|FG002|Overall Study|Not Noted|0|||
164270199|NCT00599755|593358456|FG000|Overall Study|Adverse Event|11|||
164270200|NCT00599755|593358456|FG000|Overall Study|Withdrawal by Subject|2|||
164270201|NCT00599755|593358456|FG000|Overall Study|Progression of Disease|3|||
164270202|NCT00599755|593358456|FG000|Overall Study|Other Reason|2|||
164270203|NCT00599755|593358456|FG000|Overall Study|No data available|1|||
164270204|NCT04037254|593358457|FG000|Overall Study|Protocol Violation|1|||
164270205|NCT04037254|593358458|FG001|Overall Study|Protocol Violation|0|||
164270206|NCT04037254|593358459|FG002|Overall Study|Protocol Violation|0|||
164270207|NCT04037254|593358460|FG003|Overall Study|Protocol Violation|0|||
164270208|NCT04037254|593358461|FG004|Overall Study|Protocol Violation|0|||
164270209|NCT04037254|593358457|FG000|Overall Study|Withdrawal by Subject|0|||
164270210|NCT04037254|593358458|FG001|Overall Study|Withdrawal by Subject|0|||
164270211|NCT04037254|593358459|FG002|Overall Study|Withdrawal by Subject|1|||
164270212|NCT04037254|593358460|FG003|Overall Study|Withdrawal by Subject|0|||
164270213|NCT04037254|593358461|FG004|Overall Study|Withdrawal by Subject|0|||
164270214|NCT04037254|593358457|FG000|Overall Study|Delayed or incomplete treatment|0|||
164270215|NCT04037254|593358458|FG001|Overall Study|Delayed or incomplete treatment|2|||
164270216|NCT04037254|593358459|FG002|Overall Study|Delayed or incomplete treatment|1|||
164270217|NCT04037254|593358460|FG003|Overall Study|Delayed or incomplete treatment|0|||
164270218|NCT04037254|593358461|FG004|Overall Study|Delayed or incomplete treatment|0|||
164270219|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
164270220|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
164270221|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
164270222|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
164270223|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
164270224|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
164270225|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
164270226|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
164270227|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
164270228|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
164270229|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
164270230|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
164270231|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
164270232|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
164270233|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
164270234|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
164270235|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
164270236|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
164270237|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
164270238|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
164270239|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
164270240|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
164270241|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
164270242|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
164270243|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
164270244|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
164270245|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
164270246|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
164270247|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
164270248|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
164270249|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
164270250|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
163893173|NCT03505008|591980576|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
163893174|NCT03505008|591980577|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
163893175|NCT03505008|591980574|FG000|Before Week 24 Randomization|Physician Decision|2|||
163893176|NCT03505008|591980575|FG001|Before Week 24 Randomization|Physician Decision|0|||
163893177|NCT03505008|591980576|FG002|Before Week 24 Randomization|Physician Decision|0|||
164085909|NCT00310856|592678587|FG002|Overall Study|Unable to classify|0|||
164270251|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
164270252|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
164270253|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
164270254|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
164270255|NCT02198794|593358462|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
164342194|NCT02165215|593629374|FG002|Maintenance Phase|Adverse Event|1|||
164270256|NCT02198794|593358463|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
164270257|NCT02198794|593358464|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
164270258|NCT02198794|593358465|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
164270259|NCT02198794|593358462|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
164270260|NCT02198794|593358463|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
164270261|NCT02198794|593358464|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
164270262|NCT02198794|593358465|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
164270263|NCT02198794|593358462|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
164270264|NCT02198794|593358463|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
164270265|NCT02198794|593358464|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
164270266|NCT02198794|593358465|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
164270267|NCT02198794|593358462|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
164270268|NCT02198794|593358463|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
164270269|NCT02198794|593358464|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
164270270|NCT02198794|593358465|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
164270271|NCT02198794|593358462|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
164270272|NCT02198794|593358463|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
164270273|NCT02198794|593358464|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
164270274|NCT02198794|593358465|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
164270275|NCT02198794|593358462|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
164270276|NCT02198794|593358463|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
164270277|NCT02198794|593358464|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
164270278|NCT02198794|593358465|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
164270279|NCT01306656|593358466|FG000|Overall Study|Lost to Follow-up|1|||
164270280|NCT01306656|593358467|FG001|Overall Study|Lost to Follow-up|0|||
164270281|NCT01918332|593358471|FG000|Overall Study|Adverse Event|0|||
164270282|NCT01918332|593358472|FG001|Overall Study|Adverse Event|0|||
164270283|NCT01918332|593358473|FG002|Overall Study|Adverse Event|0|||
164270284|NCT01918332|593358474|FG003|Overall Study|Adverse Event|1|||
164270285|NCT01918332|593358471|FG000|Overall Study|Withdrawal by Subject|2|||
164270286|NCT01918332|593358472|FG001|Overall Study|Withdrawal by Subject|3|||
164270287|NCT01918332|593358473|FG002|Overall Study|Withdrawal by Subject|2|||
164270288|NCT01918332|593358474|FG003|Overall Study|Withdrawal by Subject|3|||
164270289|NCT01918332|593358471|FG000|Overall Study|Protocol Violation|6|||
164270290|NCT01918332|593358472|FG001|Overall Study|Protocol Violation|2|||
164270291|NCT01918332|593358473|FG002|Overall Study|Protocol Violation|6|||
164270292|NCT01918332|593358474|FG003|Overall Study|Protocol Violation|3|||
164270293|NCT01918332|593358471|FG000|Overall Study|lipid result by central lab did not meet|0|||
164270294|NCT01918332|593358472|FG001|Overall Study|lipid result by central lab did not meet|0|||
164270295|NCT01918332|593358473|FG002|Overall Study|lipid result by central lab did not meet|1|||
164270296|NCT01918332|593358474|FG003|Overall Study|lipid result by central lab did not meet|0|||
164270297|NCT02252965|593358477|FG000|Overall Study|Adverse Event|9|||
164270298|NCT02252965|593358478|FG001|Overall Study|Adverse Event|14|||
164270299|NCT02252965|593358477|FG000|Overall Study|Lost to Follow-up|16|||
164270300|NCT02252965|593358478|FG001|Overall Study|Lost to Follow-up|8|||
164270301|NCT02252965|593358477|FG000|Overall Study|Protocol Violation|4|||
164270302|NCT02252965|593358478|FG001|Overall Study|Protocol Violation|5|||
163893178|NCT03505008|591980577|FG003|Before Week 24 Randomization|Physician Decision|0|||
163893179|NCT03505008|591980574|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
163893180|NCT03505008|591980575|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
163893181|NCT03505008|591980576|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
163893182|NCT03505008|591980577|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
163893183|NCT03505008|591980574|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
163893184|NCT03505008|591980575|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
163893185|NCT03505008|591980576|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
163893186|NCT03505008|591980577|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
163893187|NCT03505008|591980574|FG000|Before Week 24 Randomization|Complication|1|||
163893188|NCT03505008|591980575|FG001|Before Week 24 Randomization|Complication|0|||
163893189|NCT03505008|591980576|FG002|Before Week 24 Randomization|Complication|0|||
163893190|NCT03505008|591980577|FG003|Before Week 24 Randomization|Complication|0|||
163893191|NCT03505008|591980574|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
163893192|NCT03505008|591980575|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
163893193|NCT03505008|591980576|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
163893194|NCT03505008|591980577|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
163893195|NCT03505008|591980574|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
163893196|NCT03505008|591980575|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
164270303|NCT02252965|593358477|FG000|Overall Study|Lack of Efficacy|0|||
164270304|NCT02252965|593358478|FG001|Overall Study|Lack of Efficacy|2|||
164270305|NCT02252965|593358477|FG000|Overall Study|Withdrawal by Subject|7|||
164270306|NCT02252965|593358478|FG001|Overall Study|Withdrawal by Subject|9|||
164270307|NCT02252965|593358477|FG000|Overall Study|Other|4|||
163999170|NCT01707992|592359202|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163999171|NCT01707992|592359203|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163999172|NCT01707992|592359204|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163999173|NCT01707992|592359205|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
163999174|NCT01707992|592359206|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
163999175|NCT00998738|592359207|FG000|Overall Study|Uknown|1|||
163999176|NCT03498521|592359208|FG000|Overall Study|Death|227|||
163999177|NCT03498521|592359209|FG001|Overall Study|Death|79|||
163999178|NCT03498521|592359210|FG002|Overall Study|Death|84|||
163999179|NCT03498521|592359208|FG000|Overall Study|Exclusion criteria|1|||
163999180|NCT03498521|592359209|FG001|Overall Study|Exclusion criteria|0|||
163999181|NCT03498521|592359210|FG002|Overall Study|Exclusion criteria|0|||
163999182|NCT03498521|592359208|FG000|Overall Study|Lost to Follow-up|4|||
163999183|NCT03498521|592359209|FG001|Overall Study|Lost to Follow-up|3|||
163999184|NCT03498521|592359210|FG002|Overall Study|Lost to Follow-up|3|||
163999185|NCT03498521|592359208|FG000|Overall Study|No profile due to technical failure|1|||
163999186|NCT03498521|592359209|FG001|Overall Study|No profile due to technical failure|0|||
163999187|NCT03498521|592359210|FG002|Overall Study|No profile due to technical failure|0|||
163999188|NCT03498521|592359208|FG000|Overall Study|Physician Decision|3|||
163999189|NCT03498521|592359209|FG001|Overall Study|Physician Decision|1|||
163999190|NCT03498521|592359210|FG002|Overall Study|Physician Decision|0|||
163999191|NCT03498521|592359208|FG000|Overall Study|Withdrawal by Subject|11|||
163999192|NCT03498521|592359209|FG001|Overall Study|Withdrawal by Subject|6|||
163999193|NCT03498521|592359210|FG002|Overall Study|Withdrawal by Subject|2|||
163999194|NCT03498521|592359208|FG000|Overall Study|Study terminated by sponsor|79|||
163999195|NCT03498521|592359209|FG001|Overall Study|Study terminated by sponsor|21|||
163999196|NCT03498521|592359210|FG002|Overall Study|Study terminated by sponsor|4|||
163999197|NCT02848833|592359219|FG000|Overall Study|subject who are duplicated|1|||
163999198|NCT02848833|592359219|FG000|Overall Study|have not taken the study drug|11|||
163999199|NCT02848833|592359219|FG000|Overall Study|follow-up failure|6|||
163999200|NCT02848833|592359219|FG000|Overall Study|Protocol Violation|119|||
163999201|NCT04375761|592361939|FG000|Overall Study|Death|1|||
163999202|NCT04375761|592361940|FG001|Overall Study|Death|2|||
163999203|NCT04375761|592361939|FG000|Overall Study|Lost to Follow-up|203|||
163999204|NCT04375761|592361940|FG001|Overall Study|Lost to Follow-up|380|||
163999205|NCT04375761|592361939|FG000|Overall Study|Withdrawal by Subject|47|||
163999206|NCT04375761|592361940|FG001|Overall Study|Withdrawal by Subject|98|||
163999207|NCT04375761|592361939|FG000|Overall Study|Noncompliance with study procedure|121|||
163999208|NCT04375761|592361940|FG001|Overall Study|Noncompliance with study procedure|251|||
163999209|NCT04375761|592361939|FG000|Overall Study|Reimbursement not enough|1|||
163999210|NCT04375761|592361940|FG001|Overall Study|Reimbursement not enough|2|||
163999211|NCT04375761|592361939|FG000|Overall Study|Unforeseen family circumstances|1|||
163999212|NCT04375761|592361940|FG001|Overall Study|Unforeseen family circumstances|3|||
163999213|NCT04375761|592361939|FG000|Overall Study|Test too painful|1|||
163999214|NCT04375761|592361940|FG001|Overall Study|Test too painful|1|||
163999215|NCT04375761|592361939|FG000|Overall Study|Moved|0|||
163999216|NCT04375761|592361940|FG001|Overall Study|Moved|2|||
163999217|NCT04375761|592361939|FG000|Overall Study|Nonresponsive|0|||
163999218|NCT04375761|592361940|FG001|Overall Study|Nonresponsive|5|||
163999219|NCT02251743|592361952|FG000|Overall Study|Withdrawal by Subject|1|||
163999220|NCT02251743|592361953|FG001|Overall Study|Withdrawal by Subject|1|||
163999221|NCT00824564|592361954|FG000|Overall Study|Lost to Follow-up|5|||
163999222|NCT00824564|592361955|FG001|Overall Study|Lost to Follow-up|7|||
163999223|NCT00824564|592361954|FG000|Overall Study|Withdrawal by Subject|1|||
163999224|NCT00824564|592361955|FG001|Overall Study|Withdrawal by Subject|1|||
163999225|NCT00824564|592361954|FG000|Overall Study|Other|1|||
163999226|NCT00824564|592361955|FG001|Overall Study|Other|2|||
164270308|NCT02252965|593358478|FG001|Overall Study|Other|5|||
164270309|NCT04736628|593358483|FG000|Overall Study|Not treated|0|||
164270310|NCT04736628|593358484|FG001|Overall Study|Not treated|0|||
164270311|NCT04736628|593358485|FG002|Overall Study|Not treated|0|||
164270312|NCT04736628|593358486|FG003|Overall Study|Not treated|2|||
164270313|NCT04736628|593358483|FG000|Overall Study|Other reason than listed|1|||
164270314|NCT04736628|593358484|FG001|Overall Study|Other reason than listed|2|||
164270315|NCT04736628|593358485|FG002|Overall Study|Other reason than listed|2|||
164270316|NCT04736628|593358486|FG003|Overall Study|Other reason than listed|3|||
163999227|NCT00824564|592361954|FG000|Overall Study|Randomized, but not treated|1|||
163999228|NCT00824564|592361955|FG001|Overall Study|Randomized, but not treated|0|||
163999229|NCT00476086|592361956|FG000|Overall Study|Alternative therapy|1|||
163999230|NCT00476086|592361956|FG000|Overall Study|Progressive Disease|4|||
163999231|NCT02900092|592361957|FG000|Overall Study|Adverse Event|1|||
163999232|NCT01287754|592361958|FG000|Overall Study|Death|2|||
163999233|NCT01287754|592361959|FG001|Overall Study|Death|12|||
164270317|NCT04736628|593358483|FG000|Overall Study|Protocol deviation|0|||
163999234|NCT01287754|592361958|FG000|Overall Study|Lost to Follow-up|1|||
163999235|NCT01287754|592361959|FG001|Overall Study|Lost to Follow-up|6|||
163999236|NCT01287754|592361958|FG000|Overall Study|Protocol Violation|0|||
164270318|NCT04736628|593358484|FG001|Overall Study|Protocol deviation|0|||
164270319|NCT04736628|593358485|FG002|Overall Study|Protocol deviation|0|||
164270320|NCT04736628|593358486|FG003|Overall Study|Protocol deviation|1|||
164270321|NCT04736628|593358483|FG000|Overall Study|Burden of study procedures|1|||
164270322|NCT04736628|593358484|FG001|Overall Study|Burden of study procedures|0|||
164270323|NCT04736628|593358485|FG002|Overall Study|Burden of study procedures|0|||
163893197|NCT03505008|591980576|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
163893198|NCT03505008|591980577|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
163893199|NCT03505008|591980574|FG000|After Week 24 Randomization|Adverse Event|0|||
163893200|NCT03505008|591980575|FG001|After Week 24 Randomization|Adverse Event|1|||
163893201|NCT03505008|591980576|FG002|After Week 24 Randomization|Adverse Event|2|||
163893202|NCT03505008|591980577|FG003|After Week 24 Randomization|Adverse Event|2|||
163893203|NCT03505008|591980574|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
163893204|NCT03505008|591980575|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
163893205|NCT03505008|591980576|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
163893206|NCT03505008|591980577|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
163893207|NCT03505008|591980574|FG000|After Week 24 Randomization|Protocol Violation|0|||
163893208|NCT03505008|591980575|FG001|After Week 24 Randomization|Protocol Violation|0|||
163893209|NCT03505008|591980576|FG002|After Week 24 Randomization|Protocol Violation|1|||
163893210|NCT03505008|591980577|FG003|After Week 24 Randomization|Protocol Violation|0|||
163893211|NCT02437136|591980578|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
163893212|NCT02437136|591980579|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163893213|NCT02437136|591980580|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163893214|NCT02437136|591980581|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163893215|NCT02437136|591980582|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163893216|NCT02437136|591980583|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163893217|NCT02437136|591980584|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
163893218|NCT02437136|591980578|FG000|Expansion (Phase 2)|Death|0|||
163893219|NCT02437136|591980579|FG001|Expansion (Phase 2)|Death|0|||
163893220|NCT02437136|591980580|FG002|Expansion (Phase 2)|Death|0|||
163893221|NCT02437136|591980581|FG003|Expansion (Phase 2)|Death|6|||
163893222|NCT02437136|591980582|FG004|Expansion (Phase 2)|Death|37|||
163893223|NCT02437136|591980583|FG005|Expansion (Phase 2)|Death|29|||
163893224|NCT02437136|591980584|FG006|Expansion (Phase 2)|Death|24|||
163893225|NCT02437136|591980578|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
163893226|NCT02437136|591980579|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
163893227|NCT02437136|591980580|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
163893228|NCT02437136|591980581|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
163893229|NCT02437136|591980582|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
163893230|NCT02437136|591980583|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
163893231|NCT02437136|591980584|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
163893232|NCT02437136|591980578|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
163893233|NCT02437136|591980579|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
163893234|NCT02437136|591980580|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
163893235|NCT02437136|591980581|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
163893236|NCT02437136|591980582|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
163893237|NCT02437136|591980583|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
163893238|NCT02437136|591980584|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
163893239|NCT02780700|591980588|FG000|Overall Study|Progressive disease|1|||
163893240|NCT03824366|591980594|FG000|Overall Study|Death|1|||
163893241|NCT03824366|591980594|FG000|Overall Study|Previously unidentified metal artifact|1|||
163893242|NCT03824366|591980594|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
163893243|NCT03824366|591980594|FG000|Overall Study|Withdrawal by Subject|1|||
163893244|NCT04068831|591980595|FG000|Overall Study|Disease Progression|10|||
163893245|NCT04068831|591980596|FG001|Overall Study|Disease Progression|8|||
163893246|NCT00323856|591980597|FG000|Overall Study|Withdrawal by Subject|1|||
163893247|NCT00323856|591980597|FG000|Overall Study|Was uncooperative and noncompliant|1|||
163893248|NCT00323856|591980597|FG000|Overall Study|Reason not specified|1|||
163893249|NCT00323856|591980597|FG000|Overall Study|Missing|2|||
163893250|NCT04086121|591980599|FG000|Overall Study|Other than listed|8|||
163893251|NCT04086121|591980599|FG000|Overall Study|Withdrawal by Subject|3|||
163893252|NCT04086121|591980599|FG000|Overall Study|Lost to Follow-up|2|||
163893253|NCT04086121|591980599|FG000|Overall Study|Adverse Event|1|||
163893254|NCT02834390|591980604|FG000|Induction Phase|Progressive disease|0|||
163893255|NCT02834390|591980605|FG001|Induction Phase|Progressive disease|1|||
163893256|NCT02834390|591980604|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
163893257|NCT02834390|591980605|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
163893258|NCT02834390|591980604|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
163893259|NCT02834390|591980605|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
163893260|NCT02834390|591980604|FG000|Consolidation Phase|Physician Decision|1|||
164270324|NCT04736628|593358486|FG003|Overall Study|Burden of study procedures|1|||
164270325|NCT04736628|593358483|FG000|Overall Study|Change of residence|0|||
164270326|NCT04736628|593358484|FG001|Overall Study|Change of residence|1|||
164270327|NCT04736628|593358485|FG002|Overall Study|Change of residence|0|||
164270328|NCT04736628|593358486|FG003|Overall Study|Change of residence|0|||
164270329|NCT04736628|593358483|FG000|Overall Study|Perceived lack of efficacy|1|||
164270330|NCT04736628|593358484|FG001|Overall Study|Perceived lack of efficacy|0|||
164270331|NCT04736628|593358485|FG002|Overall Study|Perceived lack of efficacy|0|||
164270332|NCT04736628|593358486|FG003|Overall Study|Perceived lack of efficacy|1|||
164270333|NCT04736628|593358483|FG000|Overall Study|Adverse Event|3|||
164270334|NCT04736628|593358484|FG001|Overall Study|Adverse Event|2|||
164270335|NCT04736628|593358485|FG002|Overall Study|Adverse Event|4|||
164270336|NCT04736628|593358486|FG003|Overall Study|Adverse Event|3|||
164270337|NCT04279613|593358487|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270338|NCT04279613|593358488|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270339|NCT04279613|593358489|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270340|NCT04279613|593358490|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
164270341|NCT04279613|593358491|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
164270342|NCT04279613|593358487|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270343|NCT04279613|593358488|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
164270344|NCT04279613|593358489|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270345|NCT04279613|593358490|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270346|NCT04279613|593358491|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
164270347|NCT04279613|593358487|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270348|NCT04279613|593358488|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270349|NCT04279613|593358489|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
164270350|NCT04279613|593358490|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270351|NCT04279613|593358491|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
164270352|NCT04279613|593358487|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270353|NCT04279613|593358488|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270354|NCT04279613|593358489|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270355|NCT04279613|593358490|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
164270356|NCT04279613|593358491|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
164270357|NCT04279613|593358487|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270358|NCT04279613|593358488|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270359|NCT04279613|593358489|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270360|NCT04279613|593358490|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
164270361|NCT04279613|593358491|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
164270362|NCT02478164|593358492|FG000|Overall Study|Lack of Efficacy|13|||
164270363|NCT02478164|593358492|FG000|Overall Study|Adverse Event|1|||
164270364|NCT02478164|593358492|FG000|Overall Study|Withdrawal by Subject|1|||
164270365|NCT04051827|593358493|FG000|Overall Study|Death|1|||
164270366|NCT04051827|593358493|FG000|Overall Study|Withdrawal by Subject|4|||
164270367|NCT04051827|593358493|FG000|Overall Study|Progressive disease|16|||
164270368|NCT04051827|593358493|FG000|Overall Study|Physician Decision|1|||
164270369|NCT04051827|593358493|FG000|Overall Study|Other|4|||
164270370|NCT05779007|593358494|FG000|Overall Study|not meeting eligibility criteria|3517|||
164270371|NCT05779007|593358495|FG001|Overall Study|not meeting eligibility criteria|2009|||
164342195|NCT01877265|593629375|FG000|Treatment Period 1|Sponsor Decision|0|||
163999237|NCT01287754|592361959|FG001|Overall Study|Protocol Violation|3|||
163999238|NCT06161012|592361966|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
163999239|NCT06161012|592361967|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
163999240|NCT04607408|592361968|FG000|Overall Study|Lost to Follow-up|0|||
163999241|NCT04607408|592361969|FG001|Overall Study|Lost to Follow-up|0|||
163999242|NCT04607408|592361970|FG002|Overall Study|Lost to Follow-up|0|||
163999243|NCT04607408|592361971|FG003|Overall Study|Lost to Follow-up|1|||
163999244|NCT04607408|592361972|FG004|Overall Study|Lost to Follow-up|0|||
164270372|NCT01424566|593358496|FG000|Single-blind Treatment|Adverse Event|71|||
164270373|NCT01424566|593358497|FG001|Single-blind Treatment|Adverse Event|0|||
164270374|NCT01424566|593358498|FG002|Single-blind Treatment|Adverse Event|0|||
164270375|NCT01424566|593358496|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
164270376|NCT01424566|593358497|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
164270377|NCT01424566|593358498|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
164270378|NCT01424566|593358496|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
164270379|NCT01424566|593358497|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
164270380|NCT01424566|593358498|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
164270381|NCT01424566|593358496|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
164270382|NCT01424566|593358497|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
164270383|NCT01424566|593358498|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
163999245|NCT04607408|592361968|FG000|Overall Study|Withdrawal by Subject|0|||
164270384|NCT01424566|593358496|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
164270385|NCT01424566|593358497|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
164270386|NCT01424566|593358498|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
164270387|NCT01424566|593358496|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
164270388|NCT01424566|593358497|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
164270389|NCT01424566|593358498|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
163999246|NCT04607408|592361969|FG001|Overall Study|Withdrawal by Subject|1|||
163999247|NCT04607408|592361970|FG002|Overall Study|Withdrawal by Subject|0|||
164270390|NCT01424566|593358496|FG000|Double-blind Treatment|Adverse Event|0|||
164270391|NCT01424566|593358497|FG001|Double-blind Treatment|Adverse Event|21|||
164270392|NCT01424566|593358498|FG002|Double-blind Treatment|Adverse Event|13|||
164270393|NCT01424566|593358496|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
164270394|NCT01424566|593358497|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
164270395|NCT01424566|593358498|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
164270396|NCT01424566|593358496|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
164270397|NCT01424566|593358497|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
164270398|NCT01424566|593358498|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
164270399|NCT01424566|593358496|FG000|Double-blind Treatment|Lack of Efficacy|0|||
164270400|NCT01424566|593358497|FG001|Double-blind Treatment|Lack of Efficacy|1|||
164270401|NCT01424566|593358498|FG002|Double-blind Treatment|Lack of Efficacy|1|||
164270402|NCT00680368|593358501|FG000|Overall Study|not supervised, not eligible|15|||
164270403|NCT03779503|593358502|FG000|First Intervention|Adverse Event|0|||
164270404|NCT03779503|593358503|FG001|First Intervention|Adverse Event|1|||
164270405|NCT03779503|593358502|FG000|First Intervention|Withdrawal by Subject|1|||
164270406|NCT03779503|593358503|FG001|First Intervention|Withdrawal by Subject|0|||
164270407|NCT02771626|593358507|FG000|Overall Study|Adverse Event|1|||
164270408|NCT02771626|593358508|FG001|Overall Study|Adverse Event|5|||
164270409|NCT02771626|593358509|FG002|Overall Study|Adverse Event|3|||
164270410|NCT02771626|593358510|FG003|Overall Study|Adverse Event|0|||
164270411|NCT02771626|593358511|FG004|Overall Study|Adverse Event|1|||
164270412|NCT02771626|593358512|FG005|Overall Study|Adverse Event|1|||
164270413|NCT02771626|593358507|FG000|Overall Study|Radiologic Disease Progression|6|||
164270414|NCT02771626|593358508|FG001|Overall Study|Radiologic Disease Progression|13|||
164270415|NCT02771626|593358509|FG002|Overall Study|Radiologic Disease Progression|10|||
164270416|NCT02771626|593358510|FG003|Overall Study|Radiologic Disease Progression|7|||
164270417|NCT02771626|593358511|FG004|Overall Study|Radiologic Disease Progression|28|||
164270418|NCT02771626|593358512|FG005|Overall Study|Radiologic Disease Progression|15|||
164270419|NCT02771626|593358507|FG000|Overall Study|Symptomatic Deterioration|0|||
164270420|NCT02771626|593358508|FG001|Overall Study|Symptomatic Deterioration|4|||
164270421|NCT02771626|593358509|FG002|Overall Study|Symptomatic Deterioration|2|||
164270422|NCT02771626|593358510|FG003|Overall Study|Symptomatic Deterioration|0|||
164270423|NCT02771626|593358511|FG004|Overall Study|Symptomatic Deterioration|5|||
164270424|NCT02771626|593358512|FG005|Overall Study|Symptomatic Deterioration|2|||
164270425|NCT02771626|593358507|FG000|Overall Study|Participant Request|0|||
164270426|NCT02771626|593358508|FG001|Overall Study|Participant Request|1|||
164270427|NCT02771626|593358509|FG002|Overall Study|Participant Request|0|||
164270428|NCT02771626|593358510|FG003|Overall Study|Participant Request|2|||
164270429|NCT02771626|593358511|FG004|Overall Study|Participant Request|0|||
164270430|NCT02771626|593358512|FG005|Overall Study|Participant Request|1|||
164270431|NCT02771626|593358507|FG000|Overall Study|Investigator Decision|0|||
164270432|NCT02771626|593358508|FG001|Overall Study|Investigator Decision|1|||
164270433|NCT02771626|593358509|FG002|Overall Study|Investigator Decision|0|||
164270434|NCT02771626|593358510|FG003|Overall Study|Investigator Decision|0|||
164270435|NCT02771626|593358511|FG004|Overall Study|Investigator Decision|1|||
164270436|NCT02771626|593358512|FG005|Overall Study|Investigator Decision|0|||
164270437|NCT02771626|593358507|FG000|Overall Study|Study Termination by Sponsor|0|||
164270438|NCT02771626|593358508|FG001|Overall Study|Study Termination by Sponsor|2|||
164270439|NCT02771626|593358509|FG002|Overall Study|Study Termination by Sponsor|1|||
164270440|NCT02771626|593358510|FG003|Overall Study|Study Termination by Sponsor|0|||
164270441|NCT02771626|593358511|FG004|Overall Study|Study Termination by Sponsor|1|||
164270442|NCT02771626|593358512|FG005|Overall Study|Study Termination by Sponsor|0|||
163893261|NCT02834390|591980605|FG001|Consolidation Phase|Physician Decision|1|||
164270443|NCT02771626|593358507|FG000|Overall Study|Informed Consent Withdrawn|0|||
164270444|NCT02771626|593358508|FG001|Overall Study|Informed Consent Withdrawn|0|||
164270445|NCT02771626|593358509|FG002|Overall Study|Informed Consent Withdrawn|1|||
164270446|NCT02771626|593358510|FG003|Overall Study|Informed Consent Withdrawn|0|||
163893262|NCT03118518|591980606|FG000|Overall Study|Early Exit after treatment|2|||
163893263|NCT03118518|591980607|FG001|Overall Study|Early Exit after treatment|8|||
163893264|NCT03118518|591980606|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
163893265|NCT03118518|591980607|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
163893266|NCT03106740|591982013|FG000|Overall Study|Lost to Follow-up|2|||
163893267|NCT03106740|591982014|FG001|Overall Study|Lost to Follow-up|2|||
163893268|NCT03106740|591982013|FG000|Overall Study|Withdrawal by Subject|2|||
163893269|NCT03106740|591982014|FG001|Overall Study|Withdrawal by Subject|4|||
163893270|NCT03106740|591982013|FG000|Overall Study|Physician Decision|0|||
164270447|NCT02771626|593358511|FG004|Overall Study|Informed Consent Withdrawn|1|||
164270448|NCT02771626|593358512|FG005|Overall Study|Informed Consent Withdrawn|1|||
164270449|NCT02771626|593358507|FG000|Overall Study|Other, Not Specified|1|||
164270450|NCT02771626|593358508|FG001|Overall Study|Other, Not Specified|0|||
164270451|NCT02771626|593358509|FG002|Overall Study|Other, Not Specified|0|||
163893271|NCT03106740|591982014|FG001|Overall Study|Physician Decision|1|||
164270452|NCT02771626|593358510|FG003|Overall Study|Other, Not Specified|0|||
163999248|NCT04607408|592361971|FG003|Overall Study|Withdrawal by Subject|1|||
163999249|NCT04607408|592361972|FG004|Overall Study|Withdrawal by Subject|0|||
163999250|NCT05424276|592361975|FG000|Overall Study|Adverse Event|1|||
163999251|NCT05424276|592361976|FG001|Overall Study|Adverse Event|0|||
163999252|NCT05424276|592361977|FG002|Overall Study|Adverse Event|0|||
163999253|NCT05424276|592361978|FG003|Overall Study|Adverse Event|2|||
163999254|NCT05424276|592361975|FG000|Overall Study|Withdrawal by Subject|0|||
163999255|NCT05424276|592361976|FG001|Overall Study|Withdrawal by Subject|0|||
163999256|NCT05424276|592361977|FG002|Overall Study|Withdrawal by Subject|2|||
163999257|NCT05424276|592361978|FG003|Overall Study|Withdrawal by Subject|0|||
163999258|NCT05424276|592361975|FG000|Overall Study|Protocol Violation|0|||
163999259|NCT05424276|592361976|FG001|Overall Study|Protocol Violation|1|||
163999260|NCT05424276|592361977|FG002|Overall Study|Protocol Violation|0|||
163999261|NCT05424276|592361978|FG003|Overall Study|Protocol Violation|0|||
163999262|NCT05424276|592361975|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
163999263|NCT05424276|592361976|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
163999264|NCT05424276|592361977|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
164270453|NCT02771626|593358511|FG004|Overall Study|Other, Not Specified|0|||
164270454|NCT02771626|593358512|FG005|Overall Study|Other, Not Specified|1|||
164270455|NCT02392403|593358513|FG000|Overall Study|Adverse Event|1|||
164270456|NCT02392403|593358513|FG000|Overall Study|Death|1|||
164270457|NCT02392403|593358513|FG000|Overall Study|Withdrawal by Subject|1|||
164270458|NCT02616393|593358516|FG000|Overall Study|Death|5|||
164270459|NCT02616393|593358517|FG001|Overall Study|Death|12|||
164270460|NCT02616393|593358518|FG002|Overall Study|Death|1|||
164270461|NCT02616393|593358516|FG000|Overall Study|Termination by Sponsor|4|||
164270462|NCT02616393|593358517|FG001|Overall Study|Termination by Sponsor|5|||
164270463|NCT02616393|593358518|FG002|Overall Study|Termination by Sponsor|2|||
163999265|NCT05424276|592361978|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
163999266|NCT01725165|592361979|FG000|Overall Study|Death|11|||
163999267|NCT01725165|592361980|FG001|Overall Study|Death|18|||
163999268|NCT05113940|592361983|FG000|Part A (18 Days)|Adverse Event|0|||
163999269|NCT05113940|592361984|FG001|Part A (18 Days)|Adverse Event|0|||
163999270|NCT05113940|592361985|FG002|Part A (18 Days)|Adverse Event|1|||
163999271|NCT05113940|592361986|FG003|Part A (18 Days)|Adverse Event|1|||
163999272|NCT05113940|592361987|FG004|Part A (18 Days)|Adverse Event|1|||
163999273|NCT05113940|592361988|FG005|Part A (18 Days)|Adverse Event|0|||
163999274|NCT05113940|592361989|FG006|Part A (18 Days)|Adverse Event|0|||
163999275|NCT05113940|592361990|FG007|Part A (18 Days)|Adverse Event|0|||
163999276|NCT05113940|592361991|FG008|Part A (18 Days)|Adverse Event|0|||
163999277|NCT05113940|592361992|FG009|Part A (18 Days)|Adverse Event|0|||
163999278|NCT05113940|592361993|FG010|Part A (18 Days)|Adverse Event|0|||
163999279|NCT05113940|592361994|FG011|Part A (18 Days)|Adverse Event|2|||
163999280|NCT05113940|592361995|FG012|Part A (18 Days)|Adverse Event|0|||
163999281|NCT05113940|592361996|FG013|Part A (18 Days)|Adverse Event|0|||
163999282|NCT05113940|592361997|FG014|Part A (18 Days)|Adverse Event|0|||
163999283|NCT05113940|592361983|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999284|NCT05113940|592361984|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999285|NCT05113940|592361985|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999286|NCT05113940|592361986|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999287|NCT05113940|592361987|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999288|NCT05113940|592361988|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999289|NCT05113940|592361989|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999290|NCT05113940|592361990|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999291|NCT05113940|592361991|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999292|NCT05113940|592361992|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999293|NCT05113940|592361993|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999294|NCT05113940|592361994|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999295|NCT05113940|592361995|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
164270464|NCT02616393|593358516|FG000|Overall Study|Other|3|||
164270465|NCT02616393|593358517|FG001|Overall Study|Other|0|||
164270466|NCT02616393|593358518|FG002|Overall Study|Other|0|||
164270467|NCT02616393|593358516|FG000|Overall Study|Withdrawal by Subject|1|||
163999296|NCT05113940|592361996|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
163999297|NCT05113940|592361997|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
163999298|NCT03619213|592361999|FG000|Overall Study|Lost to Follow-up|2|||
163999299|NCT03619213|592362000|FG001|Overall Study|Lost to Follow-up|1|||
163999300|NCT03619213|592361999|FG000|Overall Study|Withdrawal by Subject|8|||
164270468|NCT02616393|593358517|FG001|Overall Study|Withdrawal by Subject|1|||
164270469|NCT02616393|593358518|FG002|Overall Study|Withdrawal by Subject|0|||
163999301|NCT03619213|592362000|FG001|Overall Study|Withdrawal by Subject|10|||
163999302|NCT00501228|592362001|FG000|Overall Study|Withdrawal by Subject|1|||
163999303|NCT01756274|592362002|FG000|Overall Study|Protocol Violation|2|||
163999304|NCT01756274|592362002|FG000|Overall Study|Laboratory error|1|||
163999305|NCT01147926|592362003|FG000|Overall Study|Subject Withdrew Consent|9|||
163999306|NCT01147926|592362004|FG001|Overall Study|Subject Withdrew Consent|10|||
163999307|NCT01147926|592362003|FG000|Overall Study|Adverse Event|7|||
164270470|NCT02616393|593358516|FG000|Overall Study|Lost to Follow-up|0|||
163893272|NCT03106740|591982013|FG000|Overall Study|Partial data|1|||
163893273|NCT03106740|591982014|FG001|Overall Study|Partial data|0|||
163893274|NCT04797858|591982015|FG000|Overall Study|Withdrawal by Subject|0|||
163893275|NCT04797858|591982016|FG001|Overall Study|Withdrawal by Subject|1|||
163893276|NCT04797858|591982015|FG000|Overall Study|Excluded due to administrative error|7|||
163893277|NCT04797858|591982016|FG001|Overall Study|Excluded due to administrative error|8|||
163893278|NCT01880515|591982020|FG000|Overall Study|Lost to Follow-up|3|||
163893279|NCT01880515|591982021|FG001|Overall Study|Lost to Follow-up|2|||
163893280|NCT01880515|591982020|FG000|Overall Study|Disease Progression|5|||
163893281|NCT01880515|591982021|FG001|Overall Study|Disease Progression|7|||
163893282|NCT02593773|591982023|FG000|Overall Study|Voluntary Withdrawal|3|||
163893283|NCT02593773|591982023|FG000|Overall Study|Study Terminated by Sponsor|31|||
163893284|NCT02593773|591982023|FG000|Overall Study|Death|1|||
163893285|NCT04304144|591982024|FG000|DLT Observation Period|Physician Decision|0|||
163893286|NCT04304144|591982025|FG001|DLT Observation Period|Physician Decision|1|||
163893287|NCT04304144|591982026|FG002|DLT Observation Period|Physician Decision|0|||
163893288|NCT04304144|591982027|FG003|DLT Observation Period|Physician Decision|0|||
163893289|NCT04304144|591982024|FG000|Continued Treatment Period|Adverse Event|0|||
163893290|NCT04304144|591982025|FG001|Continued Treatment Period|Adverse Event|1|||
163893291|NCT04304144|591982026|FG002|Continued Treatment Period|Adverse Event|0|||
163893292|NCT04304144|591982027|FG003|Continued Treatment Period|Adverse Event|0|||
163893293|NCT04304144|591982024|FG000|Continued Treatment Period|Death|0|||
163893294|NCT04304144|591982025|FG001|Continued Treatment Period|Death|0|||
163893295|NCT04304144|591982026|FG002|Continued Treatment Period|Death|1|||
163893296|NCT04304144|591982027|FG003|Continued Treatment Period|Death|2|||
163893297|NCT04304144|591982024|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
163893298|NCT04304144|591982025|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
163893299|NCT04304144|591982026|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
163893300|NCT04304144|591982027|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
163893301|NCT04304144|591982024|FG000|Continued Treatment Period|Other than specified|2|||
163893302|NCT04304144|591982025|FG001|Continued Treatment Period|Other than specified|0|||
163893303|NCT04304144|591982026|FG002|Continued Treatment Period|Other than specified|1|||
163893304|NCT04304144|591982027|FG003|Continued Treatment Period|Other than specified|1|||
163893305|NCT04101357|591982028|FG000|Overall Study|Death|1|||
163893306|NCT04101357|591982029|FG001|Overall Study|Death|1|||
163893307|NCT04101357|591982030|FG002|Overall Study|Death|1|||
163893308|NCT04101357|591982031|FG003|Overall Study|Death|2|||
163893309|NCT04101357|591982032|FG004|Overall Study|Death|4|||
163893310|NCT04101357|591982033|FG005|Overall Study|Death|11|||
163893311|NCT04101357|591982034|FG006|Overall Study|Death|4|||
163893312|NCT04101357|591982035|FG007|Overall Study|Death|4|||
163893313|NCT04101357|591982036|FG008|Overall Study|Death|5|||
163893314|NCT04101357|591982037|FG009|Overall Study|Death|2|||
163893315|NCT04101357|591982038|FG010|Overall Study|Death|3|||
163893316|NCT04101357|591982028|FG000|Overall Study|Trial closure|0|||
163893317|NCT04101357|591982029|FG001|Overall Study|Trial closure|0|||
163893318|NCT04101357|591982030|FG002|Overall Study|Trial closure|0|||
163893319|NCT04101357|591982031|FG003|Overall Study|Trial closure|0|||
163893320|NCT04101357|591982032|FG004|Overall Study|Trial closure|0|||
163893321|NCT04101357|591982033|FG005|Overall Study|Trial closure|2|||
163893322|NCT04101357|591982034|FG006|Overall Study|Trial closure|2|||
163893323|NCT04101357|591982035|FG007|Overall Study|Trial closure|0|||
163893324|NCT04101357|591982036|FG008|Overall Study|Trial closure|0|||
163893325|NCT04101357|591982037|FG009|Overall Study|Trial closure|0|||
163893326|NCT04101357|591982038|FG010|Overall Study|Trial closure|1|||
163893327|NCT04101357|591982028|FG000|Overall Study|Lost to Follow-up|0|||
163893328|NCT04101357|591982029|FG001|Overall Study|Lost to Follow-up|0|||
163893329|NCT04101357|591982030|FG002|Overall Study|Lost to Follow-up|0|||
163893330|NCT04101357|591982031|FG003|Overall Study|Lost to Follow-up|1|||
163893331|NCT04101357|591982032|FG004|Overall Study|Lost to Follow-up|0|||
163893332|NCT04101357|591982033|FG005|Overall Study|Lost to Follow-up|0|||
163893333|NCT04101357|591982034|FG006|Overall Study|Lost to Follow-up|0|||
163893334|NCT04101357|591982035|FG007|Overall Study|Lost to Follow-up|1|||
163893335|NCT04101357|591982036|FG008|Overall Study|Lost to Follow-up|0|||
163893336|NCT04101357|591982037|FG009|Overall Study|Lost to Follow-up|0|||
163893337|NCT04101357|591982038|FG010|Overall Study|Lost to Follow-up|0|||
163893338|NCT04101357|591982028|FG000|Overall Study|Withdrawal by Subject|1|||
163893339|NCT04101357|591982029|FG001|Overall Study|Withdrawal by Subject|0|||
163893340|NCT04101357|591982030|FG002|Overall Study|Withdrawal by Subject|0|||
163893341|NCT04101357|591982031|FG003|Overall Study|Withdrawal by Subject|0|||
163893342|NCT04101357|591982032|FG004|Overall Study|Withdrawal by Subject|0|||
163893343|NCT04101357|591982033|FG005|Overall Study|Withdrawal by Subject|0|||
163893344|NCT04101357|591982034|FG006|Overall Study|Withdrawal by Subject|0|||
163893345|NCT04101357|591982035|FG007|Overall Study|Withdrawal by Subject|0|||
163893346|NCT04101357|591982036|FG008|Overall Study|Withdrawal by Subject|1|||
163893347|NCT04101357|591982037|FG009|Overall Study|Withdrawal by Subject|1|||
163893348|NCT04101357|591982038|FG010|Overall Study|Withdrawal by Subject|0|||
163893349|NCT04101357|591982028|FG000|Overall Study|Other|0|||
163893350|NCT04101357|591982029|FG001|Overall Study|Other|0|||
163999308|NCT01147926|592362004|FG001|Overall Study|Adverse Event|6|||
163999309|NCT01147926|592362003|FG000|Overall Study|Subject Non-Compliant|5|||
163999310|NCT01147926|592362004|FG001|Overall Study|Subject Non-Compliant|4|||
163999311|NCT01147926|592362003|FG000|Overall Study|Principal investigator left hospital|1|||
163999312|NCT01147926|592362004|FG001|Overall Study|Principal investigator left hospital|3|||
163999313|NCT01147926|592362003|FG000|Overall Study|Selection criteria not met|3|||
163999314|NCT01147926|592362004|FG001|Overall Study|Selection criteria not met|1|||
163999315|NCT01147926|592362003|FG000|Overall Study|Lost to Follow-up|0|||
163999316|NCT01147926|592362004|FG001|Overall Study|Lost to Follow-up|2|||
163999317|NCT01147926|592362003|FG000|Overall Study|Sponsor's Decision|0|||
163999318|NCT01147926|592362004|FG001|Overall Study|Sponsor's Decision|1|||
163999319|NCT01147926|592362003|FG000|Overall Study|Lack of Efficacy|1|||
163999320|NCT01147926|592362004|FG001|Overall Study|Lack of Efficacy|0|||
164270471|NCT02616393|593358517|FG001|Overall Study|Lost to Follow-up|2|||
164270472|NCT02616393|593358518|FG002|Overall Study|Lost to Follow-up|0|||
164270473|NCT00657371|593358519|FG000|Overall Study|Poor bowel preparation|15|||
164270474|NCT00657371|593358519|FG000|Overall Study|Unable to intubate the cecum|5|||
164270475|NCT00657371|593358519|FG000|Overall Study|Protocol Violation|2|||
164270476|NCT00657371|593358519|FG000|Overall Study|Device- related reasons|13|||
164270477|NCT00657371|593358519|FG000|Overall Study|Pre-existing medical condition|4|||
164270478|NCT02642965|593358520|FG000|Overall Study|Lack of Efficacy|4|||
163999321|NCT01147926|592362003|FG000|Overall Study|Too busy, no time for study|1|||
163999322|NCT01147926|592362004|FG001|Overall Study|Too busy, no time for study|0|||
163999323|NCT01147926|592362003|FG000|Overall Study|Went on holiday|0|||
163999324|NCT01147926|592362004|FG001|Overall Study|Went on holiday|1|||
163999325|NCT01147926|592362003|FG000|Overall Study|Colonoscopy result|0|||
163999326|NCT01147926|592362004|FG001|Overall Study|Colonoscopy result|1|||
163999327|NCT01085682|592362005|FG000|Overall Study|Withdrawal by Subject|25|||
163999328|NCT01085682|592362006|FG001|Overall Study|Withdrawal by Subject|25|||
163999329|NCT03926143|592362010|FG000|Overall Study|Physician Decision|3|||
163999330|NCT03926143|592362010|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
163999331|NCT03926143|592362010|FG000|Overall Study|Adverse Event|2|||
163999332|NCT03926143|592362010|FG000|Overall Study|Progressive disease|3|||
163999333|NCT02561156|592362015|FG000|Part 2|Adverse Event|0|||
163999334|NCT02561156|592362016|FG001|Part 2|Adverse Event|0|||
163999335|NCT02561156|592362017|FG002|Part 2|Adverse Event|0|||
164270479|NCT02642965|593358520|FG000|Overall Study|Physician Decision|9|||
164270480|NCT00652899|593358521|FG000|Overall Study|Death|1|||
163999336|NCT02561156|592362018|FG003|Part 2|Adverse Event|0|||
163999337|NCT02561156|592362019|FG004|Part 2|Adverse Event|0|||
163999338|NCT02561156|592362020|FG005|Part 2|Adverse Event|0|||
163999339|NCT02561156|592362021|FG006|Part 2|Adverse Event|0|||
163999340|NCT02561156|592362022|FG007|Part 2|Adverse Event|0|||
163999341|NCT02561156|592362023|FG008|Part 2|Adverse Event|0|||
163999342|NCT02561156|592362024|FG009|Part 2|Adverse Event|0|||
163999343|NCT02561156|592362025|FG010|Part 2|Adverse Event|0|||
163999344|NCT02561156|592362026|FG011|Part 2|Adverse Event|1|||
163999345|NCT02561156|592362027|FG012|Part 2|Adverse Event|0|||
163999346|NCT01071070|592362028|FG000|Overall Study|Adverse Event|0|||
163999347|NCT01071070|592362029|FG001|Overall Study|Adverse Event|3|||
163999348|NCT01071070|592362028|FG000|Overall Study|Withdrawal by Subject|1|||
163999349|NCT01071070|592362029|FG001|Overall Study|Withdrawal by Subject|0|||
164270481|NCT00652899|593358521|FG000|Overall Study|Treating physician decision|1|||
164270482|NCT02713867|593358528|FG000|Randomization|Other Reason|2|||
164270483|NCT02713867|593358529|FG001|Randomization|Other Reason|1|||
163999350|NCT01071070|592362028|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
163999351|NCT01071070|592362029|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
163999352|NCT01071070|592362028|FG000|Overall Study|Hypercalcemia|1|||
163999353|NCT01071070|592362029|FG001|Overall Study|Hypercalcemia|0|||
164270484|NCT02713867|593358528|FG000|Randomization|Participant Withdrew consent|0|||
164270485|NCT02713867|593358529|FG001|Randomization|Participant Withdrew consent|2|||
163999354|NCT02207907|592362039|FG000|Overall Study|Lost to Follow-up|3|||
163999355|NCT02207907|592362040|FG001|Overall Study|Lost to Follow-up|1|||
163999356|NCT02207907|592362039|FG000|Overall Study|Withdrawal by Subject|5|||
163999357|NCT02207907|592362040|FG001|Overall Study|Withdrawal by Subject|6|||
163999358|NCT02207907|592362039|FG000|Overall Study|Did not meet study criteria|3|||
163999359|NCT02207907|592362040|FG001|Overall Study|Did not meet study criteria|0|||
163999360|NCT02207907|592362039|FG000|Overall Study|Pregnancy|0|||
163999361|NCT02207907|592362040|FG001|Overall Study|Pregnancy|1|||
163999362|NCT00158184|592362041|FG000|Overall Study|personal issues|3|||
163999363|NCT00158184|592362042|FG001|Overall Study|personal issues|1|||
163999364|NCT00158184|592362041|FG000|Overall Study|failed for follow unit/study rules|2|||
163999365|NCT00158184|592362042|FG001|Overall Study|failed for follow unit/study rules|0|||
163999366|NCT00158184|592362041|FG000|Overall Study|Adverse Event|1|||
163999367|NCT00158184|592362042|FG001|Overall Study|Adverse Event|1|||
164270486|NCT02713867|593358528|FG000|Treatment Period|Other Reasons|22|||
164270487|NCT02713867|593358529|FG001|Treatment Period|Other Reasons|28|||
164270488|NCT02713867|593358528|FG000|Treatment Period|Administrative reason by sponsor|21|||
163999368|NCT00195650|592362045|FG000|Overall Study|Adverse Event|194|||
164270489|NCT02713867|593358529|FG001|Treatment Period|Administrative reason by sponsor|16|||
164270490|NCT02713867|593358528|FG000|Treatment Period|No longer meets study criteria|2|||
164270491|NCT02713867|593358529|FG001|Treatment Period|No longer meets study criteria|1|||
164270492|NCT02713867|593358528|FG000|Treatment Period|Poor/Non Compliance|1|||
164270493|NCT02713867|593358529|FG001|Treatment Period|Poor/Non Compliance|0|||
164270494|NCT02713867|593358528|FG000|Treatment Period|Maximum Clinical Benefit|5|||
164270495|NCT02713867|593358529|FG001|Treatment Period|Maximum Clinical Benefit|6|||
164270496|NCT02713867|593358528|FG000|Treatment Period|Withdrew consent|3|||
164270497|NCT02713867|593358529|FG001|Treatment Period|Withdrew consent|6|||
163893351|NCT04101357|591982030|FG002|Overall Study|Other|0|||
163893352|NCT04101357|591982031|FG003|Overall Study|Other|0|||
163893353|NCT04101357|591982032|FG004|Overall Study|Other|0|||
163893354|NCT04101357|591982033|FG005|Overall Study|Other|1|||
163893355|NCT04101357|591982034|FG006|Overall Study|Other|2|||
163893356|NCT04101357|591982035|FG007|Overall Study|Other|1|||
163893357|NCT04101357|591982036|FG008|Overall Study|Other|0|||
163893358|NCT04101357|591982037|FG009|Overall Study|Other|0|||
163893359|NCT04101357|591982038|FG010|Overall Study|Other|0|||
163893360|NCT04101357|591982028|FG000|Overall Study|Enrolled but not treated|0|||
163893361|NCT04101357|591982029|FG001|Overall Study|Enrolled but not treated|0|||
163893362|NCT04101357|591982030|FG002|Overall Study|Enrolled but not treated|0|||
163893363|NCT04101357|591982031|FG003|Overall Study|Enrolled but not treated|0|||
163893364|NCT04101357|591982032|FG004|Overall Study|Enrolled but not treated|0|||
163893365|NCT04101357|591982033|FG005|Overall Study|Enrolled but not treated|1|||
163893366|NCT04101357|591982034|FG006|Overall Study|Enrolled but not treated|1|||
163893367|NCT04101357|591982035|FG007|Overall Study|Enrolled but not treated|0|||
163893368|NCT04101357|591982036|FG008|Overall Study|Enrolled but not treated|0|||
163893369|NCT04101357|591982037|FG009|Overall Study|Enrolled but not treated|0|||
163893370|NCT04101357|591982038|FG010|Overall Study|Enrolled but not treated|0|||
163893371|NCT04871529|591982044|FG000|Overall Study|Withdrawal by Subject|0|||
163893372|NCT04871529|591982045|FG001|Overall Study|Withdrawal by Subject|1|||
163893373|NCT04871529|591982044|FG000|Overall Study|Death|0|||
163893374|NCT04871529|591982045|FG001|Overall Study|Death|1|||
163893375|NCT04871529|591982044|FG000|Overall Study|Not protocol specified|0|||
163893376|NCT04871529|591982045|FG001|Overall Study|Not protocol specified|1|||
163893377|NCT05184452|591982046|FG000|Overall Study|Lost to Follow-up|0|||
163893378|NCT05184452|591982047|FG001|Overall Study|Lost to Follow-up|0|||
163893379|NCT05184452|591982048|FG002|Overall Study|Lost to Follow-up|0|||
163893380|NCT05184452|591982049|FG003|Overall Study|Lost to Follow-up|0|||
163893381|NCT05184452|591982050|FG004|Overall Study|Lost to Follow-up|0|||
163893382|NCT05184452|591982051|FG005|Overall Study|Lost to Follow-up|2|||
163893383|NCT05184452|591982052|FG006|Overall Study|Lost to Follow-up|0|||
163893384|NCT05184452|591982053|FG007|Overall Study|Lost to Follow-up|0|||
163893385|NCT05184452|591982054|FG008|Overall Study|Lost to Follow-up|0|||
163893386|NCT05184452|591982055|FG009|Overall Study|Lost to Follow-up|1|||
163893387|NCT05184452|591982046|FG000|Overall Study|Withdrawal by Subject|0|||
163893388|NCT05184452|591982047|FG001|Overall Study|Withdrawal by Subject|0|||
163893389|NCT05184452|591982048|FG002|Overall Study|Withdrawal by Subject|0|||
163893390|NCT05184452|591982049|FG003|Overall Study|Withdrawal by Subject|0|||
163893391|NCT05184452|591982050|FG004|Overall Study|Withdrawal by Subject|0|||
163893392|NCT05184452|591982051|FG005|Overall Study|Withdrawal by Subject|1|||
163893393|NCT05184452|591982052|FG006|Overall Study|Withdrawal by Subject|0|||
163893394|NCT05184452|591982053|FG007|Overall Study|Withdrawal by Subject|0|||
163893395|NCT05184452|591982054|FG008|Overall Study|Withdrawal by Subject|0|||
163893396|NCT05184452|591982055|FG009|Overall Study|Withdrawal by Subject|1|||
163893397|NCT05290493|591982061|FG000|Overall Study|Withdrawal by Subject|2|||
163893398|NCT05290493|591982062|FG001|Overall Study|Withdrawal by Subject|2|||
163893399|NCT05290493|591982061|FG000|Overall Study|Adverse Event|1|||
163893400|NCT05290493|591982062|FG001|Overall Study|Adverse Event|0|||
163893401|NCT04003246|591982063|FG000|Overall Study|Death|9|||
163893402|NCT05363163|591982069|FG000|Overall Study|Withdrawal by Subject|13|||
163893403|NCT03673501|591982071|FG000|Overall Study|Participants ongoing.|36|||
163893404|NCT03673501|591982072|FG001|Overall Study|Participants ongoing.|24|||
163893405|NCT05838027|591982073|FG000|Overall Study|Lost to Follow-up|5|||
163893406|NCT05838027|591982074|FG001|Overall Study|Lost to Follow-up|1|||
163893407|NCT05838027|591982073|FG000|Overall Study|Withdrawal by Subject|1|||
163893408|NCT05838027|591982074|FG001|Overall Study|Withdrawal by Subject|0|||
163893409|NCT04599634|591982075|FG000|Overall Study|Dose limiting toxicity|0|||
163893410|NCT04599634|591982076|FG001|Overall Study|Dose limiting toxicity|0|||
163893411|NCT04599634|591982077|FG002|Overall Study|Dose limiting toxicity|2|||
163893412|NCT04599634|591982078|FG003|Overall Study|Dose limiting toxicity|0|||
163893413|NCT04526886|591982081|FG000|Overall Study|Physician Decision|4|||
163893414|NCT03276676|591982084|FG000|Overall Study|Withdrawal by Subject|2|||
163893415|NCT03276676|591982085|FG001|Overall Study|Withdrawal by Subject|1|||
163893416|NCT02962076|591982088|FG000|Overall Study|MHED tracer not available|5|||
163893417|NCT02962076|591982088|FG000|Overall Study|Protocol Violation|1|||
164270498|NCT02713867|593358528|FG000|Treatment Period|Requested to Discontinue|8|||
164270499|NCT02713867|593358529|FG001|Treatment Period|Requested to Discontinue|8|||
164270500|NCT02713867|593358528|FG000|Treatment Period|AE unrelated to Study Drug|11|||
164270501|NCT02713867|593358529|FG001|Treatment Period|AE unrelated to Study Drug|10|||
164270502|NCT02713867|593358528|FG000|Treatment Period|Death|7|||
164270503|NCT02713867|593358529|FG001|Treatment Period|Death|3|||
164270504|NCT02713867|593358528|FG000|Treatment Period|Study Drug Toxicity|16|||
164270505|NCT02713867|593358529|FG001|Treatment Period|Study Drug Toxicity|19|||
164270506|NCT02713867|593358528|FG000|Treatment Period|Disease Progression|82|||
164270507|NCT02713867|593358529|FG001|Treatment Period|Disease Progression|83|||
164270508|NCT04135859|593358533|FG000|Overall Study|Withdrawal by Subject|1|||
164270509|NCT04135859|593358534|FG001|Overall Study|Withdrawal by Subject|0|||
164270510|NCT04135859|593358533|FG000|Overall Study|Withdrawal due to screening failure|1|||
164270511|NCT04135859|593358534|FG001|Overall Study|Withdrawal due to screening failure|2|||
164270512|NCT04135859|593358533|FG000|Overall Study|Did not complete stress test|3|||
164270513|NCT04135859|593358534|FG001|Overall Study|Did not complete stress test|3|||
164270514|NCT04135859|593358533|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
164270515|NCT04135859|593358534|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
164270516|NCT01600053|593358537|FG000|Overall Study|Adverse Event|2|||
164270517|NCT01600053|593358537|FG000|Overall Study|trial will not meet the interim endpoint|9|||
164270518|NCT02715726|593358540|FG000|Overall Study|Adverse Event|2|||
164270519|NCT02715726|593358541|FG001|Overall Study|Adverse Event|6|||
164270520|NCT02715726|593358540|FG000|Overall Study|Protocol Violation|1|||
164270521|NCT02715726|593358541|FG001|Overall Study|Protocol Violation|0|||
164342196|NCT01877265|593629376|FG001|Treatment Period 1|Sponsor Decision|0|||
164342197|NCT01877265|593629377|FG002|Treatment Period 1|Sponsor Decision|1|||
164342198|NCT01877265|593629378|FG003|Treatment Period 1|Sponsor Decision|0|||
164342199|NCT01877265|593629379|FG004|Treatment Period 1|Sponsor Decision|0|||
164342200|NCT01877265|593629380|FG005|Treatment Period 1|Sponsor Decision|0|||
164342201|NCT01877265|593629375|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342202|NCT01877265|593629376|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342203|NCT01877265|593629377|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342204|NCT01877265|593629378|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342205|NCT01877265|593629379|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
164342206|NCT01877265|593629380|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
164342207|NCT01877265|593629375|FG000|Treatment Period 3|Lost to Follow-up|1|||
163893418|NCT02962076|591982088|FG000|Overall Study|Physician Decision|1|||
163893419|NCT03580356|591982097|FG000|Treatment Period|Withdrawal by Subject|13|||
163893420|NCT03580356|591982098|FG001|Treatment Period|Withdrawal by Subject|0|||
163893421|NCT03580356|591982099|FG002|Treatment Period|Withdrawal by Subject|13|||
163893422|NCT03580356|591982100|FG003|Treatment Period|Withdrawal by Subject|1|||
163893423|NCT03580356|591982101|FG004|Treatment Period|Withdrawal by Subject|17|||
163893424|NCT03580356|591982102|FG005|Treatment Period|Withdrawal by Subject|0|||
163893425|NCT03580356|591982103|FG006|Treatment Period|Withdrawal by Subject|5|||
163893426|NCT03580356|591982104|FG007|Treatment Period|Withdrawal by Subject|0|||
163893427|NCT03580356|591982097|FG000|Treatment Period|Adverse Event|10|||
163893428|NCT03580356|591982098|FG001|Treatment Period|Adverse Event|0|||
163893429|NCT03580356|591982099|FG002|Treatment Period|Adverse Event|13|||
163893430|NCT03580356|591982100|FG003|Treatment Period|Adverse Event|0|||
163893431|NCT03580356|591982101|FG004|Treatment Period|Adverse Event|5|||
163893432|NCT03580356|591982102|FG005|Treatment Period|Adverse Event|0|||
163893433|NCT03580356|591982103|FG006|Treatment Period|Adverse Event|8|||
163893434|NCT03580356|591982104|FG007|Treatment Period|Adverse Event|0|||
163893435|NCT03580356|591982097|FG000|Treatment Period|Protocol Violation|5|||
163893436|NCT03580356|591982098|FG001|Treatment Period|Protocol Violation|0|||
163893437|NCT03580356|591982099|FG002|Treatment Period|Protocol Violation|6|||
163893438|NCT03580356|591982100|FG003|Treatment Period|Protocol Violation|1|||
163893439|NCT03580356|591982101|FG004|Treatment Period|Protocol Violation|9|||
163893440|NCT03580356|591982102|FG005|Treatment Period|Protocol Violation|1|||
163893441|NCT03580356|591982103|FG006|Treatment Period|Protocol Violation|1|||
163893442|NCT03580356|591982104|FG007|Treatment Period|Protocol Violation|0|||
163893443|NCT03580356|591982097|FG000|Treatment Period|Lack of Efficacy|6|||
163893444|NCT03580356|591982098|FG001|Treatment Period|Lack of Efficacy|0|||
163893445|NCT03580356|591982099|FG002|Treatment Period|Lack of Efficacy|2|||
163893446|NCT03580356|591982100|FG003|Treatment Period|Lack of Efficacy|0|||
163893447|NCT03580356|591982101|FG004|Treatment Period|Lack of Efficacy|3|||
163893448|NCT03580356|591982102|FG005|Treatment Period|Lack of Efficacy|0|||
163893449|NCT03580356|591982103|FG006|Treatment Period|Lack of Efficacy|3|||
163893450|NCT03580356|591982104|FG007|Treatment Period|Lack of Efficacy|0|||
163893451|NCT03580356|591982097|FG000|Treatment Period|Pregnancy|1|||
164270522|NCT02715726|593358540|FG000|Overall Study|Death|2|||
164270523|NCT02715726|593358541|FG001|Overall Study|Death|1|||
164270524|NCT02715726|593358540|FG000|Overall Study|Participant moved|1|||
164342208|NCT01877265|593629376|FG001|Treatment Period 3|Lost to Follow-up|0|||
164342209|NCT01877265|593629377|FG002|Treatment Period 3|Lost to Follow-up|0|||
163893452|NCT03580356|591982098|FG001|Treatment Period|Pregnancy|0|||
163893453|NCT03580356|591982099|FG002|Treatment Period|Pregnancy|7|||
164342210|NCT01877265|593629378|FG003|Treatment Period 3|Lost to Follow-up|0|||
164342211|NCT01877265|593629379|FG004|Treatment Period 3|Lost to Follow-up|0|||
164342212|NCT01877265|593629380|FG005|Treatment Period 3|Lost to Follow-up|0|||
164342213|NCT01947582|593629381|FG000|Overall Study|Withdrawal by Subject|1|||
164342214|NCT00592384|593629382|FG000|Overall Study|Withdrawal by Subject|5|||
164342215|NCT00592384|593629383|FG001|Overall Study|Withdrawal by Subject|6|||
164342216|NCT01153347|593629387|FG000|Overall Study|Withdrawal by Subject|7|||
164342217|NCT01153347|593629388|FG001|Overall Study|Withdrawal by Subject|7|||
164342218|NCT01153347|593629389|FG002|Overall Study|Withdrawal by Subject|7|||
164342219|NCT01153347|593629390|FG003|Overall Study|Withdrawal by Subject|7|||
164342220|NCT01153347|593629387|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164342221|NCT01153347|593629388|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164342222|NCT01153347|593629389|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
164342223|NCT01153347|593629390|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164342224|NCT01153347|593629387|FG000|Overall Study|Adverse Event|3|||
164342225|NCT01153347|593629388|FG001|Overall Study|Adverse Event|9|||
164342226|NCT01153347|593629389|FG002|Overall Study|Adverse Event|21|||
164342227|NCT01153347|593629390|FG003|Overall Study|Adverse Event|7|||
164342228|NCT01153347|593629387|FG000|Overall Study|Severe non-compliance to protocol|6|||
164342229|NCT01153347|593629388|FG001|Overall Study|Severe non-compliance to protocol|7|||
164342230|NCT01153347|593629389|FG002|Overall Study|Severe non-compliance to protocol|4|||
164342231|NCT01153347|593629390|FG003|Overall Study|Severe non-compliance to protocol|3|||
164342232|NCT01153347|593629387|FG000|Overall Study|Condition under investigation worsened|1|||
164342233|NCT01153347|593629388|FG001|Overall Study|Condition under investigation worsened|1|||
164342234|NCT01153347|593629389|FG002|Overall Study|Condition under investigation worsened|0|||
164342235|NCT01153347|593629390|FG003|Overall Study|Condition under investigation worsened|0|||
164342236|NCT01153347|593629387|FG000|Overall Study|Lack of Efficacy|2|||
164342237|NCT01153347|593629388|FG001|Overall Study|Lack of Efficacy|2|||
164342238|NCT01153347|593629389|FG002|Overall Study|Lack of Efficacy|0|||
164342239|NCT01153347|593629390|FG003|Overall Study|Lack of Efficacy|4|||
164342240|NCT01153347|593629387|FG000|Overall Study|Study-specific withdrawal criteria|4|||
164342241|NCT01153347|593629388|FG001|Overall Study|Study-specific withdrawal criteria|3|||
164342242|NCT01153347|593629389|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164342243|NCT01153347|593629390|FG003|Overall Study|Study-specific withdrawal criteria|2|||
164342244|NCT01153347|593629387|FG000|Overall Study|Lost to Follow-up|4|||
164342245|NCT01153347|593629388|FG001|Overall Study|Lost to Follow-up|9|||
164342246|NCT01153347|593629389|FG002|Overall Study|Lost to Follow-up|11|||
164342247|NCT01153347|593629390|FG003|Overall Study|Lost to Follow-up|8|||
164342248|NCT01153347|593629387|FG000|Overall Study|Other|5|||
164342249|NCT01153347|593629388|FG001|Overall Study|Other|5|||
164342250|NCT01153347|593629389|FG002|Overall Study|Other|4|||
164342251|NCT01153347|593629390|FG003|Overall Study|Other|0|||
164342252|NCT01153347|593629387|FG000|Overall Study|Death|1|||
164342253|NCT01153347|593629388|FG001|Overall Study|Death|0|||
164342254|NCT01153347|593629389|FG002|Overall Study|Death|0|||
164342255|NCT01153347|593629390|FG003|Overall Study|Death|0|||
164342256|NCT04401423|593629393|FG000|Overall Study|Withdrawal by Subject|3|||
164342257|NCT04401423|593629394|FG001|Overall Study|Withdrawal by Subject|1|||
164342258|NCT04401423|593629393|FG000|Overall Study|Physician Decision|2|||
164342259|NCT04401423|593629394|FG001|Overall Study|Physician Decision|1|||
163999369|NCT00195650|592362045|FG000|Overall Study|Lack of Efficacy|99|||
163999370|NCT00195650|592362045|FG000|Overall Study|Withdrawal by Subject|67|||
163999371|NCT00195650|592362045|FG000|Overall Study|Lost to Follow-up|44|||
163999372|NCT00195650|592362045|FG000|Overall Study|Death|23|||
163999373|NCT00195650|592362045|FG000|Overall Study|Protocol Violation|15|||
163999374|NCT00195650|592362045|FG000|Overall Study|Administrative reasons|83|||
163999375|NCT00432809|592362046|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
163999376|NCT00432809|592362047|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
163999377|NCT00432809|592362048|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
163999378|NCT00432809|592362046|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
164342260|NCT00003473|593629395|FG000|Overall Study|Three patients were not evaluable.|3|||
164342261|NCT04678661|593629396|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
164342262|NCT04678661|593629397|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
164342263|NCT04678661|593629396|FG000|Overall Study|Protocol Violation|2|||
164342264|NCT04678661|593629397|FG001|Overall Study|Protocol Violation|0|||
164342265|NCT04678661|593629396|FG000|Overall Study|Withdrawal by Subject|1|||
164342266|NCT04678661|593629397|FG001|Overall Study|Withdrawal by Subject|0|||
164342267|NCT04678661|593629396|FG000|Overall Study|Lost to Follow-up|2|||
164342268|NCT04678661|593629397|FG001|Overall Study|Lost to Follow-up|0|||
164342269|NCT04678661|593629396|FG000|Overall Study|Death|2|||
164342270|NCT04678661|593629397|FG001|Overall Study|Death|0|||
164342271|NCT03039283|593629400|FG000|Overall Study|Protocol Violation|2|||
164342272|NCT01086033|593629401|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
164342273|NCT01086033|593629401|FG000|Overall Study|Lost to Follow-up|86|||
163999379|NCT00432809|592362047|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
164342274|NCT01086033|593629401|FG000|Overall Study|Adverse Event|42|||
164342275|NCT01086033|593629401|FG000|Overall Study|Withdrawal by Subject|41|||
164342276|NCT01086033|593629401|FG000|Overall Study|Other|14|||
164342277|NCT01086033|593629401|FG000|Overall Study|Other|13|||
164342278|NCT01086033|593629401|FG000|Overall Study|AE and Withdrew Consent|5|||
164342279|NCT01086033|593629401|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
164342280|NCT01086033|593629401|FG000|Overall Study|Withdrew consent and Other Reason|4|||
164342281|NCT01086033|593629401|FG000|Overall Study|AE and Lack of Efficacy|4|||
164342282|NCT01086033|593629401|FG000|Overall Study|Death|1|||
164342283|NCT01086033|593629401|FG000|Overall Study|AE and Lost to Follow-up|1|||
164342284|NCT01086033|593629401|FG000|Overall Study|AE and Other Reason|1|||
164342285|NCT01086033|593629401|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
164342286|NCT02193867|593629402|FG000|Overall Study|Death|2|||
164342287|NCT02193867|593629402|FG000|Overall Study|Sponsor Study Termination|2|||
164342288|NCT03639935|593629403|FG000|Overall Study|Death|3|||
164342289|NCT03639935|593629403|FG000|Overall Study|Adverse Event|1|||
164342290|NCT02924571|593629404|FG000|Overall Study|Lost to Follow-up|1|||
164342291|NCT02924571|593629405|FG001|Overall Study|Lost to Follow-up|1|||
164342292|NCT02924571|593629406|FG002|Overall Study|Lost to Follow-up|0|||
164342293|NCT00864721|593629407|FG000|Overall Study|Patient request|11|||
164342294|NCT00864721|593629407|FG000|Overall Study|Hospitalized|1|||
164342295|NCT00864721|593629407|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
164342296|NCT00864721|593629407|FG000|Overall Study|Adverse Event|21|||
164342297|NCT00261807|593629410|FG000|Overall Study|Lost to Follow-up|2|||
164342298|NCT00261807|593629410|FG000|Overall Study|Adverse Event|2|||
164342299|NCT00261807|593629410|FG000|Overall Study|Death|1|||
164342300|NCT00261807|593629410|FG000|Overall Study|Protocol Violation|2|||
164342301|NCT02590003|593629420|FG000|Overall Study|Death|1|||
164342302|NCT02590003|593629421|FG001|Overall Study|Death|2|||
164342303|NCT03733470|593629422|FG000|Overall Study|PI Decision|1|||
164342304|NCT03733470|593629423|FG001|Overall Study|PI Decision|1|||
164342305|NCT04457336|593629426|FG000|Period 2: Part A|Withdrawal by Subject|0|||
164342306|NCT04457336|593629427|FG001|Period 2: Part A|Withdrawal by Subject|1|||
164342307|NCT04457336|593629428|FG002|Period 2: Part A|Withdrawal by Subject|1|||
164270525|NCT02715726|593358541|FG001|Overall Study|Participant moved|3|||
164270526|NCT02715726|593358540|FG000|Overall Study|Other than specified above|11|||
164270527|NCT02715726|593358541|FG001|Overall Study|Other than specified above|15|||
164270528|NCT02715726|593358540|FG000|Overall Study|Randomized but not treated|1|||
164270529|NCT02715726|593358541|FG001|Overall Study|Randomized but not treated|2|||
164270530|NCT02445573|593358542|FG000|Overall Study|Withdrawal by Subject|1|||
164270531|NCT02445573|593358543|FG001|Overall Study|Withdrawal by Subject|1|||
164270532|NCT02445573|593358542|FG000|Overall Study|Lost to Follow-up|0|||
164270533|NCT02445573|593358543|FG001|Overall Study|Lost to Follow-up|1|||
164270534|NCT04047420|593358546|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
164270535|NCT04047420|593358546|FG000|Washout Period|Refused Participation|2|||
164270536|NCT03629912|593358554|FG000|Overall Study|Lost to Follow-up|19|||
164270537|NCT03629912|593358555|FG001|Overall Study|Lost to Follow-up|7|||
164270538|NCT03629912|593358556|FG002|Overall Study|Lost to Follow-up|5|||
164270539|NCT03629912|593358557|FG003|Overall Study|Lost to Follow-up|1|||
164270540|NCT03629912|593358554|FG000|Overall Study|Withdrawal by Subject|6|||
164270541|NCT03629912|593358555|FG001|Overall Study|Withdrawal by Subject|0|||
164270542|NCT03629912|593358556|FG002|Overall Study|Withdrawal by Subject|1|||
164270543|NCT03629912|593358557|FG003|Overall Study|Withdrawal by Subject|2|||
164270544|NCT03629912|593358554|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
164270545|NCT03629912|593358555|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
164270546|NCT03629912|593358556|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
164270547|NCT03629912|593358557|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
164270548|NCT03629912|593358554|FG000|Overall Study|Death|1|||
164270549|NCT03629912|593358555|FG001|Overall Study|Death|0|||
164342308|NCT04457336|593629429|FG003|Period 2: Part A|Withdrawal by Subject|1|||
164342309|NCT04457336|593629430|FG004|Period 2: Part A|Withdrawal by Subject|0|||
164342310|NCT04457336|593629431|FG005|Period 2: Part A|Withdrawal by Subject|0|||
164342311|NCT04457336|593629432|FG006|Period 2: Part A|Withdrawal by Subject|0|||
164342312|NCT04457336|593629433|FG007|Period 2: Part A|Withdrawal by Subject|0|||
164270550|NCT03629912|593358556|FG002|Overall Study|Death|0|||
164270551|NCT03629912|593358557|FG003|Overall Study|Death|0|||
164270552|NCT02608450|593358558|FG000|Overall Study|Lost to Follow-up|39|||
164270553|NCT02608450|593358559|FG001|Overall Study|Lost to Follow-up|32|||
164270554|NCT02608450|593358558|FG000|Overall Study|Withdrawal by Subject|21|||
164270555|NCT02608450|593358559|FG001|Overall Study|Withdrawal by Subject|15|||
164342313|NCT04457336|593629426|FG000|Period 2: Part A|Adverse Event|0|||
164342314|NCT04457336|593629427|FG001|Period 2: Part A|Adverse Event|0|||
164342315|NCT04457336|593629428|FG002|Period 2: Part A|Adverse Event|1|||
164342316|NCT04457336|593629429|FG003|Period 2: Part A|Adverse Event|1|||
164342317|NCT04457336|593629430|FG004|Period 2: Part A|Adverse Event|0|||
164342318|NCT04457336|593629431|FG005|Period 2: Part A|Adverse Event|0|||
164342319|NCT04457336|593629432|FG006|Period 2: Part A|Adverse Event|0|||
164342320|NCT04457336|593629433|FG007|Period 2: Part A|Adverse Event|0|||
164270556|NCT02608450|593358558|FG000|Overall Study|Adverse Event|3|||
164270557|NCT02608450|593358559|FG001|Overall Study|Adverse Event|6|||
164270558|NCT02608450|593358558|FG000|Overall Study|Withdrawal by parent|2|||
164270559|NCT02608450|593358559|FG001|Overall Study|Withdrawal by parent|3|||
164270560|NCT02608450|593358558|FG000|Overall Study|Lack of Efficacy|0|||
164270561|NCT02608450|593358559|FG001|Overall Study|Lack of Efficacy|3|||
164270562|NCT02608450|593358558|FG000|Overall Study|Noncompliance with study drug|0|||
164270563|NCT02608450|593358559|FG001|Overall Study|Noncompliance with study drug|2|||
164270564|NCT02608450|593358558|FG000|Overall Study|Physician Decision|0|||
164270565|NCT02608450|593358559|FG001|Overall Study|Physician Decision|1|||
164270566|NCT02608450|593358558|FG000|Overall Study|Pregnancy|0|||
164270567|NCT02608450|593358559|FG001|Overall Study|Pregnancy|1|||
164270568|NCT02608450|593358558|FG000|Overall Study|Progressive disease|1|||
164270569|NCT02608450|593358559|FG001|Overall Study|Progressive disease|0|||
164270570|NCT02608450|593358558|FG000|Overall Study|Multiple reasons|0|||
164270571|NCT02608450|593358559|FG001|Overall Study|Multiple reasons|2|||
164270572|NCT02565810|593358560|FG000|Overall Study|Withdrawal by Subject|1|||
164270573|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
164270574|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
164270575|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
164270576|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
164270577|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
164270578|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
164270579|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
164270580|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
164270581|NCT02636946|593358563|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
164270582|NCT02636946|593358564|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
164270583|NCT02636946|593358563|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
164270584|NCT02636946|593358564|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
164270585|NCT03089944|593358565|FG000|Overall Study|Lost to Follow-up|8|||
164270586|NCT03089944|593358565|FG000|Overall Study|Withdrew Consent|2|||
164270587|NCT03089944|593358565|FG000|Overall Study|Adverse Event|1|||
164085910|NCT01306253|592678588|FG000|Overall Study|Lost to Follow-up|1|||
164085911|NCT01306253|592678589|FG001|Overall Study|Lost to Follow-up|1|||
164270588|NCT03089944|593358565|FG000|Overall Study|Other|1|||
164270589|NCT02308488|593358566|FG000|Overall Study|Withdrawal by Subject|2|||
164270590|NCT03263780|593358569|FG000|Overall Study|Withdrawal by Subject|3|||
163999380|NCT00432809|592362048|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
163999381|NCT01499290|592362049|FG000|Overall Study|Withdrawal by Subject|22|||
163999382|NCT01499290|592362050|FG001|Overall Study|Withdrawal by Subject|15|||
163999383|NCT01499290|592362049|FG000|Overall Study|Not specified in study report|11|||
163999384|NCT01499290|592362050|FG001|Overall Study|Not specified in study report|5|||
163999385|NCT01499290|592362049|FG000|Overall Study|Condition improved/subject recovered|1|||
163999386|NCT01499290|592362050|FG001|Overall Study|Condition improved/subject recovered|0|||
163999387|NCT01499290|592362049|FG000|Overall Study|Lack of Efficacy|7|||
163999388|NCT01499290|592362050|FG001|Overall Study|Lack of Efficacy|8|||
163999389|NCT01499290|592362049|FG000|Overall Study|Adverse Event|14|||
163999390|NCT01499290|592362050|FG001|Overall Study|Adverse Event|7|||
163999391|NCT03308188|592362051|FG000|Overall Study|Withdrawal by Subject|0|||
163999392|NCT03308188|592362052|FG001|Overall Study|Withdrawal by Subject|3|||
163999393|NCT03308188|592362051|FG000|Overall Study|Death|0|||
163999394|NCT03308188|592362052|FG001|Overall Study|Death|1|||
163999395|NCT01791855|592362053|FG000|Overall Study|Adverse Event|0|||
163999396|NCT01791855|592362054|FG001|Overall Study|Adverse Event|0|||
163999397|NCT01791855|592362055|FG002|Overall Study|Adverse Event|0|||
163999398|NCT01791855|592362056|FG003|Overall Study|Adverse Event|1|||
164270591|NCT03263780|593358569|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
164270592|NCT01839656|593358573|FG000|Overall Study|Withdrawal by Subject|1|||
164270593|NCT01839656|593358574|FG001|Overall Study|Withdrawal by Subject|1|||
164270594|NCT01839656|593358573|FG000|Overall Study|Adverse event, serious fatal|1|||
164270595|NCT01839656|593358574|FG001|Overall Study|Adverse event, serious fatal|4|||
164270596|NCT01839656|593358573|FG000|Overall Study|Early study closure|0|||
164270597|NCT01839656|593358574|FG001|Overall Study|Early study closure|11|||
164270598|NCT01839656|593358573|FG000|Overall Study|Adverse Event|1|||
164270599|NCT01839656|593358574|FG001|Overall Study|Adverse Event|0|||
164270600|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
164270601|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
164270602|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
163999399|NCT01791855|592362053|FG000|Overall Study|Randomized, not treated|0|||
163999400|NCT01791855|592362054|FG001|Overall Study|Randomized, not treated|1|||
164085912|NCT01261325|592678590|FG000|Overall Study|Lack of Efficacy|1|||
164270603|NCT00499746|593358580|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
164270604|NCT01012323|593358583|FG000|Overall Study|Investigator Judgment|1|||
164270605|NCT00558272|593358586|FG000|Overall Study|Adverse Event|10|||
163999401|NCT01791855|592362055|FG002|Overall Study|Randomized, not treated|0|||
164270606|NCT00558272|593358587|FG001|Overall Study|Adverse Event|0|||
164270607|NCT00558272|593358586|FG000|Overall Study|Death|1|||
164270608|NCT00558272|593358587|FG001|Overall Study|Death|0|||
164270609|NCT00558272|593358586|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
164270610|NCT00558272|593358587|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
164270611|NCT00558272|593358586|FG000|Overall Study|AZ study team decision|0|||
164270612|NCT00558272|593358587|FG001|Overall Study|AZ study team decision|1|||
164270613|NCT00558272|593358586|FG000|Overall Study|Incorrectly enrolled|1|||
164270614|NCT00558272|593358587|FG001|Overall Study|Incorrectly enrolled|0|||
164270615|NCT00558272|593358586|FG000|Overall Study|Withdrawal by Subject|0|||
164270616|NCT00558272|593358587|FG001|Overall Study|Withdrawal by Subject|1|||
164270617|NCT00737633|593358593|FG000|Overall Study|Study terminated by sponsor|44|||
164270618|NCT00737633|593358594|FG001|Overall Study|Study terminated by sponsor|55|||
163893454|NCT03580356|591982100|FG003|Treatment Period|Pregnancy|0|||
164270619|NCT00737633|593358593|FG000|Overall Study|Lost to Follow-up|0|||
164270620|NCT00737633|593358594|FG001|Overall Study|Lost to Follow-up|1|||
164270621|NCT00737633|593358593|FG000|Overall Study|protocol non-compliance|0|||
164270622|NCT00737633|593358594|FG001|Overall Study|protocol non-compliance|1|||
164270623|NCT01105377|593358600|FG000|Overall Study|Withdrawal by Subject|0|||
164270624|NCT01105377|593358601|FG001|Overall Study|Withdrawal by Subject|1|||
164270625|NCT02409342|593358603|FG000|Overall Study|Death|211|||
164270626|NCT02409342|593358604|FG001|Overall Study|Death|201|||
164270627|NCT02409342|593358603|FG000|Overall Study|Withdrawal by Subject|24|||
164270628|NCT02409342|593358604|FG001|Overall Study|Withdrawal by Subject|17|||
164270629|NCT02409342|593358603|FG000|Overall Study|Study Terminated By Sponsor|48|||
164270630|NCT02409342|593358604|FG001|Overall Study|Study Terminated By Sponsor|59|||
164270631|NCT02409342|593358603|FG000|Overall Study|Lost to Follow-up|3|||
163893455|NCT03580356|591982101|FG004|Treatment Period|Pregnancy|2|||
164270632|NCT02409342|593358604|FG001|Overall Study|Lost to Follow-up|5|||
164270633|NCT02409342|593358603|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
164270634|NCT02409342|593358604|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
164270635|NCT02409342|593358603|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
164342321|NCT04457336|593629426|FG000|Period 2: Part A|Study Terminated|0|||
164342322|NCT04457336|593629427|FG001|Period 2: Part A|Study Terminated|0|||
163893456|NCT03580356|591982102|FG005|Treatment Period|Pregnancy|0|||
163893457|NCT03580356|591982103|FG006|Treatment Period|Pregnancy|1|||
163893458|NCT03580356|591982104|FG007|Treatment Period|Pregnancy|0|||
163893459|NCT03580356|591982097|FG000|Treatment Period|Physician Decision|2|||
163893460|NCT03580356|591982098|FG001|Treatment Period|Physician Decision|0|||
163893461|NCT03580356|591982099|FG002|Treatment Period|Physician Decision|1|||
163893462|NCT03580356|591982100|FG003|Treatment Period|Physician Decision|0|||
163893463|NCT03580356|591982101|FG004|Treatment Period|Physician Decision|4|||
163893464|NCT03580356|591982102|FG005|Treatment Period|Physician Decision|0|||
163893465|NCT03580356|591982103|FG006|Treatment Period|Physician Decision|2|||
163893466|NCT03580356|591982104|FG007|Treatment Period|Physician Decision|0|||
163893467|NCT03580356|591982097|FG000|Treatment Period|Lost to Follow-up|1|||
163893468|NCT03580356|591982098|FG001|Treatment Period|Lost to Follow-up|1|||
163893469|NCT03580356|591982099|FG002|Treatment Period|Lost to Follow-up|1|||
163893470|NCT03580356|591982100|FG003|Treatment Period|Lost to Follow-up|0|||
163893471|NCT03580356|591982101|FG004|Treatment Period|Lost to Follow-up|3|||
163893472|NCT03580356|591982102|FG005|Treatment Period|Lost to Follow-up|0|||
163893473|NCT03580356|591982103|FG006|Treatment Period|Lost to Follow-up|1|||
163893474|NCT03580356|591982104|FG007|Treatment Period|Lost to Follow-up|0|||
163893475|NCT03580356|591982097|FG000|Treatment Period|Death|0|||
163893476|NCT03580356|591982098|FG001|Treatment Period|Death|0|||
163893477|NCT03580356|591982099|FG002|Treatment Period|Death|1|||
163893478|NCT03580356|591982100|FG003|Treatment Period|Death|0|||
163893479|NCT03580356|591982101|FG004|Treatment Period|Death|0|||
163893480|NCT03580356|591982102|FG005|Treatment Period|Death|0|||
163893481|NCT03580356|591982103|FG006|Treatment Period|Death|0|||
163893482|NCT03580356|591982104|FG007|Treatment Period|Death|0|||
163893483|NCT03580356|591982097|FG000|Treatment Period|Technical problems|0|||
163893484|NCT03580356|591982098|FG001|Treatment Period|Technical problems|0|||
163893485|NCT03580356|591982099|FG002|Treatment Period|Technical problems|0|||
163893486|NCT03580356|591982100|FG003|Treatment Period|Technical problems|0|||
163893487|NCT03580356|591982101|FG004|Treatment Period|Technical problems|1|||
163893488|NCT03580356|591982102|FG005|Treatment Period|Technical problems|0|||
163893489|NCT03580356|591982103|FG006|Treatment Period|Technical problems|0|||
163893490|NCT03580356|591982104|FG007|Treatment Period|Technical problems|0|||
163893491|NCT03580356|591982097|FG000|Treatment Period|Misrandomized, no treatment|0|||
163893492|NCT03580356|591982098|FG001|Treatment Period|Misrandomized, no treatment|0|||
163893493|NCT03580356|591982099|FG002|Treatment Period|Misrandomized, no treatment|1|||
163893494|NCT03580356|591982100|FG003|Treatment Period|Misrandomized, no treatment|0|||
163893495|NCT03580356|591982101|FG004|Treatment Period|Misrandomized, no treatment|2|||
163893496|NCT03580356|591982102|FG005|Treatment Period|Misrandomized, no treatment|0|||
164270636|NCT02409342|593358604|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
164270637|NCT02409342|593358603|FG000|Overall Study|Sponsor Decision|1|||
164270638|NCT02409342|593358604|FG001|Overall Study|Sponsor Decision|0|||
164270639|NCT00279812|593358605|FG000|Overall Study|Protocol Violation|1|||
164270640|NCT00279812|593358606|FG001|Overall Study|Protocol Violation|1|||
164270641|NCT00279812|593358607|FG002|Overall Study|Protocol Violation|0|||
164270642|NCT00279812|593358608|FG003|Overall Study|Protocol Violation|0|||
164270643|NCT00279812|593358609|FG004|Overall Study|Protocol Violation|1|||
164270644|NCT00279812|593358610|FG005|Overall Study|Protocol Violation|0|||
164270645|NCT00279812|593358605|FG000|Overall Study|Withdrawal by Subject|0|||
164270646|NCT00279812|593358606|FG001|Overall Study|Withdrawal by Subject|4|||
164270647|NCT00279812|593358607|FG002|Overall Study|Withdrawal by Subject|2|||
164270648|NCT00279812|593358608|FG003|Overall Study|Withdrawal by Subject|0|||
164270649|NCT00279812|593358609|FG004|Overall Study|Withdrawal by Subject|0|||
164270650|NCT00279812|593358610|FG005|Overall Study|Withdrawal by Subject|0|||
164270651|NCT00279812|593358605|FG000|Overall Study|Adverse Event|0|||
164270652|NCT00279812|593358606|FG001|Overall Study|Adverse Event|1|||
164270653|NCT00279812|593358607|FG002|Overall Study|Adverse Event|1|||
164270654|NCT00279812|593358608|FG003|Overall Study|Adverse Event|0|||
164270655|NCT00279812|593358609|FG004|Overall Study|Adverse Event|2|||
164270656|NCT00279812|593358610|FG005|Overall Study|Adverse Event|1|||
164270657|NCT03834220|593358616|FG000|Overall Study|Adverse Event|1|||
164270658|NCT03834220|593358617|FG001|Overall Study|Adverse Event|0|||
164270659|NCT03834220|593358618|FG002|Overall Study|Adverse Event|0|||
164270660|NCT03834220|593358616|FG000|Overall Study|Death|8|||
164270661|NCT03834220|593358617|FG001|Overall Study|Death|1|||
164270662|NCT03834220|593358618|FG002|Overall Study|Death|17|||
164270663|NCT03834220|593358616|FG000|Overall Study|Reason not Specified|9|||
164270664|NCT03834220|593358617|FG001|Overall Study|Reason not Specified|0|||
164270665|NCT03834220|593358618|FG002|Overall Study|Reason not Specified|6|||
164270666|NCT03834220|593358616|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
164270667|NCT03834220|593358617|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
164270668|NCT03834220|593358618|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
164270669|NCT03834220|593358616|FG000|Overall Study|Withdrawal of Consent|2|||
164270670|NCT03834220|593358617|FG001|Overall Study|Withdrawal of Consent|2|||
164270671|NCT03834220|593358618|FG002|Overall Study|Withdrawal of Consent|2|||
164270672|NCT00527332|593358619|FG000|Overall Study|Protocol Violation|4|||
164270673|NCT00527332|593358620|FG001|Overall Study|Protocol Violation|8|||
164270674|NCT00527332|593358619|FG000|Overall Study|Withdrew consent|5|||
164270675|NCT00527332|593358620|FG001|Overall Study|Withdrew consent|1|||
164270676|NCT03684694|593358623|FG000|Phase 1|Withdrawal by Subject|1|||
164270677|NCT03684694|593358624|FG001|Phase 1|Withdrawal by Subject|0|||
164270678|NCT03684694|593358625|FG002|Phase 1|Withdrawal by Subject|0|||
164270679|NCT03684694|593358626|FG003|Phase 1|Withdrawal by Subject|0|||
163999402|NCT01791855|592362056|FG003|Overall Study|Randomized, not treated|0|||
163999403|NCT00481065|592362057|FG000|Overall Study|Adverse event or death|1|||
163999404|NCT00481065|592362058|FG001|Overall Study|Adverse event or death|1|||
163999405|NCT00481065|592362059|FG002|Overall Study|Adverse event or death|3|||
163999406|NCT00481065|592362060|FG003|Overall Study|Adverse event or death|0|||
163999407|NCT00481065|592362061|FG004|Overall Study|Adverse event or death|2|||
163999408|NCT00481065|592362062|FG005|Overall Study|Adverse event or death|0|||
163999409|NCT00481065|592362063|FG006|Overall Study|Adverse event or death|1|||
163999410|NCT00481065|592362064|FG007|Overall Study|Adverse event or death|1|||
163999411|NCT00481065|592362057|FG000|Overall Study|Withdrawal by Subject|11|||
163999412|NCT00481065|592362058|FG001|Overall Study|Withdrawal by Subject|12|||
163999413|NCT00481065|592362059|FG002|Overall Study|Withdrawal by Subject|7|||
163999414|NCT00481065|592362060|FG003|Overall Study|Withdrawal by Subject|11|||
163999415|NCT00481065|592362061|FG004|Overall Study|Withdrawal by Subject|13|||
163999416|NCT00481065|592362062|FG005|Overall Study|Withdrawal by Subject|12|||
163999417|NCT00481065|592362063|FG006|Overall Study|Withdrawal by Subject|9|||
163999418|NCT00481065|592362064|FG007|Overall Study|Withdrawal by Subject|10|||
163999419|NCT00481065|592362057|FG000|Overall Study|Lost to Follow-up|4|||
163999420|NCT00481065|592362058|FG001|Overall Study|Lost to Follow-up|2|||
163999421|NCT00481065|592362059|FG002|Overall Study|Lost to Follow-up|4|||
164270680|NCT03684694|593358627|FG004|Phase 1|Withdrawal by Subject|0|||
164270681|NCT03684694|593358628|FG005|Phase 1|Withdrawal by Subject|0|||
164270682|NCT03684694|593358623|FG000|Phase 1|Investigator/Sponsor Decision|12|||
164270683|NCT03684694|593358624|FG001|Phase 1|Investigator/Sponsor Decision|2|||
164270684|NCT03684694|593358625|FG002|Phase 1|Investigator/Sponsor Decision|1|||
164270685|NCT03684694|593358626|FG003|Phase 1|Investigator/Sponsor Decision|0|||
163999422|NCT00481065|592362060|FG003|Overall Study|Lost to Follow-up|3|||
163999423|NCT00481065|592362061|FG004|Overall Study|Lost to Follow-up|3|||
164085913|NCT01261325|592678591|FG001|Overall Study|Lack of Efficacy|1|||
164270686|NCT03684694|593358627|FG004|Phase 1|Investigator/Sponsor Decision|0|||
164270687|NCT03684694|593358628|FG005|Phase 1|Investigator/Sponsor Decision|0|||
164270688|NCT03684694|593358623|FG000|Phase 1|Death|24|||
164270689|NCT03684694|593358624|FG001|Phase 1|Death|0|||
164270690|NCT03684694|593358625|FG002|Phase 1|Death|3|||
164270691|NCT03684694|593358626|FG003|Phase 1|Death|0|||
164270692|NCT03684694|593358627|FG004|Phase 1|Death|0|||
164270693|NCT03684694|593358628|FG005|Phase 1|Death|0|||
163999424|NCT00481065|592362062|FG005|Overall Study|Lost to Follow-up|3|||
163999425|NCT00481065|592362063|FG006|Overall Study|Lost to Follow-up|2|||
163999426|NCT00481065|592362064|FG007|Overall Study|Lost to Follow-up|5|||
163999427|NCT00481065|592362057|FG000|Overall Study|Inappropriate enrollment|4|||
163999428|NCT00481065|592362058|FG001|Overall Study|Inappropriate enrollment|0|||
163999429|NCT00481065|592362059|FG002|Overall Study|Inappropriate enrollment|2|||
163999430|NCT00481065|592362060|FG003|Overall Study|Inappropriate enrollment|0|||
163999431|NCT00481065|592362061|FG004|Overall Study|Inappropriate enrollment|2|||
163999432|NCT00481065|592362062|FG005|Overall Study|Inappropriate enrollment|1|||
163999433|NCT00481065|592362063|FG006|Overall Study|Inappropriate enrollment|0|||
163999434|NCT00481065|592362064|FG007|Overall Study|Inappropriate enrollment|1|||
163999435|NCT00481065|592362057|FG000|Overall Study|Administrative reason|0|||
163999436|NCT00481065|592362058|FG001|Overall Study|Administrative reason|0|||
163999437|NCT00481065|592362059|FG002|Overall Study|Administrative reason|0|||
163999438|NCT00481065|592362060|FG003|Overall Study|Administrative reason|0|||
163999439|NCT00481065|592362061|FG004|Overall Study|Administrative reason|0|||
163999440|NCT00481065|592362062|FG005|Overall Study|Administrative reason|2|||
163999441|NCT00481065|592362063|FG006|Overall Study|Administrative reason|1|||
163999442|NCT00481065|592362064|FG007|Overall Study|Administrative reason|0|||
163999443|NCT00481065|592362057|FG000|Overall Study|Protocol Violation|2|||
163999444|NCT00481065|592362058|FG001|Overall Study|Protocol Violation|1|||
163999445|NCT00481065|592362059|FG002|Overall Study|Protocol Violation|1|||
163999446|NCT00481065|592362060|FG003|Overall Study|Protocol Violation|1|||
163999447|NCT00481065|592362061|FG004|Overall Study|Protocol Violation|2|||
163999448|NCT00481065|592362062|FG005|Overall Study|Protocol Violation|6|||
163999449|NCT00481065|592362063|FG006|Overall Study|Protocol Violation|3|||
163999450|NCT00481065|592362064|FG007|Overall Study|Protocol Violation|2|||
163999451|NCT00481065|592362057|FG000|Overall Study|Unable to classify|0|||
163999452|NCT00481065|592362058|FG001|Overall Study|Unable to classify|1|||
163999453|NCT00481065|592362059|FG002|Overall Study|Unable to classify|2|||
163999454|NCT00481065|592362060|FG003|Overall Study|Unable to classify|0|||
163999455|NCT00481065|592362061|FG004|Overall Study|Unable to classify|1|||
163999456|NCT00481065|592362062|FG005|Overall Study|Unable to classify|0|||
163999457|NCT00481065|592362063|FG006|Overall Study|Unable to classify|0|||
163999458|NCT00481065|592362064|FG007|Overall Study|Unable to classify|0|||
163999459|NCT01709331|592362065|FG000|Overall Study|Adverse Event|1|||
163999460|NCT00772447|592362066|FG000|Overall Study|Withdrawal by Subject|9|||
163999461|NCT00772447|592362067|FG001|Overall Study|Withdrawal by Subject|5|||
163999462|NCT00772447|592362066|FG000|Overall Study|Physician Decision|4|||
163893497|NCT03580356|591982103|FG006|Treatment Period|Misrandomized, no treatment|0|||
163893498|NCT03580356|591982104|FG007|Treatment Period|Misrandomized, no treatment|0|||
163893499|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
163893500|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
163893501|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
163893502|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
163893503|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
163893504|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
163893505|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
163893506|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
163893507|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
163893508|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163893509|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
163893510|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163893511|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
163893512|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163893513|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163893514|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
163893515|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
163893516|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
163893517|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
163893518|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
163893519|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
163893520|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
163893521|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
163893522|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
163893523|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163893524|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163893525|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
163893526|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163893527|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
163893528|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163893529|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163999463|NCT00772447|592362067|FG001|Overall Study|Physician Decision|8|||
163999464|NCT00772447|592362066|FG000|Overall Study|Lost to Follow-up|2|||
163999465|NCT00772447|592362067|FG001|Overall Study|Lost to Follow-up|4|||
163999466|NCT00772447|592362066|FG000|Overall Study|incorrect enrolment|3|||
163999467|NCT00772447|592362067|FG001|Overall Study|incorrect enrolment|4|||
163999468|NCT00772447|592362066|FG000|Overall Study|Protocol Violation|0|||
163999469|NCT00772447|592362067|FG001|Overall Study|Protocol Violation|1|||
163999470|NCT00772447|592362066|FG000|Overall Study|all others|2|||
163999471|NCT00772447|592362067|FG001|Overall Study|all others|2|||
163999472|NCT04439344|592362068|FG000|Overall Study|Never started threapy|3|||
163999473|NCT04439344|592362068|FG000|Overall Study|Ineligible|3|||
163999474|NCT04439344|592362068|FG000|Overall Study|Adverse Event|13|||
163999475|NCT04439344|592362068|FG000|Overall Study|Death|2|||
163999476|NCT04439344|592362068|FG000|Overall Study|Disease progression|29|||
163999477|NCT04439344|592362068|FG000|Overall Study|Withdrawal by Subject|2|||
163999478|NCT04439344|592362068|FG000|Overall Study|Alternative therapy|1|||
163999479|NCT03770403|592362074|FG000|Overall Study|Adverse Event|8|||
163999480|NCT03770403|592362074|FG000|Overall Study|Death|5|||
163999481|NCT03770403|592362074|FG000|Overall Study|Physician Decision|1|||
163999482|NCT03770403|592362074|FG000|Overall Study|Sponsor decision|1|||
163999483|NCT03770403|592362074|FG000|Overall Study|Study terminated by Sponsor|1|||
163999484|NCT03770403|592362074|FG000|Overall Study|Withdrawal by Subject|13|||
163999485|NCT03770403|592362074|FG000|Overall Study|Other|88|||
163999486|NCT03896295|592362075|FG000|Overall Study|Adverse Event|0|||
163999487|NCT03896295|592362076|FG001|Overall Study|Adverse Event|1|||
163999488|NCT03896295|592362075|FG000|Overall Study|COVID-19|7|||
163999489|NCT03896295|592362076|FG001|Overall Study|COVID-19|29|||
163999490|NCT01957137|592362077|FG000|Randomized Portion|Adverse Event|1|||
163999491|NCT01957137|592362077|FG000|Randomized Portion|Withdrawal by Subject|1|||
163999492|NCT00700804|592362090|FG000|Overall Study|Withdrawal by Subject|1|||
163999493|NCT00700804|592362091|FG001|Overall Study|Withdrawal by Subject|2|||
163999494|NCT00700804|592362090|FG000|Overall Study|Protocol Violation|1|||
163999495|NCT00700804|592362091|FG001|Overall Study|Protocol Violation|1|||
163999496|NCT00700804|592362090|FG000|Overall Study|Loose Stools|1|||
163999497|NCT00700804|592362091|FG001|Overall Study|Loose Stools|1|||
163999498|NCT02901431|592362092|FG000|PK Part|Adverse Event|0|||
163999499|NCT02901431|592362093|FG001|PK Part|Adverse Event|1|||
163999500|NCT02901431|592362094|FG002|PK Part|Adverse Event|0|||
163999501|NCT02901431|592362095|FG003|PK Part|Adverse Event|0|||
163999502|NCT02901431|592362096|FG004|PK Part|Adverse Event|0|||
164270694|NCT03684694|593358623|FG000|Phase 1|Lost to Follow-up|0|||
164270695|NCT03684694|593358624|FG001|Phase 1|Lost to Follow-up|0|||
164270696|NCT03684694|593358625|FG002|Phase 1|Lost to Follow-up|1|||
164270697|NCT03684694|593358626|FG003|Phase 1|Lost to Follow-up|0|||
164270698|NCT03684694|593358627|FG004|Phase 1|Lost to Follow-up|0|||
164270699|NCT03684694|593358628|FG005|Phase 1|Lost to Follow-up|0|||
164270700|NCT03684694|593358623|FG000|Phase 1|Miscellaneous|0|||
164270701|NCT03684694|593358624|FG001|Phase 1|Miscellaneous|1|||
164270702|NCT03684694|593358625|FG002|Phase 1|Miscellaneous|0|||
164270703|NCT03684694|593358626|FG003|Phase 1|Miscellaneous|0|||
164270704|NCT03684694|593358627|FG004|Phase 1|Miscellaneous|0|||
164270705|NCT03684694|593358628|FG005|Phase 1|Miscellaneous|0|||
164270706|NCT03684694|593358623|FG000|Phase 2|Withdrawal by Subject|0|||
164270707|NCT03684694|593358624|FG001|Phase 2|Withdrawal by Subject|0|||
164270708|NCT03684694|593358625|FG002|Phase 2|Withdrawal by Subject|0|||
164270709|NCT03684694|593358626|FG003|Phase 2|Withdrawal by Subject|0|||
164270710|NCT03684694|593358627|FG004|Phase 2|Withdrawal by Subject|0|||
164270711|NCT03684694|593358628|FG005|Phase 2|Withdrawal by Subject|1|||
164270712|NCT03684694|593358623|FG000|Phase 2|Investigator/Sponsor Decision|0|||
164270713|NCT03684694|593358624|FG001|Phase 2|Investigator/Sponsor Decision|0|||
164270714|NCT03684694|593358625|FG002|Phase 2|Investigator/Sponsor Decision|0|||
164270715|NCT03684694|593358626|FG003|Phase 2|Investigator/Sponsor Decision|17|||
164270716|NCT03684694|593358627|FG004|Phase 2|Investigator/Sponsor Decision|16|||
164270717|NCT03684694|593358628|FG005|Phase 2|Investigator/Sponsor Decision|6|||
164270718|NCT03684694|593358623|FG000|Phase 2|Death|0|||
164270719|NCT03684694|593358624|FG001|Phase 2|Death|0|||
164270720|NCT03684694|593358625|FG002|Phase 2|Death|0|||
164270721|NCT03684694|593358626|FG003|Phase 2|Death|28|||
163999503|NCT02901431|592362097|FG005|PK Part|Adverse Event|0|||
163999504|NCT02901431|592362098|FG006|PK Part|Adverse Event|0|||
163999505|NCT02901431|592362099|FG007|PK Part|Adverse Event|0|||
163999506|NCT02901431|592362100|FG008|PK Part|Adverse Event|0|||
163999507|NCT02901431|592362101|FG009|PK Part|Adverse Event|0|||
163999508|NCT02901431|592362102|FG010|PK Part|Adverse Event|0|||
163999509|NCT02901431|592362103|FG011|PK Part|Adverse Event|0|||
163999510|NCT02901431|592362104|FG012|PK Part|Adverse Event|0|||
164270722|NCT03684694|593358627|FG004|Phase 2|Death|14|||
164270723|NCT03684694|593358628|FG005|Phase 2|Death|3|||
164270724|NCT03684694|593358623|FG000|Phase 2|Lost to Follow-up|0|||
163999511|NCT02901431|592362092|FG000|PK Part|Lost to Follow-up|0|||
163999512|NCT02901431|592362093|FG001|PK Part|Lost to Follow-up|0|||
163999513|NCT02901431|592362094|FG002|PK Part|Lost to Follow-up|1|||
164270725|NCT03684694|593358624|FG001|Phase 2|Lost to Follow-up|0|||
164270726|NCT03684694|593358625|FG002|Phase 2|Lost to Follow-up|0|||
164270727|NCT03684694|593358626|FG003|Phase 2|Lost to Follow-up|1|||
163999514|NCT02901431|592362095|FG003|PK Part|Lost to Follow-up|0|||
163999515|NCT02901431|592362096|FG004|PK Part|Lost to Follow-up|0|||
163999516|NCT02901431|592362097|FG005|PK Part|Lost to Follow-up|0|||
163999517|NCT02901431|592362098|FG006|PK Part|Lost to Follow-up|0|||
163999518|NCT02901431|592362099|FG007|PK Part|Lost to Follow-up|0|||
163999519|NCT02901431|592362100|FG008|PK Part|Lost to Follow-up|0|||
163999520|NCT02901431|592362101|FG009|PK Part|Lost to Follow-up|0|||
163999521|NCT02901431|592362102|FG010|PK Part|Lost to Follow-up|0|||
163999522|NCT02901431|592362103|FG011|PK Part|Lost to Follow-up|0|||
163999523|NCT02901431|592362104|FG012|PK Part|Lost to Follow-up|0|||
163999524|NCT02901431|592362092|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
163999525|NCT02901431|592362093|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999526|NCT02901431|592362094|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999527|NCT02901431|592362095|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999528|NCT02901431|592362096|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999529|NCT02901431|592362097|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999530|NCT02901431|592362098|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999531|NCT02901431|592362099|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999532|NCT02901431|592362100|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999533|NCT02901431|592362101|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999534|NCT02901431|592362102|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999535|NCT02901431|592362103|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999536|NCT02901431|592362104|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
163999537|NCT02901431|592362092|FG000|PK Part|Pending dose confirmation|0|||
163999538|NCT02901431|592362093|FG001|PK Part|Pending dose confirmation|1|||
163999539|NCT02901431|592362094|FG002|PK Part|Pending dose confirmation|0|||
163999540|NCT02901431|592362095|FG003|PK Part|Pending dose confirmation|0|||
163999541|NCT02901431|592362096|FG004|PK Part|Pending dose confirmation|0|||
163999542|NCT02901431|592362097|FG005|PK Part|Pending dose confirmation|0|||
163999543|NCT02901431|592362098|FG006|PK Part|Pending dose confirmation|0|||
163999544|NCT02901431|592362099|FG007|PK Part|Pending dose confirmation|0|||
163999545|NCT02901431|592362100|FG008|PK Part|Pending dose confirmation|0|||
163999546|NCT02901431|592362101|FG009|PK Part|Pending dose confirmation|0|||
163999547|NCT02901431|592362102|FG010|PK Part|Pending dose confirmation|0|||
163999548|NCT02901431|592362103|FG011|PK Part|Pending dose confirmation|0|||
163999549|NCT02901431|592362104|FG012|PK Part|Pending dose confirmation|0|||
163999550|NCT02901431|592362092|FG000|PK Part|8 weeks of treatment ran out|2|||
163999551|NCT02901431|592362093|FG001|PK Part|8 weeks of treatment ran out|0|||
163999552|NCT02901431|592362094|FG002|PK Part|8 weeks of treatment ran out|0|||
163999553|NCT02901431|592362095|FG003|PK Part|8 weeks of treatment ran out|0|||
163999554|NCT02901431|592362096|FG004|PK Part|8 weeks of treatment ran out|0|||
163999555|NCT02901431|592362097|FG005|PK Part|8 weeks of treatment ran out|0|||
164270728|NCT03684694|593358627|FG004|Phase 2|Lost to Follow-up|0|||
164270729|NCT03684694|593358628|FG005|Phase 2|Lost to Follow-up|0|||
164270730|NCT03684694|593358623|FG000|Phase 2|Miscellaneous|0|||
164270731|NCT03684694|593358624|FG001|Phase 2|Miscellaneous|0|||
164270732|NCT03684694|593358625|FG002|Phase 2|Miscellaneous|0|||
164270733|NCT03684694|593358626|FG003|Phase 2|Miscellaneous|3|||
164270734|NCT03684694|593358627|FG004|Phase 2|Miscellaneous|0|||
164270735|NCT03684694|593358628|FG005|Phase 2|Miscellaneous|0|||
164270736|NCT02100475|593360417|FG000|Overall Study|Unclassified|1|||
164270737|NCT02100475|593360418|FG001|Overall Study|Unclassified|2|||
164270738|NCT02100475|593360417|FG000|Overall Study|Withdrawal criteria|1|||
164270739|NCT02100475|593360418|FG001|Overall Study|Withdrawal criteria|0|||
164270740|NCT03268941|593360419|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164270741|NCT03268941|593360420|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163999556|NCT02901431|592362098|FG006|PK Part|8 weeks of treatment ran out|0|||
163999557|NCT02901431|592362099|FG007|PK Part|8 weeks of treatment ran out|0|||
163999558|NCT02901431|592362100|FG008|PK Part|8 weeks of treatment ran out|0|||
163999559|NCT02901431|592362101|FG009|PK Part|8 weeks of treatment ran out|0|||
163999560|NCT02901431|592362102|FG010|PK Part|8 weeks of treatment ran out|0|||
163999561|NCT02901431|592362103|FG011|PK Part|8 weeks of treatment ran out|0|||
163999562|NCT02901431|592362104|FG012|PK Part|8 weeks of treatment ran out|0|||
163999563|NCT02901431|592362092|FG000|PK Part|Stopped treatment after 8 weeks|1|||
163999564|NCT02901431|592362093|FG001|PK Part|Stopped treatment after 8 weeks|0|||
163999565|NCT02901431|592362094|FG002|PK Part|Stopped treatment after 8 weeks|1|||
163999566|NCT02901431|592362095|FG003|PK Part|Stopped treatment after 8 weeks|0|||
163999567|NCT02901431|592362096|FG004|PK Part|Stopped treatment after 8 weeks|0|||
163999568|NCT02901431|592362097|FG005|PK Part|Stopped treatment after 8 weeks|0|||
163999569|NCT02901431|592362098|FG006|PK Part|Stopped treatment after 8 weeks|0|||
164270742|NCT03268941|593360421|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164270743|NCT03268941|593360422|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
164270744|NCT03268941|593360423|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163999570|NCT02901431|592362099|FG007|PK Part|Stopped treatment after 8 weeks|0|||
163999571|NCT02901431|592362100|FG008|PK Part|Stopped treatment after 8 weeks|0|||
163999572|NCT02901431|592362101|FG009|PK Part|Stopped treatment after 8 weeks|0|||
163999573|NCT02901431|592362102|FG010|PK Part|Stopped treatment after 8 weeks|0|||
163999574|NCT02901431|592362103|FG011|PK Part|Stopped treatment after 8 weeks|0|||
164270745|NCT03268941|593360424|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
163999575|NCT02901431|592362104|FG012|PK Part|Stopped treatment after 8 weeks|0|||
163999576|NCT02901431|592362092|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
163999577|NCT02901431|592362093|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999578|NCT02901431|592362094|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
163999579|NCT02901431|592362095|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999580|NCT02901431|592362096|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999581|NCT02901431|592362097|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999582|NCT02901431|592362098|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999583|NCT02901431|592362099|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999584|NCT02901431|592362100|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999585|NCT02901431|592362101|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999586|NCT02901431|592362102|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999587|NCT02901431|592362103|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999588|NCT02901431|592362104|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
163999589|NCT02901431|592362092|FG000|PK Part|Discontinued per Sponsor|0|||
163999590|NCT02901431|592362093|FG001|PK Part|Discontinued per Sponsor|3|||
163999591|NCT02901431|592362094|FG002|PK Part|Discontinued per Sponsor|0|||
163999592|NCT02901431|592362095|FG003|PK Part|Discontinued per Sponsor|0|||
163999593|NCT02901431|592362096|FG004|PK Part|Discontinued per Sponsor|0|||
163999594|NCT02901431|592362097|FG005|PK Part|Discontinued per Sponsor|0|||
163999595|NCT02901431|592362098|FG006|PK Part|Discontinued per Sponsor|0|||
163999596|NCT02901431|592362099|FG007|PK Part|Discontinued per Sponsor|0|||
163999597|NCT02901431|592362100|FG008|PK Part|Discontinued per Sponsor|0|||
163999598|NCT02901431|592362101|FG009|PK Part|Discontinued per Sponsor|0|||
163999599|NCT02901431|592362102|FG010|PK Part|Discontinued per Sponsor|0|||
163999600|NCT02901431|592362103|FG011|PK Part|Discontinued per Sponsor|0|||
163999601|NCT02901431|592362104|FG012|PK Part|Discontinued per Sponsor|0|||
163999602|NCT02901431|592362092|FG000|PK Part|Withdrawal by Subject|1|||
163999603|NCT02901431|592362093|FG001|PK Part|Withdrawal by Subject|1|||
163999604|NCT02901431|592362094|FG002|PK Part|Withdrawal by Subject|3|||
163999605|NCT02901431|592362095|FG003|PK Part|Withdrawal by Subject|0|||
163999606|NCT02901431|592362096|FG004|PK Part|Withdrawal by Subject|0|||
163999607|NCT02901431|592362097|FG005|PK Part|Withdrawal by Subject|0|||
163999608|NCT02901431|592362098|FG006|PK Part|Withdrawal by Subject|0|||
163999609|NCT02901431|592362099|FG007|PK Part|Withdrawal by Subject|0|||
163999610|NCT02901431|592362100|FG008|PK Part|Withdrawal by Subject|0|||
163999611|NCT02901431|592362101|FG009|PK Part|Withdrawal by Subject|0|||
163999612|NCT02901431|592362102|FG010|PK Part|Withdrawal by Subject|0|||
163999613|NCT02901431|592362103|FG011|PK Part|Withdrawal by Subject|0|||
163999614|NCT02901431|592362104|FG012|PK Part|Withdrawal by Subject|0|||
163999615|NCT02901431|592362092|FG000|Main Treatment Part|Adverse Event|0|||
163999616|NCT02901431|592362093|FG001|Main Treatment Part|Adverse Event|0|||
163999617|NCT02901431|592362094|FG002|Main Treatment Part|Adverse Event|0|||
163999618|NCT02901431|592362095|FG003|Main Treatment Part|Adverse Event|3|||
163999619|NCT02901431|592362096|FG004|Main Treatment Part|Adverse Event|3|||
163999620|NCT02901431|592362097|FG005|Main Treatment Part|Adverse Event|4|||
163999621|NCT02901431|592362098|FG006|Main Treatment Part|Adverse Event|1|||
163999622|NCT02901431|592362099|FG007|Main Treatment Part|Adverse Event|0|||
163999623|NCT02901431|592362100|FG008|Main Treatment Part|Adverse Event|0|||
163999624|NCT02901431|592362101|FG009|Main Treatment Part|Adverse Event|0|||
163999625|NCT02901431|592362102|FG010|Main Treatment Part|Adverse Event|0|||
163999626|NCT02901431|592362103|FG011|Main Treatment Part|Adverse Event|0|||
163999627|NCT02901431|592362104|FG012|Main Treatment Part|Adverse Event|0|||
163999628|NCT02901431|592362092|FG000|Main Treatment Part|Lack of Efficacy|0|||
163999629|NCT02901431|592362093|FG001|Main Treatment Part|Lack of Efficacy|0|||
163999630|NCT02901431|592362094|FG002|Main Treatment Part|Lack of Efficacy|0|||
163999631|NCT02901431|592362095|FG003|Main Treatment Part|Lack of Efficacy|1|||
163999632|NCT02901431|592362096|FG004|Main Treatment Part|Lack of Efficacy|0|||
163999633|NCT02901431|592362097|FG005|Main Treatment Part|Lack of Efficacy|0|||
163999634|NCT02901431|592362098|FG006|Main Treatment Part|Lack of Efficacy|0|||
163999635|NCT02901431|592362099|FG007|Main Treatment Part|Lack of Efficacy|0|||
164085914|NCT01261325|592678592|FG002|Overall Study|Lack of Efficacy|0|||
163999636|NCT02901431|592362100|FG008|Main Treatment Part|Lack of Efficacy|0|||
163999637|NCT02901431|592362101|FG009|Main Treatment Part|Lack of Efficacy|0|||
163999638|NCT02901431|592362102|FG010|Main Treatment Part|Lack of Efficacy|0|||
163999639|NCT02901431|592362103|FG011|Main Treatment Part|Lack of Efficacy|0|||
163999640|NCT02901431|592362104|FG012|Main Treatment Part|Lack of Efficacy|0|||
163999641|NCT02901431|592362092|FG000|Main Treatment Part|Lost to Follow-up|0|||
163999642|NCT02901431|592362093|FG001|Main Treatment Part|Lost to Follow-up|0|||
163999643|NCT02901431|592362094|FG002|Main Treatment Part|Lost to Follow-up|0|||
163999644|NCT02901431|592362095|FG003|Main Treatment Part|Lost to Follow-up|3|||
163999645|NCT02901431|592362096|FG004|Main Treatment Part|Lost to Follow-up|1|||
163999646|NCT02901431|592362097|FG005|Main Treatment Part|Lost to Follow-up|2|||
163999647|NCT02901431|592362098|FG006|Main Treatment Part|Lost to Follow-up|3|||
163999648|NCT02901431|592362099|FG007|Main Treatment Part|Lost to Follow-up|0|||
163999649|NCT02901431|592362100|FG008|Main Treatment Part|Lost to Follow-up|0|||
163999650|NCT02901431|592362101|FG009|Main Treatment Part|Lost to Follow-up|0|||
163999651|NCT02901431|592362102|FG010|Main Treatment Part|Lost to Follow-up|0|||
163999652|NCT02901431|592362103|FG011|Main Treatment Part|Lost to Follow-up|0|||
163999653|NCT02901431|592362104|FG012|Main Treatment Part|Lost to Follow-up|0|||
163999654|NCT02901431|592362092|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
163999655|NCT02901431|592362093|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
163999656|NCT02901431|592362094|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
163999657|NCT02901431|592362095|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
163999658|NCT02901431|592362096|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
163999659|NCT02901431|592362097|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
163999660|NCT02901431|592362098|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
163999661|NCT02901431|592362099|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
163999662|NCT02901431|592362100|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
163999663|NCT02901431|592362101|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
163999664|NCT02901431|592362102|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
164270746|NCT03268941|593360425|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
164270747|NCT03268941|593360419|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
163999665|NCT02901431|592362103|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
163999666|NCT02901431|592362104|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
163999667|NCT02901431|592362092|FG000|Main Treatment Part|Physician Decision|0|||
163999668|NCT02901431|592362093|FG001|Main Treatment Part|Physician Decision|0|||
163999669|NCT02901431|592362094|FG002|Main Treatment Part|Physician Decision|0|||
163999670|NCT02901431|592362095|FG003|Main Treatment Part|Physician Decision|1|||
163999671|NCT02901431|592362096|FG004|Main Treatment Part|Physician Decision|0|||
163999672|NCT02901431|592362097|FG005|Main Treatment Part|Physician Decision|0|||
163999673|NCT02901431|592362098|FG006|Main Treatment Part|Physician Decision|1|||
163999674|NCT02901431|592362099|FG007|Main Treatment Part|Physician Decision|0|||
164270748|NCT03268941|593360420|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
164270749|NCT03268941|593360421|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
164270750|NCT03268941|593360422|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
163999675|NCT02901431|592362100|FG008|Main Treatment Part|Physician Decision|0|||
163999676|NCT02901431|592362101|FG009|Main Treatment Part|Physician Decision|0|||
163999677|NCT02901431|592362102|FG010|Main Treatment Part|Physician Decision|0|||
163999678|NCT02901431|592362103|FG011|Main Treatment Part|Physician Decision|0|||
163999679|NCT02901431|592362104|FG012|Main Treatment Part|Physician Decision|0|||
163999680|NCT02901431|592362092|FG000|Main Treatment Part|Withdrawal by Subject|0|||
163999681|NCT02901431|592362093|FG001|Main Treatment Part|Withdrawal by Subject|0|||
163999682|NCT02901431|592362094|FG002|Main Treatment Part|Withdrawal by Subject|0|||
163999683|NCT02901431|592362095|FG003|Main Treatment Part|Withdrawal by Subject|18|||
163999684|NCT02901431|592362096|FG004|Main Treatment Part|Withdrawal by Subject|3|||
163999685|NCT02901431|592362097|FG005|Main Treatment Part|Withdrawal by Subject|5|||
163999686|NCT02901431|592362098|FG006|Main Treatment Part|Withdrawal by Subject|6|||
163999687|NCT02901431|592362099|FG007|Main Treatment Part|Withdrawal by Subject|0|||
163999688|NCT02901431|592362100|FG008|Main Treatment Part|Withdrawal by Subject|0|||
163999689|NCT02901431|592362101|FG009|Main Treatment Part|Withdrawal by Subject|0|||
163999690|NCT02901431|592362102|FG010|Main Treatment Part|Withdrawal by Subject|0|||
163999691|NCT02901431|592362103|FG011|Main Treatment Part|Withdrawal by Subject|0|||
163999692|NCT02901431|592362104|FG012|Main Treatment Part|Withdrawal by Subject|0|||
163999693|NCT02901431|592362092|FG000|Open Label Part|Adverse Event|0|||
163999694|NCT02901431|592362093|FG001|Open Label Part|Adverse Event|0|||
163999695|NCT02901431|592362094|FG002|Open Label Part|Adverse Event|0|||
163999696|NCT02901431|592362095|FG003|Open Label Part|Adverse Event|0|||
163999697|NCT02901431|592362096|FG004|Open Label Part|Adverse Event|0|||
164270751|NCT03268941|593360423|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
164270752|NCT03268941|593360424|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
164342323|NCT04457336|593629428|FG002|Period 2: Part A|Study Terminated|1|||
163999698|NCT02901431|592362097|FG005|Open Label Part|Adverse Event|0|||
163999699|NCT02901431|592362098|FG006|Open Label Part|Adverse Event|0|||
163999700|NCT02901431|592362099|FG007|Open Label Part|Adverse Event|0|||
163999701|NCT02901431|592362100|FG008|Open Label Part|Adverse Event|4|||
163999702|NCT02901431|592362101|FG009|Open Label Part|Adverse Event|4|||
163999703|NCT02901431|592362102|FG010|Open Label Part|Adverse Event|0|||
163999704|NCT02901431|592362103|FG011|Open Label Part|Adverse Event|4|||
163999705|NCT02901431|592362104|FG012|Open Label Part|Adverse Event|1|||
164270753|NCT03268941|593360425|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
164342324|NCT04457336|593629429|FG003|Period 2: Part A|Study Terminated|0|||
164085915|NCT01261325|592678590|FG000|Overall Study|Withdrawal by Subject|2|||
164085916|NCT01261325|592678591|FG001|Overall Study|Withdrawal by Subject|2|||
164085917|NCT01261325|592678592|FG002|Overall Study|Withdrawal by Subject|4|||
163999706|NCT02901431|592362092|FG000|Open Label Part|Lost to Follow-up|0|||
163999707|NCT02901431|592362093|FG001|Open Label Part|Lost to Follow-up|0|||
163999708|NCT02901431|592362094|FG002|Open Label Part|Lost to Follow-up|0|||
163999709|NCT02901431|592362095|FG003|Open Label Part|Lost to Follow-up|0|||
163999710|NCT02901431|592362096|FG004|Open Label Part|Lost to Follow-up|0|||
163999711|NCT02901431|592362097|FG005|Open Label Part|Lost to Follow-up|0|||
163999712|NCT02901431|592362098|FG006|Open Label Part|Lost to Follow-up|0|||
163999713|NCT02901431|592362099|FG007|Open Label Part|Lost to Follow-up|0|||
163999714|NCT02901431|592362100|FG008|Open Label Part|Lost to Follow-up|2|||
163999715|NCT02901431|592362101|FG009|Open Label Part|Lost to Follow-up|2|||
163999716|NCT02901431|592362102|FG010|Open Label Part|Lost to Follow-up|1|||
163999717|NCT02901431|592362103|FG011|Open Label Part|Lost to Follow-up|1|||
163999718|NCT02901431|592362104|FG012|Open Label Part|Lost to Follow-up|1|||
163999719|NCT02901431|592362092|FG000|Open Label Part|Physician Decision|0|||
163999720|NCT02901431|592362093|FG001|Open Label Part|Physician Decision|0|||
163999721|NCT02901431|592362094|FG002|Open Label Part|Physician Decision|0|||
163999722|NCT02901431|592362095|FG003|Open Label Part|Physician Decision|0|||
163999723|NCT02901431|592362096|FG004|Open Label Part|Physician Decision|0|||
163999724|NCT02901431|592362097|FG005|Open Label Part|Physician Decision|0|||
163999725|NCT02901431|592362098|FG006|Open Label Part|Physician Decision|0|||
163999726|NCT02901431|592362099|FG007|Open Label Part|Physician Decision|0|||
163999727|NCT02901431|592362100|FG008|Open Label Part|Physician Decision|1|||
163999728|NCT02901431|592362101|FG009|Open Label Part|Physician Decision|1|||
163999729|NCT02901431|592362102|FG010|Open Label Part|Physician Decision|0|||
163999730|NCT02901431|592362103|FG011|Open Label Part|Physician Decision|0|||
163999731|NCT02901431|592362104|FG012|Open Label Part|Physician Decision|0|||
163999732|NCT02901431|592362092|FG000|Open Label Part|Study Terminated By Sponsor|0|||
163999733|NCT02901431|592362093|FG001|Open Label Part|Study Terminated By Sponsor|0|||
163999734|NCT02901431|592362094|FG002|Open Label Part|Study Terminated By Sponsor|0|||
163999735|NCT02901431|592362095|FG003|Open Label Part|Study Terminated By Sponsor|0|||
163999736|NCT02901431|592362096|FG004|Open Label Part|Study Terminated By Sponsor|0|||
163999737|NCT02901431|592362097|FG005|Open Label Part|Study Terminated By Sponsor|0|||
163999738|NCT02901431|592362098|FG006|Open Label Part|Study Terminated By Sponsor|0|||
163999739|NCT02901431|592362099|FG007|Open Label Part|Study Terminated By Sponsor|0|||
163999740|NCT02901431|592362100|FG008|Open Label Part|Study Terminated By Sponsor|35|||
163999741|NCT02901431|592362101|FG009|Open Label Part|Study Terminated By Sponsor|12|||
163999742|NCT02901431|592362102|FG010|Open Label Part|Study Terminated By Sponsor|21|||
163999743|NCT02901431|592362103|FG011|Open Label Part|Study Terminated By Sponsor|31|||
163999744|NCT02901431|592362104|FG012|Open Label Part|Study Terminated By Sponsor|0|||
163999745|NCT02901431|592362092|FG000|Open Label Part|Withdrawal by Subject|0|||
163999746|NCT02901431|592362093|FG001|Open Label Part|Withdrawal by Subject|0|||
163999747|NCT02901431|592362094|FG002|Open Label Part|Withdrawal by Subject|0|||
163999748|NCT02901431|592362095|FG003|Open Label Part|Withdrawal by Subject|0|||
163999749|NCT02901431|592362096|FG004|Open Label Part|Withdrawal by Subject|0|||
163999750|NCT02901431|592362097|FG005|Open Label Part|Withdrawal by Subject|0|||
163999751|NCT02901431|592362098|FG006|Open Label Part|Withdrawal by Subject|0|||
164085918|NCT01261325|592678590|FG000|Overall Study|SAE, non-fatal|1|||
164085919|NCT01261325|592678591|FG001|Overall Study|SAE, non-fatal|5|||
164085920|NCT01261325|592678592|FG002|Overall Study|SAE, non-fatal|1|||
164085921|NCT01261325|592678590|FG000|Overall Study|AE, non-serious non-fatal|9|||
164085922|NCT01261325|592678591|FG001|Overall Study|AE, non-serious non-fatal|15|||
164085923|NCT01261325|592678592|FG002|Overall Study|AE, non-serious non-fatal|13|||
164085924|NCT01261325|592678590|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164085925|NCT01261325|592678591|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164085926|NCT01261325|592678592|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164085927|NCT01261325|592678590|FG000|Overall Study|Non Compliance|2|||
164085928|NCT01261325|592678591|FG001|Overall Study|Non Compliance|0|||
163999752|NCT02901431|592362099|FG007|Open Label Part|Withdrawal by Subject|0|||
163999753|NCT02901431|592362100|FG008|Open Label Part|Withdrawal by Subject|6|||
163999754|NCT02901431|592362101|FG009|Open Label Part|Withdrawal by Subject|5|||
163999755|NCT02901431|592362102|FG010|Open Label Part|Withdrawal by Subject|7|||
163999756|NCT02901431|592362103|FG011|Open Label Part|Withdrawal by Subject|3|||
163999757|NCT02901431|592362104|FG012|Open Label Part|Withdrawal by Subject|1|||
163999758|NCT02500537|592362105|FG000|Overall Study|Death|2|||
163999759|NCT02500537|592362106|FG001|Overall Study|Death|0|||
163999760|NCT02500537|592362105|FG000|Overall Study|Lost to Follow-up|0|||
163999761|NCT02500537|592362106|FG001|Overall Study|Lost to Follow-up|1|||
163999762|NCT02500537|592362105|FG000|Overall Study|Withdrawal by Subject|1|||
163999763|NCT02500537|592362106|FG001|Overall Study|Withdrawal by Subject|0|||
163999764|NCT03832387|592362109|FG000|Overall Study|Protocol Violation|2|||
163999765|NCT03832387|592362110|FG001|Overall Study|Protocol Violation|6|||
163999766|NCT03832387|592362109|FG000|Overall Study|EXCLUSION CRITERIA|3|||
163999767|NCT03832387|592362110|FG001|Overall Study|EXCLUSION CRITERIA|1|||
163999768|NCT05775289|592362111|FG000|Overall Study|Study Ongoing|20|||
163999769|NCT05775289|592362112|FG001|Overall Study|Study Ongoing|53|||
163999770|NCT05775289|592362113|FG002|Overall Study|Study Ongoing|15|||
163999771|NCT05775289|592362114|FG003|Overall Study|Study Ongoing|55|||
163999772|NCT05775289|592362111|FG000|Overall Study|Death|4|||
163999773|NCT05775289|592362112|FG001|Overall Study|Death|11|||
163999774|NCT05775289|592362113|FG002|Overall Study|Death|8|||
163999775|NCT05775289|592362114|FG003|Overall Study|Death|12|||
163999776|NCT05775289|592362111|FG000|Overall Study|Lost to Follow-up|0|||
163999777|NCT05775289|592362112|FG001|Overall Study|Lost to Follow-up|1|||
163999778|NCT05775289|592362113|FG002|Overall Study|Lost to Follow-up|0|||
163999779|NCT05775289|592362114|FG003|Overall Study|Lost to Follow-up|0|||
163999780|NCT05775289|592362111|FG000|Overall Study|Progressive Disease|0|||
164270754|NCT03268941|593360419|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
164270755|NCT03268941|593360420|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270756|NCT03268941|593360421|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270757|NCT03268941|593360422|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270758|NCT03268941|593360423|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270759|NCT03268941|593360424|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164270760|NCT03268941|593360425|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
164342325|NCT04457336|593629430|FG004|Period 2: Part A|Study Terminated|0|||
163999781|NCT05775289|592362112|FG001|Overall Study|Progressive Disease|0|||
163999782|NCT05775289|592362113|FG002|Overall Study|Progressive Disease|1|||
163999783|NCT05775289|592362114|FG003|Overall Study|Progressive Disease|0|||
163999784|NCT05775289|592362111|FG000|Overall Study|Withdrawal by Subject|1|||
163999785|NCT05775289|592362112|FG001|Overall Study|Withdrawal by Subject|1|||
163999786|NCT05775289|592362113|FG002|Overall Study|Withdrawal by Subject|0|||
163999787|NCT05775289|592362114|FG003|Overall Study|Withdrawal by Subject|0|||
163999788|NCT02330419|592362119|FG000|Overall Study|Lost to Follow-up|3|||
163999789|NCT02330419|592362120|FG001|Overall Study|Lost to Follow-up|7|||
163999790|NCT01587989|592362125|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
163999791|NCT01587989|592362126|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
163999792|NCT01587989|592362127|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
163999793|NCT01587989|592362125|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
163999794|NCT01587989|592362126|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
163999795|NCT01587989|592362127|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
163999796|NCT01587989|592362125|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
163999797|NCT01587989|592362126|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
163999798|NCT01587989|592362127|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
163999799|NCT01587989|592362125|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
163999800|NCT01587989|592362126|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
163999801|NCT01587989|592362127|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
163999802|NCT01587989|592362125|FG000|Randomized Study Treatment|Screening failure|0|||
163999803|NCT01587989|592362126|FG001|Randomized Study Treatment|Screening failure|1|||
163999804|NCT01587989|592362127|FG002|Randomized Study Treatment|Screening failure|0|||
163999805|NCT01587989|592362125|FG000|Randomized Study Treatment|Physician Decision|0|||
163999806|NCT01587989|592362126|FG001|Randomized Study Treatment|Physician Decision|0|||
163999807|NCT01587989|592362127|FG002|Randomized Study Treatment|Physician Decision|1|||
163999808|NCT03313050|592362128|FG000|Stage 2: 12 Months|Adverse Event|0|||
163999809|NCT03313050|592362129|FG001|Stage 2: 12 Months|Adverse Event|0|||
163999810|NCT03313050|592362130|FG002|Stage 2: 12 Months|Adverse Event|0|||
163999811|NCT03313050|592362131|FG003|Stage 2: 12 Months|Adverse Event|1|||
163999812|NCT03313050|592362128|FG000|Stage 2: 12 Months|Death|0|||
163999813|NCT03313050|592362129|FG001|Stage 2: 12 Months|Death|0|||
163999814|NCT03313050|592362130|FG002|Stage 2: 12 Months|Death|3|||
163999815|NCT03313050|592362131|FG003|Stage 2: 12 Months|Death|0|||
163999816|NCT03313050|592362128|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
163999817|NCT03313050|592362129|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
163999818|NCT03313050|592362130|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
163999819|NCT03313050|592362131|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
163999820|NCT03313050|592362128|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
163999821|NCT03313050|592362129|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
163999822|NCT03313050|592362130|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
163999823|NCT03313050|592362131|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
163999824|NCT03313050|592362128|FG000|Stage 2: 12 Months|Protocol deviation|0|||
163999825|NCT03313050|592362129|FG001|Stage 2: 12 Months|Protocol deviation|0|||
163999826|NCT03313050|592362130|FG002|Stage 2: 12 Months|Protocol deviation|7|||
163999827|NCT03313050|592362131|FG003|Stage 2: 12 Months|Protocol deviation|7|||
164270761|NCT03268941|593360419|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
164270762|NCT03268941|593360420|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
164270763|NCT03268941|593360421|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
164342326|NCT04457336|593629431|FG005|Period 2: Part A|Study Terminated|0|||
163999828|NCT03313050|592362128|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
163999829|NCT03313050|592362129|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
163999830|NCT03313050|592362130|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
163999831|NCT03313050|592362131|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
163999832|NCT03313050|592362128|FG000|Stage 2: 12 Months|Other|0|||
163999833|NCT03313050|592362129|FG001|Stage 2: 12 Months|Other|0|||
163999834|NCT03313050|592362130|FG002|Stage 2: 12 Months|Other|0|||
163999835|NCT03313050|592362131|FG003|Stage 2: 12 Months|Other|1|||
163999836|NCT01291017|592362132|FG000|Overall Study|Lost to Follow-up|2|||
163999837|NCT01291017|592362132|FG000|Overall Study|Withdrawal by Subject|3|||
163999838|NCT00215150|592364605|FG000|Open Label Phase|Lost to Follow-up|7|||
163999839|NCT00215150|592364605|FG000|Open Label Phase|Withdrawal by Subject|1|||
163999840|NCT00215150|592364605|FG000|Open Label Phase|Did not complete a post base visit|13|||
163999841|NCT00215150|592364605|FG000|Open Label Phase|Did not meet randomization criteria|9|||
163999842|NCT00215150|592364605|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
163999843|NCT00215150|592364605|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
163999844|NCT00215150|592364605|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
163999845|NCT00783289|592364608|FG000|Overall Study|Protocol Violation|0|||
163999846|NCT00783289|592364609|FG001|Overall Study|Protocol Violation|1|||
163999847|NCT00783289|592364610|FG002|Overall Study|Protocol Violation|0|||
163999848|NCT00783289|592364611|FG003|Overall Study|Protocol Violation|0|||
163999849|NCT00506389|592364612|FG000|In-treatment Period|Other|3|||
163999850|NCT00506389|592364613|FG001|In-treatment Period|Other|3|||
163999851|NCT00506389|592364614|FG002|In-treatment Period|Other|4|||
163999852|NCT00506389|592364612|FG000|In-treatment Period|Lost to Follow-up|0|||
163999853|NCT00506389|592364613|FG001|In-treatment Period|Lost to Follow-up|0|||
163999854|NCT00506389|592364614|FG002|In-treatment Period|Lost to Follow-up|1|||
163999855|NCT00506389|592364612|FG000|In-treatment Period|Lack of compliance|1|||
163999856|NCT00506389|592364613|FG001|In-treatment Period|Lack of compliance|0|||
163999857|NCT00506389|592364614|FG002|In-treatment Period|Lack of compliance|0|||
163999858|NCT00506389|592364612|FG000|In-treatment Period|Reasons not related to trial|4|||
163999859|NCT00506389|592364613|FG001|In-treatment Period|Reasons not related to trial|1|||
163999860|NCT00506389|592364614|FG002|In-treatment Period|Reasons not related to trial|0|||
163999861|NCT00506389|592364612|FG000|In-treatment Period|Withdrawal by Subject|3|||
163999862|NCT00506389|592364613|FG001|In-treatment Period|Withdrawal by Subject|3|||
163999863|NCT00506389|592364614|FG002|In-treatment Period|Withdrawal by Subject|4|||
163999864|NCT00506389|592364612|FG000|In-treatment Period|Lack of Efficacy|0|||
163999865|NCT00506389|592364613|FG001|In-treatment Period|Lack of Efficacy|2|||
163999866|NCT00506389|592364614|FG002|In-treatment Period|Lack of Efficacy|0|||
163999867|NCT00506389|592364612|FG000|In-treatment Period|Adverse Event|11|||
163999868|NCT00506389|592364613|FG001|In-treatment Period|Adverse Event|5|||
163999869|NCT00506389|592364614|FG002|In-treatment Period|Adverse Event|2|||
163999870|NCT00506389|592364612|FG000|In-treatment Period|Randomized but not treated|4|||
163999871|NCT00506389|592364613|FG001|In-treatment Period|Randomized but not treated|1|||
163999872|NCT00506389|592364614|FG002|In-treatment Period|Randomized but not treated|1|||
164270764|NCT03268941|593360422|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
164270765|NCT03268941|593360423|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
164270766|NCT03268941|593360424|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
164270767|NCT03268941|593360425|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
164270768|NCT03268941|593360419|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270769|NCT03268941|593360420|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270770|NCT03268941|593360421|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270771|NCT03268941|593360422|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270772|NCT03268941|593360423|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270773|NCT03268941|593360424|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
164270774|NCT03268941|593360425|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
164270775|NCT02720692|593360430|FG000|Overall Study|Withdrawal by Subject|3|||
164270776|NCT02720692|593360431|FG001|Overall Study|Withdrawal by Subject|0|||
164270777|NCT02720692|593360430|FG000|Overall Study|Physician Decision|1|||
164270778|NCT02720692|593360431|FG001|Overall Study|Physician Decision|0|||
164270779|NCT02720692|593360430|FG000|Overall Study|Lost to Follow-up|8|||
164270780|NCT02720692|593360431|FG001|Overall Study|Lost to Follow-up|3|||
164270781|NCT02720692|593360430|FG000|Overall Study|Subject unable to return for visit|1|||
164270782|NCT02720692|593360431|FG001|Overall Study|Subject unable to return for visit|0|||
164342327|NCT04457336|593629432|FG006|Period 2: Part A|Study Terminated|0|||
164270783|NCT03878758|593360432|FG000|Overall Study|Withdrawal by Subject|1|||
164270784|NCT03878758|593360432|FG000|Overall Study|Protocol defined|2|||
164342328|NCT04457336|593629433|FG007|Period 2: Part A|Study Terminated|0|||
163999873|NCT05224258|592364616|FG000|Overall Study|Withdrawal by Subject|1|||
163999874|NCT05224258|592364617|FG001|Overall Study|Withdrawal by Subject|1|||
163999875|NCT05224258|592364616|FG000|Overall Study|Physician Decision|1|||
163999876|NCT05224258|592364617|FG001|Overall Study|Physician Decision|1|||
163999877|NCT05224258|592364616|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164270785|NCT03878758|593360432|FG000|Overall Study|Improper consent documentation|1|||
164270786|NCT01769196|593360433|FG000|Overall Study|Adverse Event|24|||
164270787|NCT01769196|593360434|FG001|Overall Study|Adverse Event|20|||
163999878|NCT05224258|592364617|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164085929|NCT01261325|592678592|FG002|Overall Study|Non Compliance|0|||
163999879|NCT05224258|592364616|FG000|Overall Study|Study Product No Longer in Use|1|||
163999880|NCT05224258|592364617|FG001|Overall Study|Study Product No Longer in Use|0|||
163999881|NCT05224258|592364616|FG000|Overall Study|Adverse Event|0|||
163999882|NCT05224258|592364617|FG001|Overall Study|Adverse Event|1|||
163999883|NCT05224258|592364616|FG000|Overall Study|Protocol Deviation|0|||
163999884|NCT05224258|592364617|FG001|Overall Study|Protocol Deviation|1|||
163999885|NCT03095703|592364619|FG000|Overall Study|Withdrawal by Subject|1|||
163999886|NCT03539432|592364620|FG000|Overall Study|Lost to Follow-up|0|||
163999887|NCT03539432|592364621|FG001|Overall Study|Lost to Follow-up|1|||
163999888|NCT01381094|592364622|FG000|Overall Study|Adverse Event|1|||
163999889|NCT01381094|592364623|FG001|Overall Study|Adverse Event|2|||
163999890|NCT01381094|592364624|FG002|Overall Study|Adverse Event|0|||
163999891|NCT01381094|592364625|FG003|Overall Study|Adverse Event|1|||
163999892|NCT01381094|592364626|FG004|Overall Study|Adverse Event|0|||
163999893|NCT01381094|592364622|FG000|Overall Study|Lost to Follow-up|0|||
163999894|NCT01381094|592364623|FG001|Overall Study|Lost to Follow-up|0|||
163999895|NCT01381094|592364624|FG002|Overall Study|Lost to Follow-up|0|||
163999896|NCT01381094|592364625|FG003|Overall Study|Lost to Follow-up|0|||
163999897|NCT01381094|592364626|FG004|Overall Study|Lost to Follow-up|1|||
163999898|NCT01381094|592364622|FG000|Overall Study|Withdrawal of informed consent|0|||
163999899|NCT01381094|592364623|FG001|Overall Study|Withdrawal of informed consent|1|||
163999900|NCT01381094|592364624|FG002|Overall Study|Withdrawal of informed consent|0|||
163999901|NCT01381094|592364625|FG003|Overall Study|Withdrawal of informed consent|0|||
163999902|NCT01381094|592364626|FG004|Overall Study|Withdrawal of informed consent|0|||
163999903|NCT01381094|592364622|FG000|Overall Study|Participant given Aranesp injection|1|||
163999904|NCT01381094|592364623|FG001|Overall Study|Participant given Aranesp injection|0|||
163999905|NCT01381094|592364624|FG002|Overall Study|Participant given Aranesp injection|0|||
163999906|NCT01381094|592364625|FG003|Overall Study|Participant given Aranesp injection|0|||
163999907|NCT01381094|592364626|FG004|Overall Study|Participant given Aranesp injection|0|||
163999908|NCT02443402|592364629|FG000|Overall Study|Withdrawal by Subject|3|||
163999909|NCT02443402|592364630|FG001|Overall Study|Withdrawal by Subject|1|||
163999910|NCT02443402|592364629|FG000|Overall Study|Screen Failure|1|||
163999911|NCT02443402|592364630|FG001|Overall Study|Screen Failure|2|||
163999912|NCT01934504|592364632|FG000|Overall Study|Protocol Deviation|0|||
163999913|NCT01934504|592364633|FG001|Overall Study|Protocol Deviation|0|||
163999914|NCT01934504|592364634|FG002|Overall Study|Protocol Deviation|0|||
163999915|NCT01934504|592364635|FG003|Overall Study|Protocol Deviation|2|||
163999916|NCT01934504|592364632|FG000|Overall Study|Study Terminated by Sponsor|1|||
163999917|NCT01934504|592364633|FG001|Overall Study|Study Terminated by Sponsor|0|||
163999918|NCT01934504|592364634|FG002|Overall Study|Study Terminated by Sponsor|5|||
163999919|NCT01934504|592364635|FG003|Overall Study|Study Terminated by Sponsor|5|||
163999920|NCT02665689|592364636|FG000|Overall Study|Adverse Event|1|||
163999921|NCT02665689|592364637|FG001|Overall Study|Adverse Event|0|||
163999922|NCT02665689|592364636|FG000|Overall Study|Trial termination|1|||
163999923|NCT02665689|592364637|FG001|Overall Study|Trial termination|1|||
163999924|NCT02665689|592364636|FG000|Overall Study|Lost to Follow-up|0|||
163999925|NCT02665689|592364637|FG001|Overall Study|Lost to Follow-up|1|||
163999926|NCT00996840|592364646|FG000|Overall Study|Adverse Event|0|||
163999927|NCT00996840|592364647|FG001|Overall Study|Adverse Event|1|||
163999928|NCT00996840|592364648|FG002|Overall Study|Adverse Event|0|||
163999929|NCT00996840|592364649|FG003|Overall Study|Adverse Event|0|||
163999930|NCT00996840|592364650|FG004|Overall Study|Adverse Event|0|||
163999931|NCT00996840|592364646|FG000|Overall Study|Physician Decision|0|||
163999932|NCT00996840|592364647|FG001|Overall Study|Physician Decision|0|||
163999933|NCT00996840|592364648|FG002|Overall Study|Physician Decision|1|||
163999934|NCT00996840|592364649|FG003|Overall Study|Physician Decision|1|||
163999935|NCT00996840|592364650|FG004|Overall Study|Physician Decision|2|||
163999936|NCT00996840|592364646|FG000|Overall Study|Withdrawal by Subject|1|||
163999937|NCT00996840|592364647|FG001|Overall Study|Withdrawal by Subject|1|||
163999938|NCT00996840|592364648|FG002|Overall Study|Withdrawal by Subject|0|||
163999939|NCT00996840|592364649|FG003|Overall Study|Withdrawal by Subject|0|||
163999940|NCT00996840|592364650|FG004|Overall Study|Withdrawal by Subject|0|||
163999941|NCT00603239|592364651|FG000|Overall Study|Adverse Event|4|||
163999942|NCT00603239|592364652|FG001|Overall Study|Adverse Event|1|||
163999943|NCT00603239|592364651|FG000|Overall Study|Entry criteria not met|0|||
163999944|NCT00603239|592364652|FG001|Overall Study|Entry criteria not met|1|||
164085930|NCT01261325|592678590|FG000|Overall Study|Patient Randomized by Mistake|0|||
163999945|NCT00603239|592364651|FG000|Overall Study|Loss of glucose control|3|||
163999946|NCT00603239|592364652|FG001|Overall Study|Loss of glucose control|0|||
163999947|NCT00603239|592364651|FG000|Overall Study|Lost to Follow-up|2|||
163999948|NCT00603239|592364652|FG001|Overall Study|Lost to Follow-up|1|||
163999949|NCT00603239|592364651|FG000|Overall Study|Physician Decision|2|||
163999950|NCT00603239|592364652|FG001|Overall Study|Physician Decision|0|||
163999951|NCT00603239|592364651|FG000|Overall Study|Protocol Violation|2|||
163999952|NCT00603239|592364652|FG001|Overall Study|Protocol Violation|0|||
163999953|NCT00603239|592364651|FG000|Overall Study|Subject decision|2|||
163999954|NCT00603239|592364652|FG001|Overall Study|Subject decision|1|||
163999955|NCT02292849|592364653|FG000|Overall Study|Lost to Follow-up|0|||
163999956|NCT02292849|592364654|FG001|Overall Study|Lost to Follow-up|2|||
163999957|NCT02292849|592364655|FG002|Overall Study|Lost to Follow-up|2|||
163999958|NCT02292849|592364653|FG000|Overall Study|Physician Decision|4|||
163999959|NCT02292849|592364654|FG001|Overall Study|Physician Decision|0|||
163999960|NCT02292849|592364655|FG002|Overall Study|Physician Decision|0|||
163999961|NCT02210780|592364657|FG000|Overall Study|Adverse Event|0|||
163999962|NCT02210780|592364658|FG001|Overall Study|Adverse Event|5|||
163999963|NCT02210780|592364657|FG000|Overall Study|Lost to Follow-up|2|||
163999964|NCT02210780|592364658|FG001|Overall Study|Lost to Follow-up|1|||
163999965|NCT02210780|592364657|FG000|Overall Study|Withdrawal by Subject|1|||
163999966|NCT02210780|592364658|FG001|Overall Study|Withdrawal by Subject|1|||
163999967|NCT02210780|592364657|FG000|Overall Study|Physician Decision|1|||
163999968|NCT02210780|592364658|FG001|Overall Study|Physician Decision|0|||
163999969|NCT02210780|592364657|FG000|Overall Study|Protocol Violation|1|||
163999970|NCT02210780|592364658|FG001|Overall Study|Protocol Violation|0|||
163999971|NCT02210780|592364657|FG000|Overall Study|Other than specified above|0|||
163999972|NCT02210780|592364658|FG001|Overall Study|Other than specified above|1|||
163999973|NCT01562028|592364659|FG000|Overall Study|Withdrawal by Subject|1|||
163999974|NCT01562028|592364660|FG001|Overall Study|Withdrawal by Subject|1|||
163999975|NCT01562028|592364659|FG000|Overall Study|Lost to Follow-up|2|||
163999976|NCT01562028|592364660|FG001|Overall Study|Lost to Follow-up|1|||
163999977|NCT04938648|592364661|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
163999978|NCT04938648|592364662|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
163999979|NCT04938648|592364661|FG000|Overall Study|Patient too ill|0|||
163999980|NCT04938648|592364662|FG001|Overall Study|Patient too ill|1|||
163999981|NCT04938648|592364661|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
163999982|NCT04938648|592364662|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
163999983|NCT04938648|592364661|FG000|Overall Study|Patient did not have memory problems|1|||
163999984|NCT04938648|592364662|FG001|Overall Study|Patient did not have memory problems|1|||
163999985|NCT04938648|592364661|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
163999986|NCT04938648|592364662|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
163999987|NCT04938648|592364661|FG000|Overall Study|Care partner could not be reached|0|||
163999988|NCT04938648|592364662|FG001|Overall Study|Care partner could not be reached|1|||
163999989|NCT04938648|592364661|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
163999990|NCT04938648|592364662|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
163999991|NCT04938648|592364661|FG000|Overall Study|Withdrawal by Subject|2|||
163999992|NCT04938648|592364662|FG001|Overall Study|Withdrawal by Subject|1|||
163999993|NCT00364793|592364663|FG000|Overall Study|Adverse Event|2|||
163999994|NCT00364793|592364664|FG001|Overall Study|Adverse Event|0|||
163999995|NCT00364793|592364665|FG002|Overall Study|Adverse Event|0|||
163999996|NCT00364793|592364666|FG003|Overall Study|Adverse Event|0|||
163999997|NCT00364793|592364663|FG000|Overall Study|Death|1|||
163999998|NCT00364793|592364664|FG001|Overall Study|Death|0|||
163999999|NCT00364793|592364665|FG002|Overall Study|Death|1|||
164000000|NCT00364793|592364666|FG003|Overall Study|Death|0|||
164000001|NCT00364793|592364663|FG000|Overall Study|Lack of Efficacy|3|||
164000002|NCT00364793|592364664|FG001|Overall Study|Lack of Efficacy|3|||
164000003|NCT00364793|592364665|FG002|Overall Study|Lack of Efficacy|1|||
164000004|NCT00364793|592364666|FG003|Overall Study|Lack of Efficacy|1|||
164000005|NCT00364793|592364663|FG000|Overall Study|Lost to Follow-up|1|||
164000006|NCT00364793|592364664|FG001|Overall Study|Lost to Follow-up|0|||
164000007|NCT00364793|592364665|FG002|Overall Study|Lost to Follow-up|2|||
164000008|NCT00364793|592364666|FG003|Overall Study|Lost to Follow-up|0|||
164000009|NCT00364793|592364663|FG000|Overall Study|Poor or non-compliance|1|||
164000010|NCT00364793|592364664|FG001|Overall Study|Poor or non-compliance|1|||
164000011|NCT00364793|592364665|FG002|Overall Study|Poor or non-compliance|0|||
164000012|NCT00364793|592364666|FG003|Overall Study|Poor or non-compliance|1|||
164000013|NCT00364793|592364663|FG000|Overall Study|No longer meets criteria|0|||
164000014|NCT00364793|592364664|FG001|Overall Study|No longer meets criteria|0|||
164000015|NCT00364793|592364665|FG002|Overall Study|No longer meets criteria|0|||
164000016|NCT00364793|592364666|FG003|Overall Study|No longer meets criteria|1|||
164000017|NCT00364793|592364663|FG000|Overall Study|Withdrawal by Subject|0|||
164000018|NCT00364793|592364664|FG001|Overall Study|Withdrawal by Subject|1|||
164000019|NCT00364793|592364665|FG002|Overall Study|Withdrawal by Subject|0|||
164000020|NCT00364793|592364666|FG003|Overall Study|Withdrawal by Subject|0|||
164000021|NCT00775021|592364670|FG000|First Intervention|Lost to Follow-up|1|||
164000022|NCT00775021|592364671|FG001|First Intervention|Lost to Follow-up|0|||
164000023|NCT00775021|592364670|FG000|Second Intervention|Adverse Event|0|||
164000024|NCT00775021|592364671|FG001|Second Intervention|Adverse Event|1|||
164000025|NCT00363415|592364672|FG000|Overall Study|Progressive Disease|196|||
164000026|NCT00363415|592364673|FG001|Overall Study|Progressive Disease|107|||
164000027|NCT00363415|592364672|FG000|Overall Study|Sponsor Decision|67|||
164000028|NCT00363415|592364673|FG001|Overall Study|Sponsor Decision|31|||
164000029|NCT00363415|592364672|FG000|Overall Study|Death|32|||
164000030|NCT00363415|592364673|FG001|Overall Study|Death|29|||
164000031|NCT00363415|592364672|FG000|Overall Study|Adverse Event|24|||
164000032|NCT00363415|592364673|FG001|Overall Study|Adverse Event|15|||
164270788|NCT01769196|593360433|FG000|Overall Study|Death|21|||
164270789|NCT01769196|593360434|FG001|Overall Study|Death|26|||
164270790|NCT01769196|593360433|FG000|Overall Study|Investigator Discretion|7|||
164270791|NCT01769196|593360434|FG001|Overall Study|Investigator Discretion|3|||
164270792|NCT01769196|593360433|FG000|Overall Study|Lack of Efficacy|3|||
164270793|NCT01769196|593360434|FG001|Overall Study|Lack of Efficacy|2|||
164270794|NCT01769196|593360433|FG000|Overall Study|Progressive disease|11|||
164270795|NCT01769196|593360434|FG001|Overall Study|Progressive disease|6|||
164270796|NCT01769196|593360433|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
164270797|NCT01769196|593360434|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
164270798|NCT01769196|593360433|FG000|Overall Study|Protocol Violation|0|||
164270799|NCT01769196|593360434|FG001|Overall Study|Protocol Violation|3|||
164270800|NCT01769196|593360433|FG000|Overall Study|Study terminated by sponsor|160|||
164270801|NCT01769196|593360434|FG001|Overall Study|Study terminated by sponsor|161|||
164270802|NCT01769196|593360433|FG000|Overall Study|Participant never dosed with study drug|1|||
164270803|NCT01769196|593360434|FG001|Overall Study|Participant never dosed with study drug|0|||
164270804|NCT01769196|593360433|FG000|Overall Study|Withdrew consent|36|||
164270805|NCT01769196|593360434|FG001|Overall Study|Withdrew consent|40|||
164270806|NCT00765063|593360435|FG000|Overall Study|Lack of Efficacy|5|||
164270807|NCT00765063|593360435|FG000|Overall Study|Withdrawal by Subject|1|||
164270808|NCT00765063|593360435|FG000|Overall Study|Other|16|||
164270809|NCT00765063|593360435|FG000|Overall Study|Protocol Violation|6|||
164270810|NCT00765063|593360435|FG000|Overall Study|Adverse Event|4|||
164270811|NCT03614325|593360436|FG000|Overall Study|Withdrawal by Subject|0|||
164270812|NCT03614325|593360437|FG001|Overall Study|Withdrawal by Subject|2|||
164270813|NCT03614325|593360436|FG000|Overall Study|Surgery Cancelled|2|||
164270814|NCT03614325|593360437|FG001|Overall Study|Surgery Cancelled|1|||
163893530|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
163893531|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
163893532|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
163893533|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
163893534|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
163893535|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
163893536|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
163893537|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
163893538|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
163893539|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
163893540|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
163893541|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
163893542|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
163893543|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
163893544|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
163893545|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
163893546|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
163893547|NCT03580356|591982097|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
163893548|NCT03580356|591982098|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
163893549|NCT03580356|591982099|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
163893550|NCT03580356|591982100|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
163893551|NCT03580356|591982101|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
163893552|NCT03580356|591982102|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
163893553|NCT03580356|591982103|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
163893554|NCT03580356|591982104|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
163893555|NCT05715528|591982105|FG000|Overall Study|Randomized but never treated|11|||
163893556|NCT05715528|591982106|FG001|Overall Study|Randomized but never treated|13|||
163893557|NCT05715528|591982105|FG000|Overall Study|Withdrew consent|7|||
163893558|NCT05715528|591982106|FG001|Overall Study|Withdrew consent|15|||
163893559|NCT05715528|591982105|FG000|Overall Study|Lost to Follow-up|5|||
163893560|NCT05715528|591982106|FG001|Overall Study|Lost to Follow-up|13|||
163893561|NCT05715528|591982105|FG000|Overall Study|Investigator's discretion|3|||
163893562|NCT05715528|591982106|FG001|Overall Study|Investigator's discretion|1|||
164000033|NCT00363415|592364672|FG000|Overall Study|Physician Decision|18|||
164000034|NCT00363415|592364673|FG001|Overall Study|Physician Decision|35|||
164270815|NCT03614325|593360436|FG000|Overall Study|Lost to Follow-up|2|||
164270816|NCT03614325|593360437|FG001|Overall Study|Lost to Follow-up|1|||
164270817|NCT03614325|593360436|FG000|Overall Study|Surgery never scheduled|1|||
164270818|NCT03614325|593360437|FG001|Overall Study|Surgery never scheduled|0|||
164270819|NCT00321464|593360438|FG000|Overall Study|Death|169|||
164270820|NCT00321464|593360439|FG001|Overall Study|Death|174|||
164270821|NCT00321464|593360438|FG000|Overall Study|Disease progression|124|||
164270822|NCT00321464|593360439|FG001|Overall Study|Disease progression|124|||
164270823|NCT00321464|593360438|FG000|Overall Study|Withdrawal by Subject|117|||
164270824|NCT00321464|593360439|FG001|Overall Study|Withdrawal by Subject|118|||
164270825|NCT00321464|593360438|FG000|Overall Study|Participant request|57|||
164270826|NCT00321464|593360439|FG001|Overall Study|Participant request|61|||
164270827|NCT00321464|593360438|FG000|Overall Study|Adverse Event|43|||
164270828|NCT00321464|593360439|FG001|Overall Study|Adverse Event|28|||
164270829|NCT00321464|593360438|FG000|Overall Study|Physician Decision|15|||
164270830|NCT00321464|593360439|FG001|Overall Study|Physician Decision|14|||
164270831|NCT00321464|593360438|FG000|Overall Study|Noncompliance|4|||
164270832|NCT00321464|593360439|FG001|Overall Study|Noncompliance|10|||
164270833|NCT00321464|593360438|FG000|Overall Study|Lost to Follow-up|7|||
164270834|NCT00321464|593360439|FG001|Overall Study|Lost to Follow-up|8|||
164270835|NCT00321464|593360438|FG000|Overall Study|Protocol deviation|0|||
164270836|NCT00321464|593360439|FG001|Overall Study|Protocol deviation|2|||
164270837|NCT00321464|593360438|FG000|Overall Study|Ineligibility determined|2|||
164270838|NCT00321464|593360439|FG001|Overall Study|Ineligibility determined|1|||
164270839|NCT00321464|593360438|FG000|Overall Study|Other|21|||
164270840|NCT00321464|593360439|FG001|Overall Study|Other|18|||
164270841|NCT01673620|593360445|FG000|Overall Study|Adverse Event|1|||
164000035|NCT00363415|592364672|FG000|Overall Study|Entry Criteria Not Met|11|||
164000036|NCT00363415|592364673|FG001|Overall Study|Entry Criteria Not Met|10|||
164000037|NCT00363415|592364672|FG000|Overall Study|Withdrawal by Subject|9|||
164000038|NCT00363415|592364673|FG001|Overall Study|Withdrawal by Subject|15|||
164270842|NCT01673620|593360446|FG001|Overall Study|Adverse Event|0|||
164270843|NCT00652951|593360447|FG000|Booster Phase|Adverse event, non-fatal|0|||
164270844|NCT00652951|593360448|FG001|Booster Phase|Adverse event, non-fatal|1|||
164270845|NCT00652951|593360449|FG002|Booster Phase|Adverse event, non-fatal|0|||
164270846|NCT00652951|593360447|FG000|Booster Phase|Other|1|||
164270847|NCT00652951|593360448|FG001|Booster Phase|Other|0|||
164270848|NCT00652951|593360449|FG002|Booster Phase|Other|0|||
164270849|NCT01022424|593360450|FG000|Overall Study|Adverse Event|1|||
164270850|NCT01022424|593360450|FG000|Overall Study|Physician Decision|1|||
164270851|NCT01022424|593360450|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
164270852|NCT01206582|593360451|FG000|Overall Study|Withdrew prior to study|1|||
164270853|NCT01206582|593360452|FG001|Overall Study|Withdrew prior to study|0|||
164270854|NCT01206582|593360451|FG000|Overall Study|Discontinued intervention before week 8|1|||
164270855|NCT01206582|593360452|FG001|Overall Study|Discontinued intervention before week 8|2|||
164270856|NCT02100969|593360453|FG000|Overall Study|Did not pass screening phase|1|||
164270857|NCT00528801|593360454|FG000|Overall Study|Withdrawal by Subject|1|||
164270858|NCT00528801|593360455|FG001|Overall Study|Withdrawal by Subject|1|||
164270859|NCT00528801|593360454|FG000|Overall Study|Protocol Violation|11|||
164270860|NCT00528801|593360455|FG001|Overall Study|Protocol Violation|5|||
164270861|NCT00528801|593360454|FG000|Overall Study|Lost to Follow-up|15|||
164270862|NCT00528801|593360455|FG001|Overall Study|Lost to Follow-up|4|||
164270863|NCT00528801|593360454|FG000|Overall Study|Administrative Reasons|0|||
164000039|NCT00363415|592364672|FG000|Overall Study|Lost to Follow-up|3|||
164270864|NCT00528801|593360455|FG001|Overall Study|Administrative Reasons|1|||
164270865|NCT02207491|593360456|FG000|Overall Study|Adverse Event|20|||
164342329|NCT04457336|593629426|FG000|Period 2: Part A|Protocol Violation|0|||
164000040|NCT00363415|592364673|FG001|Overall Study|Lost to Follow-up|3|||
164000041|NCT00363415|592364672|FG000|Overall Study|Protocol Violation|1|||
164000042|NCT00363415|592364673|FG001|Overall Study|Protocol Violation|4|||
164000043|NCT04439266|592364686|FG000|Overall Study|Ineligible|1|||
164000044|NCT04439266|592364686|FG000|Overall Study|Adverse Event|1|||
164000045|NCT04439266|592364686|FG000|Overall Study|Death|1|||
164000046|NCT04439266|592364686|FG000|Overall Study|Disease progression|1|||
164000047|NCT04439266|592364686|FG000|Overall Study|Still on treatment|1|||
164342330|NCT04457336|593629427|FG001|Period 2: Part A|Protocol Violation|1|||
164342331|NCT04457336|593629428|FG002|Period 2: Part A|Protocol Violation|0|||
164342332|NCT04457336|593629429|FG003|Period 2: Part A|Protocol Violation|0|||
164000048|NCT05027802|592364688|FG000|Overall Study|Adverse Event|2|||
164000049|NCT05027802|592364688|FG000|Overall Study|Withdrawal by Subject|18|||
164270866|NCT02207491|593360457|FG001|Overall Study|Adverse Event|4|||
164270867|NCT02207491|593360456|FG000|Overall Study|Withdrawal by Subject|3|||
164270868|NCT02207491|593360457|FG001|Overall Study|Withdrawal by Subject|2|||
164270869|NCT02207491|593360456|FG000|Overall Study|Non-compliant|0|||
164000050|NCT05027802|592364688|FG000|Overall Study|Death|2|||
164000051|NCT05027802|592364688|FG000|Overall Study|Other|1|||
164270870|NCT02207491|593360457|FG001|Overall Study|Non-compliant|1|||
164270871|NCT02207491|593360456|FG000|Overall Study|Lost to Follow-up|0|||
164270872|NCT02207491|593360457|FG001|Overall Study|Lost to Follow-up|1|||
164270873|NCT02207491|593360456|FG000|Overall Study|Lack of Efficacy|3|||
164270874|NCT02207491|593360457|FG001|Overall Study|Lack of Efficacy|0|||
164270875|NCT02207491|593360456|FG000|Overall Study|Physician Decision|2|||
164270876|NCT02207491|593360457|FG001|Overall Study|Physician Decision|0|||
164000052|NCT00001337|592364689|FG000|Overall Study|Switched to alternate treatment|2|||
164270877|NCT02207491|593360456|FG000|Overall Study|Protocol Violation|3|||
164270878|NCT02207491|593360457|FG001|Overall Study|Protocol Violation|5|||
164270879|NCT00477152|593360458|FG000|Overall Study|Parent withdrew consent|2|||
164270880|NCT00477152|593360458|FG000|Overall Study|Adverse Event|1|||
164270881|NCT00372697|593360459|FG000|Overall Study|Protocol Violation|1|||
164270882|NCT00372697|593360460|FG001|Overall Study|Protocol Violation|1|||
164270883|NCT00527982|593360462|FG000|Overall Study|Physician Decision|1|||
164270884|NCT00527982|593360463|FG001|Overall Study|Physician Decision|0|||
163893563|NCT05715528|591982105|FG000|Overall Study|Protocol Violation|2|||
163893564|NCT05715528|591982106|FG001|Overall Study|Protocol Violation|0|||
163893565|NCT05715528|591982105|FG000|Overall Study|Non-compliance with study drug|0|||
163893566|NCT05715528|591982106|FG001|Overall Study|Non-compliance with study drug|1|||
164270885|NCT01939366|593360466|FG000|Overall Study|Adverse Event|8|||
164270886|NCT01939366|593360467|FG001|Overall Study|Adverse Event|17|||
164270887|NCT01939366|593360468|FG002|Overall Study|Adverse Event|30|||
164270888|NCT01939366|593360469|FG003|Overall Study|Adverse Event|8|||
163893567|NCT03485729|591982109|FG000|Overall Study|Withdrawal by Subject|0|||
163893568|NCT03485729|591982110|FG001|Overall Study|Withdrawal by Subject|0|||
163893569|NCT03485729|591982111|FG002|Overall Study|Withdrawal by Subject|1|||
163893570|NCT03485729|591982109|FG000|Overall Study|Disease progression|8|||
163893571|NCT03485729|591982110|FG001|Overall Study|Disease progression|13|||
163893572|NCT03485729|591982111|FG002|Overall Study|Disease progression|1|||
163893573|NCT03485729|591982109|FG000|Overall Study|Hospice care|1|||
163893574|NCT03485729|591982110|FG001|Overall Study|Hospice care|0|||
163893575|NCT03485729|591982111|FG002|Overall Study|Hospice care|0|||
163893576|NCT03485729|591982109|FG000|Overall Study|Poor performance status|1|||
163893577|NCT03485729|591982110|FG001|Overall Study|Poor performance status|0|||
163893578|NCT03485729|591982111|FG002|Overall Study|Poor performance status|0|||
163893579|NCT03485729|591982109|FG000|Overall Study|Illness|0|||
163893580|NCT03485729|591982110|FG001|Overall Study|Illness|1|||
163893581|NCT03485729|591982111|FG002|Overall Study|Illness|0|||
163893582|NCT05035654|591982112|FG000|Overall Study|Physician Decision|0|||
163893583|NCT05035654|591982113|FG001|Overall Study|Physician Decision|1|||
163893584|NCT05035654|591982114|FG002|Overall Study|Physician Decision|0|||
163893585|NCT05035654|591982112|FG000|Overall Study|Adverse Event|0|||
163893586|NCT05035654|591982113|FG001|Overall Study|Adverse Event|1|||
163893587|NCT05035654|591982114|FG002|Overall Study|Adverse Event|0|||
163893588|NCT05035654|591982112|FG000|Overall Study|Withdrawal by Subject|0|||
163893589|NCT05035654|591982113|FG001|Overall Study|Withdrawal by Subject|0|||
163893590|NCT05035654|591982114|FG002|Overall Study|Withdrawal by Subject|4|||
163893591|NCT05035654|591982112|FG000|Overall Study|Bilateral Dislodgement|1|||
163893592|NCT05035654|591982113|FG001|Overall Study|Bilateral Dislodgement|0|||
163893593|NCT05035654|591982114|FG002|Overall Study|Bilateral Dislodgement|0|||
163893594|NCT05533190|591982116|FG000|Overall Study|Lost to Follow-up|19|||
163893595|NCT05533190|591982117|FG001|Overall Study|Lost to Follow-up|7|||
163893596|NCT05533190|591982116|FG000|Overall Study|Failed to download app|1|||
163893597|NCT05533190|591982117|FG001|Overall Study|Failed to download app|0|||
163893598|NCT05533190|591982116|FG000|Overall Study|Thought app was a scam|1|||
163893599|NCT05533190|591982117|FG001|Overall Study|Thought app was a scam|0|||
163893600|NCT05533190|591982116|FG000|Overall Study|Withdrawal by Subject|2|||
163893601|NCT05533190|591982117|FG001|Overall Study|Withdrawal by Subject|0|||
163893602|NCT05552508|591982118|FG000|Overall Study|Adverse Event|3|||
163893603|NCT04451772|591982121|FG000|Overall Study|Adverse Event|1|||
164085931|NCT01261325|592678591|FG001|Overall Study|Patient Randomized by Mistake|1|||
164270889|NCT01939366|593360470|FG004|Overall Study|Adverse Event|5|||
164270890|NCT01939366|593360466|FG000|Overall Study|Lack of Efficacy|2|||
163893604|NCT04451772|591982122|FG001|Overall Study|Adverse Event|0|||
163893605|NCT04451772|591982123|FG002|Overall Study|Adverse Event|1|||
163893606|NCT04451772|591982124|FG003|Overall Study|Adverse Event|1|||
163893607|NCT04451772|591982125|FG004|Overall Study|Adverse Event|0|||
163893608|NCT04451772|591982126|FG005|Overall Study|Adverse Event|3|||
163893609|NCT04451772|591982121|FG000|Overall Study|Withdrawal by Subject|2|||
163893610|NCT04451772|591982122|FG001|Overall Study|Withdrawal by Subject|7|||
163893611|NCT04451772|591982123|FG002|Overall Study|Withdrawal by Subject|2|||
164270891|NCT01939366|593360467|FG001|Overall Study|Lack of Efficacy|1|||
164270892|NCT01939366|593360468|FG002|Overall Study|Lack of Efficacy|1|||
164270893|NCT01939366|593360469|FG003|Overall Study|Lack of Efficacy|1|||
164270894|NCT01939366|593360470|FG004|Overall Study|Lack of Efficacy|3|||
164270895|NCT01939366|593360466|FG000|Overall Study|Lost to Follow-up|1|||
164270896|NCT01939366|593360467|FG001|Overall Study|Lost to Follow-up|1|||
164270897|NCT01939366|593360468|FG002|Overall Study|Lost to Follow-up|0|||
164270898|NCT01939366|593360469|FG003|Overall Study|Lost to Follow-up|0|||
164270899|NCT01939366|593360470|FG004|Overall Study|Lost to Follow-up|0|||
164270900|NCT01939366|593360466|FG000|Overall Study|Withdrawal by Subject|1|||
164270901|NCT01939366|593360467|FG001|Overall Study|Withdrawal by Subject|0|||
164270902|NCT01939366|593360468|FG002|Overall Study|Withdrawal by Subject|2|||
164270903|NCT01939366|593360469|FG003|Overall Study|Withdrawal by Subject|2|||
164270904|NCT01939366|593360470|FG004|Overall Study|Withdrawal by Subject|3|||
164270905|NCT01939366|593360466|FG000|Overall Study|Inclusion criteria not met|0|||
164270906|NCT01939366|593360467|FG001|Overall Study|Inclusion criteria not met|1|||
164000053|NCT00001337|592364690|FG001|Overall Study|Switched to alternate treatment|2|||
164000054|NCT00001337|592364691|FG002|Overall Study|Switched to alternate treatment|0|||
164000055|NCT00001337|592364689|FG000|Overall Study|Refused further treatment|2|||
164000056|NCT00001337|592364690|FG001|Overall Study|Refused further treatment|1|||
164000057|NCT00001337|592364691|FG002|Overall Study|Refused further treatment|0|||
164000058|NCT00001337|592364689|FG000|Overall Study|Began other Tx|1|||
164000059|NCT00001337|592364690|FG001|Overall Study|Began other Tx|0|||
164000060|NCT00001337|592364691|FG002|Overall Study|Began other Tx|0|||
164000061|NCT00001337|592364689|FG000|Overall Study|Physician Decision|3|||
164270907|NCT01939366|593360468|FG002|Overall Study|Inclusion criteria not met|1|||
164270908|NCT01939366|593360469|FG003|Overall Study|Inclusion criteria not met|0|||
164270909|NCT01939366|593360470|FG004|Overall Study|Inclusion criteria not met|1|||
164270910|NCT01939366|593360466|FG000|Overall Study|Other|0|||
164270911|NCT01939366|593360467|FG001|Overall Study|Other|0|||
164270912|NCT01939366|593360468|FG002|Overall Study|Other|2|||
164270913|NCT01939366|593360469|FG003|Overall Study|Other|2|||
164270914|NCT01939366|593360470|FG004|Overall Study|Other|1|||
164270915|NCT01939366|593360466|FG000|Overall Study|Protocol Violation|0|||
164270916|NCT01939366|593360467|FG001|Overall Study|Protocol Violation|0|||
164270917|NCT01939366|593360468|FG002|Overall Study|Protocol Violation|0|||
164270918|NCT01939366|593360469|FG003|Overall Study|Protocol Violation|1|||
164270919|NCT01939366|593360470|FG004|Overall Study|Protocol Violation|0|||
164270920|NCT01939366|593360466|FG000|Overall Study|Sponsor decision|0|||
164270921|NCT01939366|593360467|FG001|Overall Study|Sponsor decision|0|||
164270922|NCT01939366|593360468|FG002|Overall Study|Sponsor decision|0|||
164270923|NCT01939366|593360469|FG003|Overall Study|Sponsor decision|0|||
164270924|NCT01939366|593360470|FG004|Overall Study|Sponsor decision|2|||
164270925|NCT01939366|593360466|FG000|Overall Study|GCP non-compliance at site|2|||
164270926|NCT01939366|593360467|FG001|Overall Study|GCP non-compliance at site|3|||
164270927|NCT01939366|593360468|FG002|Overall Study|GCP non-compliance at site|2|||
164000062|NCT00001337|592364690|FG001|Overall Study|Physician Decision|1|||
164000063|NCT00001337|592364691|FG002|Overall Study|Physician Decision|0|||
164000064|NCT00001337|592364689|FG000|Overall Study|Doesn't have NHL|0|||
164000065|NCT00001337|592364690|FG001|Overall Study|Doesn't have NHL|1|||
164000066|NCT00001337|592364691|FG002|Overall Study|Doesn't have NHL|0|||
164000067|NCT00001337|592364689|FG000|Overall Study|Non protocol tx needed|3|||
164000068|NCT00001337|592364690|FG001|Overall Study|Non protocol tx needed|1|||
164000069|NCT00001337|592364691|FG002|Overall Study|Non protocol tx needed|0|||
164000070|NCT00001337|592364689|FG000|Overall Study|Protocol change|1|||
164000071|NCT00001337|592364690|FG001|Overall Study|Protocol change|0|||
164000072|NCT00001337|592364691|FG002|Overall Study|Protocol change|0|||
164000073|NCT00001337|592364689|FG000|Overall Study|2nd primary disease|0|||
164000074|NCT00001337|592364690|FG001|Overall Study|2nd primary disease|0|||
164000075|NCT00001337|592364691|FG002|Overall Study|2nd primary disease|1|||
164000076|NCT00001337|592364689|FG000|Overall Study|Death during follow up period|9|||
164000077|NCT00001337|592364690|FG001|Overall Study|Death during follow up period|4|||
164000078|NCT00001337|592364691|FG002|Overall Study|Death during follow up period|0|||
164000079|NCT00001337|592364689|FG000|Overall Study|Death on study|19|||
164270928|NCT01939366|593360469|FG003|Overall Study|GCP non-compliance at site|3|||
164270929|NCT01939366|593360470|FG004|Overall Study|GCP non-compliance at site|3|||
164270930|NCT02708485|593360471|FG000|Overall Study|Withdrawal by Subject|3|||
164270931|NCT02708485|593360472|FG001|Overall Study|Withdrawal by Subject|2|||
164270932|NCT00231413|593360473|FG000|Overall Study|Non-serious AE|0|||
164270933|NCT00231413|593360474|FG001|Overall Study|Non-serious AE|0|||
164270934|NCT00231413|593360475|FG002|Overall Study|Non-serious AE|1|||
164000080|NCT00001337|592364690|FG001|Overall Study|Death on study|9|||
164000081|NCT00001337|592364691|FG002|Overall Study|Death on study|0|||
164000082|NCT00001337|592364689|FG000|Overall Study|Disease progression during follow-up period|3|||
164270935|NCT00231413|593360476|FG003|Overall Study|Non-serious AE|0|||
164270936|NCT00231413|593360477|FG004|Overall Study|Non-serious AE|0|||
164270937|NCT00231413|593360478|FG005|Overall Study|Non-serious AE|0|||
164270938|NCT00231413|593360479|FG006|Overall Study|Non-serious AE|1|||
164000083|NCT00001337|592364690|FG001|Overall Study|Disease progression during follow-up period|1|||
164270939|NCT00231413|593360473|FG000|Overall Study|Withdrawal by Subject|3|||
164270940|NCT00231413|593360474|FG001|Overall Study|Withdrawal by Subject|1|||
164270941|NCT00231413|593360475|FG002|Overall Study|Withdrawal by Subject|4|||
164270942|NCT00231413|593360476|FG003|Overall Study|Withdrawal by Subject|2|||
164270943|NCT00231413|593360477|FG004|Overall Study|Withdrawal by Subject|2|||
164270944|NCT00231413|593360478|FG005|Overall Study|Withdrawal by Subject|0|||
164270945|NCT00231413|593360479|FG006|Overall Study|Withdrawal by Subject|3|||
164270946|NCT00231413|593360473|FG000|Overall Study|Migrated/moved from study area|0|||
164270947|NCT00231413|593360474|FG001|Overall Study|Migrated/moved from study area|0|||
164270948|NCT00231413|593360475|FG002|Overall Study|Migrated/moved from study area|1|||
164270949|NCT00231413|593360476|FG003|Overall Study|Migrated/moved from study area|0|||
164270950|NCT00231413|593360477|FG004|Overall Study|Migrated/moved from study area|0|||
164270951|NCT00231413|593360478|FG005|Overall Study|Migrated/moved from study area|1|||
164270952|NCT00231413|593360479|FG006|Overall Study|Migrated/moved from study area|0|||
164000084|NCT00001337|592364691|FG002|Overall Study|Disease progression during follow-up period|0|||
164000085|NCT00001337|592364689|FG000|Overall Study|Disease progression on study|33|||
164000086|NCT00001337|592364690|FG001|Overall Study|Disease progression on study|41|||
164000087|NCT00001337|592364691|FG002|Overall Study|Disease progression on study|0|||
164000088|NCT00001337|592364689|FG000|Overall Study|Lost to further follow-up|10|||
164000089|NCT00001337|592364690|FG001|Overall Study|Lost to further follow-up|6|||
164270953|NCT00231413|593360473|FG000|Overall Study|Lost to Follow-up|4|||
164270954|NCT00231413|593360474|FG001|Overall Study|Lost to Follow-up|4|||
164270955|NCT00231413|593360475|FG002|Overall Study|Lost to Follow-up|1|||
164270956|NCT00231413|593360476|FG003|Overall Study|Lost to Follow-up|1|||
164270957|NCT00231413|593360477|FG004|Overall Study|Lost to Follow-up|1|||
164000090|NCT00001337|592364691|FG002|Overall Study|Lost to further follow-up|0|||
164000091|NCT00001337|592364689|FG000|Overall Study|2nd malignancy|1|||
164000092|NCT00001337|592364690|FG001|Overall Study|2nd malignancy|0|||
164000093|NCT00001337|592364691|FG002|Overall Study|2nd malignancy|0|||
164000094|NCT00001337|592364689|FG000|Overall Study|Treatment for second lymphoma|0|||
164000095|NCT00001337|592364690|FG001|Overall Study|Treatment for second lymphoma|1|||
164000096|NCT00001337|592364691|FG002|Overall Study|Treatment for second lymphoma|0|||
164000097|NCT00001337|592364689|FG000|Overall Study|Transfer to transplant|0|||
164000098|NCT00001337|592364690|FG001|Overall Study|Transfer to transplant|1|||
164000099|NCT00001337|592364691|FG002|Overall Study|Transfer to transplant|0|||
164000100|NCT00408005|592364696|FG000|Induction|Adverse Event|19|||
164000101|NCT00408005|592364697|FG001|Induction|Adverse Event|3|||
164000102|NCT00408005|592364698|FG002|Induction|Adverse Event|0|||
164000103|NCT00408005|592364699|FG003|Induction|Adverse Event|0|||
164000104|NCT00408005|592364700|FG004|Induction|Adverse Event|0|||
164000105|NCT00408005|592364701|FG005|Induction|Adverse Event|0|||
164000106|NCT00408005|592364702|FG006|Induction|Adverse Event|0|||
164000107|NCT00408005|592364703|FG007|Induction|Adverse Event|0|||
164000108|NCT00408005|592364696|FG000|Induction|Death|6|||
164000109|NCT00408005|592364697|FG001|Induction|Death|0|||
164000110|NCT00408005|592364698|FG002|Induction|Death|0|||
164000111|NCT00408005|592364699|FG003|Induction|Death|0|||
164000112|NCT00408005|592364700|FG004|Induction|Death|0|||
164000113|NCT00408005|592364701|FG005|Induction|Death|0|||
164000114|NCT00408005|592364702|FG006|Induction|Death|0|||
164000115|NCT00408005|592364703|FG007|Induction|Death|0|||
164000116|NCT00408005|592364696|FG000|Induction|Physician Decision|83|||
164000117|NCT00408005|592364697|FG001|Induction|Physician Decision|9|||
164000118|NCT00408005|592364698|FG002|Induction|Physician Decision|0|||
164000119|NCT00408005|592364699|FG003|Induction|Physician Decision|0|||
164000120|NCT00408005|592364700|FG004|Induction|Physician Decision|0|||
164000121|NCT00408005|592364701|FG005|Induction|Physician Decision|0|||
164000122|NCT00408005|592364702|FG006|Induction|Physician Decision|0|||
164000123|NCT00408005|592364703|FG007|Induction|Physician Decision|0|||
164000124|NCT00408005|592364696|FG000|Induction|Withdrawal by Subject|2|||
164000125|NCT00408005|592364697|FG001|Induction|Withdrawal by Subject|4|||
164000126|NCT00408005|592364698|FG002|Induction|Withdrawal by Subject|0|||
164000127|NCT00408005|592364699|FG003|Induction|Withdrawal by Subject|0|||
164000128|NCT00408005|592364700|FG004|Induction|Withdrawal by Subject|0|||
164270958|NCT00231413|593360478|FG005|Overall Study|Lost to Follow-up|4|||
164270959|NCT00231413|593360479|FG006|Overall Study|Lost to Follow-up|0|||
164270960|NCT00231413|593360473|FG000|Overall Study|Pregnancy|1|||
164270961|NCT00231413|593360474|FG001|Overall Study|Pregnancy|0|||
164000129|NCT00408005|592364701|FG005|Induction|Withdrawal by Subject|0|||
164000130|NCT00408005|592364702|FG006|Induction|Withdrawal by Subject|0|||
164000131|NCT00408005|592364703|FG007|Induction|Withdrawal by Subject|0|||
164000132|NCT00408005|592364696|FG000|Induction|Ineligible|33|||
164000133|NCT00408005|592364697|FG001|Induction|Ineligible|14|||
164270962|NCT00231413|593360475|FG002|Overall Study|Pregnancy|0|||
164270963|NCT00231413|593360476|FG003|Overall Study|Pregnancy|0|||
164000134|NCT00408005|592364698|FG002|Induction|Ineligible|0|||
164000135|NCT00408005|592364699|FG003|Induction|Ineligible|0|||
164000136|NCT00408005|592364700|FG004|Induction|Ineligible|0|||
164000137|NCT00408005|592364701|FG005|Induction|Ineligible|0|||
164000138|NCT00408005|592364702|FG006|Induction|Ineligible|0|||
164270964|NCT00231413|593360477|FG004|Overall Study|Pregnancy|0|||
164270965|NCT00231413|593360478|FG005|Overall Study|Pregnancy|0|||
164270966|NCT00231413|593360479|FG006|Overall Study|Pregnancy|0|||
164270967|NCT02066415|593360480|FG000|Overall Study|Decision by Sponsor|5|||
164270968|NCT02066415|593360481|FG001|Overall Study|Decision by Sponsor|4|||
164270969|NCT02066415|593360482|FG002|Overall Study|Decision by Sponsor|2|||
164270970|NCT02066415|593360480|FG000|Overall Study|Withdrawal by Subject|9|||
164270971|NCT02066415|593360481|FG001|Overall Study|Withdrawal by Subject|1|||
164270972|NCT02066415|593360482|FG002|Overall Study|Withdrawal by Subject|4|||
164270973|NCT02066415|593360480|FG000|Overall Study|Lost to Follow-up|7|||
164270974|NCT02066415|593360481|FG001|Overall Study|Lost to Follow-up|2|||
164270975|NCT02066415|593360482|FG002|Overall Study|Lost to Follow-up|2|||
164270976|NCT01423916|593360484|FG000|Overall Study|Adverse Event|5|||
164270977|NCT01423916|593360485|FG001|Overall Study|Adverse Event|9|||
164270978|NCT01423916|593360486|FG002|Overall Study|Adverse Event|2|||
164270979|NCT01423916|593360484|FG000|Overall Study|Met Withdrawal Criteria|1|||
164270980|NCT01423916|593360485|FG001|Overall Study|Met Withdrawal Criteria|1|||
164270981|NCT01423916|593360486|FG002|Overall Study|Met Withdrawal Criteria|1|||
164270982|NCT01423916|593360484|FG000|Overall Study|Physician Decision|1|||
164270983|NCT01423916|593360485|FG001|Overall Study|Physician Decision|0|||
164270984|NCT01423916|593360486|FG002|Overall Study|Physician Decision|1|||
164270985|NCT01423916|593360484|FG000|Overall Study|Withdrawal by Subject|3|||
164270986|NCT01423916|593360485|FG001|Overall Study|Withdrawal by Subject|10|||
164270987|NCT01423916|593360486|FG002|Overall Study|Withdrawal by Subject|3|||
164270988|NCT01423916|593360484|FG000|Overall Study|Protocol Deviation|1|||
164270989|NCT01423916|593360485|FG001|Overall Study|Protocol Deviation|0|||
164270990|NCT01423916|593360486|FG002|Overall Study|Protocol Deviation|0|||
164270991|NCT02276547|593360487|FG000|Overall Study|Death|2|||
164270992|NCT02276547|593360487|FG000|Overall Study|Explant|2|||
164270993|NCT00106691|593360488|FG000|Overall Study|Adverse Event|60|||
164270994|NCT00106691|593360489|FG001|Overall Study|Adverse Event|64|||
164270995|NCT00106691|593360488|FG000|Overall Study|Lost to Follow-up|23|||
164270996|NCT00106691|593360489|FG001|Overall Study|Lost to Follow-up|18|||
164270997|NCT00106691|593360488|FG000|Overall Study|Physician Decision|18|||
164270998|NCT00106691|593360489|FG001|Overall Study|Physician Decision|21|||
164270999|NCT00106691|593360488|FG000|Overall Study|Protocol Violation|13|||
164271000|NCT00106691|593360489|FG001|Overall Study|Protocol Violation|18|||
164271001|NCT00106691|593360488|FG000|Overall Study|Withdrawal by Subject|75|||
164271002|NCT00106691|593360489|FG001|Overall Study|Withdrawal by Subject|70|||
164271003|NCT00106691|593360488|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
164271004|NCT00106691|593360489|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
164271005|NCT00106691|593360488|FG000|Overall Study|QTc>480|3|||
164271006|NCT00106691|593360489|FG001|Overall Study|QTc>480|1|||
164271007|NCT00106691|593360488|FG000|Overall Study|mililtary deployment|2|||
164271008|NCT00106691|593360489|FG001|Overall Study|mililtary deployment|0|||
164271009|NCT00106691|593360488|FG000|Overall Study|Study Site Closing/PI Moved|1|||
164271010|NCT00106691|593360489|FG001|Overall Study|Study Site Closing/PI Moved|2|||
164271011|NCT00106691|593360488|FG000|Overall Study|Cardiologist recommendation|1|||
164271012|NCT00106691|593360489|FG001|Overall Study|Cardiologist recommendation|0|||
164271013|NCT00106691|593360488|FG000|Overall Study|Pt. moved to another state|1|||
164271014|NCT00106691|593360489|FG001|Overall Study|Pt. moved to another state|0|||
164271015|NCT00106691|593360488|FG000|Overall Study|Taking exclusionary avodart|1|||
164271016|NCT00106691|593360489|FG001|Overall Study|Taking exclusionary avodart|0|||
164271017|NCT00106691|593360488|FG000|Overall Study|Not able to discontinue plavix|0|||
164000139|NCT00408005|592364703|FG007|Induction|Ineligible|0|||
164000140|NCT00408005|592364696|FG000|Induction|Refusal of Further Protocol Therapy|225|||
164000141|NCT00408005|592364697|FG001|Induction|Refusal of Further Protocol Therapy|44|||
164000142|NCT00408005|592364698|FG002|Induction|Refusal of Further Protocol Therapy|0|||
164000143|NCT00408005|592364699|FG003|Induction|Refusal of Further Protocol Therapy|0|||
164000144|NCT00408005|592364700|FG004|Induction|Refusal of Further Protocol Therapy|0|||
164000145|NCT00408005|592364701|FG005|Induction|Refusal of Further Protocol Therapy|0|||
164000146|NCT00408005|592364702|FG006|Induction|Refusal of Further Protocol Therapy|0|||
164000147|NCT00408005|592364703|FG007|Induction|Refusal of Further Protocol Therapy|0|||
164000148|NCT00408005|592364696|FG000|Induction|Entered another COG therapeutic protocol|4|||
164271018|NCT00106691|593360489|FG001|Overall Study|Not able to discontinue plavix|1|||
164271019|NCT00530920|593360490|FG000|Overall Study|Randomized but not treated|0|||
164271020|NCT00530920|593360491|FG001|Overall Study|Randomized but not treated|2|||
164271021|NCT00530920|593360492|FG002|Overall Study|Randomized but not treated|0|||
164271022|NCT00530920|593360490|FG000|Overall Study|Adverse Event|0|||
164271023|NCT00530920|593360491|FG001|Overall Study|Adverse Event|0|||
164271024|NCT00530920|593360492|FG002|Overall Study|Adverse Event|3|||
164271025|NCT00530920|593360490|FG000|Overall Study|Withdrawal by Subject|0|||
164000149|NCT00408005|592364697|FG001|Induction|Entered another COG therapeutic protocol|0|||
164271026|NCT00530920|593360491|FG001|Overall Study|Withdrawal by Subject|0|||
164271027|NCT00530920|593360492|FG002|Overall Study|Withdrawal by Subject|1|||
164271028|NCT01177969|593360497|FG000|Overall Study|Protocol Violation|2|||
164271029|NCT01177969|593360498|FG001|Overall Study|Protocol Violation|1|||
164271030|NCT01177969|593360497|FG000|Overall Study|Withdrawal by Subject|1|||
164271031|NCT01177969|593360498|FG001|Overall Study|Withdrawal by Subject|2|||
164271032|NCT01353911|593360505|FG000|Overall Study|Lost to Follow-up|2|||
164271033|NCT01353911|593360506|FG001|Overall Study|Lost to Follow-up|6|||
164271034|NCT01353911|593360507|FG002|Overall Study|Lost to Follow-up|4|||
164271035|NCT01353911|593360508|FG003|Overall Study|Lost to Follow-up|0|||
164271036|NCT01353911|593360509|FG004|Overall Study|Lost to Follow-up|4|||
164271037|NCT01353911|593360510|FG005|Overall Study|Lost to Follow-up|4|||
164271038|NCT01353911|593360511|FG006|Overall Study|Lost to Follow-up|3|||
164271039|NCT01353911|593360512|FG007|Overall Study|Lost to Follow-up|6|||
164271040|NCT01353911|593360505|FG000|Overall Study|Withdrawal by Subject|2|||
164271041|NCT01353911|593360506|FG001|Overall Study|Withdrawal by Subject|3|||
164271042|NCT01353911|593360507|FG002|Overall Study|Withdrawal by Subject|4|||
164271043|NCT01353911|593360508|FG003|Overall Study|Withdrawal by Subject|2|||
164271044|NCT01353911|593360509|FG004|Overall Study|Withdrawal by Subject|2|||
164271045|NCT01353911|593360510|FG005|Overall Study|Withdrawal by Subject|3|||
164271046|NCT01353911|593360511|FG006|Overall Study|Withdrawal by Subject|3|||
164271047|NCT01353911|593360512|FG007|Overall Study|Withdrawal by Subject|9|||
164271048|NCT01353911|593360505|FG000|Overall Study|Status Not Recorded|4|||
164271049|NCT01353911|593360506|FG001|Overall Study|Status Not Recorded|0|||
164271050|NCT01353911|593360507|FG002|Overall Study|Status Not Recorded|1|||
164271051|NCT01353911|593360508|FG003|Overall Study|Status Not Recorded|0|||
164271052|NCT01353911|593360509|FG004|Overall Study|Status Not Recorded|0|||
164271053|NCT01353911|593360510|FG005|Overall Study|Status Not Recorded|0|||
164271054|NCT01353911|593360511|FG006|Overall Study|Status Not Recorded|0|||
164271055|NCT01353911|593360512|FG007|Overall Study|Status Not Recorded|0|||
164271056|NCT01504204|593360513|FG000|Overall Study|Lost to Follow-up|1|||
164271057|NCT01504204|593360514|FG001|Overall Study|Lost to Follow-up|1|||
164271058|NCT02049138|593360519|FG000|Overall Study|Adverse Event|46|||
164271059|NCT02049138|593360520|FG001|Overall Study|Adverse Event|25|||
164271060|NCT02049138|593360521|FG002|Overall Study|Adverse Event|1|||
164271061|NCT02049138|593360519|FG000|Overall Study|Withdrawal by Subject|57|||
164271062|NCT02049138|593360520|FG001|Overall Study|Withdrawal by Subject|21|||
164271063|NCT02049138|593360521|FG002|Overall Study|Withdrawal by Subject|5|||
164271064|NCT02049138|593360519|FG000|Overall Study|Lost to Follow-up|18|||
164271065|NCT02049138|593360520|FG001|Overall Study|Lost to Follow-up|5|||
164271066|NCT02049138|593360521|FG002|Overall Study|Lost to Follow-up|1|||
164271067|NCT02049138|593360519|FG000|Overall Study|Lack of Efficacy|10|||
164271068|NCT02049138|593360520|FG001|Overall Study|Lack of Efficacy|26|||
164271069|NCT02049138|593360521|FG002|Overall Study|Lack of Efficacy|1|||
164271070|NCT02049138|593360519|FG000|Overall Study|Non-Compliance|15|||
164271071|NCT02049138|593360520|FG001|Overall Study|Non-Compliance|6|||
164271072|NCT02049138|593360521|FG002|Overall Study|Non-Compliance|0|||
164271073|NCT02049138|593360519|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
164271074|NCT02049138|593360520|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
164271075|NCT02049138|593360521|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
164271076|NCT02049138|593360519|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
164271077|NCT02049138|593360520|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164271078|NCT02049138|593360521|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164271079|NCT02049138|593360519|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164271080|NCT02049138|593360520|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
164271081|NCT02049138|593360521|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
164271082|NCT02049138|593360519|FG000|Overall Study|Other|15|||
164271083|NCT02049138|593360520|FG001|Overall Study|Other|13|||
164271084|NCT02049138|593360521|FG002|Overall Study|Other|0|||
164271085|NCT02049138|593360519|FG000|Overall Study|Missing|0|||
164271086|NCT02049138|593360520|FG001|Overall Study|Missing|1|||
164271087|NCT02049138|593360521|FG002|Overall Study|Missing|0|||
164271088|NCT03995355|593360522|FG000|Overall Study|Adverse Event|1|||
164271089|NCT03995355|593360523|FG001|Overall Study|Adverse Event|0|||
164271090|NCT03995355|593360522|FG000|Overall Study|Withdrawal by Subject|1|||
164271091|NCT03995355|593360523|FG001|Overall Study|Withdrawal by Subject|0|||
164271092|NCT03995355|593360522|FG000|Overall Study|Scheduling Issues|0|||
164271093|NCT03995355|593360523|FG001|Overall Study|Scheduling Issues|1|||
164342333|NCT04457336|593629430|FG004|Period 2: Part A|Protocol Violation|0|||
164342334|NCT04457336|593629431|FG005|Period 2: Part A|Protocol Violation|0|||
164271094|NCT00094107|593360524|FG000|Overall Study|Lack of Efficacy|23|||
164271095|NCT00094107|593360524|FG000|Overall Study|Death|5|||
164271096|NCT00094107|593360524|FG000|Overall Study|Adverse Event|3|||
164271097|NCT00094107|593360524|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
164271098|NCT00587847|593360525|FG000|Overall Study|Lack of Efficacy|5|||
164271099|NCT00587847|593360525|FG000|Overall Study|Adverse Event|2|||
164271100|NCT00343382|593360527|FG000|Overall Study|Adverse Event|2|||
164271101|NCT00343382|593360528|FG001|Overall Study|Adverse Event|10|||
164271102|NCT00343382|593360529|FG002|Overall Study|Adverse Event|7|||
164271103|NCT00343382|593360527|FG000|Overall Study|Withdrawal by Subject|1|||
164271104|NCT00343382|593360528|FG001|Overall Study|Withdrawal by Subject|2|||
164342335|NCT04457336|593629432|FG006|Period 2: Part A|Protocol Violation|0|||
164000150|NCT00408005|592364698|FG002|Induction|Entered another COG therapeutic protocol|0|||
164000151|NCT00408005|592364699|FG003|Induction|Entered another COG therapeutic protocol|0|||
164271105|NCT00343382|593360529|FG002|Overall Study|Withdrawal by Subject|6|||
164271106|NCT00343382|593360527|FG000|Overall Study|Other Reason Not Specified|1|||
164271107|NCT00343382|593360528|FG001|Overall Study|Other Reason Not Specified|2|||
164271108|NCT00343382|593360529|FG002|Overall Study|Other Reason Not Specified|4|||
164271109|NCT02966015|593360538|FG000|Inclusion Visit|did not answer questionnaire|8|||
164271110|NCT02966015|593360539|FG001|Inclusion Visit|did not answer questionnaire|3|||
164271111|NCT02241187|593360540|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
164271112|NCT02356887|593360541|FG000|Overall Study|poor compliance|2|||
164271113|NCT00199888|593360542|FG000|Overall Study|Lost to Follow-up|1|||
164271114|NCT05219669|593360547|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271115|NCT05219669|593360548|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271116|NCT05219669|593360549|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
164271117|NCT05219669|593360550|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271118|NCT05219669|593360551|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271119|NCT05219669|593360552|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
164271120|NCT02177838|593360554|FG000|Overall Study|Withdrawal by Subject|1|||
164271121|NCT02177838|593360554|FG000|Overall Study|Physician Decision|1|||
164271122|NCT02177838|593360554|FG000|Overall Study|Death|1|||
164271123|NCT02404649|593360556|FG000|Overall Study|Adverse Event|1|||
163893612|NCT04451772|591982124|FG003|Overall Study|Withdrawal by Subject|1|||
163893613|NCT04451772|591982125|FG004|Overall Study|Withdrawal by Subject|1|||
164271124|NCT02404649|593360557|FG001|Overall Study|Adverse Event|2|||
164271125|NCT02299076|593360558|FG000|Overall Study|Fraudulent Entries|20|||
164271126|NCT02299076|593360559|FG001|Overall Study|Fraudulent Entries|14|||
164271127|NCT00162266|593360560|FG000|Double-Blind Period|Adverse Event|5|||
164271128|NCT00162266|593360561|FG001|Double-Blind Period|Adverse Event|9|||
164271129|NCT00162266|593360562|FG002|Double-Blind Period|Adverse Event|11|||
164271130|NCT00162266|593360563|FG003|Double-Blind Period|Adverse Event|0|||
164271131|NCT00162266|593360560|FG000|Double-Blind Period|Death|0|||
164271132|NCT00162266|593360561|FG001|Double-Blind Period|Death|1|||
164271133|NCT00162266|593360562|FG002|Double-Blind Period|Death|0|||
164271134|NCT00162266|593360563|FG003|Double-Blind Period|Death|0|||
164271135|NCT00162266|593360560|FG000|Double-Blind Period|Lost to Follow-up|1|||
164271136|NCT00162266|593360561|FG001|Double-Blind Period|Lost to Follow-up|2|||
164271137|NCT00162266|593360562|FG002|Double-Blind Period|Lost to Follow-up|0|||
164271138|NCT00162266|593360563|FG003|Double-Blind Period|Lost to Follow-up|0|||
164271139|NCT00162266|593360560|FG000|Double-Blind Period|Other Reason|1|||
164271140|NCT00162266|593360561|FG001|Double-Blind Period|Other Reason|0|||
164271141|NCT00162266|593360562|FG002|Double-Blind Period|Other Reason|1|||
164271142|NCT00162266|593360563|FG003|Double-Blind Period|Other Reason|0|||
164271143|NCT00162266|593360560|FG000|Double-Blind Period|Lack of Efficacy|13|||
164271144|NCT00162266|593360561|FG001|Double-Blind Period|Lack of Efficacy|17|||
164271145|NCT00162266|593360562|FG002|Double-Blind Period|Lack of Efficacy|30|||
164271146|NCT00162266|593360563|FG003|Double-Blind Period|Lack of Efficacy|0|||
164271147|NCT00162266|593360560|FG000|Double-Blind Period|Withdrawal by Subject|5|||
164271148|NCT00162266|593360561|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164271149|NCT00162266|593360562|FG002|Double-Blind Period|Withdrawal by Subject|6|||
164271150|NCT00162266|593360563|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164271151|NCT00162266|593360560|FG000|Open-Label Period|Death|0|||
163893614|NCT04451772|591982126|FG005|Overall Study|Withdrawal by Subject|0|||
163893615|NCT04451772|591982121|FG000|Overall Study|Other, not specified|1|||
163893616|NCT04451772|591982122|FG001|Overall Study|Other, not specified|2|||
163893617|NCT04451772|591982123|FG002|Overall Study|Other, not specified|1|||
163893618|NCT04451772|591982124|FG003|Overall Study|Other, not specified|0|||
163893619|NCT04451772|591982125|FG004|Overall Study|Other, not specified|0|||
163893620|NCT04451772|591982126|FG005|Overall Study|Other, not specified|1|||
163893621|NCT04451772|591982121|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
163893622|NCT04451772|591982122|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
163893623|NCT04451772|591982123|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
163893624|NCT04451772|591982124|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
163893625|NCT04451772|591982125|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
163893626|NCT04451772|591982126|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
164000152|NCT00408005|592364700|FG004|Induction|Entered another COG therapeutic protocol|0|||
164271152|NCT00162266|593360561|FG001|Open-Label Period|Death|0|||
164271153|NCT00162266|593360562|FG002|Open-Label Period|Death|0|||
164271154|NCT00162266|593360563|FG003|Open-Label Period|Death|7|||
164271155|NCT00162266|593360560|FG000|Open-Label Period|Adverse Event|0|||
164271156|NCT00162266|593360561|FG001|Open-Label Period|Adverse Event|0|||
164271157|NCT00162266|593360562|FG002|Open-Label Period|Adverse Event|0|||
164271158|NCT00162266|593360563|FG003|Open-Label Period|Adverse Event|46|||
164271159|NCT00162266|593360560|FG000|Open-Label Period|Lack of Efficacy|0|||
164271160|NCT00162266|593360561|FG001|Open-Label Period|Lack of Efficacy|0|||
164271161|NCT00162266|593360562|FG002|Open-Label Period|Lack of Efficacy|0|||
164271162|NCT00162266|593360563|FG003|Open-Label Period|Lack of Efficacy|26|||
164271163|NCT00162266|593360560|FG000|Open-Label Period|Lost to Follow-up|0|||
164271164|NCT00162266|593360561|FG001|Open-Label Period|Lost to Follow-up|0|||
164271165|NCT00162266|593360562|FG002|Open-Label Period|Lost to Follow-up|0|||
164271166|NCT00162266|593360563|FG003|Open-Label Period|Lost to Follow-up|3|||
164000153|NCT00408005|592364701|FG005|Induction|Entered another COG therapeutic protocol|0|||
164000154|NCT00408005|592364702|FG006|Induction|Entered another COG therapeutic protocol|0|||
164000155|NCT00408005|592364703|FG007|Induction|Entered another COG therapeutic protocol|0|||
164000156|NCT00408005|592364696|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
164271167|NCT00162266|593360560|FG000|Open-Label Period|Withdrawal by Subject|0|||
164271168|NCT00162266|593360561|FG001|Open-Label Period|Withdrawal by Subject|0|||
164271169|NCT00162266|593360562|FG002|Open-Label Period|Withdrawal by Subject|0|||
164271170|NCT00162266|593360563|FG003|Open-Label Period|Withdrawal by Subject|31|||
164271171|NCT00162266|593360560|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
164271172|NCT00162266|593360561|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
164271173|NCT00162266|593360562|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
164271174|NCT00162266|593360563|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
164271175|NCT00162266|593360560|FG000|Open-Label Period|Other Reasons|0|||
164271176|NCT00162266|593360561|FG001|Open-Label Period|Other Reasons|0|||
164271177|NCT00162266|593360562|FG002|Open-Label Period|Other Reasons|0|||
164271178|NCT00162266|593360563|FG003|Open-Label Period|Other Reasons|15|||
164271179|NCT00330668|593360564|FG000|BID Dosing Period|Adverse Event|1|||
164271180|NCT00330668|593360564|FG000|BID Dosing Period|Lost to Follow-up|7|||
164271181|NCT00330668|593360564|FG000|BID Dosing Period|Non-Compliance|5|||
164271182|NCT00330668|593360564|FG000|BID Dosing Period|Withdrawal by Subject|19|||
164271183|NCT00330668|593360564|FG000|BID Dosing Period|Sponsor's decision|1|||
164271184|NCT00330668|593360564|FG000|BID Dosing Period|Other|3|||
164271185|NCT00330668|593360564|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
164000157|NCT00408005|592364697|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
164000158|NCT00408005|592364698|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
164000159|NCT00408005|592364699|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
164000160|NCT00408005|592364700|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
164000161|NCT00408005|592364701|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
164000162|NCT00408005|592364702|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
164000163|NCT00408005|592364703|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
164000164|NCT00408005|592364696|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
164000165|NCT00408005|592364697|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
164142374|NCT00182325|592882693|FG001|Overall Study|Miscarriage|3|||
164271186|NCT00330668|593360564|FG000|QD Dosing Period|Other|1|||
164271187|NCT00330668|593360564|FG000|QD Dosing Period|Withdrawal by Subject|1|||
164271188|NCT00330668|593360564|FG000|QD Dosing Period|Lost to Follow-up|2|||
164271189|NCT02273960|593360565|FG000|Short Term Period|Lost to Follow-up|1|||
164271190|NCT02273960|593360566|FG001|Short Term Period|Lost to Follow-up|0|||
164271191|NCT02273960|593360567|FG002|Short Term Period|Lost to Follow-up|0|||
164271192|NCT02273960|593360568|FG003|Short Term Period|Lost to Follow-up|0|||
164271193|NCT02273960|593360565|FG000|Short Term Period|Lack of Efficacy|0|||
164271194|NCT02273960|593360566|FG001|Short Term Period|Lack of Efficacy|0|||
164271195|NCT02273960|593360567|FG002|Short Term Period|Lack of Efficacy|0|||
164271196|NCT02273960|593360568|FG003|Short Term Period|Lack of Efficacy|1|||
164271197|NCT02273960|593360565|FG000|Short Term Period|ST complete, not entering LTE|4|||
164271198|NCT02273960|593360566|FG001|Short Term Period|ST complete, not entering LTE|6|||
164271199|NCT02273960|593360567|FG002|Short Term Period|ST complete, not entering LTE|4|||
164271200|NCT02273960|593360568|FG003|Short Term Period|ST complete, not entering LTE|5|||
164271201|NCT02273960|593360565|FG000|Long Term Extension|Death|0|||
164271202|NCT02273960|593360566|FG001|Long Term Extension|Death|0|||
164271203|NCT02273960|593360567|FG002|Long Term Extension|Death|0|||
164271204|NCT02273960|593360568|FG003|Long Term Extension|Death|1|||
164271205|NCT03442296|593360573|FG000|3 Month Follow-up|Death|3|||
164271206|NCT03442296|593360574|FG001|3 Month Follow-up|Death|1|||
164271207|NCT03442296|593360573|FG000|3 Month Follow-up|Lost to Follow-up|1|||
164271208|NCT03442296|593360574|FG001|3 Month Follow-up|Lost to Follow-up|1|||
164271209|NCT03442296|593360573|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
164271210|NCT03442296|593360574|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
164271211|NCT03442296|593360573|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
164271212|NCT03442296|593360574|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
164271213|NCT03442296|593360573|FG000|12 Month Follow-up|Incomplete measurement|1|||
164271214|NCT03442296|593360574|FG001|12 Month Follow-up|Incomplete measurement|1|||
164271215|NCT00447122|593360575|FG000|Overall Study|worsening medical condition -came off|0|||
164271216|NCT00447122|593360576|FG001|Overall Study|worsening medical condition -came off|1|||
164271217|NCT00447122|593360577|FG002|Overall Study|worsening medical condition -came off|0|||
164271218|NCT00447122|593360578|FG003|Overall Study|worsening medical condition -came off|0|||
164271219|NCT04046250|593360581|FG000|Overall Study|Death|0|||
164271220|NCT04046250|593360582|FG001|Overall Study|Death|1|||
164271221|NCT04046250|593360581|FG000|Overall Study|Withdrawal by Subject|3|||
164271222|NCT04046250|593360582|FG001|Overall Study|Withdrawal by Subject|3|||
164271223|NCT02806960|593362633|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271224|NCT02806960|593362634|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271225|NCT02806960|593362635|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271226|NCT02806960|593362636|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
164271227|NCT01629953|593362638|FG000|Overall Study|Death|3|||
164271228|NCT01629953|593362639|FG001|Overall Study|Death|1|||
164271229|NCT01629953|593362638|FG000|Overall Study|Lost to Follow-up|10|||
164271230|NCT01629953|593362639|FG001|Overall Study|Lost to Follow-up|14|||
164271231|NCT03221842|593362642|FG000|Period 1 (Open-label)|Adverse Event|4|||
164271232|NCT03221842|593362643|FG001|Period 1 (Open-label)|Adverse Event|0|||
164271233|NCT03221842|593362642|FG000|Period 1 (Open-label)|Physician Decision|2|||
164271234|NCT03221842|593362643|FG001|Period 1 (Open-label)|Physician Decision|0|||
164271235|NCT03221842|593362642|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
164271236|NCT03221842|593362643|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
164271237|NCT03221842|593362642|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
164271238|NCT03221842|593362643|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
164271239|NCT03221842|593362642|FG000|Period 1 (Open-label)|Other|2|||
164271240|NCT03221842|593362643|FG001|Period 1 (Open-label)|Other|0|||
164271241|NCT03221842|593362642|FG000|Period 2 (Randomized, Blinded)|Death|0|||
164271242|NCT03221842|593362643|FG001|Period 2 (Randomized, Blinded)|Death|1|||
164271243|NCT03221842|593362642|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
164271244|NCT03221842|593362643|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
164271245|NCT02504580|593362644|FG000|Overall Study|Other|1|||
164271246|NCT02504580|593362645|FG001|Overall Study|Other|0|||
164271247|NCT02504580|593362646|FG002|Overall Study|Other|0|||
164271248|NCT02504580|593362647|FG003|Overall Study|Other|2|||
164271249|NCT02504580|593362648|FG004|Overall Study|Other|1|||
164271250|NCT02504580|593362649|FG005|Overall Study|Other|1|||
164271251|NCT02504580|593362650|FG006|Overall Study|Other|1|||
164271252|NCT02504580|593362651|FG007|Overall Study|Other|2|||
164271253|NCT02504580|593362652|FG008|Overall Study|Other|0|||
164271254|NCT02504580|593362653|FG009|Overall Study|Other|0|||
164271255|NCT02504580|593362654|FG010|Overall Study|Other|0|||
164271256|NCT02504580|593362655|FG011|Overall Study|Other|2|||
164271257|NCT02504580|593362644|FG000|Overall Study|Subject refusal to continue|0|||
164271258|NCT02504580|593362645|FG001|Overall Study|Subject refusal to continue|1|||
164271259|NCT02504580|593362646|FG002|Overall Study|Subject refusal to continue|0|||
164271260|NCT02504580|593362647|FG003|Overall Study|Subject refusal to continue|0|||
164271261|NCT02504580|593362648|FG004|Overall Study|Subject refusal to continue|0|||
164271262|NCT02504580|593362649|FG005|Overall Study|Subject refusal to continue|0|||
164271263|NCT02504580|593362650|FG006|Overall Study|Subject refusal to continue|0|||
164271264|NCT02504580|593362651|FG007|Overall Study|Subject refusal to continue|0|||
164271265|NCT02504580|593362652|FG008|Overall Study|Subject refusal to continue|0|||
164271266|NCT02504580|593362653|FG009|Overall Study|Subject refusal to continue|0|||
164271267|NCT02504580|593362654|FG010|Overall Study|Subject refusal to continue|0|||
164271268|NCT02504580|593362655|FG011|Overall Study|Subject refusal to continue|0|||
164271269|NCT00007020|593362658|FG000|Overall Study|Death|16|||
164271270|NCT00007020|593362658|FG000|Overall Study|Lost to Follow-up|13|||
164271271|NCT00007020|593362658|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
164271272|NCT00007020|593362658|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
164271273|NCT00007020|593362658|FG000|Overall Study|Pt cared for by outside physician|4|||
164271274|NCT00007020|593362658|FG000|Overall Study|No evidence of treatment|6|||
164271275|NCT01100528|593362664|FG000|Overall Study|Death|1|||
164271276|NCT01100528|593362664|FG000|Overall Study|Withdrawal by Subject|2|||
164271277|NCT03242252|593362665|FG000|Overall Study|At the Participant's own Request|18|||
164271278|NCT03242252|593362666|FG001|Overall Study|At the Participant's own Request|10|||
164271279|NCT03242252|593362667|FG002|Overall Study|At the Participant's own Request|15|||
164000166|NCT00408005|592364698|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
164000167|NCT00408005|592364699|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
164000168|NCT00408005|592364700|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
164000169|NCT00408005|592364701|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
164000170|NCT00408005|592364702|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
164000171|NCT00408005|592364703|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
164271280|NCT03242252|593362665|FG000|Overall Study|Adverse Event|8|||
164271281|NCT03242252|593362666|FG001|Overall Study|Adverse Event|6|||
164271282|NCT03242252|593362667|FG002|Overall Study|Adverse Event|9|||
164271283|NCT03242252|593362665|FG000|Overall Study|Poor Compliance to Protocol|0|||
164271284|NCT03242252|593362666|FG001|Overall Study|Poor Compliance to Protocol|2|||
164271285|NCT03242252|593362667|FG002|Overall Study|Poor Compliance to Protocol|3|||
164271286|NCT03242252|593362665|FG000|Overall Study|Study Terminated by Sponsor|1|||
164271287|NCT03242252|593362666|FG001|Overall Study|Study Terminated by Sponsor|0|||
164271288|NCT03242252|593362667|FG002|Overall Study|Study Terminated by Sponsor|0|||
164271289|NCT03242252|593362665|FG000|Overall Study|Reason not Specified|4|||
164271290|NCT03242252|593362666|FG001|Overall Study|Reason not Specified|4|||
164271291|NCT03242252|593362667|FG002|Overall Study|Reason not Specified|1|||
163893627|NCT04311632|591982127|FG000|Overall Study|Withdrawal by Subject|0|||
163893628|NCT04311632|591982128|FG001|Overall Study|Withdrawal by Subject|0|||
164271292|NCT03242252|593362665|FG000|Overall Study|Lost to Follow-up|5|||
164271293|NCT03242252|593362666|FG001|Overall Study|Lost to Follow-up|1|||
164271294|NCT03242252|593362667|FG002|Overall Study|Lost to Follow-up|4|||
164271295|NCT01659255|593362668|FG000|Overall Study|Adverse Event|0|||
164271296|NCT01659255|593362669|FG001|Overall Study|Adverse Event|0|||
164271297|NCT01659255|593362670|FG002|Overall Study|Adverse Event|0|||
164271298|NCT01659255|593362671|FG003|Overall Study|Adverse Event|0|||
164271299|NCT01659255|593362672|FG004|Overall Study|Adverse Event|0|||
164271300|NCT01659255|593362673|FG005|Overall Study|Adverse Event|1|||
164271301|NCT01659255|593362674|FG006|Overall Study|Adverse Event|1|||
164271302|NCT01659255|593362675|FG007|Overall Study|Adverse Event|0|||
164271303|NCT01659255|593362676|FG008|Overall Study|Adverse Event|0|||
164271304|NCT01659255|593362677|FG009|Overall Study|Adverse Event|1|||
164271305|NCT01659255|593362678|FG010|Overall Study|Adverse Event|0|||
164271306|NCT01659255|593362679|FG011|Overall Study|Adverse Event|1|||
164271307|NCT01659255|593362680|FG012|Overall Study|Adverse Event|0|||
164271308|NCT01659255|593362681|FG013|Overall Study|Adverse Event|2|||
164271309|NCT01659255|593362682|FG014|Overall Study|Adverse Event|0|||
164271310|NCT01659255|593362683|FG015|Overall Study|Adverse Event|1|||
164271311|NCT01659255|593362684|FG016|Overall Study|Adverse Event|0|||
164271312|NCT01659255|593362668|FG000|Overall Study|Death|0|||
164271313|NCT01659255|593362669|FG001|Overall Study|Death|1|||
164271314|NCT01659255|593362670|FG002|Overall Study|Death|0|||
164271315|NCT01659255|593362671|FG003|Overall Study|Death|0|||
164271316|NCT01659255|593362672|FG004|Overall Study|Death|0|||
164271317|NCT01659255|593362673|FG005|Overall Study|Death|0|||
164271318|NCT01659255|593362674|FG006|Overall Study|Death|0|||
164271319|NCT01659255|593362675|FG007|Overall Study|Death|1|||
164271320|NCT01659255|593362676|FG008|Overall Study|Death|1|||
164271321|NCT01659255|593362677|FG009|Overall Study|Death|0|||
164271322|NCT01659255|593362678|FG010|Overall Study|Death|0|||
164271323|NCT01659255|593362679|FG011|Overall Study|Death|0|||
164271324|NCT01659255|593362680|FG012|Overall Study|Death|1|||
164271325|NCT01659255|593362681|FG013|Overall Study|Death|1|||
164271326|NCT01659255|593362682|FG014|Overall Study|Death|2|||
164271327|NCT01659255|593362683|FG015|Overall Study|Death|1|||
164271328|NCT01659255|593362684|FG016|Overall Study|Death|0|||
164271329|NCT01659255|593362668|FG000|Overall Study|Progressive Disease|2|||
164271330|NCT01659255|593362669|FG001|Overall Study|Progressive Disease|0|||
164271331|NCT01659255|593362670|FG002|Overall Study|Progressive Disease|0|||
164271332|NCT01659255|593362671|FG003|Overall Study|Progressive Disease|0|||
164271333|NCT01659255|593362672|FG004|Overall Study|Progressive Disease|0|||
164271334|NCT01659255|593362673|FG005|Overall Study|Progressive Disease|0|||
164271335|NCT01659255|593362674|FG006|Overall Study|Progressive Disease|0|||
164271336|NCT01659255|593362675|FG007|Overall Study|Progressive Disease|1|||
164271337|NCT01659255|593362676|FG008|Overall Study|Progressive Disease|0|||
164271338|NCT01659255|593362677|FG009|Overall Study|Progressive Disease|2|||
164271339|NCT01659255|593362678|FG010|Overall Study|Progressive Disease|2|||
164271340|NCT01659255|593362679|FG011|Overall Study|Progressive Disease|3|||
164271341|NCT01659255|593362680|FG012|Overall Study|Progressive Disease|5|||
164271342|NCT01659255|593362681|FG013|Overall Study|Progressive Disease|13|||
163893629|NCT04311632|591982129|FG002|Overall Study|Withdrawal by Subject|1|||
164271343|NCT01659255|593362682|FG014|Overall Study|Progressive Disease|6|||
164271344|NCT01659255|593362683|FG015|Overall Study|Progressive Disease|2|||
163893630|NCT05856435|591982130|FG000|Overall Study|Lost to Follow-up|6|||
163893631|NCT04632225|591982131|FG000|Overall Study|Withdrawal by Subject|2|||
163893632|NCT04632225|591982132|FG001|Overall Study|Withdrawal by Subject|2|||
163893633|NCT05660434|591982137|FG000|Overall Study|Never obtained study materials|2|||
163893634|NCT05660434|591982138|FG001|Overall Study|Never obtained study materials|1|||
163893635|NCT01199133|591982142|FG000|Year 1|Adverse Event|16|||
163893636|NCT01199133|591982143|FG001|Year 1|Adverse Event|4|||
163893637|NCT01199133|591982142|FG000|Year 1|Withdrawal by Subject|8|||
163893638|NCT01199133|591982143|FG001|Year 1|Withdrawal by Subject|4|||
164271345|NCT01659255|593362684|FG016|Overall Study|Progressive Disease|3|||
164271346|NCT01659255|593362668|FG000|Overall Study|Withdrew Consent|0|||
164271347|NCT01659255|593362669|FG001|Overall Study|Withdrew Consent|0|||
164271348|NCT01659255|593362670|FG002|Overall Study|Withdrew Consent|0|||
164271349|NCT01659255|593362671|FG003|Overall Study|Withdrew Consent|0|||
164271350|NCT01659255|593362672|FG004|Overall Study|Withdrew Consent|0|||
164271351|NCT01659255|593362673|FG005|Overall Study|Withdrew Consent|0|||
164271352|NCT01659255|593362674|FG006|Overall Study|Withdrew Consent|0|||
164271353|NCT01659255|593362675|FG007|Overall Study|Withdrew Consent|0|||
163893639|NCT01199133|591982142|FG000|Year 1|Any other reason not above-mentioned|6|||
163893640|NCT01199133|591982143|FG001|Year 1|Any other reason not above-mentioned|7|||
164271354|NCT01659255|593362676|FG008|Overall Study|Withdrew Consent|0|||
164271355|NCT01659255|593362677|FG009|Overall Study|Withdrew Consent|0|||
164271356|NCT01659255|593362678|FG010|Overall Study|Withdrew Consent|1|||
164271357|NCT01659255|593362679|FG011|Overall Study|Withdrew Consent|0|||
164271358|NCT01659255|593362680|FG012|Overall Study|Withdrew Consent|0|||
164271359|NCT01659255|593362681|FG013|Overall Study|Withdrew Consent|1|||
164271360|NCT01659255|593362682|FG014|Overall Study|Withdrew Consent|0|||
164271361|NCT01659255|593362683|FG015|Overall Study|Withdrew Consent|0|||
164271362|NCT01659255|593362684|FG016|Overall Study|Withdrew Consent|0|||
164271363|NCT01659255|593362668|FG000|Overall Study|Investigator Decision|0|||
164271364|NCT01659255|593362669|FG001|Overall Study|Investigator Decision|0|||
164271365|NCT01659255|593362670|FG002|Overall Study|Investigator Decision|0|||
164271366|NCT01659255|593362671|FG003|Overall Study|Investigator Decision|0|||
164271367|NCT01659255|593362672|FG004|Overall Study|Investigator Decision|0|||
164271368|NCT01659255|593362673|FG005|Overall Study|Investigator Decision|0|||
164271369|NCT01659255|593362674|FG006|Overall Study|Investigator Decision|0|||
164271370|NCT01659255|593362675|FG007|Overall Study|Investigator Decision|0|||
164271371|NCT01659255|593362676|FG008|Overall Study|Investigator Decision|0|||
164271372|NCT01659255|593362677|FG009|Overall Study|Investigator Decision|0|||
164271373|NCT01659255|593362678|FG010|Overall Study|Investigator Decision|0|||
164271374|NCT01659255|593362679|FG011|Overall Study|Investigator Decision|0|||
164271375|NCT01659255|593362680|FG012|Overall Study|Investigator Decision|1|||
164271376|NCT01659255|593362681|FG013|Overall Study|Investigator Decision|1|||
164271377|NCT01659255|593362682|FG014|Overall Study|Investigator Decision|0|||
164271378|NCT01659255|593362683|FG015|Overall Study|Investigator Decision|0|||
164271379|NCT01659255|593362684|FG016|Overall Study|Investigator Decision|0|||
164271380|NCT01659255|593362668|FG000|Overall Study|Sponsor's Decision|0|||
164271381|NCT01659255|593362669|FG001|Overall Study|Sponsor's Decision|0|||
164271382|NCT01659255|593362670|FG002|Overall Study|Sponsor's Decision|0|||
164271383|NCT01659255|593362671|FG003|Overall Study|Sponsor's Decision|0|||
164271384|NCT01659255|593362672|FG004|Overall Study|Sponsor's Decision|0|||
164271385|NCT01659255|593362673|FG005|Overall Study|Sponsor's Decision|0|||
164271386|NCT01659255|593362674|FG006|Overall Study|Sponsor's Decision|1|||
164271387|NCT01659255|593362675|FG007|Overall Study|Sponsor's Decision|0|||
164271388|NCT01659255|593362676|FG008|Overall Study|Sponsor's Decision|0|||
164271389|NCT01659255|593362677|FG009|Overall Study|Sponsor's Decision|0|||
164271390|NCT01659255|593362678|FG010|Overall Study|Sponsor's Decision|0|||
164271391|NCT01659255|593362679|FG011|Overall Study|Sponsor's Decision|0|||
164271392|NCT01659255|593362680|FG012|Overall Study|Sponsor's Decision|0|||
164271393|NCT01659255|593362681|FG013|Overall Study|Sponsor's Decision|0|||
164271394|NCT01659255|593362682|FG014|Overall Study|Sponsor's Decision|0|||
164271395|NCT01659255|593362683|FG015|Overall Study|Sponsor's Decision|0|||
164271396|NCT01659255|593362684|FG016|Overall Study|Sponsor's Decision|0|||
164271397|NCT01659255|593362668|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271398|NCT01659255|593362669|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271399|NCT01659255|593362670|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271400|NCT01659255|593362671|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271401|NCT01659255|593362672|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163893641|NCT01199133|591982142|FG000|Year 2|Adverse Event|1|||
163893642|NCT01199133|591982143|FG001|Year 2|Adverse Event|0|||
164271402|NCT01659255|593362673|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271403|NCT01659255|593362674|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271404|NCT01659255|593362675|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271405|NCT01659255|593362676|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271406|NCT01659255|593362677|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271407|NCT01659255|593362678|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271408|NCT01659255|593362679|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163893643|NCT01199133|591982142|FG000|Year 2|Withdrawal by Subject|1|||
163893644|NCT01199133|591982143|FG001|Year 2|Withdrawal by Subject|1|||
163893645|NCT01199133|591982142|FG000|Year 2|Any other reason not above-mentioned|1|||
163893646|NCT01199133|591982143|FG001|Year 2|Any other reason not above-mentioned|2|||
164271409|NCT01659255|593362680|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271410|NCT01659255|593362681|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
163893647|NCT02575950|591982144|FG000|Overall Study|Withdrawal by Subject|0|||
164271411|NCT01659255|593362682|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271412|NCT01659255|593362683|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
164271413|NCT01659255|593362684|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
164271414|NCT01659255|593362668|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
164271415|NCT01659255|593362669|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
164271416|NCT01659255|593362670|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
163893648|NCT02575950|591982145|FG001|Overall Study|Withdrawal by Subject|0|||
164271417|NCT01659255|593362671|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
164271418|NCT01659255|593362672|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
164271419|NCT01659255|593362673|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
164271420|NCT01659255|593362674|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
164271421|NCT01659255|593362675|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
164271422|NCT01659255|593362676|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
164271423|NCT01659255|593362677|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
164271424|NCT01659255|593362678|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
164271425|NCT01659255|593362679|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
164271426|NCT01659255|593362680|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
164271427|NCT01659255|593362681|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
164271428|NCT01659255|593362682|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
164271429|NCT01659255|593362683|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
164271430|NCT01659255|593362684|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
164271431|NCT01116427|593362685|FG000|Core Phase|Adverse Event|0|||
164271432|NCT01116427|593362686|FG001|Core Phase|Adverse Event|1|||
164271433|NCT01116427|593362685|FG000|Core Phase|Lost to Follow-up|1|||
164271434|NCT01116427|593362686|FG001|Core Phase|Lost to Follow-up|0|||
164271435|NCT01116427|593362685|FG000|Core Phase|Withdrawal by Subject|3|||
164271436|NCT01116427|593362686|FG001|Core Phase|Withdrawal by Subject|0|||
164271437|NCT01116427|593362685|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
164271438|NCT01116427|593362686|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
164271439|NCT01116427|593362685|FG000|Extension Phase|Adverse Event|1|||
164271440|NCT01116427|593362686|FG001|Extension Phase|Adverse Event|1|||
164271441|NCT01116427|593362685|FG000|Extension Phase|Lost to Follow-up|2|||
164271442|NCT01116427|593362686|FG001|Extension Phase|Lost to Follow-up|0|||
164271443|NCT01116427|593362685|FG000|Extension Phase|Withdrawal by Subject|5|||
164271444|NCT01116427|593362686|FG001|Extension Phase|Withdrawal by Subject|1|||
164271445|NCT01116427|593362685|FG000|Extension Phase|Not using appropriate birth control|1|||
164271446|NCT01116427|593362686|FG001|Extension Phase|Not using appropriate birth control|0|||
164271447|NCT03316950|593362689|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
164271448|NCT03316950|593362690|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
164271449|NCT03316950|593362691|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
164271450|NCT03316950|593362692|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
164271451|NCT03316950|593362689|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
164271452|NCT03316950|593362690|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
164271453|NCT03316950|593362691|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
164271454|NCT03316950|593362692|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
164271455|NCT03316950|593362689|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
164271456|NCT03316950|593362690|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
164271457|NCT03316950|593362691|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
164271458|NCT03316950|593362692|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
164271459|NCT04094584|593362693|FG000|Overall Study|No interest in study|88|||
164271460|NCT04094584|593362693|FG000|Overall Study|Unwilling to undergo screening tests|36|||
164271461|NCT04094584|593362693|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
164271462|NCT04094584|593362693|FG000|Overall Study|Opioid use|7|||
164271463|NCT04094584|593362693|FG000|Overall Study|Need for major surgery in study period|4|||
164271464|NCT04094584|593362693|FG000|Overall Study|eligible but declined enrollment|4|||
164271465|NCT04094584|593362693|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
164271466|NCT04094584|593362693|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
164271467|NCT04094584|593362693|FG000|Overall Study|Lost to Follow-up|3|||
164271468|NCT04094584|593362693|FG000|Overall Study|Withdrawal by Subject|2|||
164271469|NCT01754194|593362694|FG000|Overall Study|Lost to Follow-up|39|||
164271470|NCT01754194|593362695|FG001|Overall Study|Lost to Follow-up|14|||
164271471|NCT01754194|593362694|FG000|Overall Study|Withdrawal by Subject|4|||
164271472|NCT01754194|593362695|FG001|Overall Study|Withdrawal by Subject|5|||
164271473|NCT01754194|593362694|FG000|Overall Study|Other|9|||
164271474|NCT01754194|593362695|FG001|Overall Study|Other|8|||
164271475|NCT00907296|593362696|FG000|Overall Study|Ineligibility Determined|1|||
163893649|NCT02575950|591982146|FG002|Overall Study|Withdrawal by Subject|0|||
163893650|NCT02575950|591982147|FG003|Overall Study|Withdrawal by Subject|2|||
163893651|NCT02575950|591982144|FG000|Overall Study|Lost to Follow-up|0|||
163893652|NCT02575950|591982145|FG001|Overall Study|Lost to Follow-up|1|||
164271476|NCT00907296|593362697|FG001|Overall Study|Ineligibility Determined|0|||
164271477|NCT00907296|593362698|FG002|Overall Study|Ineligibility Determined|0|||
164271478|NCT00907296|593362699|FG003|Overall Study|Ineligibility Determined|1|||
164271479|NCT00907296|593362700|FG004|Overall Study|Ineligibility Determined|0|||
164271480|NCT00907296|593362701|FG005|Overall Study|Ineligibility Determined|0|||
163893653|NCT02575950|591982146|FG002|Overall Study|Lost to Follow-up|0|||
163893654|NCT02575950|591982147|FG003|Overall Study|Lost to Follow-up|3|||
164271481|NCT00907296|593362702|FG006|Overall Study|Ineligibility Determined|0|||
164271482|NCT00907296|593362703|FG007|Overall Study|Ineligibility Determined|1|||
164271483|NCT00907296|593362704|FG008|Overall Study|Ineligibility Determined|0|||
164271484|NCT00907296|593362705|FG009|Overall Study|Ineligibility Determined|0|||
164271485|NCT00907296|593362696|FG000|Overall Study|Protocol Deviation|0|||
164271486|NCT00907296|593362697|FG001|Overall Study|Protocol Deviation|1|||
164271487|NCT00907296|593362698|FG002|Overall Study|Protocol Deviation|0|||
164271488|NCT00907296|593362699|FG003|Overall Study|Protocol Deviation|0|||
164271489|NCT00907296|593362700|FG004|Overall Study|Protocol Deviation|0|||
164271490|NCT00907296|593362701|FG005|Overall Study|Protocol Deviation|0|||
164271491|NCT00907296|593362702|FG006|Overall Study|Protocol Deviation|0|||
164271492|NCT00907296|593362703|FG007|Overall Study|Protocol Deviation|0|||
164271493|NCT00907296|593362704|FG008|Overall Study|Protocol Deviation|0|||
164271494|NCT00907296|593362705|FG009|Overall Study|Protocol Deviation|0|||
164271495|NCT00907296|593362696|FG000|Overall Study|Noncompliance|1|||
164271496|NCT00907296|593362697|FG001|Overall Study|Noncompliance|1|||
164271497|NCT00907296|593362698|FG002|Overall Study|Noncompliance|1|||
164271498|NCT00907296|593362699|FG003|Overall Study|Noncompliance|0|||
164271499|NCT00907296|593362700|FG004|Overall Study|Noncompliance|0|||
164271500|NCT00907296|593362701|FG005|Overall Study|Noncompliance|1|||
164271501|NCT00907296|593362702|FG006|Overall Study|Noncompliance|0|||
164271502|NCT00907296|593362703|FG007|Overall Study|Noncompliance|2|||
164271503|NCT00907296|593362704|FG008|Overall Study|Noncompliance|0|||
164271504|NCT00907296|593362705|FG009|Overall Study|Noncompliance|0|||
164271505|NCT00907296|593362696|FG000|Overall Study|Adverse Event|2|||
164271506|NCT00907296|593362697|FG001|Overall Study|Adverse Event|0|||
164271507|NCT00907296|593362698|FG002|Overall Study|Adverse Event|0|||
164271508|NCT00907296|593362699|FG003|Overall Study|Adverse Event|0|||
164271509|NCT00907296|593362700|FG004|Overall Study|Adverse Event|0|||
164342336|NCT04457336|593629433|FG007|Period 2: Part A|Protocol Violation|0|||
164342337|NCT04457336|593629426|FG000|Period 2: Part A|Lost to Follow-up|0|||
164342338|NCT04457336|593629427|FG001|Period 2: Part A|Lost to Follow-up|1|||
164342339|NCT04457336|593629428|FG002|Period 2: Part A|Lost to Follow-up|0|||
164342340|NCT04457336|593629429|FG003|Period 2: Part A|Lost to Follow-up|0|||
164342341|NCT04457336|593629430|FG004|Period 2: Part A|Lost to Follow-up|0|||
164342342|NCT04457336|593629431|FG005|Period 2: Part A|Lost to Follow-up|0|||
164342343|NCT04457336|593629432|FG006|Period 2: Part A|Lost to Follow-up|0|||
164342344|NCT04457336|593629433|FG007|Period 2: Part A|Lost to Follow-up|0|||
164342345|NCT04457336|593629426|FG000|Period 2: Part A|Other|0|||
164342346|NCT04457336|593629427|FG001|Period 2: Part A|Other|1|||
164342347|NCT04457336|593629428|FG002|Period 2: Part A|Other|0|||
164342348|NCT04457336|593629429|FG003|Period 2: Part A|Other|0|||
164342349|NCT04457336|593629430|FG004|Period 2: Part A|Other|0|||
164342350|NCT04457336|593629431|FG005|Period 2: Part A|Other|0|||
164342351|NCT04457336|593629432|FG006|Period 2: Part A|Other|0|||
164342352|NCT04457336|593629433|FG007|Period 2: Part A|Other|0|||
164342353|NCT04457336|593629426|FG000|Period 2: Part A|Physician Decision|0|||
164342354|NCT04457336|593629427|FG001|Period 2: Part A|Physician Decision|0|||
164342355|NCT04457336|593629428|FG002|Period 2: Part A|Physician Decision|0|||
164342356|NCT04457336|593629429|FG003|Period 2: Part A|Physician Decision|1|||
164342357|NCT04457336|593629430|FG004|Period 2: Part A|Physician Decision|0|||
164342358|NCT04457336|593629431|FG005|Period 2: Part A|Physician Decision|0|||
164342359|NCT04457336|593629432|FG006|Period 2: Part A|Physician Decision|0|||
164342360|NCT04457336|593629433|FG007|Period 2: Part A|Physician Decision|0|||
164342361|NCT04457336|593629426|FG000|Period 3: Part B|Study Terminated|0|||
164342362|NCT04457336|593629427|FG001|Period 3: Part B|Study Terminated|0|||
164342363|NCT04457336|593629428|FG002|Period 3: Part B|Study Terminated|0|||
164342364|NCT04457336|593629429|FG003|Period 3: Part B|Study Terminated|0|||
164271510|NCT00907296|593362701|FG005|Overall Study|Adverse Event|0|||
164271511|NCT00907296|593362702|FG006|Overall Study|Adverse Event|1|||
164271512|NCT00907296|593362703|FG007|Overall Study|Adverse Event|0|||
164342365|NCT04457336|593629430|FG004|Period 3: Part B|Study Terminated|1|||
164342366|NCT04457336|593629431|FG005|Period 3: Part B|Study Terminated|10|||
163893655|NCT03993392|591982149|FG000|Overall Study|Withdrawal by Subject|3|||
164342367|NCT04457336|593629432|FG006|Period 3: Part B|Study Terminated|13|||
164342368|NCT04457336|593629433|FG007|Period 3: Part B|Study Terminated|0|||
163893656|NCT03993392|591982149|FG000|Overall Study|Lost to Follow-up|2|||
163893657|NCT03993392|591982149|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
163893658|NCT05292391|591982152|FG000|Overall Study|Lost to Follow-up|0|||
163893659|NCT05292391|591982153|FG001|Overall Study|Lost to Follow-up|0|||
163893660|NCT05292391|591982154|FG002|Overall Study|Lost to Follow-up|0|||
164271513|NCT00907296|593362704|FG008|Overall Study|Adverse Event|0|||
164271514|NCT00907296|593362705|FG009|Overall Study|Adverse Event|1|||
164271515|NCT00907296|593362696|FG000|Overall Study|Withdrawal by Subject|7|||
164271516|NCT00907296|593362697|FG001|Overall Study|Withdrawal by Subject|2|||
164271517|NCT00907296|593362698|FG002|Overall Study|Withdrawal by Subject|1|||
164342369|NCT04457336|593629426|FG000|Period 3: Part B|Withdrawal by Subject|0|||
164342370|NCT04457336|593629427|FG001|Period 3: Part B|Withdrawal by Subject|0|||
164342371|NCT04457336|593629428|FG002|Period 3: Part B|Withdrawal by Subject|0|||
164271518|NCT00907296|593362699|FG003|Overall Study|Withdrawal by Subject|1|||
164271519|NCT00907296|593362700|FG004|Overall Study|Withdrawal by Subject|1|||
164271520|NCT00907296|593362701|FG005|Overall Study|Withdrawal by Subject|5|||
164271521|NCT00907296|593362702|FG006|Overall Study|Withdrawal by Subject|3|||
164271522|NCT00907296|593362703|FG007|Overall Study|Withdrawal by Subject|2|||
164271523|NCT00907296|593362704|FG008|Overall Study|Withdrawal by Subject|4|||
164271524|NCT00907296|593362705|FG009|Overall Study|Withdrawal by Subject|2|||
164271525|NCT00907296|593362696|FG000|Overall Study|Lost to Follow-up|9|||
164271526|NCT00907296|593362697|FG001|Overall Study|Lost to Follow-up|1|||
164271527|NCT00907296|593362698|FG002|Overall Study|Lost to Follow-up|0|||
164085932|NCT01261325|592678592|FG002|Overall Study|Patient Randomized by Mistake|0|||
164271528|NCT00907296|593362699|FG003|Overall Study|Lost to Follow-up|2|||
164271529|NCT00907296|593362700|FG004|Overall Study|Lost to Follow-up|0|||
164271530|NCT00907296|593362701|FG005|Overall Study|Lost to Follow-up|3|||
164271531|NCT00907296|593362702|FG006|Overall Study|Lost to Follow-up|2|||
164271532|NCT00907296|593362703|FG007|Overall Study|Lost to Follow-up|2|||
164271533|NCT00907296|593362704|FG008|Overall Study|Lost to Follow-up|0|||
164271534|NCT00907296|593362705|FG009|Overall Study|Lost to Follow-up|4|||
164271535|NCT00791557|593362706|FG000|Overall Study|Adverse Event|1|||
163893661|NCT05292391|591982155|FG003|Overall Study|Lost to Follow-up|1|||
163893662|NCT05292391|591982156|FG004|Overall Study|Lost to Follow-up|0|||
163893663|NCT04857723|591982159|FG000|Overall Study|Withdrawal by Subject|2|||
163893664|NCT01064440|591983726|FG000|Overall Study|Lost to Follow-up|1|||
163893665|NCT01064440|591983727|FG001|Overall Study|Lost to Follow-up|1|||
163893666|NCT01064440|591983728|FG002|Overall Study|Lost to Follow-up|1|||
163893667|NCT01064440|591983726|FG000|Overall Study|Non-compliance|0|||
163893668|NCT01064440|591983727|FG001|Overall Study|Non-compliance|1|||
163893669|NCT01064440|591983728|FG002|Overall Study|Non-compliance|0|||
163893670|NCT01064440|591983726|FG000|Overall Study|Death|1|||
163893671|NCT01064440|591983727|FG001|Overall Study|Death|0|||
163893672|NCT01064440|591983728|FG002|Overall Study|Death|1|||
163893673|NCT01064440|591983726|FG000|Overall Study|Withdrawal by Subject|0|||
163893674|NCT01064440|591983727|FG001|Overall Study|Withdrawal by Subject|1|||
163893675|NCT01064440|591983728|FG002|Overall Study|Withdrawal by Subject|1|||
163893676|NCT01064440|591983726|FG000|Overall Study|Other: amputation|1|||
164085933|NCT01261325|592678590|FG000|Overall Study|Erroneously Randomized|1|||
164271536|NCT01079936|593362707|FG000|Phase I: MTD|First Remission Status|2|||
163893677|NCT01064440|591983727|FG001|Overall Study|Other: amputation|0|||
163893678|NCT01064440|591983728|FG002|Overall Study|Other: amputation|0|||
163893679|NCT03505710|591983729|FG000|Overall Study|Progressive Disease|24|||
164271537|NCT01079936|593362708|FG001|Phase I: MTD|First Remission Status|0|||
164271538|NCT01079936|593362709|FG002|Phase I: MTD|First Remission Status|0|||
164271539|NCT01079936|593362710|FG003|Phase I: MTD|First Remission Status|0|||
164271540|NCT01079936|593362711|FG004|Phase I: MTD|First Remission Status|0|||
164271541|NCT01079936|593362707|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
164271542|NCT01079936|593362708|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
164271543|NCT01079936|593362709|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
164271544|NCT01079936|593362710|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
164271545|NCT01079936|593362711|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
164271546|NCT01079936|593362707|FG000|Phase II|Adverse Event|0|||
164271547|NCT01079936|593362708|FG001|Phase II|Adverse Event|0|||
164271548|NCT01079936|593362709|FG002|Phase II|Adverse Event|1|||
164271549|NCT01079936|593362710|FG003|Phase II|Adverse Event|0|||
164271550|NCT01079936|593362711|FG004|Phase II|Adverse Event|0|||
164271551|NCT01079936|593362707|FG000|Phase II|Insurance Issue|0|||
164271552|NCT01079936|593362708|FG001|Phase II|Insurance Issue|0|||
164271553|NCT01079936|593362709|FG002|Phase II|Insurance Issue|0|||
164271554|NCT01079936|593362710|FG003|Phase II|Insurance Issue|0|||
164271555|NCT01079936|593362711|FG004|Phase II|Insurance Issue|1|||
164271556|NCT02322190|593362712|FG000|Overall Study|Death on study|1|||
164271557|NCT02322190|593362713|FG001|Overall Study|Death on study|0|||
164271558|NCT03344640|593362714|FG000|Overall Study|Adverse Event|1|||
164271559|NCT03344640|593362715|FG001|Overall Study|Adverse Event|0|||
164271560|NCT03344640|593362714|FG000|Overall Study|Physician Decision|1|||
164271561|NCT03344640|593362715|FG001|Overall Study|Physician Decision|1|||
164271562|NCT03344640|593362714|FG000|Overall Study|Withdrawal by Subject|1|||
164271563|NCT03344640|593362715|FG001|Overall Study|Withdrawal by Subject|2|||
164271564|NCT03344640|593362714|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
164271565|NCT03344640|593362715|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
164271566|NCT02809053|593362721|FG000|Overall Study|Death|0|||
164271567|NCT02809053|593362722|FG001|Overall Study|Death|1|||
164271568|NCT02809053|593362721|FG000|Overall Study|Lost to Follow-up|3|||
164271569|NCT02809053|593362722|FG001|Overall Study|Lost to Follow-up|1|||
164271570|NCT02809053|593362721|FG000|Overall Study|Withdrawal by Subject|2|||
164271571|NCT02809053|593362722|FG001|Overall Study|Withdrawal by Subject|3|||
164271572|NCT02809053|593362721|FG000|Overall Study|Disease Progression|2|||
164271573|NCT02809053|593362722|FG001|Overall Study|Disease Progression|1|||
164271574|NCT01147900|593362723|FG000|At Year 10|Lost to Follow-up|0|||
164271575|NCT01147900|593362724|FG001|At Year 10|Lost to Follow-up|1|||
164342372|NCT04457336|593629429|FG003|Period 3: Part B|Withdrawal by Subject|0|||
164342373|NCT04457336|593629430|FG004|Period 3: Part B|Withdrawal by Subject|0|||
164342374|NCT04457336|593629431|FG005|Period 3: Part B|Withdrawal by Subject|1|||
164342375|NCT04457336|593629432|FG006|Period 3: Part B|Withdrawal by Subject|2|||
164342376|NCT04457336|593629433|FG007|Period 3: Part B|Withdrawal by Subject|0|||
164271576|NCT01147900|593362725|FG002|At Year 10|Lost to Follow-up|0|||
164271577|NCT00025155|593362726|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
164342377|NCT04457336|593629426|FG000|Period 4: Part C|Study Terminated|0|||
164342378|NCT04457336|593629427|FG001|Period 4: Part C|Study Terminated|0|||
164342379|NCT04457336|593629428|FG002|Period 4: Part C|Study Terminated|0|||
164342380|NCT04457336|593629429|FG003|Period 4: Part C|Study Terminated|0|||
164342381|NCT04457336|593629430|FG004|Period 4: Part C|Study Terminated|0|||
164342382|NCT04457336|593629431|FG005|Period 4: Part C|Study Terminated|0|||
164342383|NCT04457336|593629432|FG006|Period 4: Part C|Study Terminated|0|||
164342384|NCT04457336|593629433|FG007|Period 4: Part C|Study Terminated|30|||
164342385|NCT04457336|593629426|FG000|Period 4: Part C|Adverse Event|0|||
164342386|NCT04457336|593629427|FG001|Period 4: Part C|Adverse Event|0|||
164342387|NCT04457336|593629428|FG002|Period 4: Part C|Adverse Event|0|||
164085934|NCT01261325|592678591|FG001|Overall Study|Erroneously Randomized|0|||
164271578|NCT00025155|593362726|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
164271579|NCT05086510|593362727|FG000|Overall Study|Lost to Follow-up|0|||
164271580|NCT05086510|593362728|FG001|Overall Study|Lost to Follow-up|2|||
164271581|NCT05086510|593362727|FG000|Overall Study|Death|0|||
164271582|NCT05086510|593362728|FG001|Overall Study|Death|2|||
164271583|NCT03022981|593362729|FG000|Overall Study|Adverse Event|0|||
164271584|NCT03022981|593362730|FG001|Overall Study|Adverse Event|1|||
164271585|NCT03022981|593362731|FG002|Overall Study|Adverse Event|0|||
164271586|NCT03022981|593362729|FG000|Overall Study|Investigator's Discretion|0|||
164271587|NCT03022981|593362730|FG001|Overall Study|Investigator's Discretion|1|||
164342388|NCT04457336|593629429|FG003|Period 4: Part C|Adverse Event|0|||
164342389|NCT04457336|593629430|FG004|Period 4: Part C|Adverse Event|0|||
164342390|NCT04457336|593629431|FG005|Period 4: Part C|Adverse Event|0|||
164342391|NCT04457336|593629432|FG006|Period 4: Part C|Adverse Event|0|||
164342392|NCT04457336|593629433|FG007|Period 4: Part C|Adverse Event|2|||
164342393|NCT04457336|593629426|FG000|Period 4: Part C|Site Terminated|0|||
164271588|NCT03022981|593362731|FG002|Overall Study|Investigator's Discretion|2|||
164271589|NCT03022981|593362729|FG000|Overall Study|Lost to Follow-up|6|||
164271590|NCT03022981|593362730|FG001|Overall Study|Lost to Follow-up|2|||
164342394|NCT04457336|593629427|FG001|Period 4: Part C|Site Terminated|0|||
164342395|NCT04457336|593629428|FG002|Period 4: Part C|Site Terminated|0|||
164342396|NCT04457336|593629429|FG003|Period 4: Part C|Site Terminated|0|||
164271591|NCT03022981|593362731|FG002|Overall Study|Lost to Follow-up|1|||
164271592|NCT03022981|593362729|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164271593|NCT03022981|593362730|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164271594|NCT03022981|593362731|FG002|Overall Study|Non-Compliance With Study Drug|2|||
164271595|NCT03022981|593362729|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
164271596|NCT03022981|593362730|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
164271597|NCT03022981|593362731|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
164271598|NCT00884832|593362733|FG000|Overall Study|Withdrawal by Subject|0|||
163893680|NCT03505710|591983730|FG001|Overall Study|Progressive Disease|17|||
163893681|NCT03505710|591983731|FG002|Overall Study|Progressive Disease|43|||
163893682|NCT03505710|591983729|FG000|Overall Study|Clinical Progression|6|||
163893683|NCT03505710|591983730|FG001|Overall Study|Clinical Progression|8|||
163893684|NCT03505710|591983731|FG002|Overall Study|Clinical Progression|3|||
163893685|NCT03505710|591983729|FG000|Overall Study|Adverse Event|12|||
163893686|NCT03505710|591983730|FG001|Overall Study|Adverse Event|6|||
163893687|NCT03505710|591983731|FG002|Overall Study|Adverse Event|28|||
163893688|NCT03505710|591983729|FG000|Overall Study|Withdrawal by Subject|1|||
163893689|NCT03505710|591983730|FG001|Overall Study|Withdrawal by Subject|3|||
163893690|NCT03505710|591983731|FG002|Overall Study|Withdrawal by Subject|7|||
163893691|NCT03505710|591983729|FG000|Overall Study|Physician Decision|1|||
163893692|NCT03505710|591983730|FG001|Overall Study|Physician Decision|1|||
163893693|NCT03505710|591983731|FG002|Overall Study|Physician Decision|2|||
163893694|NCT03505710|591983729|FG000|Overall Study|Death|4|||
163893695|NCT03505710|591983730|FG001|Overall Study|Death|5|||
163893696|NCT03505710|591983731|FG002|Overall Study|Death|6|||
163893697|NCT03505710|591983729|FG000|Overall Study|Other Reasons|1|||
163893698|NCT03505710|591983730|FG001|Overall Study|Other Reasons|1|||
163893699|NCT03505710|591983731|FG002|Overall Study|Other Reasons|1|||
163893700|NCT03505710|591983729|FG000|Overall Study|Study Terminated by Sponsor|0|||
163893701|NCT03505710|591983730|FG001|Overall Study|Study Terminated by Sponsor|0|||
163893702|NCT03505710|591983731|FG002|Overall Study|Study Terminated by Sponsor|1|||
163893703|NCT04414722|591983732|FG000|Overall Study|Lost to Follow-up|3|||
163893704|NCT04414722|591983733|FG001|Overall Study|Lost to Follow-up|4|||
163893705|NCT04414722|591983734|FG002|Overall Study|Lost to Follow-up|3|||
163893706|NCT04414722|591983735|FG003|Overall Study|Lost to Follow-up|2|||
163893707|NCT04414722|591983736|FG004|Overall Study|Lost to Follow-up|3|||
163893708|NCT04414722|591983732|FG000|Overall Study|Withdrawal by Subject|6|||
163893709|NCT04414722|591983733|FG001|Overall Study|Withdrawal by Subject|3|||
163893710|NCT04414722|591983734|FG002|Overall Study|Withdrawal by Subject|1|||
163893711|NCT04414722|591983735|FG003|Overall Study|Withdrawal by Subject|5|||
163893712|NCT04414722|591983736|FG004|Overall Study|Withdrawal by Subject|1|||
163893713|NCT04414722|591983732|FG000|Overall Study|Physician Decision|0|||
163893714|NCT04414722|591983733|FG001|Overall Study|Physician Decision|1|||
163893715|NCT04414722|591983734|FG002|Overall Study|Physician Decision|2|||
163893716|NCT04414722|591983735|FG003|Overall Study|Physician Decision|0|||
163893717|NCT04414722|591983736|FG004|Overall Study|Physician Decision|0|||
163893718|NCT04414722|591983732|FG000|Overall Study|Non-participatory|0|||
163893719|NCT04414722|591983733|FG001|Overall Study|Non-participatory|1|||
163893720|NCT04414722|591983734|FG002|Overall Study|Non-participatory|1|||
163893721|NCT04414722|591983735|FG003|Overall Study|Non-participatory|0|||
163893722|NCT04414722|591983736|FG004|Overall Study|Non-participatory|0|||
163893723|NCT04766892|591983737|FG000|Overall Study|Withdrawal by Subject|1|||
163893724|NCT04766892|591983737|FG000|Overall Study|Lost to Follow-up|1|||
163893725|NCT04766892|591983737|FG000|Overall Study|Adverse Event|3|||
164271599|NCT00884832|593362734|FG001|Overall Study|Withdrawal by Subject|1|||
164271600|NCT02337725|593362735|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
164271601|NCT02337725|593362736|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
164271602|NCT02337725|593362735|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
164271603|NCT02337725|593362736|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
164271604|NCT02337725|593362735|FG000|Overall Study|Major Protocol Deviation|0|||
164271605|NCT02337725|593362736|FG001|Overall Study|Major Protocol Deviation|1|||
164271606|NCT02337725|593362735|FG000|Overall Study|Voluntary Withdrawal|14|||
164271607|NCT02337725|593362736|FG001|Overall Study|Voluntary Withdrawal|3|||
164271608|NCT02337725|593362735|FG000|Overall Study|Lack of Efficacy|4|||
164271609|NCT02337725|593362736|FG001|Overall Study|Lack of Efficacy|0|||
164271610|NCT01264770|593362738|FG000|Overall Study|Not reported|0|||
164271611|NCT01264770|593362739|FG001|Overall Study|Not reported|0|||
164271612|NCT01264770|593362740|FG002|Overall Study|Not reported|1|||
164271613|NCT01264770|593362741|FG003|Overall Study|Not reported|0|||
164271614|NCT01264770|593362742|FG004|Overall Study|Not reported|0|||
164271615|NCT01264770|593362743|FG005|Overall Study|Not reported|0|||
164271616|NCT01264770|593362738|FG000|Overall Study|e.g., change in circumstances|8|||
164271617|NCT01264770|593362739|FG001|Overall Study|e.g., change in circumstances|3|||
164271618|NCT01264770|593362740|FG002|Overall Study|e.g., change in circumstances|3|||
164271619|NCT01264770|593362741|FG003|Overall Study|e.g., change in circumstances|3|||
164271620|NCT01264770|593362742|FG004|Overall Study|e.g., change in circumstances|4|||
164271621|NCT01264770|593362743|FG005|Overall Study|e.g., change in circumstances|4|||
164271622|NCT01264770|593362738|FG000|Overall Study|Severe non-compliance to protocol|0|||
164271623|NCT01264770|593362739|FG001|Overall Study|Severe non-compliance to protocol|0|||
164271624|NCT01264770|593362740|FG002|Overall Study|Severe non-compliance to protocol|1|||
164271625|NCT01264770|593362741|FG003|Overall Study|Severe non-compliance to protocol|1|||
164271626|NCT01264770|593362742|FG004|Overall Study|Severe non-compliance to protocol|0|||
164271627|NCT01264770|593362743|FG005|Overall Study|Severe non-compliance to protocol|0|||
164271628|NCT01264770|593362738|FG000|Overall Study|Lack of therapeutic response|1|||
164271629|NCT01264770|593362739|FG001|Overall Study|Lack of therapeutic response|0|||
164271630|NCT01264770|593362740|FG002|Overall Study|Lack of therapeutic response|2|||
164271631|NCT01264770|593362741|FG003|Overall Study|Lack of therapeutic response|1|||
164271632|NCT01264770|593362742|FG004|Overall Study|Lack of therapeutic response|1|||
164271633|NCT01264770|593362743|FG005|Overall Study|Lack of therapeutic response|0|||
164271634|NCT01264770|593362738|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
164271635|NCT01264770|593362739|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
164271636|NCT01264770|593362740|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
164271637|NCT01264770|593362741|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
164271638|NCT01264770|593362742|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
164271639|NCT01264770|593362743|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
164271640|NCT01264770|593362738|FG000|Overall Study|Lost to Follow-up|0|||
164271641|NCT01264770|593362739|FG001|Overall Study|Lost to Follow-up|0|||
164271642|NCT01264770|593362740|FG002|Overall Study|Lost to Follow-up|1|||
164271643|NCT01264770|593362741|FG003|Overall Study|Lost to Follow-up|1|||
164271644|NCT01264770|593362742|FG004|Overall Study|Lost to Follow-up|0|||
164271645|NCT01264770|593362743|FG005|Overall Study|Lost to Follow-up|0|||
164271646|NCT01264770|593362738|FG000|Overall Study|Adverse Event|7|||
164271647|NCT01264770|593362739|FG001|Overall Study|Adverse Event|7|||
164271648|NCT01264770|593362740|FG002|Overall Study|Adverse Event|8|||
164271649|NCT01264770|593362741|FG003|Overall Study|Adverse Event|0|||
164271650|NCT01264770|593362742|FG004|Overall Study|Adverse Event|2|||
164271651|NCT01264770|593362743|FG005|Overall Study|Adverse Event|1|||
164271652|NCT00129961|593362744|FG000|Overall Study|Adverse Event|1|||
164271653|NCT00129961|593362745|FG001|Overall Study|Adverse Event|0|||
164271654|NCT00129961|593362744|FG000|Overall Study|Death|1|||
164271655|NCT00129961|593362745|FG001|Overall Study|Death|1|||
164271656|NCT00129961|593362744|FG000|Overall Study|Withdrawal by Sponsor|14|||
164271657|NCT00129961|593362745|FG001|Overall Study|Withdrawal by Sponsor|20|||
164271658|NCT00129961|593362744|FG000|Overall Study|Physician Decision|1|||
164271659|NCT00129961|593362745|FG001|Overall Study|Physician Decision|0|||
164271660|NCT00129961|593362744|FG000|Overall Study|Withdrawal by Subject|2|||
164271661|NCT00129961|593362745|FG001|Overall Study|Withdrawal by Subject|1|||
164271662|NCT00129961|593362744|FG000|Overall Study|Missing Record|0|||
164271663|NCT00129961|593362745|FG001|Overall Study|Missing Record|1|||
164271664|NCT00084487|593362746|FG000|Overall Study|Death|1|||
164271665|NCT04881747|593362749|FG000|Period 2 Washout|Adverse Event|1|||
164271666|NCT04881747|593362750|FG001|Period 2 Washout|Adverse Event|0|||
164271667|NCT04881747|593362751|FG002|Period 2 Washout|Adverse Event|0|||
164271668|NCT04881747|593362752|FG003|Period 2 Washout|Adverse Event|0|||
164271669|NCT04881747|593362753|FG004|Period 2 Washout|Adverse Event|1|||
164271670|NCT04881747|593362754|FG005|Period 2 Washout|Adverse Event|0|||
164271671|NCT04881747|593362749|FG000|Period 2 Washout|Withdrawal by Subject|1|||
164271672|NCT04881747|593362750|FG001|Period 2 Washout|Withdrawal by Subject|0|||
164271673|NCT04881747|593362751|FG002|Period 2 Washout|Withdrawal by Subject|0|||
164271674|NCT04881747|593362752|FG003|Period 2 Washout|Withdrawal by Subject|1|||
164271675|NCT04881747|593362753|FG004|Period 2 Washout|Withdrawal by Subject|0|||
164271676|NCT04881747|593362754|FG005|Period 2 Washout|Withdrawal by Subject|0|||
164271677|NCT02598128|593362760|FG000|Period A: Days -7 to -1|Adverse Event|1|||
164271678|NCT02598128|593362761|FG001|Period A: Days -7 to -1|Adverse Event|0|||
164271679|NCT02598128|593362762|FG002|Period A: Days -7 to -1|Adverse Event|0|||
164271680|NCT02598128|593362763|FG003|Period A: Days -7 to -1|Adverse Event|0|||
164271681|NCT01378429|593362764|FG000|Overall Study|Noncompliance with study drug|1|||
164271682|NCT01378429|593362765|FG001|Overall Study|Noncompliance with study drug|0|||
164271683|NCT01064687|593362766|FG000|Overall Study|Adverse Event|9|||
164271684|NCT01064687|593362767|FG001|Overall Study|Adverse Event|4|||
164271685|NCT01064687|593362768|FG002|Overall Study|Adverse Event|10|||
164271686|NCT01064687|593362769|FG003|Overall Study|Adverse Event|3|||
164271687|NCT01064687|593362766|FG000|Overall Study|Death|1|||
164271688|NCT01064687|593362767|FG001|Overall Study|Death|1|||
164271689|NCT01064687|593362768|FG002|Overall Study|Death|0|||
164271690|NCT01064687|593362769|FG003|Overall Study|Death|0|||
164271691|NCT01064687|593362766|FG000|Overall Study|Entry Criteria Not Met|3|||
164271692|NCT01064687|593362767|FG001|Overall Study|Entry Criteria Not Met|0|||
164271693|NCT01064687|593362768|FG002|Overall Study|Entry Criteria Not Met|0|||
164271694|NCT01064687|593362769|FG003|Overall Study|Entry Criteria Not Met|0|||
163893726|NCT04766892|591983737|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
163893727|NCT04359654|591983738|FG000|Overall Study|Withdrawal by Subject|1|||
163893728|NCT04359654|591983739|FG001|Overall Study|Withdrawal by Subject|0|||
163893729|NCT04359654|591983738|FG000|Overall Study|Adverse Event|0|||
163893730|NCT04359654|591983739|FG001|Overall Study|Adverse Event|1|||
163893731|NCT03711474|591983742|FG000|Overall Study|Physician Decision|2|||
163893732|NCT03711474|591983743|FG001|Overall Study|Physician Decision|0|||
163893733|NCT05237284|591983749|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
163893734|NCT05237284|591983750|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
163893735|NCT05237284|591983751|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
163893736|NCT05237284|591983752|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
163893737|NCT05237284|591983749|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
163893738|NCT05237284|591983750|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
163893739|NCT05237284|591983751|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
163893740|NCT05237284|591983752|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
163893741|NCT05237284|591983749|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
163893742|NCT05237284|591983750|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
163893743|NCT05237284|591983751|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
163893744|NCT05237284|591983752|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
163893745|NCT05237284|591983749|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
163893746|NCT05237284|591983750|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
163893747|NCT05237284|591983751|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
163893748|NCT05237284|591983752|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
163893749|NCT05237284|591983749|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
163893750|NCT05237284|591983750|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
163893751|NCT05237284|591983751|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
163893752|NCT05237284|591983752|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
163893753|NCT05237284|591983749|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
163893754|NCT05237284|591983750|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
163893755|NCT05237284|591983751|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
163893756|NCT05237284|591983752|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
163893757|NCT05237284|591983749|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
163893758|NCT05237284|591983750|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
163893759|NCT05237284|591983751|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
163893760|NCT05237284|591983752|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
163893761|NCT05237284|591983749|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
163893762|NCT05237284|591983750|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
163893763|NCT05237284|591983751|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
163893764|NCT05237284|591983752|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
163893765|NCT05237284|591983749|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
163893766|NCT05237284|591983750|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
163893767|NCT05237284|591983751|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
163893768|NCT05237284|591983752|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
163893769|NCT03583333|591983753|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
163893770|NCT03583333|591983754|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
163893771|NCT03583333|591983753|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
164271695|NCT01064687|593362766|FG000|Overall Study|Lack of Efficacy|1|||
164271696|NCT01064687|593362767|FG001|Overall Study|Lack of Efficacy|0|||
163893772|NCT03583333|591983754|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
163893773|NCT03583333|591983753|FG000|Overall Study|Withdrawal by Subject|9|||
163893774|NCT03583333|591983754|FG001|Overall Study|Withdrawal by Subject|5|||
164271697|NCT01064687|593362768|FG002|Overall Study|Lack of Efficacy|2|||
164271698|NCT01064687|593362769|FG003|Overall Study|Lack of Efficacy|3|||
164271699|NCT01064687|593362766|FG000|Overall Study|Lost to Follow-up|7|||
164271700|NCT01064687|593362767|FG001|Overall Study|Lost to Follow-up|10|||
164271701|NCT01064687|593362768|FG002|Overall Study|Lost to Follow-up|13|||
164271702|NCT01064687|593362769|FG003|Overall Study|Lost to Follow-up|5|||
164271703|NCT01064687|593362766|FG000|Overall Study|Physician Decision|2|||
164271704|NCT01064687|593362767|FG001|Overall Study|Physician Decision|2|||
164271705|NCT01064687|593362768|FG002|Overall Study|Physician Decision|0|||
164271706|NCT01064687|593362769|FG003|Overall Study|Physician Decision|0|||
164271707|NCT01064687|593362766|FG000|Overall Study|Protocol Violation|1|||
164271708|NCT01064687|593362767|FG001|Overall Study|Protocol Violation|1|||
164271709|NCT01064687|593362768|FG002|Overall Study|Protocol Violation|0|||
164271710|NCT01064687|593362769|FG003|Overall Study|Protocol Violation|1|||
164271711|NCT01064687|593362766|FG000|Overall Study|Sponsor Decision|0|||
164271712|NCT01064687|593362767|FG001|Overall Study|Sponsor Decision|0|||
164271713|NCT01064687|593362768|FG002|Overall Study|Sponsor Decision|3|||
164271714|NCT01064687|593362769|FG003|Overall Study|Sponsor Decision|0|||
164271715|NCT01064687|593362766|FG000|Overall Study|Withdrawal by Subject|9|||
164271716|NCT01064687|593362767|FG001|Overall Study|Withdrawal by Subject|7|||
164271717|NCT01064687|593362768|FG002|Overall Study|Withdrawal by Subject|12|||
164271718|NCT01064687|593362769|FG003|Overall Study|Withdrawal by Subject|5|||
164271719|NCT01064687|593362766|FG000|Overall Study|Treatment Noncompliance|1|||
164271720|NCT01064687|593362767|FG001|Overall Study|Treatment Noncompliance|1|||
164271721|NCT01064687|593362768|FG002|Overall Study|Treatment Noncompliance|1|||
164271722|NCT01064687|593362769|FG003|Overall Study|Treatment Noncompliance|0|||
164271723|NCT00619489|593362770|FG000|Overall Study|Adverse Event|0|||
164271724|NCT00619489|593362771|FG001|Overall Study|Adverse Event|7|||
164271725|NCT00619489|593362770|FG000|Overall Study|Withdrawal by Subject|1|||
164271726|NCT00619489|593362771|FG001|Overall Study|Withdrawal by Subject|1|||
164271727|NCT00619489|593362770|FG000|Overall Study|Lack of Efficacy|0|||
164271728|NCT00619489|593362771|FG001|Overall Study|Lack of Efficacy|11|||
164271729|NCT00619489|593362770|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
164271730|NCT00619489|593362771|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
164271731|NCT03134183|593362772|FG000|Overall Study|Withdrawal by Subject|1|||
164271732|NCT03134183|593362773|FG001|Overall Study|Withdrawal by Subject|1|||
164271733|NCT02265796|593362776|FG000|Overall Study|Death|1|||
164271734|NCT02265796|593362777|FG001|Overall Study|Death|0|||
164271735|NCT02265796|593362776|FG000|Overall Study|started on excluded medication|1|||
164271736|NCT02265796|593362777|FG001|Overall Study|started on excluded medication|0|||
164271737|NCT02265796|593362776|FG000|Overall Study|Withdrawal by Subject|1|||
164271738|NCT02265796|593362777|FG001|Overall Study|Withdrawal by Subject|1|||
164271739|NCT02477553|593362778|FG000|Overall Study|Screening up-to-date|12|||
164271740|NCT02477553|593362779|FG001|Overall Study|Screening up-to-date|13|||
164271741|NCT02477553|593362778|FG000|Overall Study|No MD visit|1|||
164271742|NCT02477553|593362779|FG001|Overall Study|No MD visit|1|||
164271743|NCT02477553|593362778|FG000|Overall Study|Workup consistent w/CRC|1|||
164271744|NCT02477553|593362779|FG001|Overall Study|Workup consistent w/CRC|1|||
164271745|NCT02477553|593362778|FG000|Overall Study|Technical issues with intervention|2|||
164271746|NCT02477553|593362779|FG001|Overall Study|Technical issues with intervention|0|||
164271747|NCT02477553|593362778|FG000|Overall Study|Elevated risk for CRC|2|||
164271748|NCT02477553|593362779|FG001|Overall Study|Elevated risk for CRC|2|||
164271749|NCT02477553|593362778|FG000|Overall Study|MD advised against screening|1|||
164271750|NCT02477553|593362779|FG001|Overall Study|MD advised against screening|3|||
164271751|NCT02477553|593362778|FG000|Overall Study|patient deceased|1|||
164271752|NCT02477553|593362779|FG001|Overall Study|patient deceased|0|||
164271753|NCT04311463|593362780|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
164271754|NCT04311463|593362781|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
164271755|NCT04311463|593362780|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
164271756|NCT04311463|593362781|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
164271757|NCT04311463|593362780|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
164271758|NCT04311463|593362781|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
164271759|NCT04023682|593362782|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
164271760|NCT00454649|593362783|FG000|Overall Study|Lack of Efficacy|2|||
164271761|NCT00454649|593362784|FG001|Overall Study|Lack of Efficacy|2|||
163893775|NCT03583333|591983753|FG000|Overall Study|Physician Decision|3|||
163893776|NCT03583333|591983754|FG001|Overall Study|Physician Decision|2|||
163893777|NCT03583333|591983753|FG000|Overall Study|Death|12|||
163893778|NCT03583333|591983754|FG001|Overall Study|Death|7|||
163893779|NCT03926130|591983755|FG000|Overall Study|Adverse Event|9|||
163893780|NCT03926130|591983756|FG001|Overall Study|Adverse Event|11|||
163893781|NCT03926130|591983757|FG002|Overall Study|Adverse Event|2|||
163893782|NCT03926130|591983758|FG003|Overall Study|Adverse Event|0|||
163893783|NCT03926130|591983755|FG000|Overall Study|Death|2|||
163893784|NCT03926130|591983756|FG001|Overall Study|Death|0|||
163893785|NCT03926130|591983757|FG002|Overall Study|Death|1|||
163893786|NCT03926130|591983758|FG003|Overall Study|Death|0|||
163893787|NCT03926130|591983755|FG000|Overall Study|Lack of Efficacy|14|||
163893788|NCT03926130|591983756|FG001|Overall Study|Lack of Efficacy|11|||
163893789|NCT03926130|591983757|FG002|Overall Study|Lack of Efficacy|7|||
163893790|NCT03926130|591983758|FG003|Overall Study|Lack of Efficacy|1|||
163893791|NCT03926130|591983755|FG000|Overall Study|Lost to Follow-up|0|||
163893792|NCT03926130|591983756|FG001|Overall Study|Lost to Follow-up|7|||
163893793|NCT03926130|591983757|FG002|Overall Study|Lost to Follow-up|1|||
163893794|NCT03926130|591983758|FG003|Overall Study|Lost to Follow-up|0|||
163893795|NCT03926130|591983755|FG000|Overall Study|As Reported by Investigator|2|||
163893796|NCT03926130|591983756|FG001|Overall Study|As Reported by Investigator|6|||
163893797|NCT03926130|591983757|FG002|Overall Study|As Reported by Investigator|6|||
163893798|NCT03926130|591983758|FG003|Overall Study|As Reported by Investigator|0|||
163893799|NCT03926130|591983755|FG000|Overall Study|Physician Decision|3|||
163893800|NCT03926130|591983756|FG001|Overall Study|Physician Decision|2|||
163893801|NCT03926130|591983757|FG002|Overall Study|Physician Decision|1|||
163893802|NCT03926130|591983758|FG003|Overall Study|Physician Decision|0|||
163893803|NCT03926130|591983755|FG000|Overall Study|Pregnancy|2|||
163893804|NCT03926130|591983756|FG001|Overall Study|Pregnancy|2|||
163893805|NCT03926130|591983757|FG002|Overall Study|Pregnancy|1|||
163893806|NCT03926130|591983758|FG003|Overall Study|Pregnancy|0|||
164271762|NCT00454649|593362785|FG002|Overall Study|Lack of Efficacy|10|||
164271763|NCT00454649|593362786|FG003|Overall Study|Lack of Efficacy|3|||
164271764|NCT00454649|593362787|FG004|Overall Study|Lack of Efficacy|0|||
164271765|NCT00454649|593362788|FG005|Overall Study|Lack of Efficacy|4|||
164271766|NCT00454649|593362789|FG006|Overall Study|Lack of Efficacy|5|||
164271767|NCT00454649|593362790|FG007|Overall Study|Lack of Efficacy|13|||
164271768|NCT00454649|593362791|FG008|Overall Study|Lack of Efficacy|10|||
164271769|NCT00454649|593362792|FG009|Overall Study|Lack of Efficacy|2|||
164271770|NCT00454649|593362783|FG000|Overall Study|Adverse Event|0|||
164271771|NCT00454649|593362784|FG001|Overall Study|Adverse Event|1|||
164271772|NCT00454649|593362785|FG002|Overall Study|Adverse Event|3|||
164271773|NCT00454649|593362786|FG003|Overall Study|Adverse Event|0|||
164271774|NCT00454649|593362787|FG004|Overall Study|Adverse Event|1|||
164271775|NCT00454649|593362788|FG005|Overall Study|Adverse Event|2|||
164271776|NCT00454649|593362789|FG006|Overall Study|Adverse Event|3|||
164271777|NCT00454649|593362790|FG007|Overall Study|Adverse Event|4|||
164271778|NCT00454649|593362791|FG008|Overall Study|Adverse Event|6|||
164271779|NCT00454649|593362792|FG009|Overall Study|Adverse Event|2|||
164271780|NCT00454649|593362783|FG000|Overall Study|Lost to Follow-up|0|||
164271781|NCT00454649|593362784|FG001|Overall Study|Lost to Follow-up|0|||
164271782|NCT00454649|593362785|FG002|Overall Study|Lost to Follow-up|1|||
164271783|NCT00454649|593362786|FG003|Overall Study|Lost to Follow-up|0|||
164271784|NCT00454649|593362787|FG004|Overall Study|Lost to Follow-up|0|||
164271785|NCT00454649|593362788|FG005|Overall Study|Lost to Follow-up|0|||
164271786|NCT00454649|593362789|FG006|Overall Study|Lost to Follow-up|1|||
164271787|NCT00454649|593362790|FG007|Overall Study|Lost to Follow-up|0|||
164271788|NCT00454649|593362791|FG008|Overall Study|Lost to Follow-up|0|||
164271789|NCT00454649|593362792|FG009|Overall Study|Lost to Follow-up|0|||
164271790|NCT00454649|593362783|FG000|Overall Study|Other|1|||
164271791|NCT00454649|593362784|FG001|Overall Study|Other|1|||
164271792|NCT00454649|593362785|FG002|Overall Study|Other|5|||
164271793|NCT00454649|593362786|FG003|Overall Study|Other|3|||
164271794|NCT00454649|593362787|FG004|Overall Study|Other|0|||
164271795|NCT00454649|593362788|FG005|Overall Study|Other|0|||
164271796|NCT00454649|593362789|FG006|Overall Study|Other|0|||
164271797|NCT00454649|593362790|FG007|Overall Study|Other|0|||
164271798|NCT00454649|593362791|FG008|Overall Study|Other|3|||
164271799|NCT00454649|593362792|FG009|Overall Study|Other|1|||
164271800|NCT00454649|593362783|FG000|Overall Study|Withdrawal by Subject|0|||
163893807|NCT03926130|591983755|FG000|Overall Study|Withdrawal by Subject|20|||
163893808|NCT03926130|591983756|FG001|Overall Study|Withdrawal by Subject|28|||
163893809|NCT03926130|591983757|FG002|Overall Study|Withdrawal by Subject|18|||
163893810|NCT03926130|591983758|FG003|Overall Study|Withdrawal by Subject|1|||
163893811|NCT03926130|591983755|FG000|Overall Study|Non-Compliance|1|||
163893812|NCT03926130|591983756|FG001|Overall Study|Non-Compliance|1|||
163893813|NCT03926130|591983757|FG002|Overall Study|Non-Compliance|0|||
163893814|NCT03926130|591983758|FG003|Overall Study|Non-Compliance|0|||
163893815|NCT03926130|591983755|FG000|Overall Study|Disposition Not Captured|0|||
163893816|NCT03926130|591983756|FG001|Overall Study|Disposition Not Captured|2|||
163893817|NCT03926130|591983757|FG002|Overall Study|Disposition Not Captured|1|||
163893818|NCT03926130|591983758|FG003|Overall Study|Disposition Not Captured|0|||
164271801|NCT00454649|593362784|FG001|Overall Study|Withdrawal by Subject|0|||
164271802|NCT00454649|593362785|FG002|Overall Study|Withdrawal by Subject|0|||
164271803|NCT00454649|593362786|FG003|Overall Study|Withdrawal by Subject|0|||
164271804|NCT00454649|593362787|FG004|Overall Study|Withdrawal by Subject|0|||
164271805|NCT00454649|593362788|FG005|Overall Study|Withdrawal by Subject|1|||
164000172|NCT00408005|592364696|FG000|Induction|Progressive Disease|0|||
164000173|NCT00408005|592364697|FG001|Induction|Progressive Disease|1|||
164000174|NCT00408005|592364698|FG002|Induction|Progressive Disease|0|||
164000175|NCT00408005|592364699|FG003|Induction|Progressive Disease|0|||
164000176|NCT00408005|592364700|FG004|Induction|Progressive Disease|0|||
164000177|NCT00408005|592364701|FG005|Induction|Progressive Disease|0|||
164271806|NCT00454649|593362789|FG006|Overall Study|Withdrawal by Subject|0|||
164271807|NCT00454649|593362790|FG007|Overall Study|Withdrawal by Subject|2|||
164271808|NCT00454649|593362791|FG008|Overall Study|Withdrawal by Subject|1|||
164271809|NCT00454649|593362792|FG009|Overall Study|Withdrawal by Subject|0|||
164271810|NCT02745535|593362794|FG000|Overall Study|Death|1|||
164271811|NCT02745535|593362794|FG000|Overall Study|Adverse Event|3|||
164271812|NCT02745535|593362794|FG000|Overall Study|Lost to Follow-up|2|||
164271813|NCT01291277|593362799|FG000|Overall Study|Death|2|||
164271814|NCT01291277|593362800|FG001|Overall Study|Death|2|||
164271815|NCT01291277|593362799|FG000|Overall Study|Lost to Follow-up|3|||
164271816|NCT01291277|593362800|FG001|Overall Study|Lost to Follow-up|1|||
164271817|NCT00377364|593362801|FG000|Overall Study|Lost to Follow-up|1|||
164271818|NCT00377364|593362802|FG001|Overall Study|Lost to Follow-up|0|||
164271819|NCT00377364|593362801|FG000|Overall Study|Withdrawal by Subject|1|||
164271820|NCT00377364|593362802|FG001|Overall Study|Withdrawal by Subject|0|||
164271821|NCT03480009|593362806|FG000|Overall Study|Lost to Follow-up|4|||
164271822|NCT03480009|593362807|FG001|Overall Study|Lost to Follow-up|5|||
164271823|NCT03480009|593362808|FG002|Overall Study|Lost to Follow-up|4|||
164271824|NCT03480009|593362809|FG003|Overall Study|Lost to Follow-up|0|||
164271825|NCT01638559|593362810|FG000|Overall Study|Lost to Follow-up|1|||
164271826|NCT01638559|593362810|FG000|Overall Study|Withdrawal by Subject|1|||
164271827|NCT01638559|593362810|FG000|Overall Study|Subject declined to travel for biopsy|1|||
164271828|NCT02014584|593362811|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271829|NCT02014584|593362812|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
164271830|NCT02014584|593362813|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271831|NCT02014584|593362814|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271832|NCT02014584|593362815|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271833|NCT02014584|593362816|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
164271834|NCT02014584|593362811|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
164000178|NCT00408005|592364702|FG006|Induction|Progressive Disease|0|||
164271835|NCT02014584|593362812|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
164271836|NCT02014584|593362813|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271837|NCT02014584|593362814|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271838|NCT02014584|593362815|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271839|NCT02014584|593362816|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
164271840|NCT02014584|593362811|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271841|NCT02014584|593362812|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271842|NCT02014584|593362813|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
164271843|NCT02014584|593362814|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271844|NCT02014584|593362815|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271845|NCT02014584|593362816|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
164271846|NCT02014584|593362811|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271847|NCT02014584|593362812|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271848|NCT02014584|593362813|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
164271849|NCT02014584|593362814|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
164271850|NCT02014584|593362815|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271851|NCT02014584|593362816|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
164271852|NCT02014584|593362811|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271853|NCT02014584|593362812|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271854|NCT02014584|593362813|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271855|NCT02014584|593362814|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271856|NCT02014584|593362815|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
164271857|NCT02014584|593362816|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
164271858|NCT00483002|593362817|FG000|Overall Study|Adverse Event|68|||
164271859|NCT00483002|593362817|FG000|Overall Study|Lack of Efficacy|555|||
164271860|NCT00483002|593362817|FG000|Overall Study|Lost to Follow-up|962|||
164271861|NCT00483002|593362817|FG000|Overall Study|Other|2|||
164271862|NCT00483002|593362817|FG000|Overall Study|Other|967|||
164271863|NCT02651220|593362821|FG000|Overall Study|Adverse Event|1|||
164271864|NCT02651220|593362822|FG001|Overall Study|Adverse Event|5|||
164000179|NCT00408005|592364703|FG007|Induction|Progressive Disease|0|||
164000180|NCT00408005|592364696|FG000|Induction|Inevaluable|18|||
164271865|NCT02651220|593362823|FG002|Overall Study|Adverse Event|1|||
164271866|NCT02651220|593362821|FG000|Overall Study|Lost to Follow-up|8|||
164271867|NCT02651220|593362822|FG001|Overall Study|Lost to Follow-up|14|||
164271868|NCT02651220|593362823|FG002|Overall Study|Lost to Follow-up|14|||
164271869|NCT02651220|593362821|FG000|Overall Study|Non-Compliance with Study Drug|4|||
164000181|NCT00408005|592364697|FG001|Induction|Inevaluable|14|||
164271870|NCT02651220|593362822|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164271871|NCT02651220|593362823|FG002|Overall Study|Non-Compliance with Study Drug|1|||
164271872|NCT02651220|593362821|FG000|Overall Study|Pregnancy|1|||
164271873|NCT02651220|593362822|FG001|Overall Study|Pregnancy|0|||
164271874|NCT02651220|593362823|FG002|Overall Study|Pregnancy|1|||
164271875|NCT02651220|593362821|FG000|Overall Study|Protocol Violation|0|||
164000182|NCT00408005|592364698|FG002|Induction|Inevaluable|0|||
164000183|NCT00408005|592364699|FG003|Induction|Inevaluable|0|||
164000184|NCT00408005|592364700|FG004|Induction|Inevaluable|0|||
164000185|NCT00408005|592364701|FG005|Induction|Inevaluable|0|||
164000186|NCT00408005|592364702|FG006|Induction|Inevaluable|0|||
164000187|NCT00408005|592364703|FG007|Induction|Inevaluable|0|||
164000188|NCT00408005|592364696|FG000|Induction|Failed to Complete Randomization|3|||
164000189|NCT00408005|592364697|FG001|Induction|Failed to Complete Randomization|2|||
164000190|NCT00408005|592364698|FG002|Induction|Failed to Complete Randomization|0|||
164000191|NCT00408005|592364699|FG003|Induction|Failed to Complete Randomization|0|||
164000192|NCT00408005|592364700|FG004|Induction|Failed to Complete Randomization|0|||
164000193|NCT00408005|592364701|FG005|Induction|Failed to Complete Randomization|0|||
164000194|NCT00408005|592364702|FG006|Induction|Failed to Complete Randomization|0|||
164000195|NCT00408005|592364703|FG007|Induction|Failed to Complete Randomization|0|||
164000196|NCT00408005|592364696|FG000|Induction|Protocol Deviation|3|||
164000197|NCT00408005|592364697|FG001|Induction|Protocol Deviation|1|||
164000198|NCT00408005|592364698|FG002|Induction|Protocol Deviation|0|||
164000199|NCT00408005|592364699|FG003|Induction|Protocol Deviation|0|||
164000200|NCT00408005|592364700|FG004|Induction|Protocol Deviation|0|||
164000201|NCT00408005|592364701|FG005|Induction|Protocol Deviation|0|||
164085935|NCT01261325|592678592|FG002|Overall Study|Erroneously Randomized|0|||
164085936|NCT01261325|592678590|FG000|Overall Study|Screen Failure|1|||
164271876|NCT02651220|593362822|FG001|Overall Study|Protocol Violation|0|||
164271877|NCT02651220|593362823|FG002|Overall Study|Protocol Violation|1|||
164271878|NCT02651220|593362821|FG000|Overall Study|Withdrawal by Subject|5|||
164271879|NCT02651220|593362822|FG001|Overall Study|Withdrawal by Subject|6|||
164271880|NCT02651220|593362823|FG002|Overall Study|Withdrawal by Subject|8|||
164271881|NCT02651220|593362821|FG000|Overall Study|Miscellaneous|4|||
164271882|NCT02651220|593362822|FG001|Overall Study|Miscellaneous|1|||
164271883|NCT02651220|593362823|FG002|Overall Study|Miscellaneous|2|||
164271884|NCT02651220|593362821|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164271885|NCT02651220|593362822|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164271886|NCT02651220|593362823|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
164271887|NCT01274429|593362825|FG000|Overall Study|Study closed do to lack of funding|5|||
164271888|NCT01439373|593362826|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
164271889|NCT01439373|593362827|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
164271890|NCT01439373|593362826|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
164271891|NCT01439373|593362827|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
164271892|NCT04576897|593362830|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
164271893|NCT02593318|593362833|FG000|Overall Study|Withdrawal by Subject|1|||
164271894|NCT02593318|593362834|FG001|Overall Study|Withdrawal by Subject|1|||
164271895|NCT03109184|593364442|FG000|Overall Study|Lost to Follow-up|6|||
164271896|NCT03109184|593364443|FG001|Overall Study|Lost to Follow-up|6|||
164271897|NCT03109184|593364442|FG000|Overall Study|Withdrawal by Subject|1|||
164271898|NCT03109184|593364443|FG001|Overall Study|Withdrawal by Subject|1|||
164271899|NCT02315560|593364444|FG000|Overall Study|noncompliance by subjects|3|||
164271900|NCT04599465|593364445|FG000|Overall Study|Physician Decision|1|||
164271901|NCT04599465|593364445|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
164271902|NCT04566601|593364446|FG000|Overall Study|Other than listed|13|||
164271903|NCT04566601|593364447|FG001|Overall Study|Other than listed|4|||
164271904|NCT04566601|593364448|FG002|Overall Study|Other than listed|2|||
164271905|NCT04566601|593364449|FG003|Overall Study|Other than listed|1|||
164271906|NCT04566601|593364450|FG004|Overall Study|Other than listed|4|||
164271907|NCT04566601|593364446|FG000|Overall Study|Protocol deviation|3|||
164271908|NCT04566601|593364447|FG001|Overall Study|Protocol deviation|0|||
164271909|NCT04566601|593364448|FG002|Overall Study|Protocol deviation|1|||
164271910|NCT04566601|593364449|FG003|Overall Study|Protocol deviation|1|||
164000202|NCT00408005|592364702|FG006|Induction|Protocol Deviation|0|||
164000203|NCT00408005|592364703|FG007|Induction|Protocol Deviation|0|||
164000204|NCT00408005|592364696|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
164000205|NCT00408005|592364697|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
164000206|NCT00408005|592364698|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
164000207|NCT00408005|592364699|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
164000208|NCT00408005|592364700|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
164000209|NCT00408005|592364701|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
164271911|NCT04566601|593364450|FG004|Overall Study|Protocol deviation|1|||
164271912|NCT04566601|593364446|FG000|Overall Study|Technical problems|0|||
164271913|NCT04566601|593364447|FG001|Overall Study|Technical problems|0|||
164271914|NCT04566601|593364448|FG002|Overall Study|Technical problems|1|||
164271915|NCT04566601|593364449|FG003|Overall Study|Technical problems|0|||
163893819|NCT05069896|591983763|FG000|Overall Study|Adverse Event|0|||
163893820|NCT05069896|591983764|FG001|Overall Study|Adverse Event|1|||
163893821|NCT05069896|591983765|FG002|Overall Study|Adverse Event|1|||
163893822|NCT05069896|591983766|FG003|Overall Study|Adverse Event|0|||
163893823|NCT05069896|591983767|FG004|Overall Study|Adverse Event|0|||
163893824|NCT05069896|591983768|FG005|Overall Study|Adverse Event|0|||
163893825|NCT05069896|591983763|FG000|Overall Study|Lost to Follow-up|0|||
163893826|NCT05069896|591983764|FG001|Overall Study|Lost to Follow-up|0|||
163893827|NCT05069896|591983765|FG002|Overall Study|Lost to Follow-up|1|||
163893828|NCT05069896|591983766|FG003|Overall Study|Lost to Follow-up|0|||
163893829|NCT05069896|591983767|FG004|Overall Study|Lost to Follow-up|1|||
163893830|NCT05069896|591983768|FG005|Overall Study|Lost to Follow-up|2|||
163893831|NCT04605159|591983784|FG000|Overall Study|Adverse Event|6|||
163893832|NCT04605159|591983785|FG001|Overall Study|Adverse Event|3|||
163893833|NCT04605159|591983786|FG002|Overall Study|Adverse Event|21|||
163893834|NCT04605159|591983787|FG003|Overall Study|Adverse Event|4|||
163893835|NCT04605159|591983784|FG000|Overall Study|Lost to Follow-up|74|||
163893836|NCT04605159|591983785|FG001|Overall Study|Lost to Follow-up|45|||
163893837|NCT04605159|591983786|FG002|Overall Study|Lost to Follow-up|119|||
163893838|NCT04605159|591983787|FG003|Overall Study|Lost to Follow-up|80|||
163893839|NCT04605159|591983784|FG000|Overall Study|Protocol Violation|4|||
163893840|NCT04605159|591983785|FG001|Overall Study|Protocol Violation|5|||
163893841|NCT04605159|591983786|FG002|Overall Study|Protocol Violation|2|||
163893842|NCT04605159|591983787|FG003|Overall Study|Protocol Violation|0|||
163893843|NCT04605159|591983784|FG000|Overall Study|Withdrawal by Subject|66|||
163893844|NCT04605159|591983785|FG001|Overall Study|Withdrawal by Subject|37|||
163893845|NCT04605159|591983786|FG002|Overall Study|Withdrawal by Subject|68|||
164271916|NCT04566601|593364450|FG004|Overall Study|Technical problems|0|||
164271917|NCT04566601|593364446|FG000|Overall Study|No reason available|3|||
164271918|NCT04566601|593364447|FG001|Overall Study|No reason available|2|||
164271919|NCT04566601|593364448|FG002|Overall Study|No reason available|7|||
164271920|NCT04566601|593364449|FG003|Overall Study|No reason available|1|||
164271921|NCT04566601|593364450|FG004|Overall Study|No reason available|5|||
164271922|NCT04566601|593364446|FG000|Overall Study|Burden of study procedures|3|||
164271923|NCT04566601|593364447|FG001|Overall Study|Burden of study procedures|0|||
164271924|NCT04566601|593364448|FG002|Overall Study|Burden of study procedures|0|||
164271925|NCT04566601|593364449|FG003|Overall Study|Burden of study procedures|3|||
164271926|NCT04566601|593364450|FG004|Overall Study|Burden of study procedures|1|||
164271927|NCT04566601|593364446|FG000|Overall Study|Change of residence|2|||
164271928|NCT04566601|593364447|FG001|Overall Study|Change of residence|2|||
164271929|NCT04566601|593364448|FG002|Overall Study|Change of residence|0|||
164271930|NCT04566601|593364449|FG003|Overall Study|Change of residence|1|||
164271931|NCT04566601|593364450|FG004|Overall Study|Change of residence|2|||
164271932|NCT04566601|593364446|FG000|Overall Study|Perceived lack of efficacy|2|||
164271933|NCT04566601|593364447|FG001|Overall Study|Perceived lack of efficacy|0|||
164271934|NCT04566601|593364448|FG002|Overall Study|Perceived lack of efficacy|1|||
164271935|NCT04566601|593364449|FG003|Overall Study|Perceived lack of efficacy|1|||
164271936|NCT04566601|593364450|FG004|Overall Study|Perceived lack of efficacy|2|||
164271937|NCT04566601|593364446|FG000|Overall Study|Adverse Event|7|||
164271938|NCT04566601|593364447|FG001|Overall Study|Adverse Event|4|||
164271939|NCT04566601|593364448|FG002|Overall Study|Adverse Event|6|||
164271940|NCT04566601|593364449|FG003|Overall Study|Adverse Event|5|||
164271941|NCT04566601|593364450|FG004|Overall Study|Adverse Event|12|||
163893846|NCT04605159|591983787|FG003|Overall Study|Withdrawal by Subject|50|||
163893847|NCT04605159|591983784|FG000|Overall Study|Migrated / moved from the study area|32|||
163893848|NCT04605159|591983785|FG001|Overall Study|Migrated / moved from the study area|22|||
163893849|NCT04605159|591983786|FG002|Overall Study|Migrated / moved from the study area|41|||
163893850|NCT04605159|591983787|FG003|Overall Study|Migrated / moved from the study area|21|||
164000210|NCT00408005|592364702|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
164000211|NCT00408005|592364703|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
164000212|NCT00408005|592364696|FG000|Induction|Recurrent leukemia|1|||
164271942|NCT02522325|593364451|FG000|Overall Study|Adverse Event|0|||
164271943|NCT02522325|593364452|FG001|Overall Study|Adverse Event|1|||
164271944|NCT01209078|593364453|FG000|Overall Study|Adverse Event|5|||
164271945|NCT01209078|593364454|FG001|Overall Study|Adverse Event|0|||
164271946|NCT01209078|593364453|FG000|Overall Study|Lost to Follow-up|4|||
164271947|NCT01209078|593364454|FG001|Overall Study|Lost to Follow-up|0|||
164271948|NCT01209078|593364453|FG000|Overall Study|Physician Decision|5|||
163893851|NCT04605159|591983784|FG000|Overall Study|Other|1|||
163893852|NCT04605159|591983785|FG001|Overall Study|Other|2|||
163893853|NCT04605159|591983786|FG002|Overall Study|Other|7|||
163893854|NCT04605159|591983787|FG003|Overall Study|Other|3|||
163893855|NCT04934072|591983789|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
163893856|NCT04934072|591983790|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
163893857|NCT04934072|591983791|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
163893858|NCT04934072|591983792|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
163893859|NCT04934072|591983793|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
164271949|NCT01209078|593364454|FG001|Overall Study|Physician Decision|2|||
164000213|NCT00408005|592364697|FG001|Induction|Recurrent leukemia|0|||
164000214|NCT00408005|592364698|FG002|Induction|Recurrent leukemia|0|||
164000215|NCT00408005|592364699|FG003|Induction|Recurrent leukemia|0|||
164000216|NCT00408005|592364700|FG004|Induction|Recurrent leukemia|0|||
164000217|NCT00408005|592364701|FG005|Induction|Recurrent leukemia|0|||
164000218|NCT00408005|592364702|FG006|Induction|Recurrent leukemia|0|||
164000219|NCT00408005|592364703|FG007|Induction|Recurrent leukemia|0|||
164000220|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164271950|NCT01209078|593364453|FG000|Overall Study|Withdrawal by Subject|2|||
164271951|NCT01209078|593364454|FG001|Overall Study|Withdrawal by Subject|1|||
164271952|NCT02702180|593364459|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164271953|NCT02702180|593364460|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164271954|NCT02702180|593364461|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164271955|NCT02702180|593364459|FG000|Double-blind Treatment Period|Adverse Event|0|||
164271956|NCT02702180|593364460|FG001|Double-blind Treatment Period|Adverse Event|0|||
164271957|NCT02702180|593364461|FG002|Double-blind Treatment Period|Adverse Event|1|||
164271958|NCT02702180|593364459|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164271959|NCT02702180|593364460|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164000221|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164000222|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
164271960|NCT02702180|593364461|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
164271961|NCT02702180|593364459|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164271962|NCT02702180|593364460|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164271963|NCT02702180|593364461|FG002|Double-blind Treatment Period|Protocol Violation|2|||
164271964|NCT02702180|593364459|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
164271965|NCT02702180|593364460|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
164271966|NCT02702180|593364461|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
164271967|NCT02702180|593364459|FG000|Open-label Treatment Period|Withdrawn in error|0|||
164271968|NCT02702180|593364460|FG001|Open-label Treatment Period|Withdrawn in error|0|||
164271969|NCT02702180|593364461|FG002|Open-label Treatment Period|Withdrawn in error|1|||
164271970|NCT00785980|593364462|FG000|7 Day Washout Period|Protocol Violation|3|||
164271971|NCT00448747|593364475|FG000|Overall Study|collapsed veins|1|||
164271972|NCT00448747|593364476|FG001|Overall Study|collapsed veins|0|||
164271973|NCT00387725|593364477|FG000|Overall Study|Adverse Event|0|||
164271974|NCT00387725|593364478|FG001|Overall Study|Adverse Event|0|||
164271975|NCT00387725|593364479|FG002|Overall Study|Adverse Event|0|||
164271976|NCT00387725|593364480|FG003|Overall Study|Adverse Event|1|||
164271977|NCT00387725|593364477|FG000|Overall Study|Protocol Violation|0|||
164271978|NCT00387725|593364478|FG001|Overall Study|Protocol Violation|1|||
164271979|NCT00387725|593364479|FG002|Overall Study|Protocol Violation|0|||
164271980|NCT00387725|593364480|FG003|Overall Study|Protocol Violation|0|||
164271981|NCT00387725|593364477|FG000|Overall Study|Withdrawal by Subject|1|||
164271982|NCT00387725|593364478|FG001|Overall Study|Withdrawal by Subject|0|||
164271983|NCT00387725|593364479|FG002|Overall Study|Withdrawal by Subject|1|||
164271984|NCT00387725|593364480|FG003|Overall Study|Withdrawal by Subject|0|||
164271985|NCT00387725|593364477|FG000|Overall Study|Parent/legal guardian request|0|||
164000223|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
164000224|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
164000225|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
164271986|NCT00387725|593364478|FG001|Overall Study|Parent/legal guardian request|0|||
164271987|NCT00387725|593364479|FG002|Overall Study|Parent/legal guardian request|1|||
164271988|NCT00387725|593364480|FG003|Overall Study|Parent/legal guardian request|1|||
164271989|NCT00568126|593364481|FG000|Overall Study|Adverse Event|3|||
164271990|NCT00568126|593364482|FG001|Overall Study|Adverse Event|0|||
164271991|NCT00568126|593364481|FG000|Overall Study|Withdrawal by Subject|2|||
164271992|NCT00568126|593364482|FG001|Overall Study|Withdrawal by Subject|3|||
164271993|NCT00568126|593364481|FG000|Overall Study|Lost to Follow-up|4|||
164000226|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
164271994|NCT00568126|593364482|FG001|Overall Study|Lost to Follow-up|3|||
164271995|NCT00568126|593364481|FG000|Overall Study|Lack of Efficacy|0|||
164271996|NCT00568126|593364482|FG001|Overall Study|Lack of Efficacy|1|||
164271997|NCT00568126|593364481|FG000|Overall Study|Physician Decision|2|||
164271998|NCT00568126|593364482|FG001|Overall Study|Physician Decision|2|||
164271999|NCT02241343|593364483|FG000|Overall Study|Adverse Event|1|||
164272000|NCT04680975|593364484|FG000|Overall Study|Adverse Event|3|||
164000227|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
164000228|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
164085937|NCT01261325|592678591|FG001|Overall Study|Screen Failure|0|||
164272001|NCT04680975|593364484|FG000|Overall Study|Death|1|||
164272002|NCT04680975|593364484|FG000|Overall Study|Progressive Disease|1|||
164272003|NCT04680975|593364484|FG000|Overall Study|Withdrawal by Subject|1|||
164272004|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
164272005|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
164272006|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
164272007|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
164272008|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
164272009|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
164272010|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
164272011|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
164272012|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
164272013|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
164272014|NCT02429791|593364486|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
164272015|NCT02429791|593364487|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
164272016|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
164272017|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
164272018|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
164272019|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
164272020|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
164272021|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
164272022|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
164272023|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
164272024|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
164272025|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
164272026|NCT02429791|593364486|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
164272027|NCT02429791|593364487|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
164272028|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
164272029|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
164272030|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
164272031|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
164272032|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
164272033|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
164272034|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
164272035|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
164272036|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
164272037|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
164085938|NCT01261325|592678592|FG002|Overall Study|Screen Failure|0|||
164272038|NCT02429791|593364486|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
164272039|NCT02429791|593364487|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
164272040|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
164272041|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
164272042|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
164272043|NCT02615691|593364488|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
164272044|NCT04201093|593364489|FG000|Overall Study|Adverse Event|6|||
164272045|NCT04201093|593364490|FG001|Overall Study|Adverse Event|29|||
164272046|NCT04201093|593364491|FG002|Overall Study|Adverse Event|35|||
164272047|NCT04201093|593364489|FG000|Overall Study|Death|2|||
164272048|NCT04201093|593364490|FG001|Overall Study|Death|1|||
164272049|NCT04201093|593364491|FG002|Overall Study|Death|0|||
164272050|NCT04201093|593364489|FG000|Overall Study|Lack of Efficacy|5|||
164272051|NCT04201093|593364490|FG001|Overall Study|Lack of Efficacy|1|||
164272052|NCT04201093|593364491|FG002|Overall Study|Lack of Efficacy|2|||
164272053|NCT04201093|593364489|FG000|Overall Study|Lost to Follow-up|0|||
164272054|NCT04201093|593364490|FG001|Overall Study|Lost to Follow-up|0|||
164272055|NCT04201093|593364491|FG002|Overall Study|Lost to Follow-up|1|||
164272056|NCT04201093|593364489|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
164272057|NCT04201093|593364490|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164272058|NCT04201093|593364491|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
164272059|NCT04201093|593364489|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164272060|NCT04201093|593364490|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164272061|NCT04201093|593364491|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
164272062|NCT04201093|593364489|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
164272063|NCT04201093|593364490|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
164272064|NCT04201093|593364491|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
164272065|NCT04201093|593364489|FG000|Overall Study|Physician Decision|1|||
164272066|NCT04201093|593364490|FG001|Overall Study|Physician Decision|0|||
164272067|NCT04201093|593364491|FG002|Overall Study|Physician Decision|0|||
164272068|NCT04201093|593364489|FG000|Overall Study|Protocol Deviation|1|||
164272069|NCT04201093|593364490|FG001|Overall Study|Protocol Deviation|0|||
164272070|NCT04201093|593364491|FG002|Overall Study|Protocol Deviation|0|||
164272071|NCT04201093|593364489|FG000|Overall Study|Site Terminated by Sponsor|5|||
164272072|NCT04201093|593364490|FG001|Overall Study|Site Terminated by Sponsor|3|||
164272073|NCT04201093|593364491|FG002|Overall Study|Site Terminated by Sponsor|1|||
164272074|NCT04201093|593364489|FG000|Overall Study|Withdrawal by Subject|7|||
164272075|NCT04201093|593364490|FG001|Overall Study|Withdrawal by Subject|8|||
164272076|NCT04201093|593364491|FG002|Overall Study|Withdrawal by Subject|15|||
164272077|NCT04201093|593364489|FG000|Overall Study|Other|0|||
164272078|NCT04201093|593364490|FG001|Overall Study|Other|1|||
164272079|NCT04201093|593364491|FG002|Overall Study|Other|2|||
164272080|NCT00881504|593364492|FG000|Overall Study|Withdrawal by Subject|1|||
164272081|NCT01276223|593364493|FG000|Overall Study|Adverse Event|7|||
164272082|NCT01276223|593364494|FG001|Overall Study|Adverse Event|4|||
164272083|NCT01276223|593364495|FG002|Overall Study|Adverse Event|1|||
164272084|NCT01276223|593364493|FG000|Overall Study|Lost to Follow-up|0|||
164272085|NCT01276223|593364494|FG001|Overall Study|Lost to Follow-up|0|||
164272086|NCT01276223|593364495|FG002|Overall Study|Lost to Follow-up|1|||
164272087|NCT01276223|593364493|FG000|Overall Study|Other|0|||
164272088|NCT01276223|593364494|FG001|Overall Study|Other|0|||
164272089|NCT01276223|593364495|FG002|Overall Study|Other|1|||
164272090|NCT01276223|593364493|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
164272091|NCT01276223|593364494|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
164272092|NCT01276223|593364495|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
164272093|NCT01276223|593364493|FG000|Overall Study|Protocol Violation|1|||
164272094|NCT01276223|593364494|FG001|Overall Study|Protocol Violation|0|||
164272095|NCT01276223|593364495|FG002|Overall Study|Protocol Violation|0|||
164272096|NCT02017522|593364496|FG000|Overall Study|Withdrawal by Subject|1|||
164272097|NCT02596230|593364497|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
164272098|NCT02596230|593364498|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
164272099|NCT02596230|593364499|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
164085939|NCT01261325|592678590|FG000|Overall Study|Randomized in Error|0|||
164272100|NCT02596230|593364500|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
164272101|NCT02596230|593364501|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
164272102|NCT02596230|593364497|FG000|Objective 2, One Year|Lost to Follow-up|0|||
164272103|NCT02596230|593364498|FG001|Objective 2, One Year|Lost to Follow-up|41|||
164272104|NCT02596230|593364499|FG002|Objective 2, One Year|Lost to Follow-up|41|||
164272105|NCT02596230|593364500|FG003|Objective 2, One Year|Lost to Follow-up|32|||
164272106|NCT02596230|593364501|FG004|Objective 2, One Year|Lost to Follow-up|46|||
164272107|NCT02596230|593364497|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
163893860|NCT04934072|591983789|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
163893861|NCT04934072|591983790|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
163893862|NCT04934072|591983791|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
163893863|NCT04934072|591983792|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
163893864|NCT04934072|591983793|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
164272108|NCT02596230|593364498|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
164272109|NCT02596230|593364499|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
164272110|NCT02596230|593364500|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
164272111|NCT02596230|593364501|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
164272112|NCT02596230|593364497|FG000|Objective 2, One Year|Adverse drug reaction|0|||
164272113|NCT02596230|593364498|FG001|Objective 2, One Year|Adverse drug reaction|1|||
164272114|NCT02596230|593364499|FG002|Objective 2, One Year|Adverse drug reaction|0|||
164272115|NCT02596230|593364500|FG003|Objective 2, One Year|Adverse drug reaction|0|||
164272116|NCT02596230|593364501|FG004|Objective 2, One Year|Adverse drug reaction|0|||
164272117|NCT02596230|593364497|FG000|Objective 2, One Year|Death|0|||
164272118|NCT02596230|593364498|FG001|Objective 2, One Year|Death|12|||
164272119|NCT02596230|593364499|FG002|Objective 2, One Year|Death|41|||
164272120|NCT02596230|593364500|FG003|Objective 2, One Year|Death|21|||
164272121|NCT02596230|593364501|FG004|Objective 2, One Year|Death|30|||
164272122|NCT02596230|593364497|FG000|Objective 2, One Year|Other|0|||
164272123|NCT02596230|593364498|FG001|Objective 2, One Year|Other|3|||
164272124|NCT02596230|593364499|FG002|Objective 2, One Year|Other|2|||
164272125|NCT02596230|593364500|FG003|Objective 2, One Year|Other|0|||
164272126|NCT02596230|593364501|FG004|Objective 2, One Year|Other|0|||
164272127|NCT00771615|593364502|FG000|Overall Study|Withdrawal by Subject|0|||
164272128|NCT00771615|593364503|FG001|Overall Study|Withdrawal by Subject|1|||
164272129|NCT00771615|593364504|FG002|Overall Study|Withdrawal by Subject|0|||
164272130|NCT00771615|593364505|FG003|Overall Study|Withdrawal by Subject|0|||
164272131|NCT00771615|593364506|FG004|Overall Study|Withdrawal by Subject|0|||
164272132|NCT00771615|593364507|FG005|Overall Study|Withdrawal by Subject|0|||
164272133|NCT00771615|593364508|FG006|Overall Study|Withdrawal by Subject|0|||
164272134|NCT00771615|593364509|FG007|Overall Study|Withdrawal by Subject|1|||
164272135|NCT00771615|593364510|FG008|Overall Study|Withdrawal by Subject|0|||
164272136|NCT00771615|593364502|FG000|Overall Study|Lost to Follow-up|1|||
164272137|NCT00771615|593364503|FG001|Overall Study|Lost to Follow-up|1|||
164272138|NCT00771615|593364504|FG002|Overall Study|Lost to Follow-up|1|||
164272139|NCT00771615|593364505|FG003|Overall Study|Lost to Follow-up|1|||
164272140|NCT00771615|593364506|FG004|Overall Study|Lost to Follow-up|0|||
164272141|NCT00771615|593364507|FG005|Overall Study|Lost to Follow-up|1|||
164272142|NCT00771615|593364508|FG006|Overall Study|Lost to Follow-up|1|||
164272143|NCT00771615|593364509|FG007|Overall Study|Lost to Follow-up|0|||
164272144|NCT00771615|593364510|FG008|Overall Study|Lost to Follow-up|0|||
164272145|NCT02704689|593364512|FG000|Overall Study|Physician Decision|1|||
164272146|NCT02704689|593364512|FG000|Overall Study|Study device not implanted|2|||
164272147|NCT00802893|593364513|FG000|Overall Study|study terminated|3|||
164272148|NCT00320424|593364514|FG000|Overall Study|Adverse Event|3|||
164272149|NCT00320424|593364514|FG000|Overall Study|Other|3|||
164272150|NCT02540668|593364516|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
164272151|NCT02540668|593364517|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
164272152|NCT03270891|593364518|FG000|Overall Study|Lost to Follow-up|3|||
164272153|NCT03270891|593364519|FG001|Overall Study|Lost to Follow-up|6|||
164272154|NCT03270891|593364520|FG002|Overall Study|Lost to Follow-up|0|||
164272155|NCT03270891|593364518|FG000|Overall Study|Withdrawal by Subject|1|||
164272156|NCT03270891|593364519|FG001|Overall Study|Withdrawal by Subject|0|||
164272157|NCT03270891|593364520|FG002|Overall Study|Withdrawal by Subject|0|||
164272158|NCT03270891|593364518|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
164272159|NCT03270891|593364519|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
164272160|NCT03270891|593364520|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
164342397|NCT04457336|593629430|FG004|Period 4: Part C|Site Terminated|0|||
164272161|NCT00849108|593364521|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
164342398|NCT04457336|593629431|FG005|Period 4: Part C|Site Terminated|0|||
163893865|NCT04934072|591983789|FG000|Day 0 to Week 52|Other|3|||
163893866|NCT04934072|591983790|FG001|Day 0 to Week 52|Other|1|||
164272162|NCT00849108|593364522|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
164272163|NCT00849108|593364521|FG000|Cohort 2 Efficacy|Adverse Event|0|||
163893867|NCT04934072|591983791|FG002|Day 0 to Week 52|Other|0|||
163893868|NCT04934072|591983792|FG003|Day 0 to Week 52|Other|0|||
163893869|NCT04934072|591983793|FG004|Day 0 to Week 52|Other|0|||
163893870|NCT04934072|591983789|FG000|Day 0 to Week 52|Adverse Event|1|||
163893871|NCT04934072|591983790|FG001|Day 0 to Week 52|Adverse Event|3|||
164272164|NCT00849108|593364522|FG001|Cohort 2 Efficacy|Adverse Event|1|||
164342399|NCT04457336|593629432|FG006|Period 4: Part C|Site Terminated|0|||
163893872|NCT04934072|591983791|FG002|Day 0 to Week 52|Adverse Event|0|||
163893873|NCT04934072|591983792|FG003|Day 0 to Week 52|Adverse Event|0|||
164342400|NCT04457336|593629433|FG007|Period 4: Part C|Site Terminated|1|||
164272165|NCT00849108|593364521|FG000|Cohort 2 Efficacy|Other|0|||
164085940|NCT01261325|592678591|FG001|Overall Study|Randomized in Error|0|||
164272166|NCT00849108|593364522|FG001|Cohort 2 Efficacy|Other|9|||
164272167|NCT02211313|593364523|FG000|Overall Study|Treatment Failure|5|||
164272168|NCT02211313|593364524|FG001|Overall Study|Treatment Failure|2|||
164272169|NCT02211313|593364523|FG000|Overall Study|No Follow up Questionnaires|1|||
164272170|NCT02211313|593364524|FG001|Overall Study|No Follow up Questionnaires|1|||
164272171|NCT01943552|593364525|FG000|Overall Study|Adverse Event|3|||
164272172|NCT01943552|593364526|FG001|Overall Study|Adverse Event|2|||
164272173|NCT01943552|593364525|FG000|Overall Study|Withdrawal by Subject|6|||
164272174|NCT01943552|593364526|FG001|Overall Study|Withdrawal by Subject|6|||
164272175|NCT01943552|593364525|FG000|Overall Study|Other Reasons|16|||
164272176|NCT01943552|593364526|FG001|Overall Study|Other Reasons|17|||
164272177|NCT01475162|593364527|FG000|Overall Study|Physician Decision|1|||
164272178|NCT01475162|593364527|FG000|Overall Study|Death|10|||
164272179|NCT01475162|593364527|FG000|Overall Study|Study closed for safety|3|||
164272180|NCT00545103|593364528|FG000|Overall Study|Lack of Efficacy|48|||
164272181|NCT00545103|593364529|FG001|Overall Study|Lack of Efficacy|45|||
164272182|NCT00545103|593364530|FG002|Overall Study|Lack of Efficacy|31|||
164272183|NCT00545103|593364531|FG003|Overall Study|Lack of Efficacy|27|||
164272184|NCT00545103|593364528|FG000|Overall Study|Withdrawal by Subject|6|||
164272185|NCT00545103|593364529|FG001|Overall Study|Withdrawal by Subject|10|||
164272186|NCT00545103|593364530|FG002|Overall Study|Withdrawal by Subject|18|||
164272187|NCT00545103|593364531|FG003|Overall Study|Withdrawal by Subject|22|||
164272188|NCT00545103|593364528|FG000|Overall Study|Adverse Event|11|||
164272189|NCT00545103|593364529|FG001|Overall Study|Adverse Event|12|||
164272190|NCT00545103|593364530|FG002|Overall Study|Adverse Event|17|||
164272191|NCT00545103|593364531|FG003|Overall Study|Adverse Event|10|||
164272192|NCT00545103|593364528|FG000|Overall Study|Lost to Follow-up|4|||
164272193|NCT00545103|593364529|FG001|Overall Study|Lost to Follow-up|6|||
164272194|NCT00545103|593364530|FG002|Overall Study|Lost to Follow-up|3|||
164272195|NCT00545103|593364531|FG003|Overall Study|Lost to Follow-up|4|||
164272196|NCT00545103|593364528|FG000|Overall Study|Protocol Violation|1|||
164272197|NCT00545103|593364529|FG001|Overall Study|Protocol Violation|2|||
164272198|NCT00545103|593364530|FG002|Overall Study|Protocol Violation|3|||
164272199|NCT00545103|593364531|FG003|Overall Study|Protocol Violation|0|||
164272200|NCT00545103|593364528|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
164272201|NCT00545103|593364529|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
164272202|NCT00545103|593364530|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
164272203|NCT00545103|593364531|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
164272204|NCT00545103|593364528|FG000|Overall Study|Difficult to open package|0|||
164272205|NCT00545103|593364529|FG001|Overall Study|Difficult to open package|0|||
164272206|NCT00545103|593364530|FG002|Overall Study|Difficult to open package|0|||
164272207|NCT00545103|593364531|FG003|Overall Study|Difficult to open package|1|||
164272208|NCT00545103|593364528|FG000|Overall Study|Investigational product not taken|1|||
164272209|NCT00545103|593364529|FG001|Overall Study|Investigational product not taken|0|||
164272210|NCT00545103|593364530|FG002|Overall Study|Investigational product not taken|0|||
164272211|NCT00545103|593364531|FG003|Overall Study|Investigational product not taken|1|||
164272212|NCT00545103|593364528|FG000|Overall Study|Wish to start a family|0|||
164272213|NCT00545103|593364529|FG001|Overall Study|Wish to start a family|0|||
164272214|NCT00545103|593364530|FG002|Overall Study|Wish to start a family|0|||
164272215|NCT00545103|593364531|FG003|Overall Study|Wish to start a family|1|||
164272216|NCT00545103|593364528|FG000|Overall Study|Diverticulitis crisis|0|||
164272217|NCT00545103|593364529|FG001|Overall Study|Diverticulitis crisis|0|||
164272218|NCT00545103|593364530|FG002|Overall Study|Diverticulitis crisis|0|||
164272219|NCT00545103|593364531|FG003|Overall Study|Diverticulitis crisis|1|||
164272220|NCT00545103|593364528|FG000|Overall Study|Personal reasons|1|||
164272221|NCT00545103|593364529|FG001|Overall Study|Personal reasons|0|||
163893874|NCT04934072|591983793|FG004|Day 0 to Week 52|Adverse Event|0|||
163893875|NCT04934072|591983789|FG000|Week 52 to Week 78|Adverse Event|0|||
163893876|NCT04934072|591983790|FG001|Week 52 to Week 78|Adverse Event|0|||
163893877|NCT04934072|591983791|FG002|Week 52 to Week 78|Adverse Event|0|||
163893878|NCT04934072|591983792|FG003|Week 52 to Week 78|Adverse Event|1|||
163893879|NCT04934072|591983793|FG004|Week 52 to Week 78|Adverse Event|1|||
163893880|NCT04934072|591983789|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
163893881|NCT04934072|591983790|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
163893882|NCT04934072|591983791|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
164085941|NCT01261325|592678592|FG002|Overall Study|Randomized in Error|1|||
164272222|NCT00545103|593364530|FG002|Overall Study|Personal reasons|0|||
164272223|NCT00545103|593364531|FG003|Overall Study|Personal reasons|0|||
164272224|NCT00545103|593364528|FG000|Overall Study|Subject's decision|1|||
164272225|NCT00545103|593364529|FG001|Overall Study|Subject's decision|0|||
164272226|NCT00545103|593364530|FG002|Overall Study|Subject's decision|0|||
164272227|NCT00545103|593364531|FG003|Overall Study|Subject's decision|0|||
164272228|NCT00545103|593364528|FG000|Overall Study|Noncompliance|0|||
164272229|NCT00545103|593364529|FG001|Overall Study|Noncompliance|1|||
164272230|NCT00545103|593364530|FG002|Overall Study|Noncompliance|0|||
164272231|NCT00545103|593364531|FG003|Overall Study|Noncompliance|0|||
164272232|NCT00545103|593364528|FG000|Overall Study|Investigator decision|0|||
164272233|NCT00545103|593364529|FG001|Overall Study|Investigator decision|0|||
164272234|NCT00545103|593364530|FG002|Overall Study|Investigator decision|1|||
164272235|NCT00545103|593364531|FG003|Overall Study|Investigator decision|0|||
164272236|NCT00545103|593364528|FG000|Overall Study|Subject moved|0|||
164272237|NCT00545103|593364529|FG001|Overall Study|Subject moved|1|||
164272238|NCT00545103|593364530|FG002|Overall Study|Subject moved|0|||
164272239|NCT00545103|593364531|FG003|Overall Study|Subject moved|0|||
164272240|NCT00545103|593364528|FG000|Overall Study|Use of prohibited medication|0|||
164342401|NCT04457336|593629426|FG000|Period 4: Part C|Other|0|||
164342402|NCT04457336|593629427|FG001|Period 4: Part C|Other|0|||
164342403|NCT04457336|593629428|FG002|Period 4: Part C|Other|0|||
164342404|NCT04457336|593629429|FG003|Period 4: Part C|Other|0|||
164342405|NCT04457336|593629430|FG004|Period 4: Part C|Other|0|||
164342406|NCT04457336|593629431|FG005|Period 4: Part C|Other|0|||
164342407|NCT04457336|593629432|FG006|Period 4: Part C|Other|0|||
164342408|NCT04457336|593629433|FG007|Period 4: Part C|Other|2|||
164342409|NCT04457336|593629426|FG000|Period 4: Part C|Withdrawal by Subject|0|||
164342410|NCT04457336|593629427|FG001|Period 4: Part C|Withdrawal by Subject|0|||
164342411|NCT04457336|593629428|FG002|Period 4: Part C|Withdrawal by Subject|0|||
164342412|NCT04457336|593629429|FG003|Period 4: Part C|Withdrawal by Subject|0|||
164342413|NCT04457336|593629430|FG004|Period 4: Part C|Withdrawal by Subject|0|||
164342414|NCT04457336|593629431|FG005|Period 4: Part C|Withdrawal by Subject|0|||
164342415|NCT04457336|593629432|FG006|Period 4: Part C|Withdrawal by Subject|0|||
164342416|NCT04457336|593629433|FG007|Period 4: Part C|Withdrawal by Subject|3|||
164342417|NCT00446251|593629442|FG000|Overall Study|On-study Transplants|2|||
164342418|NCT00446251|593629442|FG000|Overall Study|Rituximab Infusion Reaction|2|||
164342419|NCT00446251|593629442|FG000|Overall Study|Lost to Follow-up|1|||
164342420|NCT01416272|593629446|FG000|Overall Study|Unacceptable distance visual acuity|2|||
164342421|NCT01416272|593629446|FG000|Overall Study|Lost to Follow-up|1|||
164342422|NCT01416272|593629446|FG000|Overall Study|Study related complaints|1|||
164342423|NCT00702689|593629447|FG000|Overall Study|Withdrawal by Subject|4|||
164342424|NCT00702689|593629447|FG000|Overall Study|Recurrent malignancy|1|||
164342425|NCT00702689|593629447|FG000|Overall Study|Adverse Event|1|||
164342426|NCT01986907|593629450|FG000|Overall Study|Adverse Event|11|||
164342427|NCT01986907|593629450|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
164342428|NCT01986907|593629450|FG000|Overall Study|Protocol Violation|4|||
164342429|NCT01986907|593629450|FG000|Overall Study|Withdrawal by Subject|76|||
164342430|NCT01986907|593629450|FG000|Overall Study|Lost to Follow-up|38|||
164342431|NCT01986907|593629450|FG000|Overall Study|Death|9|||
164342432|NCT00239590|593629453|FG000|Randomized|Lost to Follow-up|0|||
164342433|NCT00239590|593629454|FG001|Randomized|Lost to Follow-up|1|||
164342434|NCT00239590|593629453|FG000|Randomized|Withdrawal by Subject|0|||
164342435|NCT00239590|593629454|FG001|Randomized|Withdrawal by Subject|1|||
164342436|NCT00239590|593629453|FG000|Completed Study Protocol|Adverse Event|1|||
164342437|NCT00239590|593629454|FG001|Completed Study Protocol|Adverse Event|1|||
164342438|NCT00239590|593629453|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
164342439|NCT00239590|593629454|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
164342440|NCT00892047|593629459|FG000|Overall Study|Adverse Event|2|||
164342441|NCT00892047|593629460|FG001|Overall Study|Adverse Event|2|||
164342442|NCT00892047|593629459|FG000|Overall Study|subject burden|2|||
164342443|NCT00892047|593629460|FG001|Overall Study|subject burden|3|||
164342444|NCT00892047|593629459|FG000|Overall Study|Lack of Efficacy|0|||
164342445|NCT00892047|593629460|FG001|Overall Study|Lack of Efficacy|2|||
164342446|NCT02217878|593629461|FG000|Overall Study|required morphine due to chest pain|1|||
164342447|NCT02217878|593629462|FG001|Overall Study|required morphine due to chest pain|2|||
164342448|NCT02217878|593629461|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
164272241|NCT00545103|593364529|FG001|Overall Study|Use of prohibited medication|0|||
164342449|NCT02217878|593629462|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
164272242|NCT00545103|593364530|FG002|Overall Study|Use of prohibited medication|1|||
164272243|NCT00545103|593364531|FG003|Overall Study|Use of prohibited medication|0|||
164272244|NCT00545103|593364528|FG000|Overall Study|Does not want to take study drug anymore|1|||
164272245|NCT00545103|593364529|FG001|Overall Study|Does not want to take study drug anymore|0|||
164272246|NCT00545103|593364530|FG002|Overall Study|Does not want to take study drug anymore|1|||
164272247|NCT00545103|593364531|FG003|Overall Study|Does not want to take study drug anymore|0|||
164342450|NCT00259610|593629465|FG000|Overall Study|Withdrawal by Subject|33|||
164342451|NCT00259610|593629466|FG001|Overall Study|Withdrawal by Subject|25|||
164342452|NCT00259610|593629467|FG002|Overall Study|Withdrawal by Subject|29|||
164342453|NCT00259610|593629468|FG003|Overall Study|Withdrawal by Subject|19|||
164272248|NCT00545103|593364528|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
164342454|NCT00259610|593629465|FG000|Overall Study|Lost to Follow-up|19|||
164342455|NCT00259610|593629466|FG001|Overall Study|Lost to Follow-up|8|||
164272249|NCT00545103|593364529|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
164272250|NCT00545103|593364530|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
164272251|NCT00545103|593364531|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
164272252|NCT00545103|593364528|FG000|Overall Study|Death|0|||
164272253|NCT00545103|593364529|FG001|Overall Study|Death|1|||
164272254|NCT00545103|593364530|FG002|Overall Study|Death|0|||
164272255|NCT00545103|593364531|FG003|Overall Study|Death|0|||
164272256|NCT05026853|593364532|FG000|Overall Study|Cancelled appointment|1|||
164272257|NCT05026853|593364533|FG001|Overall Study|Cancelled appointment|0|||
164272258|NCT05026853|593364532|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
164272259|NCT05026853|593364533|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
164272260|NCT05026853|593364532|FG000|Overall Study|Did not complete 12-week survey|16|||
164272261|NCT05026853|593364533|FG001|Overall Study|Did not complete 12-week survey|16|||
164272262|NCT02358044|593364534|FG000|Overall Study|Adverse Event|0|||
164272263|NCT02358044|593364535|FG001|Overall Study|Adverse Event|1|||
164272264|NCT02358044|593364534|FG000|Overall Study|Lost to Follow-up|2|||
164272265|NCT02358044|593364535|FG001|Overall Study|Lost to Follow-up|1|||
164272266|NCT02358044|593364534|FG000|Overall Study|Physician Decision|0|||
164272267|NCT02358044|593364535|FG001|Overall Study|Physician Decision|1|||
164272268|NCT02358044|593364534|FG000|Overall Study|Withdrawal by Subject|0|||
164272269|NCT02358044|593364535|FG001|Overall Study|Withdrawal by Subject|4|||
164272270|NCT01732913|593364536|FG000|Overall Study|Study Terminated by Sponsor|105|||
164272271|NCT01732913|593364537|FG001|Overall Study|Study Terminated by Sponsor|55|||
164272272|NCT01732913|593364536|FG000|Overall Study|Withdrawal by Subject|27|||
164272273|NCT01732913|593364537|FG001|Overall Study|Withdrawal by Subject|4|||
164272274|NCT01732913|593364536|FG000|Overall Study|Physician Decision|14|||
164272275|NCT01732913|593364537|FG001|Overall Study|Physician Decision|7|||
164272276|NCT01732913|593364536|FG000|Overall Study|Other|7|||
164272277|NCT01732913|593364537|FG001|Overall Study|Other|1|||
164272278|NCT01732913|593364536|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
164272279|NCT01732913|593364537|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
164272280|NCT00903331|593364538|FG000|Overall Study|Death|4|||
164272281|NCT00903331|593364539|FG001|Overall Study|Death|8|||
164272282|NCT00903331|593364538|FG000|Overall Study|Withdrawal of consent|1|||
164272283|NCT00903331|593364539|FG001|Overall Study|Withdrawal of consent|8|||
164272284|NCT00903331|593364538|FG000|Overall Study|Lung transplant|0|||
164272285|NCT00903331|593364539|FG001|Overall Study|Lung transplant|2|||
164272286|NCT02723175|593364540|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
164272287|NCT02723175|593364541|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
164272288|NCT02723175|593364540|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
164272289|NCT02723175|593364541|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
164272290|NCT03233438|593364542|FG000|Overall Study|Lost to Follow-up|4|||
164272291|NCT03233438|593364543|FG001|Overall Study|Lost to Follow-up|9|||
163893883|NCT04934072|591983792|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
164000229|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
164272292|NCT03233438|593364542|FG000|Overall Study|Withdrawal by Subject|2|||
164272293|NCT03233438|593364543|FG001|Overall Study|Withdrawal by Subject|1|||
164272294|NCT03233438|593364542|FG000|Overall Study|No recording of dalbavancin|0|||
164272295|NCT03233438|593364543|FG001|Overall Study|No recording of dalbavancin|1|||
164272296|NCT00257660|593364548|FG000|Overall Study|Lack of Efficacy|5|||
164272297|NCT00257660|593364549|FG001|Overall Study|Lack of Efficacy|23|||
164272298|NCT00257660|593364548|FG000|Overall Study|Withdrawal by Subject|2|||
164272299|NCT00257660|593364549|FG001|Overall Study|Withdrawal by Subject|0|||
164272300|NCT00257660|593364548|FG000|Overall Study|Lost to Follow-up|1|||
164272301|NCT00257660|593364549|FG001|Overall Study|Lost to Follow-up|0|||
164272302|NCT00257660|593364548|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
164272303|NCT00257660|593364549|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
164272304|NCT00257660|593364548|FG000|Overall Study|No longer wanted to do blood draws|1|||
164272305|NCT00257660|593364549|FG001|Overall Study|No longer wanted to do blood draws|0|||
164272306|NCT04109976|593364550|FG000|Overall Study|Withdrawal by Subject|1|||
164272307|NCT04109976|593364551|FG001|Overall Study|Withdrawal by Subject|0|||
164272308|NCT00491608|593364552|FG000|Overall Study|Death|2|||
164272309|NCT00491608|593364552|FG000|Overall Study|Withdrawal by Subject|1|||
163893884|NCT04934072|591983793|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
163893885|NCT04934072|591983789|FG000|Week 52 to Week 78|Other|0|||
163893886|NCT04934072|591983790|FG001|Week 52 to Week 78|Other|0|||
163893887|NCT04934072|591983791|FG002|Week 52 to Week 78|Other|1|||
163893888|NCT04934072|591983792|FG003|Week 52 to Week 78|Other|0|||
163893889|NCT04934072|591983793|FG004|Week 52 to Week 78|Other|0|||
163893890|NCT05424380|591983796|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
164272310|NCT00413374|593364559|FG000|Overall Study|Ineligible due to screening criteria.|3|||
164272311|NCT00413374|593364560|FG001|Overall Study|Ineligible due to screening criteria.|0|||
163893891|NCT05424380|591983797|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
164272312|NCT00413374|593364559|FG000|Overall Study|Adverse Event|1|||
164272313|NCT00413374|593364560|FG001|Overall Study|Adverse Event|0|||
164272314|NCT00413374|593364559|FG000|Overall Study|Lost to Follow-up|1|||
164000230|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
164000231|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
164000232|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
164000233|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
164000234|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
164000235|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
164000236|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164000237|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164000238|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
164000239|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164000240|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
164000241|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164000242|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164000243|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
164000244|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
164000245|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
164000246|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
164272315|NCT00413374|593364560|FG001|Overall Study|Lost to Follow-up|0|||
164272316|NCT00413374|593364559|FG000|Overall Study|Surgery|1|||
164272317|NCT00413374|593364560|FG001|Overall Study|Surgery|0|||
164272318|NCT00552760|593364561|FG000|Overall Study|Adverse Event|3|||
164272319|NCT00552760|593364562|FG001|Overall Study|Adverse Event|5|||
164272320|NCT00552760|593364561|FG000|Overall Study|Relapsed- Depressed Event|10|||
164272321|NCT00552760|593364562|FG001|Overall Study|Relapsed- Depressed Event|16|||
164272322|NCT00552760|593364561|FG000|Overall Study|Relapse- Manic Event|3|||
164272323|NCT00552760|593364562|FG001|Overall Study|Relapse- Manic Event|3|||
164272324|NCT00552760|593364561|FG000|Overall Study|Relapsed- Mixed Event|3|||
164272325|NCT00552760|593364562|FG001|Overall Study|Relapsed- Mixed Event|5|||
164272326|NCT00552760|593364561|FG000|Overall Study|Protocol Violation|0|||
164272327|NCT00552760|593364562|FG001|Overall Study|Protocol Violation|1|||
164272328|NCT00552760|593364561|FG000|Overall Study|Lost to Follow-up|1|||
164272329|NCT00552760|593364562|FG001|Overall Study|Lost to Follow-up|1|||
164272330|NCT00552760|593364561|FG000|Overall Study|Non-compliance|1|||
164272331|NCT00552760|593364562|FG001|Overall Study|Non-compliance|1|||
164272332|NCT00552760|593364561|FG000|Overall Study|Medical Condition|1|||
164272333|NCT00552760|593364562|FG001|Overall Study|Medical Condition|1|||
164272334|NCT00552760|593364561|FG000|Overall Study|Withdrawal by Subject|3|||
164272335|NCT00552760|593364562|FG001|Overall Study|Withdrawal by Subject|0|||
164272336|NCT00552760|593364561|FG000|Overall Study|Medication Change|1|||
164272337|NCT00552760|593364562|FG001|Overall Study|Medication Change|0|||
164272338|NCT03615066|593364564|FG000|Main Study|Withdrew Consent|0|||
164272339|NCT03615066|593364565|FG001|Main Study|Withdrew Consent|1|||
164272340|NCT03615066|593364566|FG002|Main Study|Withdrew Consent|1|||
164272341|NCT03615066|593364564|FG000|Main Study|Lost to Follow-up|0|||
164272342|NCT03615066|593364565|FG001|Main Study|Lost to Follow-up|0|||
164272343|NCT03615066|593364566|FG002|Main Study|Lost to Follow-up|1|||
164272344|NCT03615066|593364564|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
164272345|NCT03615066|593364565|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
164272346|NCT03615066|593364566|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
164272347|NCT03615066|593364564|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
164272348|NCT03615066|593364565|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
164272349|NCT03615066|593364566|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
164272350|NCT03615066|593364564|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
164272351|NCT03615066|593364565|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
164272352|NCT03615066|593364566|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
164272353|NCT00924404|593364569|FG000|Overall Study|Lost to Follow-up|6|||
164272354|NCT00924404|593364570|FG001|Overall Study|Lost to Follow-up|4|||
164272355|NCT03831945|593364571|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
164272356|NCT03831945|593364572|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
164272357|NCT03831945|593364571|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
164272358|NCT03831945|593364572|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
164272359|NCT03831945|593364571|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
164272360|NCT03831945|593364572|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
164272361|NCT03426631|593364573|FG000|Overall Study|Lost to Follow-up|0|||
164272362|NCT03426631|593364574|FG001|Overall Study|Lost to Follow-up|1|||
164272363|NCT04032080|593364575|FG000|Overall Study|Death|6|||
164272364|NCT00500760|593364576|FG000|Overall Study|Death|32|||
164272365|NCT00500760|593364577|FG001|Overall Study|Death|15|||
164085942|NCT01261325|592678590|FG000|Overall Study|Protocol Violation|0|||
164085943|NCT01261325|592678591|FG001|Overall Study|Protocol Violation|3|||
164000247|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
164000248|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
164000249|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
164000250|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
164000251|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
164000252|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164000253|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164000254|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
164000255|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
164000256|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164000257|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
164000258|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164000259|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
164000260|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
164000261|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
164000262|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
164000263|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
164000264|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
164000265|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
164000266|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
164000267|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
164000268|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000269|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000270|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000271|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000272|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
164000273|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000274|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000275|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
164000276|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164000277|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164000278|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
164000279|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
164000280|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
164000281|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164000282|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
164000283|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
164000284|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164000285|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164000286|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164000287|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164000288|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
164000289|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
164000290|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
164000291|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
164000292|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000293|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000294|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000295|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000296|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000297|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
164000298|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000299|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
164000300|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164085944|NCT01261325|592678592|FG002|Overall Study|Protocol Violation|1|||
164342456|NCT00259610|593629467|FG002|Overall Study|Lost to Follow-up|18|||
164342457|NCT00259610|593629468|FG003|Overall Study|Lost to Follow-up|15|||
164342458|NCT00259610|593629465|FG000|Overall Study|Physician Decision|6|||
164342459|NCT00259610|593629466|FG001|Overall Study|Physician Decision|4|||
164342460|NCT00259610|593629467|FG002|Overall Study|Physician Decision|7|||
164342461|NCT00259610|593629468|FG003|Overall Study|Physician Decision|2|||
164000301|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164000302|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
164000303|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
164000304|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
164000305|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
164000306|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164000307|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
164000308|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164000309|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164000310|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164000311|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164000312|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
164000313|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
164000314|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164000315|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
164000316|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
164000317|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
164000318|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
164000319|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
164000320|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
164000321|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
164000322|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
164000323|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
164000324|NCT00408005|592364696|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164000325|NCT00408005|592364697|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164000326|NCT00408005|592364698|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
164000327|NCT00408005|592364699|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
164000328|NCT00408005|592364700|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
164000329|NCT00408005|592364701|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
164000330|NCT00408005|592364702|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164000331|NCT00408005|592364703|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
164000332|NCT05817045|592364704|FG000|Overall Study|Protocol Violation|0|||
164272366|NCT00500760|593364576|FG000|Overall Study|Withdrawal by Subject|5|||
164272367|NCT00500760|593364577|FG001|Overall Study|Withdrawal by Subject|7|||
164272368|NCT00500760|593364576|FG000|Overall Study|Administrative decision|2|||
164272369|NCT00500760|593364577|FG001|Overall Study|Administrative decision|0|||
164272370|NCT00500760|593364576|FG000|Overall Study|Lost to Follow-up|3|||
164272371|NCT00500760|593364577|FG001|Overall Study|Lost to Follow-up|0|||
164272372|NCT00500760|593364576|FG000|Overall Study|Other|1|||
164272373|NCT00500760|593364577|FG001|Overall Study|Other|2|||
164272374|NCT03691779|593364582|FG000|Part B (24 Weeks)|Adverse Event|0|||
164272375|NCT03691779|593364583|FG001|Part B (24 Weeks)|Adverse Event|1|||
164272376|NCT03691779|593364582|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
164272377|NCT03691779|593364583|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
164272378|NCT00521222|593364584|FG000|Overall Study|Lost to Follow-up|0|||
164272379|NCT00521222|593364585|FG001|Overall Study|Lost to Follow-up|0|||
164272380|NCT00521222|593364586|FG002|Overall Study|Lost to Follow-up|1|||
164272381|NCT00521222|593364587|FG003|Overall Study|Lost to Follow-up|1|||
164272382|NCT00521222|593364584|FG000|Overall Study|Withdrawal by Subject|0|||
164272383|NCT00521222|593364585|FG001|Overall Study|Withdrawal by Subject|0|||
164272384|NCT00521222|593364586|FG002|Overall Study|Withdrawal by Subject|2|||
164272385|NCT00521222|593364587|FG003|Overall Study|Withdrawal by Subject|0|||
164272386|NCT00521222|593364584|FG000|Overall Study|Physician Decision|0|||
164272387|NCT00521222|593364585|FG001|Overall Study|Physician Decision|1|||
164272388|NCT00521222|593364586|FG002|Overall Study|Physician Decision|0|||
164272389|NCT00521222|593364587|FG003|Overall Study|Physician Decision|1|||
164272390|NCT03869333|593364588|FG000|Overall Study|Lost to Follow-up|1|||
164272391|NCT03869333|593364589|FG001|Overall Study|Lost to Follow-up|0|||
164272392|NCT03869333|593364590|FG002|Overall Study|Lost to Follow-up|0|||
164272393|NCT03869333|593364591|FG003|Overall Study|Lost to Follow-up|0|||
164272394|NCT03869333|593364588|FG000|Overall Study|Pregnancy|1|||
164272395|NCT03869333|593364589|FG001|Overall Study|Pregnancy|0|||
164272396|NCT03869333|593364590|FG002|Overall Study|Pregnancy|0|||
164272397|NCT03869333|593364591|FG003|Overall Study|Pregnancy|0|||
164272398|NCT03869333|593364588|FG000|Overall Study|Physician Decision|0|||
164272399|NCT03869333|593364589|FG001|Overall Study|Physician Decision|1|||
164272400|NCT03869333|593364590|FG002|Overall Study|Physician Decision|0|||
164272401|NCT03869333|593364591|FG003|Overall Study|Physician Decision|0|||
164000333|NCT05817045|592364705|FG001|Overall Study|Protocol Violation|3|||
164000334|NCT05817045|592364704|FG000|Overall Study|Withdrawal by Subject|10|||
164000335|NCT05817045|592364705|FG001|Overall Study|Withdrawal by Subject|7|||
164000336|NCT05817045|592364704|FG000|Overall Study|Physician Decision|3|||
164000337|NCT05817045|592364705|FG001|Overall Study|Physician Decision|0|||
164000338|NCT05817045|592364704|FG000|Overall Study|Lost to Follow-up|0|||
164000339|NCT05817045|592364705|FG001|Overall Study|Lost to Follow-up|1|||
164000340|NCT05817045|592364704|FG000|Overall Study|Device Deficiency|1|||
164000341|NCT05817045|592364705|FG001|Overall Study|Device Deficiency|0|||
164000342|NCT05817045|592364704|FG000|Overall Study|System Error|1|||
164000343|NCT05817045|592364705|FG001|Overall Study|System Error|0|||
164000344|NCT01506141|592364706|FG000|Overall Study|Adverse Event|0|||
164000345|NCT01506141|592364707|FG001|Overall Study|Adverse Event|2|||
164000346|NCT01506141|592364706|FG000|Overall Study|Participation Terminated by Investigator|1|||
164000347|NCT01506141|592364707|FG001|Overall Study|Participation Terminated by Investigator|1|||
164000348|NCT01506141|592364706|FG000|Overall Study|Site Terminated by Sponsor|2|||
164000349|NCT01506141|592364707|FG001|Overall Study|Site Terminated by Sponsor|0|||
164000350|NCT01506141|592364706|FG000|Overall Study|Reason Not Specified|4|||
164000351|NCT01506141|592364707|FG001|Overall Study|Reason Not Specified|2|||
164000352|NCT04889209|592364708|FG000|All Cohorts Except 15E|Adverse Event|0|||
164000353|NCT04889209|592364709|FG001|All Cohorts Except 15E|Adverse Event|0|||
164000354|NCT04889209|592364710|FG002|All Cohorts Except 15E|Adverse Event|0|||
164000355|NCT04889209|592364711|FG003|All Cohorts Except 15E|Adverse Event|0|||
164000356|NCT04889209|592364712|FG004|All Cohorts Except 15E|Adverse Event|0|||
164272402|NCT01927055|593364592|FG000|Open-label|Adverse Event|6|||
164272403|NCT01927055|593364593|FG001|Open-label|Adverse Event|0|||
164272404|NCT01927055|593364594|FG002|Open-label|Adverse Event|0|||
164272405|NCT01927055|593364592|FG000|Open-label|Withdrawal by Subject|1|||
164272406|NCT01927055|593364593|FG001|Open-label|Withdrawal by Subject|0|||
164272407|NCT01927055|593364594|FG002|Open-label|Withdrawal by Subject|0|||
164272408|NCT01927055|593364592|FG000|Open-label|Study Stopped|4|||
164272409|NCT01927055|593364593|FG001|Open-label|Study Stopped|0|||
164272410|NCT01927055|593364594|FG002|Open-label|Study Stopped|0|||
164272411|NCT01927055|593364592|FG000|Open-label|Supine Hypertension|4|||
164272412|NCT01927055|593364593|FG001|Open-label|Supine Hypertension|0|||
164272413|NCT01927055|593364594|FG002|Open-label|Supine Hypertension|0|||
164272414|NCT01927055|593364592|FG000|Open-label|Difficulty attending study visits|1|||
164272415|NCT01927055|593364593|FG001|Open-label|Difficulty attending study visits|0|||
164272416|NCT01927055|593364594|FG002|Open-label|Difficulty attending study visits|0|||
164000357|NCT04889209|592364713|FG005|All Cohorts Except 15E|Adverse Event|0|||
164000358|NCT04889209|592364714|FG006|All Cohorts Except 15E|Adverse Event|1|||
164000359|NCT04889209|592364715|FG007|All Cohorts Except 15E|Adverse Event|0|||
164000360|NCT04889209|592364716|FG008|All Cohorts Except 15E|Adverse Event|0|||
164000361|NCT04889209|592364717|FG009|All Cohorts Except 15E|Adverse Event|0|||
164000362|NCT04889209|592364718|FG010|All Cohorts Except 15E|Adverse Event|0|||
164000363|NCT04889209|592364719|FG011|All Cohorts Except 15E|Adverse Event|0|||
164272417|NCT01927055|593364592|FG000|Double-Blind|Adverse Event|0|||
164272418|NCT01927055|593364593|FG001|Double-Blind|Adverse Event|1|||
164000364|NCT04889209|592364720|FG012|All Cohorts Except 15E|Adverse Event|0|||
164000365|NCT04889209|592364721|FG013|All Cohorts Except 15E|Adverse Event|0|||
164000366|NCT04889209|592364722|FG014|All Cohorts Except 15E|Adverse Event|0|||
164000367|NCT04889209|592364723|FG015|All Cohorts Except 15E|Adverse Event|0|||
164000368|NCT04889209|592364724|FG016|All Cohorts Except 15E|Adverse Event|0|||
164000369|NCT04889209|592364725|FG017|All Cohorts Except 15E|Adverse Event|0|||
164000370|NCT04889209|592364708|FG000|All Cohorts Except 15E|Death|0|||
164000371|NCT04889209|592364709|FG001|All Cohorts Except 15E|Death|1|||
164000372|NCT04889209|592364710|FG002|All Cohorts Except 15E|Death|0|||
164000373|NCT04889209|592364711|FG003|All Cohorts Except 15E|Death|0|||
164000374|NCT04889209|592364712|FG004|All Cohorts Except 15E|Death|0|||
164000375|NCT04889209|592364713|FG005|All Cohorts Except 15E|Death|0|||
164000376|NCT04889209|592364714|FG006|All Cohorts Except 15E|Death|0|||
164000377|NCT04889209|592364715|FG007|All Cohorts Except 15E|Death|0|||
164000378|NCT04889209|592364716|FG008|All Cohorts Except 15E|Death|0|||
164000379|NCT04889209|592364717|FG009|All Cohorts Except 15E|Death|0|||
164000380|NCT04889209|592364718|FG010|All Cohorts Except 15E|Death|0|||
164000381|NCT04889209|592364719|FG011|All Cohorts Except 15E|Death|0|||
164000382|NCT04889209|592364720|FG012|All Cohorts Except 15E|Death|0|||
164000383|NCT04889209|592364721|FG013|All Cohorts Except 15E|Death|0|||
164000384|NCT04889209|592364722|FG014|All Cohorts Except 15E|Death|0|||
164000385|NCT04889209|592364723|FG015|All Cohorts Except 15E|Death|0|||
164000386|NCT04889209|592364724|FG016|All Cohorts Except 15E|Death|0|||
164000387|NCT04889209|592364725|FG017|All Cohorts Except 15E|Death|0|||
164000388|NCT04889209|592364708|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
164000389|NCT04889209|592364709|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
164000390|NCT04889209|592364710|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
164000391|NCT04889209|592364711|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
164000392|NCT04889209|592364712|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
164000393|NCT04889209|592364713|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
164272419|NCT01927055|593364594|FG002|Double-Blind|Adverse Event|1|||
164272420|NCT01927055|593364592|FG000|Double-Blind|Protocol Violation|0|||
164272421|NCT01927055|593364593|FG001|Double-Blind|Protocol Violation|0|||
164272422|NCT01927055|593364594|FG002|Double-Blind|Protocol Violation|1|||
164272423|NCT01927055|593364592|FG000|Double-Blind|Withdrawal by Subject|0|||
164272424|NCT01927055|593364593|FG001|Double-Blind|Withdrawal by Subject|2|||
164272425|NCT01927055|593364594|FG002|Double-Blind|Withdrawal by Subject|3|||
164272426|NCT01927055|593364592|FG000|Double-Blind|Study Stopped|0|||
164272427|NCT01927055|593364593|FG001|Double-Blind|Study Stopped|7|||
164272428|NCT01927055|593364594|FG002|Double-Blind|Study Stopped|7|||
164272429|NCT01927055|593364592|FG000|Double-Blind|Supine Hypertension|0|||
164272430|NCT01927055|593364593|FG001|Double-Blind|Supine Hypertension|0|||
164272431|NCT01927055|593364594|FG002|Double-Blind|Supine Hypertension|1|||
164272432|NCT01927055|593364592|FG000|Double-Blind|Extended Vacation|0|||
164272433|NCT01927055|593364593|FG001|Double-Blind|Extended Vacation|1|||
164272434|NCT01927055|593364594|FG002|Double-Blind|Extended Vacation|0|||
164272435|NCT00649428|593366190|FG000|Overall Study|Adverse Event|2|||
164272436|NCT00649428|593366191|FG001|Overall Study|Adverse Event|2|||
164272437|NCT00649428|593366190|FG000|Overall Study|Withdrawal by Subject|6|||
164272438|NCT00649428|593366191|FG001|Overall Study|Withdrawal by Subject|6|||
164272439|NCT00649428|593366190|FG000|Overall Study|Lost to Follow-up|1|||
164272440|NCT00649428|593366191|FG001|Overall Study|Lost to Follow-up|3|||
164272441|NCT00649428|593366190|FG000|Overall Study|Insufficient manufacturing yield|5|||
164000394|NCT04889209|592364714|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
164000395|NCT04889209|592364715|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
164000396|NCT04889209|592364716|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
164000397|NCT04889209|592364717|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
164000398|NCT04889209|592364718|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
164000399|NCT04889209|592364719|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
164000400|NCT04889209|592364720|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
164000401|NCT04889209|592364721|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
164272442|NCT00649428|593366191|FG001|Overall Study|Insufficient manufacturing yield|1|||
164272443|NCT00649428|593366190|FG000|Overall Study|Protocol Violation|6|||
164272444|NCT00649428|593366191|FG001|Overall Study|Protocol Violation|2|||
164272445|NCT00649428|593366190|FG000|Overall Study|Physician Decision|0|||
164000402|NCT04889209|592364722|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
164000403|NCT04889209|592364723|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
164272446|NCT00649428|593366191|FG001|Overall Study|Physician Decision|1|||
164000404|NCT04889209|592364724|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
164000405|NCT04889209|592364725|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
164000406|NCT04889209|592364708|FG000|All Cohorts Except 15E|Physician Decision|0|||
164000407|NCT04889209|592364709|FG001|All Cohorts Except 15E|Physician Decision|0|||
164000408|NCT04889209|592364710|FG002|All Cohorts Except 15E|Physician Decision|0|||
164000409|NCT04889209|592364711|FG003|All Cohorts Except 15E|Physician Decision|0|||
164000410|NCT04889209|592364712|FG004|All Cohorts Except 15E|Physician Decision|1|||
164000411|NCT04889209|592364713|FG005|All Cohorts Except 15E|Physician Decision|0|||
164272447|NCT02503501|593366193|FG000|Overall Study|Physician Decision|1|||
164272448|NCT02503501|593366194|FG001|Overall Study|Physician Decision|0|||
164342462|NCT00259610|593629465|FG000|Overall Study|Death|1|||
164342463|NCT00259610|593629466|FG001|Overall Study|Death|1|||
164342464|NCT00259610|593629467|FG002|Overall Study|Death|2|||
164342465|NCT00259610|593629468|FG003|Overall Study|Death|0|||
164342466|NCT00259610|593629465|FG000|Overall Study|non medical reason|6|||
164342467|NCT00259610|593629466|FG001|Overall Study|non medical reason|2|||
164342468|NCT00259610|593629467|FG002|Overall Study|non medical reason|10|||
164342469|NCT00259610|593629468|FG003|Overall Study|non medical reason|3|||
164342470|NCT00259610|593629465|FG000|Overall Study|Adverse Event|3|||
164342471|NCT00259610|593629466|FG001|Overall Study|Adverse Event|4|||
164342472|NCT00259610|593629467|FG002|Overall Study|Adverse Event|5|||
164342473|NCT00259610|593629468|FG003|Overall Study|Adverse Event|2|||
164342474|NCT00259610|593629465|FG000|Overall Study|Serious Adverse Event|8|||
164342475|NCT00259610|593629466|FG001|Overall Study|Serious Adverse Event|2|||
164272449|NCT02503501|593366193|FG000|Overall Study|Protocol Violation|0|||
164272450|NCT02503501|593366194|FG001|Overall Study|Protocol Violation|1|||
164272451|NCT02503501|593366193|FG000|Overall Study|Withdrawal by Subject|0|||
164272452|NCT02503501|593366194|FG001|Overall Study|Withdrawal by Subject|2|||
164272453|NCT01740401|593366195|FG000|Overall Study|Progression of disease|6|||
164272454|NCT01740401|593366195|FG000|Overall Study|Adverse Event|2|||
164272455|NCT01740401|593366195|FG000|Overall Study|Did not reach primary endpoint|2|||
164272456|NCT02008227|593366196|FG000|Overall Study|Lost to Follow-up|7|||
164272457|NCT02008227|593366197|FG001|Overall Study|Lost to Follow-up|9|||
164272458|NCT02008227|593366196|FG000|Overall Study|Death|494|||
164272459|NCT02008227|593366197|FG001|Overall Study|Death|485|||
164272460|NCT02008227|593366196|FG000|Overall Study|Withdrawal by Subject|67|||
164272461|NCT02008227|593366197|FG001|Overall Study|Withdrawal by Subject|36|||
164272462|NCT02008227|593366196|FG000|Overall Study|Study Terminated By Sponsor|44|||
164272463|NCT02008227|593366197|FG001|Overall Study|Study Terminated By Sponsor|83|||
164272464|NCT05856227|593366202|FG000|Overall Study|Adverse Event|0|||
164272465|NCT05856227|593366203|FG001|Overall Study|Adverse Event|1|||
164272466|NCT05856227|593366202|FG000|Overall Study|Due to Investigator absence|1|||
164272467|NCT05856227|593366203|FG001|Overall Study|Due to Investigator absence|0|||
164272468|NCT05856227|593366202|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
164272469|NCT05856227|593366203|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
164272470|NCT01571232|593366204|FG000|Overall Study|Lost to Follow-up|0|||
164272471|NCT01571232|593366205|FG001|Overall Study|Lost to Follow-up|1|||
164272472|NCT01571232|593366204|FG000|Overall Study|Withdrawal by Subject|1|||
164272473|NCT01571232|593366205|FG001|Overall Study|Withdrawal by Subject|0|||
164272474|NCT02294734|593366210|FG000|Overall Study|Adverse Event|5|||
164272475|NCT02294734|593366211|FG001|Overall Study|Adverse Event|5|||
164342476|NCT00259610|593629467|FG002|Overall Study|Serious Adverse Event|2|||
164342477|NCT00259610|593629468|FG003|Overall Study|Serious Adverse Event|2|||
164342478|NCT01201785|593629472|FG000|Overall Study|Lost to Follow-up|16|||
164342479|NCT02151110|593629473|FG000|Overall Study|Withdrawal by Subject|0|||
164342480|NCT02151110|593629474|FG001|Overall Study|Withdrawal by Subject|0|||
164342481|NCT02151110|593629475|FG002|Overall Study|Withdrawal by Subject|0|||
164342482|NCT02151110|593629476|FG003|Overall Study|Withdrawal by Subject|0|||
164342483|NCT02151110|593629477|FG004|Overall Study|Withdrawal by Subject|0|||
164342484|NCT02151110|593629478|FG005|Overall Study|Withdrawal by Subject|0|||
164342485|NCT02151110|593629479|FG006|Overall Study|Withdrawal by Subject|0|||
164342486|NCT02151110|593629480|FG007|Overall Study|Withdrawal by Subject|1|||
164342487|NCT02151110|593629473|FG000|Overall Study|Lost to Follow-up|0|||
164342488|NCT02151110|593629474|FG001|Overall Study|Lost to Follow-up|0|||
164342489|NCT02151110|593629475|FG002|Overall Study|Lost to Follow-up|0|||
164342490|NCT02151110|593629476|FG003|Overall Study|Lost to Follow-up|0|||
164342491|NCT02151110|593629477|FG004|Overall Study|Lost to Follow-up|0|||
164342492|NCT02151110|593629478|FG005|Overall Study|Lost to Follow-up|0|||
164272476|NCT02294734|593366210|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
164272477|NCT02294734|593366211|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
164272478|NCT02294734|593366210|FG000|Overall Study|Lost to Follow-up|2|||
164272479|NCT02294734|593366211|FG001|Overall Study|Lost to Follow-up|0|||
164272480|NCT02294734|593366210|FG000|Overall Study|Physician Decision|2|||
164342493|NCT02151110|593629479|FG006|Overall Study|Lost to Follow-up|0|||
164342494|NCT02151110|593629480|FG007|Overall Study|Lost to Follow-up|2|||
164342495|NCT01999179|593629481|FG000|Overall Study|Adverse Event|1|||
164272481|NCT02294734|593366211|FG001|Overall Study|Physician Decision|1|||
164272482|NCT02294734|593366210|FG000|Overall Study|Withdrawal by Subject|4|||
164272483|NCT02294734|593366211|FG001|Overall Study|Withdrawal by Subject|2|||
164272484|NCT00548717|593366212|FG000|Overall Study|Death|5|||
164272485|NCT00548717|593366213|FG001|Overall Study|Death|2|||
164272486|NCT00548717|593366212|FG000|Overall Study|Relapse|3|||
164272487|NCT00548717|593366213|FG001|Overall Study|Relapse|0|||
164272488|NCT00548717|593366212|FG000|Overall Study|Alternative treatment for GVHD|1|||
164272489|NCT00548717|593366213|FG001|Overall Study|Alternative treatment for GVHD|0|||
164272490|NCT03157583|593366214|FG000|Overall Study|Other (did not meet study criteria)|1|||
164272491|NCT00908037|593366216|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272492|NCT00908037|593366217|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272493|NCT00908037|593366218|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272494|NCT00908037|593366219|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272495|NCT00908037|593366220|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
164272496|NCT00908037|593366221|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272497|NCT00908037|593366222|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
164272498|NCT00908037|593366223|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272499|NCT00908037|593366224|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
164272500|NCT00908037|593366225|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272501|NCT00908037|593366226|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272502|NCT00908037|593366227|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
164272503|NCT00908037|593366216|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272504|NCT00908037|593366217|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272505|NCT00908037|593366218|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272506|NCT00908037|593366219|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272507|NCT00908037|593366220|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
164272508|NCT00908037|593366221|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272509|NCT00908037|593366222|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272510|NCT00908037|593366223|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272511|NCT00908037|593366224|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
164272512|NCT00908037|593366225|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272513|NCT00908037|593366226|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272514|NCT00908037|593366227|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
164272515|NCT00908037|593366216|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272516|NCT00908037|593366217|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272517|NCT00908037|593366218|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272518|NCT00908037|593366219|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
164272519|NCT00908037|593366220|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272520|NCT00908037|593366221|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272521|NCT00908037|593366222|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
164272522|NCT00908037|593366223|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272523|NCT00908037|593366224|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272524|NCT00908037|593366225|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272525|NCT00908037|593366226|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272526|NCT00908037|593366227|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
164272527|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272528|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272529|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272530|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164342496|NCT01999179|593629481|FG000|Overall Study|Lost to Follow-up|1|||
164342497|NCT01999179|593629481|FG000|Overall Study|Change in Therapy|3|||
164342498|NCT01999179|593629481|FG000|Overall Study|New catheter|2|||
164342499|NCT01146665|593629482|FG000|Overall Study|Withdrawal by Subject|10|||
164342500|NCT01146665|593629483|FG001|Overall Study|Withdrawal by Subject|16|||
164342501|NCT02538029|593629485|FG000|Overall Study|unable to complete cognitive assessments|1|||
164342502|NCT02538029|593629486|FG001|Overall Study|unable to complete cognitive assessments|0|||
164342503|NCT02538029|593629487|FG002|Overall Study|unable to complete cognitive assessments|1|||
164342504|NCT01064310|593629490|FG000|Period 1|Adverse Event|7|||
164342505|NCT01064310|593629491|FG001|Period 1|Adverse Event|10|||
164342506|NCT01064310|593629492|FG002|Period 1|Adverse Event|0|||
164342507|NCT01064310|593629490|FG000|Period 1|Physician Decision|1|||
164342508|NCT01064310|593629491|FG001|Period 1|Physician Decision|0|||
164342509|NCT01064310|593629492|FG002|Period 1|Physician Decision|0|||
164342510|NCT01064310|593629490|FG000|Period 1|Withdrawal by Subject|2|||
164342511|NCT01064310|593629491|FG001|Period 1|Withdrawal by Subject|2|||
164342512|NCT01064310|593629492|FG002|Period 1|Withdrawal by Subject|0|||
164342513|NCT01064310|593629490|FG000|Period 1|Lack of Efficacy|3|||
164342514|NCT01064310|593629491|FG001|Period 1|Lack of Efficacy|5|||
164342515|NCT01064310|593629492|FG002|Period 1|Lack of Efficacy|0|||
164342516|NCT01064310|593629490|FG000|Period 1|Entered Open-label Period|1|||
164342517|NCT01064310|593629491|FG001|Period 1|Entered Open-label Period|1|||
164342518|NCT01064310|593629492|FG002|Period 1|Entered Open-label Period|0|||
164342519|NCT01064310|593629490|FG000|Period 2|Adverse Event|2|||
164272531|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272532|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272533|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272534|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272535|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272536|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272537|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
164272538|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
164272539|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272540|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272541|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272542|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272543|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272544|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272545|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272546|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272547|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272548|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
164272549|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
164272550|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
164272551|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272552|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272553|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272554|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272555|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272556|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272557|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272558|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272559|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272560|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
164272561|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272562|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
164272563|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272564|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272565|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272566|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272567|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272568|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164000412|NCT04889209|592364714|FG006|All Cohorts Except 15E|Physician Decision|0|||
164000413|NCT04889209|592364715|FG007|All Cohorts Except 15E|Physician Decision|1|||
164272569|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272570|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272571|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272572|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272573|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
164272574|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
164272575|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272576|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272577|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272578|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272579|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272580|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272581|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272582|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272583|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272584|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
164272585|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164000414|NCT04889209|592364716|FG008|All Cohorts Except 15E|Physician Decision|0|||
164000415|NCT04889209|592364717|FG009|All Cohorts Except 15E|Physician Decision|1|||
164000416|NCT04889209|592364718|FG010|All Cohorts Except 15E|Physician Decision|0|||
164000417|NCT04889209|592364719|FG011|All Cohorts Except 15E|Physician Decision|1|||
164000418|NCT04889209|592364720|FG012|All Cohorts Except 15E|Physician Decision|1|||
164000419|NCT04889209|592364721|FG013|All Cohorts Except 15E|Physician Decision|0|||
164000420|NCT04889209|592364722|FG014|All Cohorts Except 15E|Physician Decision|0|||
164272586|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
164272587|NCT00908037|593366216|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272588|NCT00908037|593366217|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272589|NCT00908037|593366218|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272590|NCT00908037|593366219|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272591|NCT00908037|593366220|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272592|NCT00908037|593366221|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272593|NCT00908037|593366222|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272594|NCT00908037|593366223|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272595|NCT00908037|593366224|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272596|NCT00908037|593366225|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272597|NCT00908037|593366226|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
164272598|NCT00908037|593366227|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
164272599|NCT01953913|593366228|FG000|Overall Study|Disease Progression|349|||
164272600|NCT01953913|593366228|FG000|Overall Study|Worsening of underlying cancer|22|||
164272601|NCT01953913|593366228|FG000|Overall Study|Adverse Event|20|||
164272602|NCT01953913|593366228|FG000|Overall Study|Protocol Violation|6|||
164272603|NCT01953913|593366228|FG000|Overall Study|Lost to Follow-up|4|||
164272604|NCT01953913|593366228|FG000|Overall Study|Withdrawal by Subject|32|||
164272605|NCT01953913|593366228|FG000|Overall Study|Other than listed|108|||
164272606|NCT01953913|593366228|FG000|Overall Study|Not Treated|1|||
164272607|NCT02925741|593366229|FG000|Overall Study|Withdrawal by Subject|11|||
164272608|NCT02925741|593366230|FG001|Overall Study|Withdrawal by Subject|0|||
164272609|NCT00494507|593366231|FG000|Double-Blind Phase|Adverse Event|2|||
164272610|NCT00494507|593366232|FG001|Double-Blind Phase|Adverse Event|0|||
164272611|NCT00494507|593366233|FG002|Double-Blind Phase|Adverse Event|1|||
164272612|NCT00494507|593366234|FG003|Double-Blind Phase|Adverse Event|0|||
164272613|NCT00494507|593366231|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
164272614|NCT00494507|593366232|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
164272615|NCT00494507|593366233|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164272616|NCT00494507|593366234|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164272617|NCT00494507|593366231|FG000|Double-Blind Phase|Subject Non-compliance|0|||
164272618|NCT00494507|593366232|FG001|Double-Blind Phase|Subject Non-compliance|0|||
164272619|NCT00494507|593366233|FG002|Double-Blind Phase|Subject Non-compliance|1|||
164272620|NCT00494507|593366234|FG003|Double-Blind Phase|Subject Non-compliance|0|||
164272621|NCT00494507|593366231|FG000|Double-Blind Phase|Negative DNA test|0|||
164272622|NCT00494507|593366232|FG001|Double-Blind Phase|Negative DNA test|0|||
164272623|NCT00494507|593366233|FG002|Double-Blind Phase|Negative DNA test|0|||
164272624|NCT00494507|593366234|FG003|Double-Blind Phase|Negative DNA test|1|||
164272625|NCT00494507|593366231|FG000|Open-Label Phase|Adverse Event|0|||
164272626|NCT00494507|593366232|FG001|Open-Label Phase|Adverse Event|1|||
164272627|NCT00494507|593366233|FG002|Open-Label Phase|Adverse Event|5|||
164272628|NCT00494507|593366234|FG003|Open-Label Phase|Adverse Event|3|||
164272629|NCT00494507|593366231|FG000|Open-Label Phase|Worsening Disease|0|||
164272630|NCT00494507|593366232|FG001|Open-Label Phase|Worsening Disease|0|||
164272631|NCT00494507|593366233|FG002|Open-Label Phase|Worsening Disease|0|||
164272632|NCT00494507|593366234|FG003|Open-Label Phase|Worsening Disease|2|||
164272633|NCT02437084|593366237|FG000|Overall Study|Withdrawal by Subject|2|||
164272634|NCT02437084|593366237|FG000|Overall Study|Physician Decision|1|||
164272635|NCT00454181|593366238|FG000|Overall Study|Adverse Event|1|||
164272636|NCT00454181|593366239|FG001|Overall Study|Adverse Event|1|||
164272637|NCT00454181|593366238|FG000|Overall Study|Lost to Follow-up|11|||
164272638|NCT00454181|593366239|FG001|Overall Study|Lost to Follow-up|1|||
164272639|NCT00454181|593366238|FG000|Overall Study|Protocol Violation|1|||
164000421|NCT04889209|592364723|FG015|All Cohorts Except 15E|Physician Decision|0|||
164000422|NCT04889209|592364724|FG016|All Cohorts Except 15E|Physician Decision|0|||
164000423|NCT04889209|592364725|FG017|All Cohorts Except 15E|Physician Decision|0|||
164000424|NCT04889209|592364708|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
164000425|NCT04889209|592364709|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
164000426|NCT04889209|592364710|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
164000427|NCT04889209|592364711|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
164000428|NCT04889209|592364712|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
164000429|NCT04889209|592364713|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
164000430|NCT04889209|592364714|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
164272640|NCT00454181|593366239|FG001|Overall Study|Protocol Violation|1|||
164272641|NCT00454181|593366238|FG000|Overall Study|Withdrawal by Subject|2|||
164272642|NCT00454181|593366239|FG001|Overall Study|Withdrawal by Subject|0|||
164272643|NCT02613169|593366240|FG000|Overall Study|Withdrawal by Subject|4|||
164272644|NCT02613169|593366241|FG001|Overall Study|Withdrawal by Subject|1|||
164000431|NCT04889209|592364715|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
164000432|NCT04889209|592364716|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
164272645|NCT02613169|593366240|FG000|Overall Study|Lost to Follow-up|0|||
164272646|NCT02613169|593366241|FG001|Overall Study|Lost to Follow-up|5|||
164272647|NCT02613169|593366240|FG000|Overall Study|HIV|0|||
164272648|NCT02613169|593366241|FG001|Overall Study|HIV|2|||
164272649|NCT02613169|593366240|FG000|Overall Study|No TB infection endpoint|14|||
164272650|NCT02613169|593366241|FG001|Overall Study|No TB infection endpoint|9|||
164272651|NCT03729245|593366242|FG000|Overall Study|Lost to Follow-up|5|||
164272652|NCT03729245|593366243|FG001|Overall Study|Lost to Follow-up|6|||
164272653|NCT03729245|593366242|FG000|Overall Study|Withdrawal by Subject|16|||
164000433|NCT04889209|592364717|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
164272654|NCT03729245|593366243|FG001|Overall Study|Withdrawal by Subject|19|||
164272655|NCT03729245|593366242|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
164272656|NCT03729245|593366243|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
164272657|NCT02096263|593366244|FG000|Overall Study|Adverse Event|1|||
164272658|NCT02096263|593366245|FG001|Overall Study|Adverse Event|0|||
164272659|NCT02096263|593366246|FG002|Overall Study|Adverse Event|1|||
164272660|NCT02096263|593366244|FG000|Overall Study|Lost to Follow-up|14|||
164272661|NCT02096263|593366245|FG001|Overall Study|Lost to Follow-up|18|||
164272662|NCT02096263|593366246|FG002|Overall Study|Lost to Follow-up|15|||
164272663|NCT02096263|593366244|FG000|Overall Study|Other|7|||
164272664|NCT02096263|593366245|FG001|Overall Study|Other|9|||
164342520|NCT01064310|593629491|FG001|Period 2|Adverse Event|1|||
164342521|NCT01064310|593629492|FG002|Period 2|Adverse Event|0|||
164342522|NCT01064310|593629490|FG000|Period 2|Physician Decision|0|||
164342523|NCT01064310|593629491|FG001|Period 2|Physician Decision|1|||
164342524|NCT01064310|593629492|FG002|Period 2|Physician Decision|0|||
164342525|NCT01064310|593629490|FG000|Period 2|Entered Open-label Period|1|||
164342526|NCT01064310|593629491|FG001|Period 2|Entered Open-label Period|0|||
164342527|NCT01064310|593629492|FG002|Period 2|Entered Open-label Period|0|||
164342528|NCT01064310|593629490|FG000|Period 2|Lack of Efficacy|1|||
164342529|NCT01064310|593629491|FG001|Period 2|Lack of Efficacy|4|||
164342530|NCT01064310|593629492|FG002|Period 2|Lack of Efficacy|0|||
164342531|NCT01064310|593629490|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
164342532|NCT01064310|593629491|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
164342533|NCT01064310|593629492|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
164342534|NCT01064310|593629490|FG000|Open Label Pazopinib|Adverse Event|0|||
164342535|NCT01064310|593629491|FG001|Open Label Pazopinib|Adverse Event|0|||
164342536|NCT01064310|593629492|FG002|Open Label Pazopinib|Adverse Event|12|||
164342537|NCT01064310|593629490|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
164342538|NCT01064310|593629491|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
164342539|NCT01064310|593629492|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
164342540|NCT01064310|593629490|FG000|Open Label Pazopinib|Physician Decision|0|||
164342541|NCT01064310|593629491|FG001|Open Label Pazopinib|Physician Decision|0|||
164342542|NCT01064310|593629492|FG002|Open Label Pazopinib|Physician Decision|20|||
164342543|NCT00001880|593629493|FG000|Overall Study|Death|14|||
164342544|NCT02639065|593629494|FG000|Study Treatment|Disease Progression|13|||
164342545|NCT02639065|593629494|FG000|Study Treatment|Adverse Event|9|||
164342546|NCT02639065|593629494|FG000|Study Treatment|Withdrawal by Subject|1|||
164342547|NCT02639065|593629494|FG000|Follow up|Subject refused to follow up|1|||
164342548|NCT02639065|593629494|FG000|Follow up|Symptomatic Deterioration|2|||
164342549|NCT02639065|593629494|FG000|Follow up|Death|2|||
164342550|NCT02639065|593629494|FG000|Follow up|Study Terminated|1|||
164342551|NCT02639065|593629494|FG000|Follow up|Disease Progression|3|||
164342552|NCT00660699|593629497|FG000|Overall Study|Withdrawal by Subject|2|||
164342553|NCT05147428|593629498|FG000|Overall Study|Removed prior to mailing|289|||
164342554|NCT05147428|593629499|FG001|Overall Study|Removed prior to mailing|306|||
164342555|NCT05147428|593629500|FG002|Overall Study|Removed prior to mailing|270|||
164342556|NCT05147428|593629498|FG000|Overall Study|Died or disenrolled during blackout period|239|||
164342557|NCT05147428|593629499|FG001|Overall Study|Died or disenrolled during blackout period|278|||
164342558|NCT05147428|593629500|FG002|Overall Study|Died or disenrolled during blackout period|273|||
164342559|NCT03128047|593629501|FG000|Overall Study|Withdrawal by Subject|1|||
164000434|NCT04889209|592364718|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
164000435|NCT04889209|592364719|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
164272665|NCT02096263|593366246|FG002|Overall Study|Other|6|||
164272666|NCT02096263|593366244|FG000|Overall Study|Sponsor study termination|0|||
164342560|NCT05996718|593631450|FG000|Overall Study|Lost to Follow-up|3|||
164342561|NCT01713686|593631451|FG000|Overall Study|Lost to Follow-up|9|||
164272667|NCT02096263|593366245|FG001|Overall Study|Sponsor study termination|0|||
164272668|NCT02096263|593366246|FG002|Overall Study|Sponsor study termination|1|||
164000436|NCT04889209|592364720|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
164272669|NCT02096263|593366244|FG000|Overall Study|Protocol Violation|7|||
164342562|NCT01713686|593631451|FG000|Overall Study|Withdrawal by Subject|6|||
164342563|NCT02385045|593631452|FG000|Overall Study|Endoscopy could not be completed|4|||
164000437|NCT04889209|592364721|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
164342564|NCT00115739|593631453|FG000|Overall Study|Lost to Follow-up|3|||
164342565|NCT02200211|593631457|FG000|Overall Study|Lost to Follow-up|7|||
164272670|NCT02096263|593366245|FG001|Overall Study|Protocol Violation|2|||
164272671|NCT02096263|593366246|FG002|Overall Study|Protocol Violation|8|||
164272672|NCT02096263|593366244|FG000|Overall Study|Withdrawal by Subject|5|||
164272673|NCT02096263|593366245|FG001|Overall Study|Withdrawal by Subject|7|||
164272674|NCT02096263|593366246|FG002|Overall Study|Withdrawal by Subject|8|||
164272675|NCT01571453|593366248|FG000|Overall Study|Adverse Event|14|||
164272676|NCT01571453|593366249|FG001|Overall Study|Adverse Event|32|||
164272677|NCT01571453|593366248|FG000|Overall Study|Lack of Efficacy|8|||
164272678|NCT01571453|593366249|FG001|Overall Study|Lack of Efficacy|3|||
164272679|NCT01571453|593366248|FG000|Overall Study|Non-compliance|2|||
164272680|NCT01571453|593366249|FG001|Overall Study|Non-compliance|4|||
164272681|NCT01571453|593366248|FG000|Overall Study|Protocol Violation|1|||
164272682|NCT01571453|593366249|FG001|Overall Study|Protocol Violation|5|||
164272683|NCT01571453|593366248|FG000|Overall Study|Withdrawal of consent|5|||
164272684|NCT01571453|593366249|FG001|Overall Study|Withdrawal of consent|13|||
164272685|NCT01571453|593366248|FG000|Overall Study|Lost to Follow-up|4|||
164272686|NCT01571453|593366249|FG001|Overall Study|Lost to Follow-up|2|||
164272687|NCT01571453|593366248|FG000|Overall Study|Administrative or other reason(s)|4|||
164272688|NCT01571453|593366249|FG001|Overall Study|Administrative or other reason(s)|3|||
164272689|NCT02976103|593366254|FG000|Overall Study|Withdrawal by Subject|1|||
164272690|NCT02976103|593366255|FG001|Overall Study|Withdrawal by Subject|0|||
164272691|NCT02976103|593366254|FG000|Overall Study|Lost to Follow-up|12|||
164272692|NCT02976103|593366255|FG001|Overall Study|Lost to Follow-up|8|||
164272693|NCT01985360|593366256|FG000|Overall Study|Withdrawal by Subject|4|||
164272694|NCT01985360|593366257|FG001|Overall Study|Withdrawal by Subject|0|||
164272695|NCT01985360|593366256|FG000|Overall Study|Lost to Follow-up|5|||
164272696|NCT01985360|593366257|FG001|Overall Study|Lost to Follow-up|3|||
164272697|NCT00694304|593366258|FG000|Overall Study|Adverse Event|42|||
164272698|NCT00694304|593366258|FG000|Overall Study|Lack of Efficacy|35|||
164272699|NCT00694304|593366258|FG000|Overall Study|Non-compliance With Study Product|16|||
164272700|NCT00694304|593366258|FG000|Overall Study|Protocol Violation|6|||
164272701|NCT00694304|593366258|FG000|Overall Study|Withdrawal of Consent|61|||
164272702|NCT00694304|593366258|FG000|Overall Study|Lost to Follow-up|15|||
164272703|NCT00694304|593366258|FG000|Overall Study|Administrative or Other Reasons|32|||
164272704|NCT00845065|593366262|FG000|Overall Study|Adverse Event|3|||
164272705|NCT00845065|593366263|FG001|Overall Study|Adverse Event|23|||
164272706|NCT00845065|593366262|FG000|Overall Study|Lack of Efficacy|43|||
164272707|NCT00845065|593366263|FG001|Overall Study|Lack of Efficacy|21|||
164272708|NCT00845065|593366262|FG000|Overall Study|Non-Medical Reasons|1|||
164272709|NCT00845065|593366263|FG001|Overall Study|Non-Medical Reasons|11|||
164272710|NCT02228096|593366267|FG000|Overall Study|Study terminated by Sponsor|24|||
164272711|NCT02228096|593366267|FG000|Overall Study|Lack of Efficacy|18|||
164272712|NCT02228096|593366267|FG000|Overall Study|Death|12|||
164272713|NCT02228096|593366267|FG000|Overall Study|Physician Decision|3|||
164272714|NCT02228096|593366267|FG000|Overall Study|Subject/guardian decision|2|||
164272715|NCT02228096|593366267|FG000|Overall Study|New therapy for study indication|1|||
164342566|NCT02200211|593631458|FG001|Overall Study|Lost to Follow-up|7|||
164342567|NCT02200211|593631459|FG002|Overall Study|Lost to Follow-up|1|||
164342568|NCT02200211|593631460|FG003|Overall Study|Lost to Follow-up|2|||
164342569|NCT02200211|593631457|FG000|Overall Study|Withdrawal by Subject|1|||
164342570|NCT02200211|593631458|FG001|Overall Study|Withdrawal by Subject|0|||
164342571|NCT02200211|593631459|FG002|Overall Study|Withdrawal by Subject|0|||
164342572|NCT02200211|593631460|FG003|Overall Study|Withdrawal by Subject|0|||
164342573|NCT00381485|593631461|FG000|Open-Label Run-In Period|Adverse Event|9|||
163893892|NCT05424380|591983798|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163893893|NCT05424380|591983799|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163893894|NCT05424380|591983800|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163893895|NCT05424380|591983801|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
163893896|NCT05424380|591983796|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
163893897|NCT05424380|591983797|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163893898|NCT05424380|591983798|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163893899|NCT05424380|591983799|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163893900|NCT05424380|591983800|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
164272716|NCT02228096|593366267|FG000|Overall Study|Enrolled, not infused|11|||
164272717|NCT02383433|593366268|FG000|Overall Study|Disease progression|2|||
164272718|NCT00952614|593366271|FG000|Overall Study|Death|3|||
164272719|NCT00952614|593366271|FG000|Overall Study|Lost to Follow-up|3|||
164272720|NCT00952614|593366271|FG000|Overall Study|other reason|1|||
164272721|NCT02963701|593366273|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
164272722|NCT02963701|593366274|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
164272723|NCT01345682|593366275|FG000|Overall Study|Progressive disease per RECIST|226|||
164272724|NCT01345682|593366276|FG001|Overall Study|Progressive disease per RECIST|93|||
164272725|NCT01345682|593366275|FG000|Overall Study|Worsening of underlying cancer disease|23|||
164272726|NCT01345682|593366276|FG001|Overall Study|Worsening of underlying cancer disease|12|||
164272727|NCT01345682|593366275|FG000|Overall Study|Adverse Event|51|||
164342574|NCT00381485|593631462|FG001|Open-Label Run-In Period|Adverse Event|0|||
164000438|NCT04889209|592364722|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
164000439|NCT04889209|592364723|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
164000440|NCT04889209|592364724|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
164272728|NCT01345682|593366276|FG001|Overall Study|Adverse Event|41|||
164272729|NCT01345682|593366275|FG000|Overall Study|Non-compliance with protocol|0|||
164272730|NCT01345682|593366276|FG001|Overall Study|Non-compliance with protocol|1|||
164272731|NCT01345682|593366275|FG000|Overall Study|Lost to Follow-up|0|||
164272732|NCT01345682|593366276|FG001|Overall Study|Lost to Follow-up|1|||
164272733|NCT01345682|593366275|FG000|Overall Study|Refused to continue trial medication|16|||
164272734|NCT01345682|593366276|FG001|Overall Study|Refused to continue trial medication|9|||
164272735|NCT01345682|593366275|FG000|Overall Study|Not treated|2|||
164272736|NCT01345682|593366276|FG001|Overall Study|Not treated|1|||
164272737|NCT01345682|593366275|FG000|Overall Study|Reason other than those specified above|4|||
164272738|NCT01345682|593366276|FG001|Overall Study|Reason other than those specified above|3|||
164272739|NCT00896649|593366277|FG000|Overall Study|Physician Decision|1|||
164272740|NCT00896649|593366277|FG000|Overall Study|Pregnancy|1|||
164272741|NCT00896649|593366277|FG000|Overall Study|missing documentation|1|||
164272742|NCT00896649|593366277|FG000|Overall Study|technical difficulties|2|||
164272743|NCT01075984|593366279|FG000|Treatment Phase|Adverse Event|0|||
164272744|NCT01075984|593366280|FG001|Treatment Phase|Adverse Event|1|||
164272745|NCT01075984|593366281|FG002|Treatment Phase|Adverse Event|3|||
164272746|NCT01075984|593366282|FG003|Treatment Phase|Adverse Event|7|||
164272747|NCT01075984|593366283|FG004|Treatment Phase|Adverse Event|35|||
164272748|NCT01075984|593366279|FG000|Treatment Phase|Protocol Violation|0|||
164272749|NCT01075984|593366280|FG001|Treatment Phase|Protocol Violation|0|||
164272750|NCT01075984|593366281|FG002|Treatment Phase|Protocol Violation|1|||
164272751|NCT01075984|593366282|FG003|Treatment Phase|Protocol Violation|0|||
164272752|NCT01075984|593366283|FG004|Treatment Phase|Protocol Violation|3|||
164272753|NCT01075984|593366279|FG000|Treatment Phase|Withdrawal by Subject|0|||
164272754|NCT01075984|593366280|FG001|Treatment Phase|Withdrawal by Subject|0|||
164272755|NCT01075984|593366281|FG002|Treatment Phase|Withdrawal by Subject|2|||
164272756|NCT01075984|593366282|FG003|Treatment Phase|Withdrawal by Subject|0|||
164272757|NCT01075984|593366283|FG004|Treatment Phase|Withdrawal by Subject|15|||
164272758|NCT01075984|593366279|FG000|Treatment Phase|Treatment Failure|0|||
164272759|NCT01075984|593366280|FG001|Treatment Phase|Treatment Failure|0|||
164272760|NCT01075984|593366281|FG002|Treatment Phase|Treatment Failure|1|||
164272761|NCT01075984|593366282|FG003|Treatment Phase|Treatment Failure|0|||
164272762|NCT01075984|593366283|FG004|Treatment Phase|Treatment Failure|5|||
164272763|NCT01075984|593366279|FG000|Treatment Phase|Progression of disease|0|||
164272764|NCT01075984|593366280|FG001|Treatment Phase|Progression of disease|0|||
164272765|NCT01075984|593366281|FG002|Treatment Phase|Progression of disease|0|||
164272766|NCT01075984|593366282|FG003|Treatment Phase|Progression of disease|0|||
164272767|NCT01075984|593366283|FG004|Treatment Phase|Progression of disease|2|||
164272768|NCT01075984|593366279|FG000|Follow-up Phase|Protocol Violation|0|||
164272769|NCT01075984|593366280|FG001|Follow-up Phase|Protocol Violation|0|||
164272770|NCT01075984|593366281|FG002|Follow-up Phase|Protocol Violation|1|||
164272771|NCT01075984|593366282|FG003|Follow-up Phase|Protocol Violation|0|||
164272772|NCT01075984|593366283|FG004|Follow-up Phase|Protocol Violation|3|||
164272773|NCT01075984|593366279|FG000|Follow-up Phase|Adverse Event|0|||
164272774|NCT01075984|593366280|FG001|Follow-up Phase|Adverse Event|0|||
164272775|NCT01075984|593366281|FG002|Follow-up Phase|Adverse Event|0|||
164272776|NCT01075984|593366282|FG003|Follow-up Phase|Adverse Event|2|||
164272777|NCT01075984|593366283|FG004|Follow-up Phase|Adverse Event|27|||
164272778|NCT01075984|593366279|FG000|Follow-up Phase|Administrative|0|||
164272779|NCT01075984|593366280|FG001|Follow-up Phase|Administrative|0|||
164272780|NCT01075984|593366281|FG002|Follow-up Phase|Administrative|0|||
164272781|NCT01075984|593366282|FG003|Follow-up Phase|Administrative|0|||
164272782|NCT01075984|593366283|FG004|Follow-up Phase|Administrative|1|||
164272783|NCT01075984|593366279|FG000|Follow-up Phase|Withdrawal by Subject|0|||
164272784|NCT01075984|593366280|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164272785|NCT01075984|593366281|FG002|Follow-up Phase|Withdrawal by Subject|0|||
164272786|NCT01075984|593366282|FG003|Follow-up Phase|Withdrawal by Subject|0|||
164272787|NCT01075984|593366283|FG004|Follow-up Phase|Withdrawal by Subject|10|||
164272788|NCT01075984|593366279|FG000|Follow-up Phase|Progression of disease|0|||
164272789|NCT01075984|593366280|FG001|Follow-up Phase|Progression of disease|0|||
164272790|NCT01075984|593366281|FG002|Follow-up Phase|Progression of disease|0|||
164272791|NCT01075984|593366282|FG003|Follow-up Phase|Progression of disease|0|||
164272792|NCT01075984|593366283|FG004|Follow-up Phase|Progression of disease|2|||
164272793|NCT01075984|593366279|FG000|Follow-up Phase|Treatment failure|0|||
164272794|NCT01075984|593366280|FG001|Follow-up Phase|Treatment failure|0|||
164272795|NCT01075984|593366281|FG002|Follow-up Phase|Treatment failure|0|||
164272796|NCT01075984|593366282|FG003|Follow-up Phase|Treatment failure|0|||
164272797|NCT01075984|593366283|FG004|Follow-up Phase|Treatment failure|4|||
164272798|NCT03652675|593366284|FG000|Overall Study|Lost to Follow-up|4|||
164272799|NCT03652675|593366285|FG001|Overall Study|Lost to Follow-up|4|||
164085945|NCT01261325|592678590|FG000|Overall Study|Lost to Follow-up|0|||
164272800|NCT03101085|593366286|FG000|Overall Study|Lost to Follow-up|0|||
164000441|NCT04889209|592364725|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
164000442|NCT04889209|592364708|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
164000443|NCT04889209|592364709|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
164000444|NCT04889209|592364710|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000445|NCT04889209|592364711|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000446|NCT04889209|592364712|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000447|NCT04889209|592364713|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164000448|NCT04889209|592364714|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000449|NCT04889209|592364715|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164000450|NCT04889209|592364716|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000451|NCT04889209|592364717|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164000452|NCT04889209|592364718|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000453|NCT04889209|592364719|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000454|NCT04889209|592364720|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000455|NCT04889209|592364721|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000456|NCT04889209|592364722|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000457|NCT04889209|592364723|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000458|NCT04889209|592364724|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
164000459|NCT04889209|592364725|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
164000460|NCT04889209|592364708|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000461|NCT04889209|592364709|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000462|NCT04889209|592364710|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000463|NCT04889209|592364711|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
164272801|NCT03101085|593366287|FG001|Overall Study|Lost to Follow-up|1|||
164272802|NCT02986854|593366289|FG000|Overall Study|Withdrawal by Subject|0|||
164272803|NCT02986854|593366290|FG001|Overall Study|Withdrawal by Subject|1|||
164272804|NCT02986854|593366291|FG002|Overall Study|Withdrawal by Subject|1|||
164272805|NCT02986854|593366289|FG000|Overall Study|Lost to Follow-up|3|||
164272806|NCT02986854|593366290|FG001|Overall Study|Lost to Follow-up|11|||
164272807|NCT02986854|593366291|FG002|Overall Study|Lost to Follow-up|2|||
164272808|NCT01895309|593366294|FG000|Overall Study|Adverse Event|13|||
164272809|NCT01895309|593366295|FG001|Overall Study|Adverse Event|17|||
164272810|NCT01895309|593366294|FG000|Overall Study|Protocol Violation|1|||
164272811|NCT01895309|593366295|FG001|Overall Study|Protocol Violation|0|||
164342575|NCT00381485|593631463|FG002|Open-Label Run-In Period|Adverse Event|0|||
164342576|NCT00381485|593631464|FG003|Open-Label Run-In Period|Adverse Event|0|||
164342577|NCT00381485|593631461|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
164000464|NCT04889209|592364712|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000465|NCT04889209|592364713|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000466|NCT04889209|592364714|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164272812|NCT01895309|593366294|FG000|Overall Study|Lack of Efficacy|1|||
164342578|NCT00381485|593631462|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
164342579|NCT00381485|593631463|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
164342580|NCT00381485|593631464|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
164342581|NCT00381485|593631461|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
164342582|NCT00381485|593631462|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
164342583|NCT00381485|593631463|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
164342584|NCT00381485|593631464|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
164342585|NCT00381485|593631461|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
163893901|NCT05424380|591983801|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
163893902|NCT05424380|591983796|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
163893903|NCT05424380|591983797|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163893904|NCT05424380|591983798|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163893905|NCT05424380|591983799|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163893906|NCT05424380|591983800|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163893907|NCT05424380|591983801|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
163893908|NCT05424380|591983796|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163893909|NCT05424380|591983797|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
163893910|NCT05424380|591983798|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163893911|NCT05424380|591983799|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163893912|NCT05424380|591983800|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163893913|NCT05424380|591983801|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
163893914|NCT05424380|591983796|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163893915|NCT05424380|591983797|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
163893916|NCT05424380|591983798|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163893917|NCT05424380|591983799|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163893918|NCT05424380|591983800|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163893919|NCT05424380|591983801|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
163893920|NCT05424380|591983796|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163893921|NCT05424380|591983797|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163893922|NCT05424380|591983798|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
163893923|NCT05424380|591983799|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163893924|NCT05424380|591983800|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163893925|NCT05424380|591983801|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
163893926|NCT05424380|591983796|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163893927|NCT05424380|591983797|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163893928|NCT05424380|591983798|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
163893929|NCT05424380|591983799|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163893930|NCT05424380|591983800|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163893931|NCT05424380|591983801|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
163893932|NCT05424380|591983796|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163893933|NCT05424380|591983797|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163893934|NCT05424380|591983798|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
163893935|NCT05424380|591983799|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163893936|NCT05424380|591983800|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163893937|NCT05424380|591983801|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
163893938|NCT05424380|591983796|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893939|NCT05424380|591983797|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893940|NCT05424380|591983798|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893941|NCT05424380|591983799|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
163893942|NCT05424380|591983800|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893943|NCT05424380|591983801|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893944|NCT05424380|591983796|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163893945|NCT05424380|591983797|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163893946|NCT05424380|591983798|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163893947|NCT05424380|591983799|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
163893948|NCT05424380|591983800|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
164000467|NCT04889209|592364715|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164342586|NCT00381485|593631462|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
164342587|NCT00381485|593631463|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
164342588|NCT00381485|593631464|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
164342589|NCT00381485|593631461|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
164342590|NCT00381485|593631462|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
164342591|NCT00381485|593631463|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
164342592|NCT00381485|593631464|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
164342593|NCT00381485|593631461|FG000|Open-Label Run-In Period|Treatment failure|1|||
164342594|NCT00381485|593631462|FG001|Open-Label Run-In Period|Treatment failure|0|||
164342595|NCT00381485|593631463|FG002|Open-Label Run-In Period|Treatment failure|0|||
163893949|NCT05424380|591983801|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
163893950|NCT05424380|591983796|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163893951|NCT05424380|591983797|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163893952|NCT05424380|591983798|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163893953|NCT05424380|591983799|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
164006735|NCT03519178|592391059|FG010|PF-06873600 Treatment|Progressive disease|4|||
164272813|NCT01895309|593366295|FG001|Overall Study|Lack of Efficacy|3|||
164272814|NCT01895309|593366294|FG000|Overall Study|Lost to Follow-up|1|||
164272815|NCT01895309|593366295|FG001|Overall Study|Lost to Follow-up|3|||
164272816|NCT01895309|593366294|FG000|Overall Study|Physician Decision|15|||
164272817|NCT01895309|593366295|FG001|Overall Study|Physician Decision|10|||
164272818|NCT01895309|593366294|FG000|Overall Study|Withdrawal by Subject|9|||
164272819|NCT01895309|593366295|FG001|Overall Study|Withdrawal by Subject|18|||
164272820|NCT01555125|593366298|FG000|Induction Period|Lost to Follow-up|0|||
164272821|NCT01555125|593366299|FG001|Induction Period|Lost to Follow-up|2|||
164272822|NCT01555125|593366300|FG002|Induction Period|Lost to Follow-up|0|||
164272823|NCT01555125|593366301|FG003|Induction Period|Lost to Follow-up|0|||
164272824|NCT01555125|593366302|FG004|Induction Period|Lost to Follow-up|0|||
164272825|NCT01555125|593366298|FG000|Induction Period|Adverse Event|0|||
164272826|NCT01555125|593366299|FG001|Induction Period|Adverse Event|1|||
164272827|NCT01555125|593366300|FG002|Induction Period|Adverse Event|0|||
164272828|NCT01555125|593366301|FG003|Induction Period|Adverse Event|0|||
164272829|NCT01555125|593366302|FG004|Induction Period|Adverse Event|1|||
164272830|NCT01555125|593366298|FG000|Induction Period|Subject / guardian decision|0|||
164272831|NCT01555125|593366299|FG001|Induction Period|Subject / guardian decision|0|||
164272832|NCT01555125|593366300|FG002|Induction Period|Subject / guardian decision|0|||
164272833|NCT01555125|593366301|FG003|Induction Period|Subject / guardian decision|0|||
164272834|NCT01555125|593366302|FG004|Induction Period|Subject / guardian decision|2|||
164272835|NCT01555125|593366298|FG000|Induction Period|Death|1|||
164272836|NCT01555125|593366299|FG001|Induction Period|Death|0|||
163893954|NCT05424380|591983800|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
163893955|NCT05424380|591983801|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
164272837|NCT01555125|593366300|FG002|Induction Period|Death|0|||
164272838|NCT01555125|593366301|FG003|Induction Period|Death|0|||
164272839|NCT01555125|593366302|FG004|Induction Period|Death|0|||
164272840|NCT01555125|593366298|FG000|Maintenance Period|Adverse Event|1|||
164272841|NCT01555125|593366299|FG001|Maintenance Period|Adverse Event|1|||
164272842|NCT01555125|593366300|FG002|Maintenance Period|Adverse Event|0|||
164272843|NCT01555125|593366301|FG003|Maintenance Period|Adverse Event|0|||
164272844|NCT01555125|593366302|FG004|Maintenance Period|Adverse Event|0|||
164272845|NCT01555125|593366298|FG000|Maintenance Period|Subject / guardian decision|1|||
164272846|NCT01555125|593366299|FG001|Maintenance Period|Subject / guardian decision|2|||
164272847|NCT01555125|593366300|FG002|Maintenance Period|Subject / guardian decision|0|||
164272848|NCT01555125|593366301|FG003|Maintenance Period|Subject / guardian decision|0|||
164272849|NCT01555125|593366302|FG004|Maintenance Period|Subject / guardian decision|0|||
164272850|NCT01555125|593366298|FG000|Maintenance Period|Lost to Follow-up|2|||
163893956|NCT05424380|591983796|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
164272851|NCT01555125|593366299|FG001|Maintenance Period|Lost to Follow-up|0|||
164272852|NCT01555125|593366300|FG002|Maintenance Period|Lost to Follow-up|0|||
164272853|NCT01555125|593366301|FG003|Maintenance Period|Lost to Follow-up|1|||
164272854|NCT01555125|593366302|FG004|Maintenance Period|Lost to Follow-up|0|||
164272855|NCT01555125|593366298|FG000|Maintenance Period|Lack of Efficacy|6|||
164000468|NCT04889209|592364716|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000469|NCT04889209|592364717|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000470|NCT04889209|592364718|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000471|NCT04889209|592364719|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164272856|NCT01555125|593366299|FG001|Maintenance Period|Lack of Efficacy|1|||
164272857|NCT01555125|593366300|FG002|Maintenance Period|Lack of Efficacy|3|||
164272858|NCT01555125|593366301|FG003|Maintenance Period|Lack of Efficacy|0|||
164272859|NCT01555125|593366302|FG004|Maintenance Period|Lack of Efficacy|0|||
164272860|NCT01555125|593366298|FG000|Maintenance Period|Physician Decision|0|||
164000472|NCT04889209|592364720|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000473|NCT04889209|592364721|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000474|NCT04889209|592364722|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000475|NCT04889209|592364723|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000476|NCT04889209|592364724|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000477|NCT04889209|592364725|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
164000478|NCT04889209|592364708|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000479|NCT04889209|592364709|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000480|NCT04889209|592364710|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164085946|NCT01261325|592678591|FG001|Overall Study|Lost to Follow-up|1|||
164085947|NCT01261325|592678592|FG002|Overall Study|Lost to Follow-up|3|||
164085948|NCT01261325|592678590|FG000|Overall Study|AE, serious fatal|0|||
164272861|NCT01555125|593366299|FG001|Maintenance Period|Physician Decision|0|||
164272862|NCT01555125|593366300|FG002|Maintenance Period|Physician Decision|1|||
164272863|NCT01555125|593366301|FG003|Maintenance Period|Physician Decision|0|||
164272864|NCT01555125|593366302|FG004|Maintenance Period|Physician Decision|0|||
164272865|NCT01555125|593366298|FG000|Maintenance Period|Death|0|||
164272866|NCT01555125|593366299|FG001|Maintenance Period|Death|0|||
164272867|NCT01555125|593366300|FG002|Maintenance Period|Death|0|||
164272868|NCT01555125|593366301|FG003|Maintenance Period|Death|1|||
164272869|NCT01555125|593366302|FG004|Maintenance Period|Death|0|||
164272870|NCT01555125|593366298|FG000|Extension|Adverse Event|1|||
164272871|NCT01555125|593366299|FG001|Extension|Adverse Event|2|||
164272872|NCT01555125|593366300|FG002|Extension|Adverse Event|1|||
164272873|NCT01555125|593366301|FG003|Extension|Adverse Event|1|||
164272874|NCT01555125|593366302|FG004|Extension|Adverse Event|0|||
164272875|NCT01555125|593366298|FG000|Extension|Protocol deviation|1|||
164272876|NCT01555125|593366299|FG001|Extension|Protocol deviation|0|||
164272877|NCT01555125|593366300|FG002|Extension|Protocol deviation|0|||
164272878|NCT01555125|593366301|FG003|Extension|Protocol deviation|0|||
164272879|NCT01555125|593366302|FG004|Extension|Protocol deviation|0|||
164272880|NCT01555125|593366298|FG000|Extension|Lack of Efficacy|7|||
164272881|NCT01555125|593366299|FG001|Extension|Lack of Efficacy|6|||
164272882|NCT01555125|593366300|FG002|Extension|Lack of Efficacy|3|||
164272883|NCT01555125|593366301|FG003|Extension|Lack of Efficacy|0|||
164272884|NCT01555125|593366302|FG004|Extension|Lack of Efficacy|0|||
164272885|NCT01555125|593366298|FG000|Extension|Lost to Follow-up|2|||
164272886|NCT01555125|593366299|FG001|Extension|Lost to Follow-up|1|||
164272887|NCT01555125|593366300|FG002|Extension|Lost to Follow-up|2|||
164272888|NCT01555125|593366301|FG003|Extension|Lost to Follow-up|0|||
164272889|NCT01555125|593366302|FG004|Extension|Lost to Follow-up|0|||
164272890|NCT01555125|593366298|FG000|Extension|Study terminated by sponsor|32|||
164272891|NCT01555125|593366299|FG001|Extension|Study terminated by sponsor|33|||
164272892|NCT01555125|593366300|FG002|Extension|Study terminated by sponsor|16|||
164272893|NCT01555125|593366301|FG003|Extension|Study terminated by sponsor|20|||
164272894|NCT01555125|593366302|FG004|Extension|Study terminated by sponsor|0|||
164272895|NCT01555125|593366298|FG000|Extension|Subject/guardian decision|1|||
164272896|NCT01555125|593366299|FG001|Extension|Subject/guardian decision|9|||
164272897|NCT01555125|593366300|FG002|Extension|Subject/guardian decision|1|||
164272898|NCT01555125|593366301|FG003|Extension|Subject/guardian decision|0|||
164342596|NCT00381485|593631464|FG003|Open-Label Run-In Period|Treatment failure|0|||
164342597|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164342598|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164272899|NCT01555125|593366302|FG004|Extension|Subject/guardian decision|0|||
164272900|NCT01555125|593366298|FG000|Extension|Technical Problems|1|||
164272901|NCT01555125|593366299|FG001|Extension|Technical Problems|0|||
164272902|NCT01555125|593366300|FG002|Extension|Technical Problems|0|||
164272903|NCT01555125|593366301|FG003|Extension|Technical Problems|1|||
164272904|NCT01555125|593366302|FG004|Extension|Technical Problems|0|||
164272905|NCT01555125|593366298|FG000|Follow-Up Period|Lost to Follow-up|1|||
164272906|NCT01555125|593366299|FG001|Follow-Up Period|Lost to Follow-up|0|||
164272907|NCT01555125|593366300|FG002|Follow-Up Period|Lost to Follow-up|0|||
164342599|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Adverse Event|2|||
164342600|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Adverse Event|5|||
164000481|NCT04889209|592364711|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000482|NCT04889209|592364712|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000483|NCT04889209|592364713|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000484|NCT04889209|592364714|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000485|NCT04889209|592364715|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000486|NCT04889209|592364716|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000487|NCT04889209|592364717|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000488|NCT04889209|592364718|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000489|NCT04889209|592364719|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000490|NCT04889209|592364720|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000491|NCT04889209|592364721|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000492|NCT04889209|592364722|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000493|NCT04889209|592364723|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000494|NCT04889209|592364724|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
164000495|NCT04889209|592364725|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
164000496|NCT04889209|592364708|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000497|NCT04889209|592364709|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000498|NCT04889209|592364710|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000499|NCT04889209|592364711|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000500|NCT04889209|592364712|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000501|NCT04889209|592364713|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000502|NCT04889209|592364714|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000503|NCT04889209|592364715|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000504|NCT04889209|592364716|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164272908|NCT01555125|593366301|FG003|Follow-Up Period|Lost to Follow-up|0|||
164272909|NCT01555125|593366302|FG004|Follow-Up Period|Lost to Follow-up|0|||
164272910|NCT01555125|593366298|FG000|Follow-Up Period|Subject / guardian decision|3|||
164000505|NCT04889209|592364717|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000506|NCT04889209|592364718|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000507|NCT04889209|592364719|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000508|NCT04889209|592364720|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000509|NCT04889209|592364721|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000510|NCT04889209|592364722|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000511|NCT04889209|592364723|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000512|NCT04889209|592364724|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
164000513|NCT04889209|592364725|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
164000514|NCT04889209|592364708|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000515|NCT04889209|592364709|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000516|NCT04889209|592364710|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000517|NCT04889209|592364711|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000518|NCT04889209|592364712|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000519|NCT04889209|592364713|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164272911|NCT01555125|593366299|FG001|Follow-Up Period|Subject / guardian decision|1|||
164272912|NCT01555125|593366300|FG002|Follow-Up Period|Subject / guardian decision|1|||
164272913|NCT01555125|593366301|FG003|Follow-Up Period|Subject / guardian decision|1|||
164272914|NCT01555125|593366302|FG004|Follow-Up Period|Subject / guardian decision|0|||
164272915|NCT02039856|593366305|FG000|Overall Study|Death|5|||
164272916|NCT02039856|593366306|FG001|Overall Study|Death|3|||
164272917|NCT02039856|593366305|FG000|Overall Study|Partial survey completion|61|||
164272918|NCT02039856|593366306|FG001|Overall Study|Partial survey completion|26|||
164272919|NCT02039856|593366305|FG000|Overall Study|Lost to Follow-up|388|||
164272920|NCT02039856|593366306|FG001|Overall Study|Lost to Follow-up|206|||
164272921|NCT02039856|593366305|FG000|Overall Study|Withdrawal by Subject|1573|||
164085949|NCT01261325|592678591|FG001|Overall Study|AE, serious fatal|0|||
164272922|NCT02039856|593366306|FG001|Overall Study|Withdrawal by Subject|618|||
164272923|NCT01174173|593366318|FG000|Overall Study|drug-drug interaction|1|||
164272924|NCT00602420|593367903|FG000|Overall Study|Death|1|||
164272925|NCT00602420|593367904|FG001|Overall Study|Death|4|||
164272926|NCT00602420|593367903|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
164272927|NCT00602420|593367904|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
164272928|NCT00602420|593367903|FG000|Overall Study|Withdrawal by Subject|18|||
164272929|NCT00602420|593367904|FG001|Overall Study|Withdrawal by Subject|17|||
164272930|NCT00602420|593367903|FG000|Overall Study|Adverse Event|1|||
164000520|NCT04889209|592364714|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164272931|NCT00602420|593367904|FG001|Overall Study|Adverse Event|0|||
164272932|NCT03775512|593367922|FG000|Overall Study|Death|1|||
164272933|NCT03775512|593367923|FG001|Overall Study|Death|1|||
164272934|NCT03775512|593367922|FG000|Overall Study|Withdrawal by Subject|7|||
164272935|NCT03775512|593367923|FG001|Overall Study|Withdrawal by Subject|4|||
164085950|NCT01261325|592678592|FG002|Overall Study|AE, serious fatal|2|||
164085951|NCT02668302|592678593|FG000|Overall Study|Withdrawal by Subject|1|||
164272936|NCT03775512|593367922|FG000|Overall Study|Lost to Follow-up|5|||
164272937|NCT03775512|593367923|FG001|Overall Study|Lost to Follow-up|5|||
164272938|NCT03775512|593367922|FG000|Overall Study|Excluded before Catheter insertion|14|||
164272939|NCT03775512|593367923|FG001|Overall Study|Excluded before Catheter insertion|5|||
164272940|NCT03775512|593367922|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
164272941|NCT03775512|593367923|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
164272942|NCT03775512|593367922|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
164272943|NCT03775512|593367923|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
164272944|NCT00082407|593367924|FG000|Overall Study|Adverse Event|20|||
164272945|NCT00082407|593367925|FG001|Overall Study|Adverse Event|0|||
164272946|NCT00082407|593367924|FG000|Overall Study|Protocol Violation|14|||
164272947|NCT00082407|593367925|FG001|Overall Study|Protocol Violation|12|||
164272948|NCT00082407|593367924|FG000|Overall Study|Patient Decision|13|||
164272949|NCT00082407|593367925|FG001|Overall Study|Patient Decision|6|||
164272950|NCT00082407|593367924|FG000|Overall Study|Physician Decision|5|||
164272951|NCT00082407|593367925|FG001|Overall Study|Physician Decision|3|||
164272952|NCT00082407|593367924|FG000|Overall Study|Loss of Glucose Control|2|||
164272953|NCT00082407|593367925|FG001|Overall Study|Loss of Glucose Control|2|||
164272954|NCT00082407|593367924|FG000|Overall Study|Death|2|||
164272955|NCT00082407|593367925|FG001|Overall Study|Death|1|||
164272956|NCT00082407|593367924|FG000|Overall Study|Lost to Follow-up|0|||
164272957|NCT00082407|593367925|FG001|Overall Study|Lost to Follow-up|3|||
164272958|NCT03464019|593367926|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
164272959|NCT03464019|593367927|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
164272960|NCT03464019|593367928|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
164272961|NCT03464019|593367926|FG000|NODE-301 Part 1|Ablation|0|||
164342601|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164342602|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
164342603|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
164342604|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
164342605|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164342606|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
164342607|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
164342608|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
164342609|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
164342610|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
164342611|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
164342612|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
164342613|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
164342614|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164342615|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
164342616|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164342617|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
164342618|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
164342619|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
164342620|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
164342621|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
164342622|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
164342623|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
163893957|NCT05424380|591983797|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163893958|NCT05424380|591983798|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163893959|NCT05424380|591983799|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163893960|NCT05424380|591983800|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
163893961|NCT05424380|591983801|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
163893962|NCT05424380|591983796|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893963|NCT05424380|591983797|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893964|NCT05424380|591983798|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893965|NCT05424380|591983799|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893966|NCT05424380|591983800|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
163893967|NCT05424380|591983801|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
163893968|NCT05424380|591983796|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164272962|NCT03464019|593367927|FG001|NODE-301 Part 1|Ablation|0|||
164272963|NCT03464019|593367928|FG002|NODE-301 Part 1|Ablation|16|||
164272964|NCT03464019|593367926|FG000|NODE-301 Part 1|Test Dose Failure|0|||
164272965|NCT03464019|593367927|FG001|NODE-301 Part 1|Test Dose Failure|0|||
164272966|NCT03464019|593367928|FG002|NODE-301 Part 1|Test Dose Failure|8|||
164272967|NCT03464019|593367926|FG000|NODE-301 Part 1|Adverse Event|0|||
164272968|NCT03464019|593367927|FG001|NODE-301 Part 1|Adverse Event|0|||
164272969|NCT03464019|593367928|FG002|NODE-301 Part 1|Adverse Event|5|||
164272970|NCT03464019|593367926|FG000|NODE-301 Part 1|Physician Decision|0|||
164272971|NCT03464019|593367927|FG001|NODE-301 Part 1|Physician Decision|0|||
164272972|NCT03464019|593367928|FG002|NODE-301 Part 1|Physician Decision|4|||
164272973|NCT03464019|593367926|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
164272974|NCT03464019|593367927|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
164272975|NCT03464019|593367928|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
164272976|NCT03464019|593367926|FG000|NODE-301 Part 1|Protocol Violation|0|||
164272977|NCT03464019|593367927|FG001|NODE-301 Part 1|Protocol Violation|0|||
164272978|NCT03464019|593367928|FG002|NODE-301 Part 1|Protocol Violation|2|||
164272979|NCT03464019|593367926|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
164272980|NCT03464019|593367927|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
164272981|NCT03464019|593367928|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
164272982|NCT03464019|593367926|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
164272983|NCT03464019|593367927|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
164272984|NCT03464019|593367928|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
164272985|NCT03464019|593367926|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
164272986|NCT03464019|593367927|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
164272987|NCT03464019|593367928|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
164272988|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
164272989|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
164272990|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
164272991|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
164272992|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
164272993|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
164272994|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
164272995|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
164272996|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
164272997|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
164272998|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
164272999|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
164273000|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
164273001|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
164273002|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
163893969|NCT05424380|591983797|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163893970|NCT05424380|591983798|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
164273003|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
164273004|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
164273005|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
164273006|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
164273007|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
164273008|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
164273009|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
164273010|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
164273011|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
164273012|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
164273013|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
163893971|NCT05424380|591983799|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163893972|NCT05424380|591983800|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
164273014|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
164273015|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
164273016|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
164273017|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
164273018|NCT03464019|593367926|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
164273019|NCT03464019|593367927|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
164273020|NCT03464019|593367928|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
164273021|NCT00767806|593367929|FG000|Overall Study|Adverse Event|30|||
164273022|NCT00767806|593367930|FG001|Overall Study|Adverse Event|11|||
164273023|NCT00767806|593367929|FG000|Overall Study|Withdrawal by Subject|8|||
164273024|NCT00767806|593367930|FG001|Overall Study|Withdrawal by Subject|13|||
164273025|NCT00767806|593367929|FG000|Overall Study|Protocol Violation|6|||
164273026|NCT00767806|593367930|FG001|Overall Study|Protocol Violation|5|||
164273027|NCT00767806|593367929|FG000|Overall Study|Lack of Efficacy|1|||
163893973|NCT05424380|591983801|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
163893974|NCT03213678|591983807|FG000|Overall Study|Death|1|||
164085952|NCT02668302|592678594|FG001|Overall Study|Withdrawal by Subject|0|||
164273028|NCT00767806|593367930|FG001|Overall Study|Lack of Efficacy|9|||
164273029|NCT00767806|593367929|FG000|Overall Study|Physician Decision|4|||
164273030|NCT00767806|593367930|FG001|Overall Study|Physician Decision|3|||
164273031|NCT00767806|593367929|FG000|Overall Study|Lost to Follow-up|1|||
164273032|NCT00767806|593367930|FG001|Overall Study|Lost to Follow-up|4|||
164273033|NCT00767806|593367929|FG000|Overall Study|Entry Criteria Not Met|1|||
164273034|NCT00767806|593367930|FG001|Overall Study|Entry Criteria Not Met|1|||
164273035|NCT00767806|593367929|FG000|Overall Study|Sponsor Decision|0|||
164273036|NCT00767806|593367930|FG001|Overall Study|Sponsor Decision|1|||
164273037|NCT02489942|593367931|FG000|Overall Study|Request by patient|602|||
164273038|NCT02489942|593367931|FG000|Overall Study|Improvement/remission|157|||
164000521|NCT04889209|592364715|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000522|NCT04889209|592364716|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000523|NCT04889209|592364717|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000524|NCT04889209|592364718|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000525|NCT04889209|592364719|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000526|NCT04889209|592364720|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000527|NCT04889209|592364721|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000528|NCT04889209|592364722|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000529|NCT04889209|592364723|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000530|NCT04889209|592364724|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
164000531|NCT04889209|592364725|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
164000532|NCT04889209|592364708|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000533|NCT04889209|592364709|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000534|NCT04889209|592364710|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000535|NCT04889209|592364711|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000536|NCT04889209|592364712|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000537|NCT04889209|592364713|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000538|NCT04889209|592364714|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000539|NCT04889209|592364715|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000540|NCT04889209|592364716|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000541|NCT04889209|592364717|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000542|NCT04889209|592364718|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000543|NCT04889209|592364719|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164273039|NCT02489942|593367931|FG000|Overall Study|No change/Progressive disease|263|||
164273040|NCT02489942|593367931|FG000|Overall Study|Adverse Event|522|||
164273041|NCT02489942|593367931|FG000|Overall Study|Other personal reasons|1218|||
164273042|NCT02489942|593367931|FG000|Overall Study|Lost to Follow-up|456|||
164273043|NCT02489942|593367931|FG000|Overall Study|Not continuously investigated|7|||
164273044|NCT02489942|593367931|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
164273045|NCT02489942|593367931|FG000|Overall Study|Multiple registration|1|||
164273046|NCT02489942|593367931|FG000|Overall Study|No patient visit after entry|100|||
164273047|NCT02489942|593367931|FG000|Overall Study|No treatment with Jardiance|2|||
164273048|NCT02489942|593367931|FG000|Overall Study|Patient received Jardiance before registration|1|||
164273049|NCT02489942|593367931|FG000|Overall Study|No CRF collected|86|||
164273050|NCT00858208|593367932|FG000|Overall Study|Adverse Event|3|||
164273051|NCT00858208|593367932|FG000|Overall Study|Lost to Follow-up|26|||
164273052|NCT00858208|593367932|FG000|Overall Study|Participant refused|40|||
164273053|NCT00858208|593367932|FG000|Overall Study|Other|10|||
164273054|NCT01272635|593367933|FG000|Overall Study|Lost to Follow-up|31|||
164273055|NCT01272635|593367934|FG001|Overall Study|Lost to Follow-up|20|||
164273056|NCT01272635|593367935|FG002|Overall Study|Lost to Follow-up|31|||
164273057|NCT01272635|593367936|FG003|Overall Study|Lost to Follow-up|23|||
164273058|NCT01543776|593367937|FG000|Overall Study|Withdrawal by Subject|2|||
164273059|NCT01543776|593367938|FG001|Overall Study|Withdrawal by Subject|2|||
164273060|NCT00306527|593367939|FG000|Overall Study|Lost to Follow-up|3|||
164273061|NCT00306527|593367940|FG001|Overall Study|Lost to Follow-up|4|||
164273062|NCT00306527|593367941|FG002|Overall Study|Lost to Follow-up|3|||
164273063|NCT00306527|593367942|FG003|Overall Study|Lost to Follow-up|0|||
164273064|NCT00306527|593367939|FG000|Overall Study|Withdrawal by Subject|2|||
164273065|NCT00306527|593367940|FG001|Overall Study|Withdrawal by Subject|3|||
164273066|NCT00306527|593367941|FG002|Overall Study|Withdrawal by Subject|0|||
164273067|NCT00306527|593367942|FG003|Overall Study|Withdrawal by Subject|3|||
164273068|NCT00306527|593367939|FG000|Overall Study|Adverse Event|0|||
164273069|NCT00306527|593367940|FG001|Overall Study|Adverse Event|0|||
164273070|NCT00306527|593367941|FG002|Overall Study|Adverse Event|1|||
164273071|NCT00306527|593367942|FG003|Overall Study|Adverse Event|1|||
164000544|NCT04889209|592364720|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164273072|NCT00306527|593367939|FG000|Overall Study|Death|1|||
164273073|NCT00306527|593367940|FG001|Overall Study|Death|0|||
164273074|NCT00306527|593367941|FG002|Overall Study|Death|1|||
164273075|NCT00306527|593367942|FG003|Overall Study|Death|2|||
164273076|NCT00567359|593367943|FG000|Overall Study|Withdrawal by Subject|1|||
164273077|NCT00539305|593367944|FG000|Overall Study|Adverse Event|1|||
164273078|NCT00539305|593367945|FG001|Overall Study|Adverse Event|0|||
164273079|NCT00539305|593367944|FG000|Overall Study|Substance Use|0|||
163893975|NCT03213678|591983807|FG000|Overall Study|Physician Decision|1|||
163893976|NCT03213678|591983807|FG000|Overall Study|Progressive disease|16|||
163893977|NCT04218851|591983808|FG000|Overall Study|Death|1|||
164273080|NCT00539305|593367945|FG001|Overall Study|Substance Use|1|||
164273081|NCT00539305|593367944|FG000|Overall Study|Withdrawal by Subject|0|||
164273082|NCT00539305|593367945|FG001|Overall Study|Withdrawal by Subject|1|||
163893978|NCT04218851|591983809|FG001|Overall Study|Death|3|||
163893979|NCT03717935|591983810|FG000|Overall Study|Withdrawal by Subject|0|||
163893980|NCT03717935|591983811|FG001|Overall Study|Withdrawal by Subject|2|||
163893981|NCT04456296|591983812|FG000|Overall Study|Withdrawal by Subject|14|||
163893982|NCT04456296|591983813|FG001|Overall Study|Withdrawal by Subject|21|||
163893983|NCT04456296|591983814|FG002|Overall Study|Withdrawal by Subject|21|||
163893984|NCT04456296|591983812|FG000|Overall Study|Adverse Event|2|||
163893985|NCT04456296|591983813|FG001|Overall Study|Adverse Event|2|||
163893986|NCT04456296|591983814|FG002|Overall Study|Adverse Event|2|||
163893987|NCT04456296|591983812|FG000|Overall Study|Death|1|||
163893988|NCT04456296|591983813|FG001|Overall Study|Death|0|||
163893989|NCT04456296|591983814|FG002|Overall Study|Death|0|||
163893990|NCT04456296|591983812|FG000|Overall Study|Lost to Follow-up|3|||
163893991|NCT04456296|591983813|FG001|Overall Study|Lost to Follow-up|5|||
163893992|NCT04456296|591983814|FG002|Overall Study|Lost to Follow-up|6|||
163893993|NCT04456296|591983812|FG000|Overall Study|Other than specified|0|||
163893994|NCT04456296|591983813|FG001|Overall Study|Other than specified|1|||
163893995|NCT04456296|591983814|FG002|Overall Study|Other than specified|4|||
163893996|NCT04456296|591983812|FG000|Overall Study|Randomized, not treated|2|||
163893997|NCT04456296|591983813|FG001|Overall Study|Randomized, not treated|1|||
163893998|NCT04456296|591983814|FG002|Overall Study|Randomized, not treated|0|||
163893999|NCT05736458|591983815|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
163894000|NCT05736458|591983816|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
163894001|NCT05736458|591983817|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
163894002|NCT05736458|591983815|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
163894003|NCT05736458|591983816|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
163894004|NCT05736458|591983817|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
163894005|NCT05736458|591983815|FG000|TMS/fMRI #1|Physician Decision|0|||
163894006|NCT05736458|591983816|FG001|TMS/fMRI #1|Physician Decision|0|||
163894007|NCT05736458|591983817|FG002|TMS/fMRI #1|Physician Decision|2|||
163894008|NCT05736458|591983815|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
163894009|NCT05736458|591983816|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
164273083|NCT00126776|593367947|FG000|Overall Study|follow up complete on all patients|0|||
164000545|NCT04889209|592364721|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000546|NCT04889209|592364722|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
164273084|NCT00126776|593367948|FG001|Overall Study|follow up complete on all patients|0|||
164273085|NCT01815840|593367951|FG000|Overall Study|Missing|1|||
164273086|NCT01815840|593367952|FG001|Overall Study|Missing|0|||
164273087|NCT01815840|593367951|FG000|Overall Study|Withdrew Consent|31|||
164273088|NCT01815840|593367952|FG001|Overall Study|Withdrew Consent|30|||
164273089|NCT01815840|593367951|FG000|Overall Study|Administrative/Other|1|||
164273090|NCT01815840|593367952|FG001|Overall Study|Administrative/Other|3|||
164273091|NCT01815840|593367951|FG000|Overall Study|Adverse Event|10|||
164273092|NCT01815840|593367952|FG001|Overall Study|Adverse Event|16|||
164273093|NCT01815840|593367951|FG000|Overall Study|Death|2|||
164273094|NCT01815840|593367952|FG001|Overall Study|Death|2|||
164273095|NCT01815840|593367951|FG000|Overall Study|Disease progression|3|||
164273096|NCT01815840|593367952|FG001|Overall Study|Disease progression|2|||
164273097|NCT01815840|593367951|FG000|Overall Study|Investigators Decision|2|||
164273098|NCT01815840|593367952|FG001|Overall Study|Investigators Decision|3|||
164273099|NCT01815840|593367951|FG000|Overall Study|Lost to Follow-up|3|||
164273100|NCT01815840|593367952|FG001|Overall Study|Lost to Follow-up|6|||
164273101|NCT01815840|593367951|FG000|Overall Study|Refused Treatment|5|||
164273102|NCT01815840|593367952|FG001|Overall Study|Refused Treatment|1|||
164273103|NCT01815840|593367951|FG000|Overall Study|Sponsor Termination Treatment|1|||
164273104|NCT01815840|593367952|FG001|Overall Study|Sponsor Termination Treatment|0|||
164273105|NCT01055314|593367953|FG000|Overall Study|Adverse Event|7|||
164273106|NCT01055314|593367954|FG001|Overall Study|Adverse Event|4|||
164273107|NCT01055314|593367953|FG000|Overall Study|Death|2|||
164273108|NCT01055314|593367954|FG001|Overall Study|Death|1|||
164273109|NCT01055314|593367953|FG000|Overall Study|Lack of Efficacy|11|||
164273110|NCT01055314|593367954|FG001|Overall Study|Lack of Efficacy|19|||
164273111|NCT01055314|593367953|FG000|Overall Study|Physician Decision|10|||
164273112|NCT01055314|593367954|FG001|Overall Study|Physician Decision|5|||
164273113|NCT01055314|593367953|FG000|Overall Study|Withdrawal by Subject|1|||
164273114|NCT01055314|593367954|FG001|Overall Study|Withdrawal by Subject|0|||
164273115|NCT01055314|593367953|FG000|Overall Study|Ineligible|3|||
164273116|NCT01055314|593367954|FG001|Overall Study|Ineligible|5|||
164273117|NCT01055314|593367953|FG000|Overall Study|Refusal of further protocol therapy|10|||
164273118|NCT01055314|593367954|FG001|Overall Study|Refusal of further protocol therapy|4|||
164273119|NCT01055314|593367953|FG000|Overall Study|No treatment|1|||
164273120|NCT01055314|593367954|FG001|Overall Study|No treatment|0|||
164273121|NCT04395690|593367955|FG000|Overall Study|Lost to Follow-up|1|||
164273122|NCT04395690|593367956|FG001|Overall Study|Lost to Follow-up|1|||
164000547|NCT04889209|592364723|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000548|NCT04889209|592364724|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000549|NCT04889209|592364725|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
164000550|NCT00382967|592364736|FG000|Overall Study|Protocol Violation|1|||
164273123|NCT00434642|593367957|FG000|Blinded Treatment Phase|Adverse Event|12|||
164273124|NCT00434642|593367958|FG001|Blinded Treatment Phase|Adverse Event|58|||
164273125|NCT00434642|593367957|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
164273126|NCT00434642|593367958|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
164273127|NCT00434642|593367957|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
164273128|NCT00434642|593367958|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
164273129|NCT00434642|593367957|FG000|Blinded Treatment Phase|Physician Decision|19|||
164273130|NCT00434642|593367958|FG001|Blinded Treatment Phase|Physician Decision|27|||
164273131|NCT00434642|593367957|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
164273132|NCT00434642|593367958|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
164342624|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
164342625|NCT00381485|593631461|FG000|Double-Blind Treatment Period|Administrative|0|||
164342626|NCT00381485|593631462|FG001|Double-Blind Treatment Period|Administrative|1|||
164342627|NCT00381485|593631463|FG002|Double-Blind Treatment Period|Administrative|0|||
164342628|NCT00381485|593631464|FG003|Double-Blind Treatment Period|Administrative|1|||
164342629|NCT01235351|593631465|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
164342630|NCT01235351|593631466|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
164342631|NCT00745823|593631467|FG000|Overall Study|Adverse Event|5|||
164342632|NCT00745823|593631468|FG001|Overall Study|Adverse Event|3|||
164342633|NCT00745823|593631467|FG000|Overall Study|Lack of Efficacy|20|||
164273133|NCT00434642|593367957|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
164273134|NCT00434642|593367958|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
164273135|NCT00434642|593367957|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
164273136|NCT00434642|593367958|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
164273137|NCT00434642|593367957|FG000|Open-label Treatment Phase|Adverse Event|0|||
164273138|NCT00434642|593367958|FG001|Open-label Treatment Phase|Adverse Event|5|||
164273139|NCT00434642|593367957|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
164273140|NCT00434642|593367958|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
164273141|NCT00753454|593367961|FG000|Overall Study|Adverse Event|4|||
164273142|NCT00753454|593367961|FG000|Overall Study|Lack of Efficacy|1|||
164273143|NCT00753454|593367961|FG000|Overall Study|Lost to Follow-up|3|||
164273144|NCT00753454|593367961|FG000|Overall Study|Withdrawal by Subject|5|||
164273145|NCT00753454|593367961|FG000|Overall Study|Investigator Decision|1|||
164273146|NCT03909152|593367962|FG000|Overall Study|Adverse Event|14|||
164273147|NCT03909152|593367963|FG001|Overall Study|Adverse Event|5|||
164273148|NCT03909152|593367964|FG002|Overall Study|Adverse Event|1|||
164273149|NCT03909152|593367965|FG003|Overall Study|Adverse Event|14|||
164273150|NCT05011058|593367966|FG000|Overall Study|Sponsor Decision|2|||
164273151|NCT05011058|593367967|FG001|Overall Study|Sponsor Decision|0|||
164273152|NCT05011058|593367968|FG002|Overall Study|Sponsor Decision|14|||
164273153|NCT05011058|593367969|FG003|Overall Study|Sponsor Decision|0|||
164273154|NCT05011058|593367970|FG004|Overall Study|Sponsor Decision|0|||
164273155|NCT05011058|593367971|FG005|Overall Study|Sponsor Decision|1|||
164273156|NCT05011058|593367972|FG006|Overall Study|Sponsor Decision|0|||
164273157|NCT05011058|593367973|FG007|Overall Study|Sponsor Decision|5|||
164273158|NCT01272869|593367974|FG000|Period 2 (14 Days)|Adverse Event|1|||
164273159|NCT01272869|593367975|FG001|Period 2 (14 Days)|Adverse Event|0|||
164273160|NCT02271945|593367976|FG000|Overall Study|Death|3|||
164273161|NCT02271945|593367977|FG001|Overall Study|Death|3|||
164273162|NCT02271945|593367976|FG000|Overall Study|Withdrawal by Subject|1|||
164273163|NCT02271945|593367977|FG001|Overall Study|Withdrawal by Subject|1|||
164273164|NCT02271945|593367976|FG000|Overall Study|Other|1|||
164273165|NCT02271945|593367977|FG001|Overall Study|Other|1|||
164273166|NCT02455076|593367978|FG000|Inpatient|Withdrawal by Subject|1|||
164273167|NCT02455076|593367979|FG001|Inpatient|Withdrawal by Subject|0|||
164273168|NCT02455076|593367980|FG002|Inpatient|Withdrawal by Subject|0|||
164342634|NCT00745823|593631468|FG001|Overall Study|Lack of Efficacy|6|||
164342635|NCT00745823|593631467|FG000|Overall Study|Lost to Follow-up|10|||
164342636|NCT00745823|593631468|FG001|Overall Study|Lost to Follow-up|11|||
163894010|NCT05736458|591983817|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
163894011|NCT02990338|591983818|FG000|Overall Study|Randomized and not treated|4|||
164342637|NCT00745823|593631467|FG000|Overall Study|Physician Decision|10|||
164342638|NCT00745823|593631468|FG001|Overall Study|Physician Decision|5|||
164342639|NCT00745823|593631467|FG000|Overall Study|Pregnancy|0|||
164342640|NCT00745823|593631468|FG001|Overall Study|Pregnancy|4|||
164342641|NCT00745823|593631467|FG000|Overall Study|Withdrawal by Subject|14|||
164342642|NCT00745823|593631468|FG001|Overall Study|Withdrawal by Subject|8|||
164342643|NCT00745823|593631467|FG000|Overall Study|Study Terminated by Sponsor|326|||
164342644|NCT00745823|593631468|FG001|Overall Study|Study Terminated by Sponsor|349|||
164342645|NCT02980601|593631480|FG000|Overall Study|Lost to Follow-up|2|||
164342646|NCT02980601|593631481|FG001|Overall Study|Lost to Follow-up|2|||
164342647|NCT02980601|593631480|FG000|Overall Study|Death|0|||
164342648|NCT02980601|593631481|FG001|Overall Study|Death|1|||
164342649|NCT02980601|593631480|FG000|Overall Study|Graft loss|1|||
164342650|NCT02980601|593631481|FG001|Overall Study|Graft loss|0|||
164342651|NCT02980601|593631480|FG000|Overall Study|Failed to sign consent|2|||
164342652|NCT02980601|593631481|FG001|Overall Study|Failed to sign consent|0|||
164342653|NCT01575769|593631482|FG000|Overall Study|Adverse Event|1|||
164342654|NCT01575769|593631482|FG000|Overall Study|Study terminated by sponsor|40|||
164342655|NCT00290888|593631483|FG000|Overall Study|Physician Decision|3|||
164342656|NCT00290888|593631484|FG001|Overall Study|Physician Decision|1|||
164342657|NCT02501473|593631485|FG000|Overall Study|Study Terminated|2|||
164342658|NCT02501473|593631486|FG001|Overall Study|Study Terminated|3|||
164342659|NCT02501473|593631487|FG002|Overall Study|Study Terminated|7|||
164342660|NCT02501473|593631488|FG003|Overall Study|Study Terminated|9|||
164342661|NCT02501473|593631489|FG004|Overall Study|Study Terminated|2|||
164342662|NCT02501473|593631490|FG005|Overall Study|Study Terminated|10|||
164342663|NCT02501473|593631491|FG006|Overall Study|Study Terminated|1|||
164342664|NCT02501473|593631492|FG007|Overall Study|Study Terminated|0|||
164342665|NCT02501473|593631485|FG000|Overall Study|Withdrawal by Subject|0|||
164342666|NCT02501473|593631486|FG001|Overall Study|Withdrawal by Subject|0|||
163894012|NCT02990338|591983819|FG001|Overall Study|Randomized and not treated|2|||
163894013|NCT02990338|591983818|FG000|Overall Study|Adverse Event|23|||
163894014|NCT02990338|591983819|FG001|Overall Study|Adverse Event|22|||
163894015|NCT02990338|591983818|FG000|Overall Study|Progressive disease|118|||
163894016|NCT02990338|591983819|FG001|Overall Study|Progressive disease|107|||
163894017|NCT02990338|591983818|FG000|Overall Study|Poor compliance to protocol|0|||
163894018|NCT02990338|591983819|FG001|Overall Study|Poor compliance to protocol|1|||
163894019|NCT02990338|591983818|FG000|Overall Study|Withdrawal by Subject|6|||
163894020|NCT02990338|591983819|FG001|Overall Study|Withdrawal by Subject|8|||
163894021|NCT02990338|591983818|FG000|Overall Study|Physician's decision|2|||
163894022|NCT02990338|591983819|FG001|Overall Study|Physician's decision|6|||
164273169|NCT02455076|593367981|FG003|Inpatient|Withdrawal by Subject|0|||
164273170|NCT02455076|593367982|FG004|Inpatient|Withdrawal by Subject|0|||
164273171|NCT02455076|593367978|FG000|Inpatient|Discharged <24 h after admission|0|||
164342667|NCT02501473|593631487|FG002|Overall Study|Withdrawal by Subject|3|||
164342668|NCT02501473|593631488|FG003|Overall Study|Withdrawal by Subject|3|||
164273172|NCT02455076|593367979|FG001|Inpatient|Discharged <24 h after admission|1|||
164342669|NCT02501473|593631489|FG004|Overall Study|Withdrawal by Subject|2|||
164273173|NCT02455076|593367980|FG002|Inpatient|Discharged <24 h after admission|0|||
164273174|NCT02455076|593367981|FG003|Inpatient|Discharged <24 h after admission|0|||
164273175|NCT02455076|593367982|FG004|Inpatient|Discharged <24 h after admission|0|||
164273176|NCT02455076|593367978|FG000|Inpatient|Adverse Event|3|||
164273177|NCT02455076|593367979|FG001|Inpatient|Adverse Event|0|||
164273178|NCT02455076|593367980|FG002|Inpatient|Adverse Event|0|||
164273179|NCT02455076|593367981|FG003|Inpatient|Adverse Event|0|||
164273180|NCT02455076|593367982|FG004|Inpatient|Adverse Event|0|||
164273181|NCT02455076|593367978|FG000|Outpatient|Adverse Event|0|||
164273182|NCT02455076|593367979|FG001|Outpatient|Adverse Event|0|||
164273183|NCT02455076|593367980|FG002|Outpatient|Adverse Event|0|||
164273184|NCT02455076|593367981|FG003|Outpatient|Adverse Event|5|||
164273185|NCT02455076|593367982|FG004|Outpatient|Adverse Event|0|||
164273186|NCT02455076|593367978|FG000|Outpatient|Lost to Follow-up|0|||
164273187|NCT02455076|593367979|FG001|Outpatient|Lost to Follow-up|0|||
164273188|NCT02455076|593367980|FG002|Outpatient|Lost to Follow-up|0|||
164273189|NCT02455076|593367981|FG003|Outpatient|Lost to Follow-up|1|||
164273190|NCT02455076|593367982|FG004|Outpatient|Lost to Follow-up|12|||
164273191|NCT00719680|593367986|FG000|Overall Study|Adverse Event|1|||
164273192|NCT00719680|593367986|FG000|Overall Study|Lost to Follow-up|1|||
164273193|NCT00719680|593367986|FG000|Overall Study|Withdrawal by Subject|3|||
164273194|NCT04676867|593367998|FG000|Overall Study|Screen failure|0|||
164273195|NCT04676867|593367999|FG001|Overall Study|Screen failure|0|||
164273196|NCT04676867|593368000|FG002|Overall Study|Screen failure|6|||
164273197|NCT04676867|593368001|FG003|Overall Study|Screen failure|2|||
164273198|NCT04676867|593367998|FG000|Overall Study|Death|0|||
164273199|NCT04676867|593367999|FG001|Overall Study|Death|0|||
164273200|NCT04676867|593368000|FG002|Overall Study|Death|1|||
164273201|NCT04676867|593368001|FG003|Overall Study|Death|0|||
164273202|NCT04676867|593367998|FG000|Overall Study|Withdrawal by Subject|2|||
164085953|NCT01995058|592678601|FG000|Overall Study|Sponsor Decision to terminate study|14|||
164273203|NCT04676867|593367999|FG001|Overall Study|Withdrawal by Subject|2|||
164273204|NCT04676867|593368000|FG002|Overall Study|Withdrawal by Subject|4|||
164273205|NCT04676867|593368001|FG003|Overall Study|Withdrawal by Subject|4|||
164273206|NCT04676867|593367998|FG000|Overall Study|Lost to Follow-up|1|||
164273207|NCT04676867|593367999|FG001|Overall Study|Lost to Follow-up|0|||
164273208|NCT04676867|593368000|FG002|Overall Study|Lost to Follow-up|0|||
164273209|NCT04676867|593368001|FG003|Overall Study|Lost to Follow-up|0|||
164273210|NCT01141478|593368005|FG000|Overall Study|Withdrawal by Subject|1|||
164273211|NCT01141478|593368006|FG001|Overall Study|Withdrawal by Subject|1|||
164273212|NCT00551291|593368012|FG000|Overall Study|Physician Decision|1|||
164273213|NCT01581619|593368014|FG000|Overall Study|Withdrawal by Subject|1|||
164273214|NCT01581619|593368014|FG000|Overall Study|Lost to Follow-up|1|||
164273215|NCT04268173|593368015|FG000|Overall Study|Lost to Follow-up|75|||
164273216|NCT04268173|593368016|FG001|Overall Study|Lost to Follow-up|108|||
164273217|NCT01375608|593368017|FG000|Overall Study|Withdrawal by Subject|2|||
164273218|NCT03836677|593368021|FG000|Period 1|Adverse Event|0|||
164273219|NCT03836677|593368022|FG001|Period 1|Adverse Event|1|||
164273220|NCT03836677|593368021|FG000|Period 2|Severe non-compliance to protocol|1|||
164273221|NCT03836677|593368022|FG001|Period 2|Severe non-compliance to protocol|0|||
164000551|NCT00382967|592364737|FG001|Overall Study|Protocol Violation|1|||
164000552|NCT02731742|592364739|FG000|Overall Study|Death|1|||
164000553|NCT02731742|592364740|FG001|Overall Study|Death|2|||
164000554|NCT02731742|592364741|FG002|Overall Study|Death|5|||
164000555|NCT02731742|592364742|FG003|Overall Study|Death|0|||
164000556|NCT02731742|592364739|FG000|Overall Study|Physician Decision|0|||
164000557|NCT02731742|592364740|FG001|Overall Study|Physician Decision|0|||
164000558|NCT02731742|592364741|FG002|Overall Study|Physician Decision|0|||
164273222|NCT00710385|593368031|FG000|Overall Study|Did not qualify|1|||
164273223|NCT00710385|593368031|FG000|Overall Study|Withdrawal by Subject|1|||
164273224|NCT00710385|593368031|FG000|Overall Study|Undisclosed back pain|1|||
164273225|NCT00710385|593368031|FG000|Overall Study|Physician Decision|1|||
164273226|NCT00710385|593368031|FG000|Overall Study|Undisclosed excessive methadone use|1|||
164273227|NCT00079677|593368032|FG000|Overall Study|Adverse Event|5|||
164273228|NCT00079677|593368033|FG001|Overall Study|Adverse Event|6|||
164273229|NCT00079677|593368032|FG000|Overall Study|Lack of Efficacy|1|||
164273230|NCT00079677|593368033|FG001|Overall Study|Lack of Efficacy|0|||
164273231|NCT00079677|593368032|FG000|Overall Study|Lost to Follow-up|2|||
164273232|NCT00079677|593368033|FG001|Overall Study|Lost to Follow-up|2|||
164273233|NCT00079677|593368032|FG000|Overall Study|Physician Decision|3|||
164273234|NCT00079677|593368033|FG001|Overall Study|Physician Decision|0|||
164273235|NCT00079677|593368032|FG000|Overall Study|Protocol Violation|2|||
164273236|NCT00079677|593368033|FG001|Overall Study|Protocol Violation|3|||
164273237|NCT00079677|593368032|FG000|Overall Study|Withdrawal by Subject|5|||
164273238|NCT00079677|593368033|FG001|Overall Study|Withdrawal by Subject|3|||
164273239|NCT00079677|593368032|FG000|Overall Study|Miscellaneous|2|||
164273240|NCT00079677|593368033|FG001|Overall Study|Miscellaneous|0|||
164273241|NCT04598269|593368034|FG000|Overall Study|Adverse Event|0|||
164273242|NCT04598269|593368035|FG001|Overall Study|Adverse Event|3|||
164273243|NCT04598269|593368034|FG000|Overall Study|Withdrawal by Subject|1|||
164273244|NCT04598269|593368035|FG001|Overall Study|Withdrawal by Subject|4|||
164273245|NCT04598269|593368034|FG000|Overall Study|Lost to Follow-up|1|||
164273246|NCT04598269|593368035|FG001|Overall Study|Lost to Follow-up|0|||
164273247|NCT04598269|593368034|FG000|Overall Study|Not Treated|2|||
164273248|NCT04598269|593368035|FG001|Overall Study|Not Treated|0|||
164000559|NCT02731742|592364742|FG003|Overall Study|Physician Decision|1|||
164000560|NCT02731742|592364739|FG000|Overall Study|Study Terminated by Sponsor|2|||
164273249|NCT00424190|593368036|FG000|Overall Study|Withdrew consent|3|||
164273250|NCT00424190|593368037|FG001|Overall Study|Withdrew consent|4|||
164273251|NCT00424190|593368036|FG000|Overall Study|Death|3|||
164273252|NCT00424190|593368037|FG001|Overall Study|Death|0|||
164273253|NCT00424190|593368036|FG000|Overall Study|Noncompliance|1|||
164273254|NCT00424190|593368037|FG001|Overall Study|Noncompliance|2|||
164273255|NCT00424190|593368036|FG000|Overall Study|Request of sponsor or investigator|0|||
164273256|NCT00424190|593368037|FG001|Overall Study|Request of sponsor or investigator|2|||
164273257|NCT00424190|593368036|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
164273258|NCT00424190|593368037|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
164273259|NCT00424190|593368036|FG000|Overall Study|Other|15|||
164273260|NCT00424190|593368037|FG001|Overall Study|Other|21|||
164273261|NCT03040986|593368038|FG000|Overall Study|Hospice|1|||
164273262|NCT03040986|593368039|FG001|Overall Study|Hospice|0|||
164273263|NCT03040986|593368038|FG000|Overall Study|Adverse Event|2|||
164273264|NCT03040986|593368039|FG001|Overall Study|Adverse Event|1|||
164273265|NCT03040986|593368038|FG000|Overall Study|Disease progression on study|3|||
164000561|NCT02731742|592364740|FG001|Overall Study|Study Terminated by Sponsor|1|||
164273266|NCT03040986|593368039|FG001|Overall Study|Disease progression on study|1|||
164273267|NCT02925728|593368040|FG000|Overall Study|Death|3|||
164273268|NCT02925728|593368041|FG001|Overall Study|Death|5|||
164273269|NCT02925728|593368040|FG000|Overall Study|Physician Decision|1|||
164273270|NCT02925728|593368041|FG001|Overall Study|Physician Decision|0|||
164273271|NCT02925728|593368040|FG000|Overall Study|Withdrawal by Subject|1|||
164273272|NCT02925728|593368041|FG001|Overall Study|Withdrawal by Subject|0|||
164273273|NCT02102399|593368044|FG000|Overall Study|Withdrawal by Subject|6|||
164273274|NCT02102399|593368045|FG001|Overall Study|Withdrawal by Subject|4|||
164273275|NCT00086411|593368052|FG000|Overall Study|Lost to Follow-up|11|||
164273276|NCT00086411|593368053|FG001|Overall Study|Lost to Follow-up|11|||
164273277|NCT00086411|593368054|FG002|Overall Study|Lost to Follow-up|13|||
164273278|NCT00086411|593368055|FG003|Overall Study|Lost to Follow-up|12|||
164273279|NCT00695864|593368058|FG000|Placebo|Withdrawal by Subject|1|||
164273280|NCT00695864|593368058|FG000|Placebo|Physician Decision|4|||
164273281|NCT01624090|593368062|FG000|Overall Study|DLT, taken off therapy|0|||
164000562|NCT02731742|592364741|FG002|Overall Study|Study Terminated by Sponsor|1|||
164000563|NCT02731742|592364742|FG003|Overall Study|Study Terminated by Sponsor|1|||
164273282|NCT01624090|593368063|FG001|Overall Study|DLT, taken off therapy|1|||
164273283|NCT01624090|593368064|FG002|Overall Study|DLT, taken off therapy|0|||
164273284|NCT01624090|593368065|FG003|Overall Study|DLT, taken off therapy|0|||
164273285|NCT01624090|593368062|FG000|Overall Study|Withdrew prior to treatment|0|||
164273286|NCT01624090|593368063|FG001|Overall Study|Withdrew prior to treatment|1|||
164273287|NCT01624090|593368064|FG002|Overall Study|Withdrew prior to treatment|0|||
164273288|NCT01624090|593368065|FG003|Overall Study|Withdrew prior to treatment|0|||
164273289|NCT01624090|593368062|FG000|Overall Study|Died on study|0|||
164273290|NCT01624090|593368063|FG001|Overall Study|Died on study|0|||
164273291|NCT01624090|593368064|FG002|Overall Study|Died on study|2|||
164273292|NCT01624090|593368065|FG003|Overall Study|Died on study|0|||
164273293|NCT01624090|593368062|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
164273294|NCT01624090|593368063|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
164273295|NCT01624090|593368064|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
164273296|NCT01624090|593368065|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
164273297|NCT01624090|593368062|FG000|Overall Study|Dose escalated|0|||
164273298|NCT01624090|593368063|FG001|Overall Study|Dose escalated|0|||
164273299|NCT01624090|593368064|FG002|Overall Study|Dose escalated|3|||
164273300|NCT01624090|593368065|FG003|Overall Study|Dose escalated|0|||
164273301|NCT00752726|593368066|FG000|Overall Study|Lost to Follow-up|2|||
164273302|NCT00752726|593368067|FG001|Overall Study|Lost to Follow-up|1|||
164273303|NCT00752726|593368066|FG000|Overall Study|Adverse Event|3|||
164273304|NCT00752726|593368067|FG001|Overall Study|Adverse Event|0|||
164273305|NCT00752726|593368066|FG000|Overall Study|Withdrawal by Subject|5|||
164273306|NCT00752726|593368067|FG001|Overall Study|Withdrawal by Subject|10|||
164273307|NCT00752726|593368066|FG000|Overall Study|Other Reason|1|||
164273308|NCT00752726|593368067|FG001|Overall Study|Other Reason|2|||
164273309|NCT01403116|593368068|FG000|Overall Study|Adverse Event|7|||
164273310|NCT01403116|593368069|FG001|Overall Study|Adverse Event|4|||
164273311|NCT01403116|593368068|FG000|Overall Study|Lost to Follow-up|7|||
164273312|NCT01403116|593368069|FG001|Overall Study|Lost to Follow-up|5|||
164273313|NCT01403116|593368068|FG000|Overall Study|Withdrawal by Subject|12|||
164273314|NCT01403116|593368069|FG001|Overall Study|Withdrawal by Subject|15|||
164273315|NCT01403116|593368068|FG000|Overall Study|Non-compliance of study drug|3|||
164273316|NCT01403116|593368069|FG001|Overall Study|Non-compliance of study drug|0|||
164273317|NCT01403116|593368068|FG000|Overall Study|Protocol Violation|0|||
164273318|NCT01403116|593368069|FG001|Overall Study|Protocol Violation|1|||
164273319|NCT01403116|593368068|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
164273320|NCT01403116|593368069|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
164273321|NCT01403116|593368068|FG000|Overall Study|Hct >54%|2|||
164273322|NCT01403116|593368069|FG001|Overall Study|Hct >54%|0|||
164273323|NCT01403116|593368068|FG000|Overall Study|unable to keep appointments|0|||
163894023|NCT02990338|591983818|FG000|Overall Study|Treatment extension study|0|||
163894024|NCT02990338|591983819|FG001|Overall Study|Treatment extension study|6|||
163894025|NCT02990338|591983818|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
163894026|NCT02990338|591983819|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
163894027|NCT02990338|591983818|FG000|Overall Study|Continue with therapy available commercially|0|||
164273324|NCT01403116|593368069|FG001|Overall Study|unable to keep appointments|2|||
164273325|NCT00042666|593368070|FG000|Overall Study|Adverse Event|2|||
164273326|NCT00042666|593368070|FG000|Overall Study|Death|4|||
164273327|NCT00042666|593368070|FG000|Overall Study|Protocol Violation|1|||
164273328|NCT00042666|593368070|FG000|Overall Study|Participant/Physician Perception|1|||
164273329|NCT00042666|593368070|FG000|Overall Study|Progressive Disease|41|||
164273330|NCT00042666|593368070|FG000|Overall Study|Other|1|||
164273331|NCT00042666|593368070|FG000|Overall Study|Other|4|||
164273332|NCT04232215|593368071|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164273333|NCT04232215|593368072|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164273334|NCT04268745|593368073|FG000|Overall Study|Lost to Follow-up|2|||
164273335|NCT04268745|593368074|FG001|Overall Study|Lost to Follow-up|3|||
164273336|NCT04268745|593368073|FG000|Overall Study|Withdrawal by Subject|4|||
164273337|NCT04268745|593368074|FG001|Overall Study|Withdrawal by Subject|2|||
164273338|NCT04268745|593368073|FG000|Overall Study|Death in the family|1|||
164273339|NCT04268745|593368074|FG001|Overall Study|Death in the family|0|||
164273340|NCT05327361|593368076|FG000|Overall Study|Lost to Follow-up|4|||
164273341|NCT00626405|593368077|FG000|Overall Study|Deemed Ineligible|1|||
164273342|NCT00626405|593368078|FG001|Overall Study|Deemed Ineligible|0|||
163894028|NCT02990338|591983819|FG001|Overall Study|Continue with therapy available commercially|1|||
163894029|NCT05100628|591983825|FG000|Overall Study|Progressive Disease|1|||
163894030|NCT05100628|591983826|FG001|Overall Study|Progressive Disease|0|||
163894031|NCT05100628|591983827|FG002|Overall Study|Progressive Disease|0|||
163894032|NCT05100628|591983828|FG003|Overall Study|Progressive Disease|0|||
163894033|NCT05100628|591983825|FG000|Overall Study|Study Terminated by Sponsor|0|||
163894034|NCT05100628|591983826|FG001|Overall Study|Study Terminated by Sponsor|0|||
163894035|NCT05100628|591983827|FG002|Overall Study|Study Terminated by Sponsor|3|||
164273343|NCT00626405|593368077|FG000|Overall Study|Withdrawal by Subject|0|||
164273344|NCT00626405|593368078|FG001|Overall Study|Withdrawal by Subject|1|||
164273345|NCT03047031|593370477|FG000|Overall Study|Other than listed|1|||
164273346|NCT03047031|593370478|FG001|Overall Study|Other than listed|0|||
164273347|NCT03047031|593370479|FG002|Overall Study|Other than listed|0|||
163894036|NCT05100628|591983828|FG003|Overall Study|Study Terminated by Sponsor|0|||
164273348|NCT03047031|593370477|FG000|Overall Study|Lost to Follow-up|4|||
164273349|NCT03047031|593370478|FG001|Overall Study|Lost to Follow-up|0|||
164273350|NCT03047031|593370479|FG002|Overall Study|Lost to Follow-up|0|||
164273351|NCT03047031|593370477|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
164273352|NCT03047031|593370478|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
164273353|NCT03047031|593370479|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
164273354|NCT03047031|593370477|FG000|Overall Study|Adverse Event|1|||
164273355|NCT03047031|593370478|FG001|Overall Study|Adverse Event|0|||
164273356|NCT03047031|593370479|FG002|Overall Study|Adverse Event|0|||
164273357|NCT03047031|593370477|FG000|Overall Study|Withdrawal by Subject|2|||
164273358|NCT03047031|593370478|FG001|Overall Study|Withdrawal by Subject|0|||
164273359|NCT03047031|593370479|FG002|Overall Study|Withdrawal by Subject|0|||
164273360|NCT03047031|593370477|FG000|Overall Study|Change to other medication|2|||
164273361|NCT03047031|593370478|FG001|Overall Study|Change to other medication|0|||
164273362|NCT03047031|593370479|FG002|Overall Study|Change to other medication|0|||
164273363|NCT03047031|593370477|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
164273364|NCT03047031|593370478|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
164273365|NCT03047031|593370479|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
164273366|NCT01041287|593370480|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
164273367|NCT01041287|593370481|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
164273368|NCT01041287|593370480|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
164273369|NCT01041287|593370481|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
164273370|NCT01971008|593370484|FG000|Overall Study|Protocol Violation|2|||
164273371|NCT01971008|593370485|FG001|Overall Study|Protocol Violation|1|||
164273372|NCT03416127|593370486|FG000|Overall Study|Withdrawal by Subject|0|||
164273373|NCT03416127|593370487|FG001|Overall Study|Withdrawal by Subject|1|||
164273374|NCT03416127|593370488|FG002|Overall Study|Withdrawal by Subject|1|||
164273375|NCT02629822|593370489|FG000|Base Study|Lost to Follow-up|2|||
164273376|NCT02629822|593370489|FG000|Base Study|Non-Compliance With Study Drug|1|||
164273377|NCT02629822|593370489|FG000|Extension Study|Adverse Event|1|||
164273378|NCT02629822|593370489|FG000|Extension Study|Lost to Follow-up|1|||
164273379|NCT01610336|593370490|FG000|Overall Study|Progressive Disease|4|||
164273380|NCT01610336|593370491|FG001|Overall Study|Progressive Disease|6|||
164273381|NCT01610336|593370492|FG002|Overall Study|Progressive Disease|6|||
164273382|NCT01610336|593370493|FG003|Overall Study|Progressive Disease|5|||
164273383|NCT01610336|593370494|FG004|Overall Study|Progressive Disease|3|||
164273384|NCT01610336|593370495|FG005|Overall Study|Progressive Disease|10|||
164273385|NCT01610336|593370496|FG006|Overall Study|Progressive Disease|1|||
164273386|NCT01610336|593370497|FG007|Overall Study|Progressive Disease|6|||
164273387|NCT01610336|593370498|FG008|Overall Study|Progressive Disease|6|||
164273388|NCT01610336|593370499|FG009|Overall Study|Progressive Disease|40|||
164273389|NCT01610336|593370500|FG010|Overall Study|Progressive Disease|36|||
164273390|NCT01610336|593370490|FG000|Overall Study|Adverse Event|0|||
164273391|NCT01610336|593370491|FG001|Overall Study|Adverse Event|0|||
164273392|NCT01610336|593370492|FG002|Overall Study|Adverse Event|0|||
164273393|NCT01610336|593370493|FG003|Overall Study|Adverse Event|1|||
164273394|NCT01610336|593370494|FG004|Overall Study|Adverse Event|1|||
164273395|NCT01610336|593370495|FG005|Overall Study|Adverse Event|1|||
164273396|NCT01610336|593370496|FG006|Overall Study|Adverse Event|0|||
164273397|NCT01610336|593370497|FG007|Overall Study|Adverse Event|0|||
164273398|NCT01610336|593370498|FG008|Overall Study|Adverse Event|2|||
164273399|NCT01610336|593370499|FG009|Overall Study|Adverse Event|8|||
164273400|NCT01610336|593370500|FG010|Overall Study|Adverse Event|6|||
164273401|NCT01610336|593370490|FG000|Overall Study|Subject/Guardian decision|1|||
164273402|NCT01610336|593370491|FG001|Overall Study|Subject/Guardian decision|1|||
164273403|NCT01610336|593370492|FG002|Overall Study|Subject/Guardian decision|0|||
164273404|NCT01610336|593370493|FG003|Overall Study|Subject/Guardian decision|1|||
164273405|NCT01610336|593370494|FG004|Overall Study|Subject/Guardian decision|0|||
164273406|NCT01610336|593370495|FG005|Overall Study|Subject/Guardian decision|0|||
164273407|NCT01610336|593370496|FG006|Overall Study|Subject/Guardian decision|0|||
164273408|NCT01610336|593370497|FG007|Overall Study|Subject/Guardian decision|1|||
164273409|NCT01610336|593370498|FG008|Overall Study|Subject/Guardian decision|0|||
164273410|NCT01610336|593370499|FG009|Overall Study|Subject/Guardian decision|2|||
164273411|NCT01610336|593370500|FG010|Overall Study|Subject/Guardian decision|2|||
164273412|NCT01610336|593370490|FG000|Overall Study|Death|0|||
164273413|NCT01610336|593370491|FG001|Overall Study|Death|0|||
164273414|NCT01610336|593370492|FG002|Overall Study|Death|0|||
164273415|NCT01610336|593370493|FG003|Overall Study|Death|0|||
164273416|NCT01610336|593370494|FG004|Overall Study|Death|0|||
164273417|NCT01610336|593370495|FG005|Overall Study|Death|1|||
164273418|NCT01610336|593370496|FG006|Overall Study|Death|3|||
164273419|NCT01610336|593370497|FG007|Overall Study|Death|0|||
164273420|NCT01610336|593370498|FG008|Overall Study|Death|0|||
164273421|NCT01610336|593370499|FG009|Overall Study|Death|1|||
164273422|NCT01610336|593370500|FG010|Overall Study|Death|2|||
164273423|NCT01610336|593370490|FG000|Overall Study|Non-Compliance with study treatment|0|||
164273424|NCT01610336|593370491|FG001|Overall Study|Non-Compliance with study treatment|0|||
164000564|NCT04026568|592364743|FG000|Overall Study|study terminated|0|||
164000565|NCT04026568|592364744|FG001|Overall Study|study terminated|1|||
164000566|NCT00331760|592364745|FG000|Overall Study|Ineligible / no protocol treatment|15|||
164000567|NCT00331760|592364746|FG001|Overall Study|Ineligible / no protocol treatment|8|||
164000568|NCT00461175|592364747|FG000|Overall Study|Protocol Violation|522|||
164000569|NCT00461175|592364748|FG001|Overall Study|Protocol Violation|365|||
164000570|NCT00833092|592364750|FG000|Overall Study|Withdrawal by Subject|2|||
164000571|NCT00833092|592364751|FG001|Overall Study|Withdrawal by Subject|3|||
164000572|NCT00833092|592364750|FG000|Overall Study|Protocol Violation|2|||
164000573|NCT00833092|592364751|FG001|Overall Study|Protocol Violation|1|||
164273425|NCT01610336|593370492|FG002|Overall Study|Non-Compliance with study treatment|0|||
164273426|NCT01610336|593370493|FG003|Overall Study|Non-Compliance with study treatment|0|||
164273427|NCT01610336|593370494|FG004|Overall Study|Non-Compliance with study treatment|0|||
164273428|NCT01610336|593370495|FG005|Overall Study|Non-Compliance with study treatment|0|||
164273429|NCT01610336|593370496|FG006|Overall Study|Non-Compliance with study treatment|0|||
164273430|NCT01610336|593370497|FG007|Overall Study|Non-Compliance with study treatment|0|||
164273431|NCT01610336|593370498|FG008|Overall Study|Non-Compliance with study treatment|0|||
164273432|NCT01610336|593370499|FG009|Overall Study|Non-Compliance with study treatment|1|||
164273433|NCT01610336|593370500|FG010|Overall Study|Non-Compliance with study treatment|0|||
164273434|NCT01610336|593370490|FG000|Overall Study|Physician Decision|0|||
164273435|NCT01610336|593370491|FG001|Overall Study|Physician Decision|0|||
164273436|NCT01610336|593370492|FG002|Overall Study|Physician Decision|0|||
164273437|NCT01610336|593370493|FG003|Overall Study|Physician Decision|0|||
164273438|NCT01610336|593370494|FG004|Overall Study|Physician Decision|0|||
164273439|NCT01610336|593370495|FG005|Overall Study|Physician Decision|0|||
164273440|NCT01610336|593370496|FG006|Overall Study|Physician Decision|1|||
164273441|NCT01610336|593370497|FG007|Overall Study|Physician Decision|0|||
164273442|NCT01610336|593370498|FG008|Overall Study|Physician Decision|0|||
164273443|NCT01610336|593370499|FG009|Overall Study|Physician Decision|0|||
164273444|NCT01610336|593370500|FG010|Overall Study|Physician Decision|0|||
164273445|NCT01610336|593370490|FG000|Overall Study|Protocol Deviation|0|||
164273446|NCT01610336|593370491|FG001|Overall Study|Protocol Deviation|0|||
164273447|NCT01610336|593370492|FG002|Overall Study|Protocol Deviation|0|||
164273448|NCT01610336|593370493|FG003|Overall Study|Protocol Deviation|0|||
164273449|NCT01610336|593370494|FG004|Overall Study|Protocol Deviation|0|||
164273450|NCT01610336|593370495|FG005|Overall Study|Protocol Deviation|0|||
164273451|NCT01610336|593370496|FG006|Overall Study|Protocol Deviation|0|||
164000574|NCT00833092|592364750|FG000|Overall Study|Diarrhea|0|||
164000575|NCT00833092|592364751|FG001|Overall Study|Diarrhea|2|||
164000576|NCT00833092|592364750|FG000|Overall Study|constipation|0|||
164000577|NCT00833092|592364751|FG001|Overall Study|constipation|1|||
164000578|NCT00619229|592364754|FG000|Overall Study|Withdrawal by Subject|1|||
164000579|NCT00619229|592364755|FG001|Overall Study|Withdrawal by Subject|1|||
164000580|NCT00619229|592364754|FG000|Overall Study|Lost to Follow-up|1|||
164000581|NCT00619229|592364755|FG001|Overall Study|Lost to Follow-up|0|||
164000582|NCT00619229|592364754|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
164000583|NCT00619229|592364755|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
164000584|NCT00619229|592364754|FG000|Overall Study|Investigator planned Cataract Operation|1|||
164000585|NCT00619229|592364755|FG001|Overall Study|Investigator planned Cataract Operation|0|||
164000586|NCT03417440|592364756|FG000|Overall Study|Lost to Follow-up|0|||
164000587|NCT03417440|592364757|FG001|Overall Study|Lost to Follow-up|1|||
164273452|NCT01610336|593370497|FG007|Overall Study|Protocol Deviation|0|||
164273453|NCT01610336|593370498|FG008|Overall Study|Protocol Deviation|0|||
164273454|NCT01610336|593370499|FG009|Overall Study|Protocol Deviation|1|||
164273455|NCT01610336|593370500|FG010|Overall Study|Protocol Deviation|0|||
164273456|NCT01610336|593370490|FG000|Overall Study|Transfer to another trial|0|||
164273457|NCT01610336|593370491|FG001|Overall Study|Transfer to another trial|0|||
164000588|NCT03417440|592364758|FG002|Overall Study|Lost to Follow-up|0|||
164000589|NCT03417440|592364759|FG003|Overall Study|Lost to Follow-up|0|||
164273458|NCT01610336|593370492|FG002|Overall Study|Transfer to another trial|0|||
164273459|NCT01610336|593370493|FG003|Overall Study|Transfer to another trial|0|||
164273460|NCT01610336|593370494|FG004|Overall Study|Transfer to another trial|0|||
164000590|NCT03417440|592364760|FG004|Overall Study|Lost to Follow-up|1|||
164000591|NCT03417440|592364761|FG005|Overall Study|Lost to Follow-up|0|||
164000592|NCT03417440|592364762|FG006|Overall Study|Lost to Follow-up|0|||
164000593|NCT03417440|592364763|FG007|Overall Study|Lost to Follow-up|0|||
164000594|NCT03417440|592364756|FG000|Overall Study|Withdrawal by Subject|2|||
164000595|NCT03417440|592364757|FG001|Overall Study|Withdrawal by Subject|0|||
164273461|NCT01610336|593370495|FG005|Overall Study|Transfer to another trial|0|||
164273462|NCT01610336|593370496|FG006|Overall Study|Transfer to another trial|0|||
164273463|NCT01610336|593370497|FG007|Overall Study|Transfer to another trial|0|||
164273464|NCT01610336|593370498|FG008|Overall Study|Transfer to another trial|0|||
164273465|NCT01610336|593370499|FG009|Overall Study|Transfer to another trial|0|||
164273466|NCT01610336|593370500|FG010|Overall Study|Transfer to another trial|1|||
164273467|NCT02397057|593370502|FG000|Overall Study|Withdrawal by Subject|6|||
164273468|NCT02397057|593370503|FG001|Overall Study|Withdrawal by Subject|7|||
164273469|NCT02397057|593370502|FG000|Overall Study|Lost to Follow-up|4|||
164273470|NCT02397057|593370503|FG001|Overall Study|Lost to Follow-up|3|||
164273471|NCT02397057|593370502|FG000|Overall Study|Death|1|||
164273472|NCT02397057|593370503|FG001|Overall Study|Death|0|||
164273473|NCT02397057|593370502|FG000|Overall Study|Adverse Event|0|||
164273474|NCT02397057|593370503|FG001|Overall Study|Adverse Event|1|||
164273475|NCT02397057|593370502|FG000|Overall Study|Physician Decision|0|||
164273476|NCT02397057|593370503|FG001|Overall Study|Physician Decision|1|||
164273477|NCT02397057|593370502|FG000|Overall Study|Subject did not receive study drug|0|||
164273478|NCT02397057|593370503|FG001|Overall Study|Subject did not receive study drug|1|||
164273479|NCT02352753|593370504|FG000|6-Month Dosing Period|Decision by sponsor|2|||
164273480|NCT02352753|593370504|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
164273481|NCT02352753|593370504|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
164273482|NCT02352753|593370504|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
164273483|NCT02352753|593370504|FG000|3-Month Dosing Period|Decision by sponsor|14|||
164273484|NCT02352753|593370504|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
164273485|NCT00679172|593370506|FG000|Overall Study|Non-compliance|1|||
164273486|NCT00679172|593370507|FG001|Overall Study|Non-compliance|1|||
164273487|NCT00679172|593370508|FG002|Overall Study|Non-compliance|0|||
164273488|NCT00679172|593370509|FG003|Overall Study|Non-compliance|1|||
164273489|NCT00679172|593370510|FG004|Overall Study|Non-compliance|0|||
164273490|NCT00679172|593370506|FG000|Overall Study|Other not specified|0|||
164273491|NCT00679172|593370507|FG001|Overall Study|Other not specified|0|||
164273492|NCT00679172|593370508|FG002|Overall Study|Other not specified|1|||
164273493|NCT00679172|593370509|FG003|Overall Study|Other not specified|0|||
164273494|NCT00679172|593370510|FG004|Overall Study|Other not specified|0|||
164273495|NCT00417963|593370511|FG000|Overall Study|Lost to Follow-up|3|||
164273496|NCT00417963|593370511|FG000|Overall Study|Withdrawal by Subject|18|||
164273497|NCT00417963|593370511|FG000|Overall Study|Death|17|||
164273498|NCT00417963|593370511|FG000|Overall Study|Study device could not be deployed|3|||
164273499|NCT00704288|593370513|FG000|Overall Treatment Period|Adverse Event|11|||
164273500|NCT00704288|593370514|FG001|Overall Treatment Period|Adverse Event|8|||
164273501|NCT00704288|593370515|FG002|Overall Treatment Period|Adverse Event|22|||
164273502|NCT00704288|593370513|FG000|Overall Treatment Period|Death|0|||
164273503|NCT00704288|593370514|FG001|Overall Treatment Period|Death|0|||
164273504|NCT00704288|593370515|FG002|Overall Treatment Period|Death|1|||
164273505|NCT00704288|593370513|FG000|Overall Treatment Period|Physician Decision|0|||
164273506|NCT00704288|593370514|FG001|Overall Treatment Period|Physician Decision|2|||
164273507|NCT00704288|593370515|FG002|Overall Treatment Period|Physician Decision|0|||
164273508|NCT00704288|593370513|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
164273509|NCT00704288|593370514|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
164273510|NCT00704288|593370515|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
164273511|NCT00704288|593370513|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
164273512|NCT00704288|593370514|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
164273513|NCT00704288|593370515|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
164273514|NCT00704288|593370513|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
164273515|NCT00704288|593370514|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
164273516|NCT00704288|593370515|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
164273517|NCT00704288|593370513|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
164273518|NCT00704288|593370514|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
164273519|NCT00704288|593370515|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
164273520|NCT00704288|593370513|FG000|Overall Treatment Period|Roll-over to another study|1|||
164273521|NCT00704288|593370514|FG001|Overall Treatment Period|Roll-over to another study|0|||
164273522|NCT00704288|593370515|FG002|Overall Treatment Period|Roll-over to another study|4|||
164273523|NCT00704288|593370513|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
164273524|NCT00704288|593370514|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
164273525|NCT00704288|593370515|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
164273526|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Death|41|||
164273527|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Death|50|||
164273528|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Death|93|||
164273529|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
164273530|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
164273531|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
164273532|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
164273533|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
164273534|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
164273535|NCT00704288|593370513|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
164273536|NCT00704288|593370514|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
164273537|NCT00704288|593370515|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
164273538|NCT03927144|593370518|FG000|Core Phase|Adverse Event|9|||
164273539|NCT03927144|593370519|FG001|Core Phase|Adverse Event|5|||
164273540|NCT03927144|593370518|FG000|Core Phase|Lost to Follow-up|3|||
164342670|NCT02501473|593631490|FG005|Overall Study|Withdrawal by Subject|2|||
164342671|NCT02501473|593631491|FG006|Overall Study|Withdrawal by Subject|0|||
164342672|NCT02501473|593631492|FG007|Overall Study|Withdrawal by Subject|0|||
164342673|NCT02501473|593631485|FG000|Overall Study|Death|0|||
164342674|NCT02501473|593631486|FG001|Overall Study|Death|0|||
164342675|NCT02501473|593631487|FG002|Overall Study|Death|1|||
164342676|NCT02501473|593631488|FG003|Overall Study|Death|1|||
164342677|NCT02501473|593631489|FG004|Overall Study|Death|0|||
164342678|NCT02501473|593631490|FG005|Overall Study|Death|1|||
164342679|NCT02501473|593631491|FG006|Overall Study|Death|0|||
164342680|NCT02501473|593631492|FG007|Overall Study|Death|0|||
164342681|NCT02501473|593631485|FG000|Overall Study|Lost to Follow-up|1|||
164342682|NCT02501473|593631486|FG001|Overall Study|Lost to Follow-up|0|||
164342683|NCT02501473|593631487|FG002|Overall Study|Lost to Follow-up|1|||
164342684|NCT02501473|593631488|FG003|Overall Study|Lost to Follow-up|0|||
164342685|NCT02501473|593631489|FG004|Overall Study|Lost to Follow-up|0|||
164342686|NCT02501473|593631490|FG005|Overall Study|Lost to Follow-up|1|||
164342687|NCT02501473|593631491|FG006|Overall Study|Lost to Follow-up|0|||
164342688|NCT02501473|593631492|FG007|Overall Study|Lost to Follow-up|0|||
164342689|NCT02501473|593631485|FG000|Overall Study|Reason not specified|0|||
164342690|NCT02501473|593631486|FG001|Overall Study|Reason not specified|0|||
164342691|NCT02501473|593631487|FG002|Overall Study|Reason not specified|1|||
164342692|NCT02501473|593631488|FG003|Overall Study|Reason not specified|1|||
164342693|NCT02501473|593631489|FG004|Overall Study|Reason not specified|0|||
164342694|NCT02501473|593631490|FG005|Overall Study|Reason not specified|0|||
164342695|NCT02501473|593631491|FG006|Overall Study|Reason not specified|0|||
164342696|NCT02501473|593631492|FG007|Overall Study|Reason not specified|0|||
164342697|NCT01473836|593631493|FG000|Overall Study|Adverse Event|4|||
164342698|NCT01473836|593631493|FG000|Overall Study|Lack of Efficacy|1|||
164342699|NCT01473836|593631493|FG000|Overall Study|Does not meet entrance criteria|1|||
164342700|NCT01709513|593631494|FG000|Overall Study|Randomized but not treated|0|||
164342701|NCT01709513|593631495|FG001|Overall Study|Randomized but not treated|1|||
164342702|NCT01709513|593631496|FG002|Overall Study|Randomized but not treated|0|||
164342703|NCT01709513|593631494|FG000|Overall Study|Adverse Event|16|||
163894037|NCT05100628|591983825|FG000|Overall Study|unkown|0|||
163894038|NCT05100628|591983826|FG001|Overall Study|unkown|1|||
163894039|NCT05100628|591983827|FG002|Overall Study|unkown|0|||
163894040|NCT05100628|591983828|FG003|Overall Study|unkown|0|||
163894041|NCT03914469|591983829|FG000|Overall Study|Lost to Follow-up|1|||
163894042|NCT03914469|591983830|FG001|Overall Study|Lost to Follow-up|4|||
164273541|NCT03927144|593370519|FG001|Core Phase|Lost to Follow-up|2|||
164273542|NCT03927144|593370518|FG000|Core Phase|New Therapy for Study Indication|0|||
164273543|NCT03927144|593370519|FG001|Core Phase|New Therapy for Study Indication|1|||
164273544|NCT03927144|593370518|FG000|Core Phase|No Longer Clinically Benefiting|4|||
164273545|NCT03927144|593370519|FG001|Core Phase|No Longer Clinically Benefiting|4|||
164273546|NCT03927144|593370518|FG000|Core Phase|Physician Decision|2|||
164273547|NCT03927144|593370519|FG001|Core Phase|Physician Decision|8|||
164273548|NCT03927144|593370518|FG000|Core Phase|Protocol Violation|2|||
164273549|NCT03927144|593370519|FG001|Core Phase|Protocol Violation|2|||
164273550|NCT03927144|593370518|FG000|Core Phase|Withdrawal by Subject|16|||
164273551|NCT03927144|593370519|FG001|Core Phase|Withdrawal by Subject|40|||
164273552|NCT03927144|593370518|FG000|Extension Phase|Adverse Event|2|||
164273553|NCT03927144|593370519|FG001|Extension Phase|Adverse Event|1|||
164342704|NCT01709513|593631495|FG001|Overall Study|Adverse Event|31|||
164342705|NCT01709513|593631496|FG002|Overall Study|Adverse Event|23|||
164342706|NCT01709513|593631494|FG000|Overall Study|Poor compliance to protocol|2|||
164342707|NCT01709513|593631495|FG001|Overall Study|Poor compliance to protocol|0|||
163894043|NCT03334695|591983841|FG000|Overall Study|Lost to Follow-up|3|||
163894044|NCT03334695|591983842|FG001|Overall Study|Lost to Follow-up|3|||
163894045|NCT03334695|591983841|FG000|Overall Study|Physician Decision|1|||
163894046|NCT03334695|591983842|FG001|Overall Study|Physician Decision|2|||
163894047|NCT03334695|591983841|FG000|Overall Study|Protocol Violation|0|||
164273554|NCT03927144|593370518|FG000|Extension Phase|No longer clinically benefiting|4|||
164273555|NCT03927144|593370519|FG001|Extension Phase|No longer clinically benefiting|5|||
164273556|NCT03927144|593370518|FG000|Extension Phase|Pregnancy|1|||
164273557|NCT03927144|593370519|FG001|Extension Phase|Pregnancy|0|||
164342708|NCT01709513|593631496|FG002|Overall Study|Poor compliance to protocol|0|||
164342709|NCT01709513|593631494|FG000|Overall Study|Other|3|||
163894048|NCT03334695|591983842|FG001|Overall Study|Protocol Violation|1|||
164342710|NCT01709513|593631495|FG001|Overall Study|Other|11|||
163894049|NCT00721149|591983843|FG000|Overall Study|Physician Decision|1|||
164342711|NCT01709513|593631496|FG002|Overall Study|Other|7|||
164342712|NCT02954237|593631497|FG000|Overall Study|Withdrawal by Subject|25|||
164000596|NCT03417440|592364758|FG002|Overall Study|Withdrawal by Subject|2|||
164000597|NCT03417440|592364759|FG003|Overall Study|Withdrawal by Subject|1|||
164000598|NCT03417440|592364760|FG004|Overall Study|Withdrawal by Subject|1|||
164000599|NCT03417440|592364761|FG005|Overall Study|Withdrawal by Subject|0|||
164000600|NCT03417440|592364762|FG006|Overall Study|Withdrawal by Subject|0|||
164000601|NCT03417440|592364763|FG007|Overall Study|Withdrawal by Subject|1|||
164000602|NCT00316264|592364764|FG000|Overall Study|Lost to Follow-up|0|||
164000603|NCT00316264|592364765|FG001|Overall Study|Lost to Follow-up|1|||
164273558|NCT03927144|593370518|FG000|Extension Phase|Protocol Violation|0|||
164273559|NCT03927144|593370519|FG001|Extension Phase|Protocol Violation|1|||
164273560|NCT03927144|593370518|FG000|Extension Phase|Withdrawal by Subject|8|||
164273561|NCT03927144|593370519|FG001|Extension Phase|Withdrawal by Subject|3|||
164273562|NCT00615030|593370522|FG000|Period I|Administrative problem|0|||
164273563|NCT00615030|593370523|FG001|Period I|Administrative problem|0|||
164273564|NCT00615030|593370524|FG002|Period I|Administrative problem|0|||
164273565|NCT00615030|593370525|FG003|Period I|Administrative problem|0|||
164273566|NCT00615030|593370526|FG004|Period I|Administrative problem|1|||
164273567|NCT00615030|593370527|FG005|Period I|Administrative problem|0|||
164273568|NCT00615030|593370528|FG006|Period I|Administrative problem|0|||
164273569|NCT00615030|593370529|FG007|Period I|Administrative problem|0|||
164273570|NCT00615030|593370530|FG008|Period I|Administrative problem|0|||
164273571|NCT00615030|593370531|FG009|Period I|Administrative problem|0|||
164273572|NCT00615030|593370532|FG010|Period I|Administrative problem|0|||
164273573|NCT00615030|593370533|FG011|Period I|Administrative problem|0|||
164273574|NCT00615030|593370522|FG000|Period I|Protocol deviation|1|||
164273575|NCT00615030|593370523|FG001|Period I|Protocol deviation|0|||
164273576|NCT00615030|593370524|FG002|Period I|Protocol deviation|0|||
164273577|NCT00615030|593370525|FG003|Period I|Protocol deviation|0|||
164273578|NCT00615030|593370526|FG004|Period I|Protocol deviation|0|||
164273579|NCT00615030|593370527|FG005|Period I|Protocol deviation|0|||
164273580|NCT00615030|593370528|FG006|Period I|Protocol deviation|0|||
164273581|NCT00615030|593370529|FG007|Period I|Protocol deviation|0|||
164273582|NCT00615030|593370530|FG008|Period I|Protocol deviation|0|||
164273583|NCT00615030|593370531|FG009|Period I|Protocol deviation|0|||
164273584|NCT00615030|593370532|FG010|Period I|Protocol deviation|0|||
164273585|NCT00615030|593370533|FG011|Period I|Protocol deviation|0|||
164273586|NCT00615030|593370522|FG000|Period I|Subject withdrew consent|0|||
164273587|NCT00615030|593370523|FG001|Period I|Subject withdrew consent|0|||
164000604|NCT00316264|592364766|FG002|Overall Study|Lost to Follow-up|0|||
164000605|NCT00316264|592364764|FG000|Overall Study|Withdrawal of Consent|3|||
164000606|NCT00316264|592364765|FG001|Overall Study|Withdrawal of Consent|5|||
164273588|NCT00615030|593370524|FG002|Period I|Subject withdrew consent|0|||
164273589|NCT00615030|593370525|FG003|Period I|Subject withdrew consent|0|||
164273590|NCT00615030|593370526|FG004|Period I|Subject withdrew consent|0|||
164273591|NCT00615030|593370527|FG005|Period I|Subject withdrew consent|0|||
164273592|NCT00615030|593370528|FG006|Period I|Subject withdrew consent|0|||
164273593|NCT00615030|593370529|FG007|Period I|Subject withdrew consent|0|||
164273594|NCT00615030|593370530|FG008|Period I|Subject withdrew consent|1|||
164273595|NCT00615030|593370531|FG009|Period I|Subject withdrew consent|0|||
164273596|NCT00615030|593370532|FG010|Period I|Subject withdrew consent|1|||
164273597|NCT00615030|593370533|FG011|Period I|Subject withdrew consent|1|||
164273598|NCT00615030|593370522|FG000|Period I|Abnormal laboratory value(s)|0|||
164273599|NCT00615030|593370523|FG001|Period I|Abnormal laboratory value(s)|0|||
164273600|NCT00615030|593370524|FG002|Period I|Abnormal laboratory value(s)|0|||
164273601|NCT00615030|593370525|FG003|Period I|Abnormal laboratory value(s)|0|||
164273602|NCT00615030|593370526|FG004|Period I|Abnormal laboratory value(s)|0|||
164273603|NCT00615030|593370527|FG005|Period I|Abnormal laboratory value(s)|1|||
164273604|NCT00615030|593370528|FG006|Period I|Abnormal laboratory value(s)|0|||
164273605|NCT00615030|593370529|FG007|Period I|Abnormal laboratory value(s)|0|||
164273606|NCT00615030|593370530|FG008|Period I|Abnormal laboratory value(s)|0|||
164273607|NCT00615030|593370531|FG009|Period I|Abnormal laboratory value(s)|0|||
164273608|NCT00615030|593370532|FG010|Period I|Abnormal laboratory value(s)|0|||
164273609|NCT00615030|593370533|FG011|Period I|Abnormal laboratory value(s)|0|||
164273610|NCT00615030|593370522|FG000|Period II|Adverse Event|0|||
164273611|NCT00615030|593370523|FG001|Period II|Adverse Event|0|||
164273612|NCT00615030|593370524|FG002|Period II|Adverse Event|1|||
164273613|NCT00615030|593370525|FG003|Period II|Adverse Event|0|||
164273614|NCT00615030|593370526|FG004|Period II|Adverse Event|0|||
164273615|NCT00615030|593370527|FG005|Period II|Adverse Event|0|||
164273616|NCT00615030|593370528|FG006|Period II|Adverse Event|0|||
164273617|NCT00615030|593370529|FG007|Period II|Adverse Event|0|||
164273618|NCT00615030|593370530|FG008|Period II|Adverse Event|1|||
164273619|NCT00615030|593370531|FG009|Period II|Adverse Event|0|||
164273620|NCT00615030|593370532|FG010|Period II|Adverse Event|0|||
164273621|NCT00615030|593370533|FG011|Period II|Adverse Event|0|||
164000607|NCT00316264|592364766|FG002|Overall Study|Withdrawal of Consent|6|||
164000608|NCT00316264|592364764|FG000|Overall Study|Death|2|||
164273622|NCT00615030|593370522|FG000|Period II|Subject withdrew consent|0|||
164273623|NCT00615030|593370523|FG001|Period II|Subject withdrew consent|0|||
164273624|NCT00615030|593370524|FG002|Period II|Subject withdrew consent|0|||
164000609|NCT00316264|592364765|FG001|Overall Study|Death|0|||
164000610|NCT00316264|592364766|FG002|Overall Study|Death|0|||
164000611|NCT00316264|592364764|FG000|Overall Study|Other|1|||
164000612|NCT00316264|592364765|FG001|Overall Study|Other|1|||
164000613|NCT00316264|592364766|FG002|Overall Study|Other|0|||
164000614|NCT00355264|592364767|FG000|Extension (Variable Duration)|Adverse Event|1|||
164000615|NCT00355264|592364767|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
164000616|NCT01451645|592364768|FG000|Overall Study|Protocol Violation|1|||
164000617|NCT01451645|592364769|FG001|Overall Study|Protocol Violation|0|||
164000618|NCT01451645|592364768|FG000|Overall Study|Adverse Event|0|||
164000619|NCT01451645|592364769|FG001|Overall Study|Adverse Event|3|||
164000620|NCT01451645|592364768|FG000|Overall Study|Withdrawal by Subject|4|||
164000621|NCT01451645|592364769|FG001|Overall Study|Withdrawal by Subject|2|||
164000622|NCT01451645|592364768|FG000|Overall Study|Lost to Follow-up|4|||
164000623|NCT01451645|592364769|FG001|Overall Study|Lost to Follow-up|3|||
164000624|NCT02209506|592364772|FG000|Overall Study|Withdrawal by Subject|0|||
164000625|NCT02209506|592364773|FG001|Overall Study|Withdrawal by Subject|0|||
164000626|NCT02209506|592364774|FG002|Overall Study|Withdrawal by Subject|0|||
164000627|NCT02209506|592364775|FG003|Overall Study|Withdrawal by Subject|0|||
164000628|NCT02209506|592364776|FG004|Overall Study|Withdrawal by Subject|1|||
164000629|NCT02203149|592364777|FG000|Part 1|Adverse Event|0|||
164000630|NCT02203149|592364778|FG001|Part 1|Adverse Event|1|||
164000631|NCT02203149|592364779|FG002|Part 1|Adverse Event|0|||
164000632|NCT02203149|592364780|FG003|Part 1|Adverse Event|0|||
164000633|NCT02203149|592364781|FG004|Part 1|Adverse Event|0|||
164000634|NCT02203149|592364777|FG000|Part 2|Death|0|||
164000635|NCT02203149|592364778|FG001|Part 2|Death|0|||
164000636|NCT02203149|592364779|FG002|Part 2|Death|1|||
164000637|NCT02203149|592364780|FG003|Part 2|Death|1|||
164000638|NCT02203149|592364781|FG004|Part 2|Death|0|||
164000639|NCT02203149|592364777|FG000|Part 2|Withdrawal by Subject|0|||
164000640|NCT02203149|592364778|FG001|Part 2|Withdrawal by Subject|0|||
164000641|NCT02203149|592364779|FG002|Part 2|Withdrawal by Subject|0|||
164000642|NCT02203149|592364780|FG003|Part 2|Withdrawal by Subject|1|||
164000643|NCT02203149|592364781|FG004|Part 2|Withdrawal by Subject|0|||
164000644|NCT02203149|592364777|FG000|Part 2|Adverse Event|0|||
164000645|NCT02203149|592364778|FG001|Part 2|Adverse Event|0|||
164000646|NCT02203149|592364779|FG002|Part 2|Adverse Event|0|||
164000647|NCT02203149|592364780|FG003|Part 2|Adverse Event|1|||
164000648|NCT02203149|592364781|FG004|Part 2|Adverse Event|1|||
164000649|NCT02537678|592364782|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
164000650|NCT02537678|592364783|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
164000651|NCT02537678|592364782|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
164000652|NCT02537678|592364783|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
164000653|NCT02537678|592364782|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
164000654|NCT02537678|592364783|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
164273625|NCT00615030|593370525|FG003|Period II|Subject withdrew consent|1|||
164273626|NCT00615030|593370526|FG004|Period II|Subject withdrew consent|0|||
164273627|NCT00615030|593370527|FG005|Period II|Subject withdrew consent|0|||
164273628|NCT00615030|593370528|FG006|Period II|Subject withdrew consent|1|||
164273629|NCT00615030|593370529|FG007|Period II|Subject withdrew consent|0|||
164273630|NCT00615030|593370530|FG008|Period II|Subject withdrew consent|0|||
164273631|NCT00615030|593370531|FG009|Period II|Subject withdrew consent|0|||
164273632|NCT00615030|593370532|FG010|Period II|Subject withdrew consent|0|||
164273633|NCT00615030|593370533|FG011|Period II|Subject withdrew consent|0|||
164273634|NCT00615030|593370522|FG000|Period III|Administrative problems|1|||
164273635|NCT00615030|593370523|FG001|Period III|Administrative problems|0|||
164273636|NCT00615030|593370524|FG002|Period III|Administrative problems|0|||
164000655|NCT02537678|592364782|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
164000656|NCT02537678|592364783|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
164000657|NCT02537678|592364782|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
164000658|NCT02537678|592364783|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
164273637|NCT00615030|593370525|FG003|Period III|Administrative problems|1|||
164273638|NCT00615030|593370526|FG004|Period III|Administrative problems|0|||
164273639|NCT00615030|593370527|FG005|Period III|Administrative problems|0|||
164000659|NCT02537678|592364782|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
164000660|NCT02537678|592364783|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
164000661|NCT02537678|592364782|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
164000662|NCT02537678|592364783|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
164000663|NCT04348851|592364784|FG000|Post-Test 1|Withdrawal by Subject|0|||
164000664|NCT04348851|592364785|FG001|Post-Test 1|Withdrawal by Subject|1|||
164000665|NCT04348851|592364786|FG002|Post-Test 1|Withdrawal by Subject|0|||
164000666|NCT04348851|592364787|FG003|Post-Test 1|Withdrawal by Subject|0|||
164000667|NCT04348851|592364784|FG000|Post-Test 1|Lost to Follow-up|0|||
164000668|NCT04348851|592364785|FG001|Post-Test 1|Lost to Follow-up|1|||
164000669|NCT04348851|592364786|FG002|Post-Test 1|Lost to Follow-up|0|||
164000670|NCT04348851|592364787|FG003|Post-Test 1|Lost to Follow-up|0|||
164000671|NCT04348851|592364784|FG000|Post-Test 2|Stroke survivor death|0|||
164273640|NCT00615030|593370528|FG006|Period III|Administrative problems|0|||
164000672|NCT04348851|592364785|FG001|Post-Test 2|Stroke survivor death|1|||
164000673|NCT04348851|592364786|FG002|Post-Test 2|Stroke survivor death|0|||
164000674|NCT04348851|592364787|FG003|Post-Test 2|Stroke survivor death|1|||
164000675|NCT00552110|592364788|FG000|Overall Study|Serious or Life-Threatening AE|0|||
164000676|NCT00552110|592364789|FG001|Overall Study|Serious or Life-Threatening AE|0|||
164000677|NCT00552110|592364790|FG002|Overall Study|Serious or Life-Threatening AE|1|||
164000678|NCT00552110|592364791|FG003|Overall Study|Serious or Life-Threatening AE|0|||
164000679|NCT00552110|592364792|FG004|Overall Study|Serious or Life-Threatening AE|0|||
164000680|NCT00552110|592364788|FG000|Overall Study|Lack of Efficacy|1|||
164000681|NCT00552110|592364789|FG001|Overall Study|Lack of Efficacy|0|||
164000682|NCT00552110|592364790|FG002|Overall Study|Lack of Efficacy|0|||
164000683|NCT00552110|592364791|FG003|Overall Study|Lack of Efficacy|1|||
164000684|NCT00552110|592364792|FG004|Overall Study|Lack of Efficacy|4|||
164000685|NCT00552110|592364788|FG000|Overall Study|Withdrawal by Subject|0|||
164000686|NCT00552110|592364789|FG001|Overall Study|Withdrawal by Subject|2|||
164000687|NCT00552110|592364790|FG002|Overall Study|Withdrawal by Subject|0|||
164000688|NCT00552110|592364791|FG003|Overall Study|Withdrawal by Subject|3|||
164000689|NCT00552110|592364792|FG004|Overall Study|Withdrawal by Subject|2|||
164000690|NCT00552110|592364788|FG000|Overall Study|Lost to Follow-up|0|||
164000691|NCT00552110|592364789|FG001|Overall Study|Lost to Follow-up|0|||
164273641|NCT00615030|593370529|FG007|Period III|Administrative problems|0|||
164273642|NCT00615030|593370530|FG008|Period III|Administrative problems|0|||
164273643|NCT00615030|593370531|FG009|Period III|Administrative problems|0|||
164273644|NCT00615030|593370532|FG010|Period III|Administrative problems|0|||
164273645|NCT00615030|593370533|FG011|Period III|Administrative problems|0|||
164273646|NCT00308074|593370545|FG000|Overall Study|Withdrawal by Subject|1|||
164273647|NCT03002311|593370546|FG000|Overall Study|Lost to Follow-up|13|||
164273648|NCT03002311|593370547|FG001|Overall Study|Lost to Follow-up|26|||
164273649|NCT03002311|593370546|FG000|Overall Study|Referral provider called to schedule app|3|||
164273650|NCT03002311|593370547|FG001|Overall Study|Referral provider called to schedule app|3|||
164273651|NCT03002311|593370546|FG000|Overall Study|Physician Decision|3|||
164273652|NCT03002311|593370547|FG001|Overall Study|Physician Decision|1|||
164273653|NCT03908476|593370550|FG000|Overall Study|Death|3|||
164273654|NCT03908476|593370551|FG001|Overall Study|Death|0|||
164273655|NCT03908476|593370550|FG000|Overall Study|Lost to Follow-up|3|||
164273656|NCT03908476|593370551|FG001|Overall Study|Lost to Follow-up|1|||
164273657|NCT03908476|593370550|FG000|Overall Study|Withdrawal by Subject|7|||
164273658|NCT03908476|593370551|FG001|Overall Study|Withdrawal by Subject|1|||
164273659|NCT03908476|593370550|FG000|Overall Study|Physician Decision|2|||
164273660|NCT03908476|593370551|FG001|Overall Study|Physician Decision|0|||
164273661|NCT03908476|593370550|FG000|Overall Study|System Explanted and not Replaced|4|||
164273662|NCT03908476|593370551|FG001|Overall Study|System Explanted and not Replaced|0|||
164273663|NCT03908476|593370550|FG000|Overall Study|Intrathecal Pump|1|||
164273664|NCT03908476|593370551|FG001|Overall Study|Intrathecal Pump|0|||
164273665|NCT03908476|593370550|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
164273666|NCT03908476|593370551|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
164273667|NCT05194267|593370552|FG000|Overall Study|Withdrawal by Subject|2|||
164273668|NCT01329939|593370554|FG000|Overall Study|Lost to Follow-up|3|||
164273669|NCT01329939|593370555|FG001|Overall Study|Lost to Follow-up|0|||
164273670|NCT01329939|593370556|FG002|Overall Study|Lost to Follow-up|1|||
164273671|NCT01329939|593370557|FG003|Overall Study|Lost to Follow-up|2|||
164000692|NCT00552110|592364790|FG002|Overall Study|Lost to Follow-up|0|||
164000693|NCT00552110|592364791|FG003|Overall Study|Lost to Follow-up|1|||
164000694|NCT00552110|592364792|FG004|Overall Study|Lost to Follow-up|1|||
164273672|NCT01329939|593370554|FG000|Overall Study|Withdrawal by Subject|0|||
164273673|NCT01329939|593370555|FG001|Overall Study|Withdrawal by Subject|1|||
164273674|NCT01329939|593370556|FG002|Overall Study|Withdrawal by Subject|0|||
164273675|NCT01329939|593370557|FG003|Overall Study|Withdrawal by Subject|0|||
164273676|NCT01329939|593370554|FG000|Overall Study|Adverse Event|0|||
164273677|NCT01329939|593370555|FG001|Overall Study|Adverse Event|0|||
164273678|NCT01329939|593370556|FG002|Overall Study|Adverse Event|0|||
164273679|NCT01329939|593370557|FG003|Overall Study|Adverse Event|3|||
164273680|NCT03722524|593370558|FG000|Overall Study|Protocol Violation|86|||
164273681|NCT03722524|593370558|FG000|Overall Study|Adverse Event|7|||
164273682|NCT03722524|593370558|FG000|Overall Study|Lost to Follow-up|1|||
164273683|NCT03722524|593370558|FG000|Overall Study|Reason is not stated|1|||
164273684|NCT03722524|593370558|FG000|Overall Study|Physician Decision|1|||
164273685|NCT03722524|593370558|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
164273686|NCT02868229|593370559|FG000|Overall Study|Adverse Event|1|||
164273687|NCT02868229|593370560|FG001|Overall Study|Adverse Event|0|||
164000695|NCT00552110|592364788|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
164000696|NCT00552110|592364789|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
164000697|NCT00552110|592364790|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
164273688|NCT02868229|593370561|FG002|Overall Study|Adverse Event|0|||
164273689|NCT02868229|593370562|FG003|Overall Study|Adverse Event|1|||
164273690|NCT02868229|593370559|FG000|Overall Study|Death|0|||
164273691|NCT02868229|593370560|FG001|Overall Study|Death|0|||
164273692|NCT02868229|593370561|FG002|Overall Study|Death|1|||
164273693|NCT02868229|593370562|FG003|Overall Study|Death|1|||
164273694|NCT02868229|593370559|FG000|Overall Study|Missed dose|0|||
164273695|NCT02868229|593370560|FG001|Overall Study|Missed dose|0|||
164273696|NCT02868229|593370561|FG002|Overall Study|Missed dose|0|||
164273697|NCT02868229|593370562|FG003|Overall Study|Missed dose|3|||
164273698|NCT06151288|593370564|FG000|Overall Study|Lost to Follow-up|4|||
164273699|NCT06151288|593370565|FG001|Overall Study|Lost to Follow-up|2|||
164273700|NCT06151288|593370566|FG002|Overall Study|Lost to Follow-up|4|||
164273701|NCT06151288|593370567|FG003|Overall Study|Lost to Follow-up|3|||
164273702|NCT06151288|593370564|FG000|Overall Study|Withdrawal by Subject|4|||
164273703|NCT06151288|593370565|FG001|Overall Study|Withdrawal by Subject|5|||
164273704|NCT06151288|593370566|FG002|Overall Study|Withdrawal by Subject|1|||
164273705|NCT06151288|593370567|FG003|Overall Study|Withdrawal by Subject|1|||
164273706|NCT04369950|593370568|FG000|Overall Study|Protocol Violation|2|||
164273707|NCT04369950|593370569|FG001|Overall Study|Protocol Violation|2|||
164273708|NCT00989963|593370570|FG000|Overall Study|Adverse Event|1|||
164273709|NCT00989963|593370571|FG001|Overall Study|Adverse Event|1|||
164273710|NCT00989963|593370572|FG002|Overall Study|Adverse Event|1|||
164273711|NCT01240200|593370580|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
164273712|NCT01240200|593370581|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
164273713|NCT04071158|593370585|FG000|Overall Study|Lost to Follow-up|1|||
164273714|NCT04071158|593370586|FG001|Overall Study|Lost to Follow-up|2|||
164273715|NCT04071158|593370587|FG002|Overall Study|Lost to Follow-up|3|||
164273716|NCT04071158|593370588|FG003|Overall Study|Lost to Follow-up|3|||
164273717|NCT04071158|593370589|FG004|Overall Study|Lost to Follow-up|5|||
164273718|NCT04071158|593370585|FG000|Overall Study|Randomized but not treated|2|||
164273719|NCT04071158|593370586|FG001|Overall Study|Randomized but not treated|2|||
164273720|NCT04071158|593370587|FG002|Overall Study|Randomized but not treated|0|||
164273721|NCT04071158|593370588|FG003|Overall Study|Randomized but not treated|0|||
164273722|NCT04071158|593370589|FG004|Overall Study|Randomized but not treated|0|||
164273723|NCT01178099|593370590|FG000|Overall Study|Physician Decision|0|||
164000698|NCT00552110|592364791|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
164000699|NCT00552110|592364792|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
164000700|NCT00552110|592364788|FG000|Overall Study|Withdrawn per Sponsor|0|||
164000701|NCT00552110|592364789|FG001|Overall Study|Withdrawn per Sponsor|1|||
164000702|NCT00552110|592364790|FG002|Overall Study|Withdrawn per Sponsor|0|||
164000703|NCT00552110|592364791|FG003|Overall Study|Withdrawn per Sponsor|0|||
164000704|NCT00552110|592364792|FG004|Overall Study|Withdrawn per Sponsor|1|||
164000705|NCT00552110|592364788|FG000|Overall Study|Use of Prohibited Medication|1|||
164000706|NCT00552110|592364789|FG001|Overall Study|Use of Prohibited Medication|1|||
164000707|NCT00552110|592364790|FG002|Overall Study|Use of Prohibited Medication|0|||
164000708|NCT00552110|592364791|FG003|Overall Study|Use of Prohibited Medication|0|||
164000709|NCT00552110|592364792|FG004|Overall Study|Use of Prohibited Medication|0|||
164000710|NCT00552110|592364788|FG000|Overall Study|Delay of Study due to Relabeling|0|||
164000711|NCT00552110|592364789|FG001|Overall Study|Delay of Study due to Relabeling|0|||
164273724|NCT01178099|593370591|FG001|Overall Study|Physician Decision|1|||
164273725|NCT02473367|593370592|FG000|Wait 1|Withdrawal by Subject|1|||
164273726|NCT02473367|593370592|FG000|Period 4|Lost to Follow-up|1|||
164273727|NCT03194438|593370595|FG000|Overall Study|Withdrawal by Subject|2|||
164273728|NCT01286740|593370596|FG000|Overall Study|Enrolled but not treated|1|||
164273729|NCT01286740|593370596|FG000|Overall Study|Protocol Violation|1|||
164273730|NCT01646203|593370597|FG000|Overall Study|Adverse Event|2|||
164273731|NCT01646203|593370598|FG001|Overall Study|Adverse Event|0|||
164273732|NCT01646203|593370599|FG002|Overall Study|Adverse Event|1|||
164273733|NCT01646203|593370597|FG000|Overall Study|Withdrawal by Subject|0|||
164273734|NCT01646203|593370598|FG001|Overall Study|Withdrawal by Subject|1|||
164273735|NCT01646203|593370599|FG002|Overall Study|Withdrawal by Subject|0|||
164273736|NCT01646203|593370597|FG000|Overall Study|Physician's Decision|0|||
164273737|NCT01646203|593370598|FG001|Overall Study|Physician's Decision|1|||
164273738|NCT01646203|593370599|FG002|Overall Study|Physician's Decision|0|||
164273739|NCT02717130|593370605|FG000|Overall Study|Withdrawal by Subject|1|||
164000712|NCT00552110|592364790|FG002|Overall Study|Delay of Study due to Relabeling|0|||
164273740|NCT02717130|593370605|FG000|Overall Study|Adverse Event|1|||
164000713|NCT00552110|592364791|FG003|Overall Study|Delay of Study due to Relabeling|1|||
164000714|NCT00552110|592364792|FG004|Overall Study|Delay of Study due to Relabeling|0|||
164273741|NCT02717130|593370605|FG000|Overall Study|Physician Decision|1|||
164273742|NCT02717130|593370605|FG000|Overall Study|Study Closure|4|||
164273743|NCT00549770|593370606|FG000|Overall Study|Protocol deviation|1|||
164273744|NCT00549770|593370607|FG001|Overall Study|Protocol deviation|1|||
164273745|NCT00549770|593370608|FG002|Overall Study|Protocol deviation|1|||
164273746|NCT00549770|593370609|FG003|Overall Study|Protocol deviation|2|||
164273747|NCT00549770|593370610|FG004|Overall Study|Protocol deviation|2|||
164273748|NCT00549770|593370611|FG005|Overall Study|Protocol deviation|2|||
164273749|NCT00549770|593370612|FG006|Overall Study|Protocol deviation|1|||
164273750|NCT00549770|593370613|FG007|Overall Study|Protocol deviation|2|||
164273751|NCT00549770|593370606|FG000|Overall Study|Administrative problems|0|||
164273752|NCT00549770|593370607|FG001|Overall Study|Administrative problems|1|||
164273753|NCT00549770|593370608|FG002|Overall Study|Administrative problems|0|||
164273754|NCT00549770|593370609|FG003|Overall Study|Administrative problems|0|||
164273755|NCT00549770|593370610|FG004|Overall Study|Administrative problems|0|||
164273756|NCT00549770|593370611|FG005|Overall Study|Administrative problems|0|||
164273757|NCT00549770|593370612|FG006|Overall Study|Administrative problems|0|||
164273758|NCT00549770|593370613|FG007|Overall Study|Administrative problems|1|||
164273759|NCT00549770|593370606|FG000|Overall Study|Lost to Follow-up|0|||
164273760|NCT00549770|593370607|FG001|Overall Study|Lost to Follow-up|0|||
164273761|NCT00549770|593370608|FG002|Overall Study|Lost to Follow-up|2|||
164273762|NCT00549770|593370609|FG003|Overall Study|Lost to Follow-up|2|||
164273763|NCT00549770|593370610|FG004|Overall Study|Lost to Follow-up|3|||
164273764|NCT00549770|593370611|FG005|Overall Study|Lost to Follow-up|2|||
164273765|NCT00549770|593370612|FG006|Overall Study|Lost to Follow-up|0|||
164273766|NCT00549770|593370613|FG007|Overall Study|Lost to Follow-up|0|||
164273767|NCT00549770|593370606|FG000|Overall Study|Withdrawal by Subject|4|||
164273768|NCT00549770|593370607|FG001|Overall Study|Withdrawal by Subject|6|||
164273769|NCT00549770|593370608|FG002|Overall Study|Withdrawal by Subject|4|||
164273770|NCT00549770|593370609|FG003|Overall Study|Withdrawal by Subject|5|||
164273771|NCT00549770|593370610|FG004|Overall Study|Withdrawal by Subject|6|||
164273772|NCT00549770|593370611|FG005|Overall Study|Withdrawal by Subject|6|||
164273773|NCT00549770|593370612|FG006|Overall Study|Withdrawal by Subject|4|||
164273774|NCT00549770|593370613|FG007|Overall Study|Withdrawal by Subject|9|||
164273775|NCT00549770|593370606|FG000|Overall Study|Lack of Efficacy|1|||
164273776|NCT00549770|593370607|FG001|Overall Study|Lack of Efficacy|0|||
164273777|NCT00549770|593370608|FG002|Overall Study|Lack of Efficacy|2|||
164273778|NCT00549770|593370609|FG003|Overall Study|Lack of Efficacy|3|||
164273779|NCT00549770|593370610|FG004|Overall Study|Lack of Efficacy|5|||
164000715|NCT00552110|592364788|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
164000716|NCT00552110|592364789|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
164000717|NCT00552110|592364790|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
164000718|NCT00552110|592364791|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
164273780|NCT00549770|593370611|FG005|Overall Study|Lack of Efficacy|1|||
164273781|NCT00549770|593370612|FG006|Overall Study|Lack of Efficacy|3|||
164000719|NCT00552110|592364792|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
164000720|NCT00552110|592364788|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
164273782|NCT00549770|593370613|FG007|Overall Study|Lack of Efficacy|8|||
164273783|NCT00549770|593370606|FG000|Overall Study|Abnormal test procedure results|0|||
164273784|NCT00549770|593370607|FG001|Overall Study|Abnormal test procedure results|0|||
164273785|NCT00549770|593370608|FG002|Overall Study|Abnormal test procedure results|0|||
164273786|NCT00549770|593370609|FG003|Overall Study|Abnormal test procedure results|2|||
164273787|NCT00549770|593370610|FG004|Overall Study|Abnormal test procedure results|0|||
164273788|NCT00549770|593370611|FG005|Overall Study|Abnormal test procedure results|1|||
164273789|NCT00549770|593370612|FG006|Overall Study|Abnormal test procedure results|1|||
164273790|NCT00549770|593370613|FG007|Overall Study|Abnormal test procedure results|1|||
164273791|NCT00549770|593370606|FG000|Overall Study|Abnormal laboratory values|0|||
164273792|NCT00549770|593370607|FG001|Overall Study|Abnormal laboratory values|0|||
164273793|NCT00549770|593370608|FG002|Overall Study|Abnormal laboratory values|0|||
164273794|NCT00549770|593370609|FG003|Overall Study|Abnormal laboratory values|0|||
164273795|NCT00549770|593370610|FG004|Overall Study|Abnormal laboratory values|0|||
164273796|NCT00549770|593370611|FG005|Overall Study|Abnormal laboratory values|1|||
164273797|NCT00549770|593370612|FG006|Overall Study|Abnormal laboratory values|0|||
164273798|NCT00549770|593370613|FG007|Overall Study|Abnormal laboratory values|0|||
164000721|NCT00552110|592364789|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
164000722|NCT00552110|592364790|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
164273799|NCT00549770|593370606|FG000|Overall Study|Adverse Event|1|||
164273800|NCT00549770|593370607|FG001|Overall Study|Adverse Event|3|||
164273801|NCT00549770|593370608|FG002|Overall Study|Adverse Event|1|||
164273802|NCT00549770|593370609|FG003|Overall Study|Adverse Event|2|||
164273803|NCT00549770|593370610|FG004|Overall Study|Adverse Event|1|||
164273804|NCT00549770|593370611|FG005|Overall Study|Adverse Event|0|||
164273805|NCT00549770|593370612|FG006|Overall Study|Adverse Event|5|||
164273806|NCT00549770|593370613|FG007|Overall Study|Adverse Event|4|||
164273807|NCT02335424|593370618|FG000|Overall Study|Withdrawal by Subject|19|||
164273808|NCT02335424|593370618|FG000|Overall Study|Adverse Event|25|||
164273809|NCT02335424|593370618|FG000|Overall Study|Death|273|||
164273810|NCT02335424|593370618|FG000|Overall Study|Lost to Follow-up|3|||
164273811|NCT02335424|593370618|FG000|Overall Study|Physician Decision|13|||
164273812|NCT02335424|593370618|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
164273813|NCT02335424|593370618|FG000|Overall Study|Protocol Violation|1|||
164273814|NCT02335424|593370618|FG000|Overall Study|Screen failure|1|||
164273815|NCT02712424|593370619|FG000|Overall Study|Lost to Follow-up|34|||
164000723|NCT00552110|592364791|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
164000724|NCT00552110|592364792|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
164000725|NCT00963807|592364793|FG000|Overall Study|Physician Decision|2|||
164000726|NCT00963807|592364793|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
164000727|NCT00963807|592364793|FG000|Overall Study|Disease progression|15|||
164000728|NCT04211337|592364794|FG000|Overall Study|On Treatment|175|||
164000729|NCT04211337|592364795|FG001|Overall Study|On Treatment|40|||
164000730|NCT04211337|592364794|FG000|Overall Study|Withdrawal by Subject|0|||
164000731|NCT04211337|592364795|FG001|Overall Study|Withdrawal by Subject|2|||
164000732|NCT05630846|592366678|FG000|Overall Study|Death|1|||
164000733|NCT05630846|592366679|FG001|Overall Study|Death|0|||
164000734|NCT05630846|592366680|FG002|Overall Study|Death|0|||
164000735|NCT05630846|592366681|FG003|Overall Study|Death|0|||
164000736|NCT05630846|592366678|FG000|Overall Study|Withdrawal by Subject|3|||
164273816|NCT02712424|593370620|FG001|Overall Study|Lost to Follow-up|32|||
164273817|NCT02421601|593370623|FG000|Overall Study|Adverse Event|4|||
164273818|NCT02421601|593370623|FG000|Overall Study|Lack of Efficacy|5|||
164273819|NCT02421601|593370623|FG000|Overall Study|Physician Decision|1|||
164273820|NCT02421601|593370623|FG000|Overall Study|Withdrawal by Subject|31|||
164273821|NCT02421601|593370623|FG000|Overall Study|Others|41|||
164273822|NCT00290498|593370624|FG000|Overall Study|Death|2|||
164273823|NCT00290498|593370625|FG001|Overall Study|Death|0|||
164273824|NCT00290498|593370624|FG000|Overall Study|Physician Decision|1|||
164273825|NCT00290498|593370625|FG001|Overall Study|Physician Decision|0|||
164273826|NCT00290498|593370624|FG000|Overall Study|Withdrawal by Subject|1|||
164000737|NCT05630846|592366679|FG001|Overall Study|Withdrawal by Subject|3|||
164000738|NCT05630846|592366680|FG002|Overall Study|Withdrawal by Subject|4|||
164000739|NCT05630846|592366681|FG003|Overall Study|Withdrawal by Subject|1|||
164000740|NCT05630846|592366678|FG000|Overall Study|Lost to Follow-up|6|||
164000741|NCT05630846|592366679|FG001|Overall Study|Lost to Follow-up|5|||
164000742|NCT05630846|592366680|FG002|Overall Study|Lost to Follow-up|2|||
164000743|NCT05630846|592366681|FG003|Overall Study|Lost to Follow-up|5|||
164000744|NCT05630846|592366678|FG000|Overall Study|Other|1|||
164000745|NCT05630846|592366679|FG001|Overall Study|Other|0|||
164000746|NCT05630846|592366680|FG002|Overall Study|Other|0|||
164000747|NCT05630846|592366681|FG003|Overall Study|Other|0|||
164000748|NCT01431287|592366683|FG000|Overall Study|not treated|0|||
164000749|NCT01431287|592366684|FG001|Overall Study|not treated|0|||
164000750|NCT01431287|592366685|FG002|Overall Study|not treated|1|||
164000751|NCT01431287|592366686|FG003|Overall Study|not treated|0|||
164000752|NCT01431287|592366687|FG004|Overall Study|not treated|0|||
164000753|NCT01431287|592366683|FG000|Overall Study|Adverse Event|59|||
164000754|NCT01431287|592366684|FG001|Overall Study|Adverse Event|57|||
164273827|NCT00290498|593370625|FG001|Overall Study|Withdrawal by Subject|0|||
164000755|NCT01431287|592366685|FG002|Overall Study|Adverse Event|53|||
164000756|NCT01431287|592366686|FG003|Overall Study|Adverse Event|33|||
164000757|NCT01431287|592366687|FG004|Overall Study|Adverse Event|41|||
164273828|NCT00290498|593370624|FG000|Overall Study|Ineligible|3|||
164273829|NCT00290498|593370625|FG001|Overall Study|Ineligible|0|||
164273830|NCT00290498|593370624|FG000|Overall Study|Non-Compliance|1|||
164273831|NCT00290498|593370625|FG001|Overall Study|Non-Compliance|0|||
164273832|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
164273833|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
164273834|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
164000758|NCT01431287|592366683|FG000|Overall Study|Non compliant with protocol|6|||
164000759|NCT01431287|592366684|FG001|Overall Study|Non compliant with protocol|6|||
164000760|NCT01431287|592366685|FG002|Overall Study|Non compliant with protocol|5|||
164000761|NCT01431287|592366686|FG003|Overall Study|Non compliant with protocol|6|||
164000762|NCT01431287|592366687|FG004|Overall Study|Non compliant with protocol|5|||
164273835|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
164273836|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
164273837|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
164273838|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
164273839|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
164273840|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
164273841|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
164273842|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
164273843|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
164273844|NCT00599638|593370628|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
164273845|NCT00599638|593370629|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
164273846|NCT00599638|593370630|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
164273847|NCT00599638|593370631|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
164273848|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
164273849|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
164273850|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
164273851|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
164273852|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
164273853|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
164273854|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
164273855|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
164273856|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
164273857|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
164273858|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
164273859|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
164273860|NCT00599638|593370628|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
164273861|NCT00599638|593370629|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
164273862|NCT00599638|593370630|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
164273863|NCT00599638|593370631|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
164273864|NCT00599638|593370628|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
164273865|NCT00599638|593370629|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
164273866|NCT00599638|593370630|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
164273867|NCT00599638|593370631|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
164273868|NCT03006887|593370632|FG000|Overall Study|Adverse Event|1|||
164273869|NCT02895945|593370633|FG000|Overall Study|Physician Decision|2|||
164273870|NCT02895945|593370634|FG001|Overall Study|Physician Decision|1|||
164273871|NCT00462748|593370635|FG000|Overall Study|Adverse Event|7|||
164273872|NCT00462748|593370636|FG001|Overall Study|Adverse Event|5|||
164273873|NCT00462748|593370637|FG002|Overall Study|Adverse Event|9|||
164273874|NCT00462748|593370635|FG000|Overall Study|Protocol Violation|0|||
164273875|NCT00462748|593370636|FG001|Overall Study|Protocol Violation|2|||
164273876|NCT00462748|593370637|FG002|Overall Study|Protocol Violation|1|||
163894050|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
164273877|NCT00462748|593370635|FG000|Overall Study|Withdrew consent|3|||
164273878|NCT00462748|593370636|FG001|Overall Study|Withdrew consent|3|||
164273879|NCT00462748|593370637|FG002|Overall Study|Withdrew consent|0|||
164273880|NCT00462748|593370635|FG000|Overall Study|Lost to Follow-up|1|||
164273881|NCT00462748|593370636|FG001|Overall Study|Lost to Follow-up|1|||
164273882|NCT00462748|593370637|FG002|Overall Study|Lost to Follow-up|1|||
164273883|NCT00462748|593370635|FG000|Overall Study|Discontinued after 41 days Rx|1|||
164273884|NCT00462748|593370636|FG001|Overall Study|Discontinued after 41 days Rx|0|||
164273885|NCT00462748|593370637|FG002|Overall Study|Discontinued after 41 days Rx|0|||
164273886|NCT03429543|593370638|FG000|Overall Study|Adverse Event|1|||
164273887|NCT03429543|593370639|FG001|Overall Study|Adverse Event|1|||
164273888|NCT03429543|593370640|FG002|Overall Study|Adverse Event|0|||
164273889|NCT03429543|593370641|FG003|Overall Study|Adverse Event|0|||
164273890|NCT03429543|593370642|FG004|Overall Study|Adverse Event|0|||
164273891|NCT03429543|593370643|FG005|Overall Study|Adverse Event|2|||
164273892|NCT03429543|593370644|FG006|Overall Study|Adverse Event|0|||
164273893|NCT03429543|593370638|FG000|Overall Study|Lost to Follow-up|1|||
164273894|NCT03429543|593370639|FG001|Overall Study|Lost to Follow-up|0|||
163894051|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
164273895|NCT03429543|593370640|FG002|Overall Study|Lost to Follow-up|0|||
164273896|NCT03429543|593370641|FG003|Overall Study|Lost to Follow-up|0|||
164273897|NCT03429543|593370642|FG004|Overall Study|Lost to Follow-up|1|||
164273898|NCT03429543|593370643|FG005|Overall Study|Lost to Follow-up|0|||
164273899|NCT03429543|593370644|FG006|Overall Study|Lost to Follow-up|0|||
164342713|NCT02954237|593631497|FG000|Overall Study|Missed visit|16|||
163894052|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
163894053|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
163894054|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
164273900|NCT03429543|593370638|FG000|Overall Study|Withdrawal by Subject|5|||
163894055|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
164000763|NCT01431287|592366683|FG000|Overall Study|Lost to Follow-up|0|||
164000764|NCT01431287|592366684|FG001|Overall Study|Lost to Follow-up|3|||
164000765|NCT01431287|592366685|FG002|Overall Study|Lost to Follow-up|2|||
164000766|NCT01431287|592366686|FG003|Overall Study|Lost to Follow-up|3|||
164000767|NCT01431287|592366687|FG004|Overall Study|Lost to Follow-up|1|||
164273901|NCT03429543|593370639|FG001|Overall Study|Withdrawal by Subject|0|||
164273902|NCT03429543|593370640|FG002|Overall Study|Withdrawal by Subject|1|||
164273903|NCT03429543|593370641|FG003|Overall Study|Withdrawal by Subject|2|||
164273904|NCT03429543|593370642|FG004|Overall Study|Withdrawal by Subject|6|||
164273905|NCT03429543|593370643|FG005|Overall Study|Withdrawal by Subject|3|||
164273906|NCT03429543|593370644|FG006|Overall Study|Withdrawal by Subject|1|||
164273907|NCT03429543|593370638|FG000|Overall Study|Other reason than listed|0|||
164273908|NCT03429543|593370639|FG001|Overall Study|Other reason than listed|1|||
164273909|NCT03429543|593370640|FG002|Overall Study|Other reason than listed|0|||
164273910|NCT03429543|593370641|FG003|Overall Study|Other reason than listed|0|||
164273911|NCT03429543|593370642|FG004|Overall Study|Other reason than listed|4|||
164273912|NCT03429543|593370643|FG005|Overall Study|Other reason than listed|4|||
164273913|NCT03429543|593370644|FG006|Overall Study|Other reason than listed|0|||
164273914|NCT03429543|593370638|FG000|Overall Study|Not treated|0|||
164273915|NCT03429543|593370639|FG001|Overall Study|Not treated|0|||
164273916|NCT03429543|593370640|FG002|Overall Study|Not treated|0|||
164273917|NCT03429543|593370641|FG003|Overall Study|Not treated|0|||
164273918|NCT03429543|593370642|FG004|Overall Study|Not treated|1|||
164273919|NCT03429543|593370643|FG005|Overall Study|Not treated|0|||
164273920|NCT03429543|593370644|FG006|Overall Study|Not treated|0|||
164273921|NCT01600092|593370645|FG000|Overall Study|Adverse Event|2|||
164273922|NCT01600092|593370646|FG001|Overall Study|Adverse Event|0|||
164273923|NCT01600092|593370645|FG000|Overall Study|Lost to Follow-up|4|||
164273924|NCT01600092|593370646|FG001|Overall Study|Lost to Follow-up|6|||
164273925|NCT01600092|593370645|FG000|Overall Study|Withdrawal by parent/guardian|8|||
164273926|NCT01600092|593370646|FG001|Overall Study|Withdrawal by parent/guardian|6|||
164273927|NCT01600092|593370645|FG000|Overall Study|Physician Decision|1|||
164273928|NCT01600092|593370646|FG001|Overall Study|Physician Decision|1|||
164273929|NCT01600092|593370645|FG000|Overall Study|Randomized but not vaccinated|3|||
164273930|NCT01600092|593370646|FG001|Overall Study|Randomized but not vaccinated|3|||
164273931|NCT01561963|593370647|FG000|Overall Study|Adverse Event|1|||
164273932|NCT00637572|593370655|FG000|Overall Study|Adverse Event|1|||
164273933|NCT00637572|593370656|FG001|Overall Study|Adverse Event|2|||
164273934|NCT00637572|593370655|FG000|Overall Study|Death|0|||
164273935|NCT00637572|593370656|FG001|Overall Study|Death|1|||
164273936|NCT00637572|593370655|FG000|Overall Study|Lost to Follow-up|0|||
164273937|NCT00637572|593370656|FG001|Overall Study|Lost to Follow-up|1|||
164273938|NCT00637572|593370655|FG000|Overall Study|Physician Decision|1|||
164273939|NCT00637572|593370656|FG001|Overall Study|Physician Decision|1|||
164273940|NCT00637572|593370655|FG000|Overall Study|Withdrawal by Subject|0|||
164273941|NCT00637572|593370656|FG001|Overall Study|Withdrawal by Subject|2|||
164273942|NCT00637572|593370655|FG000|Overall Study|Illicit Drug Use|1|||
164273943|NCT00637572|593370656|FG001|Overall Study|Illicit Drug Use|0|||
164273944|NCT01887353|593370657|FG000|Overall Study|Study stopped early|4|||
164273945|NCT01887353|593370658|FG001|Overall Study|Study stopped early|3|||
164273946|NCT04667104|593370662|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
164000768|NCT01431287|592366683|FG000|Overall Study|Consent withdrawn not due to AE|29|||
164000769|NCT01431287|592366684|FG001|Overall Study|Consent withdrawn not due to AE|30|||
164000770|NCT01431287|592366685|FG002|Overall Study|Consent withdrawn not due to AE|34|||
164000771|NCT01431287|592366686|FG003|Overall Study|Consent withdrawn not due to AE|19|||
164000772|NCT01431287|592366687|FG004|Overall Study|Consent withdrawn not due to AE|29|||
164000773|NCT01431287|592366683|FG000|Overall Study|not stated above|4|||
164000774|NCT01431287|592366684|FG001|Overall Study|not stated above|2|||
164273947|NCT04667104|593370663|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
164273948|NCT04667104|593370664|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
164273949|NCT01078168|593370668|FG000|Overall Study|Physician Decision|0|||
164273950|NCT01078168|593370669|FG001|Overall Study|Physician Decision|1|||
164273951|NCT05066165|593372759|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
164273952|NCT05066165|593372760|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
164273953|NCT05066165|593372759|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
164273954|NCT05066165|593372760|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
164273955|NCT03210961|593372761|FG000|Overall Study|Adverse Event|0|||
164273956|NCT03210961|593372762|FG001|Overall Study|Adverse Event|0|||
164273957|NCT03210961|593372763|FG002|Overall Study|Adverse Event|0|||
164273958|NCT03210961|593372764|FG003|Overall Study|Adverse Event|0|||
164273959|NCT03210961|593372765|FG004|Overall Study|Adverse Event|0|||
164273960|NCT03210961|593372766|FG005|Overall Study|Adverse Event|0|||
164000775|NCT01431287|592366685|FG002|Overall Study|not stated above|2|||
164273961|NCT03210961|593372767|FG006|Overall Study|Adverse Event|0|||
164273962|NCT03210961|593372768|FG007|Overall Study|Adverse Event|0|||
164273963|NCT03210961|593372769|FG008|Overall Study|Adverse Event|0|||
164273964|NCT03210961|593372770|FG009|Overall Study|Adverse Event|0|||
164273965|NCT03210961|593372771|FG010|Overall Study|Adverse Event|0|||
164273966|NCT03210961|593372772|FG011|Overall Study|Adverse Event|0|||
164273967|NCT03210961|593372773|FG012|Overall Study|Adverse Event|0|||
164273968|NCT03210961|593372774|FG013|Overall Study|Adverse Event|1|||
164273969|NCT03210961|593372775|FG014|Overall Study|Adverse Event|0|||
164273970|NCT03210961|593372761|FG000|Overall Study|Lost to Follow-up|0|||
164273971|NCT03210961|593372762|FG001|Overall Study|Lost to Follow-up|0|||
164273972|NCT03210961|593372763|FG002|Overall Study|Lost to Follow-up|0|||
164273973|NCT03210961|593372764|FG003|Overall Study|Lost to Follow-up|0|||
164273974|NCT03210961|593372765|FG004|Overall Study|Lost to Follow-up|0|||
164273975|NCT03210961|593372766|FG005|Overall Study|Lost to Follow-up|0|||
164273976|NCT03210961|593372767|FG006|Overall Study|Lost to Follow-up|0|||
164273977|NCT03210961|593372768|FG007|Overall Study|Lost to Follow-up|0|||
164273978|NCT03210961|593372769|FG008|Overall Study|Lost to Follow-up|0|||
164273979|NCT03210961|593372770|FG009|Overall Study|Lost to Follow-up|0|||
164273980|NCT03210961|593372771|FG010|Overall Study|Lost to Follow-up|0|||
164273981|NCT03210961|593372772|FG011|Overall Study|Lost to Follow-up|0|||
164273982|NCT03210961|593372773|FG012|Overall Study|Lost to Follow-up|0|||
164273983|NCT03210961|593372774|FG013|Overall Study|Lost to Follow-up|0|||
164273984|NCT03210961|593372775|FG014|Overall Study|Lost to Follow-up|1|||
164273985|NCT03210961|593372761|FG000|Overall Study|Withdrawal by Subject|0|||
164273986|NCT03210961|593372762|FG001|Overall Study|Withdrawal by Subject|0|||
164273987|NCT03210961|593372763|FG002|Overall Study|Withdrawal by Subject|0|||
164273988|NCT03210961|593372764|FG003|Overall Study|Withdrawal by Subject|0|||
164273989|NCT03210961|593372765|FG004|Overall Study|Withdrawal by Subject|0|||
164273990|NCT03210961|593372766|FG005|Overall Study|Withdrawal by Subject|0|||
164273991|NCT03210961|593372767|FG006|Overall Study|Withdrawal by Subject|0|||
164273992|NCT03210961|593372768|FG007|Overall Study|Withdrawal by Subject|0|||
164273993|NCT03210961|593372769|FG008|Overall Study|Withdrawal by Subject|0|||
164273994|NCT03210961|593372770|FG009|Overall Study|Withdrawal by Subject|0|||
164273995|NCT03210961|593372771|FG010|Overall Study|Withdrawal by Subject|0|||
164273996|NCT03210961|593372772|FG011|Overall Study|Withdrawal by Subject|0|||
164273997|NCT03210961|593372773|FG012|Overall Study|Withdrawal by Subject|0|||
164273998|NCT03210961|593372774|FG013|Overall Study|Withdrawal by Subject|0|||
164273999|NCT03210961|593372775|FG014|Overall Study|Withdrawal by Subject|1|||
164274000|NCT03210961|593372761|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274001|NCT03210961|593372762|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274002|NCT03210961|593372763|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274003|NCT03210961|593372764|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274004|NCT03210961|593372765|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274005|NCT03210961|593372766|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274006|NCT03210961|593372767|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274007|NCT03210961|593372768|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274008|NCT03210961|593372769|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274009|NCT03210961|593372770|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274010|NCT03210961|593372771|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274011|NCT03210961|593372772|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274012|NCT03210961|593372773|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
163894056|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
164274013|NCT03210961|593372774|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
164274014|NCT03210961|593372775|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
164274015|NCT03210961|593372761|FG000|Overall Study|Other|0|||
164274016|NCT03210961|593372762|FG001|Overall Study|Other|0|||
164274017|NCT03210961|593372763|FG002|Overall Study|Other|0|||
164274018|NCT03210961|593372764|FG003|Overall Study|Other|1|||
164274019|NCT03210961|593372765|FG004|Overall Study|Other|0|||
164274020|NCT03210961|593372766|FG005|Overall Study|Other|0|||
164274021|NCT03210961|593372767|FG006|Overall Study|Other|1|||
164274022|NCT03210961|593372768|FG007|Overall Study|Other|0|||
164274023|NCT03210961|593372769|FG008|Overall Study|Other|0|||
164274024|NCT03210961|593372770|FG009|Overall Study|Other|0|||
164274025|NCT03210961|593372771|FG010|Overall Study|Other|1|||
164274026|NCT03210961|593372772|FG011|Overall Study|Other|0|||
164274027|NCT03210961|593372773|FG012|Overall Study|Other|2|||
164274028|NCT03210961|593372774|FG013|Overall Study|Other|2|||
164274029|NCT03210961|593372775|FG014|Overall Study|Other|0|||
164274030|NCT02467582|593372776|FG000|Allocation|Withdrawal by Subject|1|||
164274031|NCT02467582|593372777|FG001|Allocation|Withdrawal by Subject|0|||
164274032|NCT02467582|593372776|FG000|Follow-up|Death|5|||
164274033|NCT02467582|593372777|FG001|Follow-up|Death|4|||
164274034|NCT02467582|593372776|FG000|Follow-up|Lost to Follow-up|6|||
163894057|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
163894058|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
163894059|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
163894060|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
164274035|NCT02467582|593372777|FG001|Follow-up|Lost to Follow-up|5|||
164274036|NCT01370265|593372778|FG000|First Intervention|Adverse Event|1|||
164274037|NCT01370265|593372779|FG001|First Intervention|Adverse Event|1|||
164274038|NCT03343626|593372780|FG000|Overall Study|Lost to Follow-up|4|||
164274039|NCT03343626|593372781|FG001|Overall Study|Lost to Follow-up|3|||
164274040|NCT03343626|593372782|FG002|Overall Study|Lost to Follow-up|2|||
164274041|NCT03343626|593372783|FG003|Overall Study|Lost to Follow-up|5|||
164274042|NCT03343626|593372784|FG004|Overall Study|Lost to Follow-up|4|||
164274043|NCT03343626|593372785|FG005|Overall Study|Lost to Follow-up|4|||
164274044|NCT03343626|593372786|FG006|Overall Study|Lost to Follow-up|4|||
164274045|NCT03343626|593372787|FG007|Overall Study|Lost to Follow-up|7|||
164274046|NCT03343626|593372780|FG000|Overall Study|Withdrawal of Consent|2|||
164274047|NCT03343626|593372781|FG001|Overall Study|Withdrawal of Consent|1|||
164274048|NCT03343626|593372782|FG002|Overall Study|Withdrawal of Consent|0|||
164274049|NCT03343626|593372783|FG003|Overall Study|Withdrawal of Consent|3|||
164274050|NCT03343626|593372784|FG004|Overall Study|Withdrawal of Consent|3|||
164274051|NCT03343626|593372785|FG005|Overall Study|Withdrawal of Consent|1|||
164274052|NCT03343626|593372786|FG006|Overall Study|Withdrawal of Consent|1|||
164274053|NCT03343626|593372787|FG007|Overall Study|Withdrawal of Consent|2|||
164274054|NCT03343626|593372780|FG000|Overall Study|Reason not Specified|0|||
164274055|NCT03343626|593372781|FG001|Overall Study|Reason not Specified|1|||
164274056|NCT03343626|593372782|FG002|Overall Study|Reason not Specified|0|||
164274057|NCT03343626|593372783|FG003|Overall Study|Reason not Specified|0|||
164274058|NCT03343626|593372784|FG004|Overall Study|Reason not Specified|0|||
164274059|NCT03343626|593372785|FG005|Overall Study|Reason not Specified|0|||
164274060|NCT03343626|593372786|FG006|Overall Study|Reason not Specified|0|||
164274061|NCT03343626|593372787|FG007|Overall Study|Reason not Specified|1|||
164274062|NCT03343626|593372780|FG000|Overall Study|Data Entry Error|0|||
164274063|NCT03343626|593372781|FG001|Overall Study|Data Entry Error|0|||
164274064|NCT03343626|593372782|FG002|Overall Study|Data Entry Error|0|||
164274065|NCT03343626|593372783|FG003|Overall Study|Data Entry Error|0|||
164000776|NCT01431287|592366686|FG003|Overall Study|not stated above|2|||
164274066|NCT03343626|593372784|FG004|Overall Study|Data Entry Error|0|||
164274067|NCT03343626|593372785|FG005|Overall Study|Data Entry Error|0|||
164274068|NCT03343626|593372786|FG006|Overall Study|Data Entry Error|0|||
164274069|NCT03343626|593372787|FG007|Overall Study|Data Entry Error|1|||
164274070|NCT03592368|593372793|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
164274071|NCT03592368|593372794|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
164274072|NCT03592368|593372795|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
164274073|NCT03592368|593372796|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
164274074|NCT03592368|593372793|FG000|Overall Study|Adverse Event|0|||
164274075|NCT03592368|593372794|FG001|Overall Study|Adverse Event|0|||
164274076|NCT03592368|593372795|FG002|Overall Study|Adverse Event|0|||
164274077|NCT03592368|593372796|FG003|Overall Study|Adverse Event|1|||
164274078|NCT03592368|593372793|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
164274079|NCT03592368|593372794|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
164274080|NCT03592368|593372795|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
164274081|NCT03592368|593372796|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
164274082|NCT00742417|593372798|FG000|Randomized|Withdrawal by legal representative|0|||
164274083|NCT00742417|593372799|FG001|Randomized|Withdrawal by legal representative|1|||
164274084|NCT00742417|593372798|FG000|Randomized|Withdrawal by Subject|1|||
164274085|NCT00742417|593372799|FG001|Randomized|Withdrawal by Subject|0|||
164274086|NCT00742417|593372798|FG000|Randomized|Physician Decision|1|||
164274087|NCT00742417|593372799|FG001|Randomized|Physician Decision|0|||
164274088|NCT00742417|593372798|FG000|Intensive Period|Withdrawal by Subject|1|||
164274089|NCT00742417|593372799|FG001|Intensive Period|Withdrawal by Subject|1|||
164274090|NCT00742417|593372798|FG000|Intensive Period|Adverse Event|2|||
164274091|NCT00742417|593372799|FG001|Intensive Period|Adverse Event|0|||
164274092|NCT00965575|593372804|FG000|Overall Study|subject unwillingness to swallow study c|1|||
164274093|NCT00965575|593372805|FG001|Overall Study|subject unwillingness to swallow study c|0|||
164274094|NCT02814175|593372806|FG000|Part 1|Adverse Event|2|||
164274095|NCT02814175|593372807|FG001|Part 1|Adverse Event|3|||
164274096|NCT02814175|593372808|FG002|Part 1|Adverse Event|0|||
164274097|NCT02814175|593372809|FG003|Part 1|Adverse Event|0|||
164274098|NCT02814175|593372810|FG004|Part 1|Adverse Event|0|||
164274099|NCT02814175|593372811|FG005|Part 1|Adverse Event|0|||
164274100|NCT02814175|593372806|FG000|Part 1|Withdrawal Consent|8|||
164274101|NCT02814175|593372807|FG001|Part 1|Withdrawal Consent|1|||
164274102|NCT02814175|593372808|FG002|Part 1|Withdrawal Consent|0|||
164274103|NCT02814175|593372809|FG003|Part 1|Withdrawal Consent|0|||
164274104|NCT02814175|593372810|FG004|Part 1|Withdrawal Consent|0|||
164274105|NCT02814175|593372811|FG005|Part 1|Withdrawal Consent|0|||
164274106|NCT02814175|593372806|FG000|Part 1|Lost to Follow-up|1|||
164274107|NCT02814175|593372807|FG001|Part 1|Lost to Follow-up|0|||
164274108|NCT02814175|593372808|FG002|Part 1|Lost to Follow-up|0|||
164274109|NCT02814175|593372809|FG003|Part 1|Lost to Follow-up|0|||
164274110|NCT02814175|593372810|FG004|Part 1|Lost to Follow-up|0|||
164000777|NCT01431287|592366687|FG004|Overall Study|not stated above|1|||
164274111|NCT02814175|593372811|FG005|Part 1|Lost to Follow-up|0|||
164274112|NCT02814175|593372806|FG000|Part 1|Lack of Efficacy|1|||
164274113|NCT02814175|593372807|FG001|Part 1|Lack of Efficacy|2|||
164274114|NCT02814175|593372808|FG002|Part 1|Lack of Efficacy|0|||
164274115|NCT02814175|593372809|FG003|Part 1|Lack of Efficacy|0|||
164274116|NCT02814175|593372810|FG004|Part 1|Lack of Efficacy|0|||
164274117|NCT02814175|593372811|FG005|Part 1|Lack of Efficacy|0|||
164274118|NCT02814175|593372806|FG000|Part 2|Adverse Event|0|||
164274119|NCT02814175|593372807|FG001|Part 2|Adverse Event|0|||
164274120|NCT02814175|593372808|FG002|Part 2|Adverse Event|0|||
164274121|NCT02814175|593372809|FG003|Part 2|Adverse Event|1|||
164274122|NCT02814175|593372810|FG004|Part 2|Adverse Event|1|||
164274123|NCT02814175|593372811|FG005|Part 2|Adverse Event|2|||
164274124|NCT02814175|593372806|FG000|Part 2|Withdrawal Consent|0|||
164274125|NCT02814175|593372807|FG001|Part 2|Withdrawal Consent|0|||
164274126|NCT02814175|593372808|FG002|Part 2|Withdrawal Consent|0|||
164274127|NCT02814175|593372809|FG003|Part 2|Withdrawal Consent|2|||
164274128|NCT02814175|593372810|FG004|Part 2|Withdrawal Consent|1|||
164274129|NCT02814175|593372811|FG005|Part 2|Withdrawal Consent|1|||
164274130|NCT02814175|593372806|FG000|Part 2|Lost to Follow-up|0|||
164274131|NCT02814175|593372807|FG001|Part 2|Lost to Follow-up|0|||
164274132|NCT02814175|593372808|FG002|Part 2|Lost to Follow-up|0|||
164274133|NCT02814175|593372809|FG003|Part 2|Lost to Follow-up|1|||
164274134|NCT02814175|593372810|FG004|Part 2|Lost to Follow-up|0|||
164274135|NCT02814175|593372811|FG005|Part 2|Lost to Follow-up|0|||
164274136|NCT02814175|593372806|FG000|Part 2|Lack of Efficacy|0|||
164274137|NCT02814175|593372807|FG001|Part 2|Lack of Efficacy|0|||
164274138|NCT02814175|593372808|FG002|Part 2|Lack of Efficacy|0|||
164274139|NCT02814175|593372809|FG003|Part 2|Lack of Efficacy|0|||
164274140|NCT02814175|593372810|FG004|Part 2|Lack of Efficacy|0|||
164274141|NCT02814175|593372811|FG005|Part 2|Lack of Efficacy|3|||
164142453|NCT04642365|592882728|FG006|Overall Study|Progressive Disease|1|||
164274142|NCT04207749|593372814|FG000|Overall Study|Lost to Follow-up|0|||
164274143|NCT04207749|593372815|FG001|Overall Study|Lost to Follow-up|2|||
164274144|NCT04207749|593372814|FG000|Overall Study|Protocol Violation|0|||
164274145|NCT04207749|593372815|FG001|Overall Study|Protocol Violation|1|||
164274146|NCT04207749|593372814|FG000|Overall Study|Withdrawal by Subject|3|||
164274147|NCT04207749|593372815|FG001|Overall Study|Withdrawal by Subject|0|||
164274148|NCT04207749|593372814|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
164274149|NCT04207749|593372815|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
164274150|NCT00655629|593372816|FG000|Overall Study|Adverse Event|4|||
164274151|NCT00655629|593372817|FG001|Overall Study|Adverse Event|1|||
164274152|NCT00655629|593372816|FG000|Overall Study|Lack of Efficacy|2|||
164274153|NCT00655629|593372817|FG001|Overall Study|Lack of Efficacy|12|||
164274154|NCT00655629|593372816|FG000|Overall Study|Lost to Follow-up|4|||
164274155|NCT00655629|593372817|FG001|Overall Study|Lost to Follow-up|3|||
164274156|NCT00655629|593372816|FG000|Overall Study|Protocol Violation|5|||
164274157|NCT00655629|593372817|FG001|Overall Study|Protocol Violation|3|||
164274158|NCT00655629|593372816|FG000|Overall Study|consent withdrawn|6|||
164274159|NCT00655629|593372817|FG001|Overall Study|consent withdrawn|4|||
164274160|NCT00741013|593372818|FG000|Overall Study|Adverse Event|1|||
164274161|NCT00741013|593372819|FG001|Overall Study|Adverse Event|0|||
164274162|NCT00741013|593372820|FG002|Overall Study|Adverse Event|0|||
164274163|NCT00741013|593372818|FG000|Overall Study|Withdrawal by Subject|0|||
164274164|NCT00741013|593372819|FG001|Overall Study|Withdrawal by Subject|0|||
164274165|NCT00741013|593372820|FG002|Overall Study|Withdrawal by Subject|1|||
164274166|NCT00741013|593372818|FG000|Overall Study|Discovered failed screen after enrolled|0|||
164274167|NCT00741013|593372819|FG001|Overall Study|Discovered failed screen after enrolled|2|||
164274168|NCT00741013|593372820|FG002|Overall Study|Discovered failed screen after enrolled|0|||
164274169|NCT01754493|593372821|FG000|Overall Study|Adverse Event|1|||
164274170|NCT01754493|593372821|FG000|Overall Study|Lost to Follow-up|3|||
164274171|NCT01754493|593372821|FG000|Overall Study|Withdrawal by Subject|1|||
164274172|NCT01754493|593372821|FG000|Overall Study|Moved out of town|1|||
164274173|NCT01754493|593372821|FG000|Overall Study|Scheduling conflict|1|||
164274174|NCT01425632|593372822|FG000|Overall Study|Adverse Event|0|||
164274175|NCT01425632|593372823|FG001|Overall Study|Adverse Event|1|||
164274176|NCT01425632|593372824|FG002|Overall Study|Adverse Event|1|||
164274177|NCT01425632|593372822|FG000|Overall Study|Physician Decision|1|||
164274178|NCT01425632|593372823|FG001|Overall Study|Physician Decision|0|||
164274179|NCT01425632|593372824|FG002|Overall Study|Physician Decision|0|||
164274180|NCT01425632|593372822|FG000|Overall Study|Protocol Violation|0|||
164274181|NCT01425632|593372823|FG001|Overall Study|Protocol Violation|0|||
164274182|NCT01425632|593372824|FG002|Overall Study|Protocol Violation|2|||
164274183|NCT01425632|593372822|FG000|Overall Study|Withdrawal by Subject|0|||
164274184|NCT01425632|593372823|FG001|Overall Study|Withdrawal by Subject|0|||
164274185|NCT01425632|593372824|FG002|Overall Study|Withdrawal by Subject|1|||
164274186|NCT03461146|593372825|FG000|Overall Study|Adverse Event|2|||
164274187|NCT03461146|593372825|FG000|Overall Study|Physician Decision|1|||
164274188|NCT02140047|593372826|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164274189|NCT02140047|593372827|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164274190|NCT02140047|593372828|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164342714|NCT02954237|593631497|FG000|Overall Study|Death|2|||
164342715|NCT01034631|593631498|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
164342716|NCT01034631|593631499|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
164342717|NCT01034631|593631500|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
164342718|NCT01034631|593631498|FG000|Phase II|Not Evaluable per protocol|0|||
164342719|NCT01034631|593631499|FG001|Phase II|Not Evaluable per protocol|0|||
164342720|NCT01034631|593631500|FG002|Phase II|Not Evaluable per protocol|2|||
164342721|NCT01034631|593631498|FG000|Phase II|Determined Ineligible per protocol|0|||
164342722|NCT01034631|593631499|FG001|Phase II|Determined Ineligible per protocol|1|||
164342723|NCT01034631|593631500|FG002|Phase II|Determined Ineligible per protocol|0|||
164342724|NCT04218695|593631501|FG000|Overall Study|Adverse Event|1|||
164342725|NCT04218695|593631502|FG001|Overall Study|Adverse Event|0|||
164342726|NCT03166735|593631503|FG000|Overall Study|Not Treated|1|||
163894061|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
163894062|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
164342727|NCT03166735|593631504|FG001|Overall Study|Not Treated|0|||
164342728|NCT03166735|593631505|FG002|Overall Study|Not Treated|0|||
163894063|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
164342729|NCT03166735|593631506|FG003|Overall Study|Not Treated|0|||
164342730|NCT03166735|593631507|FG004|Overall Study|Not Treated|0|||
164342731|NCT03166735|593631503|FG000|Overall Study|follow-up not completed as planned|0|||
164274191|NCT02702414|593372829|FG000|Overall Study|Death|96|||
164274192|NCT02702414|593372830|FG001|Overall Study|Death|42|||
164274193|NCT02702414|593372829|FG000|Overall Study|Lost to Follow-up|0|||
164274194|NCT02702414|593372830|FG001|Overall Study|Lost to Follow-up|1|||
164274195|NCT02702414|593372829|FG000|Overall Study|Withdrawal by Subject|0|||
164274196|NCT02702414|593372830|FG001|Overall Study|Withdrawal by Subject|1|||
164274197|NCT02702414|593372829|FG000|Overall Study|Protocol Violation|1|||
164274198|NCT02702414|593372830|FG001|Overall Study|Protocol Violation|0|||
164274199|NCT02702414|593372829|FG000|Overall Study|Sponsor Decision|8|||
164274200|NCT02702414|593372830|FG001|Overall Study|Sponsor Decision|7|||
164274201|NCT04541628|593372831|FG000|Overall Study|Study Terminated|1|||
164274202|NCT04541628|593372832|FG001|Overall Study|Study Terminated|1|||
164274203|NCT04541628|593372833|FG002|Overall Study|Study Terminated|1|||
164274204|NCT01452919|593372837|FG000|Open-Label Treatment|Adverse Event|5|||
164274205|NCT01452919|593372838|FG001|Open-Label Treatment|Adverse Event|0|||
164274206|NCT01452919|593372839|FG002|Open-Label Treatment|Adverse Event|0|||
164274207|NCT01452919|593372837|FG000|Open-Label Treatment|Lost to Follow-up|4|||
164274208|NCT01452919|593372838|FG001|Open-Label Treatment|Lost to Follow-up|0|||
164274209|NCT01452919|593372839|FG002|Open-Label Treatment|Lost to Follow-up|0|||
164274210|NCT01452919|593372837|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
164274211|NCT01452919|593372838|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
164274212|NCT01452919|593372839|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
164274213|NCT01452919|593372837|FG000|Open-Label Treatment|Protocol Violation|4|||
164274214|NCT01452919|593372838|FG001|Open-Label Treatment|Protocol Violation|0|||
164274215|NCT01452919|593372839|FG002|Open-Label Treatment|Protocol Violation|0|||
164274216|NCT01452919|593372837|FG000|Open-Label Treatment|Sponsor Decision|1|||
164274217|NCT01452919|593372838|FG001|Open-Label Treatment|Sponsor Decision|0|||
164274218|NCT01452919|593372839|FG002|Open-Label Treatment|Sponsor Decision|0|||
164274219|NCT01452919|593372837|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
164274220|NCT01452919|593372838|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164274221|NCT01452919|593372839|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
164274222|NCT01452919|593372837|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
164274223|NCT01452919|593372838|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
164274224|NCT01452919|593372839|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
164274225|NCT01452919|593372837|FG000|Randomization Treatment|Adverse Event|0|||
164274226|NCT01452919|593372838|FG001|Randomization Treatment|Adverse Event|0|||
164274227|NCT01452919|593372839|FG002|Randomization Treatment|Adverse Event|2|||
164274228|NCT01452919|593372837|FG000|Randomization Treatment|Sponsor Decision|0|||
164274229|NCT01452919|593372838|FG001|Randomization Treatment|Sponsor Decision|1|||
164274230|NCT01452919|593372839|FG002|Randomization Treatment|Sponsor Decision|0|||
164274231|NCT01452919|593372837|FG000|Randomization Treatment|Withdrawal by Subject|0|||
164274232|NCT01452919|593372838|FG001|Randomization Treatment|Withdrawal by Subject|1|||
164274233|NCT01452919|593372839|FG002|Randomization Treatment|Withdrawal by Subject|0|||
164274234|NCT01452919|593372837|FG000|Randomization Treatment|Subject is moving or has moved|0|||
164274235|NCT01452919|593372838|FG001|Randomization Treatment|Subject is moving or has moved|1|||
164274236|NCT01452919|593372839|FG002|Randomization Treatment|Subject is moving or has moved|0|||
164274237|NCT00859937|593372840|FG000|Overall Study|Protocol Violation|1|||
164274238|NCT00859937|593372841|FG001|Overall Study|Protocol Violation|0|||
164274239|NCT00151476|593372842|FG000|FAP Identified Subjects|Protocol Violation|0|||
164274240|NCT00151476|593372843|FG001|FAP Identified Subjects|Protocol Violation|1|||
164274241|NCT00151476|593372842|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
164274242|NCT00151476|593372843|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
164342732|NCT03166735|593631504|FG001|Overall Study|follow-up not completed as planned|1|||
164342733|NCT03166735|593631505|FG002|Overall Study|follow-up not completed as planned|1|||
164342734|NCT03166735|593631506|FG003|Overall Study|follow-up not completed as planned|0|||
164342735|NCT03166735|593631507|FG004|Overall Study|follow-up not completed as planned|1|||
164342736|NCT03166735|593631503|FG000|Overall Study|Withdrawal by Subject|0|||
164342737|NCT03166735|593631504|FG001|Overall Study|Withdrawal by Subject|0|||
164342738|NCT03166735|593631505|FG002|Overall Study|Withdrawal by Subject|1|||
164342739|NCT03166735|593631506|FG003|Overall Study|Withdrawal by Subject|1|||
164342740|NCT03166735|593631507|FG004|Overall Study|Withdrawal by Subject|2|||
164274243|NCT00151476|593372842|FG000|FAP Analyzed Subjects|Other study participation|0|||
164274244|NCT00151476|593372843|FG001|FAP Analyzed Subjects|Other study participation|1|||
164274245|NCT03446456|593372844|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
164342741|NCT03166735|593631503|FG000|Overall Study|Lost to Follow-up|0|||
164342742|NCT03166735|593631504|FG001|Overall Study|Lost to Follow-up|2|||
164342743|NCT03166735|593631505|FG002|Overall Study|Lost to Follow-up|1|||
164274246|NCT03446456|593372845|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
164274247|NCT03446456|593372844|FG000|Overall Study|Lost to Follow-up|1|||
164274248|NCT03446456|593372845|FG001|Overall Study|Lost to Follow-up|3|||
164274249|NCT03446456|593372844|FG000|Overall Study|Participant failed the toxicology test|1|||
164342744|NCT03166735|593631506|FG003|Overall Study|Lost to Follow-up|0|||
164342745|NCT03166735|593631507|FG004|Overall Study|Lost to Follow-up|1|||
164342746|NCT00799383|593631508|FG000|Overall Study|Protocol Violation|1|||
164000778|NCT03019549|592366688|FG000|Washout|DId not meet genotype criteria|11|||
164000779|NCT03019549|592366688|FG000|Period 2|Adverse Event|2|||
164000780|NCT03019549|592366688|FG000|Period 2|Physician Decision|2|||
164000781|NCT03019549|592366688|FG000|Period 2|Withdrawal by Subject|1|||
164000782|NCT01412879|592366691|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
164000783|NCT01412879|592366692|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
164000784|NCT01412879|592366693|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
164000785|NCT01412879|592366691|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
164000786|NCT01412879|592366692|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
164000787|NCT01412879|592366693|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
164000788|NCT01412879|592366691|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
164000789|NCT01412879|592366692|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
164000790|NCT01412879|592366693|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
164000791|NCT01412879|592366691|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
164000792|NCT01412879|592366692|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
164000793|NCT01412879|592366693|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
164000794|NCT01412879|592366691|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
164000795|NCT01412879|592366692|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
164000796|NCT01412879|592366693|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
164000797|NCT04030195|592366694|FG000|Overall Study|Withdrawal by Subject|2|||
164000798|NCT04030195|592366695|FG001|Overall Study|Withdrawal by Subject|0|||
164000799|NCT04030195|592366696|FG002|Overall Study|Withdrawal by Subject|0|||
164000800|NCT02109029|592366697|FG000|Part B|Adverse Event|0|||
164000801|NCT02109029|592366698|FG001|Part B|Adverse Event|0|||
164000802|NCT02109029|592366699|FG002|Part B|Adverse Event|0|||
164000803|NCT02109029|592366700|FG003|Part B|Adverse Event|0|||
164000804|NCT02109029|592366701|FG004|Part B|Adverse Event|1|||
164000805|NCT02109029|592366702|FG005|Part B|Adverse Event|1|||
164000806|NCT03195894|592366703|FG000|Overall Study|"An example is Started other treatment."|4|||
164000807|NCT03195894|592366704|FG001|Overall Study|"An example is Started other treatment."|5|||
164000808|NCT03195894|592366703|FG000|Overall Study|Withdrawal by Subject|15|||
164274250|NCT03446456|593372845|FG001|Overall Study|Participant failed the toxicology test|0|||
164274251|NCT03446456|593372844|FG000|Overall Study|Break down of the experimental equipment|1|||
164274252|NCT03446456|593372845|FG001|Overall Study|Break down of the experimental equipment|0|||
164274253|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
164274254|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
164274255|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
164274256|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
164274257|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
164274258|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
164274259|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Death|1|||
164274260|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Death|4|||
164274261|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
164274262|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
164274263|NCT00658814|593372850|FG000|Remission Induction Chemotherapy|Not eligible|1|||
164274264|NCT00658814|593372851|FG001|Remission Induction Chemotherapy|Not eligible|2|||
164274265|NCT00658814|593372850|FG000|Consolidation Therapy|Not protocol specified|0|||
164274266|NCT00658814|593372851|FG001|Consolidation Therapy|Not protocol specified|1|||
164274267|NCT00658814|593372850|FG000|Consolidation Therapy|Not eligible|2|||
164274268|NCT00658814|593372851|FG001|Consolidation Therapy|Not eligible|2|||
164274269|NCT00658814|593372850|FG000|Maintenance Therapy|Adverse Event|1|||
164274270|NCT00658814|593372851|FG001|Maintenance Therapy|Adverse Event|1|||
164274271|NCT00658814|593372850|FG000|Maintenance Therapy|Not protocol specified|1|||
164274272|NCT00658814|593372851|FG001|Maintenance Therapy|Not protocol specified|0|||
164274273|NCT00658814|593372850|FG000|Maintenance Therapy|Not eligible|1|||
164274274|NCT00658814|593372851|FG001|Maintenance Therapy|Not eligible|0|||
164274275|NCT04816721|593372854|FG000|Overall Study|Withdrawal by Subject|0|||
164274276|NCT04816721|593372855|FG001|Overall Study|Withdrawal by Subject|2|||
164274277|NCT04816721|593372856|FG002|Overall Study|Withdrawal by Subject|0|||
164274278|NCT04816721|593372857|FG003|Overall Study|Withdrawal by Subject|1|||
164274279|NCT04816721|593372858|FG004|Overall Study|Withdrawal by Subject|1|||
164274280|NCT04816721|593372859|FG005|Overall Study|Withdrawal by Subject|0|||
164274281|NCT04816721|593372860|FG006|Overall Study|Withdrawal by Subject|0|||
164274282|NCT04816721|593372861|FG007|Overall Study|Withdrawal by Subject|0|||
164274283|NCT04816721|593372854|FG000|Overall Study|Miscellaneous|0|||
164274284|NCT04816721|593372855|FG001|Overall Study|Miscellaneous|0|||
164274285|NCT04816721|593372856|FG002|Overall Study|Miscellaneous|0|||
164274286|NCT04816721|593372857|FG003|Overall Study|Miscellaneous|0|||
164000809|NCT03195894|592366704|FG001|Overall Study|Withdrawal by Subject|4|||
164000810|NCT03195894|592366703|FG000|Overall Study|Lost to Follow-up|14|||
164000811|NCT03195894|592366704|FG001|Overall Study|Lost to Follow-up|19|||
164274287|NCT04816721|593372858|FG004|Overall Study|Miscellaneous|0|||
164274288|NCT04816721|593372859|FG005|Overall Study|Miscellaneous|1|||
164274289|NCT04816721|593372860|FG006|Overall Study|Miscellaneous|0|||
164274290|NCT04816721|593372861|FG007|Overall Study|Miscellaneous|0|||
164274291|NCT04816721|593372854|FG000|Overall Study|Lost to Follow-up|0|||
164274292|NCT04816721|593372855|FG001|Overall Study|Lost to Follow-up|0|||
164274293|NCT04816721|593372856|FG002|Overall Study|Lost to Follow-up|0|||
164274294|NCT04816721|593372857|FG003|Overall Study|Lost to Follow-up|1|||
164274295|NCT04816721|593372858|FG004|Overall Study|Lost to Follow-up|0|||
164274296|NCT04816721|593372859|FG005|Overall Study|Lost to Follow-up|0|||
164274297|NCT04816721|593372860|FG006|Overall Study|Lost to Follow-up|0|||
164274298|NCT04816721|593372861|FG007|Overall Study|Lost to Follow-up|0|||
164274299|NCT00455143|593372862|FG000|Overall Study|Physician Decision|1|||
164274300|NCT00455143|593372862|FG000|Overall Study|Withdrawal by Subject|1|||
164274301|NCT00455143|593372862|FG000|Overall Study|Staff was not avail to follow patient|2|||
164274302|NCT00455143|593372862|FG000|Overall Study|No longer met Inclusion Criteria|1|||
164274303|NCT00455143|593372862|FG000|Overall Study|Surgical time, staff not available|1|||
164274304|NCT04856904|593372865|FG000|Overall Study|Physician Decision|1|||
164274305|NCT04856904|593372866|FG001|Overall Study|Physician Decision|1|||
164274306|NCT04856904|593372865|FG000|Overall Study|Withdrawal by Subject|13|||
164274307|NCT04856904|593372866|FG001|Overall Study|Withdrawal by Subject|13|||
164274308|NCT04856904|593372865|FG000|Overall Study|Adverse Event|1|||
164274309|NCT04856904|593372866|FG001|Overall Study|Adverse Event|1|||
164274310|NCT04856904|593372865|FG000|Overall Study|Non-compliance with study drug|1|||
164274311|NCT04856904|593372866|FG001|Overall Study|Non-compliance with study drug|1|||
164274312|NCT04856904|593372865|FG000|Overall Study|Lost to Follow-up|4|||
164274313|NCT04856904|593372866|FG001|Overall Study|Lost to Follow-up|4|||
164274314|NCT04856904|593372865|FG000|Overall Study|Withdrawal by Subject|1|||
164274315|NCT04856904|593372866|FG001|Overall Study|Withdrawal by Subject|1|||
164274316|NCT04856904|593372865|FG000|Overall Study|Protocol Violation|1|||
164274317|NCT04856904|593372866|FG001|Overall Study|Protocol Violation|1|||
164274318|NCT00847015|593372867|FG000|Overall Study|Withdrawal by Subject|1|||
164274319|NCT00847015|593372867|FG000|Overall Study|declined any surgery|1|||
164274320|NCT00847015|593372867|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
164274321|NCT01641822|593372868|FG000|Run-in Phase|Noncompliance with study drug|1|||
164274322|NCT01641822|593372869|FG001|Run-in Phase|Noncompliance with study drug|0|||
164274323|NCT01641822|593372870|FG002|Run-in Phase|Noncompliance with study drug|0|||
164274324|NCT01641822|593372868|FG000|Run-in Phase|Adverse Event|3|||
164274325|NCT01641822|593372869|FG001|Run-in Phase|Adverse Event|0|||
164274326|NCT01641822|593372870|FG002|Run-in Phase|Adverse Event|0|||
164274327|NCT01641822|593372868|FG000|Run-in Phase|Withdrew consent|1|||
164274328|NCT01641822|593372869|FG001|Run-in Phase|Withdrew consent|0|||
164274329|NCT01641822|593372870|FG002|Run-in Phase|Withdrew consent|0|||
164274330|NCT01641822|593372868|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
164274331|NCT01641822|593372869|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
164274332|NCT01641822|593372870|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
164274333|NCT01641822|593372868|FG000|Comparative Phase|Noncompliance with study drug|0|||
164274334|NCT01641822|593372869|FG001|Comparative Phase|Noncompliance with study drug|1|||
164274335|NCT01641822|593372870|FG002|Comparative Phase|Noncompliance with study drug|0|||
164274336|NCT01641822|593372868|FG000|Comparative Phase|Investigator's discretion|0|||
164274337|NCT01641822|593372869|FG001|Comparative Phase|Investigator's discretion|0|||
164274338|NCT01641822|593372870|FG002|Comparative Phase|Investigator's discretion|1|||
164274339|NCT01641822|593372868|FG000|Comparative Phase|Pregnancy|0|||
164274340|NCT01641822|593372869|FG001|Comparative Phase|Pregnancy|0|||
164274341|NCT01641822|593372870|FG002|Comparative Phase|Pregnancy|1|||
164274342|NCT01641822|593372868|FG000|Comparative Phase|Adverse event, serious fatal|0|||
164274343|NCT01641822|593372869|FG001|Comparative Phase|Adverse event, serious fatal|1|||
164274344|NCT01641822|593372870|FG002|Comparative Phase|Adverse event, serious fatal|0|||
164274345|NCT01641822|593372868|FG000|Comparative Phase|Withdrew consent|0|||
164342747|NCT00799383|593631509|FG001|Overall Study|Protocol Violation|1|||
164342748|NCT00799383|593631508|FG000|Overall Study|Adverse Event|0|||
164342749|NCT00799383|593631509|FG001|Overall Study|Adverse Event|1|||
164274346|NCT01641822|593372869|FG001|Comparative Phase|Withdrew consent|3|||
164274347|NCT01641822|593372870|FG002|Comparative Phase|Withdrew consent|7|||
164342750|NCT00799383|593631508|FG000|Overall Study|Lost to Follow-up|1|||
164342751|NCT00799383|593631509|FG001|Overall Study|Lost to Follow-up|2|||
164342752|NCT00799383|593631508|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
164274348|NCT01641822|593372868|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
164274349|NCT01641822|593372869|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
164274350|NCT01641822|593372870|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
164274351|NCT02760810|593372871|FG000|Overall Study|Protocol Violation|1|||
164274352|NCT03847909|593372874|FG000|Overall Study|Withdrawal by Subject|1|||
164274353|NCT03847909|593372875|FG001|Overall Study|Withdrawal by Subject|1|||
164274354|NCT00869401|593372876|FG000|Overall Study|Withdrawal by Subject|0|||
164342753|NCT00799383|593631509|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
164274355|NCT00869401|593372877|FG001|Overall Study|Withdrawal by Subject|0|||
164274356|NCT00869401|593372878|FG002|Overall Study|Withdrawal by Subject|0|||
164274357|NCT00869401|593372879|FG003|Overall Study|Withdrawal by Subject|5|||
164274358|NCT00869401|593372880|FG004|Overall Study|Withdrawal by Subject|3|||
164274359|NCT00581360|593372881|FG000|Overall Study|Withdrawal by Subject|1|||
164274360|NCT00082381|593372882|FG000|Overall Study|Adverse Event|27|||
164274361|NCT00082381|593372883|FG001|Overall Study|Adverse Event|2|||
164274362|NCT00082381|593372882|FG000|Overall Study|Lost to Follow-up|5|||
164274363|NCT00082381|593372883|FG001|Overall Study|Lost to Follow-up|7|||
164274364|NCT00082381|593372882|FG000|Overall Study|Patient Decision|8|||
164274365|NCT00082381|593372883|FG001|Overall Study|Patient Decision|4|||
164274366|NCT00082381|593372882|FG000|Overall Study|Physician Decision|1|||
164274367|NCT00082381|593372883|FG001|Overall Study|Physician Decision|2|||
164274368|NCT00082381|593372882|FG000|Overall Study|Protocol Violation|10|||
164274369|NCT00082381|593372883|FG001|Overall Study|Protocol Violation|11|||
164274370|NCT00082381|593372882|FG000|Overall Study|Loss of Glucose Control|4|||
164274371|NCT00082381|593372883|FG001|Overall Study|Loss of Glucose Control|0|||
164274372|NCT02345330|593372885|FG000|Overall Study|Death|1|||
164274373|NCT02345330|593372885|FG000|Overall Study|Progressive Disease|2|||
164274374|NCT00109577|593372888|FG000|Overall Study|Withdrawal by Subject|3|||
164274375|NCT00109577|593372889|FG001|Overall Study|Withdrawal by Subject|3|||
164274376|NCT03322423|593372890|FG000|Period 1|Subject no longer eligible|0|||
164274377|NCT03322423|593372891|FG001|Period 1|Subject no longer eligible|1|||
164274378|NCT03322423|593372890|FG000|Period 1|Withdrawal by Subject|0|||
164274379|NCT03322423|593372891|FG001|Period 1|Withdrawal by Subject|1|||
164274380|NCT03322423|593372890|FG000|Period 1|Incorrect Lens Dispensed|1|||
164274381|NCT03322423|593372891|FG001|Period 1|Incorrect Lens Dispensed|0|||
164274382|NCT03322423|593372890|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
164274383|NCT03322423|593372891|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
164274384|NCT03322423|593372890|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
164274385|NCT03322423|593372891|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
164274386|NCT03322423|593372890|FG000|Period 2|Protocol Violation|1|||
164274387|NCT03322423|593372891|FG001|Period 2|Protocol Violation|0|||
164274388|NCT03322423|593372890|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
164274389|NCT03322423|593372891|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
164274390|NCT04891107|593372892|FG000|Overall Study|Physician Decision|1|||
164274391|NCT04891107|593372892|FG000|Overall Study|Withdrawal by Subject|1|||
164274392|NCT04891107|593372892|FG000|Overall Study|Screen failure after consent|1|||
163894064|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
163894065|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
163894066|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
163894067|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
163894068|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
163894069|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
163894070|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
164000812|NCT01056107|592366713|FG000|Overall Study|Withdrawal by Subject|0|||
164000813|NCT01056107|592366714|FG001|Overall Study|Withdrawal by Subject|1|||
164000814|NCT01056107|592366715|FG002|Overall Study|Withdrawal by Subject|3|||
164274393|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
164274394|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
164274395|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
164274396|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
164274397|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
164274398|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
164274399|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
164274400|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164274401|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
163894071|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
164274402|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164274403|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164274404|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
164142454|NCT04642365|592882729|FG007|Overall Study|Progressive Disease|0|||
164274405|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
164274406|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
164274407|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274408|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274409|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274410|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164274411|NCT02453555|593372893|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
164274412|NCT02453555|593372894|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
164274413|NCT02453555|593372895|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
164274414|NCT02453555|593372896|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
164274415|NCT02453555|593372897|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
164274416|NCT02453555|593372898|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
164274417|NCT02453555|593372893|FG000|Extension Period|Adverse Event|0|||
164274418|NCT02453555|593372894|FG001|Extension Period|Adverse Event|0|||
164274419|NCT02453555|593372895|FG002|Extension Period|Adverse Event|1|||
164274420|NCT02453555|593372896|FG003|Extension Period|Adverse Event|2|||
164274421|NCT02453555|593372897|FG004|Extension Period|Adverse Event|1|||
164274422|NCT02453555|593372898|FG005|Extension Period|Adverse Event|1|||
164274423|NCT02453555|593372893|FG000|Extension Period|Protocol Violation|0|||
164274424|NCT02453555|593372894|FG001|Extension Period|Protocol Violation|0|||
164274425|NCT02453555|593372895|FG002|Extension Period|Protocol Violation|1|||
164274426|NCT02453555|593372896|FG003|Extension Period|Protocol Violation|0|||
164274427|NCT02453555|593372897|FG004|Extension Period|Protocol Violation|0|||
164274428|NCT02453555|593372898|FG005|Extension Period|Protocol Violation|0|||
164274429|NCT02453555|593372893|FG000|Extension Period|Withdrawal by Subject|0|||
164274430|NCT02453555|593372894|FG001|Extension Period|Withdrawal by Subject|0|||
164274431|NCT02453555|593372895|FG002|Extension Period|Withdrawal by Subject|1|||
164274432|NCT02453555|593372896|FG003|Extension Period|Withdrawal by Subject|0|||
164274433|NCT02453555|593372897|FG004|Extension Period|Withdrawal by Subject|0|||
164342754|NCT00799383|593631508|FG000|Overall Study|Withdrawal by Subject|0|||
164342755|NCT00799383|593631509|FG001|Overall Study|Withdrawal by Subject|1|||
164342756|NCT03486223|593631519|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
164342757|NCT03486223|593631520|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
164342758|NCT03068130|593631531|FG000|Overall Study|Adverse Event|19|||
164342759|NCT03068130|593631531|FG000|Overall Study|Death|14|||
164342760|NCT03068130|593631531|FG000|Overall Study|Lost to Follow-up|4|||
164342761|NCT03068130|593631531|FG000|Overall Study|Withdrawal by Subject|26|||
164342762|NCT03068130|593631531|FG000|Overall Study|Administrative Reasons|3|||
164342763|NCT03068130|593631531|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
164342764|NCT03068130|593631531|FG000|Overall Study|Study terminated by sponsor|194|||
164342765|NCT00590720|593631532|FG000|Overall Study|Lost to Follow-up|1|||
164342766|NCT00590720|593631533|FG001|Overall Study|Lost to Follow-up|0|||
164342767|NCT00590720|593631532|FG000|Overall Study|Withdrawal by Subject|0|||
164342768|NCT00590720|593631533|FG001|Overall Study|Withdrawal by Subject|1|||
164342769|NCT03741062|593631538|FG000|Overall Study|Protocol Violation|1|||
164342770|NCT03741062|593631539|FG001|Overall Study|Protocol Violation|0|||
164342771|NCT02527161|593631540|FG000|Overall Study|Failed MRI|52|||
164342772|NCT02527161|593631540|FG000|Overall Study|Withdrawal by Subject|19|||
164342773|NCT02527161|593631540|FG000|Overall Study|Delay in or unfit for surgery|16|||
164342774|NCT02527161|593631540|FG000|Overall Study|MRI contraindication|6|||
164342775|NCT02527161|593631540|FG000|Overall Study|Consent violation|4|||
164342776|NCT02527161|593631540|FG000|Overall Study|Only Recruited to Part A|27|||
164342777|NCT02527161|593631540|FG000|Overall Study|Physician Decision|1|||
164274434|NCT02453555|593372898|FG005|Extension Period|Withdrawal by Subject|0|||
164274435|NCT03689855|593372903|FG000|Overall Study|Adverse Event|3|||
164274436|NCT03689855|593372903|FG000|Overall Study|Withdrawal by Subject|1|||
164274437|NCT03178669|593372904|FG000|Overall Study|Adverse Event|4|||
164274438|NCT03178669|593372905|FG001|Overall Study|Adverse Event|1|||
164274439|NCT03178669|593372906|FG002|Overall Study|Adverse Event|4|||
164274440|NCT03178669|593372907|FG003|Overall Study|Adverse Event|2|||
164342778|NCT02527161|593631540|FG000|Overall Study|Adverse Event|1|||
164342779|NCT02527161|593631540|FG000|Overall Study|Lost to Follow-up|6|||
164342780|NCT02609828|593631541|FG000|Overall Study|Adverse Event|8|||
164342781|NCT02609828|593631542|FG001|Overall Study|Adverse Event|1|||
164274441|NCT03178669|593372908|FG004|Overall Study|Adverse Event|2|||
164274442|NCT03178669|593372904|FG000|Overall Study|Lack of Efficacy|0|||
164274443|NCT03178669|593372905|FG001|Overall Study|Lack of Efficacy|0|||
164274444|NCT03178669|593372906|FG002|Overall Study|Lack of Efficacy|2|||
164274445|NCT03178669|593372907|FG003|Overall Study|Lack of Efficacy|0|||
164274446|NCT03178669|593372908|FG004|Overall Study|Lack of Efficacy|1|||
164342782|NCT02609828|593631543|FG002|Overall Study|Adverse Event|0|||
164342783|NCT02609828|593631544|FG003|Overall Study|Adverse Event|6|||
164342784|NCT02609828|593631541|FG000|Overall Study|Death|15|||
164342785|NCT02609828|593631542|FG001|Overall Study|Death|1|||
164000815|NCT01056107|592366716|FG003|Overall Study|Withdrawal by Subject|0|||
164000816|NCT00377962|592366719|FG000|Core Study: 0-12 Months|Adverse Event|18|||
164000817|NCT00377962|592366720|FG001|Core Study: 0-12 Months|Adverse Event|2|||
164000818|NCT00377962|592366719|FG000|Core Study: 0-12 Months|Death|3|||
164000819|NCT00377962|592366720|FG001|Core Study: 0-12 Months|Death|0|||
164000820|NCT00377962|592366719|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
164000821|NCT00377962|592366720|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
164000822|NCT00377962|592366719|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
164000823|NCT00377962|592366720|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
164000824|NCT00377962|592366719|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
164000825|NCT00377962|592366720|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
164000826|NCT00377962|592366719|FG000|Extension Study: 12-24 Months|Death|1|||
164000827|NCT00377962|592366720|FG001|Extension Study: 12-24 Months|Death|1|||
164000828|NCT00377962|592366719|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
164000829|NCT00377962|592366720|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
164000830|NCT00377962|592366719|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
164000831|NCT00377962|592366720|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
164000832|NCT00377962|592366719|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
164000833|NCT00377962|592366720|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
164000834|NCT00496366|592366730|FG000|Overall Study|Death|1|||
164000835|NCT00260208|592366732|FG000|Overall Study|Subject withdrew consent|11|||
164000836|NCT00260208|592366733|FG001|Overall Study|Subject withdrew consent|7|||
164000837|NCT00260208|592366732|FG000|Overall Study|Lost to Follow-up|6|||
164000838|NCT00260208|592366733|FG001|Overall Study|Lost to Follow-up|1|||
164000839|NCT00260208|592366732|FG000|Overall Study|Death|12|||
164000840|NCT00260208|592366733|FG001|Overall Study|Death|10|||
164000841|NCT00260208|592366732|FG000|Overall Study|Missing|18|||
164000842|NCT00260208|592366733|FG001|Overall Study|Missing|16|||
164000843|NCT02091440|592366734|FG000|Overall Study|Death|2|||
164000844|NCT00278629|592366741|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
164000845|NCT03323749|592366742|FG000|Double-blind Period|Lost to Follow-up|4|||
164000846|NCT03323749|592366743|FG001|Double-blind Period|Lost to Follow-up|5|||
164000847|NCT03323749|592366742|FG000|Double-blind Period|Adverse Event|3|||
164000848|NCT03323749|592366743|FG001|Double-blind Period|Adverse Event|1|||
164000849|NCT03323749|592366742|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
164000850|NCT03323749|592366743|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
164000851|NCT03323749|592366742|FG000|Open-Label Period|Adverse Event|3|||
164274447|NCT03178669|593372904|FG000|Overall Study|Physician Decision|0|||
164274448|NCT03178669|593372905|FG001|Overall Study|Physician Decision|0|||
164274449|NCT03178669|593372906|FG002|Overall Study|Physician Decision|0|||
164274450|NCT03178669|593372907|FG003|Overall Study|Physician Decision|0|||
164274451|NCT03178669|593372908|FG004|Overall Study|Physician Decision|1|||
164274452|NCT03178669|593372904|FG000|Overall Study|Withdrawal by Subject|1|||
164274453|NCT03178669|593372905|FG001|Overall Study|Withdrawal by Subject|0|||
164274454|NCT03178669|593372906|FG002|Overall Study|Withdrawal by Subject|1|||
164274455|NCT03178669|593372907|FG003|Overall Study|Withdrawal by Subject|1|||
164274456|NCT03178669|593372908|FG004|Overall Study|Withdrawal by Subject|0|||
164274457|NCT03178669|593372904|FG000|Overall Study|Lost to Follow-up|0|||
164274458|NCT03178669|593372905|FG001|Overall Study|Lost to Follow-up|0|||
164274459|NCT03178669|593372906|FG002|Overall Study|Lost to Follow-up|0|||
164274460|NCT03178669|593372907|FG003|Overall Study|Lost to Follow-up|1|||
164274461|NCT03178669|593372908|FG004|Overall Study|Lost to Follow-up|0|||
164274462|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
164274463|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
163894072|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
163894073|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
163894074|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
163894075|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
163894076|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
163894077|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
163894078|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
163894079|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
163894080|NCT04614948|591983845|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
163894081|NCT04614948|591983846|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
163894082|NCT04614948|591983847|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
163894083|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
164000852|NCT03323749|592366743|FG001|Open-Label Period|Adverse Event|10|||
164000853|NCT03323749|592366742|FG000|Open-Label Period|Withdrawal by Subject|7|||
164000854|NCT03323749|592366743|FG001|Open-Label Period|Withdrawal by Subject|5|||
164274464|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
164000855|NCT01821963|592366744|FG000|Overall Study|Adverse Event|1|||
164000856|NCT00097539|592366752|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
164000857|NCT00097539|592366753|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
164274465|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
164274466|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
164274467|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
164274468|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274469|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274470|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274471|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274472|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
164274473|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
164274474|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
164274475|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
164274476|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274477|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
164274478|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
164274479|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274480|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274481|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274482|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274483|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
164274484|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274485|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
163894084|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
163894085|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
164274486|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
164274487|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
164274488|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
164274489|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
164274490|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274491|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274492|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274493|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274494|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
164274495|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
164274496|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
164274497|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
164274498|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274499|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
164274500|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
164274501|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274502|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274503|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274504|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274505|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
164274506|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274507|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274508|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
164274509|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274510|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274511|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
164274512|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274513|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274514|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274515|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274516|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
164274517|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
164274518|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274519|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
163894086|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
163894087|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
163894088|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
163894089|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
163894090|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
163894091|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
163894092|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
163894093|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
164274520|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274521|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274522|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274523|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274524|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274525|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164000858|NCT00097539|592366754|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
164000859|NCT00097539|592366755|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
164000860|NCT00097539|592366756|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
164000861|NCT00097539|592366757|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
164000862|NCT00097539|592366758|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
164000863|NCT00097539|592366752|FG000|Overall Study|Withdrawal by Subject|925|||
164274526|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274527|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
164274528|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274529|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274530|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
164274531|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274532|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274533|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274534|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274535|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274536|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274537|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274538|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
164274539|NCT02914561|593372909|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
164274540|NCT02914561|593372910|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274541|NCT02914561|593372911|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274542|NCT02914561|593372912|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274543|NCT02914561|593372913|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274544|NCT02914561|593372914|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
164274545|NCT02914561|593372915|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274546|NCT02914561|593372916|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274547|NCT02914561|593372917|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274548|NCT02914561|593372918|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274549|NCT02914561|593372919|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
164274550|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274551|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274552|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274553|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274554|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274555|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
164274556|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
164274557|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
164274558|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
164274559|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
164274560|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
164274561|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274562|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274563|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274564|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274565|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274566|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
164274567|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
164274568|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
164274569|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
164274570|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
164274571|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
164274572|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274573|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274574|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274575|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274576|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164274577|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
164342786|NCT02609828|593631543|FG002|Overall Study|Death|1|||
163894094|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
163894095|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
163894096|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
163894097|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
163894098|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
163894099|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
163894100|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
163894101|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
163894102|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
163894103|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
163894104|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
163894105|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
163894106|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
163894107|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
163894108|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
163894109|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
163894110|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
163894111|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
163894112|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
163894113|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
163894114|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
163894115|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
163894116|NCT04614948|591983845|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
163894117|NCT04614948|591983846|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
163894118|NCT04614948|591983847|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
163894119|NCT04271046|591983848|FG000|Overall Study|Death|0|||
163894120|NCT04271046|591983849|FG001|Overall Study|Death|2|||
163894121|NCT04271046|591983850|FG002|Overall Study|Death|0|||
163894122|NCT04271046|591983851|FG003|Overall Study|Death|2|||
163894123|NCT04271046|591983848|FG000|Overall Study|Lost to Follow-up|12|||
163894124|NCT04271046|591983849|FG001|Overall Study|Lost to Follow-up|12|||
163894125|NCT04271046|591983850|FG002|Overall Study|Lost to Follow-up|11|||
163894126|NCT04271046|591983851|FG003|Overall Study|Lost to Follow-up|11|||
163894127|NCT04271046|591983848|FG000|Overall Study|Patient with Dementia Died|2|||
163894128|NCT04271046|591983849|FG001|Overall Study|Patient with Dementia Died|0|||
163894129|NCT04271046|591983850|FG002|Overall Study|Patient with Dementia Died|2|||
163894130|NCT04271046|591983851|FG003|Overall Study|Patient with Dementia Died|0|||
163894131|NCT04271046|591983848|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
163894132|NCT04271046|591983849|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
163894133|NCT04271046|591983850|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
163894134|NCT04271046|591983851|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
163894135|NCT01570361|591983852|FG000|Overall Study|Subject discontinued|1|||
163894136|NCT01570361|591983853|FG001|Overall Study|Subject discontinued|2|||
163894137|NCT01570361|591983852|FG000|Overall Study|Sponsor closing the study|51|||
163894138|NCT01570361|591983853|FG001|Overall Study|Sponsor closing the study|50|||
163894139|NCT01570361|591983852|FG000|Overall Study|Subject excluded|5|||
163894140|NCT01570361|591983853|FG001|Overall Study|Subject excluded|3|||
163894141|NCT01570361|591983852|FG000|Overall Study|Subject withdrew consent|14|||
163894142|NCT01570361|591983853|FG001|Overall Study|Subject withdrew consent|9|||
163894143|NCT01570361|591983852|FG000|Overall Study|Adverse Event|2|||
163894144|NCT01570361|591983853|FG001|Overall Study|Adverse Event|1|||
163894145|NCT01570361|591983852|FG000|Overall Study|Lost to Follow-up|4|||
163894146|NCT01570361|591983853|FG001|Overall Study|Lost to Follow-up|4|||
163894147|NCT01570361|591983852|FG000|Overall Study|Death|5|||
163894148|NCT01570361|591983853|FG001|Overall Study|Death|4|||
163894149|NCT01570361|591983852|FG000|Overall Study|Other|0|||
163894150|NCT01570361|591983853|FG001|Overall Study|Other|2|||
164274578|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
164274579|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
164274580|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
164274581|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
163894151|NCT05158504|591983854|FG000|Overall Study|Lost to Follow-up|2|||
163894152|NCT05158504|591983855|FG001|Overall Study|Lost to Follow-up|3|||
163894153|NCT03606512|591983858|FG000|Overall Study|Lost to Follow-up|0|||
163894154|NCT03606512|591983859|FG001|Overall Study|Lost to Follow-up|1|||
164274582|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
163894155|NCT03606512|591983858|FG000|Overall Study|'moved from study area|0|||
163894156|NCT03606512|591983859|FG001|Overall Study|'moved from study area|1|||
163900164|NCT00115934|592005622|FG000|Overall Study|Did not receive intervention|3|||
164274583|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164000864|NCT00097539|592366753|FG001|Overall Study|Withdrawal by Subject|323|||
164000865|NCT00097539|592366754|FG002|Overall Study|Withdrawal by Subject|346|||
164000866|NCT00097539|592366755|FG003|Overall Study|Withdrawal by Subject|217|||
164000867|NCT00097539|592366756|FG004|Overall Study|Withdrawal by Subject|68|||
164000868|NCT00097539|592366757|FG005|Overall Study|Withdrawal by Subject|229|||
164000869|NCT00097539|592366758|FG006|Overall Study|Withdrawal by Subject|3|||
164000870|NCT00097539|592366752|FG000|Overall Study|Participant Non-compliant|2140|||
164000871|NCT00097539|592366753|FG001|Overall Study|Participant Non-compliant|567|||
164000872|NCT00097539|592366754|FG002|Overall Study|Participant Non-compliant|1067|||
164000873|NCT00097539|592366755|FG003|Overall Study|Participant Non-compliant|353|||
164000874|NCT00097539|592366756|FG004|Overall Study|Participant Non-compliant|136|||
164000875|NCT00097539|592366757|FG005|Overall Study|Participant Non-compliant|543|||
164000876|NCT00097539|592366758|FG006|Overall Study|Participant Non-compliant|18|||
164000877|NCT00097539|592366752|FG000|Overall Study|Lack of Efficacy|249|||
164000878|NCT00097539|592366753|FG001|Overall Study|Lack of Efficacy|122|||
164000879|NCT00097539|592366754|FG002|Overall Study|Lack of Efficacy|202|||
164000880|NCT00097539|592366755|FG003|Overall Study|Lack of Efficacy|105|||
164000881|NCT00097539|592366756|FG004|Overall Study|Lack of Efficacy|45|||
164000882|NCT00097539|592366757|FG005|Overall Study|Lack of Efficacy|228|||
164000883|NCT00097539|592366758|FG006|Overall Study|Lack of Efficacy|5|||
164000884|NCT00097539|592366752|FG000|Overall Study|Adverse Event|78|||
164000885|NCT00097539|592366753|FG001|Overall Study|Adverse Event|133|||
164000886|NCT00097539|592366754|FG002|Overall Study|Adverse Event|37|||
164000887|NCT00097539|592366755|FG003|Overall Study|Adverse Event|27|||
164000888|NCT00097539|592366756|FG004|Overall Study|Adverse Event|30|||
164000889|NCT00097539|592366757|FG005|Overall Study|Adverse Event|59|||
164000890|NCT00097539|592366758|FG006|Overall Study|Adverse Event|1|||
164000891|NCT00097539|592366752|FG000|Overall Study|Death|2|||
164000892|NCT00097539|592366753|FG001|Overall Study|Death|7|||
164000893|NCT00097539|592366754|FG002|Overall Study|Death|0|||
164000894|NCT00097539|592366755|FG003|Overall Study|Death|0|||
164000895|NCT00097539|592366756|FG004|Overall Study|Death|1|||
164000896|NCT00097539|592366757|FG005|Overall Study|Death|3|||
164000897|NCT00097539|592366758|FG006|Overall Study|Death|0|||
164000898|NCT00097539|592366752|FG000|Overall Study|Reasons Other Than Above|3602|||
164000899|NCT00097539|592366753|FG001|Overall Study|Reasons Other Than Above|1382|||
164000900|NCT00097539|592366754|FG002|Overall Study|Reasons Other Than Above|1757|||
164000901|NCT00097539|592366755|FG003|Overall Study|Reasons Other Than Above|692|||
164000902|NCT00097539|592366756|FG004|Overall Study|Reasons Other Than Above|361|||
164000903|NCT00097539|592366757|FG005|Overall Study|Reasons Other Than Above|1244|||
164000904|NCT00097539|592366758|FG006|Overall Study|Reasons Other Than Above|34|||
164000905|NCT00097539|592366752|FG000|Overall Study|Reason not Specified|111|||
164000906|NCT00097539|592366753|FG001|Overall Study|Reason not Specified|49|||
164274584|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274585|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274586|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274587|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274588|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274589|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
164274590|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274591|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
164274592|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
164274593|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
164274594|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274595|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274596|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274597|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274598|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274599|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274600|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
164274601|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
164274602|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
164274603|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
164274604|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
164274605|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164000907|NCT00097539|592366754|FG002|Overall Study|Reason not Specified|53|||
164000908|NCT00097539|592366755|FG003|Overall Study|Reason not Specified|21|||
164000909|NCT00097539|592366756|FG004|Overall Study|Reason not Specified|11|||
164000910|NCT00097539|592366757|FG005|Overall Study|Reason not Specified|40|||
164000911|NCT00097539|592366758|FG006|Overall Study|Reason not Specified|2|||
164000912|NCT02966314|592366759|FG000|Overall Study|Lost to Follow-up|1|||
164000913|NCT02966314|592366760|FG001|Overall Study|Lost to Follow-up|0|||
164000914|NCT05127486|592366761|FG000|Overall Study|Adverse Event|2|||
164000915|NCT05127486|592366762|FG001|Overall Study|Adverse Event|4|||
164274606|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274607|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274608|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274609|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274610|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274611|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
164274612|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274613|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
164274614|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274615|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
164274616|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274617|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274618|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274619|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274620|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274621|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274622|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274623|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164342787|NCT02609828|593631544|FG003|Overall Study|Death|19|||
164342788|NCT02609828|593631541|FG000|Overall Study|Insufficient clinical response|2|||
164342789|NCT02609828|593631542|FG001|Overall Study|Insufficient clinical response|1|||
164342790|NCT02609828|593631543|FG002|Overall Study|Insufficient clinical response|0|||
164342791|NCT02609828|593631544|FG003|Overall Study|Insufficient clinical response|0|||
164342792|NCT02609828|593631541|FG000|Overall Study|Lost to Follow-up|0|||
163894157|NCT05513937|591983860|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
163894158|NCT05513937|591983861|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
163900165|NCT00115934|592005623|FG001|Overall Study|Did not receive intervention|2|||
164274624|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
164274625|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274626|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
164274627|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274628|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274629|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274630|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274631|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274632|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274633|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
164274634|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274635|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274636|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274637|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
164274638|NCT02914561|593372909|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274639|NCT02914561|593372910|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274640|NCT02914561|593372911|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274641|NCT02914561|593372912|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274642|NCT02914561|593372913|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274643|NCT02914561|593372914|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274644|NCT02914561|593372915|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274645|NCT02914561|593372916|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
164274646|NCT02914561|593372917|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
164274647|NCT02914561|593372918|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
164274648|NCT02914561|593372919|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
164274649|NCT01300455|593372920|FG000|Washout|Withdrawal by Subject|1|||
164274650|NCT01300455|593372921|FG001|Washout|Withdrawal by Subject|0|||
164274651|NCT00576576|593372931|FG000|Overall Study|Lost to Follow-up|6|||
164274652|NCT00576576|593372931|FG000|Overall Study|Protocol Violation|1|||
164274653|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274654|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274655|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274656|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274657|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274658|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274659|NCT00718770|593372938|FG000|Overall Study|Lack of Efficacy|1|||
164274660|NCT00718770|593372938|FG000|Overall Study|Adverse Event|1|||
164274661|NCT00772109|593372939|FG000|Overall Study|Serious adverse event|1|||
164274662|NCT00772109|593372940|FG001|Overall Study|Serious adverse event|0|||
164274663|NCT00772109|593372941|FG002|Overall Study|Serious adverse event|1|||
164342793|NCT02609828|593631542|FG001|Overall Study|Lost to Follow-up|0|||
164274664|NCT00772109|593372942|FG003|Overall Study|Serious adverse event|0|||
164274665|NCT00772109|593372939|FG000|Overall Study|Protocol Violation|5|||
164274666|NCT00772109|593372940|FG001|Overall Study|Protocol Violation|8|||
164274667|NCT00772109|593372941|FG002|Overall Study|Protocol Violation|7|||
164274668|NCT00772109|593372942|FG003|Overall Study|Protocol Violation|6|||
164274669|NCT00772109|593372939|FG000|Overall Study|Lost to Follow-up|7|||
164274670|NCT00772109|593372940|FG001|Overall Study|Lost to Follow-up|3|||
164274671|NCT00772109|593372941|FG002|Overall Study|Lost to Follow-up|5|||
164274672|NCT00772109|593372942|FG003|Overall Study|Lost to Follow-up|9|||
164274673|NCT00772109|593372939|FG000|Overall Study|Withdrawal by Subject|8|||
164274674|NCT00772109|593372940|FG001|Overall Study|Withdrawal by Subject|8|||
164274675|NCT00772109|593372941|FG002|Overall Study|Withdrawal by Subject|6|||
164274676|NCT00772109|593372942|FG003|Overall Study|Withdrawal by Subject|16|||
164274677|NCT00410605|593372943|FG000|Overall Study|Adverse Event|12|||
164274678|NCT00410605|593372943|FG000|Overall Study|Physician Decision|3|||
164274679|NCT00410605|593372943|FG000|Overall Study|Withdrawal by Subject|5|||
164274680|NCT00410605|593372943|FG000|Overall Study|Started Non-Protocol Therapy|3|||
164274681|NCT00410605|593372943|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
164274682|NCT00410605|593372943|FG000|Overall Study|Transferred to another Institution|1|||
164274683|NCT04583956|593372944|FG000|Overall Study|Death|9|||
164274684|NCT04583956|593372945|FG001|Overall Study|Death|11|||
164274685|NCT04583956|593372944|FG000|Overall Study|Lost to Follow-up|7|||
164274686|NCT04583956|593372945|FG001|Overall Study|Lost to Follow-up|9|||
164274687|NCT04583956|593372944|FG000|Overall Study|Protocol Violation|2|||
164274688|NCT04583956|593372945|FG001|Overall Study|Protocol Violation|0|||
164274689|NCT04583956|593372944|FG000|Overall Study|Withdrawal by Subject|0|||
164274690|NCT04583956|593372945|FG001|Overall Study|Withdrawal by Subject|2|||
164274691|NCT04583956|593372944|FG000|Overall Study|Randomized but not dosed|2|||
164274692|NCT04583956|593372945|FG001|Overall Study|Randomized but not dosed|3|||
164274693|NCT04583956|593372944|FG000|Overall Study|Withdrawal of consent before product administration|1|||
164274694|NCT04583956|593372945|FG001|Overall Study|Withdrawal of consent before product administration|0|||
164274695|NCT00703924|593374501|FG000|Overall Study|Withdrawal by Subject|1|||
164274696|NCT00703924|593374502|FG001|Overall Study|Withdrawal by Subject|1|||
164274697|NCT01900054|593374514|FG000|Overall Study|Physician Decision|1|||
164274698|NCT01900054|593374514|FG000|Overall Study|Withdrawal by Subject|1|||
164274699|NCT01959841|593374517|FG000|Overall Study|Adverse Event|1|||
164274700|NCT01959841|593374518|FG001|Overall Study|Adverse Event|3|||
164274701|NCT01959841|593374519|FG002|Overall Study|Adverse Event|2|||
164274702|NCT01959841|593374517|FG000|Overall Study|Lack of Efficacy|5|||
164274703|NCT01959841|593374518|FG001|Overall Study|Lack of Efficacy|0|||
164274704|NCT01959841|593374519|FG002|Overall Study|Lack of Efficacy|0|||
164274705|NCT01959841|593374517|FG000|Overall Study|Lost to Follow-up|1|||
164274706|NCT01959841|593374518|FG001|Overall Study|Lost to Follow-up|1|||
164274707|NCT01959841|593374519|FG002|Overall Study|Lost to Follow-up|0|||
164274708|NCT01959841|593374517|FG000|Overall Study|Physician Decision|0|||
164274709|NCT01959841|593374518|FG001|Overall Study|Physician Decision|2|||
164274710|NCT01959841|593374519|FG002|Overall Study|Physician Decision|3|||
164274711|NCT01959841|593374517|FG000|Overall Study|Protocol Violation|16|||
164274712|NCT01959841|593374518|FG001|Overall Study|Protocol Violation|23|||
164274713|NCT01959841|593374519|FG002|Overall Study|Protocol Violation|16|||
164274714|NCT01959841|593374517|FG000|Overall Study|Withdrawal by Subject|7|||
164274715|NCT01959841|593374518|FG001|Overall Study|Withdrawal by Subject|7|||
164274716|NCT01959841|593374519|FG002|Overall Study|Withdrawal by Subject|5|||
164274717|NCT01959841|593374517|FG000|Overall Study|Clinical laboratory value|2|||
164274718|NCT01959841|593374518|FG001|Overall Study|Clinical laboratory value|6|||
164274719|NCT01959841|593374519|FG002|Overall Study|Clinical laboratory value|6|||
164274720|NCT01959841|593374517|FG000|Overall Study|Platelet count below on day1 or 4|11|||
164274721|NCT01959841|593374518|FG001|Overall Study|Platelet count below on day1 or 4|15|||
164274722|NCT01959841|593374519|FG002|Overall Study|Platelet count below on day1 or 4|11|||
164274723|NCT00924508|593374535|FG000|Overall Study|Withdrawal by Subject|3|||
164274724|NCT01835223|593374538|FG000|Overall Study|Adverse Event|1|||
164274725|NCT01835223|593374539|FG001|Overall Study|Adverse Event|0|||
164274726|NCT01835223|593374538|FG000|Overall Study|Withdrawal by Subject|2|||
164274727|NCT01835223|593374539|FG001|Overall Study|Withdrawal by Subject|0|||
164274728|NCT01835223|593374538|FG000|Overall Study|Disease progression|2|||
164274729|NCT01835223|593374539|FG001|Overall Study|Disease progression|1|||
164274730|NCT01835223|593374538|FG000|Overall Study|Became Inelligible|4|||
164274731|NCT01835223|593374539|FG001|Overall Study|Became Inelligible|0|||
164274732|NCT00495625|593374543|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
164274733|NCT03679624|593374544|FG000|Overall Study|Adverse Event|1|||
164274734|NCT03679624|593374545|FG001|Overall Study|Adverse Event|0|||
164274735|NCT01912339|593374546|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
164274736|NCT01912339|593374547|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
164274737|NCT01912339|593374548|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
164274738|NCT01912339|593374546|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
164274739|NCT01912339|593374547|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
164274740|NCT01912339|593374548|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
163894159|NCT05513937|591983862|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
163894160|NCT05513937|591983863|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
163894161|NCT05513937|591983860|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
163894162|NCT05513937|591983861|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
163894163|NCT05513937|591983862|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
163894164|NCT05513937|591983863|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
163894165|NCT05513937|591983860|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
163894166|NCT05513937|591983861|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
163894167|NCT05513937|591983862|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
163894168|NCT05513937|591983863|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
163894169|NCT05513937|591983860|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
163894170|NCT05513937|591983861|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
163894171|NCT05513937|591983862|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
163894172|NCT05513937|591983863|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
163894173|NCT05513937|591983860|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
163894174|NCT05513937|591983861|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
163894175|NCT05513937|591983862|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
163894176|NCT05513937|591983863|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
163894177|NCT05513937|591983860|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
163894178|NCT05513937|591983861|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
163894179|NCT05513937|591983862|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
163894180|NCT05513937|591983863|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
163894181|NCT02846545|591983864|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
163894182|NCT02846545|591983865|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
163894183|NCT02846545|591983864|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
163894184|NCT02846545|591983865|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
163894185|NCT02846545|591983864|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
163894186|NCT02846545|591983865|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
163894187|NCT02846545|591983864|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
163894188|NCT02846545|591983865|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
163894189|NCT02846545|591983864|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
163894190|NCT02846545|591983865|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
163894191|NCT02326974|591983868|FG000|Overall Study|Withdrawal by Subject|2|||
163894192|NCT02326974|591983868|FG000|Overall Study|failed heterogenity evaluation|5|||
163894193|NCT04924400|591983870|FG000|Overall Study|Lost to Follow-up|3|||
163894194|NCT04924400|591983871|FG001|Overall Study|Lost to Follow-up|0|||
163894195|NCT04633538|591983872|FG000|Overall Study|Death|1|||
163894196|NCT04633538|591983872|FG000|Overall Study|Lost to Follow-up|3|||
164274741|NCT01912339|593374546|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
164274742|NCT01912339|593374547|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
164274743|NCT01912339|593374548|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
164274744|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
164274745|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
164274746|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
164274747|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
164274748|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
164274749|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
164274750|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
164274751|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
164274752|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
164274753|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
164274754|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
164274755|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
164274756|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
163894197|NCT04633538|591983872|FG000|Overall Study|Withdrawal by Subject|1|||
164000916|NCT05127486|592366761|FG000|Overall Study|Lack of Efficacy|1|||
164000917|NCT05127486|592366762|FG001|Overall Study|Lack of Efficacy|0|||
164000918|NCT05127486|592366761|FG000|Overall Study|Pregnancy|0|||
164000919|NCT05127486|592366762|FG001|Overall Study|Pregnancy|1|||
164000920|NCT05127486|592366761|FG000|Overall Study|Physician Decision|4|||
164000921|NCT05127486|592366762|FG001|Overall Study|Physician Decision|1|||
164000922|NCT05127486|592366761|FG000|Overall Study|Withdrawal by Subject|14|||
164000923|NCT05127486|592366762|FG001|Overall Study|Withdrawal by Subject|13|||
164000924|NCT05127486|592366761|FG000|Overall Study|Lost to Follow-up|5|||
164000925|NCT05127486|592366762|FG001|Overall Study|Lost to Follow-up|8|||
164000926|NCT02582515|592366763|FG000|Overall Study|Withdrawal by Subject|0|||
164000927|NCT02582515|592366764|FG001|Overall Study|Withdrawal by Subject|1|||
164000928|NCT02688647|592366765|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
164000929|NCT02688647|592366766|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
164000930|NCT02688647|592366765|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
164000931|NCT02688647|592366766|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
164000932|NCT02688647|592366765|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
164000933|NCT02688647|592366766|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
164000934|NCT02688647|592366765|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
164000935|NCT02688647|592366766|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
164000936|NCT02688647|592366765|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
164000937|NCT02688647|592366766|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
164274757|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
164274758|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
164274759|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
164274760|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
164274761|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
164274762|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
164000938|NCT02688647|592366765|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
164274763|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
164000939|NCT02688647|592366766|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
164000940|NCT02688647|592366765|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
164274764|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
164274765|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
164274766|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
164274767|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
164274768|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
164274769|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
164274770|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
164274771|NCT01912339|593374546|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
164274772|NCT01912339|593374547|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
164274773|NCT01912339|593374548|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
164274774|NCT04097379|593374549|FG000|Overall Study|Adverse Event|1|||
164274775|NCT04097379|593374550|FG001|Overall Study|Adverse Event|0|||
164274776|NCT04097379|593374551|FG002|Overall Study|Adverse Event|0|||
164274777|NCT04097379|593374552|FG003|Overall Study|Adverse Event|0|||
164274778|NCT04097379|593374549|FG000|Overall Study|Physician Decision|0|||
163894198|NCT04565990|591985498|FG000|Overall Study|Death|5|||
164274779|NCT04097379|593374550|FG001|Overall Study|Physician Decision|1|||
163894199|NCT04565990|591985498|FG000|Overall Study|Lost to Follow-up|1|||
164274780|NCT04097379|593374551|FG002|Overall Study|Physician Decision|0|||
164274781|NCT04097379|593374552|FG003|Overall Study|Physician Decision|0|||
164274782|NCT00200356|593374557|FG000|Overall Study|Lack of Efficacy|3|||
164274783|NCT00200356|593374558|FG001|Overall Study|Lack of Efficacy|3|||
164274784|NCT00200356|593374557|FG000|Overall Study|Protocol Violation|4|||
164274785|NCT00200356|593374558|FG001|Overall Study|Protocol Violation|4|||
164274786|NCT00200356|593374557|FG000|Overall Study|Nontreatment|1|||
164274787|NCT00200356|593374558|FG001|Overall Study|Nontreatment|0|||
164274788|NCT05216224|593374564|FG000|Overall Study|Adverse Event|6|||
164274789|NCT05216224|593374565|FG001|Overall Study|Adverse Event|3|||
164274790|NCT05216224|593374564|FG000|Overall Study|Lack of Efficacy|1|||
164274791|NCT05216224|593374565|FG001|Overall Study|Lack of Efficacy|0|||
164274792|NCT05216224|593374564|FG000|Overall Study|Lost to Follow-up|8|||
164274793|NCT05216224|593374565|FG001|Overall Study|Lost to Follow-up|6|||
164274794|NCT05216224|593374564|FG000|Overall Study|Protocol Violation|1|||
164274795|NCT05216224|593374565|FG001|Overall Study|Protocol Violation|1|||
164274796|NCT05216224|593374564|FG000|Overall Study|Withdrawal by Subject|6|||
164274797|NCT05216224|593374565|FG001|Overall Study|Withdrawal by Subject|5|||
164274798|NCT05216224|593374564|FG000|Overall Study|Other than specified|1|||
164274799|NCT05216224|593374565|FG001|Overall Study|Other than specified|0|||
164274800|NCT03245008|593374566|FG000|Overall Study|Adverse Event|15|||
164274801|NCT03245008|593374567|FG001|Overall Study|Adverse Event|18|||
164274802|NCT03245008|593374568|FG002|Overall Study|Adverse Event|15|||
164274803|NCT03245008|593374569|FG003|Overall Study|Adverse Event|0|||
164274804|NCT03245008|593374570|FG004|Overall Study|Adverse Event|1|||
164274805|NCT03245008|593374566|FG000|Overall Study|Lack of Efficacy|0|||
164274806|NCT03245008|593374567|FG001|Overall Study|Lack of Efficacy|1|||
164274807|NCT03245008|593374568|FG002|Overall Study|Lack of Efficacy|0|||
164274808|NCT03245008|593374569|FG003|Overall Study|Lack of Efficacy|0|||
164274809|NCT03245008|593374570|FG004|Overall Study|Lack of Efficacy|0|||
164274810|NCT03245008|593374566|FG000|Overall Study|Lost to Follow-up|4|||
164274811|NCT03245008|593374567|FG001|Overall Study|Lost to Follow-up|1|||
164274812|NCT03245008|593374568|FG002|Overall Study|Lost to Follow-up|0|||
164274813|NCT03245008|593374569|FG003|Overall Study|Lost to Follow-up|0|||
164274814|NCT03245008|593374570|FG004|Overall Study|Lost to Follow-up|1|||
164274815|NCT03245008|593374566|FG000|Overall Study|Physician Decision|1|||
164274816|NCT03245008|593374567|FG001|Overall Study|Physician Decision|3|||
164274817|NCT03245008|593374568|FG002|Overall Study|Physician Decision|4|||
164274818|NCT03245008|593374569|FG003|Overall Study|Physician Decision|0|||
164274819|NCT03245008|593374570|FG004|Overall Study|Physician Decision|0|||
164274820|NCT03245008|593374566|FG000|Overall Study|Protocol Violation|0|||
164274821|NCT03245008|593374567|FG001|Overall Study|Protocol Violation|1|||
164274822|NCT03245008|593374568|FG002|Overall Study|Protocol Violation|0|||
164274823|NCT03245008|593374569|FG003|Overall Study|Protocol Violation|0|||
164274824|NCT03245008|593374570|FG004|Overall Study|Protocol Violation|0|||
164274825|NCT03245008|593374566|FG000|Overall Study|Withdrawal by Subject|20|||
164274826|NCT03245008|593374567|FG001|Overall Study|Withdrawal by Subject|19|||
164274827|NCT03245008|593374568|FG002|Overall Study|Withdrawal by Subject|11|||
164274828|NCT03245008|593374569|FG003|Overall Study|Withdrawal by Subject|0|||
163894200|NCT04565990|591985498|FG000|Overall Study|Withdrawal by Subject|1|||
163894201|NCT05507333|591985499|FG000|Overall Study|Protocol Violation|1|||
163894202|NCT01960452|591985502|FG000|Overall Study|Withdrawal by Subject|2|||
163894203|NCT01960452|591985503|FG001|Overall Study|Withdrawal by Subject|1|||
164274829|NCT03245008|593374570|FG004|Overall Study|Withdrawal by Subject|0|||
164274830|NCT03245008|593374566|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
164274831|NCT03245008|593374567|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
164274832|NCT03245008|593374568|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
164274833|NCT03245008|593374569|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
164274834|NCT03245008|593374570|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
164274835|NCT03245008|593374566|FG000|Overall Study|Failure to meet randomization criteria|0|||
164274836|NCT03245008|593374567|FG001|Overall Study|Failure to meet randomization criteria|1|||
164274837|NCT03245008|593374568|FG002|Overall Study|Failure to meet randomization criteria|0|||
164274838|NCT03245008|593374569|FG003|Overall Study|Failure to meet randomization criteria|1|||
164274839|NCT03245008|593374570|FG004|Overall Study|Failure to meet randomization criteria|0|||
164274840|NCT01580670|593374571|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
164274841|NCT01580670|593374571|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
164274842|NCT03266172|593374575|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
164274843|NCT03266172|593374576|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
164274844|NCT03266172|593374577|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
164274845|NCT03266172|593374575|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
164274846|NCT03266172|593374576|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
164274847|NCT03266172|593374577|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
164274848|NCT03266172|593374575|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
164274849|NCT03266172|593374576|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
164274850|NCT03266172|593374577|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
164274851|NCT03266172|593374575|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
164274852|NCT03266172|593374576|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
164274853|NCT03266172|593374577|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
164274854|NCT03266172|593374575|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274855|NCT03266172|593374576|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274856|NCT03266172|593374577|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
164274857|NCT03266172|593374575|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274858|NCT03266172|593374576|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
164274859|NCT03266172|593374577|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
164274860|NCT00454584|593374578|FG000|Controlled Period|Adverse Event|5|||
164274861|NCT00454584|593374579|FG001|Controlled Period|Adverse Event|2|||
164274862|NCT00454584|593374580|FG002|Controlled Period|Adverse Event|1|||
164274863|NCT00454584|593374581|FG003|Controlled Period|Adverse Event|0|||
164274864|NCT00454584|593374582|FG004|Controlled Period|Adverse Event|0|||
164274865|NCT00454584|593374583|FG005|Controlled Period|Adverse Event|0|||
164274866|NCT00454584|593374578|FG000|Controlled Period|Lost to Follow-up|1|||
164274867|NCT00454584|593374579|FG001|Controlled Period|Lost to Follow-up|2|||
164274868|NCT00454584|593374580|FG002|Controlled Period|Lost to Follow-up|2|||
164274869|NCT00454584|593374581|FG003|Controlled Period|Lost to Follow-up|0|||
164274870|NCT00454584|593374582|FG004|Controlled Period|Lost to Follow-up|0|||
164274871|NCT00454584|593374583|FG005|Controlled Period|Lost to Follow-up|0|||
164274872|NCT00454584|593374578|FG000|Controlled Period|Other|5|||
164274873|NCT00454584|593374579|FG001|Controlled Period|Other|4|||
164274874|NCT00454584|593374580|FG002|Controlled Period|Other|2|||
164274875|NCT00454584|593374581|FG003|Controlled Period|Other|0|||
164274876|NCT00454584|593374582|FG004|Controlled Period|Other|0|||
164274877|NCT00454584|593374583|FG005|Controlled Period|Other|0|||
164274878|NCT00454584|593374578|FG000|After Controlled Period|Adverse Event|0|||
164274879|NCT00454584|593374579|FG001|After Controlled Period|Adverse Event|0|||
164274880|NCT00454584|593374580|FG002|After Controlled Period|Adverse Event|0|||
164274881|NCT00454584|593374581|FG003|After Controlled Period|Adverse Event|9|||
164274882|NCT00454584|593374582|FG004|After Controlled Period|Adverse Event|3|||
164274883|NCT00454584|593374583|FG005|After Controlled Period|Adverse Event|9|||
164274884|NCT00454584|593374578|FG000|After Controlled Period|Lack of Efficacy|0|||
164274885|NCT00454584|593374579|FG001|After Controlled Period|Lack of Efficacy|0|||
164274886|NCT00454584|593374580|FG002|After Controlled Period|Lack of Efficacy|0|||
164274887|NCT00454584|593374581|FG003|After Controlled Period|Lack of Efficacy|1|||
164274888|NCT00454584|593374582|FG004|After Controlled Period|Lack of Efficacy|0|||
164274889|NCT00454584|593374583|FG005|After Controlled Period|Lack of Efficacy|0|||
164274890|NCT00454584|593374578|FG000|After Controlled Period|Lost to Follow-up|0|||
164274891|NCT00454584|593374579|FG001|After Controlled Period|Lost to Follow-up|0|||
164274892|NCT00454584|593374580|FG002|After Controlled Period|Lost to Follow-up|0|||
164274893|NCT00454584|593374581|FG003|After Controlled Period|Lost to Follow-up|2|||
164274894|NCT00454584|593374582|FG004|After Controlled Period|Lost to Follow-up|4|||
164274895|NCT00454584|593374583|FG005|After Controlled Period|Lost to Follow-up|6|||
164274896|NCT00454584|593374578|FG000|After Controlled Period|Other|0|||
164274897|NCT00454584|593374579|FG001|After Controlled Period|Other|0|||
164274898|NCT00454584|593374580|FG002|After Controlled Period|Other|0|||
164274899|NCT00454584|593374581|FG003|After Controlled Period|Other|1|||
164274900|NCT00454584|593374582|FG004|After Controlled Period|Other|0|||
164274901|NCT00454584|593374583|FG005|After Controlled Period|Other|0|||
164274902|NCT00454584|593374578|FG000|After Controlled Period|Other|0|||
164274903|NCT00454584|593374579|FG001|After Controlled Period|Other|0|||
164274904|NCT00454584|593374580|FG002|After Controlled Period|Other|0|||
164274905|NCT00454584|593374581|FG003|After Controlled Period|Other|13|||
164274906|NCT00454584|593374582|FG004|After Controlled Period|Other|5|||
163894204|NCT01960452|591985502|FG000|Overall Study|Sleep apnea in Night 1|1|||
164274907|NCT00454584|593374583|FG005|After Controlled Period|Other|17|||
164274908|NCT02250664|593374584|FG000|Overall Study|Lost to Follow-up|18|||
164274909|NCT02250664|593374585|FG001|Overall Study|Lost to Follow-up|28|||
164274910|NCT02250664|593374586|FG002|Overall Study|Lost to Follow-up|33|||
164274911|NCT02250664|593374584|FG000|Overall Study|Personal Reasons|7|||
164274912|NCT02250664|593374585|FG001|Overall Study|Personal Reasons|8|||
164274913|NCT02250664|593374586|FG002|Overall Study|Personal Reasons|14|||
164274914|NCT02250664|593374584|FG000|Overall Study|Adverse Event|6|||
164274915|NCT02250664|593374585|FG001|Overall Study|Adverse Event|3|||
164274916|NCT02250664|593374586|FG002|Overall Study|Adverse Event|8|||
164274917|NCT02250664|593374584|FG000|Overall Study|Incarcerated|2|||
164274918|NCT02250664|593374585|FG001|Overall Study|Incarcerated|1|||
164274919|NCT02250664|593374586|FG002|Overall Study|Incarcerated|2|||
164274920|NCT02250664|593374584|FG000|Overall Study|Withdrawal by Subject|0|||
164274921|NCT02250664|593374585|FG001|Overall Study|Withdrawal by Subject|1|||
164274922|NCT02250664|593374586|FG002|Overall Study|Withdrawal by Subject|2|||
164274923|NCT02250664|593374584|FG000|Overall Study|Death|0|||
164274924|NCT02250664|593374585|FG001|Overall Study|Death|1|||
164274925|NCT02250664|593374586|FG002|Overall Study|Death|1|||
164274926|NCT02250664|593374584|FG000|Overall Study|Physician Decision|1|||
164274927|NCT02250664|593374585|FG001|Overall Study|Physician Decision|3|||
164274928|NCT02250664|593374586|FG002|Overall Study|Physician Decision|1|||
164274929|NCT02250664|593374584|FG000|Overall Study|Protocol Violation|1|||
164274930|NCT02250664|593374585|FG001|Overall Study|Protocol Violation|0|||
164274931|NCT02250664|593374586|FG002|Overall Study|Protocol Violation|1|||
164274932|NCT02250664|593374584|FG000|Overall Study|Reason unknown|1|||
164274933|NCT02250664|593374585|FG001|Overall Study|Reason unknown|0|||
164274934|NCT02250664|593374586|FG002|Overall Study|Reason unknown|0|||
164274935|NCT01753401|593374588|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
164274936|NCT01753401|593374589|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
164274937|NCT01753401|593374590|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
163894205|NCT01960452|591985503|FG001|Overall Study|Sleep apnea in Night 1|0|||
163894206|NCT01960452|591985502|FG000|Overall Study|Poor Sleep in Night 1|0|||
163894207|NCT01960452|591985503|FG001|Overall Study|Poor Sleep in Night 1|2|||
163894208|NCT01960452|591985502|FG000|Overall Study|No Sex/Age Match Night 1|1|||
163894209|NCT01960452|591985503|FG001|Overall Study|No Sex/Age Match Night 1|0|||
163894210|NCT01960452|591985502|FG000|Overall Study|No Sex/Age Match Night 2|0|||
164274938|NCT01753401|593374591|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
164274939|NCT01753401|593374588|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
164274940|NCT01753401|593374589|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
164274941|NCT01753401|593374590|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
164274942|NCT01753401|593374591|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
163894211|NCT01960452|591985503|FG001|Overall Study|No Sex/Age Match Night 2|2|||
163894212|NCT01960452|591985502|FG000|Overall Study|Technical Difficulties Night 2|2|||
163894213|NCT01960452|591985503|FG001|Overall Study|Technical Difficulties Night 2|0|||
163894214|NCT03981926|591985504|FG000|Overall Study|Lost to Follow-up|5|||
163894215|NCT03981926|591985505|FG001|Overall Study|Lost to Follow-up|9|||
164000941|NCT02688647|592366766|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
164000942|NCT02542267|592366767|FG000|Overall Study|Withdrawal by Subject|10|||
164000943|NCT02542267|592366767|FG000|Overall Study|Physician Decision|6|||
164274943|NCT01753401|593374588|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
164274944|NCT01753401|593374589|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
164274945|NCT01753401|593374590|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
164274946|NCT01753401|593374591|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
164274947|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
164000944|NCT02542267|592366767|FG000|Overall Study|Lost to Follow-up|4|||
164000945|NCT02542267|592366767|FG000|Overall Study|Death|13|||
164000946|NCT02542267|592366767|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
164274948|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
164274949|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
164274950|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
163894216|NCT02446236|591985506|FG000|Overall Study|Screen Failure|1|||
163894217|NCT02446236|591985507|FG001|Overall Study|Screen Failure|0|||
163894218|NCT02446236|591985508|FG002|Overall Study|Screen Failure|1|||
163894219|NCT02446236|591985506|FG000|Overall Study|Actively Receiving Therapy|0|||
163894220|NCT02446236|591985507|FG001|Overall Study|Actively Receiving Therapy|0|||
163894221|NCT02446236|591985508|FG002|Overall Study|Actively Receiving Therapy|1|||
164274951|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
164274952|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
164274953|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
164274954|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
164274955|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
164342794|NCT02609828|593631543|FG002|Overall Study|Lost to Follow-up|0|||
163894222|NCT03677141|591985509|FG000|Overall Study|Death|2|||
163894223|NCT03677141|591985510|FG001|Overall Study|Death|1|||
163894224|NCT03677141|591985511|FG002|Overall Study|Death|6|||
163894225|NCT03677141|591985512|FG003|Overall Study|Death|9|||
163894226|NCT03677141|591985513|FG004|Overall Study|Death|5|||
163894227|NCT03677141|591985514|FG005|Overall Study|Death|3|||
163894228|NCT03677141|591985509|FG000|Overall Study|Lost to Follow-up|0|||
163894229|NCT03677141|591985510|FG001|Overall Study|Lost to Follow-up|0|||
163894230|NCT03677141|591985511|FG002|Overall Study|Lost to Follow-up|0|||
163894231|NCT03677141|591985512|FG003|Overall Study|Lost to Follow-up|2|||
163894232|NCT03677141|591985513|FG004|Overall Study|Lost to Follow-up|0|||
163894233|NCT03677141|591985514|FG005|Overall Study|Lost to Follow-up|0|||
163894234|NCT03677141|591985509|FG000|Overall Study|Screen failure or enrolled in error|0|||
163894235|NCT03677141|591985510|FG001|Overall Study|Screen failure or enrolled in error|0|||
163894236|NCT03677141|591985511|FG002|Overall Study|Screen failure or enrolled in error|0|||
163894237|NCT03677141|591985512|FG003|Overall Study|Screen failure or enrolled in error|0|||
163894238|NCT03677141|591985513|FG004|Overall Study|Screen failure or enrolled in error|2|||
163894239|NCT03677141|591985514|FG005|Overall Study|Screen failure or enrolled in error|0|||
163894240|NCT03677141|591985509|FG000|Overall Study|Physician Decision|0|||
163894241|NCT03677141|591985510|FG001|Overall Study|Physician Decision|0|||
163894242|NCT03677141|591985511|FG002|Overall Study|Physician Decision|0|||
163894243|NCT03677141|591985512|FG003|Overall Study|Physician Decision|0|||
163894244|NCT03677141|591985513|FG004|Overall Study|Physician Decision|1|||
163894245|NCT03677141|591985514|FG005|Overall Study|Physician Decision|0|||
163894246|NCT03677141|591985509|FG000|Overall Study|Withdrawal by Subject|0|||
163894247|NCT03677141|591985510|FG001|Overall Study|Withdrawal by Subject|0|||
163894248|NCT03677141|591985511|FG002|Overall Study|Withdrawal by Subject|1|||
163894249|NCT03677141|591985512|FG003|Overall Study|Withdrawal by Subject|1|||
163894250|NCT03677141|591985513|FG004|Overall Study|Withdrawal by Subject|1|||
163894251|NCT03677141|591985514|FG005|Overall Study|Withdrawal by Subject|0|||
163894252|NCT04820322|591985528|FG000|Overall Study|Adverse Event|1|||
163894253|NCT04820322|591985529|FG001|Overall Study|Adverse Event|0|||
163894254|NCT03156465|591985535|FG000|Overall Study|Withdrawal by Subject|2|||
163894255|NCT05524116|591985543|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
163894256|NCT05524116|591985544|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
163894257|NCT05524116|591985543|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
163894258|NCT05524116|591985544|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
163894259|NCT05524116|591985543|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
163894260|NCT05524116|591985544|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
163894261|NCT05524116|591985543|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
163894262|NCT05524116|591985544|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
163894263|NCT05524116|591985543|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
163894264|NCT05524116|591985544|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
163894265|NCT03181516|591985546|FG000|Overall Study|Withdrawal by Subject|14|||
163894266|NCT03181516|591985547|FG001|Overall Study|Withdrawal by Subject|7|||
163894267|NCT03181516|591985546|FG000|Overall Study|Lost to Follow-up|2|||
163894268|NCT03181516|591985547|FG001|Overall Study|Lost to Follow-up|2|||
163894269|NCT04544007|591985550|FG000|Overall Study|Withdrawal by Subject|1|||
163894270|NCT04544007|591985550|FG000|Overall Study|Confirmed Progressive Disease|1|||
163894271|NCT02839265|591985558|FG000|Overall Study|Screen Failure|2|||
163894272|NCT02839265|591985558|FG000|Overall Study|Death|1|||
163894273|NCT02839265|591985558|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
163894274|NCT02323880|591985559|FG000|Overall Study|Adverse Event|2|||
163894275|NCT02323880|591985560|FG001|Overall Study|Adverse Event|0|||
163894276|NCT02323880|591985561|FG002|Overall Study|Adverse Event|1|||
163894277|NCT02323880|591985562|FG003|Overall Study|Adverse Event|1|||
163894278|NCT02323880|591985563|FG004|Overall Study|Adverse Event|1|||
163894279|NCT02323880|591985564|FG005|Overall Study|Adverse Event|0|||
163894280|NCT02323880|591985565|FG006|Overall Study|Adverse Event|1|||
163894281|NCT02323880|591985566|FG007|Overall Study|Adverse Event|0|||
163894282|NCT02323880|591985559|FG000|Overall Study|Death|0|||
163894283|NCT02323880|591985560|FG001|Overall Study|Death|0|||
163894284|NCT02323880|591985561|FG002|Overall Study|Death|0|||
163894285|NCT02323880|591985562|FG003|Overall Study|Death|0|||
163894286|NCT02323880|591985563|FG004|Overall Study|Death|0|||
163894287|NCT02323880|591985564|FG005|Overall Study|Death|1|||
163894288|NCT02323880|591985565|FG006|Overall Study|Death|0|||
163894289|NCT02323880|591985566|FG007|Overall Study|Death|0|||
163894290|NCT02323880|591985559|FG000|Overall Study|Lack of Efficacy|4|||
163894291|NCT02323880|591985560|FG001|Overall Study|Lack of Efficacy|11|||
163894292|NCT02323880|591985561|FG002|Overall Study|Lack of Efficacy|5|||
163894293|NCT02323880|591985562|FG003|Overall Study|Lack of Efficacy|5|||
163894294|NCT02323880|591985563|FG004|Overall Study|Lack of Efficacy|4|||
163894295|NCT02323880|591985564|FG005|Overall Study|Lack of Efficacy|8|||
163894296|NCT02323880|591985565|FG006|Overall Study|Lack of Efficacy|4|||
163894297|NCT02323880|591985566|FG007|Overall Study|Lack of Efficacy|6|||
163894298|NCT02323880|591985559|FG000|Overall Study|Physician Decision|0|||
163894299|NCT02323880|591985560|FG001|Overall Study|Physician Decision|0|||
163894300|NCT02323880|591985561|FG002|Overall Study|Physician Decision|0|||
163894301|NCT02323880|591985562|FG003|Overall Study|Physician Decision|0|||
164274956|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
164274957|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
164274958|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
164274959|NCT01753401|593374588|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
164274960|NCT01753401|593374589|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
164274961|NCT01753401|593374590|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
164274962|NCT01753401|593374591|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
164274963|NCT00295932|593374594|FG000|Overall Study|Not Treated|0|||
164274964|NCT00295932|593374595|FG001|Overall Study|Not Treated|0|||
164274965|NCT00295932|593374596|FG002|Overall Study|Not Treated|0|||
164342795|NCT02609828|593631544|FG003|Overall Study|Lost to Follow-up|1|||
164342796|NCT02609828|593631541|FG000|Overall Study|Protocol Violation|2|||
164342797|NCT02609828|593631542|FG001|Overall Study|Protocol Violation|0|||
164342798|NCT02609828|593631543|FG002|Overall Study|Protocol Violation|0|||
164342799|NCT02609828|593631544|FG003|Overall Study|Protocol Violation|1|||
164342800|NCT02609828|593631541|FG000|Overall Study|Withdrawal by Subject|12|||
164342801|NCT02609828|593631542|FG001|Overall Study|Withdrawal by Subject|1|||
164342802|NCT02609828|593631543|FG002|Overall Study|Withdrawal by Subject|0|||
164342803|NCT02609828|593631544|FG003|Overall Study|Withdrawal by Subject|10|||
164342804|NCT02609828|593631541|FG000|Overall Study|Other|3|||
164342805|NCT02609828|593631542|FG001|Overall Study|Other|0|||
164342806|NCT02609828|593631543|FG002|Overall Study|Other|0|||
164342807|NCT02609828|593631544|FG003|Overall Study|Other|6|||
164342808|NCT02609828|593631541|FG000|Overall Study|Randomized but not treated|1|||
164342809|NCT02609828|593631542|FG001|Overall Study|Randomized but not treated|0|||
164342810|NCT02609828|593631543|FG002|Overall Study|Randomized but not treated|0|||
164342811|NCT02609828|593631544|FG003|Overall Study|Randomized but not treated|0|||
164342812|NCT01786668|593631547|FG000|Overall Study|Adverse Event|0|||
164342813|NCT01786668|593631548|FG001|Overall Study|Adverse Event|1|||
164342814|NCT01786668|593631549|FG002|Overall Study|Adverse Event|1|||
164342815|NCT01786668|593631550|FG003|Overall Study|Adverse Event|2|||
164342816|NCT01786668|593631547|FG000|Overall Study|Withdrawal by Subject|0|||
164342817|NCT01786668|593631548|FG001|Overall Study|Withdrawal by Subject|0|||
164342818|NCT01786668|593631549|FG002|Overall Study|Withdrawal by Subject|3|||
164342819|NCT01786668|593631550|FG003|Overall Study|Withdrawal by Subject|1|||
164342820|NCT01786668|593631547|FG000|Overall Study|Pregnancy|0|||
164342821|NCT01786668|593631548|FG001|Overall Study|Pregnancy|0|||
164342822|NCT01786668|593631549|FG002|Overall Study|Pregnancy|0|||
164342823|NCT01786668|593631550|FG003|Overall Study|Pregnancy|1|||
164342824|NCT01786668|593631547|FG000|Overall Study|Lost to Follow-up|1|||
164342825|NCT01786668|593631548|FG001|Overall Study|Lost to Follow-up|0|||
164342826|NCT01786668|593631549|FG002|Overall Study|Lost to Follow-up|1|||
164342827|NCT01786668|593631550|FG003|Overall Study|Lost to Follow-up|0|||
164342828|NCT03068455|593631555|FG000|Pre-treatment Period|Disease progression|0|||
164342829|NCT03068455|593631556|FG001|Pre-treatment Period|Disease progression|1|||
164342830|NCT03068455|593631555|FG000|Pre-treatment Period|Participant withdrew consent|1|||
164342831|NCT03068455|593631556|FG001|Pre-treatment Period|Participant withdrew consent|1|||
164342832|NCT03068455|593631555|FG000|Pre-treatment Period|Poor/non-compliance|0|||
164342833|NCT03068455|593631556|FG001|Pre-treatment Period|Poor/non-compliance|1|||
164342834|NCT03068455|593631555|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
164342835|NCT03068455|593631556|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
164342836|NCT03068455|593631555|FG000|Pre-treatment Period|Not reported|2|||
164342837|NCT03068455|593631556|FG001|Pre-treatment Period|Not reported|1|||
164342838|NCT03068455|593631555|FG000|Treatment Period|Disease progression|166|||
164342839|NCT03068455|593631556|FG001|Treatment Period|Disease progression|208|||
164342840|NCT03068455|593631555|FG000|Treatment Period|Study drug toxicity|317|||
164342841|NCT03068455|593631556|FG001|Treatment Period|Study drug toxicity|104|||
163894302|NCT02323880|591985563|FG004|Overall Study|Physician Decision|1|||
163894303|NCT02323880|591985564|FG005|Overall Study|Physician Decision|1|||
163894304|NCT02323880|591985565|FG006|Overall Study|Physician Decision|1|||
164274966|NCT00295932|593374597|FG003|Overall Study|Not Treated|0|||
164274967|NCT00295932|593374598|FG004|Overall Study|Not Treated|0|||
164274968|NCT00295932|593374599|FG005|Overall Study|Not Treated|0|||
164274969|NCT00295932|593374600|FG006|Overall Study|Not Treated|0|||
164274970|NCT00295932|593374601|FG007|Overall Study|Not Treated|0|||
164274971|NCT00295932|593374602|FG008|Overall Study|Not Treated|0|||
164342842|NCT03068455|593631555|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
164342843|NCT03068455|593631556|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
164342844|NCT03068455|593631555|FG000|Treatment Period|Participant request to stop therapy|33|||
164342845|NCT03068455|593631556|FG001|Treatment Period|Participant request to stop therapy|20|||
164342846|NCT03068455|593631555|FG000|Treatment Period|Participant withdrew consent|5|||
164342847|NCT03068455|593631556|FG001|Treatment Period|Participant withdrew consent|10|||
164342848|NCT03068455|593631555|FG000|Treatment Period|Poor/non-compliance|3|||
164342849|NCT03068455|593631556|FG001|Treatment Period|Poor/non-compliance|0|||
164342850|NCT03068455|593631555|FG000|Treatment Period|Participant no longer meets study criteria|1|||
164274972|NCT00295932|593374603|FG009|Overall Study|Not Treated|0|||
164274973|NCT00295932|593374604|FG010|Overall Study|Not Treated|1|||
164274974|NCT02409719|593374610|FG000|Overall Study|Lost to Follow-up|3|||
164274975|NCT02409719|593374611|FG001|Overall Study|Lost to Follow-up|3|||
164274976|NCT00565136|593374613|FG000|Overall Study|Lost to Follow-up|1|||
164274977|NCT00565136|593374613|FG000|Overall Study|Withdrawal by Subject|1|||
164274978|NCT00565136|593374613|FG000|Overall Study|Protocol Violation|1|||
164274979|NCT01026220|593374619|FG000|Induction|Death|1|||
164274980|NCT01026220|593374620|FG001|Induction|Death|0|||
164274981|NCT01026220|593374621|FG002|Induction|Death|0|||
164274982|NCT01026220|593374619|FG000|Induction|Lack of Efficacy|2|||
164274983|NCT01026220|593374620|FG001|Induction|Lack of Efficacy|0|||
164274984|NCT01026220|593374621|FG002|Induction|Lack of Efficacy|0|||
164274985|NCT01026220|593374619|FG000|Induction|Physician Decision|12|||
164274986|NCT01026220|593374620|FG001|Induction|Physician Decision|0|||
164342851|NCT03068455|593631556|FG001|Treatment Period|Participant no longer meets study criteria|3|||
164342852|NCT03068455|593631555|FG000|Treatment Period|Other reasons|12|||
164342853|NCT03068455|593631556|FG001|Treatment Period|Other reasons|4|||
164342854|NCT05379231|593631557|FG000|Home Visit|Withdrawal by Subject|2|||
164342855|NCT05379231|593631557|FG000|In-lab Visit|Withdrawal by Subject|2|||
164342856|NCT01496807|593631558|FG000|Overall Study|Progressive Disease|21|||
164342857|NCT01496807|593631558|FG000|Overall Study|Participant preference/toxicity|8|||
164342858|NCT01496807|593631558|FG000|Overall Study|Change in diagnosis|1|||
164342859|NCT03330288|593631564|FG000|Overall Study|Other reason|1|||
164342860|NCT03330288|593631565|FG001|Overall Study|Other reason|1|||
164342861|NCT03330288|593631564|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
164342862|NCT03330288|593631565|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
164342863|NCT03330288|593631564|FG000|Overall Study|Adverse Event|1|||
164342864|NCT03330288|593631565|FG001|Overall Study|Adverse Event|0|||
164342865|NCT03330288|593631564|FG000|Overall Study|Withdrawal by Subject|1|||
164342866|NCT03330288|593631565|FG001|Overall Study|Withdrawal by Subject|0|||
164342867|NCT03330288|593631564|FG000|Overall Study|Lost to Follow-up|26|||
164342868|NCT03330288|593631565|FG001|Overall Study|Lost to Follow-up|7|||
164342869|NCT02805972|593631570|FG000|Washout Period|Lost to Follow-up|3|||
164342870|NCT02805972|593631571|FG001|Washout Period|Lost to Follow-up|0|||
164342871|NCT00939640|593631573|FG000|Overall Study|Physician Decision|1|||
164342872|NCT00389597|593631580|FG000|Overall Study|Lost to Follow-up|8|||
164342873|NCT00389597|593631581|FG001|Overall Study|Lost to Follow-up|6|||
164342874|NCT00389597|593631582|FG002|Overall Study|Lost to Follow-up|4|||
164342875|NCT00389597|593631583|FG003|Overall Study|Lost to Follow-up|6|||
164342876|NCT00334958|593631584|FG000|Overall Study|Medication Noncompliance|0|||
164342877|NCT00334958|593631585|FG001|Overall Study|Medication Noncompliance|3|||
164342878|NCT00334958|593631584|FG000|Overall Study|Protocol Violation|2|||
164342879|NCT00334958|593631585|FG001|Overall Study|Protocol Violation|2|||
164342880|NCT00334958|593631584|FG000|Overall Study|Request of the investigator or sponsor|0|||
164342881|NCT00334958|593631585|FG001|Overall Study|Request of the investigator or sponsor|1|||
164342882|NCT00334958|593631584|FG000|Overall Study|Withdrawal by Subject|7|||
164342883|NCT00334958|593631585|FG001|Overall Study|Withdrawal by Subject|4|||
164342884|NCT00334958|593631584|FG000|Overall Study|Adverse Event|27|||
164342885|NCT00334958|593631585|FG001|Overall Study|Adverse Event|12|||
164342886|NCT00334958|593631584|FG000|Overall Study|Other|1|||
163894305|NCT02323880|591985566|FG007|Overall Study|Physician Decision|0|||
164274987|NCT01026220|593374621|FG002|Induction|Physician Decision|0|||
164274988|NCT01026220|593374619|FG000|Induction|Withdrawal by Subject|9|||
164274989|NCT01026220|593374620|FG001|Induction|Withdrawal by Subject|0|||
164274990|NCT01026220|593374621|FG002|Induction|Withdrawal by Subject|0|||
164274991|NCT01026220|593374619|FG000|Induction|Ineligible|1|||
164274992|NCT01026220|593374620|FG001|Induction|Ineligible|0|||
164274993|NCT01026220|593374621|FG002|Induction|Ineligible|0|||
164274994|NCT01026220|593374619|FG000|Consolidation Maintenance|Death|0|||
164342887|NCT00334958|593631585|FG001|Overall Study|Other|2|||
164342888|NCT00306189|593631586|FG000|Overall Study|Physician Decision|0|||
163894306|NCT02323880|591985559|FG000|Overall Study|Withdrawal by Subject|0|||
163894307|NCT02323880|591985560|FG001|Overall Study|Withdrawal by Subject|2|||
163894308|NCT02323880|591985561|FG002|Overall Study|Withdrawal by Subject|0|||
163894309|NCT02323880|591985562|FG003|Overall Study|Withdrawal by Subject|0|||
163894310|NCT02323880|591985563|FG004|Overall Study|Withdrawal by Subject|0|||
163894311|NCT02323880|591985564|FG005|Overall Study|Withdrawal by Subject|0|||
163894312|NCT02323880|591985565|FG006|Overall Study|Withdrawal by Subject|0|||
164274995|NCT01026220|593374620|FG001|Consolidation Maintenance|Death|1|||
164274996|NCT01026220|593374621|FG002|Consolidation Maintenance|Death|0|||
164342889|NCT00306189|593631587|FG001|Overall Study|Physician Decision|0|||
164342890|NCT00306189|593631588|FG002|Overall Study|Physician Decision|0|||
164342891|NCT00306189|593631589|FG003|Overall Study|Physician Decision|1|||
164342892|NCT00306189|593631586|FG000|Overall Study|Adverse Event|3|||
164342893|NCT00306189|593631587|FG001|Overall Study|Adverse Event|3|||
164342894|NCT00306189|593631588|FG002|Overall Study|Adverse Event|2|||
164342895|NCT00306189|593631589|FG003|Overall Study|Adverse Event|2|||
164342896|NCT00306189|593631586|FG000|Overall Study|Withdrawal by Subject|4|||
164274997|NCT01026220|593374619|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
164274998|NCT01026220|593374620|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
164274999|NCT01026220|593374621|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
164275000|NCT01026220|593374619|FG000|Consolidation Maintenance|Physician Decision|0|||
164275001|NCT01026220|593374620|FG001|Consolidation Maintenance|Physician Decision|2|||
164275002|NCT01026220|593374621|FG002|Consolidation Maintenance|Physician Decision|7|||
164275003|NCT01026220|593374619|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
164275004|NCT01026220|593374620|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
164275005|NCT01026220|593374621|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
164275006|NCT00778895|593374622|FG000|Active Phase|Adverse Event|3|||
164275007|NCT00778895|593374623|FG001|Active Phase|Adverse Event|1|||
164275008|NCT00778895|593374624|FG002|Active Phase|Adverse Event|0|||
164275009|NCT00778895|593374622|FG000|Active Phase|Withdrawal by Subject|1|||
164275010|NCT00778895|593374623|FG001|Active Phase|Withdrawal by Subject|4|||
164275011|NCT00778895|593374624|FG002|Active Phase|Withdrawal by Subject|0|||
164275012|NCT00778895|593374622|FG000|Active Phase|Lost to Follow-up|1|||
164275013|NCT00778895|593374623|FG001|Active Phase|Lost to Follow-up|1|||
164275014|NCT00778895|593374624|FG002|Active Phase|Lost to Follow-up|0|||
164275015|NCT00778895|593374622|FG000|Active Phase|Other|2|||
164275016|NCT00778895|593374623|FG001|Active Phase|Other|0|||
164275017|NCT00778895|593374624|FG002|Active Phase|Other|0|||
164275018|NCT00778895|593374622|FG000|ESFU Phase|Adverse Event|2|||
164275019|NCT00778895|593374623|FG001|ESFU Phase|Adverse Event|1|||
164275020|NCT00778895|593374624|FG002|ESFU Phase|Adverse Event|0|||
164275021|NCT00778895|593374622|FG000|ESFU Phase|Withdrawal by Subject|1|||
164275022|NCT00778895|593374623|FG001|ESFU Phase|Withdrawal by Subject|4|||
164275023|NCT00778895|593374624|FG002|ESFU Phase|Withdrawal by Subject|0|||
164275024|NCT00778895|593374622|FG000|ESFU Phase|Lost to Follow-up|6|||
164275025|NCT00778895|593374623|FG001|ESFU Phase|Lost to Follow-up|7|||
164275026|NCT00778895|593374624|FG002|ESFU Phase|Lost to Follow-up|2|||
164275027|NCT00778895|593374622|FG000|ESFU Phase|Other|2|||
164275028|NCT00778895|593374623|FG001|ESFU Phase|Other|0|||
164275029|NCT00778895|593374624|FG002|ESFU Phase|Other|0|||
164275030|NCT03332160|593374625|FG000|Overall Study|Withdrawal by Subject|1|||
164275031|NCT03332160|593374626|FG001|Overall Study|Withdrawal by Subject|1|||
164275032|NCT03332160|593374625|FG000|Overall Study|Adverse Event|0|||
164275033|NCT03332160|593374626|FG001|Overall Study|Adverse Event|1|||
164275034|NCT03332160|593374625|FG000|Overall Study|Developed Exclusion Criteria|0|||
164275035|NCT03332160|593374626|FG001|Overall Study|Developed Exclusion Criteria|1|||
164275036|NCT03332160|593374625|FG000|Overall Study|Non-adherence to treatment|0|||
164275037|NCT03332160|593374626|FG001|Overall Study|Non-adherence to treatment|2|||
164275038|NCT01459913|593374628|FG000|Overall Study|Adverse Event|0|||
164275039|NCT01459913|593374629|FG001|Overall Study|Adverse Event|0|||
164275040|NCT01459913|593374630|FG002|Overall Study|Adverse Event|0|||
164275041|NCT01459913|593374631|FG003|Overall Study|Adverse Event|3|||
164275042|NCT01459913|593374628|FG000|Overall Study|Withdrawal by Subject|4|||
164275043|NCT01459913|593374629|FG001|Overall Study|Withdrawal by Subject|0|||
164275044|NCT01459913|593374630|FG002|Overall Study|Withdrawal by Subject|0|||
164275045|NCT01459913|593374631|FG003|Overall Study|Withdrawal by Subject|5|||
164275046|NCT01459913|593374628|FG000|Overall Study|Lost to Follow-up|7|||
164275047|NCT01459913|593374629|FG001|Overall Study|Lost to Follow-up|4|||
164275048|NCT01459913|593374630|FG002|Overall Study|Lost to Follow-up|1|||
164275049|NCT01459913|593374631|FG003|Overall Study|Lost to Follow-up|8|||
164275050|NCT01459913|593374628|FG000|Overall Study|Death|0|||
164275051|NCT01459913|593374629|FG001|Overall Study|Death|0|||
164275052|NCT01459913|593374630|FG002|Overall Study|Death|0|||
164275053|NCT01459913|593374631|FG003|Overall Study|Death|1|||
164275054|NCT01459913|593374628|FG000|Overall Study|Non- Compliance|0|||
164275055|NCT01459913|593374629|FG001|Overall Study|Non- Compliance|0|||
164275056|NCT01459913|593374630|FG002|Overall Study|Non- Compliance|0|||
164275057|NCT01459913|593374631|FG003|Overall Study|Non- Compliance|3|||
164275058|NCT01459913|593374628|FG000|Overall Study|Physician Decision|0|||
164275059|NCT01459913|593374629|FG001|Overall Study|Physician Decision|1|||
164275060|NCT01459913|593374630|FG002|Overall Study|Physician Decision|0|||
164000947|NCT02542267|592366767|FG000|Overall Study|Other|9|||
164000948|NCT03093402|592366768|FG000|Overall Study|Lost to Follow-up|1|||
164275061|NCT01459913|593374631|FG003|Overall Study|Physician Decision|0|||
164275062|NCT01459913|593374628|FG000|Overall Study|Study Terminated by Sponsor|30|||
164275063|NCT01459913|593374629|FG001|Overall Study|Study Terminated by Sponsor|15|||
164275064|NCT01459913|593374630|FG002|Overall Study|Study Terminated by Sponsor|9|||
164275065|NCT01459913|593374631|FG003|Overall Study|Study Terminated by Sponsor|11|||
164275066|NCT01459913|593374628|FG000|Overall Study|Other|0|||
164275067|NCT01459913|593374629|FG001|Overall Study|Other|0|||
164275068|NCT01459913|593374630|FG002|Overall Study|Other|3|||
164275069|NCT01459913|593374631|FG003|Overall Study|Other|1|||
164000949|NCT03093402|592366769|FG001|Overall Study|Lost to Follow-up|0|||
164275070|NCT01459913|593374628|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
164275071|NCT01459913|593374629|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
164275072|NCT01459913|593374630|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
164275073|NCT01459913|593374631|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
164000950|NCT03093402|592366770|FG002|Overall Study|Lost to Follow-up|0|||
164000951|NCT03093402|592366771|FG003|Overall Study|Lost to Follow-up|0|||
164275074|NCT05096312|593374634|FG000|Overall Study|Lost to Follow-up|2|||
164275075|NCT05096312|593374635|FG001|Overall Study|Lost to Follow-up|4|||
164275076|NCT05096312|593374634|FG000|Overall Study|Adverse Event|1|||
164275077|NCT05096312|593374635|FG001|Overall Study|Adverse Event|0|||
164275078|NCT03135210|593374636|FG000|Overall Study|Death|0|||
164275079|NCT03135210|593374637|FG001|Overall Study|Death|1|||
164275080|NCT03517566|593374638|FG000|Overall Study|Adverse Event|5|||
164275081|NCT03517566|593374639|FG001|Overall Study|Adverse Event|2|||
164275082|NCT03517566|593374640|FG002|Overall Study|Adverse Event|2|||
164275083|NCT03517566|593374641|FG003|Overall Study|Adverse Event|8|||
164275084|NCT03517566|593374642|FG004|Overall Study|Adverse Event|7|||
164000952|NCT03093402|592366768|FG000|Overall Study|Withdrawal by Subject|3|||
164000953|NCT03093402|592366769|FG001|Overall Study|Withdrawal by Subject|3|||
164275085|NCT03517566|593374638|FG000|Overall Study|Lack of Efficacy|3|||
164275086|NCT03517566|593374639|FG001|Overall Study|Lack of Efficacy|2|||
164275087|NCT03517566|593374640|FG002|Overall Study|Lack of Efficacy|1|||
164275088|NCT03517566|593374641|FG003|Overall Study|Lack of Efficacy|1|||
164000954|NCT03093402|592366770|FG002|Overall Study|Withdrawal by Subject|0|||
164000955|NCT03093402|592366771|FG003|Overall Study|Withdrawal by Subject|1|||
164000956|NCT03093402|592366768|FG000|Overall Study|Withdrew prior to dosing|2|||
164000957|NCT03093402|592366769|FG001|Overall Study|Withdrew prior to dosing|1|||
164000958|NCT03093402|592366770|FG002|Overall Study|Withdrew prior to dosing|2|||
164000959|NCT03093402|592366771|FG003|Overall Study|Withdrew prior to dosing|3|||
164000960|NCT03093402|592366768|FG000|Overall Study|Ineligible for study|1|||
164000961|NCT03093402|592366769|FG001|Overall Study|Ineligible for study|0|||
164000962|NCT03093402|592366770|FG002|Overall Study|Ineligible for study|0|||
164000963|NCT03093402|592366771|FG003|Overall Study|Ineligible for study|0|||
164000964|NCT03093402|592366768|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
164000965|NCT03093402|592366769|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
164000966|NCT03093402|592366770|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
164000967|NCT03093402|592366771|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
164000968|NCT01147497|592366776|FG000|Overall Study|failed insertion|2|||
164000969|NCT01147497|592366777|FG001|Overall Study|failed insertion|0|||
164000970|NCT02197377|592366778|FG000|Overall Study|Insertion Failure|0|||
164000971|NCT02197377|592366779|FG001|Overall Study|Insertion Failure|3|||
164275089|NCT03517566|593374642|FG004|Overall Study|Lack of Efficacy|4|||
164275090|NCT03517566|593374638|FG000|Overall Study|Lost to Follow-up|3|||
164275091|NCT03517566|593374639|FG001|Overall Study|Lost to Follow-up|1|||
164275092|NCT03517566|593374640|FG002|Overall Study|Lost to Follow-up|1|||
164275093|NCT03517566|593374641|FG003|Overall Study|Lost to Follow-up|1|||
164275094|NCT03517566|593374642|FG004|Overall Study|Lost to Follow-up|0|||
164275095|NCT03517566|593374638|FG000|Overall Study|Physician Decision|1|||
164275096|NCT03517566|593374639|FG001|Overall Study|Physician Decision|1|||
164275097|NCT03517566|593374640|FG002|Overall Study|Physician Decision|0|||
164275098|NCT03517566|593374641|FG003|Overall Study|Physician Decision|1|||
164275099|NCT03517566|593374642|FG004|Overall Study|Physician Decision|0|||
164275100|NCT03517566|593374638|FG000|Overall Study|Pregnancy|0|||
164275101|NCT03517566|593374639|FG001|Overall Study|Pregnancy|1|||
164275102|NCT03517566|593374640|FG002|Overall Study|Pregnancy|0|||
164275103|NCT03517566|593374641|FG003|Overall Study|Pregnancy|0|||
164275104|NCT03517566|593374642|FG004|Overall Study|Pregnancy|0|||
164275105|NCT03517566|593374638|FG000|Overall Study|Protocol Deviation|0|||
164275106|NCT03517566|593374639|FG001|Overall Study|Protocol Deviation|1|||
164275107|NCT03517566|593374640|FG002|Overall Study|Protocol Deviation|0|||
164275108|NCT03517566|593374641|FG003|Overall Study|Protocol Deviation|1|||
164275109|NCT03517566|593374642|FG004|Overall Study|Protocol Deviation|1|||
164275110|NCT03517566|593374638|FG000|Overall Study|Study terminated by Sponsor|11|||
164275111|NCT03517566|593374639|FG001|Overall Study|Study terminated by Sponsor|5|||
164275112|NCT03517566|593374640|FG002|Overall Study|Study terminated by Sponsor|6|||
164275113|NCT03517566|593374641|FG003|Overall Study|Study terminated by Sponsor|14|||
164275114|NCT03517566|593374642|FG004|Overall Study|Study terminated by Sponsor|12|||
164275115|NCT03517566|593374638|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
164275116|NCT03517566|593374639|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
164275117|NCT03517566|593374640|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
164275118|NCT03517566|593374641|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
164275119|NCT03517566|593374642|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
164275120|NCT00671437|593374643|FG000|Overall Study|Progressive disease before C1 week 8|8|||
164275121|NCT00671437|593374643|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
164275122|NCT00671437|593374643|FG000|Overall Study|Adverse Event|3|||
164275123|NCT00671437|593374643|FG000|Overall Study|Ineligible post-hoc|1|||
164275124|NCT04349033|593374644|FG000|Overall Study|Lost to Follow-up|3|||
164275125|NCT04349033|593374645|FG001|Overall Study|Lost to Follow-up|1|||
164000972|NCT01974323|592366780|FG000|Overall Study|Other Reasons|25|||
164000973|NCT01974323|592366781|FG001|Overall Study|Other Reasons|28|||
164000974|NCT01974323|592366780|FG000|Overall Study|Protocol Violation|2|||
164275126|NCT04349033|593374646|FG002|Overall Study|Lost to Follow-up|1|||
164000975|NCT01974323|592366781|FG001|Overall Study|Protocol Violation|2|||
164275127|NCT01704456|593374650|FG000|Overall Study|Lost to Follow-up|8|||
164275128|NCT01704456|593374651|FG001|Overall Study|Lost to Follow-up|14|||
164275129|NCT00915551|593374657|FG000|Overall Study|Withdrawal by Subject|0|||
164275130|NCT00915551|593374658|FG001|Overall Study|Withdrawal by Subject|1|||
164275131|NCT04390841|593374659|FG000|Overall Study|Withdrawal by Subject|2|||
164275132|NCT02540291|593374660|FG000|Overall Study|Death|7|||
163894313|NCT02323880|591985566|FG007|Overall Study|Withdrawal by Subject|0|||
163894314|NCT00844415|591985571|FG000|Overall Study|Withdrawal by Subject|1|||
163894315|NCT03174275|591985572|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
164275133|NCT02540291|593374661|FG001|Overall Study|Death|7|||
164275134|NCT02540291|593374662|FG002|Overall Study|Death|5|||
164275135|NCT02540291|593374663|FG003|Overall Study|Death|7|||
164275136|NCT02540291|593374660|FG000|Overall Study|Lost to Follow-up|0|||
164275137|NCT02540291|593374661|FG001|Overall Study|Lost to Follow-up|0|||
164275138|NCT02540291|593374662|FG002|Overall Study|Lost to Follow-up|1|||
164275139|NCT02540291|593374663|FG003|Overall Study|Lost to Follow-up|0|||
164275140|NCT02540291|593374660|FG000|Overall Study|Withdrawal Of Consent|0|||
164275141|NCT02540291|593374661|FG001|Overall Study|Withdrawal Of Consent|1|||
164275142|NCT02540291|593374662|FG002|Overall Study|Withdrawal Of Consent|0|||
164275143|NCT02540291|593374663|FG003|Overall Study|Withdrawal Of Consent|0|||
164275144|NCT02540291|593374660|FG000|Overall Study|Study Terminated By Sponsor|1|||
164275145|NCT02540291|593374661|FG001|Overall Study|Study Terminated By Sponsor|0|||
164275146|NCT02540291|593374662|FG002|Overall Study|Study Terminated By Sponsor|0|||
164275147|NCT02540291|593374663|FG003|Overall Study|Study Terminated By Sponsor|0|||
164275148|NCT02540291|593374660|FG000|Overall Study|Other|0|||
164275149|NCT02540291|593374661|FG001|Overall Study|Other|0|||
164275150|NCT02540291|593374662|FG002|Overall Study|Other|1|||
164275151|NCT02540291|593374663|FG003|Overall Study|Other|0|||
164299924|NCT02234843|593472945|FG001|Overall Study|Non-compliance with study drug|0|||
164299925|NCT02234843|593472946|FG002|Overall Study|Non-compliance with study drug|0|||
164299926|NCT02234843|593472947|FG003|Overall Study|Non-compliance with study drug|0|||
164299927|NCT02234843|593472948|FG004|Overall Study|Non-compliance with study drug|0|||
164299928|NCT02234843|593472949|FG005|Overall Study|Non-compliance with study drug|1|||
164299929|NCT02234843|593472950|FG006|Overall Study|Non-compliance with study drug|1|||
164299930|NCT02234843|593472951|FG007|Overall Study|Non-compliance with study drug|0|||
164299931|NCT02234843|593472952|FG008|Overall Study|Non-compliance with study drug|0|||
164299932|NCT02234843|593472953|FG009|Overall Study|Non-compliance with study drug|0|||
164299933|NCT02234843|593472944|FG000|Overall Study|Lost to Follow-up|0|||
164299934|NCT02234843|593472945|FG001|Overall Study|Lost to Follow-up|1|||
164299935|NCT02234843|593472946|FG002|Overall Study|Lost to Follow-up|0|||
164299936|NCT02234843|593472947|FG003|Overall Study|Lost to Follow-up|0|||
164299937|NCT02234843|593472948|FG004|Overall Study|Lost to Follow-up|0|||
164299938|NCT02234843|593472949|FG005|Overall Study|Lost to Follow-up|0|||
164342897|NCT00306189|593631587|FG001|Overall Study|Withdrawal by Subject|2|||
164342898|NCT00306189|593631588|FG002|Overall Study|Withdrawal by Subject|8|||
164342899|NCT00306189|593631589|FG003|Overall Study|Withdrawal by Subject|1|||
164342900|NCT00306189|593631586|FG000|Overall Study|Ineligibility determined|1|||
164342901|NCT00306189|593631587|FG001|Overall Study|Ineligibility determined|1|||
164342902|NCT00306189|593631588|FG002|Overall Study|Ineligibility determined|1|||
164342903|NCT00306189|593631589|FG003|Overall Study|Ineligibility determined|1|||
163894316|NCT03174275|591985572|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
163894317|NCT03174275|591985572|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
163894318|NCT03174275|591985572|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
163894319|NCT03174275|591985572|FG000|Adjuvant Chemotherapy|Progression|1|||
163894320|NCT03174275|591985572|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
163894321|NCT03174275|591985572|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
163894322|NCT03174275|591985572|FG000|Adjuvant Durvalumab|Progression|1|||
163894323|NCT03174275|591985572|FG000|Adjuvant Durvalumab|Adverse Event|3|||
163894324|NCT03174275|591985572|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
163894325|NCT03174275|591985572|FG000|Adjuvant Radiotherapy|Progression|1|||
163894326|NCT03174275|591985572|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
163894327|NCT02413489|591985573|FG000|Overall Study|Death|11|||
163894328|NCT02413489|591985574|FG001|Overall Study|Death|3|||
163894329|NCT02413489|591985575|FG002|Overall Study|Death|4|||
163894330|NCT02413489|591985573|FG000|Overall Study|Withdrawal by Subject|2|||
163894331|NCT02413489|591985574|FG001|Overall Study|Withdrawal by Subject|0|||
163894332|NCT02413489|591985575|FG002|Overall Study|Withdrawal by Subject|0|||
163894333|NCT02413489|591985573|FG000|Overall Study|Study Terminated By Sponsor|2|||
163894334|NCT02413489|591985574|FG001|Overall Study|Study Terminated By Sponsor|13|||
163894335|NCT02413489|591985575|FG002|Overall Study|Study Terminated By Sponsor|1|||
164299939|NCT02234843|593472950|FG006|Overall Study|Lost to Follow-up|1|||
164299940|NCT02234843|593472951|FG007|Overall Study|Lost to Follow-up|0|||
164299941|NCT02234843|593472952|FG008|Overall Study|Lost to Follow-up|0|||
164299942|NCT02234843|593472953|FG009|Overall Study|Lost to Follow-up|0|||
164299943|NCT01652235|593472960|FG000|Overall Study|Death|9|||
164299944|NCT01652235|593472960|FG000|Overall Study|Lost to Follow-up|5|||
164000976|NCT01974323|592366780|FG000|Overall Study|Personal Reasons|15|||
164000977|NCT01974323|592366781|FG001|Overall Study|Personal Reasons|19|||
164000978|NCT01974323|592366780|FG000|Overall Study|Lost to Follow-up|45|||
164000979|NCT01974323|592366781|FG001|Overall Study|Lost to Follow-up|40|||
164000980|NCT01974323|592366780|FG000|Overall Study|Pregnancy|2|||
164000981|NCT01974323|592366781|FG001|Overall Study|Pregnancy|1|||
164000982|NCT01974323|592366780|FG000|Overall Study|Lack of Efficacy|1|||
164000983|NCT01974323|592366781|FG001|Overall Study|Lack of Efficacy|1|||
164000984|NCT01974323|592366780|FG000|Overall Study|Adverse Event|2|||
164000985|NCT01974323|592366781|FG001|Overall Study|Adverse Event|2|||
164000986|NCT00699192|592366782|FG000|Overall Study|Missing|1|||
164000987|NCT00699192|592366783|FG001|Overall Study|Missing|1|||
164000988|NCT00699192|592366784|FG002|Overall Study|Missing|1|||
164000989|NCT00699192|592366782|FG000|Overall Study|Adverse Event|9|||
164000990|NCT00699192|592366783|FG001|Overall Study|Adverse Event|4|||
164000991|NCT00699192|592366784|FG002|Overall Study|Adverse Event|3|||
164000992|NCT00699192|592366782|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164000993|NCT00699192|592366783|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164000994|NCT00699192|592366784|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164000995|NCT00699192|592366782|FG000|Overall Study|Lack of Efficacy|0|||
164000996|NCT00699192|592366783|FG001|Overall Study|Lack of Efficacy|0|||
164000997|NCT00699192|592366784|FG002|Overall Study|Lack of Efficacy|1|||
164000998|NCT00699192|592366782|FG000|Overall Study|Withdrawal by Subject|3|||
164000999|NCT00699192|592366783|FG001|Overall Study|Withdrawal by Subject|2|||
164001000|NCT00699192|592366784|FG002|Overall Study|Withdrawal by Subject|4|||
164001001|NCT00699192|592366782|FG000|Overall Study|Administrative problems|1|||
164001002|NCT00699192|592366783|FG001|Overall Study|Administrative problems|3|||
164001003|NCT00699192|592366784|FG002|Overall Study|Administrative problems|1|||
163894336|NCT05970861|591985576|FG000|Overall Study|Physician Decision|4|||
163894337|NCT05970861|591985577|FG001|Overall Study|Physician Decision|4|||
163894338|NCT05970861|591985576|FG000|Overall Study|Lost to Follow-up|4|||
163894339|NCT05970861|591985577|FG001|Overall Study|Lost to Follow-up|3|||
164001004|NCT00699192|592366782|FG000|Overall Study|Protocol Violation|2|||
164001005|NCT00699192|592366783|FG001|Overall Study|Protocol Violation|2|||
163894340|NCT04186819|591985578|FG000|Overall Study|Adverse Event|1|||
163894341|NCT04186819|591985578|FG000|Overall Study|Lost to Follow-up|1|||
163894342|NCT04186819|591985578|FG000|Overall Study|Opted for EBRT|1|||
163894343|NCT04186819|591985578|FG000|Overall Study|Opted SBRT|1|||
163894344|NCT04186819|591985578|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
163894345|NCT04186819|591985578|FG000|Overall Study|Physician Decision|1|||
163894346|NCT04186819|591985578|FG000|Overall Study|RP Delayed|1|||
163894347|NCT04186819|591985578|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
163894348|NCT04186819|591985578|FG000|Overall Study|Subject declined for financial reasons|1|||
163894349|NCT04186819|591985578|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
163894350|NCT04186819|591985578|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
163894351|NCT04186819|591985578|FG000|Overall Study|The subject opted for other treatment option|2|||
163894352|NCT04186819|591985578|FG000|Overall Study|The subject opted for other treatment options|1|||
163894353|NCT04186819|591985578|FG000|Overall Study|Withdrawal by Subject|3|||
163894354|NCT04186819|591985578|FG000|Overall Study|Reason not specified|1|||
163894355|NCT03252288|591985581|FG000|Overall Study|Death|1|||
163894356|NCT03252288|591985582|FG001|Overall Study|Death|0|||
163894357|NCT03252288|591985583|FG002|Overall Study|Death|0|||
163894358|NCT03252288|591985581|FG000|Overall Study|Death|11|||
163894359|NCT03252288|591985582|FG001|Overall Study|Death|0|||
163894360|NCT03252288|591985583|FG002|Overall Study|Death|0|||
163894361|NCT03252288|591985581|FG000|Overall Study|Withdrawal by Subject|2|||
163894362|NCT03252288|591985582|FG001|Overall Study|Withdrawal by Subject|0|||
163894363|NCT03252288|591985583|FG002|Overall Study|Withdrawal by Subject|0|||
163894364|NCT03252288|591985581|FG000|Overall Study|Lost to Follow-up|79|||
163894365|NCT03252288|591985582|FG001|Overall Study|Lost to Follow-up|0|||
164001006|NCT00699192|592366784|FG002|Overall Study|Protocol Violation|0|||
164001007|NCT01773473|592366785|FG000|Overall Study|Adverse Event|3|||
164001008|NCT01773473|592366786|FG001|Overall Study|Adverse Event|2|||
164001009|NCT01773473|592366785|FG000|Overall Study|Protocol Violation|0|||
164001010|NCT01773473|592366786|FG001|Overall Study|Protocol Violation|4|||
163894366|NCT03252288|591985583|FG002|Overall Study|Lost to Follow-up|0|||
163894367|NCT03252288|591985581|FG000|Overall Study|Loss of baseline data on tablets|6|||
163894368|NCT03252288|591985582|FG001|Overall Study|Loss of baseline data on tablets|0|||
163894369|NCT03252288|591985583|FG002|Overall Study|Loss of baseline data on tablets|0|||
164001011|NCT01773473|592366785|FG000|Overall Study|Physician Decision|3|||
164001012|NCT01773473|592366786|FG001|Overall Study|Physician Decision|5|||
164001013|NCT01773473|592366785|FG000|Overall Study|Sponsor Decision|2|||
164001014|NCT01773473|592366786|FG001|Overall Study|Sponsor Decision|0|||
164001015|NCT01773473|592366785|FG000|Overall Study|Lack of Efficacy|0|||
164001016|NCT01773473|592366786|FG001|Overall Study|Lack of Efficacy|1|||
164001017|NCT01773473|592366785|FG000|Overall Study|Non-Compliance with study drug|1|||
164001018|NCT01773473|592366786|FG001|Overall Study|Non-Compliance with study drug|4|||
164001019|NCT01773473|592366785|FG000|Overall Study|Withdrawal by Subject|5|||
163894370|NCT05900154|591985584|FG000|Follow-Up Period|Lost to Follow-up|1|||
163894371|NCT05900154|591985585|FG001|Follow-Up Period|Lost to Follow-up|2|||
163894372|NCT05900154|591985586|FG002|Follow-Up Period|Lost to Follow-up|1|||
163894373|NCT05900154|591985587|FG003|Follow-Up Period|Lost to Follow-up|0|||
163894374|NCT05900154|591985588|FG004|Follow-Up Period|Lost to Follow-up|1|||
163894375|NCT05900154|591985589|FG005|Follow-Up Period|Lost to Follow-up|1|||
163894376|NCT04102111|591985591|FG000|Overall Study|Withdrawal by Subject|2|||
163894377|NCT04102111|591985592|FG001|Overall Study|Withdrawal by Subject|3|||
163894378|NCT04102111|591985591|FG000|Overall Study|Adverse Event|1|||
163894379|NCT04102111|591985592|FG001|Overall Study|Adverse Event|1|||
163894380|NCT04102111|591985591|FG000|Overall Study|Study terminated by sponsor|1|||
163894381|NCT04102111|591985592|FG001|Overall Study|Study terminated by sponsor|3|||
163894382|NCT02542631|591985593|FG000|Overall Study|Adverse Event|1|||
163894383|NCT02542631|591985594|FG001|Overall Study|Adverse Event|1|||
163894384|NCT02542631|591985593|FG000|Overall Study|Sponsor Termination|1|||
163894385|NCT02542631|591985594|FG001|Overall Study|Sponsor Termination|0|||
163894386|NCT02542631|591985593|FG000|Overall Study|Withdrawal by Subject|11|||
163894387|NCT02542631|591985594|FG001|Overall Study|Withdrawal by Subject|16|||
163894388|NCT02542631|591985593|FG000|Overall Study|Protocol Violation|1|||
163894389|NCT02542631|591985594|FG001|Overall Study|Protocol Violation|1|||
163894390|NCT02542631|591985593|FG000|Overall Study|Physician Decision|6|||
163894391|NCT02542631|591985594|FG001|Overall Study|Physician Decision|4|||
163894392|NCT02542631|591985593|FG000|Overall Study|Lost to Follow-up|6|||
163894393|NCT02542631|591985594|FG001|Overall Study|Lost to Follow-up|5|||
163894394|NCT02542631|591985593|FG000|Overall Study|Death|1|||
163894395|NCT02542631|591985594|FG001|Overall Study|Death|2|||
163894396|NCT02542631|591985593|FG000|Overall Study|Other|2|||
163894397|NCT02542631|591985594|FG001|Overall Study|Other|1|||
163894398|NCT02542631|591985593|FG000|Overall Study|Used Prohibited Medication|2|||
163894399|NCT02542631|591985594|FG001|Overall Study|Used Prohibited Medication|1|||
163894400|NCT02641730|591985595|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
163894401|NCT02641730|591985596|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163894402|NCT02641730|591985597|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
163894403|NCT02641730|591985598|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
163894404|NCT02641730|591985599|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
163894405|NCT02641730|591985595|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
164275152|NCT01031979|593376233|FG000|Overall Study|Lost to Follow-up|5|||
164275153|NCT01031979|593376234|FG001|Overall Study|Lost to Follow-up|4|||
164275154|NCT03831100|593376235|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
164275155|NCT03831100|593376236|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
164275156|NCT02454478|593376239|FG000|Overall Study|Incomplete DLT Evaluation|1|||
164275157|NCT01732770|593376240|FG000|Overall Study|Lost to Follow-up|2|||
164275158|NCT01732770|593376241|FG001|Overall Study|Lost to Follow-up|3|||
164275159|NCT01732770|593376240|FG000|Overall Study|Withdrawal by Subject|5|||
164275160|NCT01732770|593376241|FG001|Overall Study|Withdrawal by Subject|3|||
164275161|NCT01732770|593376240|FG000|Overall Study|Decision by Sponsor|2|||
164275162|NCT01732770|593376241|FG001|Overall Study|Decision by Sponsor|2|||
164275163|NCT01732770|593376240|FG000|Overall Study|Death|1|||
164275164|NCT01732770|593376241|FG001|Overall Study|Death|0|||
163894406|NCT02641730|591985596|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
163894407|NCT02641730|591985597|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
163894408|NCT02641730|591985598|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
164275165|NCT01450098|593376242|FG000|Period 3|Protocol Violation|0|||
164275166|NCT01450098|593376243|FG001|Period 3|Protocol Violation|1|||
164275167|NCT01450098|593376242|FG000|Period 3|Withdrawal by Subject|0|||
164275168|NCT01450098|593376243|FG001|Period 3|Withdrawal by Subject|2|||
164275169|NCT03229109|593376246|FG000|Overall Study|Withdrawal by Subject|0|||
164275170|NCT03229109|593376247|FG001|Overall Study|Withdrawal by Subject|0|||
164275171|NCT03229109|593376248|FG002|Overall Study|Withdrawal by Subject|0|||
164275172|NCT03229109|593376249|FG003|Overall Study|Withdrawal by Subject|1|||
164275173|NCT03329196|593376252|FG000|Overall Study|Adverse Event|10|||
164275174|NCT03329196|593376253|FG001|Overall Study|Adverse Event|5|||
164275175|NCT03329196|593376252|FG000|Overall Study|Physician Decision|2|||
164275176|NCT03329196|593376253|FG001|Overall Study|Physician Decision|2|||
164275177|NCT03329196|593376252|FG000|Overall Study|Withdrawal by Subject|11|||
164275178|NCT03329196|593376253|FG001|Overall Study|Withdrawal by Subject|3|||
164275179|NCT03329196|593376252|FG000|Overall Study|Hepatic function abnormalities|0|||
164275180|NCT03329196|593376253|FG001|Overall Study|Hepatic function abnormalities|1|||
164275181|NCT03329196|593376252|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
164275182|NCT03329196|593376253|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
164275183|NCT03329196|593376252|FG000|Overall Study|Difficult to control Hb|2|||
164275184|NCT03329196|593376253|FG001|Overall Study|Difficult to control Hb|3|||
164275185|NCT03329196|593376252|FG000|Overall Study|Dialysis or renal transplant|13|||
164275186|NCT03329196|593376253|FG001|Overall Study|Dialysis or renal transplant|15|||
164275187|NCT04481750|593376257|FG000|Period 1 (Fasted)|Adverse Event|0|||
164275188|NCT04481750|593376258|FG001|Period 1 (Fasted)|Adverse Event|0|||
164275189|NCT04481750|593376259|FG002|Period 1 (Fasted)|Adverse Event|1|||
164275190|NCT04481750|593376260|FG003|Period 1 (Fasted)|Adverse Event|0|||
164275191|NCT04481750|593376261|FG004|Period 1 (Fasted)|Adverse Event|0|||
163894409|NCT02641730|591985599|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
163894410|NCT02641730|591985595|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
163894411|NCT02641730|591985596|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
163894412|NCT02641730|591985597|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
163894413|NCT02641730|591985598|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
163894414|NCT02641730|591985599|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
163894415|NCT02641730|591985595|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163894416|NCT02641730|591985596|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163894417|NCT02641730|591985597|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
163894418|NCT02641730|591985598|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
163894419|NCT02641730|591985599|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
163894420|NCT02641730|591985595|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
163894421|NCT02641730|591985596|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
163894422|NCT02641730|591985597|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
163894423|NCT02641730|591985598|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
163894424|NCT02641730|591985599|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
163894425|NCT02641730|591985595|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
163894426|NCT02641730|591985596|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
163894427|NCT02641730|591985597|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
163894428|NCT02641730|591985598|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
163894429|NCT02641730|591985599|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
163894430|NCT05460871|591985600|FG000|Overall Study|Withdrawal by Subject|1|||
163894431|NCT05460871|591985601|FG001|Overall Study|Withdrawal by Subject|2|||
163894432|NCT02938923|591985602|FG000|Overall Study|Death|1|||
163894433|NCT02938923|591985603|FG001|Overall Study|Death|0|||
163894434|NCT02938923|591985604|FG002|Overall Study|Death|0|||
164275192|NCT04481750|593376262|FG005|Period 1 (Fasted)|Adverse Event|0|||
164275193|NCT04481750|593376263|FG006|Period 1 (Fasted)|Adverse Event|0|||
164001020|NCT01773473|592366786|FG001|Overall Study|Withdrawal by Subject|3|||
164001021|NCT01773473|592366785|FG000|Overall Study|Lost to Follow-up|2|||
164001022|NCT01773473|592366786|FG001|Overall Study|Lost to Follow-up|0|||
164001023|NCT00826514|592366787|FG000|Overall Study|Adverse Event|1|||
164001024|NCT00826514|592366788|FG001|Overall Study|Adverse Event|1|||
164001025|NCT00826514|592366787|FG000|Overall Study|Lack of Efficacy|0|||
164001026|NCT00826514|592366788|FG001|Overall Study|Lack of Efficacy|1|||
164001027|NCT00826514|592366787|FG000|Overall Study|Withdrawal by Subject|2|||
164001028|NCT00826514|592366788|FG001|Overall Study|Withdrawal by Subject|3|||
164001029|NCT03663166|592366789|FG000|Overall Study|Withdrawal by Subject|1|||
164001030|NCT00707577|592366791|FG000|Overall Study|Withdrawal by Subject|3|||
164001031|NCT00707577|592366792|FG001|Overall Study|Withdrawal by Subject|2|||
164001032|NCT00707577|592366791|FG000|Overall Study|Lost to Follow-up|34|||
164001033|NCT00707577|592366792|FG001|Overall Study|Lost to Follow-up|25|||
164001034|NCT00707577|592366791|FG000|Overall Study|Left employment|13|||
164001035|NCT00707577|592366792|FG001|Overall Study|Left employment|10|||
164001036|NCT00707577|592366791|FG000|Overall Study|Pregnancy|4|||
164001037|NCT00707577|592366792|FG001|Overall Study|Pregnancy|1|||
164001038|NCT00190775|592366793|FG000|Overall Study|Adverse Event|57|||
164001039|NCT00190775|592366794|FG001|Overall Study|Adverse Event|22|||
164001040|NCT00190775|592366793|FG000|Overall Study|Satisfactory Response|1|||
164001041|NCT00190775|592366794|FG001|Overall Study|Satisfactory Response|0|||
164001042|NCT00190775|592366793|FG000|Overall Study|Lack of Efficacy|28|||
164001043|NCT00190775|592366794|FG001|Overall Study|Lack of Efficacy|32|||
164001044|NCT00190775|592366793|FG000|Overall Study|Lost to Follow-up|31|||
164001045|NCT00190775|592366794|FG001|Overall Study|Lost to Follow-up|23|||
164001046|NCT00190775|592366793|FG000|Overall Study|Participant Moved|0|||
164001047|NCT00190775|592366794|FG001|Overall Study|Participant Moved|1|||
164001048|NCT00190775|592366793|FG000|Overall Study|Withdrawal by Subject|24|||
164275194|NCT04481750|593376264|FG007|Period 1 (Fasted)|Adverse Event|0|||
164275195|NCT04481750|593376265|FG008|Period 1 (Fasted)|Adverse Event|0|||
164275196|NCT04481750|593376266|FG009|Period 1 (Fasted)|Adverse Event|0|||
164275197|NCT04481750|593376267|FG010|Period 1 (Fasted)|Adverse Event|0|||
164275198|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
164275199|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
164275200|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
164275201|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
164275202|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
164275203|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275204|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
164275205|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275206|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275207|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
164275208|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
164275209|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
164275210|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
164275211|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
164275212|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
164275213|NCT03176771|593376268|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275214|NCT03176771|593376269|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275215|NCT03176771|593376270|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
164275216|NCT03176771|593376271|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275217|NCT03176771|593376272|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
164275218|NCT03176771|593376268|FG000|Double-Blind Extension Period|Adverse Event|0|||
164342904|NCT00306189|593631586|FG000|Overall Study|Other|1|||
164001049|NCT00190775|592366794|FG001|Overall Study|Withdrawal by Subject|13|||
164001050|NCT00190775|592366793|FG000|Overall Study|Sponsor Decision|1|||
164275219|NCT03176771|593376269|FG001|Double-Blind Extension Period|Adverse Event|0|||
164275220|NCT03176771|593376270|FG002|Double-Blind Extension Period|Adverse Event|0|||
164275221|NCT03176771|593376271|FG003|Double-Blind Extension Period|Adverse Event|15|||
164275222|NCT03176771|593376272|FG004|Double-Blind Extension Period|Adverse Event|18|||
164342905|NCT00306189|593631587|FG001|Overall Study|Other|0|||
164342906|NCT00306189|593631588|FG002|Overall Study|Other|0|||
164342907|NCT00306189|593631589|FG003|Overall Study|Other|0|||
164001051|NCT00190775|592366794|FG001|Overall Study|Sponsor Decision|0|||
164001052|NCT00190775|592366793|FG000|Overall Study|Physician Decision|3|||
164001053|NCT00190775|592366794|FG001|Overall Study|Physician Decision|0|||
164001054|NCT00190775|592366793|FG000|Overall Study|Noncompliance|3|||
164001055|NCT00190775|592366794|FG001|Overall Study|Noncompliance|5|||
164001056|NCT00190775|592366793|FG000|Overall Study|Protocol Violation|0|||
164001057|NCT00190775|592366794|FG001|Overall Study|Protocol Violation|1|||
164001058|NCT00190775|592366793|FG000|Overall Study|Exclusion Criteria Met|1|||
164001059|NCT00190775|592366794|FG001|Overall Study|Exclusion Criteria Met|3|||
164001060|NCT01794780|592366795|FG000|Overall Study|Adverse Event|0|||
164275223|NCT03176771|593376268|FG000|Double-Blind Extension Period|Death|0|||
164275224|NCT03176771|593376269|FG001|Double-Blind Extension Period|Death|0|||
164275225|NCT03176771|593376270|FG002|Double-Blind Extension Period|Death|0|||
164275226|NCT03176771|593376271|FG003|Double-Blind Extension Period|Death|3|||
164275227|NCT03176771|593376272|FG004|Double-Blind Extension Period|Death|4|||
164275228|NCT03176771|593376268|FG000|Double-Blind Extension Period|Physician Decision|0|||
164275229|NCT03176771|593376269|FG001|Double-Blind Extension Period|Physician Decision|0|||
164275230|NCT03176771|593376270|FG002|Double-Blind Extension Period|Physician Decision|0|||
164275231|NCT03176771|593376271|FG003|Double-Blind Extension Period|Physician Decision|3|||
164275232|NCT03176771|593376272|FG004|Double-Blind Extension Period|Physician Decision|1|||
164275233|NCT03176771|593376268|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
164275234|NCT03176771|593376269|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
164275235|NCT03176771|593376270|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
164275236|NCT03176771|593376271|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
164275237|NCT03176771|593376272|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
164275238|NCT03439137|593376273|FG000|Overall Study|Adverse Event|16|||
164275239|NCT03439137|593376274|FG001|Overall Study|Adverse Event|12|||
164275240|NCT03439137|593376273|FG000|Overall Study|Physician Decision|0|||
164275241|NCT03439137|593376274|FG001|Overall Study|Physician Decision|5|||
164275242|NCT03439137|593376273|FG000|Overall Study|Withdrawal by Subject|14|||
164275243|NCT03439137|593376274|FG001|Overall Study|Withdrawal by Subject|4|||
164275244|NCT03439137|593376273|FG000|Overall Study|Conducting rescue therapy|2|||
164275245|NCT03439137|593376274|FG001|Overall Study|Conducting rescue therapy|1|||
164275246|NCT03439137|593376273|FG000|Overall Study|Difficult to control Hb|10|||
164275247|NCT03439137|593376274|FG001|Overall Study|Difficult to control Hb|2|||
164275248|NCT03439137|593376273|FG000|Overall Study|Initiation of a renal transplant|0|||
164275249|NCT03439137|593376274|FG001|Overall Study|Initiation of a renal transplant|2|||
164275250|NCT00691028|593376275|FG000|Open-label Period|Adverse Event|0|||
164275251|NCT00691028|593376276|FG001|Open-label Period|Adverse Event|0|||
164275252|NCT00691028|593376277|FG002|Open-label Period|Adverse Event|0|||
164275253|NCT00691028|593376278|FG003|Open-label Period|Adverse Event|16|||
164275254|NCT00691028|593376275|FG000|Open-label Period|Withdrawal by Subject|0|||
164275255|NCT00691028|593376276|FG001|Open-label Period|Withdrawal by Subject|0|||
164275256|NCT00691028|593376277|FG002|Open-label Period|Withdrawal by Subject|0|||
164275257|NCT00691028|593376278|FG003|Open-label Period|Withdrawal by Subject|3|||
164275258|NCT00691028|593376275|FG000|Open-label Period|not come to a hospital|0|||
164275259|NCT00691028|593376276|FG001|Open-label Period|not come to a hospital|0|||
164275260|NCT00691028|593376277|FG002|Open-label Period|not come to a hospital|0|||
164275261|NCT00691028|593376278|FG003|Open-label Period|not come to a hospital|1|||
164275262|NCT00691028|593376275|FG000|Double-blind Period|Adverse Event|8|||
164275263|NCT00691028|593376276|FG001|Double-blind Period|Adverse Event|9|||
164275264|NCT00691028|593376277|FG002|Double-blind Period|Adverse Event|6|||
164275265|NCT00691028|593376278|FG003|Double-blind Period|Adverse Event|0|||
164275266|NCT00691028|593376275|FG000|Double-blind Period|Lack of Efficacy|4|||
164275267|NCT00691028|593376276|FG001|Double-blind Period|Lack of Efficacy|3|||
164275268|NCT00691028|593376277|FG002|Double-blind Period|Lack of Efficacy|2|||
164275269|NCT00691028|593376278|FG003|Double-blind Period|Lack of Efficacy|0|||
164275270|NCT00691028|593376275|FG000|Double-blind Period|Withdrawal by Subject|1|||
164275271|NCT00691028|593376276|FG001|Double-blind Period|Withdrawal by Subject|0|||
164275272|NCT00691028|593376277|FG002|Double-blind Period|Withdrawal by Subject|1|||
164275273|NCT00691028|593376278|FG003|Double-blind Period|Withdrawal by Subject|0|||
164275274|NCT00691028|593376275|FG000|Double-blind Period|not come to a hospital.|0|||
164275275|NCT00691028|593376276|FG001|Double-blind Period|not come to a hospital.|1|||
164275276|NCT00691028|593376277|FG002|Double-blind Period|not come to a hospital.|0|||
164275277|NCT00691028|593376278|FG003|Double-blind Period|not come to a hospital.|0|||
164275278|NCT03387020|593376279|FG000|Overall Study|Adverse Event|0|||
164275279|NCT03387020|593376280|FG001|Overall Study|Adverse Event|2|||
164275280|NCT03387020|593376281|FG002|Overall Study|Adverse Event|0|||
164275281|NCT03387020|593376279|FG000|Overall Study|Withdrawal by Subject|2|||
164275282|NCT03387020|593376280|FG001|Overall Study|Withdrawal by Subject|0|||
164275283|NCT03387020|593376281|FG002|Overall Study|Withdrawal by Subject|0|||
164275284|NCT04512976|593376286|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275285|NCT04512976|593376287|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275286|NCT04512976|593376288|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275287|NCT04512976|593376289|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275288|NCT04512976|593376290|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
164275289|NCT04512976|593376291|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
164275290|NCT04617496|593376295|FG000|Overall Study|Death|2|||
164275291|NCT04617496|593376296|FG001|Overall Study|Death|1|||
164275292|NCT04617496|593376295|FG000|Overall Study|Lost to Follow-up|3|||
164275293|NCT04617496|593376296|FG001|Overall Study|Lost to Follow-up|3|||
164275294|NCT01596335|593376297|FG000|Overall Study|exacerbation of primary disease|5|||
164275295|NCT01596335|593376298|FG001|Overall Study|exacerbation of primary disease|9|||
164001061|NCT01794780|592366796|FG001|Overall Study|Adverse Event|1|||
164001062|NCT01794780|592366797|FG002|Overall Study|Adverse Event|2|||
164001063|NCT01794780|592366798|FG003|Overall Study|Adverse Event|0|||
164001064|NCT01794780|592366799|FG004|Overall Study|Adverse Event|0|||
164001065|NCT01794780|592366800|FG005|Overall Study|Adverse Event|0|||
164001066|NCT01794780|592366801|FG006|Overall Study|Adverse Event|0|||
164001067|NCT01794780|592366802|FG007|Overall Study|Adverse Event|0|||
164001068|NCT01794780|592366795|FG000|Overall Study|Death|0|||
164001069|NCT01794780|592366796|FG001|Overall Study|Death|2|||
164001070|NCT01794780|592366797|FG002|Overall Study|Death|14|||
164001071|NCT01794780|592366798|FG003|Overall Study|Death|1|||
164001072|NCT01794780|592366799|FG004|Overall Study|Death|0|||
164001073|NCT01794780|592366800|FG005|Overall Study|Death|9|||
164001074|NCT01794780|592366801|FG006|Overall Study|Death|4|||
164001075|NCT01794780|592366802|FG007|Overall Study|Death|0|||
164001076|NCT01794780|592366795|FG000|Overall Study|Lost to Follow-up|10|||
164001077|NCT01794780|592366796|FG001|Overall Study|Lost to Follow-up|64|||
164001078|NCT01794780|592366797|FG002|Overall Study|Lost to Follow-up|165|||
164001079|NCT01794780|592366798|FG003|Overall Study|Lost to Follow-up|53|||
164001080|NCT01794780|592366799|FG004|Overall Study|Lost to Follow-up|2|||
164001081|NCT01794780|592366800|FG005|Overall Study|Lost to Follow-up|99|||
164001082|NCT01794780|592366801|FG006|Overall Study|Lost to Follow-up|30|||
164001083|NCT01794780|592366802|FG007|Overall Study|Lost to Follow-up|5|||
164001084|NCT01794780|592366795|FG000|Overall Study|Withdrew informed consent|7|||
164001085|NCT01794780|592366796|FG001|Overall Study|Withdrew informed consent|17|||
164001086|NCT01794780|592366797|FG002|Overall Study|Withdrew informed consent|36|||
164001087|NCT01794780|592366798|FG003|Overall Study|Withdrew informed consent|9|||
164001088|NCT01794780|592366799|FG004|Overall Study|Withdrew informed consent|0|||
164001089|NCT01794780|592366800|FG005|Overall Study|Withdrew informed consent|48|||
164001090|NCT01794780|592366801|FG006|Overall Study|Withdrew informed consent|4|||
164001091|NCT01794780|592366802|FG007|Overall Study|Withdrew informed consent|3|||
164001092|NCT01794780|592366795|FG000|Overall Study|Other|0|||
164001093|NCT01794780|592366796|FG001|Overall Study|Other|12|||
164001094|NCT01794780|592366797|FG002|Overall Study|Other|25|||
164001095|NCT01794780|592366798|FG003|Overall Study|Other|20|||
164001096|NCT01794780|592366799|FG004|Overall Study|Other|1|||
164001097|NCT01794780|592366800|FG005|Overall Study|Other|24|||
164001098|NCT01794780|592366801|FG006|Overall Study|Other|4|||
164001099|NCT01794780|592366802|FG007|Overall Study|Other|1|||
164001100|NCT02286102|592366803|FG000|Overall Study|Screen Failure|1|||
164275296|NCT01192412|593376299|FG000|Overall Study|Lost to Follow-up|2|||
164275297|NCT01192412|593376300|FG001|Overall Study|Lost to Follow-up|1|||
164275298|NCT01192412|593376299|FG000|Overall Study|Withdrawal by Subject|2|||
164275299|NCT01192412|593376300|FG001|Overall Study|Withdrawal by Subject|1|||
164275300|NCT02421588|593376301|FG000|Overall Study|Non-treatment-related AE|8|||
164275301|NCT02421588|593376302|FG001|Overall Study|Non-treatment-related AE|8|||
164275302|NCT02421588|593376301|FG000|Overall Study|Progressive disease|152|||
164275303|NCT02421588|593376302|FG001|Overall Study|Progressive disease|135|||
164275304|NCT02421588|593376301|FG000|Overall Study|Death|11|||
164275305|NCT02421588|593376302|FG001|Overall Study|Death|3|||
164275306|NCT02421588|593376301|FG000|Overall Study|Physician Decision|8|||
164275307|NCT02421588|593376302|FG001|Overall Study|Physician Decision|17|||
164275308|NCT02421588|593376301|FG000|Overall Study|Other reason not specified|3|||
164275309|NCT02421588|593376302|FG001|Overall Study|Other reason not specified|1|||
164275310|NCT02421588|593376301|FG000|Overall Study|Symptomatic deterioration|13|||
164275311|NCT02421588|593376302|FG001|Overall Study|Symptomatic deterioration|19|||
164275312|NCT02421588|593376301|FG000|Overall Study|Treatment-related AE|10|||
164275313|NCT02421588|593376302|FG001|Overall Study|Treatment-related AE|14|||
164275314|NCT02421588|593376301|FG000|Overall Study|Withdrawal by Subject|14|||
164275315|NCT02421588|593376302|FG001|Overall Study|Withdrawal by Subject|16|||
164275316|NCT02421588|593376301|FG000|Overall Study|Not treated|2|||
164275317|NCT02421588|593376302|FG001|Overall Study|Not treated|8|||
164001101|NCT02286102|592366804|FG001|Overall Study|Screen Failure|1|||
164001102|NCT01967225|592366805|FG000|Overall Study|Adverse Event|3|||
164001103|NCT01967225|592366806|FG001|Overall Study|Adverse Event|1|||
164001104|NCT01967225|592366805|FG000|Overall Study|Withdrawal by Subject|2|||
164001105|NCT01967225|592366806|FG001|Overall Study|Withdrawal by Subject|1|||
164001106|NCT01967225|592366805|FG000|Overall Study|Lack of Efficacy|1|||
164001107|NCT01967225|592366806|FG001|Overall Study|Lack of Efficacy|1|||
164001108|NCT01967225|592366805|FG000|Overall Study|Switching to other therapy|2|||
164001109|NCT01967225|592366806|FG001|Overall Study|Switching to other therapy|0|||
164001110|NCT01967225|592366805|FG000|Overall Study|Protocol driven decision point|1|||
164275318|NCT01004952|593376305|FG000|Overall Study|Lost to Follow-up|0|||
164001111|NCT01967225|592366806|FG001|Overall Study|Protocol driven decision point|0|||
164001112|NCT01967225|592366805|FG000|Overall Study|Logistical difficulties|1|||
164001113|NCT01967225|592366806|FG001|Overall Study|Logistical difficulties|0|||
164275319|NCT01004952|593376306|FG001|Overall Study|Lost to Follow-up|11|||
164275320|NCT01004952|593376305|FG000|Overall Study|Withdrawal by Subject|0|||
164275321|NCT01004952|593376306|FG001|Overall Study|Withdrawal by Subject|5|||
164275322|NCT01359943|593376307|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
164001114|NCT01967225|592366805|FG000|Overall Study|Protocol Violation|2|||
164001115|NCT01967225|592366806|FG001|Overall Study|Protocol Violation|0|||
164001116|NCT00327444|592366807|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
164001117|NCT00327444|592366808|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
164001118|NCT00327444|592366807|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
164001119|NCT00327444|592366808|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
164001120|NCT00327444|592366807|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
164001121|NCT00327444|592366808|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
164001122|NCT00327444|592366807|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
164001123|NCT00327444|592366808|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
164001124|NCT00327444|592366807|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
164001125|NCT00327444|592366808|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
164001126|NCT00327444|592366807|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
164001127|NCT00327444|592366808|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
164001128|NCT00327444|592366807|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
164001129|NCT00327444|592366808|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
164001130|NCT00327444|592366807|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
164001131|NCT00327444|592366808|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
164001132|NCT01658514|592366810|FG000|Overall Study|Protocol Violation|1|||
164001133|NCT01658514|592366811|FG001|Overall Study|Protocol Violation|0|||
164001134|NCT01658514|592366812|FG002|Overall Study|Protocol Violation|2|||
164001135|NCT00144170|592366814|FG000|Overall Study|Adverse Event|84|||
164001136|NCT00144170|592366815|FG001|Overall Study|Adverse Event|41|||
164001137|NCT00144170|592366814|FG000|Overall Study|Protocol Violation|23|||
164001138|NCT00144170|592366815|FG001|Overall Study|Protocol Violation|16|||
164001139|NCT00144170|592366814|FG000|Overall Study|Lost to Follow-up|5|||
164001140|NCT00144170|592366815|FG001|Overall Study|Lost to Follow-up|10|||
164001141|NCT00144170|592366814|FG000|Overall Study|Withdrawal by Subject|29|||
164001142|NCT00144170|592366815|FG001|Overall Study|Withdrawal by Subject|13|||
164001143|NCT00144170|592366814|FG000|Overall Study|Other reason not defined above|211|||
164001144|NCT00144170|592366815|FG001|Overall Study|Other reason not defined above|316|||
164001145|NCT00981526|592366816|FG000|Overall Study|Withdrawal by Subject|0|||
164001146|NCT00981526|592366817|FG001|Overall Study|Withdrawal by Subject|2|||
164001147|NCT00981526|592366816|FG000|Overall Study|Physician Decision|4|||
164001148|NCT00981526|592366817|FG001|Overall Study|Physician Decision|4|||
164001149|NCT00332202|592366818|FG000|Overall Study|Adverse Event|72|||
164001150|NCT00332202|592366819|FG001|Overall Study|Adverse Event|28|||
164001151|NCT00332202|592366818|FG000|Overall Study|Lost to Follow-up|2|||
164001152|NCT00332202|592366819|FG001|Overall Study|Lost to Follow-up|1|||
164001153|NCT00332202|592366818|FG000|Overall Study|Physician Decision|6|||
164001154|NCT00332202|592366819|FG001|Overall Study|Physician Decision|8|||
164001155|NCT00332202|592366818|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
164001156|NCT00332202|592366819|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
164001157|NCT00332202|592366818|FG000|Overall Study|Protocol Violation|7|||
164001158|NCT00332202|592366819|FG001|Overall Study|Protocol Violation|2|||
164001159|NCT00332202|592366818|FG000|Overall Study|Sponsor Decision|1|||
164001160|NCT00332202|592366819|FG001|Overall Study|Sponsor Decision|2|||
164001161|NCT00332202|592366818|FG000|Overall Study|Withdrawal by Subject|36|||
164001162|NCT00332202|592366819|FG001|Overall Study|Withdrawal by Subject|17|||
164001163|NCT00332202|592366818|FG000|Overall Study|Progressive Disease|106|||
164001164|NCT00332202|592366819|FG001|Overall Study|Progressive Disease|60|||
164001165|NCT00332202|592366818|FG000|Overall Study|Death|5|||
164001166|NCT00332202|592366819|FG001|Overall Study|Death|2|||
164001167|NCT01392183|592366820|FG000|First Drug Administration|Adverse Event|3|||
164275323|NCT01359943|593376308|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
164275324|NCT01359943|593376309|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
164275325|NCT01359943|593376307|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
164275326|NCT01359943|593376308|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
164275327|NCT01359943|593376309|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
164275328|NCT01359943|593376307|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
164001168|NCT01392183|592366821|FG001|First Drug Administration|Adverse Event|2|||
164001169|NCT01392183|592366820|FG000|First Drug Administration|Death|1|||
164001170|NCT01392183|592366821|FG001|First Drug Administration|Death|0|||
164001171|NCT01392183|592366820|FG000|First Drug Administration|Withdrawal by Subject|10|||
164001172|NCT01392183|592366821|FG001|First Drug Administration|Withdrawal by Subject|17|||
164001173|NCT00075881|592368438|FG000|Overall Study|Lack of Efficacy|18|||
164001174|NCT00075881|592368438|FG000|Overall Study|Adverse Event|7|||
164001175|NCT00075881|592368438|FG000|Overall Study|Death|1|||
164001176|NCT00075881|592368438|FG000|Overall Study|Withdrawal by Subject|2|||
164001177|NCT00075881|592368438|FG000|Overall Study|Protocol Violation|4|||
164001178|NCT00075881|592368438|FG000|Overall Study|other complicating disease|3|||
164001179|NCT00075881|592368438|FG000|Overall Study|other|4|||
164275329|NCT01359943|593376308|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
164275330|NCT01359943|593376309|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
164275331|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
164275332|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
164275333|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
164001180|NCT00075881|592368438|FG000|Overall Study|missing data|2|||
164001181|NCT00075881|592368438|FG000|Overall Study|Ineligible|1|||
164275334|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
164275335|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
164275336|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
164275337|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
164001182|NCT00075881|592368438|FG000|Overall Study|never start protocol therapy|1|||
164001183|NCT02224664|592368439|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
164275338|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
164275339|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
164275340|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
164275341|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
164275342|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
164275343|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
164275344|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
164275345|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
164275346|NCT01359943|593376307|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
164275347|NCT01359943|593376308|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
164275348|NCT01359943|593376309|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
164275349|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
164275350|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
164275351|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
164275352|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
164275353|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
164275354|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
164275355|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
164275356|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
164275357|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
164275358|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
164275359|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
164275360|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
164275361|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
164275362|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
164275363|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
164275364|NCT01359943|593376307|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
164275365|NCT01359943|593376308|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
164275366|NCT01359943|593376309|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
164275367|NCT01529034|593376310|FG000|Overall Study|Discontinued prior to study treatment|14|||
164275368|NCT01529034|593376310|FG000|Overall Study|Site closure|62|||
164275369|NCT01529034|593376310|FG000|Overall Study|Study termination|29|||
164275370|NCT01529034|593376310|FG000|Overall Study|Withdrawal by Subject|25|||
164275371|NCT01529034|593376310|FG000|Overall Study|No treated SCs within protocol window|13|||
164275372|NCT01529034|593376310|FG000|Overall Study|Noncompliance|8|||
164275373|NCT01529034|593376310|FG000|Overall Study|Caregiver no longer available|7|||
164275374|NCT01529034|593376310|FG000|Overall Study|Adverse Event|4|||
164275375|NCT01529034|593376310|FG000|Overall Study|Protocol Violation|4|||
164275376|NCT01529034|593376310|FG000|Overall Study|Lack of Efficacy|4|||
164275377|NCT01529034|593376310|FG000|Overall Study|Investigator no longer available|2|||
164275378|NCT01529034|593376310|FG000|Overall Study|Study drug not available|2|||
164275379|NCT03436693|593376313|FG000|Overall Study|Adverse Event|22|||
164275380|NCT03436693|593376314|FG001|Overall Study|Adverse Event|10|||
164275381|NCT03436693|593376313|FG000|Overall Study|Physician Decision|3|||
164275382|NCT03436693|593376314|FG001|Overall Study|Physician Decision|3|||
164275383|NCT03436693|593376313|FG000|Overall Study|Withdrawal by Subject|4|||
164275384|NCT03436693|593376314|FG001|Overall Study|Withdrawal by Subject|13|||
164275385|NCT03436693|593376313|FG000|Overall Study|Progressive Disease|1|||
164275386|NCT03436693|593376314|FG001|Overall Study|Progressive Disease|1|||
164275387|NCT04481789|593376315|FG000|Period 1|Withdrawal by Subject|1|||
164275388|NCT04481789|593376316|FG001|Period 1|Withdrawal by Subject|0|||
164275389|NCT04481789|593376317|FG002|Period 1|Withdrawal by Subject|0|||
164275390|NCT04481789|593376318|FG003|Period 1|Withdrawal by Subject|0|||
164275391|NCT04481789|593376319|FG004|Period 1|Withdrawal by Subject|0|||
164275392|NCT04481789|593376320|FG005|Period 1|Withdrawal by Subject|0|||
164275393|NCT04655144|593376326|FG000|Overall Study|Consumed THC|1|||
164275394|NCT04655144|593376327|FG001|Overall Study|Consumed THC|0|||
164275395|NCT04655144|593376326|FG000|Overall Study|Unilateral embolization|0|||
164275396|NCT04655144|593376327|FG001|Overall Study|Unilateral embolization|1|||
164275397|NCT04317742|593376328|FG000|Overall Study|Lost to Follow-up|57|||
164275398|NCT04317742|593376329|FG001|Overall Study|Lost to Follow-up|59|||
164275399|NCT04317742|593376328|FG000|Overall Study|Pregnancy|1|||
164275400|NCT04317742|593376329|FG001|Overall Study|Pregnancy|1|||
164275401|NCT04317742|593376328|FG000|Overall Study|Withdrawal by Subject|46|||
164275402|NCT04317742|593376329|FG001|Overall Study|Withdrawal by Subject|24|||
164275403|NCT02678923|593376330|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
164275404|NCT02678923|593376331|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
164275405|NCT02678923|593376330|FG000|Overall Study|Withdrawal by Subject|3|||
164275406|NCT02678923|593376331|FG001|Overall Study|Withdrawal by Subject|2|||
164275407|NCT02678923|593376330|FG000|Overall Study|Lost to Follow-up|1|||
164275408|NCT02678923|593376331|FG001|Overall Study|Lost to Follow-up|0|||
164275409|NCT02678923|593376330|FG000|Overall Study|Did Not Return for Study Visits|1|||
164342908|NCT01548287|593631590|FG000|Screening|No reason provided|0|||
164342909|NCT01548287|593631591|FG001|Screening|No reason provided|0|||
164342910|NCT01548287|593631592|FG002|Screening|No reason provided|0|||
164342911|NCT01548287|593631593|FG003|Screening|No reason provided|0|||
164342912|NCT01548287|593631594|FG004|Screening|No reason provided|9|||
164342913|NCT01548287|593631590|FG000|Screening|Did not meet eligibility criteria|0|||
164342914|NCT01548287|593631591|FG001|Screening|Did not meet eligibility criteria|0|||
164342915|NCT01548287|593631592|FG002|Screening|Did not meet eligibility criteria|0|||
164342916|NCT01548287|593631593|FG003|Screening|Did not meet eligibility criteria|0|||
164342917|NCT01548287|593631594|FG004|Screening|Did not meet eligibility criteria|74|||
164342918|NCT01548287|593631590|FG000|Randomized Period|Did not meet inclusion criteria|0|||
164342919|NCT01548287|593631591|FG001|Randomized Period|Did not meet inclusion criteria|0|||
164342920|NCT01548287|593631592|FG002|Randomized Period|Did not meet inclusion criteria|2|||
164342921|NCT01548287|593631593|FG003|Randomized Period|Did not meet inclusion criteria|0|||
164342922|NCT01548287|593631594|FG004|Randomized Period|Did not meet inclusion criteria|0|||
164342923|NCT01548287|593631590|FG000|Randomized Period|Adverse Event|0|||
164342924|NCT01548287|593631591|FG001|Randomized Period|Adverse Event|2|||
164342925|NCT01548287|593631592|FG002|Randomized Period|Adverse Event|5|||
164342926|NCT01548287|593631593|FG003|Randomized Period|Adverse Event|0|||
164342927|NCT01548287|593631594|FG004|Randomized Period|Adverse Event|0|||
164342928|NCT02762578|593631599|FG000|Overall Study|Adverse Event|1|||
164342929|NCT02762578|593631600|FG001|Overall Study|Adverse Event|6|||
164342930|NCT02762578|593631599|FG000|Overall Study|Protocol Violation|4|||
164342931|NCT02762578|593631600|FG001|Overall Study|Protocol Violation|2|||
164342932|NCT02762578|593631599|FG000|Overall Study|Withdrawal by Subject|4|||
164342933|NCT02762578|593631600|FG001|Overall Study|Withdrawal by Subject|2|||
164342934|NCT02762578|593631599|FG000|Overall Study|Unclassified|6|||
164342935|NCT02762578|593631600|FG001|Overall Study|Unclassified|0|||
164342936|NCT02083965|593631601|FG000|Treatment Period|Other|1|||
164342937|NCT02083965|593631602|FG001|Treatment Period|Other|0|||
164342938|NCT00282984|593631603|FG000|Overall Study|Death|2|||
164342939|NCT00282984|593631604|FG001|Overall Study|Death|5|||
164342940|NCT00282984|593631603|FG000|Overall Study|Adverse Event|8|||
164342941|NCT00282984|593631604|FG001|Overall Study|Adverse Event|5|||
164342942|NCT00282984|593631603|FG000|Overall Study|Lack of Efficacy|0|||
164342943|NCT00282984|593631604|FG001|Overall Study|Lack of Efficacy|2|||
164342944|NCT00282984|593631603|FG000|Overall Study|Lost to Follow-up|14|||
164342945|NCT00282984|593631604|FG001|Overall Study|Lost to Follow-up|10|||
164342946|NCT00282984|593631603|FG000|Overall Study|Withdrawal by Participant|22|||
164342947|NCT00282984|593631604|FG001|Overall Study|Withdrawal by Participant|34|||
164342948|NCT00282984|593631603|FG000|Overall Study|Participant stopped study medication|2|||
164342949|NCT00282984|593631604|FG001|Overall Study|Participant stopped study medication|2|||
164342950|NCT00282984|593631603|FG000|Overall Study|Participant only allowed phone follow-up|0|||
164342951|NCT00282984|593631604|FG001|Overall Study|Participant only allowed phone follow-up|1|||
164342952|NCT00282984|593631603|FG000|Overall Study|Participant used antipsychosis meds|0|||
164342953|NCT00282984|593631604|FG001|Overall Study|Participant used antipsychosis meds|1|||
164342954|NCT00282984|593631603|FG000|Overall Study|lack of motivation|1|||
164342955|NCT00282984|593631604|FG001|Overall Study|lack of motivation|0|||
163894435|NCT02938923|591985602|FG000|Overall Study|Physician Decision|0|||
163894436|NCT02938923|591985603|FG001|Overall Study|Physician Decision|2|||
163894437|NCT02938923|591985604|FG002|Overall Study|Physician Decision|0|||
163894438|NCT02938923|591985602|FG000|Overall Study|Withdrawal by Subject|0|||
163894439|NCT02938923|591985603|FG001|Overall Study|Withdrawal by Subject|1|||
163894440|NCT02938923|591985604|FG002|Overall Study|Withdrawal by Subject|1|||
163894441|NCT04129554|591985606|FG000|Overall Study|Withdrawal by Subject|4|||
163894442|NCT04129554|591985607|FG001|Overall Study|Withdrawal by Subject|3|||
163894443|NCT04129554|591985606|FG000|Overall Study|Other|0|||
164142613|NCT00704730|592882766|FG001|Overall Study|data unavailable|0|||
164342956|NCT00282984|593631603|FG000|Overall Study|in prison|0|||
163894444|NCT04129554|591985607|FG001|Overall Study|Other|2|||
163894445|NCT03663205|591985608|FG000|Overall Study|Death|144|||
163894446|NCT03663205|591985609|FG001|Overall Study|Death|69|||
164085954|NCT01995058|592678602|FG001|Overall Study|Sponsor Decision to terminate study|12|||
164085955|NCT01995058|592678603|FG002|Overall Study|Sponsor Decision to terminate study|12|||
164085956|NCT01995058|592678604|FG003|Overall Study|Sponsor Decision to terminate study|10|||
164275410|NCT02678923|593376331|FG001|Overall Study|Did Not Return for Study Visits|0|||
164275411|NCT01554514|593376334|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
164275412|NCT01554514|593376334|FG000|Overall Study|Physician Decision|1|||
164275413|NCT01966445|593376337|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275414|NCT01966445|593376338|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275415|NCT01966445|593376339|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275416|NCT01966445|593376340|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
164275417|NCT01966445|593376341|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275418|NCT01966445|593376342|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
164275419|NCT01966445|593376343|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
164275420|NCT01966445|593376337|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275421|NCT01966445|593376338|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
164275422|NCT01966445|593376339|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275423|NCT01966445|593376340|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
164275424|NCT01966445|593376341|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
164275425|NCT01966445|593376342|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275426|NCT01966445|593376343|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
164275427|NCT01966445|593376337|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275428|NCT01966445|593376338|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
164275429|NCT01966445|593376339|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
164275430|NCT01966445|593376340|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275431|NCT01966445|593376341|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
164275432|NCT01966445|593376342|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275433|NCT01966445|593376343|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
164275434|NCT01966445|593376337|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275435|NCT01966445|593376338|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275436|NCT01966445|593376339|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275437|NCT01966445|593376340|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275438|NCT01966445|593376341|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275439|NCT01966445|593376342|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
164275440|NCT01966445|593376343|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
164275441|NCT01966445|593376337|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275442|NCT01966445|593376338|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275443|NCT01966445|593376339|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275444|NCT01966445|593376340|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275445|NCT01966445|593376341|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275446|NCT01966445|593376342|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
164275447|NCT01966445|593376343|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
164275448|NCT01374178|593376344|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
164275449|NCT01374178|593376345|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
164275450|NCT01374178|593376344|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
164275451|NCT01374178|593376345|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
164275452|NCT01422824|593376346|FG000|Overall Study|Case record form not evaluated|1|||
163894447|NCT03663205|591985608|FG000|Overall Study|Sponsor decision|53|||
163894448|NCT03663205|591985609|FG001|Overall Study|Sponsor decision|19|||
163894449|NCT03663205|591985608|FG000|Overall Study|Withdrawal by Subject|8|||
163894450|NCT03663205|591985609|FG001|Overall Study|Withdrawal by Subject|11|||
163894451|NCT03663205|591985608|FG000|Overall Study|Lost to Follow-up|7|||
163894452|NCT03663205|591985609|FG001|Overall Study|Lost to Follow-up|9|||
163894453|NCT03663205|591985608|FG000|Overall Study|Transferred to long term extension study|11|||
163894454|NCT03663205|591985609|FG001|Overall Study|Transferred to long term extension study|3|||
163894455|NCT03582033|591985614|FG000|Part A|Other|0|||
163894456|NCT03582033|591985615|FG001|Part A|Other|0|||
163894457|NCT03582033|591985616|FG002|Part A|Other|0|||
163894458|NCT03582033|591985617|FG003|Part A|Other|0|||
163894459|NCT03582033|591985618|FG004|Part A|Other|2|||
163894460|NCT03582033|591985619|FG005|Part A|Other|0|||
163894461|NCT03582033|591985620|FG006|Part A|Other|0|||
163894462|NCT03582033|591985621|FG007|Part A|Other|0|||
163894463|NCT03582033|591985622|FG008|Part A|Other|0|||
163894464|NCT03582033|591985623|FG009|Part A|Other|0|||
163894465|NCT03582033|591985614|FG000|Part A|Death|1|||
164275453|NCT01422824|593376346|FG000|Overall Study|Lost to Follow-up|37|||
164275454|NCT00490022|593376347|FG000|Overall Study|Adverse Event|0|||
164275455|NCT00490022|593376348|FG001|Overall Study|Adverse Event|2|||
164275456|NCT00490022|593376347|FG000|Overall Study|Withdrawal by Subject|1|||
164275457|NCT00490022|593376348|FG001|Overall Study|Withdrawal by Subject|0|||
164275458|NCT00490022|593376347|FG000|Overall Study|Subject failed to disclose concommitant|0|||
164275459|NCT00490022|593376348|FG001|Overall Study|Subject failed to disclose concommitant|1|||
164275460|NCT00975143|593376355|FG000|Overall Study|Adverse Event|19|||
164275461|NCT00975143|593376356|FG001|Overall Study|Adverse Event|15|||
164275462|NCT00975143|593376355|FG000|Overall Study|Withdrawal by Subject|15|||
163894466|NCT03582033|591985615|FG001|Part A|Death|1|||
163894467|NCT03582033|591985616|FG002|Part A|Death|2|||
163894468|NCT03582033|591985617|FG003|Part A|Death|4|||
163894469|NCT03582033|591985618|FG004|Part A|Death|11|||
163894470|NCT03582033|591985619|FG005|Part A|Death|0|||
163894471|NCT03582033|591985620|FG006|Part A|Death|0|||
163894472|NCT03582033|591985621|FG007|Part A|Death|0|||
163894473|NCT03582033|591985622|FG008|Part A|Death|0|||
163894474|NCT03582033|591985623|FG009|Part A|Death|0|||
163894475|NCT03582033|591985614|FG000|Part A|Lost to Follow-up|0|||
163894476|NCT03582033|591985615|FG001|Part A|Lost to Follow-up|0|||
163894477|NCT03582033|591985616|FG002|Part A|Lost to Follow-up|0|||
163894478|NCT03582033|591985617|FG003|Part A|Lost to Follow-up|0|||
163894479|NCT03582033|591985618|FG004|Part A|Lost to Follow-up|1|||
163894480|NCT03582033|591985619|FG005|Part A|Lost to Follow-up|0|||
163894481|NCT03582033|591985620|FG006|Part A|Lost to Follow-up|0|||
163894482|NCT03582033|591985621|FG007|Part A|Lost to Follow-up|0|||
163894483|NCT03582033|591985622|FG008|Part A|Lost to Follow-up|0|||
163894484|NCT03582033|591985623|FG009|Part A|Lost to Follow-up|0|||
163894485|NCT03582033|591985614|FG000|Part A|Study terminated by sponsor|0|||
163894486|NCT03582033|591985615|FG001|Part A|Study terminated by sponsor|0|||
163894487|NCT03582033|591985616|FG002|Part A|Study terminated by sponsor|0|||
163894488|NCT03582033|591985617|FG003|Part A|Study terminated by sponsor|2|||
163894489|NCT03582033|591985618|FG004|Part A|Study terminated by sponsor|1|||
163894490|NCT03582033|591985619|FG005|Part A|Study terminated by sponsor|0|||
163894491|NCT03582033|591985620|FG006|Part A|Study terminated by sponsor|0|||
163894492|NCT03582033|591985621|FG007|Part A|Study terminated by sponsor|0|||
163894493|NCT03582033|591985622|FG008|Part A|Study terminated by sponsor|0|||
163894494|NCT03582033|591985623|FG009|Part A|Study terminated by sponsor|0|||
163894495|NCT03582033|591985614|FG000|Part A|Withdrawal by Subject|1|||
163894496|NCT03582033|591985615|FG001|Part A|Withdrawal by Subject|1|||
163894497|NCT03582033|591985616|FG002|Part A|Withdrawal by Subject|0|||
163894498|NCT03582033|591985617|FG003|Part A|Withdrawal by Subject|1|||
163894499|NCT03582033|591985618|FG004|Part A|Withdrawal by Subject|7|||
163894500|NCT03582033|591985619|FG005|Part A|Withdrawal by Subject|0|||
163894501|NCT03582033|591985620|FG006|Part A|Withdrawal by Subject|0|||
163894502|NCT03582033|591985621|FG007|Part A|Withdrawal by Subject|0|||
163894503|NCT03582033|591985622|FG008|Part A|Withdrawal by Subject|0|||
163894504|NCT03582033|591985623|FG009|Part A|Withdrawal by Subject|0|||
163894505|NCT03582033|591985614|FG000|Part B|Death|0|||
163894506|NCT03582033|591985615|FG001|Part B|Death|0|||
163894507|NCT03582033|591985616|FG002|Part B|Death|0|||
163894508|NCT03582033|591985617|FG003|Part B|Death|0|||
163894509|NCT03582033|591985618|FG004|Part B|Death|0|||
163894510|NCT03582033|591985619|FG005|Part B|Death|2|||
163894511|NCT03582033|591985620|FG006|Part B|Death|0|||
163894512|NCT03582033|591985621|FG007|Part B|Death|0|||
163894513|NCT03582033|591985622|FG008|Part B|Death|0|||
163894514|NCT03582033|591985623|FG009|Part B|Death|0|||
163894515|NCT03582033|591985614|FG000|Part B|Study terminated by sponsor|0|||
163894516|NCT03582033|591985615|FG001|Part B|Study terminated by sponsor|0|||
163894517|NCT03582033|591985616|FG002|Part B|Study terminated by sponsor|0|||
163894518|NCT03582033|591985617|FG003|Part B|Study terminated by sponsor|0|||
163894519|NCT03582033|591985618|FG004|Part B|Study terminated by sponsor|0|||
163894520|NCT03582033|591985619|FG005|Part B|Study terminated by sponsor|12|||
163894521|NCT03582033|591985620|FG006|Part B|Study terminated by sponsor|0|||
163894522|NCT03582033|591985621|FG007|Part B|Study terminated by sponsor|0|||
163894523|NCT03582033|591985622|FG008|Part B|Study terminated by sponsor|0|||
163894524|NCT03582033|591985623|FG009|Part B|Study terminated by sponsor|0|||
163894525|NCT03582033|591985614|FG000|Part B|Withdrawal by Subject|0|||
163894526|NCT03582033|591985615|FG001|Part B|Withdrawal by Subject|0|||
163894527|NCT03582033|591985616|FG002|Part B|Withdrawal by Subject|0|||
164275463|NCT00975143|593376356|FG001|Overall Study|Withdrawal by Subject|15|||
164275464|NCT00975143|593376355|FG000|Overall Study|Lost to Follow-up|20|||
163894528|NCT03582033|591985617|FG003|Part B|Withdrawal by Subject|0|||
163894529|NCT03582033|591985618|FG004|Part B|Withdrawal by Subject|0|||
163894530|NCT03582033|591985619|FG005|Part B|Withdrawal by Subject|6|||
163894531|NCT03582033|591985620|FG006|Part B|Withdrawal by Subject|0|||
163894532|NCT03582033|591985621|FG007|Part B|Withdrawal by Subject|0|||
164275465|NCT00975143|593376356|FG001|Overall Study|Lost to Follow-up|16|||
163894533|NCT03582033|591985622|FG008|Part B|Withdrawal by Subject|0|||
163894534|NCT03582033|591985623|FG009|Part B|Withdrawal by Subject|0|||
163894535|NCT03582033|591985614|FG000|Part C|Other|0|||
163894536|NCT03582033|591985615|FG001|Part C|Other|0|||
163894537|NCT03582033|591985616|FG002|Part C|Other|0|||
163894538|NCT03582033|591985617|FG003|Part C|Other|0|||
163894539|NCT03582033|591985618|FG004|Part C|Other|0|||
163894540|NCT03582033|591985619|FG005|Part C|Other|0|||
163894541|NCT03582033|591985620|FG006|Part C|Other|2|||
163894542|NCT03582033|591985621|FG007|Part C|Other|0|||
163894543|NCT03582033|591985622|FG008|Part C|Other|0|||
163894544|NCT03582033|591985623|FG009|Part C|Other|0|||
163894545|NCT03582033|591985614|FG000|Part C|Death|0|||
163894546|NCT03582033|591985615|FG001|Part C|Death|0|||
163894547|NCT03582033|591985616|FG002|Part C|Death|0|||
163894548|NCT03582033|591985617|FG003|Part C|Death|0|||
163894549|NCT03582033|591985618|FG004|Part C|Death|0|||
163894550|NCT03582033|591985619|FG005|Part C|Death|0|||
163894551|NCT03582033|591985620|FG006|Part C|Death|6|||
163894552|NCT03582033|591985621|FG007|Part C|Death|1|||
163894553|NCT03582033|591985622|FG008|Part C|Death|2|||
163894554|NCT03582033|591985623|FG009|Part C|Death|0|||
163894555|NCT03582033|591985614|FG000|Part C|Study terminated by sponsor|0|||
163894556|NCT03582033|591985615|FG001|Part C|Study terminated by sponsor|0|||
163894557|NCT03582033|591985616|FG002|Part C|Study terminated by sponsor|0|||
163894558|NCT03582033|591985617|FG003|Part C|Study terminated by sponsor|0|||
163894559|NCT03582033|591985618|FG004|Part C|Study terminated by sponsor|0|||
163894560|NCT03582033|591985619|FG005|Part C|Study terminated by sponsor|0|||
163894561|NCT03582033|591985620|FG006|Part C|Study terminated by sponsor|3|||
163894562|NCT03582033|591985621|FG007|Part C|Study terminated by sponsor|3|||
163894563|NCT03582033|591985622|FG008|Part C|Study terminated by sponsor|2|||
163894564|NCT03582033|591985623|FG009|Part C|Study terminated by sponsor|0|||
163894565|NCT03582033|591985614|FG000|Part C|Withdrawal by Subject|0|||
163894566|NCT03582033|591985615|FG001|Part C|Withdrawal by Subject|0|||
163894567|NCT03582033|591985616|FG002|Part C|Withdrawal by Subject|0|||
163894568|NCT03582033|591985617|FG003|Part C|Withdrawal by Subject|0|||
163894569|NCT03582033|591985618|FG004|Part C|Withdrawal by Subject|0|||
163894570|NCT03582033|591985619|FG005|Part C|Withdrawal by Subject|0|||
163894571|NCT03582033|591985620|FG006|Part C|Withdrawal by Subject|1|||
163894572|NCT03582033|591985621|FG007|Part C|Withdrawal by Subject|2|||
163894573|NCT03582033|591985622|FG008|Part C|Withdrawal by Subject|1|||
164342957|NCT00282984|593631604|FG001|Overall Study|in prison|1|||
163894574|NCT03582033|591985623|FG009|Part C|Withdrawal by Subject|0|||
164342958|NCT00282984|593631603|FG000|Overall Study|Protocol Violation|2|||
164342959|NCT00282984|593631604|FG001|Overall Study|Protocol Violation|0|||
164342960|NCT00674362|593631605|FG000|Double Blind|Adverse Event|6|||
164342961|NCT00674362|593631606|FG001|Double Blind|Adverse Event|6|||
164342962|NCT00674362|593631605|FG000|Double Blind|Lack of Efficacy|2|||
164342963|NCT00674362|593631606|FG001|Double Blind|Lack of Efficacy|6|||
164342964|NCT00674362|593631605|FG000|Double Blind|Loss of efficacy|0|||
164342965|NCT00674362|593631606|FG001|Double Blind|Loss of efficacy|1|||
164342966|NCT00674362|593631605|FG000|Double Blind|Withdrawal by Subject|4|||
164342967|NCT00674362|593631606|FG001|Double Blind|Withdrawal by Subject|3|||
164342968|NCT00674362|593631605|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
164342969|NCT00674362|593631606|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
164342970|NCT00674362|593631605|FG000|Double Blind|Other: Surgery|0|||
164342971|NCT00674362|593631606|FG001|Double Blind|Other: Surgery|1|||
163894575|NCT03582033|591985614|FG000|Part D|Death|0|||
163894576|NCT03582033|591985615|FG001|Part D|Death|0|||
163894577|NCT03582033|591985616|FG002|Part D|Death|0|||
163894578|NCT03582033|591985617|FG003|Part D|Death|0|||
163894579|NCT03582033|591985618|FG004|Part D|Death|0|||
163894580|NCT03582033|591985619|FG005|Part D|Death|0|||
163894581|NCT03582033|591985620|FG006|Part D|Death|0|||
163894582|NCT03582033|591985621|FG007|Part D|Death|0|||
163894583|NCT03582033|591985622|FG008|Part D|Death|0|||
163894584|NCT03582033|591985623|FG009|Part D|Death|1|||
163894585|NCT03582033|591985614|FG000|Part D|Study terminated by sponsor|0|||
163894586|NCT03582033|591985615|FG001|Part D|Study terminated by sponsor|0|||
163894587|NCT03582033|591985616|FG002|Part D|Study terminated by sponsor|0|||
163894588|NCT03582033|591985617|FG003|Part D|Study terminated by sponsor|0|||
163894589|NCT03582033|591985618|FG004|Part D|Study terminated by sponsor|0|||
163894590|NCT03582033|591985619|FG005|Part D|Study terminated by sponsor|0|||
163894591|NCT03582033|591985620|FG006|Part D|Study terminated by sponsor|0|||
164342972|NCT00674362|593631605|FG000|Open Label|Adverse Event|1|||
164342973|NCT00674362|593631606|FG001|Open Label|Adverse Event|0|||
164342974|NCT00674362|593631605|FG000|Open Label|Other: Subject moved to extension study|1|||
163894592|NCT03582033|591985621|FG007|Part D|Study terminated by sponsor|0|||
163894593|NCT03582033|591985622|FG008|Part D|Study terminated by sponsor|0|||
163894594|NCT03582033|591985623|FG009|Part D|Study terminated by sponsor|4|||
163894595|NCT06010836|591985624|FG000|Overall Study|Lost to Follow-up|2|||
163894596|NCT06010836|591985625|FG001|Overall Study|Lost to Follow-up|2|||
163894597|NCT06010836|591985624|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
164275466|NCT00975143|593376355|FG000|Overall Study|Non-compliance|5|||
164275467|NCT00975143|593376356|FG001|Overall Study|Non-compliance|8|||
164275468|NCT00975143|593376355|FG000|Overall Study|Physician Decision|1|||
164275469|NCT00975143|593376356|FG001|Overall Study|Physician Decision|2|||
164275470|NCT00975143|593376355|FG000|Overall Study|Details not available|10|||
164275471|NCT00975143|593376356|FG001|Overall Study|Details not available|4|||
164275472|NCT00470418|593376357|FG000|Overall Study|Withdrawal by Subject|1|||
164275473|NCT00470418|593376358|FG001|Overall Study|Withdrawal by Subject|0|||
164275474|NCT03129360|593376359|FG000|Overall Study|Did not meet entry criteria|0|||
164275475|NCT03129360|593376360|FG001|Overall Study|Did not meet entry criteria|2|||
164275476|NCT03129360|593376361|FG002|Overall Study|Did not meet entry criteria|1|||
164275477|NCT03129360|593376359|FG000|Overall Study|Excluded due to motion in scanner|1|||
164275478|NCT03129360|593376360|FG001|Overall Study|Excluded due to motion in scanner|0|||
164275479|NCT03129360|593376361|FG002|Overall Study|Excluded due to motion in scanner|0|||
164275480|NCT01818492|593376362|FG000|Overall Study|Adverse Event|2|||
164275481|NCT01818492|593376362|FG000|Overall Study|Death|3|||
164275482|NCT01818492|593376362|FG000|Overall Study|Withdrawal by Subject|1|||
164275483|NCT01818492|593376362|FG000|Overall Study|Additional therapy when not allowed PP|4|||
164275484|NCT01729208|593376363|FG000|Baseline|Physician Decision|5|||
164275485|NCT01729208|593376364|FG001|Baseline|Physician Decision|4|||
164275486|NCT01729208|593376363|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
164275487|NCT01729208|593376364|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
164275488|NCT01729208|593376363|FG000|12 Months Follow-up|Lost to Follow-up|3|||
164275489|NCT01729208|593376364|FG001|12 Months Follow-up|Lost to Follow-up|3|||
163894598|NCT06010836|591985625|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
163894599|NCT06010836|591985624|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
163894600|NCT06010836|591985625|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
163894601|NCT06010836|591985624|FG000|Overall Study|Did not receive intervention discussion|0|||
163894602|NCT06010836|591985625|FG001|Overall Study|Did not receive intervention discussion|4|||
163894603|NCT03812614|591985626|FG000|Intervention|Withdrawal by Subject|7|||
163894604|NCT03812614|591985627|FG001|Intervention|Withdrawal by Subject|2|||
163894605|NCT03812614|591985628|FG002|Intervention|Withdrawal by Subject|7|||
163894606|NCT03812614|591985629|FG003|Intervention|Withdrawal by Subject|2|||
163894607|NCT03812614|591985626|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
163894608|NCT03812614|591985627|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
163894609|NCT03812614|591985628|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
163894610|NCT03812614|591985629|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
163894611|NCT03812614|591985626|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
163894612|NCT03812614|591985627|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
163894613|NCT03812614|591985628|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
163894614|NCT03812614|591985629|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
163894615|NCT03812614|591985626|FG000|6-month Follow-up|Lost to Follow-up|0|||
163894616|NCT03812614|591985627|FG001|6-month Follow-up|Lost to Follow-up|0|||
163894617|NCT03812614|591985628|FG002|6-month Follow-up|Lost to Follow-up|12|||
163894618|NCT03812614|591985629|FG003|6-month Follow-up|Lost to Follow-up|8|||
163894619|NCT03812614|591985626|FG000|12-month Follow-up|Lost to Follow-up|18|||
163894620|NCT03812614|591985627|FG001|12-month Follow-up|Lost to Follow-up|17|||
163894621|NCT03812614|591985628|FG002|12-month Follow-up|Lost to Follow-up|5|||
163894622|NCT03812614|591985629|FG003|12-month Follow-up|Lost to Follow-up|2|||
163894623|NCT03372057|591985642|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
163894624|NCT03372057|591985643|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
163894625|NCT03372057|591985644|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
163894626|NCT03372057|591985642|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
163894627|NCT03372057|591985643|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
163894628|NCT03372057|591985644|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
163894629|NCT03372057|591985642|FG000|Dose Optimization Phase|Death|16|||
163894630|NCT03372057|591985643|FG001|Dose Optimization Phase|Death|11|||
163894631|NCT03372057|591985644|FG002|Dose Optimization Phase|Death|0|||
163894632|NCT03372057|591985642|FG000|Expansion Phase|Withdrawal by Subject|0|||
163894633|NCT03372057|591985643|FG001|Expansion Phase|Withdrawal by Subject|0|||
163894634|NCT03372057|591985644|FG002|Expansion Phase|Withdrawal by Subject|4|||
163894635|NCT03372057|591985642|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
163894636|NCT03372057|591985643|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
163894637|NCT03372057|591985644|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
163894638|NCT03372057|591985642|FG000|Expansion Phase|Death|0|||
163894639|NCT03372057|591985643|FG001|Expansion Phase|Death|0|||
163894640|NCT03372057|591985644|FG002|Expansion Phase|Death|78|||
163894641|NCT03372057|591985642|FG000|Expansion Phase|Progressive Disease|0|||
163894642|NCT03372057|591985643|FG001|Expansion Phase|Progressive Disease|0|||
164001184|NCT02224664|592368440|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164001185|NCT02224664|592368441|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164001186|NCT02224664|592368442|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164001187|NCT02224664|592368443|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
164001188|NCT02224664|592368439|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
164001189|NCT02224664|592368440|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
164001190|NCT02224664|592368441|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
164001191|NCT02224664|592368442|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
164001192|NCT02224664|592368443|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
164001193|NCT02224664|592368439|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
164275490|NCT01729208|593376363|FG000|24 Months Follow-up|Lost to Follow-up|3|||
164275491|NCT01729208|593376364|FG001|24 Months Follow-up|Lost to Follow-up|0|||
164275492|NCT01729208|593376363|FG000|36 Months Follow-up|Physician Decision|1|||
164275493|NCT01729208|593376364|FG001|36 Months Follow-up|Physician Decision|0|||
164275494|NCT01729208|593376363|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
164275495|NCT01729208|593376364|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
164275496|NCT02428413|593376365|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
164275497|NCT02428413|593376366|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
164275498|NCT02428413|593376365|FG000|Overall Study|Protocol Violation|1|||
164275499|NCT02428413|593376366|FG001|Overall Study|Protocol Violation|2|||
164275500|NCT02428413|593376365|FG000|Overall Study|Case Cancelled|2|||
164275501|NCT02428413|593376366|FG001|Overall Study|Case Cancelled|0|||
164275502|NCT02428413|593376365|FG000|Overall Study|Missed Cases|1|||
164275503|NCT02428413|593376366|FG001|Overall Study|Missed Cases|2|||
164275504|NCT02428413|593376365|FG000|Overall Study|Nurse Refusal|1|||
164275505|NCT02428413|593376366|FG001|Overall Study|Nurse Refusal|0|||
164275506|NCT00885482|593376367|FG000|Overall Study|Pregnancy|1|||
164275507|NCT00885482|593376367|FG000|Overall Study|Lack of Efficacy|1|||
164275508|NCT00885482|593376367|FG000|Overall Study|Death|1|||
164275509|NCT00885482|593376367|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
164275510|NCT02772978|593376368|FG000|Overall Study|Withdrawal by Subject|1|||
164275511|NCT02772978|593376369|FG001|Overall Study|Withdrawal by Subject|1|||
164275512|NCT02438813|593376370|FG000|Overall Study|Patient Decision|59|||
164275513|NCT02438813|593376370|FG000|Overall Study|Patient Lost to Follow-Up|137|||
164275514|NCT02438813|593376370|FG000|Overall Study|Study Ended by Sponsor|80|||
164275515|NCT02438813|593376370|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
164275516|NCT00409344|593376372|FG000|Overall Study|no enrollment|0|||
164275517|NCT00409344|593376373|FG001|Overall Study|no enrollment|0|||
164275518|NCT02879578|593376376|FG000|Overall Study|Adverse Event|1|||
164275519|NCT02879578|593376377|FG001|Overall Study|Adverse Event|2|||
164275520|NCT02879578|593376378|FG002|Overall Study|Adverse Event|14|||
164275521|NCT02879578|593376376|FG000|Overall Study|Protocol Violation|0|||
164275522|NCT02879578|593376377|FG001|Overall Study|Protocol Violation|1|||
164275523|NCT02879578|593376378|FG002|Overall Study|Protocol Violation|1|||
164275524|NCT02879578|593376376|FG000|Overall Study|Withdrawal by Subject|8|||
164275525|NCT02879578|593376377|FG001|Overall Study|Withdrawal by Subject|6|||
164275526|NCT02879578|593376378|FG002|Overall Study|Withdrawal by Subject|9|||
164275527|NCT02879578|593376376|FG000|Overall Study|Lost to Follow-up|1|||
164275528|NCT02879578|593376377|FG001|Overall Study|Lost to Follow-up|0|||
164275529|NCT02879578|593376378|FG002|Overall Study|Lost to Follow-up|4|||
164085957|NCT01995058|592678601|FG000|Overall Study|Progressive Disease|0|||
164275530|NCT02879578|593376376|FG000|Overall Study|Physician Decision|0|||
164275531|NCT02879578|593376377|FG001|Overall Study|Physician Decision|0|||
164275532|NCT02879578|593376378|FG002|Overall Study|Physician Decision|4|||
164275533|NCT01879072|593376384|FG000|Overall Study|Withdrawal by Subject|121|||
164275534|NCT01879072|593376384|FG000|Overall Study|Not Transplanted|30|||
164275535|NCT02666105|593376391|FG000|Overall Study|Death|1|||
164275536|NCT00411632|593376392|FG000|Overall Study|Death|1|||
164275537|NCT01264419|593376393|FG000|Overall Study|Lost to Follow-up|3|||
164275538|NCT00659230|593376394|FG000|Overall Study|Lost to Follow-up|2|||
164275539|NCT00659230|593376395|FG001|Overall Study|Lost to Follow-up|5|||
164275540|NCT00659230|593376394|FG000|Overall Study|Lost source documentation|5|||
164275541|NCT00659230|593376395|FG001|Overall Study|Lost source documentation|4|||
164275542|NCT00659230|593376394|FG000|Overall Study|Did not return post-randomization|2|||
164275543|NCT00659230|593376395|FG001|Overall Study|Did not return post-randomization|3|||
164275544|NCT05249569|593377378|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
164275545|NCT03703856|593377379|FG000|Enrolled in study|Withdrawal by Subject|23|||
164275546|NCT03703856|593377379|FG000|Titrated to full dose|Withdrawal by Subject|5|||
164275547|NCT03703856|593377379|FG000|16 week assessment|Withdrawal by Subject|1|||
164275548|NCT03703856|593377379|FG000|24 week assessment|Withdrawal by Subject|1|||
164275549|NCT03402386|593377380|FG000|Overall Study|Adverse Event|3|||
164275550|NCT03402386|593377380|FG000|Overall Study|Physician Decision|1|||
164275551|NCT03402386|593377380|FG000|Overall Study|Difficult to control Hb|2|||
164275552|NCT05138419|593377381|FG000|Overall Study|Study terminated before participant completed.|0|||
164275553|NCT05138419|593377382|FG001|Overall Study|Study terminated before participant completed.|0|||
164275554|NCT05138419|593377383|FG002|Overall Study|Study terminated before participant completed.|1|||
164275555|NCT01048853|593377384|FG000|Overall Study|Death|1|||
164275556|NCT01048853|593377385|FG001|Overall Study|Death|0|||
164275557|NCT01048853|593377386|FG002|Overall Study|Death|0|||
164275558|NCT01048853|593377384|FG000|Overall Study|Lost to Follow-up|1|||
164275559|NCT01048853|593377385|FG001|Overall Study|Lost to Follow-up|4|||
164275560|NCT01048853|593377386|FG002|Overall Study|Lost to Follow-up|0|||
164275561|NCT01532570|593377394|FG000|Overall Study|Lack of Efficacy|1|||
164275562|NCT01532570|593377395|FG001|Overall Study|Lack of Efficacy|0|||
164275563|NCT01532570|593377396|FG002|Overall Study|Lack of Efficacy|0|||
164275564|NCT01532570|593377397|FG003|Overall Study|Lack of Efficacy|0|||
164275565|NCT01532570|593377394|FG000|Overall Study|Withdrawal by Subject|0|||
164275566|NCT01532570|593377395|FG001|Overall Study|Withdrawal by Subject|1|||
164275567|NCT01532570|593377396|FG002|Overall Study|Withdrawal by Subject|0|||
164275568|NCT01532570|593377397|FG003|Overall Study|Withdrawal by Subject|0|||
164275569|NCT01585155|593377398|FG000|Overall Study|Adverse Event|1|||
164275570|NCT01585155|593377398|FG000|Overall Study|Lack of Efficacy|2|||
164275571|NCT01585155|593377398|FG000|Overall Study|Worsening ulcerative colitis|2|||
164275572|NCT00805766|593377400|FG000|Screening Period|Adverse Event|1|||
164275573|NCT00805766|593377400|FG000|Screening Period|Lack of Efficacy|2|||
164275574|NCT00805766|593377400|FG000|Screening Period|Pregnancy|1|||
164275575|NCT00805766|593377400|FG000|Screening Period|Responder|2|||
164275576|NCT00805766|593377400|FG000|Increased Dose Period|Adverse Event|4|||
164275577|NCT00805766|593377400|FG000|Increased Dose Period|Lack of Efficacy|7|||
164275578|NCT00805766|593377400|FG000|Increased Dose Period|Pregnancy|1|||
164275579|NCT00805766|593377400|FG000|Increased Dose Period|Withdrawal by Subject|1|||
164275580|NCT04254913|593377401|FG000|Overall Study|Adverse Event|1|||
164275581|NCT02354222|593377402|FG000|Overall Study|Adverse Event|0|||
164275582|NCT02354222|593377403|FG001|Overall Study|Adverse Event|3|||
164085958|NCT01995058|592678602|FG001|Overall Study|Progressive Disease|1|||
164275583|NCT02354222|593377402|FG000|Overall Study|Physician Decision|1|||
164275584|NCT02354222|593377403|FG001|Overall Study|Physician Decision|1|||
164275585|NCT02354222|593377402|FG000|Overall Study|Pregnancy|1|||
164275586|NCT02354222|593377403|FG001|Overall Study|Pregnancy|0|||
164275587|NCT02354222|593377402|FG000|Overall Study|Withdrawal by Subject|2|||
164275588|NCT02354222|593377403|FG001|Overall Study|Withdrawal by Subject|3|||
164275589|NCT02354222|593377402|FG000|Overall Study|Conflict with the stopping criteria|0|||
164275590|NCT02354222|593377403|FG001|Overall Study|Conflict with the stopping criteria|4|||
164275591|NCT04300218|593377404|FG000|Overall Study|Lost to Follow-up|6|||
164275592|NCT04300218|593377405|FG001|Overall Study|Lost to Follow-up|8|||
164275593|NCT02911142|593377406|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
164275594|NCT02911142|593377406|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
164275595|NCT02911142|593377406|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
164275596|NCT02911142|593377406|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
164275597|NCT05451940|593377407|FG000|Treatment Period|Physician Decision|1|||
164275598|NCT03645863|593377408|FG000|Overall Study|Withdrawal by Subject|1|||
164275599|NCT03645863|593377409|FG001|Overall Study|Withdrawal by Subject|0|||
164275600|NCT03645863|593377410|FG002|Overall Study|Withdrawal by Subject|0|||
164275601|NCT02220907|593377411|FG000|Overall Study|Adverse Event|7|||
164275602|NCT02220907|593377411|FG000|Overall Study|Physician Decision|1|||
164275603|NCT02220907|593377411|FG000|Overall Study|Withdrawal by Subject|2|||
164275604|NCT02220907|593377411|FG000|Overall Study|Conflict with the stopping criteria|1|||
164275605|NCT00542815|593377412|FG000|Overall Study|Adverse Event|19|||
164275606|NCT00542815|593377413|FG001|Overall Study|Adverse Event|6|||
164275607|NCT00542815|593377414|FG002|Overall Study|Adverse Event|9|||
164275608|NCT00542815|593377412|FG000|Overall Study|Death|10|||
164275609|NCT00542815|593377413|FG001|Overall Study|Death|7|||
164275610|NCT00542815|593377414|FG002|Overall Study|Death|3|||
164275611|NCT00542815|593377412|FG000|Overall Study|Lack of Efficacy|9|||
164275612|NCT00542815|593377413|FG001|Overall Study|Lack of Efficacy|2|||
164275613|NCT00542815|593377414|FG002|Overall Study|Lack of Efficacy|0|||
164275614|NCT00542815|593377412|FG000|Overall Study|Physician Decision|2|||
164275615|NCT00542815|593377413|FG001|Overall Study|Physician Decision|1|||
164275616|NCT00542815|593377414|FG002|Overall Study|Physician Decision|0|||
164275617|NCT00542815|593377412|FG000|Overall Study|Protocol Violation|1|||
164275618|NCT00542815|593377413|FG001|Overall Study|Protocol Violation|1|||
164275619|NCT00542815|593377414|FG002|Overall Study|Protocol Violation|2|||
164275620|NCT00542815|593377412|FG000|Overall Study|Withdrawal by Subject|41|||
164275621|NCT00542815|593377413|FG001|Overall Study|Withdrawal by Subject|5|||
164275622|NCT00542815|593377414|FG002|Overall Study|Withdrawal by Subject|8|||
164275623|NCT00542815|593377412|FG000|Overall Study|Other reasons|24|||
164275624|NCT00542815|593377413|FG001|Overall Study|Other reasons|10|||
164275625|NCT00542815|593377414|FG002|Overall Study|Other reasons|10|||
164275626|NCT01716104|593377418|FG000|Overall Study|Do not meet inclusion criteria|6|||
164275627|NCT01716104|593377419|FG001|Overall Study|Do not meet inclusion criteria|7|||
164275628|NCT00117793|593377420|FG000|Overall Study|Withdrawal by Subject|12|||
164275629|NCT01069705|593377423|FG000|Overall Study|Adverse Event|1|||
164275630|NCT01069705|593377423|FG000|Overall Study|Withdrawal by Subject|2|||
164275631|NCT03624127|593377424|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
164275632|NCT03624127|593377425|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
164275633|NCT03624127|593377426|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
164275634|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
164275635|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
164275636|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
164275637|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Death|0|||
164275638|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Death|1|||
164275639|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Death|0|||
164275640|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
163900166|NCT03789110|592005624|FG000|Overall Study|Adverse Event|2|||
164275641|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
164275642|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
164275643|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
164275644|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
164275645|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
164275646|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
164275647|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
163894643|NCT03372057|591985644|FG002|Expansion Phase|Progressive Disease|1|||
163894644|NCT03372057|591985642|FG000|Expansion Phase|Adverse Event|0|||
163894645|NCT03372057|591985643|FG001|Expansion Phase|Adverse Event|0|||
163894646|NCT03372057|591985644|FG002|Expansion Phase|Adverse Event|1|||
163894647|NCT02518048|591985645|FG000|Overall Study|Withdrawal by Subject|1|||
163894648|NCT04505410|591985646|FG000|Overall Study|Adverse Event|2|||
163894649|NCT04505410|591985647|FG001|Overall Study|Adverse Event|0|||
163894650|NCT04505410|591985646|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
163894651|NCT04505410|591985647|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
163894652|NCT04505410|591985646|FG000|Overall Study|did not want to follow diet|1|||
163894653|NCT04505410|591985647|FG001|Overall Study|did not want to follow diet|0|||
163894654|NCT04505410|591985646|FG000|Overall Study|flare up of ulcerative colitis|0|||
163894655|NCT04505410|591985647|FG001|Overall Study|flare up of ulcerative colitis|1|||
163894656|NCT04505410|591985646|FG000|Overall Study|Lost to Follow-up|0|||
163894657|NCT04505410|591985647|FG001|Overall Study|Lost to Follow-up|2|||
163894658|NCT04505410|591985646|FG000|Overall Study|Lost to Follow-up|1|||
163894659|NCT04505410|591985647|FG001|Overall Study|Lost to Follow-up|0|||
163894660|NCT04505410|591985646|FG000|Overall Study|initiated another diet on their own|0|||
163894661|NCT04505410|591985647|FG001|Overall Study|initiated another diet on their own|2|||
163894662|NCT05123027|591985648|FG000|Overall Study|Lost to Follow-up|17|||
163894663|NCT05123027|591985649|FG001|Overall Study|Lost to Follow-up|22|||
163894664|NCT05123027|591985648|FG000|Overall Study|Incarceration|3|||
163894665|NCT05123027|591985649|FG001|Overall Study|Incarceration|4|||
163894666|NCT05123027|591985648|FG000|Overall Study|Death|2|||
163894667|NCT05123027|591985649|FG001|Overall Study|Death|2|||
163894668|NCT05123027|591985648|FG000|Overall Study|Other|2|||
163894669|NCT05123027|591985649|FG001|Overall Study|Other|0|||
163894670|NCT05654662|591985650|FG000|Overall Study|Withdrawal by Subject|1|||
163894671|NCT05654662|591985651|FG001|Overall Study|Withdrawal by Subject|0|||
163894672|NCT05654662|591985650|FG000|Overall Study|A death in the family|1|||
163894673|NCT05654662|591985651|FG001|Overall Study|A death in the family|0|||
163894674|NCT04330040|591985652|FG000|Overall Study|Other: Adverse event|5|||
163894675|NCT04330040|591985653|FG001|Overall Study|Other: Adverse event|0|||
163894676|NCT04330040|591985654|FG002|Overall Study|Other: Adverse event|0|||
163894677|NCT04330040|591985652|FG000|Overall Study|Disease progression|38|||
164001194|NCT02224664|592368440|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
164001195|NCT02224664|592368441|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
164001196|NCT02224664|592368442|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
164001197|NCT02224664|592368443|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
164001198|NCT00768222|592368444|FG000|Overall Study|Lost to Follow-up|1|||
164001199|NCT00768222|592368445|FG001|Overall Study|Lost to Follow-up|1|||
164001200|NCT00768222|592368444|FG000|Overall Study|Withdrawal by Subject|3|||
163894678|NCT04330040|591985653|FG001|Overall Study|Disease progression|10|||
163894679|NCT04330040|591985654|FG002|Overall Study|Disease progression|0|||
163894680|NCT04330040|591985652|FG000|Overall Study|Physician Decision|5|||
163894681|NCT04330040|591985653|FG001|Overall Study|Physician Decision|3|||
163894682|NCT04330040|591985654|FG002|Overall Study|Physician Decision|0|||
163894683|NCT04330040|591985652|FG000|Overall Study|Lost to Follow-up|1|||
163894684|NCT04330040|591985653|FG001|Overall Study|Lost to Follow-up|1|||
163894685|NCT04330040|591985654|FG002|Overall Study|Lost to Follow-up|0|||
163894686|NCT04330040|591985652|FG000|Overall Study|Death|2|||
163894687|NCT04330040|591985653|FG001|Overall Study|Death|1|||
163894688|NCT04330040|591985654|FG002|Overall Study|Death|0|||
164342975|NCT00674362|593631606|FG001|Open Label|Other: Subject moved to extension study|0|||
164342976|NCT00939770|593631609|FG000|Overall Study|Adverse Event|1|||
164342977|NCT00939770|593631610|FG001|Overall Study|Adverse Event|1|||
164342978|NCT00939770|593631611|FG002|Overall Study|Adverse Event|0|||
164342979|NCT00939770|593631612|FG003|Overall Study|Adverse Event|0|||
163894689|NCT04330040|591985652|FG000|Overall Study|Withdrawal by Subject|3|||
163894690|NCT04330040|591985653|FG001|Overall Study|Withdrawal by Subject|3|||
163894691|NCT04330040|591985654|FG002|Overall Study|Withdrawal by Subject|0|||
163894692|NCT04330040|591985652|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
163894693|NCT04330040|591985653|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
163894694|NCT04330040|591985654|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
163894695|NCT04330040|591985652|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
163894696|NCT04330040|591985653|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
163894697|NCT04330040|591985654|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
163894698|NCT04330040|591985652|FG000|Overall Study|Other: Disease progression|1|||
163894699|NCT04330040|591985653|FG001|Overall Study|Other: Disease progression|0|||
163894700|NCT04330040|591985654|FG002|Overall Study|Other: Disease progression|0|||
163894701|NCT04330040|591985652|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
163894702|NCT04330040|591985653|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
163894703|NCT04330040|591985654|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
163894704|NCT04330040|591985652|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
163894705|NCT04330040|591985653|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
163894706|NCT04330040|591985654|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
163894707|NCT04330040|591985652|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
163894708|NCT04330040|591985653|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
163894709|NCT04330040|591985654|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
163894710|NCT04230681|591985655|FG000|Overall Study|Physician Decision|2|||
163894711|NCT04230681|591985656|FG001|Overall Study|Physician Decision|3|||
163894712|NCT04230681|591985655|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
163894713|NCT04230681|591985656|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
163894714|NCT04230681|591985655|FG000|Overall Study|IV inadvertently removed|0|||
163894715|NCT04230681|591985656|FG001|Overall Study|IV inadvertently removed|1|||
163894716|NCT05962814|591985657|FG000|Overall Study|failed eligibility|1|||
163894717|NCT03057054|591985658|FG000|Overall Study|Death|4|||
163894718|NCT03057054|591985659|FG001|Overall Study|Death|4|||
163894719|NCT03057054|591985658|FG000|Overall Study|Withdrawal by Subject|6|||
163894720|NCT03057054|591985659|FG001|Overall Study|Withdrawal by Subject|3|||
163894721|NCT03057054|591985658|FG000|Overall Study|Ineligible|1|||
163894722|NCT03057054|591985659|FG001|Overall Study|Ineligible|1|||
163894723|NCT04427007|591986750|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
163894724|NCT04427007|591986751|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
163894725|NCT05311176|591986754|FG000|Overall Study|Death|6|||
163894726|NCT05311176|591986754|FG000|Overall Study|Sponsor discontinued the study|1|||
163894727|NCT05247034|591986755|FG000|Overall Study|Lost to Follow-up|3|||
163894728|NCT05247034|591986756|FG001|Overall Study|Lost to Follow-up|2|||
163894729|NCT05247034|591986755|FG000|Overall Study|Organizational problems when attending appointments|1|||
163894730|NCT05247034|591986756|FG001|Overall Study|Organizational problems when attending appointments|0|||
163894731|NCT05464069|591986762|FG000|Overall Study|Protocol Violation|3|||
163894732|NCT05464069|591986763|FG001|Overall Study|Protocol Violation|2|||
163894733|NCT04615273|591986771|FG000|Overall Study|Withdrawal by Subject|3|||
163894734|NCT04615273|591986772|FG001|Overall Study|Withdrawal by Subject|1|||
163894735|NCT04615273|591986773|FG002|Overall Study|Withdrawal by Subject|2|||
163894736|NCT04615273|591986771|FG000|Overall Study|Adverse Event|1|||
163894737|NCT04615273|591986772|FG001|Overall Study|Adverse Event|0|||
163894738|NCT04615273|591986773|FG002|Overall Study|Adverse Event|1|||
163894739|NCT04615273|591986771|FG000|Overall Study|Lost to Follow-up|0|||
163894740|NCT04615273|591986772|FG001|Overall Study|Lost to Follow-up|1|||
163894741|NCT04615273|591986773|FG002|Overall Study|Lost to Follow-up|0|||
163894742|NCT04615273|591986771|FG000|Overall Study|Physician Decision|0|||
163894743|NCT04615273|591986772|FG001|Overall Study|Physician Decision|0|||
163894744|NCT04615273|591986773|FG002|Overall Study|Physician Decision|1|||
164001201|NCT00768222|592368445|FG001|Overall Study|Withdrawal by Subject|1|||
163894745|NCT04615273|591986771|FG000|Overall Study|Other|0|||
163894746|NCT04615273|591986772|FG001|Overall Study|Other|1|||
164342980|NCT00939770|593631613|FG004|Overall Study|Adverse Event|6|||
164342981|NCT00939770|593631614|FG005|Overall Study|Adverse Event|2|||
164342982|NCT00939770|593631615|FG006|Overall Study|Adverse Event|1|||
164342983|NCT00939770|593631616|FG007|Overall Study|Adverse Event|1|||
164342984|NCT00939770|593631609|FG000|Overall Study|Lack of Efficacy|4|||
164342985|NCT00939770|593631610|FG001|Overall Study|Lack of Efficacy|6|||
164342986|NCT00939770|593631611|FG002|Overall Study|Lack of Efficacy|13|||
164342987|NCT00939770|593631612|FG003|Overall Study|Lack of Efficacy|9|||
164342988|NCT00939770|593631613|FG004|Overall Study|Lack of Efficacy|16|||
164342989|NCT00939770|593631614|FG005|Overall Study|Lack of Efficacy|8|||
164342990|NCT00939770|593631615|FG006|Overall Study|Lack of Efficacy|11|||
164342991|NCT00939770|593631616|FG007|Overall Study|Lack of Efficacy|1|||
164085959|NCT01995058|592678603|FG002|Overall Study|Progressive Disease|1|||
164342992|NCT00939770|593631609|FG000|Overall Study|Lost to Follow-up|0|||
164342993|NCT00939770|593631610|FG001|Overall Study|Lost to Follow-up|0|||
164342994|NCT00939770|593631611|FG002|Overall Study|Lost to Follow-up|0|||
164342995|NCT00939770|593631612|FG003|Overall Study|Lost to Follow-up|0|||
164342996|NCT00939770|593631613|FG004|Overall Study|Lost to Follow-up|1|||
164342997|NCT00939770|593631614|FG005|Overall Study|Lost to Follow-up|0|||
164342998|NCT00939770|593631615|FG006|Overall Study|Lost to Follow-up|0|||
164342999|NCT00939770|593631616|FG007|Overall Study|Lost to Follow-up|0|||
164343000|NCT00939770|593631609|FG000|Overall Study|Physician Decision|0|||
164343001|NCT00939770|593631610|FG001|Overall Study|Physician Decision|0|||
164343002|NCT00939770|593631611|FG002|Overall Study|Physician Decision|2|||
164343003|NCT00939770|593631612|FG003|Overall Study|Physician Decision|0|||
164343004|NCT00939770|593631613|FG004|Overall Study|Physician Decision|7|||
164343005|NCT00939770|593631614|FG005|Overall Study|Physician Decision|1|||
164343006|NCT00939770|593631615|FG006|Overall Study|Physician Decision|0|||
164343007|NCT00939770|593631616|FG007|Overall Study|Physician Decision|6|||
164343008|NCT00939770|593631609|FG000|Overall Study|Protocol Violation|0|||
164343009|NCT00939770|593631610|FG001|Overall Study|Protocol Violation|0|||
164343010|NCT00939770|593631611|FG002|Overall Study|Protocol Violation|0|||
164343011|NCT00939770|593631612|FG003|Overall Study|Protocol Violation|0|||
164343012|NCT00939770|593631613|FG004|Overall Study|Protocol Violation|1|||
164343013|NCT00939770|593631614|FG005|Overall Study|Protocol Violation|0|||
164343014|NCT00939770|593631615|FG006|Overall Study|Protocol Violation|0|||
164343015|NCT00939770|593631616|FG007|Overall Study|Protocol Violation|0|||
164343016|NCT00939770|593631609|FG000|Overall Study|Withdrawal by Subject|0|||
164343017|NCT00939770|593631610|FG001|Overall Study|Withdrawal by Subject|1|||
164343018|NCT00939770|593631611|FG002|Overall Study|Withdrawal by Subject|5|||
164343019|NCT00939770|593631612|FG003|Overall Study|Withdrawal by Subject|2|||
164343020|NCT00939770|593631613|FG004|Overall Study|Withdrawal by Subject|6|||
164343021|NCT00939770|593631614|FG005|Overall Study|Withdrawal by Subject|0|||
164343022|NCT00939770|593631615|FG006|Overall Study|Withdrawal by Subject|2|||
164343023|NCT00939770|593631616|FG007|Overall Study|Withdrawal by Subject|2|||
164343024|NCT04665856|593631617|FG000|Overall Study|Site Terminated by Sponsor|1|||
164343025|NCT04665856|593631618|FG001|Overall Study|Site Terminated by Sponsor|0|||
164343026|NCT04665856|593631617|FG000|Overall Study|Withdrawal by Subject|2|||
164343027|NCT04665856|593631618|FG001|Overall Study|Withdrawal by Subject|0|||
164343028|NCT04665856|593631617|FG000|Overall Study|Lost to Follow-up|3|||
164343029|NCT04665856|593631618|FG001|Overall Study|Lost to Follow-up|2|||
164343030|NCT04665856|593631617|FG000|Overall Study|Death|39|||
164343031|NCT04665856|593631618|FG001|Overall Study|Death|44|||
164343032|NCT04665856|593631617|FG000|Overall Study|Ongoing in study|17|||
164343033|NCT04665856|593631618|FG001|Overall Study|Ongoing in study|15|||
164343034|NCT03386448|593631619|FG000|Overall Study|Adverse Event|0|||
164343035|NCT03386448|593631620|FG001|Overall Study|Adverse Event|2|||
164343036|NCT02564796|593631621|FG000|Overall Study|Physician Decision|2|||
164343037|NCT02564796|593631622|FG001|Overall Study|Physician Decision|2|||
164343038|NCT00114530|593631623|FG000|Overall Study|Death|3|||
164343039|NCT00114530|593631624|FG001|Overall Study|Death|11|||
164343040|NCT00114530|593631623|FG000|Overall Study|Lost to Follow-up|1|||
164343041|NCT00114530|593631624|FG001|Overall Study|Lost to Follow-up|1|||
164343042|NCT00114530|593631623|FG000|Overall Study|Physician Decision|1|||
164343043|NCT00114530|593631624|FG001|Overall Study|Physician Decision|1|||
164343044|NCT00114530|593631623|FG000|Overall Study|Withdrawal by Subject|2|||
164343045|NCT00114530|593631624|FG001|Overall Study|Withdrawal by Subject|6|||
164343046|NCT00114530|593631623|FG000|Overall Study|Breast Cancer|1|||
163894747|NCT04615273|591986773|FG002|Overall Study|Other|0|||
163894748|NCT04615273|591986771|FG000|Overall Study|Randomized but not treated|1|||
164343047|NCT00114530|593631624|FG001|Overall Study|Breast Cancer|0|||
164343048|NCT00114530|593631623|FG000|Overall Study|Subject decision after endpoint failure|0|||
164343049|NCT00114530|593631624|FG001|Overall Study|Subject decision after endpoint failure|1|||
164343050|NCT00114530|593631623|FG000|Overall Study|Ineligible|1|||
164343051|NCT00114530|593631624|FG001|Overall Study|Ineligible|0|||
164343052|NCT01466153|593631626|FG000|Overall Study|Disease Progression|2|||
164343053|NCT01466153|593631627|FG001|Overall Study|Disease Progression|2|||
164343054|NCT01466153|593631628|FG002|Overall Study|Disease Progression|0|||
163894749|NCT04615273|591986772|FG001|Overall Study|Randomized but not treated|3|||
164343055|NCT01466153|593631626|FG000|Overall Study|Adverse Event|14|||
164343056|NCT01466153|593631627|FG001|Overall Study|Adverse Event|13|||
164001202|NCT00768222|592368444|FG000|Overall Study|Protocol Violation|0|||
164001203|NCT00768222|592368445|FG001|Overall Study|Protocol Violation|2|||
164001204|NCT03263091|592368447|FG000|OL Component|Withdrawal by Subject|1|||
164001205|NCT03263091|592368448|FG001|OL Component|Withdrawal by Subject|1|||
164275648|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
164275649|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
164275650|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
164275651|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
164275652|NCT03624127|593377424|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
164275653|NCT03624127|593377425|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
164275654|NCT03624127|593377426|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
164275655|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
164275656|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
164275657|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
164275658|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
164275659|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
164275660|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
164001206|NCT03263091|592368449|FG002|OL Component|Withdrawal by Subject|0|||
164001207|NCT03263091|592368450|FG003|OL Component|Withdrawal by Subject|0|||
164343057|NCT01466153|593631628|FG002|Overall Study|Adverse Event|17|||
164343058|NCT01466153|593631626|FG000|Overall Study|Withdrawal of Consent|2|||
164343059|NCT01466153|593631627|FG001|Overall Study|Withdrawal of Consent|0|||
164343060|NCT01466153|593631628|FG002|Overall Study|Withdrawal of Consent|0|||
164343061|NCT01466153|593631626|FG000|Overall Study|Investigator Discretion|3|||
164343062|NCT01466153|593631627|FG001|Overall Study|Investigator Discretion|2|||
164343063|NCT01466153|593631628|FG002|Overall Study|Investigator Discretion|2|||
164343064|NCT01466153|593631626|FG000|Overall Study|Randomized-Not Treated|2|||
164001208|NCT03263091|592368451|FG004|OL Component|Withdrawal by Subject|0|||
164001209|NCT03263091|592368452|FG005|OL Component|Withdrawal by Subject|0|||
164343065|NCT01466153|593631627|FG001|Overall Study|Randomized-Not Treated|3|||
164343066|NCT01466153|593631628|FG002|Overall Study|Randomized-Not Treated|4|||
164343067|NCT01466153|593631626|FG000|Overall Study|Other-Unspecified|6|||
164343068|NCT01466153|593631627|FG001|Overall Study|Other-Unspecified|4|||
164343069|NCT01466153|593631628|FG002|Overall Study|Other-Unspecified|2|||
164343070|NCT00688753|593632899|FG000|Overall Study|Disease progression|55|||
164343071|NCT00688753|593632899|FG000|Overall Study|Missing|1|||
164343072|NCT00688753|593632899|FG000|Overall Study|Death|9|||
164343073|NCT00688753|593632899|FG000|Overall Study|Withdrawal by Subject|3|||
164343074|NCT00688753|593632899|FG000|Overall Study|Adverse Event|20|||
164343075|NCT00688753|593632899|FG000|Overall Study|Protocol Violation|1|||
164343076|NCT00688753|593632899|FG000|Overall Study|Lost to Follow-up|3|||
164343077|NCT03192462|593632908|FG000|Overall Study|Death|13|||
164343078|NCT03192462|593632909|FG001|Overall Study|Death|11|||
164343079|NCT03192462|593632910|FG002|Overall Study|Death|10|||
164343080|NCT03192462|593632908|FG000|Overall Study|Lost to Follow-up|0|||
164343081|NCT03192462|593632909|FG001|Overall Study|Lost to Follow-up|1|||
164343082|NCT03192462|593632910|FG002|Overall Study|Lost to Follow-up|0|||
164343083|NCT03187197|593632912|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
164343084|NCT03187197|593632913|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
164343085|NCT03187197|593632914|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
164343086|NCT03187197|593632912|FG000|Overall Study|Withdrawal by Subject|8|||
164343087|NCT03187197|593632913|FG001|Overall Study|Withdrawal by Subject|63|||
164343088|NCT03187197|593632914|FG002|Overall Study|Withdrawal by Subject|4|||
164343089|NCT03187197|593632912|FG000|Overall Study|Lost to Follow-up|1|||
164343090|NCT03187197|593632913|FG001|Overall Study|Lost to Follow-up|60|||
164343091|NCT03187197|593632914|FG002|Overall Study|Lost to Follow-up|7|||
164343092|NCT03187197|593632912|FG000|Overall Study|Adverse Event|6|||
164343093|NCT03187197|593632913|FG001|Overall Study|Adverse Event|29|||
164343094|NCT03187197|593632914|FG002|Overall Study|Adverse Event|0|||
164343095|NCT03187197|593632912|FG000|Overall Study|Death|0|||
164343096|NCT03187197|593632913|FG001|Overall Study|Death|11|||
164343097|NCT03187197|593632914|FG002|Overall Study|Death|0|||
164343098|NCT03187197|593632912|FG000|Overall Study|Administrative problem|1|||
164343099|NCT03187197|593632913|FG001|Overall Study|Administrative problem|1|||
164343100|NCT03187197|593632914|FG002|Overall Study|Administrative problem|0|||
164343101|NCT03187197|593632912|FG000|Overall Study|Reason not listed|2|||
164343102|NCT03187197|593632913|FG001|Overall Study|Reason not listed|54|||
164343103|NCT03187197|593632914|FG002|Overall Study|Reason not listed|1|||
164343104|NCT03187197|593632912|FG000|Overall Study|Missing|1|||
164343105|NCT03187197|593632913|FG001|Overall Study|Missing|32|||
164343106|NCT03187197|593632914|FG002|Overall Study|Missing|3|||
164343107|NCT03187197|593632912|FG000|Overall Study|Status missing|2|||
164343108|NCT03187197|593632913|FG001|Overall Study|Status missing|33|||
164343109|NCT03187197|593632914|FG002|Overall Study|Status missing|3|||
164343110|NCT03187197|593632912|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
164343111|NCT03187197|593632913|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
164343112|NCT03187197|593632914|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
164343113|NCT04840615|593632915|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
164343114|NCT04840615|593632916|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
164343115|NCT04840615|593632917|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
164343116|NCT00259649|593632918|FG000|Overall Study|Lost to Follow-up|7|||
164343117|NCT00259649|593632918|FG000|Overall Study|irregular menses|3|||
164343118|NCT00982137|593632919|FG000|Overall Study|Lost to Follow-up|0|||
164343119|NCT00982137|593632920|FG001|Overall Study|Lost to Follow-up|0|||
164343120|NCT00982137|593632921|FG002|Overall Study|Lost to Follow-up|0|||
164343121|NCT00982137|593632922|FG003|Overall Study|Lost to Follow-up|1|||
164343122|NCT00982137|593632919|FG000|Overall Study|Withdrawal by Subject|0|||
164343123|NCT00982137|593632920|FG001|Overall Study|Withdrawal by Subject|1|||
164343124|NCT00982137|593632921|FG002|Overall Study|Withdrawal by Subject|0|||
164343125|NCT00982137|593632922|FG003|Overall Study|Withdrawal by Subject|0|||
164343126|NCT00126191|593632923|FG000|Overall Study|Physician Decision|0|||
164343127|NCT00126191|593632924|FG001|Overall Study|Physician Decision|1|||
164343128|NCT00126191|593632923|FG000|Overall Study|Death|0|||
164343129|NCT00126191|593632924|FG001|Overall Study|Death|1|||
164343130|NCT00674700|593632936|FG000|Year 1|Adverse Event|17|||
164343131|NCT00674700|593632937|FG001|Year 1|Adverse Event|20|||
164343132|NCT00674700|593632938|FG002|Year 1|Adverse Event|5|||
164343133|NCT00674700|593632936|FG000|Year 1|Withdrawal by Subject|7|||
164343134|NCT00674700|593632937|FG001|Year 1|Withdrawal by Subject|7|||
164343135|NCT00674700|593632938|FG002|Year 1|Withdrawal by Subject|6|||
164343136|NCT00674700|593632936|FG000|Year 1|Any other reason not above-mentioned|7|||
164343137|NCT00674700|593632937|FG001|Year 1|Any other reason not above-mentioned|7|||
164343138|NCT00674700|593632938|FG002|Year 1|Any other reason not above-mentioned|6|||
164343139|NCT00674700|593632936|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
164343140|NCT00674700|593632937|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
164343141|NCT00674700|593632938|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
164275661|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164275662|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164275663|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
164275664|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
164275665|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
164275666|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
164275667|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
164275668|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
164275669|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
164275670|NCT03624127|593377424|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
163894750|NCT04615273|591986773|FG002|Overall Study|Randomized but not treated|1|||
163894751|NCT06106022|591986776|FG000|Overall Study|Lost to Follow-up|1|||
163894752|NCT06106022|591986777|FG001|Overall Study|Lost to Follow-up|0|||
163894753|NCT06106022|591986776|FG000|Overall Study|Voluntary Withdrawal|0|||
163894754|NCT06106022|591986777|FG001|Overall Study|Voluntary Withdrawal|2|||
164275671|NCT03624127|593377425|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
164275672|NCT03624127|593377426|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
164275673|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
164275674|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
164275675|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
164275676|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
164275677|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
163894755|NCT05405985|591986781|FG000|Overall Study|Withdrawal by Subject|1|||
164275678|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
163894756|NCT05405985|591986782|FG001|Overall Study|Withdrawal by Subject|0|||
163894757|NCT01820611|591986793|FG000|Overall Study|Death|8|||
164085960|NCT01995058|592678604|FG003|Overall Study|Progressive Disease|1|||
164085961|NCT01995058|592678601|FG000|Overall Study|Adverse Event|0|||
164085962|NCT01995058|592678602|FG001|Overall Study|Adverse Event|0|||
164275679|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
164275680|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
164275681|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
164275682|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
164275683|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
164275684|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
164275685|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
164275686|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
164275687|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
164275688|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
164275689|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
164275690|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
164275691|NCT03624127|593377424|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
164275692|NCT03624127|593377425|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
164275693|NCT03624127|593377426|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
164275694|NCT02891382|593377428|FG000|Overall Study|Lost to Follow-up|3|||
164275695|NCT02891382|593377429|FG001|Overall Study|Lost to Follow-up|4|||
164275696|NCT02891382|593377430|FG002|Overall Study|Lost to Follow-up|5|||
164275697|NCT02891382|593377431|FG003|Overall Study|Lost to Follow-up|3|||
164275698|NCT02891382|593377432|FG004|Overall Study|Lost to Follow-up|4|||
164275699|NCT02516228|593377433|FG000|Overall Study|Lost to Follow-up|1|||
163894758|NCT01820611|591986793|FG000|Overall Study|Adverse Event|1|||
163894759|NCT01820611|591986793|FG000|Overall Study|Withdrawal by Subject|9|||
163894760|NCT03015532|591986794|FG000|Overall Study|Adverse Event|0|||
163894761|NCT03015532|591986795|FG001|Overall Study|Adverse Event|0|||
163894762|NCT03015532|591986796|FG002|Overall Study|Adverse Event|0|||
163894763|NCT03015532|591986797|FG003|Overall Study|Adverse Event|0|||
163894764|NCT03015532|591986798|FG004|Overall Study|Adverse Event|0|||
163894765|NCT03015532|591986799|FG005|Overall Study|Adverse Event|2|||
163894766|NCT03015532|591986800|FG006|Overall Study|Adverse Event|1|||
163894767|NCT03015532|591986801|FG007|Overall Study|Adverse Event|0|||
163894768|NCT03015532|591986794|FG000|Overall Study|Withdrawal by Subject|0|||
163894769|NCT03015532|591986795|FG001|Overall Study|Withdrawal by Subject|0|||
163894770|NCT03015532|591986796|FG002|Overall Study|Withdrawal by Subject|0|||
163894771|NCT03015532|591986797|FG003|Overall Study|Withdrawal by Subject|0|||
163894772|NCT03015532|591986798|FG004|Overall Study|Withdrawal by Subject|0|||
163894773|NCT03015532|591986799|FG005|Overall Study|Withdrawal by Subject|0|||
163894774|NCT03015532|591986800|FG006|Overall Study|Withdrawal by Subject|1|||
163894775|NCT03015532|591986801|FG007|Overall Study|Withdrawal by Subject|0|||
163894776|NCT03484819|591986802|FG000|Overall Study|Death|2|||
163894777|NCT03484819|591986802|FG000|Overall Study|Adverse Event|2|||
163894778|NCT03484819|591986802|FG000|Overall Study|Physician Decision|1|||
163894779|NCT03484819|591986802|FG000|Overall Study|Withdrawal by Subject|2|||
163894780|NCT03484819|591986802|FG000|Overall Study|Disease Progression|4|||
163894781|NCT03484819|591986802|FG000|Overall Study|Complicating Condition|1|||
163894782|NCT05013385|591986807|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
163894783|NCT00677365|591986808|FG000|Overall Study|Adverse Event|2|||
163894784|NCT00677365|591986809|FG001|Overall Study|Adverse Event|1|||
163894785|NCT00677365|591986810|FG002|Overall Study|Adverse Event|1|||
163894786|NCT00677365|591986811|FG003|Overall Study|Adverse Event|2|||
163894787|NCT00677365|591986808|FG000|Overall Study|Withdrawal by Subject|0|||
163894788|NCT00677365|591986809|FG001|Overall Study|Withdrawal by Subject|0|||
163894789|NCT00677365|591986810|FG002|Overall Study|Withdrawal by Subject|1|||
163894790|NCT00677365|591986811|FG003|Overall Study|Withdrawal by Subject|0|||
163894791|NCT00677365|591986808|FG000|Overall Study|Other reason|0|||
163894792|NCT00677365|591986809|FG001|Overall Study|Other reason|0|||
163894793|NCT00677365|591986810|FG002|Overall Study|Other reason|0|||
163894794|NCT00677365|591986811|FG003|Overall Study|Other reason|1|||
163894795|NCT04424316|591986817|FG000|Overall Study|Adverse Event|0|||
163894796|NCT04424316|591986818|FG001|Overall Study|Adverse Event|1|||
163894797|NCT04424316|591986819|FG002|Overall Study|Adverse Event|0|||
163894798|NCT04424316|591986820|FG003|Overall Study|Adverse Event|0|||
163894799|NCT04424316|591986817|FG000|Overall Study|Death|1|||
163894800|NCT04424316|591986818|FG001|Overall Study|Death|0|||
163894801|NCT04424316|591986819|FG002|Overall Study|Death|8|||
164275700|NCT02516228|593377433|FG000|Overall Study|Withdrawal by Subject|1|||
163894802|NCT04424316|591986820|FG003|Overall Study|Death|14|||
163894803|NCT04424316|591986817|FG000|Overall Study|Lost to Follow-up|93|||
163894804|NCT04424316|591986818|FG001|Overall Study|Lost to Follow-up|88|||
163894805|NCT04424316|591986819|FG002|Overall Study|Lost to Follow-up|224|||
163894806|NCT04424316|591986820|FG003|Overall Study|Lost to Follow-up|211|||
163894807|NCT04424316|591986817|FG000|Overall Study|No longer met eligibility criteria|1|||
163894808|NCT04424316|591986818|FG001|Overall Study|No longer met eligibility criteria|0|||
164275701|NCT02516228|593377433|FG000|Overall Study|Physician Decision|1|||
164001210|NCT03263091|592368447|FG000|OL Component|Physician Decision|0|||
164001211|NCT03263091|592368448|FG001|OL Component|Physician Decision|1|||
164275702|NCT03916484|593377434|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164275703|NCT03916484|593377435|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
164275704|NCT03916484|593377436|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164275705|NCT03916484|593377437|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
164275706|NCT03916484|593377434|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
164275707|NCT03916484|593377435|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
164275708|NCT03916484|593377436|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
164275709|NCT03916484|593377437|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
164275710|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
164275711|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
164275712|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
164275713|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
164275714|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
164275715|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
164275716|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
164275717|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
164275718|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Death|0|||
164275719|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Death|1|||
164275720|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
164275721|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
164275722|NCT03281304|593377445|FG000|Treatment Phase (up to 42 Months)|Other|0|||
164275723|NCT03281304|593377446|FG001|Treatment Phase (up to 42 Months)|Other|2|||
164275724|NCT03281304|593377445|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
164275725|NCT03281304|593377446|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
164275726|NCT00858637|593377447|FG000|Active Comparison Phase|Adverse Event|14|||
164275727|NCT00858637|593377448|FG001|Active Comparison Phase|Adverse Event|0|||
164275728|NCT00858637|593377449|FG002|Active Comparison Phase|Adverse Event|0|||
164275729|NCT00858637|593377450|FG003|Active Comparison Phase|Adverse Event|9|||
164275730|NCT00858637|593377451|FG004|Active Comparison Phase|Adverse Event|0|||
164275731|NCT00858637|593377452|FG005|Active Comparison Phase|Adverse Event|0|||
164275732|NCT00858637|593377447|FG000|Active Comparison Phase|Death|1|||
164275733|NCT00858637|593377448|FG001|Active Comparison Phase|Death|0|||
164275734|NCT00858637|593377449|FG002|Active Comparison Phase|Death|0|||
164275735|NCT00858637|593377450|FG003|Active Comparison Phase|Death|1|||
164275736|NCT00858637|593377451|FG004|Active Comparison Phase|Death|0|||
164275737|NCT00858637|593377452|FG005|Active Comparison Phase|Death|0|||
164275738|NCT00858637|593377447|FG000|Active Comparison Phase|Physician Decision|1|||
164275739|NCT00858637|593377448|FG001|Active Comparison Phase|Physician Decision|0|||
164275740|NCT00858637|593377449|FG002|Active Comparison Phase|Physician Decision|0|||
164275741|NCT00858637|593377450|FG003|Active Comparison Phase|Physician Decision|1|||
164275742|NCT00858637|593377451|FG004|Active Comparison Phase|Physician Decision|0|||
164275743|NCT00858637|593377452|FG005|Active Comparison Phase|Physician Decision|0|||
164275744|NCT00858637|593377447|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
164275745|NCT00858637|593377448|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
164275746|NCT00858637|593377449|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
164275747|NCT00858637|593377450|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
164275748|NCT00858637|593377451|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
164275749|NCT00858637|593377452|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
164275750|NCT00858637|593377447|FG000|Active Comparison Phase|Other Reasons|1|||
164275751|NCT00858637|593377448|FG001|Active Comparison Phase|Other Reasons|0|||
164275752|NCT00858637|593377449|FG002|Active Comparison Phase|Other Reasons|0|||
164275753|NCT00858637|593377450|FG003|Active Comparison Phase|Other Reasons|1|||
164275754|NCT00858637|593377451|FG004|Active Comparison Phase|Other Reasons|0|||
164275755|NCT00858637|593377452|FG005|Active Comparison Phase|Other Reasons|0|||
164275756|NCT00858637|593377447|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
164343142|NCT00674700|593632936|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
164343143|NCT00674700|593632937|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
164343144|NCT00674700|593632938|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
164343145|NCT00674700|593632936|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
164343146|NCT00674700|593632937|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
164343147|NCT00674700|593632938|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
164343148|NCT00621985|593632947|FG000|Dexamethasone Admission|Adverse Event|1|||
164343149|NCT01806298|593632948|FG000|Overall Study|Adverse Event|3|||
164343150|NCT01806298|593632948|FG000|Overall Study|Protocol Non-compliance|1|||
164343151|NCT01806298|593632948|FG000|Overall Study|Withdrawal by Subject|1|||
164343152|NCT01806298|593632948|FG000|Overall Study|Other|5|||
164343153|NCT01001377|593632951|FG000|Overall Study|Ineligibility determined|2|||
164343154|NCT01001377|593632952|FG001|Overall Study|Ineligibility determined|0|||
164343155|NCT01001377|593632951|FG000|Overall Study|Withdrawal by Subject|19|||
164275757|NCT00858637|593377448|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
164275758|NCT00858637|593377449|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
164275759|NCT00858637|593377450|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
164275760|NCT00858637|593377451|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
164275761|NCT00858637|593377452|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
164275762|NCT00858637|593377447|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275763|NCT00858637|593377448|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275764|NCT00858637|593377449|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275765|NCT00858637|593377450|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275766|NCT00858637|593377451|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
164275767|NCT00858637|593377452|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
164275768|NCT02292706|593377455|FG000|Overall Study|Lost to Follow-up|20|||
164275769|NCT02292706|593377456|FG001|Overall Study|Lost to Follow-up|44|||
164275770|NCT02292706|593377457|FG002|Overall Study|Lost to Follow-up|24|||
164275771|NCT02292706|593377458|FG003|Overall Study|Lost to Follow-up|61|||
164275772|NCT02292706|593377459|FG004|Overall Study|Lost to Follow-up|21|||
164275773|NCT02292706|593377460|FG005|Overall Study|Lost to Follow-up|52|||
164275774|NCT02292706|593377461|FG006|Overall Study|Lost to Follow-up|25|||
164275775|NCT02292706|593377462|FG007|Overall Study|Lost to Follow-up|0|||
164275776|NCT02292706|593377455|FG000|Overall Study|Withdrew consent|15|||
164275777|NCT02292706|593377456|FG001|Overall Study|Withdrew consent|56|||
164275778|NCT02292706|593377457|FG002|Overall Study|Withdrew consent|43|||
164275779|NCT02292706|593377458|FG003|Overall Study|Withdrew consent|36|||
164275780|NCT02292706|593377459|FG004|Overall Study|Withdrew consent|13|||
164275781|NCT02292706|593377460|FG005|Overall Study|Withdrew consent|51|||
164275782|NCT02292706|593377461|FG006|Overall Study|Withdrew consent|20|||
164275783|NCT02292706|593377462|FG007|Overall Study|Withdrew consent|0|||
164275784|NCT02292706|593377455|FG000|Overall Study|Death|3|||
164275785|NCT02292706|593377456|FG001|Overall Study|Death|11|||
164275786|NCT02292706|593377457|FG002|Overall Study|Death|16|||
164275787|NCT02292706|593377458|FG003|Overall Study|Death|22|||
164275788|NCT02292706|593377459|FG004|Overall Study|Death|8|||
164275789|NCT02292706|593377460|FG005|Overall Study|Death|17|||
164275790|NCT02292706|593377461|FG006|Overall Study|Death|3|||
164275791|NCT02292706|593377462|FG007|Overall Study|Death|0|||
164275792|NCT02292706|593377455|FG000|Overall Study|Study terminated by sponsor|0|||
164275793|NCT02292706|593377456|FG001|Overall Study|Study terminated by sponsor|9|||
164275794|NCT02292706|593377457|FG002|Overall Study|Study terminated by sponsor|4|||
164275795|NCT02292706|593377458|FG003|Overall Study|Study terminated by sponsor|21|||
164275796|NCT02292706|593377459|FG004|Overall Study|Study terminated by sponsor|11|||
164275797|NCT02292706|593377460|FG005|Overall Study|Study terminated by sponsor|13|||
164275798|NCT02292706|593377461|FG006|Overall Study|Study terminated by sponsor|3|||
164275799|NCT02292706|593377462|FG007|Overall Study|Study terminated by sponsor|0|||
164275800|NCT02292706|593377455|FG000|Overall Study|Investigator's discretion|4|||
164275801|NCT02292706|593377456|FG001|Overall Study|Investigator's discretion|9|||
164275802|NCT02292706|593377457|FG002|Overall Study|Investigator's discretion|7|||
164275803|NCT02292706|593377458|FG003|Overall Study|Investigator's discretion|11|||
164275804|NCT02292706|593377459|FG004|Overall Study|Investigator's discretion|4|||
164275805|NCT02292706|593377460|FG005|Overall Study|Investigator's discretion|10|||
164275806|NCT02292706|593377461|FG006|Overall Study|Investigator's discretion|1|||
164275807|NCT02292706|593377462|FG007|Overall Study|Investigator's discretion|0|||
164275808|NCT02292706|593377455|FG000|Overall Study|Liver transplant|1|||
164275809|NCT02292706|593377456|FG001|Overall Study|Liver transplant|1|||
164275810|NCT02292706|593377457|FG002|Overall Study|Liver transplant|11|||
164275811|NCT02292706|593377458|FG003|Overall Study|Liver transplant|16|||
164275812|NCT02292706|593377459|FG004|Overall Study|Liver transplant|5|||
164275813|NCT02292706|593377460|FG005|Overall Study|Liver transplant|6|||
164275814|NCT02292706|593377461|FG006|Overall Study|Liver transplant|5|||
164275815|NCT02292706|593377462|FG007|Overall Study|Liver transplant|0|||
164275816|NCT02292706|593377455|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
164275817|NCT02292706|593377456|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
164275818|NCT02292706|593377457|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
164275819|NCT02292706|593377458|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
164275820|NCT02292706|593377459|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
164343156|NCT01001377|593632952|FG001|Overall Study|Withdrawal by Subject|20|||
164343157|NCT01001377|593632951|FG000|Overall Study|Lost to Follow-up|14|||
164343158|NCT01001377|593632952|FG001|Overall Study|Lost to Follow-up|17|||
164343159|NCT01001377|593632951|FG000|Overall Study|Death|391|||
164343160|NCT01001377|593632952|FG001|Overall Study|Death|384|||
164343161|NCT04343261|593632953|FG000|Overall Study|Adverse Event|1|||
164343162|NCT04343261|593632953|FG000|Overall Study|received inadequate amount of antibodies|7|||
164343163|NCT02849678|593632954|FG000|Overall Study|Protocol Violation|3|||
163894809|NCT04424316|591986819|FG002|Overall Study|No longer met eligibility criteria|0|||
164275821|NCT02292706|593377460|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
164275822|NCT02292706|593377461|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
164275823|NCT02292706|593377462|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
164343164|NCT02849678|593632955|FG001|Overall Study|Protocol Violation|6|||
164343165|NCT00289991|593632956|FG000|Overall Study|Death|35|||
164343166|NCT00289991|593632957|FG001|Overall Study|Death|38|||
164343167|NCT00289991|593632956|FG000|Overall Study|Adverse Event|15|||
164343168|NCT00289991|593632957|FG001|Overall Study|Adverse Event|13|||
164343169|NCT00289991|593632956|FG000|Overall Study|Failure of prophylaxis|1|||
164343170|NCT00289991|593632957|FG001|Overall Study|Failure of prophylaxis|1|||
164343171|NCT00289991|593632956|FG000|Overall Study|Fungal breakthrough infection|0|||
164343172|NCT00289991|593632957|FG001|Overall Study|Fungal breakthrough infection|1|||
164343173|NCT00289991|593632956|FG000|Overall Study|Lost to Follow-up|0|||
164343174|NCT00289991|593632957|FG001|Overall Study|Lost to Follow-up|1|||
164343175|NCT00289991|593632956|FG000|Overall Study|Withdrawal by Subject|2|||
164343176|NCT00289991|593632957|FG001|Overall Study|Withdrawal by Subject|12|||
164343177|NCT00289991|593632956|FG000|Overall Study|Other|5|||
164343178|NCT00289991|593632957|FG001|Overall Study|Other|14|||
164343179|NCT04447794|593632958|FG000|Overall Study|Lost to Follow-up|2|||
164343180|NCT04447794|593632959|FG001|Overall Study|Lost to Follow-up|3|||
164343181|NCT04447794|593632960|FG002|Overall Study|Lost to Follow-up|8|||
164343182|NCT04447794|593632958|FG000|Overall Study|Withdrawal by Subject|1|||
164343183|NCT04447794|593632959|FG001|Overall Study|Withdrawal by Subject|1|||
164343184|NCT04447794|593632960|FG002|Overall Study|Withdrawal by Subject|0|||
164343185|NCT00205881|593632961|FG000|Overall Study|Withdrawal by Subject|16|||
164343186|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343187|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343188|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343189|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
164343190|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
164343191|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
164343192|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
164343193|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
164343194|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343195|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
164343196|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343197|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343198|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343199|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164275824|NCT02292706|593377455|FG000|Overall Study|Subject terminated by sponsor|1|||
164275825|NCT02292706|593377456|FG001|Overall Study|Subject terminated by sponsor|0|||
164275826|NCT02292706|593377457|FG002|Overall Study|Subject terminated by sponsor|0|||
164275827|NCT02292706|593377458|FG003|Overall Study|Subject terminated by sponsor|2|||
164275828|NCT02292706|593377459|FG004|Overall Study|Subject terminated by sponsor|1|||
164275829|NCT02292706|593377460|FG005|Overall Study|Subject terminated by sponsor|0|||
164085963|NCT01995058|592678603|FG002|Overall Study|Adverse Event|0|||
164275830|NCT02292706|593377461|FG006|Overall Study|Subject terminated by sponsor|0|||
164275831|NCT02292706|593377462|FG007|Overall Study|Subject terminated by sponsor|0|||
164275832|NCT02292706|593377455|FG000|Overall Study|Missing|0|||
164275833|NCT02292706|593377456|FG001|Overall Study|Missing|0|||
164275834|NCT02292706|593377457|FG002|Overall Study|Missing|1|||
164275835|NCT02292706|593377458|FG003|Overall Study|Missing|1|||
164275836|NCT02292706|593377459|FG004|Overall Study|Missing|0|||
164275837|NCT02292706|593377460|FG005|Overall Study|Missing|1|||
164275838|NCT02292706|593377461|FG006|Overall Study|Missing|0|||
164275839|NCT02292706|593377462|FG007|Overall Study|Missing|0|||
164275840|NCT02292706|593377455|FG000|Overall Study|Virologic relapse or reinfection|1|||
163894810|NCT04424316|591986820|FG003|Overall Study|No longer met eligibility criteria|0|||
163894811|NCT04424316|591986817|FG000|Overall Study|Other|15|||
163894812|NCT04424316|591986818|FG001|Overall Study|Other|11|||
163894813|NCT04424316|591986819|FG002|Overall Study|Other|34|||
163894814|NCT04424316|591986820|FG003|Overall Study|Other|45|||
163894815|NCT04424316|591986817|FG000|Overall Study|Physician Decision|1|||
163894816|NCT04424316|591986818|FG001|Overall Study|Physician Decision|0|||
163894817|NCT04424316|591986819|FG002|Overall Study|Physician Decision|1|||
163894818|NCT04424316|591986820|FG003|Overall Study|Physician Decision|1|||
163894819|NCT04424316|591986817|FG000|Overall Study|Protocol Violation|0|||
163894820|NCT04424316|591986818|FG001|Overall Study|Protocol Violation|1|||
163894821|NCT04424316|591986819|FG002|Overall Study|Protocol Violation|0|||
163894822|NCT04424316|591986820|FG003|Overall Study|Protocol Violation|0|||
164085964|NCT01995058|592678604|FG003|Overall Study|Adverse Event|1|||
164275841|NCT02292706|593377456|FG001|Overall Study|Virologic relapse or reinfection|0|||
164275842|NCT02292706|593377457|FG002|Overall Study|Virologic relapse or reinfection|0|||
164275843|NCT02292706|593377458|FG003|Overall Study|Virologic relapse or reinfection|1|||
164275844|NCT02292706|593377459|FG004|Overall Study|Virologic relapse or reinfection|0|||
164343200|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
164343201|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
164275845|NCT02292706|593377460|FG005|Overall Study|Virologic relapse or reinfection|1|||
164275846|NCT02292706|593377461|FG006|Overall Study|Virologic relapse or reinfection|0|||
164275847|NCT02292706|593377462|FG007|Overall Study|Virologic relapse or reinfection|0|||
164275848|NCT02188849|593377466|FG000|Overall Study|Lost to Follow-up|3|||
164275849|NCT02188849|593377467|FG001|Overall Study|Lost to Follow-up|8|||
164275850|NCT05740618|593378637|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|1|||
164275851|NCT05740618|593378637|FG000|Overall Study|Physician Decision|1|||
164275852|NCT04588389|593378638|FG000|Overall Study|Issues with anesthesia during surgery|2|||
164275853|NCT04588389|593378639|FG001|Overall Study|Issues with anesthesia during surgery|0|||
164275854|NCT04588389|593378640|FG002|Overall Study|Issues with anesthesia during surgery|0|||
164275855|NCT02354235|593378641|FG000|Overall Study|Adverse Event|2|||
164275856|NCT02354235|593378642|FG001|Overall Study|Adverse Event|2|||
164275857|NCT02354235|593378641|FG000|Overall Study|Physician Decision|0|||
164275858|NCT02354235|593378642|FG001|Overall Study|Physician Decision|1|||
164275859|NCT02354235|593378641|FG000|Overall Study|Withdrawal by Subject|1|||
164275860|NCT02354235|593378642|FG001|Overall Study|Withdrawal by Subject|3|||
164275861|NCT02354235|593378641|FG000|Overall Study|Conflict with the stopping criteria|0|||
164275862|NCT02354235|593378642|FG001|Overall Study|Conflict with the stopping criteria|1|||
164275863|NCT06045507|593378644|FG000|Overall Study|Death|0|||
164275864|NCT06045507|593378645|FG001|Overall Study|Death|0|||
164275865|NCT06045507|593378646|FG002|Overall Study|Death|1|||
164275866|NCT06045507|593378647|FG003|Overall Study|Death|0|||
164275867|NCT06045507|593378644|FG000|Overall Study|Lost to Follow-up|3|||
164275868|NCT06045507|593378645|FG001|Overall Study|Lost to Follow-up|3|||
164275869|NCT06045507|593378646|FG002|Overall Study|Lost to Follow-up|0|||
164275870|NCT06045507|593378647|FG003|Overall Study|Lost to Follow-up|0|||
164275871|NCT06045507|593378644|FG000|Overall Study|Randomized by mistake (no study treatment given)|0|||
164275872|NCT06045507|593378645|FG001|Overall Study|Randomized by mistake (no study treatment given)|1|||
164275873|NCT06045507|593378646|FG002|Overall Study|Randomized by mistake (no study treatment given)|1|||
164275874|NCT06045507|593378647|FG003|Overall Study|Randomized by mistake (no study treatment given)|0|||
164275875|NCT06045507|593378644|FG000|Overall Study|Withdrawal by Subject|4|||
164275876|NCT06045507|593378645|FG001|Overall Study|Withdrawal by Subject|1|||
164275877|NCT06045507|593378646|FG002|Overall Study|Withdrawal by Subject|0|||
164275878|NCT06045507|593378647|FG003|Overall Study|Withdrawal by Subject|2|||
164275879|NCT06045507|593378644|FG000|Overall Study|Miscellaneous|2|||
164275880|NCT06045507|593378645|FG001|Overall Study|Miscellaneous|0|||
164275881|NCT06045507|593378646|FG002|Overall Study|Miscellaneous|0|||
164275882|NCT06045507|593378647|FG003|Overall Study|Miscellaneous|1|||
163894823|NCT04424316|591986817|FG000|Overall Study|Withdrawal by Subject|71|||
164275883|NCT00902174|593378652|FG000|Overall Study|Adverse Event|27|||
164275884|NCT00902174|593378653|FG001|Overall Study|Adverse Event|7|||
164275885|NCT00902174|593378652|FG000|Overall Study|Lack of Efficacy|1|||
163894824|NCT04424316|591986818|FG001|Overall Study|Withdrawal by Subject|77|||
163894825|NCT04424316|591986819|FG002|Overall Study|Withdrawal by Subject|0|||
163894826|NCT04424316|591986820|FG003|Overall Study|Withdrawal by Subject|0|||
163894827|NCT04424316|591986817|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163894828|NCT04424316|591986818|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163894829|NCT04424316|591986819|FG002|Overall Study|Withdrawal by parent/guardian|74|||
163894830|NCT04424316|591986820|FG003|Overall Study|Withdrawal by parent/guardian|81|||
163894831|NCT04424316|591986817|FG000|Overall Study|Randomized but not vaccinated|13|||
163894832|NCT04424316|591986818|FG001|Overall Study|Randomized but not vaccinated|21|||
163894833|NCT04424316|591986819|FG002|Overall Study|Randomized but not vaccinated|0|||
163894834|NCT04424316|591986820|FG003|Overall Study|Randomized but not vaccinated|0|||
163894835|NCT04424316|591986817|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
163894836|NCT04424316|591986818|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
163894837|NCT04424316|591986819|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
163894838|NCT04424316|591986820|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
163894839|NCT05070741|591986821|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
163894840|NCT03245840|591986822|FG000|Overall Study|Adverse Event|6|||
163894841|NCT03245840|591986823|FG001|Overall Study|Adverse Event|0|||
163894842|NCT03245840|591986822|FG000|Overall Study|Death|2|||
163894843|NCT03245840|591986823|FG001|Overall Study|Death|0|||
163894844|NCT03245840|591986822|FG000|Overall Study|Withdrawal by Subject|31|||
163894845|NCT03245840|591986823|FG001|Overall Study|Withdrawal by Subject|1|||
163894846|NCT03245840|591986822|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
163894847|NCT03245840|591986823|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163894848|NCT03245840|591986822|FG000|Overall Study|Physician Decision|4|||
163894849|NCT03245840|591986823|FG001|Overall Study|Physician Decision|1|||
164275886|NCT00902174|593378653|FG001|Overall Study|Lack of Efficacy|5|||
164275887|NCT00902174|593378652|FG000|Overall Study|Death|2|||
164275888|NCT00902174|593378653|FG001|Overall Study|Death|2|||
164275889|NCT00902174|593378652|FG000|Overall Study|Withdrawal by Subject|2|||
164275890|NCT00902174|593378653|FG001|Overall Study|Withdrawal by Subject|1|||
164275891|NCT00902174|593378652|FG000|Overall Study|Abnormal labs|1|||
164275892|NCT00902174|593378653|FG001|Overall Study|Abnormal labs|1|||
164275893|NCT00902174|593378652|FG000|Overall Study|Protocol Violation|1|||
164275894|NCT00902174|593378653|FG001|Overall Study|Protocol Violation|1|||
164275895|NCT00902174|593378652|FG000|Overall Study|Administration problem|0|||
164275896|NCT00902174|593378653|FG001|Overall Study|Administration problem|1|||
164275897|NCT03688100|593378654|FG000|Overall Study|Lost to Follow-up|21|||
164275898|NCT03688100|593378655|FG001|Overall Study|Lost to Follow-up|15|||
164343202|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343203|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343204|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
164275899|NCT03688100|593378656|FG002|Overall Study|Lost to Follow-up|15|||
164343205|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343206|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343207|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343208|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343209|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343210|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Other|0|||
164343211|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Other|0|||
164343212|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Other|1|||
164343213|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Other|1|||
164343214|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Other|2|||
164343215|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Other|0|||
164343216|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Other|0|||
164343217|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Other|0|||
164343218|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343219|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343220|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
164275900|NCT03688100|593378657|FG003|Overall Study|Lost to Follow-up|18|||
164343221|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
164275901|NCT03688100|593378654|FG000|Overall Study|Withdrawal by Subject|19|||
164275902|NCT03688100|593378655|FG001|Overall Study|Withdrawal by Subject|16|||
164275903|NCT03688100|593378656|FG002|Overall Study|Withdrawal by Subject|0|||
164275904|NCT03688100|593378657|FG003|Overall Study|Withdrawal by Subject|0|||
164275905|NCT03688100|593378654|FG000|Overall Study|Death|36|||
164275906|NCT03688100|593378655|FG001|Overall Study|Death|27|||
164275907|NCT03688100|593378656|FG002|Overall Study|Death|0|||
164275908|NCT03688100|593378657|FG003|Overall Study|Death|0|||
164275909|NCT02479139|593378663|FG000|Overall Study|Lost to Follow-up|2|||
164275910|NCT02479139|593378664|FG001|Overall Study|Lost to Follow-up|4|||
164275911|NCT02479139|593378665|FG002|Overall Study|Lost to Follow-up|4|||
164275912|NCT02479139|593378666|FG003|Overall Study|Lost to Follow-up|2|||
164275913|NCT02479139|593378667|FG004|Overall Study|Lost to Follow-up|3|||
164275914|NCT02479139|593378668|FG005|Overall Study|Lost to Follow-up|5|||
164275915|NCT02479139|593378663|FG000|Overall Study|Withdrew Consent|5|||
164275916|NCT02479139|593378664|FG001|Overall Study|Withdrew Consent|6|||
164275917|NCT02479139|593378665|FG002|Overall Study|Withdrew Consent|1|||
164275918|NCT02479139|593378666|FG003|Overall Study|Withdrew Consent|4|||
164275919|NCT02479139|593378667|FG004|Overall Study|Withdrew Consent|1|||
164275920|NCT02479139|593378668|FG005|Overall Study|Withdrew Consent|1|||
164275921|NCT02479139|593378663|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275922|NCT02479139|593378664|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275923|NCT02479139|593378665|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
164275924|NCT02479139|593378666|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275925|NCT02479139|593378667|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275926|NCT02479139|593378668|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
164275927|NCT02479139|593378663|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164275928|NCT02479139|593378664|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164275929|NCT02479139|593378665|FG002|Overall Study|Other Miscellaneous Reasons|1|||
164275930|NCT02479139|593378666|FG003|Overall Study|Other Miscellaneous Reasons|1|||
164275931|NCT02479139|593378667|FG004|Overall Study|Other Miscellaneous Reasons|1|||
164275932|NCT02479139|593378668|FG005|Overall Study|Other Miscellaneous Reasons|0|||
164275933|NCT00084656|593378671|FG000|Overall Study|Other reasons|0|||
164275934|NCT00084656|593378672|FG001|Overall Study|Other reasons|12|||
164275935|NCT00084656|593378673|FG002|Overall Study|Other reasons|11|||
164275936|NCT00084656|593378671|FG000|Overall Study|Withdrawal by Subject|15|||
164275937|NCT00084656|593378672|FG001|Overall Study|Withdrawal by Subject|4|||
164275938|NCT00084656|593378673|FG002|Overall Study|Withdrawal by Subject|4|||
164275939|NCT00084656|593378671|FG000|Overall Study|Disease relapse|0|||
164275940|NCT00084656|593378672|FG001|Overall Study|Disease relapse|9|||
164275941|NCT00084656|593378673|FG002|Overall Study|Disease relapse|10|||
164085965|NCT01995058|592678601|FG000|Overall Study|Lack of Efficacy|0|||
164085966|NCT01995058|592678602|FG001|Overall Study|Lack of Efficacy|0|||
164275942|NCT00084656|593378671|FG000|Overall Study|Disease progression|9|||
164275943|NCT00084656|593378672|FG001|Overall Study|Disease progression|0|||
164275944|NCT00084656|593378673|FG002|Overall Study|Disease progression|0|||
164275945|NCT00084656|593378671|FG000|Overall Study|Lost to Follow-up|1|||
164275946|NCT00084656|593378672|FG001|Overall Study|Lost to Follow-up|0|||
164275947|NCT00084656|593378673|FG002|Overall Study|Lost to Follow-up|1|||
164275948|NCT00989781|593378674|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
164275949|NCT00989781|593378675|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
164275950|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
164275951|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
164275952|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
164275953|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
164275954|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
164001212|NCT03263091|592368449|FG002|OL Component|Physician Decision|2|||
164001213|NCT03263091|592368450|FG003|OL Component|Physician Decision|0|||
164001214|NCT03263091|592368451|FG004|OL Component|Physician Decision|0|||
164001215|NCT03263091|592368452|FG005|OL Component|Physician Decision|0|||
164001216|NCT03263091|592368447|FG000|OL Component|Death|1|||
164001217|NCT03263091|592368448|FG001|OL Component|Death|0|||
164001218|NCT03263091|592368449|FG002|OL Component|Death|0|||
164001219|NCT03263091|592368450|FG003|OL Component|Death|0|||
164001220|NCT03263091|592368451|FG004|OL Component|Death|0|||
164001221|NCT03263091|592368452|FG005|OL Component|Death|0|||
164001222|NCT03263091|592368447|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
164001223|NCT03263091|592368448|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
164001224|NCT03263091|592368449|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
164001225|NCT03263091|592368450|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
164001226|NCT03263091|592368451|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
164001227|NCT03263091|592368452|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
164001228|NCT03263091|592368447|FG000|OL High-EPO Component|Physician Decision|0|||
164001229|NCT03263091|592368448|FG001|OL High-EPO Component|Physician Decision|0|||
164001230|NCT03263091|592368449|FG002|OL High-EPO Component|Physician Decision|0|||
164001231|NCT03263091|592368450|FG003|OL High-EPO Component|Physician Decision|1|||
164001232|NCT03263091|592368451|FG004|OL High-EPO Component|Physician Decision|0|||
164001233|NCT03263091|592368452|FG005|OL High-EPO Component|Physician Decision|0|||
164001234|NCT03263091|592368447|FG000|OL High-EPO Component|Death|0|||
164001235|NCT03263091|592368448|FG001|OL High-EPO Component|Death|0|||
164001236|NCT03263091|592368449|FG002|OL High-EPO Component|Death|0|||
164001237|NCT03263091|592368450|FG003|OL High-EPO Component|Death|3|||
164001238|NCT03263091|592368451|FG004|OL High-EPO Component|Death|0|||
164001239|NCT03263091|592368452|FG005|OL High-EPO Component|Death|0|||
164001240|NCT03263091|592368447|FG000|DB Component|Withdrawal by Subject|0|||
164001241|NCT03263091|592368448|FG001|DB Component|Withdrawal by Subject|0|||
164275955|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
164275956|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
164275957|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
164275958|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
164275959|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
164275960|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
164275961|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
164275962|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
164275963|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
164343222|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
164343223|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343224|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343225|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
164343226|NCT01090492|593632965|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
164343227|NCT01090492|593632966|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
163894850|NCT03245840|591986822|FG000|Overall Study|Study Terminated by Sponsor|56|||
163894851|NCT03245840|591986823|FG001|Overall Study|Study Terminated by Sponsor|6|||
163894852|NCT03245840|591986822|FG000|Overall Study|Site Terminated by Sponsor|4|||
163894853|NCT03245840|591986823|FG001|Overall Study|Site Terminated by Sponsor|0|||
164343228|NCT01090492|593632967|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
164343229|NCT01090492|593632968|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
164343230|NCT01090492|593632969|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
164343231|NCT01090492|593632970|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
164343232|NCT01090492|593632971|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
164343233|NCT01090492|593632972|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
164343234|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
163894854|NCT03245840|591986822|FG000|Overall Study|Lost to Follow-up|12|||
163894855|NCT03245840|591986823|FG001|Overall Study|Lost to Follow-up|2|||
164343235|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164343236|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
163894856|NCT03245840|591986822|FG000|Overall Study|Pregnancy|2|||
164343237|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164343238|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
163894857|NCT03245840|591986823|FG001|Overall Study|Pregnancy|0|||
163894858|NCT03245840|591986822|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163894859|NCT03245840|591986823|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163894860|NCT03245840|591986822|FG000|Overall Study|Not treated|1|||
163894861|NCT03245840|591986823|FG001|Overall Study|Not treated|1|||
163894862|NCT05890105|591986831|FG000|Overall Study|Adverse Event|1|||
163894863|NCT05890105|591986832|FG001|Overall Study|Adverse Event|0|||
163894864|NCT05890105|591986833|FG002|Overall Study|Adverse Event|0|||
163894865|NCT05890105|591986831|FG000|Overall Study|Other|1|||
163894866|NCT05890105|591986832|FG001|Overall Study|Other|2|||
163894867|NCT05890105|591986833|FG002|Overall Study|Other|0|||
163894868|NCT04206787|591986834|FG000|Overall Study|Other than listed|2|||
163894869|NCT04206787|591986834|FG000|Overall Study|Investigator decision|1|||
163894870|NCT04206787|591986834|FG000|Overall Study|Death|25|||
163894871|NCT04206787|591986834|FG000|Overall Study|Lost to Follow-up|9|||
163894872|NCT04206787|591986834|FG000|Overall Study|Withdrawal of consent|9|||
164343239|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
164343240|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
164343241|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
164343242|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343243|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
164343244|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343245|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343246|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343247|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343248|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343249|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
164343250|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Other|0|||
164343251|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Other|1|||
164343252|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Other|1|||
164343253|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Other|0|||
164343254|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Other|0|||
164343255|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Other|0|||
164343256|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Other|0|||
164343257|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Other|0|||
164343258|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
164343259|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
164343260|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343261|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
163894873|NCT05008055|591986835|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
164275964|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
164275965|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
164275966|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
164275967|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
164275968|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
164275969|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
164275970|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
164275971|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
164275972|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
164275973|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
164275974|NCT01532869|593378676|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
164275975|NCT01532869|593378677|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
164275976|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
164275977|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
164275978|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
164275979|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
164275980|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
164275981|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
164275982|NCT01532869|593378676|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
164275983|NCT01532869|593378677|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
164275984|NCT01331291|593378678|FG000|Overall Study|Lack of Efficacy|2|||
164275985|NCT01331291|593378679|FG001|Overall Study|Lack of Efficacy|8|||
164275986|NCT01331291|593378678|FG000|Overall Study|Death|0|||
164275987|NCT01331291|593378679|FG001|Overall Study|Death|1|||
164275988|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
164275989|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
164275990|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
164275991|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
164343262|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343263|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343264|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
164343265|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
164343266|NCT01090492|593632965|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343267|NCT01090492|593632966|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343268|NCT01090492|593632967|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343269|NCT01090492|593632968|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343270|NCT01090492|593632969|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343271|NCT01090492|593632970|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343272|NCT01090492|593632971|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
164343273|NCT01090492|593632972|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
164343274|NCT00868608|593632975|FG000|Overall Study|Withdrawal by Subject|3|||
164343275|NCT00868608|593632976|FG001|Overall Study|Withdrawal by Subject|1|||
164343276|NCT00868608|593632977|FG002|Overall Study|Withdrawal by Subject|0|||
164343277|NCT00868608|593632975|FG000|Overall Study|Lost to Follow-up|3|||
164343278|NCT00868608|593632976|FG001|Overall Study|Lost to Follow-up|0|||
164343279|NCT00868608|593632977|FG002|Overall Study|Lost to Follow-up|1|||
164343280|NCT00868608|593632975|FG000|Overall Study|Death|16|||
164343281|NCT00868608|593632976|FG001|Overall Study|Death|2|||
164343282|NCT00868608|593632977|FG002|Overall Study|Death|4|||
164343283|NCT00868608|593632975|FG000|Overall Study|Other - Unspecified|1|||
163894874|NCT05008055|591986836|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
163894875|NCT05008055|591986837|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
163894876|NCT03011034|591986846|FG000|Overall Study|Adverse Event|1|||
163894877|NCT03011034|591986847|FG001|Overall Study|Adverse Event|0|||
163894878|NCT03735979|591986855|FG000|Overall Study|Lost to Follow-up|1|||
164085967|NCT01995058|592678603|FG002|Overall Study|Lack of Efficacy|0|||
164275992|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
164275993|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
164343284|NCT00868608|593632976|FG001|Overall Study|Other - Unspecified|0|||
163894879|NCT03735979|591986856|FG001|Overall Study|Lost to Follow-up|12|||
163894880|NCT03735979|591986857|FG002|Overall Study|Lost to Follow-up|14|||
163894881|NCT03735979|591986855|FG000|Overall Study|Withdrawal by Subject|1|||
164275994|NCT01389323|593378685|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
164275995|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
164275996|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
164275997|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
164275998|NCT01389323|593378685|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
164275999|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
164276000|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
164276001|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
164085968|NCT01995058|592678604|FG003|Overall Study|Lack of Efficacy|1|||
163894882|NCT03735979|591986856|FG001|Overall Study|Withdrawal by Subject|5|||
163894883|NCT03735979|591986857|FG002|Overall Study|Withdrawal by Subject|2|||
163894884|NCT03735979|591986855|FG000|Overall Study|Not due to the above reasons|1|||
163894885|NCT03735979|591986856|FG001|Overall Study|Not due to the above reasons|0|||
163894886|NCT03735979|591986857|FG002|Overall Study|Not due to the above reasons|0|||
163894887|NCT03417284|591988026|FG000|Overall Study|Inadequate supply on study drug|1|||
163894888|NCT03417284|591988027|FG001|Overall Study|Inadequate supply on study drug|0|||
163894889|NCT03417284|591988028|FG002|Overall Study|Inadequate supply on study drug|0|||
163894890|NCT03417284|591988029|FG003|Overall Study|Inadequate supply on study drug|0|||
163894891|NCT03417284|591988026|FG000|Overall Study|Disease Progression|0|||
163894892|NCT03417284|591988027|FG001|Overall Study|Disease Progression|0|||
163894893|NCT03417284|591988028|FG002|Overall Study|Disease Progression|1|||
163894894|NCT03417284|591988029|FG003|Overall Study|Disease Progression|0|||
163894895|NCT03972150|591988030|FG000|Overall Study|Adverse Event|0|||
163894896|NCT03972150|591988031|FG001|Overall Study|Adverse Event|1|||
163894897|NCT03972150|591988032|FG002|Overall Study|Adverse Event|1|||
164085969|NCT01995058|592678601|FG000|Overall Study|No Treatment Given|0|||
164085970|NCT01995058|592678602|FG001|Overall Study|No Treatment Given|0|||
163894898|NCT03972150|591988033|FG003|Overall Study|Adverse Event|0|||
163894899|NCT03972150|591988034|FG004|Overall Study|Adverse Event|0|||
163894900|NCT03972150|591988030|FG000|Overall Study|Progressive disease|3|||
164276002|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
163894901|NCT03972150|591988031|FG001|Overall Study|Progressive disease|5|||
164276003|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
164276004|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
164276005|NCT01805037|593378687|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
164276006|NCT01805037|593378688|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
164276007|NCT01805037|593378687|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
164276008|NCT01805037|593378688|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
164276009|NCT01805037|593378687|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
164276010|NCT01805037|593378688|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
164276011|NCT01805037|593378687|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
164276012|NCT01805037|593378688|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
164276013|NCT01805037|593378687|FG000|Follow Up (up to 3 Years)|Death|0|||
164276014|NCT01805037|593378688|FG001|Follow Up (up to 3 Years)|Death|2|||
164276015|NCT01805037|593378687|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
164276016|NCT01805037|593378688|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
164276017|NCT01805037|593378687|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
164276018|NCT01805037|593378688|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
164276019|NCT04566692|593378689|FG000|Overall Study|Adverse Event|2|||
164343285|NCT00868608|593632977|FG002|Overall Study|Other - Unspecified|0|||
163894902|NCT03972150|591988032|FG002|Overall Study|Progressive disease|2|||
163894903|NCT03972150|591988033|FG003|Overall Study|Progressive disease|2|||
163894904|NCT03972150|591988034|FG004|Overall Study|Progressive disease|3|||
163894905|NCT02668692|591988035|FG000|Overall Study|Adverse Event|1|||
163894906|NCT02668692|591988036|FG001|Overall Study|Adverse Event|0|||
164276020|NCT04566692|593378690|FG001|Overall Study|Adverse Event|0|||
164276021|NCT04566692|593378689|FG000|Overall Study|Withdrawal by Subject|1|||
164276022|NCT04566692|593378690|FG001|Overall Study|Withdrawal by Subject|1|||
163894907|NCT03442309|591988037|FG000|Overall Study|Lost to Follow-up|1676|||
164276023|NCT01183468|593378691|FG000|Overall Study|Lost to Follow-up|2|||
164343286|NCT00911547|593632978|FG000|Overall Study|Adverse Event|8|||
163894908|NCT03442309|591988038|FG001|Overall Study|Lost to Follow-up|1642|||
163894909|NCT01314105|591988044|FG000|Overall Study|Progressive Disease|6|||
163894910|NCT01314105|591988045|FG001|Overall Study|Progressive Disease|10|||
163894911|NCT01314105|591988044|FG000|Overall Study|Refused to continue taking medication|0|||
163894912|NCT01314105|591988045|FG001|Overall Study|Refused to continue taking medication|1|||
163894913|NCT01314105|591988044|FG000|Overall Study|Other Adverse Event|1|||
163894914|NCT01314105|591988045|FG001|Overall Study|Other Adverse Event|1|||
163894915|NCT04089865|591988046|FG000|Overall Study|Withdrawal by Subject|2|||
163894916|NCT04089865|591988047|FG001|Overall Study|Withdrawal by Subject|2|||
164276024|NCT01183468|593378692|FG001|Overall Study|Lost to Follow-up|1|||
164276025|NCT01183468|593378693|FG002|Overall Study|Lost to Follow-up|0|||
164276026|NCT01183468|593378694|FG003|Overall Study|Lost to Follow-up|0|||
163894917|NCT04089865|591988048|FG002|Overall Study|Withdrawal by Subject|7|||
164276027|NCT01183468|593378691|FG000|Overall Study|Physician Decision|1|||
164276028|NCT01183468|593378692|FG001|Overall Study|Physician Decision|0|||
164276029|NCT01183468|593378693|FG002|Overall Study|Physician Decision|0|||
164276030|NCT01183468|593378694|FG003|Overall Study|Physician Decision|0|||
164276031|NCT01183468|593378691|FG000|Overall Study|Withdrawal by Subject|0|||
164276032|NCT01183468|593378692|FG001|Overall Study|Withdrawal by Subject|1|||
164276033|NCT01183468|593378693|FG002|Overall Study|Withdrawal by Subject|0|||
164276034|NCT01183468|593378694|FG003|Overall Study|Withdrawal by Subject|0|||
164276035|NCT00590577|593378695|FG000|Overall Study|Lack of Efficacy|31|||
164276036|NCT00590577|593378696|FG001|Overall Study|Lack of Efficacy|28|||
164276037|NCT00590577|593378697|FG002|Overall Study|Lack of Efficacy|23|||
164276038|NCT00590577|593378698|FG003|Overall Study|Lack of Efficacy|45|||
164276039|NCT00590577|593378695|FG000|Overall Study|Withdrawal by Subject|23|||
164276040|NCT00590577|593378696|FG001|Overall Study|Withdrawal by Subject|28|||
164276041|NCT00590577|593378697|FG002|Overall Study|Withdrawal by Subject|30|||
164276042|NCT00590577|593378698|FG003|Overall Study|Withdrawal by Subject|26|||
164276043|NCT00590577|593378695|FG000|Overall Study|Adverse Event|10|||
164276044|NCT00590577|593378696|FG001|Overall Study|Adverse Event|10|||
164276045|NCT00590577|593378697|FG002|Overall Study|Adverse Event|13|||
164276046|NCT00590577|593378698|FG003|Overall Study|Adverse Event|11|||
164276047|NCT00590577|593378695|FG000|Overall Study|Lost to Follow-up|12|||
164276048|NCT00590577|593378696|FG001|Overall Study|Lost to Follow-up|6|||
164276049|NCT00590577|593378697|FG002|Overall Study|Lost to Follow-up|6|||
164276050|NCT00590577|593378698|FG003|Overall Study|Lost to Follow-up|9|||
164276051|NCT00590577|593378695|FG000|Overall Study|Pregnancy|0|||
164276052|NCT00590577|593378696|FG001|Overall Study|Pregnancy|1|||
164276053|NCT00590577|593378697|FG002|Overall Study|Pregnancy|0|||
164276054|NCT00590577|593378698|FG003|Overall Study|Pregnancy|0|||
164276055|NCT00590577|593378695|FG000|Overall Study|Various reasons|1|||
164085971|NCT01995058|592678603|FG002|Overall Study|No Treatment Given|0|||
164276056|NCT00590577|593378696|FG001|Overall Study|Various reasons|3|||
164276057|NCT00590577|593378697|FG002|Overall Study|Various reasons|1|||
164276058|NCT00590577|593378698|FG003|Overall Study|Various reasons|2|||
164276059|NCT04033068|593378703|FG000|Overall Study|Withdrawal by Subject|0|||
164276060|NCT04033068|593378704|FG001|Overall Study|Withdrawal by Subject|0|||
164276061|NCT04033068|593378705|FG002|Overall Study|Withdrawal by Subject|1|||
164276062|NCT04033068|593378706|FG003|Overall Study|Withdrawal by Subject|0|||
164276063|NCT04033068|593378703|FG000|Overall Study|Lost to Follow-up|0|||
164276064|NCT04033068|593378704|FG001|Overall Study|Lost to Follow-up|1|||
164276065|NCT04033068|593378705|FG002|Overall Study|Lost to Follow-up|0|||
164276066|NCT04033068|593378706|FG003|Overall Study|Lost to Follow-up|0|||
164276067|NCT04033068|593378703|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
164276068|NCT04033068|593378704|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
164276069|NCT04033068|593378705|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
164276070|NCT04033068|593378706|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
164276071|NCT01817959|593378707|FG000|Overall Study|Graft loss|1|||
164276072|NCT01817959|593378708|FG001|Overall Study|Graft loss|1|||
164276073|NCT01817959|593378707|FG000|Overall Study|forbidden medication|1|||
164276074|NCT01817959|593378708|FG001|Overall Study|forbidden medication|1|||
164276075|NCT01817959|593378707|FG000|Overall Study|Adverse Event|1|||
164276076|NCT01817959|593378708|FG001|Overall Study|Adverse Event|0|||
164276077|NCT01817959|593378707|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
164276078|NCT01817959|593378708|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
164276079|NCT03235089|593378709|FG000|Overall Study|Lost to Follow-up|1|||
164276080|NCT03235089|593378710|FG001|Overall Study|Lost to Follow-up|1|||
164276081|NCT03235089|593378709|FG000|Overall Study|Physician Decision|2|||
163894918|NCT04089865|591988049|FG003|Overall Study|Withdrawal by Subject|2|||
164276082|NCT03235089|593378710|FG001|Overall Study|Physician Decision|2|||
164276083|NCT03238924|593378715|FG000|Overall Study|Withdrawal by Subject|2|||
164276084|NCT03238924|593378716|FG001|Overall Study|Withdrawal by Subject|2|||
164276085|NCT03576716|593378717|FG000|Overall Study|Withdrawal by Subject|0|||
164276086|NCT03576716|593378718|FG001|Overall Study|Withdrawal by Subject|1|||
164276087|NCT00559988|593378719|FG000|Overall Study|Death|147|||
164276088|NCT00559988|593378720|FG001|Overall Study|Death|140|||
164276089|NCT00559988|593378719|FG000|Overall Study|Withdrawal by Subject|152|||
164276090|NCT00559988|593378720|FG001|Overall Study|Withdrawal by Subject|139|||
164276091|NCT00559988|593378719|FG000|Overall Study|Lost to Follow-up|42|||
164276092|NCT00559988|593378720|FG001|Overall Study|Lost to Follow-up|56|||
164276093|NCT00559988|593378719|FG000|Overall Study|ICD device explanted|10|||
164276094|NCT00559988|593378720|FG001|Overall Study|ICD device explanted|17|||
164276095|NCT01123707|593378722|FG000|Overall Study|Lost to Follow-up|3|||
164276096|NCT01123707|593378723|FG001|Overall Study|Lost to Follow-up|1|||
164276097|NCT01123707|593378724|FG002|Overall Study|Lost to Follow-up|3|||
164276098|NCT01123707|593378725|FG003|Overall Study|Lost to Follow-up|2|||
164276099|NCT01123707|593378722|FG000|Overall Study|Adverse Event|5|||
164276100|NCT01123707|593378723|FG001|Overall Study|Adverse Event|7|||
164276101|NCT01123707|593378724|FG002|Overall Study|Adverse Event|5|||
164276102|NCT01123707|593378725|FG003|Overall Study|Adverse Event|3|||
164276103|NCT01123707|593378722|FG000|Overall Study|Sponsor Discontinued Study|30|||
164276104|NCT01123707|593378723|FG001|Overall Study|Sponsor Discontinued Study|24|||
164276105|NCT01123707|593378724|FG002|Overall Study|Sponsor Discontinued Study|25|||
163894919|NCT03640286|591988050|FG000|Overall Study|Adverse Event|6|||
163894920|NCT03640286|591988051|FG001|Overall Study|Adverse Event|6|||
163894921|NCT03640286|591988050|FG000|Overall Study|Lost to Follow-up|3|||
163894922|NCT03640286|591988051|FG001|Overall Study|Lost to Follow-up|6|||
163894923|NCT03640286|591988050|FG000|Overall Study|Pregnancy|1|||
163894924|NCT03640286|591988051|FG001|Overall Study|Pregnancy|0|||
163894925|NCT03640286|591988050|FG000|Overall Study|Withdrawal by Subject|10|||
163894926|NCT03640286|591988051|FG001|Overall Study|Withdrawal by Subject|10|||
163894927|NCT03640286|591988050|FG000|Overall Study|Non-compliance|4|||
163894928|NCT03640286|591988051|FG001|Overall Study|Non-compliance|10|||
163894929|NCT03640286|591988050|FG000|Overall Study|Medication change|1|||
163894930|NCT03640286|591988051|FG001|Overall Study|Medication change|0|||
163894931|NCT03640286|591988050|FG000|Overall Study|Other|1|||
163894932|NCT03640286|591988051|FG001|Overall Study|Other|2|||
163894933|NCT03640286|591988050|FG000|Overall Study|Joined another lifestyle program|0|||
163894934|NCT03640286|591988051|FG001|Overall Study|Joined another lifestyle program|1|||
163894935|NCT04389957|591988052|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
163894936|NCT04389957|591988053|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
163894937|NCT04389957|591988054|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
163894938|NCT04389957|591988055|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
163894939|NCT04389957|591988056|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
163894940|NCT01447719|591988058|FG000|Overall Study|Image acquisition failure|2|||
163894941|NCT01447719|591988058|FG000|Overall Study|Invalid image or not imaged|3|||
163894942|NCT01447719|591988058|FG000|Overall Study|Subject still living at end of study|79|||
163894943|NCT01447719|591988058|FG000|Overall Study|Withdrawal by Subject|2|||
163894944|NCT01447719|591988058|FG000|Overall Study|Family withdrew autopsy consent|7|||
163894945|NCT02944968|591988064|FG000|Overall Study|Subject excluded before study procedure|1|||
163894946|NCT02944968|591988064|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
163894947|NCT02905331|591988065|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
163894948|NCT02905331|591988066|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
163894949|NCT02905331|591988067|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
163894950|NCT02905331|591988065|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
163894951|NCT02905331|591988066|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
163894952|NCT02905331|591988067|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
163894953|NCT02905331|591988065|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
163894954|NCT02905331|591988066|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
163894955|NCT02905331|591988067|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
163894956|NCT02905331|591988065|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
163894957|NCT02905331|591988066|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
164276106|NCT01123707|593378725|FG003|Overall Study|Sponsor Discontinued Study|40|||
164276107|NCT01123707|593378722|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164276108|NCT01123707|593378723|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
164276109|NCT01123707|593378724|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
164276110|NCT01123707|593378725|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
164276111|NCT01123707|593378722|FG000|Overall Study|Investigator Withdrew Participant|0|||
164343287|NCT00911547|593632979|FG001|Overall Study|Adverse Event|27|||
164343288|NCT00911547|593632980|FG002|Overall Study|Adverse Event|11|||
164343289|NCT00911547|593632981|FG003|Overall Study|Adverse Event|6|||
164343290|NCT00911547|593632978|FG000|Overall Study|Lost to Follow-up|0|||
164343291|NCT00911547|593632979|FG001|Overall Study|Lost to Follow-up|0|||
164343292|NCT00911547|593632980|FG002|Overall Study|Lost to Follow-up|2|||
164343293|NCT00911547|593632981|FG003|Overall Study|Lost to Follow-up|1|||
164343294|NCT00911547|593632978|FG000|Overall Study|Protocol Violation|0|||
164343295|NCT00911547|593632979|FG001|Overall Study|Protocol Violation|5|||
164343296|NCT00911547|593632980|FG002|Overall Study|Protocol Violation|5|||
164343297|NCT00911547|593632981|FG003|Overall Study|Protocol Violation|1|||
164343298|NCT00911547|593632978|FG000|Overall Study|Withdrawal by Subject|3|||
164343299|NCT00911547|593632979|FG001|Overall Study|Withdrawal by Subject|10|||
164343300|NCT00911547|593632980|FG002|Overall Study|Withdrawal by Subject|4|||
164343301|NCT00911547|593632981|FG003|Overall Study|Withdrawal by Subject|8|||
164343302|NCT00457301|593632982|FG000|Overall Study|Withdrawal by Subject|3|||
164343303|NCT00457301|593632983|FG001|Overall Study|Withdrawal by Subject|3|||
164343304|NCT00457301|593632982|FG000|Overall Study|Censored out of the study|15|||
164343305|NCT00457301|593632983|FG001|Overall Study|Censored out of the study|14|||
164343306|NCT00457301|593632982|FG000|Overall Study|Death|5|||
164343307|NCT00457301|593632983|FG001|Overall Study|Death|7|||
164343308|NCT00191269|593632984|FG000|Overall Study|Protocol Violation|0|||
164343309|NCT00191269|593632985|FG001|Overall Study|Protocol Violation|2|||
164343310|NCT00191269|593632984|FG000|Overall Study|Adverse Event|1|||
164343311|NCT00191269|593632985|FG001|Overall Study|Adverse Event|4|||
164343312|NCT00191269|593632984|FG000|Overall Study|Progression of Disease|4|||
164343313|NCT00191269|593632985|FG001|Overall Study|Progression of Disease|42|||
164343314|NCT00191269|593632984|FG000|Overall Study|Lack of Efficacy|1|||
164343315|NCT00191269|593632985|FG001|Overall Study|Lack of Efficacy|5|||
164343316|NCT00191269|593632984|FG000|Overall Study|Withdrawal by Subject|0|||
164343317|NCT00191269|593632985|FG001|Overall Study|Withdrawal by Subject|1|||
164343318|NCT00191269|593632984|FG000|Overall Study|Pathologic Aggrevation|0|||
164343319|NCT00191269|593632985|FG001|Overall Study|Pathologic Aggrevation|1|||
164343320|NCT00191269|593632984|FG000|Overall Study|Physician Decision|0|||
164343321|NCT00191269|593632985|FG001|Overall Study|Physician Decision|3|||
164343322|NCT03583697|593632988|FG000|Overall Study|Withdrawal by Subject|0|||
164343323|NCT03583697|593632989|FG001|Overall Study|Withdrawal by Subject|0|||
164343324|NCT03583697|593632990|FG002|Overall Study|Withdrawal by Subject|1|||
164343325|NCT03583697|593632988|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
164343326|NCT03583697|593632989|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
164343327|NCT03583697|593632990|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
164343328|NCT00365508|593632991|FG000|Overall Study|Lost to Follow-up|139|||
164343329|NCT00365508|593632992|FG001|Overall Study|Lost to Follow-up|154|||
164343330|NCT00404235|593632995|FG000|Overall Study|Withdrawal by Subject|1|||
164343331|NCT00404235|593632996|FG001|Overall Study|Withdrawal by Subject|2|||
164343332|NCT00679432|593632997|FG000|Overall Study|Adverse Event|5|||
164343333|NCT00679432|593632998|FG001|Overall Study|Adverse Event|6|||
164343334|NCT00679432|593632999|FG002|Overall Study|Adverse Event|10|||
164343335|NCT00679432|593633000|FG003|Overall Study|Adverse Event|7|||
164343336|NCT00679432|593632997|FG000|Overall Study|Protocol Violation|1|||
164343337|NCT00679432|593632998|FG001|Overall Study|Protocol Violation|1|||
164343338|NCT00679432|593632999|FG002|Overall Study|Protocol Violation|2|||
164343339|NCT00679432|593633000|FG003|Overall Study|Protocol Violation|1|||
164343340|NCT00679432|593632997|FG000|Overall Study|Withdrawal by Subject|8|||
164343341|NCT00679432|593632998|FG001|Overall Study|Withdrawal by Subject|11|||
164343342|NCT00679432|593632999|FG002|Overall Study|Withdrawal by Subject|10|||
164343343|NCT00679432|593633000|FG003|Overall Study|Withdrawal by Subject|9|||
164343344|NCT00679432|593632997|FG000|Overall Study|Lost to Follow-up|1|||
164343345|NCT00679432|593632998|FG001|Overall Study|Lost to Follow-up|5|||
164343346|NCT00679432|593632999|FG002|Overall Study|Lost to Follow-up|4|||
164343347|NCT00679432|593633000|FG003|Overall Study|Lost to Follow-up|2|||
164343348|NCT00679432|593632997|FG000|Overall Study|Physician Decision|3|||
164343349|NCT00679432|593632998|FG001|Overall Study|Physician Decision|2|||
164343350|NCT00679432|593632999|FG002|Overall Study|Physician Decision|2|||
164343351|NCT00679432|593633000|FG003|Overall Study|Physician Decision|2|||
164343352|NCT00679432|593632997|FG000|Overall Study|Sponsor decision|1|||
164343353|NCT00679432|593632998|FG001|Overall Study|Sponsor decision|0|||
164343354|NCT00679432|593632999|FG002|Overall Study|Sponsor decision|0|||
164343355|NCT00679432|593633000|FG003|Overall Study|Sponsor decision|0|||
164343356|NCT00679432|593632997|FG000|Overall Study|Lack of Efficacy|13|||
164343357|NCT00679432|593632998|FG001|Overall Study|Lack of Efficacy|9|||
164343358|NCT00679432|593632999|FG002|Overall Study|Lack of Efficacy|14|||
164343359|NCT00679432|593633000|FG003|Overall Study|Lack of Efficacy|8|||
164343360|NCT00679432|593632997|FG000|Overall Study|Infectious colitis, normal histology|5|||
164343361|NCT00679432|593632998|FG001|Overall Study|Infectious colitis, normal histology|4|||
164343362|NCT00679432|593632999|FG002|Overall Study|Infectious colitis, normal histology|8|||
164343363|NCT00679432|593633000|FG003|Overall Study|Infectious colitis, normal histology|3|||
164276112|NCT01123707|593378723|FG001|Overall Study|Investigator Withdrew Participant|1|||
164276113|NCT01123707|593378724|FG002|Overall Study|Investigator Withdrew Participant|1|||
164276114|NCT01123707|593378725|FG003|Overall Study|Investigator Withdrew Participant|1|||
164276115|NCT01123707|593378722|FG000|Overall Study|Subject Withdrew Consent|4|||
164276116|NCT01123707|593378723|FG001|Overall Study|Subject Withdrew Consent|5|||
164276117|NCT01123707|593378724|FG002|Overall Study|Subject Withdrew Consent|1|||
164276118|NCT01123707|593378725|FG003|Overall Study|Subject Withdrew Consent|2|||
164276119|NCT01123707|593378722|FG000|Overall Study|Lack of Efficacy|1|||
164276120|NCT01123707|593378723|FG001|Overall Study|Lack of Efficacy|2|||
164276121|NCT01123707|593378724|FG002|Overall Study|Lack of Efficacy|1|||
164276122|NCT01123707|593378725|FG003|Overall Study|Lack of Efficacy|0|||
164276123|NCT01123707|593378722|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
164276124|NCT01123707|593378723|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
164276125|NCT01123707|593378724|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
164276126|NCT01123707|593378725|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
164276127|NCT01990612|593378730|FG000|Overall Study|Lost to Follow-up|2|||
164276128|NCT01990612|593378731|FG001|Overall Study|Lost to Follow-up|1|||
164276129|NCT01990612|593378730|FG000|Overall Study|Withdrawal by Subject|5|||
164276130|NCT01990612|593378731|FG001|Overall Study|Withdrawal by Subject|2|||
164276131|NCT02725866|593378732|FG000|Overall Study|Failure to return|6|||
164276132|NCT02725866|593378732|FG000|Overall Study|Withdrew consent|3|||
164276133|NCT02725866|593378732|FG000|Overall Study|Insufficient virological response|1|||
164276134|NCT02725866|593378732|FG000|Overall Study|Other, not specified|4|||
164276135|NCT02980133|593378736|FG000|Overall Study|Other than specified|1|||
164276136|NCT02980133|593378737|FG001|Overall Study|Other than specified|1|||
164276137|NCT02980133|593378738|FG002|Overall Study|Other than specified|2|||
164276138|NCT02980133|593378739|FG003|Overall Study|Other than specified|2|||
164276139|NCT02980133|593378736|FG000|Overall Study|Lost to Follow-up|0|||
164276140|NCT02980133|593378737|FG001|Overall Study|Lost to Follow-up|0|||
164276141|NCT02980133|593378738|FG002|Overall Study|Lost to Follow-up|1|||
164276142|NCT02980133|593378739|FG003|Overall Study|Lost to Follow-up|3|||
164276143|NCT02980133|593378736|FG000|Overall Study|Protocol Violation|0|||
164276144|NCT02980133|593378737|FG001|Overall Study|Protocol Violation|1|||
164276145|NCT02980133|593378738|FG002|Overall Study|Protocol Violation|0|||
164276146|NCT02980133|593378739|FG003|Overall Study|Protocol Violation|0|||
164276147|NCT02980133|593378736|FG000|Overall Study|Withdrawal by parent/guardian|6|||
164276148|NCT02980133|593378737|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164276149|NCT02980133|593378738|FG002|Overall Study|Withdrawal by parent/guardian|3|||
164276150|NCT02980133|593378739|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164276151|NCT02980133|593378736|FG000|Overall Study|Withdrawal by Subject|0|||
164276152|NCT02980133|593378737|FG001|Overall Study|Withdrawal by Subject|0|||
164276153|NCT02980133|593378738|FG002|Overall Study|Withdrawal by Subject|1|||
164276154|NCT02980133|593378739|FG003|Overall Study|Withdrawal by Subject|0|||
164276155|NCT03208088|593378744|FG000|Period 2|Withdrawal by Subject|0|||
164276156|NCT03208088|593378745|FG001|Period 2|Withdrawal by Subject|0|||
164276157|NCT03208088|593378746|FG002|Period 2|Withdrawal by Subject|0|||
164276158|NCT03208088|593378747|FG003|Period 2|Withdrawal by Subject|0|||
163894958|NCT02905331|591988067|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
163894959|NCT02905331|591988065|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
163894960|NCT02905331|591988066|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
163894961|NCT02905331|591988067|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
163894962|NCT05007080|591988068|FG000|Overall Study|Lost to Follow-up|0|||
163894963|NCT05007080|591988069|FG001|Overall Study|Lost to Follow-up|1|||
163894964|NCT05007080|591988070|FG002|Overall Study|Lost to Follow-up|0|||
163894965|NCT05007080|591988071|FG003|Overall Study|Lost to Follow-up|1|||
163894966|NCT05007080|591988072|FG004|Overall Study|Lost to Follow-up|1|||
163894967|NCT05007080|591988073|FG005|Overall Study|Lost to Follow-up|1|||
163894968|NCT05007080|591988068|FG000|Overall Study|Death|0|||
163894969|NCT05007080|591988069|FG001|Overall Study|Death|1|||
163894970|NCT05007080|591988070|FG002|Overall Study|Death|0|||
163894971|NCT05007080|591988071|FG003|Overall Study|Death|0|||
163894972|NCT05007080|591988072|FG004|Overall Study|Death|0|||
163894973|NCT05007080|591988073|FG005|Overall Study|Death|0|||
163894974|NCT05007080|591988068|FG000|Overall Study|Withdrawal by Subject|1|||
163894975|NCT05007080|591988069|FG001|Overall Study|Withdrawal by Subject|2|||
164276159|NCT03208088|593378748|FG004|Period 2|Withdrawal by Subject|0|||
164276160|NCT03208088|593378749|FG005|Period 2|Withdrawal by Subject|0|||
164276161|NCT03208088|593378750|FG006|Period 2|Withdrawal by Subject|0|||
164276162|NCT03208088|593378751|FG007|Period 2|Withdrawal by Subject|0|||
164276163|NCT03208088|593378752|FG008|Period 2|Withdrawal by Subject|1|||
164276164|NCT03208088|593378753|FG009|Period 2|Withdrawal by Subject|0|||
164276165|NCT03208088|593378744|FG000|Period 3|Unsatisfactory Test Article|0|||
164276166|NCT03208088|593378745|FG001|Period 3|Unsatisfactory Test Article|0|||
164276167|NCT03208088|593378746|FG002|Period 3|Unsatisfactory Test Article|0|||
164276168|NCT03208088|593378747|FG003|Period 3|Unsatisfactory Test Article|1|||
164276169|NCT03208088|593378748|FG004|Period 3|Unsatisfactory Test Article|0|||
164276170|NCT03208088|593378749|FG005|Period 3|Unsatisfactory Test Article|0|||
164276171|NCT03208088|593378750|FG006|Period 3|Unsatisfactory Test Article|0|||
164276172|NCT03208088|593378751|FG007|Period 3|Unsatisfactory Test Article|0|||
164276173|NCT03208088|593378752|FG008|Period 3|Unsatisfactory Test Article|0|||
164276174|NCT03208088|593378753|FG009|Period 3|Unsatisfactory Test Article|0|||
164276175|NCT03208088|593378744|FG000|Period 4|Unsatisfactory Test Article|0|||
164276176|NCT03208088|593378745|FG001|Period 4|Unsatisfactory Test Article|0|||
164276177|NCT03208088|593378746|FG002|Period 4|Unsatisfactory Test Article|0|||
164276178|NCT03208088|593378747|FG003|Period 4|Unsatisfactory Test Article|1|||
164276179|NCT03208088|593378748|FG004|Period 4|Unsatisfactory Test Article|0|||
164276180|NCT03208088|593378749|FG005|Period 4|Unsatisfactory Test Article|0|||
164276181|NCT03208088|593378750|FG006|Period 4|Unsatisfactory Test Article|0|||
164276182|NCT03208088|593378751|FG007|Period 4|Unsatisfactory Test Article|0|||
164276183|NCT03208088|593378752|FG008|Period 4|Unsatisfactory Test Article|0|||
164276184|NCT03208088|593378753|FG009|Period 4|Unsatisfactory Test Article|0|||
164276185|NCT00605345|593378759|FG000|Overall Study|Withdrawal by Subject|1|||
164276186|NCT00605345|593378760|FG001|Overall Study|Withdrawal by Subject|0|||
164276187|NCT00605345|593378759|FG000|Overall Study|Adverse Event|0|||
164276188|NCT00605345|593378760|FG001|Overall Study|Adverse Event|1|||
164276189|NCT00605345|593378759|FG000|Overall Study|Protocol Violation|0|||
164276190|NCT00605345|593378760|FG001|Overall Study|Protocol Violation|2|||
164276191|NCT02577016|593378761|FG000|Overall Study|Adverse Event|2|||
164276192|NCT02577016|593378762|FG001|Overall Study|Adverse Event|1|||
164276193|NCT02577016|593378761|FG000|Overall Study|Physician Decision|0|||
164276194|NCT02577016|593378762|FG001|Overall Study|Physician Decision|1|||
164276195|NCT00666224|593380550|FG000|Double-Blind|Adverse Event|15|||
164276196|NCT00666224|593380551|FG001|Double-Blind|Adverse Event|5|||
164276197|NCT00666224|593380550|FG000|Double-Blind|Lost to Follow-up|2|||
164276198|NCT00666224|593380551|FG001|Double-Blind|Lost to Follow-up|2|||
164276199|NCT00666224|593380550|FG000|Double-Blind|Withdrawal by Subject|18|||
164276200|NCT00666224|593380551|FG001|Double-Blind|Withdrawal by Subject|14|||
164276201|NCT00666224|593380550|FG000|Double-Blind|Physician Decision|0|||
164276202|NCT00666224|593380551|FG001|Double-Blind|Physician Decision|3|||
164276203|NCT00666224|593380550|FG000|Double-Blind|Sponsor decision|1|||
164276204|NCT00666224|593380551|FG001|Double-Blind|Sponsor decision|0|||
164276205|NCT00666224|593380550|FG000|Double-Blind|Pregnancy|3|||
164276206|NCT00666224|593380551|FG001|Double-Blind|Pregnancy|2|||
164276207|NCT00666224|593380550|FG000|Double-Blind|Noncompliance|1|||
164276208|NCT00666224|593380551|FG001|Double-Blind|Noncompliance|0|||
164276209|NCT00666224|593380550|FG000|Double-Blind|Death|1|||
164276210|NCT00666224|593380551|FG001|Double-Blind|Death|0|||
164276211|NCT00666224|593380550|FG000|Double-Blind|Undefined/Unknown|4|||
164276212|NCT00666224|593380551|FG001|Double-Blind|Undefined/Unknown|1|||
164276213|NCT00666224|593380550|FG000|Open-Label|Adverse Event|8|||
164276214|NCT00666224|593380551|FG001|Open-Label|Adverse Event|43|||
164276215|NCT00666224|593380550|FG000|Open-Label|Lost to Follow-up|4|||
164276216|NCT00666224|593380551|FG001|Open-Label|Lost to Follow-up|5|||
164276217|NCT00666224|593380550|FG000|Open-Label|Withdrawal by Subject|12|||
164276218|NCT00666224|593380551|FG001|Open-Label|Withdrawal by Subject|25|||
164276219|NCT00666224|593380550|FG000|Open-Label|Physician Decision|7|||
164276220|NCT00666224|593380551|FG001|Open-Label|Physician Decision|5|||
164276221|NCT00666224|593380550|FG000|Open-Label|Pregnancy|1|||
164276222|NCT00666224|593380551|FG001|Open-Label|Pregnancy|5|||
164276223|NCT00666224|593380550|FG000|Open-Label|Noncompliance|2|||
164276224|NCT00666224|593380551|FG001|Open-Label|Noncompliance|1|||
164276225|NCT00666224|593380550|FG000|Open-Label|Undefined/Unknown|1|||
164276226|NCT00666224|593380551|FG001|Open-Label|Undefined/Unknown|1|||
163894976|NCT05007080|591988070|FG002|Overall Study|Withdrawal by Subject|0|||
163894977|NCT05007080|591988071|FG003|Overall Study|Withdrawal by Subject|2|||
163894978|NCT05007080|591988072|FG004|Overall Study|Withdrawal by Subject|1|||
163894979|NCT05007080|591988073|FG005|Overall Study|Withdrawal by Subject|1|||
163894980|NCT05007080|591988068|FG000|Overall Study|Other|1|||
163894981|NCT05007080|591988069|FG001|Overall Study|Other|0|||
163894982|NCT05007080|591988070|FG002|Overall Study|Other|1|||
163894983|NCT05007080|591988071|FG003|Overall Study|Other|1|||
164276227|NCT03521141|593380552|FG000|Overall Study|Death|1|||
164276228|NCT03521141|593380553|FG001|Overall Study|Death|0|||
164276229|NCT03521141|593380554|FG002|Overall Study|Death|1|||
164276230|NCT03828617|593380556|FG000|Overall Study|Lost to Follow-up|22|||
164276231|NCT03828617|593380557|FG001|Overall Study|Lost to Follow-up|12|||
164276232|NCT03828617|593380558|FG002|Overall Study|Lost to Follow-up|23|||
164276233|NCT03828617|593380559|FG003|Overall Study|Lost to Follow-up|7|||
164276234|NCT03828617|593380556|FG000|Overall Study|No longer met eligibility criteria|0|||
164276235|NCT03828617|593380557|FG001|Overall Study|No longer met eligibility criteria|1|||
164276236|NCT03828617|593380558|FG002|Overall Study|No longer met eligibility criteria|1|||
164276237|NCT03828617|593380559|FG003|Overall Study|No longer met eligibility criteria|3|||
164276238|NCT03828617|593380556|FG000|Overall Study|Protocol Violation|0|||
164276239|NCT03828617|593380557|FG001|Overall Study|Protocol Violation|2|||
164276240|NCT03828617|593380558|FG002|Overall Study|Protocol Violation|0|||
164276241|NCT03828617|593380559|FG003|Overall Study|Protocol Violation|0|||
164276242|NCT03828617|593380556|FG000|Overall Study|Withdrawal by Subject|2|||
164276243|NCT03828617|593380557|FG001|Overall Study|Withdrawal by Subject|0|||
164276244|NCT03828617|593380558|FG002|Overall Study|Withdrawal by Subject|2|||
164276245|NCT03828617|593380559|FG003|Overall Study|Withdrawal by Subject|0|||
164276246|NCT03354273|593380560|FG000|Overall Study|Adverse Event|5|||
164276247|NCT03354273|593380560|FG000|Overall Study|Screen Failure|21|||
164276248|NCT03354273|593380560|FG000|Overall Study|Withdrawal by Subject|34|||
164276249|NCT03354273|593380560|FG000|Overall Study|Technical Problems|30|||
164276250|NCT03354273|593380560|FG000|Overall Study|Lost to Follow-up|4|||
164276251|NCT03354273|593380560|FG000|Overall Study|Investigator Decision|3|||
164276252|NCT03354273|593380560|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
164276253|NCT03354273|593380560|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
164276254|NCT03354273|593380560|FG000|Overall Study|COVID-19 Restrictions|9|||
164276255|NCT03354273|593380560|FG000|Overall Study|Other|5|||
164276256|NCT00303485|593380561|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
164276257|NCT00303485|593380562|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
164276258|NCT00303485|593380561|FG000|Overall Study|Failure to return|0|||
164276259|NCT00303485|593380562|FG001|Overall Study|Failure to return|1|||
164276260|NCT00303485|593380561|FG000|Overall Study|Withdrawal by Subject|1|||
163894984|NCT05007080|591988072|FG004|Overall Study|Other|0|||
163894985|NCT05007080|591988073|FG005|Overall Study|Other|2|||
163894986|NCT05007080|591988068|FG000|Overall Study|Randomized not vaccinated|0|||
163894987|NCT05007080|591988069|FG001|Overall Study|Randomized not vaccinated|0|||
164276261|NCT00303485|593380562|FG001|Overall Study|Withdrawal by Subject|0|||
164276262|NCT00971243|593380567|FG000|Double Blind Period|Adverse Event|2|||
164276263|NCT00971243|593380568|FG001|Double Blind Period|Adverse Event|3|||
164276264|NCT00971243|593380569|FG002|Double Blind Period|Adverse Event|2|||
164276265|NCT00971243|593380570|FG003|Double Blind Period|Adverse Event|2|||
164276266|NCT00971243|593380571|FG004|Double Blind Period|Adverse Event|3|||
164276267|NCT00971243|593380567|FG000|Double Blind Period|Lost to Follow-up|0|||
164276268|NCT00971243|593380568|FG001|Double Blind Period|Lost to Follow-up|1|||
164276269|NCT00971243|593380569|FG002|Double Blind Period|Lost to Follow-up|1|||
164276270|NCT00971243|593380570|FG003|Double Blind Period|Lost to Follow-up|0|||
164276271|NCT00971243|593380571|FG004|Double Blind Period|Lost to Follow-up|1|||
164276272|NCT00971243|593380567|FG000|Double Blind Period|Physician Decision|10|||
164276273|NCT00971243|593380568|FG001|Double Blind Period|Physician Decision|6|||
164276274|NCT00971243|593380569|FG002|Double Blind Period|Physician Decision|7|||
164276275|NCT00971243|593380570|FG003|Double Blind Period|Physician Decision|6|||
164276276|NCT00971243|593380571|FG004|Double Blind Period|Physician Decision|7|||
164276277|NCT00971243|593380567|FG000|Double Blind Period|Protocol Violation|2|||
164276278|NCT00971243|593380568|FG001|Double Blind Period|Protocol Violation|0|||
164276279|NCT00971243|593380569|FG002|Double Blind Period|Protocol Violation|3|||
164276280|NCT00971243|593380570|FG003|Double Blind Period|Protocol Violation|2|||
164276281|NCT00971243|593380571|FG004|Double Blind Period|Protocol Violation|2|||
164276282|NCT00971243|593380567|FG000|Double Blind Period|Withdrawal by Subject|4|||
164276283|NCT00971243|593380568|FG001|Double Blind Period|Withdrawal by Subject|1|||
164276284|NCT00971243|593380569|FG002|Double Blind Period|Withdrawal by Subject|4|||
163894988|NCT05007080|591988070|FG002|Overall Study|Randomized not vaccinated|0|||
163894989|NCT05007080|591988071|FG003|Overall Study|Randomized not vaccinated|0|||
163894990|NCT05007080|591988072|FG004|Overall Study|Randomized not vaccinated|0|||
163894991|NCT05007080|591988073|FG005|Overall Study|Randomized not vaccinated|1|||
163894992|NCT02874742|591988075|FG000|Overall Study|Death|0|||
163894993|NCT02874742|591988076|FG001|Overall Study|Death|1|||
163894994|NCT02874742|591988077|FG002|Overall Study|Death|0|||
163894995|NCT02874742|591988075|FG000|Overall Study|Lost to Follow-up|5|||
163894996|NCT02874742|591988076|FG001|Overall Study|Lost to Follow-up|4|||
163894997|NCT02874742|591988077|FG002|Overall Study|Lost to Follow-up|1|||
163894998|NCT02874742|591988075|FG000|Overall Study|Withdrawal by Subject|17|||
163894999|NCT02874742|591988076|FG001|Overall Study|Withdrawal by Subject|8|||
163895000|NCT02874742|591988077|FG002|Overall Study|Withdrawal by Subject|0|||
163895001|NCT02874742|591988075|FG000|Overall Study|Other|4|||
163895002|NCT02874742|591988076|FG001|Overall Study|Other|1|||
163895003|NCT02874742|591988077|FG002|Overall Study|Other|0|||
163895004|NCT02874742|591988075|FG000|Overall Study|Progressive Disease|1|||
163895005|NCT02874742|591988076|FG001|Overall Study|Progressive Disease|0|||
163895006|NCT02874742|591988077|FG002|Overall Study|Progressive Disease|0|||
163895007|NCT02874742|591988075|FG000|Overall Study|Screen Failure|0|||
163895008|NCT02874742|591988076|FG001|Overall Study|Screen Failure|2|||
163895009|NCT02874742|591988077|FG002|Overall Study|Screen Failure|0|||
164276285|NCT00971243|593380570|FG003|Double Blind Period|Withdrawal by Subject|4|||
164276286|NCT00971243|593380571|FG004|Double Blind Period|Withdrawal by Subject|4|||
164276287|NCT00971243|593380567|FG000|Double Blind Period|Other reasons|1|||
164276288|NCT00971243|593380568|FG001|Double Blind Period|Other reasons|0|||
164276289|NCT00971243|593380569|FG002|Double Blind Period|Other reasons|2|||
164276290|NCT00971243|593380570|FG003|Double Blind Period|Other reasons|0|||
164276291|NCT00971243|593380571|FG004|Double Blind Period|Other reasons|1|||
164276292|NCT00971243|593380567|FG000|Open-label Period|Adverse Event|1|||
163895010|NCT04583280|591988081|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
163895011|NCT04583280|591988082|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
164276293|NCT00971243|593380568|FG001|Open-label Period|Adverse Event|0|||
164276294|NCT00971243|593380569|FG002|Open-label Period|Adverse Event|1|||
164276295|NCT00971243|593380570|FG003|Open-label Period|Adverse Event|1|||
164276296|NCT00971243|593380571|FG004|Open-label Period|Adverse Event|0|||
164276297|NCT00971243|593380567|FG000|Open-label Period|Physician Decision|5|||
164276298|NCT00971243|593380568|FG001|Open-label Period|Physician Decision|9|||
164276299|NCT00971243|593380569|FG002|Open-label Period|Physician Decision|3|||
164276300|NCT00971243|593380570|FG003|Open-label Period|Physician Decision|7|||
164276301|NCT00971243|593380571|FG004|Open-label Period|Physician Decision|2|||
164276302|NCT00971243|593380567|FG000|Open-label Period|Protocol Violation|1|||
164276303|NCT00971243|593380568|FG001|Open-label Period|Protocol Violation|1|||
164276304|NCT00971243|593380569|FG002|Open-label Period|Protocol Violation|1|||
164276305|NCT00971243|593380570|FG003|Open-label Period|Protocol Violation|0|||
164276306|NCT00971243|593380571|FG004|Open-label Period|Protocol Violation|1|||
164276307|NCT00971243|593380567|FG000|Open-label Period|Withdrawal by Subject|1|||
164276308|NCT00971243|593380568|FG001|Open-label Period|Withdrawal by Subject|0|||
164276309|NCT00971243|593380569|FG002|Open-label Period|Withdrawal by Subject|0|||
164276310|NCT00971243|593380570|FG003|Open-label Period|Withdrawal by Subject|2|||
164276311|NCT00971243|593380571|FG004|Open-label Period|Withdrawal by Subject|1|||
164276312|NCT00971243|593380567|FG000|Open-label Period|Other reason|0|||
164276313|NCT00971243|593380568|FG001|Open-label Period|Other reason|0|||
163895012|NCT03691298|591988083|FG000|Overall Study|Lost to Follow-up|8|||
163895013|NCT03691298|591988083|FG000|Overall Study|Sponsor terminated study|2|||
163895014|NCT02577354|591988084|FG000|Overall Study|Lack of Efficacy|4|||
163895015|NCT02577354|591988085|FG001|Overall Study|Lack of Efficacy|4|||
163895016|NCT02577354|591988084|FG000|Overall Study|Lost to Follow-up|3|||
163895017|NCT02577354|591988085|FG001|Overall Study|Lost to Follow-up|1|||
163895018|NCT02577354|591988084|FG000|Overall Study|Missed Visit|4|||
163895019|NCT02577354|591988085|FG001|Overall Study|Missed Visit|3|||
163895020|NCT02577354|591988084|FG000|Overall Study|Adverse Event|4|||
163895021|NCT02577354|591988085|FG001|Overall Study|Adverse Event|5|||
163895022|NCT04173247|591988086|FG000|Overall Study|Withdrawal by Subject|0|||
163895023|NCT04173247|591988087|FG001|Overall Study|Withdrawal by Subject|2|||
163895024|NCT04173247|591988086|FG000|Overall Study|Death|1|||
163895025|NCT04173247|591988087|FG001|Overall Study|Death|0|||
163895026|NCT04173247|591988086|FG000|Overall Study|Physician Decision|1|||
163895027|NCT04173247|591988087|FG001|Overall Study|Physician Decision|0|||
163895028|NCT05652010|591988100|FG000|First Intervention|Withdrawal by Subject|0|||
163895029|NCT05652010|591988101|FG001|First Intervention|Withdrawal by Subject|1|||
163895030|NCT05652010|591988100|FG000|Second Intervention|Withdrawal by Subject|1|||
163895031|NCT05652010|591988101|FG001|Second Intervention|Withdrawal by Subject|0|||
163895032|NCT05451693|591988102|FG000|Overall Study|Withdrawal by Subject|1|||
163895033|NCT05451693|591988103|FG001|Overall Study|Withdrawal by Subject|1|||
163895034|NCT00319111|591988108|FG000|Overall Study|Adverse Event|20|||
163895035|NCT00319111|591988108|FG000|Overall Study|Withdrawal of consent|11|||
163895036|NCT00319111|591988108|FG000|Overall Study|Death|9|||
163895037|NCT00319111|591988108|FG000|Overall Study|Lack of clinical improvement|4|||
163895038|NCT00319111|591988108|FG000|Overall Study|Administrative|2|||
163895039|NCT00319111|591988108|FG000|Overall Study|Treatment failure|1|||
163895040|NCT01475786|591988109|FG000|Overall Study|Adverse Event|0|||
163895041|NCT01475786|591988110|FG001|Overall Study|Adverse Event|1|||
163895042|NCT01475786|591988111|FG002|Overall Study|Adverse Event|0|||
163895043|NCT01475786|591988109|FG000|Overall Study|Lost to Follow-up|1|||
163895044|NCT01475786|591988110|FG001|Overall Study|Lost to Follow-up|2|||
163895045|NCT01475786|591988111|FG002|Overall Study|Lost to Follow-up|1|||
163895046|NCT01475786|591988109|FG000|Overall Study|Withdrawal by Subject|0|||
163895047|NCT01475786|591988110|FG001|Overall Study|Withdrawal by Subject|1|||
163895048|NCT01475786|591988111|FG002|Overall Study|Withdrawal by Subject|1|||
163895049|NCT01475786|591988109|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
163895050|NCT01475786|591988110|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
163895051|NCT01475786|591988111|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
163895052|NCT03165955|591988113|FG000|Treatment|Withdrawal by Subject|3|||
163895053|NCT03165955|591988113|FG000|Treatment|Death|1|||
163895054|NCT03165955|591988113|FG000|Treatment|Adverse Event|1|||
164276314|NCT00971243|593380569|FG002|Open-label Period|Other reason|0|||
164276315|NCT00971243|593380570|FG003|Open-label Period|Other reason|0|||
164276316|NCT00971243|593380571|FG004|Open-label Period|Other reason|2|||
164276317|NCT04099511|593380575|FG000|Overall Study|Lost to Follow-up|2|||
163895055|NCT03165955|591988113|FG000|Treatment|Progressive disease|3|||
163895056|NCT04761198|591988116|FG000|Overall Study|Progressive Disease|1|||
163895057|NCT04761198|591988117|FG001|Overall Study|Progressive Disease|0|||
163895058|NCT04761198|591988118|FG002|Overall Study|Progressive Disease|0|||
163895059|NCT04761198|591988119|FG003|Overall Study|Progressive Disease|1|||
163895060|NCT04761198|591988120|FG004|Overall Study|Progressive Disease|4|||
164276318|NCT04099511|593380576|FG001|Overall Study|Lost to Follow-up|2|||
164276319|NCT04099511|593380575|FG000|Overall Study|Withdrawal by Subject|8|||
164276320|NCT04099511|593380576|FG001|Overall Study|Withdrawal by Subject|4|||
164276321|NCT06581094|593380577|FG000|Overall Study|Lost to Follow-up|1|||
164276322|NCT06581094|593380578|FG001|Overall Study|Lost to Follow-up|1|||
164276323|NCT02942485|593380579|FG000|Overall Study|Lost to Follow-up|1|||
164276324|NCT02942485|593380580|FG001|Overall Study|Lost to Follow-up|0|||
164276325|NCT04302545|593380588|FG000|Overall Study|Lost to Follow-up|3|||
164276326|NCT04302545|593380589|FG001|Overall Study|Lost to Follow-up|4|||
164276327|NCT02516592|593380590|FG000|Overall Study|Patient withdrew consent|5|||
164276328|NCT02516592|593380591|FG001|Overall Study|Patient withdrew consent|2|||
164276329|NCT02516592|593380590|FG000|Overall Study|Protocol deviation|4|||
164276330|NCT02516592|593380591|FG001|Overall Study|Protocol deviation|4|||
164276331|NCT02516592|593380590|FG000|Overall Study|Lost to Follow-up|2|||
164276332|NCT02516592|593380591|FG001|Overall Study|Lost to Follow-up|3|||
164276333|NCT02516592|593380590|FG000|Overall Study|Patient/guardian decision|2|||
164276334|NCT02516592|593380591|FG001|Overall Study|Patient/guardian decision|1|||
164276335|NCT02516592|593380590|FG000|Overall Study|Adverse Event|1|||
164276336|NCT02516592|593380591|FG001|Overall Study|Adverse Event|2|||
164276337|NCT02516592|593380590|FG000|Overall Study|Abnormal test procedure result|1|||
164276338|NCT02516592|593380591|FG001|Overall Study|Abnormal test procedure result|0|||
164276339|NCT02516592|593380590|FG000|Overall Study|Death|1|||
164276340|NCT02516592|593380591|FG001|Overall Study|Death|1|||
164276341|NCT00764673|593380594|FG000|Overall Study|Death|1|||
164276342|NCT00764673|593380594|FG000|Overall Study|Lost to Follow-up|3|||
164276343|NCT00764673|593380594|FG000|Overall Study|Withdrawal by Subject|6|||
164276344|NCT00764673|593380594|FG000|Overall Study|Revision of Device|2|||
164276345|NCT01438177|593380595|FG000|Overall Study|Withdrawal by Subject|1|||
164276346|NCT01438177|593380595|FG000|Overall Study|Initiation of new therapy|1|||
164276347|NCT00619099|593380596|FG000|Overall Study|Progressive Disease|7|||
164276348|NCT00619099|593380597|FG001|Overall Study|Progressive Disease|5|||
164276349|NCT00619099|593380596|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
164276350|NCT00619099|593380597|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
164276351|NCT00619099|593380596|FG000|Overall Study|Adverse Event|4|||
164276352|NCT00619099|593380597|FG001|Overall Study|Adverse Event|3|||
164276353|NCT00619099|593380596|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
164276354|NCT00619099|593380597|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
164276355|NCT00619099|593380596|FG000|Overall Study|Withdrawal by Subject|10|||
164276356|NCT00619099|593380597|FG001|Overall Study|Withdrawal by Subject|2|||
164276357|NCT00619099|593380596|FG000|Overall Study|Physician Decision|9|||
164276358|NCT00619099|593380597|FG001|Overall Study|Physician Decision|6|||
164276359|NCT01270256|593380598|FG000|Overall Study|Withdrawal by Subject|1|||
164276360|NCT01270256|593380599|FG001|Overall Study|Withdrawal by Subject|0|||
164276361|NCT03927404|593380604|FG000|Overall Study|Withdrawal by Subject|1|||
164276362|NCT01229449|593380607|FG000|Overall Study|Withdrawal by Subject|0|||
164276363|NCT01229449|593380608|FG001|Overall Study|Withdrawal by Subject|3|||
164276364|NCT01229449|593380609|FG002|Overall Study|Withdrawal by Subject|0|||
164276365|NCT01229449|593380610|FG003|Overall Study|Withdrawal by Subject|1|||
164276366|NCT01229449|593380611|FG004|Overall Study|Withdrawal by Subject|1|||
164276367|NCT01229449|593380607|FG000|Overall Study|Lost to Follow-up|1|||
164276368|NCT01229449|593380608|FG001|Overall Study|Lost to Follow-up|1|||
164276369|NCT01229449|593380609|FG002|Overall Study|Lost to Follow-up|1|||
164276370|NCT01229449|593380610|FG003|Overall Study|Lost to Follow-up|0|||
164276371|NCT01229449|593380611|FG004|Overall Study|Lost to Follow-up|0|||
164276372|NCT01229449|593380607|FG000|Overall Study|Physician Decision|0|||
164276373|NCT01229449|593380608|FG001|Overall Study|Physician Decision|0|||
164343364|NCT00679432|593632997|FG000|Overall Study|Randomization error, return to prior Rx|0|||
164343365|NCT00679432|593632998|FG001|Overall Study|Randomization error, return to prior Rx|0|||
164343366|NCT00679432|593632999|FG002|Overall Study|Randomization error, return to prior Rx|3|||
164343367|NCT00679432|593633000|FG003|Overall Study|Randomization error, return to prior Rx|0|||
164343368|NCT00824720|593633001|FG000|Overall Study|failed plug insertion|3|||
164343369|NCT00824720|593633002|FG001|Overall Study|failed plug insertion|1|||
164276374|NCT01229449|593380609|FG002|Overall Study|Physician Decision|1|||
164276375|NCT01229449|593380610|FG003|Overall Study|Physician Decision|0|||
164276376|NCT01229449|593380611|FG004|Overall Study|Physician Decision|0|||
164276377|NCT03203291|593380613|FG000|Overall Study|Withdrawal by Subject|1|||
164276378|NCT01300260|593380614|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
164276379|NCT01300260|593380615|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
164276380|NCT01300260|593380614|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
164276381|NCT01300260|593380615|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
164276382|NCT01300260|593380614|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
164276383|NCT01300260|593380615|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
164276384|NCT05098509|593380618|FG000|Overall Study|Withdrawal by Subject|0|||
164276385|NCT05098509|593380619|FG001|Overall Study|Withdrawal by Subject|0|||
164343370|NCT00824720|593633003|FG002|Overall Study|failed plug insertion|0|||
164343371|NCT00824720|593633001|FG000|Overall Study|Protocol Violation|0|||
164343372|NCT00824720|593633002|FG001|Overall Study|Protocol Violation|0|||
164343373|NCT00824720|593633003|FG002|Overall Study|Protocol Violation|1|||
164276386|NCT05098509|593380620|FG002|Overall Study|Withdrawal by Subject|1|||
163895061|NCT04761198|591988121|FG005|Overall Study|Progressive Disease|1|||
163895062|NCT04761198|591988122|FG006|Overall Study|Progressive Disease|2|||
163895063|NCT04761198|591988116|FG000|Overall Study|Protocol Violation|0|||
163895064|NCT04761198|591988117|FG001|Overall Study|Protocol Violation|0|||
163895065|NCT04761198|591988118|FG002|Overall Study|Protocol Violation|0|||
163895066|NCT04761198|591988119|FG003|Overall Study|Protocol Violation|0|||
163895067|NCT04761198|591988120|FG004|Overall Study|Protocol Violation|1|||
163895068|NCT04761198|591988121|FG005|Overall Study|Protocol Violation|0|||
163895069|NCT04761198|591988122|FG006|Overall Study|Protocol Violation|0|||
163895070|NCT04761198|591988116|FG000|Overall Study|Death|2|||
163895071|NCT04761198|591988117|FG001|Overall Study|Death|1|||
163895072|NCT04761198|591988118|FG002|Overall Study|Death|2|||
163895073|NCT04761198|591988119|FG003|Overall Study|Death|5|||
163895074|NCT04761198|591988120|FG004|Overall Study|Death|14|||
163895075|NCT04761198|591988121|FG005|Overall Study|Death|2|||
164001242|NCT03263091|592368449|FG002|DB Component|Withdrawal by Subject|0|||
164276387|NCT05098509|593380621|FG003|Overall Study|Withdrawal by Subject|0|||
164276388|NCT05098509|593380618|FG000|Overall Study|Early study termination|1|||
164276389|NCT05098509|593380619|FG001|Overall Study|Early study termination|1|||
164276390|NCT05098509|593380620|FG002|Overall Study|Early study termination|1|||
164276391|NCT05098509|593380621|FG003|Overall Study|Early study termination|0|||
164276392|NCT01147848|593380622|FG000|Run-in Period|Screen Failure|623|||
164276393|NCT01147848|593380623|FG001|Run-in Period|Screen Failure|0|||
164276394|NCT01147848|593380624|FG002|Run-in Period|Screen Failure|0|||
164276395|NCT01147848|593380622|FG000|Run-in Period|Run-in Failure|135|||
164276396|NCT01147848|593380623|FG001|Run-in Period|Run-in Failure|0|||
164276397|NCT01147848|593380624|FG002|Run-in Period|Run-in Failure|0|||
164276398|NCT01147848|593380622|FG000|Randomized Phase|Adverse Event|0|||
164276399|NCT01147848|593380623|FG001|Randomized Phase|Adverse Event|6|||
164001243|NCT03263091|592368450|FG003|DB Component|Withdrawal by Subject|0|||
164001244|NCT03263091|592368451|FG004|DB Component|Withdrawal by Subject|22|||
164001245|NCT03263091|592368452|FG005|DB Component|Withdrawal by Subject|8|||
164001246|NCT03263091|592368447|FG000|DB Component|Physician Decision|0|||
164001247|NCT03263091|592368448|FG001|DB Component|Physician Decision|0|||
164001248|NCT03263091|592368449|FG002|DB Component|Physician Decision|0|||
164001249|NCT03263091|592368450|FG003|DB Component|Physician Decision|0|||
164001250|NCT03263091|592368451|FG004|DB Component|Physician Decision|3|||
164001251|NCT03263091|592368452|FG005|DB Component|Physician Decision|1|||
164001252|NCT03263091|592368447|FG000|DB Component|Adverse Event|0|||
163895076|NCT04761198|591988122|FG006|Overall Study|Death|5|||
164276400|NCT01147848|593380624|FG002|Randomized Phase|Adverse Event|8|||
164276401|NCT01147848|593380622|FG000|Randomized Phase|Lack of Efficacy|0|||
164276402|NCT01147848|593380623|FG001|Randomized Phase|Lack of Efficacy|20|||
164276403|NCT01147848|593380624|FG002|Randomized Phase|Lack of Efficacy|11|||
163895077|NCT04761198|591988116|FG000|Overall Study|Lost to Follow-up|0|||
164001253|NCT03263091|592368448|FG001|DB Component|Adverse Event|0|||
163895078|NCT04761198|591988117|FG001|Overall Study|Lost to Follow-up|0|||
163895079|NCT04761198|591988118|FG002|Overall Study|Lost to Follow-up|0|||
164001254|NCT03263091|592368449|FG002|DB Component|Adverse Event|0|||
164276404|NCT01147848|593380622|FG000|Randomized Phase|Protocol Violation|0|||
164276405|NCT01147848|593380623|FG001|Randomized Phase|Protocol Violation|7|||
164276406|NCT01147848|593380624|FG002|Randomized Phase|Protocol Violation|10|||
164276407|NCT01147848|593380622|FG000|Randomized Phase|Lost to Follow-up|0|||
164085972|NCT01995058|592678604|FG003|Overall Study|No Treatment Given|1|||
163895080|NCT04761198|591988119|FG003|Overall Study|Lost to Follow-up|0|||
163895081|NCT04761198|591988120|FG004|Overall Study|Lost to Follow-up|1|||
163895082|NCT04761198|591988121|FG005|Overall Study|Lost to Follow-up|0|||
163895083|NCT04761198|591988122|FG006|Overall Study|Lost to Follow-up|0|||
163895084|NCT04761198|591988116|FG000|Overall Study|Withdrawal by Subject|2|||
163895085|NCT04761198|591988117|FG001|Overall Study|Withdrawal by Subject|0|||
163895086|NCT04761198|591988118|FG002|Overall Study|Withdrawal by Subject|1|||
163895087|NCT04761198|591988119|FG003|Overall Study|Withdrawal by Subject|0|||
163895088|NCT04761198|591988120|FG004|Overall Study|Withdrawal by Subject|2|||
163895089|NCT04761198|591988121|FG005|Overall Study|Withdrawal by Subject|0|||
163895090|NCT04761198|591988122|FG006|Overall Study|Withdrawal by Subject|1|||
163895091|NCT04761198|591988116|FG000|Overall Study|Study Terminated by Sponsor|6|||
163895092|NCT04761198|591988117|FG001|Overall Study|Study Terminated by Sponsor|0|||
163895093|NCT04761198|591988118|FG002|Overall Study|Study Terminated by Sponsor|5|||
163895094|NCT04761198|591988119|FG003|Overall Study|Study Terminated by Sponsor|3|||
163895095|NCT04761198|591988120|FG004|Overall Study|Study Terminated by Sponsor|10|||
163895096|NCT04761198|591988121|FG005|Overall Study|Study Terminated by Sponsor|1|||
163895097|NCT04761198|591988122|FG006|Overall Study|Study Terminated by Sponsor|2|||
163895098|NCT02994927|591988123|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163895099|NCT02994927|591988124|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163895100|NCT02994927|591988123|FG000|Overall Study|Did not meet eligibility criteria|0|||
163895101|NCT02994927|591988124|FG001|Overall Study|Did not meet eligibility criteria|1|||
163895102|NCT02994927|591988123|FG000|Overall Study|Physician Decision|4|||
164085973|NCT03611309|592678607|FG000|Overall Study|Lost to Follow-up|16|||
163895103|NCT02994927|591988124|FG001|Overall Study|Physician Decision|3|||
163895104|NCT02994927|591988123|FG000|Overall Study|Death|4|||
164276408|NCT01147848|593380623|FG001|Randomized Phase|Lost to Follow-up|5|||
164276409|NCT01147848|593380624|FG002|Randomized Phase|Lost to Follow-up|7|||
164276410|NCT01147848|593380622|FG000|Randomized Phase|Physician Decision|0|||
164276411|NCT01147848|593380623|FG001|Randomized Phase|Physician Decision|0|||
164276412|NCT01147848|593380624|FG002|Randomized Phase|Physician Decision|1|||
164276413|NCT01147848|593380622|FG000|Randomized Phase|Withdrawal by Subject|0|||
164276414|NCT01147848|593380623|FG001|Randomized Phase|Withdrawal by Subject|7|||
164276415|NCT01147848|593380624|FG002|Randomized Phase|Withdrawal by Subject|9|||
164276416|NCT02540265|593380625|FG000|Overall Study|Lost to Follow-up|0|||
164276417|NCT02540265|593380626|FG001|Overall Study|Lost to Follow-up|0|||
164276418|NCT02540265|593380627|FG002|Overall Study|Lost to Follow-up|1|||
164276419|NCT03157037|593380630|FG000|Overall Study|Death|1|||
164276420|NCT00324233|593380631|FG000|First Period|unable to insert catheter|1|||
164276421|NCT00324233|593380632|FG001|First Period|unable to insert catheter|0|||
164276422|NCT00324233|593380631|FG000|Second Period|unable to insert catheter|1|||
164276423|NCT00324233|593380632|FG001|Second Period|unable to insert catheter|1|||
164276424|NCT00324233|593380631|FG000|Second Period|Protocol Violation|4|||
164276425|NCT00324233|593380632|FG001|Second Period|Protocol Violation|6|||
164276426|NCT01972789|593380633|FG000|Overall Study|Adverse Event|11|||
164276427|NCT01972789|593380634|FG001|Overall Study|Adverse Event|4|||
164276428|NCT01972789|593380633|FG000|Overall Study|Subject withdrew consent|14|||
164276429|NCT01972789|593380634|FG001|Overall Study|Subject withdrew consent|12|||
164276430|NCT01972789|593380633|FG000|Overall Study|Lost to Follow-up|4|||
164343374|NCT01558271|593633006|FG000|Overall Study|Adverse Event|6|||
164343375|NCT01558271|593633007|FG001|Overall Study|Adverse Event|3|||
164343376|NCT01558271|593633008|FG002|Overall Study|Adverse Event|4|||
164343377|NCT01558271|593633006|FG000|Overall Study|Lost to Follow-up|1|||
164343378|NCT01558271|593633007|FG001|Overall Study|Lost to Follow-up|0|||
164343379|NCT01558271|593633008|FG002|Overall Study|Lost to Follow-up|0|||
164343380|NCT01558271|593633006|FG000|Overall Study|Protocol Violation|1|||
164343381|NCT01558271|593633007|FG001|Overall Study|Protocol Violation|0|||
164343382|NCT01558271|593633008|FG002|Overall Study|Protocol Violation|0|||
164343383|NCT01558271|593633006|FG000|Overall Study|Withdrawal by Subject|10|||
164343384|NCT01558271|593633007|FG001|Overall Study|Withdrawal by Subject|6|||
164343385|NCT01558271|593633008|FG002|Overall Study|Withdrawal by Subject|12|||
164343386|NCT01558271|593633006|FG000|Overall Study|Physician Decision|0|||
164343387|NCT01558271|593633007|FG001|Overall Study|Physician Decision|2|||
164343388|NCT01558271|593633008|FG002|Overall Study|Physician Decision|1|||
164343389|NCT02610725|593633009|FG000|Overall Study|Lost to Follow-up|197|||
164343390|NCT02610725|593633009|FG000|Overall Study|self-reported contraindication|9|||
164343391|NCT04094883|593633010|FG000|Overall Study|Withdrawal by Subject|1|||
164343392|NCT00743483|593633011|FG000|Baseline Period|Physician Decision|1|||
164343393|NCT00743483|593633011|FG000|Treatment Period|Adverse Event|1|||
164343394|NCT01084083|593633012|FG000|Overall Study|Adverse Event|5|||
164343395|NCT01084083|593633012|FG000|Overall Study|Death|1|||
164343396|NCT01084083|593633012|FG000|Overall Study|Withdrawal by Subject|2|||
164343397|NCT01084083|593633012|FG000|Overall Study|Complicating disease|1|||
164343398|NCT01084083|593633012|FG000|Overall Study|Other|2|||
164343399|NCT01084083|593633012|FG000|Overall Study|Never started assigned therapy|1|||
164343400|NCT00873912|593633014|FG000|Overall Study|Withdrawal by Subject|1|||
164343401|NCT00873912|593633015|FG001|Overall Study|Withdrawal by Subject|0|||
164343402|NCT00873912|593633014|FG000|Overall Study|Lost to Follow-up|2|||
164343403|NCT00873912|593633015|FG001|Overall Study|Lost to Follow-up|0|||
164343404|NCT01088997|593633018|FG000|Overall Study|Physician Decision|1|||
164343405|NCT01088997|593633019|FG001|Overall Study|Physician Decision|1|||
164343406|NCT01088997|593633018|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
164343407|NCT01088997|593633019|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
164343408|NCT01088997|593633018|FG000|Overall Study|Excluded prior to receiving drug|1|||
164343409|NCT01088997|593633019|FG001|Overall Study|Excluded prior to receiving drug|1|||
164343410|NCT05570500|593633022|FG000|Overall Study|Lost to Follow-up|7|||
164343411|NCT05570500|593633023|FG001|Overall Study|Lost to Follow-up|5|||
164343412|NCT01095731|593633024|FG000|Overall Study|Protocol Violation|1|||
164343413|NCT01095731|593633025|FG001|Overall Study|Protocol Violation|1|||
164343414|NCT01095731|593633024|FG000|Overall Study|Withdrawal by Subject|0|||
164343415|NCT01095731|593633025|FG001|Overall Study|Withdrawal by Subject|1|||
164343416|NCT02302807|593633028|FG000|Overall Study|Withdrawal by Subject|28|||
164343417|NCT02302807|593633029|FG001|Overall Study|Withdrawal by Subject|11|||
164276431|NCT01972789|593380634|FG001|Overall Study|Lost to Follow-up|7|||
164276432|NCT01972789|593380633|FG000|Overall Study|Death|7|||
164276433|NCT01972789|593380634|FG001|Overall Study|Death|5|||
164276434|NCT01972789|593380633|FG000|Overall Study|Protocol deviation|1|||
164276435|NCT01972789|593380634|FG001|Overall Study|Protocol deviation|0|||
164276436|NCT01972789|593380633|FG000|Overall Study|Physician Decision|3|||
164276437|NCT01972789|593380634|FG001|Overall Study|Physician Decision|2|||
164276438|NCT00498355|593380637|FG000|Overall Study|Lost to Follow-up|1|||
164276439|NCT03262441|593380642|FG000|Overall Study|Withdrawal by Subject|1|||
164343418|NCT02302807|593633028|FG000|Overall Study|Lost to Follow-up|4|||
164343419|NCT02302807|593633029|FG001|Overall Study|Lost to Follow-up|6|||
164001255|NCT03263091|592368450|FG003|DB Component|Adverse Event|0|||
164001256|NCT03263091|592368451|FG004|DB Component|Adverse Event|2|||
164276440|NCT01455194|593380650|FG000|Overall Study|Screen Failure|20|||
164276441|NCT01455194|593380651|FG001|Overall Study|Screen Failure|0|||
164276442|NCT01455194|593380652|FG002|Overall Study|Screen Failure|0|||
164276443|NCT01455194|593380653|FG003|Overall Study|Screen Failure|0|||
164276444|NCT01455194|593380650|FG000|Overall Study|Randomisation Failure|90|||
164276445|NCT01455194|593380651|FG001|Overall Study|Randomisation Failure|0|||
164276446|NCT01455194|593380652|FG002|Overall Study|Randomisation Failure|0|||
164276447|NCT01455194|593380653|FG003|Overall Study|Randomisation Failure|0|||
164276448|NCT01455194|593380650|FG000|Overall Study|Deterioration in asthma|12|||
164276449|NCT01455194|593380651|FG001|Overall Study|Deterioration in asthma|6|||
164276450|NCT01455194|593380652|FG002|Overall Study|Deterioration in asthma|14|||
164276451|NCT01455194|593380653|FG003|Overall Study|Deterioration in asthma|9|||
164276452|NCT01455194|593380650|FG000|Overall Study|Adverse Event|1|||
164276453|NCT01455194|593380651|FG001|Overall Study|Adverse Event|1|||
164276454|NCT01455194|593380652|FG002|Overall Study|Adverse Event|1|||
164276455|NCT01455194|593380653|FG003|Overall Study|Adverse Event|3|||
164276456|NCT01455194|593380650|FG000|Overall Study|Withdrawal by Subject|21|||
164276457|NCT01455194|593380651|FG001|Overall Study|Withdrawal by Subject|16|||
164276458|NCT01455194|593380652|FG002|Overall Study|Withdrawal by Subject|12|||
164276459|NCT01455194|593380653|FG003|Overall Study|Withdrawal by Subject|9|||
164276460|NCT01455194|593380650|FG000|Overall Study|Lost to Follow-up|2|||
164276461|NCT01455194|593380651|FG001|Overall Study|Lost to Follow-up|0|||
164276462|NCT01455194|593380652|FG002|Overall Study|Lost to Follow-up|1|||
164276463|NCT01455194|593380653|FG003|Overall Study|Lost to Follow-up|1|||
164276464|NCT01455194|593380650|FG000|Overall Study|Pregnancy|0|||
164276465|NCT01455194|593380651|FG001|Overall Study|Pregnancy|1|||
164276466|NCT01455194|593380652|FG002|Overall Study|Pregnancy|1|||
164276467|NCT01455194|593380653|FG003|Overall Study|Pregnancy|0|||
164276468|NCT01455194|593380650|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
164276469|NCT01455194|593380651|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
164343420|NCT02302807|593633028|FG000|Overall Study|Death|397|||
164343421|NCT02302807|593633029|FG001|Overall Study|Death|385|||
164343422|NCT02302807|593633028|FG000|Overall Study|Study Terminated By Sponsor|35|||
164343423|NCT02302807|593633029|FG001|Overall Study|Study Terminated By Sponsor|64|||
164343424|NCT02302807|593633028|FG000|Overall Study|Physician Decision|0|||
164343425|NCT02302807|593633029|FG001|Overall Study|Physician Decision|1|||
164343426|NCT04731363|593633033|FG000|Overall Study|Could not obtain samples|0|||
164343427|NCT04731363|593633034|FG001|Overall Study|Could not obtain samples|1|||
164343428|NCT04731363|593633035|FG002|Overall Study|Could not obtain samples|0|||
164343429|NCT04731363|593633036|FG003|Overall Study|Could not obtain samples|0|||
164343430|NCT04731363|593633033|FG000|Overall Study|Physician Decision|0|||
164343431|NCT04731363|593633034|FG001|Overall Study|Physician Decision|1|||
164343432|NCT04731363|593633035|FG002|Overall Study|Physician Decision|0|||
164343433|NCT04731363|593633036|FG003|Overall Study|Physician Decision|0|||
164343434|NCT00717197|593635232|FG000|Overall Study|Unable to purchase study drug|5|||
164343435|NCT00717197|593635232|FG000|Overall Study|Tumor Progression|1|||
164343436|NCT00717197|593635232|FG000|Overall Study|Physician Decision|1|||
164343437|NCT01898806|593635235|FG000|Overall Study|Withdrawal by Subject|2|||
164343438|NCT01898806|593635235|FG000|Overall Study|Physician Decision|1|||
164343439|NCT03003390|593635236|FG000|Overall Study|Physician Decision|2|||
164343440|NCT03003390|593635237|FG001|Overall Study|Physician Decision|0|||
164343441|NCT03003390|593635236|FG000|Overall Study|Parent refused intervention|2|||
164343442|NCT03003390|593635237|FG001|Overall Study|Parent refused intervention|0|||
164343443|NCT01648101|593635238|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
164343444|NCT01648101|593635239|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
164343445|NCT01648101|593635240|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
164343446|NCT01648101|593635238|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
164343447|NCT01648101|593635239|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
164343448|NCT01648101|593635240|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
164343449|NCT01648101|593635238|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
164343450|NCT01648101|593635239|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
164343451|NCT01648101|593635240|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
164001257|NCT03263091|592368452|FG005|DB Component|Adverse Event|1|||
164276470|NCT01455194|593380652|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
164276471|NCT01455194|593380653|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
164276472|NCT01455194|593380650|FG000|Overall Study|Miscellaneous|4|||
164276473|NCT01455194|593380651|FG001|Overall Study|Miscellaneous|5|||
164276474|NCT01455194|593380652|FG002|Overall Study|Miscellaneous|1|||
164276475|NCT01455194|593380653|FG003|Overall Study|Miscellaneous|4|||
164343452|NCT01648101|593635238|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
164276476|NCT05090852|593380654|FG000|Overall Study|Physician Decision|5|||
164276477|NCT01196416|593380655|FG000|Overall Study|Withdrawal by Subject|2|||
164276478|NCT00504894|593380656|FG000|Overall Study|fMRI technical problems|1|||
164276479|NCT00504894|593380657|FG001|Overall Study|fMRI technical problems|1|||
164276480|NCT00504894|593380658|FG002|Overall Study|fMRI technical problems|0|||
164276481|NCT00504894|593380656|FG000|Overall Study|Withdrawal by Subject|0|||
164276482|NCT00504894|593380657|FG001|Overall Study|Withdrawal by Subject|1|||
164276483|NCT00504894|593380658|FG002|Overall Study|Withdrawal by Subject|0|||
164276484|NCT00504894|593380656|FG000|Overall Study|Infusion technical problems|0|||
164276485|NCT00504894|593380657|FG001|Overall Study|Infusion technical problems|1|||
164276486|NCT00504894|593380658|FG002|Overall Study|Infusion technical problems|0|||
164276487|NCT00504894|593380656|FG000|Overall Study|poor subject data|2|||
164276488|NCT00504894|593380657|FG001|Overall Study|poor subject data|0|||
164276489|NCT00504894|593380658|FG002|Overall Study|poor subject data|0|||
164276490|NCT00148941|593380659|FG000|Overall Study|Lost to Follow-up|17|||
164276491|NCT00148941|593380660|FG001|Overall Study|Lost to Follow-up|24|||
163895105|NCT02994927|591988124|FG001|Overall Study|Death|2|||
163895106|NCT02994927|591988123|FG000|Overall Study|Adverse Event|2|||
163895107|NCT02994927|591988124|FG001|Overall Study|Adverse Event|1|||
163895108|NCT02994927|591988123|FG000|Overall Study|Withdrawal by Subject|3|||
163895109|NCT02994927|591988124|FG001|Overall Study|Withdrawal by Subject|6|||
163895110|NCT02994927|591988123|FG000|Overall Study|Lost to Follow-up|2|||
163895111|NCT02994927|591988124|FG001|Overall Study|Lost to Follow-up|1|||
163895112|NCT03533257|591988132|FG000|Overall Study|Adverse Event|4|||
163895113|NCT03533257|591988133|FG001|Overall Study|Adverse Event|2|||
163895114|NCT03533257|591988132|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
163895115|NCT03533257|591988133|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
163895116|NCT02039401|591988137|FG000|Overall Study|Adverse Event|0|||
163895117|NCT02039401|591988138|FG001|Overall Study|Adverse Event|1|||
163895118|NCT04282980|591989547|FG000|Overall Study|Remained on treatment|6|||
163895119|NCT04282980|591989547|FG000|Overall Study|Survival follow-up|11|||
163895120|NCT04282980|591989547|FG000|Overall Study|Withdrawal of informed consent|1|||
163895121|NCT04282980|591989547|FG000|Overall Study|Lost to Follow-up|1|||
163895122|NCT01917084|591989549|FG000|Overall Study|Withdrawal by Subject|1|||
163895123|NCT03571386|591989550|FG000|Overall Study|scheduling conflict|4|||
163895124|NCT03571386|591989551|FG001|Overall Study|scheduling conflict|0|||
163895125|NCT03571386|591989550|FG000|Overall Study|Withdrawal by Subject|15|||
163895126|NCT03571386|591989551|FG001|Overall Study|Withdrawal by Subject|5|||
163895127|NCT06037668|591989558|FG000|Overall Study|Lost to Follow-up|1|||
163895128|NCT06037668|591989559|FG001|Overall Study|Lost to Follow-up|1|||
163895129|NCT06037668|591989558|FG000|Overall Study|Protocol Violation|1|||
163895130|NCT06037668|591989559|FG001|Overall Study|Protocol Violation|0|||
163895131|NCT06037668|591989558|FG000|Overall Study|Withdrawal by Subject|1|||
163895132|NCT06037668|591989559|FG001|Overall Study|Withdrawal by Subject|0|||
163895133|NCT06037668|591989558|FG000|Overall Study|Other Study Discontinuation Reason|1|||
163895134|NCT06037668|591989559|FG001|Overall Study|Other Study Discontinuation Reason|0|||
163895135|NCT02473445|591989560|FG000|Overall Study|Withdrawal by Subject|2|||
163895136|NCT02473445|591989560|FG000|Overall Study|Sponsor Decision|20|||
163895137|NCT04881461|591989561|FG000|Overall Study|Adverse Event|2|||
163895138|NCT04881461|591989562|FG001|Overall Study|Adverse Event|4|||
163895139|NCT04881461|591989561|FG000|Overall Study|Withdrawal by Subject|19|||
163895140|NCT04881461|591989562|FG001|Overall Study|Withdrawal by Subject|19|||
163895141|NCT04881461|591989561|FG000|Overall Study|Lost to Follow-up|4|||
163895142|NCT04881461|591989562|FG001|Overall Study|Lost to Follow-up|4|||
163895143|NCT04881461|591989561|FG000|Overall Study|Lack of Efficacy|1|||
163895144|NCT04881461|591989562|FG001|Overall Study|Lack of Efficacy|0|||
163895145|NCT04881461|591989561|FG000|Overall Study|"Reason stated as other in CRF"|1|||
163895146|NCT04881461|591989562|FG001|Overall Study|"Reason stated as other in CRF"|2|||
163895147|NCT03988621|591989563|FG000|Overall Study|Lost to Follow-up|16|||
163895148|NCT03988621|591989564|FG001|Overall Study|Lost to Follow-up|17|||
163895149|NCT03988621|591989563|FG000|Overall Study|Withdrawal by Subject|14|||
163895150|NCT03988621|591989564|FG001|Overall Study|Withdrawal by Subject|7|||
164276492|NCT00148941|593380661|FG002|Overall Study|Lost to Follow-up|18|||
164276493|NCT00148941|593380662|FG003|Overall Study|Lost to Follow-up|22|||
164276494|NCT00148941|593380659|FG000|Overall Study|Withdrawal by Subject|1|||
163895151|NCT03988621|591989563|FG000|Overall Study|Patient Lost to Follow Up|15|||
163895152|NCT03988621|591989564|FG001|Overall Study|Patient Lost to Follow Up|15|||
163895153|NCT03988621|591989563|FG000|Overall Study|Patient death|1|||
163895154|NCT03988621|591989564|FG001|Overall Study|Patient death|5|||
163895155|NCT04247802|591989565|FG000|Overall Study|Withdrawal by Subject|1|||
163895156|NCT04247802|591989566|FG001|Overall Study|Withdrawal by Subject|3|||
164276495|NCT00148941|593380660|FG001|Overall Study|Withdrawal by Subject|0|||
163895157|NCT04247802|591989565|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
163895158|NCT04247802|591989566|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
164276496|NCT00148941|593380661|FG002|Overall Study|Withdrawal by Subject|1|||
164276497|NCT00148941|593380662|FG003|Overall Study|Withdrawal by Subject|0|||
164276498|NCT00148941|593380659|FG000|Overall Study|Other|0|||
164343453|NCT01648101|593635239|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
164343454|NCT01648101|593635240|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
164276499|NCT00148941|593380660|FG001|Overall Study|Other|0|||
164276500|NCT00148941|593380661|FG002|Overall Study|Other|1|||
164276501|NCT00148941|593380662|FG003|Overall Study|Other|2|||
164276502|NCT02673684|593380665|FG000|Overall Study|Study not completed d/t loss of funding|9|||
164276503|NCT02673684|593380666|FG001|Overall Study|Study not completed d/t loss of funding|8|||
164276504|NCT01092663|593380667|FG000|Overall Study|Withdrawal by Subject|3|||
164276505|NCT01092663|593380668|FG001|Overall Study|Withdrawal by Subject|2|||
164276506|NCT01092663|593380667|FG000|Overall Study|Glucose >300mg/dL|1|||
164276507|NCT01092663|593380668|FG001|Overall Study|Glucose >300mg/dL|0|||
164276508|NCT01092663|593380667|FG000|Overall Study|High fasting triglyceride|2|||
164276509|NCT01092663|593380668|FG001|Overall Study|High fasting triglyceride|0|||
164276510|NCT01092663|593380667|FG000|Overall Study|Adverse Event|1|||
164276511|NCT01092663|593380668|FG001|Overall Study|Adverse Event|1|||
164276512|NCT01092663|593380667|FG000|Overall Study|Protocol Violation|0|||
164276513|NCT01092663|593380668|FG001|Overall Study|Protocol Violation|1|||
164276514|NCT01008904|593380669|FG000|Overall Study|Lost to Follow-up|1|||
164276515|NCT01008904|593380669|FG000|Overall Study|Adverse Event|2|||
164276516|NCT01008904|593380669|FG000|Overall Study|unexpected unrelated surgery|1|||
164276517|NCT00788710|593380670|FG000|Overall Study|Adverse Event|1|||
164276518|NCT00788710|593380671|FG001|Overall Study|Adverse Event|3|||
164276519|NCT00788710|593380672|FG002|Overall Study|Adverse Event|4|||
164276520|NCT00788710|593380670|FG000|Overall Study|Lack of Efficacy|0|||
164276521|NCT00788710|593380671|FG001|Overall Study|Lack of Efficacy|0|||
164276522|NCT00788710|593380672|FG002|Overall Study|Lack of Efficacy|1|||
164276523|NCT00788710|593380670|FG000|Overall Study|Lost to Follow-up|0|||
164276524|NCT00788710|593380671|FG001|Overall Study|Lost to Follow-up|1|||
164276525|NCT00788710|593380672|FG002|Overall Study|Lost to Follow-up|0|||
164276526|NCT00788710|593380670|FG000|Overall Study|Physician Decision|2|||
164276527|NCT00788710|593380671|FG001|Overall Study|Physician Decision|1|||
164276528|NCT00788710|593380672|FG002|Overall Study|Physician Decision|0|||
164276529|NCT00788710|593380670|FG000|Overall Study|Protocol Violation|0|||
164276530|NCT00788710|593380671|FG001|Overall Study|Protocol Violation|1|||
164276531|NCT00788710|593380672|FG002|Overall Study|Protocol Violation|1|||
164276532|NCT00788710|593380670|FG000|Overall Study|Withdrawal by Subject|2|||
164276533|NCT00788710|593380671|FG001|Overall Study|Withdrawal by Subject|2|||
164276534|NCT00788710|593380672|FG002|Overall Study|Withdrawal by Subject|0|||
164276535|NCT04407234|593380673|FG000|Overall Study|Adverse Event|3|||
164276536|NCT04407234|593380674|FG001|Overall Study|Adverse Event|3|||
164276537|NCT03908970|593380675|FG000|Overall Study|Adverse Event|7|||
164276538|NCT03908970|593380676|FG001|Overall Study|Adverse Event|21|||
164276539|NCT03908970|593380675|FG000|Overall Study|Physician Decision|1|||
164276540|NCT03908970|593380676|FG001|Overall Study|Physician Decision|4|||
164276541|NCT03908970|593380675|FG000|Overall Study|Withdrawal by Subject|9|||
164276542|NCT03908970|593380676|FG001|Overall Study|Withdrawal by Subject|22|||
164276543|NCT00727558|593380682|FG000|Overall Study|Lens issue|0|||
164343455|NCT01648101|593635238|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
164343456|NCT01648101|593635239|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
164343457|NCT01648101|593635240|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
164343458|NCT01648101|593635238|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
163895159|NCT04629339|591989572|FG000|Overall Study|Death|1|||
163895160|NCT04629339|591989573|FG001|Overall Study|Death|0|||
163895161|NCT04629339|591989574|FG002|Overall Study|Death|2|||
163895162|NCT04629339|591989575|FG003|Overall Study|Death|2|||
163895163|NCT04629339|591989576|FG004|Overall Study|Death|0|||
163895164|NCT04629339|591989572|FG000|Overall Study|Disease Progression|0|||
163895165|NCT04629339|591989573|FG001|Overall Study|Disease Progression|0|||
163895166|NCT04629339|591989574|FG002|Overall Study|Disease Progression|1|||
163895167|NCT04629339|591989575|FG003|Overall Study|Disease Progression|1|||
163895168|NCT04629339|591989576|FG004|Overall Study|Disease Progression|0|||
163895169|NCT04629339|591989572|FG000|Overall Study|Lost to Follow-up|0|||
163895170|NCT04629339|591989573|FG001|Overall Study|Lost to Follow-up|0|||
163895171|NCT04629339|591989574|FG002|Overall Study|Lost to Follow-up|0|||
163895172|NCT04629339|591989575|FG003|Overall Study|Lost to Follow-up|1|||
163895173|NCT04629339|591989576|FG004|Overall Study|Lost to Follow-up|0|||
163895174|NCT04629339|591989572|FG000|Overall Study|Physician Decision|0|||
163895175|NCT04629339|591989573|FG001|Overall Study|Physician Decision|1|||
163895176|NCT04629339|591989574|FG002|Overall Study|Physician Decision|0|||
163895177|NCT04629339|591989575|FG003|Overall Study|Physician Decision|0|||
163895178|NCT04629339|591989576|FG004|Overall Study|Physician Decision|0|||
163895179|NCT04629339|591989572|FG000|Overall Study|Study Terminated by Sponsor|0|||
163895180|NCT04629339|591989573|FG001|Overall Study|Study Terminated by Sponsor|0|||
164276544|NCT00727558|593380683|FG001|Overall Study|Lens issue|1|||
164276545|NCT00727558|593380682|FG000|Overall Study|Adverse Event|0|||
163895181|NCT04629339|591989574|FG002|Overall Study|Study Terminated by Sponsor|0|||
163895182|NCT04629339|591989575|FG003|Overall Study|Study Terminated by Sponsor|1|||
164276546|NCT00727558|593380683|FG001|Overall Study|Adverse Event|1|||
164276547|NCT00727558|593380682|FG000|Overall Study|Subject unable to return for follow-up|1|||
164276548|NCT00727558|593380683|FG001|Overall Study|Subject unable to return for follow-up|1|||
164276549|NCT00727558|593380682|FG000|Overall Study|Lost to Follow-up|1|||
164276550|NCT00727558|593380683|FG001|Overall Study|Lost to Follow-up|0|||
164276551|NCT01717326|593380690|FG000|Overall Study|Death|0|||
164276552|NCT01717326|593380691|FG001|Overall Study|Death|0|||
164276553|NCT01717326|593380692|FG002|Overall Study|Death|0|||
164276554|NCT01717326|593380693|FG003|Overall Study|Death|0|||
164276555|NCT01717326|593380694|FG004|Overall Study|Death|0|||
164276556|NCT01717326|593380695|FG005|Overall Study|Death|0|||
164276557|NCT01717326|593380696|FG006|Overall Study|Death|0|||
164276558|NCT01717326|593380697|FG007|Overall Study|Death|0|||
164276559|NCT01717326|593380698|FG008|Overall Study|Death|0|||
164276560|NCT01717326|593380699|FG009|Overall Study|Death|0|||
164276561|NCT01717326|593380700|FG010|Overall Study|Death|1|||
164276562|NCT01717326|593380701|FG011|Overall Study|Death|0|||
164276563|NCT01717326|593380702|FG012|Overall Study|Death|0|||
164276564|NCT01717326|593380703|FG013|Overall Study|Death|0|||
164276565|NCT01717326|593380704|FG014|Overall Study|Death|0|||
164276566|NCT01717326|593380705|FG015|Overall Study|Death|0|||
164276567|NCT01717326|593380706|FG016|Overall Study|Death|0|||
164276568|NCT01717326|593380707|FG017|Overall Study|Death|0|||
164276569|NCT01717326|593380708|FG018|Overall Study|Death|0|||
164276570|NCT01717326|593380709|FG019|Overall Study|Death|0|||
164276571|NCT01717326|593380690|FG000|Overall Study|Lost to Follow-up|3|||
164276572|NCT01717326|593380691|FG001|Overall Study|Lost to Follow-up|0|||
164276573|NCT01717326|593380692|FG002|Overall Study|Lost to Follow-up|0|||
164276574|NCT01717326|593380693|FG003|Overall Study|Lost to Follow-up|2|||
164276575|NCT01717326|593380694|FG004|Overall Study|Lost to Follow-up|1|||
164276576|NCT01717326|593380695|FG005|Overall Study|Lost to Follow-up|0|||
164276577|NCT01717326|593380696|FG006|Overall Study|Lost to Follow-up|1|||
164276578|NCT01717326|593380697|FG007|Overall Study|Lost to Follow-up|0|||
164276579|NCT01717326|593380698|FG008|Overall Study|Lost to Follow-up|0|||
164276580|NCT01717326|593380699|FG009|Overall Study|Lost to Follow-up|0|||
164276581|NCT01717326|593380700|FG010|Overall Study|Lost to Follow-up|1|||
164276582|NCT01717326|593380701|FG011|Overall Study|Lost to Follow-up|0|||
164276583|NCT01717326|593380702|FG012|Overall Study|Lost to Follow-up|0|||
164276584|NCT01717326|593380703|FG013|Overall Study|Lost to Follow-up|0|||
164276585|NCT01717326|593380704|FG014|Overall Study|Lost to Follow-up|0|||
164276586|NCT01717326|593380705|FG015|Overall Study|Lost to Follow-up|2|||
164276587|NCT01717326|593380706|FG016|Overall Study|Lost to Follow-up|1|||
164276588|NCT01717326|593380707|FG017|Overall Study|Lost to Follow-up|0|||
164276589|NCT01717326|593380708|FG018|Overall Study|Lost to Follow-up|2|||
164276590|NCT01717326|593380709|FG019|Overall Study|Lost to Follow-up|3|||
164276591|NCT01717326|593380690|FG000|Overall Study|Physician Decision|0|||
164276592|NCT01717326|593380691|FG001|Overall Study|Physician Decision|0|||
164276593|NCT01717326|593380692|FG002|Overall Study|Physician Decision|0|||
164276594|NCT01717326|593380693|FG003|Overall Study|Physician Decision|0|||
164276595|NCT01717326|593380694|FG004|Overall Study|Physician Decision|0|||
164276596|NCT01717326|593380695|FG005|Overall Study|Physician Decision|0|||
164276597|NCT01717326|593380696|FG006|Overall Study|Physician Decision|0|||
164276598|NCT01717326|593380697|FG007|Overall Study|Physician Decision|0|||
164276599|NCT01717326|593380698|FG008|Overall Study|Physician Decision|0|||
164276600|NCT01717326|593380699|FG009|Overall Study|Physician Decision|1|||
164276601|NCT01717326|593380700|FG010|Overall Study|Physician Decision|0|||
164276602|NCT01717326|593380701|FG011|Overall Study|Physician Decision|0|||
164276603|NCT01717326|593380702|FG012|Overall Study|Physician Decision|0|||
164276604|NCT01717326|593380703|FG013|Overall Study|Physician Decision|0|||
164276605|NCT01717326|593380704|FG014|Overall Study|Physician Decision|0|||
164276606|NCT01717326|593380705|FG015|Overall Study|Physician Decision|0|||
164276607|NCT01717326|593380706|FG016|Overall Study|Physician Decision|0|||
164276608|NCT01717326|593380707|FG017|Overall Study|Physician Decision|0|||
164276609|NCT01717326|593380708|FG018|Overall Study|Physician Decision|0|||
164276610|NCT01717326|593380709|FG019|Overall Study|Physician Decision|0|||
164276611|NCT01717326|593380690|FG000|Overall Study|Protocol Violation|0|||
164001258|NCT03263091|592368447|FG000|DB Component|Lost to Follow-up|0|||
164276612|NCT01717326|593380691|FG001|Overall Study|Protocol Violation|0|||
164276613|NCT01717326|593380692|FG002|Overall Study|Protocol Violation|0|||
164276614|NCT01717326|593380693|FG003|Overall Study|Protocol Violation|0|||
164276615|NCT01717326|593380694|FG004|Overall Study|Protocol Violation|1|||
164276616|NCT01717326|593380695|FG005|Overall Study|Protocol Violation|0|||
164276617|NCT01717326|593380696|FG006|Overall Study|Protocol Violation|0|||
164276618|NCT01717326|593380697|FG007|Overall Study|Protocol Violation|0|||
164276619|NCT01717326|593380698|FG008|Overall Study|Protocol Violation|0|||
164276620|NCT01717326|593380699|FG009|Overall Study|Protocol Violation|0|||
164276621|NCT01717326|593380700|FG010|Overall Study|Protocol Violation|0|||
164276622|NCT01717326|593380701|FG011|Overall Study|Protocol Violation|0|||
164276623|NCT01717326|593380702|FG012|Overall Study|Protocol Violation|0|||
164276624|NCT01717326|593380703|FG013|Overall Study|Protocol Violation|0|||
164276625|NCT01717326|593380704|FG014|Overall Study|Protocol Violation|0|||
164276626|NCT01717326|593380705|FG015|Overall Study|Protocol Violation|0|||
164276627|NCT01717326|593380706|FG016|Overall Study|Protocol Violation|0|||
164276628|NCT01717326|593380707|FG017|Overall Study|Protocol Violation|0|||
164276629|NCT01717326|593380708|FG018|Overall Study|Protocol Violation|0|||
164276630|NCT01717326|593380709|FG019|Overall Study|Protocol Violation|0|||
164276631|NCT01717326|593380690|FG000|Overall Study|Withdrawal by Subject|0|||
163895183|NCT04629339|591989576|FG004|Overall Study|Study Terminated by Sponsor|0|||
163895184|NCT04629339|591989572|FG000|Overall Study|Withdrawal by Subject|0|||
163895185|NCT04629339|591989573|FG001|Overall Study|Withdrawal by Subject|0|||
163895186|NCT04629339|591989574|FG002|Overall Study|Withdrawal by Subject|2|||
163895187|NCT04629339|591989575|FG003|Overall Study|Withdrawal by Subject|2|||
163895188|NCT04629339|591989576|FG004|Overall Study|Withdrawal by Subject|0|||
164276632|NCT01717326|593380691|FG001|Overall Study|Withdrawal by Subject|1|||
164276633|NCT01717326|593380692|FG002|Overall Study|Withdrawal by Subject|0|||
164276634|NCT01717326|593380693|FG003|Overall Study|Withdrawal by Subject|0|||
164276635|NCT01717326|593380694|FG004|Overall Study|Withdrawal by Subject|0|||
164276636|NCT01717326|593380695|FG005|Overall Study|Withdrawal by Subject|0|||
164276637|NCT01717326|593380696|FG006|Overall Study|Withdrawal by Subject|0|||
164276638|NCT01717326|593380697|FG007|Overall Study|Withdrawal by Subject|0|||
164276639|NCT01717326|593380698|FG008|Overall Study|Withdrawal by Subject|0|||
164276640|NCT01717326|593380699|FG009|Overall Study|Withdrawal by Subject|1|||
164276641|NCT01717326|593380700|FG010|Overall Study|Withdrawal by Subject|0|||
163895199|NCT04778410|591989585|FG000|Safety Run-in Period|Death|5|||
164276642|NCT01717326|593380701|FG011|Overall Study|Withdrawal by Subject|0|||
164276643|NCT01717326|593380702|FG012|Overall Study|Withdrawal by Subject|1|||
164276644|NCT01717326|593380703|FG013|Overall Study|Withdrawal by Subject|0|||
164276645|NCT01717326|593380704|FG014|Overall Study|Withdrawal by Subject|0|||
164276646|NCT01717326|593380705|FG015|Overall Study|Withdrawal by Subject|1|||
164276647|NCT01717326|593380706|FG016|Overall Study|Withdrawal by Subject|0|||
164276648|NCT01717326|593380707|FG017|Overall Study|Withdrawal by Subject|0|||
164276649|NCT01717326|593380708|FG018|Overall Study|Withdrawal by Subject|2|||
164276650|NCT01717326|593380709|FG019|Overall Study|Withdrawal by Subject|3|||
164276651|NCT02262754|593380711|FG000|Overall Study|Adverse Event|3|||
164276652|NCT02262754|593380712|FG001|Overall Study|Adverse Event|4|||
164276653|NCT02262754|593380713|FG002|Overall Study|Adverse Event|0|||
164276654|NCT02262754|593380711|FG000|Overall Study|Lack of Efficacy|2|||
164276655|NCT02262754|593380712|FG001|Overall Study|Lack of Efficacy|0|||
164276656|NCT02262754|593380713|FG002|Overall Study|Lack of Efficacy|1|||
164276657|NCT02262754|593380711|FG000|Overall Study|Lost to Follow-up|0|||
164276658|NCT02262754|593380712|FG001|Overall Study|Lost to Follow-up|0|||
164276659|NCT02262754|593380713|FG002|Overall Study|Lost to Follow-up|1|||
164276660|NCT02262754|593380711|FG000|Overall Study|No longer meets eligibility criteria|0|||
164276661|NCT02262754|593380712|FG001|Overall Study|No longer meets eligibility criteria|1|||
164276662|NCT02262754|593380713|FG002|Overall Study|No longer meets eligibility criteria|0|||
164276663|NCT02262754|593380711|FG000|Overall Study|Study terminated by sponsor|5|||
164276664|NCT02262754|593380712|FG001|Overall Study|Study terminated by sponsor|4|||
164276665|NCT02262754|593380713|FG002|Overall Study|Study terminated by sponsor|4|||
164276666|NCT02262754|593380711|FG000|Overall Study|Protocol Violation|1|||
164276667|NCT02262754|593380712|FG001|Overall Study|Protocol Violation|0|||
164276668|NCT02262754|593380713|FG002|Overall Study|Protocol Violation|0|||
164276669|NCT02262754|593380711|FG000|Overall Study|Withdrawal by Subject|1|||
164276670|NCT02262754|593380712|FG001|Overall Study|Withdrawal by Subject|0|||
164276671|NCT02262754|593380713|FG002|Overall Study|Withdrawal by Subject|1|||
164276672|NCT02262754|593380711|FG000|Overall Study|Other|4|||
164276673|NCT02262754|593380712|FG001|Overall Study|Other|0|||
164276674|NCT02262754|593380713|FG002|Overall Study|Other|2|||
164276675|NCT01299116|593380717|FG000|Overall Study|Lost to Follow-up|65|||
164276676|NCT01299116|593380718|FG001|Overall Study|Lost to Follow-up|9|||
164276677|NCT01299116|593380719|FG002|Overall Study|Lost to Follow-up|11|||
163895200|NCT04778410|591989586|FG001|Safety Run-in Period|Death|6|||
164001259|NCT03263091|592368448|FG001|DB Component|Lost to Follow-up|0|||
164001260|NCT03263091|592368449|FG002|DB Component|Lost to Follow-up|0|||
164001261|NCT03263091|592368450|FG003|DB Component|Lost to Follow-up|0|||
164001262|NCT03263091|592368451|FG004|DB Component|Lost to Follow-up|2|||
164001263|NCT03263091|592368452|FG005|DB Component|Lost to Follow-up|1|||
164001264|NCT03263091|592368447|FG000|DB Component|Death|0|||
164001265|NCT03263091|592368448|FG001|DB Component|Death|0|||
164001266|NCT03263091|592368449|FG002|DB Component|Death|0|||
164276678|NCT04079114|593380724|FG000|Overall Study|Study prematuely terminated.|166|||
164276679|NCT00629798|593380725|FG000|Overall Study|Not Treated|4|||
163895201|NCT04778410|591989587|FG002|Safety Run-in Period|Death|0|||
164276680|NCT01108523|593380726|FG000|Overall Study|Protocol Violation|4|||
164276681|NCT00687531|593380727|FG000|Overall Study|Did not meet protocol eligibility|104|||
163895202|NCT04778410|591989588|FG003|Safety Run-in Period|Death|0|||
163895203|NCT04778410|591989589|FG004|Safety Run-in Period|Death|0|||
163895204|NCT04778410|591989590|FG005|Safety Run-in Period|Death|0|||
163895205|NCT04778410|591989585|FG000|Phase 2 Period|Death|0|||
163895206|NCT04778410|591989586|FG001|Phase 2 Period|Death|0|||
164001267|NCT03263091|592368450|FG003|DB Component|Death|0|||
164001268|NCT03263091|592368451|FG004|DB Component|Death|7|||
164276682|NCT00687531|593380727|FG000|Overall Study|Adverse Event|5|||
164276683|NCT00687531|593380727|FG000|Overall Study|Lost to Follow-up|26|||
164276684|NCT00547521|593380730|FG000|Short Term Study (4 Months)|Adverse Event|1|||
164001269|NCT03263091|592368452|FG005|DB Component|Death|4|||
164001270|NCT03263091|592368447|FG000|DB Component|Other than specified|0|||
164001271|NCT03263091|592368448|FG001|DB Component|Other than specified|0|||
164001272|NCT03263091|592368449|FG002|DB Component|Other than specified|0|||
164001273|NCT03263091|592368450|FG003|DB Component|Other than specified|0|||
164001274|NCT03263091|592368451|FG004|DB Component|Other than specified|8|||
164001275|NCT03263091|592368452|FG005|DB Component|Other than specified|6|||
164001276|NCT00265941|592368454|FG000|Overall Study|Protocol Violation|22|||
164001277|NCT00265941|592368455|FG001|Overall Study|Protocol Violation|25|||
164001278|NCT00265941|592368454|FG000|Overall Study|Lost to Follow-up|1|||
164001279|NCT00265941|592368455|FG001|Overall Study|Lost to Follow-up|1|||
164001280|NCT02432807|592368465|FG000|Overall Study|Adverse Event|0|||
164001281|NCT02432807|592368466|FG001|Overall Study|Adverse Event|2|||
164001282|NCT02432807|592368465|FG000|Overall Study|Lost to Follow-up|1|||
164001283|NCT02432807|592368466|FG001|Overall Study|Lost to Follow-up|0|||
164001284|NCT02432807|592368465|FG000|Overall Study|Withdrawal by Subject|1|||
164001285|NCT02432807|592368466|FG001|Overall Study|Withdrawal by Subject|1|||
164001286|NCT02432807|592368465|FG000|Overall Study|Other|1|||
164001287|NCT02432807|592368466|FG001|Overall Study|Other|1|||
164001288|NCT03976401|592368467|FG000|Overall Study|Adverse Event|2|||
164001289|NCT03976401|592368468|FG001|Overall Study|Adverse Event|0|||
164001290|NCT03976401|592368469|FG002|Overall Study|Adverse Event|4|||
164001291|NCT03976401|592368470|FG003|Overall Study|Adverse Event|1|||
164001292|NCT03976401|592368471|FG004|Overall Study|Adverse Event|1|||
164001293|NCT03976401|592368472|FG005|Overall Study|Adverse Event|0|||
164001294|NCT03976401|592368467|FG000|Overall Study|Withdrawal by Subject|0|||
164001295|NCT03976401|592368468|FG001|Overall Study|Withdrawal by Subject|1|||
164001296|NCT03976401|592368469|FG002|Overall Study|Withdrawal by Subject|0|||
164001297|NCT03976401|592368470|FG003|Overall Study|Withdrawal by Subject|0|||
164001298|NCT03976401|592368471|FG004|Overall Study|Withdrawal by Subject|0|||
164001299|NCT03976401|592368472|FG005|Overall Study|Withdrawal by Subject|1|||
164001300|NCT03976401|592368467|FG000|Overall Study|Physician Decision|0|||
164001301|NCT03976401|592368468|FG001|Overall Study|Physician Decision|0|||
164001302|NCT03976401|592368469|FG002|Overall Study|Physician Decision|1|||
164001303|NCT03976401|592368470|FG003|Overall Study|Physician Decision|0|||
164001304|NCT03976401|592368471|FG004|Overall Study|Physician Decision|0|||
164001305|NCT03976401|592368472|FG005|Overall Study|Physician Decision|0|||
164001306|NCT03976401|592368467|FG000|Overall Study|Lost to Follow-up|1|||
164001307|NCT03976401|592368468|FG001|Overall Study|Lost to Follow-up|2|||
164001308|NCT03976401|592368469|FG002|Overall Study|Lost to Follow-up|0|||
164276685|NCT00547521|593380731|FG001|Short Term Study (4 Months)|Adverse Event|0|||
164001309|NCT03976401|592368470|FG003|Overall Study|Lost to Follow-up|0|||
164001310|NCT03976401|592368471|FG004|Overall Study|Lost to Follow-up|0|||
164001311|NCT03976401|592368472|FG005|Overall Study|Lost to Follow-up|0|||
164276686|NCT00547521|593380730|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
164001312|NCT03976401|592368467|FG000|Overall Study|Protocol Violation|0|||
164001313|NCT03976401|592368468|FG001|Overall Study|Protocol Violation|1|||
164001314|NCT03976401|592368469|FG002|Overall Study|Protocol Violation|0|||
164001315|NCT03976401|592368470|FG003|Overall Study|Protocol Violation|0|||
164001316|NCT03976401|592368471|FG004|Overall Study|Protocol Violation|0|||
164001317|NCT03976401|592368472|FG005|Overall Study|Protocol Violation|0|||
164001318|NCT03976401|592368467|FG000|Overall Study|Withdrew Consent|0|||
164001319|NCT03976401|592368468|FG001|Overall Study|Withdrew Consent|0|||
164001320|NCT03976401|592368469|FG002|Overall Study|Withdrew Consent|0|||
164001321|NCT03976401|592368470|FG003|Overall Study|Withdrew Consent|1|||
164001322|NCT03976401|592368471|FG004|Overall Study|Withdrew Consent|0|||
164001323|NCT03976401|592368472|FG005|Overall Study|Withdrew Consent|0|||
164001324|NCT04125680|592368474|FG000|Overall Study|Lost to Follow-up|15|||
164001325|NCT00391976|592368477|FG000|Overall Study|Adverse Event|0|||
164001326|NCT00391976|592368478|FG001|Overall Study|Adverse Event|0|||
164001327|NCT00391976|592368479|FG002|Overall Study|Adverse Event|1|||
164001328|NCT00391976|592368477|FG000|Overall Study|Withdrawal of consent|0|||
164001329|NCT00391976|592368478|FG001|Overall Study|Withdrawal of consent|1|||
164001330|NCT00391976|592368479|FG002|Overall Study|Withdrawal of consent|1|||
164276687|NCT00547521|593380731|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
164276688|NCT00547521|593380730|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
164276689|NCT00547521|593380731|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
164001331|NCT00391976|592368477|FG000|Overall Study|Lost to Follow-up|1|||
164001332|NCT00391976|592368478|FG001|Overall Study|Lost to Follow-up|2|||
164001333|NCT00391976|592368479|FG002|Overall Study|Lost to Follow-up|0|||
164276690|NCT00547521|593380730|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
164276691|NCT00547521|593380731|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
164276692|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
164276693|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
164276694|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
164276695|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
164276696|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
164276697|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
164276698|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
164276699|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
164276700|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Other|0|||
164276701|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Other|2|||
164276702|NCT00547521|593380730|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
164276703|NCT00547521|593380731|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
164276704|NCT03077919|593382630|FG000|Overall Study|Lost to Follow-up|4|||
164276705|NCT03077919|593382631|FG001|Overall Study|Lost to Follow-up|1|||
164276706|NCT00826618|593382632|FG000|Overall Study|Withdrawal by Subject|1|||
164276707|NCT01487265|593382635|FG000|Overall Study|Adverse Event|8|||
164276708|NCT01487265|593382635|FG000|Overall Study|Withdrawal by Subject|5|||
164276709|NCT01487265|593382635|FG000|Overall Study|Disease Progression|21|||
164276710|NCT01487265|593382635|FG000|Overall Study|Death|2|||
164276711|NCT01487265|593382635|FG000|Overall Study|Still on Treatment|1|||
164276712|NCT00193180|593382644|FG000|Overall Study|Lack of Efficacy|1|||
164276713|NCT00193180|593382644|FG000|Overall Study|Adverse Event|8|||
164276714|NCT00193180|593382644|FG000|Overall Study|Protocol Violation|1|||
164001334|NCT00391976|592368477|FG000|Overall Study|Inappropriate enrollment|1|||
164001335|NCT00391976|592368478|FG001|Overall Study|Inappropriate enrollment|1|||
164276715|NCT02688985|593382652|FG000|Overall Study|Adverse Event|1|||
164276716|NCT02688985|593382653|FG001|Overall Study|Adverse Event|2|||
164276717|NCT02688985|593382654|FG002|Overall Study|Adverse Event|2|||
164276718|NCT02688985|593382655|FG003|Overall Study|Adverse Event|0|||
164276719|NCT02688985|593382656|FG004|Overall Study|Adverse Event|0|||
164276720|NCT02688985|593382652|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
164276721|NCT02688985|593382653|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
164276722|NCT02688985|593382654|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
164276723|NCT02688985|593382655|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
164276724|NCT02688985|593382656|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
164276725|NCT02688985|593382652|FG000|Overall Study|Death|0|||
164276726|NCT02688985|593382653|FG001|Overall Study|Death|0|||
164276727|NCT02688985|593382654|FG002|Overall Study|Death|0|||
164276728|NCT02688985|593382655|FG003|Overall Study|Death|0|||
164276729|NCT02688985|593382656|FG004|Overall Study|Death|1|||
164276730|NCT02688985|593382652|FG000|Overall Study|Lack of Efficacy|0|||
164276731|NCT02688985|593382653|FG001|Overall Study|Lack of Efficacy|0|||
164343459|NCT01648101|593635239|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
164343460|NCT01648101|593635240|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
163895207|NCT04778410|591989587|FG002|Phase 2 Period|Death|0|||
164343461|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
164343462|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
164343463|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
164343464|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
164343465|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
164343466|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
164343467|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
164343468|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
164343469|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
164343470|NCT01648101|593635238|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
164343471|NCT01648101|593635239|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
164343472|NCT01648101|593635240|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
164343473|NCT01648101|593635238|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
164343474|NCT01648101|593635239|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
164343475|NCT01648101|593635240|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
164343476|NCT02469298|593635253|FG000|Overall Study|Protocol Violation|0|||
164343477|NCT02469298|593635254|FG001|Overall Study|Protocol Violation|1|||
164343478|NCT02469298|593635255|FG002|Overall Study|Protocol Violation|1|||
164343479|NCT02469298|593635256|FG003|Overall Study|Protocol Violation|0|||
164343480|NCT02469298|593635253|FG000|Overall Study|Lost to Follow-up|1|||
164343481|NCT02469298|593635254|FG001|Overall Study|Lost to Follow-up|0|||
164343482|NCT02469298|593635255|FG002|Overall Study|Lost to Follow-up|1|||
164343483|NCT02469298|593635256|FG003|Overall Study|Lost to Follow-up|0|||
164343484|NCT02469298|593635253|FG000|Overall Study|Physician Decision|0|||
164343485|NCT02469298|593635254|FG001|Overall Study|Physician Decision|0|||
164343486|NCT02469298|593635255|FG002|Overall Study|Physician Decision|0|||
164343487|NCT02469298|593635256|FG003|Overall Study|Physician Decision|1|||
164343488|NCT02469298|593635253|FG000|Overall Study|Withdrawal by Subject|0|||
164343489|NCT02469298|593635254|FG001|Overall Study|Withdrawal by Subject|0|||
164343490|NCT02469298|593635255|FG002|Overall Study|Withdrawal by Subject|0|||
164343491|NCT02469298|593635256|FG003|Overall Study|Withdrawal by Subject|1|||
164343492|NCT00307294|593635257|FG000|Overall Study|Withdrawal by Subject|1|||
164343493|NCT03311724|593635258|FG000|Overall Study|Physician Decision|0|||
164343494|NCT03311724|593635259|FG001|Overall Study|Physician Decision|0|||
164343495|NCT03311724|593635260|FG002|Overall Study|Physician Decision|0|||
164343496|NCT03311724|593635261|FG003|Overall Study|Physician Decision|1|||
164343497|NCT03311724|593635258|FG000|Overall Study|Protocol Violation|1|||
164343498|NCT03311724|593635259|FG001|Overall Study|Protocol Violation|0|||
164343499|NCT03311724|593635260|FG002|Overall Study|Protocol Violation|1|||
164343500|NCT03311724|593635261|FG003|Overall Study|Protocol Violation|0|||
164343501|NCT03311724|593635258|FG000|Overall Study|Withdrawal by Subject|1|||
164343502|NCT03311724|593635259|FG001|Overall Study|Withdrawal by Subject|1|||
164343503|NCT03311724|593635260|FG002|Overall Study|Withdrawal by Subject|0|||
164343504|NCT03311724|593635261|FG003|Overall Study|Withdrawal by Subject|0|||
164343505|NCT03311724|593635258|FG000|Overall Study|Lost to Follow-up|1|||
164343506|NCT03311724|593635259|FG001|Overall Study|Lost to Follow-up|0|||
164343507|NCT03311724|593635260|FG002|Overall Study|Lost to Follow-up|0|||
164343508|NCT03311724|593635261|FG003|Overall Study|Lost to Follow-up|0|||
163895208|NCT04778410|591989588|FG003|Phase 2 Period|Death|5|||
163895209|NCT04778410|591989589|FG004|Phase 2 Period|Death|18|||
163895210|NCT04778410|591989590|FG005|Phase 2 Period|Death|0|||
163895211|NCT04778410|591989585|FG000|Phase 2 Period|Lost to Follow-up|0|||
163895212|NCT04778410|591989586|FG001|Phase 2 Period|Lost to Follow-up|0|||
163895213|NCT04778410|591989587|FG002|Phase 2 Period|Lost to Follow-up|0|||
163895214|NCT04778410|591989588|FG003|Phase 2 Period|Lost to Follow-up|1|||
164343509|NCT03311724|593635258|FG000|Overall Study|Sponsor Decision|0|||
163895215|NCT04778410|591989589|FG004|Phase 2 Period|Lost to Follow-up|1|||
164276732|NCT02688985|593382654|FG002|Overall Study|Lack of Efficacy|0|||
164276733|NCT02688985|593382655|FG003|Overall Study|Lack of Efficacy|0|||
164343510|NCT03311724|593635259|FG001|Overall Study|Sponsor Decision|0|||
164276734|NCT02688985|593382656|FG004|Overall Study|Lack of Efficacy|1|||
164276735|NCT02688985|593382652|FG000|Overall Study|Lost to Follow-up|2|||
164276736|NCT02688985|593382653|FG001|Overall Study|Lost to Follow-up|0|||
164276737|NCT02688985|593382654|FG002|Overall Study|Lost to Follow-up|1|||
164276738|NCT02688985|593382655|FG003|Overall Study|Lost to Follow-up|1|||
164276739|NCT02688985|593382656|FG004|Overall Study|Lost to Follow-up|1|||
164276740|NCT02688985|593382652|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164276741|NCT02688985|593382653|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164276742|NCT02688985|593382654|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164276743|NCT02688985|593382655|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164276744|NCT02688985|593382656|FG004|Overall Study|Non-Compliance With Study Drug|1|||
164276745|NCT02688985|593382652|FG000|Overall Study|Other|3|||
164276746|NCT02688985|593382653|FG001|Overall Study|Other|4|||
164276747|NCT02688985|593382654|FG002|Overall Study|Other|1|||
164276748|NCT02688985|593382655|FG003|Overall Study|Other|0|||
164276749|NCT02688985|593382656|FG004|Overall Study|Other|0|||
164276750|NCT02688985|593382652|FG000|Overall Study|Physician Decision|2|||
164276751|NCT02688985|593382653|FG001|Overall Study|Physician Decision|2|||
164276752|NCT02688985|593382654|FG002|Overall Study|Physician Decision|0|||
164276753|NCT02688985|593382655|FG003|Overall Study|Physician Decision|0|||
164276754|NCT02688985|593382656|FG004|Overall Study|Physician Decision|1|||
164276755|NCT02688985|593382652|FG000|Overall Study|Pregnancy|0|||
164276756|NCT02688985|593382653|FG001|Overall Study|Pregnancy|0|||
164276757|NCT02688985|593382654|FG002|Overall Study|Pregnancy|2|||
164276758|NCT02688985|593382655|FG003|Overall Study|Pregnancy|1|||
164276759|NCT02688985|593382656|FG004|Overall Study|Pregnancy|0|||
164276760|NCT02688985|593382652|FG000|Overall Study|Study Terminated By Sponsor|0|||
164276761|NCT02688985|593382653|FG001|Overall Study|Study Terminated By Sponsor|0|||
164276762|NCT02688985|593382654|FG002|Overall Study|Study Terminated By Sponsor|0|||
164276763|NCT02688985|593382655|FG003|Overall Study|Study Terminated By Sponsor|1|||
164276764|NCT02688985|593382656|FG004|Overall Study|Study Terminated By Sponsor|0|||
164276765|NCT02688985|593382652|FG000|Overall Study|Withdrawal by Subject|2|||
164276766|NCT02688985|593382653|FG001|Overall Study|Withdrawal by Subject|8|||
164276767|NCT02688985|593382654|FG002|Overall Study|Withdrawal by Subject|7|||
164276768|NCT02688985|593382655|FG003|Overall Study|Withdrawal by Subject|1|||
164276769|NCT02688985|593382656|FG004|Overall Study|Withdrawal by Subject|4|||
164276770|NCT01726582|593382657|FG000|Overall Study|Physician Decision|99|||
164276771|NCT01726582|593382657|FG000|Overall Study|Death|85|||
164276772|NCT02630472|593382658|FG000|Overall Study|Physician Decision|10|||
164276773|NCT02630472|593382659|FG001|Overall Study|Physician Decision|0|||
164276774|NCT01832155|593382664|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
164276775|NCT01832155|593382665|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
164276776|NCT01832155|593382664|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
164276777|NCT01832155|593382665|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
164276778|NCT00787189|593382666|FG000|Overall Study|Lost to Follow-up|2|||
164276779|NCT00787189|593382667|FG001|Overall Study|Lost to Follow-up|2|||
164276780|NCT01279616|593382668|FG000|Overall Study|donor could not be located|5|||
164276781|NCT01279616|593382668|FG000|Overall Study|no signs of sickle cell disease|2|||
164276782|NCT00413036|593382669|FG000|Overall Study|Adverse Event|44|||
164276783|NCT00413036|593382669|FG000|Overall Study|Lack of Efficacy|129|||
164276784|NCT00413036|593382669|FG000|Overall Study|Withdrawal by Subject|7|||
164276785|NCT00413036|593382669|FG000|Overall Study|Death|9|||
164276786|NCT00413036|593382669|FG000|Overall Study|Other|26|||
164276787|NCT00413036|593382669|FG000|Overall Study|Missing|2|||
164276788|NCT01369641|593382670|FG000|Overall Study|Withdrawal by Subject|1|||
164276789|NCT01483183|593382675|FG000|Overall Study|Physician Decision|0|||
164276790|NCT01483183|593382676|FG001|Overall Study|Physician Decision|0|||
164276791|NCT01483183|593382677|FG002|Overall Study|Physician Decision|0|||
164276792|NCT01483183|593382678|FG003|Overall Study|Physician Decision|0|||
164276793|NCT01483183|593382679|FG004|Overall Study|Physician Decision|0|||
164276794|NCT01483183|593382680|FG005|Overall Study|Physician Decision|0|||
164276795|NCT01483183|593382681|FG006|Overall Study|Physician Decision|2|||
164276796|NCT01483183|593382682|FG007|Overall Study|Physician Decision|0|||
164276797|NCT01483183|593382683|FG008|Overall Study|Physician Decision|0|||
164276798|NCT01483183|593382684|FG009|Overall Study|Physician Decision|0|||
164276799|NCT01483183|593382675|FG000|Overall Study|Withdrawal by Subject|0|||
164343511|NCT03311724|593635260|FG002|Overall Study|Sponsor Decision|1|||
164343512|NCT03311724|593635261|FG003|Overall Study|Sponsor Decision|0|||
164343513|NCT01433991|593635262|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
164343514|NCT01433991|593635263|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
164343515|NCT01433991|593635264|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
164343516|NCT01433991|593635265|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
164343517|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
164343518|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
164276800|NCT01483183|593382676|FG001|Overall Study|Withdrawal by Subject|0|||
164276801|NCT01483183|593382677|FG002|Overall Study|Withdrawal by Subject|0|||
164276802|NCT01483183|593382678|FG003|Overall Study|Withdrawal by Subject|0|||
164001336|NCT00391976|592368479|FG002|Overall Study|Inappropriate enrollment|0|||
164001337|NCT00391976|592368477|FG000|Overall Study|Protocol deviation/violation|4|||
164001338|NCT00391976|592368478|FG001|Overall Study|Protocol deviation/violation|2|||
164001339|NCT00391976|592368479|FG002|Overall Study|Protocol deviation/violation|1|||
164001340|NCT00391976|592368477|FG000|Overall Study|Recurrence/no eradication of infection|21|||
164001341|NCT00391976|592368478|FG001|Overall Study|Recurrence/no eradication of infection|19|||
164001342|NCT00391976|592368479|FG002|Overall Study|Recurrence/no eradication of infection|0|||
164001343|NCT00391976|592368477|FG000|Overall Study|Unable to classify|0|||
164001344|NCT00391976|592368478|FG001|Overall Study|Unable to classify|0|||
164001345|NCT00391976|592368479|FG002|Overall Study|Unable to classify|1|||
164001346|NCT00391976|592368477|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
164001347|NCT00391976|592368478|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
164001348|NCT00391976|592368479|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
164001349|NCT00049127|592368480|FG000|Overall Study|Withdrawal by Subject|0|||
164001350|NCT00049127|592368481|FG001|Overall Study|Withdrawal by Subject|0|||
164001351|NCT00049127|592368482|FG002|Overall Study|Withdrawal by Subject|1|||
164001352|NCT00049127|592368483|FG003|Overall Study|Withdrawal by Subject|0|||
164001353|NCT00049127|592368484|FG004|Overall Study|Withdrawal by Subject|0|||
164001354|NCT02725788|592368489|FG000|Overall Study|Lost to Follow-up|1|||
164001355|NCT02725788|592368490|FG001|Overall Study|Lost to Follow-up|1|||
164001356|NCT02725788|592368489|FG000|Overall Study|Protocol Violation|0|||
164001357|NCT02725788|592368490|FG001|Overall Study|Protocol Violation|1|||
164001358|NCT00828464|592368491|FG000|Overall Study|Withdrawal by Subject|1|||
164001359|NCT00474240|592368492|FG000|Overall Study|Withdrawal by Subject|1|||
164001360|NCT00474240|592368493|FG001|Overall Study|Withdrawal by Subject|1|||
164001361|NCT00474240|592368494|FG002|Overall Study|Withdrawal by Subject|0|||
164001362|NCT00474240|592368495|FG003|Overall Study|Withdrawal by Subject|2|||
164085974|NCT03611309|592678608|FG001|Overall Study|Lost to Follow-up|8|||
164085975|NCT03611309|592678607|FG000|Overall Study|Withdrawal by Subject|5|||
164085976|NCT03611309|592678608|FG001|Overall Study|Withdrawal by Subject|5|||
164085977|NCT03611309|592678607|FG000|Overall Study|Physician Decision|0|||
164276803|NCT01483183|593382679|FG004|Overall Study|Withdrawal by Subject|0|||
164276804|NCT01483183|593382680|FG005|Overall Study|Withdrawal by Subject|0|||
164276805|NCT01483183|593382681|FG006|Overall Study|Withdrawal by Subject|0|||
164276806|NCT01483183|593382682|FG007|Overall Study|Withdrawal by Subject|0|||
164276807|NCT01483183|593382683|FG008|Overall Study|Withdrawal by Subject|0|||
164276808|NCT01483183|593382684|FG009|Overall Study|Withdrawal by Subject|1|||
164276809|NCT00239928|593382685|FG000|Overall Study|Lack of Efficacy|1|||
164276810|NCT00239928|593382685|FG000|Overall Study|Adverse Event|4|||
164276811|NCT00239928|593382685|FG000|Overall Study|Not need to continue study|3|||
164276812|NCT00239928|593382685|FG000|Overall Study|Withdrawal by Subject|2|||
164276813|NCT02524158|593382686|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
164276814|NCT02524158|593382687|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
164276815|NCT02524158|593382686|FG000|12-weeks Assessment|Lost to Follow-up|18|||
164276816|NCT02524158|593382687|FG001|12-weeks Assessment|Lost to Follow-up|12|||
164276817|NCT02524158|593382686|FG000|6-month Assessment|Withdrawal by Subject|1|||
164276818|NCT02524158|593382687|FG001|6-month Assessment|Withdrawal by Subject|1|||
164276819|NCT02524158|593382686|FG000|6-month Assessment|Lost to Follow-up|21|||
164276820|NCT02524158|593382687|FG001|6-month Assessment|Lost to Follow-up|20|||
164276821|NCT04427072|593382692|FG000|Randomized Treatment Phase|Progressive disease|9|||
164276822|NCT04427072|593382693|FG001|Randomized Treatment Phase|Progressive disease|4|||
164276823|NCT04427072|593382692|FG000|Randomized Treatment Phase|Adverse Event|3|||
164276824|NCT04427072|593382693|FG001|Randomized Treatment Phase|Adverse Event|1|||
164276825|NCT04427072|593382692|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
164276826|NCT04427072|593382693|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
164276827|NCT04427072|593382692|FG000|Randomized Treatment Phase|Death|0|||
164276828|NCT04427072|593382693|FG001|Randomized Treatment Phase|Death|1|||
164276829|NCT04427072|593382692|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
164276830|NCT04427072|593382693|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
164276831|NCT04427072|593382692|FG000|Extension Treatment Phase|Progressive disease|0|||
164276832|NCT04427072|593382693|FG001|Extension Treatment Phase|Progressive disease|5|||
164276833|NCT00300365|593382694|FG000|Overall Study|Lost to Follow-up|1|||
164276834|NCT00300365|593382695|FG001|Overall Study|Lost to Follow-up|0|||
164276835|NCT00300365|593382694|FG000|Overall Study|Physician Decision|2|||
164343519|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
164343520|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
164276836|NCT00300365|593382695|FG001|Overall Study|Physician Decision|0|||
164276837|NCT00300365|593382694|FG000|Overall Study|Withdrawal by Subject|1|||
164343521|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
164343522|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
164343523|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
164343524|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
164343525|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
164343526|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
164343527|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
164343528|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
164343529|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
164343530|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
164343531|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
164343532|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
164343533|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
164343534|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
164343535|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
164343536|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
164343537|NCT01433991|593635262|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
164343538|NCT01433991|593635263|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
164343539|NCT01433991|593635264|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
164343540|NCT01433991|593635265|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
164343541|NCT02955602|593635266|FG000|Overall Study|Adverse Event|0|||
164343542|NCT02955602|593635267|FG001|Overall Study|Adverse Event|3|||
164343543|NCT02955602|593635268|FG002|Overall Study|Adverse Event|0|||
164343544|NCT02955602|593635266|FG000|Overall Study|Withdrawal of informed consent|1|||
164343545|NCT02955602|593635267|FG001|Overall Study|Withdrawal of informed consent|3|||
164343546|NCT02955602|593635268|FG002|Overall Study|Withdrawal of informed consent|2|||
164343547|NCT02955602|593635266|FG000|Overall Study|Lost to Follow-up|0|||
164276838|NCT00300365|593382695|FG001|Overall Study|Withdrawal by Subject|0|||
164343548|NCT02955602|593635267|FG001|Overall Study|Lost to Follow-up|0|||
164343549|NCT02955602|593635268|FG002|Overall Study|Lost to Follow-up|1|||
164343550|NCT02955602|593635266|FG000|Overall Study|Other|0|||
163895216|NCT04778410|591989590|FG005|Phase 2 Period|Lost to Follow-up|0|||
164276839|NCT00300365|593382694|FG000|Overall Study|Adverse Event|0|||
164276840|NCT00300365|593382695|FG001|Overall Study|Adverse Event|2|||
164276841|NCT00077649|593382696|FG000|Overall Study|Adverse Event|5|||
164276842|NCT00077649|593382697|FG001|Overall Study|Adverse Event|1|||
164276843|NCT00077649|593382698|FG002|Overall Study|Adverse Event|7|||
164276844|NCT00077649|593382699|FG003|Overall Study|Adverse Event|9|||
164276845|NCT00077649|593382696|FG000|Overall Study|Lack of Efficacy|5|||
164276846|NCT00077649|593382697|FG001|Overall Study|Lack of Efficacy|3|||
164276847|NCT00077649|593382698|FG002|Overall Study|Lack of Efficacy|3|||
164276848|NCT00077649|593382699|FG003|Overall Study|Lack of Efficacy|2|||
164276849|NCT00077649|593382696|FG000|Overall Study|Withdrawal by Subject|0|||
164276850|NCT00077649|593382697|FG001|Overall Study|Withdrawal by Subject|1|||
164276851|NCT00077649|593382698|FG002|Overall Study|Withdrawal by Subject|1|||
164276852|NCT00077649|593382699|FG003|Overall Study|Withdrawal by Subject|2|||
164276853|NCT00077649|593382696|FG000|Overall Study|Lost to Follow-up|2|||
164276854|NCT00077649|593382697|FG001|Overall Study|Lost to Follow-up|2|||
164276855|NCT00077649|593382698|FG002|Overall Study|Lost to Follow-up|3|||
164276856|NCT00077649|593382699|FG003|Overall Study|Lost to Follow-up|2|||
164276857|NCT00077649|593382696|FG000|Overall Study|Abnormality of Laboratory Test|1|||
164276858|NCT00077649|593382697|FG001|Overall Study|Abnormality of Laboratory Test|2|||
164276859|NCT00077649|593382698|FG002|Overall Study|Abnormality of Laboratory Test|1|||
164276860|NCT00077649|593382699|FG003|Overall Study|Abnormality of Laboratory Test|2|||
164276861|NCT00077649|593382696|FG000|Overall Study|Randomized but never dosed|1|||
164276862|NCT00077649|593382697|FG001|Overall Study|Randomized but never dosed|0|||
164276863|NCT00077649|593382698|FG002|Overall Study|Randomized but never dosed|0|||
164276864|NCT00077649|593382699|FG003|Overall Study|Randomized but never dosed|0|||
164276865|NCT01727336|593382702|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276866|NCT01727336|593382703|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
164276867|NCT01727336|593382704|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
164276868|NCT01727336|593382705|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276869|NCT01727336|593382706|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276870|NCT01727336|593382707|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
164276871|NCT01727336|593382702|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
164276872|NCT01727336|593382703|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
164276873|NCT01727336|593382704|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
164276874|NCT01727336|593382705|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
164276875|NCT01727336|593382706|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
164276876|NCT01727336|593382707|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
164276877|NCT01727336|593382702|FG000|Part 2 Blinded|Death|0|||
164276878|NCT01727336|593382703|FG001|Part 2 Blinded|Death|0|||
164276879|NCT01727336|593382704|FG002|Part 2 Blinded|Death|0|||
164276880|NCT01727336|593382705|FG003|Part 2 Blinded|Death|0|||
164276881|NCT01727336|593382706|FG004|Part 2 Blinded|Death|20|||
164276882|NCT01727336|593382707|FG005|Part 2 Blinded|Death|16|||
164276883|NCT01727336|593382702|FG000|Part 2 Blinded|Lack of Efficacy|0|||
164276884|NCT01727336|593382703|FG001|Part 2 Blinded|Lack of Efficacy|0|||
164276885|NCT01727336|593382704|FG002|Part 2 Blinded|Lack of Efficacy|0|||
164276886|NCT01727336|593382705|FG003|Part 2 Blinded|Lack of Efficacy|0|||
164276887|NCT01727336|593382706|FG004|Part 2 Blinded|Lack of Efficacy|42|||
164276888|NCT01727336|593382707|FG005|Part 2 Blinded|Lack of Efficacy|44|||
164276889|NCT01727336|593382702|FG000|Part 2 Blinded|Lost to Follow-up|0|||
164276890|NCT01727336|593382703|FG001|Part 2 Blinded|Lost to Follow-up|0|||
164276891|NCT01727336|593382704|FG002|Part 2 Blinded|Lost to Follow-up|0|||
164276892|NCT01727336|593382705|FG003|Part 2 Blinded|Lost to Follow-up|0|||
164276893|NCT01727336|593382706|FG004|Part 2 Blinded|Lost to Follow-up|0|||
164276894|NCT01727336|593382707|FG005|Part 2 Blinded|Lost to Follow-up|1|||
164276895|NCT01727336|593382702|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
164276896|NCT01727336|593382703|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
164276897|NCT01727336|593382704|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
164276898|NCT01727336|593382705|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
164276899|NCT01727336|593382706|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
164276900|NCT01727336|593382707|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
164276901|NCT01727336|593382702|FG000|Part 2 Blinded|use of prohibited medications|0|||
164276902|NCT01727336|593382703|FG001|Part 2 Blinded|use of prohibited medications|0|||
164276903|NCT01727336|593382704|FG002|Part 2 Blinded|use of prohibited medications|0|||
164276904|NCT01727336|593382705|FG003|Part 2 Blinded|use of prohibited medications|0|||
164276905|NCT01727336|593382706|FG004|Part 2 Blinded|use of prohibited medications|1|||
164343551|NCT02955602|593635267|FG001|Overall Study|Other|1|||
164343552|NCT02955602|593635268|FG002|Overall Study|Other|3|||
164343553|NCT01581931|593635271|FG000|Washout|Adverse Event|0|||
164343554|NCT01581931|593635272|FG001|Washout|Adverse Event|1|||
164343555|NCT00395304|593635279|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164343556|NCT00395304|593635280|FG001|Treatment Period 1|Withdrawal by Subject|3|||
164343557|NCT00395304|593635281|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164343558|NCT00395304|593635282|FG003|Treatment Period 1|Withdrawal by Subject|2|||
164343559|NCT00395304|593635283|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164343560|NCT00395304|593635284|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164276906|NCT01727336|593382707|FG005|Part 2 Blinded|use of prohibited medications|3|||
164276907|NCT03550404|593382708|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
164276908|NCT03550404|593382709|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
164276909|NCT03550404|593382710|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
164276910|NCT03550404|593382708|FG000|Phase 2|Vacated position|1|||
164276911|NCT03550404|593382709|FG001|Phase 2|Vacated position|0|||
164276912|NCT03550404|593382710|FG002|Phase 2|Vacated position|0|||
164276913|NCT00820222|593382712|FG000|Overall Study|Lost to Follow-up|10|||
164276914|NCT00820222|593382713|FG001|Overall Study|Lost to Follow-up|9|||
164276915|NCT00820222|593382712|FG000|Overall Study|Withdrawal by Subject|19|||
164276916|NCT00820222|593382713|FG001|Overall Study|Withdrawal by Subject|21|||
164276917|NCT00820222|593382712|FG000|Overall Study|Physician Decision|93|||
164276918|NCT00820222|593382713|FG001|Overall Study|Physician Decision|88|||
164276919|NCT00820222|593382712|FG000|Overall Study|Sponsor Terminated Study|43|||
164276920|NCT00820222|593382713|FG001|Overall Study|Sponsor Terminated Study|65|||
164276921|NCT00820222|593382712|FG000|Overall Study|Unkown|11|||
164276922|NCT00820222|593382713|FG001|Overall Study|Unkown|7|||
164276923|NCT02690714|593382714|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
164276924|NCT02690714|593382714|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
164276925|NCT00666965|593382715|FG000|Overall Study|Adverse Event|0|||
164276926|NCT00666965|593382716|FG001|Overall Study|Adverse Event|2|||
164276927|NCT00666965|593382717|FG002|Overall Study|Adverse Event|1|||
164276928|NCT00666965|593382718|FG003|Overall Study|Adverse Event|9|||
164001363|NCT00474240|592368496|FG004|Overall Study|Withdrawal by Subject|3|||
164001364|NCT00474240|592368497|FG005|Overall Study|Withdrawal by Subject|1|||
164001365|NCT00474240|592368492|FG000|Overall Study|Adverse Event|0|||
164276929|NCT00666965|593382715|FG000|Overall Study|Lack of Efficacy|1|||
164276930|NCT00666965|593382716|FG001|Overall Study|Lack of Efficacy|1|||
164276931|NCT00666965|593382717|FG002|Overall Study|Lack of Efficacy|0|||
164276932|NCT00666965|593382718|FG003|Overall Study|Lack of Efficacy|0|||
164276933|NCT00666965|593382715|FG000|Overall Study|Protocol Violation|0|||
164276934|NCT00666965|593382716|FG001|Overall Study|Protocol Violation|0|||
164276935|NCT00666965|593382717|FG002|Overall Study|Protocol Violation|0|||
164276936|NCT00666965|593382718|FG003|Overall Study|Protocol Violation|2|||
164276937|NCT00666965|593382715|FG000|Overall Study|Discontinuation criteria|2|||
164276938|NCT00666965|593382716|FG001|Overall Study|Discontinuation criteria|1|||
164276939|NCT00666965|593382717|FG002|Overall Study|Discontinuation criteria|1|||
164276940|NCT00666965|593382718|FG003|Overall Study|Discontinuation criteria|2|||
164276941|NCT00666965|593382715|FG000|Overall Study|Withdrawal by Subject|0|||
164276942|NCT00666965|593382716|FG001|Overall Study|Withdrawal by Subject|0|||
164276943|NCT00666965|593382717|FG002|Overall Study|Withdrawal by Subject|0|||
164276944|NCT00666965|593382718|FG003|Overall Study|Withdrawal by Subject|2|||
164276945|NCT03596450|593382724|FG000|Overall Study|Death|9|||
164276946|NCT03596450|593382725|FG001|Overall Study|Death|9|||
164276947|NCT03596450|593382724|FG000|Overall Study|Protocol Violation|18|||
164276948|NCT03596450|593382725|FG001|Overall Study|Protocol Violation|26|||
164276949|NCT03596450|593382724|FG000|Overall Study|Lost to Follow-up|50|||
164276950|NCT03596450|593382725|FG001|Overall Study|Lost to Follow-up|56|||
164276951|NCT03596450|593382724|FG000|Overall Study|Adverse Event|14|||
164276952|NCT03596450|593382725|FG001|Overall Study|Adverse Event|7|||
164276953|NCT03596450|593382724|FG000|Overall Study|Withdrawal by Subject|38|||
164276954|NCT03596450|593382725|FG001|Overall Study|Withdrawal by Subject|36|||
164276955|NCT03596450|593382724|FG000|Overall Study|Accidentally Randomized|2|||
164276956|NCT03596450|593382725|FG001|Overall Study|Accidentally Randomized|0|||
164276957|NCT03596450|593382724|FG000|Overall Study|Other reasons|48|||
164276958|NCT03596450|593382725|FG001|Overall Study|Other reasons|53|||
164276959|NCT03596450|593382724|FG000|Overall Study|Pregnancy|2|||
164276960|NCT03596450|593382725|FG001|Overall Study|Pregnancy|0|||
164276961|NCT04058886|593382732|FG000|Overall Study|Withdrawal by Subject|4|||
164276962|NCT04058886|593382732|FG000|Overall Study|Inadequate deafness interpreter service|1|||
164276963|NCT00699335|593382735|FG000|Overall Study|Combination of multiple reasons|176|||
164276964|NCT00699335|593382735|FG000|Overall Study|Missing data|52|||
164276965|NCT02607228|593382741|FG000|Overall Study|Progressive Disease|4|||
164276966|NCT02607228|593382742|FG001|Overall Study|Progressive Disease|3|||
164276967|NCT02607228|593382743|FG002|Overall Study|Progressive Disease|1|||
164276968|NCT02607228|593382744|FG003|Overall Study|Progressive Disease|5|||
164276969|NCT02607228|593382745|FG004|Overall Study|Progressive Disease|4|||
164276970|NCT02607228|593382746|FG005|Overall Study|Progressive Disease|3|||
164276971|NCT02607228|593382747|FG006|Overall Study|Progressive Disease|1|||
164276972|NCT02607228|593382741|FG000|Overall Study|Adverse Event|1|||
164276973|NCT02607228|593382742|FG001|Overall Study|Adverse Event|0|||
164276974|NCT02607228|593382743|FG002|Overall Study|Adverse Event|1|||
164276975|NCT02607228|593382744|FG003|Overall Study|Adverse Event|0|||
164276976|NCT02607228|593382745|FG004|Overall Study|Adverse Event|1|||
164276977|NCT02607228|593382746|FG005|Overall Study|Adverse Event|1|||
164276978|NCT02607228|593382747|FG006|Overall Study|Adverse Event|1|||
164276979|NCT02607228|593382741|FG000|Overall Study|Investigator's Discretion|0|||
164276980|NCT02607228|593382742|FG001|Overall Study|Investigator's Discretion|0|||
164276981|NCT02607228|593382743|FG002|Overall Study|Investigator's Discretion|1|||
164276982|NCT02607228|593382744|FG003|Overall Study|Investigator's Discretion|0|||
164276983|NCT02607228|593382745|FG004|Overall Study|Investigator's Discretion|0|||
164276984|NCT02607228|593382746|FG005|Overall Study|Investigator's Discretion|1|||
164276985|NCT02607228|593382747|FG006|Overall Study|Investigator's Discretion|0|||
164276986|NCT02607228|593382741|FG000|Overall Study|Withdrew Consent|0|||
164276987|NCT02607228|593382742|FG001|Overall Study|Withdrew Consent|1|||
164276988|NCT02607228|593382743|FG002|Overall Study|Withdrew Consent|0|||
164276989|NCT02607228|593382744|FG003|Overall Study|Withdrew Consent|0|||
164276990|NCT02607228|593382745|FG004|Overall Study|Withdrew Consent|0|||
164276991|NCT02607228|593382746|FG005|Overall Study|Withdrew Consent|1|||
164276992|NCT02607228|593382747|FG006|Overall Study|Withdrew Consent|0|||
164276993|NCT02607228|593382741|FG000|Overall Study|Study Terminated by Sponsor|0|||
164276994|NCT02607228|593382742|FG001|Overall Study|Study Terminated by Sponsor|0|||
164276995|NCT02607228|593382743|FG002|Overall Study|Study Terminated by Sponsor|0|||
164276996|NCT02607228|593382744|FG003|Overall Study|Study Terminated by Sponsor|1|||
164276997|NCT02607228|593382745|FG004|Overall Study|Study Terminated by Sponsor|0|||
164276998|NCT02607228|593382746|FG005|Overall Study|Study Terminated by Sponsor|0|||
164276999|NCT02607228|593382747|FG006|Overall Study|Study Terminated by Sponsor|0|||
164277000|NCT00488826|593382752|FG000|Overall Study|Withdrawal by Subject|40|||
164277001|NCT00488826|593382753|FG001|Overall Study|Withdrawal by Subject|35|||
164277002|NCT00488826|593382754|FG002|Overall Study|Withdrawal by Subject|19|||
164277003|NCT00488826|593382752|FG000|Overall Study|Protocol Violation|0|||
164277004|NCT00488826|593382753|FG001|Overall Study|Protocol Violation|0|||
164277005|NCT00488826|593382754|FG002|Overall Study|Protocol Violation|2|||
164277006|NCT00488826|593382752|FG000|Overall Study|Adverse Event|9|||
164277007|NCT00488826|593382753|FG001|Overall Study|Adverse Event|15|||
164277008|NCT00488826|593382754|FG002|Overall Study|Adverse Event|4|||
164277009|NCT00488826|593382752|FG000|Overall Study|Lost to Follow-up|5|||
164277010|NCT00488826|593382753|FG001|Overall Study|Lost to Follow-up|1|||
164277011|NCT00488826|593382754|FG002|Overall Study|Lost to Follow-up|0|||
164277012|NCT00488826|593382752|FG000|Overall Study|Protocol Deviations|2|||
164277013|NCT00488826|593382753|FG001|Overall Study|Protocol Deviations|1|||
164277014|NCT00488826|593382754|FG002|Overall Study|Protocol Deviations|1|||
164277015|NCT02974842|593382757|FG000|Overall Study|Withdrawal by Subject|4|||
164277016|NCT02974842|593382757|FG000|Overall Study|Screen failures|4|||
164277017|NCT01959243|593382758|FG000|Overall Study|Investigator Decision|3|||
164277018|NCT01959243|593382759|FG001|Overall Study|Investigator Decision|0|||
164277019|NCT01959243|593382758|FG000|Overall Study|Adverse Event|5|||
164277020|NCT01959243|593382759|FG001|Overall Study|Adverse Event|2|||
164277021|NCT01959243|593382758|FG000|Overall Study|Administrative reasons|2|||
164277022|NCT01959243|593382759|FG001|Overall Study|Administrative reasons|1|||
164277023|NCT01959243|593382758|FG000|Overall Study|Lost to Follow-up|3|||
164277024|NCT01959243|593382759|FG001|Overall Study|Lost to Follow-up|1|||
164277025|NCT02126839|593382760|FG000|Overall Study|Adverse Event|0|||
164277026|NCT02126839|593382761|FG001|Overall Study|Adverse Event|1|||
164277027|NCT02126839|593382760|FG000|Overall Study|Withdrawal by Subject|1|||
164277028|NCT02126839|593382761|FG001|Overall Study|Withdrawal by Subject|0|||
164277029|NCT02126839|593382760|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164277030|NCT02126839|593382761|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164277031|NCT02126839|593382760|FG000|Overall Study|Protocol Violation|2|||
164277032|NCT02126839|593382761|FG001|Overall Study|Protocol Violation|3|||
164277033|NCT02126839|593382760|FG000|Overall Study|Sponsor request|0|||
164277034|NCT02126839|593382761|FG001|Overall Study|Sponsor request|1|||
164277035|NCT02126839|593382760|FG000|Overall Study|Lost to Follow-up|1|||
164277036|NCT02126839|593382761|FG001|Overall Study|Lost to Follow-up|4|||
164277037|NCT02126839|593382760|FG000|Overall Study|Other|5|||
164277038|NCT02126839|593382761|FG001|Overall Study|Other|5|||
164277039|NCT00812565|593382764|FG000|Overall Study|Did Not Receive Study Medication|1|||
164277040|NCT00812565|593382765|FG001|Overall Study|Did Not Receive Study Medication|1|||
164277041|NCT00812565|593382766|FG002|Overall Study|Did Not Receive Study Medication|0|||
164277042|NCT00812565|593382767|FG003|Overall Study|Did Not Receive Study Medication|0|||
164277043|NCT00812565|593382768|FG004|Overall Study|Did Not Receive Study Medication|0|||
164277044|NCT00812565|593382769|FG005|Overall Study|Did Not Receive Study Medication|0|||
164277045|NCT00812565|593382770|FG006|Overall Study|Did Not Receive Study Medication|0|||
164277046|NCT00812565|593382771|FG007|Overall Study|Did Not Receive Study Medication|0|||
164277047|NCT00812565|593382764|FG000|Overall Study|Adverse Event|0|||
164277048|NCT00812565|593382765|FG001|Overall Study|Adverse Event|0|||
164277049|NCT00812565|593382766|FG002|Overall Study|Adverse Event|0|||
164277050|NCT00812565|593382767|FG003|Overall Study|Adverse Event|2|||
164277051|NCT00812565|593382768|FG004|Overall Study|Adverse Event|0|||
164277052|NCT00812565|593382769|FG005|Overall Study|Adverse Event|0|||
164277053|NCT00812565|593382770|FG006|Overall Study|Adverse Event|0|||
164277054|NCT00812565|593382771|FG007|Overall Study|Adverse Event|1|||
164277055|NCT00812565|593382764|FG000|Overall Study|Did Not Come to Study Visit|1|||
164277056|NCT00812565|593382765|FG001|Overall Study|Did Not Come to Study Visit|0|||
164277057|NCT00812565|593382766|FG002|Overall Study|Did Not Come to Study Visit|0|||
164277058|NCT00812565|593382767|FG003|Overall Study|Did Not Come to Study Visit|0|||
164277059|NCT00812565|593382768|FG004|Overall Study|Did Not Come to Study Visit|0|||
164277060|NCT00812565|593382769|FG005|Overall Study|Did Not Come to Study Visit|0|||
164277061|NCT00812565|593382770|FG006|Overall Study|Did Not Come to Study Visit|0|||
164277062|NCT00812565|593382771|FG007|Overall Study|Did Not Come to Study Visit|0|||
164277063|NCT00812565|593382764|FG000|Overall Study|Withdrawal of Consent|1|||
164277064|NCT00812565|593382765|FG001|Overall Study|Withdrawal of Consent|0|||
164277065|NCT00812565|593382766|FG002|Overall Study|Withdrawal of Consent|0|||
164277066|NCT00812565|593382767|FG003|Overall Study|Withdrawal of Consent|0|||
164277067|NCT00812565|593382768|FG004|Overall Study|Withdrawal of Consent|1|||
164277068|NCT00812565|593382769|FG005|Overall Study|Withdrawal of Consent|0|||
164277069|NCT00812565|593382770|FG006|Overall Study|Withdrawal of Consent|0|||
164277070|NCT00812565|593382771|FG007|Overall Study|Withdrawal of Consent|0|||
164277071|NCT00812565|593382764|FG000|Overall Study|Reason Not Specified|0|||
164277072|NCT00812565|593382765|FG001|Overall Study|Reason Not Specified|0|||
164277073|NCT00812565|593382766|FG002|Overall Study|Reason Not Specified|0|||
164277074|NCT00812565|593382767|FG003|Overall Study|Reason Not Specified|0|||
164277075|NCT00812565|593382768|FG004|Overall Study|Reason Not Specified|0|||
164277076|NCT00812565|593382769|FG005|Overall Study|Reason Not Specified|1|||
164277077|NCT00812565|593382770|FG006|Overall Study|Reason Not Specified|0|||
164277078|NCT00812565|593382771|FG007|Overall Study|Reason Not Specified|0|||
164277079|NCT02596945|593382772|FG000|Overall Study|No documentation of study drug dosing|3|||
164277080|NCT02596945|593382772|FG000|Overall Study|Other|32|||
164277081|NCT02596945|593382772|FG000|Overall Study|Change to hemodialysis|15|||
164277082|NCT02596945|593382772|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
164277083|NCT02596945|593382772|FG000|Overall Study|Withdrawal by Subject|1|||
164277084|NCT02596945|593382772|FG000|Overall Study|Missing|1|||
164277085|NCT00422383|593382773|FG000|Overall Study|Adverse Event|5|||
164277086|NCT00422383|593382774|FG001|Overall Study|Adverse Event|3|||
164277087|NCT00422383|593382775|FG002|Overall Study|Adverse Event|1|||
164277088|NCT00422383|593382776|FG003|Overall Study|Adverse Event|1|||
164277089|NCT00422383|593382777|FG004|Overall Study|Adverse Event|0|||
164277090|NCT00422383|593382773|FG000|Overall Study|Lack of Efficacy|4|||
164277091|NCT00422383|593382774|FG001|Overall Study|Lack of Efficacy|4|||
164277092|NCT00422383|593382775|FG002|Overall Study|Lack of Efficacy|2|||
164277093|NCT00422383|593382776|FG003|Overall Study|Lack of Efficacy|1|||
164277094|NCT00422383|593382777|FG004|Overall Study|Lack of Efficacy|1|||
164277095|NCT00422383|593382773|FG000|Overall Study|Lost to Follow-up|0|||
164277096|NCT00422383|593382774|FG001|Overall Study|Lost to Follow-up|1|||
164277097|NCT00422383|593382775|FG002|Overall Study|Lost to Follow-up|0|||
164277098|NCT00422383|593382776|FG003|Overall Study|Lost to Follow-up|0|||
164277099|NCT00422383|593382777|FG004|Overall Study|Lost to Follow-up|1|||
164277100|NCT00422383|593382773|FG000|Overall Study|Protocol Violation|1|||
164277101|NCT00422383|593382774|FG001|Overall Study|Protocol Violation|1|||
164277102|NCT00422383|593382775|FG002|Overall Study|Protocol Violation|1|||
164277103|NCT00422383|593382776|FG003|Overall Study|Protocol Violation|0|||
164277104|NCT00422383|593382777|FG004|Overall Study|Protocol Violation|0|||
164277105|NCT00422383|593382773|FG000|Overall Study|Withdrawal by Subject|5|||
164277106|NCT00422383|593382774|FG001|Overall Study|Withdrawal by Subject|5|||
164277107|NCT00422383|593382775|FG002|Overall Study|Withdrawal by Subject|0|||
164277108|NCT00422383|593382776|FG003|Overall Study|Withdrawal by Subject|0|||
164277109|NCT00422383|593382777|FG004|Overall Study|Withdrawal by Subject|1|||
164277110|NCT00566254|593382778|FG000|Overall Study|Adverse Event|3|||
164277111|NCT00566254|593382779|FG001|Overall Study|Adverse Event|1|||
164277112|NCT00566254|593382778|FG000|Overall Study|Protocol Violation|1|||
164277113|NCT00566254|593382779|FG001|Overall Study|Protocol Violation|3|||
164277114|NCT00566254|593382778|FG000|Overall Study|Withdrawal by Subject|1|||
164277115|NCT00566254|593382779|FG001|Overall Study|Withdrawal by Subject|2|||
164277116|NCT00566254|593382778|FG000|Overall Study|Lack of Efficacy|5|||
164277117|NCT00566254|593382779|FG001|Overall Study|Lack of Efficacy|6|||
164277118|NCT00566254|593382778|FG000|Overall Study|Other|0|||
164277119|NCT00566254|593382779|FG001|Overall Study|Other|2|||
164277120|NCT00238238|593382780|FG000|Overall Study|Withdrawal by Subject|0|||
164277121|NCT00238238|593382781|FG001|Overall Study|Withdrawal by Subject|3|||
164277122|NCT00238238|593382782|FG002|Overall Study|Withdrawal by Subject|0|||
164277123|NCT01007838|593382786|FG000|Overall Study|Withdrawal by Subject|1|||
164277124|NCT01007838|593382787|FG001|Overall Study|Withdrawal by Subject|0|||
164277125|NCT01007838|593382788|FG002|Overall Study|Withdrawal by Subject|0|||
164277126|NCT01007838|593382789|FG003|Overall Study|Withdrawal by Subject|0|||
164277127|NCT01007838|593382786|FG000|Overall Study|Physician Decision|1|||
164277128|NCT01007838|593382787|FG001|Overall Study|Physician Decision|0|||
164277129|NCT01007838|593382788|FG002|Overall Study|Physician Decision|0|||
164277130|NCT01007838|593382789|FG003|Overall Study|Physician Decision|0|||
164277131|NCT01007838|593382786|FG000|Overall Study|Started home haemodialysis|1|||
164277132|NCT01007838|593382787|FG001|Overall Study|Started home haemodialysis|0|||
164277133|NCT01007838|593382788|FG002|Overall Study|Started home haemodialysis|0|||
164277134|NCT01007838|593382789|FG003|Overall Study|Started home haemodialysis|0|||
164277135|NCT02277119|593382790|FG000|Overall Study|Lack of Efficacy|1|||
164277136|NCT02277119|593382791|FG001|Overall Study|Lack of Efficacy|1|||
164277137|NCT02277119|593382792|FG002|Overall Study|Lack of Efficacy|1|||
164277138|NCT02277119|593382790|FG000|Overall Study|Protocol Violation|2|||
164277139|NCT02277119|593382791|FG001|Overall Study|Protocol Violation|3|||
164277140|NCT02277119|593382792|FG002|Overall Study|Protocol Violation|7|||
164277141|NCT04699461|593382793|FG000|Overall Study|Withdrawal by Subject|1|||
164277142|NCT04699461|593382794|FG001|Overall Study|Withdrawal by Subject|0|||
164277143|NCT04699461|593382793|FG000|Overall Study|Study termination by sponsor|2|||
164277144|NCT04699461|593382794|FG001|Overall Study|Study termination by sponsor|1|||
164277145|NCT04699461|593382793|FG000|Overall Study|Death|1|||
164277146|NCT04699461|593382794|FG001|Overall Study|Death|0|||
164277147|NCT04699461|593382793|FG000|Overall Study|Radiographic progression|0|||
164277148|NCT04699461|593382794|FG001|Overall Study|Radiographic progression|1|||
164277149|NCT00761527|593382795|FG000|Overall Study|Adverse Event|3|||
164277150|NCT00761527|593382795|FG000|Overall Study|Poor Compliance|8|||
164277151|NCT00761527|593382795|FG000|Overall Study|Lost to Follow-up|9|||
164343561|NCT00395304|593635279|FG000|Treatment Period 1|Lost to Follow-up|1|||
164343562|NCT00395304|593635280|FG001|Treatment Period 1|Lost to Follow-up|0|||
164343563|NCT00395304|593635281|FG002|Treatment Period 1|Lost to Follow-up|0|||
164343564|NCT00395304|593635282|FG003|Treatment Period 1|Lost to Follow-up|1|||
163895217|NCT04778410|591989585|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
163895218|NCT04778410|591989586|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
163895219|NCT04778410|591989587|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
163900167|NCT03789110|592005624|FG000|Overall Study|Physician Decision|1|||
164277152|NCT00761527|593382795|FG000|Overall Study|Unknown reason|2|||
164277153|NCT02301624|593382798|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
164277154|NCT02301624|593382799|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
164277155|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
164277156|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
164277157|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Adverse Event|2|||
164277158|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Adverse Event|5|||
164277159|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Physician Decision|3|||
164277160|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Physician Decision|3|||
164277161|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Death|2|||
164277162|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Death|1|||
164277163|NCT02301624|593382798|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
164277164|NCT02301624|593382799|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
164277165|NCT00895310|593382800|FG000|Overall Study|Withdrawal by Subject|1|||
164277166|NCT03738618|593384666|FG000|Overall Study|Protocol deviation|23|||
164001366|NCT00474240|592368493|FG001|Overall Study|Adverse Event|0|||
164001367|NCT00474240|592368494|FG002|Overall Study|Adverse Event|9|||
164001368|NCT00474240|592368495|FG003|Overall Study|Adverse Event|14|||
164001369|NCT00474240|592368496|FG004|Overall Study|Adverse Event|5|||
164001370|NCT00474240|592368497|FG005|Overall Study|Adverse Event|16|||
164001371|NCT00474240|592368492|FG000|Overall Study|Removed due to lab value|0|||
164001372|NCT00474240|592368493|FG001|Overall Study|Removed due to lab value|0|||
164001373|NCT00474240|592368494|FG002|Overall Study|Removed due to lab value|0|||
164001374|NCT00474240|592368495|FG003|Overall Study|Removed due to lab value|0|||
164001375|NCT00474240|592368496|FG004|Overall Study|Removed due to lab value|0|||
164001376|NCT00474240|592368497|FG005|Overall Study|Removed due to lab value|1|||
164277167|NCT03738618|593384667|FG001|Overall Study|Protocol deviation|0|||
164277168|NCT03738618|593384666|FG000|Overall Study|Adverse Event|4|||
164277169|NCT03738618|593384667|FG001|Overall Study|Adverse Event|0|||
164277170|NCT03738618|593384666|FG000|Overall Study|Lost to Follow-up|2|||
164277171|NCT03738618|593384667|FG001|Overall Study|Lost to Follow-up|0|||
164001377|NCT00502840|592368498|FG000|Overall Study|Adverse Event|5|||
164001378|NCT00502840|592368498|FG000|Overall Study|Additional or changed therapy|48|||
164277172|NCT03738618|593384666|FG000|Overall Study|Randomization failure|1|||
164277173|NCT03738618|593384667|FG001|Overall Study|Randomization failure|0|||
164277174|NCT03738618|593384666|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
164277175|NCT03738618|593384667|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
164001379|NCT00502840|592368498|FG000|Overall Study|Lack of Efficacy|11|||
164001380|NCT00502840|592368498|FG000|Overall Study|Protocol Violation|4|||
164001381|NCT00502840|592368498|FG000|Overall Study|Withdrawal by Subject|5|||
164001382|NCT00502840|592368498|FG000|Overall Study|Lost to Follow-up|6|||
164001383|NCT00502840|592368498|FG000|Overall Study|Administrative problems|1|||
164001384|NCT00502840|592368498|FG000|Overall Study|Other|20|||
164001385|NCT02786901|592368499|FG000|Overall Study|Adverse Event|1|||
164001386|NCT02786901|592368500|FG001|Overall Study|Adverse Event|1|||
164001387|NCT02786901|592368501|FG002|Overall Study|Adverse Event|2|||
164001388|NCT02786901|592368499|FG000|Overall Study|Physician Decision|1|||
164001389|NCT02786901|592368500|FG001|Overall Study|Physician Decision|0|||
164001390|NCT02786901|592368501|FG002|Overall Study|Physician Decision|0|||
164001391|NCT02786901|592368499|FG000|Overall Study|Rescue Therapy Use|71|||
164001392|NCT02786901|592368500|FG001|Overall Study|Rescue Therapy Use|49|||
164001393|NCT02786901|592368501|FG002|Overall Study|Rescue Therapy Use|33|||
164085978|NCT03611309|592678608|FG001|Overall Study|Physician Decision|2|||
164277176|NCT03738618|593384666|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
164277177|NCT03738618|593384667|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
164277178|NCT00801229|593384674|FG000|Signed Consent|Withdrawal by Subject|2|||
164277179|NCT00801229|593384675|FG001|Signed Consent|Withdrawal by Subject|2|||
164277180|NCT00801229|593384674|FG000|Signed Consent|Found Ineligible|1|||
164277181|NCT00801229|593384675|FG001|Signed Consent|Found Ineligible|1|||
164277182|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
164277183|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
164277184|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
164277185|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
164277186|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
164277187|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
164277188|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
164277189|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
164277190|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
164277191|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
164277192|NCT00801229|593384674|FG000|Received Study Drug/Placebo|Adverse Event|1|||
164277193|NCT00801229|593384675|FG001|Received Study Drug/Placebo|Adverse Event|1|||
164277194|NCT02950480|593384678|FG000|Overall Study|Withdrawal by Subject|1|||
164277195|NCT02950480|593384679|FG001|Overall Study|Withdrawal by Subject|0|||
164277196|NCT01363661|593384680|FG000|Overall Study|Adverse Event|9|||
164277197|NCT01363661|593384681|FG001|Overall Study|Adverse Event|2|||
164277198|NCT01363661|593384680|FG000|Overall Study|Withdrawal by Subject|1|||
164277199|NCT01363661|593384681|FG001|Overall Study|Withdrawal by Subject|1|||
164277200|NCT01363661|593384680|FG000|Overall Study|Protocol Violation|1|||
164277201|NCT01363661|593384681|FG001|Overall Study|Protocol Violation|0|||
164277202|NCT01363661|593384680|FG000|Overall Study|Lost to Follow-up|3|||
164277203|NCT01363661|593384681|FG001|Overall Study|Lost to Follow-up|1|||
164277204|NCT00705367|593384682|FG000|Long-term Extension Period|Adverse Event|2|||
164277205|NCT00705367|593384683|FG001|Long-term Extension Period|Adverse Event|0|||
164277206|NCT00705367|593384682|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
164277207|NCT00705367|593384683|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
164277208|NCT00705367|593384682|FG000|Long-term Extension Period|Lack of Efficacy|1|||
164277209|NCT00705367|593384683|FG001|Long-term Extension Period|Lack of Efficacy|0|||
164277210|NCT00705367|593384682|FG000|Long-term Extension Period|No longer met study criteria|1|||
164277211|NCT00705367|593384683|FG001|Long-term Extension Period|No longer met study criteria|0|||
164277212|NCT00705367|593384682|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
164277213|NCT00705367|593384683|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
164277214|NCT01959139|593384684|FG000|Phase II|Disease progression|0|||
164277215|NCT01959139|593384685|FG001|Phase II|Disease progression|0|||
164277216|NCT01959139|593384686|FG002|Phase II|Disease progression|26|||
164277217|NCT01959139|593384687|FG003|Phase II|Disease progression|34|||
164277218|NCT01959139|593384684|FG000|Phase II|Adverse Event|0|||
164277219|NCT01959139|593384685|FG001|Phase II|Adverse Event|0|||
164277220|NCT01959139|593384686|FG002|Phase II|Adverse Event|10|||
164277221|NCT01959139|593384687|FG003|Phase II|Adverse Event|11|||
164277222|NCT01959139|593384684|FG000|Phase II|Patient Refusal|0|||
164277223|NCT01959139|593384685|FG001|Phase II|Patient Refusal|0|||
164277224|NCT01959139|593384686|FG002|Phase II|Patient Refusal|5|||
164277225|NCT01959139|593384687|FG003|Phase II|Patient Refusal|4|||
164277226|NCT01959139|593384684|FG000|Phase II|Death|0|||
164277227|NCT01959139|593384685|FG001|Phase II|Death|0|||
164277228|NCT01959139|593384686|FG002|Phase II|Death|3|||
164277229|NCT01959139|593384687|FG003|Phase II|Death|1|||
164277230|NCT01959139|593384684|FG000|Phase II|Other/Unknown|0|||
164277231|NCT01959139|593384685|FG001|Phase II|Other/Unknown|0|||
164277232|NCT01959139|593384686|FG002|Phase II|Other/Unknown|8|||
164277233|NCT01959139|593384687|FG003|Phase II|Other/Unknown|5|||
164277234|NCT01959139|593384684|FG000|Phase II|On treatment|0|||
164277235|NCT01959139|593384685|FG001|Phase II|On treatment|0|||
164277236|NCT01959139|593384686|FG002|Phase II|On treatment|4|||
164277237|NCT01959139|593384687|FG003|Phase II|On treatment|0|||
164277238|NCT02255461|593384690|FG000|Overall Study|Adverse Event|0|||
164277239|NCT02255461|593384691|FG001|Overall Study|Adverse Event|1|||
164277240|NCT02255461|593384692|FG002|Overall Study|Adverse Event|0|||
164277241|NCT02255461|593384693|FG003|Overall Study|Adverse Event|0|||
164277242|NCT02255461|593384694|FG004|Overall Study|Adverse Event|1|||
164277243|NCT02255461|593384690|FG000|Overall Study|Withdrawal by Subject|0|||
164277244|NCT02255461|593384691|FG001|Overall Study|Withdrawal by Subject|0|||
164277245|NCT02255461|593384692|FG002|Overall Study|Withdrawal by Subject|1|||
164277246|NCT02255461|593384693|FG003|Overall Study|Withdrawal by Subject|0|||
164277247|NCT02255461|593384694|FG004|Overall Study|Withdrawal by Subject|1|||
164277248|NCT02255461|593384690|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
164277249|NCT02255461|593384691|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
164277250|NCT02255461|593384692|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
164277251|NCT02255461|593384693|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
164277252|NCT02255461|593384694|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
164277253|NCT01378325|593384695|FG000|Overall Study|Protocol Violation|0|||
164277254|NCT01378325|593384696|FG001|Overall Study|Protocol Violation|1|||
164277255|NCT01559675|593384697|FG000|Overall Study|Protocol Violation|1|||
164277256|NCT01559675|593384698|FG001|Overall Study|Protocol Violation|2|||
164277257|NCT01559675|593384697|FG000|Overall Study|2nd operation on same patient excluded|14|||
164277258|NCT01559675|593384698|FG001|Overall Study|2nd operation on same patient excluded|12|||
164277259|NCT01496469|593384699|FG000|Overall Study|Adverse Event|1|||
164277260|NCT01496469|593384700|FG001|Overall Study|Adverse Event|0|||
164277261|NCT01496469|593384699|FG000|Overall Study|Protocol Violation|2|||
164277262|NCT01496469|593384700|FG001|Overall Study|Protocol Violation|0|||
164277263|NCT01496469|593384699|FG000|Overall Study|Lost to Follow-up|1|||
164277264|NCT01496469|593384700|FG001|Overall Study|Lost to Follow-up|1|||
164277265|NCT01496469|593384699|FG000|Overall Study|Withdrawal by Subject|4|||
164277266|NCT01496469|593384700|FG001|Overall Study|Withdrawal by Subject|4|||
164277267|NCT01496469|593384699|FG000|Overall Study|BP exceeds protocol limits|1|||
164277268|NCT01496469|593384700|FG001|Overall Study|BP exceeds protocol limits|2|||
164277269|NCT01496469|593384699|FG000|Overall Study|Other|1|||
164277270|NCT01496469|593384700|FG001|Overall Study|Other|1|||
164277271|NCT01357551|593384703|FG000|Overall Study|Withdrawal by Subject|6|||
164277272|NCT01357551|593384704|FG001|Overall Study|Withdrawal by Subject|4|||
164277273|NCT01357551|593384703|FG000|Overall Study|Death|0|||
164277274|NCT01357551|593384704|FG001|Overall Study|Death|1|||
164277275|NCT01357551|593384703|FG000|Overall Study|Lost to Follow-up|16|||
164277276|NCT01357551|593384704|FG001|Overall Study|Lost to Follow-up|6|||
164277277|NCT02219334|593384705|FG000|Overall Study|Withdrawal by Subject|1|||
164277278|NCT02219334|593384706|FG001|Overall Study|Withdrawal by Subject|0|||
164277279|NCT02219334|593384705|FG000|Overall Study|Protocol Violation|7|||
164277280|NCT02219334|593384706|FG001|Overall Study|Protocol Violation|3|||
164277281|NCT00891228|593384710|FG000|Overall Study|Adverse Event|0|||
164277282|NCT00891228|593384711|FG001|Overall Study|Adverse Event|2|||
164277283|NCT00891228|593384712|FG002|Overall Study|Adverse Event|3|||
164277284|NCT00891228|593384710|FG000|Overall Study|Withdrawal by Subject|2|||
164277285|NCT00891228|593384711|FG001|Overall Study|Withdrawal by Subject|4|||
164277286|NCT00891228|593384712|FG002|Overall Study|Withdrawal by Subject|5|||
164277287|NCT00891228|593384710|FG000|Overall Study|Protocol Violation|3|||
164277288|NCT00891228|593384711|FG001|Overall Study|Protocol Violation|1|||
164277289|NCT00891228|593384712|FG002|Overall Study|Protocol Violation|2|||
164277290|NCT00891228|593384710|FG000|Overall Study|Physician Decision|2|||
164277291|NCT00891228|593384711|FG001|Overall Study|Physician Decision|1|||
164277292|NCT00891228|593384712|FG002|Overall Study|Physician Decision|0|||
164277293|NCT00891228|593384710|FG000|Overall Study|Lost to Follow-up|4|||
164277294|NCT00891228|593384711|FG001|Overall Study|Lost to Follow-up|4|||
164277295|NCT00891228|593384712|FG002|Overall Study|Lost to Follow-up|5|||
164277296|NCT00891228|593384710|FG000|Overall Study|Pregnancy|0|||
164277297|NCT00891228|593384711|FG001|Overall Study|Pregnancy|1|||
164277298|NCT00891228|593384712|FG002|Overall Study|Pregnancy|0|||
164277299|NCT00930553|593384717|FG000|Overall Study|Adverse Event|1|||
164277300|NCT00930553|593384717|FG000|Overall Study|Lack of Efficacy|7|||
164277301|NCT00930553|593384717|FG000|Overall Study|Physician Decision|39|||
164277302|NCT00930553|593384717|FG000|Overall Study|Protocol Violation|1|||
164277303|NCT00930553|593384717|FG000|Overall Study|Pregnancy|1|||
164277304|NCT00930553|593384717|FG000|Overall Study|Withdrawal by Subject|88|||
164277305|NCT00930553|593384717|FG000|Overall Study|Lost to Follow-up|25|||
164277306|NCT00930553|593384717|FG000|Overall Study|Death|9|||
164277307|NCT00930553|593384717|FG000|Overall Study|Study terminated by sponsor|24|||
164277308|NCT00930553|593384717|FG000|Overall Study|Other than specified above|28|||
164277309|NCT01964963|593384718|FG000|Overall Study|Case Report Forms Uncollected|888|||
164277310|NCT01964963|593384718|FG000|Overall Study|Protocol Deviation|50|||
164277311|NCT01964963|593384718|FG000|Overall Study|Data Reliability was not Assured|5|||
164277312|NCT01235234|593384719|FG000|Overall Study|Adverse Event|2|||
164277313|NCT01235234|593384720|FG001|Overall Study|Adverse Event|2|||
164277314|NCT01235234|593384721|FG002|Overall Study|Adverse Event|1|||
164277315|NCT03704688|593384730|FG000|Overall Study|Adverse Event|0|||
164277316|NCT03704688|593384731|FG001|Overall Study|Adverse Event|0|||
164277317|NCT03704688|593384732|FG002|Overall Study|Adverse Event|0|||
164277318|NCT03704688|593384733|FG003|Overall Study|Adverse Event|4|||
164277319|NCT03704688|593384734|FG004|Overall Study|Adverse Event|1|||
164277320|NCT03704688|593384735|FG005|Overall Study|Adverse Event|0|||
164277321|NCT03704688|593384730|FG000|Overall Study|Disease Progression|0|||
164277322|NCT03704688|593384731|FG001|Overall Study|Disease Progression|0|||
164277323|NCT03704688|593384732|FG002|Overall Study|Disease Progression|0|||
164277324|NCT03704688|593384733|FG003|Overall Study|Disease Progression|3|||
164277325|NCT03704688|593384734|FG004|Overall Study|Disease Progression|1|||
164277326|NCT03704688|593384735|FG005|Overall Study|Disease Progression|0|||
164277327|NCT03704688|593384730|FG000|Overall Study|Death|0|||
164277328|NCT03704688|593384731|FG001|Overall Study|Death|0|||
164277329|NCT03704688|593384732|FG002|Overall Study|Death|0|||
164277330|NCT03704688|593384733|FG003|Overall Study|Death|0|||
164277331|NCT03704688|593384734|FG004|Overall Study|Death|3|||
164277332|NCT03704688|593384735|FG005|Overall Study|Death|0|||
164277333|NCT00847886|593384737|FG000|Overall Study|Adverse Event|0|||
164277334|NCT00847886|593384738|FG001|Overall Study|Adverse Event|1|||
164277335|NCT00183625|593384739|FG000|Overall Study|Withdrawal by Subject|18|||
164277336|NCT00183625|593384740|FG001|Overall Study|Withdrawal by Subject|18|||
164277337|NCT00183625|593384741|FG002|Overall Study|Withdrawal by Subject|19|||
164277338|NCT00183625|593384742|FG003|Overall Study|Withdrawal by Subject|14|||
164277339|NCT00842543|593384745|FG000|Overall Study|Withdrawal by Subject|2|||
164277340|NCT00842543|593384746|FG001|Overall Study|Withdrawal by Subject|0|||
164277341|NCT00842543|593384747|FG002|Overall Study|Withdrawal by Subject|3|||
164277342|NCT00842543|593384748|FG003|Overall Study|Withdrawal by Subject|4|||
164277343|NCT01835158|593384750|FG000|Overall Study|Withdrawal by Subject|1|||
164277344|NCT01835158|593384751|FG001|Overall Study|Withdrawal by Subject|6|||
164277345|NCT00596830|593384752|FG000|Overall Study|Death|258|||
164277346|NCT00596830|593384753|FG001|Overall Study|Death|247|||
164277347|NCT00596830|593384752|FG000|Overall Study|Lost to Follow-up|7|||
164277348|NCT00596830|593384753|FG001|Overall Study|Lost to Follow-up|11|||
164277349|NCT00596830|593384752|FG000|Overall Study|Withdrawal by Subject|22|||
164277350|NCT00596830|593384753|FG001|Overall Study|Withdrawal by Subject|12|||
164277351|NCT00596830|593384752|FG000|Overall Study|Study terminated by sponsor|51|||
164277352|NCT00596830|593384753|FG001|Overall Study|Study terminated by sponsor|62|||
164277353|NCT00596830|593384752|FG000|Overall Study|Follow-up was discontinued|1|||
164277354|NCT00596830|593384753|FG001|Overall Study|Follow-up was discontinued|0|||
164277355|NCT00596830|593384752|FG000|Overall Study|Randomized but not treated|3|||
164277356|NCT00596830|593384753|FG001|Overall Study|Randomized but not treated|7|||
164277357|NCT00887926|593384754|FG000|Overall Study|Withdrawal by Subject|0|||
164277358|NCT00887926|593384755|FG001|Overall Study|Withdrawal by Subject|1|||
164277359|NCT00887926|593384756|FG002|Overall Study|Withdrawal by Subject|0|||
164277360|NCT00887926|593384757|FG003|Overall Study|Withdrawal by Subject|0|||
164277361|NCT00293020|593384763|FG000|Overall Study|Withdrawal by Subject|34|||
164277362|NCT00293020|593384763|FG000|Overall Study|Adverse Event|30|||
164277363|NCT00293020|593384763|FG000|Overall Study|Death|32|||
164277364|NCT00293020|593384763|FG000|Overall Study|Lack of Efficacy|12|||
164277365|NCT00293020|593384763|FG000|Overall Study|Lost to Follow-up|4|||
164277366|NCT00293020|593384763|FG000|Overall Study|Protocol Violation|6|||
164277367|NCT00293020|593384763|FG000|Overall Study|Physician Decision|21|||
164277368|NCT00293020|593384763|FG000|Overall Study|Other Reason|22|||
164277369|NCT00293020|593384763|FG000|Overall Study|No dose taken|1|||
164277370|NCT01336023|593384764|FG000|Week 0 to Week 26|Adverse Event|8|||
164277371|NCT01336023|593384765|FG001|Week 0 to Week 26|Adverse Event|10|||
164277372|NCT01336023|593384766|FG002|Week 0 to Week 26|Adverse Event|24|||
164277373|NCT01336023|593384764|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
164277374|NCT01336023|593384765|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
164277375|NCT01336023|593384766|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
164277376|NCT01336023|593384764|FG000|Week 0 to Week 26|Protocol Violation|1|||
164277377|NCT01336023|593384765|FG001|Week 0 to Week 26|Protocol Violation|2|||
164277378|NCT01336023|593384766|FG002|Week 0 to Week 26|Protocol Violation|0|||
164277379|NCT01336023|593384764|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
164277380|NCT01336023|593384765|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
164277381|NCT01336023|593384766|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
164277382|NCT01336023|593384764|FG000|Week 0 to Week 26|Unclassified|5|||
164277383|NCT01336023|593384765|FG001|Week 0 to Week 26|Unclassified|16|||
164277384|NCT01336023|593384766|FG002|Week 0 to Week 26|Unclassified|9|||
164277385|NCT01336023|593384764|FG000|Week 27 to 52|Adverse Event|1|||
164277386|NCT01336023|593384765|FG001|Week 27 to 52|Adverse Event|5|||
164277387|NCT01336023|593384766|FG002|Week 27 to 52|Adverse Event|2|||
164277388|NCT01336023|593384764|FG000|Week 27 to 52|Protocol Violation|0|||
164277389|NCT01336023|593384765|FG001|Week 27 to 52|Protocol Violation|2|||
164277390|NCT01336023|593384766|FG002|Week 27 to 52|Protocol Violation|1|||
164277391|NCT01336023|593384764|FG000|Week 27 to 52|Withdrawal Criteria|14|||
164277392|NCT01336023|593384765|FG001|Week 27 to 52|Withdrawal Criteria|19|||
164277393|NCT01336023|593384766|FG002|Week 27 to 52|Withdrawal Criteria|16|||
164277394|NCT01336023|593384764|FG000|Week 27 to 52|Unclassified|13|||
164277395|NCT01336023|593384765|FG001|Week 27 to 52|Unclassified|18|||
164277396|NCT01336023|593384766|FG002|Week 27 to 52|Unclassified|9|||
164277397|NCT01894022|593384779|FG000|Overall Study|Death|1|||
164277398|NCT01894022|593384780|FG001|Overall Study|Death|0|||
163895220|NCT04778410|591989588|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
163895221|NCT04778410|591989589|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
163895222|NCT04778410|591989590|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
163895223|NCT04778410|591989585|FG000|Phase 2 Period|Withdrew Consent|0|||
163895224|NCT04778410|591989586|FG001|Phase 2 Period|Withdrew Consent|0|||
163895225|NCT04778410|591989587|FG002|Phase 2 Period|Withdrew Consent|0|||
163895226|NCT04778410|591989588|FG003|Phase 2 Period|Withdrew Consent|0|||
163895227|NCT04778410|591989589|FG004|Phase 2 Period|Withdrew Consent|2|||
163895228|NCT04778410|591989590|FG005|Phase 2 Period|Withdrew Consent|0|||
163895229|NCT05422885|591989597|FG000|Overall Study|Lost to Follow-up|1|||
163895230|NCT05422885|591989597|FG000|Overall Study|Withdrawal by Subject|2|||
163895231|NCT04084574|591989598|FG000|Overall Study|Lost to Follow-up|1|||
163895232|NCT04084574|591989599|FG001|Overall Study|Lost to Follow-up|0|||
164277399|NCT01894022|593384779|FG000|Overall Study|Adverse Event, non-fatal|1|||
164277400|NCT01894022|593384780|FG001|Overall Study|Adverse Event, non-fatal|0|||
164277401|NCT01894022|593384779|FG000|Overall Study|Study Closed/terminated|7|||
164277402|NCT01894022|593384780|FG001|Overall Study|Study Closed/terminated|10|||
164277403|NCT02202538|593384782|FG000|Overall Study|Withdrawal by Subject|5|||
164277404|NCT02202538|593384782|FG000|Overall Study|Did not meet all inclusion criteria|2|||
164277405|NCT02202538|593384782|FG000|Overall Study|Investigator Decision|1|||
164343565|NCT00395304|593635283|FG004|Treatment Period 1|Lost to Follow-up|0|||
164343566|NCT00395304|593635284|FG005|Treatment Period 1|Lost to Follow-up|1|||
164343567|NCT00395304|593635279|FG000|Treatment Period 1|Physician Decision|0|||
164343568|NCT00395304|593635280|FG001|Treatment Period 1|Physician Decision|1|||
164343569|NCT00395304|593635281|FG002|Treatment Period 1|Physician Decision|0|||
164343570|NCT00395304|593635282|FG003|Treatment Period 1|Physician Decision|0|||
164343571|NCT00395304|593635283|FG004|Treatment Period 1|Physician Decision|0|||
164343572|NCT00395304|593635284|FG005|Treatment Period 1|Physician Decision|0|||
164343573|NCT00395304|593635279|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164343574|NCT00395304|593635280|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164343575|NCT00395304|593635281|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164343576|NCT00395304|593635282|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164343577|NCT00395304|593635283|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164343578|NCT00395304|593635284|FG005|Treatment Period 2|Withdrawal by Subject|2|||
164343579|NCT00395304|593635279|FG000|Treatment Period 2|Lost to Follow-up|0|||
164343580|NCT00395304|593635280|FG001|Treatment Period 2|Lost to Follow-up|3|||
164343581|NCT00395304|593635281|FG002|Treatment Period 2|Lost to Follow-up|0|||
164343582|NCT00395304|593635282|FG003|Treatment Period 2|Lost to Follow-up|0|||
164343583|NCT00395304|593635283|FG004|Treatment Period 2|Lost to Follow-up|0|||
164343584|NCT00395304|593635284|FG005|Treatment Period 2|Lost to Follow-up|0|||
164343585|NCT00395304|593635279|FG000|Treatment Period 2|Physician Decision|0|||
164343586|NCT00395304|593635280|FG001|Treatment Period 2|Physician Decision|0|||
164343587|NCT00395304|593635281|FG002|Treatment Period 2|Physician Decision|1|||
164343588|NCT00395304|593635282|FG003|Treatment Period 2|Physician Decision|0|||
164343589|NCT00395304|593635283|FG004|Treatment Period 2|Physician Decision|0|||
164343590|NCT00395304|593635284|FG005|Treatment Period 2|Physician Decision|0|||
164343591|NCT00395304|593635279|FG000|Treatment Period 2|Other|0|||
164343592|NCT00395304|593635280|FG001|Treatment Period 2|Other|1|||
164343593|NCT00395304|593635281|FG002|Treatment Period 2|Other|0|||
164343594|NCT00395304|593635282|FG003|Treatment Period 2|Other|0|||
164343595|NCT00395304|593635283|FG004|Treatment Period 2|Other|0|||
164343596|NCT00395304|593635284|FG005|Treatment Period 2|Other|0|||
164343597|NCT00395304|593635279|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164343598|NCT00395304|593635280|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164343599|NCT00395304|593635281|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164343600|NCT00395304|593635282|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164343601|NCT00395304|593635283|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164343602|NCT00395304|593635284|FG005|Treatment Period 3|Withdrawal by Subject|1|||
164343603|NCT00395304|593635279|FG000|Treatment Period 3|Lost to Follow-up|1|||
164343604|NCT00395304|593635280|FG001|Treatment Period 3|Lost to Follow-up|1|||
164343605|NCT00395304|593635281|FG002|Treatment Period 3|Lost to Follow-up|0|||
164343606|NCT00395304|593635282|FG003|Treatment Period 3|Lost to Follow-up|0|||
164343607|NCT00395304|593635283|FG004|Treatment Period 3|Lost to Follow-up|0|||
164343608|NCT00395304|593635284|FG005|Treatment Period 3|Lost to Follow-up|0|||
164343609|NCT00395304|593635279|FG000|Treatment Period 3|Physician Decision|0|||
164343610|NCT00395304|593635280|FG001|Treatment Period 3|Physician Decision|1|||
164343611|NCT00395304|593635281|FG002|Treatment Period 3|Physician Decision|0|||
164343612|NCT00395304|593635282|FG003|Treatment Period 3|Physician Decision|0|||
164343613|NCT00395304|593635283|FG004|Treatment Period 3|Physician Decision|0|||
164343614|NCT00395304|593635284|FG005|Treatment Period 3|Physician Decision|0|||
164343615|NCT00395304|593635279|FG000|Treatment Period 3|Other|0|||
164343616|NCT00395304|593635280|FG001|Treatment Period 3|Other|0|||
164343617|NCT00395304|593635281|FG002|Treatment Period 3|Other|0|||
164343618|NCT00395304|593635282|FG003|Treatment Period 3|Other|1|||
164343619|NCT00395304|593635283|FG004|Treatment Period 3|Other|0|||
164343620|NCT00395304|593635284|FG005|Treatment Period 3|Other|0|||
164343621|NCT00980057|593635293|FG000|Overall Study|Death|13|||
164343622|NCT00980057|593635294|FG001|Overall Study|Death|3|||
164343623|NCT00980057|593635293|FG000|Overall Study|Adverse Event|0|||
164343624|NCT00980057|593635294|FG001|Overall Study|Adverse Event|1|||
164343625|NCT00980057|593635293|FG000|Overall Study|Physician Decision|4|||
164343626|NCT00980057|593635294|FG001|Overall Study|Physician Decision|0|||
164343627|NCT00980057|593635293|FG000|Overall Study|Lost to Follow-up|1|||
164343628|NCT00980057|593635294|FG001|Overall Study|Lost to Follow-up|0|||
164343629|NCT00980057|593635293|FG000|Overall Study|Withdrawal by Subject|1|||
164343630|NCT00980057|593635294|FG001|Overall Study|Withdrawal by Subject|1|||
164343631|NCT02732119|593635295|FG000|Phase I|Adverse Event|1|||
164343632|NCT02732119|593635296|FG001|Phase I|Adverse Event|3|||
164343633|NCT02732119|593635297|FG002|Phase I|Adverse Event|1|||
164343634|NCT02732119|593635298|FG003|Phase I|Adverse Event|0|||
164343635|NCT02732119|593635299|FG004|Phase I|Adverse Event|0|||
164343636|NCT02732119|593635295|FG000|Phase I|Progressive disease|7|||
164343637|NCT02732119|593635296|FG001|Phase I|Progressive disease|3|||
164343638|NCT02732119|593635297|FG002|Phase I|Progressive disease|2|||
164343639|NCT02732119|593635298|FG003|Phase I|Progressive disease|0|||
164343640|NCT02732119|593635299|FG004|Phase I|Progressive disease|0|||
164343641|NCT02732119|593635295|FG000|Phase I|Protocol deviation|0|||
164343642|NCT02732119|593635296|FG001|Phase I|Protocol deviation|1|||
164343643|NCT02732119|593635297|FG002|Phase I|Protocol deviation|0|||
164277406|NCT04496453|593384783|FG000|Overall Study|Lost to Follow-up|6|||
164277407|NCT01846741|593384784|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
164277408|NCT01853878|593384785|FG000|Overall Study|Recurrence|2|||
164277409|NCT01853878|593384786|FG001|Overall Study|Recurrence|0|||
164277410|NCT01853878|593384785|FG000|Overall Study|Adverse Event|2|||
164277411|NCT01853878|593384786|FG001|Overall Study|Adverse Event|0|||
164277412|NCT01853878|593384785|FG000|Overall Study|Withdrawal by Subject|3|||
164277413|NCT01853878|593384786|FG001|Overall Study|Withdrawal by Subject|1|||
164277414|NCT01853878|593384785|FG000|Overall Study|Migrated/moved from the study area|1|||
164277415|NCT01853878|593384786|FG001|Overall Study|Migrated/moved from the study area|0|||
164277416|NCT01853878|593384785|FG000|Overall Study|Other|55|||
164277417|NCT01853878|593384786|FG001|Overall Study|Other|43|||
164277418|NCT01361178|593384787|FG000|Overall Study|Death|13|||
164277419|NCT01361178|593384788|FG001|Overall Study|Death|0|||
164277420|NCT00767819|593384791|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
164277421|NCT00767819|593384792|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
164277422|NCT00767819|593384793|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164343644|NCT02732119|593635298|FG003|Phase I|Protocol deviation|0|||
164277423|NCT00767819|593384791|FG000|Overall Study|Withdrawal by Subject|1|||
164277424|NCT00767819|593384792|FG001|Overall Study|Withdrawal by Subject|1|||
164277425|NCT00767819|593384793|FG002|Overall Study|Withdrawal by Subject|0|||
164277426|NCT00767819|593384791|FG000|Overall Study|Administrative problems|0|||
164277427|NCT00767819|593384792|FG001|Overall Study|Administrative problems|1|||
164343645|NCT02732119|593635299|FG004|Phase I|Protocol deviation|0|||
164343646|NCT02732119|593635295|FG000|Phase I|Physician Decision|0|||
164343647|NCT02732119|593635296|FG001|Phase I|Physician Decision|3|||
164343648|NCT02732119|593635297|FG002|Phase I|Physician Decision|4|||
164343649|NCT02732119|593635298|FG003|Phase I|Physician Decision|0|||
164343650|NCT02732119|593635299|FG004|Phase I|Physician Decision|0|||
164277428|NCT00767819|593384793|FG002|Overall Study|Administrative problems|0|||
164343651|NCT02732119|593635295|FG000|Phase II|Adverse Event|0|||
164277429|NCT00767819|593384791|FG000|Overall Study|Death|2|||
164343652|NCT02732119|593635296|FG001|Phase II|Adverse Event|0|||
164343653|NCT02732119|593635297|FG002|Phase II|Adverse Event|0|||
164277430|NCT00767819|593384792|FG001|Overall Study|Death|3|||
164277431|NCT00767819|593384793|FG002|Overall Study|Death|0|||
164277432|NCT00767819|593384791|FG000|Overall Study|Adverse Event|2|||
164277433|NCT00767819|593384792|FG001|Overall Study|Adverse Event|0|||
164277434|NCT00767819|593384793|FG002|Overall Study|Adverse Event|0|||
164277435|NCT00767819|593384791|FG000|Overall Study|Abnormal lab values|1|||
164277436|NCT00767819|593384792|FG001|Overall Study|Abnormal lab values|0|||
164277437|NCT00767819|593384793|FG002|Overall Study|Abnormal lab values|0|||
164277438|NCT00767819|593384791|FG000|Overall Study|Lost to Follow-up|1|||
164277439|NCT00767819|593384792|FG001|Overall Study|Lost to Follow-up|0|||
164277440|NCT00767819|593384793|FG002|Overall Study|Lost to Follow-up|0|||
164277441|NCT04294147|593384794|FG000|Overall Study|Protocol Violation|2|||
164277442|NCT04294147|593384795|FG001|Overall Study|Protocol Violation|0|||
164277443|NCT03916081|593384800|FG000|Overall Study|Adverse Event|1|||
164277444|NCT03916081|593384801|FG001|Overall Study|Adverse Event|0|||
164277445|NCT03916081|593384802|FG002|Overall Study|Adverse Event|0|||
164277446|NCT03916081|593384800|FG000|Overall Study|Physician Decision|0|||
163895233|NCT04084574|591989598|FG000|Overall Study|Physician Decision|1|||
164277447|NCT03916081|593384801|FG001|Overall Study|Physician Decision|0|||
164277448|NCT03916081|593384802|FG002|Overall Study|Physician Decision|1|||
164277449|NCT03916081|593384800|FG000|Overall Study|Lost to Follow-up|0|||
164277450|NCT03916081|593384801|FG001|Overall Study|Lost to Follow-up|1|||
164277451|NCT03916081|593384802|FG002|Overall Study|Lost to Follow-up|0|||
164277452|NCT03916081|593384800|FG000|Overall Study|Withdrawal by Subject|3|||
164277453|NCT03916081|593384801|FG001|Overall Study|Withdrawal by Subject|0|||
164277454|NCT03916081|593384802|FG002|Overall Study|Withdrawal by Subject|1|||
164277455|NCT03916081|593384800|FG000|Overall Study|Worsening of AD|0|||
164277456|NCT03916081|593384801|FG001|Overall Study|Worsening of AD|0|||
164277457|NCT03916081|593384802|FG002|Overall Study|Worsening of AD|1|||
164277458|NCT01371305|593384806|FG000|Overall Study|Adverse Event|0|||
164277459|NCT01371305|593384807|FG001|Overall Study|Adverse Event|0|||
164277460|NCT01371305|593384808|FG002|Overall Study|Adverse Event|0|||
164277461|NCT01371305|593384809|FG003|Overall Study|Adverse Event|2|||
164277462|NCT01371305|593384810|FG004|Overall Study|Adverse Event|1|||
164277463|NCT01371305|593384811|FG005|Overall Study|Adverse Event|0|||
164277464|NCT01371305|593384806|FG000|Overall Study|Study terminated by sponsor|0|||
164277465|NCT01371305|593384807|FG001|Overall Study|Study terminated by sponsor|0|||
164277466|NCT01371305|593384808|FG002|Overall Study|Study terminated by sponsor|0|||
164277467|NCT01371305|593384809|FG003|Overall Study|Study terminated by sponsor|0|||
164277468|NCT01371305|593384810|FG004|Overall Study|Study terminated by sponsor|3|||
164277469|NCT01371305|593384811|FG005|Overall Study|Study terminated by sponsor|1|||
164277470|NCT01371305|593384806|FG000|Overall Study|Subject request|0|||
164277471|NCT01371305|593384807|FG001|Overall Study|Subject request|0|||
164277472|NCT01371305|593384808|FG002|Overall Study|Subject request|0|||
164277473|NCT01371305|593384809|FG003|Overall Study|Subject request|0|||
164277474|NCT01371305|593384810|FG004|Overall Study|Subject request|0|||
164277475|NCT01371305|593384811|FG005|Overall Study|Subject request|1|||
164277476|NCT04038567|593384812|FG000|Overall Study|Lost to Follow-up|6|||
164277477|NCT04038567|593384813|FG001|Overall Study|Lost to Follow-up|4|||
164277478|NCT04038567|593384814|FG002|Overall Study|Lost to Follow-up|5|||
164277479|NCT04038567|593384815|FG003|Overall Study|Lost to Follow-up|4|||
164277480|NCT04038567|593384816|FG004|Overall Study|Lost to Follow-up|6|||
164277481|NCT04038567|593384817|FG005|Overall Study|Lost to Follow-up|4|||
164277482|NCT04038567|593384818|FG006|Overall Study|Lost to Follow-up|4|||
164277483|NCT04038567|593384819|FG007|Overall Study|Lost to Follow-up|1|||
164277484|NCT04038567|593384812|FG000|Overall Study|Withdrawal by Subject|2|||
164277485|NCT04038567|593384813|FG001|Overall Study|Withdrawal by Subject|1|||
164277486|NCT04038567|593384814|FG002|Overall Study|Withdrawal by Subject|1|||
164277487|NCT04038567|593384815|FG003|Overall Study|Withdrawal by Subject|1|||
164277488|NCT04038567|593384816|FG004|Overall Study|Withdrawal by Subject|4|||
164277489|NCT04038567|593384817|FG005|Overall Study|Withdrawal by Subject|1|||
164277490|NCT04038567|593384818|FG006|Overall Study|Withdrawal by Subject|1|||
164277491|NCT04038567|593384819|FG007|Overall Study|Withdrawal by Subject|1|||
164277492|NCT04038567|593384812|FG000|Overall Study|missed survey window|1|||
164277493|NCT04038567|593384813|FG001|Overall Study|missed survey window|2|||
164277494|NCT04038567|593384814|FG002|Overall Study|missed survey window|0|||
164277495|NCT04038567|593384815|FG003|Overall Study|missed survey window|0|||
164277496|NCT04038567|593384816|FG004|Overall Study|missed survey window|1|||
164277497|NCT04038567|593384817|FG005|Overall Study|missed survey window|1|||
164277498|NCT04038567|593384818|FG006|Overall Study|missed survey window|2|||
164277499|NCT04038567|593384819|FG007|Overall Study|missed survey window|2|||
164277500|NCT04038567|593384812|FG000|Overall Study|technical issues|0|||
164277501|NCT04038567|593384813|FG001|Overall Study|technical issues|0|||
164277502|NCT04038567|593384814|FG002|Overall Study|technical issues|0|||
164277503|NCT04038567|593384815|FG003|Overall Study|technical issues|0|||
164277504|NCT04038567|593384816|FG004|Overall Study|technical issues|0|||
164277505|NCT04038567|593384817|FG005|Overall Study|technical issues|0|||
164277506|NCT04038567|593384818|FG006|Overall Study|technical issues|1|||
164277507|NCT04038567|593384819|FG007|Overall Study|technical issues|0|||
164277508|NCT04038567|593384812|FG000|Overall Study|Medical issues (i.e., illness)|0|||
164277509|NCT04038567|593384813|FG001|Overall Study|Medical issues (i.e., illness)|1|||
164277510|NCT04038567|593384814|FG002|Overall Study|Medical issues (i.e., illness)|2|||
164277511|NCT04038567|593384815|FG003|Overall Study|Medical issues (i.e., illness)|1|||
164277512|NCT04038567|593384816|FG004|Overall Study|Medical issues (i.e., illness)|1|||
164277513|NCT04038567|593384817|FG005|Overall Study|Medical issues (i.e., illness)|1|||
164277514|NCT04038567|593384818|FG006|Overall Study|Medical issues (i.e., illness)|0|||
164277515|NCT04038567|593384819|FG007|Overall Study|Medical issues (i.e., illness)|0|||
164277516|NCT04038567|593384812|FG000|Overall Study|Death|0|||
164277517|NCT04038567|593384813|FG001|Overall Study|Death|0|||
164277518|NCT04038567|593384814|FG002|Overall Study|Death|0|||
164277519|NCT04038567|593384815|FG003|Overall Study|Death|1|||
164277520|NCT04038567|593384816|FG004|Overall Study|Death|1|||
164277521|NCT04038567|593384817|FG005|Overall Study|Death|0|||
164277522|NCT04038567|593384818|FG006|Overall Study|Death|0|||
164277523|NCT04038567|593384819|FG007|Overall Study|Death|1|||
164277524|NCT02726022|593384820|FG000|Overall Study|Adverse Event|14|||
164277525|NCT02726022|593384820|FG000|Overall Study|Treatment Failure|8|||
164277526|NCT02726022|593384820|FG000|Overall Study|Poor Compliance|13|||
164277527|NCT02726022|593384820|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
164277528|NCT00235716|593384821|FG000|Overall Study|Death|26|||
164277529|NCT00235716|593384822|FG001|Overall Study|Death|39|||
164277530|NCT00235716|593384823|FG002|Overall Study|Death|32|||
164277531|NCT00235716|593384824|FG003|Overall Study|Death|31|||
164277532|NCT00235716|593384821|FG000|Overall Study|Withdrawal by Subject|23|||
164277533|NCT00235716|593384822|FG001|Overall Study|Withdrawal by Subject|19|||
164277534|NCT00235716|593384823|FG002|Overall Study|Withdrawal by Subject|17|||
164277535|NCT00235716|593384824|FG003|Overall Study|Withdrawal by Subject|18|||
164277536|NCT00235716|593384821|FG000|Overall Study|Lost to Follow-up|12|||
164277537|NCT00235716|593384822|FG001|Overall Study|Lost to Follow-up|7|||
164277538|NCT00235716|593384823|FG002|Overall Study|Lost to Follow-up|14|||
164277539|NCT00235716|593384824|FG003|Overall Study|Lost to Follow-up|10|||
164277540|NCT00235716|593384821|FG000|Overall Study|Adverse Event|1|||
164277541|NCT00235716|593384822|FG001|Overall Study|Adverse Event|1|||
164277542|NCT00235716|593384823|FG002|Overall Study|Adverse Event|1|||
164277543|NCT00235716|593384824|FG003|Overall Study|Adverse Event|0|||
164277544|NCT00235716|593384821|FG000|Overall Study|Physician Decision|0|||
164277545|NCT00235716|593384822|FG001|Overall Study|Physician Decision|1|||
164277546|NCT00235716|593384823|FG002|Overall Study|Physician Decision|1|||
164277547|NCT00235716|593384824|FG003|Overall Study|Physician Decision|3|||
164277548|NCT02999633|593384825|FG000|Overall Study|Adverse Event|2|||
164277549|NCT02999633|593384825|FG000|Overall Study|Progressive disease|12|||
164277550|NCT01545050|593384826|FG000|Overall Study|Lack of Efficacy|0|||
164277551|NCT01545050|593384827|FG001|Overall Study|Lack of Efficacy|0|||
164277552|NCT01545050|593384828|FG002|Overall Study|Lack of Efficacy|0|||
164277553|NCT01545050|593384829|FG003|Overall Study|Lack of Efficacy|3|||
164277554|NCT01545050|593384830|FG004|Overall Study|Lack of Efficacy|2|||
164277555|NCT01545050|593384826|FG000|Overall Study|Adverse Event|1|||
164277556|NCT01545050|593384827|FG001|Overall Study|Adverse Event|1|||
164277557|NCT01545050|593384828|FG002|Overall Study|Adverse Event|2|||
164277558|NCT01545050|593384829|FG003|Overall Study|Adverse Event|2|||
164277559|NCT01545050|593384830|FG004|Overall Study|Adverse Event|0|||
164277560|NCT01545050|593384826|FG000|Overall Study|Discontinued study treatment|1|||
164343654|NCT02732119|593635298|FG003|Phase II|Adverse Event|3|||
164343655|NCT02732119|593635299|FG004|Phase II|Adverse Event|3|||
164343656|NCT02732119|593635295|FG000|Phase II|Death|0|||
164343657|NCT02732119|593635296|FG001|Phase II|Death|0|||
164343658|NCT02732119|593635297|FG002|Phase II|Death|0|||
164343659|NCT02732119|593635298|FG003|Phase II|Death|1|||
164343660|NCT02732119|593635299|FG004|Phase II|Death|0|||
164343661|NCT02732119|593635295|FG000|Phase II|Progressive dissease|0|||
164343662|NCT02732119|593635296|FG001|Phase II|Progressive dissease|0|||
164343663|NCT02732119|593635297|FG002|Phase II|Progressive dissease|0|||
164343664|NCT02732119|593635298|FG003|Phase II|Progressive dissease|30|||
163895234|NCT04084574|591989599|FG001|Overall Study|Physician Decision|0|||
164343665|NCT02732119|593635299|FG004|Phase II|Progressive dissease|23|||
164343666|NCT02732119|593635295|FG000|Phase II|Study terminated by sponsor|0|||
164277561|NCT01545050|593384827|FG001|Overall Study|Discontinued study treatment|0|||
164277562|NCT01545050|593384828|FG002|Overall Study|Discontinued study treatment|0|||
164277563|NCT01545050|593384829|FG003|Overall Study|Discontinued study treatment|0|||
164277564|NCT01545050|593384830|FG004|Overall Study|Discontinued study treatment|0|||
164277565|NCT01545050|593384826|FG000|Overall Study|Withdrawal by Subject|1|||
164277566|NCT01545050|593384827|FG001|Overall Study|Withdrawal by Subject|0|||
164277567|NCT01545050|593384828|FG002|Overall Study|Withdrawal by Subject|0|||
164277568|NCT01545050|593384829|FG003|Overall Study|Withdrawal by Subject|2|||
164277569|NCT01545050|593384830|FG004|Overall Study|Withdrawal by Subject|1|||
164277570|NCT01545050|593384826|FG000|Overall Study|Participant no longer meets study criteria|0|||
164277571|NCT01545050|593384827|FG001|Overall Study|Participant no longer meets study criteria|2|||
164343667|NCT02732119|593635296|FG001|Phase II|Study terminated by sponsor|0|||
164343668|NCT02732119|593635297|FG002|Phase II|Study terminated by sponsor|0|||
164343669|NCT02732119|593635298|FG003|Phase II|Study terminated by sponsor|2|||
163895235|NCT04084574|591989598|FG000|Overall Study|Relocated out of state|1|||
164277572|NCT01545050|593384828|FG002|Overall Study|Participant no longer meets study criteria|0|||
164343670|NCT02732119|593635299|FG004|Phase II|Study terminated by sponsor|2|||
164343671|NCT02732119|593635295|FG000|Phase II|Other|0|||
164277573|NCT01545050|593384829|FG003|Overall Study|Participant no longer meets study criteria|0|||
164277574|NCT01545050|593384830|FG004|Overall Study|Participant no longer meets study criteria|1|||
164277575|NCT01545050|593384826|FG000|Overall Study|Administrative reason by sponsor|4|||
164277576|NCT01545050|593384827|FG001|Overall Study|Administrative reason by sponsor|2|||
164277577|NCT01545050|593384828|FG002|Overall Study|Administrative reason by sponsor|3|||
164277578|NCT01545050|593384829|FG003|Overall Study|Administrative reason by sponsor|5|||
164277579|NCT01545050|593384830|FG004|Overall Study|Administrative reason by sponsor|5|||
164277580|NCT02249182|593384833|FG000|Treatment Phase|Lost to Follow-up|4|||
164277581|NCT02249182|593384834|FG001|Treatment Phase|Lost to Follow-up|0|||
164277582|NCT02249182|593384835|FG002|Treatment Phase|Lost to Follow-up|0|||
164277583|NCT02249182|593384836|FG003|Treatment Phase|Lost to Follow-up|0|||
164277584|NCT02249182|593384837|FG004|Treatment Phase|Lost to Follow-up|0|||
164277585|NCT03244826|593384846|FG000|Overall Study|Withdrawal by Subject|2|||
164277586|NCT03244826|593384847|FG001|Overall Study|Withdrawal by Subject|0|||
164277587|NCT03244826|593384846|FG000|Overall Study|Transplant delayed or withdrawn|12|||
164277588|NCT03244826|593384847|FG001|Overall Study|Transplant delayed or withdrawn|10|||
164277589|NCT04356040|593384848|FG000|Overall Study|Death|2|||
164277590|NCT04356040|593384849|FG001|Overall Study|Death|0|||
164277591|NCT04356040|593384848|FG000|Overall Study|Lost to Follow-up|1|||
164277592|NCT04356040|593384849|FG001|Overall Study|Lost to Follow-up|0|||
164277593|NCT04356040|593384848|FG000|Overall Study|Physician Decision|0|||
164277594|NCT04356040|593384849|FG001|Overall Study|Physician Decision|1|||
164277595|NCT04356040|593384848|FG000|Overall Study|Withdrawal by Subject|13|||
163895236|NCT04084574|591989599|FG001|Overall Study|Relocated out of state|0|||
163895237|NCT01121588|591989600|FG000|Overall Study|Death|5|||
163895238|NCT01121588|591989601|FG001|Overall Study|Death|3|||
164277596|NCT04356040|593384849|FG001|Overall Study|Withdrawal by Subject|1|||
164277597|NCT04356040|593384848|FG000|Overall Study|Enrollment Pause|10|||
164277598|NCT04356040|593384849|FG001|Overall Study|Enrollment Pause|0|||
164277599|NCT04356040|593384848|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
164277600|NCT04356040|593384849|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
164277601|NCT04356040|593384848|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
164277602|NCT04356040|593384849|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
164277603|NCT04356040|593384848|FG000|Overall Study|PI left institution|3|||
164277604|NCT04356040|593384849|FG001|Overall Study|PI left institution|0|||
164277605|NCT00416455|593384850|FG000|Overall Study|PET / CT not done|3|||
164277606|NCT00416455|593384851|FG001|Overall Study|PET / CT not done|5|||
164343672|NCT02732119|593635296|FG001|Phase II|Other|0|||
164343673|NCT02732119|593635297|FG002|Phase II|Other|0|||
164343674|NCT02732119|593635298|FG003|Phase II|Other|2|||
164343675|NCT02732119|593635299|FG004|Phase II|Other|0|||
164343676|NCT02732119|593635295|FG000|Phase II|Physician Decision|0|||
164277607|NCT00416455|593384850|FG000|Overall Study|PET / CT poor quality|2|||
164277608|NCT00416455|593384851|FG001|Overall Study|PET / CT poor quality|1|||
164277609|NCT00416455|593384850|FG000|Overall Study|Inadequate pathology|11|||
164277610|NCT00416455|593384851|FG001|Overall Study|Inadequate pathology|2|||
164277611|NCT01008449|593384852|FG000|Overall Study|Lost to Follow-up|29|||
164277612|NCT01008449|593384853|FG001|Overall Study|Lost to Follow-up|19|||
164277613|NCT01114438|593384854|FG000|Overall Study|Adverse Event|10|||
164277614|NCT01114438|593384854|FG000|Overall Study|concomitant medication|1|||
164277615|NCT01114438|593384854|FG000|Overall Study|Physician Decision|1|||
164277616|NCT01114438|593384854|FG000|Overall Study|Withdrawal by Subject|2|||
164277617|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Adverse Event|2|||
164277618|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Adverse Event|4|||
164277619|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Adverse Event|4|||
164277620|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
164277621|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
164277622|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
164277623|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
164277624|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
164277625|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
164277626|NCT00428844|593384855|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
164277627|NCT00428844|593384856|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
164277628|NCT00428844|593384857|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
164277629|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
164277630|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
164277631|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
164277632|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
164277633|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
164277634|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
164277635|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
164277636|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
164277637|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
164277638|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
164277639|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
164277640|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
164277641|NCT00428844|593384855|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
164277642|NCT00428844|593384856|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
164277643|NCT00428844|593384857|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
164277644|NCT03043651|593384862|FG000|Overall Study|Death|1|||
164277645|NCT03043651|593384862|FG000|Overall Study|Progressive Disease|2|||
164277646|NCT03043651|593384862|FG000|Overall Study|Adverse Event|2|||
164277647|NCT03043651|593384862|FG000|Overall Study|Withdrawal by Subject|4|||
164277648|NCT03043651|593384862|FG000|Overall Study|Study Terminated by Sponsor|39|||
164277649|NCT01345669|593384863|FG000|Overall Study|Primary tumour recurrence|53|||
164277650|NCT01345669|593384864|FG001|Overall Study|Primary tumour recurrence|32|||
164277651|NCT01345669|593384863|FG000|Overall Study|Second primary tumour|4|||
164343677|NCT02732119|593635296|FG001|Phase II|Physician Decision|0|||
164343678|NCT02732119|593635297|FG002|Phase II|Physician Decision|0|||
164343679|NCT02732119|593635298|FG003|Phase II|Physician Decision|8|||
164343680|NCT02732119|593635299|FG004|Phase II|Physician Decision|5|||
164343681|NCT00964860|593635300|FG000|Overall Study|Withdrawal by Subject|0|||
164343682|NCT00964860|593635301|FG001|Overall Study|Withdrawal by Subject|1|||
164343683|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Physician Decision|0|||
164343684|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Physician Decision|1|||
164277652|NCT01345669|593384864|FG001|Overall Study|Second primary tumour|3|||
164277653|NCT01345669|593384863|FG000|Overall Study|Adverse Event|63|||
164277654|NCT01345669|593384864|FG001|Overall Study|Adverse Event|9|||
164343685|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Physician Decision|0|||
164343686|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
164343687|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
164343688|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
164277655|NCT01345669|593384863|FG000|Overall Study|Protocol Violation|3|||
164277656|NCT01345669|593384864|FG001|Overall Study|Protocol Violation|1|||
164277657|NCT01345669|593384863|FG000|Overall Study|Lost to Follow-up|1|||
164277658|NCT01345669|593384864|FG001|Overall Study|Lost to Follow-up|1|||
164277659|NCT01345669|593384863|FG000|Overall Study|Withdrawal by Subject|52|||
164277660|NCT01345669|593384864|FG001|Overall Study|Withdrawal by Subject|13|||
164277661|NCT01345669|593384863|FG000|Overall Study|Other Reasons|111|||
164277662|NCT01345669|593384864|FG001|Overall Study|Other Reasons|60|||
164277663|NCT01793883|593384865|FG000|Overall Study|Withdrawal by Subject|3|||
164277664|NCT01793883|593384866|FG001|Overall Study|Withdrawal by Subject|7|||
164277665|NCT01793883|593384867|FG002|Overall Study|Withdrawal by Subject|3|||
164277666|NCT01793883|593384865|FG000|Overall Study|Subject noncompliance|0|||
164277667|NCT01793883|593384866|FG001|Overall Study|Subject noncompliance|1|||
164277668|NCT01793883|593384867|FG002|Overall Study|Subject noncompliance|1|||
164277669|NCT01793883|593384865|FG000|Overall Study|Lost to Follow-up|5|||
164277670|NCT01793883|593384866|FG001|Overall Study|Lost to Follow-up|1|||
164277671|NCT01793883|593384867|FG002|Overall Study|Lost to Follow-up|3|||
164277672|NCT01793883|593384865|FG000|Overall Study|Randomized in error|1|||
164277673|NCT01793883|593384866|FG001|Overall Study|Randomized in error|0|||
164277674|NCT01793883|593384867|FG002|Overall Study|Randomized in error|0|||
164277675|NCT01793883|593384865|FG000|Overall Study|Unable to complete spriometry|1|||
164277676|NCT01793883|593384866|FG001|Overall Study|Unable to complete spriometry|0|||
164277677|NCT01793883|593384867|FG002|Overall Study|Unable to complete spriometry|0|||
164277678|NCT01793883|593384865|FG000|Overall Study|Unable to complete measurements|1|||
164277679|NCT01793883|593384866|FG001|Overall Study|Unable to complete measurements|0|||
164277680|NCT01793883|593384867|FG002|Overall Study|Unable to complete measurements|0|||
164277681|NCT01793883|593384865|FG000|Overall Study|Met exclusion criteria|1|||
164277682|NCT01793883|593384866|FG001|Overall Study|Met exclusion criteria|0|||
164277683|NCT01793883|593384867|FG002|Overall Study|Met exclusion criteria|0|||
164277684|NCT01793883|593384865|FG000|Overall Study|Dosing error|0|||
164277685|NCT01793883|593384866|FG001|Overall Study|Dosing error|1|||
164277686|NCT01793883|593384867|FG002|Overall Study|Dosing error|0|||
164277687|NCT01793883|593384865|FG000|Overall Study|Respiratory distress during spirometry|0|||
164277688|NCT01793883|593384866|FG001|Overall Study|Respiratory distress during spirometry|0|||
164277689|NCT01793883|593384867|FG002|Overall Study|Respiratory distress during spirometry|1|||
164277690|NCT02353728|593384870|FG000|Overall Study|Subject non-compliance|1|||
164277691|NCT02611817|593387734|FG000|Open-label Induction Phase|Reason not Specified|9|||
164277692|NCT02611817|593387735|FG001|Open-label Induction Phase|Reason not Specified|0|||
164277693|NCT02611817|593387736|FG002|Open-label Induction Phase|Reason not Specified|0|||
164277694|NCT02611817|593387734|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
164277695|NCT02611817|593387735|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
164277696|NCT02611817|593387736|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
164277697|NCT02611817|593387734|FG000|Open-label Induction Phase|Pregnancy|1|||
164277698|NCT02611817|593387735|FG001|Open-label Induction Phase|Pregnancy|0|||
164277699|NCT02611817|593387736|FG002|Open-label Induction Phase|Pregnancy|0|||
164277700|NCT02611817|593387734|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
164277701|NCT02611817|593387735|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
164277702|NCT02611817|593387736|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
164277703|NCT02611817|593387734|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
164277704|NCT02611817|593387735|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
164277705|NCT02611817|593387736|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
164277706|NCT02611817|593387734|FG000|Open-label Induction Phase|Protocol Violation|5|||
164277707|NCT02611817|593387735|FG001|Open-label Induction Phase|Protocol Violation|0|||
164277708|NCT02611817|593387736|FG002|Open-label Induction Phase|Protocol Violation|0|||
164277709|NCT02611817|593387734|FG000|Open-label Induction Phase|Adverse Event|16|||
164277710|NCT02611817|593387735|FG001|Open-label Induction Phase|Adverse Event|0|||
164277711|NCT02611817|593387736|FG002|Open-label Induction Phase|Adverse Event|0|||
164277712|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
164277713|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
164277714|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
164277715|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
164277716|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
164277717|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
164277718|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
164277719|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
164277720|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
164277721|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
164277722|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
164277723|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
164277724|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
164277725|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
164277726|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
164277727|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
164277728|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
164277729|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
164277730|NCT02611817|593387734|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
164277731|NCT02611817|593387735|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
164277732|NCT02611817|593387736|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
164277733|NCT02475278|593387744|FG000|Overall Study|Lost to Follow-up|1|||
164277734|NCT02475278|593387744|FG000|Overall Study|Reason Not Specified|1|||
164277735|NCT03712787|593387745|FG000|Overall Study|Adverse Event|2|||
164277736|NCT03712787|593387746|FG001|Overall Study|Adverse Event|3|||
164277737|NCT03712787|593387747|FG002|Overall Study|Adverse Event|0|||
164277738|NCT03712787|593387748|FG003|Overall Study|Adverse Event|4|||
164277739|NCT03712787|593387745|FG000|Overall Study|Withdrawal by Subject|4|||
164277740|NCT03712787|593387746|FG001|Overall Study|Withdrawal by Subject|14|||
164277741|NCT03712787|593387747|FG002|Overall Study|Withdrawal by Subject|12|||
164277742|NCT03712787|593387748|FG003|Overall Study|Withdrawal by Subject|8|||
164277743|NCT03712787|593387745|FG000|Overall Study|Lost to Follow-up|1|||
164277744|NCT03712787|593387746|FG001|Overall Study|Lost to Follow-up|1|||
164277745|NCT03712787|593387747|FG002|Overall Study|Lost to Follow-up|2|||
164277746|NCT03712787|593387748|FG003|Overall Study|Lost to Follow-up|1|||
164277747|NCT03712787|593387745|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
164277748|NCT03712787|593387746|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
164277749|NCT03712787|593387747|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
164277750|NCT03712787|593387748|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
164277751|NCT03712787|593387745|FG000|Overall Study|COVID-19 Infection|0|||
164277752|NCT03712787|593387746|FG001|Overall Study|COVID-19 Infection|1|||
164277753|NCT03712787|593387747|FG002|Overall Study|COVID-19 Infection|0|||
164277754|NCT03712787|593387748|FG003|Overall Study|COVID-19 Infection|0|||
164277755|NCT03712787|593387745|FG000|Overall Study|Other, Not Specified|79|||
164277756|NCT03712787|593387746|FG001|Overall Study|Other, Not Specified|77|||
164277757|NCT03712787|593387747|FG002|Overall Study|Other, Not Specified|74|||
164277758|NCT03712787|593387748|FG003|Overall Study|Other, Not Specified|78|||
164277759|NCT01865448|593387749|FG000|Overall Study|Adverse Event|1|||
164277760|NCT01865448|593387750|FG001|Overall Study|Adverse Event|1|||
164277761|NCT01865448|593387749|FG000|Overall Study|Pregnancy|0|||
164277762|NCT01865448|593387750|FG001|Overall Study|Pregnancy|1|||
164277763|NCT01865448|593387749|FG000|Overall Study|dropout unrelated to study|1|||
164277764|NCT01865448|593387750|FG001|Overall Study|dropout unrelated to study|1|||
164277765|NCT03499314|593387751|FG000|Overall Study|Time Commitment|1|||
164277766|NCT03499314|593387752|FG001|Overall Study|Time Commitment|2|||
164277767|NCT03499314|593387751|FG000|Overall Study|Medical issue unrelated to research study|1|||
164277768|NCT03499314|593387752|FG001|Overall Study|Medical issue unrelated to research study|1|||
164277769|NCT01618695|593387753|FG000|Core Phase|Adverse Event|4|||
164277770|NCT01618695|593387754|FG001|Core Phase|Adverse Event|5|||
164277771|NCT01618695|593387755|FG002|Core Phase|Adverse Event|15|||
164277772|NCT01618695|593387756|FG003|Core Phase|Adverse Event|20|||
164277773|NCT01618695|593387753|FG000|Core Phase|Lost to Follow-up|0|||
163895239|NCT01121588|591989602|FG002|Overall Study|Death|13|||
163895240|NCT01121588|591989600|FG000|Overall Study|Study Terminated by Sponsor|1|||
163895241|NCT01121588|591989601|FG001|Overall Study|Study Terminated by Sponsor|1|||
163895242|NCT01121588|591989602|FG002|Overall Study|Study Terminated by Sponsor|0|||
163895243|NCT01121588|591989600|FG000|Overall Study|Participant Refused Further Followup|2|||
164277774|NCT01618695|593387754|FG001|Core Phase|Lost to Follow-up|0|||
164277775|NCT01618695|593387755|FG002|Core Phase|Lost to Follow-up|1|||
164277776|NCT01618695|593387756|FG003|Core Phase|Lost to Follow-up|0|||
164277777|NCT01618695|593387753|FG000|Core Phase|Withdrawal by Subject|16|||
164277778|NCT01618695|593387754|FG001|Core Phase|Withdrawal by Subject|11|||
164277779|NCT01618695|593387755|FG002|Core Phase|Withdrawal by Subject|9|||
164277780|NCT01618695|593387756|FG003|Core Phase|Withdrawal by Subject|13|||
164277781|NCT01618695|593387753|FG000|Core Phase|Pregnancy|2|||
164277782|NCT01618695|593387754|FG001|Core Phase|Pregnancy|0|||
164277783|NCT01618695|593387755|FG002|Core Phase|Pregnancy|0|||
164277784|NCT01618695|593387756|FG003|Core Phase|Pregnancy|0|||
164277785|NCT01618695|593387753|FG000|Core Phase|Lack of Efficacy|1|||
164277786|NCT01618695|593387754|FG001|Core Phase|Lack of Efficacy|2|||
164277787|NCT01618695|593387755|FG002|Core Phase|Lack of Efficacy|1|||
164277788|NCT01618695|593387756|FG003|Core Phase|Lack of Efficacy|1|||
164277789|NCT01618695|593387753|FG000|Core Phase|Other than specified|1|||
164277790|NCT01618695|593387754|FG001|Core Phase|Other than specified|2|||
164277791|NCT01618695|593387755|FG002|Core Phase|Other than specified|2|||
164277792|NCT01618695|593387756|FG003|Core Phase|Other than specified|2|||
164277793|NCT01618695|593387753|FG000|Core Phase|Not treated|1|||
164277794|NCT01618695|593387754|FG001|Core Phase|Not treated|0|||
164277795|NCT01618695|593387755|FG002|Core Phase|Not treated|2|||
164277796|NCT01618695|593387756|FG003|Core Phase|Not treated|0|||
164277797|NCT01618695|593387753|FG000|Extension Phase|Lack of Efficacy|17|||
164277798|NCT01618695|593387754|FG001|Extension Phase|Lack of Efficacy|33|||
164277799|NCT01618695|593387755|FG002|Extension Phase|Lack of Efficacy|26|||
164277800|NCT01618695|593387756|FG003|Extension Phase|Lack of Efficacy|24|||
164277801|NCT01618695|593387753|FG000|Extension Phase|Pregnancy|2|||
164277802|NCT01618695|593387754|FG001|Extension Phase|Pregnancy|0|||
164277803|NCT01618695|593387755|FG002|Extension Phase|Pregnancy|1|||
164277804|NCT01618695|593387756|FG003|Extension Phase|Pregnancy|1|||
164277805|NCT01618695|593387753|FG000|Extension Phase|Withdrawal by Subject|43|||
164277806|NCT01618695|593387754|FG001|Extension Phase|Withdrawal by Subject|48|||
164277807|NCT01618695|593387755|FG002|Extension Phase|Withdrawal by Subject|42|||
164277808|NCT01618695|593387756|FG003|Extension Phase|Withdrawal by Subject|33|||
164277809|NCT01618695|593387753|FG000|Extension Phase|Adverse Event|18|||
164277810|NCT01618695|593387754|FG001|Extension Phase|Adverse Event|16|||
164277811|NCT01618695|593387755|FG002|Extension Phase|Adverse Event|9|||
164277812|NCT01618695|593387756|FG003|Extension Phase|Adverse Event|20|||
164277813|NCT01618695|593387753|FG000|Extension Phase|Lost to Follow-up|2|||
164277814|NCT01618695|593387754|FG001|Extension Phase|Lost to Follow-up|1|||
163895244|NCT01121588|591989601|FG001|Overall Study|Participant Refused Further Followup|0|||
163895245|NCT01121588|591989602|FG002|Overall Study|Participant Refused Further Followup|2|||
163895246|NCT01121588|591989600|FG000|Overall Study|Lost to Follow-up|0|||
163895247|NCT01121588|591989601|FG001|Overall Study|Lost to Follow-up|1|||
164277815|NCT01618695|593387755|FG002|Extension Phase|Lost to Follow-up|1|||
164277816|NCT01618695|593387756|FG003|Extension Phase|Lost to Follow-up|1|||
164277817|NCT01618695|593387753|FG000|Extension Phase|Other than specified|13|||
164277818|NCT01618695|593387754|FG001|Extension Phase|Other than specified|18|||
164277819|NCT01618695|593387755|FG002|Extension Phase|Other than specified|13|||
164277820|NCT01618695|593387756|FG003|Extension Phase|Other than specified|18|||
164277821|NCT01016600|593387760|FG000|Overall Study|Did not start treatment|1|||
164277822|NCT01016600|593387761|FG001|Overall Study|Did not start treatment|0|||
164277823|NCT01016600|593387762|FG002|Overall Study|Did not start treatment|0|||
164277824|NCT01016600|593387763|FG003|Overall Study|Did not start treatment|0|||
164277825|NCT04794270|593387764|FG000|Period 1|Non Compliance|1|||
164277826|NCT04794270|593387765|FG001|Period 1|Non Compliance|0|||
164277827|NCT04794270|593387764|FG000|Period 1|Adverse Event|1|||
164001394|NCT02786901|592368499|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
164001395|NCT02786901|592368500|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
164001396|NCT02786901|592368501|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
164001397|NCT02786901|592368499|FG000|Overall Study|Disallowed medication|1|||
164001398|NCT02786901|592368500|FG001|Overall Study|Disallowed medication|1|||
164001399|NCT02786901|592368501|FG002|Overall Study|Disallowed medication|0|||
164001400|NCT02786901|592368499|FG000|Overall Study|Randomized in error|2|||
164001401|NCT02786901|592368500|FG001|Overall Study|Randomized in error|0|||
164001402|NCT02786901|592368501|FG002|Overall Study|Randomized in error|1|||
164277828|NCT04794270|593387765|FG001|Period 1|Adverse Event|0|||
164277829|NCT04794270|593387764|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
164277830|NCT04794270|593387765|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
164277831|NCT01271725|593387767|FG000|Part A|Progressive disease according to RECIST|8|||
164001403|NCT00466505|592368502|FG000|Overall Study|disease progression|13|||
164001404|NCT00466505|592368502|FG000|Overall Study|Adverse Event|4|||
164001405|NCT01241786|592368507|FG000|Overall Study|Lack of Efficacy|5|||
164001406|NCT02620020|592368520|FG000|Overall Study|Adverse Event|8|||
164001407|NCT02620020|592368521|FG001|Overall Study|Adverse Event|4|||
164001408|NCT02620020|592368522|FG002|Overall Study|Adverse Event|3|||
164001409|NCT02620020|592368523|FG003|Overall Study|Adverse Event|5|||
164001410|NCT02620020|592368520|FG000|Overall Study|Lost to Follow-up|4|||
164001411|NCT02620020|592368521|FG001|Overall Study|Lost to Follow-up|8|||
164277832|NCT01271725|593387768|FG001|Part A|Progressive disease according to RECIST|0|||
164277833|NCT01271725|593387767|FG000|Part A|Clinical signs/symptoms of progression|2|||
164277834|NCT01271725|593387768|FG001|Part A|Clinical signs/symptoms of progression|0|||
164277835|NCT01271725|593387767|FG000|Part A|Other Adverse Event|8|||
164277836|NCT01271725|593387768|FG001|Part A|Other Adverse Event|0|||
164277837|NCT01271725|593387767|FG000|Part A|Lost to Follow-up|1|||
164277838|NCT01271725|593387768|FG001|Part A|Lost to Follow-up|0|||
164277839|NCT01271725|593387767|FG000|Part A|Withdrawal by Subject|12|||
164277840|NCT01271725|593387768|FG001|Part A|Withdrawal by Subject|0|||
164277841|NCT01271725|593387767|FG000|Part A|Other than specified|3|||
164277842|NCT01271725|593387768|FG001|Part A|Other than specified|0|||
164277843|NCT01271725|593387767|FG000|Part A|Protocol Violation|1|||
164277844|NCT01271725|593387768|FG001|Part A|Protocol Violation|0|||
164277845|NCT01271725|593387767|FG000|Part B|Other than specified|0|||
164277846|NCT01271725|593387768|FG001|Part B|Other than specified|2|||
164277847|NCT01271725|593387767|FG000|Part B|Clinical signs/symptoms of progression|0|||
164277848|NCT01271725|593387768|FG001|Part B|Clinical signs/symptoms of progression|2|||
164277849|NCT01271725|593387767|FG000|Part B|Other Adverse Event|0|||
164277850|NCT01271725|593387768|FG001|Part B|Other Adverse Event|1|||
164277851|NCT01271725|593387767|FG000|Part B|Protocol Violation|0|||
164277852|NCT01271725|593387768|FG001|Part B|Protocol Violation|1|||
164277853|NCT01271725|593387767|FG000|Part B|Withdrawal by Subject|0|||
164277854|NCT01271725|593387768|FG001|Part B|Withdrawal by Subject|6|||
164277855|NCT00265317|593387771|FG000|Lead-In|Objective progression or relapse|6|||
164277856|NCT00265317|593387772|FG001|Lead-In|Objective progression or relapse|11|||
164277857|NCT00265317|593387773|FG002|Lead-In|Objective progression or relapse|0|||
164277858|NCT00265317|593387774|FG003|Lead-In|Objective progression or relapse|0|||
164277859|NCT00265317|593387771|FG000|Lead-In|Adverse Event|2|||
164277860|NCT00265317|593387772|FG001|Lead-In|Adverse Event|1|||
164277861|NCT00265317|593387773|FG002|Lead-In|Adverse Event|0|||
164277862|NCT00265317|593387774|FG003|Lead-In|Adverse Event|0|||
164277863|NCT00265317|593387771|FG000|Lead-In|Death|3|||
164277864|NCT00265317|593387772|FG001|Lead-In|Death|5|||
164277865|NCT00265317|593387773|FG002|Lead-In|Death|0|||
164277866|NCT00265317|593387774|FG003|Lead-In|Death|0|||
164277867|NCT00265317|593387771|FG000|Lead-In|Withdrawal/other than adverse event|1|||
164343689|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
164343690|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
164343691|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
164343692|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Other|4|||
164343693|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Other|4|||
164343694|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Other|0|||
164343695|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
164343696|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
164343697|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
164343698|NCT02585960|593635302|FG000|PK/Safety Assessment Period|Screen Failure|0|||
164343699|NCT02585960|593635303|FG001|PK/Safety Assessment Period|Screen Failure|0|||
164343700|NCT02585960|593635304|FG002|PK/Safety Assessment Period|Screen Failure|1|||
164343701|NCT02585960|593635302|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
164343702|NCT02585960|593635303|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
164343703|NCT02585960|593635304|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
164343704|NCT02585960|593635302|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
164277868|NCT00265317|593387772|FG001|Lead-In|Withdrawal/other than adverse event|0|||
164277869|NCT00265317|593387773|FG002|Lead-In|Withdrawal/other than adverse event|0|||
164277870|NCT00265317|593387774|FG003|Lead-In|Withdrawal/other than adverse event|0|||
164277871|NCT00265317|593387771|FG000|Phase 2|Objective progression or relapse|0|||
164277872|NCT00265317|593387772|FG001|Phase 2|Objective progression or relapse|0|||
164277873|NCT00265317|593387773|FG002|Phase 2|Objective progression or relapse|37|||
164277874|NCT00265317|593387774|FG003|Phase 2|Objective progression or relapse|38|||
164277875|NCT00265317|593387771|FG000|Phase 2|Global deterioration of health status|0|||
164277876|NCT00265317|593387772|FG001|Phase 2|Global deterioration of health status|0|||
164277877|NCT00265317|593387773|FG002|Phase 2|Global deterioration of health status|3|||
164277878|NCT00265317|593387774|FG003|Phase 2|Global deterioration of health status|0|||
164277879|NCT00265317|593387771|FG000|Phase 2|Adverse Event|0|||
164277880|NCT00265317|593387772|FG001|Phase 2|Adverse Event|0|||
164277881|NCT00265317|593387773|FG002|Phase 2|Adverse Event|7|||
164277882|NCT00265317|593387774|FG003|Phase 2|Adverse Event|5|||
164277883|NCT00265317|593387771|FG000|Phase 2|Death|0|||
164277884|NCT00265317|593387772|FG001|Phase 2|Death|0|||
164277885|NCT00265317|593387773|FG002|Phase 2|Death|12|||
164277886|NCT00265317|593387774|FG003|Phase 2|Death|15|||
164277887|NCT00265317|593387771|FG000|Phase 2|Protocol Violation|0|||
164277888|NCT00265317|593387772|FG001|Phase 2|Protocol Violation|0|||
164277889|NCT00265317|593387773|FG002|Phase 2|Protocol Violation|1|||
164277890|NCT00265317|593387774|FG003|Phase 2|Protocol Violation|4|||
164277891|NCT00265317|593387771|FG000|Phase 2|Lost to Follow-up|0|||
164277892|NCT00265317|593387772|FG001|Phase 2|Lost to Follow-up|0|||
164277893|NCT00265317|593387773|FG002|Phase 2|Lost to Follow-up|0|||
164277894|NCT00265317|593387774|FG003|Phase 2|Lost to Follow-up|1|||
164277895|NCT00265317|593387771|FG000|Phase 2|Withdrawal/other than adverse event|0|||
164277896|NCT00265317|593387772|FG001|Phase 2|Withdrawal/other than adverse event|0|||
164277897|NCT00265317|593387773|FG002|Phase 2|Withdrawal/other than adverse event|2|||
164277898|NCT00265317|593387774|FG003|Phase 2|Withdrawal/other than adverse event|1|||
164277899|NCT00265317|593387771|FG000|Phase 2|Study terminated by sponsor|0|||
164277900|NCT00265317|593387772|FG001|Phase 2|Study terminated by sponsor|0|||
164277901|NCT00265317|593387773|FG002|Phase 2|Study terminated by sponsor|1|||
164277902|NCT00265317|593387774|FG003|Phase 2|Study terminated by sponsor|0|||
164277903|NCT00265317|593387771|FG000|Phase 2|Other|0|||
164277904|NCT00265317|593387772|FG001|Phase 2|Other|0|||
164277905|NCT00265317|593387773|FG002|Phase 2|Other|1|||
164277906|NCT00265317|593387774|FG003|Phase 2|Other|1|||
164277907|NCT00732875|593387777|FG000|Overall Study|Adverse Event|16|||
164277908|NCT00732875|593387777|FG000|Overall Study|Withdrawal by Subject|6|||
164277909|NCT00732875|593387777|FG000|Overall Study|Lack of Efficacy|13|||
164277910|NCT03826186|593387778|FG000|Overall Study|Protocol Violation|2|||
164277911|NCT03826186|593387779|FG001|Overall Study|Protocol Violation|0|||
164277912|NCT03826186|593387778|FG000|Overall Study|Withdrawal by Subject|1|||
164277913|NCT03826186|593387779|FG001|Overall Study|Withdrawal by Subject|0|||
164277914|NCT02300259|593387780|FG000|Period 1|Adverse Event|0|||
164277915|NCT02300259|593387781|FG001|Period 1|Adverse Event|0|||
164277916|NCT02300259|593387782|FG002|Period 1|Adverse Event|1|||
164277917|NCT02300259|593387780|FG000|Period 1|Withdrawal by Subject|0|||
164277918|NCT02300259|593387781|FG001|Period 1|Withdrawal by Subject|0|||
164277919|NCT02300259|593387782|FG002|Period 1|Withdrawal by Subject|1|||
164277920|NCT02300259|593387780|FG000|Period 2|Adverse Event|1|||
164277921|NCT02300259|593387781|FG001|Period 2|Adverse Event|0|||
164277922|NCT02300259|593387782|FG002|Period 2|Adverse Event|0|||
164277923|NCT02300259|593387780|FG000|Period 2|Withdrawal by Subject|0|||
164277924|NCT02300259|593387781|FG001|Period 2|Withdrawal by Subject|0|||
164277925|NCT02300259|593387782|FG002|Period 2|Withdrawal by Subject|1|||
164277926|NCT02737475|593387783|FG000|Overall Study|Other reasons|0|||
164277927|NCT02737475|593387784|FG001|Overall Study|Other reasons|0|||
164277928|NCT02737475|593387785|FG002|Overall Study|Other reasons|0|||
164277929|NCT02737475|593387786|FG003|Overall Study|Other reasons|0|||
164277930|NCT02737475|593387787|FG004|Overall Study|Other reasons|1|||
164277931|NCT02737475|593387788|FG005|Overall Study|Other reasons|1|||
164277932|NCT02737475|593387789|FG006|Overall Study|Other reasons|0|||
164277933|NCT02737475|593387790|FG007|Overall Study|Other reasons|0|||
164343705|NCT02585960|593635303|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
164343706|NCT02585960|593635304|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
164277934|NCT02737475|593387791|FG008|Overall Study|Other reasons|1|||
164277935|NCT02737475|593387792|FG009|Overall Study|Other reasons|0|||
164277936|NCT02737475|593387793|FG010|Overall Study|Other reasons|1|||
164277937|NCT02737475|593387794|FG011|Overall Study|Other reasons|0|||
164277938|NCT02737475|593387795|FG012|Overall Study|Other reasons|0|||
164277939|NCT02737475|593387796|FG013|Overall Study|Other reasons|0|||
164277940|NCT02737475|593387797|FG014|Overall Study|Other reasons|0|||
164277941|NCT02737475|593387798|FG015|Overall Study|Other reasons|0|||
164277942|NCT02737475|593387799|FG016|Overall Study|Other reasons|0|||
164343707|NCT06333613|593635306|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
164277943|NCT02737475|593387800|FG017|Overall Study|Other reasons|0|||
164277944|NCT02737475|593387801|FG018|Overall Study|Other reasons|0|||
164277945|NCT02737475|593387802|FG019|Overall Study|Other reasons|0|||
164277946|NCT02737475|593387803|FG020|Overall Study|Other reasons|0|||
164001412|NCT02620020|592368522|FG002|Overall Study|Lost to Follow-up|1|||
164001413|NCT02620020|592368523|FG003|Overall Study|Lost to Follow-up|4|||
164001414|NCT02620020|592368520|FG000|Overall Study|Physician Decision|7|||
164001415|NCT02620020|592368521|FG001|Overall Study|Physician Decision|4|||
164001416|NCT02620020|592368522|FG002|Overall Study|Physician Decision|3|||
164277947|NCT02737475|593387804|FG021|Overall Study|Other reasons|1|||
164277948|NCT02737475|593387805|FG022|Overall Study|Other reasons|0|||
164277949|NCT02737475|593387806|FG023|Overall Study|Other reasons|1|||
164277950|NCT02737475|593387807|FG024|Overall Study|Other reasons|1|||
164277951|NCT02737475|593387808|FG025|Overall Study|Other reasons|1|||
164277952|NCT02737475|593387809|FG026|Overall Study|Other reasons|0|||
164277953|NCT02737475|593387783|FG000|Overall Study|Death|1|||
164001417|NCT02620020|592368523|FG003|Overall Study|Physician Decision|4|||
164001418|NCT02620020|592368520|FG000|Overall Study|Protocol Violation|5|||
164277954|NCT02737475|593387784|FG001|Overall Study|Death|0|||
164277955|NCT02737475|593387785|FG002|Overall Study|Death|0|||
164277956|NCT02737475|593387786|FG003|Overall Study|Death|1|||
164277957|NCT02737475|593387787|FG004|Overall Study|Death|0|||
164277958|NCT02737475|593387788|FG005|Overall Study|Death|0|||
164277959|NCT02737475|593387789|FG006|Overall Study|Death|0|||
164277960|NCT02737475|593387790|FG007|Overall Study|Death|2|||
164277961|NCT02737475|593387791|FG008|Overall Study|Death|0|||
164277962|NCT02737475|593387792|FG009|Overall Study|Death|0|||
164277963|NCT02737475|593387793|FG010|Overall Study|Death|0|||
164277964|NCT02737475|593387794|FG011|Overall Study|Death|4|||
164277965|NCT02737475|593387795|FG012|Overall Study|Death|2|||
164277966|NCT02737475|593387796|FG013|Overall Study|Death|2|||
164277967|NCT02737475|593387797|FG014|Overall Study|Death|0|||
164001419|NCT02620020|592368521|FG001|Overall Study|Protocol Violation|2|||
164001420|NCT02620020|592368522|FG002|Overall Study|Protocol Violation|1|||
164001421|NCT02620020|592368523|FG003|Overall Study|Protocol Violation|1|||
164277968|NCT02737475|593387798|FG015|Overall Study|Death|2|||
164277969|NCT02737475|593387799|FG016|Overall Study|Death|2|||
164277970|NCT02737475|593387800|FG017|Overall Study|Death|2|||
164277971|NCT02737475|593387801|FG018|Overall Study|Death|1|||
164277972|NCT02737475|593387802|FG019|Overall Study|Death|0|||
164277973|NCT02737475|593387803|FG020|Overall Study|Death|0|||
164277974|NCT02737475|593387804|FG021|Overall Study|Death|0|||
164277975|NCT02737475|593387805|FG022|Overall Study|Death|0|||
164001422|NCT02620020|592368520|FG000|Overall Study|Withdrawal by Subject|20|||
164001423|NCT02620020|592368521|FG001|Overall Study|Withdrawal by Subject|16|||
164001424|NCT02620020|592368522|FG002|Overall Study|Withdrawal by Subject|17|||
164001425|NCT02620020|592368523|FG003|Overall Study|Withdrawal by Subject|12|||
164001426|NCT02620020|592368520|FG000|Overall Study|Death|0|||
164001427|NCT02620020|592368521|FG001|Overall Study|Death|1|||
164001428|NCT02620020|592368522|FG002|Overall Study|Death|0|||
164277976|NCT02737475|593387806|FG023|Overall Study|Death|0|||
164277977|NCT02737475|593387807|FG024|Overall Study|Death|0|||
164277978|NCT02737475|593387808|FG025|Overall Study|Death|0|||
164277979|NCT02737475|593387809|FG026|Overall Study|Death|0|||
164277980|NCT02737475|593387783|FG000|Overall Study|Participant withdrew consent|0|||
164277981|NCT02737475|593387784|FG001|Overall Study|Participant withdrew consent|0|||
164277982|NCT02737475|593387785|FG002|Overall Study|Participant withdrew consent|0|||
164277983|NCT02737475|593387786|FG003|Overall Study|Participant withdrew consent|0|||
164277984|NCT02737475|593387787|FG004|Overall Study|Participant withdrew consent|0|||
164277985|NCT02737475|593387788|FG005|Overall Study|Participant withdrew consent|2|||
164277986|NCT02737475|593387789|FG006|Overall Study|Participant withdrew consent|0|||
164277987|NCT02737475|593387790|FG007|Overall Study|Participant withdrew consent|0|||
164277988|NCT02737475|593387791|FG008|Overall Study|Participant withdrew consent|0|||
164277989|NCT02737475|593387792|FG009|Overall Study|Participant withdrew consent|0|||
164277990|NCT02737475|593387793|FG010|Overall Study|Participant withdrew consent|0|||
164277991|NCT02737475|593387794|FG011|Overall Study|Participant withdrew consent|0|||
164277992|NCT02737475|593387795|FG012|Overall Study|Participant withdrew consent|0|||
164277993|NCT02737475|593387796|FG013|Overall Study|Participant withdrew consent|0|||
164343708|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
164343709|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
164343710|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
164343711|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
164343712|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343713|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343714|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164001429|NCT02620020|592368523|FG003|Overall Study|Death|0|||
164343715|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343716|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343717|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343718|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
164343719|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
164343720|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
164343721|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
164343722|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
164001430|NCT03182738|592368535|FG000|Overall Study|Lost to Follow-up|9|||
164001431|NCT03182738|592368536|FG001|Overall Study|Lost to Follow-up|3|||
164277994|NCT02737475|593387797|FG014|Overall Study|Participant withdrew consent|1|||
164277995|NCT02737475|593387798|FG015|Overall Study|Participant withdrew consent|0|||
164277996|NCT02737475|593387799|FG016|Overall Study|Participant withdrew consent|0|||
164277997|NCT02737475|593387800|FG017|Overall Study|Participant withdrew consent|2|||
164277998|NCT02737475|593387801|FG018|Overall Study|Participant withdrew consent|1|||
164277999|NCT02737475|593387802|FG019|Overall Study|Participant withdrew consent|0|||
164278000|NCT02737475|593387803|FG020|Overall Study|Participant withdrew consent|2|||
164278001|NCT02737475|593387804|FG021|Overall Study|Participant withdrew consent|0|||
164278002|NCT02737475|593387805|FG022|Overall Study|Participant withdrew consent|0|||
164278003|NCT02737475|593387806|FG023|Overall Study|Participant withdrew consent|0|||
164278004|NCT02737475|593387807|FG024|Overall Study|Participant withdrew consent|0|||
164343723|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343724|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343725|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343726|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343727|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343728|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343729|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
164343730|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
164343731|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
164343732|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
164343733|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
164343734|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343735|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343736|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343737|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343738|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343739|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343740|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
164343741|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343742|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343743|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343744|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
164343745|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343746|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343747|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343748|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343749|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343750|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343751|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
164343752|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
164343753|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
164343754|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
164343755|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
164343756|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343757|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343758|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343759|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343760|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343761|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343762|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
164343763|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
164343764|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
164343765|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
164343766|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
164343767|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343768|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343769|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343770|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343771|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343772|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
164343773|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
163895248|NCT01121588|591989602|FG002|Overall Study|Lost to Follow-up|1|||
164278005|NCT02737475|593387808|FG025|Overall Study|Participant withdrew consent|0|||
164278006|NCT02737475|593387809|FG026|Overall Study|Participant withdrew consent|0|||
164001432|NCT03182738|592368535|FG000|Overall Study|Pregnancy|0|||
164001433|NCT03182738|592368536|FG001|Overall Study|Pregnancy|1|||
164001434|NCT03182738|592368535|FG000|Overall Study|Withdrawal by Subject|0|||
164001435|NCT03182738|592368536|FG001|Overall Study|Withdrawal by Subject|1|||
164278007|NCT02737475|593387783|FG000|Overall Study|Lost to Follow-up|0|||
164278008|NCT02737475|593387784|FG001|Overall Study|Lost to Follow-up|0|||
164278009|NCT02737475|593387785|FG002|Overall Study|Lost to Follow-up|0|||
164278010|NCT02737475|593387786|FG003|Overall Study|Lost to Follow-up|0|||
164001436|NCT00098787|592368537|FG000|Overall Study|Never started treatment|3|||
164001437|NCT00098787|592368538|FG001|Overall Study|Never started treatment|2|||
164001438|NCT00098787|592368539|FG002|Overall Study|Never started treatment|1|||
164001439|NCT00098787|592368537|FG000|Overall Study|Ineligible|9|||
164001440|NCT00098787|592368538|FG001|Overall Study|Ineligible|7|||
164001441|NCT00098787|592368539|FG002|Overall Study|Ineligible|3|||
164001442|NCT00098787|592368537|FG000|Overall Study|Disease progression|28|||
164001443|NCT00098787|592368538|FG001|Overall Study|Disease progression|17|||
164001444|NCT00098787|592368539|FG002|Overall Study|Disease progression|23|||
164001445|NCT00098787|592368537|FG000|Overall Study|Adverse Event|8|||
164001446|NCT00098787|592368538|FG001|Overall Study|Adverse Event|17|||
164001447|NCT00098787|592368539|FG002|Overall Study|Adverse Event|8|||
164001448|NCT00098787|592368537|FG000|Overall Study|Death|6|||
164001449|NCT00098787|592368538|FG001|Overall Study|Death|1|||
164001450|NCT00098787|592368539|FG002|Overall Study|Death|0|||
164001451|NCT00098787|592368537|FG000|Overall Study|Withdrawal by Subject|4|||
164001452|NCT00098787|592368538|FG001|Overall Study|Withdrawal by Subject|12|||
164001453|NCT00098787|592368539|FG002|Overall Study|Withdrawal by Subject|6|||
164001454|NCT00098787|592368537|FG000|Overall Study|Alternative therapy|8|||
164001455|NCT00098787|592368538|FG001|Overall Study|Alternative therapy|13|||
164001456|NCT00098787|592368539|FG002|Overall Study|Alternative therapy|13|||
164001457|NCT00098787|592368537|FG000|Overall Study|Other|7|||
164001458|NCT00098787|592368538|FG001|Overall Study|Other|6|||
164001459|NCT00098787|592368539|FG002|Overall Study|Other|9|||
164278011|NCT02737475|593387787|FG004|Overall Study|Lost to Follow-up|0|||
164085979|NCT03280537|592678613|FG000|Overall Study|Withdrawal by Subject|2|||
164085980|NCT03280537|592678614|FG001|Overall Study|Withdrawal by Subject|4|||
164001460|NCT00684814|592368540|FG000|Washout Period of 7 Days|Adverse Event|1|||
164001461|NCT00684814|592368541|FG001|Washout Period of 7 Days|Adverse Event|2|||
164001462|NCT00684814|592368540|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164001463|NCT00684814|592368541|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
164001464|NCT00684814|592368540|FG000|Second Intervention|Adverse Event|1|||
164001465|NCT00684814|592368541|FG001|Second Intervention|Adverse Event|0|||
164001466|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
164001467|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
164001468|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
164001469|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
164001470|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
164001471|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
164001472|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
164001473|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
164001474|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
164001475|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
164001476|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
164001477|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
164001478|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
164001479|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
164278012|NCT02737475|593387788|FG005|Overall Study|Lost to Follow-up|0|||
164278013|NCT02737475|593387789|FG006|Overall Study|Lost to Follow-up|0|||
164278014|NCT02737475|593387790|FG007|Overall Study|Lost to Follow-up|0|||
164278015|NCT02737475|593387791|FG008|Overall Study|Lost to Follow-up|0|||
164278016|NCT02737475|593387792|FG009|Overall Study|Lost to Follow-up|0|||
164278017|NCT02737475|593387793|FG010|Overall Study|Lost to Follow-up|0|||
164278018|NCT02737475|593387794|FG011|Overall Study|Lost to Follow-up|0|||
164278019|NCT02737475|593387795|FG012|Overall Study|Lost to Follow-up|0|||
164278020|NCT02737475|593387796|FG013|Overall Study|Lost to Follow-up|0|||
164278021|NCT02737475|593387797|FG014|Overall Study|Lost to Follow-up|0|||
164278022|NCT02737475|593387798|FG015|Overall Study|Lost to Follow-up|1|||
164278023|NCT02737475|593387799|FG016|Overall Study|Lost to Follow-up|0|||
164278024|NCT02737475|593387800|FG017|Overall Study|Lost to Follow-up|0|||
164278025|NCT02737475|593387801|FG018|Overall Study|Lost to Follow-up|0|||
164278026|NCT02737475|593387802|FG019|Overall Study|Lost to Follow-up|0|||
164278027|NCT02737475|593387803|FG020|Overall Study|Lost to Follow-up|0|||
164278028|NCT02737475|593387804|FG021|Overall Study|Lost to Follow-up|0|||
164278029|NCT02737475|593387805|FG022|Overall Study|Lost to Follow-up|0|||
164278030|NCT02737475|593387806|FG023|Overall Study|Lost to Follow-up|0|||
164278031|NCT02737475|593387807|FG024|Overall Study|Lost to Follow-up|0|||
164278032|NCT02737475|593387808|FG025|Overall Study|Lost to Follow-up|0|||
164278033|NCT02737475|593387809|FG026|Overall Study|Lost to Follow-up|0|||
164278034|NCT02737475|593387783|FG000|Overall Study|Disease Progression|0|||
164278035|NCT02737475|593387784|FG001|Overall Study|Disease Progression|0|||
164278036|NCT02737475|593387785|FG002|Overall Study|Disease Progression|0|||
164278037|NCT02737475|593387786|FG003|Overall Study|Disease Progression|0|||
164278038|NCT02737475|593387787|FG004|Overall Study|Disease Progression|0|||
164278039|NCT02737475|593387788|FG005|Overall Study|Disease Progression|0|||
164278040|NCT02737475|593387789|FG006|Overall Study|Disease Progression|0|||
164278041|NCT02737475|593387790|FG007|Overall Study|Disease Progression|0|||
164278042|NCT02737475|593387791|FG008|Overall Study|Disease Progression|0|||
164278043|NCT02737475|593387792|FG009|Overall Study|Disease Progression|0|||
164278044|NCT02737475|593387793|FG010|Overall Study|Disease Progression|0|||
164278045|NCT02737475|593387794|FG011|Overall Study|Disease Progression|0|||
164278046|NCT02737475|593387795|FG012|Overall Study|Disease Progression|0|||
164278047|NCT02737475|593387796|FG013|Overall Study|Disease Progression|0|||
164001480|NCT00446030|592368542|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
164278048|NCT02737475|593387797|FG014|Overall Study|Disease Progression|0|||
164278049|NCT02737475|593387798|FG015|Overall Study|Disease Progression|0|||
164278050|NCT02737475|593387799|FG016|Overall Study|Disease Progression|0|||
164278051|NCT02737475|593387800|FG017|Overall Study|Disease Progression|0|||
164278052|NCT02737475|593387801|FG018|Overall Study|Disease Progression|0|||
164278053|NCT02737475|593387802|FG019|Overall Study|Disease Progression|0|||
164278054|NCT02737475|593387803|FG020|Overall Study|Disease Progression|0|||
164278055|NCT02737475|593387804|FG021|Overall Study|Disease Progression|0|||
164278056|NCT02737475|593387805|FG022|Overall Study|Disease Progression|0|||
164278057|NCT02737475|593387806|FG023|Overall Study|Disease Progression|0|||
164278058|NCT02737475|593387807|FG024|Overall Study|Disease Progression|0|||
164278059|NCT02737475|593387808|FG025|Overall Study|Disease Progression|0|||
164278060|NCT02737475|593387809|FG026|Overall Study|Disease Progression|1|||
164278061|NCT02510001|593387810|FG000|Overall Study|Early disease progression|0|||
164278062|NCT02510001|593387811|FG001|Overall Study|Early disease progression|0|||
164278063|NCT02510001|593387812|FG002|Overall Study|Early disease progression|0|||
164278064|NCT02510001|593387813|FG003|Overall Study|Early disease progression|1|||
164278065|NCT02510001|593387814|FG004|Overall Study|Early disease progression|1|||
164278066|NCT02510001|593387815|FG005|Overall Study|Early disease progression|1|||
164278067|NCT02510001|593387816|FG006|Overall Study|Early disease progression|0|||
164278068|NCT02510001|593387817|FG007|Overall Study|Early disease progression|0|||
164278069|NCT02510001|593387810|FG000|Overall Study|Adverse Event|0|||
164278070|NCT02510001|593387811|FG001|Overall Study|Adverse Event|0|||
164278071|NCT02510001|593387812|FG002|Overall Study|Adverse Event|0|||
164278072|NCT02510001|593387813|FG003|Overall Study|Adverse Event|1|||
164278073|NCT02510001|593387814|FG004|Overall Study|Adverse Event|2|||
164278074|NCT02510001|593387815|FG005|Overall Study|Adverse Event|1|||
164278075|NCT02510001|593387816|FG006|Overall Study|Adverse Event|2|||
164278076|NCT02510001|593387817|FG007|Overall Study|Adverse Event|5|||
164278077|NCT02510001|593387810|FG000|Overall Study|Physician Decision|0|||
164278078|NCT02510001|593387811|FG001|Overall Study|Physician Decision|0|||
164278079|NCT02510001|593387812|FG002|Overall Study|Physician Decision|0|||
164278080|NCT02510001|593387813|FG003|Overall Study|Physician Decision|0|||
164278081|NCT02510001|593387814|FG004|Overall Study|Physician Decision|1|||
164278082|NCT02510001|593387815|FG005|Overall Study|Physician Decision|0|||
164278083|NCT02510001|593387816|FG006|Overall Study|Physician Decision|0|||
164278084|NCT02510001|593387817|FG007|Overall Study|Physician Decision|0|||
164278085|NCT02510001|593387810|FG000|Overall Study|Withdrawal by Subject|0|||
164278086|NCT02510001|593387811|FG001|Overall Study|Withdrawal by Subject|0|||
164278087|NCT02510001|593387812|FG002|Overall Study|Withdrawal by Subject|0|||
164278088|NCT02510001|593387813|FG003|Overall Study|Withdrawal by Subject|0|||
164278089|NCT02510001|593387814|FG004|Overall Study|Withdrawal by Subject|0|||
164278090|NCT02510001|593387815|FG005|Overall Study|Withdrawal by Subject|0|||
164278091|NCT02510001|593387816|FG006|Overall Study|Withdrawal by Subject|0|||
164343774|NCT01847274|593635307|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
164343775|NCT01847274|593635308|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
164343776|NCT01847274|593635309|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
164343777|NCT01847274|593635310|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
164343778|NCT01847274|593635311|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343779|NCT01847274|593635312|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343780|NCT01847274|593635313|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343781|NCT01847274|593635314|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343782|NCT01847274|593635315|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343783|NCT01847274|593635316|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343784|NCT01847274|593635317|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
164343785|NCT01847274|593635307|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343786|NCT01847274|593635308|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343787|NCT01847274|593635309|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343788|NCT01847274|593635310|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343789|NCT01847274|593635311|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343790|NCT01847274|593635312|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
164343791|NCT01847274|593635313|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343792|NCT01847274|593635314|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343793|NCT01847274|593635315|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343794|NCT01847274|593635316|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343795|NCT01847274|593635317|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
164343796|NCT01847274|593635307|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343797|NCT01847274|593635308|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343798|NCT01847274|593635309|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164278092|NCT02510001|593387817|FG007|Overall Study|Withdrawal by Subject|2|||
164343799|NCT01847274|593635310|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343800|NCT01847274|593635311|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
164142993|NCT00863772|592884484|FG000|Overall Study|Lost to Follow-up|5|||
164278093|NCT00711971|593387840|FG000|Overall Study|Lost to Follow-up|3|||
164278094|NCT00711971|593387841|FG001|Overall Study|Lost to Follow-up|4|||
164278095|NCT00711971|593387842|FG002|Overall Study|Lost to Follow-up|1|||
164278096|NCT00887549|593387845|FG000|Induction Therapy|Adverse Event|8|||
164278097|NCT00887549|593387845|FG000|Induction Therapy|Physician Decision|1|||
164278098|NCT00887549|593387845|FG000|Induction Therapy|Progressive Disease|13|||
164278099|NCT00887549|593387845|FG000|Induction Therapy|Death due to Study Disease|4|||
164278100|NCT00887549|593387845|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
164278101|NCT00887549|593387845|FG000|Maintenance Therapy|Adverse Event|16|||
164278102|NCT00887549|593387845|FG000|Maintenance Therapy|Physician Decision|1|||
164278103|NCT00887549|593387845|FG000|Maintenance Therapy|Progressive Disease|25|||
164278104|NCT00887549|593387845|FG000|Maintenance Therapy|Death due to adverse event|1|||
164278105|NCT02097030|593387852|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
164278106|NCT02097030|593387853|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
164278107|NCT02097030|593387852|FG000|First Intervention (3 Days)|Visual Acuity|0|||
164278108|NCT02097030|593387853|FG001|First Intervention (3 Days)|Visual Acuity|1|||
164278109|NCT01919801|593387854|FG000|Overall Study|Withdrawal by Subject|1|||
164278110|NCT01919801|593387855|FG001|Overall Study|Withdrawal by Subject|0|||
164278111|NCT01919801|593387854|FG000|Overall Study|Physician Decision|0|||
164278112|NCT01919801|593387855|FG001|Overall Study|Physician Decision|1|||
164278113|NCT01919801|593387854|FG000|Overall Study|Lost to Follow-up|0|||
164278114|NCT01919801|593387855|FG001|Overall Study|Lost to Follow-up|1|||
164278115|NCT01919801|593387854|FG000|Overall Study|Other|0|||
164278116|NCT01919801|593387855|FG001|Overall Study|Other|1|||
164278117|NCT01677858|593387860|FG000|Overall Study|Adverse Event|0|||
164278118|NCT01677858|593387861|FG001|Overall Study|Adverse Event|0|||
164278119|NCT01677858|593387862|FG002|Overall Study|Adverse Event|2|||
164278120|NCT01677858|593387863|FG003|Overall Study|Adverse Event|3|||
164278121|NCT01677858|593387864|FG004|Overall Study|Adverse Event|13|||
164278122|NCT01677858|593387860|FG000|Overall Study|Death|0|||
164278123|NCT01677858|593387861|FG001|Overall Study|Death|0|||
164278124|NCT01677858|593387862|FG002|Overall Study|Death|0|||
164278125|NCT01677858|593387863|FG003|Overall Study|Death|0|||
164278126|NCT01677858|593387864|FG004|Overall Study|Death|1|||
164278127|NCT01677858|593387860|FG000|Overall Study|Physician Decision|1|||
164278128|NCT01677858|593387861|FG001|Overall Study|Physician Decision|0|||
164278129|NCT01677858|593387862|FG002|Overall Study|Physician Decision|2|||
164278130|NCT01677858|593387863|FG003|Overall Study|Physician Decision|0|||
164278131|NCT01677858|593387864|FG004|Overall Study|Physician Decision|12|||
164278132|NCT01677858|593387860|FG000|Overall Study|Progressive Disease|2|||
164278133|NCT01677858|593387861|FG001|Overall Study|Progressive Disease|1|||
164278134|NCT01677858|593387862|FG002|Overall Study|Progressive Disease|9|||
164278135|NCT01677858|593387863|FG003|Overall Study|Progressive Disease|3|||
164278136|NCT01677858|593387864|FG004|Overall Study|Progressive Disease|43|||
164278137|NCT01677858|593387860|FG000|Overall Study|Withdrawal by Subject|0|||
164278138|NCT01677858|593387861|FG001|Overall Study|Withdrawal by Subject|1|||
164278139|NCT01677858|593387862|FG002|Overall Study|Withdrawal by Subject|1|||
164278140|NCT01677858|593387863|FG003|Overall Study|Withdrawal by Subject|0|||
164278141|NCT01677858|593387864|FG004|Overall Study|Withdrawal by Subject|15|||
164278142|NCT01677858|593387860|FG000|Overall Study|Lost to Follow-up|0|||
164278143|NCT01677858|593387861|FG001|Overall Study|Lost to Follow-up|0|||
164278144|NCT01677858|593387862|FG002|Overall Study|Lost to Follow-up|0|||
164278145|NCT01677858|593387863|FG003|Overall Study|Lost to Follow-up|0|||
164278146|NCT01677858|593387864|FG004|Overall Study|Lost to Follow-up|1|||
164278147|NCT00988091|593387865|FG000|Double-blind Period|Withdrawal by Subject|15|||
164278148|NCT00988091|593387866|FG001|Double-blind Period|Withdrawal by Subject|13|||
164278149|NCT00988091|593387865|FG000|Double-blind Period|Lost to Follow-up|12|||
164278150|NCT00988091|593387866|FG001|Double-blind Period|Lost to Follow-up|14|||
164278151|NCT00988091|593387865|FG000|Double-blind Period|Other|8|||
164278152|NCT00988091|593387866|FG001|Double-blind Period|Other|8|||
164278153|NCT00988091|593387865|FG000|Double-blind Period|Adverse Event|6|||
164278154|NCT00988091|593387866|FG001|Double-blind Period|Adverse Event|9|||
164278155|NCT00988091|593387865|FG000|Double-blind Period|Use of exclusionary medication|2|||
164343801|NCT01847274|593635312|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343802|NCT01847274|593635313|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343803|NCT01847274|593635314|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343804|NCT01847274|593635315|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343805|NCT01847274|593635316|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343806|NCT01847274|593635317|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
164343807|NCT01847274|593635307|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343808|NCT01847274|593635308|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343809|NCT01847274|593635309|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343810|NCT01847274|593635310|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343811|NCT01847274|593635311|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343812|NCT01847274|593635312|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343813|NCT01847274|593635313|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
164278156|NCT00988091|593387866|FG001|Double-blind Period|Use of exclusionary medication|3|||
164278157|NCT00988091|593387865|FG000|Open-label Period|Adverse Event|4|||
164278158|NCT00988091|593387866|FG001|Open-label Period|Adverse Event|7|||
164278159|NCT00988091|593387865|FG000|Open-label Period|Use of exclusionary medication|1|||
164278160|NCT00988091|593387866|FG001|Open-label Period|Use of exclusionary medication|1|||
164278161|NCT00988091|593387865|FG000|Open-label Period|Protocol Violation|1|||
164278162|NCT00988091|593387866|FG001|Open-label Period|Protocol Violation|1|||
164278163|NCT00988091|593387865|FG000|Open-label Period|Withdrawal by Subject|10|||
164278164|NCT00988091|593387866|FG001|Open-label Period|Withdrawal by Subject|16|||
164278165|NCT00988091|593387865|FG000|Open-label Period|Lost to Follow-up|3|||
164278166|NCT00988091|593387866|FG001|Open-label Period|Lost to Follow-up|5|||
164278167|NCT00988091|593387865|FG000|Open-label Period|Other|2|||
164278168|NCT00988091|593387866|FG001|Open-label Period|Other|3|||
164278169|NCT03078855|593387870|FG000|Overall Study|Lack of Efficacy|62|||
164278170|NCT03078855|593387871|FG001|Overall Study|Lack of Efficacy|31|||
164278171|NCT03078855|593387870|FG000|Overall Study|Death|1|||
164278172|NCT03078855|593387871|FG001|Overall Study|Death|0|||
164278173|NCT03078855|593387870|FG000|Overall Study|Withdrawal by Subject|12|||
164278174|NCT03078855|593387871|FG001|Overall Study|Withdrawal by Subject|6|||
164278175|NCT03078855|593387870|FG000|Overall Study|Physician Decision|3|||
164278176|NCT03078855|593387871|FG001|Overall Study|Physician Decision|2|||
164278177|NCT03078855|593387870|FG000|Overall Study|Second Malignancy|4|||
164278178|NCT03078855|593387871|FG001|Overall Study|Second Malignancy|0|||
164278179|NCT03078855|593387870|FG000|Overall Study|Ineligible|2|||
164278180|NCT03078855|593387871|FG001|Overall Study|Ineligible|0|||
164278181|NCT03078855|593387870|FG000|Overall Study|Withdrew before day 1 treatment|2|||
164278182|NCT03078855|593387871|FG001|Overall Study|Withdrew before day 1 treatment|1|||
164278183|NCT00391027|593387872|FG000|Overall Study|Adverse Event|8|||
164278184|NCT00391027|593387873|FG001|Overall Study|Adverse Event|8|||
164278185|NCT00391027|593387872|FG000|Overall Study|Lack of Efficacy|3|||
164278186|NCT00391027|593387873|FG001|Overall Study|Lack of Efficacy|0|||
164278187|NCT00391027|593387872|FG000|Overall Study|Withdrawal by Subject|10|||
164278188|NCT00391027|593387873|FG001|Overall Study|Withdrawal by Subject|1|||
164278189|NCT00391027|593387872|FG000|Overall Study|Other|4|||
164278190|NCT00391027|593387873|FG001|Overall Study|Other|3|||
164278191|NCT03194646|593387874|FG000|Overall Study|Adverse Event|24|||
164278192|NCT03194646|593387875|FG001|Overall Study|Adverse Event|25|||
164278193|NCT03194646|593387876|FG002|Overall Study|Adverse Event|14|||
164278194|NCT03194646|593387877|FG003|Overall Study|Adverse Event|17|||
164278195|NCT03194646|593387874|FG000|Overall Study|Lack of Efficacy|4|||
164278196|NCT03194646|593387875|FG001|Overall Study|Lack of Efficacy|2|||
164278197|NCT03194646|593387876|FG002|Overall Study|Lack of Efficacy|2|||
164278198|NCT03194646|593387877|FG003|Overall Study|Lack of Efficacy|12|||
164278199|NCT03194646|593387874|FG000|Overall Study|Lost to Follow-up|30|||
164278200|NCT03194646|593387875|FG001|Overall Study|Lost to Follow-up|22|||
164278201|NCT03194646|593387876|FG002|Overall Study|Lost to Follow-up|12|||
164278202|NCT03194646|593387877|FG003|Overall Study|Lost to Follow-up|35|||
164278203|NCT03194646|593387874|FG000|Overall Study|Non-compliance with study drug|4|||
164278204|NCT03194646|593387875|FG001|Overall Study|Non-compliance with study drug|0|||
164278205|NCT03194646|593387876|FG002|Overall Study|Non-compliance with study drug|1|||
164278206|NCT03194646|593387877|FG003|Overall Study|Non-compliance with study drug|1|||
164278207|NCT03194646|593387874|FG000|Overall Study|Other|89|||
164278208|NCT03194646|593387875|FG001|Overall Study|Other|68|||
164278209|NCT03194646|593387876|FG002|Overall Study|Other|34|||
164278210|NCT03194646|593387877|FG003|Overall Study|Other|31|||
164278211|NCT03194646|593387874|FG000|Overall Study|Physician Decision|7|||
164278212|NCT03194646|593387875|FG001|Overall Study|Physician Decision|9|||
164278213|NCT03194646|593387876|FG002|Overall Study|Physician Decision|5|||
164278214|NCT03194646|593387877|FG003|Overall Study|Physician Decision|4|||
164278215|NCT03194646|593387874|FG000|Overall Study|Pregnancy|4|||
164278216|NCT03194646|593387875|FG001|Overall Study|Pregnancy|5|||
164278217|NCT03194646|593387876|FG002|Overall Study|Pregnancy|1|||
164278218|NCT03194646|593387877|FG003|Overall Study|Pregnancy|2|||
164278219|NCT03194646|593387874|FG000|Overall Study|Protocol Violation|4|||
164278220|NCT03194646|593387875|FG001|Overall Study|Protocol Violation|2|||
164278221|NCT03194646|593387876|FG002|Overall Study|Protocol Violation|1|||
164278222|NCT03194646|593387877|FG003|Overall Study|Protocol Violation|1|||
164278223|NCT03194646|593387874|FG000|Overall Study|Site terminated by sponsor|0|||
164278224|NCT03194646|593387875|FG001|Overall Study|Site terminated by sponsor|0|||
164278225|NCT03194646|593387876|FG002|Overall Study|Site terminated by sponsor|2|||
164278226|NCT03194646|593387877|FG003|Overall Study|Site terminated by sponsor|0|||
164278227|NCT03194646|593387874|FG000|Overall Study|Study terminated by sponsor|62|||
164278228|NCT03194646|593387875|FG001|Overall Study|Study terminated by sponsor|61|||
164278229|NCT03194646|593387876|FG002|Overall Study|Study terminated by sponsor|30|||
164278230|NCT03194646|593387877|FG003|Overall Study|Study terminated by sponsor|34|||
164278231|NCT03194646|593387874|FG000|Overall Study|Withdrawal by Subject|75|||
164278232|NCT03194646|593387875|FG001|Overall Study|Withdrawal by Subject|74|||
164278233|NCT03194646|593387876|FG002|Overall Study|Withdrawal by Subject|36|||
164278234|NCT03194646|593387877|FG003|Overall Study|Withdrawal by Subject|131|||
164278235|NCT03194646|593387874|FG000|Overall Study|Missing|1|||
164278236|NCT03194646|593387875|FG001|Overall Study|Missing|0|||
164278237|NCT03194646|593387876|FG002|Overall Study|Missing|1|||
164278238|NCT03194646|593387877|FG003|Overall Study|Missing|12|||
164278239|NCT04869358|593387878|FG000|Overall Study|Wish to have children.|1|||
164278240|NCT04869358|593387879|FG001|Overall Study|Wish to have children.|0|||
164278241|NCT04869358|593387880|FG002|Overall Study|Wish to have children.|0|||
164278242|NCT04869358|593387881|FG003|Overall Study|Wish to have children.|0|||
164278243|NCT05232864|593387882|FG000|Overall Study|Adverse Event|0|||
164278244|NCT05232864|593387883|FG001|Overall Study|Adverse Event|1|||
164278245|NCT05232864|593387882|FG000|Overall Study|Study terminated by sponsor|16|||
164278246|NCT05232864|593387883|FG001|Overall Study|Study terminated by sponsor|14|||
164278247|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
164278248|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
164278249|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
164278250|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
164278251|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Death|2|||
164278252|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Death|2|||
164278253|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Death|0|||
164278254|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Death|0|||
164278255|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
164278256|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
164278257|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
164278258|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
164278259|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
164278260|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
164278261|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
164278262|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
164278263|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
164278264|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
164278265|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
164278266|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
164278267|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
164278268|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
164278269|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
164278270|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
164278271|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
164278272|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
164278273|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
164278274|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
164278275|NCT03068754|593387886|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
164278276|NCT03068754|593387887|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
164278277|NCT03068754|593387888|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
164278278|NCT03068754|593387889|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
164278279|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
164343814|NCT01847274|593635314|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343815|NCT01847274|593635315|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343816|NCT01847274|593635316|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343817|NCT01847274|593635317|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
164343818|NCT01847274|593635307|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343819|NCT01847274|593635308|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343820|NCT01847274|593635309|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343821|NCT01847274|593635310|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343822|NCT01847274|593635311|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343823|NCT01847274|593635312|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343824|NCT01847274|593635313|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
164343825|NCT01847274|593635314|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164278280|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
164278281|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
164343826|NCT01847274|593635315|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164278282|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
164278283|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Death|0|||
164278284|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Death|0|||
164278285|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Death|0|||
164278286|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Death|1|||
164278287|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
164278288|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
164278289|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
164278290|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
164278291|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
164278292|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
164278293|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
164278294|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
164278295|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
164278296|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
164278297|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
164278298|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
164278299|NCT03068754|593387886|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
164278300|NCT03068754|593387887|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
164278301|NCT03068754|593387888|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
164278302|NCT03068754|593387889|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
164278303|NCT01110382|593387890|FG000|Overall Study|Withdrawal by Subject|0|||
164278304|NCT01110382|593387891|FG001|Overall Study|Withdrawal by Subject|1|||
164278305|NCT01110382|593387890|FG000|Overall Study|Protocol Violation|0|||
164278306|NCT01110382|593387891|FG001|Overall Study|Protocol Violation|1|||
164278307|NCT00098306|593387892|FG000|Double Blind|Randomized, not treated|9|||
164278308|NCT00098306|593387893|FG001|Double Blind|Randomized, not treated|5|||
164278309|NCT00098306|593387894|FG002|Double Blind|Randomized, not treated|2|||
164278310|NCT00098306|593387895|FG003|Double Blind|Randomized, not treated|0|||
164278311|NCT00098306|593387896|FG004|Double Blind|Randomized, not treated|0|||
164278312|NCT00098306|593387897|FG005|Double Blind|Randomized, not treated|0|||
164278313|NCT00098306|593387898|FG006|Double Blind|Randomized, not treated|0|||
164278314|NCT00098306|593387892|FG000|Double Blind|Ongoing at cut-off date|151|||
164278315|NCT00098306|593387893|FG001|Double Blind|Ongoing at cut-off date|166|||
164278316|NCT00098306|593387894|FG002|Double Blind|Ongoing at cut-off date|72|||
164278317|NCT00098306|593387895|FG003|Double Blind|Ongoing at cut-off date|0|||
164278318|NCT00098306|593387896|FG004|Double Blind|Ongoing at cut-off date|0|||
164278319|NCT00098306|593387897|FG005|Double Blind|Ongoing at cut-off date|0|||
164278320|NCT00098306|593387898|FG006|Double Blind|Ongoing at cut-off date|0|||
164278321|NCT00098306|593387892|FG000|Double Blind|Adverse Event|11|||
164278322|NCT00098306|593387893|FG001|Double Blind|Adverse Event|10|||
164278323|NCT00098306|593387894|FG002|Double Blind|Adverse Event|6|||
164278324|NCT00098306|593387895|FG003|Double Blind|Adverse Event|0|||
164278325|NCT00098306|593387896|FG004|Double Blind|Adverse Event|0|||
164278326|NCT00098306|593387897|FG005|Double Blind|Adverse Event|0|||
164278327|NCT00098306|593387898|FG006|Double Blind|Adverse Event|0|||
164278328|NCT00098306|593387892|FG000|Double Blind|Lack of Efficacy|43|||
164278329|NCT00098306|593387893|FG001|Double Blind|Lack of Efficacy|34|||
164278330|NCT00098306|593387894|FG002|Double Blind|Lack of Efficacy|17|||
164278331|NCT00098306|593387895|FG003|Double Blind|Lack of Efficacy|0|||
164278332|NCT00098306|593387896|FG004|Double Blind|Lack of Efficacy|0|||
164278333|NCT00098306|593387897|FG005|Double Blind|Lack of Efficacy|0|||
164278334|NCT00098306|593387898|FG006|Double Blind|Lack of Efficacy|0|||
164278335|NCT00098306|593387892|FG000|Double Blind|Death|1|||
164278336|NCT00098306|593387893|FG001|Double Blind|Death|4|||
164278337|NCT00098306|593387894|FG002|Double Blind|Death|1|||
164278338|NCT00098306|593387895|FG003|Double Blind|Death|0|||
164278339|NCT00098306|593387896|FG004|Double Blind|Death|0|||
164278340|NCT00098306|593387897|FG005|Double Blind|Death|0|||
164278341|NCT00098306|593387898|FG006|Double Blind|Death|0|||
164278342|NCT00098306|593387892|FG000|Double Blind|Participant defaulted|19|||
164278343|NCT00098306|593387893|FG001|Double Blind|Participant defaulted|18|||
164278344|NCT00098306|593387894|FG002|Double Blind|Participant defaulted|11|||
164278345|NCT00098306|593387895|FG003|Double Blind|Participant defaulted|0|||
164278346|NCT00098306|593387896|FG004|Double Blind|Participant defaulted|0|||
164278347|NCT00098306|593387897|FG005|Double Blind|Participant defaulted|0|||
164278348|NCT00098306|593387898|FG006|Double Blind|Participant defaulted|0|||
164278349|NCT00098306|593387892|FG000|Double Blind|Un-specified|7|||
164278350|NCT00098306|593387893|FG001|Double Blind|Un-specified|3|||
164278351|NCT00098306|593387894|FG002|Double Blind|Un-specified|11|||
164278352|NCT00098306|593387895|FG003|Double Blind|Un-specified|0|||
164278353|NCT00098306|593387896|FG004|Double Blind|Un-specified|0|||
164278354|NCT00098306|593387897|FG005|Double Blind|Un-specified|0|||
164278355|NCT00098306|593387898|FG006|Double Blind|Un-specified|0|||
164278356|NCT00098306|593387892|FG000|Open Label|Lack of Efficacy|0|||
164278357|NCT00098306|593387893|FG001|Open Label|Lack of Efficacy|0|||
164278358|NCT00098306|593387894|FG002|Open Label|Lack of Efficacy|0|||
164278359|NCT00098306|593387895|FG003|Open Label|Lack of Efficacy|13|||
164278360|NCT00098306|593387896|FG004|Open Label|Lack of Efficacy|0|||
164278361|NCT00098306|593387897|FG005|Open Label|Lack of Efficacy|0|||
164278362|NCT00098306|593387898|FG006|Open Label|Lack of Efficacy|0|||
164278363|NCT00098306|593387892|FG000|Open Label|Adverse Event|0|||
164278364|NCT00098306|593387893|FG001|Open Label|Adverse Event|0|||
164278365|NCT00098306|593387894|FG002|Open Label|Adverse Event|0|||
164278366|NCT00098306|593387895|FG003|Open Label|Adverse Event|2|||
164278367|NCT00098306|593387896|FG004|Open Label|Adverse Event|0|||
164278368|NCT00098306|593387897|FG005|Open Label|Adverse Event|0|||
164343827|NCT01847274|593635316|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343828|NCT01847274|593635317|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
164343829|NCT01847274|593635307|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343830|NCT01847274|593635308|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343831|NCT01847274|593635309|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343832|NCT01847274|593635310|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343833|NCT01847274|593635311|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343834|NCT01847274|593635312|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343835|NCT01847274|593635313|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
164343836|NCT01847274|593635314|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343837|NCT01847274|593635315|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343838|NCT01847274|593635316|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343839|NCT01847274|593635317|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
164343840|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343841|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343842|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343843|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343844|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343845|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343846|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
164343847|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
164343848|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
164343849|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
164343850|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
164343851|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343852|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343853|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343854|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343855|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343856|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343857|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343858|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
164343859|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343860|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
164343861|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
164343862|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343863|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343864|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343865|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343866|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343867|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343868|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343869|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
164343870|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
164343871|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
164343872|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
164343873|NCT01847274|593635307|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343874|NCT01847274|593635308|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343875|NCT01847274|593635309|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343876|NCT01847274|593635310|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343877|NCT01847274|593635311|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343878|NCT01847274|593635312|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343879|NCT01847274|593635313|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164278369|NCT00098306|593387898|FG006|Open Label|Adverse Event|0|||
164278370|NCT00098306|593387892|FG000|Open Label|Death|0|||
164278371|NCT00098306|593387893|FG001|Open Label|Death|0|||
164278372|NCT00098306|593387894|FG002|Open Label|Death|0|||
164278373|NCT00098306|593387895|FG003|Open Label|Death|4|||
164278374|NCT00098306|593387896|FG004|Open Label|Death|0|||
164278375|NCT00098306|593387897|FG005|Open Label|Death|0|||
164278376|NCT00098306|593387898|FG006|Open Label|Death|0|||
164278377|NCT00098306|593387892|FG000|Open Label|Participant defaulted|0|||
164278378|NCT00098306|593387893|FG001|Open Label|Participant defaulted|0|||
164278379|NCT00098306|593387894|FG002|Open Label|Participant defaulted|0|||
164278380|NCT00098306|593387895|FG003|Open Label|Participant defaulted|24|||
164278381|NCT00098306|593387896|FG004|Open Label|Participant defaulted|0|||
164278382|NCT00098306|593387897|FG005|Open Label|Participant defaulted|0|||
164278383|NCT00098306|593387898|FG006|Open Label|Participant defaulted|0|||
164278384|NCT00098306|593387892|FG000|Open Label|Un-specified|0|||
164278385|NCT00098306|593387893|FG001|Open Label|Un-specified|0|||
164278386|NCT00098306|593387894|FG002|Open Label|Un-specified|0|||
164278387|NCT00098306|593387895|FG003|Open Label|Un-specified|15|||
164278388|NCT00098306|593387896|FG004|Open Label|Un-specified|0|||
164278389|NCT00098306|593387897|FG005|Open Label|Un-specified|0|||
164278390|NCT00098306|593387898|FG006|Open Label|Un-specified|0|||
164278391|NCT00098306|593387892|FG000|Open Label|Ongoing at cut-off date|0|||
164278392|NCT00098306|593387893|FG001|Open Label|Ongoing at cut-off date|0|||
164278393|NCT00098306|593387894|FG002|Open Label|Ongoing at cut-off date|0|||
164278394|NCT00098306|593387895|FG003|Open Label|Ongoing at cut-off date|269|||
164278395|NCT00098306|593387896|FG004|Open Label|Ongoing at cut-off date|62|||
164278396|NCT00098306|593387897|FG005|Open Label|Ongoing at cut-off date|0|||
164278397|NCT00098306|593387898|FG006|Open Label|Ongoing at cut-off date|0|||
164278398|NCT00098306|593387892|FG000|Observational Phase|Death|0|||
164278399|NCT00098306|593387893|FG001|Observational Phase|Death|0|||
164278400|NCT00098306|593387894|FG002|Observational Phase|Death|0|||
164278401|NCT00098306|593387895|FG003|Observational Phase|Death|0|||
164278402|NCT00098306|593387896|FG004|Observational Phase|Death|0|||
164278403|NCT00098306|593387897|FG005|Observational Phase|Death|5|||
164278404|NCT00098306|593387898|FG006|Observational Phase|Death|4|||
164278405|NCT00098306|593387892|FG000|Observational Phase|Participant defaulted|0|||
164278406|NCT00098306|593387893|FG001|Observational Phase|Participant defaulted|0|||
164278407|NCT00098306|593387894|FG002|Observational Phase|Participant defaulted|0|||
164278408|NCT00098306|593387895|FG003|Observational Phase|Participant defaulted|0|||
164278409|NCT00098306|593387896|FG004|Observational Phase|Participant defaulted|0|||
164278410|NCT00098306|593387897|FG005|Observational Phase|Participant defaulted|34|||
164278411|NCT00098306|593387898|FG006|Observational Phase|Participant defaulted|18|||
164278412|NCT00098306|593387892|FG000|Observational Phase|Un-specified|0|||
164278413|NCT00098306|593387893|FG001|Observational Phase|Un-specified|0|||
164278414|NCT00098306|593387894|FG002|Observational Phase|Un-specified|0|||
164278415|NCT00098306|593387895|FG003|Observational Phase|Un-specified|0|||
164278416|NCT00098306|593387896|FG004|Observational Phase|Un-specified|0|||
164278417|NCT00098306|593387897|FG005|Observational Phase|Un-specified|7|||
164278418|NCT00098306|593387898|FG006|Observational Phase|Un-specified|4|||
164278419|NCT00129467|593387899|FG000|Received Intervention|Death|1|||
164278420|NCT00129467|593387900|FG001|Received Intervention|Death|1|||
164278421|NCT00129467|593387899|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
164278422|NCT00129467|593387900|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
164278423|NCT00129467|593387899|FG000|Received Intervention|Delirium|2|||
164278424|NCT00129467|593387900|FG001|Received Intervention|Delirium|0|||
164278425|NCT00129467|593387899|FG000|Received Intervention|Withdrawal by Subject|1|||
164278426|NCT00129467|593387900|FG001|Received Intervention|Withdrawal by Subject|0|||
164278427|NCT00129467|593387899|FG000|Received Intervention|Nausea|1|||
164278428|NCT00129467|593387900|FG001|Received Intervention|Nausea|0|||
164278429|NCT00129467|593387899|FG000|Received Intervention|Intolerance to citalopram|0|||
164278430|NCT00129467|593387900|FG001|Received Intervention|Intolerance to citalopram|1|||
164278431|NCT00129467|593387899|FG000|Received Intervention|Dizzyness, fatigue|0|||
164278432|NCT00129467|593387900|FG001|Received Intervention|Dizzyness, fatigue|1|||
164278433|NCT00129467|593387899|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
164278434|NCT00129467|593387900|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
164278435|NCT00129467|593387899|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
164278436|NCT00129467|593387900|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
164278437|NCT01009086|593387901|FG000|Overall Study|Lack of Efficacy|16|||
164278438|NCT01009086|593387902|FG001|Overall Study|Lack of Efficacy|15|||
164278439|NCT01009086|593387903|FG002|Overall Study|Lack of Efficacy|9|||
164278440|NCT01009086|593387901|FG000|Overall Study|Lost to Follow-up|4|||
164278441|NCT01009086|593387902|FG001|Overall Study|Lost to Follow-up|5|||
164278442|NCT01009086|593387903|FG002|Overall Study|Lost to Follow-up|3|||
164278443|NCT01009086|593387901|FG000|Overall Study|Adverse Event|12|||
164278444|NCT01009086|593387902|FG001|Overall Study|Adverse Event|11|||
164278445|NCT01009086|593387903|FG002|Overall Study|Adverse Event|8|||
164278446|NCT01009086|593387901|FG000|Overall Study|Withdrawal by Subject|9|||
164278447|NCT01009086|593387902|FG001|Overall Study|Withdrawal by Subject|11|||
164278448|NCT01009086|593387903|FG002|Overall Study|Withdrawal by Subject|13|||
164278449|NCT01009086|593387901|FG000|Overall Study|Other|3|||
164278450|NCT01009086|593387902|FG001|Overall Study|Other|5|||
164278451|NCT01009086|593387903|FG002|Overall Study|Other|1|||
164278452|NCT02456857|593387905|FG000|Overall Study|Disease Progression|4|||
164278453|NCT00781859|593387906|FG000|Overall Study|Adverse Event|2|||
164278454|NCT00781859|593387907|FG001|Overall Study|Adverse Event|2|||
164278455|NCT00781859|593387906|FG000|Overall Study|Withdrawal by Subject|8|||
164278456|NCT00781859|593387907|FG001|Overall Study|Withdrawal by Subject|4|||
164278457|NCT00781859|593387906|FG000|Overall Study|Lost to Follow-up|6|||
164278458|NCT00781859|593387907|FG001|Overall Study|Lost to Follow-up|3|||
164278459|NCT00781859|593387906|FG000|Overall Study|Death|3|||
164278460|NCT00781859|593387907|FG001|Overall Study|Death|0|||
164278461|NCT01138501|593387908|FG000|Overall Study|Protocol Violation|2|||
164278462|NCT01138501|593387908|FG000|Overall Study|Withdrawal by Subject|3|||
164278463|NCT00360568|593387909|FG000|Overall Study|Adverse Event|1|||
164278464|NCT00360568|593387910|FG001|Overall Study|Adverse Event|2|||
164278465|NCT00360568|593387909|FG000|Overall Study|Lack of Efficacy|1|||
164278466|NCT00360568|593387910|FG001|Overall Study|Lack of Efficacy|0|||
164278467|NCT00360568|593387909|FG000|Overall Study|Withdrawal by Subject|0|||
164278468|NCT00360568|593387910|FG001|Overall Study|Withdrawal by Subject|3|||
164278469|NCT01220180|593387912|FG000|Overall Study|Lost to Follow-up|76|||
164278470|NCT01220180|593387912|FG000|Overall Study|Other|72|||
164278471|NCT01220180|593387912|FG000|Overall Study|Adverse Event|35|||
164278472|NCT01220180|593387912|FG000|Overall Study|Lack of Efficacy|22|||
164278473|NCT01220180|593387912|FG000|Overall Study|Death|1|||
164278474|NCT01220180|593387912|FG000|Overall Study|Randomized but not treated|1|||
164278475|NCT01990859|593387913|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
164278476|NCT01990859|593387913|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
164278477|NCT00348309|593387914|FG000|Overall Study|Adverse Event|56|||
164278478|NCT00348309|593387915|FG001|Overall Study|Adverse Event|28|||
164278479|NCT00348309|593387916|FG002|Overall Study|Adverse Event|63|||
164278480|NCT00348309|593387914|FG000|Overall Study|Lost to Follow-up|6|||
164278481|NCT00348309|593387915|FG001|Overall Study|Lost to Follow-up|7|||
164278482|NCT00348309|593387916|FG002|Overall Study|Lost to Follow-up|4|||
164343880|NCT01847274|593635314|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343881|NCT01847274|593635315|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343882|NCT01847274|593635316|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
164343883|NCT01847274|593635317|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
164343884|NCT02059395|593635319|FG000|Overall Study|Lost to Follow-up|2|||
164343885|NCT02059395|593635320|FG001|Overall Study|Lost to Follow-up|4|||
164343886|NCT00134082|593635321|FG000|Overall Study|Adverse Event|2|||
164343887|NCT00134082|593635321|FG000|Overall Study|Death|1|||
163895249|NCT01121588|591989600|FG000|Overall Study|Non-Specified Reasons|9|||
163895250|NCT01121588|591989601|FG001|Overall Study|Non-Specified Reasons|4|||
163895251|NCT01121588|591989602|FG002|Overall Study|Non-Specified Reasons|2|||
163895252|NCT00942877|591989603|FG000|Overall Study|Refused further treatment|1|||
163895253|NCT00942877|591989604|FG001|Overall Study|Refused further treatment|1|||
163895254|NCT00942877|591989603|FG000|Overall Study|Patient was not treated|1|||
163895255|NCT00942877|591989604|FG001|Overall Study|Patient was not treated|0|||
163895256|NCT00942877|591989603|FG000|Overall Study|Adverse Event|1|||
163895257|NCT00942877|591989604|FG001|Overall Study|Adverse Event|0|||
163895258|NCT00942877|591989603|FG000|Overall Study|Progressive disease|42|||
163895259|NCT00942877|591989604|FG001|Overall Study|Progressive disease|3|||
163895260|NCT02095691|591989605|FG000|Overall Study|Physician Decision|1|||
163895261|NCT00964392|591989609|FG000|Overall Study|Withdrawal by Subject|4|||
163895262|NCT00964392|591989610|FG001|Overall Study|Withdrawal by Subject|6|||
163895263|NCT00964392|591989609|FG000|Overall Study|Lost to Follow-up|4|||
163895264|NCT00964392|591989610|FG001|Overall Study|Lost to Follow-up|10|||
163895265|NCT00964392|591989609|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
163895266|NCT00964392|591989610|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
163895267|NCT00964392|591989609|FG000|Overall Study|Not completed|44|||
163895268|NCT00964392|591989610|FG001|Overall Study|Not completed|168|||
163895269|NCT00631475|591989611|FG000|Overall Study|Death|18|||
163895270|NCT00631475|591989611|FG000|Overall Study|Adverse Event|14|||
163895271|NCT00631475|591989611|FG000|Overall Study|Withdrew consent|5|||
163895272|NCT00631475|591989611|FG000|Overall Study|Preparation for lung transplant|8|||
163895273|NCT04214834|591989619|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
164278483|NCT00348309|593387914|FG000|Overall Study|Protocol Violation|7|||
164278484|NCT00348309|593387915|FG001|Overall Study|Protocol Violation|12|||
164278485|NCT00348309|593387916|FG002|Overall Study|Protocol Violation|7|||
164278486|NCT00348309|593387914|FG000|Overall Study|Withdrawal by Subject|33|||
164278487|NCT00348309|593387915|FG001|Overall Study|Withdrawal by Subject|37|||
164278488|NCT00348309|593387916|FG002|Overall Study|Withdrawal by Subject|40|||
164278489|NCT00348309|593387914|FG000|Overall Study|Non-compliance|8|||
164343888|NCT00724932|593635324|FG000|Overall Study|Lost to Follow-up|1|||
164278490|NCT00348309|593387915|FG001|Overall Study|Non-compliance|6|||
164278491|NCT00348309|593387916|FG002|Overall Study|Non-compliance|8|||
164278492|NCT00348309|593387914|FG000|Overall Study|Death of caregiver|1|||
164278493|NCT00348309|593387915|FG001|Overall Study|Death of caregiver|0|||
164278494|NCT00348309|593387916|FG002|Overall Study|Death of caregiver|1|||
164278495|NCT00348309|593387914|FG000|Overall Study|Lack of insight, dementia|1|||
164278496|NCT00348309|593387915|FG001|Overall Study|Lack of insight, dementia|0|||
164278497|NCT00348309|593387916|FG002|Overall Study|Lack of insight, dementia|0|||
164278498|NCT00348309|593387914|FG000|Overall Study|Wrong bottle allocated|1|||
164278499|NCT00348309|593387915|FG001|Overall Study|Wrong bottle allocated|0|||
164278500|NCT00348309|593387916|FG002|Overall Study|Wrong bottle allocated|0|||
164278501|NCT00348309|593387914|FG000|Overall Study|Caregiver sick|1|||
164278502|NCT00348309|593387915|FG001|Overall Study|Caregiver sick|0|||
164278503|NCT00348309|593387916|FG002|Overall Study|Caregiver sick|0|||
163895274|NCT04214834|591989620|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
163895275|NCT04109066|591989626|FG000|Pre-treatment|Participant withdrew consent|2|||
163895276|NCT04109066|591989627|FG001|Pre-treatment|Participant withdrew consent|0|||
163895277|NCT04109066|591989626|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
163895278|NCT04109066|591989627|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
163895279|NCT04109066|591989626|FG000|Treatment|Lack of Efficacy|2|||
163895280|NCT04109066|591989627|FG001|Treatment|Lack of Efficacy|4|||
163895281|NCT04109066|591989626|FG000|Treatment|Adverse Event|23|||
163895282|NCT04109066|591989627|FG001|Treatment|Adverse Event|7|||
163895283|NCT04109066|591989626|FG000|Treatment|Participant request to discontinue Study treatment|15|||
163895284|NCT04109066|591989627|FG001|Treatment|Participant request to discontinue Study treatment|14|||
163895285|NCT04109066|591989626|FG000|Treatment|Withdrawal by Subject|8|||
164278504|NCT00348309|593387914|FG000|Overall Study|Use of prohibited medication|5|||
164278505|NCT00348309|593387915|FG001|Overall Study|Use of prohibited medication|2|||
164278506|NCT00348309|593387916|FG002|Overall Study|Use of prohibited medication|2|||
164278507|NCT00348309|593387914|FG000|Overall Study|Caregiver withdrawal|3|||
164278508|NCT00348309|593387915|FG001|Overall Study|Caregiver withdrawal|0|||
164278509|NCT00348309|593387916|FG002|Overall Study|Caregiver withdrawal|7|||
164278510|NCT00348309|593387914|FG000|Overall Study|Unable to complete ET visit|1|||
164278511|NCT00348309|593387915|FG001|Overall Study|Unable to complete ET visit|0|||
164278512|NCT00348309|593387916|FG002|Overall Study|Unable to complete ET visit|0|||
164278513|NCT00348309|593387914|FG000|Overall Study|PI closing medical practice|1|||
164278514|NCT00348309|593387915|FG001|Overall Study|PI closing medical practice|0|||
164278515|NCT00348309|593387916|FG002|Overall Study|PI closing medical practice|0|||
164278516|NCT00348309|593387914|FG000|Overall Study|Principal investigator's decision|1|||
164278517|NCT00348309|593387915|FG001|Overall Study|Principal investigator's decision|0|||
164278518|NCT00348309|593387916|FG002|Overall Study|Principal investigator's decision|0|||
164278519|NCT00348309|593387914|FG000|Overall Study|No disponibility of medication|1|||
164278520|NCT00348309|593387915|FG001|Overall Study|No disponibility of medication|0|||
164278521|NCT00348309|593387916|FG002|Overall Study|No disponibility of medication|0|||
164278522|NCT00348309|593387914|FG000|Overall Study|Worsened neurodegenerative disease|1|||
164278523|NCT00348309|593387915|FG001|Overall Study|Worsened neurodegenerative disease|0|||
164278524|NCT00348309|593387916|FG002|Overall Study|Worsened neurodegenerative disease|0|||
164278525|NCT00348309|593387914|FG000|Overall Study|Cognitive and behaviour worsening|2|||
164278526|NCT00348309|593387915|FG001|Overall Study|Cognitive and behaviour worsening|0|||
164278527|NCT00348309|593387916|FG002|Overall Study|Cognitive and behaviour worsening|0|||
164278528|NCT00348309|593387914|FG000|Overall Study|Worsening of alzheimer|1|||
164278529|NCT00348309|593387915|FG001|Overall Study|Worsening of alzheimer|0|||
164278530|NCT00348309|593387916|FG002|Overall Study|Worsening of alzheimer|1|||
164278531|NCT00348309|593387914|FG000|Overall Study|Did not appear in time for Visit 3|1|||
164278532|NCT00348309|593387915|FG001|Overall Study|Did not appear in time for Visit 3|0|||
164278533|NCT00348309|593387916|FG002|Overall Study|Did not appear in time for Visit 3|0|||
164278534|NCT00348309|593387914|FG000|Overall Study|Participant died|2|||
164278535|NCT00348309|593387915|FG001|Overall Study|Participant died|1|||
164278536|NCT00348309|593387916|FG002|Overall Study|Participant died|1|||
164278537|NCT00348309|593387914|FG000|Overall Study|Decision of sponsor|1|||
164278538|NCT00348309|593387915|FG001|Overall Study|Decision of sponsor|0|||
164278539|NCT00348309|593387916|FG002|Overall Study|Decision of sponsor|0|||
164278540|NCT00348309|593387914|FG000|Overall Study|Ineffectiveness of treatment|0|||
164278541|NCT00348309|593387915|FG001|Overall Study|Ineffectiveness of treatment|1|||
164278542|NCT00348309|593387916|FG002|Overall Study|Ineffectiveness of treatment|0|||
164278543|NCT00348309|593387914|FG000|Overall Study|A foul of exclusion criteria|0|||
164278544|NCT00348309|593387915|FG001|Overall Study|A foul of exclusion criteria|1|||
164278545|NCT00348309|593387916|FG002|Overall Study|A foul of exclusion criteria|0|||
164001481|NCT00446030|592368543|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
164278546|NCT00348309|593387914|FG000|Overall Study|Participant was hospitalized|0|||
164278547|NCT00348309|593387915|FG001|Overall Study|Participant was hospitalized|1|||
164278548|NCT00348309|593387916|FG002|Overall Study|Participant was hospitalized|0|||
164278549|NCT00348309|593387914|FG000|Overall Study|Sponsor refuseal|0|||
163895286|NCT04109066|591989627|FG001|Treatment|Withdrawal by Subject|8|||
164278550|NCT00348309|593387915|FG001|Overall Study|Sponsor refuseal|1|||
164278551|NCT00348309|593387916|FG002|Overall Study|Sponsor refuseal|1|||
164278552|NCT00348309|593387914|FG000|Overall Study|Forgot often medication|0|||
164278553|NCT00348309|593387915|FG001|Overall Study|Forgot often medication|1|||
164278554|NCT00348309|593387916|FG002|Overall Study|Forgot often medication|0|||
164278555|NCT00348309|593387914|FG000|Overall Study|Medical Monitor decision|0|||
164278556|NCT00348309|593387915|FG001|Overall Study|Medical Monitor decision|0|||
164278557|NCT00348309|593387916|FG002|Overall Study|Medical Monitor decision|1|||
164278558|NCT00348309|593387914|FG000|Overall Study|Increased dose of Aricept|0|||
164278559|NCT00348309|593387915|FG001|Overall Study|Increased dose of Aricept|0|||
164278560|NCT00348309|593387916|FG002|Overall Study|Increased dose of Aricept|1|||
164278561|NCT00348309|593387914|FG000|Overall Study|Site closure|0|||
164278562|NCT00348309|593387915|FG001|Overall Study|Site closure|0|||
164278563|NCT00348309|593387916|FG002|Overall Study|Site closure|1|||
164278564|NCT00348309|593387914|FG000|Overall Study|Adverse event not attended|0|||
164278565|NCT00348309|593387915|FG001|Overall Study|Adverse event not attended|0|||
164278566|NCT00348309|593387916|FG002|Overall Study|Adverse event not attended|1|||
164278567|NCT00348309|593387914|FG000|Overall Study|ECG abnormal|0|||
164278568|NCT00348309|593387915|FG001|Overall Study|ECG abnormal|0|||
164278569|NCT00348309|593387916|FG002|Overall Study|ECG abnormal|2|||
164278570|NCT00348309|593387914|FG000|Overall Study|Cardiologist recommendations|0|||
164278571|NCT00348309|593387915|FG001|Overall Study|Cardiologist recommendations|0|||
164278572|NCT00348309|593387916|FG002|Overall Study|Cardiologist recommendations|1|||
164278573|NCT00348309|593387914|FG000|Overall Study|HCV career|0|||
164278574|NCT00348309|593387915|FG001|Overall Study|HCV career|0|||
164278575|NCT00348309|593387916|FG002|Overall Study|HCV career|1|||
164278576|NCT01364389|593387919|FG000|Overall Study|Withdrawal by Subject|0|||
164278577|NCT01364389|593387920|FG001|Overall Study|Withdrawal by Subject|1|||
164278578|NCT01364389|593387921|FG002|Overall Study|Withdrawal by Subject|0|||
164278579|NCT01364389|593387919|FG000|Overall Study|Protocol deviation|0|||
164278580|NCT01364389|593387920|FG001|Overall Study|Protocol deviation|0|||
164278581|NCT01364389|593387921|FG002|Overall Study|Protocol deviation|1|||
164343889|NCT00724932|593635325|FG001|Overall Study|Lost to Follow-up|0|||
164343890|NCT00724932|593635324|FG000|Overall Study|Not treated|4|||
164343891|NCT00724932|593635325|FG001|Overall Study|Not treated|3|||
164343892|NCT02021331|593635326|FG000|Overall Study|Adverse Event|0|||
164343893|NCT02021331|593635327|FG001|Overall Study|Adverse Event|2|||
164343894|NCT01488370|593635328|FG000|Overall Study|Protocol Violation|0|||
164343895|NCT01488370|593635329|FG001|Overall Study|Protocol Violation|1|||
164343896|NCT01488370|593635330|FG002|Overall Study|Protocol Violation|1|||
164343897|NCT02340975|593635343|FG000|Overall Study|Death|6|||
164343898|NCT02340975|593635344|FG001|Overall Study|Death|23|||
164343899|NCT02340975|593635345|FG002|Overall Study|Death|21|||
164343900|NCT02340975|593635346|FG003|Overall Study|Death|7|||
164343901|NCT02340975|593635347|FG004|Overall Study|Death|21|||
164343902|NCT02340975|593635348|FG005|Overall Study|Death|13|||
164343903|NCT02340975|593635343|FG000|Overall Study|Lost to Follow-up|0|||
164343904|NCT02340975|593635344|FG001|Overall Study|Lost to Follow-up|0|||
164343905|NCT02340975|593635345|FG002|Overall Study|Lost to Follow-up|0|||
164343906|NCT02340975|593635346|FG003|Overall Study|Lost to Follow-up|0|||
164343907|NCT02340975|593635347|FG004|Overall Study|Lost to Follow-up|2|||
164343908|NCT02340975|593635348|FG005|Overall Study|Lost to Follow-up|0|||
164343909|NCT02340975|593635343|FG000|Overall Study|Withdrawal by Subject|0|||
164343910|NCT02340975|593635344|FG001|Overall Study|Withdrawal by Subject|0|||
164343911|NCT02340975|593635345|FG002|Overall Study|Withdrawal by Subject|3|||
164278582|NCT01364389|593387919|FG000|Overall Study|Administrative problems|1|||
164278583|NCT01364389|593387920|FG001|Overall Study|Administrative problems|0|||
164278584|NCT01364389|593387921|FG002|Overall Study|Administrative problems|0|||
164278585|NCT01364389|593387919|FG000|Overall Study|Adverse Event|1|||
164278586|NCT01364389|593387920|FG001|Overall Study|Adverse Event|0|||
164278587|NCT01364389|593387921|FG002|Overall Study|Adverse Event|0|||
164343912|NCT02340975|593635346|FG003|Overall Study|Withdrawal by Subject|3|||
163895287|NCT04109066|591989626|FG000|Treatment|Death|3|||
163895288|NCT04109066|591989627|FG001|Treatment|Death|0|||
164278588|NCT01534195|593387922|FG000|Overall Study|Withdrawal by Subject|1|||
164278589|NCT01534195|593387923|FG001|Overall Study|Withdrawal by Subject|1|||
164278590|NCT02554981|593387924|FG000|Overall Study|Adverse Event|1|||
164278591|NCT02554981|593387924|FG000|Overall Study|Administrative Reasons|1|||
164278592|NCT02554981|593387924|FG000|Overall Study|Other Miscellaneous Reasons|3|||
164278593|NCT03068767|593387931|FG000|Overall Study|Lost to Follow-up|7|||
164343913|NCT02340975|593635347|FG004|Overall Study|Withdrawal by Subject|2|||
164343914|NCT02340975|593635348|FG005|Overall Study|Withdrawal by Subject|0|||
164343915|NCT02340975|593635343|FG000|Overall Study|Other|0|||
164343916|NCT02340975|593635344|FG001|Overall Study|Other|4|||
164343917|NCT02340975|593635345|FG002|Overall Study|Other|0|||
163895289|NCT04109066|591989626|FG000|Treatment|Participant no longer meets study criteria|2|||
163895290|NCT04109066|591989627|FG001|Treatment|Participant no longer meets study criteria|2|||
164343918|NCT02340975|593635346|FG003|Overall Study|Other|2|||
164343919|NCT02340975|593635347|FG004|Overall Study|Other|0|||
164343920|NCT02340975|593635348|FG005|Overall Study|Other|6|||
164343921|NCT01007812|593635351|FG000|Period 1, One Week|Lost to Follow-up|0|||
164343922|NCT01007812|593635352|FG001|Period 1, One Week|Lost to Follow-up|1|||
164343923|NCT01007812|593635351|FG000|Period 1, One Week|Discomfort|1|||
164343924|NCT01007812|593635352|FG001|Period 1, One Week|Discomfort|0|||
164343925|NCT01091974|593635353|FG000|Overall Study|Did not start intervention|3|||
164343926|NCT01091974|593635354|FG001|Overall Study|Did not start intervention|1|||
164343927|NCT01091974|593635355|FG002|Overall Study|Did not start intervention|3|||
164343928|NCT01091974|593635356|FG003|Overall Study|Did not start intervention|1|||
164343929|NCT01091974|593635353|FG000|Overall Study|resumed sleep medication|0|||
164343930|NCT01091974|593635354|FG001|Overall Study|resumed sleep medication|0|||
164343931|NCT01091974|593635355|FG002|Overall Study|resumed sleep medication|1|||
164343932|NCT01091974|593635356|FG003|Overall Study|resumed sleep medication|2|||
164343933|NCT01091974|593635353|FG000|Overall Study|Withdrawal by Subject|1|||
164343934|NCT01091974|593635354|FG001|Overall Study|Withdrawal by Subject|3|||
164343935|NCT01091974|593635355|FG002|Overall Study|Withdrawal by Subject|2|||
164343936|NCT01091974|593635356|FG003|Overall Study|Withdrawal by Subject|2|||
164343937|NCT01091974|593635353|FG000|Overall Study|side-effects|1|||
164343938|NCT01091974|593635354|FG001|Overall Study|side-effects|1|||
164343939|NCT01091974|593635355|FG002|Overall Study|side-effects|0|||
164343940|NCT01091974|593635356|FG003|Overall Study|side-effects|2|||
164343941|NCT03948581|593635357|FG000|Overall Study|Lost to Follow-up|0|||
164343942|NCT03948581|593635358|FG001|Overall Study|Lost to Follow-up|1|||
164343943|NCT01876420|593635359|FG000|Overall Study|Missed 30 day visit|1|||
164343944|NCT03173313|593635360|FG000|Overall Study|Lost to Follow-up|2|||
164343945|NCT03173313|593635361|FG001|Overall Study|Lost to Follow-up|3|||
164343946|NCT03173313|593635360|FG000|Overall Study|Withdrawal by Subject|0|||
164343947|NCT03173313|593635361|FG001|Overall Study|Withdrawal by Subject|1|||
164343948|NCT03173313|593635360|FG000|Overall Study|Death|5|||
164343949|NCT03173313|593635361|FG001|Overall Study|Death|0|||
164343950|NCT03173313|593635360|FG000|Overall Study|Physician Decision|1|||
164343951|NCT03173313|593635361|FG001|Overall Study|Physician Decision|0|||
164343952|NCT03173313|593635360|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
164343953|NCT03173313|593635361|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
164343954|NCT03173313|593635360|FG000|Overall Study|Bone Fracture|1|||
164343955|NCT03173313|593635361|FG001|Overall Study|Bone Fracture|0|||
164343956|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
164343957|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
164343958|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
164278594|NCT03068767|593387932|FG001|Overall Study|Lost to Follow-up|3|||
164278595|NCT03068767|593387931|FG000|Overall Study|Protocol Violation|3|||
164278596|NCT03068767|593387932|FG001|Overall Study|Protocol Violation|0|||
164278597|NCT00061633|593387933|FG000|Overall Study|Adverse Event|1|||
164278598|NCT00061633|593387934|FG001|Overall Study|Adverse Event|2|||
164278599|NCT00061633|593387933|FG000|Overall Study|Withdrawal by Subject|2|||
164278600|NCT00061633|593387934|FG001|Overall Study|Withdrawal by Subject|2|||
164278601|NCT00061633|593387933|FG000|Overall Study|Lost to Follow-up|1|||
164278602|NCT00061633|593387934|FG001|Overall Study|Lost to Follow-up|4|||
164278603|NCT00061633|593387933|FG000|Overall Study|Other|1|||
164278604|NCT00061633|593387934|FG001|Overall Study|Other|1|||
164278605|NCT00061633|593387933|FG000|Overall Study|Never received study treatment|0|||
164278606|NCT00061633|593387934|FG001|Overall Study|Never received study treatment|2|||
164278607|NCT01431963|593387935|FG000|Overall Study|Adverse Event|18|||
164278608|NCT01431963|593387935|FG000|Overall Study|Lack of Efficacy|7|||
164278609|NCT01431963|593387935|FG000|Overall Study|Protocol Violation|1|||
164278610|NCT01431963|593387935|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
164278611|NCT01431963|593387935|FG000|Overall Study|Physician Decision|4|||
164278612|NCT01431963|593387935|FG000|Overall Study|Withdrawal by Subject|3|||
164278613|NCT01946152|593390381|FG000|Overall Study|Adverse Event|1|||
164278614|NCT01946152|593390382|FG001|Overall Study|Adverse Event|0|||
164278615|NCT01946152|593390383|FG002|Overall Study|Adverse Event|0|||
164343959|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
164343960|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
164343961|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
164343962|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
164343963|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
164343964|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
164343965|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
164278616|NCT01946152|593390384|FG003|Overall Study|Adverse Event|0|||
164278617|NCT01946152|593390381|FG000|Overall Study|Withdrawal by Subject|0|||
164278618|NCT01946152|593390382|FG001|Overall Study|Withdrawal by Subject|2|||
164278619|NCT01946152|593390383|FG002|Overall Study|Withdrawal by Subject|0|||
164278620|NCT01946152|593390384|FG003|Overall Study|Withdrawal by Subject|0|||
164278621|NCT01946152|593390381|FG000|Overall Study|Progression|0|||
164278622|NCT01946152|593390382|FG001|Overall Study|Progression|1|||
164278623|NCT01946152|593390383|FG002|Overall Study|Progression|4|||
164278624|NCT01946152|593390384|FG003|Overall Study|Progression|7|||
164278625|NCT01946152|593390381|FG000|Overall Study|Physician Decision|0|||
164278626|NCT01946152|593390382|FG001|Overall Study|Physician Decision|0|||
164278627|NCT01946152|593390383|FG002|Overall Study|Physician Decision|1|||
164278628|NCT01946152|593390384|FG003|Overall Study|Physician Decision|0|||
164278629|NCT01946152|593390381|FG000|Overall Study|Second malignancy|0|||
164278630|NCT01946152|593390382|FG001|Overall Study|Second malignancy|0|||
164278631|NCT01946152|593390383|FG002|Overall Study|Second malignancy|1|||
164278632|NCT01946152|593390384|FG003|Overall Study|Second malignancy|0|||
164278633|NCT01946152|593390381|FG000|Overall Study|Adverse Event|0|||
164278634|NCT01946152|593390382|FG001|Overall Study|Adverse Event|0|||
164278635|NCT01946152|593390383|FG002|Overall Study|Adverse Event|0|||
164278636|NCT01946152|593390384|FG003|Overall Study|Adverse Event|1|||
164278637|NCT02291419|593390385|FG000|Overall Study|Early study termination|1|||
164278638|NCT02291419|593390386|FG001|Overall Study|Early study termination|5|||
164278639|NCT00931606|593390387|FG000|Overall Study|Death|1|||
164278640|NCT00931606|593390388|FG001|Overall Study|Death|3|||
164278641|NCT00931606|593390389|FG002|Overall Study|Death|2|||
164278642|NCT00931606|593390390|FG003|Overall Study|Death|0|||
164278643|NCT00931606|593390387|FG000|Overall Study|Lost to Follow-up|0|||
164278644|NCT00931606|593390388|FG001|Overall Study|Lost to Follow-up|1|||
164278645|NCT00931606|593390389|FG002|Overall Study|Lost to Follow-up|0|||
164278646|NCT00931606|593390390|FG003|Overall Study|Lost to Follow-up|0|||
164278647|NCT00931606|593390387|FG000|Overall Study|Physician Decision|0|||
164278648|NCT00931606|593390388|FG001|Overall Study|Physician Decision|0|||
164278649|NCT00931606|593390389|FG002|Overall Study|Physician Decision|3|||
164278650|NCT00931606|593390390|FG003|Overall Study|Physician Decision|0|||
164278651|NCT00931606|593390387|FG000|Overall Study|Sponsor Decision|1|||
164278652|NCT00931606|593390388|FG001|Overall Study|Sponsor Decision|4|||
164278653|NCT00931606|593390389|FG002|Overall Study|Sponsor Decision|0|||
164278654|NCT00931606|593390390|FG003|Overall Study|Sponsor Decision|2|||
164278655|NCT00931606|593390387|FG000|Overall Study|Withdrawal by Subject|3|||
164278656|NCT00931606|593390388|FG001|Overall Study|Withdrawal by Subject|1|||
164278657|NCT00931606|593390389|FG002|Overall Study|Withdrawal by Subject|1|||
164278658|NCT00931606|593390390|FG003|Overall Study|Withdrawal by Subject|1|||
164278659|NCT00871338|593390391|FG000|Prior to Booster|Withdrawal by Subject|1|||
164278660|NCT00871338|593390392|FG001|Prior to Booster|Withdrawal by Subject|3|||
164278661|NCT00871338|593390391|FG000|Prior to Booster|Lost to Follow-up|1|||
164278662|NCT00871338|593390392|FG001|Prior to Booster|Lost to Follow-up|0|||
164278663|NCT02391363|593390393|FG000|Overall Study|Lost to Follow-up|5|||
164278664|NCT02391363|593390394|FG001|Overall Study|Lost to Follow-up|5|||
164278665|NCT02391363|593390393|FG000|Overall Study|Withdrawal by Subject|6|||
164278666|NCT02391363|593390394|FG001|Overall Study|Withdrawal by Subject|3|||
164278667|NCT00799266|593390395|FG000|Overall Study|Adverse Event|0|||
164278668|NCT00799266|593390396|FG001|Overall Study|Adverse Event|1|||
164278669|NCT00799266|593390395|FG000|Overall Study|Subject withdrew consent|3|||
164278670|NCT00799266|593390396|FG001|Overall Study|Subject withdrew consent|0|||
164278671|NCT00872599|593390397|FG000|Second Washout Period|Adverse Event|1|||
164278672|NCT00872599|593390398|FG001|Second Washout Period|Adverse Event|1|||
164278673|NCT01504841|593390401|FG000|Overall Study|Withdrawal by Subject|1|||
164278674|NCT01504841|593390402|FG001|Overall Study|Withdrawal by Subject|1|||
164278675|NCT01504841|593390403|FG002|Overall Study|Withdrawal by Subject|0|||
164278676|NCT03149055|593390406|FG000|Overall Study|Not treated|4|||
164278677|NCT04440813|593390407|FG000|Overall Study|Lost to Follow-up|5|||
164278678|NCT04440813|593390408|FG001|Overall Study|Lost to Follow-up|5|||
164278679|NCT00660179|593390409|FG000|Overall Study|Death|44|||
164278680|NCT00660179|593390410|FG001|Overall Study|Death|47|||
164278681|NCT00660179|593390411|FG002|Overall Study|Death|34|||
164278682|NCT00660179|593390409|FG000|Overall Study|Withdrawal of consent|4|||
164142994|NCT00863772|592884485|FG001|Overall Study|Lost to Follow-up|1|||
164278683|NCT00660179|593390410|FG001|Overall Study|Withdrawal of consent|6|||
164278684|NCT00660179|593390411|FG002|Overall Study|Withdrawal of consent|4|||
164278685|NCT00660179|593390409|FG000|Overall Study|Lost to Follow-up|7|||
164278686|NCT00660179|593390410|FG001|Overall Study|Lost to Follow-up|5|||
164278687|NCT00660179|593390411|FG002|Overall Study|Lost to Follow-up|2|||
164278688|NCT00660179|593390409|FG000|Overall Study|Administrative reason|0|||
164278689|NCT00660179|593390410|FG001|Overall Study|Administrative reason|0|||
164278690|NCT00660179|593390411|FG002|Overall Study|Administrative reason|1|||
164278691|NCT00660179|593390409|FG000|Overall Study|Incorrect randomization|1|||
164278692|NCT00660179|593390410|FG001|Overall Study|Incorrect randomization|0|||
164278693|NCT00660179|593390411|FG002|Overall Study|Incorrect randomization|0|||
164278694|NCT00291018|593390416|FG000|Overall Study|Not Consented or Declined PAS|12|||
164278695|NCT00291018|593390417|FG001|Overall Study|Not Consented or Declined PAS|15|||
164278696|NCT00291018|593390418|FG002|Overall Study|Not Consented or Declined PAS|15|||
164278697|NCT00291018|593390416|FG000|Overall Study|Death|3|||
164278698|NCT00291018|593390417|FG001|Overall Study|Death|3|||
164278699|NCT00291018|593390418|FG002|Overall Study|Death|4|||
164278700|NCT00291018|593390416|FG000|Overall Study|Withdrawal by Subject|2|||
164278701|NCT00291018|593390417|FG001|Overall Study|Withdrawal by Subject|8|||
164278702|NCT00291018|593390418|FG002|Overall Study|Withdrawal by Subject|1|||
164278703|NCT00291018|593390416|FG000|Overall Study|Failures|5|||
164278704|NCT00291018|593390417|FG001|Overall Study|Failures|12|||
164278705|NCT00291018|593390418|FG002|Overall Study|Failures|5|||
164278706|NCT00291018|593390416|FG000|Overall Study|Lost to Follow-up|3|||
164278707|NCT00291018|593390417|FG001|Overall Study|Lost to Follow-up|4|||
164278708|NCT00291018|593390418|FG002|Overall Study|Lost to Follow-up|18|||
164278709|NCT01504412|593390419|FG000|Overall Study|Adverse Event|1|||
164278710|NCT01504412|593390420|FG001|Overall Study|Adverse Event|8|||
164278711|NCT01504412|593390421|FG002|Overall Study|Adverse Event|1|||
164278712|NCT01504412|593390422|FG003|Overall Study|Adverse Event|7|||
164278713|NCT01504412|593390423|FG004|Overall Study|Adverse Event|10|||
164278714|NCT01504412|593390419|FG000|Overall Study|Withdrawal by Subject|2|||
164278715|NCT01504412|593390420|FG001|Overall Study|Withdrawal by Subject|1|||
164278716|NCT01504412|593390421|FG002|Overall Study|Withdrawal by Subject|1|||
164278717|NCT01504412|593390422|FG003|Overall Study|Withdrawal by Subject|5|||
164278718|NCT01504412|593390423|FG004|Overall Study|Withdrawal by Subject|1|||
164278719|NCT01504412|593390419|FG000|Overall Study|Other|2|||
164278720|NCT01504412|593390420|FG001|Overall Study|Other|1|||
164278721|NCT01504412|593390421|FG002|Overall Study|Other|1|||
164278722|NCT01504412|593390422|FG003|Overall Study|Other|6|||
164278723|NCT01504412|593390423|FG004|Overall Study|Other|1|||
164278724|NCT01504412|593390419|FG000|Overall Study|Lost to Follow-up|0|||
164278725|NCT01504412|593390420|FG001|Overall Study|Lost to Follow-up|2|||
164278726|NCT01504412|593390421|FG002|Overall Study|Lost to Follow-up|0|||
164278727|NCT01504412|593390422|FG003|Overall Study|Lost to Follow-up|0|||
164278728|NCT01504412|593390423|FG004|Overall Study|Lost to Follow-up|0|||
164278729|NCT01504412|593390419|FG000|Overall Study|Lack of Efficacy|0|||
164278730|NCT01504412|593390420|FG001|Overall Study|Lack of Efficacy|0|||
164278731|NCT01504412|593390421|FG002|Overall Study|Lack of Efficacy|1|||
164278732|NCT01504412|593390422|FG003|Overall Study|Lack of Efficacy|0|||
164278733|NCT01504412|593390423|FG004|Overall Study|Lack of Efficacy|1|||
164278734|NCT01504412|593390419|FG000|Overall Study|Death|0|||
164278735|NCT01504412|593390420|FG001|Overall Study|Death|0|||
164278736|NCT01504412|593390421|FG002|Overall Study|Death|0|||
164278737|NCT01504412|593390422|FG003|Overall Study|Death|1|||
164278738|NCT01504412|593390423|FG004|Overall Study|Death|0|||
164278739|NCT00630344|593390424|FG000|Overall Study|Adverse Event|5|||
164278740|NCT00630344|593390424|FG000|Overall Study|Progressive Disease|19|||
164278741|NCT00630344|593390424|FG000|Overall Study|Physician Decision|9|||
164278742|NCT00630344|593390424|FG000|Overall Study|Withdrawal by Subject|1|||
164278743|NCT00630344|593390424|FG000|Overall Study|Intercurrent Illness|1|||
164278744|NCT00630344|593390424|FG000|Overall Study|Other|1|||
164278745|NCT05362058|593390429|FG000|Treatment Period|Adverse Event|3|||
164278746|NCT05362058|593390430|FG001|Treatment Period|Adverse Event|3|||
164278747|NCT05362058|593390429|FG000|Treatment Period|Assigned treatment by mistake|3|||
164278748|NCT05362058|593390430|FG001|Treatment Period|Assigned treatment by mistake|4|||
164278749|NCT05362058|593390429|FG000|Treatment Period|Death|1|||
164278750|NCT05362058|593390430|FG001|Treatment Period|Death|1|||
164278751|NCT05362058|593390429|FG000|Treatment Period|Lost to Follow-up|6|||
164278752|NCT05362058|593390430|FG001|Treatment Period|Lost to Follow-up|3|||
164278753|NCT05362058|593390429|FG000|Treatment Period|Non-compliance with study drug|0|||
164278754|NCT05362058|593390430|FG001|Treatment Period|Non-compliance with study drug|1|||
164278755|NCT05362058|593390429|FG000|Treatment Period|Physician Decision|1|||
164278756|NCT05362058|593390430|FG001|Treatment Period|Physician Decision|0|||
164278757|NCT05362058|593390429|FG000|Treatment Period|Protocol deviation|1|||
164278758|NCT05362058|593390430|FG001|Treatment Period|Protocol deviation|0|||
164278759|NCT05362058|593390429|FG000|Treatment Period|Withdrawal by Subject|10|||
164278760|NCT05362058|593390430|FG001|Treatment Period|Withdrawal by Subject|11|||
164278761|NCT05362058|593390429|FG000|Follow-Up Period|Death|1|||
164278762|NCT05362058|593390430|FG001|Follow-Up Period|Death|0|||
164278763|NCT05362058|593390429|FG000|Follow-Up Period|Lost to Follow-up|2|||
164278764|NCT05362058|593390430|FG001|Follow-Up Period|Lost to Follow-up|1|||
164278765|NCT05362058|593390429|FG000|Follow-Up Period|Protocol deviation|1|||
164278766|NCT05362058|593390430|FG001|Follow-Up Period|Protocol deviation|1|||
164278767|NCT05362058|593390429|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164278768|NCT05362058|593390430|FG001|Follow-Up Period|Withdrawal by Subject|3|||
164278769|NCT03626545|593390437|FG000|Overall Study|Progressive disease|3|||
164278770|NCT03626545|593390438|FG001|Overall Study|Progressive disease|82|||
164278771|NCT03626545|593390439|FG002|Overall Study|Progressive disease|85|||
164278772|NCT03626545|593390437|FG000|Overall Study|Adverse Event|3|||
164278773|NCT03626545|593390438|FG001|Overall Study|Adverse Event|13|||
164278774|NCT03626545|593390439|FG002|Overall Study|Adverse Event|10|||
164278775|NCT03626545|593390437|FG000|Overall Study|Physician Decision|1|||
164278776|NCT03626545|593390438|FG001|Overall Study|Physician Decision|18|||
164278777|NCT03626545|593390439|FG002|Overall Study|Physician Decision|14|||
164278778|NCT03626545|593390437|FG000|Overall Study|Subject Decision|0|||
164278779|NCT03626545|593390438|FG001|Overall Study|Subject Decision|5|||
164278780|NCT03626545|593390439|FG002|Overall Study|Subject Decision|5|||
164278781|NCT03626545|593390437|FG000|Overall Study|Death|1|||
164278782|NCT03626545|593390438|FG001|Overall Study|Death|1|||
164278783|NCT03626545|593390439|FG002|Overall Study|Death|1|||
164278784|NCT03626545|593390437|FG000|Overall Study|Protocol Deviation|0|||
164278785|NCT03626545|593390438|FG001|Overall Study|Protocol Deviation|1|||
164278786|NCT03626545|593390439|FG002|Overall Study|Protocol Deviation|1|||
164278787|NCT03626545|593390437|FG000|Overall Study|Guardian Decision|0|||
164278788|NCT03626545|593390438|FG001|Overall Study|Guardian Decision|0|||
164278789|NCT03626545|593390439|FG002|Overall Study|Guardian Decision|1|||
164278790|NCT02462720|593390441|FG000|Part 2|Withdrawal by Subject|1|||
164278791|NCT02462720|593390442|FG001|Part 2|Withdrawal by Subject|0|||
164278792|NCT02462720|593390441|FG000|Part 2|Protocol Violation|0|||
164278793|NCT02462720|593390442|FG001|Part 2|Protocol Violation|1|||
164278794|NCT05173012|593390448|FG000|Overall Study|Adverse Event|2|||
164278795|NCT05173012|593390449|FG001|Overall Study|Adverse Event|3|||
164278796|NCT05173012|593390450|FG002|Overall Study|Adverse Event|4|||
164278797|NCT05173012|593390451|FG003|Overall Study|Adverse Event|13|||
164278798|NCT05173012|593390452|FG004|Overall Study|Adverse Event|0|||
164278799|NCT05173012|593390453|FG005|Overall Study|Adverse Event|0|||
164278800|NCT05173012|593390454|FG006|Overall Study|Adverse Event|2|||
164278801|NCT05173012|593390455|FG007|Overall Study|Adverse Event|4|||
164278802|NCT05173012|593390448|FG000|Overall Study|Lost to Follow-up|0|||
164278803|NCT05173012|593390449|FG001|Overall Study|Lost to Follow-up|0|||
164278804|NCT05173012|593390450|FG002|Overall Study|Lost to Follow-up|0|||
164278805|NCT05173012|593390451|FG003|Overall Study|Lost to Follow-up|1|||
164278806|NCT05173012|593390452|FG004|Overall Study|Lost to Follow-up|0|||
164278807|NCT05173012|593390453|FG005|Overall Study|Lost to Follow-up|0|||
164278808|NCT05173012|593390454|FG006|Overall Study|Lost to Follow-up|0|||
164278809|NCT05173012|593390455|FG007|Overall Study|Lost to Follow-up|0|||
164278810|NCT05173012|593390448|FG000|Overall Study|Withdrawal by Subject|1|||
164278811|NCT05173012|593390449|FG001|Overall Study|Withdrawal by Subject|0|||
164278812|NCT05173012|593390450|FG002|Overall Study|Withdrawal by Subject|1|||
164278813|NCT05173012|593390451|FG003|Overall Study|Withdrawal by Subject|3|||
164278814|NCT05173012|593390452|FG004|Overall Study|Withdrawal by Subject|1|||
164278815|NCT05173012|593390453|FG005|Overall Study|Withdrawal by Subject|0|||
164278816|NCT05173012|593390454|FG006|Overall Study|Withdrawal by Subject|1|||
164278817|NCT05173012|593390455|FG007|Overall Study|Withdrawal by Subject|0|||
164278818|NCT05173012|593390448|FG000|Overall Study|Protocol Deviation|0|||
164278819|NCT05173012|593390449|FG001|Overall Study|Protocol Deviation|0|||
164278820|NCT05173012|593390450|FG002|Overall Study|Protocol Deviation|0|||
164278821|NCT05173012|593390451|FG003|Overall Study|Protocol Deviation|1|||
164278822|NCT05173012|593390452|FG004|Overall Study|Protocol Deviation|0|||
164278823|NCT05173012|593390453|FG005|Overall Study|Protocol Deviation|0|||
164278824|NCT05173012|593390454|FG006|Overall Study|Protocol Deviation|0|||
164278825|NCT05173012|593390455|FG007|Overall Study|Protocol Deviation|0|||
164278826|NCT05173012|593390448|FG000|Overall Study|Other|0|||
164278827|NCT05173012|593390449|FG001|Overall Study|Other|0|||
164278828|NCT05173012|593390450|FG002|Overall Study|Other|0|||
164278829|NCT05173012|593390451|FG003|Overall Study|Other|2|||
164278830|NCT05173012|593390452|FG004|Overall Study|Other|0|||
164278831|NCT05173012|593390453|FG005|Overall Study|Other|0|||
164278832|NCT05173012|593390454|FG006|Overall Study|Other|0|||
164278833|NCT05173012|593390455|FG007|Overall Study|Other|0|||
164278834|NCT03668613|593390456|FG000|Overall Study|Adverse Event|1|||
164278835|NCT03668613|593390457|FG001|Overall Study|Adverse Event|2|||
164278836|NCT03668613|593390456|FG000|Overall Study|Lack of Efficacy|5|||
164343966|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
164343967|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
164278837|NCT03668613|593390457|FG001|Overall Study|Lack of Efficacy|1|||
164278838|NCT03668613|593390456|FG000|Overall Study|Pregnancy|0|||
164278839|NCT03668613|593390457|FG001|Overall Study|Pregnancy|2|||
164278840|NCT03668613|593390456|FG000|Overall Study|Protocol Violation|1|||
164278841|NCT03668613|593390457|FG001|Overall Study|Protocol Violation|0|||
164278842|NCT03668613|593390456|FG000|Overall Study|Physician Decision|1|||
164278843|NCT03668613|593390457|FG001|Overall Study|Physician Decision|0|||
164278844|NCT03668613|593390456|FG000|Overall Study|Withdrawal by Subject|2|||
164278845|NCT03668613|593390457|FG001|Overall Study|Withdrawal by Subject|1|||
164278846|NCT03668613|593390456|FG000|Overall Study|Guardian decision|1|||
164278847|NCT03668613|593390457|FG001|Overall Study|Guardian decision|0|||
164278848|NCT01858740|593390458|FG000|Overall Study|Death|4|||
164278849|NCT00517361|593390461|FG000|Overall Study|Death|6|||
164278850|NCT00517361|593390461|FG000|Overall Study|The study was terminated|5|||
164278851|NCT00286494|593390470|FG000|Overall Study|Hyperglycemic rescue|12|||
164278852|NCT00286494|593390471|FG001|Overall Study|Hyperglycemic rescue|19|||
164278853|NCT00286494|593390472|FG002|Overall Study|Hyperglycemic rescue|18|||
164278854|NCT00286494|593390470|FG000|Overall Study|Withdrawal by Subject|2|||
164278855|NCT00286494|593390471|FG001|Overall Study|Withdrawal by Subject|10|||
164278856|NCT00286494|593390472|FG002|Overall Study|Withdrawal by Subject|9|||
164278857|NCT00286494|593390470|FG000|Overall Study|Adverse Event|3|||
164278858|NCT00286494|593390471|FG001|Overall Study|Adverse Event|8|||
164278859|NCT00286494|593390472|FG002|Overall Study|Adverse Event|6|||
164278860|NCT00286494|593390470|FG000|Overall Study|Physician Decision|5|||
164278861|NCT00286494|593390471|FG001|Overall Study|Physician Decision|5|||
164278862|NCT00286494|593390472|FG002|Overall Study|Physician Decision|1|||
164278863|NCT00286494|593390470|FG000|Overall Study|Lost to Follow-up|3|||
164278864|NCT00286494|593390471|FG001|Overall Study|Lost to Follow-up|1|||
164278865|NCT00286494|593390472|FG002|Overall Study|Lost to Follow-up|3|||
164278866|NCT00286494|593390470|FG000|Overall Study|Protocol Violation|1|||
164278867|NCT00286494|593390471|FG001|Overall Study|Protocol Violation|1|||
164278868|NCT00286494|593390472|FG002|Overall Study|Protocol Violation|2|||
164278869|NCT04776317|593390473|FG000|Overall Study|Physician Decision|0|||
164278870|NCT04776317|593390474|FG001|Overall Study|Physician Decision|1|||
164278871|NCT04776317|593390475|FG002|Overall Study|Physician Decision|0|||
164278872|NCT04776317|593390476|FG003|Overall Study|Physician Decision|0|||
164278873|NCT04776317|593390477|FG004|Overall Study|Physician Decision|0|||
164278874|NCT04776317|593390478|FG005|Overall Study|Physician Decision|0|||
164278875|NCT04776317|593390479|FG006|Overall Study|Physician Decision|0|||
164278876|NCT04776317|593390480|FG007|Overall Study|Physician Decision|0|||
164278877|NCT04776317|593390481|FG008|Overall Study|Physician Decision|0|||
164278878|NCT04776317|593390482|FG009|Overall Study|Physician Decision|0|||
164278879|NCT04776317|593390483|FG010|Overall Study|Physician Decision|0|||
164278880|NCT04776317|593390484|FG011|Overall Study|Physician Decision|0|||
164278881|NCT04776317|593390485|FG012|Overall Study|Physician Decision|0|||
164278882|NCT04776317|593390486|FG013|Overall Study|Physician Decision|0|||
164278883|NCT04776317|593390487|FG014|Overall Study|Physician Decision|0|||
164278884|NCT04776317|593390473|FG000|Overall Study|Protocol Violation|0|||
164278885|NCT04776317|593390474|FG001|Overall Study|Protocol Violation|0|||
164278886|NCT04776317|593390475|FG002|Overall Study|Protocol Violation|1|||
164278887|NCT04776317|593390476|FG003|Overall Study|Protocol Violation|0|||
164278888|NCT04776317|593390477|FG004|Overall Study|Protocol Violation|0|||
164278889|NCT04776317|593390478|FG005|Overall Study|Protocol Violation|0|||
164278890|NCT04776317|593390479|FG006|Overall Study|Protocol Violation|0|||
164278891|NCT04776317|593390480|FG007|Overall Study|Protocol Violation|0|||
164278892|NCT04776317|593390481|FG008|Overall Study|Protocol Violation|0|||
164278893|NCT04776317|593390482|FG009|Overall Study|Protocol Violation|0|||
164278894|NCT04776317|593390483|FG010|Overall Study|Protocol Violation|0|||
164278895|NCT04776317|593390484|FG011|Overall Study|Protocol Violation|0|||
164278896|NCT04776317|593390485|FG012|Overall Study|Protocol Violation|0|||
164278897|NCT04776317|593390486|FG013|Overall Study|Protocol Violation|0|||
164278898|NCT04776317|593390487|FG014|Overall Study|Protocol Violation|0|||
164278899|NCT04776317|593390473|FG000|Overall Study|Withdrawal by Subject|0|||
164278900|NCT04776317|593390474|FG001|Overall Study|Withdrawal by Subject|0|||
164278901|NCT04776317|593390475|FG002|Overall Study|Withdrawal by Subject|0|||
164278902|NCT04776317|593390476|FG003|Overall Study|Withdrawal by Subject|0|||
164278903|NCT04776317|593390477|FG004|Overall Study|Withdrawal by Subject|1|||
164278904|NCT04776317|593390478|FG005|Overall Study|Withdrawal by Subject|0|||
164278905|NCT04776317|593390479|FG006|Overall Study|Withdrawal by Subject|0|||
164278906|NCT04776317|593390480|FG007|Overall Study|Withdrawal by Subject|0|||
164278907|NCT04776317|593390481|FG008|Overall Study|Withdrawal by Subject|0|||
164278908|NCT04776317|593390482|FG009|Overall Study|Withdrawal by Subject|0|||
164278909|NCT04776317|593390483|FG010|Overall Study|Withdrawal by Subject|0|||
164278910|NCT04776317|593390484|FG011|Overall Study|Withdrawal by Subject|0|||
164278911|NCT04776317|593390485|FG012|Overall Study|Withdrawal by Subject|0|||
164278912|NCT04776317|593390486|FG013|Overall Study|Withdrawal by Subject|0|||
164278913|NCT04776317|593390487|FG014|Overall Study|Withdrawal by Subject|0|||
164278914|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278915|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278916|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
164278917|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
164278918|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
164278919|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278920|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
164278921|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
164278922|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
164278923|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278924|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278925|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278926|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
164278927|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
164278928|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
164278929|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
164278930|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
164278931|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
164278932|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
164278933|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
164278934|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
164278935|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
164278936|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278937|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278938|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278939|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
164278940|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278941|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278942|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278943|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278944|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278945|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278946|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
164278947|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278948|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278949|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278950|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278951|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278952|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
164278953|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278954|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278955|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278956|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278957|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278958|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278959|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278960|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278961|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
164278962|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278963|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278964|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278965|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
164278966|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278967|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278968|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278969|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
164278970|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278971|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278972|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278973|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
164278974|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278975|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278976|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278977|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278978|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
164278979|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278980|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278981|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278982|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
164278983|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278984|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278985|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
164085981|NCT01588106|592678615|FG000|Overall Study|Withdrawal by Subject|5|||
164085982|NCT01588106|592678616|FG001|Overall Study|Withdrawal by Subject|4|||
164085983|NCT03083132|592678617|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
164085984|NCT03083132|592678618|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
164085985|NCT03083132|592678617|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
164278986|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164085986|NCT03083132|592678618|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
164278987|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278988|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278989|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278990|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278991|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
164278992|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278993|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
164278994|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278995|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278996|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278997|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278998|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164278999|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279000|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279001|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279002|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279003|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279004|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
164279005|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
164279006|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279007|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279008|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279009|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279010|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279011|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279012|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279013|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279014|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279015|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279016|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279017|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
164279018|NCT03100058|593390489|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279019|NCT03100058|593390490|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279020|NCT03100058|593390491|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279021|NCT03100058|593390492|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279022|NCT03100058|593390493|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279023|NCT03100058|593390494|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279024|NCT03100058|593390495|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
164279025|NCT03100058|593390496|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279026|NCT03100058|593390497|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279027|NCT03100058|593390498|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279028|NCT03100058|593390499|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279029|NCT03100058|593390500|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279030|NCT03100058|593390501|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
164279031|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164142995|NCT00863772|592884486|FG002|Overall Study|Lost to Follow-up|1|||
164279032|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279033|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279034|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279035|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279036|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279037|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279038|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279039|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279040|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
164279041|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
164279042|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
164279043|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
164279044|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279045|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279046|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279047|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279048|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279049|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279050|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279051|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279052|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279053|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279054|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
164343968|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
164343969|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
164343970|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
164343971|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
164343972|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
164343973|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
164343974|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
164343975|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
164343976|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
163895291|NCT04109066|591989626|FG000|Treatment|Administrative reasons by sponsor|2|||
163895292|NCT04109066|591989627|FG001|Treatment|Administrative reasons by sponsor|3|||
163895293|NCT04109066|591989626|FG000|Treatment|Other reasons|17|||
163895294|NCT04109066|591989627|FG001|Treatment|Other reasons|23|||
164279055|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
164279056|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
164279057|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279058|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279059|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279060|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279061|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279062|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279063|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279064|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279065|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279066|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
164279067|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
164279068|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
164279069|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
164279070|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279071|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279072|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279073|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279074|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279075|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279076|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279077|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279078|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279079|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279080|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
164279081|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164343977|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
164343978|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
164343979|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
163895295|NCT04109066|591989626|FG000|Treatment|Disease Progression|4|||
163895296|NCT04109066|591989627|FG001|Treatment|Disease Progression|7|||
164085987|NCT03083132|592678617|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
164279082|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
164279083|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
163895297|NCT04109066|591989626|FG000|Treatment|Study drug toxicity|12|||
163895298|NCT04109066|591989627|FG001|Treatment|Study drug toxicity|5|||
163895299|NCT04109066|591989626|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
164279084|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279085|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279086|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279087|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279088|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279089|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279090|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279091|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164343980|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
164343981|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164343982|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164343983|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
164343984|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164343985|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
164279092|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279093|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279094|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
164279095|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
164279096|NCT03100058|593390489|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279097|NCT03100058|593390490|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279098|NCT03100058|593390491|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164343986|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
164343987|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343988|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343989|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343990|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
164343991|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343992|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
164343993|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343994|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343995|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
164343996|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
164279099|NCT03100058|593390492|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279100|NCT03100058|593390493|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164343997|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
164343998|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
164343999|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
164344000|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
164344001|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344002|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344003|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
164279101|NCT03100058|593390494|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279102|NCT03100058|593390495|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279103|NCT03100058|593390496|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279104|NCT03100058|593390497|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279105|NCT03100058|593390498|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
164279106|NCT03100058|593390499|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279107|NCT03100058|593390500|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279108|NCT03100058|593390501|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
164279109|NCT03671304|593390504|FG000|Overall Study|study terminated|7|||
164279110|NCT01067144|593390505|FG000|Treatment|Did not receive allocated intervention|4|||
164279111|NCT01067144|593390506|FG001|Treatment|Did not receive allocated intervention|7|||
164279112|NCT01067144|593390505|FG000|Follow-up|Lost to Follow-up|22|||
164279113|NCT01067144|593390506|FG001|Follow-up|Lost to Follow-up|12|||
164279114|NCT01067144|593390505|FG000|Follow-up|Censored owing to second surgery|19|||
164279115|NCT01067144|593390506|FG001|Follow-up|Censored owing to second surgery|28|||
164279116|NCT01067144|593390505|FG000|Follow-up|Withdrawal by Subject|18|||
164279117|NCT01067144|593390506|FG001|Follow-up|Withdrawal by Subject|14|||
164279118|NCT01067144|593390505|FG000|Follow-up|Surgery cancelled|0|||
164279119|NCT01067144|593390506|FG001|Follow-up|Surgery cancelled|1|||
164279120|NCT01067144|593390505|FG000|Follow-up|Death|0|||
164279121|NCT01067144|593390506|FG001|Follow-up|Death|1|||
164279122|NCT02718716|593390508|FG000|Overall Study|Lack of Efficacy|1|||
164279123|NCT02718716|593390509|FG001|Overall Study|Lack of Efficacy|0|||
164279124|NCT02718716|593390510|FG002|Overall Study|Lack of Efficacy|0|||
164279125|NCT02718716|593390511|FG003|Overall Study|Lack of Efficacy|0|||
164279126|NCT02718716|593390512|FG004|Overall Study|Lack of Efficacy|0|||
164279127|NCT00646399|593390516|FG000|Overall Study|Death|63|||
164279128|NCT00646399|593390517|FG001|Overall Study|Death|53|||
164279129|NCT00646399|593390516|FG000|Overall Study|Withdrawal by Subject|9|||
164279130|NCT00646399|593390517|FG001|Overall Study|Withdrawal by Subject|10|||
164279131|NCT00646399|593390516|FG000|Overall Study|Other Reason|11|||
164279132|NCT00646399|593390517|FG001|Overall Study|Other Reason|11|||
164279133|NCT04765202|593390520|FG000|Overall Study|Lost to Follow-up|1|||
164279134|NCT04765202|593390521|FG001|Overall Study|Lost to Follow-up|1|||
164279135|NCT04765202|593390522|FG002|Overall Study|Lost to Follow-up|2|||
164279136|NCT04765202|593390523|FG003|Overall Study|Lost to Follow-up|2|||
164279137|NCT04765202|593390520|FG000|Overall Study|Physician Decision|0|||
164279138|NCT04765202|593390521|FG001|Overall Study|Physician Decision|0|||
164279139|NCT04765202|593390522|FG002|Overall Study|Physician Decision|1|||
164279140|NCT04765202|593390523|FG003|Overall Study|Physician Decision|1|||
164279141|NCT04929249|593390524|FG000|Overall Study|Adverse Event|2|||
164279142|NCT04929249|593390525|FG001|Overall Study|Adverse Event|1|||
164279143|NCT04929249|593390524|FG000|Overall Study|Death|2|||
164279144|NCT04929249|593390525|FG001|Overall Study|Death|1|||
164279145|NCT04929249|593390524|FG000|Overall Study|Lost to Follow-up|3|||
164279146|NCT04929249|593390525|FG001|Overall Study|Lost to Follow-up|11|||
164279147|NCT04929249|593390524|FG000|Overall Study|Technical problems|0|||
164279148|NCT04929249|593390525|FG001|Overall Study|Technical problems|1|||
164279149|NCT04929249|593390524|FG000|Overall Study|Subject decision|6|||
164279150|NCT04929249|593390525|FG001|Overall Study|Subject decision|8|||
164279151|NCT04929249|593390524|FG000|Overall Study|Withdrew consent|0|||
164279152|NCT04929249|593390525|FG001|Overall Study|Withdrew consent|8|||
164279153|NCT02332291|593390528|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
164279154|NCT02332291|593390529|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
164279155|NCT02332291|593390528|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
164279156|NCT02332291|593390529|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
164279157|NCT02332291|593390528|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
164279158|NCT02332291|593390529|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
163895300|NCT04109066|591989627|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
164279159|NCT02332291|593390528|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
164279160|NCT02332291|593390529|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
164279161|NCT02332291|593390528|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
164279162|NCT02332291|593390529|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
163895301|NCT04109066|591989626|FG000|Treatment|Disease Recurrence|0|||
163895302|NCT04109066|591989627|FG001|Treatment|Disease Recurrence|2|||
163895303|NCT04109066|591989626|FG000|Treatment|Not reported|4|||
163895304|NCT04109066|591989627|FG001|Treatment|Not reported|8|||
163895305|NCT04967599|591989628|FG000|Overall Study|Lost to Follow-up|35|||
163895306|NCT04967599|591989629|FG001|Overall Study|Lost to Follow-up|19|||
163895307|NCT04967599|591989630|FG002|Overall Study|Lost to Follow-up|23|||
163895308|NCT04369911|591989632|FG000|Overall Study|Lost to Follow-up|3|||
163895309|NCT04369911|591989633|FG001|Overall Study|Lost to Follow-up|3|||
163895310|NCT04369911|591989632|FG000|Overall Study|Withdrawal by Subject|1|||
163895311|NCT04369911|591989633|FG001|Overall Study|Withdrawal by Subject|2|||
163895312|NCT05741294|591989634|FG000|Overall Study|Lost to Follow-up|3|||
164085988|NCT03083132|592678618|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
164085989|NCT03118739|592678619|FG000|Overall Study|Physician Decision|0|||
164279163|NCT02332291|593390528|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
164279164|NCT02332291|593390529|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
164279165|NCT01424228|593390532|FG000|Overall Study|Withdrawal by Subject|27|||
164279166|NCT01424228|593390533|FG001|Overall Study|Withdrawal by Subject|11|||
164279167|NCT01424228|593390532|FG000|Overall Study|Adverse Event|10|||
164279168|NCT01424228|593390533|FG001|Overall Study|Adverse Event|14|||
164279169|NCT01424228|593390532|FG000|Overall Study|Sponsor's decision|9|||
164279170|NCT01424228|593390533|FG001|Overall Study|Sponsor's decision|12|||
164279171|NCT01424228|593390532|FG000|Overall Study|Lack of Efficacy|5|||
164279172|NCT01424228|593390533|FG001|Overall Study|Lack of Efficacy|7|||
164279173|NCT01424228|593390532|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
164279174|NCT01424228|593390533|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
164279175|NCT01424228|593390532|FG000|Overall Study|Non-compliance|2|||
164279176|NCT01424228|593390533|FG001|Overall Study|Non-compliance|0|||
164279177|NCT01424228|593390532|FG000|Overall Study|Worsening of symptoms|1|||
164279178|NCT01424228|593390533|FG001|Overall Study|Worsening of symptoms|0|||
164279179|NCT01424228|593390532|FG000|Overall Study|Unplanned journey|0|||
164279180|NCT01424228|593390533|FG001|Overall Study|Unplanned journey|1|||
164279181|NCT00844558|593390534|FG000|Overall Study|Withdrawal by Subject|9|||
164279182|NCT00844558|593390535|FG001|Overall Study|Withdrawal by Subject|2|||
164279183|NCT00844558|593390534|FG000|Overall Study|Death|1|||
164279184|NCT00844558|593390535|FG001|Overall Study|Death|0|||
164279185|NCT00844558|593390534|FG000|Overall Study|Protocol Violation|1|||
164279186|NCT00844558|593390535|FG001|Overall Study|Protocol Violation|1|||
164279187|NCT00844558|593390534|FG000|Overall Study|Lost to Follow-up|0|||
164279188|NCT00844558|593390535|FG001|Overall Study|Lost to Follow-up|1|||
164279189|NCT00844558|593390534|FG000|Overall Study|Physician Decision|1|||
164279190|NCT00844558|593390535|FG001|Overall Study|Physician Decision|0|||
164279191|NCT02951429|593390536|FG000|Overall Study|Adverse Event|3|||
164279192|NCT02951429|593390537|FG001|Overall Study|Adverse Event|7|||
164279193|NCT02951429|593390536|FG000|Overall Study|Death|28|||
164279194|NCT02951429|593390537|FG001|Overall Study|Death|36|||
164279195|NCT02951429|593390536|FG000|Overall Study|Lack of Efficacy|0|||
164279196|NCT02951429|593390537|FG001|Overall Study|Lack of Efficacy|1|||
164279197|NCT02951429|593390536|FG000|Overall Study|Lost to Follow-up|0|||
164279198|NCT02951429|593390537|FG001|Overall Study|Lost to Follow-up|1|||
164279199|NCT02951429|593390536|FG000|Overall Study|Lung Transplantation|9|||
164279200|NCT02951429|593390537|FG001|Overall Study|Lung Transplantation|6|||
164279201|NCT02951429|593390536|FG000|Overall Study|Other|1|||
164279202|NCT02951429|593390537|FG001|Overall Study|Other|3|||
164279203|NCT02951429|593390536|FG000|Overall Study|Progressive Disease|1|||
164279204|NCT02951429|593390537|FG001|Overall Study|Progressive Disease|1|||
164279205|NCT02951429|593390536|FG000|Overall Study|Withdrawal by Subject|7|||
164279206|NCT02951429|593390537|FG001|Overall Study|Withdrawal by Subject|11|||
164279207|NCT02951429|593390536|FG000|Overall Study|Participant ongoing in the study|23|||
164279208|NCT02951429|593390537|FG001|Overall Study|Participant ongoing in the study|17|||
164279209|NCT01628965|593390540|FG000|Overall Study|Adverse Event|30|||
164279210|NCT01628965|593390540|FG000|Overall Study|Lack of Efficacy|7|||
164279211|NCT01628965|593390540|FG000|Overall Study|Withdrawal by Subject|3|||
164279212|NCT01628965|593390540|FG000|Overall Study|Lost to Follow-up|1|||
164279213|NCT01628965|593390540|FG000|Overall Study|Discontinuation criteria|8|||
164279214|NCT04356352|593390545|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
164279215|NCT04356352|593390546|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
164279216|NCT04356352|593390547|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
164279217|NCT04356352|593390545|FG000|Overall Study|Protocol Violation|0|||
164279218|NCT04356352|593390546|FG001|Overall Study|Protocol Violation|3|||
164279219|NCT04356352|593390547|FG002|Overall Study|Protocol Violation|1|||
164279220|NCT01983774|593390551|FG000|Overall Study|Lung Transplant|0|||
164279221|NCT01983774|593390552|FG001|Overall Study|Lung Transplant|1|||
164279222|NCT01983774|593390551|FG000|Overall Study|Lost to Follow-up|1|||
164279223|NCT01983774|593390552|FG001|Overall Study|Lost to Follow-up|0|||
164279224|NCT01339897|593390553|FG000|Overall Study|Adverse Event|1|||
164279225|NCT01339897|593390554|FG001|Overall Study|Adverse Event|0|||
164279226|NCT01339897|593390555|FG002|Overall Study|Adverse Event|0|||
164279227|NCT01339897|593390556|FG003|Overall Study|Adverse Event|1|||
164279228|NCT00847197|593390557|FG000|Overall Study|Adverse Event|21|||
164279229|NCT00847197|593390558|FG001|Overall Study|Adverse Event|3|||
164279230|NCT00847197|593390557|FG000|Overall Study|Protocol Violation|0|||
164279231|NCT00847197|593390558|FG001|Overall Study|Protocol Violation|1|||
164279232|NCT00847197|593390557|FG000|Overall Study|Withdrawal by Subject|3|||
164279233|NCT00847197|593390558|FG001|Overall Study|Withdrawal by Subject|1|||
164279234|NCT00622388|593390559|FG000|Overall Study|Disease Progression|47|||
164279235|NCT00622388|593390559|FG000|Overall Study|Adverse Event|6|||
164279236|NCT00622388|593390559|FG000|Overall Study|Protocol Violation|3|||
164279237|NCT00622388|593390559|FG000|Overall Study|Participant Refusal|1|||
164279238|NCT00622388|593390559|FG000|Overall Study|Death|3|||
164279239|NCT00622388|593390559|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
164001482|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
164001483|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
164001484|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
164001485|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
164001486|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
164001487|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
164001488|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
164001489|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
164001490|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
164001491|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
164001492|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
164001493|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
164001494|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
164279240|NCT00622388|593390559|FG000|Overall Study|Took Prohibited Medication|2|||
164279241|NCT00622388|593390559|FG000|Overall Study|Withdrew Consent|1|||
164279242|NCT00622388|593390559|FG000|Overall Study|Insurance Expired|1|||
164279243|NCT01068158|593390560|FG000|Overall Study|Withdrawal by Subject|1|||
164279244|NCT01068158|593390561|FG001|Overall Study|Withdrawal by Subject|2|||
164279245|NCT01068158|593390560|FG000|Overall Study|Lost to Follow-up|7|||
164279246|NCT01068158|593390561|FG001|Overall Study|Lost to Follow-up|0|||
164279247|NCT01068158|593390560|FG000|Overall Study|Protocol Violation|0|||
164279248|NCT01068158|593390561|FG001|Overall Study|Protocol Violation|2|||
164279249|NCT02478255|593390562|FG000|Overall Study|Physician Decision|6|||
164279250|NCT02478255|593390563|FG001|Overall Study|Physician Decision|0|||
164279251|NCT02478255|593390562|FG000|Overall Study|Withdrawal by Subject|2|||
164279252|NCT02478255|593390563|FG001|Overall Study|Withdrawal by Subject|0|||
164279253|NCT02813889|593392093|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
164279254|NCT02813889|593392094|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
164279255|NCT05128578|593392095|FG000|Overall Study|Withdrawal by Subject|9|||
164279256|NCT05128578|593392095|FG000|Overall Study|Lost to Follow-up|5|||
164279257|NCT01128244|593392099|FG000|Overall Study|Adverse Event|1|||
164279258|NCT01128244|593392099|FG000|Overall Study|Scheduling conflict|2|||
164279259|NCT02974257|593392100|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
164279260|NCT02974257|593392101|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
164279261|NCT02974257|593392100|FG000|Overall Study|Clinical indication for thiamine|1|||
164279262|NCT02974257|593392101|FG001|Overall Study|Clinical indication for thiamine|0|||
164279263|NCT02974257|593392100|FG000|Overall Study|Already on thiamine|1|||
164279264|NCT02974257|593392101|FG001|Overall Study|Already on thiamine|0|||
164279265|NCT02974257|593392100|FG000|Overall Study|Extubated prior to study drug|0|||
164279266|NCT02974257|593392101|FG001|Overall Study|Extubated prior to study drug|1|||
164279267|NCT02974257|593392100|FG000|Overall Study|Death|0|||
164279268|NCT02974257|593392101|FG001|Overall Study|Death|1|||
164279269|NCT00398567|593392102|FG000|Overall Study|Disease Progression|3|||
164279270|NCT00398567|593392103|FG001|Overall Study|Disease Progression|4|||
164279271|NCT00398567|593392104|FG002|Overall Study|Disease Progression|27|||
164279272|NCT00398567|593392102|FG000|Overall Study|Withdrawal by Subject|1|||
164279273|NCT00398567|593392103|FG001|Overall Study|Withdrawal by Subject|0|||
164279274|NCT00398567|593392104|FG002|Overall Study|Withdrawal by Subject|4|||
164279275|NCT00398567|593392102|FG000|Overall Study|Adverse Event|0|||
164344004|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344005|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
164344006|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
164344007|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
164344008|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
164344009|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
164344010|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
164344011|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344012|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
164344013|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344014|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344015|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
164344016|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344017|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344018|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344019|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
164344020|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
164344021|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164279276|NCT00398567|593392103|FG001|Overall Study|Adverse Event|0|||
164279277|NCT00398567|593392104|FG002|Overall Study|Adverse Event|2|||
164279278|NCT00398567|593392102|FG000|Overall Study|Protocol Violation|0|||
164279279|NCT00398567|593392103|FG001|Overall Study|Protocol Violation|0|||
164279280|NCT00398567|593392104|FG002|Overall Study|Protocol Violation|1|||
164279281|NCT02837029|593392105|FG000|Screening|Failed to meet screening requirements.|7|||
164279282|NCT02837029|593392106|FG001|Screening|Failed to meet screening requirements.|3|||
164279283|NCT02837029|593392107|FG002|Screening|Failed to meet screening requirements.|0|||
164279284|NCT02837029|593392105|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
164279285|NCT02837029|593392106|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
164279286|NCT02837029|593392107|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
164279287|NCT02837029|593392105|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
164279288|NCT02837029|593392106|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
164279289|NCT02837029|593392107|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
164279290|NCT02837029|593392105|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
164279291|NCT02837029|593392106|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
164279292|NCT02837029|593392107|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
164279293|NCT02837029|593392105|FG000|Cycle 2 and Beyond|Adverse Event|1|||
164279294|NCT02837029|593392106|FG001|Cycle 2 and Beyond|Adverse Event|0|||
164279295|NCT02837029|593392107|FG002|Cycle 2 and Beyond|Adverse Event|0|||
164279296|NCT02837029|593392105|FG000|2 Year Follow-up|Death|6|||
164279297|NCT02837029|593392106|FG001|2 Year Follow-up|Death|7|||
164279298|NCT02837029|593392107|FG002|2 Year Follow-up|Death|0|||
164279299|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
164279300|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
164279301|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
164279302|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
164279303|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
164279304|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
164279305|NCT01363908|593392108|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
164279306|NCT01363908|593392109|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
164279307|NCT05258149|593392110|FG000|Period 1|Protocol Deviation|1|||
164279308|NCT05258149|593392111|FG001|Period 1|Protocol Deviation|0|||
164279309|NCT05258149|593392110|FG000|Period 1|Adverse Event|0|||
164279310|NCT05258149|593392111|FG001|Period 1|Adverse Event|1|||
164279311|NCT05258149|593392110|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
164279312|NCT05258149|593392111|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
164279313|NCT05258149|593392110|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
164279314|NCT05258149|593392111|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
164279315|NCT05258149|593392110|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
164279316|NCT05258149|593392111|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
164279317|NCT03437577|593392114|FG000|Pre-Randomization|Withdrawal by Subject|0|||
164279318|NCT03437577|593392115|FG001|Pre-Randomization|Withdrawal by Subject|0|||
164279319|NCT03437577|593392116|FG002|Pre-Randomization|Withdrawal by Subject|10|||
164279320|NCT03437577|593392114|FG000|Post-Randomization|Physician Decision|0|||
164279321|NCT03437577|593392115|FG001|Post-Randomization|Physician Decision|2|||
164279322|NCT03437577|593392116|FG002|Post-Randomization|Physician Decision|0|||
164279323|NCT04273893|593392124|FG000|Overall Study|Withdrawal by Subject|0|||
164279324|NCT04273893|593392125|FG001|Overall Study|Withdrawal by Subject|2|||
164279325|NCT04273893|593392124|FG000|Overall Study|Treatment of Disease Progression|0|||
164279326|NCT04273893|593392125|FG001|Overall Study|Treatment of Disease Progression|2|||
164279327|NCT04273893|593392124|FG000|Overall Study|Death|1|||
164279328|NCT04273893|593392125|FG001|Overall Study|Death|2|||
164279329|NCT04273893|593392124|FG000|Overall Study|Lost to Follow-up|0|||
164279330|NCT04273893|593392125|FG001|Overall Study|Lost to Follow-up|2|||
164279331|NCT04273893|593392124|FG000|Overall Study|Physician Decision|1|||
164279332|NCT04273893|593392125|FG001|Overall Study|Physician Decision|0|||
164279333|NCT04774926|593392126|FG000|Overall Study|Adverse Event|15|||
164279334|NCT04774926|593392126|FG000|Overall Study|Lost to Follow-up|3|||
164279335|NCT04774926|593392126|FG000|Overall Study|Physician Decision|6|||
164279336|NCT04774926|593392126|FG000|Overall Study|Withdrawal by Subject|3|||
164279337|NCT04774926|593392126|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
164279338|NCT01393639|593392127|FG000|Overall Study|Protocol Violation|0|||
164279339|NCT01393639|593392128|FG001|Overall Study|Protocol Violation|0|||
164279340|NCT01393639|593392129|FG002|Overall Study|Protocol Violation|0|||
164279341|NCT01393639|593392130|FG003|Overall Study|Protocol Violation|1|||
164279342|NCT01393639|593392131|FG004|Overall Study|Protocol Violation|0|||
164279343|NCT01393639|593392132|FG005|Overall Study|Protocol Violation|0|||
164279344|NCT01393639|593392133|FG006|Overall Study|Protocol Violation|0|||
163895313|NCT05741294|591989634|FG000|Overall Study|Protocol deviation|3|||
164279345|NCT01393639|593392127|FG000|Overall Study|Other|0|||
164279346|NCT01393639|593392128|FG001|Overall Study|Other|2|||
164279347|NCT01393639|593392129|FG002|Overall Study|Other|0|||
164279348|NCT01393639|593392130|FG003|Overall Study|Other|2|||
164279349|NCT01393639|593392131|FG004|Overall Study|Other|1|||
164279350|NCT01393639|593392132|FG005|Overall Study|Other|0|||
164279351|NCT01393639|593392133|FG006|Overall Study|Other|1|||
164279352|NCT01393639|593392127|FG000|Overall Study|Withdrawal by Subject|1|||
164279353|NCT01393639|593392128|FG001|Overall Study|Withdrawal by Subject|1|||
164279354|NCT01393639|593392129|FG002|Overall Study|Withdrawal by Subject|0|||
164279355|NCT01393639|593392130|FG003|Overall Study|Withdrawal by Subject|0|||
164279356|NCT01393639|593392131|FG004|Overall Study|Withdrawal by Subject|0|||
164279357|NCT01393639|593392132|FG005|Overall Study|Withdrawal by Subject|0|||
164279358|NCT01393639|593392133|FG006|Overall Study|Withdrawal by Subject|1|||
164279359|NCT01393639|593392127|FG000|Overall Study|Medication error without associated AE|0|||
164279360|NCT01393639|593392128|FG001|Overall Study|Medication error without associated AE|0|||
164279361|NCT01393639|593392129|FG002|Overall Study|Medication error without associated AE|0|||
164279362|NCT01393639|593392130|FG003|Overall Study|Medication error without associated AE|0|||
164279363|NCT01393639|593392131|FG004|Overall Study|Medication error without associated AE|0|||
164279364|NCT01393639|593392132|FG005|Overall Study|Medication error without associated AE|0|||
164279365|NCT01393639|593392133|FG006|Overall Study|Medication error without associated AE|1|||
164279366|NCT01393639|593392127|FG000|Overall Study|Lost to Follow-up|0|||
164279367|NCT01393639|593392128|FG001|Overall Study|Lost to Follow-up|1|||
164279368|NCT01393639|593392129|FG002|Overall Study|Lost to Follow-up|0|||
164279369|NCT01393639|593392130|FG003|Overall Study|Lost to Follow-up|0|||
164279370|NCT01393639|593392131|FG004|Overall Study|Lost to Follow-up|0|||
164279371|NCT01393639|593392132|FG005|Overall Study|Lost to Follow-up|0|||
164279372|NCT01393639|593392133|FG006|Overall Study|Lost to Follow-up|1|||
164279373|NCT01393639|593392127|FG000|Overall Study|Lack of Efficacy|0|||
164279374|NCT01393639|593392128|FG001|Overall Study|Lack of Efficacy|0|||
164279375|NCT01393639|593392129|FG002|Overall Study|Lack of Efficacy|0|||
164279376|NCT01393639|593392130|FG003|Overall Study|Lack of Efficacy|0|||
164279377|NCT01393639|593392131|FG004|Overall Study|Lack of Efficacy|0|||
164279378|NCT01393639|593392132|FG005|Overall Study|Lack of Efficacy|0|||
164279379|NCT01393639|593392133|FG006|Overall Study|Lack of Efficacy|1|||
164279380|NCT01393639|593392127|FG000|Overall Study|Adverse Event|2|||
164279381|NCT01393639|593392128|FG001|Overall Study|Adverse Event|3|||
164279382|NCT01393639|593392129|FG002|Overall Study|Adverse Event|1|||
164279383|NCT01393639|593392130|FG003|Overall Study|Adverse Event|2|||
164279384|NCT01393639|593392131|FG004|Overall Study|Adverse Event|0|||
164279385|NCT01393639|593392132|FG005|Overall Study|Adverse Event|2|||
164279386|NCT01393639|593392133|FG006|Overall Study|Adverse Event|3|||
164279387|NCT00793325|593392137|FG000|Overall Study|Protocol Violation|18|||
164279388|NCT00793325|593392137|FG000|Overall Study|Lost to Follow-up|1|||
164279389|NCT01440816|593392138|FG000|Overall Study|Disease Progression|0|||
164279390|NCT01440816|593392139|FG001|Overall Study|Disease Progression|9|||
164279391|NCT01440816|593392138|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
164279392|NCT01440816|593392139|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
164279393|NCT03250182|593392149|FG000|Overall Study|Withdrawal by Subject|1|||
164279394|NCT00100789|593392152|FG000|Overall Study|Adverse Event|10|||
164279395|NCT00100789|593392152|FG000|Overall Study|Withdrawal by Subject|1|||
164279396|NCT00100789|593392152|FG000|Overall Study|Progression/relapse|42|||
164279397|NCT00100789|593392152|FG000|Overall Study|Death|2|||
164279398|NCT00100789|593392152|FG000|Overall Study|Not protocol specified|5|||
164279399|NCT00100789|593392152|FG000|Overall Study|Ineligible|3|||
164279400|NCT00100789|593392152|FG000|Overall Study|Never received treatment|1|||
164279401|NCT02936843|593392153|FG000|Overall Study|Lost to Follow-up|3|||
164279402|NCT02936843|593392154|FG001|Overall Study|Lost to Follow-up|1|||
164279403|NCT02936843|593392153|FG000|Overall Study|Withdrawal by Subject|1|||
164279404|NCT02936843|593392154|FG001|Overall Study|Withdrawal by Subject|1|||
164279405|NCT03472950|593392155|FG000|Overall Study|Lost to Follow-up|0|||
164279406|NCT03472950|593392156|FG001|Overall Study|Lost to Follow-up|1|||
164279407|NCT03472950|593392155|FG000|Overall Study|Adverse Event|0|||
164279408|NCT03472950|593392156|FG001|Overall Study|Adverse Event|3|||
164279409|NCT01393821|593392157|FG000|Overall Study|Cancel|1|||
164279410|NCT01393821|593392158|FG001|Overall Study|Cancel|1|||
164279411|NCT01393821|593392157|FG000|Overall Study|not evaluable for primary endpoint|4|||
164279412|NCT01393821|593392158|FG001|Overall Study|not evaluable for primary endpoint|2|||
164279413|NCT03386487|593392171|FG000|Overall Study|Lost to Follow-up|5|||
164279414|NCT03386487|593392172|FG001|Overall Study|Lost to Follow-up|6|||
164279415|NCT03386487|593392171|FG000|Overall Study|Withdrawal by Subject|11|||
164279416|NCT03386487|593392172|FG001|Overall Study|Withdrawal by Subject|7|||
164279417|NCT03386487|593392171|FG000|Overall Study|Physician Decision|11|||
164279418|NCT03386487|593392172|FG001|Overall Study|Physician Decision|8|||
164279419|NCT01068769|593392174|FG000|Overall Study|Ineligible|1|||
164279420|NCT01948063|593392175|FG000|Overall Study|Boston MCI halted research protocol|0|||
164344022|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164344023|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
164279421|NCT01948063|593392176|FG001|Overall Study|Boston MCI halted research protocol|1|||
164279422|NCT01948063|593392175|FG000|Overall Study|Discovered an enrollment in other study|0|||
164279423|NCT01948063|593392176|FG001|Overall Study|Discovered an enrollment in other study|1|||
164279424|NCT01948063|593392175|FG000|Overall Study|Blood samples were accidentally thawed|1|||
164344024|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164344025|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
164344026|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Change of location|0|||
164344027|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Change of location|0|||
164344028|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Change of location|0|||
164344029|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Change of location|1|||
164344030|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Change of location|0|||
164344031|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
164344032|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
164344033|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
164344034|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
164344035|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
164344036|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344037|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344038|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344039|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
164344040|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
164344041|NCT00730405|593635367|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
164344042|NCT00730405|593635368|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164344043|NCT00730405|593635369|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164279425|NCT01948063|593392176|FG001|Overall Study|Blood samples were accidentally thawed|0|||
164279426|NCT01858766|593392177|FG000|Overall Study|Randomized but Never Treated|0|||
164279427|NCT01858766|593392178|FG001|Overall Study|Randomized but Never Treated|0|||
164279428|NCT01858766|593392179|FG002|Overall Study|Randomized but Never Treated|0|||
164279429|NCT01858766|593392180|FG003|Overall Study|Randomized but Never Treated|0|||
164279430|NCT01858766|593392181|FG004|Overall Study|Randomized but Never Treated|0|||
164279431|NCT01858766|593392182|FG005|Overall Study|Randomized but Never Treated|1|||
164279432|NCT01858766|593392183|FG006|Overall Study|Randomized but Never Treated|0|||
164279433|NCT01858766|593392184|FG007|Overall Study|Randomized but Never Treated|0|||
164279434|NCT01858766|593392185|FG008|Overall Study|Randomized but Never Treated|0|||
164279435|NCT01858766|593392186|FG009|Overall Study|Randomized but Never Treated|0|||
164279436|NCT01858766|593392187|FG010|Overall Study|Randomized but Never Treated|0|||
164279437|NCT01858766|593392188|FG011|Overall Study|Randomized but Never Treated|0|||
164279438|NCT01858766|593392189|FG012|Overall Study|Randomized but Never Treated|0|||
164279439|NCT01858766|593392190|FG013|Overall Study|Randomized but Never Treated|0|||
164344044|NCT00730405|593635370|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164344045|NCT00730405|593635371|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
164344046|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
164344047|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
164344048|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
164344049|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
164344050|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
164344051|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
164344052|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
164344053|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
164344054|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
164344055|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
164344056|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
164344057|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
164279440|NCT01858766|593392191|FG014|Overall Study|Randomized but Never Treated|0|||
164279441|NCT01858766|593392192|FG015|Overall Study|Randomized but Never Treated|0|||
164279442|NCT01858766|593392193|FG016|Overall Study|Randomized but Never Treated|0|||
164279443|NCT01858766|593392194|FG017|Overall Study|Randomized but Never Treated|1|||
164279444|NCT01858766|593392195|FG018|Overall Study|Randomized but Never Treated|0|||
164279445|NCT01858766|593392177|FG000|Overall Study|Death|0|||
164279446|NCT01858766|593392178|FG001|Overall Study|Death|0|||
164279447|NCT01858766|593392179|FG002|Overall Study|Death|1|||
164279448|NCT01858766|593392180|FG003|Overall Study|Death|0|||
164279449|NCT01858766|593392181|FG004|Overall Study|Death|0|||
164279450|NCT01858766|593392182|FG005|Overall Study|Death|0|||
164279451|NCT01858766|593392183|FG006|Overall Study|Death|0|||
164279452|NCT01858766|593392184|FG007|Overall Study|Death|0|||
164279453|NCT01858766|593392185|FG008|Overall Study|Death|0|||
164279454|NCT01858766|593392186|FG009|Overall Study|Death|0|||
164279455|NCT01858766|593392187|FG010|Overall Study|Death|0|||
164279456|NCT01858766|593392188|FG011|Overall Study|Death|0|||
164279457|NCT01858766|593392189|FG012|Overall Study|Death|0|||
164279458|NCT01858766|593392190|FG013|Overall Study|Death|0|||
164279459|NCT01858766|593392191|FG014|Overall Study|Death|0|||
164279460|NCT01858766|593392192|FG015|Overall Study|Death|0|||
164279461|NCT01858766|593392193|FG016|Overall Study|Death|0|||
164279462|NCT01858766|593392194|FG017|Overall Study|Death|0|||
164279463|NCT01858766|593392195|FG018|Overall Study|Death|0|||
164279464|NCT01858766|593392177|FG000|Overall Study|Lack of Efficacy|1|||
164279465|NCT01858766|593392178|FG001|Overall Study|Lack of Efficacy|0|||
164279466|NCT01858766|593392179|FG002|Overall Study|Lack of Efficacy|0|||
164279467|NCT01858766|593392180|FG003|Overall Study|Lack of Efficacy|0|||
164279468|NCT01858766|593392181|FG004|Overall Study|Lack of Efficacy|1|||
164279469|NCT01858766|593392182|FG005|Overall Study|Lack of Efficacy|2|||
164279470|NCT01858766|593392183|FG006|Overall Study|Lack of Efficacy|0|||
164279471|NCT01858766|593392184|FG007|Overall Study|Lack of Efficacy|0|||
164279472|NCT01858766|593392185|FG008|Overall Study|Lack of Efficacy|0|||
164279473|NCT01858766|593392186|FG009|Overall Study|Lack of Efficacy|0|||
164279474|NCT01858766|593392187|FG010|Overall Study|Lack of Efficacy|0|||
164279475|NCT01858766|593392188|FG011|Overall Study|Lack of Efficacy|3|||
164279476|NCT01858766|593392189|FG012|Overall Study|Lack of Efficacy|5|||
164279477|NCT01858766|593392190|FG013|Overall Study|Lack of Efficacy|3|||
164279478|NCT01858766|593392191|FG014|Overall Study|Lack of Efficacy|5|||
164279479|NCT01858766|593392192|FG015|Overall Study|Lack of Efficacy|5|||
164279480|NCT01858766|593392193|FG016|Overall Study|Lack of Efficacy|2|||
164279481|NCT01858766|593392194|FG017|Overall Study|Lack of Efficacy|3|||
164279482|NCT01858766|593392195|FG018|Overall Study|Lack of Efficacy|3|||
164279483|NCT01858766|593392177|FG000|Overall Study|Lost to Follow-up|0|||
164279484|NCT01858766|593392178|FG001|Overall Study|Lost to Follow-up|0|||
164279485|NCT01858766|593392179|FG002|Overall Study|Lost to Follow-up|0|||
164279486|NCT01858766|593392180|FG003|Overall Study|Lost to Follow-up|0|||
164279487|NCT01858766|593392181|FG004|Overall Study|Lost to Follow-up|0|||
164279488|NCT01858766|593392182|FG005|Overall Study|Lost to Follow-up|1|||
164279489|NCT01858766|593392183|FG006|Overall Study|Lost to Follow-up|0|||
164279490|NCT01858766|593392184|FG007|Overall Study|Lost to Follow-up|2|||
164279491|NCT01858766|593392185|FG008|Overall Study|Lost to Follow-up|0|||
164279492|NCT01858766|593392186|FG009|Overall Study|Lost to Follow-up|0|||
164279493|NCT01858766|593392187|FG010|Overall Study|Lost to Follow-up|0|||
164279494|NCT01858766|593392188|FG011|Overall Study|Lost to Follow-up|1|||
164279495|NCT01858766|593392189|FG012|Overall Study|Lost to Follow-up|0|||
164279496|NCT01858766|593392190|FG013|Overall Study|Lost to Follow-up|0|||
164279497|NCT01858766|593392191|FG014|Overall Study|Lost to Follow-up|3|||
164279498|NCT01858766|593392192|FG015|Overall Study|Lost to Follow-up|1|||
164279499|NCT01858766|593392193|FG016|Overall Study|Lost to Follow-up|1|||
164279500|NCT01858766|593392194|FG017|Overall Study|Lost to Follow-up|0|||
164279501|NCT01858766|593392195|FG018|Overall Study|Lost to Follow-up|1|||
164085990|NCT03118739|592678620|FG001|Overall Study|Physician Decision|1|||
164279502|NCT01858766|593392177|FG000|Overall Study|Withdrew Consent|0|||
164279503|NCT01858766|593392178|FG001|Overall Study|Withdrew Consent|0|||
164279504|NCT01858766|593392179|FG002|Overall Study|Withdrew Consent|0|||
164279505|NCT01858766|593392180|FG003|Overall Study|Withdrew Consent|0|||
164279506|NCT01858766|593392181|FG004|Overall Study|Withdrew Consent|0|||
164279507|NCT01858766|593392182|FG005|Overall Study|Withdrew Consent|0|||
164279508|NCT01858766|593392183|FG006|Overall Study|Withdrew Consent|0|||
164279509|NCT01858766|593392184|FG007|Overall Study|Withdrew Consent|0|||
164279510|NCT01858766|593392185|FG008|Overall Study|Withdrew Consent|0|||
164279511|NCT01858766|593392186|FG009|Overall Study|Withdrew Consent|0|||
164279512|NCT01858766|593392187|FG010|Overall Study|Withdrew Consent|0|||
164279513|NCT01858766|593392188|FG011|Overall Study|Withdrew Consent|1|||
164279514|NCT01858766|593392189|FG012|Overall Study|Withdrew Consent|0|||
164279515|NCT01858766|593392190|FG013|Overall Study|Withdrew Consent|0|||
164279516|NCT01858766|593392191|FG014|Overall Study|Withdrew Consent|0|||
164279517|NCT01858766|593392192|FG015|Overall Study|Withdrew Consent|0|||
164279518|NCT01858766|593392193|FG016|Overall Study|Withdrew Consent|0|||
164279519|NCT01858766|593392194|FG017|Overall Study|Withdrew Consent|0|||
164279520|NCT01858766|593392195|FG018|Overall Study|Withdrew Consent|0|||
164279521|NCT00894361|593392200|FG000|Overall Study|deaths and less than 2 years followup|24|||
164279522|NCT00894361|593392201|FG001|Overall Study|deaths and less than 2 years followup|64|||
164279523|NCT04207060|593392206|FG000|Overall Study|Lost to Follow-up|2|||
164279524|NCT04207060|593392207|FG001|Overall Study|Lost to Follow-up|0|||
164279525|NCT05438576|593392208|FG000|Overall Study|Death|1|||
164279526|NCT05438576|593392209|FG001|Overall Study|Death|1|||
164279527|NCT05438576|593392208|FG000|Overall Study|Withdrawal by Subject|4|||
164279528|NCT05438576|593392209|FG001|Overall Study|Withdrawal by Subject|2|||
164279529|NCT05438576|593392208|FG000|Overall Study|Not Eligible|2|||
164279530|NCT05438576|593392209|FG001|Overall Study|Not Eligible|1|||
164279531|NCT05438576|593392208|FG000|Overall Study|Did not complete baseline testing|22|||
164279532|NCT05438576|593392209|FG001|Overall Study|Did not complete baseline testing|4|||
164279533|NCT02881762|593392212|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164279534|NCT02881762|593392213|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164279535|NCT00245037|593392214|FG000|Overall Study|Death|17|||
164279536|NCT00296140|593392216|FG000|Overall Study|Lost to Follow-up|1|||
164279537|NCT00296140|593392217|FG001|Overall Study|Lost to Follow-up|0|||
164279538|NCT00296140|593392216|FG000|Overall Study|Withdrawal by Subject|1|||
164279539|NCT00296140|593392217|FG001|Overall Study|Withdrawal by Subject|0|||
164279540|NCT00296140|593392216|FG000|Overall Study|Discharge to Nursing Home|1|||
164279541|NCT00296140|593392217|FG001|Overall Study|Discharge to Nursing Home|0|||
164279542|NCT00774800|593392218|FG000|Intervention 4|Withdrawal by Subject|1|||
164279543|NCT01843062|593392219|FG000|Overall Study|Protocol Violation|1|||
164279544|NCT01843062|593392220|FG001|Overall Study|Protocol Violation|0|||
164279545|NCT01843062|593392219|FG000|Overall Study|New treatment following progression|2|||
164279546|NCT01843062|593392220|FG001|Overall Study|New treatment following progression|0|||
164279547|NCT01843062|593392219|FG000|Overall Study|Pregnancy|1|||
164279548|NCT01843062|593392220|FG001|Overall Study|Pregnancy|0|||
164279549|NCT01843062|593392219|FG000|Overall Study|Adverse Event|2|||
164279550|NCT01843062|593392220|FG001|Overall Study|Adverse Event|0|||
164279551|NCT01843062|593392219|FG000|Overall Study|Incorrect randomisation|1|||
164279552|NCT01843062|593392220|FG001|Overall Study|Incorrect randomisation|0|||
164279553|NCT01843062|593392219|FG000|Overall Study|Withdrawal by Subject|12|||
164279554|NCT01843062|593392220|FG001|Overall Study|Withdrawal by Subject|3|||
164279555|NCT01843062|593392219|FG000|Overall Study|Death|1|||
164279556|NCT01843062|593392220|FG001|Overall Study|Death|2|||
164279557|NCT01843062|593392219|FG000|Overall Study|Lost to Follow-up|2|||
164279558|NCT01843062|593392220|FG001|Overall Study|Lost to Follow-up|4|||
164279559|NCT00994422|593392221|FG000|Overall Study|Lost to Follow-up|7|||
164279560|NCT00994422|593392222|FG001|Overall Study|Lost to Follow-up|1|||
164279561|NCT02669212|593392223|FG000|Overall Study|Lost to Follow-up|1|||
164279562|NCT02669212|593392224|FG001|Overall Study|Lost to Follow-up|0|||
164279563|NCT02669212|593392223|FG000|Overall Study|Medical Condition|3|||
164279564|NCT02669212|593392224|FG001|Overall Study|Medical Condition|4|||
164279565|NCT02669212|593392223|FG000|Overall Study|Withdrawal by Subject|0|||
164279566|NCT02669212|593392224|FG001|Overall Study|Withdrawal by Subject|2|||
164279567|NCT02669212|593392223|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
164279568|NCT02669212|593392224|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
164279569|NCT03549104|593392227|FG000|Overall Study|Withdrawal by Subject|5|||
164279570|NCT03549104|593392228|FG001|Overall Study|Withdrawal by Subject|2|||
164279571|NCT03549104|593392227|FG000|Overall Study|Covid shelter in place|1|||
164279572|NCT03549104|593392228|FG001|Overall Study|Covid shelter in place|2|||
164279573|NCT04124705|593392229|FG000|Titration Period|Adverse Event|9|||
164279574|NCT04124705|593392230|FG001|Titration Period|Adverse Event|5|||
164279575|NCT04124705|593392229|FG000|Titration Period|Withdrawal by Subject|6|||
164279576|NCT04124705|593392230|FG001|Titration Period|Withdrawal by Subject|3|||
164279577|NCT04124705|593392229|FG000|Titration Period|Lost to Follow-up|0|||
164279578|NCT04124705|593392230|FG001|Titration Period|Lost to Follow-up|1|||
164279579|NCT04124705|593392229|FG000|Titration Period|Death|1|||
164279580|NCT04124705|593392230|FG001|Titration Period|Death|1|||
164279581|NCT04124705|593392229|FG000|Titration Period|Lack of Efficacy|2|||
164279582|NCT04124705|593392230|FG001|Titration Period|Lack of Efficacy|0|||
164279583|NCT04124705|593392229|FG000|Titration Period|Physician Decision|2|||
164279584|NCT04124705|593392230|FG001|Titration Period|Physician Decision|0|||
164279585|NCT04124705|593392229|FG000|Titration Period|Non-compliance with Study Drug|2|||
164279586|NCT04124705|593392230|FG001|Titration Period|Non-compliance with Study Drug|0|||
164279587|NCT04124705|593392229|FG000|Titration Period|Other|4|||
164279588|NCT04124705|593392230|FG001|Titration Period|Other|9|||
163895314|NCT05741294|591989634|FG000|Overall Study|Withdrawal by Subject|1|||
163895315|NCT03817983|591989635|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
163895316|NCT03817983|591989636|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
163895317|NCT03817983|591989637|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
164279589|NCT04124705|593392229|FG000|Stabilization Period|Adverse Event|4|||
164279590|NCT04124705|593392230|FG001|Stabilization Period|Adverse Event|2|||
164344058|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
164279591|NCT04124705|593392229|FG000|Stabilization Period|Withdrawal by Subject|1|||
164279592|NCT04124705|593392230|FG001|Stabilization Period|Withdrawal by Subject|1|||
164279593|NCT04124705|593392229|FG000|Stabilization Period|Lost to Follow-up|0|||
164279594|NCT04124705|593392230|FG001|Stabilization Period|Lost to Follow-up|1|||
164279595|NCT04124705|593392229|FG000|Stabilization Period|Lack of Efficacy|4|||
164279596|NCT04124705|593392230|FG001|Stabilization Period|Lack of Efficacy|2|||
164279597|NCT04124705|593392229|FG000|Stabilization Period|Protocol Deviation|0|||
164279598|NCT04124705|593392230|FG001|Stabilization Period|Protocol Deviation|2|||
164279599|NCT04124705|593392229|FG000|Stabilization Period|Other|2|||
164279600|NCT04124705|593392230|FG001|Stabilization Period|Other|2|||
164279601|NCT00532298|593392231|FG000|Overall Study|Adverse Event|1|||
164279602|NCT00532298|593392232|FG001|Overall Study|Adverse Event|0|||
164279603|NCT00532298|593392233|FG002|Overall Study|Adverse Event|0|||
164279604|NCT00532298|593392234|FG003|Overall Study|Adverse Event|0|||
164279605|NCT00532298|593392235|FG004|Overall Study|Adverse Event|1|||
164279606|NCT00532298|593392236|FG005|Overall Study|Adverse Event|1|||
164279607|NCT00532298|593392231|FG000|Overall Study|Lost to Follow-up|1|||
164279608|NCT00532298|593392232|FG001|Overall Study|Lost to Follow-up|1|||
164279609|NCT00532298|593392233|FG002|Overall Study|Lost to Follow-up|1|||
164279610|NCT00532298|593392234|FG003|Overall Study|Lost to Follow-up|0|||
164279611|NCT00532298|593392235|FG004|Overall Study|Lost to Follow-up|0|||
164279612|NCT00532298|593392236|FG005|Overall Study|Lost to Follow-up|1|||
164279613|NCT00479856|593392237|FG000|Overall Study|Adverse Event|1|||
164279614|NCT00479856|593392237|FG000|Overall Study|Withdrawal by Subject|1|||
164279615|NCT00479856|593392237|FG000|Overall Study|Physician Decision|1|||
164279616|NCT04164732|593392239|FG000|Treatment run-in Period|Adverse Event|4|||
164279617|NCT04164732|593392240|FG001|Treatment run-in Period|Adverse Event|0|||
164279618|NCT04164732|593392241|FG002|Treatment run-in Period|Adverse Event|0|||
164279619|NCT04164732|593392239|FG000|Treatment run-in Period|Physician Decision|1|||
164279620|NCT04164732|593392240|FG001|Treatment run-in Period|Physician Decision|0|||
164279621|NCT04164732|593392241|FG002|Treatment run-in Period|Physician Decision|0|||
164279622|NCT04164732|593392239|FG000|Treatment run-in Period|Screen Failure|1|||
164279623|NCT04164732|593392240|FG001|Treatment run-in Period|Screen Failure|0|||
164279624|NCT04164732|593392241|FG002|Treatment run-in Period|Screen Failure|0|||
164279625|NCT04164732|593392239|FG000|Randomized Treatment Period|Adverse Event|0|||
164279626|NCT04164732|593392240|FG001|Randomized Treatment Period|Adverse Event|1|||
164279627|NCT04164732|593392241|FG002|Randomized Treatment Period|Adverse Event|0|||
164279628|NCT04164732|593392239|FG000|Randomized Treatment Period|Protocol Deviation|0|||
164279629|NCT04164732|593392240|FG001|Randomized Treatment Period|Protocol Deviation|1|||
164279630|NCT04164732|593392241|FG002|Randomized Treatment Period|Protocol Deviation|1|||
164279631|NCT04164732|593392239|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
164279632|NCT04164732|593392240|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
164279633|NCT04164732|593392241|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
164279634|NCT02141360|593392242|FG000|Overall Study|Withdrawal by Subject|6|||
164279635|NCT02141360|593392243|FG001|Overall Study|Withdrawal by Subject|0|||
164279636|NCT02141360|593392244|FG002|Overall Study|Withdrawal by Subject|0|||
164279637|NCT02141360|593392242|FG000|Overall Study|Study Terminated before Visit|1|||
164279638|NCT02141360|593392243|FG001|Overall Study|Study Terminated before Visit|0|||
164279639|NCT02141360|593392244|FG002|Overall Study|Study Terminated before Visit|0|||
164279640|NCT00661622|593392245|FG000|Overall Study|Protocol Violation|1|||
164279641|NCT00661622|593392246|FG001|Overall Study|Protocol Violation|0|||
164279642|NCT00932165|593392255|FG000|Overall Study|Lost to Follow-up|1|||
164279643|NCT03997825|593392260|FG000|Overall Study|Death|3|||
164279644|NCT03997825|593392260|FG000|Overall Study|Lost to Follow-up|10|||
164279645|NCT03997825|593392260|FG000|Overall Study|Withdrawal by Subject|3|||
163895318|NCT03744676|591989638|FG000|Pre-Treatment Phase|Disease related complications|2|||
163895319|NCT03744676|591989638|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
163895320|NCT03744676|591989638|FG000|Pre-Treatment Phase|Death|7|||
163895321|NCT03744676|591989638|FG000|Pre-Treatment Phase|Other Reasons|7|||
163895322|NCT03744676|591989638|FG000|Treatment Phase|Participant withdrew consent|8|||
163895323|NCT03744676|591989638|FG000|Treatment Phase|Death|33|||
163895324|NCT03744676|591989638|FG000|Treatment Phase|other reasons|6|||
163895325|NCT02510235|591989639|FG000|Overall Study|Withdrawal by Subject|1|||
163895326|NCT02510235|591989640|FG001|Overall Study|Withdrawal by Subject|0|||
163895327|NCT00450216|591989641|FG000|Overall Study|Adverse Event|38|||
163895328|NCT00450216|591989642|FG001|Overall Study|Adverse Event|23|||
163895329|NCT00450216|591989641|FG000|Overall Study|Withdrawal by Subject|48|||
164279646|NCT03997825|593392260|FG000|Overall Study|Refused participation|1|||
164279647|NCT03824587|593392271|FG000|Run-in Period|Screen Failure|0|||
164279648|NCT03824587|593392272|FG001|Run-in Period|Screen Failure|275|||
164279649|NCT03824587|593392271|FG000|Treatment Period|Adverse Event|4|||
164279650|NCT03824587|593392272|FG001|Treatment Period|Adverse Event|1|||
164279651|NCT03824587|593392271|FG000|Treatment Period|Withdrawal by Subject|0|||
164279652|NCT03824587|593392272|FG001|Treatment Period|Withdrawal by Subject|1|||
164279653|NCT03824587|593392271|FG000|Treatment Period|Kidney Transplant|1|||
164279654|NCT03824587|593392272|FG001|Treatment Period|Kidney Transplant|1|||
164279655|NCT01300572|593392273|FG000|Overall Study|HAMA + post dosimetry|1|||
164279656|NCT01368081|593392274|FG000|Overall Study|Adverse Event|4|||
164279657|NCT01368081|593392275|FG001|Overall Study|Adverse Event|4|||
164279658|NCT01368081|593392276|FG002|Overall Study|Adverse Event|3|||
164279659|NCT01368081|593392277|FG003|Overall Study|Adverse Event|2|||
164279660|NCT01368081|593392278|FG004|Overall Study|Adverse Event|2|||
164279661|NCT01368081|593392279|FG005|Overall Study|Adverse Event|5|||
164279662|NCT01368081|593392280|FG006|Overall Study|Adverse Event|6|||
164279663|NCT01368081|593392281|FG007|Overall Study|Adverse Event|2|||
164279664|NCT01368081|593392282|FG008|Overall Study|Adverse Event|3|||
164279665|NCT01368081|593392283|FG009|Overall Study|Adverse Event|5|||
164279666|NCT01368081|593392284|FG010|Overall Study|Adverse Event|6|||
164279667|NCT01368081|593392285|FG011|Overall Study|Adverse Event|1|||
164279668|NCT01368081|593392286|FG012|Overall Study|Adverse Event|3|||
164279669|NCT01368081|593392274|FG000|Overall Study|Lack of Efficacy|0|||
164279670|NCT01368081|593392275|FG001|Overall Study|Lack of Efficacy|1|||
164279671|NCT01368081|593392276|FG002|Overall Study|Lack of Efficacy|0|||
164279672|NCT01368081|593392277|FG003|Overall Study|Lack of Efficacy|1|||
164279673|NCT01368081|593392278|FG004|Overall Study|Lack of Efficacy|0|||
164279674|NCT01368081|593392279|FG005|Overall Study|Lack of Efficacy|0|||
164279675|NCT01368081|593392280|FG006|Overall Study|Lack of Efficacy|0|||
164279676|NCT01368081|593392281|FG007|Overall Study|Lack of Efficacy|2|||
164279677|NCT01368081|593392282|FG008|Overall Study|Lack of Efficacy|0|||
164279678|NCT01368081|593392283|FG009|Overall Study|Lack of Efficacy|0|||
164279679|NCT01368081|593392284|FG010|Overall Study|Lack of Efficacy|0|||
164279680|NCT01368081|593392285|FG011|Overall Study|Lack of Efficacy|0|||
164279681|NCT01368081|593392286|FG012|Overall Study|Lack of Efficacy|0|||
164279682|NCT01368081|593392274|FG000|Overall Study|Protocol Violation|0|||
164279683|NCT01368081|593392275|FG001|Overall Study|Protocol Violation|0|||
164279684|NCT01368081|593392276|FG002|Overall Study|Protocol Violation|0|||
164279685|NCT01368081|593392277|FG003|Overall Study|Protocol Violation|0|||
164279686|NCT01368081|593392278|FG004|Overall Study|Protocol Violation|0|||
164279687|NCT01368081|593392279|FG005|Overall Study|Protocol Violation|1|||
164279688|NCT01368081|593392280|FG006|Overall Study|Protocol Violation|0|||
164279689|NCT01368081|593392281|FG007|Overall Study|Protocol Violation|1|||
164279690|NCT01368081|593392282|FG008|Overall Study|Protocol Violation|0|||
164279691|NCT01368081|593392283|FG009|Overall Study|Protocol Violation|0|||
164279692|NCT01368081|593392284|FG010|Overall Study|Protocol Violation|0|||
164279693|NCT01368081|593392285|FG011|Overall Study|Protocol Violation|0|||
164279694|NCT01368081|593392286|FG012|Overall Study|Protocol Violation|0|||
164279695|NCT01368081|593392274|FG000|Overall Study|Lost to Follow-up|0|||
164279696|NCT01368081|593392275|FG001|Overall Study|Lost to Follow-up|0|||
163895330|NCT00450216|591989642|FG001|Overall Study|Withdrawal by Subject|26|||
164279697|NCT01368081|593392276|FG002|Overall Study|Lost to Follow-up|0|||
164279698|NCT01368081|593392277|FG003|Overall Study|Lost to Follow-up|0|||
164279699|NCT01368081|593392278|FG004|Overall Study|Lost to Follow-up|0|||
164279700|NCT01368081|593392279|FG005|Overall Study|Lost to Follow-up|0|||
164279701|NCT01368081|593392280|FG006|Overall Study|Lost to Follow-up|0|||
164279702|NCT01368081|593392281|FG007|Overall Study|Lost to Follow-up|0|||
164279703|NCT01368081|593392282|FG008|Overall Study|Lost to Follow-up|0|||
164279704|NCT01368081|593392283|FG009|Overall Study|Lost to Follow-up|0|||
164279705|NCT01368081|593392284|FG010|Overall Study|Lost to Follow-up|0|||
164279706|NCT01368081|593392285|FG011|Overall Study|Lost to Follow-up|0|||
164279707|NCT01368081|593392286|FG012|Overall Study|Lost to Follow-up|1|||
164279708|NCT01368081|593392274|FG000|Overall Study|Withdrawal by Subject|4|||
164279709|NCT01368081|593392275|FG001|Overall Study|Withdrawal by Subject|4|||
164279710|NCT01368081|593392276|FG002|Overall Study|Withdrawal by Subject|1|||
164279711|NCT01368081|593392277|FG003|Overall Study|Withdrawal by Subject|1|||
164279712|NCT01368081|593392278|FG004|Overall Study|Withdrawal by Subject|0|||
164279713|NCT01368081|593392279|FG005|Overall Study|Withdrawal by Subject|3|||
164279714|NCT01368081|593392280|FG006|Overall Study|Withdrawal by Subject|4|||
164279715|NCT01368081|593392281|FG007|Overall Study|Withdrawal by Subject|2|||
164279716|NCT01368081|593392282|FG008|Overall Study|Withdrawal by Subject|5|||
164279717|NCT01368081|593392283|FG009|Overall Study|Withdrawal by Subject|4|||
164279718|NCT01368081|593392284|FG010|Overall Study|Withdrawal by Subject|3|||
164279719|NCT01368081|593392285|FG011|Overall Study|Withdrawal by Subject|2|||
164279720|NCT01368081|593392286|FG012|Overall Study|Withdrawal by Subject|0|||
164279721|NCT01368081|593392274|FG000|Overall Study|Other reason not defined above|2|||
164279722|NCT01368081|593392275|FG001|Overall Study|Other reason not defined above|0|||
164279723|NCT01368081|593392276|FG002|Overall Study|Other reason not defined above|0|||
164279724|NCT01368081|593392277|FG003|Overall Study|Other reason not defined above|1|||
164279725|NCT01368081|593392278|FG004|Overall Study|Other reason not defined above|0|||
164279726|NCT01368081|593392279|FG005|Overall Study|Other reason not defined above|1|||
164279727|NCT01368081|593392280|FG006|Overall Study|Other reason not defined above|2|||
164279728|NCT01368081|593392281|FG007|Overall Study|Other reason not defined above|0|||
164279729|NCT01368081|593392282|FG008|Overall Study|Other reason not defined above|0|||
164279730|NCT01368081|593392283|FG009|Overall Study|Other reason not defined above|1|||
164279731|NCT01368081|593392284|FG010|Overall Study|Other reason not defined above|0|||
164279732|NCT01368081|593392285|FG011|Overall Study|Other reason not defined above|0|||
164279733|NCT01368081|593392286|FG012|Overall Study|Other reason not defined above|3|||
164279734|NCT02461745|593392288|FG000|Overall Study|Lack of Efficacy|9|||
164279735|NCT02461745|593392289|FG001|Overall Study|Lack of Efficacy|1|||
164085991|NCT03118739|592678619|FG000|Overall Study|Withdrawal by Subject|5|||
164085992|NCT03118739|592678620|FG001|Overall Study|Withdrawal by Subject|3|||
164085993|NCT03118739|592678619|FG000|Overall Study|Lost to Follow-up|2|||
164085994|NCT03118739|592678620|FG001|Overall Study|Lost to Follow-up|0|||
164279736|NCT02461745|593392288|FG000|Overall Study|Lost to Follow-up|2|||
164279737|NCT02461745|593392289|FG001|Overall Study|Lost to Follow-up|2|||
164279738|NCT02461745|593392288|FG000|Overall Study|Withdrawal by Subject|3|||
164279739|NCT02461745|593392289|FG001|Overall Study|Withdrawal by Subject|1|||
164279740|NCT02921087|593392290|FG000|Overall Study|Withdrawal by Subject|0|||
164279741|NCT02921087|593392291|FG001|Overall Study|Withdrawal by Subject|1|||
164279742|NCT02828436|593394144|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
164279743|NCT02828436|593394145|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
164279744|NCT02828436|593394144|FG000|Period 1|Lost to Follow-up|0|||
164279745|NCT02828436|593394145|FG001|Period 1|Lost to Follow-up|1|||
164279746|NCT02828436|593394144|FG000|Period 2|Withdrawal by Subject|4|||
164279747|NCT02828436|593394145|FG001|Period 2|Withdrawal by Subject|0|||
164279748|NCT02828436|593394144|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
164279749|NCT02828436|593394145|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
164279750|NCT02828436|593394144|FG000|Period 2|Lost to Follow-up|1|||
164279751|NCT02828436|593394145|FG001|Period 2|Lost to Follow-up|0|||
164279752|NCT02644343|593394146|FG000|Overall Study|Withdrawal by Subject|1|||
164279753|NCT00536471|593394147|FG000|Overall Study|Lost to Follow-up|48|||
164279754|NCT00536471|593394148|FG001|Overall Study|Lost to Follow-up|23|||
164279755|NCT00536471|593394149|FG002|Overall Study|Lost to Follow-up|48|||
164279756|NCT00536471|593394150|FG003|Overall Study|Lost to Follow-up|22|||
164279757|NCT00536471|593394147|FG000|Overall Study|Adverse Event|32|||
164279758|NCT00536471|593394148|FG001|Overall Study|Adverse Event|16|||
164279759|NCT00536471|593394149|FG002|Overall Study|Adverse Event|28|||
164279760|NCT00536471|593394150|FG003|Overall Study|Adverse Event|13|||
164279761|NCT00536471|593394147|FG000|Overall Study|Withdrawal by Subject|40|||
164279762|NCT00536471|593394148|FG001|Overall Study|Withdrawal by Subject|24|||
164279763|NCT00536471|593394149|FG002|Overall Study|Withdrawal by Subject|43|||
164279764|NCT00536471|593394150|FG003|Overall Study|Withdrawal by Subject|21|||
164279765|NCT00536471|593394147|FG000|Overall Study|Lack of Efficacy|17|||
164279766|NCT00536471|593394148|FG001|Overall Study|Lack of Efficacy|18|||
164279767|NCT00536471|593394149|FG002|Overall Study|Lack of Efficacy|11|||
164279768|NCT00536471|593394150|FG003|Overall Study|Lack of Efficacy|9|||
164279769|NCT00536471|593394147|FG000|Overall Study|Protocol Violation|8|||
164279770|NCT00536471|593394148|FG001|Overall Study|Protocol Violation|1|||
164279771|NCT00536471|593394149|FG002|Overall Study|Protocol Violation|2|||
164279772|NCT00536471|593394150|FG003|Overall Study|Protocol Violation|3|||
164279773|NCT00536471|593394147|FG000|Overall Study|Physician Decision|11|||
164279774|NCT00536471|593394148|FG001|Overall Study|Physician Decision|1|||
164279775|NCT00536471|593394149|FG002|Overall Study|Physician Decision|3|||
164279776|NCT00536471|593394150|FG003|Overall Study|Physician Decision|2|||
164279777|NCT00536471|593394147|FG000|Overall Study|Death|0|||
164279778|NCT00536471|593394148|FG001|Overall Study|Death|0|||
164279779|NCT00536471|593394149|FG002|Overall Study|Death|1|||
164279780|NCT00536471|593394150|FG003|Overall Study|Death|2|||
164279781|NCT00536471|593394147|FG000|Overall Study|Sponsor Decision|0|||
164279782|NCT00536471|593394148|FG001|Overall Study|Sponsor Decision|1|||
164279783|NCT00536471|593394149|FG002|Overall Study|Sponsor Decision|3|||
164279784|NCT00536471|593394150|FG003|Overall Study|Sponsor Decision|2|||
164279785|NCT00880191|593394158|FG000|Overall Study|Refused further treatment|4|||
164279786|NCT00880191|593394159|FG001|Overall Study|Refused further treatment|1|||
164279787|NCT00880191|593394158|FG000|Overall Study|Adverse Event|8|||
164279788|NCT00880191|593394159|FG001|Overall Study|Adverse Event|6|||
164279789|NCT00880191|593394158|FG000|Overall Study|Hospitalization/efficacy|1|||
164279790|NCT00880191|593394159|FG001|Overall Study|Hospitalization/efficacy|1|||
164279791|NCT00773747|593394164|FG000|Overall Study|Lack of Efficacy|112|||
164279792|NCT00773747|593394165|FG001|Overall Study|Lack of Efficacy|144|||
164279793|NCT00773747|593394164|FG000|Overall Study|Physician Decision|26|||
164344059|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
164344060|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
164344061|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Death|0|||
164344062|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Death|1|||
164344063|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Death|0|||
164344064|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Death|1|||
164344065|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Death|0|||
164344066|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Change of location|1|||
164344067|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Change of location|1|||
164344068|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Change of location|0|||
164279794|NCT00773747|593394165|FG001|Overall Study|Physician Decision|18|||
164279795|NCT00773747|593394164|FG000|Overall Study|Lost to Follow-up|0|||
164279796|NCT00773747|593394165|FG001|Overall Study|Lost to Follow-up|1|||
164279797|NCT00773747|593394164|FG000|Overall Study|Protocol Violation|2|||
164279798|NCT00773747|593394165|FG001|Overall Study|Protocol Violation|2|||
164279799|NCT00773747|593394164|FG000|Overall Study|Withdrawal by Subject|89|||
164279800|NCT00773747|593394165|FG001|Overall Study|Withdrawal by Subject|61|||
164279801|NCT00773747|593394164|FG000|Overall Study|Adverse Event|61|||
164279802|NCT00773747|593394165|FG001|Overall Study|Adverse Event|62|||
164279803|NCT00773747|593394164|FG000|Overall Study|Death|5|||
164279804|NCT00773747|593394165|FG001|Overall Study|Death|8|||
164279805|NCT00773747|593394164|FG000|Overall Study|Not Treated|2|||
164085995|NCT02995837|592678621|FG000|Overall Study|Lost to Follow-up|9|||
164279806|NCT00773747|593394165|FG001|Overall Study|Not Treated|0|||
164279807|NCT00836186|593394166|FG000|Overall Study|Blood could not be drawn|1|||
164279808|NCT04079816|593394167|FG000|Overall Study|Request of Subject|2|||
164279809|NCT04079816|593394167|FG000|Overall Study|Unable to draw samples|1|||
164279810|NCT03422536|593394168|FG000|Randomized|Physician Decision|1|||
164279811|NCT03422536|593394169|FG001|Randomized|Physician Decision|1|||
164279812|NCT03422536|593394168|FG000|Allocation - Received Intervention|Disease progression|19|||
164279813|NCT03422536|593394169|FG001|Allocation - Received Intervention|Disease progression|25|||
164279814|NCT03422536|593394168|FG000|Allocation - Received Intervention|Death|1|||
164279815|NCT03422536|593394169|FG001|Allocation - Received Intervention|Death|3|||
164279816|NCT03422536|593394168|FG000|Allocation - Received Intervention|Adverse Event|1|||
164279817|NCT03422536|593394169|FG001|Allocation - Received Intervention|Adverse Event|0|||
164085996|NCT02995837|592678622|FG001|Overall Study|Lost to Follow-up|8|||
164279818|NCT03422536|593394168|FG000|Allocation - Received Intervention|Physician Decision|1|||
164279819|NCT03422536|593394169|FG001|Allocation - Received Intervention|Physician Decision|1|||
164279820|NCT03422536|593394168|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
164279821|NCT03422536|593394169|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
164279822|NCT03422536|593394168|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
164279823|NCT03422536|593394169|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
164279824|NCT01973998|593394170|FG000|Overall Study|Death|2|||
164279825|NCT01973998|593394171|FG001|Overall Study|Death|2|||
164279826|NCT01636986|593394174|FG000|Overall Study|Withdrawal by Subject|0|||
164279827|NCT01636986|593394175|FG001|Overall Study|Withdrawal by Subject|1|||
164279828|NCT01636986|593394174|FG000|Overall Study|Corneal Staining|0|||
164279829|NCT01636986|593394175|FG001|Overall Study|Corneal Staining|1|||
164279830|NCT02160145|593394178|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
164279831|NCT02160145|593394179|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
164279832|NCT02160145|593394180|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
164279833|NCT02160145|593394178|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
164279834|NCT02160145|593394179|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
164279835|NCT02160145|593394180|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
164279836|NCT02160145|593394178|FG000|Randomized Double-blind Period|Subject decision|0|||
164279837|NCT02160145|593394179|FG001|Randomized Double-blind Period|Subject decision|21|||
164279838|NCT02160145|593394180|FG002|Randomized Double-blind Period|Subject decision|20|||
164279839|NCT02160145|593394178|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
164279840|NCT02160145|593394179|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
164279841|NCT02160145|593394180|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
164279842|NCT02160145|593394178|FG000|Randomized Double-blind Period|Physician Decision|0|||
164279843|NCT02160145|593394179|FG001|Randomized Double-blind Period|Physician Decision|7|||
164279844|NCT02160145|593394180|FG002|Randomized Double-blind Period|Physician Decision|5|||
164279845|NCT00395850|593394182|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
164279846|NCT00395850|593394183|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
164279847|NCT00395850|593394184|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
164279848|NCT00395850|593394185|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
164279849|NCT00395850|593394182|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
164279850|NCT00395850|593394183|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
164279851|NCT00395850|593394184|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
163895331|NCT00450216|591989641|FG000|Overall Study|Lost to Follow-up|16|||
164279852|NCT00395850|593394185|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
164279853|NCT00395850|593394182|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
164279854|NCT00395850|593394183|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
164279855|NCT00395850|593394184|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
164279856|NCT00395850|593394185|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
164279857|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
164279858|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
164279859|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
164279860|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
164279861|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
164279862|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
164279863|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
164279864|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
164279865|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
164279866|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
164279867|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
164279868|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
164279869|NCT00395850|593394182|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
164279870|NCT00395850|593394183|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
164279871|NCT00395850|593394184|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
164279872|NCT00395850|593394185|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
164279873|NCT02540993|593394190|FG000|Overall Study|Lost to Follow-up|5|||
164279874|NCT02540993|593394191|FG001|Overall Study|Lost to Follow-up|3|||
164279875|NCT02540993|593394190|FG000|Overall Study|Withdrawal by Subject|4|||
164279876|NCT02540993|593394191|FG001|Overall Study|Withdrawal by Subject|6|||
164279877|NCT02540993|593394190|FG000|Overall Study|GCP violations|33|||
164279878|NCT02540993|593394191|FG001|Overall Study|GCP violations|27|||
164279879|NCT00588094|593394194|FG000|Overall Study|Adverse Event|3|||
164279880|NCT00588094|593394194|FG000|Overall Study|Progression of Disease|2|||
164279881|NCT00705146|593394195|FG000|Overall Study|Lost to Follow-up|1|||
164344069|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Change of location|1|||
164344070|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Change of location|0|||
164344071|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344072|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344073|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
164344074|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344075|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
164344076|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344077|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344078|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
164344079|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344080|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
164344081|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344082|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344083|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
164344084|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344085|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
164344086|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344087|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344088|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344089|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
164344090|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
164344091|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
164344092|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164344093|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164279882|NCT00705146|593394196|FG001|Overall Study|Lost to Follow-up|1|||
164279883|NCT01620528|593394199|FG000|Treatment Period|Did Not Receive Study Drug|0|||
164279884|NCT01620528|593394200|FG001|Treatment Period|Did Not Receive Study Drug|0|||
164279885|NCT01620528|593394201|FG002|Treatment Period|Did Not Receive Study Drug|1|||
164279886|NCT01620528|593394199|FG000|Treatment Period|Withdrawal by Subject|35|||
164279887|NCT01620528|593394200|FG001|Treatment Period|Withdrawal by Subject|21|||
164085997|NCT03996005|592678625|FG000|Overall Study|Withdrawal by Subject|1|||
164279888|NCT01620528|593394201|FG002|Treatment Period|Withdrawal by Subject|16|||
164279889|NCT01620528|593394199|FG000|Treatment Period|Adverse Event|17|||
164279890|NCT01620528|593394200|FG001|Treatment Period|Adverse Event|13|||
164279891|NCT01620528|593394201|FG002|Treatment Period|Adverse Event|21|||
164279892|NCT01620528|593394199|FG000|Treatment Period|Lost to Follow-up|16|||
164279893|NCT01620528|593394200|FG001|Treatment Period|Lost to Follow-up|8|||
164279894|NCT01620528|593394201|FG002|Treatment Period|Lost to Follow-up|14|||
164279895|NCT01620528|593394199|FG000|Treatment Period|Other|9|||
164279896|NCT01620528|593394200|FG001|Treatment Period|Other|5|||
164279897|NCT01620528|593394201|FG002|Treatment Period|Other|7|||
164279898|NCT01620528|593394199|FG000|Treatment Period|Subject Noncompliant|11|||
164279899|NCT01620528|593394200|FG001|Treatment Period|Subject Noncompliant|2|||
164279900|NCT01620528|593394201|FG002|Treatment Period|Subject Noncompliant|2|||
164279901|NCT01620528|593394199|FG000|Treatment Period|Pregnancy|7|||
164279902|NCT01620528|593394200|FG001|Treatment Period|Pregnancy|2|||
164279903|NCT01620528|593394201|FG002|Treatment Period|Pregnancy|2|||
164279904|NCT01620528|593394199|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
164279905|NCT01620528|593394200|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
164279906|NCT01620528|593394201|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
164279907|NCT01620528|593394199|FG000|Treatment Period|Exclusionary Medication Received|0|||
164279908|NCT01620528|593394200|FG001|Treatment Period|Exclusionary Medication Received|1|||
164279909|NCT01620528|593394201|FG002|Treatment Period|Exclusionary Medication Received|0|||
164279910|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
164279911|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
164279912|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
164279913|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164279914|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164279915|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
164279916|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
164279917|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
164279918|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
164279919|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
164279920|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
164279921|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
164279922|NCT01620528|593394199|FG000|Post-Treatment Follow-Up Period|Other|6|||
164279923|NCT01620528|593394200|FG001|Post-Treatment Follow-Up Period|Other|4|||
164279924|NCT01620528|593394201|FG002|Post-Treatment Follow-Up Period|Other|2|||
164279925|NCT01457846|593394208|FG000|Overall Study|Death before treatment|1|||
164279926|NCT01457846|593394209|FG001|Overall Study|Death before treatment|2|||
164279927|NCT01457846|593394208|FG000|Overall Study|Did not receive treatment|0|||
164279928|NCT01457846|593394209|FG001|Overall Study|Did not receive treatment|1|||
164279929|NCT01457846|593394208|FG000|Overall Study|Death|27|||
164279930|NCT01457846|593394209|FG001|Overall Study|Death|16|||
164279931|NCT01457846|593394208|FG000|Overall Study|Unclassified reason for not completed|11|||
164279932|NCT01457846|593394209|FG001|Overall Study|Unclassified reason for not completed|10|||
164279933|NCT01457846|593394208|FG000|Overall Study|Withdrawal by Subject|1|||
164279934|NCT01457846|593394209|FG001|Overall Study|Withdrawal by Subject|1|||
164279935|NCT01457846|593394208|FG000|Overall Study|Lost to Follow-up|1|||
164279936|NCT01457846|593394209|FG001|Overall Study|Lost to Follow-up|0|||
164279937|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
164279938|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
164279939|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
164279940|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
164279941|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
164279942|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
164279943|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
164279944|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
164279945|NCT00383162|593394210|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
164279946|NCT00383162|593394211|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
164279947|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
164279948|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
164279949|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
164279950|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
164344094|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164344095|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
164344096|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344097|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344098|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344099|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
164344100|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
164344101|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
164279951|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
164279952|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
164279953|NCT00383162|593394210|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
164279954|NCT00383162|593394211|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
164279955|NCT01153698|593394212|FG000|Overall Study|Adverse Event|12|||
164279956|NCT01153698|593394212|FG000|Overall Study|Lost to Follow-up|4|||
164279957|NCT01153698|593394212|FG000|Overall Study|Withdrawal by Subject|2|||
164279958|NCT01153698|593394212|FG000|Overall Study|Switch to other anticoagulants|4|||
164279959|NCT01153698|593394212|FG000|Overall Study|Other|2|||
164279960|NCT01153698|593394212|FG000|Overall Study|Not treated with Pradaxa|5|||
164279961|NCT05392803|593394216|FG000|Overall Study|Lost to Follow-up|0|||
164279962|NCT05392803|593394217|FG001|Overall Study|Lost to Follow-up|2|||
164279963|NCT00465647|593394218|FG000|Overall Study|Administrative|2|||
164279964|NCT00465647|593394219|FG001|Overall Study|Administrative|2|||
164279965|NCT00465647|593394220|FG002|Overall Study|Administrative|3|||
164279966|NCT00465647|593394221|FG003|Overall Study|Administrative|2|||
164279967|NCT00465647|593394218|FG000|Overall Study|Adverse Event|2|||
164279968|NCT00465647|593394219|FG001|Overall Study|Adverse Event|0|||
164279969|NCT00465647|593394220|FG002|Overall Study|Adverse Event|3|||
164279970|NCT00465647|593394221|FG003|Overall Study|Adverse Event|2|||
164279971|NCT00465647|593394218|FG000|Overall Study|Withdrawal by Subject|1|||
164279972|NCT00465647|593394219|FG001|Overall Study|Withdrawal by Subject|2|||
164279973|NCT00465647|593394220|FG002|Overall Study|Withdrawal by Subject|2|||
164279974|NCT00465647|593394221|FG003|Overall Study|Withdrawal by Subject|7|||
164279975|NCT00465647|593394218|FG000|Overall Study|"The other reasons included loss of IV"|8|||
164279976|NCT00465647|593394219|FG001|Overall Study|"The other reasons included loss of IV"|4|||
164279977|NCT00465647|593394220|FG002|Overall Study|"The other reasons included loss of IV"|3|||
164279978|NCT00465647|593394221|FG003|Overall Study|"The other reasons included loss of IV"|2|||
164279979|NCT01240135|593394222|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
164279980|NCT01240135|593394223|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
164279981|NCT01240135|593394222|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
164279982|NCT01240135|593394223|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
164279983|NCT02220712|593394224|FG000|Overall Study|Adverse Event|1|||
164279984|NCT02220712|593394224|FG000|Overall Study|Withdrawal by Subject|2|||
164279985|NCT02220712|593394224|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
164279986|NCT00760838|593394228|FG000|Overall Study|Adverse Event|1|||
164279987|NCT00760838|593394229|FG001|Overall Study|Adverse Event|1|||
164279988|NCT00760838|593394228|FG000|Overall Study|Lack of Efficacy|1|||
164279989|NCT00760838|593394229|FG001|Overall Study|Lack of Efficacy|0|||
164279990|NCT00760838|593394228|FG000|Overall Study|Lost to Follow-up|2|||
164279991|NCT00760838|593394229|FG001|Overall Study|Lost to Follow-up|0|||
164279992|NCT00760838|593394228|FG000|Overall Study|Withdrawal by Subject|1|||
164279993|NCT00760838|593394229|FG001|Overall Study|Withdrawal by Subject|1|||
164279994|NCT00923845|593394230|FG000|Induction Therapy|Poor performance status|0|||
164279995|NCT00923845|593394231|FG001|Induction Therapy|Poor performance status|2|||
164279996|NCT01743040|593394236|FG000|Overall Study|Death|1|||
164279997|NCT01743040|593394236|FG000|Overall Study|Lost to Follow-up|66|||
164279998|NCT01743040|593394236|FG000|Overall Study|Physician Decision|40|||
164279999|NCT01743040|593394236|FG000|Overall Study|Protocol Violation|1|||
164280000|NCT01743040|593394236|FG000|Overall Study|Withdrawal by Subject|121|||
164280001|NCT00830180|593394237|FG000|Overall Study|Adverse Event|6|||
164280002|NCT00830180|593394237|FG000|Overall Study|Death|11|||
164280003|NCT00830180|593394237|FG000|Overall Study|Insufficient clinical response|1|||
164280004|NCT00830180|593394237|FG000|Overall Study|Withdrawal by Subject|5|||
164280005|NCT00830180|593394237|FG000|Overall Study|Progressive disease|2|||
164280006|NCT00830180|593394237|FG000|Overall Study|Other - Unspecified|1|||
164280007|NCT01832532|593394238|FG000|Overall Study|Withdrawal by Subject|5|||
164280008|NCT01832532|593394239|FG001|Overall Study|Withdrawal by Subject|2|||
164280009|NCT00392990|593394241|FG000|Treatment on Study|Adverse Event|3|||
164280010|NCT00392990|593394242|FG001|Treatment on Study|Adverse Event|1|||
164344102|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
164344103|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
164344104|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
164280011|NCT00392990|593394241|FG000|Follow up for 2 Years|Death|4|||
164280012|NCT00392990|593394242|FG001|Follow up for 2 Years|Death|0|||
164280013|NCT01630889|593394245|FG000|Overall Study|Death|2|||
164280014|NCT01630889|593394245|FG000|Overall Study|Withdrawal by Subject|1|||
164280015|NCT01630889|593394245|FG000|Overall Study|Other than Specified|2|||
164280016|NCT01630889|593394245|FG000|Overall Study|Lost to Follow-up|4|||
164280017|NCT01630889|593394245|FG000|Overall Study|Other|1|||
164280018|NCT00991406|593394247|FG000|Overall Study|One participant did not respond to FES.|1|||
164280019|NCT03755661|593394248|FG000|Overall Study|Lost to Follow-up|1|||
164280020|NCT03755661|593394249|FG001|Overall Study|Lost to Follow-up|0|||
164280021|NCT02038075|593394250|FG000|Overall Study|Withdrawal by Subject|3|||
164280022|NCT02038075|593394251|FG001|Overall Study|Withdrawal by Subject|0|||
164280023|NCT04000581|593394252|FG000|Overall Study|Withdrawal by Subject|0|||
164344105|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
164344106|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
164344107|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
164344108|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
164344109|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
164344110|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
164344111|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
164344112|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
164344113|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
164344114|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
164280024|NCT04000581|593394253|FG001|Overall Study|Withdrawal by Subject|1|||
164344115|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
164344116|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
164344117|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
164344118|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
164344119|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
164344120|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
164344121|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Missing|0|||
164344122|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Missing|0|||
164344123|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Missing|2|||
164344124|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Missing|0|||
164344125|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Missing|0|||
164344126|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164344127|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164344128|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164344129|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
164280025|NCT02519595|593394257|FG000|Overall Study|Protocol Violation|8|||
164280026|NCT02519595|593394258|FG001|Overall Study|Protocol Violation|22|||
164280027|NCT02519595|593394259|FG002|Overall Study|Protocol Violation|16|||
164280028|NCT03188510|593394262|FG000|Overall Study|Inappropriate behavior with site staff|0|||
164280029|NCT03188510|593394263|FG001|Overall Study|Inappropriate behavior with site staff|1|||
164280030|NCT03188510|593394264|FG002|Overall Study|Inappropriate behavior with site staff|0|||
164280031|NCT01736618|593394267|FG000|Overall Study|Death|294|||
164280032|NCT01736618|593394267|FG000|Overall Study|Lost to Follow-up|193|||
164280033|NCT01736618|593394267|FG000|Overall Study|Withdrawal by Subject|54|||
164344130|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
164344131|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344132|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344133|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
164344134|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344135|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
164344136|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
164344137|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
164344138|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
164344139|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
164344140|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
164344141|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344142|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344143|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
164344144|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344145|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
164344146|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344147|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344148|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344149|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
164344150|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
164344151|NCT00730405|593635367|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
164344152|NCT00730405|593635368|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344153|NCT00730405|593635369|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344154|NCT00730405|593635370|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344155|NCT00730405|593635371|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
164344156|NCT00963937|593635372|FG000|Overall Study|Protocol Violation|1|||
164280034|NCT01736618|593394267|FG000|Overall Study|Subject unable to be followed at study location|223|||
164280035|NCT01736618|593394267|FG000|Overall Study|Physician Decision|33|||
164280036|NCT01736618|593394267|FG000|Overall Study|Transplant or removal of target organ|19|||
164280037|NCT01736618|593394267|FG000|Overall Study|Change in indication or condition|78|||
164280038|NCT01736618|593394267|FG000|Overall Study|Study device explant|103|||
164280039|NCT01736618|593394267|FG000|Overall Study|Unable to complete implant|2|||
164280040|NCT04167137|593394269|FG000|Overall Study|Disease progression|1|||
164280041|NCT04167137|593394270|FG001|Overall Study|Disease progression|1|||
164280042|NCT04167137|593394271|FG002|Overall Study|Disease progression|3|||
164280043|NCT04167137|593394272|FG003|Overall Study|Disease progression|3|||
164280044|NCT04167137|593394273|FG004|Overall Study|Disease progression|2|||
164280045|NCT04167137|593394274|FG005|Overall Study|Disease progression|3|||
164280046|NCT04167137|593394275|FG006|Overall Study|Disease progression|2|||
164280047|NCT04167137|593394276|FG007|Overall Study|Disease progression|2|||
164280048|NCT04167137|593394269|FG000|Overall Study|Withdrawal by Subject|1|||
164280049|NCT04167137|593394270|FG001|Overall Study|Withdrawal by Subject|0|||
164280050|NCT04167137|593394271|FG002|Overall Study|Withdrawal by Subject|0|||
164280051|NCT04167137|593394272|FG003|Overall Study|Withdrawal by Subject|1|||
164280052|NCT04167137|593394273|FG004|Overall Study|Withdrawal by Subject|0|||
164280053|NCT04167137|593394274|FG005|Overall Study|Withdrawal by Subject|2|||
164280054|NCT04167137|593394275|FG006|Overall Study|Withdrawal by Subject|1|||
164280055|NCT04167137|593394276|FG007|Overall Study|Withdrawal by Subject|0|||
164280056|NCT04167137|593394269|FG000|Overall Study|Adverse Event|0|||
164280057|NCT04167137|593394270|FG001|Overall Study|Adverse Event|0|||
164280058|NCT04167137|593394271|FG002|Overall Study|Adverse Event|0|||
164280059|NCT04167137|593394272|FG003|Overall Study|Adverse Event|0|||
164280060|NCT04167137|593394273|FG004|Overall Study|Adverse Event|0|||
164280061|NCT04167137|593394274|FG005|Overall Study|Adverse Event|1|||
164280062|NCT04167137|593394275|FG006|Overall Study|Adverse Event|0|||
164280063|NCT04167137|593394276|FG007|Overall Study|Adverse Event|1|||
164280064|NCT04167137|593394269|FG000|Overall Study|Physician Decision|0|||
164280065|NCT04167137|593394270|FG001|Overall Study|Physician Decision|0|||
164280066|NCT04167137|593394271|FG002|Overall Study|Physician Decision|0|||
164280067|NCT04167137|593394272|FG003|Overall Study|Physician Decision|1|||
164280068|NCT04167137|593394273|FG004|Overall Study|Physician Decision|0|||
164280069|NCT04167137|593394274|FG005|Overall Study|Physician Decision|0|||
164280070|NCT04167137|593394275|FG006|Overall Study|Physician Decision|1|||
164280071|NCT04167137|593394276|FG007|Overall Study|Physician Decision|0|||
164280072|NCT04167137|593394269|FG000|Overall Study|Death|0|||
164280073|NCT04167137|593394270|FG001|Overall Study|Death|1|||
164280074|NCT04167137|593394271|FG002|Overall Study|Death|0|||
164280075|NCT04167137|593394272|FG003|Overall Study|Death|0|||
164280076|NCT04167137|593394273|FG004|Overall Study|Death|0|||
164280077|NCT04167137|593394274|FG005|Overall Study|Death|0|||
164280078|NCT04167137|593394275|FG006|Overall Study|Death|0|||
164280079|NCT04167137|593394276|FG007|Overall Study|Death|0|||
164280080|NCT04167137|593394269|FG000|Overall Study|Study terminated by Sponsor|0|||
164280081|NCT04167137|593394270|FG001|Overall Study|Study terminated by Sponsor|0|||
164280082|NCT04167137|593394271|FG002|Overall Study|Study terminated by Sponsor|0|||
164280083|NCT04167137|593394272|FG003|Overall Study|Study terminated by Sponsor|0|||
164280084|NCT04167137|593394273|FG004|Overall Study|Study terminated by Sponsor|0|||
164280085|NCT04167137|593394274|FG005|Overall Study|Study terminated by Sponsor|0|||
164280086|NCT04167137|593394275|FG006|Overall Study|Study terminated by Sponsor|0|||
164280087|NCT04167137|593394276|FG007|Overall Study|Study terminated by Sponsor|1|||
164280088|NCT01748825|593394279|FG000|Dose Escalation|Refused further treatment|2|||
164280089|NCT01748825|593394280|FG001|Dose Escalation|Refused further treatment|2|||
164280090|NCT01748825|593394281|FG002|Dose Escalation|Refused further treatment|0|||
164280091|NCT01748825|593394282|FG003|Dose Escalation|Refused further treatment|0|||
164280092|NCT01748825|593394283|FG004|Dose Escalation|Refused further treatment|1|||
164280093|NCT01748825|593394284|FG005|Dose Escalation|Refused further treatment|2|||
164280094|NCT01748825|593394285|FG006|Dose Escalation|Refused further treatment|0|||
164280095|NCT01748825|593394286|FG007|Dose Escalation|Refused further treatment|0|||
164280096|NCT01748825|593394287|FG008|Dose Escalation|Refused further treatment|0|||
164280097|NCT01748825|593394288|FG009|Dose Escalation|Refused further treatment|0|||
164280098|NCT01748825|593394279|FG000|Dose Escalation|Switched to alternative treatment|0|||
164280099|NCT01748825|593394280|FG001|Dose Escalation|Switched to alternative treatment|0|||
164280100|NCT01748825|593394281|FG002|Dose Escalation|Switched to alternative treatment|0|||
164280101|NCT01748825|593394282|FG003|Dose Escalation|Switched to alternative treatment|1|||
164280102|NCT01748825|593394283|FG004|Dose Escalation|Switched to alternative treatment|0|||
164280103|NCT01748825|593394284|FG005|Dose Escalation|Switched to alternative treatment|0|||
164280104|NCT01748825|593394285|FG006|Dose Escalation|Switched to alternative treatment|0|||
164280105|NCT01748825|593394286|FG007|Dose Escalation|Switched to alternative treatment|0|||
164280106|NCT01748825|593394287|FG008|Dose Escalation|Switched to alternative treatment|0|||
164280107|NCT01748825|593394288|FG009|Dose Escalation|Switched to alternative treatment|0|||
164280108|NCT01748825|593394279|FG000|Dose Escalation|Adverse Event|0|||
164280109|NCT01748825|593394280|FG001|Dose Escalation|Adverse Event|0|||
164280110|NCT01748825|593394281|FG002|Dose Escalation|Adverse Event|0|||
164280111|NCT01748825|593394282|FG003|Dose Escalation|Adverse Event|0|||
164280112|NCT01748825|593394283|FG004|Dose Escalation|Adverse Event|0|||
164280113|NCT01748825|593394284|FG005|Dose Escalation|Adverse Event|0|||
164280114|NCT01748825|593394285|FG006|Dose Escalation|Adverse Event|1|||
164280115|NCT01748825|593394286|FG007|Dose Escalation|Adverse Event|0|||
164280116|NCT01748825|593394287|FG008|Dose Escalation|Adverse Event|0|||
164280117|NCT01748825|593394288|FG009|Dose Escalation|Adverse Event|0|||
164280118|NCT01748825|593394279|FG000|Dose Expansion|Refused further treatment|0|||
164280119|NCT01748825|593394280|FG001|Dose Expansion|Refused further treatment|0|||
164280120|NCT01748825|593394281|FG002|Dose Expansion|Refused further treatment|0|||
164280121|NCT01748825|593394282|FG003|Dose Expansion|Refused further treatment|0|||
164280122|NCT01748825|593394283|FG004|Dose Expansion|Refused further treatment|0|||
164280123|NCT01748825|593394284|FG005|Dose Expansion|Refused further treatment|0|||
164280124|NCT01748825|593394285|FG006|Dose Expansion|Refused further treatment|0|||
164280125|NCT01748825|593394286|FG007|Dose Expansion|Refused further treatment|0|||
164280126|NCT01748825|593394287|FG008|Dose Expansion|Refused further treatment|1|||
164280127|NCT01748825|593394288|FG009|Dose Expansion|Refused further treatment|1|||
164280128|NCT01748825|593394279|FG000|Dose Expansion|Switched to alternative treatment|0|||
164280129|NCT01748825|593394280|FG001|Dose Expansion|Switched to alternative treatment|0|||
164280130|NCT01748825|593394281|FG002|Dose Expansion|Switched to alternative treatment|0|||
164280131|NCT01748825|593394282|FG003|Dose Expansion|Switched to alternative treatment|0|||
164280132|NCT01748825|593394283|FG004|Dose Expansion|Switched to alternative treatment|0|||
164280133|NCT01748825|593394284|FG005|Dose Expansion|Switched to alternative treatment|0|||
164280134|NCT01748825|593394285|FG006|Dose Expansion|Switched to alternative treatment|0|||
164280135|NCT01748825|593394286|FG007|Dose Expansion|Switched to alternative treatment|0|||
164280136|NCT01748825|593394287|FG008|Dose Expansion|Switched to alternative treatment|0|||
164280137|NCT01748825|593394288|FG009|Dose Expansion|Switched to alternative treatment|1|||
164280138|NCT01748825|593394279|FG000|Dose Expansion|Adverse Event|0|||
164280139|NCT01748825|593394280|FG001|Dose Expansion|Adverse Event|0|||
164280140|NCT01748825|593394281|FG002|Dose Expansion|Adverse Event|0|||
164280141|NCT01748825|593394282|FG003|Dose Expansion|Adverse Event|0|||
164280142|NCT01748825|593394283|FG004|Dose Expansion|Adverse Event|0|||
164280143|NCT01748825|593394284|FG005|Dose Expansion|Adverse Event|0|||
164280144|NCT01748825|593394285|FG006|Dose Expansion|Adverse Event|0|||
164280145|NCT01748825|593394286|FG007|Dose Expansion|Adverse Event|0|||
164280146|NCT01748825|593394287|FG008|Dose Expansion|Adverse Event|0|||
164280147|NCT01748825|593394288|FG009|Dose Expansion|Adverse Event|3|||
164280148|NCT01748825|593394279|FG000|Dose Expansion|Physician Decision|0|||
164280149|NCT01748825|593394280|FG001|Dose Expansion|Physician Decision|0|||
164280150|NCT01748825|593394281|FG002|Dose Expansion|Physician Decision|0|||
164280151|NCT01748825|593394282|FG003|Dose Expansion|Physician Decision|0|||
164280152|NCT01748825|593394283|FG004|Dose Expansion|Physician Decision|0|||
164280153|NCT01748825|593394284|FG005|Dose Expansion|Physician Decision|0|||
164280154|NCT01748825|593394285|FG006|Dose Expansion|Physician Decision|0|||
164280155|NCT01748825|593394286|FG007|Dose Expansion|Physician Decision|0|||
164280156|NCT01748825|593394287|FG008|Dose Expansion|Physician Decision|1|||
164280157|NCT01748825|593394288|FG009|Dose Expansion|Physician Decision|0|||
164280158|NCT01730586|593394292|FG000|Overall Study|Progressive Disease|2|||
164280159|NCT01730586|593394292|FG000|Overall Study|Inadequate Trial|8|||
164280160|NCT01730586|593394292|FG000|Overall Study|Adverse Event|2|||
164280161|NCT01730586|593394292|FG000|Overall Study|Hospice|1|||
164280162|NCT00211887|593394293|FG000|Overall Study|Adverse Event|8|||
164280163|NCT00211887|593394294|FG001|Overall Study|Adverse Event|4|||
164280164|NCT00211887|593394295|FG002|Overall Study|Adverse Event|6|||
164280165|NCT00211887|593394293|FG000|Overall Study|Death|1|||
164280166|NCT00211887|593394294|FG001|Overall Study|Death|1|||
164280167|NCT00211887|593394295|FG002|Overall Study|Death|1|||
164280168|NCT00211887|593394293|FG000|Overall Study|Lost to Follow-up|28|||
164280169|NCT00211887|593394294|FG001|Overall Study|Lost to Follow-up|13|||
164280170|NCT00211887|593394295|FG002|Overall Study|Lost to Follow-up|9|||
164280171|NCT00211887|593394293|FG000|Overall Study|Non-medical reason|31|||
164280172|NCT00211887|593394294|FG001|Overall Study|Non-medical reason|14|||
164280173|NCT00211887|593394295|FG002|Overall Study|Non-medical reason|8|||
164280174|NCT00211887|593394293|FG000|Overall Study|Other medical reason|15|||
164280175|NCT00211887|593394294|FG001|Overall Study|Other medical reason|11|||
164280176|NCT00211887|593394295|FG002|Overall Study|Other medical reason|7|||
164280177|NCT00211887|593394293|FG000|Overall Study|Side effects|19|||
164280178|NCT00211887|593394294|FG001|Overall Study|Side effects|13|||
164280179|NCT00211887|593394295|FG002|Overall Study|Side effects|5|||
164280180|NCT03058692|593396382|FG000|Overall Study|Lost to Follow-up|2|||
164280181|NCT03058692|593396383|FG001|Overall Study|Lost to Follow-up|1|||
164280182|NCT03058692|593396382|FG000|Overall Study|Withdrawal by Subject|1|||
164280183|NCT03058692|593396383|FG001|Overall Study|Withdrawal by Subject|1|||
164280184|NCT05111249|593396388|FG000|Overall Study|Lost to Follow-up|0|||
164280185|NCT05111249|593396389|FG001|Overall Study|Lost to Follow-up|2|||
164280186|NCT05111249|593396388|FG000|Overall Study|Physician Decision|0|||
164280187|NCT05111249|593396389|FG001|Overall Study|Physician Decision|1|||
164280188|NCT05111249|593396388|FG000|Overall Study|Participant decision|1|||
164280189|NCT05111249|593396389|FG001|Overall Study|Participant decision|5|||
164280190|NCT01702025|593396397|FG000|Overall Study|Equipment failure|1|||
164280191|NCT01702025|593396398|FG001|Overall Study|Equipment failure|0|||
164280192|NCT01702025|593396399|FG002|Overall Study|Equipment failure|0|||
164280193|NCT01702025|593396400|FG003|Overall Study|Equipment failure|0|||
164001495|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
164280194|NCT01702025|593396397|FG000|Overall Study|Adverse Event|1|||
164280195|NCT01702025|593396398|FG001|Overall Study|Adverse Event|1|||
164280196|NCT01702025|593396399|FG002|Overall Study|Adverse Event|1|||
164280197|NCT01702025|593396400|FG003|Overall Study|Adverse Event|0|||
164280198|NCT02679755|593396401|FG000|Overall Study|Death|0|||
164280199|NCT02679755|593396402|FG001|Overall Study|Death|3|||
164280200|NCT02679755|593396401|FG000|Overall Study|Global deterioration of health status|1|||
164280201|NCT02679755|593396402|FG001|Overall Study|Global deterioration of health status|8|||
164280202|NCT02679755|593396401|FG000|Overall Study|Lost to Follow-up|1|||
164280203|NCT02679755|593396402|FG001|Overall Study|Lost to Follow-up|0|||
164280204|NCT02679755|593396401|FG000|Overall Study|Objective progression or relapse|24|||
164280205|NCT02679755|593396402|FG001|Overall Study|Objective progression or relapse|83|||
164280206|NCT02679755|593396401|FG000|Overall Study|Not defined|0|||
164280207|NCT02679755|593396402|FG001|Overall Study|Not defined|2|||
164280208|NCT02679755|593396401|FG000|Overall Study|Withdrawal by participant|6|||
164280209|NCT02679755|593396402|FG001|Overall Study|Withdrawal by participant|3|||
164280210|NCT02679755|593396401|FG000|Overall Study|Adverse Event|1|||
164280211|NCT02679755|593396402|FG001|Overall Study|Adverse Event|4|||
164280212|NCT02679755|593396401|FG000|Overall Study|Adverse events not related to study drug|1|||
164280213|NCT02679755|593396402|FG001|Overall Study|Adverse events not related to study drug|2|||
164280214|NCT01061359|593396403|FG000|Overall Study|Death|32|||
164280215|NCT01061359|593396403|FG000|Overall Study|Lost to Follow-up|1072|||
164280216|NCT01061359|593396403|FG000|Overall Study|Relapse|187|||
164280217|NCT01061359|593396403|FG000|Overall Study|Secondary neoplasm|11|||
164280218|NCT03038126|593396405|FG000|Overall Study|Death|1|||
164280219|NCT03038126|593396406|FG001|Overall Study|Death|1|||
164280220|NCT03038126|593396405|FG000|Overall Study|Withdrawal by Subject|5|||
164280221|NCT03038126|593396406|FG001|Overall Study|Withdrawal by Subject|0|||
164280222|NCT03038126|593396405|FG000|Overall Study|Lost to Follow-up|0|||
164280223|NCT03038126|593396406|FG001|Overall Study|Lost to Follow-up|1|||
164280224|NCT03038126|593396405|FG000|Overall Study|Long Term Hospitalization|2|||
164280225|NCT03038126|593396406|FG001|Overall Study|Long Term Hospitalization|0|||
164280226|NCT03038126|593396405|FG000|Overall Study|Too Ill to Participate|1|||
164280227|NCT03038126|593396406|FG001|Overall Study|Too Ill to Participate|2|||
164280228|NCT02610777|593396407|FG000|Overall Study|Lost to Follow-up|1|||
164280229|NCT02610777|593396408|FG001|Overall Study|Lost to Follow-up|0|||
164280230|NCT02610777|593396407|FG000|Overall Study|Site Terminated by Sponsor|9|||
164280231|NCT02610777|593396408|FG001|Overall Study|Site Terminated by Sponsor|8|||
164280232|NCT02610777|593396407|FG000|Overall Study|Withdrawal by Subject|2|||
164280233|NCT02610777|593396408|FG001|Overall Study|Withdrawal by Subject|2|||
164280234|NCT02610777|593396407|FG000|Overall Study|Reason not Specified|0|||
164280235|NCT02610777|593396408|FG001|Overall Study|Reason not Specified|1|||
164280236|NCT02610777|593396407|FG000|Overall Study|Death|50|||
164280237|NCT02610777|593396408|FG001|Overall Study|Death|47|||
164280238|NCT01724866|593396409|FG000|Overall Study|Adverse Event|0|||
164280239|NCT01724866|593396410|FG001|Overall Study|Adverse Event|0|||
164280240|NCT01724866|593396411|FG002|Overall Study|Adverse Event|1|||
164280241|NCT01724866|593396412|FG003|Overall Study|Adverse Event|1|||
164280242|NCT01724866|593396409|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
164280243|NCT01724866|593396410|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
164280244|NCT01724866|593396411|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
164280245|NCT01724866|593396412|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
164280246|NCT01724866|593396409|FG000|Overall Study|Investigator's Discretion|0|||
164280247|NCT01724866|593396410|FG001|Overall Study|Investigator's Discretion|1|||
164280248|NCT01724866|593396411|FG002|Overall Study|Investigator's Discretion|1|||
164280249|NCT01724866|593396412|FG003|Overall Study|Investigator's Discretion|0|||
164344157|NCT00963937|593635373|FG001|Overall Study|Protocol Violation|1|||
164001496|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
164344158|NCT00963937|593635374|FG002|Overall Study|Protocol Violation|0|||
164344159|NCT00963937|593635372|FG000|Overall Study|Physician Decision|18|||
164344160|NCT00963937|593635373|FG001|Overall Study|Physician Decision|10|||
164344161|NCT00963937|593635374|FG002|Overall Study|Physician Decision|4|||
164001497|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
164001498|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
164001499|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
164280250|NCT01724866|593396409|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
164280251|NCT01724866|593396410|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
164280252|NCT01724866|593396411|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
164280253|NCT01724866|593396412|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
164280254|NCT01724866|593396409|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
164344162|NCT04203498|593635375|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
164280255|NCT01724866|593396410|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
164280256|NCT01724866|593396411|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
164280257|NCT01724866|593396412|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
164280258|NCT00411671|593396417|FG000|Overall Study|Adverse Event|15|||
164280259|NCT00411671|593396417|FG000|Overall Study|Death|2|||
164280260|NCT00411671|593396417|FG000|Overall Study|Lost to Follow-up|3|||
164280261|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
164280262|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164001500|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
164001501|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
164001502|NCT00446030|592368542|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
164001503|NCT00446030|592368543|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
164280263|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164280264|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164280265|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164280266|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
164280267|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280268|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280269|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280270|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
164280271|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
164280272|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280273|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280274|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280275|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
164280276|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
164280277|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280278|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280279|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280280|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
164280281|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
164280282|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280283|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280284|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280285|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164280286|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
164280287|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280288|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280289|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280290|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
164280291|NCT01173601|593396418|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
164280292|NCT01173601|593396419|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280293|NCT01173601|593396420|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280294|NCT01173601|593396421|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280295|NCT01173601|593396422|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164280296|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
164280297|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
164280298|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
164280299|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
164280300|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
164280301|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
164280302|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
164001504|NCT02886715|592368545|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164280303|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
164280304|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
164280305|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
164280306|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
164280307|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
164280308|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
164280309|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
164280310|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
164280311|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164280312|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
164280313|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
164280314|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
164280315|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
164280316|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
164280317|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
164280318|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164280319|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
164280320|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164280321|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
164280322|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
164280323|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
164280324|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
164280325|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
164280326|NCT01173601|593396418|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164280327|NCT01173601|593396419|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164280328|NCT01173601|593396420|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
164280329|NCT01173601|593396421|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
164280330|NCT01173601|593396422|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
164280331|NCT04737278|593396423|FG000|Overall Study|Lost to Follow-up|1|||
164280332|NCT04737278|593396424|FG001|Overall Study|Lost to Follow-up|1|||
164280333|NCT04737278|593396423|FG000|Overall Study|Withdrawal by Subject|1|||
164280334|NCT04737278|593396424|FG001|Overall Study|Withdrawal by Subject|0|||
164280335|NCT04737278|593396423|FG000|Overall Study|Protocol Violation|1|||
164280336|NCT04737278|593396424|FG001|Overall Study|Protocol Violation|1|||
164280337|NCT04737278|593396423|FG000|Overall Study|failure to complete questionnaire|1|||
164280338|NCT04737278|593396424|FG001|Overall Study|failure to complete questionnaire|1|||
164280339|NCT00546000|593396429|FG000|Overall Study|Adverse Event|1|||
164280340|NCT00546000|593396429|FG000|Overall Study|Lost to Follow-up|1|||
164280341|NCT00546000|593396429|FG000|Overall Study|Baseline HPA Axis Supression|2|||
164280342|NCT03688074|593396434|FG000|Overall Study|Adverse Event|0|||
164280343|NCT03688074|593396435|FG001|Overall Study|Adverse Event|1|||
164280344|NCT03688074|593396434|FG000|Overall Study|Other|1|||
164280345|NCT03688074|593396435|FG001|Overall Study|Other|0|||
164280346|NCT01362608|593396436|FG000|Overall Study|Protocol Violation|0|||
164280347|NCT01362608|593396437|FG001|Overall Study|Protocol Violation|1|||
164280348|NCT01362608|593396436|FG000|Overall Study|Lost to Follow-up|3|||
164280349|NCT01362608|593396437|FG001|Overall Study|Lost to Follow-up|1|||
164280350|NCT01362608|593396436|FG000|Overall Study|Withdrawal by Subject|1|||
164001505|NCT02886715|592368546|FG001|Overall Study|Non-Compliance With Study Drug|2|||
164280351|NCT01362608|593396437|FG001|Overall Study|Withdrawal by Subject|2|||
164280352|NCT01362608|593396436|FG000|Overall Study|Lack of Efficacy|0|||
164280353|NCT01362608|593396437|FG001|Overall Study|Lack of Efficacy|2|||
164280354|NCT01362608|593396436|FG000|Overall Study|Adverse Event|0|||
164280355|NCT01362608|593396437|FG001|Overall Study|Adverse Event|2|||
164280356|NCT04171219|593396445|FG000|Overall Study|Adverse Event|1|||
164280357|NCT04171219|593396446|FG001|Overall Study|Adverse Event|0|||
164280358|NCT04171219|593396445|FG000|Overall Study|Death|0|||
164280359|NCT04171219|593396446|FG001|Overall Study|Death|1|||
164280360|NCT04171219|593396445|FG000|Overall Study|Lack of Efficacy|9|||
164280361|NCT04171219|593396446|FG001|Overall Study|Lack of Efficacy|13|||
164280362|NCT04171219|593396445|FG000|Overall Study|Withdrawal by Subject|1|||
164280363|NCT04171219|593396446|FG001|Overall Study|Withdrawal by Subject|2|||
164280364|NCT04171219|593396445|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
164280365|NCT04171219|593396446|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
164280366|NCT04171219|593396445|FG000|Overall Study|Clinical PD/Patient choice|1|||
164280367|NCT04171219|593396446|FG001|Overall Study|Clinical PD/Patient choice|0|||
164280368|NCT04171219|593396445|FG000|Overall Study|Toxicity/ Patient choice|1|||
164280369|NCT04171219|593396446|FG001|Overall Study|Toxicity/ Patient choice|0|||
164280370|NCT04809285|593396447|FG000|Phase 1|Lost to Follow-up|6|||
164280371|NCT04809285|593396447|FG000|Phase 1|Protocol Violation|2|||
164280372|NCT04809285|593396447|FG000|Phase 1|Physician Decision|3|||
164280373|NCT04809285|593396447|FG000|Phase 1|Withdrawal by Subject|29|||
164280374|NCT04809285|593396447|FG000|Phase 2|Protocol Violation|3|||
164344163|NCT04203498|593635376|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
164280375|NCT04809285|593396447|FG000|Phase 2|Withdrawal by Subject|4|||
164280376|NCT03350815|593396448|FG000|Period 1|Adverse Event|10|||
164280377|NCT03350815|593396449|FG001|Period 1|Adverse Event|0|||
164280378|NCT03350815|593396450|FG002|Period 1|Adverse Event|0|||
164280379|NCT03350815|593396451|FG003|Period 1|Adverse Event|0|||
164280380|NCT03350815|593396448|FG000|Period 1|Technical problems|1|||
164344164|NCT04203498|593635375|FG000|Overall Study|Withdrawal of patient consent|7|||
164280381|NCT03350815|593396449|FG001|Period 1|Technical problems|0|||
164280382|NCT03350815|593396450|FG002|Period 1|Technical problems|0|||
164280383|NCT03350815|593396451|FG003|Period 1|Technical problems|0|||
164280384|NCT03350815|593396448|FG000|Period 1|Lost to Follow-up|3|||
164280385|NCT03350815|593396449|FG001|Period 1|Lost to Follow-up|0|||
164280386|NCT03350815|593396450|FG002|Period 1|Lost to Follow-up|0|||
164280387|NCT03350815|593396451|FG003|Period 1|Lost to Follow-up|0|||
164280388|NCT03350815|593396448|FG000|Period 1|Physician Decision|1|||
164280389|NCT03350815|593396449|FG001|Period 1|Physician Decision|0|||
164280390|NCT03350815|593396450|FG002|Period 1|Physician Decision|0|||
164280391|NCT03350815|593396451|FG003|Period 1|Physician Decision|0|||
164280392|NCT03350815|593396448|FG000|Period 1|Withdrawal by Subject|8|||
164280393|NCT03350815|593396449|FG001|Period 1|Withdrawal by Subject|0|||
164280394|NCT03350815|593396450|FG002|Period 1|Withdrawal by Subject|0|||
164280395|NCT03350815|593396451|FG003|Period 1|Withdrawal by Subject|0|||
164280396|NCT03350815|593396448|FG000|Period 1|Lack of Efficacy|15|||
164280397|NCT03350815|593396449|FG001|Period 1|Lack of Efficacy|0|||
164280398|NCT03350815|593396450|FG002|Period 1|Lack of Efficacy|0|||
164280399|NCT03350815|593396451|FG003|Period 1|Lack of Efficacy|0|||
164280400|NCT03350815|593396448|FG000|Period 1|Non-compliance with study treatment|2|||
164280401|NCT03350815|593396449|FG001|Period 1|Non-compliance with study treatment|0|||
164280402|NCT03350815|593396450|FG002|Period 1|Non-compliance with study treatment|0|||
164280403|NCT03350815|593396451|FG003|Period 1|Non-compliance with study treatment|0|||
164280404|NCT03350815|593396448|FG000|Period 1|Protocol Violation|3|||
164280405|NCT03350815|593396449|FG001|Period 1|Protocol Violation|0|||
164280406|NCT03350815|593396450|FG002|Period 1|Protocol Violation|0|||
164280407|NCT03350815|593396451|FG003|Period 1|Protocol Violation|0|||
164280408|NCT03350815|593396448|FG000|Period 2|Adverse Event|0|||
164280409|NCT03350815|593396449|FG001|Period 2|Adverse Event|3|||
164280410|NCT03350815|593396450|FG002|Period 2|Adverse Event|5|||
164280411|NCT03350815|593396451|FG003|Period 2|Adverse Event|0|||
164280412|NCT03350815|593396448|FG000|Period 2|Technical problem|0|||
164280413|NCT03350815|593396449|FG001|Period 2|Technical problem|1|||
164280414|NCT03350815|593396450|FG002|Period 2|Technical problem|0|||
164280415|NCT03350815|593396451|FG003|Period 2|Technical problem|0|||
164280416|NCT03350815|593396448|FG000|Period 2|Lost to Follow-up|0|||
164280417|NCT03350815|593396449|FG001|Period 2|Lost to Follow-up|3|||
164280418|NCT03350815|593396450|FG002|Period 2|Lost to Follow-up|3|||
164280419|NCT03350815|593396451|FG003|Period 2|Lost to Follow-up|0|||
164280420|NCT03350815|593396448|FG000|Period 2|Physician Decision|0|||
164280421|NCT03350815|593396449|FG001|Period 2|Physician Decision|0|||
164280422|NCT03350815|593396450|FG002|Period 2|Physician Decision|1|||
164280423|NCT03350815|593396451|FG003|Period 2|Physician Decision|0|||
164280424|NCT03350815|593396448|FG000|Period 2|Withdrawal by Subject|0|||
164280425|NCT03350815|593396449|FG001|Period 2|Withdrawal by Subject|3|||
164280426|NCT03350815|593396450|FG002|Period 2|Withdrawal by Subject|4|||
164280427|NCT03350815|593396451|FG003|Period 2|Withdrawal by Subject|0|||
164280428|NCT03350815|593396448|FG000|Period 2|Lack of Efficacy|0|||
164280429|NCT03350815|593396449|FG001|Period 2|Lack of Efficacy|6|||
164085998|NCT01022112|592678627|FG000|Overall Study|Adverse Event|1|||
164085999|NCT01022112|592678628|FG001|Overall Study|Adverse Event|2|||
164280430|NCT03350815|593396450|FG002|Period 2|Lack of Efficacy|2|||
164280431|NCT03350815|593396451|FG003|Period 2|Lack of Efficacy|0|||
164280432|NCT03350815|593396448|FG000|Period 2|Protocol Violation|0|||
164280433|NCT03350815|593396449|FG001|Period 2|Protocol Violation|0|||
164280434|NCT03350815|593396450|FG002|Period 2|Protocol Violation|1|||
164280435|NCT03350815|593396451|FG003|Period 2|Protocol Violation|0|||
164280436|NCT03350815|593396448|FG000|Period 2|New therapy for study indication|0|||
164280437|NCT03350815|593396449|FG001|Period 2|New therapy for study indication|0|||
164280438|NCT03350815|593396450|FG002|Period 2|New therapy for study indication|1|||
164280439|NCT03350815|593396451|FG003|Period 2|New therapy for study indication|0|||
164280440|NCT03526146|593396452|FG000|Overall Study|Lost to Follow-up|5|||
164280441|NCT03526146|593396452|FG000|Overall Study|Withdrawal by Subject|6|||
164280442|NCT03526146|593396452|FG000|Overall Study|class canceled due to COVID-19|4|||
164280443|NCT01442714|593396455|FG000|Overall Study|Death|11|||
164280444|NCT01442714|593396455|FG000|Overall Study|Withdrawal by Subject|1|||
164280445|NCT01979952|593396466|FG000|Overall Study|Adverse Event|4|||
164280446|NCT01979952|593396467|FG001|Overall Study|Adverse Event|5|||
164280447|NCT01979952|593396466|FG000|Overall Study|Protocol Violation|1|||
164280448|NCT01979952|593396467|FG001|Overall Study|Protocol Violation|0|||
164280449|NCT01979952|593396466|FG000|Overall Study|Withdrawal by Subject|2|||
164280450|NCT01979952|593396467|FG001|Overall Study|Withdrawal by Subject|1|||
164280451|NCT01979952|593396466|FG000|Overall Study|Other than specified above|1|||
164280452|NCT01979952|593396467|FG001|Overall Study|Other than specified above|0|||
164280453|NCT00203424|593396469|FG000|Treatment Period|Withdrawal by Subject|4|||
164280454|NCT00203424|593396469|FG000|Treatment Period|Adverse Event|5|||
164280455|NCT00203424|593396469|FG000|Treatment Period|progressive disease|2|||
164280456|NCT00203424|593396469|FG000|Follow-up Period|Withdrawal by Subject|1|||
164280457|NCT00203424|593396469|FG000|Follow-up Period|progressive disease|4|||
164280458|NCT00203424|593396469|FG000|Follow-up Period|Lost to Follow-up|1|||
164280459|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
164280460|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280461|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280462|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280463|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280464|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164280465|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
164280466|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280467|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280468|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280469|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280470|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164280471|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
164280472|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280473|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280474|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280475|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280476|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164280477|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
164280478|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280479|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280480|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280481|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280482|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
164280483|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
164280484|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280485|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280486|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280487|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280488|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
164280489|NCT01053988|593396470|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
164280490|NCT01053988|593396471|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280491|NCT01053988|593396472|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280492|NCT01053988|593396473|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280493|NCT01053988|593396474|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280494|NCT01053988|593396475|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164280495|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164280496|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
164280497|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
164280498|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
164280499|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
164280500|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
164280501|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164280502|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
164280503|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
164344165|NCT04203498|593635376|FG001|Overall Study|Withdrawal of patient consent|2|||
163895332|NCT00450216|591989642|FG001|Overall Study|Lost to Follow-up|9|||
163895333|NCT00450216|591989641|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
163895334|NCT00450216|591989642|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
163895335|NCT00450216|591989641|FG000|Overall Study|misc|21|||
163895336|NCT00450216|591989642|FG001|Overall Study|misc|20|||
163895337|NCT03418740|591989645|FG000|Overall Study|Lost to Follow-up|13|||
164280504|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
164280505|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
164280506|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164280507|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
164280508|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
164280509|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
164280510|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
164280511|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
164280512|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
164280513|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164086000|NCT01022112|592678629|FG002|Overall Study|Adverse Event|0|||
164280514|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164280515|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164280516|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164280517|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
164280518|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164280519|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164280520|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
164280521|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
164280522|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
164280523|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
164280524|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
164280525|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164280526|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
164280527|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164280528|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164280529|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164280530|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
164280531|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164280532|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
164280533|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
164280534|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
164280535|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
164280536|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
164280537|NCT01053988|593396470|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164280538|NCT01053988|593396471|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
164280539|NCT01053988|593396472|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164280540|NCT01053988|593396473|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
164280541|NCT01053988|593396474|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
164280542|NCT01053988|593396475|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164280543|NCT01922271|593396477|FG000|WASHOUT Period|Withdrawal by Subject|1|||
164280544|NCT01922271|593396478|FG001|WASHOUT Period|Withdrawal by Subject|0|||
164280545|NCT00719355|593396479|FG000|Overall Study|Death|0|||
164280546|NCT00719355|593396480|FG001|Overall Study|Death|1|||
164280547|NCT00719355|593396479|FG000|Overall Study|Medical|14|||
164280548|NCT00719355|593396480|FG001|Overall Study|Medical|5|||
164280549|NCT00719355|593396479|FG000|Overall Study|Compliance|4|||
164280550|NCT00719355|593396480|FG001|Overall Study|Compliance|6|||
164280551|NCT00719355|593396479|FG000|Overall Study|Moved|0|||
164280552|NCT00719355|593396480|FG001|Overall Study|Moved|1|||
164344166|NCT04203498|593635375|FG000|Overall Study|Adverse Event|4|||
164344167|NCT04203498|593635376|FG001|Overall Study|Adverse Event|1|||
164344168|NCT04203498|593635375|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
164344169|NCT04203498|593635376|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
164344170|NCT04203498|593635375|FG000|Overall Study|Did not receive IMP|2|||
164344171|NCT04203498|593635376|FG001|Overall Study|Did not receive IMP|0|||
164344172|NCT02106975|593635377|FG000|Overall Study|Death|25|||
164344173|NCT02106975|593635378|FG001|Overall Study|Death|39|||
164344174|NCT00622401|593635379|FG000|Overall Study|Disease progression prior to treatment|3|||
164344175|NCT00622401|593635380|FG001|Overall Study|Disease progression prior to treatment|2|||
164344176|NCT00622401|593635381|FG002|Overall Study|Disease progression prior to treatment|0|||
164344177|NCT03546062|593635382|FG000|Overall Study|Adverse Event|6|||
164344178|NCT03546062|593635383|FG001|Overall Study|Adverse Event|5|||
164344179|NCT03546062|593635384|FG002|Overall Study|Adverse Event|8|||
164344180|NCT00181155|593635385|FG000|Overall Study|Physician Decision|1|||
164344181|NCT00181155|593635386|FG001|Overall Study|Physician Decision|0|||
164344182|NCT00181155|593635385|FG000|Overall Study|Withdrawal by Subject|1|||
164344183|NCT00181155|593635386|FG001|Overall Study|Withdrawal by Subject|0|||
164344184|NCT02572401|593635387|FG000|Overall Study|Lost to Follow-up|5|||
164344185|NCT02572401|593635388|FG001|Overall Study|Lost to Follow-up|8|||
164344186|NCT02572401|593635389|FG002|Overall Study|Lost to Follow-up|9|||
164344187|NCT02572401|593635390|FG003|Overall Study|Lost to Follow-up|9|||
164344188|NCT02572401|593635387|FG000|Overall Study|Death|0|||
164344189|NCT02572401|593635388|FG001|Overall Study|Death|0|||
164344190|NCT02572401|593635389|FG002|Overall Study|Death|0|||
164344191|NCT02572401|593635390|FG003|Overall Study|Death|1|||
164344192|NCT01768286|593635396|FG000|Overall Study|Randomized But Not Treated|0|||
164344193|NCT01768286|593635397|FG001|Overall Study|Randomized But Not Treated|0|||
164344194|NCT01768286|593635398|FG002|Overall Study|Randomized But Not Treated|1|||
164344195|NCT01768286|593635399|FG003|Overall Study|Randomized But Not Treated|0|||
164344196|NCT01768286|593635396|FG000|Overall Study|Lack of Efficacy|7|||
164344197|NCT01768286|593635397|FG001|Overall Study|Lack of Efficacy|4|||
164344198|NCT01768286|593635398|FG002|Overall Study|Lack of Efficacy|0|||
164280553|NCT01856582|593396481|FG000|Overall Study|Died prior to Boost infusion|1|||
164280554|NCT01824355|593396482|FG000|Overall Study|Adverse Event|2|||
164280555|NCT01824355|593396482|FG000|Overall Study|unevaluable reference method results per|1|||
164280556|NCT01331109|593396483|FG000|Overall Study|Adverse Event|6|||
164280557|NCT01331109|593396483|FG000|Overall Study|Lack of Efficacy|2|||
164280558|NCT01331109|593396483|FG000|Overall Study|Protocol Violation|3|||
164280559|NCT01331109|593396483|FG000|Overall Study|Withdrawal by Subject|7|||
164280560|NCT01331109|593396483|FG000|Overall Study|Lost to Follow-up|1|||
164280561|NCT01331109|593396483|FG000|Overall Study|Study Terminated by Sponsor|38|||
164280562|NCT03688620|593396489|FG000|Overall Study|Other|0|||
164280563|NCT03688620|593396490|FG001|Overall Study|Other|0|||
164280564|NCT03688620|593396491|FG002|Overall Study|Other|1|||
164280565|NCT03688620|593396489|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
164280566|NCT03688620|593396490|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
164280567|NCT03688620|593396491|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
164280568|NCT03688620|593396489|FG000|Overall Study|Lost to Follow-up|16|||
164280569|NCT03688620|593396490|FG001|Overall Study|Lost to Follow-up|0|||
164280570|NCT03688620|593396491|FG002|Overall Study|Lost to Follow-up|1|||
164280571|NCT03688620|593396489|FG000|Overall Study|Withdrawal by Subject|0|||
164280572|NCT03688620|593396490|FG001|Overall Study|Withdrawal by Subject|0|||
164280573|NCT03688620|593396491|FG002|Overall Study|Withdrawal by Subject|6|||
164280574|NCT02828020|593396492|FG000|Treatment Period|Adverse Event|3|||
164280575|NCT02828020|593396493|FG001|Treatment Period|Adverse Event|1|||
164280576|NCT02828020|593396494|FG002|Treatment Period|Adverse Event|1|||
164280577|NCT02828020|593396492|FG000|Treatment Period|Withdrawal of Consent|10|||
164280578|NCT02828020|593396493|FG001|Treatment Period|Withdrawal of Consent|14|||
164280579|NCT02828020|593396494|FG002|Treatment Period|Withdrawal of Consent|9|||
164280580|NCT02828020|593396492|FG000|Treatment Period|Lost to Follow-up|21|||
164280581|NCT02828020|593396493|FG001|Treatment Period|Lost to Follow-up|24|||
164280582|NCT02828020|593396494|FG002|Treatment Period|Lost to Follow-up|18|||
164280583|NCT02828020|593396492|FG000|Treatment Period|Lack of Qualifying Event|44|||
164280584|NCT02828020|593396493|FG001|Treatment Period|Lack of Qualifying Event|53|||
164280585|NCT02828020|593396494|FG002|Treatment Period|Lack of Qualifying Event|43|||
164280586|NCT02828020|593396492|FG000|Treatment Period|Pregnancy|0|||
164280587|NCT02828020|593396493|FG001|Treatment Period|Pregnancy|2|||
164280588|NCT02828020|593396494|FG002|Treatment Period|Pregnancy|0|||
164280589|NCT02828020|593396492|FG000|Treatment Period|Protocol Violation|2|||
164280590|NCT02828020|593396493|FG001|Treatment Period|Protocol Violation|4|||
164280591|NCT02828020|593396494|FG002|Treatment Period|Protocol Violation|7|||
164280592|NCT02828020|593396492|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
164280593|NCT02828020|593396493|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
164280594|NCT02828020|593396494|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
164280595|NCT02828020|593396492|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
164280596|NCT02828020|593396493|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
164280597|NCT02828020|593396494|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
164280598|NCT02828020|593396492|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
164280599|NCT02828020|593396493|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
164280600|NCT02828020|593396494|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
164280601|NCT02828020|593396492|FG000|Safety Follow-up Period|Protocol Violation|0|||
164280602|NCT02828020|593396493|FG001|Safety Follow-up Period|Protocol Violation|2|||
164280603|NCT02828020|593396494|FG002|Safety Follow-up Period|Protocol Violation|1|||
164280604|NCT02828020|593396492|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
164280605|NCT02828020|593396493|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164280606|NCT02828020|593396494|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164280607|NCT01183065|593396496|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
164280608|NCT02578186|593396497|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
164280609|NCT02578186|593396498|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
164280610|NCT02578186|593396497|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
164280611|NCT02578186|593396498|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
164280612|NCT03657095|593396499|FG000|Overall Study|Withdrawal by Subject|1|||
164280613|NCT03657095|593396500|FG001|Overall Study|Withdrawal by Subject|1|||
164280614|NCT03657095|593396499|FG000|Overall Study|Adverse Event|0|||
164280615|NCT03657095|593396500|FG001|Overall Study|Adverse Event|3|||
164344199|NCT01768286|593635399|FG003|Overall Study|Lack of Efficacy|1|||
164280616|NCT03657095|593396499|FG000|Overall Study|Study Terminated by Sponsor|58|||
164280617|NCT03657095|593396500|FG001|Overall Study|Study Terminated by Sponsor|49|||
164280618|NCT01894243|593396501|FG000|Overall Study|Adverse Event|0|||
164344200|NCT01768286|593635396|FG000|Overall Study|Withdrew Consent|0|||
164344201|NCT01768286|593635397|FG001|Overall Study|Withdrew Consent|0|||
164344202|NCT01768286|593635398|FG002|Overall Study|Withdrew Consent|1|||
164344203|NCT01768286|593635399|FG003|Overall Study|Withdrew Consent|0|||
164344204|NCT02243696|593635400|FG000|Overall Study|Death|282|||
164344205|NCT02243696|593635400|FG000|Overall Study|Withdrawal by Subject|79|||
164344206|NCT02243696|593635400|FG000|Overall Study|Lost to Follow-up|57|||
164344207|NCT02243696|593635400|FG000|Overall Study|Subject No Longer has Study System|42|||
164344208|NCT02243696|593635400|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
164344209|NCT02243696|593635400|FG000|Overall Study|Study Terminated for EP PASSION|961|||
164344210|NCT00622284|593635401|FG000|Overall Study|Lack of Efficacy|45|||
164344211|NCT00622284|593635402|FG001|Overall Study|Lack of Efficacy|15|||
164344212|NCT00622284|593635401|FG000|Overall Study|Adverse Event|61|||
164344213|NCT00622284|593635402|FG001|Overall Study|Adverse Event|90|||
164344214|NCT00622284|593635401|FG000|Overall Study|Protocol Violation|12|||
164344215|NCT00622284|593635402|FG001|Overall Study|Protocol Violation|5|||
164344216|NCT00622284|593635401|FG000|Overall Study|Lost to Follow-up|11|||
164344217|NCT00622284|593635402|FG001|Overall Study|Lost to Follow-up|13|||
164344218|NCT00622284|593635401|FG000|Overall Study|Withdrawal by Subject|27|||
164344219|NCT00622284|593635402|FG001|Overall Study|Withdrawal by Subject|24|||
164344220|NCT00622284|593635401|FG000|Overall Study|Other reason (not specified)|33|||
164344221|NCT00622284|593635402|FG001|Overall Study|Other reason (not specified)|24|||
164344222|NCT02935842|593635403|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
164344223|NCT02935842|593635404|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
164344224|NCT02935842|593635405|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
164344225|NCT02935842|593635406|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
164344226|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
164344227|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
164344228|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
164344229|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
164344230|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
164344231|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
164344232|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
164344233|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
164344234|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
164344235|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
164344236|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
164344237|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
164344238|NCT02935842|593635403|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
164344239|NCT02935842|593635404|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
164344240|NCT02935842|593635405|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
164344241|NCT02935842|593635406|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
164344242|NCT01201850|593635409|FG000|Overall Study|Tumor progression|4|||
164344243|NCT04066023|593635410|FG000|Overall Study|Adverse Event|0|||
164344244|NCT04066023|593635411|FG001|Overall Study|Adverse Event|0|||
164344245|NCT04066023|593635412|FG002|Overall Study|Adverse Event|1|||
164344246|NCT04066023|593635410|FG000|Overall Study|Sponsor decision|3|||
164344247|NCT04066023|593635411|FG001|Overall Study|Sponsor decision|6|||
164344248|NCT04066023|593635412|FG002|Overall Study|Sponsor decision|2|||
164344249|NCT04066023|593635410|FG000|Overall Study|Physician Decision|0|||
164344250|NCT04066023|593635411|FG001|Overall Study|Physician Decision|0|||
164344251|NCT04066023|593635412|FG002|Overall Study|Physician Decision|1|||
164344252|NCT04066023|593635410|FG000|Overall Study|Lost to Follow-up|0|||
164344253|NCT04066023|593635411|FG001|Overall Study|Lost to Follow-up|1|||
164344254|NCT04066023|593635412|FG002|Overall Study|Lost to Follow-up|1|||
164344255|NCT04066023|593635410|FG000|Overall Study|Noncompliance|0|||
164344256|NCT04066023|593635411|FG001|Overall Study|Noncompliance|1|||
164344257|NCT04066023|593635412|FG002|Overall Study|Noncompliance|1|||
164344258|NCT01552694|593635413|FG000|Overall Study|Lost to Follow-up|0|||
164344259|NCT01552694|593635414|FG001|Overall Study|Lost to Follow-up|1|||
164344260|NCT01552694|593635413|FG000|Overall Study|Protocol Violation|0|||
164344261|NCT01552694|593635414|FG001|Overall Study|Protocol Violation|1|||
164344262|NCT03338010|593635415|FG000|Overall Study|Withdrawal by Subject|14|||
164344263|NCT03338010|593635416|FG001|Overall Study|Withdrawal by Subject|8|||
164344264|NCT03338010|593635415|FG000|Overall Study|Lost to Follow-up|4|||
164344265|NCT03338010|593635416|FG001|Overall Study|Lost to Follow-up|2|||
164344266|NCT03338010|593635415|FG000|Overall Study|Adverse Event|3|||
164344267|NCT03338010|593635416|FG001|Overall Study|Adverse Event|2|||
164344268|NCT03338010|593635415|FG000|Overall Study|Physician Decision|2|||
164344269|NCT03338010|593635416|FG001|Overall Study|Physician Decision|2|||
164344270|NCT03338010|593635415|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164344271|NCT03338010|593635416|FG001|Overall Study|Non-Compliance with Study Drug|3|||
164344272|NCT03338010|593635415|FG000|Overall Study|Protocol Violation|0|||
164344273|NCT03338010|593635416|FG001|Overall Study|Protocol Violation|1|||
164344274|NCT00293033|593635421|FG000|Open-label Titration Period|Adverse Event|10|||
164344275|NCT00293033|593635421|FG000|Open-label Titration Period|Death|3|||
164344276|NCT00293033|593635421|FG000|Open-label Titration Period|Lack of Efficacy|5|||
164344277|NCT00293033|593635421|FG000|Open-label Titration Period|Protocol Violation|2|||
164086001|NCT01022112|592678630|FG003|Overall Study|Adverse Event|1|||
164344278|NCT00293033|593635421|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
164344279|NCT00293033|593635421|FG000|Open-label Titration Period|Noncompliance and other|27|||
164344280|NCT00293033|593635421|FG000|Double-blind Treatment Period|Adverse Event|3|||
164280619|NCT01894243|593396502|FG001|Overall Study|Adverse Event|1|||
164280620|NCT01894243|593396503|FG002|Overall Study|Adverse Event|2|||
164280621|NCT01894243|593396501|FG000|Overall Study|Death|0|||
164280622|NCT01894243|593396502|FG001|Overall Study|Death|0|||
164280623|NCT01894243|593396503|FG002|Overall Study|Death|3|||
164280624|NCT01894243|593396501|FG000|Overall Study|Lack of Efficacy|3|||
164280625|NCT01894243|593396502|FG001|Overall Study|Lack of Efficacy|3|||
164280626|NCT01894243|593396503|FG002|Overall Study|Lack of Efficacy|1|||
164280627|NCT01894243|593396501|FG000|Overall Study|Condition under investigation worsened|8|||
164280628|NCT01894243|593396502|FG001|Overall Study|Condition under investigation worsened|6|||
164280629|NCT01894243|593396503|FG002|Overall Study|Condition under investigation worsened|2|||
164280630|NCT01894243|593396501|FG000|Overall Study|Subject decision|1|||
164280631|NCT01894243|593396502|FG001|Overall Study|Subject decision|0|||
164280632|NCT01894243|593396503|FG002|Overall Study|Subject decision|0|||
164280633|NCT01894243|593396501|FG000|Overall Study|Other|1|||
164280634|NCT01894243|593396502|FG001|Overall Study|Other|0|||
164280635|NCT01894243|593396503|FG002|Overall Study|Other|0|||
164280636|NCT00828750|593396506|FG000|Overall Study|Lack of Efficacy|3|||
164280637|NCT00828750|593396506|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
164280638|NCT04006392|593396507|FG000|Overall Study|Lost to Follow-up|0|||
164280639|NCT04006392|593396508|FG001|Overall Study|Lost to Follow-up|1|||
164280640|NCT01067469|593396509|FG000|Overall Study|Withdrawal by Subject|0|||
164280641|NCT01067469|593396510|FG001|Overall Study|Withdrawal by Subject|1|||
164280642|NCT01067469|593396509|FG000|Overall Study|Disease Progression|0|||
164280643|NCT01067469|593396510|FG001|Overall Study|Disease Progression|1|||
164280644|NCT01620944|593396511|FG000|Overall Study|Early termination of Study|2|||
164280645|NCT01620944|593396512|FG001|Overall Study|Early termination of Study|1|||
164280646|NCT04378114|593396513|FG000|Overall Study|Withdrawal by Subject|5|||
164280647|NCT00825812|593396514|FG000|Overall Study|Never entered follow up|0|||
164280648|NCT00825812|593396515|FG001|Overall Study|Never entered follow up|0|||
164280649|NCT00825812|593396516|FG002|Overall Study|Never entered follow up|0|||
164280650|NCT00825812|593396517|FG003|Overall Study|Never entered follow up|1|||
164280651|NCT00825812|593396514|FG000|Overall Study|Adverse Event|0|||
164280652|NCT00825812|593396515|FG001|Overall Study|Adverse Event|0|||
164280653|NCT00825812|593396516|FG002|Overall Study|Adverse Event|0|||
164280654|NCT00825812|593396517|FG003|Overall Study|Adverse Event|1|||
164280655|NCT00825812|593396514|FG000|Overall Study|Subject withdrew consent|0|||
164280656|NCT00825812|593396515|FG001|Overall Study|Subject withdrew consent|0|||
164280657|NCT00825812|593396516|FG002|Overall Study|Subject withdrew consent|3|||
164280658|NCT00825812|593396517|FG003|Overall Study|Subject withdrew consent|2|||
164280659|NCT00825812|593396514|FG000|Overall Study|Non-compliance with protocol|0|||
164280660|NCT00825812|593396515|FG001|Overall Study|Non-compliance with protocol|0|||
164280661|NCT00825812|593396516|FG002|Overall Study|Non-compliance with protocol|0|||
164280662|NCT00825812|593396517|FG003|Overall Study|Non-compliance with protocol|1|||
164280663|NCT00825812|593396514|FG000|Overall Study|Administrative|0|||
164280664|NCT00825812|593396515|FG001|Overall Study|Administrative|1|||
164280665|NCT00825812|593396516|FG002|Overall Study|Administrative|3|||
164280666|NCT00825812|593396517|FG003|Overall Study|Administrative|5|||
164280667|NCT00986362|593396519|FG000|Overall Study|Death|2|||
164280668|NCT00986362|593396520|FG001|Overall Study|Death|0|||
164280669|NCT00986362|593396519|FG000|Overall Study|Lost to Follow-up|0|||
164280670|NCT00986362|593396520|FG001|Overall Study|Lost to Follow-up|1|||
164280671|NCT03597061|593396521|FG000|Overall Study|Lost to Follow-up|1|||
164280672|NCT03597061|593396522|FG001|Overall Study|Lost to Follow-up|0|||
164280673|NCT03597061|593396521|FG000|Overall Study|Protocol Violation|0|||
164280674|NCT03597061|593396522|FG001|Overall Study|Protocol Violation|1|||
164344281|NCT00293033|593635421|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
164280675|NCT00895453|593396527|FG000|Overall Study|Lost to Follow-up|25|||
164344282|NCT00293033|593635421|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
164344283|NCT00293033|593635421|FG000|Double-blind Treatment Period|Noncompliance|4|||
164344284|NCT01980940|593635423|FG000|Overall Study|Protocol Violation|0|||
163895338|NCT03418740|591989645|FG000|Overall Study|Scheduling Issues|7|||
163895339|NCT03418740|591989645|FG000|Overall Study|Withdrawal by Subject|2|||
163895340|NCT03418740|591989645|FG000|Overall Study|Unable to Continue Consent|1|||
163895341|NCT05525104|591989646|FG000|Overall Study|Failed caudal analgesia|1|||
163895342|NCT05525104|591989647|FG001|Overall Study|Failed caudal analgesia|3|||
163895343|NCT05525104|591989646|FG000|Overall Study|Premedication needed|0|||
163895344|NCT05525104|591989647|FG001|Overall Study|Premedication needed|1|||
163895345|NCT05525104|591989646|FG000|Overall Study|Protocol Violation|10|||
163895346|NCT05525104|591989647|FG001|Overall Study|Protocol Violation|0|||
163895347|NCT05525104|591989646|FG000|Overall Study|Cancelled operation|1|||
163895348|NCT05525104|591989647|FG001|Overall Study|Cancelled operation|0|||
164280676|NCT00895453|593396528|FG001|Overall Study|Lost to Follow-up|25|||
164280677|NCT00895453|593396529|FG002|Overall Study|Lost to Follow-up|23|||
164280678|NCT00850538|593396530|FG000|Overall Study|unable/unwilling to complete MRI|13|||
164280679|NCT00850538|593396530|FG000|Overall Study|specimen missed due to scheduling error|14|||
164280680|NCT00850538|593396530|FG000|Overall Study|specimen unusable|7|||
164280681|NCT00850538|593396530|FG000|Overall Study|Withdrawal by Subject|3|||
164280682|NCT00850538|593396530|FG000|Overall Study|radiology error|2|||
164280683|NCT00850538|593396530|FG000|Overall Study|Protocol Violation|2|||
164280684|NCT01088399|593396531|FG000|Overall Study|Adverse Event|211|||
164280685|NCT01088399|593396532|FG001|Overall Study|Adverse Event|16|||
164280686|NCT01088399|593396533|FG002|Overall Study|Adverse Event|0|||
164280687|NCT01088399|593396531|FG000|Overall Study|Death|204|||
164280688|NCT01088399|593396532|FG001|Overall Study|Death|45|||
164280689|NCT01088399|593396533|FG002|Overall Study|Death|0|||
164280690|NCT01088399|593396531|FG000|Overall Study|Lack of Efficacy|298|||
164280691|NCT01088399|593396532|FG001|Overall Study|Lack of Efficacy|7|||
164280692|NCT01088399|593396533|FG002|Overall Study|Lack of Efficacy|5|||
164280693|NCT01088399|593396531|FG000|Overall Study|Lost to Follow-up|1070|||
164280694|NCT01088399|593396532|FG001|Overall Study|Lost to Follow-up|278|||
164280695|NCT01088399|593396533|FG002|Overall Study|Lost to Follow-up|58|||
164280696|NCT01088399|593396531|FG000|Overall Study|Physician Decision|531|||
164280697|NCT01088399|593396532|FG001|Overall Study|Physician Decision|88|||
164280698|NCT01088399|593396533|FG002|Overall Study|Physician Decision|16|||
164280699|NCT01088399|593396531|FG000|Overall Study|Withdrawal by Subject|544|||
164280700|NCT01088399|593396532|FG001|Overall Study|Withdrawal by Subject|195|||
164280701|NCT01088399|593396533|FG002|Overall Study|Withdrawal by Subject|33|||
164280702|NCT01088399|593396531|FG000|Overall Study|Change to or start of somatropin therapy|234|||
164280703|NCT01088399|593396532|FG001|Overall Study|Change to or start of somatropin therapy|17|||
164280704|NCT01088399|593396533|FG002|Overall Study|Change to or start of somatropin therapy|12|||
164280705|NCT01088399|593396531|FG000|Overall Study|Sponsor decision|1573|||
164280706|NCT01088399|593396532|FG001|Overall Study|Sponsor decision|298|||
164280707|NCT01088399|593396533|FG002|Overall Study|Sponsor decision|7|||
164280708|NCT01088399|593396531|FG000|Overall Study|Protocol Violation|10|||
164280709|NCT01088399|593396532|FG001|Overall Study|Protocol Violation|1|||
164280710|NCT01088399|593396533|FG002|Overall Study|Protocol Violation|0|||
164280711|NCT01088399|593396531|FG000|Overall Study|Enrollment criteria not met|48|||
164280712|NCT01088399|593396532|FG001|Overall Study|Enrollment criteria not met|119|||
164280713|NCT01088399|593396533|FG002|Overall Study|Enrollment criteria not met|70|||
164280714|NCT01088399|593396531|FG000|Overall Study|Study summary visit not completed|2398|||
164280715|NCT01088399|593396532|FG001|Overall Study|Study summary visit not completed|283|||
164280716|NCT01088399|593396533|FG002|Overall Study|Study summary visit not completed|80|||
164280717|NCT03193736|593396534|FG000|Overall Study|Death|2|||
164280718|NCT03193736|593396534|FG000|Overall Study|Withdrawal by Subject|1|||
164280719|NCT03193736|593396534|FG000|Overall Study|Lost to Follow-up|1|||
164280720|NCT03193736|593396534|FG000|Overall Study|implant not received|1|||
164280721|NCT00852241|593396535|FG000|Overall Study|Physician Decision|18|||
164280722|NCT02697435|593396536|FG000|Overall Study|Withdrawal by Subject|1|||
164280723|NCT02697435|593396537|FG001|Overall Study|Withdrawal by Subject|0|||
164280724|NCT02697435|593396536|FG000|Overall Study|Physician Decision|0|||
164280725|NCT02697435|593396537|FG001|Overall Study|Physician Decision|4|||
164280726|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
164280727|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
164280728|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
164280729|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
164280730|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
164280731|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
163895349|NCT02865538|591989648|FG000|Overall Study|Withdrawal by Subject|0|||
164280732|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
164280733|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
163895350|NCT02865538|591989649|FG001|Overall Study|Withdrawal by Subject|0|||
163895351|NCT02865538|591989650|FG002|Overall Study|Withdrawal by Subject|1|||
164280734|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
164280735|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
164280736|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
164280737|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
164280738|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
164280739|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
164280740|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
164280741|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
164280742|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
164280743|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
164280744|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
164280745|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
164280746|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
164280747|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
164280748|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
164280749|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
164280750|NCT03777059|593397778|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
164280751|NCT03777059|593397779|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
164280752|NCT03777059|593397780|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
164280753|NCT03777059|593397781|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
164280754|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
164280755|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
164280756|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
164280757|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
164280758|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
164280759|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
164280760|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
164280761|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
164280762|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
164280763|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
164280764|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
164280765|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
164280766|NCT03777059|593397778|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
164280767|NCT03777059|593397779|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
164280768|NCT03777059|593397780|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
164280769|NCT03777059|593397781|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
164280770|NCT03056339|593397785|FG000|Overall Study|Failed Requirements|0|||
164280771|NCT03056339|593397786|FG001|Overall Study|Failed Requirements|2|||
164280772|NCT03056339|593397787|FG002|Overall Study|Failed Requirements|7|||
164280773|NCT03056339|593397788|FG003|Overall Study|Failed Requirements|1|||
164280774|NCT04506502|593397792|FG000|Overall Study|Withdrawal by Subject|1|||
164280775|NCT04506502|593397792|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
164280776|NCT01449006|593397793|FG000|Overall Study|Lost to Follow-up|1|||
164280777|NCT01449006|593397794|FG001|Overall Study|Lost to Follow-up|0|||
164280778|NCT01449006|593397793|FG000|Overall Study|Withdrawal by Subject|1|||
164280779|NCT01449006|593397794|FG001|Overall Study|Withdrawal by Subject|0|||
164280780|NCT01449006|593397793|FG000|Overall Study|Protocol Violation|1|||
164280781|NCT01449006|593397794|FG001|Overall Study|Protocol Violation|0|||
164280782|NCT02517541|593397797|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
164280783|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
164280784|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
164280785|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
164280786|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
164280787|NCT02517541|593397797|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
164280788|NCT02034877|593397800|FG000|Overall Study|Lost to Follow-up|0|||
164280789|NCT02034877|593397801|FG001|Overall Study|Lost to Follow-up|3|||
164280790|NCT02034877|593397800|FG000|Overall Study|No Longer Willing to Participate|0|||
164086002|NCT01022112|592678631|FG004|Overall Study|Adverse Event|0|||
164086003|NCT01022112|592678627|FG000|Overall Study|Lack of Efficacy|1|||
164086004|NCT01022112|592678628|FG001|Overall Study|Lack of Efficacy|0|||
164280791|NCT02034877|593397801|FG001|Overall Study|No Longer Willing to Participate|3|||
164280792|NCT01036321|593397808|FG000|Overall Study|Ineligible after randomization|0|||
164280793|NCT01036321|593397809|FG001|Overall Study|Ineligible after randomization|1|||
164280794|NCT01036321|593397808|FG000|Overall Study|Withdrawal by Subject|3|||
164280795|NCT01036321|593397809|FG001|Overall Study|Withdrawal by Subject|2|||
164280796|NCT01036321|593397808|FG000|Overall Study|Adverse Event|2|||
164280797|NCT01036321|593397809|FG001|Overall Study|Adverse Event|1|||
164280798|NCT00381693|593397810|FG000|Overall Study|Death|1|||
164280799|NCT00381693|593397810|FG000|Overall Study|Adverse Event|4|||
164280800|NCT00381693|593397810|FG000|Overall Study|Patient Choice|1|||
164280801|NCT00381693|593397810|FG000|Overall Study|Progression|2|||
164280802|NCT01687101|593397811|FG000|Overall Study|Lost to Follow-up|7|||
164280803|NCT02598297|593397812|FG000|Overall Study|Study terminated by Sponsor|21|||
164280804|NCT02598297|593397813|FG001|Overall Study|Study terminated by Sponsor|23|||
164280805|NCT02598297|593397812|FG000|Overall Study|Adverse Event|1|||
164280806|NCT02598297|593397813|FG001|Overall Study|Adverse Event|1|||
164280807|NCT02598297|593397812|FG000|Overall Study|Physician Decision|1|||
164280808|NCT02598297|593397813|FG001|Overall Study|Physician Decision|0|||
164280809|NCT02598297|593397812|FG000|Overall Study|Subject/guardian decision|1|||
164280810|NCT02598297|593397813|FG001|Overall Study|Subject/guardian decision|0|||
164280811|NCT02598297|593397812|FG000|Overall Study|Followed for survival|1|||
164280812|NCT02598297|593397813|FG001|Overall Study|Followed for survival|0|||
164280813|NCT02003534|593397819|FG000|Overall Study|Lost to Follow-up|47|||
164280814|NCT03040674|593397820|FG000|Overall Study|Lost to Follow-up|225|||
164280815|NCT03040674|593397820|FG000|Overall Study|Death|23|||
164280816|NCT02206035|593397822|FG000|Overall Study|Physician Decision|10|||
164280817|NCT02206035|593397823|FG001|Overall Study|Physician Decision|0|||
164280818|NCT02206035|593397824|FG002|Overall Study|Physician Decision|175|||
164280819|NCT01934010|593397825|FG000|Overall Study|Adverse Event|1|||
164280820|NCT01934010|593397826|FG001|Overall Study|Adverse Event|1|||
164280821|NCT01934010|593397827|FG002|Overall Study|Adverse Event|0|||
164280822|NCT01934010|593397825|FG000|Overall Study|Withdrawal by Subject|15|||
164280823|NCT01934010|593397826|FG001|Overall Study|Withdrawal by Subject|6|||
164280824|NCT01934010|593397827|FG002|Overall Study|Withdrawal by Subject|2|||
164280825|NCT01934010|593397825|FG000|Overall Study|Lost to Follow-up|7|||
164280826|NCT01934010|593397826|FG001|Overall Study|Lost to Follow-up|4|||
164280827|NCT01934010|593397827|FG002|Overall Study|Lost to Follow-up|0|||
164280828|NCT04112303|593397828|FG000|Overall Study|Death|1|||
164280829|NCT01685697|593397829|FG000|Overall Study|Protocol Violation|3|||
164280830|NCT01685697|593397830|FG001|Overall Study|Protocol Violation|3|||
164280831|NCT02703324|593397831|FG000|Period Two|Withdrawal by Subject|0|||
164280832|NCT02703324|593397832|FG001|Period Two|Withdrawal by Subject|0|||
164280833|NCT02703324|593397833|FG002|Period Two|Withdrawal by Subject|1|||
164280834|NCT02703324|593397834|FG003|Period Two|Withdrawal by Subject|0|||
164280835|NCT02703324|593397835|FG004|Period Two|Withdrawal by Subject|0|||
164280836|NCT02703324|593397836|FG005|Period Two|Withdrawal by Subject|0|||
164280837|NCT04303572|593397839|FG000|Overall Study|Study closed due to poor enrollment|1|||
164280838|NCT03517228|593397842|FG000|Overall Study|Withdrawal by Subject|2|||
164280839|NCT03517228|593397842|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
164280840|NCT03517228|593397842|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
164280841|NCT03517228|593397842|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
164280842|NCT03517228|593397842|FG000|Overall Study|Canceled due to device being updated|1|||
164280843|NCT03517228|593397842|FG000|Overall Study|No V Cares in stock|1|||
164280844|NCT03517228|593397842|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
164280845|NCT03781414|593397852|FG000|Overall Study|Study terminated by sponsor|39|||
164280846|NCT03781414|593397853|FG001|Overall Study|Study terminated by sponsor|34|||
164280847|NCT03781414|593397854|FG002|Overall Study|Study terminated by sponsor|25|||
164280848|NCT03781414|593397852|FG000|Overall Study|Adverse Event|3|||
164280849|NCT03781414|593397853|FG001|Overall Study|Adverse Event|6|||
164280850|NCT03781414|593397854|FG002|Overall Study|Adverse Event|3|||
164280851|NCT03781414|593397852|FG000|Overall Study|Physician Decision|2|||
164280852|NCT03781414|593397853|FG001|Overall Study|Physician Decision|0|||
164280853|NCT03781414|593397854|FG002|Overall Study|Physician Decision|1|||
164280854|NCT03781414|593397852|FG000|Overall Study|Withdrawal by Subject|2|||
164280855|NCT03781414|593397853|FG001|Overall Study|Withdrawal by Subject|3|||
164280856|NCT03781414|593397854|FG002|Overall Study|Withdrawal by Subject|3|||
164280857|NCT03781414|593397852|FG000|Overall Study|Death|1|||
164280858|NCT03781414|593397853|FG001|Overall Study|Death|4|||
164280859|NCT03781414|593397854|FG002|Overall Study|Death|0|||
164280860|NCT03781414|593397852|FG000|Overall Study|Lost to Follow-up|1|||
164280861|NCT03781414|593397853|FG001|Overall Study|Lost to Follow-up|1|||
164280862|NCT03781414|593397854|FG002|Overall Study|Lost to Follow-up|0|||
164280863|NCT06041919|593397855|FG000|Overall Study|Lost to Follow-up|1|||
164280864|NCT06041919|593397856|FG001|Overall Study|Lost to Follow-up|0|||
164280865|NCT06041919|593397857|FG002|Overall Study|Lost to Follow-up|0|||
164280866|NCT06041919|593397858|FG003|Overall Study|Lost to Follow-up|0|||
164280867|NCT06041919|593397859|FG004|Overall Study|Lost to Follow-up|0|||
164344285|NCT01980940|593635424|FG001|Overall Study|Protocol Violation|0|||
164344286|NCT01980940|593635425|FG002|Overall Study|Protocol Violation|0|||
163895352|NCT02865538|591989651|FG003|Overall Study|Withdrawal by Subject|0|||
163895353|NCT02865538|591989652|FG004|Overall Study|Withdrawal by Subject|0|||
164280868|NCT06041919|593397855|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
164280869|NCT06041919|593397856|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
164280870|NCT06041919|593397857|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
164280871|NCT06041919|593397858|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
164280872|NCT06041919|593397859|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
164280873|NCT02576795|593397860|FG000|Overall Study|Lost to Follow-up|0|||
164280874|NCT02576795|593397861|FG001|Overall Study|Lost to Follow-up|0|||
164280875|NCT02576795|593397862|FG002|Overall Study|Lost to Follow-up|1|||
164280876|NCT02576795|593397863|FG003|Overall Study|Lost to Follow-up|0|||
164280877|NCT01620762|593397866|FG000|Overall Study|Protocol Violation|1|||
164280878|NCT01620762|593397867|FG001|Overall Study|Protocol Violation|1|||
164280879|NCT01620762|593397868|FG002|Overall Study|Protocol Violation|1|||
164344287|NCT01980940|593635426|FG003|Overall Study|Protocol Violation|0|||
164280880|NCT01620762|593397866|FG000|Overall Study|Adverse Event|9|||
164280881|NCT01620762|593397867|FG001|Overall Study|Adverse Event|5|||
164280882|NCT01620762|593397868|FG002|Overall Study|Adverse Event|2|||
164280883|NCT01620762|593397866|FG000|Overall Study|Withdrawal by Subject|23|||
164280884|NCT01620762|593397867|FG001|Overall Study|Withdrawal by Subject|26|||
164280885|NCT01620762|593397868|FG002|Overall Study|Withdrawal by Subject|27|||
164280886|NCT01620762|593397866|FG000|Overall Study|Lost to Follow-up|11|||
164280887|NCT01620762|593397867|FG001|Overall Study|Lost to Follow-up|17|||
164280888|NCT01620762|593397868|FG002|Overall Study|Lost to Follow-up|10|||
164280889|NCT01620762|593397866|FG000|Overall Study|Protocol deviation|1|||
164280890|NCT01620762|593397867|FG001|Overall Study|Protocol deviation|1|||
164280891|NCT01620762|593397868|FG002|Overall Study|Protocol deviation|6|||
164280892|NCT01620762|593397866|FG000|Overall Study|Subject deterioration|0|||
164280893|NCT01620762|593397867|FG001|Overall Study|Subject deterioration|1|||
164280894|NCT01620762|593397868|FG002|Overall Study|Subject deterioration|1|||
164280895|NCT01620762|593397866|FG000|Overall Study|Non-specified|3|||
164280896|NCT01620762|593397867|FG001|Overall Study|Non-specified|6|||
164280897|NCT01620762|593397868|FG002|Overall Study|Non-specified|5|||
164280898|NCT01620762|593397866|FG000|Overall Study|Use of prohibted therapies|0|||
164280899|NCT01620762|593397867|FG001|Overall Study|Use of prohibted therapies|1|||
164280900|NCT01620762|593397868|FG002|Overall Study|Use of prohibted therapies|1|||
164280901|NCT03664765|593397869|FG000|Overall Study|Withdrawal by Subject|4|||
164280902|NCT03664765|593397870|FG001|Overall Study|Withdrawal by Subject|1|||
164280903|NCT03664765|593397869|FG000|Overall Study|Lost to Follow-up|0|||
164280904|NCT03664765|593397870|FG001|Overall Study|Lost to Follow-up|1|||
164280905|NCT01128946|593397876|FG000|Period I|Protocol Violation|0|||
164280906|NCT01128946|593397877|FG001|Period I|Protocol Violation|1|||
164280907|NCT01128946|593397878|FG002|Period I|Protocol Violation|0|||
164280908|NCT01128946|593397879|FG003|Period I|Protocol Violation|0|||
164280909|NCT01128946|593397876|FG000|Period I|Withdrawal by Subject|0|||
164280910|NCT01128946|593397877|FG001|Period I|Withdrawal by Subject|0|||
164280911|NCT01128946|593397878|FG002|Period I|Withdrawal by Subject|1|||
164280912|NCT01128946|593397879|FG003|Period I|Withdrawal by Subject|1|||
164280913|NCT01128946|593397876|FG000|Period II|Protocol Violation|0|||
164280914|NCT01128946|593397877|FG001|Period II|Protocol Violation|1|||
164280915|NCT01128946|593397878|FG002|Period II|Protocol Violation|0|||
164280916|NCT01128946|593397879|FG003|Period II|Protocol Violation|0|||
164280917|NCT01128946|593397876|FG000|Period II|Withdrawal by Subject|0|||
164280918|NCT01128946|593397877|FG001|Period II|Withdrawal by Subject|0|||
164280919|NCT01128946|593397878|FG002|Period II|Withdrawal by Subject|0|||
164280920|NCT01128946|593397879|FG003|Period II|Withdrawal by Subject|1|||
164280921|NCT01128946|593397876|FG000|Period III|Protocol Violation|1|||
164280922|NCT01128946|593397877|FG001|Period III|Protocol Violation|0|||
164280923|NCT01128946|593397878|FG002|Period III|Protocol Violation|0|||
164280924|NCT01128946|593397879|FG003|Period III|Protocol Violation|0|||
164280925|NCT00527904|593397880|FG000|Overall Study|Adverse Event|45|||
164280926|NCT00527904|593397880|FG000|Overall Study|Withdrawal by Subject|21|||
164280927|NCT00527904|593397880|FG000|Overall Study|Lost to Follow-up|8|||
164280928|NCT00527904|593397880|FG000|Overall Study|misc|22|||
164280929|NCT02873338|593397884|FG000|Overall Study|Adverse Event|0|||
164280930|NCT02873338|593397885|FG001|Overall Study|Adverse Event|2|||
164280931|NCT02873338|593397886|FG002|Overall Study|Adverse Event|1|||
164280932|NCT02873338|593397884|FG000|Overall Study|Death|2|||
164280933|NCT02873338|593397885|FG001|Overall Study|Death|1|||
164280934|NCT02873338|593397886|FG002|Overall Study|Death|1|||
164280935|NCT02873338|593397884|FG000|Overall Study|Withdrawal by Subject|2|||
164280936|NCT02873338|593397885|FG001|Overall Study|Withdrawal by Subject|1|||
164280937|NCT02873338|593397886|FG002|Overall Study|Withdrawal by Subject|3|||
164280938|NCT02873338|593397884|FG000|Overall Study|Lack of Efficacy|0|||
164280939|NCT02873338|593397885|FG001|Overall Study|Lack of Efficacy|2|||
164280940|NCT02873338|593397886|FG002|Overall Study|Lack of Efficacy|0|||
164280941|NCT02873338|593397884|FG000|Overall Study|Other or Missing|14|||
164280942|NCT02873338|593397885|FG001|Overall Study|Other or Missing|15|||
164280943|NCT02873338|593397886|FG002|Overall Study|Other or Missing|13|||
164280944|NCT00766051|593397888|FG000|Overall Study|Withdrawal by Subject|2|||
164280945|NCT00766051|593397889|FG001|Overall Study|Withdrawal by Subject|0|||
164280946|NCT01320202|593397890|FG000|Overall Study|Adverse Event|5|||
164280947|NCT01320202|593397891|FG001|Overall Study|Adverse Event|5|||
164280948|NCT01320202|593397890|FG000|Overall Study|Death|5|||
164280949|NCT01320202|593397891|FG001|Overall Study|Death|3|||
164280950|NCT01320202|593397890|FG000|Overall Study|Lost to Follow-up|1|||
164280951|NCT01320202|593397891|FG001|Overall Study|Lost to Follow-up|0|||
164280952|NCT01320202|593397890|FG000|Overall Study|Physician Decision|3|||
164280953|NCT01320202|593397891|FG001|Overall Study|Physician Decision|1|||
164280954|NCT01320202|593397890|FG000|Overall Study|Protocol Violation|2|||
164280955|NCT01320202|593397891|FG001|Overall Study|Protocol Violation|1|||
164280956|NCT01320202|593397890|FG000|Overall Study|Withdrawal by Subject|10|||
164280957|NCT01320202|593397891|FG001|Overall Study|Withdrawal by Subject|3|||
164280958|NCT01320202|593397890|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
164280959|NCT01320202|593397891|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
164280960|NCT01320202|593397890|FG000|Overall Study|kidney transplant|1|||
164280961|NCT01320202|593397891|FG001|Overall Study|kidney transplant|2|||
164280962|NCT01320202|593397890|FG000|Overall Study|blood transfusion|1|||
164280963|NCT01320202|593397891|FG001|Overall Study|blood transfusion|7|||
164280964|NCT01320202|593397890|FG000|Overall Study|moved/changed dialysis|5|||
164280965|NCT01320202|593397891|FG001|Overall Study|moved/changed dialysis|2|||
164280966|NCT01320202|593397890|FG000|Overall Study|sponsor request|2|||
164280967|NCT01320202|593397891|FG001|Overall Study|sponsor request|0|||
164280968|NCT01320202|593397890|FG000|Overall Study|ineligible|3|||
164280969|NCT01320202|593397891|FG001|Overall Study|ineligible|0|||
164280970|NCT01320202|593397890|FG000|Overall Study|regained renal function|1|||
164280971|NCT01320202|593397891|FG001|Overall Study|regained renal function|0|||
164280972|NCT00635882|593397892|FG000|Overall Study|Protocol Violation|1|||
164280973|NCT00635882|593397893|FG001|Overall Study|Protocol Violation|0|||
164280974|NCT00635882|593397894|FG002|Overall Study|Protocol Violation|0|||
164280975|NCT00635882|593397895|FG003|Overall Study|Protocol Violation|0|||
164280976|NCT00635882|593397896|FG004|Overall Study|Protocol Violation|0|||
164280977|NCT00635882|593397897|FG005|Overall Study|Protocol Violation|0|||
164280978|NCT02006979|593397898|FG000|Overall Study|Withdrawal by Subject|1|||
164280979|NCT02006979|593397899|FG001|Overall Study|Withdrawal by Subject|1|||
164280980|NCT02006979|593397898|FG000|Overall Study|Protocol Violation|0|||
164280981|NCT02006979|593397899|FG001|Overall Study|Protocol Violation|1|||
164280982|NCT03477838|593397904|FG000|Overall Study|Lost to Follow-up|14|||
164280983|NCT04230213|593397911|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
164280984|NCT04230213|593397912|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
164280985|NCT04230213|593397913|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
164280986|NCT04230213|593397911|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
164280987|NCT04230213|593397912|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
164280988|NCT04230213|593397913|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
164280989|NCT04230213|593397911|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
164280990|NCT04230213|593397912|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
164280991|NCT04230213|593397913|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
164280992|NCT04230213|593397911|FG000|TP2: Week 10 to Week 16|Other|0|||
164280993|NCT04230213|593397912|FG001|TP2: Week 10 to Week 16|Other|2|||
164280994|NCT04230213|593397913|FG002|TP2: Week 10 to Week 16|Other|1|||
164280995|NCT04230213|593397911|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
164280996|NCT04230213|593397912|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
164280997|NCT04230213|593397913|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
164280998|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
164280999|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
164281000|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
164281001|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
164281002|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
164281003|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
164281004|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
164281005|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
164281006|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
164281007|NCT04230213|593397911|FG000|TP3: Week 16 to Week 22|Other|0|||
164281008|NCT04230213|593397912|FG001|TP3: Week 16 to Week 22|Other|1|||
164281009|NCT04230213|593397913|FG002|TP3: Week 16 to Week 22|Other|3|||
164281010|NCT04230213|593397911|FG000|TP4: Week 22 to Week 32|Other|0|||
164281011|NCT04230213|593397912|FG001|TP4: Week 22 to Week 32|Other|5|||
164281012|NCT04230213|593397913|FG002|TP4: Week 22 to Week 32|Other|5|||
164281013|NCT04230213|593397911|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
164281014|NCT04230213|593397912|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
164281015|NCT04230213|593397913|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
164281016|NCT04230213|593397911|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
164281017|NCT04230213|593397912|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
163895354|NCT02865538|591989648|FG000|Overall Study|Lost to Follow-up|1|||
163895355|NCT02865538|591989649|FG001|Overall Study|Lost to Follow-up|0|||
163895356|NCT02865538|591989650|FG002|Overall Study|Lost to Follow-up|0|||
164281018|NCT04230213|593397913|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
164281019|NCT04230213|593397911|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
164281020|NCT04230213|593397912|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
164281021|NCT04230213|593397913|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
164281022|NCT04230213|593397911|FG000|Follow up: Week 32 to Week 36|Other|0|||
164281023|NCT04230213|593397912|FG001|Follow up: Week 32 to Week 36|Other|1|||
164281024|NCT04230213|593397913|FG002|Follow up: Week 32 to Week 36|Other|1|||
164281025|NCT00619307|593397925|FG000|Overall Study|Adverse Event|0|||
164281026|NCT00619307|593397926|FG001|Overall Study|Adverse Event|1|||
164281027|NCT00619307|593397925|FG000|Overall Study|Lost to Follow-up|0|||
164281028|NCT00619307|593397926|FG001|Overall Study|Lost to Follow-up|1|||
164281029|NCT00619307|593397925|FG000|Overall Study|Protocol Violation|3|||
164281030|NCT00619307|593397926|FG001|Overall Study|Protocol Violation|0|||
164344288|NCT01980940|593635427|FG004|Overall Study|Protocol Violation|0|||
164281031|NCT00619307|593397925|FG000|Overall Study|Withdrew consent|1|||
164344289|NCT01980940|593635428|FG005|Overall Study|Protocol Violation|2|||
164344290|NCT01980940|593635429|FG006|Overall Study|Protocol Violation|0|||
164344291|NCT01980940|593635430|FG007|Overall Study|Protocol Violation|0|||
164344292|NCT00837811|593635431|FG000|Overall Study|Adverse Event|4|||
164344293|NCT00837811|593635432|FG001|Overall Study|Adverse Event|6|||
164344294|NCT00837811|593635433|FG002|Overall Study|Adverse Event|0|||
164344295|NCT00837811|593635431|FG000|Overall Study|Death|1|||
164344296|NCT00837811|593635432|FG001|Overall Study|Death|1|||
164344297|NCT00837811|593635433|FG002|Overall Study|Death|0|||
164344298|NCT00837811|593635431|FG000|Overall Study|Lack of Efficacy|0|||
164344299|NCT00837811|593635432|FG001|Overall Study|Lack of Efficacy|11|||
164344300|NCT00837811|593635433|FG002|Overall Study|Lack of Efficacy|0|||
164344301|NCT00837811|593635431|FG000|Overall Study|Lost to Follow-up|1|||
164344302|NCT00837811|593635432|FG001|Overall Study|Lost to Follow-up|3|||
164344303|NCT00837811|593635433|FG002|Overall Study|Lost to Follow-up|0|||
164344304|NCT00837811|593635431|FG000|Overall Study|Physician Decision|0|||
164344305|NCT00837811|593635432|FG001|Overall Study|Physician Decision|2|||
164344306|NCT00837811|593635433|FG002|Overall Study|Physician Decision|1|||
164344307|NCT00837811|593635431|FG000|Overall Study|Withdrawal by Subject|1|||
164344308|NCT00837811|593635432|FG001|Overall Study|Withdrawal by Subject|9|||
164344309|NCT00837811|593635433|FG002|Overall Study|Withdrawal by Subject|0|||
164344310|NCT00837811|593635431|FG000|Overall Study|Sponsor Decision|0|||
164344311|NCT00837811|593635432|FG001|Overall Study|Sponsor Decision|2|||
164344312|NCT00837811|593635433|FG002|Overall Study|Sponsor Decision|0|||
164344313|NCT00691015|593636910|FG000|Overall Study|Refused further treatment|1|||
164344314|NCT01397084|593636911|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
164344315|NCT01397084|593636911|FG000|Overall Study|Protocol Violation|2|||
164344316|NCT01397084|593636911|FG000|Overall Study|Adverse Event|2|||
164344317|NCT01397084|593636911|FG000|Overall Study|Withdrawal by Subject|1|||
164344318|NCT01397084|593636911|FG000|Overall Study|Lost to Follow-up|1|||
164344319|NCT01397084|593636911|FG000|Overall Study|Used other proton pump inhibitor|1|||
164344320|NCT04160195|593636914|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
164344321|NCT04160195|593636915|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
164344322|NCT03130257|593636918|FG000|Overall Study|Withdrawal by Subject|1|||
164344323|NCT03130257|593636919|FG001|Overall Study|Withdrawal by Subject|0|||
164344324|NCT03130257|593636920|FG002|Overall Study|Withdrawal by Subject|2|||
164344325|NCT03766581|593636921|FG000|Randomization|Other reasons|2|||
164344326|NCT03766581|593636922|FG001|Randomization|Other reasons|1|||
164344327|NCT03766581|593636923|FG002|Randomization|Other reasons|0|||
164344328|NCT03766581|593636924|FG003|Randomization|Other reasons|1|||
164344329|NCT03766581|593636925|FG004|Randomization|Other reasons|0|||
164344330|NCT03766581|593636926|FG005|Randomization|Other reasons|0|||
164344331|NCT03766581|593636927|FG006|Randomization|Other reasons|0|||
163895357|NCT02865538|591989651|FG003|Overall Study|Lost to Follow-up|0|||
163895358|NCT02865538|591989652|FG004|Overall Study|Lost to Follow-up|0|||
163895359|NCT04244175|591990968|FG000|Overall Study|Adverse Event|3|||
163895360|NCT04244175|591990969|FG001|Overall Study|Adverse Event|2|||
163895361|NCT04244175|591990970|FG002|Overall Study|Adverse Event|5|||
163895362|NCT04244175|591990968|FG000|Overall Study|Lack of Efficacy|1|||
163895363|NCT04244175|591990969|FG001|Overall Study|Lack of Efficacy|0|||
163895364|NCT04244175|591990970|FG002|Overall Study|Lack of Efficacy|1|||
163895365|NCT04244175|591990968|FG000|Overall Study|Lost to Follow-up|1|||
163895366|NCT04244175|591990969|FG001|Overall Study|Lost to Follow-up|0|||
163895367|NCT04244175|591990970|FG002|Overall Study|Lost to Follow-up|0|||
163895368|NCT04244175|591990968|FG000|Overall Study|Non-compliance with study drug|1|||
163895369|NCT04244175|591990969|FG001|Overall Study|Non-compliance with study drug|0|||
163895370|NCT04244175|591990970|FG002|Overall Study|Non-compliance with study drug|1|||
163895371|NCT04244175|591990968|FG000|Overall Study|Protocol deviation|0|||
163895372|NCT04244175|591990969|FG001|Overall Study|Protocol deviation|1|||
163895373|NCT04244175|591990970|FG002|Overall Study|Protocol deviation|0|||
163895374|NCT04244175|591990968|FG000|Overall Study|Withdrawal by Subject|1|||
163895375|NCT04244175|591990969|FG001|Overall Study|Withdrawal by Subject|3|||
163895376|NCT04244175|591990970|FG002|Overall Study|Withdrawal by Subject|1|||
163895377|NCT04244175|591990968|FG000|Overall Study|Other, not specified|0|||
163895378|NCT04244175|591990969|FG001|Overall Study|Other, not specified|1|||
163895379|NCT04244175|591990970|FG002|Overall Study|Other, not specified|2|||
163895380|NCT02585323|591990973|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
163895381|NCT02585323|591990974|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
163895382|NCT02585323|591990973|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
163895383|NCT02585323|591990974|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
164344332|NCT03766581|593636928|FG007|Randomization|Other reasons|0|||
164344333|NCT03766581|593636921|FG000|Randomization|Participant no longer meets study criteria|5|||
163895384|NCT02585323|591990973|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
163895385|NCT02585323|591990974|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
163895386|NCT02585323|591990973|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
164086005|NCT01022112|592678629|FG002|Overall Study|Lack of Efficacy|0|||
163895387|NCT02585323|591990974|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
163895388|NCT01130883|591990975|FG000|Overall Study|Patient Noncompliance|6|||
163895389|NCT01130883|591990975|FG000|Overall Study|Reason Unknown|1|||
163895390|NCT01130883|591990975|FG000|Overall Study|Adverse Event|3|||
163895391|NCT02278211|591990981|FG000|Overall Study|Unable to analyse PET scan|2|||
163895392|NCT02909686|591990983|FG000|Overall Study|Physician Decision|3|||
163895393|NCT02909686|591990983|FG000|Overall Study|Withdrawal by Subject|2|||
163895394|NCT03858517|591990984|FG000|Overall Study|Adverse Event|1|||
163895395|NCT03858517|591990984|FG000|Overall Study|Lost to Follow-up|1|||
163895396|NCT03858517|591990984|FG000|Overall Study|removed for being incarcerated|1|||
163895397|NCT03858517|591990984|FG000|Overall Study|Sponsor Closure|48|||
163895398|NCT04804540|591990987|FG000|Overall Study|Adverse Event|26|||
163895399|NCT04804540|591990988|FG001|Overall Study|Adverse Event|13|||
163895400|NCT05172232|591990989|FG000|Overall Study|Lost to Follow-up|3|||
163895401|NCT01828021|591990990|FG000|Overall Study|Adverse Event|5|||
163895402|NCT01828021|591990990|FG000|Overall Study|Lack of Efficacy|17|||
163895403|NCT01828021|591990990|FG000|Overall Study|Withdrawal by Subject|2|||
163895404|NCT01828021|591990990|FG000|Overall Study|Ileal obstruction, unrelated|1|||
163895405|NCT01385202|591990995|FG000|Overall Study|Lost to Follow-up|6|||
163895406|NCT01385202|591990995|FG000|Overall Study|Not Eligible|11|||
163895407|NCT01385202|591990995|FG000|Overall Study|Withdrawn|1|||
164281032|NCT00619307|593397926|FG001|Overall Study|Withdrew consent|0|||
164281033|NCT00619307|593397925|FG000|Overall Study|Severe migraine|0|||
164281034|NCT00619307|593397926|FG001|Overall Study|Severe migraine|1|||
164281035|NCT00619307|593397925|FG000|Overall Study|MS attack plus steroids|0|||
164281036|NCT00619307|593397926|FG001|Overall Study|MS attack plus steroids|1|||
164281037|NCT00861471|593397929|FG000|Overall Study|Withdrawal by Subject|1|||
164281038|NCT00861471|593397929|FG000|Overall Study|Adverse Event|2|||
164281039|NCT00861471|593397929|FG000|Overall Study|Lack of Efficacy|3|||
164281040|NCT00861471|593397929|FG000|Overall Study|treatment for lumbar laminectomy|1|||
164281041|NCT00861471|593397929|FG000|Overall Study|Physician Decision|2|||
164281042|NCT02069392|593397932|FG000|Overall Study|Withdrawal by Subject|4|||
164281043|NCT02069392|593397933|FG001|Overall Study|Withdrawal by Subject|2|||
164281044|NCT00269633|593397934|FG000|Overall Study|Withdrawal by Subject|1|||
164281045|NCT00269633|593397935|FG001|Overall Study|Withdrawal by Subject|0|||
164281046|NCT01574651|593397936|FG000|Overall Study|Lost to Follow-up|2|||
164281047|NCT01574651|593397937|FG001|Overall Study|Lost to Follow-up|4|||
164281048|NCT01574651|593397936|FG000|Overall Study|Administrative problems|0|||
164281049|NCT01574651|593397937|FG001|Overall Study|Administrative problems|1|||
164281050|NCT01574651|593397936|FG000|Overall Study|Death|3|||
164281051|NCT01574651|593397937|FG001|Overall Study|Death|3|||
164281052|NCT01574651|593397936|FG000|Overall Study|Patient's inability to use the device|0|||
164281053|NCT01574651|593397937|FG001|Overall Study|Patient's inability to use the device|1|||
164281054|NCT01574651|593397936|FG000|Overall Study|Adverse Event|36|||
164281055|NCT01574651|593397937|FG001|Overall Study|Adverse Event|27|||
164281056|NCT01574651|593397936|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164281057|NCT01574651|593397937|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164281058|NCT01574651|593397936|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164281059|NCT01574651|593397937|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164281060|NCT01574651|593397936|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164281061|NCT01574651|593397937|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164281062|NCT01574651|593397936|FG000|Overall Study|Protocol Violation|3|||
164281063|NCT01574651|593397937|FG001|Overall Study|Protocol Violation|5|||
164281064|NCT01574651|593397936|FG000|Overall Study|Withdrawal by Subject|9|||
164281065|NCT01574651|593397937|FG001|Overall Study|Withdrawal by Subject|10|||
164281066|NCT04412707|593397938|FG000|Cycle 1|Death|0|||
163895408|NCT03681262|591990996|FG000|Overall Study|Continuing on study|3|||
163895409|NCT03681262|591990997|FG001|Overall Study|Continuing on study|3|||
164281067|NCT04412707|593397939|FG001|Cycle 1|Death|3|||
164281068|NCT04412707|593397938|FG000|Cycle 1|Disease progression|1|||
164281069|NCT04412707|593397939|FG001|Cycle 1|Disease progression|2|||
164281070|NCT04412707|593397938|FG000|Cycle 2|Death|0|||
163895410|NCT03681262|591990996|FG000|Overall Study|Lost to Follow-up|1|||
163895411|NCT03681262|591990997|FG001|Overall Study|Lost to Follow-up|0|||
164281071|NCT04412707|593397939|FG001|Cycle 2|Death|1|||
163895412|NCT00887198|591990998|FG000|Randomized Period|Ongoing|42|||
163895413|NCT00887198|591990999|FG001|Randomized Period|Ongoing|0|||
164281072|NCT04412707|593397938|FG000|Cycle 2|Disease progression|3|||
164086006|NCT01022112|592678630|FG003|Overall Study|Lack of Efficacy|0|||
164086007|NCT01022112|592678631|FG004|Overall Study|Lack of Efficacy|1|||
164281073|NCT04412707|593397939|FG001|Cycle 2|Disease progression|0|||
164281074|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
164281075|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
164281076|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
164281077|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
164281078|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
164281079|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
164281080|NCT04412707|593397938|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
164281081|NCT04412707|593397939|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
164281082|NCT00855959|593400541|FG000|Overall Study|Adverse Event|2|||
164281083|NCT00855959|593400541|FG000|Overall Study|Lost to Follow-up|2|||
164281084|NCT00855959|593400541|FG000|Overall Study|Withdrawal by Subject|3|||
164281085|NCT00855959|593400541|FG000|Overall Study|Pregnancy|1|||
164281086|NCT00855959|593400541|FG000|Overall Study|Incorrect enrolment|1|||
164281087|NCT01424501|593400542|FG000|Overall Study|Withdrawal by Subject|1|||
164281088|NCT01424501|593400543|FG001|Overall Study|Withdrawal by Subject|0|||
163895414|NCT00887198|591991000|FG002|Randomized Period|Ongoing|0|||
163895415|NCT00887198|591990998|FG000|Randomized Period|Adverse Event|50|||
163895416|NCT00887198|591990999|FG001|Randomized Period|Adverse Event|33|||
164281089|NCT01424501|593400544|FG002|Overall Study|Withdrawal by Subject|1|||
163895417|NCT00887198|591991000|FG002|Randomized Period|Adverse Event|0|||
163895418|NCT00887198|591990998|FG000|Randomized Period|Lost to Follow-up|1|||
163895419|NCT00887198|591990999|FG001|Randomized Period|Lost to Follow-up|0|||
163895420|NCT00887198|591991000|FG002|Randomized Period|Lost to Follow-up|0|||
163895421|NCT00887198|591990998|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
163895422|NCT00887198|591990999|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
163895423|NCT00887198|591991000|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
163895424|NCT00887198|591990998|FG000|Randomized Period|Withdrawal by Subject|41|||
163895425|NCT00887198|591990999|FG001|Randomized Period|Withdrawal by Subject|56|||
163895426|NCT00887198|591991000|FG002|Randomized Period|Withdrawal by Subject|0|||
163895427|NCT00887198|591990998|FG000|Randomized Period|Progressive disease|366|||
163895428|NCT00887198|591990999|FG001|Randomized Period|Progressive disease|370|||
163895429|NCT00887198|591991000|FG002|Randomized Period|Progressive disease|0|||
163895430|NCT00887198|591990998|FG000|Randomized Period|Other|42|||
163895431|NCT00887198|591990999|FG001|Randomized Period|Other|30|||
163895432|NCT00887198|591991000|FG002|Randomized Period|Other|0|||
163895433|NCT00887198|591990998|FG000|Randomized Period|Randomized, Not treated|4|||
163895434|NCT00887198|591990999|FG001|Randomized Period|Randomized, Not treated|2|||
163895435|NCT00887198|591991000|FG002|Randomized Period|Randomized, Not treated|0|||
163895436|NCT00887198|591990998|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
164281090|NCT01424501|593400545|FG003|Overall Study|Withdrawal by Subject|0|||
164281091|NCT01424501|593400546|FG004|Overall Study|Withdrawal by Subject|0|||
164281092|NCT01424501|593400547|FG005|Overall Study|Withdrawal by Subject|0|||
164281093|NCT01424501|593400542|FG000|Overall Study|Lost to Follow-up|0|||
164281094|NCT01424501|593400543|FG001|Overall Study|Lost to Follow-up|1|||
164281095|NCT01424501|593400544|FG002|Overall Study|Lost to Follow-up|1|||
164281096|NCT01424501|593400545|FG003|Overall Study|Lost to Follow-up|0|||
164281097|NCT01424501|593400546|FG004|Overall Study|Lost to Follow-up|0|||
164281098|NCT01424501|593400547|FG005|Overall Study|Lost to Follow-up|0|||
164281099|NCT00699608|593400548|FG000|First Intervention|Withdrawal by Subject|0|||
164281100|NCT00699608|593400549|FG001|First Intervention|Withdrawal by Subject|0|||
164281101|NCT00699608|593400550|FG002|First Intervention|Withdrawal by Subject|1|||
164281102|NCT00699608|593400551|FG003|First Intervention|Withdrawal by Subject|0|||
164281103|NCT00699608|593400552|FG004|First Intervention|Withdrawal by Subject|0|||
164281104|NCT00699608|593400553|FG005|First Intervention|Withdrawal by Subject|0|||
164281105|NCT00699608|593400548|FG000|First Intervention|Protocol Violation|0|||
164281106|NCT00699608|593400549|FG001|First Intervention|Protocol Violation|0|||
164281107|NCT00699608|593400550|FG002|First Intervention|Protocol Violation|0|||
164281108|NCT00699608|593400551|FG003|First Intervention|Protocol Violation|0|||
164281109|NCT00699608|593400552|FG004|First Intervention|Protocol Violation|1|||
164281110|NCT00699608|593400553|FG005|First Intervention|Protocol Violation|0|||
164281111|NCT00699608|593400548|FG000|Second Intervention|Adverse Event|0|||
164281112|NCT00699608|593400549|FG001|Second Intervention|Adverse Event|0|||
164281113|NCT00699608|593400550|FG002|Second Intervention|Adverse Event|1|||
164281114|NCT00699608|593400551|FG003|Second Intervention|Adverse Event|0|||
164281115|NCT00699608|593400552|FG004|Second Intervention|Adverse Event|0|||
164281116|NCT00699608|593400553|FG005|Second Intervention|Adverse Event|0|||
164281117|NCT00699608|593400548|FG000|Second Intervention|Withdrawal by Subject|0|||
164281118|NCT00699608|593400549|FG001|Second Intervention|Withdrawal by Subject|0|||
164281119|NCT00699608|593400550|FG002|Second Intervention|Withdrawal by Subject|0|||
164281120|NCT00699608|593400551|FG003|Second Intervention|Withdrawal by Subject|1|||
164281121|NCT00699608|593400552|FG004|Second Intervention|Withdrawal by Subject|0|||
164281122|NCT00699608|593400553|FG005|Second Intervention|Withdrawal by Subject|0|||
164281123|NCT04306510|593400558|FG000|Overall Study|Voluntarily withdrawal|1|||
164281124|NCT04306510|593400558|FG000|Overall Study|Enrolled but Not Treated|1|||
164281125|NCT04720417|593400559|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
164281126|NCT03329092|593400560|FG000|Overall Study|Other|2|||
164281127|NCT03329092|593400561|FG001|Overall Study|Other|2|||
164281128|NCT03329092|593400560|FG000|Overall Study|Withdrawal by Subject|16|||
164281129|NCT03329092|593400561|FG001|Overall Study|Withdrawal by Subject|3|||
164281130|NCT03329092|593400560|FG000|Overall Study|Physician Decision|1|||
163895437|NCT00887198|591990999|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
163895438|NCT00887198|591991000|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
163895439|NCT00887198|591990998|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
164086008|NCT01022112|592678627|FG000|Overall Study|Physician Decision|0|||
164281131|NCT03329092|593400561|FG001|Overall Study|Physician Decision|0|||
164281132|NCT03329092|593400560|FG000|Overall Study|Death|17|||
164281133|NCT03329092|593400561|FG001|Overall Study|Death|11|||
164281134|NCT03329092|593400560|FG000|Overall Study|Adverse Event|3|||
164281135|NCT03329092|593400561|FG001|Overall Study|Adverse Event|1|||
164281136|NCT03329092|593400560|FG000|Overall Study|Lost to Follow-up|1|||
164281137|NCT03329092|593400561|FG001|Overall Study|Lost to Follow-up|1|||
164281138|NCT04878211|593400562|FG000|Overall Study|Lost to Follow-up|0|||
164281139|NCT04878211|593400563|FG001|Overall Study|Lost to Follow-up|0|||
164281140|NCT04878211|593400564|FG002|Overall Study|Lost to Follow-up|0|||
164281141|NCT04878211|593400565|FG003|Overall Study|Lost to Follow-up|1|||
164281142|NCT04878211|593400566|FG004|Overall Study|Lost to Follow-up|0|||
164281143|NCT04878211|593400567|FG005|Overall Study|Lost to Follow-up|1|||
164281144|NCT04878211|593400562|FG000|Overall Study|Protocol deviation|1|||
164281145|NCT04878211|593400563|FG001|Overall Study|Protocol deviation|0|||
164281146|NCT04878211|593400564|FG002|Overall Study|Protocol deviation|0|||
164281147|NCT04878211|593400565|FG003|Overall Study|Protocol deviation|0|||
164281148|NCT04878211|593400566|FG004|Overall Study|Protocol deviation|0|||
164281149|NCT04878211|593400567|FG005|Overall Study|Protocol deviation|0|||
164281150|NCT04878211|593400562|FG000|Overall Study|Study terminated by sponsor|0|||
164281151|NCT04878211|593400563|FG001|Overall Study|Study terminated by sponsor|0|||
164281152|NCT04878211|593400564|FG002|Overall Study|Study terminated by sponsor|0|||
164281153|NCT04878211|593400565|FG003|Overall Study|Study terminated by sponsor|0|||
164281154|NCT04878211|593400566|FG004|Overall Study|Study terminated by sponsor|9|||
164281155|NCT04878211|593400567|FG005|Overall Study|Study terminated by sponsor|4|||
164281156|NCT04878211|593400562|FG000|Overall Study|Subject decision|0|||
164281157|NCT04878211|593400563|FG001|Overall Study|Subject decision|0|||
164281158|NCT04878211|593400564|FG002|Overall Study|Subject decision|0|||
164281159|NCT04878211|593400565|FG003|Overall Study|Subject decision|0|||
164281160|NCT04878211|593400566|FG004|Overall Study|Subject decision|1|||
164281161|NCT04878211|593400567|FG005|Overall Study|Subject decision|0|||
164281162|NCT03574779|593400568|FG000|Overall Study|Screening failure|13|||
164281163|NCT03574779|593400569|FG001|Overall Study|Screening failure|83|||
163895440|NCT00887198|591990999|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
164281164|NCT00856544|593400570|FG000|Overall Study|Randomized but not treated|3|||
164281165|NCT00856544|593400571|FG001|Overall Study|Randomized but not treated|0|||
164281166|NCT00856544|593400572|FG002|Overall Study|Randomized but not treated|0|||
164344334|NCT03766581|593636922|FG001|Randomization|Participant no longer meets study criteria|3|||
164344335|NCT03766581|593636923|FG002|Randomization|Participant no longer meets study criteria|4|||
164344336|NCT03766581|593636924|FG003|Randomization|Participant no longer meets study criteria|0|||
164344337|NCT03766581|593636925|FG004|Randomization|Participant no longer meets study criteria|2|||
164344338|NCT03766581|593636926|FG005|Randomization|Participant no longer meets study criteria|3|||
164344339|NCT03766581|593636927|FG006|Randomization|Participant no longer meets study criteria|0|||
164344340|NCT03766581|593636928|FG007|Randomization|Participant no longer meets study criteria|1|||
164344341|NCT03766581|593636921|FG000|Randomization|Participant request to discontinue study treatment|1|||
164344342|NCT03766581|593636922|FG001|Randomization|Participant request to discontinue study treatment|0|||
164344343|NCT03766581|593636923|FG002|Randomization|Participant request to discontinue study treatment|0|||
164344344|NCT03766581|593636924|FG003|Randomization|Participant request to discontinue study treatment|0|||
164344345|NCT03766581|593636925|FG004|Randomization|Participant request to discontinue study treatment|1|||
164344346|NCT03766581|593636926|FG005|Randomization|Participant request to discontinue study treatment|2|||
164344347|NCT03766581|593636927|FG006|Randomization|Participant request to discontinue study treatment|0|||
164344348|NCT03766581|593636928|FG007|Randomization|Participant request to discontinue study treatment|0|||
164344349|NCT03766581|593636921|FG000|Randomization|Participant withdrew consent|1|||
164344350|NCT03766581|593636922|FG001|Randomization|Participant withdrew consent|0|||
163895441|NCT00887198|591991000|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
164344351|NCT03766581|593636923|FG002|Randomization|Participant withdrew consent|1|||
163895442|NCT00887198|591990998|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
163895443|NCT00887198|591990999|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
163895444|NCT00887198|591991000|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
163895445|NCT00887198|591990998|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
163895446|NCT00887198|591990999|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
163895447|NCT00887198|591991000|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
163895448|NCT00887198|591990998|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
163895449|NCT00887198|591990999|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
163895450|NCT00887198|591991000|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
163895451|NCT00887198|591990998|FG000|Cross Over (Placebo to AA)|Other|0|||
163895452|NCT00887198|591990999|FG001|Cross Over (Placebo to AA)|Other|0|||
164281167|NCT00856544|593400573|FG003|Overall Study|Randomized but not treated|0|||
164281168|NCT00856544|593400570|FG000|Overall Study|Death|0|||
164281169|NCT00856544|593400571|FG001|Overall Study|Death|2|||
164281170|NCT00856544|593400572|FG002|Overall Study|Death|0|||
164281171|NCT00856544|593400573|FG003|Overall Study|Death|0|||
164281172|NCT00856544|593400570|FG000|Overall Study|Adverse Event|20|||
164281173|NCT00856544|593400571|FG001|Overall Study|Adverse Event|29|||
164281174|NCT00856544|593400572|FG002|Overall Study|Adverse Event|2|||
164281175|NCT00856544|593400573|FG003|Overall Study|Adverse Event|3|||
164281176|NCT00856544|593400570|FG000|Overall Study|Lack of Efficacy|16|||
164281177|NCT00856544|593400571|FG001|Overall Study|Lack of Efficacy|12|||
164281178|NCT00856544|593400572|FG002|Overall Study|Lack of Efficacy|3|||
164281179|NCT00856544|593400573|FG003|Overall Study|Lack of Efficacy|3|||
164281180|NCT00856544|593400570|FG000|Overall Study|Other|9|||
164281181|NCT00856544|593400571|FG001|Overall Study|Other|16|||
164281182|NCT00856544|593400572|FG002|Overall Study|Other|1|||
164281183|NCT00856544|593400573|FG003|Overall Study|Other|6|||
164281184|NCT00856544|593400570|FG000|Overall Study|Lost to Follow-up|1|||
164281185|NCT00856544|593400571|FG001|Overall Study|Lost to Follow-up|2|||
164281186|NCT00856544|593400572|FG002|Overall Study|Lost to Follow-up|2|||
164281187|NCT00856544|593400573|FG003|Overall Study|Lost to Follow-up|0|||
164281188|NCT00856544|593400570|FG000|Overall Study|Withdrawal by Subject|8|||
164281189|NCT00856544|593400571|FG001|Overall Study|Withdrawal by Subject|5|||
164281190|NCT00856544|593400572|FG002|Overall Study|Withdrawal by Subject|0|||
164281191|NCT00856544|593400573|FG003|Overall Study|Withdrawal by Subject|1|||
164281192|NCT03755882|593400574|FG000|Period 1|Protocol Violation|1|||
164281193|NCT03755882|593400575|FG001|Period 1|Protocol Violation|0|||
164281194|NCT03755882|593400574|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
164281195|NCT03755882|593400575|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
164281196|NCT00377858|593400582|FG000|Overall Study|Withdrawal by Subject|12|||
164281197|NCT00377858|593400583|FG001|Overall Study|Withdrawal by Subject|11|||
164281198|NCT00377858|593400582|FG000|Overall Study|Lost to Follow-up|6|||
164281199|NCT00377858|593400583|FG001|Overall Study|Lost to Follow-up|1|||
164281200|NCT00377858|593400582|FG000|Overall Study|Physician Decision|5|||
164281201|NCT00377858|593400583|FG001|Overall Study|Physician Decision|5|||
164281202|NCT00377858|593400582|FG000|Overall Study|Protocol Violation|3|||
164281203|NCT00377858|593400583|FG001|Overall Study|Protocol Violation|4|||
164281204|NCT00377858|593400582|FG000|Overall Study|Adverse Event|2|||
164281205|NCT00377858|593400583|FG001|Overall Study|Adverse Event|1|||
164281206|NCT00377858|593400582|FG000|Overall Study|Entry Criteria Not Met|2|||
164281207|NCT00377858|593400583|FG001|Overall Study|Entry Criteria Not Met|0|||
164281208|NCT00377858|593400582|FG000|Overall Study|Sponsor Decision|1|||
164281209|NCT00377858|593400583|FG001|Overall Study|Sponsor Decision|2|||
164281210|NCT00377858|593400582|FG000|Overall Study|Death|0|||
164281211|NCT00377858|593400583|FG001|Overall Study|Death|3|||
164281212|NCT02506192|593400584|FG000|Overall Study|Withdrawal by Subject|1|||
164281213|NCT02506192|593400585|FG001|Overall Study|Withdrawal by Subject|1|||
164281214|NCT04042909|593400586|FG000|Overall Study|Withdrawal by Subject|1|||
164281215|NCT04042909|593400587|FG001|Overall Study|Withdrawal by Subject|0|||
164281216|NCT04042909|593400588|FG002|Overall Study|Withdrawal by Subject|0|||
164281217|NCT04042909|593400586|FG000|Overall Study|duplicate cases|2|||
164281218|NCT04042909|593400587|FG001|Overall Study|duplicate cases|0|||
164281219|NCT04042909|593400588|FG002|Overall Study|duplicate cases|0|||
164281220|NCT04042909|593400586|FG000|Overall Study|technical problem|0|||
164281221|NCT04042909|593400587|FG001|Overall Study|technical problem|1|||
164281222|NCT04042909|593400588|FG002|Overall Study|technical problem|0|||
164281223|NCT06312592|593400589|FG000|Overall Study|Lost to Follow-up|29|||
164281224|NCT06312592|593400590|FG001|Overall Study|Lost to Follow-up|13|||
164281225|NCT03785405|593400591|FG000|Overall Study|Adverse Event|16|||
164281226|NCT03785405|593400592|FG001|Overall Study|Adverse Event|1|||
164281227|NCT03785405|593400591|FG000|Overall Study|Death|6|||
164281228|NCT03785405|593400592|FG001|Overall Study|Death|4|||
164281229|NCT03785405|593400591|FG000|Overall Study|Guardian decision|4|||
164281230|NCT03785405|593400592|FG001|Overall Study|Guardian decision|1|||
164281231|NCT03785405|593400591|FG000|Overall Study|Lost to Follow-up|1|||
164281232|NCT03785405|593400592|FG001|Overall Study|Lost to Follow-up|0|||
164281233|NCT03785405|593400591|FG000|Overall Study|Physician Decision|8|||
164281234|NCT03785405|593400592|FG001|Overall Study|Physician Decision|5|||
164281235|NCT03785405|593400591|FG000|Overall Study|Participant decision|2|||
164281236|NCT03785405|593400592|FG001|Overall Study|Participant decision|0|||
164281237|NCT03785405|593400591|FG000|Overall Study|Other|1|||
164281238|NCT03785405|593400592|FG001|Overall Study|Other|0|||
164281239|NCT03785405|593400591|FG000|Overall Study|No treatment was received|0|||
164281240|NCT03785405|593400592|FG001|Overall Study|No treatment was received|1|||
164281241|NCT03705559|593400593|FG000|Overall Study|COVID Shut down|1|||
164281242|NCT01147055|593400594|FG000|First Intervention Period|Lost to Follow-up|1|||
164281243|NCT01147055|593400595|FG001|First Intervention Period|Lost to Follow-up|0|||
164281244|NCT03724890|593400596|FG000|Overall Study|Death|2|||
164281245|NCT03724890|593400597|FG001|Overall Study|Death|6|||
164281246|NCT03724890|593400598|FG002|Overall Study|Death|3|||
164281247|NCT03724890|593400599|FG003|Overall Study|Death|5|||
164281248|NCT03724890|593400600|FG004|Overall Study|Death|2|||
164281249|NCT03724890|593400601|FG005|Overall Study|Death|0|||
164281250|NCT03724890|593400602|FG006|Overall Study|Death|2|||
164281251|NCT03724890|593400603|FG007|Overall Study|Death|3|||
164281252|NCT03724890|593400604|FG008|Overall Study|Death|4|||
163895453|NCT00887198|591991000|FG002|Cross Over (Placebo to AA)|Other|19|||
163895454|NCT02782676|591991001|FG000|Overall Study|Lost to Follow-up|0|||
163895455|NCT02782676|591991002|FG001|Overall Study|Lost to Follow-up|1|||
163895456|NCT05830799|591991003|FG000|Overall Study|Withdrawal by Subject|1|||
163895457|NCT04631016|591991007|FG000|Overall Study|Adverse Event|3|||
163895458|NCT04631016|591991008|FG001|Overall Study|Adverse Event|0|||
163895459|NCT04631016|591991007|FG000|Overall Study|Withdrawal by Subject|5|||
163895460|NCT04631016|591991008|FG001|Overall Study|Withdrawal by Subject|4|||
163895461|NCT04631016|591991007|FG000|Overall Study|Reason unspecified|1|||
163895462|NCT04631016|591991008|FG001|Overall Study|Reason unspecified|0|||
163895463|NCT04631016|591991007|FG000|Overall Study|Failure to meet randomization criteria|2|||
163895464|NCT04631016|591991008|FG001|Overall Study|Failure to meet randomization criteria|1|||
163895465|NCT05205161|591991009|FG000|Overall Study|Study terminated by sponsor|3|||
163895466|NCT05205161|591991010|FG001|Overall Study|Study terminated by sponsor|3|||
163895467|NCT05205161|591991011|FG002|Overall Study|Study terminated by sponsor|1|||
163895468|NCT04707768|591991016|FG000|Overall Study|Adverse Event|9|||
163895469|NCT04707768|591991017|FG001|Overall Study|Adverse Event|18|||
163895470|NCT04707768|591991018|FG002|Overall Study|Adverse Event|3|||
163895471|NCT04707768|591991016|FG000|Overall Study|Investigator's Discretion|8|||
163895472|NCT04707768|591991017|FG001|Overall Study|Investigator's Discretion|4|||
164281253|NCT03724890|593400605|FG009|Overall Study|Death|2|||
164281254|NCT03724890|593400606|FG010|Overall Study|Death|2|||
164281255|NCT03724890|593400596|FG000|Overall Study|Lost to Follow-up|0|||
164281256|NCT03724890|593400597|FG001|Overall Study|Lost to Follow-up|3|||
164281257|NCT03724890|593400598|FG002|Overall Study|Lost to Follow-up|0|||
164281258|NCT03724890|593400599|FG003|Overall Study|Lost to Follow-up|1|||
164281259|NCT03724890|593400600|FG004|Overall Study|Lost to Follow-up|2|||
164281260|NCT03724890|593400601|FG005|Overall Study|Lost to Follow-up|2|||
164281261|NCT03724890|593400602|FG006|Overall Study|Lost to Follow-up|1|||
164281262|NCT03724890|593400603|FG007|Overall Study|Lost to Follow-up|0|||
164281263|NCT03724890|593400604|FG008|Overall Study|Lost to Follow-up|2|||
164281264|NCT03724890|593400605|FG009|Overall Study|Lost to Follow-up|0|||
164281265|NCT03724890|593400606|FG010|Overall Study|Lost to Follow-up|0|||
164281266|NCT03724890|593400596|FG000|Overall Study|Withdrawal by Subject|1|||
164281267|NCT03724890|593400597|FG001|Overall Study|Withdrawal by Subject|2|||
163895473|NCT04707768|591991018|FG002|Overall Study|Investigator's Discretion|3|||
163895474|NCT04707768|591991016|FG000|Overall Study|Withdrawal by Subject|6|||
163895475|NCT04707768|591991017|FG001|Overall Study|Withdrawal by Subject|8|||
163895476|NCT04707768|591991018|FG002|Overall Study|Withdrawal by Subject|2|||
163895477|NCT04707768|591991016|FG000|Overall Study|Lack of Efficacy|1|||
163895478|NCT04707768|591991017|FG001|Overall Study|Lack of Efficacy|3|||
163895479|NCT04707768|591991018|FG002|Overall Study|Lack of Efficacy|0|||
163895480|NCT04707768|591991016|FG000|Overall Study|Lost to Follow-up|0|||
163895481|NCT04707768|591991017|FG001|Overall Study|Lost to Follow-up|0|||
163895482|NCT04707768|591991018|FG002|Overall Study|Lost to Follow-up|3|||
163895483|NCT04707768|591991016|FG000|Overall Study|Death|13|||
163895484|NCT04707768|591991017|FG001|Overall Study|Death|11|||
163895485|NCT04707768|591991018|FG002|Overall Study|Death|13|||
163895486|NCT04707768|591991016|FG000|Overall Study|Protocol Violation|2|||
163895487|NCT04707768|591991017|FG001|Overall Study|Protocol Violation|1|||
163895488|NCT04707768|591991018|FG002|Overall Study|Protocol Violation|0|||
163895489|NCT04707768|591991016|FG000|Overall Study|Non Compliance with Study Drug|1|||
163895490|NCT04707768|591991017|FG001|Overall Study|Non Compliance with Study Drug|0|||
164281268|NCT03724890|593400598|FG002|Overall Study|Withdrawal by Subject|1|||
164281269|NCT03724890|593400599|FG003|Overall Study|Withdrawal by Subject|0|||
163895491|NCT04707768|591991018|FG002|Overall Study|Non Compliance with Study Drug|0|||
163895492|NCT04707768|591991016|FG000|Overall Study|Transplant|4|||
163895493|NCT04707768|591991017|FG001|Overall Study|Transplant|4|||
163895494|NCT04707768|591991018|FG002|Overall Study|Transplant|8|||
164281270|NCT03724890|593400600|FG004|Overall Study|Withdrawal by Subject|0|||
164281271|NCT03724890|593400601|FG005|Overall Study|Withdrawal by Subject|1|||
164281272|NCT03724890|593400602|FG006|Overall Study|Withdrawal by Subject|0|||
164281273|NCT03724890|593400603|FG007|Overall Study|Withdrawal by Subject|0|||
164281274|NCT03724890|593400604|FG008|Overall Study|Withdrawal by Subject|2|||
163895495|NCT04707768|591991016|FG000|Overall Study|Other|9|||
163895496|NCT04707768|591991017|FG001|Overall Study|Other|5|||
163895497|NCT04707768|591991018|FG002|Overall Study|Other|2|||
163895498|NCT04490109|591991019|FG000|Overall Study|Lost to Follow-up|3|||
164281275|NCT03724890|593400605|FG009|Overall Study|Withdrawal by Subject|2|||
164281276|NCT03724890|593400606|FG010|Overall Study|Withdrawal by Subject|1|||
164281277|NCT03724890|593400596|FG000|Overall Study|Other|1|||
164281278|NCT03724890|593400597|FG001|Overall Study|Other|0|||
164281279|NCT03724890|593400598|FG002|Overall Study|Other|0|||
164281280|NCT03724890|593400599|FG003|Overall Study|Other|0|||
164281281|NCT03724890|593400600|FG004|Overall Study|Other|0|||
164281282|NCT03724890|593400601|FG005|Overall Study|Other|0|||
164281283|NCT03724890|593400602|FG006|Overall Study|Other|0|||
164281284|NCT03724890|593400603|FG007|Overall Study|Other|1|||
164281285|NCT03724890|593400604|FG008|Overall Study|Other|1|||
164281286|NCT03724890|593400605|FG009|Overall Study|Other|0|||
164281287|NCT03724890|593400606|FG010|Overall Study|Other|2|||
164281288|NCT02362464|593400608|FG000|Overall Study|Switched to alternative therapy|1|||
164281289|NCT02362464|593400608|FG000|Overall Study|Refused further treatment|1|||
164281290|NCT02362464|593400608|FG000|Overall Study|Physician Decision|4|||
164281291|NCT02123823|593400609|FG000|Overall Study|Lack of Efficacy|0|||
164281292|NCT02123823|593400610|FG001|Overall Study|Lack of Efficacy|2|||
164281293|NCT02123823|593400611|FG002|Overall Study|Lack of Efficacy|8|||
164281294|NCT02123823|593400612|FG003|Overall Study|Lack of Efficacy|10|||
164281295|NCT02123823|593400609|FG000|Overall Study|Progressive disease|3|||
164281296|NCT02123823|593400610|FG001|Overall Study|Progressive disease|19|||
164281297|NCT02123823|593400611|FG002|Overall Study|Progressive disease|52|||
164281298|NCT02123823|593400612|FG003|Overall Study|Progressive disease|53|||
164281299|NCT02123823|593400609|FG000|Overall Study|Withdrawal by Subject|0|||
164281300|NCT02123823|593400610|FG001|Overall Study|Withdrawal by Subject|0|||
164281301|NCT02123823|593400611|FG002|Overall Study|Withdrawal by Subject|7|||
164281302|NCT02123823|593400612|FG003|Overall Study|Withdrawal by Subject|2|||
164281303|NCT02123823|593400609|FG000|Overall Study|Adverse Event|0|||
164281304|NCT02123823|593400610|FG001|Overall Study|Adverse Event|0|||
164281305|NCT02123823|593400611|FG002|Overall Study|Adverse Event|3|||
164281306|NCT02123823|593400612|FG003|Overall Study|Adverse Event|5|||
164281307|NCT01635855|593400647|FG000|Overall Study|Withdrawal by Subject|4|||
164281308|NCT02104947|593400650|FG000|Overall Study|Withdrawal by Subject|10|||
164281309|NCT02104947|593400651|FG001|Overall Study|Withdrawal by Subject|3|||
164281310|NCT02104947|593400650|FG000|Overall Study|Lost to Follow-up|4|||
164281311|NCT02104947|593400651|FG001|Overall Study|Lost to Follow-up|4|||
164281312|NCT02104947|593400650|FG000|Overall Study|Protocol Violation|6|||
164281313|NCT02104947|593400651|FG001|Overall Study|Protocol Violation|8|||
164281314|NCT02104947|593400650|FG000|Overall Study|Adverse Event|57|||
164281315|NCT02104947|593400651|FG001|Overall Study|Adverse Event|38|||
164281316|NCT02104947|593400650|FG000|Overall Study|Other than stated above|2|||
164281317|NCT02104947|593400651|FG001|Overall Study|Other than stated above|3|||
164281318|NCT01844778|593400652|FG000|Overall Study|Protocol deviation|0|||
163895499|NCT04490109|591991020|FG001|Overall Study|Lost to Follow-up|10|||
163895500|NCT04490109|591991021|FG002|Overall Study|Lost to Follow-up|4|||
163895501|NCT04490109|591991019|FG000|Overall Study|Withdrawal by Subject|8|||
163895502|NCT04490109|591991020|FG001|Overall Study|Withdrawal by Subject|6|||
163895503|NCT04490109|591991021|FG002|Overall Study|Withdrawal by Subject|9|||
163895504|NCT04490109|591991019|FG000|Overall Study|Physician Decision|0|||
163895505|NCT04490109|591991020|FG001|Overall Study|Physician Decision|2|||
163895506|NCT04490109|591991021|FG002|Overall Study|Physician Decision|3|||
163895507|NCT04490109|591991019|FG000|Overall Study|Adverse Event|2|||
163895508|NCT04490109|591991020|FG001|Overall Study|Adverse Event|1|||
163895509|NCT04490109|591991021|FG002|Overall Study|Adverse Event|0|||
163895510|NCT04490109|591991019|FG000|Overall Study|Significant Non-Compliance|2|||
163895511|NCT04490109|591991020|FG001|Overall Study|Significant Non-Compliance|4|||
163895512|NCT04490109|591991021|FG002|Overall Study|Significant Non-Compliance|4|||
163895513|NCT04490109|591991019|FG000|Overall Study|Significant Clinical Event|0|||
163895514|NCT04490109|591991020|FG001|Overall Study|Significant Clinical Event|1|||
163895515|NCT04490109|591991021|FG002|Overall Study|Significant Clinical Event|0|||
163895516|NCT04490109|591991019|FG000|Overall Study|Other Reason|4|||
163895517|NCT04490109|591991020|FG001|Overall Study|Other Reason|1|||
163895518|NCT04490109|591991021|FG002|Overall Study|Other Reason|1|||
163895519|NCT04163991|591991022|FG000|Overall Study|Adverse Event|0|||
163895520|NCT04163991|591991023|FG001|Overall Study|Adverse Event|0|||
163895521|NCT04163991|591991024|FG002|Overall Study|Adverse Event|0|||
164281319|NCT01844778|593400653|FG001|Overall Study|Protocol deviation|1|||
164281320|NCT01844778|593400654|FG002|Overall Study|Protocol deviation|2|||
163895522|NCT04163991|591991025|FG003|Overall Study|Adverse Event|1|||
163895523|NCT04163991|591991026|FG004|Overall Study|Adverse Event|0|||
163895524|NCT04163991|591991022|FG000|Overall Study|Death|0|||
163895525|NCT04163991|591991023|FG001|Overall Study|Death|0|||
163895526|NCT04163991|591991024|FG002|Overall Study|Death|1|||
163895527|NCT04163991|591991025|FG003|Overall Study|Death|0|||
164086009|NCT01022112|592678628|FG001|Overall Study|Physician Decision|0|||
164281321|NCT01844778|593400652|FG000|Overall Study|Withdrawal by Subject|2|||
164281322|NCT01844778|593400653|FG001|Overall Study|Withdrawal by Subject|0|||
164281323|NCT01844778|593400654|FG002|Overall Study|Withdrawal by Subject|0|||
164281324|NCT01844778|593400652|FG000|Overall Study|Adverse Event|0|||
164281325|NCT01844778|593400653|FG001|Overall Study|Adverse Event|2|||
164001506|NCT02886715|592368547|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164001507|NCT02886715|592368545|FG000|Overall Study|Adverse Event|4|||
164001508|NCT02886715|592368546|FG001|Overall Study|Adverse Event|2|||
164001509|NCT02886715|592368547|FG002|Overall Study|Adverse Event|0|||
164001510|NCT02886715|592368545|FG000|Overall Study|Lack of Efficacy|0|||
164001511|NCT02886715|592368546|FG001|Overall Study|Lack of Efficacy|2|||
164001512|NCT02886715|592368547|FG002|Overall Study|Lack of Efficacy|1|||
164001513|NCT02886715|592368545|FG000|Overall Study|Lost to Follow-up|29|||
163895528|NCT04163991|591991026|FG004|Overall Study|Death|0|||
163895529|NCT04163991|591991022|FG000|Overall Study|Lost to Follow-up|0|||
163895530|NCT04163991|591991023|FG001|Overall Study|Lost to Follow-up|1|||
164344352|NCT03766581|593636924|FG003|Randomization|Participant withdrew consent|2|||
163895531|NCT04163991|591991024|FG002|Overall Study|Lost to Follow-up|0|||
163895532|NCT04163991|591991025|FG003|Overall Study|Lost to Follow-up|0|||
163895533|NCT04163991|591991026|FG004|Overall Study|Lost to Follow-up|0|||
163895534|NCT04163991|591991022|FG000|Overall Study|Withdrawal by Subject|1|||
163895535|NCT04163991|591991023|FG001|Overall Study|Withdrawal by Subject|1|||
163895536|NCT04163991|591991024|FG002|Overall Study|Withdrawal by Subject|3|||
163895537|NCT04163991|591991025|FG003|Overall Study|Withdrawal by Subject|1|||
163895538|NCT04163991|591991026|FG004|Overall Study|Withdrawal by Subject|1|||
163895539|NCT04163991|591991022|FG000|Overall Study|Other, Not Specified|0|||
163895540|NCT04163991|591991023|FG001|Overall Study|Other, Not Specified|1|||
163895541|NCT04163991|591991024|FG002|Overall Study|Other, Not Specified|1|||
164344353|NCT03766581|593636925|FG004|Randomization|Participant withdrew consent|1|||
164344354|NCT03766581|593636926|FG005|Randomization|Participant withdrew consent|1|||
164344355|NCT03766581|593636927|FG006|Randomization|Participant withdrew consent|0|||
164344356|NCT03766581|593636928|FG007|Randomization|Participant withdrew consent|0|||
164344357|NCT03766581|593636921|FG000|Treatment|Adverse Event|82|||
164344358|NCT03766581|593636922|FG001|Treatment|Adverse Event|44|||
164344359|NCT03766581|593636923|FG002|Treatment|Adverse Event|47|||
164344360|NCT03766581|593636924|FG003|Treatment|Adverse Event|46|||
164344361|NCT03766581|593636925|FG004|Treatment|Adverse Event|50|||
164344362|NCT03766581|593636926|FG005|Treatment|Adverse Event|77|||
164344363|NCT03766581|593636927|FG006|Treatment|Adverse Event|5|||
164001514|NCT02886715|592368546|FG001|Overall Study|Lost to Follow-up|26|||
164001515|NCT02886715|592368547|FG002|Overall Study|Lost to Follow-up|10|||
163895542|NCT04163991|591991025|FG003|Overall Study|Other, Not Specified|1|||
164344364|NCT03766581|593636928|FG007|Treatment|Adverse Event|2|||
164001516|NCT02886715|592368545|FG000|Overall Study|Pregnancy|1|||
164344365|NCT03766581|593636921|FG000|Treatment|Participant request to discontinue treatment|34|||
163895543|NCT04163991|591991026|FG004|Overall Study|Other, Not Specified|0|||
163895544|NCT05953740|591991027|FG000|Period 1|Physician Decision|0|||
163895545|NCT05953740|591991028|FG001|Period 1|Physician Decision|1|||
164001517|NCT02886715|592368546|FG001|Overall Study|Pregnancy|1|||
164001518|NCT02886715|592368547|FG002|Overall Study|Pregnancy|1|||
164001519|NCT02886715|592368545|FG000|Overall Study|Protocol Violation|3|||
163895546|NCT05953740|591991029|FG002|Period 1|Physician Decision|0|||
163895547|NCT05953740|591991030|FG003|Period 1|Physician Decision|0|||
163895548|NCT05953740|591991031|FG004|Period 1|Physician Decision|0|||
163895549|NCT05953740|591991032|FG005|Period 1|Physician Decision|0|||
163895550|NCT05953740|591991033|FG006|Period 1|Physician Decision|0|||
163895551|NCT05953740|591991034|FG007|Period 1|Physician Decision|0|||
163895552|NCT05953740|591991027|FG000|Period 2|Withdrawal by Subject|0|||
163895553|NCT05953740|591991028|FG001|Period 2|Withdrawal by Subject|1|||
163895554|NCT05953740|591991029|FG002|Period 2|Withdrawal by Subject|1|||
163895555|NCT05953740|591991030|FG003|Period 2|Withdrawal by Subject|0|||
163895556|NCT05953740|591991031|FG004|Period 2|Withdrawal by Subject|0|||
163895557|NCT05953740|591991032|FG005|Period 2|Withdrawal by Subject|0|||
163895558|NCT05953740|591991033|FG006|Period 2|Withdrawal by Subject|0|||
163895559|NCT05953740|591991034|FG007|Period 2|Withdrawal by Subject|0|||
163895560|NCT05541484|591991037|FG000|Overall Study|Withdrawal by Subject|1|||
164344366|NCT03766581|593636922|FG001|Treatment|Participant request to discontinue treatment|6|||
164344367|NCT03766581|593636923|FG002|Treatment|Participant request to discontinue treatment|10|||
164344368|NCT03766581|593636924|FG003|Treatment|Participant request to discontinue treatment|10|||
164344369|NCT03766581|593636925|FG004|Treatment|Participant request to discontinue treatment|14|||
164344370|NCT03766581|593636926|FG005|Treatment|Participant request to discontinue treatment|15|||
163895561|NCT05541484|591991038|FG001|Overall Study|Withdrawal by Subject|0|||
163895562|NCT00626795|591991043|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
163895563|NCT00626795|591991044|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
163895564|NCT00626795|591991045|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
163895565|NCT00626795|591991043|FG000|Blinded Treatment|Lack of Efficacy|2|||
164086010|NCT01022112|592678629|FG002|Overall Study|Physician Decision|1|||
164086011|NCT01022112|592678630|FG003|Overall Study|Physician Decision|0|||
164086012|NCT01022112|592678631|FG004|Overall Study|Physician Decision|1|||
164086013|NCT01022112|592678627|FG000|Overall Study|Withdrawal by Subject|0|||
164086014|NCT01022112|592678628|FG001|Overall Study|Withdrawal by Subject|1|||
164086015|NCT01022112|592678629|FG002|Overall Study|Withdrawal by Subject|2|||
164086016|NCT01022112|592678630|FG003|Overall Study|Withdrawal by Subject|2|||
164086017|NCT01022112|592678631|FG004|Overall Study|Withdrawal by Subject|1|||
164086018|NCT01022112|592678627|FG000|Overall Study|Fasting plasma glucose level increased|1|||
164086019|NCT01022112|592678628|FG001|Overall Study|Fasting plasma glucose level increased|0|||
164086020|NCT01022112|592678629|FG002|Overall Study|Fasting plasma glucose level increased|0|||
164086021|NCT01022112|592678630|FG003|Overall Study|Fasting plasma glucose level increased|0|||
164086022|NCT01022112|592678631|FG004|Overall Study|Fasting plasma glucose level increased|7|||
164086023|NCT00289458|592678632|FG000|Overall Study|Death|1|||
164086024|NCT00289458|592678633|FG001|Overall Study|Death|0|||
164086025|NCT00289458|592678634|FG002|Overall Study|Death|0|||
164086026|NCT00289458|592678632|FG000|Overall Study|Physician Decision|3|||
164086027|NCT00289458|592678633|FG001|Overall Study|Physician Decision|4|||
164086028|NCT00289458|592678634|FG002|Overall Study|Physician Decision|2|||
164086029|NCT00289458|592678632|FG000|Overall Study|Withdrawal by Subject|2|||
164086030|NCT00289458|592678633|FG001|Overall Study|Withdrawal by Subject|2|||
164344371|NCT03766581|593636927|FG006|Treatment|Participant request to discontinue treatment|0|||
164344372|NCT03766581|593636928|FG007|Treatment|Participant request to discontinue treatment|1|||
164344373|NCT03766581|593636921|FG000|Treatment|Participant withdrew consent|11|||
164344374|NCT03766581|593636922|FG001|Treatment|Participant withdrew consent|4|||
164344375|NCT03766581|593636923|FG002|Treatment|Participant withdrew consent|5|||
164344376|NCT03766581|593636924|FG003|Treatment|Participant withdrew consent|5|||
164344377|NCT03766581|593636925|FG004|Treatment|Participant withdrew consent|4|||
164344378|NCT03766581|593636926|FG005|Treatment|Participant withdrew consent|4|||
164344379|NCT03766581|593636927|FG006|Treatment|Participant withdrew consent|0|||
164344380|NCT03766581|593636928|FG007|Treatment|Participant withdrew consent|0|||
164344381|NCT03766581|593636921|FG000|Treatment|Death|1|||
164344382|NCT03766581|593636922|FG001|Treatment|Death|0|||
164344383|NCT03766581|593636923|FG002|Treatment|Death|0|||
164344384|NCT03766581|593636924|FG003|Treatment|Death|0|||
164344385|NCT03766581|593636925|FG004|Treatment|Death|0|||
164344386|NCT03766581|593636926|FG005|Treatment|Death|0|||
164344387|NCT03766581|593636927|FG006|Treatment|Death|0|||
164344388|NCT03766581|593636928|FG007|Treatment|Death|0|||
164344389|NCT03766581|593636921|FG000|Treatment|Lost to Follow-up|1|||
164344390|NCT03766581|593636922|FG001|Treatment|Lost to Follow-up|0|||
163895566|NCT00626795|591991044|FG001|Blinded Treatment|Lack of Efficacy|0|||
164344391|NCT03766581|593636923|FG002|Treatment|Lost to Follow-up|0|||
164344392|NCT03766581|593636924|FG003|Treatment|Lost to Follow-up|1|||
164344393|NCT03766581|593636925|FG004|Treatment|Lost to Follow-up|0|||
164086031|NCT00289458|592678634|FG002|Overall Study|Withdrawal by Subject|4|||
164344394|NCT03766581|593636926|FG005|Treatment|Lost to Follow-up|0|||
164086032|NCT04274192|592678635|FG000|Overall Study|Protocol Violation|1|||
164344395|NCT03766581|593636927|FG006|Treatment|Lost to Follow-up|0|||
164344396|NCT03766581|593636928|FG007|Treatment|Lost to Follow-up|0|||
164344397|NCT03766581|593636921|FG000|Treatment|Poor/Non compliance|2|||
164344398|NCT03766581|593636922|FG001|Treatment|Poor/Non compliance|2|||
164344399|NCT03766581|593636923|FG002|Treatment|Poor/Non compliance|1|||
164281326|NCT01844778|593400654|FG002|Overall Study|Adverse Event|2|||
164281327|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
164281328|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281329|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164001520|NCT02886715|592368546|FG001|Overall Study|Protocol Violation|2|||
164281330|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281331|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164281332|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
164001521|NCT02886715|592368547|FG002|Overall Study|Protocol Violation|1|||
164281333|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
164281334|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164001522|NCT02886715|592368545|FG000|Overall Study|Withdrawal by Subject|20|||
164001523|NCT02886715|592368546|FG001|Overall Study|Withdrawal by Subject|18|||
164001524|NCT02886715|592368547|FG002|Overall Study|Withdrawal by Subject|5|||
164001525|NCT02886715|592368545|FG000|Overall Study|missing|7|||
164001526|NCT02886715|592368546|FG001|Overall Study|missing|2|||
164001527|NCT02886715|592368547|FG002|Overall Study|missing|2|||
164001528|NCT00503399|592368550|FG000|Overall Study|Death|2|||
164001529|NCT00503399|592368551|FG001|Overall Study|Death|1|||
164001530|NCT00503399|592368550|FG000|Overall Study|Protocol Violation|1|||
164001531|NCT00503399|592368551|FG001|Overall Study|Protocol Violation|0|||
164001532|NCT00503399|592368550|FG000|Overall Study|Withdrawal by Subject|4|||
164001533|NCT00503399|592368551|FG001|Overall Study|Withdrawal by Subject|2|||
164281335|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281336|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281337|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281338|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
164281339|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
164281340|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164281341|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163895567|NCT00626795|591991045|FG002|Blinded Treatment|Lack of Efficacy|0|||
163895568|NCT00626795|591991043|FG000|Blinded Treatment|Unacceptable adverse event|0|||
164281342|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164344400|NCT03766581|593636924|FG003|Treatment|Poor/Non compliance|1|||
164344401|NCT03766581|593636925|FG004|Treatment|Poor/Non compliance|1|||
164344402|NCT03766581|593636926|FG005|Treatment|Poor/Non compliance|1|||
163895569|NCT00626795|591991044|FG001|Blinded Treatment|Unacceptable adverse event|0|||
163895570|NCT00626795|591991045|FG002|Blinded Treatment|Unacceptable adverse event|1|||
163895571|NCT00626795|591991043|FG000|Blinded Treatment|Protocol Violation|0|||
163895572|NCT00626795|591991044|FG001|Blinded Treatment|Protocol Violation|1|||
163895573|NCT00626795|591991045|FG002|Blinded Treatment|Protocol Violation|1|||
163895574|NCT00626795|591991043|FG000|Blinded Treatment|Withdrawal by Subject|1|||
163895575|NCT00626795|591991044|FG001|Blinded Treatment|Withdrawal by Subject|1|||
163895576|NCT00626795|591991045|FG002|Blinded Treatment|Withdrawal by Subject|0|||
163895577|NCT00626795|591991043|FG000|Blinded Treatment|Other reasons|2|||
163895578|NCT00626795|591991044|FG001|Blinded Treatment|Other reasons|0|||
163895579|NCT00626795|591991045|FG002|Blinded Treatment|Other reasons|2|||
163895580|NCT00626795|591991043|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
164001534|NCT00503399|592368550|FG000|Overall Study|Adverse Event|0|||
164001535|NCT00503399|592368551|FG001|Overall Study|Adverse Event|3|||
164001536|NCT00503399|592368550|FG000|Overall Study|Lost to Follow-up|0|||
164001537|NCT00503399|592368551|FG001|Overall Study|Lost to Follow-up|2|||
164001538|NCT01676961|592368552|FG000|Overall Study|Death|3|||
164001539|NCT01676961|592368552|FG000|Overall Study|Lost to Follow-up|1|||
164001540|NCT01676961|592368552|FG000|Overall Study|Withdrawal by Subject|1|||
164001541|NCT05292755|592368555|FG000|Overall Study|Lost to Follow-up|5|||
164001542|NCT05292755|592368556|FG001|Overall Study|Lost to Follow-up|9|||
164001543|NCT04052139|592368560|FG000|Overall Study|Lost to Follow-up|2|||
164001544|NCT04052139|592368561|FG001|Overall Study|Lost to Follow-up|0|||
164001545|NCT04052139|592368562|FG002|Overall Study|Lost to Follow-up|0|||
164001546|NCT04052139|592368560|FG000|Overall Study|Withdrawal by Subject|1|||
164001547|NCT04052139|592368561|FG001|Overall Study|Withdrawal by Subject|0|||
164001548|NCT04052139|592368562|FG002|Overall Study|Withdrawal by Subject|0|||
164001549|NCT02499952|592368563|FG000|Overall Study|Lost to Follow-up|1|||
164001550|NCT02499952|592368563|FG000|Overall Study|Death|9|||
164001551|NCT00519077|592368564|FG000|Overall Study|Death|6|||
164001552|NCT00519077|592368564|FG000|Overall Study|Other|2|||
164001553|NCT02120417|592368566|FG000|Overall Study|Death|5|||
164001554|NCT02120417|592368567|FG001|Overall Study|Death|1|||
164001555|NCT02120417|592368566|FG000|Overall Study|Adverse Event|3|||
164001556|NCT02120417|592368567|FG001|Overall Study|Adverse Event|9|||
164001557|NCT02120417|592368566|FG000|Overall Study|Participant decision|4|||
164001558|NCT02120417|592368567|FG001|Overall Study|Participant decision|4|||
164001559|NCT02120417|592368566|FG000|Overall Study|Disease progression|41|||
164001560|NCT02120417|592368567|FG001|Overall Study|Disease progression|45|||
164001561|NCT02120417|592368566|FG000|Overall Study|Noncompliance with study treatment|0|||
164001562|NCT02120417|592368567|FG001|Overall Study|Noncompliance with study treatment|2|||
164001563|NCT02120417|592368566|FG000|Overall Study|Physician Decision|2|||
164001564|NCT02120417|592368567|FG001|Overall Study|Physician Decision|3|||
164001565|NCT02120417|592368566|FG000|Overall Study|Other unspecified|5|||
164001566|NCT02120417|592368567|FG001|Overall Study|Other unspecified|4|||
164001567|NCT00927485|592368568|FG000|Overall Study|Adverse Event|4|||
164001568|NCT00927485|592368569|FG001|Overall Study|Adverse Event|2|||
164001569|NCT00927485|592368568|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
164001570|NCT00927485|592368569|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
164001571|NCT01440101|592368570|FG000|Overall Study|Adverse Event|2|||
164001572|NCT01440101|592368571|FG001|Overall Study|Adverse Event|0|||
164001573|NCT01440101|592368572|FG002|Overall Study|Adverse Event|0|||
164001574|NCT01440101|592368570|FG000|Overall Study|Withdrawal by Subject|0|||
164001575|NCT01440101|592368571|FG001|Overall Study|Withdrawal by Subject|3|||
164001576|NCT01440101|592368572|FG002|Overall Study|Withdrawal by Subject|1|||
164001577|NCT01440101|592368570|FG000|Overall Study|Other|0|||
164001578|NCT01440101|592368571|FG001|Overall Study|Other|1|||
164001579|NCT01440101|592368572|FG002|Overall Study|Other|0|||
164001580|NCT02305563|592368576|FG000|Treatment Period|Disease progression|0|||
164001581|NCT02305563|592368577|FG001|Treatment Period|Disease progression|0|||
164001582|NCT02305563|592368578|FG002|Treatment Period|Disease progression|15|||
164001583|NCT02305563|592368579|FG003|Treatment Period|Disease progression|6|||
163895581|NCT00626795|591991044|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
163895582|NCT00626795|591991045|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
163895583|NCT04499521|591991049|FG000|Overall Study|Disease Progression|1|||
163895584|NCT04499521|591991050|FG001|Overall Study|Disease Progression|0|||
163895585|NCT04108130|591991913|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
163895586|NCT04108130|591991914|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
163895587|NCT04108130|591991913|FG000|Overall Study|Consent Withdrawn|9|||
163895588|NCT04108130|591991914|FG001|Overall Study|Consent Withdrawn|6|||
163895589|NCT04108130|591991913|FG000|Overall Study|Surgery Cancelled|4|||
163895590|NCT04108130|591991914|FG001|Overall Study|Surgery Cancelled|4|||
163895591|NCT04108130|591991913|FG000|Overall Study|Found Ineligible for Study|4|||
163895592|NCT04108130|591991914|FG001|Overall Study|Found Ineligible for Study|3|||
163895593|NCT04108130|591991913|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
163895594|NCT04108130|591991914|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
163895595|NCT04108130|591991913|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
163895596|NCT04108130|591991914|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
163895597|NCT05132400|591991915|FG000|Overall Study|Withdrawal by Subject|14|||
163895598|NCT05132400|591991916|FG001|Overall Study|Withdrawal by Subject|8|||
163895599|NCT05132400|591991915|FG000|Overall Study|Lost to Follow-up|132|||
163895600|NCT05132400|591991916|FG001|Overall Study|Lost to Follow-up|121|||
163895601|NCT03636490|591991919|FG000|Overall Study|Dropped out or incomplete data|141|||
163895602|NCT00739908|591991920|FG000|Overall Study|Adverse Event|5|||
163895603|NCT00739908|591991921|FG001|Overall Study|Adverse Event|6|||
163895604|NCT00739908|591991920|FG000|Overall Study|Withdrawal by Subject|4|||
163895605|NCT00739908|591991921|FG001|Overall Study|Withdrawal by Subject|2|||
163895606|NCT00739908|591991920|FG000|Overall Study|Lost to Follow-up|14|||
163895607|NCT00739908|591991921|FG001|Overall Study|Lost to Follow-up|9|||
163895608|NCT00739908|591991920|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
163895609|NCT00739908|591991921|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
163895610|NCT00739908|591991920|FG000|Overall Study|Non-Compliance With Study Medication|0|||
163895611|NCT00739908|591991921|FG001|Overall Study|Non-Compliance With Study Medication|3|||
163895612|NCT00739908|591991920|FG000|Overall Study|Lack of Efficacy|0|||
163895613|NCT00739908|591991921|FG001|Overall Study|Lack of Efficacy|1|||
163895614|NCT00739908|591991920|FG000|Overall Study|Relocation|0|||
163895615|NCT00739908|591991921|FG001|Overall Study|Relocation|1|||
163895616|NCT02076009|591991931|FG000|Overall Study|Death|172|||
163895617|NCT02076009|591991932|FG001|Overall Study|Death|153|||
163895618|NCT02076009|591991931|FG000|Overall Study|Withdrawal by Subject|16|||
163895619|NCT02076009|591991932|FG001|Overall Study|Withdrawal by Subject|12|||
163895620|NCT02076009|591991931|FG000|Overall Study|Lost to Follow-up|4|||
163895621|NCT02076009|591991932|FG001|Overall Study|Lost to Follow-up|2|||
163895622|NCT02076009|591991931|FG000|Overall Study|Progressive Disease|1|||
163895623|NCT02076009|591991932|FG001|Overall Study|Progressive Disease|0|||
163895624|NCT02076009|591991931|FG000|Overall Study|Physician Decision|0|||
163895625|NCT02076009|591991932|FG001|Overall Study|Physician Decision|1|||
163895626|NCT02076009|591991931|FG000|Overall Study|End of data collection|90|||
163895627|NCT02076009|591991932|FG001|Overall Study|End of data collection|118|||
163895628|NCT04165213|591991933|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
163895629|NCT04165213|591991934|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
163895630|NCT04165213|591991933|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
163895631|NCT04165213|591991934|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
163895632|NCT04165213|591991933|FG000|Clinician Enrollment|Termination from site|0|||
163895633|NCT04165213|591991934|FG001|Clinician Enrollment|Termination from site|1|||
163895634|NCT04165213|591991933|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
163895635|NCT04165213|591991934|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
163895636|NCT04165213|591991933|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
163895637|NCT04165213|591991934|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
163895638|NCT04165213|591991933|FG000|Caregiver Enrollment|Physician Decision|1|||
163895639|NCT04165213|591991934|FG001|Caregiver Enrollment|Physician Decision|0|||
163895640|NCT04165213|591991933|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
163895641|NCT04165213|591991934|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
163895642|NCT04165213|591991933|FG000|Caregiver Enrollment|PLWD death|2|||
163895643|NCT04165213|591991934|FG001|Caregiver Enrollment|PLWD death|0|||
163895644|NCT04165213|591991933|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
163895645|NCT04165213|591991934|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
163895646|NCT04165213|591991933|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
163895647|NCT04165213|591991934|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
163895648|NCT04165213|591991933|FG000|PLWD Enrollment|Lost to Follow-up|1|||
163895649|NCT04165213|591991934|FG001|PLWD Enrollment|Lost to Follow-up|1|||
163895650|NCT04165213|591991933|FG000|PLWD Enrollment|Physician Decision|1|||
163895651|NCT04165213|591991934|FG001|PLWD Enrollment|Physician Decision|0|||
163895652|NCT04165213|591991933|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
163895653|NCT04165213|591991934|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
163895654|NCT04165213|591991933|FG000|PLWD Enrollment|Death|2|||
163895655|NCT04165213|591991934|FG001|PLWD Enrollment|Death|0|||
163895656|NCT04165213|591991933|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
163895657|NCT04165213|591991934|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
163895658|NCT04464564|591991935|FG000|Period A (Placebo lead-in)|Other|5|||
163895659|NCT04464564|591991936|FG001|Period A (Placebo lead-in)|Other|0|||
163895660|NCT04464564|591991937|FG002|Period A (Placebo lead-in)|Other|0|||
163895661|NCT04464564|591991938|FG003|Period A (Placebo lead-in)|Other|0|||
163895662|NCT04464564|591991935|FG000|Period B (Randomization Period)|Adverse Event|0|||
163895663|NCT04464564|591991936|FG001|Period B (Randomization Period)|Adverse Event|1|||
163895664|NCT04464564|591991937|FG002|Period B (Randomization Period)|Adverse Event|2|||
163895665|NCT04464564|591991938|FG003|Period B (Randomization Period)|Adverse Event|8|||
163895666|NCT04464564|591991935|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
163895667|NCT04464564|591991936|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
163895668|NCT04464564|591991937|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
163895669|NCT04464564|591991938|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
163895670|NCT04464564|591991935|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
163895671|NCT04464564|591991936|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
163895672|NCT04464564|591991937|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
163895673|NCT04464564|591991938|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
163895674|NCT04464564|591991935|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
163895675|NCT04464564|591991936|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
163895676|NCT04464564|591991937|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
163895677|NCT04464564|591991938|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
163895678|NCT04464564|591991935|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
163895679|NCT04464564|591991936|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
163895680|NCT04464564|591991937|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
163895681|NCT04464564|591991938|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
163895682|NCT04464564|591991935|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
163895683|NCT04464564|591991936|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
163895684|NCT04464564|591991937|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
163895685|NCT04464564|591991938|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
163895686|NCT04464564|591991935|FG000|Period B (Randomization Period)|Reason not Specified|0|||
163895687|NCT04464564|591991936|FG001|Period B (Randomization Period)|Reason not Specified|3|||
163895688|NCT04464564|591991937|FG002|Period B (Randomization Period)|Reason not Specified|3|||
163895689|NCT04464564|591991938|FG003|Period B (Randomization Period)|Reason not Specified|3|||
163895690|NCT03786926|591991941|FG000|Overall Study|Adverse Event|0|||
163895691|NCT03786926|591991942|FG001|Overall Study|Adverse Event|0|||
163895692|NCT03786926|591991943|FG002|Overall Study|Adverse Event|0|||
163895693|NCT03786926|591991944|FG003|Overall Study|Adverse Event|0|||
163895694|NCT03786926|591991945|FG004|Overall Study|Adverse Event|0|||
163895695|NCT03786926|591991946|FG005|Overall Study|Adverse Event|0|||
163895696|NCT03786926|591991947|FG006|Overall Study|Adverse Event|0|||
163895697|NCT03786926|591991948|FG007|Overall Study|Adverse Event|1|||
163895698|NCT03786926|591991949|FG008|Overall Study|Adverse Event|1|||
163895699|NCT03786926|591991950|FG009|Overall Study|Adverse Event|0|||
163895700|NCT03786926|591991951|FG010|Overall Study|Adverse Event|1|||
163895701|NCT03786926|591991941|FG000|Overall Study|Progressive disease|3|||
163895702|NCT03786926|591991942|FG001|Overall Study|Progressive disease|0|||
163895703|NCT03786926|591991943|FG002|Overall Study|Progressive disease|3|||
163895704|NCT03786926|591991944|FG003|Overall Study|Progressive disease|1|||
163895705|NCT03786926|591991945|FG004|Overall Study|Progressive disease|2|||
163895706|NCT03786926|591991946|FG005|Overall Study|Progressive disease|2|||
163895707|NCT03786926|591991947|FG006|Overall Study|Progressive disease|1|||
163895708|NCT03786926|591991948|FG007|Overall Study|Progressive disease|6|||
163895709|NCT03786926|591991949|FG008|Overall Study|Progressive disease|1|||
163895710|NCT03786926|591991950|FG009|Overall Study|Progressive disease|1|||
163895711|NCT03786926|591991951|FG010|Overall Study|Progressive disease|1|||
163895712|NCT03786926|591991941|FG000|Overall Study|Death|0|||
163895713|NCT03786926|591991942|FG001|Overall Study|Death|1|||
163895714|NCT03786926|591991943|FG002|Overall Study|Death|1|||
163895715|NCT03786926|591991944|FG003|Overall Study|Death|0|||
163895716|NCT03786926|591991945|FG004|Overall Study|Death|0|||
163895717|NCT03786926|591991946|FG005|Overall Study|Death|0|||
163895718|NCT03786926|591991947|FG006|Overall Study|Death|0|||
163895719|NCT03786926|591991948|FG007|Overall Study|Death|0|||
163895720|NCT03786926|591991949|FG008|Overall Study|Death|0|||
163895721|NCT03786926|591991950|FG009|Overall Study|Death|1|||
163895722|NCT03786926|591991951|FG010|Overall Study|Death|2|||
163895723|NCT03786926|591991941|FG000|Overall Study|Physician Decision|0|||
163895724|NCT03786926|591991942|FG001|Overall Study|Physician Decision|1|||
163895725|NCT03786926|591991943|FG002|Overall Study|Physician Decision|0|||
163895726|NCT03786926|591991944|FG003|Overall Study|Physician Decision|1|||
163895727|NCT03786926|591991945|FG004|Overall Study|Physician Decision|2|||
164281343|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
163895728|NCT03786926|591991946|FG005|Overall Study|Physician Decision|0|||
163895729|NCT03786926|591991947|FG006|Overall Study|Physician Decision|0|||
163895730|NCT03786926|591991948|FG007|Overall Study|Physician Decision|2|||
163895731|NCT03786926|591991949|FG008|Overall Study|Physician Decision|1|||
163895732|NCT03786926|591991950|FG009|Overall Study|Physician Decision|1|||
163895733|NCT03786926|591991951|FG010|Overall Study|Physician Decision|0|||
163895734|NCT03786926|591991941|FG000|Overall Study|Withdrawal by Subject|0|||
163895735|NCT03786926|591991942|FG001|Overall Study|Withdrawal by Subject|1|||
163895736|NCT03786926|591991943|FG002|Overall Study|Withdrawal by Subject|1|||
163895737|NCT03786926|591991944|FG003|Overall Study|Withdrawal by Subject|0|||
163895738|NCT03786926|591991945|FG004|Overall Study|Withdrawal by Subject|0|||
163895739|NCT03786926|591991946|FG005|Overall Study|Withdrawal by Subject|0|||
163895740|NCT03786926|591991947|FG006|Overall Study|Withdrawal by Subject|1|||
163895741|NCT03786926|591991948|FG007|Overall Study|Withdrawal by Subject|0|||
163895742|NCT03786926|591991949|FG008|Overall Study|Withdrawal by Subject|1|||
163895743|NCT03786926|591991950|FG009|Overall Study|Withdrawal by Subject|0|||
163895744|NCT03786926|591991951|FG010|Overall Study|Withdrawal by Subject|1|||
163895745|NCT03786926|591991941|FG000|Overall Study|Study terminated by Sponsor|0|||
163895746|NCT03786926|591991942|FG001|Overall Study|Study terminated by Sponsor|0|||
163895747|NCT03786926|591991943|FG002|Overall Study|Study terminated by Sponsor|0|||
163895748|NCT03786926|591991944|FG003|Overall Study|Study terminated by Sponsor|0|||
164086033|NCT04274192|592678636|FG001|Overall Study|Protocol Violation|0|||
164086034|NCT07174544|592678637|FG000|Overall Study|Lost to Follow-up|43|||
164086035|NCT07174544|592678638|FG001|Overall Study|Lost to Follow-up|15|||
164086036|NCT03419234|592678639|FG000|Overall Study|Disease progression|37|||
163895749|NCT03786926|591991945|FG004|Overall Study|Study terminated by Sponsor|1|||
163895750|NCT03786926|591991946|FG005|Overall Study|Study terminated by Sponsor|0|||
164086037|NCT03419234|592678640|FG001|Overall Study|Disease progression|36|||
164086038|NCT03419234|592678639|FG000|Overall Study|Adverse Event|6|||
164086039|NCT03419234|592678640|FG001|Overall Study|Adverse Event|9|||
164086040|NCT03419234|592678639|FG000|Overall Study|Withdrawal by Subject|9|||
164086041|NCT03419234|592678640|FG001|Overall Study|Withdrawal by Subject|7|||
164086042|NCT03419234|592678639|FG000|Overall Study|Death|5|||
164086043|NCT03419234|592678640|FG001|Overall Study|Death|1|||
164086044|NCT03419234|592678639|FG000|Overall Study|Alternative therapy|4|||
164086045|NCT03419234|592678640|FG001|Overall Study|Alternative therapy|2|||
164086046|NCT03419234|592678639|FG000|Overall Study|PSA progression|8|||
164086047|NCT03419234|592678640|FG001|Overall Study|PSA progression|10|||
164086048|NCT03419234|592678639|FG000|Overall Study|Rising PSA and bone issues|3|||
164086049|NCT03419234|592678640|FG001|Overall Study|Rising PSA and bone issues|2|||
164086050|NCT03419234|592678639|FG000|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|10|||
164086051|NCT03419234|592678640|FG001|Overall Study|Clinical deterioration/clinical progression/symptomatic progression|16|||
164086052|NCT03419234|592678639|FG000|Overall Study|Physician Decision|12|||
164086053|NCT03419234|592678640|FG001|Overall Study|Physician Decision|11|||
164086054|NCT03419234|592678639|FG000|Overall Study|Second malignancy|1|||
164086055|NCT03419234|592678640|FG001|Overall Study|Second malignancy|0|||
164086056|NCT03419234|592678639|FG000|Overall Study|Insurance status change/patient could not afford|2|||
164086057|NCT03419234|592678640|FG001|Overall Study|Insurance status change/patient could not afford|1|||
164086058|NCT03419234|592678639|FG000|Overall Study|Non-compliance|1|||
164086059|NCT03419234|592678640|FG001|Overall Study|Non-compliance|3|||
164086060|NCT03419234|592678639|FG000|Overall Study|Mistakenly off treatment|1|||
164086061|NCT03419234|592678640|FG001|Overall Study|Mistakenly off treatment|0|||
164086062|NCT03419234|592678639|FG000|Overall Study|Transition to hospice|1|||
164086063|NCT03419234|592678640|FG001|Overall Study|Transition to hospice|0|||
164086064|NCT03419234|592678639|FG000|Overall Study|Still on treatment|9|||
164086065|NCT03419234|592678640|FG001|Overall Study|Still on treatment|8|||
164086066|NCT03419234|592678639|FG000|Overall Study|Never received protocol therapy|2|||
164086067|NCT03419234|592678640|FG001|Overall Study|Never received protocol therapy|4|||
163895751|NCT03786926|591991947|FG006|Overall Study|Study terminated by Sponsor|0|||
163895752|NCT03786926|591991948|FG007|Overall Study|Study terminated by Sponsor|4|||
163895753|NCT03786926|591991949|FG008|Overall Study|Study terminated by Sponsor|0|||
163895754|NCT03786926|591991950|FG009|Overall Study|Study terminated by Sponsor|0|||
163895755|NCT03786926|591991951|FG010|Overall Study|Study terminated by Sponsor|0|||
163895756|NCT03786926|591991941|FG000|Overall Study|Anti-neoplasm treatment|0|||
163895757|NCT03786926|591991942|FG001|Overall Study|Anti-neoplasm treatment|0|||
163895758|NCT03786926|591991943|FG002|Overall Study|Anti-neoplasm treatment|0|||
163895759|NCT03786926|591991944|FG003|Overall Study|Anti-neoplasm treatment|0|||
163895760|NCT03786926|591991945|FG004|Overall Study|Anti-neoplasm treatment|1|||
163895761|NCT03786926|591991946|FG005|Overall Study|Anti-neoplasm treatment|0|||
163895762|NCT03786926|591991947|FG006|Overall Study|Anti-neoplasm treatment|1|||
163895763|NCT03786926|591991948|FG007|Overall Study|Anti-neoplasm treatment|0|||
163895764|NCT03786926|591991949|FG008|Overall Study|Anti-neoplasm treatment|0|||
163895765|NCT03786926|591991950|FG009|Overall Study|Anti-neoplasm treatment|0|||
163895766|NCT03786926|591991951|FG010|Overall Study|Anti-neoplasm treatment|0|||
163895767|NCT03786926|591991941|FG000|Overall Study|Other|0|||
163895768|NCT03786926|591991942|FG001|Overall Study|Other|0|||
163895769|NCT03786926|591991943|FG002|Overall Study|Other|0|||
163895770|NCT03786926|591991944|FG003|Overall Study|Other|1|||
163895771|NCT03786926|591991945|FG004|Overall Study|Other|0|||
163895772|NCT03786926|591991946|FG005|Overall Study|Other|1|||
163895773|NCT03786926|591991947|FG006|Overall Study|Other|0|||
164086068|NCT03419234|592678639|FG000|Overall Study|Other complicating disease|0|||
164086069|NCT03419234|592678640|FG001|Overall Study|Other complicating disease|1|||
164086070|NCT03419234|592678639|FG000|Overall Study|patient switched from prednisone to another steroid|0|||
164086071|NCT03419234|592678640|FG001|Overall Study|patient switched from prednisone to another steroid|1|||
164086072|NCT03355742|592679903|FG000|Overall Study|Lost to Follow-up|4|||
164086073|NCT03355742|592679903|FG000|Overall Study|Withdrawal by Subject|29|||
164086074|NCT03355742|592679903|FG000|Overall Study|Physician Decision|6|||
164086075|NCT03355742|592679903|FG000|Overall Study|Death|55|||
164086076|NCT03355742|592679903|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
164086077|NCT02207621|592679904|FG000|Overall Study|Adverse Event|71|||
164086078|NCT02207621|592679905|FG001|Overall Study|Adverse Event|15|||
164086079|NCT02207621|592679906|FG002|Overall Study|Adverse Event|132|||
164086080|NCT02207621|592679904|FG000|Overall Study|Withdrawal by Subject|9|||
164086081|NCT02207621|592679905|FG001|Overall Study|Withdrawal by Subject|9|||
164086082|NCT02207621|592679906|FG002|Overall Study|Withdrawal by Subject|13|||
164086083|NCT02207621|592679904|FG000|Overall Study|Non-Compliant|3|||
163895774|NCT03786926|591991948|FG007|Overall Study|Other|0|||
163895775|NCT03786926|591991949|FG008|Overall Study|Other|2|||
163895776|NCT03786926|591991950|FG009|Overall Study|Other|0|||
163895777|NCT03786926|591991951|FG010|Overall Study|Other|0|||
163895778|NCT02997202|591991953|FG000|Overall Study|Miscellaneous|2|||
163895779|NCT02997202|591991954|FG001|Overall Study|Miscellaneous|2|||
163895780|NCT02997202|591991953|FG000|Overall Study|Withdrawal by Subject|8|||
163895781|NCT02997202|591991954|FG001|Overall Study|Withdrawal by Subject|12|||
163895782|NCT02997202|591991953|FG000|Overall Study|Lost to Follow-up|5|||
163895783|NCT02997202|591991954|FG001|Overall Study|Lost to Follow-up|3|||
164086084|NCT02207621|592679905|FG001|Overall Study|Non-Compliant|3|||
164086085|NCT02207621|592679906|FG002|Overall Study|Non-Compliant|1|||
164086086|NCT02207621|592679904|FG000|Overall Study|Lost to Follow-up|1|||
164086087|NCT02207621|592679905|FG001|Overall Study|Lost to Follow-up|0|||
164086088|NCT02207621|592679906|FG002|Overall Study|Lost to Follow-up|3|||
164086089|NCT02207621|592679904|FG000|Overall Study|Lack of Efficacy|10|||
164086090|NCT02207621|592679905|FG001|Overall Study|Lack of Efficacy|2|||
164086091|NCT02207621|592679906|FG002|Overall Study|Lack of Efficacy|4|||
164086092|NCT02207621|592679904|FG000|Overall Study|Disallowed Concurrent Medication|2|||
163895784|NCT02997202|591991953|FG000|Overall Study|Death|41|||
163895785|NCT02997202|591991954|FG001|Overall Study|Death|45|||
163895786|NCT00303459|591991966|FG000|Overall Study|Death|33|||
163895787|NCT00303459|591991967|FG001|Overall Study|Death|44|||
163895788|NCT00303459|591991966|FG000|Overall Study|Withdrawal of consent|32|||
163895789|NCT00303459|591991967|FG001|Overall Study|Withdrawal of consent|26|||
164086093|NCT02207621|592679905|FG001|Overall Study|Disallowed Concurrent Medication|5|||
163895790|NCT00303459|591991966|FG000|Overall Study|Lost to Follow-up|5|||
164086094|NCT02207621|592679906|FG002|Overall Study|Disallowed Concurrent Medication|2|||
164086095|NCT02207621|592679904|FG000|Overall Study|Physician Decision|1|||
164086096|NCT02207621|592679905|FG001|Overall Study|Physician Decision|2|||
164086097|NCT02207621|592679906|FG002|Overall Study|Physician Decision|2|||
164086098|NCT02207621|592679904|FG000|Overall Study|Protocol Violation|4|||
164086099|NCT02207621|592679905|FG001|Overall Study|Protocol Violation|10|||
164086100|NCT02207621|592679906|FG002|Overall Study|Protocol Violation|6|||
164086101|NCT02207621|592679904|FG000|Overall Study|Death|2|||
164086102|NCT02207621|592679905|FG001|Overall Study|Death|0|||
164086103|NCT02207621|592679906|FG002|Overall Study|Death|0|||
164086104|NCT02207621|592679904|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
164086105|NCT02207621|592679905|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
164086106|NCT02207621|592679906|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
164086107|NCT02623959|592679907|FG000|Overall Study|Progression|0|||
164086108|NCT02623959|592679908|FG001|Overall Study|Progression|1|||
164086109|NCT00135707|592679909|FG000|Overall Study|Lost to Follow-up|94|||
164086110|NCT00135707|592679910|FG001|Overall Study|Lost to Follow-up|89|||
164086111|NCT00135707|592679909|FG000|Overall Study|Withdrawal by Subject|0|||
164086112|NCT00135707|592679910|FG001|Overall Study|Withdrawal by Subject|1|||
164086113|NCT00135707|592679909|FG000|Overall Study|Institutional review board request|1|||
164086114|NCT00135707|592679910|FG001|Overall Study|Institutional review board request|0|||
164086115|NCT00812253|592679914|FG000|Overall Study|Withdrawal by Subject|3|||
164086116|NCT00812253|592679915|FG001|Overall Study|Withdrawal by Subject|2|||
164086117|NCT00812253|592679914|FG000|Overall Study|Protocol Violation|1|||
164086118|NCT00812253|592679915|FG001|Overall Study|Protocol Violation|1|||
163895791|NCT00303459|591991967|FG001|Overall Study|Lost to Follow-up|4|||
163895792|NCT00303459|591991966|FG000|Overall Study|Administrative reason|7|||
163895793|NCT00303459|591991967|FG001|Overall Study|Administrative reason|7|||
163895794|NCT00303459|591991966|FG000|Overall Study|Decision by the investigator|5|||
163895795|NCT00303459|591991967|FG001|Overall Study|Decision by the investigator|7|||
163895796|NCT00303459|591991966|FG000|Overall Study|Lung transplantation|1|||
163895797|NCT00303459|591991967|FG001|Overall Study|Lung transplantation|1|||
163895798|NCT04055012|591991968|FG000|Overall Study|Withdrawal by Subject|1|||
163895799|NCT04055012|591991969|FG001|Overall Study|Withdrawal by Subject|3|||
163895800|NCT04055012|591991970|FG002|Overall Study|Withdrawal by Subject|1|||
163895801|NCT04055012|591991971|FG003|Overall Study|Withdrawal by Subject|0|||
163895802|NCT04055012|591991968|FG000|Overall Study|Metformin Recall|1|||
164086119|NCT00812253|592679914|FG000|Overall Study|Lost to Follow-up|2|||
164086120|NCT00812253|592679915|FG001|Overall Study|Lost to Follow-up|0|||
164086121|NCT04903288|592679916|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
163895803|NCT04055012|591991969|FG001|Overall Study|Metformin Recall|1|||
163895804|NCT04055012|591991970|FG002|Overall Study|Metformin Recall|1|||
163895805|NCT04055012|591991971|FG003|Overall Study|Metformin Recall|0|||
163895806|NCT02492711|591991975|FG000|Overall Study|Adverse Event|9|||
164344403|NCT03766581|593636927|FG006|Treatment|Poor/Non compliance|0|||
164344404|NCT03766581|593636928|FG007|Treatment|Poor/Non compliance|0|||
164344405|NCT03766581|593636921|FG000|Treatment|Participant no longer meets study criteria|9|||
164344406|NCT03766581|593636922|FG001|Treatment|Participant no longer meets study criteria|1|||
164344407|NCT03766581|593636923|FG002|Treatment|Participant no longer meets study criteria|5|||
164344408|NCT03766581|593636924|FG003|Treatment|Participant no longer meets study criteria|4|||
164344409|NCT03766581|593636925|FG004|Treatment|Participant no longer meets study criteria|4|||
164344410|NCT03766581|593636926|FG005|Treatment|Participant no longer meets study criteria|4|||
164344411|NCT03766581|593636927|FG006|Treatment|Participant no longer meets study criteria|2|||
164344412|NCT03766581|593636928|FG007|Treatment|Participant no longer meets study criteria|0|||
164344413|NCT03766581|593636921|FG000|Treatment|Other reasons|13|||
164344414|NCT03766581|593636922|FG001|Treatment|Other reasons|8|||
164344415|NCT03766581|593636923|FG002|Treatment|Other reasons|3|||
164344416|NCT03766581|593636924|FG003|Treatment|Other reasons|7|||
164344417|NCT03766581|593636925|FG004|Treatment|Other reasons|3|||
164344418|NCT03766581|593636926|FG005|Treatment|Other reasons|3|||
164344419|NCT03766581|593636927|FG006|Treatment|Other reasons|0|||
164344420|NCT03766581|593636928|FG007|Treatment|Other reasons|0|||
164344421|NCT03716024|593636929|FG000|Overall Study|Randomized, not Treated|7|||
164344422|NCT03716024|593636930|FG001|Overall Study|Randomized, not Treated|8|||
164344423|NCT03716024|593636929|FG000|Overall Study|Adverse Event|1|||
164344424|NCT03716024|593636930|FG001|Overall Study|Adverse Event|2|||
164344425|NCT03716024|593636929|FG000|Overall Study|Treatment Failure|1|||
164344426|NCT03716024|593636930|FG001|Overall Study|Treatment Failure|0|||
164344427|NCT03716024|593636929|FG000|Overall Study|Lost to Follow-up|2|||
164344428|NCT03716024|593636930|FG001|Overall Study|Lost to Follow-up|6|||
164344429|NCT03716024|593636929|FG000|Overall Study|Withdrawal by Subject|0|||
163895807|NCT02492711|591991976|FG001|Overall Study|Adverse Event|9|||
164086122|NCT04903288|592679916|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
164344430|NCT03716024|593636930|FG001|Overall Study|Withdrawal by Subject|1|||
164344431|NCT03716024|593636929|FG000|Overall Study|Missing Reason|0|||
164344432|NCT03716024|593636930|FG001|Overall Study|Missing Reason|1|||
164344433|NCT00867568|593636931|FG000|Overall Study|Lack of Efficacy|10|||
164001584|NCT02305563|592368580|FG004|Treatment Period|Disease progression|6|||
164001585|NCT02305563|592368576|FG000|Treatment Period|Study drug toxicity|0|||
164001586|NCT02305563|592368577|FG001|Treatment Period|Study drug toxicity|0|||
164001587|NCT02305563|592368578|FG002|Treatment Period|Study drug toxicity|0|||
164001588|NCT02305563|592368579|FG003|Treatment Period|Study drug toxicity|1|||
164001589|NCT02305563|592368580|FG004|Treatment Period|Study drug toxicity|2|||
164001590|NCT02305563|592368576|FG000|Treatment Period|Death|0|||
164001591|NCT02305563|592368577|FG001|Treatment Period|Death|0|||
164001592|NCT02305563|592368578|FG002|Treatment Period|Death|1|||
164001593|NCT02305563|592368579|FG003|Treatment Period|Death|2|||
164001594|NCT02305563|592368580|FG004|Treatment Period|Death|1|||
164001595|NCT02305563|592368576|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
164001596|NCT02305563|592368577|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
164001597|NCT02305563|592368578|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
164001598|NCT02305563|592368579|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
164001599|NCT02305563|592368580|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
164001600|NCT02305563|592368576|FG000|Treatment Period|Participant request to stop therapy|0|||
164001601|NCT02305563|592368577|FG001|Treatment Period|Participant request to stop therapy|2|||
164001602|NCT02305563|592368578|FG002|Treatment Period|Participant request to stop therapy|0|||
164001603|NCT02305563|592368579|FG003|Treatment Period|Participant request to stop therapy|1|||
164001604|NCT02305563|592368580|FG004|Treatment Period|Participant request to stop therapy|0|||
164001605|NCT02305563|592368576|FG000|Treatment Period|Participant withdrew consent|0|||
164001606|NCT02305563|592368577|FG001|Treatment Period|Participant withdrew consent|0|||
164001607|NCT02305563|592368578|FG002|Treatment Period|Participant withdrew consent|1|||
164001608|NCT02305563|592368579|FG003|Treatment Period|Participant withdrew consent|1|||
164001609|NCT02305563|592368580|FG004|Treatment Period|Participant withdrew consent|1|||
164001610|NCT02305563|592368576|FG000|Treatment Period|Maximum clinical benefit|0|||
164001611|NCT02305563|592368577|FG001|Treatment Period|Maximum clinical benefit|0|||
164001612|NCT02305563|592368578|FG002|Treatment Period|Maximum clinical benefit|0|||
164001613|NCT02305563|592368579|FG003|Treatment Period|Maximum clinical benefit|0|||
164001614|NCT02305563|592368580|FG004|Treatment Period|Maximum clinical benefit|1|||
164086123|NCT04903288|592679916|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
164086124|NCT04903288|592679916|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
164086125|NCT00634907|592679924|FG000|Overall Study|Withdrawal by Subject|3|||
164086126|NCT00634907|592679925|FG001|Overall Study|Withdrawal by Subject|0|||
164086127|NCT00634907|592679924|FG000|Overall Study|Physician Decision|3|||
164086128|NCT00634907|592679925|FG001|Overall Study|Physician Decision|9|||
164086129|NCT00634907|592679924|FG000|Overall Study|Withdrawal by Subject|11|||
164086130|NCT00634907|592679925|FG001|Overall Study|Withdrawal by Subject|8|||
164086131|NCT01180244|592679934|FG000|Overall Study|Lack of Efficacy|0|||
164086132|NCT01180244|592679935|FG001|Overall Study|Lack of Efficacy|7|||
164086133|NCT01180244|592679934|FG000|Overall Study|Physician Decision|3|||
164086134|NCT01180244|592679935|FG001|Overall Study|Physician Decision|0|||
163895808|NCT02492711|591991977|FG002|Overall Study|Adverse Event|2|||
163895809|NCT02492711|591991975|FG000|Overall Study|Death|3|||
163895810|NCT02492711|591991976|FG001|Overall Study|Death|3|||
163895811|NCT02492711|591991977|FG002|Overall Study|Death|0|||
163895812|NCT02492711|591991975|FG000|Overall Study|Withdrawal by Subject|10|||
163895813|NCT02492711|591991976|FG001|Overall Study|Withdrawal by Subject|16|||
163895814|NCT02492711|591991977|FG002|Overall Study|Withdrawal by Subject|5|||
163895815|NCT02492711|591991975|FG000|Overall Study|Physician Decision|10|||
163895816|NCT02492711|591991976|FG001|Overall Study|Physician Decision|6|||
163895817|NCT02492711|591991977|FG002|Overall Study|Physician Decision|4|||
163895818|NCT02492711|591991975|FG000|Overall Study|Lost to Follow-up|0|||
163895819|NCT02492711|591991976|FG001|Overall Study|Lost to Follow-up|0|||
163895820|NCT02492711|591991977|FG002|Overall Study|Lost to Follow-up|1|||
163895821|NCT02492711|591991975|FG000|Overall Study|study treatment delay|2|||
163895822|NCT02492711|591991976|FG001|Overall Study|study treatment delay|1|||
163895823|NCT02492711|591991977|FG002|Overall Study|study treatment delay|0|||
163895824|NCT02492711|591991975|FG000|Overall Study|change in chemotherapy|0|||
163895825|NCT02492711|591991976|FG001|Overall Study|change in chemotherapy|1|||
163895826|NCT02492711|591991977|FG002|Overall Study|change in chemotherapy|0|||
163895827|NCT02492711|591991975|FG000|Overall Study|never treated|2|||
163895828|NCT02492711|591991976|FG001|Overall Study|never treated|4|||
163895829|NCT02492711|591991977|FG002|Overall Study|never treated|0|||
163895830|NCT02492711|591991975|FG000|Overall Study|Other|0|||
163895831|NCT02492711|591991976|FG001|Overall Study|Other|0|||
163895832|NCT02492711|591991977|FG002|Overall Study|Other|1|||
163895833|NCT03652272|591991981|FG000|3 Month|Withdrawal by Subject|1|||
164001615|NCT02305563|592368576|FG000|Treatment Period|Poor/non-compliance|0|||
164001616|NCT02305563|592368577|FG001|Treatment Period|Poor/non-compliance|0|||
164001617|NCT02305563|592368578|FG002|Treatment Period|Poor/non-compliance|0|||
164001618|NCT02305563|592368579|FG003|Treatment Period|Poor/non-compliance|0|||
164086135|NCT01180244|592679934|FG000|Overall Study|Adverse Event|1|||
164086136|NCT01180244|592679935|FG001|Overall Study|Adverse Event|0|||
164086137|NCT01180244|592679934|FG000|Overall Study|Withdrawal by Subject|0|||
164086138|NCT01180244|592679935|FG001|Overall Study|Withdrawal by Subject|1|||
164086139|NCT01180244|592679934|FG000|Overall Study|Protocol Violation|1|||
164086140|NCT01180244|592679935|FG001|Overall Study|Protocol Violation|0|||
164086141|NCT01180244|592679934|FG000|Overall Study|Lost to Follow-up|1|||
164086142|NCT01180244|592679935|FG001|Overall Study|Lost to Follow-up|0|||
164086143|NCT01595009|592679940|FG000|Core|Patients completed per protocol|85|||
164086144|NCT01595009|592679941|FG001|Core|Patients completed per protocol|44|||
164086145|NCT01595009|592679942|FG002|Core|Patients completed per protocol|0|||
164086146|NCT01595009|592679943|FG003|Core|Patients completed per protocol|0|||
163895834|NCT03652272|591991982|FG001|3 Month|Withdrawal by Subject|1|||
163895835|NCT03652272|591991981|FG000|3 Month|Lost to Follow-up|16|||
163895836|NCT03652272|591991982|FG001|3 Month|Lost to Follow-up|14|||
163895837|NCT02163694|591991983|FG000|Overall Study|Adverse event- related to progression|4|||
163895838|NCT02163694|591991984|FG001|Overall Study|Adverse event- related to progression|10|||
163895839|NCT02163694|591991983|FG000|Overall Study|Adverse event- not related to progression|7|||
163895840|NCT02163694|591991984|FG001|Overall Study|Adverse event- not related to progression|22|||
163895841|NCT02163694|591991983|FG000|Overall Study|Withdrew consent|13|||
163895842|NCT02163694|591991984|FG001|Overall Study|Withdrew consent|28|||
163895843|NCT02163694|591991983|FG000|Overall Study|Lost to Follow-up|2|||
164001619|NCT02305563|592368580|FG004|Treatment Period|Poor/non-compliance|1|||
164001620|NCT02305563|592368576|FG000|Treatment Period|Administrative reason by Sponsor|0|||
164001621|NCT02305563|592368577|FG001|Treatment Period|Administrative reason by Sponsor|0|||
164086147|NCT01595009|592679940|FG000|Core|Adverse Event|19|||
164086148|NCT01595009|592679941|FG001|Core|Adverse Event|23|||
163895844|NCT02163694|591991984|FG001|Overall Study|Lost to Follow-up|2|||
163895845|NCT02163694|591991983|FG000|Overall Study|Sponsor discontinued study|3|||
163895846|NCT02163694|591991984|FG001|Overall Study|Sponsor discontinued study|29|||
163895847|NCT02163694|591991983|FG000|Overall Study|Progressive disease per protocol|125|||
164086149|NCT01595009|592679942|FG002|Core|Adverse Event|0|||
164086150|NCT01595009|592679943|FG003|Core|Adverse Event|0|||
163895848|NCT02163694|591991984|FG001|Overall Study|Progressive disease per protocol|224|||
163895849|NCT02163694|591991983|FG000|Overall Study|Other, not specified|17|||
164001622|NCT02305563|592368578|FG002|Treatment Period|Administrative reason by Sponsor|0|||
163895850|NCT02163694|591991984|FG001|Overall Study|Other, not specified|22|||
163895851|NCT02163694|591991983|FG000|Overall Study|Randomized but Not Treated|1|||
163895852|NCT02163694|591991984|FG001|Overall Study|Randomized but Not Treated|0|||
163895853|NCT02163694|591991983|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
163895854|NCT02163694|591991984|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
163895855|NCT03884101|591991985|FG000|Overall Study|Participant Ongoing in Study|202|||
163895856|NCT03884101|591991986|FG001|Overall Study|Participant Ongoing in Study|186|||
163895857|NCT03884101|591991985|FG000|Overall Study|Death|212|||
164086151|NCT01595009|592679940|FG000|Core|Disease progression|14|||
164086152|NCT01595009|592679941|FG001|Core|Disease progression|26|||
164086153|NCT01595009|592679942|FG002|Core|Disease progression|0|||
163895858|NCT03884101|591991986|FG001|Overall Study|Death|224|||
163895859|NCT03884101|591991985|FG000|Overall Study|Lost to Follow-up|0|||
163895860|NCT03884101|591991986|FG001|Overall Study|Lost to Follow-up|1|||
163895861|NCT03884101|591991985|FG000|Overall Study|Withdrawal by Subject|6|||
164086154|NCT01595009|592679943|FG003|Core|Disease progression|0|||
164086155|NCT01595009|592679940|FG000|Core|Withdrawal by Subject|4|||
164086156|NCT01595009|592679941|FG001|Core|Withdrawal by Subject|17|||
164086157|NCT01595009|592679942|FG002|Core|Withdrawal by Subject|0|||
164086158|NCT01595009|592679943|FG003|Core|Withdrawal by Subject|0|||
164086159|NCT01595009|592679940|FG000|Core|Death|3|||
164086160|NCT01595009|592679941|FG001|Core|Death|6|||
164086161|NCT01595009|592679942|FG002|Core|Death|0|||
164086162|NCT01595009|592679943|FG003|Core|Death|0|||
164086163|NCT01595009|592679940|FG000|Core|Lost to Follow-up|1|||
164086164|NCT01595009|592679941|FG001|Core|Lost to Follow-up|2|||
164086165|NCT01595009|592679942|FG002|Core|Lost to Follow-up|0|||
164086166|NCT01595009|592679943|FG003|Core|Lost to Follow-up|0|||
164086167|NCT01595009|592679940|FG000|Core|Protocol deviation|0|||
164086168|NCT01595009|592679941|FG001|Core|Protocol deviation|1|||
164086169|NCT01595009|592679942|FG002|Core|Protocol deviation|0|||
164086170|NCT01595009|592679943|FG003|Core|Protocol deviation|0|||
164086171|NCT01595009|592679940|FG000|Core|Administrative problems|0|||
164086172|NCT01595009|592679941|FG001|Core|Administrative problems|1|||
164086173|NCT01595009|592679942|FG002|Core|Administrative problems|0|||
164086174|NCT01595009|592679943|FG003|Core|Administrative problems|0|||
164086175|NCT01595009|592679940|FG000|Extension|Administrative problems|0|||
164086176|NCT01595009|592679941|FG001|Extension|Administrative problems|0|||
164086177|NCT01595009|592679942|FG002|Extension|Administrative problems|0|||
164086178|NCT01595009|592679943|FG003|Extension|Administrative problems|1|||
164086179|NCT01595009|592679940|FG000|Extension|Patients completed per protocol|0|||
164086180|NCT01595009|592679941|FG001|Extension|Patients completed per protocol|0|||
164086181|NCT01595009|592679942|FG002|Extension|Patients completed per protocol|0|||
164086182|NCT01595009|592679943|FG003|Extension|Patients completed per protocol|2|||
164086183|NCT01595009|592679940|FG000|Extension|Disease progression|0|||
164086184|NCT01595009|592679941|FG001|Extension|Disease progression|0|||
164086185|NCT01595009|592679942|FG002|Extension|Disease progression|4|||
164086186|NCT01595009|592679943|FG003|Extension|Disease progression|7|||
164086187|NCT01595009|592679940|FG000|Extension|Adverse Event|0|||
164086188|NCT01595009|592679941|FG001|Extension|Adverse Event|0|||
164086189|NCT01595009|592679942|FG002|Extension|Adverse Event|0|||
164086190|NCT01595009|592679943|FG003|Extension|Adverse Event|1|||
164086191|NCT02623829|592679950|FG000|Overall Study|Lost to Follow-up|1|||
164086192|NCT02623829|592679951|FG001|Overall Study|Lost to Follow-up|1|||
164086193|NCT00681863|592679952|FG000|Overall Study|Adverse Event|1|||
164086194|NCT00681863|592679952|FG000|Overall Study|Lost to Follow-up|2|||
164086195|NCT00681863|592679952|FG000|Overall Study|Lack of Efficacy|2|||
164086196|NCT00681863|592679952|FG000|Overall Study|Other|18|||
164086197|NCT01388647|592679958|FG000|Overall Study|Adverse Event|1|||
164086198|NCT01388647|592679959|FG001|Overall Study|Adverse Event|2|||
163895862|NCT03884101|591991986|FG001|Overall Study|Withdrawal by Subject|11|||
163895863|NCT03880955|591991993|FG000|Overall Study|Adverse Event|1|||
163895864|NCT03880955|591991993|FG000|Overall Study|Death|1|||
163895865|NCT03880955|591991993|FG000|Overall Study|Lost to Follow-up|12|||
163895866|NCT03880955|591991993|FG000|Overall Study|Withdrawal by Subject|4|||
163895867|NCT03880955|591991993|FG000|Overall Study|Missing- Study Site Closed|27|||
163895868|NCT05112900|591991994|FG000|Overall Study|Withdrawal by Subject|960|||
163895869|NCT05112900|591991995|FG001|Overall Study|Withdrawal by Subject|921|||
163895870|NCT05112900|591991996|FG002|Overall Study|Withdrawal by Subject|968|||
163895871|NCT01438853|591991999|FG000|Overall Study|Death|0|||
164086199|NCT01006707|592679960|FG000|Study Session 1|Lost to Follow-up|2|||
164086200|NCT01006707|592679961|FG001|Study Session 1|Lost to Follow-up|0|||
164086201|NCT01006707|592679962|FG002|Study Session 1|Lost to Follow-up|0|||
164086202|NCT01006707|592679960|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
164086203|NCT01006707|592679961|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
164086204|NCT01006707|592679962|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
164086205|NCT00622908|592679965|FG000|Overall Study|Protocol Violation|1|||
164086206|NCT00622908|592679966|FG001|Overall Study|Protocol Violation|0|||
164086207|NCT00622908|592679965|FG000|Overall Study|Adverse Event|0|||
164086208|NCT00622908|592679966|FG001|Overall Study|Adverse Event|1|||
164281344|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
164281345|NCT00095173|593400659|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
164281346|NCT00095173|593400660|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
164281347|NCT00095173|593400661|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
164281348|NCT00095173|593400662|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
164281349|NCT00095173|593400663|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
164281350|NCT00095173|593400664|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
164281351|NCT00095173|593400659|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164281352|NCT00095173|593400660|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
164001623|NCT02305563|592368579|FG003|Treatment Period|Administrative reason by Sponsor|0|||
164281353|NCT00095173|593400661|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
164001624|NCT02305563|592368580|FG004|Treatment Period|Administrative reason by Sponsor|1|||
164001625|NCT02305563|592368576|FG000|Treatment Period|other reason|2|||
164281354|NCT00095173|593400662|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
163895872|NCT01438853|591992000|FG001|Overall Study|Death|0|||
163895873|NCT01438853|591992001|FG002|Overall Study|Death|0|||
163895874|NCT01438853|591992002|FG003|Overall Study|Death|1|||
163895875|NCT01438853|591991999|FG000|Overall Study|Withdrawal by Subject|0|||
163895876|NCT01438853|591992000|FG001|Overall Study|Withdrawal by Subject|0|||
163895877|NCT01438853|591992001|FG002|Overall Study|Withdrawal by Subject|1|||
163895878|NCT01438853|591992002|FG003|Overall Study|Withdrawal by Subject|0|||
163895879|NCT02919917|591992003|FG000|Overall Study|Withdrawal by Subject|4|||
163895880|NCT02919917|591992004|FG001|Overall Study|Withdrawal by Subject|8|||
163895881|NCT04743973|591992005|FG000|Overall Study|Withdrawal by Subject|5|||
163895882|NCT05412004|591992583|FG000|Overall Study|Adverse Event|0|||
163895883|NCT05412004|591992584|FG001|Overall Study|Adverse Event|2|||
163895884|NCT05412004|591992585|FG002|Overall Study|Adverse Event|1|||
163895885|NCT05412004|591992586|FG003|Overall Study|Adverse Event|5|||
163895886|NCT05412004|591992583|FG000|Overall Study|Assigned Treatment by Mistake|5|||
163895887|NCT05412004|591992584|FG001|Overall Study|Assigned Treatment by Mistake|10|||
163895888|NCT05412004|591992585|FG002|Overall Study|Assigned Treatment by Mistake|2|||
163895889|NCT05412004|591992586|FG003|Overall Study|Assigned Treatment by Mistake|5|||
163895890|NCT05412004|591992583|FG000|Overall Study|Lost to Follow-up|3|||
163895891|NCT05412004|591992584|FG001|Overall Study|Lost to Follow-up|0|||
163895892|NCT05412004|591992585|FG002|Overall Study|Lost to Follow-up|0|||
163895893|NCT05412004|591992586|FG003|Overall Study|Lost to Follow-up|0|||
163895894|NCT05412004|591992583|FG000|Overall Study|Patient could not travel to site|0|||
163895895|NCT05412004|591992584|FG001|Overall Study|Patient could not travel to site|1|||
164086209|NCT00622908|592679965|FG000|Overall Study|Lack of Efficacy|1|||
164086210|NCT00622908|592679966|FG001|Overall Study|Lack of Efficacy|7|||
164086211|NCT00622908|592679965|FG000|Overall Study|Lost to Follow-up|1|||
164086212|NCT00622908|592679966|FG001|Overall Study|Lost to Follow-up|0|||
163895896|NCT05412004|591992585|FG002|Overall Study|Patient could not travel to site|0|||
163895897|NCT05412004|591992586|FG003|Overall Study|Patient could not travel to site|0|||
163895898|NCT05412004|591992583|FG000|Overall Study|Physician Decision|0|||
163895899|NCT05412004|591992584|FG001|Overall Study|Physician Decision|1|||
163895900|NCT05412004|591992585|FG002|Overall Study|Physician Decision|0|||
163895901|NCT05412004|591992586|FG003|Overall Study|Physician Decision|0|||
163895902|NCT05412004|591992583|FG000|Overall Study|Pregnancy|0|||
163895903|NCT05412004|591992584|FG001|Overall Study|Pregnancy|1|||
163895904|NCT05412004|591992585|FG002|Overall Study|Pregnancy|0|||
163895905|NCT05412004|591992586|FG003|Overall Study|Pregnancy|0|||
163895906|NCT05412004|591992583|FG000|Overall Study|Protocol Violation|1|||
163895907|NCT05412004|591992584|FG001|Overall Study|Protocol Violation|0|||
163895908|NCT05412004|591992585|FG002|Overall Study|Protocol Violation|0|||
163895909|NCT05412004|591992586|FG003|Overall Study|Protocol Violation|0|||
163895910|NCT05412004|591992583|FG000|Overall Study|Withdrawal by Subject|4|||
163895911|NCT05412004|591992584|FG001|Overall Study|Withdrawal by Subject|19|||
163895912|NCT05412004|591992585|FG002|Overall Study|Withdrawal by Subject|4|||
163895913|NCT05412004|591992586|FG003|Overall Study|Withdrawal by Subject|14|||
163895914|NCT05412004|591992583|FG000|Overall Study|Screen Failure|0|||
164086213|NCT00622908|592679965|FG000|Overall Study|Refusal|0|||
164086214|NCT00622908|592679966|FG001|Overall Study|Refusal|1|||
163895915|NCT05412004|591992584|FG001|Overall Study|Screen Failure|0|||
163895916|NCT05412004|591992585|FG002|Overall Study|Screen Failure|0|||
163895917|NCT05412004|591992586|FG003|Overall Study|Screen Failure|1|||
163895918|NCT05412004|591992583|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
163895919|NCT05412004|591992584|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
163895920|NCT05412004|591992585|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
163895921|NCT05412004|591992586|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
163895922|NCT03781089|591992587|FG000|Overall Study|Constipation|1|||
163895923|NCT03781089|591992588|FG001|Overall Study|Constipation|0|||
163895924|NCT03781089|591992587|FG000|Overall Study|Positive pregnancy test|0|||
163895925|NCT03781089|591992588|FG001|Overall Study|Positive pregnancy test|1|||
163895926|NCT04644029|591992589|FG000|Overall Study|Death|1|||
163895927|NCT04644029|591992590|FG001|Overall Study|Death|0|||
163895928|NCT04644029|591992589|FG000|Overall Study|Physician Decision|1|||
163895929|NCT04644029|591992590|FG001|Overall Study|Physician Decision|2|||
163895930|NCT04644029|591992589|FG000|Overall Study|Withdrawal by Subject|21|||
163895931|NCT04644029|591992590|FG001|Overall Study|Withdrawal by Subject|19|||
163895932|NCT04644029|591992589|FG000|Overall Study|Lost to Follow-up|31|||
163895933|NCT04644029|591992590|FG001|Overall Study|Lost to Follow-up|34|||
164086215|NCT00622908|592679965|FG000|Overall Study|Termination by study sponser|0|||
164086216|NCT00622908|592679966|FG001|Overall Study|Termination by study sponser|1|||
164086217|NCT03937466|592679967|FG000|Overall Study|not eligbile after the 2-week diary|9|||
164086218|NCT03937466|592679967|FG000|Overall Study|never returned their diary|6|||
164086219|NCT03937466|592679967|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
164086220|NCT03937466|592679967|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
164086221|NCT01851590|592679971|FG000|Overall Study|Withdrawal by Subject|0|||
163895934|NCT04644029|591992589|FG000|Overall Study|Study Terminated by Sponsor|308|||
163895935|NCT04644029|591992590|FG001|Overall Study|Study Terminated by Sponsor|309|||
163895936|NCT04644029|591992589|FG000|Overall Study|Randomized in Error|2|||
163895937|NCT04644029|591992590|FG001|Overall Study|Randomized in Error|1|||
163895938|NCT04644029|591992589|FG000|Overall Study|Other|0|||
163895939|NCT04644029|591992590|FG001|Overall Study|Other|1|||
163895940|NCT02246127|591992591|FG000|First Course Treatment|Adverse Event|9|||
163895941|NCT02246127|591992592|FG001|First Course Treatment|Adverse Event|7|||
163895942|NCT02246127|591992591|FG000|First Course Treatment|Withdrawal by Subject|6|||
163895943|NCT02246127|591992592|FG001|First Course Treatment|Withdrawal by Subject|7|||
163895944|NCT02246127|591992591|FG000|First Course Treatment|Physician Decision|9|||
163895945|NCT02246127|591992592|FG001|First Course Treatment|Physician Decision|9|||
164086222|NCT01851590|592679972|FG001|Overall Study|Withdrawal by Subject|0|||
164086223|NCT01851590|592679973|FG002|Overall Study|Withdrawal by Subject|1|||
164086224|NCT01851590|592679971|FG000|Overall Study|Adverse Event|0|||
163895946|NCT02246127|591992591|FG000|First Course Treatment|Death|3|||
163895947|NCT02246127|591992592|FG001|First Course Treatment|Death|3|||
163895948|NCT02246127|591992591|FG000|First Course Treatment|Not reported reasons|6|||
163895949|NCT02246127|591992592|FG001|First Course Treatment|Not reported reasons|7|||
163895950|NCT02246127|591992591|FG000|First Course Treatment|Not treated|3|||
164086225|NCT01851590|592679972|FG001|Overall Study|Adverse Event|0|||
164086226|NCT01851590|592679973|FG002|Overall Study|Adverse Event|2|||
164086227|NCT01851590|592679971|FG000|Overall Study|Lack of Efficacy|0|||
164086228|NCT01851590|592679972|FG001|Overall Study|Lack of Efficacy|1|||
164086229|NCT01851590|592679973|FG002|Overall Study|Lack of Efficacy|0|||
164086230|NCT00321711|592679976|FG000|Part A|Adverse Event|3|||
164086231|NCT00321711|592679977|FG001|Part A|Adverse Event|3|||
164086232|NCT00321711|592679978|FG002|Part A|Adverse Event|2|||
164086233|NCT00321711|592679979|FG003|Part A|Adverse Event|0|||
164086234|NCT00321711|592679980|FG004|Part A|Adverse Event|0|||
164086235|NCT00321711|592679976|FG000|Part A|Withdrawal by Subject|1|||
164086236|NCT00321711|592679977|FG001|Part A|Withdrawal by Subject|1|||
164086237|NCT00321711|592679978|FG002|Part A|Withdrawal by Subject|1|||
164086238|NCT00321711|592679979|FG003|Part A|Withdrawal by Subject|0|||
164086239|NCT00321711|592679980|FG004|Part A|Withdrawal by Subject|0|||
164086240|NCT00321711|592679976|FG000|Part A|Disease progression|0|||
164086241|NCT00321711|592679977|FG001|Part A|Disease progression|1|||
164086242|NCT00321711|592679978|FG002|Part A|Disease progression|0|||
164086243|NCT00321711|592679979|FG003|Part A|Disease progression|0|||
164086244|NCT00321711|592679980|FG004|Part A|Disease progression|0|||
164086245|NCT00321711|592679976|FG000|Part A|Requirement for alternative therapy|0|||
164281355|NCT00095173|593400663|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164281356|NCT00095173|593400664|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
164281357|NCT00095173|593400659|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281358|NCT00095173|593400660|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
164281359|NCT00095173|593400661|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281360|NCT00095173|593400662|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281361|NCT00095173|593400663|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164086246|NCT00321711|592679977|FG001|Part A|Requirement for alternative therapy|2|||
164086247|NCT00321711|592679978|FG002|Part A|Requirement for alternative therapy|1|||
164086248|NCT00321711|592679979|FG003|Part A|Requirement for alternative therapy|0|||
164086249|NCT00321711|592679980|FG004|Part A|Requirement for alternative therapy|0|||
164086250|NCT00321711|592679976|FG000|Part A|Physician Decision|0|||
164086251|NCT00321711|592679977|FG001|Part A|Physician Decision|1|||
164086252|NCT00321711|592679978|FG002|Part A|Physician Decision|3|||
164086253|NCT00321711|592679979|FG003|Part A|Physician Decision|0|||
164086254|NCT00321711|592679980|FG004|Part A|Physician Decision|0|||
164086255|NCT00321711|592679976|FG000|Part A|Other|1|||
164086256|NCT00321711|592679977|FG001|Part A|Other|2|||
164086257|NCT00321711|592679978|FG002|Part A|Other|3|||
164086258|NCT00321711|592679979|FG003|Part A|Other|0|||
164086259|NCT00321711|592679980|FG004|Part A|Other|0|||
164086260|NCT00321711|592679976|FG000|Part A|Protocol deviation|0|||
164086261|NCT00321711|592679977|FG001|Part A|Protocol deviation|0|||
163895951|NCT02246127|591992592|FG001|First Course Treatment|Not treated|3|||
164086262|NCT00321711|592679978|FG002|Part A|Protocol deviation|1|||
163895952|NCT05988398|591992593|FG000|Overall Study|Lack of time|21|||
163895953|NCT05988398|591992594|FG001|Overall Study|Lack of time|0|||
163895954|NCT05988398|591992593|FG000|Overall Study|Absent from school|0|||
163895955|NCT05988398|591992594|FG001|Overall Study|Absent from school|38|||
163895956|NCT05988398|591992593|FG000|Overall Study|Chose not to participate|0|||
163895957|NCT05988398|591992594|FG001|Overall Study|Chose not to participate|42|||
163895958|NCT05988398|591992593|FG000|Overall Study|Other commitments (e.g., sports)|0|||
163895959|NCT05988398|591992594|FG001|Overall Study|Other commitments (e.g., sports)|25|||
163895960|NCT03733626|591992596|FG000|Overall Study|Physician Decision|4|||
163895961|NCT03733626|591992597|FG001|Overall Study|Physician Decision|4|||
163895962|NCT05147584|591992598|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
163895963|NCT03370913|591992599|FG000|Overall Study|Death|1|||
163895964|NCT03370913|591992599|FG000|Overall Study|Lost to Follow-up|1|||
163895965|NCT04560179|591992600|FG000|Overall Study|Physician Decision|1|||
163895966|NCT04560179|591992601|FG001|Overall Study|Physician Decision|0|||
163895967|NCT04560179|591992602|FG002|Overall Study|Physician Decision|0|||
163895968|NCT04560179|591992603|FG003|Overall Study|Physician Decision|0|||
163895969|NCT04560179|591992604|FG004|Overall Study|Physician Decision|0|||
163895970|NCT04560179|591992600|FG000|Overall Study|Adverse Event|0|||
163895971|NCT04560179|591992601|FG001|Overall Study|Adverse Event|0|||
163895972|NCT04560179|591992602|FG002|Overall Study|Adverse Event|0|||
163895973|NCT04560179|591992603|FG003|Overall Study|Adverse Event|1|||
163895974|NCT04560179|591992604|FG004|Overall Study|Adverse Event|0|||
163895975|NCT04078152|591992605|FG000|Overall Study|Other|83|||
163895976|NCT04078152|591992606|FG001|Overall Study|Other|22|||
164086263|NCT00321711|592679979|FG003|Part A|Protocol deviation|0|||
164086264|NCT00321711|592679980|FG004|Part A|Protocol deviation|0|||
164086265|NCT00321711|592679976|FG000|Part B|Noncompliance|0|||
164086266|NCT00321711|592679977|FG001|Part B|Noncompliance|0|||
164086267|NCT00321711|592679978|FG002|Part B|Noncompliance|0|||
164086268|NCT00321711|592679979|FG003|Part B|Noncompliance|0|||
164086269|NCT00321711|592679980|FG004|Part B|Noncompliance|1|||
164086270|NCT00321711|592679976|FG000|Part B|Adverse Event|0|||
164086271|NCT00321711|592679977|FG001|Part B|Adverse Event|0|||
164086272|NCT00321711|592679978|FG002|Part B|Adverse Event|0|||
164086273|NCT00321711|592679979|FG003|Part B|Adverse Event|2|||
164086274|NCT00321711|592679980|FG004|Part B|Adverse Event|1|||
164344434|NCT00867568|593636931|FG000|Overall Study|Adverse Event|4|||
164344435|NCT00867568|593636931|FG000|Overall Study|Withdrawal by Subject|1|||
164344436|NCT01056653|593636932|FG000|Overall Study|Lost to Follow-up|0|||
164344437|NCT01056653|593636933|FG001|Overall Study|Lost to Follow-up|0|||
164344438|NCT01056653|593636934|FG002|Overall Study|Lost to Follow-up|2|||
164344439|NCT05275400|593636935|FG000|Treatment Period|Adverse Event|7|||
164344440|NCT05275400|593636936|FG001|Treatment Period|Adverse Event|1|||
164344441|NCT05275400|593636935|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
164344442|NCT05275400|593636936|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
164344443|NCT05275400|593636935|FG000|Treatment Period|Death|5|||
164344444|NCT05275400|593636936|FG001|Treatment Period|Death|2|||
164344445|NCT05275400|593636935|FG000|Treatment Period|Protocol Violation|1|||
164344446|NCT05275400|593636936|FG001|Treatment Period|Protocol Violation|0|||
164344447|NCT05275400|593636935|FG000|Treatment Period|Physician Decision|5|||
164344448|NCT05275400|593636936|FG001|Treatment Period|Physician Decision|4|||
164344449|NCT05275400|593636935|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
164344450|NCT05275400|593636936|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
164344451|NCT05275400|593636935|FG000|Treatment Period|Withdrawal by Subject|30|||
164344452|NCT05275400|593636936|FG001|Treatment Period|Withdrawal by Subject|12|||
164344453|NCT05275400|593636935|FG000|Treatment Period|Lost to Follow-up|1|||
164344454|NCT05275400|593636936|FG001|Treatment Period|Lost to Follow-up|5|||
164344455|NCT05275400|593636935|FG000|Treatment Period|Lack of Efficacy|1|||
164344456|NCT05275400|593636936|FG001|Treatment Period|Lack of Efficacy|0|||
164344457|NCT05275400|593636935|FG000|Treatment Period|Sponsor Decision|1|||
164344458|NCT05275400|593636936|FG001|Treatment Period|Sponsor Decision|0|||
164344459|NCT05275400|593636935|FG000|Follow-Up Period|Death|2|||
164344460|NCT05275400|593636936|FG001|Follow-Up Period|Death|0|||
164001626|NCT02305563|592368577|FG001|Treatment Period|other reason|0|||
164001627|NCT02305563|592368578|FG002|Treatment Period|other reason|2|||
164001628|NCT02305563|592368579|FG003|Treatment Period|other reason|2|||
164001629|NCT02305563|592368580|FG004|Treatment Period|other reason|1|||
164001630|NCT02305563|592368576|FG000|Treatment Period|Randomized but not treated|0|||
164001631|NCT02305563|592368577|FG001|Treatment Period|Randomized but not treated|0|||
164001632|NCT02305563|592368578|FG002|Treatment Period|Randomized but not treated|0|||
164344461|NCT05275400|593636935|FG000|Follow-Up Period|Protocol Violation|1|||
164001633|NCT02305563|592368579|FG003|Treatment Period|Randomized but not treated|0|||
164001634|NCT02305563|592368580|FG004|Treatment Period|Randomized but not treated|2|||
164344462|NCT05275400|593636936|FG001|Follow-Up Period|Protocol Violation|0|||
164344463|NCT05275400|593636935|FG000|Follow-Up Period|Withdrawal by Subject|3|||
164344464|NCT05275400|593636936|FG001|Follow-Up Period|Withdrawal by Subject|0|||
164344465|NCT01651039|593636938|FG000|Overall Study|Non-evaluables|5|||
164344466|NCT01651039|593636938|FG000|Overall Study|Physician Decision|2|||
164344467|NCT01651039|593636938|FG000|Overall Study|Withdrawal by Subject|1|||
164086275|NCT00321711|592679976|FG000|Part B|Disease progression|0|||
164086276|NCT00321711|592679977|FG001|Part B|Disease progression|0|||
164086277|NCT00321711|592679978|FG002|Part B|Disease progression|0|||
164086278|NCT00321711|592679979|FG003|Part B|Disease progression|1|||
164086279|NCT00321711|592679980|FG004|Part B|Disease progression|0|||
164086280|NCT00321711|592679976|FG000|Part B|Physician Decision|0|||
164086281|NCT00321711|592679977|FG001|Part B|Physician Decision|0|||
164086282|NCT00321711|592679978|FG002|Part B|Physician Decision|0|||
164086283|NCT00321711|592679979|FG003|Part B|Physician Decision|1|||
164001635|NCT02305563|592368576|FG000|Treatment Period|added ULO, then disease progression|0|||
164001636|NCT02305563|592368577|FG001|Treatment Period|added ULO, then disease progression|0|||
164001637|NCT02305563|592368578|FG002|Treatment Period|added ULO, then disease progression|0|||
164001638|NCT02305563|592368579|FG003|Treatment Period|added ULO, then disease progression|0|||
164001639|NCT02305563|592368580|FG004|Treatment Period|added ULO, then disease progression|4|||
164086284|NCT00321711|592679980|FG004|Part B|Physician Decision|2|||
164086285|NCT00321711|592679976|FG000|Part B|Death|0|||
164086286|NCT00321711|592679977|FG001|Part B|Death|0|||
164086287|NCT00321711|592679978|FG002|Part B|Death|0|||
164086288|NCT00321711|592679979|FG003|Part B|Death|2|||
164086289|NCT00321711|592679980|FG004|Part B|Death|1|||
164086290|NCT00543439|592679981|FG000|Period 1|Adverse Event|0|||
164281362|NCT00095173|593400664|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
164281363|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Death|0|||
164281364|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Death|0|||
164281365|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Death|0|||
164281366|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Death|0|||
164281367|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Death|0|||
164281368|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Death|1|||
164281369|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
164281370|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
164281371|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
163895977|NCT04078152|591992607|FG002|Overall Study|Other|25|||
163895978|NCT04078152|591992605|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
163895979|NCT04078152|591992606|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
163895980|NCT04078152|591992607|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
163895981|NCT04078152|591992605|FG000|Overall Study|Withdrawal by Subject|5|||
163895982|NCT04078152|591992606|FG001|Overall Study|Withdrawal by Subject|0|||
164001640|NCT02305563|592368576|FG000|Treatment Period|added ULO; then other reason|0|||
164001641|NCT02305563|592368577|FG001|Treatment Period|added ULO; then other reason|0|||
164001642|NCT02305563|592368578|FG002|Treatment Period|added ULO; then other reason|0|||
164001643|NCT02305563|592368579|FG003|Treatment Period|added ULO; then other reason|0|||
164001644|NCT02305563|592368580|FG004|Treatment Period|added ULO; then other reason|1|||
164001645|NCT02305563|592368576|FG000|Treatment Period|added ULO, then request to stop|0|||
164086291|NCT00543439|592679982|FG001|Period 1|Adverse Event|2|||
164086292|NCT00543439|592679983|FG002|Period 1|Adverse Event|1|||
164086293|NCT00543439|592679981|FG000|Period 1|Withdrawal by Subject|1|||
164086294|NCT00543439|592679982|FG001|Period 1|Withdrawal by Subject|1|||
164281372|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
164281373|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
164281374|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
164281375|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
164281376|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
163895983|NCT04078152|591992607|FG002|Overall Study|Withdrawal by Subject|1|||
163895984|NCT04078152|591992605|FG000|Overall Study|Death|10|||
163895985|NCT04078152|591992606|FG001|Overall Study|Death|2|||
163895986|NCT04078152|591992607|FG002|Overall Study|Death|12|||
163895987|NCT04078152|591992605|FG000|Overall Study|Adverse Event|1|||
163895988|NCT04078152|591992606|FG001|Overall Study|Adverse Event|0|||
163895989|NCT04078152|591992607|FG002|Overall Study|Adverse Event|0|||
163895990|NCT05454514|591992613|FG000|Overall Study|Withdrawal by Subject|4|||
163895991|NCT04795245|591992614|FG000|Overall Study|Unkown reason|7|||
163895992|NCT04795245|591992614|FG000|Overall Study|Death|17|||
163895993|NCT04795245|591992614|FG000|Overall Study|Other than listed|19|||
164086295|NCT00543439|592679983|FG002|Period 1|Withdrawal by Subject|0|||
164086296|NCT00543439|592679981|FG000|Period 1|Physician Decision|0|||
164281377|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
164281378|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
164281379|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
164281380|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
163895994|NCT04795245|591992614|FG000|Overall Study|Adverse Event|143|||
163895995|NCT04795245|591992614|FG000|Overall Study|Progressive disease|512|||
163895996|NCT04795245|591992614|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
164086297|NCT00543439|592679982|FG001|Period 1|Physician Decision|0|||
164086298|NCT00543439|592679983|FG002|Period 1|Physician Decision|1|||
164086299|NCT00543439|592679981|FG000|Period 2|Protocol Violation|1|||
164001646|NCT02305563|592368577|FG001|Treatment Period|added ULO, then request to stop|0|||
164001647|NCT02305563|592368578|FG002|Treatment Period|added ULO, then request to stop|0|||
164001648|NCT02305563|592368579|FG003|Treatment Period|added ULO, then request to stop|0|||
164001649|NCT02305563|592368580|FG004|Treatment Period|added ULO, then request to stop|1|||
164001650|NCT02305563|592368576|FG000|Follow-up Period|Death|0|||
164001651|NCT02305563|592368577|FG001|Follow-up Period|Death|0|||
164001652|NCT02305563|592368578|FG002|Follow-up Period|Death|5|||
164281381|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
164281382|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
164086300|NCT00543439|592679982|FG001|Period 2|Protocol Violation|0|||
164086301|NCT00543439|592679983|FG002|Period 2|Protocol Violation|1|||
164086302|NCT00543439|592679981|FG000|Period 2|Adverse Event|0|||
164086303|NCT00543439|592679982|FG001|Period 2|Adverse Event|1|||
164001653|NCT02305563|592368579|FG003|Follow-up Period|Death|4|||
164001654|NCT02305563|592368580|FG004|Follow-up Period|Death|7|||
164001655|NCT02305563|592368576|FG000|Follow-up Period|Participant withdrew consent|0|||
164001656|NCT02305563|592368577|FG001|Follow-up Period|Participant withdrew consent|0|||
164001657|NCT02305563|592368578|FG002|Follow-up Period|Participant withdrew consent|2|||
164001658|NCT02305563|592368579|FG003|Follow-up Period|Participant withdrew consent|1|||
164001659|NCT02305563|592368580|FG004|Follow-up Period|Participant withdrew consent|0|||
164001660|NCT02305563|592368576|FG000|Follow-up Period|other reason|0|||
164001661|NCT02305563|592368577|FG001|Follow-up Period|other reason|0|||
164001662|NCT02305563|592368578|FG002|Follow-up Period|other reason|0|||
164001663|NCT02305563|592368579|FG003|Follow-up Period|other reason|0|||
164001664|NCT02305563|592368580|FG004|Follow-up Period|other reason|1|||
164086304|NCT00543439|592679983|FG002|Period 2|Adverse Event|1|||
164086305|NCT03264066|592679986|FG000|Overall Study|Adverse Event|1|||
164086306|NCT03264066|592679987|FG001|Overall Study|Adverse Event|1|||
164086307|NCT03264066|592679988|FG002|Overall Study|Adverse Event|0|||
164086308|NCT03264066|592679989|FG003|Overall Study|Adverse Event|0|||
164086309|NCT03264066|592679990|FG004|Overall Study|Adverse Event|0|||
164086310|NCT03264066|592679991|FG005|Overall Study|Adverse Event|0|||
164086311|NCT03264066|592679986|FG000|Overall Study|Death|12|||
164086312|NCT03264066|592679987|FG001|Overall Study|Death|12|||
164001665|NCT02305563|592368576|FG000|Follow-up Period|Followup no longer required per protocol|3|||
164001666|NCT02305563|592368577|FG001|Follow-up Period|Followup no longer required per protocol|3|||
164001667|NCT02305563|592368578|FG002|Follow-up Period|Followup no longer required per protocol|4|||
164001668|NCT02305563|592368579|FG003|Follow-up Period|Followup no longer required per protocol|1|||
164086313|NCT03264066|592679988|FG002|Overall Study|Death|8|||
164086314|NCT03264066|592679989|FG003|Overall Study|Death|10|||
164086315|NCT03264066|592679990|FG004|Overall Study|Death|6|||
164086316|NCT03264066|592679991|FG005|Overall Study|Death|1|||
164086317|NCT03264066|592679986|FG000|Overall Study|Lost to Follow-up|1|||
164086318|NCT03264066|592679987|FG001|Overall Study|Lost to Follow-up|0|||
164086319|NCT03264066|592679988|FG002|Overall Study|Lost to Follow-up|0|||
164086320|NCT03264066|592679989|FG003|Overall Study|Lost to Follow-up|0|||
164086321|NCT03264066|592679990|FG004|Overall Study|Lost to Follow-up|0|||
164086322|NCT03264066|592679991|FG005|Overall Study|Lost to Follow-up|0|||
164086323|NCT03264066|592679986|FG000|Overall Study|Progressive Disease|0|||
164086324|NCT03264066|592679987|FG001|Overall Study|Progressive Disease|2|||
164281383|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
164281384|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
164281385|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
164001669|NCT02305563|592368580|FG004|Follow-up Period|Followup no longer required per protocol|4|||
164001670|NCT01275222|592368582|FG000|Phase l by Treatment|Adverse Event|1|||
164001671|NCT01275222|592368583|FG001|Phase l by Treatment|Adverse Event|4|||
164001672|NCT01275222|592368584|FG002|Phase l by Treatment|Adverse Event|2|||
164281386|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
164281387|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281388|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281389|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281390|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
164281391|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
164281392|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
164281393|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164281394|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164344468|NCT01651039|593636938|FG000|Overall Study|Progressive Disease|22|||
164001673|NCT01275222|592368585|FG003|Phase l by Treatment|Adverse Event|3|||
164086325|NCT03264066|592679988|FG002|Overall Study|Progressive Disease|1|||
164086326|NCT03264066|592679989|FG003|Overall Study|Progressive Disease|0|||
164086327|NCT03264066|592679990|FG004|Overall Study|Progressive Disease|0|||
164086328|NCT03264066|592679991|FG005|Overall Study|Progressive Disease|0|||
164086329|NCT03264066|592679986|FG000|Overall Study|Study Terminated by Sponsor|5|||
164086330|NCT03264066|592679987|FG001|Overall Study|Study Terminated by Sponsor|5|||
164086331|NCT03264066|592679988|FG002|Overall Study|Study Terminated by Sponsor|8|||
164086332|NCT03264066|592679989|FG003|Overall Study|Study Terminated by Sponsor|5|||
164086333|NCT03264066|592679990|FG004|Overall Study|Study Terminated by Sponsor|1|||
164086334|NCT03264066|592679991|FG005|Overall Study|Study Terminated by Sponsor|2|||
164086335|NCT03264066|592679986|FG000|Overall Study|Withdrawal by Subject|1|||
164086336|NCT03264066|592679987|FG001|Overall Study|Withdrawal by Subject|0|||
164086337|NCT03264066|592679988|FG002|Overall Study|Withdrawal by Subject|0|||
164086338|NCT03264066|592679989|FG003|Overall Study|Withdrawal by Subject|5|||
164086339|NCT03264066|592679990|FG004|Overall Study|Withdrawal by Subject|0|||
164086340|NCT03264066|592679991|FG005|Overall Study|Withdrawal by Subject|0|||
164086341|NCT01484028|592679992|FG000|Period 1|Lost to Follow-up|0|||
164086342|NCT01484028|592679993|FG001|Period 1|Lost to Follow-up|1|||
164086343|NCT01484028|592679994|FG002|Period 1|Lost to Follow-up|0|||
164086344|NCT01484028|592679995|FG003|Period 1|Lost to Follow-up|0|||
164086345|NCT01484028|592679992|FG000|Period 1|Non-Compliance to Protocol|0|||
164086346|NCT01484028|592679993|FG001|Period 1|Non-Compliance to Protocol|1|||
164086347|NCT01484028|592679994|FG002|Period 1|Non-Compliance to Protocol|0|||
164086348|NCT01484028|592679995|FG003|Period 1|Non-Compliance to Protocol|1|||
164086349|NCT01484028|592679992|FG000|Period 1|Lens Discomfort|0|||
164086350|NCT01484028|592679993|FG001|Period 1|Lens Discomfort|1|||
164086351|NCT01484028|592679994|FG002|Period 1|Lens Discomfort|0|||
164086352|NCT01484028|592679995|FG003|Period 1|Lens Discomfort|0|||
164086353|NCT00146770|592680011|FG000|Overall Study|Adverse Event|2|||
164086354|NCT00146770|592680012|FG001|Overall Study|Adverse Event|0|||
164086355|NCT00146770|592680011|FG000|Overall Study|Pregnancy|1|||
164086356|NCT00146770|592680012|FG001|Overall Study|Pregnancy|0|||
164086357|NCT00146770|592680011|FG000|Overall Study|Withdrawal by Subject|2|||
164086358|NCT00146770|592680012|FG001|Overall Study|Withdrawal by Subject|0|||
164086359|NCT02826603|592680015|FG000|Overall Study|Adverse Event|17|||
164086360|NCT02826603|592680016|FG001|Overall Study|Adverse Event|9|||
164086361|NCT02826603|592680015|FG000|Overall Study|Lack of Efficacy|4|||
163895997|NCT03279978|591992616|FG000|Overall Study|Withdrawal by Subject|0|||
163895998|NCT03279978|591992617|FG001|Overall Study|Withdrawal by Subject|1|||
163895999|NCT03279978|591992618|FG002|Overall Study|Withdrawal by Subject|0|||
163896000|NCT03279978|591992619|FG003|Overall Study|Withdrawal by Subject|0|||
163896001|NCT03279978|591992620|FG004|Overall Study|Withdrawal by Subject|0|||
163896002|NCT03279978|591992621|FG005|Overall Study|Withdrawal by Subject|0|||
163896003|NCT03279978|591992622|FG006|Overall Study|Withdrawal by Subject|0|||
163896004|NCT03279978|591992623|FG007|Overall Study|Withdrawal by Subject|0|||
163896005|NCT03279978|591992624|FG008|Overall Study|Withdrawal by Subject|0|||
163896006|NCT03279978|591992625|FG009|Overall Study|Withdrawal by Subject|1|||
163896007|NCT03279978|591992616|FG000|Overall Study|Lost to Follow-up|1|||
163896008|NCT03279978|591992617|FG001|Overall Study|Lost to Follow-up|0|||
163896009|NCT03279978|591992618|FG002|Overall Study|Lost to Follow-up|1|||
163896010|NCT03279978|591992619|FG003|Overall Study|Lost to Follow-up|0|||
163896011|NCT03279978|591992620|FG004|Overall Study|Lost to Follow-up|0|||
163896012|NCT03279978|591992621|FG005|Overall Study|Lost to Follow-up|0|||
163896013|NCT03279978|591992622|FG006|Overall Study|Lost to Follow-up|0|||
163896014|NCT03279978|591992623|FG007|Overall Study|Lost to Follow-up|0|||
163896015|NCT03279978|591992624|FG008|Overall Study|Lost to Follow-up|0|||
163896016|NCT03279978|591992625|FG009|Overall Study|Lost to Follow-up|0|||
163896017|NCT03279978|591992616|FG000|Overall Study|Other than stated above|0|||
163896018|NCT03279978|591992617|FG001|Overall Study|Other than stated above|0|||
163896019|NCT03279978|591992618|FG002|Overall Study|Other than stated above|0|||
163896020|NCT03279978|591992619|FG003|Overall Study|Other than stated above|0|||
163896021|NCT03279978|591992620|FG004|Overall Study|Other than stated above|0|||
163896022|NCT03279978|591992621|FG005|Overall Study|Other than stated above|0|||
163896023|NCT03279978|591992622|FG006|Overall Study|Other than stated above|1|||
163896024|NCT03279978|591992623|FG007|Overall Study|Other than stated above|0|||
163896025|NCT03279978|591992624|FG008|Overall Study|Other than stated above|0|||
163896026|NCT03279978|591992625|FG009|Overall Study|Other than stated above|0|||
163896027|NCT02461134|591992627|FG000|Overall Study|Adverse Event|1|||
163896028|NCT04159519|591992628|FG000|Overall Study|Adverse Event|1|||
163896029|NCT04159519|591992629|FG001|Overall Study|Adverse Event|1|||
163896030|NCT04159519|591992628|FG000|Overall Study|Lack of Efficacy|1|||
163896031|NCT04159519|591992629|FG001|Overall Study|Lack of Efficacy|0|||
163896032|NCT04159519|591992628|FG000|Overall Study|Discontinued from study|1|||
163896033|NCT04159519|591992629|FG001|Overall Study|Discontinued from study|0|||
163896034|NCT04159519|591992628|FG000|Overall Study|Protocol Violation|1|||
163896035|NCT04159519|591992629|FG001|Overall Study|Protocol Violation|1|||
163896036|NCT04159519|591992628|FG000|Overall Study|Withdrawal by Subject|4|||
163896037|NCT04159519|591992629|FG001|Overall Study|Withdrawal by Subject|4|||
163896038|NCT03493542|591992632|FG000|Base Study|Withdrawal by Subject|0|||
163896039|NCT03493542|591992633|FG001|Base Study|Withdrawal by Subject|4|||
163896040|NCT03493542|591992634|FG002|Base Study|Withdrawal by Subject|0|||
164086362|NCT02826603|592680016|FG001|Overall Study|Lack of Efficacy|9|||
164086363|NCT02826603|592680015|FG000|Overall Study|Lost to Follow-up|13|||
164086364|NCT02826603|592680016|FG001|Overall Study|Lost to Follow-up|12|||
164086365|NCT02826603|592680015|FG000|Overall Study|Noncompliance with treatment|0|||
163896041|NCT03493542|591992632|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
163896042|NCT03493542|591992633|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
163896043|NCT03493542|591992634|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
163896044|NCT03493542|591992632|FG000|Extension Study|Withdrawal by Subject|0|||
163896045|NCT03493542|591992633|FG001|Extension Study|Withdrawal by Subject|0|||
163896046|NCT03493542|591992634|FG002|Extension Study|Withdrawal by Subject|25|||
163896047|NCT01651000|591992635|FG000|Overall Study|Adverse Event|2|||
163896048|NCT01651000|591992636|FG001|Overall Study|Adverse Event|8|||
163896049|NCT01651000|591992635|FG000|Overall Study|Lost to Follow-up|3|||
163896050|NCT01651000|591992636|FG001|Overall Study|Lost to Follow-up|2|||
163896051|NCT01651000|591992635|FG000|Overall Study|Protocol Violation|0|||
163896052|NCT01651000|591992636|FG001|Overall Study|Protocol Violation|3|||
163896053|NCT01651000|591992635|FG000|Overall Study|Withdrawal by Subject|2|||
163896054|NCT01651000|591992636|FG001|Overall Study|Withdrawal by Subject|10|||
163896055|NCT01651000|591992635|FG000|Overall Study|Subject noncompliance|0|||
163896056|NCT01651000|591992636|FG001|Overall Study|Subject noncompliance|3|||
163896057|NCT01651000|591992635|FG000|Overall Study|Lack of Efficacy|1|||
163896058|NCT01651000|591992636|FG001|Overall Study|Lack of Efficacy|1|||
163896059|NCT01651000|591992635|FG000|Overall Study|Physician Decision|1|||
163896060|NCT01651000|591992636|FG001|Overall Study|Physician Decision|0|||
163896061|NCT01651000|591992635|FG000|Overall Study|Administrative reason|1|||
163896062|NCT01651000|591992636|FG001|Overall Study|Administrative reason|0|||
164086366|NCT02826603|592680016|FG001|Overall Study|Noncompliance with treatment|2|||
164086367|NCT02826603|592680015|FG000|Overall Study|Physician Decision|1|||
164086368|NCT02826603|592680016|FG001|Overall Study|Physician Decision|7|||
164086369|NCT02826603|592680015|FG000|Overall Study|Pregnancy|1|||
164086370|NCT02826603|592680016|FG001|Overall Study|Pregnancy|2|||
164086371|NCT02826603|592680015|FG000|Overall Study|Protocol Violation|3|||
164086372|NCT02826603|592680016|FG001|Overall Study|Protocol Violation|3|||
164281395|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
163896063|NCT01651000|591992635|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
163896064|NCT01651000|591992636|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
163896065|NCT02765412|591992637|FG000|Overall Study|Death|482|||
163896066|NCT02765412|591992638|FG001|Overall Study|Death|855|||
163896067|NCT04595331|591993483|FG000|Overall Study|Withdrawal by Subject|0|||
163896068|NCT04595331|591993484|FG001|Overall Study|Withdrawal by Subject|1|||
163896069|NCT04595331|591993483|FG000|Overall Study|Lost to Follow-up|0|||
163896070|NCT04595331|591993484|FG001|Overall Study|Lost to Follow-up|5|||
163896071|NCT04595331|591993483|FG000|Overall Study|Medical reason|0|||
164001674|NCT01275222|592368586|FG004|Phase l by Treatment|Adverse Event|0|||
164001675|NCT01275222|592368587|FG005|Phase l by Treatment|Adverse Event|0|||
164001676|NCT01275222|592368582|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164001677|NCT01275222|592368583|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164001678|NCT01275222|592368584|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
164001679|NCT01275222|592368585|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164001680|NCT01275222|592368586|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164001681|NCT01275222|592368587|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
164001682|NCT01275222|592368582|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164001683|NCT01275222|592368583|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164001684|NCT01275222|592368584|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164001685|NCT01275222|592368585|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
164001686|NCT01275222|592368586|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164001687|NCT01275222|592368587|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
164001688|NCT01275222|592368582|FG000|Phase l by Treatment|Disease progression|12|||
164001689|NCT01275222|592368583|FG001|Phase l by Treatment|Disease progression|8|||
164001690|NCT01275222|592368584|FG002|Phase l by Treatment|Disease progression|2|||
164001691|NCT01275222|592368585|FG003|Phase l by Treatment|Disease progression|5|||
164001692|NCT01275222|592368586|FG004|Phase l by Treatment|Disease progression|0|||
164001693|NCT01275222|592368587|FG005|Phase l by Treatment|Disease progression|0|||
164281396|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
164281397|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
164281398|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
164281399|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281400|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281401|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281402|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
164281403|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
164281404|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
163896072|NCT04595331|591993484|FG001|Overall Study|Medical reason|1|||
163896073|NCT05020353|591993487|FG000|Overall Study|Protocol Violation|7|||
163896074|NCT05020353|591993487|FG000|Overall Study|Withdrawal by Subject|33|||
163896075|NCT02611687|591993488|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
164086373|NCT02826603|592680015|FG000|Overall Study|Withdrawal by Subject|20|||
164001694|NCT01275222|592368582|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
164281405|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
164281406|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
164281407|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
164281408|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
164281409|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
164281410|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
164281411|NCT00095173|593400659|FG000|Open-Label Extension Phase (Period C)|Other|0|||
164001695|NCT01275222|592368583|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
164001696|NCT01275222|592368584|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
164001697|NCT01275222|592368585|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
164001698|NCT01275222|592368586|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
164001699|NCT01275222|592368587|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
164001700|NCT01275222|592368582|FG000|Phase l by Treatment|Death|0|||
164001701|NCT01275222|592368583|FG001|Phase l by Treatment|Death|1|||
164001702|NCT01275222|592368584|FG002|Phase l by Treatment|Death|0|||
164001703|NCT01275222|592368585|FG003|Phase l by Treatment|Death|1|||
164001704|NCT01275222|592368586|FG004|Phase l by Treatment|Death|0|||
164001705|NCT01275222|592368587|FG005|Phase l by Treatment|Death|0|||
164001706|NCT01275222|592368582|FG000|Phase ll by Stratum|Adverse Event|0|||
164001707|NCT01275222|592368583|FG001|Phase ll by Stratum|Adverse Event|0|||
164001708|NCT01275222|592368584|FG002|Phase ll by Stratum|Adverse Event|0|||
164001709|NCT01275222|592368585|FG003|Phase ll by Stratum|Adverse Event|0|||
164001710|NCT01275222|592368586|FG004|Phase ll by Stratum|Adverse Event|2|||
164001711|NCT01275222|592368587|FG005|Phase ll by Stratum|Adverse Event|10|||
164001712|NCT01275222|592368582|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
164001713|NCT01275222|592368583|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
164001714|NCT01275222|592368584|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
164001715|NCT01275222|592368585|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
164001716|NCT01275222|592368586|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
164001717|NCT01275222|592368587|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
164001718|NCT01275222|592368582|FG000|Phase ll by Stratum|Disease progression|0|||
164001719|NCT01275222|592368583|FG001|Phase ll by Stratum|Disease progression|0|||
164001720|NCT01275222|592368584|FG002|Phase ll by Stratum|Disease progression|0|||
164001721|NCT01275222|592368585|FG003|Phase ll by Stratum|Disease progression|0|||
164001722|NCT01275222|592368586|FG004|Phase ll by Stratum|Disease progression|23|||
164001723|NCT01275222|592368587|FG005|Phase ll by Stratum|Disease progression|31|||
164001724|NCT01275222|592368582|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
164001725|NCT01275222|592368583|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
164001726|NCT01275222|592368584|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
164001727|NCT01275222|592368585|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
164001728|NCT01275222|592368586|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
164001729|NCT01275222|592368587|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
164001730|NCT01275222|592368582|FG000|Phase ll by Stratum|Death|0|||
164001731|NCT01275222|592368583|FG001|Phase ll by Stratum|Death|0|||
164001732|NCT01275222|592368584|FG002|Phase ll by Stratum|Death|0|||
164001733|NCT01275222|592368585|FG003|Phase ll by Stratum|Death|0|||
164001734|NCT01275222|592368586|FG004|Phase ll by Stratum|Death|1|||
164001735|NCT01275222|592368587|FG005|Phase ll by Stratum|Death|1|||
164001736|NCT00655928|592368588|FG000|Overall Study|Withdrawal by Subject|2|||
164001737|NCT00655928|592368589|FG001|Overall Study|Withdrawal by Subject|1|||
164001738|NCT00655928|592368588|FG000|Overall Study|Physician Decision|1|||
164001739|NCT00655928|592368589|FG001|Overall Study|Physician Decision|1|||
164001740|NCT02370121|592368590|FG000|Overall Study|Lost to Follow-up|1|||
164001741|NCT02370121|592368591|FG001|Overall Study|Lost to Follow-up|1|||
164001742|NCT02654002|592368598|FG000|Overall Study|Adverse Event|0|||
164001743|NCT02654002|592368599|FG001|Overall Study|Adverse Event|0|||
164001744|NCT02654002|592368600|FG002|Overall Study|Adverse Event|0|||
164001745|NCT02654002|592368601|FG003|Overall Study|Adverse Event|0|||
164001746|NCT02654002|592368602|FG004|Overall Study|Adverse Event|0|||
164001747|NCT02654002|592368603|FG005|Overall Study|Adverse Event|0|||
164001748|NCT02654002|592368604|FG006|Overall Study|Adverse Event|1|||
164001749|NCT02654002|592368605|FG007|Overall Study|Adverse Event|0|||
164001750|NCT02654002|592368606|FG008|Overall Study|Adverse Event|0|||
164001751|NCT02654002|592368598|FG000|Overall Study|Withdrew Consent|0|||
164001752|NCT02654002|592368599|FG001|Overall Study|Withdrew Consent|0|||
164001753|NCT02654002|592368600|FG002|Overall Study|Withdrew Consent|0|||
164001754|NCT02654002|592368601|FG003|Overall Study|Withdrew Consent|0|||
164001755|NCT02654002|592368602|FG004|Overall Study|Withdrew Consent|0|||
164001756|NCT02654002|592368603|FG005|Overall Study|Withdrew Consent|1|||
164281412|NCT00095173|593400660|FG001|Open-Label Extension Phase (Period C)|Other|0|||
164281413|NCT00095173|593400661|FG002|Open-Label Extension Phase (Period C)|Other|0|||
164001757|NCT02654002|592368604|FG006|Overall Study|Withdrew Consent|0|||
164001758|NCT02654002|592368605|FG007|Overall Study|Withdrew Consent|1|||
164001759|NCT02654002|592368606|FG008|Overall Study|Withdrew Consent|0|||
164001760|NCT05262764|592368610|FG000|Overall Study|Case report form not collected|9|||
164001761|NCT05262764|592368610|FG000|Overall Study|No patient visits after entry|23|||
163896076|NCT02611687|591993489|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
163896077|NCT03934931|591993490|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
163896078|NCT03934931|591993491|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
163896079|NCT03934931|591993492|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
163896080|NCT03635567|591993495|FG000|Overall Study|Lost to Follow-up|4|||
163896081|NCT03635567|591993496|FG001|Overall Study|Lost to Follow-up|1|||
163896082|NCT03635567|591993495|FG000|Overall Study|Withdrawal by Subject|11|||
163896083|NCT03635567|591993496|FG001|Overall Study|Withdrawal by Subject|16|||
164001762|NCT05262764|592368610|FG000|Overall Study|Registration rule not followed|2|||
164001763|NCT05262764|592368610|FG000|Overall Study|Patient of non-chronic heart failure|1|||
163896084|NCT03635567|591993495|FG000|Overall Study|Sponsor Decision|99|||
163896085|NCT03635567|591993496|FG001|Overall Study|Sponsor Decision|57|||
164001764|NCT00275561|592368611|FG000|Overall Study|Withdrawal by Subject|0|||
164001765|NCT00275561|592368612|FG001|Overall Study|Withdrawal by Subject|1|||
164001766|NCT00275561|592368611|FG000|Overall Study|Travel|1|||
164001767|NCT00275561|592368612|FG001|Overall Study|Travel|1|||
164001768|NCT00275561|592368611|FG000|Overall Study|Scheduling|1|||
164001769|NCT00275561|592368612|FG001|Overall Study|Scheduling|2|||
164001770|NCT00275561|592368611|FG000|Overall Study|Family Issues|0|||
164001771|NCT00275561|592368612|FG001|Overall Study|Family Issues|2|||
164001772|NCT01769105|592368613|FG000|First Intervention|Protocol Violation|2|||
164001773|NCT01769105|592368614|FG001|First Intervention|Protocol Violation|2|||
164001774|NCT01769105|592368613|FG000|Cross-over|Lost to Follow-up|5|||
164001775|NCT01769105|592368614|FG001|Cross-over|Lost to Follow-up|0|||
164001776|NCT00684177|592368619|FG000|Overall Study|Adverse Event|4|||
164001777|NCT00684177|592368620|FG001|Overall Study|Adverse Event|3|||
164001778|NCT00684177|592368619|FG000|Overall Study|Lack of Efficacy|10|||
163896086|NCT03635567|591993495|FG000|Overall Study|Death|194|||
163896087|NCT03635567|591993496|FG001|Overall Study|Death|235|||
163896088|NCT05157841|591993497|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
163896089|NCT05157841|591993498|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
163896090|NCT05157841|591993499|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
163896091|NCT05157841|591993497|FG000|Part A (14 Days)|Adverse Event|1|||
163896092|NCT05157841|591993498|FG001|Part A (14 Days)|Adverse Event|0|||
163896093|NCT05157841|591993499|FG002|Part A (14 Days)|Adverse Event|0|||
163896094|NCT05157841|591993497|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
163896095|NCT05157841|591993498|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
163896096|NCT05157841|591993499|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
163896097|NCT02075554|591993501|FG000|Overall Study|Lost to Follow-up|7|||
163896098|NCT02075554|591993501|FG000|Overall Study|Withdrawal by Subject|5|||
163896099|NCT02075554|591993501|FG000|Overall Study|Physician Decision|3|||
163896100|NCT04757753|591993518|FG000|Overall Study|Lost to Follow-up|7|||
163896101|NCT04757753|591993519|FG001|Overall Study|Lost to Follow-up|7|||
163896102|NCT04757753|591993518|FG000|Overall Study|Withdrawal by Subject|0|||
163896103|NCT04757753|591993519|FG001|Overall Study|Withdrawal by Subject|3|||
163896104|NCT04757753|591993518|FG000|Overall Study|Endodontic treatment failure|1|||
163896105|NCT04757753|591993519|FG001|Overall Study|Endodontic treatment failure|2|||
163896106|NCT04757753|591993518|FG000|Overall Study|Tooth fracture/extraction|3|||
163896107|NCT04757753|591993519|FG001|Overall Study|Tooth fracture/extraction|0|||
163896108|NCT00942734|591993524|FG000|Overall Study|Adverse Event|2|||
163896109|NCT00942734|591993524|FG000|Overall Study|Protocol Violation|3|||
163896110|NCT00942734|591993524|FG000|Overall Study|Disease Progression|2|||
163896111|NCT00942734|591993524|FG000|Overall Study|Physician Decision|1|||
163896112|NCT00319046|591993525|FG000|Overall Study|withdrawal of subject's consent|7|||
163896113|NCT00319046|591993525|FG000|Overall Study|administrative reason|1|||
163896114|NCT03816397|591993529|FG000|Overall Study|Censored at interim analysis date.|13|||
163896115|NCT03816397|591993530|FG001|Overall Study|Censored at interim analysis date.|6|||
163896116|NCT03816397|591993529|FG000|Overall Study|Withdrawal by Subject|1|||
164001779|NCT00684177|592368620|FG001|Overall Study|Lack of Efficacy|15|||
164001780|NCT00684177|592368619|FG000|Overall Study|Protocol Violation|1|||
164001781|NCT00684177|592368620|FG001|Overall Study|Protocol Violation|0|||
164001782|NCT00684177|592368619|FG000|Overall Study|Lost to Follow-up|2|||
164001783|NCT00684177|592368620|FG001|Overall Study|Lost to Follow-up|1|||
164001784|NCT00684177|592368619|FG000|Overall Study|Physician Decision|2|||
164001785|NCT00684177|592368620|FG001|Overall Study|Physician Decision|0|||
164001786|NCT00684177|592368619|FG000|Overall Study|Withdrawal by Subject|1|||
164001787|NCT00684177|592368620|FG001|Overall Study|Withdrawal by Subject|2|||
164001788|NCT00684177|592368619|FG000|Overall Study|Other|1|||
163896117|NCT03816397|591993530|FG001|Overall Study|Withdrawal by Subject|1|||
163896118|NCT04908930|591993535|FG000|Overall Study|Lost to Follow-up|1|||
163896119|NCT04908930|591993536|FG001|Overall Study|Lost to Follow-up|1|||
164001789|NCT00684177|592368620|FG001|Overall Study|Other|2|||
164001790|NCT03874234|592370546|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001791|NCT03874234|592370547|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001792|NCT03874234|592370548|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001793|NCT03874234|592370549|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
164142996|NCT00863772|592884484|FG000|Overall Study|Protocol Violation|2|||
164001794|NCT03874234|592370550|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001795|NCT03874234|592370551|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001796|NCT03874234|592370552|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001797|NCT03874234|592370553|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001798|NCT03874234|592370554|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163896120|NCT04908930|591993537|FG002|Overall Study|Lost to Follow-up|0|||
163896121|NCT04908930|591993538|FG003|Overall Study|Lost to Follow-up|0|||
163896122|NCT04908930|591993539|FG004|Overall Study|Lost to Follow-up|0|||
163896123|NCT04908930|591993535|FG000|Overall Study|hardware in mouth|1|||
163896124|NCT04908930|591993536|FG001|Overall Study|hardware in mouth|1|||
163896125|NCT04908930|591993537|FG002|Overall Study|hardware in mouth|0|||
163896126|NCT04908930|591993538|FG003|Overall Study|hardware in mouth|0|||
163896127|NCT04908930|591993539|FG004|Overall Study|hardware in mouth|0|||
163896128|NCT04908930|591993535|FG000|Overall Study|wrong team|1|||
163896129|NCT04908930|591993536|FG001|Overall Study|wrong team|0|||
163896130|NCT04908930|591993537|FG002|Overall Study|wrong team|0|||
163896131|NCT04908930|591993538|FG003|Overall Study|wrong team|0|||
163896132|NCT04908930|591993539|FG004|Overall Study|wrong team|0|||
163896133|NCT04908930|591993535|FG000|Overall Study|quit team|2|||
163896134|NCT04908930|591993536|FG001|Overall Study|quit team|4|||
163896135|NCT04908930|591993537|FG002|Overall Study|quit team|0|||
163896136|NCT04908930|591993538|FG003|Overall Study|quit team|0|||
163896137|NCT04908930|591993539|FG004|Overall Study|quit team|0|||
163896138|NCT04908930|591993535|FG000|Overall Study|Withdrawal by Subject|1|||
163896139|NCT04908930|591993536|FG001|Overall Study|Withdrawal by Subject|2|||
163896140|NCT04908930|591993537|FG002|Overall Study|Withdrawal by Subject|0|||
163896141|NCT04908930|591993538|FG003|Overall Study|Withdrawal by Subject|0|||
163896142|NCT04908930|591993539|FG004|Overall Study|Withdrawal by Subject|0|||
163896143|NCT04908930|591993535|FG000|Overall Study|parent not liking program|0|||
163896144|NCT04908930|591993536|FG001|Overall Study|parent not liking program|1|||
163896145|NCT04908930|591993537|FG002|Overall Study|parent not liking program|0|||
163896146|NCT04908930|591993538|FG003|Overall Study|parent not liking program|0|||
163896147|NCT04908930|591993539|FG004|Overall Study|parent not liking program|0|||
163896148|NCT04679389|591993540|FG000|Overall Study|Adverse Event|1|||
163896149|NCT04679389|591993541|FG001|Overall Study|Adverse Event|0|||
163896150|NCT04679389|591993540|FG000|Overall Study|Protocol Violation|2|||
163896151|NCT04679389|591993541|FG001|Overall Study|Protocol Violation|0|||
163896152|NCT04679389|591993540|FG000|Overall Study|Physician Decision|3|||
163896153|NCT04679389|591993541|FG001|Overall Study|Physician Decision|5|||
163896154|NCT04679389|591993540|FG000|Overall Study|Withdrawal by Subject|5|||
163896155|NCT04679389|591993541|FG001|Overall Study|Withdrawal by Subject|7|||
163896156|NCT02777593|591993542|FG000|Overall Study|Still in study|1|||
163896157|NCT02777593|591993543|FG001|Overall Study|Still in study|32|||
163896158|NCT02777593|591993544|FG002|Overall Study|Still in study|3|||
163896159|NCT02777593|591993545|FG003|Overall Study|Still in study|6|||
163896160|NCT02777593|591993546|FG004|Overall Study|Still in study|5|||
163896161|NCT02777593|591993542|FG000|Overall Study|Death|21|||
163896162|NCT02777593|591993543|FG001|Overall Study|Death|28|||
163896163|NCT02777593|591993544|FG002|Overall Study|Death|0|||
163896164|NCT02777593|591993545|FG003|Overall Study|Death|5|||
163896165|NCT02777593|591993546|FG004|Overall Study|Death|0|||
163896166|NCT02777593|591993542|FG000|Overall Study|Withdrawal by Subject|8|||
163896167|NCT02777593|591993543|FG001|Overall Study|Withdrawal by Subject|4|||
163896168|NCT02777593|591993544|FG002|Overall Study|Withdrawal by Subject|1|||
163896169|NCT02777593|591993545|FG003|Overall Study|Withdrawal by Subject|1|||
163896170|NCT02777593|591993546|FG004|Overall Study|Withdrawal by Subject|0|||
163896171|NCT02777593|591993542|FG000|Overall Study|Lost to Follow-up|8|||
163896172|NCT02777593|591993543|FG001|Overall Study|Lost to Follow-up|16|||
163896173|NCT02777593|591993544|FG002|Overall Study|Lost to Follow-up|5|||
163896174|NCT02777593|591993545|FG003|Overall Study|Lost to Follow-up|0|||
163896175|NCT02777593|591993546|FG004|Overall Study|Lost to Follow-up|1|||
163896176|NCT02777593|591993542|FG000|Overall Study|Physician Decision|2|||
164001799|NCT03874234|592370555|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001800|NCT03874234|592370556|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001801|NCT03874234|592370557|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
164001802|NCT03874234|592370558|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
163896177|NCT02777593|591993543|FG001|Overall Study|Physician Decision|2|||
163896178|NCT02777593|591993544|FG002|Overall Study|Physician Decision|0|||
163896179|NCT02777593|591993545|FG003|Overall Study|Physician Decision|0|||
163896180|NCT02777593|591993546|FG004|Overall Study|Physician Decision|0|||
163896181|NCT02777593|591993542|FG000|Overall Study|Discontinued due to Other|1|||
163896182|NCT02777593|591993543|FG001|Overall Study|Discontinued due to Other|0|||
163896183|NCT02777593|591993544|FG002|Overall Study|Discontinued due to Other|0|||
163896184|NCT02777593|591993545|FG003|Overall Study|Discontinued due to Other|0|||
163896185|NCT02777593|591993546|FG004|Overall Study|Discontinued due to Other|0|||
163896186|NCT03904576|591993553|FG000|Washout Period|Protocol Violation|1|||
163896187|NCT03904576|591993554|FG001|Washout Period|Protocol Violation|1|||
163896188|NCT05215054|591993557|FG000|Overall Study|Lost to Follow-up|1|||
163896189|NCT05215054|591993558|FG001|Overall Study|Lost to Follow-up|1|||
163896190|NCT05215054|591993557|FG000|Overall Study|Protocol Violation|1|||
163896191|NCT05215054|591993558|FG001|Overall Study|Protocol Violation|1|||
163896192|NCT05215054|591993557|FG000|Overall Study|Withdrawal by Subject|4|||
163896193|NCT05215054|591993558|FG001|Overall Study|Withdrawal by Subject|4|||
164001803|NCT03874234|592370546|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
164001804|NCT03874234|592370547|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163896194|NCT01897441|591993559|FG000|Overall Study|Lost to Follow-up|0|||
163896195|NCT01897441|591993560|FG001|Overall Study|Lost to Follow-up|0|||
163896196|NCT01897441|591993561|FG002|Overall Study|Lost to Follow-up|1|||
163896197|NCT01897441|591993562|FG003|Overall Study|Lost to Follow-up|0|||
163896198|NCT01897441|591993563|FG004|Overall Study|Lost to Follow-up|0|||
163896199|NCT01897441|591993564|FG005|Overall Study|Lost to Follow-up|0|||
163896200|NCT01897441|591993559|FG000|Overall Study|Withdrawal by Subject|0|||
163896201|NCT01897441|591993560|FG001|Overall Study|Withdrawal by Subject|0|||
163896202|NCT01897441|591993561|FG002|Overall Study|Withdrawal by Subject|0|||
163896203|NCT01897441|591993562|FG003|Overall Study|Withdrawal by Subject|0|||
163896204|NCT01897441|591993563|FG004|Overall Study|Withdrawal by Subject|1|||
163896205|NCT01897441|591993564|FG005|Overall Study|Withdrawal by Subject|0|||
163896206|NCT01897441|591993559|FG000|Overall Study|Withdrawn by Provider|0|||
163896207|NCT01897441|591993560|FG001|Overall Study|Withdrawn by Provider|2|||
163896208|NCT01897441|591993561|FG002|Overall Study|Withdrawn by Provider|0|||
163896209|NCT01897441|591993562|FG003|Overall Study|Withdrawn by Provider|0|||
163896210|NCT01897441|591993563|FG004|Overall Study|Withdrawn by Provider|0|||
163896211|NCT01897441|591993564|FG005|Overall Study|Withdrawn by Provider|0|||
163896212|NCT02933489|591993565|FG000|Overall Study|Ineligible|3|||
163896213|NCT02933489|591993566|FG001|Overall Study|Ineligible|3|||
163896214|NCT02933489|591993565|FG000|Overall Study|Withdrawal by Subject|27|||
163896215|NCT02933489|591993566|FG001|Overall Study|Withdrawal by Subject|18|||
163896216|NCT02933489|591993565|FG000|Overall Study|Unable to complete exams (other)|14|||
163896217|NCT02933489|591993566|FG001|Overall Study|Unable to complete exams (other)|7|||
163896218|NCT01756300|591993567|FG000|Overall Study|Death|1|||
163896219|NCT01756300|591993567|FG000|Overall Study|Withdrawal by Subject|1|||
163896220|NCT04780581|591993568|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
163896221|NCT04780581|591993569|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
163896222|NCT04780581|591993568|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
163896223|NCT04780581|591993569|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
163896224|NCT04678856|591993570|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
163896225|NCT04678856|591993571|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
163896226|NCT04678856|591993570|FG000|Overall Study|Withdrawal by Subject|5|||
163896227|NCT04678856|591993571|FG001|Overall Study|Withdrawal by Subject|1|||
164001805|NCT03874234|592370548|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001806|NCT03874234|592370549|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001807|NCT03874234|592370550|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001808|NCT03874234|592370551|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163896228|NCT03734029|591993572|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
163896229|NCT03734029|591993573|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
163896230|NCT03734029|591993572|FG000|Overall Study|Adverse Event|60|||
163896231|NCT03734029|591993573|FG001|Overall Study|Adverse Event|14|||
163896232|NCT03734029|591993572|FG000|Overall Study|Withdrawal by Subject|12|||
163896233|NCT03734029|591993573|FG001|Overall Study|Withdrawal by Subject|11|||
164001809|NCT03874234|592370552|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001810|NCT03874234|592370553|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
163896234|NCT03734029|591993572|FG000|Overall Study|Clinical progression by investigator|10|||
163896235|NCT03734029|591993573|FG001|Overall Study|Clinical progression by investigator|8|||
163896236|NCT03734029|591993572|FG000|Overall Study|Death|5|||
163896237|NCT03734029|591993573|FG001|Overall Study|Death|2|||
163896238|NCT03734029|591993572|FG000|Overall Study|Physician Decision|4|||
163896239|NCT03734029|591993573|FG001|Overall Study|Physician Decision|3|||
163896240|NCT03734029|591993572|FG000|Overall Study|Other|2|||
163896241|NCT03734029|591993573|FG001|Overall Study|Other|0|||
163896242|NCT03734029|591993572|FG000|Overall Study|Lost to Follow-up|0|||
163896243|NCT03734029|591993573|FG001|Overall Study|Lost to Follow-up|1|||
163896244|NCT03734029|591993572|FG000|Overall Study|Randomized, but not treated|2|||
163896245|NCT03734029|591993573|FG001|Overall Study|Randomized, but not treated|12|||
163896246|NCT04633278|591994621|FG000|Overall Study|Adverse Event|1|||
163896247|NCT04633278|591994622|FG001|Overall Study|Adverse Event|0|||
163896248|NCT04633278|591994621|FG000|Overall Study|Withdrawal by Subject|1|||
163896249|NCT04633278|591994622|FG001|Overall Study|Withdrawal by Subject|0|||
163896250|NCT04633278|591994621|FG000|Overall Study|Death|11|||
163896251|NCT04633278|591994622|FG001|Overall Study|Death|7|||
163896252|NCT04633278|591994621|FG000|Overall Study|Sponsor Decision|3|||
163896253|NCT04633278|591994622|FG001|Overall Study|Sponsor Decision|0|||
163896254|NCT04633278|591994621|FG000|Overall Study|Not Listed|1|||
163896255|NCT04633278|591994622|FG001|Overall Study|Not Listed|0|||
163896256|NCT03705793|591994623|FG000|Overall Study|Lost to Follow-up|3|||
163896257|NCT03705793|591994624|FG001|Overall Study|Lost to Follow-up|4|||
163896258|NCT03705793|591994623|FG000|Overall Study|Withdrawal by Subject|2|||
163896259|NCT03705793|591994624|FG001|Overall Study|Withdrawal by Subject|1|||
163896260|NCT00447980|591994627|FG000|Overall Study|Withdrawal by Subject|1|||
163896261|NCT00447980|591994628|FG001|Overall Study|Withdrawal by Subject|1|||
163896262|NCT00447980|591994629|FG002|Overall Study|Withdrawal by Subject|4|||
163896263|NCT00447980|591994630|FG003|Overall Study|Withdrawal by Subject|4|||
163896264|NCT00447980|591994627|FG000|Overall Study|Lost to Follow-up|1|||
163896265|NCT00447980|591994628|FG001|Overall Study|Lost to Follow-up|1|||
163896266|NCT00447980|591994629|FG002|Overall Study|Lost to Follow-up|0|||
163896267|NCT00447980|591994630|FG003|Overall Study|Lost to Follow-up|0|||
163896268|NCT00447980|591994627|FG000|Overall Study|Did not proceed with surgery|3|||
163896269|NCT00447980|591994628|FG001|Overall Study|Did not proceed with surgery|3|||
163896270|NCT00447980|591994629|FG002|Overall Study|Did not proceed with surgery|2|||
163896271|NCT00447980|591994630|FG003|Overall Study|Did not proceed with surgery|2|||
163896272|NCT02720068|591994631|FG000|Overall Study|Adverse Event|0|||
163896273|NCT02720068|591994632|FG001|Overall Study|Adverse Event|0|||
164086374|NCT02826603|592680016|FG001|Overall Study|Withdrawal by Subject|19|||
163896274|NCT02720068|591994633|FG002|Overall Study|Adverse Event|0|||
163896275|NCT02720068|591994634|FG003|Overall Study|Adverse Event|0|||
163896276|NCT02720068|591994635|FG004|Overall Study|Adverse Event|0|||
163896277|NCT02720068|591994636|FG005|Overall Study|Adverse Event|0|||
163896278|NCT02720068|591994637|FG006|Overall Study|Adverse Event|0|||
163896279|NCT02720068|591994638|FG007|Overall Study|Adverse Event|0|||
163896280|NCT02720068|591994639|FG008|Overall Study|Adverse Event|0|||
163896281|NCT02720068|591994640|FG009|Overall Study|Adverse Event|0|||
163896282|NCT02720068|591994641|FG010|Overall Study|Adverse Event|0|||
163896283|NCT02720068|591994642|FG011|Overall Study|Adverse Event|1|||
163896284|NCT02720068|591994643|FG012|Overall Study|Adverse Event|0|||
163896285|NCT02720068|591994644|FG013|Overall Study|Adverse Event|0|||
163896286|NCT02720068|591994645|FG014|Overall Study|Adverse Event|0|||
164086375|NCT02826603|592680015|FG000|Overall Study|Death|2|||
164086376|NCT02826603|592680016|FG001|Overall Study|Death|0|||
164086377|NCT02826603|592680015|FG000|Overall Study|New therapy for study indication|0|||
164086378|NCT02826603|592680016|FG001|Overall Study|New therapy for study indication|1|||
164086379|NCT00905489|592680017|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
164086380|NCT00905489|592680017|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
164086381|NCT00905489|592680017|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
164086382|NCT00583596|592680018|FG000|Overall Study|Lost to Follow-up|110|||
164086383|NCT00583596|592680018|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
164086384|NCT00583596|592680018|FG000|Overall Study|Death|2|||
164086385|NCT00583596|592680018|FG000|Overall Study|Withdrawal by Subject|6|||
164086386|NCT00583596|592680018|FG000|Overall Study|Lost to Follow-up|94|||
164086387|NCT00583596|592680018|FG000|Overall Study|Data not complete|1|||
164086388|NCT00583596|592680018|FG000|Overall Study|Not consented|15|||
164086389|NCT00583596|592680018|FG000|Overall Study|Outside f-up window|26|||
164086390|NCT03558997|592680019|FG000|Overall Study|Adverse Event|0|||
164086391|NCT03558997|592680020|FG001|Overall Study|Adverse Event|2|||
164086392|NCT03558997|592680021|FG002|Overall Study|Adverse Event|5|||
164086393|NCT03558997|592680022|FG003|Overall Study|Adverse Event|1|||
164344469|NCT03727230|593636939|FG000|Overall Study|Lost to Follow-up|12|||
163896287|NCT02720068|591994646|FG015|Overall Study|Adverse Event|0|||
163896288|NCT02720068|591994647|FG016|Overall Study|Adverse Event|0|||
163896289|NCT02720068|591994648|FG017|Overall Study|Adverse Event|0|||
163896290|NCT02720068|591994631|FG000|Overall Study|Death|1|||
163896291|NCT02720068|591994632|FG001|Overall Study|Death|3|||
163896292|NCT02720068|591994633|FG002|Overall Study|Death|2|||
163896293|NCT02720068|591994634|FG003|Overall Study|Death|1|||
163896294|NCT02720068|591994635|FG004|Overall Study|Death|2|||
163896295|NCT02720068|591994636|FG005|Overall Study|Death|1|||
164086394|NCT03558997|592680019|FG000|Overall Study|Physician Decision|0|||
164086395|NCT03558997|592680020|FG001|Overall Study|Physician Decision|0|||
164086396|NCT03558997|592680021|FG002|Overall Study|Physician Decision|1|||
164086397|NCT03558997|592680022|FG003|Overall Study|Physician Decision|0|||
164086398|NCT03558997|592680019|FG000|Overall Study|Withdrawal by Subject|1|||
163896296|NCT02720068|591994637|FG006|Overall Study|Death|2|||
163896297|NCT02720068|591994638|FG007|Overall Study|Death|2|||
163896298|NCT02720068|591994639|FG008|Overall Study|Death|3|||
163896299|NCT02720068|591994640|FG009|Overall Study|Death|1|||
163896300|NCT02720068|591994641|FG010|Overall Study|Death|20|||
163896301|NCT02720068|591994642|FG011|Overall Study|Death|166|||
163896302|NCT02720068|591994643|FG012|Overall Study|Death|34|||
163896303|NCT02720068|591994644|FG013|Overall Study|Death|30|||
163896304|NCT02720068|591994645|FG014|Overall Study|Death|45|||
163896305|NCT02720068|591994646|FG015|Overall Study|Death|16|||
163896306|NCT02720068|591994647|FG016|Overall Study|Death|20|||
163896307|NCT02720068|591994648|FG017|Overall Study|Death|28|||
163896308|NCT02720068|591994631|FG000|Overall Study|Lost to Follow-up|0|||
163896309|NCT02720068|591994632|FG001|Overall Study|Lost to Follow-up|0|||
163896310|NCT02720068|591994633|FG002|Overall Study|Lost to Follow-up|0|||
163896311|NCT02720068|591994634|FG003|Overall Study|Lost to Follow-up|0|||
163896312|NCT02720068|591994635|FG004|Overall Study|Lost to Follow-up|0|||
164086399|NCT03558997|592680020|FG001|Overall Study|Withdrawal by Subject|0|||
164086400|NCT03558997|592680021|FG002|Overall Study|Withdrawal by Subject|1|||
164086401|NCT03558997|592680022|FG003|Overall Study|Withdrawal by Subject|1|||
164086402|NCT03558997|592680019|FG000|Overall Study|Lost to Follow-up|0|||
164086403|NCT03558997|592680020|FG001|Overall Study|Lost to Follow-up|0|||
164086404|NCT03558997|592680021|FG002|Overall Study|Lost to Follow-up|1|||
164086405|NCT03558997|592680022|FG003|Overall Study|Lost to Follow-up|0|||
164086406|NCT02619682|592680023|FG000|Overall Study|Withdrawal by Subject|3|||
164281414|NCT00095173|593400662|FG003|Open-Label Extension Phase (Period C)|Other|4|||
164281415|NCT00095173|593400663|FG004|Open-Label Extension Phase (Period C)|Other|6|||
164281416|NCT00095173|593400664|FG005|Open-Label Extension Phase (Period C)|Other|8|||
164281417|NCT02161757|593400671|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
164281418|NCT02161757|593400672|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
164281419|NCT02161757|593400673|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
164281420|NCT02161757|593400671|FG000|Treatment Through Study Completion|Adverse Event|1|||
164281421|NCT02161757|593400672|FG001|Treatment Through Study Completion|Adverse Event|1|||
164281422|NCT02161757|593400673|FG002|Treatment Through Study Completion|Adverse Event|0|||
164281423|NCT02161757|593400671|FG000|Treatment Through Study Completion|Protocol Violation|0|||
164281424|NCT02161757|593400672|FG001|Treatment Through Study Completion|Protocol Violation|1|||
164281425|NCT02161757|593400673|FG002|Treatment Through Study Completion|Protocol Violation|2|||
164281426|NCT02161757|593400671|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
164281427|NCT02161757|593400672|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
164281428|NCT02161757|593400673|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
164281429|NCT02161757|593400671|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
164281430|NCT02161757|593400672|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
164281431|NCT02161757|593400673|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
164344470|NCT03600818|593636940|FG000|Overall Study|Adverse Event|4|||
164086407|NCT02619682|592680023|FG000|Overall Study|Lack of Efficacy|8|||
164086408|NCT02619682|592680023|FG000|Overall Study|new secondary cancer|1|||
164086409|NCT02619682|592680023|FG000|Overall Study|post surgery complications|2|||
164086410|NCT01861522|592680027|FG000|Overall Study|Adverse Event|1|||
164086411|NCT01861522|592680028|FG001|Overall Study|Adverse Event|0|||
164086412|NCT01861522|592680027|FG000|Overall Study|Withdrawal by Subject|2|||
164086413|NCT01861522|592680028|FG001|Overall Study|Withdrawal by Subject|0|||
164086414|NCT00526890|592680029|FG000|Overall Study|Adverse Event|2|||
164086415|NCT01859702|592680031|FG000|Overall Study|Protocol deviation|3|||
164086416|NCT01859702|592680031|FG000|Overall Study|Adverse Event|2|||
163896313|NCT02720068|591994636|FG005|Overall Study|Lost to Follow-up|0|||
163896314|NCT02720068|591994637|FG006|Overall Study|Lost to Follow-up|0|||
163896315|NCT02720068|591994638|FG007|Overall Study|Lost to Follow-up|0|||
163896316|NCT02720068|591994639|FG008|Overall Study|Lost to Follow-up|0|||
163896317|NCT02720068|591994640|FG009|Overall Study|Lost to Follow-up|0|||
163896318|NCT02720068|591994641|FG010|Overall Study|Lost to Follow-up|0|||
163896319|NCT02720068|591994642|FG011|Overall Study|Lost to Follow-up|1|||
163896320|NCT02720068|591994643|FG012|Overall Study|Lost to Follow-up|0|||
163896321|NCT02720068|591994644|FG013|Overall Study|Lost to Follow-up|1|||
163896322|NCT02720068|591994645|FG014|Overall Study|Lost to Follow-up|2|||
163896323|NCT02720068|591994646|FG015|Overall Study|Lost to Follow-up|0|||
164086417|NCT01893138|592680032|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164086418|NCT01893138|592680033|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164086419|NCT01893138|592680032|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
164086420|NCT01893138|592680033|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
164086421|NCT01893138|592680032|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
163896324|NCT02720068|591994647|FG016|Overall Study|Lost to Follow-up|0|||
163896325|NCT02720068|591994648|FG017|Overall Study|Lost to Follow-up|1|||
164281432|NCT02161757|593400671|FG000|Treatment Through Study Completion|Other|20|||
164281433|NCT02161757|593400672|FG001|Treatment Through Study Completion|Other|19|||
164281434|NCT02161757|593400673|FG002|Treatment Through Study Completion|Other|12|||
164281435|NCT02161757|593400671|FG000|Treatment Through Study Completion|Death|2|||
164281436|NCT02161757|593400672|FG001|Treatment Through Study Completion|Death|1|||
164281437|NCT02161757|593400673|FG002|Treatment Through Study Completion|Death|1|||
164281438|NCT00391625|593400674|FG000|Month 14|Withdrawal by Subject|1|||
164281439|NCT00391625|593400674|FG000|Month 50|Physician Decision|1|||
164281440|NCT02106403|593400681|FG000|Follow-Up Visit 3|Other Reason|0|||
164281441|NCT02106403|593400682|FG001|Follow-Up Visit 3|Other Reason|0|||
164281442|NCT02106403|593400683|FG002|Follow-Up Visit 3|Other Reason|0|||
164281443|NCT02106403|593400684|FG003|Follow-Up Visit 3|Other Reason|0|||
164281444|NCT02106403|593400685|FG004|Follow-Up Visit 3|Other Reason|0|||
164281445|NCT02106403|593400686|FG005|Follow-Up Visit 3|Other Reason|1|||
164281446|NCT02343406|593400687|FG000|Overall Study|Progressive disease|72|||
164281447|NCT02343406|593400688|FG001|Overall Study|Progressive disease|70|||
164086422|NCT01893138|592680033|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
164086423|NCT01893138|592680032|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
164086424|NCT01893138|592680033|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
164086425|NCT01893138|592680032|FG000|Open Label - Unblinded Period|Adverse Event|1|||
164086426|NCT01893138|592680033|FG001|Open Label - Unblinded Period|Adverse Event|0|||
163896326|NCT02720068|591994631|FG000|Overall Study|Physician Decision|0|||
163896327|NCT02720068|591994632|FG001|Overall Study|Physician Decision|0|||
163896328|NCT02720068|591994633|FG002|Overall Study|Physician Decision|0|||
164281448|NCT02343406|593400689|FG002|Overall Study|Progressive disease|43|||
164281449|NCT02343406|593400690|FG003|Overall Study|Progressive disease|15|||
164281450|NCT02343406|593400691|FG004|Overall Study|Progressive disease|5|||
164281451|NCT02343406|593400687|FG000|Overall Study|Adverse Event|6|||
164281452|NCT02343406|593400688|FG001|Overall Study|Adverse Event|8|||
164281453|NCT02343406|593400689|FG002|Overall Study|Adverse Event|6|||
164281454|NCT02343406|593400690|FG003|Overall Study|Adverse Event|3|||
164281455|NCT02343406|593400691|FG004|Overall Study|Adverse Event|0|||
164281456|NCT02343406|593400687|FG000|Overall Study|Withdrawal by Subject|6|||
164281457|NCT02343406|593400688|FG001|Overall Study|Withdrawal by Subject|4|||
164281458|NCT02343406|593400689|FG002|Overall Study|Withdrawal by Subject|8|||
164281459|NCT02343406|593400690|FG003|Overall Study|Withdrawal by Subject|3|||
164281460|NCT02343406|593400691|FG004|Overall Study|Withdrawal by Subject|0|||
164281461|NCT02343406|593400687|FG000|Overall Study|Death|2|||
164281462|NCT02343406|593400688|FG001|Overall Study|Death|1|||
164281463|NCT02343406|593400689|FG002|Overall Study|Death|0|||
164281464|NCT02343406|593400690|FG003|Overall Study|Death|0|||
164281465|NCT02343406|593400691|FG004|Overall Study|Death|0|||
164281466|NCT02343406|593400687|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
164281467|NCT02343406|593400688|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
164281468|NCT02343406|593400689|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
164281469|NCT02343406|593400690|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
164281470|NCT02343406|593400691|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
164281471|NCT02343406|593400687|FG000|Overall Study|Other primary malignancy|0|||
164281472|NCT02343406|593400688|FG001|Overall Study|Other primary malignancy|1|||
164281473|NCT02343406|593400689|FG002|Overall Study|Other primary malignancy|0|||
164281474|NCT02343406|593400690|FG003|Overall Study|Other primary malignancy|0|||
164281475|NCT02343406|593400691|FG004|Overall Study|Other primary malignancy|0|||
164281476|NCT02343406|593400687|FG000|Overall Study|Other, not specified|2|||
164281477|NCT02343406|593400688|FG001|Overall Study|Other, not specified|1|||
164281478|NCT02343406|593400689|FG002|Overall Study|Other, not specified|1|||
163896329|NCT02720068|591994634|FG003|Overall Study|Physician Decision|1|||
164281479|NCT02343406|593400690|FG003|Overall Study|Other, not specified|4|||
164281480|NCT02343406|593400691|FG004|Overall Study|Other, not specified|0|||
164281481|NCT00874848|593400692|FG000|Overall Study|Adverse Event|13|||
164281482|NCT00874848|593400693|FG001|Overall Study|Adverse Event|2|||
164281483|NCT00874848|593400692|FG000|Overall Study|Progressive neoplastic disease|38|||
164281484|NCT00874848|593400693|FG001|Overall Study|Progressive neoplastic disease|18|||
164281485|NCT00874848|593400692|FG000|Overall Study|Withdrawal by Subject|7|||
163896330|NCT02720068|591994635|FG004|Overall Study|Physician Decision|0|||
163896331|NCT02720068|591994636|FG005|Overall Study|Physician Decision|0|||
163896332|NCT02720068|591994637|FG006|Overall Study|Physician Decision|0|||
163896333|NCT02720068|591994638|FG007|Overall Study|Physician Decision|0|||
163896334|NCT02720068|591994639|FG008|Overall Study|Physician Decision|0|||
163896335|NCT02720068|591994640|FG009|Overall Study|Physician Decision|0|||
163896336|NCT02720068|591994641|FG010|Overall Study|Physician Decision|0|||
164281486|NCT00874848|593400693|FG001|Overall Study|Withdrawal by Subject|4|||
164281487|NCT00874848|593400692|FG000|Overall Study|Noncompliance|1|||
163896337|NCT02720068|591994642|FG011|Overall Study|Physician Decision|1|||
164281488|NCT00874848|593400693|FG001|Overall Study|Noncompliance|1|||
164281489|NCT00874848|593400692|FG000|Overall Study|Failure to comply with protocol|0|||
164281490|NCT00874848|593400693|FG001|Overall Study|Failure to comply with protocol|1|||
163896338|NCT02720068|591994643|FG012|Overall Study|Physician Decision|0|||
164086427|NCT01326026|592680036|FG000|Overall Study|Adverse Event|4|||
164086428|NCT01326026|592680037|FG001|Overall Study|Adverse Event|3|||
164086429|NCT01326026|592680036|FG000|Overall Study|Withdrawal Criteria|5|||
164086430|NCT01326026|592680037|FG001|Overall Study|Withdrawal Criteria|7|||
164086431|NCT01326026|592680036|FG000|Overall Study|Other|3|||
164086432|NCT01326026|592680037|FG001|Overall Study|Other|3|||
163896339|NCT02720068|591994644|FG013|Overall Study|Physician Decision|0|||
163896340|NCT02720068|591994645|FG014|Overall Study|Physician Decision|0|||
163896341|NCT02720068|591994646|FG015|Overall Study|Physician Decision|0|||
163896342|NCT02720068|591994647|FG016|Overall Study|Physician Decision|0|||
163896343|NCT02720068|591994648|FG017|Overall Study|Physician Decision|1|||
163896344|NCT02720068|591994631|FG000|Overall Study|Progressive Disease|2|||
163896345|NCT02720068|591994632|FG001|Overall Study|Progressive Disease|3|||
163896346|NCT02720068|591994633|FG002|Overall Study|Progressive Disease|1|||
163896347|NCT02720068|591994634|FG003|Overall Study|Progressive Disease|1|||
163896348|NCT02720068|591994635|FG004|Overall Study|Progressive Disease|1|||
164281491|NCT00874848|593400692|FG000|Overall Study|Physician Decision|0|||
164281492|NCT00874848|593400693|FG001|Overall Study|Physician Decision|2|||
164281493|NCT01496846|593400694|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
164281494|NCT01496846|593400695|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
164281495|NCT01496846|593400696|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164281496|NCT01496846|593400697|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164281497|NCT01496846|593400698|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
163896349|NCT02720068|591994636|FG005|Overall Study|Progressive Disease|2|||
163896350|NCT02720068|591994637|FG006|Overall Study|Progressive Disease|1|||
163896351|NCT02720068|591994638|FG007|Overall Study|Progressive Disease|1|||
163896352|NCT02720068|591994639|FG008|Overall Study|Progressive Disease|0|||
163896353|NCT02720068|591994640|FG009|Overall Study|Progressive Disease|1|||
164086433|NCT04567615|592680041|FG000|Randomization|Participant withdrew consent|1|||
164086434|NCT04567615|592680042|FG001|Randomization|Participant withdrew consent|0|||
164086435|NCT04567615|592680043|FG002|Randomization|Participant withdrew consent|0|||
164086436|NCT04567615|592680041|FG000|Randomization|Adverse event unrelated to study drug|0|||
164086437|NCT04567615|592680042|FG001|Randomization|Adverse event unrelated to study drug|1|||
164086438|NCT04567615|592680043|FG002|Randomization|Adverse event unrelated to study drug|0|||
164086439|NCT04567615|592680041|FG000|Treatment Period|Participant Withdrew Consent|2|||
164086440|NCT04567615|592680042|FG001|Treatment Period|Participant Withdrew Consent|5|||
164086441|NCT04567615|592680043|FG002|Treatment Period|Participant Withdrew Consent|1|||
164086442|NCT04567615|592680041|FG000|Treatment Period|Death|1|||
164086443|NCT04567615|592680042|FG001|Treatment Period|Death|2|||
164086444|NCT04567615|592680043|FG002|Treatment Period|Death|0|||
164086445|NCT04567615|592680041|FG000|Treatment Period|Lost to Follow-up|0|||
164086446|NCT04567615|592680042|FG001|Treatment Period|Lost to Follow-up|1|||
164086447|NCT04567615|592680043|FG002|Treatment Period|Lost to Follow-up|0|||
164086448|NCT04567615|592680041|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164086449|NCT04567615|592680042|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
164086450|NCT04567615|592680043|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
164086451|NCT04567615|592680041|FG000|Treatment Period|Disease Progression|85|||
164086452|NCT04567615|592680042|FG001|Treatment Period|Disease Progression|63|||
164086453|NCT04567615|592680043|FG002|Treatment Period|Disease Progression|16|||
164086454|NCT04567615|592680041|FG000|Treatment Period|Study Drug Toxicity|3|||
164086455|NCT04567615|592680042|FG001|Treatment Period|Study Drug Toxicity|10|||
164086456|NCT04567615|592680043|FG002|Treatment Period|Study Drug Toxicity|4|||
164086457|NCT04567615|592680041|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
164086458|NCT04567615|592680042|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
164086459|NCT04567615|592680043|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
163896354|NCT02720068|591994641|FG010|Overall Study|Progressive Disease|0|||
163896355|NCT02720068|591994642|FG011|Overall Study|Progressive Disease|4|||
163896356|NCT02720068|591994643|FG012|Overall Study|Progressive Disease|1|||
163896357|NCT02720068|591994644|FG013|Overall Study|Progressive Disease|0|||
163896358|NCT02720068|591994645|FG014|Overall Study|Progressive Disease|0|||
163896359|NCT02720068|591994646|FG015|Overall Study|Progressive Disease|0|||
163896360|NCT02720068|591994647|FG016|Overall Study|Progressive Disease|0|||
163896361|NCT02720068|591994648|FG017|Overall Study|Progressive Disease|0|||
163896362|NCT02720068|591994631|FG000|Overall Study|Sponsor Decision|0|||
163896363|NCT02720068|591994632|FG001|Overall Study|Sponsor Decision|0|||
163896364|NCT02720068|591994633|FG002|Overall Study|Sponsor Decision|0|||
163896365|NCT02720068|591994634|FG003|Overall Study|Sponsor Decision|0|||
163896366|NCT02720068|591994635|FG004|Overall Study|Sponsor Decision|0|||
163896367|NCT02720068|591994636|FG005|Overall Study|Sponsor Decision|0|||
163896368|NCT02720068|591994637|FG006|Overall Study|Sponsor Decision|0|||
163896369|NCT02720068|591994638|FG007|Overall Study|Sponsor Decision|0|||
163896370|NCT02720068|591994639|FG008|Overall Study|Sponsor Decision|0|||
163896371|NCT02720068|591994640|FG009|Overall Study|Sponsor Decision|0|||
164086460|NCT04567615|592680041|FG000|Treatment Period|Other Reasons|1|||
163896372|NCT02720068|591994641|FG010|Overall Study|Sponsor Decision|0|||
163896373|NCT02720068|591994642|FG011|Overall Study|Sponsor Decision|6|||
163896374|NCT02720068|591994643|FG012|Overall Study|Sponsor Decision|3|||
163896375|NCT02720068|591994644|FG013|Overall Study|Sponsor Decision|2|||
163896376|NCT02720068|591994645|FG014|Overall Study|Sponsor Decision|4|||
163896377|NCT02720068|591994646|FG015|Overall Study|Sponsor Decision|4|||
163896378|NCT02720068|591994647|FG016|Overall Study|Sponsor Decision|0|||
163896379|NCT02720068|591994648|FG017|Overall Study|Sponsor Decision|8|||
163896380|NCT02720068|591994631|FG000|Overall Study|Withdrawal by Subject|0|||
163896381|NCT02720068|591994632|FG001|Overall Study|Withdrawal by Subject|0|||
163896382|NCT02720068|591994633|FG002|Overall Study|Withdrawal by Subject|0|||
163896383|NCT02720068|591994634|FG003|Overall Study|Withdrawal by Subject|0|||
163896384|NCT02720068|591994635|FG004|Overall Study|Withdrawal by Subject|0|||
163896385|NCT02720068|591994636|FG005|Overall Study|Withdrawal by Subject|0|||
163896386|NCT02720068|591994637|FG006|Overall Study|Withdrawal by Subject|0|||
163896387|NCT02720068|591994638|FG007|Overall Study|Withdrawal by Subject|0|||
163896388|NCT02720068|591994639|FG008|Overall Study|Withdrawal by Subject|0|||
163896389|NCT02720068|591994640|FG009|Overall Study|Withdrawal by Subject|1|||
163896390|NCT02720068|591994641|FG010|Overall Study|Withdrawal by Subject|0|||
163896391|NCT02720068|591994642|FG011|Overall Study|Withdrawal by Subject|27|||
163896392|NCT02720068|591994643|FG012|Overall Study|Withdrawal by Subject|2|||
163896393|NCT02720068|591994644|FG013|Overall Study|Withdrawal by Subject|8|||
163896394|NCT02720068|591994645|FG014|Overall Study|Withdrawal by Subject|7|||
163896395|NCT02720068|591994646|FG015|Overall Study|Withdrawal by Subject|0|||
163896396|NCT02720068|591994647|FG016|Overall Study|Withdrawal by Subject|0|||
163896397|NCT02720068|591994648|FG017|Overall Study|Withdrawal by Subject|2|||
163896398|NCT02720068|591994631|FG000|Overall Study|Protocol Violation|0|||
163896399|NCT02720068|591994632|FG001|Overall Study|Protocol Violation|0|||
163896400|NCT02720068|591994633|FG002|Overall Study|Protocol Violation|0|||
163896401|NCT02720068|591994634|FG003|Overall Study|Protocol Violation|0|||
163896402|NCT02720068|591994635|FG004|Overall Study|Protocol Violation|0|||
163896403|NCT02720068|591994636|FG005|Overall Study|Protocol Violation|0|||
163896404|NCT02720068|591994637|FG006|Overall Study|Protocol Violation|0|||
163896405|NCT02720068|591994638|FG007|Overall Study|Protocol Violation|0|||
163896406|NCT02720068|591994639|FG008|Overall Study|Protocol Violation|0|||
163896407|NCT02720068|591994640|FG009|Overall Study|Protocol Violation|0|||
163896408|NCT02720068|591994641|FG010|Overall Study|Protocol Violation|1|||
163896409|NCT02720068|591994642|FG011|Overall Study|Protocol Violation|0|||
163896410|NCT02720068|591994643|FG012|Overall Study|Protocol Violation|0|||
163896411|NCT02720068|591994644|FG013|Overall Study|Protocol Violation|0|||
163896412|NCT02720068|591994645|FG014|Overall Study|Protocol Violation|1|||
163896413|NCT02720068|591994646|FG015|Overall Study|Protocol Violation|0|||
163896414|NCT02720068|591994647|FG016|Overall Study|Protocol Violation|1|||
163896415|NCT02720068|591994648|FG017|Overall Study|Protocol Violation|0|||
163896416|NCT01773993|591994653|FG000|Overall Study|No Visit After Treatment|35|||
163896417|NCT04664881|591994654|FG000|Overall Study|Withdrawal by Subject|1|||
163896418|NCT04664881|591994655|FG001|Overall Study|Withdrawal by Subject|8|||
163896419|NCT04664881|591994654|FG000|Overall Study|Physician Decision|0|||
163896420|NCT04664881|591994655|FG001|Overall Study|Physician Decision|5|||
164086461|NCT04567615|592680042|FG001|Treatment Period|Other Reasons|2|||
164086462|NCT04567615|592680043|FG002|Treatment Period|Other Reasons|0|||
164086463|NCT04567615|592680041|FG000|Treatment Period|Still On-going Treatment|21|||
164086464|NCT04567615|592680042|FG001|Treatment Period|Still On-going Treatment|22|||
164086465|NCT04567615|592680043|FG002|Treatment Period|Still On-going Treatment|2|||
164086466|NCT04317053|592680044|FG000|Overall Study|Withdrawn (screen failure)|4|||
164086467|NCT04317053|592680045|FG001|Overall Study|Withdrawn (screen failure)|2|||
164086468|NCT04680052|592681401|FG000|Overall Study|Ongoing|244|||
164086469|NCT04680052|592681402|FG001|Overall Study|Ongoing|229|||
164086470|NCT04680052|592681403|FG002|Overall Study|Ongoing|39|||
164086471|NCT04680052|592681404|FG003|Overall Study|Ongoing|46|||
164086472|NCT04680052|592681401|FG000|Overall Study|Death|15|||
164086473|NCT04680052|592681402|FG001|Overall Study|Death|22|||
164086474|NCT04680052|592681403|FG002|Overall Study|Death|7|||
164086475|NCT04680052|592681404|FG003|Overall Study|Death|1|||
164086476|NCT04680052|592681401|FG000|Overall Study|Lost to Follow-up|3|||
164086477|NCT04680052|592681402|FG001|Overall Study|Lost to Follow-up|2|||
163896421|NCT04664881|591994654|FG000|Overall Study|Lost to Follow-up|1|||
164086478|NCT04680052|592681403|FG002|Overall Study|Lost to Follow-up|0|||
163896422|NCT04664881|591994655|FG001|Overall Study|Lost to Follow-up|0|||
163896423|NCT04496752|591994675|FG000|Second Assessment|Lost to Follow-up|3|||
163896424|NCT04496752|591994676|FG001|Second Assessment|Lost to Follow-up|3|||
163896425|NCT04496752|591994675|FG000|Second Assessment|Adverse Event|2|||
164086479|NCT04680052|592681404|FG003|Overall Study|Lost to Follow-up|1|||
164086480|NCT04680052|592681401|FG000|Overall Study|Withdrawal by Subject|11|||
164086481|NCT04680052|592681402|FG001|Overall Study|Withdrawal by Subject|19|||
164086482|NCT04680052|592681403|FG002|Overall Study|Withdrawal by Subject|7|||
164086483|NCT04680052|592681404|FG003|Overall Study|Withdrawal by Subject|5|||
164086484|NCT04680052|592681401|FG000|Overall Study|Missing|0|||
164086485|NCT04680052|592681402|FG001|Overall Study|Missing|1|||
164086486|NCT04680052|592681403|FG002|Overall Study|Missing|0|||
164086487|NCT04680052|592681404|FG003|Overall Study|Missing|0|||
164086488|NCT04680052|592681401|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
164086489|NCT04680052|592681402|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
164086490|NCT04680052|592681403|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
164086491|NCT04680052|592681404|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
164086492|NCT04680052|592681401|FG000|Overall Study|Physician Decision|0|||
164086493|NCT04680052|592681402|FG001|Overall Study|Physician Decision|1|||
164086494|NCT04680052|592681403|FG002|Overall Study|Physician Decision|0|||
164086495|NCT04680052|592681404|FG003|Overall Study|Physician Decision|0|||
163896426|NCT04496752|591994676|FG001|Second Assessment|Adverse Event|0|||
163896427|NCT04214418|591994677|FG000|Overall Study|Withdrawal by Subject|1|||
163896428|NCT04214418|591994678|FG001|Overall Study|Withdrawal by Subject|0|||
163896429|NCT04214418|591994679|FG002|Overall Study|Withdrawal by Subject|0|||
163896430|NCT04214418|591994680|FG003|Overall Study|Withdrawal by Subject|0|||
163896431|NCT04214418|591994681|FG004|Overall Study|Withdrawal by Subject|0|||
163896432|NCT04214418|591994682|FG005|Overall Study|Withdrawal by Subject|0|||
163896433|NCT04214418|591994677|FG000|Overall Study|Adverse Event|0|||
163896434|NCT04214418|591994678|FG001|Overall Study|Adverse Event|2|||
163896435|NCT04214418|591994679|FG002|Overall Study|Adverse Event|0|||
163896436|NCT04214418|591994680|FG003|Overall Study|Adverse Event|0|||
163896437|NCT04214418|591994681|FG004|Overall Study|Adverse Event|0|||
163896438|NCT04214418|591994682|FG005|Overall Study|Adverse Event|0|||
163896439|NCT04214418|591994677|FG000|Overall Study|Death|1|||
163896440|NCT04214418|591994678|FG001|Overall Study|Death|0|||
163896441|NCT04214418|591994679|FG002|Overall Study|Death|0|||
163896442|NCT04214418|591994680|FG003|Overall Study|Death|0|||
163896443|NCT04214418|591994681|FG004|Overall Study|Death|0|||
163896444|NCT04214418|591994682|FG005|Overall Study|Death|0|||
163896445|NCT05785130|591994687|FG000|Overall Study|Withdrawal by Subject|1|||
163896446|NCT05785130|591994688|FG001|Overall Study|Withdrawal by Subject|0|||
164086496|NCT00759148|592681406|FG000|Overall Study|Adverse Event|1|||
164086497|NCT00759148|592681407|FG001|Overall Study|Adverse Event|6|||
164086498|NCT00759148|592681406|FG000|Overall Study|Withdrawal by Subject|3|||
164086499|NCT00759148|592681407|FG001|Overall Study|Withdrawal by Subject|7|||
164086500|NCT00759148|592681406|FG000|Overall Study|Lost to Follow-up|3|||
164086501|NCT00759148|592681407|FG001|Overall Study|Lost to Follow-up|9|||
164086502|NCT00759148|592681406|FG000|Overall Study|Treatment Failure|6|||
164086503|NCT00759148|592681407|FG001|Overall Study|Treatment Failure|10|||
164086504|NCT00759148|592681406|FG000|Overall Study|Reason not given|1|||
164086505|NCT00759148|592681407|FG001|Overall Study|Reason not given|0|||
164086506|NCT01073020|592681408|FG000|Overall Study|Withdrawal by Subject|6|||
164086507|NCT01073020|592681409|FG001|Overall Study|Withdrawal by Subject|4|||
164086508|NCT01073020|592681410|FG002|Overall Study|Withdrawal by Subject|1|||
164086509|NCT01073020|592681411|FG003|Overall Study|Withdrawal by Subject|2|||
164086510|NCT01073020|592681408|FG000|Overall Study|Physician Decision|1|||
164086511|NCT01073020|592681409|FG001|Overall Study|Physician Decision|0|||
164086512|NCT01073020|592681410|FG002|Overall Study|Physician Decision|2|||
164086513|NCT01073020|592681411|FG003|Overall Study|Physician Decision|0|||
164086514|NCT01073020|592681408|FG000|Overall Study|Death|0|||
164086515|NCT01073020|592681409|FG001|Overall Study|Death|1|||
164086516|NCT01073020|592681410|FG002|Overall Study|Death|0|||
164086517|NCT01073020|592681411|FG003|Overall Study|Death|0|||
164086518|NCT00094302|592681414|FG000|Overall Study|Lost to Follow-up|43|||
164086519|NCT00094302|592681415|FG001|Overall Study|Lost to Follow-up|41|||
164086520|NCT00094302|592681414|FG000|Overall Study|Physician Decision|5|||
163896447|NCT05785130|591994687|FG000|Overall Study|Lack of Efficacy|0|||
163896448|NCT05785130|591994688|FG001|Overall Study|Lack of Efficacy|1|||
164086521|NCT00094302|592681415|FG001|Overall Study|Physician Decision|8|||
164086522|NCT00094302|592681414|FG000|Overall Study|Withdrawal by Subject|103|||
163896449|NCT02624050|591994693|FG000|Overall Study|Physician Decision|4|||
163896450|NCT02624050|591994694|FG001|Overall Study|Physician Decision|0|||
163896451|NCT02624050|591994693|FG000|Overall Study|Protocol Violation|2|||
163896452|NCT02624050|591994694|FG001|Overall Study|Protocol Violation|0|||
163896453|NCT03547271|591994695|FG000|Overall Study|Adverse Event|1|||
163896454|NCT03547271|591994696|FG001|Overall Study|Adverse Event|1|||
163896455|NCT03547271|591994697|FG002|Overall Study|Adverse Event|0|||
163896456|NCT03547271|591994698|FG003|Overall Study|Adverse Event|0|||
164086523|NCT00094302|592681415|FG001|Overall Study|Withdrawal by Subject|111|||
164086524|NCT00094302|592681414|FG000|Overall Study|Death|266|||
164086525|NCT00094302|592681415|FG001|Overall Study|Death|246|||
164086526|NCT03329027|592681416|FG000|Overall Study|Lost to Follow-up|1|||
164086527|NCT03329027|592681417|FG001|Overall Study|Lost to Follow-up|0|||
164001811|NCT03874234|592370554|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001812|NCT03874234|592370555|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001813|NCT03874234|592370556|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001814|NCT03874234|592370557|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001815|NCT03874234|592370558|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
164001816|NCT03874234|592370546|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001817|NCT03874234|592370547|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001818|NCT03874234|592370548|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001819|NCT03874234|592370549|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
164001820|NCT03874234|592370550|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001821|NCT03874234|592370551|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001822|NCT03874234|592370552|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001823|NCT03874234|592370553|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001824|NCT03874234|592370554|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001825|NCT03874234|592370555|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001826|NCT03874234|592370556|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001827|NCT03874234|592370557|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001828|NCT03874234|592370558|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
164001829|NCT03874234|592370546|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001830|NCT03874234|592370547|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001831|NCT03874234|592370548|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001832|NCT03874234|592370549|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001833|NCT03874234|592370550|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
164001834|NCT03874234|592370551|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001835|NCT03874234|592370552|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001836|NCT03874234|592370553|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001837|NCT03874234|592370554|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001838|NCT03874234|592370555|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001839|NCT03874234|592370556|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001840|NCT03874234|592370557|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001841|NCT03874234|592370558|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
164001842|NCT03874234|592370546|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001843|NCT03874234|592370547|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001844|NCT03874234|592370548|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001845|NCT03874234|592370549|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001846|NCT03874234|592370550|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001847|NCT03874234|592370551|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001848|NCT03874234|592370552|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001849|NCT03874234|592370553|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
164001850|NCT03874234|592370554|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001851|NCT03874234|592370555|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001852|NCT03874234|592370556|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001853|NCT03874234|592370557|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001854|NCT03874234|592370558|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
164001855|NCT03874234|592370546|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001856|NCT03874234|592370547|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001857|NCT03874234|592370548|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001858|NCT03874234|592370549|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001859|NCT03874234|592370550|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
164001860|NCT03874234|592370551|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
164001861|NCT03874234|592370552|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001862|NCT03874234|592370553|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001863|NCT03874234|592370554|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001864|NCT03874234|592370555|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001865|NCT03874234|592370556|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001866|NCT03874234|592370557|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001867|NCT03874234|592370558|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
164001868|NCT03874234|592370546|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001869|NCT03874234|592370547|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001870|NCT03874234|592370548|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001871|NCT03874234|592370549|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001872|NCT03874234|592370550|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001873|NCT03874234|592370551|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001874|NCT03874234|592370552|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
164001875|NCT03874234|592370553|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001876|NCT03874234|592370554|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164086528|NCT03329027|592681418|FG002|Overall Study|Lost to Follow-up|1|||
164086529|NCT03329027|592681416|FG000|Overall Study|Protocol Violation|9|||
164086530|NCT03329027|592681417|FG001|Overall Study|Protocol Violation|5|||
164086531|NCT03329027|592681418|FG002|Overall Study|Protocol Violation|7|||
164086532|NCT02761980|592681423|FG000|Overall Study|Adverse Event|4|||
164086533|NCT02761980|592681424|FG001|Overall Study|Adverse Event|6|||
164086534|NCT02761980|592681425|FG002|Overall Study|Adverse Event|5|||
164086535|NCT02761980|592681426|FG003|Overall Study|Adverse Event|6|||
164086536|NCT02761980|592681423|FG000|Overall Study|Withdrawal by Subject|0|||
164086537|NCT02761980|592681424|FG001|Overall Study|Withdrawal by Subject|1|||
164086538|NCT02761980|592681425|FG002|Overall Study|Withdrawal by Subject|0|||
164086539|NCT02761980|592681426|FG003|Overall Study|Withdrawal by Subject|0|||
164086540|NCT02761980|592681423|FG000|Overall Study|Other|0|||
164086541|NCT02761980|592681424|FG001|Overall Study|Other|0|||
164086542|NCT02761980|592681425|FG002|Overall Study|Other|1|||
164086543|NCT02761980|592681426|FG003|Overall Study|Other|0|||
164086544|NCT00101582|592681427|FG000|Overall Study|Ineligibility determined|0|||
164086545|NCT00101582|592681428|FG001|Overall Study|Ineligibility determined|1|||
164086546|NCT00101582|592681427|FG000|Overall Study|Adverse Event|1|||
164086547|NCT00101582|592681428|FG001|Overall Study|Adverse Event|4|||
164086548|NCT00101582|592681427|FG000|Overall Study|Withdrawal by Subject|6|||
164086549|NCT00101582|592681428|FG001|Overall Study|Withdrawal by Subject|4|||
164086550|NCT00101582|592681427|FG000|Overall Study|Physician Decision|1|||
164086551|NCT00101582|592681428|FG001|Overall Study|Physician Decision|0|||
164086552|NCT00101582|592681427|FG000|Overall Study|Death|3|||
164086553|NCT00101582|592681428|FG001|Overall Study|Death|5|||
164086554|NCT00101582|592681427|FG000|Overall Study|Other|0|||
164086555|NCT00101582|592681428|FG001|Overall Study|Other|1|||
164086556|NCT01907087|592681429|FG000|Overall Study|Withdrawal by Subject|1|||
164086557|NCT01919190|592681430|FG000|Overall Study|Intra-op findings, etc.|3|||
164086558|NCT01919190|592681431|FG001|Overall Study|Intra-op findings, etc.|0|||
164086559|NCT01829464|592681441|FG000|Overall Study|Adverse Event|1|||
164086560|NCT01829464|592681442|FG001|Overall Study|Adverse Event|0|||
164086561|NCT01829464|592681443|FG002|Overall Study|Adverse Event|0|||
164086562|NCT01829464|592681441|FG000|Overall Study|Lost to Follow-up|0|||
164086563|NCT01829464|592681442|FG001|Overall Study|Lost to Follow-up|0|||
164086564|NCT01829464|592681443|FG002|Overall Study|Lost to Follow-up|1|||
164086565|NCT01829464|592681441|FG000|Overall Study|Withdrawal by Subject|2|||
164086566|NCT01829464|592681442|FG001|Overall Study|Withdrawal by Subject|0|||
164086567|NCT01829464|592681443|FG002|Overall Study|Withdrawal by Subject|0|||
164086568|NCT01829464|592681441|FG000|Overall Study|Study terminated by sponsor|25|||
164086569|NCT01829464|592681442|FG001|Overall Study|Study terminated by sponsor|28|||
164086570|NCT01829464|592681443|FG002|Overall Study|Study terminated by sponsor|25|||
164086571|NCT01829464|592681441|FG000|Overall Study|Lack of Efficacy|0|||
164086572|NCT01829464|592681442|FG001|Overall Study|Lack of Efficacy|1|||
164086573|NCT01829464|592681443|FG002|Overall Study|Lack of Efficacy|0|||
164086574|NCT00635778|592681448|FG000|Overall Study|Adverse Event|1|||
164086575|NCT00635778|592681449|FG001|Overall Study|Adverse Event|0|||
164086576|NCT00635778|592681450|FG002|Overall Study|Adverse Event|0|||
164086577|NCT00635778|592681451|FG003|Overall Study|Adverse Event|3|||
164086578|NCT00635778|592681452|FG004|Overall Study|Adverse Event|3|||
164086579|NCT00635778|592681453|FG005|Overall Study|Adverse Event|6|||
164086580|NCT00635778|592681454|FG006|Overall Study|Adverse Event|1|||
164086581|NCT00635778|592681448|FG000|Overall Study|Withdrawal by Subject|0|||
164086582|NCT00635778|592681449|FG001|Overall Study|Withdrawal by Subject|0|||
164344471|NCT03600818|593636941|FG001|Overall Study|Adverse Event|7|||
164344472|NCT03600818|593636940|FG000|Overall Study|Lack of Efficacy|9|||
164086583|NCT00635778|592681450|FG002|Overall Study|Withdrawal by Subject|0|||
164086584|NCT00635778|592681451|FG003|Overall Study|Withdrawal by Subject|1|||
164086585|NCT00635778|592681452|FG004|Overall Study|Withdrawal by Subject|0|||
164086586|NCT00635778|592681453|FG005|Overall Study|Withdrawal by Subject|1|||
164086587|NCT00635778|592681454|FG006|Overall Study|Withdrawal by Subject|1|||
164086588|NCT00635778|592681448|FG000|Overall Study|Progressive disease|0|||
164086589|NCT00635778|592681449|FG001|Overall Study|Progressive disease|3|||
164086590|NCT00635778|592681450|FG002|Overall Study|Progressive disease|3|||
164086591|NCT00635778|592681451|FG003|Overall Study|Progressive disease|4|||
164086592|NCT00635778|592681452|FG004|Overall Study|Progressive disease|5|||
164086593|NCT00635778|592681453|FG005|Overall Study|Progressive disease|14|||
164086594|NCT00635778|592681454|FG006|Overall Study|Progressive disease|4|||
164086595|NCT00755326|592681455|FG000|Overall Study|Lost to Follow-up|2|||
164344473|NCT03600818|593636941|FG001|Overall Study|Lack of Efficacy|4|||
164086596|NCT00755326|592681456|FG001|Overall Study|Lost to Follow-up|3|||
164086597|NCT01338636|592681459|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
164086598|NCT02385526|592681460|FG000|Overall Study|Withdrawal by Subject|0|||
164086599|NCT02385526|592681461|FG001|Overall Study|Withdrawal by Subject|2|||
164086600|NCT02385526|592681462|FG002|Overall Study|Withdrawal by Subject|0|||
164086601|NCT02385526|592681460|FG000|Overall Study|Lost to Follow-up|0|||
164086602|NCT02385526|592681461|FG001|Overall Study|Lost to Follow-up|1|||
164086603|NCT02385526|592681462|FG002|Overall Study|Lost to Follow-up|0|||
164001877|NCT03874234|592370555|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001878|NCT03874234|592370556|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001879|NCT03874234|592370557|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001880|NCT03874234|592370558|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
164001881|NCT03874234|592370546|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001882|NCT03874234|592370547|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001883|NCT03874234|592370548|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001884|NCT03874234|592370549|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001885|NCT03874234|592370550|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
164001886|NCT03874234|592370551|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001887|NCT03874234|592370552|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001888|NCT03874234|592370553|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001889|NCT03874234|592370554|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001890|NCT03874234|592370555|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001891|NCT03874234|592370556|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001892|NCT03874234|592370557|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001893|NCT03874234|592370558|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
164001894|NCT01217606|592370573|FG000|Initial Treatment Phase|Other Reasons|0|||
164001895|NCT01217606|592370574|FG001|Initial Treatment Phase|Other Reasons|2|||
164001896|NCT01217606|592370573|FG000|Initial Treatment Phase|Protocol Violation|3|||
164001897|NCT01217606|592370574|FG001|Initial Treatment Phase|Protocol Violation|2|||
164001898|NCT01217606|592370573|FG000|Initial Treatment Phase|Personal Reasons|0|||
164001899|NCT01217606|592370574|FG001|Initial Treatment Phase|Personal Reasons|2|||
164001900|NCT01217606|592370573|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
164001901|NCT01217606|592370574|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
164001902|NCT01217606|592370573|FG000|Initial Treatment Phase|Adverse Event|10|||
164001903|NCT01217606|592370574|FG001|Initial Treatment Phase|Adverse Event|6|||
164001904|NCT01217606|592370573|FG000|9-Month Masked Extension|Adverse Event|3|||
164001905|NCT01217606|592370574|FG001|9-Month Masked Extension|Adverse Event|6|||
164001906|NCT01217606|592370573|FG000|9-Month Masked Extension|Other Reasons|4|||
164001907|NCT01217606|592370574|FG001|9-Month Masked Extension|Other Reasons|4|||
164001908|NCT01217606|592370573|FG000|9-Month Masked Extension|Personal Reasons|2|||
164001909|NCT01217606|592370574|FG001|9-Month Masked Extension|Personal Reasons|1|||
164001910|NCT01217606|592370573|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
164001911|NCT01217606|592370574|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
164001912|NCT01217606|592370573|FG000|9-Month Masked Extension|Pregnancy|1|||
164001913|NCT01217606|592370574|FG001|9-Month Masked Extension|Pregnancy|0|||
164001914|NCT01217606|592370573|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
164001915|NCT01217606|592370574|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
164001916|NCT00809133|592370575|FG000|Overall Study|Progressive disease|2|||
164001917|NCT00809133|592370576|FG001|Overall Study|Progressive disease|5|||
164001918|NCT00809133|592370577|FG002|Overall Study|Progressive disease|5|||
164001919|NCT00809133|592370578|FG003|Overall Study|Progressive disease|3|||
164001920|NCT00809133|592370579|FG004|Overall Study|Progressive disease|4|||
164001921|NCT00809133|592370580|FG005|Overall Study|Progressive disease|1|||
164001922|NCT00809133|592370581|FG006|Overall Study|Progressive disease|3|||
164001923|NCT00809133|592370582|FG007|Overall Study|Progressive disease|3|||
164001924|NCT00809133|592370583|FG008|Overall Study|Progressive disease|3|||
164001925|NCT00809133|592370584|FG009|Overall Study|Progressive disease|9|||
164001926|NCT00809133|592370585|FG010|Overall Study|Progressive disease|5|||
164001927|NCT00809133|592370586|FG011|Overall Study|Progressive disease|7|||
164001928|NCT00809133|592370587|FG012|Overall Study|Progressive disease|5|||
164001929|NCT00809133|592370588|FG013|Overall Study|Progressive disease|4|||
164001930|NCT00809133|592370575|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001931|NCT00809133|592370576|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001932|NCT00809133|592370577|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001933|NCT00809133|592370578|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001934|NCT00809133|592370579|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001935|NCT00809133|592370580|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164001936|NCT00809133|592370581|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164086604|NCT02385526|592681460|FG000|Overall Study|Physician Decision|1|||
164086605|NCT02385526|592681461|FG001|Overall Study|Physician Decision|0|||
164086606|NCT02385526|592681462|FG002|Overall Study|Physician Decision|0|||
164086607|NCT02385526|592681460|FG000|Overall Study|Protocol Violation|1|||
164086608|NCT02385526|592681461|FG001|Overall Study|Protocol Violation|0|||
164086609|NCT02385526|592681462|FG002|Overall Study|Protocol Violation|0|||
164086610|NCT00662025|592681463|FG000|Overall Study|Objective progression or relapse|51|||
164086611|NCT00662025|592681463|FG000|Overall Study|Adverse Event|7|||
164086612|NCT00662025|592681463|FG000|Overall Study|Withdrawal by Subject|1|||
164086613|NCT00662025|592681463|FG000|Overall Study|Results of other clinical study|2|||
164086614|NCT00662025|592681463|FG000|Overall Study|Target lesion cannot be evaluated|1|||
164086615|NCT00662025|592681463|FG000|Overall Study|Domestic circumstances|1|||
164086616|NCT01689974|592681464|FG000|Overall Study|Termination of Study|5|||
164086617|NCT01689974|592681465|FG001|Overall Study|Termination of Study|5|||
164086618|NCT01333033|592681466|FG000|Overall Study|Ineligible|0|||
164086619|NCT01333033|592681467|FG001|Overall Study|Ineligible|0|||
164086620|NCT01333033|592681468|FG002|Overall Study|Ineligible|0|||
164086621|NCT01333033|592681469|FG003|Overall Study|Ineligible|0|||
164086622|NCT01333033|592681470|FG004|Overall Study|Ineligible|6|||
164086623|NCT01333033|592681471|FG005|Overall Study|Ineligible|8|||
164086624|NCT01333033|592681466|FG000|Overall Study|Withdrawal by Subject|0|||
164086625|NCT01333033|592681467|FG001|Overall Study|Withdrawal by Subject|0|||
164086626|NCT01333033|592681468|FG002|Overall Study|Withdrawal by Subject|0|||
164086627|NCT01333033|592681469|FG003|Overall Study|Withdrawal by Subject|0|||
164086628|NCT01333033|592681470|FG004|Overall Study|Withdrawal by Subject|4|||
164086629|NCT01333033|592681471|FG005|Overall Study|Withdrawal by Subject|2|||
164086630|NCT01333033|592681466|FG000|Overall Study|PET inevaluable|0|||
164086631|NCT01333033|592681467|FG001|Overall Study|PET inevaluable|0|||
164086632|NCT01333033|592681468|FG002|Overall Study|PET inevaluable|0|||
164086633|NCT01333033|592681469|FG003|Overall Study|PET inevaluable|0|||
164086634|NCT01333033|592681470|FG004|Overall Study|PET inevaluable|2|||
164086635|NCT01333033|592681471|FG005|Overall Study|PET inevaluable|4|||
164086636|NCT01333033|592681466|FG000|Overall Study|Adverse Event|0|||
164086637|NCT01333033|592681467|FG001|Overall Study|Adverse Event|0|||
164086638|NCT01333033|592681468|FG002|Overall Study|Adverse Event|0|||
164086639|NCT01333033|592681469|FG003|Overall Study|Adverse Event|0|||
164086640|NCT01333033|592681470|FG004|Overall Study|Adverse Event|2|||
164086641|NCT01333033|592681471|FG005|Overall Study|Adverse Event|1|||
164086642|NCT01333033|592681466|FG000|Overall Study|Progression|0|||
164086643|NCT01333033|592681467|FG001|Overall Study|Progression|0|||
164086644|NCT01333033|592681468|FG002|Overall Study|Progression|0|||
164086645|NCT01333033|592681469|FG003|Overall Study|Progression|0|||
164086646|NCT01333033|592681470|FG004|Overall Study|Progression|0|||
164086647|NCT01333033|592681471|FG005|Overall Study|Progression|1|||
164086648|NCT01333033|592681466|FG000|Overall Study|MD Decision|0|||
164086649|NCT01333033|592681467|FG001|Overall Study|MD Decision|0|||
164086650|NCT01333033|592681468|FG002|Overall Study|MD Decision|0|||
164086651|NCT01333033|592681469|FG003|Overall Study|MD Decision|0|||
164086652|NCT01333033|592681470|FG004|Overall Study|MD Decision|0|||
164086653|NCT01333033|592681471|FG005|Overall Study|MD Decision|2|||
164086654|NCT00384033|592681481|FG000|Overall Study|Adverse Event|10|||
164086655|NCT00384033|592681482|FG001|Overall Study|Adverse Event|8|||
164086656|NCT00384033|592681483|FG002|Overall Study|Adverse Event|11|||
164086657|NCT00384033|592681484|FG003|Overall Study|Adverse Event|20|||
164086658|NCT00384033|592681481|FG000|Overall Study|Failed to return|1|||
164086659|NCT00384033|592681482|FG001|Overall Study|Failed to return|3|||
164086660|NCT00384033|592681483|FG002|Overall Study|Failed to return|2|||
164086661|NCT00384033|592681484|FG003|Overall Study|Failed to return|2|||
164086662|NCT00384033|592681481|FG000|Overall Study|Physician Decision|1|||
164086663|NCT00384033|592681482|FG001|Overall Study|Physician Decision|0|||
164086664|NCT00384033|592681483|FG002|Overall Study|Physician Decision|0|||
164086665|NCT00384033|592681484|FG003|Overall Study|Physician Decision|0|||
164086666|NCT00384033|592681481|FG000|Overall Study|Lost to Follow-up|6|||
164086667|NCT00384033|592681482|FG001|Overall Study|Lost to Follow-up|12|||
164086668|NCT00384033|592681483|FG002|Overall Study|Lost to Follow-up|7|||
164086669|NCT00384033|592681484|FG003|Overall Study|Lost to Follow-up|7|||
164086670|NCT00384033|592681481|FG000|Overall Study|Other|2|||
164086671|NCT00384033|592681482|FG001|Overall Study|Other|0|||
164086672|NCT00384033|592681483|FG002|Overall Study|Other|0|||
164086673|NCT00384033|592681484|FG003|Overall Study|Other|0|||
164086674|NCT00384033|592681481|FG000|Overall Study|Protocol Violation|5|||
164086675|NCT00384033|592681482|FG001|Overall Study|Protocol Violation|0|||
164086676|NCT00384033|592681483|FG002|Overall Study|Protocol Violation|5|||
164086677|NCT00384033|592681484|FG003|Overall Study|Protocol Violation|6|||
164086678|NCT00384033|592681481|FG000|Overall Study|Withdrawal by Subject|6|||
164086679|NCT00384033|592681482|FG001|Overall Study|Withdrawal by Subject|2|||
164086680|NCT00384033|592681483|FG002|Overall Study|Withdrawal by Subject|5|||
164086681|NCT00384033|592681484|FG003|Overall Study|Withdrawal by Subject|2|||
164086682|NCT00384033|592681481|FG000|Overall Study|Lack of Efficacy|7|||
164086683|NCT00384033|592681482|FG001|Overall Study|Lack of Efficacy|3|||
164086684|NCT00384033|592681483|FG002|Overall Study|Lack of Efficacy|3|||
163896457|NCT03547271|591994695|FG000|Overall Study|Protocol deviation|5|||
163896458|NCT03547271|591994696|FG001|Overall Study|Protocol deviation|7|||
163896459|NCT03547271|591994697|FG002|Overall Study|Protocol deviation|3|||
163896460|NCT03547271|591994698|FG003|Overall Study|Protocol deviation|0|||
164281498|NCT01496846|593400699|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
164281499|NCT01772576|593400703|FG000|Overall Study|Death|15|||
164281500|NCT01772576|593400703|FG000|Overall Study|Protocol Violation|1|||
164281501|NCT01772576|593400703|FG000|Overall Study|Lost to Follow-up|3|||
164281502|NCT01772576|593400703|FG000|Overall Study|Study device not used|3|||
164281503|NCT01772576|593400703|FG000|Overall Study|Adverse Event|6|||
164281504|NCT01772576|593400703|FG000|Overall Study|Withdrawal by Subject|6|||
164281505|NCT03301350|593400715|FG000|Overall Study|Withdrawal by Subject|4|||
164281506|NCT03301350|593400715|FG000|Overall Study|Adverse Event|1|||
164281507|NCT03301350|593400715|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
164281508|NCT03301350|593400715|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
164281509|NCT03301350|593400715|FG000|Overall Study|no detail provided|1|||
164281510|NCT00379912|593400716|FG000|Overall Study|Lack of Efficacy|1|||
164281511|NCT00379912|593400717|FG001|Overall Study|Lack of Efficacy|0|||
164281512|NCT04698993|593400718|FG000|Overall Study|PCR results not accessible|2|||
164281513|NCT04698993|593400719|FG001|Overall Study|PCR results not accessible|7|||
164281514|NCT04698993|593400718|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
164281515|NCT04698993|593400719|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
163896461|NCT03547271|591994695|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
164001937|NCT00809133|592370582|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164281516|NCT01371734|593400720|FG000|Overall Study|Other|2|||
164281517|NCT01371734|593400721|FG001|Overall Study|Other|1|||
164281518|NCT01371734|593400722|FG002|Overall Study|Other|2|||
164281519|NCT01371734|593400720|FG000|Overall Study|Withdrawal by Subject|3|||
164281520|NCT01371734|593400721|FG001|Overall Study|Withdrawal by Subject|4|||
164281521|NCT01371734|593400722|FG002|Overall Study|Withdrawal by Subject|9|||
163896462|NCT03547271|591994696|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
163896463|NCT03547271|591994697|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
163896464|NCT03547271|591994698|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
163896465|NCT03547271|591994695|FG000|Overall Study|Lost to Follow-up|3|||
163896466|NCT03547271|591994696|FG001|Overall Study|Lost to Follow-up|3|||
163896467|NCT03547271|591994697|FG002|Overall Study|Lost to Follow-up|1|||
163896468|NCT03547271|591994698|FG003|Overall Study|Lost to Follow-up|0|||
163896469|NCT06065735|591994703|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
163896470|NCT06065735|591994704|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
163896471|NCT06065735|591994705|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
163896472|NCT06065735|591994703|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
163896473|NCT06065735|591994704|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
163896474|NCT06065735|591994705|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
163896475|NCT06065735|591994703|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
163896476|NCT06065735|591994704|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
163896477|NCT06065735|591994705|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
163896478|NCT06065735|591994703|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
163896479|NCT06065735|591994704|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
163896480|NCT06065735|591994705|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
163896481|NCT06065735|591994703|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
164001938|NCT00809133|592370583|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001939|NCT00809133|592370584|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001940|NCT00809133|592370585|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001941|NCT00809133|592370586|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001942|NCT00809133|592370587|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164001943|NCT00809133|592370588|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164001944|NCT00809133|592370575|FG000|Overall Study|Other adverse event|1|||
164001945|NCT00809133|592370576|FG001|Overall Study|Other adverse event|1|||
164001946|NCT00809133|592370577|FG002|Overall Study|Other adverse event|1|||
164001947|NCT00809133|592370578|FG003|Overall Study|Other adverse event|0|||
164001948|NCT00809133|592370579|FG004|Overall Study|Other adverse event|0|||
164001949|NCT00809133|592370580|FG005|Overall Study|Other adverse event|3|||
164001950|NCT00809133|592370581|FG006|Overall Study|Other adverse event|2|||
164001951|NCT00809133|592370582|FG007|Overall Study|Other adverse event|4|||
164001952|NCT00809133|592370583|FG008|Overall Study|Other adverse event|0|||
164001953|NCT00809133|592370584|FG009|Overall Study|Other adverse event|0|||
164001954|NCT00809133|592370585|FG010|Overall Study|Other adverse event|1|||
164001955|NCT00809133|592370586|FG011|Overall Study|Other adverse event|1|||
164001956|NCT00809133|592370587|FG012|Overall Study|Other adverse event|0|||
164001957|NCT00809133|592370588|FG013|Overall Study|Other adverse event|1|||
164001958|NCT00809133|592370575|FG000|Overall Study|Lost to Follow-up|0|||
164001959|NCT00809133|592370576|FG001|Overall Study|Lost to Follow-up|0|||
164001960|NCT00809133|592370577|FG002|Overall Study|Lost to Follow-up|0|||
164001961|NCT00809133|592370578|FG003|Overall Study|Lost to Follow-up|0|||
164001962|NCT00809133|592370579|FG004|Overall Study|Lost to Follow-up|0|||
164281522|NCT01371734|593400720|FG000|Overall Study|Lost to Follow-up|5|||
164281523|NCT01371734|593400721|FG001|Overall Study|Lost to Follow-up|3|||
164281524|NCT01371734|593400722|FG002|Overall Study|Lost to Follow-up|1|||
164281525|NCT01371734|593400720|FG000|Overall Study|Protocol Violation|3|||
164281526|NCT01371734|593400721|FG001|Overall Study|Protocol Violation|1|||
164281527|NCT01371734|593400722|FG002|Overall Study|Protocol Violation|2|||
164281528|NCT01371734|593400720|FG000|Overall Study|Adverse Event|8|||
164281529|NCT01371734|593400721|FG001|Overall Study|Adverse Event|8|||
164281530|NCT01371734|593400722|FG002|Overall Study|Adverse Event|3|||
164281531|NCT01371734|593400720|FG000|Overall Study|Lack of Efficacy|2|||
164281532|NCT01371734|593400721|FG001|Overall Study|Lack of Efficacy|2|||
164281533|NCT01371734|593400722|FG002|Overall Study|Lack of Efficacy|0|||
164281534|NCT00958165|593400723|FG000|Overall Study|Lost to Follow-up|5|||
164281535|NCT00958165|593400723|FG000|Overall Study|Not eligible|9|||
164281536|NCT00145574|593400724|FG000|Double Blind|Adverse Event|0|||
163896482|NCT06065735|591994704|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
163896483|NCT06065735|591994705|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
163896484|NCT03522298|591994706|FG000|Overall Study|Adverse Event|1|||
163896485|NCT03522298|591994707|FG001|Overall Study|Adverse Event|0|||
163896486|NCT03522298|591994708|FG002|Overall Study|Adverse Event|0|||
163896487|NCT03522298|591994709|FG003|Overall Study|Adverse Event|1|||
163896488|NCT03522298|591994706|FG000|Overall Study|Death|2|||
163896489|NCT03522298|591994707|FG001|Overall Study|Death|4|||
163896490|NCT03522298|591994708|FG002|Overall Study|Death|8|||
163896491|NCT03522298|591994709|FG003|Overall Study|Death|8|||
163896492|NCT03522298|591994706|FG000|Overall Study|Patient decision|0|||
163896493|NCT03522298|591994707|FG001|Overall Study|Patient decision|2|||
163896494|NCT03522298|591994708|FG002|Overall Study|Patient decision|2|||
163896495|NCT03522298|591994709|FG003|Overall Study|Patient decision|2|||
163896496|NCT05718687|591994712|FG000|Overall Study|Withdrawal by Subject|3|||
163896497|NCT05485935|591994715|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
163896498|NCT05485935|591994716|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
163896499|NCT05485935|591994715|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
163896500|NCT05485935|591994716|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
163896501|NCT05485935|591994715|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
163896502|NCT05485935|591994716|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
163896503|NCT05485935|591994715|FG000|Period 2 (T2 and V3)|loss of contact|0|||
163896504|NCT05485935|591994716|FG001|Period 2 (T2 and V3)|loss of contact|1|||
163896505|NCT04093869|591994717|FG000|Overall Study|Death|0|||
163896506|NCT04093869|591994718|FG001|Overall Study|Death|1|||
163896507|NCT04093869|591994717|FG000|Overall Study|Withdrawal by Subject|1|||
163896508|NCT04093869|591994718|FG001|Overall Study|Withdrawal by Subject|0|||
163896509|NCT02325154|591994719|FG000|Overall Study|Physician Decision|1|||
163896510|NCT03990883|591994720|FG000|Blinded Treatment Phase|Adverse Event|1|||
163896511|NCT03990883|591994721|FG001|Blinded Treatment Phase|Adverse Event|1|||
163896512|NCT03990883|591994722|FG002|Blinded Treatment Phase|Adverse Event|0|||
163896513|NCT03990883|591994720|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
163896514|NCT03990883|591994721|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
163896515|NCT03990883|591994722|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
163896516|NCT03990883|591994720|FG000|Blinded Treatment Phase|Physician Decision|1|||
163896517|NCT03990883|591994721|FG001|Blinded Treatment Phase|Physician Decision|0|||
163896518|NCT03990883|591994722|FG002|Blinded Treatment Phase|Physician Decision|0|||
163896519|NCT03990883|591994720|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
163896520|NCT03990883|591994721|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
163896521|NCT03990883|591994722|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
163896522|NCT03990883|591994720|FG000|Blinded Treatment Phase|COVID-19|3|||
163896523|NCT03990883|591994721|FG001|Blinded Treatment Phase|COVID-19|2|||
163896524|NCT03990883|591994722|FG002|Blinded Treatment Phase|COVID-19|0|||
163896525|NCT03990883|591994720|FG000|Blinded Treatment Phase|Personal Reasons|6|||
164001963|NCT00809133|592370580|FG005|Overall Study|Lost to Follow-up|1|||
164001964|NCT00809133|592370581|FG006|Overall Study|Lost to Follow-up|0|||
164001965|NCT00809133|592370582|FG007|Overall Study|Lost to Follow-up|0|||
164001966|NCT00809133|592370583|FG008|Overall Study|Lost to Follow-up|0|||
164001967|NCT00809133|592370584|FG009|Overall Study|Lost to Follow-up|0|||
164001968|NCT00809133|592370585|FG010|Overall Study|Lost to Follow-up|0|||
164001969|NCT00809133|592370586|FG011|Overall Study|Lost to Follow-up|0|||
164001970|NCT00809133|592370587|FG012|Overall Study|Lost to Follow-up|0|||
164001971|NCT00809133|592370588|FG013|Overall Study|Lost to Follow-up|0|||
164001972|NCT00809133|592370575|FG000|Overall Study|Consent withdrawn|0|||
164001973|NCT00809133|592370576|FG001|Overall Study|Consent withdrawn|0|||
164001974|NCT00809133|592370577|FG002|Overall Study|Consent withdrawn|0|||
164001975|NCT00809133|592370578|FG003|Overall Study|Consent withdrawn|0|||
164086685|NCT00384033|592681484|FG003|Overall Study|Lack of Efficacy|1|||
163896526|NCT03990883|591994721|FG001|Blinded Treatment Phase|Personal Reasons|3|||
163896527|NCT03990883|591994722|FG002|Blinded Treatment Phase|Personal Reasons|0|||
164001976|NCT00809133|592370579|FG004|Overall Study|Consent withdrawn|1|||
164001977|NCT00809133|592370580|FG005|Overall Study|Consent withdrawn|0|||
164281537|NCT00145574|593400725|FG001|Double Blind|Adverse Event|3|||
164086686|NCT00384033|592681481|FG000|Overall Study|Randomized but not treated|3|||
164086687|NCT00384033|592681482|FG001|Overall Study|Randomized but not treated|7|||
164086688|NCT00384033|592681483|FG002|Overall Study|Randomized but not treated|10|||
164086689|NCT00384033|592681484|FG003|Overall Study|Randomized but not treated|2|||
164086690|NCT01842958|592681486|FG000|Overall Study|Lost to Follow-up|1|||
164086691|NCT01842958|592681487|FG001|Overall Study|Lost to Follow-up|1|||
164086692|NCT01829477|592681488|FG000|Overall Study|Study Terminated by Sponsor|15|||
164086693|NCT01829477|592681489|FG001|Overall Study|Study Terminated by Sponsor|15|||
164086694|NCT01829477|592681488|FG000|Overall Study|Withdrawal by Subject|1|||
164086695|NCT01829477|592681489|FG001|Overall Study|Withdrawal by Subject|0|||
164086696|NCT03465891|592681491|FG000|Overall Study|Withdrawal by Subject|0|||
164086697|NCT03465891|592681492|FG001|Overall Study|Withdrawal by Subject|1|||
164086698|NCT03465891|592681491|FG000|Overall Study|Disease progression|1|||
164086699|NCT03465891|592681492|FG001|Overall Study|Disease progression|0|||
164086700|NCT02737306|592681493|FG000|Overall Study|Adverse Event|3|||
164086701|NCT02737306|592681494|FG001|Overall Study|Adverse Event|0|||
164086702|NCT02737306|592681493|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
164086703|NCT02737306|592681494|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
164086704|NCT03361423|592681495|FG000|Overall Study|Withdrawal by Subject|4|||
164086705|NCT03361423|592681496|FG001|Overall Study|Withdrawal by Subject|3|||
164086706|NCT03361423|592681495|FG000|Overall Study|Did not treat|19|||
164086707|NCT03361423|592681496|FG001|Overall Study|Did not treat|18|||
164086708|NCT03361423|592681495|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
164086709|NCT03361423|592681496|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
164086710|NCT03361423|592681495|FG000|Overall Study|Missing data|4|||
164086711|NCT03361423|592681496|FG001|Overall Study|Missing data|1|||
164086712|NCT00818623|592681497|FG000|Overall Study|Adverse Event|1|||
164086713|NCT00818623|592681498|FG001|Overall Study|Adverse Event|0|||
164086714|NCT00818623|592681499|FG002|Overall Study|Adverse Event|1|||
164086715|NCT00818623|592681500|FG003|Overall Study|Adverse Event|0|||
164086716|NCT00818623|592681501|FG004|Overall Study|Adverse Event|0|||
164086717|NCT00818623|592681502|FG005|Overall Study|Adverse Event|1|||
164086718|NCT00818623|592681503|FG006|Overall Study|Adverse Event|0|||
164086719|NCT00818623|592681504|FG007|Overall Study|Adverse Event|0|||
164086720|NCT00818623|592681497|FG000|Overall Study|Bad prostate specific antigen response|0|||
164086721|NCT00818623|592681498|FG001|Overall Study|Bad prostate specific antigen response|3|||
164086722|NCT00818623|592681499|FG002|Overall Study|Bad prostate specific antigen response|2|||
164086723|NCT00818623|592681500|FG003|Overall Study|Bad prostate specific antigen response|5|||
164086724|NCT00818623|592681501|FG004|Overall Study|Bad prostate specific antigen response|0|||
164086725|NCT00818623|592681502|FG005|Overall Study|Bad prostate specific antigen response|1|||
164086726|NCT00818623|592681503|FG006|Overall Study|Bad prostate specific antigen response|0|||
164086727|NCT00818623|592681504|FG007|Overall Study|Bad prostate specific antigen response|0|||
164086728|NCT00818623|592681497|FG000|Overall Study|Withdrawal by Subject|0|||
164086729|NCT00818623|592681498|FG001|Overall Study|Withdrawal by Subject|1|||
164086730|NCT00818623|592681499|FG002|Overall Study|Withdrawal by Subject|1|||
164086731|NCT00818623|592681500|FG003|Overall Study|Withdrawal by Subject|0|||
164086732|NCT00818623|592681501|FG004|Overall Study|Withdrawal by Subject|0|||
164086733|NCT00818623|592681502|FG005|Overall Study|Withdrawal by Subject|1|||
164281538|NCT00145574|593400726|FG002|Double Blind|Adverse Event|1|||
164281539|NCT00145574|593400724|FG000|Double Blind|Withdrawal by Subject|1|||
163896528|NCT03990883|591994720|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
163896529|NCT03990883|591994721|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
164086734|NCT00818623|592681503|FG006|Overall Study|Withdrawal by Subject|1|||
164086735|NCT00818623|592681504|FG007|Overall Study|Withdrawal by Subject|1|||
164086736|NCT00818623|592681497|FG000|Overall Study|Protocol Violation|1|||
164086737|NCT00818623|592681498|FG001|Overall Study|Protocol Violation|0|||
164086738|NCT00818623|592681499|FG002|Overall Study|Protocol Violation|0|||
164086739|NCT00818623|592681500|FG003|Overall Study|Protocol Violation|0|||
164086740|NCT00818623|592681501|FG004|Overall Study|Protocol Violation|1|||
164281540|NCT00145574|593400725|FG001|Double Blind|Withdrawal by Subject|1|||
164086741|NCT00818623|592681502|FG005|Overall Study|Protocol Violation|0|||
164086742|NCT00818623|592681503|FG006|Overall Study|Protocol Violation|1|||
164086743|NCT00818623|592681504|FG007|Overall Study|Protocol Violation|0|||
164086744|NCT00818623|592681497|FG000|Overall Study|Need of additional treatment|0|||
164086745|NCT00818623|592681498|FG001|Overall Study|Need of additional treatment|0|||
164086746|NCT00818623|592681499|FG002|Overall Study|Need of additional treatment|0|||
164281541|NCT00145574|593400726|FG002|Double Blind|Withdrawal by Subject|1|||
164281542|NCT00145574|593400724|FG000|Double Blind|required restricted medicine|0|||
164281543|NCT00145574|593400725|FG001|Double Blind|required restricted medicine|1|||
164281544|NCT00145574|593400726|FG002|Double Blind|required restricted medicine|0|||
164281545|NCT00145574|593400724|FG000|Open Label Long-term Extension|Adverse Event|0|||
164281546|NCT00145574|593400725|FG001|Open Label Long-term Extension|Adverse Event|0|||
164281547|NCT00145574|593400726|FG002|Open Label Long-term Extension|Adverse Event|5|||
164281548|NCT00145574|593400724|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
163896530|NCT03990883|591994722|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
163896531|NCT03990883|591994720|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
163896532|NCT03990883|591994721|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
163896533|NCT03990883|591994722|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
163896534|NCT03990883|591994720|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
163896535|NCT03990883|591994721|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
163896536|NCT03990883|591994722|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
163896537|NCT04408755|591995279|FG000|Period A (Placebo lead-in)|Other|11|||
163896538|NCT04408755|591995280|FG001|Period A (Placebo lead-in)|Other|0|||
163896539|NCT04408755|591995281|FG002|Period A (Placebo lead-in)|Other|0|||
163896540|NCT04408755|591995282|FG003|Period A (Placebo lead-in)|Other|0|||
163896541|NCT04408755|591995279|FG000|Period B (Randomization Period)|Adverse Event|0|||
163896542|NCT04408755|591995280|FG001|Period B (Randomization Period)|Adverse Event|3|||
163896543|NCT04408755|591995281|FG002|Period B (Randomization Period)|Adverse Event|0|||
163896544|NCT04408755|591995282|FG003|Period B (Randomization Period)|Adverse Event|1|||
163896545|NCT04408755|591995279|FG000|Period B (Randomization Period)|Death|0|||
163896546|NCT04408755|591995280|FG001|Period B (Randomization Period)|Death|0|||
163896547|NCT04408755|591995281|FG002|Period B (Randomization Period)|Death|1|||
163896548|NCT04408755|591995282|FG003|Period B (Randomization Period)|Death|0|||
163896549|NCT04408755|591995279|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
163896550|NCT04408755|591995280|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
163896551|NCT04408755|591995281|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
163896552|NCT04408755|591995282|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
163896553|NCT04408755|591995279|FG000|Period B (Randomization Period)|Physician Decision|0|||
164086747|NCT00818623|592681500|FG003|Overall Study|Need of additional treatment|0|||
164086748|NCT00818623|592681501|FG004|Overall Study|Need of additional treatment|1|||
164086749|NCT00818623|592681502|FG005|Overall Study|Need of additional treatment|0|||
163896554|NCT04408755|591995280|FG001|Period B (Randomization Period)|Physician Decision|0|||
163896555|NCT04408755|591995281|FG002|Period B (Randomization Period)|Physician Decision|1|||
163896556|NCT04408755|591995282|FG003|Period B (Randomization Period)|Physician Decision|0|||
163896557|NCT04408755|591995279|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
164086750|NCT00818623|592681503|FG006|Overall Study|Need of additional treatment|0|||
164086751|NCT00818623|592681504|FG007|Overall Study|Need of additional treatment|0|||
164086752|NCT00818623|592681497|FG000|Overall Study|Lack of trial drug at site|0|||
164086753|NCT00818623|592681498|FG001|Overall Study|Lack of trial drug at site|0|||
164086754|NCT00818623|592681499|FG002|Overall Study|Lack of trial drug at site|0|||
164086755|NCT00818623|592681500|FG003|Overall Study|Lack of trial drug at site|0|||
164086756|NCT00818623|592681501|FG004|Overall Study|Lack of trial drug at site|2|||
164086757|NCT00818623|592681502|FG005|Overall Study|Lack of trial drug at site|0|||
164086758|NCT00818623|592681503|FG006|Overall Study|Lack of trial drug at site|1|||
164086759|NCT00818623|592681504|FG007|Overall Study|Lack of trial drug at site|0|||
164086760|NCT00818623|592681497|FG000|Overall Study|Disease progression|0|||
164086761|NCT00818623|592681498|FG001|Overall Study|Disease progression|0|||
164086762|NCT00818623|592681499|FG002|Overall Study|Disease progression|0|||
164086763|NCT00818623|592681500|FG003|Overall Study|Disease progression|0|||
164086764|NCT00818623|592681501|FG004|Overall Study|Disease progression|0|||
164086765|NCT00818623|592681502|FG005|Overall Study|Disease progression|0|||
164086766|NCT00818623|592681503|FG006|Overall Study|Disease progression|1|||
164086767|NCT00818623|592681504|FG007|Overall Study|Disease progression|0|||
164086768|NCT00299156|592681505|FG000|Period 2 (Randomized)|Screen Failure|0|||
164086769|NCT00299156|592681506|FG001|Period 2 (Randomized)|Screen Failure|1|||
164086770|NCT00299156|592681507|FG002|Period 2 (Randomized)|Screen Failure|0|||
164086771|NCT01166568|592681508|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
164086772|NCT01166568|592681509|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
164086773|NCT01166568|592681510|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
164086774|NCT01166568|592681508|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
163896558|NCT04408755|591995280|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
163896559|NCT04408755|591995281|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
163896560|NCT04408755|591995282|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
163896561|NCT04408755|591995279|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
164086775|NCT01166568|592681509|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
164086776|NCT01166568|592681510|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
164086777|NCT01166568|592681508|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
164086778|NCT01166568|592681509|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
164086779|NCT01166568|592681510|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
164086780|NCT00903383|592681511|FG000|Overall Study|Adverse Event|1|||
164086781|NCT00903383|592681512|FG001|Overall Study|Adverse Event|2|||
164086782|NCT00903383|592681513|FG002|Overall Study|Adverse Event|3|||
164086783|NCT00903383|592681514|FG003|Overall Study|Adverse Event|1|||
163896562|NCT04408755|591995280|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
163896563|NCT04408755|591995281|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
163896564|NCT04408755|591995282|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
163896565|NCT04408755|591995279|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
163896566|NCT04408755|591995280|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
163896567|NCT04408755|591995281|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
163896568|NCT04408755|591995282|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
163896569|NCT04408755|591995279|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
163896570|NCT04408755|591995280|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
163896571|NCT04408755|591995281|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
163896572|NCT04408755|591995282|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
164001978|NCT00809133|592370581|FG006|Overall Study|Consent withdrawn|0|||
164001979|NCT00809133|592370582|FG007|Overall Study|Consent withdrawn|0|||
164001980|NCT00809133|592370583|FG008|Overall Study|Consent withdrawn|0|||
164001981|NCT00809133|592370584|FG009|Overall Study|Consent withdrawn|0|||
164001982|NCT00809133|592370585|FG010|Overall Study|Consent withdrawn|0|||
164001983|NCT00809133|592370586|FG011|Overall Study|Consent withdrawn|0|||
164001984|NCT00809133|592370587|FG012|Overall Study|Consent withdrawn|0|||
164001985|NCT00809133|592370588|FG013|Overall Study|Consent withdrawn|0|||
164001986|NCT00809133|592370575|FG000|Overall Study|Other not mentioned above|0|||
164001987|NCT00809133|592370576|FG001|Overall Study|Other not mentioned above|1|||
164001988|NCT00809133|592370577|FG002|Overall Study|Other not mentioned above|0|||
164001989|NCT00809133|592370578|FG003|Overall Study|Other not mentioned above|0|||
164001990|NCT00809133|592370579|FG004|Overall Study|Other not mentioned above|0|||
164001991|NCT00809133|592370580|FG005|Overall Study|Other not mentioned above|1|||
164001992|NCT00809133|592370581|FG006|Overall Study|Other not mentioned above|0|||
164001993|NCT00809133|592370582|FG007|Overall Study|Other not mentioned above|0|||
164001994|NCT00809133|592370583|FG008|Overall Study|Other not mentioned above|0|||
164001995|NCT00809133|592370584|FG009|Overall Study|Other not mentioned above|0|||
164001996|NCT00809133|592370585|FG010|Overall Study|Other not mentioned above|0|||
164001997|NCT00809133|592370586|FG011|Overall Study|Other not mentioned above|0|||
164001998|NCT00809133|592370587|FG012|Overall Study|Other not mentioned above|0|||
164001999|NCT00809133|592370588|FG013|Overall Study|Other not mentioned above|0|||
164002000|NCT03093155|592370590|FG000|Overall Study|Not Eligible|1|||
164002001|NCT03093155|592370591|FG001|Overall Study|Not Eligible|0|||
164002002|NCT03093155|592370590|FG000|Overall Study|Withdrawal by Subject|0|||
164002003|NCT03093155|592370591|FG001|Overall Study|Withdrawal by Subject|1|||
164002004|NCT01700829|592370592|FG000|Overall Study|Withdrawal by Subject|1|||
164002005|NCT01700829|592370593|FG001|Overall Study|Withdrawal by Subject|1|||
164002006|NCT01075178|592370594|FG000|Subject Matching|eligible but not matched|130|||
164002007|NCT01075178|592370595|FG001|Subject Matching|eligible but not matched|403|||
164002008|NCT01075178|592370594|FG000|Subject Chart Review|died before chart review period|0|||
164002009|NCT01075178|592370595|FG001|Subject Chart Review|died before chart review period|2|||
164002010|NCT01075178|592370594|FG000|Subject Chart Review|no data collected due to site closure|3|||
164002011|NCT01075178|592370595|FG001|Subject Chart Review|no data collected due to site closure|4|||
164002012|NCT01075178|592370594|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
164002013|NCT01075178|592370595|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
164002014|NCT02983604|592370596|FG000|Overall Study|Enrolled but not Treated|0|||
164002015|NCT02983604|592370597|FG001|Overall Study|Enrolled but not Treated|0|||
164002016|NCT02983604|592370598|FG002|Overall Study|Enrolled but not Treated|1|||
164002017|NCT02983604|592370599|FG003|Overall Study|Enrolled but not Treated|0|||
164002018|NCT00607048|592370601|FG000|Overall Study|Adverse Event|0|||
164002019|NCT00607048|592370602|FG001|Overall Study|Adverse Event|1|||
164002020|NCT00607048|592370603|FG002|Overall Study|Adverse Event|0|||
164002021|NCT00607048|592370604|FG003|Overall Study|Adverse Event|0|||
164002022|NCT00607048|592370605|FG004|Overall Study|Adverse Event|4|||
164002023|NCT00607048|592370606|FG005|Overall Study|Adverse Event|0|||
164002024|NCT00607048|592370601|FG000|Overall Study|Global deterioration of health|1|||
164002025|NCT00607048|592370602|FG001|Overall Study|Global deterioration of health|0|||
164002026|NCT00607048|592370603|FG002|Overall Study|Global deterioration of health|0|||
164002027|NCT00607048|592370604|FG003|Overall Study|Global deterioration of health|0|||
164002028|NCT00607048|592370605|FG004|Overall Study|Global deterioration of health|0|||
164002029|NCT00607048|592370606|FG005|Overall Study|Global deterioration of health|0|||
164002030|NCT00607048|592370601|FG000|Overall Study|Objective disease progression - relapse|1|||
164002031|NCT00607048|592370602|FG001|Overall Study|Objective disease progression - relapse|2|||
164002032|NCT00607048|592370603|FG002|Overall Study|Objective disease progression - relapse|4|||
164002033|NCT00607048|592370604|FG003|Overall Study|Objective disease progression - relapse|2|||
164002034|NCT00607048|592370605|FG004|Overall Study|Objective disease progression - relapse|2|||
164002035|NCT00607048|592370606|FG005|Overall Study|Objective disease progression - relapse|2|||
164002036|NCT00607048|592370601|FG000|Overall Study|Withdrawal by Subject|0|||
164002037|NCT00607048|592370602|FG001|Overall Study|Withdrawal by Subject|0|||
164086784|NCT00903383|592681511|FG000|Overall Study|Physician Decision|1|||
164086785|NCT00903383|592681512|FG001|Overall Study|Physician Decision|2|||
164086786|NCT00903383|592681513|FG002|Overall Study|Physician Decision|0|||
164086787|NCT00903383|592681514|FG003|Overall Study|Physician Decision|0|||
164086788|NCT00903383|592681511|FG000|Overall Study|Lost to Follow-up|0|||
164086789|NCT00903383|592681512|FG001|Overall Study|Lost to Follow-up|0|||
164086790|NCT00903383|592681513|FG002|Overall Study|Lost to Follow-up|0|||
164086791|NCT00903383|592681514|FG003|Overall Study|Lost to Follow-up|1|||
164086792|NCT00903383|592681511|FG000|Overall Study|Decision of Sponsor|1|||
164086793|NCT00903383|592681512|FG001|Overall Study|Decision of Sponsor|0|||
164086794|NCT00903383|592681513|FG002|Overall Study|Decision of Sponsor|0|||
164086795|NCT00903383|592681514|FG003|Overall Study|Decision of Sponsor|0|||
164086796|NCT00903383|592681511|FG000|Overall Study|Withdrawal by Subject|4|||
164086797|NCT00903383|592681512|FG001|Overall Study|Withdrawal by Subject|1|||
164086798|NCT00903383|592681513|FG002|Overall Study|Withdrawal by Subject|0|||
164086799|NCT00903383|592681514|FG003|Overall Study|Withdrawal by Subject|2|||
164086800|NCT00903383|592681511|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
164086801|NCT00903383|592681512|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
164086802|NCT00903383|592681513|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
164086803|NCT00903383|592681514|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
164086804|NCT00903383|592681511|FG000|Overall Study|Patient Decision|0|||
164086805|NCT00903383|592681512|FG001|Overall Study|Patient Decision|0|||
164086806|NCT00903383|592681513|FG002|Overall Study|Patient Decision|0|||
164086807|NCT00903383|592681514|FG003|Overall Study|Patient Decision|1|||
164086808|NCT02015793|592681522|FG000|Overall Study|Adverse Event|3|||
164281549|NCT00145574|593400725|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
164281550|NCT00145574|593400726|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
164281551|NCT00145574|593400724|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
164281552|NCT00145574|593400725|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
164281553|NCT00145574|593400726|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
164281554|NCT00145574|593400724|FG000|Open Label Long-term Extension|required restricted medicine|0|||
164281555|NCT00145574|593400725|FG001|Open Label Long-term Extension|required restricted medicine|0|||
164281556|NCT00145574|593400726|FG002|Open Label Long-term Extension|required restricted medicine|1|||
164281557|NCT00621140|593400727|FG000|Overall Study|Adverse Event|4|||
164281558|NCT00621140|593400728|FG001|Overall Study|Adverse Event|5|||
164281559|NCT00621140|593400727|FG000|Overall Study|Lost to Follow-up|1|||
164281560|NCT00621140|593400728|FG001|Overall Study|Lost to Follow-up|2|||
164281561|NCT00621140|593400727|FG000|Overall Study|Withdrawal by Subject|4|||
164281562|NCT00621140|593400728|FG001|Overall Study|Withdrawal by Subject|6|||
164281563|NCT00621140|593400727|FG000|Overall Study|Other incl. lack of efficacy|6|||
164281564|NCT00621140|593400728|FG001|Overall Study|Other incl. lack of efficacy|5|||
164281565|NCT01298765|593400730|FG000|Titration Period|Adverse Event|26|||
164281566|NCT01298765|593400730|FG000|Titration Period|Death|1|||
164281567|NCT01298765|593400730|FG000|Titration Period|Lack of Efficacy|21|||
164281568|NCT01298765|593400730|FG000|Titration Period|Lost to Follow-up|9|||
164281569|NCT01298765|593400730|FG000|Titration Period|Physician Decision|1|||
164281570|NCT01298765|593400730|FG000|Titration Period|Withdrawal by Subject|10|||
164281571|NCT01298765|593400730|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
164281572|NCT01298765|593400730|FG000|Long-Term Treatment Period|Adverse Event|19|||
164281573|NCT01298765|593400730|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
164281574|NCT01298765|593400730|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
164086809|NCT02015793|592681523|FG001|Overall Study|Adverse Event|3|||
164086810|NCT02015793|592681522|FG000|Overall Study|Withdrawal by Subject|1|||
164086811|NCT02015793|592681523|FG001|Overall Study|Withdrawal by Subject|1|||
164086812|NCT00320593|592681524|FG000|Overall Study|Lost to Follow-up|3|||
164086813|NCT00320593|592681525|FG001|Overall Study|Lost to Follow-up|0|||
164086814|NCT00320593|592681524|FG000|Overall Study|Moved to another state|1|||
164086815|NCT00320593|592681525|FG001|Overall Study|Moved to another state|0|||
164086816|NCT00320593|592681524|FG000|Overall Study|Withdrawal by Subject|2|||
164086817|NCT00320593|592681525|FG001|Overall Study|Withdrawal by Subject|1|||
164086818|NCT00320593|592681524|FG000|Overall Study|Withdrawal by clinical center|1|||
164086819|NCT00320593|592681525|FG001|Overall Study|Withdrawal by clinical center|0|||
164086820|NCT01076166|592681526|FG000|Overall Study|Adverse Event|3|||
164086821|NCT01076166|592681526|FG000|Overall Study|Symptoms improved/resolved|6|||
164086822|NCT02087059|592681527|FG000|Overall Study|Disease Progression|1|||
164086823|NCT02087059|592681527|FG000|Overall Study|Adverse Event|5|||
164086824|NCT02087059|592681527|FG000|Overall Study|Lost to Follow-up|1|||
164086825|NCT04281485|592681531|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
164086826|NCT04281485|592681532|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
164086827|NCT04281485|592681531|FG000|Overall Study|Ongoing (Safety data collection)|10|||
164086828|NCT04281485|592681532|FG001|Overall Study|Ongoing (Safety data collection)|5|||
164086829|NCT01211769|592681535|FG000|Overall Study|Lost to Follow-up|7|||
164086830|NCT01211769|592681536|FG001|Overall Study|Lost to Follow-up|9|||
164086831|NCT01211769|592681537|FG002|Overall Study|Lost to Follow-up|5|||
164086832|NCT01211769|592681538|FG003|Overall Study|Lost to Follow-up|9|||
164086833|NCT01211769|592681535|FG000|Overall Study|Physician Decision|2|||
164086834|NCT01211769|592681536|FG001|Overall Study|Physician Decision|0|||
164086835|NCT01211769|592681537|FG002|Overall Study|Physician Decision|2|||
164086836|NCT01211769|592681538|FG003|Overall Study|Physician Decision|1|||
164086837|NCT01211769|592681535|FG000|Overall Study|Adverse Event|0|||
164086838|NCT01211769|592681536|FG001|Overall Study|Adverse Event|1|||
164086839|NCT01211769|592681537|FG002|Overall Study|Adverse Event|1|||
164086840|NCT01211769|592681538|FG003|Overall Study|Adverse Event|1|||
164086841|NCT01709383|592681543|FG000|Overall Study|Lost to Follow-up|1|||
164086842|NCT01709383|592681544|FG001|Overall Study|Lost to Follow-up|0|||
164086843|NCT01193517|592681545|FG000|Overall Study|Early Progression|1|||
164086844|NCT01193517|592681546|FG001|Overall Study|Early Progression|0|||
164086845|NCT01193517|592681547|FG002|Overall Study|Early Progression|0|||
164086846|NCT01688037|592681548|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
164086847|NCT01688037|592681549|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
164086848|NCT01688037|592681550|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
164086849|NCT01688037|592681548|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
164086850|NCT01688037|592681549|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
164086851|NCT01688037|592681550|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
164086852|NCT01688037|592681548|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
164086853|NCT01688037|592681549|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
164086854|NCT01688037|592681550|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
164086855|NCT01688037|592681548|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
164086856|NCT01688037|592681549|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
164086857|NCT01688037|592681550|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
164086858|NCT01688037|592681548|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
164086859|NCT01688037|592681549|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
164086860|NCT01688037|592681550|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
164086861|NCT01688037|592681548|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
164086862|NCT01688037|592681549|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
164086863|NCT01688037|592681550|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
164086864|NCT01688037|592681548|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
164086865|NCT01688037|592681549|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
164086866|NCT01688037|592681550|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
164086867|NCT01688037|592681548|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
164086868|NCT01688037|592681549|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
164086869|NCT01688037|592681550|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
164086870|NCT01688037|592681548|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
164086871|NCT01688037|592681549|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
164086872|NCT01688037|592681550|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
164086873|NCT01688037|592681548|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
164086874|NCT01688037|592681549|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
164086875|NCT01688037|592681550|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
164086876|NCT05590585|592682525|FG000|Overall Study|Lost to Follow-up|3|||
164086877|NCT05590585|592682525|FG000|Overall Study|Withdrawal by Subject|1|||
164086878|NCT01673009|592682526|FG000|Overall Study|Physician Decision|5|||
164086879|NCT01673009|592682526|FG000|Overall Study|Withdrawal by Subject|8|||
164086880|NCT04161144|592682527|FG000|Overall Study|Withdrawal by Subject|0|||
164086881|NCT04161144|592682528|FG001|Overall Study|Withdrawal by Subject|1|||
164086882|NCT04161144|592682527|FG000|Overall Study|Protocol Violation|1|||
164086883|NCT04161144|592682528|FG001|Overall Study|Protocol Violation|0|||
164086884|NCT02848599|592682530|FG000|Overall Study|Protocol Violation|7|||
164086885|NCT02848599|592682531|FG001|Overall Study|Protocol Violation|9|||
164086886|NCT04828161|592682532|FG000|Overall Study|Withdrawal by Subject|0|||
164086887|NCT04828161|592682533|FG001|Overall Study|Withdrawal by Subject|3|||
164086888|NCT04828161|592682534|FG002|Overall Study|Withdrawal by Subject|3|||
164086889|NCT04828161|592682535|FG003|Overall Study|Withdrawal by Subject|4|||
164086890|NCT04828161|592682532|FG000|Overall Study|Lost to Follow-up|1|||
164086891|NCT04828161|592682533|FG001|Overall Study|Lost to Follow-up|4|||
164086892|NCT04828161|592682534|FG002|Overall Study|Lost to Follow-up|2|||
164086893|NCT04828161|592682535|FG003|Overall Study|Lost to Follow-up|2|||
164086894|NCT04828161|592682532|FG000|Overall Study|Other|2|||
164086895|NCT04828161|592682533|FG001|Overall Study|Other|0|||
164086896|NCT04828161|592682534|FG002|Overall Study|Other|2|||
164086897|NCT04828161|592682535|FG003|Overall Study|Other|0|||
164086898|NCT04828161|592682532|FG000|Overall Study|Death|0|||
164086899|NCT04828161|592682533|FG001|Overall Study|Death|0|||
164086900|NCT04828161|592682534|FG002|Overall Study|Death|0|||
164086901|NCT04828161|592682535|FG003|Overall Study|Death|2|||
164086902|NCT03093454|592682536|FG000|Overall Study|Withdrawal by Subject|1|||
164086903|NCT03093454|592682537|FG001|Overall Study|Withdrawal by Subject|1|||
164086904|NCT03093454|592682536|FG000|Overall Study|Scheduling conflict|3|||
164086905|NCT03093454|592682537|FG001|Overall Study|Scheduling conflict|1|||
164086906|NCT03093454|592682536|FG000|Overall Study|Physician Decision|2|||
164086907|NCT03093454|592682537|FG001|Overall Study|Physician Decision|1|||
163896573|NCT04408755|591995279|FG000|Period B (Randomization Period)|Reason not Specified|0|||
163896574|NCT04408755|591995280|FG001|Period B (Randomization Period)|Reason not Specified|1|||
163896575|NCT04408755|591995281|FG002|Period B (Randomization Period)|Reason not Specified|0|||
163896576|NCT04408755|591995282|FG003|Period B (Randomization Period)|Reason not Specified|2|||
163896577|NCT00308997|591995283|FG000|Overall Study|Subject feigned clinical data|0|||
163896578|NCT00308997|591995284|FG001|Overall Study|Subject feigned clinical data|1|||
163896579|NCT00308997|591995283|FG000|Overall Study|Unable to tolerate intervention|1|||
163896580|NCT00308997|591995284|FG001|Overall Study|Unable to tolerate intervention|0|||
163896581|NCT06655818|591995285|FG000|Overall Study|Withdrawal by Subject|1|||
163896582|NCT03662022|591995286|FG000|Year 1 2019|prevalent case|83|||
163896583|NCT03662022|591995287|FG001|Year 1 2019|prevalent case|116|||
163896584|NCT03662022|591995288|FG002|Year 1 2019|prevalent case|158|||
163896585|NCT03662022|591995289|FG003|Year 1 2019|prevalent case|99|||
164002038|NCT00607048|592370603|FG002|Overall Study|Withdrawal by Subject|0|||
164002039|NCT00607048|592370604|FG003|Overall Study|Withdrawal by Subject|1|||
164002040|NCT00607048|592370605|FG004|Overall Study|Withdrawal by Subject|0|||
164002041|NCT00607048|592370606|FG005|Overall Study|Withdrawal by Subject|2|||
164002042|NCT00607048|592370601|FG000|Overall Study|Other|1|||
164002043|NCT00607048|592370602|FG001|Overall Study|Other|1|||
164002044|NCT00607048|592370603|FG002|Overall Study|Other|0|||
164002045|NCT00607048|592370604|FG003|Overall Study|Other|0|||
164002046|NCT00607048|592370605|FG004|Overall Study|Other|0|||
164002047|NCT00607048|592370606|FG005|Overall Study|Other|1|||
164002048|NCT04336163|592370607|FG000|Overall Study|Lost to Follow-up|55|||
164002049|NCT04336163|592370608|FG001|Overall Study|Lost to Follow-up|0|||
164002050|NCT04927312|592370609|FG000|Overall Study|Adverse Event|1|||
164002051|NCT04927312|592370609|FG000|Overall Study|Death|1|||
164002052|NCT04927312|592370609|FG000|Overall Study|Withdrawal by Subject|1|||
164002053|NCT04927312|592370609|FG000|Overall Study|Other|1|||
164002054|NCT04919564|592370615|FG000|Overall Study|Lost to Follow-up|1|||
164002055|NCT04919564|592370616|FG001|Overall Study|Lost to Follow-up|0|||
164002056|NCT04919564|592370615|FG000|Overall Study|Physician Decision|1|||
164002057|NCT04919564|592370616|FG001|Overall Study|Physician Decision|1|||
164002058|NCT03812510|592370619|FG000|Overall Study|Lost to Follow-up|39|||
164002059|NCT03812510|592370619|FG000|Overall Study|Withdrawal by Subject|42|||
164002060|NCT03812510|592370619|FG000|Overall Study|Physician Decision|2|||
164002061|NCT03812510|592370619|FG000|Overall Study|Study Terminated by Sponsor|9|||
164002062|NCT03812510|592370619|FG000|Overall Study|Did Not Start Study Medication|55|||
164002063|NCT03812510|592370619|FG000|Overall Study|Adverse Event|5|||
164002064|NCT03168867|592370620|FG000|Overall Study|Withdrawal by Subject|1|||
164002065|NCT03168867|592370621|FG001|Overall Study|Withdrawal by Subject|5|||
164002066|NCT01128387|592370622|FG000|Overall Study|Physician Decision|0|||
164002067|NCT01128387|592370623|FG001|Overall Study|Physician Decision|1|||
164002068|NCT01535235|592370625|FG000|Overall Study|Adverse Event|1|||
164002069|NCT01535235|592370626|FG001|Overall Study|Adverse Event|0|||
164002070|NCT00858832|592370627|FG000|Overall Study|became ineligible: delivered vaginally|1|||
164002071|NCT00858832|592370628|FG001|Overall Study|became ineligible: delivered vaginally|0|||
164002072|NCT00858832|592370627|FG000|Overall Study|Adverse Event|0|||
164002073|NCT00858832|592370628|FG001|Overall Study|Adverse Event|1|||
164002074|NCT00659438|592370630|FG000|Overall Study|Withdrawal by Subject|2|||
164002075|NCT00659438|592370631|FG001|Overall Study|Withdrawal by Subject|2|||
164002076|NCT00659438|592370630|FG000|Overall Study|Death|11|||
164002077|NCT00659438|592370631|FG001|Overall Study|Death|6|||
164002078|NCT00659438|592370630|FG000|Overall Study|Lost to Follow-up|1|||
164002079|NCT00659438|592370631|FG001|Overall Study|Lost to Follow-up|0|||
164002080|NCT00201851|592370632|FG000|Overall Study|Lost to Follow-up|2|||
164002081|NCT00201851|592370633|FG001|Overall Study|Lost to Follow-up|1|||
164002082|NCT00201851|592370634|FG002|Overall Study|Lost to Follow-up|0|||
164002083|NCT00201851|592370632|FG000|Overall Study|Ineligible post enrollment|6|||
164002084|NCT00201851|592370633|FG001|Overall Study|Ineligible post enrollment|1|||
164002085|NCT00201851|592370634|FG002|Overall Study|Ineligible post enrollment|1|||
164002086|NCT02469246|592370635|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
164002087|NCT02469246|592370636|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
164002088|NCT02469246|592370635|FG000|Double-Blind Phase|Adverse Event|12|||
164002089|NCT02469246|592370636|FG001|Double-Blind Phase|Adverse Event|9|||
164002090|NCT02469246|592370635|FG000|Double-Blind Phase|Death|2|||
163896586|NCT03662022|591995286|FG000|Year 2 2020|incident case|18|||
163896587|NCT03662022|591995287|FG001|Year 2 2020|incident case|18|||
163896588|NCT03662022|591995288|FG002|Year 2 2020|incident case|16|||
164002091|NCT02469246|592370636|FG001|Double-Blind Phase|Death|0|||
164002092|NCT02469246|592370635|FG000|Double-Blind Phase|Lack of Efficacy|2|||
164002093|NCT02469246|592370636|FG001|Double-Blind Phase|Lack of Efficacy|1|||
164002094|NCT02469246|592370635|FG000|Double-Blind Phase|Investigator's Discretion|8|||
164002095|NCT02469246|592370636|FG001|Double-Blind Phase|Investigator's Discretion|8|||
164002096|NCT02469246|592370635|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
164002097|NCT02469246|592370636|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164086908|NCT02524379|592682538|FG000|Overall Study|Death|1|||
164002098|NCT02469246|592370635|FG000|Double-Blind Phase|Protocol Violation|1|||
164086909|NCT01884025|592682539|FG000|Overall Study|Lost to Follow-up|3|||
164086910|NCT01884025|592682540|FG001|Overall Study|Lost to Follow-up|4|||
164086911|NCT02854436|592682542|FG000|Overall Study|Adverse Event|1|||
164086912|NCT02854436|592682542|FG000|Overall Study|Death|208|||
164086913|NCT02854436|592682542|FG000|Overall Study|Lost to Follow-up|5|||
164086914|NCT02854436|592682542|FG000|Overall Study|Withdrawal by Subject|24|||
164086915|NCT02854436|592682542|FG000|Overall Study|Other|45|||
164086916|NCT02854436|592682542|FG000|Overall Study|Physician Decision|6|||
164086917|NCT01700621|592682545|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
164086918|NCT01700621|592682546|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
164086919|NCT01700621|592682545|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
164086920|NCT01700621|592682546|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
164086921|NCT01700621|592682545|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
164086922|NCT01700621|592682546|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
164086923|NCT02985151|592682547|FG000|Original Randomization|Withdrawal by Subject|0|||
164086924|NCT02985151|592682548|FG001|Original Randomization|Withdrawal by Subject|1|||
164086925|NCT02843074|592682558|FG000|Overall Study|Withdrawal by Subject|5|||
164086926|NCT02843074|592682558|FG000|Overall Study|Progressive disease|1|||
164086927|NCT02843074|592682558|FG000|Overall Study|Physician Decision|1|||
164086928|NCT02843074|592682558|FG000|Overall Study|Lost to Follow-up|1|||
164086929|NCT02843074|592682558|FG000|Overall Study|Death|9|||
164086930|NCT01564758|592682559|FG000|Overall Study|Death|8|||
164086931|NCT01564758|592682559|FG000|Overall Study|Adverse Event|3|||
164086932|NCT01564758|592682559|FG000|Overall Study|Other|3|||
164086933|NCT01186978|592682560|FG000|Overall Study|Withdrawal by Subject|1|||
164086934|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
164344474|NCT03600818|593636940|FG000|Overall Study|Withdrawal by Subject|4|||
164344475|NCT03600818|593636941|FG001|Overall Study|Withdrawal by Subject|3|||
164344476|NCT03600818|593636940|FG000|Overall Study|Other-unspecified|5|||
164344477|NCT03600818|593636941|FG001|Overall Study|Other-unspecified|3|||
164344478|NCT03600818|593636940|FG000|Overall Study|Randomized and not treated|0|||
164344479|NCT03600818|593636941|FG001|Overall Study|Randomized and not treated|1|||
164344480|NCT01706146|593636942|FG000|Overall Study|Withdrawal by Subject|1|||
164344481|NCT01706146|593636942|FG000|Overall Study|Adverse Event|3|||
164344482|NCT01706146|593636942|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
164344483|NCT02582983|593636946|FG000|Overall Study|Death|3|||
164344484|NCT02582983|593636946|FG000|Overall Study|Withdrawal by Subject|2|||
164344485|NCT02582983|593636946|FG000|Overall Study|Adverse Event|1|||
164344486|NCT04930965|593636947|FG000|Overall Study|Lost to Follow-up|7|||
164344487|NCT04930965|593636948|FG001|Overall Study|Lost to Follow-up|5|||
164344488|NCT04377620|593636949|FG000|Overall Study|Death|42|||
164344489|NCT04377620|593636950|FG001|Overall Study|Death|48|||
164344490|NCT04377620|593636951|FG002|Overall Study|Death|36|||
164344491|NCT04377620|593636949|FG000|Overall Study|Withdrawal by Subject|0|||
164344492|NCT04377620|593636950|FG001|Overall Study|Withdrawal by Subject|2|||
164344493|NCT04377620|593636951|FG002|Overall Study|Withdrawal by Subject|0|||
164344494|NCT05209360|593636952|FG000|Overall Study|Withdrawal by Subject|0|||
164344495|NCT05209360|593636953|FG001|Overall Study|Withdrawal by Subject|0|||
164344496|NCT05209360|593636954|FG002|Overall Study|Withdrawal by Subject|1|||
164344497|NCT05209360|593636955|FG003|Overall Study|Withdrawal by Subject|0|||
164344498|NCT05209360|593636956|FG004|Overall Study|Withdrawal by Subject|0|||
164344499|NCT05209360|593636957|FG005|Overall Study|Withdrawal by Subject|0|||
164344500|NCT04189081|593636959|FG000|Overall Study|Lost to Follow-up|1|||
164344501|NCT04189081|593636960|FG001|Overall Study|Lost to Follow-up|0|||
164344502|NCT04189081|593636961|FG002|Overall Study|Lost to Follow-up|0|||
164344503|NCT04189081|593636959|FG000|Overall Study|Withdrawal by Subject|0|||
163896589|NCT03662022|591995289|FG003|Year 2 2020|incident case|26|||
163896590|NCT03662022|591995286|FG000|Year 2 2020|other case|18|||
163896591|NCT03662022|591995287|FG001|Year 2 2020|other case|16|||
163896592|NCT03662022|591995288|FG002|Year 2 2020|other case|16|||
163896593|NCT03662022|591995289|FG003|Year 2 2020|other case|24|||
163896594|NCT03662022|591995286|FG000|Year 2 2020|Lost to Follow-up|1633|||
163896595|NCT03662022|591995287|FG001|Year 2 2020|Lost to Follow-up|1183|||
163896596|NCT03662022|591995288|FG002|Year 2 2020|Lost to Follow-up|1381|||
163896597|NCT03662022|591995289|FG003|Year 2 2020|Lost to Follow-up|2858|||
163896598|NCT03662022|591995286|FG000|Year 3 2021|incident case|24|||
163896599|NCT03662022|591995287|FG001|Year 3 2021|incident case|27|||
163896600|NCT03662022|591995288|FG002|Year 3 2021|incident case|24|||
163896601|NCT03662022|591995289|FG003|Year 3 2021|incident case|11|||
163896602|NCT03662022|591995286|FG000|Year 3 2021|other case|4|||
163896603|NCT03662022|591995287|FG001|Year 3 2021|other case|15|||
163896604|NCT03662022|591995288|FG002|Year 3 2021|other case|10|||
163896605|NCT03662022|591995289|FG003|Year 3 2021|other case|14|||
163896606|NCT03662022|591995286|FG000|Year 3 2021|Lost to Follow-up|179|||
163896607|NCT03662022|591995287|FG001|Year 3 2021|Lost to Follow-up|244|||
163896608|NCT03662022|591995288|FG002|Year 3 2021|Lost to Follow-up|480|||
163896609|NCT03662022|591995289|FG003|Year 3 2021|Lost to Follow-up|477|||
163896610|NCT03662022|591995286|FG000|Year 4 2022|incident case|25|||
164002099|NCT02469246|592370636|FG001|Double-Blind Phase|Protocol Violation|1|||
164002100|NCT02469246|592370635|FG000|Double-Blind Phase|Withdrew Consent|25|||
164002101|NCT02469246|592370636|FG001|Double-Blind Phase|Withdrew Consent|25|||
164002102|NCT02469246|592370635|FG000|Double-Blind Phase|Lost to Follow-up|9|||
164002103|NCT02469246|592370636|FG001|Double-Blind Phase|Lost to Follow-up|5|||
164002104|NCT02690701|592370643|FG000|Treatment Period 1|Adverse Event|2|||
164002105|NCT02690701|592370644|FG001|Treatment Period 1|Adverse Event|2|||
164002106|NCT02690701|592370643|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164086935|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
164086936|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
164344504|NCT04189081|593636960|FG001|Overall Study|Withdrawal by Subject|0|||
164344505|NCT04189081|593636961|FG002|Overall Study|Withdrawal by Subject|1|||
164344506|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
164344507|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
164344508|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
164344509|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
164344510|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
163896611|NCT03662022|591995287|FG001|Year 4 2022|incident case|41|||
163896612|NCT03662022|591995288|FG002|Year 4 2022|incident case|28|||
163896613|NCT03662022|591995289|FG003|Year 4 2022|incident case|7|||
163896614|NCT03662022|591995286|FG000|Year 4 2022|other case|8|||
163896615|NCT03662022|591995287|FG001|Year 4 2022|other case|19|||
163896616|NCT03662022|591995288|FG002|Year 4 2022|other case|13|||
163896617|NCT03662022|591995289|FG003|Year 4 2022|other case|7|||
163896618|NCT03662022|591995286|FG000|Year 4 2022|Lost to Follow-up|986|||
163896619|NCT03662022|591995287|FG001|Year 4 2022|Lost to Follow-up|1079|||
163896620|NCT03662022|591995288|FG002|Year 4 2022|Lost to Follow-up|1236|||
163896621|NCT03662022|591995289|FG003|Year 4 2022|Lost to Follow-up|1826|||
163896622|NCT05836012|591995292|FG000|Overall Study|Lost to Follow-up|1|||
163896623|NCT05836012|591995293|FG001|Overall Study|Lost to Follow-up|0|||
163896624|NCT05836012|591995292|FG000|Overall Study|Withdrawal by Subject|1|||
163896625|NCT05836012|591995293|FG001|Overall Study|Withdrawal by Subject|3|||
163896626|NCT05836012|591995292|FG000|Overall Study|Reason not included in pre-specified categories|2|||
163896627|NCT05836012|591995293|FG001|Overall Study|Reason not included in pre-specified categories|1|||
163896628|NCT03248479|591995294|FG000|Overall Study|Death|12|||
163896629|NCT03248479|591995295|FG001|Overall Study|Death|44|||
163896630|NCT03248479|591995296|FG002|Overall Study|Death|1|||
163896631|NCT03248479|591995297|FG003|Overall Study|Death|72|||
163896632|NCT03248479|591995298|FG004|Overall Study|Death|17|||
163896633|NCT03248479|591995299|FG005|Overall Study|Death|6|||
163896634|NCT03248479|591995300|FG006|Overall Study|Death|1|||
163896635|NCT03248479|591995301|FG007|Overall Study|Death|14|||
163896636|NCT03248479|591995302|FG008|Overall Study|Death|3|||
163896637|NCT03248479|591995303|FG009|Overall Study|Death|7|||
163896638|NCT03248479|591995304|FG010|Overall Study|Death|3|||
163896639|NCT03248479|591995305|FG011|Overall Study|Death|1|||
163896640|NCT03248479|591995306|FG012|Overall Study|Death|1|||
163896641|NCT03248479|591995294|FG000|Overall Study|Study terminated by sponsor|12|||
163896642|NCT03248479|591995295|FG001|Overall Study|Study terminated by sponsor|15|||
163896643|NCT03248479|591995296|FG002|Overall Study|Study terminated by sponsor|0|||
163896644|NCT03248479|591995297|FG003|Overall Study|Study terminated by sponsor|5|||
163896645|NCT03248479|591995298|FG004|Overall Study|Study terminated by sponsor|0|||
163896646|NCT03248479|591995299|FG005|Overall Study|Study terminated by sponsor|0|||
163896647|NCT03248479|591995300|FG006|Overall Study|Study terminated by sponsor|0|||
163896648|NCT03248479|591995301|FG007|Overall Study|Study terminated by sponsor|1|||
163896649|NCT03248479|591995302|FG008|Overall Study|Study terminated by sponsor|1|||
163896650|NCT03248479|591995303|FG009|Overall Study|Study terminated by sponsor|0|||
163896651|NCT03248479|591995304|FG010|Overall Study|Study terminated by sponsor|5|||
163896652|NCT03248479|591995305|FG011|Overall Study|Study terminated by sponsor|4|||
163896653|NCT03248479|591995306|FG012|Overall Study|Study terminated by sponsor|0|||
163896654|NCT03248479|591995294|FG000|Overall Study|Consent withdrawn|6|||
163896655|NCT03248479|591995295|FG001|Overall Study|Consent withdrawn|3|||
163896656|NCT03248479|591995296|FG002|Overall Study|Consent withdrawn|0|||
163896657|NCT03248479|591995297|FG003|Overall Study|Consent withdrawn|9|||
163896658|NCT03248479|591995298|FG004|Overall Study|Consent withdrawn|1|||
163896659|NCT03248479|591995299|FG005|Overall Study|Consent withdrawn|0|||
163896660|NCT03248479|591995300|FG006|Overall Study|Consent withdrawn|0|||
163896661|NCT03248479|591995301|FG007|Overall Study|Consent withdrawn|1|||
163896662|NCT03248479|591995302|FG008|Overall Study|Consent withdrawn|0|||
163896663|NCT03248479|591995303|FG009|Overall Study|Consent withdrawn|3|||
163896664|NCT03248479|591995304|FG010|Overall Study|Consent withdrawn|1|||
163896665|NCT03248479|591995305|FG011|Overall Study|Consent withdrawn|0|||
163896666|NCT03248479|591995306|FG012|Overall Study|Consent withdrawn|1|||
163896667|NCT03248479|591995294|FG000|Overall Study|Lost to Follow-up|2|||
163896668|NCT03248479|591995295|FG001|Overall Study|Lost to Follow-up|1|||
163896669|NCT03248479|591995296|FG002|Overall Study|Lost to Follow-up|0|||
164002107|NCT02690701|592370644|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164002108|NCT02690701|592370643|FG000|Treatment Period 2|Adverse Event|2|||
164086937|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
164086938|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
164086939|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
164086940|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
164086941|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
164086942|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
164086943|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
164086944|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
164086945|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
164086946|NCT01227668|592682561|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
164086947|NCT01227668|592682562|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
164086948|NCT01227668|592682561|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
164086949|NCT01227668|592682562|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
164086950|NCT01227668|592682561|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
164086951|NCT01227668|592682562|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
164086952|NCT01227668|592682561|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
164086953|NCT01227668|592682562|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
164086954|NCT01227668|592682561|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
164086955|NCT01227668|592682562|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
164086956|NCT01227668|592682561|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
164086957|NCT01227668|592682562|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
164086958|NCT04317599|592682563|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
164086959|NCT04317599|592682563|FG000|Overall Study|treatment outside standard of care|4|||
164086960|NCT02115256|592682573|FG000|Overall Study|Withdrawal by Subject|0|||
164086961|NCT02115256|592682574|FG001|Overall Study|Withdrawal by Subject|1|||
164086962|NCT02427607|592682577|FG000|Overall Study|Withdrawal by Subject|1|||
164086963|NCT03211416|592682578|FG000|Overall Study|Adverse Event|7|||
164086964|NCT03211416|592682578|FG000|Overall Study|Lack of Efficacy|2|||
164086965|NCT03211416|592682578|FG000|Overall Study|Physician Decision|1|||
164086966|NCT01789320|592682579|FG000|Overall Study|Re-enrolled into study|1|||
164086967|NCT01789320|592682579|FG000|Overall Study|Lost to Follow-up|1|||
164086968|NCT03199274|592682582|FG000|Overall Study|Withdrawal by Subject|4|||
164086969|NCT03199274|592682583|FG001|Overall Study|Withdrawal by Subject|0|||
164086970|NCT03199274|592682582|FG000|Overall Study|Lost to Follow-up|0|||
164086971|NCT03199274|592682583|FG001|Overall Study|Lost to Follow-up|1|||
164086972|NCT03199274|592682582|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
164086973|NCT03199274|592682583|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
164086974|NCT04071769|592682596|FG000|Overall Study|Lost to Follow-up|3|||
164086975|NCT04071769|592682596|FG000|Overall Study|Physician Decision|2|||
164086976|NCT04071769|592682596|FG000|Overall Study|Withdrawal by Subject|8|||
164086977|NCT00385541|592682599|FG000|Overall Study|severe pain, clinician requested unblind|0|||
164086978|NCT00385541|592682600|FG001|Overall Study|severe pain, clinician requested unblind|1|||
164086979|NCT00929708|592682601|FG000|Overall Study|Protocol Violation|2|||
164086980|NCT00929708|592682602|FG001|Overall Study|Protocol Violation|1|||
164086981|NCT00929708|592682603|FG002|Overall Study|Protocol Violation|1|||
164086982|NCT00929708|592682604|FG003|Overall Study|Protocol Violation|1|||
164086983|NCT00929708|592682605|FG004|Overall Study|Protocol Violation|1|||
164086984|NCT00929708|592682601|FG000|Overall Study|Withdrawal by Subject|2|||
164086985|NCT00929708|592682602|FG001|Overall Study|Withdrawal by Subject|0|||
164086986|NCT00929708|592682603|FG002|Overall Study|Withdrawal by Subject|0|||
164086987|NCT00929708|592682604|FG003|Overall Study|Withdrawal by Subject|2|||
164086988|NCT00929708|592682605|FG004|Overall Study|Withdrawal by Subject|1|||
164086989|NCT00929708|592682601|FG000|Overall Study|Adverse Event|0|||
164086990|NCT00929708|592682602|FG001|Overall Study|Adverse Event|0|||
164086991|NCT00929708|592682603|FG002|Overall Study|Adverse Event|0|||
164086992|NCT00929708|592682604|FG003|Overall Study|Adverse Event|0|||
164086993|NCT00929708|592682605|FG004|Overall Study|Adverse Event|3|||
164086994|NCT00929708|592682601|FG000|Overall Study|Physician Decision|0|||
164086995|NCT00929708|592682602|FG001|Overall Study|Physician Decision|2|||
164086996|NCT00929708|592682603|FG002|Overall Study|Physician Decision|2|||
164086997|NCT00929708|592682604|FG003|Overall Study|Physician Decision|2|||
164086998|NCT00929708|592682605|FG004|Overall Study|Physician Decision|1|||
164086999|NCT00929708|592682601|FG000|Overall Study|Lost to Follow-up|0|||
164087000|NCT00929708|592682602|FG001|Overall Study|Lost to Follow-up|0|||
164087001|NCT00929708|592682603|FG002|Overall Study|Lost to Follow-up|0|||
164087002|NCT00929708|592682604|FG003|Overall Study|Lost to Follow-up|1|||
164087003|NCT00929708|592682605|FG004|Overall Study|Lost to Follow-up|0|||
164087004|NCT02154529|592682606|FG000|Overall Study|Death|1|||
164087005|NCT02154529|592682607|FG001|Overall Study|Death|1|||
164087006|NCT02154529|592682608|FG002|Overall Study|Death|5|||
164087007|NCT02154529|592682609|FG003|Overall Study|Death|1|||
164087008|NCT02154529|592682606|FG000|Overall Study|Termination of study by sponsor|2|||
164087009|NCT02154529|592682607|FG001|Overall Study|Termination of study by sponsor|2|||
164087010|NCT02154529|592682608|FG002|Overall Study|Termination of study by sponsor|3|||
164087011|NCT02154529|592682609|FG003|Overall Study|Termination of study by sponsor|1|||
164087012|NCT02154529|592682606|FG000|Overall Study|Lost to Follow-up|1|||
164087013|NCT02154529|592682607|FG001|Overall Study|Lost to Follow-up|0|||
164087014|NCT02154529|592682608|FG002|Overall Study|Lost to Follow-up|0|||
164087015|NCT02154529|592682609|FG003|Overall Study|Lost to Follow-up|0|||
164087016|NCT05440097|592684092|FG000|Overall Study|Withdrawal by Subject|154|||
164087017|NCT05440097|592684092|FG000|Overall Study|Death|2|||
164087018|NCT05440097|592684092|FG000|Overall Study|Physician Decision|2|||
164087019|NCT05440097|592684092|FG000|Overall Study|Lost to Follow-up|56|||
164087020|NCT05440097|592684092|FG000|Overall Study|"Include enrolled by mistake and withdrawed by mistake."|15|||
164087021|NCT02081599|592684093|FG000|Period 1：Double-blind Period|Adverse Event|3|||
164087022|NCT02081599|592684094|FG001|Period 1：Double-blind Period|Adverse Event|0|||
164087023|NCT02081599|592684093|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
164087024|NCT02081599|592684094|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
164087025|NCT02081599|592684093|FG000|Period 1：Double-blind Period|Physician Decision|1|||
164087026|NCT02081599|592684094|FG001|Period 1：Double-blind Period|Physician Decision|0|||
164087027|NCT02081599|592684093|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
164087028|NCT02081599|592684094|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
164087029|NCT02081599|592684093|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
164087030|NCT02081599|592684094|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
164087031|NCT02081599|592684093|FG000|Period 1：Double-blind Period|stopping criteria|1|||
164087032|NCT02081599|592684094|FG001|Period 1：Double-blind Period|stopping criteria|0|||
164087033|NCT02081599|592684093|FG000|Period 2：Open-label Period|Adverse Event|1|||
164087034|NCT02081599|592684094|FG001|Period 2：Open-label Period|Adverse Event|0|||
164087035|NCT02081599|592684093|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
164087036|NCT02081599|592684094|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
164087037|NCT02081599|592684093|FG000|Period 2：Open-label Period|Physician Decision|1|||
164087038|NCT02081599|592684094|FG001|Period 2：Open-label Period|Physician Decision|0|||
164087039|NCT02081599|592684093|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
164087040|NCT02081599|592684094|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
164087041|NCT02146430|592684103|FG000|Overall Study|Protocol Violation|5|||
164087042|NCT02146430|592684104|FG001|Overall Study|Protocol Violation|4|||
164087043|NCT02146430|592684105|FG002|Overall Study|Protocol Violation|8|||
164087044|NCT02146430|592684106|FG003|Overall Study|Protocol Violation|6|||
164087045|NCT02146430|592684103|FG000|Overall Study|Lack of Efficacy|13|||
164087046|NCT02146430|592684104|FG001|Overall Study|Lack of Efficacy|11|||
164087047|NCT02146430|592684105|FG002|Overall Study|Lack of Efficacy|8|||
164087048|NCT02146430|592684106|FG003|Overall Study|Lack of Efficacy|5|||
164087049|NCT02146430|592684103|FG000|Overall Study|Adverse Event|20|||
164087050|NCT02146430|592684104|FG001|Overall Study|Adverse Event|40|||
164087051|NCT02146430|592684105|FG002|Overall Study|Adverse Event|32|||
164087052|NCT02146430|592684106|FG003|Overall Study|Adverse Event|49|||
164087053|NCT02146430|592684103|FG000|Overall Study|Reason missing or not reported|2|||
164087054|NCT02146430|592684104|FG001|Overall Study|Reason missing or not reported|3|||
164087055|NCT02146430|592684105|FG002|Overall Study|Reason missing or not reported|4|||
164087056|NCT02146430|592684106|FG003|Overall Study|Reason missing or not reported|5|||
164087057|NCT02146430|592684103|FG000|Overall Study|Withdrawal by Subject|27|||
164087058|NCT02146430|592684104|FG001|Overall Study|Withdrawal by Subject|29|||
164087059|NCT02146430|592684105|FG002|Overall Study|Withdrawal by Subject|30|||
164087060|NCT02146430|592684106|FG003|Overall Study|Withdrawal by Subject|34|||
164087061|NCT03093324|592684107|FG000|Overall Study|Adverse Event|4|||
164087062|NCT03093324|592684108|FG001|Overall Study|Adverse Event|15|||
164087063|NCT03093324|592684107|FG000|Overall Study|Lost to Follow-up|1|||
164087064|NCT03093324|592684108|FG001|Overall Study|Lost to Follow-up|0|||
164087065|NCT03093324|592684107|FG000|Overall Study|Protocol Deviation|2|||
164087066|NCT03093324|592684108|FG001|Overall Study|Protocol Deviation|2|||
164087067|NCT03093324|592684107|FG000|Overall Study|Withdrawal by Subject|2|||
164087068|NCT03093324|592684108|FG001|Overall Study|Withdrawal by Subject|2|||
164087069|NCT01767597|592684109|FG000|Overall Study|Incomplete intervention|3|||
164087070|NCT01767597|592684110|FG001|Overall Study|Incomplete intervention|1|||
164087071|NCT01767597|592684109|FG000|Overall Study|Withdrawal by Subject|1|||
164087072|NCT01767597|592684110|FG001|Overall Study|Withdrawal by Subject|0|||
164087073|NCT05342753|592684111|FG000|Overall Study|Withdrawal by Subject|6|||
164087074|NCT05342753|592684111|FG000|Overall Study|Lost to Follow-up|1|||
164087075|NCT00836927|592684112|FG000|Overall Study|Progressive disease|2|||
164087076|NCT00836927|592684113|FG001|Overall Study|Progressive disease|0|||
164087077|NCT00836927|592684114|FG002|Overall Study|Progressive disease|0|||
164087078|NCT00836927|592684115|FG003|Overall Study|Progressive disease|1|||
164087079|NCT00836927|592684116|FG004|Overall Study|Progressive disease|1|||
164087080|NCT00836927|592684112|FG000|Overall Study|Withdrawal by Subject|1|||
164087081|NCT00836927|592684113|FG001|Overall Study|Withdrawal by Subject|0|||
164087082|NCT00836927|592684114|FG002|Overall Study|Withdrawal by Subject|0|||
164087083|NCT00836927|592684115|FG003|Overall Study|Withdrawal by Subject|0|||
164087084|NCT00836927|592684116|FG004|Overall Study|Withdrawal by Subject|0|||
164087085|NCT04583579|592684119|FG000|Overall Study|Lost to Follow-up|4|||
164087086|NCT02006706|592684120|FG000|Overall Study|Lost to Follow-up|1|||
164087087|NCT04700449|592684123|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
164087088|NCT04700449|592684124|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
164087089|NCT04700449|592684125|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
164087090|NCT04700449|592684126|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
164087091|NCT04700449|592684123|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
164087092|NCT04700449|592684124|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
164087093|NCT04700449|592684125|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
164087094|NCT04700449|592684126|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
164087095|NCT04700449|592684123|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
164087096|NCT04700449|592684124|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
164087097|NCT04700449|592684125|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
164087098|NCT04700449|592684126|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
164087099|NCT04700449|592684123|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
164087100|NCT04700449|592684124|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
164087101|NCT04700449|592684125|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
164087102|NCT04700449|592684126|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
164087103|NCT04700449|592684123|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
164087104|NCT04700449|592684124|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
164087105|NCT04700449|592684125|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
164087106|NCT04700449|592684126|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
164087107|NCT04700449|592684123|FG000|Stage 1: Double-Blind Period|Other|0|||
164087108|NCT04700449|592684124|FG001|Stage 1: Double-Blind Period|Other|0|||
164087109|NCT04700449|592684125|FG002|Stage 1: Double-Blind Period|Other|1|||
164087110|NCT04700449|592684126|FG003|Stage 1: Double-Blind Period|Other|0|||
164087111|NCT04700449|592684123|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
164087112|NCT04700449|592684124|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
164087113|NCT04700449|592684125|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
164087114|NCT04700449|592684126|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
164087115|NCT04700449|592684123|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
164087116|NCT04700449|592684124|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
164087117|NCT04700449|592684125|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
164087118|NCT04700449|592684126|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
164087119|NCT04700449|592684123|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
164087120|NCT04700449|592684124|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
164087121|NCT04700449|592684125|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
164087122|NCT04700449|592684126|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
164087123|NCT04700449|592684123|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
164087124|NCT04700449|592684124|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
164087125|NCT04700449|592684125|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
164087126|NCT04700449|592684126|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
164087127|NCT04700449|592684123|FG000|Stage 2 Sub-study 1|Other|1|||
164087128|NCT04700449|592684124|FG001|Stage 2 Sub-study 1|Other|2|||
164087129|NCT04700449|592684125|FG002|Stage 2 Sub-study 1|Other|0|||
164087130|NCT04700449|592684126|FG003|Stage 2 Sub-study 1|Other|0|||
164087131|NCT04700449|592684123|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
164087132|NCT04700449|592684124|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
164087133|NCT04700449|592684125|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
164087134|NCT04700449|592684126|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
164087135|NCT04700449|592684123|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
164087136|NCT04700449|592684124|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
164087137|NCT04700449|592684125|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
164087138|NCT04700449|592684126|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
164087139|NCT04700449|592684123|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
164087140|NCT04700449|592684124|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
164087141|NCT04700449|592684125|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
164087142|NCT04700449|592684126|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
164087143|NCT04700449|592684123|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
164087144|NCT04700449|592684124|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
164087145|NCT04700449|592684125|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
164087146|NCT04700449|592684126|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
164087147|NCT04700449|592684123|FG000|Stage 2 Sub-study 2|Other|0|||
164087148|NCT04700449|592684124|FG001|Stage 2 Sub-study 2|Other|0|||
164087149|NCT04700449|592684125|FG002|Stage 2 Sub-study 2|Other|0|||
164344511|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
164344512|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
164087150|NCT04700449|592684126|FG003|Stage 2 Sub-study 2|Other|5|||
164087151|NCT06041646|592684127|FG000|Overall Study|Withdrawal by Subject|1|||
164087152|NCT00356200|592684128|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
164087153|NCT00356200|592684129|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
164087154|NCT00356200|592684128|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
164087155|NCT00356200|592684129|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
164087156|NCT03209570|592684130|FG000|Overall Study|Death|1|||
164087157|NCT03209570|592684131|FG001|Overall Study|Death|0|||
164087158|NCT03209570|592684130|FG000|Overall Study|Incomplete Data|8|||
164087159|NCT03209570|592684131|FG001|Overall Study|Incomplete Data|10|||
164087160|NCT03209570|592684130|FG000|Overall Study|Protocol Violation|1|||
164087161|NCT03209570|592684131|FG001|Overall Study|Protocol Violation|0|||
164087162|NCT03209570|592684130|FG000|Overall Study|Withdrawal by Subject|0|||
164087163|NCT03209570|592684131|FG001|Overall Study|Withdrawal by Subject|3|||
164087164|NCT01000337|592684132|FG000|Overall Study|Lost to Follow-up|4|||
164087165|NCT01000337|592684133|FG001|Overall Study|Lost to Follow-up|3|||
164087166|NCT02173704|592684134|FG000|Overall Study|Adverse Event|1|||
164087167|NCT02173704|592684135|FG001|Overall Study|Adverse Event|0|||
164087168|NCT02173704|592684134|FG000|Overall Study|Lost to Follow-up|1|||
164087169|NCT02173704|592684135|FG001|Overall Study|Lost to Follow-up|0|||
164087170|NCT02173704|592684134|FG000|Overall Study|Other|1|||
164087171|NCT02173704|592684135|FG001|Overall Study|Other|0|||
164087172|NCT02173704|592684134|FG000|Overall Study|Protocol Violation|1|||
164087173|NCT02173704|592684135|FG001|Overall Study|Protocol Violation|0|||
164087174|NCT02173704|592684134|FG000|Overall Study|Withdrawal by Subject|9|||
164087175|NCT02173704|592684135|FG001|Overall Study|Withdrawal by Subject|4|||
164087176|NCT03901963|592684136|FG000|Overall Study|Lost to Follow-up|1|||
164087177|NCT03901963|592684137|FG001|Overall Study|Lost to Follow-up|1|||
164087178|NCT03901963|592684136|FG000|Overall Study|Physician Decision|1|||
164087179|NCT03901963|592684137|FG001|Overall Study|Physician Decision|2|||
164087180|NCT03901963|592684136|FG000|Overall Study|Protocol Violation|1|||
164087181|NCT03901963|592684137|FG001|Overall Study|Protocol Violation|1|||
164087182|NCT03901963|592684136|FG000|Overall Study|Withdrawal by Subject|4|||
164087183|NCT03901963|592684137|FG001|Overall Study|Withdrawal by Subject|11|||
164087184|NCT03901963|592684136|FG000|Overall Study|Ongoing|84|||
164087185|NCT03901963|592684137|FG001|Overall Study|Ongoing|73|||
164087186|NCT03901963|592684136|FG000|Overall Study|Randomized but not treated|3|||
164087187|NCT03901963|592684137|FG001|Overall Study|Randomized but not treated|3|||
164087188|NCT04956666|592684138|FG000|Overall Study|Adverse Event|18|||
164087189|NCT04956666|592684138|FG000|Overall Study|Physician Decision|5|||
164087190|NCT02909673|592684139|FG000|Overall Study|Did not meet inclusion criteria|129|||
164087191|NCT02909673|592684140|FG001|Overall Study|Did not meet inclusion criteria|29|||
164087192|NCT02909673|592684139|FG000|Overall Study|Surveys lost by scanner|95|||
164087193|NCT02909673|592684140|FG001|Overall Study|Surveys lost by scanner|2|||
164087194|NCT02909673|592684139|FG000|Overall Study|Tracking info missing|0|||
164087195|NCT02909673|592684140|FG001|Overall Study|Tracking info missing|5|||
164087196|NCT02035137|592684143|FG000|Overall Study|Physician Decision|0|||
164087197|NCT02035137|592684144|FG001|Overall Study|Physician Decision|0|||
164087198|NCT02035137|592684145|FG002|Overall Study|Physician Decision|1|||
164087199|NCT02035137|592684143|FG000|Overall Study|Withdrawal by Subject|0|||
164087200|NCT02035137|592684144|FG001|Overall Study|Withdrawal by Subject|1|||
164087201|NCT02035137|592684145|FG002|Overall Study|Withdrawal by Subject|2|||
164087202|NCT02035137|592684143|FG000|Overall Study|Ineligible|0|||
164087203|NCT02035137|592684144|FG001|Overall Study|Ineligible|1|||
164087204|NCT02035137|592684145|FG002|Overall Study|Ineligible|2|||
164087205|NCT02035137|592684143|FG000|Overall Study|Disease progression prior to treatment start|2|||
164087206|NCT02035137|592684144|FG001|Overall Study|Disease progression prior to treatment start|0|||
164087207|NCT02035137|592684145|FG002|Overall Study|Disease progression prior to treatment start|0|||
164087208|NCT03349333|592684152|FG000|Overall Study|Progression of Disease|36|||
164087209|NCT03349333|592684152|FG000|Overall Study|Adverse Event|11|||
164087210|NCT03349333|592684152|FG000|Overall Study|Other|6|||
164087211|NCT03349333|592684152|FG000|Overall Study|Withdrawal by Subject|5|||
164087212|NCT03349333|592684152|FG000|Overall Study|Conditions interfere with participation|2|||
164087213|NCT03349333|592684152|FG000|Overall Study|Physician Decision|2|||
164281575|NCT01298765|593400730|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
164281576|NCT01298765|593400730|FG000|Long-Term Treatment Period|Physician Decision|1|||
164281577|NCT01298765|593400730|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
164281578|NCT03565237|593400731|FG000|Overall Study|Non-compliance of Investigational Product|1|||
164281579|NCT03565237|593400731|FG000|Overall Study|Physician Decision|1|||
164281580|NCT01140061|593400734|FG000|Part I|Adverse Event|1|||
164281581|NCT01140061|593400735|FG001|Part I|Adverse Event|0|||
164281582|NCT01140061|593400736|FG002|Part I|Adverse Event|0|||
164281583|NCT01140061|593400737|FG003|Part I|Adverse Event|0|||
164281584|NCT01140061|593400738|FG004|Part I|Adverse Event|0|||
164281585|NCT01140061|593400739|FG005|Part I|Adverse Event|0|||
164281586|NCT01140061|593400740|FG006|Part I|Adverse Event|0|||
164087214|NCT03349333|592684152|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
164087215|NCT03349333|592684152|FG000|Overall Study|Patients in treatment less than 24 month|8|||
164087216|NCT00783796|592684153|FG000|Overall Study|Did not receive any stent|4|||
164087217|NCT00783796|592684153|FG000|Overall Study|Received non-XIENCE V stent|1|||
164087218|NCT00783796|592684153|FG000|Overall Study|Received commercial XIENCE V stent|1|||
164087219|NCT01215942|592684156|FG000|Treatment Period|Adverse Event|15|||
164087220|NCT01215942|592684157|FG001|Treatment Period|Adverse Event|26|||
164087221|NCT01215942|592684156|FG000|Treatment Period|Death|2|||
164281587|NCT01140061|593400741|FG007|Part I|Adverse Event|0|||
164087222|NCT01215942|592684157|FG001|Treatment Period|Death|4|||
164087223|NCT01215942|592684156|FG000|Treatment Period|Lack of Efficacy|23|||
164087224|NCT01215942|592684157|FG001|Treatment Period|Lack of Efficacy|62|||
164087225|NCT01215942|592684156|FG000|Treatment Period|Lost to Follow-up|3|||
164087226|NCT01215942|592684157|FG001|Treatment Period|Lost to Follow-up|4|||
164087227|NCT01215942|592684156|FG000|Treatment Period|Withdrawal by Subject|17|||
164087228|NCT01215942|592684157|FG001|Treatment Period|Withdrawal by Subject|40|||
164087229|NCT01215942|592684156|FG000|Treatment Period|Physician Decision|5|||
164087230|NCT01215942|592684157|FG001|Treatment Period|Physician Decision|5|||
164087231|NCT01215942|592684156|FG000|Treatment Period|Protocol Violation|0|||
164087232|NCT01215942|592684157|FG001|Treatment Period|Protocol Violation|1|||
164087233|NCT01215942|592684156|FG000|Treatment Period|Sponsor Decision|349|||
164087234|NCT01215942|592684157|FG001|Treatment Period|Sponsor Decision|530|||
164087235|NCT01215942|592684156|FG000|Post-Treatment Follow-Up Period|Death|0|||
164087236|NCT01215942|592684157|FG001|Post-Treatment Follow-Up Period|Death|1|||
164087237|NCT01215942|592684156|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
164087238|NCT01215942|592684157|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
164087239|NCT01215942|592684156|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
164087240|NCT01215942|592684157|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
164281588|NCT01140061|593400742|FG008|Part I|Adverse Event|0|||
164281589|NCT01140061|593400743|FG009|Part I|Adverse Event|0|||
164281590|NCT01140061|593400734|FG000|Extension|Laboratory Adverse Event|0|||
164087241|NCT01215942|592684156|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
164087242|NCT01215942|592684157|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
164087243|NCT01215942|592684156|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
164087244|NCT01215942|592684157|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
164087245|NCT02752776|592684158|FG000|Overall Study|Adverse Event|15|||
164087246|NCT02752776|592684159|FG001|Overall Study|Adverse Event|23|||
164087247|NCT02752776|592684160|FG002|Overall Study|Adverse Event|11|||
164087248|NCT02752776|592684158|FG000|Overall Study|Lack of Efficacy|2|||
164087249|NCT02752776|592684159|FG001|Overall Study|Lack of Efficacy|6|||
164087250|NCT02752776|592684160|FG002|Overall Study|Lack of Efficacy|14|||
164087251|NCT02752776|592684158|FG000|Overall Study|Lost to Follow-up|11|||
164087252|NCT02752776|592684159|FG001|Overall Study|Lost to Follow-up|12|||
164087253|NCT02752776|592684160|FG002|Overall Study|Lost to Follow-up|4|||
164087254|NCT02752776|592684158|FG000|Overall Study|Non-compliance with study treatment|0|||
164087255|NCT02752776|592684159|FG001|Overall Study|Non-compliance with study treatment|0|||
164087256|NCT02752776|592684160|FG002|Overall Study|Non-compliance with study treatment|1|||
164087257|NCT02752776|592684158|FG000|Overall Study|Physician Decision|2|||
164087258|NCT02752776|592684159|FG001|Overall Study|Physician Decision|6|||
164087259|NCT02752776|592684160|FG002|Overall Study|Physician Decision|2|||
164087260|NCT02752776|592684158|FG000|Overall Study|Pregnancy|1|||
164087261|NCT02752776|592684159|FG001|Overall Study|Pregnancy|6|||
164087262|NCT02752776|592684160|FG002|Overall Study|Pregnancy|3|||
164087263|NCT02752776|592684158|FG000|Overall Study|Protocol Violation|10|||
164087264|NCT02752776|592684159|FG001|Overall Study|Protocol Violation|13|||
164087265|NCT02752776|592684160|FG002|Overall Study|Protocol Violation|6|||
164281591|NCT01140061|593400735|FG001|Extension|Laboratory Adverse Event|0|||
164281592|NCT01140061|593400736|FG002|Extension|Laboratory Adverse Event|0|||
164281593|NCT01140061|593400737|FG003|Extension|Laboratory Adverse Event|0|||
164281594|NCT01140061|593400738|FG004|Extension|Laboratory Adverse Event|0|||
164281595|NCT01140061|593400739|FG005|Extension|Laboratory Adverse Event|0|||
164281596|NCT01140061|593400740|FG006|Extension|Laboratory Adverse Event|0|||
164281597|NCT01140061|593400741|FG007|Extension|Laboratory Adverse Event|0|||
164281598|NCT01140061|593400742|FG008|Extension|Laboratory Adverse Event|0|||
164281599|NCT01140061|593400743|FG009|Extension|Laboratory Adverse Event|1|||
164281600|NCT00428389|593400744|FG000|Core Phase|Adverse Event|6|||
164281601|NCT00428389|593400745|FG001|Core Phase|Adverse Event|4|||
164281602|NCT00428389|593400744|FG000|Core Phase|Lack of Efficacy|2|||
164281603|NCT00428389|593400745|FG001|Core Phase|Lack of Efficacy|0|||
164281604|NCT00428389|593400744|FG000|Core Phase|Abnormal test procedure result(s)|0|||
164281605|NCT00428389|593400745|FG001|Core Phase|Abnormal test procedure result(s)|1|||
164281606|NCT00428389|593400744|FG000|Core Phase|Withdrawal by Subject|3|||
164281607|NCT00428389|593400745|FG001|Core Phase|Withdrawal by Subject|4|||
164281608|NCT00428389|593400744|FG000|Core Phase|Protocol deviation|0|||
164087266|NCT02752776|592684158|FG000|Overall Study|Subject/guardian decision|8|||
164087267|NCT02752776|592684159|FG001|Overall Study|Subject/guardian decision|6|||
164087268|NCT02752776|592684160|FG002|Overall Study|Subject/guardian decision|4|||
164087269|NCT02752776|592684158|FG000|Overall Study|Death|0|||
164087270|NCT02752776|592684159|FG001|Overall Study|Death|0|||
164087271|NCT02752776|592684160|FG002|Overall Study|Death|1|||
164281609|NCT00428389|593400745|FG001|Core Phase|Protocol deviation|2|||
164281610|NCT00428389|593400744|FG000|Extension Phase|Adverse Event|17|||
164087272|NCT02752776|592684158|FG000|Overall Study|Withdrawal by Subject|3|||
164087273|NCT02752776|592684159|FG001|Overall Study|Withdrawal by Subject|4|||
164087274|NCT02752776|592684160|FG002|Overall Study|Withdrawal by Subject|2|||
164281611|NCT00428389|593400745|FG001|Extension Phase|Adverse Event|11|||
164281612|NCT00428389|593400744|FG000|Extension Phase|Lack of Efficacy|4|||
164002109|NCT02690701|592370644|FG001|Treatment Period 2|Adverse Event|0|||
164281613|NCT00428389|593400745|FG001|Extension Phase|Lack of Efficacy|3|||
164281614|NCT00428389|593400744|FG000|Extension Phase|Withdrawal by Subject|6|||
164281615|NCT00428389|593400745|FG001|Extension Phase|Withdrawal by Subject|6|||
164281616|NCT00428389|593400744|FG000|Extension Phase|Lost to Follow-up|0|||
164281617|NCT00428389|593400745|FG001|Extension Phase|Lost to Follow-up|3|||
164281618|NCT00428389|593400744|FG000|Extension Phase|Death|1|||
164281619|NCT00428389|593400745|FG001|Extension Phase|Death|0|||
164281620|NCT00428389|593400744|FG000|Extension Phase|Protocol Violation|3|||
164281621|NCT00428389|593400745|FG001|Extension Phase|Protocol Violation|2|||
164281622|NCT00428389|593400744|FG000|Extension Phase|Administrative problems|1|||
164281623|NCT00428389|593400745|FG001|Extension Phase|Administrative problems|1|||
164281624|NCT03302247|593400746|FG000|Overall Study|the study has closed prematurely|2|||
164281625|NCT03302247|593400746|FG000|Overall Study|Death|1|||
164281626|NCT02669121|593400747|FG000|Overall Study|Adverse Event|4|||
164281627|NCT02669121|593400748|FG001|Overall Study|Adverse Event|5|||
164281628|NCT02669121|593400747|FG000|Overall Study|Lost to Follow-up|15|||
164281629|NCT02669121|593400748|FG001|Overall Study|Lost to Follow-up|27|||
164281630|NCT02669121|593400747|FG000|Overall Study|Withdrawal by Subject|132|||
164281631|NCT02669121|593400748|FG001|Overall Study|Withdrawal by Subject|140|||
164281632|NCT02669121|593400747|FG000|Overall Study|Pregnancy|0|||
164281633|NCT02669121|593400748|FG001|Overall Study|Pregnancy|1|||
164281634|NCT02669121|593400747|FG000|Overall Study|Discharged from US Military Active Service|117|||
164281635|NCT02669121|593400748|FG001|Overall Study|Discharged from US Military Active Service|91|||
164281636|NCT02669121|593400747|FG000|Overall Study|Reason not Specified|22|||
164281637|NCT02669121|593400748|FG001|Overall Study|Reason not Specified|18|||
164281638|NCT02708355|593400749|FG000|Overall Study|Adverse Event|1|||
164281639|NCT02708355|593400750|FG001|Overall Study|Adverse Event|0|||
164281640|NCT02708355|593400751|FG002|Overall Study|Adverse Event|0|||
164281641|NCT04384523|593400752|FG000|Overall Study|Lost to Follow-up|0|||
164002110|NCT02690701|592370643|FG000|Treatment Period 2|Lack of Efficacy|1|||
164002111|NCT02690701|592370644|FG001|Treatment Period 2|Lack of Efficacy|0|||
164002112|NCT02690701|592370643|FG000|Treatment Period 2|Lost to Follow-up|0|||
164002113|NCT02690701|592370644|FG001|Treatment Period 2|Lost to Follow-up|2|||
164281642|NCT04384523|593400753|FG001|Overall Study|Lost to Follow-up|0|||
164281643|NCT04384523|593400754|FG002|Overall Study|Lost to Follow-up|0|||
164281644|NCT04384523|593400755|FG003|Overall Study|Lost to Follow-up|0|||
164281645|NCT04384523|593400756|FG004|Overall Study|Lost to Follow-up|0|||
164281646|NCT04384523|593400757|FG005|Overall Study|Lost to Follow-up|1|||
164281647|NCT04384523|593400752|FG000|Overall Study|Protocol Violation|0|||
163896670|NCT03248479|591995297|FG003|Overall Study|Lost to Follow-up|0|||
163896671|NCT03248479|591995298|FG004|Overall Study|Lost to Follow-up|0|||
163896672|NCT03248479|591995299|FG005|Overall Study|Lost to Follow-up|0|||
163896673|NCT03248479|591995300|FG006|Overall Study|Lost to Follow-up|0|||
163896674|NCT03248479|591995301|FG007|Overall Study|Lost to Follow-up|0|||
163896675|NCT03248479|591995302|FG008|Overall Study|Lost to Follow-up|0|||
163896676|NCT03248479|591995303|FG009|Overall Study|Lost to Follow-up|0|||
163896677|NCT03248479|591995304|FG010|Overall Study|Lost to Follow-up|0|||
163896678|NCT03248479|591995305|FG011|Overall Study|Lost to Follow-up|0|||
163896679|NCT03248479|591995306|FG012|Overall Study|Lost to Follow-up|1|||
163896680|NCT03248479|591995294|FG000|Overall Study|Not reported|0|||
163896681|NCT03248479|591995295|FG001|Overall Study|Not reported|0|||
163896682|NCT03248479|591995296|FG002|Overall Study|Not reported|0|||
163896683|NCT03248479|591995297|FG003|Overall Study|Not reported|1|||
163896684|NCT03248479|591995298|FG004|Overall Study|Not reported|1|||
163896685|NCT03248479|591995299|FG005|Overall Study|Not reported|0|||
163896686|NCT03248479|591995300|FG006|Overall Study|Not reported|0|||
163896687|NCT03248479|591995301|FG007|Overall Study|Not reported|1|||
163896688|NCT03248479|591995302|FG008|Overall Study|Not reported|1|||
163896689|NCT03248479|591995303|FG009|Overall Study|Not reported|0|||
163896690|NCT03248479|591995304|FG010|Overall Study|Not reported|0|||
163896691|NCT03248479|591995305|FG011|Overall Study|Not reported|0|||
163896692|NCT03248479|591995306|FG012|Overall Study|Not reported|0|||
163896693|NCT05129501|591995316|FG000|Overall Study|Lost to Follow-up|54|||
163896694|NCT05129501|591995317|FG001|Overall Study|Lost to Follow-up|41|||
163896695|NCT01499368|591995318|FG000|Overall Study|Did not meet I/E criteria|8|||
163896696|NCT01499368|591995319|FG001|Overall Study|Did not meet I/E criteria|4|||
163896697|NCT01499368|591995320|FG002|Overall Study|Did not meet I/E criteria|4|||
163896698|NCT01499368|591995318|FG000|Overall Study|Prohibited Concomitant medication|1|||
163896699|NCT01499368|591995319|FG001|Overall Study|Prohibited Concomitant medication|1|||
163896700|NCT01499368|591995320|FG002|Overall Study|Prohibited Concomitant medication|0|||
163896701|NCT01499368|591995318|FG000|Overall Study|Withdrawal by Subject|11|||
163896702|NCT01499368|591995319|FG001|Overall Study|Withdrawal by Subject|10|||
163896703|NCT01499368|591995320|FG002|Overall Study|Withdrawal by Subject|8|||
163896704|NCT01499368|591995318|FG000|Overall Study|Lost to Follow-up|3|||
163896705|NCT01499368|591995319|FG001|Overall Study|Lost to Follow-up|2|||
163896706|NCT01499368|591995320|FG002|Overall Study|Lost to Follow-up|5|||
163896707|NCT01499368|591995318|FG000|Overall Study|Adverse Event|4|||
164281648|NCT04384523|593400753|FG001|Overall Study|Protocol Violation|1|||
164002114|NCT02690701|592370643|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164002115|NCT02690701|592370644|FG001|Treatment Period 2|Withdrawal by Subject|2|||
164002116|NCT02690701|592370643|FG000|Treatment Period 2|Protocol Violation|0|||
164002117|NCT02690701|592370644|FG001|Treatment Period 2|Protocol Violation|1|||
164002118|NCT02700451|592370645|FG000|Overall Study|Protocol Violation|2|||
164002119|NCT02700451|592370646|FG001|Overall Study|Protocol Violation|2|||
164002120|NCT02700451|592370647|FG002|Overall Study|Protocol Violation|3|||
164002121|NCT02700451|592370645|FG000|Overall Study|Discontinued intervention|14|||
164002122|NCT02700451|592370646|FG001|Overall Study|Discontinued intervention|15|||
164002123|NCT02700451|592370647|FG002|Overall Study|Discontinued intervention|14|||
164002124|NCT00404092|592370653|FG000|Overall Study|Death|1|||
164002125|NCT00404092|592370654|FG001|Overall Study|Death|0|||
164002126|NCT00404092|592370655|FG002|Overall Study|Death|0|||
164002127|NCT00404092|592370656|FG003|Overall Study|Death|0|||
164281649|NCT04384523|593400754|FG002|Overall Study|Protocol Violation|0|||
164281650|NCT04384523|593400755|FG003|Overall Study|Protocol Violation|0|||
164281651|NCT04384523|593400756|FG004|Overall Study|Protocol Violation|0|||
164281652|NCT04384523|593400757|FG005|Overall Study|Protocol Violation|0|||
164281653|NCT04384523|593400752|FG000|Overall Study|Withdrawal by Subject|1|||
164281654|NCT04384523|593400753|FG001|Overall Study|Withdrawal by Subject|0|||
164281655|NCT04384523|593400754|FG002|Overall Study|Withdrawal by Subject|0|||
164281656|NCT04384523|593400755|FG003|Overall Study|Withdrawal by Subject|0|||
164281657|NCT04384523|593400756|FG004|Overall Study|Withdrawal by Subject|0|||
164281658|NCT04384523|593400757|FG005|Overall Study|Withdrawal by Subject|0|||
164002128|NCT00404092|592370653|FG000|Overall Study|Adverse Event|0|||
164002129|NCT00404092|592370654|FG001|Overall Study|Adverse Event|0|||
164002130|NCT00404092|592370655|FG002|Overall Study|Adverse Event|1|||
164002131|NCT00404092|592370656|FG003|Overall Study|Adverse Event|0|||
164002132|NCT04325503|592370659|FG000|Overall Study|Withdrawal by Subject|1|||
164002133|NCT04325503|592370659|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
164002134|NCT02337387|592370660|FG000|Overall Study|Adverse Event|0|||
164002135|NCT02337387|592370661|FG001|Overall Study|Adverse Event|1|||
164002136|NCT02337387|592370662|FG002|Overall Study|Adverse Event|0|||
164002137|NCT02337387|592370663|FG003|Overall Study|Adverse Event|0|||
164002138|NCT02337387|592370660|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
164002139|NCT02337387|592370661|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
164002140|NCT02337387|592370662|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
164002141|NCT02337387|592370663|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
164002142|NCT01642212|592370664|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
164281659|NCT03216746|593400758|FG000|Overall Study|Lost to Follow-up|6|||
164281660|NCT03216746|593400759|FG001|Overall Study|Lost to Follow-up|8|||
164281661|NCT03216746|593400760|FG002|Overall Study|Lost to Follow-up|5|||
164281662|NCT03216746|593400761|FG003|Overall Study|Lost to Follow-up|6|||
164281663|NCT02687581|593400762|FG000|Overall Study|Withdrawal by Subject|1|||
164281664|NCT02687581|593400763|FG001|Overall Study|Withdrawal by Subject|0|||
164281665|NCT02687581|593400764|FG002|Overall Study|Withdrawal by Subject|0|||
164281666|NCT02687581|593400765|FG003|Overall Study|Withdrawal by Subject|1|||
164281667|NCT02687581|593400762|FG000|Overall Study|Lost to Follow-up|2|||
164281668|NCT02687581|593400763|FG001|Overall Study|Lost to Follow-up|2|||
164281669|NCT02687581|593400764|FG002|Overall Study|Lost to Follow-up|0|||
164281670|NCT02687581|593400765|FG003|Overall Study|Lost to Follow-up|0|||
164281671|NCT02687581|593400762|FG000|Overall Study|the device is too small for the patient.|1|||
164281672|NCT02687581|593400763|FG001|Overall Study|the device is too small for the patient.|0|||
164281673|NCT02687581|593400764|FG002|Overall Study|the device is too small for the patient.|0|||
164281674|NCT02687581|593400765|FG003|Overall Study|the device is too small for the patient.|0|||
164281675|NCT00835341|593400766|FG000|Overall Study|Lost to Follow-up|3|||
164281676|NCT00835341|593400767|FG001|Overall Study|Lost to Follow-up|12|||
164281677|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
164281678|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
164281679|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
164281680|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Death|0|||
164281681|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Death|2|||
164281682|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Death|0|||
164281683|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
164281684|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
164281685|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
164281686|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
164281687|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
164002143|NCT01642212|592370665|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164002144|NCT01642212|592370666|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164281688|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
164281689|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
164281690|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
163896708|NCT01499368|591995319|FG001|Overall Study|Adverse Event|0|||
163896709|NCT01499368|591995320|FG002|Overall Study|Adverse Event|2|||
163896710|NCT01499368|591995318|FG000|Overall Study|Physician Decision|0|||
163896711|NCT01499368|591995319|FG001|Overall Study|Physician Decision|1|||
163896712|NCT01499368|591995320|FG002|Overall Study|Physician Decision|0|||
163896713|NCT01499368|591995318|FG000|Overall Study|Deviation from visit window|0|||
164281691|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
164281692|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
164281693|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
164281694|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
164281695|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
164281696|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
164281697|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
164281698|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Recovery|1|||
164281699|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Recovery|0|||
164281700|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Recovery|1|||
164281701|NCT00195663|593400769|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
164281702|NCT00195663|593400770|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
164281703|NCT00195663|593400771|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
164281704|NCT00195663|593400769|FG000|Open-Label Extension Period|Adverse Event|21|||
164281705|NCT00195663|593400770|FG001|Open-Label Extension Period|Adverse Event|32|||
164281706|NCT00195663|593400771|FG002|Open-Label Extension Period|Adverse Event|36|||
164281707|NCT00195663|593400769|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
164281708|NCT00195663|593400770|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
164281709|NCT00195663|593400771|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
164281710|NCT00195663|593400769|FG000|Open-Label Extension Period|Recovery|0|||
164281711|NCT00195663|593400770|FG001|Open-Label Extension Period|Recovery|2|||
164281712|NCT00195663|593400771|FG002|Open-Label Extension Period|Recovery|2|||
164281713|NCT00195663|593400769|FG000|Open-Label Extension Period|Protocol Violation|3|||
164281714|NCT00195663|593400770|FG001|Open-Label Extension Period|Protocol Violation|4|||
164281715|NCT00195663|593400771|FG002|Open-Label Extension Period|Protocol Violation|4|||
164281716|NCT00195663|593400769|FG000|Open-Label Extension Period|Death|2|||
164281717|NCT00195663|593400770|FG001|Open-Label Extension Period|Death|2|||
164281718|NCT00195663|593400771|FG002|Open-Label Extension Period|Death|2|||
164281719|NCT00195663|593400769|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
164281720|NCT00195663|593400770|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
164281721|NCT00195663|593400771|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
164281722|NCT00195663|593400769|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
164281723|NCT00195663|593400770|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
163896714|NCT01499368|591995319|FG001|Overall Study|Deviation from visit window|0|||
164281724|NCT00195663|593400771|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
164281725|NCT00195663|593400769|FG000|Open-Label Extension Period|Administrative reasons|11|||
164281726|NCT00195663|593400770|FG001|Open-Label Extension Period|Administrative reasons|11|||
164281727|NCT00195663|593400771|FG002|Open-Label Extension Period|Administrative reasons|13|||
164281728|NCT03214406|593400772|FG000|Overall Study|did not meet enrollment criteria|9|||
164281729|NCT03214406|593400773|FG001|Overall Study|did not meet enrollment criteria|13|||
164281730|NCT03214406|593400772|FG000|Overall Study|Withdrawal by Subject|1|||
164281731|NCT03214406|593400773|FG001|Overall Study|Withdrawal by Subject|0|||
164281732|NCT03214406|593400772|FG000|Overall Study|Lost to Follow-up|0|||
164281733|NCT03214406|593400773|FG001|Overall Study|Lost to Follow-up|2|||
164281734|NCT01098305|593400774|FG000|Overall Study|Lost to Follow-up|31|||
164281735|NCT01098305|593400775|FG001|Overall Study|Lost to Follow-up|33|||
163896715|NCT01499368|591995320|FG002|Overall Study|Deviation from visit window|1|||
163896716|NCT01499368|591995318|FG000|Overall Study|Error of Prescriptions|0|||
163896717|NCT01499368|591995319|FG001|Overall Study|Error of Prescriptions|0|||
163896718|NCT01499368|591995320|FG002|Overall Study|Error of Prescriptions|1|||
163896719|NCT03092674|591995321|FG000|Overall Study|Adverse Event or Side Effects|1|||
163896720|NCT03092674|591995322|FG001|Overall Study|Adverse Event or Side Effects|4|||
163896721|NCT03092674|591995323|FG002|Overall Study|Adverse Event or Side Effects|4|||
163896722|NCT03092674|591995321|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
163896723|NCT03092674|591995322|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
163896724|NCT03092674|591995323|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
163896725|NCT03092674|591995321|FG000|Overall Study|Progression/Relapse|5|||
163896726|NCT03092674|591995322|FG001|Overall Study|Progression/Relapse|4|||
163896727|NCT03092674|591995323|FG002|Overall Study|Progression/Relapse|8|||
163896728|NCT03092674|591995321|FG000|Overall Study|Death|4|||
163896729|NCT03092674|591995322|FG001|Overall Study|Death|8|||
163896730|NCT03092674|591995323|FG002|Overall Study|Death|2|||
163896731|NCT03092674|591995321|FG000|Overall Study|Other - Not Protocol Specified|11|||
163896732|NCT03092674|591995322|FG001|Overall Study|Other - Not Protocol Specified|8|||
164281736|NCT04310566|593400782|FG000|Period 1|Study Termination due to COVID-19|15|||
164281737|NCT04310566|593400783|FG001|Period 1|Study Termination due to COVID-19|17|||
164002145|NCT01642212|592370667|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164281738|NCT04310566|593400782|FG000|Period 1|Protocol Violation|0|||
164281739|NCT04310566|593400783|FG001|Period 1|Protocol Violation|1|||
164281740|NCT04310566|593400782|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
164281741|NCT04310566|593400783|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
164002146|NCT01642212|592370668|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
164002147|NCT01642212|592370664|FG000|Double-blind Treatment|Other|0|||
164002148|NCT01642212|592370665|FG001|Double-blind Treatment|Other|2|||
164002149|NCT01642212|592370666|FG002|Double-blind Treatment|Other|1|||
164002150|NCT01642212|592370667|FG003|Double-blind Treatment|Other|0|||
164002151|NCT01642212|592370668|FG004|Double-blind Treatment|Other|0|||
164002152|NCT01642212|592370664|FG000|Double-blind Treatment|Non-compliance|0|||
164002153|NCT01642212|592370665|FG001|Double-blind Treatment|Non-compliance|1|||
164002154|NCT01642212|592370666|FG002|Double-blind Treatment|Non-compliance|0|||
164002155|NCT01642212|592370667|FG003|Double-blind Treatment|Non-compliance|0|||
164002156|NCT01642212|592370668|FG004|Double-blind Treatment|Non-compliance|0|||
164002157|NCT01642212|592370664|FG000|Double-blind Treatment|Adverse Event|0|||
164002158|NCT01642212|592370665|FG001|Double-blind Treatment|Adverse Event|0|||
164002159|NCT01642212|592370666|FG002|Double-blind Treatment|Adverse Event|1|||
164002160|NCT01642212|592370667|FG003|Double-blind Treatment|Adverse Event|0|||
164002161|NCT01642212|592370668|FG004|Double-blind Treatment|Adverse Event|0|||
164002162|NCT01642212|592370664|FG000|Open-label Extension|Adverse Event|0|||
164002163|NCT01642212|592370665|FG001|Open-label Extension|Adverse Event|0|||
164002164|NCT01642212|592370666|FG002|Open-label Extension|Adverse Event|0|||
164002165|NCT01642212|592370667|FG003|Open-label Extension|Adverse Event|3|||
164002166|NCT01642212|592370668|FG004|Open-label Extension|Adverse Event|0|||
164002167|NCT01642212|592370664|FG000|Open-label Extension|Sponsor Decision|0|||
164002168|NCT01642212|592370665|FG001|Open-label Extension|Sponsor Decision|0|||
164002169|NCT01642212|592370666|FG002|Open-label Extension|Sponsor Decision|0|||
164002170|NCT01642212|592370667|FG003|Open-label Extension|Sponsor Decision|7|||
164002171|NCT01642212|592370668|FG004|Open-label Extension|Sponsor Decision|4|||
164002172|NCT01642212|592370664|FG000|Open-label Extension|Consent Withdrawn|0|||
164002173|NCT01642212|592370665|FG001|Open-label Extension|Consent Withdrawn|0|||
164002174|NCT01642212|592370666|FG002|Open-label Extension|Consent Withdrawn|0|||
164002175|NCT01642212|592370667|FG003|Open-label Extension|Consent Withdrawn|0|||
164002176|NCT01642212|592370668|FG004|Open-label Extension|Consent Withdrawn|2|||
164002177|NCT01642212|592370664|FG000|Open-label Extension|Lost to Follow-up|0|||
164002178|NCT01642212|592370665|FG001|Open-label Extension|Lost to Follow-up|0|||
164002179|NCT01642212|592370666|FG002|Open-label Extension|Lost to Follow-up|0|||
164002180|NCT01642212|592370667|FG003|Open-label Extension|Lost to Follow-up|0|||
164002181|NCT01642212|592370668|FG004|Open-label Extension|Lost to Follow-up|1|||
164002182|NCT01642212|592370664|FG000|Open-label Extension|Other|0|||
164002183|NCT01642212|592370665|FG001|Open-label Extension|Other|0|||
164002184|NCT01642212|592370666|FG002|Open-label Extension|Other|0|||
164002185|NCT01642212|592370667|FG003|Open-label Extension|Other|0|||
164002186|NCT01642212|592370668|FG004|Open-label Extension|Other|1|||
164002187|NCT00957853|592370670|FG000|Overall Study|Withdrawal by Subject|1|||
164002188|NCT00957853|592370671|FG001|Overall Study|Withdrawal by Subject|0|||
164002189|NCT00957853|592370672|FG002|Overall Study|Withdrawal by Subject|0|||
164002190|NCT03871491|592370675|FG000|Overall Study|Withdrawal by Subject|14|||
164002191|NCT03871491|592370676|FG001|Overall Study|Withdrawal by Subject|14|||
164002192|NCT03871491|592370677|FG002|Overall Study|Withdrawal by Subject|14|||
164002193|NCT03871491|592370678|FG003|Overall Study|Withdrawal by Subject|14|||
164002194|NCT03871491|592370675|FG000|Overall Study|Physician Decision|0|||
164002195|NCT03871491|592370676|FG001|Overall Study|Physician Decision|0|||
164002196|NCT03871491|592370677|FG002|Overall Study|Physician Decision|1|||
164002197|NCT03871491|592370678|FG003|Overall Study|Physician Decision|1|||
164281742|NCT04310566|593400782|FG000|Period 1|Lost to Follow-up|1|||
164281743|NCT04310566|593400783|FG001|Period 1|Lost to Follow-up|0|||
164281744|NCT04310566|593400782|FG000|Period 1|Withdrawal by Subject|0|||
164281745|NCT04310566|593400783|FG001|Period 1|Withdrawal by Subject|1|||
164281746|NCT04310566|593400782|FG000|Period 2|Study Termination|7|||
164281747|NCT04310566|593400783|FG001|Period 2|Study Termination|5|||
164002198|NCT03871491|592370675|FG000|Overall Study|Lost to Follow-up|50|||
164002199|NCT03871491|592370676|FG001|Overall Study|Lost to Follow-up|15|||
164002200|NCT03871491|592370677|FG002|Overall Study|Lost to Follow-up|36|||
164002201|NCT03871491|592370678|FG003|Overall Study|Lost to Follow-up|11|||
164002202|NCT05202808|592370679|FG000|Overall Study|Lost to Follow-up|3|||
164002203|NCT05202808|592370680|FG001|Overall Study|Lost to Follow-up|1|||
164087275|NCT01816477|592684161|FG000|Overall Study|Withdrawal by Subject|13|||
164281748|NCT04677504|593400785|FG000|Overall Study|Death|51|||
164281749|NCT04677504|593400786|FG001|Overall Study|Death|49|||
164002204|NCT04996797|592370681|FG000|Overall Study|Adverse Event|0|||
164002205|NCT04996797|592370682|FG001|Overall Study|Adverse Event|2|||
164002206|NCT04996797|592370683|FG002|Overall Study|Adverse Event|0|||
164002207|NCT04996797|592370684|FG003|Overall Study|Adverse Event|1|||
164002208|NCT04996797|592370681|FG000|Overall Study|Lack of Efficacy|0|||
164281750|NCT04677504|593400785|FG000|Overall Study|Progressive Disease|1|||
164281751|NCT04677504|593400786|FG001|Overall Study|Progressive Disease|0|||
164281752|NCT04677504|593400785|FG000|Overall Study|Symptomatic Deterioration|1|||
164281753|NCT04677504|593400786|FG001|Overall Study|Symptomatic Deterioration|0|||
164281754|NCT04677504|593400785|FG000|Overall Study|Withdrawal by Subject|2|||
164281755|NCT04677504|593400786|FG001|Overall Study|Withdrawal by Subject|5|||
164281756|NCT04677504|593400785|FG000|Overall Study|Study Terminated By Sponsor|28|||
164281757|NCT04677504|593400786|FG001|Overall Study|Study Terminated By Sponsor|24|||
164281758|NCT04677504|593400785|FG000|Overall Study|Adverse Event|0|||
163896733|NCT03092674|591995323|FG002|Overall Study|Other - Not Protocol Specified|8|||
163896734|NCT01527188|591995324|FG000|Overall Study|Adverse Event|5|||
163896735|NCT01527188|591995325|FG001|Overall Study|Adverse Event|5|||
163896736|NCT01527188|591995326|FG002|Overall Study|Adverse Event|11|||
163896737|NCT01527188|591995327|FG003|Overall Study|Adverse Event|0|||
163896738|NCT01527188|591995324|FG000|Overall Study|Withdrawal by Subject|3|||
163896739|NCT01527188|591995325|FG001|Overall Study|Withdrawal by Subject|6|||
163896740|NCT01527188|591995326|FG002|Overall Study|Withdrawal by Subject|4|||
163896741|NCT01527188|591995327|FG003|Overall Study|Withdrawal by Subject|4|||
163896742|NCT01527188|591995324|FG000|Overall Study|Any other reason not above-mentioned|6|||
163896743|NCT01527188|591995325|FG001|Overall Study|Any other reason not above-mentioned|7|||
163896744|NCT01527188|591995326|FG002|Overall Study|Any other reason not above-mentioned|8|||
163896745|NCT01527188|591995327|FG003|Overall Study|Any other reason not above-mentioned|8|||
163896746|NCT04626427|591995328|FG000|Overall Study|Death|1|||
163896747|NCT04626427|591995328|FG000|Overall Study|Withdrawal by Subject|1|||
163896748|NCT04626427|591995328|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
163896749|NCT04626427|591995328|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
163896750|NCT01553149|591995329|FG000|Overall Study|Adverse Event|0|||
163896751|NCT01553149|591995330|FG001|Overall Study|Adverse Event|9|||
163896752|NCT01553149|591995329|FG000|Overall Study|Physician Decision|5|||
163896753|NCT01553149|591995330|FG001|Overall Study|Physician Decision|10|||
163896754|NCT01553149|591995329|FG000|Overall Study|Ineligible|0|||
163896755|NCT01553149|591995330|FG001|Overall Study|Ineligible|1|||
163896756|NCT01265537|591995331|FG000|Overall Study|Adverse Event|2|||
163896757|NCT01265537|591995332|FG001|Overall Study|Adverse Event|1|||
163896758|NCT01265537|591995331|FG000|Overall Study|Physician Decision|0|||
163896759|NCT01265537|591995332|FG001|Overall Study|Physician Decision|1|||
164281759|NCT04677504|593400786|FG001|Overall Study|Adverse Event|1|||
164281760|NCT03182907|593400794|FG000|Overall Study|Death|3|||
164281761|NCT03182907|593400795|FG001|Overall Study|Death|0|||
164281762|NCT03182907|593400794|FG000|Overall Study|Protocol Violation|4|||
164281763|NCT03182907|593400795|FG001|Overall Study|Protocol Violation|0|||
164281764|NCT03182907|593400794|FG000|Overall Study|Lost to Follow-up|1|||
164281765|NCT03182907|593400795|FG001|Overall Study|Lost to Follow-up|0|||
164281766|NCT03182907|593400794|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164281767|NCT03182907|593400795|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163896760|NCT04518943|591996082|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
163896761|NCT04518943|591996083|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
163896762|NCT04518943|591996084|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
163896763|NCT04518943|591996085|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
163896764|NCT04518943|591996086|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
163896765|NCT04518943|591996087|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
163896766|NCT04518943|591996088|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
163896767|NCT04518943|591996089|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
163896768|NCT04518943|591996090|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
163896769|NCT04518943|591996091|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
163896770|NCT04518943|591996092|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
163896771|NCT04518943|591996093|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
163896772|NCT04518943|591996094|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
163896773|NCT04518943|591996095|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
163896774|NCT04518943|591996096|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
163896775|NCT04518943|591996097|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
163896776|NCT06408870|591996101|FG000|Washout period|Withdrawal by Subject|1|||
163896777|NCT06408870|591996102|FG001|Washout period|Withdrawal by Subject|0|||
163896778|NCT06408870|591996101|FG000|Washout period|Adverse Event|2|||
163896779|NCT06408870|591996102|FG001|Washout period|Adverse Event|0|||
163896780|NCT04993677|591996106|FG000|Overall Study|Lost to Follow-up|1|||
163896781|NCT04993677|591996107|FG001|Overall Study|Lost to Follow-up|0|||
163896782|NCT04993677|591996108|FG002|Overall Study|Lost to Follow-up|0|||
163896783|NCT04993677|591996109|FG003|Overall Study|Lost to Follow-up|0|||
163896784|NCT04993677|591996106|FG000|Overall Study|Death|11|||
163896785|NCT04993677|591996107|FG001|Overall Study|Death|8|||
163896786|NCT04993677|591996108|FG002|Overall Study|Death|3|||
163896787|NCT04993677|591996109|FG003|Overall Study|Death|1|||
164281768|NCT01711645|593400796|FG000|Overall Study|Withdrawal by Subject|8|||
164281769|NCT01711645|593400796|FG000|Overall Study|Lost to Follow-up|6|||
164281770|NCT01711645|593400796|FG000|Overall Study|Physician Decision|5|||
164281771|NCT03170193|593400799|FG000|Overall Study|Withdrawal by Subject|0|||
164281772|NCT03170193|593400800|FG001|Overall Study|Withdrawal by Subject|0|||
164281773|NCT03170193|593400801|FG002|Overall Study|Withdrawal by Subject|0|||
164281774|NCT03170193|593400802|FG003|Overall Study|Withdrawal by Subject|1|||
164281775|NCT03170193|593400803|FG004|Overall Study|Withdrawal by Subject|0|||
164281776|NCT03170193|593400804|FG005|Overall Study|Withdrawal by Subject|0|||
164281777|NCT03170193|593400805|FG006|Overall Study|Withdrawal by Subject|0|||
164281778|NCT03170193|593400799|FG000|Overall Study|Lost to Follow-up|1|||
164281779|NCT03170193|593400800|FG001|Overall Study|Lost to Follow-up|1|||
164281780|NCT03170193|593400801|FG002|Overall Study|Lost to Follow-up|0|||
164281781|NCT03170193|593400802|FG003|Overall Study|Lost to Follow-up|0|||
164281782|NCT03170193|593400803|FG004|Overall Study|Lost to Follow-up|0|||
164281783|NCT03170193|593400804|FG005|Overall Study|Lost to Follow-up|0|||
164281784|NCT03170193|593400805|FG006|Overall Study|Lost to Follow-up|0|||
164281785|NCT03848949|593400809|FG000|Overall Study|Lost to Follow-up|5|||
164281786|NCT03848949|593400810|FG001|Overall Study|Lost to Follow-up|7|||
164281787|NCT00118430|593400811|FG000|Overall Study|Withdrawal by Subject|6|||
164281788|NCT00118430|593400812|FG001|Overall Study|Withdrawal by Subject|2|||
164281789|NCT00118430|593400813|FG002|Overall Study|Withdrawal by Subject|0|||
164281790|NCT00118430|593400811|FG000|Overall Study|Lost to Follow-up|15|||
164281791|NCT00118430|593400812|FG001|Overall Study|Lost to Follow-up|22|||
164281792|NCT00118430|593400813|FG002|Overall Study|Lost to Follow-up|28|||
164281793|NCT00534976|593400814|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
164281794|NCT00534976|593400815|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
164281795|NCT00534976|593400814|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
164281796|NCT00534976|593400815|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
164281797|NCT00534976|593400814|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
164281798|NCT00534976|593400815|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
164281799|NCT02147288|593400816|FG000|Overall Study|post-operative hematoma|1|||
164281800|NCT02147288|593400817|FG001|Overall Study|post-operative hematoma|1|||
164281801|NCT02147288|593400818|FG002|Overall Study|post-operative hematoma|0|||
164281802|NCT02147288|593400819|FG003|Overall Study|post-operative hematoma|0|||
164281803|NCT02147288|593400820|FG004|Overall Study|post-operative hematoma|0|||
164281804|NCT02147288|593400821|FG005|Overall Study|post-operative hematoma|0|||
164281805|NCT02147288|593400822|FG006|Overall Study|post-operative hematoma|0|||
164281806|NCT02147288|593400823|FG007|Overall Study|post-operative hematoma|0|||
164281807|NCT02147288|593400824|FG008|Overall Study|post-operative hematoma|0|||
164281808|NCT02147288|593400825|FG009|Overall Study|post-operative hematoma|0|||
164281809|NCT02147288|593400816|FG000|Overall Study|complications from concurrent hernia rep|0|||
164281810|NCT02147288|593400817|FG001|Overall Study|complications from concurrent hernia rep|1|||
164281811|NCT02147288|593400818|FG002|Overall Study|complications from concurrent hernia rep|0|||
164281812|NCT02147288|593400819|FG003|Overall Study|complications from concurrent hernia rep|0|||
164281813|NCT02147288|593400820|FG004|Overall Study|complications from concurrent hernia rep|0|||
164281814|NCT02147288|593400821|FG005|Overall Study|complications from concurrent hernia rep|0|||
164281815|NCT02147288|593400822|FG006|Overall Study|complications from concurrent hernia rep|0|||
164281816|NCT02147288|593400823|FG007|Overall Study|complications from concurrent hernia rep|0|||
164281817|NCT02147288|593400824|FG008|Overall Study|complications from concurrent hernia rep|0|||
164281818|NCT02147288|593400825|FG009|Overall Study|complications from concurrent hernia rep|0|||
164281819|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Adverse Event|33|||
164281820|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
164281821|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
164002209|NCT04996797|592370682|FG001|Overall Study|Lack of Efficacy|2|||
164281822|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
164002210|NCT04996797|592370683|FG002|Overall Study|Lack of Efficacy|0|||
164002211|NCT04996797|592370684|FG003|Overall Study|Lack of Efficacy|0|||
164002212|NCT04996797|592370681|FG000|Overall Study|Prohibited Medication|0|||
164281823|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Physician Decision|6|||
164281824|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
164281825|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
164281826|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
164281827|NCT00965419|593400826|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
164281828|NCT00965419|593400826|FG000|Follow-up Phase|Adverse Event|9|||
164281829|NCT00965419|593400826|FG000|Follow-up Phase|Protocol Violation|4|||
164281830|NCT00965419|593400826|FG000|Follow-up Phase|Withdrawal by Subject|8|||
164281831|NCT00965419|593400826|FG000|Follow-up Phase|Physician Decision|4|||
164281832|NCT00965419|593400826|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
164281833|NCT00965419|593400826|FG000|Follow-up Phase|Lack of Efficacy|28|||
164281834|NCT00615017|593402478|FG000|Overall Study|Adverse Event|0|||
164281835|NCT00615017|593402479|FG001|Overall Study|Adverse Event|1|||
164281836|NCT00615017|593402480|FG002|Overall Study|Adverse Event|2|||
164281837|NCT00615017|593402481|FG003|Overall Study|Adverse Event|0|||
164281838|NCT00615017|593402482|FG004|Overall Study|Adverse Event|0|||
164281839|NCT00615017|593402483|FG005|Overall Study|Adverse Event|1|||
164281840|NCT00615017|593402478|FG000|Overall Study|Death|0|||
164281841|NCT00615017|593402479|FG001|Overall Study|Death|0|||
164281842|NCT00615017|593402480|FG002|Overall Study|Death|2|||
164281843|NCT00615017|593402481|FG003|Overall Study|Death|0|||
164281844|NCT00615017|593402482|FG004|Overall Study|Death|1|||
164281845|NCT00615017|593402483|FG005|Overall Study|Death|1|||
164281846|NCT00615017|593402478|FG000|Overall Study|Sepsis resolved|0|||
164281847|NCT00615017|593402479|FG001|Overall Study|Sepsis resolved|0|||
164281848|NCT00615017|593402480|FG002|Overall Study|Sepsis resolved|1|||
164281849|NCT00615017|593402481|FG003|Overall Study|Sepsis resolved|0|||
164281850|NCT00615017|593402482|FG004|Overall Study|Sepsis resolved|0|||
164002213|NCT04996797|592370682|FG001|Overall Study|Prohibited Medication|1|||
164281851|NCT00615017|593402483|FG005|Overall Study|Sepsis resolved|0|||
164281852|NCT00615017|593402478|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
164281853|NCT00615017|593402479|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
164281854|NCT00615017|593402480|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
164281855|NCT00615017|593402481|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
164281856|NCT00615017|593402482|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
164281857|NCT00615017|593402483|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
164281858|NCT00615017|593402478|FG000|Overall Study|Physician discontinued drug|0|||
164281859|NCT00615017|593402479|FG001|Overall Study|Physician discontinued drug|0|||
164281860|NCT00615017|593402480|FG002|Overall Study|Physician discontinued drug|0|||
164281861|NCT00615017|593402481|FG003|Overall Study|Physician discontinued drug|0|||
164281862|NCT00615017|593402482|FG004|Overall Study|Physician discontinued drug|0|||
164281863|NCT00615017|593402483|FG005|Overall Study|Physician discontinued drug|1|||
164281864|NCT00806988|593402484|FG000|Overall Study|Death|15|||
164281865|NCT00806988|593402485|FG001|Overall Study|Death|16|||
164281866|NCT00806988|593402484|FG000|Overall Study|Withdrawal by Subject|8|||
164281867|NCT00806988|593402485|FG001|Overall Study|Withdrawal by Subject|8|||
164281868|NCT00806988|593402484|FG000|Overall Study|Lost to Follow-up|4|||
164281869|NCT00806988|593402485|FG001|Overall Study|Lost to Follow-up|19|||
164281870|NCT04775953|593402487|FG000|Overall Study|Lost to Follow-up|6|||
164281871|NCT04775953|593402488|FG001|Overall Study|Lost to Follow-up|11|||
164281872|NCT04775953|593402487|FG000|Overall Study|Death|5|||
164281873|NCT04775953|593402488|FG001|Overall Study|Death|4|||
164281874|NCT04775953|593402487|FG000|Overall Study|Withdrawal by Subject|3|||
164281875|NCT04775953|593402488|FG001|Overall Study|Withdrawal by Subject|3|||
164281876|NCT04775953|593402487|FG000|Overall Study|Protocol Violation|2|||
164281877|NCT04775953|593402488|FG001|Overall Study|Protocol Violation|0|||
164281878|NCT04775953|593402487|FG000|Overall Study|Participant non-compliance|0|||
164281879|NCT04775953|593402488|FG001|Overall Study|Participant non-compliance|1|||
164281880|NCT01698814|593402489|FG000|Overall Study|Adverse Event|0|||
164281881|NCT01698814|593402490|FG001|Overall Study|Adverse Event|2|||
164281882|NCT01698814|593402489|FG000|Overall Study|Lost to Follow-up|0|||
164002214|NCT04996797|592370683|FG002|Overall Study|Prohibited Medication|0|||
164281883|NCT01698814|593402490|FG001|Overall Study|Lost to Follow-up|1|||
164281884|NCT01698814|593402489|FG000|Overall Study|Pregnancy|1|||
164281885|NCT01698814|593402490|FG001|Overall Study|Pregnancy|0|||
164281886|NCT01698814|593402489|FG000|Overall Study|Randomized in error|1|||
164281887|NCT01698814|593402490|FG001|Overall Study|Randomized in error|0|||
164281888|NCT00368641|593402491|FG000|Overall Study|Adverse Event|2|||
164281889|NCT00368641|593402492|FG001|Overall Study|Adverse Event|1|||
164281890|NCT00368641|593402491|FG000|Overall Study|Death|1|||
164281891|NCT00368641|593402492|FG001|Overall Study|Death|0|||
164281892|NCT00368641|593402491|FG000|Overall Study|Withdrawal by Subject|1|||
164142997|NCT00863772|592884485|FG001|Overall Study|Protocol Violation|0|||
164281893|NCT00368641|593402492|FG001|Overall Study|Withdrawal by Subject|0|||
164281894|NCT00368641|593402491|FG000|Overall Study|Sponsor decision to terminate study|2|||
164281895|NCT00368641|593402492|FG001|Overall Study|Sponsor decision to terminate study|5|||
164281896|NCT04014062|593402493|FG000|Period I: Dosing|Medical Grounds|4|||
164281897|NCT04014062|593402494|FG001|Period I: Dosing|Medical Grounds|5|||
164281898|NCT04014062|593402493|FG000|Period I: Dosing|Withdrawal by Subject|3|||
164281899|NCT04014062|593402494|FG001|Period I: Dosing|Withdrawal by Subject|1|||
164281900|NCT01980095|593402495|FG000|Overall Study|Lost to Follow-up|6|||
164281901|NCT01980095|593402496|FG001|Overall Study|Lost to Follow-up|7|||
164281902|NCT01980095|593402495|FG000|Overall Study|Withdrawal by Subject|2|||
164281903|NCT01980095|593402496|FG001|Overall Study|Withdrawal by Subject|3|||
164281904|NCT01980095|593402495|FG000|Overall Study|Poor compliance|5|||
164002215|NCT04996797|592370684|FG003|Overall Study|Prohibited Medication|0|||
164002216|NCT04996797|592370681|FG000|Overall Study|Ongoing|68|||
164002217|NCT04996797|592370682|FG001|Overall Study|Ongoing|60|||
164002218|NCT04996797|592370683|FG002|Overall Study|Ongoing|22|||
164002219|NCT04996797|592370684|FG003|Overall Study|Ongoing|20|||
164281905|NCT01980095|593402496|FG001|Overall Study|Poor compliance|0|||
164281906|NCT01980095|593402495|FG000|Overall Study|Safety issue|0|||
164281907|NCT01980095|593402496|FG001|Overall Study|Safety issue|1|||
164281908|NCT01980095|593402495|FG000|Overall Study|Study drug discontinued|1|||
164281909|NCT01980095|593402496|FG001|Overall Study|Study drug discontinued|0|||
164281910|NCT01980095|593402495|FG000|Overall Study|Randomized by mistake|1|||
164281911|NCT01980095|593402496|FG001|Overall Study|Randomized by mistake|0|||
164281912|NCT02783599|593402503|FG000|Overall Study|Progressive disease|23|||
164281913|NCT02783599|593402503|FG000|Overall Study|Surgical Resection|10|||
164281914|NCT02783599|593402503|FG000|Overall Study|Adverse Event|4|||
164281915|NCT02783599|593402503|FG000|Overall Study|Physician Decision|2|||
164281916|NCT02783599|593402503|FG000|Overall Study|Death|1|||
164281917|NCT01564732|593402504|FG000|Overall Study|Early termination by the study sponsor|6|||
164281918|NCT01564732|593402505|FG001|Overall Study|Early termination by the study sponsor|5|||
164281919|NCT04343755|593402506|FG000|Overall Study|Death|11|||
164281920|NCT04343755|593402506|FG000|Overall Study|Screen Failure|1|||
164281921|NCT00394706|593402507|FG000|Overall Study|Withdrawal by Subject|2|||
164281922|NCT00394706|593402508|FG001|Overall Study|Withdrawal by Subject|0|||
164281923|NCT00394706|593402509|FG002|Overall Study|Withdrawal by Subject|1|||
164281924|NCT00394706|593402510|FG003|Overall Study|Withdrawal by Subject|0|||
164281925|NCT00394706|593402511|FG004|Overall Study|Withdrawal by Subject|0|||
164281926|NCT00394706|593402512|FG005|Overall Study|Withdrawal by Subject|2|||
164281927|NCT00394706|593402513|FG006|Overall Study|Withdrawal by Subject|1|||
164281928|NCT00394706|593402514|FG007|Overall Study|Withdrawal by Subject|0|||
164281929|NCT00394706|593402507|FG000|Overall Study|Lost to Follow-up|2|||
164281930|NCT00394706|593402508|FG001|Overall Study|Lost to Follow-up|2|||
164281931|NCT00394706|593402509|FG002|Overall Study|Lost to Follow-up|8|||
164281932|NCT00394706|593402510|FG003|Overall Study|Lost to Follow-up|1|||
164281933|NCT00394706|593402511|FG004|Overall Study|Lost to Follow-up|2|||
164281934|NCT00394706|593402512|FG005|Overall Study|Lost to Follow-up|5|||
164281935|NCT00394706|593402513|FG006|Overall Study|Lost to Follow-up|2|||
164281936|NCT00394706|593402514|FG007|Overall Study|Lost to Follow-up|0|||
164281937|NCT03920254|593402515|FG000|Overall Study|Adverse Event|1|||
164281938|NCT03920254|593402516|FG001|Overall Study|Adverse Event|0|||
164281939|NCT03920254|593402517|FG002|Overall Study|Adverse Event|0|||
164281940|NCT03920254|593402515|FG000|Overall Study|Physician Decision|0|||
164281941|NCT03920254|593402516|FG001|Overall Study|Physician Decision|1|||
164281942|NCT03920254|593402517|FG002|Overall Study|Physician Decision|2|||
164281943|NCT03920254|593402515|FG000|Overall Study|Study Terminated By Sponsor|12|||
164281944|NCT03920254|593402516|FG001|Overall Study|Study Terminated By Sponsor|17|||
164281945|NCT03920254|593402517|FG002|Overall Study|Study Terminated By Sponsor|12|||
164281946|NCT03920254|593402515|FG000|Overall Study|Withdrawal by Subject|0|||
164281947|NCT03920254|593402516|FG001|Overall Study|Withdrawal by Subject|0|||
164281948|NCT03920254|593402517|FG002|Overall Study|Withdrawal by Subject|1|||
164281949|NCT05274269|593402518|FG000|Overall Study|Adverse Event|0|||
164281950|NCT05274269|593402519|FG001|Overall Study|Adverse Event|3|||
164281951|NCT05274269|593402518|FG000|Overall Study|Death|0|||
164002220|NCT04996797|592370681|FG000|Overall Study|Withdrawal by Subject|0|||
164002221|NCT04996797|592370682|FG001|Overall Study|Withdrawal by Subject|2|||
164002222|NCT04996797|592370683|FG002|Overall Study|Withdrawal by Subject|0|||
164002223|NCT04996797|592370684|FG003|Overall Study|Withdrawal by Subject|0|||
164002224|NCT02793544|592370685|FG000|Overall Study|Death|10|||
164002225|NCT02793544|592370686|FG001|Overall Study|Death|8|||
164281952|NCT05274269|593402519|FG001|Overall Study|Death|1|||
164281953|NCT05274269|593402518|FG000|Overall Study|Other|0|||
164281954|NCT05274269|593402519|FG001|Overall Study|Other|2|||
164281955|NCT05274269|593402518|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164281956|NCT05274269|593402519|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164281957|NCT00108862|593402520|FG000|Overall Study|Death|31|||
164281958|NCT00108862|593402521|FG001|Overall Study|Death|37|||
164281959|NCT00108862|593402520|FG000|Overall Study|Withdrawal by Subject|10|||
164002226|NCT02793544|592370685|FG000|Overall Study|Lost to Follow-up|2|||
164281960|NCT00108862|593402521|FG001|Overall Study|Withdrawal by Subject|6|||
164281961|NCT00108862|593402520|FG000|Overall Study|Lost to Follow-up|27|||
164281962|NCT00108862|593402521|FG001|Overall Study|Lost to Follow-up|19|||
164002227|NCT02793544|592370686|FG001|Overall Study|Lost to Follow-up|0|||
164002228|NCT02793544|592370685|FG000|Overall Study|Withdrawal by Subject|1|||
164281963|NCT01746368|593402525|FG000|Overall Study|Lost to Follow-up|2|||
164344513|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
164344514|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
164344515|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
164344516|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
164344517|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
164344518|NCT00044083|593636962|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
164344519|NCT00044083|593636963|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
164344520|NCT00044083|593636962|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
164344521|NCT00044083|593636963|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
164344522|NCT00044083|593636962|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
164344523|NCT00044083|593636963|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
164344524|NCT00044083|593636962|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
164344525|NCT00044083|593636963|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
164002229|NCT02793544|592370686|FG001|Overall Study|Withdrawal by Subject|0|||
164002230|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
164002231|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
164002232|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
164002233|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
164281964|NCT01746368|593402526|FG001|Overall Study|Lost to Follow-up|0|||
164281965|NCT01746368|593402525|FG000|Overall Study|Withdrawal by Subject|0|||
164281966|NCT01746368|593402526|FG001|Overall Study|Withdrawal by Subject|1|||
164281967|NCT05636852|593402527|FG000|Overall Study|Withdrawal by Subject|1|||
164281968|NCT05636852|593402527|FG000|Overall Study|Other than specified|1|||
164281969|NCT03534141|593402528|FG000|Overall Study|Enrolled in other clinical trial|1|||
164344526|NCT00288054|593636967|FG000|Overall Study|Protocol Violation|2|||
164344527|NCT00288054|593636967|FG000|Overall Study|Lack of Efficacy|16|||
164344528|NCT00288054|593636967|FG000|Overall Study|Adverse Event|3|||
164281970|NCT03534141|593402529|FG001|Overall Study|Enrolled in other clinical trial|0|||
164281971|NCT03534141|593402528|FG000|Overall Study|Liver transplant aborted after randomization|0|||
164281972|NCT03534141|593402529|FG001|Overall Study|Liver transplant aborted after randomization|2|||
164281973|NCT03534141|593402528|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
164281974|NCT03534141|593402529|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
164281975|NCT00709618|593402530|FG000|Overall Study|Withdrawal by Subject|4|||
164281976|NCT00709618|593402530|FG000|Overall Study|Lost to Follow-up|1|||
164281977|NCT00709618|593402530|FG000|Overall Study|Study Closed/Terminated|25|||
164281978|NCT00687804|593402531|FG000|Core Study|Adverse Event|5|||
164281979|NCT00687804|593402532|FG001|Core Study|Adverse Event|3|||
164281980|NCT00687804|593402533|FG002|Core Study|Adverse Event|3|||
164344529|NCT00288054|593636967|FG000|Overall Study|Withdrawal by Subject|1|||
164344530|NCT00288054|593636967|FG000|Overall Study|Not protocol specified|2|||
164002234|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
164002235|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
164002236|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
164142998|NCT00863772|592884486|FG002|Overall Study|Protocol Violation|2|||
164281981|NCT00687804|593402531|FG000|Core Study|Abnormal laboratory value(s)|1|||
164002237|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
164002238|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
164002239|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
164002240|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
164002241|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164002242|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164002243|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164281982|NCT00687804|593402532|FG001|Core Study|Abnormal laboratory value(s)|0|||
164281983|NCT00687804|593402533|FG002|Core Study|Abnormal laboratory value(s)|0|||
164281984|NCT00687804|593402531|FG000|Core Study|Lack of Efficacy|1|||
164281985|NCT00687804|593402532|FG001|Core Study|Lack of Efficacy|1|||
164281986|NCT00687804|593402533|FG002|Core Study|Lack of Efficacy|1|||
164281987|NCT00687804|593402531|FG000|Core Study|Withdrawal by Subject|4|||
164281988|NCT00687804|593402532|FG001|Core Study|Withdrawal by Subject|7|||
164281989|NCT00687804|593402533|FG002|Core Study|Withdrawal by Subject|7|||
164281990|NCT00687804|593402531|FG000|Core Study|Lost to Follow-up|0|||
164281991|NCT00687804|593402532|FG001|Core Study|Lost to Follow-up|1|||
164281992|NCT00687804|593402533|FG002|Core Study|Lost to Follow-up|0|||
164281993|NCT00687804|593402531|FG000|Core Study|Death|2|||
164281994|NCT00687804|593402532|FG001|Core Study|Death|2|||
164281995|NCT00687804|593402533|FG002|Core Study|Death|2|||
164281996|NCT00687804|593402531|FG000|Core Study|Protocol Violation|1|||
164281997|NCT00687804|593402532|FG001|Core Study|Protocol Violation|1|||
164281998|NCT00687804|593402533|FG002|Core Study|Protocol Violation|0|||
164281999|NCT00687804|593402531|FG000|Open-Label Extension Study|Adverse Event|2|||
164282000|NCT00687804|593402532|FG001|Open-Label Extension Study|Adverse Event|2|||
164282001|NCT00687804|593402533|FG002|Open-Label Extension Study|Adverse Event|2|||
164282002|NCT00687804|593402531|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
164282003|NCT00687804|593402532|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
164282004|NCT00687804|593402533|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
164002244|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164002245|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
164002246|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164002247|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164002248|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164002249|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
164002250|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Death|0|||
164002251|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Death|1|||
164002252|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Death|0|||
164002253|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Death|0|||
164002254|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Death|0|||
164002255|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164002256|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
164002257|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164002258|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164002259|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
164002260|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
164002261|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164002262|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164002263|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164002264|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
164002265|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
164282005|NCT00687804|593402531|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
164282006|NCT00687804|593402532|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
164282007|NCT00687804|593402533|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
164282008|NCT00687804|593402531|FG000|Open-Label Extension Study|Administrative problems|1|||
164002266|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164002267|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164002268|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164282009|NCT00687804|593402532|FG001|Open-Label Extension Study|Administrative problems|1|||
164282010|NCT00687804|593402533|FG002|Open-Label Extension Study|Administrative problems|0|||
164282011|NCT00687804|593402531|FG000|Open-Label Extension Study|Death|2|||
164282012|NCT00687804|593402532|FG001|Open-Label Extension Study|Death|3|||
164282013|NCT00687804|593402533|FG002|Open-Label Extension Study|Death|3|||
164282014|NCT04390880|593402535|FG000|Overall Study|Withdrawal by Subject|1|||
164282015|NCT02557542|593402536|FG000|Overall Study|Poor recruitment|3|||
164282016|NCT02557542|593402537|FG001|Overall Study|Poor recruitment|0|||
164282017|NCT00195091|593402538|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
164282018|NCT00475709|593402544|FG000|Overall Study|Did not meet eligibility criteria|8|||
164282019|NCT00475709|593402544|FG000|Overall Study|Death|41|||
164282020|NCT00475709|593402544|FG000|Overall Study|Device Explant|6|||
164282021|NCT00475709|593402544|FG000|Overall Study|Lost to Follow-up|21|||
164282022|NCT00555672|593402547|FG000|Overall Study|Death|0|||
164002269|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
164002270|NCT05087030|592370690|FG000|Main Period (Week 0 to Week 52)|Other|1|||
164002271|NCT05087030|592370691|FG001|Main Period (Week 0 to Week 52)|Other|2|||
164002272|NCT05087030|592370692|FG002|Main Period (Week 0 to Week 52)|Other|0|||
164002273|NCT05087030|592370693|FG003|Main Period (Week 0 to Week 52)|Other|0|||
164002274|NCT05087030|592370694|FG004|Main Period (Week 0 to Week 52)|Other|0|||
164002275|NCT05087030|592370690|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164002276|NCT05087030|592370691|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164002277|NCT05087030|592370692|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164002278|NCT05087030|592370693|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
164002279|NCT05087030|592370694|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
164002280|NCT02722044|592370695|FG000|Overall Study|Adverse Event|2|||
164002281|NCT02722044|592370695|FG000|Overall Study|Physician Decision|1|||
164002282|NCT02722044|592370695|FG000|Overall Study|Withdrawal by Subject|1|||
164002283|NCT02722044|592370695|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
164002284|NCT04640766|592370696|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
164002285|NCT00609622|592370697|FG000|Overall Study|Adverse Event|14|||
164002286|NCT00609622|592370698|FG001|Overall Study|Adverse Event|10|||
164002287|NCT00609622|592370697|FG000|Overall Study|Withdrawal by Subject|4|||
164002288|NCT00609622|592370698|FG001|Overall Study|Withdrawal by Subject|20|||
164002289|NCT00609622|592370697|FG000|Overall Study|Death|1|||
164002290|NCT00609622|592370698|FG001|Overall Study|Death|4|||
164002291|NCT00609622|592370697|FG000|Overall Study|Protocol Violation|1|||
164002292|NCT00609622|592370698|FG001|Overall Study|Protocol Violation|1|||
164002293|NCT00609622|592370697|FG000|Overall Study|Objective progression or relapse|47|||
164002294|NCT00609622|592370698|FG001|Overall Study|Objective progression or relapse|41|||
164002295|NCT00609622|592370697|FG000|Overall Study|Study terminated by sponsor|16|||
164002296|NCT00609622|592370698|FG001|Overall Study|Study terminated by sponsor|3|||
164002297|NCT00609622|592370697|FG000|Overall Study|Other|7|||
164002298|NCT00609622|592370698|FG001|Overall Study|Other|14|||
164002299|NCT00609622|592370697|FG000|Overall Study|Global deterioration of health status|6|||
164002300|NCT00609622|592370698|FG001|Overall Study|Global deterioration of health status|2|||
164002301|NCT01237951|592370701|FG000|Overall Study|Death|1|||
164002302|NCT01708057|592370702|FG000|Overall Study|Withdrawal due to study termination.|1|||
164002303|NCT01708057|592370703|FG001|Overall Study|Withdrawal due to study termination.|1|||
164002304|NCT01708057|592370704|FG002|Overall Study|Withdrawal due to study termination.|1|||
164002305|NCT02970929|592370709|FG000|Overall Study|Adverse Event|18|||
164002306|NCT02970929|592370709|FG000|Overall Study|Lack of Efficacy|8|||
164002307|NCT02970929|592370709|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
164002308|NCT02970929|592370709|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
164002309|NCT02970929|592370709|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
164002310|NCT02970929|592370709|FG000|Overall Study|LOST TO FOLLOWUP|6|||
164002311|NCT02970929|592370709|FG000|Overall Study|MOVED OUT OF STATE|1|||
164002312|NCT02970929|592370709|FG000|Overall Study|Withdrawal by Subject|16|||
164002313|NCT00666562|592370712|FG000|Overall Study|Withdrawal by Subject|0|||
164002314|NCT00666562|592370713|FG001|Overall Study|Withdrawal by Subject|1|||
164002315|NCT00666562|592370714|FG002|Overall Study|Withdrawal by Subject|0|||
164002316|NCT00666562|592370712|FG000|Overall Study|Concomitant Medication|0|||
164002317|NCT00666562|592370713|FG001|Overall Study|Concomitant Medication|1|||
164002318|NCT00666562|592370714|FG002|Overall Study|Concomitant Medication|0|||
164002319|NCT01024244|592371816|FG000|Overall Study|Adverse Event|1|||
164002320|NCT01024244|592371817|FG001|Overall Study|Adverse Event|2|||
164002321|NCT01024244|592371818|FG002|Overall Study|Adverse Event|0|||
164002322|NCT01024244|592371819|FG003|Overall Study|Adverse Event|1|||
164282023|NCT00555672|593402548|FG001|Overall Study|Death|2|||
164282024|NCT00555672|593402547|FG000|Overall Study|Adverse Event|8|||
164282025|NCT00555672|593402548|FG001|Overall Study|Adverse Event|2|||
164282026|NCT00555672|593402547|FG000|Overall Study|Objective progression or relapse|11|||
164282027|NCT00555672|593402548|FG001|Overall Study|Objective progression or relapse|5|||
164282028|NCT00555672|593402547|FG000|Overall Study|Other|3|||
164002323|NCT01024244|592371820|FG004|Overall Study|Adverse Event|2|||
164002324|NCT01024244|592371816|FG000|Overall Study|Entry Criteria Not Met|0|||
164002325|NCT01024244|592371817|FG001|Overall Study|Entry Criteria Not Met|1|||
164002326|NCT01024244|592371818|FG002|Overall Study|Entry Criteria Not Met|0|||
164002327|NCT01024244|592371819|FG003|Overall Study|Entry Criteria Not Met|0|||
164002328|NCT01024244|592371820|FG004|Overall Study|Entry Criteria Not Met|0|||
164002329|NCT01024244|592371816|FG000|Overall Study|Lack of Efficacy|1|||
164282029|NCT00555672|593402548|FG001|Overall Study|Other|1|||
164282030|NCT00555672|593402547|FG000|Overall Study|Participant refused|2|||
164282031|NCT00555672|593402548|FG001|Overall Study|Participant refused|0|||
164282032|NCT04526145|593402549|FG000|Overall Study|Withdrawal by Subject|5|||
164002330|NCT01024244|592371817|FG001|Overall Study|Lack of Efficacy|0|||
164282033|NCT01415401|593402557|FG000|Overall Study|Adverse Event|5|||
164282034|NCT01415401|593402557|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
164282035|NCT01415401|593402557|FG000|Overall Study|Terminated by Sponsor|1|||
164282036|NCT00548145|593402559|FG000|Overall Study|Death|0|||
164282037|NCT00548145|593402560|FG001|Overall Study|Death|1|||
164282038|NCT00548145|593402559|FG000|Overall Study|Withdrawal by Subject|0|||
164282039|NCT00548145|593402560|FG001|Overall Study|Withdrawal by Subject|2|||
164002331|NCT01024244|592371818|FG002|Overall Study|Lack of Efficacy|0|||
164002332|NCT01024244|592371819|FG003|Overall Study|Lack of Efficacy|0|||
164002333|NCT01024244|592371820|FG004|Overall Study|Lack of Efficacy|0|||
164002334|NCT01024244|592371816|FG000|Overall Study|Protocol Violation|1|||
164002335|NCT01024244|592371817|FG001|Overall Study|Protocol Violation|0|||
164002336|NCT01024244|592371818|FG002|Overall Study|Protocol Violation|0|||
164002337|NCT01024244|592371819|FG003|Overall Study|Protocol Violation|0|||
164002338|NCT01024244|592371820|FG004|Overall Study|Protocol Violation|2|||
164002339|NCT01024244|592371816|FG000|Overall Study|Sponsor Decision|14|||
164002340|NCT01024244|592371817|FG001|Overall Study|Sponsor Decision|7|||
164002341|NCT01024244|592371818|FG002|Overall Study|Sponsor Decision|14|||
164002342|NCT01024244|592371819|FG003|Overall Study|Sponsor Decision|12|||
164002343|NCT01024244|592371820|FG004|Overall Study|Sponsor Decision|10|||
164002344|NCT01024244|592371816|FG000|Overall Study|Withdrawal by Subject|0|||
164002345|NCT01024244|592371817|FG001|Overall Study|Withdrawal by Subject|1|||
164002346|NCT01024244|592371818|FG002|Overall Study|Withdrawal by Subject|0|||
164002347|NCT01024244|592371819|FG003|Overall Study|Withdrawal by Subject|0|||
164002348|NCT01024244|592371820|FG004|Overall Study|Withdrawal by Subject|0|||
164002349|NCT01896232|592371826|FG000|Overall Study|Death|6|||
164002350|NCT01896232|592371827|FG001|Overall Study|Death|10|||
164002351|NCT01896232|592371826|FG000|Overall Study|Withdrawal by Subject|32|||
164002352|NCT01896232|592371827|FG001|Overall Study|Withdrawal by Subject|31|||
164002353|NCT01896232|592371826|FG000|Overall Study|Sponsor Decision|2|||
164002354|NCT01896232|592371827|FG001|Overall Study|Sponsor Decision|0|||
164002355|NCT01896232|592371826|FG000|Overall Study|Lost to Follow-up|9|||
164002356|NCT01896232|592371827|FG001|Overall Study|Lost to Follow-up|12|||
164002357|NCT00686205|592371828|FG000|Overall Study|Protocol Violation|127|||
164282040|NCT00548145|593402559|FG000|Overall Study|Physician Decision|1|||
164282041|NCT00548145|593402560|FG001|Overall Study|Physician Decision|1|||
164282042|NCT00206440|593402563|FG000|Overall Study|Protocol Violation|1|||
164282043|NCT00206440|593402564|FG001|Overall Study|Protocol Violation|2|||
164282044|NCT00206440|593402563|FG000|Overall Study|Adverse Event|4|||
164282045|NCT00206440|593402564|FG001|Overall Study|Adverse Event|2|||
164282046|NCT01746225|593402565|FG000|Overall Study|Death|1|||
164282047|NCT01746225|593402566|FG001|Overall Study|Death|0|||
164282048|NCT01746225|593402567|FG002|Overall Study|Death|1|||
163896788|NCT04993677|591996106|FG000|Overall Study|Subject withdrawal of consent|4|||
163896789|NCT04993677|591996107|FG001|Overall Study|Subject withdrawal of consent|3|||
163896790|NCT04993677|591996108|FG002|Overall Study|Subject withdrawal of consent|0|||
163896791|NCT04993677|591996109|FG003|Overall Study|Subject withdrawal of consent|2|||
163896792|NCT04993677|591996106|FG000|Overall Study|Study termination by sponsor|3|||
163896793|NCT04993677|591996107|FG001|Overall Study|Study termination by sponsor|25|||
163896794|NCT04993677|591996108|FG002|Overall Study|Study termination by sponsor|3|||
163896795|NCT04993677|591996109|FG003|Overall Study|Study termination by sponsor|3|||
163896796|NCT04993677|591996106|FG000|Overall Study|Other|2|||
163896797|NCT04993677|591996107|FG001|Overall Study|Other|3|||
163896798|NCT04993677|591996108|FG002|Overall Study|Other|3|||
163896799|NCT04993677|591996109|FG003|Overall Study|Other|2|||
163896800|NCT04174170|591996110|FG000|Placebo Run-in Period|Not Randomized|38|||
163896801|NCT04174170|591996111|FG001|Placebo Run-in Period|Not Randomized|0|||
163896802|NCT04174170|591996112|FG002|Placebo Run-in Period|Not Randomized|0|||
163896803|NCT04174170|591996113|FG003|Placebo Run-in Period|Not Randomized|0|||
163896804|NCT04174170|591996110|FG000|Double Blind Treatment Period|Adverse Event|0|||
163896805|NCT04174170|591996111|FG001|Double Blind Treatment Period|Adverse Event|9|||
163896806|NCT04174170|591996112|FG002|Double Blind Treatment Period|Adverse Event|9|||
164002358|NCT00686205|592371829|FG001|Overall Study|Protocol Violation|0|||
164002359|NCT00686205|592371828|FG000|Overall Study|Withdrawal by Subject|2|||
164002360|NCT00686205|592371829|FG001|Overall Study|Withdrawal by Subject|0|||
164282049|NCT01746225|593402565|FG000|Overall Study|Withdrawal by Subject|5|||
164282050|NCT01746225|593402566|FG001|Overall Study|Withdrawal by Subject|15|||
164282051|NCT01746225|593402567|FG002|Overall Study|Withdrawal by Subject|19|||
163896807|NCT04174170|591996113|FG003|Double Blind Treatment Period|Adverse Event|8|||
163896808|NCT04174170|591996110|FG000|Double Blind Treatment Period|Death|0|||
163896809|NCT04174170|591996111|FG001|Double Blind Treatment Period|Death|1|||
164002361|NCT00686205|592371828|FG000|Overall Study|Specimen handling procedure altered|5878|||
164002362|NCT00686205|592371829|FG001|Overall Study|Specimen handling procedure altered|0|||
164002363|NCT00686205|592371828|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
164282052|NCT01746225|593402565|FG000|Overall Study|Physician Decision|14|||
164282053|NCT01746225|593402566|FG001|Overall Study|Physician Decision|11|||
164282054|NCT01746225|593402567|FG002|Overall Study|Physician Decision|3|||
164087276|NCT01816477|592684162|FG001|Overall Study|Withdrawal by Subject|1|||
164087277|NCT01816477|592684161|FG000|Overall Study|Unable to tolerate catheter placement|3|||
164087278|NCT01816477|592684162|FG001|Overall Study|Unable to tolerate catheter placement|0|||
164087279|NCT02162758|592684163|FG000|Overall Study|Study termination|0|||
164087280|NCT02162758|592684164|FG001|Overall Study|Study termination|1|||
164087281|NCT04471935|592684165|FG000|Overall Study|Withdrawal by Subject|1|||
164087282|NCT04471935|592684165|FG000|Overall Study|Deemed ineligible to participate|1|||
164087283|NCT02116803|592684166|FG000|Overall Study|Adverse Event|2|||
164087284|NCT02116803|592684167|FG001|Overall Study|Adverse Event|1|||
164087285|NCT02116803|592684166|FG000|Overall Study|Physician Decision|1|||
164087286|NCT02116803|592684167|FG001|Overall Study|Physician Decision|0|||
164087287|NCT02116803|592684166|FG000|Overall Study|Progressive disease|4|||
164087288|NCT02116803|592684167|FG001|Overall Study|Progressive disease|0|||
164087289|NCT02116803|592684166|FG000|Overall Study|Study terminated by sponsor|2|||
164087290|NCT02116803|592684167|FG001|Overall Study|Study terminated by sponsor|1|||
164087291|NCT02116803|592684166|FG000|Overall Study|Death|1|||
164087292|NCT02116803|592684167|FG001|Overall Study|Death|0|||
163896810|NCT04174170|591996112|FG002|Double Blind Treatment Period|Death|0|||
163896811|NCT04174170|591996113|FG003|Double Blind Treatment Period|Death|0|||
163896812|NCT04174170|591996110|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
163896813|NCT04174170|591996111|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
164002364|NCT00686205|592371829|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
164002365|NCT01697215|592371830|FG000|Overall Study|Physician Decision|5|||
164002366|NCT01697215|592371830|FG000|Overall Study|Malfunction|9|||
164002367|NCT01697215|592371830|FG000|Overall Study|CXR not available|9|||
164002368|NCT02945657|592371831|FG000|Overall Study|Adverse Event|1|||
164002369|NCT02945657|592371831|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
164002370|NCT03075839|592371835|FG000|Overall Study|Lost to Follow-up|4|||
164002371|NCT05421754|592371839|FG000|Overall Study|Technical issue with sensor|1|||
164002372|NCT04433117|592371840|FG000|Overall Study|Withdrawal by Subject|1|||
164002373|NCT04433117|592371841|FG001|Overall Study|Withdrawal by Subject|0|||
164002374|NCT01051739|592371842|FG000|Overall Study|Death|3|||
164002375|NCT01051739|592371843|FG001|Overall Study|Death|3|||
164002376|NCT01051739|592371842|FG000|Overall Study|Withdrawal by Subject|25|||
164002377|NCT01051739|592371843|FG001|Overall Study|Withdrawal by Subject|10|||
164002378|NCT00824421|592371844|FG000|Overall Study|Adverse Event|6|||
164002379|NCT00824421|592371845|FG001|Overall Study|Adverse Event|6|||
164002380|NCT00824421|592371846|FG002|Overall Study|Adverse Event|6|||
164002381|NCT00824421|592371844|FG000|Overall Study|Death|0|||
164002382|NCT00824421|592371845|FG001|Overall Study|Death|1|||
164087293|NCT03213210|592684168|FG000|Overall Study|Lost to Follow-up|2|||
164087294|NCT03213210|592684168|FG000|Overall Study|Study termination|3|||
163896814|NCT04174170|591996112|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
163896815|NCT04174170|591996113|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
163896816|NCT04174170|591996110|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
163896817|NCT04174170|591996111|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
163896818|NCT04174170|591996112|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
163896819|NCT04174170|591996113|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
163896820|NCT04174170|591996110|FG000|Double Blind Treatment Period|Physician Decision|0|||
163896821|NCT04174170|591996111|FG001|Double Blind Treatment Period|Physician Decision|1|||
163896822|NCT04174170|591996112|FG002|Double Blind Treatment Period|Physician Decision|0|||
163896823|NCT04174170|591996113|FG003|Double Blind Treatment Period|Physician Decision|1|||
163896824|NCT04174170|591996110|FG000|Double Blind Treatment Period|Pregnancy|0|||
163896825|NCT04174170|591996111|FG001|Double Blind Treatment Period|Pregnancy|1|||
163896826|NCT04174170|591996112|FG002|Double Blind Treatment Period|Pregnancy|0|||
163896827|NCT04174170|591996113|FG003|Double Blind Treatment Period|Pregnancy|1|||
163896828|NCT04174170|591996110|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
163896829|NCT04174170|591996111|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
163896830|NCT04174170|591996112|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
163896831|NCT04174170|591996113|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
163896832|NCT04174170|591996110|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
163896833|NCT04174170|591996111|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
163896834|NCT04174170|591996112|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
163896835|NCT04174170|591996113|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
163896836|NCT04174170|591996110|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
163896837|NCT04174170|591996111|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
163896838|NCT04174170|591996112|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
163896839|NCT04174170|591996113|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
163896840|NCT04772534|591996115|FG000|Overall Study|Physician Decision|1|||
163896841|NCT04772534|591996116|FG001|Overall Study|Physician Decision|0|||
163896842|NCT04772534|591996117|FG002|Overall Study|Physician Decision|0|||
164002383|NCT00824421|592371846|FG002|Overall Study|Death|0|||
164002384|NCT00824421|592371844|FG000|Overall Study|Lack of Efficacy|5|||
164002385|NCT00824421|592371845|FG001|Overall Study|Lack of Efficacy|7|||
164087295|NCT01399736|592684169|FG000|Overall Study|Withdrawal by Subject|4|||
164087296|NCT01399736|592684170|FG001|Overall Study|Withdrawal by Subject|2|||
164087297|NCT01399736|592684169|FG000|Overall Study|Lost to Follow-up|0|||
164087298|NCT01399736|592684170|FG001|Overall Study|Lost to Follow-up|2|||
164087299|NCT03500484|592684171|FG000|Overall Study|Adverse Event|2|||
164087300|NCT03500484|592684172|FG001|Overall Study|Adverse Event|0|||
164087301|NCT03500484|592684171|FG000|Overall Study|Physician Decision|1|||
164087302|NCT03500484|592684172|FG001|Overall Study|Physician Decision|0|||
164087303|NCT03500484|592684171|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
164087304|NCT03500484|592684172|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
164087305|NCT02795104|592684173|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
164087306|NCT02795104|592684174|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
164087307|NCT02795104|592684175|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
164087308|NCT02795104|592684173|FG000|Overall Study|Withdrawal by Subject|0|||
164002386|NCT00824421|592371846|FG002|Overall Study|Lack of Efficacy|4|||
164002387|NCT00824421|592371844|FG000|Overall Study|Lost to Follow-up|2|||
164002388|NCT00824421|592371845|FG001|Overall Study|Lost to Follow-up|3|||
164002389|NCT00824421|592371846|FG002|Overall Study|Lost to Follow-up|0|||
164002390|NCT00824421|592371844|FG000|Overall Study|Pregnancy|1|||
164002391|NCT00824421|592371845|FG001|Overall Study|Pregnancy|0|||
164002392|NCT00824421|592371846|FG002|Overall Study|Pregnancy|1|||
164002393|NCT00824421|592371844|FG000|Overall Study|Withdrawal by Subject|2|||
164002394|NCT00824421|592371845|FG001|Overall Study|Withdrawal by Subject|3|||
164002395|NCT00824421|592371846|FG002|Overall Study|Withdrawal by Subject|3|||
164002396|NCT00824421|592371844|FG000|Overall Study|Randomized but not Treated|1|||
164002397|NCT00824421|592371845|FG001|Overall Study|Randomized but not Treated|1|||
164087309|NCT02795104|592684174|FG001|Overall Study|Withdrawal by Subject|2|||
164087310|NCT02795104|592684175|FG002|Overall Study|Withdrawal by Subject|0|||
164087311|NCT02795104|592684173|FG000|Overall Study|Lost to Follow-up|0|||
164087312|NCT02795104|592684174|FG001|Overall Study|Lost to Follow-up|0|||
164087313|NCT02795104|592684175|FG002|Overall Study|Lost to Follow-up|1|||
164087314|NCT00948675|592684176|FG000|Overall Study|Lost to Follow-up|1|||
164087315|NCT00948675|592684177|FG001|Overall Study|Lost to Follow-up|0|||
164087316|NCT00684671|592684178|FG000|Overall Study|Adverse Event|1|||
164087317|NCT00684671|592684179|FG001|Overall Study|Adverse Event|0|||
164087318|NCT00684671|592684180|FG002|Overall Study|Adverse Event|0|||
164087319|NCT00684671|592684178|FG000|Overall Study|Lost to Follow-up|1|||
164087320|NCT00684671|592684179|FG001|Overall Study|Lost to Follow-up|0|||
164087321|NCT00684671|592684180|FG002|Overall Study|Lost to Follow-up|0|||
164087322|NCT00684671|592684178|FG000|Overall Study|Alcoholic dependance|1|||
164087323|NCT00684671|592684179|FG001|Overall Study|Alcoholic dependance|0|||
164087324|NCT00684671|592684180|FG002|Overall Study|Alcoholic dependance|0|||
164087325|NCT04128007|592684181|FG000|Overall Study|Withdrawal by Subject|9|||
164087326|NCT04128007|592684182|FG001|Overall Study|Withdrawal by Subject|6|||
164087327|NCT04128007|592684181|FG000|Overall Study|Protocol Violation|1|||
164087328|NCT04128007|592684182|FG001|Overall Study|Protocol Violation|0|||
164087329|NCT04128007|592684181|FG000|Overall Study|Lost to Follow-up|8|||
164087330|NCT04128007|592684182|FG001|Overall Study|Lost to Follow-up|7|||
164087331|NCT04128007|592684181|FG000|Overall Study|Adverse Event|5|||
164087332|NCT04128007|592684182|FG001|Overall Study|Adverse Event|2|||
164087333|NCT04128007|592684181|FG000|Overall Study|Not reported|0|||
164087334|NCT04128007|592684182|FG001|Overall Study|Not reported|2|||
164087335|NCT00481247|592684187|FG000|Overall Study|Death|0|||
164087336|NCT00481247|592684188|FG001|Overall Study|Death|1|||
164087337|NCT00481247|592684187|FG000|Overall Study|Disease progression|18|||
164087338|NCT00481247|592684188|FG001|Overall Study|Disease progression|22|||
164087339|NCT00481247|592684187|FG000|Overall Study|Intolerance|42|||
164087340|NCT00481247|592684188|FG001|Overall Study|Intolerance|17|||
164087341|NCT00481247|592684187|FG000|Overall Study|Treatment failure|10|||
164087342|NCT00481247|592684188|FG001|Overall Study|Treatment failure|14|||
164087343|NCT00481247|592684187|FG000|Overall Study|AE unrelated to study drug|13|||
164087344|NCT00481247|592684188|FG001|Overall Study|AE unrelated to study drug|4|||
164087345|NCT00481247|592684187|FG000|Overall Study|Withdrawal by Subject|8|||
164087346|NCT00481247|592684188|FG001|Overall Study|Withdrawal by Subject|13|||
164087347|NCT00481247|592684187|FG000|Overall Study|Pregnancy|2|||
164087348|NCT00481247|592684188|FG001|Overall Study|Pregnancy|1|||
164002398|NCT00824421|592371846|FG002|Overall Study|Randomized but not Treated|0|||
164002399|NCT00824421|592371844|FG000|Overall Study|Other|0|||
164087349|NCT00481247|592684187|FG000|Overall Study|Lost to Follow-up|1|||
164087350|NCT00481247|592684188|FG001|Overall Study|Lost to Follow-up|2|||
164087351|NCT00481247|592684187|FG000|Overall Study|Poor compliance/noncompliance|1|||
164087352|NCT00481247|592684188|FG001|Overall Study|Poor compliance/noncompliance|7|||
164002400|NCT00824421|592371845|FG001|Overall Study|Other|1|||
164002401|NCT00824421|592371846|FG002|Overall Study|Other|0|||
164087353|NCT00481247|592684187|FG000|Overall Study|Administrative reason by sponsor|157|||
164087354|NCT00481247|592684188|FG001|Overall Study|Administrative reason by sponsor|162|||
164087355|NCT00481247|592684187|FG000|Overall Study|Varied|6|||
164087356|NCT00481247|592684188|FG001|Overall Study|Varied|15|||
164002402|NCT03527043|592371848|FG000|Overall Study|Withdrawal by Subject|1|||
164282055|NCT01746225|593402565|FG000|Overall Study|Adverse Event|15|||
164282056|NCT01746225|593402566|FG001|Overall Study|Adverse Event|12|||
164282057|NCT01746225|593402567|FG002|Overall Study|Adverse Event|17|||
164282058|NCT01746225|593402565|FG000|Overall Study|Continuing Treatment|5|||
164282059|NCT01746225|593402566|FG001|Overall Study|Continuing Treatment|8|||
164282060|NCT01746225|593402567|FG002|Overall Study|Continuing Treatment|3|||
164282061|NCT00595478|593402568|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
164282062|NCT00595478|593402569|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
164282063|NCT00595478|593402568|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
164282064|NCT00595478|593402569|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
163896843|NCT04772534|591996115|FG000|Overall Study|Withdrawal by Subject|3|||
163896844|NCT04772534|591996116|FG001|Overall Study|Withdrawal by Subject|0|||
164002403|NCT03527043|592371849|FG001|Overall Study|Withdrawal by Subject|0|||
164002404|NCT02500550|592371850|FG000|Overall Study|Death|7|||
164002405|NCT02201940|592371851|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
164282065|NCT02713828|593402570|FG000|Overall Study|Death|2|||
164282066|NCT02713828|593402571|FG001|Overall Study|Death|0|||
163896845|NCT04772534|591996117|FG002|Overall Study|Withdrawal by Subject|1|||
163896846|NCT04194450|591996118|FG000|Overall Study|not eligible|1|||
163896847|NCT04194450|591996119|FG001|Overall Study|not eligible|0|||
163896848|NCT05875701|591996128|FG000|Overall Study|Lost to Follow-up|2|||
163896849|NCT05875701|591996129|FG001|Overall Study|Lost to Follow-up|0|||
163896850|NCT05875701|591996128|FG000|Overall Study|Withdrawal by Subject|1|||
163896851|NCT05875701|591996129|FG001|Overall Study|Withdrawal by Subject|1|||
163896852|NCT04490356|591996135|FG000|Overall Study|Lost to Follow-up|1|||
163896853|NCT00412607|591996138|FG000|Overall Study|Withdrawal by Subject|9|||
163896854|NCT00412607|591996138|FG000|Overall Study|Lost to Follow-up|19|||
163896855|NCT00412607|591996138|FG000|Overall Study|Death|61|||
163896856|NCT00412607|591996138|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
163896857|NCT04675034|591996143|FG000|Overall Study|Lost to Follow-up|1|||
163896858|NCT04675034|591996144|FG001|Overall Study|Lost to Follow-up|1|||
163896859|NCT04675034|591996145|FG002|Overall Study|Lost to Follow-up|0|||
163896860|NCT04675034|591996146|FG003|Overall Study|Lost to Follow-up|2|||
163896861|NCT04675034|591996147|FG004|Overall Study|Lost to Follow-up|0|||
163896862|NCT04675034|591996143|FG000|Overall Study|Protocol Violation|1|||
163896863|NCT04675034|591996144|FG001|Overall Study|Protocol Violation|0|||
163896864|NCT04675034|591996145|FG002|Overall Study|Protocol Violation|0|||
163896865|NCT04675034|591996146|FG003|Overall Study|Protocol Violation|1|||
163896866|NCT04675034|591996147|FG004|Overall Study|Protocol Violation|3|||
163896867|NCT04675034|591996143|FG000|Overall Study|Withdrawal by Subject|9|||
163896868|NCT04675034|591996144|FG001|Overall Study|Withdrawal by Subject|3|||
163896869|NCT04675034|591996145|FG002|Overall Study|Withdrawal by Subject|4|||
163896870|NCT04675034|591996146|FG003|Overall Study|Withdrawal by Subject|8|||
163896871|NCT04675034|591996147|FG004|Overall Study|Withdrawal by Subject|6|||
163896872|NCT03201939|591996148|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
163896873|NCT03201939|591996149|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
163896874|NCT02806726|591996158|FG000|Overall Study|Lost to Follow-up|1|||
163896875|NCT03512301|591997052|FG000|Overall Study|Protocol Violation|2|||
163896876|NCT03512301|591997052|FG000|Overall Study|Did Not Qualify|3|||
163896877|NCT03512301|591997052|FG000|Overall Study|Age-ineligible|1|||
163896878|NCT03512301|591997052|FG000|Overall Study|Inadequate fluency with the English language|3|||
163896879|NCT03884439|591997071|FG000|Overall Study|No informed consent for publication of study results|38|||
163896880|NCT03884439|591997071|FG000|Overall Study|Contract violation/deficiency|7|||
163896881|NCT03250676|591997072|FG000|Overall Study|Adverse Event|0|||
163896882|NCT03250676|591997073|FG001|Overall Study|Adverse Event|0|||
163896883|NCT03250676|591997074|FG002|Overall Study|Adverse Event|0|||
163896884|NCT03250676|591997075|FG003|Overall Study|Adverse Event|1|||
163896885|NCT03250676|591997076|FG004|Overall Study|Adverse Event|2|||
163896886|NCT03250676|591997077|FG005|Overall Study|Adverse Event|9|||
163896887|NCT03250676|591997072|FG000|Overall Study|Withdrawal by Subject|1|||
163896888|NCT03250676|591997073|FG001|Overall Study|Withdrawal by Subject|0|||
163896889|NCT03250676|591997074|FG002|Overall Study|Withdrawal by Subject|0|||
163896890|NCT03250676|591997075|FG003|Overall Study|Withdrawal by Subject|1|||
163896891|NCT03250676|591997076|FG004|Overall Study|Withdrawal by Subject|1|||
163896892|NCT03250676|591997077|FG005|Overall Study|Withdrawal by Subject|2|||
163896893|NCT03250676|591997072|FG000|Overall Study|Physician Decision|0|||
163896894|NCT03250676|591997073|FG001|Overall Study|Physician Decision|0|||
163896895|NCT03250676|591997074|FG002|Overall Study|Physician Decision|0|||
163896896|NCT03250676|591997075|FG003|Overall Study|Physician Decision|2|||
163896897|NCT03250676|591997076|FG004|Overall Study|Physician Decision|0|||
163896898|NCT03250676|591997077|FG005|Overall Study|Physician Decision|3|||
163896899|NCT03250676|591997072|FG000|Overall Study|Withdrawal of consent|0|||
164002406|NCT02201940|592371852|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
164282067|NCT02713828|593402570|FG000|Overall Study|Withdrawal by Subject|1|||
163896900|NCT03250676|591997073|FG001|Overall Study|Withdrawal of consent|0|||
163896901|NCT03250676|591997074|FG002|Overall Study|Withdrawal of consent|2|||
164087357|NCT00481247|592684187|FG000|Overall Study|Did not receive treatment|1|||
164087358|NCT00481247|592684188|FG001|Overall Study|Did not receive treatment|2|||
164282068|NCT02713828|593402571|FG001|Overall Study|Withdrawal by Subject|0|||
164282069|NCT02713828|593402570|FG000|Overall Study|study terminated but patient allowed to|2|||
164282070|NCT02713828|593402571|FG001|Overall Study|study terminated but patient allowed to|0|||
164282071|NCT04090242|593402572|FG000|Overall Study|Withdrawal by Subject|1|||
164282072|NCT04090242|593402573|FG001|Overall Study|Withdrawal by Subject|0|||
164282073|NCT02513472|593402574|FG000|Overall Study|Radiological Disease Progression|45|||
164282074|NCT02513472|593402575|FG001|Overall Study|Radiological Disease Progression|57|||
164282075|NCT02513472|593402574|FG000|Overall Study|Clinical Disease Progression|5|||
164282076|NCT02513472|593402575|FG001|Overall Study|Clinical Disease Progression|13|||
164282077|NCT02513472|593402574|FG000|Overall Study|Adverse Event|8|||
164282078|NCT02513472|593402575|FG001|Overall Study|Adverse Event|11|||
164282079|NCT02513472|593402574|FG000|Overall Study|Withdrawal by Subject|0|||
164282080|NCT02513472|593402575|FG001|Overall Study|Withdrawal by Subject|4|||
164282081|NCT02513472|593402574|FG000|Overall Study|Subject Choice|2|||
164282082|NCT02513472|593402575|FG001|Overall Study|Subject Choice|7|||
164282083|NCT02513472|593402574|FG000|Overall Study|Treatment Completed as per Protocol|3|||
164282084|NCT02513472|593402575|FG001|Overall Study|Treatment Completed as per Protocol|3|||
164282085|NCT02513472|593402574|FG000|Overall Study|Other|3|||
164282086|NCT02513472|593402575|FG001|Overall Study|Other|6|||
164282087|NCT01019369|593402576|FG000|Overall Study|Lost to Follow-up|10|||
164282088|NCT01019369|593402577|FG001|Overall Study|Lost to Follow-up|6|||
164282089|NCT01019369|593402576|FG000|Overall Study|Withdrawal by Subject|0|||
164282090|NCT01019369|593402577|FG001|Overall Study|Withdrawal by Subject|1|||
164282091|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
164282092|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
164282093|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
164282094|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282095|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282096|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282097|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282098|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282099|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
164282100|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Physician Decision|1|||
164282101|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Physician Decision|2|||
164282102|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Physician Decision|0|||
164282103|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Physician Decision|0|||
164282104|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Physician Decision|0|||
164282105|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Physician Decision|0|||
164282106|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Physician Decision|0|||
164282107|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Physician Decision|0|||
164282108|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Physician Decision|0|||
164282109|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
164282110|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
164282111|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
164282112|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
164282113|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
164282114|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
164282115|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
164282116|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
164282117|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
164282118|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
164282119|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282120|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
163896902|NCT03250676|591997075|FG003|Overall Study|Withdrawal of consent|0|||
163896903|NCT03250676|591997076|FG004|Overall Study|Withdrawal of consent|0|||
163896904|NCT03250676|591997077|FG005|Overall Study|Withdrawal of consent|2|||
163896905|NCT03250676|591997072|FG000|Overall Study|Other|1|||
163896906|NCT03250676|591997073|FG001|Overall Study|Other|0|||
163896907|NCT03250676|591997074|FG002|Overall Study|Other|0|||
163896908|NCT03250676|591997075|FG003|Overall Study|Other|0|||
163896909|NCT03250676|591997076|FG004|Overall Study|Other|0|||
163896910|NCT03250676|591997077|FG005|Overall Study|Other|0|||
163896911|NCT03250676|591997072|FG000|Overall Study|Disease progression|4|||
163896912|NCT03250676|591997073|FG001|Overall Study|Disease progression|12|||
163896913|NCT03250676|591997074|FG002|Overall Study|Disease progression|9|||
163896914|NCT03250676|591997075|FG003|Overall Study|Disease progression|7|||
163896915|NCT03250676|591997076|FG004|Overall Study|Disease progression|4|||
163896916|NCT03250676|591997077|FG005|Overall Study|Disease progression|88|||
163896917|NCT04281498|591997079|FG000|Overall Study|Progression of disease|1|||
163896918|NCT04281498|591997079|FG000|Overall Study|Planned SCT|1|||
163896919|NCT04281498|591997079|FG000|Overall Study|Alternative Treatment|1|||
163896920|NCT03142009|591997082|FG000|Overall Study|Lost to Follow-up|45|||
164002407|NCT02201940|592371851|FG000|Overall Study|Lack of Efficacy|2|||
164002408|NCT02201940|592371852|FG001|Overall Study|Lack of Efficacy|113|||
164002409|NCT02201940|592371851|FG000|Overall Study|Lost to Follow-up|5|||
164002410|NCT02201940|592371852|FG001|Overall Study|Lost to Follow-up|0|||
164002411|NCT02201940|592371851|FG000|Overall Study|Withdrew Consent|2|||
164002412|NCT02201940|592371852|FG001|Overall Study|Withdrew Consent|1|||
164002413|NCT02201940|592371851|FG000|Overall Study|Investigator's Discretion|1|||
164002414|NCT02201940|592371852|FG001|Overall Study|Investigator's Discretion|1|||
164002415|NCT02201940|592371851|FG000|Overall Study|Death|1|||
164002416|NCT02201940|592371852|FG001|Overall Study|Death|0|||
164002417|NCT02201940|592371851|FG000|Overall Study|Adverse Event|0|||
164002418|NCT02201940|592371852|FG001|Overall Study|Adverse Event|1|||
164002419|NCT00636818|592371853|FG000|Overall Study|Adverse Event|1|||
164002420|NCT00636818|592371853|FG000|Overall Study|Lost to Follow-up|2|||
164002421|NCT00636818|592371853|FG000|Overall Study|Entry Criteria Exclusion|3|||
164002422|NCT00636818|592371853|FG000|Overall Study|Protocol Violation|1|||
164002423|NCT00636818|592371853|FG000|Overall Study|Withdrawal by Subject|4|||
164002424|NCT02604264|592371854|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
164002425|NCT02604264|592371855|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
164002426|NCT01511445|592371856|FG000|Overall Study|Lost to Follow-up|3|||
164002427|NCT01511445|592371857|FG001|Overall Study|Lost to Follow-up|1|||
164002428|NCT01511445|592371856|FG000|Overall Study|Protocol Violation|1|||
164002429|NCT01511445|592371857|FG001|Overall Study|Protocol Violation|3|||
164002430|NCT01511445|592371856|FG000|Overall Study|Protocol Violation|1|||
164002431|NCT01511445|592371857|FG001|Overall Study|Protocol Violation|0|||
164002432|NCT02344576|592371861|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
164002433|NCT02344576|592371862|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
164002434|NCT02344576|592371863|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
164002435|NCT02344576|592371864|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
164002436|NCT02344576|592371861|FG000|1-Month Follow-Up|Death|13|||
164002437|NCT02344576|592371862|FG001|1-Month Follow-Up|Death|8|||
164002438|NCT02344576|592371863|FG002|1-Month Follow-Up|Death|0|||
164002439|NCT02344576|592371864|FG003|1-Month Follow-Up|Death|0|||
164002440|NCT02344576|592371861|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
164002441|NCT02344576|592371862|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
164002442|NCT02344576|592371863|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
164002443|NCT02344576|592371864|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
164002444|NCT02344576|592371861|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
164002445|NCT02344576|592371862|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
164002446|NCT02344576|592371863|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
164002447|NCT02344576|592371864|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
164002448|NCT02344576|592371861|FG000|6-Month Follow-Up|Death|14|||
164002449|NCT02344576|592371862|FG001|6-Month Follow-Up|Death|14|||
164002450|NCT02344576|592371863|FG002|6-Month Follow-Up|Death|0|||
164002451|NCT02344576|592371864|FG003|6-Month Follow-Up|Death|0|||
164002452|NCT02344576|592371861|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
164002453|NCT02344576|592371862|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
164002454|NCT02344576|592371863|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
164002455|NCT02344576|592371864|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
164002456|NCT02344576|592371861|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
164002457|NCT02344576|592371862|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
164002458|NCT02344576|592371863|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
164002459|NCT02344576|592371864|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
164002460|NCT01243268|592371866|FG000|Overall Study|Lost to Follow-up|4|||
164002461|NCT01243268|592371866|FG000|Overall Study|Protocol Violation|51|||
164002462|NCT01243268|592371866|FG000|Overall Study|Deviation with contract date|7|||
164002463|NCT01243268|592371866|FG000|Overall Study|Duplicate subject|2|||
164002464|NCT00702143|592371869|FG000|Overall Study|Lost to Follow-up|0|||
164002465|NCT00702143|592371870|FG001|Overall Study|Lost to Follow-up|0|||
164002466|NCT00702143|592371871|FG002|Overall Study|Lost to Follow-up|1|||
164344531|NCT02197247|593636971|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
164344532|NCT02197247|593636971|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
164344533|NCT02197247|593636971|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
164344534|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
164344535|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
164002467|NCT04091217|592371872|FG000|Overall Study|Lost to Follow-up|2|||
164002468|NCT02495948|592371875|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
164002469|NCT02495948|592371876|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
164002470|NCT02495948|592371875|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
164002471|NCT02495948|592371876|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
164002472|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
164002473|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164002474|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164002475|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164002476|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
164002477|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
164002478|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
164002479|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
164002480|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
164002481|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
164002482|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
164002483|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
164002484|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
164002485|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
164002486|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
164002487|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
164002488|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
164002489|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
164002490|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
164002491|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
164002492|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
164002493|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
164002494|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
164002495|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
164002496|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
164002497|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
164002498|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
164002499|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
164002500|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
164002501|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
164002502|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
164002503|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
164002504|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
164002505|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
164002506|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
164002507|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
164002508|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
164002509|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
164002510|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
164002511|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
164087359|NCT01716754|592684189|FG000|Overall Study|Death|0|||
164087360|NCT01716754|592684190|FG001|Overall Study|Death|0|||
164282121|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282122|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282123|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282124|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282125|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282126|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
164282127|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
164282128|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
164282129|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282130|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282131|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282132|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282133|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282134|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282135|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
164282136|NCT04405076|593402578|FG000|Part A (Blinded Phase)|Other than Specified|0|||
164282137|NCT04405076|593402579|FG001|Part A (Blinded Phase)|Other than Specified|0|||
164282138|NCT04405076|593402580|FG002|Part A (Blinded Phase)|Other than Specified|3|||
164282139|NCT04405076|593402581|FG003|Part A (Blinded Phase)|Other than Specified|0|||
164282140|NCT04405076|593402582|FG004|Part A (Blinded Phase)|Other than Specified|0|||
164282141|NCT04405076|593402583|FG005|Part A (Blinded Phase)|Other than Specified|0|||
164282142|NCT04405076|593402584|FG006|Part A (Blinded Phase)|Other than Specified|0|||
164282143|NCT04405076|593402585|FG007|Part A (Blinded Phase)|Other than Specified|0|||
164282144|NCT04405076|593402586|FG008|Part A (Blinded Phase)|Other than Specified|0|||
164282145|NCT04405076|593402578|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282146|NCT04405076|593402579|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282147|NCT04405076|593402580|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164087361|NCT01716754|592684191|FG002|Overall Study|Death|0|||
164087362|NCT01716754|592684192|FG003|Overall Study|Death|1|||
164087363|NCT01716754|592684189|FG000|Overall Study|Protocol deviation|0|||
164087364|NCT01716754|592684190|FG001|Overall Study|Protocol deviation|2|||
164087365|NCT01716754|592684191|FG002|Overall Study|Protocol deviation|7|||
164087366|NCT01716754|592684192|FG003|Overall Study|Protocol deviation|2|||
164087367|NCT01716754|592684189|FG000|Overall Study|Non-compliance with study treatment|0|||
164087368|NCT01716754|592684190|FG001|Overall Study|Non-compliance with study treatment|0|||
164087369|NCT01716754|592684191|FG002|Overall Study|Non-compliance with study treatment|1|||
164087370|NCT01716754|592684192|FG003|Overall Study|Non-compliance with study treatment|0|||
164087371|NCT01716754|592684189|FG000|Overall Study|Physician Decision|1|||
164087372|NCT01716754|592684190|FG001|Overall Study|Physician Decision|0|||
164282148|NCT04405076|593402581|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
164282149|NCT04405076|593402582|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
164282150|NCT04405076|593402583|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
164282151|NCT04405076|593402584|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282152|NCT04405076|593402585|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282153|NCT04405076|593402586|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
164282154|NCT04405076|593402578|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282155|NCT04405076|593402579|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282156|NCT04405076|593402580|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282157|NCT04405076|593402581|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282158|NCT04405076|593402582|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
164282159|NCT04405076|593402583|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282160|NCT04405076|593402584|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282161|NCT04405076|593402585|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282162|NCT04405076|593402586|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
164282163|NCT04405076|593402578|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282164|NCT04405076|593402579|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282165|NCT04405076|593402580|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282166|NCT04405076|593402581|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
164282167|NCT04405076|593402582|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
164282168|NCT04405076|593402583|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
164282169|NCT04405076|593402584|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282170|NCT04405076|593402585|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282171|NCT04405076|593402586|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
164282172|NCT04405076|593402578|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282173|NCT04405076|593402579|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282174|NCT04405076|593402580|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282175|NCT04405076|593402581|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282176|NCT04405076|593402582|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282177|NCT04405076|593402583|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282178|NCT04405076|593402584|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
164282179|NCT04405076|593402585|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
164282180|NCT04405076|593402586|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
164282181|NCT04405076|593402578|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282182|NCT04405076|593402579|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282183|NCT04405076|593402580|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282184|NCT04405076|593402581|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282185|NCT04405076|593402582|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282186|NCT04405076|593402583|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282187|NCT04405076|593402584|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
164282188|NCT04405076|593402585|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282189|NCT04405076|593402586|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
164282190|NCT01380834|593402587|FG000|Overall Study|Physician Decision|1|||
164282191|NCT01380834|593402588|FG001|Overall Study|Physician Decision|0|||
164282192|NCT00604695|593402589|FG000|Overall Study|Did not receive first bolus.|0|||
164282193|NCT00604695|593402590|FG001|Overall Study|Did not receive first bolus.|4|||
164282194|NCT00172042|593402598|FG000|Overall Study|Adverse Event|27|||
164282195|NCT00172042|593402599|FG001|Overall Study|Adverse Event|13|||
164087373|NCT01716754|592684191|FG002|Overall Study|Physician Decision|0|||
164087374|NCT01716754|592684192|FG003|Overall Study|Physician Decision|0|||
164087375|NCT01716754|592684189|FG000|Overall Study|Lost to Follow-up|1|||
164087376|NCT01716754|592684190|FG001|Overall Study|Lost to Follow-up|0|||
164002512|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
164002513|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
164002514|NCT00100048|592371877|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164002515|NCT00100048|592371878|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164002516|NCT00100048|592371879|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164002517|NCT00100048|592371880|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
164002518|NCT00100048|592371881|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164002519|NCT00100048|592371882|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
164002520|NCT01822561|592371884|FG000|Overall Study|Withdrawal by Subject|2|||
164002521|NCT01624142|592371885|FG000|Overall Study|Withdrawal by Subject|14|||
164002522|NCT01624142|592371886|FG001|Overall Study|Withdrawal by Subject|4|||
164002523|NCT01624142|592371885|FG000|Overall Study|Death|3|||
164002524|NCT01624142|592371886|FG001|Overall Study|Death|6|||
164002525|NCT01624142|592371885|FG000|Overall Study|Study Closure|12|||
164002526|NCT01624142|592371886|FG001|Overall Study|Study Closure|6|||
164002527|NCT01624142|592371885|FG000|Overall Study|Lost to Follow-up|2|||
164002528|NCT01624142|592371886|FG001|Overall Study|Lost to Follow-up|0|||
164002529|NCT01624142|592371885|FG000|Overall Study|Other|1|||
164002530|NCT01624142|592371886|FG001|Overall Study|Other|0|||
164002531|NCT00667277|592371887|FG000|Overall Study|Withdrawal by Subject|2|||
164002532|NCT02747004|592371888|FG000|Overall Study|Withdrawal by Subject|8|||
164002533|NCT02747004|592371889|FG001|Overall Study|Withdrawal by Subject|5|||
164002534|NCT02747004|592371890|FG002|Overall Study|Withdrawal by Subject|4|||
164002535|NCT02747004|592371888|FG000|Overall Study|Lost to Follow-up|1|||
164002536|NCT02747004|592371889|FG001|Overall Study|Lost to Follow-up|2|||
164002537|NCT02747004|592371890|FG002|Overall Study|Lost to Follow-up|2|||
164002538|NCT02747004|592371888|FG000|Overall Study|on study treatment/follow-up|48|||
164002539|NCT02747004|592371889|FG001|Overall Study|on study treatment/follow-up|42|||
164002540|NCT02747004|592371890|FG002|Overall Study|on study treatment/follow-up|41|||
164002541|NCT04826900|592371891|FG000|Overall Study|Family factor|1|||
164002542|NCT04826900|592371892|FG001|Overall Study|Family factor|1|||
164002543|NCT04885257|592371897|FG000|Overall Study|Withdrawal by Subject|1|||
164002544|NCT04885257|592371898|FG001|Overall Study|Withdrawal by Subject|0|||
164002545|NCT00818259|592371899|FG000|Part I|Withdrawal by Subject|1|||
164002546|NCT00818259|592371900|FG001|Part I|Withdrawal by Subject|0|||
164002547|NCT00818259|592371901|FG002|Part I|Withdrawal by Subject|0|||
164002548|NCT00818259|592371902|FG003|Part I|Withdrawal by Subject|0|||
164002549|NCT00818259|592371903|FG004|Part I|Withdrawal by Subject|0|||
164002550|NCT00818259|592371904|FG005|Part I|Withdrawal by Subject|0|||
164002551|NCT00818259|592371905|FG006|Part I|Withdrawal by Subject|0|||
164002552|NCT00818259|592371906|FG007|Part I|Withdrawal by Subject|0|||
164002553|NCT00818259|592371907|FG008|Part I|Withdrawal by Subject|0|||
164002554|NCT00818259|592371899|FG000|Part II|Physician Decision|0|||
164002555|NCT00818259|592371900|FG001|Part II|Physician Decision|0|||
164002556|NCT00818259|592371901|FG002|Part II|Physician Decision|1|||
164002557|NCT00818259|592371902|FG003|Part II|Physician Decision|0|||
164002558|NCT00818259|592371903|FG004|Part II|Physician Decision|0|||
164002559|NCT00818259|592371904|FG005|Part II|Physician Decision|0|||
164002560|NCT00818259|592371905|FG006|Part II|Physician Decision|0|||
164002561|NCT00818259|592371906|FG007|Part II|Physician Decision|0|||
164002562|NCT00818259|592371907|FG008|Part II|Physician Decision|0|||
164002563|NCT00818259|592371899|FG000|Part II|Lack of Efficacy|0|||
164002564|NCT00818259|592371900|FG001|Part II|Lack of Efficacy|0|||
164002565|NCT00818259|592371901|FG002|Part II|Lack of Efficacy|0|||
164002566|NCT00818259|592371902|FG003|Part II|Lack of Efficacy|1|||
164002567|NCT00818259|592371903|FG004|Part II|Lack of Efficacy|0|||
164002568|NCT00818259|592371904|FG005|Part II|Lack of Efficacy|0|||
164002569|NCT00818259|592371905|FG006|Part II|Lack of Efficacy|0|||
164002570|NCT00818259|592371906|FG007|Part II|Lack of Efficacy|0|||
164002571|NCT00818259|592371907|FG008|Part II|Lack of Efficacy|0|||
164002572|NCT00818259|592371899|FG000|Part II|Not Treated|0|||
164002573|NCT00818259|592371900|FG001|Part II|Not Treated|0|||
164002574|NCT00818259|592371901|FG002|Part II|Not Treated|0|||
164002575|NCT00818259|592371902|FG003|Part II|Not Treated|1|||
164282196|NCT00172042|593402598|FG000|Overall Study|Abnormal laboratory value(s)|5|||
164282197|NCT00172042|593402599|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164282198|NCT00172042|593402598|FG000|Overall Study|Abnormal test procedure(s)|0|||
164002576|NCT00818259|592371903|FG004|Part II|Not Treated|0|||
164002577|NCT00818259|592371904|FG005|Part II|Not Treated|0|||
164002578|NCT00818259|592371905|FG006|Part II|Not Treated|0|||
164002579|NCT00818259|592371906|FG007|Part II|Not Treated|0|||
164002580|NCT00818259|592371907|FG008|Part II|Not Treated|0|||
164002581|NCT00818259|592371899|FG000|Part IV|Physician Decision|0|||
164002582|NCT00818259|592371900|FG001|Part IV|Physician Decision|0|||
164002583|NCT00818259|592371901|FG002|Part IV|Physician Decision|0|||
164002584|NCT00818259|592371902|FG003|Part IV|Physician Decision|0|||
164002585|NCT00818259|592371903|FG004|Part IV|Physician Decision|0|||
164002586|NCT00818259|592371904|FG005|Part IV|Physician Decision|1|||
164087377|NCT01716754|592684191|FG002|Overall Study|Lost to Follow-up|0|||
164087378|NCT01716754|592684192|FG003|Overall Study|Lost to Follow-up|1|||
164087379|NCT01716754|592684189|FG000|Overall Study|Adverse Event|4|||
164087380|NCT01716754|592684190|FG001|Overall Study|Adverse Event|2|||
164087381|NCT01716754|592684191|FG002|Overall Study|Adverse Event|2|||
164087382|NCT01716754|592684192|FG003|Overall Study|Adverse Event|1|||
164087383|NCT01716754|592684189|FG000|Overall Study|Withdrawal by Subject|5|||
164087384|NCT01716754|592684190|FG001|Overall Study|Withdrawal by Subject|0|||
164087385|NCT01716754|592684191|FG002|Overall Study|Withdrawal by Subject|4|||
164087386|NCT01716754|592684192|FG003|Overall Study|Withdrawal by Subject|3|||
164087387|NCT02110706|592684212|FG000|Overall Study|Adverse Event|2|||
164087388|NCT02110706|592684213|FG001|Overall Study|Adverse Event|3|||
164087389|NCT02110706|592684212|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
164087390|NCT02110706|592684213|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
164087391|NCT03521999|592684215|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
164087392|NCT03521999|592684216|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
164087393|NCT03521999|592684215|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
164087394|NCT03521999|592684216|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
164087395|NCT03521999|592684215|FG000|Completed 3 Month Follow up|Death|0|||
164087396|NCT03521999|592684216|FG001|Completed 3 Month Follow up|Death|1|||
164087397|NCT03521999|592684215|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
164002587|NCT00818259|592371905|FG006|Part IV|Physician Decision|0|||
164002588|NCT00818259|592371906|FG007|Part IV|Physician Decision|0|||
164002589|NCT00818259|592371907|FG008|Part IV|Physician Decision|0|||
164002590|NCT00818259|592371899|FG000|Part V|Adverse Event|0|||
164002591|NCT00818259|592371900|FG001|Part V|Adverse Event|0|||
164002592|NCT00818259|592371901|FG002|Part V|Adverse Event|0|||
164002593|NCT00818259|592371902|FG003|Part V|Adverse Event|0|||
164002594|NCT00818259|592371903|FG004|Part V|Adverse Event|0|||
164002595|NCT00818259|592371904|FG005|Part V|Adverse Event|0|||
164002596|NCT00818259|592371905|FG006|Part V|Adverse Event|0|||
164002597|NCT00818259|592371906|FG007|Part V|Adverse Event|1|||
164002598|NCT00818259|592371907|FG008|Part V|Adverse Event|0|||
164002599|NCT02597062|592371908|FG000|Overall Study|Ineligible|1|||
164002600|NCT01053429|592371911|FG000|Overall Study|Adverse Event|64|||
164002601|NCT01053429|592371911|FG000|Overall Study|Other|309|||
164002602|NCT01697345|592371912|FG000|Overall Study|Withdrawal by Subject|1|||
164002603|NCT01976806|592371913|FG000|Overall Study|Lost to Follow-up|1|||
164002604|NCT01976806|592371914|FG001|Overall Study|Lost to Follow-up|4|||
164002605|NCT01976806|592371913|FG000|Overall Study|Adverse Event|1|||
164002606|NCT01976806|592371914|FG001|Overall Study|Adverse Event|1|||
164002607|NCT01976806|592371913|FG000|Overall Study|Withdrawal by Subject|1|||
164002608|NCT01976806|592371914|FG001|Overall Study|Withdrawal by Subject|1|||
164002609|NCT03929250|592371919|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
164002610|NCT03929250|592371920|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
164002611|NCT01523873|592371922|FG000|Overall Study|Protocol Violation|422|||
164002612|NCT06119191|592371923|FG000|Overall Study|Adverse Event|0|||
164002613|NCT06119191|592371924|FG001|Overall Study|Adverse Event|1|||
164002614|NCT06119191|592371923|FG000|Overall Study|Protocol Violation|1|||
164002615|NCT06119191|592371924|FG001|Overall Study|Protocol Violation|0|||
164002616|NCT02468193|592373700|FG000|Overall Study|Adverse Event|4|||
164002617|NCT02468193|592373700|FG000|Overall Study|Subject/ Guardian decision|2|||
164002618|NCT01485614|592373701|FG000|Randomization|Not Treated|1|||
164002619|NCT01485614|592373702|FG001|Randomization|Not Treated|0|||
164002620|NCT01485614|592373703|FG002|Randomization|Not Treated|0|||
164002621|NCT01485614|592373704|FG003|Randomization|Not Treated|0|||
164002622|NCT01485614|592373701|FG000|Weeks 0-20|Lost to Follow-up|2|||
164002623|NCT01485614|592373702|FG001|Weeks 0-20|Lost to Follow-up|0|||
164002624|NCT01485614|592373703|FG002|Weeks 0-20|Lost to Follow-up|0|||
164002625|NCT01485614|592373704|FG003|Weeks 0-20|Lost to Follow-up|0|||
164002626|NCT01485614|592373701|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
164002627|NCT01485614|592373702|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
164002628|NCT01485614|592373703|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
164087398|NCT03521999|592684216|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
164087399|NCT04182204|592684219|FG000|Safety Run-in|Lost to Follow-up|1|||
164087400|NCT04182204|592684220|FG001|Safety Run-in|Lost to Follow-up|0|||
164087401|NCT04182204|592684221|FG002|Safety Run-in|Lost to Follow-up|0|||
164002629|NCT01485614|592373704|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
164087402|NCT04182204|592684219|FG000|Safety Run-in|Withdrawal by Subject|2|||
164087403|NCT04182204|592684220|FG001|Safety Run-in|Withdrawal by Subject|0|||
164002630|NCT01485614|592373701|FG000|Weeks 0-20|Withdrawal by Subject|3|||
164002631|NCT01485614|592373702|FG001|Weeks 0-20|Withdrawal by Subject|2|||
164002632|NCT01485614|592373703|FG002|Weeks 0-20|Withdrawal by Subject|1|||
164002633|NCT01485614|592373704|FG003|Weeks 0-20|Withdrawal by Subject|0|||
164002634|NCT01485614|592373701|FG000|Weeks 20-54|Lost to Follow-up|4|||
164002635|NCT01485614|592373702|FG001|Weeks 20-54|Lost to Follow-up|3|||
164002636|NCT01485614|592373703|FG002|Weeks 20-54|Lost to Follow-up|1|||
164087404|NCT04182204|592684221|FG002|Safety Run-in|Withdrawal by Subject|0|||
164087405|NCT04182204|592684219|FG000|Safety Run-in|Death|7|||
164002637|NCT01485614|592373704|FG003|Weeks 20-54|Lost to Follow-up|0|||
164002638|NCT01485614|592373701|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
164002639|NCT01485614|592373702|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
164002640|NCT01485614|592373703|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
164002641|NCT01485614|592373704|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
164002642|NCT01485614|592373701|FG000|Weeks 20-54|Withdrawal by Subject|5|||
164002643|NCT01485614|592373702|FG001|Weeks 20-54|Withdrawal by Subject|3|||
164002644|NCT01485614|592373703|FG002|Weeks 20-54|Withdrawal by Subject|0|||
164002645|NCT01485614|592373704|FG003|Weeks 20-54|Withdrawal by Subject|0|||
164002646|NCT00942409|592373705|FG000|Overall Study|Lack of Efficacy|1|||
164002647|NCT00942409|592373705|FG000|Overall Study|study drug unavailable|2|||
164002648|NCT01503021|592373710|FG000|Overall Study|Adverse Event|7|||
164002649|NCT01503021|592373711|FG001|Overall Study|Adverse Event|6|||
164002650|NCT01503021|592373710|FG000|Overall Study|Death|0|||
164002651|NCT01503021|592373711|FG001|Overall Study|Death|2|||
164002652|NCT01503021|592373710|FG000|Overall Study|Lost to Follow-up|2|||
164002653|NCT01503021|592373711|FG001|Overall Study|Lost to Follow-up|0|||
164002654|NCT01503021|592373710|FG000|Overall Study|Physician Decision|3|||
164002655|NCT01503021|592373711|FG001|Overall Study|Physician Decision|0|||
164002656|NCT01503021|592373710|FG000|Overall Study|Protocol Violation|1|||
164002657|NCT01503021|592373711|FG001|Overall Study|Protocol Violation|3|||
164002658|NCT01503021|592373710|FG000|Overall Study|Withdrawal by Subject|9|||
164002659|NCT01503021|592373711|FG001|Overall Study|Withdrawal by Subject|8|||
164002660|NCT01503021|592373710|FG000|Overall Study|Moved, received transplant, etc.|5|||
164002661|NCT01503021|592373711|FG001|Overall Study|Moved, received transplant, etc.|7|||
164002662|NCT03941548|592373712|FG000|Overall Study|Adverse Event|0|||
164002663|NCT03941548|592373713|FG001|Overall Study|Adverse Event|1|||
164002664|NCT03941548|592373712|FG000|Overall Study|Lost to Follow-up|0|||
164002665|NCT03941548|592373713|FG001|Overall Study|Lost to Follow-up|1|||
164002666|NCT03941548|592373712|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
164002667|NCT03941548|592373713|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
164002668|NCT01242111|592373715|FG000|Overall Study|Adverse Event|1|||
164002669|NCT01242111|592373715|FG000|Overall Study|Withdrawal by Subject|1|||
164002670|NCT01242111|592373715|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
164002671|NCT00870688|592373716|FG000|Overall Study|Lost to Follow-up|2|||
164002672|NCT00870688|592373716|FG000|Overall Study|Death, Unrelated|1|||
164002673|NCT00870688|592373716|FG000|Overall Study|Granules in the Stools|1|||
164002674|NCT02015819|592373717|FG000|Overall Study|Rickham catheter was misaligned|0|||
164002675|NCT02015819|592373718|FG001|Overall Study|Rickham catheter was misaligned|0|||
164002676|NCT02015819|592373719|FG002|Overall Study|Rickham catheter was misaligned|0|||
164002677|NCT02015819|592373720|FG003|Overall Study|Rickham catheter was misaligned|1|||
164002678|NCT01929083|592373725|FG000|Intervention 1|Lost to Follow-up|2|||
164002679|NCT01929083|592373726|FG001|Intervention 1|Lost to Follow-up|0|||
164002680|NCT01929083|592373725|FG000|Intervention 1|Nonadherent to study medications|1|||
164002681|NCT01929083|592373726|FG001|Intervention 1|Nonadherent to study medications|0|||
164002682|NCT01929083|592373725|FG000|Intervention 2|Adverse Event|0|||
164002683|NCT01929083|592373726|FG001|Intervention 2|Adverse Event|1|||
164002684|NCT02599402|592373727|FG000|Overall Study|Disease progression|153|||
164002685|NCT02599402|592373727|FG000|Overall Study|Study drug toxicity|201|||
164282199|NCT00172042|593402599|FG001|Overall Study|Abnormal test procedure(s)|3|||
164282200|NCT00172042|593402598|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
164282201|NCT00172042|593402599|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
164002686|NCT02599402|592373727|FG000|Overall Study|Death|26|||
164282202|NCT00172042|593402598|FG000|Overall Study|Patient no longer requires study drug|10|||
164282203|NCT00172042|593402599|FG001|Overall Study|Patient no longer requires study drug|8|||
164282204|NCT00172042|593402598|FG000|Overall Study|Protocol Violation|8|||
164282205|NCT00172042|593402599|FG001|Overall Study|Protocol Violation|7|||
164282206|NCT00172042|593402598|FG000|Overall Study|Withdrawal by Subject|37|||
164282207|NCT00172042|593402599|FG001|Overall Study|Withdrawal by Subject|25|||
164282208|NCT00172042|593402598|FG000|Overall Study|Lost to Follow-up|3|||
164282209|NCT00172042|593402599|FG001|Overall Study|Lost to Follow-up|5|||
164282210|NCT00172042|593402598|FG000|Overall Study|Administrative problems|13|||
164282211|NCT00172042|593402599|FG001|Overall Study|Administrative problems|10|||
164282212|NCT00172042|593402598|FG000|Overall Study|Death|42|||
164282213|NCT00172042|593402599|FG001|Overall Study|Death|42|||
164282214|NCT00384332|593402600|FG000|Overall Study|Lost to Follow-up|4|||
164282215|NCT00384332|593402601|FG001|Overall Study|Lost to Follow-up|0|||
164002687|NCT02599402|592373727|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
164002688|NCT02599402|592373727|FG000|Overall Study|Participant request to discontinue study treatment|13|||
164002689|NCT02599402|592373727|FG000|Overall Study|Participant withdrew consent|5|||
164002690|NCT02599402|592373727|FG000|Overall Study|Lost to Follow-up|1|||
164002691|NCT02599402|592373727|FG000|Overall Study|Maximum Clinical Benefit|7|||
164002692|NCT02599402|592373727|FG000|Overall Study|Poor/non-compliance|1|||
164002693|NCT02599402|592373727|FG000|Overall Study|Pregnancy|1|||
164002694|NCT02599402|592373727|FG000|Overall Study|Participant no longer met study criteria|7|||
164002695|NCT02599402|592373727|FG000|Overall Study|Other Reasons|95|||
164002696|NCT00087438|592373734|FG000|Overall Study|Ineligible / No protocol treatment|4|||
164002697|NCT01486264|592373735|FG000|Overall Study|Death|1|||
164002698|NCT01486264|592373736|FG001|Overall Study|Death|1|||
164002699|NCT01486264|592373735|FG000|Overall Study|Adverse Event|3|||
164002700|NCT01486264|592373736|FG001|Overall Study|Adverse Event|3|||
164002701|NCT01486264|592373735|FG000|Overall Study|Lack of Efficacy|6|||
164002702|NCT01486264|592373736|FG001|Overall Study|Lack of Efficacy|10|||
164002703|NCT01486264|592373735|FG000|Overall Study|Withdrawal by Subject|7|||
164002704|NCT01486264|592373736|FG001|Overall Study|Withdrawal by Subject|18|||
164002705|NCT01486264|592373735|FG000|Overall Study|Physician Decision|1|||
164002706|NCT01486264|592373736|FG001|Overall Study|Physician Decision|1|||
164002707|NCT01486264|592373735|FG000|Overall Study|Protocol Violation|3|||
164002708|NCT01486264|592373736|FG001|Overall Study|Protocol Violation|0|||
164002709|NCT01486264|592373735|FG000|Overall Study|Lost to Follow-up|3|||
164002710|NCT01486264|592373736|FG001|Overall Study|Lost to Follow-up|2|||
164002711|NCT01486264|592373735|FG000|Overall Study|Other|5|||
164002712|NCT01486264|592373736|FG001|Overall Study|Other|11|||
164002713|NCT01486264|592373735|FG000|Overall Study|Not treated|0|||
164002714|NCT01486264|592373736|FG001|Overall Study|Not treated|1|||
164002715|NCT00283387|592373737|FG000|First Intervention|Subject non-compliant|1|||
164002716|NCT00283387|592373738|FG001|First Intervention|Subject non-compliant|1|||
164002717|NCT00283387|592373737|FG000|First Intervention|Withdrawal by Subject|0|||
164002718|NCT00283387|592373738|FG001|First Intervention|Withdrawal by Subject|1|||
164002719|NCT05340504|592373739|FG000|Overall Study|Withdrawal by Subject|1|||
164002720|NCT05340504|592373740|FG001|Overall Study|Withdrawal by Subject|0|||
164002721|NCT03068715|592373744|FG000|Overall Study|No longer met inclusion criteria|1|||
164002722|NCT03068715|592373745|FG001|Overall Study|No longer met inclusion criteria|0|||
164002723|NCT00728416|592373746|FG000|Overall Study|Adverse Event|1|||
164002724|NCT00728416|592373747|FG001|Overall Study|Adverse Event|1|||
164002725|NCT00728416|592373746|FG000|Overall Study|Treatment Failure|0|||
164002726|NCT00728416|592373747|FG001|Overall Study|Treatment Failure|1|||
164002727|NCT00728416|592373746|FG000|Overall Study|Withdrawal by Subject|1|||
164002728|NCT00728416|592373747|FG001|Overall Study|Withdrawal by Subject|0|||
164002729|NCT00117312|592373748|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
164002730|NCT00117312|592373749|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
164002731|NCT00117312|592373750|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
164002732|NCT00117312|592373751|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
164002733|NCT00117312|592373748|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
164002734|NCT00117312|592373749|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
164002735|NCT00117312|592373750|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
164002736|NCT00117312|592373751|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
164002737|NCT00117312|592373748|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
164002738|NCT00117312|592373749|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
164002739|NCT00117312|592373750|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
164002740|NCT00117312|592373751|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
164002741|NCT00117312|592373748|FG000|Overall Study|Other|0|||
164002742|NCT00117312|592373749|FG001|Overall Study|Other|1|||
164002743|NCT00117312|592373750|FG002|Overall Study|Other|3|||
164002744|NCT00117312|592373751|FG003|Overall Study|Other|1|||
164002745|NCT00117312|592373748|FG000|Overall Study|Patient choice|0|||
164002746|NCT00117312|592373749|FG001|Overall Study|Patient choice|0|||
164002747|NCT00117312|592373750|FG002|Overall Study|Patient choice|2|||
164002748|NCT00117312|592373751|FG003|Overall Study|Patient choice|1|||
164002749|NCT00117312|592373748|FG000|Overall Study|Adverse Event|0|||
164002750|NCT00117312|592373749|FG001|Overall Study|Adverse Event|2|||
164002751|NCT00117312|592373750|FG002|Overall Study|Adverse Event|0|||
164002752|NCT00117312|592373751|FG003|Overall Study|Adverse Event|0|||
164002753|NCT00117312|592373748|FG000|Overall Study|Protocol Violation|0|||
164002754|NCT00117312|592373749|FG001|Overall Study|Protocol Violation|1|||
164002755|NCT00117312|592373750|FG002|Overall Study|Protocol Violation|3|||
164002756|NCT00117312|592373751|FG003|Overall Study|Protocol Violation|0|||
164282216|NCT00375518|593402602|FG000|Overall Study|Withdrawal by Subject|2|||
164002757|NCT00117312|592373748|FG000|Overall Study|PSA decrease <=50%|0|||
164002758|NCT00117312|592373749|FG001|Overall Study|PSA decrease <=50%|2|||
164002759|NCT00117312|592373750|FG002|Overall Study|PSA decrease <=50%|2|||
164002760|NCT00117312|592373751|FG003|Overall Study|PSA decrease <=50%|4|||
164002761|NCT00117312|592373748|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
164002762|NCT00117312|592373749|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
164002763|NCT00117312|592373750|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
164002764|NCT00117312|592373751|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
164282217|NCT00375518|593402603|FG001|Overall Study|Withdrawal by Subject|10|||
164002765|NCT00117312|592373748|FG000|Overall Study|Hepatic abnormality|0|||
164002766|NCT00117312|592373749|FG001|Overall Study|Hepatic abnormality|1|||
164002767|NCT00117312|592373750|FG002|Overall Study|Hepatic abnormality|0|||
164002768|NCT00117312|592373751|FG003|Overall Study|Hepatic abnormality|1|||
164002769|NCT00117312|592373748|FG000|Overall Study|Withdrawal by Subject|0|||
164002770|NCT00117312|592373749|FG001|Overall Study|Withdrawal by Subject|2|||
164002771|NCT00117312|592373750|FG002|Overall Study|Withdrawal by Subject|0|||
164002772|NCT00117312|592373751|FG003|Overall Study|Withdrawal by Subject|0|||
164002773|NCT01120626|592373752|FG000|Overall Study|Withdrawal by Subject|1|||
164002774|NCT01120626|592373753|FG001|Overall Study|Withdrawal by Subject|0|||
164002775|NCT00509106|592373754|FG000|Overall Study|Adverse Event|3|||
164002776|NCT00509106|592373755|FG001|Overall Study|Adverse Event|2|||
164002777|NCT00509106|592373754|FG000|Overall Study|Noncompliance|0|||
164002778|NCT00509106|592373755|FG001|Overall Study|Noncompliance|1|||
164002779|NCT00509106|592373754|FG000|Overall Study|At the request of sponsor/investigator|1|||
164002780|NCT00509106|592373755|FG001|Overall Study|At the request of sponsor/investigator|2|||
164002781|NCT00509106|592373754|FG000|Overall Study|Withdrew consent|4|||
164002782|NCT00509106|592373755|FG001|Overall Study|Withdrew consent|8|||
164002783|NCT00509106|592373754|FG000|Overall Study|Lost to Follow-up|16|||
164002784|NCT00509106|592373755|FG001|Overall Study|Lost to Follow-up|10|||
164002785|NCT00509106|592373754|FG000|Overall Study|Other|1|||
164002786|NCT00509106|592373755|FG001|Overall Study|Other|0|||
164002787|NCT00509106|592373754|FG000|Overall Study|Death|6|||
164002788|NCT00509106|592373755|FG001|Overall Study|Death|6|||
164002789|NCT05089708|592373759|FG000|Overall Study|Lost to Follow-up|9|||
164002790|NCT05089708|592373760|FG001|Overall Study|Lost to Follow-up|7|||
164002791|NCT05089708|592373759|FG000|Overall Study|Withdrawal by Subject|3|||
164002792|NCT05089708|592373760|FG001|Overall Study|Withdrawal by Subject|1|||
164002793|NCT05089708|592373759|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
164002794|NCT05089708|592373760|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
164002795|NCT05089708|592373759|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
164282218|NCT00375518|593402602|FG000|Overall Study|Patient Not Treated|6|||
164282219|NCT00375518|593402603|FG001|Overall Study|Patient Not Treated|6|||
164282220|NCT00375518|593402602|FG000|Overall Study|Death|0|||
164282221|NCT00375518|593402603|FG001|Overall Study|Death|1|||
164002796|NCT05089708|592373760|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
164002797|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
164002798|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
164002799|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
164002800|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
164002801|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
164282222|NCT01771250|593402604|FG000|Period 1|Met exclusion criteria|1|||
164282223|NCT01771250|593402605|FG001|Period 1|Met exclusion criteria|0|||
164282224|NCT02058563|593402606|FG000|Overall Study|Lost to Follow-up|26|||
164282225|NCT02058563|593402607|FG001|Overall Study|Lost to Follow-up|22|||
164282226|NCT02058563|593402606|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
164282227|NCT02058563|593402607|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
164282228|NCT02058563|593402606|FG000|Overall Study|Consent Withdrawal|1|||
164282229|NCT02058563|593402607|FG001|Overall Study|Consent Withdrawal|1|||
164282230|NCT02058563|593402606|FG000|Overall Study|Other (patient incarcerated)|0|||
164282231|NCT02058563|593402607|FG001|Overall Study|Other (patient incarcerated)|1|||
164282232|NCT00166439|593402608|FG000|Overall Study|Ineligible|5|||
164282233|NCT01180296|593402609|FG000|Overall Study|Protocol Violation|1|||
164282234|NCT01180296|593402610|FG001|Overall Study|Protocol Violation|2|||
164282235|NCT02560012|593402611|FG000|Overall Study|Study Terminated|2|||
164282236|NCT00483938|593402612|FG000|Overall Study|Protocol Violation|0|||
164282237|NCT00483938|593402613|FG001|Overall Study|Protocol Violation|0|||
164282238|NCT00483938|593402614|FG002|Overall Study|Protocol Violation|0|||
164282239|NCT00483938|593402615|FG003|Overall Study|Protocol Violation|0|||
164282240|NCT00483938|593402616|FG004|Overall Study|Protocol Violation|0|||
164282241|NCT00483938|593402617|FG005|Overall Study|Protocol Violation|0|||
164282242|NCT00483938|593402618|FG006|Overall Study|Protocol Violation|3|||
164282243|NCT00483938|593402612|FG000|Overall Study|Withdrawal by Subject|1|||
164282244|NCT00483938|593402613|FG001|Overall Study|Withdrawal by Subject|6|||
164282245|NCT00483938|593402614|FG002|Overall Study|Withdrawal by Subject|0|||
164282246|NCT00483938|593402615|FG003|Overall Study|Withdrawal by Subject|0|||
164282247|NCT00483938|593402616|FG004|Overall Study|Withdrawal by Subject|1|||
164282248|NCT00483938|593402617|FG005|Overall Study|Withdrawal by Subject|3|||
164282249|NCT00483938|593402618|FG006|Overall Study|Withdrawal by Subject|2|||
164282250|NCT00483938|593402612|FG000|Overall Study|Lost to Follow-up|1|||
164282251|NCT00483938|593402613|FG001|Overall Study|Lost to Follow-up|2|||
164282252|NCT00483938|593402614|FG002|Overall Study|Lost to Follow-up|0|||
164002802|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
164002803|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Personal issues|2|||
164282253|NCT00483938|593402615|FG003|Overall Study|Lost to Follow-up|2|||
164282254|NCT00483938|593402616|FG004|Overall Study|Lost to Follow-up|1|||
164002804|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Personal issues|0|||
164282255|NCT00483938|593402617|FG005|Overall Study|Lost to Follow-up|1|||
164282256|NCT00483938|593402618|FG006|Overall Study|Lost to Follow-up|3|||
164282257|NCT00483938|593402612|FG000|Overall Study|Death|0|||
164282258|NCT00483938|593402613|FG001|Overall Study|Death|2|||
164282259|NCT00483938|593402614|FG002|Overall Study|Death|0|||
164282260|NCT00483938|593402615|FG003|Overall Study|Death|0|||
164282261|NCT00483938|593402616|FG004|Overall Study|Death|0|||
164282262|NCT00483938|593402617|FG005|Overall Study|Death|0|||
164087406|NCT04182204|592684220|FG001|Safety Run-in|Death|0|||
164087407|NCT04182204|592684221|FG002|Safety Run-in|Death|0|||
164087408|NCT04182204|592684219|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
164087409|NCT04182204|592684220|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
164087410|NCT04182204|592684221|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
164087411|NCT04182204|592684219|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
164087412|NCT04182204|592684220|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
164087413|NCT04182204|592684221|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
164282263|NCT00483938|593402618|FG006|Overall Study|Death|0|||
164282264|NCT00483938|593402612|FG000|Overall Study|Other|3|||
164282265|NCT00483938|593402613|FG001|Overall Study|Other|9|||
164282266|NCT00483938|593402614|FG002|Overall Study|Other|0|||
164282267|NCT00483938|593402615|FG003|Overall Study|Other|4|||
164282268|NCT00483938|593402616|FG004|Overall Study|Other|0|||
164282269|NCT00483938|593402617|FG005|Overall Study|Other|4|||
164282270|NCT00483938|593402618|FG006|Overall Study|Other|32|||
164282271|NCT03052816|593402619|FG000|Overall Study|Withdrawal by Subject|1|||
164282272|NCT03052816|593402620|FG001|Overall Study|Withdrawal by Subject|0|||
164282273|NCT03052816|593402619|FG000|Overall Study|Desired opioids|2|||
164282274|NCT03052816|593402620|FG001|Overall Study|Desired opioids|0|||
164282275|NCT00264537|593402631|FG000|Overall Study|Death|0|||
164282276|NCT00264537|593402632|FG001|Overall Study|Death|3|||
164282277|NCT00264537|593402633|FG002|Overall Study|Death|3|||
164282278|NCT00264537|593402634|FG003|Overall Study|Death|2|||
164282279|NCT00264537|593402631|FG000|Overall Study|Lost to Follow-up|3|||
164282280|NCT00264537|593402632|FG001|Overall Study|Lost to Follow-up|4|||
164282281|NCT00264537|593402633|FG002|Overall Study|Lost to Follow-up|7|||
164282282|NCT00264537|593402634|FG003|Overall Study|Lost to Follow-up|6|||
164282283|NCT00264537|593402631|FG000|Overall Study|Adverse Event|21|||
164087414|NCT04182204|592684219|FG000|Randomized Controlled Trial|Death|0|||
164282284|NCT00264537|593402632|FG001|Overall Study|Adverse Event|32|||
164282285|NCT00264537|593402633|FG002|Overall Study|Adverse Event|24|||
164282286|NCT00264537|593402634|FG003|Overall Study|Adverse Event|34|||
164282287|NCT00264537|593402631|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164344536|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
163896921|NCT03142009|591997083|FG001|Overall Study|Lost to Follow-up|30|||
163896922|NCT03587805|591997085|FG000|Overall Study|Adverse Event|72|||
163896923|NCT03587805|591997085|FG000|Overall Study|Death|1|||
163896924|NCT03587805|591997085|FG000|Overall Study|Lost to Follow-up|78|||
163896925|NCT03587805|591997085|FG000|Overall Study|Withdrawal by Subject|105|||
163896926|NCT03587805|591997085|FG000|Overall Study|Lack of Efficacy|119|||
163896927|NCT03587805|591997085|FG000|Overall Study|Reason unknown|26|||
163896928|NCT03587805|591997085|FG000|Overall Study|COVID_19 pandemic|4|||
163896929|NCT03587805|591997085|FG000|Overall Study|Various reasons|121|||
163896930|NCT03587805|591997085|FG000|Overall Study|Withdrawal by parent/guardian|3|||
163896931|NCT03982186|591997086|FG000|Overall Study|Lost to Follow-up|0|||
163896932|NCT03982186|591997087|FG001|Overall Study|Lost to Follow-up|1|||
163896933|NCT03982186|591997088|FG002|Overall Study|Lost to Follow-up|2|||
163896934|NCT03982186|591997089|FG003|Overall Study|Lost to Follow-up|1|||
163896935|NCT03982186|591997090|FG004|Overall Study|Lost to Follow-up|1|||
163896936|NCT03982186|591997091|FG005|Overall Study|Lost to Follow-up|0|||
163896937|NCT03982186|591997086|FG000|Overall Study|Physician Decision|0|||
163896938|NCT03982186|591997087|FG001|Overall Study|Physician Decision|1|||
163896939|NCT03982186|591997088|FG002|Overall Study|Physician Decision|0|||
163896940|NCT03982186|591997089|FG003|Overall Study|Physician Decision|0|||
163896941|NCT03982186|591997090|FG004|Overall Study|Physician Decision|0|||
163896942|NCT03982186|591997091|FG005|Overall Study|Physician Decision|0|||
163896943|NCT03982186|591997086|FG000|Overall Study|Withdrawal by Subject|3|||
163896944|NCT03982186|591997087|FG001|Overall Study|Withdrawal by Subject|4|||
163896945|NCT03982186|591997088|FG002|Overall Study|Withdrawal by Subject|1|||
163896946|NCT03982186|591997089|FG003|Overall Study|Withdrawal by Subject|7|||
163896947|NCT03982186|591997090|FG004|Overall Study|Withdrawal by Subject|2|||
163896948|NCT03982186|591997091|FG005|Overall Study|Withdrawal by Subject|0|||
163896949|NCT03982186|591997086|FG000|Overall Study|Randomized and not treated|0|||
163896950|NCT03982186|591997087|FG001|Overall Study|Randomized and not treated|0|||
163896951|NCT03982186|591997088|FG002|Overall Study|Randomized and not treated|0|||
163896952|NCT03982186|591997089|FG003|Overall Study|Randomized and not treated|1|||
163896953|NCT03982186|591997090|FG004|Overall Study|Randomized and not treated|0|||
163896954|NCT03982186|591997091|FG005|Overall Study|Randomized and not treated|0|||
163896955|NCT03008382|591997093|FG000|Overall Study|Withdrawal by Subject|2|||
163896956|NCT03008382|591997094|FG001|Overall Study|Withdrawal by Subject|5|||
163896957|NCT03008382|591997095|FG002|Overall Study|Withdrawal by Subject|2|||
163896958|NCT03008382|591997096|FG003|Overall Study|Withdrawal by Subject|0|||
163896959|NCT03008382|591997093|FG000|Overall Study|Protocol Violation|1|||
163896960|NCT03008382|591997094|FG001|Overall Study|Protocol Violation|0|||
163896961|NCT03008382|591997095|FG002|Overall Study|Protocol Violation|0|||
164087415|NCT04182204|592684220|FG001|Randomized Controlled Trial|Death|83|||
164282288|NCT00264537|593402632|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164282289|NCT00264537|593402633|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
164282290|NCT00264537|593402634|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
164282291|NCT00264537|593402631|FG000|Overall Study|Other|21|||
164282292|NCT00264537|593402632|FG001|Overall Study|Other|11|||
164282293|NCT00264537|593402633|FG002|Overall Study|Other|10|||
164282294|NCT00264537|593402634|FG003|Overall Study|Other|11|||
164282295|NCT00264537|593402631|FG000|Overall Study|Not treated|0|||
164282296|NCT00264537|593402632|FG001|Overall Study|Not treated|2|||
164282297|NCT00264537|593402633|FG002|Overall Study|Not treated|1|||
164282298|NCT00264537|593402634|FG003|Overall Study|Not treated|0|||
164282299|NCT00447226|593404354|FG000|12-Week Open-label Phase|Adverse Event|0|||
164282300|NCT00447226|593404355|FG001|12-Week Open-label Phase|Adverse Event|3|||
164282301|NCT00447226|593404354|FG000|12-Week Open-label Phase|Protocol Violation|0|||
164282302|NCT00447226|593404355|FG001|12-Week Open-label Phase|Protocol Violation|1|||
164282303|NCT00447226|593404354|FG000|12-Week Open-label Phase|Disease Progression|0|||
164282304|NCT00447226|593404355|FG001|12-Week Open-label Phase|Disease Progression|20|||
164282305|NCT00447226|593404354|FG000|12-Week Open-label Phase|Physician Decision|0|||
164282306|NCT00447226|593404355|FG001|12-Week Open-label Phase|Physician Decision|1|||
164282307|NCT00447226|593404354|FG000|Double-blind Phase|Disease Progression|4|||
164282308|NCT00447226|593404355|FG001|Double-blind Phase|Disease Progression|3|||
164282309|NCT03449758|593404356|FG000|Overall Study|Major protocol deviation|1|||
164282310|NCT03449758|593404356|FG000|Overall Study|Treatment inefficacy|5|||
164282311|NCT03449758|593404356|FG000|Overall Study|Adverse Event|9|||
164282312|NCT03449758|593404356|FG000|Overall Study|Consent withdrawal|1|||
164282313|NCT03449758|593404356|FG000|Overall Study|Other unspecified reason|3|||
164282314|NCT00584012|593404359|FG000|Overall Study|Withdrawal by Subject|1|||
164282315|NCT03937713|593404362|FG000|Overall Study|Withdrawal by Subject|3|||
164282316|NCT03937713|593404363|FG001|Overall Study|Withdrawal by Subject|6|||
164282317|NCT03937713|593404362|FG000|Overall Study|Lost to Follow-up|1|||
164282318|NCT03937713|593404363|FG001|Overall Study|Lost to Follow-up|0|||
164282319|NCT02871635|593404364|FG000|Overall Study|Primary lack of efficacy|4|||
164282320|NCT02871635|593404365|FG001|Overall Study|Primary lack of efficacy|4|||
164282321|NCT02871635|593404364|FG000|Overall Study|Protocol Violation|3|||
164282322|NCT02871635|593404365|FG001|Overall Study|Protocol Violation|1|||
164282323|NCT02871635|593404364|FG000|Overall Study|Lost to Follow-up|1|||
164282324|NCT02871635|593404365|FG001|Overall Study|Lost to Follow-up|2|||
164282325|NCT02871635|593404364|FG000|Overall Study|Pregnancy|0|||
164344537|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
164344538|NCT02197247|593636971|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
163896962|NCT03008382|591997096|FG003|Overall Study|Protocol Violation|0|||
163896963|NCT03008382|591997093|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
163896964|NCT03008382|591997094|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
163896965|NCT03008382|591997095|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
163896966|NCT03008382|591997096|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
163896967|NCT03008382|591997093|FG000|Overall Study|Lost to Follow-up|0|||
163896968|NCT03008382|591997094|FG001|Overall Study|Lost to Follow-up|0|||
163896969|NCT03008382|591997095|FG002|Overall Study|Lost to Follow-up|1|||
163896970|NCT03008382|591997096|FG003|Overall Study|Lost to Follow-up|0|||
163896971|NCT03008382|591997093|FG000|Overall Study|Screenfail|0|||
163896972|NCT03008382|591997094|FG001|Overall Study|Screenfail|0|||
163896973|NCT03008382|591997095|FG002|Overall Study|Screenfail|2|||
163896974|NCT03008382|591997096|FG003|Overall Study|Screenfail|0|||
163896975|NCT04039113|591997099|FG000|Overall Study|Withdrawal by Subject|8|||
163896976|NCT04039113|591997100|FG001|Overall Study|Withdrawal by Subject|11|||
163896977|NCT04039113|591997099|FG000|Overall Study|Lost to Follow-up|1|||
163896978|NCT04039113|591997100|FG001|Overall Study|Lost to Follow-up|1|||
163896979|NCT04039113|591997099|FG000|Overall Study|Adverse Event|2|||
163896980|NCT04039113|591997100|FG001|Overall Study|Adverse Event|2|||
163896981|NCT04039113|591997099|FG000|Overall Study|Death|2|||
163896982|NCT04039113|591997100|FG001|Overall Study|Death|4|||
163896983|NCT04039113|591997099|FG000|Overall Study|Site Closure|6|||
163896984|NCT04039113|591997100|FG001|Overall Study|Site Closure|0|||
163896985|NCT04039113|591997099|FG000|Overall Study|Failure to meet randomisation criteria|4|||
163896986|NCT04039113|591997100|FG001|Overall Study|Failure to meet randomisation criteria|0|||
163896987|NCT00353496|591997101|FG000|Overall Study|Adverse Event|1|||
163896988|NCT00353496|591997102|FG001|Overall Study|Adverse Event|0|||
163896989|NCT00353496|591997101|FG000|Overall Study|Protocol Violation|2|||
163896990|NCT00353496|591997102|FG001|Overall Study|Protocol Violation|2|||
163896991|NCT00353496|591997101|FG000|Overall Study|Withdrawal by Subject|3|||
163896992|NCT00353496|591997102|FG001|Overall Study|Withdrawal by Subject|4|||
164002805|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Personal issues|0|||
164282326|NCT02871635|593404365|FG001|Overall Study|Pregnancy|2|||
164282327|NCT02871635|593404364|FG000|Overall Study|Physician Decision|1|||
164282328|NCT02871635|593404365|FG001|Overall Study|Physician Decision|1|||
164282329|NCT02871635|593404364|FG000|Overall Study|Withdrawal by Subject|3|||
164282330|NCT02871635|593404365|FG001|Overall Study|Withdrawal by Subject|4|||
164282331|NCT02871635|593404364|FG000|Overall Study|Adverse Event|4|||
164282332|NCT02871635|593404365|FG001|Overall Study|Adverse Event|4|||
164282333|NCT02871635|593404364|FG000|Overall Study|Secondary lack of efficacy|2|||
164282334|NCT02871635|593404365|FG001|Overall Study|Secondary lack of efficacy|1|||
164282335|NCT02420379|593404366|FG000|Overall Study|Withdrawal by Subject|0|||
164282336|NCT02420379|593404367|FG001|Overall Study|Withdrawal by Subject|3|||
164282337|NCT02420379|593404366|FG000|Overall Study|Unable to complete due to schooling|0|||
164282338|NCT02420379|593404367|FG001|Overall Study|Unable to complete due to schooling|1|||
164002806|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Too busy|7|||
164002807|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Too busy|1|||
164002808|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Too busy|0|||
164002809|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Pain|2|||
164002810|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Pain|0|||
164002811|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Pain|0|||
164002812|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Moved|1|||
164002813|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Moved|0|||
164002814|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Moved|0|||
164002815|NCT00594399|592373762|FG000|Initial 3 Month Counseling|Family illness|1|||
164002816|NCT00594399|592373763|FG001|Initial 3 Month Counseling|Family illness|0|||
164002817|NCT00594399|592373764|FG002|Initial 3 Month Counseling|Family illness|0|||
164002818|NCT00594399|592373762|FG000|Rerandomization Arm 1 Only|Death|2|||
164002819|NCT00594399|592373763|FG001|Rerandomization Arm 1 Only|Death|1|||
164002820|NCT00594399|592373764|FG002|Rerandomization Arm 1 Only|Death|0|||
164002821|NCT00594399|592373762|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
164002822|NCT00594399|592373763|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
164002823|NCT00594399|592373764|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
164002824|NCT03293680|592373765|FG000|Overall Study|Death|1|||
164002825|NCT03293680|592373765|FG000|Overall Study|Did not meet inclusion criteria|8|||
164002826|NCT02853760|592373773|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
164002827|NCT02853760|592373774|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
164002828|NCT02853760|592373775|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
164002829|NCT02853760|592373776|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
164002830|NCT02853760|592373777|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
164002831|NCT02853760|592373778|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
164002832|NCT00488631|592373779|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
164002833|NCT00488631|592373780|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
164002834|NCT00488631|592373781|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
164002835|NCT00488631|592373782|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
164002836|NCT00488631|592373783|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
164002837|NCT00488631|592373784|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
164002838|NCT00488631|592373785|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
164002839|NCT00488631|592373786|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
164282339|NCT02420379|593404366|FG000|Overall Study|Transitioned to commercial drug|1|||
163896993|NCT00353496|591997101|FG000|Overall Study|Physician Decision|6|||
163896994|NCT00353496|591997102|FG001|Overall Study|Physician Decision|9|||
163896995|NCT00353496|591997101|FG000|Overall Study|Not otherwise specified|4|||
163896996|NCT00353496|591997102|FG001|Overall Study|Not otherwise specified|2|||
163896997|NCT02180867|591997103|FG000|Overall Study|Adverse Event|3|||
163896998|NCT02180867|591997104|FG001|Overall Study|Adverse Event|4|||
163896999|NCT02180867|591997105|FG002|Overall Study|Adverse Event|1|||
163897000|NCT02180867|591997106|FG003|Overall Study|Adverse Event|5|||
163897001|NCT02180867|591997107|FG004|Overall Study|Adverse Event|0|||
163897002|NCT02180867|591997108|FG005|Overall Study|Adverse Event|0|||
163897003|NCT02180867|591997109|FG006|Overall Study|Adverse Event|0|||
163897004|NCT02180867|591997103|FG000|Overall Study|Death|0|||
163897005|NCT02180867|591997104|FG001|Overall Study|Death|0|||
163897006|NCT02180867|591997105|FG002|Overall Study|Death|0|||
163897007|NCT02180867|591997106|FG003|Overall Study|Death|0|||
163897008|NCT02180867|591997107|FG004|Overall Study|Death|1|||
163897009|NCT02180867|591997108|FG005|Overall Study|Death|0|||
163897010|NCT02180867|591997109|FG006|Overall Study|Death|0|||
163897011|NCT02180867|591997103|FG000|Overall Study|Lack of Efficacy|0|||
164002840|NCT00488631|592373787|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
163897012|NCT02180867|591997104|FG001|Overall Study|Lack of Efficacy|2|||
164002841|NCT00488631|592373788|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
164002842|NCT00488631|592373779|FG000|Double Blind Period (Week 0-54)|Death|0|||
164282340|NCT02420379|593404367|FG001|Overall Study|Transitioned to commercial drug|0|||
164282341|NCT01402817|593404368|FG000|Overall Study|Withdrawal by Subject|3|||
164282342|NCT01402817|593404368|FG000|Overall Study|Study Suspended by FDA|8|||
164282343|NCT00502671|593404369|FG000|Overall Study|Disease Progression|13|||
164282344|NCT00502671|593404369|FG000|Overall Study|Personal Reasons|22|||
164282345|NCT00502671|593404369|FG000|Overall Study|Lost to Follow-up|7|||
164282346|NCT00502671|593404369|FG000|Overall Study|Protocol Violation|16|||
164282347|NCT00502671|593404369|FG000|Overall Study|Adverse Event|19|||
164282348|NCT00681629|593404376|FG000|Overall Study|Study termination|4|||
164282349|NCT00681629|593404377|FG001|Overall Study|Study termination|2|||
164282350|NCT00681629|593404376|FG000|Overall Study|Adverse Event|1|||
164002843|NCT00488631|592373780|FG001|Double Blind Period (Week 0-54)|Death|0|||
164002844|NCT00488631|592373781|FG002|Double Blind Period (Week 0-54)|Death|0|||
164002845|NCT00488631|592373782|FG003|Double Blind Period (Week 0-54)|Death|0|||
164002846|NCT00488631|592373783|FG004|Double Blind Period (Week 0-54)|Death|0|||
164002847|NCT00488631|592373784|FG005|Double Blind Period (Week 0-54)|Death|1|||
164002848|NCT00488631|592373785|FG006|Double Blind Period (Week 0-54)|Death|0|||
164002849|NCT00488631|592373786|FG007|Double Blind Period (Week 0-54)|Death|0|||
164002850|NCT00488631|592373787|FG008|Double Blind Period (Week 0-54)|Death|0|||
164002851|NCT00488631|592373788|FG009|Double Blind Period (Week 0-54)|Death|0|||
164002852|NCT00488631|592373779|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
164002853|NCT00488631|592373780|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
164002854|NCT00488631|592373781|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
164002855|NCT00488631|592373782|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
164002856|NCT00488631|592373783|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
164002857|NCT00488631|592373784|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
164002858|NCT00488631|592373785|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164002859|NCT00488631|592373786|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164002860|NCT00488631|592373787|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164002861|NCT00488631|592373788|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
164002862|NCT00488631|592373779|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
164002863|NCT00488631|592373780|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
164002864|NCT00488631|592373781|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
164002865|NCT00488631|592373782|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164282351|NCT00681629|593404377|FG001|Overall Study|Adverse Event|0|||
164282352|NCT01410890|593404379|FG000|Overall Study|Withdrawal by Subject|0|||
164282353|NCT01410890|593404380|FG001|Overall Study|Withdrawal by Subject|1|||
164282354|NCT00412893|593404381|FG000|Overall Study|Adverse Event|31|||
164282355|NCT00412893|593404382|FG001|Overall Study|Adverse Event|53|||
164282356|NCT00412893|593404381|FG000|Overall Study|Death|17|||
164282357|NCT00412893|593404382|FG001|Overall Study|Death|21|||
164282358|NCT00412893|593404381|FG000|Overall Study|Insufficient Therapeutic Response|39|||
164282359|NCT00412893|593404382|FG001|Overall Study|Insufficient Therapeutic Response|23|||
164282360|NCT00412893|593404381|FG000|Overall Study|Lost to Follow-up|2|||
164282361|NCT00412893|593404382|FG001|Overall Study|Lost to Follow-up|1|||
164282362|NCT00412893|593404381|FG000|Overall Study|Violation of Selection at Entry|17|||
164282363|NCT00412893|593404382|FG001|Overall Study|Violation of Selection at Entry|10|||
164282364|NCT00412893|593404381|FG000|Overall Study|Other Protocol Violation|10|||
164282365|NCT00412893|593404382|FG001|Overall Study|Other Protocol Violation|6|||
164282366|NCT00412893|593404381|FG000|Overall Study|Did Not Cooperate|12|||
164282367|NCT00412893|593404382|FG001|Overall Study|Did Not Cooperate|9|||
164282368|NCT00412893|593404381|FG000|Overall Study|Administrative Reason|12|||
164282369|NCT00412893|593404382|FG001|Overall Study|Administrative Reason|15|||
164282370|NCT00412893|593404381|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
164282371|NCT00412893|593404382|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
164282372|NCT02305238|593404385|FG000|Overall Study|Death|2|||
164282373|NCT02305238|593404386|FG001|Overall Study|Death|1|||
164282374|NCT02305238|593404387|FG002|Overall Study|Death|0|||
164282375|NCT02305238|593404385|FG000|Overall Study|Progressive disease|4|||
164282376|NCT02305238|593404386|FG001|Overall Study|Progressive disease|4|||
164002866|NCT00488631|592373783|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
164282377|NCT02305238|593404387|FG002|Overall Study|Progressive disease|0|||
164282378|NCT02305238|593404385|FG000|Overall Study|Logistical difficulties|1|||
164282379|NCT02305238|593404386|FG001|Overall Study|Logistical difficulties|3|||
164282380|NCT02305238|593404387|FG002|Overall Study|Logistical difficulties|0|||
164282381|NCT02305238|593404385|FG000|Overall Study|Protocol Violation|0|||
164282382|NCT02305238|593404386|FG001|Overall Study|Protocol Violation|3|||
164282383|NCT02305238|593404387|FG002|Overall Study|Protocol Violation|0|||
164282384|NCT02305238|593404385|FG000|Overall Study|Physician Decision|2|||
164282385|NCT02305238|593404386|FG001|Overall Study|Physician Decision|1|||
164282386|NCT02305238|593404387|FG002|Overall Study|Physician Decision|0|||
164282387|NCT02305238|593404385|FG000|Overall Study|Adverse Event|4|||
164282388|NCT02305238|593404386|FG001|Overall Study|Adverse Event|2|||
164282389|NCT02305238|593404387|FG002|Overall Study|Adverse Event|0|||
164282390|NCT02305238|593404385|FG000|Overall Study|Withdrawal by Subject|3|||
164282391|NCT02305238|593404386|FG001|Overall Study|Withdrawal by Subject|4|||
164282392|NCT02305238|593404387|FG002|Overall Study|Withdrawal by Subject|0|||
164282393|NCT02305238|593404385|FG000|Overall Study|Randomized failure|0|||
164282394|NCT02305238|593404386|FG001|Overall Study|Randomized failure|0|||
164282395|NCT02305238|593404387|FG002|Overall Study|Randomized failure|8|||
164282396|NCT02305238|593404385|FG000|Overall Study|Required procedure failed|0|||
164282397|NCT02305238|593404386|FG001|Overall Study|Required procedure failed|1|||
164282398|NCT02305238|593404387|FG002|Overall Study|Required procedure failed|0|||
164282399|NCT01746173|593404388|FG000|Overall Study|Disease Progression|2|||
164282400|NCT02218008|593404393|FG000|Stage 1 (S1)|Adverse Event|6|||
164282401|NCT02218008|593404394|FG001|Stage 1 (S1)|Adverse Event|5|||
164282402|NCT02218008|593404395|FG002|Stage 1 (S1)|Adverse Event|11|||
164282403|NCT02218008|593404396|FG003|Stage 1 (S1)|Adverse Event|0|||
164282404|NCT02218008|593404397|FG004|Stage 1 (S1)|Adverse Event|0|||
164282405|NCT02218008|593404398|FG005|Stage 1 (S1)|Adverse Event|0|||
164282406|NCT02218008|593404393|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
164282407|NCT02218008|593404394|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
164002867|NCT00488631|592373784|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
164002868|NCT00488631|592373785|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164002869|NCT00488631|592373786|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164002870|NCT00488631|592373787|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164002871|NCT00488631|592373788|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
164002872|NCT00488631|592373779|FG000|Double Blind Period (Week 0-54)|Other|6|||
164002873|NCT00488631|592373780|FG001|Double Blind Period (Week 0-54)|Other|12|||
164282408|NCT02218008|593404395|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
164282409|NCT02218008|593404396|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
164282410|NCT02218008|593404397|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
164282411|NCT02218008|593404398|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
164282412|NCT02218008|593404393|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
164282413|NCT02218008|593404394|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
164282414|NCT02218008|593404395|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
164282415|NCT02218008|593404396|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
164282416|NCT02218008|593404397|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
164282417|NCT02218008|593404398|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
164282418|NCT02218008|593404393|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
164282419|NCT02218008|593404394|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
164282420|NCT02218008|593404395|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
164282421|NCT02218008|593404396|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
164282422|NCT02218008|593404397|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
164282423|NCT02218008|593404398|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
164282424|NCT02218008|593404393|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
164282425|NCT02218008|593404394|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
164282426|NCT02218008|593404395|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282427|NCT02218008|593404396|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282428|NCT02218008|593404397|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282429|NCT02218008|593404398|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
164282430|NCT02218008|593404393|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
164282431|NCT02218008|593404394|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
164282432|NCT02218008|593404395|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
164282433|NCT02218008|593404396|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
164282434|NCT02218008|593404397|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
164282435|NCT02218008|593404398|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
164282436|NCT02218008|593404393|FG000|Stage 1 (S1)|Pregnancy|0|||
164002874|NCT00488631|592373781|FG002|Double Blind Period (Week 0-54)|Other|10|||
164002875|NCT00488631|592373782|FG003|Double Blind Period (Week 0-54)|Other|11|||
164002876|NCT00488631|592373783|FG004|Double Blind Period (Week 0-54)|Other|14|||
164002877|NCT00488631|592373784|FG005|Double Blind Period (Week 0-54)|Other|34|||
164002878|NCT00488631|592373785|FG006|Double Blind Period (Week 0-54)|Other|0|||
164282437|NCT02218008|593404394|FG001|Stage 1 (S1)|Pregnancy|0|||
164282438|NCT02218008|593404395|FG002|Stage 1 (S1)|Pregnancy|1|||
164282439|NCT02218008|593404396|FG003|Stage 1 (S1)|Pregnancy|0|||
164282440|NCT02218008|593404397|FG004|Stage 1 (S1)|Pregnancy|0|||
164282441|NCT02218008|593404398|FG005|Stage 1 (S1)|Pregnancy|0|||
164282442|NCT02218008|593404393|FG000|Stage 1 (S1)|Protocol Violation|0|||
164282443|NCT02218008|593404394|FG001|Stage 1 (S1)|Protocol Violation|0|||
164282444|NCT02218008|593404395|FG002|Stage 1 (S1)|Protocol Violation|1|||
164282445|NCT02218008|593404396|FG003|Stage 1 (S1)|Protocol Violation|0|||
164282446|NCT02218008|593404397|FG004|Stage 1 (S1)|Protocol Violation|0|||
164282447|NCT02218008|593404398|FG005|Stage 1 (S1)|Protocol Violation|0|||
164002879|NCT00488631|592373786|FG007|Double Blind Period (Week 0-54)|Other|0|||
164282448|NCT02218008|593404393|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
164282449|NCT02218008|593404394|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282450|NCT02218008|593404395|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282451|NCT02218008|593404396|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164087416|NCT04182204|592684221|FG002|Randomized Controlled Trial|Death|66|||
164087417|NCT03933202|592684222|FG000|Overall Study|Participant withdrawn by Principal Investigator|1|||
164087418|NCT03933202|592684223|FG001|Overall Study|Participant withdrawn by Principal Investigator|0|||
164087419|NCT03933202|592684222|FG000|Overall Study|Participant transferred care|1|||
164087420|NCT03933202|592684223|FG001|Overall Study|Participant transferred care|0|||
164087421|NCT03933202|592684222|FG000|Overall Study|Site research department closing|1|||
164087422|NCT03933202|592684223|FG001|Overall Study|Site research department closing|0|||
164087423|NCT03933202|592684222|FG000|Overall Study|Site closed prematurely due to unexpected circumstances|0|||
164087424|NCT03933202|592684223|FG001|Overall Study|Site closed prematurely due to unexpected circumstances|1|||
164087425|NCT03933202|592684222|FG000|Overall Study|Participant discontinuation due to Sponsor decision to close study|0|||
164087426|NCT03933202|592684223|FG001|Overall Study|Participant discontinuation due to Sponsor decision to close study|2|||
164087427|NCT03933202|592684222|FG000|Overall Study|Participant changed primary neurology provider|1|||
164282452|NCT02218008|593404397|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282453|NCT02218008|593404398|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
164282454|NCT02218008|593404393|FG000|Stage 2 (S2)|Adverse Event|0|||
164282455|NCT02218008|593404394|FG001|Stage 2 (S2)|Adverse Event|0|||
164282456|NCT02218008|593404395|FG002|Stage 2 (S2)|Adverse Event|0|||
164282457|NCT02218008|593404396|FG003|Stage 2 (S2)|Adverse Event|2|||
164282458|NCT02218008|593404397|FG004|Stage 2 (S2)|Adverse Event|3|||
164282459|NCT02218008|593404398|FG005|Stage 2 (S2)|Adverse Event|3|||
164282460|NCT02218008|593404393|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
164282461|NCT02218008|593404394|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
164282462|NCT02218008|593404395|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
164282463|NCT02218008|593404396|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
164282464|NCT02218008|593404397|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
164282465|NCT02218008|593404398|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
164282466|NCT02218008|593404393|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
164282467|NCT02218008|593404394|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
164282468|NCT02218008|593404395|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
164282469|NCT02218008|593404396|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
164282470|NCT02218008|593404397|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
164282471|NCT02218008|593404398|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
164282472|NCT02218008|593404393|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282473|NCT02218008|593404394|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282474|NCT02218008|593404395|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282475|NCT02218008|593404396|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
163897013|NCT02180867|591997105|FG002|Overall Study|Lack of Efficacy|0|||
163897014|NCT02180867|591997106|FG003|Overall Study|Lack of Efficacy|1|||
163897015|NCT02180867|591997107|FG004|Overall Study|Lack of Efficacy|6|||
164087428|NCT03933202|592684223|FG001|Overall Study|Participant changed primary neurology provider|0|||
164282476|NCT02218008|593404397|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
164282477|NCT02218008|593404398|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
163897016|NCT02180867|591997108|FG005|Overall Study|Lack of Efficacy|0|||
163897017|NCT02180867|591997109|FG006|Overall Study|Lack of Efficacy|1|||
163897018|NCT02180867|591997103|FG000|Overall Study|Physician Decision|1|||
163897019|NCT02180867|591997104|FG001|Overall Study|Physician Decision|3|||
163897020|NCT02180867|591997105|FG002|Overall Study|Physician Decision|1|||
163897021|NCT02180867|591997106|FG003|Overall Study|Physician Decision|10|||
163897022|NCT02180867|591997107|FG004|Overall Study|Physician Decision|9|||
163897023|NCT02180867|591997108|FG005|Overall Study|Physician Decision|3|||
163897024|NCT02180867|591997109|FG006|Overall Study|Physician Decision|4|||
163897025|NCT02180867|591997103|FG000|Overall Study|Withdrawal by Subject|0|||
163897026|NCT02180867|591997104|FG001|Overall Study|Withdrawal by Subject|0|||
163897027|NCT02180867|591997105|FG002|Overall Study|Withdrawal by Subject|0|||
163897028|NCT02180867|591997106|FG003|Overall Study|Withdrawal by Subject|1|||
163897029|NCT02180867|591997107|FG004|Overall Study|Withdrawal by Subject|1|||
163897030|NCT02180867|591997108|FG005|Overall Study|Withdrawal by Subject|0|||
163897031|NCT02180867|591997109|FG006|Overall Study|Withdrawal by Subject|0|||
163897032|NCT02180867|591997103|FG000|Overall Study|Ineligible|1|||
163897033|NCT02180867|591997104|FG001|Overall Study|Ineligible|2|||
163897034|NCT02180867|591997105|FG002|Overall Study|Ineligible|0|||
163897035|NCT02180867|591997106|FG003|Overall Study|Ineligible|3|||
163897036|NCT02180867|591997107|FG004|Overall Study|Ineligible|5|||
163897037|NCT02180867|591997108|FG005|Overall Study|Ineligible|0|||
163897038|NCT02180867|591997109|FG006|Overall Study|Ineligible|0|||
163897039|NCT02180867|591997103|FG000|Overall Study|Repeat Eligibility Studies|0|||
163897040|NCT02180867|591997104|FG001|Overall Study|Repeat Eligibility Studies|0|||
163897041|NCT02180867|591997105|FG002|Overall Study|Repeat Eligibility Studies|0|||
163897042|NCT02180867|591997106|FG003|Overall Study|Repeat Eligibility Studies|0|||
163897043|NCT02180867|591997107|FG004|Overall Study|Repeat Eligibility Studies|1|||
163897044|NCT02180867|591997108|FG005|Overall Study|Repeat Eligibility Studies|0|||
163897045|NCT02180867|591997109|FG006|Overall Study|Repeat Eligibility Studies|0|||
163897046|NCT02180867|591997103|FG000|Overall Study|Refusal of further protocol therapy|1|||
164282478|NCT02218008|593404393|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
164282479|NCT02218008|593404394|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
163897047|NCT02180867|591997104|FG001|Overall Study|Refusal of further protocol therapy|0|||
163897048|NCT02180867|591997105|FG002|Overall Study|Refusal of further protocol therapy|2|||
163897049|NCT02180867|591997106|FG003|Overall Study|Refusal of further protocol therapy|6|||
163897050|NCT02180867|591997107|FG004|Overall Study|Refusal of further protocol therapy|4|||
163897051|NCT02180867|591997108|FG005|Overall Study|Refusal of further protocol therapy|0|||
163897052|NCT02180867|591997109|FG006|Overall Study|Refusal of further protocol therapy|0|||
163897053|NCT05267639|591997827|FG000|Overall Study|Withdrawal by Subject|1|||
163897054|NCT05267639|591997828|FG001|Overall Study|Withdrawal by Subject|0|||
163897055|NCT04732871|591997829|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
163897056|NCT04732871|591997830|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
163897057|NCT04732871|591997831|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
163897058|NCT04732871|591997829|FG000|Overall Study|Lost to Follow-up|7|||
163897059|NCT04732871|591997830|FG001|Overall Study|Lost to Follow-up|4|||
163897060|NCT04732871|591997831|FG002|Overall Study|Lost to Follow-up|3|||
163897061|NCT04732871|591997829|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
163897062|NCT04732871|591997830|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
163897063|NCT04732871|591997831|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
163897064|NCT04732871|591997829|FG000|Overall Study|Migrated / moved from the study area|5|||
163897065|NCT04732871|591997830|FG001|Overall Study|Migrated / moved from the study area|0|||
163897066|NCT04732871|591997831|FG002|Overall Study|Migrated / moved from the study area|0|||
163897067|NCT04732871|591997829|FG000|Overall Study|Other|1|||
163897068|NCT04732871|591997830|FG001|Overall Study|Other|0|||
163897069|NCT04732871|591997831|FG002|Overall Study|Other|1|||
163897070|NCT04732871|591997829|FG000|Overall Study|Ongoing|6|||
163897071|NCT04732871|591997830|FG001|Overall Study|Ongoing|0|||
163897072|NCT04732871|591997831|FG002|Overall Study|Ongoing|1|||
163897073|NCT04732871|591997829|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
163897074|NCT04732871|591997830|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
163897075|NCT04732871|591997831|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
163897076|NCT05180539|591997837|FG000|Overall Study|Lost to Follow-up|27|||
163897077|NCT05180539|591997838|FG001|Overall Study|Lost to Follow-up|30|||
163897078|NCT00968149|591997839|FG000|Overall Study|Adverse Event|5|||
163897079|NCT00968149|591997840|FG001|Overall Study|Adverse Event|1|||
163897080|NCT00968149|591997839|FG000|Overall Study|Lack of Efficacy|0|||
163897081|NCT00968149|591997840|FG001|Overall Study|Lack of Efficacy|4|||
163897082|NCT00968149|591997839|FG000|Overall Study|Lost to Follow-up|0|||
163897083|NCT00968149|591997840|FG001|Overall Study|Lost to Follow-up|1|||
164002880|NCT00488631|592373787|FG008|Double Blind Period (Week 0-54)|Other|0|||
164002881|NCT00488631|592373788|FG009|Double Blind Period (Week 0-54)|Other|0|||
164002882|NCT00488631|592373779|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002883|NCT00488631|592373780|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002884|NCT00488631|592373781|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002885|NCT00488631|592373782|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002886|NCT00488631|592373783|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002887|NCT00488631|592373784|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002888|NCT00488631|592373785|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
164002889|NCT00488631|592373786|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
164002890|NCT00488631|592373787|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
164002891|NCT00488631|592373788|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
164002892|NCT00488631|592373779|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
164002893|NCT00488631|592373780|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
164002894|NCT00488631|592373781|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
164002895|NCT00488631|592373782|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
164002896|NCT00488631|592373783|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
164002897|NCT00488631|592373784|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
164002898|NCT00488631|592373785|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
164002899|NCT00488631|592373786|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
164002900|NCT00488631|592373787|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
164002901|NCT00488631|592373788|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
164002902|NCT00488631|592373779|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164002903|NCT00488631|592373780|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164002904|NCT00488631|592373781|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164002905|NCT00488631|592373782|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163897084|NCT00968149|591997839|FG000|Overall Study|Protocol Violation|4|||
163897085|NCT00968149|591997840|FG001|Overall Study|Protocol Violation|0|||
163897086|NCT00968149|591997839|FG000|Overall Study|Withdrawal by Subject|2|||
163897087|NCT00968149|591997840|FG001|Overall Study|Withdrawal by Subject|0|||
163897088|NCT02502266|591997841|FG000|Overall Study|Adverse Event|0|||
164002906|NCT00488631|592373783|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
163897089|NCT02502266|591997842|FG001|Overall Study|Adverse Event|0|||
164002907|NCT00488631|592373784|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
164087429|NCT03933202|592684222|FG000|Overall Study|Participant could not be entered as a follow-up|0|||
164087430|NCT03933202|592684223|FG001|Overall Study|Participant could not be entered as a follow-up|1|||
164087431|NCT03933202|592684222|FG000|Overall Study|Participant non-compliant, therefore, has been discontinued|1|||
164087432|NCT03933202|592684223|FG001|Overall Study|Participant non-compliant, therefore, has been discontinued|0|||
164087433|NCT03933202|592684222|FG000|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|1|||
164087434|NCT03933202|592684223|FG001|Overall Study|Participant delayed year 2 due to subject fear of COVID-19|0|||
164087435|NCT03933202|592684222|FG000|Overall Study|Missed visit|0|||
164087436|NCT03933202|592684223|FG001|Overall Study|Missed visit|1|||
164087437|NCT03933202|592684222|FG000|Overall Study|Investigator decision|4|||
164087438|NCT03933202|592684223|FG001|Overall Study|Investigator decision|0|||
164087439|NCT03933202|592684222|FG000|Overall Study|Discontinuation due to safety extension removal by Sponsor|0|||
164087440|NCT03933202|592684223|FG001|Overall Study|Discontinuation due to safety extension removal by Sponsor|1|||
164282480|NCT02218008|593404395|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
164282481|NCT02218008|593404396|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
164282482|NCT02218008|593404397|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
164282483|NCT02218008|593404398|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
164282484|NCT00408434|593404403|FG000|Overall Study|Adverse Event|0|||
164282485|NCT00408434|593404404|FG001|Overall Study|Adverse Event|0|||
163897090|NCT02502266|591997843|FG002|Overall Study|Adverse Event|0|||
164002908|NCT00488631|592373785|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
164002909|NCT00488631|592373786|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
164002910|NCT00488631|592373787|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
164002911|NCT00488631|592373788|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
164002912|NCT00488631|592373779|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002913|NCT00488631|592373780|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002914|NCT00488631|592373781|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002915|NCT00488631|592373782|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002916|NCT00488631|592373783|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002917|NCT00488631|592373784|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002918|NCT00488631|592373785|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
164002919|NCT00488631|592373786|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002920|NCT00488631|592373787|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
164002921|NCT00488631|592373788|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
164002922|NCT00488631|592373779|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002923|NCT00488631|592373780|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002924|NCT00488631|592373781|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002925|NCT00488631|592373782|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002926|NCT00488631|592373783|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002927|NCT00488631|592373784|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002928|NCT00488631|592373785|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
164002929|NCT00488631|592373786|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
164002930|NCT00488631|592373787|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
164002931|NCT00488631|592373788|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
164002932|NCT05300087|592373789|FG000|Overall Study|Withdrawal by Subject|0|||
164002933|NCT05300087|592373790|FG001|Overall Study|Withdrawal by Subject|1|||
164002934|NCT01444300|592373791|FG000|Overall Study|Adverse Event|4|||
164002935|NCT01444300|592373792|FG001|Overall Study|Adverse Event|0|||
164002936|NCT03372941|592373793|FG000|Overall Study|Lost to Follow-up|2|||
164002937|NCT03372941|592373794|FG001|Overall Study|Lost to Follow-up|4|||
164002938|NCT00741819|592373795|FG000|Overall Study|Adverse Event|3|||
164002939|NCT00741819|592373795|FG000|Overall Study|Withdrawal by Subject|3|||
164087441|NCT03933202|592684222|FG000|Overall Study|Withdrawal by Subject|10|||
164087442|NCT03933202|592684223|FG001|Overall Study|Withdrawal by Subject|8|||
164087443|NCT03933202|592684222|FG000|Overall Study|Death|2|||
164087444|NCT03933202|592684223|FG001|Overall Study|Death|0|||
164282486|NCT00408434|593404405|FG002|Overall Study|Adverse Event|1|||
164282487|NCT00408434|593404406|FG003|Overall Study|Adverse Event|0|||
164282488|NCT00408434|593404407|FG004|Overall Study|Adverse Event|0|||
163897091|NCT02502266|591997844|FG003|Overall Study|Adverse Event|0|||
163897092|NCT02502266|591997845|FG004|Overall Study|Adverse Event|1|||
163897093|NCT02502266|591997846|FG005|Overall Study|Adverse Event|1|||
163897094|NCT02502266|591997847|FG006|Overall Study|Adverse Event|1|||
163897095|NCT02502266|591997841|FG000|Overall Study|Withdrawal by Subject|30|||
163897096|NCT02502266|591997842|FG001|Overall Study|Withdrawal by Subject|15|||
163897097|NCT02502266|591997843|FG002|Overall Study|Withdrawal by Subject|16|||
163897098|NCT02502266|591997844|FG003|Overall Study|Withdrawal by Subject|0|||
163897099|NCT02502266|591997845|FG004|Overall Study|Withdrawal by Subject|0|||
164087445|NCT03933202|592684222|FG000|Overall Study|Progressive disease|0|||
164087446|NCT03933202|592684223|FG001|Overall Study|Progressive disease|3|||
164087447|NCT03933202|592684222|FG000|Overall Study|Protocol non-compliance|6|||
164282489|NCT00408434|593404408|FG005|Overall Study|Adverse Event|0|||
164282490|NCT00408434|593404409|FG006|Overall Study|Adverse Event|0|||
164087448|NCT03933202|592684223|FG001|Overall Study|Protocol non-compliance|3|||
164087449|NCT03933202|592684222|FG000|Overall Study|Lost to Follow-up|16|||
164282491|NCT00408434|593404403|FG000|Overall Study|Progressive disease|6|||
164282492|NCT00408434|593404404|FG001|Overall Study|Progressive disease|3|||
164282493|NCT00408434|593404405|FG002|Overall Study|Progressive disease|4|||
164282494|NCT00408434|593404406|FG003|Overall Study|Progressive disease|3|||
164282495|NCT00408434|593404407|FG004|Overall Study|Progressive disease|3|||
164282496|NCT00408434|593404408|FG005|Overall Study|Progressive disease|1|||
164087450|NCT03933202|592684223|FG001|Overall Study|Lost to Follow-up|8|||
164087451|NCT03933202|592684222|FG000|Overall Study|Adverse Event|3|||
164087452|NCT03933202|592684223|FG001|Overall Study|Adverse Event|0|||
164087453|NCT00947427|592684224|FG000|Overall Study|Withdrawal by Subject|1|||
164087454|NCT00947427|592684225|FG001|Overall Study|Withdrawal by Subject|3|||
164087455|NCT00947427|592684224|FG000|Overall Study|Protocol Violation|0|||
164087456|NCT00947427|592684225|FG001|Overall Study|Protocol Violation|1|||
164087457|NCT01348542|592684227|FG000|Overall Study|Withdrawal by Subject|3|||
164087458|NCT01348542|592684228|FG001|Overall Study|Withdrawal by Subject|0|||
164087459|NCT00686036|592684231|FG000|Overall Study|Adverse Event|3|||
164087460|NCT00686036|592684232|FG001|Overall Study|Adverse Event|0|||
164282497|NCT00408434|593404409|FG006|Overall Study|Progressive disease|4|||
164282498|NCT00408434|593404403|FG000|Overall Study|Other|0|||
164087461|NCT00686036|592684231|FG000|Overall Study|Withdrawal by Subject|3|||
164087462|NCT00686036|592684232|FG001|Overall Study|Withdrawal by Subject|1|||
164087463|NCT00686036|592684231|FG000|Overall Study|Study terminated by AstraZeneca|2|||
164087464|NCT00686036|592684232|FG001|Overall Study|Study terminated by AstraZeneca|1|||
164087465|NCT00686036|592684231|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
164087466|NCT00686036|592684232|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
164087467|NCT00686036|592684231|FG000|Overall Study|Other reasons not identified|0|||
164087468|NCT00686036|592684232|FG001|Overall Study|Other reasons not identified|4|||
164087469|NCT01411995|592684233|FG000|Overall Study|Failed IUD insertion|0|||
164087470|NCT01411995|592684234|FG001|Overall Study|Failed IUD insertion|1|||
164087471|NCT05658523|592684235|FG000|Baseline|No blood draw|1|||
164087472|NCT05658523|592684236|FG001|Baseline|No blood draw|0|||
164282499|NCT00408434|593404404|FG001|Overall Study|Other|0|||
164282500|NCT00408434|593404405|FG002|Overall Study|Other|1|||
164282501|NCT00408434|593404406|FG003|Overall Study|Other|0|||
164282502|NCT00408434|593404407|FG004|Overall Study|Other|2|||
164282503|NCT00408434|593404408|FG005|Overall Study|Other|1|||
164282504|NCT00408434|593404409|FG006|Overall Study|Other|0|||
164282505|NCT00408434|593404403|FG000|Overall Study|Terminated by Investigator|0|||
164282506|NCT00408434|593404404|FG001|Overall Study|Terminated by Investigator|0|||
164282507|NCT00408434|593404405|FG002|Overall Study|Terminated by Investigator|0|||
164282508|NCT00408434|593404406|FG003|Overall Study|Terminated by Investigator|0|||
164282509|NCT00408434|593404407|FG004|Overall Study|Terminated by Investigator|1|||
164282510|NCT00408434|593404408|FG005|Overall Study|Terminated by Investigator|1|||
164282511|NCT00408434|593404409|FG006|Overall Study|Terminated by Investigator|0|||
164282512|NCT04039217|593404410|FG000|Overall Study|Lost to Follow-up|1|||
164282513|NCT00106353|593404411|FG000|Part 1|Disease progression|3|||
164282514|NCT00106353|593404412|FG001|Part 1|Disease progression|4|||
164282515|NCT00106353|593404413|FG002|Part 1|Disease progression|1|||
164282516|NCT00106353|593404414|FG003|Part 1|Disease progression|3|||
164282517|NCT00106353|593404415|FG004|Part 1|Disease progression|0|||
164282518|NCT00106353|593404416|FG005|Part 1|Disease progression|0|||
164282519|NCT00106353|593404417|FG006|Part 1|Disease progression|0|||
164282520|NCT00106353|593404411|FG000|Part 1|Withdrawal by Subject|0|||
164087473|NCT05658523|592684237|FG002|Baseline|No blood draw|0|||
164282521|NCT00106353|593404412|FG001|Part 1|Withdrawal by Subject|0|||
164282522|NCT00106353|593404413|FG002|Part 1|Withdrawal by Subject|1|||
164282523|NCT00106353|593404414|FG003|Part 1|Withdrawal by Subject|2|||
164282524|NCT00106353|593404415|FG004|Part 1|Withdrawal by Subject|0|||
164282525|NCT00106353|593404416|FG005|Part 1|Withdrawal by Subject|0|||
164282526|NCT00106353|593404417|FG006|Part 1|Withdrawal by Subject|0|||
164344539|NCT00444912|593636972|FG000|Overall Study|Death|1|||
164087474|NCT05658523|592684235|FG000|28 Days|Lost to Follow-up|1|||
164087475|NCT05658523|592684236|FG001|28 Days|Lost to Follow-up|0|||
164087476|NCT05658523|592684237|FG002|28 Days|Lost to Follow-up|0|||
164087477|NCT05658523|592684235|FG000|28 Days|Withdrawal by Subject|1|||
164087478|NCT05658523|592684236|FG001|28 Days|Withdrawal by Subject|1|||
164087479|NCT05658523|592684237|FG002|28 Days|Withdrawal by Subject|0|||
164344540|NCT00444912|593636973|FG001|Overall Study|Death|2|||
164087480|NCT05658523|592684235|FG000|28 Days|Visit missed|0|||
164087481|NCT05658523|592684236|FG001|28 Days|Visit missed|4|||
164282527|NCT00106353|593404411|FG000|Part 1|Symptomatic deterioration|0|||
164282528|NCT00106353|593404412|FG001|Part 1|Symptomatic deterioration|0|||
164282529|NCT00106353|593404413|FG002|Part 1|Symptomatic deterioration|1|||
164344541|NCT00444912|593636972|FG000|Overall Study|Lost to Follow-up|1|||
164002940|NCT00741819|592373795|FG000|Overall Study|Death|1|||
164002941|NCT00741819|592373795|FG000|Overall Study|Disease progression|1|||
164002942|NCT00686543|592373796|FG000|Overall Study|Adverse Event|9|||
164282530|NCT00106353|593404414|FG003|Part 1|Symptomatic deterioration|0|||
164282531|NCT00106353|593404415|FG004|Part 1|Symptomatic deterioration|0|||
164282532|NCT00106353|593404416|FG005|Part 1|Symptomatic deterioration|0|||
164282533|NCT00106353|593404417|FG006|Part 1|Symptomatic deterioration|0|||
164282534|NCT00106353|593404411|FG000|Part 1|Entered follow-up phase|1|||
164282535|NCT00106353|593404412|FG001|Part 1|Entered follow-up phase|1|||
164282536|NCT00106353|593404413|FG002|Part 1|Entered follow-up phase|0|||
164282537|NCT00106353|593404414|FG003|Part 1|Entered follow-up phase|1|||
164282538|NCT00106353|593404415|FG004|Part 1|Entered follow-up phase|0|||
164282539|NCT00106353|593404416|FG005|Part 1|Entered follow-up phase|0|||
164282540|NCT00106353|593404417|FG006|Part 1|Entered follow-up phase|0|||
164282541|NCT00106353|593404411|FG000|Part 1|Adverse Event|0|||
164282542|NCT00106353|593404412|FG001|Part 1|Adverse Event|0|||
164282543|NCT00106353|593404413|FG002|Part 1|Adverse Event|0|||
164282544|NCT00106353|593404414|FG003|Part 1|Adverse Event|1|||
164282545|NCT00106353|593404415|FG004|Part 1|Adverse Event|0|||
164282546|NCT00106353|593404416|FG005|Part 1|Adverse Event|0|||
164282547|NCT00106353|593404417|FG006|Part 1|Adverse Event|0|||
164282548|NCT00106353|593404411|FG000|Part 2|Disease progression|0|||
164282549|NCT00106353|593404412|FG001|Part 2|Disease progression|0|||
164282550|NCT00106353|593404413|FG002|Part 2|Disease progression|0|||
164282551|NCT00106353|593404414|FG003|Part 2|Disease progression|0|||
164282552|NCT00106353|593404415|FG004|Part 2|Disease progression|8|||
164282553|NCT00106353|593404416|FG005|Part 2|Disease progression|14|||
164282554|NCT00106353|593404417|FG006|Part 2|Disease progression|13|||
164282555|NCT00106353|593404411|FG000|Part 2|Death|0|||
164282556|NCT00106353|593404412|FG001|Part 2|Death|0|||
164282557|NCT00106353|593404413|FG002|Part 2|Death|0|||
164282558|NCT00106353|593404414|FG003|Part 2|Death|0|||
164282559|NCT00106353|593404415|FG004|Part 2|Death|3|||
164282560|NCT00106353|593404416|FG005|Part 2|Death|0|||
164282561|NCT00106353|593404417|FG006|Part 2|Death|1|||
164282562|NCT00106353|593404411|FG000|Part 2|Symptomatic deterioration|0|||
164282563|NCT00106353|593404412|FG001|Part 2|Symptomatic deterioration|0|||
164002943|NCT00686543|592373797|FG001|Overall Study|Adverse Event|1|||
164002944|NCT00686543|592373798|FG002|Overall Study|Adverse Event|3|||
164282564|NCT00106353|593404413|FG002|Part 2|Symptomatic deterioration|0|||
164282565|NCT00106353|593404414|FG003|Part 2|Symptomatic deterioration|0|||
164282566|NCT00106353|593404415|FG004|Part 2|Symptomatic deterioration|3|||
164282567|NCT00106353|593404416|FG005|Part 2|Symptomatic deterioration|0|||
164282568|NCT00106353|593404417|FG006|Part 2|Symptomatic deterioration|0|||
164282569|NCT00106353|593404411|FG000|Part 2|Adverse Event|0|||
164282570|NCT00106353|593404412|FG001|Part 2|Adverse Event|0|||
164282571|NCT00106353|593404413|FG002|Part 2|Adverse Event|0|||
164282572|NCT00106353|593404414|FG003|Part 2|Adverse Event|0|||
164282573|NCT00106353|593404415|FG004|Part 2|Adverse Event|0|||
164282574|NCT00106353|593404416|FG005|Part 2|Adverse Event|2|||
164282575|NCT00106353|593404417|FG006|Part 2|Adverse Event|1|||
164282576|NCT00106353|593404411|FG000|Part 2|Other|0|||
164282577|NCT00106353|593404412|FG001|Part 2|Other|0|||
164282578|NCT00106353|593404413|FG002|Part 2|Other|0|||
164282579|NCT00106353|593404414|FG003|Part 2|Other|0|||
164282580|NCT00106353|593404415|FG004|Part 2|Other|1|||
164282581|NCT00106353|593404416|FG005|Part 2|Other|1|||
164282582|NCT00106353|593404417|FG006|Part 2|Other|1|||
164282583|NCT00106353|593404411|FG000|Part 2|Withdrawal by Subject|0|||
164282584|NCT00106353|593404412|FG001|Part 2|Withdrawal by Subject|0|||
164282585|NCT00106353|593404413|FG002|Part 2|Withdrawal by Subject|0|||
164282586|NCT00106353|593404414|FG003|Part 2|Withdrawal by Subject|0|||
164282587|NCT00106353|593404415|FG004|Part 2|Withdrawal by Subject|1|||
164282588|NCT00106353|593404416|FG005|Part 2|Withdrawal by Subject|0|||
164282589|NCT00106353|593404417|FG006|Part 2|Withdrawal by Subject|0|||
164282590|NCT00106353|593404411|FG000|Part 2|Physician Decision|0|||
164282591|NCT00106353|593404412|FG001|Part 2|Physician Decision|0|||
164282592|NCT00106353|593404413|FG002|Part 2|Physician Decision|0|||
164282593|NCT00106353|593404414|FG003|Part 2|Physician Decision|0|||
164282594|NCT00106353|593404415|FG004|Part 2|Physician Decision|0|||
164282595|NCT00106353|593404416|FG005|Part 2|Physician Decision|1|||
164282596|NCT00106353|593404417|FG006|Part 2|Physician Decision|0|||
164282597|NCT01278797|593404418|FG000|Period 1|Adverse Event|0|||
164282598|NCT01278797|593404419|FG001|Period 1|Adverse Event|1|||
164282599|NCT01278797|593404418|FG000|Period 1|Protocol Violation|1|||
164282600|NCT01278797|593404419|FG001|Period 1|Protocol Violation|0|||
164282601|NCT00588354|593404420|FG000|Baseline to 2 Weeks|Adverse Event|1|||
164282602|NCT00588354|593404421|FG001|Baseline to 2 Weeks|Adverse Event|0|||
164282603|NCT00588354|593404420|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
164282604|NCT00588354|593404421|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
164282605|NCT00588354|593404420|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
164282606|NCT00588354|593404421|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
164282607|NCT01371552|593404422|FG000|Part 1, First 3 Days|Inconvenience|0|||
164282608|NCT01371552|593404423|FG001|Part 1, First 3 Days|Inconvenience|0|||
164282609|NCT01371552|593404424|FG002|Part 1, First 3 Days|Inconvenience|1|||
164282610|NCT01371552|593404425|FG003|Part 1, First 3 Days|Inconvenience|0|||
164282611|NCT01371552|593404426|FG004|Part 1, First 3 Days|Inconvenience|0|||
164282612|NCT01371552|593404427|FG005|Part 1, First 3 Days|Inconvenience|0|||
164282613|NCT03364309|593404428|FG000|Induction Period|Adverse Event|4|||
164282614|NCT03364309|593404429|FG001|Induction Period|Adverse Event|0|||
164282615|NCT03364309|593404430|FG002|Induction Period|Adverse Event|1|||
164282616|NCT03364309|593404431|FG003|Induction Period|Adverse Event|0|||
164282617|NCT03364309|593404432|FG004|Induction Period|Adverse Event|0|||
164282618|NCT03364309|593404433|FG005|Induction Period|Adverse Event|0|||
164282619|NCT03364309|593404434|FG006|Induction Period|Adverse Event|0|||
164282620|NCT03364309|593404435|FG007|Induction Period|Adverse Event|0|||
164282621|NCT03364309|593404436|FG008|Induction Period|Adverse Event|0|||
164282622|NCT03364309|593404437|FG009|Induction Period|Adverse Event|0|||
164282623|NCT03364309|593404438|FG010|Induction Period|Adverse Event|0|||
164282624|NCT03364309|593404439|FG011|Induction Period|Adverse Event|0|||
164282625|NCT03364309|593404440|FG012|Induction Period|Adverse Event|0|||
164282626|NCT03364309|593404441|FG013|Induction Period|Adverse Event|0|||
164282627|NCT03364309|593404442|FG014|Induction Period|Adverse Event|0|||
164282628|NCT03364309|593404443|FG015|Induction Period|Adverse Event|0|||
164282629|NCT03364309|593404444|FG016|Induction Period|Adverse Event|0|||
164282630|NCT03364309|593404445|FG017|Induction Period|Adverse Event|0|||
164282631|NCT03364309|593404446|FG018|Induction Period|Adverse Event|0|||
164282632|NCT03364309|593404428|FG000|Induction Period|Withdrawal by Subject|1|||
164282633|NCT03364309|593404429|FG001|Induction Period|Withdrawal by Subject|3|||
164282634|NCT03364309|593404430|FG002|Induction Period|Withdrawal by Subject|0|||
164282635|NCT03364309|593404431|FG003|Induction Period|Withdrawal by Subject|0|||
164282636|NCT03364309|593404432|FG004|Induction Period|Withdrawal by Subject|0|||
164282637|NCT03364309|593404433|FG005|Induction Period|Withdrawal by Subject|0|||
164282638|NCT03364309|593404434|FG006|Induction Period|Withdrawal by Subject|0|||
164282639|NCT03364309|593404435|FG007|Induction Period|Withdrawal by Subject|0|||
164282640|NCT03364309|593404436|FG008|Induction Period|Withdrawal by Subject|0|||
164282641|NCT03364309|593404437|FG009|Induction Period|Withdrawal by Subject|0|||
164282642|NCT03364309|593404438|FG010|Induction Period|Withdrawal by Subject|0|||
164282643|NCT03364309|593404439|FG011|Induction Period|Withdrawal by Subject|0|||
164282644|NCT03364309|593404440|FG012|Induction Period|Withdrawal by Subject|0|||
164282645|NCT03364309|593404441|FG013|Induction Period|Withdrawal by Subject|0|||
164282646|NCT03364309|593404442|FG014|Induction Period|Withdrawal by Subject|0|||
164282647|NCT03364309|593404443|FG015|Induction Period|Withdrawal by Subject|0|||
164282648|NCT03364309|593404444|FG016|Induction Period|Withdrawal by Subject|0|||
164282649|NCT03364309|593404445|FG017|Induction Period|Withdrawal by Subject|0|||
164282650|NCT03364309|593404446|FG018|Induction Period|Withdrawal by Subject|0|||
164282651|NCT03364309|593404428|FG000|Induction Period|Lost to Follow-up|1|||
164282652|NCT03364309|593404429|FG001|Induction Period|Lost to Follow-up|0|||
164282653|NCT03364309|593404430|FG002|Induction Period|Lost to Follow-up|0|||
164282654|NCT03364309|593404431|FG003|Induction Period|Lost to Follow-up|0|||
164282655|NCT03364309|593404432|FG004|Induction Period|Lost to Follow-up|0|||
164282656|NCT03364309|593404433|FG005|Induction Period|Lost to Follow-up|0|||
164282657|NCT03364309|593404434|FG006|Induction Period|Lost to Follow-up|0|||
164282658|NCT03364309|593404435|FG007|Induction Period|Lost to Follow-up|0|||
164282659|NCT03364309|593404436|FG008|Induction Period|Lost to Follow-up|0|||
164282660|NCT03364309|593404437|FG009|Induction Period|Lost to Follow-up|0|||
164282661|NCT03364309|593404438|FG010|Induction Period|Lost to Follow-up|0|||
164282662|NCT03364309|593404439|FG011|Induction Period|Lost to Follow-up|0|||
164282663|NCT03364309|593404440|FG012|Induction Period|Lost to Follow-up|0|||
164282664|NCT03364309|593404441|FG013|Induction Period|Lost to Follow-up|0|||
164282665|NCT03364309|593404442|FG014|Induction Period|Lost to Follow-up|0|||
164282666|NCT03364309|593404443|FG015|Induction Period|Lost to Follow-up|0|||
164282667|NCT03364309|593404444|FG016|Induction Period|Lost to Follow-up|0|||
164282668|NCT03364309|593404445|FG017|Induction Period|Lost to Follow-up|0|||
164282669|NCT03364309|593404446|FG018|Induction Period|Lost to Follow-up|0|||
164282670|NCT03364309|593404428|FG000|Induction Period|Physician Decision|0|||
164282671|NCT03364309|593404429|FG001|Induction Period|Physician Decision|1|||
164282672|NCT03364309|593404430|FG002|Induction Period|Physician Decision|0|||
164282673|NCT03364309|593404431|FG003|Induction Period|Physician Decision|0|||
164282674|NCT03364309|593404432|FG004|Induction Period|Physician Decision|0|||
164282675|NCT03364309|593404433|FG005|Induction Period|Physician Decision|0|||
164282676|NCT03364309|593404434|FG006|Induction Period|Physician Decision|0|||
164282677|NCT03364309|593404435|FG007|Induction Period|Physician Decision|0|||
164282678|NCT03364309|593404436|FG008|Induction Period|Physician Decision|0|||
164282679|NCT03364309|593404437|FG009|Induction Period|Physician Decision|0|||
164282680|NCT03364309|593404438|FG010|Induction Period|Physician Decision|0|||
164282681|NCT03364309|593404439|FG011|Induction Period|Physician Decision|0|||
164282682|NCT03364309|593404440|FG012|Induction Period|Physician Decision|0|||
164282683|NCT03364309|593404441|FG013|Induction Period|Physician Decision|0|||
164282684|NCT03364309|593404442|FG014|Induction Period|Physician Decision|0|||
164282685|NCT03364309|593404443|FG015|Induction Period|Physician Decision|0|||
164282686|NCT03364309|593404444|FG016|Induction Period|Physician Decision|0|||
164282687|NCT03364309|593404445|FG017|Induction Period|Physician Decision|0|||
164282688|NCT03364309|593404446|FG018|Induction Period|Physician Decision|0|||
164282689|NCT03364309|593404428|FG000|Maintenance Period|Withdrawal by Subject|0|||
164282690|NCT03364309|593404429|FG001|Maintenance Period|Withdrawal by Subject|0|||
164087482|NCT05658523|592684237|FG002|28 Days|Visit missed|0|||
164087483|NCT05658523|592684235|FG000|6 Months|Lost to Follow-up|1|||
164087484|NCT05658523|592684236|FG001|6 Months|Lost to Follow-up|7|||
164087485|NCT05658523|592684237|FG002|6 Months|Lost to Follow-up|2|||
164087486|NCT05658523|592684235|FG000|6 Months|Withdrawal by Subject|1|||
164087487|NCT05658523|592684236|FG001|6 Months|Withdrawal by Subject|3|||
164087488|NCT05658523|592684237|FG002|6 Months|Withdrawal by Subject|4|||
164087489|NCT05658523|592684235|FG000|6 Months|Visit missed|5|||
164087490|NCT05658523|592684236|FG001|6 Months|Visit missed|7|||
164087491|NCT05658523|592684237|FG002|6 Months|Visit missed|0|||
164282691|NCT03364309|593404430|FG002|Maintenance Period|Withdrawal by Subject|0|||
164282692|NCT03364309|593404431|FG003|Maintenance Period|Withdrawal by Subject|1|||
164282693|NCT03364309|593404432|FG004|Maintenance Period|Withdrawal by Subject|3|||
164282694|NCT03364309|593404433|FG005|Maintenance Period|Withdrawal by Subject|1|||
164282695|NCT03364309|593404434|FG006|Maintenance Period|Withdrawal by Subject|3|||
164282696|NCT03364309|593404435|FG007|Maintenance Period|Withdrawal by Subject|0|||
164282697|NCT03364309|593404436|FG008|Maintenance Period|Withdrawal by Subject|1|||
164282698|NCT03364309|593404437|FG009|Maintenance Period|Withdrawal by Subject|1|||
164282699|NCT03364309|593404438|FG010|Maintenance Period|Withdrawal by Subject|2|||
164282700|NCT03364309|593404439|FG011|Maintenance Period|Withdrawal by Subject|0|||
164282701|NCT03364309|593404440|FG012|Maintenance Period|Withdrawal by Subject|0|||
164282702|NCT03364309|593404441|FG013|Maintenance Period|Withdrawal by Subject|0|||
164282703|NCT03364309|593404442|FG014|Maintenance Period|Withdrawal by Subject|0|||
164282704|NCT03364309|593404443|FG015|Maintenance Period|Withdrawal by Subject|0|||
164282705|NCT03364309|593404444|FG016|Maintenance Period|Withdrawal by Subject|0|||
164282706|NCT03364309|593404445|FG017|Maintenance Period|Withdrawal by Subject|0|||
164282707|NCT03364309|593404446|FG018|Maintenance Period|Withdrawal by Subject|0|||
164002945|NCT00686543|592373799|FG003|Overall Study|Adverse Event|2|||
164002946|NCT00686543|592373796|FG000|Overall Study|Withdrawal by Subject|2|||
164002947|NCT00686543|592373797|FG001|Overall Study|Withdrawal by Subject|0|||
164002948|NCT00686543|592373798|FG002|Overall Study|Withdrawal by Subject|0|||
164002949|NCT00686543|592373799|FG003|Overall Study|Withdrawal by Subject|0|||
164002950|NCT00686543|592373796|FG000|Overall Study|Protocol Violation|3|||
164002951|NCT00686543|592373797|FG001|Overall Study|Protocol Violation|0|||
164002952|NCT00686543|592373798|FG002|Overall Study|Protocol Violation|2|||
164002953|NCT00686543|592373799|FG003|Overall Study|Protocol Violation|1|||
164002954|NCT00752986|592373800|FG000|Overall Study|Withdrawal by Subject|2|||
164002955|NCT00752986|592373801|FG001|Overall Study|Withdrawal by Subject|1|||
164002956|NCT00752986|592373802|FG002|Overall Study|Withdrawal by Subject|2|||
164002957|NCT00752986|592373800|FG000|Overall Study|Protocol Violation|3|||
164002958|NCT00752986|592373801|FG001|Overall Study|Protocol Violation|0|||
164002959|NCT00752986|592373802|FG002|Overall Study|Protocol Violation|0|||
164002960|NCT00924703|592373803|FG000|Overall Study|Withdrawal by Subject|11|||
164002961|NCT00924703|592373803|FG000|Overall Study|Physician Decision|5|||
164002962|NCT00924703|592373803|FG000|Overall Study|Lost to Follow-up|3|||
164002963|NCT00924703|592373803|FG000|Overall Study|Adverse Event|2|||
164002964|NCT00924703|592373803|FG000|Overall Study|Withdrawal by Sponsor|1|||
164002965|NCT02382133|592373806|FG000|Overall Study|Death|22|||
164002966|NCT02382133|592373806|FG000|Overall Study|transfer out of ICU|4|||
164002967|NCT02382133|592373806|FG000|Overall Study|Physician Decision|2|||
164002968|NCT02382133|592373806|FG000|Overall Study|arterial catheter loss|4|||
164002969|NCT02382133|592373806|FG000|Overall Study|pressure injury both sites|1|||
164002970|NCT04906707|592373807|FG000|Overall Study|Withdrawal by Subject|2|||
164002971|NCT04906707|592373808|FG001|Overall Study|Withdrawal by Subject|0|||
164002972|NCT04906707|592373807|FG000|Overall Study|Withdrawal due to PI decision|1|||
164002973|NCT04906707|592373808|FG001|Overall Study|Withdrawal due to PI decision|0|||
164002974|NCT04906707|592373807|FG000|Overall Study|Lost to Follow-up|0|||
164002975|NCT04906707|592373808|FG001|Overall Study|Lost to Follow-up|1|||
164002976|NCT04429022|592373814|FG000|Overall Study|Protocol Violation|18|||
164002977|NCT04429022|592373815|FG001|Overall Study|Protocol Violation|1|||
164002978|NCT04321343|592373816|FG000|Overall Study|Adverse Event|0|||
164002979|NCT04321343|592373817|FG001|Overall Study|Adverse Event|0|||
164002980|NCT04321343|592373818|FG002|Overall Study|Adverse Event|1|||
164002981|NCT04321343|592373819|FG003|Overall Study|Adverse Event|0|||
164002982|NCT04321343|592373816|FG000|Overall Study|Death|0|||
164002983|NCT04321343|592373817|FG001|Overall Study|Death|0|||
164002984|NCT04321343|592373818|FG002|Overall Study|Death|0|||
164002985|NCT04321343|592373819|FG003|Overall Study|Death|1|||
164002986|NCT04321343|592373816|FG000|Overall Study|Pregnancy|1|||
164002987|NCT04321343|592373817|FG001|Overall Study|Pregnancy|0|||
164002988|NCT04321343|592373818|FG002|Overall Study|Pregnancy|0|||
164002989|NCT04321343|592373819|FG003|Overall Study|Pregnancy|0|||
164002990|NCT04321343|592373816|FG000|Overall Study|Protocol Violation|1|||
164087492|NCT05658523|592684235|FG000|6 Months|No blood draw|0|||
164087493|NCT05658523|592684236|FG001|6 Months|No blood draw|0|||
164002991|NCT04321343|592373817|FG001|Overall Study|Protocol Violation|1|||
164002992|NCT04321343|592373818|FG002|Overall Study|Protocol Violation|1|||
164002993|NCT04321343|592373819|FG003|Overall Study|Protocol Violation|1|||
164002994|NCT04321343|592373816|FG000|Overall Study|Withdrawal by Subject|0|||
164002995|NCT04321343|592373817|FG001|Overall Study|Withdrawal by Subject|6|||
164002996|NCT04321343|592373818|FG002|Overall Study|Withdrawal by Subject|0|||
164002997|NCT04321343|592373819|FG003|Overall Study|Withdrawal by Subject|2|||
164002998|NCT04321343|592373816|FG000|Overall Study|Lost to Follow-up|2|||
164002999|NCT04321343|592373817|FG001|Overall Study|Lost to Follow-up|2|||
164003000|NCT04321343|592373818|FG002|Overall Study|Lost to Follow-up|1|||
164003001|NCT04321343|592373819|FG003|Overall Study|Lost to Follow-up|3|||
164003002|NCT03430310|592373820|FG000|Overall Study|Protocol Violation|2|||
164003003|NCT03430310|592373821|FG001|Overall Study|Protocol Violation|0|||
164003004|NCT03430310|592373820|FG000|Overall Study|Withdrawal by Subject|3|||
164003005|NCT03430310|592373821|FG001|Overall Study|Withdrawal by Subject|2|||
164003006|NCT03430310|592373820|FG000|Overall Study|COVID shutdown March 2020|0|||
164003007|NCT03430310|592373821|FG001|Overall Study|COVID shutdown March 2020|1|||
164003008|NCT00045032|592373826|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
164003009|NCT00045032|592373827|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
164003010|NCT00045032|592373828|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
164344542|NCT00444912|593636973|FG001|Overall Study|Lost to Follow-up|0|||
164344543|NCT00444912|593636972|FG000|Overall Study|Participant Failed Mobilization|1|||
164344544|NCT00444912|593636973|FG001|Overall Study|Participant Failed Mobilization|0|||
164344545|NCT03758066|593636974|FG000|Overall Study|Lost to Follow-up|14|||
164344546|NCT03706079|593636981|FG000|Predecessor Study|Death|0|||
164344547|NCT03706079|593636982|FG001|Predecessor Study|Death|2|||
164344548|NCT03706079|593636983|FG002|Predecessor Study|Death|0|||
164344549|NCT03706079|593636984|FG003|Predecessor Study|Death|1|||
164344550|NCT03706079|593636985|FG004|Predecessor Study|Death|0|||
164344551|NCT03706079|593636986|FG005|Predecessor Study|Death|0|||
164344552|NCT03706079|593636981|FG000|Predecessor Study|Lost to Follow-up|5|||
164344553|NCT03706079|593636982|FG001|Predecessor Study|Lost to Follow-up|2|||
164344554|NCT03706079|593636983|FG002|Predecessor Study|Lost to Follow-up|0|||
164344555|NCT03706079|593636984|FG003|Predecessor Study|Lost to Follow-up|0|||
164344556|NCT03706079|593636985|FG004|Predecessor Study|Lost to Follow-up|1|||
164344557|NCT03706079|593636986|FG005|Predecessor Study|Lost to Follow-up|0|||
164344558|NCT03706079|593636981|FG000|Predecessor Study|Withdrawal by Subject|8|||
164344559|NCT03706079|593636982|FG001|Predecessor Study|Withdrawal by Subject|15|||
164344560|NCT03706079|593636983|FG002|Predecessor Study|Withdrawal by Subject|0|||
164344561|NCT03706079|593636984|FG003|Predecessor Study|Withdrawal by Subject|5|||
164344562|NCT03706079|593636985|FG004|Predecessor Study|Withdrawal by Subject|2|||
164344563|NCT03706079|593636986|FG005|Predecessor Study|Withdrawal by Subject|0|||
164344564|NCT03706079|593636981|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
164344565|NCT03706079|593636982|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
164344566|NCT03706079|593636983|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
163897100|NCT02502266|591997846|FG005|Overall Study|Withdrawal by Subject|0|||
163897101|NCT02502266|591997847|FG006|Overall Study|Withdrawal by Subject|0|||
163897102|NCT02502266|591997841|FG000|Overall Study|Still on Treatment|0|||
163897103|NCT02502266|591997842|FG001|Overall Study|Still on Treatment|0|||
163897104|NCT02502266|591997843|FG002|Overall Study|Still on Treatment|1|||
163897105|NCT02502266|591997844|FG003|Overall Study|Still on Treatment|0|||
163897106|NCT02502266|591997845|FG004|Overall Study|Still on Treatment|0|||
163897107|NCT02502266|591997846|FG005|Overall Study|Still on Treatment|0|||
163897108|NCT02502266|591997847|FG006|Overall Study|Still on Treatment|0|||
163897109|NCT02502266|591997841|FG000|Overall Study|Other Reasons|19|||
163897110|NCT02502266|591997842|FG001|Overall Study|Other Reasons|6|||
163897111|NCT02502266|591997843|FG002|Overall Study|Other Reasons|14|||
163897112|NCT02502266|591997844|FG003|Overall Study|Other Reasons|0|||
163897113|NCT02502266|591997845|FG004|Overall Study|Other Reasons|1|||
163897114|NCT02502266|591997846|FG005|Overall Study|Other Reasons|1|||
163897115|NCT02502266|591997847|FG006|Overall Study|Other Reasons|0|||
163897116|NCT02502266|591997841|FG000|Overall Study|Arm 4 Discontinued|0|||
163897117|NCT02502266|591997842|FG001|Overall Study|Arm 4 Discontinued|0|||
163897118|NCT02502266|591997843|FG002|Overall Study|Arm 4 Discontinued|0|||
163897119|NCT02502266|591997844|FG003|Overall Study|Arm 4 Discontinued|52|||
163897120|NCT02502266|591997845|FG004|Overall Study|Arm 4 Discontinued|0|||
163897121|NCT02502266|591997846|FG005|Overall Study|Arm 4 Discontinued|0|||
163897122|NCT02502266|591997847|FG006|Overall Study|Arm 4 Discontinued|0|||
164003011|NCT00045032|592373826|FG000|Overall Study|Death|22|||
164003012|NCT00045032|592373827|FG001|Overall Study|Death|24|||
163897123|NCT02502266|591997841|FG000|Overall Study|Never treated|0|||
163897124|NCT02502266|591997842|FG001|Overall Study|Never treated|0|||
163897125|NCT02502266|591997843|FG002|Overall Study|Never treated|0|||
163897126|NCT02502266|591997844|FG003|Overall Study|Never treated|0|||
163897127|NCT02502266|591997845|FG004|Overall Study|Never treated|0|||
163897128|NCT02502266|591997846|FG005|Overall Study|Never treated|1|||
164003013|NCT00045032|592373828|FG002|Overall Study|Death|17|||
164003014|NCT00045032|592373826|FG000|Overall Study|Insufficient Therapeutic Response|542|||
164003015|NCT00045032|592373827|FG001|Overall Study|Insufficient Therapeutic Response|437|||
164003016|NCT00045032|592373828|FG002|Overall Study|Insufficient Therapeutic Response|445|||
164003017|NCT00045032|592373826|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
164003018|NCT00045032|592373827|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
164003019|NCT00045032|592373828|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
164282708|NCT03364309|593404428|FG000|Maintenance Period|Adverse Event|0|||
164282709|NCT03364309|593404429|FG001|Maintenance Period|Adverse Event|0|||
164282710|NCT03364309|593404430|FG002|Maintenance Period|Adverse Event|0|||
164282711|NCT03364309|593404431|FG003|Maintenance Period|Adverse Event|0|||
164282712|NCT03364309|593404432|FG004|Maintenance Period|Adverse Event|2|||
164282713|NCT03364309|593404433|FG005|Maintenance Period|Adverse Event|0|||
164003020|NCT00045032|592373826|FG000|Overall Study|Other Protocol Violation|2|||
164003021|NCT00045032|592373827|FG001|Overall Study|Other Protocol Violation|0|||
164003022|NCT00045032|592373828|FG002|Overall Study|Other Protocol Violation|1|||
164003023|NCT00045032|592373826|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
164003024|NCT00045032|592373827|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
164003025|NCT00045032|592373828|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
164003026|NCT00045032|592373826|FG000|Overall Study|Failure to Return|57|||
164003027|NCT00045032|592373827|FG001|Overall Study|Failure to Return|62|||
164003028|NCT00045032|592373828|FG002|Overall Study|Failure to Return|61|||
164003029|NCT00045032|592373826|FG000|Overall Study|Other|93|||
164003030|NCT00045032|592373827|FG001|Overall Study|Other|84|||
164003031|NCT00045032|592373828|FG002|Overall Study|Other|105|||
164003032|NCT02582658|592373829|FG000|Overall Study|Failure to Return|10|||
164003033|NCT02582658|592373829|FG000|Overall Study|Insufficient Virological Response|2|||
164003034|NCT02582658|592373829|FG000|Overall Study|Withdrawn Consent|1|||
164003035|NCT02582658|592373829|FG000|Overall Study|Death|1|||
164003036|NCT02582658|592373829|FG000|Overall Study|Not further specified|11|||
164003037|NCT02581995|592373830|FG000|Overall Study|Unspecified other|3|||
164003038|NCT02581995|592373830|FG000|Overall Study|Adverse Event|6|||
164003039|NCT02581995|592373830|FG000|Overall Study|Lost to Follow-up|5|||
164003040|NCT02581995|592373830|FG000|Overall Study|Withdrawal by participant|12|||
164003041|NCT02581995|592373830|FG000|Overall Study|Physician Decision|1|||
164003042|NCT02581995|592373830|FG000|Overall Study|Death|4|||
164003043|NCT02770807|592373831|FG000|Overall Study|Adverse Event|3|||
164003044|NCT02770807|592373832|FG001|Overall Study|Adverse Event|3|||
164003045|NCT02770807|592373833|FG002|Overall Study|Adverse Event|1|||
164003046|NCT02770807|592373831|FG000|Overall Study|Withdrawal by Subject|7|||
164003047|NCT02770807|592373832|FG001|Overall Study|Withdrawal by Subject|3|||
164003048|NCT02770807|592373833|FG002|Overall Study|Withdrawal by Subject|4|||
164003049|NCT02770807|592373831|FG000|Overall Study|Other|0|||
164003050|NCT02770807|592373832|FG001|Overall Study|Other|1|||
164003051|NCT02770807|592373833|FG002|Overall Study|Other|0|||
164003052|NCT02770807|592373831|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
164003053|NCT02770807|592373832|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
164003054|NCT02770807|592373833|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
164003055|NCT02770807|592373831|FG000|Overall Study|Physician Decision|0|||
164003056|NCT02770807|592373832|FG001|Overall Study|Physician Decision|0|||
164003057|NCT02770807|592373833|FG002|Overall Study|Physician Decision|1|||
164003058|NCT01084252|592375646|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003059|NCT01084252|592375647|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003060|NCT01084252|592375648|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003061|NCT01084252|592375649|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003062|NCT01084252|592375650|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003063|NCT01084252|592375651|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003064|NCT01084252|592375652|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003065|NCT01084252|592375653|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003066|NCT01084252|592375654|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003067|NCT01084252|592375655|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003068|NCT01084252|592375656|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164003069|NCT01084252|592375657|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164282714|NCT03364309|593404434|FG006|Maintenance Period|Adverse Event|3|||
164282715|NCT03364309|593404435|FG007|Maintenance Period|Adverse Event|0|||
164282716|NCT03364309|593404436|FG008|Maintenance Period|Adverse Event|1|||
164282717|NCT03364309|593404437|FG009|Maintenance Period|Adverse Event|0|||
164003070|NCT01084252|592375658|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
164003071|NCT01084252|592375659|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
164282718|NCT03364309|593404438|FG010|Maintenance Period|Adverse Event|2|||
164282719|NCT03364309|593404439|FG011|Maintenance Period|Adverse Event|0|||
164003072|NCT04909463|592375660|FG000|Overall Study|Withdrawal by Subject|0|||
164087494|NCT05658523|592684237|FG002|6 Months|No blood draw|1|||
164087495|NCT05658523|592684235|FG000|12 Months|Lost to Follow-up|2|||
164282720|NCT03364309|593404440|FG012|Maintenance Period|Adverse Event|0|||
164282721|NCT03364309|593404441|FG013|Maintenance Period|Adverse Event|0|||
164003073|NCT04909463|592375661|FG001|Overall Study|Withdrawal by Subject|1|||
164282722|NCT03364309|593404442|FG014|Maintenance Period|Adverse Event|0|||
164282723|NCT03364309|593404443|FG015|Maintenance Period|Adverse Event|0|||
164282724|NCT03364309|593404444|FG016|Maintenance Period|Adverse Event|0|||
164282725|NCT03364309|593404445|FG017|Maintenance Period|Adverse Event|0|||
164282726|NCT03364309|593404446|FG018|Maintenance Period|Adverse Event|0|||
164282727|NCT03364309|593404428|FG000|Maintenance Period|Relapsed|0|||
164282728|NCT03364309|593404429|FG001|Maintenance Period|Relapsed|0|||
164282729|NCT03364309|593404430|FG002|Maintenance Period|Relapsed|0|||
164282730|NCT03364309|593404431|FG003|Maintenance Period|Relapsed|43|||
164282731|NCT03364309|593404432|FG004|Maintenance Period|Relapsed|7|||
164282732|NCT03364309|593404433|FG005|Maintenance Period|Relapsed|45|||
164282733|NCT03364309|593404434|FG006|Maintenance Period|Relapsed|10|||
164282734|NCT03364309|593404435|FG007|Maintenance Period|Relapsed|2|||
164282735|NCT03364309|593404436|FG008|Maintenance Period|Relapsed|0|||
164282736|NCT03364309|593404437|FG009|Maintenance Period|Relapsed|0|||
164282737|NCT03364309|593404438|FG010|Maintenance Period|Relapsed|0|||
164282738|NCT03364309|593404439|FG011|Maintenance Period|Relapsed|0|||
164282739|NCT03364309|593404440|FG012|Maintenance Period|Relapsed|0|||
164282740|NCT03364309|593404441|FG013|Maintenance Period|Relapsed|0|||
164282741|NCT03364309|593404442|FG014|Maintenance Period|Relapsed|0|||
164282742|NCT03364309|593404443|FG015|Maintenance Period|Relapsed|0|||
164282743|NCT03364309|593404444|FG016|Maintenance Period|Relapsed|0|||
164282744|NCT03364309|593404445|FG017|Maintenance Period|Relapsed|0|||
164282745|NCT03364309|593404446|FG018|Maintenance Period|Relapsed|0|||
164282746|NCT03364309|593404428|FG000|Maintenance Period|Lack of Efficacy|0|||
164282747|NCT03364309|593404429|FG001|Maintenance Period|Lack of Efficacy|0|||
164282748|NCT03364309|593404430|FG002|Maintenance Period|Lack of Efficacy|0|||
164282749|NCT03364309|593404431|FG003|Maintenance Period|Lack of Efficacy|0|||
164003074|NCT04909463|592375662|FG002|Overall Study|Withdrawal by Subject|0|||
164003075|NCT04909463|592375663|FG003|Overall Study|Withdrawal by Subject|0|||
164003076|NCT04909463|592375660|FG000|Overall Study|Lost to Follow-up|2|||
164003077|NCT04909463|592375661|FG001|Overall Study|Lost to Follow-up|1|||
164003078|NCT04909463|592375662|FG002|Overall Study|Lost to Follow-up|1|||
164003079|NCT04909463|592375663|FG003|Overall Study|Lost to Follow-up|0|||
164003080|NCT00853632|592375664|FG000|Overall Study|Death|88|||
164003081|NCT00853632|592375664|FG000|Overall Study|Withdrawal by Subject|45|||
164003082|NCT00853632|592375664|FG000|Overall Study|Lost to Follow-up|30|||
164003083|NCT00853632|592375664|FG000|Overall Study|Reoperation/Explant|17|||
164003084|NCT00853632|592375664|FG000|Overall Study|Exit with other reason|22|||
164003085|NCT04364854|592375665|FG000|Overall Study|Withdrawal by Subject|1|||
164003086|NCT04364854|592375666|FG001|Overall Study|Withdrawal by Subject|0|||
164003087|NCT04364854|592375667|FG002|Overall Study|Withdrawal by Subject|1|||
164003088|NCT04364854|592375668|FG003|Overall Study|Withdrawal by Subject|3|||
164003089|NCT04364854|592375665|FG000|Overall Study|Death|1|||
164003090|NCT04364854|592375666|FG001|Overall Study|Death|0|||
164003091|NCT04364854|592375667|FG002|Overall Study|Death|0|||
164003092|NCT04364854|592375668|FG003|Overall Study|Death|0|||
164003093|NCT04364854|592375665|FG000|Overall Study|Lost to Follow-up|0|||
164003094|NCT04364854|592375666|FG001|Overall Study|Lost to Follow-up|0|||
164003095|NCT04364854|592375667|FG002|Overall Study|Lost to Follow-up|0|||
164003096|NCT04364854|592375668|FG003|Overall Study|Lost to Follow-up|1|||
164003097|NCT04493619|592375670|FG000|Overall Study|Death|4|||
164282750|NCT03364309|593404432|FG004|Maintenance Period|Lack of Efficacy|0|||
164282751|NCT03364309|593404433|FG005|Maintenance Period|Lack of Efficacy|0|||
164282752|NCT03364309|593404434|FG006|Maintenance Period|Lack of Efficacy|0|||
164282753|NCT03364309|593404435|FG007|Maintenance Period|Lack of Efficacy|0|||
164282754|NCT03364309|593404436|FG008|Maintenance Period|Lack of Efficacy|1|||
164282755|NCT03364309|593404437|FG009|Maintenance Period|Lack of Efficacy|3|||
164282756|NCT03364309|593404438|FG010|Maintenance Period|Lack of Efficacy|2|||
164282757|NCT03364309|593404439|FG011|Maintenance Period|Lack of Efficacy|0|||
164282758|NCT03364309|593404440|FG012|Maintenance Period|Lack of Efficacy|0|||
164282759|NCT03364309|593404441|FG013|Maintenance Period|Lack of Efficacy|0|||
164282760|NCT03364309|593404442|FG014|Maintenance Period|Lack of Efficacy|0|||
164282761|NCT03364309|593404443|FG015|Maintenance Period|Lack of Efficacy|0|||
164282762|NCT03364309|593404444|FG016|Maintenance Period|Lack of Efficacy|0|||
164282763|NCT03364309|593404445|FG017|Maintenance Period|Lack of Efficacy|0|||
164003098|NCT04493619|592375671|FG001|Overall Study|Death|3|||
164003099|NCT04493619|592375672|FG002|Overall Study|Death|3|||
164282764|NCT03364309|593404446|FG018|Maintenance Period|Lack of Efficacy|0|||
164282765|NCT03364309|593404428|FG000|Maintenance Period|Death|0|||
164282766|NCT03364309|593404429|FG001|Maintenance Period|Death|0|||
164282767|NCT03364309|593404430|FG002|Maintenance Period|Death|0|||
164282768|NCT03364309|593404431|FG003|Maintenance Period|Death|0|||
164003100|NCT04493619|592375673|FG003|Overall Study|Death|4|||
164003101|NCT04493619|592375670|FG000|Overall Study|Study discontinued early|10|||
164003102|NCT04493619|592375671|FG001|Overall Study|Study discontinued early|0|||
164003103|NCT04493619|592375672|FG002|Overall Study|Study discontinued early|4|||
164003104|NCT04493619|592375673|FG003|Overall Study|Study discontinued early|8|||
164003105|NCT04493619|592375670|FG000|Overall Study|Lost to Follow-up|0|||
164087496|NCT05658523|592684236|FG001|12 Months|Lost to Follow-up|6|||
164087497|NCT05658523|592684237|FG002|12 Months|Lost to Follow-up|3|||
164087498|NCT05658523|592684235|FG000|12 Months|Withdrawal by Subject|4|||
164087499|NCT05658523|592684236|FG001|12 Months|Withdrawal by Subject|4|||
164087500|NCT05658523|592684237|FG002|12 Months|Withdrawal by Subject|2|||
164087501|NCT05658523|592684235|FG000|12 Months|Visit missed|4|||
164087502|NCT05658523|592684236|FG001|12 Months|Visit missed|8|||
164087503|NCT05658523|592684237|FG002|12 Months|Visit missed|8|||
164087504|NCT05658523|592684235|FG000|18 Months|Lost to Follow-up|5|||
164087505|NCT05658523|592684236|FG001|18 Months|Lost to Follow-up|8|||
164087506|NCT05658523|592684237|FG002|18 Months|Lost to Follow-up|2|||
164087507|NCT05658523|592684235|FG000|18 Months|Withdrawal by Subject|17|||
164087508|NCT05658523|592684236|FG001|18 Months|Withdrawal by Subject|9|||
164087509|NCT05658523|592684237|FG002|18 Months|Withdrawal by Subject|16|||
164087510|NCT05658523|592684235|FG000|18 Months|Visit missed|12|||
164087511|NCT05658523|592684236|FG001|18 Months|Visit missed|14|||
164087512|NCT05658523|592684237|FG002|18 Months|Visit missed|6|||
164087513|NCT03212170|592684238|FG000|Overall Study|Withdrawal by Subject|1|||
164087514|NCT01937364|592684239|FG000|Overall Study|Adverse Event|2|||
164087515|NCT01937364|592684240|FG001|Overall Study|Adverse Event|1|||
164087516|NCT00628212|592684243|FG000|Overall Study|Adverse Event|2|||
164087517|NCT00628212|592684244|FG001|Overall Study|Adverse Event|0|||
164087518|NCT00628212|592684245|FG002|Overall Study|Adverse Event|1|||
164087519|NCT00628212|592684246|FG003|Overall Study|Adverse Event|2|||
164282769|NCT03364309|593404432|FG004|Maintenance Period|Death|0|||
164282770|NCT03364309|593404433|FG005|Maintenance Period|Death|0|||
164282771|NCT03364309|593404434|FG006|Maintenance Period|Death|0|||
164282772|NCT03364309|593404435|FG007|Maintenance Period|Death|0|||
164282773|NCT03364309|593404436|FG008|Maintenance Period|Death|1|||
164282774|NCT03364309|593404437|FG009|Maintenance Period|Death|0|||
164282775|NCT03364309|593404438|FG010|Maintenance Period|Death|0|||
164282776|NCT03364309|593404439|FG011|Maintenance Period|Death|0|||
164282777|NCT03364309|593404440|FG012|Maintenance Period|Death|0|||
164282778|NCT03364309|593404441|FG013|Maintenance Period|Death|0|||
164282779|NCT03364309|593404442|FG014|Maintenance Period|Death|0|||
164282780|NCT03364309|593404443|FG015|Maintenance Period|Death|0|||
164282781|NCT03364309|593404444|FG016|Maintenance Period|Death|0|||
164282782|NCT03364309|593404445|FG017|Maintenance Period|Death|0|||
164087520|NCT00628212|592684243|FG000|Overall Study|Physician Decision|1|||
164087521|NCT00628212|592684244|FG001|Overall Study|Physician Decision|1|||
164087522|NCT00628212|592684245|FG002|Overall Study|Physician Decision|2|||
164087523|NCT00628212|592684246|FG003|Overall Study|Physician Decision|3|||
164087524|NCT02482571|592684247|FG000|Overall Study|Adverse Event|1|||
164087525|NCT02482571|592684247|FG000|Overall Study|Scanner or Respiract failure|3|||
164087526|NCT02482571|592684247|FG000|Overall Study|Withdrawal by Subject|4|||
164087527|NCT01533428|592684248|FG000|Overall Study|Adverse Event|0|||
164087528|NCT01533428|592684249|FG001|Overall Study|Adverse Event|1|||
164087529|NCT01533428|592684248|FG000|Overall Study|Lost to Follow-up|2|||
164087530|NCT01533428|592684249|FG001|Overall Study|Lost to Follow-up|1|||
164087531|NCT01533428|592684248|FG000|Overall Study|Withdrawal by Subject|7|||
164087532|NCT01533428|592684249|FG001|Overall Study|Withdrawal by Subject|6|||
164087533|NCT02102490|592684250|FG000|Overall Study|Death|6|||
164282783|NCT03364309|593404446|FG018|Maintenance Period|Death|0|||
164282784|NCT03364309|593404428|FG000|Maintenance Period|Lost to Follow-up|0|||
164344567|NCT03706079|593636984|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164344568|NCT03706079|593636985|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164344569|NCT03706079|593636986|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
164344570|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164087534|NCT02102490|592684250|FG000|Overall Study|Lost to Follow-up|1|||
164344571|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344572|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344573|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344574|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
164344575|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
164344576|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
164087535|NCT00095199|592684251|FG000|Overall Study|Adverse Event|40|||
164087536|NCT00095199|592684252|FG001|Overall Study|Adverse Event|22|||
164087537|NCT00095199|592684253|FG002|Overall Study|Adverse Event|26|||
164087538|NCT00095199|592684254|FG003|Overall Study|Adverse Event|11|||
164087539|NCT00095199|592684251|FG000|Overall Study|Progressive disease|213|||
164282785|NCT03364309|593404429|FG001|Maintenance Period|Lost to Follow-up|0|||
164282786|NCT03364309|593404430|FG002|Maintenance Period|Lost to Follow-up|0|||
164282787|NCT03364309|593404431|FG003|Maintenance Period|Lost to Follow-up|0|||
164282788|NCT03364309|593404432|FG004|Maintenance Period|Lost to Follow-up|0|||
164087540|NCT00095199|592684252|FG001|Overall Study|Progressive disease|179|||
164087541|NCT00095199|592684253|FG002|Overall Study|Progressive disease|105|||
164087542|NCT00095199|592684254|FG003|Overall Study|Progressive disease|98|||
164282789|NCT03364309|593404433|FG005|Maintenance Period|Lost to Follow-up|0|||
164282790|NCT03364309|593404434|FG006|Maintenance Period|Lost to Follow-up|0|||
164282791|NCT03364309|593404435|FG007|Maintenance Period|Lost to Follow-up|0|||
164282792|NCT03364309|593404436|FG008|Maintenance Period|Lost to Follow-up|1|||
164282793|NCT03364309|593404437|FG009|Maintenance Period|Lost to Follow-up|0|||
164003106|NCT04493619|592375671|FG001|Overall Study|Lost to Follow-up|0|||
164003107|NCT04493619|592375672|FG002|Overall Study|Lost to Follow-up|0|||
164003108|NCT04493619|592375673|FG003|Overall Study|Lost to Follow-up|1|||
164003109|NCT03528681|592375679|FG000|Open-Label Phase|Physician Decision|2|||
164003110|NCT03528681|592375680|FG001|Open-Label Phase|Physician Decision|0|||
164003111|NCT03528681|592375681|FG002|Open-Label Phase|Physician Decision|0|||
164003112|NCT03528681|592375682|FG003|Open-Label Phase|Physician Decision|0|||
164282794|NCT03364309|593404438|FG010|Maintenance Period|Lost to Follow-up|0|||
164282795|NCT03364309|593404439|FG011|Maintenance Period|Lost to Follow-up|0|||
164282796|NCT03364309|593404440|FG012|Maintenance Period|Lost to Follow-up|0|||
164282797|NCT03364309|593404441|FG013|Maintenance Period|Lost to Follow-up|0|||
164282798|NCT03364309|593404442|FG014|Maintenance Period|Lost to Follow-up|0|||
164282799|NCT03364309|593404443|FG015|Maintenance Period|Lost to Follow-up|0|||
164282800|NCT03364309|593404444|FG016|Maintenance Period|Lost to Follow-up|0|||
164282801|NCT03364309|593404445|FG017|Maintenance Period|Lost to Follow-up|0|||
164282802|NCT03364309|593404446|FG018|Maintenance Period|Lost to Follow-up|0|||
164282803|NCT03364309|593404428|FG000|Maintenance Period|Miscellaneous|0|||
164282804|NCT03364309|593404429|FG001|Maintenance Period|Miscellaneous|0|||
164282805|NCT03364309|593404430|FG002|Maintenance Period|Miscellaneous|0|||
164282806|NCT03364309|593404431|FG003|Maintenance Period|Miscellaneous|0|||
164282807|NCT03364309|593404432|FG004|Maintenance Period|Miscellaneous|0|||
164282808|NCT03364309|593404433|FG005|Maintenance Period|Miscellaneous|0|||
164282809|NCT03364309|593404434|FG006|Maintenance Period|Miscellaneous|0|||
164282810|NCT03364309|593404435|FG007|Maintenance Period|Miscellaneous|0|||
164282811|NCT03364309|593404436|FG008|Maintenance Period|Miscellaneous|1|||
164282812|NCT03364309|593404437|FG009|Maintenance Period|Miscellaneous|0|||
164282813|NCT03364309|593404438|FG010|Maintenance Period|Miscellaneous|0|||
164282814|NCT03364309|593404439|FG011|Maintenance Period|Miscellaneous|0|||
164282815|NCT03364309|593404440|FG012|Maintenance Period|Miscellaneous|0|||
164282816|NCT03364309|593404441|FG013|Maintenance Period|Miscellaneous|0|||
164282817|NCT03364309|593404442|FG014|Maintenance Period|Miscellaneous|0|||
164282818|NCT03364309|593404443|FG015|Maintenance Period|Miscellaneous|0|||
164282819|NCT03364309|593404444|FG016|Maintenance Period|Miscellaneous|0|||
164282820|NCT03364309|593404445|FG017|Maintenance Period|Miscellaneous|0|||
164003113|NCT03528681|592375679|FG000|Open-Label Phase|Withdrawal by Subject|8|||
164003114|NCT03528681|592375680|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164003115|NCT03528681|592375681|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164003116|NCT03528681|592375682|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164003117|NCT03528681|592375679|FG000|Open-Label Phase|(Not collected)|4|||
164003118|NCT03528681|592375680|FG001|Open-Label Phase|(Not collected)|0|||
164003119|NCT03528681|592375681|FG002|Open-Label Phase|(Not collected)|0|||
164003120|NCT03528681|592375682|FG003|Open-Label Phase|(Not collected)|0|||
164003121|NCT03528681|592375679|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
164003122|NCT03528681|592375680|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
164003123|NCT03528681|592375681|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
164003124|NCT03528681|592375682|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
164003125|NCT03528681|592375679|FG000|Randomized Treatment Phase|Physician Decision|0|||
164003126|NCT03528681|592375680|FG001|Randomized Treatment Phase|Physician Decision|5|||
164003127|NCT03528681|592375681|FG002|Randomized Treatment Phase|Physician Decision|1|||
164003128|NCT03528681|592375682|FG003|Randomized Treatment Phase|Physician Decision|2|||
164003129|NCT03528681|592375679|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
164003130|NCT03528681|592375680|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
164282821|NCT03364309|593404446|FG018|Maintenance Period|Miscellaneous|0|||
164282822|NCT03364309|593404428|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282823|NCT03364309|593404429|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282824|NCT03364309|593404430|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282825|NCT03364309|593404431|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164344577|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344578|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
164003131|NCT03528681|592375681|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
164003132|NCT03528681|592375682|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
164087543|NCT00095199|592684251|FG000|Overall Study|Death|10|||
164282826|NCT03364309|593404432|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282827|NCT03364309|593404433|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282828|NCT03364309|593404434|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282829|NCT03364309|593404435|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164003133|NCT03528681|592375679|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
164003134|NCT03528681|592375680|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
164087544|NCT00095199|592684252|FG001|Overall Study|Death|6|||
163897129|NCT02502266|591997847|FG006|Overall Study|Never treated|0|||
163897130|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|Other|0|||
163897131|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|Other|2|||
164282830|NCT03364309|593404436|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282831|NCT03364309|593404437|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
163897132|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|Other|1|||
163897133|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|Other|2|||
164282832|NCT03364309|593404438|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282833|NCT03364309|593404439|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282834|NCT03364309|593404440|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282835|NCT03364309|593404441|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
164282836|NCT03364309|593404442|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
164282837|NCT03364309|593404443|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
164282838|NCT03364309|593404444|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282839|NCT03364309|593404445|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282840|NCT03364309|593404446|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
164282841|NCT03364309|593404428|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282842|NCT03364309|593404429|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282843|NCT03364309|593404430|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282844|NCT03364309|593404431|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282845|NCT03364309|593404432|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282846|NCT03364309|593404433|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282847|NCT03364309|593404434|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282848|NCT03364309|593404435|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282849|NCT03364309|593404436|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282850|NCT03364309|593404437|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282851|NCT03364309|593404438|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282852|NCT03364309|593404439|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282853|NCT03364309|593404440|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282854|NCT03364309|593404441|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282855|NCT03364309|593404442|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
164282856|NCT03364309|593404443|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282857|NCT03364309|593404444|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282858|NCT03364309|593404445|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282859|NCT03364309|593404446|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
164282860|NCT03364309|593404428|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
164282861|NCT03364309|593404429|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
164282862|NCT03364309|593404430|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
164282863|NCT03364309|593404431|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
164282864|NCT03364309|593404432|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
164282865|NCT03364309|593404433|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
164282866|NCT03364309|593404434|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
164282867|NCT03364309|593404435|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
164282868|NCT03364309|593404436|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
164282869|NCT03364309|593404437|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
163897134|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|Other|2|||
164282870|NCT03364309|593404438|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
164282871|NCT03364309|593404439|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
164282872|NCT03364309|593404440|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
163897135|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|Other|0|||
163897136|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|Other|0|||
163897137|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|Other|0|||
163897138|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|Other|0|||
163897139|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|Other|0|||
163897140|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|Other|0|||
163897141|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|Other|0|||
163897142|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|Other|0|||
163897143|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|Other|0|||
163897144|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|Other|0|||
163897145|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|Other|0|||
163897146|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|Other|0|||
163897147|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
163897148|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
163897149|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
163897150|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
163897151|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
163897152|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
164003135|NCT03528681|592375681|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
164003136|NCT03528681|592375682|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
164003137|NCT03528681|592375679|FG000|Randomized Treatment Phase|(Not collected)|0|||
164003138|NCT03528681|592375680|FG001|Randomized Treatment Phase|(Not collected)|4|||
164003139|NCT03528681|592375681|FG002|Randomized Treatment Phase|(Not collected)|6|||
164003140|NCT03528681|592375682|FG003|Randomized Treatment Phase|(Not collected)|5|||
164003141|NCT02342171|592375687|FG000|Overall Study|Death|4|||
164087545|NCT00095199|592684253|FG002|Overall Study|Death|11|||
164087546|NCT00095199|592684254|FG003|Overall Study|Death|9|||
164087547|NCT00095199|592684251|FG000|Overall Study|Withdrawal by Subject|21|||
164087548|NCT00095199|592684252|FG001|Overall Study|Withdrawal by Subject|16|||
164087549|NCT00095199|592684253|FG002|Overall Study|Withdrawal by Subject|13|||
164087550|NCT00095199|592684254|FG003|Overall Study|Withdrawal by Subject|22|||
164087551|NCT00095199|592684251|FG000|Overall Study|Protocol Violation|4|||
164087552|NCT00095199|592684252|FG001|Overall Study|Protocol Violation|4|||
164087553|NCT00095199|592684253|FG002|Overall Study|Protocol Violation|2|||
164282873|NCT03364309|593404441|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
164282874|NCT03364309|593404442|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
164282875|NCT03364309|593404443|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
164282876|NCT03364309|593404444|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
164282877|NCT03364309|593404445|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
164282878|NCT03364309|593404446|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
164282879|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282880|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282881|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282882|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282883|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282884|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164003142|NCT02342171|592375688|FG001|Overall Study|Death|87|||
164003143|NCT02342171|592375687|FG000|Overall Study|Received favipiravir|10|||
164003144|NCT02342171|592375688|FG001|Overall Study|Received favipiravir|0|||
164003145|NCT02342171|592375687|FG000|Overall Study|Missing cycle treshold value|1|||
164003146|NCT02342171|592375688|FG001|Overall Study|Missing cycle treshold value|0|||
164003147|NCT02342171|592375687|FG000|Overall Study|Unknown outcome|0|||
164003148|NCT02342171|592375688|FG001|Overall Study|Unknown outcome|1|||
164087554|NCT00095199|592684254|FG003|Overall Study|Protocol Violation|0|||
164282885|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282886|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282887|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282888|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282889|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282890|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282891|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282892|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282893|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282894|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164282895|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
164282896|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
164282897|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
164282898|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Adverse Event|0|||
164282899|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Adverse Event|0|||
164282900|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Adverse Event|0|||
164344579|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344580|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344581|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
164344582|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
164344583|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344584|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344585|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344586|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344587|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
164344588|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164344589|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164344590|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164344591|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
164344592|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
164003149|NCT02342171|592375687|FG000|Overall Study|Missing age data|0|||
164087555|NCT00095199|592684251|FG000|Overall Study|Liver function test results elevated|0|||
164087556|NCT00095199|592684252|FG001|Overall Study|Liver function test results elevated|0|||
164344593|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
164344594|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
164344595|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
164344596|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
164344597|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
164344598|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
164344599|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
164344600|NCT03706079|593636981|FG000|Long Term Extension (DESTINATION)|Death|8|||
164344601|NCT03706079|593636982|FG001|Long Term Extension (DESTINATION)|Death|2|||
164344602|NCT03706079|593636983|FG002|Long Term Extension (DESTINATION)|Death|2|||
164344603|NCT03706079|593636984|FG003|Long Term Extension (DESTINATION)|Death|1|||
164344604|NCT03706079|593636985|FG004|Long Term Extension (DESTINATION)|Death|0|||
164344605|NCT03706079|593636986|FG005|Long Term Extension (DESTINATION)|Death|0|||
164344606|NCT00329238|593636987|FG000|Overall Study|Adverse Event|147|||
164344607|NCT00329238|593636988|FG001|Overall Study|Adverse Event|129|||
164344608|NCT00329238|593636987|FG000|Overall Study|Protocol Violation|23|||
164344609|NCT00329238|593636988|FG001|Overall Study|Protocol Violation|34|||
164344610|NCT00329238|593636987|FG000|Overall Study|Lost to Follow-up|2|||
164344611|NCT00329238|593636988|FG001|Overall Study|Lost to Follow-up|6|||
164344612|NCT00329238|593636987|FG000|Overall Study|Withdrawal by Subject|64|||
164003150|NCT02342171|592375688|FG001|Overall Study|Missing age data|1|||
164003151|NCT03518840|592375691|FG000|Overall Study|Lost to Follow-up|6|||
164003152|NCT00875420|592375694|FG000|Overall Study|Adverse Event|0|||
164003153|NCT00875420|592375695|FG001|Overall Study|Adverse Event|1|||
164003154|NCT00875420|592375696|FG002|Overall Study|Adverse Event|1|||
164003155|NCT00875420|592375697|FG003|Overall Study|Adverse Event|0|||
164003156|NCT00875420|592375698|FG004|Overall Study|Adverse Event|0|||
164003157|NCT00875420|592375694|FG000|Overall Study|Inability to complete study procedures|1|||
164003158|NCT00875420|592375695|FG001|Overall Study|Inability to complete study procedures|0|||
164003159|NCT00875420|592375696|FG002|Overall Study|Inability to complete study procedures|1|||
164003160|NCT00875420|592375697|FG003|Overall Study|Inability to complete study procedures|1|||
164003161|NCT00875420|592375698|FG004|Overall Study|Inability to complete study procedures|1|||
164003162|NCT00875420|592375694|FG000|Overall Study|Lost to Follow-up|1|||
164003163|NCT00875420|592375695|FG001|Overall Study|Lost to Follow-up|0|||
164003164|NCT00875420|592375696|FG002|Overall Study|Lost to Follow-up|0|||
164003165|NCT00875420|592375697|FG003|Overall Study|Lost to Follow-up|0|||
164003166|NCT00875420|592375698|FG004|Overall Study|Lost to Follow-up|0|||
164003167|NCT00875420|592375694|FG000|Overall Study|Personal reason|0|||
164003168|NCT00875420|592375695|FG001|Overall Study|Personal reason|0|||
164003169|NCT00875420|592375696|FG002|Overall Study|Personal reason|0|||
164003170|NCT00875420|592375697|FG003|Overall Study|Personal reason|0|||
164003171|NCT00875420|592375698|FG004|Overall Study|Personal reason|1|||
164003172|NCT00875420|592375694|FG000|Overall Study|Prohibited medication|0|||
164003173|NCT00875420|592375695|FG001|Overall Study|Prohibited medication|0|||
164003174|NCT00875420|592375696|FG002|Overall Study|Prohibited medication|0|||
164003175|NCT00875420|592375697|FG003|Overall Study|Prohibited medication|1|||
164003176|NCT00875420|592375698|FG004|Overall Study|Prohibited medication|0|||
164003177|NCT00875420|592375694|FG000|Overall Study|Sponsor decision|0|||
164003178|NCT00875420|592375695|FG001|Overall Study|Sponsor decision|1|||
164003179|NCT00875420|592375696|FG002|Overall Study|Sponsor decision|0|||
164003180|NCT00875420|592375697|FG003|Overall Study|Sponsor decision|0|||
164003181|NCT00875420|592375698|FG004|Overall Study|Sponsor decision|0|||
164003182|NCT00875420|592375694|FG000|Overall Study|Withdrawal by Subject|0|||
164003183|NCT00875420|592375695|FG001|Overall Study|Withdrawal by Subject|0|||
164003184|NCT00875420|592375696|FG002|Overall Study|Withdrawal by Subject|1|||
164003185|NCT00875420|592375697|FG003|Overall Study|Withdrawal by Subject|0|||
164003186|NCT00875420|592375698|FG004|Overall Study|Withdrawal by Subject|0|||
164143313|NCT05246670|592886587|FG001|Overall Study|Protocol Violation|0|||
164003187|NCT00914628|592375701|FG000|Overall Study|Death|35|||
164003188|NCT00914628|592375702|FG001|Overall Study|Death|17|||
164003189|NCT00914628|592375701|FG000|Overall Study|Medical decision|4|||
164003190|NCT00914628|592375702|FG001|Overall Study|Medical decision|0|||
164003191|NCT00914628|592375701|FG000|Overall Study|Protocol Violation|1|||
164003192|NCT00914628|592375702|FG001|Overall Study|Protocol Violation|0|||
164003193|NCT00914628|592375701|FG000|Overall Study|Lack of Efficacy|1|||
164344613|NCT00329238|593636988|FG001|Overall Study|Withdrawal by Subject|58|||
164344614|NCT00329238|593636987|FG000|Overall Study|Other reason (not specified)|40|||
164344615|NCT00329238|593636988|FG001|Overall Study|Other reason (not specified)|54|||
164344616|NCT01306942|593636999|FG000|Phase I|Adverse Event|2|||
164344617|NCT01306942|593637000|FG001|Phase I|Adverse Event|2|||
164003194|NCT00914628|592375702|FG001|Overall Study|Lack of Efficacy|0|||
164003195|NCT00914628|592375701|FG000|Overall Study|non-randomized|1|||
164003196|NCT00914628|592375702|FG001|Overall Study|non-randomized|0|||
164003197|NCT00914628|592375701|FG000|Overall Study|Relapse|1|||
164003198|NCT00914628|592375702|FG001|Overall Study|Relapse|2|||
164003199|NCT00914628|592375701|FG000|Overall Study|Study terminated by Sponsor|14|||
164003200|NCT00914628|592375702|FG001|Overall Study|Study terminated by Sponsor|8|||
164003201|NCT00914628|592375701|FG000|Overall Study|Patients who did not receive a single dose|7|||
164003202|NCT00914628|592375702|FG001|Overall Study|Patients who did not receive a single dose|1|||
164003203|NCT00374556|592375703|FG000|Overall Study|Lost to Follow-up|1|||
164003204|NCT00374556|592375704|FG001|Overall Study|Lost to Follow-up|0|||
164003205|NCT00374556|592375703|FG000|Overall Study|Removed at baseline due to medical cond|0|||
164003206|NCT00374556|592375704|FG001|Overall Study|Removed at baseline due to medical cond|1|||
164003207|NCT00473694|592375705|FG000|Overall Study|Adverse Event|0|||
164003208|NCT00473694|592375706|FG001|Overall Study|Adverse Event|1|||
164003209|NCT00473694|592375707|FG002|Overall Study|Adverse Event|0|||
164003210|NCT00473694|592375708|FG003|Overall Study|Adverse Event|0|||
164003211|NCT00473694|592375705|FG000|Overall Study|Participants did not receive treatment|11|||
164003212|NCT00473694|592375706|FG001|Overall Study|Participants did not receive treatment|3|||
164003213|NCT00473694|592375707|FG002|Overall Study|Participants did not receive treatment|5|||
164003214|NCT00473694|592375708|FG003|Overall Study|Participants did not receive treatment|6|||
164003215|NCT00473694|592375705|FG000|Overall Study|Lost to Follow-up|0|||
164003216|NCT00473694|592375706|FG001|Overall Study|Lost to Follow-up|0|||
164003217|NCT00473694|592375707|FG002|Overall Study|Lost to Follow-up|0|||
164003218|NCT00473694|592375708|FG003|Overall Study|Lost to Follow-up|1|||
164003219|NCT00742781|592375709|FG000|Overall Study|Withdrawal by Subject|3|||
164003220|NCT01416181|592375710|FG000|Part 1|Other|10|||
164003221|NCT01416181|592375711|FG001|Part 1|Other|24|||
164003222|NCT01416181|592375710|FG000|Part 1|Death|0|||
164003223|NCT01416181|592375711|FG001|Part 1|Death|1|||
164003224|NCT01416181|592375710|FG000|Part 1|Investigator Decision|7|||
164003225|NCT01416181|592375711|FG001|Part 1|Investigator Decision|6|||
164003226|NCT01416181|592375710|FG000|Part 1|Withdrawal by Subject|74|||
164003227|NCT01416181|592375711|FG001|Part 1|Withdrawal by Subject|48|||
164003228|NCT01416181|592375710|FG000|Part 1|Lack of Efficacy|16|||
164003229|NCT01416181|592375711|FG001|Part 1|Lack of Efficacy|8|||
164003230|NCT01416181|592375710|FG000|Part 1|Lost to Follow-up|1|||
164003231|NCT01416181|592375711|FG001|Part 1|Lost to Follow-up|1|||
164003232|NCT01416181|592375710|FG000|Part 1|Adverse Event|15|||
164003233|NCT01416181|592375711|FG001|Part 1|Adverse Event|18|||
164003234|NCT01416181|592375710|FG000|Part 1|Ongoing in Follow-Up|14|||
164003235|NCT01416181|592375711|FG001|Part 1|Ongoing in Follow-Up|8|||
164003236|NCT01416181|592375710|FG000|Part 2|Adverse Event|11|||
164003237|NCT01416181|592375711|FG001|Part 2|Adverse Event|4|||
164003238|NCT01416181|592375710|FG000|Part 2|Other|234|||
164003239|NCT01416181|592375711|FG001|Part 2|Other|267|||
164003240|NCT01416181|592375710|FG000|Part 2|Investigator Decision|6|||
164003241|NCT01416181|592375711|FG001|Part 2|Investigator Decision|7|||
164282901|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Adverse Event|0|||
164282902|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Adverse Event|0|||
164282903|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Adverse Event|0|||
164282904|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Adverse Event|0|||
164282905|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Adverse Event|0|||
164003242|NCT01416181|592375710|FG000|Part 2|Withdrawal by Subject|14|||
164003243|NCT01416181|592375711|FG001|Part 2|Withdrawal by Subject|5|||
164003244|NCT01416181|592375710|FG000|Part 2|Lack of Efficacy|4|||
164003245|NCT01416181|592375711|FG001|Part 2|Lack of Efficacy|1|||
164003246|NCT01416181|592375710|FG000|Part 2|Lost to Follow-up|2|||
164282906|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Adverse Event|0|||
164282907|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Adverse Event|0|||
164003247|NCT01416181|592375711|FG001|Part 2|Lost to Follow-up|2|||
164003248|NCT01756157|592375712|FG000|First Intervention Period|Withdrawal by Subject|1|||
164003249|NCT01756157|592375713|FG001|First Intervention Period|Withdrawal by Subject|0|||
164003250|NCT01756157|592375712|FG000|First Intervention Period|Lost to Follow-up|0|||
164003251|NCT01756157|592375713|FG001|First Intervention Period|Lost to Follow-up|2|||
164003252|NCT02799381|592375716|FG000|Overall Study|Withdrew consent|3|||
164003253|NCT02799381|592375717|FG001|Overall Study|Withdrew consent|2|||
164003254|NCT02799381|592375716|FG000|Overall Study|Adverse Event|0|||
164003255|NCT02799381|592375717|FG001|Overall Study|Adverse Event|1|||
164003256|NCT02799381|592375716|FG000|Overall Study|Participant did not take any study drug|1|||
164003257|NCT02799381|592375717|FG001|Overall Study|Participant did not take any study drug|0|||
164003258|NCT02638012|592375720|FG000|Overall Study|Lost to Follow-up|1|||
164003259|NCT00621023|592375721|FG000|Overall Study|Death|5|||
164003260|NCT00621023|592375721|FG000|Overall Study|Follow up discontinued|1|||
164003261|NCT03816995|592375724|FG000|Overall Study|Withdrawal by Subject|3|||
164003262|NCT03816995|592375725|FG001|Overall Study|Withdrawal by Subject|1|||
164282908|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Adverse Event|0|||
164282909|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Adverse Event|0|||
164282910|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Adverse Event|0|||
164282911|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Adverse Event|0|||
164282912|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Adverse Event|0|||
164282913|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Adverse Event|0|||
164282914|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Adverse Event|2|||
164282915|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Adverse Event|6|||
164282916|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Adverse Event|1|||
164282917|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282918|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282919|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282920|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
163897153|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
164003263|NCT03816995|592375724|FG000|Overall Study|Cancelled Surgery|8|||
164003264|NCT03816995|592375725|FG001|Overall Study|Cancelled Surgery|12|||
164003265|NCT03816995|592375724|FG000|Overall Study|No wound protector used|11|||
164003266|NCT03816995|592375725|FG001|Overall Study|No wound protector used|17|||
164003267|NCT03816995|592375724|FG000|Overall Study|Protocol Violation|2|||
164003268|NCT03816995|592375725|FG001|Overall Study|Protocol Violation|3|||
164003269|NCT00486902|592375726|FG000|Overall Study|Withdrawal by Subject|1|||
164003270|NCT00486902|592375727|FG001|Overall Study|Withdrawal by Subject|2|||
164003271|NCT00486902|592375726|FG000|Overall Study|decision for postpartum tubal ligation|3|||
164003272|NCT00486902|592375727|FG001|Overall Study|decision for postpartum tubal ligation|1|||
164003273|NCT00486902|592375726|FG000|Overall Study|spinal anesthetic protocal violation|1|||
164003274|NCT00486902|592375727|FG001|Overall Study|spinal anesthetic protocal violation|1|||
164003275|NCT00486902|592375726|FG000|Overall Study|Did not meet inclusion criteria|1|||
164003276|NCT00486902|592375727|FG001|Overall Study|Did not meet inclusion criteria|0|||
164003277|NCT00486902|592375726|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
164003278|NCT00486902|592375727|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
164003279|NCT04331899|592375728|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
164003280|NCT04331899|592375729|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
164003281|NCT01062399|592375730|FG000|Overall Study|Protocol Violation|0|||
164003282|NCT01062399|592375731|FG001|Overall Study|Protocol Violation|1|||
164003283|NCT01062399|592375732|FG002|Overall Study|Protocol Violation|0|||
164003284|NCT01062399|592375733|FG003|Overall Study|Protocol Violation|6|||
164003285|NCT01062399|592375734|FG004|Overall Study|Protocol Violation|4|||
164003286|NCT00813748|592375735|FG000|Skin Test Substudy|Physician Decision|0|||
164003287|NCT00813748|592375736|FG001|Skin Test Substudy|Physician Decision|1|||
164003288|NCT01829048|592375737|FG000|Overall Study|Withdrawal by Subject|0|||
164003289|NCT01829048|592375738|FG001|Overall Study|Withdrawal by Subject|0|||
163897154|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897155|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897156|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897157|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897158|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897159|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897160|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897161|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897162|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897163|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
163897164|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897165|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
163897166|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
163897167|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897168|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
163897169|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
163897170|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897171|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897172|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
164282921|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282922|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282923|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282924|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282925|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282926|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282927|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282928|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282929|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282930|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282931|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282932|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282933|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282934|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
164282935|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
164282936|NCT03364309|593404428|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
164344618|NCT01306942|593637001|FG002|Phase I|Adverse Event|0|||
164344619|NCT01306942|593637002|FG003|Phase I|Adverse Event|0|||
164344620|NCT01306942|593636999|FG000|Phase I|Physician Decision|3|||
164344621|NCT01306942|593637000|FG001|Phase I|Physician Decision|1|||
164344622|NCT01306942|593637001|FG002|Phase I|Physician Decision|0|||
164344623|NCT01306942|593637002|FG003|Phase I|Physician Decision|0|||
164344624|NCT01306942|593636999|FG000|Phase II|Adverse Event|0|||
164344625|NCT01306942|593637000|FG001|Phase II|Adverse Event|0|||
164344626|NCT01306942|593637001|FG002|Phase II|Adverse Event|0|||
164344627|NCT01306942|593637002|FG003|Phase II|Adverse Event|6|||
164344628|NCT01306942|593636999|FG000|Phase II|Physician Decision|2|||
164344629|NCT01306942|593637000|FG001|Phase II|Physician Decision|0|||
164344630|NCT01306942|593637001|FG002|Phase II|Physician Decision|0|||
164344631|NCT01306942|593637002|FG003|Phase II|Physician Decision|5|||
164344632|NCT01306942|593636999|FG000|Phase II|Withdrawal by Subject|0|||
164344633|NCT01306942|593637000|FG001|Phase II|Withdrawal by Subject|0|||
164344634|NCT01306942|593637001|FG002|Phase II|Withdrawal by Subject|0|||
164344635|NCT01306942|593637002|FG003|Phase II|Withdrawal by Subject|2|||
163897173|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897174|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897175|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897176|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897177|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897178|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897179|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897180|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
163897181|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|Death|2|||
163897182|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|Death|1|||
163897183|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|Death|1|||
163897184|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|Death|0|||
163897185|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|Death|0|||
163897186|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|Death|0|||
163897187|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|Death|0|||
163897188|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|Death|0|||
163897189|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|Death|0|||
163897190|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|Death|0|||
163897191|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|Death|0|||
163897192|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|Death|0|||
163897193|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|Death|0|||
163897194|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|Death|0|||
163897195|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|Death|0|||
163897196|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|Death|0|||
163897197|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|Death|0|||
163897198|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897199|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
163897200|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897201|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897202|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
163897203|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
163897204|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897205|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897206|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897207|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897208|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897209|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897210|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
164344636|NCT01306942|593636999|FG000|Phase II|Death|0|||
163897211|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
164344637|NCT01306942|593637000|FG001|Phase II|Death|0|||
164344638|NCT01306942|593637001|FG002|Phase II|Death|0|||
164282937|NCT03364309|593404429|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
164282938|NCT03364309|593404430|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
164282939|NCT03364309|593404431|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
164282940|NCT03364309|593404432|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
164282941|NCT03364309|593404433|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
164282942|NCT03364309|593404434|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
164282943|NCT03364309|593404435|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
164282944|NCT03364309|593404436|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
163897212|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897213|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897214|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
163897215|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897216|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897217|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897218|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897219|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
163897220|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
163897221|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897222|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897223|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897224|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897225|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897226|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897227|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897228|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897229|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897230|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897231|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
163897232|NCT02719574|591997848|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897233|NCT02719574|591997849|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897234|NCT02719574|591997850|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
163897235|NCT02719574|591997851|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897236|NCT02719574|591997852|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897237|NCT02719574|591997853|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897238|NCT02719574|591997854|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897239|NCT02719574|591997855|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897240|NCT02719574|591997856|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897241|NCT02719574|591997857|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897242|NCT02719574|591997858|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897243|NCT02719574|591997859|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897244|NCT02719574|591997860|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897245|NCT02719574|591997861|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897246|NCT02719574|591997862|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897247|NCT02719574|591997863|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897248|NCT02719574|591997864|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
163897249|NCT02719574|591997848|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897250|NCT02719574|591997849|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897251|NCT02719574|591997850|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897252|NCT02719574|591997851|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897253|NCT02719574|591997852|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897254|NCT02719574|591997853|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897255|NCT02719574|591997854|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
163897256|NCT02719574|591997855|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
163897257|NCT02719574|591997856|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
163897258|NCT02719574|591997857|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897259|NCT02719574|591997858|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897260|NCT02719574|591997859|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897261|NCT02719574|591997860|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897262|NCT02719574|591997861|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897263|NCT02719574|591997862|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897264|NCT02719574|591997863|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897265|NCT02719574|591997864|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
163897266|NCT02719574|591997848|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897267|NCT02719574|591997849|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897268|NCT02719574|591997850|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897269|NCT02719574|591997851|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897270|NCT02719574|591997852|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897271|NCT02719574|591997853|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897272|NCT02719574|591997854|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
163897273|NCT02719574|591997855|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
163897274|NCT02719574|591997856|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
164282945|NCT03364309|593404437|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
164282946|NCT03364309|593404438|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
164282947|NCT03364309|593404439|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
164282948|NCT03364309|593404440|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
164282949|NCT03364309|593404441|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
164282950|NCT03364309|593404442|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
164282951|NCT03364309|593404443|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
164282952|NCT03364309|593404444|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
164282953|NCT03364309|593404445|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
164282954|NCT03364309|593404446|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
164282955|NCT00167310|593404447|FG000|Overall Study|Protocol Violation|5|||
164282956|NCT00167310|593404448|FG001|Overall Study|Protocol Violation|3|||
164282957|NCT00167310|593404447|FG000|Overall Study|Withdrawal by Subject|3|||
164282958|NCT00167310|593404448|FG001|Overall Study|Withdrawal by Subject|7|||
164282959|NCT00615992|593404449|FG000|Overall Study|Protocol Violation|67|||
164282960|NCT04522141|593404451|FG000|Overall Study|Withdrawal by Subject|1|||
164282961|NCT04522141|593404452|FG001|Overall Study|Withdrawal by Subject|0|||
164282962|NCT03052049|593404453|FG000|Overall Study|Withdrawal by Subject|2|||
164282963|NCT03508609|593404454|FG000|Overall Study|Withdrawal by Subject|1|||
164282964|NCT02328027|593404455|FG000|Overall Study|Withdrawal by Subject|0|||
164282965|NCT02328027|593404456|FG001|Overall Study|Withdrawal by Subject|1|||
164282966|NCT03304873|593404457|FG000|Overall Study|Lost to Follow-up|1|||
164282967|NCT03304873|593404458|FG001|Overall Study|Lost to Follow-up|8|||
164282968|NCT03319212|593404459|FG000|Overall Study|Discontinued as moving out of local area|0|||
164282969|NCT03319212|593404460|FG001|Overall Study|Discontinued as moving out of local area|1|||
164282970|NCT03319212|593404459|FG000|Overall Study|Adverse Event|2|||
164282971|NCT03319212|593404460|FG001|Overall Study|Adverse Event|2|||
164282972|NCT03319212|593404459|FG000|Overall Study|Withdrawal by Subject|0|||
164282973|NCT03319212|593404460|FG001|Overall Study|Withdrawal by Subject|1|||
164344639|NCT01306942|593637002|FG003|Phase II|Death|1|||
164344640|NCT01306942|593636999|FG000|Phase II|Not finished treatment|0|||
164344641|NCT01306942|593637000|FG001|Phase II|Not finished treatment|0|||
164003290|NCT01829048|592375739|FG002|Overall Study|Withdrawal by Subject|0|||
164003291|NCT01829048|592375740|FG003|Overall Study|Withdrawal by Subject|2|||
164003292|NCT01829048|592375741|FG004|Overall Study|Withdrawal by Subject|0|||
164003293|NCT03584009|592375745|FG000|Overall Study|Death|25|||
164003294|NCT03584009|592375746|FG001|Overall Study|Death|18|||
164003295|NCT03584009|592375745|FG000|Overall Study|Lost to Follow-up|0|||
164003296|NCT03584009|592375746|FG001|Overall Study|Lost to Follow-up|1|||
164003297|NCT03584009|592375745|FG000|Overall Study|Physician Decision|1|||
164003298|NCT03584009|592375746|FG001|Overall Study|Physician Decision|1|||
164003299|NCT03584009|592375745|FG000|Overall Study|Study Terminated by Sponsor|22|||
164003300|NCT03584009|592375746|FG001|Overall Study|Study Terminated by Sponsor|30|||
164003301|NCT03584009|592375745|FG000|Overall Study|Withdrawal by Subject|3|||
164003302|NCT03584009|592375746|FG001|Overall Study|Withdrawal by Subject|2|||
164003303|NCT04112914|592375747|FG000|Overall Study|Lost to Follow-up|13|||
164003304|NCT04112914|592375748|FG001|Overall Study|Lost to Follow-up|9|||
164003305|NCT04112914|592375747|FG000|Overall Study|Withdrawal by Subject|1|||
164003306|NCT04112914|592375748|FG001|Overall Study|Withdrawal by Subject|0|||
164003307|NCT00768560|592375749|FG000|Intervention Set 1|Adverse Event|0|||
164003308|NCT00768560|592375750|FG001|Intervention Set 1|Adverse Event|1|||
164003309|NCT00768560|592375751|FG002|Intervention Set 1|Adverse Event|0|||
164003310|NCT00768560|592375752|FG003|Intervention Set 1|Adverse Event|0|||
164003311|NCT00768560|592375753|FG004|Intervention Set 1|Adverse Event|0|||
164003312|NCT00768560|592375754|FG005|Intervention Set 1|Adverse Event|0|||
164003313|NCT02635204|592375755|FG000|Overall Study|Adverse Event|1|||
164003314|NCT02635204|592375756|FG001|Overall Study|Adverse Event|0|||
164003315|NCT02635204|592375755|FG000|Overall Study|Lost to Follow-up|1|||
164003316|NCT02635204|592375756|FG001|Overall Study|Lost to Follow-up|1|||
164003317|NCT00389207|592375757|FG000|Overall Study|Adverse Event|26|||
164003318|NCT00389207|592375758|FG001|Overall Study|Adverse Event|32|||
164003319|NCT00389207|592375759|FG002|Overall Study|Adverse Event|10|||
164003320|NCT00389207|592375757|FG000|Overall Study|Protocol Violation|3|||
164003321|NCT00389207|592375758|FG001|Overall Study|Protocol Violation|1|||
164003322|NCT00389207|592375759|FG002|Overall Study|Protocol Violation|4|||
164003323|NCT00389207|592375757|FG000|Overall Study|Lost to Follow-up|12|||
164003324|NCT00389207|592375758|FG001|Overall Study|Lost to Follow-up|9|||
164003325|NCT00389207|592375759|FG002|Overall Study|Lost to Follow-up|7|||
164003326|NCT00389207|592375757|FG000|Overall Study|Withdrawal by Subject|5|||
164003327|NCT00389207|592375758|FG001|Overall Study|Withdrawal by Subject|7|||
164003328|NCT00389207|592375759|FG002|Overall Study|Withdrawal by Subject|11|||
164003329|NCT00389207|592375757|FG000|Overall Study|Other|17|||
164003330|NCT00389207|592375758|FG001|Overall Study|Other|23|||
164003331|NCT00389207|592375759|FG002|Overall Study|Other|9|||
164003332|NCT01772134|592375765|FG000|Overall Study|Adverse Event|6|||
164282974|NCT03319212|593404459|FG000|Overall Study|Lost to Follow-up|0|||
164003333|NCT01772134|592375766|FG001|Overall Study|Adverse Event|5|||
164003334|NCT01772134|592375767|FG002|Overall Study|Adverse Event|10|||
164282975|NCT03319212|593404460|FG001|Overall Study|Lost to Follow-up|1|||
164282976|NCT03319212|593404459|FG000|Overall Study|Physician Decision|1|||
164282977|NCT03319212|593404460|FG001|Overall Study|Physician Decision|0|||
164282978|NCT00400569|593404461|FG000|Overall Study|Death|1|||
164282979|NCT01868477|593404463|FG000|Overall Study|Adverse Event|2|||
164282980|NCT01868477|593404464|FG001|Overall Study|Adverse Event|4|||
164282981|NCT01868477|593404463|FG000|Overall Study|Disease progression|1|||
164282982|NCT01868477|593404464|FG001|Overall Study|Disease progression|1|||
164282983|NCT01868477|593404463|FG000|Overall Study|Withdrawal by Subject|1|||
164282984|NCT01868477|593404464|FG001|Overall Study|Withdrawal by Subject|0|||
164282985|NCT02465203|593404466|FG000|Overall Study|Protocol Violation|1|||
164282986|NCT02465203|593404467|FG001|Overall Study|Protocol Violation|1|||
164282987|NCT02465203|593404468|FG002|Overall Study|Protocol Violation|1|||
164282988|NCT02465203|593404466|FG000|Overall Study|Study terminated by sponsor|50|||
164282989|NCT02465203|593404467|FG001|Overall Study|Study terminated by sponsor|34|||
164282990|NCT02465203|593404468|FG002|Overall Study|Study terminated by sponsor|11|||
164282991|NCT02465203|593404466|FG000|Overall Study|New therapy for study indication|4|||
164282992|NCT02465203|593404467|FG001|Overall Study|New therapy for study indication|0|||
164282993|NCT02465203|593404468|FG002|Overall Study|New therapy for study indication|0|||
164282994|NCT02465203|593404466|FG000|Overall Study|Patient/guardian decision|1|||
164282995|NCT02465203|593404467|FG001|Overall Study|Patient/guardian decision|1|||
164282996|NCT02465203|593404468|FG002|Overall Study|Patient/guardian decision|1|||
164282997|NCT00620113|593404469|FG000|Overall Study|Adverse Event|3|||
164282998|NCT00620113|593404470|FG001|Overall Study|Adverse Event|2|||
164282999|NCT00620113|593404471|FG002|Overall Study|Adverse Event|2|||
164283000|NCT00620113|593404472|FG003|Overall Study|Adverse Event|1|||
164283001|NCT00620113|593404469|FG000|Overall Study|Lack of Efficacy|2|||
164283002|NCT00620113|593404470|FG001|Overall Study|Lack of Efficacy|3|||
164283003|NCT00620113|593404471|FG002|Overall Study|Lack of Efficacy|0|||
164283004|NCT00620113|593404472|FG003|Overall Study|Lack of Efficacy|2|||
164283005|NCT00620113|593404469|FG000|Overall Study|Physician Decision|1|||
164003335|NCT01772134|592375765|FG000|Overall Study|Withdrew Consent|3|||
164003336|NCT01772134|592375766|FG001|Overall Study|Withdrew Consent|1|||
164003337|NCT01772134|592375767|FG002|Overall Study|Withdrew Consent|5|||
164003338|NCT01772134|592375765|FG000|Overall Study|Lost to Follow-up|2|||
164003339|NCT01772134|592375766|FG001|Overall Study|Lost to Follow-up|0|||
164003340|NCT01772134|592375767|FG002|Overall Study|Lost to Follow-up|0|||
164003341|NCT01772134|592375765|FG000|Overall Study|Protocol Deviation|4|||
164003342|NCT01772134|592375766|FG001|Overall Study|Protocol Deviation|3|||
164003343|NCT01772134|592375767|FG002|Overall Study|Protocol Deviation|3|||
164003344|NCT01772134|592375765|FG000|Overall Study|Lack of Efficacy|11|||
164003345|NCT01772134|592375766|FG001|Overall Study|Lack of Efficacy|5|||
164003346|NCT01772134|592375767|FG002|Overall Study|Lack of Efficacy|3|||
164003347|NCT01772134|592375765|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
164003348|NCT01772134|592375766|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
164003349|NCT01772134|592375767|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
164003350|NCT01772134|592375765|FG000|Overall Study|Randomized Study Medication Not Received|2|||
164003351|NCT01772134|592375766|FG001|Overall Study|Randomized Study Medication Not Received|0|||
164003352|NCT01772134|592375767|FG002|Overall Study|Randomized Study Medication Not Received|1|||
164003353|NCT03830281|592375772|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
164003354|NCT03830281|592375773|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
164003355|NCT03830281|592375772|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
164087557|NCT00095199|592684253|FG002|Overall Study|Liver function test results elevated|1|||
164283006|NCT00620113|593404470|FG001|Overall Study|Physician Decision|0|||
164003356|NCT03830281|592375773|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
164003357|NCT03830281|592375772|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
164003358|NCT03830281|592375773|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
164003359|NCT03830281|592375772|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
164003360|NCT03830281|592375773|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
164283007|NCT00620113|593404471|FG002|Overall Study|Physician Decision|0|||
164283008|NCT00620113|593404472|FG003|Overall Study|Physician Decision|2|||
164003361|NCT03830281|592375772|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
164283009|NCT00620113|593404469|FG000|Overall Study|Protocol Violation|2|||
164283010|NCT00620113|593404470|FG001|Overall Study|Protocol Violation|1|||
164283011|NCT00620113|593404471|FG002|Overall Study|Protocol Violation|0|||
164283012|NCT00620113|593404472|FG003|Overall Study|Protocol Violation|0|||
164283013|NCT00620113|593404469|FG000|Overall Study|Withdrawal by Subject|5|||
164283014|NCT00620113|593404470|FG001|Overall Study|Withdrawal by Subject|1|||
164003362|NCT03830281|592375773|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
164283015|NCT00620113|593404471|FG002|Overall Study|Withdrawal by Subject|3|||
164003363|NCT03830281|592375772|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
164003364|NCT03830281|592375773|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
164003365|NCT03830281|592375772|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
164283016|NCT00620113|593404472|FG003|Overall Study|Withdrawal by Subject|5|||
164283017|NCT00042991|593404475|FG000|Overall Study|Adverse Event|1|||
164283018|NCT00042991|593404476|FG001|Overall Study|Adverse Event|4|||
164283019|NCT00042991|593404477|FG002|Overall Study|Adverse Event|2|||
164283020|NCT00042991|593404478|FG003|Overall Study|Adverse Event|0|||
164283021|NCT00042991|593404479|FG004|Overall Study|Adverse Event|0|||
164283022|NCT00042991|593404480|FG005|Overall Study|Adverse Event|1|||
164283023|NCT00042991|593404481|FG006|Overall Study|Adverse Event|0|||
164283024|NCT00042991|593404475|FG000|Overall Study|Withdrawal by Subject|0|||
164283025|NCT00042991|593404476|FG001|Overall Study|Withdrawal by Subject|7|||
164283026|NCT00042991|593404477|FG002|Overall Study|Withdrawal by Subject|2|||
164283027|NCT00042991|593404478|FG003|Overall Study|Withdrawal by Subject|0|||
164283028|NCT00042991|593404479|FG004|Overall Study|Withdrawal by Subject|1|||
164283029|NCT00042991|593404480|FG005|Overall Study|Withdrawal by Subject|0|||
164283030|NCT00042991|593404481|FG006|Overall Study|Withdrawal by Subject|0|||
164283031|NCT00042991|593404475|FG000|Overall Study|Disease Progression|5|||
164283032|NCT00042991|593404476|FG001|Overall Study|Disease Progression|29|||
164283033|NCT00042991|593404477|FG002|Overall Study|Disease Progression|2|||
164283034|NCT00042991|593404478|FG003|Overall Study|Disease Progression|2|||
164283035|NCT00042991|593404479|FG004|Overall Study|Disease Progression|1|||
164283036|NCT00042991|593404480|FG005|Overall Study|Disease Progression|4|||
164283037|NCT00042991|593404481|FG006|Overall Study|Disease Progression|2|||
164283038|NCT00042991|593404475|FG000|Overall Study|Alternative Therapy|0|||
164003366|NCT03830281|592375773|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
164003367|NCT03830281|592375772|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
164003368|NCT03830281|592375773|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
164003369|NCT03830281|592375772|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
164003370|NCT03830281|592375773|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
164003371|NCT00922935|592375774|FG000|Overall Study|Protocol Violation|0|||
164003372|NCT00922935|592375775|FG001|Overall Study|Protocol Violation|3|||
164003373|NCT00922935|592375776|FG002|Overall Study|Protocol Violation|0|||
164003374|NCT00922935|592375774|FG000|Overall Study|Physician Decision|1|||
164283039|NCT00042991|593404476|FG001|Overall Study|Alternative Therapy|0|||
164003375|NCT00922935|592375775|FG001|Overall Study|Physician Decision|1|||
164003376|NCT00922935|592375776|FG002|Overall Study|Physician Decision|0|||
164003377|NCT00922935|592375774|FG000|Overall Study|Lost to Follow-up|0|||
164003378|NCT00922935|592375775|FG001|Overall Study|Lost to Follow-up|1|||
164003379|NCT00922935|592375776|FG002|Overall Study|Lost to Follow-up|0|||
164003380|NCT01491945|592375777|FG000|Overall Study|Death|30|||
164003381|NCT01491945|592375777|FG000|Overall Study|Withdrwan/LTF|16|||
164003382|NCT01491945|592375777|FG000|Overall Study|Conversion|4|||
164003383|NCT01491945|592375777|FG000|Overall Study|Missed Visit|1|||
164003384|NCT00074958|592375778|FG000|Overall Study|Adverse Event|1|||
164003385|NCT03192904|592375781|FG000|Overall Study|Physician Decision|3|||
164003386|NCT03192904|592375782|FG001|Overall Study|Physician Decision|1|||
164003387|NCT03192904|592375781|FG000|Overall Study|Lost to Follow-up|0|||
164003388|NCT03192904|592375782|FG001|Overall Study|Lost to Follow-up|1|||
164003389|NCT00709202|592375783|FG000|Overall Study|Withdrawal by Subject|6|||
164003390|NCT00709202|592375784|FG001|Overall Study|Withdrawal by Subject|6|||
164003391|NCT03133767|592375785|FG000|Overall Study|Lost to Follow-up|38|||
164003392|NCT03133767|592375786|FG001|Overall Study|Lost to Follow-up|24|||
164003393|NCT03133767|592375785|FG000|Overall Study|Protocol Violation|0|||
164003394|NCT03133767|592375786|FG001|Overall Study|Protocol Violation|1|||
164003395|NCT02240706|592375787|FG000|Overall Study|Lack of Efficacy|2|||
164087558|NCT00095199|592684254|FG003|Overall Study|Liver function test results elevated|1|||
164087559|NCT00095199|592684251|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
164087560|NCT00095199|592684252|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
164087561|NCT00095199|592684253|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
164087562|NCT00095199|592684254|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
164003396|NCT02240706|592375788|FG001|Overall Study|Lack of Efficacy|2|||
164283040|NCT00042991|593404477|FG002|Overall Study|Alternative Therapy|0|||
164283041|NCT00042991|593404478|FG003|Overall Study|Alternative Therapy|0|||
164283042|NCT00042991|593404479|FG004|Overall Study|Alternative Therapy|1|||
164283043|NCT00042991|593404480|FG005|Overall Study|Alternative Therapy|0|||
164283044|NCT00042991|593404481|FG006|Overall Study|Alternative Therapy|0|||
164344642|NCT01306942|593637001|FG002|Phase II|Not finished treatment|0|||
164344643|NCT01306942|593637002|FG003|Phase II|Not finished treatment|1|||
164344644|NCT01306942|593636999|FG000|Phase II|Protocol Violation|0|||
164344645|NCT01306942|593637000|FG001|Phase II|Protocol Violation|0|||
164344646|NCT01306942|593637001|FG002|Phase II|Protocol Violation|0|||
164344647|NCT01306942|593637002|FG003|Phase II|Protocol Violation|1|||
164344648|NCT03988088|593637003|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
164344649|NCT03988088|593637004|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
164003397|NCT02240706|592375789|FG002|Overall Study|Lack of Efficacy|2|||
164003398|NCT02240706|592375790|FG003|Overall Study|Lack of Efficacy|2|||
164003399|NCT02240706|592375791|FG004|Overall Study|Lack of Efficacy|5|||
164003400|NCT02240706|592375792|FG005|Overall Study|Lack of Efficacy|0|||
164344650|NCT03988088|593637005|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
164003401|NCT02240706|592375793|FG006|Overall Study|Lack of Efficacy|0|||
164003402|NCT02240706|592375787|FG000|Overall Study|Adverse Event|1|||
164283045|NCT04072887|593404486|FG000|Overall Study|Withdrawal by Subject|3|||
164283046|NCT04072887|593404487|FG001|Overall Study|Withdrawal by Subject|8|||
164283047|NCT04072887|593404488|FG002|Overall Study|Withdrawal by Subject|1|||
164283048|NCT04072887|593404489|FG003|Overall Study|Withdrawal by Subject|3|||
164283049|NCT04072887|593404490|FG004|Overall Study|Withdrawal by Subject|3|||
164283050|NCT04072887|593404491|FG005|Overall Study|Withdrawal by Subject|13|||
164283051|NCT04072887|593404486|FG000|Overall Study|Adverse Event|2|||
164283052|NCT04072887|593404487|FG001|Overall Study|Adverse Event|4|||
164283053|NCT04072887|593404488|FG002|Overall Study|Adverse Event|1|||
164283054|NCT04072887|593404489|FG003|Overall Study|Adverse Event|4|||
164283055|NCT04072887|593404490|FG004|Overall Study|Adverse Event|0|||
164283056|NCT04072887|593404491|FG005|Overall Study|Adverse Event|1|||
164283057|NCT04072887|593404486|FG000|Overall Study|Physician Decision|2|||
164283058|NCT04072887|593404487|FG001|Overall Study|Physician Decision|0|||
164283059|NCT04072887|593404488|FG002|Overall Study|Physician Decision|0|||
164283060|NCT04072887|593404489|FG003|Overall Study|Physician Decision|0|||
164283061|NCT04072887|593404490|FG004|Overall Study|Physician Decision|0|||
164283062|NCT04072887|593404491|FG005|Overall Study|Physician Decision|1|||
164283063|NCT04072887|593404486|FG000|Overall Study|Lost to Follow-up|1|||
164283064|NCT04072887|593404487|FG001|Overall Study|Lost to Follow-up|3|||
164283065|NCT04072887|593404488|FG002|Overall Study|Lost to Follow-up|0|||
164283066|NCT04072887|593404489|FG003|Overall Study|Lost to Follow-up|0|||
164283067|NCT04072887|593404490|FG004|Overall Study|Lost to Follow-up|0|||
164283068|NCT04072887|593404491|FG005|Overall Study|Lost to Follow-up|0|||
164283069|NCT04072887|593404486|FG000|Overall Study|Death|0|||
164283070|NCT04072887|593404487|FG001|Overall Study|Death|2|||
164283071|NCT04072887|593404488|FG002|Overall Study|Death|0|||
163897275|NCT02719574|591997857|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897276|NCT02719574|591997858|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897277|NCT02719574|591997859|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897278|NCT02719574|591997860|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897279|NCT02719574|591997861|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897280|NCT02719574|591997862|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897281|NCT02719574|591997863|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897282|NCT02719574|591997864|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
163897283|NCT02719574|591997848|FG000|Phase 1 (Dose Expansion)|Death|0|||
163897284|NCT02719574|591997849|FG001|Phase 1 (Dose Expansion)|Death|0|||
163897285|NCT02719574|591997850|FG002|Phase 1 (Dose Expansion)|Death|0|||
163897286|NCT02719574|591997851|FG003|Phase 1 (Dose Expansion)|Death|0|||
163897287|NCT02719574|591997852|FG004|Phase 1 (Dose Expansion)|Death|0|||
163897288|NCT02719574|591997853|FG005|Phase 1 (Dose Expansion)|Death|0|||
163897289|NCT02719574|591997854|FG006|Phase 1 (Dose Expansion)|Death|1|||
163897290|NCT02719574|591997855|FG007|Phase 1 (Dose Expansion)|Death|6|||
163897291|NCT02719574|591997856|FG008|Phase 1 (Dose Expansion)|Death|0|||
163897292|NCT02719574|591997857|FG009|Phase 1 (Dose Expansion)|Death|0|||
163897293|NCT02719574|591997858|FG010|Phase 1 (Dose Expansion)|Death|0|||
163897294|NCT02719574|591997859|FG011|Phase 1 (Dose Expansion)|Death|0|||
163897295|NCT02719574|591997860|FG012|Phase 1 (Dose Expansion)|Death|0|||
163897296|NCT02719574|591997861|FG013|Phase 1 (Dose Expansion)|Death|0|||
163897297|NCT02719574|591997862|FG014|Phase 1 (Dose Expansion)|Death|0|||
163897298|NCT02719574|591997863|FG015|Phase 1 (Dose Expansion)|Death|0|||
163897299|NCT02719574|591997864|FG016|Phase 1 (Dose Expansion)|Death|0|||
163897300|NCT02719574|591997848|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897301|NCT02719574|591997849|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897302|NCT02719574|591997850|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897303|NCT02719574|591997851|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897304|NCT02719574|591997852|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897305|NCT02719574|591997853|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897306|NCT02719574|591997854|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
163897307|NCT02719574|591997855|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
163897308|NCT02719574|591997856|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897309|NCT02719574|591997857|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897310|NCT02719574|591997858|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897311|NCT02719574|591997859|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897312|NCT02719574|591997860|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897313|NCT02719574|591997861|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897314|NCT02719574|591997862|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897315|NCT02719574|591997863|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897316|NCT02719574|591997864|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
163897317|NCT02719574|591997848|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897318|NCT02719574|591997849|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897319|NCT02719574|591997850|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897320|NCT02719574|591997851|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897321|NCT02719574|591997852|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897322|NCT02719574|591997853|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897323|NCT02719574|591997854|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
163897324|NCT02719574|591997855|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
164283072|NCT04072887|593404489|FG003|Overall Study|Death|2|||
164283073|NCT04072887|593404490|FG004|Overall Study|Death|3|||
164283074|NCT04072887|593404491|FG005|Overall Study|Death|0|||
164283075|NCT00856297|593404492|FG000|Overall Study|Unable to classify|2|||
164283076|NCT00856297|593404493|FG001|Overall Study|Unable to classify|0|||
164283077|NCT00856297|593404494|FG002|Overall Study|Unable to classify|0|||
164283078|NCT00856297|593404495|FG003|Overall Study|Unable to classify|0|||
164283079|NCT00856297|593404496|FG004|Overall Study|Unable to classify|0|||
164283080|NCT03369236|593404501|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
164283081|NCT03369236|593404502|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
164003403|NCT02240706|592375788|FG001|Overall Study|Adverse Event|0|||
164003404|NCT02240706|592375789|FG002|Overall Study|Adverse Event|1|||
164003405|NCT02240706|592375790|FG003|Overall Study|Adverse Event|0|||
164003406|NCT02240706|592375791|FG004|Overall Study|Adverse Event|2|||
164003407|NCT02240706|592375792|FG005|Overall Study|Adverse Event|0|||
164003408|NCT02240706|592375793|FG006|Overall Study|Adverse Event|0|||
164003409|NCT02240706|592375787|FG000|Overall Study|Progressive disease|0|||
164003410|NCT02240706|592375788|FG001|Overall Study|Progressive disease|0|||
164003411|NCT02240706|592375789|FG002|Overall Study|Progressive disease|0|||
164003412|NCT02240706|592375790|FG003|Overall Study|Progressive disease|0|||
164003413|NCT02240706|592375791|FG004|Overall Study|Progressive disease|1|||
164003414|NCT02240706|592375792|FG005|Overall Study|Progressive disease|0|||
164003415|NCT02240706|592375793|FG006|Overall Study|Progressive disease|0|||
164003416|NCT02240706|592375787|FG000|Overall Study|Dose limiting toxicity|0|||
164003417|NCT02240706|592375788|FG001|Overall Study|Dose limiting toxicity|0|||
164003418|NCT02240706|592375789|FG002|Overall Study|Dose limiting toxicity|0|||
164003419|NCT02240706|592375790|FG003|Overall Study|Dose limiting toxicity|0|||
164003420|NCT02240706|592375791|FG004|Overall Study|Dose limiting toxicity|1|||
164003421|NCT02240706|592375792|FG005|Overall Study|Dose limiting toxicity|0|||
164003422|NCT02240706|592375793|FG006|Overall Study|Dose limiting toxicity|0|||
164003423|NCT02240706|592375787|FG000|Overall Study|Refused to continue taking medication|0|||
164003424|NCT02240706|592375788|FG001|Overall Study|Refused to continue taking medication|1|||
164003425|NCT02240706|592375789|FG002|Overall Study|Refused to continue taking medication|3|||
164003426|NCT02240706|592375790|FG003|Overall Study|Refused to continue taking medication|1|||
164003427|NCT02240706|592375791|FG004|Overall Study|Refused to continue taking medication|2|||
164003428|NCT02240706|592375792|FG005|Overall Study|Refused to continue taking medication|0|||
164003429|NCT02240706|592375793|FG006|Overall Study|Refused to continue taking medication|0|||
164003430|NCT02240706|592375787|FG000|Overall Study|Insurance billing concerns|0|||
164003431|NCT02240706|592375788|FG001|Overall Study|Insurance billing concerns|0|||
164003432|NCT02240706|592375789|FG002|Overall Study|Insurance billing concerns|0|||
164003433|NCT02240706|592375790|FG003|Overall Study|Insurance billing concerns|1|||
164003434|NCT02240706|592375791|FG004|Overall Study|Insurance billing concerns|0|||
164003435|NCT02240706|592375792|FG005|Overall Study|Insurance billing concerns|0|||
164003436|NCT02240706|592375793|FG006|Overall Study|Insurance billing concerns|0|||
164003437|NCT03301857|592375794|FG000|Overall Study|Death|0|||
164087563|NCT00095199|592684251|FG000|Overall Study|Physician Decision|5|||
164087564|NCT00095199|592684252|FG001|Overall Study|Physician Decision|6|||
164087565|NCT00095199|592684253|FG002|Overall Study|Physician Decision|1|||
164283082|NCT03369236|593404501|FG000|Open-label Extension Period|Lack of Efficacy|2|||
164283083|NCT03369236|593404502|FG001|Open-label Extension Period|Lack of Efficacy|1|||
164283084|NCT03369236|593404501|FG000|Open-label Extension Period|Adverse Event|0|||
164283085|NCT03369236|593404502|FG001|Open-label Extension Period|Adverse Event|1|||
164283086|NCT03369236|593404501|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
164283087|NCT03369236|593404502|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
164283088|NCT00423449|593404503|FG000|Overall Study|Clinical Adverse Event|1|||
164283089|NCT00423449|593404504|FG001|Overall Study|Clinical Adverse Event|0|||
164283090|NCT00423449|593404505|FG002|Overall Study|Clinical Adverse Event|1|||
164283091|NCT00423449|593404506|FG003|Overall Study|Clinical Adverse Event|8|||
164283092|NCT00423449|593404507|FG004|Overall Study|Clinical Adverse Event|2|||
164283093|NCT00423449|593404503|FG000|Overall Study|Death|1|||
164283094|NCT00423449|593404504|FG001|Overall Study|Death|0|||
164283095|NCT00423449|593404505|FG002|Overall Study|Death|2|||
164283096|NCT00423449|593404506|FG003|Overall Study|Death|1|||
164283097|NCT00423449|593404507|FG004|Overall Study|Death|1|||
164283098|NCT00423449|593404503|FG000|Overall Study|Progressive Disease|1|||
164283099|NCT00423449|593404504|FG001|Overall Study|Progressive Disease|3|||
164283100|NCT00423449|593404505|FG002|Overall Study|Progressive Disease|8|||
164283101|NCT00423449|593404506|FG003|Overall Study|Progressive Disease|11|||
164003438|NCT03301857|592375795|FG001|Overall Study|Death|2|||
164003439|NCT03301857|592375794|FG000|Overall Study|Lost to Follow-up|4|||
164003440|NCT03301857|592375795|FG001|Overall Study|Lost to Follow-up|2|||
164003441|NCT03301857|592375794|FG000|Overall Study|Decision by Sponsor|6|||
164003442|NCT03301857|592375795|FG001|Overall Study|Decision by Sponsor|0|||
164003443|NCT03301857|592375794|FG000|Overall Study|Withdrawal by Subject|12|||
164283102|NCT00423449|593404507|FG004|Overall Study|Progressive Disease|4|||
164283103|NCT00423449|593404503|FG000|Overall Study|Laboratory Adverse Event|0|||
164087566|NCT00095199|592684254|FG003|Overall Study|Physician Decision|1|||
164283104|NCT00423449|593404504|FG001|Overall Study|Laboratory Adverse Event|1|||
164283105|NCT00423449|593404505|FG002|Overall Study|Laboratory Adverse Event|2|||
164283106|NCT00423449|593404506|FG003|Overall Study|Laboratory Adverse Event|0|||
164283107|NCT00423449|593404507|FG004|Overall Study|Laboratory Adverse Event|0|||
164283108|NCT00423449|593404503|FG000|Overall Study|Other|0|||
164283109|NCT00423449|593404504|FG001|Overall Study|Other|0|||
164283110|NCT00423449|593404505|FG002|Overall Study|Other|0|||
164283111|NCT00423449|593404506|FG003|Overall Study|Other|1|||
164283112|NCT00423449|593404507|FG004|Overall Study|Other|0|||
164283113|NCT00423449|593404503|FG000|Overall Study|Protocol Violation|0|||
164283114|NCT00423449|593404504|FG001|Overall Study|Protocol Violation|0|||
164283115|NCT00423449|593404505|FG002|Overall Study|Protocol Violation|2|||
164283116|NCT00423449|593404506|FG003|Overall Study|Protocol Violation|1|||
164283117|NCT00423449|593404507|FG004|Overall Study|Protocol Violation|0|||
164283118|NCT01153724|593404513|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164283119|NCT01153724|593404513|FG000|Treatment Period 2|Adverse Event|1|||
164283120|NCT01153724|593404513|FG000|Treatment Period 2|Other reason not defined above|1|||
164283121|NCT02508428|593404514|FG000|Overall Study|Death|32|||
164283122|NCT02508428|593404515|FG001|Overall Study|Death|33|||
164283123|NCT02508428|593404514|FG000|Overall Study|Liner revised|3|||
164283124|NCT02508428|593404515|FG001|Overall Study|Liner revised|19|||
164283125|NCT02508428|593404514|FG000|Overall Study|Incomplete follow-up|17|||
164283126|NCT02508428|593404515|FG001|Overall Study|Incomplete follow-up|15|||
164283127|NCT04371666|593404520|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
164283128|NCT04371666|593404521|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
164283129|NCT04371666|593404520|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
164283130|NCT04371666|593404521|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
164283131|NCT04371666|593404520|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
164283132|NCT04371666|593404521|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
164283133|NCT04371666|593404520|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
164283134|NCT04371666|593404521|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
164283135|NCT04371666|593404520|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
164283136|NCT04371666|593404521|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
164283137|NCT04371666|593404520|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
164283138|NCT04371666|593404521|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
164283139|NCT00445770|593404522|FG000|Overall Study|Adverse Event|9|||
164283140|NCT00445770|593404523|FG001|Overall Study|Adverse Event|15|||
164283141|NCT00445770|593404524|FG002|Overall Study|Adverse Event|19|||
164283142|NCT00445770|593404522|FG000|Overall Study|Lack of Efficacy|38|||
164283143|NCT00445770|593404523|FG001|Overall Study|Lack of Efficacy|13|||
164283144|NCT00445770|593404524|FG002|Overall Study|Lack of Efficacy|6|||
164283145|NCT00445770|593404522|FG000|Overall Study|Lost to Follow-up|0|||
164283146|NCT00445770|593404523|FG001|Overall Study|Lost to Follow-up|2|||
164283147|NCT00445770|593404524|FG002|Overall Study|Lost to Follow-up|0|||
164283148|NCT00445770|593404522|FG000|Overall Study|Other|6|||
164283149|NCT00445770|593404523|FG001|Overall Study|Other|5|||
164283150|NCT00445770|593404524|FG002|Overall Study|Other|6|||
164283151|NCT00947115|593404525|FG000|Overall Study|Missed reporting interval|3|||
164283152|NCT00947115|593404526|FG001|Overall Study|Missed reporting interval|4|||
164283153|NCT00947115|593404527|FG002|Overall Study|Missed reporting interval|2|||
164283154|NCT00947115|593404525|FG000|Overall Study|Physician Decision|0|||
164283155|NCT00947115|593404526|FG001|Overall Study|Physician Decision|2|||
164283156|NCT00947115|593404527|FG002|Overall Study|Physician Decision|0|||
164283157|NCT00947115|593404525|FG000|Overall Study|Death|0|||
164283158|NCT00947115|593404526|FG001|Overall Study|Death|1|||
164283159|NCT00947115|593404527|FG002|Overall Study|Death|1|||
164283160|NCT00947115|593404525|FG000|Overall Study|Migrated from study area|2|||
164283161|NCT00947115|593404526|FG001|Overall Study|Migrated from study area|0|||
164283162|NCT00947115|593404527|FG002|Overall Study|Migrated from study area|0|||
163897325|NCT02719574|591997856|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897326|NCT02719574|591997857|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
164283163|NCT00947115|593404525|FG000|Overall Study|Withdrawal by Subject|1|||
164283164|NCT00947115|593404526|FG001|Overall Study|Withdrawal by Subject|3|||
164283165|NCT00947115|593404527|FG002|Overall Study|Withdrawal by Subject|4|||
164283166|NCT00947115|593404525|FG000|Overall Study|Lost to Follow-up|11|||
164283167|NCT00947115|593404526|FG001|Overall Study|Lost to Follow-up|12|||
163897327|NCT02719574|591997858|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897328|NCT02719574|591997859|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897329|NCT02719574|591997860|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
164087567|NCT00095199|592684251|FG000|Overall Study|Not eligible|1|||
164283168|NCT00947115|593404527|FG002|Overall Study|Lost to Follow-up|8|||
164283169|NCT02092025|593404528|FG000|Overall Study|Case Report Forms Uncollected|44|||
164283170|NCT02092025|593404528|FG000|Overall Study|Protocol Deviation|24|||
164283171|NCT02927938|593404529|FG000|Overall Study|Death|0|||
164283172|NCT02927938|593404530|FG001|Overall Study|Death|1|||
164283173|NCT02927938|593404531|FG002|Overall Study|Death|0|||
164283174|NCT02927938|593404532|FG003|Overall Study|Death|4|||
164283175|NCT02927938|593404529|FG000|Overall Study|Early Study Termination|1|||
164283176|NCT02927938|593404530|FG001|Overall Study|Early Study Termination|5|||
164283177|NCT02927938|593404531|FG002|Overall Study|Early Study Termination|4|||
164283178|NCT02927938|593404532|FG003|Overall Study|Early Study Termination|3|||
164283179|NCT00934128|593404535|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
164283180|NCT00934128|593404536|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
164283181|NCT00934128|593404535|FG000|First Intervention (2 Hours)|Adverse Event|4|||
164283182|NCT00934128|593404536|FG001|First Intervention (2 Hours)|Adverse Event|1|||
164283183|NCT00934128|593404535|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
164283184|NCT00934128|593404536|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
164283185|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Patient preference|1|||
164283186|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Patient preference|3|||
164283187|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Pain|1|||
164283188|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Pain|0|||
164283189|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Too tired|1|||
164283190|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Too tired|0|||
164283191|NCT00934128|593404535|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
164283192|NCT00934128|593404536|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
164283193|NCT00934128|593404535|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
164283194|NCT00934128|593404536|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
164283195|NCT03228212|593404537|FG000|Period 1|Adverse Event|1|||
164283196|NCT03228212|593404538|FG001|Period 1|Adverse Event|0|||
164283197|NCT03228212|593404537|FG000|Period 1|no longer meets eligibility criteria|0|||
164283198|NCT03228212|593404538|FG001|Period 1|no longer meets eligibility criteria|1|||
164283199|NCT03228212|593404537|FG000|Period 2|Lost to Follow-up|1|||
164283200|NCT03228212|593404538|FG001|Period 2|Lost to Follow-up|0|||
164283201|NCT02834247|593404539|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
164283202|NCT02834247|593404540|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
164283203|NCT02834247|593404541|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
164283204|NCT02834247|593404542|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
164283205|NCT02834247|593404539|FG000|Dose Escalation Phase|Death|5|||
164283206|NCT02834247|593404540|FG001|Dose Escalation Phase|Death|6|||
164283207|NCT02834247|593404541|FG002|Dose Escalation Phase|Death|5|||
164283208|NCT02834247|593404542|FG003|Dose Escalation Phase|Death|0|||
164283209|NCT02834247|593404539|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
164283210|NCT02834247|593404540|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
164283211|NCT02834247|593404541|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
164283212|NCT02834247|593404542|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
164283213|NCT02834247|593404539|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
164283214|NCT02834247|593404540|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
164283215|NCT02834247|593404541|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164283216|NCT02834247|593404542|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164283217|NCT02834247|593404539|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
164283218|NCT02834247|593404540|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
164283219|NCT02834247|593404541|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
164283220|NCT02834247|593404542|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
164283221|NCT02834247|593404539|FG000|Dose Expansion Phase|Death|0|||
164283222|NCT02834247|593404540|FG001|Dose Expansion Phase|Death|0|||
164283223|NCT02834247|593404541|FG002|Dose Expansion Phase|Death|0|||
164283224|NCT02834247|593404542|FG003|Dose Expansion Phase|Death|8|||
164283225|NCT02834247|593404539|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
164283226|NCT02834247|593404540|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
164283227|NCT02834247|593404541|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
164283228|NCT02834247|593404542|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
164283229|NCT02834247|593404539|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
164283230|NCT02834247|593404540|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
164283231|NCT02834247|593404541|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
164283232|NCT02834247|593404542|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
164283233|NCT02476006|593404543|FG000|Overall Study|Death|4|||
164283234|NCT02476006|593404543|FG000|Overall Study|Lack of treatment efficacy|2|||
164283235|NCT02476006|593404543|FG000|Overall Study|Pregnancy|1|||
164283236|NCT02476006|593404543|FG000|Overall Study|Participant did not wish to continue|39|||
164283237|NCT02476006|593404543|FG000|Overall Study|Adverse Event|41|||
164283238|NCT02476006|593404543|FG000|Overall Study|Poor compliance to study protocol|3|||
164283239|NCT02476006|593404543|FG000|Overall Study|Sponsor decision|6|||
164283240|NCT02476006|593404543|FG000|Overall Study|Lost to Follow-up|5|||
164283241|NCT02476006|593404543|FG000|Overall Study|Physician Decision|5|||
164283242|NCT02476006|593404543|FG000|Overall Study|Study ended treatment not available|4|||
163897330|NCT02719574|591997861|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
164283243|NCT02476006|593404543|FG000|Overall Study|Switched to commercial drug|4|||
164283244|NCT02476006|593404543|FG000|Overall Study|Excluded from study|1|||
164283245|NCT02476006|593404543|FG000|Overall Study|Protocol Violation|1|||
164283246|NCT02476006|593404543|FG000|Overall Study|Enrolled but not treated|4|||
164283247|NCT01807299|593404550|FG000|Overall Study|Protocol Violation|3|||
164283248|NCT01807299|593404551|FG001|Overall Study|Protocol Violation|1|||
164283249|NCT01807299|593404552|FG002|Overall Study|Protocol Violation|0|||
164283250|NCT01807299|593404553|FG003|Overall Study|Protocol Violation|2|||
164283251|NCT00811174|593404554|FG000|Overall Study|Protocol Violation|2|||
164283252|NCT00811174|593404554|FG000|Overall Study|Sponsors Decision|1|||
164283253|NCT02451943|593406271|FG000|Overall Study|Withdrawal by Subject|13|||
164283254|NCT02451943|593406272|FG001|Overall Study|Withdrawal by Subject|16|||
164283255|NCT02451943|593406271|FG000|Overall Study|Lost to Follow-up|3|||
164283256|NCT02451943|593406272|FG001|Overall Study|Lost to Follow-up|4|||
164283257|NCT02451943|593406271|FG000|Overall Study|Sponsor Decision|0|||
164283258|NCT02451943|593406272|FG001|Overall Study|Sponsor Decision|4|||
164283259|NCT03951077|593406273|FG000|Overall Study|Adverse Event|1|||
164283260|NCT03951077|593406274|FG001|Overall Study|Adverse Event|0|||
164283261|NCT03951077|593406275|FG002|Overall Study|Adverse Event|0|||
164283262|NCT03951077|593406276|FG003|Overall Study|Adverse Event|0|||
164283263|NCT03951077|593406277|FG004|Overall Study|Adverse Event|0|||
164283264|NCT03951077|593406278|FG005|Overall Study|Adverse Event|0|||
164283265|NCT03951077|593406273|FG000|Overall Study|Withdrawal by Subject|3|||
164283266|NCT03951077|593406274|FG001|Overall Study|Withdrawal by Subject|3|||
164283267|NCT03951077|593406275|FG002|Overall Study|Withdrawal by Subject|0|||
164283268|NCT03951077|593406276|FG003|Overall Study|Withdrawal by Subject|3|||
164283269|NCT03951077|593406277|FG004|Overall Study|Withdrawal by Subject|3|||
164283270|NCT03951077|593406278|FG005|Overall Study|Withdrawal by Subject|2|||
164283271|NCT03951077|593406273|FG000|Overall Study|Lost to Follow-up|1|||
164283272|NCT03951077|593406274|FG001|Overall Study|Lost to Follow-up|1|||
164283273|NCT03951077|593406275|FG002|Overall Study|Lost to Follow-up|2|||
164283274|NCT03951077|593406276|FG003|Overall Study|Lost to Follow-up|3|||
164283275|NCT03951077|593406277|FG004|Overall Study|Lost to Follow-up|2|||
164283276|NCT03951077|593406278|FG005|Overall Study|Lost to Follow-up|3|||
164283277|NCT03951077|593406273|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
164283278|NCT03951077|593406274|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
164283279|NCT03951077|593406275|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
164283280|NCT03951077|593406276|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
164283281|NCT03951077|593406277|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
164283282|NCT03951077|593406278|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
164283283|NCT03951077|593406273|FG000|Overall Study|Other, Not Specified|12|||
164283284|NCT03951077|593406274|FG001|Overall Study|Other, Not Specified|10|||
164283285|NCT03951077|593406275|FG002|Overall Study|Other, Not Specified|10|||
164283286|NCT03951077|593406276|FG003|Overall Study|Other, Not Specified|5|||
164283287|NCT03951077|593406277|FG004|Overall Study|Other, Not Specified|9|||
164283288|NCT03951077|593406278|FG005|Overall Study|Other, Not Specified|6|||
164283289|NCT03951077|593406273|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
164283290|NCT03951077|593406274|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
164283291|NCT03951077|593406275|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
164283292|NCT03951077|593406276|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
164283293|NCT03951077|593406277|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
164283294|NCT03951077|593406278|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
164283295|NCT00086047|593406280|FG000|Overall Study|Lost to Follow-up|7|||
164283296|NCT00086047|593406281|FG001|Overall Study|Lost to Follow-up|6|||
164283297|NCT00086047|593406280|FG000|Overall Study|Physician Decision|0|||
164283298|NCT00086047|593406281|FG001|Overall Study|Physician Decision|1|||
164283299|NCT01395901|593406282|FG000|Overall Study|Lost to Follow-up|4|||
164283300|NCT01395901|593406283|FG001|Overall Study|Lost to Follow-up|0|||
164283301|NCT01395901|593406282|FG000|Overall Study|Randomized but not received study drug|5|||
164283302|NCT01395901|593406283|FG001|Overall Study|Randomized but not received study drug|4|||
164283303|NCT01395901|593406282|FG000|Overall Study|Adverse Event|0|||
164283304|NCT01395901|593406283|FG001|Overall Study|Adverse Event|1|||
164283305|NCT01395901|593406282|FG000|Overall Study|Withdrawal of consent|1|||
164283306|NCT01395901|593406283|FG001|Overall Study|Withdrawal of consent|0|||
164283307|NCT03579940|593406288|FG000|Period 2|Withdrawal by Subject|0|||
164283308|NCT03579940|593406289|FG001|Period 2|Withdrawal by Subject|0|||
164283309|NCT03579940|593406290|FG002|Period 2|Withdrawal by Subject|1|||
164283310|NCT03579940|593406291|FG003|Period 2|Withdrawal by Subject|0|||
164283311|NCT03579940|593406292|FG004|Period 2|Withdrawal by Subject|0|||
164003444|NCT03301857|592375795|FG001|Overall Study|Withdrawal by Subject|4|||
164003445|NCT01856114|592375813|FG000|Overall Study|Withdrawal by Subject|1|||
164003446|NCT01856114|592375814|FG001|Overall Study|Withdrawal by Subject|0|||
164003447|NCT01856114|592375813|FG000|Overall Study|Adverse Event|1|||
164003448|NCT01856114|592375814|FG001|Overall Study|Adverse Event|0|||
164003449|NCT03248128|592375820|FG000|Overall Study|Lost to Follow-up|1|||
164003450|NCT03248128|592375821|FG001|Overall Study|Lost to Follow-up|0|||
164003451|NCT03248128|592375820|FG000|Overall Study|Withdrawal by Subject|16|||
164003452|NCT03248128|592375821|FG001|Overall Study|Withdrawal by Subject|14|||
164283312|NCT03579940|593406293|FG005|Period 2|Withdrawal by Subject|0|||
164283313|NCT03579940|593406294|FG006|Period 2|Withdrawal by Subject|0|||
164283314|NCT03579940|593406295|FG007|Period 2|Withdrawal by Subject|0|||
164283315|NCT03579940|593406296|FG008|Period 2|Withdrawal by Subject|0|||
164283316|NCT03579940|593406297|FG009|Period 2|Withdrawal by Subject|0|||
164283317|NCT03579940|593406298|FG010|Period 2|Withdrawal by Subject|0|||
164283318|NCT01217944|593406299|FG000|Overall Study|Protocol Violation|1|||
164283319|NCT01217944|593406300|FG001|Overall Study|Protocol Violation|1|||
164283320|NCT01217944|593406301|FG002|Overall Study|Protocol Violation|0|||
163897331|NCT02719574|591997862|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897332|NCT02719574|591997863|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
163897333|NCT02719574|591997864|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
164283321|NCT01217944|593406299|FG000|Overall Study|Lost to Follow-up|3|||
164283322|NCT01217944|593406300|FG001|Overall Study|Lost to Follow-up|1|||
164283323|NCT01217944|593406301|FG002|Overall Study|Lost to Follow-up|0|||
164283324|NCT01217944|593406299|FG000|Overall Study|Withdrawal by Subject|1|||
164283325|NCT01217944|593406300|FG001|Overall Study|Withdrawal by Subject|2|||
164283326|NCT01217944|593406301|FG002|Overall Study|Withdrawal by Subject|0|||
164283327|NCT01217944|593406299|FG000|Overall Study|Lack of Efficacy|1|||
164283328|NCT01217944|593406300|FG001|Overall Study|Lack of Efficacy|0|||
164283329|NCT01217944|593406301|FG002|Overall Study|Lack of Efficacy|0|||
164283330|NCT00853151|593406302|FG000|Overall Study|Adverse Event|1|||
164283331|NCT00853151|593406303|FG001|Overall Study|Adverse Event|4|||
164283332|NCT00853151|593406304|FG002|Overall Study|Adverse Event|2|||
164283333|NCT00853151|593406305|FG003|Overall Study|Adverse Event|0|||
164283334|NCT00853151|593406302|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
164283335|NCT00853151|593406303|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164283336|NCT00853151|593406304|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164283337|NCT00853151|593406305|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
164283338|NCT00853151|593406302|FG000|Overall Study|Lost to Follow-up|2|||
164283339|NCT00853151|593406303|FG001|Overall Study|Lost to Follow-up|0|||
164283340|NCT00853151|593406304|FG002|Overall Study|Lost to Follow-up|3|||
164283341|NCT00853151|593406305|FG003|Overall Study|Lost to Follow-up|0|||
164283342|NCT00853151|593406302|FG000|Overall Study|Death|1|||
164283343|NCT00853151|593406303|FG001|Overall Study|Death|0|||
164283344|NCT00853151|593406304|FG002|Overall Study|Death|0|||
164283345|NCT00853151|593406305|FG003|Overall Study|Death|1|||
164283346|NCT00853151|593406302|FG000|Overall Study|Protocol Violation|0|||
164283347|NCT00853151|593406303|FG001|Overall Study|Protocol Violation|0|||
164283348|NCT00853151|593406304|FG002|Overall Study|Protocol Violation|0|||
164283349|NCT00853151|593406305|FG003|Overall Study|Protocol Violation|1|||
164283350|NCT00853151|593406302|FG000|Overall Study|Withdrawal by Subject|5|||
164283351|NCT00853151|593406303|FG001|Overall Study|Withdrawal by Subject|4|||
164283352|NCT00853151|593406304|FG002|Overall Study|Withdrawal by Subject|2|||
164283353|NCT00853151|593406305|FG003|Overall Study|Withdrawal by Subject|1|||
164283354|NCT00853151|593406302|FG000|Overall Study|Physician Decision|0|||
164283355|NCT00853151|593406303|FG001|Overall Study|Physician Decision|2|||
164283356|NCT00853151|593406304|FG002|Overall Study|Physician Decision|1|||
164283357|NCT00853151|593406305|FG003|Overall Study|Physician Decision|0|||
164283358|NCT00853151|593406302|FG000|Overall Study|Sponsor Decision|0|||
164283359|NCT00853151|593406303|FG001|Overall Study|Sponsor Decision|3|||
164283360|NCT00853151|593406304|FG002|Overall Study|Sponsor Decision|0|||
164283361|NCT00853151|593406305|FG003|Overall Study|Sponsor Decision|0|||
164283362|NCT01751984|593406306|FG000|Overall Study|Adverse Event|5|||
163897334|NCT02719574|591997848|FG000|Phase 1 (Dose Expansion)|Other|0|||
163897335|NCT02719574|591997849|FG001|Phase 1 (Dose Expansion)|Other|0|||
163897336|NCT02719574|591997850|FG002|Phase 1 (Dose Expansion)|Other|0|||
163897337|NCT02719574|591997851|FG003|Phase 1 (Dose Expansion)|Other|0|||
163897338|NCT02719574|591997852|FG004|Phase 1 (Dose Expansion)|Other|0|||
163897339|NCT02719574|591997853|FG005|Phase 1 (Dose Expansion)|Other|0|||
163897340|NCT02719574|591997854|FG006|Phase 1 (Dose Expansion)|Other|1|||
163897341|NCT02719574|591997855|FG007|Phase 1 (Dose Expansion)|Other|7|||
164283363|NCT01751984|593406307|FG001|Overall Study|Adverse Event|3|||
164283364|NCT01751984|593406306|FG000|Overall Study|Withdrawal by Subject|0|||
164283365|NCT01751984|593406307|FG001|Overall Study|Withdrawal by Subject|1|||
164283366|NCT01751984|593406306|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
164283367|NCT01751984|593406307|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
164283368|NCT00587158|593406308|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
164283369|NCT00587158|593406309|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
164283370|NCT00587158|593406308|FG000|Overall Study|Physician Decision|0|||
164283371|NCT00587158|593406309|FG001|Overall Study|Physician Decision|1|||
164283372|NCT00587158|593406308|FG000|Overall Study|Lost to Follow-up|1|||
164283373|NCT00587158|593406309|FG001|Overall Study|Lost to Follow-up|2|||
164283374|NCT00587158|593406308|FG000|Overall Study|Death|0|||
164283375|NCT00587158|593406309|FG001|Overall Study|Death|1|||
163897342|NCT02719574|591997856|FG008|Phase 1 (Dose Expansion)|Other|0|||
163897343|NCT02719574|591997857|FG009|Phase 1 (Dose Expansion)|Other|0|||
163897344|NCT02719574|591997858|FG010|Phase 1 (Dose Expansion)|Other|0|||
163897345|NCT02719574|591997859|FG011|Phase 1 (Dose Expansion)|Other|0|||
164283376|NCT00587158|593406308|FG000|Overall Study|Subject did not want to take study med|0|||
164283377|NCT00587158|593406309|FG001|Overall Study|Subject did not want to take study med|1|||
164283378|NCT01136408|593406310|FG000|Overall Study|Adverse Event|4|||
164283379|NCT01136408|593406311|FG001|Overall Study|Adverse Event|8|||
164283380|NCT01136408|593406312|FG002|Overall Study|Adverse Event|4|||
164283381|NCT01136408|593406310|FG000|Overall Study|Protocol Violation|1|||
164283382|NCT01136408|593406311|FG001|Overall Study|Protocol Violation|1|||
164283383|NCT01136408|593406312|FG002|Overall Study|Protocol Violation|1|||
164283384|NCT02274792|593406313|FG000|Overall Study|Withdrawal by Subject|13|||
164283385|NCT02274792|593406313|FG000|Overall Study|Lost to Follow-up|8|||
164283386|NCT02274792|593406313|FG000|Overall Study|Protocol Specified Criteria|2|||
164283387|NCT02274792|593406313|FG000|Overall Study|Sponsor Decision|2|||
164283388|NCT01510158|593406314|FG000|Overall Study|Adverse Event|7|||
164283389|NCT01510158|593406315|FG001|Overall Study|Adverse Event|8|||
164283390|NCT01510158|593406316|FG002|Overall Study|Adverse Event|5|||
164283391|NCT01510158|593406314|FG000|Overall Study|Gout flare|1|||
164283392|NCT01510158|593406315|FG001|Overall Study|Gout flare|0|||
164283393|NCT01510158|593406316|FG002|Overall Study|Gout flare|0|||
164283394|NCT01510158|593406314|FG000|Overall Study|Protocol Violation|17|||
164283395|NCT01510158|593406315|FG001|Overall Study|Protocol Violation|16|||
164283396|NCT01510158|593406316|FG002|Overall Study|Protocol Violation|24|||
164283397|NCT01510158|593406314|FG000|Overall Study|Sponsor terminated study.|2|||
164283398|NCT01510158|593406315|FG001|Overall Study|Sponsor terminated study.|0|||
164283399|NCT01510158|593406316|FG002|Overall Study|Sponsor terminated study.|2|||
164283400|NCT01510158|593406314|FG000|Overall Study|Lost to Follow-up|13|||
164283401|NCT01510158|593406315|FG001|Overall Study|Lost to Follow-up|16|||
164283402|NCT01510158|593406316|FG002|Overall Study|Lost to Follow-up|9|||
164283403|NCT01510158|593406314|FG000|Overall Study|Withdrawal by Subject|10|||
164283404|NCT01510158|593406315|FG001|Overall Study|Withdrawal by Subject|13|||
164283405|NCT01510158|593406316|FG002|Overall Study|Withdrawal by Subject|10|||
164283406|NCT01510158|593406314|FG000|Overall Study|Death|1|||
164283407|NCT01510158|593406315|FG001|Overall Study|Death|0|||
164283408|NCT01510158|593406316|FG002|Overall Study|Death|0|||
164283409|NCT03078556|593406317|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
164283410|NCT03078556|593406318|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
164283411|NCT03078556|593406319|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
164283412|NCT03078556|593406320|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
164283413|NCT03078556|593406317|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
164283414|NCT03078556|593406318|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
164283415|NCT03078556|593406319|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
164283416|NCT03078556|593406320|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
164283417|NCT03078556|593406317|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
164283418|NCT03078556|593406318|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
164283419|NCT03078556|593406319|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
164283420|NCT03078556|593406320|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
164283421|NCT03078556|593406317|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
164283422|NCT03078556|593406318|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
164283423|NCT03078556|593406319|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
164283424|NCT03078556|593406320|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
164283425|NCT00832416|593406321|FG000|Overall Study|Lack of Efficacy|17|||
164283426|NCT00832416|593406322|FG001|Overall Study|Lack of Efficacy|15|||
164283427|NCT00832416|593406323|FG002|Overall Study|Lack of Efficacy|13|||
164283428|NCT00832416|593406324|FG003|Overall Study|Lack of Efficacy|52|||
164283429|NCT00832416|593406321|FG000|Overall Study|Withdrawal by Subject|5|||
164283430|NCT00832416|593406322|FG001|Overall Study|Withdrawal by Subject|7|||
164283431|NCT00832416|593406323|FG002|Overall Study|Withdrawal by Subject|2|||
164283432|NCT00832416|593406324|FG003|Overall Study|Withdrawal by Subject|10|||
164283433|NCT00832416|593406321|FG000|Overall Study|Physician Decision|2|||
164283434|NCT00832416|593406322|FG001|Overall Study|Physician Decision|12|||
164283435|NCT00832416|593406323|FG002|Overall Study|Physician Decision|5|||
164283436|NCT00832416|593406324|FG003|Overall Study|Physician Decision|10|||
164283437|NCT00832416|593406321|FG000|Overall Study|Administrative|0|||
164283438|NCT00832416|593406322|FG001|Overall Study|Administrative|0|||
164283439|NCT00832416|593406323|FG002|Overall Study|Administrative|0|||
164283440|NCT00832416|593406324|FG003|Overall Study|Administrative|1|||
164283441|NCT00832416|593406321|FG000|Overall Study|Adverse Event|21|||
164283442|NCT00832416|593406322|FG001|Overall Study|Adverse Event|19|||
164283443|NCT00832416|593406323|FG002|Overall Study|Adverse Event|41|||
164283444|NCT00832416|593406324|FG003|Overall Study|Adverse Event|10|||
164283445|NCT00832416|593406321|FG000|Overall Study|Death|1|||
164283446|NCT00832416|593406322|FG001|Overall Study|Death|0|||
164283447|NCT00832416|593406323|FG002|Overall Study|Death|0|||
164283448|NCT00832416|593406324|FG003|Overall Study|Death|0|||
164283449|NCT04421482|593406331|FG000|Overall Study|Physician Decision|1|||
164283450|NCT05786508|593406334|FG000|Overall Study|Withdrawal by Subject|2|||
164283451|NCT05786508|593406335|FG001|Overall Study|Withdrawal by Subject|0|||
164283452|NCT04426318|593406336|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
164283453|NCT04426318|593406337|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
164283454|NCT02751580|593406338|FG000|Overall Study|Lost to Follow-up|4|||
164283455|NCT02751580|593406338|FG000|Overall Study|Death|2|||
164283456|NCT02588261|593406341|FG000|Overall Study|Study Terminated by Sponsor|157|||
164283457|NCT02588261|593406342|FG001|Overall Study|Study Terminated by Sponsor|142|||
164283458|NCT02588261|593406341|FG000|Overall Study|Protocol Deviation|1|||
164283459|NCT02588261|593406342|FG001|Overall Study|Protocol Deviation|0|||
164283460|NCT02588261|593406341|FG000|Overall Study|Death|1|||
164283461|NCT02588261|593406342|FG001|Overall Study|Death|2|||
164283462|NCT02588261|593406341|FG000|Overall Study|Withdrawal by Subject|12|||
164283463|NCT02588261|593406342|FG001|Overall Study|Withdrawal by Subject|8|||
164283464|NCT02588261|593406341|FG000|Overall Study|Noncompliance with Study Drug|0|||
164283465|NCT02588261|593406342|FG001|Overall Study|Noncompliance with Study Drug|1|||
164283466|NCT02588261|593406341|FG000|Overall Study|Miscellaneous|5|||
164283467|NCT02588261|593406342|FG001|Overall Study|Miscellaneous|4|||
164283468|NCT02588261|593406341|FG000|Overall Study|Progressive Disease|61|||
164283469|NCT02588261|593406342|FG001|Overall Study|Progressive Disease|82|||
164283470|NCT02588261|593406341|FG000|Overall Study|Adverse Event|29|||
164283471|NCT02588261|593406342|FG001|Overall Study|Adverse Event|24|||
164283472|NCT02588261|593406341|FG000|Overall Study|Lost to Follow-up|1|||
164283473|NCT02588261|593406342|FG001|Overall Study|Lost to Follow-up|0|||
164283474|NCT03781778|593406343|FG000|Overall Study|Withdrawal by Subject|2|||
164283475|NCT03781778|593406344|FG001|Overall Study|Withdrawal by Subject|2|||
164283476|NCT02287467|593406345|FG000|Overall Study|Protocol Violation|12|||
164283477|NCT02287467|593406346|FG001|Overall Study|Protocol Violation|9|||
164087568|NCT00095199|592684252|FG001|Overall Study|Not eligible|7|||
164087569|NCT00095199|592684253|FG002|Overall Study|Not eligible|0|||
164087570|NCT00095199|592684254|FG003|Overall Study|Not eligible|1|||
164087571|NCT00095199|592684251|FG000|Overall Study|Started Palliative Radiotherapy|1|||
164087572|NCT00095199|592684252|FG001|Overall Study|Started Palliative Radiotherapy|0|||
164087573|NCT00095199|592684253|FG002|Overall Study|Started Palliative Radiotherapy|0|||
164283478|NCT01456169|593406353|FG000|Overall Study|Adverse Event|1|||
164283479|NCT01456169|593406354|FG001|Overall Study|Adverse Event|2|||
164283480|NCT01456169|593406355|FG002|Overall Study|Adverse Event|7|||
164283481|NCT01456169|593406353|FG000|Overall Study|Major Protocol Deviation|3|||
164283482|NCT01456169|593406354|FG001|Overall Study|Major Protocol Deviation|2|||
164283483|NCT01456169|593406355|FG002|Overall Study|Major Protocol Deviation|3|||
164283484|NCT01456169|593406353|FG000|Overall Study|Voluntary Withdrawal|3|||
164283485|NCT01456169|593406354|FG001|Overall Study|Voluntary Withdrawal|0|||
164283486|NCT01456169|593406355|FG002|Overall Study|Voluntary Withdrawal|2|||
164283487|NCT01456169|593406353|FG000|Overall Study|Lack of Efficacy|2|||
164283488|NCT01456169|593406354|FG001|Overall Study|Lack of Efficacy|0|||
164283489|NCT01456169|593406355|FG002|Overall Study|Lack of Efficacy|0|||
164283490|NCT01456169|593406353|FG000|Overall Study|Other|1|||
164283491|NCT01456169|593406354|FG001|Overall Study|Other|1|||
164283492|NCT01456169|593406355|FG002|Overall Study|Other|0|||
164283493|NCT02292446|593406356|FG000|Overall Study|Adverse Event|12|||
164087574|NCT00095199|592684254|FG003|Overall Study|Started Palliative Radiotherapy|0|||
164087575|NCT00095199|592684251|FG000|Overall Study|Started radiotherapy regimen|0|||
164283494|NCT02292446|593406356|FG000|Overall Study|Death|1|||
164283495|NCT02292446|593406356|FG000|Overall Study|Disease progression|2|||
164283496|NCT02292446|593406356|FG000|Overall Study|Subject/guardian decision|2|||
164283497|NCT02292446|593406356|FG000|Overall Study|Withdrawal by Subject|3|||
164283498|NCT02652156|593406361|FG000|Overall Study|Physician Decision|1|||
164283499|NCT02652156|593406362|FG001|Overall Study|Physician Decision|0|||
164283500|NCT02652156|593406363|FG002|Overall Study|Physician Decision|0|||
164283501|NCT00496080|593406366|FG000|Overall Study|Lost to Follow-up|9|||
164283502|NCT00496080|593406366|FG000|Overall Study|Surgical re-intervention|7|||
164283503|NCT00496080|593406366|FG000|Overall Study|Withdrawal by Subject|5|||
164283504|NCT00496080|593406366|FG000|Overall Study|Physician Decision|6|||
164283505|NCT03329846|593406367|FG000|Overall Study|Disease progression|4|||
164283506|NCT03329846|593406368|FG001|Overall Study|Disease progression|6|||
164283507|NCT03329846|593406367|FG000|Overall Study|Study drug toxicity|1|||
164283508|NCT03329846|593406368|FG001|Overall Study|Study drug toxicity|0|||
164283509|NCT03329846|593406367|FG000|Overall Study|Participant request to discontinue treatment|0|||
163897346|NCT02719574|591997860|FG012|Phase 1 (Dose Expansion)|Other|0|||
163897347|NCT02719574|591997861|FG013|Phase 1 (Dose Expansion)|Other|0|||
164087576|NCT00095199|592684252|FG001|Overall Study|Started radiotherapy regimen|1|||
164283510|NCT03329846|593406368|FG001|Overall Study|Participant request to discontinue treatment|1|||
164283511|NCT03329846|593406367|FG000|Overall Study|Participant withdrew consent|1|||
164283512|NCT03329846|593406368|FG001|Overall Study|Participant withdrew consent|0|||
164283513|NCT03329846|593406367|FG000|Overall Study|Other reasons|2|||
164283514|NCT03329846|593406368|FG001|Overall Study|Other reasons|2|||
164283515|NCT00479336|593406369|FG000|Overall Study|Adverse Event|1|||
164283516|NCT00479336|593406370|FG001|Overall Study|Adverse Event|1|||
164283517|NCT00479336|593406371|FG002|Overall Study|Adverse Event|1|||
164283518|NCT00479336|593406372|FG003|Overall Study|Adverse Event|3|||
164283519|NCT00479336|593406369|FG000|Overall Study|Lack of Efficacy|1|||
163897348|NCT02719574|591997862|FG014|Phase 1 (Dose Expansion)|Other|0|||
163897349|NCT02719574|591997863|FG015|Phase 1 (Dose Expansion)|Other|0|||
163897350|NCT02719574|591997864|FG016|Phase 1 (Dose Expansion)|Other|0|||
164283520|NCT00479336|593406370|FG001|Overall Study|Lack of Efficacy|0|||
164283521|NCT00479336|593406371|FG002|Overall Study|Lack of Efficacy|0|||
164283522|NCT00479336|593406372|FG003|Overall Study|Lack of Efficacy|0|||
164283523|NCT00479336|593406369|FG000|Overall Study|Protocol Violation|0|||
164283524|NCT00479336|593406370|FG001|Overall Study|Protocol Violation|1|||
164283525|NCT00479336|593406371|FG002|Overall Study|Protocol Violation|0|||
164283526|NCT00479336|593406372|FG003|Overall Study|Protocol Violation|0|||
164283527|NCT00479336|593406369|FG000|Overall Study|Withdrawal by Subject|1|||
164283528|NCT00479336|593406370|FG001|Overall Study|Withdrawal by Subject|2|||
164283529|NCT00479336|593406371|FG002|Overall Study|Withdrawal by Subject|0|||
164283530|NCT00479336|593406372|FG003|Overall Study|Withdrawal by Subject|0|||
164283531|NCT00479336|593406369|FG000|Overall Study|Physician Decision|0|||
164283532|NCT00479336|593406370|FG001|Overall Study|Physician Decision|1|||
164283533|NCT00479336|593406371|FG002|Overall Study|Physician Decision|0|||
164283534|NCT00479336|593406372|FG003|Overall Study|Physician Decision|2|||
164283535|NCT00479336|593406369|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
164283536|NCT00479336|593406370|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
164283537|NCT00479336|593406371|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
164283538|NCT00479336|593406372|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
164283539|NCT02741596|593406373|FG000|Overall Study|Adverse Event|1|||
164283540|NCT02741596|593406374|FG001|Overall Study|Adverse Event|5|||
164283541|NCT02741596|593406373|FG000|Overall Study|Lost to Follow-up|1|||
164283542|NCT02741596|593406374|FG001|Overall Study|Lost to Follow-up|1|||
164283543|NCT02741596|593406373|FG000|Overall Study|Physician Decision|2|||
164283544|NCT02741596|593406374|FG001|Overall Study|Physician Decision|1|||
164283545|NCT02741596|593406373|FG000|Overall Study|Pregnancy|3|||
164283546|NCT02741596|593406374|FG001|Overall Study|Pregnancy|1|||
164283547|NCT02741596|593406373|FG000|Overall Study|Other (Unspecified)|0|||
164283548|NCT02741596|593406374|FG001|Overall Study|Other (Unspecified)|3|||
164283549|NCT02741596|593406373|FG000|Overall Study|Subject withdrawn-Other|17|||
164283550|NCT02741596|593406374|FG001|Overall Study|Subject withdrawn-Other|4|||
164283551|NCT02741596|593406373|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
164283552|NCT02741596|593406374|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
164283553|NCT02021643|593406375|FG000|Overall Study|Enrolled but Never Treated|1|||
164283554|NCT02021643|593406376|FG001|Overall Study|Enrolled but Never Treated|0|||
164283555|NCT02021643|593406377|FG002|Overall Study|Enrolled but Never Treated|0|||
164283556|NCT02021643|593406378|FG003|Overall Study|Enrolled but Never Treated|0|||
164283557|NCT02021643|593406375|FG000|Overall Study|Adverse Event|0|||
164283558|NCT02021643|593406376|FG001|Overall Study|Adverse Event|1|||
164283559|NCT02021643|593406377|FG002|Overall Study|Adverse Event|0|||
164283560|NCT02021643|593406378|FG003|Overall Study|Adverse Event|0|||
164283561|NCT02021643|593406375|FG000|Overall Study|Death|0|||
164283562|NCT02021643|593406376|FG001|Overall Study|Death|1|||
164283563|NCT02021643|593406377|FG002|Overall Study|Death|0|||
164283564|NCT02021643|593406378|FG003|Overall Study|Death|0|||
164283565|NCT02021643|593406375|FG000|Overall Study|Investigator's Discretion|1|||
164283566|NCT02021643|593406376|FG001|Overall Study|Investigator's Discretion|0|||
164283567|NCT02021643|593406377|FG002|Overall Study|Investigator's Discretion|0|||
164283568|NCT02021643|593406378|FG003|Overall Study|Investigator's Discretion|0|||
164283569|NCT02021643|593406375|FG000|Overall Study|Lack of Efficacy|7|||
164283570|NCT02021643|593406376|FG001|Overall Study|Lack of Efficacy|6|||
164283571|NCT02021643|593406377|FG002|Overall Study|Lack of Efficacy|0|||
164283572|NCT02021643|593406378|FG003|Overall Study|Lack of Efficacy|12|||
164283573|NCT02021643|593406375|FG000|Overall Study|Lost to Follow-up|0|||
164283574|NCT02021643|593406376|FG001|Overall Study|Lost to Follow-up|1|||
164283575|NCT02021643|593406377|FG002|Overall Study|Lost to Follow-up|0|||
164283576|NCT02021643|593406378|FG003|Overall Study|Lost to Follow-up|0|||
164283577|NCT02021643|593406375|FG000|Overall Study|Withdrew Consent|0|||
164283578|NCT02021643|593406376|FG001|Overall Study|Withdrew Consent|1|||
164283579|NCT02021643|593406377|FG002|Overall Study|Withdrew Consent|0|||
164283580|NCT02021643|593406378|FG003|Overall Study|Withdrew Consent|0|||
164283581|NCT02631551|593406381|FG000|Overall Study|Adverse Event|1|||
164283582|NCT02631551|593406382|FG001|Overall Study|Adverse Event|2|||
164283583|NCT02631551|593406383|FG002|Overall Study|Adverse Event|4|||
164283584|NCT02631551|593406384|FG003|Overall Study|Adverse Event|0|||
164283585|NCT02631551|593406381|FG000|Overall Study|Lack of Efficacy|0|||
164283586|NCT02631551|593406382|FG001|Overall Study|Lack of Efficacy|0|||
164283587|NCT02631551|593406383|FG002|Overall Study|Lack of Efficacy|1|||
164283588|NCT02631551|593406384|FG003|Overall Study|Lack of Efficacy|0|||
164283589|NCT02631551|593406381|FG000|Overall Study|Lost to Follow-up|1|||
164283590|NCT02631551|593406382|FG001|Overall Study|Lost to Follow-up|2|||
164283591|NCT02631551|593406383|FG002|Overall Study|Lost to Follow-up|0|||
164283592|NCT02631551|593406384|FG003|Overall Study|Lost to Follow-up|3|||
164283593|NCT02631551|593406381|FG000|Overall Study|Withdrawal by Subject|2|||
164283594|NCT02631551|593406382|FG001|Overall Study|Withdrawal by Subject|2|||
164283595|NCT02631551|593406383|FG002|Overall Study|Withdrawal by Subject|0|||
164283596|NCT02631551|593406384|FG003|Overall Study|Withdrawal by Subject|5|||
164283597|NCT02631551|593406381|FG000|Overall Study|Protocol deviation|3|||
164283598|NCT02631551|593406382|FG001|Overall Study|Protocol deviation|6|||
164283599|NCT02631551|593406383|FG002|Overall Study|Protocol deviation|3|||
164283600|NCT02631551|593406384|FG003|Overall Study|Protocol deviation|0|||
164283601|NCT02631551|593406381|FG000|Overall Study|Non-compliance with study procedures|0|||
164283602|NCT02631551|593406382|FG001|Overall Study|Non-compliance with study procedures|0|||
164283603|NCT02631551|593406383|FG002|Overall Study|Non-compliance with study procedures|1|||
164283604|NCT02631551|593406384|FG003|Overall Study|Non-compliance with study procedures|1|||
164283605|NCT02631551|593406381|FG000|Overall Study|Non-compliance with study drug|1|||
164283606|NCT02631551|593406382|FG001|Overall Study|Non-compliance with study drug|0|||
164283607|NCT02631551|593406383|FG002|Overall Study|Non-compliance with study drug|0|||
164283608|NCT02631551|593406384|FG003|Overall Study|Non-compliance with study drug|0|||
164283609|NCT02631551|593406381|FG000|Overall Study|Other, specific reasons not collected|5|||
164283610|NCT02631551|593406382|FG001|Overall Study|Other, specific reasons not collected|7|||
164283611|NCT02631551|593406383|FG002|Overall Study|Other, specific reasons not collected|2|||
164283612|NCT02631551|593406384|FG003|Overall Study|Other, specific reasons not collected|2|||
164283613|NCT01076036|593406387|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
164283614|NCT02221674|593406388|FG000|Overall Study|Lost to Follow-up|1|||
164283615|NCT02221674|593406389|FG001|Overall Study|Lost to Follow-up|0|||
164283616|NCT02221674|593406390|FG002|Overall Study|Lost to Follow-up|0|||
164283617|NCT05292131|593406391|FG000|Overall Study|Lost to Follow-up|1|||
164283618|NCT05292131|593406392|FG001|Overall Study|Lost to Follow-up|1|||
164283619|NCT05292131|593406391|FG000|Overall Study|Withdrawal by Subject|0|||
164283620|NCT05292131|593406392|FG001|Overall Study|Withdrawal by Subject|1|||
164283621|NCT01345188|593406393|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
164283622|NCT01345188|593406393|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
164283623|NCT04752358|593406394|FG000|Overall Study|Death|2|||
164283624|NCT04752358|593406395|FG001|Overall Study|Death|1|||
164283625|NCT04607837|593406396|FG000|Overall Study|Adverse Event|8|||
164283626|NCT04607837|593406397|FG001|Overall Study|Adverse Event|2|||
164283627|NCT04607837|593406396|FG000|Overall Study|Withdrawal by Subject|8|||
164283628|NCT04607837|593406397|FG001|Overall Study|Withdrawal by Subject|7|||
164283629|NCT04607837|593406396|FG000|Overall Study|Physician Decision|2|||
164283630|NCT04607837|593406397|FG001|Overall Study|Physician Decision|0|||
164283631|NCT04607837|593406396|FG000|Overall Study|Lack of Efficacy|2|||
164283632|NCT04607837|593406397|FG001|Overall Study|Lack of Efficacy|0|||
164283633|NCT04607837|593406396|FG000|Overall Study|Participant terminated by sponsor|1|||
164283634|NCT04607837|593406397|FG001|Overall Study|Participant terminated by sponsor|0|||
164283635|NCT04607837|593406396|FG000|Overall Study|Disease worsening|36|||
164283636|NCT04607837|593406397|FG001|Overall Study|Disease worsening|36|||
164283637|NCT04607837|593406396|FG000|Overall Study|Other|1|||
164283638|NCT04607837|593406397|FG001|Overall Study|Other|0|||
164283639|NCT00465452|593406407|FG000|Overall Study|Adverse Event|1|||
164283640|NCT05236257|593406411|FG000|Overall Study|Ongoing with study treatment|29|||
164283641|NCT05236257|593406412|FG001|Overall Study|Ongoing with study treatment|1|||
164283642|NCT05236257|593406411|FG000|Overall Study|Discontinued study treatment|22|||
164283643|NCT05236257|593406412|FG001|Overall Study|Discontinued study treatment|41|||
164283644|NCT05870865|593406413|FG000|Randomized|Did not receive study treatment|2|||
164283645|NCT05870865|593406414|FG001|Randomized|Did not receive study treatment|4|||
164283646|NCT05870865|593406415|FG002|Randomized|Did not receive study treatment|4|||
164283647|NCT05870865|593406416|FG003|Randomized|Did not receive study treatment|3|||
164283648|NCT05870865|593406413|FG000|Treatment Period|Adverse Event|1|||
164283649|NCT05870865|593406414|FG001|Treatment Period|Adverse Event|1|||
164283650|NCT05870865|593406415|FG002|Treatment Period|Adverse Event|1|||
164283651|NCT05870865|593406416|FG003|Treatment Period|Adverse Event|1|||
164283652|NCT05870865|593406413|FG000|Treatment Period|Lost to Follow-up|0|||
164283653|NCT05870865|593406414|FG001|Treatment Period|Lost to Follow-up|1|||
164283654|NCT05870865|593406415|FG002|Treatment Period|Lost to Follow-up|2|||
164003453|NCT03248128|592375820|FG000|Overall Study|Site Closed|4|||
164003454|NCT03248128|592375821|FG001|Overall Study|Site Closed|3|||
164003455|NCT03248128|592375820|FG000|Overall Study|Randomized, but did not receive treatment|1|||
164283655|NCT05870865|593406416|FG003|Treatment Period|Lost to Follow-up|0|||
164283656|NCT05870865|593406413|FG000|Treatment Period|Protocol Violation|0|||
164283657|NCT05870865|593406414|FG001|Treatment Period|Protocol Violation|0|||
164283658|NCT05870865|593406415|FG002|Treatment Period|Protocol Violation|0|||
164283659|NCT05870865|593406416|FG003|Treatment Period|Protocol Violation|1|||
164283660|NCT05870865|593406413|FG000|Treatment Period|Withdrawal by Subject|0|||
164283661|NCT05870865|593406414|FG001|Treatment Period|Withdrawal by Subject|1|||
164283662|NCT05870865|593406415|FG002|Treatment Period|Withdrawal by Subject|1|||
164283663|NCT05870865|593406416|FG003|Treatment Period|Withdrawal by Subject|1|||
164283664|NCT03828019|593406419|FG000|Overall Study|Withdrawal by Subject|3|||
164283665|NCT03828019|593406420|FG001|Overall Study|Withdrawal by Subject|8|||
164283666|NCT03828019|593406419|FG000|Overall Study|Lost to Follow-up|1|||
164283667|NCT03828019|593406420|FG001|Overall Study|Lost to Follow-up|6|||
164283668|NCT03828019|593406419|FG000|Overall Study|Incarcerated|1|||
164283669|NCT03828019|593406420|FG001|Overall Study|Incarcerated|0|||
164283670|NCT03828019|593406419|FG000|Overall Study|Adverse Event|0|||
164283671|NCT03828019|593406420|FG001|Overall Study|Adverse Event|1|||
164283672|NCT05715242|593406421|FG000|Overall Study|Lost to Follow-up|0|||
164283673|NCT05715242|593406422|FG001|Overall Study|Lost to Follow-up|0|||
164283674|NCT05715242|593406423|FG002|Overall Study|Lost to Follow-up|1|||
164283675|NCT05715242|593406424|FG003|Overall Study|Lost to Follow-up|0|||
164283676|NCT05715242|593406425|FG004|Overall Study|Lost to Follow-up|0|||
164283677|NCT05715242|593406426|FG005|Overall Study|Lost to Follow-up|1|||
164283678|NCT05715242|593406427|FG006|Overall Study|Lost to Follow-up|0|||
164283679|NCT05715242|593406428|FG007|Overall Study|Lost to Follow-up|0|||
164283680|NCT05715242|593406429|FG008|Overall Study|Lost to Follow-up|0|||
164283681|NCT05715242|593406430|FG009|Overall Study|Lost to Follow-up|0|||
164283682|NCT05715242|593406431|FG010|Overall Study|Lost to Follow-up|0|||
164283683|NCT05715242|593406432|FG011|Overall Study|Lost to Follow-up|0|||
164283684|NCT05715242|593406433|FG012|Overall Study|Lost to Follow-up|0|||
164283685|NCT05715242|593406434|FG013|Overall Study|Lost to Follow-up|0|||
164283686|NCT05715242|593406435|FG014|Overall Study|Lost to Follow-up|0|||
164283687|NCT05715242|593406436|FG015|Overall Study|Lost to Follow-up|0|||
164283688|NCT01090063|593406438|FG000|Screen|Screen Failed|4|||
164283689|NCT01090063|593406438|FG000|Treatment|Withdrawal by Subject|4|||
164283690|NCT02936635|593407686|FG000|Overall Study|Adverse Event|43|||
164283691|NCT02936635|593407687|FG001|Overall Study|Adverse Event|25|||
164283692|NCT02936635|593407686|FG000|Overall Study|Progressive Disease|10|||
164283693|NCT02936635|593407687|FG001|Overall Study|Progressive Disease|18|||
164283694|NCT02936635|593407686|FG000|Overall Study|Sponsor Discretion|10|||
164283695|NCT02936635|593407687|FG001|Overall Study|Sponsor Discretion|16|||
164283696|NCT02936635|593407686|FG000|Overall Study|Death|9|||
164283697|NCT02936635|593407687|FG001|Overall Study|Death|15|||
164283698|NCT02936635|593407686|FG000|Overall Study|Withdrawal by Subject|8|||
164283699|NCT02936635|593407687|FG001|Overall Study|Withdrawal by Subject|15|||
164283700|NCT02936635|593407686|FG000|Overall Study|Physician Decision|2|||
164283701|NCT02936635|593407687|FG001|Overall Study|Physician Decision|9|||
164283702|NCT02936635|593407686|FG000|Overall Study|Lost to Follow-up|1|||
164283703|NCT02936635|593407687|FG001|Overall Study|Lost to Follow-up|2|||
164283704|NCT02936635|593407686|FG000|Overall Study|Protocol Violation|1|||
164003456|NCT03248128|592375821|FG001|Overall Study|Randomized, but did not receive treatment|3|||
164003457|NCT01914679|592375822|FG000|Overall Study|Lack of Efficacy|1|||
164283705|NCT02936635|593407687|FG001|Overall Study|Protocol Violation|0|||
164283706|NCT02936635|593407686|FG000|Overall Study|Lack of effect/Entry into other study|31|||
164283707|NCT02936635|593407687|FG001|Overall Study|Lack of effect/Entry into other study|65|||
164283708|NCT02407223|593407688|FG000|Overall Study|Adverse Event|1|||
164283709|NCT02407223|593407689|FG001|Overall Study|Adverse Event|0|||
164283710|NCT02407223|593407690|FG002|Overall Study|Adverse Event|1|||
164283711|NCT02407223|593407688|FG000|Overall Study|Lack of Efficacy|6|||
164283712|NCT02407223|593407689|FG001|Overall Study|Lack of Efficacy|6|||
164283713|NCT02407223|593407690|FG002|Overall Study|Lack of Efficacy|4|||
164283714|NCT02407223|593407688|FG000|Overall Study|Lost to Follow-up|1|||
164283715|NCT02407223|593407689|FG001|Overall Study|Lost to Follow-up|0|||
164283716|NCT02407223|593407690|FG002|Overall Study|Lost to Follow-up|2|||
164283717|NCT02407223|593407688|FG000|Overall Study|Withdrawal by Subject|2|||
164283718|NCT02407223|593407689|FG001|Overall Study|Withdrawal by Subject|4|||
164283719|NCT02407223|593407690|FG002|Overall Study|Withdrawal by Subject|4|||
164283720|NCT02407223|593407688|FG000|Overall Study|Study Terminated by Sponsor|77|||
164283721|NCT02407223|593407689|FG001|Overall Study|Study Terminated by Sponsor|80|||
164283722|NCT02407223|593407690|FG002|Overall Study|Study Terminated by Sponsor|86|||
164283723|NCT02407223|593407688|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
164283724|NCT02407223|593407689|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
164283725|NCT02407223|593407690|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
164283726|NCT02407223|593407688|FG000|Overall Study|Other|29|||
164283727|NCT02407223|593407689|FG001|Overall Study|Other|27|||
164283728|NCT02407223|593407690|FG002|Overall Study|Other|25|||
164283729|NCT01478971|593407691|FG000|Standard of Care Period|Adverse Event|1|||
164283730|NCT01478971|593407691|FG000|Standard of Care Period|Withdrawal by Subject|3|||
164283731|NCT01478971|593407691|FG000|Standard of Care Period|Death|8|||
164283732|NCT01478971|593407691|FG000|Standard of Care Period|Lost to Follow-up|9|||
164283733|NCT01478971|593407691|FG000|Standard of Care Period|Other|4|||
164283734|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Adverse Event|1|||
164283735|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
164283736|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Death|4|||
164283737|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
164283738|NCT01478971|593407691|FG000|Peginesatide Treatment Period|Other|4|||
164283739|NCT00763386|593407696|FG000|Overall Study|Adverse Event|43|||
164283740|NCT00763386|593407697|FG001|Overall Study|Adverse Event|33|||
164283741|NCT00763386|593407696|FG000|Overall Study|Death|1|||
164283742|NCT00763386|593407697|FG001|Overall Study|Death|2|||
164283743|NCT00763386|593407696|FG000|Overall Study|Lost to Follow-up|3|||
164283744|NCT00763386|593407697|FG001|Overall Study|Lost to Follow-up|3|||
164283745|NCT00763386|593407696|FG000|Overall Study|Withdrawal by Subject|0|||
164283746|NCT00763386|593407697|FG001|Overall Study|Withdrawal by Subject|1|||
164283747|NCT00763386|593407696|FG000|Overall Study|CRF missing|0|||
164283748|NCT00763386|593407697|FG001|Overall Study|CRF missing|1|||
164283749|NCT00763386|593407696|FG000|Overall Study|Study Prosthesis Removed|1|||
164283750|NCT00763386|593407697|FG001|Overall Study|Study Prosthesis Removed|0|||
164283751|NCT00922623|593407698|FG000|Overall Study|Other|4|||
164283752|NCT00922623|593407698|FG000|Overall Study|Lost to Follow-up|1|||
164283753|NCT02451917|593407699|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
164283754|NCT02451917|593407700|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
164283755|NCT02451917|593407699|FG000|First Intervention (24 Weeks)|Death|0|||
164283756|NCT02451917|593407700|FG001|First Intervention (24 Weeks)|Death|1|||
164283757|NCT02451917|593407699|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
164283758|NCT02451917|593407700|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
164283759|NCT00950846|593407704|FG000|Overall Study|Death|6|||
164283760|NCT00950846|593407704|FG000|Overall Study|Lost to Follow-up|3|||
164283761|NCT00950846|593407704|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
164283762|NCT02114606|593407705|FG000|Overall Study|Unable to swallow Cytosponge|6|||
164283763|NCT03361293|593407706|FG000|Overall Study|Lost to Follow-up|0|||
164283764|NCT03361293|593407707|FG001|Overall Study|Lost to Follow-up|2|||
164283765|NCT03361293|593407706|FG000|Overall Study|Withdrawal by Subject|1|||
164283766|NCT03361293|593407707|FG001|Overall Study|Withdrawal by Subject|3|||
164283767|NCT00571038|593407708|FG000|Overall Study|Lost to Follow-up|1|||
164283768|NCT00571038|593407709|FG001|Overall Study|Lost to Follow-up|4|||
164283769|NCT00571038|593407708|FG000|Overall Study|Death|7|||
164283770|NCT00571038|593407709|FG001|Overall Study|Death|5|||
164283771|NCT00571038|593407708|FG000|Overall Study|Withdrawal by Subject|1|||
164283772|NCT00571038|593407709|FG001|Overall Study|Withdrawal by Subject|3|||
164283773|NCT00571038|593407708|FG000|Overall Study|Moved out of state|2|||
164283774|NCT00571038|593407709|FG001|Overall Study|Moved out of state|2|||
164283775|NCT04829916|593407710|FG000|Overall Study|Withdrawal by Subject|1|||
164283776|NCT04829916|593407711|FG001|Overall Study|Withdrawal by Subject|0|||
164283777|NCT03594773|593407715|FG000|Overall Study|Withdrawal by Subject|3|||
164283778|NCT03594773|593407716|FG001|Overall Study|Withdrawal by Subject|2|||
164283779|NCT03594773|593407715|FG000|Overall Study|Lost to Follow-up|3|||
164283780|NCT03594773|593407716|FG001|Overall Study|Lost to Follow-up|4|||
164283781|NCT04854551|593407717|FG000|Overall Study|Withdrawal by Subject|1|||
164283782|NCT04854551|593407718|FG001|Overall Study|Withdrawal by Subject|1|||
164283783|NCT04390243|593407724|FG000|Overall Study|Death|1|||
164283784|NCT04390243|593407724|FG000|Overall Study|Disease Progression|4|||
164283785|NCT04390243|593407724|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
164283786|NCT01521507|593407731|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
164283787|NCT01521507|593407732|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
164283788|NCT01521507|593407731|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
164283789|NCT01521507|593407732|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
164283790|NCT01521507|593407731|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
164283791|NCT01521507|593407732|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
164283792|NCT01521507|593407731|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
164283793|NCT01521507|593407732|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
164283794|NCT01521507|593407731|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
164283795|NCT01521507|593407732|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
164283796|NCT01521507|593407731|FG000|Stage 2: Observational Design|Physician Decision|1|||
164283797|NCT01521507|593407732|FG001|Stage 2: Observational Design|Physician Decision|0|||
164283798|NCT04034004|593407733|FG000|Overall Study|Withdrawal by Subject|1|||
164283799|NCT04034004|593407734|FG001|Overall Study|Withdrawal by Subject|2|||
164283800|NCT04034004|593407735|FG002|Overall Study|Withdrawal by Subject|2|||
164283801|NCT04034004|593407736|FG003|Overall Study|Withdrawal by Subject|3|||
164283802|NCT04034004|593407733|FG000|Overall Study|could not find vein to administer IV|2|||
164283803|NCT04034004|593407734|FG001|Overall Study|could not find vein to administer IV|1|||
164283804|NCT04034004|593407735|FG002|Overall Study|could not find vein to administer IV|0|||
164283805|NCT04034004|593407736|FG003|Overall Study|could not find vein to administer IV|0|||
164283806|NCT04034004|593407733|FG000|Overall Study|nurse accidentally unblinded subject|0|||
164283807|NCT04034004|593407734|FG001|Overall Study|nurse accidentally unblinded subject|0|||
164283808|NCT04034004|593407735|FG002|Overall Study|nurse accidentally unblinded subject|0|||
164283809|NCT04034004|593407736|FG003|Overall Study|nurse accidentally unblinded subject|1|||
164283810|NCT04317040|593407737|FG000|Overall Study|Lost to Follow-up|2|||
164283811|NCT04317040|593407738|FG001|Overall Study|Lost to Follow-up|0|||
164283812|NCT04317040|593407737|FG000|Overall Study|Death|16|||
164283813|NCT04317040|593407738|FG001|Overall Study|Death|18|||
164283814|NCT04317040|593407737|FG000|Overall Study|Withdrawal by Subject|0|||
164283815|NCT04317040|593407738|FG001|Overall Study|Withdrawal by Subject|1|||
164283816|NCT04317040|593407737|FG000|Overall Study|Incomplete assessments|0|||
164003458|NCT01914679|592375822|FG000|Overall Study|Sponsor terminated study|4|||
164003459|NCT00256295|592375825|FG000|Overall Study|Withdrawal by Subject|3|||
164003460|NCT00256295|592375825|FG000|Overall Study|Death|1|||
164003461|NCT01126580|592375826|FG000|Overall Study|Adverse Event|14|||
164003462|NCT01126580|592375827|FG001|Overall Study|Adverse Event|8|||
164283817|NCT04317040|593407738|FG001|Overall Study|Incomplete assessments|1|||
164283818|NCT03672292|593407739|FG000|Overall Study|Adverse Event|3|||
164283819|NCT03672292|593407740|FG001|Overall Study|Adverse Event|1|||
164283820|NCT03672292|593407739|FG000|Overall Study|Physician Decision|0|||
164283821|NCT03672292|593407740|FG001|Overall Study|Physician Decision|1|||
164283822|NCT03672292|593407739|FG000|Overall Study|Withdrawal by Subject|1|||
164283823|NCT03672292|593407740|FG001|Overall Study|Withdrawal by Subject|2|||
164283824|NCT00799903|593407741|FG000|Overall Study|Investigator Site Closed|25|||
164283825|NCT00799903|593407742|FG001|Overall Study|Investigator Site Closed|23|||
164283826|NCT00799903|593407741|FG000|Overall Study|Withdrawal by Subject|179|||
164283827|NCT00799903|593407742|FG001|Overall Study|Withdrawal by Subject|175|||
164283828|NCT00799903|593407741|FG000|Overall Study|Lost to Follow-up|69|||
164283829|NCT00799903|593407742|FG001|Overall Study|Lost to Follow-up|80|||
164283830|NCT02518971|593407743|FG000|Overall Study|Lost to Follow-up|0|||
164283831|NCT02518971|593407744|FG001|Overall Study|Lost to Follow-up|1|||
164283832|NCT02518971|593407743|FG000|Overall Study|Physician Decision|6|||
164283833|NCT02518971|593407744|FG001|Overall Study|Physician Decision|6|||
164283834|NCT02518971|593407743|FG000|Overall Study|Protocol Violation|6|||
164283835|NCT02518971|593407744|FG001|Overall Study|Protocol Violation|4|||
164283836|NCT02518971|593407743|FG000|Overall Study|Withdrawal by Subject|4|||
164283837|NCT02518971|593407744|FG001|Overall Study|Withdrawal by Subject|5|||
164003463|NCT01126580|592375828|FG002|Overall Study|Adverse Event|12|||
164003464|NCT01126580|592375826|FG000|Overall Study|Withdrawal by Subject|11|||
164344651|NCT03988088|593637006|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
164344652|NCT03988088|593637003|FG000|Open-Label Addendum|Lost to Follow-up|0|||
164344653|NCT03988088|593637004|FG001|Open-Label Addendum|Lost to Follow-up|0|||
164344654|NCT03988088|593637005|FG002|Open-Label Addendum|Lost to Follow-up|1|||
164344655|NCT03988088|593637006|FG003|Open-Label Addendum|Lost to Follow-up|0|||
164344656|NCT01546883|593637009|FG000|Overall Study|Withdrawal by Subject|3|||
164344657|NCT01546883|593637009|FG000|Overall Study|Adverse Event|4|||
164344658|NCT01546883|593637009|FG000|Overall Study|Lost to Follow-up|2|||
164344659|NCT01546883|593637009|FG000|Overall Study|early closure of study|2|||
164344660|NCT01546883|593637009|FG000|Overall Study|other unrelated illness|1|||
164344661|NCT03344796|593637010|FG000|Overall Study|Lost to Follow-up|0|||
164344662|NCT03344796|593637011|FG001|Overall Study|Lost to Follow-up|0|||
164344663|NCT03344796|593637012|FG002|Overall Study|Lost to Follow-up|0|||
164344664|NCT03344796|593637013|FG003|Overall Study|Lost to Follow-up|0|||
164344665|NCT03344796|593637014|FG004|Overall Study|Lost to Follow-up|0|||
164344666|NCT03344796|593637015|FG005|Overall Study|Lost to Follow-up|2|||
164344667|NCT00915278|593637016|FG000|Overall Study|Death|1|||
164344668|NCT00915278|593637017|FG001|Overall Study|Death|0|||
164344669|NCT00915278|593637018|FG002|Overall Study|Death|0|||
164344670|NCT00915278|593637019|FG003|Overall Study|Death|0|||
164344671|NCT00915278|593637020|FG004|Overall Study|Death|0|||
164344672|NCT00915278|593637021|FG005|Overall Study|Death|0|||
164344673|NCT00915278|593637016|FG000|Overall Study|Lost to Follow-up|0|||
164344674|NCT00915278|593637017|FG001|Overall Study|Lost to Follow-up|1|||
164344675|NCT00915278|593637018|FG002|Overall Study|Lost to Follow-up|0|||
164344676|NCT00915278|593637019|FG003|Overall Study|Lost to Follow-up|0|||
164344677|NCT00915278|593637020|FG004|Overall Study|Lost to Follow-up|0|||
164344678|NCT00915278|593637021|FG005|Overall Study|Lost to Follow-up|0|||
164344679|NCT00915278|593637016|FG000|Overall Study|Withdrawal by Subject|0|||
164344680|NCT00915278|593637017|FG001|Overall Study|Withdrawal by Subject|1|||
164344681|NCT00915278|593637018|FG002|Overall Study|Withdrawal by Subject|0|||
164344682|NCT00915278|593637019|FG003|Overall Study|Withdrawal by Subject|0|||
164344683|NCT00915278|593637020|FG004|Overall Study|Withdrawal by Subject|1|||
164344684|NCT00915278|593637021|FG005|Overall Study|Withdrawal by Subject|4|||
164344685|NCT00915278|593637016|FG000|Overall Study|Adverse Event|4|||
164283838|NCT02518971|593407743|FG000|Overall Study|Side effects|1|||
164283839|NCT02518971|593407744|FG001|Overall Study|Side effects|0|||
164344686|NCT00915278|593637017|FG001|Overall Study|Adverse Event|1|||
164344687|NCT00915278|593637018|FG002|Overall Study|Adverse Event|0|||
164344688|NCT00915278|593637019|FG003|Overall Study|Adverse Event|0|||
164344689|NCT00915278|593637020|FG004|Overall Study|Adverse Event|0|||
164344690|NCT00915278|593637021|FG005|Overall Study|Adverse Event|0|||
164003465|NCT01126580|592375827|FG001|Overall Study|Withdrawal by Subject|19|||
164283840|NCT02518971|593407743|FG000|Overall Study|medication lost in mail|0|||
164283841|NCT02518971|593407744|FG001|Overall Study|medication lost in mail|1|||
164283842|NCT02518971|593407743|FG000|Overall Study|eligibility criteria no longer met|6|||
164344691|NCT00915278|593637016|FG000|Overall Study|Progressive disease/clinical progression|0|||
164344692|NCT00915278|593637017|FG001|Overall Study|Progressive disease/clinical progression|0|||
164344693|NCT00915278|593637018|FG002|Overall Study|Progressive disease/clinical progression|0|||
164344694|NCT00915278|593637019|FG003|Overall Study|Progressive disease/clinical progression|3|||
164283843|NCT02518971|593407744|FG001|Overall Study|eligibility criteria no longer met|3|||
164283844|NCT03088917|593407745|FG000|Overall Study|In care/cured elsewhere|15|||
164283845|NCT03088917|593407745|FG000|Overall Study|Refuse re-evaluation|13|||
164283846|NCT03088917|593407745|FG000|Overall Study|Contact not established|13|||
164283847|NCT03088917|593407745|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
164283848|NCT03088917|593407745|FG000|Overall Study|Moved outside study region|50|||
164283849|NCT01514201|593407750|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
164283850|NCT01514201|593407751|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283851|NCT01514201|593407752|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283852|NCT01514201|593407753|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283853|NCT01514201|593407750|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283854|NCT01514201|593407751|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
164283855|NCT01514201|593407752|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
164283856|NCT01514201|593407753|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283857|NCT01514201|593407750|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
164283858|NCT01514201|593407751|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
164283859|NCT01514201|593407752|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
164283860|NCT01514201|593407753|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283861|NCT01514201|593407750|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
164283862|NCT01514201|593407751|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
164283863|NCT01514201|593407752|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283864|NCT01514201|593407753|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283865|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
164283866|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
164283867|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
164283868|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
164283869|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
164283870|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
164283871|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
164283872|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
164283873|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
164283874|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
164283875|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
164283876|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
164283877|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283878|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283879|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
164283880|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
164283881|NCT01514201|593407750|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
164283882|NCT01514201|593407751|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
164283883|NCT01514201|593407752|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
164283884|NCT01514201|593407753|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
164283885|NCT01514201|593407750|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283886|NCT01514201|593407751|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283887|NCT01514201|593407752|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
164283888|NCT01514201|593407753|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
164283889|NCT01514201|593407750|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283890|NCT01514201|593407751|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283891|NCT01514201|593407752|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
164283892|NCT01514201|593407753|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
164283893|NCT01514201|593407750|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283894|NCT01514201|593407751|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283895|NCT01514201|593407752|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
164283896|NCT01514201|593407753|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
164283897|NCT02735343|593407759|FG000|Overall Study|screen fail|0|||
164283898|NCT02735343|593407760|FG001|Overall Study|screen fail|2|||
164283899|NCT00566852|593407771|FG000|Overall Study|Protocol Violation|22|||
164283900|NCT00566852|593407772|FG001|Overall Study|Protocol Violation|24|||
164283901|NCT00566852|593407771|FG000|Overall Study|Death|95|||
164283902|NCT00566852|593407772|FG001|Overall Study|Death|78|||
164283903|NCT00566852|593407771|FG000|Overall Study|Withdrawal by Subject|30|||
164283904|NCT00566852|593407772|FG001|Overall Study|Withdrawal by Subject|25|||
164003466|NCT01126580|592375828|FG002|Overall Study|Withdrawal by Subject|14|||
164283905|NCT00566852|593407771|FG000|Overall Study|Patient refusal|37|||
164283906|NCT00566852|593407772|FG001|Overall Study|Patient refusal|37|||
164283907|NCT00566852|593407771|FG000|Overall Study|Not tested due to disability|6|||
164283908|NCT00566852|593407772|FG001|Overall Study|Not tested due to disability|12|||
164283909|NCT00566852|593407771|FG000|Overall Study|Missing reason not specified|1|||
164003467|NCT01126580|592375826|FG000|Overall Study|Sponsor Decision|5|||
164283910|NCT00566852|593407772|FG001|Overall Study|Missing reason not specified|2|||
164003468|NCT01126580|592375827|FG001|Overall Study|Sponsor Decision|4|||
164003469|NCT01126580|592375828|FG002|Overall Study|Sponsor Decision|7|||
164003470|NCT01126580|592375826|FG000|Overall Study|Physician Decision|1|||
164003471|NCT01126580|592375827|FG001|Overall Study|Physician Decision|1|||
164003472|NCT01126580|592375828|FG002|Overall Study|Physician Decision|2|||
164003473|NCT01126580|592375826|FG000|Overall Study|Entry Criteria Not Met|1|||
164003474|NCT01126580|592375827|FG001|Overall Study|Entry Criteria Not Met|1|||
164283911|NCT00566852|593407771|FG000|Overall Study|Missing reason not reported|16|||
164283912|NCT00566852|593407772|FG001|Overall Study|Missing reason not reported|20|||
164283913|NCT04531241|593407777|FG000|Period 1|Withdrawal by Subject|2|||
164283914|NCT04531241|593407778|FG001|Period 1|Withdrawal by Subject|0|||
164283915|NCT04531241|593407777|FG000|Period 1|Dispesed incorrect lens power|1|||
164283916|NCT04531241|593407778|FG001|Period 1|Dispesed incorrect lens power|0|||
164283917|NCT04531241|593407777|FG000|Period 1|Protocol Violation|1|||
164283918|NCT04531241|593407778|FG001|Period 1|Protocol Violation|0|||
164283919|NCT04531241|593407777|FG000|Period 1|No longer eligible|0|||
164283920|NCT04531241|593407778|FG001|Period 1|No longer eligible|1|||
164283921|NCT04531241|593407777|FG000|Period 1|Lens Discomfort|0|||
164003475|NCT01126580|592375828|FG002|Overall Study|Entry Criteria Not Met|2|||
164003476|NCT01126580|592375826|FG000|Overall Study|Lack of Efficacy|2|||
164003477|NCT01126580|592375827|FG001|Overall Study|Lack of Efficacy|3|||
164003478|NCT01126580|592375828|FG002|Overall Study|Lack of Efficacy|4|||
164003479|NCT01126580|592375826|FG000|Overall Study|Protocol Violation|0|||
164003480|NCT01126580|592375827|FG001|Overall Study|Protocol Violation|1|||
164003481|NCT01126580|592375828|FG002|Overall Study|Protocol Violation|2|||
164003482|NCT01126580|592375826|FG000|Overall Study|Lost to Follow-up|15|||
164003483|NCT01126580|592375827|FG001|Overall Study|Lost to Follow-up|13|||
164003484|NCT01126580|592375828|FG002|Overall Study|Lost to Follow-up|9|||
164003485|NCT01126580|592375826|FG000|Overall Study|Treatment Non-compliance|0|||
164003486|NCT01126580|592375827|FG001|Overall Study|Treatment Non-compliance|2|||
164003487|NCT01126580|592375828|FG002|Overall Study|Treatment Non-compliance|3|||
164003488|NCT01731002|592375838|FG000|Overall Study|Adverse Event|0|||
164003489|NCT01731002|592375839|FG001|Overall Study|Adverse Event|2|||
164003490|NCT01731002|592375840|FG002|Overall Study|Adverse Event|2|||
164003491|NCT01731002|592375838|FG000|Overall Study|Non-Compliant|0|||
164003492|NCT01731002|592375839|FG001|Overall Study|Non-Compliant|1|||
164003493|NCT01731002|592375840|FG002|Overall Study|Non-Compliant|0|||
164003494|NCT01731002|592375838|FG000|Overall Study|Lost to Follow-up|1|||
164003495|NCT01731002|592375839|FG001|Overall Study|Lost to Follow-up|0|||
164003496|NCT01731002|592375840|FG002|Overall Study|Lost to Follow-up|0|||
164003497|NCT01731002|592375838|FG000|Overall Study|Test Agent Discontinuation|0|||
164003498|NCT01731002|592375839|FG001|Overall Study|Test Agent Discontinuation|1|||
164003499|NCT01731002|592375840|FG002|Overall Study|Test Agent Discontinuation|0|||
164003500|NCT01731002|592375838|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
164003501|NCT01731002|592375839|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
164003502|NCT01731002|592375840|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
164003503|NCT01731002|592375838|FG000|Overall Study|Elevated IOP|1|||
164003504|NCT01731002|592375839|FG001|Overall Study|Elevated IOP|0|||
164003505|NCT01731002|592375840|FG002|Overall Study|Elevated IOP|0|||
164003506|NCT01731002|592375838|FG000|Overall Study|Inappropriate use of study medications|0|||
164003507|NCT01731002|592375839|FG001|Overall Study|Inappropriate use of study medications|0|||
164087577|NCT00095199|592684253|FG002|Overall Study|Started radiotherapy regimen|0|||
164283922|NCT04531241|593407778|FG001|Period 1|Lens Discomfort|1|||
164283923|NCT04531241|593407777|FG000|Period 2|Covid-19 Related|1|||
164283924|NCT04531241|593407778|FG001|Period 2|Covid-19 Related|1|||
164283925|NCT02715609|593407780|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
164283926|NCT02715609|593407781|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
164283927|NCT02715609|593407782|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
164283928|NCT02715609|593407780|FG000|Overall Study|Withdrawal by Subject|0|||
164283929|NCT02715609|593407781|FG001|Overall Study|Withdrawal by Subject|0|||
164283930|NCT02715609|593407782|FG002|Overall Study|Withdrawal by Subject|1|||
164003508|NCT01731002|592375840|FG002|Overall Study|Inappropriate use of study medications|1|||
164087578|NCT00095199|592684254|FG003|Overall Study|Started radiotherapy regimen|0|||
164283931|NCT03983304|593407783|FG000|Overall Study|Withdrawal by Subject|5|||
164283932|NCT03983304|593407783|FG000|Overall Study|Lost to Follow-up|2|||
164283933|NCT01702246|593407784|FG000|Overall Study|Lost to Follow-up|2|||
164283934|NCT01702246|593407784|FG000|Overall Study|Withdrawal by Subject|2|||
164003509|NCT05369806|592375841|FG000|Overall Study|Lost to Follow-up|1|||
164003510|NCT01331161|592375843|FG000|Overall Study|Physician Decision|1|||
163897351|NCT02719574|591997848|FG000|Phase 2|Protocol Defined Disease Progression|0|||
163897352|NCT02719574|591997849|FG001|Phase 2|Protocol Defined Disease Progression|0|||
163897353|NCT02719574|591997850|FG002|Phase 2|Protocol Defined Disease Progression|0|||
163897354|NCT02719574|591997851|FG003|Phase 2|Protocol Defined Disease Progression|0|||
163897355|NCT02719574|591997852|FG004|Phase 2|Protocol Defined Disease Progression|0|||
163897356|NCT02719574|591997853|FG005|Phase 2|Protocol Defined Disease Progression|0|||
163897357|NCT02719574|591997854|FG006|Phase 2|Protocol Defined Disease Progression|0|||
163897358|NCT02719574|591997855|FG007|Phase 2|Protocol Defined Disease Progression|0|||
163897359|NCT02719574|591997856|FG008|Phase 2|Protocol Defined Disease Progression|0|||
163897360|NCT02719574|591997857|FG009|Phase 2|Protocol Defined Disease Progression|65|||
163897361|NCT02719574|591997858|FG010|Phase 2|Protocol Defined Disease Progression|8|||
163897362|NCT02719574|591997859|FG011|Phase 2|Protocol Defined Disease Progression|2|||
163897363|NCT02719574|591997860|FG012|Phase 2|Protocol Defined Disease Progression|4|||
163897364|NCT02719574|591997861|FG013|Phase 2|Protocol Defined Disease Progression|9|||
163897365|NCT02719574|591997862|FG014|Phase 2|Protocol Defined Disease Progression|11|||
163897366|NCT02719574|591997863|FG015|Phase 2|Protocol Defined Disease Progression|3|||
163897367|NCT02719574|591997864|FG016|Phase 2|Protocol Defined Disease Progression|4|||
163897368|NCT02719574|591997848|FG000|Phase 2|Adverse Event|0|||
163897369|NCT02719574|591997849|FG001|Phase 2|Adverse Event|0|||
163897370|NCT02719574|591997850|FG002|Phase 2|Adverse Event|0|||
163897371|NCT02719574|591997851|FG003|Phase 2|Adverse Event|0|||
163897372|NCT02719574|591997852|FG004|Phase 2|Adverse Event|0|||
163897373|NCT02719574|591997853|FG005|Phase 2|Adverse Event|0|||
163897374|NCT02719574|591997854|FG006|Phase 2|Adverse Event|0|||
163897375|NCT02719574|591997855|FG007|Phase 2|Adverse Event|0|||
164003511|NCT01331161|592375844|FG001|Overall Study|Physician Decision|0|||
164003512|NCT01331161|592375843|FG000|Overall Study|Lost to Follow-up|0|||
164003513|NCT01331161|592375844|FG001|Overall Study|Lost to Follow-up|1|||
164003514|NCT01331161|592375843|FG000|Overall Study|Pregnancy|0|||
164283935|NCT01702246|593407784|FG000|Overall Study|Physician Decision|1|||
164283936|NCT01518374|593407787|FG000|Overall Study|Withdrawal by Subject|2|||
164283937|NCT01518374|593407787|FG000|Overall Study|Protocol Violation|3|||
164283938|NCT01518374|593407787|FG000|Overall Study|Lost to Follow-up|2|||
164283939|NCT02023996|593407790|FG000|Overall Study|Protocol Violation|6|||
164283940|NCT04209205|593407791|FG000|Overall Study|Adverse Event|2|||
164283941|NCT04209205|593407792|FG001|Overall Study|Adverse Event|3|||
164283942|NCT04209205|593407791|FG000|Overall Study|Lost to Follow-up|3|||
164283943|NCT04209205|593407792|FG001|Overall Study|Lost to Follow-up|1|||
164283944|NCT04209205|593407791|FG000|Overall Study|Physician Decision|1|||
164283945|NCT04209205|593407792|FG001|Overall Study|Physician Decision|1|||
164283946|NCT04209205|593407791|FG000|Overall Study|Subject decision|10|||
164283947|NCT04209205|593407792|FG001|Overall Study|Subject decision|10|||
164283948|NCT04209205|593407791|FG000|Overall Study|Progressive disease|1|||
164283949|NCT04209205|593407792|FG001|Overall Study|Progressive disease|0|||
164283950|NCT04209205|593407791|FG000|Overall Study|Protocol deviation|0|||
164283951|NCT04209205|593407792|FG001|Overall Study|Protocol deviation|1|||
164283952|NCT04209205|593407791|FG000|Overall Study|New therapy for study indication|1|||
164283953|NCT04209205|593407792|FG001|Overall Study|New therapy for study indication|0|||
164283954|NCT04209205|593407791|FG000|Overall Study|Adverse event - placebo not switched|0|||
164283955|NCT04209205|593407792|FG001|Overall Study|Adverse event - placebo not switched|1|||
164283956|NCT04209205|593407791|FG000|Overall Study|Subject decision - placebo not switched|0|||
164283957|NCT04209205|593407792|FG001|Overall Study|Subject decision - placebo not switched|5|||
164283958|NCT04209205|593407791|FG000|Overall Study|Death - placebo not switched|0|||
164283959|NCT04209205|593407792|FG001|Overall Study|Death - placebo not switched|1|||
164283960|NCT03400176|593407793|FG000|Dose Escalation|Progressive disease|1|||
164283961|NCT03400176|593407794|FG001|Dose Escalation|Progressive disease|1|||
164003515|NCT01331161|592375844|FG001|Overall Study|Pregnancy|1|||
164283962|NCT03400176|593407795|FG002|Dose Escalation|Progressive disease|0|||
164003516|NCT03277196|592375846|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
164003517|NCT03277196|592375846|FG000|Overall Study|Lost to Follow-up|3|||
164003518|NCT03277196|592375846|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
164003519|NCT03277196|592375846|FG000|Overall Study|Other|2|||
164283963|NCT03400176|593407796|FG003|Dose Escalation|Progressive disease|0|||
163897376|NCT02719574|591997856|FG008|Phase 2|Adverse Event|0|||
163897377|NCT02719574|591997857|FG009|Phase 2|Adverse Event|27|||
164283964|NCT03400176|593407797|FG004|Dose Escalation|Progressive disease|1|||
164283965|NCT03400176|593407793|FG000|Dose Escalation|Patient decision|0|||
164283966|NCT03400176|593407794|FG001|Dose Escalation|Patient decision|0|||
164283967|NCT03400176|593407795|FG002|Dose Escalation|Patient decision|0|||
164283968|NCT03400176|593407796|FG003|Dose Escalation|Patient decision|0|||
163897378|NCT02719574|591997858|FG010|Phase 2|Adverse Event|0|||
163897379|NCT02719574|591997859|FG011|Phase 2|Adverse Event|1|||
163897380|NCT02719574|591997860|FG012|Phase 2|Adverse Event|1|||
164003520|NCT05738486|592378075|FG000|Overall Study|Continuing Study|194|||
164003521|NCT05738486|592378076|FG001|Overall Study|Continuing Study|196|||
164003522|NCT05738486|592378077|FG002|Overall Study|Continuing Study|193|||
164003523|NCT05738486|592378078|FG003|Overall Study|Continuing Study|191|||
164283969|NCT03400176|593407797|FG004|Dose Escalation|Patient decision|1|||
164283970|NCT03400176|593407793|FG000|Dose Expansion|Patient decision|0|||
164283971|NCT03400176|593407794|FG001|Dose Expansion|Patient decision|0|||
164283972|NCT03400176|593407795|FG002|Dose Expansion|Patient decision|0|||
164283973|NCT03400176|593407796|FG003|Dose Expansion|Patient decision|1|||
164283974|NCT03400176|593407797|FG004|Dose Expansion|Patient decision|0|||
164283975|NCT03400176|593407793|FG000|Dose Expansion|Adverse Event|0|||
164283976|NCT03400176|593407794|FG001|Dose Expansion|Adverse Event|0|||
164283977|NCT03400176|593407795|FG002|Dose Expansion|Adverse Event|0|||
164283978|NCT03400176|593407796|FG003|Dose Expansion|Adverse Event|1|||
164283979|NCT03400176|593407797|FG004|Dose Expansion|Adverse Event|0|||
164283980|NCT03400176|593407793|FG000|Dose Expansion|Physician Decision|0|||
164283981|NCT03400176|593407794|FG001|Dose Expansion|Physician Decision|0|||
164283982|NCT03400176|593407795|FG002|Dose Expansion|Physician Decision|0|||
164283983|NCT03400176|593407796|FG003|Dose Expansion|Physician Decision|1|||
164283984|NCT03400176|593407797|FG004|Dose Expansion|Physician Decision|0|||
164283985|NCT03400176|593407793|FG000|Dose Expansion|Progressive disease|0|||
164283986|NCT03400176|593407794|FG001|Dose Expansion|Progressive disease|0|||
164283987|NCT03400176|593407795|FG002|Dose Expansion|Progressive disease|1|||
164283988|NCT03400176|593407796|FG003|Dose Expansion|Progressive disease|1|||
164283989|NCT03400176|593407797|FG004|Dose Expansion|Progressive disease|0|||
164283990|NCT00048347|593407804|FG000|Overall Study|Screen failure|2|||
164283991|NCT02863328|593407805|FG000|Overall Study|Lost to Follow-up|4|||
164283992|NCT02863328|593407806|FG001|Overall Study|Lost to Follow-up|10|||
164283993|NCT02863328|593407805|FG000|Overall Study|Withdrawal by Subject|7|||
164283994|NCT02863328|593407806|FG001|Overall Study|Withdrawal by Subject|12|||
164283995|NCT02863328|593407805|FG000|Overall Study|Died|0|||
164283996|NCT02863328|593407806|FG001|Overall Study|Died|1|||
164283997|NCT04565951|593407807|FG000|Overall Study|Lost to Follow-up|66|||
164283998|NCT04565951|593407808|FG001|Overall Study|Lost to Follow-up|38|||
164283999|NCT04565951|593407807|FG000|Overall Study|Withdrawal by Subject|14|||
164284000|NCT04565951|593407808|FG001|Overall Study|Withdrawal by Subject|7|||
164284001|NCT04565951|593407807|FG000|Overall Study|Death|0|||
164284002|NCT04565951|593407808|FG001|Overall Study|Death|1|||
164284003|NCT00429169|593407809|FG000|Overall Study|Lost to Follow-up|0|||
164284004|NCT00429169|593407810|FG001|Overall Study|Lost to Follow-up|1|||
164284005|NCT00429169|593407809|FG000|Overall Study|Ineligibility discovered after entry|2|||
164284006|NCT00429169|593407810|FG001|Overall Study|Ineligibility discovered after entry|1|||
164284007|NCT00999544|593409491|FG000|Overall Study|Withdrawal by Subject|1|||
164284008|NCT01392547|593409492|FG000|Overall Study|Adverse Event|2|||
164284009|NCT01392547|593409492|FG000|Overall Study|Non-compliance|2|||
164284010|NCT01392547|593409492|FG000|Overall Study|Withdrawal criteria|3|||
164284011|NCT01392547|593409492|FG000|Overall Study|Unclassified|1|||
164284012|NCT04864639|593409495|FG000|Overall Study|Death|1|||
164284013|NCT04864639|593409495|FG000|Overall Study|Lost to Follow-up|1|||
164284014|NCT04050618|593409496|FG000|First Intervention|Withdrawal by Subject|2|||
164284015|NCT04050618|593409497|FG001|First Intervention|Withdrawal by Subject|0|||
164284016|NCT04050618|593409496|FG000|Second Intervention|Withdrawal by Subject|1|||
163897381|NCT02719574|591997861|FG013|Phase 2|Adverse Event|1|||
163897382|NCT02719574|591997862|FG014|Phase 2|Adverse Event|2|||
163897383|NCT02719574|591997863|FG015|Phase 2|Adverse Event|2|||
163897384|NCT02719574|591997864|FG016|Phase 2|Adverse Event|3|||
163897385|NCT02719574|591997848|FG000|Phase 2|Other|0|||
163897386|NCT02719574|591997849|FG001|Phase 2|Other|0|||
163897387|NCT02719574|591997850|FG002|Phase 2|Other|0|||
163897388|NCT02719574|591997851|FG003|Phase 2|Other|0|||
163897389|NCT02719574|591997852|FG004|Phase 2|Other|0|||
163897390|NCT02719574|591997853|FG005|Phase 2|Other|0|||
163897391|NCT02719574|591997854|FG006|Phase 2|Other|0|||
163897392|NCT02719574|591997855|FG007|Phase 2|Other|0|||
163897393|NCT02719574|591997856|FG008|Phase 2|Other|0|||
163897394|NCT02719574|591997857|FG009|Phase 2|Other|20|||
163897395|NCT02719574|591997858|FG010|Phase 2|Other|7|||
163897396|NCT02719574|591997859|FG011|Phase 2|Other|0|||
163897397|NCT02719574|591997860|FG012|Phase 2|Other|5|||
163897398|NCT02719574|591997861|FG013|Phase 2|Other|7|||
163897399|NCT02719574|591997862|FG014|Phase 2|Other|0|||
163897400|NCT02719574|591997863|FG015|Phase 2|Other|1|||
163897401|NCT02719574|591997864|FG016|Phase 2|Other|4|||
163897402|NCT02719574|591997848|FG000|Phase 2|Transplant|0|||
163897403|NCT02719574|591997849|FG001|Phase 2|Transplant|0|||
163897404|NCT02719574|591997850|FG002|Phase 2|Transplant|0|||
163897405|NCT02719574|591997851|FG003|Phase 2|Transplant|0|||
164284017|NCT04050618|593409497|FG001|Second Intervention|Withdrawal by Subject|0|||
164284018|NCT04404556|593409498|FG000|Intervention|Withdrawal by Subject|15|||
164284019|NCT04404556|593409499|FG001|Intervention|Withdrawal by Subject|3|||
164284020|NCT04404556|593409498|FG000|Intervention|Did not complete all intervention sessions|2|||
164284021|NCT04404556|593409499|FG001|Intervention|Did not complete all intervention sessions|1|||
164284022|NCT04404556|593409498|FG000|Post-Intervention|Missing Data|1|||
164284023|NCT04404556|593409499|FG001|Post-Intervention|Missing Data|2|||
164284024|NCT04404556|593409498|FG000|Follow-up 1|Withdrawal by Subject|5|||
164284025|NCT04404556|593409499|FG001|Follow-up 1|Withdrawal by Subject|1|||
164284026|NCT04404556|593409498|FG000|Follow-up 1|Missing Data|4|||
164284027|NCT04404556|593409499|FG001|Follow-up 1|Missing Data|7|||
164284028|NCT04404556|593409498|FG000|Follow-up 2|Withdrawal by Subject|1|||
164284029|NCT04404556|593409499|FG001|Follow-up 2|Withdrawal by Subject|1|||
164284030|NCT04404556|593409498|FG000|Follow-up 2|Missing Data|6|||
164284031|NCT04404556|593409499|FG001|Follow-up 2|Missing Data|5|||
164284032|NCT01101035|593409509|FG000|Overall Study|Adverse Event|191|||
164284033|NCT01101035|593409510|FG001|Overall Study|Adverse Event|172|||
164284034|NCT01101035|593409509|FG000|Overall Study|Major Protocol Deviation|52|||
164284035|NCT01101035|593409510|FG001|Overall Study|Major Protocol Deviation|46|||
164284036|NCT01101035|593409509|FG000|Overall Study|Lost to Follow-up|226|||
164284037|NCT01101035|593409510|FG001|Overall Study|Lost to Follow-up|223|||
164284038|NCT01101035|593409509|FG000|Overall Study|Voluntary Withdrawal|595|||
164284039|NCT01101035|593409510|FG001|Overall Study|Voluntary Withdrawal|587|||
164284040|NCT01101035|593409509|FG000|Overall Study|Reason not Specified|333|||
164284041|NCT01101035|593409510|FG001|Overall Study|Reason not Specified|363|||
164284042|NCT00713544|593409514|FG000|Overall Study|Adverse Event|5|||
164284043|NCT00713544|593409515|FG001|Overall Study|Adverse Event|3|||
164284044|NCT00713544|593409516|FG002|Overall Study|Adverse Event|7|||
164284045|NCT00713544|593409517|FG003|Overall Study|Adverse Event|7|||
164284046|NCT00713544|593409518|FG004|Overall Study|Adverse Event|3|||
164284047|NCT00713544|593409519|FG005|Overall Study|Adverse Event|5|||
164284048|NCT00713544|593409514|FG000|Overall Study|Withdrawal by Subject|2|||
164284049|NCT00713544|593409515|FG001|Overall Study|Withdrawal by Subject|0|||
164284050|NCT00713544|593409516|FG002|Overall Study|Withdrawal by Subject|3|||
164284051|NCT00713544|593409517|FG003|Overall Study|Withdrawal by Subject|2|||
164284052|NCT00713544|593409518|FG004|Overall Study|Withdrawal by Subject|3|||
164284053|NCT00713544|593409519|FG005|Overall Study|Withdrawal by Subject|1|||
164284054|NCT00713544|593409514|FG000|Overall Study|Protocol Violation|0|||
164284055|NCT00713544|593409515|FG001|Overall Study|Protocol Violation|0|||
164284056|NCT00713544|593409516|FG002|Overall Study|Protocol Violation|0|||
164284057|NCT00713544|593409517|FG003|Overall Study|Protocol Violation|0|||
164284058|NCT00713544|593409518|FG004|Overall Study|Protocol Violation|0|||
164284059|NCT00713544|593409519|FG005|Overall Study|Protocol Violation|1|||
164284060|NCT00713544|593409514|FG000|Overall Study|Physician Decision|0|||
164284061|NCT00713544|593409515|FG001|Overall Study|Physician Decision|0|||
164284062|NCT00713544|593409516|FG002|Overall Study|Physician Decision|0|||
164284063|NCT00713544|593409517|FG003|Overall Study|Physician Decision|0|||
164284064|NCT00713544|593409518|FG004|Overall Study|Physician Decision|0|||
164284065|NCT00713544|593409519|FG005|Overall Study|Physician Decision|2|||
164284066|NCT00713544|593409514|FG000|Overall Study|Lack of Efficacy|0|||
164284067|NCT00713544|593409515|FG001|Overall Study|Lack of Efficacy|1|||
164284068|NCT00713544|593409516|FG002|Overall Study|Lack of Efficacy|0|||
164284069|NCT00713544|593409517|FG003|Overall Study|Lack of Efficacy|1|||
164284070|NCT00713544|593409518|FG004|Overall Study|Lack of Efficacy|1|||
164284071|NCT00713544|593409519|FG005|Overall Study|Lack of Efficacy|0|||
164284072|NCT00713544|593409514|FG000|Overall Study|Lost to Follow-up|0|||
164003524|NCT05738486|592378075|FG000|Overall Study|Withdrawal by Subject|8|||
164003525|NCT05738486|592378076|FG001|Overall Study|Withdrawal by Subject|5|||
164003526|NCT05738486|592378077|FG002|Overall Study|Withdrawal by Subject|7|||
164003527|NCT05738486|592378078|FG003|Overall Study|Withdrawal by Subject|13|||
164003528|NCT05738486|592378075|FG000|Overall Study|Adverse Event|4|||
164003529|NCT05738486|592378076|FG001|Overall Study|Adverse Event|6|||
164003530|NCT05738486|592378077|FG002|Overall Study|Adverse Event|4|||
164003531|NCT05738486|592378078|FG003|Overall Study|Adverse Event|5|||
164003532|NCT05738486|592378075|FG000|Overall Study|Physician Decision|0|||
164003533|NCT05738486|592378076|FG001|Overall Study|Physician Decision|2|||
164003534|NCT05738486|592378077|FG002|Overall Study|Physician Decision|4|||
164003535|NCT05738486|592378078|FG003|Overall Study|Physician Decision|1|||
164003536|NCT05738486|592378075|FG000|Overall Study|Lost to Follow-up|1|||
164003537|NCT05738486|592378076|FG001|Overall Study|Lost to Follow-up|1|||
164003538|NCT05738486|592378077|FG002|Overall Study|Lost to Follow-up|2|||
164003539|NCT05738486|592378078|FG003|Overall Study|Lost to Follow-up|1|||
164003540|NCT05738486|592378075|FG000|Overall Study|Participant was Non-ambulatory|0|||
164003541|NCT05738486|592378076|FG001|Overall Study|Participant was Non-ambulatory|0|||
164003542|NCT05738486|592378077|FG002|Overall Study|Participant was Non-ambulatory|1|||
164003543|NCT05738486|592378078|FG003|Overall Study|Participant was Non-ambulatory|0|||
164003544|NCT05738486|592378075|FG000|Overall Study|Participant had Poor Venous Access|0|||
164284073|NCT00713544|593409515|FG001|Overall Study|Lost to Follow-up|0|||
164284074|NCT00713544|593409516|FG002|Overall Study|Lost to Follow-up|1|||
164284075|NCT00713544|593409517|FG003|Overall Study|Lost to Follow-up|0|||
164284076|NCT00713544|593409518|FG004|Overall Study|Lost to Follow-up|0|||
164284077|NCT00713544|593409519|FG005|Overall Study|Lost to Follow-up|0|||
164284078|NCT00713544|593409514|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284079|NCT00713544|593409515|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
164284080|NCT00713544|593409516|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284081|NCT00713544|593409517|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284082|NCT00713544|593409518|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284083|NCT00713544|593409519|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
164284084|NCT00713544|593409514|FG000|Overall Study|Incorrect enrollment|0|||
164284085|NCT00713544|593409515|FG001|Overall Study|Incorrect enrollment|1|||
164284086|NCT00713544|593409516|FG002|Overall Study|Incorrect enrollment|0|||
164284087|NCT00713544|593409517|FG003|Overall Study|Incorrect enrollment|0|||
164284088|NCT00713544|593409518|FG004|Overall Study|Incorrect enrollment|0|||
164284089|NCT00713544|593409519|FG005|Overall Study|Incorrect enrollment|0|||
164284090|NCT00713544|593409514|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
164284091|NCT00713544|593409515|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
164284092|NCT00713544|593409516|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
164284093|NCT00713544|593409517|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
164284094|NCT00713544|593409518|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
164284095|NCT00713544|593409519|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
164284096|NCT00269919|593409520|FG000|Overall Study|Other|26|||
164284097|NCT00269919|593409520|FG000|Overall Study|Started but not treated|1|||
164284098|NCT01641601|593409521|FG000|Overall Study|Study discontinued.|3|||
164284099|NCT01641601|593409522|FG001|Overall Study|Study discontinued.|5|||
164284100|NCT01799226|593409526|FG000|Overall Study|Withdrawal by Subject|1|||
164284101|NCT01799226|593409527|FG001|Overall Study|Withdrawal by Subject|0|||
164284102|NCT01799226|593409526|FG000|Overall Study|Disqualified at Day 14|1|||
164284103|NCT01799226|593409527|FG001|Overall Study|Disqualified at Day 14|0|||
164284104|NCT02178995|593409528|FG000|Double Blind|Adverse Event|0|||
164284105|NCT02178995|593409529|FG001|Double Blind|Adverse Event|0|||
164284106|NCT02178995|593409530|FG002|Double Blind|Adverse Event|0|||
164284107|NCT02178995|593409531|FG003|Double Blind|Adverse Event|0|||
164284108|NCT02178995|593409532|FG004|Double Blind|Adverse Event|0|||
164284109|NCT02178995|593409533|FG005|Double Blind|Adverse Event|1|||
164284110|NCT02178995|593409534|FG006|Double Blind|Adverse Event|0|||
164284111|NCT02178995|593409535|FG007|Double Blind|Adverse Event|1|||
164284112|NCT02178995|593409536|FG008|Double Blind|Adverse Event|1|||
164284113|NCT02178995|593409528|FG000|Double Blind|Lost to Follow-up|0|||
164284114|NCT02178995|593409529|FG001|Double Blind|Lost to Follow-up|1|||
164284115|NCT02178995|593409530|FG002|Double Blind|Lost to Follow-up|0|||
164344695|NCT00915278|593637020|FG004|Overall Study|Progressive disease/clinical progression|1|||
164344696|NCT00915278|593637021|FG005|Overall Study|Progressive disease/clinical progression|2|||
164344697|NCT00915278|593637016|FG000|Overall Study|Infusion related AEs|0|||
164344698|NCT00915278|593637017|FG001|Overall Study|Infusion related AEs|0|||
164344699|NCT00915278|593637018|FG002|Overall Study|Infusion related AEs|0|||
164344700|NCT00915278|593637019|FG003|Overall Study|Infusion related AEs|0|||
164344701|NCT00915278|593637020|FG004|Overall Study|Infusion related AEs|0|||
164284116|NCT02178995|593409531|FG003|Double Blind|Lost to Follow-up|0|||
164284117|NCT02178995|593409532|FG004|Double Blind|Lost to Follow-up|0|||
164284118|NCT02178995|593409533|FG005|Double Blind|Lost to Follow-up|0|||
164284119|NCT02178995|593409534|FG006|Double Blind|Lost to Follow-up|0|||
164284120|NCT02178995|593409535|FG007|Double Blind|Lost to Follow-up|1|||
164284121|NCT02178995|593409536|FG008|Double Blind|Lost to Follow-up|0|||
164284122|NCT02178995|593409528|FG000|Open Label|Adverse Event|2|||
164284123|NCT02178995|593409529|FG001|Open Label|Adverse Event|0|||
164284124|NCT02178995|593409530|FG002|Open Label|Adverse Event|0|||
164284125|NCT02178995|593409531|FG003|Open Label|Adverse Event|0|||
164284126|NCT02178995|593409532|FG004|Open Label|Adverse Event|0|||
164284127|NCT02178995|593409533|FG005|Open Label|Adverse Event|0|||
164284128|NCT02178995|593409534|FG006|Open Label|Adverse Event|0|||
164284129|NCT02178995|593409535|FG007|Open Label|Adverse Event|0|||
164284130|NCT02178995|593409536|FG008|Open Label|Adverse Event|0|||
164284131|NCT01388907|593409544|FG000|Overall Study|Adverse Event|2|||
164284132|NCT01388907|593409545|FG001|Overall Study|Adverse Event|0|||
164284133|NCT00981461|593409546|FG000|Overall Study|Lost to Follow-up|5|||
164344702|NCT00915278|593637021|FG005|Overall Study|Infusion related AEs|2|||
164344703|NCT00915278|593637016|FG000|Overall Study|Admission to hospice|0|||
164344704|NCT00915278|593637017|FG001|Overall Study|Admission to hospice|0|||
163897406|NCT02719574|591997852|FG004|Phase 2|Transplant|0|||
163897407|NCT02719574|591997853|FG005|Phase 2|Transplant|0|||
163897408|NCT02719574|591997854|FG006|Phase 2|Transplant|0|||
163897409|NCT02719574|591997855|FG007|Phase 2|Transplant|0|||
163897410|NCT02719574|591997856|FG008|Phase 2|Transplant|0|||
163897411|NCT02719574|591997857|FG009|Phase 2|Transplant|15|||
163897412|NCT02719574|591997858|FG010|Phase 2|Transplant|2|||
163897413|NCT02719574|591997859|FG011|Phase 2|Transplant|0|||
164284134|NCT00981461|593409547|FG001|Overall Study|Lost to Follow-up|2|||
164284135|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
164284136|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
164284137|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
164284138|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
164284139|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
164284140|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
164284141|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
164284142|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
164284143|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
164284144|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
164284145|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
164284146|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
164003545|NCT05738486|592378076|FG001|Overall Study|Participant had Poor Venous Access|0|||
164003546|NCT05738486|592378077|FG002|Overall Study|Participant had Poor Venous Access|0|||
164284147|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
164284148|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
164284149|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
164284150|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
164284151|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
164284152|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
164284153|NCT01910402|593409548|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
164284154|NCT01910402|593409549|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
164284155|NCT01910402|593409550|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
164284156|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
164284157|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
164284158|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
164284159|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
164284160|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
164284161|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
164284162|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
164284163|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
164284164|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
164284165|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
164284166|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
164284167|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
164284168|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
164284169|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
164284170|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
164284171|NCT01910402|593409548|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
164284172|NCT01910402|593409549|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
164284173|NCT01910402|593409550|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
164284174|NCT00483405|593409551|FG000|Overall Study|Adverse Event|8|||
164284175|NCT00483405|593409551|FG000|Overall Study|Lack of Efficacy|14|||
164284176|NCT00483405|593409551|FG000|Overall Study|Death|3|||
164284177|NCT00483405|593409551|FG000|Overall Study|Withdrawal by Subject|2|||
164003547|NCT05738486|592378078|FG003|Overall Study|Participant had Poor Venous Access|1|||
164003548|NCT05738486|592378075|FG000|Overall Study|Assigned Treatment by Mistake|0|||
164003549|NCT05738486|592378076|FG001|Overall Study|Assigned Treatment by Mistake|0|||
164003550|NCT05738486|592378077|FG002|Overall Study|Assigned Treatment by Mistake|0|||
164003551|NCT05738486|592378078|FG003|Overall Study|Assigned Treatment by Mistake|1|||
164003552|NCT05738486|592378075|FG000|Overall Study|Death|0|||
164003553|NCT05738486|592378076|FG001|Overall Study|Death|0|||
164003554|NCT05738486|592378077|FG002|Overall Study|Death|1|||
164284178|NCT00483405|593409551|FG000|Overall Study|Other complicating disease|1|||
164284179|NCT03010319|593409552|FG000|Overall Study|Adverse Event|15|||
164284180|NCT03010319|593409553|FG001|Overall Study|Adverse Event|9|||
164284181|NCT03010319|593409552|FG000|Overall Study|Withdrawal by Subject|1|||
164284182|NCT03010319|593409553|FG001|Overall Study|Withdrawal by Subject|6|||
164284183|NCT03010319|593409552|FG000|Overall Study|Physician Decision|2|||
164284184|NCT03010319|593409553|FG001|Overall Study|Physician Decision|4|||
164284185|NCT03010319|593409552|FG000|Overall Study|Sponsor requested withdrawal|2|||
164284186|NCT03010319|593409553|FG001|Overall Study|Sponsor requested withdrawal|2|||
164284187|NCT03010319|593409552|FG000|Overall Study|Death|1|||
164284188|NCT03010319|593409553|FG001|Overall Study|Death|0|||
164284189|NCT03010319|593409552|FG000|Overall Study|Lost to Follow-up|0|||
164003555|NCT05738486|592378078|FG003|Overall Study|Death|0|||
164003556|NCT05738486|592378075|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
164003557|NCT05738486|592378076|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164003558|NCT05738486|592378077|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164284190|NCT03010319|593409553|FG001|Overall Study|Lost to Follow-up|1|||
164284191|NCT03010319|593409552|FG000|Overall Study|Other Reason|5|||
164284192|NCT03010319|593409553|FG001|Overall Study|Other Reason|7|||
164284193|NCT02128724|593409554|FG000|Overall Study|Death|1|||
164284194|NCT02128724|593409555|FG001|Overall Study|Death|0|||
164284195|NCT02128724|593409556|FG002|Overall Study|Death|0|||
164284196|NCT02128724|593409557|FG003|Overall Study|Death|0|||
164284197|NCT02128724|593409554|FG000|Overall Study|Adverse Event|0|||
164284198|NCT02128724|593409555|FG001|Overall Study|Adverse Event|1|||
164284199|NCT02128724|593409556|FG002|Overall Study|Adverse Event|0|||
164284200|NCT02128724|593409557|FG003|Overall Study|Adverse Event|0|||
164284201|NCT02128724|593409554|FG000|Overall Study|Physician Decision|0|||
164284202|NCT02128724|593409555|FG001|Overall Study|Physician Decision|0|||
164284203|NCT02128724|593409556|FG002|Overall Study|Physician Decision|0|||
164284204|NCT02128724|593409557|FG003|Overall Study|Physician Decision|2|||
164284205|NCT02128724|593409554|FG000|Overall Study|Withdrawal by Subject|0|||
164284206|NCT02128724|593409555|FG001|Overall Study|Withdrawal by Subject|0|||
164284207|NCT02128724|593409556|FG002|Overall Study|Withdrawal by Subject|0|||
164284208|NCT02128724|593409557|FG003|Overall Study|Withdrawal by Subject|1|||
164284209|NCT01957202|593409559|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284210|NCT01957202|593409560|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
164284211|NCT01957202|593409561|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284212|NCT01957202|593409562|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284213|NCT01957202|593409563|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284214|NCT01957202|593409564|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284215|NCT01957202|593409565|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284216|NCT01957202|593409566|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284217|NCT01957202|593409567|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284218|NCT01957202|593409568|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284219|NCT01957202|593409569|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284220|NCT01957202|593409570|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284221|NCT01957202|593409571|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
163897414|NCT02719574|591997860|FG012|Phase 2|Transplant|6|||
163897415|NCT02719574|591997861|FG013|Phase 2|Transplant|1|||
164284222|NCT01957202|593409572|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284223|NCT01957202|593409573|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284224|NCT01957202|593409574|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284225|NCT01957202|593409575|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
164284226|NCT01957202|593409576|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
164284227|NCT01957202|593409559|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284228|NCT01957202|593409560|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284229|NCT01957202|593409561|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284230|NCT01957202|593409562|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284231|NCT01957202|593409563|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284232|NCT01957202|593409564|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284233|NCT01957202|593409565|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284234|NCT01957202|593409566|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284235|NCT01957202|593409567|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284236|NCT01957202|593409568|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284237|NCT01957202|593409569|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284238|NCT01957202|593409570|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284239|NCT01957202|593409571|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284240|NCT01957202|593409572|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284241|NCT01957202|593409573|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284242|NCT01957202|593409574|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284243|NCT01957202|593409575|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
164284244|NCT01957202|593409576|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
164284245|NCT02640547|593409579|FG000|Overall Study|Failure to Return|1|||
164284246|NCT02640547|593409579|FG000|Overall Study|Withdrawal by Subject|1|||
164284247|NCT02640547|593409579|FG000|Overall Study|Death|6|||
164284248|NCT02640547|593409579|FG000|Overall Study|Miscellaneous|3|||
164284249|NCT04098809|593409580|FG000|Overall Study|Withdrawal by Subject|1|||
164284250|NCT04098809|593409581|FG001|Overall Study|Withdrawal by Subject|3|||
164284251|NCT04098809|593409580|FG000|Overall Study|Physician Decision|2|||
164284252|NCT04098809|593409581|FG001|Overall Study|Physician Decision|1|||
164284253|NCT00193206|593409582|FG000|Preoperative Therapy|Lack of Efficacy|2|||
164284254|NCT00193206|593409582|FG000|Preoperative Therapy|Adverse Event|2|||
164284255|NCT00193206|593409582|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
164284256|NCT00193206|593409582|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
164284257|NCT00193206|593409582|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
164284258|NCT00193206|593409582|FG000|Postoperative Therapy|Physician Decision|3|||
164284259|NCT00193206|593409582|FG000|Postoperative Therapy|Intercurrent Illness|2|||
164284260|NCT00193206|593409582|FG000|Postoperative Therapy|Lack of Efficacy|1|||
164284261|NCT00193206|593409582|FG000|Postoperative Therapy|Protocol Violation|1|||
164284262|NCT01200368|593409587|FG000|Infant Series|Adverse Event|2|||
164284263|NCT01200368|593409588|FG001|Infant Series|Adverse Event|2|||
164003559|NCT05738486|592378078|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
164003560|NCT02017444|592378082|FG000|Overall Study|Physician Decision|1|||
164003561|NCT02017444|592378083|FG001|Overall Study|Physician Decision|0|||
164003562|NCT02017444|592378082|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
164284264|NCT01200368|593409589|FG002|Infant Series|Adverse Event|3|||
164284265|NCT01200368|593409587|FG000|Infant Series|Withdrawal by Subject|0|||
164284266|NCT01200368|593409588|FG001|Infant Series|Withdrawal by Subject|2|||
164284267|NCT01200368|593409589|FG002|Infant Series|Withdrawal by Subject|2|||
164284268|NCT01200368|593409587|FG000|Infant Series|Did not meet entrance criteria|0|||
164284269|NCT01200368|593409588|FG001|Infant Series|Did not meet entrance criteria|1|||
164284270|NCT01200368|593409589|FG002|Infant Series|Did not meet entrance criteria|0|||
164284271|NCT01200368|593409587|FG000|Infant Series|Randomized, not vaccinated|0|||
164284272|NCT01200368|593409588|FG001|Infant Series|Randomized, not vaccinated|1|||
164284273|NCT01200368|593409589|FG002|Infant Series|Randomized, not vaccinated|1|||
164087579|NCT00095199|592684251|FG000|Overall Study|Primary tumor removed in other surgery|0|||
164003563|NCT02017444|592378083|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
164003564|NCT01614457|592378087|FG000|Overall Study|Non-Compliance|1|||
164087580|NCT00095199|592684252|FG001|Overall Study|Primary tumor removed in other surgery|1|||
164284274|NCT01200368|593409587|FG000|Infant Series|Other|1|||
164003565|NCT01614457|592378088|FG001|Overall Study|Non-Compliance|0|||
164087581|NCT00095199|592684253|FG002|Overall Study|Primary tumor removed in other surgery|0|||
164087582|NCT00095199|592684254|FG003|Overall Study|Primary tumor removed in other surgery|0|||
164087583|NCT00095199|592684251|FG000|Overall Study|Data inadvertently lost by site|1|||
164087584|NCT00095199|592684252|FG001|Overall Study|Data inadvertently lost by site|0|||
164087585|NCT00095199|592684253|FG002|Overall Study|Data inadvertently lost by site|0|||
164087586|NCT00095199|592684254|FG003|Overall Study|Data inadvertently lost by site|0|||
164087587|NCT03896490|592684255|FG000|Overall Study|Withdrawal by Subject|1|||
164087588|NCT03896490|592684256|FG001|Overall Study|Withdrawal by Subject|1|||
164087589|NCT03312530|592685703|FG000|Overall Study|Death|5|||
164087590|NCT03312530|592685704|FG001|Overall Study|Death|5|||
164087591|NCT03312530|592685705|FG002|Overall Study|Death|4|||
164087592|NCT03312530|592685706|FG003|Overall Study|Death|10|||
164087593|NCT03312530|592685707|FG004|Overall Study|Death|8|||
164087594|NCT03312530|592685703|FG000|Overall Study|Lost to Follow-up|0|||
164087595|NCT03312530|592685704|FG001|Overall Study|Lost to Follow-up|0|||
164087596|NCT03312530|592685705|FG002|Overall Study|Lost to Follow-up|0|||
164087597|NCT03312530|592685706|FG003|Overall Study|Lost to Follow-up|1|||
164087598|NCT03312530|592685707|FG004|Overall Study|Lost to Follow-up|0|||
164087599|NCT03312530|592685703|FG000|Overall Study|Participant in another sponsor study.|0|||
164087600|NCT03312530|592685704|FG001|Overall Study|Participant in another sponsor study.|0|||
164087601|NCT03312530|592685705|FG002|Overall Study|Participant in another sponsor study.|0|||
164087602|NCT03312530|592685706|FG003|Overall Study|Participant in another sponsor study.|1|||
164087603|NCT03312530|592685707|FG004|Overall Study|Participant in another sponsor study.|0|||
164087604|NCT03312530|592685703|FG000|Overall Study|Study terminated by sponsor|1|||
164087605|NCT03312530|592685704|FG001|Overall Study|Study terminated by sponsor|0|||
164087606|NCT03312530|592685705|FG002|Overall Study|Study terminated by sponsor|2|||
164087607|NCT03312530|592685706|FG003|Overall Study|Study terminated by sponsor|3|||
164087608|NCT03312530|592685707|FG004|Overall Study|Study terminated by sponsor|7|||
164087609|NCT03312530|592685703|FG000|Overall Study|Withdrawal by Subject|0|||
164087610|NCT03312530|592685704|FG001|Overall Study|Withdrawal by Subject|1|||
164087611|NCT03312530|592685705|FG002|Overall Study|Withdrawal by Subject|0|||
164087612|NCT03312530|592685706|FG003|Overall Study|Withdrawal by Subject|0|||
164087613|NCT03312530|592685707|FG004|Overall Study|Withdrawal by Subject|0|||
164087614|NCT03312530|592685703|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164087615|NCT03312530|592685704|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164087616|NCT03312530|592685705|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164087617|NCT03312530|592685706|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
164087618|NCT03312530|592685707|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
164003566|NCT01614457|592378087|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
164003567|NCT01614457|592378088|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
164003568|NCT02698410|592378089|FG000|Overall Study|Adverse Event|2|||
164003569|NCT02698410|592378089|FG000|Overall Study|Withdrawal by Subject|1|||
164003570|NCT02698410|592378089|FG000|Overall Study|Other|1|||
164087619|NCT00614055|592685708|FG000|Overall Study|Adverse Event|1|||
164087620|NCT00614055|592685709|FG001|Overall Study|Adverse Event|0|||
164087621|NCT00614055|592685710|FG002|Overall Study|Adverse Event|0|||
164284275|NCT01200368|593409588|FG001|Infant Series|Other|0|||
164284276|NCT01200368|593409589|FG002|Infant Series|Other|0|||
164284277|NCT01200368|593409587|FG000|After Infant Series|Adverse Event|6|||
164284278|NCT01200368|593409588|FG001|After Infant Series|Adverse Event|6|||
164003571|NCT03952130|592378090|FG000|Overall Study|Adverse Event|0|||
164284279|NCT01200368|593409589|FG002|After Infant Series|Adverse Event|3|||
164284280|NCT01200368|593409587|FG000|After Infant Series|Withdrawal by Subject|10|||
164284281|NCT01200368|593409588|FG001|After Infant Series|Withdrawal by Subject|8|||
164284282|NCT01200368|593409589|FG002|After Infant Series|Withdrawal by Subject|4|||
164284283|NCT01200368|593409587|FG000|After Infant Series|Lost to Follow-up|1|||
164284284|NCT01200368|593409588|FG001|After Infant Series|Lost to Follow-up|0|||
164284285|NCT01200368|593409589|FG002|After Infant Series|Lost to Follow-up|0|||
164284286|NCT01200368|593409587|FG000|After Infant Series|Other|1|||
164284287|NCT01200368|593409588|FG001|After Infant Series|Other|2|||
164284288|NCT01200368|593409589|FG002|After Infant Series|Other|2|||
164284289|NCT01200368|593409587|FG000|Toddler Dose|Adverse Event|0|||
164284290|NCT01200368|593409588|FG001|Toddler Dose|Adverse Event|3|||
164284291|NCT01200368|593409589|FG002|Toddler Dose|Adverse Event|1|||
164284292|NCT01290757|593409591|FG000|Overall Study|Adverse Event|1|||
164284293|NCT01290757|593409592|FG001|Overall Study|Adverse Event|0|||
164284294|NCT01290757|593409591|FG000|Overall Study|Protocol Violation|1|||
164284295|NCT01290757|593409592|FG001|Overall Study|Protocol Violation|1|||
164284296|NCT01290757|593409591|FG000|Overall Study|Other|0|||
164284297|NCT01290757|593409592|FG001|Overall Study|Other|1|||
164284298|NCT00570310|593409593|FG000|Overall Study|Adverse Event|1|||
164284299|NCT00570310|593409594|FG001|Overall Study|Adverse Event|2|||
164284300|NCT00570310|593409593|FG000|Overall Study|Lack of Efficacy|1|||
164284301|NCT00570310|593409594|FG001|Overall Study|Lack of Efficacy|4|||
164284302|NCT03066193|593409597|FG000|Overall Study|Withdrawal by Subject|1|||
164284303|NCT00181766|593409607|FG000|Overall Study|Lost to Follow-up|6|||
164087622|NCT00614055|592685708|FG000|Overall Study|Protocol Violation|2|||
164087623|NCT00614055|592685709|FG001|Overall Study|Protocol Violation|2|||
164087624|NCT00614055|592685710|FG002|Overall Study|Protocol Violation|1|||
164087625|NCT00614055|592685708|FG000|Overall Study|Lack of Efficacy|0|||
164087626|NCT00614055|592685709|FG001|Overall Study|Lack of Efficacy|0|||
164087627|NCT00614055|592685710|FG002|Overall Study|Lack of Efficacy|2|||
164087628|NCT00614055|592685708|FG000|Overall Study|Unclassified|1|||
164087629|NCT00614055|592685709|FG001|Overall Study|Unclassified|4|||
164087630|NCT00614055|592685710|FG002|Overall Study|Unclassified|2|||
164087631|NCT02489318|592685713|FG000|Randomized|Withdrawal by Subject|0|||
164087632|NCT02489318|592685714|FG001|Randomized|Withdrawal by Subject|1|||
164087633|NCT02489318|592685713|FG000|Treated|Adverse Event|19|||
164087634|NCT02489318|592685714|FG001|Treated|Adverse Event|62|||
164087635|NCT02489318|592685713|FG000|Treated|Death|13|||
164087636|NCT02489318|592685714|FG001|Treated|Death|11|||
164087637|NCT02489318|592685713|FG000|Treated|Physician Decision|4|||
164087638|NCT02489318|592685714|FG001|Treated|Physician Decision|6|||
164284304|NCT00181766|593409607|FG000|Overall Study|Adverse Event|4|||
164284305|NCT00181766|593409607|FG000|Overall Study|non-compliance|2|||
164284306|NCT00757237|593409612|FG000|Overall Study|Lost to Follow-up|0|||
164087639|NCT02489318|592685713|FG000|Treated|Protocol Violation|1|||
164087640|NCT02489318|592685714|FG001|Treated|Protocol Violation|2|||
164087641|NCT02489318|592685713|FG000|Treated|Withdrawal by Subject|37|||
164284307|NCT00757237|593409613|FG001|Overall Study|Lost to Follow-up|1|||
164284308|NCT00757237|593409612|FG000|Overall Study|Protocol Violation|0|||
164284309|NCT00757237|593409613|FG001|Overall Study|Protocol Violation|2|||
164284310|NCT00757237|593409612|FG000|Overall Study|Physician Decision|2|||
164284311|NCT00757237|593409613|FG001|Overall Study|Physician Decision|3|||
164284312|NCT00757237|593409612|FG000|Overall Study|Withdrawal by Subject|8|||
164284313|NCT00757237|593409613|FG001|Overall Study|Withdrawal by Subject|12|||
164284314|NCT00757237|593409612|FG000|Overall Study|Safety or Tolerability|3|||
164284315|NCT00757237|593409613|FG001|Overall Study|Safety or Tolerability|5|||
164284316|NCT00757237|593409612|FG000|Overall Study|Other|0|||
164284317|NCT00757237|593409613|FG001|Overall Study|Other|2|||
164284318|NCT01843023|593409614|FG000|Overall Study|Death|1|||
164284319|NCT01843023|593409615|FG001|Overall Study|Death|0|||
164284320|NCT01843023|593409614|FG000|Overall Study|Lost to Follow-up|24|||
164284321|NCT01843023|593409615|FG001|Overall Study|Lost to Follow-up|29|||
164284322|NCT01843023|593409614|FG000|Overall Study|Withdrawal by Subject|8|||
164284323|NCT01843023|593409615|FG001|Overall Study|Withdrawal by Subject|6|||
164284324|NCT01397461|593409617|FG000|Overall Study|Withdrawal by Subject|2|||
164284325|NCT01397461|593409618|FG001|Overall Study|Withdrawal by Subject|1|||
164284326|NCT01397461|593409619|FG002|Overall Study|Withdrawal by Subject|0|||
164284327|NCT01397461|593409617|FG000|Overall Study|Lost to Follow-up|0|||
164284328|NCT01397461|593409618|FG001|Overall Study|Lost to Follow-up|2|||
164284329|NCT01397461|593409619|FG002|Overall Study|Lost to Follow-up|1|||
164284330|NCT01397461|593409617|FG000|Overall Study|Lack of Efficacy|0|||
164284331|NCT01397461|593409618|FG001|Overall Study|Lack of Efficacy|3|||
164087642|NCT02489318|592685714|FG001|Treated|Withdrawal by Subject|36|||
164087643|NCT02489318|592685713|FG000|Treated|Other: Progressive Disease|245|||
164087644|NCT02489318|592685714|FG001|Treated|Other: Progressive Disease|138|||
164284332|NCT01397461|593409619|FG002|Overall Study|Lack of Efficacy|0|||
164284333|NCT01397461|593409617|FG000|Overall Study|Not treated|0|||
164284334|NCT01397461|593409618|FG001|Overall Study|Not treated|0|||
164284335|NCT01397461|593409619|FG002|Overall Study|Not treated|1|||
164284336|NCT04980612|593409636|FG000|Overall Study|Withdrawal by Subject|7|||
164284337|NCT04980612|593409637|FG001|Overall Study|Withdrawal by Subject|5|||
164284338|NCT05730387|593409638|FG000|Overall Study|Stillbirth|0|||
164284339|NCT05730387|593409639|FG001|Overall Study|Stillbirth|262|||
164284340|NCT05730387|593409638|FG000|Overall Study|Died during or after delivery|2|||
164284341|NCT05730387|593409639|FG001|Overall Study|Died during or after delivery|85|||
164284342|NCT05730387|593409638|FG000|Overall Study|Died after being admitted|0|||
164284343|NCT05730387|593409639|FG001|Overall Study|Died after being admitted|44|||
164284344|NCT05730387|593409638|FG000|Overall Study|Lost to Follow-up|69|||
164284345|NCT05730387|593409639|FG001|Overall Study|Lost to Follow-up|77|||
164284346|NCT03364738|593409642|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
164284347|NCT03364738|593409642|FG000|Overall Study|Withdrawal by Subject|1|||
164284348|NCT03364738|593409642|FG000|Overall Study|Adverse Event|1|||
164087645|NCT02489318|592685713|FG000|Treated|Other|0|||
164087646|NCT02489318|592685714|FG001|Treated|Other|2|||
164087647|NCT02489318|592685713|FG000|Treated|Ongoing|0|||
164087648|NCT02489318|592685714|FG001|Treated|Ongoing|267|||
164087649|NCT03679741|592685717|FG000|Period 1|No longer meet eligibility criteria|1|||
164087650|NCT03679741|592685718|FG001|Period 1|No longer meet eligibility criteria|0|||
164087651|NCT03679741|592685717|FG000|Period 1|Lost to Follow-up|0|||
164087652|NCT03679741|592685718|FG001|Period 1|Lost to Follow-up|1|||
164087653|NCT03679741|592685717|FG000|Period 1|Adverse Event|1|||
164087654|NCT03679741|592685718|FG001|Period 1|Adverse Event|1|||
164087655|NCT03679741|592685717|FG000|Period 1|Withdrawal by Subject|0|||
164087656|NCT03679741|592685718|FG001|Period 1|Withdrawal by Subject|1|||
164087657|NCT03679741|592685717|FG000|Period 2|Adverse Event|2|||
164087658|NCT03679741|592685718|FG001|Period 2|Adverse Event|1|||
164087659|NCT03679741|592685717|FG000|Period 2|Withdrawal by Subject|1|||
164087660|NCT03679741|592685718|FG001|Period 2|Withdrawal by Subject|1|||
164087661|NCT03305055|592685720|FG000|Overall Study|Withdrawal by Subject|0|||
164087662|NCT03305055|592685721|FG001|Overall Study|Withdrawal by Subject|1|||
164087663|NCT03305055|592685720|FG000|Overall Study|Adverse Event|1|||
164087664|NCT03305055|592685721|FG001|Overall Study|Adverse Event|1|||
164087665|NCT02540356|592685722|FG000|Overall Study|Terminated due to disease progression|1|||
164087666|NCT02540356|592685723|FG001|Overall Study|Terminated due to disease progression|0|||
164087667|NCT01654380|592685727|FG000|Part B, Period 1|Physician Decision|0|||
164087668|NCT01654380|592685728|FG001|Part B, Period 1|Physician Decision|0|||
164087669|NCT01654380|592685729|FG002|Part B, Period 1|Physician Decision|1|||
164087670|NCT01654380|592685730|FG003|Part B, Period 1|Physician Decision|0|||
164087671|NCT03335371|592685731|FG000|Overall Study|Lost to Follow-up|0|||
164087672|NCT03335371|592685732|FG001|Overall Study|Lost to Follow-up|0|||
164087673|NCT03335371|592685733|FG002|Overall Study|Lost to Follow-up|0|||
164087674|NCT03335371|592685734|FG003|Overall Study|Lost to Follow-up|0|||
164087675|NCT03335371|592685735|FG004|Overall Study|Lost to Follow-up|1|||
164087676|NCT03335371|592685731|FG000|Overall Study|Withdrawal by Subject|0|||
164087677|NCT03335371|592685732|FG001|Overall Study|Withdrawal by Subject|0|||
164087678|NCT03335371|592685733|FG002|Overall Study|Withdrawal by Subject|0|||
164087679|NCT03335371|592685734|FG003|Overall Study|Withdrawal by Subject|0|||
164087680|NCT03335371|592685735|FG004|Overall Study|Withdrawal by Subject|1|||
164087681|NCT03335371|592685731|FG000|Overall Study|Randomization Error|0|||
164087682|NCT03335371|592685732|FG001|Overall Study|Randomization Error|0|||
164087683|NCT03335371|592685733|FG002|Overall Study|Randomization Error|1|||
164087684|NCT03335371|592685734|FG003|Overall Study|Randomization Error|0|||
164087685|NCT03335371|592685735|FG004|Overall Study|Randomization Error|0|||
164087686|NCT05845645|592685737|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087687|NCT05845645|592685738|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087688|NCT05845645|592685739|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
164087689|NCT05845645|592685740|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087690|NCT05845645|592685741|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087691|NCT05845645|592685742|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087692|NCT05845645|592685743|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087693|NCT05845645|592685744|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164284349|NCT03245398|593409643|FG000|Overall Study|Travelled to another island|1|||
163897416|NCT02719574|591997862|FG014|Phase 2|Transplant|1|||
164087694|NCT05845645|592685745|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087695|NCT05845645|592685746|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087696|NCT05845645|592685747|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087697|NCT05845645|592685748|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
164087698|NCT05845645|592685737|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087699|NCT05845645|592685738|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087700|NCT05845645|592685739|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087701|NCT05845645|592685740|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
164284350|NCT03245398|593409644|FG001|Overall Study|Travelled to another island|0|||
164284351|NCT00637416|593409645|FG000|Overall Study|Lost to Follow-up|1|||
164284352|NCT00637416|593409646|FG001|Overall Study|Lost to Follow-up|1|||
164284353|NCT00637416|593409645|FG000|Overall Study|Unable to take study drug|0|||
164284354|NCT00637416|593409646|FG001|Overall Study|Unable to take study drug|1|||
164284355|NCT04137731|593409647|FG000|Overall Study|Surgery Cancellation|1|||
164284356|NCT04137731|593409648|FG001|Overall Study|Surgery Cancellation|2|||
164284357|NCT04137731|593409647|FG000|Overall Study|Withdrawal by Subject|2|||
164284358|NCT04137731|593409648|FG001|Overall Study|Withdrawal by Subject|0|||
164284359|NCT04137731|593409647|FG000|Overall Study|Protocol Violation|0|||
164284360|NCT04137731|593409648|FG001|Overall Study|Protocol Violation|1|||
164284361|NCT00310817|593409652|FG000|Overall Study|AE or Death|3|||
164284362|NCT00310817|593409653|FG001|Overall Study|AE or Death|1|||
164284363|NCT00310817|593409654|FG002|Overall Study|AE or Death|0|||
164284364|NCT00310817|593409655|FG003|Overall Study|AE or Death|0|||
164284365|NCT00310817|593409652|FG000|Overall Study|Withdrawal by Subject|1|||
164284366|NCT00310817|593409653|FG001|Overall Study|Withdrawal by Subject|4|||
164284367|NCT00310817|593409654|FG002|Overall Study|Withdrawal by Subject|6|||
164284368|NCT00310817|593409655|FG003|Overall Study|Withdrawal by Subject|7|||
164284369|NCT00310817|593409652|FG000|Overall Study|Lost to Follow-up|2|||
164284370|NCT00310817|593409653|FG001|Overall Study|Lost to Follow-up|1|||
164284371|NCT00310817|593409654|FG002|Overall Study|Lost to Follow-up|0|||
164284372|NCT00310817|593409655|FG003|Overall Study|Lost to Follow-up|0|||
164284373|NCT00310817|593409652|FG000|Overall Study|Inappropriate Enrollment|1|||
164284374|NCT00310817|593409653|FG001|Overall Study|Inappropriate Enrollment|0|||
164284375|NCT00310817|593409654|FG002|Overall Study|Inappropriate Enrollment|1|||
164284376|NCT00310817|593409655|FG003|Overall Study|Inappropriate Enrollment|0|||
164284377|NCT00310817|593409652|FG000|Overall Study|Protocol Violation|1|||
164284378|NCT00310817|593409653|FG001|Overall Study|Protocol Violation|1|||
164284379|NCT00310817|593409654|FG002|Overall Study|Protocol Violation|1|||
164344705|NCT00915278|593637018|FG002|Overall Study|Admission to hospice|1|||
164344706|NCT00915278|593637019|FG003|Overall Study|Admission to hospice|0|||
164003572|NCT03952130|592378091|FG001|Overall Study|Adverse Event|1|||
164003573|NCT03952130|592378090|FG000|Overall Study|Lost to Follow-up|1|||
164003574|NCT03952130|592378091|FG001|Overall Study|Lost to Follow-up|0|||
164003575|NCT03952130|592378090|FG000|Overall Study|Withdrawal by Subject|1|||
164003576|NCT03952130|592378091|FG001|Overall Study|Withdrawal by Subject|5|||
164003577|NCT01713348|592378092|FG000|Overall Study|Withdrawal by Subject|3|||
164003578|NCT01713348|592378093|FG001|Overall Study|Withdrawal by Subject|2|||
164003579|NCT01713348|592378094|FG002|Overall Study|Withdrawal by Subject|2|||
164003580|NCT01713348|592378095|FG003|Overall Study|Withdrawal by Subject|0|||
164003581|NCT01713348|592378092|FG000|Overall Study|Lost to Follow-up|1|||
164003582|NCT01713348|592378093|FG001|Overall Study|Lost to Follow-up|0|||
164003583|NCT01713348|592378094|FG002|Overall Study|Lost to Follow-up|0|||
164003584|NCT01713348|592378095|FG003|Overall Study|Lost to Follow-up|0|||
164003585|NCT03199911|592378102|FG000|Overall Study|Lost to Follow-up|5|||
164003586|NCT03199911|592378103|FG001|Overall Study|Lost to Follow-up|5|||
164003587|NCT03199911|592378102|FG000|Overall Study|Did not proceed with surgery|2|||
164003588|NCT03199911|592378103|FG001|Overall Study|Did not proceed with surgery|1|||
164003589|NCT00541307|592378104|FG000|Overall Study|Death|5|||
164003590|NCT00541307|592378104|FG000|Overall Study|Physician Decision|3|||
164003591|NCT00541307|592378104|FG000|Overall Study|Withdrawal by Subject|6|||
164003592|NCT00541307|592378104|FG000|Overall Study|Lost to Follow-up|4|||
164003593|NCT00541307|592378104|FG000|Overall Study|Subject returned early (outside window)|1|||
164003594|NCT00541307|592378104|FG000|Overall Study|Surgical Bypass|5|||
164003595|NCT02424539|592378107|FG000|Overall Study|Adverse Event|0|||
164344707|NCT00915278|593637020|FG004|Overall Study|Admission to hospice|0|||
164344708|NCT00915278|593637021|FG005|Overall Study|Admission to hospice|0|||
164344709|NCT02412618|593637022|FG000|Overall Study|Withdrawal by Subject|1|||
164344710|NCT02412618|593637023|FG001|Overall Study|Withdrawal by Subject|1|||
164344711|NCT02412618|593637022|FG000|Overall Study|Expulsion|1|||
164344712|NCT02412618|593637023|FG001|Overall Study|Expulsion|1|||
164344713|NCT01253408|593637024|FG000|Overall Study|Adverse Event|0|||
164344714|NCT01253408|593637025|FG001|Overall Study|Adverse Event|1|||
164344715|NCT01253408|593637026|FG002|Overall Study|Adverse Event|0|||
164344716|NCT03408483|593637027|FG000|Overall Study|Physician Decision|3|||
164003596|NCT02424539|592378108|FG001|Overall Study|Adverse Event|0|||
164003597|NCT02424539|592378109|FG002|Overall Study|Adverse Event|1|||
164003598|NCT02424539|592378107|FG000|Overall Study|Physician Decision|0|||
164003599|NCT02424539|592378108|FG001|Overall Study|Physician Decision|0|||
164003600|NCT02424539|592378109|FG002|Overall Study|Physician Decision|1|||
164003601|NCT02424539|592378107|FG000|Overall Study|Withdrawal by Subject|3|||
164284380|NCT00310817|593409655|FG003|Overall Study|Protocol Violation|1|||
164284381|NCT00310817|593409652|FG000|Overall Study|Unable to classify|3|||
164284382|NCT00310817|593409653|FG001|Overall Study|Unable to classify|1|||
164284383|NCT00310817|593409654|FG002|Overall Study|Unable to classify|0|||
164284384|NCT00310817|593409655|FG003|Overall Study|Unable to classify|0|||
164284385|NCT01587040|593409658|FG000|Overall Study|Protocol Violation|0|||
164284386|NCT01587040|593409659|FG001|Overall Study|Protocol Violation|0|||
164344717|NCT03408483|593637028|FG001|Overall Study|Physician Decision|3|||
164284387|NCT01587040|593409660|FG002|Overall Study|Protocol Violation|1|||
164284388|NCT01587040|593409661|FG003|Overall Study|Protocol Violation|0|||
164284389|NCT01587040|593409658|FG000|Overall Study|Adverse Event|0|||
164284390|NCT01587040|593409659|FG001|Overall Study|Adverse Event|1|||
164284391|NCT01587040|593409660|FG002|Overall Study|Adverse Event|10|||
164284392|NCT01587040|593409661|FG003|Overall Study|Adverse Event|0|||
164284393|NCT01587040|593409658|FG000|Overall Study|Disease progression|12|||
164284394|NCT01587040|593409659|FG001|Overall Study|Disease progression|1|||
164284395|NCT01587040|593409660|FG002|Overall Study|Disease progression|15|||
164003602|NCT02424539|592378108|FG001|Overall Study|Withdrawal by Subject|1|||
164003603|NCT02424539|592378109|FG002|Overall Study|Withdrawal by Subject|0|||
164003604|NCT02424539|592378107|FG000|Overall Study|Other: Reached stopping criteria|11|||
164003605|NCT02424539|592378108|FG001|Overall Study|Other: Reached stopping criteria|7|||
164003606|NCT02424539|592378109|FG002|Overall Study|Other: Reached stopping criteria|6|||
164003607|NCT04178590|592378110|FG000|Overall Study|Pregnancy|1|||
164003608|NCT04178590|592378110|FG000|Overall Study|Lost to Follow-up|1|||
164003609|NCT04723537|592378111|FG000|Overall Study|Withdrawal by Subject|3|||
164003610|NCT04723537|592378112|FG001|Overall Study|Withdrawal by Subject|0|||
164003611|NCT04723537|592378113|FG002|Overall Study|Withdrawal by Subject|0|||
164003612|NCT04723537|592378111|FG000|Overall Study|Physician Decision|0|||
164003613|NCT04723537|592378112|FG001|Overall Study|Physician Decision|0|||
164003614|NCT04723537|592378113|FG002|Overall Study|Physician Decision|1|||
164003615|NCT04723537|592378111|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
164003616|NCT04723537|592378112|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
164003617|NCT04723537|592378113|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
164003618|NCT04329949|592378114|FG000|Overall Study|Death|36|||
164003619|NCT04329949|592378114|FG000|Overall Study|Withdrawal by Subject|4|||
164003620|NCT04329949|592378114|FG000|Overall Study|Termination of study by sponsor|3|||
164003621|NCT01845025|592378115|FG000|Overall Study|Adverse Event|6|||
164003622|NCT01845025|592378116|FG001|Overall Study|Adverse Event|3|||
164003623|NCT01845025|592378115|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164003624|NCT01845025|592378116|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164003625|NCT01845025|592378115|FG000|Overall Study|Withdrawal by Subject|48|||
164003626|NCT01845025|592378116|FG001|Overall Study|Withdrawal by Subject|44|||
164003627|NCT01845025|592378115|FG000|Overall Study|Lost to Follow-up|13|||
164003628|NCT01845025|592378116|FG001|Overall Study|Lost to Follow-up|13|||
164003629|NCT01845025|592378115|FG000|Overall Study|Administrative problems|8|||
164003630|NCT01845025|592378116|FG001|Overall Study|Administrative problems|8|||
164003631|NCT01845025|592378115|FG000|Overall Study|Death|2|||
164003632|NCT01845025|592378116|FG001|Overall Study|Death|0|||
164003633|NCT01845025|592378115|FG000|Overall Study|Protocol deviation|3|||
164003634|NCT01845025|592378116|FG001|Overall Study|Protocol deviation|6|||
164003635|NCT01845025|592378115|FG000|Overall Study|Missing|1|||
164003636|NCT01845025|592378116|FG001|Overall Study|Missing|1|||
164003637|NCT00345605|592378125|FG000|Arm 1|Adverse Event|0|||
164003638|NCT00345605|592378126|FG001|Arm 1|Adverse Event|1|||
164003639|NCT00345605|592378125|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
164003640|NCT00345605|592378126|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
164003641|NCT00733902|592378127|FG000|Overall Study|Death|0|||
164003642|NCT00733902|592378128|FG001|Overall Study|Death|0|||
164003643|NCT00733902|592378129|FG002|Overall Study|Death|0|||
164003644|NCT00733902|592378130|FG003|Overall Study|Death|1|||
164003645|NCT00733902|592378127|FG000|Overall Study|Adverse Event|3|||
164003646|NCT00733902|592378128|FG001|Overall Study|Adverse Event|4|||
164003647|NCT00733902|592378129|FG002|Overall Study|Adverse Event|7|||
164003648|NCT00733902|592378130|FG003|Overall Study|Adverse Event|11|||
164003649|NCT00733902|592378127|FG000|Overall Study|Lack of Efficacy|56|||
164003650|NCT00733902|592378128|FG001|Overall Study|Lack of Efficacy|21|||
164003651|NCT00733902|592378129|FG002|Overall Study|Lack of Efficacy|34|||
164003652|NCT00733902|592378130|FG003|Overall Study|Lack of Efficacy|23|||
164003653|NCT00733902|592378127|FG000|Overall Study|Protocol Violation|4|||
164003654|NCT00733902|592378128|FG001|Overall Study|Protocol Violation|6|||
164003655|NCT00733902|592378129|FG002|Overall Study|Protocol Violation|3|||
164003656|NCT00733902|592378130|FG003|Overall Study|Protocol Violation|3|||
164003657|NCT00733902|592378127|FG000|Overall Study|Withdrawal by Subject|10|||
164003658|NCT00733902|592378128|FG001|Overall Study|Withdrawal by Subject|5|||
164003659|NCT00733902|592378129|FG002|Overall Study|Withdrawal by Subject|4|||
164003660|NCT00733902|592378130|FG003|Overall Study|Withdrawal by Subject|16|||
164003661|NCT00733902|592378127|FG000|Overall Study|Entered extension study|89|||
164003662|NCT00733902|592378128|FG001|Overall Study|Entered extension study|124|||
164003663|NCT00733902|592378129|FG002|Overall Study|Entered extension study|111|||
164284396|NCT01587040|593409661|FG003|Overall Study|Disease progression|3|||
164284397|NCT01587040|593409658|FG000|Overall Study|Other than specified|5|||
164003664|NCT00733902|592378130|FG003|Overall Study|Entered extension study|109|||
164003665|NCT00733902|592378127|FG000|Overall Study|Randomized but not treated|2|||
164003666|NCT00733902|592378128|FG001|Overall Study|Randomized but not treated|2|||
164284398|NCT01587040|593409659|FG001|Overall Study|Other than specified|1|||
164284399|NCT01587040|593409660|FG002|Overall Study|Other than specified|11|||
164284400|NCT01587040|593409661|FG003|Overall Study|Other than specified|1|||
164284401|NCT00367835|593409665|FG000|Overall Study|Adverse Event|14|||
164284402|NCT00367835|593409666|FG001|Overall Study|Adverse Event|1|||
164284403|NCT00367835|593409665|FG000|Overall Study|Protocol Violation|1|||
164284404|NCT00367835|593409666|FG001|Overall Study|Protocol Violation|7|||
164284405|NCT00367835|593409665|FG000|Overall Study|Withdrawal by Subject|7|||
164284406|NCT00367835|593409666|FG001|Overall Study|Withdrawal by Subject|6|||
164284407|NCT00367835|593409665|FG000|Overall Study|Lost to Follow-up|1|||
164284408|NCT00367835|593409666|FG001|Overall Study|Lost to Follow-up|4|||
164284409|NCT00367835|593409665|FG000|Overall Study|Lack of Efficacy|3|||
164284410|NCT00367835|593409666|FG001|Overall Study|Lack of Efficacy|12|||
164284411|NCT00367835|593409665|FG000|Overall Study|Subject in juvenile detention center|1|||
164284412|NCT00367835|593409666|FG001|Overall Study|Subject in juvenile detention center|0|||
164284413|NCT00367835|593409665|FG000|Overall Study|refused blood collection|1|||
164284414|NCT00367835|593409666|FG001|Overall Study|refused blood collection|0|||
164284415|NCT00367835|593409665|FG000|Overall Study|Did not respond to calls|1|||
164284416|NCT00367835|593409666|FG001|Overall Study|Did not respond to calls|0|||
164284417|NCT00367835|593409665|FG000|Overall Study|History of lead poisoning|0|||
164284418|NCT00367835|593409666|FG001|Overall Study|History of lead poisoning|1|||
164284419|NCT04346654|593409668|FG000|Overall Study|Adverse Event|2|||
164284420|NCT04346654|593409669|FG001|Overall Study|Adverse Event|0|||
164284421|NCT04346654|593409668|FG000|Overall Study|Non-response|1|||
164284422|NCT04346654|593409669|FG001|Overall Study|Non-response|1|||
164284423|NCT04346654|593409668|FG000|Overall Study|Withdrawal by Subject|2|||
164284424|NCT04346654|593409669|FG001|Overall Study|Withdrawal by Subject|0|||
164284425|NCT04346654|593409668|FG000|Overall Study|Lost to Follow-up|0|||
164284426|NCT04346654|593409669|FG001|Overall Study|Lost to Follow-up|1|||
164284427|NCT04346654|593409668|FG000|Overall Study|Pregnancy|0|||
164284428|NCT04346654|593409669|FG001|Overall Study|Pregnancy|1|||
164284429|NCT00999518|593409673|FG000|Overall Study|Adverse Event|1|||
164284430|NCT00999518|593409674|FG001|Overall Study|Adverse Event|6|||
164284431|NCT00999518|593409675|FG002|Overall Study|Adverse Event|3|||
164284432|NCT00999518|593409676|FG003|Overall Study|Adverse Event|1|||
164284433|NCT00999518|593409677|FG004|Overall Study|Adverse Event|2|||
164284434|NCT00999518|593409673|FG000|Overall Study|Lack of Efficacy|2|||
164284435|NCT00999518|593409674|FG001|Overall Study|Lack of Efficacy|0|||
164284436|NCT00999518|593409675|FG002|Overall Study|Lack of Efficacy|0|||
164284437|NCT00999518|593409676|FG003|Overall Study|Lack of Efficacy|2|||
164284438|NCT00999518|593409677|FG004|Overall Study|Lack of Efficacy|2|||
164284439|NCT00999518|593409673|FG000|Overall Study|Lost to Follow-up|0|||
164284440|NCT00999518|593409674|FG001|Overall Study|Lost to Follow-up|0|||
164284441|NCT00999518|593409675|FG002|Overall Study|Lost to Follow-up|0|||
164284442|NCT00999518|593409676|FG003|Overall Study|Lost to Follow-up|4|||
164284443|NCT00999518|593409677|FG004|Overall Study|Lost to Follow-up|1|||
164284444|NCT00999518|593409673|FG000|Overall Study|Did not meet entrance criteria|0|||
164284445|NCT00999518|593409674|FG001|Overall Study|Did not meet entrance criteria|0|||
164284446|NCT00999518|593409675|FG002|Overall Study|Did not meet entrance criteria|0|||
164284447|NCT00999518|593409676|FG003|Overall Study|Did not meet entrance criteria|0|||
164284448|NCT00999518|593409677|FG004|Overall Study|Did not meet entrance criteria|1|||
164284449|NCT00999518|593409673|FG000|Overall Study|Study terminated by sponsor|10|||
164284450|NCT00999518|593409674|FG001|Overall Study|Study terminated by sponsor|6|||
164284451|NCT00999518|593409675|FG002|Overall Study|Study terminated by sponsor|5|||
164284452|NCT00999518|593409676|FG003|Overall Study|Study terminated by sponsor|5|||
164284453|NCT00999518|593409677|FG004|Overall Study|Study terminated by sponsor|9|||
164284454|NCT00999518|593409673|FG000|Overall Study|Pregnancy|0|||
164284455|NCT00999518|593409674|FG001|Overall Study|Pregnancy|0|||
164284456|NCT00999518|593409675|FG002|Overall Study|Pregnancy|1|||
164284457|NCT00999518|593409676|FG003|Overall Study|Pregnancy|0|||
163897417|NCT02719574|591997863|FG015|Phase 2|Transplant|0|||
163897418|NCT02719574|591997864|FG016|Phase 2|Transplant|0|||
163897419|NCT02719574|591997848|FG000|Phase 2|Death|0|||
163897420|NCT02719574|591997849|FG001|Phase 2|Death|0|||
163897421|NCT02719574|591997850|FG002|Phase 2|Death|0|||
163897422|NCT02719574|591997851|FG003|Phase 2|Death|0|||
164284458|NCT00999518|593409677|FG004|Overall Study|Pregnancy|0|||
164284459|NCT00999518|593409673|FG000|Overall Study|Protocol Violation|0|||
164284460|NCT00999518|593409674|FG001|Overall Study|Protocol Violation|1|||
164284461|NCT00999518|593409675|FG002|Overall Study|Protocol Violation|0|||
164284462|NCT00999518|593409676|FG003|Overall Study|Protocol Violation|0|||
163897423|NCT02719574|591997852|FG004|Phase 2|Death|0|||
163897424|NCT02719574|591997853|FG005|Phase 2|Death|0|||
163897425|NCT02719574|591997854|FG006|Phase 2|Death|0|||
164284463|NCT00999518|593409677|FG004|Overall Study|Protocol Violation|2|||
164284464|NCT00999518|593409673|FG000|Overall Study|Withdrawal by Subject|5|||
164284465|NCT00999518|593409674|FG001|Overall Study|Withdrawal by Subject|4|||
164284466|NCT00999518|593409675|FG002|Overall Study|Withdrawal by Subject|10|||
164284467|NCT00999518|593409676|FG003|Overall Study|Withdrawal by Subject|6|||
164284468|NCT00999518|593409677|FG004|Overall Study|Withdrawal by Subject|1|||
164284469|NCT00999518|593409673|FG000|Overall Study|Other|5|||
164284470|NCT00999518|593409674|FG001|Overall Study|Other|7|||
164284471|NCT00999518|593409675|FG002|Overall Study|Other|1|||
164284472|NCT00999518|593409676|FG003|Overall Study|Other|4|||
164284473|NCT00999518|593409677|FG004|Overall Study|Other|5|||
164284474|NCT00999518|593409673|FG000|Overall Study|Randomized but not Treated|1|||
164284475|NCT00999518|593409674|FG001|Overall Study|Randomized but not Treated|1|||
164284476|NCT00999518|593409675|FG002|Overall Study|Randomized but not Treated|2|||
164284477|NCT00999518|593409676|FG003|Overall Study|Randomized but not Treated|0|||
164284478|NCT00999518|593409677|FG004|Overall Study|Randomized but not Treated|1|||
164003667|NCT00733902|592378129|FG002|Overall Study|Randomized but not treated|2|||
164003668|NCT00733902|592378130|FG003|Overall Study|Randomized but not treated|1|||
164003669|NCT03717922|592378133|FG000|Overall Study|Lost to Follow-up|2|||
164003670|NCT03717922|592378134|FG001|Overall Study|Lost to Follow-up|2|||
164003671|NCT03126227|592378135|FG000|Overall Study|Adverse Event|43|||
164003672|NCT03126227|592378136|FG001|Overall Study|Adverse Event|4|||
164003673|NCT03126227|592378135|FG000|Overall Study|Death|0|||
164003674|NCT03126227|592378136|FG001|Overall Study|Death|1|||
164003675|NCT03126227|592378135|FG000|Overall Study|Lost to Follow-up|0|||
164003676|NCT03126227|592378136|FG001|Overall Study|Lost to Follow-up|1|||
164003677|NCT03126227|592378135|FG000|Overall Study|Physician Decision|2|||
164003678|NCT03126227|592378136|FG001|Overall Study|Physician Decision|0|||
164003679|NCT03126227|592378135|FG000|Overall Study|Protocol Violation|1|||
164003680|NCT03126227|592378136|FG001|Overall Study|Protocol Violation|0|||
164003681|NCT03126227|592378135|FG000|Overall Study|Withdrawal by Subject|19|||
164003682|NCT03126227|592378136|FG001|Overall Study|Withdrawal by Subject|3|||
164003683|NCT03126227|592378135|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
164003684|NCT03126227|592378136|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
164003685|NCT03126227|592378135|FG000|Overall Study|Lack of dosing compliance|2|||
164003686|NCT03126227|592378136|FG001|Overall Study|Lack of dosing compliance|0|||
164003687|NCT03126227|592378135|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
164003688|NCT03126227|592378136|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
164003689|NCT03126227|592378135|FG000|Overall Study|Scheduling conflict|1|||
164003690|NCT03126227|592378136|FG001|Overall Study|Scheduling conflict|0|||
164003691|NCT01126619|592378137|FG000|Overall Study|Not eligible for the study|2|||
164284479|NCT00859547|593411286|FG000|Overall Study|Lost to Follow-up|1|||
164284480|NCT00859547|593411286|FG000|Overall Study|Parent withdrew consent|1|||
164284481|NCT00786799|593411294|FG000|Overall Study|Lost to Follow-up|1|||
164284482|NCT00786799|593411295|FG001|Overall Study|Lost to Follow-up|1|||
164284483|NCT02544503|593411296|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
164284484|NCT02544503|593411297|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
164284485|NCT02544503|593411296|FG000|Overall Study|Lost to Follow-up|9|||
164284486|NCT02544503|593411297|FG001|Overall Study|Lost to Follow-up|0|||
164284487|NCT02544503|593411296|FG000|Overall Study|Withdrawal by Subject|1|||
164284488|NCT02544503|593411297|FG001|Overall Study|Withdrawal by Subject|0|||
164284489|NCT04640311|593411298|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
164284490|NCT04640311|593411299|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284491|NCT04640311|593411300|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284492|NCT04640311|593411301|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284493|NCT04640311|593411302|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284494|NCT04640311|593411303|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284495|NCT04640311|593411304|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284496|NCT04640311|593411305|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284497|NCT04640311|593411306|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284498|NCT04640311|593411307|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284499|NCT04640311|593411308|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284500|NCT04640311|593411309|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284501|NCT04640311|593411310|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284502|NCT04640311|593411298|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284503|NCT04640311|593411299|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
164284504|NCT04640311|593411300|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284505|NCT04640311|593411301|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164003692|NCT01126619|592378137|FG000|Overall Study|Investigator decision|4|||
164003693|NCT01126619|592378137|FG000|Overall Study|Serious adverse event|1|||
164003694|NCT01126619|592378137|FG000|Overall Study|Withdrawal by Subject|9|||
164003695|NCT01126619|592378137|FG000|Overall Study|Non-compliance|1|||
164003696|NCT04876391|592378138|FG000|Overall Study|Withdrawal by Subject|1|||
164003697|NCT04876391|592378139|FG001|Overall Study|Withdrawal by Subject|10|||
164284506|NCT04640311|593411302|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284507|NCT04640311|593411303|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284508|NCT04640311|593411304|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284509|NCT04640311|593411305|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284510|NCT04640311|593411306|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284511|NCT04640311|593411307|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284512|NCT04640311|593411308|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284513|NCT04640311|593411309|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284514|NCT04640311|593411310|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
164284515|NCT04640311|593411298|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284516|NCT04640311|593411299|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
164284517|NCT04640311|593411300|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284518|NCT04640311|593411301|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284519|NCT04640311|593411302|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284520|NCT04640311|593411303|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284521|NCT04640311|593411304|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284522|NCT04640311|593411305|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284523|NCT04640311|593411306|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284524|NCT04640311|593411307|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284525|NCT04640311|593411308|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284526|NCT04640311|593411309|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284527|NCT04640311|593411310|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284528|NCT04640311|593411298|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
164284529|NCT04640311|593411299|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
164284530|NCT04640311|593411300|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
164284531|NCT04640311|593411301|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284532|NCT04640311|593411302|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284533|NCT04640311|593411303|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284534|NCT04640311|593411304|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284535|NCT04640311|593411305|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284536|NCT04640311|593411306|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284537|NCT04640311|593411307|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284538|NCT04640311|593411308|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284539|NCT04640311|593411309|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284540|NCT04640311|593411310|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
164284541|NCT04640311|593411298|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284542|NCT04640311|593411299|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284543|NCT04640311|593411300|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
164284544|NCT04640311|593411301|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284545|NCT04640311|593411302|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284546|NCT04640311|593411303|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284547|NCT04640311|593411304|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284548|NCT04640311|593411305|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284549|NCT04640311|593411306|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284550|NCT04640311|593411307|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284551|NCT04640311|593411308|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284552|NCT04640311|593411309|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284553|NCT04640311|593411310|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
164284554|NCT04640311|593411298|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284555|NCT04640311|593411299|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284556|NCT04640311|593411300|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164003698|NCT04876391|592378138|FG000|Overall Study|Lost to Follow-up|2|||
164003699|NCT04876391|592378139|FG001|Overall Study|Lost to Follow-up|4|||
164003700|NCT04876391|592378138|FG000|Overall Study|Lack of Efficacy|0|||
164003701|NCT04876391|592378139|FG001|Overall Study|Lack of Efficacy|2|||
164003702|NCT04876391|592378138|FG000|Overall Study|Adverse Event|3|||
164003703|NCT04876391|592378139|FG001|Overall Study|Adverse Event|1|||
164003704|NCT04876391|592378138|FG000|Overall Study|Patient non-compliance|0|||
164003705|NCT04876391|592378139|FG001|Overall Study|Patient non-compliance|1|||
164003706|NCT04876391|592378138|FG000|Overall Study|Personal reasons|0|||
164284557|NCT04640311|593411301|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
164284558|NCT04640311|593411302|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284559|NCT04640311|593411303|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284560|NCT04640311|593411304|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
164284561|NCT04640311|593411305|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284562|NCT04640311|593411306|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284563|NCT04640311|593411307|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284564|NCT04640311|593411308|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284565|NCT04640311|593411309|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284566|NCT04640311|593411310|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
164284567|NCT04640311|593411298|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284568|NCT04640311|593411299|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284569|NCT04640311|593411300|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284570|NCT04640311|593411301|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284571|NCT04640311|593411302|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284572|NCT04640311|593411303|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
164284573|NCT04640311|593411304|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284574|NCT04640311|593411305|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284575|NCT04640311|593411306|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
164284576|NCT04640311|593411307|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284577|NCT04640311|593411308|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284578|NCT04640311|593411309|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284579|NCT04640311|593411310|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
164284580|NCT04640311|593411298|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284581|NCT04640311|593411299|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284582|NCT04640311|593411300|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284583|NCT04640311|593411301|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284584|NCT04640311|593411302|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284585|NCT04640311|593411303|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284586|NCT04640311|593411304|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
164284587|NCT04640311|593411305|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284588|NCT04640311|593411306|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284589|NCT04640311|593411307|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284590|NCT04640311|593411308|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
164284591|NCT04640311|593411309|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284592|NCT04640311|593411310|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
164284593|NCT04640311|593411298|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284594|NCT04640311|593411299|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284595|NCT04640311|593411300|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284596|NCT04640311|593411301|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284597|NCT04640311|593411302|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284598|NCT04640311|593411303|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284599|NCT04640311|593411304|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284600|NCT04640311|593411305|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284601|NCT04640311|593411306|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284602|NCT04640311|593411307|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284603|NCT04640311|593411308|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284604|NCT04640311|593411309|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
164284605|NCT04640311|593411310|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
164284606|NCT03906071|593411311|FG000|Overall Study|Death|180|||
164284607|NCT03906071|593411312|FG001|Overall Study|Death|185|||
164284608|NCT03906071|593411311|FG000|Overall Study|Lost to Follow-up|3|||
164284609|NCT03906071|593411312|FG001|Overall Study|Lost to Follow-up|3|||
164284610|NCT03906071|593411311|FG000|Overall Study|Withdrawal by Subject|15|||
164284611|NCT03906071|593411312|FG001|Overall Study|Withdrawal by Subject|27|||
164284612|NCT03906071|593411311|FG000|Overall Study|Other|2|||
164284613|NCT03906071|593411312|FG001|Overall Study|Other|1|||
164284614|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Technical problems|0|||
164087702|NCT05845645|592685741|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
164284615|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Technical problems|0|||
164284616|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Technical problems|0|||
164284617|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Technical problems|1|||
164284618|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
164284619|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
164344718|NCT03408483|593637027|FG000|Overall Study|Lost to Follow-up|3|||
164087703|NCT05845645|592685742|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
164284620|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
164284621|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
164284622|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
164284623|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
164284624|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
164284625|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
164284626|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
164284627|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
164284628|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
164284629|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
164284630|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Death|0|||
164284631|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Death|3|||
164284632|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Death|1|||
164284633|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Death|0|||
164284634|NCT02152761|593411313|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
164284635|NCT02152761|593411314|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
164284636|NCT02152761|593411315|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
164284637|NCT02152761|593411316|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
164284638|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
164284639|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
164284640|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
164284641|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
164284642|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
164284643|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
164284644|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
164284645|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
164284646|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
164284647|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
164284648|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
164284649|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
164284650|NCT02152761|593411313|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
164284651|NCT02152761|593411314|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
164284652|NCT02152761|593411315|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
164284653|NCT02152761|593411316|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
164284654|NCT01797263|593411317|FG000|Overall Study|Withdrawal by Subject|21|||
164284655|NCT01797263|593411318|FG001|Overall Study|Withdrawal by Subject|25|||
164284656|NCT01797263|593411317|FG000|Overall Study|Death|1|||
164284657|NCT01797263|593411318|FG001|Overall Study|Death|0|||
164284658|NCT01797263|593411317|FG000|Overall Study|Lost to Follow-up|15|||
164284659|NCT01797263|593411318|FG001|Overall Study|Lost to Follow-up|15|||
164284660|NCT01485094|593411319|FG000|Overall Study|Adverse Event|1|||
164284661|NCT01485094|593411320|FG001|Overall Study|Adverse Event|1|||
164284662|NCT01485094|593411321|FG002|Overall Study|Adverse Event|1|||
164284663|NCT01485094|593411319|FG000|Overall Study|Lost to Follow-up|1|||
164284664|NCT01485094|593411320|FG001|Overall Study|Lost to Follow-up|0|||
164284665|NCT01485094|593411321|FG002|Overall Study|Lost to Follow-up|0|||
164284666|NCT01485094|593411319|FG000|Overall Study|Withdrawal by Subject|1|||
164284667|NCT01485094|593411320|FG001|Overall Study|Withdrawal by Subject|1|||
164284668|NCT01485094|593411321|FG002|Overall Study|Withdrawal by Subject|0|||
164284669|NCT00080301|593411326|FG000|Overall Study|Randomized but Never Treated|5|||
164284670|NCT00080301|593411327|FG001|Overall Study|Randomized but Never Treated|10|||
164284671|NCT00080301|593411326|FG000|Overall Study|Still on Treatment as of CSR date|0|||
164284672|NCT00080301|593411327|FG001|Overall Study|Still on Treatment as of CSR date|1|||
164284673|NCT00991939|593411328|FG000|Overall Study|Lost to Follow-up|0|||
164284674|NCT00991939|593411329|FG001|Overall Study|Lost to Follow-up|1|||
164284675|NCT00991939|593411328|FG000|Overall Study|Withdrawal by Subject|1|||
164284676|NCT00991939|593411329|FG001|Overall Study|Withdrawal by Subject|0|||
164284677|NCT00991939|593411328|FG000|Overall Study|Entire study terminated|4|||
164284678|NCT00991939|593411329|FG001|Overall Study|Entire study terminated|1|||
164087704|NCT05845645|592685743|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087705|NCT05845645|592685744|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087706|NCT05845645|592685745|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087707|NCT05845645|592685746|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
163897426|NCT02719574|591997855|FG007|Phase 2|Death|0|||
164087708|NCT05845645|592685747|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
164087709|NCT05845645|592685748|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
164284679|NCT01965704|593411330|FG000|Overall Study|Withdrawal by Subject|2|||
164284680|NCT01965704|593411331|FG001|Overall Study|Withdrawal by Subject|2|||
164284681|NCT01965704|593411332|FG002|Overall Study|Withdrawal by Subject|1|||
164284682|NCT01965704|593411333|FG003|Overall Study|Withdrawal by Subject|1|||
164284683|NCT01965704|593411330|FG000|Overall Study|Delivered at home|1|||
164284684|NCT01965704|593411331|FG001|Overall Study|Delivered at home|1|||
163897427|NCT02719574|591997856|FG008|Phase 2|Death|0|||
164087710|NCT00998881|592685751|FG000|Overall Study|Adverse Event|2|||
164087711|NCT00998881|592685752|FG001|Overall Study|Adverse Event|2|||
164087712|NCT00998881|592685751|FG000|Overall Study|Lack of Efficacy|1|||
164087713|NCT00998881|592685752|FG001|Overall Study|Lack of Efficacy|0|||
164087714|NCT00998881|592685751|FG000|Overall Study|Physician Decision|3|||
164087715|NCT00998881|592685752|FG001|Overall Study|Physician Decision|0|||
164087716|NCT00998881|592685751|FG000|Overall Study|Withdrawal by Subject|1|||
164087717|NCT00998881|592685752|FG001|Overall Study|Withdrawal by Subject|0|||
164087718|NCT00998881|592685751|FG000|Overall Study|Personal matter|1|||
164087719|NCT00998881|592685752|FG001|Overall Study|Personal matter|0|||
164087720|NCT02649231|592685753|FG000|Overall Study|Adverse Event|0|||
164087721|NCT02649231|592685754|FG001|Overall Study|Adverse Event|0|||
164087722|NCT02649231|592685755|FG002|Overall Study|Adverse Event|0|||
164087723|NCT02649231|592685756|FG003|Overall Study|Adverse Event|1|||
164087724|NCT02649231|592685753|FG000|Overall Study|Lost to Follow-up|2|||
164087725|NCT02649231|592685754|FG001|Overall Study|Lost to Follow-up|1|||
164087726|NCT02649231|592685755|FG002|Overall Study|Lost to Follow-up|1|||
164087727|NCT02649231|592685756|FG003|Overall Study|Lost to Follow-up|0|||
164087728|NCT02649231|592685753|FG000|Overall Study|Withdrawal by Subject|0|||
164284685|NCT01965704|593411332|FG002|Overall Study|Delivered at home|0|||
164284686|NCT01965704|593411333|FG003|Overall Study|Delivered at home|0|||
164284687|NCT01965704|593411330|FG000|Overall Study|Experienced complications|0|||
164284688|NCT01965704|593411331|FG001|Overall Study|Experienced complications|0|||
164284689|NCT01965704|593411332|FG002|Overall Study|Experienced complications|2|||
164284690|NCT01965704|593411333|FG003|Overall Study|Experienced complications|2|||
164284691|NCT01965704|593411330|FG000|Overall Study|Adverse Event|0|||
164284692|NCT01965704|593411331|FG001|Overall Study|Adverse Event|0|||
164284693|NCT01965704|593411332|FG002|Overall Study|Adverse Event|1|||
164284694|NCT01965704|593411333|FG003|Overall Study|Adverse Event|1|||
164284695|NCT01965704|593411330|FG000|Overall Study|Did not meet inclusion criteria|0|||
164284696|NCT01965704|593411331|FG001|Overall Study|Did not meet inclusion criteria|0|||
164284697|NCT01965704|593411332|FG002|Overall Study|Did not meet inclusion criteria|1|||
164284698|NCT01965704|593411333|FG003|Overall Study|Did not meet inclusion criteria|1|||
164284699|NCT02524171|593411335|FG000|6-month Follow-up|Lost to Follow-up|53|||
164284700|NCT02524171|593411336|FG001|6-month Follow-up|Lost to Follow-up|45|||
164284701|NCT02524171|593411335|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
164284702|NCT02524171|593411336|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
164284703|NCT02868554|593411341|FG000|Overall Study|Lost to Follow-up|3|||
164284704|NCT02868554|593411342|FG001|Overall Study|Lost to Follow-up|0|||
164284705|NCT02868554|593411343|FG002|Overall Study|Lost to Follow-up|1|||
164284706|NCT05150990|593411344|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
164284707|NCT05150990|593411345|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
164284708|NCT05150990|593411344|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
164284709|NCT05150990|593411345|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
164284710|NCT05150990|593411344|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
164284711|NCT05150990|593411345|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
164284712|NCT05150990|593411344|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
164284713|NCT05150990|593411345|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
164284714|NCT05150990|593411344|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
164284715|NCT05150990|593411345|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
164284716|NCT05150990|593411344|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
164284717|NCT05150990|593411345|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
164284718|NCT05150990|593411344|FG000|Overall Study|Death (unrelated to the intervention)|1|||
164284719|NCT05150990|593411345|FG001|Overall Study|Death (unrelated to the intervention)|2|||
164284720|NCT05447663|593411348|FG000|Overall Study|Study terminated by Sponsor|5|||
164344719|NCT03408483|593637028|FG001|Overall Study|Lost to Follow-up|0|||
164344720|NCT00923156|593637032|FG000|Overall Study|Adverse Event|0|||
164344721|NCT00923156|593637033|FG001|Overall Study|Adverse Event|2|||
164344722|NCT00923156|593637034|FG002|Overall Study|Adverse Event|1|||
164344723|NCT00923156|593637032|FG000|Overall Study|Abnormal laboratory values|0|||
164344724|NCT00923156|593637033|FG001|Overall Study|Abnormal laboratory values|0|||
164344725|NCT00923156|593637034|FG002|Overall Study|Abnormal laboratory values|1|||
164087729|NCT02649231|592685754|FG001|Overall Study|Withdrawal by Subject|1|||
164344726|NCT00923156|593637032|FG000|Overall Study|Withdrawal by Subject|0|||
164087730|NCT02649231|592685755|FG002|Overall Study|Withdrawal by Subject|0|||
164087731|NCT02649231|592685756|FG003|Overall Study|Withdrawal by Subject|1|||
164087732|NCT02649231|592685753|FG000|Overall Study|Protocol Violation|2|||
164284721|NCT05447663|593411348|FG000|Overall Study|Death|2|||
164344727|NCT00923156|593637033|FG001|Overall Study|Withdrawal by Subject|1|||
164344728|NCT00923156|593637034|FG002|Overall Study|Withdrawal by Subject|0|||
164087733|NCT02649231|592685754|FG001|Overall Study|Protocol Violation|1|||
164087734|NCT02649231|592685755|FG002|Overall Study|Protocol Violation|1|||
164087735|NCT02649231|592685756|FG003|Overall Study|Protocol Violation|0|||
164284722|NCT05447663|593411348|FG000|Overall Study|Withdrawal by Subject|1|||
164284723|NCT01100320|593411349|FG000|Period 1|Withdrawal by Subject|2|||
164284724|NCT01100320|593411350|FG001|Period 1|Withdrawal by Subject|4|||
164284725|NCT01100320|593411349|FG000|Period 1|Positive Drug Screen|1|||
164284726|NCT01100320|593411350|FG001|Period 1|Positive Drug Screen|1|||
164284727|NCT01100320|593411349|FG000|Period 1|Adverse Event|2|||
164284728|NCT01100320|593411350|FG001|Period 1|Adverse Event|2|||
164284729|NCT01100320|593411349|FG000|Period 2|Withdrawal by Subject|1|||
164284730|NCT01100320|593411350|FG001|Period 2|Withdrawal by Subject|1|||
164284731|NCT04181762|593411351|FG000|Overall Study|Adverse Event|1|||
164284732|NCT04181762|593411352|FG001|Overall Study|Adverse Event|3|||
164284733|NCT04181762|593411351|FG000|Overall Study|Lost to Follow-up|1|||
164284734|NCT04181762|593411352|FG001|Overall Study|Lost to Follow-up|1|||
164284735|NCT04181762|593411351|FG000|Overall Study|Physician Decision|1|||
164284736|NCT04181762|593411352|FG001|Overall Study|Physician Decision|3|||
164284737|NCT04181762|593411351|FG000|Overall Study|Pregnancy|0|||
164284738|NCT04181762|593411352|FG001|Overall Study|Pregnancy|1|||
164284739|NCT04181762|593411351|FG000|Overall Study|Lack of Efficacy|2|||
164284740|NCT04181762|593411352|FG001|Overall Study|Lack of Efficacy|2|||
164284741|NCT04181762|593411351|FG000|Overall Study|Study terminated by sponsor|95|||
164284742|NCT04181762|593411352|FG001|Overall Study|Study terminated by sponsor|97|||
164284743|NCT04181762|593411351|FG000|Overall Study|Subject decision|11|||
164284744|NCT04181762|593411352|FG001|Overall Study|Subject decision|4|||
164284745|NCT04181762|593411351|FG000|Overall Study|Death|1|||
164284746|NCT04181762|593411352|FG001|Overall Study|Death|1|||
164284747|NCT04181762|593411351|FG000|Overall Study|Protocol deviation|1|||
164284748|NCT04181762|593411352|FG001|Overall Study|Protocol deviation|0|||
164284749|NCT04181762|593411351|FG000|Overall Study|Withdrawal of informed consent|1|||
164284750|NCT04181762|593411352|FG001|Overall Study|Withdrawal of informed consent|3|||
164284751|NCT04669301|593411353|FG000|Overall Study|Lost to Follow-up|0|||
164284752|NCT04669301|593411354|FG001|Overall Study|Lost to Follow-up|1|||
164284753|NCT04669301|593411355|FG002|Overall Study|Lost to Follow-up|0|||
164284754|NCT04669301|593411353|FG000|Overall Study|Withdrawal by Subject|3|||
164284755|NCT04669301|593411354|FG001|Overall Study|Withdrawal by Subject|2|||
164284756|NCT04669301|593411355|FG002|Overall Study|Withdrawal by Subject|0|||
164284757|NCT02586727|593411356|FG000|Overall Study|Lost to Follow-up|1|||
164284758|NCT02586727|593411357|FG001|Overall Study|Lost to Follow-up|0|||
164284759|NCT05888181|593411358|FG000|Overall Study|Lost to Follow-up|1|||
164284760|NCT05888181|593411359|FG001|Overall Study|Lost to Follow-up|1|||
164284761|NCT05888181|593411360|FG002|Overall Study|Lost to Follow-up|0|||
164284762|NCT02534909|593411363|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
164284763|NCT00132808|593411366|FG000|Stratum I|Adverse Event|2|||
164284764|NCT00132808|593411367|FG001|Stratum I|Adverse Event|1|||
164284765|NCT00132808|593411368|FG002|Stratum I|Adverse Event|0|||
164284766|NCT00132808|593411366|FG000|Stratum I|Lost to Follow-up|3|||
164284767|NCT00132808|593411367|FG001|Stratum I|Lost to Follow-up|4|||
164284768|NCT00132808|593411368|FG002|Stratum I|Lost to Follow-up|1|||
164284769|NCT00132808|593411366|FG000|Stratum I|Withdrawal by Subject|4|||
164284770|NCT00132808|593411367|FG001|Stratum I|Withdrawal by Subject|7|||
164284771|NCT00132808|593411368|FG002|Stratum I|Withdrawal by Subject|3|||
164284772|NCT00132808|593411366|FG000|Stratum I|Abnormal test procedure result (s)|0|||
164284773|NCT00132808|593411367|FG001|Stratum I|Abnormal test procedure result (s)|0|||
164284774|NCT00132808|593411368|FG002|Stratum I|Abnormal test procedure result (s)|1|||
164284775|NCT00132808|593411366|FG000|Stratum II|Adverse Event|1|||
164284776|NCT00132808|593411367|FG001|Stratum II|Adverse Event|2|||
164284777|NCT00132808|593411368|FG002|Stratum II|Adverse Event|1|||
164284778|NCT00132808|593411366|FG000|Stratum II|Death|1|||
164284779|NCT00132808|593411367|FG001|Stratum II|Death|0|||
164284780|NCT00132808|593411368|FG002|Stratum II|Death|0|||
164284781|NCT00132808|593411366|FG000|Stratum II|Lost to Follow-up|2|||
164284782|NCT00132808|593411367|FG001|Stratum II|Lost to Follow-up|2|||
164284783|NCT00132808|593411368|FG002|Stratum II|Lost to Follow-up|1|||
164284784|NCT00132808|593411366|FG000|Stratum II|Protocol Violation|0|||
164284785|NCT00132808|593411367|FG001|Stratum II|Protocol Violation|2|||
164284786|NCT00132808|593411368|FG002|Stratum II|Protocol Violation|1|||
163897428|NCT02719574|591997857|FG009|Phase 2|Death|14|||
163897429|NCT02719574|591997858|FG010|Phase 2|Death|0|||
163897430|NCT02719574|591997859|FG011|Phase 2|Death|0|||
164284787|NCT00132808|593411366|FG000|Stratum II|Withdrawal by Subject|4|||
164284788|NCT00132808|593411367|FG001|Stratum II|Withdrawal by Subject|9|||
164284789|NCT00132808|593411368|FG002|Stratum II|Withdrawal by Subject|6|||
164284790|NCT00577824|593411372|FG000|Overall Study|Adverse Event|6|||
164284791|NCT00577824|593411373|FG001|Overall Study|Adverse Event|18|||
164284792|NCT00577824|593411374|FG002|Overall Study|Adverse Event|1|||
164284793|NCT00577824|593411372|FG000|Overall Study|Patient decision|0|||
164284794|NCT00577824|593411373|FG001|Overall Study|Patient decision|1|||
163897431|NCT02719574|591997860|FG012|Phase 2|Death|1|||
163897432|NCT02719574|591997861|FG013|Phase 2|Death|1|||
164284795|NCT00577824|593411374|FG002|Overall Study|Patient decision|1|||
164284796|NCT00577824|593411372|FG000|Overall Study|Protocol Violation|1|||
164284797|NCT00577824|593411373|FG001|Overall Study|Protocol Violation|1|||
164284798|NCT00577824|593411374|FG002|Overall Study|Protocol Violation|0|||
164284799|NCT00362648|593411375|FG000|Overall Study|Adverse Event|12|||
164284800|NCT00362648|593411376|FG001|Overall Study|Adverse Event|21|||
164284801|NCT00362648|593411377|FG002|Overall Study|Adverse Event|1|||
164284802|NCT00362648|593411378|FG003|Overall Study|Adverse Event|0|||
164284803|NCT00362648|593411375|FG000|Overall Study|Lost to Follow-up|62|||
163897433|NCT02719574|591997862|FG014|Phase 2|Death|2|||
163897434|NCT02719574|591997863|FG015|Phase 2|Death|0|||
163897435|NCT02719574|591997864|FG016|Phase 2|Death|0|||
163897436|NCT02719574|591997848|FG000|Phase 2|Investigator Decision|0|||
163897437|NCT02719574|591997849|FG001|Phase 2|Investigator Decision|0|||
163897438|NCT02719574|591997850|FG002|Phase 2|Investigator Decision|0|||
163897439|NCT02719574|591997851|FG003|Phase 2|Investigator Decision|0|||
164003707|NCT04876391|592378139|FG001|Overall Study|Personal reasons|1|||
164003708|NCT04876391|592378138|FG000|Overall Study|Withdrawn as per protocol|2|||
164003709|NCT04876391|592378139|FG001|Overall Study|Withdrawn as per protocol|2|||
164003710|NCT01859403|592378144|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
164284804|NCT00362648|593411376|FG001|Overall Study|Lost to Follow-up|69|||
164284805|NCT00362648|593411377|FG002|Overall Study|Lost to Follow-up|4|||
164284806|NCT00362648|593411378|FG003|Overall Study|Lost to Follow-up|3|||
164284807|NCT00362648|593411375|FG000|Overall Study|Protocol Violation|4|||
164284808|NCT00362648|593411376|FG001|Overall Study|Protocol Violation|2|||
164284809|NCT00362648|593411377|FG002|Overall Study|Protocol Violation|2|||
164284810|NCT00362648|593411378|FG003|Overall Study|Protocol Violation|2|||
164284811|NCT00362648|593411375|FG000|Overall Study|Withdrawal by Subject|48|||
164284812|NCT00362648|593411376|FG001|Overall Study|Withdrawal by Subject|42|||
164284813|NCT00362648|593411377|FG002|Overall Study|Withdrawal by Subject|2|||
164284814|NCT00362648|593411378|FG003|Overall Study|Withdrawal by Subject|6|||
164284815|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
164284816|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
164284817|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
164284818|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
164284819|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
164284820|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
164284821|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
164284822|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
164284823|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
164284824|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
164284825|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
164284826|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
164284827|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
164284828|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
164284829|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
164003711|NCT01859403|592378145|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
164003712|NCT01859403|592378144|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
164003713|NCT01859403|592378145|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
164003714|NCT01859403|592378144|FG000|Primary Endpoint Measure|Physician Decision|0|||
164284830|NCT02204072|593411379|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164284831|NCT02204072|593411380|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164284832|NCT02204072|593411381|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
164284833|NCT02204072|593411382|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164284834|NCT02204072|593411383|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
164003715|NCT01859403|592378145|FG001|Primary Endpoint Measure|Physician Decision|1|||
164003716|NCT01859403|592378144|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
164003717|NCT01859403|592378145|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
164003718|NCT01157117|592378146|FG000|Overall Study|Dosing Symptoms|0|||
164003719|NCT01157117|592378147|FG001|Overall Study|Dosing Symptoms|4|||
164284835|NCT02978833|593411399|FG000|Overall Study|Study terminated|1|||
163897440|NCT02719574|591997852|FG004|Phase 2|Investigator Decision|0|||
163897441|NCT02719574|591997853|FG005|Phase 2|Investigator Decision|0|||
163897442|NCT02719574|591997854|FG006|Phase 2|Investigator Decision|0|||
164003720|NCT01157117|592378148|FG002|Overall Study|Dosing Symptoms|0|||
164003721|NCT01157117|592378146|FG000|Overall Study|Withdrawal by Subject|4|||
164003722|NCT01157117|592378147|FG001|Overall Study|Withdrawal by Subject|1|||
164284836|NCT02978833|593411400|FG001|Overall Study|Study terminated|1|||
164284837|NCT00186901|593411401|FG000|Overall Study|Pregnancy|6|||
164284838|NCT00186901|593411402|FG001|Overall Study|Pregnancy|3|||
164284839|NCT00186901|593411403|FG002|Overall Study|Pregnancy|0|||
164284840|NCT00186901|593411401|FG000|Overall Study|Lost to Follow-up|6|||
164284841|NCT00186901|593411402|FG001|Overall Study|Lost to Follow-up|3|||
164284842|NCT00186901|593411403|FG002|Overall Study|Lost to Follow-up|0|||
164284843|NCT00186901|593411401|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
164284844|NCT00186901|593411402|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
164284845|NCT00186901|593411403|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
164284846|NCT00186901|593411401|FG000|Overall Study|ALL relapse or second malignancy|1|||
164284847|NCT00186901|593411402|FG001|Overall Study|ALL relapse or second malignancy|2|||
164284848|NCT00186901|593411403|FG002|Overall Study|ALL relapse or second malignancy|0|||
164284849|NCT00186901|593411401|FG000|Overall Study|Withdrawal by Subject|4|||
164284850|NCT00186901|593411402|FG001|Overall Study|Withdrawal by Subject|5|||
164284851|NCT00186901|593411403|FG002|Overall Study|Withdrawal by Subject|0|||
164284852|NCT00186901|593411401|FG000|Overall Study|Open label|3|||
164284853|NCT00186901|593411402|FG001|Overall Study|Open label|2|||
164284854|NCT00186901|593411403|FG002|Overall Study|Open label|0|||
164284855|NCT00186901|593411401|FG000|Overall Study|Limited adherence to study requirements|20|||
164087736|NCT00876733|592685759|FG000|Overall Study|Adverse Event|34|||
164284856|NCT00186901|593411402|FG001|Overall Study|Limited adherence to study requirements|23|||
164284857|NCT00186901|593411403|FG002|Overall Study|Limited adherence to study requirements|0|||
164284858|NCT00186901|593411401|FG000|Overall Study|Bone Mineral Density > 0|0|||
164284859|NCT00186901|593411402|FG001|Overall Study|Bone Mineral Density > 0|0|||
164284860|NCT00186901|593411403|FG002|Overall Study|Bone Mineral Density > 0|149|||
164284861|NCT01811186|593411404|FG000|Overall Study|Adverse Event|54|||
164284862|NCT01811186|593411405|FG001|Overall Study|Adverse Event|38|||
164284863|NCT01811186|593411404|FG000|Overall Study|Protocol Violation|5|||
164344729|NCT00923156|593637032|FG000|Overall Study|Death|0|||
164344730|NCT00923156|593637033|FG001|Overall Study|Death|1|||
164344731|NCT00923156|593637034|FG002|Overall Study|Death|0|||
164344732|NCT00923156|593637032|FG000|Overall Study|Lack of Efficacy|0|||
164344733|NCT00923156|593637033|FG001|Overall Study|Lack of Efficacy|0|||
164344734|NCT00923156|593637034|FG002|Overall Study|Lack of Efficacy|1|||
164344735|NCT03137537|593637035|FG000|Overall Study|Adverse Event|0|||
164344736|NCT03137537|593637036|FG001|Overall Study|Adverse Event|1|||
164344737|NCT02465515|593637040|FG000|Overall Study|Investigator site closed|4|||
164344738|NCT02465515|593637041|FG001|Overall Study|Investigator site closed|5|||
164344739|NCT02465515|593637040|FG000|Overall Study|Withdrawal by Subject|74|||
164344740|NCT02465515|593637041|FG001|Overall Study|Withdrawal by Subject|43|||
164344741|NCT02465515|593637040|FG000|Overall Study|Physician Decision|8|||
164344742|NCT02465515|593637041|FG001|Overall Study|Physician Decision|12|||
164344743|NCT02465515|593637040|FG000|Overall Study|Lost to Follow-up|68|||
164344744|NCT02465515|593637041|FG001|Overall Study|Lost to Follow-up|51|||
164344745|NCT00816595|593637042|FG000|Overall Study|Withdrawal by Subject|2|||
164344746|NCT00816595|593637043|FG001|Overall Study|Withdrawal by Subject|0|||
164344747|NCT00629707|593637044|FG000|Overall Study|Withdrawal by Subject|0|||
164344748|NCT00629707|593637045|FG001|Overall Study|Withdrawal by Subject|1|||
164344749|NCT00629707|593637044|FG000|Overall Study|Physician Decision|0|||
164344750|NCT00629707|593637045|FG001|Overall Study|Physician Decision|1|||
164344751|NCT00453063|593637046|FG000|Overall Study|Adverse Event|1|||
164344752|NCT00453063|593637047|FG001|Overall Study|Adverse Event|2|||
164344753|NCT00453063|593637046|FG000|Overall Study|Withdrawal by Subject|1|||
164344754|NCT00453063|593637047|FG001|Overall Study|Withdrawal by Subject|1|||
164344755|NCT00453063|593637046|FG000|Overall Study|Protocol Violation|1|||
164344756|NCT00453063|593637047|FG001|Overall Study|Protocol Violation|0|||
164344757|NCT01918774|593638831|FG000|Overall Study|Lost prior to first CBTw session|4|||
164344758|NCT01918774|593638831|FG000|Overall Study|Lost to Follow-up|1|||
164344759|NCT03000439|593638834|FG000|Open Label Part 1|Adverse Event|6|||
164344760|NCT03000439|593638835|FG001|Open Label Part 1|Adverse Event|0|||
164344761|NCT03000439|593638836|FG002|Open Label Part 1|Adverse Event|0|||
164344762|NCT03000439|593638837|FG003|Open Label Part 1|Adverse Event|0|||
164344763|NCT03000439|593638834|FG000|Open Label Part 1|Other|2|||
164344764|NCT03000439|593638835|FG001|Open Label Part 1|Other|0|||
164344765|NCT03000439|593638836|FG002|Open Label Part 1|Other|0|||
164344766|NCT03000439|593638837|FG003|Open Label Part 1|Other|0|||
164344767|NCT03000439|593638834|FG000|Open Label Part 1|Insufficient clinical response|16|||
164344768|NCT03000439|593638835|FG001|Open Label Part 1|Insufficient clinical response|0|||
164284864|NCT01811186|593411405|FG001|Overall Study|Protocol Violation|6|||
164284865|NCT01811186|593411404|FG000|Overall Study|Withdrawal by Subject|5|||
164344769|NCT03000439|593638836|FG002|Open Label Part 1|Insufficient clinical response|0|||
164344770|NCT03000439|593638837|FG003|Open Label Part 1|Insufficient clinical response|0|||
164344771|NCT03000439|593638834|FG000|Open Label Part 2|Other|0|||
164344772|NCT03000439|593638835|FG001|Open Label Part 2|Other|5|||
164344773|NCT03000439|593638836|FG002|Open Label Part 2|Other|0|||
164344774|NCT03000439|593638837|FG003|Open Label Part 2|Other|0|||
164344775|NCT03000439|593638834|FG000|Open Label Part 2|Insufficient clinical response|0|||
163897443|NCT02719574|591997855|FG007|Phase 2|Investigator Decision|0|||
163897444|NCT02719574|591997856|FG008|Phase 2|Investigator Decision|0|||
163897445|NCT02719574|591997857|FG009|Phase 2|Investigator Decision|6|||
163897446|NCT02719574|591997858|FG010|Phase 2|Investigator Decision|1|||
163897447|NCT02719574|591997859|FG011|Phase 2|Investigator Decision|2|||
163897448|NCT02719574|591997860|FG012|Phase 2|Investigator Decision|3|||
163897449|NCT02719574|591997861|FG013|Phase 2|Investigator Decision|1|||
163897450|NCT02719574|591997862|FG014|Phase 2|Investigator Decision|3|||
163897451|NCT02719574|591997863|FG015|Phase 2|Investigator Decision|2|||
163897452|NCT02719574|591997864|FG016|Phase 2|Investigator Decision|0|||
164284866|NCT01811186|593411405|FG001|Overall Study|Withdrawal by Subject|10|||
164284867|NCT01811186|593411404|FG000|Overall Study|Lack of Efficacy|3|||
163897453|NCT02719574|591997848|FG000|Phase 2|Withdrawal by Subject|0|||
163897454|NCT02719574|591997849|FG001|Phase 2|Withdrawal by Subject|0|||
163897455|NCT02719574|591997850|FG002|Phase 2|Withdrawal by Subject|0|||
163897456|NCT02719574|591997851|FG003|Phase 2|Withdrawal by Subject|0|||
163897457|NCT02719574|591997852|FG004|Phase 2|Withdrawal by Subject|0|||
164284868|NCT01811186|593411405|FG001|Overall Study|Lack of Efficacy|6|||
164284869|NCT01811186|593411404|FG000|Overall Study|Lost to Follow-up|4|||
164284870|NCT01811186|593411405|FG001|Overall Study|Lost to Follow-up|2|||
164284871|NCT00003199|593411414|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
164284872|NCT00003199|593411414|FG000|Overall Study|Lack of insurance clearance|2|||
164284873|NCT00003199|593411414|FG000|Overall Study|Screen fail|15|||
164284874|NCT01445080|593411415|FG000|Overall Study|Adverse Event|5|||
164284875|NCT01445080|593411416|FG001|Overall Study|Adverse Event|3|||
164284876|NCT01445080|593411417|FG002|Overall Study|Adverse Event|11|||
164284877|NCT01445080|593411418|FG003|Overall Study|Adverse Event|6|||
164284878|NCT01445080|593411419|FG004|Overall Study|Adverse Event|2|||
164284879|NCT01445080|593411420|FG005|Overall Study|Adverse Event|3|||
164284880|NCT01445080|593411421|FG006|Overall Study|Adverse Event|0|||
164284881|NCT01445080|593411422|FG007|Overall Study|Adverse Event|3|||
164284882|NCT01445080|593411423|FG008|Overall Study|Adverse Event|10|||
164284883|NCT01445080|593411415|FG000|Overall Study|Physician Decision|0|||
164284884|NCT01445080|593411416|FG001|Overall Study|Physician Decision|0|||
164284885|NCT01445080|593411417|FG002|Overall Study|Physician Decision|1|||
164284886|NCT01445080|593411418|FG003|Overall Study|Physician Decision|0|||
164284887|NCT01445080|593411419|FG004|Overall Study|Physician Decision|0|||
164284888|NCT01445080|593411420|FG005|Overall Study|Physician Decision|3|||
164284889|NCT01445080|593411421|FG006|Overall Study|Physician Decision|2|||
164284890|NCT01445080|593411422|FG007|Overall Study|Physician Decision|2|||
164284891|NCT01445080|593411423|FG008|Overall Study|Physician Decision|0|||
164284892|NCT01445080|593411415|FG000|Overall Study|Withdrawal by Subject|1|||
164284893|NCT01445080|593411416|FG001|Overall Study|Withdrawal by Subject|0|||
164284894|NCT01445080|593411417|FG002|Overall Study|Withdrawal by Subject|0|||
164284895|NCT01445080|593411418|FG003|Overall Study|Withdrawal by Subject|1|||
164284896|NCT01445080|593411419|FG004|Overall Study|Withdrawal by Subject|0|||
164284897|NCT01445080|593411420|FG005|Overall Study|Withdrawal by Subject|0|||
164284898|NCT01445080|593411421|FG006|Overall Study|Withdrawal by Subject|0|||
164284899|NCT01445080|593411422|FG007|Overall Study|Withdrawal by Subject|0|||
164284900|NCT01445080|593411423|FG008|Overall Study|Withdrawal by Subject|2|||
164284901|NCT01445080|593411415|FG000|Overall Study|Ineligible/Inevaluable|1|||
164284902|NCT01445080|593411416|FG001|Overall Study|Ineligible/Inevaluable|2|||
164284903|NCT01445080|593411417|FG002|Overall Study|Ineligible/Inevaluable|0|||
164284904|NCT01445080|593411418|FG003|Overall Study|Ineligible/Inevaluable|1|||
164284905|NCT01445080|593411419|FG004|Overall Study|Ineligible/Inevaluable|2|||
164003723|NCT01157117|592378148|FG002|Overall Study|Withdrawal by Subject|1|||
164003724|NCT01157117|592378146|FG000|Overall Study|Lack of Efficacy|1|||
164003725|NCT01157117|592378147|FG001|Overall Study|Lack of Efficacy|1|||
164003726|NCT01157117|592378148|FG002|Overall Study|Lack of Efficacy|0|||
164003727|NCT01157117|592378146|FG000|Overall Study|Lost to Follow-up|0|||
164003728|NCT01157117|592378147|FG001|Overall Study|Lost to Follow-up|0|||
164003729|NCT01157117|592378148|FG002|Overall Study|Lost to Follow-up|1|||
164003730|NCT01157117|592378146|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
164003731|NCT01157117|592378147|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
164284906|NCT01445080|593411420|FG005|Overall Study|Ineligible/Inevaluable|3|||
164284907|NCT01445080|593411421|FG006|Overall Study|Ineligible/Inevaluable|0|||
164284908|NCT01445080|593411422|FG007|Overall Study|Ineligible/Inevaluable|0|||
163897458|NCT02719574|591997853|FG005|Phase 2|Withdrawal by Subject|0|||
163897459|NCT02719574|591997854|FG006|Phase 2|Withdrawal by Subject|0|||
163897460|NCT02719574|591997855|FG007|Phase 2|Withdrawal by Subject|0|||
164284909|NCT01445080|593411423|FG008|Overall Study|Ineligible/Inevaluable|6|||
164284910|NCT03887221|593411424|FG000|Overall Study|Protocol Violation|1|||
164284911|NCT03887221|593411425|FG001|Overall Study|Protocol Violation|0|||
163897461|NCT02719574|591997856|FG008|Phase 2|Withdrawal by Subject|0|||
163897462|NCT02719574|591997857|FG009|Phase 2|Withdrawal by Subject|5|||
163897463|NCT02719574|591997858|FG010|Phase 2|Withdrawal by Subject|0|||
164284912|NCT02487030|593411426|FG000|Overall Study|Lack of Efficacy|2|||
164284913|NCT02487030|593411427|FG001|Overall Study|Lack of Efficacy|4|||
163897464|NCT02719574|591997859|FG011|Phase 2|Withdrawal by Subject|0|||
163897465|NCT02719574|591997860|FG012|Phase 2|Withdrawal by Subject|0|||
163897466|NCT02719574|591997861|FG013|Phase 2|Withdrawal by Subject|1|||
163897467|NCT02719574|591997862|FG014|Phase 2|Withdrawal by Subject|1|||
163897468|NCT02719574|591997863|FG015|Phase 2|Withdrawal by Subject|2|||
163897469|NCT02719574|591997864|FG016|Phase 2|Withdrawal by Subject|0|||
163897470|NCT02719574|591997848|FG000|Phase 2|Protocol Violation|0|||
163897471|NCT02719574|591997849|FG001|Phase 2|Protocol Violation|0|||
163897472|NCT02719574|591997850|FG002|Phase 2|Protocol Violation|0|||
163897473|NCT02719574|591997851|FG003|Phase 2|Protocol Violation|0|||
163897474|NCT02719574|591997852|FG004|Phase 2|Protocol Violation|0|||
163897475|NCT02719574|591997853|FG005|Phase 2|Protocol Violation|0|||
163897476|NCT02719574|591997854|FG006|Phase 2|Protocol Violation|0|||
163897477|NCT02719574|591997855|FG007|Phase 2|Protocol Violation|0|||
163897478|NCT02719574|591997856|FG008|Phase 2|Protocol Violation|0|||
163897479|NCT02719574|591997857|FG009|Phase 2|Protocol Violation|1|||
163897480|NCT02719574|591997858|FG010|Phase 2|Protocol Violation|0|||
163897481|NCT02719574|591997859|FG011|Phase 2|Protocol Violation|0|||
163897482|NCT02719574|591997860|FG012|Phase 2|Protocol Violation|0|||
163897483|NCT02719574|591997861|FG013|Phase 2|Protocol Violation|0|||
163897484|NCT02719574|591997862|FG014|Phase 2|Protocol Violation|0|||
163897485|NCT02719574|591997863|FG015|Phase 2|Protocol Violation|0|||
163897486|NCT02719574|591997864|FG016|Phase 2|Protocol Violation|0|||
163897487|NCT00113360|591997865|FG000|Overall Study|Adverse Event|3|||
163897488|NCT00113360|591997865|FG000|Overall Study|Subject required surgery|1|||
164284914|NCT02487030|593411428|FG002|Overall Study|Lack of Efficacy|1|||
164284915|NCT02487030|593411429|FG003|Overall Study|Lack of Efficacy|0|||
164284916|NCT02487030|593411430|FG004|Overall Study|Lack of Efficacy|1|||
164284917|NCT02487030|593411431|FG005|Overall Study|Lack of Efficacy|0|||
164284918|NCT02487030|593411432|FG006|Overall Study|Lack of Efficacy|0|||
164284919|NCT02487030|593411426|FG000|Overall Study|Lost to Follow-up|0|||
164284920|NCT02487030|593411427|FG001|Overall Study|Lost to Follow-up|0|||
164284921|NCT02487030|593411428|FG002|Overall Study|Lost to Follow-up|1|||
164284922|NCT02487030|593411429|FG003|Overall Study|Lost to Follow-up|1|||
164284923|NCT02487030|593411430|FG004|Overall Study|Lost to Follow-up|0|||
164284924|NCT02487030|593411431|FG005|Overall Study|Lost to Follow-up|1|||
164284925|NCT02487030|593411432|FG006|Overall Study|Lost to Follow-up|0|||
164284926|NCT02487030|593411426|FG000|Overall Study|Adverse Event|0|||
164284927|NCT02487030|593411427|FG001|Overall Study|Adverse Event|0|||
164284928|NCT02487030|593411428|FG002|Overall Study|Adverse Event|0|||
164284929|NCT02487030|593411429|FG003|Overall Study|Adverse Event|1|||
164284930|NCT02487030|593411430|FG004|Overall Study|Adverse Event|0|||
164284931|NCT02487030|593411431|FG005|Overall Study|Adverse Event|0|||
164284932|NCT02487030|593411432|FG006|Overall Study|Adverse Event|0|||
164284933|NCT02487030|593411426|FG000|Overall Study|Death|0|||
164284934|NCT02487030|593411427|FG001|Overall Study|Death|0|||
164284935|NCT02487030|593411428|FG002|Overall Study|Death|0|||
164284936|NCT02487030|593411429|FG003|Overall Study|Death|0|||
164284937|NCT02487030|593411430|FG004|Overall Study|Death|1|||
164284938|NCT02487030|593411431|FG005|Overall Study|Death|0|||
164284939|NCT02487030|593411432|FG006|Overall Study|Death|0|||
164284940|NCT03857542|593411433|FG000|Overall Study|Adverse Event|1|||
164284941|NCT03857542|593411434|FG001|Overall Study|Adverse Event|3|||
164284942|NCT03857542|593411433|FG000|Overall Study|Withdrawal by Subject|2|||
164284943|NCT03857542|593411434|FG001|Overall Study|Withdrawal by Subject|1|||
164284944|NCT03857542|593411433|FG000|Overall Study|Lost to Follow-up|2|||
164284945|NCT03857542|593411434|FG001|Overall Study|Lost to Follow-up|1|||
164284946|NCT03857542|593411433|FG000|Overall Study|Reason not Specified|1|||
163897489|NCT00113360|591997865|FG000|Overall Study|Did not meet eligibility criteria|3|||
163897490|NCT02467270|591997876|FG000|Overall Study|Participants Never Treated|0|||
163897491|NCT02467270|591997877|FG001|Overall Study|Participants Never Treated|1|||
164284947|NCT03857542|593411434|FG001|Overall Study|Reason not Specified|0|||
164284948|NCT02123576|593411435|FG000|Overall Study|Adverse Event|1|||
164284949|NCT02123576|593411436|FG001|Overall Study|Adverse Event|0|||
164284950|NCT00900029|593411437|FG000|Overall Study|Lost to Follow-up|0|||
164284951|NCT00900029|593411438|FG001|Overall Study|Lost to Follow-up|2|||
164284952|NCT00900029|593411439|FG002|Overall Study|Lost to Follow-up|1|||
164284953|NCT00900029|593411440|FG003|Overall Study|Lost to Follow-up|4|||
164284954|NCT00900029|593411441|FG004|Overall Study|Lost to Follow-up|4|||
164284955|NCT00900029|593411437|FG000|Overall Study|Withdrawal by Subject|2|||
164284956|NCT00900029|593411438|FG001|Overall Study|Withdrawal by Subject|2|||
164284957|NCT00900029|593411439|FG002|Overall Study|Withdrawal by Subject|1|||
164284958|NCT00900029|593411440|FG003|Overall Study|Withdrawal by Subject|1|||
163897492|NCT02467270|591997878|FG002|Overall Study|Participants Never Treated|0|||
163897493|NCT02467270|591997876|FG000|Overall Study|Ongoing|50|||
163897494|NCT02467270|591997877|FG001|Overall Study|Ongoing|41|||
163897495|NCT02467270|591997878|FG002|Overall Study|Ongoing|43|||
163897496|NCT02467270|591997876|FG000|Overall Study|Adverse Event|16|||
163897497|NCT02467270|591997877|FG001|Overall Study|Adverse Event|15|||
163897498|NCT02467270|591997878|FG002|Overall Study|Adverse Event|14|||
164284959|NCT00900029|593411441|FG004|Overall Study|Withdrawal by Subject|1|||
164284960|NCT00900029|593411437|FG000|Overall Study|Adverse Event|0|||
164284961|NCT00900029|593411438|FG001|Overall Study|Adverse Event|0|||
164284962|NCT00900029|593411439|FG002|Overall Study|Adverse Event|1|||
164284963|NCT00900029|593411440|FG003|Overall Study|Adverse Event|1|||
164284964|NCT00900029|593411441|FG004|Overall Study|Adverse Event|1|||
164284965|NCT00900029|593411437|FG000|Overall Study|Death|1|||
164284966|NCT00900029|593411438|FG001|Overall Study|Death|0|||
164284967|NCT00900029|593411439|FG002|Overall Study|Death|0|||
164284968|NCT00900029|593411440|FG003|Overall Study|Death|1|||
164284969|NCT00900029|593411441|FG004|Overall Study|Death|0|||
164284970|NCT02709330|593411443|FG000|Overall Study|Death|5|||
164284971|NCT02709330|593411444|FG001|Overall Study|Death|0|||
164284972|NCT02709330|593411443|FG000|Overall Study|Lost to Follow-up|2|||
164284973|NCT02709330|593411444|FG001|Overall Study|Lost to Follow-up|0|||
164284974|NCT02709330|593411443|FG000|Overall Study|Physician Decision|2|||
164284975|NCT02709330|593411444|FG001|Overall Study|Physician Decision|0|||
164284976|NCT02709330|593411443|FG000|Overall Study|Withdrawal by Subject|4|||
164087737|NCT00876733|592685760|FG001|Overall Study|Adverse Event|20|||
164087738|NCT00876733|592685761|FG002|Overall Study|Adverse Event|10|||
164087739|NCT00876733|592685762|FG003|Overall Study|Adverse Event|3|||
164087740|NCT00876733|592685759|FG000|Overall Study|Lack of Efficacy|17|||
164087741|NCT00876733|592685760|FG001|Overall Study|Lack of Efficacy|9|||
164087742|NCT00876733|592685761|FG002|Overall Study|Lack of Efficacy|10|||
164087743|NCT00876733|592685762|FG003|Overall Study|Lack of Efficacy|1|||
164087744|NCT00876733|592685759|FG000|Overall Study|Lost to Follow-up|26|||
164087745|NCT00876733|592685760|FG001|Overall Study|Lost to Follow-up|10|||
164087746|NCT00876733|592685761|FG002|Overall Study|Lost to Follow-up|3|||
164087747|NCT00876733|592685762|FG003|Overall Study|Lost to Follow-up|2|||
164087748|NCT00876733|592685759|FG000|Overall Study|Data not available|14|||
164087749|NCT00876733|592685760|FG001|Overall Study|Data not available|3|||
164284977|NCT02709330|593411444|FG001|Overall Study|Withdrawal by Subject|0|||
164284978|NCT02587819|593411449|FG000|Overall Study|Adverse Event|1|||
164284979|NCT02587819|593411449|FG000|Overall Study|Lost to Follow-up|1|||
164284980|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
164284981|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
164284982|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
164284983|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284984|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284985|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284986|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
164284987|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
164284988|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284989|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284990|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284991|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284992|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284993|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
164284994|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284995|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
164284996|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284997|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284998|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164284999|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164285000|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
164285001|NCT05280717|593414342|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285002|NCT05280717|593414343|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285003|NCT05280717|593414344|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
164285004|NCT05280717|593414345|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164087750|NCT00876733|592685761|FG002|Overall Study|Data not available|7|||
164087751|NCT00876733|592685762|FG003|Overall Study|Data not available|1|||
164087752|NCT02611752|592685765|FG000|Overall Study|Adverse Event|0|||
164087753|NCT02611752|592685766|FG001|Overall Study|Adverse Event|1|||
164087754|NCT00249821|592685767|FG000|Overall Study|Technical problem|0|||
164087755|NCT00249821|592685768|FG001|Overall Study|Technical problem|1|||
164087756|NCT00423800|592685772|FG000|Overall Study|Protocol Violation|0|||
164285005|NCT05280717|593414346|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285006|NCT05280717|593414347|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285007|NCT05280717|593414348|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
164285008|NCT05280717|593414342|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285009|NCT05280717|593414343|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285010|NCT05280717|593414344|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285011|NCT05280717|593414345|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285012|NCT05280717|593414346|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285013|NCT05280717|593414347|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
164285014|NCT05280717|593414348|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
164285015|NCT05280717|593414342|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285016|NCT05280717|593414343|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285017|NCT05280717|593414344|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285018|NCT05280717|593414345|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285019|NCT05280717|593414346|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285020|NCT05280717|593414347|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
164285021|NCT05280717|593414348|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
164285022|NCT00337207|593414351|FG000|Overall Study|Withdrawal by Subject|3|||
164285023|NCT02562716|593414352|FG000|Overall Study|Adverse Event|7|||
164285024|NCT02562716|593414353|FG001|Overall Study|Adverse Event|14|||
164285025|NCT02562716|593414352|FG000|Overall Study|Withdrawal unrelated to AE|7|||
164285026|NCT02562716|593414353|FG001|Overall Study|Withdrawal unrelated to AE|1|||
164285027|NCT02562716|593414352|FG000|Overall Study|Progression|8|||
164285028|NCT02562716|593414353|FG001|Overall Study|Progression|10|||
164285029|NCT02562716|593414352|FG000|Overall Study|Death|2|||
164285030|NCT02562716|593414353|FG001|Overall Study|Death|1|||
164285031|NCT02562716|593414352|FG000|Overall Study|Not protocol specified|4|||
164285032|NCT02562716|593414353|FG001|Overall Study|Not protocol specified|2|||
164285033|NCT02753946|593414354|FG000|Overall Study|Adverse Event|7|||
164285034|NCT02753946|593414355|FG001|Overall Study|Adverse Event|6|||
164285035|NCT02753946|593414354|FG000|Overall Study|Withdrawal by Subject|6|||
164285036|NCT02753946|593414355|FG001|Overall Study|Withdrawal by Subject|1|||
164285037|NCT02753946|593414354|FG000|Overall Study|Lack of Efficacy|1|||
164285038|NCT02753946|593414355|FG001|Overall Study|Lack of Efficacy|0|||
164285039|NCT02753946|593414354|FG000|Overall Study|Physician Decision|0|||
164285040|NCT02753946|593414355|FG001|Overall Study|Physician Decision|2|||
164087757|NCT00423800|592685773|FG001|Overall Study|Protocol Violation|1|||
164087758|NCT00814320|592685774|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
164087759|NCT00814320|592685775|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
164087760|NCT00814320|592685774|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
164087761|NCT00814320|592685775|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
164087762|NCT00814320|592685774|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
164087763|NCT00814320|592685775|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
164087764|NCT00814320|592685774|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
164087765|NCT00814320|592685775|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
164087766|NCT00814320|592685774|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
164087767|NCT00814320|592685775|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
164087768|NCT00814320|592685774|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
164087769|NCT00814320|592685775|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
164087770|NCT00814320|592685774|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
164087771|NCT00814320|592685775|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
164087772|NCT00814320|592685774|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
163897499|NCT02467270|591997876|FG000|Overall Study|Progressive Disease|7|||
163897500|NCT02467270|591997877|FG001|Overall Study|Progressive Disease|7|||
163897501|NCT02467270|591997878|FG002|Overall Study|Progressive Disease|4|||
163897502|NCT02467270|591997876|FG000|Overall Study|Death|2|||
163897503|NCT02467270|591997877|FG001|Overall Study|Death|0|||
163897504|NCT02467270|591997878|FG002|Overall Study|Death|2|||
163897505|NCT02467270|591997876|FG000|Overall Study|Lack of Efficacy|12|||
163897506|NCT02467270|591997877|FG001|Overall Study|Lack of Efficacy|18|||
164003732|NCT01157117|592378148|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
164003733|NCT00811252|592378149|FG000|Overall Study|Adverse Event|6|||
164003734|NCT00811252|592378150|FG001|Overall Study|Adverse Event|10|||
164003735|NCT00811252|592378151|FG002|Overall Study|Adverse Event|15|||
164003736|NCT00811252|592378149|FG000|Overall Study|Lack of Efficacy|7|||
164003737|NCT00811252|592378150|FG001|Overall Study|Lack of Efficacy|2|||
164003738|NCT00811252|592378151|FG002|Overall Study|Lack of Efficacy|0|||
164003739|NCT00811252|592378149|FG000|Overall Study|Protocol Violation|3|||
164003740|NCT00811252|592378150|FG001|Overall Study|Protocol Violation|3|||
164003741|NCT00811252|592378151|FG002|Overall Study|Protocol Violation|2|||
164003742|NCT00811252|592378149|FG000|Overall Study|Withdrawal of Consent|1|||
164003743|NCT00811252|592378150|FG001|Overall Study|Withdrawal of Consent|2|||
164003744|NCT00811252|592378151|FG002|Overall Study|Withdrawal of Consent|2|||
164003745|NCT00811252|592378149|FG000|Overall Study|Lost to Follow-up|0|||
164003746|NCT00811252|592378150|FG001|Overall Study|Lost to Follow-up|0|||
164003747|NCT00811252|592378151|FG002|Overall Study|Lost to Follow-up|2|||
164003748|NCT00811252|592378149|FG000|Overall Study|Administrative or Other Reasons|0|||
164003749|NCT00811252|592378150|FG001|Overall Study|Administrative or Other Reasons|3|||
164003750|NCT00811252|592378151|FG002|Overall Study|Administrative or Other Reasons|2|||
164003751|NCT01931865|592378155|FG000|Overall Study|Lost to Follow-up|2|||
164003752|NCT01931865|592378155|FG000|Overall Study|Withdrawal by Subject|2|||
164003753|NCT01121406|592378156|FG000|Overall Study|Progressive disease RECIST|44|||
164003754|NCT01121406|592378157|FG001|Overall Study|Progressive disease RECIST|28|||
164003755|NCT01121406|592378156|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
164003756|NCT01121406|592378157|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
164003757|NCT01121406|592378156|FG000|Overall Study|Other AE|3|||
164003758|NCT01121406|592378157|FG001|Overall Study|Other AE|10|||
164003759|NCT01121406|592378156|FG000|Overall Study|Non-compliant with protocol|0|||
164003760|NCT01121406|592378157|FG001|Overall Study|Non-compliant with protocol|2|||
164003761|NCT01121406|592378156|FG000|Overall Study|Lost to Follow-up|0|||
164003762|NCT01121406|592378157|FG001|Overall Study|Lost to Follow-up|1|||
164003763|NCT01121406|592378156|FG000|Overall Study|Refused continuation of study med.|1|||
164003764|NCT01121406|592378157|FG001|Overall Study|Refused continuation of study med.|2|||
164003765|NCT01121406|592378156|FG000|Overall Study|Reason other than specified above|2|||
164003766|NCT01121406|592378157|FG001|Overall Study|Reason other than specified above|6|||
164003767|NCT01121406|592378156|FG000|Overall Study|Not treated|1|||
164003768|NCT01121406|592378157|FG001|Overall Study|Not treated|0|||
164003769|NCT00504257|592378158|FG000|Overall Study|Withdrawal by Subject|2|||
164003770|NCT00504257|592378158|FG000|Overall Study|ineligible histology|2|||
164003771|NCT00892437|592378159|FG000|Randomized Phase|Randomized but not treated|6|||
164003772|NCT00892437|592378160|FG001|Randomized Phase|Randomized but not treated|0|||
164003773|NCT00892437|592378159|FG000|Randomized Phase|Adverse Event|2|||
164003774|NCT00892437|592378160|FG001|Randomized Phase|Adverse Event|2|||
164003775|NCT00892437|592378159|FG000|Randomized Phase|Lost to Follow-up|1|||
164003776|NCT00892437|592378160|FG001|Randomized Phase|Lost to Follow-up|3|||
164003777|NCT00892437|592378159|FG000|Randomized Phase|Investigator's Discretion|1|||
164003778|NCT00892437|592378160|FG001|Randomized Phase|Investigator's Discretion|0|||
164003779|NCT00892437|592378159|FG000|Randomized Phase|Withdrew Consent|1|||
164087773|NCT00814320|592685775|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
163897507|NCT02467270|591997878|FG002|Overall Study|Lack of Efficacy|23|||
164090467|NCT02984683|592693441|FG001|Overall Study|Withdrawal by Subject|0|||
163897508|NCT02467270|591997876|FG000|Overall Study|Non-compliance With Study Drug|0|||
163897509|NCT02467270|591997877|FG001|Overall Study|Non-compliance With Study Drug|2|||
163897510|NCT02467270|591997878|FG002|Overall Study|Non-compliance With Study Drug|1|||
163897511|NCT02467270|591997876|FG000|Overall Study|Lost to Follow-up|2|||
163897512|NCT02467270|591997877|FG001|Overall Study|Lost to Follow-up|1|||
163897513|NCT02467270|591997878|FG002|Overall Study|Lost to Follow-up|0|||
164285041|NCT00684996|593414356|FG000|Overall Study|Adverse Event|1|||
164003780|NCT00892437|592378160|FG001|Randomized Phase|Withdrew Consent|0|||
164003781|NCT00892437|592378159|FG000|Open-Label Extension Phase|Adverse Event|4|||
164285042|NCT00684996|593414356|FG000|Overall Study|Refusal unrelated to adverse event|1|||
164285043|NCT00684996|593414356|FG000|Overall Study|Progression/relapse|2|||
164285044|NCT00684996|593414356|FG000|Overall Study|Other reasons not protocol specified|1|||
164285045|NCT02519439|593414357|FG000|Overall Study|Study Termination|19|||
164285046|NCT02519439|593414357|FG000|Overall Study|Withdrawal by Subject|1|||
164285047|NCT02519439|593414357|FG000|Overall Study|Adverse Event|1|||
164285048|NCT03030417|593414362|FG000|Dose Expansion|Disease progression before treatment|0|||
164285049|NCT03030417|593414363|FG001|Dose Expansion|Disease progression before treatment|0|||
164285050|NCT03030417|593414364|FG002|Dose Expansion|Disease progression before treatment|0|||
164285051|NCT03030417|593414365|FG003|Dose Expansion|Disease progression before treatment|0|||
164285052|NCT03030417|593414366|FG004|Dose Expansion|Disease progression before treatment|0|||
164285053|NCT03030417|593414367|FG005|Dose Expansion|Disease progression before treatment|0|||
164285054|NCT03030417|593414368|FG006|Dose Expansion|Disease progression before treatment|0|||
164285055|NCT03030417|593414369|FG007|Dose Expansion|Disease progression before treatment|0|||
164285056|NCT03030417|593414370|FG008|Dose Expansion|Disease progression before treatment|0|||
164285057|NCT03030417|593414371|FG009|Dose Expansion|Disease progression before treatment|0|||
164285058|NCT03030417|593414372|FG010|Dose Expansion|Disease progression before treatment|0|||
164285059|NCT03030417|593414373|FG011|Dose Expansion|Disease progression before treatment|0|||
164285060|NCT03030417|593414374|FG012|Dose Expansion|Disease progression before treatment|1|||
164285061|NCT02175017|593414375|FG000|Overall Study|Did not receive the investigational product|1|||
164285062|NCT02175017|593414376|FG001|Overall Study|Did not receive the investigational product|2|||
164003782|NCT00892437|592378160|FG001|Open-Label Extension Phase|Adverse Event|2|||
164003783|NCT00892437|592378159|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
164003784|NCT00892437|592378160|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
164003785|NCT00892437|592378159|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
164003786|NCT00892437|592378160|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
164003787|NCT00892437|592378159|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
164003788|NCT00892437|592378160|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
164003789|NCT00892437|592378159|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
164003790|NCT00892437|592378160|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
164003791|NCT03185130|592378161|FG000|Overall Study|Withdrawal by Subject|0|||
164003792|NCT03185130|592378162|FG001|Overall Study|Withdrawal by Subject|2|||
164003793|NCT02286960|592378163|FG000|Overall Study|Lost to Follow-up|3|||
164003794|NCT02286960|592378164|FG001|Overall Study|Lost to Follow-up|3|||
164003795|NCT00500071|592378175|FG000|Screening and Washout Phase|Protocol Violation|1|||
164003796|NCT00500071|592378175|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
164003797|NCT00500071|592378175|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
164003798|NCT00500071|592378175|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
164003799|NCT00500071|592378175|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
164003800|NCT00500071|592378175|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
164003801|NCT00500071|592378175|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
164003802|NCT04283461|592378178|FG000|Overall Study|Enrolled in separate trial|0|||
164285063|NCT02175017|593414375|FG000|Overall Study|Withdrawal by Subject|6|||
164285064|NCT02175017|593414376|FG001|Overall Study|Withdrawal by Subject|3|||
164285065|NCT02175017|593414375|FG000|Overall Study|Met an exclusion criteria|0|||
164285066|NCT02175017|593414376|FG001|Overall Study|Met an exclusion criteria|1|||
164344776|NCT03000439|593638835|FG001|Open Label Part 2|Insufficient clinical response|12|||
164344777|NCT03000439|593638836|FG002|Open Label Part 2|Insufficient clinical response|0|||
164344778|NCT03000439|593638837|FG003|Open Label Part 2|Insufficient clinical response|0|||
164344779|NCT03000439|593638834|FG000|Double Blind Phase|Adverse Event|0|||
164344780|NCT03000439|593638835|FG001|Double Blind Phase|Adverse Event|0|||
163897514|NCT02467270|591997876|FG000|Overall Study|Pregnancy|0|||
163897515|NCT02467270|591997877|FG001|Overall Study|Pregnancy|1|||
163897516|NCT02467270|591997878|FG002|Overall Study|Pregnancy|0|||
163897517|NCT02467270|591997876|FG000|Overall Study|Physician Decision|0|||
163897518|NCT02467270|591997877|FG001|Overall Study|Physician Decision|4|||
163897519|NCT02467270|591997878|FG002|Overall Study|Physician Decision|1|||
163897520|NCT02467270|591997876|FG000|Overall Study|Withdrawal by Subject|4|||
163897521|NCT02467270|591997877|FG001|Overall Study|Withdrawal by Subject|3|||
163897522|NCT02467270|591997878|FG002|Overall Study|Withdrawal by Subject|5|||
163897523|NCT02467270|591997876|FG000|Overall Study|Reason not Specified|1|||
163897524|NCT02467270|591997877|FG001|Overall Study|Reason not Specified|2|||
163897525|NCT02467270|591997878|FG002|Overall Study|Reason not Specified|1|||
164285067|NCT02175017|593414375|FG000|Overall Study|Adverse Event|3|||
164285068|NCT02175017|593414376|FG001|Overall Study|Adverse Event|10|||
164285069|NCT02175017|593414375|FG000|Overall Study|Disease progression|20|||
164285070|NCT02175017|593414376|FG001|Overall Study|Disease progression|27|||
164285071|NCT02175017|593414375|FG000|Overall Study|Other than above reasons|3|||
164285072|NCT02175017|593414376|FG001|Overall Study|Other than above reasons|0|||
164285073|NCT04915729|593414377|FG000|Overall Study|Lost to Follow-up|20|||
164285074|NCT04915729|593414378|FG001|Overall Study|Lost to Follow-up|10|||
164285075|NCT04915729|593414377|FG000|Overall Study|Withdrawal by Subject|12|||
164285076|NCT04915729|593414378|FG001|Overall Study|Withdrawal by Subject|5|||
164285077|NCT04915729|593414377|FG000|Overall Study|Death|34|||
164285078|NCT04915729|593414378|FG001|Overall Study|Death|44|||
164285079|NCT04915729|593414377|FG000|Overall Study|not treated|3|||
164285080|NCT04915729|593414378|FG001|Overall Study|not treated|6|||
164285081|NCT04915729|593414377|FG000|Overall Study|Investigator removed subject|1|||
164285082|NCT04915729|593414378|FG001|Overall Study|Investigator removed subject|2|||
164285083|NCT04915729|593414377|FG000|Overall Study|questionnaire result not evaluated|1|||
164285084|NCT04915729|593414378|FG001|Overall Study|questionnaire result not evaluated|0|||
164285085|NCT04915729|593414377|FG000|Overall Study|refuse of hospital visit|1|||
164285086|NCT04915729|593414378|FG001|Overall Study|refuse of hospital visit|3|||
164285087|NCT04915729|593414377|FG000|Overall Study|Subject withdrew|1|||
164285088|NCT04915729|593414378|FG001|Overall Study|Subject withdrew|0|||
164285089|NCT04961541|593414379|FG000|Overall Study|Adverse Event|0|||
164285090|NCT04961541|593414380|FG001|Overall Study|Adverse Event|0|||
164285091|NCT04961541|593414381|FG002|Overall Study|Adverse Event|0|||
164285092|NCT04961541|593414382|FG003|Overall Study|Adverse Event|0|||
164285093|NCT04961541|593414383|FG004|Overall Study|Adverse Event|0|||
164285094|NCT04961541|593414384|FG005|Overall Study|Adverse Event|1|||
164285095|NCT04961541|593414385|FG006|Overall Study|Adverse Event|0|||
164285096|NCT04961541|593414386|FG007|Overall Study|Adverse Event|0|||
164285097|NCT04961541|593414387|FG008|Overall Study|Adverse Event|0|||
164285098|NCT04961541|593414388|FG009|Overall Study|Adverse Event|0|||
164285099|NCT04961541|593414389|FG010|Overall Study|Adverse Event|0|||
164285100|NCT04961541|593414390|FG011|Overall Study|Adverse Event|0|||
164285101|NCT04961541|593414391|FG012|Overall Study|Adverse Event|0|||
164285102|NCT04961541|593414392|FG013|Overall Study|Adverse Event|0|||
164285103|NCT04961541|593414379|FG000|Overall Study|Lost to Follow-up|0|||
164285104|NCT04961541|593414380|FG001|Overall Study|Lost to Follow-up|0|||
164285105|NCT04961541|593414381|FG002|Overall Study|Lost to Follow-up|3|||
164285106|NCT04961541|593414382|FG003|Overall Study|Lost to Follow-up|0|||
164285107|NCT04961541|593414383|FG004|Overall Study|Lost to Follow-up|0|||
164285108|NCT04961541|593414384|FG005|Overall Study|Lost to Follow-up|0|||
164285109|NCT04961541|593414385|FG006|Overall Study|Lost to Follow-up|1|||
164285110|NCT04961541|593414386|FG007|Overall Study|Lost to Follow-up|1|||
164285111|NCT04961541|593414387|FG008|Overall Study|Lost to Follow-up|0|||
164285112|NCT04961541|593414388|FG009|Overall Study|Lost to Follow-up|1|||
164285113|NCT04961541|593414389|FG010|Overall Study|Lost to Follow-up|0|||
164285114|NCT04961541|593414390|FG011|Overall Study|Lost to Follow-up|0|||
164285115|NCT04961541|593414391|FG012|Overall Study|Lost to Follow-up|1|||
164285116|NCT04961541|593414392|FG013|Overall Study|Lost to Follow-up|0|||
164285117|NCT04961541|593414379|FG000|Overall Study|Withdrawal by Subject|0|||
164285118|NCT04961541|593414380|FG001|Overall Study|Withdrawal by Subject|0|||
164285119|NCT04961541|593414381|FG002|Overall Study|Withdrawal by Subject|1|||
164285120|NCT04961541|593414382|FG003|Overall Study|Withdrawal by Subject|1|||
164285121|NCT04961541|593414383|FG004|Overall Study|Withdrawal by Subject|0|||
164285122|NCT04961541|593414384|FG005|Overall Study|Withdrawal by Subject|0|||
164285123|NCT04961541|593414385|FG006|Overall Study|Withdrawal by Subject|0|||
164285124|NCT04961541|593414386|FG007|Overall Study|Withdrawal by Subject|0|||
164285125|NCT04961541|593414387|FG008|Overall Study|Withdrawal by Subject|0|||
164285126|NCT04961541|593414388|FG009|Overall Study|Withdrawal by Subject|1|||
164285127|NCT04961541|593414389|FG010|Overall Study|Withdrawal by Subject|0|||
164285128|NCT04961541|593414390|FG011|Overall Study|Withdrawal by Subject|0|||
164285129|NCT04961541|593414391|FG012|Overall Study|Withdrawal by Subject|0|||
164285130|NCT04961541|593414392|FG013|Overall Study|Withdrawal by Subject|0|||
164285131|NCT00466921|593414393|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
164285132|NCT00466921|593414393|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
164285133|NCT00466921|593414393|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
164285134|NCT00466921|593414393|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
164285135|NCT00466921|593414393|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
164285136|NCT00466921|593414393|FG000|Follow up for a Minimum of 1 Year|Death|6|||
164285137|NCT03305770|593414394|FG000|Overall Study|Physician Decision - prior to dispense|0|||
164285138|NCT03305770|593414395|FG001|Overall Study|Physician Decision - prior to dispense|1|||
164285139|NCT03305770|593414394|FG000|Overall Study|Subject moved|1|||
164285140|NCT03305770|593414395|FG001|Overall Study|Subject moved|0|||
164285141|NCT03539601|593414396|FG000|Overall Study|Withdraw by parent/guardian|1|||
164285142|NCT03539601|593414397|FG001|Overall Study|Withdraw by parent/guardian|0|||
164344781|NCT03000439|593638836|FG002|Double Blind Phase|Adverse Event|2|||
164344782|NCT03000439|593638837|FG003|Double Blind Phase|Adverse Event|1|||
164285143|NCT03539601|593414398|FG002|Overall Study|Withdraw by parent/guardian|1|||
164285144|NCT03539601|593414399|FG003|Overall Study|Withdraw by parent/guardian|0|||
164285145|NCT03539601|593414396|FG000|Overall Study|Adverse Event|0|||
164285146|NCT03539601|593414397|FG001|Overall Study|Adverse Event|2|||
164285147|NCT03539601|593414398|FG002|Overall Study|Adverse Event|0|||
164285148|NCT03539601|593414399|FG003|Overall Study|Adverse Event|0|||
164285149|NCT03539601|593414396|FG000|Overall Study|Lost to Follow-up|2|||
164285150|NCT03539601|593414397|FG001|Overall Study|Lost to Follow-up|4|||
164285151|NCT03539601|593414398|FG002|Overall Study|Lost to Follow-up|5|||
164285152|NCT03539601|593414399|FG003|Overall Study|Lost to Follow-up|0|||
164285153|NCT03539601|593414396|FG000|Overall Study|Withdrawal by Subject|2|||
164285154|NCT03539601|593414397|FG001|Overall Study|Withdrawal by Subject|0|||
163897526|NCT02231749|591997884|FG000|Overall Study|Disease progression|229|||
163897527|NCT02231749|591997885|FG001|Overall Study|Disease progression|297|||
163897528|NCT02231749|591997884|FG000|Overall Study|Study Drug Toxicity|134|||
163897529|NCT02231749|591997885|FG001|Overall Study|Study Drug Toxicity|63|||
163897530|NCT02231749|591997884|FG000|Overall Study|Death|1|||
163897531|NCT02231749|591997885|FG001|Overall Study|Death|1|||
163897532|NCT02231749|591997884|FG000|Overall Study|AE unrelated to Study drug|32|||
163897533|NCT02231749|591997885|FG001|Overall Study|AE unrelated to Study drug|31|||
163897534|NCT02231749|591997884|FG000|Overall Study|Participant's request to discontinue|10|||
163897535|NCT02231749|591997885|FG001|Overall Study|Participant's request to discontinue|21|||
163897536|NCT02231749|591997884|FG000|Overall Study|Participant withdrew Consent|8|||
164285155|NCT03539601|593414398|FG002|Overall Study|Withdrawal by Subject|0|||
164285156|NCT03539601|593414399|FG003|Overall Study|Withdrawal by Subject|1|||
164285157|NCT03539601|593414396|FG000|Overall Study|Randomized but not treated|1|||
164285158|NCT03539601|593414397|FG001|Overall Study|Randomized but not treated|1|||
164285159|NCT03539601|593414398|FG002|Overall Study|Randomized but not treated|0|||
164285160|NCT03539601|593414399|FG003|Overall Study|Randomized but not treated|0|||
164285161|NCT03710642|593414403|FG000|Overall Study|Adverse Event|5|||
164285162|NCT03710642|593414404|FG001|Overall Study|Adverse Event|1|||
164285163|NCT03710642|593414403|FG000|Overall Study|non-site physician recommendation|1|||
164285164|NCT03710642|593414404|FG001|Overall Study|non-site physician recommendation|0|||
164285165|NCT03710642|593414403|FG000|Overall Study|Participant unwilling or unable to participate|1|||
164285166|NCT03710642|593414404|FG001|Overall Study|Participant unwilling or unable to participate|1|||
164285167|NCT03710642|593414403|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
163897537|NCT02231749|591997885|FG001|Overall Study|Participant withdrew Consent|15|||
163897538|NCT02231749|591997884|FG000|Overall Study|Lost to Follow-up|1|||
163897539|NCT02231749|591997885|FG001|Overall Study|Lost to Follow-up|2|||
163897540|NCT02231749|591997884|FG000|Overall Study|Maximum Clinical Benefit|5|||
163897541|NCT02231749|591997885|FG001|Overall Study|Maximum Clinical Benefit|8|||
163897542|NCT02231749|591997884|FG000|Overall Study|Poor/Non-Compliance|0|||
163897543|NCT02231749|591997885|FG001|Overall Study|Poor/Non-Compliance|3|||
163897544|NCT02231749|591997884|FG000|Overall Study|Pregnancy|1|||
163897545|NCT02231749|591997885|FG001|Overall Study|Pregnancy|0|||
163897546|NCT02231749|591997884|FG000|Overall Study|other|0|||
163897547|NCT02231749|591997885|FG001|Overall Study|other|8|||
163897548|NCT02231749|591997884|FG000|Overall Study|No longer meets Study Criteria|1|||
164285168|NCT03710642|593414404|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
164285169|NCT03710642|593414403|FG000|Overall Study|NA-no code provided|1|||
164285170|NCT03710642|593414404|FG001|Overall Study|NA-no code provided|0|||
164285171|NCT03710642|593414403|FG000|Overall Study|Withdrawal by Subject|1|||
164285172|NCT03710642|593414404|FG001|Overall Study|Withdrawal by Subject|0|||
164285173|NCT01970306|593414405|FG000|Overall Study|Not eligible|3|||
163897549|NCT02231749|591997885|FG001|Overall Study|No longer meets Study Criteria|0|||
163897550|NCT05030584|591997888|FG000|Overall Study|Adverse Event|17|||
163897551|NCT05030584|591997889|FG001|Overall Study|Adverse Event|2|||
163897552|NCT05030584|591997888|FG000|Overall Study|Lack of Efficacy|0|||
163897553|NCT05030584|591997889|FG001|Overall Study|Lack of Efficacy|6|||
163897554|NCT05030584|591997888|FG000|Overall Study|Lost to Follow-up|5|||
163897555|NCT05030584|591997889|FG001|Overall Study|Lost to Follow-up|2|||
163897556|NCT05030584|591997888|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163897557|NCT05030584|591997889|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163897558|NCT05030584|591997888|FG000|Overall Study|Other reason|4|||
163897559|NCT05030584|591997889|FG001|Overall Study|Other reason|3|||
163897560|NCT05030584|591997888|FG000|Overall Study|Physician Decision|1|||
163897561|NCT05030584|591997889|FG001|Overall Study|Physician Decision|4|||
163897562|NCT05030584|591997888|FG000|Overall Study|Protocol Violation|0|||
163897563|NCT05030584|591997889|FG001|Overall Study|Protocol Violation|2|||
163897564|NCT05030584|591997888|FG000|Overall Study|Randomized by Mistake|0|||
163897565|NCT05030584|591997889|FG001|Overall Study|Randomized by Mistake|2|||
163897566|NCT05030584|591997888|FG000|Overall Study|Withdrawal by Subject|21|||
163897567|NCT05030584|591997889|FG001|Overall Study|Withdrawal by Subject|28|||
163897568|NCT05030584|591997888|FG000|Overall Study|Technical Problems|0|||
163897569|NCT05030584|591997889|FG001|Overall Study|Technical Problems|1|||
163897570|NCT05030584|591997888|FG000|Overall Study|Completed post-treatment/FU visits|41|||
164285174|NCT01970306|593414405|FG000|Overall Study|Not able to be treated|9|||
164285175|NCT00226811|593414406|FG000|Overall Study|Death|8|||
164285176|NCT00226811|593414406|FG000|Overall Study|Adverse Event|11|||
164285177|NCT00226811|593414406|FG000|Overall Study|Lack of Efficacy|55|||
164285178|NCT00226811|593414406|FG000|Overall Study|Withdrawal by Subject|2|||
164285179|NCT01427933|593414410|FG000|Overall Study|Withdrawal by Subject|5|||
164285180|NCT01427933|593414411|FG001|Overall Study|Withdrawal by Subject|8|||
164285181|NCT01427933|593414410|FG000|Overall Study|Lost to Follow-up|1|||
164285182|NCT01427933|593414411|FG001|Overall Study|Lost to Follow-up|5|||
164285183|NCT01427933|593414410|FG000|Overall Study|Other|1|||
164285184|NCT01427933|593414411|FG001|Overall Study|Other|0|||
164285185|NCT01427933|593414410|FG000|Overall Study|Investigator's Decision|1|||
164285186|NCT01427933|593414411|FG001|Overall Study|Investigator's Decision|0|||
164285187|NCT01633541|593414412|FG000|Overall Study|Death|1|||
164285188|NCT01633541|593414413|FG001|Overall Study|Death|0|||
164285189|NCT03472326|593414416|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
164285190|NCT03472326|593414417|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
164285191|NCT03472326|593414418|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
164285192|NCT03472326|593414419|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
164285193|NCT03472326|593414416|FG000|Part 2: Combination Therapy|Pregnancy|0|||
164285194|NCT03472326|593414417|FG001|Part 2: Combination Therapy|Pregnancy|0|||
164285195|NCT03472326|593414418|FG002|Part 2: Combination Therapy|Pregnancy|0|||
164285196|NCT03472326|593414419|FG003|Part 2: Combination Therapy|Pregnancy|1|||
164285197|NCT01010971|593414420|FG000|Overall Study|Adverse Event|2|||
164285198|NCT01010971|593414421|FG001|Overall Study|Adverse Event|4|||
164285199|NCT01010971|593414422|FG002|Overall Study|Adverse Event|3|||
164285200|NCT01010971|593414420|FG000|Overall Study|Withdrawal by Subject|0|||
164285201|NCT01010971|593414421|FG001|Overall Study|Withdrawal by Subject|2|||
164285202|NCT01010971|593414422|FG002|Overall Study|Withdrawal by Subject|5|||
164285203|NCT01010971|593414420|FG000|Overall Study|Lost to Follow-up|0|||
164285204|NCT01010971|593414421|FG001|Overall Study|Lost to Follow-up|2|||
164285205|NCT01010971|593414422|FG002|Overall Study|Lost to Follow-up|3|||
164285206|NCT01010971|593414420|FG000|Overall Study|Other|1|||
164285207|NCT01010971|593414421|FG001|Overall Study|Other|0|||
164285208|NCT01010971|593414422|FG002|Overall Study|Other|2|||
164285209|NCT00773513|593414424|FG000|Overall Study|Renal Transplant|254|||
164285210|NCT00773513|593414425|FG001|Overall Study|Renal Transplant|263|||
164285211|NCT00773513|593414424|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
164285212|NCT00773513|593414425|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
164285213|NCT00773513|593414424|FG000|Overall Study|Withdrew Consent|68|||
164285214|NCT00773513|593414425|FG001|Overall Study|Withdrew Consent|69|||
164285215|NCT00773513|593414424|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
164285216|NCT00773513|593414425|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
164285217|NCT00773513|593414424|FG000|Overall Study|Failure to Return|22|||
164285218|NCT00773513|593414425|FG001|Overall Study|Failure to Return|8|||
164285219|NCT00773513|593414424|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164285220|NCT00773513|593414425|FG001|Overall Study|Insufficient Therapeutic Response|18|||
164285221|NCT00773513|593414424|FG000|Overall Study|Reason Not Specified|159|||
164285222|NCT00773513|593414425|FG001|Overall Study|Reason Not Specified|126|||
164285223|NCT00773513|593414424|FG000|Overall Study|Death|531|||
164285224|NCT00773513|593414425|FG001|Overall Study|Death|545|||
164285225|NCT02330055|593414427|FG000|Overall Study|technical issues|2|||
164285226|NCT02330055|593414428|FG001|Overall Study|technical issues|0|||
164285227|NCT02330055|593414427|FG000|Overall Study|participant forgot to wear device|5|||
164285228|NCT02330055|593414428|FG001|Overall Study|participant forgot to wear device|5|||
164285229|NCT02330055|593414427|FG000|Overall Study|data for less than 60 minutes|3|||
164285230|NCT02330055|593414428|FG001|Overall Study|data for less than 60 minutes|3|||
164285231|NCT02330055|593414427|FG000|Overall Study|participant did not sleep|0|||
164285232|NCT02330055|593414428|FG001|Overall Study|participant did not sleep|1|||
163897571|NCT05030584|591997889|FG001|Overall Study|Completed post-treatment/FU visits|31|||
163897572|NCT02532621|591997896|FG000|Overall Study|Death|3|||
164285233|NCT05729568|593414430|FG000|Overall Study|Still on Study|52|||
164285234|NCT05729568|593414431|FG001|Overall Study|Still on Study|26|||
164285235|NCT05729568|593414430|FG000|Overall Study|Randomized but Never Treated|3|||
164285236|NCT05729568|593414431|FG001|Overall Study|Randomized but Never Treated|0|||
164285237|NCT05729568|593414430|FG000|Overall Study|Adverse Event|0|||
164285238|NCT05729568|593414431|FG001|Overall Study|Adverse Event|1|||
163897573|NCT02532621|591997896|FG000|Overall Study|Lost to Follow-up|3|||
163897574|NCT02532621|591997896|FG000|Overall Study|Withdrawal by Subject|6|||
163897575|NCT02532621|591997896|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
163897576|NCT02532621|591997896|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
163897577|NCT05424718|591997897|FG000|Overall Study|Lost to Follow-up|5|||
163897578|NCT05424718|591997898|FG001|Overall Study|Lost to Follow-up|4|||
163897579|NCT04046549|591997899|FG000|Overall Study|Adverse Event|1|||
164285239|NCT05729568|593414430|FG000|Overall Study|Investigator's Discretion|1|||
164285240|NCT05729568|593414431|FG001|Overall Study|Investigator's Discretion|0|||
164285241|NCT00550953|593414432|FG000|Overall Study|Adverse Event|4|||
163897580|NCT04046549|591997899|FG000|Overall Study|Physician Decision|1|||
163897581|NCT04046549|591997899|FG000|Overall Study|Withdrawal by Subject|3|||
163897582|NCT04046549|591997899|FG000|Overall Study|Other, Not Specified|5|||
163897583|NCT06059443|591997900|FG000|Overall Study|Withdrawal by Subject|2|||
163897584|NCT06059443|591997901|FG001|Overall Study|Withdrawal by Subject|0|||
163897585|NCT06059443|591997900|FG000|Overall Study|Lost to Follow-up|2|||
164003803|NCT04283461|592378179|FG001|Overall Study|Enrolled in separate trial|0|||
164003804|NCT04283461|592378180|FG002|Overall Study|Enrolled in separate trial|8|||
164003805|NCT04283461|592378181|FG003|Overall Study|Enrolled in separate trial|13|||
164003806|NCT04283461|592378182|FG004|Overall Study|Enrolled in separate trial|12|||
164003807|NCT04283461|592378183|FG005|Overall Study|Enrolled in separate trial|0|||
164003808|NCT04283461|592378184|FG006|Overall Study|Enrolled in separate trial|0|||
164003809|NCT04283461|592378185|FG007|Overall Study|Enrolled in separate trial|8|||
164003810|NCT04283461|592378186|FG008|Overall Study|Enrolled in separate trial|0|||
164285242|NCT00550953|593414433|FG001|Overall Study|Adverse Event|3|||
164285243|NCT00550953|593414432|FG000|Overall Study|Not able to visit the site|2|||
164285244|NCT00550953|593414433|FG001|Overall Study|Not able to visit the site|3|||
164285245|NCT01502228|593414434|FG000|Overall Study|Death|1|||
164285246|NCT01221350|593414437|FG000|Overall Study|Discontinued intervention (GERD)|1|||
164285247|NCT01221350|593414438|FG001|Overall Study|Discontinued intervention (GERD)|0|||
164285248|NCT01221350|593414437|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
164285249|NCT01221350|593414438|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
164285250|NCT01221350|593414437|FG000|Overall Study|Withdrawal by Subject|4|||
164285251|NCT01221350|593414438|FG001|Overall Study|Withdrawal by Subject|2|||
164285252|NCT02326597|593414441|FG000|Overall Study|Lost to Follow-up|42|||
164285253|NCT02326597|593414442|FG001|Overall Study|Lost to Follow-up|32|||
164285254|NCT04739436|593414443|FG000|Overall Study|Lost to Follow-up|21|||
164285255|NCT04739436|593414444|FG001|Overall Study|Lost to Follow-up|23|||
164285256|NCT04739436|593414443|FG000|Overall Study|Withdrawal by Subject|4|||
164285257|NCT04739436|593414444|FG001|Overall Study|Withdrawal by Subject|6|||
164285258|NCT04739436|593414443|FG000|Overall Study|not randomized properly|1|||
164285259|NCT04739436|593414444|FG001|Overall Study|not randomized properly|0|||
164285260|NCT00428948|593414445|FG000|Overall Study|Lost to Follow-up|15|||
164285261|NCT00428948|593414446|FG001|Overall Study|Lost to Follow-up|8|||
164285262|NCT00428948|593414445|FG000|Overall Study|Adverse Event|148|||
164285263|NCT00428948|593414446|FG001|Overall Study|Adverse Event|24|||
164285264|NCT00428948|593414445|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
164285265|NCT00428948|593414446|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
164285266|NCT00428948|593414445|FG000|Overall Study|Investigator Withdrew Subject|3|||
164285267|NCT00428948|593414446|FG001|Overall Study|Investigator Withdrew Subject|4|||
164285268|NCT00428948|593414445|FG000|Overall Study|Subject Withdrew Consent|50|||
164285269|NCT00428948|593414446|FG001|Overall Study|Subject Withdrew Consent|30|||
164285270|NCT00428948|593414445|FG000|Overall Study|Protocol Deviation|1|||
164285271|NCT00428948|593414446|FG001|Overall Study|Protocol Deviation|1|||
164285272|NCT04752332|593414452|FG000|Overall Study|Adverse Event|3|||
164285273|NCT04752332|593414453|FG001|Overall Study|Adverse Event|1|||
164285274|NCT04752332|593414452|FG000|Overall Study|Disease Relapse|1|||
164285275|NCT04752332|593414453|FG001|Overall Study|Disease Relapse|0|||
164285276|NCT04752332|593414452|FG000|Overall Study|Non-compliance With Study Drug|2|||
164285277|NCT04752332|593414453|FG001|Overall Study|Non-compliance With Study Drug|0|||
164285278|NCT04752332|593414452|FG000|Overall Study|Physician Decision|2|||
164285279|NCT04752332|593414453|FG001|Overall Study|Physician Decision|1|||
164285280|NCT04752332|593414452|FG000|Overall Study|Protocol Violation|1|||
164285281|NCT04752332|593414453|FG001|Overall Study|Protocol Violation|1|||
164285282|NCT04752332|593414452|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
164285283|NCT04752332|593414453|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
164285284|NCT04752332|593414452|FG000|Overall Study|Study Terminated by Sponsor|10|||
164285285|NCT04752332|593414453|FG001|Overall Study|Study Terminated by Sponsor|48|||
164285286|NCT04752332|593414452|FG000|Overall Study|Withdrawal by Subject|11|||
164285287|NCT04752332|593414453|FG001|Overall Study|Withdrawal by Subject|3|||
164285288|NCT00924443|593414454|FG000|Overall Study|Physician Decision|2|||
164285289|NCT00924443|593414454|FG000|Overall Study|Protocol Violation|1|||
164285290|NCT02119663|593414459|FG000|Overall Study|Disease progression|26|||
164003811|NCT04283461|592378187|FG009|Overall Study|Enrolled in separate trial|0|||
164285291|NCT02119663|593414460|FG001|Overall Study|Disease progression|27|||
164285292|NCT02119663|593414459|FG000|Overall Study|Adverse Event|5|||
164285293|NCT02119663|593414460|FG001|Overall Study|Adverse Event|5|||
164285294|NCT02119663|593414459|FG000|Overall Study|Death|3|||
163897586|NCT06059443|591997901|FG001|Overall Study|Lost to Follow-up|2|||
163897587|NCT00709956|591997904|FG000|Overall Study|Withdrawal by Subject|1|||
164003812|NCT04283461|592378188|FG010|Overall Study|Enrolled in separate trial|0|||
164090468|NCT02984683|592693440|FG000|Overall Study|Disease progression|7|||
164285295|NCT02119663|593414460|FG001|Overall Study|Death|2|||
164285296|NCT02119663|593414459|FG000|Overall Study|Physician Decision|1|||
164285297|NCT02119663|593414460|FG001|Overall Study|Physician Decision|2|||
164285298|NCT02119663|593414459|FG000|Overall Study|Other unspecified|2|||
164285299|NCT02119663|593414460|FG001|Overall Study|Other unspecified|0|||
164285300|NCT02119663|593414459|FG000|Overall Study|Subject decision|0|||
164285301|NCT02119663|593414460|FG001|Overall Study|Subject decision|1|||
164285302|NCT02119663|593414459|FG000|Overall Study|Study Terminated by the Sponsor|3|||
164285303|NCT02119663|593414460|FG001|Overall Study|Study Terminated by the Sponsor|4|||
164285304|NCT01248949|593414461|FG000|Overall Study|Lost to Follow-up|2|||
164285305|NCT01248949|593414462|FG001|Overall Study|Lost to Follow-up|2|||
164285306|NCT01248949|593414463|FG002|Overall Study|Lost to Follow-up|2|||
164285307|NCT01248949|593414464|FG003|Overall Study|Lost to Follow-up|1|||
164285308|NCT01248949|593414465|FG004|Overall Study|Lost to Follow-up|0|||
164285309|NCT01248949|593414461|FG000|Overall Study|Withdrawal by Subject|5|||
164285310|NCT01248949|593414462|FG001|Overall Study|Withdrawal by Subject|3|||
164285311|NCT01248949|593414463|FG002|Overall Study|Withdrawal by Subject|11|||
164285312|NCT01248949|593414464|FG003|Overall Study|Withdrawal by Subject|3|||
164285313|NCT01248949|593414465|FG004|Overall Study|Withdrawal by Subject|1|||
164285314|NCT01248949|593414461|FG000|Overall Study|Death|22|||
164285315|NCT01248949|593414462|FG001|Overall Study|Death|7|||
164285316|NCT01248949|593414463|FG002|Overall Study|Death|21|||
164285317|NCT01248949|593414464|FG003|Overall Study|Death|6|||
164285318|NCT01248949|593414465|FG004|Overall Study|Death|2|||
164285319|NCT01248949|593414461|FG000|Overall Study|Alternative Therapy|1|||
164285320|NCT01248949|593414462|FG001|Overall Study|Alternative Therapy|0|||
164285321|NCT01248949|593414463|FG002|Overall Study|Alternative Therapy|0|||
164285322|NCT01248949|593414464|FG003|Overall Study|Alternative Therapy|0|||
164285323|NCT01248949|593414465|FG004|Overall Study|Alternative Therapy|0|||
164285324|NCT01248949|593414461|FG000|Overall Study|Alternative Therapy.|1|||
164285325|NCT01248949|593414462|FG001|Overall Study|Alternative Therapy.|0|||
164285326|NCT01248949|593414463|FG002|Overall Study|Alternative Therapy.|0|||
164285327|NCT01248949|593414464|FG003|Overall Study|Alternative Therapy.|0|||
164285328|NCT01248949|593414465|FG004|Overall Study|Alternative Therapy.|0|||
164285329|NCT01248949|593414461|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
164285330|NCT01248949|593414462|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
164285331|NCT01248949|593414463|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
164344783|NCT03000439|593638834|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
164344784|NCT03000439|593638835|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
164344785|NCT03000439|593638836|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
164344786|NCT03000439|593638837|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
164344787|NCT03000439|593638834|FG000|Double Blind Phase|Other|0|||
164344788|NCT03000439|593638835|FG001|Double Blind Phase|Other|0|||
164344789|NCT03000439|593638836|FG002|Double Blind Phase|Other|10|||
164344790|NCT03000439|593638837|FG003|Double Blind Phase|Other|11|||
164344791|NCT03000439|593638834|FG000|Double Blind Phase|Insufficient clinical response|0|||
164344792|NCT03000439|593638835|FG001|Double Blind Phase|Insufficient clinical response|0|||
164344793|NCT03000439|593638836|FG002|Double Blind Phase|Insufficient clinical response|0|||
164344794|NCT03000439|593638837|FG003|Double Blind Phase|Insufficient clinical response|2|||
164344795|NCT01389817|593638840|FG000|Overall Study|Physician Decision|1|||
164344796|NCT01389817|593638841|FG001|Overall Study|Physician Decision|0|||
164344797|NCT01389817|593638840|FG000|Overall Study|Lost to Follow-up|1|||
164344798|NCT01389817|593638841|FG001|Overall Study|Lost to Follow-up|0|||
164344799|NCT01389817|593638840|FG000|Overall Study|Withdrawal by Subject|2|||
164344800|NCT01389817|593638841|FG001|Overall Study|Withdrawal by Subject|0|||
164344801|NCT01749137|593638842|FG000|Overall Study|Adverse Event|4|||
164344802|NCT01749137|593638843|FG001|Overall Study|Adverse Event|4|||
164344803|NCT01749137|593638842|FG000|Overall Study|Lost to Follow-up|2|||
164344804|NCT01749137|593638843|FG001|Overall Study|Lost to Follow-up|3|||
164344805|NCT01749137|593638842|FG000|Overall Study|Physician Decision|1|||
164344806|NCT01749137|593638843|FG001|Overall Study|Physician Decision|0|||
164344807|NCT01749137|593638842|FG000|Overall Study|Withdrawal by Subject|8|||
164344808|NCT01749137|593638843|FG001|Overall Study|Withdrawal by Subject|4|||
164344809|NCT04980040|593638845|FG000|Overall Study|Violated the Inclusion Criteria|260|||
164344810|NCT04980040|593638845|FG000|Overall Study|Violated the Administration & Dosage|225|||
164344811|NCT04980040|593638845|FG000|Overall Study|Lost to Safety-Follow-up|4|||
164344812|NCT04980040|593638845|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
164344813|NCT01508650|593638846|FG000|Overall Study|Lost to Follow-up|0|||
164344814|NCT01508650|593638847|FG001|Overall Study|Lost to Follow-up|3|||
164344815|NCT02064894|593638848|FG000|Overall Study|Withdrawal by Subject|43|||
163897588|NCT00709956|591997905|FG001|Overall Study|Withdrawal by Subject|1|||
164344816|NCT02064894|593638849|FG001|Overall Study|Withdrawal by Subject|102|||
164344817|NCT02064894|593638850|FG002|Overall Study|Withdrawal by Subject|115|||
164285332|NCT01248949|593414464|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
164285333|NCT01248949|593414465|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
164285334|NCT01248949|593414461|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285335|NCT01248949|593414462|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285336|NCT01248949|593414463|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285337|NCT01248949|593414464|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
164285338|NCT01248949|593414465|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
164285339|NCT01248949|593414461|FG000|Overall Study|Participant Went To Hospice|0|||
164285340|NCT01248949|593414462|FG001|Overall Study|Participant Went To Hospice|0|||
164285341|NCT01248949|593414463|FG002|Overall Study|Participant Went To Hospice|1|||
164285342|NCT01248949|593414464|FG003|Overall Study|Participant Went To Hospice|0|||
164285343|NCT01248949|593414465|FG004|Overall Study|Participant Went To Hospice|0|||
164285344|NCT01248949|593414461|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
164285345|NCT01248949|593414462|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285346|NCT01248949|593414463|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285347|NCT01248949|593414464|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285348|NCT01248949|593414465|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
164285349|NCT01248949|593414461|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
164285350|NCT01248949|593414462|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
164285351|NCT01248949|593414463|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
164285352|NCT01248949|593414464|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
164285353|NCT01248949|593414465|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
164285354|NCT01248949|593414461|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285355|NCT01248949|593414462|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
164285356|NCT01248949|593414463|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285357|NCT01248949|593414464|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285358|NCT01248949|593414465|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
164285359|NCT01248949|593414461|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285360|NCT01248949|593414462|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285361|NCT01248949|593414463|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
164285362|NCT01248949|593414464|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285363|NCT01248949|593414465|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
164285364|NCT00286429|593414466|FG000|Overall Study|Adverse Event|4|||
164285365|NCT00286429|593414467|FG001|Overall Study|Adverse Event|1|||
164285366|NCT00286429|593414468|FG002|Overall Study|Adverse Event|6|||
164285367|NCT00286429|593414466|FG000|Overall Study|Lack of Efficacy|52|||
164285368|NCT00286429|593414467|FG001|Overall Study|Lack of Efficacy|27|||
164285369|NCT00286429|593414468|FG002|Overall Study|Lack of Efficacy|25|||
164285370|NCT00286429|593414466|FG000|Overall Study|Lost to Follow-up|2|||
164285371|NCT00286429|593414467|FG001|Overall Study|Lost to Follow-up|4|||
164285372|NCT00286429|593414468|FG002|Overall Study|Lost to Follow-up|3|||
164285373|NCT00286429|593414466|FG000|Overall Study|Physician Decision|10|||
164285374|NCT00286429|593414467|FG001|Overall Study|Physician Decision|7|||
164285375|NCT00286429|593414468|FG002|Overall Study|Physician Decision|7|||
164285376|NCT00286429|593414466|FG000|Overall Study|Protocol Violation|3|||
164285377|NCT00286429|593414467|FG001|Overall Study|Protocol Violation|5|||
164285378|NCT00286429|593414468|FG002|Overall Study|Protocol Violation|4|||
164285379|NCT00286429|593414466|FG000|Overall Study|Withdrawal by Subject|3|||
164285380|NCT00286429|593414467|FG001|Overall Study|Withdrawal by Subject|2|||
164285381|NCT00286429|593414468|FG002|Overall Study|Withdrawal by Subject|6|||
164285382|NCT00286429|593414466|FG000|Overall Study|Administrative Error|1|||
164285383|NCT00286429|593414467|FG001|Overall Study|Administrative Error|1|||
164285384|NCT00286429|593414468|FG002|Overall Study|Administrative Error|1|||
164285385|NCT00286429|593414466|FG000|Overall Study|Administrative Decision|0|||
164285386|NCT00286429|593414467|FG001|Overall Study|Administrative Decision|1|||
164285387|NCT00286429|593414468|FG002|Overall Study|Administrative Decision|0|||
164285388|NCT03197376|593414471|FG000|Primary and Booster Phase|Adverse Event|0|||
164285389|NCT03197376|593414472|FG001|Primary and Booster Phase|Adverse Event|0|||
164285390|NCT03197376|593414473|FG002|Primary and Booster Phase|Adverse Event|0|||
164285391|NCT03197376|593414474|FG003|Primary and Booster Phase|Adverse Event|1|||
164285392|NCT03197376|593414471|FG000|Primary and Booster Phase|Death|1|||
164285393|NCT03197376|593414472|FG001|Primary and Booster Phase|Death|0|||
164285394|NCT03197376|593414473|FG002|Primary and Booster Phase|Death|0|||
164285395|NCT03197376|593414474|FG003|Primary and Booster Phase|Death|2|||
164344818|NCT01976338|593638851|FG000|Overall Study|Physician Decision|0|||
164344819|NCT01976338|593638852|FG001|Overall Study|Physician Decision|1|||
164344820|NCT01976338|593638851|FG000|Overall Study|Lost to Follow-up|3|||
164344821|NCT01976338|593638852|FG001|Overall Study|Lost to Follow-up|0|||
164344822|NCT01976338|593638851|FG000|Overall Study|Withdrawal by Subject|5|||
164344823|NCT01976338|593638852|FG001|Overall Study|Withdrawal by Subject|2|||
164344824|NCT01976338|593638851|FG000|Overall Study|Adverse Event|5|||
164344825|NCT01976338|593638852|FG001|Overall Study|Adverse Event|1|||
164344826|NCT01471171|593638854|FG000|Treatment Period 1|Adverse Event|4|||
164344827|NCT01471171|593638855|FG001|Treatment Period 1|Adverse Event|1|||
164285396|NCT03197376|593414471|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
164285397|NCT03197376|593414472|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
164285398|NCT03197376|593414473|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
164285399|NCT03197376|593414474|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
164285400|NCT03197376|593414471|FG000|Primary and Booster Phase|Physician Decision|1|||
164285401|NCT03197376|593414472|FG001|Primary and Booster Phase|Physician Decision|0|||
164285402|NCT03197376|593414473|FG002|Primary and Booster Phase|Physician Decision|1|||
164285403|NCT03197376|593414474|FG003|Primary and Booster Phase|Physician Decision|3|||
164285404|NCT03197376|593414471|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
164285405|NCT03197376|593414472|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
164285406|NCT03197376|593414473|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
164285407|NCT03197376|593414474|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
164285408|NCT03197376|593414471|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
164285409|NCT03197376|593414472|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
164285410|NCT03197376|593414473|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
164285411|NCT03197376|593414474|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
164285412|NCT03197376|593414471|FG000|Primary and Booster Phase|Not vaccine related|1|||
164285413|NCT03197376|593414472|FG001|Primary and Booster Phase|Not vaccine related|2|||
164285414|NCT03197376|593414473|FG002|Primary and Booster Phase|Not vaccine related|0|||
164285415|NCT03197376|593414474|FG003|Primary and Booster Phase|Not vaccine related|6|||
164285416|NCT03197376|593414471|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
164285417|NCT03197376|593414472|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
164285418|NCT03197376|593414473|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
164285419|NCT03197376|593414474|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
164285420|NCT03197376|593414471|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
164285421|NCT03197376|593414472|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
164285422|NCT03197376|593414473|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
164285423|NCT03197376|593414474|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
164285424|NCT03197376|593414471|FG000|Immune Persistence Phase|Not vaccine related|1|||
164285425|NCT03197376|593414472|FG001|Immune Persistence Phase|Not vaccine related|0|||
164285426|NCT03197376|593414473|FG002|Immune Persistence Phase|Not vaccine related|1|||
164285427|NCT03197376|593414474|FG003|Immune Persistence Phase|Not vaccine related|1|||
164285428|NCT01123395|593414477|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
164285429|NCT01123395|593414478|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
164285430|NCT00782483|593414485|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
164285431|NCT01052077|593414486|FG000|Phase A|Lost to Follow-up|22|||
164285432|NCT01052077|593414487|FG001|Phase A|Lost to Follow-up|0|||
164285433|NCT01052077|593414488|FG002|Phase A|Lost to Follow-up|0|||
164285434|NCT01052077|593414489|FG003|Phase A|Lost to Follow-up|0|||
164285435|NCT01052077|593414486|FG000|Phase A|Adverse Event|32|||
164285436|NCT01052077|593414487|FG001|Phase A|Adverse Event|0|||
164285437|NCT01052077|593414488|FG002|Phase A|Adverse Event|0|||
164285438|NCT01052077|593414489|FG003|Phase A|Adverse Event|0|||
164344828|NCT01471171|593638854|FG000|Treatment Period 2|Adverse Event|1|||
164344829|NCT01471171|593638855|FG001|Treatment Period 2|Adverse Event|0|||
164344830|NCT02864498|593638856|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
164344831|NCT02864498|593638857|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
164344832|NCT02864498|593638858|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
164344833|NCT02864498|593638856|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
164344834|NCT02864498|593638857|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
164344835|NCT02864498|593638858|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
164344836|NCT02864498|593638856|FG000|Overall Study|Investigator Discretion|0|||
164344837|NCT02864498|593638857|FG001|Overall Study|Investigator Discretion|2|||
164344838|NCT02864498|593638858|FG002|Overall Study|Investigator Discretion|1|||
164344839|NCT02864498|593638856|FG000|Overall Study|Lost to Follow-up|8|||
164344840|NCT02864498|593638857|FG001|Overall Study|Lost to Follow-up|6|||
164344841|NCT02864498|593638858|FG002|Overall Study|Lost to Follow-up|3|||
164344842|NCT02864498|593638856|FG000|Overall Study|Lack of Efficacy|5|||
164344843|NCT02864498|593638857|FG001|Overall Study|Lack of Efficacy|3|||
164344844|NCT02864498|593638858|FG002|Overall Study|Lack of Efficacy|3|||
164344845|NCT02864498|593638856|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
164344846|NCT02864498|593638857|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
164344847|NCT02864498|593638858|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
164344848|NCT02864498|593638856|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
164344849|NCT02864498|593638857|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
164344850|NCT02864498|593638858|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
164344851|NCT02864498|593638856|FG000|Overall Study|Subject moved out of the country.|0|||
164344852|NCT02864498|593638857|FG001|Overall Study|Subject moved out of the country.|0|||
164344853|NCT02864498|593638858|FG002|Overall Study|Subject moved out of the country.|1|||
164344854|NCT00705484|593638861|FG000|Overall Study|Adverse Event|28|||
164285439|NCT01052077|593414486|FG000|Phase A|Met Withdrawal Criteria|26|||
164285440|NCT01052077|593414487|FG001|Phase A|Met Withdrawal Criteria|0|||
164285441|NCT01052077|593414488|FG002|Phase A|Met Withdrawal Criteria|0|||
164285442|NCT01052077|593414489|FG003|Phase A|Met Withdrawal Criteria|0|||
164344855|NCT00705484|593638862|FG001|Overall Study|Adverse Event|27|||
163897589|NCT00709956|591997904|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
163897590|NCT00709956|591997905|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
164285443|NCT01052077|593414486|FG000|Phase A|Physician Decision|10|||
164285444|NCT01052077|593414487|FG001|Phase A|Physician Decision|0|||
164285445|NCT01052077|593414488|FG002|Phase A|Physician Decision|0|||
164285446|NCT01052077|593414489|FG003|Phase A|Physician Decision|0|||
164285447|NCT01052077|593414486|FG000|Phase A|Withdrawal by Subject|29|||
164285448|NCT01052077|593414487|FG001|Phase A|Withdrawal by Subject|0|||
164285449|NCT01052077|593414488|FG002|Phase A|Withdrawal by Subject|0|||
164285450|NCT01052077|593414489|FG003|Phase A|Withdrawal by Subject|0|||
164285451|NCT01052077|593414486|FG000|Phase A|Protocol Deviation|27|||
164285452|NCT01052077|593414487|FG001|Phase A|Protocol Deviation|0|||
164285453|NCT01052077|593414488|FG002|Phase A|Protocol Deviation|0|||
164285454|NCT01052077|593414489|FG003|Phase A|Protocol Deviation|0|||
164285455|NCT01052077|593414486|FG000|Phase B|Lost to Follow-up|0|||
164285456|NCT01052077|593414487|FG001|Phase B|Lost to Follow-up|2|||
164285457|NCT01052077|593414488|FG002|Phase B|Lost to Follow-up|3|||
164285458|NCT01052077|593414489|FG003|Phase B|Lost to Follow-up|0|||
164285459|NCT01052077|593414486|FG000|Phase B|Adverse Event|0|||
164285460|NCT01052077|593414487|FG001|Phase B|Adverse Event|9|||
164285461|NCT01052077|593414488|FG002|Phase B|Adverse Event|2|||
164285462|NCT01052077|593414489|FG003|Phase B|Adverse Event|0|||
164285463|NCT01052077|593414486|FG000|Phase B|Met Withdrawal Criteria|0|||
164285464|NCT01052077|593414487|FG001|Phase B|Met Withdrawal Criteria|2|||
164285465|NCT01052077|593414488|FG002|Phase B|Met Withdrawal Criteria|1|||
164285466|NCT01052077|593414489|FG003|Phase B|Met Withdrawal Criteria|0|||
164285467|NCT01052077|593414486|FG000|Phase B|Physician Decision|0|||
164285468|NCT01052077|593414487|FG001|Phase B|Physician Decision|1|||
164285469|NCT01052077|593414488|FG002|Phase B|Physician Decision|1|||
164285470|NCT01052077|593414489|FG003|Phase B|Physician Decision|0|||
164344856|NCT00705484|593638861|FG000|Overall Study|Lost to Follow-up|169|||
164344857|NCT00705484|593638862|FG001|Overall Study|Lost to Follow-up|250|||
164344858|NCT00705484|593638861|FG000|Overall Study|Withdrawal by Subject|96|||
164087774|NCT00814320|592685774|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
164087775|NCT00814320|592685775|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
164087776|NCT00814320|592685774|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
164087777|NCT00814320|592685775|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
164087778|NCT00619385|592685776|FG000|Overall Study|Adverse Event|0|||
164087779|NCT00619385|592685777|FG001|Overall Study|Adverse Event|0|||
164087780|NCT00619385|592685778|FG002|Overall Study|Adverse Event|3|||
164087781|NCT00619385|592685776|FG000|Overall Study|Other|1|||
164087782|NCT00619385|592685777|FG001|Overall Study|Other|2|||
164087783|NCT00619385|592685778|FG002|Overall Study|Other|1|||
164087784|NCT00656019|592685782|FG000|Overall Study|Not Eligible|10|||
164087785|NCT00656019|592685783|FG001|Overall Study|Not Eligible|0|||
164087786|NCT00656019|592685784|FG002|Overall Study|Not Eligible|0|||
164087787|NCT00656019|592685785|FG003|Overall Study|Not Eligible|0|||
164087788|NCT00656019|592685782|FG000|Overall Study|Withdrawal by Subject|2|||
164087789|NCT00656019|592685783|FG001|Overall Study|Withdrawal by Subject|0|||
164087790|NCT00656019|592685784|FG002|Overall Study|Withdrawal by Subject|0|||
164087791|NCT00656019|592685785|FG003|Overall Study|Withdrawal by Subject|0|||
164087792|NCT00656019|592685782|FG000|Overall Study|Lost to Follow-up|2|||
164087793|NCT00656019|592685783|FG001|Overall Study|Lost to Follow-up|1|||
164087794|NCT00656019|592685784|FG002|Overall Study|Lost to Follow-up|0|||
164344859|NCT00705484|593638862|FG001|Overall Study|Withdrawal by Subject|72|||
164344860|NCT00705484|593638861|FG000|Overall Study|Administrative|89|||
164344861|NCT00705484|593638862|FG001|Overall Study|Administrative|59|||
164344862|NCT01606007|593638863|FG000|Overall Study|Reason 'Other' in the protocol|0|||
164344863|NCT01606007|593638864|FG001|Overall Study|Reason 'Other' in the protocol|1|||
164344864|NCT01606007|593638865|FG002|Overall Study|Reason 'Other' in the protocol|1|||
164344865|NCT01606007|593638863|FG000|Overall Study|Pregnancy|0|||
164344866|NCT01606007|593638864|FG001|Overall Study|Pregnancy|1|||
164344867|NCT01606007|593638865|FG002|Overall Study|Pregnancy|1|||
163897591|NCT04940624|591997908|FG000|Overall Study|Adverse Event|4|||
164087795|NCT00656019|592685785|FG003|Overall Study|Lost to Follow-up|0|||
164087796|NCT01488578|592685786|FG000|Overall Study|Protocol Violation|1836|||
164087797|NCT05550532|592685791|FG000|Overall Study|Withdrawal by Subject|8|||
164285471|NCT01052077|593414486|FG000|Phase B|Withdrawal by Subject|0|||
164285472|NCT01052077|593414487|FG001|Phase B|Withdrawal by Subject|0|||
164285473|NCT01052077|593414488|FG002|Phase B|Withdrawal by Subject|5|||
164285474|NCT01052077|593414489|FG003|Phase B|Withdrawal by Subject|0|||
164344868|NCT01606007|593638863|FG000|Overall Study|Withdrawal by Subject|8|||
164344869|NCT01606007|593638864|FG001|Overall Study|Withdrawal by Subject|6|||
164087798|NCT05550532|592685792|FG001|Overall Study|Withdrawal by Subject|3|||
164087799|NCT05550532|592685791|FG000|Overall Study|Adverse Event|2|||
164087800|NCT05550532|592685792|FG001|Overall Study|Adverse Event|3|||
164087801|NCT05550532|592685791|FG000|Overall Study|Lost to Follow-up|4|||
164087802|NCT05550532|592685792|FG001|Overall Study|Lost to Follow-up|0|||
164087803|NCT05550532|592685791|FG000|Overall Study|Other|0|||
164285475|NCT01052077|593414486|FG000|Phase B|Protocol Deviation|0|||
164285476|NCT01052077|593414487|FG001|Phase B|Protocol Deviation|3|||
164285477|NCT01052077|593414488|FG002|Phase B|Protocol Deviation|4|||
164285478|NCT01052077|593414489|FG003|Phase B|Protocol Deviation|0|||
164285479|NCT01052077|593414486|FG000|Phase B|Lack of Efficacy|0|||
164285480|NCT01052077|593414487|FG001|Phase B|Lack of Efficacy|1|||
164285481|NCT01052077|593414488|FG002|Phase B|Lack of Efficacy|0|||
164285482|NCT01052077|593414489|FG003|Phase B|Lack of Efficacy|0|||
164285483|NCT01052077|593414486|FG000|Phase A+|Lost to Follow-up|0|||
164285484|NCT01052077|593414487|FG001|Phase A+|Lost to Follow-up|0|||
164285485|NCT01052077|593414488|FG002|Phase A+|Lost to Follow-up|0|||
164285486|NCT01052077|593414489|FG003|Phase A+|Lost to Follow-up|8|||
164285487|NCT01052077|593414486|FG000|Phase A+|Adverse Event|0|||
164285488|NCT01052077|593414487|FG001|Phase A+|Adverse Event|0|||
164285489|NCT01052077|593414488|FG002|Phase A+|Adverse Event|0|||
164285490|NCT01052077|593414489|FG003|Phase A+|Adverse Event|4|||
164285491|NCT01052077|593414486|FG000|Phase A+|Met Withdrawal Criteria|0|||
164285492|NCT01052077|593414487|FG001|Phase A+|Met Withdrawal Criteria|0|||
164285493|NCT01052077|593414488|FG002|Phase A+|Met Withdrawal Criteria|0|||
164285494|NCT01052077|593414489|FG003|Phase A+|Met Withdrawal Criteria|2|||
164285495|NCT01052077|593414486|FG000|Phase A+|Withdrawal by Subject|0|||
164285496|NCT01052077|593414487|FG001|Phase A+|Withdrawal by Subject|0|||
164285497|NCT01052077|593414488|FG002|Phase A+|Withdrawal by Subject|0|||
164285498|NCT01052077|593414489|FG003|Phase A+|Withdrawal by Subject|7|||
164285499|NCT01099397|593414493|FG000|Overall Study|Lost to Follow-up|4|||
164285500|NCT01099397|593414493|FG000|Overall Study|Protocol Violation|4|||
164285501|NCT01099397|593414493|FG000|Overall Study|Withdrawal by Subject|5|||
164285502|NCT00950248|593414494|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
164285503|NCT00950248|593414495|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
164285504|NCT00950248|593414496|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
164285505|NCT00950248|593414494|FG000|Year 1: Baseline|worsening of symptoms|2|||
164285506|NCT00950248|593414495|FG001|Year 1: Baseline|worsening of symptoms|0|||
164285507|NCT00950248|593414496|FG002|Year 1: Baseline|worsening of symptoms|0|||
164285508|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
164285509|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
164285510|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
164285511|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
164285512|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
164285513|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
164285514|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|Death|0|||
164285515|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|Death|0|||
164285516|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|Death|1|||
164285517|NCT00950248|593414494|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
164285518|NCT00950248|593414495|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
164285519|NCT00950248|593414496|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
164285520|NCT00650845|593414500|FG000|Overall Study|Withdrawal by Subject|5|||
164285521|NCT00650845|593414501|FG001|Overall Study|Withdrawal by Subject|0|||
164003813|NCT04283461|592378189|FG011|Overall Study|Enrolled in separate trial|7|||
164003814|NCT04283461|592378190|FG012|Overall Study|Enrolled in separate trial|0|||
164285522|NCT00650845|593414500|FG000|Overall Study|Protocol Violation|0|||
164285523|NCT00650845|593414501|FG001|Overall Study|Protocol Violation|13|||
164285524|NCT01594931|593416239|FG000|Overall Study|Adverse Event|3|||
164285525|NCT01594931|593416240|FG001|Overall Study|Adverse Event|1|||
164285526|NCT01594931|593416241|FG002|Overall Study|Adverse Event|1|||
164285527|NCT01594931|593416239|FG000|Overall Study|Withdrawal by Subject|2|||
164285528|NCT01594931|593416240|FG001|Overall Study|Withdrawal by Subject|1|||
164285529|NCT01594931|593416241|FG002|Overall Study|Withdrawal by Subject|1|||
164285530|NCT01594931|593416239|FG000|Overall Study|Lack of Efficacy|7|||
164285531|NCT01594931|593416240|FG001|Overall Study|Lack of Efficacy|2|||
164285532|NCT01594931|593416241|FG002|Overall Study|Lack of Efficacy|2|||
164285533|NCT01594931|593416239|FG000|Overall Study|Lost to Follow-up|4|||
164285534|NCT01594931|593416240|FG001|Overall Study|Lost to Follow-up|3|||
164285535|NCT01594931|593416241|FG002|Overall Study|Lost to Follow-up|3|||
164285536|NCT01594931|593416239|FG000|Overall Study|Protocol Violation|2|||
164285537|NCT01594931|593416240|FG001|Overall Study|Protocol Violation|1|||
164285538|NCT01594931|593416241|FG002|Overall Study|Protocol Violation|0|||
164285539|NCT01594931|593416239|FG000|Overall Study|No defiined|11|||
164285540|NCT01594931|593416240|FG001|Overall Study|No defiined|4|||
164285541|NCT01594931|593416241|FG002|Overall Study|No defiined|7|||
164285542|NCT01929226|593416246|FG000|Overall Study|Lost to Follow-up|4|||
164285543|NCT01929226|593416247|FG001|Overall Study|Lost to Follow-up|0|||
164285544|NCT01929226|593416246|FG000|Overall Study|Withdrawal by Subject|1|||
164285545|NCT01929226|593416247|FG001|Overall Study|Withdrawal by Subject|1|||
164285546|NCT01525615|593416248|FG000|Overall Study|Adverse Event|11|||
164285547|NCT01525615|593416249|FG001|Overall Study|Adverse Event|7|||
164285548|NCT01525615|593416250|FG002|Overall Study|Adverse Event|5|||
164285549|NCT01525615|593416248|FG000|Overall Study|Lost to Follow-up|1|||
164285550|NCT01525615|593416249|FG001|Overall Study|Lost to Follow-up|0|||
164285551|NCT01525615|593416250|FG002|Overall Study|Lost to Follow-up|0|||
164285552|NCT01525615|593416248|FG000|Overall Study|Withdrawal by Subject|1|||
164285553|NCT01525615|593416249|FG001|Overall Study|Withdrawal by Subject|0|||
164285554|NCT01525615|593416250|FG002|Overall Study|Withdrawal by Subject|0|||
164285555|NCT01525615|593416248|FG000|Overall Study|Other reason not described above|1|||
164285556|NCT01525615|593416249|FG001|Overall Study|Other reason not described above|0|||
164285557|NCT01525615|593416250|FG002|Overall Study|Other reason not described above|1|||
164285558|NCT01473732|593416251|FG000|Overall Study|Adverse Event|1|||
164285559|NCT01473732|593416252|FG001|Overall Study|Adverse Event|0|||
164285560|NCT01473732|593416251|FG000|Overall Study|Death|1|||
164285561|NCT01473732|593416252|FG001|Overall Study|Death|0|||
164285562|NCT04473963|593416272|FG000|Overall Study|Withdrawal by Subject|1|||
164285563|NCT04473963|593416273|FG001|Overall Study|Withdrawal by Subject|1|||
164285564|NCT04473963|593416274|FG002|Overall Study|Withdrawal by Subject|0|||
164285565|NCT04473963|593416272|FG000|Overall Study|Not inducible in AF|0|||
164285566|NCT04473963|593416273|FG001|Overall Study|Not inducible in AF|0|||
164285567|NCT04473963|593416274|FG002|Overall Study|Not inducible in AF|2|||
164285568|NCT04685798|593416275|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
164285569|NCT00592904|593416278|FG000|Overall Study|Adverse Event|15|||
164285570|NCT00592904|593416279|FG001|Overall Study|Adverse Event|25|||
164285571|NCT00592904|593416280|FG002|Overall Study|Adverse Event|13|||
164285572|NCT00592904|593416281|FG003|Overall Study|Adverse Event|5|||
164285573|NCT00592904|593416278|FG000|Overall Study|Protocol Violation|1|||
164285574|NCT00592904|593416279|FG001|Overall Study|Protocol Violation|1|||
164285575|NCT00592904|593416280|FG002|Overall Study|Protocol Violation|0|||
164285576|NCT00592904|593416281|FG003|Overall Study|Protocol Violation|1|||
164285577|NCT00592904|593416278|FG000|Overall Study|Withdrawal by Subject|4|||
164285578|NCT00592904|593416279|FG001|Overall Study|Withdrawal by Subject|16|||
164285579|NCT00592904|593416280|FG002|Overall Study|Withdrawal by Subject|1|||
164285580|NCT00592904|593416281|FG003|Overall Study|Withdrawal by Subject|2|||
164285581|NCT00592904|593416278|FG000|Overall Study|Lack of Efficacy|2|||
164285582|NCT00592904|593416279|FG001|Overall Study|Lack of Efficacy|7|||
164285583|NCT00592904|593416280|FG002|Overall Study|Lack of Efficacy|2|||
164285584|NCT00592904|593416281|FG003|Overall Study|Lack of Efficacy|3|||
164285585|NCT00592904|593416278|FG000|Overall Study|Physician Decision|0|||
164285586|NCT00592904|593416279|FG001|Overall Study|Physician Decision|3|||
164285587|NCT00592904|593416280|FG002|Overall Study|Physician Decision|1|||
164285588|NCT00592904|593416281|FG003|Overall Study|Physician Decision|0|||
164285589|NCT00592904|593416278|FG000|Overall Study|Other|3|||
164285590|NCT00592904|593416279|FG001|Overall Study|Other|3|||
164285591|NCT00592904|593416280|FG002|Overall Study|Other|0|||
164285592|NCT00592904|593416281|FG003|Overall Study|Other|0|||
164285593|NCT03018691|593416284|FG000|Overall Study|Adverse Event|1|||
164285594|NCT03018691|593416285|FG001|Overall Study|Adverse Event|1|||
164285595|NCT03018691|593416286|FG002|Overall Study|Adverse Event|4|||
164285596|NCT03018691|593416284|FG000|Overall Study|Lack of Efficacy|0|||
164285597|NCT03018691|593416285|FG001|Overall Study|Lack of Efficacy|0|||
164285598|NCT03018691|593416286|FG002|Overall Study|Lack of Efficacy|1|||
164285599|NCT03018691|593416284|FG000|Overall Study|Withdrawal by Subject|0|||
164285600|NCT03018691|593416285|FG001|Overall Study|Withdrawal by Subject|0|||
164285601|NCT03018691|593416286|FG002|Overall Study|Withdrawal by Subject|1|||
164285602|NCT03018691|593416284|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164285603|NCT03018691|593416285|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164285604|NCT03018691|593416286|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164285605|NCT03369418|593416287|FG000|Overall Study|Withdrawal by Subject|3|||
164285606|NCT03369418|593416288|FG001|Overall Study|Withdrawal by Subject|3|||
164285607|NCT02859246|593416289|FG000|Overall Study|Screen fails|3|||
164285608|NCT02859246|593416289|FG000|Overall Study|Adverse Event|1|||
164285609|NCT02859246|593416289|FG000|Overall Study|Withdrawal by Subject|1|||
164285610|NCT00740584|593416290|FG000|Overall Study|Withdrawal by Subject|1|||
164285611|NCT01461707|593416291|FG000|Overall Study|Withdrawal by Subject|1|||
164285612|NCT01461707|593416292|FG001|Overall Study|Withdrawal by Subject|0|||
164285613|NCT00855816|593416293|FG000|Overall Study|Withdrawal by Subject|22|||
164285614|NCT00855816|593416294|FG001|Overall Study|Withdrawal by Subject|15|||
164285615|NCT00855816|593416293|FG000|Overall Study|Lost to Follow-up|3|||
164344870|NCT01606007|593638865|FG002|Overall Study|Withdrawal by Subject|1|||
164344871|NCT01606007|593638863|FG000|Overall Study|Adverse Event|0|||
164344872|NCT01606007|593638864|FG001|Overall Study|Adverse Event|1|||
164344873|NCT01606007|593638865|FG002|Overall Study|Adverse Event|1|||
164285616|NCT00855816|593416294|FG001|Overall Study|Lost to Follow-up|5|||
164285617|NCT00855816|593416293|FG000|Overall Study|Death|1|||
164285618|NCT00855816|593416294|FG001|Overall Study|Death|0|||
164285619|NCT00855816|593416293|FG000|Overall Study|Became ineligible|0|||
164285620|NCT00855816|593416294|FG001|Overall Study|Became ineligible|1|||
164344874|NCT01606007|593638863|FG000|Overall Study|discontinue study treatment|0|||
164285621|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
164285622|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
164285623|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
164285624|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
164285625|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
164285626|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
164285627|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
164285628|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
164285629|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
164285630|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
164285631|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
164285632|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
164285633|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
164285634|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
164285635|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
164285636|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
164285637|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
164285638|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
164285639|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
164285640|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
164285641|NCT03573323|593416301|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
164285642|NCT03573323|593416302|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
164285643|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
164285644|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
164285645|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
164285646|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
164285647|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
164285648|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
164285649|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
164285650|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
164285651|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
164285652|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
164285653|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
164285654|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
164285655|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
164285656|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
164285657|NCT03573323|593416301|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
164285658|NCT03573323|593416302|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
164285659|NCT03188432|593416303|FG000|Overall Study|Death|3|||
164285660|NCT03188432|593416303|FG000|Overall Study|Withdrawal by Subject|15|||
164285661|NCT03188432|593416303|FG000|Overall Study|Did not complete protocol treatment|9|||
164285662|NCT01196026|593416309|FG000|Overall Study|Withdrawal by Subject|1|||
164285663|NCT01196026|593416310|FG001|Overall Study|Withdrawal by Subject|4|||
164285664|NCT01196026|593416311|FG002|Overall Study|Withdrawal by Subject|0|||
164285665|NCT01196026|593416312|FG003|Overall Study|Withdrawal by Subject|0|||
164285666|NCT01196026|593416313|FG004|Overall Study|Withdrawal by Subject|0|||
164285667|NCT01196026|593416314|FG005|Overall Study|Withdrawal by Subject|0|||
164285668|NCT01196026|593416309|FG000|Overall Study|Lost to Follow-up|0|||
164285669|NCT01196026|593416310|FG001|Overall Study|Lost to Follow-up|3|||
164285670|NCT01196026|593416311|FG002|Overall Study|Lost to Follow-up|0|||
164285671|NCT01196026|593416312|FG003|Overall Study|Lost to Follow-up|0|||
164285672|NCT01196026|593416313|FG004|Overall Study|Lost to Follow-up|1|||
164285673|NCT01196026|593416314|FG005|Overall Study|Lost to Follow-up|0|||
164285674|NCT01196026|593416309|FG000|Overall Study|Other|0|||
164285675|NCT01196026|593416310|FG001|Overall Study|Other|1|||
164285676|NCT01196026|593416311|FG002|Overall Study|Other|0|||
164285677|NCT01196026|593416312|FG003|Overall Study|Other|0|||
164285678|NCT01196026|593416313|FG004|Overall Study|Other|0|||
164285679|NCT01196026|593416314|FG005|Overall Study|Other|0|||
164285680|NCT02336230|593416325|FG000|Overall Study|Adverse Event|1|||
164285681|NCT02336230|593416325|FG000|Overall Study|Withdrawal of consent|1|||
164285682|NCT02336230|593416325|FG000|Overall Study|Death|9|||
164285683|NCT02336230|593416325|FG000|Overall Study|Dose not received due to shipping delay|1|||
164285684|NCT02336230|593416325|FG000|Overall Study|Discontinuation of MSC infusion|1|||
164285685|NCT01620086|593416332|FG000|Overall Study|Withdrawal by Subject|3|||
164285686|NCT01620086|593416333|FG001|Overall Study|Withdrawal by Subject|3|||
164285687|NCT01620086|593416334|FG002|Overall Study|Withdrawal by Subject|0|||
164285688|NCT01620086|593416332|FG000|Overall Study|failed study criteria|1|||
164285689|NCT01620086|593416333|FG001|Overall Study|failed study criteria|4|||
163897592|NCT04940624|591997909|FG001|Overall Study|Adverse Event|11|||
163897593|NCT04940624|591997908|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163897594|NCT04940624|591997909|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
163897595|NCT04940624|591997908|FG000|Overall Study|Physician Decision|1|||
164285690|NCT01620086|593416334|FG002|Overall Study|failed study criteria|0|||
164285691|NCT01620086|593416332|FG000|Overall Study|Physician Decision|1|||
164285692|NCT01620086|593416333|FG001|Overall Study|Physician Decision|0|||
164285693|NCT01620086|593416334|FG002|Overall Study|Physician Decision|0|||
164285694|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Progressive disease|50|||
164285695|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Progressive disease|110|||
164285696|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Progressive disease|0|||
164285697|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Progressive disease|0|||
164285698|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
164285699|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
164285700|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164285701|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164285702|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Adverse Event|7|||
164285703|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Adverse Event|7|||
164285704|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Adverse Event|0|||
164285705|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Adverse Event|0|||
164285706|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Other|1|||
164285707|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Other|3|||
164285708|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Other|0|||
164285709|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Other|0|||
164285710|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Physician Decision|6|||
164285711|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Physician Decision|3|||
164285712|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Physician Decision|0|||
164285713|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Physician Decision|0|||
164285714|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Death|1|||
164285715|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Death|1|||
164285716|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Death|0|||
164285717|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Death|0|||
164285718|NCT01695135|593416335|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
164285719|NCT01695135|593416336|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
164285720|NCT01695135|593416337|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
164285721|NCT01695135|593416338|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
164285722|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
164285723|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
164285724|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
164285725|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
164285726|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
164285727|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
164285728|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
163897596|NCT04940624|591997909|FG001|Overall Study|Physician Decision|0|||
163897597|NCT04940624|591997908|FG000|Overall Study|Lost to Follow-up|1|||
163897598|NCT04940624|591997909|FG001|Overall Study|Lost to Follow-up|0|||
163897599|NCT04940624|591997908|FG000|Overall Study|Reason Not Specified|1|||
163897600|NCT04940624|591997909|FG001|Overall Study|Reason Not Specified|0|||
163897601|NCT04479787|591997910|FG000|Through 6 Months|Withdrawal by Subject|16|||
163897602|NCT04479787|591997911|FG001|Through 6 Months|Withdrawal by Subject|14|||
164285729|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
164285730|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
164285731|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
163897603|NCT04479787|591997910|FG000|Through 6 Months|Unsuccessful Trial|17|||
163897604|NCT04479787|591997911|FG001|Through 6 Months|Unsuccessful Trial|0|||
163897605|NCT04479787|591997910|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
163897606|NCT04479787|591997911|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
163897607|NCT04479787|591997910|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
163897608|NCT04479787|591997911|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
163897609|NCT04479787|591997910|FG000|Through 6 Months|Lost to Follow-up|3|||
163897610|NCT04479787|591997911|FG001|Through 6 Months|Lost to Follow-up|2|||
163897611|NCT04479787|591997910|FG000|Through 6 Months|Death|3|||
163897612|NCT04479787|591997911|FG001|Through 6 Months|Death|0|||
163897613|NCT04479787|591997910|FG000|Through 6 Months|Inclusion/Exclusion|2|||
163897614|NCT04479787|591997911|FG001|Through 6 Months|Inclusion/Exclusion|1|||
163897615|NCT04479787|591997910|FG000|Through 6 Months|Subject Became Pregnant|1|||
163897616|NCT04479787|591997911|FG001|Through 6 Months|Subject Became Pregnant|1|||
163897617|NCT04479787|591997910|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
163897618|NCT04479787|591997911|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
163897619|NCT04479787|591997910|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
163897620|NCT04479787|591997911|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
163897621|NCT04479787|591997910|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
163897622|NCT04479787|591997911|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
163897623|NCT04479787|591997910|FG000|After 6 Months|Withdrawal by Subject|3|||
163897624|NCT04479787|591997911|FG001|After 6 Months|Withdrawal by Subject|13|||
163897625|NCT04479787|591997910|FG000|After 6 Months|Unsuccessful Trial|0|||
163897626|NCT04479787|591997911|FG001|After 6 Months|Unsuccessful Trial|7|||
163897627|NCT04479787|591997910|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
163897628|NCT04479787|591997911|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
163897629|NCT04479787|591997910|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
163897630|NCT04479787|591997911|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
163897631|NCT04479787|591997910|FG000|After 6 Months|Death|2|||
163897632|NCT04479787|591997911|FG001|After 6 Months|Death|0|||
163897633|NCT04479787|591997910|FG000|After 6 Months|Lost to Follow-up|1|||
164003815|NCT05490771|592378191|FG000|Overall Study|Disease progression|18|||
164003816|NCT05490771|592378191|FG000|Overall Study|Adverse Event|3|||
164003817|NCT05490771|592378191|FG000|Overall Study|Other complicating disease|1|||
164285732|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
164285733|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
164285734|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Other|0|||
164285735|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Other|0|||
164285736|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Other|4|||
164285737|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Other|7|||
164285738|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
164285739|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
164285740|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
164285741|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
164285742|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Death|0|||
164285743|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Death|0|||
164285744|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Death|2|||
164285745|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Death|7|||
164285746|NCT01695135|593416335|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
164285747|NCT01695135|593416336|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
164285748|NCT01695135|593416337|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
164285749|NCT01695135|593416338|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
164285750|NCT00580723|593416344|FG000|Overall Study|Did not want to participate in extension|3|||
164285751|NCT00580723|593416344|FG000|Overall Study|Lost to Follow-up|5|||
164285752|NCT01078441|593416349|FG000|Overall Study|Withdrawal by Subject|1|||
164285753|NCT00216671|593416350|FG000|Overall Study|Adverse Event|4|||
164285754|NCT00216671|593416351|FG001|Overall Study|Adverse Event|9|||
164285755|NCT00216671|593416350|FG000|Overall Study|Pregnancy|0|||
164285756|NCT00216671|593416351|FG001|Overall Study|Pregnancy|1|||
164344875|NCT01606007|593638864|FG001|Overall Study|discontinue study treatment|2|||
164344876|NCT01606007|593638865|FG002|Overall Study|discontinue study treatment|1|||
164344877|NCT01606007|593638863|FG000|Overall Study|Lost to Follow-up|6|||
164344878|NCT01606007|593638864|FG001|Overall Study|Lost to Follow-up|8|||
164344879|NCT01606007|593638865|FG002|Overall Study|Lost to Follow-up|5|||
164344880|NCT01606007|593638863|FG000|Overall Study|Poor/Non-compliance|1|||
164344881|NCT01606007|593638864|FG001|Overall Study|Poor/Non-compliance|0|||
164344882|NCT01606007|593638865|FG002|Overall Study|Poor/Non-compliance|0|||
164344883|NCT00851747|593638866|FG000|Overall Study|Physician Decision|6|||
164344884|NCT00851747|593638867|FG001|Overall Study|Physician Decision|6|||
164344885|NCT00851747|593638868|FG002|Overall Study|Physician Decision|6|||
164344886|NCT02499783|593638871|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
164344887|NCT02499783|593638872|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
164344888|NCT02499783|593638873|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
164344889|NCT02499783|593638871|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
164344890|NCT02499783|593638872|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
164344891|NCT02499783|593638873|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
164344892|NCT02499783|593638871|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
164344893|NCT02499783|593638872|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
164344894|NCT02499783|593638873|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
164344895|NCT02499783|593638871|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
164344896|NCT02499783|593638872|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
164344897|NCT02499783|593638873|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
164344898|NCT02499783|593638871|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
164344899|NCT02499783|593638872|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
164344900|NCT02499783|593638873|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
163897634|NCT04479787|591997911|FG001|After 6 Months|Lost to Follow-up|1|||
164003818|NCT05490771|592378191|FG000|Overall Study|Withdrawal by Subject|3|||
164344901|NCT02499783|593638871|FG000|DB Period: Weeks 0-8|Other|1|||
164344902|NCT02499783|593638872|FG001|DB Period: Weeks 0-8|Other|1|||
164344903|NCT02499783|593638873|FG002|DB Period: Weeks 0-8|Other|0|||
164344904|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
163897635|NCT04479787|591997910|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
164285757|NCT00216671|593416350|FG000|Overall Study|Withdrawal by Subject|4|||
164285758|NCT00216671|593416351|FG001|Overall Study|Withdrawal by Subject|2|||
164285759|NCT00216671|593416350|FG000|Overall Study|Refused Injections|3|||
164285760|NCT00216671|593416351|FG001|Overall Study|Refused Injections|13|||
164285761|NCT00216671|593416350|FG000|Overall Study|No Need to Continue Medication|1|||
164285762|NCT00216671|593416351|FG001|Overall Study|No Need to Continue Medication|1|||
164285763|NCT00216671|593416350|FG000|Overall Study|Insufficient Response|9|||
164285764|NCT00216671|593416351|FG001|Overall Study|Insufficient Response|4|||
164285765|NCT00216671|593416350|FG000|Overall Study|Lost to Follow-up|3|||
164285766|NCT00216671|593416351|FG001|Overall Study|Lost to Follow-up|5|||
164285767|NCT00216671|593416350|FG000|Overall Study|Non compliant|2|||
164285768|NCT00216671|593416351|FG001|Overall Study|Non compliant|2|||
164285769|NCT00216671|593416350|FG000|Overall Study|Ineligible|0|||
164285770|NCT00216671|593416351|FG001|Overall Study|Ineligible|2|||
164285771|NCT00216671|593416350|FG000|Overall Study|Physician Decision|1|||
164285772|NCT00216671|593416351|FG001|Overall Study|Physician Decision|1|||
164285773|NCT00216671|593416350|FG000|Overall Study|Protocol Violation|3|||
164285774|NCT00216671|593416351|FG001|Overall Study|Protocol Violation|5|||
164285775|NCT00216671|593416350|FG000|Overall Study|Relapse|1|||
164285776|NCT00216671|593416351|FG001|Overall Study|Relapse|0|||
164285777|NCT00216671|593416350|FG000|Overall Study|Investigator Illness|0|||
164285778|NCT00216671|593416351|FG001|Overall Study|Investigator Illness|1|||
164285779|NCT00216671|593416350|FG000|Overall Study|Patient Moved|0|||
164285780|NCT00216671|593416351|FG001|Overall Study|Patient Moved|1|||
164285781|NCT00216671|593416350|FG000|Overall Study|Ineligible, no efficacy data|2|||
164285782|NCT00216671|593416351|FG001|Overall Study|Ineligible, no efficacy data|2|||
164285783|NCT00216671|593416350|FG000|Overall Study|Insufficient Response Adverse Event|2|||
164285784|NCT00216671|593416351|FG001|Overall Study|Insufficient Response Adverse Event|1|||
164285785|NCT02714569|593416352|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
164285786|NCT02714569|593416353|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
164285787|NCT02714569|593416354|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
164285788|NCT02714569|593416355|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
164285789|NCT02714569|593416356|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
164285790|NCT02714569|593416357|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
164285791|NCT02714569|593416358|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
164285792|NCT02714569|593416359|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
164285793|NCT02714569|593416360|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
164285794|NCT02714569|593416361|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
164285795|NCT02714569|593416362|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
164285796|NCT02714569|593416352|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285797|NCT02714569|593416353|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285798|NCT02714569|593416354|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285799|NCT02714569|593416355|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
164285800|NCT02714569|593416356|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285801|NCT02714569|593416357|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285802|NCT02714569|593416358|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285803|NCT02714569|593416359|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285804|NCT02714569|593416360|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285805|NCT02714569|593416361|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285806|NCT02714569|593416362|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
164285807|NCT02714569|593416352|FG000|Part A Third Intervention|Adverse Event|0|||
164285808|NCT02714569|593416353|FG001|Part A Third Intervention|Adverse Event|0|||
164285809|NCT02714569|593416354|FG002|Part A Third Intervention|Adverse Event|1|||
164285810|NCT02714569|593416355|FG003|Part A Third Intervention|Adverse Event|0|||
164285811|NCT02714569|593416356|FG004|Part A Third Intervention|Adverse Event|0|||
164285812|NCT02714569|593416357|FG005|Part A Third Intervention|Adverse Event|0|||
164285813|NCT02714569|593416358|FG006|Part A Third Intervention|Adverse Event|0|||
164285814|NCT02714569|593416359|FG007|Part A Third Intervention|Adverse Event|0|||
164285815|NCT02714569|593416360|FG008|Part A Third Intervention|Adverse Event|0|||
164285816|NCT02714569|593416361|FG009|Part A Third Intervention|Adverse Event|0|||
164285817|NCT02714569|593416362|FG010|Part A Third Intervention|Adverse Event|0|||
164285818|NCT02714569|593416352|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
164285819|NCT02714569|593416353|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285820|NCT02714569|593416354|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285821|NCT02714569|593416355|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285822|NCT02714569|593416356|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285823|NCT02714569|593416357|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
164285824|NCT02714569|593416358|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285825|NCT02714569|593416359|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285826|NCT02714569|593416360|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285827|NCT02714569|593416361|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285828|NCT02714569|593416362|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
164285829|NCT02714569|593416352|FG000|Part B (Overall)|Lost to Follow-up|0|||
164285830|NCT02714569|593416353|FG001|Part B (Overall)|Lost to Follow-up|0|||
164285831|NCT02714569|593416354|FG002|Part B (Overall)|Lost to Follow-up|0|||
164285832|NCT02714569|593416355|FG003|Part B (Overall)|Lost to Follow-up|0|||
164285833|NCT02714569|593416356|FG004|Part B (Overall)|Lost to Follow-up|0|||
164285834|NCT02714569|593416357|FG005|Part B (Overall)|Lost to Follow-up|0|||
164285835|NCT02714569|593416358|FG006|Part B (Overall)|Lost to Follow-up|1|||
164285836|NCT02714569|593416359|FG007|Part B (Overall)|Lost to Follow-up|0|||
164285837|NCT02714569|593416360|FG008|Part B (Overall)|Lost to Follow-up|0|||
164285838|NCT02714569|593416361|FG009|Part B (Overall)|Lost to Follow-up|0|||
164285839|NCT02714569|593416362|FG010|Part B (Overall)|Lost to Follow-up|0|||
164285840|NCT02714569|593416352|FG000|Part B (Overall)|Withdrawal by Subject|0|||
164285841|NCT02714569|593416353|FG001|Part B (Overall)|Withdrawal by Subject|0|||
164285842|NCT02714569|593416354|FG002|Part B (Overall)|Withdrawal by Subject|0|||
164285843|NCT02714569|593416355|FG003|Part B (Overall)|Withdrawal by Subject|0|||
164285844|NCT02714569|593416356|FG004|Part B (Overall)|Withdrawal by Subject|0|||
164285845|NCT02714569|593416357|FG005|Part B (Overall)|Withdrawal by Subject|0|||
164285846|NCT02714569|593416358|FG006|Part B (Overall)|Withdrawal by Subject|0|||
164285847|NCT02714569|593416359|FG007|Part B (Overall)|Withdrawal by Subject|1|||
164285848|NCT02714569|593416360|FG008|Part B (Overall)|Withdrawal by Subject|0|||
164003819|NCT05490771|592378191|FG000|Overall Study|Physician Decision|1|||
164003820|NCT05490771|592378191|FG000|Overall Study|Still on treatment|2|||
164003821|NCT05490771|592378191|FG000|Overall Study|Never start protocol therapy|5|||
164003822|NCT05490771|592378191|FG000|Overall Study|Ineligible|2|||
164003823|NCT00424398|592378197|FG000|Overall Study|Withdrawal by Subject|2|||
164003824|NCT00424398|592378198|FG001|Overall Study|Withdrawal by Subject|1|||
164003825|NCT00424398|592378199|FG002|Overall Study|Withdrawal by Subject|0|||
164003826|NCT00424398|592378197|FG000|Overall Study|Subject met exclusion criteria|1|||
164003827|NCT00424398|592378198|FG001|Overall Study|Subject met exclusion criteria|0|||
164003828|NCT00424398|592378199|FG002|Overall Study|Subject met exclusion criteria|0|||
164003829|NCT01023789|592378200|FG000|3 - Year Visit|Death|29|||
164003830|NCT01023789|592378200|FG000|3 - Year Visit|Withdrawal of consent|1|||
164003831|NCT01023789|592378200|FG000|3 - Year Visit|Lost to Follow-up|13|||
164003832|NCT02115308|592378211|FG000|Overall Study|Safety Screening|2|||
164003833|NCT02115308|592378212|FG001|Overall Study|Safety Screening|2|||
164003834|NCT01309737|592378213|FG000|Week 0 to 16|Death|1|||
164003835|NCT01309737|592378214|FG001|Week 0 to 16|Death|0|||
164003836|NCT01309737|592378215|FG002|Week 0 to 16|Death|1|||
164003837|NCT01309737|592378216|FG003|Week 0 to 16|Death|0|||
164003838|NCT01309737|592378217|FG004|Week 0 to 16|Death|0|||
164003839|NCT01309737|592378213|FG000|Week 0 to 16|Adverse Event|11|||
164003840|NCT01309737|592378214|FG001|Week 0 to 16|Adverse Event|10|||
164003841|NCT01309737|592378215|FG002|Week 0 to 16|Adverse Event|5|||
164003842|NCT01309737|592378216|FG003|Week 0 to 16|Adverse Event|0|||
164003843|NCT01309737|592378217|FG004|Week 0 to 16|Adverse Event|0|||
164003844|NCT01309737|592378213|FG000|Week 0 to 16|Lack of Efficacy|15|||
164003845|NCT01309737|592378214|FG001|Week 0 to 16|Lack of Efficacy|2|||
164003846|NCT01309737|592378215|FG002|Week 0 to 16|Lack of Efficacy|24|||
164003847|NCT01309737|592378216|FG003|Week 0 to 16|Lack of Efficacy|0|||
164003848|NCT01309737|592378217|FG004|Week 0 to 16|Lack of Efficacy|0|||
164003849|NCT01309737|592378213|FG000|Week 0 to 16|Lost to Follow-up|7|||
164003850|NCT01309737|592378214|FG001|Week 0 to 16|Lost to Follow-up|8|||
164003851|NCT01309737|592378215|FG002|Week 0 to 16|Lost to Follow-up|3|||
164003852|NCT01309737|592378216|FG003|Week 0 to 16|Lost to Follow-up|0|||
164003853|NCT01309737|592378217|FG004|Week 0 to 16|Lost to Follow-up|0|||
164003854|NCT01309737|592378213|FG000|Week 0 to 16|Withdrawal by Subject|7|||
164003855|NCT01309737|592378214|FG001|Week 0 to 16|Withdrawal by Subject|6|||
164003856|NCT01309737|592378215|FG002|Week 0 to 16|Withdrawal by Subject|7|||
164003857|NCT01309737|592378216|FG003|Week 0 to 16|Withdrawal by Subject|0|||
164003858|NCT01309737|592378217|FG004|Week 0 to 16|Withdrawal by Subject|0|||
164003859|NCT01309737|592378213|FG000|Week 0 to 16|Other|10|||
164003860|NCT01309737|592378214|FG001|Week 0 to 16|Other|14|||
164003861|NCT01309737|592378215|FG002|Week 0 to 16|Other|4|||
164003862|NCT01309737|592378216|FG003|Week 0 to 16|Other|0|||
164003863|NCT01309737|592378217|FG004|Week 0 to 16|Other|0|||
164003864|NCT01309737|592378213|FG000|Week 0 to 16|Randomized, but not treated|1|||
164003865|NCT01309737|592378214|FG001|Week 0 to 16|Randomized, but not treated|0|||
164003866|NCT01309737|592378215|FG002|Week 0 to 16|Randomized, but not treated|0|||
164003867|NCT01309737|592378216|FG003|Week 0 to 16|Randomized, but not treated|0|||
164003868|NCT01309737|592378217|FG004|Week 0 to 16|Randomized, but not treated|0|||
164003869|NCT01309737|592378213|FG000|Week 16 to 52|Death|0|||
164003870|NCT01309737|592378214|FG001|Week 16 to 52|Death|0|||
164003871|NCT01309737|592378215|FG002|Week 16 to 52|Death|0|||
164003872|NCT01309737|592378216|FG003|Week 16 to 52|Death|0|||
164003873|NCT01309737|592378217|FG004|Week 16 to 52|Death|1|||
164003874|NCT01309737|592378213|FG000|Week 16 to 52|Adverse Event|7|||
164285849|NCT02714569|593416361|FG009|Part B (Overall)|Withdrawal by Subject|1|||
164285850|NCT02714569|593416362|FG010|Part B (Overall)|Withdrawal by Subject|0|||
164285851|NCT02714569|593416352|FG000|Part B (Overall)|Adverse Event|0|||
164285852|NCT02714569|593416353|FG001|Part B (Overall)|Adverse Event|0|||
164285853|NCT02714569|593416354|FG002|Part B (Overall)|Adverse Event|0|||
164285854|NCT02714569|593416355|FG003|Part B (Overall)|Adverse Event|0|||
164285855|NCT02714569|593416356|FG004|Part B (Overall)|Adverse Event|0|||
164285856|NCT02714569|593416357|FG005|Part B (Overall)|Adverse Event|0|||
164285857|NCT02714569|593416358|FG006|Part B (Overall)|Adverse Event|0|||
164285858|NCT02714569|593416359|FG007|Part B (Overall)|Adverse Event|0|||
164285859|NCT02714569|593416360|FG008|Part B (Overall)|Adverse Event|0|||
164285860|NCT02714569|593416361|FG009|Part B (Overall)|Adverse Event|1|||
164285861|NCT02714569|593416362|FG010|Part B (Overall)|Adverse Event|0|||
164285862|NCT01684202|593416363|FG000|Dose-escalation Period|Adverse Event|0|||
164285863|NCT01684202|593416364|FG001|Dose-escalation Period|Adverse Event|1|||
164285864|NCT01684202|593416365|FG002|Dose-escalation Period|Adverse Event|0|||
164285865|NCT01684202|593416366|FG003|Dose-escalation Period|Adverse Event|0|||
164285866|NCT01684202|593416363|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
164285867|NCT01684202|593416364|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
164285868|NCT01684202|593416365|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
164285869|NCT01684202|593416366|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
164285870|NCT01684202|593416363|FG000|Maintenance Period|Adverse Event|1|||
164344905|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
164344906|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
164344907|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
164344908|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
164344909|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
164344910|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
164344911|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
164344912|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
164344913|NCT02499783|593638871|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
164344914|NCT02499783|593638872|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
164344915|NCT02499783|593638873|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
164344916|NCT02228460|593638874|FG000|Overall Study|Adverse Event|1|||
164344917|NCT02228460|593638874|FG000|Overall Study|Lost to Follow-up|1|||
164344918|NCT01243892|593638875|FG000|Overall Study|Did not meet eligibility criteria|2|||
164344919|NCT01243892|593638876|FG001|Overall Study|Did not meet eligibility criteria|0|||
164344920|NCT00119106|593638881|FG000|Overall Study|HIV infected at baseline|179|||
164344921|NCT00119106|593638882|FG001|Overall Study|HIV infected at baseline|178|||
164344922|NCT01866293|593638883|FG000|Overall Study|Adverse Event|2|||
164344923|NCT01010061|593638884|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
164344924|NCT01010061|593638885|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
164344925|NCT01010061|593638884|FG000|Overall Study|Disease Progression|2|||
164344926|NCT01010061|593638885|FG001|Overall Study|Disease Progression|8|||
164344927|NCT01010061|593638884|FG000|Overall Study|Withdrew Consent|5|||
164344928|NCT01010061|593638885|FG001|Overall Study|Withdrew Consent|1|||
164344929|NCT01010061|593638884|FG000|Overall Study|Death|3|||
164344930|NCT01010061|593638885|FG001|Overall Study|Death|6|||
164344931|NCT01010061|593638884|FG000|Overall Study|Administrative/Other|0|||
164344932|NCT01010061|593638885|FG001|Overall Study|Administrative/Other|1|||
164344933|NCT01010061|593638884|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
164344934|NCT01010061|593638885|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
164344935|NCT01010061|593638884|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164344936|NCT01010061|593638885|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164344937|NCT01010061|593638884|FG000|Overall Study|Violation of Selection Criteria|0|||
164344938|NCT01010061|593638885|FG001|Overall Study|Violation of Selection Criteria|1|||
164344939|NCT01010061|593638884|FG000|Overall Study|Did Not Receive Treatment|2|||
164344940|NCT01010061|593638885|FG001|Overall Study|Did Not Receive Treatment|2|||
164344941|NCT03066804|593638886|FG000|Overall Study|Physician Decision|0|||
164344942|NCT03066804|593638887|FG001|Overall Study|Physician Decision|4|||
164344943|NCT03066804|593638886|FG000|Overall Study|Death|23|||
163897636|NCT04479787|591997911|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
164285871|NCT01684202|593416364|FG001|Maintenance Period|Adverse Event|1|||
164285872|NCT01684202|593416365|FG002|Maintenance Period|Adverse Event|1|||
163897637|NCT04479787|591997910|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
164285873|NCT01684202|593416366|FG003|Maintenance Period|Adverse Event|1|||
163897638|NCT04479787|591997911|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
164087804|NCT05550532|592685792|FG001|Overall Study|Other|4|||
164344944|NCT03066804|593638887|FG001|Overall Study|Death|17|||
164344945|NCT03066804|593638886|FG000|Overall Study|Withdrawal by Subject|19|||
164344946|NCT03066804|593638887|FG001|Overall Study|Withdrawal by Subject|25|||
164344947|NCT03066804|593638886|FG000|Overall Study|Lost to Follow-up|2|||
164285874|NCT01684202|593416363|FG000|Maintenance Period|Physician Decision|0|||
164285875|NCT01684202|593416364|FG001|Maintenance Period|Physician Decision|1|||
164344948|NCT03066804|593638887|FG001|Overall Study|Lost to Follow-up|0|||
164285876|NCT01684202|593416365|FG002|Maintenance Period|Physician Decision|0|||
164285877|NCT01684202|593416366|FG003|Maintenance Period|Physician Decision|0|||
164285878|NCT01684202|593416363|FG000|Maintenance Period|Withdrawal by Subject|0|||
164285879|NCT01684202|593416364|FG001|Maintenance Period|Withdrawal by Subject|1|||
164285880|NCT01684202|593416365|FG002|Maintenance Period|Withdrawal by Subject|0|||
164285881|NCT01684202|593416366|FG003|Maintenance Period|Withdrawal by Subject|0|||
164285882|NCT00191308|593416367|FG000|Overall Study|Adverse Event|1|||
164285883|NCT00779025|593416368|FG000|Overall Study|Withdrawal by Subject|1|||
164285884|NCT02741635|593416369|FG000|Overall Study|Withdrawal by Subject|1|||
164285885|NCT03797586|593416370|FG000|Overall Study|Lost to Follow-up|3|||
164285886|NCT03797586|593416371|FG001|Overall Study|Lost to Follow-up|6|||
164285887|NCT03797586|593416370|FG000|Overall Study|Death|1|||
164285888|NCT03797586|593416371|FG001|Overall Study|Death|1|||
164285889|NCT03797586|593416370|FG000|Overall Study|Adverse Event|0|||
164285890|NCT03797586|593416371|FG001|Overall Study|Adverse Event|2|||
164285891|NCT02864901|593416372|FG000|Overall Study|Withdrawal by Subject|1|||
164285892|NCT02864901|593416373|FG001|Overall Study|Withdrawal by Subject|0|||
164285893|NCT01219985|593416378|FG000|Overall Study|Physician Decision|20|||
164285894|NCT01369784|593416379|FG000|Overall Study|Protocol Violation|12|||
164285895|NCT03359174|593416380|FG000|Overall Study|Adverse Event|1|||
164285896|NCT02680665|593416381|FG000|Overall Study|No visit after the first prescription|5|||
164285897|NCT02905266|593416382|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
164285898|NCT02905266|593416383|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
164285899|NCT02905266|593416382|FG000|Treatment Phase Part 1|Disease Progression|6|||
164285900|NCT02905266|593416383|FG001|Treatment Phase Part 1|Disease Progression|7|||
164285901|NCT02905266|593416382|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
164285902|NCT02905266|593416383|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
164285903|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
164285904|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
164285905|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
164285906|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
164285907|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
164285908|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
164285909|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Death|0|||
164285910|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Death|1|||
164285911|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
164285912|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
164285913|NCT02905266|593416382|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
164285914|NCT02905266|593416383|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
164285915|NCT02905266|593416382|FG000|Maintenance Phase Part 2|Disease Progression|9|||
164285916|NCT02905266|593416383|FG001|Maintenance Phase Part 2|Disease Progression|2|||
164285917|NCT02905266|593416382|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
164285918|NCT02905266|593416383|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
164285919|NCT02905266|593416382|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
164285920|NCT02905266|593416383|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
164285921|NCT00596752|593416386|FG000|Overall Study|Other Reason|44|||
164285922|NCT00596752|593416387|FG001|Overall Study|Other Reason|49|||
164285923|NCT00596752|593416386|FG000|Overall Study|Adverse Event|34|||
164285924|NCT00596752|593416387|FG001|Overall Study|Adverse Event|34|||
164285925|NCT00596752|593416386|FG000|Overall Study|Lost to Follow-up|22|||
164285926|NCT00596752|593416387|FG001|Overall Study|Lost to Follow-up|38|||
164285927|NCT00596752|593416386|FG000|Overall Study|Withdrawal by Subject|12|||
164285928|NCT00596752|593416387|FG001|Overall Study|Withdrawal by Subject|9|||
164285929|NCT00596752|593416386|FG000|Overall Study|Unsatisfactory Compliance|9|||
163897639|NCT04479787|591997910|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
164285930|NCT00596752|593416387|FG001|Overall Study|Unsatisfactory Compliance|6|||
164285931|NCT00596752|593416386|FG000|Overall Study|Lack of Efficacy|4|||
164285932|NCT00596752|593416387|FG001|Overall Study|Lack of Efficacy|7|||
164285933|NCT00596752|593416386|FG000|Overall Study|Protocol Violation|1|||
164285934|NCT00596752|593416387|FG001|Overall Study|Protocol Violation|0|||
164285935|NCT04445662|593416392|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
164285936|NCT04445662|593416393|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
163897640|NCT04479787|591997911|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
164285937|NCT04445662|593416392|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
164285938|NCT04445662|593416393|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
164285939|NCT04445662|593416392|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
163897641|NCT04479787|591997910|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
164087805|NCT03390504|592685800|FG000|Overall Study|Lost to Follow-up|2|||
164285940|NCT04445662|593416393|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
164285941|NCT04445662|593416392|FG000|Post-treatment (12-24 weeks)|Death|1|||
164285942|NCT04445662|593416393|FG001|Post-treatment (12-24 weeks)|Death|0|||
164285943|NCT01870726|593416394|FG000|Overall Study|Withdrawal of informed consent|0|||
164285944|NCT01870726|593416395|FG001|Overall Study|Withdrawal of informed consent|0|||
164285945|NCT01870726|593416396|FG002|Overall Study|Withdrawal of informed consent|0|||
164285946|NCT01870726|593416397|FG003|Overall Study|Withdrawal of informed consent|1|||
164285947|NCT01870726|593416398|FG004|Overall Study|Withdrawal of informed consent|0|||
164285948|NCT01870726|593416399|FG005|Overall Study|Withdrawal of informed consent|0|||
164285949|NCT01870726|593416400|FG006|Overall Study|Withdrawal of informed consent|0|||
164285950|NCT01870726|593416394|FG000|Overall Study|Withdrawal by Subject|0|||
164285951|NCT01870726|593416395|FG001|Overall Study|Withdrawal by Subject|1|||
164285952|NCT01870726|593416396|FG002|Overall Study|Withdrawal by Subject|0|||
164285953|NCT01870726|593416397|FG003|Overall Study|Withdrawal by Subject|0|||
164285954|NCT01870726|593416398|FG004|Overall Study|Withdrawal by Subject|0|||
164285955|NCT01870726|593416399|FG005|Overall Study|Withdrawal by Subject|0|||
164285956|NCT01870726|593416400|FG006|Overall Study|Withdrawal by Subject|0|||
164285957|NCT01870726|593416394|FG000|Overall Study|Adverse Event|0|||
164285958|NCT01870726|593416395|FG001|Overall Study|Adverse Event|0|||
164285959|NCT01870726|593416396|FG002|Overall Study|Adverse Event|0|||
164285960|NCT01870726|593416397|FG003|Overall Study|Adverse Event|0|||
164285961|NCT01870726|593416398|FG004|Overall Study|Adverse Event|1|||
164285962|NCT01870726|593416399|FG005|Overall Study|Adverse Event|1|||
164285963|NCT01870726|593416400|FG006|Overall Study|Adverse Event|0|||
164285964|NCT01870726|593416394|FG000|Overall Study|Progressive disease|5|||
164285965|NCT01870726|593416395|FG001|Overall Study|Progressive disease|5|||
164285966|NCT01870726|593416396|FG002|Overall Study|Progressive disease|4|||
164285967|NCT01870726|593416397|FG003|Overall Study|Progressive disease|5|||
164285968|NCT01870726|593416398|FG004|Overall Study|Progressive disease|6|||
164285969|NCT01870726|593416399|FG005|Overall Study|Progressive disease|4|||
164285970|NCT01870726|593416400|FG006|Overall Study|Progressive disease|10|||
164285971|NCT03245775|593416403|FG000|Overall Study|Lost to Follow-up|25|||
164285972|NCT03245775|593416404|FG001|Overall Study|Lost to Follow-up|26|||
164285973|NCT03245775|593416405|FG002|Overall Study|Lost to Follow-up|16|||
164285974|NCT03245775|593416406|FG003|Overall Study|Lost to Follow-up|16|||
164285975|NCT03691571|593416409|FG000|Overall Study|Withdrawal by Subject|9|||
164285976|NCT03691571|593416410|FG001|Overall Study|Withdrawal by Subject|2|||
164285977|NCT02363959|593416411|FG000|Overall Study|Medical instability|1|||
164285978|NCT02363959|593416412|FG001|Overall Study|Medical instability|0|||
164285979|NCT00940498|593416416|FG000|Overall Study|Death|2|||
164285980|NCT00940498|593416417|FG001|Overall Study|Death|0|||
164285981|NCT00940498|593416418|FG002|Overall Study|Death|0|||
164285982|NCT00940498|593416419|FG003|Overall Study|Death|1|||
164285983|NCT00940498|593416420|FG004|Overall Study|Death|5|||
164285984|NCT00940498|593416421|FG005|Overall Study|Death|0|||
164285985|NCT00940498|593416422|FG006|Overall Study|Death|1|||
164285986|NCT00940498|593416423|FG007|Overall Study|Death|0|||
164285987|NCT00940498|593416416|FG000|Overall Study|Lost to Follow-up|1|||
164285988|NCT00940498|593416417|FG001|Overall Study|Lost to Follow-up|1|||
164285989|NCT00940498|593416418|FG002|Overall Study|Lost to Follow-up|2|||
164285990|NCT00940498|593416419|FG003|Overall Study|Lost to Follow-up|0|||
164285991|NCT00940498|593416420|FG004|Overall Study|Lost to Follow-up|1|||
164285992|NCT00940498|593416421|FG005|Overall Study|Lost to Follow-up|0|||
164285993|NCT00940498|593416422|FG006|Overall Study|Lost to Follow-up|0|||
164285994|NCT00940498|593416423|FG007|Overall Study|Lost to Follow-up|1|||
164285995|NCT00940498|593416416|FG000|Overall Study|Disease Progression|0|||
164285996|NCT00940498|593416417|FG001|Overall Study|Disease Progression|0|||
164285997|NCT00940498|593416418|FG002|Overall Study|Disease Progression|1|||
164285998|NCT00940498|593416419|FG003|Overall Study|Disease Progression|1|||
164285999|NCT00940498|593416420|FG004|Overall Study|Disease Progression|0|||
164286000|NCT00940498|593416421|FG005|Overall Study|Disease Progression|1|||
164286001|NCT00940498|593416422|FG006|Overall Study|Disease Progression|0|||
164286002|NCT00940498|593416423|FG007|Overall Study|Disease Progression|0|||
164286003|NCT00940498|593416416|FG000|Overall Study|Physician Decision|0|||
164286004|NCT00940498|593416417|FG001|Overall Study|Physician Decision|0|||
164286005|NCT00940498|593416418|FG002|Overall Study|Physician Decision|0|||
164286006|NCT00940498|593416419|FG003|Overall Study|Physician Decision|0|||
164286007|NCT00940498|593416420|FG004|Overall Study|Physician Decision|2|||
164286008|NCT00940498|593416421|FG005|Overall Study|Physician Decision|0|||
164286009|NCT00940498|593416422|FG006|Overall Study|Physician Decision|0|||
164286010|NCT00940498|593416423|FG007|Overall Study|Physician Decision|0|||
164286011|NCT00940498|593416416|FG000|Overall Study|Not treated due to disease related pain|0|||
164286012|NCT00940498|593416417|FG001|Overall Study|Not treated due to disease related pain|0|||
164286013|NCT00940498|593416418|FG002|Overall Study|Not treated due to disease related pain|0|||
164286014|NCT00940498|593416419|FG003|Overall Study|Not treated due to disease related pain|0|||
164286015|NCT00940498|593416420|FG004|Overall Study|Not treated due to disease related pain|1|||
164286016|NCT00940498|593416421|FG005|Overall Study|Not treated due to disease related pain|0|||
164286017|NCT00940498|593416422|FG006|Overall Study|Not treated due to disease related pain|0|||
164286018|NCT00940498|593416423|FG007|Overall Study|Not treated due to disease related pain|0|||
164286019|NCT03310723|593418207|FG000|Overall Study|Withdrawal by Subject|0|||
164286020|NCT03310723|593418208|FG001|Overall Study|Withdrawal by Subject|1|||
163897642|NCT04479787|591997911|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
163897643|NCT03699163|591998667|FG000|Overall Study|Physician Decision|12|||
163897644|NCT03699163|591998668|FG001|Overall Study|Physician Decision|0|||
163897645|NCT03699163|591998667|FG000|Overall Study|failed QC measures|205|||
163897646|NCT03699163|591998668|FG001|Overall Study|failed QC measures|206|||
163897647|NCT01976936|591998671|FG000|Overall Study|Did not receive at least 9 doses|9|||
163897648|NCT01976936|591998672|FG001|Overall Study|Did not receive at least 9 doses|4|||
163897649|NCT00495677|591998673|FG000|Stage 1 (25 Days)|Adverse Event|0|||
163897650|NCT00495677|591998674|FG001|Stage 1 (25 Days)|Adverse Event|0|||
163897651|NCT00495677|591998675|FG002|Stage 1 (25 Days)|Adverse Event|1|||
163897652|NCT00495677|591998676|FG003|Stage 1 (25 Days)|Adverse Event|0|||
163897653|NCT00495677|591998677|FG004|Stage 1 (25 Days)|Adverse Event|0|||
163897654|NCT00495677|591998678|FG005|Stage 1 (25 Days)|Adverse Event|0|||
163897655|NCT00495677|591998679|FG006|Stage 1 (25 Days)|Adverse Event|0|||
163897656|NCT02306161|591998685|FG000|Overall Study|Death|1|||
163897657|NCT02306161|591998686|FG001|Overall Study|Death|3|||
164003875|NCT01309737|592378214|FG001|Week 16 to 52|Adverse Event|7|||
164003876|NCT01309737|592378215|FG002|Week 16 to 52|Adverse Event|0|||
164344949|NCT03066804|593638886|FG000|Overall Study|Adverse Event|2|||
164344950|NCT03066804|593638887|FG001|Overall Study|Adverse Event|3|||
164344951|NCT03066804|593638886|FG000|Overall Study|Technical problems|5|||
164344952|NCT03066804|593638887|FG001|Overall Study|Technical problems|1|||
164344953|NCT00730132|593638892|FG000|Overall Study|Protocol Violation|154|||
164344954|NCT00730132|593638892|FG000|Overall Study|Death|1|||
164344955|NCT03982368|593638893|FG000|Overall Study|Adverse Event|6|||
164344956|NCT03982368|593638894|FG001|Overall Study|Adverse Event|4|||
164344957|NCT03982368|593638895|FG002|Overall Study|Adverse Event|3|||
164344958|NCT03982368|593638893|FG000|Overall Study|Lost to Follow-up|2|||
164344959|NCT03982368|593638894|FG001|Overall Study|Lost to Follow-up|1|||
164344960|NCT03982368|593638895|FG002|Overall Study|Lost to Follow-up|0|||
164344961|NCT03982368|593638893|FG000|Overall Study|Withdrawal by Subject|1|||
164344962|NCT03982368|593638894|FG001|Overall Study|Withdrawal by Subject|2|||
164344963|NCT03982368|593638895|FG002|Overall Study|Withdrawal by Subject|0|||
164344964|NCT03982368|593638893|FG000|Overall Study|unknow|4|||
164344965|NCT03982368|593638894|FG001|Overall Study|unknow|0|||
164344966|NCT03982368|593638895|FG002|Overall Study|unknow|2|||
164344967|NCT03570697|593638896|FG000|Overall Study|Lost to Follow-up|0|||
164344968|NCT03570697|593638897|FG001|Overall Study|Lost to Follow-up|1|||
164344969|NCT03570697|593638896|FG000|Overall Study|Death|2|||
164344970|NCT03570697|593638897|FG001|Overall Study|Death|0|||
164344971|NCT03570697|593638896|FG000|Overall Study|Withdrawal by Subject|4|||
164344972|NCT03570697|593638897|FG001|Overall Study|Withdrawal by Subject|2|||
164344973|NCT00518284|593638898|FG000|Overall Study|Adverse Event|0|||
164344974|NCT00518284|593638899|FG001|Overall Study|Adverse Event|1|||
164344975|NCT00518284|593638900|FG002|Overall Study|Adverse Event|0|||
164344976|NCT00518284|593638901|FG003|Overall Study|Adverse Event|0|||
164344977|NCT00518284|593638898|FG000|Overall Study|Study Termination|0|||
164344978|NCT00518284|593638899|FG001|Overall Study|Study Termination|2|||
164344979|NCT00518284|593638900|FG002|Overall Study|Study Termination|1|||
164344980|NCT00518284|593638901|FG003|Overall Study|Study Termination|2|||
164344981|NCT01849783|593638902|FG000|Overall Study|Adverse Event|5|||
164344982|NCT01849783|593638902|FG000|Overall Study|Death|2|||
164344983|NCT01849783|593638902|FG000|Overall Study|Physician Decision|1|||
164344984|NCT01849783|593638902|FG000|Overall Study|Withdrawal by Subject|1|||
164344985|NCT01849783|593638902|FG000|Overall Study|Unable to comply|2|||
164344986|NCT01849783|593638902|FG000|Overall Study|Disease progression|11|||
164344987|NCT02571777|593638903|FG000|Overall Study|Subject/guardian decision|34|||
164344988|NCT02571777|593638904|FG001|Overall Study|Subject/guardian decision|26|||
164344989|NCT02571777|593638905|FG002|Overall Study|Subject/guardian decision|26|||
164344990|NCT02571777|593638906|FG003|Overall Study|Subject/guardian decision|25|||
164344991|NCT02571777|593638907|FG004|Overall Study|Subject/guardian decision|27|||
164344992|NCT02571777|593638903|FG000|Overall Study|Protocol Deviation|2|||
164344993|NCT02571777|593638904|FG001|Overall Study|Protocol Deviation|3|||
164344994|NCT02571777|593638905|FG002|Overall Study|Protocol Deviation|4|||
164344995|NCT02571777|593638906|FG003|Overall Study|Protocol Deviation|8|||
164344996|NCT02571777|593638907|FG004|Overall Study|Protocol Deviation|4|||
164344997|NCT02571777|593638903|FG000|Overall Study|Death|1|||
164344998|NCT02571777|593638904|FG001|Overall Study|Death|1|||
164344999|NCT02571777|593638905|FG002|Overall Study|Death|4|||
164345000|NCT02571777|593638906|FG003|Overall Study|Death|0|||
164345001|NCT02571777|593638907|FG004|Overall Study|Death|0|||
164345002|NCT02571777|593638903|FG000|Overall Study|Lost to Follow-up|1|||
163897658|NCT02306161|591998685|FG000|Overall Study|Lack of Efficacy|20|||
164345003|NCT02571777|593638904|FG001|Overall Study|Lost to Follow-up|1|||
163897659|NCT02306161|591998686|FG001|Overall Study|Lack of Efficacy|43|||
163897660|NCT02306161|591998685|FG000|Overall Study|Physician Decision|30|||
163897661|NCT02306161|591998686|FG001|Overall Study|Physician Decision|18|||
164345004|NCT02571777|593638905|FG002|Overall Study|Lost to Follow-up|2|||
164345005|NCT02571777|593638906|FG003|Overall Study|Lost to Follow-up|0|||
164345006|NCT02571777|593638907|FG004|Overall Study|Lost to Follow-up|1|||
164345007|NCT02571777|593638903|FG000|Overall Study|Physician Decision|1|||
164286021|NCT03310723|593418207|FG000|Overall Study|Protocol Violation|0|||
164286022|NCT03310723|593418208|FG001|Overall Study|Protocol Violation|2|||
164286023|NCT02098746|593418209|FG000|Overall Study|Changes of Investigator|2|||
164286024|NCT02098746|593418209|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164286025|NCT02098746|593418209|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
164286026|NCT02098746|593418209|FG000|Overall Study|Data Not Available After Treatment|1|||
164286027|NCT00217425|593418210|FG000|Overall Study|Never started treatment|2|||
164286028|NCT00217425|593418210|FG000|Overall Study|Patient ineligible|5|||
164345008|NCT02571777|593638904|FG001|Overall Study|Physician Decision|7|||
164286029|NCT00217425|593418210|FG000|Overall Study|Lack of Efficacy|13|||
164286030|NCT00217425|593418210|FG000|Overall Study|Adverse Event|8|||
164286031|NCT00217425|593418210|FG000|Overall Study|Withdrawal by Subject|4|||
164286032|NCT00217425|593418210|FG000|Overall Study|Other complicating disease|1|||
164286033|NCT00217425|593418210|FG000|Overall Study|Other|4|||
164286034|NCT00671034|593418213|FG000|Overall Study|Adverse Event|5|||
164286035|NCT00671034|593418214|FG001|Overall Study|Adverse Event|7|||
164286036|NCT00671034|593418215|FG002|Overall Study|Adverse Event|1|||
164286037|NCT00671034|593418213|FG000|Overall Study|Death|3|||
164286038|NCT00671034|593418214|FG001|Overall Study|Death|2|||
164286039|NCT00671034|593418215|FG002|Overall Study|Death|1|||
164286040|NCT00671034|593418213|FG000|Overall Study|Physician Decision|12|||
164286041|NCT00671034|593418214|FG001|Overall Study|Physician Decision|4|||
164286042|NCT00671034|593418215|FG002|Overall Study|Physician Decision|5|||
164286043|NCT00671034|593418213|FG000|Overall Study|VHR ALL feature|8|||
164286044|NCT00671034|593418214|FG001|Overall Study|VHR ALL feature|3|||
164286045|NCT00671034|593418215|FG002|Overall Study|VHR ALL feature|5|||
164286046|NCT00671034|593418213|FG000|Overall Study|Refusal|5|||
164286047|NCT00671034|593418214|FG001|Overall Study|Refusal|3|||
164286048|NCT00671034|593418215|FG002|Overall Study|Refusal|5|||
164286049|NCT00671034|593418213|FG000|Overall Study|includes Alternative therapy, etc.|6|||
164286050|NCT00671034|593418214|FG001|Overall Study|includes Alternative therapy, etc.|1|||
164286051|NCT00671034|593418215|FG002|Overall Study|includes Alternative therapy, etc.|7|||
164286052|NCT00330759|593418216|FG000|Overall Study|Death|316|||
164286053|NCT00330759|593418217|FG001|Overall Study|Death|310|||
164286054|NCT00330759|593418216|FG000|Overall Study|Disease progression|104|||
164286055|NCT00330759|593418217|FG001|Overall Study|Disease progression|126|||
164286056|NCT00330759|593418216|FG000|Overall Study|Withdrawal by Subject|143|||
164286057|NCT00330759|593418217|FG001|Overall Study|Withdrawal by Subject|124|||
164286058|NCT00330759|593418216|FG000|Overall Study|Adverse Event|48|||
164286059|NCT00330759|593418217|FG001|Overall Study|Adverse Event|36|||
164286060|NCT00330759|593418216|FG000|Overall Study|Participant request|31|||
164286061|NCT00330759|593418217|FG001|Overall Study|Participant request|22|||
164286062|NCT00330759|593418216|FG000|Overall Study|Lost to Follow-up|16|||
164286063|NCT00330759|593418217|FG001|Overall Study|Lost to Follow-up|22|||
164286064|NCT00330759|593418216|FG000|Overall Study|Noncompliance|15|||
164286065|NCT00330759|593418217|FG001|Overall Study|Noncompliance|17|||
164286066|NCT00330759|593418216|FG000|Overall Study|Physician Decision|1|||
164345009|NCT02571777|593638905|FG002|Overall Study|Physician Decision|5|||
164345010|NCT02571777|593638906|FG003|Overall Study|Physician Decision|2|||
164345011|NCT02571777|593638907|FG004|Overall Study|Physician Decision|4|||
164345012|NCT02571777|593638903|FG000|Overall Study|Pregnancy|0|||
164345013|NCT02571777|593638904|FG001|Overall Study|Pregnancy|0|||
164345014|NCT02571777|593638905|FG002|Overall Study|Pregnancy|0|||
164345015|NCT02571777|593638906|FG003|Overall Study|Pregnancy|2|||
164345016|NCT02571777|593638907|FG004|Overall Study|Pregnancy|0|||
164345017|NCT00801632|593638908|FG000|Overall Study|Re-transplant|1|||
164286067|NCT00330759|593418217|FG001|Overall Study|Physician Decision|2|||
164286068|NCT00330759|593418216|FG000|Overall Study|Protocol deviation|0|||
164286069|NCT00330759|593418217|FG001|Overall Study|Protocol deviation|2|||
164286070|NCT00330759|593418216|FG000|Overall Study|Ineligibility determined|2|||
164286071|NCT00330759|593418217|FG001|Overall Study|Ineligibility determined|1|||
164286072|NCT00330759|593418216|FG000|Overall Study|Other|36|||
164286073|NCT00330759|593418217|FG001|Overall Study|Other|44|||
164345018|NCT05393895|593638912|FG000|Overall Study|Adverse Event|2|||
164345019|NCT05393895|593638913|FG001|Overall Study|Adverse Event|3|||
164286074|NCT02380287|593418219|FG000|Overall Study|Adverse Event|0|||
164286075|NCT02380287|593418220|FG001|Overall Study|Adverse Event|0|||
164286076|NCT02380287|593418221|FG002|Overall Study|Adverse Event|1|||
164286077|NCT02380287|593418222|FG003|Overall Study|Adverse Event|0|||
164286078|NCT02380287|593418223|FG004|Overall Study|Adverse Event|0|||
164345020|NCT05393895|593638912|FG000|Overall Study|Lost to Follow-up|4|||
164345021|NCT05393895|593638913|FG001|Overall Study|Lost to Follow-up|3|||
164286079|NCT02380287|593418224|FG005|Overall Study|Adverse Event|0|||
164286080|NCT02380287|593418225|FG006|Overall Study|Adverse Event|0|||
164286081|NCT02380287|593418226|FG007|Overall Study|Adverse Event|0|||
164286082|NCT01508312|593418227|FG000|Overall Study|Lost to Follow-up|1|||
164286083|NCT01508312|593418228|FG001|Overall Study|Lost to Follow-up|0|||
164286084|NCT01508312|593418229|FG002|Overall Study|Lost to Follow-up|0|||
164286085|NCT01508312|593418230|FG003|Overall Study|Lost to Follow-up|0|||
164286086|NCT01508312|593418227|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
164286087|NCT01508312|593418228|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
164286088|NCT01508312|593418229|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
164286089|NCT01508312|593418230|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
164286090|NCT01508312|593418227|FG000|Overall Study|Adverse Event|0|||
164286091|NCT01508312|593418228|FG001|Overall Study|Adverse Event|0|||
164286092|NCT01508312|593418229|FG002|Overall Study|Adverse Event|2|||
164286093|NCT01508312|593418230|FG003|Overall Study|Adverse Event|0|||
164286094|NCT01508312|593418227|FG000|Overall Study|Lack of Efficacy|0|||
164286095|NCT01508312|593418228|FG001|Overall Study|Lack of Efficacy|0|||
164286096|NCT01508312|593418229|FG002|Overall Study|Lack of Efficacy|1|||
164286097|NCT01508312|593418230|FG003|Overall Study|Lack of Efficacy|0|||
164286098|NCT01508312|593418227|FG000|Overall Study|Withdrawal by Subject|0|||
164286099|NCT01508312|593418228|FG001|Overall Study|Withdrawal by Subject|0|||
164286100|NCT01508312|593418229|FG002|Overall Study|Withdrawal by Subject|1|||
164286101|NCT01508312|593418230|FG003|Overall Study|Withdrawal by Subject|0|||
164286102|NCT02322281|593418233|FG000|Overall Study|Progressive Disease|42|||
164286103|NCT02322281|593418234|FG001|Overall Study|Progressive Disease|14|||
164286104|NCT02322281|593418235|FG002|Overall Study|Progressive Disease|49|||
164286105|NCT02322281|593418233|FG000|Overall Study|Adverse Event|3|||
164286106|NCT02322281|593418234|FG001|Overall Study|Adverse Event|4|||
164286107|NCT02322281|593418235|FG002|Overall Study|Adverse Event|6|||
164286108|NCT02322281|593418233|FG000|Overall Study|Death|3|||
164286109|NCT02322281|593418234|FG001|Overall Study|Death|3|||
164286110|NCT02322281|593418235|FG002|Overall Study|Death|3|||
164286111|NCT02322281|593418233|FG000|Overall Study|Withdrawal by Subject|1|||
164286112|NCT02322281|593418234|FG001|Overall Study|Withdrawal by Subject|1|||
164286113|NCT02322281|593418235|FG002|Overall Study|Withdrawal by Subject|6|||
164286114|NCT02322281|593418233|FG000|Overall Study|Physician Decision|2|||
164286115|NCT02322281|593418234|FG001|Overall Study|Physician Decision|0|||
164286116|NCT02322281|593418235|FG002|Overall Study|Physician Decision|5|||
164286117|NCT02322281|593418233|FG000|Overall Study|Study Terminated by Sponsor|2|||
164286118|NCT02322281|593418234|FG001|Overall Study|Study Terminated by Sponsor|0|||
164286119|NCT02322281|593418235|FG002|Overall Study|Study Terminated by Sponsor|0|||
164286120|NCT02322281|593418233|FG000|Overall Study|Missing|0|||
164286121|NCT02322281|593418234|FG001|Overall Study|Missing|0|||
164286122|NCT02322281|593418235|FG002|Overall Study|Missing|1|||
164286123|NCT02322281|593418233|FG000|Overall Study|Miscellaneous|0|||
164286124|NCT02322281|593418234|FG001|Overall Study|Miscellaneous|0|||
164286125|NCT02322281|593418235|FG002|Overall Study|Miscellaneous|4|||
164286126|NCT00936702|593418236|FG000|Overall Study|Disease progression|34|||
164286127|NCT00936702|593418236|FG000|Overall Study|Adverse Event|8|||
164286128|NCT00936702|593418236|FG000|Overall Study|Withdrawal by Subject|2|||
164286129|NCT00936702|593418236|FG000|Overall Study|Alternative Treatment|1|||
164286130|NCT00936702|593418236|FG000|Overall Study|Other|1|||
164286131|NCT00824473|593418237|FG000|Overall Study|Adverse Event|4|||
164286132|NCT00824473|593418238|FG001|Overall Study|Adverse Event|5|||
164286133|NCT00824473|593418237|FG000|Overall Study|Lack of Efficacy|2|||
164286134|NCT00824473|593418238|FG001|Overall Study|Lack of Efficacy|2|||
164286135|NCT00824473|593418237|FG000|Overall Study|Protocol Violation|2|||
164286136|NCT00824473|593418238|FG001|Overall Study|Protocol Violation|0|||
164286137|NCT00824473|593418237|FG000|Overall Study|Non-Compliance|4|||
164286138|NCT00824473|593418238|FG001|Overall Study|Non-Compliance|2|||
164286139|NCT00824473|593418237|FG000|Overall Study|Withdrawal by Subject|2|||
164286140|NCT00824473|593418238|FG001|Overall Study|Withdrawal by Subject|3|||
164286141|NCT00824473|593418237|FG000|Overall Study|Other|1|||
164286142|NCT00824473|593418238|FG001|Overall Study|Other|1|||
164286143|NCT01359904|593418239|FG000|Overall Study|Withdrawal by Subject|1|||
164286144|NCT01359904|593418240|FG001|Overall Study|Withdrawal by Subject|0|||
164286145|NCT00466440|593418241|FG000|Overall Study|Adverse Event|0|||
164286146|NCT00466440|593418242|FG001|Overall Study|Adverse Event|3|||
164286147|NCT00466440|593418243|FG002|Overall Study|Adverse Event|1|||
164286148|NCT00466440|593418241|FG000|Overall Study|Death|1|||
164286149|NCT00466440|593418242|FG001|Overall Study|Death|1|||
164286150|NCT00466440|593418243|FG002|Overall Study|Death|0|||
164286151|NCT00466440|593418241|FG000|Overall Study|Progressive disease|13|||
164286152|NCT00466440|593418242|FG001|Overall Study|Progressive disease|5|||
164286153|NCT00466440|593418243|FG002|Overall Study|Progressive disease|4|||
164286154|NCT00466440|593418241|FG000|Overall Study|Lost to Follow-up|0|||
164286155|NCT00466440|593418242|FG001|Overall Study|Lost to Follow-up|1|||
164286156|NCT00466440|593418243|FG002|Overall Study|Lost to Follow-up|0|||
164286157|NCT00466440|593418241|FG000|Overall Study|Physician Decision|0|||
164286158|NCT00466440|593418242|FG001|Overall Study|Physician Decision|1|||
164286159|NCT00466440|593418243|FG002|Overall Study|Physician Decision|2|||
164286160|NCT00466440|593418241|FG000|Overall Study|Protocol entry criteria not met|0|||
164286161|NCT00466440|593418242|FG001|Overall Study|Protocol entry criteria not met|0|||
164286162|NCT00466440|593418243|FG002|Overall Study|Protocol entry criteria not met|4|||
164286163|NCT00466440|593418241|FG000|Overall Study|Withdrawal by Subject|0|||
164286164|NCT00466440|593418242|FG001|Overall Study|Withdrawal by Subject|1|||
164286165|NCT00466440|593418243|FG002|Overall Study|Withdrawal by Subject|0|||
164286166|NCT00466440|593418241|FG000|Overall Study|Sponsor decision|0|||
164286167|NCT00466440|593418242|FG001|Overall Study|Sponsor decision|0|||
164286168|NCT00466440|593418243|FG002|Overall Study|Sponsor decision|1|||
164286169|NCT03191630|593418246|FG000|Overall Study|Lost to Follow-up|7|||
164286170|NCT03191630|593418247|FG001|Overall Study|Lost to Follow-up|7|||
164286171|NCT01550757|593418248|FG000|Overall Study|Lost to Follow-up|21|||
164286172|NCT01550757|593418249|FG001|Overall Study|Lost to Follow-up|14|||
164286173|NCT01550757|593418250|FG002|Overall Study|Lost to Follow-up|42|||
164286174|NCT01550757|593418251|FG003|Overall Study|Lost to Follow-up|53|||
164286175|NCT01550757|593418248|FG000|Overall Study|Withdrawal by Subject|2|||
164286176|NCT01550757|593418249|FG001|Overall Study|Withdrawal by Subject|0|||
164286177|NCT01550757|593418250|FG002|Overall Study|Withdrawal by Subject|3|||
164286178|NCT01550757|593418251|FG003|Overall Study|Withdrawal by Subject|1|||
164286179|NCT02342223|593418252|FG000|Overall Study|Lost to Follow-up|1|||
164286180|NCT01426958|593418253|FG000|Overall Study|Adverse Event|2|||
164286181|NCT01172535|593418256|FG000|Overall Study|Death|3|||
164286182|NCT01172535|593418256|FG000|Overall Study|Withdrawal by Subject|2|||
164286183|NCT01172535|593418256|FG000|Overall Study|Lost to Follow-up|1|||
164286184|NCT01172535|593418256|FG000|Overall Study|Ineligible at study entry|1|||
164286185|NCT01172535|593418256|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
164286186|NCT00413218|593418259|FG000|Overall Study|Randomized but didn't receive study drug|2|||
164286187|NCT00413218|593418260|FG001|Overall Study|Randomized but didn't receive study drug|8|||
164286188|NCT00413218|593418259|FG000|Overall Study|Death|57|||
164286189|NCT00413218|593418260|FG001|Overall Study|Death|56|||
164286190|NCT00413218|593418259|FG000|Overall Study|Lost to Follow-up|14|||
164286191|NCT00413218|593418260|FG001|Overall Study|Lost to Follow-up|17|||
164286192|NCT00413218|593418259|FG000|Overall Study|Admin|20|||
164286193|NCT00413218|593418260|FG001|Overall Study|Admin|14|||
164286194|NCT00413218|593418259|FG000|Overall Study|Missing|1|||
164286195|NCT00413218|593418260|FG001|Overall Study|Missing|0|||
164286196|NCT00413218|593418259|FG000|Overall Study|Withdrawal by Subject|9|||
164286197|NCT00413218|593418260|FG001|Overall Study|Withdrawal by Subject|1|||
164286198|NCT00837213|593418261|FG000|Overall Study|Lost to Follow-up|3|||
164286199|NCT00837213|593418262|FG001|Overall Study|Lost to Follow-up|2|||
164286200|NCT00837213|593418261|FG000|Overall Study|Withdrawal by Subject|2|||
164286201|NCT00837213|593418262|FG001|Overall Study|Withdrawal by Subject|2|||
164286202|NCT00837213|593418261|FG000|Overall Study|not stated|1|||
164286203|NCT00837213|593418262|FG001|Overall Study|not stated|1|||
164286204|NCT01479868|593418263|FG000|Overall Study|Adverse Event|1|||
164286205|NCT01479868|593418263|FG000|Overall Study|Lost to Follow-up|4|||
164286206|NCT01479868|593418263|FG000|Overall Study|Protocol Violation|1|||
164286207|NCT01479868|593418263|FG000|Overall Study|Withdrawal by Subject|1|||
164286208|NCT01479868|593418263|FG000|Overall Study|Sponsor's Decision|1|||
164345022|NCT05393895|593638912|FG000|Overall Study|Protocol Violation|1|||
164345023|NCT05393895|593638913|FG001|Overall Study|Protocol Violation|0|||
164345024|NCT05393895|593638912|FG000|Overall Study|Withdrawal by Subject|1|||
164345025|NCT05393895|593638913|FG001|Overall Study|Withdrawal by Subject|4|||
164345026|NCT03851705|593638917|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
164345027|NCT03851705|593638918|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164345028|NCT03851705|593638919|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164345029|NCT03851705|593638920|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164345030|NCT03851705|593638917|FG000|Part 1: Double-Blind Period|Other reason|1|||
164286209|NCT01479868|593418263|FG000|Overall Study|Initiation of new HCV Therapy|1|||
164286210|NCT01618669|593418264|FG000|Overall Study|Lost to Follow-up|1|||
164286211|NCT01618669|593418265|FG001|Overall Study|Lost to Follow-up|1|||
164286212|NCT01618669|593418264|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
164286213|NCT01618669|593418265|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
164286214|NCT01618669|593418264|FG000|Overall Study|Adverse Event|16|||
164286215|NCT01618669|593418265|FG001|Overall Study|Adverse Event|7|||
164286216|NCT01618669|593418264|FG000|Overall Study|Protocol Violation|5|||
164286217|NCT01618669|593418265|FG001|Overall Study|Protocol Violation|3|||
164345031|NCT03851705|593638918|FG001|Part 1: Double-Blind Period|Other reason|0|||
164345032|NCT03851705|593638919|FG002|Part 1: Double-Blind Period|Other reason|0|||
164286218|NCT01618669|593418264|FG000|Overall Study|Withdrawal by Subject|9|||
164286219|NCT01618669|593418265|FG001|Overall Study|Withdrawal by Subject|9|||
164286220|NCT01618669|593418264|FG000|Overall Study|Miscellaneous Reason|0|||
164286221|NCT01618669|593418265|FG001|Overall Study|Miscellaneous Reason|1|||
164286222|NCT01508169|593418266|FG000|Overall Study|Adverse Event|1|||
164286223|NCT01508169|593418267|FG001|Overall Study|Adverse Event|0|||
164286224|NCT01508169|593418266|FG000|Overall Study|Withdrawal by Subject|1|||
164286225|NCT01508169|593418267|FG001|Overall Study|Withdrawal by Subject|0|||
164286226|NCT01508169|593418266|FG000|Overall Study|Lost to Follow-up|1|||
164286227|NCT01508169|593418267|FG001|Overall Study|Lost to Follow-up|2|||
164286228|NCT03600740|593418273|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
164286229|NCT02396212|593418274|FG000|Overall Study|Adverse Event|1|||
164286230|NCT02396212|593418274|FG000|Overall Study|Lack of Efficacy|2|||
164286231|NCT04950465|593418275|FG000|Overall Study|Lost to Follow-up|1|||
164286232|NCT04950465|593418276|FG001|Overall Study|Lost to Follow-up|0|||
164286233|NCT04950465|593418277|FG002|Overall Study|Lost to Follow-up|0|||
164286234|NCT01788566|593418284|FG000|Overall Study|Death|4|||
164286235|NCT01788566|593418284|FG000|Overall Study|Adverse Event|1|||
164286236|NCT01788566|593418284|FG000|Overall Study|Clinical Progressive Disease|3|||
164286237|NCT00556998|593418287|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
164286238|NCT00556998|593418287|FG000|Voriconazole Intravenous (IV)|Other|4|||
164286239|NCT00556998|593418287|FG000|Voriconazole Oral|Adverse Event|1|||
164286240|NCT00556998|593418287|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
164286241|NCT02721875|593418288|FG000|Overall Study|Progressive disease/relapse|1|||
164286242|NCT02721875|593418289|FG001|Overall Study|Progressive disease/relapse|0|||
164286243|NCT02888106|593418290|FG000|Overall Study|Withdrawal by Subject|1|||
164286244|NCT02888106|593418291|FG001|Overall Study|Withdrawal by Subject|2|||
164286245|NCT02888106|593418292|FG002|Overall Study|Withdrawal by Subject|0|||
164286246|NCT02888106|593418293|FG003|Overall Study|Withdrawal by Subject|1|||
164286247|NCT02888106|593418294|FG004|Overall Study|Withdrawal by Subject|0|||
164286248|NCT02888106|593418295|FG005|Overall Study|Withdrawal by Subject|0|||
164286249|NCT02888106|593418290|FG000|Overall Study|Lost to Follow-up|1|||
164286250|NCT02888106|593418291|FG001|Overall Study|Lost to Follow-up|0|||
164286251|NCT02888106|593418292|FG002|Overall Study|Lost to Follow-up|0|||
164286252|NCT02888106|593418293|FG003|Overall Study|Lost to Follow-up|1|||
164286253|NCT02888106|593418294|FG004|Overall Study|Lost to Follow-up|0|||
164286254|NCT02888106|593418295|FG005|Overall Study|Lost to Follow-up|1|||
164286255|NCT02888106|593418290|FG000|Overall Study|Adverse Event|2|||
164286256|NCT02888106|593418291|FG001|Overall Study|Adverse Event|0|||
164286257|NCT02888106|593418292|FG002|Overall Study|Adverse Event|0|||
164286258|NCT02888106|593418293|FG003|Overall Study|Adverse Event|0|||
164286259|NCT02888106|593418294|FG004|Overall Study|Adverse Event|0|||
164286260|NCT02888106|593418295|FG005|Overall Study|Adverse Event|0|||
164286261|NCT02888106|593418290|FG000|Overall Study|Withdrawal of consent|0|||
164286262|NCT02888106|593418291|FG001|Overall Study|Withdrawal of consent|0|||
164286263|NCT02888106|593418292|FG002|Overall Study|Withdrawal of consent|0|||
164345033|NCT03851705|593638920|FG003|Part 1: Double-Blind Period|Other reason|0|||
164345034|NCT03851705|593638917|FG000|Part 2: Open-Label Period|Other reason|0|||
164345035|NCT03851705|593638918|FG001|Part 2: Open-Label Period|Other reason|0|||
164345036|NCT03851705|593638919|FG002|Part 2: Open-Label Period|Other reason|0|||
164345037|NCT03851705|593638920|FG003|Part 2: Open-Label Period|Other reason|1|||
164345038|NCT03851705|593638917|FG000|Part 2: Open-Label Period|Death|0|||
164345039|NCT03851705|593638918|FG001|Part 2: Open-Label Period|Death|0|||
164345040|NCT03851705|593638919|FG002|Part 2: Open-Label Period|Death|3|||
164286264|NCT02888106|593418293|FG003|Overall Study|Withdrawal of consent|0|||
164286265|NCT02888106|593418294|FG004|Overall Study|Withdrawal of consent|1|||
164286266|NCT02888106|593418295|FG005|Overall Study|Withdrawal of consent|0|||
164286267|NCT02888106|593418290|FG000|Overall Study|Pregnancy|1|||
164286268|NCT02888106|593418291|FG001|Overall Study|Pregnancy|0|||
164286269|NCT02888106|593418292|FG002|Overall Study|Pregnancy|0|||
164286270|NCT02888106|593418293|FG003|Overall Study|Pregnancy|0|||
164286271|NCT02888106|593418294|FG004|Overall Study|Pregnancy|0|||
164286272|NCT02888106|593418295|FG005|Overall Study|Pregnancy|0|||
164286273|NCT00857285|593418296|FG000|Overall Study|Adverse Event|4|||
164286274|NCT00857285|593418297|FG001|Overall Study|Adverse Event|2|||
164286275|NCT00857285|593418296|FG000|Overall Study|Lack of Efficacy|0|||
164286276|NCT00857285|593418297|FG001|Overall Study|Lack of Efficacy|2|||
164286277|NCT00857285|593418296|FG000|Overall Study|Protocol Violation|3|||
164345041|NCT03851705|593638920|FG003|Part 2: Open-Label Period|Death|0|||
164286278|NCT00857285|593418297|FG001|Overall Study|Protocol Violation|1|||
164286279|NCT00857285|593418296|FG000|Overall Study|Withdrawal by Subject|4|||
164286280|NCT00857285|593418297|FG001|Overall Study|Withdrawal by Subject|0|||
164286281|NCT00857285|593418296|FG000|Overall Study|Randomization criteria not met|1|||
164286282|NCT00857285|593418297|FG001|Overall Study|Randomization criteria not met|1|||
164286283|NCT01425801|593418303|FG000|Period 1|Withdrawal by Subject|0|||
164345042|NCT03851705|593638917|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
164345043|NCT03851705|593638918|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
164345044|NCT03851705|593638919|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
164286284|NCT01425801|593418304|FG001|Period 1|Withdrawal by Subject|0|||
164286285|NCT01425801|593418305|FG002|Period 1|Withdrawal by Subject|0|||
164286286|NCT01425801|593418306|FG003|Period 1|Withdrawal by Subject|0|||
164286287|NCT01425801|593418307|FG004|Period 1|Withdrawal by Subject|1|||
164286288|NCT01425801|593418308|FG005|Period 1|Withdrawal by Subject|0|||
164345045|NCT03851705|593638920|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
164286289|NCT01425801|593418303|FG000|Period 2|Withdrawal by Subject|0|||
164286290|NCT01425801|593418304|FG001|Period 2|Withdrawal by Subject|0|||
164286291|NCT01425801|593418305|FG002|Period 2|Withdrawal by Subject|0|||
164286292|NCT01425801|593418306|FG003|Period 2|Withdrawal by Subject|0|||
164286293|NCT01425801|593418307|FG004|Period 2|Withdrawal by Subject|1|||
164286294|NCT01425801|593418308|FG005|Period 2|Withdrawal by Subject|0|||
164286295|NCT01425801|593418303|FG000|Period 3|Stability criteria not fullfilled|0|||
164286296|NCT01425801|593418304|FG001|Period 3|Stability criteria not fullfilled|0|||
164286297|NCT01425801|593418305|FG002|Period 3|Stability criteria not fullfilled|1|||
164286298|NCT01425801|593418306|FG003|Period 3|Stability criteria not fullfilled|0|||
164286299|NCT01425801|593418307|FG004|Period 3|Stability criteria not fullfilled|0|||
164286300|NCT01425801|593418308|FG005|Period 3|Stability criteria not fullfilled|0|||
164286301|NCT01425801|593418303|FG000|Period 4|Not able to maintain visit schedule|0|||
164286302|NCT01425801|593418304|FG001|Period 4|Not able to maintain visit schedule|0|||
164286303|NCT01425801|593418305|FG002|Period 4|Not able to maintain visit schedule|1|||
164286304|NCT01425801|593418306|FG003|Period 4|Not able to maintain visit schedule|0|||
164286305|NCT01425801|593418307|FG004|Period 4|Not able to maintain visit schedule|0|||
164286306|NCT01425801|593418308|FG005|Period 4|Not able to maintain visit schedule|0|||
164286307|NCT03386721|593418309|FG000|Overall Study|Death|12|||
164286308|NCT03386721|593418310|FG001|Overall Study|Death|21|||
164286309|NCT03386721|593418311|FG002|Overall Study|Death|2|||
164286310|NCT03386721|593418312|FG003|Overall Study|Death|5|||
164286311|NCT03386721|593418313|FG004|Overall Study|Death|1|||
164286312|NCT03386721|593418314|FG005|Overall Study|Death|12|||
164286313|NCT03386721|593418315|FG006|Overall Study|Death|1|||
164286314|NCT03386721|593418316|FG007|Overall Study|Death|1|||
164286315|NCT03386721|593418317|FG008|Overall Study|Death|12|||
164286316|NCT03386721|593418318|FG009|Overall Study|Death|20|||
164286317|NCT03386721|593418319|FG010|Overall Study|Death|21|||
164286318|NCT03386721|593418320|FG011|Overall Study|Death|21|||
164286319|NCT03386721|593418321|FG012|Overall Study|Death|14|||
164286320|NCT03386721|593418322|FG013|Overall Study|Death|2|||
164286321|NCT03386721|593418323|FG014|Overall Study|Death|1|||
164286322|NCT03386721|593418309|FG000|Overall Study|Lost to Follow-up|1|||
164286323|NCT03386721|593418310|FG001|Overall Study|Lost to Follow-up|3|||
164286324|NCT03386721|593418311|FG002|Overall Study|Lost to Follow-up|0|||
164286325|NCT03386721|593418312|FG003|Overall Study|Lost to Follow-up|0|||
164286326|NCT03386721|593418313|FG004|Overall Study|Lost to Follow-up|0|||
164286327|NCT03386721|593418314|FG005|Overall Study|Lost to Follow-up|2|||
164286328|NCT03386721|593418315|FG006|Overall Study|Lost to Follow-up|1|||
164286329|NCT03386721|593418316|FG007|Overall Study|Lost to Follow-up|0|||
164286330|NCT03386721|593418317|FG008|Overall Study|Lost to Follow-up|1|||
164286331|NCT03386721|593418318|FG009|Overall Study|Lost to Follow-up|2|||
164286332|NCT03386721|593418319|FG010|Overall Study|Lost to Follow-up|1|||
164286333|NCT03386721|593418320|FG011|Overall Study|Lost to Follow-up|0|||
164286334|NCT03386721|593418321|FG012|Overall Study|Lost to Follow-up|0|||
164286335|NCT03386721|593418322|FG013|Overall Study|Lost to Follow-up|0|||
164286336|NCT03386721|593418323|FG014|Overall Study|Lost to Follow-up|0|||
164286337|NCT03386721|593418309|FG000|Overall Study|Reason not specified|3|||
164286338|NCT03386721|593418310|FG001|Overall Study|Reason not specified|0|||
164286339|NCT03386721|593418311|FG002|Overall Study|Reason not specified|0|||
164286340|NCT03386721|593418312|FG003|Overall Study|Reason not specified|0|||
164286341|NCT03386721|593418313|FG004|Overall Study|Reason not specified|0|||
164345046|NCT03617185|593638921|FG000|Baseline|Lost to Follow-up|0|||
164345047|NCT03617185|593638922|FG001|Baseline|Lost to Follow-up|2|||
164345048|NCT03617185|593638923|FG002|Baseline|Lost to Follow-up|1|||
164345049|NCT03617185|593638924|FG003|Baseline|Lost to Follow-up|1|||
164345050|NCT03617185|593638921|FG000|Baseline|Withdrawal by Subject|0|||
164345051|NCT03617185|593638922|FG001|Baseline|Withdrawal by Subject|1|||
164345052|NCT03617185|593638923|FG002|Baseline|Withdrawal by Subject|0|||
164345053|NCT03617185|593638924|FG003|Baseline|Withdrawal by Subject|1|||
164345054|NCT03617185|593638921|FG000|Baseline|Driving Distance/Travel|0|||
164345055|NCT03617185|593638922|FG001|Baseline|Driving Distance/Travel|0|||
164345056|NCT03617185|593638923|FG002|Baseline|Driving Distance/Travel|2|||
164345057|NCT03617185|593638924|FG003|Baseline|Driving Distance/Travel|0|||
164345058|NCT03617185|593638921|FG000|Baseline|Family Obligations|0|||
164345059|NCT03617185|593638922|FG001|Baseline|Family Obligations|0|||
164003877|NCT01309737|592378216|FG003|Week 16 to 52|Adverse Event|6|||
164286342|NCT03386721|593418314|FG005|Overall Study|Reason not specified|3|||
164286343|NCT03386721|593418315|FG006|Overall Study|Reason not specified|1|||
164286344|NCT03386721|593418316|FG007|Overall Study|Reason not specified|0|||
164286345|NCT03386721|593418317|FG008|Overall Study|Reason not specified|0|||
164286346|NCT03386721|593418318|FG009|Overall Study|Reason not specified|1|||
164286347|NCT03386721|593418319|FG010|Overall Study|Reason not specified|2|||
164286348|NCT03386721|593418320|FG011|Overall Study|Reason not specified|6|||
164286349|NCT03386721|593418321|FG012|Overall Study|Reason not specified|1|||
164286350|NCT03386721|593418322|FG013|Overall Study|Reason not specified|0|||
164286351|NCT03386721|593418323|FG014|Overall Study|Reason not specified|0|||
164286352|NCT03386721|593418309|FG000|Overall Study|Progressive Disease|0|||
164345060|NCT03617185|593638923|FG002|Baseline|Family Obligations|0|||
164345061|NCT03617185|593638924|FG003|Baseline|Family Obligations|1|||
164345062|NCT03617185|593638921|FG000|3 Months|Lost to Follow-up|4|||
164345063|NCT03617185|593638922|FG001|3 Months|Lost to Follow-up|1|||
164345064|NCT03617185|593638923|FG002|3 Months|Lost to Follow-up|0|||
164345065|NCT03617185|593638924|FG003|3 Months|Lost to Follow-up|2|||
164345066|NCT03617185|593638921|FG000|3 Months|Withdrawal by Subject|1|||
164345067|NCT03617185|593638922|FG001|3 Months|Withdrawal by Subject|3|||
164345068|NCT03617185|593638923|FG002|3 Months|Withdrawal by Subject|0|||
164345069|NCT03617185|593638924|FG003|3 Months|Withdrawal by Subject|0|||
164345070|NCT03617185|593638921|FG000|3 Months|Driving Distance/Travel|1|||
164345071|NCT03617185|593638922|FG001|3 Months|Driving Distance/Travel|0|||
164345072|NCT03617185|593638923|FG002|3 Months|Driving Distance/Travel|0|||
164345073|NCT03617185|593638924|FG003|3 Months|Driving Distance/Travel|0|||
164345074|NCT03617185|593638921|FG000|3 Months|Family Obligations|0|||
164345075|NCT03617185|593638922|FG001|3 Months|Family Obligations|0|||
164286353|NCT03386721|593418310|FG001|Overall Study|Progressive Disease|0|||
164286354|NCT03386721|593418311|FG002|Overall Study|Progressive Disease|1|||
164286355|NCT03386721|593418312|FG003|Overall Study|Progressive Disease|0|||
164286356|NCT03386721|593418313|FG004|Overall Study|Progressive Disease|0|||
164286357|NCT03386721|593418314|FG005|Overall Study|Progressive Disease|1|||
164286358|NCT03386721|593418315|FG006|Overall Study|Progressive Disease|0|||
164286359|NCT03386721|593418316|FG007|Overall Study|Progressive Disease|0|||
164286360|NCT03386721|593418317|FG008|Overall Study|Progressive Disease|2|||
164286361|NCT03386721|593418318|FG009|Overall Study|Progressive Disease|1|||
164286362|NCT03386721|593418319|FG010|Overall Study|Progressive Disease|1|||
164286363|NCT03386721|593418320|FG011|Overall Study|Progressive Disease|0|||
164286364|NCT03386721|593418321|FG012|Overall Study|Progressive Disease|1|||
164286365|NCT03386721|593418322|FG013|Overall Study|Progressive Disease|0|||
164286366|NCT03386721|593418323|FG014|Overall Study|Progressive Disease|0|||
164286367|NCT03386721|593418309|FG000|Overall Study|Site Terminated by Sponsor|5|||
164286368|NCT03386721|593418310|FG001|Overall Study|Site Terminated by Sponsor|5|||
164286369|NCT03386721|593418311|FG002|Overall Study|Site Terminated by Sponsor|0|||
164286370|NCT03386721|593418312|FG003|Overall Study|Site Terminated by Sponsor|0|||
164286371|NCT03386721|593418313|FG004|Overall Study|Site Terminated by Sponsor|1|||
164286372|NCT03386721|593418314|FG005|Overall Study|Site Terminated by Sponsor|3|||
164286373|NCT03386721|593418315|FG006|Overall Study|Site Terminated by Sponsor|0|||
164286374|NCT03386721|593418316|FG007|Overall Study|Site Terminated by Sponsor|1|||
164286375|NCT03386721|593418317|FG008|Overall Study|Site Terminated by Sponsor|4|||
164286376|NCT03386721|593418318|FG009|Overall Study|Site Terminated by Sponsor|5|||
164286377|NCT03386721|593418319|FG010|Overall Study|Site Terminated by Sponsor|3|||
164286378|NCT03386721|593418320|FG011|Overall Study|Site Terminated by Sponsor|11|||
164286379|NCT03386721|593418321|FG012|Overall Study|Site Terminated by Sponsor|6|||
164286380|NCT03386721|593418322|FG013|Overall Study|Site Terminated by Sponsor|0|||
164286381|NCT03386721|593418323|FG014|Overall Study|Site Terminated by Sponsor|0|||
164286382|NCT03386721|593418309|FG000|Overall Study|Symptomatic Deterioration|0|||
164286383|NCT03386721|593418310|FG001|Overall Study|Symptomatic Deterioration|0|||
164286384|NCT03386721|593418311|FG002|Overall Study|Symptomatic Deterioration|0|||
164286385|NCT03386721|593418312|FG003|Overall Study|Symptomatic Deterioration|0|||
164286386|NCT03386721|593418313|FG004|Overall Study|Symptomatic Deterioration|0|||
164286387|NCT03386721|593418314|FG005|Overall Study|Symptomatic Deterioration|0|||
164286388|NCT03386721|593418315|FG006|Overall Study|Symptomatic Deterioration|0|||
164286389|NCT03386721|593418316|FG007|Overall Study|Symptomatic Deterioration|0|||
164286390|NCT03386721|593418317|FG008|Overall Study|Symptomatic Deterioration|1|||
164286391|NCT03386721|593418318|FG009|Overall Study|Symptomatic Deterioration|0|||
164286392|NCT03386721|593418319|FG010|Overall Study|Symptomatic Deterioration|0|||
164286393|NCT03386721|593418320|FG011|Overall Study|Symptomatic Deterioration|1|||
164286394|NCT03386721|593418321|FG012|Overall Study|Symptomatic Deterioration|0|||
164286395|NCT03386721|593418322|FG013|Overall Study|Symptomatic Deterioration|0|||
164286396|NCT03386721|593418323|FG014|Overall Study|Symptomatic Deterioration|0|||
164286397|NCT03386721|593418309|FG000|Overall Study|Withdrawal by Subject|1|||
164286398|NCT03386721|593418310|FG001|Overall Study|Withdrawal by Subject|2|||
164286399|NCT03386721|593418311|FG002|Overall Study|Withdrawal by Subject|0|||
164286400|NCT03386721|593418312|FG003|Overall Study|Withdrawal by Subject|0|||
164286401|NCT03386721|593418313|FG004|Overall Study|Withdrawal by Subject|0|||
164286402|NCT03386721|593418314|FG005|Overall Study|Withdrawal by Subject|0|||
164286403|NCT03386721|593418315|FG006|Overall Study|Withdrawal by Subject|0|||
164286404|NCT03386721|593418316|FG007|Overall Study|Withdrawal by Subject|0|||
164286405|NCT03386721|593418317|FG008|Overall Study|Withdrawal by Subject|2|||
164345076|NCT03617185|593638923|FG002|3 Months|Family Obligations|0|||
164345077|NCT03617185|593638924|FG003|3 Months|Family Obligations|1|||
164003878|NCT01309737|592378217|FG004|Week 16 to 52|Adverse Event|5|||
164286406|NCT03386721|593418318|FG009|Overall Study|Withdrawal by Subject|1|||
164286407|NCT03386721|593418319|FG010|Overall Study|Withdrawal by Subject|3|||
164286408|NCT03386721|593418320|FG011|Overall Study|Withdrawal by Subject|2|||
164286409|NCT03386721|593418321|FG012|Overall Study|Withdrawal by Subject|3|||
164345078|NCT03617185|593638921|FG000|12 Months|Lost to Follow-up|3|||
164345079|NCT03617185|593638922|FG001|12 Months|Lost to Follow-up|1|||
164286410|NCT03386721|593418322|FG013|Overall Study|Withdrawal by Subject|0|||
164286411|NCT03386721|593418323|FG014|Overall Study|Withdrawal by Subject|0|||
164286412|NCT03066596|593418324|FG000|Overall Study|Withdrawal by Subject|4|||
164286413|NCT03066596|593418325|FG001|Overall Study|Withdrawal by Subject|2|||
164286414|NCT03066596|593418324|FG000|Overall Study|Lost to Follow-up|14|||
164286415|NCT03066596|593418325|FG001|Overall Study|Lost to Follow-up|10|||
164286416|NCT00700713|593418326|FG000|Overall Study|Protocol Violation|1|||
164286417|NCT00700713|593418327|FG001|Overall Study|Protocol Violation|0|||
164286418|NCT00700713|593418328|FG002|Overall Study|Protocol Violation|1|||
164286419|NCT00700713|593418326|FG000|Overall Study|Withdrawal by Subject|0|||
164003879|NCT01309737|592378213|FG000|Week 16 to 52|Lack of Efficacy|107|||
164003880|NCT01309737|592378214|FG001|Week 16 to 52|Lack of Efficacy|76|||
164286420|NCT00700713|593418327|FG001|Overall Study|Withdrawal by Subject|0|||
164286421|NCT00700713|593418328|FG002|Overall Study|Withdrawal by Subject|1|||
164286422|NCT02959437|593418329|FG000|Overall Study|Death|33|||
164286423|NCT02959437|593418330|FG001|Overall Study|Death|3|||
164286424|NCT02959437|593418331|FG002|Overall Study|Death|0|||
164286425|NCT02959437|593418332|FG003|Overall Study|Death|0|||
164286426|NCT02959437|593418329|FG000|Overall Study|Lost to Follow-up|3|||
164286427|NCT02959437|593418330|FG001|Overall Study|Lost to Follow-up|1|||
164286428|NCT02959437|593418331|FG002|Overall Study|Lost to Follow-up|0|||
164003881|NCT01309737|592378215|FG002|Week 16 to 52|Lack of Efficacy|0|||
164003882|NCT01309737|592378216|FG003|Week 16 to 52|Lack of Efficacy|25|||
164003883|NCT01309737|592378217|FG004|Week 16 to 52|Lack of Efficacy|21|||
164003884|NCT01309737|592378213|FG000|Week 16 to 52|Lost to Follow-up|4|||
164286429|NCT02959437|593418332|FG003|Overall Study|Lost to Follow-up|0|||
164286430|NCT02959437|593418329|FG000|Overall Study|Withdrawal by Subject|11|||
164286431|NCT02959437|593418330|FG001|Overall Study|Withdrawal by Subject|3|||
164286432|NCT02959437|593418331|FG002|Overall Study|Withdrawal by Subject|0|||
164286433|NCT02959437|593418332|FG003|Overall Study|Withdrawal by Subject|0|||
164286434|NCT02959437|593418329|FG000|Overall Study|Progressive Disease|9|||
164286435|NCT02959437|593418330|FG001|Overall Study|Progressive Disease|1|||
164286436|NCT02959437|593418331|FG002|Overall Study|Progressive Disease|0|||
164286437|NCT02959437|593418332|FG003|Overall Study|Progressive Disease|0|||
164286438|NCT02959437|593418329|FG000|Overall Study|Study Terminated by Sponsor|4|||
164286439|NCT02959437|593418330|FG001|Overall Study|Study Terminated by Sponsor|0|||
164286440|NCT02959437|593418331|FG002|Overall Study|Study Terminated by Sponsor|0|||
164286441|NCT02959437|593418332|FG003|Overall Study|Study Terminated by Sponsor|0|||
164286442|NCT02959437|593418329|FG000|Overall Study|Other Unspecified|2|||
164286443|NCT02959437|593418330|FG001|Overall Study|Other Unspecified|0|||
164286444|NCT02959437|593418331|FG002|Overall Study|Other Unspecified|0|||
164286445|NCT02959437|593418332|FG003|Overall Study|Other Unspecified|0|||
164286446|NCT02728089|593418333|FG000|Overall Study|Physician Decision|2|||
164286447|NCT02728089|593418333|FG000|Overall Study|Withdrawal by Subject|1|||
164286448|NCT04089761|593418336|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
164003885|NCT01309737|592378214|FG001|Week 16 to 52|Lost to Follow-up|2|||
164003886|NCT01309737|592378215|FG002|Week 16 to 52|Lost to Follow-up|0|||
164003887|NCT01309737|592378216|FG003|Week 16 to 52|Lost to Follow-up|1|||
164003888|NCT01309737|592378217|FG004|Week 16 to 52|Lost to Follow-up|4|||
164003889|NCT01309737|592378213|FG000|Week 16 to 52|Withdrawal by Subject|5|||
164003890|NCT01309737|592378214|FG001|Week 16 to 52|Withdrawal by Subject|6|||
164003891|NCT01309737|592378215|FG002|Week 16 to 52|Withdrawal by Subject|0|||
164003892|NCT01309737|592378216|FG003|Week 16 to 52|Withdrawal by Subject|0|||
164003893|NCT01309737|592378217|FG004|Week 16 to 52|Withdrawal by Subject|2|||
164003894|NCT01309737|592378213|FG000|Week 16 to 52|Other|10|||
164003895|NCT01309737|592378214|FG001|Week 16 to 52|Other|12|||
164003896|NCT01309737|592378215|FG002|Week 16 to 52|Other|0|||
164003897|NCT01309737|592378216|FG003|Week 16 to 52|Other|2|||
164003898|NCT01309737|592378217|FG004|Week 16 to 52|Other|0|||
164003899|NCT01442181|592378219|FG000|Overall Study|patient refused surgery|1|||
164003900|NCT01442181|592378220|FG001|Overall Study|patient refused surgery|0|||
164286449|NCT04089761|593418336|FG000|"Run In Phase"|Lost to Follow-up|1|||
164286450|NCT04089761|593418336|FG000|"Treatment Phase"|No evaluable data|5|||
164286451|NCT04089761|593418336|FG000|"Treatment Phase"|Lost to Follow-up|1|||
164286452|NCT03868943|593418338|FG000|Overall Study|Adverse Event|1|||
164286453|NCT04896593|593418339|FG000|Overall Study|Withdrawal by Subject|2|||
164003901|NCT01442181|592378219|FG000|Overall Study|no insurance for surgery|1|||
164003902|NCT01442181|592378220|FG001|Overall Study|no insurance for surgery|0|||
164286454|NCT04896593|593418339|FG000|Overall Study|Lost to Follow-up|1|||
164286455|NCT04896593|593418339|FG000|Overall Study|Did not complete onboarding|2|||
164286456|NCT02915978|593418340|FG000|Overall Study|Adverse Event|2|||
164286457|NCT02915978|593418341|FG001|Overall Study|Adverse Event|1|||
164286458|NCT02915978|593418342|FG002|Overall Study|Adverse Event|0|||
164286459|NCT02451124|593418343|FG000|Overall Study|Withdrawal by Subject|1|||
164286460|NCT00892775|593418344|FG000|Overall Study|Protocol Violation|1|||
164286461|NCT00892775|593418345|FG001|Overall Study|Protocol Violation|0|||
164003903|NCT01442181|592378219|FG000|Overall Study|low ejection factor|0|||
164003904|NCT01442181|592378220|FG001|Overall Study|low ejection factor|1|||
164003905|NCT01442181|592378219|FG000|Overall Study|Lost to Follow-up|1|||
164003906|NCT01442181|592378220|FG001|Overall Study|Lost to Follow-up|1|||
164003907|NCT01442181|592378219|FG000|Overall Study|patient in an additional study|1|||
164003908|NCT01442181|592378220|FG001|Overall Study|patient in an additional study|0|||
164003909|NCT01442181|592378219|FG000|Overall Study|atrial fibrillation not noted|0|||
164003910|NCT01442181|592378220|FG001|Overall Study|atrial fibrillation not noted|1|||
164003911|NCT02698189|592378221|FG000|Overall Study|Physician Decision|3|||
164003912|NCT02698189|592378222|FG001|Overall Study|Physician Decision|0|||
164003913|NCT02698189|592378221|FG000|Overall Study|Progressive disease|0|||
164003914|NCT02698189|592378222|FG001|Overall Study|Progressive disease|5|||
164003915|NCT02698189|592378221|FG000|Overall Study|Study terminated by sponsor|0|||
164003916|NCT02698189|592378222|FG001|Overall Study|Study terminated by sponsor|1|||
164003917|NCT00855439|592378223|FG000|Overall Study|Withdrawal by Subject|2|||
164003918|NCT00855439|592378224|FG001|Overall Study|Withdrawal by Subject|0|||
164003919|NCT00855439|592378223|FG000|Overall Study|Pregnancy|1|||
164003920|NCT00855439|592378224|FG001|Overall Study|Pregnancy|0|||
164003921|NCT05502289|592378225|FG000|Period 1|Out Of Window|1|||
164003922|NCT05502289|592378226|FG001|Period 1|Out Of Window|0|||
164003923|NCT02333227|592378231|FG000|Overall Study|Lost to Follow-up|137|||
164003924|NCT02333227|592378232|FG001|Overall Study|Lost to Follow-up|106|||
164003925|NCT02333227|592378231|FG000|Overall Study|Pregnancy Interrupted|42|||
164003926|NCT02333227|592378232|FG001|Overall Study|Pregnancy Interrupted|89|||
164003927|NCT02333227|592378231|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
164003928|NCT02333227|592378232|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
164003929|NCT03459040|592378233|FG000|Overall Study|Death|8|||
164003930|NCT03459040|592378233|FG000|Overall Study|Withdrawal by Subject|1|||
164003931|NCT03934684|592378234|FG000|Overall Study|Participants continuing in study|11|||
164003932|NCT03934684|592378235|FG001|Overall Study|Participants continuing in study|4|||
164003933|NCT03934684|592378234|FG000|Overall Study|Discontinuation of carfilzomib|20|||
164003934|NCT03934684|592378235|FG001|Overall Study|Discontinuation of carfilzomib|30|||
164003935|NCT03934684|592378234|FG000|Overall Study|Death|2|||
164003936|NCT03934684|592378235|FG001|Overall Study|Death|2|||
164003937|NCT03934684|592378234|FG000|Overall Study|Lost to Follow-up|2|||
164003938|NCT03934684|592378235|FG001|Overall Study|Lost to Follow-up|5|||
164003939|NCT03934684|592378234|FG000|Overall Study|Withdrawal by Subject|7|||
164003940|NCT03934684|592378235|FG001|Overall Study|Withdrawal by Subject|8|||
164003941|NCT01073943|592378236|FG000|Overall Study|Withdrawal by Subject|8|||
164003942|NCT01073943|592378237|FG001|Overall Study|Withdrawal by Subject|2|||
164286462|NCT00892775|593418344|FG000|Overall Study|Subject difficulties with blood drawing|1|||
164286463|NCT00892775|593418345|FG001|Overall Study|Subject difficulties with blood drawing|0|||
164286464|NCT00892775|593418344|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
164286465|NCT00892775|593418345|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
164286466|NCT00892775|593418344|FG000|Overall Study|Migrated/ moved from study area|1|||
164286467|NCT00892775|593418345|FG001|Overall Study|Migrated/ moved from study area|0|||
164286468|NCT00892775|593418344|FG000|Overall Study|Withdrawal by Subject|0|||
164286469|NCT00892775|593418345|FG001|Overall Study|Withdrawal by Subject|1|||
164286470|NCT00892775|593418344|FG000|Overall Study|Lost to Follow-up|1|||
164286471|NCT00892775|593418345|FG001|Overall Study|Lost to Follow-up|0|||
164286472|NCT00103740|593418346|FG000|Period 1 - Core|Adverse Event|1|||
164286473|NCT00103740|593418347|FG001|Period 1 - Core|Adverse Event|0|||
164286474|NCT00103740|593418346|FG000|Period 1 - Core|Protocol Violation|3|||
164286475|NCT00103740|593418347|FG001|Period 1 - Core|Protocol Violation|2|||
164286476|NCT00103740|593418346|FG000|Period 1 - Core|Patient withdrew consent|3|||
164286477|NCT00103740|593418347|FG001|Period 1 - Core|Patient withdrew consent|2|||
164286478|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
164286479|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
164286480|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
164345080|NCT03617185|593638923|FG002|12 Months|Lost to Follow-up|3|||
164345081|NCT03617185|593638924|FG003|12 Months|Lost to Follow-up|0|||
164345082|NCT03617185|593638921|FG000|12 Months|Withdrawal by Subject|0|||
164345083|NCT03617185|593638922|FG001|12 Months|Withdrawal by Subject|0|||
164345084|NCT03617185|593638923|FG002|12 Months|Withdrawal by Subject|0|||
164345085|NCT03617185|593638924|FG003|12 Months|Withdrawal by Subject|1|||
164345086|NCT03617185|593638921|FG000|12 Months|Driving Distance/Travel|0|||
164003943|NCT01073943|592378236|FG000|Overall Study|Protocol Violation|2|||
164003944|NCT01073943|592378237|FG001|Overall Study|Protocol Violation|1|||
164003945|NCT01073943|592378236|FG000|Overall Study|Adverse Event|1|||
164087806|NCT03390504|592685801|FG001|Overall Study|Lost to Follow-up|4|||
164087807|NCT03390504|592685802|FG002|Overall Study|Lost to Follow-up|0|||
164087808|NCT03390504|592685803|FG003|Overall Study|Lost to Follow-up|1|||
164345087|NCT03617185|593638922|FG001|12 Months|Driving Distance/Travel|0|||
164345088|NCT03617185|593638923|FG002|12 Months|Driving Distance/Travel|1|||
164345089|NCT03617185|593638924|FG003|12 Months|Driving Distance/Travel|0|||
164003946|NCT01073943|592378237|FG001|Overall Study|Adverse Event|1|||
164003947|NCT01073943|592378236|FG000|Overall Study|Lost to Follow-up|0|||
164003948|NCT01073943|592378237|FG001|Overall Study|Lost to Follow-up|2|||
164087809|NCT03390504|592685800|FG000|Overall Study|Withdrawal by Subject|3|||
164286481|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
164286482|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
164286483|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
164286484|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Death|6|||
164286485|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Death|2|||
164286486|NCT00103740|593418346|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
164286487|NCT00103740|593418347|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
164286488|NCT01463306|593418348|FG000|Overall Study|Adverse Event|6|||
164286489|NCT01463306|593418349|FG001|Overall Study|Adverse Event|9|||
164286490|NCT01463306|593418350|FG002|Overall Study|Adverse Event|3|||
164286491|NCT01463306|593418348|FG000|Overall Study|Death|3|||
164003949|NCT01073943|592378236|FG000|Overall Study|Power outage; colonoscopy not done|1|||
164003950|NCT01073943|592378237|FG001|Overall Study|Power outage; colonoscopy not done|0|||
164003951|NCT01073943|592378236|FG000|Overall Study|Subject forgot|0|||
164003952|NCT01073943|592378237|FG001|Overall Study|Subject forgot|1|||
164003953|NCT01073943|592378236|FG000|Overall Study|Unable to return for follow-up|0|||
164003954|NCT01073943|592378237|FG001|Overall Study|Unable to return for follow-up|1|||
164003955|NCT01073943|592378236|FG000|Overall Study|Could not tolerate prep|1|||
164003956|NCT01073943|592378237|FG001|Overall Study|Could not tolerate prep|0|||
164003957|NCT00761215|592378238|FG000|Overall Study|Randomized but didn't receive drug|1|||
164003958|NCT00761215|592378239|FG001|Overall Study|Randomized but didn't receive drug|1|||
164286492|NCT01463306|593418349|FG001|Overall Study|Death|3|||
164286493|NCT01463306|593418350|FG002|Overall Study|Death|0|||
164286494|NCT01463306|593418348|FG000|Overall Study|Lack of Efficacy|22|||
164286495|NCT01463306|593418349|FG001|Overall Study|Lack of Efficacy|16|||
164286496|NCT01463306|593418350|FG002|Overall Study|Lack of Efficacy|1|||
164286497|NCT01463306|593418348|FG000|Overall Study|Lost to Follow-up|5|||
164286498|NCT01463306|593418349|FG001|Overall Study|Lost to Follow-up|2|||
164286499|NCT01463306|593418350|FG002|Overall Study|Lost to Follow-up|0|||
164286500|NCT01463306|593418348|FG000|Overall Study|Protocol Violation|4|||
164003959|NCT00761215|592378240|FG002|Overall Study|Randomized but didn't receive drug|2|||
164003960|NCT00761215|592378238|FG000|Overall Study|Lost to Follow-up|6|||
164003961|NCT00761215|592378239|FG001|Overall Study|Lost to Follow-up|3|||
164003962|NCT00761215|592378240|FG002|Overall Study|Lost to Follow-up|6|||
164003963|NCT00761215|592378238|FG000|Overall Study|Withdrawal by Subject|1|||
164286501|NCT01463306|593418349|FG001|Overall Study|Protocol Violation|0|||
164286502|NCT01463306|593418350|FG002|Overall Study|Protocol Violation|0|||
164003964|NCT00761215|592378239|FG001|Overall Study|Withdrawal by Subject|0|||
164003965|NCT00761215|592378240|FG002|Overall Study|Withdrawal by Subject|0|||
164003966|NCT00761215|592378238|FG000|Overall Study|Bacteremia|1|||
164003967|NCT00761215|592378239|FG001|Overall Study|Bacteremia|0|||
164003968|NCT00761215|592378240|FG002|Overall Study|Bacteremia|0|||
164003969|NCT05662332|592378241|FG000|Overall Study|Death|3|||
164003970|NCT05662332|592378242|FG001|Overall Study|Death|3|||
164003971|NCT05662332|592378241|FG000|Overall Study|Lost to Follow-up|3|||
164003972|NCT05662332|592378242|FG001|Overall Study|Lost to Follow-up|8|||
164003973|NCT05662332|592378241|FG000|Overall Study|Physician Decision|1|||
164003974|NCT05662332|592378242|FG001|Overall Study|Physician Decision|2|||
164003975|NCT05662332|592378241|FG000|Overall Study|Protocol Deviation|2|||
164003976|NCT05662332|592378242|FG001|Overall Study|Protocol Deviation|1|||
164003977|NCT05662332|592378241|FG000|Overall Study|Withdrawal by Subject|14|||
164003978|NCT05662332|592378242|FG001|Overall Study|Withdrawal by Subject|14|||
164286503|NCT01463306|593418348|FG000|Overall Study|Withdrawal by Subject|19|||
164286504|NCT01463306|593418349|FG001|Overall Study|Withdrawal by Subject|9|||
164286505|NCT01463306|593418350|FG002|Overall Study|Withdrawal by Subject|1|||
164286506|NCT01463306|593418348|FG000|Overall Study|Other|26|||
164286507|NCT01463306|593418349|FG001|Overall Study|Other|13|||
164286508|NCT01463306|593418350|FG002|Overall Study|Other|0|||
164286509|NCT01463306|593418348|FG000|Overall Study|Approval expiry at site|1|||
164286510|NCT01463306|593418349|FG001|Overall Study|Approval expiry at site|0|||
164286511|NCT01463306|593418350|FG002|Overall Study|Approval expiry at site|0|||
164003979|NCT05662332|592378241|FG000|Overall Study|Assigned Treatment by Mistake|5|||
164003980|NCT05662332|592378242|FG001|Overall Study|Assigned Treatment by Mistake|7|||
164003981|NCT05662332|592378241|FG000|Overall Study|Non-compliance with study drug|4|||
164003982|NCT05662332|592378242|FG001|Overall Study|Non-compliance with study drug|1|||
164286512|NCT00250276|593418354|FG000|Overall Study|Serious Adverse Event|0|||
164286513|NCT00250276|593418355|FG001|Overall Study|Serious Adverse Event|0|||
164286514|NCT00250276|593418356|FG002|Overall Study|Serious Adverse Event|1|||
164286515|NCT00250276|593418357|FG003|Overall Study|Serious Adverse Event|0|||
164286516|NCT00250276|593418354|FG000|Overall Study|Non-serious Adverse Event|2|||
164003983|NCT05662332|592378241|FG000|Overall Study|Due to Bariatric surgery|1|||
164003984|NCT05662332|592378242|FG001|Overall Study|Due to Bariatric surgery|0|||
164003985|NCT05662332|592378241|FG000|Overall Study|Subject Moving out of State|0|||
164003986|NCT05662332|592378242|FG001|Overall Study|Subject Moving out of State|1|||
164286517|NCT00250276|593418355|FG001|Overall Study|Non-serious Adverse Event|0|||
164286518|NCT00250276|593418356|FG002|Overall Study|Non-serious Adverse Event|0|||
164286519|NCT00250276|593418357|FG003|Overall Study|Non-serious Adverse Event|2|||
164286520|NCT00250276|593418354|FG000|Overall Study|Protocol Violation|0|||
164286521|NCT00250276|593418355|FG001|Overall Study|Protocol Violation|1|||
164286522|NCT00250276|593418356|FG002|Overall Study|Protocol Violation|0|||
164286523|NCT00250276|593418357|FG003|Overall Study|Protocol Violation|0|||
164286524|NCT00250276|593418354|FG000|Overall Study|Withdrawal by Subject|1|||
164286525|NCT00250276|593418355|FG001|Overall Study|Withdrawal by Subject|2|||
164286526|NCT00250276|593418356|FG002|Overall Study|Withdrawal by Subject|3|||
164286527|NCT00250276|593418357|FG003|Overall Study|Withdrawal by Subject|2|||
164286528|NCT00250276|593418354|FG000|Overall Study|Migrated/moved from study area|3|||
164286529|NCT00250276|593418355|FG001|Overall Study|Migrated/moved from study area|0|||
164003987|NCT05662332|592378241|FG000|Overall Study|Subject Missed the Schedule|1|||
164003988|NCT05662332|592378242|FG001|Overall Study|Subject Missed the Schedule|0|||
164003989|NCT05662332|592378241|FG000|Overall Study|The Patient Moved to Another City|1|||
164003990|NCT05662332|592378242|FG001|Overall Study|The Patient Moved to Another City|0|||
164286530|NCT00250276|593418356|FG002|Overall Study|Migrated/moved from study area|2|||
164286531|NCT00250276|593418357|FG003|Overall Study|Migrated/moved from study area|7|||
164003991|NCT00947349|592378243|FG000|Triple Treatment Combination Period|Adverse Event|0|||
164003992|NCT00947349|592378244|FG001|Triple Treatment Combination Period|Adverse Event|1|||
164003993|NCT00947349|592378245|FG002|Triple Treatment Combination Period|Adverse Event|0|||
164003994|NCT00947349|592378246|FG003|Triple Treatment Combination Period|Adverse Event|0|||
164345090|NCT01964430|593638926|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
164345091|NCT01964430|593638927|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
164345092|NCT01964430|593638926|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
164345093|NCT01964430|593638927|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
164345094|NCT01964430|593638926|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
164345095|NCT01964430|593638927|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
164345096|NCT01964430|593638926|FG000|Treatment Period|Adverse Event|71|||
164345097|NCT01964430|593638927|FG001|Treatment Period|Adverse Event|37|||
164345098|NCT01964430|593638926|FG000|Treatment Period|Withdrawal by Subject|36|||
164345099|NCT01964430|593638927|FG001|Treatment Period|Withdrawal by Subject|27|||
164345100|NCT01964430|593638926|FG000|Treatment Period|Death|1|||
164345101|NCT01964430|593638927|FG001|Treatment Period|Death|3|||
164345102|NCT01964430|593638926|FG000|Treatment Period|Protocol Deviation|0|||
164345103|NCT01964430|593638927|FG001|Treatment Period|Protocol Deviation|1|||
164345104|NCT01964430|593638926|FG000|Treatment Period|Physician Decision|5|||
164345105|NCT01964430|593638927|FG001|Treatment Period|Physician Decision|4|||
164345106|NCT01964430|593638926|FG000|Treatment Period|Disease Relapse|28|||
164345107|NCT01964430|593638927|FG001|Treatment Period|Disease Relapse|38|||
164345108|NCT01964430|593638926|FG000|Treatment Period|Other reasons|1|||
164345109|NCT01964430|593638927|FG001|Treatment Period|Other reasons|3|||
164345110|NCT02591290|593638928|FG000|Overall Study|Withdrawal by Subject|2|||
164345111|NCT02571075|593638929|FG000|Overall Study|Lost to Follow-up|20|||
164345112|NCT02571075|593638930|FG001|Overall Study|Lost to Follow-up|24|||
164345113|NCT00913497|593638933|FG000|Overall Study|Adverse Event|1|||
164345114|NCT00913497|593638933|FG000|Overall Study|Withdrawal by Subject|2|||
164345115|NCT03190915|593638934|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
164345116|NCT03190915|593638934|FG000|Overall Study|Progressive Disease|3|||
164345117|NCT02021773|593638946|FG000|Overall Study|Adverse Event|1|||
164345118|NCT02021773|593638947|FG001|Overall Study|Adverse Event|4|||
164345119|NCT02021773|593638948|FG002|Overall Study|Adverse Event|3|||
164345120|NCT02021773|593638946|FG000|Overall Study|Lack of Efficacy|2|||
164345121|NCT02021773|593638947|FG001|Overall Study|Lack of Efficacy|2|||
164345122|NCT02021773|593638948|FG002|Overall Study|Lack of Efficacy|2|||
164345123|NCT02021773|593638946|FG000|Overall Study|Protocol Violation|2|||
164345124|NCT02021773|593638947|FG001|Overall Study|Protocol Violation|3|||
164345125|NCT02021773|593638948|FG002|Overall Study|Protocol Violation|1|||
164345126|NCT02021773|593638946|FG000|Overall Study|Withdrawal by Subject|3|||
164345127|NCT02021773|593638947|FG001|Overall Study|Withdrawal by Subject|4|||
164345128|NCT02021773|593638948|FG002|Overall Study|Withdrawal by Subject|5|||
164345129|NCT02021773|593638946|FG000|Overall Study|Lost to Follow-up|1|||
164345130|NCT02021773|593638947|FG001|Overall Study|Lost to Follow-up|3|||
164345131|NCT02021773|593638948|FG002|Overall Study|Lost to Follow-up|0|||
164345132|NCT02021773|593638946|FG000|Overall Study|Reason not specified|3|||
164345133|NCT02021773|593638947|FG001|Overall Study|Reason not specified|0|||
164345134|NCT02021773|593638948|FG002|Overall Study|Reason not specified|0|||
164345135|NCT00478231|593638952|FG000|Overall Study|Death|7|||
164345136|NCT00478231|593638952|FG000|Overall Study|Lack of Efficacy|47|||
164003995|NCT00947349|592378243|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
164345137|NCT00478231|593638952|FG000|Overall Study|Lost to Follow-up|7|||
164345138|NCT00478231|593638952|FG000|Overall Study|Withdrawal by Subject|6|||
164345139|NCT00478231|593638952|FG000|Overall Study|Other|9|||
164286532|NCT00250276|593418354|FG000|Overall Study|Lost to Follow-up|11|||
164345140|NCT00478231|593638952|FG000|Overall Study|Adverse Event|5|||
164345141|NCT00478231|593638952|FG000|Overall Study|Randomized, not treated|3|||
164345142|NCT00191139|593638955|FG000|Overall Study|Adverse Event|2|||
164003996|NCT00947349|592378244|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
164003997|NCT00947349|592378245|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
164003998|NCT00947349|592378246|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
164003999|NCT00947349|592378243|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
164004000|NCT00947349|592378244|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
164004001|NCT00947349|592378245|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
164004002|NCT00947349|592378246|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
164004003|NCT00947349|592378243|FG000|Overall Study Standard of Care|Other|0|||
164004004|NCT00947349|592378244|FG001|Overall Study Standard of Care|Other|0|||
164004005|NCT00947349|592378245|FG002|Overall Study Standard of Care|Other|0|||
164004006|NCT00947349|592378246|FG003|Overall Study Standard of Care|Other|1|||
164004007|NCT00538681|592378247|FG000|Overall Study|Progressive Disease|7|||
164004008|NCT00538681|592378248|FG001|Overall Study|Progressive Disease|0|||
164004009|NCT00538681|592378249|FG002|Overall Study|Progressive Disease|1|||
164004010|NCT00538681|592378250|FG003|Overall Study|Progressive Disease|0|||
164004011|NCT00538681|592378247|FG000|Overall Study|Sponsor Decision|1|||
164004012|NCT00538681|592378248|FG001|Overall Study|Sponsor Decision|3|||
164004013|NCT00538681|592378249|FG002|Overall Study|Sponsor Decision|8|||
164004014|NCT00538681|592378250|FG003|Overall Study|Sponsor Decision|9|||
164004015|NCT00538681|592378247|FG000|Overall Study|Adverse Event|1|||
164004016|NCT00538681|592378248|FG001|Overall Study|Adverse Event|1|||
164004017|NCT00538681|592378249|FG002|Overall Study|Adverse Event|1|||
164004018|NCT00538681|592378250|FG003|Overall Study|Adverse Event|0|||
164004019|NCT00538681|592378247|FG000|Overall Study|Death|0|||
164004020|NCT00538681|592378248|FG001|Overall Study|Death|0|||
164004021|NCT00538681|592378249|FG002|Overall Study|Death|1|||
164004022|NCT00538681|592378250|FG003|Overall Study|Death|1|||
164004023|NCT00538681|592378247|FG000|Overall Study|Investigator Decision|0|||
164004024|NCT00538681|592378248|FG001|Overall Study|Investigator Decision|0|||
164004025|NCT00538681|592378249|FG002|Overall Study|Investigator Decision|0|||
164004026|NCT00538681|592378250|FG003|Overall Study|Investigator Decision|1|||
164004027|NCT00628355|592378251|FG000|Overall Study|Withdrawal by Subject|1|||
164004028|NCT00628355|592378252|FG001|Overall Study|Withdrawal by Subject|1|||
164004029|NCT01446809|592378253|FG000|Overall Study|Adverse Event|0|||
164004030|NCT01446809|592378254|FG001|Overall Study|Adverse Event|0|||
164004031|NCT01446809|592378255|FG002|Overall Study|Adverse Event|1|||
164004032|NCT01446809|592378253|FG000|Overall Study|Failure to complete study procedures|0|||
164004033|NCT01446809|592378254|FG001|Overall Study|Failure to complete study procedures|0|||
164004034|NCT01446809|592378255|FG002|Overall Study|Failure to complete study procedures|1|||
164004035|NCT03395210|592380675|FG000|Overall Study|Other|0|||
164004036|NCT03395210|592380676|FG001|Overall Study|Other|0|||
164004037|NCT03395210|592380677|FG002|Overall Study|Other|0|||
164004038|NCT03395210|592380678|FG003|Overall Study|Other|0|||
164004039|NCT03395210|592380679|FG004|Overall Study|Other|1|||
164004040|NCT03395210|592380675|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
164004041|NCT03395210|592380676|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
164004042|NCT03395210|592380677|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
164004043|NCT03395210|592380678|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
164004044|NCT03395210|592380679|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
164004045|NCT03395210|592380675|FG000|Overall Study|Adverse Event|1|||
164004046|NCT03395210|592380676|FG001|Overall Study|Adverse Event|0|||
164004047|NCT03395210|592380677|FG002|Overall Study|Adverse Event|2|||
164004048|NCT03395210|592380678|FG003|Overall Study|Adverse Event|4|||
164004049|NCT03395210|592380679|FG004|Overall Study|Adverse Event|3|||
164004050|NCT03395210|592380675|FG000|Overall Study|Need of Rescue Medication|1|||
164004051|NCT03395210|592380676|FG001|Overall Study|Need of Rescue Medication|0|||
164004052|NCT03395210|592380677|FG002|Overall Study|Need of Rescue Medication|1|||
164004053|NCT03395210|592380678|FG003|Overall Study|Need of Rescue Medication|4|||
164004054|NCT03395210|592380679|FG004|Overall Study|Need of Rescue Medication|0|||
164004055|NCT03395210|592380675|FG000|Overall Study|Lack of Response|0|||
164004056|NCT03395210|592380676|FG001|Overall Study|Lack of Response|0|||
164345143|NCT00191139|593638956|FG001|Overall Study|Adverse Event|6|||
164345144|NCT00191139|593638955|FG000|Overall Study|Death|2|||
164345145|NCT00191139|593638956|FG001|Overall Study|Death|0|||
164345146|NCT00191139|593638955|FG000|Overall Study|Withdrawal by Subject|0|||
164345147|NCT00191139|593638956|FG001|Overall Study|Withdrawal by Subject|3|||
164345148|NCT00191139|593638955|FG000|Overall Study|Disease Progression|0|||
164345149|NCT00191139|593638956|FG001|Overall Study|Disease Progression|1|||
164004057|NCT03395210|592380677|FG002|Overall Study|Lack of Response|0|||
164004058|NCT03395210|592380678|FG003|Overall Study|Lack of Response|5|||
164004059|NCT03395210|592380679|FG004|Overall Study|Lack of Response|5|||
164004060|NCT03395210|592380675|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
164004061|NCT03395210|592380676|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
164004062|NCT03395210|592380677|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
164004063|NCT03395210|592380678|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
164345150|NCT00191139|593638955|FG000|Overall Study|Other|1|||
164004064|NCT03395210|592380679|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
164004065|NCT03395210|592380675|FG000|Overall Study|Participant Decision|1|||
164004066|NCT03395210|592380676|FG001|Overall Study|Participant Decision|1|||
164004067|NCT03395210|592380677|FG002|Overall Study|Participant Decision|0|||
164004068|NCT03395210|592380678|FG003|Overall Study|Participant Decision|4|||
164004069|NCT03395210|592380679|FG004|Overall Study|Participant Decision|0|||
164004070|NCT03395210|592380675|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
164004071|NCT03395210|592380676|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
164004072|NCT03395210|592380677|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
164004073|NCT03395210|592380678|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
164004074|NCT03395210|592380679|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
164004075|NCT00886821|592380682|FG000|Stage 2|Adverse Event|0|||
164004076|NCT00886821|592380683|FG001|Stage 2|Adverse Event|0|||
164004077|NCT00886821|592380684|FG002|Stage 2|Adverse Event|0|||
164286533|NCT00250276|593418355|FG001|Overall Study|Lost to Follow-up|18|||
164286534|NCT00250276|593418356|FG002|Overall Study|Lost to Follow-up|13|||
164286535|NCT00250276|593418357|FG003|Overall Study|Lost to Follow-up|8|||
164286536|NCT00983385|593418363|FG000|Observation Period|Not eligible to be dosed|20|||
164286537|NCT00983385|593418363|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
164286538|NCT00163020|593418364|FG000|Overall Study|Lost to Follow-up|0|||
164286539|NCT00163020|593418365|FG001|Overall Study|Lost to Follow-up|2|||
164286540|NCT00985673|593420666|FG000|Overall Study|Lost to Follow-up|6|||
164286541|NCT00985673|593420667|FG001|Overall Study|Lost to Follow-up|7|||
164286542|NCT00985673|593420668|FG002|Overall Study|Lost to Follow-up|6|||
164286543|NCT00985673|593420669|FG003|Overall Study|Lost to Follow-up|10|||
164286544|NCT00985673|593420670|FG004|Overall Study|Lost to Follow-up|5|||
164286545|NCT00985673|593420671|FG005|Overall Study|Lost to Follow-up|3|||
164286546|NCT00985673|593420666|FG000|Overall Study|Withdrawal by Subject|0|||
164286547|NCT00985673|593420667|FG001|Overall Study|Withdrawal by Subject|4|||
164286548|NCT00985673|593420668|FG002|Overall Study|Withdrawal by Subject|5|||
164286549|NCT00985673|593420669|FG003|Overall Study|Withdrawal by Subject|2|||
164286550|NCT00985673|593420670|FG004|Overall Study|Withdrawal by Subject|2|||
164286551|NCT00985673|593420671|FG005|Overall Study|Withdrawal by Subject|3|||
164286552|NCT00985673|593420666|FG000|Overall Study|Other|1|||
164286553|NCT00985673|593420667|FG001|Overall Study|Other|0|||
164286554|NCT00985673|593420668|FG002|Overall Study|Other|1|||
164286555|NCT00985673|593420669|FG003|Overall Study|Other|0|||
164004078|NCT00886821|592380685|FG003|Stage 2|Adverse Event|0|||
164004079|NCT00886821|592380686|FG004|Stage 2|Adverse Event|0|||
164004080|NCT00886821|592380687|FG005|Stage 2|Adverse Event|0|||
164004081|NCT00886821|592380688|FG006|Stage 2|Adverse Event|0|||
164004082|NCT00886821|592380689|FG007|Stage 2|Adverse Event|0|||
164004083|NCT00886821|592380690|FG008|Stage 2|Adverse Event|0|||
164004084|NCT00886821|592380691|FG009|Stage 2|Adverse Event|0|||
164004085|NCT00886821|592380692|FG010|Stage 2|Adverse Event|0|||
164004086|NCT00886821|592380693|FG011|Stage 2|Adverse Event|1|||
164004087|NCT00886821|592380694|FG012|Stage 2|Adverse Event|3|||
164004088|NCT00886821|592380695|FG013|Stage 2|Adverse Event|0|||
164004089|NCT00886821|592380682|FG000|Stage 2|Lost to Follow-up|0|||
164004090|NCT00886821|592380683|FG001|Stage 2|Lost to Follow-up|0|||
164004091|NCT00886821|592380684|FG002|Stage 2|Lost to Follow-up|0|||
164004092|NCT00886821|592380685|FG003|Stage 2|Lost to Follow-up|0|||
164004093|NCT00886821|592380686|FG004|Stage 2|Lost to Follow-up|0|||
164004094|NCT00886821|592380687|FG005|Stage 2|Lost to Follow-up|0|||
164004095|NCT00886821|592380688|FG006|Stage 2|Lost to Follow-up|0|||
164004096|NCT00886821|592380689|FG007|Stage 2|Lost to Follow-up|0|||
164004097|NCT00886821|592380690|FG008|Stage 2|Lost to Follow-up|0|||
164004098|NCT00886821|592380691|FG009|Stage 2|Lost to Follow-up|0|||
164004099|NCT00886821|592380692|FG010|Stage 2|Lost to Follow-up|0|||
164004100|NCT00886821|592380693|FG011|Stage 2|Lost to Follow-up|0|||
164004101|NCT00886821|592380694|FG012|Stage 2|Lost to Follow-up|2|||
164004102|NCT00886821|592380695|FG013|Stage 2|Lost to Follow-up|1|||
164004103|NCT03716726|592380696|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
164004104|NCT03716726|592380697|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
164004105|NCT03716726|592380696|FG000|12 Months Followup|Lost to Follow-up|10|||
164004106|NCT03716726|592380697|FG001|12 Months Followup|Lost to Follow-up|17|||
164286556|NCT00985673|593420670|FG004|Overall Study|Other|1|||
164286557|NCT00985673|593420671|FG005|Overall Study|Other|0|||
164286558|NCT02252146|593420672|FG000|Overall Study|Lack of Efficacy|4|||
164286559|NCT02252146|593420672|FG000|Overall Study|Entered hospice care|1|||
164286560|NCT02252146|593420672|FG000|Overall Study|Inability to travel to study site|1|||
164286561|NCT00531284|593420673|FG000|Overall Study|Progressive Disease|1|||
164286562|NCT00531284|593420674|FG001|Overall Study|Progressive Disease|3|||
164004107|NCT02579603|592380698|FG000|Overall Study|Not treated|1|||
164004108|NCT02579603|592380699|FG001|Overall Study|Not treated|0|||
164004109|NCT02579603|592380698|FG000|Overall Study|Adverse Event|2|||
164004110|NCT02579603|592380699|FG001|Overall Study|Adverse Event|2|||
164004111|NCT02579603|592380698|FG000|Overall Study|Other than stated|1|||
164004112|NCT02579603|592380699|FG001|Overall Study|Other than stated|0|||
164286563|NCT00531284|593420675|FG002|Overall Study|Progressive Disease|5|||
164004113|NCT00469079|592380700|FG000|Overall Study|Lack of Efficacy|3|||
164004114|NCT00469079|592380701|FG001|Overall Study|Lack of Efficacy|8|||
164004115|NCT00469079|592380702|FG002|Overall Study|Lack of Efficacy|5|||
164004116|NCT00469079|592380700|FG000|Overall Study|Adverse Event|1|||
164004117|NCT00469079|592380701|FG001|Overall Study|Adverse Event|3|||
164004118|NCT00469079|592380702|FG002|Overall Study|Adverse Event|2|||
164004119|NCT00469079|592380700|FG000|Overall Study|Lost to Follow-up|4|||
164004120|NCT00469079|592380701|FG001|Overall Study|Lost to Follow-up|8|||
164004121|NCT00469079|592380702|FG002|Overall Study|Lost to Follow-up|10|||
164004122|NCT00469079|592380700|FG000|Overall Study|Withdrawal by Subject|1|||
164004123|NCT00469079|592380701|FG001|Overall Study|Withdrawal by Subject|2|||
164004124|NCT00469079|592380702|FG002|Overall Study|Withdrawal by Subject|2|||
164286564|NCT00531284|593420676|FG003|Overall Study|Progressive Disease|42|||
164286565|NCT00531284|593420677|FG004|Overall Study|Progressive Disease|4|||
164286566|NCT00531284|593420678|FG005|Overall Study|Progressive Disease|4|||
164286567|NCT00531284|593420679|FG006|Overall Study|Progressive Disease|3|||
164286568|NCT00531284|593420680|FG007|Overall Study|Progressive Disease|8|||
164286569|NCT00531284|593420681|FG008|Overall Study|Progressive Disease|6|||
164286570|NCT00531284|593420682|FG009|Overall Study|Progressive Disease|3|||
164286571|NCT00531284|593420683|FG010|Overall Study|Progressive Disease|3|||
164286572|NCT00531284|593420684|FG011|Overall Study|Progressive Disease|14|||
164286573|NCT00531284|593420685|FG012|Overall Study|Progressive Disease|2|||
164286574|NCT00531284|593420686|FG013|Overall Study|Progressive Disease|1|||
164286575|NCT00531284|593420687|FG014|Overall Study|Progressive Disease|2|||
164286576|NCT00531284|593420688|FG015|Overall Study|Progressive Disease|11|||
164286577|NCT00531284|593420689|FG016|Overall Study|Progressive Disease|5|||
164286578|NCT00531284|593420673|FG000|Overall Study|Adverse Event|0|||
164286579|NCT00531284|593420674|FG001|Overall Study|Adverse Event|1|||
164286580|NCT00531284|593420675|FG002|Overall Study|Adverse Event|1|||
164286581|NCT00531284|593420676|FG003|Overall Study|Adverse Event|7|||
164286582|NCT00531284|593420677|FG004|Overall Study|Adverse Event|0|||
164286583|NCT00531284|593420678|FG005|Overall Study|Adverse Event|2|||
164286584|NCT00531284|593420679|FG006|Overall Study|Adverse Event|3|||
164286585|NCT00531284|593420680|FG007|Overall Study|Adverse Event|2|||
164286586|NCT00531284|593420681|FG008|Overall Study|Adverse Event|3|||
164286587|NCT00531284|593420682|FG009|Overall Study|Adverse Event|0|||
164286588|NCT00531284|593420683|FG010|Overall Study|Adverse Event|0|||
164286589|NCT00531284|593420684|FG011|Overall Study|Adverse Event|5|||
164286590|NCT00531284|593420685|FG012|Overall Study|Adverse Event|0|||
164286591|NCT00531284|593420686|FG013|Overall Study|Adverse Event|1|||
164286592|NCT00531284|593420687|FG014|Overall Study|Adverse Event|1|||
164286593|NCT00531284|593420688|FG015|Overall Study|Adverse Event|0|||
164286594|NCT00531284|593420689|FG016|Overall Study|Adverse Event|2|||
164286595|NCT00531284|593420673|FG000|Overall Study|Withdrawal by Subject|1|||
164286596|NCT00531284|593420674|FG001|Overall Study|Withdrawal by Subject|0|||
164286597|NCT00531284|593420675|FG002|Overall Study|Withdrawal by Subject|0|||
164286598|NCT00531284|593420676|FG003|Overall Study|Withdrawal by Subject|4|||
164286599|NCT00531284|593420677|FG004|Overall Study|Withdrawal by Subject|0|||
164286600|NCT00531284|593420678|FG005|Overall Study|Withdrawal by Subject|0|||
164286601|NCT00531284|593420679|FG006|Overall Study|Withdrawal by Subject|0|||
164286602|NCT00531284|593420680|FG007|Overall Study|Withdrawal by Subject|0|||
164286603|NCT00531284|593420681|FG008|Overall Study|Withdrawal by Subject|0|||
164286604|NCT00531284|593420682|FG009|Overall Study|Withdrawal by Subject|0|||
164286605|NCT00531284|593420683|FG010|Overall Study|Withdrawal by Subject|0|||
164286606|NCT00531284|593420684|FG011|Overall Study|Withdrawal by Subject|3|||
164286607|NCT00531284|593420685|FG012|Overall Study|Withdrawal by Subject|0|||
164286608|NCT00531284|593420686|FG013|Overall Study|Withdrawal by Subject|1|||
164286609|NCT00531284|593420687|FG014|Overall Study|Withdrawal by Subject|0|||
164286610|NCT00531284|593420688|FG015|Overall Study|Withdrawal by Subject|1|||
164286611|NCT00531284|593420689|FG016|Overall Study|Withdrawal by Subject|1|||
164004125|NCT00469079|592380700|FG000|Overall Study|Ineligible|0|||
164004126|NCT00469079|592380701|FG001|Overall Study|Ineligible|1|||
164004127|NCT00469079|592380702|FG002|Overall Study|Ineligible|0|||
164004128|NCT00942162|592380703|FG000|Overall Study|Death|45|||
164004129|NCT00942162|592380704|FG001|Overall Study|Death|35|||
164286612|NCT00531284|593420673|FG000|Overall Study|Other|1|||
164286613|NCT00531284|593420674|FG001|Overall Study|Other|0|||
164286614|NCT00531284|593420675|FG002|Overall Study|Other|0|||
164004130|NCT00942162|592380705|FG002|Overall Study|Death|0|||
164004131|NCT00942162|592380703|FG000|Overall Study|Withdrawal by Subject|7|||
164004132|NCT00942162|592380704|FG001|Overall Study|Withdrawal by Subject|2|||
164286615|NCT00531284|593420676|FG003|Overall Study|Other|10|||
164286616|NCT00531284|593420677|FG004|Overall Study|Other|2|||
164286617|NCT00531284|593420678|FG005|Overall Study|Other|1|||
164286618|NCT00531284|593420679|FG006|Overall Study|Other|0|||
164286619|NCT00531284|593420680|FG007|Overall Study|Other|0|||
164286620|NCT00531284|593420681|FG008|Overall Study|Other|2|||
164286621|NCT00531284|593420682|FG009|Overall Study|Other|1|||
164286622|NCT00531284|593420683|FG010|Overall Study|Other|0|||
164286623|NCT00531284|593420684|FG011|Overall Study|Other|2|||
164286624|NCT00531284|593420685|FG012|Overall Study|Other|0|||
164004133|NCT00942162|592380705|FG002|Overall Study|Withdrawal by Subject|0|||
164004134|NCT00942162|592380703|FG000|Overall Study|Lost to Follow-up|4|||
164286625|NCT00531284|593420686|FG013|Overall Study|Other|0|||
164286626|NCT00531284|593420687|FG014|Overall Study|Other|1|||
164004135|NCT00942162|592380704|FG001|Overall Study|Lost to Follow-up|0|||
164004136|NCT00942162|592380705|FG002|Overall Study|Lost to Follow-up|0|||
164004137|NCT00942162|592380703|FG000|Overall Study|Other|14|||
164004138|NCT00942162|592380704|FG001|Overall Study|Other|13|||
164004139|NCT00942162|592380705|FG002|Overall Study|Other|2|||
164004140|NCT01006356|592380709|FG000|Overall Study|Adverse Event|6|||
164004141|NCT01006356|592380709|FG000|Overall Study|Physician Decision|1|||
164004142|NCT01006356|592380709|FG000|Overall Study|Paticipants did not cooperate|6|||
164004143|NCT01006356|592380709|FG000|Overall Study|Withdrawal by Subject|1|||
164004144|NCT01006356|592380709|FG000|Overall Study|Choice by participants|2|||
164004145|NCT01006356|592380709|FG000|Overall Study|Protocol Violation|3|||
164004146|NCT01006356|592380709|FG000|Overall Study|Other|23|||
164004147|NCT03368859|592380713|FG000|Overall Study|Withdrew Consent|5|||
164004148|NCT03368859|592380714|FG001|Overall Study|Withdrew Consent|4|||
164004149|NCT03368859|592380713|FG000|Overall Study|Death|12|||
164004150|NCT03368859|592380714|FG001|Overall Study|Death|6|||
164004151|NCT03368859|592380713|FG000|Overall Study|Study terminated by Sponsor|18|||
164004152|NCT03368859|592380714|FG001|Overall Study|Study terminated by Sponsor|23|||
164004153|NCT03368859|592380713|FG000|Overall Study|Other|1|||
164286627|NCT00531284|593420688|FG015|Overall Study|Other|0|||
164286628|NCT00531284|593420689|FG016|Overall Study|Other|0|||
164286629|NCT03057496|593420690|FG000|Overall Study|Withdrawal by Subject|8|||
164004154|NCT03368859|592380714|FG001|Overall Study|Other|1|||
164004155|NCT02559505|592380717|FG000|Overall Study|Lost to Follow-up|23|||
164004156|NCT02559505|592380718|FG001|Overall Study|Lost to Follow-up|20|||
164286630|NCT03057496|593420690|FG000|Overall Study|Lost to Follow-up|5|||
164004157|NCT02559505|592380717|FG000|Overall Study|Withdrawal by Subject|4|||
164286631|NCT03057496|593420690|FG000|Overall Study|Did not use device during home trial|3|||
164286632|NCT03057496|593420690|FG000|Overall Study|Device failure|2|||
164286633|NCT00280917|593420691|FG000|Overall Study|Adverse Event|1|||
164286634|NCT00280917|593420692|FG001|Overall Study|Adverse Event|1|||
164286635|NCT00280917|593420693|FG002|Overall Study|Adverse Event|4|||
164286636|NCT00280917|593420694|FG003|Overall Study|Adverse Event|1|||
164286637|NCT00280917|593420691|FG000|Overall Study|Change Therapy|1|||
164286638|NCT00280917|593420692|FG001|Overall Study|Change Therapy|2|||
164286639|NCT00280917|593420693|FG002|Overall Study|Change Therapy|0|||
164286640|NCT00280917|593420694|FG003|Overall Study|Change Therapy|0|||
164286641|NCT00280917|593420691|FG000|Overall Study|Withdrawal by Subject|0|||
164286642|NCT00280917|593420692|FG001|Overall Study|Withdrawal by Subject|2|||
164286643|NCT00280917|593420693|FG002|Overall Study|Withdrawal by Subject|0|||
164286644|NCT00280917|593420694|FG003|Overall Study|Withdrawal by Subject|1|||
164286645|NCT00280917|593420691|FG000|Overall Study|Noncompliance|0|||
164286646|NCT00280917|593420692|FG001|Overall Study|Noncompliance|1|||
164286647|NCT00280917|593420693|FG002|Overall Study|Noncompliance|2|||
164286648|NCT00280917|593420694|FG003|Overall Study|Noncompliance|0|||
164286649|NCT00997035|593420700|FG000|3-week Followup Visit|Lost to Follow-up|9|||
164286650|NCT00997035|593420701|FG001|3-week Followup Visit|Lost to Follow-up|6|||
164286651|NCT00997035|593420700|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
164286652|NCT00997035|593420701|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
164286653|NCT02471014|593420702|FG000|Overall Study|Lost to Follow-up|2|||
164286654|NCT02471014|593420703|FG001|Overall Study|Lost to Follow-up|2|||
164286655|NCT02222558|593420711|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
164286656|NCT02222558|593420712|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
164345151|NCT00191139|593638956|FG001|Overall Study|Other|2|||
164345152|NCT01817530|593638957|FG000|Overall Study|Exclusionary Medication Received|0|||
164004158|NCT02559505|592380718|FG001|Overall Study|Withdrawal by Subject|2|||
164004159|NCT03523585|592380719|FG000|Overall Study|Progressive Disease|174|||
164004160|NCT03523585|592380720|FG001|Overall Study|Progressive Disease|64|||
164087810|NCT03390504|592685801|FG001|Overall Study|Withdrawal by Subject|15|||
164286657|NCT02222558|593420713|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
164286658|NCT02222558|593420714|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
164286659|NCT02222558|593420715|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
164286660|NCT02222558|593420716|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
164286661|NCT02222558|593420711|FG000|Period 3|Withdrawal by Subject|0|||
164286662|NCT02222558|593420712|FG001|Period 3|Withdrawal by Subject|0|||
164345153|NCT01817530|593638958|FG001|Overall Study|Exclusionary Medication Received|0|||
164286663|NCT02222558|593420713|FG002|Period 3|Withdrawal by Subject|0|||
164286664|NCT02222558|593420714|FG003|Period 3|Withdrawal by Subject|0|||
164345154|NCT01817530|593638959|FG002|Overall Study|Exclusionary Medication Received|0|||
164004161|NCT03523585|592380721|FG002|Overall Study|Progressive Disease|77|||
164004162|NCT03523585|592380719|FG000|Overall Study|Adverse Event|74|||
164004163|NCT03523585|592380720|FG001|Overall Study|Adverse Event|5|||
164004164|NCT03523585|592380721|FG002|Overall Study|Adverse Event|9|||
164004165|NCT03523585|592380719|FG000|Overall Study|Withdrawal by Subject|30|||
164004166|NCT03523585|592380720|FG001|Overall Study|Withdrawal by Subject|11|||
164286665|NCT02222558|593420715|FG004|Period 3|Withdrawal by Subject|0|||
164286666|NCT02222558|593420716|FG005|Period 3|Withdrawal by Subject|1|||
164286667|NCT02532465|593420717|FG000|Overall Study|Protocol Violation|1|||
164286668|NCT02532465|593420718|FG001|Overall Study|Protocol Violation|0|||
164286669|NCT02532465|593420717|FG000|Overall Study|Lack of Efficacy|0|||
164286670|NCT02532465|593420718|FG001|Overall Study|Lack of Efficacy|1|||
164286671|NCT00354679|593420723|FG000|Overall Study|Patient Not Treated|1|||
164286672|NCT03456076|593420724|FG000|Overall Study|Withdrawal by Subject|5|||
164286673|NCT03456076|593420725|FG001|Overall Study|Withdrawal by Subject|9|||
164286674|NCT03456076|593420724|FG000|Overall Study|Protocol deviation|0|||
164286675|NCT03456076|593420725|FG001|Overall Study|Protocol deviation|1|||
163897662|NCT02306161|591998685|FG000|Overall Study|Withdrawal by Subject|4|||
163897663|NCT02306161|591998686|FG001|Overall Study|Withdrawal by Subject|0|||
164286676|NCT03456076|593420724|FG000|Overall Study|Lost to Follow-up|0|||
164286677|NCT03456076|593420725|FG001|Overall Study|Lost to Follow-up|1|||
164286678|NCT03456076|593420724|FG000|Overall Study|Death|2|||
164286679|NCT03456076|593420725|FG001|Overall Study|Death|5|||
164286680|NCT03456076|593420724|FG000|Overall Study|Study ongoing|123|||
164286681|NCT03456076|593420725|FG001|Overall Study|Study ongoing|111|||
164286682|NCT03187132|593420731|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
164286683|NCT03187132|593420732|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
164286684|NCT03187132|593420731|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
164286685|NCT03187132|593420732|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
164286686|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
164286687|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
164286688|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
164286689|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
163897664|NCT02306161|591998685|FG000|Overall Study|Ineligible|9|||
163897665|NCT02306161|591998686|FG001|Overall Study|Ineligible|5|||
163897666|NCT05162586|591998687|FG000|Overall Study|Other|0|||
163897667|NCT05162586|591998688|FG001|Overall Study|Other|0|||
163897668|NCT05162586|591998689|FG002|Overall Study|Other|0|||
163897669|NCT05162586|591998690|FG003|Overall Study|Other|0|||
163897670|NCT05162586|591998691|FG004|Overall Study|Other|1|||
163897671|NCT05162586|591998692|FG005|Overall Study|Other|0|||
163897672|NCT05162586|591998693|FG006|Overall Study|Other|2|||
163897673|NCT05162586|591998694|FG007|Overall Study|Other|2|||
163897674|NCT05162586|591998687|FG000|Overall Study|Lack of Efficacy|0|||
163897675|NCT05162586|591998688|FG001|Overall Study|Lack of Efficacy|0|||
163897676|NCT05162586|591998689|FG002|Overall Study|Lack of Efficacy|0|||
163897677|NCT05162586|591998690|FG003|Overall Study|Lack of Efficacy|0|||
163897678|NCT05162586|591998691|FG004|Overall Study|Lack of Efficacy|1|||
163897679|NCT05162586|591998692|FG005|Overall Study|Lack of Efficacy|0|||
163897680|NCT05162586|591998693|FG006|Overall Study|Lack of Efficacy|0|||
163897681|NCT05162586|591998694|FG007|Overall Study|Lack of Efficacy|1|||
163897682|NCT05162586|591998687|FG000|Overall Study|Lost to Follow-up|0|||
163897683|NCT05162586|591998688|FG001|Overall Study|Lost to Follow-up|0|||
163897684|NCT05162586|591998689|FG002|Overall Study|Lost to Follow-up|0|||
163897685|NCT05162586|591998690|FG003|Overall Study|Lost to Follow-up|0|||
163897686|NCT05162586|591998691|FG004|Overall Study|Lost to Follow-up|2|||
163897687|NCT05162586|591998692|FG005|Overall Study|Lost to Follow-up|0|||
163897688|NCT05162586|591998693|FG006|Overall Study|Lost to Follow-up|0|||
163897689|NCT05162586|591998694|FG007|Overall Study|Lost to Follow-up|2|||
163897690|NCT05162586|591998687|FG000|Overall Study|Non-Compliance|0|||
163897691|NCT05162586|591998688|FG001|Overall Study|Non-Compliance|1|||
163897692|NCT05162586|591998689|FG002|Overall Study|Non-Compliance|0|||
163897693|NCT05162586|591998690|FG003|Overall Study|Non-Compliance|0|||
163897694|NCT05162586|591998691|FG004|Overall Study|Non-Compliance|1|||
163897695|NCT05162586|591998692|FG005|Overall Study|Non-Compliance|0|||
163897696|NCT05162586|591998693|FG006|Overall Study|Non-Compliance|0|||
163897697|NCT05162586|591998694|FG007|Overall Study|Non-Compliance|1|||
163897698|NCT05162586|591998687|FG000|Overall Study|Withdrawal by Subject|2|||
163897699|NCT05162586|591998688|FG001|Overall Study|Withdrawal by Subject|0|||
163897700|NCT05162586|591998689|FG002|Overall Study|Withdrawal by Subject|0|||
163897701|NCT05162586|591998690|FG003|Overall Study|Withdrawal by Subject|0|||
163897702|NCT05162586|591998691|FG004|Overall Study|Withdrawal by Subject|7|||
163897703|NCT05162586|591998692|FG005|Overall Study|Withdrawal by Subject|6|||
163897704|NCT05162586|591998693|FG006|Overall Study|Withdrawal by Subject|2|||
163897705|NCT05162586|591998694|FG007|Overall Study|Withdrawal by Subject|2|||
163897706|NCT05162586|591998687|FG000|Overall Study|Adverse Event|2|||
163897707|NCT05162586|591998688|FG001|Overall Study|Adverse Event|0|||
164286690|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
163897708|NCT05162586|591998689|FG002|Overall Study|Adverse Event|1|||
163897709|NCT05162586|591998690|FG003|Overall Study|Adverse Event|2|||
163897710|NCT05162586|591998691|FG004|Overall Study|Adverse Event|4|||
163897711|NCT05162586|591998692|FG005|Overall Study|Adverse Event|1|||
163897712|NCT05162586|591998693|FG006|Overall Study|Adverse Event|5|||
163897713|NCT05162586|591998694|FG007|Overall Study|Adverse Event|2|||
163897714|NCT00982644|591998697|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
164286691|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
164286692|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
164286693|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
164286694|NCT03187132|593420731|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
164286695|NCT03187132|593420732|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
164286696|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
164286697|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
164286698|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
164286699|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
164286700|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
164286701|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
164286702|NCT03187132|593420731|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
164286703|NCT03187132|593420732|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
164286704|NCT02045095|593420733|FG000|Overall Study|Other|0|||
164286705|NCT02045095|593420734|FG001|Overall Study|Other|0|||
164286706|NCT02045095|593420735|FG002|Overall Study|Other|1|||
164286707|NCT02045095|593420736|FG003|Overall Study|Other|0|||
164286708|NCT02045095|593420737|FG004|Overall Study|Other|0|||
164286709|NCT02045095|593420738|FG005|Overall Study|Other|2|||
164286710|NCT02045095|593420739|FG006|Overall Study|Other|0|||
164286711|NCT02045095|593420733|FG000|Overall Study|Progressive Disease|3|||
164286712|NCT02045095|593420734|FG001|Overall Study|Progressive Disease|3|||
164286713|NCT02045095|593420735|FG002|Overall Study|Progressive Disease|2|||
164286714|NCT02045095|593420736|FG003|Overall Study|Progressive Disease|4|||
164286715|NCT02045095|593420737|FG004|Overall Study|Progressive Disease|2|||
164286716|NCT02045095|593420738|FG005|Overall Study|Progressive Disease|4|||
164286717|NCT02045095|593420739|FG006|Overall Study|Progressive Disease|1|||
164286718|NCT02045095|593420733|FG000|Overall Study|Withdrawal by Subject|0|||
164286719|NCT02045095|593420734|FG001|Overall Study|Withdrawal by Subject|0|||
164286720|NCT02045095|593420735|FG002|Overall Study|Withdrawal by Subject|0|||
164286721|NCT02045095|593420736|FG003|Overall Study|Withdrawal by Subject|0|||
164286722|NCT02045095|593420737|FG004|Overall Study|Withdrawal by Subject|3|||
164286723|NCT02045095|593420738|FG005|Overall Study|Withdrawal by Subject|0|||
164004167|NCT03523585|592380721|FG002|Overall Study|Withdrawal by Subject|6|||
164004168|NCT03523585|592380719|FG000|Overall Study|Clinical Progression|23|||
164004169|NCT03523585|592380720|FG001|Overall Study|Clinical Progression|5|||
164004170|NCT03523585|592380721|FG002|Overall Study|Clinical Progression|10|||
164004171|NCT03523585|592380719|FG000|Overall Study|Death|4|||
164004172|NCT03523585|592380720|FG001|Overall Study|Death|0|||
164004173|NCT03523585|592380721|FG002|Overall Study|Death|1|||
164004174|NCT03523585|592380719|FG000|Overall Study|Physician Decision|2|||
164004175|NCT03523585|592380720|FG001|Overall Study|Physician Decision|1|||
164004176|NCT03523585|592380721|FG002|Overall Study|Physician Decision|0|||
164004177|NCT03523585|592380719|FG000|Overall Study|Lost to Follow-up|1|||
164004178|NCT03523585|592380720|FG001|Overall Study|Lost to Follow-up|0|||
164004179|NCT03523585|592380721|FG002|Overall Study|Lost to Follow-up|0|||
164004180|NCT03523585|592380719|FG000|Overall Study|Miscellaneous|1|||
164004181|NCT03523585|592380720|FG001|Overall Study|Miscellaneous|0|||
164004182|NCT03523585|592380721|FG002|Overall Study|Miscellaneous|0|||
164286724|NCT02045095|593420739|FG006|Overall Study|Withdrawal by Subject|0|||
164286725|NCT02045095|593420733|FG000|Overall Study|Adverse Event|0|||
164286726|NCT02045095|593420734|FG001|Overall Study|Adverse Event|1|||
164286727|NCT02045095|593420735|FG002|Overall Study|Adverse Event|1|||
164286728|NCT02045095|593420736|FG003|Overall Study|Adverse Event|0|||
164286729|NCT02045095|593420737|FG004|Overall Study|Adverse Event|0|||
164286730|NCT02045095|593420738|FG005|Overall Study|Adverse Event|2|||
164286731|NCT02045095|593420739|FG006|Overall Study|Adverse Event|0|||
164286732|NCT02525588|593420740|FG000|Overall Study|Death|3|||
164286733|NCT02525588|593420741|FG001|Overall Study|Death|1|||
164286734|NCT02525588|593420740|FG000|Overall Study|Lost to Follow-up|2|||
164286735|NCT02525588|593420741|FG001|Overall Study|Lost to Follow-up|0|||
164286736|NCT02525588|593420740|FG000|Overall Study|Withdrawal by Subject|1|||
164286737|NCT02525588|593420741|FG001|Overall Study|Withdrawal by Subject|1|||
164286738|NCT02525588|593420740|FG000|Overall Study|Adverse Event|0|||
164286739|NCT02525588|593420741|FG001|Overall Study|Adverse Event|1|||
164286740|NCT00714415|593420751|FG000|Overall Study|Lack of Efficacy|1|||
164286741|NCT00714415|593420752|FG001|Overall Study|Lack of Efficacy|0|||
164286742|NCT00714415|593420751|FG000|Overall Study|Death|1|||
164286743|NCT00714415|593420752|FG001|Overall Study|Death|0|||
164286744|NCT01450761|593420755|FG000|Randomization|Subject no longer meets study criteria|1|||
164286745|NCT01450761|593420756|FG001|Randomization|Subject no longer meets study criteria|2|||
164004183|NCT03523585|592380719|FG000|Overall Study|Protocol Deviation|1|||
164004184|NCT03523585|592380720|FG001|Overall Study|Protocol Deviation|0|||
164004185|NCT03523585|592380721|FG002|Overall Study|Protocol Deviation|1|||
164004186|NCT03523585|592380719|FG000|Overall Study|Randomized But Not Treated|2|||
164286746|NCT01450761|593420755|FG000|Randomization|Withdrawal by Subject|2|||
164286747|NCT01450761|593420756|FG001|Randomization|Withdrawal by Subject|0|||
164286748|NCT01450761|593420755|FG000|Randomization|Disease progression|0|||
164286749|NCT01450761|593420756|FG001|Randomization|Disease progression|2|||
164286750|NCT01450761|593420755|FG000|Randomization|Adverse Event unrelated to study drug|1|||
164286751|NCT01450761|593420756|FG001|Randomization|Adverse Event unrelated to study drug|0|||
164286752|NCT01450761|593420755|FG000|Randomization|Other|0|||
164286753|NCT01450761|593420756|FG001|Randomization|Other|1|||
164286754|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Disease progression|33|||
164286755|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Disease progression|32|||
164286756|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
164286757|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
164286758|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
164286759|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
164004187|NCT03523585|592380720|FG001|Overall Study|Randomized But Not Treated|4|||
164004188|NCT03523585|592380721|FG002|Overall Study|Randomized But Not Treated|3|||
164004189|NCT02874794|592380722|FG000|Overall Study|Physician Decision|3|||
164004190|NCT02874794|592380723|FG001|Overall Study|Physician Decision|2|||
164004191|NCT02874794|592380722|FG000|Overall Study|Withdrawal by Subject|2|||
164004192|NCT02874794|592380723|FG001|Overall Study|Withdrawal by Subject|8|||
164004193|NCT02874794|592380722|FG000|Overall Study|Death|2|||
164004194|NCT02874794|592380723|FG001|Overall Study|Death|1|||
164004195|NCT00613314|592380725|FG000|Overall Study|Adverse Event|5|||
164004196|NCT00613314|592380725|FG000|Overall Study|Protocol Violation|14|||
164004197|NCT00613314|592380725|FG000|Overall Study|Lost to Follow-up|46|||
164004198|NCT00613314|592380725|FG000|Overall Study|Other reason not defined above|90|||
164004199|NCT04419506|592380728|FG000|Overall Study|Adverse Event|0|||
164004200|NCT04419506|592380729|FG001|Overall Study|Adverse Event|10|||
164004201|NCT04419506|592380730|FG002|Overall Study|Adverse Event|0|||
164004202|NCT04419506|592380731|FG003|Overall Study|Adverse Event|3|||
164004203|NCT04419506|592380728|FG000|Overall Study|Withdrawal by Subject|0|||
164004204|NCT04419506|592380729|FG001|Overall Study|Withdrawal by Subject|0|||
164004205|NCT04419506|592380730|FG002|Overall Study|Withdrawal by Subject|0|||
164004206|NCT04419506|592380731|FG003|Overall Study|Withdrawal by Subject|1|||
164004207|NCT04419506|592380728|FG000|Overall Study|poor-compliance|0|||
164004208|NCT04419506|592380729|FG001|Overall Study|poor-compliance|0|||
164004209|NCT04419506|592380730|FG002|Overall Study|poor-compliance|0|||
164004210|NCT04419506|592380731|FG003|Overall Study|poor-compliance|1|||
164004211|NCT04645797|592380732|FG000|Overall Study|Disease Progression|3|||
164004212|NCT04645797|592380733|FG001|Overall Study|Disease Progression|3|||
164004213|NCT04645797|592380734|FG002|Overall Study|Disease Progression|1|||
164004214|NCT04645797|592380735|FG003|Overall Study|Disease Progression|0|||
164004215|NCT04645797|592380736|FG004|Overall Study|Disease Progression|0|||
164004216|NCT04645797|592380737|FG005|Overall Study|Disease Progression|0|||
164004217|NCT04645797|592380738|FG006|Overall Study|Disease Progression|0|||
164004218|NCT04645797|592380732|FG000|Overall Study|Death|3|||
164004219|NCT04645797|592380733|FG001|Overall Study|Death|1|||
164004220|NCT04645797|592380734|FG002|Overall Study|Death|0|||
164004221|NCT04645797|592380735|FG003|Overall Study|Death|0|||
164004222|NCT04645797|592380736|FG004|Overall Study|Death|0|||
164004223|NCT04645797|592380737|FG005|Overall Study|Death|0|||
164004224|NCT04645797|592380738|FG006|Overall Study|Death|0|||
164004225|NCT00817414|592380739|FG000|Overall Study|Adverse Event|1|||
164004226|NCT00817414|592380740|FG001|Overall Study|Adverse Event|1|||
164004227|NCT00817414|592380741|FG002|Overall Study|Adverse Event|1|||
164004228|NCT00817414|592380742|FG003|Overall Study|Adverse Event|0|||
164004229|NCT00817414|592380743|FG004|Overall Study|Adverse Event|0|||
164004230|NCT00817414|592380739|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
164004231|NCT00817414|592380740|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
164004232|NCT00817414|592380741|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
164004233|NCT00817414|592380742|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
164004234|NCT00817414|592380743|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
164004235|NCT00817414|592380739|FG000|Overall Study|Withdrawal by Subject|1|||
164004236|NCT00817414|592380740|FG001|Overall Study|Withdrawal by Subject|1|||
164004237|NCT00817414|592380741|FG002|Overall Study|Withdrawal by Subject|0|||
164286760|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
164004238|NCT00817414|592380742|FG003|Overall Study|Withdrawal by Subject|0|||
164004239|NCT00817414|592380743|FG004|Overall Study|Withdrawal by Subject|0|||
164004240|NCT00817414|592380739|FG000|Overall Study|Lost to Follow-up|0|||
164004241|NCT00817414|592380740|FG001|Overall Study|Lost to Follow-up|0|||
164004242|NCT00817414|592380741|FG002|Overall Study|Lost to Follow-up|1|||
164004243|NCT00817414|592380742|FG003|Overall Study|Lost to Follow-up|1|||
164004244|NCT00817414|592380743|FG004|Overall Study|Lost to Follow-up|1|||
164286761|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
164286762|NCT01450761|593420755|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
164345155|NCT01817530|593638960|FG003|Overall Study|Exclusionary Medication Received|0|||
164004245|NCT00817414|592380739|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164004246|NCT00817414|592380740|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164004247|NCT00817414|592380741|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164286763|NCT01450761|593420756|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
164286764|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Death|3|||
164286765|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Death|3|||
164286766|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Other|2|||
164286767|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Other|2|||
164286768|NCT01450761|593420755|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
164286769|NCT01450761|593420756|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
164286770|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
164286771|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
164286772|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
164286773|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
164286774|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
164286775|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
164286776|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
164286777|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
164286778|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
164286779|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
164286780|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Death|5|||
164286781|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Death|6|||
164286782|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
164286783|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
164286784|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
164286785|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
164286786|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
164286787|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
164286788|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
164286789|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
164286790|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
164286791|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
164286792|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
164286793|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
164286794|NCT01450761|593420755|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
164286795|NCT01450761|593420756|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
164286796|NCT01818596|593420757|FG000|Overall Study|Enrolled but Not Treated|4|||
164286797|NCT01818596|593420758|FG001|Overall Study|Enrolled but Not Treated|0|||
164286798|NCT01818596|593420757|FG000|Overall Study|Adverse Event|7|||
164286799|NCT01818596|593420758|FG001|Overall Study|Adverse Event|0|||
164286800|NCT01818596|593420757|FG000|Overall Study|Death|3|||
164286801|NCT01818596|593420758|FG001|Overall Study|Death|0|||
164286802|NCT01818596|593420757|FG000|Overall Study|Investigator's Discretion|4|||
164286803|NCT01818596|593420758|FG001|Overall Study|Investigator's Discretion|0|||
164286804|NCT01818596|593420757|FG000|Overall Study|Protocol Violation|1|||
164286805|NCT01818596|593420758|FG001|Overall Study|Protocol Violation|0|||
164286806|NCT01818596|593420757|FG000|Overall Study|Withdrew Consent|5|||
164286807|NCT01818596|593420758|FG001|Overall Study|Withdrew Consent|0|||
164286808|NCT01818596|593420757|FG000|Overall Study|Lost to Follow-up|7|||
164286809|NCT01818596|593420758|FG001|Overall Study|Lost to Follow-up|0|||
164286810|NCT04435366|593420762|FG000|Year 1 (12 Months)|Adverse Event|3|||
164286811|NCT04435366|593420763|FG001|Year 1 (12 Months)|Adverse Event|0|||
164286812|NCT04435366|593420764|FG002|Year 1 (12 Months)|Adverse Event|2|||
164286813|NCT04435366|593420762|FG000|Year 1 (12 Months)|Death|2|||
164286814|NCT04435366|593420763|FG001|Year 1 (12 Months)|Death|0|||
164286815|NCT04435366|593420764|FG002|Year 1 (12 Months)|Death|1|||
164286816|NCT04435366|593420762|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
164286817|NCT04435366|593420763|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
164286818|NCT04435366|593420764|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
164286819|NCT04435366|593420762|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
164286820|NCT04435366|593420763|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
164286821|NCT04435366|593420764|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
164286822|NCT04435366|593420762|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
164286823|NCT04435366|593420763|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
164286824|NCT04435366|593420764|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
164286825|NCT04435366|593420762|FG000|Year 1 (12 Months)|Not treated|0|||
164286826|NCT04435366|593420763|FG001|Year 1 (12 Months)|Not treated|0|||
164286827|NCT04435366|593420764|FG002|Year 1 (12 Months)|Not treated|1|||
164286828|NCT04435366|593420762|FG000|Year 2 (12 Months)|Death|1|||
164286829|NCT04435366|593420763|FG001|Year 2 (12 Months)|Death|4|||
164286830|NCT04435366|593420764|FG002|Year 2 (12 Months)|Death|6|||
164286831|NCT04435366|593420762|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
164286832|NCT04435366|593420763|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
164286833|NCT04435366|593420764|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
164345156|NCT01817530|593638961|FG004|Overall Study|Exclusionary Medication Received|1|||
164286834|NCT04435366|593420762|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
164286835|NCT04435366|593420763|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
164286836|NCT04435366|593420764|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
164286837|NCT04435366|593420762|FG000|Year 2 (12 Months)|Adverse Event|2|||
164286838|NCT04435366|593420763|FG001|Year 2 (12 Months)|Adverse Event|1|||
164286839|NCT04435366|593420764|FG002|Year 2 (12 Months)|Adverse Event|6|||
164286840|NCT04497116|593420766|FG000|Overall Study|Lost to Follow-up|1|||
164286841|NCT04497116|593420767|FG001|Overall Study|Lost to Follow-up|0|||
164286842|NCT04497116|593420768|FG002|Overall Study|Lost to Follow-up|0|||
164286843|NCT04497116|593420769|FG003|Overall Study|Lost to Follow-up|0|||
164286844|NCT04497116|593420770|FG004|Overall Study|Lost to Follow-up|0|||
164286845|NCT04497116|593420771|FG005|Overall Study|Lost to Follow-up|0|||
164286846|NCT04497116|593420772|FG006|Overall Study|Lost to Follow-up|0|||
164286847|NCT04497116|593420773|FG007|Overall Study|Lost to Follow-up|3|||
164286848|NCT04497116|593420774|FG008|Overall Study|Lost to Follow-up|3|||
164286849|NCT04497116|593420775|FG009|Overall Study|Lost to Follow-up|0|||
164286850|NCT04497116|593420776|FG010|Overall Study|Lost to Follow-up|0|||
164286851|NCT04497116|593420777|FG011|Overall Study|Lost to Follow-up|0|||
164286852|NCT04497116|593420778|FG012|Overall Study|Lost to Follow-up|0|||
164286853|NCT04497116|593420779|FG013|Overall Study|Lost to Follow-up|0|||
164286854|NCT04497116|593420780|FG014|Overall Study|Lost to Follow-up|0|||
164286855|NCT04497116|593420781|FG015|Overall Study|Lost to Follow-up|0|||
164286856|NCT04497116|593420782|FG016|Overall Study|Lost to Follow-up|0|||
164286857|NCT04497116|593420783|FG017|Overall Study|Lost to Follow-up|0|||
164286858|NCT04497116|593420784|FG018|Overall Study|Lost to Follow-up|0|||
164286859|NCT04497116|593420785|FG019|Overall Study|Lost to Follow-up|0|||
164286860|NCT04497116|593420786|FG020|Overall Study|Lost to Follow-up|0|||
164286861|NCT04497116|593420787|FG021|Overall Study|Lost to Follow-up|0|||
164286862|NCT04497116|593420788|FG022|Overall Study|Lost to Follow-up|1|||
164286863|NCT04497116|593420789|FG023|Overall Study|Lost to Follow-up|0|||
164286864|NCT04497116|593420790|FG024|Overall Study|Lost to Follow-up|0|||
164286865|NCT04497116|593420766|FG000|Overall Study|Sponsor decision to terminate study|0|||
164286866|NCT04497116|593420767|FG001|Overall Study|Sponsor decision to terminate study|0|||
164286867|NCT04497116|593420768|FG002|Overall Study|Sponsor decision to terminate study|0|||
164286868|NCT04497116|593420769|FG003|Overall Study|Sponsor decision to terminate study|0|||
164286869|NCT04497116|593420770|FG004|Overall Study|Sponsor decision to terminate study|0|||
164286870|NCT04497116|593420771|FG005|Overall Study|Sponsor decision to terminate study|0|||
164286871|NCT04497116|593420772|FG006|Overall Study|Sponsor decision to terminate study|1|||
164286872|NCT04497116|593420773|FG007|Overall Study|Sponsor decision to terminate study|0|||
164286873|NCT04497116|593420774|FG008|Overall Study|Sponsor decision to terminate study|0|||
164286874|NCT04497116|593420775|FG009|Overall Study|Sponsor decision to terminate study|1|||
164286875|NCT04497116|593420776|FG010|Overall Study|Sponsor decision to terminate study|0|||
164286876|NCT04497116|593420777|FG011|Overall Study|Sponsor decision to terminate study|0|||
164286877|NCT04497116|593420778|FG012|Overall Study|Sponsor decision to terminate study|0|||
164286878|NCT04497116|593420779|FG013|Overall Study|Sponsor decision to terminate study|0|||
164286879|NCT04497116|593420780|FG014|Overall Study|Sponsor decision to terminate study|0|||
164286880|NCT04497116|593420781|FG015|Overall Study|Sponsor decision to terminate study|0|||
164286881|NCT04497116|593420782|FG016|Overall Study|Sponsor decision to terminate study|0|||
164286882|NCT04497116|593420783|FG017|Overall Study|Sponsor decision to terminate study|0|||
164004248|NCT00817414|592380742|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
164004249|NCT00817414|592380743|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
164004250|NCT00817414|592380739|FG000|Overall Study|Protocol Violation|0|||
164286883|NCT04497116|593420784|FG018|Overall Study|Sponsor decision to terminate study|0|||
164286884|NCT04497116|593420785|FG019|Overall Study|Sponsor decision to terminate study|1|||
164286885|NCT04497116|593420786|FG020|Overall Study|Sponsor decision to terminate study|0|||
164286886|NCT04497116|593420787|FG021|Overall Study|Sponsor decision to terminate study|0|||
164286887|NCT04497116|593420788|FG022|Overall Study|Sponsor decision to terminate study|0|||
164286888|NCT04497116|593420789|FG023|Overall Study|Sponsor decision to terminate study|0|||
164286889|NCT04497116|593420790|FG024|Overall Study|Sponsor decision to terminate study|0|||
164286890|NCT04497116|593420766|FG000|Overall Study|Death|4|||
164286891|NCT04497116|593420767|FG001|Overall Study|Death|5|||
164286892|NCT04497116|593420768|FG002|Overall Study|Death|2|||
164286893|NCT04497116|593420769|FG003|Overall Study|Death|2|||
164286894|NCT04497116|593420770|FG004|Overall Study|Death|1|||
164286895|NCT04497116|593420771|FG005|Overall Study|Death|1|||
164286896|NCT04497116|593420772|FG006|Overall Study|Death|3|||
164286897|NCT04497116|593420773|FG007|Overall Study|Death|10|||
164286898|NCT04497116|593420774|FG008|Overall Study|Death|37|||
164286899|NCT04497116|593420775|FG009|Overall Study|Death|17|||
164286900|NCT04497116|593420776|FG010|Overall Study|Death|2|||
164286901|NCT04497116|593420777|FG011|Overall Study|Death|1|||
164286902|NCT04497116|593420778|FG012|Overall Study|Death|1|||
164286903|NCT04497116|593420779|FG013|Overall Study|Death|3|||
164286904|NCT04497116|593420780|FG014|Overall Study|Death|18|||
164286905|NCT04497116|593420781|FG015|Overall Study|Death|3|||
164286906|NCT04497116|593420782|FG016|Overall Study|Death|2|||
164286907|NCT04497116|593420783|FG017|Overall Study|Death|1|||
164286908|NCT04497116|593420784|FG018|Overall Study|Death|4|||
164286909|NCT04497116|593420785|FG019|Overall Study|Death|17|||
164286910|NCT04497116|593420786|FG020|Overall Study|Death|1|||
164286911|NCT04497116|593420787|FG021|Overall Study|Death|0|||
164286912|NCT04497116|593420788|FG022|Overall Study|Death|3|||
164286913|NCT04497116|593420789|FG023|Overall Study|Death|5|||
164286914|NCT04497116|593420790|FG024|Overall Study|Death|4|||
164286915|NCT04497116|593420766|FG000|Overall Study|Withdrawal by Subject|1|||
164286916|NCT04497116|593420767|FG001|Overall Study|Withdrawal by Subject|0|||
164286917|NCT04497116|593420768|FG002|Overall Study|Withdrawal by Subject|1|||
164286918|NCT04497116|593420769|FG003|Overall Study|Withdrawal by Subject|0|||
164286919|NCT04497116|593420770|FG004|Overall Study|Withdrawal by Subject|0|||
164286920|NCT04497116|593420771|FG005|Overall Study|Withdrawal by Subject|0|||
164286921|NCT04497116|593420772|FG006|Overall Study|Withdrawal by Subject|0|||
164286922|NCT04497116|593420773|FG007|Overall Study|Withdrawal by Subject|7|||
164286923|NCT04497116|593420774|FG008|Overall Study|Withdrawal by Subject|14|||
164286924|NCT04497116|593420775|FG009|Overall Study|Withdrawal by Subject|3|||
164286925|NCT04497116|593420776|FG010|Overall Study|Withdrawal by Subject|3|||
164286926|NCT04497116|593420777|FG011|Overall Study|Withdrawal by Subject|0|||
164286927|NCT04497116|593420778|FG012|Overall Study|Withdrawal by Subject|1|||
164286928|NCT04497116|593420779|FG013|Overall Study|Withdrawal by Subject|0|||
164286929|NCT04497116|593420780|FG014|Overall Study|Withdrawal by Subject|7|||
164286930|NCT04497116|593420781|FG015|Overall Study|Withdrawal by Subject|1|||
164286931|NCT04497116|593420782|FG016|Overall Study|Withdrawal by Subject|3|||
164286932|NCT04497116|593420783|FG017|Overall Study|Withdrawal by Subject|1|||
164286933|NCT04497116|593420784|FG018|Overall Study|Withdrawal by Subject|1|||
164286934|NCT04497116|593420785|FG019|Overall Study|Withdrawal by Subject|5|||
164286935|NCT04497116|593420786|FG020|Overall Study|Withdrawal by Subject|2|||
164286936|NCT04497116|593420787|FG021|Overall Study|Withdrawal by Subject|2|||
164286937|NCT04497116|593420788|FG022|Overall Study|Withdrawal by Subject|2|||
164286938|NCT04497116|593420789|FG023|Overall Study|Withdrawal by Subject|4|||
164286939|NCT04497116|593420790|FG024|Overall Study|Withdrawal by Subject|3|||
164286940|NCT04497116|593420766|FG000|Overall Study|Physician Decision|0|||
164286941|NCT04497116|593420767|FG001|Overall Study|Physician Decision|0|||
164286942|NCT04497116|593420768|FG002|Overall Study|Physician Decision|0|||
164286943|NCT04497116|593420769|FG003|Overall Study|Physician Decision|0|||
164286944|NCT04497116|593420770|FG004|Overall Study|Physician Decision|0|||
164286945|NCT04497116|593420771|FG005|Overall Study|Physician Decision|0|||
164286946|NCT04497116|593420772|FG006|Overall Study|Physician Decision|0|||
164286947|NCT04497116|593420773|FG007|Overall Study|Physician Decision|0|||
164286948|NCT04497116|593420774|FG008|Overall Study|Physician Decision|0|||
164286949|NCT04497116|593420775|FG009|Overall Study|Physician Decision|0|||
164286950|NCT04497116|593420776|FG010|Overall Study|Physician Decision|0|||
164286951|NCT04497116|593420777|FG011|Overall Study|Physician Decision|0|||
164286952|NCT04497116|593420778|FG012|Overall Study|Physician Decision|0|||
164286953|NCT04497116|593420779|FG013|Overall Study|Physician Decision|0|||
164286954|NCT04497116|593420780|FG014|Overall Study|Physician Decision|0|||
164286955|NCT04497116|593420781|FG015|Overall Study|Physician Decision|0|||
164286956|NCT04497116|593420782|FG016|Overall Study|Physician Decision|0|||
164286957|NCT04497116|593420783|FG017|Overall Study|Physician Decision|0|||
164004251|NCT00817414|592380740|FG001|Overall Study|Protocol Violation|0|||
164004252|NCT00817414|592380741|FG002|Overall Study|Protocol Violation|0|||
164004253|NCT00817414|592380742|FG003|Overall Study|Protocol Violation|0|||
164286958|NCT04497116|593420784|FG018|Overall Study|Physician Decision|0|||
164286959|NCT04497116|593420785|FG019|Overall Study|Physician Decision|0|||
164286960|NCT04497116|593420786|FG020|Overall Study|Physician Decision|0|||
164286961|NCT04497116|593420787|FG021|Overall Study|Physician Decision|0|||
164286962|NCT04497116|593420788|FG022|Overall Study|Physician Decision|0|||
164286963|NCT04497116|593420789|FG023|Overall Study|Physician Decision|1|||
164286964|NCT04497116|593420790|FG024|Overall Study|Physician Decision|0|||
164286965|NCT04497116|593420766|FG000|Overall Study|Clinical Progression Related|0|||
164286966|NCT04497116|593420767|FG001|Overall Study|Clinical Progression Related|0|||
164286967|NCT04497116|593420768|FG002|Overall Study|Clinical Progression Related|0|||
164286968|NCT04497116|593420769|FG003|Overall Study|Clinical Progression Related|0|||
164286969|NCT04497116|593420770|FG004|Overall Study|Clinical Progression Related|0|||
164286970|NCT04497116|593420771|FG005|Overall Study|Clinical Progression Related|0|||
164286971|NCT04497116|593420772|FG006|Overall Study|Clinical Progression Related|0|||
164286972|NCT04497116|593420773|FG007|Overall Study|Clinical Progression Related|0|||
164286973|NCT04497116|593420774|FG008|Overall Study|Clinical Progression Related|0|||
164286974|NCT04497116|593420775|FG009|Overall Study|Clinical Progression Related|1|||
164286975|NCT04497116|593420776|FG010|Overall Study|Clinical Progression Related|0|||
164286976|NCT04497116|593420777|FG011|Overall Study|Clinical Progression Related|0|||
164286977|NCT04497116|593420778|FG012|Overall Study|Clinical Progression Related|0|||
164286978|NCT04497116|593420779|FG013|Overall Study|Clinical Progression Related|0|||
164286979|NCT04497116|593420780|FG014|Overall Study|Clinical Progression Related|0|||
164286980|NCT04497116|593420781|FG015|Overall Study|Clinical Progression Related|0|||
164286981|NCT04497116|593420782|FG016|Overall Study|Clinical Progression Related|0|||
164286982|NCT04497116|593420783|FG017|Overall Study|Clinical Progression Related|0|||
164004254|NCT00817414|592380743|FG004|Overall Study|Protocol Violation|1|||
164004255|NCT02586805|592380745|FG000|Overall Study|Withdrawal by Subject|3|||
164004256|NCT02586805|592380746|FG001|Overall Study|Withdrawal by Subject|1|||
164004257|NCT02586805|592380747|FG002|Overall Study|Withdrawal by Subject|1|||
164004258|NCT02586805|592380748|FG003|Overall Study|Withdrawal by Subject|2|||
164004259|NCT02586805|592380745|FG000|Overall Study|Adverse Event|2|||
164004260|NCT02586805|592380746|FG001|Overall Study|Adverse Event|0|||
164004261|NCT02586805|592380747|FG002|Overall Study|Adverse Event|1|||
164004262|NCT02586805|592380748|FG003|Overall Study|Adverse Event|0|||
164004263|NCT02586805|592380745|FG000|Overall Study|Lost to Follow-up|0|||
164286983|NCT04497116|593420784|FG018|Overall Study|Clinical Progression Related|0|||
164286984|NCT04497116|593420785|FG019|Overall Study|Clinical Progression Related|0|||
164286985|NCT04497116|593420786|FG020|Overall Study|Clinical Progression Related|0|||
164286986|NCT04497116|593420787|FG021|Overall Study|Clinical Progression Related|0|||
164286987|NCT04497116|593420788|FG022|Overall Study|Clinical Progression Related|0|||
164286988|NCT04497116|593420789|FG023|Overall Study|Clinical Progression Related|0|||
164286989|NCT04497116|593420790|FG024|Overall Study|Clinical Progression Related|0|||
164286990|NCT05963022|593420794|FG000|Overall Study|Adverse Event|0|||
164286991|NCT05963022|593420795|FG001|Overall Study|Adverse Event|1|||
164286992|NCT05963022|593420796|FG002|Overall Study|Adverse Event|1|||
164286993|NCT05963022|593420797|FG003|Overall Study|Adverse Event|0|||
164286994|NCT05963022|593420794|FG000|Overall Study|Protocol Violation|0|||
164286995|NCT05963022|593420795|FG001|Overall Study|Protocol Violation|3|||
164286996|NCT05963022|593420796|FG002|Overall Study|Protocol Violation|0|||
164286997|NCT05963022|593420797|FG003|Overall Study|Protocol Violation|0|||
164286998|NCT05963022|593420794|FG000|Overall Study|Pregnancy|0|||
164286999|NCT05963022|593420795|FG001|Overall Study|Pregnancy|1|||
164287000|NCT05963022|593420796|FG002|Overall Study|Pregnancy|1|||
164287001|NCT05963022|593420797|FG003|Overall Study|Pregnancy|1|||
164287002|NCT05963022|593420794|FG000|Overall Study|Withdrawal by Subject|0|||
164287003|NCT05963022|593420795|FG001|Overall Study|Withdrawal by Subject|0|||
164287004|NCT05963022|593420796|FG002|Overall Study|Withdrawal by Subject|2|||
164287005|NCT05963022|593420797|FG003|Overall Study|Withdrawal by Subject|1|||
164287006|NCT05963022|593420794|FG000|Overall Study|Lost to Follow-up|0|||
164287007|NCT05963022|593420795|FG001|Overall Study|Lost to Follow-up|0|||
164287008|NCT05963022|593420796|FG002|Overall Study|Lost to Follow-up|0|||
164287009|NCT05963022|593420797|FG003|Overall Study|Lost to Follow-up|1|||
164287010|NCT05963022|593420794|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
164287011|NCT05963022|593420795|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
164287012|NCT05963022|593420796|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
164287013|NCT05963022|593420797|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
164287014|NCT02698826|593420800|FG000|Overall Study|Death|13|||
164287015|NCT02698826|593420800|FG000|Overall Study|Adverse Event|1|||
164287016|NCT02915263|593420805|FG000|Overall Study|Covid|3|||
164287017|NCT02915263|593420806|FG001|Overall Study|Covid|2|||
164287018|NCT02478463|593420807|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
164287019|NCT02478463|593420807|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
164287020|NCT02478463|593420807|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
164287021|NCT01358825|593420808|FG000|Overall Study|Blood sample not drawn|0|||
164287022|NCT01358825|593420809|FG001|Overall Study|Blood sample not drawn|1|||
164287023|NCT01177007|593420813|FG000|Overall Study|Lost to Follow-up|2|||
164004264|NCT02586805|592380746|FG001|Overall Study|Lost to Follow-up|0|||
164004265|NCT02586805|592380747|FG002|Overall Study|Lost to Follow-up|1|||
164004266|NCT02586805|592380748|FG003|Overall Study|Lost to Follow-up|0|||
164004267|NCT02586805|592380745|FG000|Overall Study|Physician Decision|1|||
164287024|NCT01177007|593420813|FG000|Overall Study|Death|4|||
164287025|NCT01177007|593420813|FG000|Overall Study|Entered hospice care|5|||
164345157|NCT01817530|593638962|FG005|Overall Study|Exclusionary Medication Received|0|||
164345158|NCT01817530|593638963|FG006|Overall Study|Exclusionary Medication Received|0|||
164345159|NCT01817530|593638964|FG007|Overall Study|Exclusionary Medication Received|0|||
164345160|NCT01817530|593638957|FG000|Overall Study|Adverse Event|6|||
164345161|NCT01817530|593638958|FG001|Overall Study|Adverse Event|3|||
164345162|NCT01817530|593638959|FG002|Overall Study|Adverse Event|2|||
164004268|NCT02586805|592380746|FG001|Overall Study|Physician Decision|0|||
164004269|NCT02586805|592380747|FG002|Overall Study|Physician Decision|0|||
164004270|NCT02586805|592380748|FG003|Overall Study|Physician Decision|0|||
164004271|NCT00472303|592380755|FG000|Titration Phase|Adverse Event|22|||
164287026|NCT01177007|593420813|FG000|Overall Study|Required additional Y90 treatment|6|||
164287027|NCT01177007|593420813|FG000|Overall Study|Change in treatment modality|21|||
164287028|NCT01702558|593420814|FG000|Overall Study|Withdrawal by Subject|0|||
164287029|NCT01702558|593420815|FG001|Overall Study|Withdrawal by Subject|0|||
164287030|NCT01702558|593420816|FG002|Overall Study|Withdrawal by Subject|0|||
164287031|NCT01702558|593420817|FG003|Overall Study|Withdrawal by Subject|12|||
164287032|NCT01702558|593420818|FG004|Overall Study|Withdrawal by Subject|4|||
164004272|NCT00472303|592380756|FG001|Titration Phase|Adverse Event|12|||
164287033|NCT01702558|593420814|FG000|Overall Study|Lost to Follow-up|0|||
164287034|NCT01702558|593420815|FG001|Overall Study|Lost to Follow-up|0|||
164287035|NCT01702558|593420816|FG002|Overall Study|Lost to Follow-up|0|||
164004273|NCT00472303|592380757|FG002|Titration Phase|Adverse Event|0|||
164004274|NCT00472303|592380755|FG000|Titration Phase|Death|4|||
164287036|NCT01702558|593420817|FG003|Overall Study|Lost to Follow-up|3|||
164287037|NCT01702558|593420818|FG004|Overall Study|Lost to Follow-up|0|||
164287038|NCT01702558|593420814|FG000|Overall Study|Death|4|||
164287039|NCT01702558|593420815|FG001|Overall Study|Death|3|||
164287040|NCT01702558|593420816|FG002|Overall Study|Death|3|||
164287041|NCT01702558|593420817|FG003|Overall Study|Death|16|||
164287042|NCT01702558|593420818|FG004|Overall Study|Death|20|||
164287043|NCT01702558|593420814|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287044|NCT01702558|593420815|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287045|NCT01702558|593420816|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
164287046|NCT01702558|593420817|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287047|NCT01702558|593420818|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
164287048|NCT01702558|593420814|FG000|Overall Study|Study Terminated by Sponsor|0|||
164287049|NCT01702558|593420815|FG001|Overall Study|Study Terminated by Sponsor|1|||
164287050|NCT01702558|593420816|FG002|Overall Study|Study Terminated by Sponsor|0|||
164345163|NCT01817530|593638960|FG003|Overall Study|Adverse Event|5|||
164345164|NCT01817530|593638961|FG004|Overall Study|Adverse Event|0|||
164345165|NCT01817530|593638962|FG005|Overall Study|Adverse Event|10|||
164287051|NCT01702558|593420817|FG003|Overall Study|Study Terminated by Sponsor|0|||
164004275|NCT00472303|592380756|FG001|Titration Phase|Death|2|||
164004276|NCT00472303|592380757|FG002|Titration Phase|Death|0|||
164004277|NCT00472303|592380755|FG000|Titration Phase|Lack of Efficacy|10|||
164004278|NCT00472303|592380756|FG001|Titration Phase|Lack of Efficacy|0|||
164004279|NCT00472303|592380757|FG002|Titration Phase|Lack of Efficacy|0|||
164004280|NCT00472303|592380755|FG000|Titration Phase|Withdrawal by Subject|16|||
164004281|NCT00472303|592380756|FG001|Titration Phase|Withdrawal by Subject|13|||
164004282|NCT00472303|592380757|FG002|Titration Phase|Withdrawal by Subject|0|||
164004283|NCT00472303|592380755|FG000|Titration Phase|Trial Medication non-compliant|4|||
164004284|NCT00472303|592380756|FG001|Titration Phase|Trial Medication non-compliant|1|||
164004285|NCT00472303|592380757|FG002|Titration Phase|Trial Medication non-compliant|0|||
164004286|NCT00472303|592380755|FG000|Titration Phase|Other|3|||
164004287|NCT00472303|592380756|FG001|Titration Phase|Other|1|||
164004288|NCT00472303|592380757|FG002|Titration Phase|Other|0|||
164004289|NCT00472303|592380755|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
164004290|NCT00472303|592380756|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
164004291|NCT00472303|592380757|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
164004292|NCT00472303|592380755|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
164004293|NCT00472303|592380756|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
164004294|NCT00472303|592380757|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
164004295|NCT00472303|592380755|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
164345166|NCT01817530|593638963|FG006|Overall Study|Adverse Event|5|||
164345167|NCT01817530|593638964|FG007|Overall Study|Adverse Event|8|||
164345168|NCT01817530|593638957|FG000|Overall Study|Subject Noncompliant|3|||
164345169|NCT01817530|593638958|FG001|Overall Study|Subject Noncompliant|1|||
164345170|NCT01817530|593638959|FG002|Overall Study|Subject Noncompliant|0|||
164345171|NCT01817530|593638960|FG003|Overall Study|Subject Noncompliant|4|||
164345172|NCT01817530|593638961|FG004|Overall Study|Subject Noncompliant|0|||
164345173|NCT01817530|593638962|FG005|Overall Study|Subject Noncompliant|1|||
164345174|NCT01817530|593638963|FG006|Overall Study|Subject Noncompliant|1|||
164345175|NCT01817530|593638964|FG007|Overall Study|Subject Noncompliant|1|||
164345176|NCT01817530|593638957|FG000|Overall Study|Lack of Efficacy|1|||
164345177|NCT01817530|593638958|FG001|Overall Study|Lack of Efficacy|0|||
164345178|NCT01817530|593638959|FG002|Overall Study|Lack of Efficacy|0|||
164345179|NCT01817530|593638960|FG003|Overall Study|Lack of Efficacy|0|||
164345180|NCT01817530|593638961|FG004|Overall Study|Lack of Efficacy|0|||
164345181|NCT01817530|593638962|FG005|Overall Study|Lack of Efficacy|1|||
164345182|NCT01817530|593638963|FG006|Overall Study|Lack of Efficacy|0|||
164004296|NCT00472303|592380756|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
164004297|NCT00472303|592380757|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
164004298|NCT00472303|592380755|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
164345183|NCT01817530|593638964|FG007|Overall Study|Lack of Efficacy|1|||
164345184|NCT01817530|593638957|FG000|Overall Study|Pregnancy|0|||
164004299|NCT00472303|592380756|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
164004300|NCT00472303|592380757|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
164004301|NCT00472303|592380755|FG000|Discontinuations After Titration Phase|Other|5|||
164004302|NCT00472303|592380756|FG001|Discontinuations After Titration Phase|Other|0|||
164345185|NCT01817530|593638958|FG001|Overall Study|Pregnancy|0|||
164345186|NCT01817530|593638959|FG002|Overall Study|Pregnancy|0|||
164345187|NCT01817530|593638960|FG003|Overall Study|Pregnancy|0|||
164345188|NCT01817530|593638961|FG004|Overall Study|Pregnancy|0|||
164345189|NCT01817530|593638962|FG005|Overall Study|Pregnancy|1|||
164004303|NCT00472303|592380757|FG002|Discontinuations After Titration Phase|Other|0|||
164004304|NCT00472303|592380755|FG000|Maintenance Phase|Adverse Event|5|||
164004305|NCT00472303|592380756|FG001|Maintenance Phase|Adverse Event|6|||
164004306|NCT00472303|592380757|FG002|Maintenance Phase|Adverse Event|6|||
164004307|NCT00472303|592380755|FG000|Maintenance Phase|Death|3|||
164004308|NCT00472303|592380756|FG001|Maintenance Phase|Death|0|||
164004309|NCT00472303|592380757|FG002|Maintenance Phase|Death|2|||
164004310|NCT00472303|592380755|FG000|Maintenance Phase|Lack of Efficacy|2|||
164004311|NCT00472303|592380756|FG001|Maintenance Phase|Lack of Efficacy|2|||
164004312|NCT00472303|592380757|FG002|Maintenance Phase|Lack of Efficacy|4|||
164004313|NCT00472303|592380755|FG000|Maintenance Phase|Withdrawal by Subject|6|||
164004314|NCT00472303|592380756|FG001|Maintenance Phase|Withdrawal by Subject|7|||
164004315|NCT00472303|592380757|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164004316|NCT00472303|592380755|FG000|Maintenance Phase|Trial medication non-compliant|0|||
164004317|NCT00472303|592380756|FG001|Maintenance Phase|Trial medication non-compliant|0|||
164004318|NCT00472303|592380757|FG002|Maintenance Phase|Trial medication non-compliant|1|||
164004319|NCT00472303|592380755|FG000|Maintenance Phase|Resolution of pain|0|||
164004320|NCT00472303|592380756|FG001|Maintenance Phase|Resolution of pain|0|||
164004321|NCT00472303|592380757|FG002|Maintenance Phase|Resolution of pain|1|||
164004322|NCT00472303|592380755|FG000|Maintenance Phase|Other|1|||
164004323|NCT00472303|592380756|FG001|Maintenance Phase|Other|1|||
164004324|NCT00472303|592380757|FG002|Maintenance Phase|Other|0|||
164004325|NCT03596164|592380758|FG000|Overall Study|Adverse Event|0|||
164004326|NCT03596164|592380759|FG001|Overall Study|Adverse Event|1|||
164004327|NCT03596164|592380758|FG000|Overall Study|Death|1|||
164004328|NCT03596164|592380759|FG001|Overall Study|Death|0|||
164004329|NCT03427073|592380760|FG000|Overall Study|Disease Progression|1|||
164004330|NCT03427073|592380761|FG001|Overall Study|Disease Progression|1|||
164004331|NCT03427073|592380762|FG002|Overall Study|Disease Progression|1|||
164004332|NCT03427073|592380763|FG003|Overall Study|Disease Progression|3|||
164004333|NCT03427073|592380764|FG004|Overall Study|Disease Progression|3|||
164004334|NCT03427073|592380765|FG005|Overall Study|Disease Progression|4|||
164004335|NCT03427073|592380766|FG006|Overall Study|Disease Progression|2|||
164287052|NCT01702558|593420818|FG004|Overall Study|Study Terminated by Sponsor|1|||
164287053|NCT01702558|593420814|FG000|Overall Study|Other|0|||
164287054|NCT01702558|593420815|FG001|Overall Study|Other|0|||
164287055|NCT01702558|593420816|FG002|Overall Study|Other|0|||
164287056|NCT01702558|593420817|FG003|Overall Study|Other|16|||
164287057|NCT01702558|593420818|FG004|Overall Study|Other|17|||
164004336|NCT03427073|592380767|FG007|Overall Study|Disease Progression|3|||
164004337|NCT03427073|592380760|FG000|Overall Study|Physician Decision|0|||
164004338|NCT03427073|592380761|FG001|Overall Study|Physician Decision|0|||
164004339|NCT03427073|592380762|FG002|Overall Study|Physician Decision|0|||
164004340|NCT03427073|592380763|FG003|Overall Study|Physician Decision|0|||
164004341|NCT03427073|592380764|FG004|Overall Study|Physician Decision|0|||
164004342|NCT03427073|592380765|FG005|Overall Study|Physician Decision|0|||
164004343|NCT03427073|592380766|FG006|Overall Study|Physician Decision|1|||
164004344|NCT03427073|592380767|FG007|Overall Study|Physician Decision|1|||
164004345|NCT02835495|592380770|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
164004346|NCT02835495|592380771|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
164004347|NCT02835495|592380770|FG000|Overall Study|Declined in-person follow-up visit|4|||
164004348|NCT02835495|592380771|FG001|Overall Study|Declined in-person follow-up visit|2|||
164004349|NCT02580058|592380772|FG000|Overall Study|Adverse Event|16|||
164004350|NCT02580058|592380773|FG001|Overall Study|Adverse Event|30|||
164004351|NCT02580058|592380774|FG002|Overall Study|Adverse Event|20|||
164004352|NCT02580058|592380772|FG000|Overall Study|Death|4|||
164004353|NCT02580058|592380773|FG001|Overall Study|Death|4|||
164004354|NCT02580058|592380774|FG002|Overall Study|Death|5|||
164004355|NCT02580058|592380772|FG000|Overall Study|Physician Decision|1|||
164004356|NCT02580058|592380773|FG001|Overall Study|Physician Decision|3|||
164004357|NCT02580058|592380774|FG002|Overall Study|Physician Decision|11|||
164287058|NCT03259087|593420824|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287059|NCT03259087|593420825|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287060|NCT03259087|593420826|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287061|NCT03259087|593420827|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
164287062|NCT03259087|593420828|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
164004358|NCT02580058|592380772|FG000|Overall Study|Other|5|||
164004359|NCT02580058|592380773|FG001|Overall Study|Other|1|||
164004360|NCT02580058|592380774|FG002|Overall Study|Other|3|||
164004361|NCT02580058|592380772|FG000|Overall Study|Withdrawal by Subject|4|||
164004362|NCT02580058|592380773|FG001|Overall Study|Withdrawal by Subject|7|||
164004363|NCT02580058|592380774|FG002|Overall Study|Withdrawal by Subject|31|||
164004364|NCT02580058|592380772|FG000|Overall Study|Global Deterioration of Health Status|19|||
164004365|NCT02580058|592380773|FG001|Overall Study|Global Deterioration of Health Status|18|||
164004366|NCT02580058|592380774|FG002|Overall Study|Global Deterioration of Health Status|24|||
164004367|NCT02580058|592380772|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
164004368|NCT02580058|592380773|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164004369|NCT02580058|592380774|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
164004370|NCT02580058|592380772|FG000|Overall Study|Progressive Disease|137|||
164004371|NCT02580058|592380773|FG001|Overall Study|Progressive Disease|125|||
164004372|NCT02580058|592380774|FG002|Overall Study|Progressive Disease|94|||
164004373|NCT02580058|592380772|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164004374|NCT02580058|592380773|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164004375|NCT02580058|592380774|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164004376|NCT00749203|592380775|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
164004377|NCT00749203|592380776|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
164004378|NCT00749203|592380775|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
164004379|NCT00749203|592380776|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
164004380|NCT00749203|592380775|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
164004381|NCT00749203|592380776|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
164004382|NCT00749203|592380775|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
164087811|NCT03390504|592685802|FG002|Overall Study|Withdrawal by Subject|5|||
164287063|NCT03259087|593420824|FG000|Period 2 of Part 2|Adverse Event|0|||
164287064|NCT03259087|593420825|FG001|Period 2 of Part 2|Adverse Event|0|||
164287065|NCT03259087|593420826|FG002|Period 2 of Part 2|Adverse Event|0|||
164287066|NCT03259087|593420827|FG003|Period 2 of Part 2|Adverse Event|0|||
164287067|NCT03259087|593420828|FG004|Period 2 of Part 2|Adverse Event|1|||
164287068|NCT04524858|593420829|FG000|Overall Study|Adverse Event|1|||
164287069|NCT03571204|593420830|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
164287070|NCT03571204|593420831|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
164287071|NCT03571204|593420832|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
164287072|NCT03571204|593420830|FG000|Overall Study|Physician Decision|0|||
164287073|NCT03571204|593420831|FG001|Overall Study|Physician Decision|1|||
164287074|NCT03571204|593420832|FG002|Overall Study|Physician Decision|0|||
164287075|NCT01623115|593420833|FG000|Overall Study|Randomized but not treated|0|||
164287076|NCT01623115|593420834|FG001|Overall Study|Randomized but not treated|1|||
164287077|NCT01623115|593420833|FG000|Overall Study|Physician Decision|1|||
164287078|NCT01623115|593420834|FG001|Overall Study|Physician Decision|0|||
164287079|NCT01623115|593420833|FG000|Overall Study|Participants moved|1|||
164287080|NCT01623115|593420834|FG001|Overall Study|Participants moved|5|||
164287081|NCT01623115|593420833|FG000|Overall Study|Adverse Event|10|||
164287082|NCT01623115|593420834|FG001|Overall Study|Adverse Event|13|||
164287083|NCT01623115|593420833|FG000|Overall Study|Poor compliance to protocol|4|||
164287084|NCT01623115|593420834|FG001|Overall Study|Poor compliance to protocol|10|||
164287085|NCT01623115|593420833|FG000|Overall Study|Consent withdrawn by participant|2|||
164287086|NCT01623115|593420834|FG001|Overall Study|Consent withdrawn by participant|6|||
164287087|NCT01623115|593420833|FG000|Overall Study|Related to study drug administration|0|||
164287088|NCT01623115|593420834|FG001|Overall Study|Related to study drug administration|2|||
164287089|NCT01623115|593420833|FG000|Overall Study|Last visit outside protocol visit window|14|||
164287090|NCT01623115|593420834|FG001|Overall Study|Last visit outside protocol visit window|26|||
164287091|NCT01623115|593420833|FG000|Overall Study|Site closure|1|||
164287092|NCT01623115|593420834|FG001|Overall Study|Site closure|7|||
164287093|NCT01623115|593420833|FG000|Overall Study|Death|0|||
164287094|NCT01623115|593420834|FG001|Overall Study|Death|4|||
164287095|NCT01623115|593420833|FG000|Overall Study|Other than specified above|0|||
164287096|NCT01623115|593420834|FG001|Overall Study|Other than specified above|3|||
164287097|NCT04797780|593420835|FG000|Overall Study|Lost to Follow-up|1|||
164287098|NCT04797780|593420836|FG001|Overall Study|Lost to Follow-up|1|||
164287099|NCT04797780|593420835|FG000|Overall Study|Withdrawal by Subject|14|||
164287100|NCT04797780|593420836|FG001|Overall Study|Withdrawal by Subject|9|||
164287101|NCT04797780|593420835|FG000|Overall Study|Death|49|||
164287102|NCT04797780|593420836|FG001|Overall Study|Death|20|||
164287103|NCT02940496|593420837|FG000|Overall Study|Adverse Event|1|||
164287104|NCT02940496|593420838|FG001|Overall Study|Adverse Event|0|||
164287105|NCT02940496|593420837|FG000|Overall Study|Death|2|||
164287106|NCT02940496|593420838|FG001|Overall Study|Death|0|||
164287107|NCT02940496|593420837|FG000|Overall Study|Hospice Care|1|||
164287108|NCT02940496|593420838|FG001|Overall Study|Hospice Care|0|||
164287109|NCT02940496|593420837|FG000|Overall Study|No MRE Done|1|||
164287110|NCT02940496|593420838|FG001|Overall Study|No MRE Done|0|||
164287111|NCT02940496|593420837|FG000|Overall Study|MRE Failure|1|||
164287112|NCT02940496|593420838|FG001|Overall Study|MRE Failure|0|||
164287113|NCT05973006|593420839|FG000|Overall Study|Early termination|3|||
164287114|NCT05973006|593420840|FG001|Overall Study|Early termination|9|||
164287115|NCT05167825|593420841|FG000|Overall Study|Ongoing|3|||
164004383|NCT00749203|592380776|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
164004384|NCT00749203|592380775|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
164090469|NCT02984683|592693441|FG001|Overall Study|Disease progression|9|||
164287116|NCT01807598|593420842|FG000|Overall Study|Withdrawal by Subject|4|||
164287117|NCT01807598|593420842|FG000|Overall Study|Adverse Event|1|||
164287118|NCT01807598|593420842|FG000|Overall Study|Other Physician Decision|1|||
164287119|NCT03622814|593420854|FG000|Overall Study|Lost to Follow-up|8|||
164287120|NCT03622814|593420855|FG001|Overall Study|Lost to Follow-up|14|||
164287121|NCT04417361|593420856|FG000|Overall Study|Withdrawal by Subject|1|||
164287122|NCT04417361|593420857|FG001|Overall Study|Withdrawal by Subject|0|||
164287123|NCT04417361|593420856|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
164287124|NCT04417361|593420857|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
164287125|NCT00165672|593420858|FG000|Overall Study|Adverse Event|0|||
164287126|NCT00165672|593420859|FG001|Overall Study|Adverse Event|1|||
164287127|NCT04186871|593420862|FG000|Overall Study|Lack of Efficacy|0|||
164287128|NCT04186871|593420863|FG001|Overall Study|Lack of Efficacy|1|||
164287129|NCT04186871|593420864|FG002|Overall Study|Lack of Efficacy|0|||
164287130|NCT04186871|593420865|FG003|Overall Study|Lack of Efficacy|0|||
164287131|NCT04186871|593420866|FG004|Overall Study|Lack of Efficacy|1|||
164287132|NCT04186871|593420867|FG005|Overall Study|Lack of Efficacy|1|||
164287133|NCT04186871|593420862|FG000|Overall Study|Adverse Event|1|||
164287134|NCT04186871|593420863|FG001|Overall Study|Adverse Event|1|||
164287135|NCT04186871|593420864|FG002|Overall Study|Adverse Event|0|||
164287136|NCT04186871|593420865|FG003|Overall Study|Adverse Event|0|||
164287137|NCT04186871|593420866|FG004|Overall Study|Adverse Event|0|||
164287138|NCT04186871|593420867|FG005|Overall Study|Adverse Event|2|||
164287139|NCT04186871|593420862|FG000|Overall Study|Study terminated by sponsor|1|||
164287140|NCT04186871|593420863|FG001|Overall Study|Study terminated by sponsor|2|||
164287141|NCT04186871|593420864|FG002|Overall Study|Study terminated by sponsor|0|||
164287142|NCT04186871|593420865|FG003|Overall Study|Study terminated by sponsor|1|||
164287143|NCT04186871|593420866|FG004|Overall Study|Study terminated by sponsor|0|||
164287144|NCT04186871|593420867|FG005|Overall Study|Study terminated by sponsor|0|||
164287145|NCT04186871|593420862|FG000|Overall Study|Other reasons|0|||
164287146|NCT04186871|593420863|FG001|Overall Study|Other reasons|0|||
164287147|NCT04186871|593420864|FG002|Overall Study|Other reasons|0|||
164287148|NCT04186871|593420865|FG003|Overall Study|Other reasons|0|||
164287149|NCT04186871|593420866|FG004|Overall Study|Other reasons|0|||
164287150|NCT04186871|593420867|FG005|Overall Study|Other reasons|1|||
164287151|NCT04186871|593420862|FG000|Overall Study|Withdrawal by Subject|0|||
164287152|NCT04186871|593420863|FG001|Overall Study|Withdrawal by Subject|0|||
164287153|NCT04186871|593420864|FG002|Overall Study|Withdrawal by Subject|0|||
164287154|NCT04186871|593420865|FG003|Overall Study|Withdrawal by Subject|0|||
164287155|NCT04186871|593420866|FG004|Overall Study|Withdrawal by Subject|0|||
164287156|NCT04186871|593420867|FG005|Overall Study|Withdrawal by Subject|1|||
164287157|NCT04186871|593420862|FG000|Overall Study|Lost to Follow-up|0|||
164287158|NCT04186871|593420863|FG001|Overall Study|Lost to Follow-up|0|||
164287159|NCT04186871|593420864|FG002|Overall Study|Lost to Follow-up|0|||
164287160|NCT04186871|593420865|FG003|Overall Study|Lost to Follow-up|0|||
164287161|NCT04186871|593420866|FG004|Overall Study|Lost to Follow-up|0|||
164287162|NCT04186871|593420867|FG005|Overall Study|Lost to Follow-up|1|||
164287163|NCT00555217|593420869|FG000|Overall Study|Withdrawal by Subject|35|||
164287164|NCT00555217|593420870|FG001|Overall Study|Withdrawal by Subject|31|||
164287165|NCT00555217|593420869|FG000|Overall Study|Lost to Follow-up|19|||
164287166|NCT00555217|593420870|FG001|Overall Study|Lost to Follow-up|20|||
164287167|NCT00555217|593420869|FG000|Overall Study|close out sites|21|||
164287168|NCT00555217|593420870|FG001|Overall Study|close out sites|17|||
164287169|NCT01546688|593420871|FG000|Overall Study|Adverse Event|0|||
164287170|NCT01546688|593420872|FG001|Overall Study|Adverse Event|4|||
164287171|NCT01546688|593420871|FG000|Overall Study|Withdrawal by Subject|2|||
164287172|NCT01546688|593420872|FG001|Overall Study|Withdrawal by Subject|1|||
164287173|NCT01546688|593420871|FG000|Overall Study|Lack of Efficacy|1|||
164287174|NCT01546688|593420872|FG001|Overall Study|Lack of Efficacy|0|||
164287175|NCT03543137|593420874|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
164287176|NCT03543137|593420875|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
164287177|NCT03543137|593420874|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
164287178|NCT03543137|593420875|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
164287179|NCT03543137|593420874|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
164287180|NCT03543137|593420875|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
164287181|NCT01045694|593420877|FG000|Overall Study|Withdrawal by Subject|2|||
164287182|NCT01657292|593420882|FG000|Overall Study|Adverse Event|6|||
164287183|NCT01657292|593420882|FG000|Overall Study|Withdrawal by Subject|2|||
164287184|NCT01657292|593420882|FG000|Overall Study|Violation of eligibility criteria|1|||
164287185|NCT01657292|593420882|FG000|Overall Study|Change of therapy|1|||
164287186|NCT01900652|593420883|FG000|Overall Study|Progressive Disease|1|||
164287187|NCT01900652|593420884|FG001|Overall Study|Progressive Disease|0|||
164287188|NCT01900652|593420883|FG000|Overall Study|Consent withdrawn by subject|1|||
164287189|NCT01900652|593420884|FG001|Overall Study|Consent withdrawn by subject|1|||
164287190|NCT01900652|593420883|FG000|Overall Study|Death|3|||
164287191|NCT01900652|593420884|FG001|Overall Study|Death|0|||
164287192|NCT01900652|593420883|FG000|Overall Study|Adverse Event|2|||
164287193|NCT01900652|593420884|FG001|Overall Study|Adverse Event|1|||
164287194|NCT01900652|593420883|FG000|Overall Study|Physician Decision|1|||
164287195|NCT01900652|593420884|FG001|Overall Study|Physician Decision|1|||
164287196|NCT03761810|593420885|FG000|Overall Study|Adverse Event|12|||
164287197|NCT03761810|593420886|FG001|Overall Study|Adverse Event|0|||
164287198|NCT03761810|593420885|FG000|Overall Study|Lost to Follow-up|15|||
164287199|NCT03761810|593420886|FG001|Overall Study|Lost to Follow-up|7|||
164287200|NCT03761810|593420885|FG000|Overall Study|Pregnancy|1|||
164287201|NCT03761810|593420886|FG001|Overall Study|Pregnancy|0|||
164287202|NCT03761810|593420885|FG000|Overall Study|Withdrawal by Subject|14|||
164287203|NCT03761810|593420886|FG001|Overall Study|Withdrawal by Subject|5|||
164287204|NCT03761810|593420885|FG000|Overall Study|Physician Decision|1|||
164287205|NCT03761810|593420886|FG001|Overall Study|Physician Decision|0|||
164287206|NCT03761810|593420885|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
164287207|NCT03761810|593420886|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164287208|NCT03761810|593420885|FG000|Overall Study|Other Than Specified|1|||
164287209|NCT03761810|593420886|FG001|Overall Study|Other Than Specified|0|||
164287210|NCT04178720|593420887|FG000|Overall Study|Withdrawal by Subject|2|||
164287211|NCT04178720|593420888|FG001|Overall Study|Withdrawal by Subject|0|||
164287212|NCT04178720|593420887|FG000|Overall Study|Relocation|0|||
164287213|NCT04178720|593420888|FG001|Overall Study|Relocation|1|||
164287214|NCT00869518|593420889|FG000|Overall Study|Lost to Follow-up|1|||
164287215|NCT00869518|593420890|FG001|Overall Study|Lost to Follow-up|1|||
164287216|NCT03566082|593420891|FG000|Overall Study|Death|7|||
164287217|NCT03566082|593420891|FG000|Overall Study|Failures (revision required)|2|||
164287218|NCT03566082|593420891|FG000|Overall Study|Lost to Follow-up|8|||
164287219|NCT02663622|593420892|FG000|Overall Study|Death|3|||
164287220|NCT02663622|593420893|FG001|Overall Study|Death|1|||
164287221|NCT02663622|593420894|FG002|Overall Study|Death|1|||
164287222|NCT02663622|593420895|FG003|Overall Study|Death|8|||
164287223|NCT02663622|593420892|FG000|Overall Study|Protocol Violation|0|||
164287224|NCT02663622|593420893|FG001|Overall Study|Protocol Violation|0|||
164287225|NCT02663622|593420894|FG002|Overall Study|Protocol Violation|0|||
164287226|NCT02663622|593420895|FG003|Overall Study|Protocol Violation|1|||
164287227|NCT00930930|593420897|FG000|Overall Study|Death|1|||
164287228|NCT00930930|593420898|FG001|Overall Study|Death|0|||
164287229|NCT00930930|593420897|FG000|Overall Study|Physician Decision|1|||
164287230|NCT00930930|593420898|FG001|Overall Study|Physician Decision|0|||
164287231|NCT00930930|593420897|FG000|Overall Study|Adverse Event|13|||
164287232|NCT00930930|593420898|FG001|Overall Study|Adverse Event|3|||
164287233|NCT00930930|593420897|FG000|Overall Study|Withdrawal by Subject|3|||
164287234|NCT00930930|593420898|FG001|Overall Study|Withdrawal by Subject|1|||
164287235|NCT00930930|593420897|FG000|Overall Study|Disease progression|2|||
164287236|NCT00930930|593420898|FG001|Overall Study|Disease progression|3|||
164287237|NCT00930930|593420897|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
164287238|NCT00930930|593420898|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
164287239|NCT00930930|593420897|FG000|Overall Study|patients not compliant|1|||
164287240|NCT00930930|593420898|FG001|Overall Study|patients not compliant|1|||
164287241|NCT01633788|593422656|FG000|Overall Study|Adverse Event|1|||
164287242|NCT01633788|593422657|FG001|Overall Study|Adverse Event|3|||
164287243|NCT01633788|593422658|FG002|Overall Study|Adverse Event|3|||
164287244|NCT01633788|593422659|FG003|Overall Study|Adverse Event|3|||
164287245|NCT01633788|593422656|FG000|Overall Study|Lost to Follow-up|2|||
164287246|NCT01633788|593422657|FG001|Overall Study|Lost to Follow-up|2|||
164287247|NCT01633788|593422658|FG002|Overall Study|Lost to Follow-up|2|||
164287248|NCT01633788|593422659|FG003|Overall Study|Lost to Follow-up|0|||
164287249|NCT01633788|593422656|FG000|Overall Study|Personal Reasons|3|||
164287250|NCT01633788|593422657|FG001|Overall Study|Personal Reasons|1|||
164287251|NCT01633788|593422658|FG002|Overall Study|Personal Reasons|1|||
164287252|NCT01633788|593422659|FG003|Overall Study|Personal Reasons|3|||
164287253|NCT01633788|593422656|FG000|Overall Study|Protocol Violation|1|||
164287254|NCT01633788|593422657|FG001|Overall Study|Protocol Violation|0|||
164287255|NCT01633788|593422658|FG002|Overall Study|Protocol Violation|1|||
164287256|NCT01633788|593422659|FG003|Overall Study|Protocol Violation|0|||
164287257|NCT01633788|593422656|FG000|Overall Study|Other Reasons|0|||
164287258|NCT01633788|593422657|FG001|Overall Study|Other Reasons|2|||
164287259|NCT01633788|593422658|FG002|Overall Study|Other Reasons|3|||
164287260|NCT01633788|593422659|FG003|Overall Study|Other Reasons|7|||
164287261|NCT01467505|593422663|FG000|Overall Study|Adverse Event|1|||
164287262|NCT01467505|593422664|FG001|Overall Study|Adverse Event|0|||
164287263|NCT01467505|593422663|FG000|Overall Study|Withdrawal by Subject|4|||
164287264|NCT01467505|593422664|FG001|Overall Study|Withdrawal by Subject|0|||
164287265|NCT01467505|593422663|FG000|Overall Study|Study Terminated by Sponsor|28|||
164287266|NCT01467505|593422664|FG001|Overall Study|Study Terminated by Sponsor|3|||
164287267|NCT00227721|593422665|FG000|Overall Study|On study, but never treated.|1|||
164287268|NCT01389882|593422670|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
164287269|NCT01389882|593422671|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
164287270|NCT01389882|593422670|FG000|Overall Study|Withdrawal by Subject|0|||
164345190|NCT01817530|593638963|FG006|Overall Study|Pregnancy|0|||
164345191|NCT01817530|593638964|FG007|Overall Study|Pregnancy|0|||
164345192|NCT01817530|593638957|FG000|Overall Study|Other|0|||
164287271|NCT01389882|593422671|FG001|Overall Study|Withdrawal by Subject|1|||
164287272|NCT03790111|593422672|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
164287273|NCT03811340|593422674|FG000|Overall Study|subjects did not complete the survey.|90|||
164287274|NCT01045967|593422675|FG000|Second Intervention|Protocol Violation|0|||
164287275|NCT01045967|593422676|FG001|Second Intervention|Protocol Violation|1|||
164345193|NCT01817530|593638958|FG001|Overall Study|Other|1|||
164287276|NCT00383786|593422677|FG000|Overall Study|Protocol Violation|2|||
164287277|NCT00383786|593422678|FG001|Overall Study|Protocol Violation|6|||
164287278|NCT00383786|593422677|FG000|Overall Study|Withdrawal by Subject|2|||
164287279|NCT00383786|593422678|FG001|Overall Study|Withdrawal by Subject|5|||
164287280|NCT00383786|593422677|FG000|Overall Study|Physician Decision|0|||
164287281|NCT00383786|593422678|FG001|Overall Study|Physician Decision|1|||
164287282|NCT02219464|593422682|FG000|Overall Study|Withdrawal by Subject|1|||
164287283|NCT02219464|593422683|FG001|Overall Study|Withdrawal by Subject|0|||
164287284|NCT02219464|593422682|FG000|Overall Study|case cancelled|1|||
164287285|NCT02219464|593422683|FG001|Overall Study|case cancelled|0|||
164287286|NCT02219464|593422682|FG000|Overall Study|catheter malfunction|1|||
164287287|NCT02219464|593422683|FG001|Overall Study|catheter malfunction|0|||
164287288|NCT00984256|593422684|FG000|Overall Study|Withdrawal by Subject|0|||
164287289|NCT00984256|593422685|FG001|Overall Study|Withdrawal by Subject|1|||
164287290|NCT02544321|593422691|FG000|Overall Study|Withdrawal by Subject|1|||
164287291|NCT02544321|593422692|FG001|Overall Study|Withdrawal by Subject|2|||
164287292|NCT02544321|593422691|FG000|Overall Study|Adverse Event|1|||
164287293|NCT02544321|593422692|FG001|Overall Study|Adverse Event|1|||
164287294|NCT02544321|593422691|FG000|Overall Study|Protocol Violation|0|||
164287295|NCT02544321|593422692|FG001|Overall Study|Protocol Violation|1|||
164287296|NCT03529110|593422693|FG000|Overall Study|Progressive Disease|66|||
164287297|NCT03529110|593422694|FG001|Overall Study|Progressive Disease|158|||
164287298|NCT03529110|593422693|FG000|Overall Study|Clinical Progression|4|||
164287299|NCT03529110|593422694|FG001|Overall Study|Clinical Progression|12|||
164287300|NCT03529110|593422693|FG000|Overall Study|Adverse Event|35|||
164287301|NCT03529110|593422694|FG001|Overall Study|Adverse Event|17|||
164287302|NCT03529110|593422693|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
164287303|NCT03529110|593422694|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
164287304|NCT03529110|593422693|FG000|Overall Study|Lack of Efficacy|3|||
164287305|NCT03529110|593422694|FG001|Overall Study|Lack of Efficacy|3|||
164287306|NCT03529110|593422693|FG000|Overall Study|Physician Decision|2|||
164287307|NCT03529110|593422694|FG001|Overall Study|Physician Decision|8|||
164287308|NCT03529110|593422693|FG000|Overall Study|Miscellaneous|2|||
164287309|NCT03529110|593422694|FG001|Overall Study|Miscellaneous|5|||
164287310|NCT03493945|593422695|FG000|Phase I Dose Escalation|Ineligible|0|||
164287311|NCT03493945|593422696|FG001|Phase I Dose Escalation|Ineligible|0|||
164287312|NCT03493945|593422697|FG002|Phase I Dose Escalation|Ineligible|1|||
164287313|NCT03493945|593422698|FG003|Phase I Dose Escalation|Ineligible|0|||
164287314|NCT03493945|593422699|FG004|Phase I Dose Escalation|Ineligible|0|||
164287315|NCT03493945|593422700|FG005|Phase I Dose Escalation|Ineligible|0|||
164287316|NCT03493945|593422701|FG006|Phase I Dose Escalation|Ineligible|0|||
164287317|NCT03493945|593422695|FG000|Phase I Dose Escalation|New therapy|0|||
164287318|NCT03493945|593422696|FG001|Phase I Dose Escalation|New therapy|1|||
164287319|NCT03493945|593422697|FG002|Phase I Dose Escalation|New therapy|0|||
164287320|NCT03493945|593422698|FG003|Phase I Dose Escalation|New therapy|0|||
164287321|NCT03493945|593422699|FG004|Phase I Dose Escalation|New therapy|0|||
164287322|NCT03493945|593422700|FG005|Phase I Dose Escalation|New therapy|0|||
164287323|NCT03493945|593422701|FG006|Phase I Dose Escalation|New therapy|0|||
164287324|NCT03493945|593422695|FG000|Phase II Dose Expansion|Refused further treatment|0|||
164287325|NCT03493945|593422696|FG001|Phase II Dose Expansion|Refused further treatment|0|||
164287326|NCT03493945|593422697|FG002|Phase II Dose Expansion|Refused further treatment|0|||
164287327|NCT03493945|593422698|FG003|Phase II Dose Expansion|Refused further treatment|0|||
164345194|NCT01817530|593638959|FG002|Overall Study|Other|0|||
164345195|NCT01817530|593638960|FG003|Overall Study|Other|0|||
164345196|NCT01817530|593638961|FG004|Overall Study|Other|1|||
164345197|NCT01817530|593638962|FG005|Overall Study|Other|0|||
164345198|NCT01817530|593638963|FG006|Overall Study|Other|5|||
164287328|NCT03493945|593422699|FG004|Phase II Dose Expansion|Refused further treatment|1|||
164287329|NCT03493945|593422700|FG005|Phase II Dose Expansion|Refused further treatment|1|||
164287330|NCT03493945|593422701|FG006|Phase II Dose Expansion|Refused further treatment|0|||
164287331|NCT03493945|593422695|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287332|NCT03493945|593422696|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287333|NCT03493945|593422697|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
164345199|NCT01817530|593638964|FG007|Overall Study|Other|0|||
164087812|NCT03390504|592685803|FG003|Overall Study|Withdrawal by Subject|2|||
164087813|NCT03390504|592685800|FG000|Overall Study|Other|1|||
164287334|NCT03493945|593422698|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
164287335|NCT03493945|593422699|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287336|NCT03493945|593422700|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287337|NCT03493945|593422701|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
164287338|NCT05104450|593422702|FG000|Overall Study|Death|1|||
164287339|NCT05104450|593422703|FG001|Overall Study|Death|2|||
164087814|NCT03390504|592685801|FG001|Overall Study|Other|2|||
164287340|NCT05104450|593422702|FG000|Overall Study|Withdrawal by Subject|3|||
164345200|NCT01817530|593638957|FG000|Overall Study|Surgery or Invasive Intervention|1|||
164345201|NCT01817530|593638958|FG001|Overall Study|Surgery or Invasive Intervention|0|||
164287341|NCT05104450|593422703|FG001|Overall Study|Withdrawal by Subject|1|||
164287342|NCT01584232|593422704|FG000|Overall Study|Adverse Event|3|||
164287343|NCT01584232|593422705|FG001|Overall Study|Adverse Event|1|||
164287344|NCT01584232|593422704|FG000|Overall Study|Withdrawal by Subject|2|||
164287345|NCT01584232|593422705|FG001|Overall Study|Withdrawal by Subject|1|||
164287346|NCT01584232|593422704|FG000|Overall Study|Physician Decision|2|||
164287347|NCT01584232|593422705|FG001|Overall Study|Physician Decision|1|||
164287348|NCT01584232|593422704|FG000|Overall Study|Lost to Follow-up|1|||
164287349|NCT01584232|593422705|FG001|Overall Study|Lost to Follow-up|0|||
164287350|NCT01307319|593422706|FG000|Overall Study|Adverse Event|2|||
164287351|NCT01307319|593422707|FG001|Overall Study|Adverse Event|2|||
164287352|NCT01307319|593422708|FG002|Overall Study|Adverse Event|1|||
164287353|NCT01307319|593422706|FG000|Overall Study|Lost to Follow-up|1|||
164287354|NCT01307319|593422707|FG001|Overall Study|Lost to Follow-up|0|||
164287355|NCT01307319|593422708|FG002|Overall Study|Lost to Follow-up|1|||
164287356|NCT01307319|593422706|FG000|Overall Study|Protocol Violation|1|||
164287357|NCT01307319|593422707|FG001|Overall Study|Protocol Violation|1|||
164287358|NCT01307319|593422708|FG002|Overall Study|Protocol Violation|0|||
164287359|NCT01307319|593422706|FG000|Overall Study|Withdrawal by Subject|0|||
164287360|NCT01307319|593422707|FG001|Overall Study|Withdrawal by Subject|1|||
164287361|NCT01307319|593422708|FG002|Overall Study|Withdrawal by Subject|2|||
164287362|NCT01307319|593422706|FG000|Overall Study|Other|0|||
164287363|NCT01307319|593422707|FG001|Overall Study|Other|4|||
164287364|NCT01307319|593422708|FG002|Overall Study|Other|3|||
164287365|NCT02735239|593422710|FG000|Overall Study|Adverse Event|0|||
164287366|NCT02735239|593422711|FG001|Overall Study|Adverse Event|0|||
164287367|NCT02735239|593422712|FG002|Overall Study|Adverse Event|4|||
164287368|NCT02735239|593422713|FG003|Overall Study|Adverse Event|0|||
164287369|NCT02735239|593422714|FG004|Overall Study|Adverse Event|0|||
164287370|NCT02735239|593422715|FG005|Overall Study|Adverse Event|0|||
164287371|NCT02735239|593422710|FG000|Overall Study|Death|1|||
164287372|NCT02735239|593422711|FG001|Overall Study|Death|1|||
164287373|NCT02735239|593422712|FG002|Overall Study|Death|0|||
164287374|NCT02735239|593422713|FG003|Overall Study|Death|0|||
164287375|NCT02735239|593422714|FG004|Overall Study|Death|0|||
164287376|NCT02735239|593422715|FG005|Overall Study|Death|0|||
164287377|NCT02735239|593422710|FG000|Overall Study|Physician Decision|0|||
164287378|NCT02735239|593422711|FG001|Overall Study|Physician Decision|0|||
164287379|NCT02735239|593422712|FG002|Overall Study|Physician Decision|1|||
164287380|NCT02735239|593422713|FG003|Overall Study|Physician Decision|0|||
164287381|NCT02735239|593422714|FG004|Overall Study|Physician Decision|0|||
164287382|NCT02735239|593422715|FG005|Overall Study|Physician Decision|0|||
164287383|NCT02735239|593422710|FG000|Overall Study|Progressive disease|3|||
164287384|NCT02735239|593422711|FG001|Overall Study|Progressive disease|1|||
164287385|NCT02735239|593422712|FG002|Overall Study|Progressive disease|3|||
164287386|NCT02735239|593422713|FG003|Overall Study|Progressive disease|0|||
164287387|NCT02735239|593422714|FG004|Overall Study|Progressive disease|0|||
164287388|NCT02735239|593422715|FG005|Overall Study|Progressive disease|2|||
164287389|NCT02735239|593422710|FG000|Overall Study|Withdrawal by Subject|0|||
164287390|NCT02735239|593422711|FG001|Overall Study|Withdrawal by Subject|1|||
164287391|NCT02735239|593422712|FG002|Overall Study|Withdrawal by Subject|0|||
164287392|NCT02735239|593422713|FG003|Overall Study|Withdrawal by Subject|0|||
164287393|NCT02735239|593422714|FG004|Overall Study|Withdrawal by Subject|0|||
164287394|NCT02735239|593422715|FG005|Overall Study|Withdrawal by Subject|0|||
164287395|NCT02152631|593422721|FG000|Overall Study|Adverse Event|32|||
164287396|NCT02152631|593422722|FG001|Overall Study|Adverse Event|4|||
164287397|NCT02152631|593422721|FG000|Overall Study|Withdrawal by Subject|13|||
164287398|NCT02152631|593422722|FG001|Overall Study|Withdrawal by Subject|16|||
164287399|NCT02152631|593422721|FG000|Overall Study|Noncompliance with study drug|1|||
164287400|NCT02152631|593422722|FG001|Overall Study|Noncompliance with study drug|0|||
164287401|NCT02152631|593422721|FG000|Overall Study|Physician Decision|1|||
164287402|NCT02152631|593422722|FG001|Overall Study|Physician Decision|2|||
164287403|NCT02152631|593422721|FG000|Overall Study|Lost to Follow-up|0|||
164287404|NCT02152631|593422722|FG001|Overall Study|Lost to Follow-up|1|||
164287405|NCT02152631|593422721|FG000|Overall Study|On Treatment|19|||
164287406|NCT02152631|593422722|FG001|Overall Study|On Treatment|3|||
164287407|NCT00404651|593422727|FG000|Overall Study|Serious Adverse Event|0|||
164287408|NCT00404651|593422728|FG001|Overall Study|Serious Adverse Event|0|||
164287409|NCT00404651|593422729|FG002|Overall Study|Serious Adverse Event|2|||
164287410|NCT00404651|593422730|FG003|Overall Study|Serious Adverse Event|0|||
164287411|NCT00404651|593422727|FG000|Overall Study|Protocol Violation|10|||
164287412|NCT00404651|593422728|FG001|Overall Study|Protocol Violation|5|||
164287413|NCT00404651|593422729|FG002|Overall Study|Protocol Violation|14|||
164287414|NCT00404651|593422730|FG003|Overall Study|Protocol Violation|5|||
164287415|NCT00404651|593422727|FG000|Overall Study|Lost to Follow-up|15|||
164287416|NCT00404651|593422728|FG001|Overall Study|Lost to Follow-up|11|||
164287417|NCT00404651|593422729|FG002|Overall Study|Lost to Follow-up|13|||
164287418|NCT00404651|593422730|FG003|Overall Study|Lost to Follow-up|10|||
164287419|NCT00404651|593422727|FG000|Overall Study|Withdrawal by Subject|14|||
164287420|NCT00404651|593422728|FG001|Overall Study|Withdrawal by Subject|12|||
164287421|NCT00404651|593422729|FG002|Overall Study|Withdrawal by Subject|16|||
164287422|NCT00404651|593422730|FG003|Overall Study|Withdrawal by Subject|6|||
164287423|NCT02073682|593422755|FG000|Overall Study|Low Creatinine Clearance|1|||
164287424|NCT02073682|593422756|FG001|Overall Study|Low Creatinine Clearance|2|||
164287425|NCT02073682|593422755|FG000|Overall Study|Death|86|||
164287426|NCT02073682|593422756|FG001|Overall Study|Death|100|||
164287427|NCT02073682|593422755|FG000|Overall Study|Cancer Cured|10|||
164287428|NCT02073682|593422756|FG001|Overall Study|Cancer Cured|15|||
164287429|NCT02073682|593422755|FG000|Overall Study|ID: Patient Noncompliance|1|||
164287430|NCT02073682|593422756|FG001|Overall Study|ID: Patient Noncompliance|2|||
164287431|NCT02073682|593422755|FG000|Overall Study|ID: Palliative Treatment Only|10|||
164287432|NCT02073682|593422756|FG001|Overall Study|ID: Palliative Treatment Only|7|||
164287433|NCT02073682|593422755|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
164287434|NCT02073682|593422756|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
164287435|NCT02073682|593422755|FG000|Overall Study|Platelet Count <50,000/mL|1|||
164287436|NCT02073682|593422756|FG001|Overall Study|Platelet Count <50,000/mL|2|||
164287437|NCT02073682|593422755|FG000|Overall Study|Surgery/Medical Procedure|3|||
164287438|NCT02073682|593422756|FG001|Overall Study|Surgery/Medical Procedure|1|||
164287439|NCT02073682|593422755|FG000|Overall Study|Withdrawal by Subject|6|||
164287440|NCT02073682|593422756|FG001|Overall Study|Withdrawal by Subject|8|||
164287441|NCT02073682|593422755|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
164287442|NCT02073682|593422756|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
164287443|NCT02073682|593422755|FG000|Overall Study|Cancer Progression|53|||
164287444|NCT02073682|593422756|FG001|Overall Study|Cancer Progression|33|||
164287445|NCT02073682|593422755|FG000|Overall Study|Protocol Violation|1|||
164287446|NCT02073682|593422756|FG001|Overall Study|Protocol Violation|0|||
164287447|NCT02073682|593422755|FG000|Overall Study|Adverse Event|79|||
164287448|NCT02073682|593422756|FG001|Overall Study|Adverse Event|62|||
164287449|NCT02073682|593422755|FG000|Overall Study|No reason provided|11|||
164287450|NCT02073682|593422756|FG001|Overall Study|No reason provided|9|||
164287451|NCT02073682|593422755|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
164287452|NCT02073682|593422756|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
164287453|NCT02073682|593422755|FG000|Overall Study|Lost to Follow-up|1|||
164287454|NCT02073682|593422756|FG001|Overall Study|Lost to Follow-up|1|||
164287455|NCT02073682|593422755|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
164287456|NCT02073682|593422756|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
164287457|NCT03801174|593422757|FG000|Overall Study|Withdrawal by Subject|14|||
164287458|NCT03801174|593422758|FG001|Overall Study|Withdrawal by Subject|15|||
164287459|NCT03801174|593422757|FG000|Overall Study|Death|1|||
164287460|NCT03801174|593422758|FG001|Overall Study|Death|0|||
164287461|NCT03801174|593422757|FG000|Overall Study|Pregnancy|2|||
164287462|NCT03801174|593422758|FG001|Overall Study|Pregnancy|2|||
164287463|NCT03801174|593422757|FG000|Overall Study|Lost to Follow-up|19|||
164287464|NCT03801174|593422758|FG001|Overall Study|Lost to Follow-up|10|||
164287465|NCT03801174|593422757|FG000|Overall Study|Other|4|||
164287466|NCT03801174|593422758|FG001|Overall Study|Other|3|||
164287467|NCT03801174|593422757|FG000|Overall Study|Lack of Efficacy|4|||
164287468|NCT03801174|593422758|FG001|Overall Study|Lack of Efficacy|0|||
164287469|NCT03801174|593422757|FG000|Overall Study|Unwilling to complete activities|5|||
164287470|NCT03801174|593422758|FG001|Overall Study|Unwilling to complete activities|6|||
164287471|NCT03801174|593422757|FG000|Overall Study|Moved out of area|3|||
164287472|NCT03801174|593422758|FG001|Overall Study|Moved out of area|0|||
164287473|NCT04112810|593422763|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
164287474|NCT01687296|593422765|FG000|Overall Study|Lack of Efficacy|1|||
164287475|NCT01687296|593422766|FG001|Overall Study|Lack of Efficacy|1|||
164287476|NCT01687296|593422765|FG000|Overall Study|Protocol Violation|0|||
164287477|NCT01687296|593422766|FG001|Overall Study|Protocol Violation|1|||
164287478|NCT01687296|593422765|FG000|Overall Study|Withdrawal by Subject|6|||
164287479|NCT01687296|593422766|FG001|Overall Study|Withdrawal by Subject|3|||
164287480|NCT01539759|593422767|FG000|Overall Study|Lost to Follow-up|6|||
164287481|NCT01539759|593422768|FG001|Overall Study|Lost to Follow-up|8|||
164287482|NCT03201419|593422776|FG000|Overall Study|Adverse Event|3|||
164287483|NCT03201419|593422777|FG001|Overall Study|Adverse Event|1|||
164287484|NCT03201419|593422778|FG002|Overall Study|Adverse Event|0|||
164287485|NCT03201419|593422779|FG003|Overall Study|Adverse Event|0|||
164287486|NCT03201419|593422780|FG004|Overall Study|Adverse Event|1|||
164287487|NCT03201419|593422781|FG005|Overall Study|Adverse Event|1|||
164287488|NCT03201419|593422782|FG006|Overall Study|Adverse Event|5|||
164287489|NCT03201419|593422783|FG007|Overall Study|Adverse Event|0|||
164287490|NCT03201419|593422784|FG008|Overall Study|Adverse Event|0|||
164287491|NCT03201419|593422776|FG000|Overall Study|Lost to Follow-up|1|||
164287492|NCT03201419|593422777|FG001|Overall Study|Lost to Follow-up|0|||
164287493|NCT03201419|593422778|FG002|Overall Study|Lost to Follow-up|0|||
164287494|NCT03201419|593422779|FG003|Overall Study|Lost to Follow-up|0|||
164287495|NCT03201419|593422780|FG004|Overall Study|Lost to Follow-up|0|||
164287496|NCT03201419|593422781|FG005|Overall Study|Lost to Follow-up|0|||
164287497|NCT03201419|593422782|FG006|Overall Study|Lost to Follow-up|0|||
164287498|NCT03201419|593422783|FG007|Overall Study|Lost to Follow-up|0|||
164287499|NCT03201419|593422784|FG008|Overall Study|Lost to Follow-up|0|||
164287500|NCT03201419|593422776|FG000|Overall Study|Protocol Deviation|0|||
164287501|NCT03201419|593422777|FG001|Overall Study|Protocol Deviation|0|||
164287502|NCT03201419|593422778|FG002|Overall Study|Protocol Deviation|0|||
164287503|NCT03201419|593422779|FG003|Overall Study|Protocol Deviation|0|||
164287504|NCT03201419|593422780|FG004|Overall Study|Protocol Deviation|0|||
164287505|NCT03201419|593422781|FG005|Overall Study|Protocol Deviation|0|||
164287506|NCT03201419|593422782|FG006|Overall Study|Protocol Deviation|1|||
164287507|NCT03201419|593422783|FG007|Overall Study|Protocol Deviation|0|||
164287508|NCT03201419|593422784|FG008|Overall Study|Protocol Deviation|0|||
164287509|NCT03201419|593422776|FG000|Overall Study|Withdrawal by Subject|4|||
164287510|NCT03201419|593422777|FG001|Overall Study|Withdrawal by Subject|2|||
164287511|NCT03201419|593422778|FG002|Overall Study|Withdrawal by Subject|1|||
164287512|NCT03201419|593422779|FG003|Overall Study|Withdrawal by Subject|0|||
164287513|NCT03201419|593422780|FG004|Overall Study|Withdrawal by Subject|0|||
164287514|NCT03201419|593422781|FG005|Overall Study|Withdrawal by Subject|0|||
164287515|NCT03201419|593422782|FG006|Overall Study|Withdrawal by Subject|0|||
164287516|NCT03201419|593422783|FG007|Overall Study|Withdrawal by Subject|1|||
164287517|NCT03201419|593422784|FG008|Overall Study|Withdrawal by Subject|2|||
164287518|NCT03201419|593422776|FG000|Overall Study|Other|0|||
164287519|NCT03201419|593422777|FG001|Overall Study|Other|0|||
164287520|NCT03201419|593422778|FG002|Overall Study|Other|1|||
164287521|NCT03201419|593422779|FG003|Overall Study|Other|0|||
164287522|NCT03201419|593422780|FG004|Overall Study|Other|0|||
164287523|NCT03201419|593422781|FG005|Overall Study|Other|0|||
164287524|NCT03201419|593422782|FG006|Overall Study|Other|0|||
164287525|NCT03201419|593422783|FG007|Overall Study|Other|0|||
164287526|NCT03201419|593422784|FG008|Overall Study|Other|0|||
164287527|NCT03635424|593422785|FG000|Overall Study|Adverse Event|1|||
164287528|NCT03635424|593422785|FG000|Overall Study|Death|1|||
164287529|NCT03635424|593422785|FG000|Overall Study|Device not implanted|1|||
164287530|NCT02701283|593422786|FG000|Overall Study|Death|25|||
164287531|NCT02701283|593422787|FG001|Overall Study|Death|29|||
164287532|NCT02701283|593422788|FG002|Overall Study|Death|19|||
164287533|NCT02701283|593422786|FG000|Overall Study|Lost to Follow-up|3|||
164287534|NCT02701283|593422787|FG001|Overall Study|Lost to Follow-up|8|||
164287535|NCT02701283|593422788|FG002|Overall Study|Lost to Follow-up|1|||
164287536|NCT02701283|593422786|FG000|Overall Study|Withdrawal by Subject|12|||
164287537|NCT02701283|593422787|FG001|Overall Study|Withdrawal by Subject|41|||
164287538|NCT02701283|593422788|FG002|Overall Study|Withdrawal by Subject|1|||
164287539|NCT02701283|593422786|FG000|Overall Study|Missed 2-year visit|22|||
164287540|NCT02701283|593422787|FG001|Overall Study|Missed 2-year visit|27|||
164287541|NCT02701283|593422788|FG002|Overall Study|Missed 2-year visit|0|||
164287542|NCT02701283|593422786|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
164287543|NCT02701283|593422787|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
164287544|NCT02701283|593422788|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
164287545|NCT04544956|593422789|FG000|Overall Study|Withdrawal by Subject|1|||
164287546|NCT04266795|593422790|FG000|Overall Study|Adverse Event|10|||
164287547|NCT04266795|593422791|FG001|Overall Study|Adverse Event|19|||
164287548|NCT04266795|593422790|FG000|Overall Study|Death|7|||
164287549|NCT04266795|593422791|FG001|Overall Study|Death|8|||
164287550|NCT04266795|593422790|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
164287551|NCT04266795|593422791|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
164287552|NCT04266795|593422790|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164287553|NCT04266795|593422791|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164287554|NCT04266795|593422790|FG000|Overall Study|Progressive Disease|12|||
164287555|NCT04266795|593422791|FG001|Overall Study|Progressive Disease|9|||
164287556|NCT04266795|593422790|FG000|Overall Study|Withdrawal by Patient|5|||
164287557|NCT04266795|593422791|FG001|Overall Study|Withdrawal by Patient|6|||
164287558|NCT04266795|593422790|FG000|Overall Study|Disease Relapse|3|||
164287559|NCT04266795|593422791|FG001|Overall Study|Disease Relapse|6|||
164287560|NCT04266795|593422790|FG000|Overall Study|Reason not Specified|12|||
164287561|NCT04266795|593422791|FG001|Overall Study|Reason not Specified|10|||
164287562|NCT04266795|593422790|FG000|Overall Study|Participants Ongoing on Treatment|25|||
164287563|NCT04266795|593422791|FG001|Overall Study|Participants Ongoing on Treatment|23|||
164287564|NCT00699660|593422794|FG000|Overall Study|Lost to Follow-up|4|||
164287565|NCT00699660|593422795|FG001|Overall Study|Lost to Follow-up|2|||
164287566|NCT00699660|593422794|FG000|Overall Study|missing reports and recording failures|10|||
164287567|NCT00699660|593422795|FG001|Overall Study|missing reports and recording failures|6|||
164287568|NCT03915470|593422796|FG000|Overall Study|Death|3|||
164287569|NCT03915470|593422797|FG001|Overall Study|Death|1|||
164287570|NCT03915470|593422796|FG000|Overall Study|Adverse Event|1|||
164287571|NCT03915470|593422797|FG001|Overall Study|Adverse Event|0|||
164287572|NCT03915470|593422796|FG000|Overall Study|Physician Decision|1|||
164287573|NCT03915470|593422797|FG001|Overall Study|Physician Decision|0|||
164287574|NCT03915470|593422796|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
164287575|NCT03915470|593422797|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
163897715|NCT00982644|591998698|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
163897716|NCT00982644|591998697|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
163897717|NCT00982644|591998698|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
164287576|NCT03160898|593422798|FG000|Overall Study|Adverse Event|4|||
164287577|NCT03160898|593422799|FG001|Overall Study|Adverse Event|8|||
164287578|NCT03160898|593422800|FG002|Overall Study|Adverse Event|7|||
164287579|NCT03160898|593422801|FG003|Overall Study|Adverse Event|10|||
164287580|NCT03160898|593422798|FG000|Overall Study|Death|1|||
164287581|NCT03160898|593422799|FG001|Overall Study|Death|0|||
164287582|NCT03160898|593422800|FG002|Overall Study|Death|0|||
164287583|NCT03160898|593422801|FG003|Overall Study|Death|1|||
164287584|NCT03160898|593422798|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
164287585|NCT03160898|593422799|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
164287586|NCT03160898|593422800|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
164287587|NCT03160898|593422801|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
164287588|NCT03160898|593422798|FG000|Overall Study|Lost to Follow-up|1|||
164287589|NCT03160898|593422799|FG001|Overall Study|Lost to Follow-up|1|||
164287590|NCT03160898|593422800|FG002|Overall Study|Lost to Follow-up|1|||
164287591|NCT03160898|593422801|FG003|Overall Study|Lost to Follow-up|2|||
164287592|NCT03160898|593422798|FG000|Overall Study|Physician Decision|1|||
164287593|NCT03160898|593422799|FG001|Overall Study|Physician Decision|0|||
164287594|NCT03160898|593422800|FG002|Overall Study|Physician Decision|0|||
164287595|NCT03160898|593422801|FG003|Overall Study|Physician Decision|1|||
164287596|NCT03160898|593422798|FG000|Overall Study|Progressive Disease|4|||
164287597|NCT03160898|593422799|FG001|Overall Study|Progressive Disease|1|||
164287598|NCT03160898|593422800|FG002|Overall Study|Progressive Disease|2|||
164287599|NCT03160898|593422801|FG003|Overall Study|Progressive Disease|1|||
164287600|NCT03160898|593422798|FG000|Overall Study|Protocol Violation|1|||
164287601|NCT03160898|593422799|FG001|Overall Study|Protocol Violation|0|||
164287602|NCT03160898|593422800|FG002|Overall Study|Protocol Violation|2|||
164287603|NCT03160898|593422801|FG003|Overall Study|Protocol Violation|0|||
164287604|NCT03160898|593422798|FG000|Overall Study|Sponsor Discretion|2|||
164287605|NCT03160898|593422799|FG001|Overall Study|Sponsor Discretion|0|||
164287606|NCT03160898|593422800|FG002|Overall Study|Sponsor Discretion|0|||
164287607|NCT03160898|593422801|FG003|Overall Study|Sponsor Discretion|0|||
164287608|NCT03160898|593422798|FG000|Overall Study|Withdrawal by Subject|1|||
164287609|NCT03160898|593422799|FG001|Overall Study|Withdrawal by Subject|3|||
164287610|NCT03160898|593422800|FG002|Overall Study|Withdrawal by Subject|2|||
164287611|NCT03160898|593422801|FG003|Overall Study|Withdrawal by Subject|1|||
164287612|NCT03160898|593422798|FG000|Overall Study|Other|2|||
164287613|NCT03160898|593422799|FG001|Overall Study|Other|0|||
164287614|NCT03160898|593422800|FG002|Overall Study|Other|2|||
164287615|NCT03160898|593422801|FG003|Overall Study|Other|2|||
164287616|NCT03405818|593422804|FG000|Overall Study|Withdrawal by Subject|4|||
164287617|NCT03405818|593422804|FG000|Overall Study|Lost to Follow-up|4|||
164287618|NCT00434109|593422805|FG000|Overall Study|Physician Decision|9|||
164287619|NCT00434109|593422805|FG000|Overall Study|Adverse Event|5|||
164287620|NCT00434109|593422805|FG000|Overall Study|Protocol Violation|1|||
164287621|NCT00434109|593422805|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
164287622|NCT00549445|593422808|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
164287623|NCT00549445|593422809|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
164287624|NCT03932760|593422810|FG000|Overall Study|Became Ineligible|2|||
164287625|NCT03932760|593422811|FG001|Overall Study|Became Ineligible|5|||
164287626|NCT03932760|593422810|FG000|Overall Study|Withdrawal by Subject|6|||
164287627|NCT03932760|593422811|FG001|Overall Study|Withdrawal by Subject|6|||
164287628|NCT03922620|593422812|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
164287629|NCT03922620|593422813|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
164287630|NCT04725500|593422814|FG000|Screening|Screen Failure|26|||
164287631|NCT04725500|593422814|FG000|Screening|Withdrawal by Subject|1|||
164287632|NCT04725500|593422814|FG000|2 Week Take Home|Screen Fail|5|||
163897718|NCT00982644|591998697|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
164287633|NCT00511238|593422817|FG000|Overall Study|Adverse Event|13|||
164287634|NCT00511238|593422818|FG001|Overall Study|Adverse Event|33|||
164287635|NCT00511238|593422817|FG000|Overall Study|Withdrawal by Subject|2|||
164287636|NCT00511238|593422818|FG001|Overall Study|Withdrawal by Subject|22|||
164287637|NCT00511238|593422817|FG000|Overall Study|Progressive Disease|23|||
164287638|NCT00511238|593422818|FG001|Overall Study|Progressive Disease|157|||
164287639|NCT00511238|593422817|FG000|Overall Study|various reasons|4|||
164287640|NCT00511238|593422818|FG001|Overall Study|various reasons|14|||
164287641|NCT03553758|593424486|FG000|Overall Study|Lost to Follow-up|1|||
164287642|NCT02614729|593424487|FG000|Overall Study|Withdrawal by Subject|1|||
164087815|NCT03390504|592685802|FG002|Overall Study|Other|2|||
164287643|NCT02614729|593424488|FG001|Overall Study|Withdrawal by Subject|0|||
164287644|NCT00527735|593424494|FG000|Overall Study|Disease progression|47|||
164287645|NCT00527735|593424495|FG001|Overall Study|Disease progression|61|||
164287646|NCT00527735|593424496|FG002|Overall Study|Disease progression|53|||
164287647|NCT00527735|593424494|FG000|Overall Study|Death|23|||
164287648|NCT00527735|593424495|FG001|Overall Study|Death|13|||
164287649|NCT00527735|593424496|FG002|Overall Study|Death|15|||
164287650|NCT00527735|593424494|FG000|Overall Study|Completed treatment in treatment phase|14|||
164287651|NCT00527735|593424495|FG001|Overall Study|Completed treatment in treatment phase|13|||
164287652|NCT00527735|593424496|FG002|Overall Study|Completed treatment in treatment phase|18|||
164287653|NCT00527735|593424494|FG000|Overall Study|Adverse Event|10|||
164287654|NCT00527735|593424495|FG001|Overall Study|Adverse Event|6|||
164287655|NCT00527735|593424496|FG002|Overall Study|Adverse Event|7|||
164287656|NCT00527735|593424494|FG000|Overall Study|Not identified|5|||
164287657|NCT00527735|593424495|FG001|Overall Study|Not identified|5|||
164287658|NCT00527735|593424496|FG002|Overall Study|Not identified|5|||
164287659|NCT00527735|593424494|FG000|Overall Study|Withdrawal by Subject|5|||
164287660|NCT00527735|593424495|FG001|Overall Study|Withdrawal by Subject|4|||
164287661|NCT00527735|593424496|FG002|Overall Study|Withdrawal by Subject|3|||
164287662|NCT00527735|593424494|FG000|Overall Study|No longer met study criteria|2|||
164287663|NCT00527735|593424495|FG001|Overall Study|No longer met study criteria|2|||
164287664|NCT00527735|593424496|FG002|Overall Study|No longer met study criteria|1|||
164287665|NCT00527735|593424494|FG000|Overall Study|Lost to Follow-up|0|||
164287666|NCT00527735|593424495|FG001|Overall Study|Lost to Follow-up|0|||
164287667|NCT00527735|593424496|FG002|Overall Study|Lost to Follow-up|3|||
164287668|NCT00527735|593424494|FG000|Overall Study|Poor compliance or noncompliance|0|||
164287669|NCT00527735|593424495|FG001|Overall Study|Poor compliance or noncompliance|1|||
164287670|NCT00527735|593424496|FG002|Overall Study|Poor compliance or noncompliance|1|||
164287671|NCT00527735|593424494|FG000|Overall Study|Completed treatment during maintenance|2|||
164287672|NCT00527735|593424495|FG001|Overall Study|Completed treatment during maintenance|2|||
164287673|NCT00527735|593424496|FG002|Overall Study|Completed treatment during maintenance|1|||
164287674|NCT01121146|593424500|FG000|Overall Study|Death|17|||
164287675|NCT01121146|593424501|FG001|Overall Study|Death|15|||
164287676|NCT01121146|593424500|FG000|Overall Study|Adverse Event|2|||
164287677|NCT01121146|593424501|FG001|Overall Study|Adverse Event|11|||
164287678|NCT01121146|593424500|FG000|Overall Study|Lost to Follow-up|7|||
164287679|NCT01121146|593424501|FG001|Overall Study|Lost to Follow-up|16|||
164287680|NCT01276639|593424502|FG000|Week 0 to 16|Death|1|||
164287681|NCT01276639|593424503|FG001|Week 0 to 16|Death|0|||
164287682|NCT01276639|593424504|FG002|Week 0 to 16|Death|0|||
164287683|NCT01276639|593424505|FG003|Week 0 to 16|Death|0|||
164287684|NCT01276639|593424506|FG004|Week 0 to 16|Death|0|||
164287685|NCT01276639|593424502|FG000|Week 0 to 16|Adverse Event|11|||
164287686|NCT01276639|593424503|FG001|Week 0 to 16|Adverse Event|8|||
164287687|NCT01276639|593424504|FG002|Week 0 to 16|Adverse Event|11|||
164287688|NCT01276639|593424505|FG003|Week 0 to 16|Adverse Event|0|||
164287689|NCT01276639|593424506|FG004|Week 0 to 16|Adverse Event|0|||
164287690|NCT01276639|593424502|FG000|Week 0 to 16|Lack of Efficacy|20|||
164287691|NCT01276639|593424503|FG001|Week 0 to 16|Lack of Efficacy|15|||
164287692|NCT01276639|593424504|FG002|Week 0 to 16|Lack of Efficacy|25|||
164287693|NCT01276639|593424505|FG003|Week 0 to 16|Lack of Efficacy|0|||
164287694|NCT01276639|593424506|FG004|Week 0 to 16|Lack of Efficacy|0|||
164287695|NCT01276639|593424502|FG000|Week 0 to 16|Lost to Follow-up|3|||
164287696|NCT01276639|593424503|FG001|Week 0 to 16|Lost to Follow-up|5|||
164287697|NCT01276639|593424504|FG002|Week 0 to 16|Lost to Follow-up|3|||
164287698|NCT01276639|593424505|FG003|Week 0 to 16|Lost to Follow-up|0|||
164287699|NCT01276639|593424506|FG004|Week 0 to 16|Lost to Follow-up|0|||
164287700|NCT01276639|593424502|FG000|Week 0 to 16|Withdrawal by Subject|8|||
164287701|NCT01276639|593424503|FG001|Week 0 to 16|Withdrawal by Subject|5|||
164287702|NCT01276639|593424504|FG002|Week 0 to 16|Withdrawal by Subject|4|||
164287703|NCT01276639|593424505|FG003|Week 0 to 16|Withdrawal by Subject|0|||
164287704|NCT01276639|593424506|FG004|Week 0 to 16|Withdrawal by Subject|0|||
164287705|NCT01276639|593424502|FG000|Week 0 to 16|Other|7|||
164287706|NCT01276639|593424503|FG001|Week 0 to 16|Other|7|||
164287707|NCT01276639|593424504|FG002|Week 0 to 16|Other|2|||
164287708|NCT01276639|593424505|FG003|Week 0 to 16|Other|0|||
164287709|NCT01276639|593424506|FG004|Week 0 to 16|Other|0|||
164287710|NCT01276639|593424502|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
164287711|NCT01276639|593424503|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
164287712|NCT01276639|593424504|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
164287713|NCT01276639|593424505|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
164287714|NCT01276639|593424506|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
164287715|NCT01276639|593424502|FG000|Week 16 to 52|Death|1|||
164287716|NCT01276639|593424503|FG001|Week 16 to 52|Death|0|||
164287717|NCT01276639|593424504|FG002|Week 16 to 52|Death|0|||
164287718|NCT01276639|593424505|FG003|Week 16 to 52|Death|0|||
164287719|NCT01276639|593424506|FG004|Week 16 to 52|Death|0|||
164287720|NCT01276639|593424502|FG000|Week 16 to 52|Adverse Event|10|||
164287721|NCT01276639|593424503|FG001|Week 16 to 52|Adverse Event|13|||
164287722|NCT01276639|593424504|FG002|Week 16 to 52|Adverse Event|0|||
164287723|NCT01276639|593424505|FG003|Week 16 to 52|Adverse Event|1|||
164287724|NCT01276639|593424506|FG004|Week 16 to 52|Adverse Event|3|||
164287725|NCT01276639|593424502|FG000|Week 16 to 52|Lack of Efficacy|99|||
164287726|NCT01276639|593424503|FG001|Week 16 to 52|Lack of Efficacy|71|||
164287727|NCT01276639|593424504|FG002|Week 16 to 52|Lack of Efficacy|0|||
164287728|NCT01276639|593424505|FG003|Week 16 to 52|Lack of Efficacy|14|||
164287729|NCT01276639|593424506|FG004|Week 16 to 52|Lack of Efficacy|13|||
164287730|NCT01276639|593424502|FG000|Week 16 to 52|Lost to Follow-up|3|||
164287731|NCT01276639|593424503|FG001|Week 16 to 52|Lost to Follow-up|1|||
164287732|NCT01276639|593424504|FG002|Week 16 to 52|Lost to Follow-up|0|||
164287733|NCT01276639|593424505|FG003|Week 16 to 52|Lost to Follow-up|0|||
164287734|NCT01276639|593424506|FG004|Week 16 to 52|Lost to Follow-up|1|||
164287735|NCT01276639|593424502|FG000|Week 16 to 52|Withdrawal by Subject|4|||
164287736|NCT01276639|593424503|FG001|Week 16 to 52|Withdrawal by Subject|4|||
164287737|NCT01276639|593424504|FG002|Week 16 to 52|Withdrawal by Subject|0|||
164287738|NCT01276639|593424505|FG003|Week 16 to 52|Withdrawal by Subject|0|||
164287739|NCT01276639|593424506|FG004|Week 16 to 52|Withdrawal by Subject|1|||
164287740|NCT01276639|593424502|FG000|Week 16 to 52|Other|10|||
164287741|NCT01276639|593424503|FG001|Week 16 to 52|Other|12|||
164287742|NCT01276639|593424504|FG002|Week 16 to 52|Other|0|||
164287743|NCT01276639|593424505|FG003|Week 16 to 52|Other|1|||
164287744|NCT01276639|593424506|FG004|Week 16 to 52|Other|3|||
164287745|NCT01132807|593424511|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
164287746|NCT01132807|593424512|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
164287747|NCT01132807|593424513|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
164287748|NCT01132807|593424511|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
164287749|NCT01132807|593424512|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
164287750|NCT01132807|593424513|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
164287751|NCT01380769|593424514|FG000|Overall Study|Withdrawal by Subject|7|||
164287752|NCT01380769|593424515|FG001|Overall Study|Withdrawal by Subject|11|||
164287753|NCT01380769|593424514|FG000|Overall Study|Physician Decision|1|||
164287754|NCT01380769|593424515|FG001|Overall Study|Physician Decision|1|||
164287755|NCT01380769|593424514|FG000|Overall Study|Adverse Event|1|||
164287756|NCT01380769|593424515|FG001|Overall Study|Adverse Event|1|||
164287757|NCT01380769|593424514|FG000|Overall Study|Protocol Violation|0|||
164287758|NCT01380769|593424515|FG001|Overall Study|Protocol Violation|1|||
164287759|NCT03654690|593424517|FG000|Overall Study|Withdrawal by Subject|1|||
164287760|NCT03654690|593424518|FG001|Overall Study|Withdrawal by Subject|0|||
164287761|NCT03654690|593424519|FG002|Overall Study|Withdrawal by Subject|0|||
164287762|NCT01080807|593424526|FG000|Overall Study|Adverse Event|9|||
164287763|NCT01080807|593424527|FG001|Overall Study|Adverse Event|1|||
164287764|NCT01080807|593424526|FG000|Overall Study|Lack of Efficacy|0|||
164287765|NCT01080807|593424527|FG001|Overall Study|Lack of Efficacy|1|||
164287766|NCT01080807|593424526|FG000|Overall Study|Withdrawal by Subject|7|||
164287767|NCT01080807|593424527|FG001|Overall Study|Withdrawal by Subject|2|||
164287768|NCT01080807|593424526|FG000|Overall Study|Protocol Violation|7|||
164287769|NCT01080807|593424527|FG001|Overall Study|Protocol Violation|6|||
164287770|NCT01080807|593424526|FG000|Overall Study|Lost to Follow-up|6|||
164287771|NCT01080807|593424527|FG001|Overall Study|Lost to Follow-up|4|||
164287772|NCT01080807|593424526|FG000|Overall Study|Noncompliance with drug administration|1|||
164287773|NCT01080807|593424527|FG001|Overall Study|Noncompliance with drug administration|1|||
164287774|NCT01080807|593424526|FG000|Overall Study|Noncompliance to study procedures|1|||
164345202|NCT01817530|593638959|FG002|Overall Study|Surgery or Invasive Intervention|0|||
164345203|NCT01817530|593638960|FG003|Overall Study|Surgery or Invasive Intervention|0|||
164345204|NCT01817530|593638961|FG004|Overall Study|Surgery or Invasive Intervention|1|||
164345205|NCT01817530|593638962|FG005|Overall Study|Surgery or Invasive Intervention|1|||
164345206|NCT01817530|593638963|FG006|Overall Study|Surgery or Invasive Intervention|1|||
164345207|NCT01817530|593638964|FG007|Overall Study|Surgery or Invasive Intervention|0|||
164345208|NCT01817530|593638957|FG000|Overall Study|Consent Withdrawn by Subject|3|||
164345209|NCT01817530|593638958|FG001|Overall Study|Consent Withdrawn by Subject|4|||
164345210|NCT01817530|593638959|FG002|Overall Study|Consent Withdrawn by Subject|7|||
164345211|NCT01817530|593638960|FG003|Overall Study|Consent Withdrawn by Subject|3|||
163897719|NCT00982644|591998698|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
163897720|NCT00982644|591998697|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
163897721|NCT00982644|591998698|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
163897722|NCT00982644|591998697|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
163897723|NCT00982644|591998698|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
163897724|NCT00982644|591998697|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
164287775|NCT01080807|593424527|FG001|Overall Study|Noncompliance to study procedures|1|||
164287776|NCT01080807|593424526|FG000|Overall Study|Began working day shift|0|||
164287777|NCT01080807|593424527|FG001|Overall Study|Began working day shift|2|||
164287778|NCT01080807|593424526|FG000|Overall Study|Laid off or terminated from job|1|||
164287779|NCT01080807|593424527|FG001|Overall Study|Laid off or terminated from job|2|||
164287780|NCT01080807|593424526|FG000|Overall Study|Stopped working consistent night shifts|0|||
164287781|NCT01080807|593424527|FG001|Overall Study|Stopped working consistent night shifts|1|||
164287782|NCT01080807|593424526|FG000|Overall Study|Work schedule changing|1|||
164287783|NCT01080807|593424527|FG001|Overall Study|Work schedule changing|1|||
164287784|NCT01080807|593424526|FG000|Overall Study|Work schedule and travel|0|||
164287785|NCT01080807|593424527|FG001|Overall Study|Work schedule and travel|1|||
164287786|NCT01080807|593424526|FG000|Overall Study|Switched to first shift|1|||
164287787|NCT01080807|593424527|FG001|Overall Study|Switched to first shift|0|||
164287788|NCT01080807|593424526|FG000|Overall Study|Moved away without notifying center|1|||
164287789|NCT01080807|593424527|FG001|Overall Study|Moved away without notifying center|0|||
164287790|NCT03922581|593424535|FG000|Overall Study|Lost to Follow-up|20|||
164287791|NCT03922581|593424536|FG001|Overall Study|Lost to Follow-up|9|||
164287792|NCT03922581|593424535|FG000|Overall Study|Physician Decision|1|||
164287793|NCT03922581|593424536|FG001|Overall Study|Physician Decision|1|||
164287794|NCT03922581|593424535|FG000|Overall Study|Withdrawal by Subject|1|||
164287795|NCT03922581|593424536|FG001|Overall Study|Withdrawal by Subject|0|||
164287796|NCT00764699|593424539|FG000|Overall Study|PI left and study terminated|3|||
164287797|NCT02223715|593424540|FG000|Overall Study|Death|31|||
164287798|NCT02223715|593424540|FG000|Overall Study|Lost to Follow-up|73|||
164287799|NCT01745367|593424541|FG000|Overall Study|Death|1|||
164287800|NCT01745367|593424542|FG001|Overall Study|Death|0|||
164287801|NCT01745367|593424541|FG000|Overall Study|Withdrawal by Subject|1|||
164287802|NCT01745367|593424542|FG001|Overall Study|Withdrawal by Subject|2|||
164287803|NCT01745367|593424541|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
164287804|NCT01745367|593424542|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
164287805|NCT01745367|593424541|FG000|Overall Study|Other Reasons Unspecified|0|||
164287806|NCT01745367|593424542|FG001|Overall Study|Other Reasons Unspecified|2|||
164287807|NCT02366312|593424546|FG000|Overall Study|Lost to Follow-up|0|||
164287808|NCT02366312|593424547|FG001|Overall Study|Lost to Follow-up|1|||
164287809|NCT00965081|593424548|FG000|Overall Study|Adverse Event|14|||
164287810|NCT00965081|593424549|FG001|Overall Study|Adverse Event|9|||
164287811|NCT00965081|593424548|FG000|Overall Study|Lack of Efficacy|2|||
164287812|NCT00965081|593424549|FG001|Overall Study|Lack of Efficacy|5|||
164287813|NCT00965081|593424548|FG000|Overall Study|Lost to Follow-up|4|||
164287814|NCT00965081|593424549|FG001|Overall Study|Lost to Follow-up|5|||
164287815|NCT00965081|593424548|FG000|Overall Study|Physician Decision|2|||
164287816|NCT00965081|593424549|FG001|Overall Study|Physician Decision|0|||
164287817|NCT00965081|593424548|FG000|Overall Study|Protocol Violation|2|||
164287818|NCT00965081|593424549|FG001|Overall Study|Protocol Violation|5|||
164287819|NCT00965081|593424548|FG000|Overall Study|Sponsor Decision|1|||
164287820|NCT00965081|593424549|FG001|Overall Study|Sponsor Decision|0|||
164287821|NCT00965081|593424548|FG000|Overall Study|Withdrawal by Subject|4|||
164287822|NCT00965081|593424549|FG001|Overall Study|Withdrawal by Subject|7|||
164287823|NCT00965081|593424548|FG000|Overall Study|Switched to Rescue Arm|5|||
164287824|NCT00965081|593424549|FG001|Overall Study|Switched to Rescue Arm|12|||
164287825|NCT01076959|593424563|FG000|Overall Study|Adverse Event|767|||
164287826|NCT01076959|593424563|FG000|Overall Study|Lack of Efficacy|849|||
164287827|NCT01076959|593424563|FG000|Overall Study|Non-compliance|274|||
164287828|NCT01076959|593424563|FG000|Overall Study|Lost to Follow-up|241|||
164287829|NCT01076959|593424563|FG000|Overall Study|Other|119|||
164287830|NCT02491983|593424564|FG000|Overall Study|Physician Decision|1|||
164287831|NCT02491983|593424565|FG001|Overall Study|Physician Decision|0|||
164287832|NCT02491983|593424564|FG000|Overall Study|Not meet selection criteria|1|||
164287833|NCT02491983|593424565|FG001|Overall Study|Not meet selection criteria|0|||
164287834|NCT02491983|593424564|FG000|Overall Study|Withdrawal by Subject|0|||
164287835|NCT02491983|593424565|FG001|Overall Study|Withdrawal by Subject|1|||
164287836|NCT02021565|593424566|FG000|Baseline Through Intervention|Death|0|||
164287837|NCT02021565|593424567|FG001|Baseline Through Intervention|Death|1|||
164287838|NCT02021565|593424566|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
164287839|NCT02021565|593424567|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
164287840|NCT02021565|593424566|FG000|Baseline Through Intervention|Protocol Violation|0|||
164287841|NCT02021565|593424567|FG001|Baseline Through Intervention|Protocol Violation|7|||
164287842|NCT02021565|593424566|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
164287843|NCT02021565|593424567|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
164287844|NCT02021565|593424566|FG000|3-month Follow-up|Death|3|||
164287845|NCT02021565|593424567|FG001|3-month Follow-up|Death|0|||
164287846|NCT02021565|593424566|FG000|3-month Follow-up|Withdrawal by Subject|4|||
164287847|NCT02021565|593424567|FG001|3-month Follow-up|Withdrawal by Subject|0|||
164287848|NCT02021565|593424566|FG000|3-month Follow-up|Protocol Violation|3|||
164287849|NCT02021565|593424567|FG001|3-month Follow-up|Protocol Violation|2|||
164287850|NCT03575403|593424570|FG000|Overall Study|Adverse Event|1|||
164287851|NCT03575403|593424571|FG001|Overall Study|Adverse Event|0|||
164287852|NCT03575403|593424572|FG002|Overall Study|Adverse Event|0|||
164287853|NCT03575403|593424570|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
164287854|NCT03575403|593424571|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
164287855|NCT03575403|593424572|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
164287856|NCT02292719|593424573|FG000|Overall Study|Withdrawal by Subject|0|||
164287857|NCT02292719|593424574|FG001|Overall Study|Withdrawal by Subject|0|||
164287858|NCT02292719|593424575|FG002|Overall Study|Withdrawal by Subject|0|||
164287859|NCT02292719|593424576|FG003|Overall Study|Withdrawal by Subject|1|||
164287860|NCT02292719|593424577|FG004|Overall Study|Withdrawal by Subject|1|||
164287861|NCT02292719|593424578|FG005|Overall Study|Withdrawal by Subject|0|||
164287862|NCT02292719|593424573|FG000|Overall Study|Subject enrolled in new study.|0|||
164287863|NCT02292719|593424574|FG001|Overall Study|Subject enrolled in new study.|0|||
164287864|NCT02292719|593424575|FG002|Overall Study|Subject enrolled in new study.|1|||
164287865|NCT02292719|593424576|FG003|Overall Study|Subject enrolled in new study.|0|||
164287866|NCT02292719|593424577|FG004|Overall Study|Subject enrolled in new study.|0|||
164287867|NCT02292719|593424578|FG005|Overall Study|Subject enrolled in new study.|0|||
164287868|NCT01332994|593424579|FG000|Overall Study|Adverse Event|34|||
164287869|NCT01332994|593424579|FG000|Overall Study|Death|1|||
164287870|NCT01332994|593424579|FG000|Overall Study|Lack of Efficacy|1|||
164287871|NCT01332994|593424579|FG000|Overall Study|Lost to Follow-up|4|||
164287872|NCT01332994|593424579|FG000|Overall Study|Protocol Violation|6|||
164287873|NCT01332994|593424579|FG000|Overall Study|Withdrawal by Subject|15|||
164287874|NCT01332994|593424579|FG000|Overall Study|Administrative Problem|2|||
164287875|NCT01332994|593424579|FG000|Overall Study|Other|8|||
164287876|NCT00731679|593424581|FG000|Overall Study|Adverse Event|7|||
164287877|NCT00731679|593424582|FG001|Overall Study|Adverse Event|8|||
164287878|NCT00731679|593424581|FG000|Overall Study|Withdrawal by Subject|8|||
164287879|NCT00731679|593424582|FG001|Overall Study|Withdrawal by Subject|8|||
164287880|NCT00731679|593424581|FG000|Overall Study|Lost to Follow-up|7|||
164287881|NCT00731679|593424582|FG001|Overall Study|Lost to Follow-up|8|||
164287882|NCT00731679|593424581|FG000|Overall Study|Noncompliance|0|||
164287883|NCT00731679|593424582|FG001|Overall Study|Noncompliance|1|||
164287884|NCT00731679|593424581|FG000|Overall Study|Pregnancy|0|||
164287885|NCT00731679|593424582|FG001|Overall Study|Pregnancy|1|||
164287886|NCT03089580|593424588|FG000|Overall Study|Lost to Follow-up|2|||
164287887|NCT03087513|593424589|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
164287888|NCT04170543|593424590|FG000|Overall Study|Death|1|||
164287889|NCT04170543|593424591|FG001|Overall Study|Death|1|||
164287890|NCT04170543|593424592|FG002|Overall Study|Death|1|||
164287891|NCT04170543|593424593|FG003|Overall Study|Death|1|||
164287892|NCT04170543|593424594|FG004|Overall Study|Death|1|||
164287893|NCT04170543|593424590|FG000|Overall Study|Lost to Follow-up|3|||
164287894|NCT04170543|593424591|FG001|Overall Study|Lost to Follow-up|3|||
164287895|NCT04170543|593424592|FG002|Overall Study|Lost to Follow-up|0|||
164287896|NCT04170543|593424593|FG003|Overall Study|Lost to Follow-up|3|||
164287897|NCT04170543|593424594|FG004|Overall Study|Lost to Follow-up|1|||
164287898|NCT04170543|593424590|FG000|Overall Study|Withdrawal by Subject|13|||
164287899|NCT04170543|593424591|FG001|Overall Study|Withdrawal by Subject|6|||
164287900|NCT04170543|593424592|FG002|Overall Study|Withdrawal by Subject|5|||
164287901|NCT04170543|593424593|FG003|Overall Study|Withdrawal by Subject|4|||
164287902|NCT04170543|593424594|FG004|Overall Study|Withdrawal by Subject|9|||
164287903|NCT04170543|593424590|FG000|Overall Study|Not able to transition to phase 2b|8|||
164287904|NCT04170543|593424591|FG001|Overall Study|Not able to transition to phase 2b|0|||
164287905|NCT04170543|593424592|FG002|Overall Study|Not able to transition to phase 2b|10|||
164287906|NCT04170543|593424593|FG003|Overall Study|Not able to transition to phase 2b|0|||
164287907|NCT04170543|593424594|FG004|Overall Study|Not able to transition to phase 2b|6|||
164287908|NCT04170543|593424590|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
164287909|NCT04170543|593424591|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
164287910|NCT04170543|593424592|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
164287911|NCT04170543|593424593|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
164287912|NCT04170543|593424594|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
164287913|NCT04170543|593424590|FG000|Overall Study|Not Treated|0|||
164287914|NCT04170543|593424591|FG001|Overall Study|Not Treated|0|||
164287915|NCT04170543|593424592|FG002|Overall Study|Not Treated|0|||
164287916|NCT04170543|593424593|FG003|Overall Study|Not Treated|0|||
164287917|NCT04170543|593424594|FG004|Overall Study|Not Treated|2|||
164287918|NCT04170543|593424590|FG000|Overall Study|(CRF)|16|||
164287919|NCT04170543|593424591|FG001|Overall Study|(CRF)|15|||
164287920|NCT04170543|593424592|FG002|Overall Study|(CRF)|12|||
164287921|NCT04170543|593424593|FG003|Overall Study|(CRF)|17|||
164287922|NCT04170543|593424594|FG004|Overall Study|(CRF)|17|||
164345212|NCT01817530|593638961|FG004|Overall Study|Consent Withdrawn by Subject|5|||
164345213|NCT01817530|593638962|FG005|Overall Study|Consent Withdrawn by Subject|3|||
164345214|NCT01817530|593638963|FG006|Overall Study|Consent Withdrawn by Subject|3|||
164345215|NCT01817530|593638964|FG007|Overall Study|Consent Withdrawn by Subject|10|||
164345216|NCT01817530|593638957|FG000|Overall Study|Lost to Follow-up|1|||
164287923|NCT04170543|593424590|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
164287924|NCT04170543|593424591|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
164287925|NCT04170543|593424592|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
164287926|NCT04170543|593424593|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
164287927|NCT04170543|593424594|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
164287928|NCT00770601|593424595|FG000|Overall Study|Withdrawal by Subject|1|||
164287929|NCT04628780|593424596|FG000|Overall Study|Death|0|||
164287930|NCT04628780|593424597|FG001|Overall Study|Death|1|||
164287931|NCT04628780|593424598|FG002|Overall Study|Death|0|||
164287932|NCT04628780|593424599|FG003|Overall Study|Death|0|||
164287933|NCT04628780|593424600|FG004|Overall Study|Death|1|||
164287934|NCT04628780|593424601|FG005|Overall Study|Death|0|||
164287935|NCT04628780|593424596|FG000|Overall Study|Physician Decision|2|||
164287936|NCT04628780|593424597|FG001|Overall Study|Physician Decision|0|||
164287937|NCT04628780|593424598|FG002|Overall Study|Physician Decision|0|||
164287938|NCT04628780|593424599|FG003|Overall Study|Physician Decision|0|||
164287939|NCT04628780|593424600|FG004|Overall Study|Physician Decision|2|||
164287940|NCT04628780|593424601|FG005|Overall Study|Physician Decision|0|||
164287941|NCT04628780|593424596|FG000|Overall Study|Progressive disease|2|||
164287942|NCT04628780|593424597|FG001|Overall Study|Progressive disease|2|||
164287943|NCT04628780|593424598|FG002|Overall Study|Progressive disease|2|||
164287944|NCT04628780|593424599|FG003|Overall Study|Progressive disease|3|||
164287945|NCT04628780|593424600|FG004|Overall Study|Progressive disease|9|||
164287946|NCT04628780|593424601|FG005|Overall Study|Progressive disease|4|||
164287947|NCT04628780|593424596|FG000|Overall Study|Withdrawal by Subject|0|||
164287948|NCT04628780|593424597|FG001|Overall Study|Withdrawal by Subject|1|||
164287949|NCT04628780|593424598|FG002|Overall Study|Withdrawal by Subject|2|||
164287950|NCT04628780|593424599|FG003|Overall Study|Withdrawal by Subject|0|||
164287951|NCT04628780|593424600|FG004|Overall Study|Withdrawal by Subject|3|||
164287952|NCT04628780|593424601|FG005|Overall Study|Withdrawal by Subject|1|||
164287953|NCT04628780|593424596|FG000|Overall Study|Global deterioration of health status|0|||
164287954|NCT04628780|593424597|FG001|Overall Study|Global deterioration of health status|0|||
164287955|NCT04628780|593424598|FG002|Overall Study|Global deterioration of health status|0|||
164287956|NCT04628780|593424599|FG003|Overall Study|Global deterioration of health status|0|||
164287957|NCT04628780|593424600|FG004|Overall Study|Global deterioration of health status|1|||
164287958|NCT04628780|593424601|FG005|Overall Study|Global deterioration of health status|1|||
164287959|NCT03269994|593424603|FG000|Overall Study|Withdrawal by Subject|4|||
164287960|NCT03269994|593424604|FG001|Overall Study|Withdrawal by Subject|5|||
164287961|NCT03269994|593424603|FG000|Overall Study|Unresectable at surgery|39|||
164287962|NCT03269994|593424604|FG001|Overall Study|Unresectable at surgery|58|||
164287963|NCT03269994|593424603|FG000|Overall Study|Patient canceled surgery|5|||
164287964|NCT03269994|593424604|FG001|Overall Study|Patient canceled surgery|14|||
164287965|NCT03269994|593424603|FG000|Overall Study|Preoperative progression|14|||
164287966|NCT03269994|593424604|FG001|Overall Study|Preoperative progression|9|||
164287967|NCT03269994|593424603|FG000|Overall Study|Preoperative infection|10|||
164287968|NCT03269994|593424604|FG001|Overall Study|Preoperative infection|4|||
164287969|NCT03269994|593424603|FG000|Overall Study|Kidney insufficiency|1|||
164287970|NCT03269994|593424604|FG001|Overall Study|Kidney insufficiency|0|||
164287971|NCT03269994|593424603|FG000|Overall Study|Drug allergy|0|||
164287972|NCT03269994|593424604|FG001|Overall Study|Drug allergy|2|||
164287973|NCT03269994|593424603|FG000|Overall Study|Operation changed to different resection|9|||
164287974|NCT03269994|593424604|FG001|Overall Study|Operation changed to different resection|0|||
164287975|NCT03269994|593424603|FG000|Overall Study|Preoperative steroid|0|||
164345217|NCT01817530|593638958|FG001|Overall Study|Lost to Follow-up|4|||
164345218|NCT01817530|593638959|FG002|Overall Study|Lost to Follow-up|2|||
164345219|NCT01817530|593638960|FG003|Overall Study|Lost to Follow-up|1|||
164345220|NCT01817530|593638961|FG004|Overall Study|Lost to Follow-up|3|||
164345221|NCT01817530|593638962|FG005|Overall Study|Lost to Follow-up|2|||
164345222|NCT01817530|593638963|FG006|Overall Study|Lost to Follow-up|8|||
164345223|NCT01817530|593638964|FG007|Overall Study|Lost to Follow-up|4|||
164345224|NCT00566995|593638966|FG000|Overall Study|Toxicity|4|||
164345225|NCT00566995|593638966|FG000|Overall Study|Withdrew consent|3|||
164345226|NCT02657369|593638967|FG000|Overall Study|Death|27|||
164345227|NCT02657369|593638967|FG000|Overall Study|Study terminated by sponsor|7|||
164345228|NCT00481078|593638968|FG000|Overall Study|Progression of disease|11|||
164345229|NCT00481078|593638969|FG001|Overall Study|Progression of disease|11|||
164345230|NCT00481078|593638968|FG000|Overall Study|Adverse Event|15|||
164345231|NCT00481078|593638969|FG001|Overall Study|Adverse Event|3|||
164345232|NCT00481078|593638968|FG000|Overall Study|Death|5|||
164345233|NCT00481078|593638969|FG001|Overall Study|Death|3|||
164345234|NCT00481078|593638968|FG000|Overall Study|Intercurrent illness|1|||
164345235|NCT00481078|593638969|FG001|Overall Study|Intercurrent illness|0|||
164345236|NCT00481078|593638968|FG000|Overall Study|Withdrawal by Subject|7|||
164345237|NCT00481078|593638969|FG001|Overall Study|Withdrawal by Subject|1|||
164345238|NCT00481078|593638968|FG000|Overall Study|Information not available|1|||
164287976|NCT03269994|593424604|FG001|Overall Study|Preoperative steroid|3|||
164287977|NCT03269994|593424603|FG000|Overall Study|Accrual Closed|2|||
164287978|NCT03269994|593424604|FG001|Overall Study|Accrual Closed|0|||
164287979|NCT03269994|593424603|FG000|Overall Study|Operation changed to different resection|0|||
164087816|NCT03390504|592685803|FG003|Overall Study|Other|6|||
164287980|NCT03269994|593424604|FG001|Overall Study|Operation changed to different resection|10|||
164287981|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
164287982|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
164345239|NCT00481078|593638969|FG001|Overall Study|Information not available|0|||
164345240|NCT00481078|593638968|FG000|Overall Study|Received other treatment|2|||
164345241|NCT00481078|593638969|FG001|Overall Study|Received other treatment|1|||
164345242|NCT00481078|593638968|FG000|Overall Study|Brain metastasis|0|||
164345243|NCT00481078|593638969|FG001|Overall Study|Brain metastasis|1|||
164287983|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
164287984|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
164287985|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
164287986|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
164287987|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
164287988|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
164287989|NCT01987102|593424608|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
164287990|NCT01987102|593424609|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
164287991|NCT01987102|593424608|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
164287992|NCT01987102|593424609|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
164287993|NCT01288989|593424610|FG000|Overall Study|Death|0|||
164287994|NCT01288989|593424611|FG001|Overall Study|Death|0|||
164287995|NCT01288989|593424612|FG002|Overall Study|Death|0|||
164287996|NCT01288989|593424613|FG003|Overall Study|Death|1|||
164287997|NCT01288989|593424614|FG004|Overall Study|Death|0|||
164287998|NCT01288989|593424610|FG000|Overall Study|Dose limiting toxicity|1|||
164287999|NCT01288989|593424611|FG001|Overall Study|Dose limiting toxicity|0|||
164288000|NCT01288989|593424612|FG002|Overall Study|Dose limiting toxicity|0|||
164288001|NCT01288989|593424613|FG003|Overall Study|Dose limiting toxicity|0|||
164288002|NCT01288989|593424614|FG004|Overall Study|Dose limiting toxicity|0|||
164288003|NCT01288989|593424610|FG000|Overall Study|Adverse Event|0|||
164288004|NCT01288989|593424611|FG001|Overall Study|Adverse Event|0|||
164288005|NCT01288989|593424612|FG002|Overall Study|Adverse Event|0|||
164288006|NCT01288989|593424613|FG003|Overall Study|Adverse Event|0|||
164288007|NCT01288989|593424614|FG004|Overall Study|Adverse Event|2|||
164288008|NCT01288989|593424610|FG000|Overall Study|Physician Decision|0|||
164288009|NCT01288989|593424611|FG001|Overall Study|Physician Decision|0|||
164288010|NCT01288989|593424612|FG002|Overall Study|Physician Decision|0|||
164288011|NCT01288989|593424613|FG003|Overall Study|Physician Decision|0|||
164288012|NCT01288989|593424614|FG004|Overall Study|Physician Decision|1|||
164288013|NCT01288989|593424610|FG000|Overall Study|Withdrawal by Subject|0|||
164288014|NCT01288989|593424611|FG001|Overall Study|Withdrawal by Subject|0|||
164288015|NCT01288989|593424612|FG002|Overall Study|Withdrawal by Subject|0|||
164288016|NCT01288989|593424613|FG003|Overall Study|Withdrawal by Subject|0|||
164288017|NCT01288989|593424614|FG004|Overall Study|Withdrawal by Subject|3|||
164288018|NCT04378270|593424615|FG000|Overall Study|Lack of Efficacy|1|||
164288019|NCT04378270|593424615|FG000|Overall Study|Withdrawal by Subject|1|||
164288020|NCT04378270|593424615|FG000|Overall Study|Screen Failure|1|||
164288021|NCT04378270|593424615|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
164288022|NCT01327599|593424616|FG000|Overall Study|Adverse Event|1|||
164288023|NCT01327599|593424616|FG000|Overall Study|Could Not Attend Visit|1|||
164288024|NCT01327599|593424616|FG000|Overall Study|Withdrawal of Consent|1|||
164288025|NCT01132313|593424617|FG000|Overall Study|Lack of Efficacy|1|||
164288026|NCT01132313|593424618|FG001|Overall Study|Lack of Efficacy|0|||
164288027|NCT01132313|593424619|FG002|Overall Study|Lack of Efficacy|0|||
164288028|NCT01132313|593424620|FG003|Overall Study|Lack of Efficacy|0|||
164288029|NCT01132313|593424621|FG004|Overall Study|Lack of Efficacy|0|||
164288030|NCT01132313|593424622|FG005|Overall Study|Lack of Efficacy|0|||
164288031|NCT01132313|593424623|FG006|Overall Study|Lack of Efficacy|0|||
164288032|NCT01132313|593424624|FG007|Overall Study|Lack of Efficacy|3|||
164288033|NCT01132313|593424625|FG008|Overall Study|Lack of Efficacy|14|||
164288034|NCT01132313|593424626|FG009|Overall Study|Lack of Efficacy|16|||
164345244|NCT00074152|593638970|FG000|Overall Study|Death|21|||
164345245|NCT00074152|593638971|FG001|Overall Study|Death|9|||
164345246|NCT00074152|593638970|FG000|Overall Study|Lack of Efficacy|34|||
164345247|NCT00074152|593638971|FG001|Overall Study|Lack of Efficacy|24|||
164345248|NCT00228384|593638972|FG000|Overall Study|Death|9|||
164345249|NCT00228384|593638973|FG001|Overall Study|Death|3|||
164345250|NCT00228384|593638972|FG000|Overall Study|Lost to Follow-up|6|||
164345251|NCT00228384|593638973|FG001|Overall Study|Lost to Follow-up|10|||
164345252|NCT00228384|593638972|FG000|Overall Study|Surgical Intervention (bypass)|5|||
164345253|NCT00228384|593638973|FG001|Overall Study|Surgical Intervention (bypass)|5|||
164288035|NCT01132313|593424627|FG010|Overall Study|Lack of Efficacy|0|||
164288036|NCT01132313|593424628|FG011|Overall Study|Lack of Efficacy|0|||
164288037|NCT01132313|593424617|FG000|Overall Study|Not treated|2|||
164288038|NCT01132313|593424618|FG001|Overall Study|Not treated|0|||
164288039|NCT01132313|593424619|FG002|Overall Study|Not treated|0|||
164288040|NCT01132313|593424620|FG003|Overall Study|Not treated|0|||
164288041|NCT01132313|593424621|FG004|Overall Study|Not treated|2|||
164288042|NCT01132313|593424622|FG005|Overall Study|Not treated|1|||
164288043|NCT01132313|593424623|FG006|Overall Study|Not treated|3|||
164288044|NCT01132313|593424624|FG007|Overall Study|Not treated|0|||
164288045|NCT01132313|593424625|FG008|Overall Study|Not treated|0|||
164288046|NCT01132313|593424626|FG009|Overall Study|Not treated|0|||
164288047|NCT01132313|593424627|FG010|Overall Study|Not treated|0|||
164288048|NCT01132313|593424628|FG011|Overall Study|Not treated|0|||
164288049|NCT01132313|593424617|FG000|Overall Study|Adverse Event|0|||
164345254|NCT00228384|593638972|FG000|Overall Study|Withdrawal by Subject|9|||
164345255|NCT00228384|593638973|FG001|Overall Study|Withdrawal by Subject|10|||
164288050|NCT01132313|593424618|FG001|Overall Study|Adverse Event|0|||
164288051|NCT01132313|593424619|FG002|Overall Study|Adverse Event|4|||
164288052|NCT01132313|593424620|FG003|Overall Study|Adverse Event|10|||
164288053|NCT01132313|593424621|FG004|Overall Study|Adverse Event|19|||
164288054|NCT01132313|593424622|FG005|Overall Study|Adverse Event|6|||
164288055|NCT01132313|593424623|FG006|Overall Study|Adverse Event|5|||
164288056|NCT01132313|593424624|FG007|Overall Study|Adverse Event|3|||
164288057|NCT01132313|593424625|FG008|Overall Study|Adverse Event|7|||
164288058|NCT01132313|593424626|FG009|Overall Study|Adverse Event|2|||
164288059|NCT01132313|593424627|FG010|Overall Study|Adverse Event|0|||
164288060|NCT01132313|593424628|FG011|Overall Study|Adverse Event|0|||
164288061|NCT01132313|593424617|FG000|Overall Study|Protocol Violation|0|||
164288062|NCT01132313|593424618|FG001|Overall Study|Protocol Violation|0|||
164288063|NCT01132313|593424619|FG002|Overall Study|Protocol Violation|0|||
164288064|NCT01132313|593424620|FG003|Overall Study|Protocol Violation|1|||
164288065|NCT01132313|593424621|FG004|Overall Study|Protocol Violation|0|||
164345256|NCT00228384|593638972|FG000|Overall Study|Physician Decision|0|||
164345257|NCT00228384|593638973|FG001|Overall Study|Physician Decision|1|||
164345258|NCT01785069|593638974|FG000|Overall Study|Implanted with nonstudy device|1|||
164288066|NCT01132313|593424622|FG005|Overall Study|Protocol Violation|0|||
164288067|NCT01132313|593424623|FG006|Overall Study|Protocol Violation|0|||
164288068|NCT01132313|593424624|FG007|Overall Study|Protocol Violation|0|||
164288069|NCT01132313|593424625|FG008|Overall Study|Protocol Violation|0|||
164288070|NCT01132313|593424626|FG009|Overall Study|Protocol Violation|0|||
164288071|NCT01132313|593424627|FG010|Overall Study|Protocol Violation|0|||
164288072|NCT01132313|593424628|FG011|Overall Study|Protocol Violation|0|||
164288073|NCT01132313|593424617|FG000|Overall Study|Lost to Follow-up|0|||
164288074|NCT01132313|593424618|FG001|Overall Study|Lost to Follow-up|0|||
164288075|NCT01132313|593424619|FG002|Overall Study|Lost to Follow-up|1|||
164288076|NCT01132313|593424620|FG003|Overall Study|Lost to Follow-up|0|||
164288077|NCT01132313|593424621|FG004|Overall Study|Lost to Follow-up|0|||
164288078|NCT01132313|593424622|FG005|Overall Study|Lost to Follow-up|0|||
164288079|NCT01132313|593424623|FG006|Overall Study|Lost to Follow-up|0|||
164288080|NCT01132313|593424624|FG007|Overall Study|Lost to Follow-up|1|||
164288081|NCT01132313|593424625|FG008|Overall Study|Lost to Follow-up|0|||
164288082|NCT01132313|593424626|FG009|Overall Study|Lost to Follow-up|0|||
164288083|NCT01132313|593424627|FG010|Overall Study|Lost to Follow-up|0|||
164288084|NCT01132313|593424628|FG011|Overall Study|Lost to Follow-up|0|||
164345259|NCT01785069|593638975|FG001|Overall Study|Implanted with nonstudy device|2|||
164345260|NCT01785069|593638976|FG002|Overall Study|Implanted with nonstudy device|1|||
164345261|NCT01785069|593638977|FG003|Overall Study|Implanted with nonstudy device|0|||
164345262|NCT01785069|593638974|FG000|Overall Study|Death|0|||
164345263|NCT01785069|593638975|FG001|Overall Study|Death|0|||
164345264|NCT01785069|593638976|FG002|Overall Study|Death|2|||
164345265|NCT01785069|593638977|FG003|Overall Study|Death|0|||
164345266|NCT01785069|593638974|FG000|Overall Study|Subject choice|2|||
164345267|NCT01785069|593638975|FG001|Overall Study|Subject choice|2|||
164345268|NCT01785069|593638976|FG002|Overall Study|Subject choice|0|||
164345269|NCT01785069|593638977|FG003|Overall Study|Subject choice|1|||
164345270|NCT01785069|593638974|FG000|Overall Study|Lost to Follow-up|1|||
164345271|NCT01785069|593638975|FG001|Overall Study|Lost to Follow-up|2|||
164345272|NCT01785069|593638976|FG002|Overall Study|Lost to Follow-up|4|||
164345273|NCT01785069|593638977|FG003|Overall Study|Lost to Follow-up|1|||
164345274|NCT01785069|593638974|FG000|Overall Study|Reason not Specified|1|||
164345275|NCT01785069|593638975|FG001|Overall Study|Reason not Specified|2|||
164345276|NCT01785069|593638976|FG002|Overall Study|Reason not Specified|1|||
164345277|NCT01785069|593638977|FG003|Overall Study|Reason not Specified|4|||
164345278|NCT01785069|593638974|FG000|Overall Study|Not evaluable|7|||
164345279|NCT01785069|593638975|FG001|Overall Study|Not evaluable|4|||
164288085|NCT01132313|593424617|FG000|Overall Study|Withdrawal by Subject|0|||
164004385|NCT00749203|592380776|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
164004386|NCT00749203|592380775|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
164004387|NCT00749203|592380776|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
164288086|NCT01132313|593424618|FG001|Overall Study|Withdrawal by Subject|0|||
164288087|NCT01132313|593424619|FG002|Overall Study|Withdrawal by Subject|3|||
164288088|NCT01132313|593424620|FG003|Overall Study|Withdrawal by Subject|3|||
164288089|NCT01132313|593424621|FG004|Overall Study|Withdrawal by Subject|6|||
164288090|NCT01132313|593424622|FG005|Overall Study|Withdrawal by Subject|0|||
164288091|NCT01132313|593424623|FG006|Overall Study|Withdrawal by Subject|1|||
164288092|NCT01132313|593424624|FG007|Overall Study|Withdrawal by Subject|0|||
164288093|NCT01132313|593424625|FG008|Overall Study|Withdrawal by Subject|0|||
164288094|NCT01132313|593424626|FG009|Overall Study|Withdrawal by Subject|2|||
164288095|NCT01132313|593424627|FG010|Overall Study|Withdrawal by Subject|0|||
164345280|NCT01785069|593638976|FG002|Overall Study|Not evaluable|5|||
164345281|NCT01785069|593638977|FG003|Overall Study|Not evaluable|8|||
164345282|NCT03288129|593638978|FG000|Overall Study|Adverse Event|10|||
164345283|NCT03288129|593638978|FG000|Overall Study|Lost to Follow-up|3|||
164345284|NCT03288129|593638978|FG000|Overall Study|Withdrawal by Subject|3|||
164004388|NCT02034123|592380777|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004389|NCT02034123|592380778|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004390|NCT02034123|592380779|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004391|NCT02034123|592380780|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164288096|NCT01132313|593424628|FG011|Overall Study|Withdrawal by Subject|0|||
164288097|NCT01132313|593424617|FG000|Overall Study|Lack of antiviral response|0|||
164288098|NCT01132313|593424618|FG001|Overall Study|Lack of antiviral response|0|||
164288099|NCT01132313|593424619|FG002|Overall Study|Lack of antiviral response|12|||
164288100|NCT01132313|593424620|FG003|Overall Study|Lack of antiviral response|18|||
164288101|NCT01132313|593424621|FG004|Overall Study|Lack of antiviral response|18|||
164004392|NCT02034123|592380781|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
164288102|NCT01132313|593424622|FG005|Overall Study|Lack of antiviral response|18|||
164288103|NCT01132313|593424623|FG006|Overall Study|Lack of antiviral response|21|||
164288104|NCT01132313|593424624|FG007|Overall Study|Lack of antiviral response|0|||
164288105|NCT01132313|593424625|FG008|Overall Study|Lack of antiviral response|0|||
164288106|NCT01132313|593424626|FG009|Overall Study|Lack of antiviral response|0|||
164288107|NCT01132313|593424627|FG010|Overall Study|Lack of antiviral response|1|||
164288108|NCT01132313|593424628|FG011|Overall Study|Lack of antiviral response|0|||
164288109|NCT01132313|593424617|FG000|Overall Study|Other reason not defined above|0|||
164288110|NCT01132313|593424618|FG001|Overall Study|Other reason not defined above|0|||
164288111|NCT01132313|593424619|FG002|Overall Study|Other reason not defined above|0|||
164288112|NCT01132313|593424620|FG003|Overall Study|Other reason not defined above|0|||
164288113|NCT01132313|593424621|FG004|Overall Study|Other reason not defined above|0|||
164288114|NCT01132313|593424622|FG005|Overall Study|Other reason not defined above|0|||
164288115|NCT01132313|593424623|FG006|Overall Study|Other reason not defined above|0|||
164288116|NCT01132313|593424624|FG007|Overall Study|Other reason not defined above|1|||
164288117|NCT01132313|593424625|FG008|Overall Study|Other reason not defined above|0|||
164288118|NCT01132313|593424626|FG009|Overall Study|Other reason not defined above|0|||
164288119|NCT01132313|593424627|FG010|Overall Study|Other reason not defined above|0|||
164288120|NCT01132313|593424628|FG011|Overall Study|Other reason not defined above|0|||
164288121|NCT01236521|593424629|FG000|Overall Study|Withdrawal by Subject|12|||
164288122|NCT01236521|593424630|FG001|Overall Study|Withdrawal by Subject|17|||
164288123|NCT01236521|593424629|FG000|Overall Study|Death|2|||
164288124|NCT01236521|593424630|FG001|Overall Study|Death|1|||
164288125|NCT01236521|593424629|FG000|Overall Study|Lost to Follow-up|9|||
164288126|NCT01236521|593424630|FG001|Overall Study|Lost to Follow-up|7|||
164288127|NCT04661150|593424641|FG000|Overall Study|Ongoing in study|19|||
164288128|NCT04661150|593424642|FG001|Overall Study|Ongoing in study|20|||
164288129|NCT04661150|593424641|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
164288130|NCT04661150|593424642|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
164288131|NCT04661150|593424641|FG000|Overall Study|Death|2|||
164288132|NCT04661150|593424642|FG001|Overall Study|Death|0|||
164288133|NCT04965688|593424643|FG000|Overall Study|Withdrawal by Subject|2|||
164288134|NCT05864586|593424644|FG000|Overall Study|Ineligible|4|||
164288135|NCT05864586|593424645|FG001|Overall Study|Ineligible|12|||
164288136|NCT05864586|593424644|FG000|Overall Study|Pregnancy|0|||
164288137|NCT05864586|593424645|FG001|Overall Study|Pregnancy|1|||
164288138|NCT05864586|593424644|FG000|Overall Study|Withdrawal by Subject|0|||
164288139|NCT05864586|593424645|FG001|Overall Study|Withdrawal by Subject|1|||
164288140|NCT00369577|593424646|FG000|Overall Study|Withdrawal by Subject|0|||
164288141|NCT00369577|593424647|FG001|Overall Study|Withdrawal by Subject|0|||
164288142|NCT00369577|593424648|FG002|Overall Study|Withdrawal by Subject|1|||
164288143|NCT04618744|593424649|FG000|Overall Study|Adverse Event|0|||
164288144|NCT04618744|593424650|FG001|Overall Study|Adverse Event|1|||
164288145|NCT04618744|593424649|FG000|Overall Study|Withdrawal by Subject|0|||
164288146|NCT04618744|593424650|FG001|Overall Study|Withdrawal by Subject|1|||
164288147|NCT02719171|593426858|FG000|Overall Study|Adverse Event|1|||
164288148|NCT02719171|593426859|FG001|Overall Study|Adverse Event|2|||
164288149|NCT02719171|593426860|FG002|Overall Study|Adverse Event|0|||
164288150|NCT02719171|593426861|FG003|Overall Study|Adverse Event|0|||
164288151|NCT02719171|593426862|FG004|Overall Study|Adverse Event|2|||
164288152|NCT02719171|593426858|FG000|Overall Study|Lost to Follow-up|0|||
164288153|NCT02719171|593426859|FG001|Overall Study|Lost to Follow-up|0|||
164288154|NCT02719171|593426860|FG002|Overall Study|Lost to Follow-up|1|||
164288155|NCT02719171|593426861|FG003|Overall Study|Lost to Follow-up|0|||
164288156|NCT02719171|593426862|FG004|Overall Study|Lost to Follow-up|0|||
164288157|NCT02719171|593426858|FG000|Overall Study|Subject Withdrawal|0|||
164288158|NCT02719171|593426859|FG001|Overall Study|Subject Withdrawal|2|||
164288159|NCT02719171|593426860|FG002|Overall Study|Subject Withdrawal|2|||
164288160|NCT02719171|593426861|FG003|Overall Study|Subject Withdrawal|1|||
164288161|NCT02719171|593426862|FG004|Overall Study|Subject Withdrawal|0|||
164288162|NCT02719171|593426858|FG000|Overall Study|Other|0|||
164288163|NCT02719171|593426859|FG001|Overall Study|Other|0|||
164288164|NCT02719171|593426860|FG002|Overall Study|Other|0|||
164288165|NCT02719171|593426861|FG003|Overall Study|Other|1|||
164288166|NCT02719171|593426862|FG004|Overall Study|Other|0|||
164288167|NCT02807623|593426863|FG000|Overall Study|Lost to Follow-up|23|||
164288168|NCT02807623|593426864|FG001|Overall Study|Lost to Follow-up|18|||
164288169|NCT02807623|593426865|FG002|Overall Study|Lost to Follow-up|22|||
164288170|NCT02807623|593426863|FG000|Overall Study|Drug intolerance|0|||
164288171|NCT02807623|593426864|FG001|Overall Study|Drug intolerance|1|||
164288172|NCT02807623|593426865|FG002|Overall Study|Drug intolerance|0|||
164288173|NCT02807623|593426863|FG000|Overall Study|incomplete blood draw|0|||
164288174|NCT02807623|593426864|FG001|Overall Study|incomplete blood draw|2|||
164288175|NCT02807623|593426865|FG002|Overall Study|incomplete blood draw|1|||
164288176|NCT04002960|593426870|FG000|Overall Study|Withdrawn prior to Completion|2|||
164288177|NCT02107703|593426871|FG000|Overall Study|Withdrawal by Subject|46|||
164288178|NCT02107703|593426872|FG001|Overall Study|Withdrawal by Subject|21|||
164288179|NCT02107703|593426871|FG000|Overall Study|Lost to Follow-up|20|||
164288180|NCT02107703|593426872|FG001|Overall Study|Lost to Follow-up|9|||
164288181|NCT02107703|593426871|FG000|Overall Study|On study treatment/follow up|48|||
164288182|NCT02107703|593426872|FG001|Overall Study|On study treatment/follow up|5|||
164288183|NCT01020786|593426881|FG000|Induction Period|Entry Criteria Not Met|2|||
164288184|NCT01020786|593426881|FG000|Induction Period|Adverse Event|10|||
164288185|NCT01020786|593426881|FG000|Induction Period|Progressive Disease|31|||
164288186|NCT01020786|593426881|FG000|Induction Period|Investigator Decision|3|||
164288187|NCT01020786|593426881|FG000|Induction Period|Withdrawal by Subject|3|||
164288188|NCT01020786|593426881|FG000|Maintenance Period|Adverse Event|8|||
164288189|NCT01020786|593426881|FG000|Maintenance Period|Progressive Disease|43|||
164288190|NCT01020786|593426881|FG000|Maintenance Period|Withdrawal by Subject|8|||
164288191|NCT01020786|593426881|FG000|Maintenance Period|Sponsor Decision|1|||
164288192|NCT01176058|593426884|FG000|Overall Study|Adverse Event|1|||
164288193|NCT01176058|593426885|FG001|Overall Study|Adverse Event|0|||
164288194|NCT01176058|593426884|FG000|Overall Study|Insufficient clinical response|2|||
164288195|NCT01176058|593426885|FG001|Overall Study|Insufficient clinical response|2|||
164288196|NCT01176058|593426884|FG000|Overall Study|Insufficient mycological response|0|||
164288197|NCT01176058|593426885|FG001|Overall Study|Insufficient mycological response|1|||
164288198|NCT01176058|593426884|FG000|Overall Study|Withdrawal by Subject|1|||
164288199|NCT01176058|593426885|FG001|Overall Study|Withdrawal by Subject|0|||
164288200|NCT00256724|593426888|FG000|Overall Study|Physician Decision|2|||
164288201|NCT00256724|593426889|FG001|Overall Study|Physician Decision|5|||
164288202|NCT00256724|593426888|FG000|Overall Study|Protocol Violation|3|||
164288203|NCT00256724|593426889|FG001|Overall Study|Protocol Violation|3|||
164288204|NCT01217463|593426890|FG000|Overall Study|Adverse Event|8|||
164288205|NCT01217463|593426891|FG001|Overall Study|Adverse Event|5|||
164288206|NCT01217463|593426890|FG000|Overall Study|Physician Decision|0|||
164288207|NCT01217463|593426891|FG001|Overall Study|Physician Decision|1|||
164288208|NCT01217463|593426890|FG000|Overall Study|Withdrawal by Subject|3|||
164288209|NCT01217463|593426891|FG001|Overall Study|Withdrawal by Subject|0|||
164288210|NCT01217463|593426890|FG000|Overall Study|Surgery on the Target Limb|0|||
164288211|NCT01217463|593426891|FG001|Overall Study|Surgery on the Target Limb|1|||
164288212|NCT01217463|593426890|FG000|Overall Study|Patient Non-compliant|1|||
164288213|NCT01217463|593426891|FG001|Overall Study|Patient Non-compliant|0|||
164288214|NCT01217463|593426890|FG000|Overall Study|Other|1|||
164288215|NCT01217463|593426891|FG001|Overall Study|Other|1|||
164288216|NCT01879683|593426892|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
164288217|NCT01338818|593426894|FG000|Overall Study|Adverse Event|8|||
164288218|NCT01338818|593426894|FG000|Overall Study|Lack of Efficacy|5|||
164288219|NCT01338818|593426894|FG000|Overall Study|no longer require study drug|1|||
164288220|NCT01338818|593426894|FG000|Overall Study|Withdrawal by Subject|11|||
164288221|NCT01338818|593426894|FG000|Overall Study|Lost to Follow-up|4|||
164288222|NCT01338818|593426894|FG000|Overall Study|Administrative problems|3|||
164288223|NCT01338818|593426894|FG000|Overall Study|Protocol Deviation|4|||
164288224|NCT05202418|593426895|FG000|Overall Study|Withdrawal by Subject|2|||
164288225|NCT05202418|593426896|FG001|Overall Study|Withdrawal by Subject|1|||
164288226|NCT05202418|593426895|FG000|Overall Study|Lost to Follow-up|1|||
164288227|NCT05202418|593426896|FG001|Overall Study|Lost to Follow-up|1|||
164288228|NCT03901144|593426897|FG000|Overall Study|Lost to Follow-up|1|||
164288229|NCT03901144|593426898|FG001|Overall Study|Lost to Follow-up|1|||
164288230|NCT03901144|593426899|FG002|Overall Study|Lost to Follow-up|1|||
164288231|NCT03901144|593426900|FG003|Overall Study|Lost to Follow-up|1|||
164288232|NCT00279916|593426902|FG000|Overall Study|Withdrawal by Subject|4|||
164288233|NCT00279916|593426903|FG001|Overall Study|Withdrawal by Subject|3|||
164288234|NCT00279916|593426902|FG000|Overall Study|Lost to Follow-up|3|||
164288235|NCT00279916|593426903|FG001|Overall Study|Lost to Follow-up|2|||
164288236|NCT02488005|593426908|FG000|Overall Study|Lost to Follow-up|2|||
164288237|NCT00650767|593426913|FG000|Overall Study|Adverse Event|0|||
164288238|NCT00650767|593426914|FG001|Overall Study|Adverse Event|3|||
164288239|NCT00650767|593426915|FG002|Overall Study|Adverse Event|10|||
164288240|NCT00650767|593426916|FG003|Overall Study|Adverse Event|8|||
164288241|NCT00650767|593426913|FG000|Overall Study|Death|1|||
164288242|NCT00650767|593426914|FG001|Overall Study|Death|0|||
164288243|NCT00650767|593426915|FG002|Overall Study|Death|0|||
164288244|NCT00650767|593426916|FG003|Overall Study|Death|0|||
164288245|NCT00650767|593426913|FG000|Overall Study|Withdrawal by Subject|2|||
164288246|NCT00650767|593426914|FG001|Overall Study|Withdrawal by Subject|4|||
164288247|NCT00650767|593426915|FG002|Overall Study|Withdrawal by Subject|3|||
164288248|NCT00650767|593426916|FG003|Overall Study|Withdrawal by Subject|3|||
164288249|NCT00650767|593426913|FG000|Overall Study|Lost to Follow-up|1|||
164288250|NCT00650767|593426914|FG001|Overall Study|Lost to Follow-up|1|||
164288251|NCT00650767|593426915|FG002|Overall Study|Lost to Follow-up|1|||
164288252|NCT00650767|593426916|FG003|Overall Study|Lost to Follow-up|0|||
164288253|NCT00650767|593426913|FG000|Overall Study|Other|1|||
164288254|NCT00650767|593426914|FG001|Overall Study|Other|1|||
164288255|NCT00650767|593426915|FG002|Overall Study|Other|0|||
164288256|NCT00650767|593426916|FG003|Overall Study|Other|0|||
164288257|NCT03384940|593426917|FG000|Overall Study|Progressive disease|36|||
164288258|NCT03384940|593426918|FG001|Overall Study|Progressive disease|11|||
164288259|NCT03384940|593426919|FG002|Overall Study|Progressive disease|13|||
164288260|NCT03384940|593426917|FG000|Overall Study|Clinical progression|4|||
164288261|NCT03384940|593426918|FG001|Overall Study|Clinical progression|0|||
164288262|NCT03384940|593426919|FG002|Overall Study|Clinical progression|3|||
164288263|NCT03384940|593426917|FG000|Overall Study|Adverse Event|7|||
164288264|NCT03384940|593426918|FG001|Overall Study|Adverse Event|1|||
164288265|NCT03384940|593426919|FG002|Overall Study|Adverse Event|1|||
164288266|NCT03384940|593426917|FG000|Overall Study|Withdrawal by Subject|3|||
164288267|NCT03384940|593426918|FG001|Overall Study|Withdrawal by Subject|1|||
164288268|NCT03384940|593426919|FG002|Overall Study|Withdrawal by Subject|0|||
164288269|NCT03384940|593426917|FG000|Overall Study|Physician Decision|1|||
164288270|NCT03384940|593426918|FG001|Overall Study|Physician Decision|1|||
164288271|NCT03384940|593426919|FG002|Overall Study|Physician Decision|0|||
164288272|NCT03384940|593426917|FG000|Overall Study|Death|2|||
164288273|NCT03384940|593426918|FG001|Overall Study|Death|1|||
164288274|NCT03384940|593426919|FG002|Overall Study|Death|0|||
164288275|NCT03384940|593426917|FG000|Overall Study|Other|0|||
164288276|NCT03384940|593426918|FG001|Overall Study|Other|0|||
164288277|NCT03384940|593426919|FG002|Overall Study|Other|1|||
164288278|NCT03649074|593426922|FG000|Overall Study|Lost to Follow-up|2|||
164288279|NCT03649074|593426923|FG001|Overall Study|Lost to Follow-up|1|||
164288280|NCT03649074|593426922|FG000|Overall Study|Adverse Event|1|||
164288281|NCT03649074|593426923|FG001|Overall Study|Adverse Event|0|||
164288282|NCT03649074|593426922|FG000|Overall Study|Physician Decision|1|||
164288283|NCT03649074|593426923|FG001|Overall Study|Physician Decision|0|||
164288284|NCT03649074|593426922|FG000|Overall Study|Withdrawal by Subject|0|||
164288285|NCT03649074|593426923|FG001|Overall Study|Withdrawal by Subject|2|||
164288286|NCT03649074|593426922|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
164288287|NCT03649074|593426923|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
164288288|NCT03649074|593426922|FG000|Overall Study|Other|1|||
164288289|NCT03649074|593426923|FG001|Overall Study|Other|0|||
164288290|NCT04303559|593426924|FG000|Overall Study|Study closed due to poor enrollment.|1|||
164288291|NCT01156714|593426927|FG000|Overall Study|Withdrawal by Subject|9|||
164288292|NCT01156714|593426928|FG001|Overall Study|Withdrawal by Subject|4|||
164288293|NCT01156714|593426929|FG002|Overall Study|Withdrawal by Subject|3|||
164288294|NCT03775486|593426931|FG000|Initial Therapy Phase|Other reason provided|0|||
164288295|NCT03775486|593426932|FG001|Initial Therapy Phase|Other reason provided|15|||
164288296|NCT03775486|593426931|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
164288297|NCT03775486|593426932|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
164288298|NCT03775486|593426931|FG000|Initial Therapy Phase|Protocol Violation|0|||
163897725|NCT00982644|591998698|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
163897726|NCT00982644|591998697|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
163897727|NCT00982644|591998698|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
164288299|NCT03775486|593426932|FG001|Initial Therapy Phase|Protocol Violation|2|||
164288300|NCT03775486|593426931|FG000|Initial Therapy Phase|Adverse Event|0|||
163897728|NCT00982644|591998697|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
164288301|NCT03775486|593426932|FG001|Initial Therapy Phase|Adverse Event|34|||
164288302|NCT03775486|593426931|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
164288303|NCT03775486|593426932|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
164288304|NCT03775486|593426931|FG000|Maintenance Phase|Withdrawal by Subject|13|||
164288305|NCT03775486|593426932|FG001|Maintenance Phase|Withdrawal by Subject|12|||
164288306|NCT03775486|593426931|FG000|Maintenance Phase|Death|44|||
164288307|NCT03775486|593426932|FG001|Maintenance Phase|Death|45|||
164288308|NCT00801216|593426933|FG000|Overall Study|Screening Failure|2|||
164288309|NCT05907395|593426934|FG000|Period 1|No longer met eligibility criteria|0|||
164288310|NCT05907395|593426935|FG001|Period 1|No longer met eligibility criteria|1|||
164288311|NCT05907395|593426936|FG002|Period 1|No longer met eligibility criteria|0|||
164288312|NCT05907395|593426937|FG003|Period 1|No longer met eligibility criteria|0|||
164288313|NCT05907395|593426938|FG004|Period 1|No longer met eligibility criteria|0|||
164288314|NCT05907395|593426939|FG005|Period 1|No longer met eligibility criteria|1|||
164288315|NCT05907395|593426940|FG006|Period 1|No longer met eligibility criteria|1|||
164288316|NCT05907395|593426941|FG007|Period 1|No longer met eligibility criteria|0|||
164288317|NCT05907395|593426942|FG008|Period 1|No longer met eligibility criteria|0|||
164288318|NCT05907395|593426943|FG009|Period 1|No longer met eligibility criteria|0|||
164288319|NCT05907395|593426944|FG010|Period 1|No longer met eligibility criteria|0|||
164288320|NCT05907395|593426945|FG011|Period 1|No longer met eligibility criteria|0|||
164288321|NCT05907395|593426934|FG000|Period 2|Adverse Event|0|||
164288322|NCT05907395|593426935|FG001|Period 2|Adverse Event|0|||
164288323|NCT05907395|593426936|FG002|Period 2|Adverse Event|0|||
164288324|NCT05907395|593426937|FG003|Period 2|Adverse Event|1|||
164288325|NCT05907395|593426938|FG004|Period 2|Adverse Event|0|||
164288326|NCT05907395|593426939|FG005|Period 2|Adverse Event|0|||
164288327|NCT05907395|593426940|FG006|Period 2|Adverse Event|0|||
164288328|NCT05907395|593426941|FG007|Period 2|Adverse Event|1|||
164288329|NCT05907395|593426942|FG008|Period 2|Adverse Event|0|||
164288330|NCT05907395|593426943|FG009|Period 2|Adverse Event|0|||
164288331|NCT05907395|593426944|FG010|Period 2|Adverse Event|0|||
164288332|NCT05907395|593426945|FG011|Period 2|Adverse Event|0|||
164288333|NCT05907395|593426934|FG000|Period 2|Personal reason|0|||
164288334|NCT05907395|593426935|FG001|Period 2|Personal reason|0|||
164288335|NCT05907395|593426936|FG002|Period 2|Personal reason|0|||
164288336|NCT05907395|593426937|FG003|Period 2|Personal reason|0|||
164288337|NCT05907395|593426938|FG004|Period 2|Personal reason|0|||
164288338|NCT05907395|593426939|FG005|Period 2|Personal reason|0|||
164288339|NCT05907395|593426940|FG006|Period 2|Personal reason|0|||
164288340|NCT05907395|593426941|FG007|Period 2|Personal reason|0|||
164288341|NCT05907395|593426942|FG008|Period 2|Personal reason|0|||
164288342|NCT05907395|593426943|FG009|Period 2|Personal reason|1|||
164288343|NCT05907395|593426944|FG010|Period 2|Personal reason|0|||
164288344|NCT05907395|593426945|FG011|Period 2|Personal reason|0|||
164288345|NCT05907395|593426934|FG000|Period 3|Adverse Event|0|||
164288346|NCT05907395|593426935|FG001|Period 3|Adverse Event|0|||
164288347|NCT05907395|593426936|FG002|Period 3|Adverse Event|0|||
164288348|NCT05907395|593426937|FG003|Period 3|Adverse Event|0|||
164288349|NCT05907395|593426938|FG004|Period 3|Adverse Event|1|||
164288350|NCT05907395|593426939|FG005|Period 3|Adverse Event|0|||
164288351|NCT05907395|593426940|FG006|Period 3|Adverse Event|0|||
164288352|NCT05907395|593426941|FG007|Period 3|Adverse Event|0|||
164288353|NCT05907395|593426942|FG008|Period 3|Adverse Event|0|||
164288354|NCT05907395|593426943|FG009|Period 3|Adverse Event|0|||
164288355|NCT05907395|593426944|FG010|Period 3|Adverse Event|0|||
164288356|NCT05907395|593426945|FG011|Period 3|Adverse Event|0|||
164288357|NCT05214768|593426946|FG000|Induction Period|Withdrawal by Subject|1|||
164288358|NCT05214768|593426947|FG001|Induction Period|Withdrawal by Subject|0|||
164288359|NCT05214768|593426948|FG002|Induction Period|Withdrawal by Subject|0|||
164288360|NCT05214768|593426949|FG003|Induction Period|Withdrawal by Subject|0|||
164288361|NCT05214768|593426950|FG004|Induction Period|Withdrawal by Subject|0|||
164288362|NCT05214768|593426951|FG005|Induction Period|Withdrawal by Subject|0|||
164288363|NCT05214768|593426946|FG000|Induction Period|Physician Decision|1|||
164288364|NCT05214768|593426947|FG001|Induction Period|Physician Decision|0|||
164288365|NCT05214768|593426948|FG002|Induction Period|Physician Decision|0|||
164288366|NCT05214768|593426949|FG003|Induction Period|Physician Decision|0|||
164288367|NCT05214768|593426950|FG004|Induction Period|Physician Decision|0|||
164288368|NCT05214768|593426951|FG005|Induction Period|Physician Decision|0|||
164288369|NCT05214768|593426946|FG000|Maintenance Period|Other Reasons|0|||
164288370|NCT05214768|593426947|FG001|Maintenance Period|Other Reasons|0|||
164288371|NCT05214768|593426948|FG002|Maintenance Period|Other Reasons|1|||
164288372|NCT05214768|593426949|FG003|Maintenance Period|Other Reasons|1|||
164345285|NCT03288129|593638978|FG000|Overall Study|Withdrawal of consent/assent|1|||
164345286|NCT03288129|593638978|FG000|Overall Study|Other|5|||
164345287|NCT01744197|593638981|FG000|Overall Study|Received 1 patch|2|||
164345288|NCT01744197|593638982|FG001|Overall Study|Received 1 patch|1|||
164345289|NCT01744197|593638981|FG000|Overall Study|No patch received|2|||
164345290|NCT01744197|593638982|FG001|Overall Study|No patch received|2|||
164345291|NCT03305575|593640925|FG000|Overall Study|Physician Decision|1|||
164345292|NCT03305575|593640926|FG001|Overall Study|Physician Decision|0|||
164345293|NCT02871297|593640934|FG000|Overall Study|Adverse Event|34|||
164004393|NCT02034123|592380782|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164288373|NCT05214768|593426950|FG004|Maintenance Period|Other Reasons|0|||
164288374|NCT05214768|593426951|FG005|Maintenance Period|Other Reasons|0|||
164288375|NCT05214768|593426946|FG000|Maintenance Period|Withdrawal by Subject|0|||
164288376|NCT05214768|593426947|FG001|Maintenance Period|Withdrawal by Subject|0|||
164288377|NCT05214768|593426948|FG002|Maintenance Period|Withdrawal by Subject|0|||
164288378|NCT05214768|593426949|FG003|Maintenance Period|Withdrawal by Subject|1|||
164288379|NCT05214768|593426950|FG004|Maintenance Period|Withdrawal by Subject|0|||
164288380|NCT05214768|593426951|FG005|Maintenance Period|Withdrawal by Subject|0|||
164288381|NCT05214768|593426946|FG000|Maintenance Period|Lack of Efficacy|0|||
164288382|NCT05214768|593426947|FG001|Maintenance Period|Lack of Efficacy|0|||
164288383|NCT05214768|593426948|FG002|Maintenance Period|Lack of Efficacy|1|||
164288384|NCT05214768|593426949|FG003|Maintenance Period|Lack of Efficacy|0|||
164288385|NCT05214768|593426950|FG004|Maintenance Period|Lack of Efficacy|1|||
164345294|NCT02871297|593640934|FG000|Overall Study|Lack of Efficacy|10|||
164345295|NCT02871297|593640934|FG000|Overall Study|Non-compliance with study drug|15|||
164288386|NCT05214768|593426951|FG005|Maintenance Period|Lack of Efficacy|0|||
164288387|NCT05214768|593426946|FG000|Open Label Extension Period|Physician Decision|0|||
164288388|NCT05214768|593426947|FG001|Open Label Extension Period|Physician Decision|0|||
164288389|NCT05214768|593426948|FG002|Open Label Extension Period|Physician Decision|0|||
164288390|NCT05214768|593426949|FG003|Open Label Extension Period|Physician Decision|0|||
164288391|NCT05214768|593426950|FG004|Open Label Extension Period|Physician Decision|0|||
164288392|NCT05214768|593426951|FG005|Open Label Extension Period|Physician Decision|1|||
164288393|NCT05214768|593426946|FG000|Open Label Extension Period|Lack of Efficacy|0|||
164288394|NCT05214768|593426947|FG001|Open Label Extension Period|Lack of Efficacy|0|||
164288395|NCT05214768|593426948|FG002|Open Label Extension Period|Lack of Efficacy|0|||
164288396|NCT05214768|593426949|FG003|Open Label Extension Period|Lack of Efficacy|0|||
164288397|NCT05214768|593426950|FG004|Open Label Extension Period|Lack of Efficacy|0|||
164288398|NCT05214768|593426951|FG005|Open Label Extension Period|Lack of Efficacy|1|||
164288399|NCT05214768|593426946|FG000|Open Label Extension Period|Ongoing Study|0|||
164288400|NCT05214768|593426947|FG001|Open Label Extension Period|Ongoing Study|0|||
164288401|NCT05214768|593426948|FG002|Open Label Extension Period|Ongoing Study|0|||
164288402|NCT05214768|593426949|FG003|Open Label Extension Period|Ongoing Study|0|||
164288403|NCT05214768|593426950|FG004|Open Label Extension Period|Ongoing Study|0|||
164288404|NCT05214768|593426951|FG005|Open Label Extension Period|Ongoing Study|42|||
164288405|NCT05481359|593426952|FG000|Overall Study|Lost to Follow-up|3|||
164288406|NCT05481359|593426952|FG000|Overall Study|Withdrawal by Subject|1|||
164288407|NCT03043872|593426957|FG000|Overall Study|Withdrawal by Subject|6|||
164288408|NCT03043872|593426958|FG001|Overall Study|Withdrawal by Subject|6|||
164288409|NCT03043872|593426959|FG002|Overall Study|Withdrawal by Subject|15|||
164288410|NCT03043872|593426957|FG000|Overall Study|Lost to Follow-up|2|||
164288411|NCT03043872|593426958|FG001|Overall Study|Lost to Follow-up|1|||
164288412|NCT03043872|593426959|FG002|Overall Study|Lost to Follow-up|1|||
164288413|NCT03043872|593426957|FG000|Overall Study|Death|270|||
164288414|NCT03043872|593426958|FG001|Overall Study|Death|269|||
164288415|NCT03043872|593426959|FG002|Overall Study|Death|296|||
164288416|NCT02777827|593426961|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288417|NCT02777827|593426962|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288418|NCT02777827|593426963|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
164288419|NCT02777827|593426964|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288420|NCT02777827|593426965|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288421|NCT02777827|593426966|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
164288422|NCT04551066|593426967|FG000|Overall Study|Death|5|||
164288423|NCT04551066|593426968|FG001|Overall Study|Death|3|||
164288424|NCT04551066|593426967|FG000|Overall Study|Lost to Follow-up|1|||
164288425|NCT04551066|593426968|FG001|Overall Study|Lost to Follow-up|0|||
164288426|NCT04551066|593426967|FG000|Overall Study|Sponsor Decision|104|||
164288427|NCT04551066|593426968|FG001|Overall Study|Sponsor Decision|117|||
164288428|NCT04551066|593426967|FG000|Overall Study|Withdrawal by Subject|8|||
164288429|NCT04551066|593426968|FG001|Overall Study|Withdrawal by Subject|2|||
164288430|NCT04551066|593426967|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
164288431|NCT04551066|593426968|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
164288432|NCT04551066|593426967|FG000|Overall Study|Adverse Event|2|||
164288433|NCT04551066|593426968|FG001|Overall Study|Adverse Event|0|||
164288434|NCT04551066|593426967|FG000|Overall Study|Physician Decision|2|||
164288435|NCT04551066|593426968|FG001|Overall Study|Physician Decision|0|||
164288436|NCT04551066|593426967|FG000|Overall Study|Protocol Violation|1|||
164288437|NCT04551066|593426968|FG001|Overall Study|Protocol Violation|0|||
164288438|NCT04551066|593426967|FG000|Overall Study|Lack of Efficacy|0|||
164288439|NCT04551066|593426968|FG001|Overall Study|Lack of Efficacy|1|||
164288440|NCT04551066|593426967|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
164288441|NCT04551066|593426968|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
164288442|NCT04491136|593426969|FG000|Overall Study|Patient withdraw informed consent|9|||
164288443|NCT04491136|593426969|FG000|Overall Study|Adverse Event|2|||
164288444|NCT04491136|593426969|FG000|Overall Study|Death|3|||
164288445|NCT04491136|593426969|FG000|Overall Study|Lost to Follow-up|3|||
164288446|NCT04491136|593426969|FG000|Overall Study|Physician Decision|45|||
164288447|NCT04491136|593426969|FG000|Overall Study|sponsor terminated the study early|16|||
164288448|NCT04491136|593426969|FG000|Overall Study|Patient/guardian's decision|1|||
164288449|NCT00319254|593426972|FG000|Overall Study|Withdrawal by Subject|4|||
164004394|NCT02034123|592380783|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164288450|NCT00319254|593426972|FG000|Overall Study|Death|46|||
164288451|NCT00319254|593426972|FG000|Overall Study|Lost to Follow-up|2|||
164288452|NCT00319254|593426972|FG000|Overall Study|Enrolled, Not Treated|2|||
164288453|NCT01712204|593426976|FG000|Overall Study|Adverse Event|3|||
164288454|NCT01712204|593426977|FG001|Overall Study|Adverse Event|1|||
164288455|NCT01712204|593426976|FG000|Overall Study|Withdrawal by Subject|3|||
164288456|NCT01712204|593426977|FG001|Overall Study|Withdrawal by Subject|3|||
164288457|NCT01712204|593426976|FG000|Overall Study|Lost to Follow-up|1|||
164288458|NCT01712204|593426977|FG001|Overall Study|Lost to Follow-up|0|||
164288459|NCT01712204|593426976|FG000|Overall Study|Protocol Violation|1|||
164288460|NCT01712204|593426977|FG001|Overall Study|Protocol Violation|1|||
164288461|NCT02452424|593426978|FG000|Overall Study|Death|2|||
164288462|NCT02452424|593426979|FG001|Overall Study|Death|2|||
164288463|NCT02452424|593426980|FG002|Overall Study|Death|2|||
164288464|NCT02452424|593426981|FG003|Overall Study|Death|6|||
164288465|NCT02452424|593426982|FG004|Overall Study|Death|2|||
164288466|NCT02452424|593426983|FG005|Overall Study|Death|0|||
164288467|NCT02452424|593426984|FG006|Overall Study|Death|5|||
164288468|NCT02452424|593426985|FG007|Overall Study|Death|1|||
164288469|NCT02452424|593426986|FG008|Overall Study|Death|3|||
164288470|NCT02452424|593426987|FG009|Overall Study|Death|1|||
164288471|NCT02452424|593426988|FG010|Overall Study|Death|0|||
164288472|NCT02452424|593426978|FG000|Overall Study|Lost to Follow-up|0|||
164288473|NCT02452424|593426979|FG001|Overall Study|Lost to Follow-up|1|||
164288474|NCT02452424|593426980|FG002|Overall Study|Lost to Follow-up|1|||
164288475|NCT02452424|593426981|FG003|Overall Study|Lost to Follow-up|0|||
164288476|NCT02452424|593426982|FG004|Overall Study|Lost to Follow-up|0|||
164288477|NCT02452424|593426983|FG005|Overall Study|Lost to Follow-up|0|||
164288478|NCT02452424|593426984|FG006|Overall Study|Lost to Follow-up|0|||
164288479|NCT02452424|593426985|FG007|Overall Study|Lost to Follow-up|0|||
164288480|NCT02452424|593426986|FG008|Overall Study|Lost to Follow-up|0|||
164288481|NCT02452424|593426987|FG009|Overall Study|Lost to Follow-up|0|||
164288482|NCT02452424|593426988|FG010|Overall Study|Lost to Follow-up|0|||
164288483|NCT02452424|593426978|FG000|Overall Study|Withdrawal by Subject|0|||
164288484|NCT02452424|593426979|FG001|Overall Study|Withdrawal by Subject|0|||
164288485|NCT02452424|593426980|FG002|Overall Study|Withdrawal by Subject|3|||
164288486|NCT02452424|593426981|FG003|Overall Study|Withdrawal by Subject|2|||
164288487|NCT02452424|593426982|FG004|Overall Study|Withdrawal by Subject|0|||
164288488|NCT02452424|593426983|FG005|Overall Study|Withdrawal by Subject|0|||
164288489|NCT02452424|593426984|FG006|Overall Study|Withdrawal by Subject|1|||
164288490|NCT02452424|593426985|FG007|Overall Study|Withdrawal by Subject|0|||
164288491|NCT02452424|593426986|FG008|Overall Study|Withdrawal by Subject|1|||
164288492|NCT02452424|593426987|FG009|Overall Study|Withdrawal by Subject|1|||
164288493|NCT02452424|593426988|FG010|Overall Study|Withdrawal by Subject|0|||
164288494|NCT02452424|593426978|FG000|Overall Study|Other|0|||
164288495|NCT02452424|593426979|FG001|Overall Study|Other|0|||
164288496|NCT02452424|593426980|FG002|Overall Study|Other|1|||
164288497|NCT02452424|593426981|FG003|Overall Study|Other|0|||
164288498|NCT02452424|593426982|FG004|Overall Study|Other|0|||
164288499|NCT02452424|593426983|FG005|Overall Study|Other|1|||
164288500|NCT02452424|593426984|FG006|Overall Study|Other|4|||
164288501|NCT02452424|593426985|FG007|Overall Study|Other|3|||
164288502|NCT02452424|593426986|FG008|Overall Study|Other|0|||
164288503|NCT02452424|593426987|FG009|Overall Study|Other|0|||
164288504|NCT02452424|593426988|FG010|Overall Study|Other|1|||
164288505|NCT02452424|593426978|FG000|Overall Study|Progressive disease (per RECIST)|0|||
164288506|NCT02452424|593426979|FG001|Overall Study|Progressive disease (per RECIST)|0|||
164288507|NCT02452424|593426980|FG002|Overall Study|Progressive disease (per RECIST)|0|||
164288508|NCT02452424|593426981|FG003|Overall Study|Progressive disease (per RECIST)|0|||
164288509|NCT02452424|593426982|FG004|Overall Study|Progressive disease (per RECIST)|0|||
164288510|NCT02452424|593426983|FG005|Overall Study|Progressive disease (per RECIST)|0|||
164288511|NCT02452424|593426984|FG006|Overall Study|Progressive disease (per RECIST)|0|||
164288512|NCT02452424|593426985|FG007|Overall Study|Progressive disease (per RECIST)|0|||
164288513|NCT02452424|593426986|FG008|Overall Study|Progressive disease (per RECIST)|2|||
164288514|NCT02452424|593426987|FG009|Overall Study|Progressive disease (per RECIST)|0|||
164288515|NCT02452424|593426988|FG010|Overall Study|Progressive disease (per RECIST)|0|||
164288516|NCT02452424|593426978|FG000|Overall Study|Adverse Event|0|||
164288517|NCT02452424|593426979|FG001|Overall Study|Adverse Event|0|||
164288518|NCT02452424|593426980|FG002|Overall Study|Adverse Event|0|||
164288519|NCT02452424|593426981|FG003|Overall Study|Adverse Event|0|||
164288520|NCT02452424|593426982|FG004|Overall Study|Adverse Event|0|||
164288521|NCT02452424|593426983|FG005|Overall Study|Adverse Event|0|||
164288522|NCT02452424|593426984|FG006|Overall Study|Adverse Event|0|||
164288523|NCT02452424|593426985|FG007|Overall Study|Adverse Event|0|||
164288524|NCT02452424|593426986|FG008|Overall Study|Adverse Event|0|||
164288525|NCT02452424|593426987|FG009|Overall Study|Adverse Event|0|||
164288526|NCT02452424|593426988|FG010|Overall Study|Adverse Event|1|||
164288527|NCT01059318|593426989|FG000|Core Study (26 Week)|Adverse Event|3|||
164288528|NCT01059318|593426989|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
164288529|NCT01059318|593426989|FG000|Extension (36 Week)|Adverse Event|3|||
164288530|NCT03790917|593426990|FG000|Overall Study|Death|1|||
164288531|NCT00291486|593426992|FG000|Overall Study|Adverse Event|0|||
164288532|NCT00291486|593426993|FG001|Overall Study|Adverse Event|3|||
164288533|NCT00291486|593426994|FG002|Overall Study|Adverse Event|0|||
164288534|NCT00291486|593426995|FG003|Overall Study|Adverse Event|1|||
164288535|NCT00291486|593426996|FG004|Overall Study|Adverse Event|0|||
164288536|NCT00291486|593426992|FG000|Overall Study|Withdrawal by Subject|0|||
164288537|NCT00291486|593426993|FG001|Overall Study|Withdrawal by Subject|0|||
164288538|NCT00291486|593426994|FG002|Overall Study|Withdrawal by Subject|0|||
164288539|NCT00291486|593426995|FG003|Overall Study|Withdrawal by Subject|0|||
164288540|NCT00291486|593426996|FG004|Overall Study|Withdrawal by Subject|1|||
164288541|NCT00291486|593426992|FG000|Overall Study|Disease progression|1|||
164288542|NCT00291486|593426993|FG001|Overall Study|Disease progression|0|||
164288543|NCT00291486|593426994|FG002|Overall Study|Disease progression|1|||
164288544|NCT00291486|593426995|FG003|Overall Study|Disease progression|0|||
164288545|NCT00291486|593426996|FG004|Overall Study|Disease progression|0|||
164288546|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Death|2|||
164288547|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Death|0|||
164288548|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Death|0|||
164288549|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
164288550|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
164288551|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
164288552|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
164288553|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
164288554|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
164288555|NCT01150097|593426998|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
164288556|NCT01150097|593426999|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
164288557|NCT01150097|593427000|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
164288558|NCT01150097|593426998|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
164288559|NCT01150097|593426999|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
164288560|NCT01150097|593427000|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
164288561|NCT01150097|593426998|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
164288562|NCT01150097|593426999|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
164288563|NCT01150097|593427000|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
164288564|NCT01150097|593426998|FG000|Months 24 to 48 Post-transplantation|Death|2|||
164288565|NCT01150097|593426999|FG001|Months 24 to 48 Post-transplantation|Death|0|||
164288566|NCT01150097|593427000|FG002|Months 24 to 48 Post-transplantation|Death|0|||
164288567|NCT01408459|593427004|FG000|Overall Study|Withdrawal by Subject|1|||
164288568|NCT01408459|593427005|FG001|Overall Study|Withdrawal by Subject|1|||
164288569|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Adverse Event|0|||
164288570|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Adverse Event|1|||
164288571|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Adverse Event|0|||
164288572|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Adverse Event|0|||
164288573|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Adverse Event|0|||
164288574|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Adverse Event|0|||
164288575|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Adverse Event|0|||
164288576|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Adverse Event|1|||
164288577|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Adverse Event|1|||
164288578|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Adverse Event|0|||
164288579|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Adverse Event|0|||
164288580|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Physician Decision|0|||
164288581|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Physician Decision|0|||
164288582|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Physician Decision|1|||
164288583|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Physician Decision|0|||
164288584|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Physician Decision|0|||
164288585|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Physician Decision|0|||
164288586|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Physician Decision|0|||
164288587|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Physician Decision|1|||
164288588|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Physician Decision|0|||
164288589|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Physician Decision|0|||
164288590|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Physician Decision|0|||
164288591|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288592|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
164288593|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
164288594|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288595|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288596|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
164288597|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
164288598|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
164288599|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
164288600|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
164288601|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
164288602|NCT00543387|593427008|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288603|NCT00543387|593427009|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288604|NCT00543387|593427010|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288605|NCT00543387|593427011|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288606|NCT00543387|593427012|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288607|NCT00543387|593427013|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288608|NCT00543387|593427014|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
164288609|NCT00543387|593427015|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288610|NCT00543387|593427016|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288611|NCT00543387|593427017|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288612|NCT00543387|593427018|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
164288613|NCT00543387|593427008|FG000|Crossover Participants|Progressive Disease|0|||
164288614|NCT00543387|593427009|FG001|Crossover Participants|Progressive Disease|0|||
164288615|NCT00543387|593427010|FG002|Crossover Participants|Progressive Disease|0|||
164288616|NCT00543387|593427011|FG003|Crossover Participants|Progressive Disease|0|||
164288617|NCT00543387|593427012|FG004|Crossover Participants|Progressive Disease|0|||
164288618|NCT00543387|593427013|FG005|Crossover Participants|Progressive Disease|0|||
164288619|NCT00543387|593427014|FG006|Crossover Participants|Progressive Disease|0|||
164288620|NCT00543387|593427015|FG007|Crossover Participants|Progressive Disease|0|||
164288621|NCT00543387|593427016|FG008|Crossover Participants|Progressive Disease|0|||
164288622|NCT00543387|593427017|FG009|Crossover Participants|Progressive Disease|1|||
164288623|NCT00543387|593427018|FG010|Crossover Participants|Progressive Disease|2|||
164288624|NCT00543387|593427008|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
164288625|NCT00543387|593427009|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
164288626|NCT00543387|593427010|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
164288627|NCT00543387|593427011|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
164288628|NCT00543387|593427012|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
164288629|NCT00543387|593427013|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
164288630|NCT00543387|593427014|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
164288631|NCT00543387|593427015|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
164288632|NCT00543387|593427016|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
164288633|NCT00543387|593427017|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
164288634|NCT00543387|593427018|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
164288635|NCT01223183|593427028|FG000|Imaging Day 1|Physician Decision|0|||
164288636|NCT01223183|593427029|FG001|Imaging Day 1|Physician Decision|1|||
164288637|NCT01223183|593427028|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
164288638|NCT01223183|593427029|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
164288639|NCT01223183|593427028|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
164288640|NCT01223183|593427029|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
164288641|NCT01279681|593427030|FG000|Overall Study|Disease Progression|9|||
164288642|NCT01279681|593427031|FG001|Overall Study|Disease Progression|6|||
164288643|NCT01279681|593427030|FG000|Overall Study|Withdrawal by Subject|3|||
164288644|NCT01279681|593427031|FG001|Overall Study|Withdrawal by Subject|4|||
164288645|NCT01279681|593427030|FG000|Overall Study|Adverse Event|2|||
164288646|NCT01279681|593427031|FG001|Overall Study|Adverse Event|3|||
164288647|NCT01279681|593427030|FG000|Overall Study|Death|0|||
164288648|NCT01279681|593427031|FG001|Overall Study|Death|1|||
164288649|NCT01279681|593427030|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
164288650|NCT01279681|593427031|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
164288651|NCT01279681|593427030|FG000|Overall Study|Physician Decision|1|||
164288652|NCT01279681|593427031|FG001|Overall Study|Physician Decision|0|||
164288653|NCT01279681|593427030|FG000|Overall Study|Other Reason|0|||
164288654|NCT01279681|593427031|FG001|Overall Study|Other Reason|2|||
164288655|NCT01943591|593427032|FG000|Overall Study|Lost to Follow-up|3|||
164288656|NCT01943591|593427033|FG001|Overall Study|Lost to Follow-up|4|||
164288657|NCT01943591|593427032|FG000|Overall Study|Death|2|||
164288658|NCT01943591|593427033|FG001|Overall Study|Death|7|||
164288659|NCT03772665|593427034|FG000|Overall Study|Protocol Violation|1|||
164288660|NCT03772665|593427035|FG001|Overall Study|Protocol Violation|0|||
164288661|NCT01232868|593428190|FG000|Overall Study|Lost to Follow-up|2|||
164288662|NCT01232868|593428191|FG001|Overall Study|Lost to Follow-up|4|||
164288663|NCT04481243|593428193|FG000|Overall Study|Withdrawal by Subject|4|||
164288664|NCT02539797|593428194|FG000|Overall Study|Lost to Follow-up|0|||
164288665|NCT02539797|593428195|FG001|Overall Study|Lost to Follow-up|1|||
164288666|NCT02539797|593428196|FG002|Overall Study|Lost to Follow-up|0|||
164288667|NCT02796677|593428201|FG000|Overall Study|Adverse Event|11|||
164288668|NCT02796677|593428202|FG001|Overall Study|Adverse Event|22|||
164288669|NCT02796677|593428203|FG002|Overall Study|Adverse Event|14|||
164288670|NCT02796677|593428204|FG003|Overall Study|Adverse Event|14|||
164288671|NCT02796677|593428201|FG000|Overall Study|Protocol Violation|7|||
164288672|NCT02796677|593428202|FG001|Overall Study|Protocol Violation|5|||
164288673|NCT02796677|593428203|FG002|Overall Study|Protocol Violation|4|||
164288674|NCT02796677|593428204|FG003|Overall Study|Protocol Violation|8|||
164288675|NCT02796677|593428201|FG000|Overall Study|Lost to Follow-up|1|||
164288676|NCT02796677|593428202|FG001|Overall Study|Lost to Follow-up|5|||
164288677|NCT02796677|593428203|FG002|Overall Study|Lost to Follow-up|2|||
164288678|NCT02796677|593428204|FG003|Overall Study|Lost to Follow-up|2|||
164288679|NCT02796677|593428201|FG000|Overall Study|Lack of Efficacy|7|||
164288680|NCT02796677|593428202|FG001|Overall Study|Lack of Efficacy|9|||
164288681|NCT02796677|593428203|FG002|Overall Study|Lack of Efficacy|14|||
164288682|NCT02796677|593428204|FG003|Overall Study|Lack of Efficacy|20|||
164288683|NCT02796677|593428201|FG000|Overall Study|Withdrawal by Subject|4|||
164288684|NCT02796677|593428202|FG001|Overall Study|Withdrawal by Subject|14|||
164288685|NCT02796677|593428203|FG002|Overall Study|Withdrawal by Subject|6|||
164288686|NCT02796677|593428204|FG003|Overall Study|Withdrawal by Subject|7|||
164288687|NCT02796677|593428201|FG000|Overall Study|Progressive disease|6|||
164288688|NCT02796677|593428202|FG001|Overall Study|Progressive disease|15|||
164288689|NCT02796677|593428203|FG002|Overall Study|Progressive disease|13|||
164288690|NCT02796677|593428204|FG003|Overall Study|Progressive disease|18|||
164087817|NCT00859469|592685804|FG000|Overall Study|Adverse Event|2|||
164087818|NCT00859469|592685804|FG000|Overall Study|Lack of Efficacy|9|||
164087819|NCT00859469|592685804|FG000|Overall Study|Withdrawal by Subject|1|||
164087820|NCT00859469|592685804|FG000|Overall Study|Death|16|||
164087821|NCT05431686|592685805|FG000|Overall Study|unable to schedule|10|||
164087822|NCT01736553|592685826|FG000|Overall Study|Death|12|||
164087823|NCT01736553|592685827|FG001|Overall Study|Death|0|||
164087824|NCT01736553|592685826|FG000|Overall Study|Withdrawal by Subject|5|||
164087825|NCT01736553|592685827|FG001|Overall Study|Withdrawal by Subject|2|||
164087826|NCT01736553|592685826|FG000|Overall Study|Lost to Follow-up|2|||
164087827|NCT01736553|592685827|FG001|Overall Study|Lost to Follow-up|2|||
164087828|NCT01890707|592685828|FG000|Overall Study|Lost to Follow-up|1|||
164087829|NCT01890707|592685829|FG001|Overall Study|Lost to Follow-up|1|||
164087830|NCT00669955|592685830|FG000|Overall Study|Adverse Event|3|||
164087831|NCT00669955|592685831|FG001|Overall Study|Adverse Event|5|||
164087832|NCT00669955|592685830|FG000|Overall Study|Death|0|||
164087833|NCT00669955|592685831|FG001|Overall Study|Death|1|||
164087834|NCT00669955|592685830|FG000|Overall Study|Withdrawal by Subject|2|||
164087835|NCT00669955|592685831|FG001|Overall Study|Withdrawal by Subject|3|||
164087836|NCT00669955|592685830|FG000|Overall Study|Lost to Follow-up|5|||
164087837|NCT00669955|592685831|FG001|Overall Study|Lost to Follow-up|7|||
164087838|NCT00669955|592685830|FG000|Overall Study|Protocol Violation|2|||
164087839|NCT00669955|592685831|FG001|Overall Study|Protocol Violation|7|||
164087840|NCT00669955|592685830|FG000|Overall Study|Investigator Sponsor Judgement|0|||
164087841|NCT00669955|592685831|FG001|Overall Study|Investigator Sponsor Judgement|1|||
164087842|NCT00669955|592685830|FG000|Overall Study|not compliant with study drug/visit|2|||
164087843|NCT00669955|592685831|FG001|Overall Study|not compliant with study drug/visit|3|||
164087844|NCT03495869|592685832|FG000|Overall Study|Lost to Follow-up|4|||
164087845|NCT03495869|592685833|FG001|Overall Study|Lost to Follow-up|17|||
164087846|NCT03495869|592685834|FG002|Overall Study|Lost to Follow-up|8|||
164087847|NCT03495869|592685835|FG003|Overall Study|Lost to Follow-up|14|||
164087848|NCT03495869|592685832|FG000|Overall Study|Withdrawal by Subject|0|||
164087849|NCT03495869|592685833|FG001|Overall Study|Withdrawal by Subject|3|||
164087850|NCT03495869|592685834|FG002|Overall Study|Withdrawal by Subject|0|||
164087851|NCT03495869|592685835|FG003|Overall Study|Withdrawal by Subject|3|||
164087852|NCT03495869|592685832|FG000|Overall Study|Dropped from study|0|||
164087853|NCT03495869|592685833|FG001|Overall Study|Dropped from study|7|||
164087854|NCT03495869|592685834|FG002|Overall Study|Dropped from study|2|||
164087855|NCT03495869|592685835|FG003|Overall Study|Dropped from study|4|||
164087856|NCT01691508|592687269|FG000|Overall Study|Adverse Event|3|||
164087857|NCT01691508|592687270|FG001|Overall Study|Adverse Event|3|||
164087858|NCT01691508|592687269|FG000|Overall Study|Withdrawal by Subject|1|||
164087859|NCT01691508|592687270|FG001|Overall Study|Withdrawal by Subject|0|||
164087860|NCT02918162|592687272|FG000|Overall Study|Withdrawal by Subject|1|||
164087861|NCT02918162|592687272|FG000|Overall Study|Omental Disease|1|||
164087862|NCT00395226|592687273|FG000|Overall Study|Adverse Event|4|||
164087863|NCT00395226|592687274|FG001|Overall Study|Adverse Event|3|||
164087864|NCT00395226|592687273|FG000|Overall Study|Withdrawal by Subject|0|||
164087865|NCT00395226|592687274|FG001|Overall Study|Withdrawal by Subject|1|||
164087866|NCT00395226|592687273|FG000|Overall Study|Lost to Follow-up|0|||
164087867|NCT00395226|592687274|FG001|Overall Study|Lost to Follow-up|1|||
164087868|NCT02655237|592687277|FG000|Overall Study|Adverse Event|10|||
164087869|NCT02655237|592687278|FG001|Overall Study|Adverse Event|7|||
164087870|NCT02655237|592687277|FG000|Overall Study|Protocol Deviation|2|||
164087871|NCT02655237|592687278|FG001|Overall Study|Protocol Deviation|0|||
164087872|NCT02655237|592687277|FG000|Overall Study|Withdrawal by Participant|1|||
164288691|NCT02796677|593428201|FG000|Overall Study|Reason not mentioned|2|||
164288692|NCT02796677|593428202|FG001|Overall Study|Reason not mentioned|3|||
164288693|NCT02796677|593428203|FG002|Overall Study|Reason not mentioned|0|||
164288694|NCT02796677|593428204|FG003|Overall Study|Reason not mentioned|5|||
164288695|NCT00961181|593428207|FG000|Overall Study|Death|2|||
164345296|NCT02871297|593640934|FG000|Overall Study|Protocol Violation|3|||
164345297|NCT02871297|593640934|FG000|Overall Study|Withdrawal by Subject|20|||
164087873|NCT02655237|592687278|FG001|Overall Study|Withdrawal by Participant|2|||
164087874|NCT02655237|592687277|FG000|Overall Study|Lack of Efficacy|0|||
164087875|NCT02655237|592687278|FG001|Overall Study|Lack of Efficacy|1|||
164087876|NCT02655237|592687277|FG000|Overall Study|Recovery Leading to Surgery|2|||
164087877|NCT02655237|592687278|FG001|Overall Study|Recovery Leading to Surgery|1|||
164087878|NCT02655237|592687277|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
164087879|NCT02655237|592687278|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
164087880|NCT02655237|592687277|FG000|Overall Study|Randomized but Not Treated|1|||
164087881|NCT02655237|592687278|FG001|Overall Study|Randomized but Not Treated|0|||
164087882|NCT02227862|592687279|FG000|Overall Study|Protocol Violation|7|||
164288696|NCT00961181|593428207|FG000|Overall Study|Withdrawal by Subject|2|||
164288697|NCT00961181|593428207|FG000|Overall Study|Lost to Follow-up|1|||
164288698|NCT01777308|593428208|FG000|Overall Study|Withdrawal by Subject|5|||
164288699|NCT01777308|593428209|FG001|Overall Study|Withdrawal by Subject|1|||
164288700|NCT01777308|593428208|FG000|Overall Study|Migrated/moved from study area|1|||
164288701|NCT01777308|593428209|FG001|Overall Study|Migrated/moved from study area|0|||
164288702|NCT01777308|593428208|FG000|Overall Study|Lost to Follow-up|7|||
164288703|NCT01777308|593428209|FG001|Overall Study|Lost to Follow-up|2|||
164288704|NCT01777308|593428208|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
164288705|NCT01777308|593428209|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
164288706|NCT03212326|593428211|FG000|Overall Study|Physician Decision|4|||
164288707|NCT01131507|593428225|FG000|Overall Study|Adverse Event|1|||
164288708|NCT01131507|593428225|FG000|Overall Study|Lost to Follow-up|1|||
164288709|NCT01131507|593428225|FG000|Overall Study|Withdrawal by Subject|1|||
164288710|NCT01517750|593428226|FG000|Overall Study|Lost to Follow-up|1|||
164288711|NCT01517750|593428227|FG001|Overall Study|Lost to Follow-up|2|||
164288712|NCT01517750|593428228|FG002|Overall Study|Lost to Follow-up|4|||
164288713|NCT01517750|593428229|FG003|Overall Study|Lost to Follow-up|1|||
164288714|NCT01855412|593428231|FG000|Overall Study|Death|77|||
164288715|NCT01855412|593428232|FG001|Overall Study|Death|123|||
164288716|NCT01855412|593428233|FG002|Overall Study|Death|30|||
164288717|NCT01855412|593428231|FG000|Overall Study|Lost to Follow-up|28|||
164288718|NCT01855412|593428232|FG001|Overall Study|Lost to Follow-up|46|||
164288719|NCT01855412|593428233|FG002|Overall Study|Lost to Follow-up|15|||
164288720|NCT01855412|593428231|FG000|Overall Study|Withdrawal by Subject|77|||
164288721|NCT01855412|593428232|FG001|Overall Study|Withdrawal by Subject|123|||
164288722|NCT01855412|593428233|FG002|Overall Study|Withdrawal by Subject|24|||
164288723|NCT01855412|593428231|FG000|Overall Study|Physician Decision|25|||
164288724|NCT01855412|593428232|FG001|Overall Study|Physician Decision|31|||
164288725|NCT01855412|593428233|FG002|Overall Study|Physician Decision|3|||
164288726|NCT01855412|593428231|FG000|Overall Study|Site Closure|4|||
164288727|NCT01855412|593428232|FG001|Overall Study|Site Closure|18|||
164288728|NCT01855412|593428233|FG002|Overall Study|Site Closure|1|||
164087883|NCT02227862|592687280|FG001|Overall Study|Protocol Violation|9|||
164087884|NCT02227862|592687279|FG000|Overall Study|Other|0|||
164087885|NCT02227862|592687280|FG001|Overall Study|Other|2|||
164087886|NCT02227862|592687279|FG000|Overall Study|Adverse Event|4|||
164087887|NCT02227862|592687280|FG001|Overall Study|Adverse Event|3|||
164087888|NCT02227862|592687279|FG000|Overall Study|Withdrawal by Subject|7|||
164087889|NCT02227862|592687280|FG001|Overall Study|Withdrawal by Subject|6|||
164087890|NCT02227862|592687279|FG000|Overall Study|Lost to Follow-up|1|||
164087891|NCT02227862|592687280|FG001|Overall Study|Lost to Follow-up|2|||
164087892|NCT06331156|592687281|FG000|Overall Study|Adverse Event|1|||
164087893|NCT06331156|592687282|FG001|Overall Study|Adverse Event|0|||
164087894|NCT06331156|592687281|FG000|Overall Study|Lost to Follow-up|1|||
164087895|NCT06331156|592687282|FG001|Overall Study|Lost to Follow-up|0|||
164087896|NCT06331156|592687281|FG000|Overall Study|Migrated / Moved from the study area|4|||
164087897|NCT06331156|592687282|FG001|Overall Study|Migrated / Moved from the study area|3|||
164288729|NCT01855412|593428231|FG000|Overall Study|Reason not Specified|1|||
164288730|NCT01855412|593428232|FG001|Overall Study|Reason not Specified|2|||
164345298|NCT02871297|593640934|FG000|Overall Study|Lost to Follow-up|13|||
164345299|NCT02871297|593640934|FG000|Overall Study|Rolled over to 13546A|2|||
164345300|NCT02871297|593640934|FG000|Overall Study|Other than specified|39|||
164345301|NCT02966028|593640938|FG000|Overall Study|Adverse Event|7|||
164345302|NCT02966028|593640939|FG001|Overall Study|Adverse Event|13|||
164345303|NCT02966028|593640940|FG002|Overall Study|Adverse Event|10|||
164345304|NCT02966028|593640938|FG000|Overall Study|Physician Decision|1|||
164345305|NCT02966028|593640939|FG001|Overall Study|Physician Decision|0|||
164345306|NCT02966028|593640940|FG002|Overall Study|Physician Decision|2|||
164087898|NCT06331156|592687281|FG000|Overall Study|Other|7|||
164087899|NCT06331156|592687282|FG001|Overall Study|Other|0|||
164087900|NCT06331156|592687281|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
164087901|NCT06331156|592687282|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
164087902|NCT03748641|592687286|FG000|Overall Study|Ongoing|155|||
164288731|NCT01855412|593428233|FG002|Overall Study|Reason not Specified|3|||
164288732|NCT05030350|593428239|FG000|Overall Study|Adverse Event|13|||
164288733|NCT05030350|593428239|FG000|Overall Study|Lack of Efficacy|8|||
164288734|NCT05030350|593428239|FG000|Overall Study|Lost to Follow-up|35|||
164288735|NCT05030350|593428239|FG000|Overall Study|Pregnancy|2|||
164288736|NCT05030350|593428239|FG000|Overall Study|Protocol Violation|2|||
164288737|NCT05030350|593428239|FG000|Overall Study|Withdrawal by Subject|60|||
164288738|NCT05030350|593428239|FG000|Overall Study|Study terminated by sponsor|349|||
164288739|NCT05030350|593428239|FG000|Overall Study|Positive Drug Screen|4|||
164288740|NCT05030350|593428239|FG000|Overall Study|Other|8|||
164087903|NCT03748641|592687287|FG001|Overall Study|Ongoing|148|||
164288741|NCT00742183|593428240|FG000|Overall Study|Adverse Event|2|||
164288742|NCT00742183|593428241|FG001|Overall Study|Adverse Event|2|||
164345307|NCT02966028|593640938|FG000|Overall Study|Withdrawal by Subject|7|||
164345308|NCT02966028|593640939|FG001|Overall Study|Withdrawal by Subject|5|||
164288743|NCT00742183|593428240|FG000|Overall Study|Death|1|||
164288744|NCT00742183|593428241|FG001|Overall Study|Death|0|||
164288745|NCT00742183|593428240|FG000|Overall Study|Physician Decision|0|||
164288746|NCT00742183|593428241|FG001|Overall Study|Physician Decision|2|||
164288747|NCT00742183|593428240|FG000|Overall Study|Lost to Follow-up|4|||
164288748|NCT00742183|593428241|FG001|Overall Study|Lost to Follow-up|4|||
164288749|NCT00742183|593428240|FG000|Overall Study|Required skin-graft|1|||
164288750|NCT00742183|593428241|FG001|Overall Study|Required skin-graft|1|||
164288751|NCT00742183|593428240|FG000|Overall Study|Withdrawal by Subject|1|||
164288752|NCT00742183|593428241|FG001|Overall Study|Withdrawal by Subject|0|||
164288753|NCT00742183|593428240|FG000|Overall Study|Lack of Efficacy|0|||
164288754|NCT00742183|593428241|FG001|Overall Study|Lack of Efficacy|3|||
164288755|NCT03985761|593428245|FG000|Overall Study|Withdrawal by Subject|2|||
164288756|NCT03985761|593428246|FG001|Overall Study|Withdrawal by Subject|3|||
164288757|NCT01367834|593428247|FG000|Overall Study|Withdrawal by Subject|2|||
164288758|NCT01367834|593428248|FG001|Overall Study|Withdrawal by Subject|2|||
164288759|NCT01367834|593428247|FG000|Overall Study|Study was ended.|0|||
164288760|NCT01367834|593428248|FG001|Overall Study|Study was ended.|1|||
164288761|NCT01569841|593428251|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
164288762|NCT01569841|593428252|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
164288763|NCT01858363|593428253|FG000|Overall Study|Death|35|||
164288764|NCT01858363|593428254|FG001|Overall Study|Death|9|||
164288765|NCT01858363|593428253|FG000|Overall Study|Withdrawal by Subject|28|||
164288766|NCT01858363|593428254|FG001|Overall Study|Withdrawal by Subject|14|||
164288767|NCT01858363|593428253|FG000|Overall Study|Lost to Follow-up|13|||
164288768|NCT01858363|593428254|FG001|Overall Study|Lost to Follow-up|3|||
164288769|NCT00057863|593428259|FG000|Overall Study|Death|1|||
164288770|NCT00057863|593428259|FG000|Overall Study|Withdrawal by Subject|2|||
164288771|NCT00764361|593428260|FG000|Overall Study|Withdrawal by Subject|2|||
164288772|NCT00764361|593428261|FG001|Overall Study|Withdrawal by Subject|3|||
164288773|NCT00764361|593428260|FG000|Overall Study|Adverse Event|0|||
164288774|NCT00764361|593428261|FG001|Overall Study|Adverse Event|1|||
164288775|NCT02090426|593428263|FG000|Overall Study|Lost to Follow-up|12|||
164288776|NCT02090426|593428264|FG001|Overall Study|Lost to Follow-up|6|||
164288777|NCT01141712|593428268|FG000|Overall Study|Disease progression|3|||
164288778|NCT03480152|593428269|FG000|Phase I|Signed consent. Died before treatment.|1|||
164288779|NCT03480152|593428270|FG001|Phase I|Signed consent. Died before treatment.|0|||
164288780|NCT03480152|593428271|FG002|Phase I|Signed consent. Died before treatment.|0|||
164288781|NCT01308736|593428278|FG000|Overall Study|Did not attend a single session|6|||
164288782|NCT01308736|593428279|FG001|Overall Study|Did not attend a single session|5|||
164288783|NCT03634085|593428280|FG000|Overall Study|Adverse Event|1|||
164288784|NCT03634085|593428281|FG001|Overall Study|Adverse Event|0|||
164288785|NCT03634085|593428280|FG000|Overall Study|Withdrawal by Subject|0|||
164288786|NCT03634085|593428281|FG001|Overall Study|Withdrawal by Subject|2|||
164288787|NCT04276233|593428282|FG000|Overall Study|Adverse Event|1|||
164288788|NCT04276233|593428282|FG000|Overall Study|Lost to Follow-up|3|||
164288789|NCT04276233|593428282|FG000|Overall Study|Physician Decision|4|||
164288790|NCT04276233|593428282|FG000|Overall Study|Withdrawal by Subject|2|||
164288791|NCT01946139|593428291|FG000|Overall Study|Withdrawal by Subject|8|||
164288792|NCT01946139|593428291|FG000|Overall Study|ineligible|8|||
164288793|NCT01946139|593428291|FG000|Overall Study|Specimens not available|4|||
164288794|NCT00101686|593428298|FG000|Overall Study|Progressive Disease|37|||
164288795|NCT00101686|593428299|FG001|Overall Study|Progressive Disease|28|||
164288796|NCT00101686|593428300|FG002|Overall Study|Progressive Disease|37|||
164288797|NCT00101686|593428301|FG003|Overall Study|Progressive Disease|38|||
164288798|NCT00101686|593428302|FG004|Overall Study|Progressive Disease|28|||
164288799|NCT00101686|593428303|FG005|Overall Study|Progressive Disease|25|||
164288800|NCT00101686|593428304|FG006|Overall Study|Progressive Disease|5|||
164288801|NCT00101686|593428305|FG007|Overall Study|Progressive Disease|7|||
164288802|NCT00101686|593428306|FG008|Overall Study|Progressive Disease|10|||
164288803|NCT00101686|593428307|FG009|Overall Study|Progressive Disease|8|||
164288804|NCT00101686|593428298|FG000|Overall Study|initiation other anti-cancer treatment|4|||
164288805|NCT00101686|593428299|FG001|Overall Study|initiation other anti-cancer treatment|3|||
164288806|NCT00101686|593428300|FG002|Overall Study|initiation other anti-cancer treatment|4|||
164288807|NCT00101686|593428301|FG003|Overall Study|initiation other anti-cancer treatment|3|||
164288808|NCT00101686|593428302|FG004|Overall Study|initiation other anti-cancer treatment|1|||
164288809|NCT00101686|593428303|FG005|Overall Study|initiation other anti-cancer treatment|1|||
164288810|NCT00101686|593428304|FG006|Overall Study|initiation other anti-cancer treatment|2|||
164288811|NCT00101686|593428305|FG007|Overall Study|initiation other anti-cancer treatment|2|||
164288812|NCT00101686|593428306|FG008|Overall Study|initiation other anti-cancer treatment|3|||
164288813|NCT00101686|593428307|FG009|Overall Study|initiation other anti-cancer treatment|3|||
164288814|NCT00101686|593428298|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
164288815|NCT00101686|593428299|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
164288816|NCT00101686|593428300|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
164288817|NCT00101686|593428301|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
164288818|NCT00101686|593428302|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
164288819|NCT00101686|593428303|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
164288820|NCT00101686|593428304|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
164288821|NCT00101686|593428305|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
164288822|NCT00101686|593428306|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
164087904|NCT03748641|592687288|FG002|Overall Study|Ongoing|66|||
164087905|NCT03748641|592687289|FG003|Overall Study|Ongoing|79|||
164087906|NCT03748641|592687290|FG004|Overall Study|Ongoing|84|||
164087907|NCT03748641|592687286|FG000|Overall Study|Death|54|||
164087908|NCT03748641|592687287|FG001|Overall Study|Death|59|||
164087909|NCT03748641|592687288|FG002|Overall Study|Death|51|||
164087910|NCT03748641|592687289|FG003|Overall Study|Death|42|||
164087911|NCT03748641|592687290|FG004|Overall Study|Death|9|||
164087912|NCT03748641|592687286|FG000|Overall Study|Lost to Follow-up|0|||
164288823|NCT00101686|593428307|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
164288824|NCT00101686|593428298|FG000|Overall Study|unacceptable toxicity|3|||
164288825|NCT00101686|593428299|FG001|Overall Study|unacceptable toxicity|9|||
164288826|NCT00101686|593428300|FG002|Overall Study|unacceptable toxicity|10|||
164288827|NCT00101686|593428301|FG003|Overall Study|unacceptable toxicity|6|||
164288828|NCT00101686|593428302|FG004|Overall Study|unacceptable toxicity|16|||
164288829|NCT00101686|593428303|FG005|Overall Study|unacceptable toxicity|10|||
164288830|NCT00101686|593428304|FG006|Overall Study|unacceptable toxicity|4|||
164288831|NCT00101686|593428305|FG007|Overall Study|unacceptable toxicity|2|||
164288832|NCT00101686|593428306|FG008|Overall Study|unacceptable toxicity|1|||
164288833|NCT00101686|593428307|FG009|Overall Study|unacceptable toxicity|4|||
164288834|NCT00101686|593428298|FG000|Overall Study|Randomized but did not receive treament|1|||
164087913|NCT03748641|592687287|FG001|Overall Study|Lost to Follow-up|2|||
164087914|NCT03748641|592687288|FG002|Overall Study|Lost to Follow-up|1|||
164087915|NCT03748641|592687289|FG003|Overall Study|Lost to Follow-up|0|||
164087916|NCT03748641|592687290|FG004|Overall Study|Lost to Follow-up|0|||
164087917|NCT03748641|592687286|FG000|Overall Study|Withdrawal by Subject|3|||
164087918|NCT03748641|592687287|FG001|Overall Study|Withdrawal by Subject|2|||
164087919|NCT03748641|592687288|FG002|Overall Study|Withdrawal by Subject|5|||
164087920|NCT03748641|592687289|FG003|Overall Study|Withdrawal by Subject|3|||
164087921|NCT03748641|592687290|FG004|Overall Study|Withdrawal by Subject|2|||
164087922|NCT00437281|592687291|FG000|Overall Study|Adverse Event|0|||
164087923|NCT00437281|592687292|FG001|Overall Study|Adverse Event|0|||
164087924|NCT00437281|592687293|FG002|Overall Study|Adverse Event|0|||
164087925|NCT00437281|592687294|FG003|Overall Study|Adverse Event|1|||
164087926|NCT00437281|592687295|FG004|Overall Study|Adverse Event|0|||
164087927|NCT00437281|592687296|FG005|Overall Study|Adverse Event|1|||
164087928|NCT00437281|592687297|FG006|Overall Study|Adverse Event|0|||
164087929|NCT00437281|592687298|FG007|Overall Study|Adverse Event|0|||
164087930|NCT00437281|592687299|FG008|Overall Study|Adverse Event|0|||
164087931|NCT00437281|592687300|FG009|Overall Study|Adverse Event|1|||
164087932|NCT00437281|592687301|FG010|Overall Study|Adverse Event|0|||
164087933|NCT00437281|592687302|FG011|Overall Study|Adverse Event|0|||
164288835|NCT00101686|593428299|FG001|Overall Study|Randomized but did not receive treament|6|||
164288836|NCT00101686|593428300|FG002|Overall Study|Randomized but did not receive treament|2|||
164288837|NCT00101686|593428301|FG003|Overall Study|Randomized but did not receive treament|2|||
164087934|NCT00437281|592687303|FG012|Overall Study|Adverse Event|0|||
164087935|NCT00437281|592687304|FG013|Overall Study|Adverse Event|1|||
164288838|NCT00101686|593428302|FG004|Overall Study|Randomized but did not receive treament|2|||
164288839|NCT00101686|593428303|FG005|Overall Study|Randomized but did not receive treament|2|||
164288840|NCT00101686|593428304|FG006|Overall Study|Randomized but did not receive treament|0|||
164288841|NCT00101686|593428305|FG007|Overall Study|Randomized but did not receive treament|1|||
164288842|NCT00101686|593428306|FG008|Overall Study|Randomized but did not receive treament|0|||
164345309|NCT02966028|593640940|FG002|Overall Study|Withdrawal by Subject|5|||
164345310|NCT02966028|593640938|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
164345311|NCT02966028|593640939|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
164345312|NCT02966028|593640940|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
164087936|NCT00437281|592687305|FG014|Overall Study|Adverse Event|1|||
164087937|NCT00437281|592687306|FG015|Overall Study|Adverse Event|0|||
164087938|NCT00437281|592687307|FG016|Overall Study|Adverse Event|0|||
164087939|NCT00437281|592687308|FG017|Overall Study|Adverse Event|0|||
164087940|NCT00437281|592687309|FG018|Overall Study|Adverse Event|1|||
164087941|NCT00437281|592687310|FG019|Overall Study|Adverse Event|0|||
164087942|NCT00437281|592687291|FG000|Overall Study|Lost to Follow-up|0|||
164087943|NCT00437281|592687292|FG001|Overall Study|Lost to Follow-up|0|||
164087944|NCT00437281|592687293|FG002|Overall Study|Lost to Follow-up|0|||
164087945|NCT00437281|592687294|FG003|Overall Study|Lost to Follow-up|0|||
164288843|NCT00101686|593428307|FG009|Overall Study|Randomized but did not receive treament|1|||
164288844|NCT00101686|593428298|FG000|Overall Study|intercurrent non-cancer related illness|0|||
164288845|NCT00101686|593428299|FG001|Overall Study|intercurrent non-cancer related illness|0|||
164288846|NCT00101686|593428300|FG002|Overall Study|intercurrent non-cancer related illness|2|||
164288847|NCT00101686|593428301|FG003|Overall Study|intercurrent non-cancer related illness|0|||
164288848|NCT00101686|593428302|FG004|Overall Study|intercurrent non-cancer related illness|1|||
164288849|NCT00101686|593428303|FG005|Overall Study|intercurrent non-cancer related illness|3|||
164288850|NCT00101686|593428304|FG006|Overall Study|intercurrent non-cancer related illness|1|||
164288851|NCT00101686|593428305|FG007|Overall Study|intercurrent non-cancer related illness|0|||
164288852|NCT00101686|593428306|FG008|Overall Study|intercurrent non-cancer related illness|1|||
164288853|NCT00101686|593428307|FG009|Overall Study|intercurrent non-cancer related illness|1|||
164288854|NCT00101686|593428298|FG000|Overall Study|Physician Decision|10|||
164288855|NCT00101686|593428299|FG001|Overall Study|Physician Decision|13|||
164288856|NCT00101686|593428300|FG002|Overall Study|Physician Decision|6|||
164288857|NCT00101686|593428301|FG003|Overall Study|Physician Decision|7|||
164288858|NCT00101686|593428302|FG004|Overall Study|Physician Decision|8|||
164288859|NCT00101686|593428303|FG005|Overall Study|Physician Decision|9|||
164288860|NCT00101686|593428304|FG006|Overall Study|Physician Decision|5|||
164288861|NCT00101686|593428305|FG007|Overall Study|Physician Decision|5|||
164288862|NCT00101686|593428306|FG008|Overall Study|Physician Decision|1|||
164288863|NCT00101686|593428307|FG009|Overall Study|Physician Decision|1|||
164288864|NCT00101686|593428298|FG000|Overall Study|Other|1|||
164288865|NCT00101686|593428299|FG001|Overall Study|Other|4|||
164288866|NCT00101686|593428300|FG002|Overall Study|Other|1|||
164288867|NCT00101686|593428301|FG003|Overall Study|Other|6|||
164288868|NCT00101686|593428302|FG004|Overall Study|Other|2|||
164288869|NCT00101686|593428303|FG005|Overall Study|Other|12|||
164288870|NCT00101686|593428304|FG006|Overall Study|Other|1|||
164288871|NCT00101686|593428305|FG007|Overall Study|Other|5|||
164288872|NCT00101686|593428306|FG008|Overall Study|Other|3|||
164288873|NCT00101686|593428307|FG009|Overall Study|Other|3|||
164288874|NCT00101686|593428298|FG000|Overall Study|Withdrawal by Subject|9|||
164288875|NCT00101686|593428299|FG001|Overall Study|Withdrawal by Subject|8|||
164288876|NCT00101686|593428300|FG002|Overall Study|Withdrawal by Subject|6|||
164288877|NCT00101686|593428301|FG003|Overall Study|Withdrawal by Subject|8|||
164288878|NCT00101686|593428302|FG004|Overall Study|Withdrawal by Subject|8|||
164288879|NCT00101686|593428303|FG005|Overall Study|Withdrawal by Subject|7|||
164288880|NCT00101686|593428304|FG006|Overall Study|Withdrawal by Subject|7|||
164288881|NCT00101686|593428305|FG007|Overall Study|Withdrawal by Subject|7|||
164288882|NCT00101686|593428306|FG008|Overall Study|Withdrawal by Subject|8|||
164288883|NCT00101686|593428307|FG009|Overall Study|Withdrawal by Subject|9|||
164288884|NCT00296816|593428308|FG000|Overall Study|Disease Progression|37|||
164288885|NCT00296816|593428308|FG000|Overall Study|Adverse Event|18|||
164288886|NCT00296816|593428308|FG000|Overall Study|Investigator/Participant request|5|||
164288887|NCT00296816|593428308|FG000|Overall Study|Non-compliance|1|||
164288888|NCT00296816|593428308|FG000|Overall Study|Missing for end of treatment|4|||
164288889|NCT00296816|593428308|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
164288890|NCT00296816|593428308|FG000|Overall Study|Poor performance status|1|||
164288891|NCT00296816|593428308|FG000|Overall Study|Relocation to Florida|1|||
164288892|NCT00296816|593428308|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
164288893|NCT00296816|593428308|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
164288894|NCT00296816|593428308|FG000|Overall Study|Neuropathy/patient preference|1|||
164288895|NCT00296816|593428308|FG000|Overall Study|Proteinuria|1|||
164288896|NCT00296816|593428308|FG000|Overall Study|ineligibility due to radiation treatment|1|||
164288897|NCT01292187|593428309|FG000|Overall Study|Adverse Event|10|||
164288898|NCT01292187|593428310|FG001|Overall Study|Adverse Event|5|||
164288899|NCT01292187|593428309|FG000|Overall Study|Withdrawal by Subject|6|||
164288900|NCT01292187|593428310|FG001|Overall Study|Withdrawal by Subject|5|||
164288901|NCT01292187|593428309|FG000|Overall Study|All other reasons|1|||
164288902|NCT01292187|593428310|FG001|Overall Study|All other reasons|3|||
164288903|NCT01814527|593428312|FG000|Overall Study|RTP greater than 30 days|6|||
164288904|NCT01814527|593428313|FG001|Overall Study|RTP greater than 30 days|1|||
164087946|NCT00437281|592687295|FG004|Overall Study|Lost to Follow-up|0|||
164087947|NCT00437281|592687296|FG005|Overall Study|Lost to Follow-up|0|||
164087948|NCT00437281|592687297|FG006|Overall Study|Lost to Follow-up|0|||
164288905|NCT00687401|593428314|FG000|Overall Study|Protocol Violation|7|||
164288906|NCT00687401|593428314|FG000|Overall Study|Adverse Event|6|||
164288907|NCT00687401|593428314|FG000|Overall Study|Lack of Efficacy|6|||
164288908|NCT00687401|593428314|FG000|Overall Study|Withdrawal by Subject|4|||
164288909|NCT00687401|593428314|FG000|Overall Study|Did not return for visit|3|||
164288910|NCT00687401|593428314|FG000|Overall Study|For reasons different from those above|4|||
164288911|NCT02520726|593428315|FG000|Overall Study|Lost to Follow-up|3|||
164288912|NCT02520726|593428316|FG001|Overall Study|Lost to Follow-up|2|||
164288913|NCT00721396|593428317|FG000|Overall Study|Adverse Event|4|||
164288914|NCT00721396|593428318|FG001|Overall Study|Adverse Event|7|||
164288915|NCT00721396|593428319|FG002|Overall Study|Adverse Event|2|||
164288916|NCT00721396|593428320|FG003|Overall Study|Adverse Event|0|||
164288917|NCT00721396|593428317|FG000|Overall Study|Withdrawal by Subject|12|||
164288918|NCT00721396|593428318|FG001|Overall Study|Withdrawal by Subject|15|||
164288919|NCT00721396|593428319|FG002|Overall Study|Withdrawal by Subject|3|||
164288920|NCT00721396|593428320|FG003|Overall Study|Withdrawal by Subject|7|||
164288921|NCT00721396|593428317|FG000|Overall Study|Lost to Follow-up|7|||
164288922|NCT00721396|593428318|FG001|Overall Study|Lost to Follow-up|9|||
164288923|NCT00721396|593428319|FG002|Overall Study|Lost to Follow-up|3|||
164288924|NCT00721396|593428320|FG003|Overall Study|Lost to Follow-up|3|||
164288925|NCT00721396|593428317|FG000|Overall Study|Protocol Violation|4|||
164288926|NCT00721396|593428318|FG001|Overall Study|Protocol Violation|3|||
164288927|NCT00721396|593428319|FG002|Overall Study|Protocol Violation|1|||
164288928|NCT00721396|593428320|FG003|Overall Study|Protocol Violation|0|||
164288929|NCT00721396|593428317|FG000|Overall Study|Inappropriate enrollment|0|||
164288930|NCT00721396|593428318|FG001|Overall Study|Inappropriate enrollment|2|||
164288931|NCT00721396|593428319|FG002|Overall Study|Inappropriate enrollment|0|||
164288932|NCT00721396|593428320|FG003|Overall Study|Inappropriate enrollment|0|||
164288933|NCT00721396|593428317|FG000|Overall Study|Administrative reason|3|||
164288934|NCT00721396|593428318|FG001|Overall Study|Administrative reason|0|||
164288935|NCT00721396|593428319|FG002|Overall Study|Administrative reason|1|||
164288936|NCT00721396|593428320|FG003|Overall Study|Administrative reason|0|||
164288937|NCT00430716|593428324|FG000|Double Blind Phase|Death|1|||
164288938|NCT00430716|593428325|FG001|Double Blind Phase|Death|0|||
164288939|NCT00430716|593428326|FG002|Double Blind Phase|Death|0|||
164288940|NCT00430716|593428324|FG000|Double Blind Phase|No longer willing to participate|2|||
164288941|NCT00430716|593428325|FG001|Double Blind Phase|No longer willing to participate|1|||
164288942|NCT00430716|593428326|FG002|Double Blind Phase|No longer willing to participate|1|||
164288943|NCT00430716|593428324|FG000|Double Blind Phase|Other|0|||
164288944|NCT00430716|593428325|FG001|Double Blind Phase|Other|2|||
164288945|NCT00430716|593428326|FG002|Double Blind Phase|Other|0|||
164288946|NCT00430716|593428324|FG000|Double Blind Phase|Study terminated by sponsor|1|||
164288947|NCT00430716|593428325|FG001|Double Blind Phase|Study terminated by sponsor|1|||
164288948|NCT00430716|593428326|FG002|Double Blind Phase|Study terminated by sponsor|2|||
164288949|NCT00430716|593428324|FG000|Double Blind Phase|Adverse Event|1|||
164288950|NCT00430716|593428325|FG001|Double Blind Phase|Adverse Event|1|||
164288951|NCT00430716|593428326|FG002|Double Blind Phase|Adverse Event|3|||
164288952|NCT00430716|593428324|FG000|Double Blind Phase|Not treated|1|||
164288953|NCT00430716|593428325|FG001|Double Blind Phase|Not treated|0|||
164288954|NCT00430716|593428326|FG002|Double Blind Phase|Not treated|0|||
164288955|NCT00430716|593428324|FG000|Open Label Phase|Lost to Follow-up|1|||
164288956|NCT00430716|593428325|FG001|Open Label Phase|Lost to Follow-up|0|||
164288957|NCT00430716|593428326|FG002|Open Label Phase|Lost to Follow-up|1|||
164288958|NCT00430716|593428324|FG000|Open Label Phase|No longer willing to participate|0|||
164288959|NCT00430716|593428325|FG001|Open Label Phase|No longer willing to participate|1|||
164288960|NCT00430716|593428326|FG002|Open Label Phase|No longer willing to participate|1|||
164288961|NCT00430716|593428324|FG000|Open Label Phase|Other|3|||
164288962|NCT00430716|593428325|FG001|Open Label Phase|Other|1|||
164288963|NCT00430716|593428326|FG002|Open Label Phase|Other|1|||
164288964|NCT00430716|593428324|FG000|Open Label Phase|Protocol Violation|1|||
164288965|NCT00430716|593428325|FG001|Open Label Phase|Protocol Violation|0|||
164288966|NCT00430716|593428326|FG002|Open Label Phase|Protocol Violation|0|||
164288967|NCT00430716|593428324|FG000|Open Label Phase|Study terminated by sponsor|4|||
164288968|NCT00430716|593428325|FG001|Open Label Phase|Study terminated by sponsor|5|||
164288969|NCT00430716|593428326|FG002|Open Label Phase|Study terminated by sponsor|4|||
164288970|NCT00782717|593428327|FG000|Overall Study|Adverse Event|2|||
164288971|NCT00782717|593428328|FG001|Overall Study|Adverse Event|5|||
164288972|NCT00782717|593428327|FG000|Overall Study|Patient decision unrelated to AE|6|||
164288973|NCT00782717|593428328|FG001|Overall Study|Patient decision unrelated to AE|3|||
164288974|NCT00782717|593428327|FG000|Overall Study|Noncompliance|2|||
164288975|NCT00782717|593428328|FG001|Overall Study|Noncompliance|1|||
164345313|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
164345314|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
164345315|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
164345316|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345317|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345318|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345319|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
164345320|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
164345321|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
164345322|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
164288976|NCT00782717|593428327|FG000|Overall Study|Treatment failure|3|||
164288977|NCT00782717|593428328|FG001|Overall Study|Treatment failure|14|||
164288978|NCT00782717|593428327|FG000|Overall Study|Enrollment close prior to surgery|1|||
164288979|NCT00782717|593428328|FG001|Overall Study|Enrollment close prior to surgery|0|||
164288980|NCT00782717|593428327|FG000|Overall Study|Did not meet entrance criteria|1|||
164288981|NCT00782717|593428328|FG001|Overall Study|Did not meet entrance criteria|3|||
164288982|NCT00782717|593428327|FG000|Overall Study|Exited in error|0|||
164288983|NCT00782717|593428328|FG001|Overall Study|Exited in error|2|||
164288984|NCT02446717|593428329|FG000|Overall Study|Adverse Event|0|||
164288985|NCT02446717|593428330|FG001|Overall Study|Adverse Event|0|||
164288986|NCT02446717|593428331|FG002|Overall Study|Adverse Event|1|||
164288987|NCT02446717|593428332|FG003|Overall Study|Adverse Event|0|||
164288988|NCT02446717|593428333|FG004|Overall Study|Adverse Event|0|||
164288989|NCT02446717|593428329|FG000|Overall Study|Lost to Follow-up|0|||
164288990|NCT02446717|593428330|FG001|Overall Study|Lost to Follow-up|1|||
164288991|NCT02446717|593428331|FG002|Overall Study|Lost to Follow-up|1|||
164288992|NCT02446717|593428332|FG003|Overall Study|Lost to Follow-up|0|||
164288993|NCT02446717|593428333|FG004|Overall Study|Lost to Follow-up|1|||
164288994|NCT02446717|593428329|FG000|Overall Study|Withdrew consent|0|||
164288995|NCT02446717|593428330|FG001|Overall Study|Withdrew consent|0|||
164288996|NCT02446717|593428331|FG002|Overall Study|Withdrew consent|0|||
164288997|NCT02446717|593428332|FG003|Overall Study|Withdrew consent|1|||
164288998|NCT02446717|593428333|FG004|Overall Study|Withdrew consent|0|||
164288999|NCT00154297|593428340|FG000|Overall Study|Death|5|||
164289000|NCT00154297|593428341|FG001|Overall Study|Death|2|||
164289001|NCT00154297|593428340|FG000|Overall Study|Withdrawal by Subject|0|||
164289002|NCT00154297|593428341|FG001|Overall Study|Withdrawal by Subject|5|||
164289003|NCT00154297|593428340|FG000|Overall Study|Lost to Follow-up|3|||
164289004|NCT00154297|593428341|FG001|Overall Study|Lost to Follow-up|0|||
164289005|NCT03116685|593428344|FG000|Overall Study|Physician Decision|0|||
164289006|NCT03116685|593428345|FG001|Overall Study|Physician Decision|1|||
164289007|NCT00398320|593428346|FG000|Overall Study|Death|1|||
164289008|NCT00398320|593428346|FG000|Overall Study|Adverse Event|4|||
164289009|NCT00398320|593428346|FG000|Overall Study|Physician Decision|1|||
164289010|NCT00064792|593428347|FG000|Overall Study|Withdrawal by Subject|2|||
164289011|NCT00064792|593428348|FG001|Overall Study|Withdrawal by Subject|0|||
164289012|NCT00064792|593428347|FG000|Overall Study|Adverse Event|3|||
164289013|NCT00064792|593428348|FG001|Overall Study|Adverse Event|0|||
164289014|NCT00992459|593428352|FG000|Overall Study|Withdrawal by Subject|0|||
164289015|NCT00992459|593428353|FG001|Overall Study|Withdrawal by Subject|1|||
164289016|NCT00992459|593428352|FG000|Overall Study|Adverse Event|1|||
164289017|NCT00992459|593428353|FG001|Overall Study|Adverse Event|0|||
164289018|NCT04177212|593428356|FG000|Overall Study|Withdrawal by Subject|9|||
164289019|NCT04177212|593428357|FG001|Overall Study|Withdrawal by Subject|7|||
164289020|NCT04177212|593428356|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
164289021|NCT04177212|593428357|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
164289022|NCT04177212|593428356|FG000|Overall Study|Physician Decision|1|||
164289023|NCT04177212|593428357|FG001|Overall Study|Physician Decision|0|||
164289024|NCT04177212|593428356|FG000|Overall Study|Lost to Follow-up|0|||
164289025|NCT04177212|593428357|FG001|Overall Study|Lost to Follow-up|3|||
164289026|NCT04177212|593428356|FG000|Overall Study|Adverse Event|0|||
164289027|NCT04177212|593428357|FG001|Overall Study|Adverse Event|1|||
164289028|NCT04177212|593428356|FG000|Overall Study|Other|1|||
164289029|NCT04177212|593428357|FG001|Overall Study|Other|2|||
164289030|NCT01792115|593428358|FG000|Overall Study|Lost to Follow-up|0|||
164289031|NCT01792115|593428359|FG001|Overall Study|Lost to Follow-up|1|||
164289032|NCT01792115|593428360|FG002|Overall Study|Lost to Follow-up|0|||
164289033|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289034|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
164289035|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289036|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289037|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
164289038|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
164289039|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
164289040|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
164289041|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
164289042|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
164289043|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
164289044|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
164289045|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
164289046|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
164087949|NCT00437281|592687298|FG007|Overall Study|Lost to Follow-up|0|||
164345323|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164345324|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164289047|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
164289048|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
164289049|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
164289050|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
164289051|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
164289052|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
164289053|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
164289054|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
164289055|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
164289056|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
164289057|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
164289058|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
164289059|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
164289060|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
164289061|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
164289062|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
164289063|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
164289064|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
164289065|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
164289066|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
164289067|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
164289068|NCT02831764|593429665|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289069|NCT02831764|593429666|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
164289070|NCT02831764|593429667|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289071|NCT02831764|593429668|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289072|NCT02831764|593429669|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
164289073|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164289074|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164289075|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
164289076|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
164289077|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
164289078|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289079|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289080|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
164289081|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289082|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
164289083|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164289084|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164289085|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
164289086|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
164289087|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
164289088|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289089|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289090|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
164289091|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289092|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
164289093|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164289094|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164289095|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
164289096|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
164289097|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
164289098|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164289099|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164289100|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
164289101|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
164289102|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
164289103|NCT02831764|593429665|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164289104|NCT02831764|593429666|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164289105|NCT02831764|593429667|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
164289106|NCT02831764|593429668|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
164289107|NCT02831764|593429669|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
164289108|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289109|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289110|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289111|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
164289112|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
164289113|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289114|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289115|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289116|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
164289117|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
164289118|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289119|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289120|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289121|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
164289122|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
164289123|NCT02831764|593429665|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289124|NCT02831764|593429666|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289125|NCT02831764|593429667|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289126|NCT02831764|593429668|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
164289127|NCT02831764|593429669|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
164289128|NCT01790594|593429673|FG000|Overall Study|Death|1|||
164289129|NCT01790594|593429674|FG001|Overall Study|Death|0|||
164289130|NCT01790594|593429675|FG002|Overall Study|Death|0|||
164289131|NCT01790594|593429673|FG000|Overall Study|Physician Decision|2|||
164289132|NCT01790594|593429674|FG001|Overall Study|Physician Decision|1|||
164289133|NCT01790594|593429675|FG002|Overall Study|Physician Decision|0|||
164289134|NCT01790594|593429673|FG000|Overall Study|Withdrawal by Subject|2|||
164289135|NCT01790594|593429674|FG001|Overall Study|Withdrawal by Subject|0|||
164289136|NCT01790594|593429675|FG002|Overall Study|Withdrawal by Subject|0|||
164289137|NCT01790594|593429673|FG000|Overall Study|Transplant was not done|0|||
164289138|NCT01790594|593429674|FG001|Overall Study|Transplant was not done|0|||
164289139|NCT01790594|593429675|FG002|Overall Study|Transplant was not done|3|||
164289140|NCT01790594|593429673|FG000|Overall Study|Terminated prior to week 76|0|||
164289141|NCT01790594|593429674|FG001|Overall Study|Terminated prior to week 76|2|||
164289142|NCT01790594|593429675|FG002|Overall Study|Terminated prior to week 76|0|||
164289143|NCT03347123|593429676|FG000|Overall Study|Death|1|||
164289144|NCT03347123|593429677|FG001|Overall Study|Death|2|||
164289145|NCT03347123|593429678|FG002|Overall Study|Death|0|||
164289146|NCT03347123|593429679|FG003|Overall Study|Death|0|||
164289147|NCT03347123|593429680|FG004|Overall Study|Death|0|||
164289148|NCT03347123|593429681|FG005|Overall Study|Death|0|||
164289149|NCT03347123|593429682|FG006|Overall Study|Death|0|||
164289150|NCT03347123|593429676|FG000|Overall Study|Withdrawal by Subject|1|||
164289151|NCT03347123|593429677|FG001|Overall Study|Withdrawal by Subject|0|||
164289152|NCT03347123|593429678|FG002|Overall Study|Withdrawal by Subject|0|||
164289153|NCT03347123|593429679|FG003|Overall Study|Withdrawal by Subject|0|||
164289154|NCT03347123|593429680|FG004|Overall Study|Withdrawal by Subject|0|||
164289155|NCT03347123|593429681|FG005|Overall Study|Withdrawal by Subject|0|||
164289156|NCT03347123|593429682|FG006|Overall Study|Withdrawal by Subject|0|||
164087950|NCT00437281|592687299|FG008|Overall Study|Lost to Follow-up|0|||
164087951|NCT00437281|592687300|FG009|Overall Study|Lost to Follow-up|0|||
164087952|NCT00437281|592687301|FG010|Overall Study|Lost to Follow-up|0|||
164087953|NCT00437281|592687302|FG011|Overall Study|Lost to Follow-up|0|||
164087954|NCT00437281|592687303|FG012|Overall Study|Lost to Follow-up|0|||
164087955|NCT00437281|592687304|FG013|Overall Study|Lost to Follow-up|0|||
164087956|NCT00437281|592687305|FG014|Overall Study|Lost to Follow-up|0|||
164087957|NCT00437281|592687306|FG015|Overall Study|Lost to Follow-up|0|||
164087958|NCT00437281|592687307|FG016|Overall Study|Lost to Follow-up|0|||
164087959|NCT00437281|592687308|FG017|Overall Study|Lost to Follow-up|0|||
164087960|NCT00437281|592687309|FG018|Overall Study|Lost to Follow-up|0|||
164087961|NCT00437281|592687310|FG019|Overall Study|Lost to Follow-up|1|||
164087962|NCT02970669|592687311|FG000|Double-blind Period|Adverse Event|4|||
164087963|NCT02970669|592687312|FG001|Double-blind Period|Adverse Event|0|||
164087964|NCT02970669|592687311|FG000|Double-blind Period|Death|1|||
164087965|NCT02970669|592687312|FG001|Double-blind Period|Death|0|||
164087966|NCT02970669|592687311|FG000|Double-blind Period|Study terminated by sponsor|1|||
164289157|NCT03347123|593429676|FG000|Overall Study|Reason not Specified|3|||
164289158|NCT03347123|593429677|FG001|Overall Study|Reason not Specified|4|||
164289159|NCT03347123|593429678|FG002|Overall Study|Reason not Specified|0|||
164289160|NCT03347123|593429679|FG003|Overall Study|Reason not Specified|0|||
164289161|NCT03347123|593429680|FG004|Overall Study|Reason not Specified|0|||
164289162|NCT03347123|593429681|FG005|Overall Study|Reason not Specified|0|||
164289163|NCT03347123|593429682|FG006|Overall Study|Reason not Specified|0|||
164289164|NCT00346216|593429685|FG000|Overall Study|Other|181|||
164289165|NCT00346216|593429686|FG001|Overall Study|Other|231|||
164289166|NCT00346216|593429687|FG002|Overall Study|Other|205|||
164087967|NCT02970669|592687312|FG001|Double-blind Period|Study terminated by sponsor|2|||
164087968|NCT02970669|592687311|FG000|Double-blind Period|Physician Decision|0|||
164087969|NCT02970669|592687312|FG001|Double-blind Period|Physician Decision|2|||
164289167|NCT00346216|593429685|FG000|Overall Study|No longer willing to participate|600|||
164289168|NCT00346216|593429686|FG001|Overall Study|No longer willing to participate|606|||
164289169|NCT00346216|593429687|FG002|Overall Study|No longer willing to participate|585|||
164289170|NCT00346216|593429685|FG000|Overall Study|Withdrawal by Subject|661|||
164289171|NCT00346216|593429686|FG001|Overall Study|Withdrawal by Subject|692|||
164289172|NCT00346216|593429687|FG002|Overall Study|Withdrawal by Subject|651|||
164087970|NCT02970669|592687311|FG000|Double-blind Period|Withdrawal by Subject|2|||
164087971|NCT02970669|592687312|FG001|Double-blind Period|Withdrawal by Subject|2|||
164289173|NCT00346216|593429685|FG000|Overall Study|Lost to Follow-up|611|||
164289174|NCT00346216|593429686|FG001|Overall Study|Lost to Follow-up|588|||
164289175|NCT00346216|593429687|FG002|Overall Study|Lost to Follow-up|542|||
164289176|NCT00346216|593429685|FG000|Overall Study|Physician Decision|80|||
164289177|NCT00346216|593429686|FG001|Overall Study|Physician Decision|76|||
164289178|NCT00346216|593429687|FG002|Overall Study|Physician Decision|59|||
164289179|NCT00346216|593429685|FG000|Overall Study|Does not meet entrance criteria|13|||
164289180|NCT00346216|593429686|FG001|Overall Study|Does not meet entrance criteria|10|||
164289181|NCT00346216|593429687|FG002|Overall Study|Does not meet entrance criteria|8|||
164289182|NCT00346216|593429685|FG000|Overall Study|Death|189|||
164289183|NCT00346216|593429686|FG001|Overall Study|Death|192|||
164289184|NCT00346216|593429687|FG002|Overall Study|Death|228|||
164289185|NCT00346216|593429685|FG000|Overall Study|Study terminated by sponsor|11|||
164289186|NCT00346216|593429686|FG001|Overall Study|Study terminated by sponsor|4|||
164289187|NCT00346216|593429687|FG002|Overall Study|Study terminated by sponsor|8|||
164289188|NCT00346216|593429685|FG000|Overall Study|Missing Subject Summary Status|62|||
164289189|NCT00346216|593429686|FG001|Overall Study|Missing Subject Summary Status|61|||
164289190|NCT00346216|593429687|FG002|Overall Study|Missing Subject Summary Status|62|||
164289191|NCT03431441|593429688|FG000|Overall Study|Withdrawal by Subject|2|||
164289192|NCT03431441|593429688|FG000|Overall Study|Adverse Event|2|||
164289193|NCT03431441|593429688|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
164289194|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
164289195|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
164289196|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Death|1|||
164289197|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Death|2|||
164289198|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
164289199|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
164289200|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
164289201|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
164289202|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
164289203|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
164289204|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
164289205|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
164289206|NCT01794000|593429694|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
164289207|NCT01794000|593429695|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
164289208|NCT01794000|593429694|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
164289209|NCT01794000|593429695|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
164289210|NCT00255190|593429696|FG000|Overall Study|Adverse Event|17|||
164289211|NCT00255190|593429697|FG001|Overall Study|Adverse Event|36|||
164289212|NCT00255190|593429696|FG000|Overall Study|Protocol Violation|2|||
164289213|NCT00255190|593429697|FG001|Overall Study|Protocol Violation|2|||
164289214|NCT00255190|593429696|FG000|Overall Study|Lost to Follow-up|10|||
164289215|NCT00255190|593429697|FG001|Overall Study|Lost to Follow-up|27|||
164289216|NCT00255190|593429696|FG000|Overall Study|Withdrew Consent|17|||
164289217|NCT00255190|593429697|FG001|Overall Study|Withdrew Consent|48|||
164289218|NCT00255190|593429696|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164289219|NCT00255190|593429697|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
164289220|NCT00255190|593429696|FG000|Overall Study|Erosive esophagitis not healed|0|||
164289221|NCT00255190|593429697|FG001|Overall Study|Erosive esophagitis not healed|20|||
164289222|NCT00255190|593429696|FG000|Overall Study|Various|4|||
164289223|NCT00255190|593429697|FG001|Overall Study|Various|23|||
164289224|NCT01156480|593429698|FG000|Overall Study|change in diagnosis|0|||
164289225|NCT01156480|593429699|FG001|Overall Study|change in diagnosis|1|||
164289226|NCT04537793|593429700|FG000|Part B (24 Weeks)|Adverse Event|0|||
164289227|NCT04537793|593429701|FG001|Part B (24 Weeks)|Adverse Event|1|||
164289228|NCT01255423|593429702|FG000|Overall Study|Abnormal Laboratory value|3|||
164289229|NCT01255423|593429703|FG001|Overall Study|Abnormal Laboratory value|2|||
164289230|NCT01255423|593429702|FG000|Overall Study|Use of prohibited medications|0|||
164289231|NCT01255423|593429703|FG001|Overall Study|Use of prohibited medications|1|||
164289232|NCT05470387|593429704|FG000|Overall Study|Protocol Violation|0|||
164289233|NCT05470387|593429705|FG001|Overall Study|Protocol Violation|3|||
164289234|NCT00988598|593429706|FG000|Overall Study|Withdrawal by Subject|2|||
164289235|NCT00988598|593429707|FG001|Overall Study|Withdrawal by Subject|0|||
164289236|NCT03367858|593429708|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
164289237|NCT03367858|593429709|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
164087972|NCT02970669|592687311|FG000|Open-label Period|Withdrawal by Subject|2|||
164289238|NCT03367858|593429708|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
164289239|NCT03367858|593429709|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
164289240|NCT03367858|593429708|FG000|3 Month Follow Up|Lost to Follow-up|8|||
164289241|NCT03367858|593429709|FG001|3 Month Follow Up|Lost to Follow-up|3|||
164289242|NCT03367858|593429708|FG000|3 Month Follow Up|Moved out of study area|2|||
164289243|NCT03367858|593429709|FG001|3 Month Follow Up|Moved out of study area|6|||
164289244|NCT03367858|593429708|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
164289245|NCT03367858|593429709|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
164289246|NCT03367858|593429708|FG000|3 Month Follow Up|MRI contraindication|2|||
164289247|NCT03367858|593429709|FG001|3 Month Follow Up|MRI contraindication|1|||
164289248|NCT03367858|593429708|FG000|3 Month Follow Up|Incarcerated|0|||
164289249|NCT03367858|593429709|FG001|3 Month Follow Up|Incarcerated|1|||
164289250|NCT03367858|593429708|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
164289251|NCT03367858|593429709|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
164289252|NCT03367858|593429708|FG000|6 Month Follow Up|Lost to Follow-up|5|||
164289253|NCT03367858|593429709|FG001|6 Month Follow Up|Lost to Follow-up|2|||
164289254|NCT03367858|593429708|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
164289255|NCT03367858|593429709|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
164289256|NCT03367858|593429708|FG000|12 Month Follow Up|Lost to Follow-up|3|||
164289257|NCT03367858|593429709|FG001|12 Month Follow Up|Lost to Follow-up|3|||
164289258|NCT03367858|593429708|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
164289259|NCT03367858|593429709|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
164289260|NCT01859923|593429719|FG000|Overall Study|Adverse Event|0|||
164289261|NCT01859923|593429720|FG001|Overall Study|Adverse Event|0|||
164289262|NCT01859923|593429721|FG002|Overall Study|Adverse Event|1|||
164289263|NCT01859923|593429722|FG003|Overall Study|Adverse Event|1|||
164289264|NCT02079038|593429727|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
164289265|NCT02079038|593429728|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
164289266|NCT02079038|593429727|FG000|Modified Intent to Treat Population|Death|1|||
164289267|NCT02079038|593429728|FG001|Modified Intent to Treat Population|Death|0|||
164289268|NCT02079038|593429727|FG000|Completed 6 Months|Lost to Follow-up|2|||
164289269|NCT02079038|593429728|FG001|Completed 6 Months|Lost to Follow-up|1|||
164289270|NCT00985465|593429729|FG000|Overall Study|Withdrawal by Subject|1|||
164289271|NCT00985465|593429730|FG001|Overall Study|Withdrawal by Subject|2|||
164289272|NCT00985465|593429729|FG000|Overall Study|Considered to be part of the other group|0|||
164289273|NCT00985465|593429730|FG001|Overall Study|Considered to be part of the other group|1|||
164289274|NCT01054456|593429733|FG000|Overall Study|Other|1|||
164289275|NCT04701333|593429734|FG000|Overall Study|Lost to Follow-up|3|||
164289276|NCT04701333|593429735|FG001|Overall Study|Lost to Follow-up|7|||
164289277|NCT04701333|593429734|FG000|Overall Study|Withdrawal by Subject|0|||
164289278|NCT04701333|593429735|FG001|Overall Study|Withdrawal by Subject|1|||
164289279|NCT01012258|593429736|FG000|Overall Study|Death|14|||
164289280|NCT01012258|593429736|FG000|Overall Study|Lost to Follow-up|1|||
164289281|NCT01012258|593429736|FG000|Overall Study|Adverse Event|1|||
164289282|NCT01012258|593429736|FG000|Overall Study|Progressive Disease (PD)|18|||
164289283|NCT01012258|593429736|FG000|Overall Study|Symptomatic Deterioration|1|||
164289284|NCT01012258|593429736|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
164289285|NCT01012258|593429736|FG000|Overall Study|Another Tumor Discovered|1|||
164289286|NCT01012258|593429736|FG000|Overall Study|Ongoing|29|||
164289287|NCT02366195|593429739|FG000|Overall Study|Protocol-specified criteria|3|||
164289288|NCT02366195|593429739|FG000|Overall Study|Withdrawal by Subject|9|||
164289289|NCT02366195|593429739|FG000|Overall Study|Lost to Follow-up|1|||
164289290|NCT02366195|593429739|FG000|Overall Study|Death|41|||
164289291|NCT00113841|593429740|FG000|Overall Study|Disease progression|0|||
164289292|NCT00113841|593429741|FG001|Overall Study|Disease progression|2|||
164289293|NCT00113841|593429740|FG000|Overall Study|Non-compliant|1|||
164289294|NCT00113841|593429741|FG001|Overall Study|Non-compliant|0|||
164289295|NCT00148759|593429742|FG000|Overall Study|Withdrawal by Subject|1|||
164289296|NCT00148759|593429743|FG001|Overall Study|Withdrawal by Subject|1|||
164289297|NCT00148759|593429742|FG000|Overall Study|Lost to Follow-up|1|||
164289298|NCT00148759|593429743|FG001|Overall Study|Lost to Follow-up|0|||
164289299|NCT03948334|593429750|FG000|Overall Study|Adverse Event|1|||
164289300|NCT03948334|593429751|FG001|Overall Study|Adverse Event|4|||
164289301|NCT03948334|593429750|FG000|Overall Study|Lack of Efficacy|2|||
164289302|NCT03948334|593429751|FG001|Overall Study|Lack of Efficacy|0|||
164289303|NCT03948334|593429750|FG000|Overall Study|Lost to Follow-up|1|||
164289304|NCT03948334|593429751|FG001|Overall Study|Lost to Follow-up|0|||
164289305|NCT03948334|593429750|FG000|Overall Study|Physician Decision|1|||
164289306|NCT03948334|593429751|FG001|Overall Study|Physician Decision|0|||
164289307|NCT03948334|593429750|FG000|Overall Study|Pregnancy|0|||
164289308|NCT03948334|593429751|FG001|Overall Study|Pregnancy|1|||
164289309|NCT03948334|593429750|FG000|Overall Study|Protocol Deviation|1|||
164289310|NCT03948334|593429751|FG001|Overall Study|Protocol Deviation|0|||
164289311|NCT03948334|593429750|FG000|Overall Study|Study terminated by Sponsor|50|||
164289312|NCT03948334|593429751|FG001|Overall Study|Study terminated by Sponsor|51|||
164289313|NCT03948334|593429750|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
164289314|NCT03948334|593429751|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
164289315|NCT05114473|593429752|FG000|Overall Study|Lost to Follow-up|2|||
164289316|NCT05114473|593429753|FG001|Overall Study|Lost to Follow-up|2|||
164289317|NCT05114473|593429754|FG002|Overall Study|Lost to Follow-up|0|||
164289318|NCT02800863|593429761|FG000|Overall Study|Adverse Event|14|||
164289319|NCT02800863|593429761|FG000|Overall Study|Another Device Implanted|1|||
164289320|NCT02800863|593429761|FG000|Overall Study|Device Explanted|1|||
164289321|NCT02800863|593429761|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
164289322|NCT02800863|593429761|FG000|Overall Study|Health Issues|1|||
164289323|NCT02800863|593429761|FG000|Overall Study|Insurance Denial|8|||
164289324|NCT02800863|593429761|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
164289325|NCT02800863|593429761|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
164289326|NCT02800863|593429761|FG000|Overall Study|Screen Failure|1|||
164289327|NCT02800863|593429761|FG000|Overall Study|Sponsor Request|6|||
164289328|NCT02800863|593429761|FG000|Overall Study|Death|3|||
164289329|NCT02800863|593429761|FG000|Overall Study|Subject Implant at Another Facility|1|||
164289330|NCT02800863|593429761|FG000|Overall Study|Lost to Follow-up|26|||
164289331|NCT02800863|593429761|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
164289332|NCT02800863|593429761|FG000|Overall Study|Subject and/or Family Request|64|||
164289333|NCT02800863|593429761|FG000|Overall Study|Trial Failure|81|||
164289334|NCT02800863|593429761|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
164289335|NCT04332107|593429765|FG000|Day 3|Lost to Follow-up|23|||
164289336|NCT04332107|593429766|FG001|Day 3|Lost to Follow-up|14|||
164289337|NCT04332107|593429765|FG000|Day 3|Missing outcome data|3|||
164289338|NCT04332107|593429766|FG001|Day 3|Missing outcome data|6|||
164289339|NCT04332107|593429765|FG000|Day 14|Lost to Follow-up|13|||
164289340|NCT04332107|593429766|FG001|Day 14|Lost to Follow-up|4|||
164289341|NCT04332107|593429765|FG000|Day 14|Missing outcome data|4|||
164289342|NCT04332107|593429766|FG001|Day 14|Missing outcome data|4|||
164289343|NCT04332107|593429765|FG000|Day 21|Lost to Follow-up|10|||
164289344|NCT04332107|593429766|FG001|Day 21|Lost to Follow-up|2|||
164289345|NCT01670721|593429769|FG000|Overall Study|Participant's decision|15|||
164289346|NCT01670721|593429769|FG000|Overall Study|Other than specified above|38|||
164289347|NCT03061201|593429770|FG000|Overall Study|Participants Terminated at Month 36|0|||
164289348|NCT03061201|593429771|FG001|Overall Study|Participants Terminated at Month 36|1|||
164289349|NCT03061201|593429772|FG002|Overall Study|Participants Terminated at Month 36|0|||
164289350|NCT03061201|593429773|FG003|Overall Study|Participants Terminated at Month 36|1|||
164289351|NCT03061201|593429770|FG000|Overall Study|Lost to Follow-up|1|||
164289352|NCT03061201|593429771|FG001|Overall Study|Lost to Follow-up|0|||
164289353|NCT03061201|593429772|FG002|Overall Study|Lost to Follow-up|0|||
164289354|NCT03061201|593429773|FG003|Overall Study|Lost to Follow-up|0|||
164289355|NCT01572480|593429774|FG000|Participants Enrolled|Withdrawal by Subject|1|||
164289356|NCT01572480|593429774|FG000|Drug Administration|Discontinued drug/Off Study|1|||
164289357|NCT01572480|593429774|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
164289358|NCT01572480|593429774|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
164289359|NCT05081219|593429775|FG000|Overall Study|Withdrawal by Subject|4|||
164289360|NCT05081219|593429776|FG001|Overall Study|Withdrawal by Subject|0|||
164289361|NCT05081219|593429777|FG002|Overall Study|Withdrawal by Subject|0|||
164289362|NCT05081219|593429778|FG003|Overall Study|Withdrawal by Subject|1|||
164289363|NCT03446313|593429779|FG000|Overall Study|Lost to Follow-up|1|||
164289364|NCT03446313|593429780|FG001|Overall Study|Lost to Follow-up|2|||
164345325|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164345326|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
164345327|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
164345328|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345329|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345330|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345331|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345332|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345333|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
164345334|NCT04115839|593640941|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345335|NCT04115839|593640942|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345336|NCT04115839|593640943|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
164345337|NCT04115839|593640944|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345338|NCT04115839|593640945|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164004395|NCT02034123|592380784|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
164004396|NCT02034123|592380785|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
164004397|NCT02034123|592380786|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004398|NCT02034123|592380787|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004399|NCT02034123|592380788|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004400|NCT02034123|592380789|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004401|NCT02034123|592380790|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004402|NCT02034123|592380791|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004403|NCT02034123|592380792|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004404|NCT02034123|592380793|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004405|NCT02034123|592380794|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
164004406|NCT02034123|592380777|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004407|NCT02034123|592380778|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004408|NCT02034123|592380779|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164289365|NCT03446313|593429779|FG000|Overall Study|Failed primary screening|3|||
164289366|NCT03446313|593429780|FG001|Overall Study|Failed primary screening|0|||
164289367|NCT03446313|593429779|FG000|Overall Study|Diagnosed with terminal cancer|1|||
164289368|NCT03446313|593429780|FG001|Overall Study|Diagnosed with terminal cancer|0|||
164289369|NCT03446313|593429779|FG000|Overall Study|Excluded from analysis|1|||
164289370|NCT03446313|593429780|FG001|Overall Study|Excluded from analysis|1|||
164289371|NCT06235905|593429782|FG000|Overall Study|Adverse Event|1|||
164289372|NCT06235905|593429782|FG000|Overall Study|Non-compliant with protocol procedures|1|||
164289373|NCT00866814|593429784|FG000|Overall Study|Lost to Follow-up|12|||
164289374|NCT00866814|593429784|FG000|Overall Study|Adverse Event|2|||
164289375|NCT00866814|593429784|FG000|Overall Study|Physician Decision|1|||
164289376|NCT00866814|593429784|FG000|Overall Study|Death|1|||
164289377|NCT00866814|593429784|FG000|Overall Study|No longer wished to participate|1|||
164289378|NCT00866814|593429784|FG000|Overall Study|Unable to meet follow-up requirements|2|||
164289379|NCT00866814|593429784|FG000|Overall Study|Moved to area without study site|1|||
164289380|NCT03858049|593431806|FG000|Overall Study|Adverse Event|16|||
164289381|NCT03858049|593431807|FG001|Overall Study|Adverse Event|9|||
164289382|NCT03858049|593431806|FG000|Overall Study|Other|1|||
164289383|NCT03858049|593431807|FG001|Overall Study|Other|1|||
164289384|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
164289385|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
164289386|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
164289387|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
164289388|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
164289389|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
164289390|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
164289391|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
164289392|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
164289393|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
164289394|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
164289395|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
164289396|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
164289397|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
164289398|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
164289399|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
164289400|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
164289401|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
164289402|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
164289403|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
164289404|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
164289405|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
164289406|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
164289407|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
164289408|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
164289409|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
164289410|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289411|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289412|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289413|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289414|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289415|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289416|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289417|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
164289418|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289419|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289420|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289421|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289422|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
164289423|NCT02079740|593431808|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289424|NCT02079740|593431809|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289425|NCT02079740|593431810|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289426|NCT02079740|593431811|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289427|NCT02079740|593431812|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164087973|NCT02970669|592687312|FG001|Open-label Period|Withdrawal by Subject|2|||
164087974|NCT02970669|592687311|FG000|Open-label Period|Adverse Event|1|||
164087975|NCT02970669|592687312|FG001|Open-label Period|Adverse Event|0|||
164087976|NCT02970669|592687311|FG000|Open-label Period|Physician Decision|1|||
164289428|NCT02079740|593431813|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289429|NCT02079740|593431814|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289430|NCT02079740|593431815|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
164289431|NCT02079740|593431816|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289432|NCT02079740|593431817|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289433|NCT02079740|593431818|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289434|NCT02079740|593431819|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289435|NCT02079740|593431820|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
164289436|NCT02079740|593431808|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289437|NCT02079740|593431809|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289438|NCT02079740|593431810|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289439|NCT02079740|593431811|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289440|NCT02079740|593431812|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289441|NCT02079740|593431813|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289442|NCT02079740|593431814|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289443|NCT02079740|593431815|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289444|NCT02079740|593431816|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289445|NCT02079740|593431817|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
164289446|NCT02079740|593431818|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
164289447|NCT02079740|593431819|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
164289448|NCT02079740|593431820|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
164289449|NCT01474317|593431825|FG000|Overall Study|Adverse Event|1|||
164289450|NCT01474317|593431825|FG000|Overall Study|Subject ineligible for study|1|||
164289451|NCT00387881|593431826|FG000|Overall Study|Lost to Follow-up|23|||
164289452|NCT00387881|593431827|FG001|Overall Study|Lost to Follow-up|23|||
164289453|NCT00387881|593431826|FG000|Overall Study|Protocol Violation|2|||
164289454|NCT00387881|593431827|FG001|Overall Study|Protocol Violation|12|||
164289455|NCT00387881|593431826|FG000|Overall Study|Withdrawal by Subject|15|||
164289456|NCT00387881|593431827|FG001|Overall Study|Withdrawal by Subject|18|||
164289457|NCT00387881|593431826|FG000|Overall Study|Sponsor terminated Study|0|||
164289458|NCT00387881|593431827|FG001|Overall Study|Sponsor terminated Study|1|||
164289459|NCT00387881|593431826|FG000|Overall Study|Not eligible|6|||
164289460|NCT00387881|593431827|FG001|Overall Study|Not eligible|7|||
164289461|NCT00387881|593431826|FG000|Overall Study|No opportunity to treat headache|32|||
164289462|NCT00387881|593431827|FG001|Overall Study|No opportunity to treat headache|34|||
164289463|NCT00387881|593431826|FG000|Overall Study|Not otherwise specified|11|||
164289464|NCT00387881|593431827|FG001|Overall Study|Not otherwise specified|7|||
164289465|NCT00453154|593431830|FG000|Double BIind Maintenance|Adverse Event|0|||
164289466|NCT00453154|593431831|FG001|Double BIind Maintenance|Adverse Event|0|||
164289467|NCT00453154|593431832|FG002|Double BIind Maintenance|Adverse Event|3|||
164289468|NCT00453154|593431833|FG003|Double BIind Maintenance|Adverse Event|12|||
164289469|NCT00453154|593431830|FG000|Double BIind Maintenance|Death|0|||
164289470|NCT00453154|593431831|FG001|Double BIind Maintenance|Death|0|||
164289471|NCT00453154|593431832|FG002|Double BIind Maintenance|Death|2|||
164289472|NCT00453154|593431833|FG003|Double BIind Maintenance|Death|1|||
164289473|NCT00453154|593431830|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
164289474|NCT00453154|593431831|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
164289475|NCT00453154|593431832|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
164289476|NCT00453154|593431833|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
164289477|NCT00453154|593431830|FG000|Double BIind Maintenance|Progression|0|||
164289478|NCT00453154|593431831|FG001|Double BIind Maintenance|Progression|0|||
164289479|NCT00453154|593431832|FG002|Double BIind Maintenance|Progression|29|||
164289480|NCT00453154|593431833|FG003|Double BIind Maintenance|Progression|26|||
164289481|NCT00453154|593431830|FG000|Double BIind Maintenance|Medical Issues|0|||
164289482|NCT00453154|593431831|FG001|Double BIind Maintenance|Medical Issues|0|||
164289483|NCT00453154|593431832|FG002|Double BIind Maintenance|Medical Issues|3|||
164289484|NCT00453154|593431833|FG003|Double BIind Maintenance|Medical Issues|1|||
164289485|NCT00453154|593431830|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
164289486|NCT00453154|593431831|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
164289487|NCT00453154|593431832|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
164289488|NCT00453154|593431833|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
164289489|NCT03629886|593431835|FG000|Overall Study|Migrated / moved from the study area|0|||
164289490|NCT03629886|593431836|FG001|Overall Study|Migrated / moved from the study area|55|||
164289491|NCT03629886|593431835|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
164289492|NCT03629886|593431836|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
164289493|NCT03629886|593431835|FG000|Overall Study|Study vaccine not administrated|0|||
164289494|NCT03629886|593431836|FG001|Overall Study|Study vaccine not administrated|3|||
164289495|NCT03629886|593431835|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
164289496|NCT03629886|593431836|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
164289497|NCT03629886|593431835|FG000|Overall Study|Refused vaccination step of the study|0|||
164289498|NCT03629886|593431836|FG001|Overall Study|Refused vaccination step of the study|44|||
164289499|NCT05473026|593431838|FG000|Overall Study|Lost to Follow-up|5|||
164004409|NCT02034123|592380780|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
164004410|NCT02034123|592380781|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164289500|NCT05473026|593431839|FG001|Overall Study|Lost to Follow-up|2|||
164004411|NCT02034123|592380782|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164289501|NCT02038153|593431840|FG000|Overall Study|Withdrawal by Subject|1|||
164289502|NCT03683173|593431841|FG000|Completed Follow-up|Unavailable|235|||
164289503|NCT03683173|593431842|FG001|Completed Follow-up|Unavailable|217|||
164289504|NCT03683173|593431841|FG000|Completed Follow-up|Refused|69|||
164289505|NCT03683173|593431842|FG001|Completed Follow-up|Refused|59|||
164289506|NCT03683173|593431841|FG000|Completed Follow-up|Disconnected phone|65|||
164289507|NCT03683173|593431842|FG001|Completed Follow-up|Disconnected phone|95|||
164289508|NCT03683173|593431841|FG000|Completed Follow-up|Health issue/deceased|10|||
164289509|NCT03683173|593431842|FG001|Completed Follow-up|Health issue/deceased|4|||
164289510|NCT03683173|593431841|FG000|Completed Follow-up|Moved away|8|||
164289511|NCT03683173|593431842|FG001|Completed Follow-up|Moved away|1|||
164289512|NCT02647281|593431843|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289513|NCT02647281|593431844|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289514|NCT02647281|593431845|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289515|NCT02647281|593431846|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289516|NCT02647281|593431847|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289517|NCT02647281|593431848|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289518|NCT02647281|593431849|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289519|NCT02647281|593431850|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
164289520|NCT02647281|593431851|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
164289521|NCT01050634|593431852|FG000|Overall Study|Enrolled, but Not Treated|56|||
164289522|NCT01050634|593431852|FG000|Overall Study|Death|2|||
164289523|NCT01050634|593431852|FG000|Overall Study|Adverse Event|42|||
164289524|NCT01050634|593431852|FG000|Overall Study|Lost to Follow-up|2|||
164289525|NCT01050634|593431852|FG000|Overall Study|Other|21|||
164289526|NCT01050634|593431852|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
164289527|NCT00496015|593431853|FG000|Overall Study|Other|1|||
164289528|NCT00496015|593431854|FG001|Overall Study|Other|0|||
164289529|NCT00496015|593431855|FG002|Overall Study|Other|0|||
164289530|NCT00496015|593431856|FG003|Overall Study|Other|1|||
164289531|NCT00496015|593431857|FG004|Overall Study|Other|0|||
164289532|NCT02730728|593431860|FG000|Overall Study|Withdrawal by Subject|0|||
164289533|NCT02730728|593431861|FG001|Overall Study|Withdrawal by Subject|1|||
164289534|NCT02730728|593431862|FG002|Overall Study|Withdrawal by Subject|0|||
164289535|NCT02730728|593431860|FG000|Overall Study|Lack of Efficacy|0|||
164289536|NCT02730728|593431861|FG001|Overall Study|Lack of Efficacy|1|||
164289537|NCT02730728|593431862|FG002|Overall Study|Lack of Efficacy|1|||
164289538|NCT02711137|593431866|FG000|Overall Study|Death|1|||
164289539|NCT02711137|593431867|FG001|Overall Study|Death|4|||
164289540|NCT02711137|593431868|FG002|Overall Study|Death|5|||
164289541|NCT02711137|593431869|FG003|Overall Study|Death|5|||
164289542|NCT02711137|593431870|FG004|Overall Study|Death|3|||
164289543|NCT02711137|593431871|FG005|Overall Study|Death|1|||
164289544|NCT02711137|593431872|FG006|Overall Study|Death|61|||
164289545|NCT02711137|593431873|FG007|Overall Study|Death|3|||
164289546|NCT02711137|593431874|FG008|Overall Study|Death|0|||
164289547|NCT02711137|593431875|FG009|Overall Study|Death|1|||
164289548|NCT02711137|593431876|FG010|Overall Study|Death|1|||
164289549|NCT02711137|593431877|FG011|Overall Study|Death|1|||
164289550|NCT02711137|593431878|FG012|Overall Study|Death|0|||
164289551|NCT02711137|593431879|FG013|Overall Study|Death|0|||
164289552|NCT02711137|593431880|FG014|Overall Study|Death|0|||
164289553|NCT02711137|593431866|FG000|Overall Study|Study Terminated by Sponsor|0|||
164289554|NCT02711137|593431867|FG001|Overall Study|Study Terminated by Sponsor|0|||
164289555|NCT02711137|593431868|FG002|Overall Study|Study Terminated by Sponsor|1|||
164289556|NCT02711137|593431869|FG003|Overall Study|Study Terminated by Sponsor|0|||
164289557|NCT02711137|593431870|FG004|Overall Study|Study Terminated by Sponsor|0|||
164289558|NCT02711137|593431871|FG005|Overall Study|Study Terminated by Sponsor|0|||
164289559|NCT02711137|593431872|FG006|Overall Study|Study Terminated by Sponsor|1|||
164289560|NCT02711137|593431873|FG007|Overall Study|Study Terminated by Sponsor|0|||
164289561|NCT02711137|593431874|FG008|Overall Study|Study Terminated by Sponsor|0|||
164289562|NCT02711137|593431875|FG009|Overall Study|Study Terminated by Sponsor|0|||
164289563|NCT02711137|593431876|FG010|Overall Study|Study Terminated by Sponsor|0|||
164289564|NCT02711137|593431877|FG011|Overall Study|Study Terminated by Sponsor|0|||
164289565|NCT02711137|593431878|FG012|Overall Study|Study Terminated by Sponsor|0|||
164289566|NCT02711137|593431879|FG013|Overall Study|Study Terminated by Sponsor|0|||
164289567|NCT02711137|593431880|FG014|Overall Study|Study Terminated by Sponsor|0|||
164289568|NCT02711137|593431866|FG000|Overall Study|Physician Decision|1|||
164289569|NCT02711137|593431867|FG001|Overall Study|Physician Decision|0|||
164289570|NCT02711137|593431868|FG002|Overall Study|Physician Decision|2|||
164087977|NCT02970669|592687312|FG001|Open-label Period|Physician Decision|0|||
164289571|NCT02711137|593431869|FG003|Overall Study|Physician Decision|1|||
164289572|NCT02711137|593431870|FG004|Overall Study|Physician Decision|1|||
164289573|NCT02711137|593431871|FG005|Overall Study|Physician Decision|0|||
164289574|NCT02711137|593431872|FG006|Overall Study|Physician Decision|12|||
164289575|NCT02711137|593431873|FG007|Overall Study|Physician Decision|2|||
164289576|NCT02711137|593431874|FG008|Overall Study|Physician Decision|1|||
164289577|NCT02711137|593431875|FG009|Overall Study|Physician Decision|1|||
163897729|NCT00982644|591998698|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
163897730|NCT00982644|591998697|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
164289578|NCT02711137|593431876|FG010|Overall Study|Physician Decision|3|||
164289579|NCT02711137|593431877|FG011|Overall Study|Physician Decision|2|||
164289580|NCT02711137|593431878|FG012|Overall Study|Physician Decision|1|||
164289581|NCT02711137|593431879|FG013|Overall Study|Physician Decision|1|||
164289582|NCT02711137|593431880|FG014|Overall Study|Physician Decision|2|||
164289583|NCT02711137|593431866|FG000|Overall Study|Other|0|||
164289584|NCT02711137|593431867|FG001|Overall Study|Other|1|||
164289585|NCT02711137|593431868|FG002|Overall Study|Other|0|||
164289586|NCT02711137|593431869|FG003|Overall Study|Other|0|||
164289587|NCT02711137|593431870|FG004|Overall Study|Other|0|||
164289588|NCT02711137|593431871|FG005|Overall Study|Other|0|||
164289589|NCT02711137|593431872|FG006|Overall Study|Other|3|||
164289590|NCT02711137|593431873|FG007|Overall Study|Other|0|||
164289591|NCT02711137|593431874|FG008|Overall Study|Other|0|||
164289592|NCT02711137|593431875|FG009|Overall Study|Other|0|||
164289593|NCT02711137|593431876|FG010|Overall Study|Other|0|||
164289594|NCT02711137|593431877|FG011|Overall Study|Other|0|||
164289595|NCT02711137|593431878|FG012|Overall Study|Other|0|||
164289596|NCT02711137|593431879|FG013|Overall Study|Other|0|||
164289597|NCT02711137|593431880|FG014|Overall Study|Other|1|||
164289598|NCT02711137|593431866|FG000|Overall Study|Withdrawal by Subject|1|||
164289599|NCT02711137|593431867|FG001|Overall Study|Withdrawal by Subject|0|||
164289600|NCT02711137|593431868|FG002|Overall Study|Withdrawal by Subject|0|||
164289601|NCT02711137|593431869|FG003|Overall Study|Withdrawal by Subject|1|||
164289602|NCT02711137|593431870|FG004|Overall Study|Withdrawal by Subject|1|||
164289603|NCT02711137|593431871|FG005|Overall Study|Withdrawal by Subject|0|||
164289604|NCT02711137|593431872|FG006|Overall Study|Withdrawal by Subject|7|||
164289605|NCT02711137|593431873|FG007|Overall Study|Withdrawal by Subject|0|||
164289606|NCT02711137|593431874|FG008|Overall Study|Withdrawal by Subject|0|||
164289607|NCT02711137|593431875|FG009|Overall Study|Withdrawal by Subject|0|||
164289608|NCT02711137|593431876|FG010|Overall Study|Withdrawal by Subject|0|||
164289609|NCT02711137|593431877|FG011|Overall Study|Withdrawal by Subject|0|||
164289610|NCT02711137|593431878|FG012|Overall Study|Withdrawal by Subject|0|||
164289611|NCT02711137|593431879|FG013|Overall Study|Withdrawal by Subject|1|||
164289612|NCT02711137|593431880|FG014|Overall Study|Withdrawal by Subject|0|||
164289613|NCT02711137|593431866|FG000|Overall Study|Lost to Follow-up|1|||
164289614|NCT02711137|593431867|FG001|Overall Study|Lost to Follow-up|0|||
164289615|NCT02711137|593431868|FG002|Overall Study|Lost to Follow-up|0|||
164289616|NCT02711137|593431869|FG003|Overall Study|Lost to Follow-up|0|||
164289617|NCT02711137|593431870|FG004|Overall Study|Lost to Follow-up|0|||
164289618|NCT02711137|593431871|FG005|Overall Study|Lost to Follow-up|0|||
164289619|NCT02711137|593431872|FG006|Overall Study|Lost to Follow-up|2|||
164289620|NCT02711137|593431873|FG007|Overall Study|Lost to Follow-up|0|||
164289621|NCT02711137|593431874|FG008|Overall Study|Lost to Follow-up|0|||
164289622|NCT02711137|593431875|FG009|Overall Study|Lost to Follow-up|0|||
164289623|NCT02711137|593431876|FG010|Overall Study|Lost to Follow-up|0|||
164289624|NCT02711137|593431877|FG011|Overall Study|Lost to Follow-up|0|||
164289625|NCT02711137|593431878|FG012|Overall Study|Lost to Follow-up|0|||
164289626|NCT02711137|593431879|FG013|Overall Study|Lost to Follow-up|0|||
164289627|NCT02711137|593431880|FG014|Overall Study|Lost to Follow-up|0|||
164289628|NCT03956550|593431881|FG000|Overall Study|Sponsor decision|65|||
164289629|NCT03956550|593431882|FG001|Overall Study|Sponsor decision|66|||
164289630|NCT03956550|593431883|FG002|Overall Study|Sponsor decision|64|||
164289631|NCT03956550|593431881|FG000|Overall Study|Adverse Event|0|||
164289632|NCT03956550|593431882|FG001|Overall Study|Adverse Event|1|||
164289633|NCT03956550|593431883|FG002|Overall Study|Adverse Event|0|||
164289634|NCT03956550|593431881|FG000|Overall Study|Withdrawal by Subject|5|||
164289635|NCT03956550|593431882|FG001|Overall Study|Withdrawal by Subject|5|||
164289636|NCT03956550|593431883|FG002|Overall Study|Withdrawal by Subject|6|||
164289637|NCT03400852|593431884|FG000|Blinded Treatment Period|Physician Decision|0|||
164289638|NCT03400852|593431885|FG001|Blinded Treatment Period|Physician Decision|1|||
164289639|NCT03400852|593431886|FG002|Blinded Treatment Period|Physician Decision|0|||
164289640|NCT03400852|593431884|FG000|Blinded Treatment Period|Adverse Event|1|||
164289641|NCT03400852|593431885|FG001|Blinded Treatment Period|Adverse Event|1|||
164289642|NCT03400852|593431886|FG002|Blinded Treatment Period|Adverse Event|0|||
164289643|NCT03400852|593431884|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
164289644|NCT03400852|593431885|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
164345339|NCT04115839|593640946|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164289645|NCT03400852|593431886|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
164289646|NCT03400852|593431884|FG000|Open Label Period|Physician Decision|0|||
164289647|NCT03400852|593431885|FG001|Open Label Period|Physician Decision|0|||
164289648|NCT03400852|593431886|FG002|Open Label Period|Physician Decision|1|||
164289649|NCT03400852|593431884|FG000|Open Label Period|Study terminated by sponsor|0|||
164289650|NCT03400852|593431885|FG001|Open Label Period|Study terminated by sponsor|0|||
164289651|NCT03400852|593431886|FG002|Open Label Period|Study terminated by sponsor|21|||
164289652|NCT00248495|593431887|FG000|Overall Study|Withdrawal by Subject|1|||
164289653|NCT01285401|593431888|FG000|Overall Study|Prematurely withdrawn from the study|17|||
164289654|NCT01285401|593431889|FG001|Overall Study|Prematurely withdrawn from the study|29|||
164289655|NCT03719131|593431893|FG000|Overall Study|Death|1|||
164289656|NCT03719131|593431894|FG001|Overall Study|Death|2|||
164289657|NCT04244253|593431895|FG000|Overall Study|Adverse Event|2|||
164289658|NCT04244253|593431896|FG001|Overall Study|Adverse Event|2|||
164289659|NCT04244253|593431897|FG002|Overall Study|Adverse Event|4|||
164289660|NCT04244253|593431895|FG000|Overall Study|Protocol Violation|1|||
164289661|NCT04244253|593431896|FG001|Overall Study|Protocol Violation|2|||
164289662|NCT04244253|593431897|FG002|Overall Study|Protocol Violation|1|||
164289663|NCT04244253|593431895|FG000|Overall Study|Withdrawal by Subject|0|||
164289664|NCT04244253|593431896|FG001|Overall Study|Withdrawal by Subject|1|||
164289665|NCT04244253|593431897|FG002|Overall Study|Withdrawal by Subject|6|||
164289666|NCT04244253|593431895|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164289667|NCT04244253|593431896|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164289668|NCT04244253|593431897|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164289669|NCT01544920|593431898|FG000|Overall Study|Adverse Event|0|||
164289670|NCT01544920|593431899|FG001|Overall Study|Adverse Event|3|||
164289671|NCT01544920|593431898|FG000|Overall Study|Death|0|||
164289672|NCT01544920|593431899|FG001|Overall Study|Death|1|||
164289673|NCT01544920|593431898|FG000|Overall Study|Lost to Follow-up|11|||
164289674|NCT01544920|593431899|FG001|Overall Study|Lost to Follow-up|12|||
164289675|NCT01544920|593431898|FG000|Overall Study|Protocol Violation|0|||
164289676|NCT01544920|593431899|FG001|Overall Study|Protocol Violation|2|||
164289677|NCT01544920|593431898|FG000|Overall Study|Physician Decision|4|||
164289678|NCT01544920|593431899|FG001|Overall Study|Physician Decision|1|||
164289679|NCT01544920|593431898|FG000|Overall Study|Withdrawal by Subject|4|||
164289680|NCT01544920|593431899|FG001|Overall Study|Withdrawal by Subject|4|||
164289681|NCT03001557|593431903|FG000|Core Phase|Randomized but not treated|0|||
164289682|NCT03001557|593431904|FG001|Core Phase|Randomized but not treated|0|||
164289683|NCT03001557|593431905|FG002|Core Phase|Randomized but not treated|1|||
164289684|NCT03001557|593431906|FG003|Core Phase|Randomized but not treated|0|||
164289685|NCT03001557|593431907|FG004|Core Phase|Randomized but not treated|0|||
164289686|NCT03001557|593431908|FG005|Core Phase|Randomized but not treated|0|||
164289687|NCT03001557|593431909|FG006|Core Phase|Randomized but not treated|0|||
164289688|NCT03001557|593431910|FG007|Core Phase|Randomized but not treated|0|||
164289689|NCT03001557|593431903|FG000|Extension Phase|Adverse Event|0|||
164289690|NCT03001557|593431904|FG001|Extension Phase|Adverse Event|0|||
164289691|NCT03001557|593431905|FG002|Extension Phase|Adverse Event|0|||
164289692|NCT03001557|593431906|FG003|Extension Phase|Adverse Event|0|||
164289693|NCT03001557|593431907|FG004|Extension Phase|Adverse Event|0|||
164289694|NCT03001557|593431908|FG005|Extension Phase|Adverse Event|2|||
164345340|NCT04115839|593640947|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
164345341|NCT04115839|593640941|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
164345342|NCT04115839|593640942|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
164289695|NCT03001557|593431909|FG006|Extension Phase|Adverse Event|0|||
164289696|NCT03001557|593431910|FG007|Extension Phase|Adverse Event|0|||
164345343|NCT04115839|593640943|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
164289697|NCT03001557|593431903|FG000|Extension Phase|Withdrawal by Subject|0|||
164289698|NCT03001557|593431904|FG001|Extension Phase|Withdrawal by Subject|0|||
164289699|NCT03001557|593431905|FG002|Extension Phase|Withdrawal by Subject|0|||
164345344|NCT04115839|593640944|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
164345345|NCT04115839|593640945|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
164345346|NCT04115839|593640946|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
164345347|NCT04115839|593640947|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
164345348|NCT04115839|593640941|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345349|NCT04115839|593640942|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345350|NCT04115839|593640943|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345351|NCT04115839|593640944|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
164345352|NCT04115839|593640945|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
164345353|NCT04115839|593640946|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345354|NCT04115839|593640947|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
164345355|NCT02820753|593640949|FG000|2 Month|Withdrawal by Subject|3|||
164345356|NCT02820753|593640950|FG001|2 Month|Withdrawal by Subject|3|||
164345357|NCT02820753|593640949|FG000|2 Month|Lost to Follow-up|24|||
164289700|NCT03001557|593431906|FG003|Extension Phase|Withdrawal by Subject|0|||
164289701|NCT03001557|593431907|FG004|Extension Phase|Withdrawal by Subject|0|||
164289702|NCT03001557|593431908|FG005|Extension Phase|Withdrawal by Subject|1|||
164289703|NCT03001557|593431909|FG006|Extension Phase|Withdrawal by Subject|5|||
164289704|NCT03001557|593431910|FG007|Extension Phase|Withdrawal by Subject|2|||
164345358|NCT02820753|593640950|FG001|2 Month|Lost to Follow-up|26|||
164345359|NCT02820753|593640949|FG000|2 Month|Stopped per NIH Hold|51|||
164345360|NCT02820753|593640950|FG001|2 Month|Stopped per NIH Hold|13|||
164289705|NCT03001557|593431903|FG000|Extension Phase|Lost to Follow-up|0|||
164289706|NCT03001557|593431904|FG001|Extension Phase|Lost to Follow-up|0|||
164289707|NCT03001557|593431905|FG002|Extension Phase|Lost to Follow-up|0|||
164289708|NCT03001557|593431906|FG003|Extension Phase|Lost to Follow-up|0|||
164289709|NCT03001557|593431907|FG004|Extension Phase|Lost to Follow-up|0|||
164289710|NCT03001557|593431908|FG005|Extension Phase|Lost to Follow-up|0|||
164289711|NCT03001557|593431909|FG006|Extension Phase|Lost to Follow-up|2|||
164289712|NCT03001557|593431910|FG007|Extension Phase|Lost to Follow-up|1|||
164289713|NCT03001557|593431903|FG000|Extension Phase|Administrative Reason|0|||
164289714|NCT03001557|593431904|FG001|Extension Phase|Administrative Reason|0|||
164289715|NCT03001557|593431905|FG002|Extension Phase|Administrative Reason|0|||
164289716|NCT03001557|593431906|FG003|Extension Phase|Administrative Reason|0|||
164289717|NCT03001557|593431907|FG004|Extension Phase|Administrative Reason|0|||
164289718|NCT03001557|593431908|FG005|Extension Phase|Administrative Reason|1|||
164289719|NCT03001557|593431909|FG006|Extension Phase|Administrative Reason|3|||
164289720|NCT03001557|593431910|FG007|Extension Phase|Administrative Reason|3|||
164289721|NCT03001557|593431903|FG000|Extension Phase|Loss of caregiver|0|||
164289722|NCT03001557|593431904|FG001|Extension Phase|Loss of caregiver|0|||
164289723|NCT03001557|593431905|FG002|Extension Phase|Loss of caregiver|0|||
164289724|NCT03001557|593431906|FG003|Extension Phase|Loss of caregiver|0|||
164289725|NCT03001557|593431907|FG004|Extension Phase|Loss of caregiver|0|||
164289726|NCT03001557|593431908|FG005|Extension Phase|Loss of caregiver|0|||
164289727|NCT03001557|593431909|FG006|Extension Phase|Loss of caregiver|1|||
164289728|NCT03001557|593431910|FG007|Extension Phase|Loss of caregiver|0|||
164289729|NCT03001557|593431903|FG000|Extension Phase|Others|0|||
164289730|NCT03001557|593431904|FG001|Extension Phase|Others|0|||
164289731|NCT03001557|593431905|FG002|Extension Phase|Others|0|||
164289732|NCT03001557|593431906|FG003|Extension Phase|Others|0|||
164289733|NCT03001557|593431907|FG004|Extension Phase|Others|0|||
164289734|NCT03001557|593431908|FG005|Extension Phase|Others|1|||
164289735|NCT03001557|593431909|FG006|Extension Phase|Others|3|||
164289736|NCT03001557|593431910|FG007|Extension Phase|Others|0|||
164289737|NCT01272232|593431911|FG000|Weeks 0-56|Adverse Event|39|||
164289738|NCT01272232|593431912|FG001|Weeks 0-56|Adverse Event|18|||
164289739|NCT01272232|593431913|FG002|Weeks 0-56|Adverse Event|7|||
164289740|NCT01272232|593431911|FG000|Weeks 0-56|Lack of Efficacy|0|||
164289741|NCT01272232|593431912|FG001|Weeks 0-56|Lack of Efficacy|0|||
164289742|NCT01272232|593431913|FG002|Weeks 0-56|Lack of Efficacy|3|||
164289743|NCT01272232|593431911|FG000|Weeks 0-56|Protocol Violation|12|||
164289744|NCT01272232|593431912|FG001|Weeks 0-56|Protocol Violation|8|||
164289745|NCT01272232|593431913|FG002|Weeks 0-56|Protocol Violation|13|||
164289746|NCT01272232|593431911|FG000|Weeks 0-56|Withdrawal criteria|32|||
164289747|NCT01272232|593431912|FG001|Weeks 0-56|Withdrawal criteria|14|||
164289748|NCT01272232|593431913|FG002|Weeks 0-56|Withdrawal criteria|37|||
164289749|NCT01272232|593431911|FG000|Weeks 0-56|Unclassified|16|||
164289750|NCT01272232|593431912|FG001|Weeks 0-56|Unclassified|7|||
164289751|NCT01272232|593431913|FG002|Weeks 0-56|Unclassified|12|||
164289752|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
164289753|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
164289754|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
164289755|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
164289756|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
164289757|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
164289758|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
164289759|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
164289760|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
164289761|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
164289762|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
164289763|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
164289764|NCT01272232|593431911|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
164289765|NCT01272232|593431912|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
164289766|NCT01272232|593431913|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
164289767|NCT02159066|593431914|FG000|Part I|Adverse Event|7|||
164289768|NCT02159066|593431915|FG001|Part I|Adverse Event|5|||
164289769|NCT02159066|593431916|FG002|Part I|Adverse Event|0|||
164289770|NCT02159066|593431917|FG003|Part I|Adverse Event|0|||
164289771|NCT02159066|593431918|FG004|Part I|Adverse Event|0|||
164289772|NCT02159066|593431919|FG005|Part I|Adverse Event|0|||
164289773|NCT02159066|593431914|FG000|Part I|Death|11|||
164289774|NCT02159066|593431915|FG001|Part I|Death|9|||
164289775|NCT02159066|593431916|FG002|Part I|Death|0|||
164289776|NCT02159066|593431917|FG003|Part I|Death|0|||
164289777|NCT02159066|593431918|FG004|Part I|Death|0|||
164289778|NCT02159066|593431919|FG005|Part I|Death|0|||
164289779|NCT02159066|593431914|FG000|Part I|Progressive Disease|37|||
164289780|NCT02159066|593431915|FG001|Part I|Progressive Disease|46|||
164289781|NCT02159066|593431916|FG002|Part I|Progressive Disease|0|||
164289782|NCT02159066|593431917|FG003|Part I|Progressive Disease|0|||
164289783|NCT02159066|593431918|FG004|Part I|Progressive Disease|0|||
164289784|NCT02159066|593431919|FG005|Part I|Progressive Disease|0|||
164289785|NCT02159066|593431914|FG000|Part I|New Therapy for Study Indication|5|||
164289786|NCT02159066|593431915|FG001|Part I|New Therapy for Study Indication|4|||
164289787|NCT02159066|593431916|FG002|Part I|New Therapy for Study Indication|0|||
164289788|NCT02159066|593431917|FG003|Part I|New Therapy for Study Indication|0|||
164289789|NCT02159066|593431918|FG004|Part I|New Therapy for Study Indication|0|||
164289790|NCT02159066|593431919|FG005|Part I|New Therapy for Study Indication|0|||
164289791|NCT02159066|593431914|FG000|Part I|Termination of participants from the study|3|||
164289792|NCT02159066|593431915|FG001|Part I|Termination of participants from the study|3|||
164289793|NCT02159066|593431916|FG002|Part I|Termination of participants from the study|0|||
164289794|NCT02159066|593431917|FG003|Part I|Termination of participants from the study|0|||
164289795|NCT02159066|593431918|FG004|Part I|Termination of participants from the study|0|||
164289796|NCT02159066|593431919|FG005|Part I|Termination of participants from the study|0|||
164289797|NCT02159066|593431914|FG000|Part I|Physician Decision|2|||
164289798|NCT02159066|593431915|FG001|Part I|Physician Decision|9|||
164289799|NCT02159066|593431916|FG002|Part I|Physician Decision|0|||
164289800|NCT02159066|593431917|FG003|Part I|Physician Decision|0|||
164289801|NCT02159066|593431918|FG004|Part I|Physician Decision|0|||
164289802|NCT02159066|593431919|FG005|Part I|Physician Decision|0|||
164289803|NCT02159066|593431914|FG000|Part I|Participant/Guardian Decision|9|||
164289804|NCT02159066|593431915|FG001|Part I|Participant/Guardian Decision|3|||
164289805|NCT02159066|593431916|FG002|Part I|Participant/Guardian Decision|0|||
164289806|NCT02159066|593431917|FG003|Part I|Participant/Guardian Decision|0|||
164289807|NCT02159066|593431918|FG004|Part I|Participant/Guardian Decision|0|||
164289808|NCT02159066|593431919|FG005|Part I|Participant/Guardian Decision|0|||
164289809|NCT02159066|593431914|FG000|Part I|Missing Data|1|||
164289810|NCT02159066|593431915|FG001|Part I|Missing Data|0|||
164289811|NCT02159066|593431916|FG002|Part I|Missing Data|0|||
164289812|NCT02159066|593431917|FG003|Part I|Missing Data|0|||
164289813|NCT02159066|593431918|FG004|Part I|Missing Data|0|||
164289814|NCT02159066|593431919|FG005|Part I|Missing Data|0|||
164289815|NCT02159066|593431914|FG000|Part II|Adverse Event|0|||
164289816|NCT02159066|593431915|FG001|Part II|Adverse Event|0|||
164289817|NCT02159066|593431916|FG002|Part II|Adverse Event|1|||
164289818|NCT02159066|593431917|FG003|Part II|Adverse Event|0|||
164289819|NCT02159066|593431918|FG004|Part II|Adverse Event|1|||
164289820|NCT02159066|593431919|FG005|Part II|Adverse Event|1|||
164289821|NCT02159066|593431914|FG000|Part II|Death|0|||
164289822|NCT02159066|593431915|FG001|Part II|Death|0|||
164289823|NCT02159066|593431916|FG002|Part II|Death|1|||
164289824|NCT02159066|593431917|FG003|Part II|Death|0|||
164289825|NCT02159066|593431918|FG004|Part II|Death|2|||
164289826|NCT02159066|593431919|FG005|Part II|Death|1|||
164289827|NCT02159066|593431914|FG000|Part II|Progressive Disease|0|||
164289828|NCT02159066|593431915|FG001|Part II|Progressive Disease|0|||
164289829|NCT02159066|593431916|FG002|Part II|Progressive Disease|35|||
164289830|NCT02159066|593431917|FG003|Part II|Progressive Disease|1|||
164289831|NCT02159066|593431918|FG004|Part II|Progressive Disease|7|||
164289832|NCT02159066|593431919|FG005|Part II|Progressive Disease|4|||
164289833|NCT02159066|593431914|FG000|Part II|New Therapy for Study Indication|0|||
164289834|NCT02159066|593431915|FG001|Part II|New Therapy for Study Indication|0|||
164289835|NCT02159066|593431916|FG002|Part II|New Therapy for Study Indication|0|||
164289836|NCT02159066|593431917|FG003|Part II|New Therapy for Study Indication|0|||
164289837|NCT02159066|593431918|FG004|Part II|New Therapy for Study Indication|1|||
164289838|NCT02159066|593431919|FG005|Part II|New Therapy for Study Indication|0|||
164289839|NCT02159066|593431914|FG000|Part II|Physician Decision|0|||
164289840|NCT02159066|593431915|FG001|Part II|Physician Decision|0|||
164289841|NCT02159066|593431916|FG002|Part II|Physician Decision|1|||
164289842|NCT02159066|593431917|FG003|Part II|Physician Decision|0|||
164289843|NCT02159066|593431918|FG004|Part II|Physician Decision|0|||
164289844|NCT02159066|593431919|FG005|Part II|Physician Decision|0|||
164289845|NCT02159066|593431914|FG000|Part II|Participant/Guardian Decision|0|||
164289846|NCT02159066|593431915|FG001|Part II|Participant/Guardian Decision|0|||
164289847|NCT02159066|593431916|FG002|Part II|Participant/Guardian Decision|0|||
164289848|NCT02159066|593431917|FG003|Part II|Participant/Guardian Decision|0|||
164289849|NCT02159066|593431918|FG004|Part II|Participant/Guardian Decision|2|||
164289850|NCT02159066|593431919|FG005|Part II|Participant/Guardian Decision|0|||
164289851|NCT00796666|593431920|FG000|Overall Study|Death|2|||
164289852|NCT00796666|593431921|FG001|Overall Study|Death|4|||
164289853|NCT00796666|593431920|FG000|Overall Study|Withdrawal by Subject|2|||
164289854|NCT00796666|593431921|FG001|Overall Study|Withdrawal by Subject|0|||
164289855|NCT00796666|593431920|FG000|Overall Study|Adverse Event|7|||
164289856|NCT00796666|593431921|FG001|Overall Study|Adverse Event|5|||
164289857|NCT00796666|593431920|FG000|Overall Study|Protocol Violation|1|||
164289858|NCT00796666|593431921|FG001|Overall Study|Protocol Violation|0|||
164289859|NCT00796666|593431920|FG000|Overall Study|Other|1|||
164289860|NCT00796666|593431921|FG001|Overall Study|Other|0|||
164289861|NCT00796666|593431920|FG000|Overall Study|Terminated by sponsor|53|||
164289862|NCT00796666|593431921|FG001|Overall Study|Terminated by sponsor|55|||
164289863|NCT00796666|593431920|FG000|Overall Study|Randomized and not treated|1|||
164289864|NCT00796666|593431921|FG001|Overall Study|Randomized and not treated|0|||
164289865|NCT00628030|593431923|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
164289866|NCT00628030|593431924|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
164289867|NCT00628030|593431923|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
164289868|NCT00628030|593431924|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
164289869|NCT00628030|593431923|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
164289870|NCT00628030|593431924|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
164289871|NCT01894607|593431931|FG000|Overall Study|Ineligible|1|||
164289872|NCT01787461|593431934|FG000|Overall Study|Adverse Event|4|||
164289873|NCT01787461|593431935|FG001|Overall Study|Adverse Event|3|||
164289874|NCT01787461|593431934|FG000|Overall Study|Lost to Follow-up|3|||
164289875|NCT01787461|593431935|FG001|Overall Study|Lost to Follow-up|2|||
164289876|NCT01787461|593431934|FG000|Overall Study|No longer met eligibility criteria|1|||
164289877|NCT01787461|593431935|FG001|Overall Study|No longer met eligibility criteria|0|||
164289878|NCT01787461|593431934|FG000|Overall Study|Withdrawal by Subject|3|||
164289879|NCT01787461|593431935|FG001|Overall Study|Withdrawal by Subject|4|||
164289880|NCT01787461|593431934|FG000|Overall Study|Protocol Violation|3|||
164289881|NCT01787461|593431935|FG001|Overall Study|Protocol Violation|0|||
164289882|NCT03259555|593431936|FG000|Overall Study|Adverse Event|6|||
164289883|NCT03259555|593431937|FG001|Overall Study|Adverse Event|4|||
164289884|NCT03259555|593431936|FG000|Overall Study|Lack of Efficacy|6|||
164289885|NCT03259555|593431937|FG001|Overall Study|Lack of Efficacy|4|||
164289886|NCT03259555|593431936|FG000|Overall Study|Lost to Follow-up|0|||
164289887|NCT03259555|593431937|FG001|Overall Study|Lost to Follow-up|2|||
164289888|NCT03259555|593431936|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164289889|NCT03259555|593431937|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164289890|NCT03259555|593431936|FG000|Overall Study|Progressive Disease|0|||
164289891|NCT03259555|593431937|FG001|Overall Study|Progressive Disease|2|||
164289892|NCT03259555|593431936|FG000|Overall Study|Withdrawal by Subject|19|||
164289893|NCT03259555|593431937|FG001|Overall Study|Withdrawal by Subject|16|||
164289894|NCT03259555|593431936|FG000|Overall Study|Physician Decision|1|||
164289895|NCT03259555|593431937|FG001|Overall Study|Physician Decision|2|||
164289896|NCT03259555|593431936|FG000|Overall Study|Other|1|||
164289897|NCT03259555|593431937|FG001|Overall Study|Other|0|||
164289898|NCT03957551|593431938|FG000|Overall Study|Adverse Event|2|||
164289899|NCT03957551|593431939|FG001|Overall Study|Adverse Event|2|||
164289900|NCT03957551|593431940|FG002|Overall Study|Adverse Event|6|||
164289901|NCT03957551|593431938|FG000|Overall Study|Physician Decision|1|||
164289902|NCT03957551|593431939|FG001|Overall Study|Physician Decision|0|||
164289903|NCT03957551|593431940|FG002|Overall Study|Physician Decision|2|||
164289904|NCT03957551|593431938|FG000|Overall Study|Withdrawal by Subject|1|||
164289905|NCT03957551|593431939|FG001|Overall Study|Withdrawal by Subject|0|||
164289906|NCT03957551|593431940|FG002|Overall Study|Withdrawal by Subject|2|||
164289907|NCT03957551|593431938|FG000|Overall Study|Disease progression|1|||
164289908|NCT03957551|593431939|FG001|Overall Study|Disease progression|0|||
164289909|NCT03957551|593431940|FG002|Overall Study|Disease progression|8|||
164289910|NCT02717494|593431943|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
164004412|NCT02034123|592380783|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004413|NCT02034123|592380784|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004414|NCT02034123|592380785|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004415|NCT02034123|592380786|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004416|NCT02034123|592380787|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004417|NCT02034123|592380788|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004418|NCT02034123|592380789|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004419|NCT02034123|592380790|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004420|NCT02034123|592380791|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004421|NCT02034123|592380792|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004422|NCT02034123|592380793|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004423|NCT02034123|592380794|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
164004424|NCT02034123|592380777|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004425|NCT02034123|592380778|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004426|NCT02034123|592380779|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004427|NCT02034123|592380780|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004428|NCT02034123|592380781|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004429|NCT02034123|592380782|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004430|NCT02034123|592380783|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164006736|NCT03519178|592391060|FG011|PF-06873600 Treatment|Progressive disease|3|||
164006737|NCT03519178|592391061|FG012|PF-06873600 Treatment|Progressive disease|4|||
164289911|NCT02717494|593431944|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
164289912|NCT02717494|593431945|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
164289913|NCT02717494|593431943|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
164289914|NCT02717494|593431944|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
164345361|NCT02820753|593640949|FG000|6 Month|Withdrawal by Subject|2|||
164289915|NCT02717494|593431945|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
164289916|NCT02717494|593431943|FG000|First Intervention (Step 1)|Death|0|||
164289917|NCT02717494|593431944|FG001|First Intervention (Step 1)|Death|0|||
164289918|NCT02717494|593431945|FG002|First Intervention (Step 1)|Death|1|||
164289919|NCT02717494|593431943|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
164289920|NCT02717494|593431944|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
164289921|NCT02717494|593431945|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
164289922|NCT01125800|593431947|FG000|Phase I|Protocol Violation|0|||
164289923|NCT01125800|593431948|FG001|Phase I|Protocol Violation|3|||
164289924|NCT01125800|593431949|FG002|Phase I|Protocol Violation|1|||
164289925|NCT01125800|593431950|FG003|Phase I|Protocol Violation|1|||
164289926|NCT01125800|593431951|FG004|Phase I|Protocol Violation|0|||
164289927|NCT01125800|593431947|FG000|Phase I|Adverse Event|2|||
164289928|NCT01125800|593431948|FG001|Phase I|Adverse Event|2|||
164289929|NCT01125800|593431949|FG002|Phase I|Adverse Event|1|||
164289930|NCT01125800|593431950|FG003|Phase I|Adverse Event|7|||
164289931|NCT01125800|593431951|FG004|Phase I|Adverse Event|0|||
164289932|NCT01125800|593431947|FG000|Phase I|Administrative problems|1|||
164289933|NCT01125800|593431948|FG001|Phase I|Administrative problems|0|||
164289934|NCT01125800|593431949|FG002|Phase I|Administrative problems|0|||
164289935|NCT01125800|593431950|FG003|Phase I|Administrative problems|0|||
164289936|NCT01125800|593431951|FG004|Phase I|Administrative problems|0|||
164289937|NCT01125800|593431947|FG000|Phase I|Withdrawal by Subject|0|||
164289938|NCT01125800|593431948|FG001|Phase I|Withdrawal by Subject|0|||
164289939|NCT01125800|593431949|FG002|Phase I|Withdrawal by Subject|1|||
164289940|NCT01125800|593431950|FG003|Phase I|Withdrawal by Subject|0|||
164289941|NCT01125800|593431951|FG004|Phase I|Withdrawal by Subject|0|||
164289942|NCT01125800|593431947|FG000|Phase I|Disease progression|5|||
164289943|NCT01125800|593431948|FG001|Phase I|Disease progression|4|||
164289944|NCT01125800|593431949|FG002|Phase I|Disease progression|1|||
164289945|NCT01125800|593431950|FG003|Phase I|Disease progression|3|||
164289946|NCT01125800|593431951|FG004|Phase I|Disease progression|0|||
164289947|NCT01125800|593431947|FG000|Phase II|Protocol Violation|0|||
164289948|NCT01125800|593431948|FG001|Phase II|Protocol Violation|0|||
164289949|NCT01125800|593431949|FG002|Phase II|Protocol Violation|0|||
164289950|NCT01125800|593431950|FG003|Phase II|Protocol Violation|0|||
164289951|NCT01125800|593431951|FG004|Phase II|Protocol Violation|1|||
164289952|NCT01125800|593431947|FG000|Phase II|Adverse Event|0|||
164289953|NCT01125800|593431948|FG001|Phase II|Adverse Event|0|||
164289954|NCT01125800|593431949|FG002|Phase II|Adverse Event|0|||
164289955|NCT01125800|593431950|FG003|Phase II|Adverse Event|0|||
164289956|NCT01125800|593431951|FG004|Phase II|Adverse Event|2|||
164289957|NCT01125800|593431947|FG000|Phase II|Disease progression|0|||
164289958|NCT01125800|593431948|FG001|Phase II|Disease progression|0|||
164289959|NCT01125800|593431949|FG002|Phase II|Disease progression|0|||
164289960|NCT01125800|593431950|FG003|Phase II|Disease progression|1|||
164289961|NCT01125800|593431951|FG004|Phase II|Disease progression|8|||
164289962|NCT01808196|593431954|FG000|Overall Study|Lost to Follow-up|1|||
164289963|NCT00479713|593431955|FG000|Overall Study|Adverse Event|8|||
164289964|NCT00479713|593431956|FG001|Overall Study|Adverse Event|6|||
164289965|NCT00479713|593431955|FG000|Overall Study|Death|1|||
164289966|NCT00479713|593431956|FG001|Overall Study|Death|0|||
164289967|NCT00479713|593431955|FG000|Overall Study|Lost to Follow-up|0|||
164289968|NCT00479713|593431956|FG001|Overall Study|Lost to Follow-up|1|||
164289969|NCT00479713|593431955|FG000|Overall Study|Protocol Violation|0|||
164289970|NCT00479713|593431956|FG001|Overall Study|Protocol Violation|1|||
164289971|NCT00479713|593431955|FG000|Overall Study|Withdrawal by Subject|4|||
164289972|NCT00479713|593431956|FG001|Overall Study|Withdrawal by Subject|1|||
164289973|NCT00141102|593431961|FG000|Overall Study|Adverse Event|233|||
164289974|NCT00141102|593431962|FG001|Overall Study|Adverse Event|305|||
164087978|NCT03495986|592687313|FG000|Overall Study|Physician Decision|1|||
164289975|NCT00141102|593431961|FG000|Overall Study|Laboratory Abnormality|9|||
164289976|NCT00141102|593431962|FG001|Overall Study|Laboratory Abnormality|33|||
164289977|NCT00141102|593431961|FG000|Overall Study|Lack of Efficacy|21|||
164289978|NCT00141102|593431962|FG001|Overall Study|Lack of Efficacy|26|||
164289979|NCT00141102|593431961|FG000|Overall Study|Lost to Follow-up|29|||
164289980|NCT00141102|593431962|FG001|Overall Study|Lost to Follow-up|32|||
164289981|NCT00141102|593431961|FG000|Overall Study|Other|87|||
164289982|NCT00141102|593431962|FG001|Overall Study|Other|76|||
164289983|NCT00141102|593431961|FG000|Overall Study|Withdrawal by Subject|112|||
164289984|NCT00141102|593431962|FG001|Overall Study|Withdrawal by Subject|142|||
164289985|NCT00141102|593431961|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
164289986|NCT00141102|593431962|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
164289987|NCT00141102|593431961|FG000|Overall Study|Death|2|||
164289988|NCT00141102|593431962|FG001|Overall Study|Death|2|||
164289989|NCT05477485|593431963|FG000|Overall Study|Lost to Follow-up|0|||
164289990|NCT05477485|593431964|FG001|Overall Study|Lost to Follow-up|4|||
164289991|NCT05274958|593431965|FG000|Overall Study|Only completed 1 set of PROMs|22|||
164289992|NCT05274958|593431966|FG001|Overall Study|Only completed 1 set of PROMs|35|||
164289993|NCT01505374|593431967|FG000|Overall Study|Lost to Follow-up|1|||
164289994|NCT01505374|593431968|FG001|Overall Study|Lost to Follow-up|0|||
164289995|NCT00176462|593431974|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
164289996|NCT00176462|593431975|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
164289997|NCT00176462|593431974|FG000|Induction (4 Weeks)|Death|1|||
164289998|NCT00176462|593431975|FG001|Induction (4 Weeks)|Death|2|||
164289999|NCT00176462|593431974|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
164290000|NCT00176462|593431975|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
164290001|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
164290002|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
164290003|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
164290004|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
164290005|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
164290006|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
164290007|NCT00176462|593431974|FG000|Consolidation (12 Weeks)|Not documented|0|||
164290008|NCT00176462|593431975|FG001|Consolidation (12 Weeks)|Not documented|1|||
164290009|NCT00176462|593431974|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
164290010|NCT00176462|593431975|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
164290011|NCT00176462|593431974|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
164290012|NCT00176462|593431975|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
164345362|NCT02820753|593640950|FG001|6 Month|Withdrawal by Subject|2|||
164345363|NCT02820753|593640949|FG000|6 Month|Lost to Follow-up|20|||
164345364|NCT02820753|593640950|FG001|6 Month|Lost to Follow-up|27|||
164345365|NCT02820753|593640949|FG000|6 Month|Stopped per NIH Hold|81|||
164345366|NCT02820753|593640950|FG001|6 Month|Stopped per NIH Hold|81|||
164345367|NCT02820753|593640949|FG000|6 Month|Death|0|||
164345368|NCT02820753|593640950|FG001|6 Month|Death|1|||
164345369|NCT01408485|593640951|FG000|Overall Study|Withdrawal by Subject|21|||
164345370|NCT01652703|593640952|FG000|Overall Study|Withdrawal by Subject|0|||
164345371|NCT01652703|593640953|FG001|Overall Study|Withdrawal by Subject|1|||
164004431|NCT02034123|592380784|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004432|NCT02034123|592380785|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
164004433|NCT02034123|592380786|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164345372|NCT01652703|593640954|FG002|Overall Study|Withdrawal by Subject|3|||
164345373|NCT01652703|593640955|FG003|Overall Study|Withdrawal by Subject|1|||
164345374|NCT01652703|593640956|FG004|Overall Study|Withdrawal by Subject|0|||
164345375|NCT01652703|593640957|FG005|Overall Study|Withdrawal by Subject|1|||
164345376|NCT01652703|593640952|FG000|Overall Study|Other|0|||
164345377|NCT01652703|593640953|FG001|Overall Study|Other|0|||
164345378|NCT01652703|593640954|FG002|Overall Study|Other|0|||
164345379|NCT01652703|593640955|FG003|Overall Study|Other|1|||
164345380|NCT01652703|593640956|FG004|Overall Study|Other|1|||
164345381|NCT01652703|593640957|FG005|Overall Study|Other|1|||
164345382|NCT02151591|593640958|FG000|Overall Study|Lost to Follow-up|6|||
164345383|NCT02151591|593640959|FG001|Overall Study|Lost to Follow-up|3|||
164345384|NCT02380677|593640960|FG000|Overall Study|Adverse Event|0|||
164345385|NCT02380677|593640961|FG001|Overall Study|Adverse Event|0|||
164345386|NCT02380677|593640962|FG002|Overall Study|Adverse Event|0|||
164345387|NCT02380677|593640963|FG003|Overall Study|Adverse Event|1|||
164345388|NCT02380677|593640964|FG004|Overall Study|Adverse Event|1|||
164345389|NCT02380677|593640965|FG005|Overall Study|Adverse Event|4|||
164345390|NCT02380677|593640966|FG006|Overall Study|Adverse Event|2|||
164345391|NCT02380677|593640967|FG007|Overall Study|Adverse Event|2|||
164345392|NCT02380677|593640968|FG008|Overall Study|Adverse Event|2|||
164004434|NCT02034123|592380787|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164087979|NCT03495986|592687314|FG001|Overall Study|Physician Decision|0|||
164290013|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
164290014|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
164345393|NCT02380677|593640969|FG009|Overall Study|Adverse Event|1|||
164345394|NCT02380677|593640970|FG010|Overall Study|Adverse Event|2|||
164345395|NCT02380677|593640971|FG011|Overall Study|Adverse Event|1|||
164345396|NCT02380677|593640960|FG000|Overall Study|Physician Decision|1|||
164345397|NCT02380677|593640961|FG001|Overall Study|Physician Decision|0|||
164345398|NCT02380677|593640962|FG002|Overall Study|Physician Decision|1|||
164345399|NCT02380677|593640963|FG003|Overall Study|Physician Decision|1|||
164345400|NCT02380677|593640964|FG004|Overall Study|Physician Decision|0|||
164345401|NCT02380677|593640965|FG005|Overall Study|Physician Decision|0|||
164345402|NCT02380677|593640966|FG006|Overall Study|Physician Decision|0|||
164345403|NCT02380677|593640967|FG007|Overall Study|Physician Decision|0|||
164345404|NCT02380677|593640968|FG008|Overall Study|Physician Decision|0|||
164345405|NCT02380677|593640969|FG009|Overall Study|Physician Decision|0|||
164345406|NCT02380677|593640970|FG010|Overall Study|Physician Decision|0|||
164345407|NCT02380677|593640971|FG011|Overall Study|Physician Decision|0|||
164345408|NCT02380677|593640960|FG000|Overall Study|Lack of Efficacy|0|||
164345409|NCT02380677|593640961|FG001|Overall Study|Lack of Efficacy|1|||
164290015|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
164290016|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
164290017|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
164290018|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
164290019|NCT02679287|593431978|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
164290020|NCT02679287|593431979|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
164290021|NCT02679287|593431978|FG000|Period 2|Work/Scheduling Conflict|1|||
164290022|NCT02679287|593431979|FG001|Period 2|Work/Scheduling Conflict|0|||
164290023|NCT02679287|593431978|FG000|Period 2|Disliked Mobile System|2|||
164290024|NCT02679287|593431979|FG001|Period 2|Disliked Mobile System|0|||
164290025|NCT02679287|593431978|FG000|Period 3|Work/Scheduling Conflict|0|||
164290026|NCT02679287|593431979|FG001|Period 3|Work/Scheduling Conflict|1|||
164290027|NCT00320515|593431982|FG000|Overall Study|Death|33|||
164290028|NCT00320515|593431982|FG000|Overall Study|Lost to Follow-up|6|||
164290029|NCT00320515|593431982|FG000|Overall Study|Physician Decision|2|||
164290030|NCT00320515|593431982|FG000|Overall Study|Withdrawal by Subject|8|||
164290031|NCT01114828|593431983|FG000|Overall Study|Adverse Event|1|||
164290032|NCT01114828|593431984|FG001|Overall Study|Adverse Event|1|||
164290033|NCT01114828|593431983|FG000|Overall Study|Lack of Efficacy|0|||
164290034|NCT01114828|593431984|FG001|Overall Study|Lack of Efficacy|2|||
164290035|NCT01114828|593431983|FG000|Overall Study|Protocol Violation|2|||
163897731|NCT00982644|591998698|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
163897732|NCT00982644|591998697|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
163897733|NCT00982644|591998698|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
164290036|NCT01114828|593431984|FG001|Overall Study|Protocol Violation|0|||
164290037|NCT01114828|593431983|FG000|Overall Study|Withdrawal by Subject|0|||
164290038|NCT01114828|593431984|FG001|Overall Study|Withdrawal by Subject|1|||
164290039|NCT00794950|593431985|FG000|BCG Induction|Withdrawal by Subject|2|||
164290040|NCT00794950|593431985|FG000|BCG Induction|ineligible|3|||
164290041|NCT00794950|593431985|FG000|BCG Induction|noncompliant w. BCG|1|||
164290042|NCT00794950|593431985|FG000|BCG Induction|Adverse Event|1|||
164290043|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
164290044|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
164290045|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
164290046|NCT00794950|593431985|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
164290047|NCT02485704|593431986|FG000|Overall Study|Lost to Follow-up|4|||
164290048|NCT02485704|593431987|FG001|Overall Study|Lost to Follow-up|5|||
164290049|NCT02485704|593431986|FG000|Overall Study|Withdrawal by Subject|0|||
164290050|NCT02485704|593431987|FG001|Overall Study|Withdrawal by Subject|3|||
164290051|NCT02485704|593431986|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
164290052|NCT02485704|593431987|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
164290053|NCT00851786|593431990|FG000|Overall Study|Withdrawal by Subject|0|||
164290054|NCT00851786|593431991|FG001|Overall Study|Withdrawal by Subject|1|||
164290055|NCT00851786|593431990|FG000|Overall Study|Protocol Violation|0|||
164290056|NCT00851786|593431991|FG001|Overall Study|Protocol Violation|1|||
164290057|NCT00851786|593431990|FG000|Overall Study|Lost to Follow-up|1|||
164290058|NCT00851786|593431991|FG001|Overall Study|Lost to Follow-up|0|||
164290059|NCT00851786|593431990|FG000|Overall Study|Incarceration|1|||
164290060|NCT00851786|593431991|FG001|Overall Study|Incarceration|0|||
164290061|NCT00851786|593431990|FG000|Overall Study|Site Closure|1|||
164290062|NCT00851786|593431991|FG001|Overall Study|Site Closure|0|||
164290063|NCT00851786|593431990|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
164290064|NCT00851786|593431991|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
164290065|NCT04617782|593433859|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
164087980|NCT03495986|592687313|FG000|Overall Study|Withdrawal by Subject|1|||
164087981|NCT03495986|592687314|FG001|Overall Study|Withdrawal by Subject|1|||
164290066|NCT04617782|593433859|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
164290067|NCT04617782|593433859|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
164290068|NCT04617782|593433859|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
164290069|NCT04617782|593433859|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
164290070|NCT04617782|593433859|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
164290071|NCT01405768|593433872|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
164290072|NCT01405768|593433873|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
164087982|NCT03495986|592687313|FG000|Overall Study|Withdrawal by Subject|1|||
164087983|NCT03495986|592687314|FG001|Overall Study|Withdrawal by Subject|0|||
164087984|NCT05476679|592687315|FG000|Overall Study|Withdrawal by Subject|0|||
164087985|NCT05476679|592687316|FG001|Overall Study|Withdrawal by Subject|0|||
164087986|NCT05476679|592687317|FG002|Overall Study|Withdrawal by Subject|0|||
164087987|NCT05476679|592687318|FG003|Overall Study|Withdrawal by Subject|1|||
164087988|NCT05476679|592687319|FG004|Overall Study|Withdrawal by Subject|0|||
164087989|NCT05476679|592687315|FG000|Overall Study|Lost to Follow-up|0|||
164087990|NCT05476679|592687316|FG001|Overall Study|Lost to Follow-up|0|||
164087991|NCT05476679|592687317|FG002|Overall Study|Lost to Follow-up|0|||
164290073|NCT04388111|593433876|FG000|Overall Study|Lost to Follow-up|5|||
164290074|NCT04388111|593433877|FG001|Overall Study|Lost to Follow-up|3|||
164290075|NCT04388111|593433876|FG000|Overall Study|Adverse Event|1|||
164290076|NCT04388111|593433877|FG001|Overall Study|Adverse Event|1|||
164290077|NCT04388111|593433876|FG000|Overall Study|Protocol Violation|2|||
164290078|NCT04388111|593433877|FG001|Overall Study|Protocol Violation|4|||
164290079|NCT04388111|593433876|FG000|Overall Study|Withdrawal by Subject|1|||
164290080|NCT04388111|593433877|FG001|Overall Study|Withdrawal by Subject|0|||
164290081|NCT03360682|593433893|FG000|Overall Study|Adverse Event|3|||
164290082|NCT02420093|593433894|FG000|Overall Study|Withdrawal by Subject|1|||
164290083|NCT02420093|593433895|FG001|Overall Study|Withdrawal by Subject|1|||
164290084|NCT03244917|593433897|FG000|Overall Study|Lost to Follow-up|2|||
164290085|NCT03244917|593433898|FG001|Overall Study|Lost to Follow-up|2|||
164290086|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290087|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290088|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290089|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290090|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290091|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290092|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290093|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290094|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290095|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290096|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290097|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290098|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
164290099|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290100|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
164290101|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290102|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164290103|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290104|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290105|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
164290106|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164290107|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
164290108|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
164290109|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290110|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164290111|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290112|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290113|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
164345410|NCT02380677|593640962|FG002|Overall Study|Lack of Efficacy|2|||
164345411|NCT02380677|593640963|FG003|Overall Study|Lack of Efficacy|0|||
164345412|NCT02380677|593640964|FG004|Overall Study|Lack of Efficacy|4|||
164345413|NCT02380677|593640965|FG005|Overall Study|Lack of Efficacy|1|||
164345414|NCT02380677|593640966|FG006|Overall Study|Lack of Efficacy|1|||
164345415|NCT02380677|593640967|FG007|Overall Study|Lack of Efficacy|2|||
164345416|NCT02380677|593640968|FG008|Overall Study|Lack of Efficacy|2|||
164345417|NCT02380677|593640969|FG009|Overall Study|Lack of Efficacy|0|||
164345418|NCT02380677|593640970|FG010|Overall Study|Lack of Efficacy|2|||
164345419|NCT02380677|593640971|FG011|Overall Study|Lack of Efficacy|1|||
164345420|NCT02380677|593640960|FG000|Overall Study|Withdrawal by Subject|0|||
164345421|NCT02380677|593640961|FG001|Overall Study|Withdrawal by Subject|0|||
164345422|NCT02380677|593640962|FG002|Overall Study|Withdrawal by Subject|0|||
164345423|NCT02380677|593640963|FG003|Overall Study|Withdrawal by Subject|0|||
164345424|NCT02380677|593640964|FG004|Overall Study|Withdrawal by Subject|0|||
164345425|NCT02380677|593640965|FG005|Overall Study|Withdrawal by Subject|0|||
164345426|NCT02380677|593640966|FG006|Overall Study|Withdrawal by Subject|0|||
164345427|NCT02380677|593640967|FG007|Overall Study|Withdrawal by Subject|0|||
164345428|NCT02380677|593640968|FG008|Overall Study|Withdrawal by Subject|0|||
164345429|NCT02380677|593640969|FG009|Overall Study|Withdrawal by Subject|1|||
164345430|NCT02380677|593640970|FG010|Overall Study|Withdrawal by Subject|0|||
164290114|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
164290115|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
164290116|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
164290117|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
164290118|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
164290119|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
164290120|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
164345431|NCT02380677|593640971|FG011|Overall Study|Withdrawal by Subject|3|||
164345432|NCT02380677|593640960|FG000|Overall Study|Other|0|||
164290121|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
164290122|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
164290123|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
164290124|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
164290125|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
164290126|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
164290127|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
164290128|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
164290129|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
164290130|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
164290131|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
164290132|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290133|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290134|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
164290135|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290136|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290137|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290138|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290139|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290140|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290141|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
164290142|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290143|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290144|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290145|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
164290146|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290147|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290148|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290149|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290150|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290151|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290152|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290153|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290154|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290155|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290156|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290157|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290158|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290159|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
164290160|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
164290161|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290162|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290163|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290164|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
164290165|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290166|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290167|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290168|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290169|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290170|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290171|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
164290172|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290173|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290174|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290175|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
164290176|NCT01147666|593433899|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290177|NCT01147666|593433900|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290178|NCT01147666|593433901|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290179|NCT01147666|593433902|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290180|NCT01147666|593433903|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290181|NCT01147666|593433904|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290182|NCT01147666|593433905|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290183|NCT01147666|593433906|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290184|NCT01147666|593433907|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290185|NCT01147666|593433908|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290186|NCT01147666|593433909|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290187|NCT01147666|593433910|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
164290188|NCT01147666|593433911|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
164345433|NCT02380677|593640961|FG001|Overall Study|Other|0|||
164087992|NCT05476679|592687318|FG003|Overall Study|Lost to Follow-up|1|||
164087993|NCT05476679|592687319|FG004|Overall Study|Lost to Follow-up|0|||
164087994|NCT01214330|592687320|FG000|Overall Study|Withdrawal by Subject|2|||
164087995|NCT01214330|592687320|FG000|Overall Study|Withdrawal by Subject|2|||
164087996|NCT00467584|592687321|FG000|Overall Study|Withdrawal by Subject|4|||
164087997|NCT00467584|592687322|FG001|Overall Study|Withdrawal by Subject|5|||
164087998|NCT00467584|592687323|FG002|Overall Study|Withdrawal by Subject|1|||
164087999|NCT00926289|592687324|FG000|Overall Study|Adverse Event|9|||
164088000|NCT00926289|592687325|FG001|Overall Study|Adverse Event|11|||
164088001|NCT00926289|592687324|FG000|Overall Study|Protocol Violation|8|||
164088002|NCT00926289|592687325|FG001|Overall Study|Protocol Violation|12|||
164088003|NCT00926289|592687324|FG000|Overall Study|Lost to Follow-up|3|||
164088004|NCT00926289|592687325|FG001|Overall Study|Lost to Follow-up|6|||
164088005|NCT00926289|592687324|FG000|Overall Study|Withdrawal by Subject|4|||
164088006|NCT00926289|592687325|FG001|Overall Study|Withdrawal by Subject|4|||
164088007|NCT00926289|592687324|FG000|Overall Study|Other|1|||
164088008|NCT00926289|592687325|FG001|Overall Study|Other|3|||
164088009|NCT04104646|592687326|FG000|Overall Study|Withdrawal by Subject|1|||
164088010|NCT04104646|592687327|FG001|Overall Study|Withdrawal by Subject|1|||
164088011|NCT04104646|592687326|FG000|Overall Study|Lost to Follow-up|1|||
164088012|NCT04104646|592687327|FG001|Overall Study|Lost to Follow-up|0|||
164088013|NCT04104646|592687326|FG000|Overall Study|Physician Decision|2|||
164088014|NCT04104646|592687327|FG001|Overall Study|Physician Decision|0|||
164088015|NCT01498484|592687328|FG000|Overall Study|Death|6|||
164088016|NCT01498484|592687329|FG001|Overall Study|Death|3|||
164088017|NCT01498484|592687330|FG002|Overall Study|Death|1|||
164088018|NCT01498484|592687331|FG003|Overall Study|Death|1|||
164088019|NCT01498484|592687332|FG004|Overall Study|Death|0|||
164088020|NCT01498484|592687333|FG005|Overall Study|Death|0|||
164088021|NCT01498484|592687334|FG006|Overall Study|Death|10|||
164088022|NCT01498484|592687335|FG007|Overall Study|Death|1|||
164088023|NCT01498484|592687336|FG008|Overall Study|Death|0|||
164088024|NCT01498484|592687328|FG000|Overall Study|Physician Decision|3|||
164088025|NCT01498484|592687329|FG001|Overall Study|Physician Decision|2|||
164088026|NCT01498484|592687330|FG002|Overall Study|Physician Decision|1|||
164088027|NCT01498484|592687331|FG003|Overall Study|Physician Decision|1|||
164088028|NCT01498484|592687332|FG004|Overall Study|Physician Decision|0|||
164088029|NCT01498484|592687333|FG005|Overall Study|Physician Decision|0|||
164088030|NCT01498484|592687334|FG006|Overall Study|Physician Decision|8|||
164088031|NCT01498484|592687335|FG007|Overall Study|Physician Decision|13|||
164088032|NCT01498484|592687336|FG008|Overall Study|Physician Decision|1|||
164088033|NCT01498484|592687328|FG000|Overall Study|Adverse Event|0|||
164088034|NCT01498484|592687329|FG001|Overall Study|Adverse Event|0|||
164088035|NCT01498484|592687330|FG002|Overall Study|Adverse Event|0|||
164088036|NCT01498484|592687331|FG003|Overall Study|Adverse Event|0|||
164088037|NCT01498484|592687332|FG004|Overall Study|Adverse Event|0|||
164088038|NCT01498484|592687333|FG005|Overall Study|Adverse Event|1|||
164088039|NCT01498484|592687334|FG006|Overall Study|Adverse Event|0|||
164088040|NCT01498484|592687335|FG007|Overall Study|Adverse Event|0|||
164088041|NCT01498484|592687336|FG008|Overall Study|Adverse Event|0|||
164088042|NCT01498484|592687328|FG000|Overall Study|Withdrawal by Subject|0|||
164088043|NCT01498484|592687329|FG001|Overall Study|Withdrawal by Subject|0|||
164290189|NCT01147666|593433912|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
164290190|NCT01147666|593433913|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
164290191|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
164290192|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
164290193|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
164290194|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
164290195|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
164290196|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
164290197|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
164290198|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
164290199|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
164088044|NCT01498484|592687330|FG002|Overall Study|Withdrawal by Subject|0|||
164088045|NCT01498484|592687331|FG003|Overall Study|Withdrawal by Subject|1|||
164088046|NCT01498484|592687332|FG004|Overall Study|Withdrawal by Subject|0|||
164088047|NCT01498484|592687333|FG005|Overall Study|Withdrawal by Subject|0|||
164088048|NCT01498484|592687334|FG006|Overall Study|Withdrawal by Subject|1|||
164088049|NCT01498484|592687335|FG007|Overall Study|Withdrawal by Subject|0|||
164088050|NCT01498484|592687336|FG008|Overall Study|Withdrawal by Subject|0|||
164088051|NCT01498484|592687328|FG000|Overall Study|Other|5|||
164088052|NCT01498484|592687329|FG001|Overall Study|Other|2|||
164088053|NCT01498484|592687330|FG002|Overall Study|Other|0|||
164088054|NCT01498484|592687331|FG003|Overall Study|Other|0|||
164088055|NCT01498484|592687332|FG004|Overall Study|Other|1|||
164088056|NCT01498484|592687333|FG005|Overall Study|Other|0|||
164088057|NCT01498484|592687334|FG006|Overall Study|Other|3|||
164088058|NCT01498484|592687335|FG007|Overall Study|Other|0|||
164088059|NCT01498484|592687336|FG008|Overall Study|Other|1|||
164290200|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
164345434|NCT02380677|593640962|FG002|Overall Study|Other|0|||
164345435|NCT02380677|593640963|FG003|Overall Study|Other|1|||
164345436|NCT02380677|593640964|FG004|Overall Study|Other|1|||
164345437|NCT02380677|593640965|FG005|Overall Study|Other|1|||
164345438|NCT02380677|593640966|FG006|Overall Study|Other|0|||
164345439|NCT02380677|593640967|FG007|Overall Study|Other|0|||
164345440|NCT02380677|593640968|FG008|Overall Study|Other|0|||
164345441|NCT02380677|593640969|FG009|Overall Study|Other|0|||
164345442|NCT02380677|593640970|FG010|Overall Study|Other|0|||
164345443|NCT02380677|593640971|FG011|Overall Study|Other|0|||
164345444|NCT01342796|593640972|FG000|Overall Study|Withdrawal by Subject|2|||
164345445|NCT01342796|593640973|FG001|Overall Study|Withdrawal by Subject|0|||
164345446|NCT01342796|593640972|FG000|Overall Study|Lost to Follow-up|0|||
164345447|NCT01342796|593640973|FG001|Overall Study|Lost to Follow-up|3|||
164345448|NCT01342796|593640972|FG000|Overall Study|Inappropriate enrollment|1|||
164345449|NCT01342796|593640973|FG001|Overall Study|Inappropriate enrollment|0|||
164345450|NCT01751867|593640974|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
164345451|NCT01751867|593640975|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
164345452|NCT01751867|593640974|FG000|Overall Study|Diease Progression|4|||
164345453|NCT01751867|593640975|FG001|Overall Study|Diease Progression|18|||
164345454|NCT01751867|593640974|FG000|Overall Study|Adverse Event|8|||
164345455|NCT01751867|593640975|FG001|Overall Study|Adverse Event|15|||
164345456|NCT01751867|593640974|FG000|Overall Study|Poor Compliance|0|||
164345457|NCT01751867|593640975|FG001|Overall Study|Poor Compliance|5|||
164345458|NCT01751867|593640974|FG000|Overall Study|Withdrawal by Subject|3|||
164345459|NCT01751867|593640975|FG001|Overall Study|Withdrawal by Subject|1|||
164345460|NCT01751867|593640974|FG000|Overall Study|Physician Decision|4|||
164345461|NCT01751867|593640975|FG001|Overall Study|Physician Decision|7|||
164345462|NCT01751867|593640974|FG000|Overall Study|Protocol Violation|0|||
164345463|NCT01751867|593640975|FG001|Overall Study|Protocol Violation|2|||
164345464|NCT01751867|593640974|FG000|Overall Study|Death|0|||
164345465|NCT01751867|593640975|FG001|Overall Study|Death|5|||
164345466|NCT01751867|593640974|FG000|Overall Study|Other|11|||
164345467|NCT01751867|593640975|FG001|Overall Study|Other|37|||
164345468|NCT01751867|593640974|FG000|Overall Study|Randomized but not treated.|2|||
164345469|NCT01751867|593640975|FG001|Overall Study|Randomized but not treated.|1|||
164345470|NCT01396148|593640976|FG000|Overall Study|Patient Decision|1|||
164290201|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
163897754|NCT02989662|591998709|FG000|Overall Study|Lost to Follow-up|0|||
164290202|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
164290203|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
164290204|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
164290205|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
164290206|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290207|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290208|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290209|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290210|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
164290211|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
164290212|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
164290213|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
164290214|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290215|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
164290216|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290217|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290218|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
164290219|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
164290220|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
164290221|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290222|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290223|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290224|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
164290225|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290226|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164345471|NCT00224042|593640985|FG000|Overall Study|Adverse Event|2|||
164345472|NCT00224042|593640986|FG001|Overall Study|Adverse Event|1|||
164345473|NCT00224042|593640985|FG000|Overall Study|Protocol Violation|0|||
164345474|NCT00224042|593640986|FG001|Overall Study|Protocol Violation|1|||
164345475|NCT00224042|593640985|FG000|Overall Study|Physician Decision|0|||
164345476|NCT00224042|593640986|FG001|Overall Study|Physician Decision|1|||
164345477|NCT00224042|593640985|FG000|Overall Study|Did not meet lab incusion criteria|2|||
164345478|NCT00224042|593640986|FG001|Overall Study|Did not meet lab incusion criteria|3|||
164345479|NCT00224042|593640985|FG000|Overall Study|Other|2|||
164345480|NCT00224042|593640986|FG001|Overall Study|Other|0|||
164345481|NCT00840450|593640987|FG000|Overall Study|Adverse Event|1|||
163897755|NCT02989662|591998710|FG001|Overall Study|Lost to Follow-up|0|||
164088060|NCT01199601|592687337|FG000|Overall Study|Lost to Follow-up|47|||
164290227|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290228|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290229|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290230|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290231|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290232|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290233|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290234|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290235|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
164290236|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290237|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290238|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290239|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290240|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290241|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290242|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290243|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290244|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290245|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290246|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290247|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290248|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290249|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
164290250|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
164290251|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290252|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290253|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164345482|NCT00840450|593640987|FG000|Overall Study|Lack of Efficacy|2|||
164345483|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
164345484|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
164345485|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345486|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345487|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345488|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345489|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345490|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
164345491|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
164345492|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
164345493|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345494|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345495|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345496|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345497|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345498|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
164345499|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
163897756|NCT02989662|591998711|FG002|Overall Study|Lost to Follow-up|0|||
163897757|NCT02989662|591998712|FG003|Overall Study|Lost to Follow-up|2|||
163897758|NCT02989662|591998709|FG000|Overall Study|Physician Decision|3|||
163897759|NCT02989662|591998710|FG001|Overall Study|Physician Decision|0|||
163897760|NCT02989662|591998711|FG002|Overall Study|Physician Decision|0|||
163897761|NCT02989662|591998712|FG003|Overall Study|Physician Decision|0|||
163897762|NCT02989662|591998709|FG000|Overall Study|Withdrawal by Subject|1|||
163897763|NCT02989662|591998710|FG001|Overall Study|Withdrawal by Subject|0|||
163897764|NCT02989662|591998711|FG002|Overall Study|Withdrawal by Subject|0|||
163897765|NCT02989662|591998712|FG003|Overall Study|Withdrawal by Subject|0|||
163897766|NCT06393127|591998713|FG000|Washout period|Withdrawal by Subject|1|||
163897767|NCT06393127|591998714|FG001|Washout period|Withdrawal by Subject|0|||
163897768|NCT06393127|591998713|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
163897769|NCT06393127|591998714|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
163897770|NCT02446600|591998715|FG000|Overall Study|Never treated|20|||
163897771|NCT02446600|591998716|FG001|Overall Study|Never treated|2|||
163897772|NCT02446600|591998717|FG002|Overall Study|Never treated|6|||
163897773|NCT02446600|591998718|FG003|Overall Study|Never treated|0|||
163897774|NCT02446600|591998715|FG000|Overall Study|Withdrawal by Subject|19|||
163897775|NCT02446600|591998716|FG001|Overall Study|Withdrawal by Subject|5|||
163897776|NCT02446600|591998717|FG002|Overall Study|Withdrawal by Subject|17|||
164088061|NCT01199601|592687338|FG001|Overall Study|Lost to Follow-up|66|||
164290254|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
164290255|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290256|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290257|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290258|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290259|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290260|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290261|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
164290262|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290263|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290264|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290265|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
164290266|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290267|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290268|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290269|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290270|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290271|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290272|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290273|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290274|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290275|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290276|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290277|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290278|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
164290279|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290280|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
164290281|NCT01147666|593433899|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290282|NCT01147666|593433900|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290283|NCT01147666|593433901|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290284|NCT01147666|593433902|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290285|NCT01147666|593433903|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290286|NCT01147666|593433904|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290287|NCT01147666|593433905|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290288|NCT01147666|593433906|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290289|NCT01147666|593433907|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290290|NCT01147666|593433908|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290291|NCT01147666|593433909|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290292|NCT01147666|593433910|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290293|NCT01147666|593433911|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
164290294|NCT01147666|593433912|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
164290295|NCT01147666|593433913|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
164290296|NCT02748863|593433914|FG000|Treatment Period 1|Adverse Event|0|||
164290297|NCT02748863|593433915|FG001|Treatment Period 1|Adverse Event|1|||
164290298|NCT02748863|593433916|FG002|Treatment Period 1|Adverse Event|0|||
164290299|NCT02748863|593433917|FG003|Treatment Period 1|Adverse Event|0|||
164290300|NCT02748863|593433918|FG004|Treatment Period 1|Adverse Event|0|||
164290301|NCT02748863|593433914|FG000|Treatment Period 1|Lack of Efficacy|0|||
164290302|NCT02748863|593433915|FG001|Treatment Period 1|Lack of Efficacy|0|||
164290303|NCT02748863|593433916|FG002|Treatment Period 1|Lack of Efficacy|1|||
164290304|NCT02748863|593433917|FG003|Treatment Period 1|Lack of Efficacy|0|||
164290305|NCT02748863|593433918|FG004|Treatment Period 1|Lack of Efficacy|0|||
164290306|NCT02748863|593433914|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164290307|NCT02748863|593433915|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164290308|NCT02748863|593433916|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164290309|NCT02748863|593433917|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164290310|NCT02748863|593433918|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164290311|NCT02748863|593433914|FG000|Treatment Period 2|Lost to Follow-up|2|||
164290312|NCT02748863|593433915|FG001|Treatment Period 2|Lost to Follow-up|0|||
164290313|NCT02748863|593433916|FG002|Treatment Period 2|Lost to Follow-up|0|||
164290314|NCT02748863|593433917|FG003|Treatment Period 2|Lost to Follow-up|0|||
164290315|NCT02748863|593433918|FG004|Treatment Period 2|Lost to Follow-up|0|||
164290316|NCT02748863|593433914|FG000|Treatment Period 2|Adverse Event|3|||
164290317|NCT02748863|593433915|FG001|Treatment Period 2|Adverse Event|2|||
164290318|NCT02748863|593433916|FG002|Treatment Period 2|Adverse Event|0|||
164290319|NCT02748863|593433917|FG003|Treatment Period 2|Adverse Event|2|||
164290320|NCT02748863|593433918|FG004|Treatment Period 2|Adverse Event|0|||
164290321|NCT02748863|593433914|FG000|Treatment Period 2|Lack of Efficacy|0|||
164290322|NCT02748863|593433915|FG001|Treatment Period 2|Lack of Efficacy|1|||
164290323|NCT02748863|593433916|FG002|Treatment Period 2|Lack of Efficacy|0|||
164290324|NCT02748863|593433917|FG003|Treatment Period 2|Lack of Efficacy|0|||
164290325|NCT02748863|593433918|FG004|Treatment Period 2|Lack of Efficacy|0|||
164290326|NCT02748863|593433914|FG000|Treatment Period 2|Pregnancy|0|||
164290327|NCT02748863|593433915|FG001|Treatment Period 2|Pregnancy|0|||
164290328|NCT02748863|593433916|FG002|Treatment Period 2|Pregnancy|0|||
164290329|NCT02748863|593433917|FG003|Treatment Period 2|Pregnancy|0|||
164290330|NCT02748863|593433918|FG004|Treatment Period 2|Pregnancy|1|||
164290331|NCT01135134|593433919|FG000|Overall Study|Adverse Event|1|||
164290332|NCT01135134|593433920|FG001|Overall Study|Adverse Event|1|||
164290333|NCT01135134|593433919|FG000|Overall Study|Did not meet protocol eligibility|1|||
164290334|NCT01135134|593433920|FG001|Overall Study|Did not meet protocol eligibility|0|||
164290335|NCT02576639|593433921|FG000|Overall Study|Withdrawal by Subject|1|||
164290336|NCT02576639|593433922|FG001|Overall Study|Withdrawal by Subject|2|||
164290337|NCT02576639|593433923|FG002|Overall Study|Withdrawal by Subject|1|||
164290338|NCT02576639|593433924|FG003|Overall Study|Withdrawal by Subject|0|||
164290339|NCT02576639|593433925|FG004|Overall Study|Withdrawal by Subject|1|||
164290340|NCT02576639|593433921|FG000|Overall Study|Adverse Event|1|||
164290341|NCT02576639|593433922|FG001|Overall Study|Adverse Event|0|||
164290342|NCT02576639|593433923|FG002|Overall Study|Adverse Event|1|||
164290343|NCT02576639|593433924|FG003|Overall Study|Adverse Event|1|||
164290344|NCT02576639|593433925|FG004|Overall Study|Adverse Event|2|||
164290345|NCT02576639|593433921|FG000|Overall Study|Physician Decision|0|||
164290346|NCT02576639|593433922|FG001|Overall Study|Physician Decision|0|||
164290347|NCT02576639|593433923|FG002|Overall Study|Physician Decision|0|||
164290348|NCT02576639|593433924|FG003|Overall Study|Physician Decision|0|||
164290349|NCT02576639|593433925|FG004|Overall Study|Physician Decision|1|||
164290350|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
164290351|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
164290352|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
164290353|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
164290354|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
164290355|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
164290356|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
164290357|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
164290358|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
164290359|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
164290360|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
164290361|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
164345500|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
164345501|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345502|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345503|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345504|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345505|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345506|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
164345507|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345508|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
164345509|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345510|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345511|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345512|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345513|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345514|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
164345515|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
164345516|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
164345517|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345518|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345519|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345520|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345521|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345522|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
164345523|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
164290362|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
164290363|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
164290364|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
164004435|NCT02034123|592380788|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164290365|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290366|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
164290367|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290368|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290369|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
164290370|NCT01329978|593433938|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290371|NCT01329978|593433939|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
164290372|NCT01329978|593433940|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290373|NCT01329978|593433941|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290374|NCT01329978|593433942|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
164290375|NCT01329978|593433938|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
164290376|NCT01329978|593433939|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
164290377|NCT01329978|593433940|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
164290378|NCT01329978|593433941|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
164290379|NCT01329978|593433942|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
164290380|NCT01329978|593433938|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290381|NCT01329978|593433939|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290382|NCT01329978|593433940|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290383|NCT01329978|593433941|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
164290384|NCT01329978|593433942|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
164290385|NCT01188772|593433944|FG000|Overall Study|Randomized but Not Treated|0|||
164290386|NCT01188772|593433945|FG001|Overall Study|Randomized but Not Treated|1|||
164290387|NCT01188772|593433946|FG002|Overall Study|Randomized but Not Treated|0|||
164290388|NCT01188772|593433947|FG003|Overall Study|Randomized but Not Treated|0|||
164290389|NCT01188772|593433944|FG000|Overall Study|Adverse Event|0|||
164290390|NCT01188772|593433945|FG001|Overall Study|Adverse Event|1|||
164290391|NCT01188772|593433946|FG002|Overall Study|Adverse Event|2|||
164290392|NCT01188772|593433947|FG003|Overall Study|Adverse Event|0|||
164290393|NCT01188772|593433944|FG000|Overall Study|Lost to Follow-up|4|||
164290394|NCT01188772|593433945|FG001|Overall Study|Lost to Follow-up|1|||
164290395|NCT01188772|593433946|FG002|Overall Study|Lost to Follow-up|1|||
164290396|NCT01188772|593433947|FG003|Overall Study|Lost to Follow-up|1|||
164290397|NCT01188772|593433944|FG000|Overall Study|Non-responder|0|||
164290398|NCT01188772|593433945|FG001|Overall Study|Non-responder|0|||
164290399|NCT01188772|593433946|FG002|Overall Study|Non-responder|3|||
164290400|NCT01188772|593433947|FG003|Overall Study|Non-responder|0|||
164290401|NCT01188772|593433944|FG000|Overall Study|Physician Decision|0|||
164290402|NCT01188772|593433945|FG001|Overall Study|Physician Decision|0|||
164290403|NCT01188772|593433946|FG002|Overall Study|Physician Decision|1|||
164290404|NCT01188772|593433947|FG003|Overall Study|Physician Decision|0|||
164290405|NCT01188772|593433944|FG000|Overall Study|Terminated by Sponsor|0|||
164290406|NCT01188772|593433945|FG001|Overall Study|Terminated by Sponsor|0|||
164290407|NCT01188772|593433946|FG002|Overall Study|Terminated by Sponsor|1|||
164290408|NCT01188772|593433947|FG003|Overall Study|Terminated by Sponsor|0|||
164290409|NCT01188772|593433944|FG000|Overall Study|Treatment Failure|0|||
164290410|NCT01188772|593433945|FG001|Overall Study|Treatment Failure|0|||
164290411|NCT01188772|593433946|FG002|Overall Study|Treatment Failure|1|||
164290412|NCT01188772|593433947|FG003|Overall Study|Treatment Failure|0|||
164290413|NCT01188772|593433944|FG000|Overall Study|Virologic Failure|1|||
164290414|NCT01188772|593433945|FG001|Overall Study|Virologic Failure|0|||
164290415|NCT01188772|593433946|FG002|Overall Study|Virologic Failure|0|||
164290416|NCT01188772|593433947|FG003|Overall Study|Virologic Failure|0|||
164290417|NCT01188772|593433944|FG000|Overall Study|Withdrawal by Subject|0|||
164290418|NCT01188772|593433945|FG001|Overall Study|Withdrawal by Subject|0|||
164290419|NCT01188772|593433946|FG002|Overall Study|Withdrawal by Subject|2|||
164290420|NCT01188772|593433947|FG003|Overall Study|Withdrawal by Subject|0|||
164290421|NCT03081884|593433951|FG000|Overall Study|deferred prostate cancer treatment|1|||
164290422|NCT03081884|593433951|FG000|Overall Study|metastasis managed with systemic therapy|3|||
164290423|NCT02294058|593433952|FG000|Overall Study|Adverse Event|16|||
164290424|NCT02294058|593433953|FG001|Overall Study|Adverse Event|7|||
164290425|NCT02294058|593433954|FG002|Overall Study|Adverse Event|13|||
164290426|NCT02294058|593433952|FG000|Overall Study|Lack of Efficacy|3|||
164290427|NCT02294058|593433953|FG001|Overall Study|Lack of Efficacy|3|||
164290428|NCT02294058|593433954|FG002|Overall Study|Lack of Efficacy|0|||
164290429|NCT02294058|593433952|FG000|Overall Study|Lost to Follow-up|1|||
164290430|NCT02294058|593433953|FG001|Overall Study|Lost to Follow-up|0|||
164290431|NCT02294058|593433954|FG002|Overall Study|Lost to Follow-up|2|||
164290432|NCT02294058|593433952|FG000|Overall Study|Withdrawal by Subject|10|||
164004436|NCT02034123|592380789|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164345524|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345525|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164004437|NCT02034123|592380790|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164290433|NCT02294058|593433953|FG001|Overall Study|Withdrawal by Subject|14|||
164345526|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164290434|NCT02294058|593433954|FG002|Overall Study|Withdrawal by Subject|13|||
164290435|NCT02294058|593433952|FG000|Overall Study|Physician Decision|2|||
164290436|NCT02294058|593433953|FG001|Overall Study|Physician Decision|1|||
164290437|NCT02294058|593433954|FG002|Overall Study|Physician Decision|0|||
164290438|NCT02294058|593433952|FG000|Overall Study|Miscellaneous|4|||
164290439|NCT02294058|593433953|FG001|Overall Study|Miscellaneous|1|||
164290440|NCT02294058|593433954|FG002|Overall Study|Miscellaneous|1|||
164290441|NCT00510835|593433959|FG000|Overall Study|Withdrawal by Subject|6|||
164290442|NCT00510835|593433960|FG001|Overall Study|Withdrawal by Subject|2|||
164290443|NCT00510835|593433961|FG002|Overall Study|Withdrawal by Subject|2|||
164290444|NCT05470985|593433962|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
164290445|NCT05470985|593433963|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
164290446|NCT05470985|593433962|FG000|Double Blind Treatment Period|Physician Decision|0|||
164290447|NCT05470985|593433963|FG001|Double Blind Treatment Period|Physician Decision|1|||
164290448|NCT05470985|593433962|FG000|Long Term Extension|Adverse Event|0|||
164290449|NCT05470985|593433963|FG001|Long Term Extension|Adverse Event|1|||
164290450|NCT05470985|593433962|FG000|Long Term Extension|Study terminated by sponsor|2|||
164290451|NCT05470985|593433963|FG001|Long Term Extension|Study terminated by sponsor|0|||
164290452|NCT01917747|593433964|FG000|Overall Study|Withdrawal by Subject|1|||
164290453|NCT01917747|593433965|FG001|Overall Study|Withdrawal by Subject|2|||
164290454|NCT01917747|593433964|FG000|Overall Study|Lost to Follow-up|18|||
164290455|NCT01917747|593433965|FG001|Overall Study|Lost to Follow-up|9|||
164290456|NCT02741245|593433975|FG000|Overall Study|Adverse Event|0|||
164290457|NCT02741245|593433976|FG001|Overall Study|Adverse Event|0|||
164290458|NCT02741245|593433977|FG002|Overall Study|Adverse Event|0|||
164290459|NCT02741245|593433978|FG003|Overall Study|Adverse Event|2|||
164290460|NCT02741245|593433979|FG004|Overall Study|Adverse Event|2|||
164290461|NCT02741245|593433975|FG000|Overall Study|Protocol Violation|0|||
164290462|NCT02741245|593433976|FG001|Overall Study|Protocol Violation|1|||
164290463|NCT02741245|593433977|FG002|Overall Study|Protocol Violation|0|||
164290464|NCT02741245|593433978|FG003|Overall Study|Protocol Violation|1|||
164290465|NCT02741245|593433979|FG004|Overall Study|Protocol Violation|0|||
164290466|NCT02741245|593433975|FG000|Overall Study|Withdrawal by Subject|0|||
164290467|NCT02741245|593433976|FG001|Overall Study|Withdrawal by Subject|0|||
164290468|NCT02741245|593433977|FG002|Overall Study|Withdrawal by Subject|0|||
164290469|NCT02741245|593433978|FG003|Overall Study|Withdrawal by Subject|1|||
164290470|NCT02741245|593433979|FG004|Overall Study|Withdrawal by Subject|0|||
164290471|NCT00152503|593433987|FG000|Overall Study|Adverse Event|4|||
164290472|NCT00607087|593433988|FG000|Overall Study|Withdrawal by Subject|9|||
164290473|NCT00607087|593433989|FG001|Overall Study|Withdrawal by Subject|4|||
164290474|NCT00607087|593433990|FG002|Overall Study|Withdrawal by Subject|4|||
164290475|NCT00607087|593433988|FG000|Overall Study|Adverse Event|3|||
164290476|NCT00607087|593433989|FG001|Overall Study|Adverse Event|2|||
164290477|NCT00607087|593433990|FG002|Overall Study|Adverse Event|3|||
164290478|NCT00607087|593433988|FG000|Overall Study|Other reason|1|||
164290479|NCT00607087|593433989|FG001|Overall Study|Other reason|5|||
164290480|NCT00607087|593433990|FG002|Overall Study|Other reason|2|||
164290481|NCT00607087|593433988|FG000|Overall Study|Poor compliance to protocol|1|||
164290482|NCT00607087|593433989|FG001|Overall Study|Poor compliance to protocol|0|||
164290483|NCT00607087|593433990|FG002|Overall Study|Poor compliance to protocol|1|||
164290484|NCT00607087|593433988|FG000|Overall Study|Lost to Follow-up|1|||
164290485|NCT00607087|593433989|FG001|Overall Study|Lost to Follow-up|0|||
164290486|NCT00607087|593433990|FG002|Overall Study|Lost to Follow-up|0|||
164290487|NCT00607087|593433988|FG000|Period 1|Withdrawal by Subject|7|||
164290488|NCT00607087|593433989|FG001|Period 1|Withdrawal by Subject|2|||
164290489|NCT00607087|593433990|FG002|Period 1|Withdrawal by Subject|3|||
164290490|NCT00607087|593433988|FG000|Period 1|Adverse Event|3|||
164290491|NCT00607087|593433989|FG001|Period 1|Adverse Event|0|||
164290492|NCT00607087|593433990|FG002|Period 1|Adverse Event|0|||
164290493|NCT00607087|593433988|FG000|Period 1|Poor compliance to protocol|1|||
164290494|NCT00607087|593433989|FG001|Period 1|Poor compliance to protocol|0|||
164290495|NCT00607087|593433990|FG002|Period 1|Poor compliance to protocol|0|||
164004438|NCT02034123|592380791|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004439|NCT02034123|592380792|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164290496|NCT00607087|593433988|FG000|Period 1|Lost to Follow-up|1|||
164290497|NCT00607087|593433989|FG001|Period 1|Lost to Follow-up|0|||
164290498|NCT00607087|593433990|FG002|Period 1|Lost to Follow-up|0|||
164290499|NCT00607087|593433988|FG000|Period 1|Other reason|0|||
164290500|NCT00607087|593433989|FG001|Period 1|Other reason|4|||
164290501|NCT00607087|593433990|FG002|Period 1|Other reason|2|||
164290502|NCT00607087|593433988|FG000|Period 2|Withdrawal by Subject|0|||
164290503|NCT00607087|593433989|FG001|Period 2|Withdrawal by Subject|1|||
164290504|NCT00607087|593433990|FG002|Period 2|Withdrawal by Subject|1|||
164290505|NCT00607087|593433988|FG000|Period 2|Other reason|1|||
164290506|NCT00607087|593433989|FG001|Period 2|Other reason|1|||
164290507|NCT00607087|593433990|FG002|Period 2|Other reason|0|||
163897777|NCT02446600|591998718|FG003|Overall Study|Withdrawal by Subject|0|||
163897778|NCT02446600|591998715|FG000|Overall Study|Ineligible|1|||
163897779|NCT02446600|591998716|FG001|Overall Study|Ineligible|4|||
163897780|NCT02446600|591998717|FG002|Overall Study|Ineligible|4|||
163897781|NCT02446600|591998718|FG003|Overall Study|Ineligible|1|||
163897782|NCT02446600|591998715|FG000|Overall Study|Duplicate Enrollment|0|||
163897783|NCT02446600|591998716|FG001|Overall Study|Duplicate Enrollment|1|||
163897784|NCT02446600|591998717|FG002|Overall Study|Duplicate Enrollment|0|||
163897785|NCT02446600|591998718|FG003|Overall Study|Duplicate Enrollment|0|||
163897786|NCT00328783|591998719|FG000|Overall Study|Could not tolerate ABC|21|||
164290508|NCT00607087|593433988|FG000|Period 2|Adverse Event|0|||
164290509|NCT00607087|593433989|FG001|Period 2|Adverse Event|1|||
164290510|NCT00607087|593433990|FG002|Period 2|Adverse Event|3|||
164290511|NCT00607087|593433988|FG000|Period 2|Poor compliance to protocol|0|||
164290512|NCT00607087|593433989|FG001|Period 2|Poor compliance to protocol|0|||
164290513|NCT00607087|593433990|FG002|Period 2|Poor compliance to protocol|1|||
164290514|NCT00607087|593433988|FG000|Period 3|Withdrawal by Subject|2|||
164290515|NCT00607087|593433989|FG001|Period 3|Withdrawal by Subject|1|||
164290516|NCT00607087|593433990|FG002|Period 3|Withdrawal by Subject|0|||
164290517|NCT00607087|593433988|FG000|Period 3|Adverse Event|0|||
164290518|NCT00607087|593433989|FG001|Period 3|Adverse Event|1|||
164290519|NCT00607087|593433990|FG002|Period 3|Adverse Event|0|||
164290520|NCT01774799|593433993|FG000|Overall Study|Lost to Follow-up|1|||
164290521|NCT01774799|593433994|FG001|Overall Study|Lost to Follow-up|1|||
164345527|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345528|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345529|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345530|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
164345531|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
164345532|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
164345533|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345534|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345535|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345536|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345537|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345538|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
164345539|NCT03095066|593640988|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
164345540|NCT03095066|593640989|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
164345541|NCT03095066|593640990|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345542|NCT03095066|593640991|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345543|NCT03095066|593640992|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345544|NCT03095066|593640993|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345545|NCT03095066|593640994|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345546|NCT03095066|593640995|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
164345547|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345548|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345549|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
164345550|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345551|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345552|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345553|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
164345554|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
164345555|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345556|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345557|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
164345558|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345559|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345560|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345561|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
164345562|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
164345563|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345564|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
163897787|NCT00328783|591998719|FG000|Overall Study|No heart in RT field|4|||
163897788|NCT00328783|591998719|FG000|Overall Study|Withdrawal by Subject|1|||
163897789|NCT00357682|591998720|FG000|Overall Study|Did not receive allocated Treatment|10|||
163897790|NCT00357682|591998721|FG001|Overall Study|Did not receive allocated Treatment|9|||
164290522|NCT01774799|593433995|FG002|Overall Study|Lost to Follow-up|0|||
164290523|NCT01774799|593433996|FG003|Overall Study|Lost to Follow-up|0|||
164290524|NCT04393493|593433999|FG000|First 4 Days of Intervention|Early improvement|5|||
164290525|NCT04393493|593434000|FG001|First 4 Days of Intervention|Early improvement|7|||
163897791|NCT00357682|591998722|FG002|Overall Study|Did not receive allocated Treatment|9|||
164290526|NCT02910466|593434001|FG000|Overall Study|Adverse Event|1|||
164290527|NCT02910466|593434001|FG000|Overall Study|Withdrawal by Subject|3|||
164290528|NCT02910466|593434001|FG000|Overall Study|Lost to Follow-up|5|||
164290529|NCT02910466|593434001|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
164290530|NCT02910466|593434001|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
164290531|NCT05051579|593434005|FG000|Overall Study|Withdrawal by Subject|3|||
164290532|NCT05051579|593434006|FG001|Overall Study|Withdrawal by Subject|5|||
164290533|NCT05051579|593434007|FG002|Overall Study|Withdrawal by Subject|2|||
164290534|NCT05051579|593434008|FG003|Overall Study|Withdrawal by Subject|1|||
164290535|NCT05051579|593434009|FG004|Overall Study|Withdrawal by Subject|4|||
164290536|NCT05051579|593434010|FG005|Overall Study|Withdrawal by Subject|0|||
164290537|NCT05051579|593434011|FG006|Overall Study|Withdrawal by Subject|4|||
164290538|NCT05051579|593434005|FG000|Overall Study|Lost to Follow-up|1|||
164290539|NCT05051579|593434006|FG001|Overall Study|Lost to Follow-up|0|||
164290540|NCT05051579|593434007|FG002|Overall Study|Lost to Follow-up|0|||
164290541|NCT05051579|593434008|FG003|Overall Study|Lost to Follow-up|0|||
164290542|NCT05051579|593434009|FG004|Overall Study|Lost to Follow-up|1|||
164290543|NCT05051579|593434010|FG005|Overall Study|Lost to Follow-up|0|||
164290544|NCT05051579|593434011|FG006|Overall Study|Lost to Follow-up|1|||
164290545|NCT05051579|593434005|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290546|NCT05051579|593434006|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290547|NCT05051579|593434007|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290548|NCT05051579|593434008|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290549|NCT05051579|593434009|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290550|NCT05051579|593434010|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
164290551|NCT05051579|593434011|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
164290552|NCT05051579|593434005|FG000|Overall Study|Adverse Event|2|||
164290553|NCT05051579|593434006|FG001|Overall Study|Adverse Event|1|||
164290554|NCT05051579|593434007|FG002|Overall Study|Adverse Event|0|||
164290555|NCT05051579|593434008|FG003|Overall Study|Adverse Event|4|||
164290556|NCT05051579|593434009|FG004|Overall Study|Adverse Event|1|||
164290557|NCT05051579|593434010|FG005|Overall Study|Adverse Event|2|||
164290558|NCT05051579|593434011|FG006|Overall Study|Adverse Event|0|||
164290559|NCT05051579|593434005|FG000|Overall Study|Inadvertent Enrollment|0|||
164290560|NCT05051579|593434006|FG001|Overall Study|Inadvertent Enrollment|0|||
164290561|NCT05051579|593434007|FG002|Overall Study|Inadvertent Enrollment|0|||
164290562|NCT05051579|593434008|FG003|Overall Study|Inadvertent Enrollment|0|||
164290563|NCT05051579|593434009|FG004|Overall Study|Inadvertent Enrollment|0|||
164290564|NCT05051579|593434010|FG005|Overall Study|Inadvertent Enrollment|0|||
164290565|NCT05051579|593434011|FG006|Overall Study|Inadvertent Enrollment|1|||
164290566|NCT05051579|593434005|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290567|NCT05051579|593434006|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
164290568|NCT05051579|593434007|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290569|NCT05051579|593434008|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290570|NCT05051579|593434009|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290571|NCT05051579|593434010|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290572|NCT05051579|593434011|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
164290573|NCT05051579|593434005|FG000|Overall Study|Sponsor Decision|0|||
164290574|NCT05051579|593434006|FG001|Overall Study|Sponsor Decision|0|||
164290575|NCT05051579|593434007|FG002|Overall Study|Sponsor Decision|0|||
164290576|NCT05051579|593434008|FG003|Overall Study|Sponsor Decision|0|||
164290577|NCT05051579|593434009|FG004|Overall Study|Sponsor Decision|1|||
164290578|NCT05051579|593434010|FG005|Overall Study|Sponsor Decision|0|||
164290579|NCT05051579|593434011|FG006|Overall Study|Sponsor Decision|0|||
164290580|NCT05051579|593434005|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164088062|NCT01199601|592687337|FG000|Overall Study|Withdrawal by Subject|15|||
164088063|NCT01199601|592687338|FG001|Overall Study|Withdrawal by Subject|3|||
164088064|NCT01199601|592687337|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
164088065|NCT01199601|592687338|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
164088066|NCT00753714|592687339|FG000|Overall Study|Lack of Efficacy|21|||
164088067|NCT00753714|592687340|FG001|Overall Study|Lack of Efficacy|34|||
164088068|NCT00753714|592687339|FG000|Overall Study|Adverse Event|26|||
164088069|NCT00753714|592687340|FG001|Overall Study|Adverse Event|18|||
164088070|NCT00753714|592687339|FG000|Overall Study|Protocol Violation|1|||
164088071|NCT00753714|592687340|FG001|Overall Study|Protocol Violation|0|||
164088072|NCT00753714|592687339|FG000|Overall Study|Lost to Follow-up|0|||
164088073|NCT00753714|592687340|FG001|Overall Study|Lost to Follow-up|1|||
164088074|NCT00753714|592687339|FG000|Overall Study|Withdrawal by Subject|2|||
164088075|NCT00753714|592687340|FG001|Overall Study|Withdrawal by Subject|1|||
164290581|NCT05051579|593434006|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164299945|NCT01652235|593472960|FG000|Overall Study|Withdrawal by Subject|2|||
164290582|NCT05051579|593434007|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290583|NCT05051579|593434008|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290584|NCT05051579|593434009|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
164290585|NCT05051579|593434010|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290586|NCT05051579|593434011|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
164290587|NCT00717249|593434012|FG000|Overall Study|Lens Discomfort|4|||
164290588|NCT00717249|593434013|FG001|Overall Study|Lens Discomfort|1|||
164290589|NCT00717249|593434012|FG000|Overall Study|Unsatisfactory visual Response|0|||
164290590|NCT00717249|593434013|FG001|Overall Study|Unsatisfactory visual Response|2|||
164290591|NCT00717249|593434012|FG000|Overall Study|Adverse Event|4|||
164290592|NCT00717249|593434013|FG001|Overall Study|Adverse Event|2|||
164290593|NCT00717249|593434012|FG000|Overall Study|Lost to Follow-up|2|||
164290594|NCT00717249|593434013|FG001|Overall Study|Lost to Follow-up|0|||
164290595|NCT00717249|593434012|FG000|Overall Study|Withdrawal by Subject|1|||
164290596|NCT00717249|593434013|FG001|Overall Study|Withdrawal by Subject|2|||
164290597|NCT00717249|593434012|FG000|Overall Study|Pregnancy|6|||
164290598|NCT00717249|593434013|FG001|Overall Study|Pregnancy|3|||
164290599|NCT00717249|593434012|FG000|Overall Study|Protocol Violation|0|||
164290600|NCT00717249|593434013|FG001|Overall Study|Protocol Violation|2|||
164290601|NCT00717249|593434012|FG000|Overall Study|Subject became Ineligible|1|||
164290602|NCT00717249|593434013|FG001|Overall Study|Subject became Ineligible|1|||
164290603|NCT00717249|593434012|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
164290604|NCT00717249|593434013|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
164290605|NCT00717249|593434012|FG000|Overall Study|Gastric Surgery|0|||
164290606|NCT00717249|593434013|FG001|Overall Study|Gastric Surgery|1|||
164290607|NCT00717249|593434012|FG000|Overall Study|Diagnosed with Diabetes|1|||
164290608|NCT00717249|593434013|FG001|Overall Study|Diagnosed with Diabetes|0|||
164290609|NCT00717249|593434012|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
164290610|NCT00717249|593434013|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
164290611|NCT00717249|593434012|FG000|Overall Study|Subject relocated|1|||
164290612|NCT00717249|593434013|FG001|Overall Study|Subject relocated|0|||
164290613|NCT00717249|593434012|FG000|Overall Study|Headaches|1|||
164290614|NCT00717249|593434013|FG001|Overall Study|Headaches|0|||
164290615|NCT03370718|593434017|FG000|Overall Study|Withdrawal by Subject|1|||
164290616|NCT06172348|593434018|FG000|Treatment Period 2|Adverse Event|0|||
164290617|NCT06172348|593434019|FG001|Treatment Period 2|Adverse Event|0|||
164290618|NCT06172348|593434020|FG002|Treatment Period 2|Adverse Event|1|||
164290619|NCT06172348|593434021|FG003|Treatment Period 2|Adverse Event|0|||
164290620|NCT06172348|593434022|FG004|Treatment Period 2|Adverse Event|0|||
164290621|NCT06172348|593434023|FG005|Treatment Period 2|Adverse Event|0|||
164290622|NCT01116648|593434024|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
164290623|NCT01116648|593434025|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
164290624|NCT01116648|593434026|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
164290625|NCT01116648|593434027|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
164290626|NCT01116648|593434028|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
164290627|NCT01116648|593434029|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
164290628|NCT01116648|593434030|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
164290629|NCT01116648|593434031|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
164290630|NCT01116648|593434032|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
164290631|NCT01116648|593434033|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
164290632|NCT01116648|593434034|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
164290633|NCT01116648|593434035|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
164290634|NCT01116648|593434036|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
164290635|NCT01116648|593434037|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
164290636|NCT01116648|593434038|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
164290637|NCT04539938|593434039|FG000|Overall Study|Death|30|||
164290638|NCT04539938|593434039|FG000|Overall Study|Withdrawal by Subject|4|||
164290639|NCT04037891|593434040|FG000|Open-label Period|Withdrawal by Subject|1|||
164345565|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
164345566|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345567|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345568|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345569|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
164345570|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
163897792|NCT00357682|591998723|FG003|Overall Study|Did not receive allocated Treatment|10|||
163897793|NCT00357682|591998720|FG000|Overall Study|Withdrew consent|6|||
164290640|NCT04037891|593434041|FG001|Open-label Period|Withdrawal by Subject|0|||
164290641|NCT04037891|593434042|FG002|Open-label Period|Withdrawal by Subject|0|||
164345571|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164290642|NCT04037891|593434040|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
164290643|NCT04037891|593434041|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
164290644|NCT04037891|593434042|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
164290645|NCT00990106|593434043|FG000|Overall Study|"too busy to continue"|1|||
164290646|NCT00990106|593434044|FG001|Overall Study|"too busy to continue"|2|||
164290647|NCT00990106|593434043|FG000|Overall Study|Lost to Follow-up|1|||
164290648|NCT00990106|593434044|FG001|Overall Study|Lost to Follow-up|3|||
164290649|NCT00990106|593434043|FG000|Overall Study|Withdrawal by Subject|2|||
164290650|NCT00990106|593434044|FG001|Overall Study|Withdrawal by Subject|1|||
164290651|NCT00990106|593434043|FG000|Overall Study|opted for open label prazosin|1|||
164290652|NCT00990106|593434044|FG001|Overall Study|opted for open label prazosin|1|||
164345572|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345573|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
164345574|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345575|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345576|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345577|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
164345578|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
164345579|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345580|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345581|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
164345582|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345583|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345584|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345585|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345586|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
164345587|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345588|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345589|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
164345590|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345591|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345592|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164290653|NCT00990106|593434043|FG000|Overall Study|relocation/deployment|4|||
164290654|NCT00990106|593434044|FG001|Overall Study|relocation/deployment|1|||
164290655|NCT00990106|593434043|FG000|Overall Study|started exclusionary medication|0|||
164290656|NCT00990106|593434044|FG001|Overall Study|started exclusionary medication|1|||
164290657|NCT00990106|593434043|FG000|Overall Study|planned major surgery|0|||
164290658|NCT00990106|593434044|FG001|Overall Study|planned major surgery|1|||
164290659|NCT00990106|593434043|FG000|Overall Study|scheduling conflicts|0|||
164290660|NCT00990106|593434044|FG001|Overall Study|scheduling conflicts|2|||
164290661|NCT04194944|593434045|FG000|Overall Study|Lost to Follow-up|3|||
164290662|NCT04194944|593434046|FG001|Overall Study|Lost to Follow-up|0|||
164290663|NCT04194944|593434045|FG000|Overall Study|Withdrawal by Subject|2|||
164290664|NCT04194944|593434046|FG001|Overall Study|Withdrawal by Subject|2|||
164290665|NCT04194944|593434045|FG000|Overall Study|On Treatment|93|||
164290666|NCT04194944|593434046|FG001|Overall Study|On Treatment|30|||
164290667|NCT03737123|593436069|FG000|Study Treatment|Adverse Event|2|||
164290668|NCT03737123|593436070|FG001|Study Treatment|Adverse Event|0|||
164290669|NCT03737123|593436069|FG000|Study Treatment|Disease Progression|2|||
164290670|NCT03737123|593436070|FG001|Study Treatment|Disease Progression|0|||
164290671|NCT03737123|593436069|FG000|Study Treatment|Withdrawal by Subject|2|||
164290672|NCT03737123|593436070|FG001|Study Treatment|Withdrawal by Subject|0|||
164290673|NCT03737123|593436069|FG000|Follow up|Death|1|||
164290674|NCT03737123|593436070|FG001|Follow up|Death|0|||
164290675|NCT03737123|593436069|FG000|Follow up|Withdrawal by Subject|1|||
164290676|NCT03737123|593436070|FG001|Follow up|Withdrawal by Subject|0|||
164290677|NCT03737123|593436069|FG000|Follow up|Termination of study|4|||
164290678|NCT03737123|593436070|FG001|Follow up|Termination of study|0|||
164290679|NCT01519323|593436071|FG000|Overall Study|Death|3|||
164290680|NCT01519323|593436072|FG001|Overall Study|Death|2|||
164290681|NCT01519323|593436071|FG000|Overall Study|Study terminated by sponsor|0|||
164290682|NCT01519323|593436072|FG001|Overall Study|Study terminated by sponsor|1|||
164290683|NCT00445549|593436073|FG000|Overall Study|progressive disease|12|||
164345593|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
164345594|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
164345595|NCT03095066|593640988|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345596|NCT03095066|593640989|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164290684|NCT03096834|593436081|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
164290685|NCT03096834|593436082|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
164290686|NCT03096834|593436083|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
164290687|NCT03096834|593436084|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
164290688|NCT03096834|593436081|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
164290689|NCT03096834|593436082|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
164345597|NCT03095066|593640990|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164290690|NCT03096834|593436083|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
164290691|NCT03096834|593436084|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
164290692|NCT03096834|593436081|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
164290693|NCT03096834|593436082|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
164290694|NCT03096834|593436083|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
164290695|NCT03096834|593436084|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
164290696|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
164290697|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
164290698|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
164290699|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
164290700|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
164290701|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
164290702|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
164290703|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
164290704|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
164290705|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
164290706|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
164290707|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
164290708|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
164290709|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
164290710|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
164290711|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
164290712|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
164290713|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
164290714|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
164290715|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
164290716|NCT03096834|593436081|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
164290717|NCT03096834|593436082|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
164290718|NCT03096834|593436083|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
164290719|NCT03096834|593436084|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
164290720|NCT03096834|593436081|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
164290721|NCT03096834|593436082|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
164290722|NCT03096834|593436083|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
164290723|NCT03096834|593436084|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
164290724|NCT03096834|593436081|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
164290725|NCT03096834|593436082|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
164290726|NCT03096834|593436083|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
164290727|NCT03096834|593436084|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
164290728|NCT03096834|593436081|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
164290729|NCT03096834|593436082|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
164290730|NCT03096834|593436083|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
164290731|NCT03096834|593436084|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
164290732|NCT01600326|593436087|FG000|Overall Study|Lost to Follow-up|1|||
164290733|NCT01600326|593436088|FG001|Overall Study|Lost to Follow-up|1|||
164290734|NCT01169103|593436094|FG000|Overall Study|Lost to Follow-up|3|||
164290735|NCT01169103|593436095|FG001|Overall Study|Lost to Follow-up|3|||
164290736|NCT01169103|593436094|FG000|Overall Study|Withdrawal by Subject|3|||
164290737|NCT01169103|593436095|FG001|Overall Study|Withdrawal by Subject|1|||
164290738|NCT06039579|593436096|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290739|NCT06039579|593436097|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290740|NCT06039579|593436098|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290741|NCT06039579|593436099|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290742|NCT06039579|593436100|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290743|NCT06039579|593436101|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290744|NCT06039579|593436102|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
164290745|NCT06039579|593436103|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
164290746|NCT02792231|593436104|FG000|Overall Study|Patient/guardian decision|32|||
164290747|NCT02792231|593436105|FG001|Overall Study|Patient/guardian decision|42|||
164290748|NCT02792231|593436104|FG000|Overall Study|Adverse Event|15|||
164290749|NCT02792231|593436105|FG001|Overall Study|Adverse Event|11|||
164290750|NCT02792231|593436104|FG000|Overall Study|Physician Decision|14|||
164290751|NCT02792231|593436105|FG001|Overall Study|Physician Decision|12|||
164290752|NCT02792231|593436104|FG000|Overall Study|Lack of Efficacy|7|||
164290753|NCT02792231|593436105|FG001|Overall Study|Lack of Efficacy|9|||
164290754|NCT02792231|593436104|FG000|Overall Study|Lost to Follow-up|9|||
164290755|NCT02792231|593436105|FG001|Overall Study|Lost to Follow-up|5|||
164290756|NCT02792231|593436104|FG000|Overall Study|Pregnancy|1|||
164290757|NCT02792231|593436105|FG001|Overall Study|Pregnancy|3|||
164290758|NCT02792231|593436104|FG000|Overall Study|Non-compliance with study treatment|2|||
164290759|NCT02792231|593436105|FG001|Overall Study|Non-compliance with study treatment|1|||
164290760|NCT02792231|593436104|FG000|Overall Study|Protocol deviation|2|||
164290761|NCT02792231|593436105|FG001|Overall Study|Protocol deviation|0|||
164290762|NCT02792231|593436104|FG000|Overall Study|Technical problems|0|||
163897794|NCT00357682|591998721|FG001|Overall Study|Withdrew consent|6|||
164290763|NCT02792231|593436105|FG001|Overall Study|Technical problems|1|||
164290764|NCT03309878|593436106|FG000|Overall Study|Adverse Event|1|||
164290765|NCT03309878|593436107|FG001|Overall Study|Adverse Event|0|||
164290766|NCT03309878|593436108|FG002|Overall Study|Adverse Event|0|||
164290767|NCT03309878|593436109|FG003|Overall Study|Adverse Event|0|||
164290768|NCT03309878|593436106|FG000|Overall Study|Did not maintain eligibility|2|||
163897795|NCT00357682|591998722|FG002|Overall Study|Withdrew consent|5|||
163897796|NCT00357682|591998723|FG003|Overall Study|Withdrew consent|5|||
163897797|NCT00357682|591998720|FG000|Overall Study|Lost to Follow-up|39|||
163897798|NCT00357682|591998721|FG001|Overall Study|Lost to Follow-up|33|||
163897799|NCT00357682|591998722|FG002|Overall Study|Lost to Follow-up|26|||
163897800|NCT00357682|591998723|FG003|Overall Study|Lost to Follow-up|35|||
163897801|NCT00357682|591998720|FG000|Overall Study|Adverse Event|24|||
163897802|NCT00357682|591998721|FG001|Overall Study|Adverse Event|32|||
163897803|NCT00357682|591998722|FG002|Overall Study|Adverse Event|22|||
163897804|NCT00357682|591998723|FG003|Overall Study|Adverse Event|27|||
163897805|NCT00357682|591998720|FG000|Overall Study|Physician Decision|32|||
163897806|NCT00357682|591998721|FG001|Overall Study|Physician Decision|20|||
163897807|NCT00357682|591998722|FG002|Overall Study|Physician Decision|24|||
163897808|NCT00357682|591998723|FG003|Overall Study|Physician Decision|30|||
163897809|NCT00357682|591998720|FG000|Overall Study|Patient decision|73|||
163897810|NCT00357682|591998721|FG001|Overall Study|Patient decision|80|||
163897811|NCT00357682|591998722|FG002|Overall Study|Patient decision|51|||
163897812|NCT00357682|591998723|FG003|Overall Study|Patient decision|59|||
164088076|NCT00753714|592687339|FG000|Overall Study|Death|3|||
164290769|NCT03309878|593436107|FG001|Overall Study|Did not maintain eligibility|1|||
164290770|NCT03309878|593436108|FG002|Overall Study|Did not maintain eligibility|0|||
164290771|NCT03309878|593436109|FG003|Overall Study|Did not maintain eligibility|0|||
164290772|NCT03309878|593436106|FG000|Overall Study|Withdrawal by Subject|0|||
164290773|NCT03309878|593436107|FG001|Overall Study|Withdrawal by Subject|1|||
164290774|NCT03309878|593436108|FG002|Overall Study|Withdrawal by Subject|0|||
164290775|NCT03309878|593436109|FG003|Overall Study|Withdrawal by Subject|0|||
164290776|NCT00657046|593436115|FG000|Overall Study|Adverse Event|1|||
164290777|NCT00657046|593436116|FG001|Overall Study|Adverse Event|1|||
164290778|NCT00657046|593436117|FG002|Overall Study|Adverse Event|0|||
164290779|NCT00657046|593436115|FG000|Overall Study|Protocol Violation|2|||
164290780|NCT00657046|593436116|FG001|Overall Study|Protocol Violation|2|||
164290781|NCT00657046|593436117|FG002|Overall Study|Protocol Violation|0|||
164290782|NCT00657046|593436115|FG000|Overall Study|Withdrawal by Subject|1|||
164290783|NCT00657046|593436116|FG001|Overall Study|Withdrawal by Subject|0|||
164290784|NCT00657046|593436117|FG002|Overall Study|Withdrawal by Subject|0|||
164290785|NCT00657046|593436115|FG000|Overall Study|Death|0|||
164290786|NCT00657046|593436116|FG001|Overall Study|Death|0|||
164345598|NCT03095066|593640991|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345599|NCT03095066|593640992|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345600|NCT03095066|593640993|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345601|NCT03095066|593640994|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
164345602|NCT03095066|593640995|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
164345603|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345604|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345605|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345606|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345607|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345608|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
164345609|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345610|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
164345611|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345612|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345613|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345614|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345615|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
164345616|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345617|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
164345618|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
164345619|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345620|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
163897813|NCT00357682|591998720|FG000|Overall Study|Other reason|157|||
163897814|NCT00357682|591998721|FG001|Overall Study|Other reason|130|||
163897815|NCT00357682|591998722|FG002|Overall Study|Other reason|114|||
163897816|NCT00357682|591998723|FG003|Overall Study|Other reason|99|||
164290787|NCT00657046|593436117|FG002|Overall Study|Death|1|||
164290788|NCT00657046|593436115|FG000|Overall Study|Surgery|0|||
164290789|NCT00657046|593436116|FG001|Overall Study|Surgery|0|||
164290790|NCT00657046|593436117|FG002|Overall Study|Surgery|1|||
164290791|NCT03827655|593436128|FG000|Overall Study|Death|0|||
164290792|NCT03827655|593436129|FG001|Overall Study|Death|0|||
164290793|NCT03827655|593436130|FG002|Overall Study|Death|0|||
164290794|NCT03827655|593436131|FG003|Overall Study|Death|0|||
164290795|NCT03827655|593436132|FG004|Overall Study|Death|1|||
164290796|NCT03827655|593436128|FG000|Overall Study|Protocol Deviation|1|||
164290797|NCT03827655|593436129|FG001|Overall Study|Protocol Deviation|0|||
164290798|NCT03827655|593436130|FG002|Overall Study|Protocol Deviation|1|||
164290799|NCT03827655|593436131|FG003|Overall Study|Protocol Deviation|1|||
164290800|NCT03827655|593436132|FG004|Overall Study|Protocol Deviation|0|||
164290801|NCT03827655|593436128|FG000|Overall Study|Withdrawal by Subject|3|||
164290802|NCT03827655|593436129|FG001|Overall Study|Withdrawal by Subject|2|||
164290803|NCT03827655|593436130|FG002|Overall Study|Withdrawal by Subject|2|||
164290804|NCT03827655|593436131|FG003|Overall Study|Withdrawal by Subject|0|||
164290805|NCT03827655|593436132|FG004|Overall Study|Withdrawal by Subject|1|||
164290806|NCT03827655|593436128|FG000|Overall Study|Reason not Specified|3|||
164290807|NCT03827655|593436129|FG001|Overall Study|Reason not Specified|1|||
164290808|NCT03827655|593436130|FG002|Overall Study|Reason not Specified|1|||
164290809|NCT03827655|593436131|FG003|Overall Study|Reason not Specified|1|||
164290810|NCT03827655|593436132|FG004|Overall Study|Reason not Specified|1|||
164290811|NCT03935126|593436135|FG000|Overall Study|Study termination by sponsor|3|||
164290812|NCT01092728|593436136|FG000|Overall Study|Withdrawal by Subject|2|||
164290813|NCT01092728|593436137|FG001|Overall Study|Withdrawal by Subject|0|||
164290814|NCT01092728|593436136|FG000|Overall Study|Adverse Event|0|||
164290815|NCT01092728|593436137|FG001|Overall Study|Adverse Event|1|||
164290816|NCT01092728|593436136|FG000|Overall Study|Disease Progression|1|||
164290817|NCT01092728|593436137|FG001|Overall Study|Disease Progression|13|||
164290818|NCT01092728|593436136|FG000|Overall Study|Prohibited Concomitant Medications|1|||
164290819|NCT01092728|593436137|FG001|Overall Study|Prohibited Concomitant Medications|0|||
164290820|NCT02336607|593436138|FG000|Overall Study|Physician Decision|1|||
164290821|NCT02336607|593436139|FG001|Overall Study|Physician Decision|4|||
164290822|NCT02336607|593436140|FG002|Overall Study|Physician Decision|3|||
164290823|NCT02336607|593436141|FG003|Overall Study|Physician Decision|15|||
164290824|NCT02336607|593436138|FG000|Overall Study|Lack of Efficacy|1|||
164290825|NCT02336607|593436139|FG001|Overall Study|Lack of Efficacy|0|||
164290826|NCT02336607|593436140|FG002|Overall Study|Lack of Efficacy|0|||
164290827|NCT02336607|593436141|FG003|Overall Study|Lack of Efficacy|2|||
164290828|NCT02336607|593436138|FG000|Overall Study|Lost to Follow-up|2|||
164290829|NCT02336607|593436139|FG001|Overall Study|Lost to Follow-up|1|||
164290830|NCT02336607|593436140|FG002|Overall Study|Lost to Follow-up|0|||
164290831|NCT02336607|593436141|FG003|Overall Study|Lost to Follow-up|21|||
164290832|NCT02336607|593436138|FG000|Overall Study|Protocol Violation|0|||
164290833|NCT02336607|593436139|FG001|Overall Study|Protocol Violation|1|||
164290834|NCT02336607|593436140|FG002|Overall Study|Protocol Violation|1|||
164290835|NCT02336607|593436141|FG003|Overall Study|Protocol Violation|3|||
164290836|NCT02336607|593436138|FG000|Overall Study|Adverse Event|0|||
164290837|NCT02336607|593436139|FG001|Overall Study|Adverse Event|2|||
164290838|NCT02336607|593436140|FG002|Overall Study|Adverse Event|2|||
164290839|NCT02336607|593436141|FG003|Overall Study|Adverse Event|26|||
164290840|NCT02336607|593436138|FG000|Overall Study|Withdrawal by Subject|0|||
164290841|NCT02336607|593436139|FG001|Overall Study|Withdrawal by Subject|2|||
164290842|NCT02336607|593436140|FG002|Overall Study|Withdrawal by Subject|0|||
164290843|NCT02336607|593436141|FG003|Overall Study|Withdrawal by Subject|20|||
164290844|NCT01454596|593436147|FG000|Overall Study|Death|0|||
164290845|NCT01454596|593436148|FG001|Overall Study|Death|0|||
164290846|NCT01454596|593436149|FG002|Overall Study|Death|0|||
164290847|NCT01454596|593436150|FG003|Overall Study|Death|0|||
164290848|NCT01454596|593436151|FG004|Overall Study|Death|0|||
164290849|NCT01454596|593436152|FG005|Overall Study|Death|0|||
164290850|NCT01454596|593436153|FG006|Overall Study|Death|0|||
164290851|NCT01454596|593436154|FG007|Overall Study|Death|0|||
164290852|NCT01454596|593436155|FG008|Overall Study|Death|0|||
164290853|NCT01454596|593436156|FG009|Overall Study|Death|1|||
164290854|NCT01454596|593436157|FG010|Overall Study|Death|1|||
164290855|NCT01454596|593436158|FG011|Overall Study|Death|0|||
164290856|NCT03318549|593436170|FG000|Overall Study|Withdrawal by Subject|5|||
163897817|NCT03660930|591998724|FG000|Overall Study|Adverse Event|0|||
164290857|NCT03318549|593436171|FG001|Overall Study|Withdrawal by Subject|19|||
164290858|NCT03318549|593436172|FG002|Overall Study|Withdrawal by Subject|2|||
164290859|NCT03318549|593436173|FG003|Overall Study|Withdrawal by Subject|0|||
164290860|NCT03318549|593436174|FG004|Overall Study|Withdrawal by Subject|0|||
164290861|NCT03318549|593436175|FG005|Overall Study|Withdrawal by Subject|0|||
164290862|NCT03318549|593436176|FG006|Overall Study|Withdrawal by Subject|0|||
164290863|NCT03318549|593436170|FG000|Overall Study|Physician Decision|0|||
164290864|NCT03318549|593436171|FG001|Overall Study|Physician Decision|4|||
164290865|NCT03318549|593436172|FG002|Overall Study|Physician Decision|1|||
164290866|NCT03318549|593436173|FG003|Overall Study|Physician Decision|0|||
164290867|NCT03318549|593436174|FG004|Overall Study|Physician Decision|0|||
164290868|NCT03318549|593436175|FG005|Overall Study|Physician Decision|0|||
164290869|NCT03318549|593436176|FG006|Overall Study|Physician Decision|0|||
164290870|NCT03318549|593436170|FG000|Overall Study|Lost to Follow-up|0|||
164290871|NCT03318549|593436171|FG001|Overall Study|Lost to Follow-up|3|||
164088077|NCT00753714|592687340|FG001|Overall Study|Death|3|||
164088078|NCT00753714|592687339|FG000|Overall Study|Other|7|||
164088079|NCT00753714|592687340|FG001|Overall Study|Other|5|||
164088080|NCT03387098|592687341|FG000|Overall Study|progressive disease|1|||
164088081|NCT03387098|592687341|FG000|Overall Study|Withdrawal by Subject|2|||
164088082|NCT03387098|592687341|FG000|Overall Study|study terminated by sponsor|1|||
164088083|NCT00278512|592687342|FG000|Overall Study|Death|1|||
164088084|NCT00278512|592687343|FG001|Overall Study|Death|0|||
164088085|NCT01620177|592687344|FG000|Overall Study|Failure at Screening Visit|43|||
164088086|NCT01620177|592687344|FG000|Overall Study|Withdrawal by Subject|26|||
164088087|NCT01620177|592687344|FG000|Overall Study|Lost to Follow-up|7|||
164088088|NCT01620177|592687344|FG000|Overall Study|Physician Decision|2|||
164088089|NCT01620177|592687344|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
164088090|NCT02292238|592687345|FG000|Overall Study|Protocol Violation|1|||
164088091|NCT02292238|592687346|FG001|Overall Study|Protocol Violation|2|||
164088092|NCT02292238|592687345|FG000|Overall Study|Withdrawal by Subject|2|||
164088093|NCT02292238|592687346|FG001|Overall Study|Withdrawal by Subject|1|||
164290872|NCT03318549|593436172|FG002|Overall Study|Lost to Follow-up|3|||
164290873|NCT03318549|593436173|FG003|Overall Study|Lost to Follow-up|0|||
164290874|NCT03318549|593436174|FG004|Overall Study|Lost to Follow-up|0|||
164290875|NCT03318549|593436175|FG005|Overall Study|Lost to Follow-up|0|||
164290876|NCT03318549|593436176|FG006|Overall Study|Lost to Follow-up|0|||
164290877|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
164290878|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
164290879|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
164290880|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
164290881|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
164290882|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
164290883|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Death|7|||
164290884|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Death|5|||
164290885|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Death|6|||
164290886|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
164290887|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
164290888|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
164290889|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
164290890|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
164290891|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
164290892|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Other|1|||
164290893|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Other|0|||
164290894|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Other|0|||
164290895|NCT00104650|593436177|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
164290896|NCT00104650|593436178|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
164290897|NCT00104650|593436179|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
164290898|NCT00104650|593436177|FG000|Follow-up Period|Physician Decision|1|||
164290899|NCT00104650|593436178|FG001|Follow-up Period|Physician Decision|1|||
164290900|NCT00104650|593436179|FG002|Follow-up Period|Physician Decision|0|||
164290901|NCT00104650|593436177|FG000|Follow-up Period|Adverse Event|1|||
164290902|NCT00104650|593436178|FG001|Follow-up Period|Adverse Event|0|||
164290903|NCT00104650|593436179|FG002|Follow-up Period|Adverse Event|1|||
164290904|NCT00104650|593436177|FG000|Follow-up Period|Withdrawal by Subject|0|||
164290905|NCT00104650|593436178|FG001|Follow-up Period|Withdrawal by Subject|3|||
164290906|NCT00104650|593436179|FG002|Follow-up Period|Withdrawal by Subject|3|||
164290907|NCT00104650|593436177|FG000|Follow-up Period|Death|6|||
164290908|NCT00104650|593436178|FG001|Follow-up Period|Death|6|||
164290909|NCT00104650|593436179|FG002|Follow-up Period|Death|4|||
164290910|NCT00104650|593436177|FG000|Follow-up Period|Disease progression|3|||
164290911|NCT00104650|593436178|FG001|Follow-up Period|Disease progression|1|||
164290912|NCT00104650|593436179|FG002|Follow-up Period|Disease progression|0|||
164290913|NCT00104650|593436177|FG000|Follow-up Period|Lost to Follow-up|0|||
164290914|NCT00104650|593436178|FG001|Follow-up Period|Lost to Follow-up|1|||
164290915|NCT00104650|593436179|FG002|Follow-up Period|Lost to Follow-up|2|||
164290916|NCT00104650|593436177|FG000|Follow-up Period|Other|0|||
164290917|NCT00104650|593436178|FG001|Follow-up Period|Other|1|||
164290918|NCT00104650|593436179|FG002|Follow-up Period|Other|0|||
164290919|NCT03515824|593436180|FG000|Overall Study|Death|3|||
164088094|NCT02292238|592687345|FG000|Overall Study|Lost to Follow-up|1|||
164088095|NCT02292238|592687346|FG001|Overall Study|Lost to Follow-up|0|||
164088096|NCT02292238|592687345|FG000|Overall Study|Physician Decision|0|||
164088097|NCT02292238|592687346|FG001|Overall Study|Physician Decision|1|||
164088098|NCT04000009|592687347|FG000|Overall Study|Adverse Event|13|||
164290920|NCT03515824|593436181|FG001|Overall Study|Death|2|||
164290921|NCT03515824|593436182|FG002|Overall Study|Death|6|||
164290922|NCT03515824|593436183|FG003|Overall Study|Death|0|||
164290923|NCT03515824|593436180|FG000|Overall Study|Lost to Follow-up|0|||
164290924|NCT03515824|593436181|FG001|Overall Study|Lost to Follow-up|1|||
164290925|NCT03515824|593436182|FG002|Overall Study|Lost to Follow-up|1|||
164290926|NCT03515824|593436183|FG003|Overall Study|Lost to Follow-up|0|||
164088099|NCT04000009|592687347|FG000|Overall Study|Lack of Efficacy|7|||
164290927|NCT03515824|593436180|FG000|Overall Study|Study terminated by sponsor|0|||
164290928|NCT03515824|593436181|FG001|Overall Study|Study terminated by sponsor|1|||
164290929|NCT03515824|593436182|FG002|Overall Study|Study terminated by sponsor|6|||
164290930|NCT03515824|593436183|FG003|Overall Study|Study terminated by sponsor|0|||
164290931|NCT03515824|593436180|FG000|Overall Study|Status not recorded|0|||
164290932|NCT03515824|593436181|FG001|Overall Study|Status not recorded|0|||
164290933|NCT03515824|593436182|FG002|Overall Study|Status not recorded|2|||
164290934|NCT03515824|593436183|FG003|Overall Study|Status not recorded|0|||
164290935|NCT03084796|593436185|FG000|Overall Study|Adverse Event|4|||
164290936|NCT03084796|593436186|FG001|Overall Study|Adverse Event|5|||
164290937|NCT03084796|593436187|FG002|Overall Study|Adverse Event|6|||
164290938|NCT03084796|593436188|FG003|Overall Study|Adverse Event|2|||
164290939|NCT03084796|593436189|FG004|Overall Study|Adverse Event|3|||
164290940|NCT03084796|593436190|FG005|Overall Study|Adverse Event|5|||
164290941|NCT03084796|593436185|FG000|Overall Study|Withdrawal by Subject|3|||
164290942|NCT03084796|593436186|FG001|Overall Study|Withdrawal by Subject|5|||
164290943|NCT03084796|593436187|FG002|Overall Study|Withdrawal by Subject|2|||
164290944|NCT03084796|593436188|FG003|Overall Study|Withdrawal by Subject|1|||
164290945|NCT03084796|593436189|FG004|Overall Study|Withdrawal by Subject|3|||
164290946|NCT03084796|593436190|FG005|Overall Study|Withdrawal by Subject|0|||
164290947|NCT03084796|593436185|FG000|Overall Study|Protocol Violation|0|||
164290948|NCT03084796|593436186|FG001|Overall Study|Protocol Violation|0|||
164290949|NCT03084796|593436187|FG002|Overall Study|Protocol Violation|1|||
164290950|NCT03084796|593436188|FG003|Overall Study|Protocol Violation|0|||
164290951|NCT03084796|593436189|FG004|Overall Study|Protocol Violation|1|||
164290952|NCT03084796|593436190|FG005|Overall Study|Protocol Violation|1|||
164290953|NCT03084796|593436185|FG000|Overall Study|Lack of Efficacy|0|||
164290954|NCT03084796|593436186|FG001|Overall Study|Lack of Efficacy|0|||
164290955|NCT03084796|593436187|FG002|Overall Study|Lack of Efficacy|1|||
164290956|NCT03084796|593436188|FG003|Overall Study|Lack of Efficacy|0|||
164290957|NCT03084796|593436189|FG004|Overall Study|Lack of Efficacy|1|||
164290958|NCT03084796|593436190|FG005|Overall Study|Lack of Efficacy|0|||
164290959|NCT03084796|593436185|FG000|Overall Study|Lost to Follow-up|0|||
164290960|NCT03084796|593436186|FG001|Overall Study|Lost to Follow-up|0|||
164290961|NCT03084796|593436187|FG002|Overall Study|Lost to Follow-up|1|||
164290962|NCT03084796|593436188|FG003|Overall Study|Lost to Follow-up|1|||
164290963|NCT03084796|593436189|FG004|Overall Study|Lost to Follow-up|3|||
164290964|NCT03084796|593436190|FG005|Overall Study|Lost to Follow-up|1|||
164290965|NCT03084796|593436185|FG000|Overall Study|Randomization error|0|||
164290966|NCT03084796|593436186|FG001|Overall Study|Randomization error|0|||
164290967|NCT03084796|593436187|FG002|Overall Study|Randomization error|1|||
164290968|NCT03084796|593436188|FG003|Overall Study|Randomization error|0|||
164290969|NCT03084796|593436189|FG004|Overall Study|Randomization error|0|||
164290970|NCT03084796|593436190|FG005|Overall Study|Randomization error|0|||
164290971|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
164290972|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
164290973|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
164290974|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
164290975|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
164290976|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
164290977|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
164290978|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
164290979|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
164290980|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
164290981|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
164290982|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
164290983|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
164290984|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
164290985|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
164290986|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
164290987|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
164290988|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
164290989|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
164290990|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
164290991|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
164290992|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
164290993|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
164345621|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164290994|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
164290995|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
164290996|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
164290997|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
164290998|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
164290999|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
164291000|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
164291001|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
164291002|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
164291003|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
164291004|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
164291005|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
164291006|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
164291007|NCT02586623|593436191|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
164291008|NCT02586623|593436192|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
164291009|NCT02586623|593436193|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
164291010|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
164291011|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
164291012|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
164291013|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
164291014|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
164291015|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
164291016|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
164291017|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
164291018|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
164291019|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
164291020|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
164291021|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
164291022|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
164291023|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
164291024|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
164291025|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
164291026|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
164291027|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
164291028|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
164291029|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
164291030|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
164291031|NCT02586623|593436191|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
164291032|NCT02586623|593436192|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
164291033|NCT02586623|593436193|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
164291034|NCT03799341|593436194|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
164291035|NCT03799341|593436195|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
164291036|NCT03799341|593436196|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
164291037|NCT03799341|593436194|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
164291038|NCT03799341|593436195|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
164291039|NCT03799341|593436196|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
164291040|NCT03799341|593436194|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
164291041|NCT03799341|593436195|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
164291042|NCT03799341|593436196|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
164291043|NCT03799341|593436194|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
164291044|NCT03799341|593436195|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
164291045|NCT03799341|593436196|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
164291046|NCT03799341|593436194|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
164291047|NCT03799341|593436195|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
164291048|NCT03799341|593436196|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
164291049|NCT03799341|593436194|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
164291050|NCT03799341|593436195|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
164291051|NCT03799341|593436196|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
164291052|NCT03064490|593436197|FG000|Overall Study|Physician Decision|5|||
164291053|NCT05579977|593436202|FG000|Treatment Phase|Other|0|||
164291054|NCT05579977|593436203|FG001|Treatment Phase|Other|0|||
164291055|NCT05579977|593436204|FG002|Treatment Phase|Other|0|||
164291056|NCT05579977|593436205|FG003|Treatment Phase|Other|2|||
164291057|NCT05579977|593436206|FG004|Treatment Phase|Other|1|||
164291058|NCT05579977|593436207|FG005|Treatment Phase|Other|2|||
164291059|NCT05579977|593436208|FG006|Treatment Phase|Other|1|||
164291060|NCT05579977|593436209|FG007|Treatment Phase|Other|2|||
164291061|NCT05579977|593436210|FG008|Treatment Phase|Other|2|||
164291062|NCT05579977|593436211|FG009|Treatment Phase|Other|1|||
164291063|NCT05579977|593436212|FG010|Treatment Phase|Other|0|||
164291064|NCT05579977|593436213|FG011|Treatment Phase|Other|0|||
164291065|NCT05579977|593436214|FG012|Treatment Phase|Other|3|||
164291066|NCT05579977|593436202|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
164291067|NCT05579977|593436203|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
164291068|NCT05579977|593436204|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
164291069|NCT05579977|593436205|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
164291070|NCT05579977|593436206|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
164291071|NCT05579977|593436207|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
164291072|NCT05579977|593436208|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
164291073|NCT05579977|593436209|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
164291074|NCT05579977|593436210|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
164291075|NCT05579977|593436211|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
164291076|NCT05579977|593436212|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
164291077|NCT05579977|593436213|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
164291078|NCT05579977|593436214|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
164291079|NCT05579977|593436202|FG000|Treatment Phase|Withdrawal by Subject|2|||
164291080|NCT05579977|593436203|FG001|Treatment Phase|Withdrawal by Subject|0|||
164291081|NCT05579977|593436204|FG002|Treatment Phase|Withdrawal by Subject|0|||
164291082|NCT05579977|593436205|FG003|Treatment Phase|Withdrawal by Subject|1|||
164291083|NCT05579977|593436206|FG004|Treatment Phase|Withdrawal by Subject|2|||
164291084|NCT05579977|593436207|FG005|Treatment Phase|Withdrawal by Subject|0|||
164291085|NCT05579977|593436208|FG006|Treatment Phase|Withdrawal by Subject|1|||
164291086|NCT05579977|593436209|FG007|Treatment Phase|Withdrawal by Subject|8|||
164291087|NCT05579977|593436210|FG008|Treatment Phase|Withdrawal by Subject|3|||
164345622|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345623|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
164345624|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345625|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
164345626|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
164345627|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345628|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164291088|NCT05579977|593436211|FG009|Treatment Phase|Withdrawal by Subject|3|||
164291089|NCT05579977|593436212|FG010|Treatment Phase|Withdrawal by Subject|5|||
164291090|NCT05579977|593436213|FG011|Treatment Phase|Withdrawal by Subject|1|||
164291091|NCT05579977|593436214|FG012|Treatment Phase|Withdrawal by Subject|3|||
164291092|NCT05579977|593436202|FG000|Treatment Phase|Study terminated by sponsor|70|||
164291093|NCT05579977|593436203|FG001|Treatment Phase|Study terminated by sponsor|70|||
164291094|NCT05579977|593436204|FG002|Treatment Phase|Study terminated by sponsor|61|||
164291095|NCT05579977|593436205|FG003|Treatment Phase|Study terminated by sponsor|59|||
164291096|NCT05579977|593436206|FG004|Treatment Phase|Study terminated by sponsor|63|||
164291097|NCT05579977|593436207|FG005|Treatment Phase|Study terminated by sponsor|53|||
164291098|NCT05579977|593436208|FG006|Treatment Phase|Study terminated by sponsor|66|||
164291099|NCT05579977|593436209|FG007|Treatment Phase|Study terminated by sponsor|48|||
164291100|NCT05579977|593436210|FG008|Treatment Phase|Study terminated by sponsor|47|||
164291101|NCT05579977|593436211|FG009|Treatment Phase|Study terminated by sponsor|37|||
164291102|NCT05579977|593436212|FG010|Treatment Phase|Study terminated by sponsor|44|||
164291103|NCT05579977|593436213|FG011|Treatment Phase|Study terminated by sponsor|36|||
164291104|NCT05579977|593436214|FG012|Treatment Phase|Study terminated by sponsor|32|||
164291105|NCT05579977|593436202|FG000|Treatment Phase|Pregnancy|0|||
164291106|NCT05579977|593436203|FG001|Treatment Phase|Pregnancy|0|||
164291107|NCT05579977|593436204|FG002|Treatment Phase|Pregnancy|0|||
164291108|NCT05579977|593436205|FG003|Treatment Phase|Pregnancy|0|||
164291109|NCT05579977|593436206|FG004|Treatment Phase|Pregnancy|0|||
164345629|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345630|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345631|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
164345632|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345633|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
164345634|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
164345635|NCT03095066|593640988|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345636|NCT03095066|593640989|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345637|NCT03095066|593640990|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345638|NCT03095066|593640991|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
164345639|NCT03095066|593640992|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345640|NCT03095066|593640993|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
164345641|NCT03095066|593640994|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345642|NCT03095066|593640995|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
164345643|NCT05988619|593640997|FG000|Overall Study|Lost to Follow-up|1|||
164345644|NCT05988619|593640998|FG001|Overall Study|Lost to Follow-up|4|||
164345645|NCT05988619|593640997|FG000|Overall Study|Withdrawal by Subject|2|||
164345646|NCT05988619|593640998|FG001|Overall Study|Withdrawal by Subject|9|||
164345647|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Death|0|||
164345648|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Death|0|||
164345649|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Death|0|||
164345650|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Death|0|||
164345651|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Death|1|||
164345652|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Death|0|||
164345653|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Death|0|||
164345654|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Death|0|||
164345655|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
164345656|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
164345657|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
164345658|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
164345659|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
164345660|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
164345661|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
164345662|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
164345663|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
164345664|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345665|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345666|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
164345667|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345668|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
164345669|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345670|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
164345671|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
164345672|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
164345673|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
164345674|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
164345675|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
164345676|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
164345677|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
164345678|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
164345679|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
164291110|NCT05579977|593436207|FG005|Treatment Phase|Pregnancy|0|||
164291111|NCT05579977|593436208|FG006|Treatment Phase|Pregnancy|0|||
164345680|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
164345681|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
164345682|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
164291112|NCT05579977|593436209|FG007|Treatment Phase|Pregnancy|0|||
164291113|NCT05579977|593436210|FG008|Treatment Phase|Pregnancy|0|||
164291114|NCT05579977|593436211|FG009|Treatment Phase|Pregnancy|1|||
163897818|NCT03660930|591998725|FG001|Overall Study|Adverse Event|0|||
163897819|NCT03660930|591998726|FG002|Overall Study|Adverse Event|0|||
163897820|NCT03660930|591998727|FG003|Overall Study|Adverse Event|2|||
164345683|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
164345684|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
164345685|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
164345686|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
164345687|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
164345688|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164291115|NCT05579977|593436212|FG010|Treatment Phase|Pregnancy|0|||
164291116|NCT05579977|593436213|FG011|Treatment Phase|Pregnancy|0|||
164291117|NCT05579977|593436214|FG012|Treatment Phase|Pregnancy|0|||
164291118|NCT05579977|593436202|FG000|Treatment Phase|Physician Decision|0|||
164291119|NCT05579977|593436203|FG001|Treatment Phase|Physician Decision|0|||
164291120|NCT05579977|593436204|FG002|Treatment Phase|Physician Decision|0|||
164291121|NCT05579977|593436205|FG003|Treatment Phase|Physician Decision|0|||
164291122|NCT05579977|593436206|FG004|Treatment Phase|Physician Decision|0|||
164291123|NCT05579977|593436207|FG005|Treatment Phase|Physician Decision|0|||
164291124|NCT05579977|593436208|FG006|Treatment Phase|Physician Decision|0|||
164291125|NCT05579977|593436209|FG007|Treatment Phase|Physician Decision|0|||
164291126|NCT05579977|593436210|FG008|Treatment Phase|Physician Decision|0|||
164291127|NCT05579977|593436211|FG009|Treatment Phase|Physician Decision|0|||
164291128|NCT05579977|593436212|FG010|Treatment Phase|Physician Decision|0|||
164291129|NCT05579977|593436213|FG011|Treatment Phase|Physician Decision|1|||
164291130|NCT05579977|593436214|FG012|Treatment Phase|Physician Decision|0|||
164291131|NCT05579977|593436202|FG000|Treatment Phase|Lost to Follow-up|0|||
164291132|NCT05579977|593436203|FG001|Treatment Phase|Lost to Follow-up|0|||
164291133|NCT05579977|593436204|FG002|Treatment Phase|Lost to Follow-up|0|||
164291134|NCT05579977|593436205|FG003|Treatment Phase|Lost to Follow-up|1|||
164291135|NCT05579977|593436206|FG004|Treatment Phase|Lost to Follow-up|1|||
164291136|NCT05579977|593436207|FG005|Treatment Phase|Lost to Follow-up|1|||
164291137|NCT05579977|593436208|FG006|Treatment Phase|Lost to Follow-up|0|||
164291138|NCT05579977|593436209|FG007|Treatment Phase|Lost to Follow-up|1|||
164291139|NCT05579977|593436210|FG008|Treatment Phase|Lost to Follow-up|2|||
164291140|NCT05579977|593436211|FG009|Treatment Phase|Lost to Follow-up|2|||
164291141|NCT05579977|593436212|FG010|Treatment Phase|Lost to Follow-up|1|||
164291142|NCT05579977|593436213|FG011|Treatment Phase|Lost to Follow-up|4|||
164291143|NCT05579977|593436214|FG012|Treatment Phase|Lost to Follow-up|3|||
164291144|NCT05579977|593436202|FG000|Treatment Phase|Death|1|||
164291145|NCT05579977|593436203|FG001|Treatment Phase|Death|0|||
164291146|NCT05579977|593436204|FG002|Treatment Phase|Death|0|||
164291147|NCT05579977|593436205|FG003|Treatment Phase|Death|0|||
164291148|NCT05579977|593436206|FG004|Treatment Phase|Death|0|||
164291149|NCT05579977|593436207|FG005|Treatment Phase|Death|0|||
164291150|NCT05579977|593436208|FG006|Treatment Phase|Death|0|||
164291151|NCT05579977|593436209|FG007|Treatment Phase|Death|0|||
164291152|NCT05579977|593436210|FG008|Treatment Phase|Death|0|||
164291153|NCT05579977|593436211|FG009|Treatment Phase|Death|0|||
164291154|NCT05579977|593436212|FG010|Treatment Phase|Death|0|||
164291155|NCT05579977|593436213|FG011|Treatment Phase|Death|0|||
164291156|NCT05579977|593436214|FG012|Treatment Phase|Death|0|||
164291157|NCT05579977|593436202|FG000|Treatment Phase|Adverse Event|0|||
164291158|NCT05579977|593436203|FG001|Treatment Phase|Adverse Event|3|||
164291159|NCT05579977|593436204|FG002|Treatment Phase|Adverse Event|11|||
164291160|NCT05579977|593436205|FG003|Treatment Phase|Adverse Event|10|||
164291161|NCT05579977|593436206|FG004|Treatment Phase|Adverse Event|5|||
164291162|NCT05579977|593436207|FG005|Treatment Phase|Adverse Event|17|||
164291163|NCT05579977|593436208|FG006|Treatment Phase|Adverse Event|5|||
164291164|NCT05579977|593436209|FG007|Treatment Phase|Adverse Event|5|||
164291165|NCT05579977|593436210|FG008|Treatment Phase|Adverse Event|12|||
164291166|NCT05579977|593436211|FG009|Treatment Phase|Adverse Event|20|||
164291167|NCT05579977|593436212|FG010|Treatment Phase|Adverse Event|15|||
164291168|NCT05579977|593436213|FG011|Treatment Phase|Adverse Event|24|||
164291169|NCT05579977|593436214|FG012|Treatment Phase|Adverse Event|23|||
164291170|NCT05579977|593436202|FG000|Treatment Phase|Randomized not treated|0|||
164291171|NCT05579977|593436203|FG001|Treatment Phase|Randomized not treated|0|||
164345689|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
163897821|NCT03660930|591998728|FG004|Overall Study|Adverse Event|0|||
164291172|NCT05579977|593436204|FG002|Treatment Phase|Randomized not treated|0|||
164291173|NCT05579977|593436205|FG003|Treatment Phase|Randomized not treated|0|||
164291174|NCT05579977|593436206|FG004|Treatment Phase|Randomized not treated|1|||
164291175|NCT05579977|593436207|FG005|Treatment Phase|Randomized not treated|0|||
164291176|NCT05579977|593436208|FG006|Treatment Phase|Randomized not treated|0|||
164291177|NCT05579977|593436209|FG007|Treatment Phase|Randomized not treated|0|||
164291178|NCT05579977|593436210|FG008|Treatment Phase|Randomized not treated|0|||
164291179|NCT05579977|593436211|FG009|Treatment Phase|Randomized not treated|0|||
164291180|NCT05579977|593436212|FG010|Treatment Phase|Randomized not treated|0|||
164291181|NCT05579977|593436213|FG011|Treatment Phase|Randomized not treated|0|||
164291182|NCT05579977|593436214|FG012|Treatment Phase|Randomized not treated|0|||
164291183|NCT05579977|593436202|FG000|Follow up|Death|1|||
164291184|NCT05579977|593436203|FG001|Follow up|Death|0|||
164291185|NCT05579977|593436204|FG002|Follow up|Death|0|||
164291186|NCT05579977|593436205|FG003|Follow up|Death|0|||
164291187|NCT05579977|593436206|FG004|Follow up|Death|0|||
164291188|NCT05579977|593436207|FG005|Follow up|Death|0|||
164291189|NCT05579977|593436208|FG006|Follow up|Death|0|||
164291190|NCT05579977|593436209|FG007|Follow up|Death|0|||
164291191|NCT05579977|593436210|FG008|Follow up|Death|0|||
164291192|NCT05579977|593436211|FG009|Follow up|Death|0|||
164291193|NCT05579977|593436212|FG010|Follow up|Death|0|||
164291194|NCT05579977|593436213|FG011|Follow up|Death|0|||
164291195|NCT05579977|593436214|FG012|Follow up|Death|0|||
164291196|NCT05579977|593436202|FG000|Follow up|Lost to Follow-up|0|||
164291197|NCT05579977|593436203|FG001|Follow up|Lost to Follow-up|0|||
164291198|NCT05579977|593436204|FG002|Follow up|Lost to Follow-up|0|||
164291199|NCT05579977|593436205|FG003|Follow up|Lost to Follow-up|1|||
164291200|NCT05579977|593436206|FG004|Follow up|Lost to Follow-up|1|||
164291201|NCT05579977|593436207|FG005|Follow up|Lost to Follow-up|2|||
164291202|NCT05579977|593436208|FG006|Follow up|Lost to Follow-up|1|||
164291203|NCT05579977|593436209|FG007|Follow up|Lost to Follow-up|1|||
164291204|NCT05579977|593436210|FG008|Follow up|Lost to Follow-up|3|||
164291205|NCT05579977|593436211|FG009|Follow up|Lost to Follow-up|2|||
164291206|NCT05579977|593436212|FG010|Follow up|Lost to Follow-up|2|||
164291207|NCT05579977|593436213|FG011|Follow up|Lost to Follow-up|4|||
164291208|NCT05579977|593436214|FG012|Follow up|Lost to Follow-up|4|||
164291209|NCT05579977|593436202|FG000|Follow up|Withdrawal by Subject|2|||
164291210|NCT05579977|593436203|FG001|Follow up|Withdrawal by Subject|0|||
164291211|NCT05579977|593436204|FG002|Follow up|Withdrawal by Subject|0|||
164088100|NCT04000009|592687347|FG000|Overall Study|Lost to Follow-up|8|||
164088101|NCT04000009|592687347|FG000|Overall Study|Noncompliance with study drug|4|||
164291212|NCT05579977|593436205|FG003|Follow up|Withdrawal by Subject|0|||
164291213|NCT05579977|593436206|FG004|Follow up|Withdrawal by Subject|1|||
164291214|NCT05579977|593436207|FG005|Follow up|Withdrawal by Subject|0|||
164291215|NCT05579977|593436208|FG006|Follow up|Withdrawal by Subject|1|||
164291216|NCT05579977|593436209|FG007|Follow up|Withdrawal by Subject|4|||
164291217|NCT05579977|593436210|FG008|Follow up|Withdrawal by Subject|2|||
164291218|NCT05579977|593436211|FG009|Follow up|Withdrawal by Subject|3|||
164291219|NCT05579977|593436212|FG010|Follow up|Withdrawal by Subject|3|||
164291220|NCT05579977|593436213|FG011|Follow up|Withdrawal by Subject|1|||
164291221|NCT05579977|593436214|FG012|Follow up|Withdrawal by Subject|3|||
164291222|NCT00348673|593436215|FG000|Stage 1|Randomized but not Treated|0|||
164291223|NCT00348673|593436216|FG001|Stage 1|Randomized but not Treated|0|||
164291224|NCT00348673|593436217|FG002|Stage 1|Randomized but not Treated|1|||
164291225|NCT00348673|593436218|FG003|Stage 1|Randomized but not Treated|0|||
164291226|NCT00348673|593436219|FG004|Stage 1|Randomized but not Treated|0|||
164291227|NCT00348673|593436220|FG005|Stage 1|Randomized but not Treated|0|||
164291228|NCT00348673|593436221|FG006|Stage 1|Randomized but not Treated|0|||
164291229|NCT00348673|593436222|FG007|Stage 1|Randomized but not Treated|0|||
164291230|NCT00348673|593436223|FG008|Stage 1|Randomized but not Treated|0|||
164291231|NCT01928927|593436225|FG000|Overall Study|Lost to Follow-up|1|||
164291232|NCT01928927|593436226|FG001|Overall Study|Lost to Follow-up|0|||
164291233|NCT01928927|593436225|FG000|Overall Study|Withdrawal by Subject|1|||
164291234|NCT01928927|593436226|FG001|Overall Study|Withdrawal by Subject|1|||
164291235|NCT00350844|593436229|FG000|Overall Study|Lost to Follow-up|1|||
164291236|NCT01420926|593436230|FG000|Overall Study|Adverse Event|6|||
164291237|NCT01420926|593436231|FG001|Overall Study|Adverse Event|4|||
164291238|NCT01420926|593436230|FG000|Overall Study|Death|18|||
164291239|NCT01420926|593436231|FG001|Overall Study|Death|17|||
164291240|NCT01420926|593436230|FG000|Overall Study|Withdrawal by Subject|11|||
164291241|NCT01420926|593436231|FG001|Overall Study|Withdrawal by Subject|17|||
164291242|NCT01420926|593436230|FG000|Overall Study|Non-protocol treatment|17|||
164291243|NCT01420926|593436231|FG001|Overall Study|Non-protocol treatment|20|||
164291244|NCT01420926|593436230|FG000|Overall Study|Physician Decision|8|||
164291245|NCT01420926|593436231|FG001|Overall Study|Physician Decision|5|||
164291246|NCT04564846|593437997|FG000|Overall Study|Withdrawal by Subject|2|||
164291247|NCT04564846|593437998|FG001|Overall Study|Withdrawal by Subject|1|||
164291248|NCT04564846|593437997|FG000|Overall Study|Physician Decision|0|||
164291249|NCT04564846|593437998|FG001|Overall Study|Physician Decision|1|||
164291250|NCT04564846|593437997|FG000|Overall Study|Lost to Follow-up|0|||
164291251|NCT04564846|593437998|FG001|Overall Study|Lost to Follow-up|1|||
164291252|NCT04564846|593437997|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
164291253|NCT04564846|593437998|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
164291254|NCT04564846|593437997|FG000|Overall Study|Subject non-compliance|1|||
164291255|NCT04564846|593437998|FG001|Overall Study|Subject non-compliance|0|||
164088102|NCT04000009|592687347|FG000|Overall Study|Physician Decision|1|||
164291256|NCT03798717|593437999|FG000|Overall Study|Failed Screening|0|||
164291257|NCT03798717|593438000|FG001|Overall Study|Failed Screening|0|||
164291258|NCT03798717|593438001|FG002|Overall Study|Failed Screening|0|||
164291259|NCT03798717|593438002|FG003|Overall Study|Failed Screening|0|||
164291260|NCT03798717|593438003|FG004|Overall Study|Failed Screening|0|||
164291261|NCT03798717|593438004|FG005|Overall Study|Failed Screening|1|||
164291262|NCT03798717|593437999|FG000|Overall Study|Physician Decision|1|||
164291263|NCT03798717|593438000|FG001|Overall Study|Physician Decision|0|||
164291264|NCT03798717|593438001|FG002|Overall Study|Physician Decision|1|||
164291265|NCT03798717|593438002|FG003|Overall Study|Physician Decision|0|||
164291266|NCT03798717|593438003|FG004|Overall Study|Physician Decision|0|||
164291267|NCT03798717|593438004|FG005|Overall Study|Physician Decision|0|||
164291268|NCT03798717|593437999|FG000|Overall Study|Withdrawal by Subject|0|||
164291269|NCT03798717|593438000|FG001|Overall Study|Withdrawal by Subject|0|||
164291270|NCT03798717|593438001|FG002|Overall Study|Withdrawal by Subject|0|||
164291271|NCT03798717|593438002|FG003|Overall Study|Withdrawal by Subject|1|||
164291272|NCT03798717|593438003|FG004|Overall Study|Withdrawal by Subject|0|||
164291273|NCT03798717|593438004|FG005|Overall Study|Withdrawal by Subject|0|||
164291274|NCT03798717|593437999|FG000|Overall Study|Lost to Follow-up|1|||
164291275|NCT03798717|593438000|FG001|Overall Study|Lost to Follow-up|0|||
164291276|NCT03798717|593438001|FG002|Overall Study|Lost to Follow-up|0|||
164291277|NCT03798717|593438002|FG003|Overall Study|Lost to Follow-up|1|||
164291278|NCT03798717|593438003|FG004|Overall Study|Lost to Follow-up|0|||
164345690|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
164345691|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
164345692|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
164345693|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164345694|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
164345695|NCT00726232|593641001|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
164345696|NCT00726232|593641002|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345697|NCT00726232|593641003|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345698|NCT00726232|593641004|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345699|NCT00726232|593641005|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345700|NCT00726232|593641006|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345701|NCT00726232|593641007|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345702|NCT00726232|593641008|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
164345703|NCT00726232|593641001|FG000|Expansion Phase|Death|0|||
164345704|NCT00726232|593641002|FG001|Expansion Phase|Death|0|||
164345705|NCT00726232|593641003|FG002|Expansion Phase|Death|0|||
164345706|NCT00726232|593641004|FG003|Expansion Phase|Death|0|||
164345707|NCT00726232|593641005|FG004|Expansion Phase|Death|0|||
164345708|NCT00726232|593641006|FG005|Expansion Phase|Death|0|||
164345709|NCT00726232|593641007|FG006|Expansion Phase|Death|0|||
164345710|NCT00726232|593641008|FG007|Expansion Phase|Death|1|||
164345711|NCT00726232|593641001|FG000|Expansion Phase|Adverse Event|0|||
164345712|NCT00726232|593641002|FG001|Expansion Phase|Adverse Event|0|||
164345713|NCT00726232|593641003|FG002|Expansion Phase|Adverse Event|0|||
164345714|NCT00726232|593641004|FG003|Expansion Phase|Adverse Event|0|||
164345715|NCT00726232|593641005|FG004|Expansion Phase|Adverse Event|0|||
164345716|NCT00726232|593641006|FG005|Expansion Phase|Adverse Event|0|||
164291279|NCT03798717|593438004|FG005|Overall Study|Lost to Follow-up|0|||
164291280|NCT03798717|593437999|FG000|Overall Study|Adverse Event|0|||
164291281|NCT03798717|593438000|FG001|Overall Study|Adverse Event|1|||
164291282|NCT03798717|593438001|FG002|Overall Study|Adverse Event|0|||
164345717|NCT00726232|593641007|FG006|Expansion Phase|Adverse Event|6|||
164345718|NCT00726232|593641008|FG007|Expansion Phase|Adverse Event|11|||
164345719|NCT00726232|593641001|FG000|Expansion Phase|Withdrawal by Subject|0|||
164345720|NCT00726232|593641002|FG001|Expansion Phase|Withdrawal by Subject|0|||
164345721|NCT00726232|593641003|FG002|Expansion Phase|Withdrawal by Subject|0|||
164291283|NCT03798717|593438002|FG003|Overall Study|Adverse Event|0|||
164291284|NCT03798717|593438003|FG004|Overall Study|Adverse Event|0|||
164291285|NCT03798717|593438004|FG005|Overall Study|Adverse Event|0|||
164088103|NCT04000009|592687347|FG000|Overall Study|Use of prohibited medication|3|||
164088104|NCT04000009|592687347|FG000|Overall Study|Pregnancy|1|||
164345722|NCT00726232|593641004|FG003|Expansion Phase|Withdrawal by Subject|0|||
164345723|NCT00726232|593641005|FG004|Expansion Phase|Withdrawal by Subject|0|||
164345724|NCT00726232|593641006|FG005|Expansion Phase|Withdrawal by Subject|0|||
164345725|NCT00726232|593641007|FG006|Expansion Phase|Withdrawal by Subject|2|||
164345726|NCT00726232|593641008|FG007|Expansion Phase|Withdrawal by Subject|3|||
164345727|NCT00726232|593641001|FG000|Expansion Phase|Disease progression|0|||
164345728|NCT00726232|593641002|FG001|Expansion Phase|Disease progression|0|||
164345729|NCT00726232|593641003|FG002|Expansion Phase|Disease progression|0|||
164345730|NCT00726232|593641004|FG003|Expansion Phase|Disease progression|0|||
164345731|NCT00726232|593641005|FG004|Expansion Phase|Disease progression|0|||
164345732|NCT00726232|593641006|FG005|Expansion Phase|Disease progression|0|||
164345733|NCT00726232|593641007|FG006|Expansion Phase|Disease progression|4|||
164345734|NCT00726232|593641008|FG007|Expansion Phase|Disease progression|0|||
164345735|NCT00726232|593641001|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
164345736|NCT00726232|593641002|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
164345737|NCT00726232|593641003|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
164345738|NCT00726232|593641004|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
164345739|NCT00726232|593641005|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
164345740|NCT00726232|593641006|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
164345741|NCT00726232|593641007|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
164345742|NCT00726232|593641008|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
164345743|NCT00726232|593641001|FG000|Expansion Phase|Per Investigator: lack of response|0|||
164345744|NCT00726232|593641002|FG001|Expansion Phase|Per Investigator: lack of response|0|||
164345745|NCT00726232|593641003|FG002|Expansion Phase|Per Investigator: lack of response|0|||
164345746|NCT00726232|593641004|FG003|Expansion Phase|Per Investigator: lack of response|0|||
164345747|NCT00726232|593641005|FG004|Expansion Phase|Per Investigator: lack of response|0|||
164345748|NCT00726232|593641006|FG005|Expansion Phase|Per Investigator: lack of response|0|||
164345749|NCT00726232|593641007|FG006|Expansion Phase|Per Investigator: lack of response|1|||
164345750|NCT00726232|593641008|FG007|Expansion Phase|Per Investigator: lack of response|7|||
164345751|NCT00726232|593641001|FG000|Expansion Phase|Unspecified reason|0|||
164345752|NCT00726232|593641002|FG001|Expansion Phase|Unspecified reason|0|||
164345753|NCT00726232|593641003|FG002|Expansion Phase|Unspecified reason|0|||
164345754|NCT00726232|593641004|FG003|Expansion Phase|Unspecified reason|0|||
164345755|NCT00726232|593641005|FG004|Expansion Phase|Unspecified reason|0|||
164345756|NCT00726232|593641006|FG005|Expansion Phase|Unspecified reason|0|||
164345757|NCT00726232|593641007|FG006|Expansion Phase|Unspecified reason|1|||
164345758|NCT00726232|593641008|FG007|Expansion Phase|Unspecified reason|0|||
164345759|NCT01203098|593641011|FG000|Overall Study|Adverse Event|3|||
164345760|NCT01203098|593641012|FG001|Overall Study|Adverse Event|1|||
164345761|NCT01203098|593641013|FG002|Overall Study|Adverse Event|7|||
164345762|NCT01203098|593641011|FG000|Overall Study|Lost to Follow-up|0|||
164345763|NCT01203098|593641012|FG001|Overall Study|Lost to Follow-up|0|||
164345764|NCT01203098|593641013|FG002|Overall Study|Lost to Follow-up|1|||
164345765|NCT01203098|593641011|FG000|Overall Study|Physician Decision|2|||
164345766|NCT01203098|593641012|FG001|Overall Study|Physician Decision|2|||
164345767|NCT01203098|593641013|FG002|Overall Study|Physician Decision|0|||
164345768|NCT01203098|593641011|FG000|Overall Study|Withdrawal by Subject|1|||
164345769|NCT01203098|593641012|FG001|Overall Study|Withdrawal by Subject|1|||
164345770|NCT01203098|593641013|FG002|Overall Study|Withdrawal by Subject|3|||
164345771|NCT03095612|593641018|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345772|NCT03095612|593641019|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
164345773|NCT03095612|593641020|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345774|NCT03095612|593641021|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345775|NCT03095612|593641022|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345776|NCT03095612|593641023|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345777|NCT03095612|593641024|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
164345778|NCT00621582|593641025|FG000|Overall Study|Adverse Event|7|||
164345779|NCT00621582|593641025|FG000|Overall Study|Protocol Violation|57|||
164345780|NCT00621582|593641025|FG000|Overall Study|Lost to Follow-up|24|||
164345781|NCT00621582|593641025|FG000|Overall Study|issues not identified by investigators|18|||
164345782|NCT01042678|593641026|FG000|Overall Study|Physician Decision|1|||
163897822|NCT03660930|591998729|FG005|Overall Study|Adverse Event|1|||
164088105|NCT04000009|592687347|FG000|Overall Study|Withdrawal by Subject|22|||
164345783|NCT01042678|593641027|FG001|Overall Study|Physician Decision|0|||
164345784|NCT01042678|593641028|FG002|Overall Study|Physician Decision|0|||
164345785|NCT01042678|593641029|FG003|Overall Study|Physician Decision|0|||
164345786|NCT01042678|593641030|FG004|Overall Study|Physician Decision|0|||
164345787|NCT01042678|593641031|FG005|Overall Study|Physician Decision|0|||
164345788|NCT01387932|593641032|FG000|Randomized and Treated|Physician Decision|3|||
164345789|NCT01387932|593641033|FG001|Randomized and Treated|Physician Decision|2|||
164291286|NCT03798717|593437999|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291287|NCT03798717|593438000|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291288|NCT03798717|593438001|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291289|NCT03798717|593438002|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291290|NCT03798717|593438003|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
164291291|NCT03798717|593438004|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
164291292|NCT00179621|593438005|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
164291293|NCT00179621|593438006|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
164291294|NCT00179621|593438007|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
164291295|NCT00179621|593438008|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
164291296|NCT00179621|593438005|FG000|Double-Blind Period|Adverse Event|2|||
164291297|NCT00179621|593438006|FG001|Double-Blind Period|Adverse Event|7|||
164291298|NCT00179621|593438007|FG002|Double-Blind Period|Adverse Event|4|||
164291299|NCT00179621|593438008|FG003|Double-Blind Period|Adverse Event|0|||
164291300|NCT00179621|593438005|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164291301|NCT00179621|593438006|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164291302|NCT00179621|593438007|FG002|Double-Blind Period|Withdrawal by Subject|3|||
164291303|NCT00179621|593438008|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164291304|NCT00179621|593438005|FG000|Double-Blind Period|Death|0|||
164291305|NCT00179621|593438006|FG001|Double-Blind Period|Death|1|||
164291306|NCT00179621|593438007|FG002|Double-Blind Period|Death|2|||
164291307|NCT00179621|593438008|FG003|Double-Blind Period|Death|0|||
164291308|NCT00179621|593438005|FG000|Double-Blind Period|Protocol Violation|1|||
164291309|NCT00179621|593438006|FG001|Double-Blind Period|Protocol Violation|0|||
164291310|NCT00179621|593438007|FG002|Double-Blind Period|Protocol Violation|0|||
164291311|NCT00179621|593438008|FG003|Double-Blind Period|Protocol Violation|0|||
164291312|NCT00179621|593438005|FG000|Double-Blind Period|Other|0|||
164291313|NCT00179621|593438006|FG001|Double-Blind Period|Other|2|||
164291314|NCT00179621|593438007|FG002|Double-Blind Period|Other|2|||
164291315|NCT00179621|593438008|FG003|Double-Blind Period|Other|0|||
164291316|NCT00179621|593438005|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
164291317|NCT00179621|593438006|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
164291318|NCT00179621|593438007|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
164291319|NCT00179621|593438008|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
164291320|NCT00179621|593438005|FG000|Open-Label Period|Adverse Event|0|||
164291321|NCT00179621|593438006|FG001|Open-Label Period|Adverse Event|6|||
164291322|NCT00179621|593438007|FG002|Open-Label Period|Adverse Event|5|||
164291323|NCT00179621|593438008|FG003|Open-Label Period|Adverse Event|6|||
164291324|NCT00179621|593438005|FG000|Open-Label Period|Withdrawal by Subject|0|||
164291325|NCT00179621|593438006|FG001|Open-Label Period|Withdrawal by Subject|2|||
164291326|NCT00179621|593438007|FG002|Open-Label Period|Withdrawal by Subject|2|||
164291327|NCT00179621|593438008|FG003|Open-Label Period|Withdrawal by Subject|2|||
164291328|NCT00179621|593438005|FG000|Open-Label Period|Death|0|||
164291329|NCT00179621|593438006|FG001|Open-Label Period|Death|0|||
164291330|NCT00179621|593438007|FG002|Open-Label Period|Death|1|||
164291331|NCT00179621|593438008|FG003|Open-Label Period|Death|2|||
164291332|NCT00179621|593438005|FG000|Open-Label Period|Other|0|||
164291333|NCT00179621|593438006|FG001|Open-Label Period|Other|1|||
164291334|NCT00179621|593438007|FG002|Open-Label Period|Other|1|||
164291335|NCT00179621|593438008|FG003|Open-Label Period|Other|2|||
164291336|NCT00865345|593438009|FG000|Overall Study|Withdrawal by Subject|2|||
164291337|NCT00966654|593438014|FG000|Overall Study|Study was terminated,PI left institution|12|||
164291338|NCT00882440|593438017|FG000|Overall Study|Adverse Event|2|||
164291339|NCT00882440|593438018|FG001|Overall Study|Adverse Event|2|||
164291340|NCT00882440|593438019|FG002|Overall Study|Adverse Event|2|||
164291341|NCT00882440|593438020|FG003|Overall Study|Adverse Event|1|||
164291342|NCT00882440|593438021|FG004|Overall Study|Adverse Event|1|||
164291343|NCT00882440|593438022|FG005|Overall Study|Adverse Event|4|||
164291344|NCT00882440|593438023|FG006|Overall Study|Adverse Event|2|||
164291345|NCT00882440|593438017|FG000|Overall Study|Lack of Efficacy|3|||
164291346|NCT00882440|593438018|FG001|Overall Study|Lack of Efficacy|5|||
164291347|NCT00882440|593438019|FG002|Overall Study|Lack of Efficacy|2|||
164291348|NCT00882440|593438020|FG003|Overall Study|Lack of Efficacy|0|||
164291349|NCT00882440|593438021|FG004|Overall Study|Lack of Efficacy|0|||
164291350|NCT00882440|593438022|FG005|Overall Study|Lack of Efficacy|3|||
164291351|NCT00882440|593438023|FG006|Overall Study|Lack of Efficacy|0|||
164291352|NCT00882440|593438017|FG000|Overall Study|Lost to Follow-up|2|||
164291353|NCT00882440|593438018|FG001|Overall Study|Lost to Follow-up|0|||
164291354|NCT00882440|593438019|FG002|Overall Study|Lost to Follow-up|1|||
164291355|NCT00882440|593438020|FG003|Overall Study|Lost to Follow-up|1|||
164291356|NCT00882440|593438021|FG004|Overall Study|Lost to Follow-up|1|||
164291357|NCT00882440|593438022|FG005|Overall Study|Lost to Follow-up|0|||
164291358|NCT00882440|593438023|FG006|Overall Study|Lost to Follow-up|1|||
164291359|NCT00882440|593438017|FG000|Overall Study|Protocol Violation|0|||
164291360|NCT00882440|593438018|FG001|Overall Study|Protocol Violation|0|||
164291361|NCT00882440|593438019|FG002|Overall Study|Protocol Violation|1|||
164291362|NCT00882440|593438020|FG003|Overall Study|Protocol Violation|1|||
164291363|NCT00882440|593438021|FG004|Overall Study|Protocol Violation|1|||
164291364|NCT00882440|593438022|FG005|Overall Study|Protocol Violation|0|||
164345790|NCT01387932|593641032|FG000|Randomized and Treated|Withdrawal by Subject|4|||
164345791|NCT01387932|593641033|FG001|Randomized and Treated|Withdrawal by Subject|2|||
164345792|NCT01387932|593641032|FG000|Survival Follow-up|Liver Transplant|24|||
164345793|NCT01387932|593641033|FG001|Survival Follow-up|Liver Transplant|28|||
164345794|NCT01387932|593641032|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
164345795|NCT01387932|593641033|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
164345796|NCT01387932|593641032|FG000|Survival Follow-up|Withdrawal by Subject|2|||
164345797|NCT01387932|593641033|FG001|Survival Follow-up|Withdrawal by Subject|4|||
164345798|NCT01387932|593641032|FG000|Survival Follow-up|Lost to Follow-up|6|||
164345799|NCT01387932|593641033|FG001|Survival Follow-up|Lost to Follow-up|5|||
164345800|NCT02197520|593641036|FG000|Period 1|Withdrawal by Subject|1|||
164345801|NCT02197520|593641037|FG001|Period 1|Withdrawal by Subject|0|||
164345802|NCT02197520|593641036|FG000|Period 2|Adverse Event|0|||
164345803|NCT02197520|593641037|FG001|Period 2|Adverse Event|2|||
164345804|NCT02197520|593641036|FG000|Period 2|Withdrawal by Subject|1|||
164345805|NCT02197520|593641037|FG001|Period 2|Withdrawal by Subject|0|||
164345806|NCT03208244|593641038|FG000|Overall Study|Death|1|||
164345807|NCT04431453|593641043|FG000|Overall Study|Withdrew Consent|0|||
164345808|NCT04431453|593641044|FG001|Overall Study|Withdrew Consent|1|||
164345809|NCT04431453|593641045|FG002|Overall Study|Withdrew Consent|0|||
164345810|NCT04431453|593641046|FG003|Overall Study|Withdrew Consent|2|||
164345811|NCT04431453|593641047|FG004|Overall Study|Withdrew Consent|0|||
164345812|NCT04431453|593641048|FG005|Overall Study|Withdrew Consent|0|||
164345813|NCT04431453|593641049|FG006|Overall Study|Withdrew Consent|0|||
164345814|NCT04431453|593641050|FG007|Overall Study|Withdrew Consent|0|||
164345815|NCT04431453|593641043|FG000|Overall Study|Death|1|||
164345816|NCT04431453|593641044|FG001|Overall Study|Death|0|||
164345817|NCT04431453|593641045|FG002|Overall Study|Death|0|||
164345818|NCT04431453|593641046|FG003|Overall Study|Death|0|||
164345819|NCT04431453|593641047|FG004|Overall Study|Death|0|||
164345820|NCT04431453|593641048|FG005|Overall Study|Death|0|||
164345821|NCT04431453|593641049|FG006|Overall Study|Death|0|||
164345822|NCT04431453|593641050|FG007|Overall Study|Death|1|||
164345823|NCT04431453|593641043|FG000|Overall Study|Lost to Follow-up|0|||
164345824|NCT04431453|593641044|FG001|Overall Study|Lost to Follow-up|0|||
164345825|NCT04431453|593641045|FG002|Overall Study|Lost to Follow-up|1|||
164345826|NCT04431453|593641046|FG003|Overall Study|Lost to Follow-up|1|||
164345827|NCT04431453|593641047|FG004|Overall Study|Lost to Follow-up|0|||
164345828|NCT04431453|593641048|FG005|Overall Study|Lost to Follow-up|0|||
164345829|NCT04431453|593641049|FG006|Overall Study|Lost to Follow-up|0|||
164345830|NCT04431453|593641050|FG007|Overall Study|Lost to Follow-up|0|||
164345831|NCT04431453|593641043|FG000|Overall Study|Enrolled but Never Treated|0|||
164345832|NCT04431453|593641044|FG001|Overall Study|Enrolled but Never Treated|0|||
164345833|NCT04431453|593641045|FG002|Overall Study|Enrolled but Never Treated|0|||
164345834|NCT04431453|593641046|FG003|Overall Study|Enrolled but Never Treated|0|||
164345835|NCT04431453|593641047|FG004|Overall Study|Enrolled but Never Treated|1|||
164345836|NCT04431453|593641048|FG005|Overall Study|Enrolled but Never Treated|0|||
164345837|NCT04431453|593641049|FG006|Overall Study|Enrolled but Never Treated|0|||
164345838|NCT04431453|593641050|FG007|Overall Study|Enrolled but Never Treated|0|||
164345839|NCT03385564|593641051|FG000|Overall Study|Adverse Event|0|||
164345840|NCT03385564|593641052|FG001|Overall Study|Adverse Event|0|||
164345841|NCT03385564|593641053|FG002|Overall Study|Adverse Event|3|||
164345842|NCT03385564|593641054|FG003|Overall Study|Adverse Event|3|||
164291365|NCT00882440|593438023|FG006|Overall Study|Protocol Violation|0|||
164291366|NCT00882440|593438017|FG000|Overall Study|Withdrawal by Subject|2|||
164291367|NCT00882440|593438018|FG001|Overall Study|Withdrawal by Subject|1|||
164291368|NCT00882440|593438019|FG002|Overall Study|Withdrawal by Subject|1|||
164345843|NCT03385564|593641051|FG000|Overall Study|Other than listed|0|||
164345844|NCT03385564|593641052|FG001|Overall Study|Other than listed|0|||
164345845|NCT03385564|593641053|FG002|Overall Study|Other than listed|0|||
164345846|NCT03385564|593641054|FG003|Overall Study|Other than listed|5|||
164345847|NCT03385564|593641051|FG000|Overall Study|Withdrawal by Subject|0|||
164345848|NCT03385564|593641052|FG001|Overall Study|Withdrawal by Subject|1|||
164345849|NCT03385564|593641053|FG002|Overall Study|Withdrawal by Subject|1|||
164345850|NCT03385564|593641054|FG003|Overall Study|Withdrawal by Subject|0|||
164345851|NCT03385564|593641051|FG000|Overall Study|Lack of Efficacy|0|||
164345852|NCT03385564|593641052|FG001|Overall Study|Lack of Efficacy|0|||
164345853|NCT03385564|593641053|FG002|Overall Study|Lack of Efficacy|0|||
163897823|NCT03660930|591998730|FG006|Overall Study|Adverse Event|0|||
163897824|NCT03660930|591998731|FG007|Overall Study|Adverse Event|0|||
164291369|NCT00882440|593438020|FG003|Overall Study|Withdrawal by Subject|0|||
164291370|NCT00882440|593438021|FG004|Overall Study|Withdrawal by Subject|6|||
164291371|NCT00882440|593438022|FG005|Overall Study|Withdrawal by Subject|0|||
164291372|NCT00882440|593438023|FG006|Overall Study|Withdrawal by Subject|1|||
164291373|NCT00882440|593438017|FG000|Overall Study|Patient Uncooperative|2|||
164291374|NCT00882440|593438018|FG001|Overall Study|Patient Uncooperative|0|||
164291375|NCT00882440|593438019|FG002|Overall Study|Patient Uncooperative|0|||
164291376|NCT00882440|593438020|FG003|Overall Study|Patient Uncooperative|0|||
164291377|NCT00882440|593438021|FG004|Overall Study|Patient Uncooperative|1|||
164291378|NCT00882440|593438022|FG005|Overall Study|Patient Uncooperative|0|||
164291379|NCT00882440|593438023|FG006|Overall Study|Patient Uncooperative|0|||
164291380|NCT05482308|593438027|FG000|Overall Study|Withdrawal by Subject|1|||
164291381|NCT05482308|593438028|FG001|Overall Study|Withdrawal by Subject|0|||
164291382|NCT05482308|593438027|FG000|Overall Study|No longer meets eligibility criteria|0|||
164291383|NCT05482308|593438028|FG001|Overall Study|No longer meets eligibility criteria|1|||
164291384|NCT01693029|593438037|FG000|Overall Study|Withdrawal by Subject|15|||
164291385|NCT01693029|593438038|FG001|Overall Study|Withdrawal by Subject|22|||
164291386|NCT01693029|593438037|FG000|Overall Study|Kidney transplantation|7|||
164291387|NCT01693029|593438038|FG001|Overall Study|Kidney transplantation|7|||
164291388|NCT01693029|593438037|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
164291389|NCT01693029|593438038|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
164291390|NCT01693029|593438037|FG000|Overall Study|Protocol Violation|6|||
164291391|NCT01693029|593438038|FG001|Overall Study|Protocol Violation|7|||
164291392|NCT01693029|593438037|FG000|Overall Study|Change in dialysis modality|2|||
164291393|NCT01693029|593438038|FG001|Overall Study|Change in dialysis modality|1|||
164291394|NCT01693029|593438037|FG000|Overall Study|Physician Decision|0|||
164291395|NCT01693029|593438038|FG001|Overall Study|Physician Decision|2|||
164291396|NCT01693029|593438037|FG000|Overall Study|Lost to Follow-up|0|||
164291397|NCT01693029|593438038|FG001|Overall Study|Lost to Follow-up|1|||
164291398|NCT01693029|593438037|FG000|Overall Study|Adverse Event|1|||
164291399|NCT01693029|593438038|FG001|Overall Study|Adverse Event|6|||
164291400|NCT01693029|593438037|FG000|Overall Study|Death|5|||
164291401|NCT01693029|593438038|FG001|Overall Study|Death|8|||
164291402|NCT01693029|593438037|FG000|Overall Study|Non-compliance|2|||
164291403|NCT01693029|593438038|FG001|Overall Study|Non-compliance|1|||
164291404|NCT01329263|593438039|FG000|Overall Study|Lost to Follow-up|4|||
164291405|NCT01329263|593438040|FG001|Overall Study|Lost to Follow-up|21|||
164291406|NCT01329263|593438039|FG000|Overall Study|Withdrawal by Subject|1|||
164291407|NCT01329263|593438040|FG001|Overall Study|Withdrawal by Subject|2|||
164291408|NCT01631435|593438042|FG000|Overall Study|Adverse Event|2|||
164291409|NCT01631435|593438042|FG000|Overall Study|Withdrawal by Subject|2|||
164291410|NCT01631435|593438042|FG000|Overall Study|incomplete study procedure|5|||
164291411|NCT01421017|593438043|FG000|Overall Study|Withdrawal by Subject|2|||
164291412|NCT01421017|593438044|FG001|Overall Study|Withdrawal by Subject|0|||
164291413|NCT01421017|593438045|FG002|Overall Study|Withdrawal by Subject|0|||
164291414|NCT01421017|593438043|FG000|Overall Study|POD|0|||
164291415|NCT01421017|593438044|FG001|Overall Study|POD|6|||
164291416|NCT01421017|593438045|FG002|Overall Study|POD|3|||
164291417|NCT02313766|593438046|FG000|Overall Study|surgery cancelled|1|||
164291418|NCT02313766|593438047|FG001|Overall Study|surgery cancelled|0|||
164291419|NCT02313766|593438048|FG002|Overall Study|surgery cancelled|0|||
164291420|NCT02313766|593438046|FG000|Overall Study|Lost to Follow-up|0|||
164291421|NCT02313766|593438047|FG001|Overall Study|Lost to Follow-up|2|||
164291422|NCT02313766|593438048|FG002|Overall Study|Lost to Follow-up|0|||
164291423|NCT02313766|593438046|FG000|Overall Study|Adverse Event|0|||
164291424|NCT02313766|593438047|FG001|Overall Study|Adverse Event|1|||
164291425|NCT02313766|593438048|FG002|Overall Study|Adverse Event|0|||
164291426|NCT01005251|593438051|FG000|Overall Study|Withdrawal by Subject|2|||
164291427|NCT01005251|593438052|FG001|Overall Study|Withdrawal by Subject|5|||
163897825|NCT03660930|591998724|FG000|Overall Study|Withdrawal by Subject|0|||
164291428|NCT01005251|593438053|FG002|Overall Study|Withdrawal by Subject|3|||
164291429|NCT01005251|593438054|FG003|Overall Study|Withdrawal by Subject|4|||
164291430|NCT01005251|593438055|FG004|Overall Study|Withdrawal by Subject|9|||
164291431|NCT01005251|593438051|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
164291432|NCT01005251|593438052|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164291433|NCT01005251|593438053|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
164291434|NCT01005251|593438054|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164291435|NCT01005251|593438055|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164291436|NCT01005251|593438051|FG000|Overall Study|Adverse Event|2|||
164291437|NCT01005251|593438052|FG001|Overall Study|Adverse Event|6|||
164291438|NCT01005251|593438053|FG002|Overall Study|Adverse Event|8|||
164291439|NCT01005251|593438054|FG003|Overall Study|Adverse Event|5|||
163897826|NCT03660930|591998725|FG001|Overall Study|Withdrawal by Subject|0|||
164291440|NCT01005251|593438055|FG004|Overall Study|Adverse Event|4|||
164291441|NCT01005251|593438051|FG000|Overall Study|Protocol Violation|1|||
164291442|NCT01005251|593438052|FG001|Overall Study|Protocol Violation|0|||
164291443|NCT01005251|593438053|FG002|Overall Study|Protocol Violation|0|||
164291444|NCT01005251|593438054|FG003|Overall Study|Protocol Violation|0|||
164291445|NCT01005251|593438055|FG004|Overall Study|Protocol Violation|2|||
164291446|NCT01005251|593438051|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
164345854|NCT03385564|593641054|FG003|Overall Study|Lack of Efficacy|1|||
164345855|NCT03385564|593641051|FG000|Overall Study|Death|0|||
164345856|NCT03385564|593641052|FG001|Overall Study|Death|0|||
164345857|NCT03385564|593641053|FG002|Overall Study|Death|1|||
164345858|NCT03385564|593641054|FG003|Overall Study|Death|0|||
164345859|NCT01702961|593641061|FG000|Overall Study|Additional treatment|3|||
164345860|NCT01702961|593641061|FG000|Overall Study|Progressive disease|5|||
164345861|NCT01702961|593641061|FG000|Overall Study|Relapse|20|||
164345862|NCT01702961|593641061|FG000|Overall Study|Death|6|||
164345863|NCT01702961|593641061|FG000|Overall Study|Lost to Follow-up|2|||
164345864|NCT01702961|593641061|FG000|Overall Study|Ongoing|11|||
164345865|NCT02405780|593641068|FG000|Period I|Adverse Event|8|||
164345866|NCT02405780|593641069|FG001|Period I|Adverse Event|0|||
164345867|NCT02405780|593641070|FG002|Period I|Adverse Event|3|||
164345868|NCT02405780|593641071|FG003|Period I|Adverse Event|7|||
164345869|NCT02405780|593641068|FG000|Period I|Medical reasons|1|||
164345870|NCT02405780|593641069|FG001|Period I|Medical reasons|1|||
164345871|NCT02405780|593641070|FG002|Period I|Medical reasons|0|||
164345872|NCT02405780|593641071|FG003|Period I|Medical reasons|1|||
164345873|NCT02405780|593641068|FG000|Period I|Screening Failure|1|||
164345874|NCT02405780|593641069|FG001|Period I|Screening Failure|0|||
164345875|NCT02405780|593641070|FG002|Period I|Screening Failure|1|||
164345876|NCT02405780|593641071|FG003|Period I|Screening Failure|0|||
164345877|NCT02405780|593641068|FG000|Period I|Withdrawal by Subject|9|||
164345878|NCT02405780|593641069|FG001|Period I|Withdrawal by Subject|1|||
164345879|NCT02405780|593641070|FG002|Period I|Withdrawal by Subject|3|||
164345880|NCT02405780|593641071|FG003|Period I|Withdrawal by Subject|4|||
164345881|NCT02405780|593641068|FG000|Period I|Non-compliance with study procedures|8|||
164345882|NCT02405780|593641069|FG001|Period I|Non-compliance with study procedures|6|||
164345883|NCT02405780|593641070|FG002|Period I|Non-compliance with study procedures|8|||
164345884|NCT02405780|593641071|FG003|Period I|Non-compliance with study procedures|11|||
164345885|NCT02405780|593641068|FG000|Period II|Adverse Event|3|||
164345886|NCT02405780|593641069|FG001|Period II|Adverse Event|5|||
164345887|NCT02405780|593641070|FG002|Period II|Adverse Event|4|||
164345888|NCT02405780|593641071|FG003|Period II|Adverse Event|11|||
164345889|NCT02405780|593641068|FG000|Period II|Medical reason|0|||
164345890|NCT02405780|593641069|FG001|Period II|Medical reason|1|||
164345891|NCT02405780|593641070|FG002|Period II|Medical reason|0|||
164345892|NCT02405780|593641071|FG003|Period II|Medical reason|0|||
164345893|NCT02405780|593641068|FG000|Period II|Pregnancy|0|||
164345894|NCT02405780|593641069|FG001|Period II|Pregnancy|0|||
164345895|NCT02405780|593641070|FG002|Period II|Pregnancy|1|||
164345896|NCT02405780|593641071|FG003|Period II|Pregnancy|0|||
164345897|NCT02405780|593641068|FG000|Period II|Withdrawal by Subject|7|||
164345898|NCT02405780|593641069|FG001|Period II|Withdrawal by Subject|4|||
164345899|NCT02405780|593641070|FG002|Period II|Withdrawal by Subject|0|||
164345900|NCT02405780|593641071|FG003|Period II|Withdrawal by Subject|3|||
164345901|NCT02405780|593641068|FG000|Period II|Non-compliance with study procedures|5|||
164345902|NCT02405780|593641069|FG001|Period II|Non-compliance with study procedures|2|||
164345903|NCT02405780|593641070|FG002|Period II|Non-compliance with study procedures|7|||
164345904|NCT02405780|593641071|FG003|Period II|Non-compliance with study procedures|4|||
164345905|NCT00668707|593641072|FG000|Overall Study|Cancer Recurrence|58|||
164345906|NCT00668707|593641073|FG001|Overall Study|Cancer Recurrence|58|||
164345907|NCT00668707|593641072|FG000|Overall Study|Withdrawal by Subject|117|||
163897827|NCT03660930|591998726|FG002|Overall Study|Withdrawal by Subject|0|||
163897828|NCT03660930|591998727|FG003|Overall Study|Withdrawal by Subject|0|||
163897829|NCT03660930|591998728|FG004|Overall Study|Withdrawal by Subject|0|||
163897830|NCT03660930|591998729|FG005|Overall Study|Withdrawal by Subject|1|||
164132691|NCT01986010|592850670|FG015|Overall Study|Lost to Follow-up|0|||
164291447|NCT01005251|593438052|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
164345908|NCT00668707|593641073|FG001|Overall Study|Withdrawal by Subject|100|||
164345909|NCT00668707|593641072|FG000|Overall Study|Lost to Follow-up|3|||
164345910|NCT00668707|593641073|FG001|Overall Study|Lost to Follow-up|6|||
164345911|NCT00668707|593641072|FG000|Overall Study|Protocol Violation|10|||
164345912|NCT00668707|593641073|FG001|Overall Study|Protocol Violation|12|||
164345913|NCT00668707|593641072|FG000|Overall Study|Death|11|||
164345914|NCT00668707|593641073|FG001|Overall Study|Death|4|||
164345915|NCT03724032|593641077|FG000|Overall Study|Physician Decision|1|||
164345916|NCT03724032|593641078|FG001|Overall Study|Physician Decision|0|||
164345917|NCT03724032|593641079|FG002|Overall Study|Physician Decision|0|||
164345918|NCT03724032|593641077|FG000|Overall Study|Protocol Violation|2|||
164345919|NCT03724032|593641078|FG001|Overall Study|Protocol Violation|2|||
164345920|NCT03724032|593641079|FG002|Overall Study|Protocol Violation|1|||
163897831|NCT03660930|591998730|FG006|Overall Study|Withdrawal by Subject|0|||
163897832|NCT03660930|591998731|FG007|Overall Study|Withdrawal by Subject|0|||
163897833|NCT03242915|591998732|FG000|Overall Study|Adverse Event|5|||
163897834|NCT03242915|591998733|FG001|Overall Study|Adverse Event|1|||
163897835|NCT03242915|591998732|FG000|Overall Study|Withdrawal by Subject|0|||
163897836|NCT03242915|591998733|FG001|Overall Study|Withdrawal by Subject|2|||
163897837|NCT03242915|591998732|FG000|Overall Study|Physician Decision|4|||
163897838|NCT03242915|591998733|FG001|Overall Study|Physician Decision|1|||
163897839|NCT03333915|591998737|FG000|Overall Study|Lost to Follow-up|0|||
163897840|NCT03333915|591998738|FG001|Overall Study|Lost to Follow-up|0|||
163897841|NCT03333915|591998739|FG002|Overall Study|Lost to Follow-up|1|||
163897842|NCT03333915|591998740|FG003|Overall Study|Lost to Follow-up|0|||
163897843|NCT03333915|591998741|FG004|Overall Study|Lost to Follow-up|0|||
164088106|NCT04000009|592687347|FG000|Overall Study|Study terminated by sponsor|98|||
164088107|NCT04000009|592687347|FG000|Overall Study|Not further specified|8|||
164088108|NCT01754259|592687350|FG000|Overall Study|Withdrawal by Subject|2|||
164291448|NCT01005251|593438053|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
164291449|NCT01005251|593438054|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
164291450|NCT01005251|593438055|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
164291451|NCT01005251|593438051|FG000|Overall Study|Lost to Follow-up|1|||
164291452|NCT01005251|593438052|FG001|Overall Study|Lost to Follow-up|4|||
164291453|NCT01005251|593438053|FG002|Overall Study|Lost to Follow-up|2|||
164291454|NCT01005251|593438054|FG003|Overall Study|Lost to Follow-up|0|||
164291455|NCT01005251|593438055|FG004|Overall Study|Lost to Follow-up|0|||
164291456|NCT01005251|593438051|FG000|Overall Study|Physician Decision|0|||
164291457|NCT01005251|593438052|FG001|Overall Study|Physician Decision|0|||
164291458|NCT01005251|593438053|FG002|Overall Study|Physician Decision|0|||
164291459|NCT01005251|593438054|FG003|Overall Study|Physician Decision|0|||
164291460|NCT01005251|593438055|FG004|Overall Study|Physician Decision|2|||
164291461|NCT01005251|593438051|FG000|Overall Study|Patient moved|1|||
164291462|NCT01005251|593438052|FG001|Overall Study|Patient moved|0|||
164291463|NCT01005251|593438053|FG002|Overall Study|Patient moved|0|||
163897844|NCT03333915|591998737|FG000|Overall Study|Disease Progression|0|||
164088109|NCT01754259|592687351|FG001|Overall Study|Withdrawal by Subject|4|||
164088110|NCT01754259|592687350|FG000|Overall Study|Adverse Event|3|||
163897845|NCT03333915|591998738|FG001|Overall Study|Disease Progression|1|||
164291464|NCT01005251|593438054|FG003|Overall Study|Patient moved|0|||
164291465|NCT01005251|593438055|FG004|Overall Study|Patient moved|0|||
163897846|NCT03333915|591998739|FG002|Overall Study|Disease Progression|0|||
163897847|NCT03333915|591998740|FG003|Overall Study|Disease Progression|0|||
163897848|NCT03333915|591998741|FG004|Overall Study|Disease Progression|0|||
163897849|NCT03333915|591998737|FG000|Overall Study|Death|0|||
163897850|NCT03333915|591998738|FG001|Overall Study|Death|0|||
163897851|NCT03333915|591998739|FG002|Overall Study|Death|0|||
163897852|NCT03333915|591998740|FG003|Overall Study|Death|37|||
163897853|NCT03333915|591998741|FG004|Overall Study|Death|18|||
164291466|NCT01005251|593438051|FG000|Overall Study|Wrong drug dispensed|0|||
164291467|NCT01005251|593438052|FG001|Overall Study|Wrong drug dispensed|1|||
164291468|NCT01005251|593438053|FG002|Overall Study|Wrong drug dispensed|0|||
164291469|NCT01005251|593438054|FG003|Overall Study|Wrong drug dispensed|0|||
164291470|NCT01005251|593438055|FG004|Overall Study|Wrong drug dispensed|0|||
164291471|NCT01005251|593438051|FG000|Overall Study|Randomized in error|0|||
164291472|NCT01005251|593438052|FG001|Overall Study|Randomized in error|0|||
164291473|NCT01005251|593438053|FG002|Overall Study|Randomized in error|1|||
164291474|NCT01005251|593438054|FG003|Overall Study|Randomized in error|1|||
164291475|NCT01005251|593438055|FG004|Overall Study|Randomized in error|0|||
164291476|NCT01005251|593438051|FG000|Overall Study|Lack of Efficacy|0|||
164291477|NCT01005251|593438052|FG001|Overall Study|Lack of Efficacy|0|||
164291478|NCT01005251|593438053|FG002|Overall Study|Lack of Efficacy|1|||
164291479|NCT01005251|593438054|FG003|Overall Study|Lack of Efficacy|1|||
164291480|NCT01005251|593438055|FG004|Overall Study|Lack of Efficacy|0|||
164291481|NCT01702844|593438056|FG000|Overall Study|Adverse Event|9|||
164291482|NCT01702844|593438056|FG000|Overall Study|Death|1|||
164291483|NCT01702844|593438056|FG000|Overall Study|Withdrawal by Subject|3|||
164291484|NCT01702844|593438056|FG000|Overall Study|Physician Decision|6|||
164291485|NCT02123134|593438057|FG000|Overall Study|Withdrawal of consent|3|||
164291486|NCT02123134|593438058|FG001|Overall Study|Withdrawal of consent|2|||
164291487|NCT02123134|593438057|FG000|Overall Study|Administrative decision|0|||
164291488|NCT02123134|593438058|FG001|Overall Study|Administrative decision|1|||
164291489|NCT02995980|593438059|FG000|Overall Study|Lost to Follow-up|14|||
164291490|NCT00141453|593438061|FG000|Overall Study|Protocol Violation|6|||
164291491|NCT00141453|593438062|FG001|Overall Study|Protocol Violation|5|||
164291492|NCT01458639|593438063|FG000|Overall Study|Physician Decision|4|||
164291493|NCT01458639|593438063|FG000|Overall Study|Equipment issue|1|||
164291494|NCT01458639|593438063|FG000|Overall Study|Inability to obtain subject blood sample|1|||
164291495|NCT02656017|593438064|FG000|Overall Study|Study burden|3|||
164291496|NCT02656017|593438065|FG001|Overall Study|Study burden|3|||
164291497|NCT02656017|593438064|FG000|Overall Study|Adverse Event|2|||
164291498|NCT02656017|593438065|FG001|Overall Study|Adverse Event|1|||
164291499|NCT02656017|593438064|FG000|Overall Study|Unable/unwilling to take study medication|2|||
164291500|NCT02656017|593438065|FG001|Overall Study|Unable/unwilling to take study medication|1|||
164291501|NCT02656017|593438064|FG000|Overall Study|Began Tolvaptan|1|||
164291502|NCT02656017|593438065|FG001|Overall Study|Began Tolvaptan|1|||
164291503|NCT02656017|593438064|FG000|Overall Study|Withdrawal by Subject|1|||
164291504|NCT02656017|593438065|FG001|Overall Study|Withdrawal by Subject|0|||
164291505|NCT04245111|593438066|FG000|Overall Study|Lost to Follow-up|5|||
164291506|NCT04245111|593438067|FG001|Overall Study|Lost to Follow-up|1|||
164291507|NCT04245111|593438068|FG002|Overall Study|Lost to Follow-up|1|||
164291508|NCT01884077|593438069|FG000|Overall Study|screen fail|0|||
164291509|NCT01884077|593438070|FG001|Overall Study|screen fail|2|||
164291510|NCT01884077|593438069|FG000|Overall Study|canceled surgery|2|||
164291511|NCT01884077|593438070|FG001|Overall Study|canceled surgery|0|||
164291512|NCT01884077|593438069|FG000|Overall Study|Lost to Follow-up|0|||
164291513|NCT01884077|593438070|FG001|Overall Study|Lost to Follow-up|4|||
164291514|NCT01884077|593438069|FG000|Overall Study|study closed|6|||
164291515|NCT01884077|593438070|FG001|Overall Study|study closed|4|||
164291516|NCT00981149|593438071|FG000|Overall Study|Lost to Follow-up|1|||
164291517|NCT00981149|593438072|FG001|Overall Study|Lost to Follow-up|2|||
164291518|NCT00981149|593438071|FG000|Overall Study|Withdrawal by Subject|1|||
164291519|NCT00981149|593438072|FG001|Overall Study|Withdrawal by Subject|1|||
164291520|NCT01220167|593438073|FG000|Period 3|Urine positive for substance abuse|0|||
164291521|NCT01220167|593438074|FG001|Period 3|Urine positive for substance abuse|1|||
164291522|NCT01220167|593438075|FG002|Period 3|Urine positive for substance abuse|0|||
164291523|NCT01008943|593438076|FG000|Overall Study|Withdrawal by Subject|1|||
164291524|NCT00861705|593438077|FG000|Overall Study|Never Began Treatment|7|||
164291525|NCT00861705|593438078|FG001|Overall Study|Never Began Treatment|3|||
164291526|NCT00861705|593438079|FG002|Overall Study|Never Began Treatment|0|||
164345921|NCT00751933|593641080|FG000|Overall Study|Withdrawal by Subject|0|||
164345922|NCT00751933|593641081|FG001|Overall Study|Withdrawal by Subject|1|||
164291527|NCT00861705|593438080|FG003|Overall Study|Never Began Treatment|1|||
164291528|NCT02634333|593438081|FG000|Overall Study|Completed out of Window|3|||
164291529|NCT02634333|593438082|FG001|Overall Study|Completed out of Window|2|||
164291530|NCT02634333|593438081|FG000|Overall Study|Missed Visit|5|||
164291531|NCT02634333|593438082|FG001|Overall Study|Missed Visit|2|||
164291532|NCT02634333|593438081|FG000|Overall Study|Lost to Follow-up|12|||
164291533|NCT02634333|593438082|FG001|Overall Study|Lost to Follow-up|7|||
164291534|NCT02634333|593438081|FG000|Overall Study|Withdrawal by Subject|9|||
164291535|NCT02634333|593438082|FG001|Overall Study|Withdrawal by Subject|13|||
164291536|NCT02634333|593438081|FG000|Overall Study|Death|11|||
164291537|NCT02634333|593438082|FG001|Overall Study|Death|8|||
164291538|NCT00300755|593438087|FG000|Overall Study|Adverse Event|1|||
164291539|NCT00300755|593438088|FG001|Overall Study|Adverse Event|2|||
164291540|NCT00300755|593438089|FG002|Overall Study|Adverse Event|1|||
164291541|NCT00300755|593438087|FG000|Overall Study|Withdrawal by Subject|0|||
164291542|NCT00300755|593438088|FG001|Overall Study|Withdrawal by Subject|2|||
164291543|NCT00300755|593438089|FG002|Overall Study|Withdrawal by Subject|0|||
164291544|NCT00300755|593438087|FG000|Overall Study|Protocol Violation|0|||
164291545|NCT00300755|593438088|FG001|Overall Study|Protocol Violation|0|||
164291546|NCT00300755|593438089|FG002|Overall Study|Protocol Violation|1|||
164291547|NCT02694744|593438090|FG000|Overall Study|Adverse Event|2|||
164291548|NCT02694744|593438091|FG001|Overall Study|Adverse Event|1|||
164291549|NCT02694744|593438090|FG000|Overall Study|Withdrawal by Subject|2|||
164291550|NCT02694744|593438091|FG001|Overall Study|Withdrawal by Subject|1|||
164291551|NCT02694744|593438090|FG000|Overall Study|Physician Decision|1|||
164291552|NCT02694744|593438091|FG001|Overall Study|Physician Decision|2|||
164291553|NCT02694744|593438090|FG000|Overall Study|Lost to Follow-up|1|||
164291554|NCT02694744|593438091|FG001|Overall Study|Lost to Follow-up|0|||
164291555|NCT02694744|593438090|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
164291556|NCT02694744|593438091|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
164291557|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
164291558|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
164291559|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Disease progression|75|||
164291560|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Disease progression|59|||
164291561|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Adverse Event|16|||
164291562|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Adverse Event|16|||
164291563|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Death|2|||
164291564|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Death|3|||
164088111|NCT01754259|592687351|FG001|Overall Study|Adverse Event|1|||
164291565|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
164291566|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
164291567|NCT00883779|593438092|FG000|Primary Study Treatment Phase|Other|3|||
164088112|NCT01754259|592687350|FG000|Overall Study|Lost to Follow-up|0|||
164291568|NCT00883779|593438093|FG001|Primary Study Treatment Phase|Other|0|||
164291569|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Adverse Event|2|||
164291570|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Adverse Event|3|||
164291571|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Death|1|||
164291572|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Death|3|||
164291573|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
164291574|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
164291575|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
164291576|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
164291577|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Disease progression|103|||
164291578|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Disease progression|122|||
164291579|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Other|3|||
164291580|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Other|0|||
164291581|NCT00883779|593438092|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
164291582|NCT00883779|593438093|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
164291583|NCT00883779|593438092|FG000|Off-study Phase|Death|185|||
164291584|NCT00883779|593438093|FG001|Off-study Phase|Death|174|||
164291585|NCT00883779|593438092|FG000|Off-study Phase|Refused treatment|1|||
164291586|NCT00883779|593438093|FG001|Off-study Phase|Refused treatment|1|||
164291587|NCT00883779|593438092|FG000|Off-study Phase|Failure to return|5|||
164291588|NCT00883779|593438093|FG001|Off-study Phase|Failure to return|6|||
164291589|NCT00883779|593438092|FG000|Off-study Phase|Other|18|||
164291590|NCT00883779|593438093|FG001|Off-study Phase|Other|21|||
164291591|NCT04575155|593438094|FG000|2 Month|Withdrawal by Subject|1|||
164291592|NCT04575155|593438095|FG001|2 Month|Withdrawal by Subject|1|||
164291593|NCT04575155|593438094|FG000|2 Month|Lost to Follow-up|5|||
164291594|NCT04575155|593438095|FG001|2 Month|Lost to Follow-up|3|||
164291595|NCT04575155|593438094|FG000|2 Month|Ineligible|1|||
164291596|NCT04575155|593438095|FG001|2 Month|Ineligible|0|||
164291597|NCT06237049|593438096|FG000|Overall Study|Death|0|||
164291598|NCT06237049|593438097|FG001|Overall Study|Death|0|||
164291599|NCT06237049|593438098|FG002|Overall Study|Death|0|||
164291600|NCT06237049|593438099|FG003|Overall Study|Death|1|||
164291601|NCT06237049|593438096|FG000|Overall Study|Lost to Follow-up|11|||
164291602|NCT06237049|593438097|FG001|Overall Study|Lost to Follow-up|5|||
164291603|NCT06237049|593438098|FG002|Overall Study|Lost to Follow-up|8|||
164291604|NCT06237049|593438099|FG003|Overall Study|Lost to Follow-up|8|||
164291605|NCT06237049|593438096|FG000|Overall Study|Protocol Violation|0|||
164291606|NCT06237049|593438097|FG001|Overall Study|Protocol Violation|1|||
164291607|NCT06237049|593438098|FG002|Overall Study|Protocol Violation|0|||
164291608|NCT06237049|593438099|FG003|Overall Study|Protocol Violation|1|||
164291609|NCT06237049|593438096|FG000|Overall Study|Withdrawal by Subject|4|||
164291610|NCT06237049|593438097|FG001|Overall Study|Withdrawal by Subject|2|||
164291611|NCT06237049|593438098|FG002|Overall Study|Withdrawal by Subject|1|||
164291612|NCT06237049|593438099|FG003|Overall Study|Withdrawal by Subject|0|||
164291613|NCT03748823|593438100|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
164291614|NCT03748823|593438101|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
164291615|NCT03748823|593438100|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
164291616|NCT03748823|593438101|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
164291617|NCT03748823|593438100|FG000|Extension Period|Withdrawal by Subject|9|||
164291618|NCT03748823|593438101|FG001|Extension Period|Withdrawal by Subject|12|||
164291619|NCT03748823|593438100|FG000|Extension Period|Death|2|||
164291620|NCT03748823|593438101|FG001|Extension Period|Death|2|||
164291621|NCT03748823|593438100|FG000|Extension Period|Other than Specified|0|||
164291622|NCT03748823|593438101|FG001|Extension Period|Other than Specified|1|||
164291623|NCT03748823|593438100|FG000|Extension Period|Protocol Violation|1|||
164291624|NCT03748823|593438101|FG001|Extension Period|Protocol Violation|0|||
164291625|NCT03748823|593438100|FG000|Extension Period|Lost to Follow-up|0|||
164291626|NCT03748823|593438101|FG001|Extension Period|Lost to Follow-up|1|||
164291627|NCT03748823|593438100|FG000|Extension Period|Lack of Efficacy|0|||
164291628|NCT03748823|593438101|FG001|Extension Period|Lack of Efficacy|1|||
164291629|NCT03748823|593438100|FG000|Extension Period|Physician Decision|1|||
164345923|NCT00751933|593641082|FG002|Overall Study|Withdrawal by Subject|0|||
164345924|NCT00751933|593641083|FG003|Overall Study|Withdrawal by Subject|0|||
164345925|NCT00751933|593641080|FG000|Overall Study|Physician Decision|0|||
164345926|NCT00751933|593641081|FG001|Overall Study|Physician Decision|0|||
164345927|NCT00751933|593641082|FG002|Overall Study|Physician Decision|1|||
164345928|NCT00751933|593641083|FG003|Overall Study|Physician Decision|1|||
164345929|NCT03846804|593641085|FG000|Overall Study|Refused blood draw|1|||
164291630|NCT03748823|593438101|FG001|Extension Period|Physician Decision|2|||
164291631|NCT04678115|593438102|FG000|Overall Study|Lost to Follow-up|1|||
164291632|NCT04678115|593438103|FG001|Overall Study|Lost to Follow-up|0|||
164291633|NCT01363700|593438104|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164291634|NCT01363700|593438105|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
164291635|NCT01363700|593438106|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164291636|NCT01363700|593438107|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164345930|NCT03846804|593641085|FG000|Overall Study|Protocol Violation|1|||
164345931|NCT00361569|593641086|FG000|Overall Study|Protocol Violation|3|||
164291637|NCT01363700|593438108|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
164291638|NCT03649217|593438109|FG000|Overall Study|subject had severe ataxia not initially found|1|||
164345932|NCT00361569|593641087|FG001|Overall Study|Protocol Violation|2|||
164291639|NCT03649217|593438109|FG000|Overall Study|subject had cognitive issues not initially found|1|||
164291640|NCT02552966|593438112|FG000|Overall Study|Lost to Follow-up|2|||
164291641|NCT02552966|593438112|FG000|Overall Study|Withdrawal by Subject|3|||
164291642|NCT01091675|593438114|FG000|Overall Study|Adverse Event|7|||
164291643|NCT01091675|593438114|FG000|Overall Study|Lack of Efficacy|27|||
164291644|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291645|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291646|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291647|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
164291648|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291649|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291650|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291651|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291652|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291653|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
164291654|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
164345933|NCT00361569|593641088|FG002|Overall Study|Protocol Violation|4|||
164345934|NCT00361569|593641089|FG003|Overall Study|Protocol Violation|2|||
164345935|NCT00361569|593641086|FG000|Overall Study|Withdrawal by Subject|2|||
164345936|NCT00361569|593641087|FG001|Overall Study|Withdrawal by Subject|1|||
164345937|NCT00361569|593641088|FG002|Overall Study|Withdrawal by Subject|9|||
164345938|NCT00361569|593641089|FG003|Overall Study|Withdrawal by Subject|14|||
164345939|NCT00361569|593641086|FG000|Overall Study|Adverse Event|3|||
164345940|NCT00361569|593641087|FG001|Overall Study|Adverse Event|5|||
164345941|NCT00361569|593641088|FG002|Overall Study|Adverse Event|2|||
164345942|NCT00361569|593641089|FG003|Overall Study|Adverse Event|2|||
164345943|NCT00361569|593641086|FG000|Overall Study|Lost to Follow-up|2|||
164345944|NCT00361569|593641087|FG001|Overall Study|Lost to Follow-up|3|||
164345945|NCT00361569|593641088|FG002|Overall Study|Lost to Follow-up|3|||
164345946|NCT00361569|593641089|FG003|Overall Study|Lost to Follow-up|2|||
164345947|NCT00361569|593641086|FG000|Overall Study|Not specified by investigator|2|||
164345948|NCT00361569|593641087|FG001|Overall Study|Not specified by investigator|0|||
164291655|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
164291656|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291657|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
164291658|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
164291659|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
164291660|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291661|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291662|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291663|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
164291664|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
164291665|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291666|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291667|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291668|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
164291669|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
164291670|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291671|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291672|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291673|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
164291674|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291675|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291676|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291677|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291678|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291679|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
164291680|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291681|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291682|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291683|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
164291684|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
164291685|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291686|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
164291687|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291688|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
164291689|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291690|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291691|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291692|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291693|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
164291694|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
164291695|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291696|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291697|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291698|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
164291699|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
164291700|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291701|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291702|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291703|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
164291704|NCT02365649|593438122|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291705|NCT02365649|593438123|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291706|NCT02365649|593438124|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
164291707|NCT02365649|593438125|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291708|NCT02365649|593438126|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291709|NCT02365649|593438127|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291710|NCT02365649|593438128|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291711|NCT02365649|593438129|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291712|NCT02365649|593438130|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291713|NCT02365649|593438131|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
164291714|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291715|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164345949|NCT00361569|593641088|FG002|Overall Study|Not specified by investigator|0|||
164345950|NCT00361569|593641089|FG003|Overall Study|Not specified by investigator|1|||
164345951|NCT02605824|593641090|FG000|Overall Study|Physician Decision|1|||
164345952|NCT02605824|593641091|FG001|Overall Study|Physician Decision|0|||
163897854|NCT03333915|591998737|FG000|Overall Study|Sponsor's Decision|0|||
163897855|NCT03333915|591998738|FG001|Overall Study|Sponsor's Decision|0|||
164291716|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291717|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291718|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291719|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291720|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
164291721|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291722|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291723|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
164291724|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291725|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291726|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291727|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291728|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291729|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291730|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
164291731|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
164291732|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
164291733|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
164345953|NCT04875195|593641092|FG000|Overall Study|Death|9|||
164345954|NCT04875195|593641093|FG001|Overall Study|Death|3|||
164345955|NCT04875195|593641092|FG000|Overall Study|Withdrawal by Subject|2|||
164345956|NCT04875195|593641093|FG001|Overall Study|Withdrawal by Subject|1|||
164345957|NCT04875195|593641092|FG000|Overall Study|Ongoing in study|49|||
164345958|NCT04875195|593641093|FG001|Overall Study|Ongoing in study|2|||
164345959|NCT02339584|593641094|FG000|Overall Study|Adverse Event|11|||
164345960|NCT02339584|593641095|FG001|Overall Study|Adverse Event|7|||
164345961|NCT02339584|593641094|FG000|Overall Study|Lack of Efficacy|0|||
164345962|NCT02339584|593641095|FG001|Overall Study|Lack of Efficacy|1|||
164345963|NCT02339584|593641094|FG000|Overall Study|Physician Decision|1|||
164345964|NCT02339584|593641095|FG001|Overall Study|Physician Decision|2|||
164345965|NCT02339584|593641094|FG000|Overall Study|Protocol Violation|1|||
164345966|NCT02339584|593641095|FG001|Overall Study|Protocol Violation|1|||
164345967|NCT02339584|593641094|FG000|Overall Study|Withdrawal by Subject|2|||
164345968|NCT02339584|593641095|FG001|Overall Study|Withdrawal by Subject|4|||
164345969|NCT00826943|593641096|FG000|Overall Study|Withdrawal by Subject|0|||
164345970|NCT00826943|593641097|FG001|Overall Study|Withdrawal by Subject|0|||
164345971|NCT00826943|593641098|FG002|Overall Study|Withdrawal by Subject|0|||
164345972|NCT00826943|593641099|FG003|Overall Study|Withdrawal by Subject|0|||
164345973|NCT00826943|593641100|FG004|Overall Study|Withdrawal by Subject|1|||
164345974|NCT00826943|593641101|FG005|Overall Study|Withdrawal by Subject|0|||
164345975|NCT03715530|593641102|FG000|Overall Study|Lost to Follow-up|3|||
164345976|NCT03715530|593641103|FG001|Overall Study|Lost to Follow-up|1|||
164345977|NCT03715530|593641104|FG002|Overall Study|Lost to Follow-up|2|||
164345978|NCT01594762|593641105|FG000|Overall Study|Withdrawal by Subject|1|||
164345979|NCT01594762|593641106|FG001|Overall Study|Withdrawal by Subject|0|||
164345980|NCT01594762|593641105|FG000|Overall Study|Lost to Follow-up|10|||
164345981|NCT01594762|593641106|FG001|Overall Study|Lost to Follow-up|10|||
164345982|NCT03338998|593641110|FG000|Treatment Period|Withdrawal by Subject|1|||
164345983|NCT03338998|593641111|FG001|Treatment Period|Withdrawal by Subject|1|||
164345984|NCT03338998|593641110|FG000|Treatment Period|Adverse Event|0|||
164345985|NCT03338998|593641111|FG001|Treatment Period|Adverse Event|2|||
164345986|NCT03338998|593641110|FG000|Treatment Period|Protocol deviation|1|||
164345987|NCT03338998|593641111|FG001|Treatment Period|Protocol deviation|0|||
164345988|NCT03338998|593641110|FG000|Treatment Period|Physician Decision|2|||
164345989|NCT03338998|593641111|FG001|Treatment Period|Physician Decision|0|||
164345990|NCT03338998|593641110|FG000|Treatment Period|Subject failed swallow test|4|||
164345991|NCT03338998|593641111|FG001|Treatment Period|Subject failed swallow test|0|||
164345992|NCT03338998|593641110|FG000|Safety Follow-Up Period|Adverse Event|0|||
164345993|NCT03338998|593641111|FG001|Safety Follow-Up Period|Adverse Event|1|||
164291734|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291735|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291736|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164345994|NCT03338998|593641110|FG000|Safety Follow-Up Period|Protocol deviation|1|||
164345995|NCT03338998|593641111|FG001|Safety Follow-Up Period|Protocol deviation|0|||
164088113|NCT01754259|592687351|FG001|Overall Study|Lost to Follow-up|1|||
164291737|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164345996|NCT03338998|593641110|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
164345997|NCT03338998|593641111|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
164345998|NCT04706091|593641114|FG000|Treatment 2|Withdrawal by Subject|1|||
164088114|NCT02829918|592687352|FG000|Overall Study|Death|2|||
164345999|NCT04706091|593641115|FG001|Treatment 2|Withdrawal by Subject|0|||
164346000|NCT03329573|593641116|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
164346001|NCT03329573|593641117|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
164291738|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291739|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
164291740|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
164291741|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
164291742|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
164291743|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
164291744|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291745|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291746|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291747|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291748|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291749|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291750|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
164291751|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
164291752|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
164291753|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
164346002|NCT03329573|593641118|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
164346003|NCT03329573|593641119|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
164346004|NCT03329573|593641116|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
164346005|NCT03329573|593641117|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
164346006|NCT03329573|593641118|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164346007|NCT03329573|593641119|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164346008|NCT03329573|593641116|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
164346009|NCT03329573|593641117|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
164346010|NCT03329573|593641118|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
164346011|NCT03329573|593641119|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
164346012|NCT03329573|593641116|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
164346013|NCT03329573|593641117|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
164346014|NCT03329573|593641118|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
164346015|NCT03329573|593641119|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
164346016|NCT02777333|593641122|FG000|Overall Study|Withdrawal by Subject|0|||
164346017|NCT02777333|593641123|FG001|Overall Study|Withdrawal by Subject|1|||
164346018|NCT02777333|593641122|FG000|Overall Study|Lost to Follow-up|0|||
164346019|NCT02777333|593641123|FG001|Overall Study|Lost to Follow-up|1|||
164346020|NCT05695209|593641131|FG000|3-months|Withdrawal by Subject|2|||
164346021|NCT05695209|593641132|FG001|3-months|Withdrawal by Subject|0|||
164346022|NCT05695209|593641131|FG000|3-months|Unable to contact for 3-month data collection|0|||
164346023|NCT05695209|593641132|FG001|3-months|Unable to contact for 3-month data collection|1|||
164346024|NCT05695209|593641131|FG000|6-months|Lost to Follow-up|1|||
164346025|NCT05695209|593641132|FG001|6-months|Lost to Follow-up|1|||
164346026|NCT03069378|593641135|FG000|Overall Study|Withdrawal by Subject|1|||
164346027|NCT02993146|593641136|FG000|Overall Study|Withdrawal by Subject|0|||
164346028|NCT02993146|593641137|FG001|Overall Study|Withdrawal by Subject|0|||
164346029|NCT02993146|593641138|FG002|Overall Study|Withdrawal by Subject|1|||
164346030|NCT02993146|593641139|FG003|Overall Study|Withdrawal by Subject|1|||
164346031|NCT01397708|593641140|FG000|Overall Study|Withdrawal by Subject|0|||
164346032|NCT01397708|593641141|FG001|Overall Study|Withdrawal by Subject|0|||
164346033|NCT01397708|593641142|FG002|Overall Study|Withdrawal by Subject|1|||
164346034|NCT01397708|593641143|FG003|Overall Study|Withdrawal by Subject|0|||
164346035|NCT01397708|593641144|FG004|Overall Study|Withdrawal by Subject|0|||
164346036|NCT01397708|593641145|FG005|Overall Study|Withdrawal by Subject|0|||
164346037|NCT01397708|593641146|FG006|Overall Study|Withdrawal by Subject|0|||
164346038|NCT01397708|593641147|FG007|Overall Study|Withdrawal by Subject|1|||
164346039|NCT01397708|593641140|FG000|Overall Study|Death|0|||
164346040|NCT01397708|593641141|FG001|Overall Study|Death|0|||
164346041|NCT01397708|593641142|FG002|Overall Study|Death|1|||
164346042|NCT01397708|593641143|FG003|Overall Study|Death|1|||
164346043|NCT01397708|593641144|FG004|Overall Study|Death|0|||
164346044|NCT01397708|593641145|FG005|Overall Study|Death|0|||
164346045|NCT01397708|593641146|FG006|Overall Study|Death|0|||
164346046|NCT01397708|593641147|FG007|Overall Study|Death|0|||
164346047|NCT01397708|593641140|FG000|Overall Study|Lost to Follow-up|0|||
164346048|NCT01397708|593641141|FG001|Overall Study|Lost to Follow-up|0|||
164346049|NCT01397708|593641142|FG002|Overall Study|Lost to Follow-up|0|||
164346050|NCT01397708|593641143|FG003|Overall Study|Lost to Follow-up|0|||
164346051|NCT01397708|593641144|FG004|Overall Study|Lost to Follow-up|1|||
164346052|NCT01397708|593641145|FG005|Overall Study|Lost to Follow-up|0|||
164346053|NCT01397708|593641146|FG006|Overall Study|Lost to Follow-up|0|||
164346054|NCT01397708|593641147|FG007|Overall Study|Lost to Follow-up|0|||
164346055|NCT01397708|593641140|FG000|Overall Study|Other|0|||
164346056|NCT01397708|593641141|FG001|Overall Study|Other|0|||
164346057|NCT01397708|593641142|FG002|Overall Study|Other|0|||
163897856|NCT03333915|591998739|FG002|Overall Study|Sponsor's Decision|0|||
163897857|NCT03333915|591998740|FG003|Overall Study|Sponsor's Decision|48|||
163897858|NCT03333915|591998741|FG004|Overall Study|Sponsor's Decision|4|||
164291754|NCT02365649|593438122|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291755|NCT02365649|593438123|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291756|NCT02365649|593438124|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291757|NCT02365649|593438125|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291758|NCT02365649|593438126|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291759|NCT02365649|593438127|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291760|NCT02365649|593438128|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
164291761|NCT02365649|593438129|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291762|NCT02365649|593438130|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
164291763|NCT02365649|593438131|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
164291764|NCT01506271|593438132|FG000|Overall Study|Progressive disease|0|||
164291765|NCT01506271|593438133|FG001|Overall Study|Progressive disease|1|||
164291766|NCT01506271|593438134|FG002|Overall Study|Progressive disease|0|||
164291767|NCT01506271|593438132|FG000|Overall Study|Protocol Violation|3|||
164291768|NCT01506271|593438133|FG001|Overall Study|Protocol Violation|1|||
164291769|NCT01506271|593438134|FG002|Overall Study|Protocol Violation|0|||
164291770|NCT01506271|593438132|FG000|Overall Study|Death|0|||
164291771|NCT01506271|593438133|FG001|Overall Study|Death|1|||
164291772|NCT01506271|593438134|FG002|Overall Study|Death|0|||
164291773|NCT01506271|593438132|FG000|Overall Study|Adverse Event|0|||
164291774|NCT01506271|593438133|FG001|Overall Study|Adverse Event|2|||
164291775|NCT01506271|593438134|FG002|Overall Study|Adverse Event|0|||
164291776|NCT01506271|593438132|FG000|Overall Study|Insufficient supply of study drug|1|||
164291777|NCT01506271|593438133|FG001|Overall Study|Insufficient supply of study drug|0|||
164291778|NCT01506271|593438134|FG002|Overall Study|Insufficient supply of study drug|0|||
164291779|NCT01506271|593438132|FG000|Overall Study|Withdrawal by Subject|0|||
164291780|NCT01506271|593438133|FG001|Overall Study|Withdrawal by Subject|1|||
164291781|NCT01506271|593438134|FG002|Overall Study|Withdrawal by Subject|1|||
164291782|NCT01506271|593438132|FG000|Overall Study|Lost to Follow-up|0|||
164291783|NCT01506271|593438133|FG001|Overall Study|Lost to Follow-up|1|||
164291784|NCT01506271|593438134|FG002|Overall Study|Lost to Follow-up|2|||
164291785|NCT01433172|593438136|FG000|Overall Study|Withdrawal by Subject|0|||
164291786|NCT01433172|593438137|FG001|Overall Study|Withdrawal by Subject|1|||
164291787|NCT01433172|593438138|FG002|Overall Study|Withdrawal by Subject|0|||
164291788|NCT01433172|593438136|FG000|Overall Study|Disease Progression|0|||
164291789|NCT01433172|593438137|FG001|Overall Study|Disease Progression|0|||
164291790|NCT01433172|593438138|FG002|Overall Study|Disease Progression|1|||
164291791|NCT01433172|593438136|FG000|Overall Study|Death|0|||
164291792|NCT01433172|593438137|FG001|Overall Study|Death|2|||
164291793|NCT01433172|593438138|FG002|Overall Study|Death|0|||
164291794|NCT01391663|593438139|FG000|Overall Study|Withdrawal by Subject|0|||
164291795|NCT01391663|593438140|FG001|Overall Study|Withdrawal by Subject|0|||
164291796|NCT01391663|593438141|FG002|Overall Study|Withdrawal by Subject|1|||
164291797|NCT01391663|593438142|FG003|Overall Study|Withdrawal by Subject|0|||
164291798|NCT00920855|593438143|FG000|Overall Study|Adverse Event|1|||
164291799|NCT00920855|593438144|FG001|Overall Study|Adverse Event|1|||
164291800|NCT00920855|593438145|FG002|Overall Study|Adverse Event|4|||
164291801|NCT00920855|593438143|FG000|Overall Study|Withdrawal by Subject|2|||
164291802|NCT00920855|593438144|FG001|Overall Study|Withdrawal by Subject|1|||
163897859|NCT03333915|591998737|FG000|Overall Study|Withdrawal by Subject|0|||
164291803|NCT00920855|593438145|FG002|Overall Study|Withdrawal by Subject|6|||
164291804|NCT00920855|593438143|FG000|Overall Study|Disease progression|2|||
164291805|NCT00920855|593438144|FG001|Overall Study|Disease progression|1|||
164291806|NCT00920855|593438145|FG002|Overall Study|Disease progression|10|||
163897860|NCT03333915|591998738|FG001|Overall Study|Withdrawal by Subject|0|||
164291807|NCT00920855|593438143|FG000|Overall Study|Noncompliance to study medication|0|||
164291808|NCT00920855|593438144|FG001|Overall Study|Noncompliance to study medication|0|||
164291809|NCT00920855|593438145|FG002|Overall Study|Noncompliance to study medication|1|||
164291810|NCT00920855|593438143|FG000|Overall Study|Response plateau; started maintenance|0|||
164291811|NCT00920855|593438144|FG001|Overall Study|Response plateau; started maintenance|0|||
164291812|NCT00920855|593438145|FG002|Overall Study|Response plateau; started maintenance|1|||
164291813|NCT00539994|593438146|FG000|Overall Study|Lost to Follow-up|2|||
164291814|NCT00539994|593438147|FG001|Overall Study|Lost to Follow-up|1|||
164291815|NCT00539994|593438148|FG002|Overall Study|Lost to Follow-up|0|||
164291816|NCT00539994|593438146|FG000|Overall Study|Withdrawal by Subject|1|||
164291817|NCT00539994|593438147|FG001|Overall Study|Withdrawal by Subject|0|||
163897861|NCT03333915|591998739|FG002|Overall Study|Withdrawal by Subject|0|||
164291818|NCT00539994|593438148|FG002|Overall Study|Withdrawal by Subject|1|||
164291819|NCT00539994|593438146|FG000|Overall Study|Physician Decision|0|||
164291820|NCT00539994|593438147|FG001|Overall Study|Physician Decision|0|||
164291821|NCT00539994|593438148|FG002|Overall Study|Physician Decision|1|||
164291822|NCT01611194|593438152|FG000|Overall Study|Lost to Follow-up|0|||
164291823|NCT01611194|593438153|FG001|Overall Study|Lost to Follow-up|1|||
164291824|NCT01611194|593438152|FG000|Overall Study|Withdrawal by Subject|0|||
164291825|NCT01611194|593438153|FG001|Overall Study|Withdrawal by Subject|1|||
164291826|NCT01611194|593438152|FG000|Overall Study|drug use|0|||
164291827|NCT01611194|593438153|FG001|Overall Study|drug use|1|||
164291828|NCT02464410|593438165|FG000|Overall Study|Death|3|||
164291829|NCT02464410|593438166|FG001|Overall Study|Death|4|||
164291830|NCT02464410|593438165|FG000|Overall Study|Lost to Follow-up|7|||
164291831|NCT02464410|593438166|FG001|Overall Study|Lost to Follow-up|9|||
164291832|NCT02464410|593438165|FG000|Overall Study|Withdrawal by Subject|12|||
164291833|NCT02464410|593438166|FG001|Overall Study|Withdrawal by Subject|3|||
164291834|NCT01871519|593438167|FG000|Overall Study|Death|26|||
164291835|NCT01871519|593438167|FG000|Overall Study|Lost to Follow-up|15|||
164291836|NCT01871519|593438167|FG000|Overall Study|Withdrawal by Subject|49|||
164291837|NCT01777776|593438168|FG000|Overall Study|Adverse Event|2|||
164291838|NCT01777776|593438169|FG001|Overall Study|Adverse Event|4|||
164291839|NCT01777776|593438170|FG002|Overall Study|Adverse Event|0|||
164291840|NCT01777776|593438171|FG003|Overall Study|Adverse Event|0|||
164291841|NCT01777776|593438168|FG000|Overall Study|Disease Progression|4|||
164291842|NCT01777776|593438169|FG001|Overall Study|Disease Progression|8|||
164291843|NCT01777776|593438170|FG002|Overall Study|Disease Progression|6|||
164291844|NCT01777776|593438171|FG003|Overall Study|Disease Progression|3|||
164291845|NCT01777776|593438168|FG000|Overall Study|Withdrawal by Subject|0|||
164291846|NCT01777776|593438169|FG001|Overall Study|Withdrawal by Subject|0|||
164291847|NCT01777776|593438170|FG002|Overall Study|Withdrawal by Subject|0|||
164291848|NCT01777776|593438171|FG003|Overall Study|Withdrawal by Subject|1|||
164291849|NCT02775916|593438172|FG000|Overall Study|Adverse Event|1|||
164291850|NCT02775916|593438173|FG001|Overall Study|Adverse Event|0|||
164291851|NCT02775916|593438172|FG000|Overall Study|Subject/Guardian Decision|2|||
164291852|NCT02775916|593438173|FG001|Overall Study|Subject/Guardian Decision|0|||
164291853|NCT02426580|593439517|FG000|Overall Study|Death|2|||
164291854|NCT02426580|593439518|FG001|Overall Study|Death|2|||
164291855|NCT02426580|593439517|FG000|Overall Study|Lost to Follow-up|0|||
164291856|NCT02426580|593439518|FG001|Overall Study|Lost to Follow-up|9|||
164291857|NCT02426580|593439517|FG000|Overall Study|transfer to hemodialysis|5|||
164291858|NCT02426580|593439518|FG001|Overall Study|transfer to hemodialysis|5|||
164291859|NCT02426580|593439517|FG000|Overall Study|Kidney transplant|3|||
164291860|NCT02426580|593439518|FG001|Overall Study|Kidney transplant|0|||
164291861|NCT02426580|593439517|FG000|Overall Study|Allergic to egg white|1|||
164291862|NCT02426580|593439518|FG001|Overall Study|Allergic to egg white|0|||
164291863|NCT00762359|593439519|FG000|Overall Study|Adverse Event|20|||
164291864|NCT00762359|593439520|FG001|Overall Study|Adverse Event|23|||
164291865|NCT00762359|593439519|FG000|Overall Study|Protocol Violation|21|||
164291866|NCT00762359|593439520|FG001|Overall Study|Protocol Violation|13|||
164291867|NCT00762359|593439519|FG000|Overall Study|Withdrawal by Subject|13|||
164291868|NCT00762359|593439520|FG001|Overall Study|Withdrawal by Subject|10|||
164291869|NCT00762359|593439519|FG000|Overall Study|Lack of Efficacy|0|||
164291870|NCT00762359|593439520|FG001|Overall Study|Lack of Efficacy|4|||
164291871|NCT00762359|593439519|FG000|Overall Study|Institution closed|2|||
164291872|NCT00762359|593439520|FG001|Overall Study|Institution closed|3|||
164291873|NCT00762359|593439519|FG000|Overall Study|Physician Decision|2|||
164291874|NCT00762359|593439520|FG001|Overall Study|Physician Decision|3|||
164291875|NCT00762359|593439519|FG000|Overall Study|Removal|0|||
164291876|NCT00762359|593439520|FG001|Overall Study|Removal|1|||
164291877|NCT00762359|593439519|FG000|Overall Study|Withdrew consent|1|||
164291878|NCT00762359|593439520|FG001|Overall Study|Withdrew consent|0|||
164291879|NCT01535807|593439522|FG000|Overall Study|Withdrawal by Subject|1|||
164291880|NCT01535807|593439523|FG001|Overall Study|Withdrawal by Subject|1|||
164291881|NCT01535807|593439522|FG000|Overall Study|Data collection error|1|||
164291882|NCT01535807|593439523|FG001|Overall Study|Data collection error|1|||
164291883|NCT00833040|593439526|FG000|Overall Study|Adverse Event|0|||
164291884|NCT00833040|593439527|FG001|Overall Study|Adverse Event|0|||
164291885|NCT00833040|593439528|FG002|Overall Study|Adverse Event|0|||
164291886|NCT00833040|593439529|FG003|Overall Study|Adverse Event|0|||
164291887|NCT00833040|593439530|FG004|Overall Study|Adverse Event|0|||
164291888|NCT00833040|593439531|FG005|Overall Study|Adverse Event|1|||
164291889|NCT00416624|593439532|FG000|Overall Study|Withdrawal by Subject|1|||
164291890|NCT00416624|593439533|FG001|Overall Study|Withdrawal by Subject|6|||
164291891|NCT00416624|593439534|FG002|Overall Study|Withdrawal by Subject|4|||
164291892|NCT00416624|593439535|FG003|Overall Study|Withdrawal by Subject|9|||
164291893|NCT00416624|593439532|FG000|Overall Study|Death|4|||
164291894|NCT00416624|593439533|FG001|Overall Study|Death|7|||
164291895|NCT00416624|593439534|FG002|Overall Study|Death|7|||
164291896|NCT00416624|593439535|FG003|Overall Study|Death|1|||
164291897|NCT00416624|593439532|FG000|Overall Study|Adverse Event|8|||
164291898|NCT00416624|593439533|FG001|Overall Study|Adverse Event|3|||
164291899|NCT00416624|593439534|FG002|Overall Study|Adverse Event|2|||
164291900|NCT00416624|593439535|FG003|Overall Study|Adverse Event|2|||
164291901|NCT00416624|593439532|FG000|Overall Study|Other|8|||
164291902|NCT00416624|593439533|FG001|Overall Study|Other|11|||
164291903|NCT00416624|593439534|FG002|Overall Study|Other|5|||
164291904|NCT00416624|593439535|FG003|Overall Study|Other|5|||
164291905|NCT00416624|593439532|FG000|Overall Study|Cancel|1|||
164291906|NCT00416624|593439533|FG001|Overall Study|Cancel|0|||
164291907|NCT00416624|593439534|FG002|Overall Study|Cancel|0|||
164291908|NCT00416624|593439535|FG003|Overall Study|Cancel|0|||
164291909|NCT02193776|593439536|FG000|Overall Study|Consent withdrawn|1|||
164291910|NCT02193776|593439537|FG001|Overall Study|Consent withdrawn|0|||
164291911|NCT02193776|593439538|FG002|Overall Study|Consent withdrawn|0|||
164291912|NCT02193776|593439539|FG003|Overall Study|Consent withdrawn|0|||
164291913|NCT02193776|593439536|FG000|Overall Study|Failure to comply with protocol|0|||
164291914|NCT02193776|593439537|FG001|Overall Study|Failure to comply with protocol|1|||
164291915|NCT02193776|593439538|FG002|Overall Study|Failure to comply with protocol|0|||
164291916|NCT02193776|593439539|FG003|Overall Study|Failure to comply with protocol|0|||
164291917|NCT02193776|593439536|FG000|Overall Study|Investigator/Sponsor decision|1|||
164291918|NCT02193776|593439537|FG001|Overall Study|Investigator/Sponsor decision|1|||
164291919|NCT02193776|593439538|FG002|Overall Study|Investigator/Sponsor decision|0|||
164291920|NCT02193776|593439539|FG003|Overall Study|Investigator/Sponsor decision|0|||
164291921|NCT02193776|593439536|FG000|Overall Study|Death|1|||
164291922|NCT02193776|593439537|FG001|Overall Study|Death|0|||
164291923|NCT02193776|593439538|FG002|Overall Study|Death|0|||
164291924|NCT02193776|593439539|FG003|Overall Study|Death|0|||
164291925|NCT02193776|593439536|FG000|Overall Study|Adverse event/Specific toxicity|5|||
164291926|NCT02193776|593439537|FG001|Overall Study|Adverse event/Specific toxicity|5|||
164291927|NCT02193776|593439538|FG002|Overall Study|Adverse event/Specific toxicity|2|||
164291928|NCT02193776|593439539|FG003|Overall Study|Adverse event/Specific toxicity|2|||
164291929|NCT00657540|593439546|FG000|Overall Study|Lost to Follow-up|1|||
164291930|NCT00657540|593439547|FG001|Overall Study|Lost to Follow-up|4|||
164291931|NCT02043938|593439548|FG000|Overall Study|Withdrawal by Subject|7|||
164291932|NCT02043938|593439548|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
164291933|NCT02043938|593439548|FG000|Overall Study|No show by subject|1|||
164291934|NCT02043938|593439548|FG000|Overall Study|Investigator decision|1|||
164291935|NCT02611479|593439560|FG000|Baseline Enrollment|Exited study|13|||
164291936|NCT02611479|593439560|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
164291937|NCT02611479|593439560|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
164291938|NCT02611479|593439560|FG000|Data Cleaning|No baseline function or pain metrics|2|||
164291939|NCT02422498|593439565|FG000|Overall Study|Inevaluable|4|||
164291940|NCT02653326|593439566|FG000|Overall Study|Lost to Follow-up|10|||
164291941|NCT02653326|593439567|FG001|Overall Study|Lost to Follow-up|7|||
164132692|NCT01986010|592850671|FG016|Overall Study|Lost to Follow-up|0|||
164291942|NCT01620060|593439568|FG000|Overall Study|Adverse Event|9|||
164291943|NCT01620060|593439568|FG000|Overall Study|Protocol Violation|1|||
164291944|NCT01620060|593439568|FG000|Overall Study|Withdrawal by Subject|1|||
164291945|NCT01620060|593439568|FG000|Overall Study|Did not comply with Study Produre|1|||
164291946|NCT01620060|593439568|FG000|Overall Study|Family emergency|1|||
164291947|NCT01620060|593439568|FG000|Overall Study|Per Sponsor Decision|2|||
164291948|NCT01960140|593439569|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
164291949|NCT03452540|593439570|FG000|Overall Study|Adverse Event|1|||
164291950|NCT03452540|593439570|FG000|Overall Study|Withdrawal by Subject|1|||
164291951|NCT03452540|593439570|FG000|Overall Study|Other SAE and AE|2|||
164291952|NCT04664153|593439573|FG000|Overall Study|Lack of Efficacy|0|||
164291953|NCT04664153|593439574|FG001|Overall Study|Lack of Efficacy|0|||
164291954|NCT04664153|593439575|FG002|Overall Study|Lack of Efficacy|1|||
164291955|NCT04664153|593439576|FG003|Overall Study|Lack of Efficacy|0|||
164291956|NCT04664153|593439573|FG000|Overall Study|Physician Decision|0|||
164291957|NCT04664153|593439574|FG001|Overall Study|Physician Decision|0|||
164291958|NCT04664153|593439575|FG002|Overall Study|Physician Decision|1|||
164291959|NCT04664153|593439576|FG003|Overall Study|Physician Decision|0|||
164291960|NCT04664153|593439573|FG000|Overall Study|Withdrawal by Subject|3|||
164291961|NCT04664153|593439574|FG001|Overall Study|Withdrawal by Subject|2|||
164291962|NCT04664153|593439575|FG002|Overall Study|Withdrawal by Subject|1|||
164291963|NCT04664153|593439576|FG003|Overall Study|Withdrawal by Subject|2|||
164291964|NCT04664153|593439573|FG000|Overall Study|Other|0|||
164291965|NCT04664153|593439574|FG001|Overall Study|Other|1|||
164291966|NCT04664153|593439575|FG002|Overall Study|Other|0|||
164291967|NCT04664153|593439576|FG003|Overall Study|Other|0|||
164291968|NCT04664153|593439573|FG000|Overall Study|Adverse Event|4|||
164291969|NCT04664153|593439574|FG001|Overall Study|Adverse Event|0|||
164291970|NCT04664153|593439575|FG002|Overall Study|Adverse Event|1|||
164291971|NCT04664153|593439576|FG003|Overall Study|Adverse Event|0|||
164291972|NCT00231777|593439578|FG000|Overall Study|Lost to Follow-up|3|||
164291973|NCT00231777|593439579|FG001|Overall Study|Lost to Follow-up|0|||
164291974|NCT00231777|593439578|FG000|Overall Study|Other|3|||
164291975|NCT00231777|593439579|FG001|Overall Study|Other|2|||
164291976|NCT00524485|593439580|FG000|Overall Study|Withdrawal by Subject|5|||
164291977|NCT01600885|593439581|FG000|First Period|Adverse Event|1|||
164291978|NCT01600885|593439582|FG001|First Period|Adverse Event|1|||
164291979|NCT01600885|593439581|FG000|First Period|moved out of area|1|||
164291980|NCT01600885|593439582|FG001|First Period|moved out of area|0|||
164291981|NCT00642356|593439596|FG000|Overall Study|Adverse Event|1|||
164291982|NCT00642356|593439597|FG001|Overall Study|Adverse Event|0|||
164291983|NCT00642356|593439596|FG000|Overall Study|Protocol Violation|0|||
164291984|NCT00642356|593439597|FG001|Overall Study|Protocol Violation|3|||
164291985|NCT00642356|593439596|FG000|Overall Study|Lack of Efficacy|1|||
164291986|NCT00642356|593439597|FG001|Overall Study|Lack of Efficacy|0|||
164291987|NCT01009060|593439600|FG000|Overall Study|Adverse Event|1|||
164291988|NCT01009060|593439601|FG001|Overall Study|Adverse Event|2|||
164291989|NCT01009060|593439600|FG000|Overall Study|Protocol Violation|0|||
164291990|NCT01009060|593439601|FG001|Overall Study|Protocol Violation|1|||
164291991|NCT01009060|593439600|FG000|Overall Study|Lost to Follow-up|1|||
164291992|NCT01009060|593439601|FG001|Overall Study|Lost to Follow-up|0|||
164291993|NCT01009060|593439600|FG000|Overall Study|Physician Decision|1|||
164291994|NCT01009060|593439601|FG001|Overall Study|Physician Decision|1|||
164291995|NCT01009060|593439600|FG000|Overall Study|Withdrawal by Subject|1|||
164291996|NCT01009060|593439601|FG001|Overall Study|Withdrawal by Subject|1|||
164291997|NCT00005906|593439602|FG000|Overall Study|Lack of Efficacy|3|||
164291998|NCT04551989|593439603|FG000|Overall Study|Adverse Event|4|||
164291999|NCT04551989|593439603|FG000|Overall Study|Protocol Violation|3|||
164292000|NCT04551989|593439603|FG000|Overall Study|Lost to Follow-up|1|||
164292001|NCT04551989|593439603|FG000|Overall Study|Physician Decision|3|||
164292002|NCT04201431|593439604|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
164292003|NCT04201431|593439605|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
164292004|NCT04201431|593439606|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
164292005|NCT00088530|593439611|FG000|Overall Study|Progressive/Relapsed Disease|28|||
164292006|NCT00088530|593439612|FG001|Overall Study|Progressive/Relapsed Disease|39|||
164292007|NCT00088530|593439611|FG000|Overall Study|Adverse Event|15|||
164292008|NCT00088530|593439612|FG001|Overall Study|Adverse Event|9|||
164292009|NCT00088530|593439611|FG000|Overall Study|Withdrawal by Subject|2|||
164292010|NCT00088530|593439612|FG001|Overall Study|Withdrawal by Subject|5|||
164292011|NCT00088530|593439611|FG000|Overall Study|Lost to Follow-up|2|||
164292012|NCT00088530|593439612|FG001|Overall Study|Lost to Follow-up|0|||
164292013|NCT00088530|593439611|FG000|Overall Study|Physician Decision|2|||
164292014|NCT00088530|593439612|FG001|Overall Study|Physician Decision|0|||
164292015|NCT00088530|593439611|FG000|Overall Study|Sponsor decision|0|||
164292016|NCT00088530|593439612|FG001|Overall Study|Sponsor decision|1|||
164292017|NCT00088530|593439611|FG000|Overall Study|Patient never treated|1|||
164292018|NCT00088530|593439612|FG001|Overall Study|Patient never treated|0|||
164292019|NCT04571944|593439613|FG000|Overall Study|Death|1|||
164292020|NCT04571944|593439614|FG001|Overall Study|Death|0|||
164292021|NCT04571944|593439613|FG000|Overall Study|Withdrawal by Subject|3|||
164292022|NCT04571944|593439614|FG001|Overall Study|Withdrawal by Subject|0|||
164292023|NCT04571944|593439613|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
164299946|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
164299947|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299948|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299949|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299950|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299951|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299952|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299953|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
163897862|NCT03333915|591998740|FG003|Overall Study|Withdrawal by Subject|5|||
163897863|NCT03333915|591998741|FG004|Overall Study|Withdrawal by Subject|1|||
163897864|NCT05771467|591998753|FG000|Overall Study|Lost to Follow-up|6|||
163897865|NCT05771467|591998754|FG001|Overall Study|Lost to Follow-up|3|||
163897866|NCT01220531|591998757|FG000|Overall Study|Death|7|||
163897867|NCT01220531|591998757|FG000|Overall Study|Lost to Follow-up|1|||
163897868|NCT05866926|591998760|FG000|Overall Study|Death|16|||
163897869|NCT05866926|591998761|FG001|Overall Study|Death|9|||
163897870|NCT05866926|591998760|FG000|Overall Study|Lost to Follow-up|0|||
163897871|NCT05866926|591998761|FG001|Overall Study|Lost to Follow-up|1|||
163897872|NCT05866926|591998760|FG000|Overall Study|Adverse Event|1|||
163897873|NCT05866926|591998761|FG001|Overall Study|Adverse Event|0|||
163897874|NCT05866926|591998760|FG000|Overall Study|Withdrawal by Subject|5|||
163897875|NCT05866926|591998761|FG001|Overall Study|Withdrawal by Subject|1|||
163897876|NCT05866926|591998760|FG000|Overall Study|Disease progression|1|||
163897877|NCT05866926|591998761|FG001|Overall Study|Disease progression|0|||
163897878|NCT05866926|591998760|FG000|Overall Study|other causes|2|||
163897879|NCT05866926|591998761|FG001|Overall Study|other causes|1|||
163897880|NCT01105091|591998762|FG000|Overall Study|Death|2|||
163897881|NCT01105091|591998763|FG001|Overall Study|Death|0|||
163897882|NCT00557492|591999409|FG000|Overall Study|Change in health insurance|1|||
163897883|NCT02567435|591999425|FG000|Overall Study|Death|1|||
163897884|NCT02567435|591999426|FG001|Overall Study|Death|1|||
163897885|NCT02567435|591999427|FG002|Overall Study|Death|0|||
163897886|NCT02567435|591999428|FG003|Overall Study|Death|0|||
163897887|NCT02567435|591999425|FG000|Overall Study|Ineligible|1|||
163897888|NCT02567435|591999426|FG001|Overall Study|Ineligible|3|||
163897889|NCT02567435|591999427|FG002|Overall Study|Ineligible|0|||
163897890|NCT02567435|591999428|FG003|Overall Study|Ineligible|0|||
163897891|NCT02567435|591999425|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
163897892|NCT02567435|591999426|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
163897893|NCT02567435|591999427|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
163897894|NCT02567435|591999428|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
163897895|NCT02166463|591999429|FG000|Overall Study|Lost to Follow-up|0|||
163897896|NCT02166463|591999430|FG001|Overall Study|Lost to Follow-up|1|||
163897897|NCT02166463|591999429|FG000|Overall Study|Physician Decision|10|||
163897898|NCT02166463|591999430|FG001|Overall Study|Physician Decision|10|||
163897899|NCT02166463|591999429|FG000|Overall Study|Ineligible|11|||
163897900|NCT02166463|591999430|FG001|Overall Study|Ineligible|2|||
163897901|NCT02166463|591999429|FG000|Overall Study|Progressive Disease|9|||
163897902|NCT02166463|591999430|FG001|Overall Study|Progressive Disease|6|||
163897903|NCT02166463|591999429|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
163897904|NCT02166463|591999430|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
164132693|NCT01986010|592850655|FG000|Overall Study|Physician Decision|0|||
164346058|NCT01397708|593641143|FG003|Overall Study|Other|0|||
164346059|NCT01397708|593641144|FG004|Overall Study|Other|0|||
164346060|NCT01397708|593641145|FG005|Overall Study|Other|0|||
164346061|NCT01397708|593641146|FG006|Overall Study|Other|1|||
164346062|NCT01397708|593641147|FG007|Overall Study|Other|0|||
164346063|NCT04997304|593641148|FG000|Overall Study|Lost to Follow-up|11|||
164346064|NCT04997304|593641148|FG000|Overall Study|Death|1|||
164346065|NCT04997304|593641148|FG000|Overall Study|Withdrawal by Subject|14|||
164346066|NCT01606800|593642758|FG000|Overall Study|Adverse Event|3|||
164346067|NCT01606800|593642759|FG001|Overall Study|Adverse Event|1|||
164346068|NCT01606800|593642758|FG000|Overall Study|Participant withdrew consent|0|||
164346069|NCT01606800|593642759|FG001|Overall Study|Participant withdrew consent|1|||
164346070|NCT01606800|593642758|FG000|Overall Study|Missing completion status|2|||
164346071|NCT01606800|593642759|FG001|Overall Study|Missing completion status|0|||
164346072|NCT00612690|593642765|FG000|Overall Study|Lost to Follow-up|72|||
164346073|NCT00612690|593642766|FG001|Overall Study|Lost to Follow-up|98|||
164346074|NCT00612690|593642765|FG000|Overall Study|Withdrawal by Subject|32|||
164346075|NCT00612690|593642766|FG001|Overall Study|Withdrawal by Subject|20|||
164346076|NCT00612690|593642765|FG000|Overall Study|Withdrawal by Site|11|||
164346077|NCT00612690|593642766|FG001|Overall Study|Withdrawal by Site|0|||
164346078|NCT02370160|593642769|FG000|Overall Study|Death|3|||
164346079|NCT02370160|593642770|FG001|Overall Study|Death|4|||
164346080|NCT02370160|593642771|FG002|Overall Study|Death|1|||
164346081|NCT04487730|593642772|FG000|Overall Study|Withdrawal by Subject|3|||
164346082|NCT04487730|593642773|FG001|Overall Study|Withdrawal by Subject|1|||
164346083|NCT04487730|593642772|FG000|Overall Study|Lost to Follow-up|0|||
164346084|NCT04487730|593642773|FG001|Overall Study|Lost to Follow-up|1|||
164346085|NCT04487730|593642772|FG000|Overall Study|Physician Decision|0|||
164346086|NCT04487730|593642773|FG001|Overall Study|Physician Decision|1|||
164346087|NCT00907777|593642774|FG000|Overall Study|Withdrawal by Subject|0|||
164346088|NCT00907777|593642775|FG001|Overall Study|Withdrawal by Subject|1|||
164346089|NCT03291808|593642776|FG000|Overall Study|Lost to Follow-up|6|||
164346090|NCT03291808|593642776|FG000|Overall Study|Research burden|4|||
164346091|NCT00638378|593642777|FG000|Overall Study|Death|2|||
164346092|NCT00638378|593642777|FG000|Overall Study|Adverse Event|1|||
164346093|NCT00638378|593642777|FG000|Overall Study|Disease progression|15|||
164346094|NCT00638378|593642777|FG000|Overall Study|Physician Decision|4|||
164346095|NCT03364023|593642778|FG000|Overall Study|Lost to Follow-up|3|||
164346096|NCT03364023|593642778|FG000|Overall Study|Death|14|||
164346097|NCT02891850|593642779|FG000|Overall Study|Adverse Event|3|||
164346098|NCT02891850|593642780|FG001|Overall Study|Adverse Event|0|||
164346099|NCT02891850|593642779|FG000|Overall Study|Death|0|||
164346100|NCT02891850|593642780|FG001|Overall Study|Death|4|||
164346101|NCT02891850|593642779|FG000|Overall Study|Physician Decision|1|||
164346102|NCT02891850|593642780|FG001|Overall Study|Physician Decision|0|||
164346103|NCT02891850|593642779|FG000|Overall Study|Pregnancy|1|||
164346104|NCT02891850|593642780|FG001|Overall Study|Pregnancy|0|||
164346105|NCT02891850|593642779|FG000|Overall Study|Withdrawal by Subject|2|||
164346106|NCT02891850|593642780|FG001|Overall Study|Withdrawal by Subject|3|||
164346107|NCT03797014|593642783|FG000|Overall Study|Withdrawal by Subject|1|||
164346108|NCT03797014|593642783|FG000|Overall Study|Lost to Follow-up|1|||
164346109|NCT03797014|593642783|FG000|Overall Study|Protocol Violation|1|||
164346110|NCT01970397|593642784|FG000|Overall Study|Adverse Event|0|||
164346111|NCT01970397|593642785|FG001|Overall Study|Adverse Event|1|||
164346112|NCT01970397|593642784|FG000|Overall Study|Lost to Follow-up|0|||
164346113|NCT01970397|593642785|FG001|Overall Study|Lost to Follow-up|1|||
164346114|NCT01970397|593642784|FG000|Overall Study|Personal Reasons|1|||
164346115|NCT01970397|593642785|FG001|Overall Study|Personal Reasons|2|||
164346116|NCT01970397|593642784|FG000|Overall Study|Protocol Violation|1|||
164346117|NCT01970397|593642785|FG001|Overall Study|Protocol Violation|1|||
164346118|NCT00105469|593642790|FG000|Overall Study|Adverse Event|9|||
164346119|NCT00105469|593642791|FG001|Overall Study|Adverse Event|8|||
164346120|NCT00105469|593642790|FG000|Overall Study|Protocol Violation|4|||
164346121|NCT00105469|593642791|FG001|Overall Study|Protocol Violation|0|||
164346122|NCT00105469|593642790|FG000|Overall Study|Withdrawal by Subject|2|||
164346123|NCT00105469|593642791|FG001|Overall Study|Withdrawal by Subject|3|||
164346124|NCT00105469|593642790|FG000|Overall Study|Lost to Follow-up|1|||
164346125|NCT00105469|593642791|FG001|Overall Study|Lost to Follow-up|0|||
164346126|NCT00105469|593642790|FG000|Overall Study|Lack of Efficacy|2|||
164346127|NCT00105469|593642791|FG001|Overall Study|Lack of Efficacy|0|||
164346128|NCT00105469|593642790|FG000|Overall Study|Other Reason|4|||
164346129|NCT00105469|593642791|FG001|Overall Study|Other Reason|0|||
164346130|NCT00056316|593642792|FG000|Overall Study|Withdrawal by Subject|2|||
164346131|NCT00056316|593642793|FG001|Overall Study|Withdrawal by Subject|2|||
164346132|NCT00056316|593642792|FG000|Overall Study|Death/NH placement of pt|1|||
164346133|NCT00056316|593642793|FG001|Overall Study|Death/NH placement of pt|1|||
164346134|NCT00573469|593642801|FG000|Overall Study|Adverse Event|1|||
164346135|NCT00573469|593642802|FG001|Overall Study|Adverse Event|1|||
164346136|NCT00573469|593642803|FG002|Overall Study|Adverse Event|1|||
164346137|NCT00573469|593642801|FG000|Overall Study|Withdrawal by Subject|0|||
164292024|NCT04571944|593439614|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
164292025|NCT00686777|593439618|FG000|Overall Study|Adverse Event|2|||
164292026|NCT00686777|593439618|FG000|Overall Study|Pregnancy|1|||
164292027|NCT00686777|593439618|FG000|Overall Study|Withdrawal by Subject|2|||
164292028|NCT00686777|593439618|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
164292029|NCT00686777|593439618|FG000|Overall Study|No Visit|1|||
164292030|NCT00499681|593439619|FG000|Overall Study|toxicity|0|||
164292031|NCT00499681|593439620|FG001|Overall Study|toxicity|1|||
164292032|NCT00499681|593439619|FG000|Overall Study|disease progression|0|||
164292033|NCT00499681|593439620|FG001|Overall Study|disease progression|1|||
164292034|NCT00890825|593439621|FG000|Overall Study|Withdrawal by Subject|1|||
164292035|NCT00890825|593439622|FG001|Overall Study|Withdrawal by Subject|0|||
164292036|NCT00890825|593439621|FG000|Overall Study|Alive at data cut off (DCO)|13|||
164292037|NCT00890825|593439622|FG001|Overall Study|Alive at data cut off (DCO)|14|||
164292038|NCT02920892|593439623|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
164292039|NCT02920892|593439624|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
164292040|NCT02920892|593439625|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
164292041|NCT02920892|593439623|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
164292042|NCT02920892|593439624|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
164346138|NCT00573469|593642802|FG001|Overall Study|Withdrawal by Subject|2|||
164346139|NCT00573469|593642803|FG002|Overall Study|Withdrawal by Subject|0|||
164346140|NCT00573469|593642801|FG000|Overall Study|Other|5|||
164346141|NCT00573469|593642802|FG001|Overall Study|Other|1|||
164346142|NCT00573469|593642803|FG002|Overall Study|Other|3|||
164346143|NCT02468414|593642804|FG000|Overall Study|Early Study Termination by Sponsor|1|||
164346144|NCT02468414|593642805|FG001|Overall Study|Early Study Termination by Sponsor|0|||
164346145|NCT02468414|593642804|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
164346146|NCT02468414|593642805|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
164346147|NCT02468414|593642804|FG000|Overall Study|Screen Failure|1|||
164346148|NCT02468414|593642805|FG001|Overall Study|Screen Failure|0|||
164346149|NCT00004978|593642806|FG000|Overall Study|Death|107|||
164346150|NCT00004978|593642807|FG001|Overall Study|Death|116|||
164346151|NCT00004978|593642806|FG000|Overall Study|Lost to Follow-up|101|||
164346152|NCT00004978|593642807|FG001|Overall Study|Lost to Follow-up|108|||
164346153|NCT00004978|593642806|FG000|Overall Study|Withdrawal by Subject|17|||
164346154|NCT00004978|593642807|FG001|Overall Study|Withdrawal by Subject|26|||
164346155|NCT00004978|593642806|FG000|Overall Study|site closure - not in analysis cohort|19|||
164346156|NCT00004978|593642807|FG001|Overall Study|site closure - not in analysis cohort|20|||
164346157|NCT02155608|593642812|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
164346158|NCT02155608|593642813|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
164346159|NCT02155608|593642812|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
164346160|NCT02155608|593642813|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
164346161|NCT03555591|593642814|FG000|Overall Study|Protocol Violation|77|||
164346162|NCT01532414|593642817|FG000|Overall Study|Lost to Follow-up|3|||
164346163|NCT01532414|593642818|FG001|Overall Study|Lost to Follow-up|0|||
164346164|NCT01532414|593642819|FG002|Overall Study|Lost to Follow-up|1|||
164346165|NCT01532414|593642817|FG000|Overall Study|Withdrawal by Subject|3|||
164346166|NCT01532414|593642818|FG001|Overall Study|Withdrawal by Subject|0|||
164346167|NCT01532414|593642819|FG002|Overall Study|Withdrawal by Subject|0|||
164346168|NCT01532414|593642817|FG000|Overall Study|No V6 semen sample|0|||
164346169|NCT01532414|593642818|FG001|Overall Study|No V6 semen sample|1|||
164346170|NCT01532414|593642819|FG002|Overall Study|No V6 semen sample|0|||
164346171|NCT01532414|593642817|FG000|Overall Study|Adverse Event|0|||
164346172|NCT01532414|593642818|FG001|Overall Study|Adverse Event|1|||
164346173|NCT01532414|593642819|FG002|Overall Study|Adverse Event|1|||
164346174|NCT01532414|593642817|FG000|Overall Study|Unable to complete 24 hour PK|0|||
164346175|NCT01532414|593642818|FG001|Overall Study|Unable to complete 24 hour PK|0|||
164346176|NCT01532414|593642819|FG002|Overall Study|Unable to complete 24 hour PK|1|||
164346177|NCT01532414|593642817|FG000|Overall Study|Withdrawn by sponsor|1|||
164346178|NCT01532414|593642818|FG001|Overall Study|Withdrawn by sponsor|0|||
164346179|NCT01532414|593642819|FG002|Overall Study|Withdrawn by sponsor|0|||
164346180|NCT05035550|593642827|FG000|Overall Study|Withdrawal by Subject|3|||
164292043|NCT02920892|593439625|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
164292044|NCT02920892|593439623|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
164292045|NCT02920892|593439624|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
164346181|NCT05035550|593642828|FG001|Overall Study|Withdrawal by Subject|0|||
164346182|NCT00160693|593642831|FG000|Overall Study|Adverse Event|97|||
164346183|NCT00160693|593642831|FG000|Overall Study|Lack of Efficacy|30|||
164346184|NCT00160693|593642831|FG000|Overall Study|Protocol Violation|24|||
164346185|NCT00160693|593642831|FG000|Overall Study|Lost to Follow-up|15|||
164346186|NCT00160693|593642831|FG000|Overall Study|Withdrawal by Subject|54|||
164346187|NCT00160693|593642831|FG000|Overall Study|Study terminated by sponsor|15|||
164346188|NCT00617123|593642832|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
164346189|NCT00617123|593642833|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
164292046|NCT02920892|593439625|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
164292047|NCT02920892|593439623|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
164292048|NCT02920892|593439624|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
164292049|NCT02920892|593439625|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
164292050|NCT02920892|593439623|FG000|Placebo-Controlled Period|Physician Decision|0|||
164292051|NCT02920892|593439624|FG001|Placebo-Controlled Period|Physician Decision|0|||
164292052|NCT02920892|593439625|FG002|Placebo-Controlled Period|Physician Decision|1|||
164292053|NCT02920892|593439623|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
164292054|NCT02920892|593439624|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
164292055|NCT02920892|593439625|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
164292056|NCT02920892|593439623|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164292057|NCT02920892|593439624|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
164292058|NCT02920892|593439625|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164292059|NCT02920892|593439623|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
164292060|NCT02920892|593439624|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
164292061|NCT02920892|593439625|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
164292062|NCT01721161|593439626|FG000|Overall Study|Adverse Event|2|||
164292063|NCT01721161|593439627|FG001|Overall Study|Adverse Event|3|||
164088115|NCT02829918|592687352|FG000|Overall Study|Withdrawal by Subject|4|||
164088116|NCT02829918|592687352|FG000|Overall Study|Adverse Event|1|||
164292064|NCT01721161|593439626|FG000|Overall Study|Lost to Follow-up|1|||
164292065|NCT01721161|593439627|FG001|Overall Study|Lost to Follow-up|2|||
164292066|NCT01721161|593439626|FG000|Overall Study|Withdrawal by Subject|1|||
164292067|NCT01721161|593439627|FG001|Overall Study|Withdrawal by Subject|1|||
164292068|NCT01721161|593439626|FG000|Overall Study|Other|0|||
163897905|NCT02166463|591999429|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
163897906|NCT02166463|591999430|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
163897907|NCT02166463|591999429|FG000|Overall Study|Refusal of further protocol therapy|5|||
163897908|NCT02166463|591999430|FG001|Overall Study|Refusal of further protocol therapy|6|||
164088117|NCT02829918|592687352|FG000|Overall Study|Progression|1|||
164292069|NCT01721161|593439627|FG001|Overall Study|Other|1|||
164292070|NCT01216202|593439628|FG000|Overall Study|Withdrawal by Subject|8|||
164292071|NCT01216202|593439629|FG001|Overall Study|Withdrawal by Subject|0|||
164292072|NCT01216202|593439628|FG000|Overall Study|Death|0|||
164292073|NCT01216202|593439629|FG001|Overall Study|Death|2|||
164292074|NCT01216202|593439628|FG000|Overall Study|Lost to Follow-up|14|||
164292075|NCT01216202|593439629|FG001|Overall Study|Lost to Follow-up|0|||
164292076|NCT00614380|593439632|FG000|Overall Study|Adverse Event|14|||
164292077|NCT00614380|593439633|FG001|Overall Study|Adverse Event|4|||
164292078|NCT00614380|593439634|FG002|Overall Study|Adverse Event|0|||
164292079|NCT00614380|593439635|FG003|Overall Study|Adverse Event|0|||
164292080|NCT00614380|593439632|FG000|Overall Study|Lost to Follow-up|6|||
164292081|NCT00614380|593439633|FG001|Overall Study|Lost to Follow-up|1|||
164292082|NCT00614380|593439634|FG002|Overall Study|Lost to Follow-up|0|||
164292083|NCT00614380|593439635|FG003|Overall Study|Lost to Follow-up|0|||
164292084|NCT00614380|593439632|FG000|Overall Study|Non compliant with the protocol|12|||
164292085|NCT00614380|593439633|FG001|Overall Study|Non compliant with the protocol|2|||
164292086|NCT00614380|593439634|FG002|Overall Study|Non compliant with the protocol|1|||
164292087|NCT00614380|593439635|FG003|Overall Study|Non compliant with the protocol|2|||
164292088|NCT00614380|593439632|FG000|Overall Study|Consent withdrawn|3|||
164292089|NCT00614380|593439633|FG001|Overall Study|Consent withdrawn|1|||
164292090|NCT00614380|593439634|FG002|Overall Study|Consent withdrawn|0|||
164292091|NCT00614380|593439635|FG003|Overall Study|Consent withdrawn|0|||
164292092|NCT00689390|593439638|FG000|Overall Study|Adverse Event|19|||
164292093|NCT00689390|593439639|FG001|Overall Study|Adverse Event|0|||
164292094|NCT00689390|593439638|FG000|Overall Study|Lost to Follow-up|179|||
164292095|NCT00689390|593439639|FG001|Overall Study|Lost to Follow-up|7|||
164292096|NCT00689390|593439638|FG000|Overall Study|Withdrawal by Subject|117|||
164292097|NCT00689390|593439639|FG001|Overall Study|Withdrawal by Subject|3|||
164292098|NCT00689390|593439638|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
164292099|NCT00689390|593439639|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
164292100|NCT00689390|593439638|FG000|Overall Study|Non-Compliance With Protocol|21|||
164292101|NCT00689390|593439639|FG001|Overall Study|Non-Compliance With Protocol|0|||
164292102|NCT00689390|593439638|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
164292103|NCT00689390|593439639|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
164292104|NCT00689390|593439638|FG000|Overall Study|Administrative|37|||
164292105|NCT00689390|593439639|FG001|Overall Study|Administrative|0|||
164292106|NCT04908397|593439642|FG000|Overall Study|Withdrawal by Subject|2|||
164292107|NCT00462306|593439643|FG000|Overall Study|insufficient data|0|||
164292108|NCT00462306|593439644|FG001|Overall Study|insufficient data|13|||
164292109|NCT00191334|593439650|FG000|Overall Study|Adverse Event|4|||
164292110|NCT00191334|593439650|FG000|Overall Study|Disease Progression or Relapse|8|||
164292111|NCT00191334|593439650|FG000|Overall Study|Physician Decision|1|||
164292112|NCT00191334|593439650|FG000|Overall Study|Withdrawal by Subject|4|||
164292113|NCT00452790|593439651|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
164292114|NCT00452790|593439652|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
164292115|NCT00452790|593439651|FG000|Infant Series|Parent/legal guardian request|8|||
164292116|NCT00452790|593439652|FG001|Infant Series|Parent/legal guardian request|6|||
163897909|NCT03767335|591999437|FG000|Overall Study|Physician Decision|1|||
163897910|NCT03767335|591999438|FG001|Overall Study|Physician Decision|1|||
163897911|NCT03767335|591999439|FG002|Overall Study|Physician Decision|0|||
163897912|NCT03767335|591999437|FG000|Overall Study|Withdrawal by Subject|0|||
164292117|NCT00452790|593439651|FG000|Infant Series|Failed to return|4|||
164292118|NCT00452790|593439652|FG001|Infant Series|Failed to return|1|||
164292119|NCT00452790|593439651|FG000|Infant Series|Protocol Violation|1|||
164292120|NCT00452790|593439652|FG001|Infant Series|Protocol Violation|3|||
164292121|NCT00452790|593439651|FG000|Infant Series|Lost to Follow-up|2|||
164292122|NCT00452790|593439652|FG001|Infant Series|Lost to Follow-up|2|||
164292123|NCT00452790|593439651|FG000|Infant Series|Adverse Event|1|||
164004440|NCT02034123|592380793|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004441|NCT02034123|592380794|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
164004442|NCT02034123|592380777|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004443|NCT02034123|592380778|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004444|NCT02034123|592380779|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004445|NCT02034123|592380780|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
164004446|NCT02034123|592380781|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
164292124|NCT00452790|593439652|FG001|Infant Series|Adverse Event|2|||
164292125|NCT00452790|593439651|FG000|Infant Series|Other reasons|1|||
164292126|NCT00452790|593439652|FG001|Infant Series|Other reasons|2|||
164292127|NCT00452790|593439651|FG000|Infant Series|Investigator request|0|||
164292128|NCT00452790|593439652|FG001|Infant Series|Investigator request|1|||
164292129|NCT00452790|593439651|FG000|Infant Series|Death|0|||
164292130|NCT00452790|593439652|FG001|Infant Series|Death|1|||
164292131|NCT00452790|593439651|FG000|After Infant Series|Investigator request|10|||
164292132|NCT00452790|593439652|FG001|After Infant Series|Investigator request|10|||
164292133|NCT00452790|593439651|FG000|After Infant Series|Adverse Event|4|||
164292134|NCT00452790|593439652|FG001|After Infant Series|Adverse Event|1|||
164292135|NCT00452790|593439651|FG000|After Infant Series|Parent/legal guardian request|1|||
164292136|NCT00452790|593439652|FG001|After Infant Series|Parent/legal guardian request|3|||
164292137|NCT00452790|593439651|FG000|After Infant Series|Lost to Follow-up|4|||
164292138|NCT00452790|593439652|FG001|After Infant Series|Lost to Follow-up|0|||
164292139|NCT00452790|593439651|FG000|After Infant Series|Failed to return|1|||
164292140|NCT00452790|593439652|FG001|After Infant Series|Failed to return|0|||
164292141|NCT00452790|593439651|FG000|After Infant Series|Other reasons|1|||
164292142|NCT00452790|593439652|FG001|After Infant Series|Other reasons|0|||
164292143|NCT00452790|593439651|FG000|Toddler Dose|Failed to return|0|||
164292144|NCT00452790|593439652|FG001|Toddler Dose|Failed to return|1|||
164292145|NCT00452790|593439651|FG000|Toddler Dose|Parent/legal guardian request|0|||
164292146|NCT00452790|593439652|FG001|Toddler Dose|Parent/legal guardian request|1|||
164292147|NCT02926638|593439657|FG000|Overall Study|Progression|2|||
164292148|NCT02926638|593439658|FG001|Overall Study|Progression|5|||
164292149|NCT02926638|593439657|FG000|Overall Study|Ineligible|1|||
164292150|NCT02926638|593439658|FG001|Overall Study|Ineligible|0|||
164292151|NCT02926638|593439657|FG000|Overall Study|Not protocol specified|1|||
164292152|NCT02926638|593439658|FG001|Overall Study|Not protocol specified|0|||
164292153|NCT02360228|593439659|FG000|Overall Study|Withdrawal by Subject|1|||
164292154|NCT02360228|593439660|FG001|Overall Study|Withdrawal by Subject|0|||
164292155|NCT02360228|593439661|FG002|Overall Study|Withdrawal by Subject|0|||
164292156|NCT02360228|593439659|FG000|Overall Study|Self-discontinued medication|0|||
164292157|NCT02360228|593439660|FG001|Overall Study|Self-discontinued medication|1|||
164292158|NCT02360228|593439661|FG002|Overall Study|Self-discontinued medication|0|||
164292159|NCT02360228|593439659|FG000|Overall Study|Unstable symptoms during screening|0|||
164292160|NCT02360228|593439660|FG001|Overall Study|Unstable symptoms during screening|0|||
164292161|NCT02360228|593439661|FG002|Overall Study|Unstable symptoms during screening|1|||
164292162|NCT01063153|593439666|FG000|Overall Study|Found Ineligible During Screening|2|||
164292163|NCT01063153|593439667|FG001|Overall Study|Found Ineligible During Screening|0|||
164292164|NCT01063153|593439666|FG000|Overall Study|Lost to Follow-up|0|||
164292165|NCT01063153|593439667|FG001|Overall Study|Lost to Follow-up|7|||
164292166|NCT01063153|593439666|FG000|Overall Study|Withdrawal by Subject|0|||
164292167|NCT01063153|593439667|FG001|Overall Study|Withdrawal by Subject|1|||
164292168|NCT01063153|593439666|FG000|Overall Study|Physician Decision|0|||
164292169|NCT01063153|593439667|FG001|Overall Study|Physician Decision|4|||
164292170|NCT01908426|593441045|FG000|Overall Study|Adverse Event|98|||
164292171|NCT01908426|593441046|FG001|Overall Study|Adverse Event|11|||
164292172|NCT01908426|593441045|FG000|Overall Study|Clinical Deterioration|72|||
164292173|NCT01908426|593441046|FG001|Overall Study|Clinical Deterioration|38|||
164292174|NCT01908426|593441045|FG000|Overall Study|Lack of Efficacy|3|||
164292175|NCT01908426|593441046|FG001|Overall Study|Lack of Efficacy|0|||
164292176|NCT01908426|593441045|FG000|Overall Study|Lost to Follow-up|0|||
164292177|NCT01908426|593441046|FG001|Overall Study|Lost to Follow-up|1|||
164292178|NCT01908426|593441045|FG000|Overall Study|Physician Decision|3|||
164292179|NCT01908426|593441046|FG001|Overall Study|Physician Decision|3|||
164292180|NCT01908426|593441045|FG000|Overall Study|Withdrawal by Subject|11|||
164292181|NCT01908426|593441046|FG001|Overall Study|Withdrawal by Subject|6|||
164088118|NCT00491504|592687355|FG000|Overall Study|Adverse Event|0|||
164292182|NCT01908426|593441045|FG000|Overall Study|Progressive Disease|206|||
164292183|NCT01908426|593441046|FG001|Overall Study|Progressive Disease|152|||
164292184|NCT01908426|593441045|FG000|Overall Study|Protocol Violation|1|||
164292185|NCT01908426|593441046|FG001|Overall Study|Protocol Violation|0|||
164292186|NCT01908426|593441045|FG000|Overall Study|No Study Treatment Given|3|||
164292187|NCT01908426|593441046|FG001|Overall Study|No Study Treatment Given|0|||
164292188|NCT02973100|593441052|FG000|Overall Study|Adverse Event|1|||
164292189|NCT02973100|593441053|FG001|Overall Study|Adverse Event|2|||
164292190|NCT02973100|593441054|FG002|Overall Study|Adverse Event|1|||
164292191|NCT02973100|593441055|FG003|Overall Study|Adverse Event|2|||
163897913|NCT03767335|591999438|FG001|Overall Study|Withdrawal by Subject|0|||
164292192|NCT02973100|593441052|FG000|Overall Study|Lost to Follow-up|3|||
164292193|NCT02973100|593441053|FG001|Overall Study|Lost to Follow-up|1|||
164292194|NCT02973100|593441054|FG002|Overall Study|Lost to Follow-up|1|||
164292195|NCT02973100|593441055|FG003|Overall Study|Lost to Follow-up|0|||
164292196|NCT02973100|593441052|FG000|Overall Study|Withdrawal by Subject|3|||
164292197|NCT02973100|593441053|FG001|Overall Study|Withdrawal by Subject|5|||
164292198|NCT02973100|593441054|FG002|Overall Study|Withdrawal by Subject|1|||
164292199|NCT02973100|593441055|FG003|Overall Study|Withdrawal by Subject|4|||
164292200|NCT02973100|593441052|FG000|Overall Study|Notification of change in address|0|||
164292201|NCT02973100|593441053|FG001|Overall Study|Notification of change in address|0|||
164292202|NCT02973100|593441054|FG002|Overall Study|Notification of change in address|0|||
164292203|NCT02973100|593441055|FG003|Overall Study|Notification of change in address|1|||
164292204|NCT02973100|593441052|FG000|Overall Study|Failed to attend Safety followup period|0|||
164292205|NCT02973100|593441053|FG001|Overall Study|Failed to attend Safety followup period|0|||
164292206|NCT02973100|593441054|FG002|Overall Study|Failed to attend Safety followup period|1|||
164292207|NCT02973100|593441055|FG003|Overall Study|Failed to attend Safety followup period|0|||
164292208|NCT00383552|593441056|FG000|Overall Study|Adverse Event|7|||
164292209|NCT00383552|593441057|FG001|Overall Study|Adverse Event|6|||
164292210|NCT00383552|593441058|FG002|Overall Study|Adverse Event|9|||
164292211|NCT00383552|593441059|FG003|Overall Study|Adverse Event|6|||
164292212|NCT00383552|593441056|FG000|Overall Study|Lack of Efficacy|4|||
164292213|NCT00383552|593441057|FG001|Overall Study|Lack of Efficacy|13|||
164292214|NCT00383552|593441058|FG002|Overall Study|Lack of Efficacy|29|||
164292215|NCT00383552|593441059|FG003|Overall Study|Lack of Efficacy|42|||
164292216|NCT00383552|593441056|FG000|Overall Study|Lost to Follow-up|0|||
164292217|NCT00383552|593441057|FG001|Overall Study|Lost to Follow-up|1|||
164292218|NCT00383552|593441058|FG002|Overall Study|Lost to Follow-up|5|||
164292219|NCT00383552|593441059|FG003|Overall Study|Lost to Follow-up|1|||
164292220|NCT00383552|593441056|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
164292221|NCT00383552|593441057|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
164292222|NCT00383552|593441058|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
164292223|NCT00383552|593441059|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
164292224|NCT00383552|593441056|FG000|Overall Study|Did not wish to continue (related)|1|||
164292225|NCT00383552|593441057|FG001|Overall Study|Did not wish to continue (related)|0|||
164292226|NCT00383552|593441058|FG002|Overall Study|Did not wish to continue (related)|2|||
164292227|NCT00383552|593441059|FG003|Overall Study|Did not wish to continue (related)|3|||
164292228|NCT00383552|593441056|FG000|Overall Study|Noncompliance with the protocol|11|||
164292229|NCT00383552|593441057|FG001|Overall Study|Noncompliance with the protocol|6|||
164292230|NCT00383552|593441058|FG002|Overall Study|Noncompliance with the protocol|8|||
164292231|NCT00383552|593441059|FG003|Overall Study|Noncompliance with the protocol|10|||
164292232|NCT00383552|593441056|FG000|Overall Study|Did not meet protocol eligibility|8|||
164292233|NCT00383552|593441057|FG001|Overall Study|Did not meet protocol eligibility|6|||
164292234|NCT00383552|593441058|FG002|Overall Study|Did not meet protocol eligibility|2|||
164292235|NCT00383552|593441059|FG003|Overall Study|Did not meet protocol eligibility|3|||
164292236|NCT00383552|593441056|FG000|Overall Study|Administrative|1|||
164292237|NCT00383552|593441057|FG001|Overall Study|Administrative|0|||
164292238|NCT00383552|593441058|FG002|Overall Study|Administrative|1|||
164292239|NCT00383552|593441059|FG003|Overall Study|Administrative|1|||
164292240|NCT01419236|593441066|FG000|Overall Study|Adverse Event|1|||
164292241|NCT01419236|593441067|FG001|Overall Study|Adverse Event|0|||
164292242|NCT01419236|593441066|FG000|Overall Study|Lack of Efficacy|0|||
164292243|NCT01419236|593441067|FG001|Overall Study|Lack of Efficacy|1|||
164292244|NCT01419236|593441066|FG000|Overall Study|Lost to Follow-up|1|||
164292245|NCT01419236|593441067|FG001|Overall Study|Lost to Follow-up|0|||
164292246|NCT01419236|593441066|FG000|Overall Study|Physician Decision|1|||
164292247|NCT01419236|593441067|FG001|Overall Study|Physician Decision|0|||
164292248|NCT01419236|593441066|FG000|Overall Study|Withdrawal by Subject|1|||
164292249|NCT01419236|593441067|FG001|Overall Study|Withdrawal by Subject|4|||
164292250|NCT01419236|593441066|FG000|Overall Study|Entry Criteria Not Met|1|||
164292251|NCT01419236|593441067|FG001|Overall Study|Entry Criteria Not Met|0|||
164292252|NCT04456504|593441068|FG000|Overall Study|Lost to Follow-up|2|||
164292253|NCT01342913|593441071|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
164292254|NCT01342913|593441072|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164292255|NCT01342913|593441073|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
164292256|NCT01342913|593441071|FG000|2-week Run-in Period|Physician Decision|6|||
164292257|NCT01342913|593441072|FG001|2-week Run-in Period|Physician Decision|0|||
164292258|NCT01342913|593441073|FG002|2-week Run-in Period|Physician Decision|0|||
164292259|NCT01342913|593441071|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
164292260|NCT01342913|593441072|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164292261|NCT01342913|593441073|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164292262|NCT01342913|593441071|FG000|2-week Run-in Period|Adverse Event|2|||
163897914|NCT03767335|591999439|FG002|Overall Study|Withdrawal by Subject|6|||
163897915|NCT03767335|591999437|FG000|Overall Study|Participant excluded from efficacy population|0|||
164292263|NCT01342913|593441072|FG001|2-week Run-in Period|Adverse Event|0|||
164004447|NCT02034123|592380782|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004448|NCT02034123|592380783|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004449|NCT02034123|592380784|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004450|NCT02034123|592380785|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004451|NCT02034123|592380786|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004452|NCT02034123|592380787|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004453|NCT02034123|592380788|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004454|NCT02034123|592380789|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164088119|NCT00491504|592687356|FG001|Overall Study|Adverse Event|1|||
164292264|NCT01342913|593441073|FG002|2-week Run-in Period|Adverse Event|0|||
164292265|NCT01342913|593441071|FG000|2-week Run-in Period|Protocol Violation|5|||
164292266|NCT01342913|593441072|FG001|2-week Run-in Period|Protocol Violation|0|||
164292267|NCT01342913|593441073|FG002|2-week Run-in Period|Protocol Violation|0|||
164292268|NCT01342913|593441071|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
164292269|NCT01342913|593441072|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
164292270|NCT01342913|593441073|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
164292271|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164292272|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Adverse Event|3|||
164292273|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Adverse Event|6|||
164292274|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
164292275|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
164292276|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
164292277|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164292278|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
164292279|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
164292280|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164292281|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164292282|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
164292283|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Physician Decision|0|||
164292284|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Physician Decision|2|||
164292285|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Physician Decision|0|||
164292286|NCT01342913|593441071|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164292287|NCT01342913|593441072|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164292288|NCT01342913|593441073|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
164292289|NCT03287791|593441078|FG000|Overall Study|Insufficient Therapeutic Response|0|||
164292290|NCT03287791|593441079|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164292291|NCT03287791|593441080|FG002|Overall Study|Insufficient Therapeutic Response|1|||
164292292|NCT03287791|593441078|FG000|Overall Study|Adverse Event|0|||
164292293|NCT03287791|593441079|FG001|Overall Study|Adverse Event|4|||
164292294|NCT03287791|593441080|FG002|Overall Study|Adverse Event|3|||
164292295|NCT03287791|593441078|FG000|Overall Study|Withdrawal by Subject|12|||
164292296|NCT03287791|593441079|FG001|Overall Study|Withdrawal by Subject|12|||
164292297|NCT03287791|593441080|FG002|Overall Study|Withdrawal by Subject|17|||
164292298|NCT03287791|593441078|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
164292299|NCT03287791|593441079|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
164292300|NCT03287791|593441080|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
164292301|NCT03287791|593441078|FG000|Overall Study|Lost to Follow-up|8|||
164292302|NCT03287791|593441079|FG001|Overall Study|Lost to Follow-up|14|||
164292303|NCT03287791|593441080|FG002|Overall Study|Lost to Follow-up|11|||
164292304|NCT03287791|593441078|FG000|Overall Study|Protocol Violation|7|||
164292305|NCT03287791|593441079|FG001|Overall Study|Protocol Violation|2|||
164292306|NCT03287791|593441080|FG002|Overall Study|Protocol Violation|1|||
164292307|NCT03287791|593441078|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
164292308|NCT03287791|593441079|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
164292309|NCT03287791|593441080|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
164292310|NCT03287791|593441078|FG000|Overall Study|Too much time between 2 visits|0|||
164292311|NCT03287791|593441079|FG001|Overall Study|Too much time between 2 visits|1|||
164292312|NCT03287791|593441080|FG002|Overall Study|Too much time between 2 visits|0|||
164292313|NCT03287791|593441078|FG000|Overall Study|Non-compliance|0|||
164292314|NCT03287791|593441079|FG001|Overall Study|Non-compliance|1|||
164292315|NCT03287791|593441080|FG002|Overall Study|Non-compliance|0|||
164292316|NCT03287791|593441078|FG000|Overall Study|Did not meet inclusion criteria|1|||
164346190|NCT00617123|593642832|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
164346191|NCT00617123|593642833|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
164346192|NCT00617123|593642832|FG000|Referral Screening Period|Adverse Event|0|||
164292317|NCT03287791|593441079|FG001|Overall Study|Did not meet inclusion criteria|0|||
164292318|NCT03287791|593441080|FG002|Overall Study|Did not meet inclusion criteria|0|||
164292319|NCT01381016|593441081|FG000|Overall Study|Lost to Follow-up|1|||
164292320|NCT01381016|593441082|FG001|Overall Study|Lost to Follow-up|1|||
164346193|NCT00617123|593642833|FG001|Referral Screening Period|Adverse Event|1|||
163897916|NCT03767335|591999438|FG001|Overall Study|Participant excluded from efficacy population|0|||
163897917|NCT03767335|591999439|FG002|Overall Study|Participant excluded from efficacy population|1|||
163897918|NCT03767335|591999437|FG000|Overall Study|Death|0|||
164292321|NCT01381016|593441081|FG000|Overall Study|Screen Failure|2|||
164292322|NCT01381016|593441082|FG001|Overall Study|Screen Failure|2|||
164292323|NCT01381016|593441081|FG000|Overall Study|Withdrawal by Subject|0|||
164292324|NCT01381016|593441082|FG001|Overall Study|Withdrawal by Subject|1|||
164292325|NCT01381016|593441081|FG000|Overall Study|Physician Decision|0|||
164292326|NCT01381016|593441082|FG001|Overall Study|Physician Decision|2|||
164292327|NCT03598036|593441088|FG000|Overall Study|Withdrawal by Subject|1|||
164292328|NCT03598036|593441089|FG001|Overall Study|Withdrawal by Subject|0|||
164292329|NCT02891174|593441090|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
164292330|NCT02891174|593441091|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
164292331|NCT02891174|593441090|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
164292332|NCT02891174|593441091|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
164292333|NCT02891174|593441090|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
164292334|NCT02891174|593441091|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
164292335|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
164292336|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
164292337|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
164292338|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
164292339|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
164292340|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
164292341|NCT02891174|593441090|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
164292342|NCT02891174|593441091|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
164292343|NCT04319198|593441092|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
164292344|NCT04319198|593441093|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
164292345|NCT04319198|593441094|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
164292346|NCT04319198|593441092|FG000|Overall Study|Death|0|||
164292347|NCT04319198|593441093|FG001|Overall Study|Death|3|||
164292348|NCT04319198|593441094|FG002|Overall Study|Death|3|||
164292349|NCT04319198|593441092|FG000|Overall Study|Reason Not Specified|0|||
164292350|NCT04319198|593441093|FG001|Overall Study|Reason Not Specified|2|||
164292351|NCT04319198|593441094|FG002|Overall Study|Reason Not Specified|4|||
164292352|NCT04319198|593441092|FG000|Overall Study|Withdrawal of Consent|0|||
164292353|NCT04319198|593441093|FG001|Overall Study|Withdrawal of Consent|0|||
164292354|NCT04319198|593441094|FG002|Overall Study|Withdrawal of Consent|5|||
164292355|NCT04319198|593441092|FG000|Overall Study|Site Terminated by Sponsor|0|||
164292356|NCT04319198|593441093|FG001|Overall Study|Site Terminated by Sponsor|1|||
164292357|NCT04319198|593441094|FG002|Overall Study|Site Terminated by Sponsor|0|||
164292358|NCT02250326|593441098|FG000|Treatment|Death|1|||
164292359|NCT02250326|593441099|FG001|Treatment|Death|13|||
164292360|NCT02250326|593441100|FG002|Treatment|Death|2|||
164292361|NCT02250326|593441098|FG000|Treatment|Adverse Event|8|||
164292362|NCT02250326|593441099|FG001|Treatment|Adverse Event|8|||
164292363|NCT02250326|593441100|FG002|Treatment|Adverse Event|9|||
164292364|NCT02250326|593441098|FG000|Treatment|Progressive Disease|42|||
164292365|NCT02250326|593441099|FG001|Treatment|Progressive Disease|40|||
164292366|NCT02250326|593441100|FG002|Treatment|Progressive Disease|47|||
164292367|NCT02250326|593441098|FG000|Treatment|Symptomatic Deterioration|9|||
164292368|NCT02250326|593441099|FG001|Treatment|Symptomatic Deterioration|4|||
163897919|NCT03767335|591999438|FG001|Overall Study|Death|0|||
163897920|NCT03767335|591999439|FG002|Overall Study|Death|2|||
163897921|NCT03767335|591999437|FG000|Overall Study|Progressive Disease|2|||
163897922|NCT03767335|591999438|FG001|Overall Study|Progressive Disease|2|||
163897923|NCT03767335|591999439|FG002|Overall Study|Progressive Disease|2|||
163897924|NCT03767335|591999437|FG000|Overall Study|Disease progression needing additional medication|0|||
163897925|NCT03767335|591999438|FG001|Overall Study|Disease progression needing additional medication|0|||
163897926|NCT03767335|591999439|FG002|Overall Study|Disease progression needing additional medication|17|||
163897927|NCT03767335|591999437|FG000|Overall Study|Sponsor decision|0|||
163897928|NCT03767335|591999438|FG001|Overall Study|Sponsor decision|0|||
163897929|NCT03767335|591999439|FG002|Overall Study|Sponsor decision|2|||
163897930|NCT03767335|591999437|FG000|Overall Study|Other Medical Reasons|0|||
163897931|NCT03767335|591999438|FG001|Overall Study|Other Medical Reasons|0|||
163897932|NCT03767335|591999439|FG002|Overall Study|Other Medical Reasons|3|||
163897933|NCT03705390|591999440|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
163897934|NCT03705390|591999440|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
163897935|NCT03047213|591999441|FG000|Overall Study|Withdrawal by Subject|2|||
164004455|NCT02034123|592380790|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164292369|NCT02250326|593441100|FG002|Treatment|Symptomatic Deterioration|10|||
164292370|NCT02250326|593441098|FG000|Treatment|Withdrawal by Subject|11|||
164292371|NCT02250326|593441099|FG001|Treatment|Withdrawal by Subject|6|||
163897936|NCT03047213|591999442|FG001|Overall Study|Withdrawal by Subject|0|||
164292372|NCT02250326|593441100|FG002|Treatment|Withdrawal by Subject|4|||
164292373|NCT02250326|593441098|FG000|Treatment|Other reasons|8|||
164292374|NCT02250326|593441099|FG001|Treatment|Other reasons|7|||
164292375|NCT02250326|593441100|FG002|Treatment|Other reasons|7|||
164292376|NCT02250326|593441098|FG000|Extension Period|Progressive Disease|0|||
164292377|NCT02250326|593441099|FG001|Extension Period|Progressive Disease|2|||
164292378|NCT02250326|593441100|FG002|Extension Period|Progressive Disease|0|||
164292379|NCT02250326|593441098|FG000|Extension Period|Withdrawal by Subject|0|||
164292380|NCT02250326|593441099|FG001|Extension Period|Withdrawal by Subject|1|||
164292381|NCT02250326|593441100|FG002|Extension Period|Withdrawal by Subject|0|||
164292382|NCT02250326|593441098|FG000|Extension Period|Withdrawal by investigator|0|||
164292383|NCT02250326|593441099|FG001|Extension Period|Withdrawal by investigator|1|||
164292384|NCT02250326|593441100|FG002|Extension Period|Withdrawal by investigator|0|||
164292385|NCT05801991|593441101|FG000|Overall Study|Lost to Follow-up|1|||
164292386|NCT05801991|593441102|FG001|Overall Study|Lost to Follow-up|0|||
164292387|NCT01838694|593441103|FG000|Overall Study|Adverse Event|0|||
164292388|NCT01838694|593441104|FG001|Overall Study|Adverse Event|1|||
164292389|NCT04235140|593441105|FG000|Overall Study|Adverse Event|2|||
164292390|NCT04235140|593441105|FG000|Overall Study|Lost to Follow-up|1|||
164292391|NCT04235140|593441105|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
164292392|NCT04235140|593441105|FG000|Overall Study|Commercial drug is available for participants|7|||
164292393|NCT03016312|593441106|FG000|Overall Study|discontinued before the treatment started|0|||
164292394|NCT03016312|593441107|FG001|Overall Study|discontinued before the treatment started|1|||
164292395|NCT03016312|593441106|FG000|Overall Study|Withdrawal by Subject|37|||
164292396|NCT03016312|593441107|FG001|Overall Study|Withdrawal by Subject|44|||
164292397|NCT03016312|593441106|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
164292398|NCT03016312|593441107|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
164292399|NCT03016312|593441106|FG000|Overall Study|Physician Decision|1|||
164292400|NCT03016312|593441107|FG001|Overall Study|Physician Decision|3|||
164292401|NCT03016312|593441106|FG000|Overall Study|Lost to Follow-up|12|||
164292402|NCT03016312|593441107|FG001|Overall Study|Lost to Follow-up|12|||
164292403|NCT03016312|593441106|FG000|Overall Study|Death|210|||
164292404|NCT03016312|593441107|FG001|Overall Study|Death|184|||
164346194|NCT00617123|593642832|FG000|Study Treatment Period|Withdrawal by Subject|8|||
164346195|NCT00617123|593642833|FG001|Study Treatment Period|Withdrawal by Subject|12|||
164346196|NCT00617123|593642832|FG000|Study Treatment Period|Adverse Event|7|||
164004456|NCT02034123|592380791|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004457|NCT02034123|592380792|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004458|NCT02034123|592380793|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004459|NCT02034123|592380794|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
164004460|NCT00246259|592380795|FG000|Overall Study|Other|3|||
164346197|NCT00617123|593642833|FG001|Study Treatment Period|Adverse Event|3|||
164346198|NCT00617123|593642832|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
164346199|NCT00617123|593642833|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
164346200|NCT00617123|593642832|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
164346201|NCT00617123|593642833|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
164346202|NCT03052725|593642834|FG000|Overall Study|Adverse Event|2|||
164346203|NCT03052725|593642835|FG001|Overall Study|Adverse Event|0|||
164346204|NCT03052725|593642834|FG000|Overall Study|Withdrawal by Subject|3|||
164346205|NCT03052725|593642835|FG001|Overall Study|Withdrawal by Subject|4|||
164346206|NCT03052725|593642834|FG000|Overall Study|Pregnancy|0|||
164346207|NCT03052725|593642835|FG001|Overall Study|Pregnancy|1|||
164346208|NCT03052725|593642834|FG000|Overall Study|Site closure|0|||
164346209|NCT03052725|593642835|FG001|Overall Study|Site closure|1|||
164346210|NCT03052725|593642834|FG000|Overall Study|Study terminated by sponsor|143|||
164346211|NCT03052725|593642835|FG001|Overall Study|Study terminated by sponsor|144|||
164346212|NCT00777608|593642837|FG000|Overall Study|Lost to Follow-up|1|||
164346213|NCT00777608|593642838|FG001|Overall Study|Lost to Follow-up|1|||
164346214|NCT00777608|593642837|FG000|Overall Study|Withdrawal by Subject|1|||
164346215|NCT00777608|593642838|FG001|Overall Study|Withdrawal by Subject|3|||
164346216|NCT00777608|593642837|FG000|Overall Study|Protocol Violation|1|||
164346217|NCT00777608|593642838|FG001|Overall Study|Protocol Violation|0|||
164004461|NCT00246259|592380796|FG001|Overall Study|Other|3|||
164004462|NCT00246259|592380795|FG000|Overall Study|Not stable by Week 18|2|||
164292405|NCT03016312|593441106|FG000|Overall Study|loss to contact|1|||
164346218|NCT00777608|593642837|FG000|Overall Study|Investigator Decision|1|||
164292406|NCT03016312|593441107|FG001|Overall Study|loss to contact|0|||
164346219|NCT00777608|593642838|FG001|Overall Study|Investigator Decision|2|||
164346220|NCT04213079|593642839|FG000|Overall Study|Lost to Follow-up|0|||
164292407|NCT03016312|593441106|FG000|Overall Study|started a new cancer therapy|1|||
164292408|NCT03016312|593441107|FG001|Overall Study|started a new cancer therapy|0|||
164292409|NCT01755234|593441111|FG000|Overall Study|Lost to Follow-up|11|||
164292410|NCT01755234|593441112|FG001|Overall Study|Lost to Follow-up|6|||
164292411|NCT01755234|593441111|FG000|Overall Study|Change in surgical case|2|||
164292412|NCT01755234|593441112|FG001|Overall Study|Change in surgical case|1|||
164292413|NCT01755234|593441111|FG000|Overall Study|case cancelled|1|||
164292414|NCT01755234|593441112|FG001|Overall Study|case cancelled|0|||
164292415|NCT01755234|593441111|FG000|Overall Study|Withdrawal by Subject|0|||
164292416|NCT01755234|593441112|FG001|Overall Study|Withdrawal by Subject|1|||
164292417|NCT01755234|593441111|FG000|Overall Study|unblinded|1|||
164292418|NCT01755234|593441112|FG001|Overall Study|unblinded|0|||
164292419|NCT02836652|593441113|FG000|Overall Study|Death|3|||
164292420|NCT02836652|593441114|FG001|Overall Study|Death|3|||
164292421|NCT02836652|593441113|FG000|Overall Study|Transplant/Explant|3|||
164292422|NCT02836652|593441114|FG001|Overall Study|Transplant/Explant|4|||
164292423|NCT02836652|593441113|FG000|Overall Study|Withdrawn|9|||
164292424|NCT02836652|593441114|FG001|Overall Study|Withdrawn|9|||
164292425|NCT02836652|593441113|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
164292426|NCT02836652|593441114|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
164292427|NCT03812380|593441115|FG000|Overall Study|Protocol Violation|3|||
164292428|NCT03812380|593441116|FG001|Overall Study|Protocol Violation|3|||
164292429|NCT03812380|593441115|FG000|Overall Study|Withdrawal by Subject|5|||
164292430|NCT03812380|593441116|FG001|Overall Study|Withdrawal by Subject|4|||
164292431|NCT03812380|593441115|FG000|Overall Study|Early termination of study|14|||
164292432|NCT03812380|593441116|FG001|Overall Study|Early termination of study|14|||
164292433|NCT02349633|593441118|FG000|Overall Study|Death|0|||
164292434|NCT02349633|593441119|FG001|Overall Study|Death|1|||
164292435|NCT02349633|593441120|FG002|Overall Study|Death|0|||
164292436|NCT02349633|593441121|FG003|Overall Study|Death|0|||
164292437|NCT02349633|593441122|FG004|Overall Study|Death|0|||
164292438|NCT02349633|593441123|FG005|Overall Study|Death|1|||
164292439|NCT02349633|593441124|FG006|Overall Study|Death|1|||
164292440|NCT02349633|593441125|FG007|Overall Study|Death|1|||
164292441|NCT02349633|593441126|FG008|Overall Study|Death|0|||
164292442|NCT02349633|593441127|FG009|Overall Study|Death|1|||
164292443|NCT02349633|593441128|FG010|Overall Study|Death|0|||
164292444|NCT02349633|593441129|FG011|Overall Study|Death|0|||
164292445|NCT02349633|593441130|FG012|Overall Study|Death|0|||
164292446|NCT02349633|593441131|FG013|Overall Study|Death|0|||
164292447|NCT02349633|593441118|FG000|Overall Study|Withdrawal by Subject|0|||
164292448|NCT02349633|593441119|FG001|Overall Study|Withdrawal by Subject|0|||
164292449|NCT02349633|593441120|FG002|Overall Study|Withdrawal by Subject|0|||
164292450|NCT02349633|593441121|FG003|Overall Study|Withdrawal by Subject|1|||
164292451|NCT02349633|593441122|FG004|Overall Study|Withdrawal by Subject|0|||
164292452|NCT02349633|593441123|FG005|Overall Study|Withdrawal by Subject|0|||
164292453|NCT02349633|593441124|FG006|Overall Study|Withdrawal by Subject|0|||
164292454|NCT02349633|593441125|FG007|Overall Study|Withdrawal by Subject|2|||
164292455|NCT02349633|593441126|FG008|Overall Study|Withdrawal by Subject|2|||
164292456|NCT02349633|593441127|FG009|Overall Study|Withdrawal by Subject|1|||
164292457|NCT02349633|593441128|FG010|Overall Study|Withdrawal by Subject|0|||
164292458|NCT02349633|593441129|FG011|Overall Study|Withdrawal by Subject|0|||
164292459|NCT02349633|593441130|FG012|Overall Study|Withdrawal by Subject|0|||
164292460|NCT02349633|593441131|FG013|Overall Study|Withdrawal by Subject|0|||
164292461|NCT02349633|593441118|FG000|Overall Study|Withdrawal of informed consent|0|||
164292462|NCT02349633|593441119|FG001|Overall Study|Withdrawal of informed consent|0|||
164292463|NCT02349633|593441120|FG002|Overall Study|Withdrawal of informed consent|0|||
164292464|NCT02349633|593441121|FG003|Overall Study|Withdrawal of informed consent|1|||
164292465|NCT02349633|593441122|FG004|Overall Study|Withdrawal of informed consent|1|||
164292466|NCT02349633|593441123|FG005|Overall Study|Withdrawal of informed consent|0|||
164292467|NCT02349633|593441124|FG006|Overall Study|Withdrawal of informed consent|0|||
164292468|NCT02349633|593441125|FG007|Overall Study|Withdrawal of informed consent|3|||
164292469|NCT02349633|593441126|FG008|Overall Study|Withdrawal of informed consent|0|||
164292470|NCT02349633|593441127|FG009|Overall Study|Withdrawal of informed consent|0|||
164292471|NCT02349633|593441128|FG010|Overall Study|Withdrawal of informed consent|0|||
164292472|NCT02349633|593441129|FG011|Overall Study|Withdrawal of informed consent|0|||
164292473|NCT02349633|593441130|FG012|Overall Study|Withdrawal of informed consent|0|||
164292474|NCT02349633|593441131|FG013|Overall Study|Withdrawal of informed consent|0|||
164292475|NCT02349633|593441118|FG000|Overall Study|Transition to compassionate use|0|||
164292476|NCT02349633|593441119|FG001|Overall Study|Transition to compassionate use|0|||
164292477|NCT02349633|593441120|FG002|Overall Study|Transition to compassionate use|0|||
164346221|NCT04213079|593642840|FG001|Overall Study|Lost to Follow-up|2|||
164346222|NCT00520936|593642841|FG000|Overall Study|Physician Decision|0|||
164346223|NCT00520936|593642842|FG001|Overall Study|Physician Decision|2|||
164346224|NCT00520936|593642843|FG002|Overall Study|Physician Decision|1|||
164292478|NCT02349633|593441121|FG003|Overall Study|Transition to compassionate use|0|||
164292479|NCT02349633|593441122|FG004|Overall Study|Transition to compassionate use|1|||
164292480|NCT02349633|593441123|FG005|Overall Study|Transition to compassionate use|0|||
164292481|NCT02349633|593441124|FG006|Overall Study|Transition to compassionate use|0|||
164292482|NCT02349633|593441125|FG007|Overall Study|Transition to compassionate use|3|||
164292483|NCT02349633|593441126|FG008|Overall Study|Transition to compassionate use|0|||
164346225|NCT00520936|593642844|FG003|Overall Study|Physician Decision|0|||
164346226|NCT00520936|593642845|FG004|Overall Study|Physician Decision|0|||
164292484|NCT02349633|593441127|FG009|Overall Study|Transition to compassionate use|1|||
164292485|NCT02349633|593441128|FG010|Overall Study|Transition to compassionate use|0|||
164292486|NCT02349633|593441129|FG011|Overall Study|Transition to compassionate use|0|||
164292487|NCT02349633|593441130|FG012|Overall Study|Transition to compassionate use|0|||
164292488|NCT02349633|593441131|FG013|Overall Study|Transition to compassionate use|0|||
164292489|NCT02349633|593441118|FG000|Overall Study|Early termination of survival follow-up|0|||
164292490|NCT02349633|593441119|FG001|Overall Study|Early termination of survival follow-up|0|||
164292491|NCT02349633|593441120|FG002|Overall Study|Early termination of survival follow-up|0|||
164292492|NCT02349633|593441121|FG003|Overall Study|Early termination of survival follow-up|0|||
164292493|NCT02349633|593441122|FG004|Overall Study|Early termination of survival follow-up|0|||
164292494|NCT02349633|593441123|FG005|Overall Study|Early termination of survival follow-up|0|||
164292495|NCT02349633|593441124|FG006|Overall Study|Early termination of survival follow-up|0|||
164292496|NCT02349633|593441125|FG007|Overall Study|Early termination of survival follow-up|4|||
164292497|NCT02349633|593441126|FG008|Overall Study|Early termination of survival follow-up|0|||
164292498|NCT02349633|593441127|FG009|Overall Study|Early termination of survival follow-up|0|||
164292499|NCT02349633|593441128|FG010|Overall Study|Early termination of survival follow-up|0|||
164292500|NCT02349633|593441129|FG011|Overall Study|Early termination of survival follow-up|0|||
164292501|NCT02349633|593441130|FG012|Overall Study|Early termination of survival follow-up|0|||
164292502|NCT02349633|593441131|FG013|Overall Study|Early termination of survival follow-up|0|||
164292503|NCT02349633|593441118|FG000|Overall Study|Termination by sponsor|0|||
164292504|NCT02349633|593441119|FG001|Overall Study|Termination by sponsor|0|||
164292505|NCT02349633|593441120|FG002|Overall Study|Termination by sponsor|0|||
164292506|NCT02349633|593441121|FG003|Overall Study|Termination by sponsor|0|||
164292507|NCT02349633|593441122|FG004|Overall Study|Termination by sponsor|0|||
164346227|NCT00520936|593642846|FG005|Overall Study|Physician Decision|0|||
164346228|NCT00520936|593642847|FG006|Overall Study|Physician Decision|0|||
164346229|NCT00520936|593642848|FG007|Overall Study|Physician Decision|0|||
164346230|NCT00520936|593642841|FG000|Overall Study|Withdrawal by Subject|0|||
164346231|NCT00520936|593642842|FG001|Overall Study|Withdrawal by Subject|0|||
164346232|NCT00520936|593642843|FG002|Overall Study|Withdrawal by Subject|0|||
164346233|NCT00520936|593642844|FG003|Overall Study|Withdrawal by Subject|0|||
164346234|NCT00520936|593642845|FG004|Overall Study|Withdrawal by Subject|0|||
164346235|NCT00520936|593642846|FG005|Overall Study|Withdrawal by Subject|0|||
164346236|NCT00520936|593642847|FG006|Overall Study|Withdrawal by Subject|0|||
164346237|NCT00520936|593642848|FG007|Overall Study|Withdrawal by Subject|1|||
164346238|NCT00520936|593642841|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
164346239|NCT00520936|593642842|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
164346240|NCT00520936|593642843|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
164346241|NCT00520936|593642844|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
164346242|NCT00520936|593642845|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
164346243|NCT00520936|593642846|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
164346244|NCT00520936|593642847|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
164346245|NCT00520936|593642848|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
164346246|NCT00520936|593642841|FG000|Overall Study|Death|0|||
164346247|NCT00520936|593642842|FG001|Overall Study|Death|0|||
164346248|NCT00520936|593642843|FG002|Overall Study|Death|0|||
164346249|NCT00520936|593642844|FG003|Overall Study|Death|0|||
164346250|NCT00520936|593642845|FG004|Overall Study|Death|0|||
164346251|NCT00520936|593642846|FG005|Overall Study|Death|0|||
164346252|NCT00520936|593642847|FG006|Overall Study|Death|1|||
164346253|NCT00520936|593642848|FG007|Overall Study|Death|0|||
164346254|NCT00520936|593642841|FG000|Overall Study|Protocol Violation|0|||
164346255|NCT00520936|593642842|FG001|Overall Study|Protocol Violation|1|||
164346256|NCT00520936|593642843|FG002|Overall Study|Protocol Violation|1|||
164346257|NCT00520936|593642844|FG003|Overall Study|Protocol Violation|0|||
164346258|NCT00520936|593642845|FG004|Overall Study|Protocol Violation|1|||
164346259|NCT00520936|593642846|FG005|Overall Study|Protocol Violation|0|||
164346260|NCT00520936|593642847|FG006|Overall Study|Protocol Violation|1|||
164346261|NCT00520936|593642848|FG007|Overall Study|Protocol Violation|0|||
164346262|NCT00587054|593642852|FG000|Overall Study|Patient not treated|9|||
164346263|NCT03858309|593642853|FG000|Overall Study|Withdrawal by Subject|2|||
164346264|NCT03858309|593642854|FG001|Overall Study|Withdrawal by Subject|3|||
164346265|NCT01812174|593642855|FG000|Overall Study|Death|1|||
164346266|NCT01812174|593642856|FG001|Overall Study|Death|0|||
164346267|NCT01812174|593642855|FG000|Overall Study|Protocol Violation|2|||
164346268|NCT01812174|593642856|FG001|Overall Study|Protocol Violation|0|||
164346269|NCT00553644|593642857|FG000|Overall Study|Adverse Event|17|||
164346270|NCT00553644|593642857|FG000|Overall Study|Withdrawal by Subject|4|||
164346271|NCT00553644|593642857|FG000|Overall Study|Physician Decision|1|||
164346272|NCT00553644|593642857|FG000|Overall Study|Alternative therapy|6|||
164346273|NCT01336764|593642860|FG000|Overall Study|Withdrawal by Subject|5|||
164292508|NCT02349633|593441123|FG005|Overall Study|Termination by sponsor|0|||
164292509|NCT02349633|593441124|FG006|Overall Study|Termination by sponsor|0|||
164346274|NCT01336764|593642861|FG001|Overall Study|Withdrawal by Subject|5|||
164292510|NCT02349633|593441125|FG007|Overall Study|Termination by sponsor|1|||
164292511|NCT02349633|593441126|FG008|Overall Study|Termination by sponsor|0|||
164292512|NCT02349633|593441127|FG009|Overall Study|Termination by sponsor|2|||
164292513|NCT02349633|593441128|FG010|Overall Study|Termination by sponsor|0|||
164292514|NCT02349633|593441129|FG011|Overall Study|Termination by sponsor|0|||
164292515|NCT02349633|593441130|FG012|Overall Study|Termination by sponsor|0|||
164292516|NCT02349633|593441131|FG013|Overall Study|Termination by sponsor|0|||
164292517|NCT02349633|593441118|FG000|Overall Study|Other|0|||
164292518|NCT02349633|593441119|FG001|Overall Study|Other|0|||
164292519|NCT02349633|593441120|FG002|Overall Study|Other|0|||
164292520|NCT02349633|593441121|FG003|Overall Study|Other|0|||
164292521|NCT02349633|593441122|FG004|Overall Study|Other|0|||
164292522|NCT02349633|593441123|FG005|Overall Study|Other|0|||
164292523|NCT02349633|593441124|FG006|Overall Study|Other|0|||
164292524|NCT02349633|593441125|FG007|Overall Study|Other|2|||
164292525|NCT02349633|593441126|FG008|Overall Study|Other|0|||
164292526|NCT02349633|593441127|FG009|Overall Study|Other|0|||
164292527|NCT02349633|593441128|FG010|Overall Study|Other|0|||
163897937|NCT03047213|591999441|FG000|Overall Study|Adverse Event|2|||
163897938|NCT03047213|591999442|FG001|Overall Study|Adverse Event|0|||
163897939|NCT03725332|591999448|FG000|Overall Study|Adverse Event|5|||
163897940|NCT03725332|591999449|FG001|Overall Study|Adverse Event|10|||
163897941|NCT03725332|591999448|FG000|Overall Study|Death|1|||
163897942|NCT03725332|591999449|FG001|Overall Study|Death|3|||
163897943|NCT03725332|591999448|FG000|Overall Study|Lost to Follow-up|43|||
163897944|NCT03725332|591999449|FG001|Overall Study|Lost to Follow-up|122|||
164292528|NCT02349633|593441129|FG011|Overall Study|Other|0|||
164292529|NCT02349633|593441130|FG012|Overall Study|Other|0|||
164292530|NCT02349633|593441131|FG013|Overall Study|Other|0|||
164292531|NCT00667628|593441132|FG000|Overall Study|Lost to Follow-up|1|||
164292532|NCT00667628|593441133|FG001|Overall Study|Lost to Follow-up|0|||
164292533|NCT00667628|593441132|FG000|Overall Study|Death|6|||
164292534|NCT00667628|593441133|FG001|Overall Study|Death|6|||
164292535|NCT00667628|593441132|FG000|Overall Study|Investigator Considers in Best Interest|1|||
164292536|NCT00667628|593441133|FG001|Overall Study|Investigator Considers in Best Interest|0|||
164292537|NCT00667628|593441132|FG000|Overall Study|Sponsor Terminated Study|17|||
164292538|NCT00667628|593441133|FG001|Overall Study|Sponsor Terminated Study|21|||
164292539|NCT05789745|593441134|FG000|Overall Study|Withdrawal by Subject|0|||
164292540|NCT05789745|593441135|FG001|Overall Study|Withdrawal by Subject|0|||
164292541|NCT05789745|593441136|FG002|Overall Study|Withdrawal by Subject|0|||
164292542|NCT05789745|593441137|FG003|Overall Study|Withdrawal by Subject|0|||
164292543|NCT05789745|593441138|FG004|Overall Study|Withdrawal by Subject|1|||
164292544|NCT04663321|593441139|FG000|Overall Study|Study terminated by Sponsor|2|||
164292545|NCT04663321|593441140|FG001|Overall Study|Study terminated by Sponsor|1|||
164292546|NCT04663321|593441141|FG002|Overall Study|Study terminated by Sponsor|2|||
164292547|NCT04663321|593441139|FG000|Overall Study|Withdrawal by Subject|10|||
164292548|NCT04663321|593441140|FG001|Overall Study|Withdrawal by Subject|3|||
164292549|NCT04663321|593441141|FG002|Overall Study|Withdrawal by Subject|2|||
164292550|NCT04663321|593441139|FG000|Overall Study|Not provided|0|||
164292551|NCT04663321|593441140|FG001|Overall Study|Not provided|0|||
164292552|NCT04663321|593441141|FG002|Overall Study|Not provided|1|||
164292553|NCT00622505|593441144|FG000|Overall Study|Adverse Event|9|||
164292554|NCT00622505|593441145|FG001|Overall Study|Adverse Event|7|||
164292555|NCT00622505|593441144|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
164292556|NCT00622505|593441145|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
164346275|NCT01051323|593642862|FG000|Overall Study|Discontinuation of treatment|103|||
164346276|NCT01051323|593642862|FG000|Overall Study|Transplantation|28|||
164346277|NCT01051323|593642862|FG000|Overall Study|Dialysis dependency|22|||
164346278|NCT01051323|593642862|FG000|Overall Study|Withdrawal by Subject|13|||
164346279|NCT01051323|593642862|FG000|Overall Study|Lost to Follow-up|31|||
164346280|NCT01051323|593642862|FG000|Overall Study|Death|129|||
164346281|NCT01051323|593642862|FG000|Overall Study|Hospitalization|28|||
164346282|NCT01051323|593642862|FG000|Overall Study|Other|148|||
164346283|NCT01051323|593642862|FG000|Overall Study|Missing|37|||
164346284|NCT01626391|593642863|FG000|Overall Study|Physician Decision|1|||
164346285|NCT01626391|593642864|FG001|Overall Study|Physician Decision|0|||
164346286|NCT01626391|593642863|FG000|Overall Study|Withdrawal by Subject|1|||
164346287|NCT01626391|593642864|FG001|Overall Study|Withdrawal by Subject|0|||
164346288|NCT00370032|593642865|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
164346289|NCT00370032|593642866|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
164346290|NCT00370032|593642865|FG000|Washout Period|Withdrawal by Subject|0|||
164346291|NCT00370032|593642866|FG001|Washout Period|Withdrawal by Subject|1|||
164346292|NCT00370032|593642865|FG000|Washout Period|Lost to Follow-up|0|||
164346293|NCT00370032|593642866|FG001|Washout Period|Lost to Follow-up|1|||
164346294|NCT00370032|593642865|FG000|Washout Period|Adverse Event|1|||
164346295|NCT00370032|593642866|FG001|Washout Period|Adverse Event|0|||
164346296|NCT00370032|593642865|FG000|Follow-up Period|Withdrawal by Subject|1|||
164346297|NCT00370032|593642866|FG001|Follow-up Period|Withdrawal by Subject|0|||
164346298|NCT05683249|593642867|FG000|Overall Study|Adverse Event|3|||
164346299|NCT05683249|593642868|FG001|Overall Study|Adverse Event|1|||
164346300|NCT05683249|593642867|FG000|Overall Study|Lack of Efficacy|0|||
164346301|NCT05683249|593642868|FG001|Overall Study|Lack of Efficacy|2|||
164346302|NCT05683249|593642867|FG000|Overall Study|Lost to Follow-up|6|||
164292557|NCT00622505|593441144|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164346303|NCT05683249|593642868|FG001|Overall Study|Lost to Follow-up|5|||
164346304|NCT05683249|593642867|FG000|Overall Study|Non-compliance with Study Drug|2|||
164346305|NCT05683249|593642868|FG001|Overall Study|Non-compliance with Study Drug|0|||
164346306|NCT05683249|593642867|FG000|Overall Study|Protocol Violation|6|||
164346307|NCT05683249|593642868|FG001|Overall Study|Protocol Violation|3|||
164346308|NCT05683249|593642867|FG000|Overall Study|Withdrawal by Subject|9|||
164346309|NCT05683249|593642868|FG001|Overall Study|Withdrawal by Subject|8|||
164346310|NCT05683249|593642867|FG000|Overall Study|Other|0|||
164088120|NCT00491504|592687357|FG002|Overall Study|Adverse Event|0|||
164292558|NCT00622505|593441145|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164292559|NCT00622505|593441144|FG000|Overall Study|Withdrawal by Subject|12|||
164292560|NCT00622505|593441145|FG001|Overall Study|Withdrawal by Subject|5|||
164292561|NCT00622505|593441144|FG000|Overall Study|Administrative Problems|2|||
164292562|NCT00622505|593441145|FG001|Overall Study|Administrative Problems|4|||
164292563|NCT00622505|593441144|FG000|Overall Study|Death|2|||
164292564|NCT00622505|593441145|FG001|Overall Study|Death|2|||
164346311|NCT05683249|593642868|FG001|Overall Study|Other|2|||
164346312|NCT05469178|593642869|FG000|Overall Study|Death|1|||
164346313|NCT05469178|593642870|FG001|Overall Study|Death|1|||
164346314|NCT05469178|593642871|FG002|Overall Study|Death|3|||
164346315|NCT05469178|593642872|FG003|Overall Study|Death|6|||
164292565|NCT00619515|593441146|FG000|Overall Study|Study Termination by IRB|73|||
164292566|NCT03294590|593441149|FG000|Overall Study|Lost to Follow-up|105|||
164292567|NCT03294590|593441150|FG001|Overall Study|Lost to Follow-up|107|||
164292568|NCT01962441|593441153|FG000|Randomized Period|Randomized but Never Treated|4|||
164292569|NCT01962441|593441154|FG001|Randomized Period|Randomized but Never Treated|2|||
164292570|NCT01962441|593441155|FG002|Randomized Period|Randomized but Never Treated|3|||
164292571|NCT01962441|593441153|FG000|Randomized Period|Lost to Follow-up|2|||
164292572|NCT01962441|593441154|FG001|Randomized Period|Lost to Follow-up|4|||
164292573|NCT01962441|593441155|FG002|Randomized Period|Lost to Follow-up|4|||
164292574|NCT01962441|593441153|FG000|Randomized Period|Withdrew Consent|3|||
164292575|NCT01962441|593441154|FG001|Randomized Period|Withdrew Consent|3|||
164292576|NCT01962441|593441155|FG002|Randomized Period|Withdrew Consent|2|||
164292577|NCT01962441|593441153|FG000|Randomized Period|Adverse Event|1|||
164292578|NCT01962441|593441154|FG001|Randomized Period|Adverse Event|1|||
164292579|NCT01962441|593441155|FG002|Randomized Period|Adverse Event|0|||
164292580|NCT01962441|593441153|FG000|Randomized Period|Death|0|||
164292581|NCT01962441|593441154|FG001|Randomized Period|Death|0|||
164292582|NCT01962441|593441155|FG002|Randomized Period|Death|2|||
164292583|NCT01962441|593441153|FG000|Randomized Period|Protocol Violation|0|||
164292584|NCT01962441|593441154|FG001|Randomized Period|Protocol Violation|1|||
164292585|NCT01962441|593441155|FG002|Randomized Period|Protocol Violation|0|||
164292586|NCT01962441|593441153|FG000|Retreatment Substudy|Lack of Efficacy|1|||
164292587|NCT01962441|593441154|FG001|Retreatment Substudy|Lack of Efficacy|0|||
164292588|NCT01962441|593441155|FG002|Retreatment Substudy|Lack of Efficacy|0|||
164292589|NCT01962441|593441153|FG000|Retreatment Substudy|Lost to Follow-up|1|||
164292590|NCT01962441|593441154|FG001|Retreatment Substudy|Lost to Follow-up|0|||
164292591|NCT01962441|593441155|FG002|Retreatment Substudy|Lost to Follow-up|0|||
164346316|NCT05469178|593642869|FG000|Overall Study|Lack of Efficacy|2|||
164346317|NCT05469178|593642870|FG001|Overall Study|Lack of Efficacy|2|||
164346318|NCT05469178|593642871|FG002|Overall Study|Lack of Efficacy|1|||
164346319|NCT05469178|593642872|FG003|Overall Study|Lack of Efficacy|10|||
164346320|NCT00968513|593642873|FG000|Overall Study|Death|4|||
164346321|NCT00968513|593642874|FG001|Overall Study|Death|10|||
164346322|NCT00968513|593642875|FG002|Overall Study|Death|15|||
164346323|NCT05466682|593642884|FG000|Overall Study|Withdrawal by Subject|0|||
164346324|NCT05466682|593642885|FG001|Overall Study|Withdrawal by Subject|2|||
164346325|NCT05466682|593642884|FG000|Overall Study|Lost to Follow-up|2|||
164346326|NCT05466682|593642885|FG001|Overall Study|Lost to Follow-up|1|||
164346327|NCT02801396|593642886|FG000|Period 1|Withdrawal by Subject|0|||
164346328|NCT02801396|593642887|FG001|Period 1|Withdrawal by Subject|0|||
164346329|NCT02801396|593642888|FG002|Period 1|Withdrawal by Subject|0|||
164346330|NCT02801396|593642889|FG003|Period 1|Withdrawal by Subject|0|||
164346331|NCT02801396|593642890|FG004|Period 1|Withdrawal by Subject|1|||
164346332|NCT02801396|593642891|FG005|Period 1|Withdrawal by Subject|0|||
164346333|NCT03087643|593642898|FG000|Overall Study|Withdrawal by Subject|2|||
164346334|NCT03087643|593642899|FG001|Overall Study|Withdrawal by Subject|4|||
164346335|NCT03087643|593642898|FG000|Overall Study|Death|2|||
164346336|NCT03087643|593642899|FG001|Overall Study|Death|2|||
164346337|NCT02083783|593642900|FG000|Overall Study|Withdrawal by Subject|1|||
164346338|NCT02083783|593642901|FG001|Overall Study|Withdrawal by Subject|0|||
164346339|NCT02256631|593642902|FG000|Overall Study|Lost to Follow-up|1|||
164346340|NCT02256631|593642903|FG001|Overall Study|Lost to Follow-up|1|||
164346341|NCT02256631|593642904|FG002|Overall Study|Lost to Follow-up|0|||
164346342|NCT02256631|593642905|FG003|Overall Study|Lost to Follow-up|2|||
164346343|NCT02256631|593642906|FG004|Overall Study|Lost to Follow-up|0|||
164346344|NCT02256631|593642907|FG005|Overall Study|Lost to Follow-up|4|||
164346345|NCT02256631|593642908|FG006|Overall Study|Lost to Follow-up|1|||
164346346|NCT02256631|593642902|FG000|Overall Study|Withdrawal by Subject|0|||
164346347|NCT02256631|593642903|FG001|Overall Study|Withdrawal by Subject|0|||
164346348|NCT02256631|593642904|FG002|Overall Study|Withdrawal by Subject|0|||
164346349|NCT02256631|593642905|FG003|Overall Study|Withdrawal by Subject|1|||
164346350|NCT02256631|593642906|FG004|Overall Study|Withdrawal by Subject|1|||
164346351|NCT02256631|593642907|FG005|Overall Study|Withdrawal by Subject|0|||
164346352|NCT02256631|593642908|FG006|Overall Study|Withdrawal by Subject|1|||
164346353|NCT02256631|593642902|FG000|Overall Study|Unable to get to clinic|0|||
164004463|NCT00246259|592380796|FG001|Overall Study|Not stable by Week 18|1|||
164346354|NCT02256631|593642903|FG001|Overall Study|Unable to get to clinic|2|||
164346355|NCT02256631|593642904|FG002|Overall Study|Unable to get to clinic|0|||
164346356|NCT02256631|593642905|FG003|Overall Study|Unable to get to clinic|1|||
164346357|NCT02256631|593642906|FG004|Overall Study|Unable to get to clinic|0|||
164346358|NCT02256631|593642907|FG005|Overall Study|Unable to get to clinic|1|||
164346359|NCT02256631|593642908|FG006|Overall Study|Unable to get to clinic|2|||
164004464|NCT00246259|592380795|FG000|Overall Study|Participant non-compliant|4|||
164292592|NCT04862065|593441156|FG000|Screening|Protocol Violation|54|||
164346360|NCT04528732|593642909|FG000|Overall Study|Death|1|||
164292593|NCT04862065|593441157|FG001|Screening|Protocol Violation|0|||
164292594|NCT04862065|593441158|FG002|Screening|Protocol Violation|0|||
164292595|NCT04862065|593441156|FG000|Screening|Insufficient Sample|1|||
164292596|NCT04862065|593441157|FG001|Screening|Insufficient Sample|0|||
163897945|NCT03725332|591999448|FG000|Overall Study|Withdrawal by Subject|0|||
164292597|NCT04862065|593441158|FG002|Screening|Insufficient Sample|0|||
164292598|NCT04862065|593441156|FG000|Follow-Up|Lost to Follow-up|3|||
164292599|NCT04862065|593441157|FG001|Follow-Up|Lost to Follow-up|0|||
164292600|NCT04862065|593441158|FG002|Follow-Up|Lost to Follow-up|0|||
164292601|NCT02055898|593441159|FG000|First Intervention (5 Days)|Physician Decision|2|||
164292602|NCT02055898|593441160|FG001|First Intervention (5 Days)|Physician Decision|0|||
164292603|NCT02055898|593441159|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
164292604|NCT02055898|593441160|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
164292605|NCT01453140|593441161|FG000|Overall Study|Adverse Event|3|||
164292606|NCT00743249|593441163|FG000|Overall Study|Adverse Event|0|||
164292607|NCT00743249|593441164|FG001|Overall Study|Adverse Event|4|||
164292608|NCT00743249|593441163|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
164292609|NCT00743249|593441164|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
164292610|NCT00743249|593441163|FG000|Overall Study|Unsuccessful insertion of stent|2|||
164292611|NCT00743249|593441164|FG001|Overall Study|Unsuccessful insertion of stent|1|||
164292612|NCT00718510|593441165|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
164292613|NCT00718510|593441166|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164292614|NCT00718510|593441165|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
164292615|NCT00718510|593441166|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164292616|NCT02201524|593441167|FG000|Overall Study|Adverse Event|0|||
164292617|NCT02201524|593441168|FG001|Overall Study|Adverse Event|2|||
164292618|NCT02201524|593441169|FG002|Overall Study|Adverse Event|1|||
164292619|NCT02201524|593441170|FG003|Overall Study|Adverse Event|0|||
164292620|NCT02201524|593441167|FG000|Overall Study|Insufficient clinical response|1|||
164292621|NCT02201524|593441168|FG001|Overall Study|Insufficient clinical response|0|||
164292622|NCT02201524|593441169|FG002|Overall Study|Insufficient clinical response|0|||
164292623|NCT02201524|593441170|FG003|Overall Study|Insufficient clinical response|0|||
164292624|NCT02201524|593441167|FG000|Overall Study|Lost to Follow-up|0|||
164292625|NCT02201524|593441168|FG001|Overall Study|Lost to Follow-up|0|||
164292626|NCT02201524|593441169|FG002|Overall Study|Lost to Follow-up|2|||
164292627|NCT02201524|593441170|FG003|Overall Study|Lost to Follow-up|0|||
164292628|NCT02201524|593441167|FG000|Overall Study|No longer meets eligibility criteria|0|||
164292629|NCT02201524|593441168|FG001|Overall Study|No longer meets eligibility criteria|0|||
164292630|NCT02201524|593441169|FG002|Overall Study|No longer meets eligibility criteria|0|||
164292631|NCT02201524|593441170|FG003|Overall Study|No longer meets eligibility criteria|2|||
164292632|NCT02201524|593441167|FG000|Overall Study|Protocol Violation|0|||
164292633|NCT02201524|593441168|FG001|Overall Study|Protocol Violation|0|||
164292634|NCT02201524|593441169|FG002|Overall Study|Protocol Violation|0|||
164292635|NCT02201524|593441170|FG003|Overall Study|Protocol Violation|1|||
164292636|NCT02201524|593441167|FG000|Overall Study|Withdrawal by Subject|0|||
164292637|NCT02201524|593441168|FG001|Overall Study|Withdrawal by Subject|0|||
164292638|NCT02201524|593441169|FG002|Overall Study|Withdrawal by Subject|1|||
164292639|NCT02201524|593441170|FG003|Overall Study|Withdrawal by Subject|1|||
164292640|NCT02201524|593441167|FG000|Overall Study|Other|1|||
164292641|NCT02201524|593441168|FG001|Overall Study|Other|1|||
164292642|NCT02201524|593441169|FG002|Overall Study|Other|0|||
164292643|NCT02201524|593441170|FG003|Overall Study|Other|0|||
164346361|NCT04528732|593642910|FG001|Overall Study|Death|0|||
164346362|NCT04528732|593642911|FG002|Overall Study|Death|1|||
164346363|NCT04528732|593642909|FG000|Overall Study|Lost to Follow-up|0|||
164346364|NCT04528732|593642910|FG001|Overall Study|Lost to Follow-up|1|||
164346365|NCT04528732|593642911|FG002|Overall Study|Lost to Follow-up|2|||
164346366|NCT01654536|593642915|FG000|Overall Study|Lost to Follow-up|5|||
164346367|NCT01654536|593642916|FG001|Overall Study|Lost to Follow-up|5|||
164346368|NCT01654536|593642915|FG000|Overall Study|Physician Decision|12|||
164346369|NCT01654536|593642916|FG001|Overall Study|Physician Decision|8|||
164346370|NCT01654536|593642915|FG000|Overall Study|Withdrawal by Subject|27|||
164346371|NCT01654536|593642916|FG001|Overall Study|Withdrawal by Subject|25|||
164346372|NCT04698187|593642921|FG000|Overall Study|Withdrawal by Subject|7|||
164346373|NCT04698187|593642921|FG000|Overall Study|Death|21|||
164088121|NCT00491504|592687358|FG003|Overall Study|Adverse Event|0|||
164292644|NCT00423657|593441172|FG000|Overall Study|Withdrew consent|10|||
164346374|NCT04698187|593642921|FG000|Overall Study|Sponsor Decision|15|||
164346375|NCT04698187|593642921|FG000|Overall Study|In-transit Disease|1|||
164346376|NCT04362072|593642922|FG000|Treatment|Adverse Event|1|||
164292645|NCT00423657|593441173|FG001|Overall Study|Withdrew consent|8|||
164292646|NCT00423657|593441172|FG000|Overall Study|Non-compliance|0|||
164292647|NCT00423657|593441173|FG001|Overall Study|Non-compliance|1|||
164292648|NCT00423657|593441172|FG000|Overall Study|Other|15|||
164292649|NCT00423657|593441173|FG001|Overall Study|Other|16|||
164292650|NCT00423657|593441172|FG000|Overall Study|Request of sponsor/investigator|1|||
164292651|NCT00423657|593441173|FG001|Overall Study|Request of sponsor/investigator|0|||
164346377|NCT04362072|593642922|FG000|Treatment|Death|9|||
164346378|NCT04362072|593642922|FG000|Treatment|Physician Decision|2|||
164346379|NCT04362072|593642922|FG000|Treatment|Progressive disease|27|||
163897946|NCT03725332|591999449|FG001|Overall Study|Withdrawal by Subject|1|||
163897947|NCT03725332|591999448|FG000|Overall Study|Duplicate enrollment|0|||
164346380|NCT04362072|593642922|FG000|Treatment|Withdrawal by Subject|4|||
164346381|NCT04362072|593642922|FG000|Treatment|Global deterioration of health status|1|||
164346382|NCT04362072|593642922|FG000|Treatment|Switched to commercial Lorlatinib|13|||
164346383|NCT04362072|593642922|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
164346384|NCT04362072|593642922|FG000|Treatment|Other|3|||
164346385|NCT04362072|593642922|FG000|Follow up|Death|2|||
164346386|NCT04362072|593642922|FG000|Follow up|Other|2|||
164346387|NCT04524689|593642923|FG000|Overall Study|Withdrawal by Subject|1|||
164346388|NCT04524689|593642924|FG001|Overall Study|Withdrawal by Subject|1|||
164346389|NCT04524689|593642925|FG002|Overall Study|Withdrawal by Subject|0|||
164346390|NCT04524689|593642926|FG003|Overall Study|Withdrawal by Subject|0|||
164346391|NCT04524689|593642927|FG004|Overall Study|Withdrawal by Subject|2|||
164346392|NCT04524689|593642928|FG005|Overall Study|Withdrawal by Subject|0|||
164346393|NCT04524689|593642923|FG000|Overall Study|Study terminated by Sponsor|6|||
164346394|NCT04524689|593642924|FG001|Overall Study|Study terminated by Sponsor|0|||
164346395|NCT04524689|593642925|FG002|Overall Study|Study terminated by Sponsor|1|||
164346396|NCT04524689|593642926|FG003|Overall Study|Study terminated by Sponsor|0|||
164346397|NCT04524689|593642927|FG004|Overall Study|Study terminated by Sponsor|4|||
164346398|NCT04524689|593642928|FG005|Overall Study|Study terminated by Sponsor|0|||
164346399|NCT04524689|593642923|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
164346400|NCT04524689|593642924|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
164346401|NCT04524689|593642925|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
164346402|NCT04524689|593642926|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
164346403|NCT04524689|593642927|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
164346404|NCT04524689|593642928|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
164346405|NCT01133522|593642929|FG000|Overall Study|Withdrawal by Subject|0|||
164346406|NCT01133522|593642930|FG001|Overall Study|Withdrawal by Subject|1|||
164346407|NCT01133522|593642931|FG002|Overall Study|Withdrawal by Subject|0|||
164346408|NCT01133522|593642932|FG003|Overall Study|Withdrawal by Subject|1|||
164346409|NCT01133522|593642933|FG004|Overall Study|Withdrawal by Subject|0|||
164346410|NCT01133522|593642934|FG005|Overall Study|Withdrawal by Subject|0|||
164346411|NCT01133522|593642935|FG006|Overall Study|Withdrawal by Subject|0|||
164346412|NCT01133522|593642936|FG007|Overall Study|Withdrawal by Subject|0|||
164346413|NCT01133522|593642937|FG008|Overall Study|Withdrawal by Subject|0|||
164346414|NCT01133522|593642938|FG009|Overall Study|Withdrawal by Subject|0|||
164346415|NCT01133522|593642929|FG000|Overall Study|Physician Decision|0|||
164346416|NCT01133522|593642930|FG001|Overall Study|Physician Decision|0|||
164346417|NCT01133522|593642931|FG002|Overall Study|Physician Decision|0|||
164346418|NCT01133522|593642932|FG003|Overall Study|Physician Decision|0|||
164346419|NCT01133522|593642933|FG004|Overall Study|Physician Decision|1|||
164346420|NCT01133522|593642934|FG005|Overall Study|Physician Decision|0|||
164346421|NCT01133522|593642935|FG006|Overall Study|Physician Decision|0|||
164346422|NCT01133522|593642936|FG007|Overall Study|Physician Decision|0|||
164346423|NCT01133522|593642937|FG008|Overall Study|Physician Decision|0|||
164346424|NCT01133522|593642938|FG009|Overall Study|Physician Decision|0|||
164346425|NCT01664533|593644997|FG000|Overall Study|Death|42|||
164346426|NCT01664533|593644997|FG000|Overall Study|Lost to Follow-up|3|||
164346427|NCT01664533|593644997|FG000|Overall Study|Study termination|9|||
164346428|NCT01664533|593644997|FG000|Overall Study|Protocol Violation|3|||
164346429|NCT00844831|593644999|FG000|Overall Study|Withdrawal by Subject|4|||
164346430|NCT00844831|593644999|FG000|Overall Study|Adverse Event|1|||
164346431|NCT00844831|593644999|FG000|Overall Study|Physician Decision|1|||
164346432|NCT05255068|593645000|FG000|Overall Study|Lost to Follow-up|0|||
164346433|NCT05255068|593645001|FG001|Overall Study|Lost to Follow-up|1|||
164346434|NCT03156543|593645003|FG000|Overall Study|Withdrawal by Subject|1|||
164346435|NCT03156543|593645004|FG001|Overall Study|Withdrawal by Subject|0|||
164346436|NCT02397278|593645007|FG000|Overall Study|Withdrawal by Subject|0|||
164346437|NCT02397278|593645008|FG001|Overall Study|Withdrawal by Subject|2|||
164346438|NCT02397278|593645007|FG000|Overall Study|Deemed ineligible following surgery|1|||
164346439|NCT02397278|593645008|FG001|Overall Study|Deemed ineligible following surgery|1|||
164346440|NCT02601469|593645010|FG000|Overall Study|Enrolled in Error|1|||
164346441|NCT02601469|593645011|FG001|Overall Study|Enrolled in Error|0|||
164346442|NCT02161731|593645012|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
163897948|NCT03725332|591999449|FG001|Overall Study|Duplicate enrollment|1|||
163897949|NCT03725332|591999448|FG000|Overall Study|Did not consent|0|||
163897950|NCT03725332|591999449|FG001|Overall Study|Did not consent|1|||
163897951|NCT02726386|591999456|FG000|Overall Study|Adverse Event|17|||
163897952|NCT02726386|591999457|FG001|Overall Study|Adverse Event|20|||
163897953|NCT02726386|591999456|FG000|Overall Study|Withdrawal by Subject|14|||
163897954|NCT02726386|591999457|FG001|Overall Study|Withdrawal by Subject|28|||
164346443|NCT02161731|593645013|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
164346444|NCT02161731|593645012|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
164346445|NCT02161731|593645013|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
164346446|NCT01315678|593645014|FG000|Overall Study|Withdrawal by Subject|7|||
164292652|NCT02314052|593441174|FG000|Cycle One|Adverse Event|0|||
164292653|NCT02314052|593441175|FG001|Cycle One|Adverse Event|0|||
164292654|NCT02314052|593441176|FG002|Cycle One|Adverse Event|0|||
164292655|NCT02314052|593441177|FG003|Cycle One|Adverse Event|1|||
164292656|NCT02314052|593441178|FG004|Cycle One|Adverse Event|0|||
164292657|NCT02314052|593441179|FG005|Cycle One|Adverse Event|0|||
164292658|NCT00474955|593441180|FG000|Overall Study|Adverse Event|2|||
164292659|NCT00474955|593441180|FG000|Overall Study|Drug unavailability|1|||
164292660|NCT00474955|593441180|FG000|Overall Study|Personal reasons|5|||
164292661|NCT02269124|593441182|FG000|Overall Study|Lost to Follow-up|1|||
164292662|NCT02269124|593441183|FG001|Overall Study|Lost to Follow-up|0|||
164292663|NCT02269124|593441182|FG000|Overall Study|Withdrawal by Subject|0|||
164292664|NCT02269124|593441183|FG001|Overall Study|Withdrawal by Subject|2|||
164292665|NCT00667888|593441186|FG000|Overall Study|Death|1|||
164292666|NCT00667888|593441187|FG001|Overall Study|Death|1|||
164292667|NCT00667888|593441186|FG000|Overall Study|Withdrawal by Subject|6|||
164292668|NCT00667888|593441187|FG001|Overall Study|Withdrawal by Subject|3|||
164292669|NCT00667888|593441186|FG000|Overall Study|Proceed with other treatment|3|||
164292670|NCT00667888|593441187|FG001|Overall Study|Proceed with other treatment|3|||
164292671|NCT00667888|593441186|FG000|Overall Study|Ineligible after SIM|0|||
164292672|NCT00667888|593441187|FG001|Overall Study|Ineligible after SIM|2|||
164292673|NCT01945021|593441188|FG000|Overall Study|Adverse Event|1|||
164292674|NCT01945021|593441188|FG000|Overall Study|Withdrawal of consent|12|||
164292675|NCT01945021|593441188|FG000|Overall Study|Lost to Follow-up|5|||
164292676|NCT01945021|593441188|FG000|Overall Study|Death|65|||
164292677|NCT00739401|593441189|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
164292678|NCT00739401|593441189|FG000|Overall Study|Death|3|||
164292679|NCT00739401|593441189|FG000|Overall Study|Withdrawal by Subject|4|||
164292680|NCT01239381|593441191|FG000|Overall Study|Protocol Violation|1|||
164292681|NCT01239381|593441191|FG000|Overall Study|Withdrawal by Subject|1|||
164292682|NCT03409796|593442953|FG000|Overall Study|Adverse Event|2|||
164292683|NCT03409796|593442954|FG001|Overall Study|Adverse Event|0|||
164292684|NCT03409796|593442953|FG000|Overall Study|Other|0|||
164292685|NCT03409796|593442954|FG001|Overall Study|Other|1|||
164292686|NCT00770653|593442955|FG000|Overall Study|Adverse Event|13|||
164292687|NCT00770653|593442956|FG001|Overall Study|Adverse Event|5|||
164292688|NCT00770653|593442955|FG000|Overall Study|Protocol Violation|8|||
164292689|NCT00770653|593442956|FG001|Overall Study|Protocol Violation|6|||
164292690|NCT00770653|593442955|FG000|Overall Study|Withdrawal by Subject|4|||
164292691|NCT00770653|593442956|FG001|Overall Study|Withdrawal by Subject|7|||
164292692|NCT00770653|593442955|FG000|Overall Study|Lack of Compliance|1|||
164292693|NCT00770653|593442956|FG001|Overall Study|Lack of Compliance|4|||
164292694|NCT00770653|593442955|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
164292695|NCT00770653|593442956|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
164292696|NCT00770653|593442955|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
164292697|NCT00770653|593442956|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
164292698|NCT00770653|593442955|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
164292699|NCT00770653|593442956|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
164292700|NCT00770653|593442955|FG000|Overall Study|Lost to Follow-up|1|||
164292701|NCT00770653|593442956|FG001|Overall Study|Lost to Follow-up|2|||
164292702|NCT00770653|593442955|FG000|Overall Study|Physician Decision|1|||
164292703|NCT00770653|593442956|FG001|Overall Study|Physician Decision|0|||
164292704|NCT00683878|593442958|FG000|Overall Study|Lack of Efficacy|3|||
164292705|NCT00683878|593442959|FG001|Overall Study|Lack of Efficacy|0|||
164292706|NCT00683878|593442960|FG002|Overall Study|Lack of Efficacy|1|||
164292707|NCT00683878|593442958|FG000|Overall Study|Adverse Event|4|||
164292708|NCT00683878|593442959|FG001|Overall Study|Adverse Event|3|||
164292709|NCT00683878|593442960|FG002|Overall Study|Adverse Event|3|||
164292710|NCT00683878|593442958|FG000|Overall Study|Withdrawal by Subject|9|||
164292711|NCT00683878|593442959|FG001|Overall Study|Withdrawal by Subject|8|||
164292712|NCT00683878|593442960|FG002|Overall Study|Withdrawal by Subject|6|||
164292713|NCT00683878|593442958|FG000|Overall Study|Death|0|||
164292714|NCT00683878|593442959|FG001|Overall Study|Death|1|||
164292715|NCT00683878|593442960|FG002|Overall Study|Death|0|||
164292716|NCT00683878|593442958|FG000|Overall Study|Lost to Follow-up|4|||
164292717|NCT00683878|593442959|FG001|Overall Study|Lost to Follow-up|2|||
164292718|NCT00683878|593442960|FG002|Overall Study|Lost to Follow-up|4|||
164292719|NCT00683878|593442958|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
164292720|NCT00683878|593442959|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
164292721|NCT00683878|593442960|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
164292722|NCT02869633|593442961|FG000|Overall Study|Death|2|||
164292723|NCT02869633|593442962|FG001|Overall Study|Death|1|||
164292724|NCT02869633|593442961|FG000|Overall Study|Patient refused follow-up|1|||
164292725|NCT02869633|593442962|FG001|Overall Study|Patient refused follow-up|0|||
164292726|NCT02869633|593442961|FG000|Overall Study|Provider discretion|1|||
164292727|NCT02869633|593442962|FG001|Overall Study|Provider discretion|0|||
164292728|NCT02869633|593442961|FG000|Overall Study|Investigator decision|1|||
164292729|NCT02869633|593442962|FG001|Overall Study|Investigator decision|0|||
164292730|NCT02869633|593442961|FG000|Overall Study|Lost to Follow-up|0|||
164292731|NCT02869633|593442962|FG001|Overall Study|Lost to Follow-up|1|||
164292732|NCT02869633|593442961|FG000|Overall Study|Not eligible|6|||
164292733|NCT02869633|593442962|FG001|Overall Study|Not eligible|1|||
164292734|NCT02869633|593442961|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
164292735|NCT02869633|593442962|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
164292736|NCT02869633|593442961|FG000|Overall Study|Withdrawal by Subject|0|||
164292737|NCT02869633|593442962|FG001|Overall Study|Withdrawal by Subject|1|||
164292738|NCT04607668|593442971|FG000|Overall Study|Death|49|||
164292739|NCT04607668|593442972|FG001|Overall Study|Death|26|||
164292740|NCT04607668|593442971|FG000|Overall Study|Lost to Follow-up|3|||
164292741|NCT04607668|593442972|FG001|Overall Study|Lost to Follow-up|4|||
164292742|NCT04607668|593442971|FG000|Overall Study|Study terminated by Sponsor|92|||
164292743|NCT04607668|593442972|FG001|Overall Study|Study terminated by Sponsor|114|||
164292744|NCT04607668|593442971|FG000|Overall Study|Withdrawal by Subject|12|||
164292745|NCT04607668|593442972|FG001|Overall Study|Withdrawal by Subject|11|||
164292746|NCT04607668|593442971|FG000|Overall Study|Other, unspecified|8|||
164292747|NCT04607668|593442972|FG001|Overall Study|Other, unspecified|7|||
164292748|NCT01451723|593442973|FG000|Overall Study|study halted|6|||
164292749|NCT01451723|593442974|FG001|Overall Study|study halted|5|||
164292750|NCT02210000|593442975|FG000|Overall Study|Study Terminated|11|||
164292751|NCT02210000|593442976|FG001|Overall Study|Study Terminated|12|||
164292752|NCT02210000|593442975|FG000|Overall Study|Withdrawal by Subject|7|||
164292753|NCT02210000|593442976|FG001|Overall Study|Withdrawal by Subject|1|||
164292754|NCT02210000|593442975|FG000|Overall Study|Adverse Event|1|||
164292755|NCT02210000|593442976|FG001|Overall Study|Adverse Event|5|||
164292756|NCT02210000|593442975|FG000|Overall Study|Lost to Follow-up|0|||
164292757|NCT02210000|593442976|FG001|Overall Study|Lost to Follow-up|2|||
164292758|NCT02210000|593442975|FG000|Overall Study|Physician Decision|0|||
164292759|NCT02210000|593442976|FG001|Overall Study|Physician Decision|1|||
164292760|NCT00308139|593442977|FG000|Overall Study|Adverse Event|20|||
164292761|NCT00308139|593442978|FG001|Overall Study|Adverse Event|14|||
164292762|NCT00308139|593442977|FG000|Overall Study|Lost to Follow-up|13|||
164292763|NCT00308139|593442978|FG001|Overall Study|Lost to Follow-up|8|||
164292764|NCT00308139|593442977|FG000|Overall Study|Protocol Violation|3|||
164292765|NCT00308139|593442978|FG001|Overall Study|Protocol Violation|2|||
164292766|NCT00308139|593442977|FG000|Overall Study|Withdrawal of Consent|40|||
164292767|NCT00308139|593442978|FG001|Overall Study|Withdrawal of Consent|42|||
164292768|NCT00308139|593442977|FG000|Overall Study|Investigator Decision|11|||
164292769|NCT00308139|593442978|FG001|Overall Study|Investigator Decision|10|||
164292770|NCT00308139|593442977|FG000|Overall Study|Loss of Glucose Control|5|||
164292771|NCT00308139|593442978|FG001|Overall Study|Loss of Glucose Control|7|||
164292772|NCT00308139|593442977|FG000|Overall Study|Administrative|1|||
164292773|NCT00308139|593442978|FG001|Overall Study|Administrative|4|||
164292774|NCT00308139|593442977|FG000|Overall Study|Other|1|||
164292775|NCT00308139|593442978|FG001|Overall Study|Other|0|||
164292776|NCT00962208|593442987|FG000|Overall Study|Could not achieve good vision|9|||
164292777|NCT00962208|593442988|FG001|Overall Study|Could not achieve good vision|0|||
164292778|NCT00962208|593442987|FG000|Overall Study|Contraindicated to continue study|5|||
164292779|NCT00962208|593442988|FG001|Overall Study|Contraindicated to continue study|1|||
164292780|NCT00962208|593442987|FG000|Overall Study|Lost to Follow-up|0|||
164292781|NCT00962208|593442988|FG001|Overall Study|Lost to Follow-up|9|||
164292782|NCT00791388|593442989|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292783|NCT00791388|593442990|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
164292784|NCT00791388|593442991|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292785|NCT00791388|593442992|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292786|NCT00791388|593442993|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
164292787|NCT00791388|593442989|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
164292788|NCT00791388|593442990|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292789|NCT00791388|593442991|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292790|NCT00791388|593442992|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292791|NCT00791388|593442993|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
164292792|NCT00791388|593442989|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292793|NCT00791388|593442990|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292794|NCT00791388|593442991|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292795|NCT00791388|593442992|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
164292796|NCT00791388|593442993|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
164292797|NCT01731912|593443000|FG000|Overall Study|noncompliance|2|||
164292798|NCT03010527|593443002|FG000|Overall Study|Death|0|||
164292799|NCT03010527|593443003|FG001|Overall Study|Death|0|||
164292800|NCT03010527|593443004|FG002|Overall Study|Death|1|||
164292801|NCT03010527|593443002|FG000|Overall Study|Adverse Event|0|||
164292802|NCT03010527|593443003|FG001|Overall Study|Adverse Event|4|||
164292803|NCT03010527|593443004|FG002|Overall Study|Adverse Event|2|||
164292804|NCT03010527|593443002|FG000|Overall Study|Protocol Violation|0|||
164292805|NCT03010527|593443003|FG001|Overall Study|Protocol Violation|1|||
163897955|NCT02726386|591999456|FG000|Overall Study|Other reasons|7|||
164292806|NCT03010527|593443004|FG002|Overall Study|Protocol Violation|0|||
164292807|NCT03010527|593443002|FG000|Overall Study|Lost to Follow-up|0|||
164292808|NCT03010527|593443003|FG001|Overall Study|Lost to Follow-up|2|||
164292809|NCT03010527|593443004|FG002|Overall Study|Lost to Follow-up|1|||
164292810|NCT03010527|593443002|FG000|Overall Study|Withdrawal by Subject|0|||
164292811|NCT03010527|593443003|FG001|Overall Study|Withdrawal by Subject|3|||
164292812|NCT03010527|593443004|FG002|Overall Study|Withdrawal by Subject|4|||
164292813|NCT03010527|593443002|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
164292814|NCT03010527|593443003|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
164292815|NCT03010527|593443004|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
164292816|NCT03010527|593443002|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
164292817|NCT03010527|593443003|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
164292818|NCT03010527|593443004|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
164292819|NCT03010527|593443002|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
164292820|NCT03010527|593443003|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
164292821|NCT03010527|593443004|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
164292822|NCT00443040|593443005|FG000|Overall Study|Withdrawal by Subject|1|||
164292823|NCT00443040|593443006|FG001|Overall Study|Withdrawal by Subject|0|||
164292824|NCT00443040|593443007|FG002|Overall Study|Withdrawal by Subject|0|||
164292825|NCT00443040|593443005|FG000|Overall Study|Converted to an open laparotomy|3|||
164292826|NCT00443040|593443006|FG001|Overall Study|Converted to an open laparotomy|0|||
164292827|NCT00443040|593443007|FG002|Overall Study|Converted to an open laparotomy|1|||
164292828|NCT04750824|593443008|FG000|Overall Study|Toxicity/intolerability|3|||
164292829|NCT04750824|593443009|FG001|Overall Study|Toxicity/intolerability|1|||
164292830|NCT04750824|593443008|FG000|Overall Study|Death|1|||
164292831|NCT04750824|593443009|FG001|Overall Study|Death|3|||
164292832|NCT04750824|593443008|FG000|Overall Study|Scheduled duration of therapy complete|1|||
164292833|NCT04750824|593443009|FG001|Overall Study|Scheduled duration of therapy complete|9|||
164292834|NCT04750824|593443008|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
164292835|NCT04750824|593443009|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
164292836|NCT02469623|593443010|FG000|Overall Study|Not consented for long-term follow-up|4|||
164292837|NCT02469623|593443010|FG000|Overall Study|Lost to Follow-up|4|||
164292838|NCT02469623|593443010|FG000|Overall Study|Withdrawal by Subject|2|||
164292839|NCT02469623|593443010|FG000|Overall Study|Death|3|||
164292840|NCT04073186|593443011|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
164292841|NCT04073186|593443011|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
164292842|NCT04073186|593443011|FG000|First Wearing Cycle|Protocol Violation|1|||
164292843|NCT04073186|593443011|FG000|First Wearing Cycle|Lens Discomfort|2|||
164292844|NCT04073186|593443011|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
164292845|NCT04073186|593443011|FG000|Second Wearing Cycle|Adverse Event|1|||
164292846|NCT01096316|593443012|FG000|Overall Study|Lost to Follow-up|15|||
164292847|NCT01096316|593443013|FG001|Overall Study|Lost to Follow-up|9|||
164292848|NCT02763644|593443014|FG000|Overall Study|Patient/guardian decision|1|||
164292849|NCT02763644|593443015|FG001|Overall Study|Patient/guardian decision|0|||
164292850|NCT02763644|593443014|FG000|Overall Study|Death|1|||
164292851|NCT02763644|593443015|FG001|Overall Study|Death|1|||
164292852|NCT02763644|593443014|FG000|Overall Study|Adverse Event|1|||
164292853|NCT02763644|593443015|FG001|Overall Study|Adverse Event|1|||
164292854|NCT00473434|593443016|FG000|Overall Study|Physician Decision|3|||
164292855|NCT00473434|593443016|FG000|Overall Study|Withdrawal by Subject|9|||
164292856|NCT00473434|593443016|FG000|Overall Study|Compliance|3|||
164292857|NCT00473434|593443016|FG000|Overall Study|Lack of Efficacy|3|||
164292858|NCT00473434|593443016|FG000|Overall Study|Adverse Event|3|||
164292859|NCT00473434|593443016|FG000|Overall Study|Patient was selling medication to others|1|||
164292860|NCT00473434|593443016|FG000|Overall Study|Safety evaluation|1|||
164292861|NCT00473434|593443016|FG000|Overall Study|Reason not specified|6|||
164292862|NCT00473434|593443016|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
164292863|NCT00473434|593443016|FG000|Overall Study|Switching to trial medication|1|||
164292864|NCT00473434|593443016|FG000|Overall Study|No longer required|1|||
164292865|NCT02356159|593443018|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292866|NCT02356159|593443019|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292867|NCT02356159|593443020|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292868|NCT02356159|593443021|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
163897956|NCT02726386|591999457|FG001|Overall Study|Other reasons|8|||
163897957|NCT02101853|591999462|FG000|Block 1 Induction|Adverse Event|11|||
164292869|NCT02356159|593443022|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
164292870|NCT02356159|593443023|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
164292871|NCT06418152|593443024|FG000|Overall Study|Frequent DBS setting changes|1|||
164292872|NCT06418152|593443024|FG000|Overall Study|Withdrawal by Subject|2|||
164292873|NCT02529852|593443029|FG000|Overall Study|Withdrawal by Subject|2|||
164292874|NCT00117637|593443030|FG000|First Intervention (Period 1)|Adverse Event|11|||
163897958|NCT02101853|591999463|FG001|Block 1 Induction|Adverse Event|0|||
163897959|NCT02101853|591999464|FG002|Block 1 Induction|Adverse Event|0|||
163897960|NCT02101853|591999465|FG003|Block 1 Induction|Adverse Event|0|||
164292875|NCT00117637|593443031|FG001|First Intervention (Period 1)|Adverse Event|16|||
164292876|NCT00117637|593443030|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
164292877|NCT00117637|593443031|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
164292878|NCT00117637|593443030|FG000|First Intervention (Period 1)|Protocol Violation|1|||
164292879|NCT00117637|593443031|FG001|First Intervention (Period 1)|Protocol Violation|0|||
164292880|NCT00117637|593443030|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
164292881|NCT00117637|593443031|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
164292882|NCT00117637|593443030|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
164292883|NCT00117637|593443031|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
164292884|NCT00117637|593443030|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
164292885|NCT00117637|593443031|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
164292886|NCT00117637|593443030|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
164292887|NCT00117637|593443031|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
164292888|NCT00117637|593443030|FG000|First Intervention (Period 1)|reason not reported|0|||
164292889|NCT00117637|593443031|FG001|First Intervention (Period 1)|reason not reported|1|||
164292890|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Adverse Event|0|||
164292891|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Adverse Event|9|||
164292892|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
164292893|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
164292894|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
164292895|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
164292896|NCT00117637|593443030|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
164292897|NCT00117637|593443031|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
164292898|NCT00117637|593443030|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
164292899|NCT00117637|593443031|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
164292900|NCT00117637|593443030|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
164292901|NCT00117637|593443031|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
164292902|NCT00117637|593443030|FG000|Second Intervention (Period 2)|reason not reported|1|||
164292903|NCT00117637|593443031|FG001|Second Intervention (Period 2)|reason not reported|0|||
164292904|NCT03206216|593443037|FG000|Overall Study|Withdrawal by Subject|0|||
164292905|NCT03206216|593443038|FG001|Overall Study|Withdrawal by Subject|1|||
164292906|NCT01582061|593443041|FG000|Overall Study|Lack of Efficacy|3|||
164292907|NCT01582061|593443042|FG001|Overall Study|Lack of Efficacy|23|||
164292908|NCT01582061|593443041|FG000|Overall Study|Adverse Event|12|||
164292909|NCT01582061|593443042|FG001|Overall Study|Adverse Event|8|||
164292910|NCT01582061|593443041|FG000|Overall Study|Withdrawal by Subject|10|||
164292911|NCT01582061|593443042|FG001|Overall Study|Withdrawal by Subject|4|||
164292912|NCT01582061|593443041|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164292913|NCT01582061|593443042|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164292914|NCT01582061|593443041|FG000|Overall Study|Death|0|||
164292915|NCT01582061|593443042|FG001|Overall Study|Death|1|||
164292916|NCT01582061|593443041|FG000|Overall Study|condition no longer requires study drug|1|||
164292917|NCT01582061|593443042|FG001|Overall Study|condition no longer requires study drug|0|||
164292918|NCT01582061|593443041|FG000|Overall Study|Lost to Follow-up|1|||
164292919|NCT01582061|593443042|FG001|Overall Study|Lost to Follow-up|0|||
164292920|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
164292921|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
164292922|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
164292923|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
164292924|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
164292925|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
164292926|NCT00097500|593443043|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
164292927|NCT00097500|593443044|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
164292928|NCT00097500|593443043|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
164292929|NCT00097500|593443044|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
164292930|NCT00097500|593443043|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
164292931|NCT00097500|593443044|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
163897961|NCT02101853|591999466|FG004|Block 1 Induction|Adverse Event|0|||
163897962|NCT02101853|591999467|FG005|Block 1 Induction|Adverse Event|0|||
163897963|NCT02101853|591999462|FG000|Block 1 Induction|Death|20|||
163897964|NCT02101853|591999463|FG001|Block 1 Induction|Death|0|||
163897965|NCT02101853|591999464|FG002|Block 1 Induction|Death|0|||
163897966|NCT02101853|591999465|FG003|Block 1 Induction|Death|0|||
163897967|NCT02101853|591999466|FG004|Block 1 Induction|Death|0|||
163897968|NCT02101853|591999467|FG005|Block 1 Induction|Death|0|||
163897969|NCT02101853|591999462|FG000|Block 1 Induction|Lack of Efficacy|6|||
164292932|NCT00097500|593443043|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
164292933|NCT00097500|593443044|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
163897970|NCT02101853|591999463|FG001|Block 1 Induction|Lack of Efficacy|0|||
163897971|NCT02101853|591999464|FG002|Block 1 Induction|Lack of Efficacy|0|||
164292934|NCT03119259|593443051|FG000|Overall Study|Withdrawn as no longer eligible|1|||
164292935|NCT03119259|593443052|FG001|Overall Study|Withdrawn as no longer eligible|0|||
164292936|NCT03119259|593443051|FG000|Overall Study|Withdrawal by Subject|4|||
164292937|NCT03119259|593443052|FG001|Overall Study|Withdrawal by Subject|2|||
164292938|NCT03119259|593443051|FG000|Overall Study|Lost to Follow-up|0|||
164292939|NCT03119259|593443052|FG001|Overall Study|Lost to Follow-up|1|||
164292940|NCT00647296|593443060|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292941|NCT00647296|593443061|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292942|NCT00647296|593443062|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292943|NCT00647296|593443063|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
164292944|NCT00647296|593443060|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
164292945|NCT00647296|593443061|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
164292946|NCT00647296|593443062|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
164292947|NCT00647296|593443063|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
164292948|NCT00647296|593443060|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
164292949|NCT00647296|593443061|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
164292950|NCT00647296|593443062|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
164292951|NCT00647296|593443063|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
164292952|NCT00647296|593443060|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
164292953|NCT00647296|593443061|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
164292954|NCT00647296|593443062|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
164292955|NCT00647296|593443063|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
164292956|NCT00647296|593443060|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
164292957|NCT00647296|593443061|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
164292958|NCT00647296|593443062|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
164292959|NCT00647296|593443063|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
164292960|NCT00647296|593443060|FG000|Part 2: 4-week Placebo Washout|Death|3|||
164292961|NCT00647296|593443061|FG001|Part 2: 4-week Placebo Washout|Death|0|||
164292962|NCT00647296|593443062|FG002|Part 2: 4-week Placebo Washout|Death|0|||
164292963|NCT00647296|593443063|FG003|Part 2: 4-week Placebo Washout|Death|0|||
164292964|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292965|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
164292966|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
164292967|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
164292968|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
164292969|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
164292970|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
164292971|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
164292972|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
164292973|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
164292974|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
164292975|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
164292976|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
164292977|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
164292978|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
164292979|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
164292980|NCT00647296|593443060|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
164292981|NCT00647296|593443061|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
164292982|NCT00647296|593443062|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
164292983|NCT00647296|593443063|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
164292984|NCT01300234|593443064|FG000|Overall Study|Adverse Event|1|||
164292985|NCT01300234|593443065|FG001|Overall Study|Adverse Event|1|||
164292986|NCT01300234|593443064|FG000|Overall Study|Protocol Violation|2|||
164292987|NCT01300234|593443065|FG001|Overall Study|Protocol Violation|3|||
164292988|NCT01300234|593443064|FG000|Overall Study|Withdrawal by Subject|5|||
164292989|NCT01300234|593443065|FG001|Overall Study|Withdrawal by Subject|9|||
164292990|NCT01300234|593443064|FG000|Overall Study|Lost to Follow-up|14|||
164292991|NCT01300234|593443065|FG001|Overall Study|Lost to Follow-up|12|||
164292992|NCT01300234|593443064|FG000|Overall Study|Pregnancy|2|||
164292993|NCT01300234|593443065|FG001|Overall Study|Pregnancy|1|||
164292994|NCT01300234|593443064|FG000|Overall Study|Participant reached stopping critera|2|||
164292995|NCT01300234|593443065|FG001|Overall Study|Participant reached stopping critera|0|||
164292996|NCT01300234|593443064|FG000|Overall Study|Participant stopped medication|1|||
164292997|NCT01300234|593443065|FG001|Overall Study|Participant stopped medication|1|||
164292998|NCT01300234|593443064|FG000|Overall Study|Participant refused return to hospital|1|||
164292999|NCT01300234|593443065|FG001|Overall Study|Participant refused return to hospital|0|||
164293000|NCT03253679|593443066|FG000|Overall Study|Screen Failure|1|||
164293001|NCT04816214|593443067|FG000|Overall Study|Progressive Disease|4|||
164293002|NCT04816214|593443068|FG001|Overall Study|Progressive Disease|0|||
164293003|NCT04816214|593443069|FG002|Overall Study|Progressive Disease|0|||
164293004|NCT04816214|593443067|FG000|Overall Study|Death|1|||
164293005|NCT04816214|593443068|FG001|Overall Study|Death|0|||
164293006|NCT04816214|593443069|FG002|Overall Study|Death|0|||
164293007|NCT04816214|593443067|FG000|Overall Study|Study Terminated by Sponsor|1|||
164293008|NCT04816214|593443068|FG001|Overall Study|Study Terminated by Sponsor|0|||
164293009|NCT04816214|593443069|FG002|Overall Study|Study Terminated by Sponsor|0|||
164293010|NCT04879628|593443070|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
164293011|NCT04879628|593443071|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
164293012|NCT04879628|593443072|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
164293013|NCT04879628|593443073|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
164293014|NCT04879628|593443070|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164293015|NCT04879628|593443071|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164293016|NCT04879628|593443072|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
164293017|NCT04879628|593443073|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
164293018|NCT04879628|593443070|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
164293019|NCT04879628|593443071|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
164293020|NCT04879628|593443072|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
164293021|NCT04879628|593443073|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
164293022|NCT04879628|593443070|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
164293023|NCT04879628|593443071|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
164293024|NCT04879628|593443072|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
164293025|NCT04879628|593443073|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
164293026|NCT00360412|593443079|FG000|Overall Study|Adverse Event|37|||
164293027|NCT00360412|593443080|FG001|Overall Study|Adverse Event|65|||
164293028|NCT00360412|593443079|FG000|Overall Study|Protocol Violation|2|||
164293029|NCT00360412|593443080|FG001|Overall Study|Protocol Violation|5|||
164293030|NCT00360412|593443079|FG000|Overall Study|Patient withdrew consent|27|||
164293031|NCT00360412|593443080|FG001|Overall Study|Patient withdrew consent|52|||
164293032|NCT00360412|593443079|FG000|Overall Study|Lack of therapeutic efficacy|46|||
164293033|NCT00360412|593443080|FG001|Overall Study|Lack of therapeutic efficacy|61|||
164293034|NCT00360412|593443079|FG000|Overall Study|Physician Decision|2|||
164293035|NCT00360412|593443080|FG001|Overall Study|Physician Decision|4|||
164293036|NCT00360412|593443079|FG000|Overall Study|Other|5|||
164293037|NCT00360412|593443080|FG001|Overall Study|Other|6|||
164293038|NCT00360412|593443079|FG000|Overall Study|Study termination by Sponsor|214|||
164293039|NCT00360412|593443080|FG001|Overall Study|Study termination by Sponsor|469|||
164293040|NCT00871871|593443081|FG000|Part I|Adverse Event|0|||
164293041|NCT00871871|593443082|FG001|Part I|Adverse Event|2|||
164293042|NCT00871871|593443083|FG002|Part I|Adverse Event|0|||
164293043|NCT00871871|593443084|FG003|Part I|Adverse Event|0|||
164293044|NCT00871871|593443081|FG000|Part I|Withdrawal by Subject|3|||
164293045|NCT00871871|593443082|FG001|Part I|Withdrawal by Subject|0|||
164293046|NCT00871871|593443083|FG002|Part I|Withdrawal by Subject|0|||
164293047|NCT00871871|593443084|FG003|Part I|Withdrawal by Subject|0|||
164293048|NCT00871871|593443081|FG000|Part I|Laboratory abnormality|0|||
164293049|NCT00871871|593443082|FG001|Part I|Laboratory abnormality|1|||
164293050|NCT00871871|593443083|FG002|Part I|Laboratory abnormality|0|||
164293051|NCT00871871|593443084|FG003|Part I|Laboratory abnormality|0|||
164293052|NCT00871871|593443081|FG000|Part II|Lack of Efficacy|0|||
164293053|NCT00871871|593443082|FG001|Part II|Lack of Efficacy|0|||
163897972|NCT02101853|591999465|FG003|Block 1 Induction|Lack of Efficacy|0|||
164293054|NCT00871871|593443083|FG002|Part II|Lack of Efficacy|1|||
164293055|NCT00871871|593443084|FG003|Part II|Lack of Efficacy|0|||
164293056|NCT00871871|593443081|FG000|Part II|Withdrawal by Subject|0|||
164293057|NCT00871871|593443082|FG001|Part II|Withdrawal by Subject|0|||
164293058|NCT00871871|593443083|FG002|Part II|Withdrawal by Subject|2|||
164293059|NCT00871871|593443084|FG003|Part II|Withdrawal by Subject|1|||
164293060|NCT00871871|593443081|FG000|Part II|Adverse Event|0|||
164293061|NCT00871871|593443082|FG001|Part II|Adverse Event|0|||
164293062|NCT00871871|593443083|FG002|Part II|Adverse Event|1|||
164293063|NCT00871871|593443084|FG003|Part II|Adverse Event|2|||
164293064|NCT00871871|593443081|FG000|Part II|Protocol Violation|0|||
164293065|NCT00871871|593443082|FG001|Part II|Protocol Violation|0|||
164293066|NCT00871871|593443083|FG002|Part II|Protocol Violation|0|||
164293067|NCT00871871|593443084|FG003|Part II|Protocol Violation|1|||
164293068|NCT04612725|593443085|FG000|Overall Study|Adverse Event|1|||
164293069|NCT04612725|593443086|FG001|Overall Study|Adverse Event|3|||
164293070|NCT04612725|593443087|FG002|Overall Study|Adverse Event|1|||
164293071|NCT04612725|593443088|FG003|Overall Study|Adverse Event|0|||
164293072|NCT04612725|593443089|FG004|Overall Study|Adverse Event|1|||
164293073|NCT04612725|593443085|FG000|Overall Study|Lost to Follow-up|0|||
164293074|NCT04612725|593443086|FG001|Overall Study|Lost to Follow-up|1|||
164293075|NCT04612725|593443087|FG002|Overall Study|Lost to Follow-up|0|||
164293076|NCT04612725|593443088|FG003|Overall Study|Lost to Follow-up|0|||
164293077|NCT04612725|593443089|FG004|Overall Study|Lost to Follow-up|0|||
164293078|NCT04612725|593443085|FG000|Overall Study|Physician Decision|2|||
164293079|NCT04612725|593443086|FG001|Overall Study|Physician Decision|0|||
164293080|NCT04612725|593443087|FG002|Overall Study|Physician Decision|0|||
164293081|NCT04612725|593443088|FG003|Overall Study|Physician Decision|0|||
164293082|NCT04612725|593443089|FG004|Overall Study|Physician Decision|0|||
164293083|NCT04612725|593443085|FG000|Overall Study|Study terminated by sponsor|3|||
164293084|NCT04612725|593443086|FG001|Overall Study|Study terminated by sponsor|1|||
164293085|NCT04612725|593443087|FG002|Overall Study|Study terminated by sponsor|2|||
164293086|NCT04612725|593443088|FG003|Overall Study|Study terminated by sponsor|4|||
164293087|NCT04612725|593443089|FG004|Overall Study|Study terminated by sponsor|5|||
164293088|NCT04612725|593443085|FG000|Overall Study|Withdrawal by Subject|8|||
164293089|NCT04612725|593443086|FG001|Overall Study|Withdrawal by Subject|3|||
164293090|NCT04612725|593443087|FG002|Overall Study|Withdrawal by Subject|5|||
164293091|NCT04612725|593443088|FG003|Overall Study|Withdrawal by Subject|1|||
164293092|NCT04612725|593443089|FG004|Overall Study|Withdrawal by Subject|9|||
164293093|NCT04612725|593443085|FG000|Overall Study|Other|0|||
164293094|NCT04612725|593443086|FG001|Overall Study|Other|0|||
164293095|NCT04612725|593443087|FG002|Overall Study|Other|0|||
164293096|NCT04612725|593443088|FG003|Overall Study|Other|0|||
164293097|NCT04612725|593443089|FG004|Overall Study|Other|1|||
164293098|NCT03863509|593443090|FG000|Overall Study|COVID-19 shutdown period|0|||
164293099|NCT03863509|593443091|FG001|Overall Study|COVID-19 shutdown period|4|||
164293100|NCT03863509|593443092|FG002|Overall Study|COVID-19 shutdown period|0|||
164293101|NCT03863509|593443090|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
164293102|NCT03863509|593443091|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
164293103|NCT03863509|593443092|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
164293104|NCT03863509|593443090|FG000|Overall Study|Lost to Follow-up|8|||
164293105|NCT03863509|593443091|FG001|Overall Study|Lost to Follow-up|0|||
164293106|NCT03863509|593443092|FG002|Overall Study|Lost to Follow-up|2|||
164293107|NCT03863509|593443090|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
164293108|NCT03863509|593443091|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
164293109|NCT03863509|593443092|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
164293110|NCT03863509|593443090|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
164293111|NCT03863509|593443091|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
164293112|NCT03863509|593443092|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
164293113|NCT03861273|593443093|FG000|Screening Phase (3 Weeks)|Other|1|||
164293114|NCT03861273|593443093|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
164293115|NCT03861273|593443093|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
164293116|NCT03861273|593443093|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
164293117|NCT03861273|593443093|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
164293118|NCT00948064|593445130|FG000|Phase I|No treatment received|1|||
164293119|NCT00948064|593445131|FG001|Phase I|No treatment received|0|||
164293120|NCT00948064|593445132|FG002|Phase I|No treatment received|0|||
163897973|NCT02101853|591999466|FG004|Block 1 Induction|Lack of Efficacy|0|||
163897974|NCT02101853|591999467|FG005|Block 1 Induction|Lack of Efficacy|0|||
163897975|NCT02101853|591999462|FG000|Block 1 Induction|Physician Decision|61|||
163897976|NCT02101853|591999463|FG001|Block 1 Induction|Physician Decision|0|||
163897977|NCT02101853|591999464|FG002|Block 1 Induction|Physician Decision|0|||
163897978|NCT02101853|591999465|FG003|Block 1 Induction|Physician Decision|0|||
163897979|NCT02101853|591999466|FG004|Block 1 Induction|Physician Decision|0|||
163897980|NCT02101853|591999467|FG005|Block 1 Induction|Physician Decision|0|||
163897981|NCT02101853|591999462|FG000|Block 1 Induction|Protocol Violation|2|||
163897982|NCT02101853|591999463|FG001|Block 1 Induction|Protocol Violation|0|||
163897983|NCT02101853|591999464|FG002|Block 1 Induction|Protocol Violation|0|||
163897984|NCT02101853|591999465|FG003|Block 1 Induction|Protocol Violation|0|||
163897985|NCT02101853|591999466|FG004|Block 1 Induction|Protocol Violation|0|||
163897986|NCT02101853|591999467|FG005|Block 1 Induction|Protocol Violation|0|||
163897987|NCT02101853|591999462|FG000|Block 1 Induction|Withdrawal by Subject|65|||
163897988|NCT02101853|591999463|FG001|Block 1 Induction|Withdrawal by Subject|0|||
163897989|NCT02101853|591999464|FG002|Block 1 Induction|Withdrawal by Subject|0|||
163897990|NCT02101853|591999465|FG003|Block 1 Induction|Withdrawal by Subject|0|||
163897991|NCT02101853|591999466|FG004|Block 1 Induction|Withdrawal by Subject|0|||
163897992|NCT02101853|591999467|FG005|Block 1 Induction|Withdrawal by Subject|0|||
163897993|NCT02101853|591999462|FG000|Block 1 Induction|Ineligible|8|||
163897994|NCT02101853|591999463|FG001|Block 1 Induction|Ineligible|0|||
164293121|NCT00948064|593445130|FG000|Phase II|Physician Decision|0|||
163897995|NCT02101853|591999464|FG002|Block 1 Induction|Ineligible|0|||
163897996|NCT02101853|591999465|FG003|Block 1 Induction|Ineligible|0|||
164293122|NCT00948064|593445131|FG001|Phase II|Physician Decision|0|||
163897997|NCT02101853|591999466|FG004|Block 1 Induction|Ineligible|0|||
164293123|NCT00948064|593445132|FG002|Phase II|Physician Decision|1|||
164293124|NCT00948064|593445130|FG000|Phase II|Withdrawal by Subject|0|||
164293125|NCT00948064|593445131|FG001|Phase II|Withdrawal by Subject|1|||
164293126|NCT00948064|593445132|FG002|Phase II|Withdrawal by Subject|0|||
164293127|NCT00740220|593445133|FG000|Overall Study|screen failures (non-COPD patients)|9|||
164293128|NCT00633477|593445134|FG000|Overall Study|Death|1|||
164293129|NCT00633477|593445135|FG001|Overall Study|Death|0|||
164293130|NCT00633477|593445134|FG000|Overall Study|Randomized but not treated|1|||
164293131|NCT00633477|593445135|FG001|Overall Study|Randomized but not treated|0|||
164293132|NCT04906499|593445144|FG000|Overall Study|Lack of time|1|||
164293133|NCT03346434|593445146|FG000|Overall Study|Randomized in Error|0|||
164293134|NCT03346434|593445147|FG001|Overall Study|Randomized in Error|0|||
164293135|NCT03346434|593445148|FG002|Overall Study|Randomized in Error|0|||
164293136|NCT03346434|593445149|FG003|Overall Study|Randomized in Error|0|||
164293137|NCT03346434|593445150|FG004|Overall Study|Randomized in Error|1|||
164293138|NCT03346434|593445151|FG005|Overall Study|Randomized in Error|0|||
164293139|NCT03346434|593445146|FG000|Overall Study|Withdrawal by Subject|0|||
164293140|NCT03346434|593445147|FG001|Overall Study|Withdrawal by Subject|0|||
164293141|NCT03346434|593445148|FG002|Overall Study|Withdrawal by Subject|1|||
164293142|NCT03346434|593445149|FG003|Overall Study|Withdrawal by Subject|0|||
164293143|NCT03346434|593445150|FG004|Overall Study|Withdrawal by Subject|1|||
164293144|NCT03346434|593445151|FG005|Overall Study|Withdrawal by Subject|0|||
164293145|NCT03346434|593445146|FG000|Overall Study|Lost to Follow-up|0|||
164293146|NCT03346434|593445147|FG001|Overall Study|Lost to Follow-up|0|||
164004465|NCT00246259|592380796|FG001|Overall Study|Participant non-compliant|9|||
164004466|NCT00246259|592380795|FG000|Overall Study|Lack of Efficacy|2|||
164004467|NCT00246259|592380796|FG001|Overall Study|Lack of Efficacy|2|||
164004468|NCT00246259|592380795|FG000|Overall Study|Investigator withdrew participant|2|||
164004469|NCT00246259|592380796|FG001|Overall Study|Investigator withdrew participant|0|||
164004470|NCT00246259|592380795|FG000|Overall Study|Adverse Event|5|||
164004471|NCT00246259|592380796|FG001|Overall Study|Adverse Event|0|||
164004472|NCT00246259|592380795|FG000|Overall Study|Lost to Follow-up|3|||
164004473|NCT00246259|592380796|FG001|Overall Study|Lost to Follow-up|4|||
164004474|NCT00246259|592380795|FG000|Overall Study|Withdrawal by Subject|5|||
164004475|NCT00246259|592380796|FG001|Overall Study|Withdrawal by Subject|1|||
164293147|NCT03346434|593445148|FG002|Overall Study|Lost to Follow-up|0|||
164293148|NCT03346434|593445149|FG003|Overall Study|Lost to Follow-up|0|||
164293149|NCT03346434|593445150|FG004|Overall Study|Lost to Follow-up|1|||
164293150|NCT03346434|593445151|FG005|Overall Study|Lost to Follow-up|1|||
164293151|NCT03346434|593445146|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293152|NCT03346434|593445147|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293153|NCT03346434|593445148|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293154|NCT03346434|593445149|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
164293155|NCT03346434|593445150|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
164293156|NCT03346434|593445151|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
164293157|NCT02081677|593445154|FG000|Overall Study|Adverse Event|0|||
164293158|NCT02081677|593445155|FG001|Overall Study|Adverse Event|0|||
164293159|NCT02081677|593445156|FG002|Overall Study|Adverse Event|1|||
164293160|NCT02081677|593445157|FG003|Overall Study|Adverse Event|0|||
164293161|NCT02081677|593445154|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164293162|NCT02081677|593445155|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164004476|NCT00246259|592380795|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
164004477|NCT00246259|592380796|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
164004478|NCT01564784|592380797|FG000|Overall Study|Other|1|||
164004479|NCT01564784|592380798|FG001|Overall Study|Other|0|||
164293163|NCT02081677|593445156|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
164293164|NCT02081677|593445157|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164293165|NCT02081677|593445154|FG000|Overall Study|Not comfortable with lens care system|1|||
164293166|NCT02081677|593445155|FG001|Overall Study|Not comfortable with lens care system|0|||
164293167|NCT02081677|593445156|FG002|Overall Study|Not comfortable with lens care system|0|||
164293168|NCT02081677|593445157|FG003|Overall Study|Not comfortable with lens care system|0|||
164293169|NCT02081677|593445154|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164293170|NCT02081677|593445155|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164293171|NCT02081677|593445156|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
164293172|NCT02081677|593445157|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
164293173|NCT04416204|593445170|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
164293174|NCT04416204|593445171|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
164293175|NCT04416204|593445172|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
164293176|NCT04416204|593445173|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
164293177|NCT01959503|593445174|FG000|Overall Study|Death|2|||
164293178|NCT01959503|593445175|FG001|Overall Study|Death|1|||
164293179|NCT01959503|593445174|FG000|Overall Study|Randomized but not treated|1|||
164293180|NCT01959503|593445175|FG001|Overall Study|Randomized but not treated|1|||
164293181|NCT01393158|593445177|FG000|Overall Study|Adverse Event|1|||
164293182|NCT01393158|593445178|FG001|Overall Study|Adverse Event|0|||
164293183|NCT04233801|593445180|FG000|Overall Study|Other than listed|0|||
164293184|NCT04233801|593445181|FG001|Overall Study|Other than listed|0|||
164293185|NCT04233801|593445182|FG002|Overall Study|Other than listed|1|||
164293186|NCT04233801|593445180|FG000|Overall Study|Withdrawal by Subject|0|||
164293187|NCT04233801|593445181|FG001|Overall Study|Withdrawal by Subject|2|||
164293188|NCT04233801|593445182|FG002|Overall Study|Withdrawal by Subject|3|||
164293189|NCT02173769|593445183|FG000|Overall Study|Protocol Violation|4|||
164293190|NCT04024891|593445196|FG000|Overall Study|Pregnancy|0|||
164293191|NCT04024891|593445197|FG001|Overall Study|Pregnancy|1|||
164293192|NCT03095651|593445205|FG000|Overall Study|Lost to Follow-up|1|||
164293193|NCT03095651|593445206|FG001|Overall Study|Lost to Follow-up|1|||
164293194|NCT03095651|593445207|FG002|Overall Study|Lost to Follow-up|0|||
164293195|NCT03095651|593445208|FG003|Overall Study|Lost to Follow-up|1|||
164293196|NCT03095651|593445209|FG004|Overall Study|Lost to Follow-up|0|||
164293197|NCT03095651|593445210|FG005|Overall Study|Lost to Follow-up|0|||
164293198|NCT03095651|593445211|FG006|Overall Study|Lost to Follow-up|0|||
164293199|NCT03095651|593445212|FG007|Overall Study|Lost to Follow-up|0|||
164293200|NCT03095651|593445205|FG000|Overall Study|Withdrawal by Subject|0|||
164293201|NCT03095651|593445206|FG001|Overall Study|Withdrawal by Subject|0|||
164293202|NCT03095651|593445207|FG002|Overall Study|Withdrawal by Subject|0|||
164293203|NCT03095651|593445208|FG003|Overall Study|Withdrawal by Subject|0|||
164293204|NCT03095651|593445209|FG004|Overall Study|Withdrawal by Subject|0|||
164293205|NCT03095651|593445210|FG005|Overall Study|Withdrawal by Subject|1|||
164293206|NCT03095651|593445211|FG006|Overall Study|Withdrawal by Subject|0|||
164293207|NCT03095651|593445212|FG007|Overall Study|Withdrawal by Subject|0|||
164293208|NCT04124939|593445216|FG000|Overall Study|Lost to Follow-up|1|||
164293209|NCT04124939|593445217|FG001|Overall Study|Lost to Follow-up|3|||
164293210|NCT01751061|593445218|FG000|Overall Study|Death|1|||
164293211|NCT01751061|593445219|FG001|Overall Study|Death|0|||
164293212|NCT01751061|593445218|FG000|Overall Study|patient death|5|||
164293213|NCT01751061|593445219|FG001|Overall Study|patient death|0|||
164293214|NCT01751061|593445218|FG000|Overall Study|Lost to Follow-up|40|||
164293215|NCT01751061|593445219|FG001|Overall Study|Lost to Follow-up|25|||
164293216|NCT01751061|593445218|FG000|Overall Study|patient regained decisional capacity|4|||
164293217|NCT01751061|593445219|FG001|Overall Study|patient regained decisional capacity|8|||
164293218|NCT01751061|593445218|FG000|Overall Study|Withdrawal by Subject|4|||
164293219|NCT01751061|593445219|FG001|Overall Study|Withdrawal by Subject|1|||
164293220|NCT01751061|593445218|FG000|Overall Study|Physician Decision|2|||
164293221|NCT01751061|593445219|FG001|Overall Study|Physician Decision|0|||
164293222|NCT02412306|593445220|FG000|Overall Study|Lost to Follow-up|0|||
164293223|NCT02412306|593445221|FG001|Overall Study|Lost to Follow-up|1|||
164293224|NCT02412306|593445222|FG002|Overall Study|Lost to Follow-up|0|||
164293225|NCT02412306|593445223|FG003|Overall Study|Lost to Follow-up|0|||
164293226|NCT02412306|593445224|FG004|Overall Study|Lost to Follow-up|0|||
164293227|NCT02412306|593445220|FG000|Overall Study|Withdrawal by Subject|0|||
164346447|NCT01315678|593645015|FG001|Overall Study|Withdrawal by Subject|3|||
164346448|NCT01315678|593645014|FG000|Overall Study|Adverse Event|3|||
164346449|NCT01315678|593645015|FG001|Overall Study|Adverse Event|1|||
164346450|NCT01315678|593645014|FG000|Overall Study|Lost to Follow-up|1|||
164346451|NCT01315678|593645015|FG001|Overall Study|Lost to Follow-up|0|||
164346452|NCT01315678|593645014|FG000|Overall Study|similar reason to those listed above|3|||
164346453|NCT01315678|593645015|FG001|Overall Study|similar reason to those listed above|2|||
164346454|NCT00790023|593645016|FG000|Overall Study|Adverse Event|2|||
164346455|NCT00790023|593645017|FG001|Overall Study|Adverse Event|1|||
164346456|NCT00790023|593645018|FG002|Overall Study|Adverse Event|4|||
164346457|NCT00790023|593645016|FG000|Overall Study|Protocol Violation|2|||
164346458|NCT00790023|593645017|FG001|Overall Study|Protocol Violation|4|||
164346459|NCT00790023|593645018|FG002|Overall Study|Protocol Violation|2|||
164346460|NCT00790023|593645016|FG000|Overall Study|Withdrawal by Subject|2|||
163897998|NCT02101853|591999467|FG005|Block 1 Induction|Ineligible|0|||
163897999|NCT02101853|591999462|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
163898000|NCT02101853|591999463|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163898001|NCT02101853|591999464|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164293228|NCT02412306|593445221|FG001|Overall Study|Withdrawal by Subject|0|||
163898002|NCT02101853|591999465|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164293229|NCT02412306|593445222|FG002|Overall Study|Withdrawal by Subject|1|||
164293230|NCT02412306|593445223|FG003|Overall Study|Withdrawal by Subject|0|||
163898003|NCT02101853|591999466|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
163898004|NCT02101853|591999467|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
164293231|NCT02412306|593445224|FG004|Overall Study|Withdrawal by Subject|0|||
164293232|NCT02412306|593445220|FG000|Overall Study|Death|5|||
164293233|NCT02412306|593445221|FG001|Overall Study|Death|7|||
164293234|NCT02412306|593445222|FG002|Overall Study|Death|15|||
164346461|NCT00790023|593645017|FG001|Overall Study|Withdrawal by Subject|0|||
164346462|NCT00790023|593645018|FG002|Overall Study|Withdrawal by Subject|6|||
164004480|NCT01564784|592380797|FG000|Overall Study|Subject refused further follow-up|1|||
164004481|NCT01564784|592380798|FG001|Overall Study|Subject refused further follow-up|6|||
164004482|NCT01564784|592380797|FG000|Overall Study|Lost to Follow-up|1|||
164293235|NCT02412306|593445223|FG003|Overall Study|Death|0|||
164293236|NCT02412306|593445224|FG004|Overall Study|Death|2|||
164293237|NCT00435409|593445225|FG000|Overall Study|Protocol Violation|1|||
164293238|NCT00435409|593445226|FG001|Overall Study|Protocol Violation|2|||
164293239|NCT00435409|593445227|FG002|Overall Study|Protocol Violation|0|||
164293240|NCT00435409|593445225|FG000|Overall Study|Lost to Follow-up|1|||
164293241|NCT00435409|593445226|FG001|Overall Study|Lost to Follow-up|2|||
164293242|NCT00435409|593445227|FG002|Overall Study|Lost to Follow-up|0|||
164293243|NCT00435409|593445225|FG000|Overall Study|Death|8|||
164293244|NCT00435409|593445226|FG001|Overall Study|Death|6|||
164293245|NCT00435409|593445227|FG002|Overall Study|Death|6|||
164293246|NCT00435409|593445225|FG000|Overall Study|Objective progression or relapse|158|||
164293247|NCT00435409|593445226|FG001|Overall Study|Objective progression or relapse|93|||
164293248|NCT00435409|593445227|FG002|Overall Study|Objective progression or relapse|58|||
164293249|NCT00435409|593445225|FG000|Overall Study|Global deterioration of health status|0|||
164293250|NCT00435409|593445226|FG001|Overall Study|Global deterioration of health status|0|||
164293251|NCT00435409|593445227|FG002|Overall Study|Global deterioration of health status|4|||
164293252|NCT00435409|593445225|FG000|Overall Study|Withdrawal by Subject|8|||
164293253|NCT00435409|593445226|FG001|Overall Study|Withdrawal by Subject|7|||
164293254|NCT00435409|593445227|FG002|Overall Study|Withdrawal by Subject|1|||
164293255|NCT00435409|593445225|FG000|Overall Study|Other|45|||
164293256|NCT00435409|593445226|FG001|Overall Study|Other|30|||
164293257|NCT00435409|593445227|FG002|Overall Study|Other|1|||
164293258|NCT00435409|593445225|FG000|Overall Study|Adverse Event|0|||
164293259|NCT00435409|593445226|FG001|Overall Study|Adverse Event|0|||
164293260|NCT00435409|593445227|FG002|Overall Study|Adverse Event|8|||
164293261|NCT00435409|593445225|FG000|Overall Study|Sponsor decision|0|||
164293262|NCT00435409|593445226|FG001|Overall Study|Sponsor decision|3|||
164293263|NCT00435409|593445227|FG002|Overall Study|Sponsor decision|0|||
164293264|NCT05196828|593445228|FG000|Overall Study|Withdrawal by Subject|2|||
164293265|NCT05196828|593445229|FG001|Overall Study|Withdrawal by Subject|0|||
164293266|NCT05196828|593445228|FG000|Overall Study|Lost to Follow-up|0|||
164293267|NCT05196828|593445229|FG001|Overall Study|Lost to Follow-up|4|||
164293268|NCT05196828|593445228|FG000|Overall Study|Adverse Event|1|||
164293269|NCT05196828|593445229|FG001|Overall Study|Adverse Event|0|||
164293270|NCT03192176|593445230|FG000|Overall Study|Adverse Event|1|||
164293271|NCT03192176|593445231|FG001|Overall Study|Adverse Event|0|||
164293272|NCT03192176|593445232|FG002|Overall Study|Adverse Event|4|||
164293273|NCT03192176|593445233|FG003|Overall Study|Adverse Event|5|||
164293274|NCT03192176|593445234|FG004|Overall Study|Adverse Event|3|||
164293275|NCT03192176|593445235|FG005|Overall Study|Adverse Event|2|||
164293276|NCT03192176|593445236|FG006|Overall Study|Adverse Event|3|||
164293277|NCT03192176|593445237|FG007|Overall Study|Adverse Event|3|||
164293278|NCT03192176|593445230|FG000|Overall Study|Lost to Follow-up|0|||
164293279|NCT03192176|593445231|FG001|Overall Study|Lost to Follow-up|0|||
164293280|NCT03192176|593445232|FG002|Overall Study|Lost to Follow-up|1|||
164293281|NCT03192176|593445233|FG003|Overall Study|Lost to Follow-up|2|||
164293282|NCT03192176|593445234|FG004|Overall Study|Lost to Follow-up|3|||
164293283|NCT03192176|593445235|FG005|Overall Study|Lost to Follow-up|1|||
164293284|NCT03192176|593445236|FG006|Overall Study|Lost to Follow-up|1|||
164293285|NCT03192176|593445237|FG007|Overall Study|Lost to Follow-up|1|||
164293286|NCT03192176|593445230|FG000|Overall Study|Physician Decision|1|||
164293287|NCT03192176|593445231|FG001|Overall Study|Physician Decision|0|||
164293288|NCT03192176|593445232|FG002|Overall Study|Physician Decision|0|||
164293289|NCT03192176|593445233|FG003|Overall Study|Physician Decision|0|||
164293290|NCT03192176|593445234|FG004|Overall Study|Physician Decision|0|||
164293291|NCT03192176|593445235|FG005|Overall Study|Physician Decision|2|||
164293292|NCT03192176|593445236|FG006|Overall Study|Physician Decision|1|||
164293293|NCT03192176|593445237|FG007|Overall Study|Physician Decision|0|||
164293294|NCT03192176|593445230|FG000|Overall Study|Protocol Deviation|1|||
164293295|NCT03192176|593445231|FG001|Overall Study|Protocol Deviation|1|||
164293296|NCT03192176|593445232|FG002|Overall Study|Protocol Deviation|0|||
164293297|NCT03192176|593445233|FG003|Overall Study|Protocol Deviation|0|||
164293298|NCT03192176|593445234|FG004|Overall Study|Protocol Deviation|2|||
164293299|NCT03192176|593445235|FG005|Overall Study|Protocol Deviation|0|||
164293300|NCT03192176|593445236|FG006|Overall Study|Protocol Deviation|0|||
164293301|NCT03192176|593445237|FG007|Overall Study|Protocol Deviation|0|||
164293302|NCT03192176|593445230|FG000|Overall Study|Withdrawal by Subject|3|||
164293303|NCT03192176|593445231|FG001|Overall Study|Withdrawal by Subject|4|||
164293304|NCT03192176|593445232|FG002|Overall Study|Withdrawal by Subject|0|||
164293305|NCT03192176|593445233|FG003|Overall Study|Withdrawal by Subject|4|||
164293306|NCT03192176|593445234|FG004|Overall Study|Withdrawal by Subject|3|||
164293307|NCT03192176|593445235|FG005|Overall Study|Withdrawal by Subject|4|||
164293308|NCT03192176|593445236|FG006|Overall Study|Withdrawal by Subject|4|||
164293309|NCT03192176|593445237|FG007|Overall Study|Withdrawal by Subject|2|||
164293310|NCT03192176|593445230|FG000|Overall Study|Miscellaneous|1|||
164293311|NCT03192176|593445231|FG001|Overall Study|Miscellaneous|0|||
164293312|NCT03192176|593445232|FG002|Overall Study|Miscellaneous|1|||
164293313|NCT03192176|593445233|FG003|Overall Study|Miscellaneous|1|||
164293314|NCT03192176|593445234|FG004|Overall Study|Miscellaneous|1|||
164293315|NCT03192176|593445235|FG005|Overall Study|Miscellaneous|2|||
164293316|NCT03192176|593445236|FG006|Overall Study|Miscellaneous|0|||
164293317|NCT03192176|593445237|FG007|Overall Study|Miscellaneous|1|||
164293318|NCT00836589|593445240|FG000|Overall Study|Lost to Follow-up|246|||
164293319|NCT00836589|593445240|FG000|Overall Study|Death|429|||
164293320|NCT00836589|593445240|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
164293321|NCT02914639|593445242|FG000|Overall Study|Withdrawal by Subject|0|||
164293322|NCT02914639|593445243|FG001|Overall Study|Withdrawal by Subject|2|||
164293323|NCT01045460|593445247|FG000|Overall Study|Physician Decision|3|||
164293324|NCT01045460|593445248|FG001|Overall Study|Physician Decision|2|||
164293325|NCT01045460|593445247|FG000|Overall Study|Lost to Follow-up|0|||
164293326|NCT01045460|593445248|FG001|Overall Study|Lost to Follow-up|1|||
164293327|NCT01045460|593445247|FG000|Overall Study|Lack of Efficacy|3|||
164293328|NCT01045460|593445248|FG001|Overall Study|Lack of Efficacy|0|||
164293329|NCT00436332|593445249|FG000|Overall Study|Adverse Event|9|||
164293330|NCT00436332|593445249|FG000|Overall Study|Withdrawal by Subject|2|||
164293331|NCT00436332|593445249|FG000|Overall Study|Progression|59|||
164293332|NCT00436332|593445249|FG000|Overall Study|Death|2|||
164293333|NCT00436332|593445249|FG000|Overall Study|Not Protocol Specified|6|||
164293334|NCT00436332|593445249|FG000|Overall Study|Ineligible|2|||
164293335|NCT00436332|593445249|FG000|Overall Study|Never Received Treatment|3|||
164293336|NCT00472108|593445250|FG000|Overall Study|Lost to Follow-up|0|||
164293337|NCT00472108|593445251|FG001|Overall Study|Lost to Follow-up|1|||
164293338|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
164293339|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
164293340|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
164293341|NCT00062439|593445252|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
164293342|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Death|1|||
164293343|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Disease progression|2|||
164293344|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
164293345|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
164293346|NCT00062439|593445252|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
164293347|NCT00062439|593445252|FG000|Surgery|Physician Decision|4|||
164293348|NCT00062439|593445252|FG000|Surgery|Death|1|||
164293349|NCT00062439|593445252|FG000|Surgery|Adverse Event|2|||
164293350|NCT00062439|593445252|FG000|Consolidation Chemotherapy|Adverse Event|2|||
164293351|NCT01924845|593445253|FG000|Overall Study|Adverse Event|3|||
164293352|NCT01924845|593445253|FG000|Overall Study|Withdrawal by Subject|2|||
164293353|NCT01924845|593445253|FG000|Overall Study|Protocol Violation|1|||
164293354|NCT03780452|593445254|FG000|Overall Study|Screening failure|2|||
164293355|NCT02388269|593445255|FG000|Overall Study|Adverse Event|2|||
164293356|NCT02388269|593445256|FG001|Overall Study|Adverse Event|0|||
164293357|NCT02388269|593445257|FG002|Overall Study|Adverse Event|0|||
164293358|NCT02388269|593445255|FG000|Overall Study|Withdrawal by Subject|1|||
164293359|NCT02388269|593445256|FG001|Overall Study|Withdrawal by Subject|2|||
164293360|NCT02388269|593445257|FG002|Overall Study|Withdrawal by Subject|0|||
164293361|NCT02388269|593445255|FG000|Overall Study|less than 50% stimulations|1|||
164293362|NCT02388269|593445256|FG001|Overall Study|less than 50% stimulations|0|||
164293363|NCT02388269|593445257|FG002|Overall Study|less than 50% stimulations|0|||
164293364|NCT02388269|593445255|FG000|Overall Study|no diary data|3|||
164293365|NCT02388269|593445256|FG001|Overall Study|no diary data|0|||
164293366|NCT02388269|593445257|FG002|Overall Study|no diary data|0|||
164293367|NCT02388269|593445255|FG000|Overall Study|Protocol Violation|2|||
164293368|NCT02388269|593445256|FG001|Overall Study|Protocol Violation|0|||
164293369|NCT02388269|593445257|FG002|Overall Study|Protocol Violation|0|||
164293370|NCT02388269|593445255|FG000|Overall Study|Screen Failure|0|||
164293371|NCT02388269|593445256|FG001|Overall Study|Screen Failure|0|||
164293372|NCT02388269|593445257|FG002|Overall Study|Screen Failure|10|||
164293373|NCT00265564|593445260|FG000|Overall Study|Lost to Follow-up|5|||
164293374|NCT00265564|593445261|FG001|Overall Study|Lost to Follow-up|7|||
164293375|NCT00265564|593445260|FG000|Overall Study|met exclusion criteria|5|||
164293376|NCT00265564|593445261|FG001|Overall Study|met exclusion criteria|2|||
164293377|NCT01553084|593445262|FG000|Overall Study|Withdrawal by Subject|15|||
164293378|NCT01553084|593445263|FG001|Overall Study|Withdrawal by Subject|13|||
164293379|NCT01553084|593445264|FG002|Overall Study|Withdrawal by Subject|35|||
164293380|NCT04698343|593445265|FG000|Overall Study|Withdrawal by Subject|6|||
164293381|NCT04698343|593445265|FG000|Overall Study|Physician Decision|2|||
164293382|NCT04698343|593445265|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
164293383|NCT04698343|593445265|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
164293384|NCT04698343|593445265|FG000|Overall Study|Personal reasons|3|||
164293385|NCT04698343|593445265|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
164293386|NCT03882021|593445267|FG000|Enrollment|Procedure aborted/cancelled|2|||
164293387|NCT03882021|593445267|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
164293388|NCT03882021|593445267|FG000|Enrollment to 3-Month|Death|1|||
164293389|NCT03882021|593445267|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
164293390|NCT03882021|593445267|FG000|Enrollment to 3-Month|Missed Visit|4|||
164293391|NCT03882021|593445267|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
164293392|NCT03882021|593445267|FG000|6-Month to 12-Month Visit|Death|1|||
164293393|NCT03882021|593445267|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
164293394|NCT03582215|593445268|FG000|Overall Study|Adverse Event|1|||
164293395|NCT03582215|593445269|FG001|Overall Study|Adverse Event|0|||
164293396|NCT03582215|593445270|FG002|Overall Study|Adverse Event|0|||
164293397|NCT03582215|593445271|FG003|Overall Study|Adverse Event|0|||
164293398|NCT03582215|593445272|FG004|Overall Study|Adverse Event|0|||
164293399|NCT03582215|593445273|FG005|Overall Study|Adverse Event|0|||
164293400|NCT03582215|593445274|FG006|Overall Study|Adverse Event|2|||
164293401|NCT03582215|593445275|FG007|Overall Study|Adverse Event|2|||
164293402|NCT02174731|593445276|FG000|Overall Study|Participant decision|67|||
164293403|NCT02174731|593445277|FG001|Overall Study|Participant decision|64|||
164293404|NCT02174731|593445276|FG000|Overall Study|Incorrect enrolment before randomization|0|||
164293405|NCT02174731|593445277|FG001|Overall Study|Incorrect enrolment before randomization|1|||
164293406|NCT02174731|593445276|FG000|Overall Study|Missing|2|||
164293407|NCT02174731|593445277|FG001|Overall Study|Missing|0|||
164293408|NCT00325897|593445281|FG000|Overall Study|Lost to Follow-up|12|||
164293409|NCT00325897|593445282|FG001|Overall Study|Lost to Follow-up|13|||
164293410|NCT03915717|593445285|FG000|Overall Study|EchoMark Not Implanted|6|||
164293411|NCT02903160|593445288|FG000|Overall Study|Adverse Event|2|||
164293412|NCT02903160|593445288|FG000|Overall Study|Death|1|||
164293413|NCT02903160|593445288|FG000|Overall Study|Lost to Follow-up|2|||
164293414|NCT02903160|593445288|FG000|Overall Study|Withdrawal by Subject|1|||
164293415|NCT02903160|593445288|FG000|Overall Study|Medical Insurance Barriers|1|||
164293416|NCT01664910|593445291|FG000|Overall Study|Adverse Event|0|||
164293417|NCT01664910|593445292|FG001|Overall Study|Adverse Event|0|||
164293418|NCT01664910|593445293|FG002|Overall Study|Adverse Event|1|||
164293419|NCT02525471|593445294|FG000|Overall Study|Screen Failure|6|||
164293420|NCT02525471|593445294|FG000|Overall Study|Withdrawal by Subject|4|||
164293421|NCT02525471|593445294|FG000|Overall Study|Death|1|||
164293422|NCT02240485|593445295|FG000|3 Months Post-admission|Lost to Follow-up|1|||
164293423|NCT02240485|593445296|FG001|3 Months Post-admission|Lost to Follow-up|5|||
164293424|NCT02240485|593445295|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
164293425|NCT02240485|593445296|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
164293426|NCT02240485|593445295|FG000|9 Months Post-admission|Lost to Follow-up|3|||
164004483|NCT01564784|592380798|FG001|Overall Study|Lost to Follow-up|1|||
164293427|NCT02240485|593445296|FG001|9 Months Post-admission|Lost to Follow-up|1|||
164293428|NCT02240485|593445295|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
164293429|NCT02240485|593445296|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
164293430|NCT02240485|593445295|FG000|18 Months Post-admission|Lost to Follow-up|1|||
164293431|NCT02240485|593445296|FG001|18 Months Post-admission|Lost to Follow-up|1|||
164004484|NCT01564784|592380797|FG000|Overall Study|Death|131|||
164293432|NCT02240485|593445295|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
164293433|NCT02240485|593445296|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
164293434|NCT00844376|593445300|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
164293435|NCT00844376|593445301|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
164293436|NCT00539981|593445304|FG000|Overall Study|Adverse events (AE)|3|||
164293437|NCT00539981|593445305|FG001|Overall Study|Adverse events (AE)|3|||
164293438|NCT00539981|593445304|FG000|Overall Study|Lost to Follow-up|260|||
164293439|NCT00539981|593445305|FG001|Overall Study|Lost to Follow-up|251|||
164293440|NCT00539981|593445304|FG000|Overall Study|Withdrew consent|22|||
164004485|NCT01564784|592380798|FG001|Overall Study|Death|126|||
164293441|NCT00539981|593445305|FG001|Overall Study|Withdrew consent|14|||
164293442|NCT00539981|593445304|FG000|Overall Study|Death|1|||
164293443|NCT00539981|593445305|FG001|Overall Study|Death|1|||
164293444|NCT00539981|593445304|FG000|Overall Study|Other reason-unspecified|9|||
164293445|NCT00539981|593445305|FG001|Overall Study|Other reason-unspecified|13|||
164293446|NCT01759420|593445306|FG000|Overall Study|Screen failure|5|||
164293447|NCT01759420|593445306|FG000|Overall Study|Inaccurate EKG machine readings|1|||
164293448|NCT01129622|593445307|FG000|Overall Study|Withdrawal by Subject|2|||
164293449|NCT03069352|593445311|FG000|Overall Study|Ongoing|12|||
164293450|NCT03069352|593445312|FG001|Overall Study|Ongoing|40|||
164293451|NCT02621424|593445313|FG000|Overall Study|Withdrawal by Subject|1|||
164293452|NCT02621424|593445314|FG001|Overall Study|Withdrawal by Subject|2|||
164293453|NCT01690052|593447694|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
164293454|NCT01690052|593447695|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
164293455|NCT05635461|593447696|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293456|NCT05635461|593447697|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293457|NCT05635461|593447698|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293458|NCT05635461|593447699|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293459|NCT05635461|593447700|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
164293460|NCT05635461|593447701|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
164293461|NCT05635461|593447696|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293462|NCT05635461|593447697|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
164293463|NCT05635461|593447698|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293464|NCT05635461|593447699|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293465|NCT05635461|593447700|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293466|NCT05635461|593447701|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
164293467|NCT05635461|593447696|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293468|NCT05635461|593447697|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293469|NCT05635461|593447698|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293470|NCT05635461|593447699|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
164293471|NCT05635461|593447700|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293472|NCT05635461|593447701|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
164293473|NCT02648204|593447705|FG000|Overall Study|Withdrawal by Subject|12|||
164293474|NCT02648204|593447706|FG001|Overall Study|Withdrawal by Subject|8|||
164293475|NCT02648204|593447707|FG002|Overall Study|Withdrawal by Subject|2|||
164293476|NCT02648204|593447708|FG003|Overall Study|Withdrawal by Subject|6|||
164293477|NCT02648204|593447705|FG000|Overall Study|Lost to Follow-up|5|||
164293478|NCT02648204|593447706|FG001|Overall Study|Lost to Follow-up|8|||
164293479|NCT02648204|593447707|FG002|Overall Study|Lost to Follow-up|4|||
164293480|NCT02648204|593447708|FG003|Overall Study|Lost to Follow-up|6|||
164293481|NCT02648204|593447705|FG000|Overall Study|Missing follow-up information|4|||
164293482|NCT02648204|593447706|FG001|Overall Study|Missing follow-up information|4|||
164293483|NCT02648204|593447707|FG002|Overall Study|Missing follow-up information|4|||
164293484|NCT02648204|593447708|FG003|Overall Study|Missing follow-up information|2|||
164293485|NCT02648204|593447705|FG000|Overall Study|Death|1|||
164293486|NCT02648204|593447706|FG001|Overall Study|Death|1|||
164293487|NCT02648204|593447707|FG002|Overall Study|Death|2|||
164293488|NCT02648204|593447708|FG003|Overall Study|Death|2|||
164293489|NCT02648204|593447705|FG000|Overall Study|Adverse Event|0|||
164293490|NCT02648204|593447706|FG001|Overall Study|Adverse Event|0|||
164293491|NCT02648204|593447707|FG002|Overall Study|Adverse Event|1|||
164293492|NCT02648204|593447708|FG003|Overall Study|Adverse Event|0|||
164293493|NCT04349891|593447709|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
164293494|NCT04349891|593447710|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
164293495|NCT04349891|593447709|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
164293496|NCT04349891|593447710|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
164293497|NCT04349891|593447709|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
164293498|NCT04349891|593447710|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
164293499|NCT04349891|593447709|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
164293500|NCT04349891|593447710|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
164346463|NCT00790023|593645016|FG000|Overall Study|Lost to Follow-up|0|||
164346464|NCT00790023|593645017|FG001|Overall Study|Lost to Follow-up|0|||
164004486|NCT02272790|592380799|FG000|Overall Study|Physician Decision|0|||
164004487|NCT02272790|592380800|FG001|Overall Study|Physician Decision|1|||
164004488|NCT02272790|592380801|FG002|Overall Study|Physician Decision|0|||
164004489|NCT02272790|592380802|FG003|Overall Study|Physician Decision|0|||
164004490|NCT02272790|592380803|FG004|Overall Study|Physician Decision|0|||
164004491|NCT02272790|592380804|FG005|Overall Study|Physician Decision|0|||
164004492|NCT03022461|592380805|FG000|Overall Study|Death|3|||
164004493|NCT01982630|592380806|FG000|Overall Study|Adverse Event|2|||
164004494|NCT01982630|592380807|FG001|Overall Study|Adverse Event|0|||
164004495|NCT01982630|592380808|FG002|Overall Study|Adverse Event|1|||
164004496|NCT01982630|592380809|FG003|Overall Study|Adverse Event|0|||
164004497|NCT01982630|592380810|FG004|Overall Study|Adverse Event|1|||
164346465|NCT00790023|593645018|FG002|Overall Study|Lost to Follow-up|1|||
164346466|NCT00790023|593645016|FG000|Overall Study|Other|5|||
164293501|NCT00614575|593447711|FG000|Overall Study|Adverse Event|106|||
164293502|NCT00614575|593447711|FG000|Overall Study|Lost to Follow-up|55|||
164293503|NCT00614575|593447711|FG000|Overall Study|Lack of Efficacy|14|||
164293504|NCT00614575|593447711|FG000|Overall Study|Withdrawal by Subject|6|||
164293505|NCT00614575|593447711|FG000|Overall Study|Death|3|||
164293506|NCT00614575|593447711|FG000|Overall Study|Physician Decision|2|||
164293507|NCT00614575|593447711|FG000|Overall Study|No data were collected.|18|||
164293508|NCT00614575|593447711|FG000|Overall Study|Irregularly enrolled patients|23|||
164293509|NCT00614575|593447711|FG000|Overall Study|No treatment|1|||
164293510|NCT00189540|593447714|FG000|Overall Study|Withdrawal by Subject|3|||
164293511|NCT00189540|593447715|FG001|Overall Study|Withdrawal by Subject|0|||
164293512|NCT00189540|593447714|FG000|Overall Study|Death|4|||
164293513|NCT00189540|593447715|FG001|Overall Study|Death|1|||
164293514|NCT00286442|593447716|FG000|Overall Study|Hyperglycemic Rescue|19|||
164293515|NCT00286442|593447717|FG001|Overall Study|Hyperglycemic Rescue|17|||
164293516|NCT00286442|593447718|FG002|Overall Study|Hyperglycemic Rescue|25|||
164293517|NCT00286442|593447716|FG000|Overall Study|Adverse Event|7|||
164293518|NCT00286442|593447717|FG001|Overall Study|Adverse Event|6|||
164293519|NCT00286442|593447718|FG002|Overall Study|Adverse Event|1|||
164293520|NCT00286442|593447716|FG000|Overall Study|Protocol Violation|2|||
164293521|NCT00286442|593447717|FG001|Overall Study|Protocol Violation|4|||
164293522|NCT00286442|593447718|FG002|Overall Study|Protocol Violation|2|||
164293523|NCT00286442|593447716|FG000|Overall Study|Lost to Follow-up|5|||
164293524|NCT00286442|593447717|FG001|Overall Study|Lost to Follow-up|2|||
164293525|NCT00286442|593447718|FG002|Overall Study|Lost to Follow-up|1|||
164293526|NCT00286442|593447716|FG000|Overall Study|Physician Decision|1|||
164293527|NCT00286442|593447717|FG001|Overall Study|Physician Decision|1|||
164293528|NCT00286442|593447718|FG002|Overall Study|Physician Decision|1|||
164293529|NCT00286442|593447716|FG000|Overall Study|Administrative Error|1|||
164293530|NCT00286442|593447717|FG001|Overall Study|Administrative Error|1|||
164293531|NCT00286442|593447718|FG002|Overall Study|Administrative Error|0|||
164293532|NCT00286442|593447716|FG000|Overall Study|Withdrawal by Subject|2|||
164293533|NCT00286442|593447717|FG001|Overall Study|Withdrawal by Subject|14|||
164293534|NCT00286442|593447718|FG002|Overall Study|Withdrawal by Subject|2|||
164293535|NCT02163902|593447721|FG000|Overall Study|Subject's Request|3|||
164293536|NCT02163902|593447722|FG001|Overall Study|Subject's Request|4|||
164293537|NCT02163902|593447721|FG000|Overall Study|Lost to Follow-up|6|||
164293538|NCT02163902|593447722|FG001|Overall Study|Lost to Follow-up|7|||
164293539|NCT02163902|593447721|FG000|Overall Study|Administrative Decision|2|||
164293540|NCT02163902|593447722|FG001|Overall Study|Administrative Decision|2|||
164293541|NCT00079040|593447723|FG000|Overall Study|Withdrew before treatment|1|||
164293542|NCT00079040|593447723|FG000|Overall Study|Ineligible|1|||
164293543|NCT04079296|593447724|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
164293544|NCT04079296|593447725|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
164293545|NCT04079296|593447726|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
164293546|NCT04079296|593447727|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
164293547|NCT04079296|593447728|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
164293548|NCT04079296|593447724|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
164293549|NCT04079296|593447725|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
164293550|NCT04079296|593447726|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
164293551|NCT04079296|593447727|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
164293552|NCT04079296|593447728|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
164293553|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
163898005|NCT02101853|591999462|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
163898006|NCT02101853|591999463|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898007|NCT02101853|591999464|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898008|NCT02101853|591999465|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898009|NCT02101853|591999466|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898010|NCT02101853|591999467|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898011|NCT02101853|591999462|FG000|Post Induction Randomization|Adverse Event|0|||
163898012|NCT02101853|591999463|FG001|Post Induction Randomization|Adverse Event|3|||
163898013|NCT02101853|591999464|FG002|Post Induction Randomization|Adverse Event|8|||
163898014|NCT02101853|591999465|FG003|Post Induction Randomization|Adverse Event|4|||
163898015|NCT02101853|591999466|FG004|Post Induction Randomization|Adverse Event|4|||
163898016|NCT02101853|591999467|FG005|Post Induction Randomization|Adverse Event|0|||
164293554|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164293555|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164293556|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
164293557|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
164293558|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293559|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293560|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293561|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
164293562|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
164293563|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293564|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293565|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293566|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
164293567|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
164293568|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
164293569|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
164293570|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
164293571|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
164293572|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
164293573|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
164293574|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
164293575|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
164293576|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
164293577|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
164293578|NCT04079296|593447724|FG000|Dose Expansion Phase (168 Days)|Death|0|||
164293579|NCT04079296|593447725|FG001|Dose Expansion Phase (168 Days)|Death|0|||
164293580|NCT04079296|593447726|FG002|Dose Expansion Phase (168 Days)|Death|0|||
164293581|NCT04079296|593447727|FG003|Dose Expansion Phase (168 Days)|Death|1|||
164293582|NCT04079296|593447728|FG004|Dose Expansion Phase (168 Days)|Death|0|||
164293583|NCT00467740|593447741|FG000|Overall Study|Adverse Event|0|||
164293584|NCT00467740|593447742|FG001|Overall Study|Adverse Event|0|||
164293585|NCT00467740|593447743|FG002|Overall Study|Adverse Event|1|||
164293586|NCT00467740|593447744|FG003|Overall Study|Adverse Event|0|||
164293587|NCT00467740|593447745|FG004|Overall Study|Adverse Event|0|||
164293588|NCT00467740|593447741|FG000|Overall Study|Protocol Violation|0|||
164293589|NCT00467740|593447742|FG001|Overall Study|Protocol Violation|0|||
164293590|NCT00467740|593447743|FG002|Overall Study|Protocol Violation|1|||
164293591|NCT00467740|593447744|FG003|Overall Study|Protocol Violation|0|||
164293592|NCT00467740|593447745|FG004|Overall Study|Protocol Violation|0|||
164293593|NCT00467740|593447741|FG000|Overall Study|Lost to Follow-up|0|||
164293594|NCT00467740|593447742|FG001|Overall Study|Lost to Follow-up|1|||
164293595|NCT00467740|593447743|FG002|Overall Study|Lost to Follow-up|0|||
164293596|NCT00467740|593447744|FG003|Overall Study|Lost to Follow-up|0|||
164293597|NCT00467740|593447745|FG004|Overall Study|Lost to Follow-up|0|||
164293598|NCT00467740|593447741|FG000|Overall Study|Withdrawal by Subject|1|||
164293599|NCT00467740|593447742|FG001|Overall Study|Withdrawal by Subject|1|||
164293600|NCT00467740|593447743|FG002|Overall Study|Withdrawal by Subject|0|||
164293601|NCT00467740|593447744|FG003|Overall Study|Withdrawal by Subject|1|||
164293602|NCT00467740|593447745|FG004|Overall Study|Withdrawal by Subject|0|||
164293603|NCT00467740|593447741|FG000|Overall Study|Lack of Efficacy|0|||
164293604|NCT00467740|593447742|FG001|Overall Study|Lack of Efficacy|1|||
164293605|NCT00467740|593447743|FG002|Overall Study|Lack of Efficacy|0|||
164293606|NCT00467740|593447744|FG003|Overall Study|Lack of Efficacy|0|||
164293607|NCT00467740|593447745|FG004|Overall Study|Lack of Efficacy|0|||
164293608|NCT00867165|593447746|FG000|Overall Study|Adverse Event|3|||
164293609|NCT00867165|593447747|FG001|Overall Study|Adverse Event|0|||
164293610|NCT00867165|593447746|FG000|Overall Study|Withdrawal by Subject|1|||
164293611|NCT00867165|593447747|FG001|Overall Study|Withdrawal by Subject|0|||
164293612|NCT03275740|593447748|FG000|Overall Study|Adverse Event|0|||
164346467|NCT00790023|593645017|FG001|Overall Study|Other|5|||
164346468|NCT00790023|593645018|FG002|Overall Study|Other|8|||
164346469|NCT01338792|593645019|FG000|Overall Study|Adverse Event|2|||
164346470|NCT01338792|593645019|FG000|Overall Study|Death|1|||
164293613|NCT03275740|593447749|FG001|Overall Study|Adverse Event|0|||
164346471|NCT01338792|593645019|FG000|Overall Study|Withdrawal by Subject|1|||
164346472|NCT00062374|593645020|FG000|Overall Study|Not treated|12|||
164346473|NCT03633695|593645023|FG000|Overall Study|Lost to Follow-up|4|||
164346474|NCT03633695|593645024|FG001|Overall Study|Lost to Follow-up|5|||
164346475|NCT03633695|593645023|FG000|Overall Study|Discontinued|8|||
164346476|NCT03633695|593645024|FG001|Overall Study|Discontinued|4|||
164346477|NCT00684593|593645025|FG000|Overall Study|Adverse Event|0|||
164346478|NCT00684593|593645026|FG001|Overall Study|Adverse Event|2|||
164293614|NCT03275740|593447750|FG002|Overall Study|Adverse Event|0|||
164293615|NCT03275740|593447751|FG003|Overall Study|Adverse Event|0|||
164293616|NCT03275740|593447752|FG004|Overall Study|Adverse Event|1|||
164293617|NCT03275740|593447753|FG005|Overall Study|Adverse Event|0|||
164293618|NCT03275740|593447754|FG006|Overall Study|Adverse Event|0|||
164293619|NCT03275740|593447755|FG007|Overall Study|Adverse Event|0|||
164293620|NCT03275740|593447756|FG008|Overall Study|Adverse Event|0|||
164346479|NCT02599129|593645032|FG000|Overall Study|Lack of Efficacy|2|||
164346480|NCT02599129|593645033|FG001|Overall Study|Lack of Efficacy|2|||
164346481|NCT02599129|593645032|FG000|Overall Study|Lost to Follow-up|1|||
164346482|NCT02599129|593645033|FG001|Overall Study|Lost to Follow-up|0|||
164346483|NCT02599129|593645032|FG000|Overall Study|Withdrawal by Subject|2|||
164293621|NCT03275740|593447757|FG009|Overall Study|Adverse Event|0|||
164293622|NCT03275740|593447758|FG010|Overall Study|Adverse Event|0|||
164293623|NCT03275740|593447759|FG011|Overall Study|Adverse Event|0|||
164293624|NCT03275740|593447748|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293625|NCT03275740|593447749|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293626|NCT03275740|593447750|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293627|NCT03275740|593447751|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293628|NCT03275740|593447752|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293629|NCT03275740|593447753|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
164293630|NCT03275740|593447754|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293631|NCT03275740|593447755|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293632|NCT03275740|593447756|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293633|NCT03275740|593447757|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293634|NCT03275740|593447758|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293635|NCT03275740|593447759|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
164293636|NCT03275740|593447748|FG000|Overall Study|Withdrawal by Subject|0|||
164293637|NCT03275740|593447749|FG001|Overall Study|Withdrawal by Subject|0|||
164293638|NCT03275740|593447750|FG002|Overall Study|Withdrawal by Subject|0|||
164293639|NCT03275740|593447751|FG003|Overall Study|Withdrawal by Subject|0|||
164293640|NCT03275740|593447752|FG004|Overall Study|Withdrawal by Subject|0|||
164293641|NCT03275740|593447753|FG005|Overall Study|Withdrawal by Subject|0|||
164293642|NCT03275740|593447754|FG006|Overall Study|Withdrawal by Subject|0|||
164293643|NCT03275740|593447755|FG007|Overall Study|Withdrawal by Subject|0|||
164293644|NCT03275740|593447756|FG008|Overall Study|Withdrawal by Subject|1|||
164293645|NCT03275740|593447757|FG009|Overall Study|Withdrawal by Subject|1|||
164293646|NCT03275740|593447758|FG010|Overall Study|Withdrawal by Subject|0|||
164293647|NCT03275740|593447759|FG011|Overall Study|Withdrawal by Subject|0|||
164293648|NCT00988884|593447761|FG000|Overall Study|Adverse Event|0|||
164293649|NCT00988884|593447762|FG001|Overall Study|Adverse Event|1|||
164293650|NCT00988884|593447761|FG000|Overall Study|Lost to Follow-up|20|||
164293651|NCT00988884|593447762|FG001|Overall Study|Lost to Follow-up|16|||
164293652|NCT00988884|593447761|FG000|Overall Study|Protocol Violation|0|||
164293653|NCT00988884|593447762|FG001|Overall Study|Protocol Violation|1|||
164293654|NCT00988884|593447761|FG000|Overall Study|Withdrawal by Subject|15|||
164293655|NCT00988884|593447762|FG001|Overall Study|Withdrawal by Subject|18|||
164293656|NCT04621448|593447764|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
164293657|NCT04621448|593447765|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
164293658|NCT04621448|593447766|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
164293659|NCT04621448|593447767|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
164293660|NCT04621448|593447764|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
164293661|NCT04621448|593447765|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
164293662|NCT04621448|593447766|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
164293663|NCT04621448|593447767|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
164293664|NCT04621448|593447764|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
164293665|NCT04621448|593447765|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
164293666|NCT04621448|593447766|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
164293667|NCT04621448|593447767|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
164293668|NCT04621448|593447764|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
164293669|NCT04621448|593447765|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
164293670|NCT04621448|593447766|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
164293671|NCT04621448|593447767|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
164293672|NCT00549640|593447768|FG000|Overall Study|Withdrawal by Subject|6|||
164293673|NCT00549640|593447769|FG001|Overall Study|Withdrawal by Subject|12|||
164293674|NCT00549640|593447768|FG000|Overall Study|Adverse Event|5|||
164293675|NCT00549640|593447769|FG001|Overall Study|Adverse Event|0|||
164293676|NCT00549640|593447768|FG000|Overall Study|Lost to Follow-up|7|||
164293677|NCT00549640|593447769|FG001|Overall Study|Lost to Follow-up|4|||
164293678|NCT03550378|593447770|FG000|Overall Study|Death|0|||
164293679|NCT03550378|593447771|FG001|Overall Study|Death|1|||
164088122|NCT00491504|592687355|FG000|Overall Study|Withdrawal by Subject|0|||
164293680|NCT04486235|593447772|FG000|Overall Study|Pregnancy|1|||
164293681|NCT04486235|593447773|FG001|Overall Study|Pregnancy|0|||
164293682|NCT04486235|593447772|FG000|Overall Study|Lost to Follow-up|1|||
164293683|NCT04486235|593447773|FG001|Overall Study|Lost to Follow-up|0|||
164293684|NCT00626275|593447774|FG000|Part A - Treatment Period 1|Adverse Event|1|||
164293685|NCT00626275|593447775|FG001|Part A - Treatment Period 1|Adverse Event|0|||
164293686|NCT00626275|593447776|FG002|Part A - Treatment Period 1|Adverse Event|0|||
164293687|NCT00626275|593447777|FG003|Part A - Treatment Period 1|Adverse Event|0|||
164293688|NCT00626275|593447778|FG004|Part A - Treatment Period 1|Adverse Event|0|||
164293689|NCT00626275|593447779|FG005|Part A - Treatment Period 1|Adverse Event|0|||
164293690|NCT00626275|593447780|FG006|Part A - Treatment Period 1|Adverse Event|0|||
164293691|NCT00626275|593447781|FG007|Part A - Treatment Period 1|Adverse Event|0|||
164293692|NCT00626275|593447774|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293693|NCT00626275|593447775|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164346484|NCT02599129|593645033|FG001|Overall Study|Withdrawal by Subject|1|||
164346485|NCT00617773|593645034|FG000|Overall Study|Physician Decision|1|||
164346486|NCT00617773|593645034|FG000|Overall Study|Lack of compliance with the protocol|1|||
164346487|NCT00617773|593645034|FG000|Overall Study|Withdrawal by Subject|1|||
164346488|NCT00617773|593645034|FG000|Overall Study|Death|1|||
164346489|NCT00617773|593645034|FG000|Overall Study|Progressive disease|19|||
164346490|NCT00617773|593645034|FG000|Overall Study|Protocol Violation|1|||
164346491|NCT01029795|593645035|FG000|Overall Study|Entry Criteria Not Met|2|||
164293694|NCT00626275|593447776|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
164293695|NCT00626275|593447777|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293696|NCT00626275|593447778|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293697|NCT00626275|593447779|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293698|NCT00626275|593447780|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293699|NCT00626275|593447781|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
164293700|NCT00626275|593447774|FG000|Part B|Lost to Follow-up|0|||
164293701|NCT00626275|593447775|FG001|Part B|Lost to Follow-up|0|||
164293702|NCT00626275|593447776|FG002|Part B|Lost to Follow-up|0|||
164293703|NCT00626275|593447777|FG003|Part B|Lost to Follow-up|0|||
164293704|NCT00626275|593447778|FG004|Part B|Lost to Follow-up|0|||
164346492|NCT01029795|593645036|FG001|Overall Study|Entry Criteria Not Met|1|||
164293705|NCT00626275|593447779|FG005|Part B|Lost to Follow-up|0|||
164293706|NCT00626275|593447780|FG006|Part B|Lost to Follow-up|1|||
164293707|NCT00626275|593447781|FG007|Part B|Lost to Follow-up|0|||
164293708|NCT00626275|593447774|FG000|Part B|Withdrawal by Subject|0|||
164293709|NCT00626275|593447775|FG001|Part B|Withdrawal by Subject|0|||
164293710|NCT00626275|593447776|FG002|Part B|Withdrawal by Subject|0|||
164293711|NCT00626275|593447777|FG003|Part B|Withdrawal by Subject|0|||
164293712|NCT00626275|593447778|FG004|Part B|Withdrawal by Subject|0|||
164293713|NCT00626275|593447779|FG005|Part B|Withdrawal by Subject|0|||
164293714|NCT00626275|593447780|FG006|Part B|Withdrawal by Subject|0|||
164293715|NCT00626275|593447781|FG007|Part B|Withdrawal by Subject|1|||
164293716|NCT04999839|593447782|FG000|Overall Study|Adverse Event|1|||
164293717|NCT04999839|593447783|FG001|Overall Study|Adverse Event|1|||
164346493|NCT01029795|593645035|FG000|Overall Study|Physician Decision|2|||
164346494|NCT01029795|593645036|FG001|Overall Study|Physician Decision|1|||
164346495|NCT01029795|593645035|FG000|Overall Study|Sponsor Decision|11|||
164346496|NCT01029795|593645036|FG001|Overall Study|Sponsor Decision|17|||
164346497|NCT01029795|593645035|FG000|Overall Study|Withdrawal by Subject|1|||
164346498|NCT01029795|593645036|FG001|Overall Study|Withdrawal by Subject|3|||
164346499|NCT03217175|593645037|FG000|Overall Study|Physician Decision|4|||
164346500|NCT03217175|593645038|FG001|Overall Study|Physician Decision|1|||
163898017|NCT02101853|591999462|FG000|Post Induction Randomization|Death|0|||
163898018|NCT02101853|591999463|FG001|Post Induction Randomization|Death|9|||
163898019|NCT02101853|591999464|FG002|Post Induction Randomization|Death|2|||
164293718|NCT04999839|593447784|FG002|Overall Study|Adverse Event|1|||
164293719|NCT04999839|593447785|FG003|Overall Study|Adverse Event|1|||
164293720|NCT04999839|593447786|FG004|Overall Study|Adverse Event|1|||
164293721|NCT04999839|593447782|FG000|Overall Study|Lost to Follow-up|2|||
164293722|NCT04999839|593447783|FG001|Overall Study|Lost to Follow-up|0|||
164293723|NCT04999839|593447784|FG002|Overall Study|Lost to Follow-up|2|||
164293724|NCT04999839|593447785|FG003|Overall Study|Lost to Follow-up|4|||
164293725|NCT04999839|593447786|FG004|Overall Study|Lost to Follow-up|1|||
164293726|NCT04999839|593447782|FG000|Overall Study|Withdrawal by Subject|6|||
164293727|NCT04999839|593447783|FG001|Overall Study|Withdrawal by Subject|5|||
164293728|NCT04999839|593447784|FG002|Overall Study|Withdrawal by Subject|3|||
163898020|NCT02101853|591999465|FG003|Post Induction Randomization|Death|2|||
164293729|NCT04999839|593447785|FG003|Overall Study|Withdrawal by Subject|2|||
164346501|NCT00429273|593645049|FG000|Overall Study|Lost to Follow-up|1|||
164346502|NCT00429273|593645050|FG001|Overall Study|Lost to Follow-up|2|||
164346503|NCT00429273|593645051|FG002|Overall Study|Lost to Follow-up|2|||
164346504|NCT00429273|593645049|FG000|Overall Study|Physician Decision|6|||
164346505|NCT00429273|593645050|FG001|Overall Study|Physician Decision|5|||
163898021|NCT02101853|591999466|FG004|Post Induction Randomization|Death|0|||
164293730|NCT04999839|593447786|FG004|Overall Study|Withdrawal by Subject|2|||
164293731|NCT04999839|593447782|FG000|Overall Study|Lack of Efficacy|0|||
164293732|NCT04999839|593447783|FG001|Overall Study|Lack of Efficacy|1|||
164293733|NCT04999839|593447784|FG002|Overall Study|Lack of Efficacy|0|||
164293734|NCT04999839|593447785|FG003|Overall Study|Lack of Efficacy|0|||
164293735|NCT04999839|593447786|FG004|Overall Study|Lack of Efficacy|0|||
164293736|NCT04999839|593447782|FG000|Overall Study|Physician Decision|0|||
164293737|NCT04999839|593447783|FG001|Overall Study|Physician Decision|0|||
164293738|NCT04999839|593447784|FG002|Overall Study|Physician Decision|0|||
164293739|NCT04999839|593447785|FG003|Overall Study|Physician Decision|0|||
164293740|NCT04999839|593447786|FG004|Overall Study|Physician Decision|1|||
164293741|NCT04999839|593447782|FG000|Overall Study|Sponsor request|0|||
164293742|NCT04999839|593447783|FG001|Overall Study|Sponsor request|1|||
164293743|NCT04999839|593447784|FG002|Overall Study|Sponsor request|0|||
164293744|NCT04999839|593447785|FG003|Overall Study|Sponsor request|0|||
164293745|NCT04999839|593447786|FG004|Overall Study|Sponsor request|0|||
164293746|NCT04999839|593447782|FG000|Overall Study|Other|0|||
164293747|NCT04999839|593447783|FG001|Overall Study|Other|0|||
164293748|NCT04999839|593447784|FG002|Overall Study|Other|1|||
164293749|NCT04999839|593447785|FG003|Overall Study|Other|0|||
164293750|NCT04999839|593447786|FG004|Overall Study|Other|0|||
164293751|NCT01362348|593447787|FG000|Overall Study|Protocol-defined stopping criteria|9|||
164293752|NCT01362348|593447787|FG000|Overall Study|Study closed/terminated|5|||
164293753|NCT00399516|593447788|FG000|Overall Study|Lost to Follow-up|2|||
164293754|NCT01046565|593447789|FG000|Overall Study|Adverse Event|2|||
164293755|NCT01046565|593447789|FG000|Overall Study|Withdrawal by Subject|7|||
164293756|NCT00377520|593447790|FG000|Overall Study|Ineligible (Prior radiation)|1|||
164293757|NCT00292942|593447791|FG000|Overall Study|Withdrawal by Subject|0|||
164293758|NCT00292942|593447792|FG001|Overall Study|Withdrawal by Subject|0|||
164293759|NCT00292942|593447793|FG002|Overall Study|Withdrawal by Subject|1|||
164293760|NCT00292942|593447794|FG003|Overall Study|Withdrawal by Subject|0|||
164293761|NCT00292942|593447791|FG000|Overall Study|Adverse Event|0|||
164293762|NCT00292942|593447792|FG001|Overall Study|Adverse Event|0|||
164293763|NCT00292942|593447793|FG002|Overall Study|Adverse Event|0|||
164293764|NCT00292942|593447794|FG003|Overall Study|Adverse Event|1|||
164293765|NCT00644358|593447795|FG000|Overall Study|Adverse Event|124|||
164293766|NCT00644358|593447795|FG000|Overall Study|Lost to Follow-up|105|||
164293767|NCT00644358|593447795|FG000|Overall Study|Consent Withdrawal|64|||
164293768|NCT00644358|593447795|FG000|Overall Study|Lack of Effectiveness|39|||
164293769|NCT00644358|593447795|FG000|Overall Study|Protocol Violation|5|||
164293770|NCT00644358|593447795|FG000|Overall Study|Noncompliance|14|||
164293771|NCT00644358|593447795|FG000|Overall Study|Other Unspecified|11|||
164293772|NCT00651924|593447800|FG000|Overall Study|Withdrawal by PI|0|||
164293773|NCT00651924|593447801|FG001|Overall Study|Withdrawal by PI|2|||
164293774|NCT00651924|593447800|FG000|Overall Study|Withdrawal by Subject|0|||
164293775|NCT00651924|593447801|FG001|Overall Study|Withdrawal by Subject|5|||
164293776|NCT00758771|593447802|FG000|Overall Study|Withdrawal by Subject|1|||
163898022|NCT02101853|591999467|FG005|Post Induction Randomization|Death|0|||
164293777|NCT00758771|593447803|FG001|Overall Study|Withdrawal by Subject|1|||
164346506|NCT00429273|593645051|FG002|Overall Study|Physician Decision|5|||
163898023|NCT02101853|591999462|FG000|Post Induction Randomization|Lack of Efficacy|0|||
163898024|NCT02101853|591999463|FG001|Post Induction Randomization|Lack of Efficacy|14|||
163898025|NCT02101853|591999464|FG002|Post Induction Randomization|Lack of Efficacy|23|||
163898026|NCT02101853|591999465|FG003|Post Induction Randomization|Lack of Efficacy|18|||
163898027|NCT02101853|591999466|FG004|Post Induction Randomization|Lack of Efficacy|21|||
163898028|NCT02101853|591999467|FG005|Post Induction Randomization|Lack of Efficacy|0|||
163898029|NCT02101853|591999462|FG000|Post Induction Randomization|Physician Decision|0|||
163898030|NCT02101853|591999463|FG001|Post Induction Randomization|Physician Decision|43|||
163898031|NCT02101853|591999464|FG002|Post Induction Randomization|Physician Decision|23|||
163898032|NCT02101853|591999465|FG003|Post Induction Randomization|Physician Decision|14|||
164004498|NCT01982630|592380811|FG005|Overall Study|Adverse Event|2|||
164004499|NCT01982630|592380812|FG006|Overall Study|Adverse Event|1|||
164004500|NCT01982630|592380813|FG007|Overall Study|Adverse Event|0|||
164004501|NCT01982630|592380806|FG000|Overall Study|Physician Decision|1|||
164004502|NCT01982630|592380807|FG001|Overall Study|Physician Decision|0|||
164004503|NCT01982630|592380808|FG002|Overall Study|Physician Decision|2|||
164004504|NCT01982630|592380809|FG003|Overall Study|Physician Decision|1|||
164004505|NCT01982630|592380810|FG004|Overall Study|Physician Decision|2|||
164004506|NCT01982630|592380811|FG005|Overall Study|Physician Decision|0|||
164004507|NCT01982630|592380812|FG006|Overall Study|Physician Decision|0|||
164004508|NCT01982630|592380813|FG007|Overall Study|Physician Decision|0|||
164004509|NCT01982630|592380806|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164004510|NCT01982630|592380807|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164004511|NCT01982630|592380808|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
164004512|NCT01982630|592380809|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164293778|NCT00758771|593447802|FG000|Overall Study|Did not meet eligibility criteria|2|||
164293779|NCT00758771|593447803|FG001|Overall Study|Did not meet eligibility criteria|4|||
164293780|NCT00960063|593447804|FG000|Overall Study|Adverse Event|1|||
164293781|NCT00960063|593447805|FG001|Overall Study|Adverse Event|0|||
164293782|NCT00960063|593447806|FG002|Overall Study|Adverse Event|0|||
163898033|NCT02101853|591999466|FG004|Post Induction Randomization|Physician Decision|14|||
164004513|NCT01982630|592380810|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164293783|NCT00960063|593447804|FG000|Overall Study|Progression of Disease|0|||
164293784|NCT00960063|593447805|FG001|Overall Study|Progression of Disease|0|||
164293785|NCT00960063|593447806|FG002|Overall Study|Progression of Disease|3|||
164293786|NCT00625131|593447807|FG000|Overall Study|Lost to Follow-up|3|||
164088123|NCT00491504|592687356|FG001|Overall Study|Withdrawal by Subject|0|||
164088124|NCT00491504|592687357|FG002|Overall Study|Withdrawal by Subject|1|||
164088125|NCT00491504|592687358|FG003|Overall Study|Withdrawal by Subject|2|||
164088126|NCT00491504|592687355|FG000|Overall Study|Protocol Violation|0|||
164088127|NCT00491504|592687356|FG001|Overall Study|Protocol Violation|0|||
164088128|NCT00491504|592687357|FG002|Overall Study|Protocol Violation|3|||
164088129|NCT00491504|592687358|FG003|Overall Study|Protocol Violation|2|||
164088130|NCT02041702|592687363|FG000|Overall Study|Lost to Follow-up|1|||
164088131|NCT02041702|592687364|FG001|Overall Study|Lost to Follow-up|6|||
164088132|NCT02041702|592687363|FG000|Overall Study|Death|4|||
164088133|NCT02041702|592687364|FG001|Overall Study|Death|0|||
164088134|NCT02041702|592687363|FG000|Overall Study|Withdrawal by Subject|4|||
164088135|NCT02041702|592687364|FG001|Overall Study|Withdrawal by Subject|3|||
164088136|NCT02041702|592687363|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
164088137|NCT02041702|592687364|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
164088138|NCT02041702|592687363|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
164088139|NCT02041702|592687364|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
164088140|NCT00203307|592687365|FG000|First Intervention|Adverse Event|2|||
164088141|NCT00203307|592687366|FG001|First Intervention|Adverse Event|0|||
164088142|NCT03730103|592687367|FG000|Overall Study|Did not meet inclusion criteria|0|||
164088143|NCT03730103|592687368|FG001|Overall Study|Did not meet inclusion criteria|5|||
164088144|NCT02789111|592687369|FG000|Overall Study|Withdrawal by Subject|1|||
164088145|NCT02789111|592687370|FG001|Overall Study|Withdrawal by Subject|4|||
164088146|NCT02308111|592687371|FG000|Overall Study|Adverse Event|31|||
164088147|NCT02308111|592687372|FG001|Overall Study|Adverse Event|19|||
164088148|NCT02308111|592687371|FG000|Overall Study|Death|9|||
164088149|NCT02308111|592687372|FG001|Overall Study|Death|6|||
164088150|NCT02308111|592687371|FG000|Overall Study|Lost to Follow-up|2|||
164088151|NCT02308111|592687372|FG001|Overall Study|Lost to Follow-up|7|||
164088152|NCT02308111|592687371|FG000|Overall Study|Physician Decision|6|||
164088153|NCT02308111|592687372|FG001|Overall Study|Physician Decision|17|||
164088154|NCT02308111|592687371|FG000|Overall Study|Protocol Violation|0|||
164088155|NCT02308111|592687372|FG001|Overall Study|Protocol Violation|1|||
164088156|NCT02308111|592687371|FG000|Overall Study|Withdrawal by Subject|28|||
164088157|NCT02308111|592687372|FG001|Overall Study|Withdrawal by Subject|38|||
164088158|NCT02308111|592687371|FG000|Overall Study|Study Terminated by Sponsor|72|||
164088159|NCT02308111|592687372|FG001|Overall Study|Study Terminated by Sponsor|61|||
164088160|NCT02308111|592687371|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
164088161|NCT02308111|592687372|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
164088162|NCT02308111|592687371|FG000|Overall Study|Site Closure|3|||
164088163|NCT02308111|592687372|FG001|Overall Study|Site Closure|3|||
164088164|NCT02308111|592687371|FG000|Overall Study|Non-compliance with Study Drug|3|||
164088165|NCT02308111|592687372|FG001|Overall Study|Non-compliance with Study Drug|1|||
164088166|NCT02308111|592687371|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
164088167|NCT02308111|592687372|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
164088168|NCT02308111|592687371|FG000|Overall Study|Liver Transplant|3|||
164088169|NCT02308111|592687372|FG001|Overall Study|Liver Transplant|3|||
164088170|NCT02308111|592687371|FG000|Overall Study|Liver Transplant Waitlist|2|||
164088171|NCT02308111|592687372|FG001|Overall Study|Liver Transplant Waitlist|2|||
164088172|NCT02308111|592687371|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
164088173|NCT02308111|592687372|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
164088174|NCT03271528|592687374|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
164088175|NCT03271528|592687375|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
164088176|NCT03271528|592687374|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
164088177|NCT03271528|592687375|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
164088178|NCT03271528|592687374|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
164088179|NCT03271528|592687375|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
164088180|NCT03271528|592687374|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
164088181|NCT03271528|592687375|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
164088182|NCT03271528|592687374|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
164088183|NCT03271528|592687375|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
164088184|NCT03271528|592687374|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
164088185|NCT03271528|592687375|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
164088186|NCT03271528|592687374|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
164088187|NCT03271528|592687375|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
164088188|NCT03977584|592687378|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
164088189|NCT03977584|592687379|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
164088190|NCT03977584|592687380|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
164088191|NCT02257736|592687384|FG000|Overall Study|Progressive disease|365|||
164088192|NCT02257736|592687385|FG001|Overall Study|Progressive disease|327|||
164088193|NCT02257736|592687384|FG000|Overall Study|Adverse Event|45|||
164088194|NCT02257736|592687385|FG001|Overall Study|Adverse Event|56|||
164088195|NCT02257736|592687384|FG000|Overall Study|Withdrawal by Subject|21|||
164088196|NCT02257736|592687385|FG001|Overall Study|Withdrawal by Subject|38|||
164088197|NCT02257736|592687384|FG000|Overall Study|Death|11|||
164088198|NCT02257736|592687385|FG001|Overall Study|Death|6|||
164088199|NCT02257736|592687384|FG000|Overall Study|Physician Decision|5|||
164088200|NCT02257736|592687385|FG001|Overall Study|Physician Decision|9|||
164088201|NCT02257736|592687384|FG000|Overall Study|Non-Compliance with study drug|1|||
164088202|NCT02257736|592687385|FG001|Overall Study|Non-Compliance with study drug|2|||
164088203|NCT02257736|592687384|FG000|Overall Study|Protocol Violation|1|||
164088204|NCT02257736|592687385|FG001|Overall Study|Protocol Violation|0|||
164088205|NCT02257736|592687384|FG000|Overall Study|Other|1|||
164088206|NCT02257736|592687385|FG001|Overall Study|Other|7|||
164088207|NCT02257736|592687384|FG000|Overall Study|Randomized, not treated|1|||
164088208|NCT02257736|592687385|FG001|Overall Study|Randomized, not treated|2|||
164088209|NCT00745251|592687386|FG000|Overall Study|Adverse Event|1|||
164088210|NCT00745251|592687387|FG001|Overall Study|Adverse Event|2|||
164088211|NCT00745251|592687386|FG000|Overall Study|Withdrawal by Subject|1|||
164088212|NCT00745251|592687387|FG001|Overall Study|Withdrawal by Subject|1|||
164088213|NCT01618305|592687388|FG000|Overall Study|Death|0|||
164088214|NCT01618305|592687389|FG001|Overall Study|Death|1|||
164088215|NCT01618305|592687388|FG000|Overall Study|Lost to Follow-up|11|||
164088216|NCT01618305|592687389|FG001|Overall Study|Lost to Follow-up|7|||
164088217|NCT01618305|592687388|FG000|Overall Study|Protocol Violation|1|||
164088218|NCT01618305|592687389|FG001|Overall Study|Protocol Violation|0|||
164088219|NCT01618305|592687388|FG000|Overall Study|Withdrawal by Subject|3|||
164088220|NCT01618305|592687389|FG001|Overall Study|Withdrawal by Subject|2|||
164088221|NCT01565083|592687390|FG000|Overall Study|Withdrawal by Subject|6|||
164088222|NCT01565083|592687391|FG001|Overall Study|Withdrawal by Subject|4|||
164088223|NCT01565083|592687390|FG000|Overall Study|Lost to Follow-up|2|||
164088224|NCT01565083|592687391|FG001|Overall Study|Lost to Follow-up|7|||
164088225|NCT01565083|592687390|FG000|Overall Study|Death|22|||
164088226|NCT01565083|592687391|FG001|Overall Study|Death|23|||
164088227|NCT01565083|592687390|FG000|Overall Study|Other|3|||
164088228|NCT01565083|592687391|FG001|Overall Study|Other|5|||
164088229|NCT01118728|592687392|FG000|Overall Study|Adverse Event|17|||
164088230|NCT01118728|592687392|FG000|Overall Study|Lack of Efficacy|27|||
164088231|NCT01118728|592687392|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
164088232|NCT01118728|592687392|FG000|Overall Study|Withdrawal by Subject|3|||
164088233|NCT01118728|592687392|FG000|Overall Study|Lost to Follow-up|4|||
164088234|NCT01309919|592687396|FG000|Overall Study|Did not receive a postpartum IUD|17|||
164088235|NCT01309919|592687397|FG001|Overall Study|Did not receive a postpartum IUD|48|||
164088236|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
164088237|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
164088238|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
164088239|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
164088240|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
164088241|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
164088242|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
164088243|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
164088244|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
164088245|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
164088246|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
164088247|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
164088248|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
164088249|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
164088250|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
164088251|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
164088252|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
164088253|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
164088254|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
164088255|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
164088256|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
164088257|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
164088258|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
164088259|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
164088260|NCT00455533|592687398|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
164088261|NCT00455533|592687399|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
164088262|NCT00455533|592687400|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
164088263|NCT00455533|592687398|FG000|Period Two: Randomized Period|Death|0|||
164088264|NCT00455533|592687399|FG001|Period Two: Randomized Period|Death|0|||
164088265|NCT00455533|592687400|FG002|Period Two: Randomized Period|Death|3|||
164293787|NCT00625131|593447808|FG001|Overall Study|Lost to Follow-up|2|||
164293788|NCT00625131|593447809|FG002|Overall Study|Lost to Follow-up|0|||
164293789|NCT00625131|593447807|FG000|Overall Study|Withdrawal by Subject|1|||
164293790|NCT00625131|593447808|FG001|Overall Study|Withdrawal by Subject|0|||
164293791|NCT00625131|593447809|FG002|Overall Study|Withdrawal by Subject|5|||
164293792|NCT05083351|593447815|FG000|Overall Study|Adverse Event|3|||
164293793|NCT05083351|593447815|FG000|Overall Study|Did not meet data inclusion criteria|8|||
164293794|NCT05083351|593447815|FG000|Overall Study|Did not meet eligibility criteria|19|||
164293795|NCT05083351|593447815|FG000|Overall Study|Study Staff Decision|19|||
164293796|NCT02051764|593447823|FG000|Overall Study|Study terminated by sponsor|0|||
164293797|NCT02051764|593447824|FG001|Overall Study|Study terminated by sponsor|7|||
164293798|NCT00591006|593447825|FG000|Overall Study|Withdrawal by Subject|0|||
164293799|NCT00591006|593447826|FG001|Overall Study|Withdrawal by Subject|0|||
164293800|NCT00591006|593447827|FG002|Overall Study|Withdrawal by Subject|0|||
164293801|NCT00591006|593447828|FG003|Overall Study|Withdrawal by Subject|0|||
164293802|NCT00591006|593447829|FG004|Overall Study|Withdrawal by Subject|0|||
164293803|NCT00591006|593447830|FG005|Overall Study|Withdrawal by Subject|0|||
164293804|NCT00591006|593447831|FG006|Overall Study|Withdrawal by Subject|0|||
164293805|NCT00591006|593447832|FG007|Overall Study|Withdrawal by Subject|0|||
164293806|NCT00591006|593447833|FG008|Overall Study|Withdrawal by Subject|0|||
164293807|NCT00591006|593447834|FG009|Overall Study|Withdrawal by Subject|0|||
164293808|NCT00591006|593447835|FG010|Overall Study|Withdrawal by Subject|0|||
164293809|NCT00591006|593447836|FG011|Overall Study|Withdrawal by Subject|0|||
164293810|NCT00591006|593447837|FG012|Overall Study|Withdrawal by Subject|0|||
164293811|NCT00591006|593447838|FG013|Overall Study|Withdrawal by Subject|0|||
164293812|NCT00591006|593447839|FG014|Overall Study|Withdrawal by Subject|0|||
164293813|NCT00591006|593447840|FG015|Overall Study|Withdrawal by Subject|1|||
164293814|NCT00591006|593447841|FG016|Overall Study|Withdrawal by Subject|0|||
164346507|NCT00429273|593645049|FG000|Overall Study|Adverse Event|1|||
164346508|NCT00429273|593645050|FG001|Overall Study|Adverse Event|1|||
164346509|NCT00429273|593645051|FG002|Overall Study|Adverse Event|2|||
164346510|NCT01218204|593645056|FG000|Part B Washout|Adverse Event|0|||
164346511|NCT01218204|593645057|FG001|Part B Washout|Adverse Event|1|||
164346512|NCT01218204|593645058|FG002|Part B Washout|Adverse Event|0|||
164346513|NCT01218204|593645059|FG003|Part B Washout|Adverse Event|0|||
163898034|NCT02101853|591999467|FG005|Post Induction Randomization|Physician Decision|0|||
163898035|NCT02101853|591999462|FG000|Post Induction Randomization|Protocol Violation|0|||
163898036|NCT02101853|591999463|FG001|Post Induction Randomization|Protocol Violation|3|||
164293815|NCT00591006|593447842|FG017|Overall Study|Withdrawal by Subject|0|||
164293816|NCT00591006|593447843|FG018|Overall Study|Withdrawal by Subject|0|||
164293817|NCT00591006|593447844|FG019|Overall Study|Withdrawal by Subject|0|||
163898037|NCT02101853|591999464|FG002|Post Induction Randomization|Protocol Violation|0|||
163898038|NCT02101853|591999465|FG003|Post Induction Randomization|Protocol Violation|0|||
163898039|NCT02101853|591999466|FG004|Post Induction Randomization|Protocol Violation|0|||
163898040|NCT02101853|591999467|FG005|Post Induction Randomization|Protocol Violation|0|||
163898041|NCT02101853|591999462|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
163898042|NCT02101853|591999463|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
163898043|NCT02101853|591999464|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
163898044|NCT02101853|591999465|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
163898045|NCT02101853|591999466|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
163898046|NCT02101853|591999467|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
163898047|NCT02101853|591999462|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898048|NCT02101853|591999463|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898049|NCT02101853|591999464|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898050|NCT02101853|591999465|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
163898051|NCT02101853|591999466|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898052|NCT02101853|591999467|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
163898053|NCT02101853|591999462|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163898054|NCT02101853|591999463|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
163898055|NCT02101853|591999464|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
163898056|NCT02101853|591999465|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163898057|NCT02101853|591999466|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
164293818|NCT00591006|593447845|FG020|Overall Study|Withdrawal by Subject|0|||
164293819|NCT00591006|593447846|FG021|Overall Study|Withdrawal by Subject|0|||
164293820|NCT00591006|593447847|FG022|Overall Study|Withdrawal by Subject|0|||
164293821|NCT00591006|593447848|FG023|Overall Study|Withdrawal by Subject|1|||
164346514|NCT01218204|593645056|FG000|Part B Washout|Lost to Follow-up|0|||
164346515|NCT01218204|593645057|FG001|Part B Washout|Lost to Follow-up|2|||
164346516|NCT01218204|593645058|FG002|Part B Washout|Lost to Follow-up|0|||
164293822|NCT00591006|593447825|FG000|Overall Study|Adverse Event|0|||
164293823|NCT00591006|593447826|FG001|Overall Study|Adverse Event|0|||
164293824|NCT00591006|593447827|FG002|Overall Study|Adverse Event|0|||
163898058|NCT02101853|591999467|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
163898059|NCT02101853|591999462|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
164004514|NCT01982630|592380811|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
163898060|NCT02101853|591999463|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
163898061|NCT02101853|591999464|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163898062|NCT02101853|591999465|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163898063|NCT02101853|591999466|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163898064|NCT02101853|591999467|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
163898065|NCT02101853|591999462|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
163898066|NCT02101853|591999463|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
163898067|NCT02101853|591999464|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
163898068|NCT02101853|591999465|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
163898069|NCT02101853|591999466|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
163898070|NCT02101853|591999467|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
163898071|NCT02101853|591999462|FG000|Blinatumomab Salvage Therapy|Death|0|||
163898072|NCT02101853|591999463|FG001|Blinatumomab Salvage Therapy|Death|0|||
163898073|NCT02101853|591999464|FG002|Blinatumomab Salvage Therapy|Death|0|||
163898074|NCT02101853|591999465|FG003|Blinatumomab Salvage Therapy|Death|0|||
163898075|NCT02101853|591999466|FG004|Blinatumomab Salvage Therapy|Death|0|||
164004515|NCT01982630|592380812|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164004516|NCT01982630|592380813|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
164004517|NCT01982630|592380806|FG000|Overall Study|Withdrawal by Subject|0|||
164004518|NCT01982630|592380807|FG001|Overall Study|Withdrawal by Subject|0|||
164004519|NCT01982630|592380808|FG002|Overall Study|Withdrawal by Subject|0|||
164004520|NCT01982630|592380809|FG003|Overall Study|Withdrawal by Subject|0|||
164004521|NCT01982630|592380810|FG004|Overall Study|Withdrawal by Subject|0|||
164004522|NCT01982630|592380811|FG005|Overall Study|Withdrawal by Subject|1|||
164004523|NCT01982630|592380812|FG006|Overall Study|Withdrawal by Subject|0|||
164004524|NCT01982630|592380813|FG007|Overall Study|Withdrawal by Subject|0|||
164004525|NCT01076179|592380814|FG000|Overall Study|Withdrawal by Subject|1|||
164004526|NCT00986349|592380815|FG000|Overall Study|Unsuccessful implant procedure|3|||
164004527|NCT00986349|592380815|FG000|Overall Study|Adverse Event|2|||
164004528|NCT00986349|592380815|FG000|Overall Study|Physician Decision|1|||
164004529|NCT00986349|592380815|FG000|Overall Study|device migration|1|||
164293825|NCT00591006|593447828|FG003|Overall Study|Adverse Event|0|||
164293826|NCT00591006|593447829|FG004|Overall Study|Adverse Event|0|||
164293827|NCT00591006|593447830|FG005|Overall Study|Adverse Event|0|||
164293828|NCT00591006|593447831|FG006|Overall Study|Adverse Event|0|||
164293829|NCT00591006|593447832|FG007|Overall Study|Adverse Event|0|||
164293830|NCT00591006|593447833|FG008|Overall Study|Adverse Event|0|||
164293831|NCT00591006|593447834|FG009|Overall Study|Adverse Event|0|||
164346517|NCT01218204|593645059|FG003|Part B Washout|Lost to Follow-up|0|||
164346518|NCT01218204|593645056|FG000|Part B Washout|Physician Decision|0|||
164346519|NCT01218204|593645057|FG001|Part B Washout|Physician Decision|14|||
164346520|NCT01218204|593645058|FG002|Part B Washout|Physician Decision|0|||
164346521|NCT01218204|593645059|FG003|Part B Washout|Physician Decision|0|||
164346522|NCT01218204|593645056|FG000|Part B Washout|Withdrawal by Subject|0|||
164346523|NCT01218204|593645057|FG001|Part B Washout|Withdrawal by Subject|14|||
164346524|NCT01218204|593645058|FG002|Part B Washout|Withdrawal by Subject|0|||
164346525|NCT01218204|593645059|FG003|Part B Washout|Withdrawal by Subject|0|||
164346526|NCT01218204|593645056|FG000|Part B Washout|Reached defined stopping criteria|0|||
164346527|NCT01218204|593645057|FG001|Part B Washout|Reached defined stopping criteria|2|||
164346528|NCT01218204|593645058|FG002|Part B Washout|Reached defined stopping criteria|0|||
164346529|NCT01218204|593645059|FG003|Part B Washout|Reached defined stopping criteria|0|||
164346530|NCT01218204|593645056|FG000|Part B Washout|Did not meet continuation criteria|0|||
164346531|NCT01218204|593645057|FG001|Part B Washout|Did not meet continuation criteria|112|||
164346532|NCT01218204|593645058|FG002|Part B Washout|Did not meet continuation criteria|0|||
164346533|NCT01218204|593645059|FG003|Part B Washout|Did not meet continuation criteria|0|||
164346534|NCT01218204|593645056|FG000|Part B Run-in|Adverse Event|0|||
164346535|NCT01218204|593645057|FG001|Part B Run-in|Adverse Event|0|||
164346536|NCT01218204|593645058|FG002|Part B Run-in|Adverse Event|1|||
164346537|NCT01218204|593645059|FG003|Part B Run-in|Adverse Event|0|||
164346538|NCT01218204|593645056|FG000|Part B Run-in|Protocol Violation|0|||
164004530|NCT02299934|592380816|FG000|Overall Study|Termination of study|13|||
164293832|NCT00591006|593447835|FG010|Overall Study|Adverse Event|0|||
164293833|NCT00591006|593447836|FG011|Overall Study|Adverse Event|0|||
164346539|NCT01218204|593645057|FG001|Part B Run-in|Protocol Violation|0|||
164346540|NCT01218204|593645058|FG002|Part B Run-in|Protocol Violation|2|||
164293834|NCT00591006|593447837|FG012|Overall Study|Adverse Event|0|||
164293835|NCT00591006|593447838|FG013|Overall Study|Adverse Event|0|||
164293836|NCT00591006|593447839|FG014|Overall Study|Adverse Event|0|||
164293837|NCT00591006|593447840|FG015|Overall Study|Adverse Event|0|||
164293838|NCT00591006|593447841|FG016|Overall Study|Adverse Event|0|||
164293839|NCT00591006|593447842|FG017|Overall Study|Adverse Event|0|||
164293840|NCT00591006|593447843|FG018|Overall Study|Adverse Event|0|||
164293841|NCT00591006|593447844|FG019|Overall Study|Adverse Event|0|||
164293842|NCT00591006|593447845|FG020|Overall Study|Adverse Event|0|||
164293843|NCT00591006|593447846|FG021|Overall Study|Adverse Event|0|||
164293844|NCT00591006|593447847|FG022|Overall Study|Adverse Event|1|||
164293845|NCT00591006|593447848|FG023|Overall Study|Adverse Event|0|||
164293846|NCT02898454|593447849|FG000|Overall Study|Adverse Event|4|||
164293847|NCT02898454|593447850|FG001|Overall Study|Adverse Event|1|||
164293848|NCT02898454|593447851|FG002|Overall Study|Adverse Event|2|||
164293849|NCT02898454|593447849|FG000|Overall Study|Protocol Violation|1|||
164293850|NCT02898454|593447850|FG001|Overall Study|Protocol Violation|0|||
164293851|NCT02898454|593447851|FG002|Overall Study|Protocol Violation|1|||
164293852|NCT02898454|593447849|FG000|Overall Study|Lack of Efficacy|4|||
164293853|NCT02898454|593447850|FG001|Overall Study|Lack of Efficacy|1|||
164293854|NCT02898454|593447851|FG002|Overall Study|Lack of Efficacy|0|||
164293855|NCT02898454|593447849|FG000|Overall Study|Withdrawal by Subject|6|||
164293856|NCT02898454|593447850|FG001|Overall Study|Withdrawal by Subject|3|||
164293857|NCT02898454|593447851|FG002|Overall Study|Withdrawal by Subject|3|||
164293858|NCT02898454|593447849|FG000|Overall Study|Lost to Follow-up|1|||
164293859|NCT02898454|593447850|FG001|Overall Study|Lost to Follow-up|0|||
164293860|NCT02898454|593447851|FG002|Overall Study|Lost to Follow-up|0|||
164293861|NCT02898454|593447849|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
164293862|NCT02898454|593447850|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
164293863|NCT02898454|593447851|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
164293864|NCT03040141|593447852|FG000|Overall Study|Death|1|||
164293865|NCT03040141|593447853|FG001|Overall Study|Death|2|||
164293866|NCT03040141|593447854|FG002|Overall Study|Death|3|||
164293867|NCT03040141|593447852|FG000|Overall Study|Withdrawal by Subject|3|||
164293868|NCT03040141|593447853|FG001|Overall Study|Withdrawal by Subject|1|||
164293869|NCT03040141|593447854|FG002|Overall Study|Withdrawal by Subject|1|||
164293870|NCT03040141|593447852|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
164293871|NCT03040141|593447853|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
164293872|NCT03040141|593447854|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
164293873|NCT03040141|593447852|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
164293874|NCT03040141|593447853|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
164293875|NCT03040141|593447854|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
164293876|NCT01384734|593447856|FG000|Overall Study|Adverse Event|0|||
164293877|NCT01384734|593447857|FG001|Overall Study|Adverse Event|3|||
164293878|NCT01384734|593447858|FG002|Overall Study|Adverse Event|0|||
164293879|NCT01384734|593447859|FG003|Overall Study|Adverse Event|2|||
164293880|NCT01384734|593447860|FG004|Overall Study|Adverse Event|7|||
164293881|NCT01384734|593447856|FG000|Overall Study|Death|1|||
164293882|NCT01384734|593447857|FG001|Overall Study|Death|0|||
164293883|NCT01384734|593447858|FG002|Overall Study|Death|1|||
164293884|NCT01384734|593447859|FG003|Overall Study|Death|0|||
164293885|NCT01384734|593447860|FG004|Overall Study|Death|0|||
164293886|NCT01384734|593447856|FG000|Overall Study|Continuation criteria not met|0|||
164293887|NCT01384734|593447857|FG001|Overall Study|Continuation criteria not met|0|||
164293888|NCT01384734|593447858|FG002|Overall Study|Continuation criteria not met|1|||
164293889|NCT01384734|593447859|FG003|Overall Study|Continuation criteria not met|1|||
164293890|NCT01384734|593447860|FG004|Overall Study|Continuation criteria not met|0|||
164293891|NCT01384734|593447856|FG000|Overall Study|Lack of Efficacy|3|||
164293892|NCT01384734|593447857|FG001|Overall Study|Lack of Efficacy|7|||
164293893|NCT01384734|593447858|FG002|Overall Study|Lack of Efficacy|4|||
164088266|NCT00455533|592687398|FG000|Period Two: Randomized Period|Disease Progression|0|||
164293894|NCT01384734|593447859|FG003|Overall Study|Lack of Efficacy|4|||
164293895|NCT01384734|593447860|FG004|Overall Study|Lack of Efficacy|2|||
164293896|NCT01384734|593447856|FG000|Overall Study|Lost to Follow-up|5|||
164293897|NCT01384734|593447857|FG001|Overall Study|Lost to Follow-up|3|||
164293898|NCT01384734|593447858|FG002|Overall Study|Lost to Follow-up|3|||
164293899|NCT01384734|593447859|FG003|Overall Study|Lost to Follow-up|8|||
164293900|NCT01384734|593447860|FG004|Overall Study|Lost to Follow-up|5|||
164293901|NCT01384734|593447856|FG000|Overall Study|Non-compliance with study drug|1|||
163898076|NCT02101853|591999467|FG005|Blinatumomab Salvage Therapy|Death|2|||
163898077|NCT02101853|591999462|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163898078|NCT02101853|591999463|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163898079|NCT02101853|591999464|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
164088267|NCT00455533|592687399|FG001|Period Two: Randomized Period|Disease Progression|1|||
164293902|NCT01384734|593447857|FG001|Overall Study|Non-compliance with study drug|2|||
164346541|NCT01218204|593645059|FG003|Part B Run-in|Protocol Violation|0|||
164293903|NCT01384734|593447858|FG002|Overall Study|Non-compliance with study drug|6|||
164293904|NCT01384734|593447859|FG003|Overall Study|Non-compliance with study drug|0|||
164293905|NCT01384734|593447860|FG004|Overall Study|Non-compliance with study drug|2|||
164293906|NCT01384734|593447856|FG000|Overall Study|Pregnancy|0|||
164293907|NCT01384734|593447857|FG001|Overall Study|Pregnancy|1|||
164293908|NCT01384734|593447858|FG002|Overall Study|Pregnancy|0|||
164293909|NCT01384734|593447859|FG003|Overall Study|Pregnancy|0|||
164293910|NCT01384734|593447860|FG004|Overall Study|Pregnancy|1|||
164293911|NCT01384734|593447856|FG000|Overall Study|Sponsor terminated|0|||
164293912|NCT01384734|593447857|FG001|Overall Study|Sponsor terminated|0|||
164293913|NCT01384734|593447858|FG002|Overall Study|Sponsor terminated|0|||
164293914|NCT01384734|593447859|FG003|Overall Study|Sponsor terminated|0|||
164293915|NCT01384734|593447860|FG004|Overall Study|Sponsor terminated|1|||
164293916|NCT01384734|593447856|FG000|Overall Study|Withdrawal by Subject|5|||
164293917|NCT01384734|593447857|FG001|Overall Study|Withdrawal by Subject|5|||
164293918|NCT01384734|593447858|FG002|Overall Study|Withdrawal by Subject|6|||
164293919|NCT01384734|593447859|FG003|Overall Study|Withdrawal by Subject|7|||
164293920|NCT01384734|593447860|FG004|Overall Study|Withdrawal by Subject|9|||
164293921|NCT01384734|593447856|FG000|Overall Study|Investigator relocating|0|||
164293922|NCT01384734|593447857|FG001|Overall Study|Investigator relocating|2|||
164293923|NCT01384734|593447858|FG002|Overall Study|Investigator relocating|0|||
164293924|NCT01384734|593447859|FG003|Overall Study|Investigator relocating|3|||
164293925|NCT01384734|593447860|FG004|Overall Study|Investigator relocating|1|||
164293926|NCT01384734|593447856|FG000|Overall Study|Unable to come back for visit|1|||
163898080|NCT02101853|591999465|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163898081|NCT02101853|591999466|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
163898082|NCT02101853|591999467|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
163898083|NCT02101853|591999462|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
163898084|NCT02101853|591999463|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
164293927|NCT01384734|593447857|FG001|Overall Study|Unable to come back for visit|0|||
164293928|NCT01384734|593447858|FG002|Overall Study|Unable to come back for visit|1|||
164293929|NCT01384734|593447859|FG003|Overall Study|Unable to come back for visit|1|||
164293930|NCT01384734|593447860|FG004|Overall Study|Unable to come back for visit|0|||
163898085|NCT02101853|591999464|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
163898086|NCT02101853|591999465|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
163898087|NCT02101853|591999466|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
163898088|NCT02101853|591999467|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
163898089|NCT02101853|591999462|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163898090|NCT02101853|591999463|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163898091|NCT02101853|591999464|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163898092|NCT02101853|591999465|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163898093|NCT02101853|591999466|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
163898094|NCT02101853|591999467|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
163898095|NCT02112916|591999468|FG000|Overall Study|Adverse Event|6|||
163898096|NCT02112916|591999469|FG001|Overall Study|Adverse Event|9|||
164293931|NCT01384734|593447856|FG000|Overall Study|Prison|0|||
164293932|NCT01384734|593447857|FG001|Overall Study|Prison|0|||
164293933|NCT01384734|593447858|FG002|Overall Study|Prison|1|||
164293934|NCT01384734|593447859|FG003|Overall Study|Prison|0|||
164293935|NCT01384734|593447860|FG004|Overall Study|Prison|0|||
164293936|NCT01384734|593447856|FG000|Overall Study|As per Exclusion criteria|0|||
164293937|NCT01384734|593447857|FG001|Overall Study|As per Exclusion criteria|1|||
164293938|NCT01384734|593447858|FG002|Overall Study|As per Exclusion criteria|0|||
164293939|NCT01384734|593447859|FG003|Overall Study|As per Exclusion criteria|0|||
164293940|NCT01384734|593447860|FG004|Overall Study|As per Exclusion criteria|0|||
164293941|NCT01384734|593447856|FG000|Overall Study|Missed End of treatment visit|0|||
164293942|NCT01384734|593447857|FG001|Overall Study|Missed End of treatment visit|0|||
164293943|NCT01384734|593447858|FG002|Overall Study|Missed End of treatment visit|0|||
164293944|NCT01384734|593447859|FG003|Overall Study|Missed End of treatment visit|1|||
164293945|NCT01384734|593447860|FG004|Overall Study|Missed End of treatment visit|0|||
164293946|NCT01384734|593447856|FG000|Overall Study|Adhesion problem|0|||
164293947|NCT01384734|593447857|FG001|Overall Study|Adhesion problem|0|||
164293948|NCT01384734|593447858|FG002|Overall Study|Adhesion problem|0|||
164293949|NCT01384734|593447859|FG003|Overall Study|Adhesion problem|1|||
164293950|NCT01384734|593447860|FG004|Overall Study|Adhesion problem|0|||
164293951|NCT01384734|593447856|FG000|Overall Study|Early termination|0|||
164293952|NCT01384734|593447857|FG001|Overall Study|Early termination|0|||
164293953|NCT01384734|593447858|FG002|Overall Study|Early termination|0|||
164293954|NCT01384734|593447859|FG003|Overall Study|Early termination|0|||
164293955|NCT01384734|593447860|FG004|Overall Study|Early termination|1|||
164293956|NCT01384734|593447856|FG000|Overall Study|Physician Decision|1|||
164293957|NCT01384734|593447857|FG001|Overall Study|Physician Decision|0|||
164088268|NCT00455533|592687400|FG002|Period Two: Randomized Period|Disease Progression|1|||
164088269|NCT00455533|592687398|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
164088270|NCT00455533|592687399|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
164088271|NCT00455533|592687400|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
164088272|NCT00455533|592687398|FG000|Period Two: Randomized Period|Other - need reasons|0|||
164088273|NCT00455533|592687399|FG001|Period Two: Randomized Period|Other - need reasons|1|||
164088274|NCT00455533|592687400|FG002|Period Two: Randomized Period|Other - need reasons|0|||
164088275|NCT00455533|592687398|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
164088276|NCT00455533|592687399|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
164088277|NCT00455533|592687400|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
164088278|NCT00455533|592687398|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
164088279|NCT00455533|592687399|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
164088280|NCT00455533|592687400|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
164088281|NCT01896297|592687401|FG000|Overall Study|Died in post treatment phase|1|||
164088282|NCT02415959|592687402|FG000|Overall Study|Adverse Event|0|||
164088283|NCT02415959|592687403|FG001|Overall Study|Adverse Event|1|||
164088284|NCT02415959|592687404|FG002|Overall Study|Adverse Event|0|||
164088285|NCT02415959|592687405|FG003|Overall Study|Adverse Event|0|||
164088286|NCT02415959|592687406|FG004|Overall Study|Adverse Event|0|||
164088287|NCT02415959|592687402|FG000|Overall Study|Protocol Violation|0|||
164088288|NCT02415959|592687403|FG001|Overall Study|Protocol Violation|0|||
164088289|NCT02415959|592687404|FG002|Overall Study|Protocol Violation|0|||
164088290|NCT02415959|592687405|FG003|Overall Study|Protocol Violation|1|||
164088291|NCT02415959|592687406|FG004|Overall Study|Protocol Violation|0|||
164088292|NCT00003782|592687409|FG000|Overall Study|No follow up data|30|||
164088293|NCT00003782|592687410|FG001|Overall Study|No follow up data|31|||
164088294|NCT00003782|592687411|FG002|Overall Study|No follow up data|26|||
164088295|NCT03626857|592687420|FG000|Overall Study|Adverse Event|9|||
164088296|NCT03626857|592687421|FG001|Overall Study|Adverse Event|7|||
164088297|NCT03626857|592687420|FG000|Overall Study|Lost to Follow-up|8|||
164088298|NCT03626857|592687421|FG001|Overall Study|Lost to Follow-up|8|||
164088299|NCT03626857|592687420|FG000|Overall Study|Withdrawal by Subject|2|||
164088300|NCT03626857|592687421|FG001|Overall Study|Withdrawal by Subject|2|||
164088301|NCT03626857|592687420|FG000|Overall Study|Protocol Violation|1|||
164088302|NCT03626857|592687421|FG001|Overall Study|Protocol Violation|3|||
164088303|NCT01301833|592687422|FG000|Overall Study|Adverse Event|7|||
164088304|NCT01301833|592687423|FG001|Overall Study|Adverse Event|5|||
164088305|NCT01301833|592687424|FG002|Overall Study|Adverse Event|5|||
164088306|NCT01301833|592687425|FG003|Overall Study|Adverse Event|5|||
164088307|NCT01301833|592687422|FG000|Overall Study|Lack of Efficacy|1|||
164088308|NCT01301833|592687423|FG001|Overall Study|Lack of Efficacy|1|||
164088309|NCT01301833|592687424|FG002|Overall Study|Lack of Efficacy|0|||
164088310|NCT01301833|592687425|FG003|Overall Study|Lack of Efficacy|0|||
164088311|NCT01301833|592687422|FG000|Overall Study|Physician Decision|3|||
164088312|NCT01301833|592687423|FG001|Overall Study|Physician Decision|1|||
164088313|NCT01301833|592687424|FG002|Overall Study|Physician Decision|1|||
164088314|NCT01301833|592687425|FG003|Overall Study|Physician Decision|0|||
164088315|NCT01301833|592687422|FG000|Overall Study|Withdrawal by Subject|3|||
164088316|NCT01301833|592687423|FG001|Overall Study|Withdrawal by Subject|1|||
164088317|NCT01301833|592687424|FG002|Overall Study|Withdrawal by Subject|1|||
164088318|NCT01301833|592687425|FG003|Overall Study|Withdrawal by Subject|2|||
164088319|NCT01301833|592687422|FG000|Overall Study|Personal matter|1|||
164088320|NCT01301833|592687423|FG001|Overall Study|Personal matter|0|||
164088321|NCT01301833|592687424|FG002|Overall Study|Personal matter|0|||
164088322|NCT01301833|592687425|FG003|Overall Study|Personal matter|0|||
164293958|NCT01384734|593447858|FG002|Overall Study|Physician Decision|0|||
164293959|NCT01384734|593447859|FG003|Overall Study|Physician Decision|0|||
164293960|NCT01384734|593447860|FG004|Overall Study|Physician Decision|0|||
164293961|NCT01290523|593447861|FG000|Overall Study|Death|3|||
164293962|NCT03071263|593447862|FG000|Overall Study|Adverse Event|1|||
164293963|NCT03071263|593447863|FG001|Overall Study|Adverse Event|3|||
164293964|NCT03071263|593447862|FG000|Overall Study|Withdrawal by Subject|1|||
164293965|NCT03071263|593447863|FG001|Overall Study|Withdrawal by Subject|3|||
164293966|NCT03071263|593447862|FG000|Overall Study|Physician Decision|1|||
164293967|NCT03071263|593447863|FG001|Overall Study|Physician Decision|0|||
164346542|NCT01218204|593645056|FG000|Part B Run-in|Withdrawal by Subject|0|||
164293968|NCT03071263|593447862|FG000|Overall Study|Participant moved to another city|0|||
164088323|NCT02178709|592688793|FG000|Overall Study|Adverse Event|5|||
164088324|NCT02178709|592688793|FG000|Overall Study|Death|2|||
164088325|NCT02178709|592688793|FG000|Overall Study|Withdrawal by Subject|2|||
164293969|NCT03071263|593447863|FG001|Overall Study|Participant moved to another city|1|||
164088326|NCT02178709|592688793|FG000|Overall Study|Physician Decision|2|||
164088327|NCT02178709|592688793|FG000|Overall Study|Disease Progression|5|||
164088328|NCT01402908|592688796|FG000|Overall Study|Withdrawal by Subject|30|||
164088329|NCT01402908|592688797|FG001|Overall Study|Withdrawal by Subject|17|||
164088330|NCT01402908|592688796|FG000|Overall Study|Lost to Follow-up|3|||
164293970|NCT02922725|593447865|FG000|Overall Study|Withdrawal by Subject|1|||
163898097|NCT02112916|591999470|FG002|Overall Study|Adverse Event|3|||
163898098|NCT02112916|591999471|FG003|Overall Study|Adverse Event|2|||
163898099|NCT02112916|591999468|FG000|Overall Study|Death|9|||
163898100|NCT02112916|591999469|FG001|Overall Study|Death|9|||
164293971|NCT02922725|593447866|FG001|Overall Study|Withdrawal by Subject|0|||
164293972|NCT02922725|593447867|FG002|Overall Study|Withdrawal by Subject|0|||
164293973|NCT05148234|593447871|FG000|Phase I|Ineligible|0|||
164293974|NCT05148234|593447872|FG001|Phase I|Ineligible|0|||
164293975|NCT05148234|593447873|FG002|Phase I|Ineligible|0|||
164293976|NCT05148234|593447874|FG003|Phase I|Ineligible|0|||
164293977|NCT05148234|593447875|FG004|Phase I|Ineligible|0|||
164293978|NCT05148234|593447876|FG005|Phase I|Ineligible|0|||
164293979|NCT05148234|593447877|FG006|Phase I|Ineligible|0|||
164293980|NCT05148234|593447878|FG007|Phase I|Ineligible|1|||
164293981|NCT05148234|593447871|FG000|Phase I|Company closed the trial.|0|||
164293982|NCT05148234|593447872|FG001|Phase I|Company closed the trial.|1|||
163898101|NCT02112916|591999470|FG002|Overall Study|Death|3|||
163898102|NCT02112916|591999471|FG003|Overall Study|Death|4|||
163898103|NCT02112916|591999468|FG000|Overall Study|Lost to Follow-up|1|||
163898104|NCT02112916|591999469|FG001|Overall Study|Lost to Follow-up|0|||
163898105|NCT02112916|591999470|FG002|Overall Study|Lost to Follow-up|0|||
163898106|NCT02112916|591999471|FG003|Overall Study|Lost to Follow-up|0|||
163898107|NCT02112916|591999468|FG000|Overall Study|Physician Decision|94|||
163898108|NCT02112916|591999469|FG001|Overall Study|Physician Decision|72|||
163898109|NCT02112916|591999470|FG002|Overall Study|Physician Decision|24|||
163898110|NCT02112916|591999471|FG003|Overall Study|Physician Decision|15|||
164088331|NCT01402908|592688797|FG001|Overall Study|Lost to Follow-up|1|||
164088332|NCT01402908|592688796|FG000|Overall Study|Physician Decision|1|||
164088333|NCT01402908|592688797|FG001|Overall Study|Physician Decision|0|||
164088334|NCT01739790|592688798|FG000|Overall Study|Early Trial Termination|2|||
164088335|NCT01739790|592688799|FG001|Overall Study|Early Trial Termination|4|||
164088336|NCT02192905|592688801|FG000|Overall Study|Lost to Follow-up|1|||
164293983|NCT05148234|593447873|FG002|Phase I|Company closed the trial.|0|||
164293984|NCT05148234|593447874|FG003|Phase I|Company closed the trial.|0|||
164293985|NCT05148234|593447875|FG004|Phase I|Company closed the trial.|0|||
164293986|NCT05148234|593447876|FG005|Phase I|Company closed the trial.|0|||
164293987|NCT05148234|593447877|FG006|Phase I|Company closed the trial.|0|||
164088337|NCT01691859|592688802|FG000|Overall Study|Adverse Event|19|||
164088338|NCT01691859|592688802|FG000|Overall Study|Lack of Efficacy|11|||
164088339|NCT01691859|592688802|FG000|Overall Study|Protocol Violation|4|||
164088340|NCT01691859|592688802|FG000|Overall Study|Product commercially available|221|||
164088341|NCT01691859|592688802|FG000|Overall Study|Study closed/terminated|50|||
164088342|NCT01691859|592688802|FG000|Overall Study|Lost to Follow-up|5|||
164088343|NCT01691859|592688802|FG000|Overall Study|Physician Decision|6|||
164088344|NCT01691859|592688802|FG000|Overall Study|Withdrawal by Subject|31|||
164088345|NCT04820842|592688803|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164088346|NCT04820842|592688804|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
164088347|NCT04820842|592688805|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
164088348|NCT04820842|592688806|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164088349|NCT04820842|592688807|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164132694|NCT01986010|592850656|FG001|Overall Study|Physician Decision|0|||
164293988|NCT05148234|593447878|FG007|Phase I|Company closed the trial.|0|||
164293989|NCT01400698|593447880|FG000|Overall Study|Lost to Follow-up|2|||
164293990|NCT01400698|593447881|FG001|Overall Study|Lost to Follow-up|5|||
164293991|NCT01400698|593447882|FG002|Overall Study|Lost to Follow-up|2|||
164293992|NCT01400698|593447883|FG003|Overall Study|Lost to Follow-up|1|||
164293993|NCT01400698|593447884|FG004|Overall Study|Lost to Follow-up|4|||
164293994|NCT01400698|593447885|FG005|Overall Study|Lost to Follow-up|3|||
164293995|NCT01400698|593447880|FG000|Overall Study|Withdrawal by Subject|8|||
164293996|NCT01400698|593447881|FG001|Overall Study|Withdrawal by Subject|2|||
164293997|NCT01400698|593447882|FG002|Overall Study|Withdrawal by Subject|0|||
164293998|NCT01400698|593447883|FG003|Overall Study|Withdrawal by Subject|4|||
164346543|NCT01218204|593645057|FG001|Part B Run-in|Withdrawal by Subject|0|||
164346544|NCT01218204|593645058|FG002|Part B Run-in|Withdrawal by Subject|3|||
164346545|NCT01218204|593645059|FG003|Part B Run-in|Withdrawal by Subject|0|||
164346546|NCT01218204|593645056|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
164346547|NCT01218204|593645057|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
164346548|NCT01218204|593645058|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
164346549|NCT01218204|593645059|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
164346550|NCT01218204|593645056|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
164346551|NCT01218204|593645057|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
164346552|NCT01218204|593645058|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
164346553|NCT01218204|593645059|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
164346554|NCT01061177|593645064|FG000|Overall Study|Adverse Event|117|||
164346555|NCT01061177|593645064|FG000|Overall Study|Withdrawal by Subject|27|||
164346556|NCT01061177|593645064|FG000|Overall Study|Disease progression|17|||
164346557|NCT01061177|593645064|FG000|Overall Study|Protocol Violation|11|||
164346558|NCT01061177|593645064|FG000|Overall Study|Lost to Follow-up|9|||
164346559|NCT01061177|593645064|FG000|Overall Study|New cancer therapy|9|||
164346560|NCT01061177|593645064|FG000|Overall Study|Abnormal laboratory values|6|||
164346561|NCT01061177|593645064|FG000|Overall Study|Abnormal test procedure results|4|||
164346562|NCT01061177|593645064|FG000|Overall Study|Administratie problems|4|||
164346563|NCT01061177|593645064|FG000|Overall Study|Death|4|||
164346564|NCT03616600|593645065|FG000|Overall Study|Withdrawal by Subject|1|||
164346565|NCT03616600|593645066|FG001|Overall Study|Withdrawal by Subject|0|||
164346566|NCT03984994|593645067|FG000|Overall Study|Withdrawal by Subject|2|||
164346567|NCT03984994|593645068|FG001|Overall Study|Withdrawal by Subject|1|||
164346568|NCT03010176|593645070|FG000|Overall Study|Death|21|||
164346569|NCT03010176|593645071|FG001|Overall Study|Death|35|||
164346570|NCT03010176|593645072|FG002|Overall Study|Death|19|||
164346571|NCT03010176|593645073|FG003|Overall Study|Death|19|||
163898111|NCT02112916|591999468|FG000|Overall Study|Withdrawal by Subject|5|||
164004531|NCT00561353|592380817|FG000|Overall Study|Subject reached a virologic endpoint|2|||
164004532|NCT00561353|592380818|FG001|Overall Study|Subject reached a virologic endpoint|1|||
164004533|NCT00561353|592380819|FG002|Overall Study|Subject reached a virologic endpoint|1|||
164293999|NCT01400698|593447884|FG004|Overall Study|Withdrawal by Subject|1|||
163898112|NCT02112916|591999469|FG001|Overall Study|Withdrawal by Subject|3|||
163898113|NCT02112916|591999470|FG002|Overall Study|Withdrawal by Subject|1|||
163898114|NCT02112916|591999471|FG003|Overall Study|Withdrawal by Subject|1|||
163898115|NCT02112916|591999468|FG000|Overall Study|Ineligible|4|||
163898116|NCT02112916|591999469|FG001|Overall Study|Ineligible|8|||
163898117|NCT02112916|591999470|FG002|Overall Study|Ineligible|3|||
163898118|NCT02112916|591999471|FG003|Overall Study|Ineligible|8|||
163898119|NCT02112916|591999468|FG000|Overall Study|Inevaluable|6|||
163898120|NCT02112916|591999469|FG001|Overall Study|Inevaluable|4|||
163898121|NCT02112916|591999470|FG002|Overall Study|Inevaluable|5|||
163898122|NCT02112916|591999471|FG003|Overall Study|Inevaluable|5|||
163898123|NCT02112916|591999468|FG000|Overall Study|Refusal of further protocol therapy|19|||
163898124|NCT02112916|591999469|FG001|Overall Study|Refusal of further protocol therapy|16|||
163898125|NCT02112916|591999470|FG002|Overall Study|Refusal of further protocol therapy|1|||
163898126|NCT02112916|591999471|FG003|Overall Study|Refusal of further protocol therapy|7|||
163898127|NCT02112916|591999468|FG000|Overall Study|Development of SMN|1|||
163898128|NCT02112916|591999469|FG001|Overall Study|Development of SMN|0|||
163898129|NCT02112916|591999470|FG002|Overall Study|Development of SMN|0|||
163898130|NCT02112916|591999471|FG003|Overall Study|Development of SMN|1|||
164294000|NCT01400698|593447885|FG005|Overall Study|Withdrawal by Subject|3|||
163898131|NCT02112916|591999468|FG000|Overall Study|Relapse/Progression|10|||
164346572|NCT03010176|593645074|FG004|Overall Study|Death|14|||
164346573|NCT03010176|593645075|FG005|Overall Study|Death|0|||
164346574|NCT03010176|593645070|FG000|Overall Study|Lost to Follow-up|0|||
164346575|NCT03010176|593645071|FG001|Overall Study|Lost to Follow-up|0|||
164346576|NCT03010176|593645072|FG002|Overall Study|Lost to Follow-up|0|||
164346577|NCT03010176|593645073|FG003|Overall Study|Lost to Follow-up|0|||
164346578|NCT03010176|593645074|FG004|Overall Study|Lost to Follow-up|1|||
163898132|NCT02112916|591999469|FG001|Overall Study|Relapse/Progression|18|||
164088350|NCT04820842|592688808|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
163898133|NCT02112916|591999470|FG002|Overall Study|Relapse/Progression|15|||
163898134|NCT02112916|591999471|FG003|Overall Study|Relapse/Progression|2|||
163898135|NCT02112916|591999468|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
163898136|NCT02112916|591999469|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
163898137|NCT02112916|591999470|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
163898138|NCT02112916|591999471|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
163898139|NCT02112916|591999468|FG000|Overall Study|Still on Therapy|44|||
163898140|NCT02112916|591999469|FG001|Overall Study|Still on Therapy|47|||
163898141|NCT02112916|591999470|FG002|Overall Study|Still on Therapy|3|||
163898142|NCT02112916|591999471|FG003|Overall Study|Still on Therapy|2|||
163898143|NCT02112916|591999468|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
163898144|NCT02112916|591999469|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
163898145|NCT02112916|591999470|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
163898146|NCT02112916|591999471|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
164088351|NCT04820842|592688809|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
164088352|NCT04820842|592688803|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
164088353|NCT04820842|592688804|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
164088354|NCT04820842|592688805|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
164088355|NCT04820842|592688806|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088356|NCT04820842|592688807|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088357|NCT04820842|592688808|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088358|NCT04820842|592688809|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164132695|NCT01986010|592850657|FG002|Overall Study|Physician Decision|0|||
164294001|NCT01400698|593447880|FG000|Overall Study|Protocol Violation|0|||
164294002|NCT01400698|593447881|FG001|Overall Study|Protocol Violation|1|||
164294003|NCT01400698|593447882|FG002|Overall Study|Protocol Violation|0|||
164294004|NCT01400698|593447883|FG003|Overall Study|Protocol Violation|0|||
164294005|NCT01400698|593447884|FG004|Overall Study|Protocol Violation|1|||
164294006|NCT01400698|593447885|FG005|Overall Study|Protocol Violation|0|||
164294007|NCT01400698|593447880|FG000|Overall Study|Non-compliance|0|||
164294008|NCT01400698|593447881|FG001|Overall Study|Non-compliance|1|||
164294009|NCT01400698|593447882|FG002|Overall Study|Non-compliance|0|||
164294010|NCT01400698|593447883|FG003|Overall Study|Non-compliance|1|||
164294011|NCT01400698|593447884|FG004|Overall Study|Non-compliance|0|||
164294012|NCT01400698|593447885|FG005|Overall Study|Non-compliance|0|||
164294013|NCT01400698|593447880|FG000|Overall Study|Adverse Event|1|||
164294014|NCT01400698|593447881|FG001|Overall Study|Adverse Event|0|||
164294015|NCT01400698|593447882|FG002|Overall Study|Adverse Event|0|||
164294016|NCT01400698|593447883|FG003|Overall Study|Adverse Event|0|||
164294017|NCT01400698|593447884|FG004|Overall Study|Adverse Event|0|||
164294018|NCT01400698|593447885|FG005|Overall Study|Adverse Event|0|||
164294019|NCT01400698|593447880|FG000|Overall Study|Other|4|||
164294020|NCT01400698|593447881|FG001|Overall Study|Other|2|||
164294021|NCT01400698|593447882|FG002|Overall Study|Other|0|||
164294022|NCT01400698|593447883|FG003|Overall Study|Other|2|||
164294023|NCT01400698|593447884|FG004|Overall Study|Other|1|||
164294024|NCT01400698|593447885|FG005|Overall Study|Other|0|||
164294025|NCT04750642|593447886|FG000|Overall Study|Adverse Event|1|||
164294026|NCT04750642|593447887|FG001|Overall Study|Adverse Event|0|||
164294027|NCT04750642|593447886|FG000|Overall Study|Withdrawal by Subject|0|||
164294028|NCT04750642|593447887|FG001|Overall Study|Withdrawal by Subject|1|||
164294029|NCT04750642|593447886|FG000|Overall Study|Protocol Violation|0|||
164294030|NCT04750642|593447887|FG001|Overall Study|Protocol Violation|1|||
164294031|NCT01650194|593447888|FG000|Overall Study|Progressive Disease (PD)|35|||
164294032|NCT01650194|593447888|FG000|Overall Study|Withdrawal by Subject|2|||
164294033|NCT01650194|593447888|FG000|Overall Study|Miscellaneous|10|||
164294034|NCT01602224|593449987|FG000|Overall Study|Adverse Event|0|||
164294035|NCT01602224|593449988|FG001|Overall Study|Adverse Event|1|||
164294036|NCT01602224|593449989|FG002|Overall Study|Adverse Event|0|||
164294037|NCT01602224|593449987|FG000|Overall Study|Investigator Decison|1|||
164294038|NCT01602224|593449988|FG001|Overall Study|Investigator Decison|0|||
164294039|NCT01602224|593449989|FG002|Overall Study|Investigator Decison|0|||
164294040|NCT01602224|593449987|FG000|Overall Study|Lost to Follow-up|0|||
164294041|NCT01602224|593449988|FG001|Overall Study|Lost to Follow-up|0|||
164294042|NCT01602224|593449989|FG002|Overall Study|Lost to Follow-up|1|||
164294043|NCT01602224|593449987|FG000|Overall Study|Protocol Violation|0|||
164294044|NCT01602224|593449988|FG001|Overall Study|Protocol Violation|1|||
164294045|NCT01602224|593449989|FG002|Overall Study|Protocol Violation|0|||
164294046|NCT01602224|593449987|FG000|Overall Study|Sponsor Decision|2|||
164294047|NCT01602224|593449988|FG001|Overall Study|Sponsor Decision|3|||
164294048|NCT01602224|593449989|FG002|Overall Study|Sponsor Decision|2|||
164294049|NCT01602224|593449987|FG000|Overall Study|Withdrawal by Subject|5|||
164294050|NCT01602224|593449988|FG001|Overall Study|Withdrawal by Subject|3|||
164294051|NCT01602224|593449989|FG002|Overall Study|Withdrawal by Subject|3|||
164294052|NCT01352117|593449990|FG000|Overall Study|Death|15|||
164294053|NCT01352117|593449991|FG001|Overall Study|Death|16|||
164294054|NCT01352117|593449990|FG000|Overall Study|Withdrawal by Subject|1|||
164346579|NCT03010176|593645075|FG005|Overall Study|Lost to Follow-up|0|||
164294055|NCT01352117|593449991|FG001|Overall Study|Withdrawal by Subject|0|||
164294056|NCT01352117|593449990|FG000|Overall Study|Lost to Follow-up|2|||
164294057|NCT01352117|593449991|FG001|Overall Study|Lost to Follow-up|7|||
164294058|NCT01352117|593449990|FG000|Overall Study|Non-adherent to study requirements|1|||
164294059|NCT01352117|593449991|FG001|Overall Study|Non-adherent to study requirements|1|||
164294060|NCT01352117|593449990|FG000|Overall Study|Did not initiate study treatment|1|||
164294061|NCT01352117|593449991|FG001|Overall Study|Did not initiate study treatment|0|||
164346580|NCT03010176|593645070|FG000|Overall Study|Physician Decision|0|||
164346581|NCT03010176|593645071|FG001|Overall Study|Physician Decision|4|||
164294062|NCT01352117|593449990|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
164294063|NCT01352117|593449991|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
164294064|NCT00644423|593449992|FG000|Overall Study|Lost to Follow-up|1|||
164294065|NCT00644423|593449993|FG001|Overall Study|Lost to Follow-up|1|||
164294066|NCT03525444|593449994|FG000|Overall Study|Adverse Event|0|||
164004534|NCT00561353|592380820|FG003|Overall Study|Subject reached a virologic endpoint|4|||
164004535|NCT00561353|592380821|FG004|Overall Study|Subject reached a virologic endpoint|1|||
164004536|NCT00561353|592380822|FG005|Overall Study|Subject reached a virologic endpoint|3|||
164004537|NCT00561353|592380823|FG006|Overall Study|Subject reached a virologic endpoint|4|||
164004538|NCT00561353|592380824|FG007|Overall Study|Subject reached a virologic endpoint|4|||
164004539|NCT00561353|592380825|FG008|Overall Study|Subject reached a virologic endpoint|5|||
164004540|NCT00561353|592380826|FG009|Overall Study|Subject reached a virologic endpoint|0|||
164004541|NCT00561353|592380817|FG000|Overall Study|Subject ineligible to continue the trial|0|||
164004542|NCT00561353|592380818|FG001|Overall Study|Subject ineligible to continue the trial|0|||
164004543|NCT00561353|592380819|FG002|Overall Study|Subject ineligible to continue the trial|0|||
164004544|NCT00561353|592380820|FG003|Overall Study|Subject ineligible to continue the trial|0|||
164004545|NCT00561353|592380821|FG004|Overall Study|Subject ineligible to continue the trial|0|||
164004546|NCT00561353|592380822|FG005|Overall Study|Subject ineligible to continue the trial|1|||
164004547|NCT00561353|592380823|FG006|Overall Study|Subject ineligible to continue the trial|1|||
164004548|NCT00561353|592380824|FG007|Overall Study|Subject ineligible to continue the trial|0|||
164004549|NCT00561353|592380825|FG008|Overall Study|Subject ineligible to continue the trial|2|||
164004550|NCT00561353|592380826|FG009|Overall Study|Subject ineligible to continue the trial|1|||
164004551|NCT00561353|592380817|FG000|Overall Study|Other|1|||
164004552|NCT00561353|592380818|FG001|Overall Study|Other|0|||
164004553|NCT00561353|592380819|FG002|Overall Study|Other|1|||
164004554|NCT00561353|592380820|FG003|Overall Study|Other|0|||
164004555|NCT00561353|592380821|FG004|Overall Study|Other|0|||
164004556|NCT00561353|592380822|FG005|Overall Study|Other|2|||
164004557|NCT00561353|592380823|FG006|Overall Study|Other|0|||
164004558|NCT00561353|592380824|FG007|Overall Study|Other|0|||
164004559|NCT00561353|592380825|FG008|Overall Study|Other|0|||
164004560|NCT00561353|592380826|FG009|Overall Study|Other|0|||
164004561|NCT00561353|592380817|FG000|Overall Study|Adverse Event|0|||
164004562|NCT00561353|592380818|FG001|Overall Study|Adverse Event|0|||
164004563|NCT00561353|592380819|FG002|Overall Study|Adverse Event|0|||
164004564|NCT00561353|592380820|FG003|Overall Study|Adverse Event|2|||
164004565|NCT00561353|592380821|FG004|Overall Study|Adverse Event|0|||
164004566|NCT00561353|592380822|FG005|Overall Study|Adverse Event|0|||
164004567|NCT00561353|592380823|FG006|Overall Study|Adverse Event|1|||
164004568|NCT00561353|592380824|FG007|Overall Study|Adverse Event|0|||
164004569|NCT00561353|592380825|FG008|Overall Study|Adverse Event|0|||
164004570|NCT00561353|592380826|FG009|Overall Study|Adverse Event|1|||
164004571|NCT00561353|592380817|FG000|Overall Study|Lost to Follow-up|2|||
164004572|NCT00561353|592380818|FG001|Overall Study|Lost to Follow-up|0|||
164004573|NCT00561353|592380819|FG002|Overall Study|Lost to Follow-up|1|||
164004574|NCT00561353|592380820|FG003|Overall Study|Lost to Follow-up|0|||
164004575|NCT00561353|592380821|FG004|Overall Study|Lost to Follow-up|0|||
164004576|NCT00561353|592380822|FG005|Overall Study|Lost to Follow-up|0|||
164004577|NCT00561353|592380823|FG006|Overall Study|Lost to Follow-up|0|||
164088359|NCT04820842|592688803|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164088360|NCT04820842|592688804|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
164088361|NCT04820842|592688805|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164132696|NCT01986010|592850658|FG003|Overall Study|Physician Decision|0|||
164294067|NCT03525444|593449995|FG001|Overall Study|Adverse Event|1|||
164294068|NCT03525444|593449994|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164294069|NCT03525444|593449995|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
164294070|NCT03525444|593449994|FG000|Overall Study|Other|0|||
164294071|NCT03525444|593449995|FG001|Overall Study|Other|1|||
164294072|NCT00262860|593449997|FG000|Overall Study|Adverse Event|2|||
164294073|NCT02741128|593449998|FG000|Overall Study|Protocol Violation|4|||
164294074|NCT02741128|593449999|FG001|Overall Study|Protocol Violation|1|||
164294075|NCT02741128|593449998|FG000|Overall Study|Withdrawal by Subject|2|||
164294076|NCT02741128|593449999|FG001|Overall Study|Withdrawal by Subject|0|||
164294077|NCT02741128|593449998|FG000|Overall Study|Lost to Follow-up|1|||
164346582|NCT03010176|593645072|FG002|Overall Study|Physician Decision|0|||
164004578|NCT00561353|592380824|FG007|Overall Study|Lost to Follow-up|0|||
164004579|NCT00561353|592380825|FG008|Overall Study|Lost to Follow-up|0|||
164004580|NCT00561353|592380826|FG009|Overall Study|Lost to Follow-up|0|||
164004581|NCT00561353|592380817|FG000|Overall Study|Withdrawal by Subject|0|||
164004582|NCT00561353|592380818|FG001|Overall Study|Withdrawal by Subject|2|||
164004583|NCT00561353|592380819|FG002|Overall Study|Withdrawal by Subject|0|||
164294078|NCT02741128|593449999|FG001|Overall Study|Lost to Follow-up|0|||
164004584|NCT00561353|592380820|FG003|Overall Study|Withdrawal by Subject|0|||
164004585|NCT00561353|592380821|FG004|Overall Study|Withdrawal by Subject|0|||
164294079|NCT01419769|593450000|FG000|Overall Study|Did not receive the AXIOS stent|3|||
164346583|NCT03010176|593645073|FG003|Overall Study|Physician Decision|1|||
164088362|NCT04820842|592688806|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164088363|NCT04820842|592688807|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164088364|NCT04820842|592688808|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164088365|NCT04820842|592688809|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
164088366|NCT04820842|592688803|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088367|NCT04820842|592688804|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088368|NCT04820842|592688805|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088369|NCT04820842|592688806|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
164088370|NCT04820842|592688807|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088371|NCT04820842|592688808|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
164088372|NCT04820842|592688809|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
164088373|NCT01296932|592688810|FG000|Overall Study|Dose limiting toxicity|0|||
164088374|NCT01296932|592688811|FG001|Overall Study|Dose limiting toxicity|0|||
164088375|NCT01296932|592688812|FG002|Overall Study|Dose limiting toxicity|0|||
164088376|NCT01296932|592688813|FG003|Overall Study|Dose limiting toxicity|0|||
164088377|NCT01296932|592688814|FG004|Overall Study|Dose limiting toxicity|0|||
164088378|NCT01296932|592688815|FG005|Overall Study|Dose limiting toxicity|0|||
164088379|NCT01296932|592688816|FG006|Overall Study|Dose limiting toxicity|1|||
164088380|NCT01296932|592688817|FG007|Overall Study|Dose limiting toxicity|0|||
164088381|NCT01296932|592688818|FG008|Overall Study|Dose limiting toxicity|1|||
164088382|NCT01296932|592688810|FG000|Overall Study|Progressive disease|2|||
164088383|NCT01296932|592688811|FG001|Overall Study|Progressive disease|0|||
164088384|NCT01296932|592688812|FG002|Overall Study|Progressive disease|1|||
164088385|NCT01296932|592688813|FG003|Overall Study|Progressive disease|1|||
164088386|NCT01296932|592688814|FG004|Overall Study|Progressive disease|2|||
164088387|NCT01296932|592688815|FG005|Overall Study|Progressive disease|3|||
164088388|NCT01296932|592688816|FG006|Overall Study|Progressive disease|1|||
164088389|NCT01296932|592688817|FG007|Overall Study|Progressive disease|0|||
164088390|NCT01296932|592688818|FG008|Overall Study|Progressive disease|0|||
164088391|NCT01296932|592688810|FG000|Overall Study|Withdrawal by Subject|0|||
164088392|NCT01296932|592688811|FG001|Overall Study|Withdrawal by Subject|0|||
164088393|NCT01296932|592688812|FG002|Overall Study|Withdrawal by Subject|1|||
164088394|NCT01296932|592688813|FG003|Overall Study|Withdrawal by Subject|1|||
164088395|NCT01296932|592688814|FG004|Overall Study|Withdrawal by Subject|0|||
164088396|NCT01296932|592688815|FG005|Overall Study|Withdrawal by Subject|0|||
164088397|NCT01296932|592688816|FG006|Overall Study|Withdrawal by Subject|3|||
164088398|NCT01296932|592688817|FG007|Overall Study|Withdrawal by Subject|0|||
164088399|NCT01296932|592688818|FG008|Overall Study|Withdrawal by Subject|0|||
164088400|NCT01296932|592688810|FG000|Overall Study|Adverse Event|1|||
164088401|NCT01296932|592688811|FG001|Overall Study|Adverse Event|1|||
164088402|NCT01296932|592688812|FG002|Overall Study|Adverse Event|1|||
164088403|NCT01296932|592688813|FG003|Overall Study|Adverse Event|2|||
164088404|NCT01296932|592688814|FG004|Overall Study|Adverse Event|1|||
164088405|NCT01296932|592688815|FG005|Overall Study|Adverse Event|0|||
164088406|NCT01296932|592688816|FG006|Overall Study|Adverse Event|0|||
164088407|NCT01296932|592688817|FG007|Overall Study|Adverse Event|0|||
164088408|NCT01296932|592688818|FG008|Overall Study|Adverse Event|1|||
164088409|NCT01296932|592688810|FG000|Overall Study|Investigator decision|0|||
164088410|NCT01296932|592688811|FG001|Overall Study|Investigator decision|1|||
164088411|NCT01296932|592688812|FG002|Overall Study|Investigator decision|0|||
164088412|NCT01296932|592688813|FG003|Overall Study|Investigator decision|1|||
164088413|NCT01296932|592688814|FG004|Overall Study|Investigator decision|0|||
164088414|NCT01296932|592688815|FG005|Overall Study|Investigator decision|0|||
164088415|NCT01296932|592688816|FG006|Overall Study|Investigator decision|1|||
164088416|NCT01296932|592688817|FG007|Overall Study|Investigator decision|0|||
164088417|NCT01296932|592688818|FG008|Overall Study|Investigator decision|1|||
164088418|NCT01296932|592688810|FG000|Overall Study|No clinical benefit anymore|0|||
164088419|NCT01296932|592688811|FG001|Overall Study|No clinical benefit anymore|1|||
164088420|NCT01296932|592688812|FG002|Overall Study|No clinical benefit anymore|0|||
164088421|NCT01296932|592688813|FG003|Overall Study|No clinical benefit anymore|0|||
164294080|NCT01419769|593450000|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
164294081|NCT00878501|593450001|FG000|Overall Study|Adverse Event|11|||
164294082|NCT00878501|593450002|FG001|Overall Study|Adverse Event|3|||
164294083|NCT00878501|593450003|FG002|Overall Study|Adverse Event|3|||
164088422|NCT01296932|592688814|FG004|Overall Study|No clinical benefit anymore|0|||
164088423|NCT01296932|592688815|FG005|Overall Study|No clinical benefit anymore|0|||
164088424|NCT01296932|592688816|FG006|Overall Study|No clinical benefit anymore|0|||
164088425|NCT01296932|592688817|FG007|Overall Study|No clinical benefit anymore|0|||
164088426|NCT01296932|592688818|FG008|Overall Study|No clinical benefit anymore|0|||
164088427|NCT01296932|592688810|FG000|Overall Study|Physician Decision|0|||
164088428|NCT01296932|592688811|FG001|Overall Study|Physician Decision|0|||
164088429|NCT01296932|592688812|FG002|Overall Study|Physician Decision|1|||
164088430|NCT01296932|592688813|FG003|Overall Study|Physician Decision|0|||
164088431|NCT01296932|592688814|FG004|Overall Study|Physician Decision|0|||
164088432|NCT01296932|592688815|FG005|Overall Study|Physician Decision|0|||
164088433|NCT01296932|592688816|FG006|Overall Study|Physician Decision|0|||
164088434|NCT01296932|592688817|FG007|Overall Study|Physician Decision|0|||
164088435|NCT01296932|592688818|FG008|Overall Study|Physician Decision|0|||
164088436|NCT01296932|592688810|FG000|Overall Study|IV problems, administration not possible|0|||
164088437|NCT01296932|592688811|FG001|Overall Study|IV problems, administration not possible|0|||
164088438|NCT01296932|592688812|FG002|Overall Study|IV problems, administration not possible|1|||
164088439|NCT01296932|592688813|FG003|Overall Study|IV problems, administration not possible|0|||
164088440|NCT01296932|592688814|FG004|Overall Study|IV problems, administration not possible|0|||
164088441|NCT01296932|592688815|FG005|Overall Study|IV problems, administration not possible|0|||
164088442|NCT01296932|592688816|FG006|Overall Study|IV problems, administration not possible|0|||
164088443|NCT01296932|592688817|FG007|Overall Study|IV problems, administration not possible|0|||
164088444|NCT01296932|592688818|FG008|Overall Study|IV problems, administration not possible|0|||
164088445|NCT01296932|592688810|FG000|Overall Study|per protocol|0|||
164088446|NCT01296932|592688811|FG001|Overall Study|per protocol|0|||
164088447|NCT01296932|592688812|FG002|Overall Study|per protocol|1|||
164088448|NCT01296932|592688813|FG003|Overall Study|per protocol|1|||
164088449|NCT01296932|592688814|FG004|Overall Study|per protocol|0|||
164088450|NCT01296932|592688815|FG005|Overall Study|per protocol|0|||
164088451|NCT01296932|592688816|FG006|Overall Study|per protocol|0|||
164088452|NCT01296932|592688817|FG007|Overall Study|per protocol|0|||
164088453|NCT01296932|592688818|FG008|Overall Study|per protocol|0|||
164088454|NCT01296932|592688810|FG000|Overall Study|Low benefit and too many side effects|0|||
164088455|NCT01296932|592688811|FG001|Overall Study|Low benefit and too many side effects|0|||
164088456|NCT01296932|592688812|FG002|Overall Study|Low benefit and too many side effects|0|||
164088457|NCT01296932|592688813|FG003|Overall Study|Low benefit and too many side effects|0|||
164088458|NCT01296932|592688814|FG004|Overall Study|Low benefit and too many side effects|0|||
164088459|NCT01296932|592688815|FG005|Overall Study|Low benefit and too many side effects|0|||
164088460|NCT01296932|592688816|FG006|Overall Study|Low benefit and too many side effects|0|||
164088461|NCT01296932|592688817|FG007|Overall Study|Low benefit and too many side effects|1|||
164088462|NCT01296932|592688818|FG008|Overall Study|Low benefit and too many side effects|0|||
164088463|NCT01296932|592688810|FG000|Overall Study|No adequate treatment response|0|||
164088464|NCT01296932|592688811|FG001|Overall Study|No adequate treatment response|0|||
164088465|NCT01296932|592688812|FG002|Overall Study|No adequate treatment response|0|||
164088466|NCT01296932|592688813|FG003|Overall Study|No adequate treatment response|0|||
164088467|NCT01296932|592688814|FG004|Overall Study|No adequate treatment response|0|||
164088468|NCT01296932|592688815|FG005|Overall Study|No adequate treatment response|0|||
164088469|NCT01296932|592688816|FG006|Overall Study|No adequate treatment response|0|||
164088470|NCT01296932|592688817|FG007|Overall Study|No adequate treatment response|1|||
164088471|NCT01296932|592688818|FG008|Overall Study|No adequate treatment response|0|||
164088472|NCT01296932|592688810|FG000|Overall Study|Dosage already reduced, AE still present|0|||
164088473|NCT01296932|592688811|FG001|Overall Study|Dosage already reduced, AE still present|0|||
164088474|NCT01296932|592688812|FG002|Overall Study|Dosage already reduced, AE still present|0|||
164088475|NCT01296932|592688813|FG003|Overall Study|Dosage already reduced, AE still present|0|||
164088476|NCT01296932|592688814|FG004|Overall Study|Dosage already reduced, AE still present|0|||
164088477|NCT01296932|592688815|FG005|Overall Study|Dosage already reduced, AE still present|0|||
164088478|NCT01296932|592688816|FG006|Overall Study|Dosage already reduced, AE still present|0|||
164088479|NCT01296932|592688817|FG007|Overall Study|Dosage already reduced, AE still present|0|||
164088480|NCT01296932|592688818|FG008|Overall Study|Dosage already reduced, AE still present|1|||
164088481|NCT00862979|592688819|FG000|Overall Study|Adverse Event|6|||
164088482|NCT00862979|592688820|FG001|Overall Study|Adverse Event|3|||
164088483|NCT00862979|592688819|FG000|Overall Study|Protocol Violation|0|||
164088484|NCT00862979|592688820|FG001|Overall Study|Protocol Violation|1|||
164088485|NCT00862979|592688819|FG000|Overall Study|Patient withdrew consent|2|||
164088486|NCT00862979|592688820|FG001|Overall Study|Patient withdrew consent|1|||
164088487|NCT00862979|592688819|FG000|Overall Study|Administrative problems|0|||
164294084|NCT00878501|593450001|FG000|Overall Study|Lack of Efficacy|2|||
164294085|NCT00878501|593450002|FG001|Overall Study|Lack of Efficacy|1|||
164294086|NCT00878501|593450003|FG002|Overall Study|Lack of Efficacy|0|||
164294087|NCT00878501|593450001|FG000|Overall Study|Withdrawal by Subject|2|||
164088488|NCT00862979|592688820|FG001|Overall Study|Administrative problems|1|||
164088489|NCT00862979|592688819|FG000|Overall Study|Death|0|||
164088490|NCT00862979|592688820|FG001|Overall Study|Death|1|||
164088491|NCT05568225|592688821|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
164088492|NCT05568225|592688822|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
164088493|NCT05568225|592688823|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
164088494|NCT05568225|592688821|FG000|Primary Treatment Period|Physician Decision|0|||
164294088|NCT00878501|593450002|FG001|Overall Study|Withdrawal by Subject|1|||
164088495|NCT05568225|592688822|FG001|Primary Treatment Period|Physician Decision|1|||
164088496|NCT05568225|592688823|FG002|Primary Treatment Period|Physician Decision|0|||
164088497|NCT05568225|592688821|FG000|Primary Treatment Period|Disease progression|0|||
164088498|NCT05568225|592688822|FG001|Primary Treatment Period|Disease progression|1|||
164088499|NCT05568225|592688823|FG002|Primary Treatment Period|Disease progression|0|||
164088500|NCT05568225|592688821|FG000|Primary Treatment Period|Lack of Efficacy|0|||
164088501|NCT05568225|592688822|FG001|Primary Treatment Period|Lack of Efficacy|1|||
164088502|NCT05568225|592688823|FG002|Primary Treatment Period|Lack of Efficacy|0|||
164088503|NCT05568225|592688821|FG000|Primary Treatment Period|Withdrawal of conset|1|||
164088504|NCT05568225|592688822|FG001|Primary Treatment Period|Withdrawal of conset|0|||
164088505|NCT05568225|592688823|FG002|Primary Treatment Period|Withdrawal of conset|4|||
164088506|NCT05568225|592688821|FG000|Primary Treatment Period|Adverse Event|1|||
164088507|NCT05568225|592688822|FG001|Primary Treatment Period|Adverse Event|0|||
164088508|NCT05568225|592688823|FG002|Primary Treatment Period|Adverse Event|0|||
164088509|NCT05568225|592688821|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
164088510|NCT05568225|592688822|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
164088511|NCT05568225|592688823|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
164088512|NCT05568225|592688821|FG000|Extension Treatment Period|Protocol Violation|0|||
164088513|NCT05568225|592688822|FG001|Extension Treatment Period|Protocol Violation|0|||
164088514|NCT05568225|592688823|FG002|Extension Treatment Period|Protocol Violation|1|||
164088515|NCT05568225|592688821|FG000|Extension Treatment Period|Lack of Efficacy|0|||
164088516|NCT05568225|592688822|FG001|Extension Treatment Period|Lack of Efficacy|0|||
164088517|NCT05568225|592688823|FG002|Extension Treatment Period|Lack of Efficacy|1|||
164088518|NCT01027143|592688826|FG000|Overall Study|Lost to Follow-up|9|||
164088519|NCT01027143|592688827|FG001|Overall Study|Lost to Follow-up|4|||
164088520|NCT02637557|592688832|FG000|Overall Study|Adverse Event|3|||
164088521|NCT02637557|592688833|FG001|Overall Study|Adverse Event|1|||
164088522|NCT02637557|592688834|FG002|Overall Study|Adverse Event|3|||
164088523|NCT02637557|592688835|FG003|Overall Study|Adverse Event|3|||
164088524|NCT02637557|592688832|FG000|Overall Study|Lost to Follow-up|1|||
164088525|NCT02637557|592688833|FG001|Overall Study|Lost to Follow-up|1|||
164088526|NCT02637557|592688834|FG002|Overall Study|Lost to Follow-up|0|||
164088527|NCT02637557|592688835|FG003|Overall Study|Lost to Follow-up|1|||
164088528|NCT02637557|592688832|FG000|Overall Study|Physician Decision|1|||
164088529|NCT02637557|592688833|FG001|Overall Study|Physician Decision|0|||
164088530|NCT02637557|592688834|FG002|Overall Study|Physician Decision|0|||
164088531|NCT02637557|592688835|FG003|Overall Study|Physician Decision|0|||
164088532|NCT02637557|592688832|FG000|Overall Study|Protocol Violation|2|||
164088533|NCT02637557|592688833|FG001|Overall Study|Protocol Violation|0|||
164088534|NCT02637557|592688834|FG002|Overall Study|Protocol Violation|2|||
164088535|NCT02637557|592688835|FG003|Overall Study|Protocol Violation|1|||
164088536|NCT02637557|592688832|FG000|Overall Study|Withdrawal by Subject|1|||
164088537|NCT02637557|592688833|FG001|Overall Study|Withdrawal by Subject|3|||
164088538|NCT02637557|592688834|FG002|Overall Study|Withdrawal by Subject|4|||
164088539|NCT02637557|592688835|FG003|Overall Study|Withdrawal by Subject|2|||
164088540|NCT05218655|592688836|FG000|Overall Study|Adverse Event|6|||
164088541|NCT05218655|592688836|FG000|Overall Study|Sponsor's decision|85|||
164088542|NCT05218655|592688836|FG000|Overall Study|Death|1|||
164088543|NCT05218655|592688836|FG000|Overall Study|Lost to Follow-up|3|||
164088544|NCT05218655|592688836|FG000|Overall Study|Withdrawal by Subject|3|||
164088545|NCT05218655|592688836|FG000|Overall Study|Other than specified|3|||
164088546|NCT02228382|592688837|FG000|Overall Study|Death|5|||
164088547|NCT02228382|592688838|FG001|Overall Study|Death|7|||
164088548|NCT02228382|592688839|FG002|Overall Study|Death|5|||
164088549|NCT02228382|592688840|FG003|Overall Study|Death|0|||
164088550|NCT02228382|592688841|FG004|Overall Study|Death|2|||
164346584|NCT03010176|593645074|FG004|Overall Study|Physician Decision|0|||
164346585|NCT03010176|593645075|FG005|Overall Study|Physician Decision|0|||
164346586|NCT03010176|593645070|FG000|Overall Study|Sponsor Decision|0|||
164346587|NCT03010176|593645071|FG001|Overall Study|Sponsor Decision|4|||
164346588|NCT03010176|593645072|FG002|Overall Study|Sponsor Decision|4|||
164346589|NCT03010176|593645073|FG003|Overall Study|Sponsor Decision|1|||
164088551|NCT02228382|592688837|FG000|Overall Study|Participant refused further follow-up|0|||
164088552|NCT02228382|592688838|FG001|Overall Study|Participant refused further follow-up|0|||
164088553|NCT02228382|592688839|FG002|Overall Study|Participant refused further follow-up|1|||
164088554|NCT02228382|592688840|FG003|Overall Study|Participant refused further follow-up|0|||
164088555|NCT02228382|592688841|FG004|Overall Study|Participant refused further follow-up|0|||
164088556|NCT02228382|592688837|FG000|Overall Study|Study terminated by sponsor|3|||
164088557|NCT02228382|592688838|FG001|Overall Study|Study terminated by sponsor|5|||
164088558|NCT02228382|592688839|FG002|Overall Study|Study terminated by sponsor|7|||
164088559|NCT02228382|592688840|FG003|Overall Study|Study terminated by sponsor|0|||
164088560|NCT02228382|592688841|FG004|Overall Study|Study terminated by sponsor|0|||
164088561|NCT02228382|592688837|FG000|Overall Study|Lost to Follow-up|0|||
164346590|NCT03010176|593645074|FG004|Overall Study|Sponsor Decision|6|||
164346591|NCT03010176|593645075|FG005|Overall Study|Sponsor Decision|0|||
164346592|NCT03010176|593645070|FG000|Overall Study|Withdrawal by Subject|11|||
164346593|NCT03010176|593645071|FG001|Overall Study|Withdrawal by Subject|9|||
164346594|NCT03010176|593645072|FG002|Overall Study|Withdrawal by Subject|3|||
164346595|NCT03010176|593645073|FG003|Overall Study|Withdrawal by Subject|0|||
164346596|NCT03010176|593645074|FG004|Overall Study|Withdrawal by Subject|4|||
164346597|NCT03010176|593645075|FG005|Overall Study|Withdrawal by Subject|0|||
164346598|NCT04220866|593645076|FG000|Overall Study|Death|4|||
164346599|NCT04220866|593645077|FG001|Overall Study|Death|5|||
164346600|NCT04220866|593645076|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
164346601|NCT04220866|593645077|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
164346602|NCT04220866|593645076|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
164346603|NCT04220866|593645077|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
164346604|NCT04220866|593645076|FG000|Overall Study|Withdrawal by Subject|0|||
164346605|NCT04220866|593645077|FG001|Overall Study|Withdrawal by Subject|1|||
164346606|NCT00709761|593645082|FG000|Overall Study|Withdrawal by Subject|8|||
164346607|NCT00709761|593645082|FG000|Overall Study|study closed/terminated|17|||
164346608|NCT00709761|593645082|FG000|Overall Study|Lost to Follow-up|2|||
164346609|NCT03478930|593645086|FG000|Overall Study|Adverse Event|0|||
164346610|NCT03478930|593645087|FG001|Overall Study|Adverse Event|1|||
164346611|NCT03478930|593645086|FG000|Overall Study|Lack of Efficacy|3|||
164346612|NCT03478930|593645087|FG001|Overall Study|Lack of Efficacy|3|||
164346613|NCT03478930|593645086|FG000|Overall Study|Withdrawal by Subject|6|||
164346614|NCT03478930|593645087|FG001|Overall Study|Withdrawal by Subject|5|||
164346615|NCT00555971|593645090|FG000|Overall Study|Adverse Event|1|||
164346616|NCT00555971|593645091|FG001|Overall Study|Adverse Event|1|||
164346617|NCT02573311|593645092|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
164346618|NCT02573311|593645093|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
164346619|NCT02573311|593645092|FG000|Disposition for Part 2|Physician Decision|25|||
164346620|NCT02573311|593645093|FG001|Disposition for Part 2|Physician Decision|7|||
164346621|NCT02573311|593645092|FG000|Disposition for Part 2|Adverse Event|36|||
164346622|NCT02573311|593645093|FG001|Disposition for Part 2|Adverse Event|5|||
164346623|NCT02573311|593645092|FG000|Disposition for Part 2|Lost to Follow-up|76|||
164346624|NCT02573311|593645093|FG001|Disposition for Part 2|Lost to Follow-up|7|||
164346625|NCT02573311|593645092|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
164346626|NCT02573311|593645093|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
164346627|NCT02573311|593645092|FG000|Disposition for Part 2|Investigator decision|0|||
164346628|NCT02573311|593645093|FG001|Disposition for Part 2|Investigator decision|1|||
164346629|NCT02573311|593645092|FG000|Disposition for Part 2|Other than specified above|13|||
164346630|NCT02573311|593645093|FG001|Disposition for Part 2|Other than specified above|3|||
164346631|NCT01328431|593645094|FG000|Baseline|Protocol Violation|0|||
164346632|NCT01328431|593645095|FG001|Baseline|Protocol Violation|2|||
164346633|NCT01328431|593645094|FG000|1 Month (1M)|Lost to Follow-up|55|||
164346634|NCT01328431|593645095|FG001|1 Month (1M)|Lost to Follow-up|58|||
164346635|NCT01328431|593645094|FG000|3 Month (3M)|Death|2|||
164346636|NCT01328431|593645095|FG001|3 Month (3M)|Death|2|||
164346637|NCT01328431|593645094|FG000|3 Month (3M)|Lost to Follow-up|75|||
164346638|NCT01328431|593645095|FG001|3 Month (3M)|Lost to Follow-up|70|||
164346639|NCT01328431|593645094|FG000|12 Month (12M)|Death|2|||
164346640|NCT01328431|593645095|FG001|12 Month (12M)|Death|6|||
164346641|NCT01328431|593645094|FG000|12 Month (12M)|Lost to Follow-up|82|||
164346642|NCT01328431|593645095|FG001|12 Month (12M)|Lost to Follow-up|91|||
164346643|NCT01427972|593645098|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346644|NCT01427972|593645099|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346645|NCT01427972|593645100|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346646|NCT01427972|593645101|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346647|NCT01427972|593645102|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346648|NCT01427972|593645103|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346649|NCT01427972|593645104|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346650|NCT01427972|593645105|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
164346651|NCT01427972|593645106|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346652|NCT01427972|593645107|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346653|NCT01427972|593645108|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346654|NCT01427972|593645109|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
164346655|NCT01427972|593645098|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346656|NCT01427972|593645099|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346657|NCT01427972|593645100|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164088562|NCT02228382|592688838|FG001|Overall Study|Lost to Follow-up|0|||
164088563|NCT02228382|592688839|FG002|Overall Study|Lost to Follow-up|3|||
164088564|NCT02228382|592688840|FG003|Overall Study|Lost to Follow-up|1|||
164088565|NCT02228382|592688841|FG004|Overall Study|Lost to Follow-up|0|||
164088566|NCT02228382|592688837|FG000|Overall Study|Withdrawal by Subject|0|||
164088567|NCT02228382|592688838|FG001|Overall Study|Withdrawal by Subject|3|||
164088568|NCT02228382|592688839|FG002|Overall Study|Withdrawal by Subject|2|||
164088569|NCT02228382|592688840|FG003|Overall Study|Withdrawal by Subject|1|||
164088570|NCT02228382|592688841|FG004|Overall Study|Withdrawal by Subject|0|||
164088571|NCT02228382|592688837|FG000|Overall Study|Other|2|||
164088572|NCT02228382|592688838|FG001|Overall Study|Other|3|||
164088573|NCT02228382|592688839|FG002|Overall Study|Other|3|||
164088574|NCT02228382|592688840|FG003|Overall Study|Other|0|||
164088575|NCT02228382|592688841|FG004|Overall Study|Other|0|||
164088576|NCT02396381|592688843|FG000|Overall Study|Adverse Event|3|||
164088577|NCT02396381|592688844|FG001|Overall Study|Adverse Event|2|||
164088578|NCT02396381|592688843|FG000|Overall Study|Withdrawal by Subject|33|||
164088579|NCT02396381|592688844|FG001|Overall Study|Withdrawal by Subject|24|||
164088580|NCT02396381|592688843|FG000|Overall Study|Lost to Follow-up|49|||
164088581|NCT02396381|592688844|FG001|Overall Study|Lost to Follow-up|31|||
164088582|NCT02396381|592688843|FG000|Overall Study|Protocol Violation|1|||
164088583|NCT02396381|592688844|FG001|Overall Study|Protocol Violation|0|||
164088584|NCT02396381|592688843|FG000|Overall Study|Site terminated by sponsor|7|||
164088585|NCT02396381|592688844|FG001|Overall Study|Site terminated by sponsor|8|||
164088586|NCT02396381|592688843|FG000|Overall Study|Physician Decision|5|||
164088587|NCT02396381|592688844|FG001|Overall Study|Physician Decision|5|||
164088588|NCT02396381|592688843|FG000|Overall Study|Pregnancy|2|||
164088589|NCT02396381|592688844|FG001|Overall Study|Pregnancy|0|||
164088590|NCT02396381|592688843|FG000|Overall Study|Non-compliance with study procedures|1|||
164088591|NCT02396381|592688844|FG001|Overall Study|Non-compliance with study procedures|0|||
164088592|NCT02396381|592688843|FG000|Overall Study|Moved out of town/state|1|||
164088593|NCT02396381|592688844|FG001|Overall Study|Moved out of town/state|3|||
164088594|NCT02396381|592688843|FG000|Overall Study|Could not complete visit|1|||
164088595|NCT02396381|592688844|FG001|Overall Study|Could not complete visit|0|||
164088596|NCT02396381|592688843|FG000|Overall Study|Possible conflict of interest|1|||
164088597|NCT02396381|592688844|FG001|Overall Study|Possible conflict of interest|0|||
164088598|NCT02396381|592688843|FG000|Overall Study|Randomization/Screening Error|3|||
164088599|NCT02396381|592688844|FG001|Overall Study|Randomization/Screening Error|1|||
164088600|NCT00275002|592688845|FG000|Overall Study|Death|1|||
164088601|NCT00275002|592688846|FG001|Overall Study|Death|0|||
164088602|NCT00275002|592688845|FG000|Overall Study|Disease progression|21|||
164088603|NCT00275002|592688846|FG001|Overall Study|Disease progression|15|||
164088604|NCT00275002|592688845|FG000|Overall Study|Adverse Event|0|||
164088605|NCT00275002|592688846|FG001|Overall Study|Adverse Event|1|||
164088606|NCT05014204|592688847|FG000|Overall Study|Withdrawal by Subject|1|||
164088607|NCT05014204|592688847|FG000|Overall Study|Physician Decision|1|||
164088608|NCT00113490|592688851|FG000|Overall Study|Withdrawal by Subject|1|||
164088609|NCT00113490|592688852|FG001|Overall Study|Withdrawal by Subject|3|||
164088610|NCT00113490|592688851|FG000|Overall Study|Lost to Follow-up|1|||
164088611|NCT00113490|592688852|FG001|Overall Study|Lost to Follow-up|0|||
164088612|NCT00819247|592688853|FG000|Overall Study|Adverse Event|0|||
164088613|NCT00819247|592688854|FG001|Overall Study|Adverse Event|5|||
164088614|NCT00819247|592688855|FG002|Overall Study|Adverse Event|3|||
164088615|NCT00819247|592688853|FG000|Overall Study|Insufficient testosterone response|5|||
164088616|NCT00819247|592688854|FG001|Overall Study|Insufficient testosterone response|8|||
164088617|NCT00819247|592688855|FG002|Overall Study|Insufficient testosterone response|10|||
164088618|NCT00819247|592688853|FG000|Overall Study|Withdrawal by Subject|1|||
164088619|NCT00819247|592688854|FG001|Overall Study|Withdrawal by Subject|0|||
164088620|NCT00819247|592688855|FG002|Overall Study|Withdrawal by Subject|0|||
164088621|NCT00819247|592688853|FG000|Overall Study|Protocol Violation|1|||
164088622|NCT00819247|592688854|FG001|Overall Study|Protocol Violation|0|||
164294089|NCT00878501|593450003|FG002|Overall Study|Withdrawal by Subject|2|||
164294090|NCT00878501|593450001|FG000|Overall Study|Protocol Violation|0|||
164294091|NCT00878501|593450002|FG001|Overall Study|Protocol Violation|0|||
164088623|NCT00819247|592688855|FG002|Overall Study|Protocol Violation|1|||
164088624|NCT00819247|592688853|FG000|Overall Study|Mistakenly withdrawn|0|||
164088625|NCT00819247|592688854|FG001|Overall Study|Mistakenly withdrawn|1|||
164088626|NCT00819247|592688855|FG002|Overall Study|Mistakenly withdrawn|0|||
164088627|NCT00819247|592688853|FG000|Overall Study|Bad prostate-specific antigen response|3|||
164088628|NCT00819247|592688854|FG001|Overall Study|Bad prostate-specific antigen response|2|||
164088629|NCT00819247|592688855|FG002|Overall Study|Bad prostate-specific antigen response|0|||
164088630|NCT00819247|592688853|FG000|Overall Study|Other|1|||
164088631|NCT00819247|592688854|FG001|Overall Study|Other|0|||
164088632|NCT00819247|592688855|FG002|Overall Study|Other|0|||
164088633|NCT04652453|592688857|FG000|Overall Study|Death|8|||
164088634|NCT04652453|592688858|FG001|Overall Study|Death|2|||
164088635|NCT04652453|592688859|FG002|Overall Study|Death|0|||
164088636|NCT04652453|592688857|FG000|Overall Study|Hospice|5|||
164346658|NCT01427972|593645101|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346659|NCT01427972|593645102|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346660|NCT01427972|593645103|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
164346661|NCT01427972|593645104|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346662|NCT01427972|593645105|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346663|NCT01427972|593645106|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346664|NCT01427972|593645107|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346665|NCT01427972|593645108|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346666|NCT01427972|593645109|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
164346667|NCT01427972|593645098|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346668|NCT01427972|593645099|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
164346669|NCT01427972|593645100|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346670|NCT01427972|593645101|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346671|NCT01427972|593645102|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346672|NCT01427972|593645103|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346673|NCT01427972|593645104|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346674|NCT01427972|593645105|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346675|NCT01427972|593645106|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346676|NCT01427972|593645107|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346677|NCT01427972|593645108|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346678|NCT01427972|593645109|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
164346679|NCT02094677|593645110|FG000|Overall Study|Screening|3|||
164346680|NCT02094677|593645111|FG001|Overall Study|Screening|1|||
164346681|NCT04967443|593645117|FG000|Open Label Treatment|Death|1|||
164346682|NCT04967443|593645118|FG001|Open Label Treatment|Death|0|||
164346683|NCT04967443|593645119|FG002|Open Label Treatment|Death|0|||
164346684|NCT04967443|593645120|FG003|Open Label Treatment|Death|0|||
164346685|NCT04967443|593645121|FG004|Open Label Treatment|Death|0|||
164346686|NCT04967443|593645122|FG005|Open Label Treatment|Death|0|||
164346687|NCT04967443|593645123|FG006|Open Label Treatment|Death|0|||
164346688|NCT04967443|593645124|FG007|Open Label Treatment|Death|0|||
164346689|NCT04967443|593645117|FG000|Open Label Treatment|Lost to Follow-up|0|||
164346690|NCT04967443|593645118|FG001|Open Label Treatment|Lost to Follow-up|0|||
164346691|NCT04967443|593645119|FG002|Open Label Treatment|Lost to Follow-up|1|||
164346692|NCT04967443|593645120|FG003|Open Label Treatment|Lost to Follow-up|0|||
164346693|NCT04967443|593645121|FG004|Open Label Treatment|Lost to Follow-up|0|||
164346694|NCT04967443|593645122|FG005|Open Label Treatment|Lost to Follow-up|0|||
164346695|NCT04967443|593645123|FG006|Open Label Treatment|Lost to Follow-up|0|||
164346696|NCT04967443|593645124|FG007|Open Label Treatment|Lost to Follow-up|0|||
164346697|NCT04967443|593645117|FG000|Open Label Treatment|Withdrawal by Subject|0|||
164346698|NCT04967443|593645118|FG001|Open Label Treatment|Withdrawal by Subject|1|||
164346699|NCT04967443|593645119|FG002|Open Label Treatment|Withdrawal by Subject|0|||
164346700|NCT04967443|593645120|FG003|Open Label Treatment|Withdrawal by Subject|1|||
164346701|NCT04967443|593645121|FG004|Open Label Treatment|Withdrawal by Subject|0|||
164346702|NCT04967443|593645122|FG005|Open Label Treatment|Withdrawal by Subject|1|||
164346703|NCT04967443|593645123|FG006|Open Label Treatment|Withdrawal by Subject|2|||
164346704|NCT04967443|593645124|FG007|Open Label Treatment|Withdrawal by Subject|3|||
164346705|NCT04967443|593645117|FG000|Follow-Up|Death|1|||
164346706|NCT04967443|593645118|FG001|Follow-Up|Death|0|||
164346707|NCT04967443|593645119|FG002|Follow-Up|Death|0|||
164346708|NCT04967443|593645120|FG003|Follow-Up|Death|0|||
164346709|NCT04967443|593645121|FG004|Follow-Up|Death|0|||
164346710|NCT04967443|593645122|FG005|Follow-Up|Death|0|||
164346711|NCT04967443|593645123|FG006|Follow-Up|Death|0|||
164346712|NCT04967443|593645124|FG007|Follow-Up|Death|0|||
164346713|NCT04967443|593645117|FG000|Follow-Up|Lost to Follow-up|0|||
164346714|NCT04967443|593645118|FG001|Follow-Up|Lost to Follow-up|0|||
164346715|NCT04967443|593645119|FG002|Follow-Up|Lost to Follow-up|1|||
164346716|NCT04967443|593645120|FG003|Follow-Up|Lost to Follow-up|1|||
164346717|NCT04967443|593645121|FG004|Follow-Up|Lost to Follow-up|0|||
164346718|NCT04967443|593645122|FG005|Follow-Up|Lost to Follow-up|0|||
164346719|NCT04967443|593645123|FG006|Follow-Up|Lost to Follow-up|0|||
164346720|NCT04967443|593645124|FG007|Follow-Up|Lost to Follow-up|0|||
164346721|NCT04967443|593645117|FG000|Follow-Up|Withdrawal by Subject|0|||
164346722|NCT04967443|593645118|FG001|Follow-Up|Withdrawal by Subject|1|||
164346723|NCT04967443|593645119|FG002|Follow-Up|Withdrawal by Subject|0|||
164346724|NCT04967443|593645120|FG003|Follow-Up|Withdrawal by Subject|1|||
164346725|NCT04967443|593645121|FG004|Follow-Up|Withdrawal by Subject|0|||
164346726|NCT04967443|593645122|FG005|Follow-Up|Withdrawal by Subject|1|||
164346727|NCT04967443|593645123|FG006|Follow-Up|Withdrawal by Subject|2|||
164346728|NCT04967443|593645124|FG007|Follow-Up|Withdrawal by Subject|3|||
164346729|NCT04502693|593645125|FG000|Overall Study|Adverse Event|7|||
164346730|NCT04502693|593645126|FG001|Overall Study|Adverse Event|6|||
164346731|NCT04502693|593645127|FG002|Overall Study|Adverse Event|11|||
164088637|NCT04652453|592688858|FG001|Overall Study|Hospice|5|||
164088638|NCT04652453|592688859|FG002|Overall Study|Hospice|0|||
164088639|NCT04652453|592688857|FG000|Overall Study|Withdrawal by Subject|2|||
164088640|NCT04652453|592688858|FG001|Overall Study|Withdrawal by Subject|0|||
164088641|NCT04652453|592688859|FG002|Overall Study|Withdrawal by Subject|0|||
164088642|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
164088643|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
164088644|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088645|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088646|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088647|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
164088648|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
164088649|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088650|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088651|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088652|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088653|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088654|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088655|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
164088656|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088657|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088658|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088659|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088660|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088661|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
164088662|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
164088663|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
163898147|NCT02112916|591999468|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
163898148|NCT02112916|591999469|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
163898149|NCT02112916|591999470|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
164088664|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088665|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088666|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
163898150|NCT02112916|591999471|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
164088667|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088668|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088669|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
164088670|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
164088671|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088672|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088673|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088674|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088675|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088676|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
164088677|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088678|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088679|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088680|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088681|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088682|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088683|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
164088684|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088685|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088686|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088687|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088688|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088689|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
164088690|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
164088691|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088692|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088693|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088694|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088695|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088696|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088697|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
164088698|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088699|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088700|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088701|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088702|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088703|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088704|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
164088705|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088706|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088707|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088708|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088709|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088710|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088711|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
164088712|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
164088713|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
164088714|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
164088715|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088716|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088717|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
164088718|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
164088719|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088720|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088721|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088722|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088723|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088724|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088725|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
164088726|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088727|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
164088728|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088729|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088730|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088731|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
164294092|NCT00878501|593450003|FG002|Overall Study|Protocol Violation|1|||
164294093|NCT00878501|593450001|FG000|Overall Study|Incorrect enrolment|1|||
163898151|NCT03782116|591999477|FG000|Completed Intervetion|Lost to Follow-up|11|||
163898152|NCT03782116|591999478|FG001|Completed Intervetion|Lost to Follow-up|7|||
163898153|NCT03782116|591999477|FG000|Completed Intervetion|Withdrawal by Subject|6|||
163898154|NCT03782116|591999478|FG001|Completed Intervetion|Withdrawal by Subject|5|||
163898155|NCT03782116|591999477|FG000|Included in Analysis|Protocol Violation|5|||
163898156|NCT03782116|591999478|FG001|Included in Analysis|Protocol Violation|5|||
163898157|NCT04908514|591999479|FG000|Overall Study|Lost to Follow-up|2|||
163898158|NCT04908514|591999479|FG000|Overall Study|Withdrawal by Subject|1|||
163898159|NCT00945724|591999480|FG000|Overall Study|Withdrawal by Subject|2|||
163898160|NCT00945724|591999480|FG000|Overall Study|Physician Decision|1|||
163898161|NCT00945724|591999480|FG000|Overall Study|Adverse Event|5|||
163898162|NCT00945724|591999480|FG000|Overall Study|Second malignancy|1|||
163898163|NCT05039021|592000165|FG000|Overall Study|Death|1|||
163898164|NCT05039021|592000165|FG000|Overall Study|Lost to Follow-up|3|||
163898165|NCT00994643|592000166|FG000|Overall Study|Withdrawal by Subject|1|||
163898166|NCT02566889|592000167|FG000|Overall Study|Withdrawal by Subject|3|||
163898167|NCT02566889|592000168|FG001|Overall Study|Withdrawal by Subject|1|||
163898168|NCT02566889|592000167|FG000|Overall Study|Adverse Event|4|||
163898169|NCT02566889|592000168|FG001|Overall Study|Adverse Event|2|||
163898170|NCT02566889|592000167|FG000|Overall Study|Other|6|||
163898171|NCT02566889|592000168|FG001|Overall Study|Other|2|||
163898172|NCT01964300|592000185|FG000|Overall Study|Ineligible after enrollment|0|||
163898173|NCT01964300|592000186|FG001|Overall Study|Ineligible after enrollment|1|||
163898174|NCT01964300|592000185|FG000|Overall Study|Adverse Event|1|||
163898175|NCT01964300|592000186|FG001|Overall Study|Adverse Event|1|||
163898176|NCT01964300|592000185|FG000|Overall Study|Lack of Efficacy|3|||
163898177|NCT01964300|592000186|FG001|Overall Study|Lack of Efficacy|5|||
163898178|NCT01964300|592000185|FG000|Overall Study|Withdrawal by Subject|0|||
163898179|NCT01964300|592000186|FG001|Overall Study|Withdrawal by Subject|1|||
163898180|NCT01964300|592000185|FG000|Overall Study|To receive alternative therapy|1|||
163898181|NCT01964300|592000186|FG001|Overall Study|To receive alternative therapy|2|||
163898182|NCT01964300|592000185|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
163898183|NCT01964300|592000186|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
163898184|NCT01964300|592000185|FG000|Overall Study|Weight criteria not met|0|||
163898185|NCT01964300|592000186|FG001|Overall Study|Weight criteria not met|1|||
163898186|NCT03653364|592000188|FG000|Overall Study|Withdrawal by Subject|1|||
163898187|NCT03653364|592000188|FG000|Overall Study|Enrolled in Error|1|||
163898188|NCT03653364|592000188|FG000|Overall Study|Death|1|||
163898189|NCT03286114|592000191|FG000|Overall Study|Adverse Event|6|||
163898190|NCT03286114|592000191|FG000|Overall Study|Death|3|||
163898191|NCT03983382|592000194|FG000|Overall Study|Death|1|||
163898192|NCT03983382|592000194|FG000|Overall Study|Lost to Follow-up|3|||
163898193|NCT03983382|592000194|FG000|Overall Study|Physician Decision|2|||
163898194|NCT03983382|592000194|FG000|Overall Study|Withdrawal by Subject|10|||
163898195|NCT03983382|592000194|FG000|Overall Study|Change in cancer treatment|2|||
163898196|NCT01260896|592000198|FG000|First Intervention|Withdrawn Due to Emesis|2|||
163898197|NCT01260896|592000199|FG001|First Intervention|Withdrawn Due to Emesis|0|||
163898198|NCT02754596|592000206|FG000|Overall Study|Withdrawal by Subject|3|||
163898199|NCT02754596|592000207|FG001|Overall Study|Withdrawal by Subject|4|||
163898200|NCT02754596|592000208|FG002|Overall Study|Withdrawal by Subject|0|||
163898201|NCT02754596|592000206|FG000|Overall Study|Physician Decision|1|||
163898202|NCT02754596|592000207|FG001|Overall Study|Physician Decision|1|||
163898203|NCT02754596|592000208|FG002|Overall Study|Physician Decision|1|||
163898204|NCT02754596|592000206|FG000|Overall Study|Lost to Follow-up|1|||
163898205|NCT02754596|592000207|FG001|Overall Study|Lost to Follow-up|1|||
163898206|NCT02754596|592000208|FG002|Overall Study|Lost to Follow-up|2|||
163898207|NCT02754596|592000206|FG000|Overall Study|Death|0|||
163898208|NCT02754596|592000207|FG001|Overall Study|Death|2|||
163898209|NCT02754596|592000208|FG002|Overall Study|Death|0|||
163898210|NCT02754596|592000206|FG000|Overall Study|Adverse Event|1|||
163898211|NCT02754596|592000207|FG001|Overall Study|Adverse Event|0|||
163898212|NCT02754596|592000208|FG002|Overall Study|Adverse Event|1|||
163898213|NCT02754596|592000206|FG000|Overall Study|Other|1|||
163898214|NCT02754596|592000207|FG001|Overall Study|Other|0|||
163898215|NCT02754596|592000208|FG002|Overall Study|Other|0|||
163898216|NCT04018495|592000226|FG000|Overall Study|Physician Decision|1|||
163898217|NCT05934292|592000235|FG000|Overall Study|Lost to Follow-up|0|||
163898218|NCT05934292|592000236|FG001|Overall Study|Lost to Follow-up|0|||
163898219|NCT05934292|592000237|FG002|Overall Study|Lost to Follow-up|1|||
163898220|NCT05934292|592000238|FG003|Overall Study|Lost to Follow-up|0|||
163898221|NCT02890355|592000239|FG000|Overall Study|Adverse Event|5|||
163898222|NCT02890355|592000240|FG001|Overall Study|Adverse Event|5|||
163898223|NCT02890355|592000239|FG000|Overall Study|Refusal unrelated to adverse event|5|||
163898224|NCT02890355|592000240|FG001|Overall Study|Refusal unrelated to adverse event|10|||
163898225|NCT02890355|592000239|FG000|Overall Study|Progression/relapse|46|||
163898226|NCT02890355|592000240|FG001|Overall Study|Progression/relapse|39|||
163898227|NCT02890355|592000239|FG000|Overall Study|Not protocol specified|3|||
164088732|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088733|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088734|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088735|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088736|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088737|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088738|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088739|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
164088740|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
164088741|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088742|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088743|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088744|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088745|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
164088746|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088747|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088748|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088749|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088750|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088751|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088752|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088753|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
164088754|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088755|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088756|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088757|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
164088758|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
164088759|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088760|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088761|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
164088762|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
164088763|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088764|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088765|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088766|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088767|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
164088768|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088769|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088770|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088771|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088772|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088773|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088774|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088775|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
164088776|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
164088777|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088778|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088779|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088780|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088781|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
164088782|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088783|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088784|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088785|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088786|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088787|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088788|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088789|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088790|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
164088791|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164294094|NCT00878501|593450002|FG001|Overall Study|Incorrect enrolment|2|||
164294095|NCT00878501|593450003|FG002|Overall Study|Incorrect enrolment|0|||
164294096|NCT00878501|593450001|FG000|Overall Study|Intake of prohibited concom. medication|0|||
164294097|NCT00878501|593450002|FG001|Overall Study|Intake of prohibited concom. medication|0|||
164294098|NCT00878501|593450003|FG002|Overall Study|Intake of prohibited concom. medication|1|||
164294099|NCT00878501|593450001|FG000|Overall Study|Mis-randomisation of patient|1|||
164004586|NCT00561353|592380822|FG005|Overall Study|Withdrawal by Subject|0|||
164004587|NCT00561353|592380823|FG006|Overall Study|Withdrawal by Subject|0|||
164004588|NCT00561353|592380824|FG007|Overall Study|Withdrawal by Subject|0|||
164004589|NCT00561353|592380825|FG008|Overall Study|Withdrawal by Subject|0|||
164004590|NCT00561353|592380826|FG009|Overall Study|Withdrawal by Subject|0|||
164004591|NCT01273818|592380827|FG000|Overall Study|Physician Decision|13|||
164004592|NCT01273818|592380828|FG001|Overall Study|Physician Decision|2|||
164004593|NCT01273818|592380829|FG002|Overall Study|Physician Decision|9|||
164004594|NCT01097044|592380843|FG000|Overall Study|Withdrawal by Subject|4|||
164004595|NCT01097044|592380844|FG001|Overall Study|Withdrawal by Subject|4|||
164004596|NCT01097044|592380843|FG000|Overall Study|Lost to Follow-up|1|||
164004597|NCT01097044|592380844|FG001|Overall Study|Lost to Follow-up|0|||
164004598|NCT01097044|592380843|FG000|Overall Study|Withdrawal by Sponsor|0|||
164004599|NCT01097044|592380844|FG001|Overall Study|Withdrawal by Sponsor|1|||
164004600|NCT01682044|592380845|FG000|Overall Study|Death|1|||
164004601|NCT01682044|592380845|FG000|Overall Study|Progression|3|||
164004602|NCT02452359|592380849|FG000|Overall Study|Adverse Event|1|||
164004603|NCT02452359|592380849|FG000|Overall Study|Lost to Follow-up|15|||
164004604|NCT02452359|592380849|FG000|Overall Study|Pregnancy|1|||
164004605|NCT02452359|592380849|FG000|Overall Study|Withdrawal by Subject|4|||
164004606|NCT03414359|592380850|FG000|Overall Study|Lack of Efficacy|1|||
164004607|NCT03414359|592380851|FG001|Overall Study|Lack of Efficacy|1|||
164004608|NCT03414359|592380850|FG000|Overall Study|Protocol Violation|0|||
164004609|NCT03414359|592380851|FG001|Overall Study|Protocol Violation|1|||
164004610|NCT04865731|592380854|FG000|Overall Study|Physician Decision|2|||
164004611|NCT04865731|592380855|FG001|Overall Study|Physician Decision|1|||
164004612|NCT04865731|592380854|FG000|Overall Study|Adverse Event|1|||
164004613|NCT04865731|592380855|FG001|Overall Study|Adverse Event|0|||
164004614|NCT04865731|592380854|FG000|Overall Study|Withdrawal by Subject|0|||
164004615|NCT04865731|592380855|FG001|Overall Study|Withdrawal by Subject|1|||
164004616|NCT00222105|592380858|FG000|Overall Study|Removed due to wrong diagnosis|1|||
164004617|NCT00222105|592380858|FG000|Overall Study|Withdrawal by Subject|1|||
164004618|NCT00222105|592380858|FG000|Overall Study|Adverse Event|8|||
164004619|NCT00222105|592380858|FG000|Overall Study|Treatment delays|2|||
164004620|NCT00222105|592380858|FG000|Overall Study|Death|2|||
164004621|NCT01672892|592382467|FG000|Overall Study|Protocol Violation|7|||
164004622|NCT01672892|592382468|FG001|Overall Study|Protocol Violation|3|||
164004623|NCT02981472|592382479|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
164004624|NCT02981472|592382480|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
164004625|NCT02981472|592382479|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164004626|NCT02981472|592382480|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164004627|NCT02981472|592382479|FG000|Treatment Period|Adverse Event|6|||
164004628|NCT02981472|592382480|FG001|Treatment Period|Adverse Event|1|||
164004629|NCT02981472|592382479|FG000|Treatment Period|Participant withdrew consent|1|||
164004630|NCT02981472|592382480|FG001|Treatment Period|Participant withdrew consent|0|||
164004631|NCT02981472|592382479|FG000|Treatment Period|Lost to Follow-up|0|||
164004632|NCT02981472|592382480|FG001|Treatment Period|Lost to Follow-up|1|||
164004633|NCT01473004|592382486|FG000|Overall Study|Incomplete Lobar Treatment|1|||
164004634|NCT01473004|592382487|FG001|Overall Study|Incomplete Lobar Treatment|0|||
164004635|NCT00698516|592382488|FG000|Overall Study|Study Termination|2|||
164004636|NCT00698516|592382488|FG000|Overall Study|Withdrawal by Subject|3|||
164004637|NCT05882890|592382489|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
164004638|NCT01584024|592382497|FG000|Overall Study|Lost to Follow-up|10|||
164004639|NCT01584024|592382497|FG000|Overall Study|Withdrawal by Subject|3|||
164004640|NCT00719810|592382503|FG000|Overall Study|Adverse Event|0|||
164004641|NCT00719810|592382504|FG001|Overall Study|Adverse Event|2|||
164004642|NCT00719810|592382505|FG002|Overall Study|Adverse Event|3|||
164004643|NCT00719810|592382503|FG000|Overall Study|Lost to Follow-up|2|||
164004644|NCT00719810|592382504|FG001|Overall Study|Lost to Follow-up|0|||
164004645|NCT00719810|592382505|FG002|Overall Study|Lost to Follow-up|3|||
164004646|NCT00719810|592382503|FG000|Overall Study|Physician Decision|0|||
164004647|NCT00719810|592382504|FG001|Overall Study|Physician Decision|1|||
164004648|NCT00719810|592382505|FG002|Overall Study|Physician Decision|0|||
164004649|NCT00719810|592382503|FG000|Overall Study|Withdrawal by Subject|1|||
164004650|NCT00719810|592382504|FG001|Overall Study|Withdrawal by Subject|1|||
164294100|NCT00878501|593450002|FG001|Overall Study|Mis-randomisation of patient|0|||
164004651|NCT00719810|592382505|FG002|Overall Study|Withdrawal by Subject|2|||
164004652|NCT04893265|592382528|FG000|Overall Study|Withdrawal by Subject|2|||
164004653|NCT04893265|592382529|FG001|Overall Study|Withdrawal by Subject|5|||
164004654|NCT04893265|592382528|FG000|Overall Study|Lost to Follow-up|0|||
164004655|NCT04893265|592382529|FG001|Overall Study|Lost to Follow-up|4|||
164004656|NCT02465034|592382531|FG000|Overall Study|Withdrawal by Subject|1|||
164004657|NCT02465034|592382532|FG001|Overall Study|Withdrawal by Subject|1|||
164004658|NCT02465034|592382531|FG000|Overall Study|Screen fail|2|||
164004659|NCT02465034|592382532|FG001|Overall Study|Screen fail|0|||
164004660|NCT02465034|592382531|FG000|Overall Study|Could not be scheduled for study visit|0|||
164004661|NCT02465034|592382532|FG001|Overall Study|Could not be scheduled for study visit|5|||
164004662|NCT00573131|592382533|FG000|Overall Study|Withdrawal by Subject|10|||
164004663|NCT00573131|592382534|FG001|Overall Study|Withdrawal by Subject|8|||
164004664|NCT03090191|592382540|FG000|Overall Study|Adverse Event|90|||
164004665|NCT03090191|592382541|FG001|Overall Study|Adverse Event|72|||
164004666|NCT03090191|592382540|FG000|Overall Study|Death|365|||
164004667|NCT03090191|592382541|FG001|Overall Study|Death|358|||
164004668|NCT03090191|592382540|FG000|Overall Study|Lost to Follow-up|382|||
164004669|NCT03090191|592382541|FG001|Overall Study|Lost to Follow-up|394|||
164004670|NCT03090191|592382540|FG000|Overall Study|Physician Decision|77|||
164004671|NCT03090191|592382541|FG001|Overall Study|Physician Decision|66|||
164004672|NCT03090191|592382540|FG000|Overall Study|Protocol Violation|43|||
164004673|NCT03090191|592382541|FG001|Overall Study|Protocol Violation|52|||
164004674|NCT03090191|592382540|FG000|Overall Study|Withdrawal by Subject|2160|||
164004675|NCT03090191|592382541|FG001|Overall Study|Withdrawal by Subject|2133|||
164004676|NCT03090191|592382540|FG000|Overall Study|Site terminated|7|||
164004677|NCT03090191|592382541|FG001|Overall Study|Site terminated|8|||
164004678|NCT03090191|592382540|FG000|Overall Study|Other|66|||
164004679|NCT03090191|592382541|FG001|Overall Study|Other|60|||
164004680|NCT03090191|592382540|FG000|Overall Study|Withdrawn before any study vaccination|43|||
164004681|NCT03090191|592382541|FG001|Overall Study|Withdrawn before any study vaccination|52|||
164004682|NCT01324830|592382544|FG000|Overall Study|Progressive Disease|3|||
164004683|NCT01324830|592382545|FG001|Overall Study|Progressive Disease|2|||
164004684|NCT01324830|592382546|FG002|Overall Study|Progressive Disease|3|||
164004685|NCT01324830|592382547|FG003|Overall Study|Progressive Disease|3|||
164004686|NCT01324830|592382548|FG004|Overall Study|Progressive Disease|6|||
164004687|NCT01324830|592382549|FG005|Overall Study|Progressive Disease|6|||
164004688|NCT01324830|592382550|FG006|Overall Study|Progressive Disease|3|||
164004689|NCT01324830|592382551|FG007|Overall Study|Progressive Disease|3|||
164004690|NCT01324830|592382552|FG008|Overall Study|Progressive Disease|3|||
164004691|NCT01324830|592382553|FG009|Overall Study|Progressive Disease|6|||
164004692|NCT01324830|592382554|FG010|Overall Study|Progressive Disease|2|||
164004693|NCT01324830|592382555|FG011|Overall Study|Progressive Disease|1|||
164004694|NCT01324830|592382556|FG012|Overall Study|Progressive Disease|1|||
164004695|NCT01324830|592382557|FG013|Overall Study|Progressive Disease|1|||
164004696|NCT01324830|592382558|FG014|Overall Study|Progressive Disease|1|||
164004697|NCT01324830|592382559|FG015|Overall Study|Progressive Disease|3|||
164004698|NCT01324830|592382560|FG016|Overall Study|Progressive Disease|2|||
164004699|NCT01324830|592382561|FG017|Overall Study|Progressive Disease|3|||
164004700|NCT01324830|592382562|FG018|Overall Study|Progressive Disease|4|||
164004701|NCT01324830|592382544|FG000|Overall Study|Dose limiting toxicity|0|||
164004702|NCT01324830|592382545|FG001|Overall Study|Dose limiting toxicity|0|||
164004703|NCT01324830|592382546|FG002|Overall Study|Dose limiting toxicity|0|||
164004704|NCT01324830|592382547|FG003|Overall Study|Dose limiting toxicity|0|||
164004705|NCT01324830|592382548|FG004|Overall Study|Dose limiting toxicity|1|||
164004706|NCT01324830|592382549|FG005|Overall Study|Dose limiting toxicity|0|||
164004707|NCT01324830|592382550|FG006|Overall Study|Dose limiting toxicity|0|||
164004708|NCT01324830|592382551|FG007|Overall Study|Dose limiting toxicity|0|||
164004709|NCT01324830|592382552|FG008|Overall Study|Dose limiting toxicity|0|||
164004710|NCT01324830|592382553|FG009|Overall Study|Dose limiting toxicity|0|||
164004711|NCT01324830|592382554|FG010|Overall Study|Dose limiting toxicity|0|||
164004712|NCT01324830|592382555|FG011|Overall Study|Dose limiting toxicity|0|||
164004713|NCT01324830|592382556|FG012|Overall Study|Dose limiting toxicity|0|||
164004714|NCT01324830|592382557|FG013|Overall Study|Dose limiting toxicity|0|||
164004715|NCT01324830|592382558|FG014|Overall Study|Dose limiting toxicity|0|||
164004716|NCT01324830|592382559|FG015|Overall Study|Dose limiting toxicity|0|||
164004717|NCT01324830|592382560|FG016|Overall Study|Dose limiting toxicity|1|||
164004718|NCT01324830|592382561|FG017|Overall Study|Dose limiting toxicity|1|||
164004719|NCT01324830|592382562|FG018|Overall Study|Dose limiting toxicity|1|||
164004720|NCT01324830|592382544|FG000|Overall Study|Reason not mentioned above|0|||
164004721|NCT01324830|592382545|FG001|Overall Study|Reason not mentioned above|0|||
164004722|NCT01324830|592382546|FG002|Overall Study|Reason not mentioned above|0|||
164004723|NCT01324830|592382547|FG003|Overall Study|Reason not mentioned above|0|||
164004724|NCT01324830|592382548|FG004|Overall Study|Reason not mentioned above|0|||
164004725|NCT01324830|592382549|FG005|Overall Study|Reason not mentioned above|0|||
164004726|NCT01324830|592382550|FG006|Overall Study|Reason not mentioned above|0|||
164004727|NCT01324830|592382551|FG007|Overall Study|Reason not mentioned above|0|||
164004728|NCT01324830|592382552|FG008|Overall Study|Reason not mentioned above|0|||
164004729|NCT01324830|592382553|FG009|Overall Study|Reason not mentioned above|0|||
164004730|NCT01324830|592382554|FG010|Overall Study|Reason not mentioned above|0|||
164004731|NCT01324830|592382555|FG011|Overall Study|Reason not mentioned above|0|||
164004732|NCT01324830|592382556|FG012|Overall Study|Reason not mentioned above|0|||
164004733|NCT01324830|592382557|FG013|Overall Study|Reason not mentioned above|0|||
164004734|NCT01324830|592382558|FG014|Overall Study|Reason not mentioned above|0|||
164004735|NCT01324830|592382559|FG015|Overall Study|Reason not mentioned above|0|||
164004736|NCT01324830|592382560|FG016|Overall Study|Reason not mentioned above|0|||
164004737|NCT01324830|592382561|FG017|Overall Study|Reason not mentioned above|1|||
164132697|NCT01986010|592850659|FG004|Overall Study|Physician Decision|0|||
164294101|NCT00878501|593450003|FG002|Overall Study|Mis-randomisation of patient|0|||
164294102|NCT00878501|593450001|FG000|Overall Study|Administrative|0|||
163898228|NCT02890355|592000240|FG001|Overall Study|Not protocol specified|4|||
163898229|NCT02206828|592000241|FG000|Overall Study|Lost to Follow-up|7|||
163898230|NCT03391466|592001030|FG000|Overall Study|Death|84|||
163898231|NCT03391466|592001031|FG001|Overall Study|Death|91|||
163898232|NCT03391466|592001030|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
163898233|NCT03391466|592001031|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
163898234|NCT03391466|592001030|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
163898235|NCT03391466|592001031|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
163898236|NCT03391466|592001030|FG000|Overall Study|Lost to Follow-up|9|||
163898237|NCT03391466|592001031|FG001|Overall Study|Lost to Follow-up|5|||
163898238|NCT03391466|592001030|FG000|Overall Study|Reason Not Specified|2|||
163898239|NCT03391466|592001031|FG001|Overall Study|Reason Not Specified|2|||
163898240|NCT03391466|592001030|FG000|Overall Study|Investigator Decision|0|||
163898241|NCT03391466|592001031|FG001|Overall Study|Investigator Decision|1|||
163898242|NCT03140670|592001032|FG000|Overall Study|Withdrawal by Subject|2|||
163898243|NCT03140670|592001032|FG000|Overall Study|Lost to Follow-up|1|||
163898244|NCT03140670|592001032|FG000|Overall Study|Physician Decision|1|||
163898245|NCT00220805|592001033|FG000|Overall Study|Adverse Event|1|||
163898246|NCT00220805|592001034|FG001|Overall Study|Adverse Event|3|||
163898247|NCT00220805|592001033|FG000|Overall Study|Withdrawal by Subject|3|||
163898248|NCT00220805|592001034|FG001|Overall Study|Withdrawal by Subject|0|||
163898249|NCT00220805|592001033|FG000|Overall Study|Lack of Efficacy|1|||
163898250|NCT00220805|592001034|FG001|Overall Study|Lack of Efficacy|0|||
163898251|NCT00220805|592001033|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
163898252|NCT00220805|592001034|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
164088792|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088793|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088794|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088795|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
164088796|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088797|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088798|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088799|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
164088800|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088801|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088802|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088803|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088804|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088805|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088806|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088807|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088808|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088809|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
164088810|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088811|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088812|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088813|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088814|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088815|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088816|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088817|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
164088818|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
164088819|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088820|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088821|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088822|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088823|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
164088824|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088825|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088826|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088827|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088828|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088829|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088830|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088831|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
164088832|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088833|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088834|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088835|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088836|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088837|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
164088838|NCT04033445|592688861|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088839|NCT04033445|592688862|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088840|NCT04033445|592688863|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088841|NCT04033445|592688864|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088842|NCT04033445|592688865|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088843|NCT04033445|592688866|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088844|NCT04033445|592688867|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088845|NCT04033445|592688868|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
164088846|NCT04033445|592688869|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088847|NCT04033445|592688870|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088848|NCT04033445|592688871|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088849|NCT04033445|592688872|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088850|NCT04033445|592688873|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088851|NCT04033445|592688874|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
164088852|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088853|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088854|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088855|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088856|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088857|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088858|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088859|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164088860|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
164294103|NCT00878501|593450002|FG001|Overall Study|Administrative|0|||
163898253|NCT02325466|592001035|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
163898254|NCT02325466|592001036|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
164294104|NCT00878501|593450003|FG002|Overall Study|Administrative|1|||
164294105|NCT01194830|593450013|FG000|Overall Study|Adverse Event|3|||
164294106|NCT01194830|593450014|FG001|Overall Study|Adverse Event|2|||
164294107|NCT01194830|593450013|FG000|Overall Study|Protocol Violation|5|||
164294108|NCT01194830|593450014|FG001|Overall Study|Protocol Violation|4|||
164294109|NCT01194830|593450013|FG000|Overall Study|Lost to Follow-up|9|||
164088861|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
164132698|NCT01986010|592850660|FG005|Overall Study|Physician Decision|0|||
164294110|NCT01194830|593450014|FG001|Overall Study|Lost to Follow-up|7|||
164294111|NCT01194830|593450013|FG000|Overall Study|Withdrawal by Subject|2|||
164294112|NCT01194830|593450014|FG001|Overall Study|Withdrawal by Subject|1|||
164294113|NCT01194830|593450013|FG000|Overall Study|Lack of Efficacy|1|||
164294114|NCT01194830|593450014|FG001|Overall Study|Lack of Efficacy|1|||
164294115|NCT01194830|593450013|FG000|Overall Study|Non-compliance issues|4|||
164294116|NCT01194830|593450014|FG001|Overall Study|Non-compliance issues|4|||
164294117|NCT01194830|593450013|FG000|Overall Study|Other Reason|12|||
164294118|NCT01194830|593450014|FG001|Overall Study|Other Reason|8|||
164294119|NCT00866177|593450017|FG000|Overall Study|Withdrawal by Subject|1|||
164294120|NCT00866177|593450017|FG000|Overall Study|Not Treated|151|||
164294121|NCT03661723|593450029|FG000|Overall Study|Disease Progression|4|||
164294122|NCT03661723|593450030|FG001|Overall Study|Disease Progression|24|||
164294123|NCT03661723|593450031|FG002|Overall Study|Disease Progression|4|||
164294124|NCT03661723|593450032|FG003|Overall Study|Disease Progression|19|||
164294125|NCT03661723|593450029|FG000|Overall Study|Withdrawal by Subject|1|||
164294126|NCT03661723|593450030|FG001|Overall Study|Withdrawal by Subject|0|||
164294127|NCT03661723|593450031|FG002|Overall Study|Withdrawal by Subject|2|||
164294128|NCT03661723|593450032|FG003|Overall Study|Withdrawal by Subject|4|||
164294129|NCT03661723|593450029|FG000|Overall Study|Physician Decision|1|||
164294130|NCT03661723|593450030|FG001|Overall Study|Physician Decision|0|||
164294131|NCT03661723|593450031|FG002|Overall Study|Physician Decision|0|||
164294132|NCT03661723|593450032|FG003|Overall Study|Physician Decision|0|||
164294133|NCT03661723|593450029|FG000|Overall Study|Clinical Deterioration|0|||
164294134|NCT03661723|593450030|FG001|Overall Study|Clinical Deterioration|0|||
164294135|NCT03661723|593450031|FG002|Overall Study|Clinical Deterioration|0|||
164294136|NCT03661723|593450032|FG003|Overall Study|Clinical Deterioration|1|||
164294137|NCT03760029|593450033|FG000|Overall Study|Death|1|||
164294138|NCT03760029|593450034|FG001|Overall Study|Death|0|||
164294139|NCT03760029|593450035|FG002|Overall Study|Death|0|||
164294140|NCT03760029|593450033|FG000|Overall Study|Lost to Follow-up|0|||
164294141|NCT03760029|593450034|FG001|Overall Study|Lost to Follow-up|2|||
164294142|NCT03760029|593450035|FG002|Overall Study|Lost to Follow-up|1|||
164294143|NCT03760029|593450033|FG000|Overall Study|Withdrawal by Subject|1|||
164294144|NCT03760029|593450034|FG001|Overall Study|Withdrawal by Subject|4|||
164294145|NCT03760029|593450035|FG002|Overall Study|Withdrawal by Subject|1|||
164294146|NCT03760029|593450033|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164294147|NCT03760029|593450034|FG001|Overall Study|Withdrawal by parent/guardian|4|||
164294148|NCT03760029|593450035|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164294149|NCT03760029|593450033|FG000|Overall Study|Other|2|||
164294150|NCT03760029|593450034|FG001|Overall Study|Other|1|||
164294151|NCT03760029|593450035|FG002|Overall Study|Other|0|||
164294152|NCT04890652|593450043|FG000|Overall Study|Withdrawal by Subject|2|||
164294153|NCT00807911|593450049|FG000|Overall Study|Withdrawal by Subject|12|||
164294154|NCT00807911|593450050|FG001|Overall Study|Withdrawal by Subject|10|||
164294155|NCT00807911|593450049|FG000|Overall Study|Ineligible|0|||
164294156|NCT00807911|593450050|FG001|Overall Study|Ineligible|4|||
164294157|NCT02399215|593450070|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
164294158|NCT02399215|593450070|FG000|Overall Study|Withdrawal by Subject|1|||
164294159|NCT00772538|593450071|FG000|Overall Study|Adverse Event|6|||
164294160|NCT00772538|593450072|FG001|Overall Study|Adverse Event|6|||
164294161|NCT00772538|593450071|FG000|Overall Study|Protocol Violation|3|||
164294162|NCT00772538|593450072|FG001|Overall Study|Protocol Violation|3|||
164294163|NCT00772538|593450071|FG000|Overall Study|Lost to Follow-up|1|||
164294164|NCT00772538|593450072|FG001|Overall Study|Lost to Follow-up|1|||
164294165|NCT00772538|593450071|FG000|Overall Study|Withdrawal by Subject|3|||
164294166|NCT00772538|593450072|FG001|Overall Study|Withdrawal by Subject|8|||
164294167|NCT00772538|593450071|FG000|Overall Study|Lack of Efficacy|0|||
164294168|NCT00772538|593450072|FG001|Overall Study|Lack of Efficacy|1|||
164294169|NCT00772538|593450071|FG000|Overall Study|Other|7|||
164294170|NCT00772538|593450072|FG001|Overall Study|Other|7|||
164294171|NCT04602390|593450079|FG000|Overall Study|Withdrawal by Subject|0|||
164294172|NCT04602390|593450080|FG001|Overall Study|Withdrawal by Subject|0|||
164294173|NCT04602390|593450081|FG002|Overall Study|Withdrawal by Subject|0|||
164294174|NCT04602390|593450082|FG003|Overall Study|Withdrawal by Subject|0|||
164004738|NCT01324830|592382562|FG018|Overall Study|Reason not mentioned above|0|||
164004739|NCT01324830|592382544|FG000|Overall Study|Adverse Event, serious fatal|0|||
164004740|NCT01324830|592382545|FG001|Overall Study|Adverse Event, serious fatal|1|||
164004741|NCT01324830|592382546|FG002|Overall Study|Adverse Event, serious fatal|0|||
164004742|NCT01324830|592382547|FG003|Overall Study|Adverse Event, serious fatal|0|||
164004743|NCT01324830|592382548|FG004|Overall Study|Adverse Event, serious fatal|0|||
164004744|NCT01324830|592382549|FG005|Overall Study|Adverse Event, serious fatal|0|||
164004745|NCT01324830|592382550|FG006|Overall Study|Adverse Event, serious fatal|0|||
164004746|NCT01324830|592382551|FG007|Overall Study|Adverse Event, serious fatal|0|||
164004747|NCT01324830|592382552|FG008|Overall Study|Adverse Event, serious fatal|0|||
164004748|NCT01324830|592382553|FG009|Overall Study|Adverse Event, serious fatal|0|||
164004749|NCT01324830|592382554|FG010|Overall Study|Adverse Event, serious fatal|0|||
164004750|NCT01324830|592382555|FG011|Overall Study|Adverse Event, serious fatal|0|||
164004751|NCT01324830|592382556|FG012|Overall Study|Adverse Event, serious fatal|0|||
164004752|NCT01324830|592382557|FG013|Overall Study|Adverse Event, serious fatal|0|||
164004753|NCT01324830|592382558|FG014|Overall Study|Adverse Event, serious fatal|0|||
164004754|NCT01324830|592382559|FG015|Overall Study|Adverse Event, serious fatal|0|||
164004755|NCT01324830|592382560|FG016|Overall Study|Adverse Event, serious fatal|0|||
164004756|NCT01324830|592382561|FG017|Overall Study|Adverse Event, serious fatal|0|||
164004757|NCT01324830|592382562|FG018|Overall Study|Adverse Event, serious fatal|0|||
164004758|NCT01324830|592382544|FG000|Overall Study|Adverse Event, non-fatal|0|||
164004759|NCT01324830|592382545|FG001|Overall Study|Adverse Event, non-fatal|0|||
164004760|NCT01324830|592382546|FG002|Overall Study|Adverse Event, non-fatal|0|||
164004761|NCT01324830|592382547|FG003|Overall Study|Adverse Event, non-fatal|0|||
164004762|NCT01324830|592382548|FG004|Overall Study|Adverse Event, non-fatal|0|||
164004763|NCT01324830|592382549|FG005|Overall Study|Adverse Event, non-fatal|0|||
164004764|NCT01324830|592382550|FG006|Overall Study|Adverse Event, non-fatal|0|||
164004765|NCT01324830|592382551|FG007|Overall Study|Adverse Event, non-fatal|0|||
164004766|NCT01324830|592382552|FG008|Overall Study|Adverse Event, non-fatal|2|||
164004767|NCT01324830|592382553|FG009|Overall Study|Adverse Event, non-fatal|0|||
164004768|NCT01324830|592382554|FG010|Overall Study|Adverse Event, non-fatal|1|||
164004769|NCT01324830|592382555|FG011|Overall Study|Adverse Event, non-fatal|0|||
164004770|NCT01324830|592382556|FG012|Overall Study|Adverse Event, non-fatal|0|||
164004771|NCT01324830|592382557|FG013|Overall Study|Adverse Event, non-fatal|0|||
164004772|NCT01324830|592382558|FG014|Overall Study|Adverse Event, non-fatal|0|||
164004773|NCT01324830|592382559|FG015|Overall Study|Adverse Event, non-fatal|0|||
164004774|NCT01324830|592382560|FG016|Overall Study|Adverse Event, non-fatal|0|||
164004775|NCT01324830|592382561|FG017|Overall Study|Adverse Event, non-fatal|1|||
164004776|NCT01324830|592382562|FG018|Overall Study|Adverse Event, non-fatal|0|||
164004777|NCT01324830|592382544|FG000|Overall Study|Withdrawal by Subject|0|||
164004778|NCT01324830|592382545|FG001|Overall Study|Withdrawal by Subject|0|||
164004779|NCT01324830|592382546|FG002|Overall Study|Withdrawal by Subject|0|||
164004780|NCT01324830|592382547|FG003|Overall Study|Withdrawal by Subject|0|||
164004781|NCT01324830|592382548|FG004|Overall Study|Withdrawal by Subject|0|||
164004782|NCT01324830|592382549|FG005|Overall Study|Withdrawal by Subject|1|||
164004783|NCT01324830|592382550|FG006|Overall Study|Withdrawal by Subject|0|||
164004784|NCT01324830|592382551|FG007|Overall Study|Withdrawal by Subject|0|||
164004785|NCT01324830|592382552|FG008|Overall Study|Withdrawal by Subject|0|||
164004786|NCT01324830|592382553|FG009|Overall Study|Withdrawal by Subject|0|||
164004787|NCT01324830|592382554|FG010|Overall Study|Withdrawal by Subject|1|||
164004788|NCT01324830|592382555|FG011|Overall Study|Withdrawal by Subject|0|||
164004789|NCT01324830|592382556|FG012|Overall Study|Withdrawal by Subject|0|||
164004790|NCT01324830|592382557|FG013|Overall Study|Withdrawal by Subject|0|||
164004791|NCT01324830|592382558|FG014|Overall Study|Withdrawal by Subject|0|||
164004792|NCT01324830|592382559|FG015|Overall Study|Withdrawal by Subject|0|||
164004793|NCT01324830|592382560|FG016|Overall Study|Withdrawal by Subject|0|||
164004794|NCT01324830|592382561|FG017|Overall Study|Withdrawal by Subject|0|||
164004795|NCT01324830|592382562|FG018|Overall Study|Withdrawal by Subject|1|||
164004796|NCT01973283|592382563|FG000|Overall Study|Lost to Follow-up|4|||
164004797|NCT01122927|592382570|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
164004798|NCT01122927|592382571|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
164294175|NCT04602390|593450083|FG004|Overall Study|Withdrawal by Subject|1|||
164294176|NCT04602390|593450084|FG005|Overall Study|Withdrawal by Subject|0|||
164294177|NCT04602390|593450079|FG000|Overall Study|Adverse Event|0|||
164294178|NCT04602390|593450080|FG001|Overall Study|Adverse Event|0|||
164294179|NCT04602390|593450081|FG002|Overall Study|Adverse Event|0|||
164294180|NCT04602390|593450082|FG003|Overall Study|Adverse Event|0|||
164004799|NCT01122927|592382570|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
164294181|NCT04602390|593450083|FG004|Overall Study|Adverse Event|0|||
164294182|NCT04602390|593450084|FG005|Overall Study|Adverse Event|1|||
164294183|NCT01791244|593450087|FG000|Overall Study|Adverse Event|5|||
164294184|NCT01791244|593450088|FG001|Overall Study|Adverse Event|7|||
164294185|NCT01791244|593450087|FG000|Overall Study|Insufficient clinical response|10|||
164294186|NCT01791244|593450088|FG001|Overall Study|Insufficient clinical response|10|||
164294187|NCT01791244|593450087|FG000|Overall Study|Laboratory Abnormality|0|||
164294188|NCT01791244|593450088|FG001|Overall Study|Laboratory Abnormality|1|||
164294189|NCT00703014|593450089|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
164294190|NCT00703014|593450090|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
164294191|NCT00703014|593450091|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294192|NCT00703014|593450092|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294193|NCT00703014|593450089|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294194|NCT00703014|593450090|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
164294195|NCT00703014|593450091|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
164299954|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299955|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164004800|NCT01122927|592382571|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
164004801|NCT01122927|592382570|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
164299956|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299957|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299958|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299959|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299960|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299961|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
164299962|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299963|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
164299964|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299965|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299966|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299967|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299968|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299969|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299970|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
164299971|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299972|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299973|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299974|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299975|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299976|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299977|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
164299978|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299979|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
164299980|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299981|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299982|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
164299983|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299984|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299985|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299986|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299987|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299988|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299989|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299990|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299991|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299992|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299993|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
164299994|NCT05138653|593472961|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164299995|NCT05138653|593472962|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164299996|NCT05138653|593472963|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164346732|NCT04502693|593645128|FG003|Overall Study|Adverse Event|1|||
164346733|NCT04502693|593645125|FG000|Overall Study|Lost to Follow-up|32|||
164294196|NCT00703014|593450092|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
164294197|NCT04949191|593450093|FG000|Overall Study|Non-compliance with Study Drug|1|||
164294198|NCT04949191|593450094|FG001|Overall Study|Non-compliance with Study Drug|0|||
164294199|NCT04949191|593450095|FG002|Overall Study|Non-compliance with Study Drug|0|||
164294200|NCT04949191|593450096|FG003|Overall Study|Non-compliance with Study Drug|0|||
164294201|NCT04949191|593450093|FG000|Overall Study|Progressive Disease|0|||
164294202|NCT04949191|593450094|FG001|Overall Study|Progressive Disease|1|||
164294203|NCT04949191|593450095|FG002|Overall Study|Progressive Disease|0|||
164294204|NCT04949191|593450096|FG003|Overall Study|Progressive Disease|0|||
164294205|NCT04949191|593450093|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
164294206|NCT04949191|593450094|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
164294207|NCT04949191|593450095|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
164294208|NCT04949191|593450096|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
164294209|NCT04949191|593450093|FG000|Overall Study|Sponsor Terminated Study|0|||
164294210|NCT04949191|593450094|FG001|Overall Study|Sponsor Terminated Study|0|||
164294211|NCT04949191|593450095|FG002|Overall Study|Sponsor Terminated Study|1|||
164346734|NCT04502693|593645126|FG001|Overall Study|Lost to Follow-up|36|||
164346735|NCT04502693|593645127|FG002|Overall Study|Lost to Follow-up|69|||
164346736|NCT04502693|593645128|FG003|Overall Study|Lost to Follow-up|4|||
164346737|NCT04502693|593645125|FG000|Overall Study|Protocol Violation|8|||
164346738|NCT04502693|593645126|FG001|Overall Study|Protocol Violation|8|||
164346739|NCT04502693|593645127|FG002|Overall Study|Protocol Violation|16|||
164346740|NCT04502693|593645128|FG003|Overall Study|Protocol Violation|1|||
164346741|NCT04502693|593645125|FG000|Overall Study|Withdrawal by Subject|46|||
164346742|NCT04502693|593645126|FG001|Overall Study|Withdrawal by Subject|38|||
164346743|NCT04502693|593645127|FG002|Overall Study|Withdrawal by Subject|54|||
164346744|NCT04502693|593645128|FG003|Overall Study|Withdrawal by Subject|7|||
164346745|NCT04502693|593645125|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
164346746|NCT04502693|593645126|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
164346747|NCT04502693|593645127|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
164294212|NCT04949191|593450096|FG003|Overall Study|Sponsor Terminated Study|1|||
164294213|NCT04590014|593450103|FG000|Overall Study|Withdrawal by Subject|1|||
164294214|NCT04590014|593450104|FG001|Overall Study|Withdrawal by Subject|0|||
164294215|NCT00468299|593450105|FG000|Overall Study|Withdrawal by Subject|0|||
164294216|NCT00468299|593450106|FG001|Overall Study|Withdrawal by Subject|1|||
164294217|NCT03546621|593450107|FG000|Overall Study|Withdrawal by Subject|0|||
164294218|NCT03546621|593450108|FG001|Overall Study|Withdrawal by Subject|1|||
164294219|NCT03546621|593450109|FG002|Overall Study|Withdrawal by Subject|2|||
164294220|NCT03546621|593450110|FG003|Overall Study|Withdrawal by Subject|1|||
164294221|NCT03546621|593450107|FG000|Overall Study|Lost to Follow-up|0|||
164294222|NCT03546621|593450108|FG001|Overall Study|Lost to Follow-up|1|||
164294223|NCT03546621|593450109|FG002|Overall Study|Lost to Follow-up|0|||
164294224|NCT03546621|593450110|FG003|Overall Study|Lost to Follow-up|0|||
164294225|NCT03546621|593450107|FG000|Overall Study|Adverse Event|0|||
164294226|NCT03546621|593450108|FG001|Overall Study|Adverse Event|1|||
164294227|NCT03546621|593450109|FG002|Overall Study|Adverse Event|0|||
164294228|NCT03546621|593450110|FG003|Overall Study|Adverse Event|1|||
164294229|NCT03546621|593450107|FG000|Overall Study|Progressive disease|0|||
164294230|NCT03546621|593450108|FG001|Overall Study|Progressive disease|0|||
164294231|NCT03546621|593450109|FG002|Overall Study|Progressive disease|0|||
164294232|NCT03546621|593450110|FG003|Overall Study|Progressive disease|1|||
164294233|NCT00660192|593450111|FG000|Overall Study|Lost to Follow-up|2|||
164294234|NCT00660192|593450112|FG001|Overall Study|Lost to Follow-up|3|||
164294235|NCT00982735|593450113|FG000|Overall Study|Lost to Follow-up|6|||
164294236|NCT00982735|593450113|FG000|Overall Study|Patient ineligible for trial|224|||
164294237|NCT03740048|593450114|FG000|Overall Study|Withdrawal by Subject|1|||
164294238|NCT03740048|593450115|FG001|Overall Study|Withdrawal by Subject|1|||
164294239|NCT03740048|593450114|FG000|Overall Study|Death|1|||
164346748|NCT04502693|593645128|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164346749|NCT04502693|593645125|FG000|Overall Study|Other|1|||
164346750|NCT04502693|593645126|FG001|Overall Study|Other|0|||
164004802|NCT01122927|592382571|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
164346751|NCT04502693|593645127|FG002|Overall Study|Other|1|||
164004803|NCT01122927|592382570|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
164294240|NCT03740048|593450115|FG001|Overall Study|Death|6|||
164294241|NCT03740048|593450114|FG000|Overall Study|Switched to thrice-weekly HD|2|||
164294242|NCT03740048|593450115|FG001|Overall Study|Switched to thrice-weekly HD|0|||
164294243|NCT03740048|593450114|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
164346752|NCT04502693|593645128|FG003|Overall Study|Other|1|||
164294244|NCT03740048|593450115|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
164346753|NCT02784431|593645129|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
164346754|NCT02784431|593645129|FG000|Overall Study|Early Study Termination|19|||
164346755|NCT00279305|593645130|FG000|Overall Study|Pregnancy|1|||
164294245|NCT03740048|593450114|FG000|Overall Study|Lost to Follow-up|0|||
164294246|NCT03740048|593450115|FG001|Overall Study|Lost to Follow-up|1|||
164294247|NCT03740048|593450114|FG000|Overall Study|Non-compliance with HD|0|||
164294248|NCT03740048|593450115|FG001|Overall Study|Non-compliance with HD|1|||
164294249|NCT03261336|593450116|FG000|Overall Study|Adverse Event|1|||
164294250|NCT01069484|593450117|FG000|Overall Study|Death-in-near-family|1|||
164294251|NCT01069484|593450118|FG001|Overall Study|Death-in-near-family|0|||
164294252|NCT01069484|593450117|FG000|Overall Study|No specific reason|8|||
164294253|NCT01069484|593450118|FG001|Overall Study|No specific reason|2|||
164294254|NCT01069484|593450117|FG000|Overall Study|Illness mother or child|3|||
164294255|NCT01069484|593450118|FG001|Overall Study|Illness mother or child|1|||
164294256|NCT02343263|593450122|FG000|Overall Study|Physician Decision|5|||
164294257|NCT02343263|593450123|FG001|Overall Study|Physician Decision|3|||
164294258|NCT02343263|593450124|FG002|Overall Study|Physician Decision|1|||
164294259|NCT00849940|593450127|FG000|Overall Study|Physician Decision|4|||
164294260|NCT03353675|593450131|FG000|Overall Study|Adverse Event|4|||
164294261|NCT00402168|593450132|FG000|Randomized|Lost to Follow-up|1|||
164294262|NCT00402168|593450133|FG001|Randomized|Lost to Follow-up|0|||
164294263|NCT00402168|593450132|FG000|Randomized|Withdrawal by Subject|0|||
164294264|NCT00402168|593450133|FG001|Randomized|Withdrawal by Subject|1|||
164294265|NCT00402168|593450132|FG000|Treatment (up to 12 Months)|Death|0|||
164294266|NCT00402168|593450133|FG001|Treatment (up to 12 Months)|Death|1|||
164294267|NCT00402168|593450132|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
164294268|NCT00402168|593450133|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
164294269|NCT00402168|593450132|FG000|Treatment (up to 12 Months)|non-specified|0|||
164294270|NCT00402168|593450133|FG001|Treatment (up to 12 Months)|non-specified|1|||
164294271|NCT00402168|593450132|FG000|Long Term (LT)|Adverse Event|1|||
164294272|NCT00402168|593450133|FG001|Long Term (LT)|Adverse Event|5|||
164294273|NCT00402168|593450132|FG000|Long Term (LT)|Withdrawal by Subject|4|||
164294274|NCT00402168|593450133|FG001|Long Term (LT)|Withdrawal by Subject|7|||
164294275|NCT00402168|593450132|FG000|Long Term (LT)|Pregnancy|0|||
164294276|NCT00402168|593450133|FG001|Long Term (LT)|Pregnancy|1|||
164294277|NCT00402168|593450132|FG000|Long Term (LT)|Lost to Follow-up|1|||
164294278|NCT00402168|593450133|FG001|Long Term (LT)|Lost to Follow-up|0|||
164294279|NCT00402168|593450132|FG000|Long Term (LT)|Death|4|||
164294280|NCT00402168|593450133|FG001|Long Term (LT)|Death|0|||
164294281|NCT00402168|593450132|FG000|Long Term (LT)|Lack of Efficacy|0|||
164294282|NCT00402168|593450133|FG001|Long Term (LT)|Lack of Efficacy|2|||
164294283|NCT00402168|593450132|FG000|Long Term (LT)|non-specified|1|||
164294284|NCT00402168|593450133|FG001|Long Term (LT)|non-specified|2|||
164294285|NCT00402168|593450132|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
164294286|NCT00402168|593450133|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
164294287|NCT00402168|593450132|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
164294288|NCT00402168|593450133|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
164294289|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
164294290|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
164294291|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
164294292|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
164294293|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
164294294|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
164294295|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
164294296|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
164294297|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
164294298|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
164294299|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
164294300|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
164294301|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
164294302|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
164294303|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
164294304|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
164294305|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
164294306|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
164294307|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
164294308|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
164294309|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
164294310|NCT00550407|593450136|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
164294311|NCT00550407|593450137|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
164294312|NCT00550407|593450138|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
164294313|NCT00550407|593450136|FG000|26-Week Randomized Phase|Adverse Event|0|||
164294314|NCT00550407|593450137|FG001|26-Week Randomized Phase|Adverse Event|5|||
164294315|NCT00550407|593450138|FG002|26-Week Randomized Phase|Adverse Event|2|||
164294316|NCT00550407|593450136|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
164294317|NCT00550407|593450137|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
164294318|NCT00550407|593450138|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
164294319|NCT00550407|593450136|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
164294320|NCT00550407|593450137|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
164294321|NCT00550407|593450138|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
164294322|NCT00550407|593450136|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
164294323|NCT00550407|593450137|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
164294324|NCT00550407|593450138|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
164294325|NCT00584415|593450139|FG000|Overall Study|Adverse Event|7|||
164294326|NCT02370420|593450140|FG000|Overall Study|Physician Decision|3|||
164294327|NCT02370420|593450141|FG001|Overall Study|Physician Decision|3|||
164294328|NCT02370420|593450140|FG000|Overall Study|Lost to Follow-up|11|||
164294329|NCT02370420|593450141|FG001|Overall Study|Lost to Follow-up|9|||
164294330|NCT00556894|593450142|FG000|Overall Study|Adverse Event|2|||
164294331|NCT00556894|593450143|FG001|Overall Study|Adverse Event|3|||
164294332|NCT00556894|593450144|FG002|Overall Study|Adverse Event|3|||
164294333|NCT00556894|593450142|FG000|Overall Study|Death|1|||
164294334|NCT00556894|593450143|FG001|Overall Study|Death|0|||
164294335|NCT00556894|593450144|FG002|Overall Study|Death|0|||
164294336|NCT00556894|593450142|FG000|Overall Study|regulatory decision in Bulgaria|10|||
164294337|NCT00556894|593450143|FG001|Overall Study|regulatory decision in Bulgaria|14|||
164294338|NCT00556894|593450144|FG002|Overall Study|regulatory decision in Bulgaria|13|||
164294339|NCT00556894|593450142|FG000|Overall Study|Change in therapy|2|||
164294340|NCT00556894|593450143|FG001|Overall Study|Change in therapy|1|||
164294341|NCT00556894|593450144|FG002|Overall Study|Change in therapy|2|||
164294342|NCT00556894|593450142|FG000|Overall Study|Withdrawal by Subject|1|||
164294343|NCT00556894|593450143|FG001|Overall Study|Withdrawal by Subject|1|||
164294344|NCT00556894|593450144|FG002|Overall Study|Withdrawal by Subject|1|||
164294345|NCT03883581|593450145|FG000|Overall Study|Withdrawal by Subject|4|||
164294346|NCT03224130|593452093|FG000|Overall Study|consent issue|0|||
164294347|NCT03224130|593452094|FG001|Overall Study|consent issue|1|||
164294348|NCT01453049|593452095|FG000|Overall Study|Protocol Violation|2|||
164294349|NCT01453049|593452096|FG001|Overall Study|Protocol Violation|5|||
164294350|NCT01453049|593452095|FG000|Overall Study|Lost to Follow-up|2|||
164294351|NCT01453049|593452096|FG001|Overall Study|Lost to Follow-up|1|||
164294352|NCT01453049|593452095|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
164294353|NCT01453049|593452096|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
164294354|NCT01453049|593452095|FG000|Overall Study|Withdrawal by Subject|1|||
164294355|NCT01453049|593452096|FG001|Overall Study|Withdrawal by Subject|0|||
164294356|NCT01453049|593452095|FG000|Overall Study|Randomized in Error|1|||
164294357|NCT01453049|593452096|FG001|Overall Study|Randomized in Error|0|||
164294358|NCT01317472|593452101|FG000|Overall Study|Withdrawal by Subject|1|||
164294359|NCT01317472|593452102|FG001|Overall Study|Withdrawal by Subject|0|||
164294360|NCT01317472|593452101|FG000|Overall Study|Unrelated hospitalization|1|||
164294361|NCT01317472|593452102|FG001|Overall Study|Unrelated hospitalization|0|||
164004804|NCT01122927|592382571|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
164004805|NCT01122927|592382570|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
164004806|NCT01122927|592382571|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
164004807|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
164004808|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
164004809|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
164004810|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
164004811|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
164004812|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
164004813|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
164004814|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
164004815|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
164004816|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
164004817|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
164004818|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
164294362|NCT01815918|593452103|FG000|Overall Study|Patient samples not analyzable|3|||
164294363|NCT01815918|593452104|FG001|Overall Study|Patient samples not analyzable|4|||
164294364|NCT01815918|593452103|FG000|Overall Study|Lack of Efficacy|15|||
164294365|NCT01815918|593452104|FG001|Overall Study|Lack of Efficacy|15|||
164294366|NCT03532542|593452112|FG000|Overall Study|Death|1|||
164294367|NCT03532542|593452113|FG001|Overall Study|Death|0|||
164294368|NCT03532542|593452112|FG000|Overall Study|Study Terminated by Sponsor|41|||
164294369|NCT03532542|593452113|FG001|Overall Study|Study Terminated by Sponsor|65|||
164294370|NCT03532542|593452112|FG000|Overall Study|Withdrawal by Subject|6|||
164294371|NCT03532542|593452113|FG001|Overall Study|Withdrawal by Subject|5|||
164294372|NCT01018030|593452114|FG000|Overall Study|Adverse Event|10|||
164294373|NCT01018030|593452115|FG001|Overall Study|Adverse Event|5|||
164294374|NCT01018030|593452116|FG002|Overall Study|Adverse Event|5|||
164088862|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
164088863|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
164004819|NCT01122927|592382570|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
164004820|NCT01122927|592382571|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
164004821|NCT01244737|592382579|FG000|Overall Study|Physician Decision|2|||
164004822|NCT01244737|592382580|FG001|Overall Study|Physician Decision|18|||
164004823|NCT01244737|592382581|FG002|Overall Study|Physician Decision|5|||
164004824|NCT01244737|592382579|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
164004825|NCT01244737|592382580|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
164088864|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
164088865|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
164088866|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088867|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088868|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088869|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088870|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088871|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088872|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088873|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088874|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
164088875|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
164088876|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
164088877|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
164088878|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
164088879|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
164088880|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088881|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088882|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164004826|NCT01244737|592382581|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
164004827|NCT01244737|592382579|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
164004828|NCT01244737|592382580|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
164004829|NCT01244737|592382581|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
164004830|NCT01244737|592382579|FG000|Overall Study|MIB immunopathology results not available|3|||
164294375|NCT01018030|593452114|FG000|Overall Study|Withdrawal by Subject|2|||
164294376|NCT01018030|593452115|FG001|Overall Study|Withdrawal by Subject|2|||
164294377|NCT01018030|593452116|FG002|Overall Study|Withdrawal by Subject|4|||
164294378|NCT01018030|593452114|FG000|Overall Study|Lost to Follow-up|2|||
164004831|NCT01244737|592382580|FG001|Overall Study|MIB immunopathology results not available|2|||
164004832|NCT01244737|592382581|FG002|Overall Study|MIB immunopathology results not available|0|||
164088883|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088884|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164294379|NCT01018030|593452115|FG001|Overall Study|Lost to Follow-up|0|||
164294380|NCT01018030|593452116|FG002|Overall Study|Lost to Follow-up|3|||
164294381|NCT01018030|593452114|FG000|Overall Study|Protocol Violation|2|||
164294382|NCT01018030|593452115|FG001|Overall Study|Protocol Violation|1|||
164294383|NCT01018030|593452116|FG002|Overall Study|Protocol Violation|0|||
164294384|NCT01018030|593452114|FG000|Overall Study|Physician Decision|1|||
164294385|NCT01018030|593452115|FG001|Overall Study|Physician Decision|0|||
164294386|NCT01018030|593452116|FG002|Overall Study|Physician Decision|1|||
164294387|NCT01018030|593452114|FG000|Overall Study|Lack of Efficacy|1|||
164294388|NCT01018030|593452115|FG001|Overall Study|Lack of Efficacy|0|||
164294389|NCT01018030|593452116|FG002|Overall Study|Lack of Efficacy|0|||
164294390|NCT01018030|593452114|FG000|Overall Study|Did Not Receive Study Drug|1|||
164294391|NCT01018030|593452115|FG001|Overall Study|Did Not Receive Study Drug|3|||
164294392|NCT01018030|593452116|FG002|Overall Study|Did Not Receive Study Drug|0|||
164294393|NCT01089504|593452117|FG000|Overall Study|Lost to Follow-up|1|||
164294394|NCT01089504|593452118|FG001|Overall Study|Lost to Follow-up|1|||
164294395|NCT01089504|593452117|FG000|Overall Study|Withdrawal by Subject|2|||
164294396|NCT01089504|593452118|FG001|Overall Study|Withdrawal by Subject|0|||
164294397|NCT00001832|593452119|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
164294398|NCT00001832|593452120|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
164294399|NCT00001832|593452121|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
164294400|NCT00001832|593452122|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
164294401|NCT00001832|593452123|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
164294402|NCT00001832|593452124|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
164294403|NCT00001832|593452125|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
164294404|NCT00001832|593452126|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
164294405|NCT00001832|593452127|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
164004833|NCT01244737|592382579|FG000|Overall Study|PET data failure|0|||
164004834|NCT01244737|592382580|FG001|Overall Study|PET data failure|1|||
164004835|NCT01244737|592382581|FG002|Overall Study|PET data failure|0|||
164004836|NCT01244737|592382579|FG000|Overall Study|Withdrawal by Subject|0|||
164088885|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088886|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088887|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088888|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088889|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088890|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
164088891|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
164088892|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
164088893|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
164088894|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088895|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088896|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088897|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088898|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088899|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164294406|NCT00001832|593452128|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
164294407|NCT00001832|593452129|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
164294408|NCT00001832|593452130|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
164294409|NCT00001832|593452131|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
164294410|NCT00001832|593452132|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
164294411|NCT00001832|593452133|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
164294412|NCT00001832|593452119|FG000|Treatment Period|Death during treatment|0|||
164294413|NCT00001832|593452120|FG001|Treatment Period|Death during treatment|0|||
164294414|NCT00001832|593452121|FG002|Treatment Period|Death during treatment|0|||
164294415|NCT00001832|593452122|FG003|Treatment Period|Death during treatment|0|||
164294416|NCT00001832|593452123|FG004|Treatment Period|Death during treatment|0|||
164294417|NCT00001832|593452124|FG005|Treatment Period|Death during treatment|1|||
164294418|NCT00001832|593452125|FG006|Treatment Period|Death during treatment|0|||
164294419|NCT00001832|593452126|FG007|Treatment Period|Death during treatment|0|||
164294420|NCT00001832|593452127|FG008|Treatment Period|Death during treatment|0|||
164294421|NCT00001832|593452128|FG009|Treatment Period|Death during treatment|0|||
164294422|NCT00001832|593452129|FG010|Treatment Period|Death during treatment|0|||
164294423|NCT00001832|593452130|FG011|Treatment Period|Death during treatment|0|||
164294424|NCT00001832|593452131|FG012|Treatment Period|Death during treatment|0|||
164346756|NCT00279305|593645131|FG001|Overall Study|Pregnancy|0|||
164346757|NCT00279305|593645130|FG000|Overall Study|Withdrawal by Subject|2|||
164346758|NCT00279305|593645131|FG001|Overall Study|Withdrawal by Subject|0|||
164346759|NCT00279305|593645130|FG000|Overall Study|Dificulting establishing IV|1|||
164346760|NCT00279305|593645131|FG001|Overall Study|Dificulting establishing IV|0|||
164346761|NCT00279305|593645130|FG000|Overall Study|FDA Safety Alert|4|||
164346762|NCT00279305|593645131|FG001|Overall Study|FDA Safety Alert|1|||
164346763|NCT04404361|593645132|FG000|Overall Study|Death|12|||
164346764|NCT04404361|593645133|FG001|Overall Study|Death|12|||
164346765|NCT04404361|593645132|FG000|Overall Study|Withdrawal by Subject|13|||
164346766|NCT04404361|593645133|FG001|Overall Study|Withdrawal by Subject|5|||
164346767|NCT04404361|593645132|FG000|Overall Study|Lost to Follow-up|6|||
164346768|NCT04404361|593645133|FG001|Overall Study|Lost to Follow-up|3|||
164346769|NCT04404361|593645132|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
164346770|NCT04404361|593645133|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
164346771|NCT01063868|593645138|FG000|Overall Study|Adverse Event|9|||
164346772|NCT01063868|593645139|FG001|Overall Study|Adverse Event|7|||
164346773|NCT01063868|593645138|FG000|Overall Study|Withdrawal by Subject|3|||
164346774|NCT01063868|593645139|FG001|Overall Study|Withdrawal by Subject|1|||
164346775|NCT01063868|593645138|FG000|Overall Study|Study Terminated By Sponsor|23|||
164346776|NCT01063868|593645139|FG001|Overall Study|Study Terminated By Sponsor|4|||
164346777|NCT01949506|593645140|FG000|Overall Study|Physician Decision|1|||
164294425|NCT00001832|593452132|FG013|Treatment Period|Death during treatment|0|||
164346778|NCT01446289|593645141|FG000|Overall Study|Withdrawal by Subject|1|||
164346779|NCT01446289|593645142|FG001|Overall Study|Withdrawal by Subject|0|||
164346780|NCT01446289|593645143|FG002|Overall Study|Withdrawal by Subject|1|||
164088900|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164346781|NCT01446289|593645144|FG003|Overall Study|Withdrawal by Subject|0|||
164346782|NCT03307967|593645145|FG000|Overall Study|Lost to Follow-up|4|||
164346783|NCT02915016|593645146|FG000|Overall Study|Lost to Follow-up|4|||
164346784|NCT02915016|593645147|FG001|Overall Study|Lost to Follow-up|2|||
164346785|NCT02915016|593645148|FG002|Overall Study|Lost to Follow-up|5|||
164346786|NCT02915016|593645149|FG003|Overall Study|Lost to Follow-up|3|||
164346787|NCT02915016|593645150|FG004|Overall Study|Lost to Follow-up|5|||
164346788|NCT02915016|593645151|FG005|Overall Study|Lost to Follow-up|2|||
164346789|NCT02915016|593645152|FG006|Overall Study|Lost to Follow-up|8|||
164346790|NCT02915016|593645153|FG007|Overall Study|Lost to Follow-up|2|||
164346791|NCT02915016|593645146|FG000|Overall Study|Physician Decision|0|||
164346792|NCT02915016|593645147|FG001|Overall Study|Physician Decision|0|||
164346793|NCT02915016|593645148|FG002|Overall Study|Physician Decision|1|||
164346794|NCT02915016|593645149|FG003|Overall Study|Physician Decision|0|||
164346795|NCT02915016|593645150|FG004|Overall Study|Physician Decision|0|||
164346796|NCT02915016|593645151|FG005|Overall Study|Physician Decision|1|||
164346797|NCT02915016|593645152|FG006|Overall Study|Physician Decision|2|||
164346798|NCT02915016|593645153|FG007|Overall Study|Physician Decision|0|||
164346799|NCT02915016|593645146|FG000|Overall Study|Withdrawal by Subject|2|||
164346800|NCT02915016|593645147|FG001|Overall Study|Withdrawal by Subject|0|||
164346801|NCT02915016|593645148|FG002|Overall Study|Withdrawal by Subject|1|||
164346802|NCT02915016|593645149|FG003|Overall Study|Withdrawal by Subject|0|||
164346803|NCT02915016|593645150|FG004|Overall Study|Withdrawal by Subject|1|||
164346804|NCT02915016|593645151|FG005|Overall Study|Withdrawal by Subject|3|||
164346805|NCT02915016|593645152|FG006|Overall Study|Withdrawal by Subject|1|||
164346806|NCT02915016|593645153|FG007|Overall Study|Withdrawal by Subject|1|||
164346807|NCT02915016|593645146|FG000|Overall Study|Elected not to continue|0|||
164346808|NCT02915016|593645147|FG001|Overall Study|Elected not to continue|0|||
164346809|NCT02915016|593645148|FG002|Overall Study|Elected not to continue|0|||
164346810|NCT02915016|593645149|FG003|Overall Study|Elected not to continue|1|||
164346811|NCT02915016|593645150|FG004|Overall Study|Elected not to continue|0|||
164346812|NCT02915016|593645151|FG005|Overall Study|Elected not to continue|0|||
164346813|NCT02915016|593645152|FG006|Overall Study|Elected not to continue|1|||
164346814|NCT02915016|593645153|FG007|Overall Study|Elected not to continue|0|||
164346815|NCT02915016|593645146|FG000|Overall Study|HIV infection|1|||
164346816|NCT02915016|593645147|FG001|Overall Study|HIV infection|1|||
164346817|NCT02915016|593645148|FG002|Overall Study|HIV infection|1|||
164346818|NCT02915016|593645149|FG003|Overall Study|HIV infection|0|||
164346819|NCT02915016|593645150|FG004|Overall Study|HIV infection|1|||
164346820|NCT02915016|593645151|FG005|Overall Study|HIV infection|0|||
164346821|NCT02915016|593645152|FG006|Overall Study|HIV infection|0|||
164346822|NCT02915016|593645153|FG007|Overall Study|HIV infection|0|||
164346823|NCT02915016|593645146|FG000|Overall Study|Participant unable to adhere|0|||
164346824|NCT02915016|593645147|FG001|Overall Study|Participant unable to adhere|0|||
164346825|NCT02915016|593645148|FG002|Overall Study|Participant unable to adhere|0|||
164346826|NCT02915016|593645149|FG003|Overall Study|Participant unable to adhere|0|||
164346827|NCT02915016|593645150|FG004|Overall Study|Participant unable to adhere|0|||
164346828|NCT02915016|593645151|FG005|Overall Study|Participant unable to adhere|0|||
164346829|NCT02915016|593645152|FG006|Overall Study|Participant unable to adhere|0|||
164346830|NCT02915016|593645153|FG007|Overall Study|Participant unable to adhere|1|||
164346831|NCT02578316|593645154|FG000|Extension Phase|Progression of disease|6|||
164346832|NCT02166905|593645155|FG000|Overall Study|Withdrawal by Subject|1|||
164346833|NCT02166905|593645156|FG001|Overall Study|Withdrawal by Subject|0|||
164346834|NCT02166905|593645157|FG002|Overall Study|Withdrawal by Subject|0|||
164346835|NCT02166905|593645158|FG003|Overall Study|Withdrawal by Subject|0|||
164346836|NCT02617628|593645159|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
164346837|NCT02617628|593645160|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
164346838|NCT03278873|593645165|FG000|Overall Study|Withdrawal by Subject|0|||
164346839|NCT03278873|593645166|FG001|Overall Study|Withdrawal by Subject|1|||
164346840|NCT03278873|593645167|FG002|Overall Study|Withdrawal by Subject|0|||
164346841|NCT03278873|593645168|FG003|Overall Study|Withdrawal by Subject|0|||
164346842|NCT03278873|593645165|FG000|Overall Study|Sponsor's decision|0|||
164346843|NCT03278873|593645166|FG001|Overall Study|Sponsor's decision|1|||
164346844|NCT03278873|593645167|FG002|Overall Study|Sponsor's decision|0|||
164346845|NCT03278873|593645168|FG003|Overall Study|Sponsor's decision|0|||
164346846|NCT03278873|593645165|FG000|Overall Study|Early Termination|2|||
164346847|NCT03278873|593645166|FG001|Overall Study|Early Termination|6|||
163898255|NCT02325466|592001037|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
164346848|NCT03278873|593645167|FG002|Overall Study|Early Termination|0|||
164346849|NCT03278873|593645168|FG003|Overall Study|Early Termination|4|||
164346850|NCT03278873|593645165|FG000|Overall Study|Lost to Follow-up|0|||
164346851|NCT03278873|593645166|FG001|Overall Study|Lost to Follow-up|0|||
164346852|NCT03278873|593645167|FG002|Overall Study|Lost to Follow-up|2|||
164346853|NCT03278873|593645168|FG003|Overall Study|Lost to Follow-up|0|||
164346854|NCT03278873|593645165|FG000|Overall Study|The patient decided to withdraw via email|1|||
164346855|NCT03278873|593645166|FG001|Overall Study|The patient decided to withdraw via email|0|||
164346856|NCT03278873|593645167|FG002|Overall Study|The patient decided to withdraw via email|0|||
164346857|NCT03278873|593645168|FG003|Overall Study|The patient decided to withdraw via email|0|||
164346858|NCT03278873|593645165|FG000|Overall Study|The patient was unresponsive to contact|0|||
164294426|NCT00001832|593452133|FG014|Treatment Period|Death during treatment|0|||
164294427|NCT00001832|593452119|FG000|Treatment Period|Not treated|0|||
164294428|NCT00001832|593452120|FG001|Treatment Period|Not treated|0|||
164294429|NCT00001832|593452121|FG002|Treatment Period|Not treated|0|||
164294430|NCT00001832|593452122|FG003|Treatment Period|Not treated|0|||
164294431|NCT00001832|593452123|FG004|Treatment Period|Not treated|0|||
164294432|NCT00001832|593452124|FG005|Treatment Period|Not treated|0|||
164294433|NCT00001832|593452125|FG006|Treatment Period|Not treated|0|||
164294434|NCT00001832|593452126|FG007|Treatment Period|Not treated|1|||
164294435|NCT00001832|593452127|FG008|Treatment Period|Not treated|0|||
164294436|NCT00001832|593452128|FG009|Treatment Period|Not treated|0|||
164294437|NCT00001832|593452129|FG010|Treatment Period|Not treated|0|||
164294438|NCT00001832|593452130|FG011|Treatment Period|Not treated|0|||
164294439|NCT00001832|593452131|FG012|Treatment Period|Not treated|0|||
164294440|NCT00001832|593452132|FG013|Treatment Period|Not treated|0|||
164294441|NCT00001832|593452133|FG014|Treatment Period|Not treated|0|||
164294442|NCT00713609|593452134|FG000|Overall Study|Adverse Event|2|||
164294443|NCT00713609|593452135|FG001|Overall Study|Adverse Event|0|||
164294444|NCT00713609|593452136|FG002|Overall Study|Adverse Event|2|||
164294445|NCT00713609|593452137|FG003|Overall Study|Adverse Event|2|||
164294446|NCT00713609|593452138|FG004|Overall Study|Adverse Event|3|||
164294447|NCT00713609|593452139|FG005|Overall Study|Adverse Event|1|||
164294448|NCT00713609|593452134|FG000|Overall Study|Lost to Follow-up|5|||
164294449|NCT00713609|593452135|FG001|Overall Study|Lost to Follow-up|7|||
164294450|NCT00713609|593452136|FG002|Overall Study|Lost to Follow-up|5|||
164294451|NCT00713609|593452137|FG003|Overall Study|Lost to Follow-up|5|||
164294452|NCT00713609|593452138|FG004|Overall Study|Lost to Follow-up|7|||
164294453|NCT00713609|593452139|FG005|Overall Study|Lost to Follow-up|0|||
164294454|NCT00713609|593452134|FG000|Overall Study|Lack of Efficacy|1|||
164294455|NCT00713609|593452135|FG001|Overall Study|Lack of Efficacy|3|||
164294456|NCT00713609|593452136|FG002|Overall Study|Lack of Efficacy|0|||
164294457|NCT00713609|593452137|FG003|Overall Study|Lack of Efficacy|0|||
164294458|NCT00713609|593452138|FG004|Overall Study|Lack of Efficacy|1|||
164294459|NCT00713609|593452139|FG005|Overall Study|Lack of Efficacy|0|||
164294460|NCT00713609|593452134|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
164294461|NCT00713609|593452135|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
164294462|NCT00713609|593452136|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
164294463|NCT00713609|593452137|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
164294464|NCT00713609|593452138|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
164294465|NCT00713609|593452139|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
164294466|NCT00713609|593452134|FG000|Overall Study|Withdrawal by Subject|6|||
164294467|NCT00713609|593452135|FG001|Overall Study|Withdrawal by Subject|1|||
164294468|NCT00713609|593452136|FG002|Overall Study|Withdrawal by Subject|5|||
164294469|NCT00713609|593452137|FG003|Overall Study|Withdrawal by Subject|1|||
164294470|NCT00713609|593452138|FG004|Overall Study|Withdrawal by Subject|5|||
164294471|NCT00713609|593452139|FG005|Overall Study|Withdrawal by Subject|7|||
164294472|NCT00713609|593452134|FG000|Overall Study|Protocol Violation|6|||
164294473|NCT00713609|593452135|FG001|Overall Study|Protocol Violation|3|||
164294474|NCT00713609|593452136|FG002|Overall Study|Protocol Violation|1|||
164294475|NCT00713609|593452137|FG003|Overall Study|Protocol Violation|1|||
164294476|NCT00713609|593452138|FG004|Overall Study|Protocol Violation|2|||
164294477|NCT00713609|593452139|FG005|Overall Study|Protocol Violation|0|||
164294478|NCT04529083|593452140|FG000|Overall Study|Withdrawal by Subject|3|||
164294479|NCT04196686|593452145|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
164294480|NCT04196686|593452146|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
164294481|NCT00914849|593452152|FG000|Overall Study|Withdrawal by Subject|1|||
164294482|NCT00914849|593452153|FG001|Overall Study|Withdrawal by Subject|0|||
164294483|NCT00914849|593452152|FG000|Overall Study|Not eligible|0|||
164346859|NCT03278873|593645166|FG001|Overall Study|The patient was unresponsive to contact|0|||
164346860|NCT03278873|593645167|FG002|Overall Study|The patient was unresponsive to contact|0|||
164346861|NCT03278873|593645168|FG003|Overall Study|The patient was unresponsive to contact|4|||
164346862|NCT03278873|593645165|FG000|Overall Study|The patient wished to participate no longer|0|||
164346863|NCT03278873|593645166|FG001|Overall Study|The patient wished to participate no longer|1|||
164346864|NCT03278873|593645167|FG002|Overall Study|The patient wished to participate no longer|0|||
164346865|NCT03278873|593645168|FG003|Overall Study|The patient wished to participate no longer|0|||
164346866|NCT03278873|593645165|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
164346867|NCT03278873|593645166|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
164355672|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
164294484|NCT00914849|593452153|FG001|Overall Study|Not eligible|1|||
164294485|NCT01001221|593452154|FG000|Overall Study|Adverse Event|1|||
164294486|NCT01001221|593452155|FG001|Overall Study|Adverse Event|2|||
164294487|NCT01001221|593452156|FG002|Overall Study|Adverse Event|0|||
164294488|NCT01001221|593452157|FG003|Overall Study|Adverse Event|2|||
164294489|NCT01001221|593452158|FG004|Overall Study|Adverse Event|0|||
164294490|NCT01001221|593452154|FG000|Overall Study|Disease progression|3|||
164294491|NCT01001221|593452155|FG001|Overall Study|Disease progression|2|||
164346868|NCT03278873|593645167|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
164346869|NCT03278873|593645168|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
163898256|NCT02325466|592001035|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
163898257|NCT02325466|592001036|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
163898258|NCT02325466|592001037|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
164294492|NCT01001221|593452156|FG002|Overall Study|Disease progression|2|||
164294493|NCT01001221|593452157|FG003|Overall Study|Disease progression|4|||
164294494|NCT01001221|593452158|FG004|Overall Study|Disease progression|0|||
164294495|NCT01001221|593452154|FG000|Overall Study|Other|1|||
164294496|NCT01001221|593452155|FG001|Overall Study|Other|1|||
164294497|NCT01001221|593452156|FG002|Overall Study|Other|0|||
164294498|NCT01001221|593452157|FG003|Overall Study|Other|0|||
164294499|NCT01001221|593452158|FG004|Overall Study|Other|0|||
164294500|NCT01001221|593452154|FG000|Overall Study|Not treated; protocol exclusion|0|||
164294501|NCT01001221|593452155|FG001|Overall Study|Not treated; protocol exclusion|0|||
164294502|NCT01001221|593452156|FG002|Overall Study|Not treated; protocol exclusion|1|||
163898259|NCT02325466|592001035|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
163898260|NCT02325466|592001036|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
163898261|NCT02325466|592001037|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
163898262|NCT02325466|592001035|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
163898263|NCT02325466|592001036|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
163898264|NCT02325466|592001037|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
163898265|NCT02325466|592001035|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
163898266|NCT02325466|592001036|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
163898267|NCT02325466|592001037|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
163898268|NCT02325466|592001035|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
163898269|NCT02325466|592001036|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
163898270|NCT02325466|592001037|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
163898271|NCT02325466|592001035|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
163898272|NCT02325466|592001036|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
163898273|NCT02325466|592001037|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
163898274|NCT02325466|592001035|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
163898275|NCT02325466|592001036|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
163898276|NCT02325466|592001037|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
163898277|NCT02325466|592001035|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
163898278|NCT02325466|592001036|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
163898279|NCT02325466|592001037|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
163898280|NCT00692913|592001038|FG000|Overall Study|Adverse Event|8|||
163898281|NCT00692913|592001039|FG001|Overall Study|Adverse Event|4|||
163898282|NCT00692913|592001038|FG000|Overall Study|Lost to Follow-up|3|||
163898283|NCT00692913|592001039|FG001|Overall Study|Lost to Follow-up|5|||
163898284|NCT00692913|592001038|FG000|Overall Study|Physician Decision|2|||
163898285|NCT00692913|592001039|FG001|Overall Study|Physician Decision|0|||
163898286|NCT00692913|592001038|FG000|Overall Study|Protocol Violation|1|||
163898287|NCT00692913|592001039|FG001|Overall Study|Protocol Violation|1|||
163898288|NCT00692913|592001038|FG000|Overall Study|Withdrawal by Subject|15|||
163898289|NCT00692913|592001039|FG001|Overall Study|Withdrawal by Subject|20|||
164346870|NCT05243641|593645169|FG000|Overall Study|Adverse Event|3|||
164346871|NCT05243641|593645170|FG001|Overall Study|Adverse Event|0|||
164346872|NCT05243641|593645171|FG002|Overall Study|Adverse Event|0|||
164346873|NCT05243641|593645172|FG003|Overall Study|Adverse Event|1|||
163898290|NCT01637402|592001040|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
164004837|NCT01244737|592382580|FG001|Overall Study|Withdrawal by Subject|0|||
164346874|NCT05243641|593645173|FG004|Overall Study|Adverse Event|0|||
164346875|NCT05243641|593645174|FG005|Overall Study|Adverse Event|0|||
164346876|NCT05243641|593645169|FG000|Overall Study|Disease progression|4|||
164346877|NCT05243641|593645170|FG001|Overall Study|Disease progression|0|||
164346878|NCT05243641|593645171|FG002|Overall Study|Disease progression|0|||
164346879|NCT05243641|593645172|FG003|Overall Study|Disease progression|2|||
164346880|NCT05243641|593645173|FG004|Overall Study|Disease progression|0|||
164346881|NCT05243641|593645174|FG005|Overall Study|Disease progression|0|||
163898291|NCT01637402|592001041|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
163898292|NCT01637402|592001040|FG000|Standard Dose Regimen|Adverse Event|1|||
164004838|NCT01244737|592382581|FG002|Overall Study|Withdrawal by Subject|1|||
163898293|NCT01637402|592001041|FG001|Standard Dose Regimen|Adverse Event|0|||
164004839|NCT00356915|592382586|FG000|Overall Study|Non compliance|1|||
164294503|NCT01001221|593452157|FG003|Overall Study|Not treated; protocol exclusion|0|||
164294504|NCT01001221|593452158|FG004|Overall Study|Not treated; protocol exclusion|0|||
164346882|NCT05372419|593645186|FG000|Overall Study|Protocol Deviation|1|||
164346883|NCT05372419|593645186|FG000|Overall Study|Withdrawal by Subject|5|||
164346884|NCT05372419|593645186|FG000|Overall Study|Lost to Follow-up|7|||
164346885|NCT02801331|593645187|FG000|Overall Study|Transferred to another hospital|8|||
164294505|NCT05106959|593452159|FG000|Overall Study|Lost to Follow-up|1|||
164294506|NCT03448406|593452160|FG000|Overall Study|Noncompliance of scheduled visits|1|||
164294507|NCT03448406|593452161|FG001|Overall Study|Noncompliance of scheduled visits|2|||
164294508|NCT03448406|593452160|FG000|Overall Study|Withdrawal by Subject|1|||
164294509|NCT03448406|593452161|FG001|Overall Study|Withdrawal by Subject|2|||
164294510|NCT03448406|593452160|FG000|Overall Study|Protocol Violation|1|||
164294511|NCT03448406|593452161|FG001|Overall Study|Protocol Violation|0|||
164294512|NCT03448406|593452160|FG000|Overall Study|Adverse Event|8|||
164294513|NCT03448406|593452161|FG001|Overall Study|Adverse Event|9|||
164294514|NCT00087152|593452162|FG000|Overall Study|Ineligible|6|||
164294515|NCT01292486|593452163|FG000|Overall Study|Protocol Violation|2|||
164294516|NCT01292486|593452163|FG000|Overall Study|Did not meet screening criteria|2|||
164294517|NCT01292486|593452163|FG000|Overall Study|Adverse Event|1|||
164294518|NCT01292486|593452163|FG000|Overall Study|Physician Decision|1|||
164294519|NCT02542865|593452166|FG000|Overall Study|Identified as screen failure|1|||
164294520|NCT02542865|593452167|FG001|Overall Study|Identified as screen failure|0|||
164294521|NCT02542865|593452166|FG000|Overall Study|Withdrawal by Subject|16|||
164004840|NCT00356915|592382587|FG001|Overall Study|Non compliance|2|||
164004841|NCT00356915|592382588|FG002|Overall Study|Non compliance|1|||
164004842|NCT00356915|592382586|FG000|Overall Study|Protocol Violation|2|||
164004843|NCT00356915|592382587|FG001|Overall Study|Protocol Violation|3|||
164004844|NCT00356915|592382588|FG002|Overall Study|Protocol Violation|2|||
164004845|NCT00356915|592382586|FG000|Overall Study|Withdrawal by Subject|14|||
164004846|NCT00356915|592382587|FG001|Overall Study|Withdrawal by Subject|14|||
164004847|NCT00356915|592382588|FG002|Overall Study|Withdrawal by Subject|10|||
164004848|NCT00356915|592382586|FG000|Overall Study|Lack of Efficacy|0|||
164004849|NCT00356915|592382587|FG001|Overall Study|Lack of Efficacy|0|||
164004850|NCT00356915|592382588|FG002|Overall Study|Lack of Efficacy|3|||
164004851|NCT00356915|592382586|FG000|Overall Study|Lost to Follow-up|27|||
164004852|NCT00356915|592382587|FG001|Overall Study|Lost to Follow-up|34|||
164004853|NCT00356915|592382588|FG002|Overall Study|Lost to Follow-up|14|||
164004854|NCT00356915|592382586|FG000|Overall Study|Administrative Decision|0|||
164004855|NCT00356915|592382587|FG001|Overall Study|Administrative Decision|0|||
164004856|NCT00356915|592382588|FG002|Overall Study|Administrative Decision|1|||
164004857|NCT00356915|592382586|FG000|Overall Study|Physician Decision|0|||
164004858|NCT00356915|592382587|FG001|Overall Study|Physician Decision|2|||
164004859|NCT00356915|592382588|FG002|Overall Study|Physician Decision|0|||
164004860|NCT00356915|592382586|FG000|Overall Study|Adverse Event|21|||
164004861|NCT00356915|592382587|FG001|Overall Study|Adverse Event|31|||
164004862|NCT00356915|592382588|FG002|Overall Study|Adverse Event|8|||
164004863|NCT00356915|592382586|FG000|Overall Study|Miscellaneous reasons|11|||
164004864|NCT00356915|592382587|FG001|Overall Study|Miscellaneous reasons|8|||
164004865|NCT00356915|592382588|FG002|Overall Study|Miscellaneous reasons|3|||
164004866|NCT02371629|592382597|FG000|Overall Study|Patient decision|14|||
164004867|NCT02371629|592382598|FG001|Overall Study|Patient decision|10|||
164004868|NCT02371629|592382597|FG000|Overall Study|Adverse Event|8|||
164004869|NCT02371629|592382598|FG001|Overall Study|Adverse Event|8|||
164004870|NCT02371629|592382597|FG000|Overall Study|Physician Decision|2|||
164004871|NCT02371629|592382598|FG001|Overall Study|Physician Decision|3|||
164004872|NCT02371629|592382597|FG000|Overall Study|Death|1|||
164004873|NCT02371629|592382598|FG001|Overall Study|Death|1|||
164004874|NCT02371629|592382597|FG000|Overall Study|Noncompliance with study treatment|1|||
164004875|NCT02371629|592382598|FG001|Overall Study|Noncompliance with study treatment|0|||
164004876|NCT02371629|592382597|FG000|Overall Study|Lack of Efficacy|0|||
164004877|NCT02371629|592382598|FG001|Overall Study|Lack of Efficacy|2|||
164004878|NCT02371629|592382597|FG000|Overall Study|Protocol deviation|0|||
164004879|NCT02371629|592382598|FG001|Overall Study|Protocol deviation|1|||
164004880|NCT01193335|592382599|FG000|After Infant Series|Lost to Follow-up|1|||
164004881|NCT01193335|592382600|FG001|After Infant Series|Lost to Follow-up|2|||
164088901|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164004882|NCT01193335|592382599|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
164004883|NCT01193335|592382600|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
164004884|NCT01193335|592382599|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
164004885|NCT01193335|592382600|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
164004886|NCT01193335|592382599|FG000|1-Year Follow-up|Lost to Follow-up|4|||
164004887|NCT01193335|592382600|FG001|1-Year Follow-up|Lost to Follow-up|0|||
164004888|NCT01193335|592382599|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
164004889|NCT01193335|592382600|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
164004890|NCT01193335|592382599|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
164004891|NCT01193335|592382600|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
164294522|NCT02542865|593452167|FG001|Overall Study|Withdrawal by Subject|0|||
164294523|NCT01277744|593452170|FG000|Overall Study|Physician Decision|2|||
164294524|NCT02358473|593452172|FG000|Overall Study|Disease Progession|6|||
164294525|NCT02358473|593452172|FG000|Overall Study|Adverse Event|3|||
164294526|NCT02358473|593452172|FG000|Overall Study|Withdrawal by Subject|2|||
164004892|NCT03486314|592382602|FG000|Part A|Adverse Event|1|||
164294527|NCT02358473|593452172|FG000|Overall Study|Physician Decision|2|||
164294528|NCT00730158|593452175|FG000|Overall Study|Withdrawal by Subject|1|||
164294529|NCT00730158|593452176|FG001|Overall Study|Withdrawal by Subject|1|||
164294530|NCT03535974|593452178|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
164294531|NCT03535974|593452179|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
164294532|NCT03535974|593452180|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
164294533|NCT03535974|593452178|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
164294534|NCT03535974|593452179|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
164294535|NCT03535974|593452180|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
164294536|NCT04059549|593452181|FG000|Overall Study|Withdrawal by Subject|2|||
164294537|NCT04059549|593452182|FG001|Overall Study|Withdrawal by Subject|0|||
164294538|NCT02678351|593452183|FG000|Overall Study|Withdrawal by Subject|1|||
164294539|NCT03259230|593452184|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
164004893|NCT03486314|592382603|FG001|Part A|Adverse Event|0|||
164004894|NCT03486314|592382604|FG002|Part A|Adverse Event|0|||
164004895|NCT03486314|592382602|FG000|Part A|Symptomatic Deterioration|2|||
164004896|NCT03486314|592382603|FG001|Part A|Symptomatic Deterioration|0|||
164004897|NCT03486314|592382604|FG002|Part A|Symptomatic Deterioration|0|||
164004898|NCT01985321|592382605|FG000|Overall Study|Protocol Violation|4|||
164004899|NCT01985321|592382606|FG001|Overall Study|Protocol Violation|3|||
164004900|NCT01985321|592382605|FG000|Overall Study|Withdrawal by Subject|1|||
164004901|NCT01985321|592382606|FG001|Overall Study|Withdrawal by Subject|0|||
164004902|NCT01985321|592382605|FG000|Overall Study|Lost to Follow-up|5|||
164004903|NCT01985321|592382606|FG001|Overall Study|Lost to Follow-up|2|||
164004904|NCT01985321|592382605|FG000|Overall Study|Subject treated wrong type of sore|1|||
164004905|NCT01985321|592382606|FG001|Overall Study|Subject treated wrong type of sore|0|||
164004906|NCT01364467|592382609|FG000|Overall Study|Lost to Follow-up|1|||
164004907|NCT01364467|592382610|FG001|Overall Study|Lost to Follow-up|2|||
164004908|NCT03577990|592382611|FG000|Overall Study|Lost to Follow-up|4|||
164004909|NCT03577990|592382612|FG001|Overall Study|Lost to Follow-up|6|||
164004910|NCT03577990|592382611|FG000|Overall Study|Withdrawal by Subject|4|||
164004911|NCT03577990|592382612|FG001|Overall Study|Withdrawal by Subject|7|||
164004912|NCT02827877|592382613|FG000|Overall Study|Withdrawal by Subject|1|||
164004913|NCT00519532|592382616|FG000|Overall Study|Adverse Event|11|||
164004914|NCT00519532|592382616|FG000|Overall Study|Withdrawal by Subject|5|||
164004915|NCT00519532|592382616|FG000|Overall Study|Lost to Follow-up|2|||
164004916|NCT03914300|592382617|FG000|Overall Study|Adverse Event|1|||
164004917|NCT00814710|592382618|FG000|Overall Study|Adverse Event|1|||
164004918|NCT00814710|592382619|FG001|Overall Study|Adverse Event|0|||
164004919|NCT00814710|592382618|FG000|Overall Study|Lost to Follow-up|7|||
164004920|NCT00814710|592382619|FG001|Overall Study|Lost to Follow-up|3|||
164004921|NCT04090164|592382631|FG000|Overall Study|incomplete data on file|245|||
164004922|NCT04090164|592382632|FG001|Overall Study|incomplete data on file|0|||
164004923|NCT01826214|592384083|FG000|Overall Study|Adverse Event|7|||
164294540|NCT03259230|593452185|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
164294541|NCT02913482|593452186|FG000|Overall Study|Death|0|||
164294542|NCT02913482|593452187|FG001|Overall Study|Death|2|||
164294543|NCT02913482|593452188|FG002|Overall Study|Death|2|||
164294544|NCT02913482|593452186|FG000|Overall Study|Progressive Disease|1|||
164294545|NCT02913482|593452187|FG001|Overall Study|Progressive Disease|1|||
164294546|NCT02913482|593452188|FG002|Overall Study|Progressive Disease|1|||
164294547|NCT02913482|593452186|FG000|Overall Study|Reason not specified|0|||
164294548|NCT02913482|593452187|FG001|Overall Study|Reason not specified|0|||
164294549|NCT02913482|593452188|FG002|Overall Study|Reason not specified|1|||
164294550|NCT02913482|593452186|FG000|Overall Study|Withdrawal by Subject|0|||
164294551|NCT02913482|593452187|FG001|Overall Study|Withdrawal by Subject|1|||
164294552|NCT02913482|593452188|FG002|Overall Study|Withdrawal by Subject|1|||
164294553|NCT01919229|593452189|FG000|Overall Study|Subject/guardian decision|0|||
164294554|NCT01919229|593452190|FG001|Overall Study|Subject/guardian decision|0|||
164294555|NCT01919229|593452191|FG002|Overall Study|Subject/guardian decision|1|||
164004924|NCT01826214|592384084|FG001|Overall Study|Adverse Event|6|||
164004925|NCT01826214|592384083|FG000|Overall Study|Death|3|||
164004926|NCT01826214|592384084|FG001|Overall Study|Death|1|||
164294556|NCT01011673|593452192|FG000|Randomized|Secondary headache|2|||
164294557|NCT01011673|593452193|FG001|Randomized|Secondary headache|1|||
164294558|NCT01011673|593452192|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
164294559|NCT01011673|593452193|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
164294560|NCT05468814|593452194|FG000|Overall Study|Lost to Follow-up|5|||
164294561|NCT05468814|593452195|FG001|Overall Study|Lost to Follow-up|6|||
164294562|NCT04716426|593452200|FG000|Overall Study|Vaccination|1|||
164004927|NCT01826214|592384083|FG000|Overall Study|Lost to Follow-up|1|||
164004928|NCT01826214|592384084|FG001|Overall Study|Lost to Follow-up|0|||
164004929|NCT01826214|592384083|FG000|Overall Study|Physician Decision|0|||
164004930|NCT01826214|592384084|FG001|Overall Study|Physician Decision|2|||
164004931|NCT01826214|592384083|FG000|Overall Study|Progressive disease|22|||
164004932|NCT01826214|592384084|FG001|Overall Study|Progressive disease|21|||
164004933|NCT01826214|592384083|FG000|Overall Study|Study terminated by Sponsor|0|||
164294563|NCT04716426|593452201|FG001|Overall Study|Vaccination|1|||
164294564|NCT04716426|593452200|FG000|Overall Study|Contamination|1|||
164294565|NCT04716426|593452201|FG001|Overall Study|Contamination|0|||
163898294|NCT01637402|592001040|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
163898295|NCT01637402|592001041|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
163898296|NCT01637402|592001040|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
163898297|NCT01637402|592001041|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
163898298|NCT01637402|592001040|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
163898299|NCT01637402|592001041|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
163898300|NCT01637402|592001040|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
163898301|NCT01637402|592001041|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
163898302|NCT02285270|592001044|FG000|Overall Study|Lost to Follow-up|1|||
163898303|NCT02285270|592001044|FG000|Overall Study|Physician Decision|3|||
163898304|NCT02285270|592001044|FG000|Overall Study|Determined to be ineligible|1|||
163898305|NCT02111096|592001045|FG000|Overall Study|Adverse Event|4|||
163898306|NCT02111096|592001046|FG001|Overall Study|Adverse Event|1|||
163898307|NCT02111096|592001047|FG002|Overall Study|Adverse Event|2|||
163898308|NCT02111096|592001045|FG000|Overall Study|Non-Compliance with Study Drug|1|||
163898309|NCT02111096|592001046|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163898310|NCT02111096|592001047|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163898311|NCT02111096|592001045|FG000|Overall Study|Lost to Follow Up|1|||
163898312|NCT02111096|592001046|FG001|Overall Study|Lost to Follow Up|1|||
163898313|NCT02111096|592001047|FG002|Overall Study|Lost to Follow Up|1|||
163898314|NCT02111096|592001045|FG000|Overall Study|Physician Decision|0|||
163898315|NCT02111096|592001046|FG001|Overall Study|Physician Decision|1|||
163898316|NCT02111096|592001047|FG002|Overall Study|Physician Decision|0|||
163898317|NCT02111096|592001045|FG000|Overall Study|Protocol Violation|1|||
163898318|NCT02111096|592001046|FG001|Overall Study|Protocol Violation|0|||
163898319|NCT02111096|592001047|FG002|Overall Study|Protocol Violation|1|||
163898320|NCT02111096|592001045|FG000|Overall Study|Terminated by Sponsor|53|||
163898321|NCT02111096|592001046|FG001|Overall Study|Terminated by Sponsor|35|||
163898322|NCT02111096|592001047|FG002|Overall Study|Terminated by Sponsor|54|||
163898323|NCT02111096|592001045|FG000|Overall Study|Withdrawal by Subject|4|||
163898324|NCT02111096|592001046|FG001|Overall Study|Withdrawal by Subject|2|||
163898325|NCT02111096|592001047|FG002|Overall Study|Withdrawal by Subject|8|||
163898326|NCT00439270|592001050|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
163898327|NCT00439270|592001051|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
163898328|NCT00439270|592001052|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
163898329|NCT00439270|592001053|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
163898330|NCT00439270|592001054|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
163898331|NCT00439270|592001050|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163898332|NCT00439270|592001051|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
163898333|NCT00439270|592001052|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163898334|NCT00439270|592001053|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163898335|NCT00439270|592001054|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
163898336|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
163898337|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
163898338|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
163898339|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
163898340|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
163898341|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163898342|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163898343|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163898344|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
163898345|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
163898346|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163898347|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163898348|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163898349|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
163898350|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
163898351|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163898352|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163898353|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163898354|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
163898355|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
163898356|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163898357|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163898358|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
163898359|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
163898360|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
164294566|NCT01650558|593452204|FG000|Overall Study|Migration out of study area|61|||
164088902|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088903|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
164088904|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
164088905|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
164088906|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
164088907|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
164088908|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164294567|NCT01650558|593452205|FG001|Overall Study|Migration out of study area|71|||
164294568|NCT01650558|593452206|FG002|Overall Study|Migration out of study area|56|||
164294569|NCT01650558|593452204|FG000|Overall Study|Lost to Follow-up|10|||
164294570|NCT01650558|593452205|FG001|Overall Study|Lost to Follow-up|13|||
164088909|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088910|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088911|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088912|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088913|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088914|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164294571|NCT01650558|593452206|FG002|Overall Study|Lost to Follow-up|6|||
164294572|NCT01650558|593452204|FG000|Overall Study|Death|10|||
164294573|NCT01650558|593452205|FG001|Overall Study|Death|6|||
164294574|NCT01650558|593452206|FG002|Overall Study|Death|8|||
164294575|NCT01650558|593452204|FG000|Overall Study|Withdrawal by Subject|1|||
164294576|NCT01650558|593452205|FG001|Overall Study|Withdrawal by Subject|1|||
164294577|NCT01650558|593452206|FG002|Overall Study|Withdrawal by Subject|3|||
164294578|NCT01650558|593452204|FG000|Overall Study|Non-compliant participant|1|||
164294579|NCT01650558|593452205|FG001|Overall Study|Non-compliant participant|0|||
164294580|NCT01650558|593452206|FG002|Overall Study|Non-compliant participant|2|||
164294581|NCT01650558|593452204|FG000|Overall Study|Physician Decision|0|||
164294582|NCT01650558|593452205|FG001|Overall Study|Physician Decision|1|||
164294583|NCT01650558|593452206|FG002|Overall Study|Physician Decision|0|||
164294584|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
164294585|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
164294586|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
164294587|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
164088915|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088916|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
164088917|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
164088918|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
164294588|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
164294589|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
164294590|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
164294591|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
164294592|NCT02960217|593452207|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
164088919|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
164088920|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
164088921|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
164088922|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088923|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164294593|NCT02960217|593452208|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
164294594|NCT02960217|593452207|FG000|Open-Label Extension Phase|Adverse Event|1|||
164294595|NCT02960217|593452208|FG001|Open-Label Extension Phase|Adverse Event|0|||
164294596|NCT02960217|593452207|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
164294597|NCT02960217|593452208|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
164294598|NCT02960217|593452207|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
164294599|NCT02960217|593452208|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
164294600|NCT02960217|593452207|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
164294601|NCT02960217|593452208|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
164294602|NCT02734693|593452209|FG000|Overall Study|Adverse Event|1|||
164294603|NCT02734693|593452210|FG001|Overall Study|Adverse Event|3|||
164294604|NCT02734693|593452211|FG002|Overall Study|Adverse Event|3|||
164294605|NCT02734693|593452209|FG000|Overall Study|Lack of Efficacy|1|||
164294606|NCT02734693|593452210|FG001|Overall Study|Lack of Efficacy|0|||
164294607|NCT02734693|593452211|FG002|Overall Study|Lack of Efficacy|0|||
164294608|NCT02734693|593452209|FG000|Overall Study|Lost to Follow-up|2|||
164294609|NCT02734693|593452210|FG001|Overall Study|Lost to Follow-up|0|||
164294610|NCT02734693|593452211|FG002|Overall Study|Lost to Follow-up|0|||
164294611|NCT02734693|593452209|FG000|Overall Study|Protocol Violation|1|||
164294612|NCT02734693|593452210|FG001|Overall Study|Protocol Violation|0|||
164294613|NCT02734693|593452211|FG002|Overall Study|Protocol Violation|0|||
164294614|NCT02734693|593452209|FG000|Overall Study|Withdrawal by Subject|1|||
164294615|NCT02734693|593452210|FG001|Overall Study|Withdrawal by Subject|0|||
164294616|NCT02734693|593452211|FG002|Overall Study|Withdrawal by Subject|0|||
164294617|NCT02675907|593452215|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
164294618|NCT02675907|593452216|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
164294619|NCT02675907|593452215|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
164294620|NCT02675907|593452216|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
164294621|NCT02675907|593452215|FG000|Study Overall|Lack of Efficacy|1|||
164294622|NCT02675907|593452216|FG001|Study Overall|Lack of Efficacy|0|||
164294623|NCT02675907|593452215|FG000|Study Overall|Withdrawal by Subject|2|||
164294624|NCT02675907|593452216|FG001|Study Overall|Withdrawal by Subject|2|||
164294625|NCT02675907|593452215|FG000|Study Overall|Lost to Follow-up|0|||
164294626|NCT02675907|593452216|FG001|Study Overall|Lost to Follow-up|2|||
164294627|NCT01611792|593452217|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
164294628|NCT01611792|593452218|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
164294629|NCT01611792|593452217|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
164294630|NCT01611792|593452218|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
164294631|NCT03416868|593452219|FG000|Overall Study|Withdrawal by Subject|2|||
164294632|NCT03416868|593452219|FG000|Overall Study|Lost to Follow-up|1|||
164294633|NCT00960375|593452222|FG000|Overall Study|Lost to Follow-up|20|||
164294634|NCT00960375|593452223|FG001|Overall Study|Lost to Follow-up|22|||
164294635|NCT03624881|593452224|FG000|Overall Study|Screen Failure|14|||
164294636|NCT03624881|593452225|FG001|Overall Study|Screen Failure|0|||
164294637|NCT03624881|593452224|FG000|Overall Study|No Catheter Inserted|6|||
164294638|NCT03624881|593452225|FG001|Overall Study|No Catheter Inserted|1|||
164294639|NCT03624881|593452224|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
164294640|NCT03624881|593452225|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
164294641|NCT03624881|593452224|FG000|Overall Study|Death|2|||
164294642|NCT03624881|593452225|FG001|Overall Study|Death|0|||
164294643|NCT03624881|593452224|FG000|Overall Study|Lost to Follow-up|10|||
164294644|NCT03624881|593452225|FG001|Overall Study|Lost to Follow-up|4|||
164294645|NCT03624881|593452224|FG000|Overall Study|Withdrawal by Subject|12|||
164294646|NCT03624881|593452225|FG001|Overall Study|Withdrawal by Subject|1|||
164294647|NCT03473236|593452227|FG000|Overall Study|Withdrawal by Subject|0|||
164294648|NCT03473236|593452228|FG001|Overall Study|Withdrawal by Subject|0|||
164294649|NCT03473236|593452229|FG002|Overall Study|Withdrawal by Subject|0|||
164294650|NCT03473236|593452230|FG003|Overall Study|Withdrawal by Subject|0|||
164294651|NCT03473236|593452231|FG004|Overall Study|Withdrawal by Subject|0|||
164294652|NCT03473236|593452232|FG005|Overall Study|Withdrawal by Subject|1|||
164294653|NCT03473236|593452233|FG006|Overall Study|Withdrawal by Subject|0|||
164294654|NCT03473236|593452234|FG007|Overall Study|Withdrawal by Subject|0|||
164294655|NCT03473236|593452235|FG008|Overall Study|Withdrawal by Subject|1|||
164294656|NCT03473236|593452236|FG009|Overall Study|Withdrawal by Subject|0|||
164294657|NCT04264442|593452237|FG000|Overall Study|Lack of Efficacy|6|||
164294658|NCT04264442|593452237|FG000|Overall Study|Lost to Follow-up|2|||
164294659|NCT04264442|593452237|FG000|Overall Study|Sponsor Decision|23|||
164294660|NCT04264442|593452237|FG000|Overall Study|Withdrawal by Subject|11|||
164294661|NCT04264442|593452237|FG000|Overall Study|Study Termination|5|||
164294662|NCT03309020|593452238|FG000|Overall Study|Death|1|||
164294663|NCT03309020|593452239|FG001|Overall Study|Death|0|||
164294664|NCT03309020|593452238|FG000|Overall Study|Did not undergo surgery|2|||
164294665|NCT03309020|593452239|FG001|Overall Study|Did not undergo surgery|1|||
164294666|NCT02362724|593452246|FG000|Overall Study|Withdrawal by Subject|3|||
164294667|NCT02362724|593452247|FG001|Overall Study|Withdrawal by Subject|1|||
164294668|NCT02362724|593452246|FG000|Overall Study|Adverse Event|3|||
164294669|NCT02362724|593452247|FG001|Overall Study|Adverse Event|0|||
164294670|NCT05190120|593452250|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
164294671|NCT05190120|593452251|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
164294672|NCT05190120|593452252|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
164294673|NCT05190120|593452253|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
164294674|NCT05190120|593452250|FG000|Overall Study|Lost to Follow-up|5|||
164294675|NCT05190120|593452251|FG001|Overall Study|Lost to Follow-up|0|||
164294676|NCT05190120|593452252|FG002|Overall Study|Lost to Follow-up|2|||
164294677|NCT05190120|593452253|FG003|Overall Study|Lost to Follow-up|3|||
164294678|NCT03062358|593452254|FG000|Overall Study|Death|269|||
164294679|NCT03062358|593452255|FG001|Overall Study|Death|145|||
164294680|NCT03062358|593452254|FG000|Overall Study|Withdrawal by Subject|2|||
163898361|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163898362|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163898363|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
163898364|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
163898365|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
164294681|NCT03062358|593452255|FG001|Overall Study|Withdrawal by Subject|1|||
164346886|NCT02801331|593645188|FG001|Overall Study|Transferred to another hospital|7|||
163898366|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
163898367|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
164294682|NCT03062358|593452254|FG000|Overall Study|Sponsor Decision|29|||
164294683|NCT03062358|593452255|FG001|Overall Study|Sponsor Decision|7|||
164294684|NCT05893862|593452256|FG000|Overall Study|Physician Decision|0|||
164294685|NCT05893862|593452257|FG001|Overall Study|Physician Decision|1|||
164294686|NCT05893862|593452258|FG002|Overall Study|Physician Decision|0|||
164294687|NCT05893862|593452259|FG003|Overall Study|Physician Decision|0|||
164294688|NCT05893862|593452260|FG004|Overall Study|Physician Decision|1|||
164294689|NCT05893862|593452261|FG005|Overall Study|Physician Decision|0|||
164294690|NCT05893862|593452256|FG000|Overall Study|Withdrawal by Subject|1|||
164294691|NCT05893862|593452257|FG001|Overall Study|Withdrawal by Subject|7|||
164294692|NCT05893862|593452258|FG002|Overall Study|Withdrawal by Subject|1|||
164294693|NCT05893862|593452259|FG003|Overall Study|Withdrawal by Subject|3|||
164294694|NCT05893862|593452260|FG004|Overall Study|Withdrawal by Subject|3|||
164294695|NCT05893862|593452261|FG005|Overall Study|Withdrawal by Subject|2|||
164294696|NCT05893862|593452256|FG000|Overall Study|Adverse Event|1|||
164294697|NCT05893862|593452257|FG001|Overall Study|Adverse Event|4|||
164294698|NCT05893862|593452258|FG002|Overall Study|Adverse Event|2|||
164294699|NCT05893862|593452259|FG003|Overall Study|Adverse Event|2|||
164294700|NCT05893862|593452260|FG004|Overall Study|Adverse Event|1|||
164346887|NCT02801331|593645187|FG000|Overall Study|Withdrawal by Subject|0|||
164346888|NCT02801331|593645188|FG001|Overall Study|Withdrawal by Subject|4|||
164346889|NCT02801331|593645187|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
164346890|NCT02801331|593645188|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
164346891|NCT02443987|593645189|FG000|Overall Study|Bladder injury|1|||
164346892|NCT02443987|593645190|FG001|Overall Study|Bladder injury|1|||
164346893|NCT02443987|593645189|FG000|Overall Study|Other|0|||
164346894|NCT02443987|593645190|FG001|Overall Study|Other|1|||
164346895|NCT00407797|593646738|FG000|Overall Study|Lost to Follow-up|2|||
164346896|NCT00407797|593646738|FG000|Overall Study|Adverse Event|6|||
164346897|NCT00407797|593646738|FG000|Overall Study|Other|7|||
164346898|NCT00407797|593646738|FG000|Overall Study|Withdrawal by Subject|3|||
164346899|NCT01402492|593646742|FG000|Overall Study|Withdrawal by Subject|17|||
164346900|NCT01402492|593646743|FG001|Overall Study|Withdrawal by Subject|11|||
164346901|NCT01402492|593646744|FG002|Overall Study|Withdrawal by Subject|11|||
164346902|NCT01402492|593646742|FG000|Overall Study|Adverse Event|2|||
164346903|NCT01402492|593646743|FG001|Overall Study|Adverse Event|3|||
164346904|NCT01402492|593646744|FG002|Overall Study|Adverse Event|4|||
164294701|NCT05893862|593452261|FG005|Overall Study|Adverse Event|0|||
164294702|NCT04158583|593452262|FG000|Overall Study|Withdrawal by Subject|1|||
164346905|NCT01402492|593646742|FG000|Overall Study|Physician Decision|0|||
164346906|NCT01402492|593646743|FG001|Overall Study|Physician Decision|3|||
164294703|NCT04158583|593452263|FG001|Overall Study|Withdrawal by Subject|1|||
164294704|NCT04158583|593452264|FG002|Overall Study|Withdrawal by Subject|0|||
164294705|NCT04158583|593452265|FG003|Overall Study|Withdrawal by Subject|0|||
164294706|NCT04158583|593452266|FG004|Overall Study|Withdrawal by Subject|1|||
164294707|NCT04158583|593452267|FG005|Overall Study|Withdrawal by Subject|0|||
164294708|NCT04158583|593452268|FG006|Overall Study|Withdrawal by Subject|0|||
164294709|NCT04158583|593452269|FG007|Overall Study|Withdrawal by Subject|0|||
164346907|NCT01402492|593646744|FG002|Overall Study|Physician Decision|0|||
164346908|NCT01402492|593646742|FG000|Overall Study|Incarcerated (N=3)|2|||
164346909|NCT01402492|593646743|FG001|Overall Study|Incarcerated (N=3)|0|||
164088924|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088925|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164294710|NCT04158583|593452270|FG008|Overall Study|Withdrawal by Subject|2|||
164294711|NCT04158583|593452271|FG009|Overall Study|Withdrawal by Subject|0|||
164294712|NCT04158583|593452262|FG000|Overall Study|Study Terminated by Sponsor|0|||
164294713|NCT04158583|593452263|FG001|Overall Study|Study Terminated by Sponsor|0|||
164294714|NCT04158583|593452264|FG002|Overall Study|Study Terminated by Sponsor|0|||
164294715|NCT04158583|593452265|FG003|Overall Study|Study Terminated by Sponsor|1|||
164294716|NCT04158583|593452266|FG004|Overall Study|Study Terminated by Sponsor|0|||
164294717|NCT04158583|593452267|FG005|Overall Study|Study Terminated by Sponsor|0|||
164294718|NCT04158583|593452268|FG006|Overall Study|Study Terminated by Sponsor|0|||
164294719|NCT04158583|593452269|FG007|Overall Study|Study Terminated by Sponsor|0|||
164294720|NCT04158583|593452270|FG008|Overall Study|Study Terminated by Sponsor|0|||
164294721|NCT04158583|593452271|FG009|Overall Study|Study Terminated by Sponsor|0|||
164294722|NCT04158583|593452262|FG000|Overall Study|Progressive Disease|1|||
164294723|NCT04158583|593452263|FG001|Overall Study|Progressive Disease|0|||
164294724|NCT04158583|593452264|FG002|Overall Study|Progressive Disease|3|||
164294725|NCT04158583|593452265|FG003|Overall Study|Progressive Disease|5|||
164294726|NCT04158583|593452266|FG004|Overall Study|Progressive Disease|0|||
164294727|NCT04158583|593452267|FG005|Overall Study|Progressive Disease|1|||
164294728|NCT04158583|593452268|FG006|Overall Study|Progressive Disease|6|||
164294729|NCT04158583|593452269|FG007|Overall Study|Progressive Disease|2|||
164294730|NCT04158583|593452270|FG008|Overall Study|Progressive Disease|1|||
164294731|NCT04158583|593452271|FG009|Overall Study|Progressive Disease|2|||
164294732|NCT04158583|593452262|FG000|Overall Study|Lost to Follow-up|0|||
164294733|NCT04158583|593452263|FG001|Overall Study|Lost to Follow-up|0|||
164294734|NCT04158583|593452264|FG002|Overall Study|Lost to Follow-up|1|||
164294735|NCT04158583|593452265|FG003|Overall Study|Lost to Follow-up|1|||
164294736|NCT04158583|593452266|FG004|Overall Study|Lost to Follow-up|1|||
164294737|NCT04158583|593452267|FG005|Overall Study|Lost to Follow-up|0|||
164294738|NCT04158583|593452268|FG006|Overall Study|Lost to Follow-up|0|||
164294739|NCT04158583|593452269|FG007|Overall Study|Lost to Follow-up|0|||
164294740|NCT04158583|593452270|FG008|Overall Study|Lost to Follow-up|0|||
164294741|NCT04158583|593452271|FG009|Overall Study|Lost to Follow-up|0|||
164294742|NCT04158583|593452262|FG000|Overall Study|Due To Patient Status|0|||
164346910|NCT01402492|593646744|FG002|Overall Study|Incarcerated (N=3)|1|||
164346911|NCT00601458|593646758|FG000|Overall Study|Dosing Error|1|||
164346912|NCT00601458|593646759|FG001|Overall Study|Dosing Error|0|||
164346913|NCT00601458|593646760|FG002|Overall Study|Dosing Error|0|||
164088926|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088927|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088928|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088929|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088930|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088931|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088932|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088933|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088934|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
164088935|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
164088936|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088937|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088938|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088939|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088940|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088941|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088942|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088943|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088944|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
164088945|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
164294743|NCT04158583|593452263|FG001|Overall Study|Due To Patient Status|0|||
164346914|NCT00601458|593646758|FG000|Overall Study|Incomplete Data|0|||
164346915|NCT00601458|593646759|FG001|Overall Study|Incomplete Data|2|||
164088946|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
164294744|NCT04158583|593452264|FG002|Overall Study|Due To Patient Status|0|||
164294745|NCT04158583|593452265|FG003|Overall Study|Due To Patient Status|0|||
164294746|NCT04158583|593452266|FG004|Overall Study|Due To Patient Status|0|||
164294747|NCT04158583|593452267|FG005|Overall Study|Due To Patient Status|0|||
164294748|NCT04158583|593452268|FG006|Overall Study|Due To Patient Status|0|||
164294749|NCT04158583|593452269|FG007|Overall Study|Due To Patient Status|0|||
164294750|NCT04158583|593452270|FG008|Overall Study|Due To Patient Status|1|||
164346916|NCT00601458|593646760|FG002|Overall Study|Incomplete Data|0|||
164346917|NCT00601458|593646758|FG000|Overall Study|Protocol Violation|3|||
164346918|NCT00601458|593646759|FG001|Overall Study|Protocol Violation|2|||
164088947|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
164088948|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
164088949|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
164088950|NCT04033445|592688861|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088951|NCT04033445|592688862|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088952|NCT04033445|592688863|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088953|NCT04033445|592688864|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088954|NCT04033445|592688865|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088955|NCT04033445|592688866|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088956|NCT04033445|592688867|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088957|NCT04033445|592688868|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088958|NCT04033445|592688869|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088959|NCT04033445|592688870|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
164088960|NCT04033445|592688871|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088961|NCT04033445|592688872|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
164088962|NCT04033445|592688873|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
164088963|NCT04033445|592688874|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
164088964|NCT02985957|592688879|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164088965|NCT02985957|592688880|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164088966|NCT02985957|592688881|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164088967|NCT02985957|592688882|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164088968|NCT02985957|592688883|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164088969|NCT02985957|592688884|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164088970|NCT02985957|592688885|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164088971|NCT02985957|592688879|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
164088972|NCT02985957|592688880|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164088973|NCT02985957|592688881|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
164088974|NCT02985957|592688882|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
164088975|NCT02985957|592688883|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
164088976|NCT02985957|592688884|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
164088977|NCT02985957|592688885|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
164088978|NCT02985957|592688879|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164088979|NCT02985957|592688880|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164088980|NCT02985957|592688881|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164088981|NCT02985957|592688882|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164088982|NCT02985957|592688883|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164088983|NCT02985957|592688884|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
164088984|NCT02985957|592688885|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
164088985|NCT02985957|592688879|FG000|Treatment Period|Death|0|||
164088986|NCT02985957|592688880|FG001|Treatment Period|Death|0|||
164088987|NCT02985957|592688881|FG002|Treatment Period|Death|0|||
164088988|NCT02985957|592688882|FG003|Treatment Period|Death|0|||
164088989|NCT02985957|592688883|FG004|Treatment Period|Death|1|||
164088990|NCT02985957|592688884|FG005|Treatment Period|Death|0|||
164088991|NCT02985957|592688885|FG006|Treatment Period|Death|0|||
164088992|NCT02985957|592688879|FG000|Treatment Period|Participant withdrew consent|0|||
164088993|NCT02985957|592688880|FG001|Treatment Period|Participant withdrew consent|0|||
164088994|NCT02985957|592688881|FG002|Treatment Period|Participant withdrew consent|0|||
164088995|NCT02985957|592688882|FG003|Treatment Period|Participant withdrew consent|1|||
164088996|NCT02985957|592688883|FG004|Treatment Period|Participant withdrew consent|3|||
164088997|NCT02985957|592688884|FG005|Treatment Period|Participant withdrew consent|0|||
164088998|NCT02985957|592688885|FG006|Treatment Period|Participant withdrew consent|1|||
164088999|NCT02985957|592688879|FG000|Treatment Period|Lost to Follow-up|0|||
164089000|NCT02985957|592688880|FG001|Treatment Period|Lost to Follow-up|0|||
164089001|NCT02985957|592688881|FG002|Treatment Period|Lost to Follow-up|0|||
164089002|NCT02985957|592688882|FG003|Treatment Period|Lost to Follow-up|0|||
164089003|NCT02985957|592688883|FG004|Treatment Period|Lost to Follow-up|1|||
164089004|NCT02985957|592688884|FG005|Treatment Period|Lost to Follow-up|0|||
164346919|NCT00601458|593646760|FG002|Overall Study|Protocol Violation|1|||
164346920|NCT00601458|593646758|FG000|Overall Study|Early Termination|0|||
164346921|NCT00601458|593646759|FG001|Overall Study|Early Termination|1|||
164089005|NCT02985957|592688885|FG006|Treatment Period|Lost to Follow-up|0|||
164089006|NCT02985957|592688879|FG000|Treatment Period|Other reasons|0|||
164089007|NCT02985957|592688880|FG001|Treatment Period|Other reasons|0|||
164089008|NCT02985957|592688881|FG002|Treatment Period|Other reasons|1|||
164089009|NCT02985957|592688882|FG003|Treatment Period|Other reasons|3|||
164346922|NCT00601458|593646760|FG002|Overall Study|Early Termination|1|||
164346923|NCT00518986|593646761|FG000|Overall Study|Adverse Event|12|||
163898368|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
164346924|NCT00518986|593646762|FG001|Overall Study|Adverse Event|7|||
164346925|NCT00518986|593646761|FG000|Overall Study|Lack of Efficacy|0|||
164346926|NCT00518986|593646762|FG001|Overall Study|Lack of Efficacy|2|||
164346927|NCT00518986|593646761|FG000|Overall Study|Lost to Follow-up|3|||
164346928|NCT00518986|593646762|FG001|Overall Study|Lost to Follow-up|2|||
164346929|NCT00518986|593646761|FG000|Overall Study|Physician Decision|0|||
164346930|NCT00518986|593646762|FG001|Overall Study|Physician Decision|3|||
164346931|NCT00518986|593646761|FG000|Overall Study|Protocol Violation|5|||
164346932|NCT00518986|593646762|FG001|Overall Study|Protocol Violation|7|||
164346933|NCT00518986|593646761|FG000|Overall Study|Withdrawal by Subject|4|||
164346934|NCT00518986|593646762|FG001|Overall Study|Withdrawal by Subject|4|||
164346935|NCT00518986|593646761|FG000|Overall Study|Non-Specific|2|||
164346936|NCT00518986|593646762|FG001|Overall Study|Non-Specific|1|||
164346937|NCT04862585|593646766|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
164346938|NCT04862585|593646767|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
164346939|NCT04862585|593646766|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
164346940|NCT04862585|593646767|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
164346941|NCT04862585|593646766|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
164346942|NCT04862585|593646767|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
164346943|NCT04862585|593646766|FG000|Overall Study|one withdrew without providing a reason|0|||
164346944|NCT04862585|593646767|FG001|Overall Study|one withdrew without providing a reason|1|||
164346945|NCT05288062|593646768|FG000|Overall Study|Ineligible|0|||
164346946|NCT05288062|593646769|FG001|Overall Study|Ineligible|0|||
164346947|NCT05288062|593646770|FG002|Overall Study|Ineligible|1|||
164346948|NCT05288062|593646771|FG003|Overall Study|Ineligible|0|||
164346949|NCT05288062|593646768|FG000|Overall Study|Withdrawal by Subject|0|||
164346950|NCT05288062|593646769|FG001|Overall Study|Withdrawal by Subject|0|||
164346951|NCT05288062|593646770|FG002|Overall Study|Withdrawal by Subject|1|||
164346952|NCT05288062|593646771|FG003|Overall Study|Withdrawal by Subject|0|||
164346953|NCT02099708|593646773|FG000|Overall Study|Data Not Available|30|||
164346954|NCT02099708|593646773|FG000|Overall Study|Lost to Follow-up|141|||
164346955|NCT02099708|593646773|FG000|Overall Study|Other|29|||
164346956|NCT01874054|593646774|FG000|Overall Study|Withdrawal by Subject|3|||
164346957|NCT01874054|593646774|FG000|Overall Study|Study Termination by Sponsor|42|||
164346958|NCT01874054|593646774|FG000|Overall Study|Lost to Follow-up|5|||
164346959|NCT01874054|593646774|FG000|Overall Study|Death|5|||
164346960|NCT00702923|593646775|FG000|Overall Study|Adverse Event|1|||
164346961|NCT02002091|593646776|FG000|Screening|Lost to Follow-up|10|||
164346962|NCT02002091|593646777|FG001|Screening|Lost to Follow-up|12|||
164346963|NCT02002091|593646776|FG000|Screening|Death|3|||
164346964|NCT02002091|593646777|FG001|Screening|Death|2|||
164346965|NCT03953820|593646778|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
164346966|NCT03953820|593646779|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
164346967|NCT03953820|593646780|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
164346968|NCT03953820|593646778|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
164346969|NCT03953820|593646779|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
164346970|NCT03953820|593646780|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
164294751|NCT04158583|593452271|FG009|Overall Study|Due To Patient Status|0|||
164294752|NCT04158583|593452262|FG000|Overall Study|Death|3|||
164294753|NCT04158583|593452263|FG001|Overall Study|Death|4|||
164294754|NCT04158583|593452264|FG002|Overall Study|Death|2|||
164294755|NCT04158583|593452265|FG003|Overall Study|Death|2|||
164294756|NCT04158583|593452266|FG004|Overall Study|Death|4|||
164294757|NCT04158583|593452267|FG005|Overall Study|Death|3|||
164294758|NCT04158583|593452268|FG006|Overall Study|Death|5|||
164294759|NCT04158583|593452269|FG007|Overall Study|Death|2|||
164294760|NCT04158583|593452270|FG008|Overall Study|Death|0|||
164294761|NCT04158583|593452271|FG009|Overall Study|Death|1|||
164294762|NCT04158583|593452262|FG000|Overall Study|Clinical Progression Disease|0|||
164294763|NCT04158583|593452263|FG001|Overall Study|Clinical Progression Disease|0|||
164294764|NCT04158583|593452264|FG002|Overall Study|Clinical Progression Disease|0|||
164294765|NCT04158583|593452265|FG003|Overall Study|Clinical Progression Disease|1|||
164294766|NCT04158583|593452266|FG004|Overall Study|Clinical Progression Disease|0|||
164294767|NCT04158583|593452267|FG005|Overall Study|Clinical Progression Disease|0|||
164294768|NCT04158583|593452268|FG006|Overall Study|Clinical Progression Disease|0|||
164346971|NCT01233258|593646783|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346972|NCT01233258|593646784|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346973|NCT01233258|593646785|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346974|NCT01233258|593646786|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
164346975|NCT01233258|593646787|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
164346976|NCT01233258|593646788|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
164346977|NCT01233258|593646783|FG000|First Intervention (6 Months)|Protocol Violation|0|||
164346978|NCT01233258|593646784|FG001|First Intervention (6 Months)|Protocol Violation|0|||
164294769|NCT04158583|593452269|FG007|Overall Study|Clinical Progression Disease|0|||
164004934|NCT01826214|592384084|FG001|Overall Study|Study terminated by Sponsor|1|||
164004935|NCT01826214|592384083|FG000|Overall Study|Subject/guardian decision|2|||
164004936|NCT01826214|592384084|FG001|Overall Study|Subject/guardian decision|3|||
164004937|NCT00955110|592384085|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
164004938|NCT00955110|592384085|FG000|Treatment Phase|Adverse Event|2|||
164004939|NCT00955110|592384085|FG000|Treatment Phase|Administrative reasons|2|||
164004940|NCT00955110|592384085|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
164004941|NCT00955110|592384085|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
164004942|NCT02128490|592384086|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164004943|NCT02128490|592384087|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164004944|NCT02128490|592384088|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164004945|NCT02128490|592384089|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
164004946|NCT02128490|592384090|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164004947|NCT02128490|592384086|FG000|Overall Study|Major Protocol Deviation|1|||
164004948|NCT02128490|592384087|FG001|Overall Study|Major Protocol Deviation|2|||
164004949|NCT02128490|592384088|FG002|Overall Study|Major Protocol Deviation|0|||
164004950|NCT02128490|592384089|FG003|Overall Study|Major Protocol Deviation|2|||
164004951|NCT02128490|592384090|FG004|Overall Study|Major Protocol Deviation|2|||
164004952|NCT02128490|592384086|FG000|Overall Study|Lost to Follow-up|0|||
164004953|NCT02128490|592384087|FG001|Overall Study|Lost to Follow-up|0|||
164004954|NCT02128490|592384088|FG002|Overall Study|Lost to Follow-up|1|||
164004955|NCT02128490|592384089|FG003|Overall Study|Lost to Follow-up|1|||
164004956|NCT02128490|592384090|FG004|Overall Study|Lost to Follow-up|1|||
164004957|NCT02128490|592384086|FG000|Overall Study|Voluntary Withdrawal|3|||
164004958|NCT02128490|592384087|FG001|Overall Study|Voluntary Withdrawal|3|||
164004959|NCT02128490|592384088|FG002|Overall Study|Voluntary Withdrawal|1|||
164004960|NCT02128490|592384089|FG003|Overall Study|Voluntary Withdrawal|1|||
164004961|NCT02128490|592384090|FG004|Overall Study|Voluntary Withdrawal|2|||
164004962|NCT02128490|592384086|FG000|Overall Study|Lack of Efficacy|0|||
164004963|NCT02128490|592384087|FG001|Overall Study|Lack of Efficacy|1|||
164004964|NCT02128490|592384088|FG002|Overall Study|Lack of Efficacy|0|||
164004965|NCT02128490|592384089|FG003|Overall Study|Lack of Efficacy|0|||
164004966|NCT02128490|592384090|FG004|Overall Study|Lack of Efficacy|0|||
164004967|NCT02128490|592384086|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164004968|NCT02128490|592384087|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164346979|NCT01233258|593646785|FG002|First Intervention (6 Months)|Protocol Violation|1|||
164346980|NCT01233258|593646786|FG003|First Intervention (6 Months)|Protocol Violation|0|||
164346981|NCT01233258|593646787|FG004|First Intervention (6 Months)|Protocol Violation|0|||
164346982|NCT01233258|593646788|FG005|First Intervention (6 Months)|Protocol Violation|0|||
164346983|NCT01233258|593646783|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
164346984|NCT01233258|593646784|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346985|NCT01233258|593646785|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346986|NCT01233258|593646786|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346987|NCT01233258|593646787|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346988|NCT01233258|593646788|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
164346989|NCT00530946|593646792|FG000|Overall Study|Adverse Event|1|||
164346990|NCT00530946|593646793|FG001|Overall Study|Adverse Event|2|||
164346991|NCT00530946|593646794|FG002|Overall Study|Adverse Event|1|||
164346992|NCT00530946|593646795|FG003|Overall Study|Adverse Event|1|||
164346993|NCT00530946|593646792|FG000|Overall Study|Protocol Violation|0|||
164346994|NCT00530946|593646793|FG001|Overall Study|Protocol Violation|0|||
164346995|NCT00530946|593646794|FG002|Overall Study|Protocol Violation|0|||
164346996|NCT00530946|593646795|FG003|Overall Study|Protocol Violation|1|||
164346997|NCT00530946|593646792|FG000|Overall Study|Noncompliance|1|||
164346998|NCT00530946|593646793|FG001|Overall Study|Noncompliance|0|||
164346999|NCT00530946|593646794|FG002|Overall Study|Noncompliance|0|||
164347000|NCT00530946|593646795|FG003|Overall Study|Noncompliance|0|||
164347001|NCT01534962|593646796|FG000|Overall Study|Randomized but did not start treatment|2|||
164347002|NCT01534962|593646797|FG001|Overall Study|Randomized but did not start treatment|0|||
164347003|NCT01534962|593646798|FG002|Overall Study|Randomized but did not start treatment|0|||
164347004|NCT01534962|593646799|FG003|Overall Study|Randomized but did not start treatment|1|||
164347005|NCT01534962|593646796|FG000|Overall Study|Discontinued at AF recurrence|35|||
164004969|NCT02128490|592384088|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164004970|NCT02128490|592384089|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
164004971|NCT02128490|592384090|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
164004972|NCT02128490|592384086|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164004973|NCT02128490|592384087|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164004974|NCT02128490|592384088|FG002|Overall Study|Other Miscellaneous Reasons|2|||
164004975|NCT02128490|592384089|FG003|Overall Study|Other Miscellaneous Reasons|1|||
164004976|NCT02128490|592384090|FG004|Overall Study|Other Miscellaneous Reasons|1|||
164004977|NCT02243176|592384091|FG000|Overall Study|Other reason|1|||
164347006|NCT01534962|593646797|FG001|Overall Study|Discontinued at AF recurrence|26|||
164347007|NCT01534962|593646798|FG002|Overall Study|Discontinued at AF recurrence|24|||
164004978|NCT02243176|592384092|FG001|Overall Study|Other reason|2|||
164004979|NCT02243176|592384091|FG000|Overall Study|protocol specified withdrawal critera|1|||
164004980|NCT02243176|592384092|FG001|Overall Study|protocol specified withdrawal critera|3|||
164004981|NCT02243176|592384091|FG000|Overall Study|Protocol Violation|2|||
164004982|NCT02243176|592384092|FG001|Overall Study|Protocol Violation|1|||
164004983|NCT02243176|592384091|FG000|Overall Study|Withdrawal by Subject|8|||
164004984|NCT02243176|592384092|FG001|Overall Study|Withdrawal by Subject|7|||
164004985|NCT02243176|592384091|FG000|Overall Study|Adverse Event|2|||
164004986|NCT02243176|592384092|FG001|Overall Study|Adverse Event|2|||
164004987|NCT03311126|592384094|FG000|Induction|Death|1|||
164004988|NCT03311126|592384094|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
164004989|NCT03113500|592384095|FG000|Overall Study|Withdrawal by Subject|1|||
164004990|NCT02517515|592384098|FG000|Overall Study|Adverse Event|0|||
164004991|NCT02517515|592384099|FG001|Overall Study|Adverse Event|1|||
164004992|NCT02517515|592384098|FG000|Overall Study|Withdrew Consent|0|||
164004993|NCT02517515|592384099|FG001|Overall Study|Withdrew Consent|1|||
164004994|NCT02517515|592384098|FG000|Overall Study|Lost to Follow-up|1|||
164004995|NCT02517515|592384099|FG001|Overall Study|Lost to Follow-up|0|||
164004996|NCT02517515|592384098|FG000|Overall Study|Other|1|||
164004997|NCT02517515|592384099|FG001|Overall Study|Other|0|||
164004998|NCT03839524|592384101|FG000|Overall Study|Adverse Event|1|||
164004999|NCT02401256|592384107|FG000|Overall Study|Adverse Event|5|||
164005000|NCT02401256|592384107|FG000|Overall Study|Withdrawal by Subject|12|||
164005001|NCT00893789|592384109|FG000|Overall Study|Withdrawal by Subject|3|||
164005002|NCT00893789|592384110|FG001|Overall Study|Withdrawal by Subject|1|||
164005003|NCT00893789|592384111|FG002|Overall Study|Withdrawal by Subject|3|||
164005004|NCT00893789|592384112|FG003|Overall Study|Withdrawal by Subject|1|||
164005005|NCT00893789|592384109|FG000|Overall Study|Noncompliance With Study Drug|1|||
164005006|NCT00893789|592384110|FG001|Overall Study|Noncompliance With Study Drug|0|||
164005007|NCT00893789|592384111|FG002|Overall Study|Noncompliance With Study Drug|1|||
164005008|NCT00893789|592384112|FG003|Overall Study|Noncompliance With Study Drug|2|||
164005009|NCT00893789|592384109|FG000|Overall Study|Noncompliance With Study Procedures|1|||
164005010|NCT00893789|592384110|FG001|Overall Study|Noncompliance With Study Procedures|0|||
164005011|NCT00893789|592384111|FG002|Overall Study|Noncompliance With Study Procedures|0|||
164005012|NCT00893789|592384112|FG003|Overall Study|Noncompliance With Study Procedures|0|||
164005013|NCT00893789|592384109|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
164005014|NCT00893789|592384110|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
164005015|NCT00893789|592384111|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
164005016|NCT00893789|592384112|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
164005017|NCT00893789|592384109|FG000|Overall Study|Adverse Event|0|||
164005018|NCT00893789|592384110|FG001|Overall Study|Adverse Event|2|||
164005019|NCT00893789|592384111|FG002|Overall Study|Adverse Event|1|||
164005020|NCT00893789|592384112|FG003|Overall Study|Adverse Event|5|||
164005021|NCT00893789|592384109|FG000|Overall Study|Protocol Violation|0|||
164005022|NCT00893789|592384110|FG001|Overall Study|Protocol Violation|1|||
164005023|NCT00893789|592384111|FG002|Overall Study|Protocol Violation|1|||
164005024|NCT00893789|592384112|FG003|Overall Study|Protocol Violation|4|||
164005025|NCT00893789|592384109|FG000|Overall Study|Lost to Follow-up|0|||
164005026|NCT00893789|592384110|FG001|Overall Study|Lost to Follow-up|0|||
164005027|NCT00893789|592384111|FG002|Overall Study|Lost to Follow-up|0|||
164005028|NCT00893789|592384112|FG003|Overall Study|Lost to Follow-up|1|||
164005029|NCT02024464|592384113|FG000|Overall Study|Discontinued|5|||
164005030|NCT02024464|592384114|FG001|Overall Study|Discontinued|4|||
164005031|NCT02024464|592384113|FG000|Overall Study|Missed Visits|1|||
164005032|NCT02024464|592384114|FG001|Overall Study|Missed Visits|0|||
164005033|NCT02024464|592384113|FG000|Overall Study|Lost to Follow-up|4|||
164005034|NCT02024464|592384114|FG001|Overall Study|Lost to Follow-up|7|||
164005035|NCT02037919|592384117|FG000|Overall Study|Lost to Follow-up|30|||
164005036|NCT02037919|592384118|FG001|Overall Study|Lost to Follow-up|45|||
164005037|NCT00886938|592384119|FG000|Overall Study|Adverse Event|1|||
164005038|NCT00886938|592384119|FG000|Overall Study|Withdrawal by Subject|1|||
164005039|NCT00917384|592384120|FG000|Overall Study|Lost to Follow-up|4|||
164005040|NCT00917384|592384121|FG001|Overall Study|Lost to Follow-up|2|||
164005041|NCT00917384|592384120|FG000|Overall Study|Withdrawal by Subject|10|||
164005042|NCT00917384|592384121|FG001|Overall Study|Withdrawal by Subject|2|||
164005043|NCT01458340|592384126|FG000|Overall Study|Adverse Event|5|||
164005044|NCT01458340|592384127|FG001|Overall Study|Adverse Event|4|||
164005045|NCT01458340|592384128|FG002|Overall Study|Adverse Event|2|||
164005046|NCT01458340|592384126|FG000|Overall Study|Lost to Follow-up|3|||
164005047|NCT01458340|592384127|FG001|Overall Study|Lost to Follow-up|3|||
164005048|NCT01458340|592384128|FG002|Overall Study|Lost to Follow-up|10|||
164005049|NCT01458340|592384126|FG000|Overall Study|Miscellaneous|0|||
164005050|NCT01458340|592384127|FG001|Overall Study|Miscellaneous|1|||
164005051|NCT01458340|592384128|FG002|Overall Study|Miscellaneous|0|||
164005052|NCT01458340|592384126|FG000|Overall Study|Physician Decision|1|||
164347008|NCT01534962|593646799|FG003|Overall Study|Discontinued at AF recurrence|31|||
164089010|NCT02985957|592688883|FG004|Treatment Period|Other reasons|5|||
164089011|NCT02985957|592688884|FG005|Treatment Period|Other reasons|0|||
164089012|NCT02985957|592688885|FG006|Treatment Period|Other reasons|1|||
164089013|NCT02985957|592688879|FG000|Treatment Period|Not reported|0|||
164089014|NCT02985957|592688880|FG001|Treatment Period|Not reported|2|||
164089015|NCT02985957|592688881|FG002|Treatment Period|Not reported|2|||
164089016|NCT02985957|592688882|FG003|Treatment Period|Not reported|5|||
164089017|NCT02985957|592688883|FG004|Treatment Period|Not reported|0|||
164089018|NCT02985957|592688884|FG005|Treatment Period|Not reported|0|||
164089019|NCT02985957|592688885|FG006|Treatment Period|Not reported|0|||
164089020|NCT02985957|592688879|FG000|Treatment Period|Maximum clinical benefit|0|||
164089021|NCT02985957|592688880|FG001|Treatment Period|Maximum clinical benefit|0|||
164089022|NCT02985957|592688881|FG002|Treatment Period|Maximum clinical benefit|1|||
164089023|NCT02985957|592688882|FG003|Treatment Period|Maximum clinical benefit|1|||
164089024|NCT02985957|592688883|FG004|Treatment Period|Maximum clinical benefit|0|||
164089025|NCT02985957|592688884|FG005|Treatment Period|Maximum clinical benefit|0|||
164089026|NCT02985957|592688885|FG006|Treatment Period|Maximum clinical benefit|2|||
164089027|NCT02985957|592688879|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
164089028|NCT02985957|592688880|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
164089029|NCT02985957|592688881|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
164089030|NCT02985957|592688882|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
164089031|NCT02985957|592688883|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
164089032|NCT02985957|592688884|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
164089033|NCT02985957|592688885|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
164089034|NCT02985957|592688879|FG000|Treatment Period|Study drug toxicity|1|||
164089035|NCT02985957|592688880|FG001|Treatment Period|Study drug toxicity|23|||
164089036|NCT02985957|592688881|FG002|Treatment Period|Study drug toxicity|20|||
164089037|NCT02985957|592688882|FG003|Treatment Period|Study drug toxicity|12|||
164089038|NCT02985957|592688883|FG004|Treatment Period|Study drug toxicity|20|||
164089039|NCT02985957|592688884|FG005|Treatment Period|Study drug toxicity|3|||
164089040|NCT02985957|592688885|FG006|Treatment Period|Study drug toxicity|5|||
164089041|NCT02985957|592688879|FG000|Treatment Period|Disease progression|0|||
164089042|NCT02985957|592688880|FG001|Treatment Period|Disease progression|16|||
164089043|NCT02985957|592688881|FG002|Treatment Period|Disease progression|20|||
164089044|NCT02985957|592688882|FG003|Treatment Period|Disease progression|40|||
164347009|NCT00880009|593646804|FG000|Overall Study|Study terminated by sponsor|14|||
164005053|NCT01458340|592384127|FG001|Overall Study|Physician Decision|1|||
164005054|NCT01458340|592384128|FG002|Overall Study|Physician Decision|2|||
164005055|NCT01458340|592384126|FG000|Overall Study|Protocol Violation|6|||
164005056|NCT01458340|592384127|FG001|Overall Study|Protocol Violation|6|||
164005057|NCT01458340|592384128|FG002|Overall Study|Protocol Violation|5|||
164005058|NCT01458340|592384126|FG000|Overall Study|Withdrawal by Subject|12|||
164005059|NCT01458340|592384127|FG001|Overall Study|Withdrawal by Subject|6|||
164005060|NCT01458340|592384128|FG002|Overall Study|Withdrawal by Subject|4|||
164005061|NCT01575548|592384131|FG000|Overall Study|Adverse Event|15|||
164005062|NCT01575548|592384132|FG001|Overall Study|Adverse Event|2|||
164005063|NCT01575548|592384131|FG000|Overall Study|Disease progression|12|||
164005064|NCT01575548|592384132|FG001|Overall Study|Disease progression|25|||
164005065|NCT01575548|592384131|FG000|Overall Study|Death|1|||
164005066|NCT01575548|592384132|FG001|Overall Study|Death|0|||
164005067|NCT01575548|592384131|FG000|Overall Study|Other complicating disease|1|||
164005068|NCT01575548|592384132|FG001|Overall Study|Other complicating disease|0|||
164005069|NCT01575548|592384131|FG000|Overall Study|Withdrawal by Subject|7|||
164005070|NCT01575548|592384132|FG001|Overall Study|Withdrawal by Subject|3|||
164005071|NCT01575548|592384131|FG000|Overall Study|Noncompliance|1|||
164005072|NCT01575548|592384132|FG001|Overall Study|Noncompliance|0|||
164005073|NCT01575548|592384131|FG000|Overall Study|Anticipated surgery|0|||
164005074|NCT01575548|592384132|FG001|Overall Study|Anticipated surgery|1|||
164005075|NCT01575548|592384131|FG000|Overall Study|Never started protocol therapy|3|||
164005076|NCT01575548|592384132|FG001|Overall Study|Never started protocol therapy|2|||
164005077|NCT03872180|592384135|FG000|Overall Study|Adverse Event|4|||
164005078|NCT03872180|592384135|FG000|Overall Study|Lack of Efficacy|2|||
164005079|NCT02750410|592384138|FG000|Double-Blind Treatment Period|Adverse Event|2|||
164005080|NCT02750410|592384139|FG001|Double-Blind Treatment Period|Adverse Event|2|||
164005081|NCT02750410|592384138|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164089045|NCT02985957|592688883|FG004|Treatment Period|Disease progression|29|||
164089046|NCT02985957|592688884|FG005|Treatment Period|Disease progression|11|||
164089047|NCT02985957|592688885|FG006|Treatment Period|Disease progression|28|||
164089048|NCT02985957|592688879|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
164089049|NCT02985957|592688880|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
164089050|NCT02985957|592688881|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
164089051|NCT02985957|592688882|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
164005082|NCT02750410|592384139|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164005083|NCT02750410|592384138|FG000|Open-Label Extension Period|Adverse Event|5|||
164089052|NCT02985957|592688883|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
164089053|NCT02985957|592688884|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
164089054|NCT02985957|592688885|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
164089055|NCT02985957|592688879|FG000|Treatment Period|Poor/Non-Compliance|0|||
164089056|NCT02985957|592688880|FG001|Treatment Period|Poor/Non-Compliance|0|||
164089057|NCT02985957|592688881|FG002|Treatment Period|Poor/Non-Compliance|0|||
164089058|NCT02985957|592688882|FG003|Treatment Period|Poor/Non-Compliance|0|||
164089059|NCT02985957|592688883|FG004|Treatment Period|Poor/Non-Compliance|1|||
164089060|NCT02985957|592688884|FG005|Treatment Period|Poor/Non-Compliance|1|||
164089061|NCT02985957|592688885|FG006|Treatment Period|Poor/Non-Compliance|0|||
164089062|NCT02978326|592688887|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
164089063|NCT02978326|592688888|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
164089064|NCT02978326|592688889|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
164089065|NCT02978326|592688887|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
164089066|NCT02978326|592688888|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
164089067|NCT02978326|592688889|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
164089068|NCT02978326|592688887|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
164089069|NCT02978326|592688888|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
164089070|NCT02978326|592688889|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
164089071|NCT02978326|592688887|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
164089072|NCT02978326|592688888|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
164089073|NCT02978326|592688889|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
164089074|NCT02365597|592688892|FG000|Overall Study|Lost to Follow-up|0|||
164089075|NCT02365597|592688893|FG001|Overall Study|Lost to Follow-up|1|||
164089076|NCT02365597|592688894|FG002|Overall Study|Lost to Follow-up|0|||
164089077|NCT02365597|592688895|FG003|Overall Study|Lost to Follow-up|1|||
164089078|NCT02365597|592688892|FG000|Overall Study|Withdrawal by Subject|1|||
164089079|NCT02365597|592688893|FG001|Overall Study|Withdrawal by Subject|8|||
164089080|NCT02365597|592688894|FG002|Overall Study|Withdrawal by Subject|5|||
164089081|NCT02365597|592688895|FG003|Overall Study|Withdrawal by Subject|1|||
164089082|NCT02365597|592688892|FG000|Overall Study|Sponsor's decision|1|||
164089083|NCT02365597|592688893|FG001|Overall Study|Sponsor's decision|3|||
164089084|NCT02365597|592688894|FG002|Overall Study|Sponsor's decision|13|||
164089085|NCT02365597|592688895|FG003|Overall Study|Sponsor's decision|0|||
164089086|NCT02365597|592688892|FG000|Overall Study|Other|0|||
164089087|NCT02365597|592688893|FG001|Overall Study|Other|4|||
164089088|NCT02365597|592688894|FG002|Overall Study|Other|0|||
164089089|NCT02365597|592688895|FG003|Overall Study|Other|0|||
164089090|NCT02365597|592688892|FG000|Overall Study|Enrolled but not treated|0|||
164089091|NCT02365597|592688893|FG001|Overall Study|Enrolled but not treated|1|||
164089092|NCT02365597|592688894|FG002|Overall Study|Enrolled but not treated|1|||
164089093|NCT02365597|592688895|FG003|Overall Study|Enrolled but not treated|0|||
164089094|NCT02365597|592688892|FG000|Overall Study|Ongoing|0|||
164089095|NCT02365597|592688893|FG001|Overall Study|Ongoing|0|||
164089096|NCT02365597|592688894|FG002|Overall Study|Ongoing|0|||
164089097|NCT02365597|592688895|FG003|Overall Study|Ongoing|17|||
164089098|NCT04309474|592688896|FG000|Overall Study|Randomized but not treated|0|||
164089099|NCT04309474|592688897|FG001|Overall Study|Randomized but not treated|2|||
164089100|NCT04309474|592688896|FG000|Overall Study|Adverse Event|4|||
164089101|NCT04309474|592688897|FG001|Overall Study|Adverse Event|1|||
164089102|NCT04309474|592688896|FG000|Overall Study|Withdrawal by Subject|6|||
164089103|NCT04309474|592688897|FG001|Overall Study|Withdrawal by Subject|9|||
164089104|NCT04309474|592688896|FG000|Overall Study|Lost to Follow-up|1|||
164089105|NCT04309474|592688897|FG001|Overall Study|Lost to Follow-up|2|||
164089106|NCT04309474|592688896|FG000|Overall Study|Not disclosed|10|||
164089107|NCT04309474|592688897|FG001|Overall Study|Not disclosed|6|||
164089108|NCT04670068|592688898|FG000|Overall Study|Progressive Disease|1|||
164089109|NCT04670068|592688899|FG001|Overall Study|Progressive Disease|1|||
164089110|NCT04670068|592688898|FG000|Overall Study|Withdrawal by Subject|1|||
164089111|NCT04670068|592688899|FG001|Overall Study|Withdrawal by Subject|0|||
164089112|NCT02974153|592688900|FG000|Overall Study|Adverse Event|6|||
164089113|NCT02974153|592688901|FG001|Overall Study|Adverse Event|0|||
164089114|NCT02974153|592688902|FG002|Overall Study|Adverse Event|1|||
164089115|NCT02974153|592688900|FG000|Overall Study|Lack of Efficacy|6|||
164089116|NCT02974153|592688901|FG001|Overall Study|Lack of Efficacy|5|||
164089117|NCT02974153|592688902|FG002|Overall Study|Lack of Efficacy|10|||
164089118|NCT02974153|592688900|FG000|Overall Study|Lost to Follow-up|9|||
164089119|NCT02974153|592688901|FG001|Overall Study|Lost to Follow-up|10|||
164089120|NCT02974153|592688902|FG002|Overall Study|Lost to Follow-up|17|||
164089121|NCT02974153|592688900|FG000|Overall Study|Physician Decision|0|||
164089122|NCT02974153|592688901|FG001|Overall Study|Physician Decision|2|||
164089123|NCT02974153|592688902|FG002|Overall Study|Physician Decision|1|||
164089124|NCT02974153|592688900|FG000|Overall Study|Withdrawal by Subject|9|||
164089125|NCT02974153|592688901|FG001|Overall Study|Withdrawal by Subject|16|||
164089126|NCT02974153|592688902|FG002|Overall Study|Withdrawal by Subject|11|||
164089127|NCT02974153|592688900|FG000|Overall Study|Study Burden|8|||
164089128|NCT02974153|592688901|FG001|Overall Study|Study Burden|7|||
164089129|NCT02974153|592688902|FG002|Overall Study|Study Burden|3|||
164294770|NCT04158583|593452270|FG008|Overall Study|Clinical Progression Disease|0|||
164294771|NCT04158583|593452271|FG009|Overall Study|Clinical Progression Disease|0|||
163898369|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
164089130|NCT02974153|592688900|FG000|Overall Study|Other|14|||
164089131|NCT02974153|592688901|FG001|Overall Study|Other|8|||
164089132|NCT02974153|592688902|FG002|Overall Study|Other|7|||
164089133|NCT02521948|592688903|FG000|Overall Study|Adverse Event|2|||
164089134|NCT02521948|592688903|FG000|Overall Study|Death|4|||
164089135|NCT02521948|592688903|FG000|Overall Study|Lost to Follow-up|1|||
164089136|NCT02521948|592688903|FG000|Overall Study|Did not attend one or both follow-ups|6|||
164089137|NCT00717756|592688906|FG000|Overall Study|Withdrawal by Subject|1|||
164089138|NCT00673790|592688907|FG000|Overall Study|Adverse Event|23|||
164089139|NCT00673790|592688908|FG001|Overall Study|Adverse Event|14|||
164089140|NCT00673790|592688909|FG002|Overall Study|Adverse Event|2|||
164089141|NCT00673790|592688907|FG000|Overall Study|Lack of Efficacy|2|||
164089142|NCT00673790|592688908|FG001|Overall Study|Lack of Efficacy|2|||
164089143|NCT00673790|592688909|FG002|Overall Study|Lack of Efficacy|2|||
164089144|NCT00673790|592688907|FG000|Overall Study|Protocol Violation|6|||
164089145|NCT00673790|592688908|FG001|Overall Study|Protocol Violation|9|||
164089146|NCT00673790|592688909|FG002|Overall Study|Protocol Violation|1|||
164089147|NCT00673790|592688907|FG000|Overall Study|Withdrawal by Subject|7|||
164089148|NCT00673790|592688908|FG001|Overall Study|Withdrawal by Subject|4|||
164089149|NCT00673790|592688909|FG002|Overall Study|Withdrawal by Subject|1|||
164089150|NCT00673790|592688907|FG000|Overall Study|Lost to Follow-up|6|||
164089151|NCT00673790|592688908|FG001|Overall Study|Lost to Follow-up|6|||
164089152|NCT00673790|592688909|FG002|Overall Study|Lost to Follow-up|5|||
164089153|NCT00673790|592688907|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
164089154|NCT00673790|592688908|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
164089155|NCT00673790|592688909|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
164089156|NCT00673790|592688907|FG000|Overall Study|Poor compliance|1|||
164089157|NCT00673790|592688908|FG001|Overall Study|Poor compliance|0|||
164089158|NCT00673790|592688909|FG002|Overall Study|Poor compliance|0|||
164089159|NCT00673790|592688907|FG000|Overall Study|Participated in two Nebivolol studies|0|||
164089160|NCT00673790|592688908|FG001|Overall Study|Participated in two Nebivolol studies|0|||
164089161|NCT00673790|592688909|FG002|Overall Study|Participated in two Nebivolol studies|1|||
164089162|NCT00673790|592688907|FG000|Overall Study|Unconfirmed pregnancy|0|||
164089163|NCT00673790|592688908|FG001|Overall Study|Unconfirmed pregnancy|1|||
164089164|NCT00673790|592688909|FG002|Overall Study|Unconfirmed pregnancy|0|||
164089165|NCT00673790|592688907|FG000|Overall Study|Randomization criteria not met|0|||
164089166|NCT00673790|592688908|FG001|Overall Study|Randomization criteria not met|1|||
164089167|NCT00673790|592688909|FG002|Overall Study|Randomization criteria not met|0|||
164089168|NCT01873859|592688910|FG000|Overall Study|Withdrawal by Subject|0|||
164089169|NCT01873859|592688911|FG001|Overall Study|Withdrawal by Subject|4|||
164089170|NCT01364870|592688912|FG000|Overall Study|Withdrawal by Subject|13|||
164089171|NCT01364870|592688913|FG001|Overall Study|Withdrawal by Subject|24|||
164089172|NCT01364870|592688914|FG002|Overall Study|Withdrawal by Subject|10|||
164089173|NCT01364870|592688912|FG000|Overall Study|Adverse Event|8|||
164089174|NCT01364870|592688913|FG001|Overall Study|Adverse Event|6|||
164089175|NCT01364870|592688914|FG002|Overall Study|Adverse Event|4|||
164089176|NCT01364870|592688912|FG000|Overall Study|Protocol Violation|1|||
164089177|NCT01364870|592688913|FG001|Overall Study|Protocol Violation|0|||
164089178|NCT01364870|592688914|FG002|Overall Study|Protocol Violation|0|||
164089179|NCT04471428|592688915|FG000|Overall Study|Withdrawal by Subject|29|||
164089180|NCT04471428|592688916|FG001|Overall Study|Withdrawal by Subject|4|||
164089181|NCT04471428|592688915|FG000|Overall Study|Physician Decision|0|||
164089182|NCT04471428|592688916|FG001|Overall Study|Physician Decision|1|||
164089183|NCT04471428|592688915|FG000|Overall Study|Reason Not Specified|0|||
164089184|NCT04471428|592688916|FG001|Overall Study|Reason Not Specified|2|||
164089185|NCT04471428|592688915|FG000|Overall Study|Death|131|||
164089186|NCT04471428|592688916|FG001|Overall Study|Death|147|||
164089187|NCT04471428|592688915|FG000|Overall Study|Lost to Follow-up|0|||
164089188|NCT04471428|592688916|FG001|Overall Study|Lost to Follow-up|3|||
164089189|NCT04471428|592688915|FG000|Overall Study|Study Terminated by Sponsor|20|||
164089190|NCT04471428|592688916|FG001|Overall Study|Study Terminated by Sponsor|29|||
164089191|NCT03504852|592688917|FG000|Overall Study|Withdrawal of informed consent|2|||
164089192|NCT03504852|592688918|FG001|Overall Study|Withdrawal of informed consent|1|||
164089193|NCT03504852|592688919|FG002|Overall Study|Withdrawal of informed consent|0|||
164089194|NCT03504852|592688917|FG000|Overall Study|Withdrawal by Subject|5|||
164089195|NCT03504852|592688918|FG001|Overall Study|Withdrawal by Subject|5|||
164089196|NCT03504852|592688919|FG002|Overall Study|Withdrawal by Subject|1|||
164089197|NCT03504852|592688917|FG000|Overall Study|Lost to Follow-up|4|||
164089198|NCT03504852|592688918|FG001|Overall Study|Lost to Follow-up|1|||
164089199|NCT03504852|592688919|FG002|Overall Study|Lost to Follow-up|0|||
164089200|NCT03504852|592688917|FG000|Overall Study|New therapy for study indication|1|||
164089201|NCT03504852|592688918|FG001|Overall Study|New therapy for study indication|0|||
164089202|NCT03504852|592688919|FG002|Overall Study|New therapy for study indication|0|||
164089203|NCT03504852|592688917|FG000|Overall Study|Lack of Efficacy|1|||
164089204|NCT03504852|592688918|FG001|Overall Study|Lack of Efficacy|2|||
164089205|NCT03504852|592688919|FG002|Overall Study|Lack of Efficacy|0|||
164347010|NCT00880009|593646804|FG000|Overall Study|Withdrawal by Subject|1|||
164089206|NCT03504852|592688917|FG000|Overall Study|Death|0|||
164089207|NCT03504852|592688918|FG001|Overall Study|Death|1|||
164089208|NCT03504852|592688919|FG002|Overall Study|Death|0|||
164089209|NCT03504852|592688917|FG000|Overall Study|Adverse Event|4|||
164089210|NCT03504852|592688918|FG001|Overall Study|Adverse Event|8|||
164089211|NCT03504852|592688919|FG002|Overall Study|Adverse Event|2|||
164089212|NCT03290079|592688920|FG000|Overall Study|Death|2|||
164089213|NCT03850509|592688921|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
164089214|NCT03850509|592688922|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
164089215|NCT02666430|592688923|FG000|Period 1|Lost to Follow-up|1|||
164089216|NCT02666430|592688924|FG001|Period 1|Lost to Follow-up|0|||
164089217|NCT02666430|592688923|FG000|Period 1|Adverse Event|0|||
164089218|NCT02666430|592688924|FG001|Period 1|Adverse Event|1|||
164089219|NCT02666430|592688923|FG000|Period 2|Withdrawal by Subject|1|||
164089220|NCT02666430|592688924|FG001|Period 2|Withdrawal by Subject|4|||
164089221|NCT02666430|592688923|FG000|Period 3|Lost to Follow-up|1|||
164089222|NCT02666430|592688924|FG001|Period 3|Lost to Follow-up|0|||
164089223|NCT03922477|592688925|FG000|Overall Study|Death|9|||
164089224|NCT03922477|592688925|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
164089225|NCT03922477|592688925|FG000|Overall Study|Physician Decision|1|||
164089226|NCT03922477|592688925|FG000|Overall Study|Withdrawal by Subject|2|||
164089227|NCT01960816|592688929|FG000|Overall Study|Lost to Follow-up|1|||
164089228|NCT04849988|592690226|FG000|Overall Study|Lack of Efficacy|3|||
164089229|NCT04849988|592690227|FG001|Overall Study|Lack of Efficacy|4|||
164089230|NCT04849988|592690228|FG002|Overall Study|Lack of Efficacy|1|||
164089231|NCT04849988|592690229|FG003|Overall Study|Lack of Efficacy|4|||
164089232|NCT04849988|592690226|FG000|Overall Study|Other reasons|1|||
164089233|NCT04849988|592690227|FG001|Overall Study|Other reasons|2|||
164089234|NCT04849988|592690228|FG002|Overall Study|Other reasons|2|||
164089235|NCT04849988|592690229|FG003|Overall Study|Other reasons|1|||
164089236|NCT01893905|592690230|FG000|Overall Study|Withdrawal by Subject|1|||
164089237|NCT01893905|592690231|FG001|Overall Study|Withdrawal by Subject|0|||
164089238|NCT01893905|592690230|FG000|Overall Study|Adverse Event|9|||
164089239|NCT01893905|592690231|FG001|Overall Study|Adverse Event|3|||
164089240|NCT01893905|592690230|FG000|Overall Study|Lack of Efficacy|5|||
164089241|NCT01893905|592690231|FG001|Overall Study|Lack of Efficacy|7|||
164089242|NCT01893905|592690230|FG000|Overall Study|Lost to Follow-up|1|||
164089243|NCT01893905|592690231|FG001|Overall Study|Lost to Follow-up|0|||
164089244|NCT01893905|592690230|FG000|Overall Study|Protocol Violation|6|||
164089245|NCT01893905|592690231|FG001|Overall Study|Protocol Violation|1|||
164089246|NCT01893905|592690230|FG000|Overall Study|Lack of adherence to treatment|2|||
164089247|NCT01893905|592690231|FG001|Overall Study|Lack of adherence to treatment|0|||
164089248|NCT01893905|592690230|FG000|Overall Study|Other reason|1|||
164089249|NCT01893905|592690231|FG001|Overall Study|Other reason|3|||
164089250|NCT00992407|592690232|FG000|Overall Study|Protocol Violation|2|||
164089251|NCT00992407|592690233|FG001|Overall Study|Protocol Violation|1|||
164089252|NCT00992407|592690232|FG000|Overall Study|Lost to Follow-up|3|||
164089253|NCT00992407|592690233|FG001|Overall Study|Lost to Follow-up|3|||
164089254|NCT00992407|592690232|FG000|Overall Study|Adverse Event|3|||
164089255|NCT00992407|592690233|FG001|Overall Study|Adverse Event|2|||
164089256|NCT00992407|592690232|FG000|Overall Study|protocol Violation & Adverse events|2|||
164089257|NCT00992407|592690233|FG001|Overall Study|protocol Violation & Adverse events|4|||
164089258|NCT00992407|592690232|FG000|Overall Study|Other|2|||
164089259|NCT00992407|592690233|FG001|Overall Study|Other|0|||
164089260|NCT00992407|592690232|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
164089261|NCT00992407|592690233|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
164089262|NCT00992407|592690232|FG000|Overall Study|Study medication not administered|17|||
164089263|NCT00992407|592690233|FG001|Overall Study|Study medication not administered|13|||
164089264|NCT03738332|592690236|FG000|Overall Study|Withdrawal by Subject|1|||
164089265|NCT01521559|592690237|FG000|Overall Study|Adverse Event|0|||
164089266|NCT01521559|592690238|FG001|Overall Study|Adverse Event|4|||
164089267|NCT01521559|592690237|FG000|Overall Study|Death|1|||
164089268|NCT01521559|592690238|FG001|Overall Study|Death|0|||
164089269|NCT01521559|592690237|FG000|Overall Study|Withdrawal by Subject|9|||
164089270|NCT01521559|592690238|FG001|Overall Study|Withdrawal by Subject|11|||
164089271|NCT01521559|592690237|FG000|Overall Study|Lost to Follow-up|3|||
164089272|NCT01521559|592690238|FG001|Overall Study|Lost to Follow-up|1|||
164089273|NCT01521559|592690237|FG000|Overall Study|Protocol Violation|1|||
164089274|NCT01521559|592690238|FG001|Overall Study|Protocol Violation|0|||
164089275|NCT01521559|592690237|FG000|Overall Study|Other|1|||
164089276|NCT01521559|592690238|FG001|Overall Study|Other|2|||
164089277|NCT02336737|592690239|FG000|Overall Study|Withdrawal by Subject|5|||
164089278|NCT02336737|592690239|FG000|Overall Study|Physician Decision|8|||
164089279|NCT00576381|592690241|FG000|Overall Study|Reoperation|3|||
164089280|NCT00576381|592690241|FG000|Overall Study|Adverse Event|4|||
164089281|NCT00287118|592690245|FG000|Overall Study|Adverse Event|30|||
164089282|NCT00287118|592690245|FG000|Overall Study|Death|1|||
164089283|NCT00287118|592690245|FG000|Overall Study|Lack of Efficacy|11|||
164089284|NCT00287118|592690245|FG000|Overall Study|Lost to Follow-up|1|||
164089285|NCT00287118|592690245|FG000|Overall Study|Protocol Violation|2|||
164089286|NCT00287118|592690245|FG000|Overall Study|Other|7|||
164089287|NCT01631864|592690246|FG000|Overall Study|Withdrawal by Subject|0|||
164089288|NCT01631864|592690247|FG001|Overall Study|Withdrawal by Subject|1|||
164089289|NCT01631864|592690246|FG000|Overall Study|Adverse Event|2|||
164089290|NCT01631864|592690247|FG001|Overall Study|Adverse Event|3|||
164089291|NCT04543136|592690260|FG000|Overall Study|Withdrawal by Subject|0|||
164089292|NCT04543136|592690261|FG001|Overall Study|Withdrawal by Subject|1|||
164089293|NCT04543136|592690262|FG002|Overall Study|Withdrawal by Subject|0|||
164089294|NCT04543136|592690263|FG003|Overall Study|Withdrawal by Subject|1|||
164089295|NCT04543136|592690264|FG004|Overall Study|Withdrawal by Subject|0|||
164089296|NCT04543136|592690265|FG005|Overall Study|Withdrawal by Subject|0|||
164089297|NCT00638157|592690268|FG000|Overall Study|Adverse Event|0|||
164089298|NCT00638157|592690269|FG001|Overall Study|Adverse Event|1|||
164089299|NCT00638157|592690268|FG000|Overall Study|Clinical (symptomatic) failure|1|||
164089300|NCT00638157|592690269|FG001|Overall Study|Clinical (symptomatic) failure|1|||
164347011|NCT00880009|593646804|FG000|Overall Study|Protocol Violation|1|||
164347012|NCT03322631|593646807|FG000|Overall Study|Withdrawal by Subject|0|||
164347013|NCT03322631|593646808|FG001|Overall Study|Withdrawal by Subject|1|||
164347014|NCT03322631|593646809|FG002|Overall Study|Withdrawal by Subject|0|||
164347015|NCT03322631|593646810|FG003|Overall Study|Withdrawal by Subject|0|||
164347016|NCT03322631|593646807|FG000|Overall Study|Adverse Event|0|||
164089301|NCT00638157|592690268|FG000|Overall Study|Microbiological failure|1|||
164089302|NCT00638157|592690269|FG001|Overall Study|Microbiological failure|0|||
164089303|NCT00638157|592690268|FG000|Overall Study|Lost to Follow-up|1|||
164089304|NCT00638157|592690269|FG001|Overall Study|Lost to Follow-up|0|||
164089305|NCT00638157|592690268|FG000|Overall Study|Physician Decision|1|||
164089306|NCT00638157|592690269|FG001|Overall Study|Physician Decision|0|||
164089307|NCT00638157|592690268|FG000|Overall Study|Other|1|||
164089308|NCT00638157|592690269|FG001|Overall Study|Other|2|||
164089309|NCT00638157|592690268|FG000|Overall Study|Randomized, not treated|2|||
164089310|NCT00638157|592690269|FG001|Overall Study|Randomized, not treated|0|||
164089311|NCT04684524|592690270|FG000|Overall Study|Other|2|||
164089312|NCT04684524|592690271|FG001|Overall Study|Other|0|||
164089313|NCT04684524|592690270|FG000|Overall Study|Withdrawal by Subject|5|||
164347017|NCT03322631|593646808|FG001|Overall Study|Adverse Event|0|||
164347018|NCT03322631|593646809|FG002|Overall Study|Adverse Event|1|||
164347019|NCT03322631|593646810|FG003|Overall Study|Adverse Event|0|||
164347020|NCT01300650|593646812|FG000|Overall Study|Adverse Event|1|||
164347021|NCT00602797|593646813|FG000|Overall Study|Adverse Event|1|||
164347022|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
164347023|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
164347024|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
164347025|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
164347026|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
164347027|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
164347028|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
164347029|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
164347030|NCT03943147|593646814|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
164347031|NCT03943147|593646815|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
164347032|NCT03943147|593646814|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
164347033|NCT03943147|593646815|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
164347034|NCT01318993|593646816|FG000|Overall Study|Adverse Event|53|||
164347035|NCT01318993|593646816|FG000|Overall Study|Lack of Efficacy|121|||
164347036|NCT01318993|593646816|FG000|Overall Study|Protocol Violation|3|||
164347037|NCT01318993|593646816|FG000|Overall Study|Protocol based stopping criteria|6|||
164347038|NCT01318993|593646816|FG000|Overall Study|Study closed or terminated|174|||
164347039|NCT01318993|593646816|FG000|Overall Study|Lost to Follow-up|4|||
164347040|NCT01318993|593646816|FG000|Overall Study|Physician Decision|13|||
164347041|NCT01318993|593646816|FG000|Overall Study|Withdrawal by Subject|24|||
164347042|NCT03736447|593646820|FG000|Overall Study|Adverse Event|5|||
164347043|NCT03736447|593646821|FG001|Overall Study|Adverse Event|1|||
163898370|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
163898371|NCT00439270|592001050|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
164347044|NCT03736447|593646820|FG000|Overall Study|Withdrawal by Subject|5|||
164347045|NCT03736447|593646821|FG001|Overall Study|Withdrawal by Subject|1|||
163898372|NCT00439270|592001051|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
164089314|NCT04684524|592690271|FG001|Overall Study|Withdrawal by Subject|3|||
164089315|NCT04684524|592690270|FG000|Overall Study|Adverse Event|1|||
164089316|NCT04684524|592690271|FG001|Overall Study|Adverse Event|1|||
164089317|NCT00601354|592690275|FG000|Overall Study|Lost to Follow-up|4|||
164089318|NCT00601354|592690276|FG001|Overall Study|Lost to Follow-up|5|||
164089319|NCT05876091|592690277|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
164347046|NCT03736447|593646820|FG000|Overall Study|Lost to Follow-up|1|||
164132699|NCT01986010|592850661|FG006|Overall Study|Physician Decision|0|||
164089320|NCT03402893|592690278|FG000|Overall Study|Withdrawal by Subject|1|||
164089321|NCT03466411|592690279|FG000|Overall Study|Lost to Follow-up|0|||
164089322|NCT03466411|592690280|FG001|Overall Study|Lost to Follow-up|1|||
164089323|NCT03466411|592690281|FG002|Overall Study|Lost to Follow-up|1|||
164089324|NCT03466411|592690282|FG003|Overall Study|Lost to Follow-up|0|||
164089325|NCT03466411|592690283|FG004|Overall Study|Lost to Follow-up|0|||
164089326|NCT03466411|592690284|FG005|Overall Study|Lost to Follow-up|0|||
164089327|NCT03466411|592690285|FG006|Overall Study|Lost to Follow-up|1|||
164089328|NCT03466411|592690286|FG007|Overall Study|Lost to Follow-up|1|||
164089329|NCT03466411|592690287|FG008|Overall Study|Lost to Follow-up|0|||
164089330|NCT03466411|592690288|FG009|Overall Study|Lost to Follow-up|1|||
164089331|NCT03466411|592690289|FG010|Overall Study|Lost to Follow-up|1|||
164089332|NCT03466411|592690290|FG011|Overall Study|Lost to Follow-up|1|||
164089333|NCT03466411|592690291|FG012|Overall Study|Lost to Follow-up|0|||
164089334|NCT03466411|592690279|FG000|Overall Study|Withdrawal by Subject|14|||
164347047|NCT03736447|593646821|FG001|Overall Study|Lost to Follow-up|0|||
164347048|NCT03736447|593646820|FG000|Overall Study|Physician Decision|1|||
164347049|NCT03736447|593646821|FG001|Overall Study|Physician Decision|0|||
164347050|NCT03736447|593646820|FG000|Overall Study|Continued commitment to study treatment|3|||
164347051|NCT03736447|593646821|FG001|Overall Study|Continued commitment to study treatment|0|||
164347052|NCT03736447|593646820|FG000|Overall Study|Taste aversion to study product|0|||
164347053|NCT03736447|593646821|FG001|Overall Study|Taste aversion to study product|1|||
164347054|NCT02619175|593646822|FG000|Overall Study|Withdrawal by Subject|1|||
164347055|NCT02619175|593646823|FG001|Overall Study|Withdrawal by Subject|0|||
164347056|NCT02619175|593646822|FG000|Overall Study|foot pain|1|||
164347057|NCT02619175|593646823|FG001|Overall Study|foot pain|0|||
164347058|NCT02795832|593646827|FG000|Overall Study|Adverse Event|0|||
164347059|NCT02795832|593646828|FG001|Overall Study|Adverse Event|0|||
164347060|NCT02795832|593646829|FG002|Overall Study|Adverse Event|0|||
164347061|NCT02795832|593646830|FG003|Overall Study|Adverse Event|0|||
164347062|NCT02795832|593646831|FG004|Overall Study|Adverse Event|0|||
164347063|NCT02795832|593646832|FG005|Overall Study|Adverse Event|3|||
164347064|NCT02695329|593646835|FG000|Overall Study|Adverse Event|1|||
164347065|NCT02695329|593646836|FG001|Overall Study|Adverse Event|0|||
164347066|NCT02695329|593646835|FG000|Overall Study|Poor X-ray quality for measurement|4|||
164347067|NCT02695329|593646836|FG001|Overall Study|Poor X-ray quality for measurement|5|||
164347068|NCT01382212|593646837|FG000|Overall Study|Kidney transplant|1|||
164347069|NCT01382212|593646837|FG000|Overall Study|Withdrew consent|1|||
164347070|NCT01273597|593646838|FG000|Overall Study|Adverse Event|5|||
164347071|NCT01273597|593646838|FG000|Overall Study|Underwent Kidney Transplantation|2|||
164347072|NCT01273597|593646838|FG000|Overall Study|Reason Not Reported|1|||
164347073|NCT00393029|593646839|FG000|Overall Study|Not treated|0|||
164347074|NCT00393029|593646840|FG001|Overall Study|Not treated|1|||
164347075|NCT03547583|593646842|FG000|Overall Study|Adverse Event|16|||
164347076|NCT03547583|593646843|FG001|Overall Study|Adverse Event|11|||
164347077|NCT03547583|593646844|FG002|Overall Study|Adverse Event|10|||
164347078|NCT03547583|593646842|FG000|Overall Study|Death|11|||
164347079|NCT03547583|593646843|FG001|Overall Study|Death|7|||
164347080|NCT03547583|593646844|FG002|Overall Study|Death|4|||
164347081|NCT03547583|593646842|FG000|Overall Study|Lost to Follow-up|1|||
164347082|NCT03547583|593646843|FG001|Overall Study|Lost to Follow-up|0|||
164347083|NCT03547583|593646844|FG002|Overall Study|Lost to Follow-up|0|||
164347084|NCT03547583|593646842|FG000|Overall Study|Non-compliance with study drug|0|||
164347085|NCT03547583|593646843|FG001|Overall Study|Non-compliance with study drug|0|||
164347086|NCT03547583|593646844|FG002|Overall Study|Non-compliance with study drug|1|||
164347087|NCT03547583|593646842|FG000|Overall Study|Physician Decision|1|||
164347088|NCT03547583|593646843|FG001|Overall Study|Physician Decision|0|||
164347089|NCT03547583|593646844|FG002|Overall Study|Physician Decision|3|||
164347090|NCT03547583|593646842|FG000|Overall Study|Protocol Violation|2|||
164347091|NCT03547583|593646843|FG001|Overall Study|Protocol Violation|1|||
164347092|NCT03547583|593646844|FG002|Overall Study|Protocol Violation|1|||
164347093|NCT03547583|593646842|FG000|Overall Study|Withdrawal by Subject|12|||
164347094|NCT03547583|593646843|FG001|Overall Study|Withdrawal by Subject|19|||
164347095|NCT03547583|593646844|FG002|Overall Study|Withdrawal by Subject|10|||
164347096|NCT03547583|593646842|FG000|Overall Study|Other|2|||
164347097|NCT03547583|593646843|FG001|Overall Study|Other|2|||
164347098|NCT03547583|593646844|FG002|Overall Study|Other|3|||
164347099|NCT01846416|593646845|FG000|Treatment Phase|Death|2|||
164347100|NCT01846416|593646846|FG001|Treatment Phase|Death|9|||
164347101|NCT01846416|593646847|FG002|Treatment Phase|Death|1|||
164347102|NCT01846416|593646845|FG000|Treatment Phase|Withdrawal by Subject|2|||
164347103|NCT01846416|593646846|FG001|Treatment Phase|Withdrawal by Subject|4|||
164347104|NCT01846416|593646847|FG002|Treatment Phase|Withdrawal by Subject|2|||
164347105|NCT01846416|593646845|FG000|Treatment Phase|Other|1|||
164347106|NCT01846416|593646846|FG001|Treatment Phase|Other|5|||
164347107|NCT01846416|593646847|FG002|Treatment Phase|Other|1|||
164089335|NCT03466411|592690280|FG001|Overall Study|Withdrawal by Subject|7|||
164089336|NCT03466411|592690281|FG002|Overall Study|Withdrawal by Subject|8|||
164089337|NCT03466411|592690282|FG003|Overall Study|Withdrawal by Subject|4|||
164347108|NCT01846416|593646845|FG000|Treatment Phase|Physician Decision|1|||
164005084|NCT02750410|592384139|FG001|Open-Label Extension Period|Adverse Event|3|||
164005085|NCT02750410|592384138|FG000|Open-Label Extension Period|Protocol Violation|0|||
164005086|NCT02750410|592384139|FG001|Open-Label Extension Period|Protocol Violation|1|||
164005087|NCT02750410|592384138|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
164005088|NCT02750410|592384139|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
164005089|NCT02504541|592384140|FG000|Overall Study|Adverse Event|4|||
164005090|NCT02504541|592384140|FG000|Overall Study|Withdrawal by Subject|4|||
164005091|NCT02504541|592384140|FG000|Overall Study|Lost to Follow-up|1|||
164005092|NCT02504541|592384140|FG000|Overall Study|Met Stopping Criteria|1|||
164005093|NCT02504541|592384140|FG000|Overall Study|Protocol Violation|2|||
164005094|NCT02504541|592384140|FG000|Overall Study|Termination by Sponsor|1|||
164005095|NCT02504541|592384140|FG000|Overall Study|Other|2|||
164005096|NCT02504541|592384140|FG000|Overall Study|Multiple|5|||
164005097|NCT01531725|592384141|FG000|Overall Study|Protocol Violation|5|||
164005098|NCT03215277|592384142|FG000|Overall Study|Adverse Event|2|||
164005099|NCT03215277|592384143|FG001|Overall Study|Adverse Event|3|||
164005100|NCT03215277|592384142|FG000|Overall Study|Death|1|||
164005101|NCT03215277|592384143|FG001|Overall Study|Death|0|||
164005102|NCT03215277|592384142|FG000|Overall Study|Lost to Follow-up|0|||
164005103|NCT03215277|592384143|FG001|Overall Study|Lost to Follow-up|1|||
164005104|NCT03215277|592384142|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
164005105|NCT03215277|592384143|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
164005106|NCT02317510|592384144|FG000|Overall Study|Adverse Event|0|||
164005107|NCT02317510|592384145|FG001|Overall Study|Adverse Event|1|||
164005108|NCT03228186|592384146|FG000|Overall Study|Patient never started treatment|1|||
164005109|NCT03953118|592384147|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
164005110|NCT03953118|592384148|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
164089338|NCT03466411|592690283|FG004|Overall Study|Withdrawal by Subject|6|||
164294772|NCT04158583|593452262|FG000|Overall Study|Clinical Progression|0|||
164294773|NCT04158583|593452263|FG001|Overall Study|Clinical Progression|0|||
164294774|NCT04158583|593452264|FG002|Overall Study|Clinical Progression|0|||
164294775|NCT04158583|593452265|FG003|Overall Study|Clinical Progression|0|||
164294776|NCT04158583|593452266|FG004|Overall Study|Clinical Progression|1|||
164294777|NCT04158583|593452267|FG005|Overall Study|Clinical Progression|0|||
164294778|NCT04158583|593452268|FG006|Overall Study|Clinical Progression|2|||
164294779|NCT04158583|593452269|FG007|Overall Study|Clinical Progression|0|||
164294780|NCT04158583|593452270|FG008|Overall Study|Clinical Progression|0|||
164294781|NCT04158583|593452271|FG009|Overall Study|Clinical Progression|0|||
164294782|NCT04158583|593452262|FG000|Overall Study|Clinical Deterioration|0|||
164294783|NCT04158583|593452263|FG001|Overall Study|Clinical Deterioration|0|||
164294784|NCT04158583|593452264|FG002|Overall Study|Clinical Deterioration|0|||
164294785|NCT04158583|593452265|FG003|Overall Study|Clinical Deterioration|1|||
164294786|NCT04158583|593452266|FG004|Overall Study|Clinical Deterioration|0|||
164294787|NCT04158583|593452267|FG005|Overall Study|Clinical Deterioration|0|||
164294788|NCT04158583|593452268|FG006|Overall Study|Clinical Deterioration|0|||
164294789|NCT04158583|593452269|FG007|Overall Study|Clinical Deterioration|0|||
164294790|NCT04158583|593452270|FG008|Overall Study|Clinical Deterioration|0|||
164294791|NCT04158583|593452271|FG009|Overall Study|Clinical Deterioration|1|||
164294792|NCT01766050|593454176|FG000|Overall Study|Adverse Event|1|||
164294793|NCT01766050|593454176|FG000|Overall Study|Lost to Follow-up|1|||
164294794|NCT01766050|593454176|FG000|Overall Study|Withdrawal by Subject|2|||
164294795|NCT01097668|593454177|FG000|Overall Study|Withdrawal by Subject|1|||
164294796|NCT01097668|593454178|FG001|Overall Study|Withdrawal by Subject|2|||
164294797|NCT01097668|593454177|FG000|Overall Study|Lost to Follow-up|1|||
164294798|NCT01097668|593454178|FG001|Overall Study|Lost to Follow-up|0|||
164294799|NCT00812708|593454179|FG000|Overall Study|Device could not be implanted|2|||
164294800|NCT00812708|593454179|FG000|Overall Study|Lack of medical insurance|1|||
164294801|NCT00812708|593454179|FG000|Overall Study|Switched to another study|1|||
164294802|NCT00812708|593454179|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
164347109|NCT01846416|593646846|FG001|Treatment Phase|Physician Decision|2|||
164347110|NCT01846416|593646847|FG002|Treatment Phase|Physician Decision|0|||
164347111|NCT01846416|593646845|FG000|Treatment Phase|Adverse Event|3|||
164347112|NCT01846416|593646846|FG001|Treatment Phase|Adverse Event|4|||
164347113|NCT01846416|593646847|FG002|Treatment Phase|Adverse Event|0|||
164347114|NCT01846416|593646845|FG000|Treatment Phase|Non-compliance|0|||
164347115|NCT01846416|593646846|FG001|Treatment Phase|Non-compliance|2|||
164347116|NCT01846416|593646847|FG002|Treatment Phase|Non-compliance|0|||
164347117|NCT01846416|593646845|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
164347118|NCT01846416|593646846|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
164347119|NCT01846416|593646847|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
164347120|NCT01846416|593646845|FG000|Treatment Phase|Progressive Disease|21|||
164347121|NCT01846416|593646846|FG001|Treatment Phase|Progressive Disease|63|||
164347122|NCT01846416|593646847|FG002|Treatment Phase|Progressive Disease|9|||
164347123|NCT01846416|593646845|FG000|Survival Follow-up|Death|21|||
164347124|NCT01846416|593646846|FG001|Survival Follow-up|Death|62|||
164005111|NCT02502864|592384151|FG000|Overall Study|Withdrawal by Subject|1|||
164005112|NCT04375878|592384155|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
164294803|NCT00812708|593454179|FG000|Overall Study|Signed consent but later withdrew|3|||
164294804|NCT02421172|593454180|FG000|Period 1|Adverse Event|1|||
164294805|NCT02421172|593454181|FG001|Period 1|Adverse Event|0|||
164294806|NCT02421172|593454182|FG002|Period 1|Adverse Event|0|||
164294807|NCT02421172|593454183|FG003|Period 1|Adverse Event|0|||
164294808|NCT02421172|593454184|FG004|Period 1|Adverse Event|0|||
164294809|NCT02421172|593454180|FG000|Period 1|Lost to Follow-up|3|||
164294810|NCT02421172|593454181|FG001|Period 1|Lost to Follow-up|1|||
164294811|NCT02421172|593454182|FG002|Period 1|Lost to Follow-up|0|||
164294812|NCT02421172|593454183|FG003|Period 1|Lost to Follow-up|0|||
164294813|NCT02421172|593454184|FG004|Period 1|Lost to Follow-up|0|||
164005113|NCT04375878|592384156|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
164005114|NCT04375878|592384157|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164132700|NCT01986010|592850662|FG007|Overall Study|Physician Decision|0|||
164294814|NCT02421172|593454180|FG000|Period 1|Patient/guardian decision|0|||
164294815|NCT02421172|593454181|FG001|Period 1|Patient/guardian decision|1|||
164294816|NCT02421172|593454182|FG002|Period 1|Patient/guardian decision|0|||
164294817|NCT02421172|593454183|FG003|Period 1|Patient/guardian decision|0|||
164294818|NCT02421172|593454184|FG004|Period 1|Patient/guardian decision|0|||
164294819|NCT02421172|593454180|FG000|Period 2|Adverse Event|0|||
164294820|NCT02421172|593454181|FG001|Period 2|Adverse Event|0|||
164294821|NCT02421172|593454182|FG002|Period 2|Adverse Event|4|||
164294822|NCT02421172|593454183|FG003|Period 2|Adverse Event|0|||
164294823|NCT02421172|593454184|FG004|Period 2|Adverse Event|0|||
164347125|NCT01846416|593646847|FG002|Survival Follow-up|Death|9|||
164294824|NCT02421172|593454180|FG000|Period 2|Lost to Follow-up|0|||
164294825|NCT02421172|593454181|FG001|Period 2|Lost to Follow-up|0|||
164294826|NCT02421172|593454182|FG002|Period 2|Lost to Follow-up|0|||
164294827|NCT02421172|593454183|FG003|Period 2|Lost to Follow-up|1|||
164294828|NCT02421172|593454184|FG004|Period 2|Lost to Follow-up|0|||
164294829|NCT02421172|593454180|FG000|Period 2|Patient/guardian decision|0|||
164294830|NCT02421172|593454181|FG001|Period 2|Patient/guardian decision|0|||
164294831|NCT02421172|593454182|FG002|Period 2|Patient/guardian decision|3|||
164294832|NCT02421172|593454183|FG003|Period 2|Patient/guardian decision|2|||
164294833|NCT02421172|593454184|FG004|Period 2|Patient/guardian decision|1|||
164294834|NCT00928486|593454185|FG000|Overall Study|Adverse Event|2|||
164294835|NCT00928486|593454185|FG000|Overall Study|Disease Progression|7|||
164294836|NCT00928486|593454185|FG000|Overall Study|Withdrawal by Subject|1|||
164294837|NCT01021020|593454186|FG000|Period I|Protocol Violation|1|||
164294838|NCT01021020|593454186|FG000|Period I|Withdrawal by Subject|1|||
164294839|NCT01021020|593454186|FG000|14 Day Washout Period A|Physician Decision|1|||
164294840|NCT00755183|593454187|FG000|Overall Study|Adverse Event|5|||
164294841|NCT00755183|593454188|FG001|Overall Study|Adverse Event|2|||
164294842|NCT00755183|593454187|FG000|Overall Study|Protocol Violation|0|||
164294843|NCT00755183|593454188|FG001|Overall Study|Protocol Violation|1|||
164294844|NCT00755183|593454187|FG000|Overall Study|Withdrawal by Subject|0|||
164294845|NCT00755183|593454188|FG001|Overall Study|Withdrawal by Subject|2|||
164294846|NCT00755183|593454187|FG000|Overall Study|Administrative|2|||
164294847|NCT00755183|593454188|FG001|Overall Study|Administrative|1|||
164294848|NCT02587520|593454191|FG000|Overall Study|Protocol Violation|2|||
164294849|NCT02587520|593454192|FG001|Overall Study|Protocol Violation|0|||
163898373|NCT00439270|592001052|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
163898374|NCT00439270|592001053|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
163898375|NCT00439270|592001054|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
163898376|NCT01268306|592001055|FG000|Overall Study|Lost to Follow-up|1|||
163898377|NCT04121546|592001056|FG000|Overall Study|Lost to Follow-up|1|||
163898378|NCT04121546|592001057|FG001|Overall Study|Lost to Follow-up|3|||
163898379|NCT04129164|592001058|FG000|Overall Study|Non-compliance with procedures|0|||
163898380|NCT04129164|592001059|FG001|Overall Study|Non-compliance with procedures|0|||
163898381|NCT04129164|592001060|FG002|Overall Study|Non-compliance with procedures|2|||
163898382|NCT04129164|592001061|FG003|Overall Study|Non-compliance with procedures|0|||
163898383|NCT04129164|592001058|FG000|Overall Study|Adverse Event|0|||
163898384|NCT04129164|592001059|FG001|Overall Study|Adverse Event|0|||
163898385|NCT04129164|592001060|FG002|Overall Study|Adverse Event|2|||
163898386|NCT04129164|592001061|FG003|Overall Study|Adverse Event|0|||
163898387|NCT04129164|592001058|FG000|Overall Study|Pregnancy|0|||
163898388|NCT04129164|592001059|FG001|Overall Study|Pregnancy|0|||
163898389|NCT04129164|592001060|FG002|Overall Study|Pregnancy|0|||
163898390|NCT04129164|592001061|FG003|Overall Study|Pregnancy|1|||
163898391|NCT04129164|592001058|FG000|Overall Study|Withdrawal by Subject|3|||
163898392|NCT04129164|592001059|FG001|Overall Study|Withdrawal by Subject|2|||
163898393|NCT04129164|592001060|FG002|Overall Study|Withdrawal by Subject|4|||
163898394|NCT04129164|592001061|FG003|Overall Study|Withdrawal by Subject|6|||
163898395|NCT04129164|592001058|FG000|Overall Study|Death|0|||
163898396|NCT04129164|592001059|FG001|Overall Study|Death|1|||
163898397|NCT04129164|592001060|FG002|Overall Study|Death|0|||
163898398|NCT04129164|592001061|FG003|Overall Study|Death|0|||
163898399|NCT04129164|592001058|FG000|Overall Study|Lost to Follow-up|0|||
163898400|NCT04129164|592001059|FG001|Overall Study|Lost to Follow-up|1|||
163898401|NCT04129164|592001060|FG002|Overall Study|Lost to Follow-up|0|||
163898402|NCT04129164|592001061|FG003|Overall Study|Lost to Follow-up|0|||
163898403|NCT00943917|592001067|FG000|Stage I|Adverse Event|1|||
163898404|NCT00943917|592001068|FG001|Stage I|Adverse Event|2|||
163898405|NCT00943917|592001069|FG002|Stage I|Adverse Event|2|||
163898406|NCT00943917|592001070|FG003|Stage I|Adverse Event|0|||
163898407|NCT00943917|592001071|FG004|Stage I|Adverse Event|0|||
163898408|NCT00943917|592001072|FG005|Stage I|Adverse Event|0|||
163898409|NCT00943917|592001073|FG006|Stage I|Adverse Event|0|||
163898410|NCT00943917|592001074|FG007|Stage I|Adverse Event|0|||
164294850|NCT02587520|593454193|FG002|Overall Study|Protocol Violation|0|||
164294851|NCT02587520|593454194|FG003|Overall Study|Protocol Violation|2|||
164294852|NCT02587520|593454195|FG004|Overall Study|Protocol Violation|0|||
164294853|NCT02587520|593454196|FG005|Overall Study|Protocol Violation|1|||
164294854|NCT02587520|593454197|FG006|Overall Study|Protocol Violation|1|||
164294855|NCT02587520|593454198|FG007|Overall Study|Protocol Violation|1|||
164294856|NCT02587520|593454199|FG008|Overall Study|Protocol Violation|3|||
164294857|NCT02587520|593454200|FG009|Overall Study|Protocol Violation|3|||
163898411|NCT00943917|592001075|FG008|Stage I|Adverse Event|0|||
164294858|NCT02587520|593454201|FG010|Overall Study|Protocol Violation|1|||
164294859|NCT02587520|593454202|FG011|Overall Study|Protocol Violation|2|||
164294860|NCT02587520|593454203|FG012|Overall Study|Protocol Violation|0|||
164294861|NCT02587520|593454204|FG013|Overall Study|Protocol Violation|0|||
164294862|NCT02587520|593454205|FG014|Overall Study|Protocol Violation|0|||
164294863|NCT02587520|593454206|FG015|Overall Study|Protocol Violation|0|||
164294864|NCT02587520|593454207|FG016|Overall Study|Protocol Violation|0|||
164294865|NCT02587520|593454208|FG017|Overall Study|Protocol Violation|0|||
164294866|NCT02587520|593454191|FG000|Overall Study|Adverse Event|0|||
164294867|NCT02587520|593454192|FG001|Overall Study|Adverse Event|0|||
164294868|NCT02587520|593454193|FG002|Overall Study|Adverse Event|0|||
164294869|NCT02587520|593454194|FG003|Overall Study|Adverse Event|0|||
164294870|NCT02587520|593454195|FG004|Overall Study|Adverse Event|0|||
164294871|NCT02587520|593454196|FG005|Overall Study|Adverse Event|0|||
164294872|NCT02587520|593454197|FG006|Overall Study|Adverse Event|0|||
164294873|NCT02587520|593454198|FG007|Overall Study|Adverse Event|0|||
164294874|NCT02587520|593454199|FG008|Overall Study|Adverse Event|0|||
164294875|NCT02587520|593454200|FG009|Overall Study|Adverse Event|0|||
164294876|NCT02587520|593454201|FG010|Overall Study|Adverse Event|0|||
164294877|NCT02587520|593454202|FG011|Overall Study|Adverse Event|1|||
164294878|NCT02587520|593454203|FG012|Overall Study|Adverse Event|0|||
164294879|NCT02587520|593454204|FG013|Overall Study|Adverse Event|0|||
164294880|NCT02587520|593454205|FG014|Overall Study|Adverse Event|0|||
164294881|NCT02587520|593454206|FG015|Overall Study|Adverse Event|0|||
164294882|NCT02587520|593454207|FG016|Overall Study|Adverse Event|0|||
164294883|NCT02587520|593454208|FG017|Overall Study|Adverse Event|0|||
164294884|NCT02587520|593454191|FG000|Overall Study|Withdrawal by Subject|0|||
164294885|NCT02587520|593454192|FG001|Overall Study|Withdrawal by Subject|0|||
164294886|NCT02587520|593454193|FG002|Overall Study|Withdrawal by Subject|1|||
164294887|NCT02587520|593454194|FG003|Overall Study|Withdrawal by Subject|1|||
164294888|NCT02587520|593454195|FG004|Overall Study|Withdrawal by Subject|0|||
164294889|NCT02587520|593454196|FG005|Overall Study|Withdrawal by Subject|1|||
164294890|NCT02587520|593454197|FG006|Overall Study|Withdrawal by Subject|1|||
164294891|NCT02587520|593454198|FG007|Overall Study|Withdrawal by Subject|0|||
164294892|NCT02587520|593454199|FG008|Overall Study|Withdrawal by Subject|0|||
164294893|NCT02587520|593454200|FG009|Overall Study|Withdrawal by Subject|0|||
164294894|NCT02587520|593454201|FG010|Overall Study|Withdrawal by Subject|0|||
164294895|NCT02587520|593454202|FG011|Overall Study|Withdrawal by Subject|0|||
164294896|NCT02587520|593454203|FG012|Overall Study|Withdrawal by Subject|0|||
164294897|NCT02587520|593454204|FG013|Overall Study|Withdrawal by Subject|1|||
164294898|NCT02587520|593454205|FG014|Overall Study|Withdrawal by Subject|0|||
164294899|NCT02587520|593454206|FG015|Overall Study|Withdrawal by Subject|0|||
164294900|NCT02587520|593454207|FG016|Overall Study|Withdrawal by Subject|0|||
164294901|NCT02587520|593454208|FG017|Overall Study|Withdrawal by Subject|0|||
164294902|NCT02587520|593454191|FG000|Overall Study|Lost to Follow-up|0|||
164294903|NCT02587520|593454192|FG001|Overall Study|Lost to Follow-up|2|||
164294904|NCT02587520|593454193|FG002|Overall Study|Lost to Follow-up|0|||
164294905|NCT02587520|593454194|FG003|Overall Study|Lost to Follow-up|2|||
164294906|NCT02587520|593454195|FG004|Overall Study|Lost to Follow-up|0|||
164294907|NCT02587520|593454196|FG005|Overall Study|Lost to Follow-up|1|||
164294908|NCT02587520|593454197|FG006|Overall Study|Lost to Follow-up|1|||
164294909|NCT02587520|593454198|FG007|Overall Study|Lost to Follow-up|1|||
164294910|NCT02587520|593454199|FG008|Overall Study|Lost to Follow-up|0|||
164294911|NCT02587520|593454200|FG009|Overall Study|Lost to Follow-up|2|||
164294912|NCT02587520|593454201|FG010|Overall Study|Lost to Follow-up|2|||
164294913|NCT02587520|593454202|FG011|Overall Study|Lost to Follow-up|1|||
164294914|NCT02587520|593454203|FG012|Overall Study|Lost to Follow-up|0|||
164294915|NCT02587520|593454204|FG013|Overall Study|Lost to Follow-up|0|||
164294916|NCT02587520|593454205|FG014|Overall Study|Lost to Follow-up|0|||
164294917|NCT02587520|593454206|FG015|Overall Study|Lost to Follow-up|0|||
164294918|NCT02587520|593454207|FG016|Overall Study|Lost to Follow-up|0|||
164294919|NCT02587520|593454208|FG017|Overall Study|Lost to Follow-up|0|||
164294920|NCT00672555|593454209|FG000|Overall Study|Lost to Follow-up|4|||
164294921|NCT00672555|593454209|FG000|Overall Study|Did not want to answer questionnaire|2|||
164294922|NCT04516746|593454212|FG000|Overall Study|Randomized but not Treated|51|||
164294923|NCT04516746|593454213|FG001|Overall Study|Randomized but not Treated|19|||
164294924|NCT04516746|593454212|FG000|Overall Study|Adverse Event|0|||
164294925|NCT04516746|593454213|FG001|Overall Study|Adverse Event|1|||
164294926|NCT04516746|593454212|FG000|Overall Study|Death|62|||
164294927|NCT04516746|593454213|FG001|Overall Study|Death|32|||
164294928|NCT04516746|593454212|FG000|Overall Study|Lost to Follow-up|3431|||
164294929|NCT04516746|593454213|FG001|Overall Study|Lost to Follow-up|1831|||
164294930|NCT04516746|593454212|FG000|Overall Study|Withdrawal by Subject|1946|||
164294931|NCT04516746|593454213|FG001|Overall Study|Withdrawal by Subject|1696|||
164294932|NCT04516746|593454212|FG000|Overall Study|Physician Decision|10|||
164294933|NCT04516746|593454213|FG001|Overall Study|Physician Decision|8|||
164294934|NCT04516746|593454212|FG000|Overall Study|Other|35|||
164294935|NCT04516746|593454213|FG001|Overall Study|Other|16|||
164294936|NCT03489863|593454214|FG000|Overall Study|Withdrawal by Subject|0|||
164294937|NCT03489863|593454215|FG001|Overall Study|Withdrawal by Subject|1|||
164294938|NCT00768989|593454217|FG000|Prior to Week 24|Withdrawal by Subject|1|||
164294939|NCT00768989|593454218|FG001|Prior to Week 24|Withdrawal by Subject|0|||
164294940|NCT00768989|593454217|FG000|Prior to Week 24|Adverse Event|3|||
164294941|NCT00768989|593454218|FG001|Prior to Week 24|Adverse Event|0|||
164294942|NCT00768989|593454217|FG000|Prior to Week 24|Lost to Follow-up|0|||
164294943|NCT00768989|593454218|FG001|Prior to Week 24|Lost to Follow-up|1|||
164294944|NCT00768989|593454217|FG000|Prior to Week 24|Protocol Violation|0|||
164294945|NCT00768989|593454218|FG001|Prior to Week 24|Protocol Violation|2|||
164294946|NCT00768989|593454217|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
164294947|NCT00768989|593454218|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
164294948|NCT00768989|593454217|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
164294949|NCT00768989|593454218|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
164294950|NCT00768989|593454217|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
164294951|NCT00768989|593454218|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
164294952|NCT00768989|593454217|FG000|On or After Week 36|Lack of Efficacy|1|||
164294953|NCT00768989|593454218|FG001|On or After Week 36|Lack of Efficacy|0|||
164294954|NCT00768989|593454217|FG000|On or After Week 36|Adverse Event|0|||
164294955|NCT00768989|593454218|FG001|On or After Week 36|Adverse Event|1|||
164294956|NCT00768989|593454217|FG000|On or After Week 36|Lost to Follow-up|1|||
164294957|NCT00768989|593454218|FG001|On or After Week 36|Lost to Follow-up|0|||
164294958|NCT00768989|593454217|FG000|On or After Week 36|Poor Compliance|1|||
164294959|NCT00768989|593454218|FG001|On or After Week 36|Poor Compliance|0|||
164294960|NCT00768989|593454217|FG000|On or After Week 36|Protocol Violation|1|||
164294961|NCT00768989|593454218|FG001|On or After Week 36|Protocol Violation|0|||
164294962|NCT00768989|593454217|FG000|On or After Week 36|Did not attend termination visit|2|||
164294963|NCT00768989|593454218|FG001|On or After Week 36|Did not attend termination visit|0|||
164294964|NCT00768989|593454217|FG000|On or After Week 36|Sponsor Termination|45|||
164294965|NCT00768989|593454218|FG001|On or After Week 36|Sponsor Termination|26|||
164294966|NCT02153086|593454219|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
164294967|NCT02153086|593454219|FG000|Overall Study|Other|2|||
164005115|NCT04375878|592384158|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164005116|NCT04375878|592384159|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164005117|NCT04375878|592384160|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
164005118|NCT04375878|592384155|FG000|Crossover First and Second Interventions|Adverse Event|0|||
164005119|NCT04375878|592384156|FG001|Crossover First and Second Interventions|Adverse Event|0|||
164005120|NCT04375878|592384157|FG002|Crossover First and Second Interventions|Adverse Event|1|||
164005121|NCT04375878|592384158|FG003|Crossover First and Second Interventions|Adverse Event|0|||
164005122|NCT04375878|592384159|FG004|Crossover First and Second Interventions|Adverse Event|0|||
164005123|NCT04375878|592384160|FG005|Crossover First and Second Interventions|Adverse Event|0|||
164005124|NCT04375878|592384155|FG000|Extension Phase|Withdrawal by Subject|0|||
164005125|NCT04375878|592384156|FG001|Extension Phase|Withdrawal by Subject|0|||
164005126|NCT04375878|592384157|FG002|Extension Phase|Withdrawal by Subject|0|||
164005127|NCT04375878|592384158|FG003|Extension Phase|Withdrawal by Subject|0|||
164005128|NCT04375878|592384159|FG004|Extension Phase|Withdrawal by Subject|1|||
164005129|NCT04375878|592384160|FG005|Extension Phase|Withdrawal by Subject|0|||
164005130|NCT00816036|592384161|FG000|Overall Study|Death|47|||
164005131|NCT00816036|592384162|FG001|Overall Study|Death|28|||
164005132|NCT00816036|592384161|FG000|Overall Study|Lost to Follow-up|75|||
164005133|NCT00816036|592384162|FG001|Overall Study|Lost to Follow-up|57|||
164005134|NCT00816036|592384161|FG000|Overall Study|Withdrawal by Subject|54|||
164005135|NCT00816036|592384162|FG001|Overall Study|Withdrawal by Subject|23|||
164005136|NCT00004980|592384163|FG000|Overall Study|Withdrawal by Subject|1|||
164005137|NCT00004980|592384164|FG001|Overall Study|Withdrawal by Subject|0|||
164005138|NCT00004980|592384163|FG000|Overall Study|memory difficulties|1|||
164005139|NCT00004980|592384164|FG001|Overall Study|memory difficulties|1|||
164005140|NCT00004980|592384163|FG000|Overall Study|Physician Decision|0|||
164005141|NCT00004980|592384164|FG001|Overall Study|Physician Decision|1|||
164005142|NCT01624194|592384165|FG000|Overall Study|Lost to Follow-up|1|||
164005143|NCT01624194|592384166|FG001|Overall Study|Lost to Follow-up|0|||
164005144|NCT01624194|592384165|FG000|Overall Study|Withdrawal by Subject|1|||
164005145|NCT01624194|592384166|FG001|Overall Study|Withdrawal by Subject|0|||
164005146|NCT03212261|592384170|FG000|Overall Study|Became ineligible d/t tech|2|||
164005147|NCT03212261|592384170|FG000|Overall Study|Tech Trouble- No first study visit|1|||
164005148|NCT03212261|592384170|FG000|Overall Study|Lost to Follow-up|7|||
164005149|NCT03212261|592384170|FG000|Overall Study|Family Emergency|1|||
164005150|NCT03212261|592384170|FG000|Overall Study|Too busy/ No time|5|||
164089339|NCT03466411|592690284|FG005|Overall Study|Withdrawal by Subject|3|||
164294968|NCT00446849|593454220|FG000|Acute Phase|Lack of Efficacy|64|||
164294969|NCT00446849|593454220|FG000|Acute Phase|Protocol Violation|10|||
164294970|NCT00446849|593454220|FG000|Acute Phase|Consent withdrawn|4|||
164294971|NCT00446849|593454220|FG000|Acute Phase|Lost to Follow-up|2|||
164294972|NCT00446849|593454220|FG000|Acute Phase|Physician Decision|1|||
164005151|NCT03815175|592384174|FG000|Overall Study|Subject Lost to Follow-up|6|||
164005152|NCT03815175|592384174|FG000|Overall Study|Subject Withdrew Consent|48|||
164294973|NCT00446849|593454220|FG000|Acute Phase|noncompliance|1|||
164294974|NCT00446849|593454220|FG000|Maintenance Phase|Lack of Efficacy|40|||
164294975|NCT00446849|593454220|FG000|Maintenance Phase|Protocol Violation|7|||
164294976|NCT00446849|593454220|FG000|Maintenance Phase|Adverse Event|6|||
164294977|NCT00446849|593454220|FG000|Maintenance Phase|Consent withdrawn|5|||
164294978|NCT00446849|593454220|FG000|Maintenance Phase|Lost to Follow-up|3|||
164294979|NCT00446849|593454220|FG000|Maintenance Phase|Pregnancy|1|||
164294980|NCT00446849|593454220|FG000|Maintenance Phase|noncompliance|2|||
164294981|NCT00446849|593454220|FG000|Maintenance Phase|prohibited medication use|2|||
164294982|NCT00446849|593454220|FG000|Maintenance Phase|antibiotic use|1|||
164294983|NCT00446849|593454220|FG000|Maintenance Phase|study closure|1|||
164294984|NCT00446849|593454220|FG000|Maintenance Phase|hydrocodone use|1|||
164294985|NCT00446849|593454220|FG000|Maintenance Phase|concomitant medication use|1|||
164294986|NCT03115359|593454221|FG000|Overall Study|Withdrawal by Subject|29|||
164294987|NCT03115359|593454222|FG001|Overall Study|Withdrawal by Subject|39|||
164294988|NCT03115359|593454221|FG000|Overall Study|Scheduling conflict|25|||
164294989|NCT03115359|593454222|FG001|Overall Study|Scheduling conflict|23|||
164294990|NCT03115359|593454221|FG000|Overall Study|Personal reasons including health|12|||
164294991|NCT03115359|593454222|FG001|Overall Study|Personal reasons including health|9|||
164294992|NCT03115359|593454221|FG000|Overall Study|Transportation barriers|3|||
164294993|NCT03115359|593454222|FG001|Overall Study|Transportation barriers|0|||
164294994|NCT03115359|593454221|FG000|Overall Study|No longer interested|5|||
164294995|NCT03115359|593454222|FG001|Overall Study|No longer interested|4|||
164294996|NCT03115359|593454221|FG000|Overall Study|No reason provided|45|||
164294997|NCT03115359|593454222|FG001|Overall Study|No reason provided|47|||
164294998|NCT05546476|593454224|FG000|Period 1: Part A|Adverse Event|2|||
164294999|NCT05546476|593454225|FG001|Period 1: Part A|Adverse Event|0|||
164295000|NCT05546476|593454226|FG002|Period 1: Part A|Adverse Event|0|||
164295001|NCT05546476|593454227|FG003|Period 1: Part A|Adverse Event|1|||
164295002|NCT05546476|593454224|FG000|Period 1: Part A|Death|4|||
164295003|NCT05546476|593454225|FG001|Period 1: Part A|Death|4|||
164295004|NCT05546476|593454226|FG002|Period 1: Part A|Death|5|||
164295005|NCT05546476|593454227|FG003|Period 1: Part A|Death|6|||
164295006|NCT05546476|593454224|FG000|Period 1: Part A|Lack of Efficacy|0|||
164295007|NCT05546476|593454225|FG001|Period 1: Part A|Lack of Efficacy|0|||
164295008|NCT05546476|593454226|FG002|Period 1: Part A|Lack of Efficacy|0|||
164295009|NCT05546476|593454227|FG003|Period 1: Part A|Lack of Efficacy|1|||
164295010|NCT05546476|593454224|FG000|Period 1: Part A|Lost to Follow-up|0|||
164295011|NCT05546476|593454225|FG001|Period 1: Part A|Lost to Follow-up|0|||
164295012|NCT05546476|593454226|FG002|Period 1: Part A|Lost to Follow-up|0|||
164295013|NCT05546476|593454227|FG003|Period 1: Part A|Lost to Follow-up|1|||
164295014|NCT05546476|593454224|FG000|Period 1: Part A|Physician Decision|1|||
164295015|NCT05546476|593454225|FG001|Period 1: Part A|Physician Decision|0|||
164295016|NCT05546476|593454226|FG002|Period 1: Part A|Physician Decision|0|||
164295017|NCT05546476|593454227|FG003|Period 1: Part A|Physician Decision|0|||
164295018|NCT05546476|593454224|FG000|Period 1: Part A|Progressive disease|3|||
164295019|NCT05546476|593454225|FG001|Period 1: Part A|Progressive disease|5|||
164295020|NCT05546476|593454226|FG002|Period 1: Part A|Progressive disease|0|||
164295021|NCT05546476|593454227|FG003|Period 1: Part A|Progressive disease|1|||
164295022|NCT05546476|593454224|FG000|Period 1: Part A|Withdrawal by Subject|1|||
164295023|NCT05546476|593454225|FG001|Period 1: Part A|Withdrawal by Subject|1|||
164295024|NCT05546476|593454226|FG002|Period 1: Part A|Withdrawal by Subject|1|||
164295025|NCT05546476|593454227|FG003|Period 1: Part A|Withdrawal by Subject|2|||
164295026|NCT05546476|593454224|FG000|Period 1: Part A|Global deterioration of health status|2|||
164295027|NCT05546476|593454225|FG001|Period 1: Part A|Global deterioration of health status|2|||
164295028|NCT05546476|593454226|FG002|Period 1: Part A|Global deterioration of health status|1|||
164295029|NCT05546476|593454227|FG003|Period 1: Part A|Global deterioration of health status|4|||
164295030|NCT05546476|593454224|FG000|Period 1: Part A|Other: Unspecified|0|||
164295031|NCT05546476|593454225|FG001|Period 1: Part A|Other: Unspecified|2|||
164295032|NCT05546476|593454226|FG002|Period 1: Part A|Other: Unspecified|0|||
164295033|NCT05546476|593454227|FG003|Period 1: Part A|Other: Unspecified|0|||
164295034|NCT05546476|593454224|FG000|Period 2: Part B|Ongoing|26|||
164295035|NCT05546476|593454225|FG001|Period 2: Part B|Ongoing|27|||
164295036|NCT05546476|593454226|FG002|Period 2: Part B|Ongoing|35|||
164295037|NCT05546476|593454227|FG003|Period 2: Part B|Ongoing|29|||
164295038|NCT03585660|593454228|FG000|Overall Study|operator error|1|||
164005153|NCT03815175|592384174|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
164005154|NCT03815175|592384174|FG000|Overall Study|Death|86|||
164005155|NCT03815175|592384174|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
164005156|NCT03815175|592384174|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
164005157|NCT03815175|592384174|FG000|Overall Study|Other Status Change Reason|1|||
164005158|NCT03815175|592384174|FG000|Overall Study|Missed Visit|12|||
164005159|NCT01259466|592384182|FG000|Overall Study|Withdrawal by Subject|1|||
164005160|NCT01259466|592384183|FG001|Overall Study|Withdrawal by Subject|9|||
164005161|NCT02296840|592384186|FG000|Overall Study|Adverse Event|1|||
164005162|NCT02296840|592384187|FG001|Overall Study|Adverse Event|1|||
164295039|NCT03585660|593454228|FG000|Overall Study|technical error|2|||
164295040|NCT03585660|593454228|FG000|Overall Study|hip prosthesis|2|||
164295041|NCT03585660|593454228|FG000|Overall Study|did not undergo biopsy|8|||
164295042|NCT03585660|593454228|FG000|Overall Study|scanner problem|2|||
164295043|NCT05316597|593454230|FG000|First Session|Withdrawal by Subject|0|||
164295044|NCT05316597|593454231|FG001|First Session|Withdrawal by Subject|1|||
164295045|NCT05316597|593454230|FG000|Washout Period|Lost to Follow-up|1|||
164295046|NCT05316597|593454231|FG001|Washout Period|Lost to Follow-up|2|||
164295047|NCT05316597|593454230|FG000|Washout Period|Physician Decision|1|||
164295048|NCT05316597|593454231|FG001|Washout Period|Physician Decision|1|||
164295049|NCT05316597|593454230|FG000|Washout Period|Excluded before second session|1|||
164295050|NCT05316597|593454231|FG001|Washout Period|Excluded before second session|1|||
164295051|NCT05316597|593454230|FG000|Washout Period|Withdrawal by Subject|0|||
164295052|NCT05316597|593454231|FG001|Washout Period|Withdrawal by Subject|4|||
164295053|NCT01706458|593454232|FG000|Overall Study|Physician Decision|3|||
164295054|NCT01706458|593454233|FG001|Overall Study|Physician Decision|4|||
164295055|NCT03547518|593454234|FG000|Overall Study|Lost to Follow-up|2|||
164295056|NCT03547518|593454235|FG001|Overall Study|Lost to Follow-up|0|||
164295057|NCT02766023|593454240|FG000|Overall Study|Lost to Follow-up|23|||
164295058|NCT02766023|593454241|FG001|Overall Study|Lost to Follow-up|11|||
164295059|NCT02766023|593454240|FG000|Overall Study|Pregnancy|1|||
164295060|NCT02766023|593454241|FG001|Overall Study|Pregnancy|0|||
164295061|NCT02766023|593454240|FG000|Overall Study|Adverse Event|1|||
164295062|NCT02766023|593454241|FG001|Overall Study|Adverse Event|0|||
164295063|NCT02766023|593454240|FG000|Overall Study|Withdrawal by Subject|4|||
164295064|NCT02766023|593454241|FG001|Overall Study|Withdrawal by Subject|5|||
164295065|NCT02766023|593454240|FG000|Overall Study|Physician Decision|1|||
164295066|NCT02766023|593454241|FG001|Overall Study|Physician Decision|0|||
164295067|NCT02766023|593454240|FG000|Overall Study|Not Eligible at Enrollment|0|||
164295068|NCT02766023|593454241|FG001|Overall Study|Not Eligible at Enrollment|1|||
164295069|NCT00286468|593454242|FG000|Overall Study|Hyperglycemic Rescue|28|||
164295070|NCT00286468|593454243|FG001|Overall Study|Hyperglycemic Rescue|30|||
164295071|NCT00286468|593454244|FG002|Overall Study|Hyperglycemic Rescue|31|||
164295072|NCT00286468|593454242|FG000|Overall Study|Adverse Event|2|||
164005163|NCT02296840|592384186|FG000|Overall Study|Protocol Violation|2|||
164005164|NCT02296840|592384187|FG001|Overall Study|Protocol Violation|1|||
164005165|NCT02296840|592384186|FG000|Overall Study|Lost to Follow-up|6|||
164005166|NCT02296840|592384187|FG001|Overall Study|Lost to Follow-up|17|||
164005167|NCT02485717|592384193|FG000|Overall Study|Lost to Follow-up|6|||
164005168|NCT02485717|592384194|FG001|Overall Study|Lost to Follow-up|0|||
164005169|NCT02485717|592384195|FG002|Overall Study|Lost to Follow-up|0|||
164005170|NCT02485717|592384193|FG000|Overall Study|Withdrawal by Subject|0|||
164005171|NCT02485717|592384194|FG001|Overall Study|Withdrawal by Subject|0|||
164005172|NCT02485717|592384195|FG002|Overall Study|Withdrawal by Subject|1|||
164005173|NCT02485717|592384193|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
164005174|NCT02485717|592384194|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
164005175|NCT02485717|592384195|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
164005176|NCT02485717|592384193|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
164005177|NCT02485717|592384194|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
164005178|NCT02485717|592384195|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
164005179|NCT00457639|592384196|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
164005180|NCT00457639|592384197|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
164005181|NCT00457639|592384196|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
164005182|NCT00457639|592384197|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
164005183|NCT00457639|592384196|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
164005184|NCT00457639|592384197|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
164005185|NCT03885284|592384198|FG000|Overall Study|Disease Progression|1|||
164005186|NCT03885284|592384199|FG001|Overall Study|Disease Progression|3|||
164005187|NCT03885284|592384198|FG000|Overall Study|Physician Decision|0|||
164005188|NCT03885284|592384199|FG001|Overall Study|Physician Decision|1|||
164005189|NCT01450540|592384202|FG000|Overall Study|Withdrawal by Subject|19|||
164005190|NCT01450540|592384203|FG001|Overall Study|Withdrawal by Subject|13|||
164005191|NCT01450540|592384202|FG000|Overall Study|protocol deviation|3|||
164005192|NCT01450540|592384203|FG001|Overall Study|protocol deviation|23|||
164295073|NCT00286468|593454243|FG001|Overall Study|Adverse Event|6|||
164295074|NCT00286468|593454244|FG002|Overall Study|Adverse Event|4|||
164295075|NCT00286468|593454242|FG000|Overall Study|Protocol Violation|0|||
164295076|NCT00286468|593454243|FG001|Overall Study|Protocol Violation|3|||
164295077|NCT00286468|593454244|FG002|Overall Study|Protocol Violation|1|||
164295078|NCT00286468|593454242|FG000|Overall Study|Lost to Follow-up|1|||
164005193|NCT00140855|592384204|FG000|Overall Study|Progressive disease|2|||
164005194|NCT02932267|592384205|FG000|Overall Study|Withdrawal by Subject|3|||
164005195|NCT02932267|592384205|FG000|Overall Study|Lost to Follow-up|4|||
164005196|NCT02932267|592384205|FG000|Overall Study|Pregnancy|1|||
164295079|NCT00286468|593454243|FG001|Overall Study|Lost to Follow-up|1|||
164005197|NCT03542682|592384206|FG000|Overall Study|COVID-19 Protocol|0|||
164005198|NCT03542682|592384207|FG001|Overall Study|COVID-19 Protocol|1|||
164005199|NCT01887210|592384215|FG000|Overall Study|Withdrawal by Subject|1|||
164295080|NCT00286468|593454244|FG002|Overall Study|Lost to Follow-up|2|||
164295081|NCT00286468|593454242|FG000|Overall Study|Withdrawal by Subject|3|||
164295082|NCT00286468|593454243|FG001|Overall Study|Withdrawal by Subject|8|||
164295083|NCT00286468|593454244|FG002|Overall Study|Withdrawal by Subject|11|||
164295084|NCT00286468|593454242|FG000|Overall Study|Physician Decision|3|||
164295085|NCT00286468|593454243|FG001|Overall Study|Physician Decision|2|||
164295086|NCT00286468|593454244|FG002|Overall Study|Physician Decision|1|||
164295087|NCT03103542|593454245|FG000|Overall Study|Physician Decision|2|||
164295088|NCT03103542|593454245|FG000|Overall Study|Adverse Event|2|||
164295089|NCT03103542|593454245|FG000|Overall Study|Other|2|||
164295090|NCT03103542|593454245|FG000|Overall Study|Withdrawal by Subject|1|||
164295091|NCT02953652|593454246|FG000|Overall Study|Adverse Event|18|||
164295092|NCT02953652|593454246|FG000|Overall Study|Withdrawal by Subject|6|||
164295093|NCT02953652|593454246|FG000|Overall Study|Protocol Violation|1|||
164295094|NCT02953652|593454246|FG000|Overall Study|Disease Progression|27|||
164295095|NCT02384551|593454250|FG000|Overall Study|Lost to Follow-up|13|||
164295096|NCT02384551|593454251|FG001|Overall Study|Lost to Follow-up|14|||
164295097|NCT02384551|593454252|FG002|Overall Study|Lost to Follow-up|14|||
164295098|NCT02384551|593454253|FG003|Overall Study|Lost to Follow-up|14|||
164295099|NCT03035032|593454259|FG000|Overall Study|Adverse Event|2|||
164295100|NCT03035032|593454259|FG000|Overall Study|Death|9|||
164295101|NCT03035032|593454259|FG000|Overall Study|Lost to Follow-up|1|||
164295102|NCT03035032|593454259|FG000|Overall Study|Progressive Disease|22|||
164295103|NCT03035032|593454259|FG000|Overall Study|Protocol Violation|2|||
164295104|NCT03035032|593454259|FG000|Overall Study|Withdrawal by Subject|2|||
164295105|NCT03035032|593454259|FG000|Overall Study|Physician Decision|5|||
164295106|NCT03406780|593454260|FG000|Overall Study|Withdrawal by Subject|1|||
164295107|NCT03406780|593454261|FG001|Overall Study|Withdrawal by Subject|1|||
164295108|NCT03406780|593454260|FG000|Overall Study|Other|0|||
164295109|NCT03406780|593454261|FG001|Overall Study|Other|2|||
164295110|NCT01903356|593454273|FG000|Overall Study|Lost to Follow-up|7|||
164295111|NCT01903356|593454273|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
164295112|NCT01903356|593454273|FG000|Overall Study|Violated the dosage and administration|3|||
164295113|NCT03305666|593454274|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
164295114|NCT03305666|593454275|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
164295115|NCT02546609|593454278|FG000|Overall Study|Withdrawal by Subject|0|||
164295116|NCT02546609|593454279|FG001|Overall Study|Withdrawal by Subject|1|||
164295117|NCT02546609|593454280|FG002|Overall Study|Withdrawal by Subject|2|||
164295118|NCT02546609|593454278|FG000|Overall Study|Adverse Event|0|||
164295119|NCT02546609|593454279|FG001|Overall Study|Adverse Event|6|||
164295120|NCT02546609|593454280|FG002|Overall Study|Adverse Event|1|||
164295121|NCT02546609|593454278|FG000|Overall Study|Protocol Violation|0|||
164295122|NCT02546609|593454279|FG001|Overall Study|Protocol Violation|1|||
164295123|NCT02546609|593454280|FG002|Overall Study|Protocol Violation|1|||
164295124|NCT02546609|593454278|FG000|Overall Study|Lost to Follow-up|2|||
164295125|NCT02546609|593454279|FG001|Overall Study|Lost to Follow-up|3|||
164295126|NCT02546609|593454280|FG002|Overall Study|Lost to Follow-up|1|||
164295127|NCT02546609|593454278|FG000|Overall Study|travel or work schedule restriction|0|||
164295128|NCT02546609|593454279|FG001|Overall Study|travel or work schedule restriction|0|||
164295129|NCT02546609|593454280|FG002|Overall Study|travel or work schedule restriction|2|||
164295130|NCT02756338|593454282|FG000|Overall Study|Withdrawn by Investigator|1|||
164295131|NCT02756338|593454282|FG000|Overall Study|Device Replaced with Pacemaker|4|||
164295132|NCT01546857|593454284|FG000|Overall Study|Withdrawal by Subject|2|||
164295133|NCT01546857|593454285|FG001|Overall Study|Withdrawal by Subject|3|||
164295134|NCT01339689|593454286|FG000|Overall Study|Adverse Event|1|||
164295135|NCT01339689|593454287|FG001|Overall Study|Adverse Event|2|||
164295136|NCT01339689|593454286|FG000|Overall Study|Lost to Follow-up|9|||
163898412|NCT00943917|592001076|FG009|Stage I|Adverse Event|0|||
163898413|NCT00943917|592001077|FG010|Stage I|Adverse Event|0|||
164295137|NCT01339689|593454287|FG001|Overall Study|Lost to Follow-up|3|||
164295138|NCT01339689|593454286|FG000|Overall Study|Withdrawal by Subject|3|||
164295139|NCT01339689|593454287|FG001|Overall Study|Withdrawal by Subject|0|||
164295140|NCT01339689|593454286|FG000|Overall Study|Noncompliance|1|||
164295141|NCT01339689|593454287|FG001|Overall Study|Noncompliance|0|||
164295142|NCT01339689|593454286|FG000|Overall Study|Relocated out of area|0|||
164295143|NCT01339689|593454287|FG001|Overall Study|Relocated out of area|1|||
164295144|NCT01339689|593454286|FG000|Overall Study|Other|2|||
163898414|NCT00943917|592001078|FG011|Stage I|Adverse Event|0|||
163898415|NCT00943917|592001079|FG012|Stage I|Adverse Event|0|||
163898416|NCT00943917|592001080|FG013|Stage I|Adverse Event|0|||
164295145|NCT01339689|593454287|FG001|Overall Study|Other|2|||
164295146|NCT01339689|593454286|FG000|Overall Study|multiple reasons|1|||
164295147|NCT01339689|593454287|FG001|Overall Study|multiple reasons|1|||
164295148|NCT01176032|593454288|FG000|Overall Study|Adverse Event|1|||
164295149|NCT01176032|593454289|FG001|Overall Study|Adverse Event|0|||
164295150|NCT01176032|593454288|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164295151|NCT01176032|593454289|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163898417|NCT00943917|592001081|FG014|Stage I|Adverse Event|0|||
164295152|NCT01176032|593454288|FG000|Overall Study|Protocol Violation|1|||
164295153|NCT01176032|593454289|FG001|Overall Study|Protocol Violation|0|||
164295154|NCT01176032|593454288|FG000|Overall Study|Informed consent withdrawn|3|||
164295155|NCT01176032|593454289|FG001|Overall Study|Informed consent withdrawn|0|||
164295156|NCT01176032|593454288|FG000|Overall Study|Other|1|||
164295157|NCT01176032|593454289|FG001|Overall Study|Other|0|||
164295158|NCT01469221|593454290|FG000|Double Blind Phase|Protocol Violation|1|||
164295159|NCT01469221|593454291|FG001|Double Blind Phase|Protocol Violation|0|||
164295160|NCT01469221|593454292|FG002|Double Blind Phase|Protocol Violation|0|||
164295161|NCT01469221|593454290|FG000|Double Blind Phase|Physician Decision|1|||
164295162|NCT01469221|593454291|FG001|Double Blind Phase|Physician Decision|1|||
164295163|NCT01469221|593454292|FG002|Double Blind Phase|Physician Decision|0|||
164295164|NCT01469221|593454290|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
164295165|NCT01469221|593454291|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
164295166|NCT01469221|593454292|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
164295167|NCT00659061|593454294|FG000|Overall Study|Migration due to political unrest|21|||
164295168|NCT00659061|593454295|FG001|Overall Study|Migration due to political unrest|15|||
164295169|NCT05121766|593454302|FG000|Overall Study|Covid reinfection|3|||
164295170|NCT05121766|593454303|FG001|Overall Study|Covid reinfection|0|||
164295171|NCT05121766|593454302|FG000|Overall Study|Withdrawal by Subject|3|||
164295172|NCT05121766|593454303|FG001|Overall Study|Withdrawal by Subject|1|||
164295173|NCT05121766|593454302|FG000|Overall Study|Adverse Event|2|||
164295174|NCT05121766|593454303|FG001|Overall Study|Adverse Event|4|||
164295175|NCT05121766|593454302|FG000|Overall Study|Lost to Follow-up|0|||
164295176|NCT05121766|593454303|FG001|Overall Study|Lost to Follow-up|1|||
164295177|NCT01632020|593454304|FG000|Overall Study|Withdrawal by Subject|1|||
164295178|NCT01632020|593454305|FG001|Overall Study|Withdrawal by Subject|0|||
164295179|NCT01632020|593454304|FG000|Overall Study|Adverse Event|1|||
164295180|NCT01632020|593454305|FG001|Overall Study|Adverse Event|0|||
164295181|NCT00528957|593454309|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
164295182|NCT00528957|593454310|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
164295183|NCT00528957|593454309|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
164295184|NCT00528957|593454310|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
164295185|NCT00528957|593454309|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
164295186|NCT00528957|593454310|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
164295187|NCT00528957|593454309|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
164295188|NCT00528957|593454310|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
164295189|NCT00528957|593454309|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
164295190|NCT00528957|593454310|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
164295191|NCT00528957|593454309|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
164295192|NCT00528957|593454310|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
164295193|NCT00528957|593454309|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
164089340|NCT03466411|592690285|FG006|Overall Study|Withdrawal by Subject|6|||
164089341|NCT03466411|592690286|FG007|Overall Study|Withdrawal by Subject|9|||
164089342|NCT03466411|592690287|FG008|Overall Study|Withdrawal by Subject|6|||
164089343|NCT03466411|592690288|FG009|Overall Study|Withdrawal by Subject|11|||
164089344|NCT03466411|592690289|FG010|Overall Study|Withdrawal by Subject|14|||
164089345|NCT03466411|592690290|FG011|Overall Study|Withdrawal by Subject|12|||
164089346|NCT03466411|592690291|FG012|Overall Study|Withdrawal by Subject|7|||
164089347|NCT03466411|592690279|FG000|Overall Study|Other|1|||
164089348|NCT03466411|592690280|FG001|Overall Study|Other|1|||
164089349|NCT03466411|592690281|FG002|Overall Study|Other|0|||
164089350|NCT03466411|592690282|FG003|Overall Study|Other|1|||
164295194|NCT00528957|593454310|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
164295195|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
164295196|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
164295197|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
164295198|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
164295199|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
164295200|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
164295201|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
164347126|NCT01846416|593646845|FG000|Survival Follow-up|Lost to Follow-up|0|||
164347127|NCT01846416|593646846|FG001|Survival Follow-up|Lost to Follow-up|2|||
164347128|NCT01846416|593646847|FG002|Survival Follow-up|Lost to Follow-up|2|||
164295202|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
164295203|NCT00528957|593454309|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
164347129|NCT01846416|593646845|FG000|Survival Follow-up|Withdrawal by Subject|2|||
164347130|NCT01846416|593646846|FG001|Survival Follow-up|Withdrawal by Subject|7|||
164089351|NCT03466411|592690283|FG004|Overall Study|Other|2|||
164089352|NCT03466411|592690284|FG005|Overall Study|Other|0|||
164089353|NCT03466411|592690285|FG006|Overall Study|Other|0|||
164089354|NCT03466411|592690286|FG007|Overall Study|Other|0|||
164089355|NCT03466411|592690287|FG008|Overall Study|Other|0|||
164089356|NCT03466411|592690288|FG009|Overall Study|Other|1|||
164089357|NCT03466411|592690289|FG010|Overall Study|Other|2|||
164089358|NCT03466411|592690290|FG011|Overall Study|Other|0|||
164089359|NCT03466411|592690291|FG012|Overall Study|Other|0|||
164089360|NCT03466411|592690279|FG000|Overall Study|Randomized but not Treated|0|||
164089361|NCT03466411|592690280|FG001|Overall Study|Randomized but not Treated|0|||
164089362|NCT03466411|592690281|FG002|Overall Study|Randomized but not Treated|0|||
164295204|NCT00528957|593454310|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
164295205|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
164295206|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
164295207|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
164295208|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
164295209|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
164295210|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
164295211|NCT00528957|593454309|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
164295212|NCT00528957|593454310|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
164347131|NCT01846416|593646847|FG002|Survival Follow-up|Withdrawal by Subject|0|||
164089363|NCT03466411|592690282|FG003|Overall Study|Randomized but not Treated|0|||
164089364|NCT03466411|592690283|FG004|Overall Study|Randomized but not Treated|0|||
164089365|NCT03466411|592690284|FG005|Overall Study|Randomized but not Treated|0|||
164089366|NCT03466411|592690285|FG006|Overall Study|Randomized but not Treated|1|||
164089367|NCT03466411|592690286|FG007|Overall Study|Randomized but not Treated|0|||
164089368|NCT03466411|592690287|FG008|Overall Study|Randomized but not Treated|0|||
164089369|NCT03466411|592690288|FG009|Overall Study|Randomized but not Treated|0|||
164089370|NCT03466411|592690289|FG010|Overall Study|Randomized but not Treated|0|||
164089371|NCT03466411|592690290|FG011|Overall Study|Randomized but not Treated|0|||
164089372|NCT03466411|592690291|FG012|Overall Study|Randomized but not Treated|0|||
164089373|NCT03462719|592690292|FG000|Overall Study|Withdrawal by Subject|4|||
164089374|NCT03462719|592690293|FG001|Overall Study|Withdrawal by Subject|3|||
164089375|NCT03462719|592690292|FG000|Overall Study|Ongoing|87|||
164089376|NCT03462719|592690293|FG001|Overall Study|Ongoing|72|||
164089377|NCT04799158|592690294|FG000|Run-In Period|Adverse Event|6|||
164089378|NCT04799158|592690295|FG001|Run-In Period|Adverse Event|0|||
164089379|NCT04799158|592690296|FG002|Run-In Period|Adverse Event|0|||
164089380|NCT04799158|592690297|FG003|Run-In Period|Adverse Event|0|||
164089381|NCT04799158|592690298|FG004|Run-In Period|Adverse Event|0|||
164089382|NCT04799158|592690294|FG000|Run-In Period|Lost to Follow-up|4|||
164089383|NCT04799158|592690295|FG001|Run-In Period|Lost to Follow-up|0|||
164089384|NCT04799158|592690296|FG002|Run-In Period|Lost to Follow-up|0|||
164089385|NCT04799158|592690297|FG003|Run-In Period|Lost to Follow-up|0|||
164089386|NCT04799158|592690298|FG004|Run-In Period|Lost to Follow-up|0|||
164089387|NCT04799158|592690294|FG000|Run-In Period|Significant Protocol Deviation|1|||
164089388|NCT04799158|592690295|FG001|Run-In Period|Significant Protocol Deviation|0|||
164089389|NCT04799158|592690296|FG002|Run-In Period|Significant Protocol Deviation|0|||
164089390|NCT04799158|592690297|FG003|Run-In Period|Significant Protocol Deviation|0|||
164089391|NCT04799158|592690298|FG004|Run-In Period|Significant Protocol Deviation|0|||
164089392|NCT04799158|592690294|FG000|Run-In Period|Withdrawal by Subject|11|||
164089393|NCT04799158|592690295|FG001|Run-In Period|Withdrawal by Subject|0|||
164089394|NCT04799158|592690296|FG002|Run-In Period|Withdrawal by Subject|0|||
164089395|NCT04799158|592690297|FG003|Run-In Period|Withdrawal by Subject|0|||
164089396|NCT04799158|592690298|FG004|Run-In Period|Withdrawal by Subject|0|||
164089397|NCT04799158|592690294|FG000|Run-In Period|Miscellaneous|3|||
164089398|NCT04799158|592690295|FG001|Run-In Period|Miscellaneous|0|||
164089399|NCT04799158|592690296|FG002|Run-In Period|Miscellaneous|0|||
164089400|NCT04799158|592690297|FG003|Run-In Period|Miscellaneous|0|||
164089401|NCT04799158|592690298|FG004|Run-In Period|Miscellaneous|0|||
164347132|NCT01846416|593646845|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
164347133|NCT01846416|593646846|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
164347134|NCT01846416|593646847|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
164347135|NCT01846416|593646845|FG000|Survival Follow-up|Other|3|||
164089402|NCT04799158|592690294|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
164089403|NCT04799158|592690295|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164089404|NCT04799158|592690296|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164089405|NCT04799158|592690297|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164089406|NCT04799158|592690298|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
164089407|NCT04799158|592690294|FG000|On-Demand Treatment Period|Adverse Event|0|||
164089408|NCT04799158|592690295|FG001|On-Demand Treatment Period|Adverse Event|1|||
164347136|NCT01846416|593646846|FG001|Survival Follow-up|Other|1|||
164347137|NCT01846416|593646847|FG002|Survival Follow-up|Other|1|||
164347138|NCT00382252|593646848|FG000|Overall Study|Death|4|||
164089409|NCT04799158|592690296|FG002|On-Demand Treatment Period|Adverse Event|0|||
164089410|NCT04799158|592690297|FG003|On-Demand Treatment Period|Adverse Event|0|||
164295213|NCT00083889|593454315|FG000|Overall Study|Adverse Event|76|||
164295214|NCT00083889|593454316|FG001|Overall Study|Adverse Event|86|||
164295215|NCT00083889|593454315|FG000|Overall Study|Protocol Violation|2|||
164295216|NCT00083889|593454316|FG001|Overall Study|Protocol Violation|2|||
164295217|NCT00083889|593454315|FG000|Overall Study|Withdrawal by Subject|22|||
164295218|NCT00083889|593454316|FG001|Overall Study|Withdrawal by Subject|24|||
164295219|NCT00083889|593454315|FG000|Overall Study|Lack of Efficacy|240|||
164295220|NCT00083889|593454316|FG001|Overall Study|Lack of Efficacy|219|||
164295221|NCT00083889|593454315|FG000|Overall Study|Decision of sponsor|32|||
164295222|NCT00083889|593454316|FG001|Overall Study|Decision of sponsor|4|||
164295223|NCT00083889|593454315|FG000|Overall Study|Randomized: did not take study drug|0|||
164295224|NCT00083889|593454316|FG001|Overall Study|Randomized: did not take study drug|15|||
164295225|NCT00083889|593454315|FG000|Overall Study|Completed on marketed sunitinub|3|||
164295226|NCT00083889|593454316|FG001|Overall Study|Completed on marketed sunitinub|0|||
164295227|NCT00083889|593454315|FG000|Overall Study|Crossover to SU011248|0|||
164295228|NCT00083889|593454316|FG001|Overall Study|Crossover to SU011248|25|||
164295229|NCT00168844|593454317|FG000|Overall Study|Adverse Event|31|||
164295230|NCT00168844|593454318|FG001|Overall Study|Adverse Event|32|||
164089411|NCT04799158|592690298|FG004|On-Demand Treatment Period|Adverse Event|1|||
164295231|NCT00168844|593454319|FG002|Overall Study|Adverse Event|48|||
164295232|NCT00168844|593454317|FG000|Overall Study|Lost to Follow-up|4|||
164295233|NCT00168844|593454318|FG001|Overall Study|Lost to Follow-up|5|||
164295234|NCT00168844|593454319|FG002|Overall Study|Lost to Follow-up|11|||
164295235|NCT00168844|593454317|FG000|Overall Study|Withdrawal by Subject|12|||
164295236|NCT00168844|593454318|FG001|Overall Study|Withdrawal by Subject|9|||
164089412|NCT04799158|592690294|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
164089413|NCT04799158|592690295|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
164089414|NCT04799158|592690296|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
164295237|NCT00168844|593454319|FG002|Overall Study|Withdrawal by Subject|19|||
164295238|NCT00168844|593454317|FG000|Overall Study|Protocol Violation|2|||
164295239|NCT00168844|593454318|FG001|Overall Study|Protocol Violation|2|||
164295240|NCT00168844|593454319|FG002|Overall Study|Protocol Violation|4|||
164295241|NCT00168844|593454317|FG000|Overall Study|Other|6|||
164295242|NCT00168844|593454318|FG001|Overall Study|Other|7|||
164295243|NCT00168844|593454319|FG002|Overall Study|Other|9|||
164295244|NCT02994108|593455799|FG000|Intervention Messages|Withdrawal by Subject|2|||
164295245|NCT02994108|593455800|FG001|Intervention Messages|Withdrawal by Subject|0|||
164295246|NCT02994108|593455799|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
164295247|NCT02994108|593455800|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
164295248|NCT02994108|593455799|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
164295249|NCT02994108|593455800|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
164295250|NCT02994108|593455799|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
164295251|NCT02994108|593455800|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
164295252|NCT00089297|593455801|FG000|Overall Study|Adverse Event|9|||
164295253|NCT00089297|593455801|FG000|Overall Study|Death|1|||
164295254|NCT00089297|593455801|FG000|Overall Study|Withdrawal by Subject|12|||
164295255|NCT00089297|593455801|FG000|Overall Study|Disease progression|2|||
164295256|NCT00089297|593455801|FG000|Overall Study|Ineligible|11|||
164295257|NCT00089297|593455801|FG000|Overall Study|Secondary malignancy|1|||
164347139|NCT00382252|593646848|FG000|Overall Study|Protocol Violation|8|||
164347140|NCT00382252|593646848|FG000|Overall Study|Not treated by RFA|1|||
164347141|NCT00833794|593646849|FG000|Open-label Phase|Adverse Event|225|||
164347142|NCT00833794|593646850|FG001|Open-label Phase|Adverse Event|0|||
164347143|NCT00833794|593646849|FG000|Open-label Phase|Lack of Efficacy|28|||
164089415|NCT04799158|592690297|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
164295258|NCT00089297|593455801|FG000|Overall Study|IRB approval not ready|1|||
164295259|NCT00089297|593455801|FG000|Overall Study|Non-compliance|1|||
164295260|NCT00904969|593455802|FG000|Overall Study|Lost to Follow-up|4|||
164295261|NCT00904969|593455802|FG000|Overall Study|Withdrawal by Subject|3|||
164295262|NCT00904969|593455802|FG000|Overall Study|Additional Treatments|11|||
164295263|NCT00904969|593455802|FG000|Overall Study|Case Aborted; Subject Exited|1|||
164295264|NCT04515771|593455815|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
164295265|NCT04515771|593455816|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
164295266|NCT04515771|593455815|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
164295267|NCT04515771|593455816|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
164295268|NCT04515771|593455815|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
164295269|NCT04515771|593455816|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
164295270|NCT02927301|593455824|FG000|Overall Study|Death|39|||
164295271|NCT02927301|593455824|FG000|Overall Study|Lost to Follow-up|8|||
164347144|NCT00833794|593646850|FG001|Open-label Phase|Lack of Efficacy|0|||
164089416|NCT04799158|592690298|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
164295272|NCT02927301|593455824|FG000|Overall Study|Physician Decision|2|||
164295273|NCT02927301|593455824|FG000|Overall Study|Withdrawal by Subject|12|||
164347145|NCT00833794|593646849|FG000|Open-label Phase|Withdrawal by Subject|48|||
164347146|NCT00833794|593646850|FG001|Open-label Phase|Withdrawal by Subject|0|||
164347147|NCT00833794|593646849|FG000|Open-label Phase|Physician Decision|20|||
164295274|NCT02927301|593455824|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
164295275|NCT04742556|593455825|FG000|Overall Study|Withdrawal by Subject|0|||
164295276|NCT04742556|593455826|FG001|Overall Study|Withdrawal by Subject|1|||
164295277|NCT04742556|593455827|FG002|Overall Study|Withdrawal by Subject|0|||
164295278|NCT04742556|593455825|FG000|Overall Study|Adverse Event|0|||
164295279|NCT04742556|593455826|FG001|Overall Study|Adverse Event|0|||
164295280|NCT04742556|593455827|FG002|Overall Study|Adverse Event|2|||
164295281|NCT04742556|593455825|FG000|Overall Study|Clinical disease progression|0|||
164295282|NCT04742556|593455826|FG001|Overall Study|Clinical disease progression|1|||
164295283|NCT04742556|593455827|FG002|Overall Study|Clinical disease progression|2|||
164295284|NCT04742556|593455825|FG000|Overall Study|Objective disease progression|3|||
164295285|NCT04742556|593455826|FG001|Overall Study|Objective disease progression|2|||
164295286|NCT04742556|593455827|FG002|Overall Study|Objective disease progression|4|||
164295287|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
164295288|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295289|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295290|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295291|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295292|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
164295293|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
164295294|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295295|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
164295296|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295297|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295298|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295299|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295300|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
164295301|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295302|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295303|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
164295304|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295305|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295306|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
164295307|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
164295308|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295309|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295310|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295311|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295312|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
164295313|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295314|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
164295315|NCT02903771|593455828|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295316|NCT02903771|593455829|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295317|NCT02903771|593455830|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295318|NCT02903771|593455831|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295319|NCT02903771|593455832|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295320|NCT02903771|593455833|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
164295321|NCT02903771|593455834|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
164295322|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295323|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295324|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295325|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295326|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
164295327|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295328|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
164295329|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295330|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295331|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295332|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295333|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
164295334|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295335|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
164295336|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295337|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295338|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295339|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295340|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
164295341|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295342|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
164295343|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295344|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295345|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295346|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295347|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
164295348|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295349|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
164295350|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295351|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295352|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295353|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295354|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
164295355|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295356|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
164295357|NCT02903771|593455828|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295358|NCT02903771|593455829|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295359|NCT02903771|593455830|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295360|NCT02903771|593455831|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295361|NCT02903771|593455832|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
164295362|NCT02903771|593455833|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295363|NCT02903771|593455834|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
164295364|NCT04247347|593455835|FG000|Overall Study|Withdrawal by Subject|2|||
164295365|NCT04247347|593455836|FG001|Overall Study|Withdrawal by Subject|3|||
164295366|NCT04247347|593455837|FG002|Overall Study|Withdrawal by Subject|3|||
164295367|NCT04247347|593455835|FG000|Overall Study|Lost to Follow-up|1|||
164295368|NCT04247347|593455836|FG001|Overall Study|Lost to Follow-up|1|||
164295369|NCT04247347|593455837|FG002|Overall Study|Lost to Follow-up|1|||
164295370|NCT03562195|593455838|FG000|Overall Study|Adverse Event|0|||
164295371|NCT03562195|593455839|FG001|Overall Study|Adverse Event|6|||
164295372|NCT03562195|593455838|FG000|Overall Study|Lack of Efficacy|0|||
164347148|NCT00833794|593646850|FG001|Open-label Phase|Physician Decision|0|||
164347149|NCT00833794|593646849|FG000|Open-label Phase|Administrative reason|1|||
164347150|NCT00833794|593646850|FG001|Open-label Phase|Administrative reason|0|||
164347151|NCT00833794|593646849|FG000|Open-label Phase|Protocol Violation|47|||
164347152|NCT00833794|593646850|FG001|Open-label Phase|Protocol Violation|0|||
164347153|NCT00833794|593646849|FG000|Open-label Phase|Did not complete wash-out period|12|||
164347154|NCT00833794|593646850|FG001|Open-label Phase|Did not complete wash-out period|0|||
164347155|NCT00833794|593646849|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
164347156|NCT00833794|593646850|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
164347157|NCT00833794|593646849|FG000|Double-blind Phase|Adverse Event|44|||
164347158|NCT00833794|593646850|FG001|Double-blind Phase|Adverse Event|11|||
164347159|NCT00833794|593646849|FG000|Double-blind Phase|Lack of Efficacy|34|||
164347160|NCT00833794|593646850|FG001|Double-blind Phase|Lack of Efficacy|22|||
164347161|NCT00833794|593646849|FG000|Double-blind Phase|Withdrawal by Subject|23|||
164347162|NCT00833794|593646850|FG001|Double-blind Phase|Withdrawal by Subject|6|||
164347163|NCT00833794|593646849|FG000|Double-blind Phase|Physician Decision|4|||
164347164|NCT00833794|593646850|FG001|Double-blind Phase|Physician Decision|7|||
164347165|NCT00833794|593646849|FG000|Double-blind Phase|Administrative reason|1|||
164347166|NCT00833794|593646850|FG001|Double-blind Phase|Administrative reason|3|||
164347167|NCT00039130|593646853|FG000|Overall Study|Adverse Event|11|||
164347168|NCT00039130|593646853|FG000|Overall Study|Death|9|||
164347169|NCT00039130|593646853|FG000|Overall Study|Withdrawal by Subject|3|||
164347170|NCT00039130|593646853|FG000|Overall Study|Progression|2|||
164347171|NCT00039130|593646853|FG000|Overall Study|Subsequent treatment|2|||
164347172|NCT00039130|593646853|FG000|Overall Study|Physician Decision|3|||
164347173|NCT01269463|593646854|FG000|First Intervention|Withdrawal by Subject|1|||
164347174|NCT01269463|593646855|FG001|First Intervention|Withdrawal by Subject|0|||
164347175|NCT01269463|593646854|FG000|First Intervention|Adverse Event|1|||
164347176|NCT01269463|593646855|FG001|First Intervention|Adverse Event|0|||
164295373|NCT03562195|593455839|FG001|Overall Study|Lack of Efficacy|5|||
164295374|NCT03562195|593455838|FG000|Overall Study|Protocol Violation|0|||
164347177|NCT01269463|593646854|FG000|First Intervention|Lack of Efficacy|0|||
164347178|NCT01269463|593646855|FG001|First Intervention|Lack of Efficacy|1|||
164347179|NCT01269463|593646854|FG000|First Intervention|Physician Decision|0|||
164295375|NCT03562195|593455839|FG001|Overall Study|Protocol Violation|1|||
164295376|NCT03562195|593455838|FG000|Overall Study|Lost to Follow-up|0|||
164295377|NCT03562195|593455839|FG001|Overall Study|Lost to Follow-up|1|||
164295378|NCT03562195|593455838|FG000|Overall Study|Physician Decision|1|||
164295379|NCT03562195|593455839|FG001|Overall Study|Physician Decision|0|||
164295380|NCT03562195|593455838|FG000|Overall Study|Withdrawal by Subject|3|||
164295381|NCT03562195|593455839|FG001|Overall Study|Withdrawal by Subject|0|||
164295382|NCT02218372|593455840|FG000|Overall Study|Adverse Event|1|||
164295383|NCT02218372|593455841|FG001|Overall Study|Adverse Event|1|||
164295384|NCT02218372|593455840|FG000|Overall Study|Miscellaneous|2|||
164295385|NCT02218372|593455841|FG001|Overall Study|Miscellaneous|1|||
164295386|NCT02218372|593455840|FG000|Overall Study|Randomized but did not receive treatment|2|||
164295387|NCT02218372|593455841|FG001|Overall Study|Randomized but did not receive treatment|3|||
164295388|NCT02218372|593455840|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164347180|NCT01269463|593646855|FG001|First Intervention|Physician Decision|1|||
164347181|NCT02612727|593646859|FG000|Overall Study|Parent request|4|||
163898418|NCT00943917|592001067|FG000|Stage I|Lost to Follow-up|0|||
164347182|NCT02612727|593646860|FG001|Overall Study|Parent request|1|||
164347183|NCT02612727|593646859|FG000|Overall Study|Needed treatment incompatible with PT|1|||
164347184|NCT02612727|593646860|FG001|Overall Study|Needed treatment incompatible with PT|1|||
164347185|NCT02612727|593646859|FG000|Overall Study|Direct hyperbilirubinemia|0|||
164347186|NCT02612727|593646860|FG001|Overall Study|Direct hyperbilirubinemia|2|||
164347187|NCT04518306|593646863|FG000|Double-Blind Period|Run in failure|0|||
164347188|NCT04518306|593646864|FG001|Double-Blind Period|Run in failure|0|||
164347189|NCT04518306|593646865|FG002|Double-Blind Period|Run in failure|1|||
164347190|NCT04518306|593646863|FG000|Double-Blind Period|Adverse Event|0|||
164347191|NCT04518306|593646864|FG001|Double-Blind Period|Adverse Event|2|||
164347192|NCT04518306|593646865|FG002|Double-Blind Period|Adverse Event|2|||
164347193|NCT04518306|593646863|FG000|Double-Blind Period|Lost to Follow-up|1|||
164347194|NCT04518306|593646864|FG001|Double-Blind Period|Lost to Follow-up|2|||
164347195|NCT04518306|593646865|FG002|Double-Blind Period|Lost to Follow-up|2|||
164347196|NCT04518306|593646863|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
164347197|NCT04518306|593646864|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
164347198|NCT04518306|593646865|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
164347199|NCT04518306|593646863|FG000|Double-Blind Period|Other|0|||
164347200|NCT04518306|593646864|FG001|Double-Blind Period|Other|2|||
164347201|NCT04518306|593646865|FG002|Double-Blind Period|Other|0|||
164347202|NCT04518306|593646863|FG000|Double-Blind Period|Missing|0|||
164347203|NCT04518306|593646864|FG001|Double-Blind Period|Missing|1|||
164347204|NCT04518306|593646865|FG002|Double-Blind Period|Missing|0|||
164347205|NCT03268954|593646866|FG000|Overall Study|Withdrawal by Subject|27|||
164347206|NCT03268954|593646867|FG001|Overall Study|Withdrawal by Subject|17|||
164347207|NCT03268954|593646866|FG000|Overall Study|Lost to Follow-up|2|||
164347208|NCT03268954|593646867|FG001|Overall Study|Lost to Follow-up|3|||
164347209|NCT03268954|593646866|FG000|Overall Study|Reason Not Specified|3|||
164347210|NCT03268954|593646867|FG001|Overall Study|Reason Not Specified|8|||
164347211|NCT05358444|593646868|FG000|Overall Study|Withdrawal by Subject|0|||
164347212|NCT05358444|593646869|FG001|Overall Study|Withdrawal by Subject|1|||
164347213|NCT05358444|593646868|FG000|Overall Study|Lost to Follow-up|0|||
164347214|NCT05358444|593646869|FG001|Overall Study|Lost to Follow-up|3|||
164347215|NCT03820986|593646873|FG000|Overall Study|Death|201|||
164347216|NCT03820986|593646874|FG001|Overall Study|Death|175|||
164347217|NCT03820986|593646873|FG000|Overall Study|Lost to Follow-up|1|||
164347218|NCT03820986|593646874|FG001|Overall Study|Lost to Follow-up|1|||
164347219|NCT03820986|593646873|FG000|Overall Study|Physician Decision|1|||
164347220|NCT03820986|593646874|FG001|Overall Study|Physician Decision|0|||
164347221|NCT03820986|593646873|FG000|Overall Study|Sponsor Decision|122|||
164347222|NCT03820986|593646874|FG001|Overall Study|Sponsor Decision|160|||
164347223|NCT03820986|593646873|FG000|Overall Study|Withdrawal by Subject|9|||
164347224|NCT03820986|593646874|FG001|Overall Study|Withdrawal by Subject|4|||
164347225|NCT01638546|593646885|FG000|Overall Study|Adverse Event|1|||
164347226|NCT01638546|593646886|FG001|Overall Study|Adverse Event|3|||
164347227|NCT02513394|593646887|FG000|Overall Study|Withdrawal by Subject|11|||
164347228|NCT02513394|593646888|FG001|Overall Study|Withdrawal by Subject|23|||
164347229|NCT02513394|593646887|FG000|Overall Study|Ineligible|1|||
164347230|NCT02513394|593646888|FG001|Overall Study|Ineligible|0|||
163898419|NCT00943917|592001068|FG001|Stage I|Lost to Follow-up|0|||
163898420|NCT00943917|592001069|FG002|Stage I|Lost to Follow-up|1|||
164347231|NCT00540514|593648717|FG000|Overall Study|Still on treatment|3|||
163898421|NCT00943917|592001070|FG003|Stage I|Lost to Follow-up|0|||
164295389|NCT02218372|593455841|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164295390|NCT02923726|593455842|FG000|Overall Study|Death|196|||
164295391|NCT02923726|593455843|FG001|Overall Study|Death|175|||
164347232|NCT00540514|593648718|FG001|Overall Study|Still on treatment|0|||
164347233|NCT00540514|593648717|FG000|Overall Study|Unacceptable Toxicity|61|||
164347234|NCT00540514|593648718|FG001|Overall Study|Unacceptable Toxicity|62|||
164347235|NCT00540514|593648717|FG000|Overall Study|Adverse Event|20|||
164347236|NCT00540514|593648718|FG001|Overall Study|Adverse Event|24|||
164295392|NCT02923726|593455842|FG000|Overall Study|Withdrawal by Subject|337|||
164295393|NCT02923726|593455843|FG001|Overall Study|Withdrawal by Subject|307|||
164295394|NCT03988400|593455848|FG000|Overall Study|Adverse Event|1|||
164295395|NCT03988400|593455849|FG001|Overall Study|Adverse Event|0|||
164295396|NCT03988400|593455848|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
164295397|NCT03988400|593455849|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
164295398|NCT03988400|593455848|FG000|Overall Study|Lost to Follow-up|0|||
164295399|NCT03988400|593455849|FG001|Overall Study|Lost to Follow-up|1|||
164295400|NCT04913610|593455850|FG000|Randomized Participants|Did Not Receive Treatment|0|||
164295401|NCT04913610|593455851|FG001|Randomized Participants|Did Not Receive Treatment|0|||
164295402|NCT04913610|593455852|FG002|Randomized Participants|Did Not Receive Treatment|1|||
164295403|NCT04913610|593455853|FG003|Randomized Participants|Did Not Receive Treatment|1|||
164295404|NCT04913610|593455854|FG004|Randomized Participants|Did Not Receive Treatment|0|||
164295405|NCT04913610|593455850|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
164295406|NCT04913610|593455851|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
164295407|NCT04913610|593455852|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
164295408|NCT04913610|593455853|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
164295409|NCT04913610|593455854|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
164295410|NCT03186209|593455855|FG000|Overall Study|Withdrawal by Subject|11|||
164295411|NCT03186209|593455856|FG001|Overall Study|Withdrawal by Subject|22|||
164295412|NCT03186209|593455855|FG000|Overall Study|Pregnancy|1|||
164295413|NCT03186209|593455856|FG001|Overall Study|Pregnancy|0|||
164295414|NCT03186209|593455855|FG000|Overall Study|Adverse Event|4|||
164295415|NCT03186209|593455856|FG001|Overall Study|Adverse Event|0|||
164295416|NCT03186209|593455855|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
164295417|NCT03186209|593455856|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
164295418|NCT03186209|593455855|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
164089417|NCT04799158|592690294|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164089418|NCT04799158|592690295|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164089419|NCT04799158|592690296|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164089420|NCT04799158|592690297|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
164089421|NCT04799158|592690298|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
164089422|NCT04799158|592690294|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
164089423|NCT04799158|592690295|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
164089424|NCT04799158|592690296|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
164295419|NCT03186209|593455856|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
164295420|NCT03186209|593455855|FG000|Overall Study|Fail to meet randomization criteria|0|||
164295421|NCT03186209|593455856|FG001|Overall Study|Fail to meet randomization criteria|1|||
164295422|NCT03186209|593455855|FG000|Overall Study|Lost to Follow-up|0|||
164295423|NCT03186209|593455856|FG001|Overall Study|Lost to Follow-up|1|||
164295424|NCT00953667|593455864|FG000|Overall Study|Lost to Follow-up|11|||
164295425|NCT00953667|593455864|FG000|Overall Study|Physician Decision|35|||
164295426|NCT00953667|593455864|FG000|Overall Study|Withdrawal by Subject|63|||
164295427|NCT00953667|593455864|FG000|Overall Study|Adverse Event|10|||
164295428|NCT00953667|593455864|FG000|Overall Study|poor venous access,unable to draw blood|4|||
164295429|NCT04038359|593455865|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
164295430|NCT04038359|593455866|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
164295431|NCT04038359|593455865|FG000|Overall Study|Death|8|||
164295432|NCT04038359|593455866|FG001|Overall Study|Death|7|||
164295433|NCT04038359|593455865|FG000|Overall Study|Lost to Follow-up|3|||
164295434|NCT04038359|593455866|FG001|Overall Study|Lost to Follow-up|0|||
164295435|NCT04038359|593455865|FG000|Overall Study|Participant Moved|1|||
164295436|NCT04038359|593455866|FG001|Overall Study|Participant Moved|0|||
164295437|NCT04038359|593455865|FG000|Overall Study|Withdrawal by Subject|4|||
164295438|NCT04038359|593455866|FG001|Overall Study|Withdrawal by Subject|3|||
164295439|NCT04038359|593455865|FG000|Overall Study|Physician Decision|3|||
164295440|NCT04038359|593455866|FG001|Overall Study|Physician Decision|2|||
164295441|NCT04038359|593455865|FG000|Overall Study|Adverse Event|0|||
164295442|NCT04038359|593455866|FG001|Overall Study|Adverse Event|2|||
164347237|NCT00540514|593648717|FG000|Overall Study|Physician Decision|86|||
164347238|NCT00540514|593648718|FG001|Overall Study|Physician Decision|99|||
164347239|NCT00540514|593648717|FG000|Overall Study|Protocol Deviation|3|||
164347240|NCT00540514|593648718|FG001|Overall Study|Protocol Deviation|4|||
164089425|NCT04799158|592690297|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
164347241|NCT00540514|593648717|FG000|Overall Study|Lost to Follow-up|1|||
164347242|NCT00540514|593648718|FG001|Overall Study|Lost to Follow-up|1|||
164347243|NCT00540514|593648717|FG000|Overall Study|Withdrawal by Subject|65|||
164295443|NCT04038359|593455865|FG000|Overall Study|Progressive Disease|0|||
164295444|NCT04038359|593455866|FG001|Overall Study|Progressive Disease|1|||
164295445|NCT00475670|593455867|FG000|Overall Study|Death|0|||
164295446|NCT00475670|593455868|FG001|Overall Study|Death|1|||
164347244|NCT00540514|593648718|FG001|Overall Study|Withdrawal by Subject|67|||
164347245|NCT00540514|593648717|FG000|Overall Study|Excluded prior to treatment|7|||
164347246|NCT00540514|593648718|FG001|Overall Study|Excluded prior to treatment|7|||
164295447|NCT00475670|593455867|FG000|Overall Study|Lack of Efficacy|3|||
164295448|NCT00475670|593455868|FG001|Overall Study|Lack of Efficacy|34|||
164295449|NCT00475670|593455867|FG000|Overall Study|Refused treatment|0|||
164295450|NCT00475670|593455868|FG001|Overall Study|Refused treatment|2|||
164295451|NCT00475670|593455867|FG000|Overall Study|Failure to Return|0|||
164295452|NCT00475670|593455868|FG001|Overall Study|Failure to Return|1|||
164295453|NCT00475670|593455867|FG000|Overall Study|Other|0|||
164295454|NCT00475670|593455868|FG001|Overall Study|Other|3|||
164295455|NCT02004236|593455871|FG000|Overall Study|Lack of Efficacy|0|||
164295456|NCT02004236|593455872|FG001|Overall Study|Lack of Efficacy|0|||
164295457|NCT02004236|593455873|FG002|Overall Study|Lack of Efficacy|16|||
164295458|NCT00551759|593455875|FG000|Overall Study|Adverse Event|7|||
164295459|NCT00551759|593455875|FG000|Overall Study|Death|5|||
164295460|NCT00551759|593455875|FG000|Overall Study|Ineligible|1|||
164295461|NCT00918385|593455876|FG000|Monotherapy|Adverse Event|1|||
164295462|NCT00918385|593455877|FG001|Monotherapy|Adverse Event|6|||
164295463|NCT00918385|593455876|FG000|Monotherapy|Complicating illness|1|||
164295464|NCT00918385|593455877|FG001|Monotherapy|Complicating illness|0|||
164295465|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
164295466|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
164295467|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
164295468|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
164295469|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
164295470|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
164295471|NCT00918385|593455876|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
164295472|NCT00918385|593455877|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
164295473|NCT00322881|593455880|FG000|Overall Study|Death|2|||
164295474|NCT00322881|593455880|FG000|Overall Study|Adverse Event|1|||
164295475|NCT00322881|593455880|FG000|Overall Study|Disease Progression|2|||
164295476|NCT01476722|593455881|FG000|Overall Study|Adverse Event|1|||
164295477|NCT00918281|593455889|FG000|Overall Study|Physician Decision|29|||
164295478|NCT02978417|593455890|FG000|Overall Study|Lost to Follow-up|2|||
164295479|NCT02978417|593455891|FG001|Overall Study|Lost to Follow-up|2|||
164295480|NCT01323582|593455892|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
164295481|NCT01323582|593455893|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
164295482|NCT01323582|593455892|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
164295483|NCT01323582|593455893|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
164295484|NCT01323582|593455892|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
164295485|NCT01323582|593455893|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
164295486|NCT03557970|593455898|FG000|Overall Study|Study closure|1|||
164295487|NCT03557970|593455899|FG001|Overall Study|Study closure|0|||
164295488|NCT03557970|593455898|FG000|Overall Study|Physician Decision|0|||
164295489|NCT03557970|593455899|FG001|Overall Study|Physician Decision|1|||
164295490|NCT03557970|593455898|FG000|Overall Study|Death|0|||
164295491|NCT03557970|593455899|FG001|Overall Study|Death|1|||
164295492|NCT00112736|593455900|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
164295493|NCT00112736|593455901|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
164295494|NCT00525512|593455912|FG000|Double-Blind Phase|Adverse Event|48|||
164295495|NCT00525512|593455913|FG001|Double-Blind Phase|Adverse Event|28|||
164295496|NCT00525512|593455914|FG002|Double-Blind Phase|Adverse Event|0|||
164295497|NCT00525512|593455915|FG003|Double-Blind Phase|Adverse Event|0|||
164295498|NCT00525512|593455912|FG000|Double-Blind Phase|Protocol Violation|3|||
164295499|NCT00525512|593455913|FG001|Double-Blind Phase|Protocol Violation|1|||
164295500|NCT00525512|593455914|FG002|Double-Blind Phase|Protocol Violation|0|||
164295501|NCT00525512|593455915|FG003|Double-Blind Phase|Protocol Violation|0|||
164295502|NCT00525512|593455912|FG000|Double-Blind Phase|Lost to Follow-up|3|||
164295503|NCT00525512|593455913|FG001|Double-Blind Phase|Lost to Follow-up|7|||
164295504|NCT00525512|593455914|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164295505|NCT00525512|593455915|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164295506|NCT00525512|593455912|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
163898422|NCT00943917|592001071|FG004|Stage I|Lost to Follow-up|0|||
163898423|NCT00943917|592001072|FG005|Stage I|Lost to Follow-up|0|||
163898424|NCT00943917|592001073|FG006|Stage I|Lost to Follow-up|0|||
163898425|NCT00943917|592001074|FG007|Stage I|Lost to Follow-up|0|||
163898426|NCT00943917|592001075|FG008|Stage I|Lost to Follow-up|0|||
163898427|NCT00943917|592001076|FG009|Stage I|Lost to Follow-up|0|||
164295507|NCT00525512|593455913|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
164295508|NCT00525512|593455914|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164295509|NCT00525512|593455915|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164295510|NCT00525512|593455912|FG000|Double-Blind Phase|Lack of Efficacy|13|||
164295511|NCT00525512|593455913|FG001|Double-Blind Phase|Lack of Efficacy|5|||
164295512|NCT00525512|593455914|FG002|Double-Blind Phase|Lack of Efficacy|0|||
164295513|NCT00525512|593455915|FG003|Double-Blind Phase|Lack of Efficacy|0|||
163898428|NCT00943917|592001077|FG010|Stage I|Lost to Follow-up|0|||
163898429|NCT00943917|592001078|FG011|Stage I|Lost to Follow-up|0|||
164295514|NCT00525512|593455912|FG000|Double-Blind Phase|Other reason (not specified)|12|||
164295515|NCT00525512|593455913|FG001|Double-Blind Phase|Other reason (not specified)|13|||
164295516|NCT00525512|593455914|FG002|Double-Blind Phase|Other reason (not specified)|0|||
164295517|NCT00525512|593455915|FG003|Double-Blind Phase|Other reason (not specified)|0|||
164295518|NCT00525512|593455912|FG000|Open-Label Phase|Adverse Event|0|||
164295519|NCT00525512|593455913|FG001|Open-Label Phase|Adverse Event|0|||
164295520|NCT00525512|593455914|FG002|Open-Label Phase|Adverse Event|1|||
164295521|NCT00525512|593455915|FG003|Open-Label Phase|Adverse Event|0|||
164295522|NCT00525512|593455912|FG000|Open-Label Phase|Lost to Follow-up|0|||
164295523|NCT00525512|593455913|FG001|Open-Label Phase|Lost to Follow-up|0|||
164295524|NCT00525512|593455914|FG002|Open-Label Phase|Lost to Follow-up|1|||
164295525|NCT00525512|593455915|FG003|Open-Label Phase|Lost to Follow-up|0|||
164295526|NCT00525512|593455912|FG000|Open-Label Phase|Other reason (not specified)|0|||
164295527|NCT00525512|593455913|FG001|Open-Label Phase|Other reason (not specified)|0|||
164295528|NCT00525512|593455914|FG002|Open-Label Phase|Other reason (not specified)|4|||
164295529|NCT00525512|593455915|FG003|Open-Label Phase|Other reason (not specified)|5|||
164295530|NCT01601535|593455916|FG000|Phase 1|Adverse Event|1|||
164295531|NCT01601535|593455917|FG001|Phase 1|Adverse Event|0|||
164295532|NCT01601535|593455918|FG002|Phase 1|Adverse Event|2|||
164295533|NCT01601535|593455919|FG003|Phase 1|Adverse Event|1|||
164295534|NCT01601535|593455920|FG004|Phase 1|Adverse Event|0|||
164295535|NCT01601535|593455921|FG005|Phase 1|Adverse Event|0|||
164295536|NCT01601535|593455916|FG000|Phase 1|Withdrawal by Subject|2|||
164295537|NCT01601535|593455917|FG001|Phase 1|Withdrawal by Subject|1|||
164295538|NCT01601535|593455918|FG002|Phase 1|Withdrawal by Subject|1|||
164295539|NCT01601535|593455919|FG003|Phase 1|Withdrawal by Subject|2|||
164295540|NCT01601535|593455920|FG004|Phase 1|Withdrawal by Subject|0|||
164295541|NCT01601535|593455921|FG005|Phase 1|Withdrawal by Subject|0|||
164295542|NCT01601535|593455916|FG000|Phase 1|Progressive Disease|2|||
164295543|NCT01601535|593455917|FG001|Phase 1|Progressive Disease|3|||
164295544|NCT01601535|593455918|FG002|Phase 1|Progressive Disease|2|||
164295545|NCT01601535|593455919|FG003|Phase 1|Progressive Disease|1|||
164295546|NCT01601535|593455920|FG004|Phase 1|Progressive Disease|0|||
164295547|NCT01601535|593455921|FG005|Phase 1|Progressive Disease|0|||
164295548|NCT01601535|593455916|FG000|Phase 1|Started Another Treatment|1|||
164295549|NCT01601535|593455917|FG001|Phase 1|Started Another Treatment|2|||
164295550|NCT01601535|593455918|FG002|Phase 1|Started Another Treatment|0|||
164295551|NCT01601535|593455919|FG003|Phase 1|Started Another Treatment|0|||
164295552|NCT01601535|593455920|FG004|Phase 1|Started Another Treatment|0|||
164295553|NCT01601535|593455921|FG005|Phase 1|Started Another Treatment|0|||
164295554|NCT01601535|593455916|FG000|Phase 2|Adverse Event|0|||
164295555|NCT01601535|593455917|FG001|Phase 2|Adverse Event|0|||
164295556|NCT01601535|593455918|FG002|Phase 2|Adverse Event|0|||
164295557|NCT01601535|593455919|FG003|Phase 2|Adverse Event|0|||
164295558|NCT01601535|593455920|FG004|Phase 2|Adverse Event|5|||
164295559|NCT01601535|593455921|FG005|Phase 2|Adverse Event|1|||
164295560|NCT01601535|593455916|FG000|Phase 2|Withdrawal by Subject|0|||
164295561|NCT01601535|593455917|FG001|Phase 2|Withdrawal by Subject|0|||
164295562|NCT01601535|593455918|FG002|Phase 2|Withdrawal by Subject|0|||
164295563|NCT01601535|593455919|FG003|Phase 2|Withdrawal by Subject|0|||
164295564|NCT01601535|593455920|FG004|Phase 2|Withdrawal by Subject|8|||
164295565|NCT01601535|593455921|FG005|Phase 2|Withdrawal by Subject|2|||
164295566|NCT01601535|593455916|FG000|Phase 2|Progressive Disease|0|||
164295567|NCT01601535|593455917|FG001|Phase 2|Progressive Disease|0|||
164295568|NCT01601535|593455918|FG002|Phase 2|Progressive Disease|0|||
164005200|NCT01887210|592384216|FG001|Overall Study|Withdrawal by Subject|3|||
164005201|NCT01887210|592384215|FG000|Overall Study|Lost to Follow-up|0|||
164005202|NCT01887210|592384216|FG001|Overall Study|Lost to Follow-up|1|||
164005203|NCT00840463|592384217|FG000|Overall Study|Adverse Event|1|||
164005204|NCT00840463|592384218|FG001|Overall Study|Adverse Event|0|||
164005205|NCT02515669|592384228|FG000|228 Week Open-Label Phase|Other|0|||
164005206|NCT02515669|592384229|FG001|228 Week Open-Label Phase|Other|0|||
164005207|NCT02515669|592384230|FG002|228 Week Open-Label Phase|Other|1|||
164295569|NCT01601535|593455919|FG003|Phase 2|Progressive Disease|0|||
164295570|NCT01601535|593455920|FG004|Phase 2|Progressive Disease|5|||
164295571|NCT01601535|593455921|FG005|Phase 2|Progressive Disease|7|||
164295572|NCT01601535|593455916|FG000|Phase 2|Started Another Treatment|0|||
164295573|NCT01601535|593455917|FG001|Phase 2|Started Another Treatment|0|||
164295574|NCT01601535|593455918|FG002|Phase 2|Started Another Treatment|0|||
164295575|NCT01601535|593455919|FG003|Phase 2|Started Another Treatment|0|||
164295576|NCT01601535|593455920|FG004|Phase 2|Started Another Treatment|1|||
164347247|NCT00540514|593648717|FG000|Overall Study|Paclitaxel not available|0|||
164005208|NCT02515669|592384231|FG003|228 Week Open-Label Phase|Other|4|||
164005209|NCT02515669|592384228|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
164005210|NCT02515669|592384229|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
164005211|NCT02515669|592384230|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
164132701|NCT01986010|592850663|FG008|Overall Study|Physician Decision|0|||
164295577|NCT01601535|593455921|FG005|Phase 2|Started Another Treatment|2|||
164295578|NCT03600909|593455924|FG000|Overall Study|Not treated|0|||
164295579|NCT03600909|593455925|FG001|Overall Study|Not treated|3|||
164295580|NCT03600909|593455926|FG002|Overall Study|Not treated|0|||
164295581|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
164295582|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
164295583|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
164295584|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
164295585|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
164295586|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
164295587|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
164295588|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
164295589|NCT04576988|593455927|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
164295590|NCT04576988|593455928|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
164295591|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
164295592|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
164295593|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
164295594|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
164295595|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
164295596|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
164295597|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Death|2|||
164295598|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Death|1|||
164295599|NCT04576988|593455927|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
164295600|NCT04576988|593455928|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
164295601|NCT02919761|593455939|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
164295602|NCT02919761|593455940|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
164295603|NCT02919761|593455941|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
164295604|NCT02919761|593455939|FG000|Part 1: Open Label|Adverse Event|1|||
164295605|NCT02919761|593455940|FG001|Part 1: Open Label|Adverse Event|0|||
164295606|NCT02919761|593455941|FG002|Part 1: Open Label|Adverse Event|0|||
164295607|NCT02919761|593455939|FG000|Part 1: Open Label|Lost to Follow-up|1|||
164295608|NCT02919761|593455940|FG001|Part 1: Open Label|Lost to Follow-up|0|||
164295609|NCT02919761|593455941|FG002|Part 1: Open Label|Lost to Follow-up|0|||
164295610|NCT02919761|593455939|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
164295611|NCT02919761|593455940|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
164295612|NCT02919761|593455941|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
164295613|NCT02919761|593455939|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
164295614|NCT02919761|593455940|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
164295615|NCT02919761|593455941|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
164295616|NCT02919761|593455939|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
164295617|NCT02919761|593455940|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
164295618|NCT02919761|593455941|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
164295619|NCT02919761|593455939|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
164295620|NCT02919761|593455940|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
164295621|NCT02919761|593455941|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
164295622|NCT02919761|593455939|FG000|Part 1: Open Label|Termination by Sponsor|1|||
164347248|NCT00540514|593648718|FG001|Overall Study|Paclitaxel not available|2|||
164347249|NCT01892293|593648725|FG000|Overall Study|Apheresed but not treated|4|||
164347250|NCT03602482|593648730|FG000|Overall Study|Withdrawal by Subject|6|||
164347251|NCT03602482|593648731|FG001|Overall Study|Withdrawal by Subject|7|||
164347252|NCT03602482|593648732|FG002|Overall Study|Withdrawal by Subject|0|||
164347253|NCT03602482|593648733|FG003|Overall Study|Withdrawal by Subject|0|||
164347254|NCT00618072|593648753|FG000|Overall Study|Lost to Follow-up|2|||
164347255|NCT00618072|593648754|FG001|Overall Study|Lost to Follow-up|0|||
164347256|NCT00618072|593648755|FG002|Overall Study|Lost to Follow-up|3|||
164347257|NCT00618072|593648753|FG000|Overall Study|Physician Decision|0|||
164347258|NCT00618072|593648754|FG001|Overall Study|Physician Decision|1|||
164347259|NCT00618072|593648755|FG002|Overall Study|Physician Decision|1|||
164347260|NCT00684307|593648756|FG000|Overall Study|Adverse Event|11|||
164347261|NCT00684307|593648757|FG001|Overall Study|Adverse Event|6|||
164347262|NCT00684307|593648758|FG002|Overall Study|Adverse Event|15|||
164347263|NCT00684307|593648759|FG003|Overall Study|Adverse Event|16|||
164347264|NCT00684307|593648760|FG004|Overall Study|Adverse Event|8|||
163898430|NCT00943917|592001079|FG012|Stage I|Lost to Follow-up|0|||
164295623|NCT02919761|593455940|FG001|Part 1: Open Label|Termination by Sponsor|0|||
164295624|NCT02919761|593455941|FG002|Part 1: Open Label|Termination by Sponsor|0|||
164347265|NCT00684307|593648756|FG000|Overall Study|Development of increasing Liver Function|0|||
164347266|NCT00684307|593648757|FG001|Overall Study|Development of increasing Liver Function|2|||
163898431|NCT00943917|592001080|FG013|Stage I|Lost to Follow-up|0|||
164089426|NCT04799158|592690298|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
164295625|NCT02919761|593455939|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
164347267|NCT00684307|593648758|FG002|Overall Study|Development of increasing Liver Function|0|||
164347268|NCT00684307|593648759|FG003|Overall Study|Development of increasing Liver Function|1|||
163898432|NCT00943917|592001081|FG014|Stage I|Lost to Follow-up|0|||
163898433|NCT00943917|592001067|FG000|Stage I|hyperglycemia|0|||
164295626|NCT02919761|593455940|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
164295627|NCT02919761|593455941|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
164295628|NCT02919761|593455939|FG000|Part 2: Double-blind|Adverse Event|0|||
164295629|NCT02919761|593455940|FG001|Part 2: Double-blind|Adverse Event|1|||
164295630|NCT02919761|593455941|FG002|Part 2: Double-blind|Adverse Event|0|||
164295631|NCT02919761|593455939|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
164295632|NCT02919761|593455940|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
164295633|NCT02919761|593455941|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
164347269|NCT00684307|593648760|FG004|Overall Study|Development of increasing Liver Function|0|||
164347270|NCT00684307|593648756|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
164347271|NCT00684307|593648757|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
164347272|NCT00684307|593648758|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
164347273|NCT00684307|593648759|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
164347274|NCT00684307|593648760|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
164347275|NCT00684307|593648756|FG000|Overall Study|Incorrect enrolment or randomization|4|||
164005212|NCT02515669|592384231|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
164005213|NCT02515669|592384228|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
164005214|NCT02515669|592384229|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
164005215|NCT02515669|592384230|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
164005216|NCT02515669|592384231|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
164005217|NCT02515669|592384228|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
164005218|NCT02515669|592384229|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
164005219|NCT02515669|592384230|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
164005220|NCT02515669|592384231|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
164005221|NCT02515669|592384228|FG000|228 Week Open-Label Phase|Missing|0|||
164005222|NCT02515669|592384229|FG001|228 Week Open-Label Phase|Missing|2|||
164005223|NCT02515669|592384230|FG002|228 Week Open-Label Phase|Missing|2|||
164005224|NCT02515669|592384231|FG003|228 Week Open-Label Phase|Missing|2|||
164005225|NCT01444391|592384234|FG000|Overall Study|Death|1|||
164005226|NCT03191786|592384238|FG000|Overall Study|Death|236|||
164005227|NCT03191786|592384239|FG001|Overall Study|Death|127|||
164005228|NCT03191786|592384238|FG000|Overall Study|Lost to Follow-up|9|||
164005229|NCT03191786|592384239|FG001|Overall Study|Lost to Follow-up|3|||
164005230|NCT03191786|592384238|FG000|Overall Study|Physician Decision|1|||
164005231|NCT03191786|592384239|FG001|Overall Study|Physician Decision|0|||
164005232|NCT03191786|592384238|FG000|Overall Study|Moved to Post Trial Access Program|30|||
164005233|NCT03191786|592384239|FG001|Overall Study|Moved to Post Trial Access Program|5|||
164005234|NCT03191786|592384238|FG000|Overall Study|Withdrawal by Subject|26|||
164005235|NCT03191786|592384239|FG001|Overall Study|Withdrawal by Subject|16|||
164005236|NCT05847881|592384240|FG000|Overall Study|Principal Investigator Decision|8|||
164005237|NCT05847881|592384240|FG000|Overall Study|Withdrawal by Subject|2|||
164005238|NCT03439345|592385701|FG000|Overall Study|Lost to Follow-up|0|||
164005239|NCT03439345|592385702|FG001|Overall Study|Lost to Follow-up|1|||
164005240|NCT03439345|592385701|FG000|Overall Study|Consent withdrawn|0|||
164005241|NCT03439345|592385702|FG001|Overall Study|Consent withdrawn|1|||
164005242|NCT05781542|592385703|FG000|Overall Study|Lost to Follow-up|1|||
164005243|NCT05781542|592385704|FG001|Overall Study|Lost to Follow-up|0|||
164005244|NCT05781542|592385705|FG002|Overall Study|Lost to Follow-up|1|||
164005245|NCT05405166|592385708|FG000|Overall Study|Death|49|||
164005246|NCT05405166|592385709|FG001|Overall Study|Death|50|||
164005247|NCT05405166|592385708|FG000|Overall Study|Withdrawal by Subject|10|||
164005248|NCT05405166|592385709|FG001|Overall Study|Withdrawal by Subject|3|||
164005249|NCT05405166|592385708|FG000|Overall Study|Ongoing at the time of PCD|209|||
164005250|NCT05405166|592385709|FG001|Overall Study|Ongoing at the time of PCD|210|||
164005251|NCT01386385|592385712|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
164005252|NCT01386385|592385713|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164005253|NCT01386385|592385714|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164005254|NCT01386385|592385715|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164005255|NCT01386385|592385716|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164295634|NCT02919761|593455939|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
164295635|NCT02919761|593455940|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
164295636|NCT02919761|593455941|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
164295637|NCT02919761|593455939|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
164005256|NCT01386385|592385717|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164005257|NCT01386385|592385718|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164005258|NCT01386385|592385719|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
164005259|NCT01386385|592385712|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
164005260|NCT01386385|592385713|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164005261|NCT01386385|592385714|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164295638|NCT02919761|593455940|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
164295639|NCT02919761|593455941|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
164295640|NCT02919761|593455939|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
164295641|NCT02919761|593455940|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
164295642|NCT02919761|593455941|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
164295643|NCT02919761|593455939|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
164295644|NCT02919761|593455940|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
164295645|NCT02919761|593455941|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
164295646|NCT02919761|593455939|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
164295647|NCT02919761|593455940|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
164295648|NCT02919761|593455941|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
164295649|NCT03724942|593455942|FG000|Overall Study|Adverse Event|20|||
164295650|NCT03724942|593455943|FG001|Overall Study|Adverse Event|14|||
164295651|NCT03724942|593455942|FG000|Overall Study|Lack of Efficacy|0|||
164295652|NCT03724942|593455943|FG001|Overall Study|Lack of Efficacy|1|||
164295653|NCT03724942|593455942|FG000|Overall Study|Physician Decision|5|||
164295654|NCT03724942|593455943|FG001|Overall Study|Physician Decision|2|||
164295655|NCT03724942|593455942|FG000|Overall Study|Protocol Violation|1|||
164295656|NCT03724942|593455943|FG001|Overall Study|Protocol Violation|0|||
164295657|NCT03724942|593455942|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
164295658|NCT03724942|593455943|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
164295659|NCT03724942|593455942|FG000|Overall Study|Withdrawal by Legal Representative|3|||
164295660|NCT03724942|593455943|FG001|Overall Study|Withdrawal by Legal Representative|0|||
164295661|NCT00410956|593455944|FG000|Overall Study|Adverse Event|1|||
164295662|NCT00410956|593455944|FG000|Overall Study|Death|2|||
164295663|NCT00410956|593455944|FG000|Overall Study|Lack of Efficacy|10|||
164295664|NCT00410956|593455944|FG000|Overall Study|Physician Decision|6|||
164295665|NCT00880698|593455945|FG000|Overall Study|Death|0|||
164295666|NCT00880698|593455946|FG001|Overall Study|Death|0|||
164295667|NCT00880698|593455947|FG002|Overall Study|Death|1|||
164295668|NCT00880698|593455948|FG003|Overall Study|Death|2|||
164295669|NCT00880698|593455945|FG000|Overall Study|Lost to Follow-up|1|||
164295670|NCT00880698|593455946|FG001|Overall Study|Lost to Follow-up|3|||
164295671|NCT00880698|593455947|FG002|Overall Study|Lost to Follow-up|0|||
164295672|NCT00880698|593455948|FG003|Overall Study|Lost to Follow-up|1|||
164295673|NCT01295814|593458041|FG000|Overall Study|Lack of Efficacy|0|||
164295674|NCT01295814|593458042|FG001|Overall Study|Lack of Efficacy|2|||
164295675|NCT01295814|593458041|FG000|Overall Study|Withdrawal by Subject|2|||
164295676|NCT01295814|593458042|FG001|Overall Study|Withdrawal by Subject|0|||
164295677|NCT03414983|593458043|FG000|Pre-Treatment|Other reasons|1|||
164295678|NCT03414983|593458044|FG001|Pre-Treatment|Other reasons|0|||
164295679|NCT03414983|593458043|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164295680|NCT03414983|593458044|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
164295681|NCT03414983|593458043|FG000|Pre-Treatment|Participant withdrew consent|1|||
164295682|NCT03414983|593458044|FG001|Pre-Treatment|Participant withdrew consent|3|||
164295683|NCT03414983|593458043|FG000|Treatment|Participant withdrew consent|4|||
164295684|NCT03414983|593458044|FG001|Treatment|Participant withdrew consent|3|||
164295685|NCT03414983|593458043|FG000|Treatment|Participant request to discontinue study treatment|8|||
164295686|NCT03414983|593458044|FG001|Treatment|Participant request to discontinue study treatment|10|||
164295687|NCT03414983|593458043|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
164295688|NCT03414983|593458044|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
164005262|NCT01386385|592385715|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164295689|NCT03414983|593458043|FG000|Treatment|Death|0|||
164295690|NCT03414983|593458044|FG001|Treatment|Death|1|||
164295691|NCT03414983|593458043|FG000|Treatment|Study Drug Toxicity|10|||
164295692|NCT03414983|593458044|FG001|Treatment|Study Drug Toxicity|5|||
164295693|NCT03414983|593458043|FG000|Treatment|Disease Progression|75|||
164295694|NCT03414983|593458044|FG001|Treatment|Disease Progression|29|||
164295695|NCT03414983|593458043|FG000|Treatment|Not reported|1|||
164295696|NCT03414983|593458044|FG001|Treatment|Not reported|0|||
164295697|NCT03414983|593458043|FG000|Treatment|Other reasons|3|||
164295698|NCT03414983|593458044|FG001|Treatment|Other reasons|2|||
164295699|NCT03414983|593458043|FG000|Treatment|Poor/non-compliance|2|||
164295700|NCT03414983|593458044|FG001|Treatment|Poor/non-compliance|0|||
164295701|NCT03414983|593458043|FG000|Treatment|Maximum clinical benefit|5|||
164005263|NCT01386385|592385716|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164295702|NCT03414983|593458044|FG001|Treatment|Maximum clinical benefit|9|||
164295703|NCT03414983|593458043|FG000|Treatment|Lost to Follow-up|0|||
164295704|NCT03414983|593458044|FG001|Treatment|Lost to Follow-up|1|||
164295705|NCT03414983|593458043|FG000|Treatment|Administrative reasons by sponsor|1|||
164295706|NCT03414983|593458044|FG001|Treatment|Administrative reasons by sponsor|0|||
164295707|NCT00948246|593458045|FG000|Overall Study|Lost to Follow-up|11|||
164295708|NCT00948246|593458045|FG000|Overall Study|Adverse Event|11|||
164295709|NCT00948246|593458045|FG000|Overall Study|Death|1|||
164295710|NCT00948246|593458045|FG000|Overall Study|Withdrawal by Subject|1|||
164295711|NCT00148317|593458046|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
164295712|NCT00148317|593458046|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
164295713|NCT00148317|593458046|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
164295714|NCT02326155|593458047|FG000|Overall Study|Adverse Event|21|||
164295715|NCT02326155|593458048|FG001|Overall Study|Adverse Event|5|||
164295716|NCT02326155|593458047|FG000|Overall Study|Death|3|||
164295717|NCT02326155|593458048|FG001|Overall Study|Death|0|||
164295718|NCT02326155|593458047|FG000|Overall Study|Lack of Efficacy|49|||
164295719|NCT02326155|593458048|FG001|Overall Study|Lack of Efficacy|5|||
164295720|NCT02326155|593458047|FG000|Overall Study|Lost to Follow-up|14|||
164295721|NCT02326155|593458048|FG001|Overall Study|Lost to Follow-up|3|||
164295722|NCT02326155|593458047|FG000|Overall Study|Protocol Violation|2|||
164295723|NCT02326155|593458048|FG001|Overall Study|Protocol Violation|0|||
164295724|NCT02326155|593458047|FG000|Overall Study|Withdrawal by Subject|34|||
164295725|NCT02326155|593458048|FG001|Overall Study|Withdrawal by Subject|11|||
164295726|NCT02326155|593458047|FG000|Overall Study|Disease progression|37|||
164295727|NCT02326155|593458048|FG001|Overall Study|Disease progression|4|||
164295728|NCT02326155|593458047|FG000|Overall Study|Study close|188|||
164347276|NCT00684307|593648757|FG001|Overall Study|Incorrect enrolment or randomization|0|||
164347277|NCT00684307|593648758|FG002|Overall Study|Incorrect enrolment or randomization|0|||
164347278|NCT00684307|593648759|FG003|Overall Study|Incorrect enrolment or randomization|0|||
164347279|NCT00684307|593648760|FG004|Overall Study|Incorrect enrolment or randomization|0|||
164347280|NCT00684307|593648756|FG000|Overall Study|Interupted IP for more than 7 days|0|||
164347281|NCT00684307|593648757|FG001|Overall Study|Interupted IP for more than 7 days|4|||
164347282|NCT00684307|593648758|FG002|Overall Study|Interupted IP for more than 7 days|1|||
164347283|NCT00684307|593648759|FG003|Overall Study|Interupted IP for more than 7 days|3|||
164347284|NCT00684307|593648760|FG004|Overall Study|Interupted IP for more than 7 days|3|||
164347285|NCT00684307|593648756|FG000|Overall Study|Severe non compliance to protocol|1|||
164347286|NCT00684307|593648757|FG001|Overall Study|Severe non compliance to protocol|0|||
164347287|NCT00684307|593648758|FG002|Overall Study|Severe non compliance to protocol|0|||
164347288|NCT00684307|593648759|FG003|Overall Study|Severe non compliance to protocol|1|||
164347289|NCT00684307|593648760|FG004|Overall Study|Severe non compliance to protocol|2|||
164347290|NCT00684307|593648756|FG000|Overall Study|Participant not willing to continue|7|||
164347291|NCT00684307|593648757|FG001|Overall Study|Participant not willing to continue|10|||
164347292|NCT00684307|593648758|FG002|Overall Study|Participant not willing to continue|11|||
164347293|NCT00684307|593648759|FG003|Overall Study|Participant not willing to continue|5|||
164347294|NCT00684307|593648760|FG004|Overall Study|Participant not willing to continue|8|||
164347295|NCT00684307|593648756|FG000|Overall Study|Criteria from the CSR|0|||
164347296|NCT00684307|593648757|FG001|Overall Study|Criteria from the CSR|0|||
164347297|NCT00684307|593648758|FG002|Overall Study|Criteria from the CSR|1|||
164347298|NCT00684307|593648759|FG003|Overall Study|Criteria from the CSR|3|||
164347299|NCT00684307|593648760|FG004|Overall Study|Criteria from the CSR|3|||
164347300|NCT02170298|593648761|FG000|Overall Study|Withdrawal by Subject|0|||
164347301|NCT02170298|593648762|FG001|Overall Study|Withdrawal by Subject|1|||
164347302|NCT02170298|593648761|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
164347303|NCT02170298|593648762|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
164347304|NCT05048784|593648763|FG000|Period 1|Adverse Event|3|||
164347305|NCT05048784|593648764|FG001|Period 1|Adverse Event|1|||
164347306|NCT05048784|593648765|FG002|Period 1|Adverse Event|0|||
164347307|NCT05048784|593648766|FG003|Period 1|Adverse Event|0|||
164347308|NCT05048784|593648763|FG000|Period 2|Lost to Follow-up|0|||
164347309|NCT05048784|593648764|FG001|Period 2|Lost to Follow-up|1|||
164347310|NCT05048784|593648765|FG002|Period 2|Lost to Follow-up|0|||
164347311|NCT05048784|593648766|FG003|Period 2|Lost to Follow-up|0|||
164347312|NCT02853604|593648769|FG000|Overall Study|Withdrawal by Subject|12|||
164347313|NCT02853604|593648770|FG001|Overall Study|Withdrawal by Subject|35|||
164347314|NCT02853604|593648769|FG000|Overall Study|Lost to Follow-up|4|||
164347315|NCT02853604|593648770|FG001|Overall Study|Lost to Follow-up|8|||
164347316|NCT02853604|593648769|FG000|Overall Study|Death|1|||
164347317|NCT02853604|593648770|FG001|Overall Study|Death|5|||
164347318|NCT02853604|593648769|FG000|Overall Study|Miscellaneous|11|||
164347319|NCT02853604|593648770|FG001|Overall Study|Miscellaneous|2|||
164347320|NCT02853604|593648769|FG000|Overall Study|Progressive Disease|0|||
164347321|NCT02853604|593648770|FG001|Overall Study|Progressive Disease|2|||
164347322|NCT00727025|593648771|FG000|Overall Study|Physician Decision|23|||
164347323|NCT02269241|593648772|FG000|Overall Study|Lost to Follow-up|269|||
164347324|NCT02269241|593648772|FG000|Overall Study|Withdrawal by Subject|155|||
164347325|NCT02269241|593648772|FG000|Overall Study|Protocol Violation|1|||
164347326|NCT02269241|593648772|FG000|Overall Study|Physician Decision|7|||
164347327|NCT02269241|593648772|FG000|Overall Study|Pregnancy|15|||
164295729|NCT02326155|593458048|FG001|Overall Study|Study close|21|||
164295730|NCT02326155|593458047|FG000|Overall Study|except for study close|46|||
164295731|NCT02326155|593458048|FG001|Overall Study|except for study close|13|||
164295732|NCT04199351|593458049|FG000|Overall Study|Decision by sponsor|0|||
164295733|NCT04199351|593458050|FG001|Overall Study|Decision by sponsor|0|||
164295734|NCT04199351|593458051|FG002|Overall Study|Decision by sponsor|0|||
164295735|NCT04199351|593458052|FG003|Overall Study|Decision by sponsor|2|||
164295736|NCT04199351|593458053|FG004|Overall Study|Decision by sponsor|0|||
164295737|NCT04199351|593458054|FG005|Overall Study|Decision by sponsor|0|||
164295738|NCT04199351|593458055|FG006|Overall Study|Decision by sponsor|0|||
164295739|NCT04199351|593458056|FG007|Overall Study|Decision by sponsor|0|||
164295740|NCT04199351|593458057|FG008|Overall Study|Decision by sponsor|0|||
164295741|NCT04199351|593458058|FG009|Overall Study|Decision by sponsor|6|||
164295742|NCT04199351|593458049|FG000|Overall Study|Lost to Follow-up|0|||
164295743|NCT04199351|593458050|FG001|Overall Study|Lost to Follow-up|0|||
164295744|NCT04199351|593458051|FG002|Overall Study|Lost to Follow-up|1|||
164295745|NCT04199351|593458052|FG003|Overall Study|Lost to Follow-up|0|||
164295746|NCT04199351|593458053|FG004|Overall Study|Lost to Follow-up|0|||
164295747|NCT04199351|593458054|FG005|Overall Study|Lost to Follow-up|1|||
164295748|NCT04199351|593458055|FG006|Overall Study|Lost to Follow-up|0|||
164295749|NCT04199351|593458056|FG007|Overall Study|Lost to Follow-up|0|||
164295750|NCT04199351|593458057|FG008|Overall Study|Lost to Follow-up|0|||
164295751|NCT04199351|593458058|FG009|Overall Study|Lost to Follow-up|0|||
164295752|NCT04199351|593458049|FG000|Overall Study|Withdrawal by Subject|0|||
164295753|NCT04199351|593458050|FG001|Overall Study|Withdrawal by Subject|1|||
164295754|NCT04199351|593458051|FG002|Overall Study|Withdrawal by Subject|0|||
164295755|NCT04199351|593458052|FG003|Overall Study|Withdrawal by Subject|0|||
164295756|NCT04199351|593458053|FG004|Overall Study|Withdrawal by Subject|1|||
164295757|NCT04199351|593458054|FG005|Overall Study|Withdrawal by Subject|4|||
164295758|NCT04199351|593458055|FG006|Overall Study|Withdrawal by Subject|2|||
164295759|NCT04199351|593458056|FG007|Overall Study|Withdrawal by Subject|0|||
164295760|NCT04199351|593458057|FG008|Overall Study|Withdrawal by Subject|3|||
164295761|NCT04199351|593458058|FG009|Overall Study|Withdrawal by Subject|0|||
164295762|NCT03623243|593458059|FG000|Overall Study|Adverse Event|15|||
164295763|NCT03623243|593458059|FG000|Overall Study|Guardian Decision|1|||
164295764|NCT03623243|593458059|FG000|Overall Study|New Therapy for Study Indication|1|||
164295765|NCT03623243|593458059|FG000|Overall Study|Protocol Deviation|3|||
164295766|NCT03623243|593458059|FG000|Overall Study|Physician Decision|4|||
164295767|NCT03623243|593458059|FG000|Overall Study|Patient Decision|15|||
164295768|NCT00979901|593458063|FG000|Overall Study|Adverse Event|1|||
164295769|NCT00979901|593458064|FG001|Overall Study|Adverse Event|3|||
164295770|NCT00979901|593458065|FG002|Overall Study|Adverse Event|9|||
164295771|NCT00979901|593458066|FG003|Overall Study|Adverse Event|2|||
164295772|NCT00979901|593458063|FG000|Overall Study|Lack of Efficacy|8|||
164295773|NCT00979901|593458064|FG001|Overall Study|Lack of Efficacy|4|||
164295774|NCT00979901|593458065|FG002|Overall Study|Lack of Efficacy|9|||
164295775|NCT00979901|593458066|FG003|Overall Study|Lack of Efficacy|0|||
164295776|NCT00979901|593458063|FG000|Overall Study|Lost to Follow-up|1|||
164295777|NCT00979901|593458064|FG001|Overall Study|Lost to Follow-up|1|||
164295778|NCT00979901|593458065|FG002|Overall Study|Lost to Follow-up|2|||
164295779|NCT00979901|593458066|FG003|Overall Study|Lost to Follow-up|0|||
164295780|NCT00979901|593458063|FG000|Overall Study|Protocol Violation|2|||
164295781|NCT00979901|593458064|FG001|Overall Study|Protocol Violation|2|||
164295782|NCT00979901|593458065|FG002|Overall Study|Protocol Violation|7|||
164295783|NCT00979901|593458066|FG003|Overall Study|Protocol Violation|1|||
164295784|NCT00979901|593458063|FG000|Overall Study|Withdrawal by Subject|2|||
164295785|NCT00979901|593458064|FG001|Overall Study|Withdrawal by Subject|1|||
164295786|NCT00979901|593458065|FG002|Overall Study|Withdrawal by Subject|1|||
164295787|NCT00979901|593458066|FG003|Overall Study|Withdrawal by Subject|1|||
164295788|NCT00979901|593458063|FG000|Overall Study|Noncompliance|1|||
164295789|NCT00979901|593458064|FG001|Overall Study|Noncompliance|0|||
164347328|NCT02269241|593648772|FG000|Overall Study|Wish for pregnancy|5|||
164347329|NCT02269241|593648772|FG000|Overall Study|Development of an exclusion criteria|16|||
164347330|NCT02269241|593648772|FG000|Overall Study|Adverse Event|113|||
164295790|NCT00979901|593458065|FG002|Overall Study|Noncompliance|0|||
164295791|NCT00979901|593458066|FG003|Overall Study|Noncompliance|0|||
164295792|NCT00979901|593458063|FG000|Overall Study|out-of-state|1|||
164295793|NCT00979901|593458064|FG001|Overall Study|out-of-state|0|||
164295794|NCT00979901|593458065|FG002|Overall Study|out-of-state|0|||
164295795|NCT00979901|593458066|FG003|Overall Study|out-of-state|0|||
164295796|NCT00979901|593458063|FG000|Overall Study|vacation|1|||
164295797|NCT00979901|593458064|FG001|Overall Study|vacation|0|||
164295798|NCT00979901|593458065|FG002|Overall Study|vacation|0|||
164295799|NCT00979901|593458066|FG003|Overall Study|vacation|0|||
164295800|NCT00979901|593458063|FG000|Overall Study|elevated lab values pre-randomization|1|||
164089427|NCT04799158|592690294|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
164295801|NCT00979901|593458064|FG001|Overall Study|elevated lab values pre-randomization|0|||
164295802|NCT00979901|593458065|FG002|Overall Study|elevated lab values pre-randomization|0|||
164295803|NCT00979901|593458066|FG003|Overall Study|elevated lab values pre-randomization|0|||
164295804|NCT00979901|593458063|FG000|Overall Study|Discontinued in Error|0|||
164295805|NCT00979901|593458064|FG001|Overall Study|Discontinued in Error|1|||
164295806|NCT00979901|593458065|FG002|Overall Study|Discontinued in Error|0|||
163898434|NCT00943917|592001068|FG001|Stage I|hyperglycemia|0|||
163898435|NCT00943917|592001069|FG002|Stage I|hyperglycemia|1|||
164295807|NCT00979901|593458066|FG003|Overall Study|Discontinued in Error|0|||
164295808|NCT00979901|593458063|FG000|Overall Study|Left Country|0|||
164295809|NCT00979901|593458064|FG001|Overall Study|Left Country|0|||
164295810|NCT00979901|593458065|FG002|Overall Study|Left Country|1|||
164295811|NCT00979901|593458066|FG003|Overall Study|Left Country|0|||
164295812|NCT00979901|593458063|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
164295813|NCT00979901|593458064|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
164295814|NCT00979901|593458065|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
164295815|NCT00979901|593458066|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
164295816|NCT03924622|593458067|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
164295817|NCT03924622|593458068|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295818|NCT03924622|593458069|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295819|NCT03924622|593458070|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
164295820|NCT03924622|593458071|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295821|NCT03924622|593458072|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
164295822|NCT03085095|593458074|FG000|Overall Study|Adverse Event|23|||
164295823|NCT03085095|593458075|FG001|Overall Study|Adverse Event|8|||
164295824|NCT03085095|593458074|FG000|Overall Study|Protocol Violation|0|||
164295825|NCT03085095|593458075|FG001|Overall Study|Protocol Violation|1|||
164295826|NCT03085095|593458074|FG000|Overall Study|Lost to Follow-up|2|||
164295827|NCT03085095|593458075|FG001|Overall Study|Lost to Follow-up|1|||
164295828|NCT03085095|593458074|FG000|Overall Study|Withdrawal by Subject|17|||
164295829|NCT03085095|593458075|FG001|Overall Study|Withdrawal by Subject|6|||
164295830|NCT03085095|593458074|FG000|Overall Study|Physician Decision|9|||
164295831|NCT03085095|593458075|FG001|Overall Study|Physician Decision|3|||
164295832|NCT03085095|593458074|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
164295833|NCT03085095|593458075|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
164295834|NCT03085095|593458074|FG000|Overall Study|Did not Receive Study Drug|2|||
164295835|NCT03085095|593458075|FG001|Overall Study|Did not Receive Study Drug|2|||
164295836|NCT03085095|593458074|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
164295837|NCT03085095|593458075|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
164295838|NCT02814916|593458077|FG000|Overall Study|Withdrawal of consent|0|||
164295839|NCT02814916|593458078|FG001|Overall Study|Withdrawal of consent|2|||
164295840|NCT02814916|593458079|FG002|Overall Study|Withdrawal of consent|0|||
164295841|NCT02814916|593458077|FG000|Overall Study|Lost to Follow-up|0|||
164295842|NCT02814916|593458078|FG001|Overall Study|Lost to Follow-up|1|||
164295843|NCT02814916|593458079|FG002|Overall Study|Lost to Follow-up|0|||
164295844|NCT02814916|593458077|FG000|Overall Study|Other, not specified|0|||
164295845|NCT02814916|593458078|FG001|Overall Study|Other, not specified|1|||
164295846|NCT02814916|593458079|FG002|Overall Study|Other, not specified|0|||
164295847|NCT05543265|593458081|FG000|Overall Study|Lost to Follow-up|3|||
164295848|NCT05543265|593458082|FG001|Overall Study|Lost to Follow-up|3|||
164295849|NCT05543265|593458081|FG000|Overall Study|Withdrawal by Subject|0|||
164295850|NCT05543265|593458082|FG001|Overall Study|Withdrawal by Subject|1|||
164295851|NCT02182895|593458083|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
164295852|NCT02182895|593458084|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
164295853|NCT01488045|593458094|FG000|Overall Study|Withdrawal by Subject|6|||
164295854|NCT01488045|593458095|FG001|Overall Study|Withdrawal by Subject|11|||
164295855|NCT01488045|593458094|FG000|Overall Study|Failure to present for colonoscopy|3|||
164295856|NCT01488045|593458095|FG001|Overall Study|Failure to present for colonoscopy|6|||
164295857|NCT01488045|593458094|FG000|Overall Study|Failure to report exclusion criteria|0|||
164295858|NCT01488045|593458095|FG001|Overall Study|Failure to report exclusion criteria|1|||
164295859|NCT00671658|593458097|FG000|Overall Study|Physician Decision|5|||
164295860|NCT03617172|593458100|FG000|Overall Study|Lost to Follow-up|1|||
164295861|NCT03617172|593458101|FG001|Overall Study|Lost to Follow-up|0|||
164295862|NCT01680341|593458102|FG000|Overall Study|Adverse Event|3|||
164295863|NCT01680341|593458103|FG001|Overall Study|Adverse Event|2|||
164295864|NCT01680341|593458102|FG000|Overall Study|Unclassified|18|||
164295865|NCT01680341|593458103|FG001|Overall Study|Unclassified|15|||
164295866|NCT02587221|593458105|FG000|Overall Study|Adverse Event|3|||
164295867|NCT02587221|593458106|FG001|Overall Study|Adverse Event|3|||
164295868|NCT02587221|593458105|FG000|Overall Study|Death|33|||
164295869|NCT02587221|593458106|FG001|Overall Study|Death|34|||
164295870|NCT02587221|593458105|FG000|Overall Study|Withdrawal by Subject|66|||
164347331|NCT02269241|593648772|FG000|Overall Study|At the specific request of the sponsor|20|||
164295871|NCT02587221|593458106|FG001|Overall Study|Withdrawal by Subject|61|||
164295872|NCT02587221|593458105|FG000|Overall Study|Lost to Follow-up|21|||
164347332|NCT02269241|593648772|FG000|Overall Study|Several reasons not classified|53|||
164347333|NCT02269241|593648772|FG000|Overall Study|Screening failures|546|||
164347334|NCT03020160|593648773|FG000|Overall Study|Withdrawal by Subject|1|||
163898436|NCT00943917|592001070|FG003|Stage I|hyperglycemia|0|||
163898437|NCT00943917|592001071|FG004|Stage I|hyperglycemia|0|||
164005264|NCT01386385|592385717|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164005265|NCT01386385|592385718|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164295873|NCT02587221|593458106|FG001|Overall Study|Lost to Follow-up|19|||
164295874|NCT02587221|593458105|FG000|Overall Study|Protocol Violation|6|||
164295875|NCT02587221|593458106|FG001|Overall Study|Protocol Violation|5|||
164295876|NCT02587221|593458105|FG000|Overall Study|Other Reason or Unspecified|2|||
164295877|NCT02587221|593458106|FG001|Overall Study|Other Reason or Unspecified|1|||
164295878|NCT01499940|593458107|FG000|Overall Study|Study was withdrawn before completion.|9|||
164295879|NCT04739982|593458108|FG000|Overall Study|Lost to Follow-up|176|||
164295880|NCT04739982|593458109|FG001|Overall Study|Lost to Follow-up|65|||
164295881|NCT04739982|593458108|FG000|Overall Study|Withdrawal by Subject|19|||
164295882|NCT04739982|593458109|FG001|Overall Study|Withdrawal by Subject|0|||
164295883|NCT04739982|593458108|FG000|Overall Study|Protocol Violation|0|||
164295884|NCT04739982|593458109|FG001|Overall Study|Protocol Violation|5|||
164295885|NCT04914364|593458111|FG000|Overall Study|No longer eligible for study|1|||
164295886|NCT04914364|593458111|FG000|Overall Study|Lost to Follow-up|2|||
164295887|NCT01168349|593458112|FG000|Overall Study|Death|157|||
164295888|NCT01168349|593458112|FG000|Overall Study|Lost to Follow-up|34|||
164295889|NCT01168349|593458112|FG000|Overall Study|Withdrawal by Subject|9|||
164295890|NCT01168349|593458112|FG000|Overall Study|Kidney transplantation|3|||
164295891|NCT01168349|593458112|FG000|Overall Study|Other|22|||
164295892|NCT01168349|593458112|FG000|Overall Study|Protocol Violation|76|||
164295893|NCT01033240|593458113|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
164295894|NCT01033240|593458114|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
164295895|NCT01033240|593458115|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
164295896|NCT01033240|593458113|FG000|Overall Study|Death|2|||
164295897|NCT01033240|593458114|FG001|Overall Study|Death|0|||
164295898|NCT01033240|593458115|FG002|Overall Study|Death|0|||
164295899|NCT01033240|593458113|FG000|Overall Study|Withdrew Consent|2|||
164295900|NCT01033240|593458114|FG001|Overall Study|Withdrew Consent|9|||
164295901|NCT01033240|593458115|FG002|Overall Study|Withdrew Consent|2|||
164295902|NCT01033240|593458113|FG000|Overall Study|Disease Progression|35|||
164295903|NCT01033240|593458114|FG001|Overall Study|Disease Progression|32|||
164295904|NCT01033240|593458115|FG002|Overall Study|Disease Progression|41|||
164295905|NCT01033240|593458113|FG000|Overall Study|Investigator Discretion|0|||
164295906|NCT01033240|593458114|FG001|Overall Study|Investigator Discretion|0|||
164295907|NCT01033240|593458115|FG002|Overall Study|Investigator Discretion|2|||
164295908|NCT01033240|593458113|FG000|Overall Study|Other|0|||
164295909|NCT01033240|593458114|FG001|Overall Study|Other|1|||
164295910|NCT01033240|593458115|FG002|Overall Study|Other|2|||
164295911|NCT03521570|593458116|FG000|Overall Study|Not eligible|11|||
164295912|NCT02138890|593458121|FG000|Overall Study|Adverse Event|1|||
164295913|NCT02138890|593458122|FG001|Overall Study|Adverse Event|0|||
164295914|NCT05435339|593458123|FG000|Overall Study|Death|1|||
164295915|NCT05435339|593458124|FG001|Overall Study|Death|0|||
164295916|NCT05435339|593458125|FG002|Overall Study|Death|3|||
164295917|NCT05435339|593458126|FG003|Overall Study|Death|1|||
164295918|NCT05435339|593458127|FG004|Overall Study|Death|3|||
164295919|NCT05435339|593458128|FG005|Overall Study|Death|2|||
164295920|NCT05435339|593458129|FG006|Overall Study|Death|4|||
164295921|NCT05435339|593458130|FG007|Overall Study|Death|6|||
164295922|NCT05435339|593458123|FG000|Overall Study|Sponsor Decision|0|||
164295923|NCT05435339|593458124|FG001|Overall Study|Sponsor Decision|1|||
164295924|NCT05435339|593458125|FG002|Overall Study|Sponsor Decision|0|||
164295925|NCT05435339|593458126|FG003|Overall Study|Sponsor Decision|0|||
164295926|NCT05435339|593458127|FG004|Overall Study|Sponsor Decision|2|||
164295927|NCT05435339|593458128|FG005|Overall Study|Sponsor Decision|1|||
164295928|NCT05435339|593458129|FG006|Overall Study|Sponsor Decision|2|||
164295929|NCT05435339|593458130|FG007|Overall Study|Sponsor Decision|2|||
164295930|NCT05435339|593458123|FG000|Overall Study|Withdrawal by Subject|0|||
164295931|NCT05435339|593458124|FG001|Overall Study|Withdrawal by Subject|0|||
164347335|NCT03020160|593648774|FG001|Overall Study|Withdrawal by Subject|0|||
164347336|NCT02270957|593648775|FG000|Overall Study|Lack of Efficacy|2|||
164295932|NCT05435339|593458125|FG002|Overall Study|Withdrawal by Subject|0|||
164295933|NCT05435339|593458126|FG003|Overall Study|Withdrawal by Subject|0|||
164347337|NCT02270957|593648776|FG001|Overall Study|Lack of Efficacy|4|||
164347338|NCT02270957|593648775|FG000|Overall Study|Adverse Event|2|||
164347339|NCT02270957|593648776|FG001|Overall Study|Adverse Event|0|||
164347340|NCT01539538|593648784|FG000|Overall Study|Adverse Event|13|||
164347341|NCT01539538|593648785|FG001|Overall Study|Adverse Event|18|||
164005266|NCT01386385|592385719|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
164132702|NCT01986010|592850664|FG009|Overall Study|Physician Decision|0|||
164295934|NCT05435339|593458127|FG004|Overall Study|Withdrawal by Subject|1|||
164295935|NCT05435339|593458128|FG005|Overall Study|Withdrawal by Subject|0|||
164347342|NCT01539538|593648784|FG000|Overall Study|Lack of Efficacy|13|||
164347343|NCT01539538|593648785|FG001|Overall Study|Lack of Efficacy|16|||
164295936|NCT05435339|593458129|FG006|Overall Study|Withdrawal by Subject|1|||
164347344|NCT01539538|593648784|FG000|Overall Study|Withdrawal by Subject|2|||
164347345|NCT01539538|593648785|FG001|Overall Study|Withdrawal by Subject|3|||
164295937|NCT05435339|593458130|FG007|Overall Study|Withdrawal by Subject|1|||
164005267|NCT01386385|592385712|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005268|NCT01386385|592385713|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005269|NCT01386385|592385714|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
164005270|NCT01386385|592385715|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005271|NCT01386385|592385716|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005272|NCT01386385|592385717|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005273|NCT01386385|592385718|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005274|NCT01386385|592385719|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
164005275|NCT01386385|592385712|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005276|NCT01386385|592385713|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005277|NCT01386385|592385714|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005278|NCT01386385|592385715|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005279|NCT01386385|592385716|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
164005280|NCT01386385|592385717|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005281|NCT01386385|592385718|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005282|NCT01386385|592385719|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
164005283|NCT01386385|592385712|FG000|Phase II Concurrent CRT|Adverse Event|0|||
164005284|NCT01386385|592385713|FG001|Phase II Concurrent CRT|Adverse Event|0|||
164005285|NCT01386385|592385714|FG002|Phase II Concurrent CRT|Adverse Event|0|||
164005286|NCT01386385|592385715|FG003|Phase II Concurrent CRT|Adverse Event|0|||
164005287|NCT01386385|592385716|FG004|Phase II Concurrent CRT|Adverse Event|0|||
164005288|NCT01386385|592385717|FG005|Phase II Concurrent CRT|Adverse Event|0|||
164005289|NCT01386385|592385718|FG006|Phase II Concurrent CRT|Adverse Event|3|||
164005290|NCT01386385|592385719|FG007|Phase II Concurrent CRT|Adverse Event|3|||
164005291|NCT01386385|592385712|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005292|NCT01386385|592385713|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005293|NCT01386385|592385714|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005294|NCT01386385|592385715|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005295|NCT01386385|592385716|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005296|NCT01386385|592385717|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005297|NCT01386385|592385718|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
164005298|NCT01386385|592385719|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
164005299|NCT01386385|592385712|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
164005300|NCT01386385|592385713|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
164005301|NCT01386385|592385714|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
164005302|NCT01386385|592385715|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
164005303|NCT01386385|592385716|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
164005304|NCT01386385|592385717|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
164005305|NCT01386385|592385718|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
164005306|NCT01386385|592385719|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
164132703|NCT01986010|592850665|FG010|Overall Study|Physician Decision|0|||
164295938|NCT01446159|593458131|FG000|Overall Study|Withdrawal by Subject|1|||
164295939|NCT01446159|593458132|FG001|Overall Study|Withdrawal by Subject|0|||
164295940|NCT01446159|593458133|FG002|Overall Study|Withdrawal by Subject|14|||
164295941|NCT01446159|593458134|FG003|Overall Study|Withdrawal by Subject|11|||
164295942|NCT01446159|593458131|FG000|Overall Study|Lost to Follow-up|0|||
164295943|NCT01446159|593458132|FG001|Overall Study|Lost to Follow-up|0|||
164295944|NCT01446159|593458133|FG002|Overall Study|Lost to Follow-up|1|||
164295945|NCT01446159|593458134|FG003|Overall Study|Lost to Follow-up|2|||
164295946|NCT01446159|593458131|FG000|Overall Study|Death|2|||
164295947|NCT01446159|593458132|FG001|Overall Study|Death|3|||
164295948|NCT01446159|593458133|FG002|Overall Study|Death|43|||
164295949|NCT01446159|593458134|FG003|Overall Study|Death|36|||
164295950|NCT01446159|593458131|FG000|Overall Study|Other|0|||
164295951|NCT01446159|593458132|FG001|Overall Study|Other|0|||
164295952|NCT01446159|593458133|FG002|Overall Study|Other|13|||
164295953|NCT01446159|593458134|FG003|Overall Study|Other|13|||
164295954|NCT05135871|593458143|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
164295955|NCT05135871|593458144|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
164295956|NCT05135871|593458145|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
164295957|NCT05135871|593458146|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
164295958|NCT04258423|593458147|FG000|Overall Study|Study Closure|2|||
164295959|NCT04258423|593458148|FG001|Overall Study|Study Closure|2|||
164295960|NCT03980730|593458151|FG000|Overall Study|Study Terminated by Sponsor|0|||
164295961|NCT03980730|593458152|FG001|Overall Study|Study Terminated by Sponsor|3|||
164295962|NCT03980730|593458151|FG000|Overall Study|Adverse Event|2|||
164295963|NCT03980730|593458152|FG001|Overall Study|Adverse Event|0|||
164295964|NCT03980730|593458151|FG000|Overall Study|Sponsor Request|0|||
164295965|NCT03980730|593458152|FG001|Overall Study|Sponsor Request|1|||
164295966|NCT01247324|593458153|FG000|Overall Study|Death|6|||
164295967|NCT01247324|593458154|FG001|Overall Study|Death|10|||
164295968|NCT01247324|593458153|FG000|Overall Study|Physician Decision|2|||
164295969|NCT01247324|593458154|FG001|Overall Study|Physician Decision|3|||
164295970|NCT01247324|593458153|FG000|Overall Study|Non-compliance with study drug|3|||
164295971|NCT01247324|593458154|FG001|Overall Study|Non-compliance with study drug|0|||
164295972|NCT01247324|593458153|FG000|Overall Study|Lack of Efficacy|24|||
164295973|NCT01247324|593458154|FG001|Overall Study|Lack of Efficacy|14|||
164295974|NCT01247324|593458153|FG000|Overall Study|Non-compliance|3|||
163898438|NCT00943917|592001072|FG005|Stage I|hyperglycemia|0|||
164295975|NCT01247324|593458154|FG001|Overall Study|Non-compliance|2|||
164295976|NCT01247324|593458153|FG000|Overall Study|Pregnancy|5|||
164295977|NCT01247324|593458154|FG001|Overall Study|Pregnancy|10|||
163898439|NCT00943917|592001073|FG006|Stage I|hyperglycemia|0|||
163898440|NCT00943917|592001074|FG007|Stage I|hyperglycemia|0|||
164295978|NCT01247324|593458153|FG000|Overall Study|Protocol Violation|1|||
163898441|NCT00943917|592001075|FG008|Stage I|hyperglycemia|0|||
163898442|NCT00943917|592001076|FG009|Stage I|hyperglycemia|0|||
164132704|NCT01986010|592850666|FG011|Overall Study|Physician Decision|0|||
164295979|NCT01247324|593458154|FG001|Overall Study|Protocol Violation|1|||
164295980|NCT01247324|593458153|FG000|Overall Study|Reason not specified|42|||
164295981|NCT01247324|593458154|FG001|Overall Study|Reason not specified|32|||
164295982|NCT01247324|593458153|FG000|Overall Study|Consent withdrawn by participant|41|||
164295983|NCT01247324|593458154|FG001|Overall Study|Consent withdrawn by participant|56|||
164295984|NCT01247324|593458153|FG000|Overall Study|Adverse Event|49|||
164295985|NCT01247324|593458154|FG001|Overall Study|Adverse Event|35|||
164295986|NCT01247324|593458153|FG000|Overall Study|Lost to Follow-up|3|||
164295987|NCT01247324|593458154|FG001|Overall Study|Lost to Follow-up|6|||
164295988|NCT01247324|593458153|FG000|Overall Study|Study Terminated by Sponsor|4|||
164295989|NCT01247324|593458154|FG001|Overall Study|Study Terminated by Sponsor|1|||
164295990|NCT01247324|593458153|FG000|Overall Study|Missing|2|||
164295991|NCT01247324|593458154|FG001|Overall Study|Missing|1|||
164295992|NCT00880620|593458162|FG000|Overall Study|Adverse Event|4|||
164295993|NCT00880620|593458163|FG001|Overall Study|Adverse Event|5|||
164295994|NCT00880620|593458164|FG002|Overall Study|Adverse Event|15|||
164295995|NCT00880620|593458165|FG003|Overall Study|Adverse Event|15|||
164295996|NCT00880620|593458162|FG000|Overall Study|Death|0|||
164295997|NCT00880620|593458163|FG001|Overall Study|Death|0|||
164295998|NCT00880620|593458164|FG002|Overall Study|Death|1|||
164295999|NCT00880620|593458165|FG003|Overall Study|Death|0|||
164296000|NCT00880620|593458162|FG000|Overall Study|Lack of Efficacy|12|||
164296001|NCT00880620|593458163|FG001|Overall Study|Lack of Efficacy|4|||
164296002|NCT00880620|593458164|FG002|Overall Study|Lack of Efficacy|0|||
164296003|NCT00880620|593458165|FG003|Overall Study|Lack of Efficacy|1|||
164296004|NCT00880620|593458162|FG000|Overall Study|Lost to Follow-up|0|||
164296005|NCT00880620|593458163|FG001|Overall Study|Lost to Follow-up|1|||
164296006|NCT00880620|593458164|FG002|Overall Study|Lost to Follow-up|1|||
164296007|NCT00880620|593458165|FG003|Overall Study|Lost to Follow-up|0|||
164296008|NCT00880620|593458162|FG000|Overall Study|Protocol Violation|0|||
164296009|NCT00880620|593458163|FG001|Overall Study|Protocol Violation|1|||
164296010|NCT00880620|593458164|FG002|Overall Study|Protocol Violation|0|||
164296011|NCT00880620|593458165|FG003|Overall Study|Protocol Violation|2|||
164296012|NCT00880620|593458162|FG000|Overall Study|Withdrawal by Subject|4|||
164296013|NCT00880620|593458163|FG001|Overall Study|Withdrawal by Subject|3|||
164296014|NCT00880620|593458164|FG002|Overall Study|Withdrawal by Subject|1|||
164296015|NCT00880620|593458165|FG003|Overall Study|Withdrawal by Subject|3|||
164296016|NCT00880620|593458162|FG000|Overall Study|Noncompliance|0|||
164296017|NCT00880620|593458163|FG001|Overall Study|Noncompliance|0|||
164296018|NCT00880620|593458164|FG002|Overall Study|Noncompliance|1|||
164296019|NCT00880620|593458165|FG003|Overall Study|Noncompliance|1|||
164296020|NCT00880620|593458162|FG000|Overall Study|Other|1|||
164296021|NCT00880620|593458163|FG001|Overall Study|Other|1|||
164296022|NCT00880620|593458164|FG002|Overall Study|Other|2|||
164347346|NCT01539538|593648784|FG000|Overall Study|PCA no longer required or PCA problem|3|||
164347347|NCT01539538|593648785|FG001|Overall Study|PCA no longer required or PCA problem|7|||
164347348|NCT03897465|593648786|FG000|Overall Study|Lost to Follow-up|2|||
164347349|NCT03897465|593648787|FG001|Overall Study|Lost to Follow-up|1|||
164347350|NCT03897465|593648786|FG000|Overall Study|Adverse Event|2|||
164347351|NCT03897465|593648787|FG001|Overall Study|Adverse Event|0|||
164347352|NCT03897465|593648786|FG000|Overall Study|complete healing by V2|1|||
164347353|NCT03897465|593648787|FG001|Overall Study|complete healing by V2|0|||
164347354|NCT03897465|593648786|FG000|Overall Study|occurence of exclusion criterion|1|||
164347355|NCT03897465|593648787|FG001|Overall Study|occurence of exclusion criterion|1|||
164347356|NCT03897465|593648786|FG000|Overall Study|Other|1|||
164347357|NCT03897465|593648787|FG001|Overall Study|Other|0|||
164347358|NCT00847379|593648788|FG000|Overall Study|Study terminated by Sponsor|59|||
164347359|NCT00847379|593648789|FG001|Overall Study|Study terminated by Sponsor|57|||
164347360|NCT00847379|593648790|FG002|Overall Study|Study terminated by Sponsor|57|||
164347361|NCT00521014|593648791|FG000|Overall Study|Inevaluable, not treated|1|||
164347362|NCT04390191|593648792|FG000|Overall Study|Withdrawal by Subject|1|||
164347363|NCT04390191|593648793|FG001|Overall Study|Withdrawal by Subject|0|||
164347364|NCT03978832|593648796|FG000|Overall Study|Adverse Event|1|||
164347365|NCT03978832|593648796|FG000|Overall Study|Lost to Follow-up|1|||
164347366|NCT03978832|593648796|FG000|Overall Study|Withdrawal by Subject|6|||
164347367|NCT03978832|593648796|FG000|Overall Study|Physician Decision|2|||
164347368|NCT03978832|593648796|FG000|Overall Study|did not pass screening criteria|44|||
163898443|NCT00943917|592001077|FG010|Stage I|hyperglycemia|0|||
164296023|NCT00880620|593458165|FG003|Overall Study|Other|2|||
164296024|NCT03474588|593458169|FG000|Overall Study|Withdrawal by Subject|4|||
164296025|NCT03474588|593458170|FG001|Overall Study|Withdrawal by Subject|3|||
164347369|NCT00003499|593648797|FG000|Overall Study|Not evaluable|8|||
164347370|NCT02042183|593648802|FG000|Overall Study|Physician Decision|7|||
164347371|NCT02042183|593648803|FG001|Overall Study|Physician Decision|2|||
164347372|NCT02042183|593648802|FG000|Overall Study|Lack of Efficacy|4|||
164347373|NCT02042183|593648803|FG001|Overall Study|Lack of Efficacy|3|||
164347374|NCT02042183|593648802|FG000|Overall Study|Non-compliance with Study Drug|2|||
164347375|NCT02042183|593648803|FG001|Overall Study|Non-compliance with Study Drug|3|||
164347376|NCT02042183|593648802|FG000|Overall Study|Adverse Event|17|||
164347377|NCT02042183|593648803|FG001|Overall Study|Adverse Event|6|||
164347378|NCT02042183|593648802|FG000|Overall Study|Other|3|||
164347379|NCT02042183|593648803|FG001|Overall Study|Other|3|||
164347380|NCT02042183|593648802|FG000|Overall Study|Withdrawal by Subject|21|||
164347381|NCT02042183|593648803|FG001|Overall Study|Withdrawal by Subject|16|||
164347382|NCT02042183|593648802|FG000|Overall Study|Site Terminated by Sponsor|2|||
164347383|NCT02042183|593648803|FG001|Overall Study|Site Terminated by Sponsor|1|||
164347384|NCT02042183|593648802|FG000|Overall Study|Lost to Follow-up|9|||
164347385|NCT02042183|593648803|FG001|Overall Study|Lost to Follow-up|2|||
164347386|NCT01256008|593648804|FG000|Overall Study|Lost to Follow-up|6|||
164347387|NCT01256008|593648805|FG001|Overall Study|Lost to Follow-up|4|||
164347388|NCT01256008|593648806|FG002|Overall Study|Lost to Follow-up|11|||
164347389|NCT01256008|593648804|FG000|Overall Study|Withdrawal by Subject|2|||
164347390|NCT01256008|593648805|FG001|Overall Study|Withdrawal by Subject|3|||
164347391|NCT01256008|593648806|FG002|Overall Study|Withdrawal by Subject|10|||
164347392|NCT02244606|593648807|FG000|Overall Study|Adverse Event|0|||
164347393|NCT02244606|593648808|FG001|Overall Study|Adverse Event|1|||
164347394|NCT02244606|593648809|FG002|Overall Study|Adverse Event|1|||
164347395|NCT02244606|593648810|FG003|Overall Study|Adverse Event|0|||
164347396|NCT02244606|593648807|FG000|Overall Study|Lost to Follow-up|2|||
164347397|NCT02244606|593648808|FG001|Overall Study|Lost to Follow-up|2|||
164347398|NCT02244606|593648809|FG002|Overall Study|Lost to Follow-up|1|||
164347399|NCT02244606|593648810|FG003|Overall Study|Lost to Follow-up|0|||
164347400|NCT02244606|593648807|FG000|Overall Study|Protocol Violation|0|||
164347401|NCT02244606|593648808|FG001|Overall Study|Protocol Violation|0|||
164347402|NCT02244606|593648809|FG002|Overall Study|Protocol Violation|0|||
164347403|NCT02244606|593648810|FG003|Overall Study|Protocol Violation|1|||
164347404|NCT02244606|593648807|FG000|Overall Study|Withdrawal by Subject|1|||
164347405|NCT02244606|593648808|FG001|Overall Study|Withdrawal by Subject|1|||
164347406|NCT02244606|593648809|FG002|Overall Study|Withdrawal by Subject|0|||
164347407|NCT02244606|593648810|FG003|Overall Study|Withdrawal by Subject|0|||
164347408|NCT02244606|593648807|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
164347409|NCT02244606|593648808|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
164347410|NCT02244606|593648809|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
164347411|NCT02244606|593648810|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
164347412|NCT00378378|593648813|FG000|Overall Study|Withdrawal by Subject|0|||
164347413|NCT00378378|593648814|FG001|Overall Study|Withdrawal by Subject|1|||
164347414|NCT00378378|593648815|FG002|Overall Study|Withdrawal by Subject|0|||
164347415|NCT00378378|593648813|FG000|Overall Study|Treatment Failure|0|||
164347416|NCT00378378|593648814|FG001|Overall Study|Treatment Failure|0|||
164347417|NCT00378378|593648815|FG002|Overall Study|Treatment Failure|1|||
164347418|NCT00378378|593648813|FG000|Overall Study|Non-compliance with protocol|0|||
164347419|NCT00378378|593648814|FG001|Overall Study|Non-compliance with protocol|0|||
164347420|NCT00378378|593648815|FG002|Overall Study|Non-compliance with protocol|1|||
164347421|NCT02321800|593648821|FG000|Overall Study|Withdrawal by Subject|3|||
164347422|NCT02321800|593648822|FG001|Overall Study|Withdrawal by Subject|3|||
164347423|NCT02321800|593648821|FG000|Overall Study|Death|1|||
164347424|NCT02321800|593648822|FG001|Overall Study|Death|0|||
164347425|NCT02321800|593648821|FG000|Overall Study|Protocol Violation|1|||
164347426|NCT02321800|593648822|FG001|Overall Study|Protocol Violation|0|||
164347427|NCT02321800|593648821|FG000|Overall Study|Lost to Follow-up|10|||
164347428|NCT02321800|593648822|FG001|Overall Study|Lost to Follow-up|4|||
164347429|NCT02321800|593648821|FG000|Overall Study|Adverse Event|2|||
164347430|NCT02321800|593648822|FG001|Overall Study|Adverse Event|3|||
164347431|NCT02321800|593648821|FG000|Overall Study|Other, Miscellaneous|3|||
164347432|NCT02321800|593648822|FG001|Overall Study|Other, Miscellaneous|1|||
164347433|NCT01854710|593648823|FG000|Overall Study|Withdrawal by Subject|2|||
164347434|NCT01854710|593648824|FG001|Overall Study|Withdrawal by Subject|1|||
164347435|NCT01854710|593648825|FG002|Overall Study|Withdrawal by Subject|0|||
164347436|NCT01854710|593648826|FG003|Overall Study|Withdrawal by Subject|0|||
164347437|NCT01854710|593648827|FG004|Overall Study|Withdrawal by Subject|0|||
164347438|NCT01854710|593648828|FG005|Overall Study|Withdrawal by Subject|0|||
164347439|NCT01854710|593648823|FG000|Overall Study|CRI procedural error|2|||
164347440|NCT01854710|593648824|FG001|Overall Study|CRI procedural error|2|||
164347441|NCT01854710|593648825|FG002|Overall Study|CRI procedural error|2|||
164347442|NCT01854710|593648826|FG003|Overall Study|CRI procedural error|2|||
164347443|NCT01854710|593648827|FG004|Overall Study|CRI procedural error|2|||
164132705|NCT01986010|592850667|FG012|Overall Study|Physician Decision|0|||
164347444|NCT01854710|593648828|FG005|Overall Study|CRI procedural error|2|||
164089428|NCT04799158|592690295|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
164347445|NCT03132220|593648833|FG000|Overall Study|Lost to Follow-up|17|||
164347446|NCT03132220|593648834|FG001|Overall Study|Lost to Follow-up|8|||
164347447|NCT03132220|593648833|FG000|Overall Study|Withdrawal by Subject|1|||
164347448|NCT03132220|593648834|FG001|Overall Study|Withdrawal by Subject|4|||
164347449|NCT00642460|593648838|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347450|NCT00642460|593648839|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
164347451|NCT00642460|593648840|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
164347452|NCT00642460|593648841|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347453|NCT00642460|593648842|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347454|NCT00642460|593648843|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
164347455|NCT00642460|593648838|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
164347456|NCT00642460|593648839|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347457|NCT00642460|593648840|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347458|NCT00642460|593648841|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347459|NCT00642460|593648842|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347460|NCT00642460|593648843|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
164347461|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
164347462|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
164347463|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347464|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347465|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347466|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
164347467|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Death|0|||
164347468|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Death|1|||
164347469|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Death|0|||
164347470|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Death|2|||
164347471|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Death|0|||
164347472|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Death|0|||
164347473|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
164347474|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
164347475|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164347476|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164347477|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164347478|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
164347479|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
164296026|NCT03474588|593458169|FG000|Overall Study|Death|0|||
164296027|NCT03474588|593458170|FG001|Overall Study|Death|1|||
164296028|NCT01607957|593458172|FG000|Overall Study|Not treated|1|||
164005307|NCT01386385|592385712|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164005308|NCT01386385|592385713|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164005309|NCT01386385|592385714|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164089429|NCT04799158|592690296|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
164089430|NCT04799158|592690297|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
164089431|NCT04799158|592690298|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
164089432|NCT04799158|592690294|FG000|On-Demand Treatment Period|Miscellaneous|0|||
164089433|NCT04799158|592690295|FG001|On-Demand Treatment Period|Miscellaneous|0|||
164089434|NCT04799158|592690296|FG002|On-Demand Treatment Period|Miscellaneous|0|||
164089435|NCT04799158|592690297|FG003|On-Demand Treatment Period|Miscellaneous|0|||
164296029|NCT01607957|593458173|FG001|Overall Study|Not treated|1|||
164296030|NCT01607957|593458172|FG000|Overall Study|Death|367|||
164296031|NCT01607957|593458173|FG001|Overall Study|Death|211|||
164296032|NCT01607957|593458172|FG000|Overall Study|Lost to Follow-up|3|||
164296033|NCT01607957|593458173|FG001|Overall Study|Lost to Follow-up|3|||
164296034|NCT01607957|593458172|FG000|Overall Study|Participant refusal|1|||
164296035|NCT01607957|593458173|FG001|Overall Study|Participant refusal|0|||
164296036|NCT01691794|593458176|FG000|Overall Study|Poor/Non-Compliance|1|||
164296037|NCT01691794|593458177|FG001|Overall Study|Poor/Non-Compliance|4|||
164296038|NCT01691794|593458178|FG002|Overall Study|Poor/Non-Compliance|1|||
164296039|NCT01691794|593458176|FG000|Overall Study|Death|0|||
164296040|NCT01691794|593458177|FG001|Overall Study|Death|0|||
164296041|NCT01691794|593458178|FG002|Overall Study|Death|1|||
164296042|NCT01691794|593458176|FG000|Overall Study|Lack of Efficacy|0|||
164296043|NCT01691794|593458177|FG001|Overall Study|Lack of Efficacy|7|||
164296044|NCT01691794|593458178|FG002|Overall Study|Lack of Efficacy|1|||
164296045|NCT01691794|593458176|FG000|Overall Study|Participant request to discontinue|0|||
164296046|NCT01691794|593458177|FG001|Overall Study|Participant request to discontinue|1|||
164296047|NCT01691794|593458178|FG002|Overall Study|Participant request to discontinue|0|||
164296048|NCT01691794|593458176|FG000|Overall Study|Adverse Event|0|||
164296049|NCT01691794|593458177|FG001|Overall Study|Adverse Event|1|||
164296050|NCT01691794|593458178|FG002|Overall Study|Adverse Event|1|||
164296051|NCT01691794|593458176|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
164296052|NCT01691794|593458177|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
164296053|NCT01691794|593458178|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
164296054|NCT01691794|593458176|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
164296055|NCT01691794|593458177|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
164296056|NCT01691794|593458178|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
164296057|NCT04972786|593458179|FG000|First Intervention (1 Day)|Adverse Event|1|||
164296058|NCT04972786|593458180|FG001|First Intervention (1 Day)|Adverse Event|0|||
164296059|NCT02016781|593458181|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
164296060|NCT02016781|593458182|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
164296061|NCT02016781|593458181|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
164296062|NCT02016781|593458182|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
164296063|NCT02016781|593458181|FG000|Final Database Lock|Withdrawal by Subject|2|||
164296064|NCT02016781|593458182|FG001|Final Database Lock|Withdrawal by Subject|1|||
164296065|NCT02016781|593458181|FG000|Final Database Lock|Lost to Follow-up|11|||
164296066|NCT02016781|593458182|FG001|Final Database Lock|Lost to Follow-up|4|||
164296067|NCT02016781|593458181|FG000|Final Database Lock|Missing data|0|||
164296068|NCT02016781|593458182|FG001|Final Database Lock|Missing data|3|||
164296069|NCT04886154|593458183|FG000|Overall Study|Adverse Event|0|||
164296070|NCT04886154|593458184|FG001|Overall Study|Adverse Event|0|||
164296071|NCT04886154|593458185|FG002|Overall Study|Adverse Event|0|||
164296072|NCT04886154|593458186|FG003|Overall Study|Adverse Event|0|||
164296073|NCT04886154|593458187|FG004|Overall Study|Adverse Event|1|||
164296074|NCT04886154|593458188|FG005|Overall Study|Adverse Event|0|||
164296075|NCT04886154|593458189|FG006|Overall Study|Adverse Event|0|||
164296076|NCT04886154|593458190|FG007|Overall Study|Adverse Event|1|||
164296077|NCT04886154|593458191|FG008|Overall Study|Adverse Event|1|||
164296078|NCT04886154|593458192|FG009|Overall Study|Adverse Event|0|||
164296079|NCT04886154|593458193|FG010|Overall Study|Adverse Event|0|||
164296080|NCT04886154|593458194|FG011|Overall Study|Adverse Event|1|||
164296081|NCT04886154|593458195|FG012|Overall Study|Adverse Event|0|||
164296082|NCT04886154|593458196|FG013|Overall Study|Adverse Event|0|||
164296083|NCT04886154|593458197|FG014|Overall Study|Adverse Event|3|||
164296084|NCT04886154|593458183|FG000|Overall Study|Lost to Follow-up|1|||
164296085|NCT04886154|593458184|FG001|Overall Study|Lost to Follow-up|0|||
164296086|NCT04886154|593458185|FG002|Overall Study|Lost to Follow-up|2|||
164296087|NCT04886154|593458186|FG003|Overall Study|Lost to Follow-up|0|||
164296088|NCT04886154|593458187|FG004|Overall Study|Lost to Follow-up|17|||
164296089|NCT04886154|593458188|FG005|Overall Study|Lost to Follow-up|7|||
164296090|NCT04886154|593458189|FG006|Overall Study|Lost to Follow-up|8|||
164296091|NCT04886154|593458190|FG007|Overall Study|Lost to Follow-up|7|||
164296092|NCT04886154|593458191|FG008|Overall Study|Lost to Follow-up|8|||
164296093|NCT04886154|593458192|FG009|Overall Study|Lost to Follow-up|0|||
164296094|NCT04886154|593458193|FG010|Overall Study|Lost to Follow-up|2|||
164296095|NCT04886154|593458194|FG011|Overall Study|Lost to Follow-up|0|||
164296096|NCT04886154|593458195|FG012|Overall Study|Lost to Follow-up|0|||
164296097|NCT04886154|593458196|FG013|Overall Study|Lost to Follow-up|0|||
164296098|NCT04886154|593458197|FG014|Overall Study|Lost to Follow-up|0|||
164005310|NCT01386385|592385715|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164296099|NCT04886154|593458183|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296100|NCT04886154|593458184|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296101|NCT04886154|593458185|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296102|NCT04886154|593458186|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296103|NCT04886154|593458187|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296104|NCT04886154|593458188|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296105|NCT04886154|593458189|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
164296106|NCT04886154|593458190|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164005311|NCT01386385|592385716|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164005312|NCT01386385|592385717|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164005313|NCT01386385|592385718|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
164296107|NCT04886154|593458191|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296108|NCT04886154|593458192|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296109|NCT04886154|593458193|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296110|NCT04886154|593458194|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296111|NCT04886154|593458195|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296112|NCT04886154|593458196|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296113|NCT04886154|593458197|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
164296114|NCT04886154|593458183|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296115|NCT04886154|593458184|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296116|NCT04886154|593458185|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296117|NCT04886154|593458186|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296118|NCT04886154|593458187|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164296119|NCT04886154|593458188|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296120|NCT04886154|593458189|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164347480|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
164347481|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347482|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347483|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347484|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
164347485|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347486|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
164347487|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347488|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347489|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347490|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
164347491|NCT00642460|593648838|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347492|NCT00642460|593648839|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347493|NCT00642460|593648840|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347494|NCT00642460|593648841|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
164005314|NCT01386385|592385719|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
164005315|NCT01386385|592385712|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
164005316|NCT01386385|592385713|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
164005317|NCT01386385|592385714|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
164347495|NCT00642460|593648842|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347496|NCT00642460|593648843|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
164347497|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164296121|NCT04886154|593458190|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164296122|NCT04886154|593458191|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296123|NCT04886154|593458192|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296124|NCT04886154|593458193|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296125|NCT04886154|593458194|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296126|NCT04886154|593458195|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296127|NCT04886154|593458196|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164296128|NCT04886154|593458197|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164296129|NCT04886154|593458183|FG000|Overall Study|Other, Not Specified|0|||
164296130|NCT04886154|593458184|FG001|Overall Study|Other, Not Specified|0|||
164296131|NCT04886154|593458185|FG002|Overall Study|Other, Not Specified|0|||
164296132|NCT04886154|593458186|FG003|Overall Study|Other, Not Specified|0|||
164296133|NCT04886154|593458187|FG004|Overall Study|Other, Not Specified|11|||
164296134|NCT04886154|593458188|FG005|Overall Study|Other, Not Specified|8|||
164296135|NCT04886154|593458189|FG006|Overall Study|Other, Not Specified|9|||
164296136|NCT04886154|593458190|FG007|Overall Study|Other, Not Specified|10|||
164296137|NCT04886154|593458191|FG008|Overall Study|Other, Not Specified|6|||
164296138|NCT04886154|593458192|FG009|Overall Study|Other, Not Specified|1|||
164296139|NCT04886154|593458193|FG010|Overall Study|Other, Not Specified|1|||
164296140|NCT04886154|593458194|FG011|Overall Study|Other, Not Specified|2|||
164296141|NCT04886154|593458195|FG012|Overall Study|Other, Not Specified|1|||
164296142|NCT04886154|593458196|FG013|Overall Study|Other, Not Specified|2|||
164296143|NCT04886154|593458197|FG014|Overall Study|Other, Not Specified|3|||
164296144|NCT03919773|593458198|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
164296145|NCT03919773|593458199|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
164296146|NCT03919773|593458198|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
164296147|NCT03919773|593458199|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
164296148|NCT02702492|593458200|FG000|Overall Study|Disease progression|3|||
164296149|NCT02702492|593458201|FG001|Overall Study|Disease progression|3|||
164296150|NCT02702492|593458202|FG002|Overall Study|Disease progression|2|||
164296151|NCT02702492|593458203|FG003|Overall Study|Disease progression|4|||
164296152|NCT02702492|593458204|FG004|Overall Study|Disease progression|4|||
164296153|NCT02702492|593458205|FG005|Overall Study|Disease progression|1|||
164296154|NCT02702492|593458206|FG006|Overall Study|Disease progression|2|||
164296155|NCT02702492|593458207|FG007|Overall Study|Disease progression|8|||
164296156|NCT02702492|593458208|FG008|Overall Study|Disease progression|5|||
164296157|NCT02702492|593458209|FG009|Overall Study|Disease progression|1|||
164296158|NCT02702492|593458210|FG010|Overall Study|Disease progression|0|||
164296159|NCT02702492|593458211|FG011|Overall Study|Disease progression|3|||
164296160|NCT02702492|593458212|FG012|Overall Study|Disease progression|2|||
164296161|NCT02702492|593458200|FG000|Overall Study|Clinical progression|0|||
164296162|NCT02702492|593458201|FG001|Overall Study|Clinical progression|0|||
164296163|NCT02702492|593458202|FG002|Overall Study|Clinical progression|2|||
164296164|NCT02702492|593458203|FG003|Overall Study|Clinical progression|1|||
164296165|NCT02702492|593458204|FG004|Overall Study|Clinical progression|0|||
164296166|NCT02702492|593458205|FG005|Overall Study|Clinical progression|2|||
164296167|NCT02702492|593458206|FG006|Overall Study|Clinical progression|1|||
164296168|NCT02702492|593458207|FG007|Overall Study|Clinical progression|4|||
164296169|NCT02702492|593458208|FG008|Overall Study|Clinical progression|0|||
164296170|NCT02702492|593458209|FG009|Overall Study|Clinical progression|0|||
164296171|NCT02702492|593458210|FG010|Overall Study|Clinical progression|1|||
164296172|NCT02702492|593458211|FG011|Overall Study|Clinical progression|2|||
164296173|NCT02702492|593458212|FG012|Overall Study|Clinical progression|0|||
164296174|NCT02702492|593458200|FG000|Overall Study|Adverse Event|0|||
164296175|NCT02702492|593458201|FG001|Overall Study|Adverse Event|0|||
164296176|NCT02702492|593458202|FG002|Overall Study|Adverse Event|1|||
164296177|NCT02702492|593458203|FG003|Overall Study|Adverse Event|2|||
164296178|NCT02702492|593458204|FG004|Overall Study|Adverse Event|1|||
164296179|NCT02702492|593458205|FG005|Overall Study|Adverse Event|0|||
164296180|NCT02702492|593458206|FG006|Overall Study|Adverse Event|1|||
164296181|NCT02702492|593458207|FG007|Overall Study|Adverse Event|0|||
164296182|NCT02702492|593458208|FG008|Overall Study|Adverse Event|2|||
163898444|NCT00943917|592001078|FG011|Stage I|hyperglycemia|0|||
164296183|NCT02702492|593458209|FG009|Overall Study|Adverse Event|0|||
164296184|NCT02702492|593458210|FG010|Overall Study|Adverse Event|0|||
164296185|NCT02702492|593458211|FG011|Overall Study|Adverse Event|0|||
164296186|NCT02702492|593458212|FG012|Overall Study|Adverse Event|1|||
164296187|NCT02702492|593458200|FG000|Overall Study|Other|0|||
164296188|NCT02702492|593458201|FG001|Overall Study|Other|0|||
164296189|NCT02702492|593458202|FG002|Overall Study|Other|0|||
164296190|NCT02702492|593458203|FG003|Overall Study|Other|0|||
164296191|NCT02702492|593458204|FG004|Overall Study|Other|0|||
164296192|NCT02702492|593458205|FG005|Overall Study|Other|0|||
164296193|NCT02702492|593458206|FG006|Overall Study|Other|0|||
164296194|NCT02702492|593458207|FG007|Overall Study|Other|0|||
164296195|NCT02702492|593458208|FG008|Overall Study|Other|0|||
164296196|NCT02702492|593458209|FG009|Overall Study|Other|0|||
164296197|NCT02702492|593458210|FG010|Overall Study|Other|0|||
164296198|NCT02702492|593458211|FG011|Overall Study|Other|0|||
164296199|NCT02702492|593458212|FG012|Overall Study|Other|1|||
164296200|NCT01775501|593460087|FG000|Overall Study|Discontinued prior to treatment|1|||
164296201|NCT03037385|593460088|FG000|Overall Study|Adverse Event|0|||
164296202|NCT03037385|593460089|FG001|Overall Study|Adverse Event|0|||
164296203|NCT03037385|593460090|FG002|Overall Study|Adverse Event|1|||
164296204|NCT03037385|593460091|FG003|Overall Study|Adverse Event|0|||
164296205|NCT03037385|593460092|FG004|Overall Study|Adverse Event|0|||
164296206|NCT03037385|593460093|FG005|Overall Study|Adverse Event|0|||
164296207|NCT03037385|593460094|FG006|Overall Study|Adverse Event|0|||
164296208|NCT03037385|593460095|FG007|Overall Study|Adverse Event|0|||
164296209|NCT03037385|593460096|FG008|Overall Study|Adverse Event|0|||
164296210|NCT03037385|593460097|FG009|Overall Study|Adverse Event|6|||
164296211|NCT03037385|593460088|FG000|Overall Study|Death|1|||
164296212|NCT03037385|593460089|FG001|Overall Study|Death|4|||
164296213|NCT03037385|593460090|FG002|Overall Study|Death|2|||
164296214|NCT03037385|593460091|FG003|Overall Study|Death|2|||
164296215|NCT03037385|593460092|FG004|Overall Study|Death|5|||
164296216|NCT03037385|593460093|FG005|Overall Study|Death|2|||
164296217|NCT03037385|593460094|FG006|Overall Study|Death|1|||
164296218|NCT03037385|593460095|FG007|Overall Study|Death|4|||
164296219|NCT03037385|593460096|FG008|Overall Study|Death|3|||
164347498|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164347499|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164347500|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
164347501|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
164347502|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
164347503|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347504|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347505|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347506|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
164347507|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
164347508|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
164347509|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347510|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347511|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347512|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
164347513|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
164347514|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
164347515|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347516|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347517|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347518|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
164347519|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
164347520|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
164347521|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Other|0|||
164347522|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Other|0|||
164347523|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Other|0|||
164347524|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Other|0|||
164347525|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Other|2|||
164347526|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Other|2|||
164347527|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Death|0|||
164347528|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Death|0|||
164347529|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Death|0|||
164347530|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Death|0|||
164347531|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Death|0|||
164347532|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Death|3|||
164089436|NCT04799158|592690298|FG004|On-Demand Treatment Period|Miscellaneous|1|||
164296220|NCT03037385|593460097|FG009|Overall Study|Death|240|||
164296221|NCT03037385|593460088|FG000|Overall Study|Initiation of Another Therapy|1|||
164296222|NCT03037385|593460089|FG001|Overall Study|Initiation of Another Therapy|0|||
164296223|NCT03037385|593460090|FG002|Overall Study|Initiation of Another Therapy|0|||
164296224|NCT03037385|593460091|FG003|Overall Study|Initiation of Another Therapy|0|||
164347533|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347534|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164296225|NCT03037385|593460092|FG004|Overall Study|Initiation of Another Therapy|0|||
164296226|NCT03037385|593460093|FG005|Overall Study|Initiation of Another Therapy|0|||
164296227|NCT03037385|593460094|FG006|Overall Study|Initiation of Another Therapy|0|||
164296228|NCT03037385|593460095|FG007|Overall Study|Initiation of Another Therapy|1|||
164296229|NCT03037385|593460096|FG008|Overall Study|Initiation of Another Therapy|0|||
164296230|NCT03037385|593460097|FG009|Overall Study|Initiation of Another Therapy|2|||
164296231|NCT03037385|593460088|FG000|Overall Study|Lost to Follow-up|0|||
164296232|NCT03037385|593460089|FG001|Overall Study|Lost to Follow-up|0|||
164296233|NCT03037385|593460090|FG002|Overall Study|Lost to Follow-up|0|||
164296234|NCT03037385|593460091|FG003|Overall Study|Lost to Follow-up|0|||
164296235|NCT03037385|593460092|FG004|Overall Study|Lost to Follow-up|0|||
164296236|NCT03037385|593460093|FG005|Overall Study|Lost to Follow-up|1|||
164296237|NCT03037385|593460094|FG006|Overall Study|Lost to Follow-up|0|||
164296238|NCT03037385|593460095|FG007|Overall Study|Lost to Follow-up|0|||
164296239|NCT03037385|593460096|FG008|Overall Study|Lost to Follow-up|0|||
164296240|NCT03037385|593460097|FG009|Overall Study|Lost to Follow-up|16|||
164296241|NCT03037385|593460088|FG000|Overall Study|Physician Decision|0|||
164296242|NCT03037385|593460089|FG001|Overall Study|Physician Decision|0|||
164296243|NCT03037385|593460090|FG002|Overall Study|Physician Decision|0|||
164296244|NCT03037385|593460091|FG003|Overall Study|Physician Decision|0|||
164296245|NCT03037385|593460092|FG004|Overall Study|Physician Decision|0|||
164296246|NCT03037385|593460093|FG005|Overall Study|Physician Decision|0|||
164296247|NCT03037385|593460094|FG006|Overall Study|Physician Decision|0|||
164296248|NCT03037385|593460095|FG007|Overall Study|Physician Decision|0|||
164296249|NCT03037385|593460096|FG008|Overall Study|Physician Decision|0|||
164296250|NCT03037385|593460097|FG009|Overall Study|Physician Decision|1|||
164296251|NCT03037385|593460088|FG000|Overall Study|Progressive Disease|0|||
164296252|NCT03037385|593460089|FG001|Overall Study|Progressive Disease|1|||
164296253|NCT03037385|593460090|FG002|Overall Study|Progressive Disease|1|||
164296254|NCT03037385|593460091|FG003|Overall Study|Progressive Disease|5|||
164296255|NCT03037385|593460092|FG004|Overall Study|Progressive Disease|2|||
164296256|NCT03037385|593460093|FG005|Overall Study|Progressive Disease|0|||
164296257|NCT03037385|593460094|FG006|Overall Study|Progressive Disease|1|||
164296258|NCT03037385|593460095|FG007|Overall Study|Progressive Disease|0|||
164296259|NCT03037385|593460096|FG008|Overall Study|Progressive Disease|0|||
164296260|NCT03037385|593460097|FG009|Overall Study|Progressive Disease|30|||
164296261|NCT03037385|593460088|FG000|Overall Study|Withdrawal by Subject|0|||
164296262|NCT03037385|593460089|FG001|Overall Study|Withdrawal by Subject|0|||
164296263|NCT03037385|593460090|FG002|Overall Study|Withdrawal by Subject|1|||
164296264|NCT03037385|593460091|FG003|Overall Study|Withdrawal by Subject|2|||
164296265|NCT03037385|593460092|FG004|Overall Study|Withdrawal by Subject|1|||
164296266|NCT03037385|593460093|FG005|Overall Study|Withdrawal by Subject|3|||
164296267|NCT03037385|593460094|FG006|Overall Study|Withdrawal by Subject|0|||
164296268|NCT03037385|593460095|FG007|Overall Study|Withdrawal by Subject|0|||
164296269|NCT03037385|593460096|FG008|Overall Study|Withdrawal by Subject|0|||
164296270|NCT03037385|593460097|FG009|Overall Study|Withdrawal by Subject|52|||
164296271|NCT03037385|593460088|FG000|Overall Study|Reason Not Specified|0|||
164296272|NCT03037385|593460089|FG001|Overall Study|Reason Not Specified|1|||
164296273|NCT03037385|593460090|FG002|Overall Study|Reason Not Specified|0|||
164296274|NCT03037385|593460091|FG003|Overall Study|Reason Not Specified|4|||
164296275|NCT03037385|593460092|FG004|Overall Study|Reason Not Specified|3|||
164296276|NCT03037385|593460093|FG005|Overall Study|Reason Not Specified|6|||
164296277|NCT03037385|593460094|FG006|Overall Study|Reason Not Specified|2|||
164296278|NCT03037385|593460095|FG007|Overall Study|Reason Not Specified|0|||
164296279|NCT03037385|593460096|FG008|Overall Study|Reason Not Specified|1|||
164296280|NCT03037385|593460097|FG009|Overall Study|Reason Not Specified|181|||
164296281|NCT02318706|593460098|FG000|Double-blind Phase|Adverse Event|7|||
164296282|NCT02318706|593460099|FG001|Double-blind Phase|Adverse Event|4|||
164296283|NCT02318706|593460100|FG002|Double-blind Phase|Adverse Event|3|||
164296284|NCT02318706|593460101|FG003|Double-blind Phase|Adverse Event|10|||
164296285|NCT02318706|593460102|FG004|Double-blind Phase|Adverse Event|0|||
164296286|NCT02318706|593460098|FG000|Double-blind Phase|Lost to Follow-up|1|||
164296287|NCT02318706|593460099|FG001|Double-blind Phase|Lost to Follow-up|0|||
164296288|NCT02318706|593460100|FG002|Double-blind Phase|Lost to Follow-up|0|||
164296289|NCT02318706|593460101|FG003|Double-blind Phase|Lost to Follow-up|0|||
164296290|NCT02318706|593460102|FG004|Double-blind Phase|Lost to Follow-up|0|||
164296291|NCT02318706|593460098|FG000|Double-blind Phase|Protocol Violation|4|||
164296292|NCT02318706|593460099|FG001|Double-blind Phase|Protocol Violation|2|||
164296293|NCT02318706|593460100|FG002|Double-blind Phase|Protocol Violation|4|||
164296294|NCT02318706|593460101|FG003|Double-blind Phase|Protocol Violation|3|||
164296295|NCT02318706|593460102|FG004|Double-blind Phase|Protocol Violation|0|||
164296296|NCT02318706|593460098|FG000|Double-blind Phase|Withdrawal by Subject|9|||
164296297|NCT02318706|593460099|FG001|Double-blind Phase|Withdrawal by Subject|5|||
164005318|NCT01386385|592385715|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
164296298|NCT02318706|593460100|FG002|Double-blind Phase|Withdrawal by Subject|7|||
164296299|NCT02318706|593460101|FG003|Double-blind Phase|Withdrawal by Subject|10|||
164296300|NCT02318706|593460102|FG004|Double-blind Phase|Withdrawal by Subject|0|||
164296301|NCT02318706|593460098|FG000|Double-blind Phase|Other|4|||
164296302|NCT02318706|593460099|FG001|Double-blind Phase|Other|1|||
164296303|NCT02318706|593460100|FG002|Double-blind Phase|Other|2|||
164296304|NCT02318706|593460101|FG003|Double-blind Phase|Other|1|||
164296305|NCT02318706|593460102|FG004|Double-blind Phase|Other|0|||
164296306|NCT02318706|593460098|FG000|Double-blind Phase|Death|0|||
164296307|NCT02318706|593460099|FG001|Double-blind Phase|Death|0|||
164296308|NCT02318706|593460100|FG002|Double-blind Phase|Death|2|||
164296309|NCT02318706|593460101|FG003|Double-blind Phase|Death|0|||
164296310|NCT02318706|593460102|FG004|Double-blind Phase|Death|0|||
164296311|NCT02318706|593460098|FG000|Open-label Extension Phase|Adverse Event|0|||
164296312|NCT02318706|593460099|FG001|Open-label Extension Phase|Adverse Event|0|||
164296313|NCT02318706|593460100|FG002|Open-label Extension Phase|Adverse Event|0|||
164296314|NCT02318706|593460101|FG003|Open-label Extension Phase|Adverse Event|0|||
164296315|NCT02318706|593460102|FG004|Open-label Extension Phase|Adverse Event|21|||
164296316|NCT02318706|593460098|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
164296317|NCT02318706|593460099|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
164296318|NCT02318706|593460100|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
164296319|NCT02318706|593460101|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
164296320|NCT02318706|593460102|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
164296321|NCT02318706|593460098|FG000|Open-label Extension Phase|Death|0|||
164296322|NCT02318706|593460099|FG001|Open-label Extension Phase|Death|0|||
164296323|NCT02318706|593460100|FG002|Open-label Extension Phase|Death|0|||
164296324|NCT02318706|593460101|FG003|Open-label Extension Phase|Death|0|||
164296325|NCT02318706|593460102|FG004|Open-label Extension Phase|Death|1|||
164296326|NCT02318706|593460098|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
164296327|NCT02318706|593460099|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
164296328|NCT02318706|593460100|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
164296329|NCT02318706|593460101|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
164296330|NCT02318706|593460102|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
164296331|NCT04328077|593460103|FG000|Overall Study|Lost to Follow-up|0|||
164296332|NCT04328077|593460104|FG001|Overall Study|Lost to Follow-up|1|||
164296333|NCT04328077|593460105|FG002|Overall Study|Lost to Follow-up|0|||
164296334|NCT04328077|593460106|FG003|Overall Study|Lost to Follow-up|0|||
164296335|NCT04328077|593460103|FG000|Overall Study|Withdrawal by Subject|0|||
164296336|NCT04328077|593460104|FG001|Overall Study|Withdrawal by Subject|1|||
164296337|NCT04328077|593460105|FG002|Overall Study|Withdrawal by Subject|1|||
164296338|NCT04328077|593460106|FG003|Overall Study|Withdrawal by Subject|3|||
164296339|NCT01456039|593460107|FG000|Phase 1 (First Step)|Disease Progression|1|||
164296340|NCT01456039|593460108|FG001|Phase 1 (First Step)|Disease Progression|1|||
164296341|NCT01456039|593460109|FG002|Phase 1 (First Step)|Disease Progression|0|||
164296342|NCT01456039|593460107|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
164296343|NCT01456039|593460108|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
164296344|NCT01456039|593460109|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
164296345|NCT01456039|593460107|FG000|Phase 1 (First Step)|Adverse Event|0|||
164296346|NCT01456039|593460108|FG001|Phase 1 (First Step)|Adverse Event|3|||
164296347|NCT01456039|593460109|FG002|Phase 1 (First Step)|Adverse Event|0|||
164296348|NCT01456039|593460107|FG000|Phase 1 (First Step)|Other|0|||
164296349|NCT01456039|593460108|FG001|Phase 1 (First Step)|Other|1|||
164296350|NCT01456039|593460109|FG002|Phase 1 (First Step)|Other|0|||
164296351|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Disease Progression|0|||
164296352|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Disease Progression|0|||
164296353|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Disease Progression|17|||
164296354|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Adverse Event|0|||
164296355|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Adverse Event|0|||
164296356|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Adverse Event|10|||
164296357|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
164296358|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
164296359|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
164296360|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
164296361|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
164296362|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
164296363|NCT01456039|593460107|FG000|Phase 2 (Second Step)|Other|0|||
164296364|NCT01456039|593460108|FG001|Phase 2 (Second Step)|Other|0|||
164296365|NCT01456039|593460109|FG002|Phase 2 (Second Step)|Other|1|||
164296366|NCT01702311|593460113|FG000|Overall Study|Withdrawal by Subject|3|||
164296367|NCT01702311|593460114|FG001|Overall Study|Withdrawal by Subject|2|||
164296368|NCT01702311|593460113|FG000|Overall Study|Discharge less than 24 hours|10|||
164296369|NCT01702311|593460114|FG001|Overall Study|Discharge less than 24 hours|7|||
164296370|NCT01702311|593460113|FG000|Overall Study|Physician Decision|3|||
164296371|NCT01702311|593460114|FG001|Overall Study|Physician Decision|4|||
164296372|NCT04106557|593460121|FG000|Overall Study|Physician Decision|0|||
164296373|NCT04106557|593460122|FG001|Overall Study|Physician Decision|1|||
164296374|NCT04106557|593460123|FG002|Overall Study|Physician Decision|0|||
164296375|NCT04106557|593460121|FG000|Overall Study|Protocol Violation|0|||
164296376|NCT04106557|593460122|FG001|Overall Study|Protocol Violation|1|||
164296377|NCT04106557|593460123|FG002|Overall Study|Protocol Violation|0|||
163898445|NCT00943917|592001079|FG012|Stage I|hyperglycemia|0|||
164296378|NCT00313014|593460124|FG000|Overall Study|Withdrawal by Subject|11|||
164296379|NCT00313014|593460125|FG001|Overall Study|Withdrawal by Subject|7|||
164296380|NCT00313014|593460126|FG002|Overall Study|Withdrawal by Subject|5|||
164296381|NCT00313014|593460124|FG000|Overall Study|Adverse Event|14|||
164296382|NCT00313014|593460125|FG001|Overall Study|Adverse Event|29|||
164296383|NCT00313014|593460126|FG002|Overall Study|Adverse Event|16|||
164296384|NCT00313014|593460124|FG000|Overall Study|Lost to Follow-up|7|||
164296385|NCT00313014|593460125|FG001|Overall Study|Lost to Follow-up|6|||
164296386|NCT00313014|593460126|FG002|Overall Study|Lost to Follow-up|10|||
164296387|NCT00313014|593460124|FG000|Overall Study|Administrative|9|||
164296388|NCT00313014|593460125|FG001|Overall Study|Administrative|6|||
164296389|NCT00313014|593460126|FG002|Overall Study|Administrative|14|||
164296390|NCT00313014|593460124|FG000|Overall Study|Lack of Efficacy|52|||
164296391|NCT00313014|593460125|FG001|Overall Study|Lack of Efficacy|25|||
164296392|NCT00313014|593460126|FG002|Overall Study|Lack of Efficacy|16|||
164296393|NCT03714672|593460129|FG000|Overall Study|Adverse Event|0|||
164296394|NCT03714672|593460130|FG001|Overall Study|Adverse Event|0|||
164296395|NCT03714672|593460131|FG002|Overall Study|Adverse Event|3|||
164296396|NCT03714672|593460132|FG003|Overall Study|Adverse Event|0|||
164296397|NCT03714672|593460129|FG000|Overall Study|Physician Decision|0|||
164296398|NCT03714672|593460130|FG001|Overall Study|Physician Decision|1|||
164296399|NCT03714672|593460131|FG002|Overall Study|Physician Decision|0|||
164296400|NCT03714672|593460132|FG003|Overall Study|Physician Decision|0|||
164296401|NCT03714672|593460129|FG000|Overall Study|Other Reason|1|||
164296402|NCT03714672|593460130|FG001|Overall Study|Other Reason|2|||
164296403|NCT03714672|593460131|FG002|Overall Study|Other Reason|1|||
164296404|NCT03714672|593460132|FG003|Overall Study|Other Reason|1|||
164296405|NCT03714672|593460129|FG000|Overall Study|Lost to Follow-up|1|||
164296406|NCT03714672|593460130|FG001|Overall Study|Lost to Follow-up|1|||
164296407|NCT03714672|593460131|FG002|Overall Study|Lost to Follow-up|0|||
164296408|NCT03714672|593460132|FG003|Overall Study|Lost to Follow-up|0|||
164296409|NCT03007966|593460139|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
164296410|NCT03007966|593460140|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
164296411|NCT00474487|593460141|FG000|Overall Study|Withdrawal by Subject|6|||
164296412|NCT00474487|593460142|FG001|Overall Study|Withdrawal by Subject|0|||
164296413|NCT00474487|593460143|FG002|Overall Study|Withdrawal by Subject|0|||
164296414|NCT00474487|593460144|FG003|Overall Study|Withdrawal by Subject|0|||
164296415|NCT00474487|593460141|FG000|Overall Study|Lost to Follow-up|20|||
164296416|NCT00474487|593460142|FG001|Overall Study|Lost to Follow-up|1|||
164296417|NCT00474487|593460143|FG002|Overall Study|Lost to Follow-up|7|||
164296418|NCT00474487|593460144|FG003|Overall Study|Lost to Follow-up|0|||
164296419|NCT00474487|593460141|FG000|Overall Study|Inappropriate enrollment|4|||
164296420|NCT00474487|593460142|FG001|Overall Study|Inappropriate enrollment|0|||
164296421|NCT00474487|593460143|FG002|Overall Study|Inappropriate enrollment|7|||
164296422|NCT00474487|593460144|FG003|Overall Study|Inappropriate enrollment|0|||
164296423|NCT00474487|593460141|FG000|Overall Study|Death|0|||
164296424|NCT00474487|593460142|FG001|Overall Study|Death|1|||
164296425|NCT00474487|593460143|FG002|Overall Study|Death|0|||
164296426|NCT00474487|593460144|FG003|Overall Study|Death|0|||
164296427|NCT00419393|593460145|FG000|Overall Study|Adverse Event|5|||
164296428|NCT00419393|593460145|FG000|Overall Study|Protocol Violation|5|||
164296429|NCT00419393|593460145|FG000|Overall Study|Withdrawal by Subject|7|||
164296430|NCT00419393|593460145|FG000|Overall Study|Other: Sponsor request|3|||
164296431|NCT00419393|593460145|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
164296432|NCT00419393|593460145|FG000|Overall Study|Other: Site closure|1|||
164296433|NCT00419393|593460145|FG000|Overall Study|Other: Other health problems|1|||
164296434|NCT00419393|593460145|FG000|Overall Study|Other: Investigator decision|1|||
164296435|NCT00248625|593460148|FG000|Overall Study|Withdrawal by Subject|0|||
164296436|NCT00248625|593460149|FG001|Overall Study|Withdrawal by Subject|2|||
164296437|NCT03284710|593460152|FG000|Overall Study|Withdrawal by Subject|1|||
164296438|NCT03284710|593460153|FG001|Overall Study|Withdrawal by Subject|0|||
164296439|NCT03284710|593460154|FG002|Overall Study|Withdrawal by Subject|1|||
164296440|NCT03284710|593460155|FG003|Overall Study|Withdrawal by Subject|6|||
164296441|NCT03284710|593460152|FG000|Overall Study|Lost to Follow-up|3|||
164296442|NCT03284710|593460153|FG001|Overall Study|Lost to Follow-up|3|||
164296443|NCT03284710|593460154|FG002|Overall Study|Lost to Follow-up|1|||
164296444|NCT03284710|593460155|FG003|Overall Study|Lost to Follow-up|0|||
164296445|NCT03284710|593460152|FG000|Overall Study|Physician Decision|1|||
164296446|NCT03284710|593460153|FG001|Overall Study|Physician Decision|0|||
164296447|NCT03284710|593460154|FG002|Overall Study|Physician Decision|0|||
164296448|NCT03284710|593460155|FG003|Overall Study|Physician Decision|0|||
164296449|NCT03284710|593460152|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164296450|NCT03284710|593460153|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164296451|NCT03284710|593460154|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
164296452|NCT03284710|593460155|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
164296453|NCT03284710|593460152|FG000|Overall Study|HIV Infection|0|||
164296454|NCT03284710|593460153|FG001|Overall Study|HIV Infection|2|||
164296455|NCT03284710|593460154|FG002|Overall Study|HIV Infection|2|||
164296456|NCT03284710|593460155|FG003|Overall Study|HIV Infection|1|||
164296457|NCT05176314|593460158|FG000|Overall Study|Lost to Follow-up|2|||
164296458|NCT05176314|593460158|FG000|Overall Study|Physician Decision|1|||
164296459|NCT05176314|593460158|FG000|Overall Study|Adverse Event|1|||
164296460|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
164296461|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
164296462|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
164296463|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Death|9|||
164296464|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Death|0|||
164296465|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Death|0|||
164296466|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
164296467|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
164296468|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
164296469|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
164296470|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
164296471|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
164296472|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Other|135|||
164296473|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Other|0|||
164296474|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Other|0|||
164296475|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
164296476|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
164296477|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
164296478|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
164296479|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
164296480|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
164296481|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
164296482|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
164296483|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
164296484|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Other|3|||
164296485|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Other|0|||
164296486|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Other|0|||
164296487|NCT02118584|593460160|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
164296488|NCT02118584|593460161|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
164296489|NCT02118584|593460162|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
164296490|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
164296491|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
164296492|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
164296493|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
164296494|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
164296495|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
164296496|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
164296497|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
164296498|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
164296499|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
164296500|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
164296501|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
164296502|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
164296503|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
164296504|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
164296505|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
164296506|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
164296507|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
164296508|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164296509|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
164296510|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
164296511|NCT02118584|593460160|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
164296512|NCT02118584|593460161|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
164296513|NCT02118584|593460162|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
164296514|NCT01231984|593460163|FG000|Study Period 1|Withdrawal by Subject|0|||
164296515|NCT01231984|593460164|FG001|Study Period 1|Withdrawal by Subject|0|||
164296516|NCT01231984|593460165|FG002|Study Period 1|Withdrawal by Subject|0|||
164296517|NCT01231984|593460166|FG003|Study Period 1|Withdrawal by Subject|1|||
164296518|NCT01231984|593460163|FG000|Study Period 1|Lost to Follow-up|1|||
164296519|NCT01231984|593460164|FG001|Study Period 1|Lost to Follow-up|1|||
164296520|NCT01231984|593460165|FG002|Study Period 1|Lost to Follow-up|1|||
164296521|NCT01231984|593460166|FG003|Study Period 1|Lost to Follow-up|0|||
164296522|NCT01231984|593460163|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296523|NCT01231984|593460164|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296524|NCT01231984|593460165|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296525|NCT01231984|593460166|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
164296526|NCT01231984|593460163|FG000|Study Period 1|Screen Failure|0|||
164296527|NCT01231984|593460164|FG001|Study Period 1|Screen Failure|0|||
164296528|NCT01231984|593460165|FG002|Study Period 1|Screen Failure|0|||
164296529|NCT01231984|593460166|FG003|Study Period 1|Screen Failure|1|||
164296530|NCT01231984|593460163|FG000|Study Period 1|Non-compliance with study requirements|5|||
164296531|NCT01231984|593460164|FG001|Study Period 1|Non-compliance with study requirements|0|||
164296532|NCT01231984|593460165|FG002|Study Period 1|Non-compliance with study requirements|2|||
164296533|NCT01231984|593460166|FG003|Study Period 1|Non-compliance with study requirements|1|||
164296534|NCT01231984|593460163|FG000|Study Period 1|Protocol Violation|3|||
164296535|NCT01231984|593460164|FG001|Study Period 1|Protocol Violation|4|||
164296536|NCT01231984|593460165|FG002|Study Period 1|Protocol Violation|2|||
164296537|NCT01231984|593460166|FG003|Study Period 1|Protocol Violation|3|||
164296538|NCT01231984|593460163|FG000|Study Period 1|Adverse Event|1|||
164296539|NCT01231984|593460164|FG001|Study Period 1|Adverse Event|0|||
164296540|NCT01231984|593460165|FG002|Study Period 1|Adverse Event|0|||
164296541|NCT01231984|593460166|FG003|Study Period 1|Adverse Event|0|||
164296542|NCT01231984|593460163|FG000|Study Period 1|Other|0|||
164296543|NCT01231984|593460164|FG001|Study Period 1|Other|0|||
164296544|NCT01231984|593460165|FG002|Study Period 1|Other|0|||
164296545|NCT01231984|593460166|FG003|Study Period 1|Other|1|||
164296546|NCT01231984|593460163|FG000|Study Period 2|Withdrawal by Subject|1|||
164296547|NCT01231984|593460164|FG001|Study Period 2|Withdrawal by Subject|1|||
164296548|NCT01231984|593460165|FG002|Study Period 2|Withdrawal by Subject|0|||
164296549|NCT01231984|593460166|FG003|Study Period 2|Withdrawal by Subject|0|||
164296550|NCT01231984|593460163|FG000|Study Period 2|Lost to Follow-up|1|||
164296551|NCT01231984|593460164|FG001|Study Period 2|Lost to Follow-up|0|||
164296552|NCT01231984|593460165|FG002|Study Period 2|Lost to Follow-up|0|||
164296553|NCT01231984|593460166|FG003|Study Period 2|Lost to Follow-up|3|||
164296554|NCT01231984|593460163|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
164296555|NCT01231984|593460164|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
164296556|NCT01231984|593460165|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
164296557|NCT01231984|593460166|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
164296558|NCT00537394|593460172|FG000|First Year of Follow-up|Death|7|||
164296559|NCT00537394|593460173|FG001|First Year of Follow-up|Death|0|||
164296560|NCT00537394|593460174|FG002|First Year of Follow-up|Death|0|||
164296561|NCT00537394|593460172|FG000|First Year of Follow-up|Severe debilitation|1|||
164296562|NCT00537394|593460173|FG001|First Year of Follow-up|Severe debilitation|0|||
164296563|NCT00537394|593460174|FG002|First Year of Follow-up|Severe debilitation|1|||
164296564|NCT00537394|593460172|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
164296565|NCT00537394|593460173|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
164296566|NCT00537394|593460174|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
164296567|NCT00537394|593460172|FG000|First Year of Follow-up|Lost to Follow-up|1|||
164296568|NCT00537394|593460173|FG001|First Year of Follow-up|Lost to Follow-up|5|||
164296569|NCT00537394|593460174|FG002|First Year of Follow-up|Lost to Follow-up|1|||
164296570|NCT00537394|593460172|FG000|2nd Year of Follow-up|Death|4|||
164296571|NCT00537394|593460173|FG001|2nd Year of Follow-up|Death|1|||
164296572|NCT00537394|593460174|FG002|2nd Year of Follow-up|Death|2|||
164296573|NCT00537394|593460172|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
164296574|NCT00537394|593460173|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
164347535|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347536|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347537|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
164347538|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
164347539|NCT00642460|593648838|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164347540|NCT00642460|593648839|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164296575|NCT00537394|593460174|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
164296576|NCT00537394|593460172|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
164296577|NCT00537394|593460173|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
164296578|NCT00537394|593460174|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
164296579|NCT00537394|593460172|FG000|2nd Year of Follow-up|Clinic site closure|1|||
164296580|NCT00537394|593460173|FG001|2nd Year of Follow-up|Clinic site closure|0|||
164296581|NCT00537394|593460174|FG002|2nd Year of Follow-up|Clinic site closure|0|||
164296582|NCT01283139|593460175|FG000|Overall Study|Lost to Follow-up|5|||
164296583|NCT01283139|593460176|FG001|Overall Study|Lost to Follow-up|2|||
164296584|NCT01283139|593460177|FG002|Overall Study|Lost to Follow-up|3|||
164296585|NCT01283139|593460178|FG003|Overall Study|Lost to Follow-up|1|||
164296586|NCT01283139|593460175|FG000|Overall Study|Withdrawal by Subject|8|||
164296587|NCT01283139|593460176|FG001|Overall Study|Withdrawal by Subject|8|||
164296588|NCT01283139|593460177|FG002|Overall Study|Withdrawal by Subject|6|||
164296589|NCT01283139|593460178|FG003|Overall Study|Withdrawal by Subject|8|||
164296590|NCT01283139|593460175|FG000|Overall Study|Death|2|||
164296591|NCT01283139|593460176|FG001|Overall Study|Death|0|||
164296592|NCT01283139|593460177|FG002|Overall Study|Death|2|||
164296593|NCT01283139|593460178|FG003|Overall Study|Death|2|||
164296594|NCT01283139|593460175|FG000|Overall Study|Lack of Efficacy|1|||
164296595|NCT01283139|593460176|FG001|Overall Study|Lack of Efficacy|2|||
164296596|NCT01283139|593460177|FG002|Overall Study|Lack of Efficacy|2|||
164296597|NCT01283139|593460178|FG003|Overall Study|Lack of Efficacy|1|||
164296598|NCT01283139|593460175|FG000|Overall Study|Early termination due to AE/SAE|1|||
164296599|NCT01283139|593460176|FG001|Overall Study|Early termination due to AE/SAE|1|||
164296600|NCT01283139|593460177|FG002|Overall Study|Early termination due to AE/SAE|0|||
164296601|NCT01283139|593460178|FG003|Overall Study|Early termination due to AE/SAE|0|||
164296602|NCT01283139|593460175|FG000|Overall Study|Participant's refusal to continue|0|||
164296603|NCT01283139|593460176|FG001|Overall Study|Participant's refusal to continue|3|||
164296604|NCT01283139|593460177|FG002|Overall Study|Participant's refusal to continue|1|||
164296605|NCT01283139|593460178|FG003|Overall Study|Participant's refusal to continue|1|||
164296606|NCT01283139|593460175|FG000|Overall Study|Pregnancy|0|||
164296607|NCT01283139|593460176|FG001|Overall Study|Pregnancy|1|||
164296608|NCT01283139|593460177|FG002|Overall Study|Pregnancy|1|||
164296609|NCT01283139|593460178|FG003|Overall Study|Pregnancy|0|||
164296610|NCT01283139|593460175|FG000|Overall Study|Missed follow-up visit|0|||
164296611|NCT01283139|593460176|FG001|Overall Study|Missed follow-up visit|1|||
164296612|NCT01283139|593460177|FG002|Overall Study|Missed follow-up visit|2|||
164296613|NCT01283139|593460178|FG003|Overall Study|Missed follow-up visit|2|||
164296614|NCT01283139|593460175|FG000|Overall Study|Participant randomized in error|0|||
164296615|NCT01283139|593460176|FG001|Overall Study|Participant randomized in error|0|||
164296616|NCT01283139|593460177|FG002|Overall Study|Participant randomized in error|1|||
164296617|NCT01283139|593460178|FG003|Overall Study|Participant randomized in error|0|||
164296618|NCT00004563|593460183|FG000|Overall Study|Withdrawal by Subject|20|||
164296619|NCT00004563|593460184|FG001|Overall Study|Withdrawal by Subject|16|||
164296620|NCT00004563|593460183|FG000|Overall Study|Lack of Efficacy|3|||
164296621|NCT00004563|593460184|FG001|Overall Study|Lack of Efficacy|5|||
164296622|NCT00004563|593460183|FG000|Overall Study|Death|2|||
164296623|NCT00004563|593460184|FG001|Overall Study|Death|3|||
164296624|NCT01056822|593460185|FG000|Overall Study|Adverse Event|0|||
164296625|NCT01056822|593460186|FG001|Overall Study|Adverse Event|1|||
164296626|NCT01056822|593460185|FG000|Overall Study|Protocol Violation|6|||
164296627|NCT01056822|593460186|FG001|Overall Study|Protocol Violation|5|||
164296628|NCT01056822|593460185|FG000|Overall Study|Withdrawal by Subject|1|||
164296629|NCT01056822|593460186|FG001|Overall Study|Withdrawal by Subject|1|||
164347541|NCT00642460|593648840|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164347542|NCT00642460|593648841|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
164347543|NCT00642460|593648842|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
164347544|NCT00642460|593648843|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
164347545|NCT04171531|593648847|FG000|Overall Study|Lost to Follow-up|4|||
164089437|NCT00319956|592690299|FG000|Overall Study|Death|20|||
164089438|NCT00319956|592690300|FG001|Overall Study|Death|24|||
164089439|NCT02607800|592690301|FG000|Overall Study|Lost to Follow-up|7|||
164089440|NCT02607800|592690302|FG001|Overall Study|Lost to Follow-up|10|||
164089441|NCT02607800|592690301|FG000|Overall Study|Withdrew Consent|2|||
164089442|NCT02607800|592690302|FG001|Overall Study|Withdrew Consent|0|||
164089443|NCT02607800|592690301|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
164089444|NCT02607800|592690302|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
164089445|NCT01185288|592690303|FG000|Overall Study|Adverse Event|7|||
164089446|NCT01185288|592690304|FG001|Overall Study|Adverse Event|6|||
164089447|NCT01185288|592690303|FG000|Overall Study|Withdrawal by Subject|6|||
164089448|NCT01185288|592690304|FG001|Overall Study|Withdrawal by Subject|4|||
164089449|NCT01185288|592690303|FG000|Overall Study|Lost to Follow-up|2|||
164089450|NCT01185288|592690304|FG001|Overall Study|Lost to Follow-up|5|||
164089451|NCT01185288|592690303|FG000|Overall Study|Lack of Efficacy|2|||
164089452|NCT01185288|592690304|FG001|Overall Study|Lack of Efficacy|0|||
164089453|NCT01185288|592690303|FG000|Overall Study|Investigator discretion|1|||
164089454|NCT01185288|592690304|FG001|Overall Study|Investigator discretion|0|||
164089455|NCT01185288|592690303|FG000|Overall Study|Did not meet inclusion criteria|1|||
164089456|NCT01185288|592690304|FG001|Overall Study|Did not meet inclusion criteria|0|||
164089457|NCT01185288|592690303|FG000|Overall Study|Noncompliance|0|||
164089458|NCT01185288|592690304|FG001|Overall Study|Noncompliance|1|||
164296630|NCT01056822|593460185|FG000|Overall Study|Lost to Follow-up|1|||
164296631|NCT01056822|593460186|FG001|Overall Study|Lost to Follow-up|0|||
164296632|NCT00784563|593460187|FG000|Years 1 & 2|Withdrawal by Subject|3|||
164347546|NCT04171531|593648848|FG001|Overall Study|Lost to Follow-up|5|||
164089459|NCT01202747|592690305|FG000|Overall Study|Withdrawal by Subject|1|||
164089460|NCT01446913|592690306|FG000|Overall Study|Significant illness|1|||
164089461|NCT01446913|592690307|FG001|Overall Study|Significant illness|1|||
164296633|NCT00784563|593460188|FG001|Years 1 & 2|Withdrawal by Subject|2|||
164296634|NCT00784563|593460189|FG002|Years 1 & 2|Withdrawal by Subject|0|||
164296635|NCT00784563|593460187|FG000|Years 1 & 2|Adverse Event|0|||
164296636|NCT00784563|593460188|FG001|Years 1 & 2|Adverse Event|3|||
164296637|NCT00784563|593460189|FG002|Years 1 & 2|Adverse Event|0|||
164296638|NCT00784563|593460187|FG000|Year 3|Withdrawal by Subject|0|||
164296639|NCT00784563|593460188|FG001|Year 3|Withdrawal by Subject|0|||
164296640|NCT00784563|593460189|FG002|Year 3|Withdrawal by Subject|2|||
164296641|NCT00784563|593460187|FG000|Year 3|Adverse Event|0|||
163898446|NCT00943917|592001080|FG013|Stage I|hyperglycemia|0|||
163898447|NCT00943917|592001081|FG014|Stage I|hyperglycemia|0|||
163898448|NCT00943917|592001067|FG000|Stage I|A1C elevation|1|||
163898449|NCT00943917|592001068|FG001|Stage I|A1C elevation|0|||
163898450|NCT00943917|592001069|FG002|Stage I|A1C elevation|0|||
163898451|NCT00943917|592001070|FG003|Stage I|A1C elevation|0|||
163898452|NCT00943917|592001071|FG004|Stage I|A1C elevation|0|||
163898453|NCT00943917|592001072|FG005|Stage I|A1C elevation|0|||
163898454|NCT00943917|592001073|FG006|Stage I|A1C elevation|0|||
163898455|NCT00943917|592001074|FG007|Stage I|A1C elevation|0|||
163898456|NCT00943917|592001075|FG008|Stage I|A1C elevation|0|||
163898457|NCT00943917|592001076|FG009|Stage I|A1C elevation|0|||
163898458|NCT00943917|592001077|FG010|Stage I|A1C elevation|0|||
163898459|NCT00943917|592001078|FG011|Stage I|A1C elevation|0|||
163898460|NCT00943917|592001079|FG012|Stage I|A1C elevation|0|||
163898461|NCT00943917|592001080|FG013|Stage I|A1C elevation|0|||
163898462|NCT00943917|592001081|FG014|Stage I|A1C elevation|0|||
163898463|NCT00943917|592001067|FG000|Stage I|Withdrawal by Subject|2|||
163898464|NCT00943917|592001068|FG001|Stage I|Withdrawal by Subject|1|||
163898465|NCT00943917|592001069|FG002|Stage I|Withdrawal by Subject|2|||
163898466|NCT00943917|592001070|FG003|Stage I|Withdrawal by Subject|0|||
163898467|NCT00943917|592001071|FG004|Stage I|Withdrawal by Subject|0|||
163898468|NCT00943917|592001072|FG005|Stage I|Withdrawal by Subject|0|||
163898469|NCT00943917|592001073|FG006|Stage I|Withdrawal by Subject|0|||
163898470|NCT00943917|592001074|FG007|Stage I|Withdrawal by Subject|0|||
163898471|NCT00943917|592001075|FG008|Stage I|Withdrawal by Subject|0|||
163898472|NCT00943917|592001076|FG009|Stage I|Withdrawal by Subject|0|||
163898473|NCT00943917|592001077|FG010|Stage I|Withdrawal by Subject|0|||
163898474|NCT00943917|592001078|FG011|Stage I|Withdrawal by Subject|0|||
163898475|NCT00943917|592001079|FG012|Stage I|Withdrawal by Subject|0|||
163898476|NCT00943917|592001080|FG013|Stage I|Withdrawal by Subject|0|||
163898477|NCT00943917|592001081|FG014|Stage I|Withdrawal by Subject|0|||
163898478|NCT00943917|592001067|FG000|Stage II|Adverse Event|0|||
163898479|NCT00943917|592001068|FG001|Stage II|Adverse Event|0|||
163898480|NCT00943917|592001069|FG002|Stage II|Adverse Event|0|||
163898481|NCT00943917|592001070|FG003|Stage II|Adverse Event|0|||
163898482|NCT00943917|592001071|FG004|Stage II|Adverse Event|0|||
163898483|NCT00943917|592001072|FG005|Stage II|Adverse Event|1|||
163898484|NCT00943917|592001073|FG006|Stage II|Adverse Event|3|||
163898485|NCT00943917|592001074|FG007|Stage II|Adverse Event|0|||
163898486|NCT00943917|592001075|FG008|Stage II|Adverse Event|1|||
163898487|NCT00943917|592001076|FG009|Stage II|Adverse Event|0|||
163898488|NCT00943917|592001077|FG010|Stage II|Adverse Event|0|||
163898489|NCT00943917|592001078|FG011|Stage II|Adverse Event|0|||
163898490|NCT00943917|592001079|FG012|Stage II|Adverse Event|0|||
163898491|NCT00943917|592001080|FG013|Stage II|Adverse Event|0|||
163898492|NCT00943917|592001081|FG014|Stage II|Adverse Event|0|||
163898493|NCT00943917|592001067|FG000|Stage II|Withdrawal by Subject|0|||
163898494|NCT00943917|592001068|FG001|Stage II|Withdrawal by Subject|0|||
163898495|NCT00943917|592001069|FG002|Stage II|Withdrawal by Subject|0|||
163898496|NCT00943917|592001070|FG003|Stage II|Withdrawal by Subject|0|||
163898497|NCT00943917|592001071|FG004|Stage II|Withdrawal by Subject|0|||
163898498|NCT00943917|592001072|FG005|Stage II|Withdrawal by Subject|1|||
163898499|NCT00943917|592001073|FG006|Stage II|Withdrawal by Subject|0|||
163898500|NCT00943917|592001074|FG007|Stage II|Withdrawal by Subject|0|||
163898501|NCT00943917|592001075|FG008|Stage II|Withdrawal by Subject|0|||
163898502|NCT00943917|592001076|FG009|Stage II|Withdrawal by Subject|0|||
163898503|NCT00943917|592001077|FG010|Stage II|Withdrawal by Subject|0|||
163898504|NCT00943917|592001078|FG011|Stage II|Withdrawal by Subject|0|||
163898505|NCT00943917|592001079|FG012|Stage II|Withdrawal by Subject|0|||
163898506|NCT00943917|592001080|FG013|Stage II|Withdrawal by Subject|0|||
163898507|NCT00943917|592001081|FG014|Stage II|Withdrawal by Subject|0|||
163898508|NCT00943917|592001067|FG000|Stage II|Pregnancy|0|||
163898509|NCT00943917|592001068|FG001|Stage II|Pregnancy|0|||
164005319|NCT01386385|592385716|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
164005320|NCT01386385|592385717|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
164005321|NCT01386385|592385718|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
163898510|NCT00943917|592001069|FG002|Stage II|Pregnancy|0|||
163898511|NCT00943917|592001070|FG003|Stage II|Pregnancy|0|||
163898512|NCT00943917|592001071|FG004|Stage II|Pregnancy|0|||
163898513|NCT00943917|592001072|FG005|Stage II|Pregnancy|1|||
163898514|NCT00943917|592001073|FG006|Stage II|Pregnancy|0|||
163898515|NCT00943917|592001074|FG007|Stage II|Pregnancy|0|||
163898516|NCT00943917|592001075|FG008|Stage II|Pregnancy|0|||
163898517|NCT00943917|592001076|FG009|Stage II|Pregnancy|0|||
163898518|NCT00943917|592001077|FG010|Stage II|Pregnancy|0|||
163898519|NCT00943917|592001078|FG011|Stage II|Pregnancy|0|||
163898520|NCT00943917|592001079|FG012|Stage II|Pregnancy|0|||
163898521|NCT00943917|592001080|FG013|Stage II|Pregnancy|0|||
163898522|NCT00943917|592001081|FG014|Stage II|Pregnancy|0|||
163898523|NCT00943917|592001067|FG000|Stage II Continuation|Adverse Event|0|||
163898524|NCT00943917|592001068|FG001|Stage II Continuation|Adverse Event|0|||
163898525|NCT00943917|592001069|FG002|Stage II Continuation|Adverse Event|0|||
163898526|NCT00943917|592001070|FG003|Stage II Continuation|Adverse Event|0|||
163898527|NCT00943917|592001071|FG004|Stage II Continuation|Adverse Event|0|||
163898528|NCT00943917|592001072|FG005|Stage II Continuation|Adverse Event|0|||
163898529|NCT00943917|592001073|FG006|Stage II Continuation|Adverse Event|0|||
163898530|NCT00943917|592001074|FG007|Stage II Continuation|Adverse Event|0|||
163898531|NCT00943917|592001075|FG008|Stage II Continuation|Adverse Event|0|||
163898532|NCT00943917|592001076|FG009|Stage II Continuation|Adverse Event|0|||
163898533|NCT00943917|592001077|FG010|Stage II Continuation|Adverse Event|0|||
164296642|NCT00784563|593460188|FG001|Year 3|Adverse Event|0|||
164296643|NCT00784563|593460189|FG002|Year 3|Adverse Event|1|||
164296644|NCT00762164|593460190|FG000|Overall Study|Lost to Follow-up|1|||
164296645|NCT00762164|593460191|FG001|Overall Study|Lost to Follow-up|1|||
164296646|NCT00762164|593460190|FG000|Overall Study|Discontinued medication|2|||
164296647|NCT00762164|593460191|FG001|Overall Study|Discontinued medication|0|||
164296648|NCT00762164|593460190|FG000|Overall Study|Withdrawal by Subject|0|||
164296649|NCT00762164|593460191|FG001|Overall Study|Withdrawal by Subject|1|||
164296650|NCT01844765|593460194|FG000|Overall Study|Adverse Event|6|||
164296651|NCT01844765|593460195|FG001|Overall Study|Adverse Event|8|||
164296652|NCT01844765|593460194|FG000|Overall Study|Withdrawal by Subject|2|||
164296653|NCT01844765|593460195|FG001|Overall Study|Withdrawal by Subject|3|||
164296654|NCT01844765|593460194|FG000|Overall Study|Disease progression|1|||
164296655|NCT01844765|593460195|FG001|Overall Study|Disease progression|0|||
164296656|NCT01844765|593460194|FG000|Overall Study|Administrative problems|3|||
164296657|NCT01844765|593460195|FG001|Overall Study|Administrative problems|4|||
164296658|NCT01844765|593460194|FG000|Overall Study|Protocol deviation|2|||
164296659|NCT01844765|593460195|FG001|Overall Study|Protocol deviation|0|||
164296660|NCT01844765|593460194|FG000|Overall Study|Untreated|1|||
164296661|NCT01844765|593460195|FG001|Overall Study|Untreated|0|||
164296662|NCT02025179|593460196|FG000|Overall Study|Lost to Follow-up|0|||
164296663|NCT02025179|593460197|FG001|Overall Study|Lost to Follow-up|0|||
164296664|NCT02025179|593460198|FG002|Overall Study|Lost to Follow-up|1|||
164296665|NCT00556075|593460199|FG000|Overall Study|Lost to Follow-up|3|||
164296666|NCT00556075|593460200|FG001|Overall Study|Lost to Follow-up|0|||
164296667|NCT00556075|593460201|FG002|Overall Study|Lost to Follow-up|3|||
164296668|NCT00556075|593460199|FG000|Overall Study|Withdrawal by Subject|3|||
164296669|NCT00556075|593460200|FG001|Overall Study|Withdrawal by Subject|3|||
164296670|NCT00556075|593460201|FG002|Overall Study|Withdrawal by Subject|0|||
164296671|NCT00556075|593460199|FG000|Overall Study|Protocol Violation|1|||
164296672|NCT00556075|593460200|FG001|Overall Study|Protocol Violation|1|||
164296673|NCT00556075|593460201|FG002|Overall Study|Protocol Violation|3|||
164296674|NCT00556075|593460199|FG000|Overall Study|Not eligible|1|||
164296675|NCT00556075|593460200|FG001|Overall Study|Not eligible|1|||
164296676|NCT00556075|593460201|FG002|Overall Study|Not eligible|2|||
164296677|NCT00556075|593460199|FG000|Overall Study|Adverse Event|1|||
164296678|NCT00556075|593460200|FG001|Overall Study|Adverse Event|2|||
164296679|NCT00556075|593460201|FG002|Overall Study|Adverse Event|0|||
164296680|NCT00556075|593460199|FG000|Overall Study|Personal issues|4|||
164296681|NCT00556075|593460200|FG001|Overall Study|Personal issues|1|||
164296682|NCT00556075|593460201|FG002|Overall Study|Personal issues|0|||
164296683|NCT00556075|593460199|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
164296684|NCT00556075|593460200|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
164296685|NCT00556075|593460201|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
164296686|NCT00601835|593460202|FG000|Overall Study|Withdrawal by Subject|9|||
164296687|NCT00601835|593460203|FG001|Overall Study|Withdrawal by Subject|6|||
164296688|NCT00601835|593460202|FG000|Overall Study|Physician Decision|1|||
164296689|NCT00601835|593460203|FG001|Overall Study|Physician Decision|0|||
164296690|NCT00601835|593460202|FG000|Overall Study|Lost to Follow-up|37|||
164296691|NCT00601835|593460203|FG001|Overall Study|Lost to Follow-up|5|||
164296692|NCT00601835|593460202|FG000|Overall Study|Adverse Event|1|||
164296693|NCT00601835|593460203|FG001|Overall Study|Adverse Event|1|||
164296694|NCT00601835|593460202|FG000|Overall Study|Relocate|12|||
164296695|NCT00601835|593460203|FG001|Overall Study|Relocate|2|||
164296696|NCT01927497|593460204|FG000|Overall Study|Death|0|||
163898534|NCT00943917|592001078|FG011|Stage II Continuation|Adverse Event|1|||
164296697|NCT01927497|593460205|FG001|Overall Study|Death|1|||
164296698|NCT01927497|593460204|FG000|Overall Study|Protocol Violation|2|||
164296699|NCT01927497|593460205|FG001|Overall Study|Protocol Violation|0|||
164296700|NCT00395746|593460206|FG000|Overall Study|Adverse Event|5|||
164296701|NCT00395746|593460207|FG001|Overall Study|Adverse Event|2|||
164296702|NCT00395746|593460208|FG002|Overall Study|Adverse Event|2|||
164296703|NCT00395746|593460206|FG000|Overall Study|Protocol Violation|0|||
164296704|NCT00395746|593460207|FG001|Overall Study|Protocol Violation|1|||
164296705|NCT00395746|593460208|FG002|Overall Study|Protocol Violation|0|||
164296706|NCT00395746|593460206|FG000|Overall Study|Lack of Efficacy|2|||
164296707|NCT00395746|593460207|FG001|Overall Study|Lack of Efficacy|0|||
164296708|NCT00395746|593460208|FG002|Overall Study|Lack of Efficacy|17|||
164296709|NCT00395746|593460206|FG000|Overall Study|Hypoglycaemia|2|||
164296710|NCT00395746|593460207|FG001|Overall Study|Hypoglycaemia|1|||
164296711|NCT00395746|593460208|FG002|Overall Study|Hypoglycaemia|0|||
164296712|NCT00395746|593460206|FG000|Overall Study|Subject decision|0|||
164296713|NCT00395746|593460207|FG001|Overall Study|Subject decision|0|||
164296714|NCT00395746|593460208|FG002|Overall Study|Subject decision|1|||
164296715|NCT00395746|593460206|FG000|Overall Study|Withdrawal of consent|0|||
164296716|NCT00395746|593460207|FG001|Overall Study|Withdrawal of consent|0|||
164296717|NCT00395746|593460208|FG002|Overall Study|Withdrawal of consent|1|||
164296718|NCT00395746|593460206|FG000|Overall Study|Difficultulty in use of device|0|||
164296719|NCT00395746|593460207|FG001|Overall Study|Difficultulty in use of device|0|||
164296720|NCT00395746|593460208|FG002|Overall Study|Difficultulty in use of device|1|||
164296721|NCT00395746|593460206|FG000|Overall Study|Unable to visit site on schedule|1|||
164296722|NCT00395746|593460207|FG001|Overall Study|Unable to visit site on schedule|0|||
164296723|NCT00395746|593460208|FG002|Overall Study|Unable to visit site on schedule|0|||
164296724|NCT04528641|593460209|FG000|Overall Study|Withdrawal by Subject|0|||
164296725|NCT04528641|593460210|FG001|Overall Study|Withdrawal by Subject|0|||
164296726|NCT04528641|593460211|FG002|Overall Study|Withdrawal by Subject|0|||
164296727|NCT04528641|593460212|FG003|Overall Study|Withdrawal by Subject|1|||
164296728|NCT04528641|593460213|FG004|Overall Study|Withdrawal by Subject|0|||
164296729|NCT04528641|593460214|FG005|Overall Study|Withdrawal by Subject|1|||
164296730|NCT03914417|593460215|FG000|Overall Study|Withdrawal by Subject|2|||
164296731|NCT00517296|593460220|FG000|Overall Study|Withdrawal by Subject|1|||
164296732|NCT00517296|593460221|FG001|Overall Study|Withdrawal by Subject|0|||
164296733|NCT04764162|593460224|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
164296734|NCT04764162|593460225|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
164296735|NCT00791934|593460226|FG000|Overall Study|Withdrawal by Subject|2|||
164296736|NCT00791934|593460226|FG000|Overall Study|Did not consent for extended follow-up|13|||
164296737|NCT01300728|593460227|FG000|Overall Study|Withdrawal by Subject|1|||
164296738|NCT01300728|593460228|FG001|Overall Study|Withdrawal by Subject|1|||
164296739|NCT01300728|593460227|FG000|Overall Study|Physician Decision|1|||
164296740|NCT01300728|593460228|FG001|Overall Study|Physician Decision|0|||
164296741|NCT00506350|593460229|FG000|Overall Study|Serious Adverse Event|1|||
164296742|NCT00506350|593460230|FG001|Overall Study|Serious Adverse Event|0|||
164296743|NCT00506350|593460231|FG002|Overall Study|Serious Adverse Event|0|||
164296744|NCT00506350|593460232|FG003|Overall Study|Serious Adverse Event|0|||
164296745|NCT00506350|593460233|FG004|Overall Study|Serious Adverse Event|0|||
164296746|NCT00506350|593460234|FG005|Overall Study|Serious Adverse Event|0|||
164296747|NCT00506350|593460235|FG006|Overall Study|Serious Adverse Event|0|||
164296748|NCT00506350|593460236|FG007|Overall Study|Serious Adverse Event|0|||
164296749|NCT00506350|593460237|FG008|Overall Study|Serious Adverse Event|0|||
164296750|NCT00506350|593460229|FG000|Overall Study|Adverse Event|0|||
164296751|NCT00506350|593460230|FG001|Overall Study|Adverse Event|0|||
164296752|NCT00506350|593460231|FG002|Overall Study|Adverse Event|0|||
164296753|NCT00506350|593460232|FG003|Overall Study|Adverse Event|0|||
164296754|NCT00506350|593460233|FG004|Overall Study|Adverse Event|0|||
164296755|NCT00506350|593460234|FG005|Overall Study|Adverse Event|0|||
164296756|NCT00506350|593460235|FG006|Overall Study|Adverse Event|0|||
164296757|NCT00506350|593460236|FG007|Overall Study|Adverse Event|1|||
164296758|NCT00506350|593460237|FG008|Overall Study|Adverse Event|1|||
164296759|NCT00506350|593460229|FG000|Overall Study|Protocol Violation|0|||
164296760|NCT00506350|593460230|FG001|Overall Study|Protocol Violation|0|||
164296761|NCT00506350|593460231|FG002|Overall Study|Protocol Violation|1|||
164296762|NCT00506350|593460232|FG003|Overall Study|Protocol Violation|0|||
164296763|NCT00506350|593460233|FG004|Overall Study|Protocol Violation|0|||
164296764|NCT00506350|593460234|FG005|Overall Study|Protocol Violation|0|||
164296765|NCT00506350|593460235|FG006|Overall Study|Protocol Violation|1|||
164296766|NCT00506350|593460236|FG007|Overall Study|Protocol Violation|0|||
164296767|NCT00506350|593460237|FG008|Overall Study|Protocol Violation|0|||
164296768|NCT00506350|593460229|FG000|Overall Study|Withdrawal by Subject|0|||
164296769|NCT00506350|593460230|FG001|Overall Study|Withdrawal by Subject|1|||
164296770|NCT00506350|593460231|FG002|Overall Study|Withdrawal by Subject|1|||
164296771|NCT00506350|593460232|FG003|Overall Study|Withdrawal by Subject|1|||
164296772|NCT00506350|593460233|FG004|Overall Study|Withdrawal by Subject|4|||
164296773|NCT00506350|593460234|FG005|Overall Study|Withdrawal by Subject|1|||
164296774|NCT00506350|593460235|FG006|Overall Study|Withdrawal by Subject|1|||
164296775|NCT00506350|593460236|FG007|Overall Study|Withdrawal by Subject|2|||
164296776|NCT00506350|593460237|FG008|Overall Study|Withdrawal by Subject|0|||
164296777|NCT00506350|593460229|FG000|Overall Study|Lost to Follow-up|1|||
164296778|NCT00506350|593460230|FG001|Overall Study|Lost to Follow-up|1|||
164296779|NCT00506350|593460231|FG002|Overall Study|Lost to Follow-up|1|||
164296780|NCT00506350|593460232|FG003|Overall Study|Lost to Follow-up|1|||
164296781|NCT00506350|593460233|FG004|Overall Study|Lost to Follow-up|2|||
164296782|NCT00506350|593460234|FG005|Overall Study|Lost to Follow-up|1|||
164296783|NCT00506350|593460235|FG006|Overall Study|Lost to Follow-up|0|||
164296784|NCT00506350|593460236|FG007|Overall Study|Lost to Follow-up|0|||
164296785|NCT00506350|593460237|FG008|Overall Study|Lost to Follow-up|2|||
164296786|NCT00506350|593460229|FG000|Overall Study|Medical Reason|0|||
164296787|NCT00506350|593460230|FG001|Overall Study|Medical Reason|0|||
164005322|NCT01386385|592385719|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
164296788|NCT00506350|593460231|FG002|Overall Study|Medical Reason|0|||
164296789|NCT00506350|593460232|FG003|Overall Study|Medical Reason|0|||
164296790|NCT00506350|593460233|FG004|Overall Study|Medical Reason|1|||
164296791|NCT00506350|593460234|FG005|Overall Study|Medical Reason|0|||
164296792|NCT00506350|593460235|FG006|Overall Study|Medical Reason|0|||
164296793|NCT00506350|593460236|FG007|Overall Study|Medical Reason|0|||
164296794|NCT00506350|593460237|FG008|Overall Study|Medical Reason|0|||
164296795|NCT00506350|593460229|FG000|Overall Study|Other|1|||
164296796|NCT00506350|593460230|FG001|Overall Study|Other|1|||
164296797|NCT00506350|593460231|FG002|Overall Study|Other|3|||
164296798|NCT00506350|593460232|FG003|Overall Study|Other|0|||
164296799|NCT00506350|593460233|FG004|Overall Study|Other|3|||
164296800|NCT00506350|593460234|FG005|Overall Study|Other|0|||
164296801|NCT00506350|593460235|FG006|Overall Study|Other|0|||
164296802|NCT00506350|593460236|FG007|Overall Study|Other|2|||
164296803|NCT00506350|593460237|FG008|Overall Study|Other|2|||
164296804|NCT00945009|593460238|FG000|Overall Study|Lack of Efficacy|10|||
164296805|NCT00945009|593460239|FG001|Overall Study|Lack of Efficacy|0|||
164296806|NCT00945009|593460240|FG002|Overall Study|Lack of Efficacy|0|||
164296807|NCT00945009|593460238|FG000|Overall Study|Physician Decision|21|||
164296808|NCT00945009|593460239|FG001|Overall Study|Physician Decision|4|||
164296809|NCT00945009|593460240|FG002|Overall Study|Physician Decision|3|||
164296810|NCT00945009|593460238|FG000|Overall Study|Protocol Violation|6|||
164296811|NCT00945009|593460239|FG001|Overall Study|Protocol Violation|1|||
164296812|NCT00945009|593460240|FG002|Overall Study|Protocol Violation|0|||
164296813|NCT00945009|593460238|FG000|Overall Study|Withdrawal by Subject|1|||
164296814|NCT00945009|593460239|FG001|Overall Study|Withdrawal by Subject|0|||
164296815|NCT00945009|593460240|FG002|Overall Study|Withdrawal by Subject|0|||
164296816|NCT00945009|593460238|FG000|Overall Study|Ineligible|6|||
164296817|NCT00945009|593460239|FG001|Overall Study|Ineligible|1|||
164296818|NCT00945009|593460240|FG002|Overall Study|Ineligible|0|||
164296819|NCT00945009|593460238|FG000|Overall Study|Inevaluable|0|||
164296820|NCT00945009|593460239|FG001|Overall Study|Inevaluable|1|||
164296821|NCT00945009|593460240|FG002|Overall Study|Inevaluable|0|||
164296822|NCT00945009|593460238|FG000|Overall Study|Refusal of further protocol|1|||
164296823|NCT00945009|593460239|FG001|Overall Study|Refusal of further protocol|0|||
164296824|NCT00945009|593460240|FG002|Overall Study|Refusal of further protocol|0|||
164296825|NCT04972162|593460243|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
164296826|NCT04972162|593460244|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
164296827|NCT00781768|593461884|FG000|Overall Study|Not transplanted.|0|||
164296828|NCT00781768|593461885|FG001|Overall Study|Not transplanted.|2|||
164296829|NCT02458313|593461886|FG000|Overall Study|Withdrawal by Subject|6|||
164296830|NCT02458313|593461887|FG001|Overall Study|Withdrawal by Subject|8|||
164296831|NCT02458313|593461886|FG000|Overall Study|Excluded for motion during MRI|1|||
164296832|NCT02458313|593461887|FG001|Overall Study|Excluded for motion during MRI|2|||
164296833|NCT00199381|593461891|FG000|Overall Study|Withdrawal by Subject|38|||
164296834|NCT00199381|593461891|FG000|Overall Study|Adverse Event|73|||
164296835|NCT00199381|593461891|FG000|Overall Study|Protocol Violation|6|||
164296836|NCT00199381|593461891|FG000|Overall Study|Lack of Efficacy|27|||
164296837|NCT00199381|593461891|FG000|Overall Study|Not including due to early termination|37|||
164296838|NCT00199381|593461891|FG000|Overall Study|Study termination by Sponsor|323|||
164296839|NCT00385671|593461893|FG000|Overall Study|Adverse Event|14|||
164296840|NCT00385671|593461894|FG001|Overall Study|Adverse Event|27|||
164296841|NCT00385671|593461895|FG002|Overall Study|Adverse Event|18|||
164296842|NCT00385671|593461893|FG000|Overall Study|Lack of Efficacy|5|||
164296843|NCT00385671|593461894|FG001|Overall Study|Lack of Efficacy|9|||
164296844|NCT00385671|593461895|FG002|Overall Study|Lack of Efficacy|5|||
164296845|NCT00385671|593461893|FG000|Overall Study|Lost to Follow-up|6|||
164005323|NCT03746080|592385721|FG000|Overall Study|In follow up|2|||
164296846|NCT00385671|593461894|FG001|Overall Study|Lost to Follow-up|6|||
164347547|NCT04171531|593648847|FG000|Overall Study|Consent only through 6 months|1|||
164347548|NCT04171531|593648848|FG001|Overall Study|Consent only through 6 months|1|||
164347549|NCT04171531|593648847|FG000|Overall Study|Insurance did not cover procedure|0|||
164347550|NCT04171531|593648848|FG001|Overall Study|Insurance did not cover procedure|1|||
164347551|NCT04171531|593648847|FG000|Overall Study|Physician Decision|0|||
164005324|NCT03746080|592385721|FG000|Overall Study|Death|15|||
164005325|NCT01843374|592385722|FG000|Overall Study|Death|155|||
164296847|NCT00385671|593461895|FG002|Overall Study|Lost to Follow-up|5|||
164296848|NCT00385671|593461893|FG000|Overall Study|Physician Decision|2|||
164296849|NCT00385671|593461894|FG001|Overall Study|Physician Decision|1|||
164296850|NCT00385671|593461895|FG002|Overall Study|Physician Decision|2|||
164296851|NCT00385671|593461893|FG000|Overall Study|Protocol Violation|5|||
164296852|NCT00385671|593461894|FG001|Overall Study|Protocol Violation|2|||
164296853|NCT00385671|593461895|FG002|Overall Study|Protocol Violation|1|||
164347552|NCT04171531|593648848|FG001|Overall Study|Physician Decision|3|||
164005326|NCT01843374|592385723|FG001|Overall Study|Death|313|||
164296854|NCT00385671|593461893|FG000|Overall Study|Sponsor Decision|2|||
164296855|NCT00385671|593461894|FG001|Overall Study|Sponsor Decision|2|||
164296856|NCT00385671|593461895|FG002|Overall Study|Sponsor Decision|1|||
163898535|NCT00943917|592001079|FG012|Stage II Continuation|Adverse Event|2|||
163898536|NCT00943917|592001080|FG013|Stage II Continuation|Adverse Event|1|||
164296857|NCT00385671|593461893|FG000|Overall Study|Withdrawal by Subject|4|||
164296858|NCT00385671|593461894|FG001|Overall Study|Withdrawal by Subject|4|||
164296859|NCT00385671|593461895|FG002|Overall Study|Withdrawal by Subject|4|||
164296860|NCT02608684|593461896|FG000|Overall Study|Physician Decision|2|||
164296861|NCT02608684|593461896|FG000|Overall Study|Withdrawal by Subject|1|||
164296862|NCT00751296|593461897|FG000|Overall Study|Adverse Event|2|||
164296863|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
164296864|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
164296865|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
164296866|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
164296867|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
164296868|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
164296869|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
164296870|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
164296871|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
164296872|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
164296873|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
164296874|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
164296875|NCT01972217|593461898|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
164296876|NCT01972217|593461899|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
164296877|NCT01972217|593461900|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
164296878|NCT01972217|593461901|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
164296879|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Death|0|||
164296880|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Death|0|||
164296881|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Death|43|||
164296882|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Death|44|||
164296883|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
164296884|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
164296885|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
164296886|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
164296887|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
164296888|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
164296889|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
164296890|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
164296891|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
164296892|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
164296893|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
164296894|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
164296895|NCT01972217|593461898|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
164296896|NCT01972217|593461899|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
164296897|NCT01972217|593461900|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
164296898|NCT01972217|593461901|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
164296899|NCT03453164|593461904|FG000|Overall Study|Lack of Efficacy|16|||
164296900|NCT03453164|593461904|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
164296901|NCT01428258|593461905|FG000|Intervention 1|Withdrawal by Subject|2|||
164296902|NCT01428258|593461906|FG001|Intervention 1|Withdrawal by Subject|0|||
164296903|NCT03566511|593461907|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
164296904|NCT03566511|593461908|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
164296905|NCT02939287|593461913|FG000|Overall Study|met exclusion criteria|1|||
164296906|NCT02939287|593461914|FG001|Overall Study|met exclusion criteria|1|||
164296907|NCT02939287|593461915|FG002|Overall Study|met exclusion criteria|1|||
164296908|NCT02939287|593461913|FG000|Overall Study|Did not complete survey|2|||
164296909|NCT02939287|593461914|FG001|Overall Study|Did not complete survey|2|||
164296910|NCT02939287|593461915|FG002|Overall Study|Did not complete survey|0|||
164296911|NCT02939287|593461913|FG000|Overall Study|Withdrawal by Subject|1|||
164296912|NCT02939287|593461914|FG001|Overall Study|Withdrawal by Subject|1|||
164296913|NCT02939287|593461915|FG002|Overall Study|Withdrawal by Subject|0|||
164296914|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
164296915|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
164296916|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
164347553|NCT04171531|593648847|FG000|Overall Study|Withdrawal by Subject|1|||
163898537|NCT00943917|592001081|FG014|Stage II Continuation|Adverse Event|1|||
163898538|NCT00943917|592001067|FG000|Stage II Continuation|Withdrawal by Subject|0|||
163898539|NCT00943917|592001068|FG001|Stage II Continuation|Withdrawal by Subject|0|||
163898540|NCT00943917|592001069|FG002|Stage II Continuation|Withdrawal by Subject|0|||
164347554|NCT04171531|593648848|FG001|Overall Study|Withdrawal by Subject|5|||
164347555|NCT05537883|593648851|FG000|Overall Study|revisional surgery|4|||
164347556|NCT05537883|593648852|FG001|Overall Study|revisional surgery|2|||
164347557|NCT05537883|593648851|FG000|Overall Study|surgeries were cancelled|0|||
164347558|NCT05537883|593648852|FG001|Overall Study|surgeries were cancelled|2|||
164347559|NCT05537883|593648851|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
164347560|NCT05537883|593648852|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
164347561|NCT02296320|593648854|FG000|Overall Study|Withdrawal by Subject|4|||
164347562|NCT02296320|593648855|FG001|Overall Study|Withdrawal by Subject|0|||
164347563|NCT02296320|593648856|FG002|Overall Study|Withdrawal by Subject|2|||
164347564|NCT02296320|593648854|FG000|Overall Study|Death|24|||
164347565|NCT02296320|593648855|FG001|Overall Study|Death|3|||
164347566|NCT02296320|593648856|FG002|Overall Study|Death|27|||
164347567|NCT02296320|593648854|FG000|Overall Study|Lost to Follow-up|5|||
164347568|NCT02296320|593648855|FG001|Overall Study|Lost to Follow-up|2|||
164347569|NCT02296320|593648856|FG002|Overall Study|Lost to Follow-up|7|||
164347570|NCT02296320|593648854|FG000|Overall Study|Not treated|2|||
164347571|NCT02296320|593648855|FG001|Overall Study|Not treated|0|||
164347572|NCT02296320|593648856|FG002|Overall Study|Not treated|0|||
164347573|NCT02296320|593648854|FG000|Overall Study|Not - specified|0|||
164347574|NCT02296320|593648855|FG001|Overall Study|Not - specified|0|||
164005327|NCT01843374|592385722|FG000|Overall Study|Withdrawal by Subject|14|||
164005328|NCT01843374|592385723|FG001|Overall Study|Withdrawal by Subject|20|||
164347575|NCT02296320|593648856|FG002|Overall Study|Not - specified|1|||
164347576|NCT05229406|593648857|FG000|Overall Study|Withdrawal by Subject|1|||
164347577|NCT05229406|593648858|FG001|Overall Study|Withdrawal by Subject|2|||
164347578|NCT01697566|593648861|FG000|Overall Study|Withdrawal by Subject|0|||
164347579|NCT01697566|593648862|FG001|Overall Study|Withdrawal by Subject|0|||
164347580|NCT01697566|593648863|FG002|Overall Study|Withdrawal by Subject|1|||
164347581|NCT01697566|593648864|FG003|Overall Study|Withdrawal by Subject|1|||
164347582|NCT01697566|593648861|FG000|Overall Study|Final biopsy not obtained|0|||
164347583|NCT01697566|593648862|FG001|Overall Study|Final biopsy not obtained|0|||
164347584|NCT01697566|593648863|FG002|Overall Study|Final biopsy not obtained|1|||
164347585|NCT01697566|593648864|FG003|Overall Study|Final biopsy not obtained|0|||
164347586|NCT01930123|593648865|FG000|Overall Study|Adverse Event|1|||
164296917|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
164296918|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
164296919|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
163898541|NCT00943917|592001070|FG003|Stage II Continuation|Withdrawal by Subject|0|||
163898542|NCT00943917|592001071|FG004|Stage II Continuation|Withdrawal by Subject|0|||
163898543|NCT00943917|592001072|FG005|Stage II Continuation|Withdrawal by Subject|0|||
163898544|NCT00943917|592001073|FG006|Stage II Continuation|Withdrawal by Subject|0|||
163898545|NCT00943917|592001074|FG007|Stage II Continuation|Withdrawal by Subject|0|||
163898546|NCT00943917|592001075|FG008|Stage II Continuation|Withdrawal by Subject|0|||
164296920|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
164296921|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
164296922|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
164296923|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164296924|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
164296925|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
164296926|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
164296927|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
164296928|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
164296929|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
164296930|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
164296931|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
164296932|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
164296933|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
164296934|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
164296935|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
164296936|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
164296937|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
163898547|NCT00943917|592001076|FG009|Stage II Continuation|Withdrawal by Subject|0|||
163898548|NCT00943917|592001077|FG010|Stage II Continuation|Withdrawal by Subject|0|||
163898549|NCT00943917|592001078|FG011|Stage II Continuation|Withdrawal by Subject|0|||
164296938|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
164296939|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
164296940|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
164296941|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
164296942|NCT04026113|593461916|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164296943|NCT04026113|593461917|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
164296944|NCT04026113|593461918|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
164296945|NCT04026113|593461919|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
163898550|NCT00943917|592001079|FG012|Stage II Continuation|Withdrawal by Subject|0|||
163898551|NCT00943917|592001080|FG013|Stage II Continuation|Withdrawal by Subject|1|||
164089462|NCT01446913|592690308|FG002|Overall Study|Significant illness|1|||
164089463|NCT01446913|592690306|FG000|Overall Study|Withdrawal by Subject|5|||
164089464|NCT01446913|592690307|FG001|Overall Study|Withdrawal by Subject|3|||
164089465|NCT01446913|592690308|FG002|Overall Study|Withdrawal by Subject|5|||
164089466|NCT01446913|592690306|FG000|Overall Study|Physician Decision|0|||
164089467|NCT01446913|592690307|FG001|Overall Study|Physician Decision|0|||
164089468|NCT01446913|592690308|FG002|Overall Study|Physician Decision|2|||
164089469|NCT01446913|592690306|FG000|Overall Study|Lost to Follow-up|3|||
164089470|NCT01446913|592690307|FG001|Overall Study|Lost to Follow-up|5|||
164089471|NCT01446913|592690308|FG002|Overall Study|Lost to Follow-up|3|||
164089472|NCT00601484|592690313|FG000|Overall Study|Adverse Event|0|||
164089473|NCT00601484|592690314|FG001|Overall Study|Adverse Event|1|||
164089474|NCT00601484|592690313|FG000|Overall Study|Lost to Follow-up|4|||
164089475|NCT00601484|592690314|FG001|Overall Study|Lost to Follow-up|3|||
164089476|NCT00601484|592690313|FG000|Overall Study|Lack of Efficacy|0|||
164089477|NCT00601484|592690314|FG001|Overall Study|Lack of Efficacy|2|||
164089478|NCT00601484|592690313|FG000|Overall Study|Withdrawal by Subject|1|||
164089479|NCT00601484|592690314|FG001|Overall Study|Withdrawal by Subject|1|||
164089480|NCT00601484|592690313|FG000|Overall Study|Randomized, but not treated|0|||
164089481|NCT00601484|592690314|FG001|Overall Study|Randomized, but not treated|1|||
164089482|NCT02928848|592690315|FG000|Arm 2|Withdrawal by Subject|1|||
164089483|NCT02928848|592690316|FG001|Arm 2|Withdrawal by Subject|0|||
164089484|NCT00969332|592690317|FG000|Overall Study|Physician Decision|8|||
164296946|NCT04026113|593461916|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
164296947|NCT04026113|593461917|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
164089485|NCT00969332|592690317|FG000|Overall Study|Withdrawal by Subject|3|||
164089486|NCT03828461|592690318|FG000|Overall Study|Lost to Follow-up|1|||
164296948|NCT04026113|593461918|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
164296949|NCT04026113|593461919|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
164296950|NCT01709721|593461920|FG000|Open Label Phase|Withdrawal by Subject|0|||
164089487|NCT03828461|592690318|FG000|Overall Study|Withdrawal by Subject|3|||
164089488|NCT00663871|592690320|FG000|Overall Study|Lost to Follow-up|5|||
164089489|NCT00663871|592690321|FG001|Overall Study|Lost to Follow-up|5|||
164296951|NCT01709721|593461921|FG001|Open Label Phase|Withdrawal by Subject|0|||
164296952|NCT01709721|593461922|FG002|Open Label Phase|Withdrawal by Subject|5|||
164296953|NCT01709721|593461920|FG000|Open Label Phase|Adverse Event|0|||
164296954|NCT01709721|593461921|FG001|Open Label Phase|Adverse Event|0|||
164296955|NCT01709721|593461922|FG002|Open Label Phase|Adverse Event|8|||
164296956|NCT01709721|593461920|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
164296957|NCT01709721|593461921|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
164296958|NCT01709721|593461922|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
164296959|NCT01709721|593461920|FG000|Open Label Phase|Investigator Decision|0|||
164296960|NCT01709721|593461921|FG001|Open Label Phase|Investigator Decision|0|||
164296961|NCT01709721|593461922|FG002|Open Label Phase|Investigator Decision|1|||
164296962|NCT01709721|593461920|FG000|Open Label Phase|Sponsor Decision|0|||
164296963|NCT01709721|593461921|FG001|Open Label Phase|Sponsor Decision|0|||
164296964|NCT01709721|593461922|FG002|Open Label Phase|Sponsor Decision|2|||
164296965|NCT01709721|593461920|FG000|Open Label Phase|Protocol Violation|0|||
164296966|NCT01709721|593461921|FG001|Open Label Phase|Protocol Violation|0|||
164296967|NCT01709721|593461922|FG002|Open Label Phase|Protocol Violation|1|||
164296968|NCT01709721|593461920|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
164296969|NCT01709721|593461921|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
164296970|NCT01709721|593461922|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
164296971|NCT01709721|593461920|FG000|Open Label Phase|Inadequate Pain Control|0|||
164296972|NCT01709721|593461921|FG001|Open Label Phase|Inadequate Pain Control|0|||
164296973|NCT01709721|593461922|FG002|Open Label Phase|Inadequate Pain Control|37|||
164296974|NCT01709721|593461920|FG000|Open Label Phase|Other, Specify in text field in database|0|||
164296975|NCT01709721|593461921|FG001|Open Label Phase|Other, Specify in text field in database|0|||
164296976|NCT01709721|593461922|FG002|Open Label Phase|Other, Specify in text field in database|14|||
164296977|NCT01709721|593461920|FG000|Randomized Phase|Adverse Event|0|||
164296978|NCT01709721|593461921|FG001|Randomized Phase|Adverse Event|1|||
164296979|NCT01709721|593461922|FG002|Randomized Phase|Adverse Event|0|||
164296980|NCT01709721|593461920|FG000|Randomized Phase|Lost to Follow-up|1|||
164296981|NCT01709721|593461921|FG001|Randomized Phase|Lost to Follow-up|0|||
164296982|NCT01709721|593461922|FG002|Randomized Phase|Lost to Follow-up|0|||
164347587|NCT01930123|593648866|FG001|Overall Study|Adverse Event|0|||
164347588|NCT01930123|593648865|FG000|Overall Study|Physician Decision|21|||
164347589|NCT01930123|593648866|FG001|Overall Study|Physician Decision|8|||
164347590|NCT01930123|593648865|FG000|Overall Study|Withdrawal by Subject|1|||
164347591|NCT01930123|593648866|FG001|Overall Study|Withdrawal by Subject|0|||
164347592|NCT01447433|593648867|FG000|Overall Study|Lost to Follow-up|0|||
164347593|NCT01447433|593648868|FG001|Overall Study|Lost to Follow-up|2|||
164347594|NCT01447433|593648867|FG000|Overall Study|Withdrawal by Subject|3|||
164296983|NCT01709721|593461920|FG000|Randomized Phase|Inadequate Pain Control|1|||
164089490|NCT00663871|592690320|FG000|Overall Study|Withdrawal by Subject|5|||
164296984|NCT01709721|593461921|FG001|Randomized Phase|Inadequate Pain Control|2|||
164296985|NCT01709721|593461922|FG002|Randomized Phase|Inadequate Pain Control|0|||
164296986|NCT01709721|593461920|FG000|Randomized Phase|Other, Specify text field in database|1|||
164296987|NCT01709721|593461921|FG001|Randomized Phase|Other, Specify text field in database|3|||
164296988|NCT01709721|593461922|FG002|Randomized Phase|Other, Specify text field in database|0|||
164296989|NCT02558894|593461925|FG000|Overall Study|Death; any cause, entire study duration|28|||
164296990|NCT02558894|593461926|FG001|Overall Study|Death; any cause, entire study duration|31|||
164296991|NCT02558894|593461925|FG000|Overall Study|Withdrawal by Subject|2|||
164296992|NCT02558894|593461926|FG001|Overall Study|Withdrawal by Subject|1|||
164296993|NCT02558894|593461925|FG000|Overall Study|Closure of Part A|2|||
164296994|NCT02558894|593461926|FG001|Overall Study|Closure of Part A|1|||
164296995|NCT05236270|593461930|FG000|Overall Study|Lost to Follow-up|3|||
164296996|NCT05236270|593461931|FG001|Overall Study|Lost to Follow-up|2|||
164296997|NCT05236270|593461932|FG002|Overall Study|Lost to Follow-up|0|||
164296998|NCT05236270|593461933|FG003|Overall Study|Lost to Follow-up|0|||
164296999|NCT05236270|593461934|FG004|Overall Study|Lost to Follow-up|2|||
164297000|NCT05236270|593461935|FG005|Overall Study|Lost to Follow-up|0|||
164297001|NCT05236270|593461936|FG006|Overall Study|Lost to Follow-up|1|||
164347595|NCT01447433|593648868|FG001|Overall Study|Withdrawal by Subject|3|||
164347596|NCT01447433|593648867|FG000|Overall Study|Protocol Violation|1|||
164347597|NCT01447433|593648868|FG001|Overall Study|Protocol Violation|1|||
164347598|NCT00729651|593648871|FG000|Overall Study|Withdrawal by Subject|5|||
164347599|NCT00729651|593648872|FG001|Overall Study|Withdrawal by Subject|6|||
164347600|NCT00729651|593648871|FG000|Overall Study|Lost to Follow-up|5|||
164347601|NCT00729651|593648872|FG001|Overall Study|Lost to Follow-up|4|||
164347602|NCT00729651|593648871|FG000|Overall Study|Protocol Violation|0|||
164347603|NCT00729651|593648872|FG001|Overall Study|Protocol Violation|1|||
164347604|NCT00729651|593648871|FG000|Overall Study|Adverse Event|7|||
164347605|NCT00729651|593648872|FG001|Overall Study|Adverse Event|3|||
164347606|NCT00729651|593648871|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
164347607|NCT00729651|593648872|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
164347608|NCT00729651|593648871|FG000|Overall Study|Subject's private reason|2|||
164347609|NCT00729651|593648872|FG001|Overall Study|Subject's private reason|0|||
164347610|NCT03310021|593648873|FG000|Overall Study|Withdrawal by Subject|0|||
164347611|NCT03310021|593648874|FG001|Overall Study|Withdrawal by Subject|0|||
164347612|NCT03310021|593648875|FG002|Overall Study|Withdrawal by Subject|0|||
164347613|NCT03310021|593648876|FG003|Overall Study|Withdrawal by Subject|0|||
164347614|NCT03310021|593648877|FG004|Overall Study|Withdrawal by Subject|0|||
164347615|NCT03310021|593648878|FG005|Overall Study|Withdrawal by Subject|0|||
164347616|NCT03310021|593648879|FG006|Overall Study|Withdrawal by Subject|1|||
164347617|NCT03310021|593648880|FG007|Overall Study|Withdrawal by Subject|0|||
164347618|NCT03310021|593648881|FG008|Overall Study|Withdrawal by Subject|0|||
164347619|NCT03310021|593648882|FG009|Overall Study|Withdrawal by Subject|0|||
164347620|NCT03310021|593648883|FG010|Overall Study|Withdrawal by Subject|0|||
164347621|NCT03310021|593648884|FG011|Overall Study|Withdrawal by Subject|0|||
164347622|NCT03310021|593648885|FG012|Overall Study|Withdrawal by Subject|0|||
164347623|NCT03310021|593648886|FG013|Overall Study|Withdrawal by Subject|0|||
164347624|NCT03310021|593648887|FG014|Overall Study|Withdrawal by Subject|0|||
164347625|NCT03310021|593648888|FG015|Overall Study|Withdrawal by Subject|0|||
164347626|NCT03310021|593648889|FG016|Overall Study|Withdrawal by Subject|0|||
164347627|NCT03310021|593648890|FG017|Overall Study|Withdrawal by Subject|0|||
164347628|NCT03310021|593648891|FG018|Overall Study|Withdrawal by Subject|0|||
164347629|NCT03310021|593648892|FG019|Overall Study|Withdrawal by Subject|0|||
164347630|NCT03310021|593648873|FG000|Overall Study|Lost to Follow-up|0|||
164347631|NCT03310021|593648874|FG001|Overall Study|Lost to Follow-up|0|||
164347632|NCT03310021|593648875|FG002|Overall Study|Lost to Follow-up|0|||
164347633|NCT03310021|593648876|FG003|Overall Study|Lost to Follow-up|0|||
164347634|NCT03310021|593648877|FG004|Overall Study|Lost to Follow-up|0|||
164347635|NCT03310021|593648878|FG005|Overall Study|Lost to Follow-up|0|||
164347636|NCT03310021|593648879|FG006|Overall Study|Lost to Follow-up|0|||
164347637|NCT03310021|593648880|FG007|Overall Study|Lost to Follow-up|0|||
164347638|NCT03310021|593648881|FG008|Overall Study|Lost to Follow-up|0|||
164347639|NCT03310021|593648882|FG009|Overall Study|Lost to Follow-up|0|||
164347640|NCT03310021|593648883|FG010|Overall Study|Lost to Follow-up|1|||
164347641|NCT03310021|593648884|FG011|Overall Study|Lost to Follow-up|0|||
164347642|NCT03310021|593648885|FG012|Overall Study|Lost to Follow-up|0|||
164347643|NCT03310021|593648886|FG013|Overall Study|Lost to Follow-up|0|||
164347644|NCT03310021|593648887|FG014|Overall Study|Lost to Follow-up|0|||
164297002|NCT05236270|593461937|FG007|Overall Study|Lost to Follow-up|3|||
164297003|NCT02476617|593461938|FG000|Overall Study|Adverse Event|1|||
164297004|NCT02476617|593461938|FG000|Overall Study|Lost to Follow-up|1|||
164297005|NCT01383928|593461939|FG000|Overall Study|Initiation of ASCT|2|||
164297006|NCT01383928|593461940|FG001|Overall Study|Initiation of ASCT|1|||
164347645|NCT03310021|593648888|FG015|Overall Study|Lost to Follow-up|0|||
164347646|NCT03310021|593648889|FG016|Overall Study|Lost to Follow-up|0|||
164347647|NCT03310021|593648890|FG017|Overall Study|Lost to Follow-up|0|||
164347648|NCT03310021|593648891|FG018|Overall Study|Lost to Follow-up|0|||
164297007|NCT01383928|593461941|FG002|Overall Study|Initiation of ASCT|18|||
164297008|NCT01383928|593461939|FG000|Overall Study|Adverse Event|1|||
164297009|NCT01383928|593461940|FG001|Overall Study|Adverse Event|2|||
164297010|NCT01383928|593461941|FG002|Overall Study|Adverse Event|8|||
164297011|NCT01383928|593461939|FG000|Overall Study|Other|1|||
164297012|NCT01383928|593461940|FG001|Overall Study|Other|3|||
164297013|NCT01383928|593461941|FG002|Overall Study|Other|4|||
164297014|NCT01383928|593461939|FG000|Overall Study|Progressive Disease|1|||
164297015|NCT01383928|593461940|FG001|Overall Study|Progressive Disease|1|||
164297016|NCT01383928|593461941|FG002|Overall Study|Progressive Disease|5|||
164297017|NCT01383928|593461939|FG000|Overall Study|Withdrawal by Subject|0|||
164297018|NCT01383928|593461940|FG001|Overall Study|Withdrawal by Subject|0|||
164297019|NCT01383928|593461941|FG002|Overall Study|Withdrawal by Subject|4|||
164297020|NCT01383928|593461939|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
164297021|NCT01383928|593461940|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164297022|NCT01383928|593461941|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
164297023|NCT03486912|593461942|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
164297024|NCT03486912|593461943|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
164297025|NCT03486912|593461944|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
164297026|NCT03486912|593461945|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
164297027|NCT03486912|593461942|FG000|Treatment Period|Withdrawal by Subject|3|||
164297028|NCT03486912|593461943|FG001|Treatment Period|Withdrawal by Subject|3|||
164297029|NCT03486912|593461944|FG002|Treatment Period|Withdrawal by Subject|3|||
164297030|NCT03486912|593461945|FG003|Treatment Period|Withdrawal by Subject|2|||
164297031|NCT03486912|593461942|FG000|Treatment Period|Other Reasons|0|||
164297032|NCT03486912|593461943|FG001|Treatment Period|Other Reasons|2|||
164297033|NCT03486912|593461944|FG002|Treatment Period|Other Reasons|1|||
164297034|NCT03486912|593461945|FG003|Treatment Period|Other Reasons|1|||
164297035|NCT03486912|593461942|FG000|Treatment Period|Adverse Event|0|||
164297036|NCT03486912|593461943|FG001|Treatment Period|Adverse Event|1|||
164297037|NCT03486912|593461944|FG002|Treatment Period|Adverse Event|1|||
164297038|NCT03486912|593461945|FG003|Treatment Period|Adverse Event|0|||
164297039|NCT03486912|593461942|FG000|Treatment Period|Lost to Follow-up|1|||
164297040|NCT03486912|593461943|FG001|Treatment Period|Lost to Follow-up|0|||
164297041|NCT03486912|593461944|FG002|Treatment Period|Lost to Follow-up|0|||
164297042|NCT03486912|593461945|FG003|Treatment Period|Lost to Follow-up|2|||
164297043|NCT02491684|593461946|FG000|Treatment Phase|Adverse Event|2|||
164297044|NCT02491684|593461947|FG001|Treatment Phase|Adverse Event|2|||
164297045|NCT02491684|593461946|FG000|Treatment Phase|Incorrect randomisation|1|||
164297046|NCT02491684|593461947|FG001|Treatment Phase|Incorrect randomisation|0|||
164297047|NCT02491684|593461946|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
164297048|NCT02491684|593461947|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
164297049|NCT01149096|593461948|FG000|Overall Study|Lost to Follow-up|0|||
164297050|NCT01149096|593461949|FG001|Overall Study|Lost to Follow-up|1|||
164297051|NCT01263769|593461950|FG000|Overall Study|Non-Compliant with treatment|1|||
164297052|NCT03267277|593461951|FG000|Overall Study|Withdrawal by Subject|1|||
164297053|NCT01451606|593461952|FG000|Overall Study|Withdrawal by Subject|4|||
164297054|NCT01451606|593461953|FG001|Overall Study|Withdrawal by Subject|3|||
164297055|NCT00468169|593461954|FG000|Overall Study|Withdrawal by Subject|1|||
164297056|NCT00468169|593461955|FG001|Overall Study|Withdrawal by Subject|0|||
164297057|NCT01126749|593461960|FG000|Phase 1b|Other|0|||
164297058|NCT01126749|593461961|FG001|Phase 1b|Other|1|||
164297059|NCT01126749|593461962|FG002|Phase 1b|Other|0|||
164297060|NCT01126749|593461963|FG003|Phase 1b|Other|0|||
164297061|NCT01126749|593461960|FG000|Phase 1b|Withdrawal by Subject|0|||
164297062|NCT01126749|593461961|FG001|Phase 1b|Withdrawal by Subject|1|||
164297063|NCT01126749|593461962|FG002|Phase 1b|Withdrawal by Subject|0|||
164297064|NCT01126749|593461963|FG003|Phase 1b|Withdrawal by Subject|0|||
164297065|NCT01126749|593461960|FG000|Phase 1b|Death|3|||
164297066|NCT01126749|593461961|FG001|Phase 1b|Death|4|||
164297067|NCT01126749|593461962|FG002|Phase 1b|Death|0|||
164297068|NCT01126749|593461963|FG003|Phase 1b|Death|0|||
164297069|NCT01126749|593461960|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
164297070|NCT01126749|593461961|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
164297071|NCT01126749|593461962|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
163898552|NCT00943917|592001081|FG014|Stage II Continuation|Withdrawal by Subject|3|||
164297072|NCT01126749|593461963|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
163898553|NCT00943917|592001067|FG000|Stage II Continuation|Protocol Violation|0|||
164297073|NCT01126749|593461960|FG000|Phase 2|Study Termination by Sponsor|0|||
163898554|NCT00943917|592001068|FG001|Stage II Continuation|Protocol Violation|0|||
164297074|NCT01126749|593461961|FG001|Phase 2|Study Termination by Sponsor|0|||
164297075|NCT01126749|593461962|FG002|Phase 2|Study Termination by Sponsor|12|||
164297076|NCT01126749|593461963|FG003|Phase 2|Study Termination by Sponsor|6|||
164297077|NCT01126749|593461960|FG000|Phase 2|Other|0|||
164297078|NCT01126749|593461961|FG001|Phase 2|Other|0|||
164297079|NCT01126749|593461962|FG002|Phase 2|Other|4|||
164297080|NCT01126749|593461963|FG003|Phase 2|Other|2|||
164297081|NCT01126749|593461960|FG000|Phase 2|Withdrawal by Subject|0|||
164297082|NCT01126749|593461961|FG001|Phase 2|Withdrawal by Subject|0|||
164297083|NCT01126749|593461962|FG002|Phase 2|Withdrawal by Subject|0|||
164297084|NCT01126749|593461963|FG003|Phase 2|Withdrawal by Subject|2|||
164297085|NCT01126749|593461960|FG000|Phase 2|Lost to Follow-up|0|||
164297086|NCT01126749|593461961|FG001|Phase 2|Lost to Follow-up|0|||
164297087|NCT01126749|593461962|FG002|Phase 2|Lost to Follow-up|0|||
164297088|NCT01126749|593461963|FG003|Phase 2|Lost to Follow-up|1|||
164297089|NCT01126749|593461960|FG000|Phase 2|Death|0|||
164297090|NCT01126749|593461961|FG001|Phase 2|Death|0|||
164297091|NCT01126749|593461962|FG002|Phase 2|Death|22|||
164297092|NCT01126749|593461963|FG003|Phase 2|Death|22|||
164297093|NCT01126749|593461960|FG000|Phase 2|Adverse Event|0|||
164297094|NCT01126749|593461961|FG001|Phase 2|Adverse Event|0|||
164297095|NCT01126749|593461962|FG002|Phase 2|Adverse Event|0|||
164297096|NCT01126749|593461963|FG003|Phase 2|Adverse Event|1|||
164297097|NCT03668873|593461964|FG000|Overall Study|Lost to Follow-up|6|||
164297098|NCT03668873|593461965|FG001|Overall Study|Lost to Follow-up|3|||
164297099|NCT02183675|593461966|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297100|NCT02183675|593461967|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297101|NCT02183675|593461968|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297102|NCT02183675|593461969|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297103|NCT02183675|593461970|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
164297104|NCT02183675|593461971|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
164297105|NCT01521117|593461972|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
164297106|NCT01521117|593461973|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164297107|NCT01521117|593461972|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
164297108|NCT01521117|593461973|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
164297109|NCT01521117|593461972|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164297110|NCT01521117|593461973|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
164297111|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
164297112|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
164297113|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
164297114|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
164297115|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
164297116|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
164297117|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
164297118|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
164297119|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
164297120|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
164297121|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
164297122|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
164297123|NCT02657889|593461983|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
164297124|NCT02657889|593461984|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
164297125|NCT02657889|593461985|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
164297126|NCT02657889|593461986|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
164297127|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
164297128|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
164297129|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
164297130|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
164297131|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
164297132|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
164297133|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
164297134|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
164297135|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
164347649|NCT03310021|593648892|FG019|Overall Study|Lost to Follow-up|0|||
164347650|NCT01128842|593648893|FG000|Overall Study|Adverse Event|1|||
164347651|NCT01128842|593648893|FG000|Overall Study|Disease Progression|6|||
164005329|NCT01843374|592385722|FG000|Overall Study|Withdrawing due to Other reason|20|||
164005330|NCT01843374|592385723|FG001|Overall Study|Withdrawing due to Other reason|46|||
164005331|NCT03704051|592385728|FG000|Overall Study|Withdrawal by Subject|4|||
164005332|NCT03704051|592385729|FG001|Overall Study|Withdrawal by Subject|0|||
164005333|NCT03167619|592385738|FG000|Overall Study|Death|11|||
164005334|NCT03167619|592385739|FG001|Overall Study|Death|8|||
164005335|NCT03167619|592385738|FG000|Overall Study|Withdrawal by Subject|1|||
164005336|NCT03167619|592385739|FG001|Overall Study|Withdrawal by Subject|2|||
164297136|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
164297137|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
164005337|NCT03167619|592385738|FG000|Overall Study|Physician Decision|0|||
164297138|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
164297139|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
164297140|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
164297141|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
164297142|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
164089491|NCT00663871|592690321|FG001|Overall Study|Withdrawal by Subject|2|||
164089492|NCT00582309|592690322|FG000|Overall Study|Protocol Violation|0|||
164089493|NCT00582309|592690323|FG001|Overall Study|Protocol Violation|0|||
164089494|NCT00582309|592690324|FG002|Overall Study|Protocol Violation|2|||
164089495|NCT03095352|592690328|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
164089496|NCT03095352|592690329|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
164297143|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
164297144|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
164089497|NCT02779855|592690330|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
164089498|NCT02779855|592690331|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
164297145|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
164297146|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
164297147|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
164297148|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
164089499|NCT02779855|592690332|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
164089500|NCT00319449|592690341|FG000|Overall Study|Subject did not wish to continue|1|||
164089501|NCT00319449|592690342|FG001|Overall Study|Subject did not wish to continue|0|||
164089502|NCT00319449|592690341|FG000|Overall Study|Noncompliance with the protocol|1|||
164089503|NCT00319449|592690342|FG001|Overall Study|Noncompliance with the protocol|0|||
164089504|NCT00365352|592690345|FG000|Overall Study|Adverse Event|6|||
164089505|NCT00365352|592690346|FG001|Overall Study|Adverse Event|7|||
164089506|NCT00365352|592690347|FG002|Overall Study|Adverse Event|8|||
164089507|NCT00365352|592690345|FG000|Overall Study|Participant Withdrew Consent|8|||
164089508|NCT00365352|592690346|FG001|Overall Study|Participant Withdrew Consent|3|||
164089509|NCT00365352|592690347|FG002|Overall Study|Participant Withdrew Consent|4|||
164089510|NCT00365352|592690345|FG000|Overall Study|Lack of Efficacy|3|||
164089511|NCT00365352|592690346|FG001|Overall Study|Lack of Efficacy|0|||
164089512|NCT00365352|592690347|FG002|Overall Study|Lack of Efficacy|0|||
164089513|NCT00365352|592690345|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
164089514|NCT00365352|592690346|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
164089515|NCT00365352|592690347|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
164089516|NCT00365352|592690345|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
164089517|NCT00365352|592690346|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
164089518|NCT00365352|592690347|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
164089519|NCT00365352|592690345|FG000|Overall Study|Lost to Follow-up|1|||
164089520|NCT00365352|592690346|FG001|Overall Study|Lost to Follow-up|1|||
164089521|NCT00365352|592690347|FG002|Overall Study|Lost to Follow-up|0|||
164089522|NCT00365352|592690345|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
164089523|NCT00365352|592690346|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
164089524|NCT00365352|592690347|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
164089525|NCT03708211|592690348|FG000|Overall Study|Progressive Disease|10|||
164089526|NCT03708211|592690349|FG001|Overall Study|Progressive Disease|7|||
164089527|NCT03708211|592690348|FG000|Overall Study|Withdrawal by Subject|0|||
164297149|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
164297150|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
164297151|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
164297152|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
164297153|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
164297154|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
164297155|NCT02657889|593461983|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
164297156|NCT02657889|593461984|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
164297157|NCT02657889|593461985|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
164297158|NCT02657889|593461986|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
164297159|NCT03050801|593461995|FG000|Experiment 1|Lost to Follow-up|0|||
164297160|NCT03050801|593461996|FG001|Experiment 1|Lost to Follow-up|1|||
164297161|NCT03050801|593461997|FG002|Experiment 1|Lost to Follow-up|0|||
164297162|NCT03050801|593461998|FG003|Experiment 1|Lost to Follow-up|0|||
164297163|NCT03050801|593461999|FG004|Experiment 1|Lost to Follow-up|0|||
164347652|NCT02378961|593648894|FG000|Overall Study|Lack of Efficacy|4|||
164347653|NCT02378961|593648895|FG001|Overall Study|Lack of Efficacy|2|||
164347654|NCT02378961|593648896|FG002|Overall Study|Lack of Efficacy|0|||
164089528|NCT03708211|592690349|FG001|Overall Study|Withdrawal by Subject|1|||
164347655|NCT02378961|593648897|FG003|Overall Study|Lack of Efficacy|1|||
164347656|NCT02378961|593648894|FG000|Overall Study|Death|0|||
164347657|NCT02378961|593648895|FG001|Overall Study|Death|0|||
164347658|NCT02378961|593648896|FG002|Overall Study|Death|1|||
164347659|NCT02378961|593648897|FG003|Overall Study|Death|0|||
164347660|NCT00390468|593648898|FG000|Overall Study|Protocol Violation|2|||
164347661|NCT00390468|593648898|FG000|Overall Study|Lack of Efficacy|1|||
164347662|NCT01049308|593648899|FG000|Pill Counts|Withdrawal by Subject|83|||
164347663|NCT01348165|593648901|FG000|Overall Study|Adverse Event|0|||
164297164|NCT03050801|593462000|FG005|Experiment 1|Lost to Follow-up|0|||
164297165|NCT03050801|593461995|FG000|Experiment 1|Physician Decision|0|||
164297166|NCT03050801|593461996|FG001|Experiment 1|Physician Decision|3|||
164297167|NCT03050801|593461997|FG002|Experiment 1|Physician Decision|0|||
164297168|NCT03050801|593461998|FG003|Experiment 1|Physician Decision|0|||
164297169|NCT03050801|593461999|FG004|Experiment 1|Physician Decision|0|||
164297170|NCT03050801|593462000|FG005|Experiment 1|Physician Decision|0|||
164297171|NCT03050801|593461995|FG000|Experiment 1|Change of experimental design|0|||
164297172|NCT03050801|593461996|FG001|Experiment 1|Change of experimental design|3|||
164297173|NCT03050801|593461997|FG002|Experiment 1|Change of experimental design|0|||
164005338|NCT03167619|592385739|FG001|Overall Study|Physician Decision|1|||
164005339|NCT01348919|592385743|FG000|Overall Study|Adverse Event|3|||
164297174|NCT03050801|593461998|FG003|Experiment 1|Change of experimental design|0|||
164297175|NCT03050801|593461999|FG004|Experiment 1|Change of experimental design|0|||
164297176|NCT03050801|593462000|FG005|Experiment 1|Change of experimental design|0|||
164297177|NCT03050801|593461995|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297178|NCT03050801|593461996|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297179|NCT03050801|593461997|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
164297180|NCT03050801|593461998|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297181|NCT03050801|593461999|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297182|NCT03050801|593462000|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
164297183|NCT03050801|593461995|FG000|Experiment 2|Lost to Follow-up|0|||
164297184|NCT03050801|593461996|FG001|Experiment 2|Lost to Follow-up|0|||
164297185|NCT03050801|593461997|FG002|Experiment 2|Lost to Follow-up|0|||
164297186|NCT03050801|593461998|FG003|Experiment 2|Lost to Follow-up|1|||
164297187|NCT03050801|593461999|FG004|Experiment 2|Lost to Follow-up|1|||
164297188|NCT03050801|593462000|FG005|Experiment 2|Lost to Follow-up|0|||
164297189|NCT03050801|593461995|FG000|Experiment 2|Physician Decision|0|||
164297190|NCT03050801|593461996|FG001|Experiment 2|Physician Decision|0|||
164297191|NCT03050801|593461997|FG002|Experiment 2|Physician Decision|0|||
164297192|NCT03050801|593461998|FG003|Experiment 2|Physician Decision|0|||
164297193|NCT03050801|593461999|FG004|Experiment 2|Physician Decision|1|||
164297194|NCT03050801|593462000|FG005|Experiment 2|Physician Decision|0|||
164297195|NCT03050801|593461995|FG000|Experiment 2|Pregnancy|0|||
164297196|NCT03050801|593461996|FG001|Experiment 2|Pregnancy|0|||
164297197|NCT03050801|593461997|FG002|Experiment 2|Pregnancy|0|||
164297198|NCT03050801|593461998|FG003|Experiment 2|Pregnancy|0|||
164297199|NCT03050801|593461999|FG004|Experiment 2|Pregnancy|1|||
164297200|NCT03050801|593462000|FG005|Experiment 2|Pregnancy|0|||
164297201|NCT03050801|593461995|FG000|Experiment 2|Withdrawal by Subject|0|||
164297202|NCT03050801|593461996|FG001|Experiment 2|Withdrawal by Subject|0|||
164297203|NCT03050801|593461997|FG002|Experiment 2|Withdrawal by Subject|0|||
164297204|NCT03050801|593461998|FG003|Experiment 2|Withdrawal by Subject|1|||
164297205|NCT03050801|593461999|FG004|Experiment 2|Withdrawal by Subject|0|||
164297206|NCT03050801|593462000|FG005|Experiment 2|Withdrawal by Subject|0|||
164297207|NCT03050801|593461995|FG000|Experiment 2|Poor data quality|0|||
164297208|NCT03050801|593461996|FG001|Experiment 2|Poor data quality|0|||
164297209|NCT03050801|593461997|FG002|Experiment 2|Poor data quality|0|||
164297210|NCT03050801|593461998|FG003|Experiment 2|Poor data quality|4|||
164297211|NCT03050801|593461999|FG004|Experiment 2|Poor data quality|1|||
164297212|NCT03050801|593462000|FG005|Experiment 2|Poor data quality|0|||
164297213|NCT03050801|593461995|FG000|Experiment 2|Discomfort during stimulation|0|||
164297214|NCT03050801|593461996|FG001|Experiment 2|Discomfort during stimulation|0|||
164297215|NCT03050801|593461997|FG002|Experiment 2|Discomfort during stimulation|0|||
164297216|NCT03050801|593461998|FG003|Experiment 2|Discomfort during stimulation|0|||
164297217|NCT03050801|593461999|FG004|Experiment 2|Discomfort during stimulation|0|||
164297218|NCT03050801|593462000|FG005|Experiment 2|Discomfort during stimulation|2|||
164297219|NCT01576341|593462001|FG000|Overall Study|Withdrawal by Subject|24|||
164297220|NCT01576341|593462001|FG000|Overall Study|Adverse Event|10|||
164297221|NCT01576341|593462001|FG000|Overall Study|Death|21|||
164297222|NCT01576341|593462001|FG000|Overall Study|Physician Decision|2|||
164297223|NCT01576341|593462001|FG000|Overall Study|Lost to Follow-up|2|||
164297224|NCT01576341|593462001|FG000|Overall Study|Kidney transplantation|10|||
164297225|NCT01576341|593462001|FG000|Overall Study|Protocol Violation|12|||
164297226|NCT01576341|593462001|FG000|Overall Study|Other|12|||
164297227|NCT03836625|593462002|FG000|Overall Study|Lost to Follow-up|9|||
164297228|NCT03836625|593462003|FG001|Overall Study|Lost to Follow-up|9|||
164297229|NCT03836625|593462002|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
164297230|NCT03836625|593462003|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
164297231|NCT03836625|593462002|FG000|Overall Study|Death|0|||
164297232|NCT03836625|593462003|FG001|Overall Study|Death|1|||
164297233|NCT03836625|593462002|FG000|Overall Study|Refused follow-up|0|||
164297234|NCT03836625|593462003|FG001|Overall Study|Refused follow-up|1|||
164297235|NCT03361137|593462004|FG000|Overall Study|Reason not specified|1|||
164297236|NCT03361137|593462005|FG001|Overall Study|Reason not specified|0|||
164297237|NCT03361137|593462006|FG002|Overall Study|Reason not specified|0|||
164297238|NCT03361137|593462007|FG003|Overall Study|Reason not specified|0|||
164347664|NCT01348165|593648902|FG001|Overall Study|Adverse Event|0|||
164297239|NCT03361137|593462008|FG004|Overall Study|Reason not specified|0|||
164297240|NCT03413891|593462010|FG000|Overall Study|Lost to Follow-up|2|||
164297241|NCT03413891|593462011|FG001|Overall Study|Lost to Follow-up|1|||
164297242|NCT03413891|593462010|FG000|Overall Study|Protocol Violation|0|||
164297243|NCT03413891|593462011|FG001|Overall Study|Protocol Violation|1|||
164297244|NCT03077542|593462016|FG000|Overall Study|Death|4|||
164297245|NCT03077542|593462017|FG001|Overall Study|Death|0|||
163898555|NCT00943917|592001069|FG002|Stage II Continuation|Protocol Violation|0|||
164297246|NCT03077542|593462016|FG000|Overall Study|Physician Decision|6|||
164297247|NCT03077542|593462017|FG001|Overall Study|Physician Decision|1|||
164297248|NCT03077542|593462016|FG000|Overall Study|Withdrawal by Subject|0|||
164297249|NCT03077542|593462017|FG001|Overall Study|Withdrawal by Subject|1|||
164297250|NCT00795704|593462018|FG000|Overall Study|Withdrawal by Subject|3|||
164297251|NCT00795704|593462019|FG001|Overall Study|Withdrawal by Subject|2|||
164297252|NCT00795704|593462018|FG000|Overall Study|Adverse Event|1|||
164297253|NCT00795704|593462019|FG001|Overall Study|Adverse Event|1|||
164297254|NCT00301808|593462020|FG000|Overall Study|Adverse Event|5|||
164297255|NCT00301808|593462020|FG000|Overall Study|Death|3|||
164297256|NCT00301808|593462020|FG000|Overall Study|Lack of Efficacy|4|||
164297257|NCT00844844|593462021|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
164297258|NCT00844844|593462021|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
164297259|NCT00844844|593462021|FG000|Extension Treatment Period|Adverse Event|2|||
164297260|NCT00844844|593462021|FG000|Post Treatment Period|Withdrawal by Subject|1|||
164297261|NCT03905096|593462022|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
164297262|NCT03905096|593462023|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
164297263|NCT04659044|593462037|FG000|Induction|Physician Decision|1|||
164297264|NCT04659044|593462037|FG000|Induction|Adverse Event|2|||
164297265|NCT04966013|593462039|FG000|Overall Study|Withdrawal by Subject|0|||
164297266|NCT04966013|593462040|FG001|Overall Study|Withdrawal by Subject|2|||
164297267|NCT04966013|593462041|FG002|Overall Study|Withdrawal by Subject|1|||
164297268|NCT04966013|593462039|FG000|Overall Study|Adverse Event|2|||
164297269|NCT04966013|593462040|FG001|Overall Study|Adverse Event|1|||
164297270|NCT04966013|593462041|FG002|Overall Study|Adverse Event|1|||
164297271|NCT04875975|593462045|FG000|Overall Study|Adverse Event|1|||
164297272|NCT04875975|593462046|FG001|Overall Study|Adverse Event|2|||
164297273|NCT04875975|593462045|FG000|Overall Study|Lack of Efficacy|2|||
164297274|NCT04875975|593462046|FG001|Overall Study|Lack of Efficacy|2|||
164297275|NCT04875975|593462045|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
164297276|NCT04875975|593462046|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
164297277|NCT04875975|593462045|FG000|Overall Study|Relapse With Insults|0|||
164297278|NCT04875975|593462046|FG001|Overall Study|Relapse With Insults|1|||
164297279|NCT04875975|593462045|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
164297280|NCT04875975|593462046|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
164297281|NCT01910298|593462047|FG000|Overall Study|Adverse Event|1|||
164297282|NCT01910298|593462048|FG001|Overall Study|Adverse Event|0|||
164297283|NCT01910298|593462047|FG000|Overall Study|Withdrawal by Subject|2|||
164297284|NCT01910298|593462048|FG001|Overall Study|Withdrawal by Subject|7|||
164297285|NCT01910298|593462047|FG000|Overall Study|Protocol Deviation|0|||
164297286|NCT01910298|593462048|FG001|Overall Study|Protocol Deviation|5|||
164297287|NCT01910298|593462047|FG000|Overall Study|Lost to Follow-up|1|||
164297288|NCT01910298|593462048|FG001|Overall Study|Lost to Follow-up|1|||
164297289|NCT01910298|593462047|FG000|Overall Study|Study Terminated by Sponsor|1|||
164297290|NCT01910298|593462048|FG001|Overall Study|Study Terminated by Sponsor|17|||
164297291|NCT01910298|593462047|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164297292|NCT01910298|593462048|FG001|Overall Study|Other Miscellaneous Reasons|2|||
164297293|NCT02429830|593462051|FG000|Overall Study|Lost to Follow-up|1|||
164297294|NCT02429830|593462051|FG000|Overall Study|Device Explant|2|||
164297295|NCT04944992|593463803|FG000|Overall Study|Lost to Follow-up|1|||
164297296|NCT04944992|593463804|FG001|Overall Study|Lost to Follow-up|1|||
164297297|NCT04944992|593463803|FG000|Overall Study|Physician Decision|1|||
164297298|NCT04944992|593463804|FG001|Overall Study|Physician Decision|0|||
164297299|NCT04944992|593463803|FG000|Overall Study|Withdrawal by Subject|6|||
164297300|NCT04944992|593463804|FG001|Overall Study|Withdrawal by Subject|1|||
164297301|NCT05024032|593463808|FG000|Overall Study|Withdrawal by Subject|0|||
164297302|NCT05024032|593463809|FG001|Overall Study|Withdrawal by Subject|3|||
164297303|NCT05024032|593463810|FG002|Overall Study|Withdrawal by Subject|4|||
164297304|NCT05024032|593463808|FG000|Overall Study|Adverse Event|0|||
164297305|NCT05024032|593463809|FG001|Overall Study|Adverse Event|1|||
164297306|NCT05024032|593463810|FG002|Overall Study|Adverse Event|0|||
164297307|NCT05024032|593463808|FG000|Overall Study|Protocol Deviation|1|||
164297308|NCT05024032|593463809|FG001|Overall Study|Protocol Deviation|0|||
164297309|NCT05024032|593463810|FG002|Overall Study|Protocol Deviation|0|||
164297310|NCT00939393|593463811|FG000|Overall Study|Withdrawal by Subject|1|||
164297311|NCT00939393|593463812|FG001|Overall Study|Withdrawal by Subject|0|||
164297312|NCT00939393|593463811|FG000|Overall Study|Lost to Follow-up|3|||
164297313|NCT00939393|593463812|FG001|Overall Study|Lost to Follow-up|0|||
164297314|NCT00744497|593463817|FG000|Overall Study|Withdrawal by Subject|21|||
164297315|NCT00744497|593463818|FG001|Overall Study|Withdrawal by Subject|18|||
164297316|NCT00744497|593463817|FG000|Overall Study|Death|11|||
164297317|NCT00744497|593463818|FG001|Overall Study|Death|9|||
164297318|NCT00744497|593463817|FG000|Overall Study|Lost to Follow-up|4|||
164297319|NCT00744497|593463818|FG001|Overall Study|Lost to Follow-up|2|||
164297320|NCT00744497|593463817|FG000|Overall Study|Poor compliance/noncompliance|9|||
164297321|NCT00744497|593463818|FG001|Overall Study|Poor compliance/noncompliance|5|||
164297322|NCT00744497|593463817|FG000|Overall Study|No longer meets study criteria|7|||
164297323|NCT00744497|593463818|FG001|Overall Study|No longer meets study criteria|3|||
164297324|NCT00744497|593463817|FG000|Overall Study|Administrative Reason By Sponsor|25|||
164297325|NCT00744497|593463818|FG001|Overall Study|Administrative Reason By Sponsor|8|||
164297326|NCT00744497|593463817|FG000|Overall Study|Disease progression|312|||
164297327|NCT00744497|593463818|FG001|Overall Study|Disease progression|219|||
164297328|NCT00744497|593463817|FG000|Overall Study|Study drug toxicity|68|||
164297329|NCT00744497|593463818|FG001|Overall Study|Study drug toxicity|141|||
164297330|NCT00744497|593463817|FG000|Overall Study|Adverse event unrelated to study drug|78|||
164297331|NCT00744497|593463818|FG001|Overall Study|Adverse event unrelated to study drug|122|||
164297332|NCT00744497|593463817|FG000|Overall Study|Patient requested to stop study drug|65|||
164297333|NCT00744497|593463818|FG001|Overall Study|Patient requested to stop study drug|80|||
164297334|NCT00744497|593463817|FG000|Overall Study|Maximum clinical benefit|141|||
164297335|NCT00744497|593463818|FG001|Overall Study|Maximum clinical benefit|142|||
164297336|NCT00744497|593463817|FG000|Overall Study|Not defined|19|||
164297337|NCT00744497|593463818|FG001|Overall Study|Not defined|13|||
164297338|NCT01074502|593463820|FG000|Overall Study|Withdrawal by Subject|1|||
164297339|NCT03459079|593463821|FG000|Overall Study|Adverse Event|4|||
164297340|NCT03459079|593463822|FG001|Overall Study|Adverse Event|2|||
164297341|NCT03459079|593463823|FG002|Overall Study|Adverse Event|0|||
164297342|NCT03459079|593463821|FG000|Overall Study|Withdrawal by Subject|2|||
164297343|NCT03459079|593463822|FG001|Overall Study|Withdrawal by Subject|2|||
164297344|NCT03459079|593463823|FG002|Overall Study|Withdrawal by Subject|0|||
164297345|NCT00674817|593463831|FG000|Period 1|Withdrawal by Subject|2|||
164297346|NCT00674817|593463831|FG000|Period 1|Protocol Violation|1|||
164297347|NCT00674817|593463831|FG000|Period 3|Adverse Event|1|||
164297348|NCT00674817|593463831|FG000|Period 3|Protocol Violation|1|||
164297349|NCT00674817|593463831|FG000|Period 4|Adverse Event|1|||
164297350|NCT04945733|593463835|FG000|Overall Study|Physician Decision|1|||
164297351|NCT04945733|593463836|FG001|Overall Study|Physician Decision|3|||
164297352|NCT04945733|593463837|FG002|Overall Study|Physician Decision|0|||
164297353|NCT04945733|593463835|FG000|Overall Study|Withdrawal by Subject|3|||
164297354|NCT04945733|593463836|FG001|Overall Study|Withdrawal by Subject|3|||
164297355|NCT04945733|593463837|FG002|Overall Study|Withdrawal by Subject|0|||
164297356|NCT05660577|593463838|FG000|Overall Study|Discontinued|9|||
164297357|NCT03363841|593463843|FG000|Overall Study|Adverse Event|1|||
164297358|NCT03363841|593463843|FG000|Overall Study|Withdrawal by Subject|1|||
164297359|NCT03363841|593463843|FG000|Overall Study|Death|7|||
164297360|NCT03363841|593463843|FG000|Overall Study|Physician Decision|1|||
164297361|NCT02156076|593463848|FG000|Treatment Period|no longer meets study criteria|0|||
164297362|NCT02156076|593463849|FG001|Treatment Period|no longer meets study criteria|0|||
164297363|NCT02156076|593463850|FG002|Treatment Period|no longer meets study criteria|1|||
164297364|NCT02156076|593463851|FG003|Treatment Period|no longer meets study criteria|0|||
164297365|NCT02156076|593463848|FG000|Treatment Period|Poor/non-compliance|0|||
164297366|NCT02156076|593463849|FG001|Treatment Period|Poor/non-compliance|1|||
164297367|NCT02156076|593463850|FG002|Treatment Period|Poor/non-compliance|0|||
164297368|NCT02156076|593463851|FG003|Treatment Period|Poor/non-compliance|0|||
164297369|NCT02156076|593463848|FG000|Treatment Period|Lost to Follow-up|0|||
164297370|NCT02156076|593463849|FG001|Treatment Period|Lost to Follow-up|0|||
164005340|NCT01348919|592385744|FG001|Overall Study|Adverse Event|1|||
164005341|NCT01348919|592385745|FG002|Overall Study|Adverse Event|0|||
164005342|NCT01348919|592385743|FG000|Overall Study|Withdrawal by Subject|0|||
164005343|NCT01348919|592385744|FG001|Overall Study|Withdrawal by Subject|1|||
164297371|NCT02156076|593463850|FG002|Treatment Period|Lost to Follow-up|0|||
164297372|NCT02156076|593463851|FG003|Treatment Period|Lost to Follow-up|1|||
164297373|NCT02156076|593463848|FG000|Treatment Period|Withdrawal by Subject|0|||
164297374|NCT02156076|593463849|FG001|Treatment Period|Withdrawal by Subject|0|||
164297375|NCT02156076|593463850|FG002|Treatment Period|Withdrawal by Subject|1|||
164297376|NCT02156076|593463851|FG003|Treatment Period|Withdrawal by Subject|0|||
164297377|NCT02156076|593463848|FG000|Treatment Period|Subject request to discontinue treatment|0|||
164005344|NCT01348919|592385745|FG002|Overall Study|Withdrawal by Subject|0|||
164005345|NCT01348919|592385743|FG000|Overall Study|Disease progression|0|||
164005346|NCT01348919|592385744|FG001|Overall Study|Disease progression|1|||
164297378|NCT02156076|593463849|FG001|Treatment Period|Subject request to discontinue treatment|1|||
164297379|NCT02156076|593463850|FG002|Treatment Period|Subject request to discontinue treatment|0|||
164297380|NCT02156076|593463851|FG003|Treatment Period|Subject request to discontinue treatment|0|||
164297381|NCT02156076|593463848|FG000|Treatment Period|Adverse Event|0|||
164297382|NCT02156076|593463849|FG001|Treatment Period|Adverse Event|0|||
164297383|NCT02156076|593463850|FG002|Treatment Period|Adverse Event|0|||
164005347|NCT01348919|592385745|FG002|Overall Study|Disease progression|1|||
164005348|NCT06400238|592385746|FG000|Overall Study|Started Protocol Therapy|2|||
164297384|NCT02156076|593463851|FG003|Treatment Period|Adverse Event|1|||
164297385|NCT02156076|593463848|FG000|Follow-up Period|Withdrawal by Subject|1|||
164297386|NCT02156076|593463849|FG001|Follow-up Period|Withdrawal by Subject|0|||
164297387|NCT02156076|593463850|FG002|Follow-up Period|Withdrawal by Subject|0|||
164297388|NCT02156076|593463851|FG003|Follow-up Period|Withdrawal by Subject|0|||
164297389|NCT00981656|593463856|FG000|Overall Study|Protocol Violation|1|||
164297390|NCT00981656|593463856|FG000|Overall Study|Did not start protocol treatment|2|||
164297391|NCT00687596|593463857|FG000|Overall Study|Adverse Event (AE)|10|||
164297392|NCT00687596|593463858|FG001|Overall Study|Adverse Event (AE)|3|||
164297393|NCT00687596|593463857|FG000|Overall Study|Radiological Disease Progression|6|||
164297394|NCT00687596|593463858|FG001|Overall Study|Radiological Disease Progression|2|||
164297395|NCT00687596|593463857|FG000|Overall Study|Clinical Disease Progression|1|||
164297396|NCT00687596|593463858|FG001|Overall Study|Clinical Disease Progression|3|||
164297397|NCT00687596|593463857|FG000|Overall Study|Investigator Discretion|3|||
164297398|NCT00687596|593463858|FG001|Overall Study|Investigator Discretion|1|||
164297399|NCT00687596|593463857|FG000|Overall Study|Sponsor Terminated Study|6|||
164297400|NCT00687596|593463858|FG001|Overall Study|Sponsor Terminated Study|17|||
164297401|NCT01527149|593463859|FG000|Overall Study|Death|2|||
164297402|NCT02230410|593463862|FG000|Overall Study|Screen Failure|3|||
164297403|NCT02992288|593463866|FG000|Overall Study|Adverse Event|8|||
164297404|NCT02992288|593463867|FG001|Overall Study|Adverse Event|2|||
164297405|NCT02992288|593463868|FG002|Overall Study|Adverse Event|2|||
164297406|NCT02992288|593463869|FG003|Overall Study|Adverse Event|2|||
164297407|NCT02992288|593463870|FG004|Overall Study|Adverse Event|2|||
164297408|NCT02992288|593463871|FG005|Overall Study|Adverse Event|7|||
164297409|NCT02992288|593463866|FG000|Overall Study|Non-compliance with study drug|0|||
164297410|NCT02992288|593463867|FG001|Overall Study|Non-compliance with study drug|1|||
164297411|NCT02992288|593463868|FG002|Overall Study|Non-compliance with study drug|1|||
164297412|NCT02992288|593463869|FG003|Overall Study|Non-compliance with study drug|0|||
164297413|NCT02992288|593463870|FG004|Overall Study|Non-compliance with study drug|1|||
164297414|NCT02992288|593463871|FG005|Overall Study|Non-compliance with study drug|0|||
164297415|NCT02992288|593463866|FG000|Overall Study|Physician Decision|3|||
164297416|NCT02992288|593463867|FG001|Overall Study|Physician Decision|0|||
164297417|NCT02992288|593463868|FG002|Overall Study|Physician Decision|1|||
164297418|NCT02992288|593463869|FG003|Overall Study|Physician Decision|0|||
164297419|NCT02992288|593463870|FG004|Overall Study|Physician Decision|0|||
164297420|NCT02992288|593463871|FG005|Overall Study|Physician Decision|1|||
164297421|NCT02992288|593463866|FG000|Overall Study|Death|2|||
164297422|NCT02992288|593463867|FG001|Overall Study|Death|0|||
164297423|NCT02992288|593463868|FG002|Overall Study|Death|2|||
164297424|NCT02992288|593463869|FG003|Overall Study|Death|1|||
164297425|NCT02992288|593463870|FG004|Overall Study|Death|2|||
164297426|NCT02992288|593463871|FG005|Overall Study|Death|0|||
164297427|NCT02992288|593463866|FG000|Overall Study|Lost to Follow-up|0|||
164297428|NCT02992288|593463867|FG001|Overall Study|Lost to Follow-up|0|||
164297429|NCT02992288|593463868|FG002|Overall Study|Lost to Follow-up|0|||
164297430|NCT02992288|593463869|FG003|Overall Study|Lost to Follow-up|1|||
164297431|NCT02992288|593463870|FG004|Overall Study|Lost to Follow-up|0|||
164297432|NCT02992288|593463871|FG005|Overall Study|Lost to Follow-up|0|||
164297433|NCT02992288|593463866|FG000|Overall Study|Protocol Violation|0|||
164297434|NCT02992288|593463867|FG001|Overall Study|Protocol Violation|0|||
164297435|NCT02992288|593463868|FG002|Overall Study|Protocol Violation|0|||
164297436|NCT02992288|593463869|FG003|Overall Study|Protocol Violation|0|||
164297437|NCT02992288|593463870|FG004|Overall Study|Protocol Violation|0|||
164297438|NCT02992288|593463871|FG005|Overall Study|Protocol Violation|1|||
164297439|NCT02992288|593463866|FG000|Overall Study|Withdrawal by Subject|4|||
164297440|NCT02992288|593463867|FG001|Overall Study|Withdrawal by Subject|2|||
164347665|NCT01348165|593648903|FG002|Overall Study|Adverse Event|0|||
164347666|NCT01348165|593648904|FG003|Overall Study|Adverse Event|0|||
164347667|NCT01348165|593648905|FG004|Overall Study|Adverse Event|0|||
164347668|NCT01348165|593648906|FG005|Overall Study|Adverse Event|0|||
164347669|NCT01348165|593648907|FG006|Overall Study|Adverse Event|1|||
164347670|NCT05766423|593648913|FG000|Overall Study|Withdrawal by Subject|1|||
164347671|NCT05766423|593648914|FG001|Overall Study|Withdrawal by Subject|0|||
164347672|NCT05766423|593648913|FG000|Overall Study|Consented, not scheduled|3|||
164347673|NCT05766423|593648914|FG001|Overall Study|Consented, not scheduled|5|||
164347674|NCT00996216|593650838|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
164297441|NCT02992288|593463868|FG002|Overall Study|Withdrawal by Subject|1|||
164297442|NCT02992288|593463869|FG003|Overall Study|Withdrawal by Subject|5|||
164297443|NCT02992288|593463870|FG004|Overall Study|Withdrawal by Subject|3|||
164297444|NCT02992288|593463871|FG005|Overall Study|Withdrawal by Subject|4|||
164297445|NCT00499486|593463872|FG000|Overall Study|Withdrawal by Subject|16|||
164347675|NCT00996216|593650838|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
164347676|NCT00996216|593650838|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
164347677|NCT01411774|593650844|FG000|Overall Study|Withdrawal by Subject|0|||
164297446|NCT00656513|593463873|FG000|Overall Study|Protocol Violation|1|||
164297447|NCT00656513|593463874|FG001|Overall Study|Protocol Violation|0|||
164297448|NCT00656513|593463875|FG002|Overall Study|Protocol Violation|2|||
163898556|NCT00943917|592001070|FG003|Stage II Continuation|Protocol Violation|0|||
163898557|NCT00943917|592001071|FG004|Stage II Continuation|Protocol Violation|0|||
164297449|NCT00656513|593463873|FG000|Overall Study|Withdrawal by Subject|0|||
164297450|NCT00656513|593463874|FG001|Overall Study|Withdrawal by Subject|11|||
164297451|NCT00656513|593463875|FG002|Overall Study|Withdrawal by Subject|4|||
164297452|NCT00656513|593463873|FG000|Overall Study|Death|0|||
164297453|NCT00656513|593463874|FG001|Overall Study|Death|0|||
164297454|NCT00656513|593463875|FG002|Overall Study|Death|1|||
164297455|NCT00656513|593463873|FG000|Overall Study|Missing data|0|||
164297456|NCT00656513|593463874|FG001|Overall Study|Missing data|11|||
164297457|NCT00656513|593463875|FG002|Overall Study|Missing data|9|||
164297458|NCT00656513|593463873|FG000|Overall Study|Incomplete treatment|3|||
164297459|NCT00656513|593463874|FG001|Overall Study|Incomplete treatment|0|||
164297460|NCT00656513|593463875|FG002|Overall Study|Incomplete treatment|0|||
164297461|NCT00656513|593463873|FG000|Overall Study|Treatment completed outside of timeframe|0|||
164297462|NCT00656513|593463874|FG001|Overall Study|Treatment completed outside of timeframe|3|||
164297463|NCT00656513|593463875|FG002|Overall Study|Treatment completed outside of timeframe|1|||
164297464|NCT00656513|593463873|FG000|Overall Study|Missing baseline form|0|||
164297465|NCT00656513|593463874|FG001|Overall Study|Missing baseline form|5|||
164297466|NCT00656513|593463875|FG002|Overall Study|Missing baseline form|5|||
164297467|NCT03796728|593463877|FG000|Overall Study|Lost to Follow-up|8|||
164297468|NCT03796728|593463877|FG000|Overall Study|Reason not Specified|16|||
164297469|NCT00333775|593463878|FG000|Overall Study|Death|144|||
164297470|NCT00333775|593463879|FG001|Overall Study|Death|149|||
164297471|NCT00333775|593463880|FG002|Overall Study|Death|143|||
164297472|NCT00333775|593463878|FG000|Overall Study|In Follow-up When Study Stopped|87|||
164297473|NCT00333775|593463879|FG001|Overall Study|In Follow-up When Study Stopped|92|||
164297474|NCT00333775|593463880|FG002|Overall Study|In Follow-up When Study Stopped|96|||
164297475|NCT00333775|593463878|FG000|Overall Study|Lost to Follow-up|10|||
164297476|NCT00333775|593463879|FG001|Overall Study|Lost to Follow-up|7|||
164297477|NCT00333775|593463880|FG002|Overall Study|Lost to Follow-up|8|||
164297478|NCT00412984|593463885|FG000|Overall Study|Death|331|||
164297479|NCT00412984|593463886|FG001|Overall Study|Death|349|||
164297480|NCT00412984|593463885|FG000|Overall Study|Adverse Event|679|||
164297481|NCT00412984|593463886|FG001|Overall Study|Adverse Event|738|||
164297482|NCT00412984|593463885|FG000|Overall Study|Withdrawal by Subject|921|||
164297483|NCT00412984|593463886|FG001|Overall Study|Withdrawal by Subject|989|||
164297484|NCT00412984|593463885|FG000|Overall Study|Lost to Follow-up|51|||
164297485|NCT00412984|593463886|FG001|Overall Study|Lost to Follow-up|39|||
164297486|NCT00412984|593463885|FG000|Overall Study|Poor/Noncompliance|57|||
164297487|NCT00412984|593463886|FG001|Overall Study|Poor/Noncompliance|77|||
164297488|NCT00412984|593463885|FG000|Overall Study|Pregnancy|1|||
164297489|NCT00412984|593463886|FG001|Overall Study|Pregnancy|0|||
164297490|NCT00412984|593463885|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
164297491|NCT00412984|593463886|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
164297492|NCT00412984|593463885|FG000|Overall Study|Administrative Reason by Sponsor|11|||
164297493|NCT00412984|593463886|FG001|Overall Study|Administrative Reason by Sponsor|8|||
164297494|NCT00412984|593463885|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
164297495|NCT00412984|593463886|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
164297496|NCT00412984|593463885|FG000|Overall Study|Other Reason|80|||
164297497|NCT00412984|593463886|FG001|Overall Study|Other Reason|92|||
164297498|NCT00412984|593463885|FG000|Overall Study|Not Reported|11|||
164297499|NCT00412984|593463886|FG001|Overall Study|Not Reported|12|||
164297500|NCT03651765|593463888|FG000|Overall Study|Adverse Event|6|||
164297501|NCT03651765|593463888|FG000|Overall Study|Lack of Efficacy|18|||
164297502|NCT03651765|593463888|FG000|Overall Study|Lost to Follow-up|5|||
164297503|NCT03651765|593463888|FG000|Overall Study|Non-Compliance with Study Drug|4|||
163898558|NCT00943917|592001072|FG005|Stage II Continuation|Protocol Violation|0|||
163898559|NCT00943917|592001073|FG006|Stage II Continuation|Protocol Violation|0|||
163898560|NCT00943917|592001074|FG007|Stage II Continuation|Protocol Violation|0|||
164297504|NCT03651765|593463888|FG000|Overall Study|Physician Decision|6|||
164297505|NCT03651765|593463888|FG000|Overall Study|Pregnancy|1|||
164297506|NCT03651765|593463888|FG000|Overall Study|Discontinued by Sponsor|40|||
164297507|NCT03651765|593463888|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
164297508|NCT03651765|593463888|FG000|Overall Study|Withdrawal by Subject|24|||
164297509|NCT03651765|593463888|FG000|Overall Study|Miscellaneous|6|||
164297510|NCT04218240|593463889|FG000|Overall Study|Withdrawal by Subject|6|||
164297511|NCT04218240|593463890|FG001|Overall Study|Withdrawal by Subject|0|||
164297512|NCT04218240|593463889|FG000|Overall Study|Lack of Efficacy|24|||
164297513|NCT04218240|593463890|FG001|Overall Study|Lack of Efficacy|19|||
164297514|NCT04218240|593463889|FG000|Overall Study|Physician Decision|0|||
163898561|NCT00943917|592001075|FG008|Stage II Continuation|Protocol Violation|0|||
164297515|NCT04218240|593463890|FG001|Overall Study|Physician Decision|1|||
164297516|NCT04218240|593463889|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
163898562|NCT00943917|592001076|FG009|Stage II Continuation|Protocol Violation|1|||
164297517|NCT04218240|593463890|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
164297518|NCT04097678|593463893|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
164005349|NCT06400238|592385746|FG000|Overall Study|Adverse Event|1|||
164005350|NCT06400238|592385746|FG000|Overall Study|Death|1|||
164005351|NCT06400238|592385746|FG000|Overall Study|Disease Progression|27|||
164347678|NCT01411774|593650845|FG001|Overall Study|Withdrawal by Subject|3|||
164347679|NCT03808545|593650846|FG000|Overall Study|Withdrawal by Subject|1|||
164347680|NCT03808545|593650847|FG001|Overall Study|Withdrawal by Subject|1|||
164347681|NCT03292588|593650851|FG000|Overall Study|Death|1|||
164297519|NCT04097678|593463894|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
164297520|NCT03694678|593463895|FG000|Overall Study|Withdrawal by Subject|2|||
164297521|NCT03694678|593463896|FG001|Overall Study|Withdrawal by Subject|0|||
164297522|NCT03694678|593463895|FG000|Overall Study|Lost to Follow-up|2|||
164297523|NCT03694678|593463896|FG001|Overall Study|Lost to Follow-up|3|||
164297524|NCT02435212|593463897|FG000|Core Phase|Adverse Event|8|||
164297525|NCT02435212|593463898|FG001|Core Phase|Adverse Event|5|||
164297526|NCT02435212|593463897|FG000|Core Phase|Withdrawal by Subject|3|||
164297527|NCT02435212|593463898|FG001|Core Phase|Withdrawal by Subject|0|||
164297528|NCT02435212|593463897|FG000|Core Phase|Withdrawal by parent/guardian|9|||
164297529|NCT02435212|593463898|FG001|Core Phase|Withdrawal by parent/guardian|4|||
164297530|NCT02435212|593463897|FG000|Core Phase|Protocol Violation|1|||
164297531|NCT02435212|593463898|FG001|Core Phase|Protocol Violation|2|||
164297532|NCT02435212|593463897|FG000|Core Phase|Physician Decision|3|||
164297533|NCT02435212|593463898|FG001|Core Phase|Physician Decision|0|||
164297534|NCT02435212|593463897|FG000|Core Phase|Lost to Follow-up|0|||
164297535|NCT02435212|593463898|FG001|Core Phase|Lost to Follow-up|1|||
164297536|NCT02435212|593463897|FG000|Core Phase|Lack of Efficacy|0|||
164297537|NCT02435212|593463898|FG001|Core Phase|Lack of Efficacy|1|||
164297538|NCT02435212|593463897|FG000|Core Phase|Recovery|1|||
164297539|NCT02435212|593463898|FG001|Core Phase|Recovery|0|||
164297540|NCT02435212|593463897|FG000|Optional Extension Phase|Adverse Event|3|||
164297541|NCT02435212|593463898|FG001|Optional Extension Phase|Adverse Event|9|||
164297542|NCT02435212|593463897|FG000|Optional Extension Phase|Physician Decision|6|||
164297543|NCT02435212|593463898|FG001|Optional Extension Phase|Physician Decision|8|||
164297544|NCT02435212|593463897|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
164297545|NCT02435212|593463898|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
164297546|NCT02435212|593463897|FG000|Optional Extension Phase|Lack of Efficacy|2|||
164297547|NCT02435212|593463898|FG001|Optional Extension Phase|Lack of Efficacy|3|||
164297548|NCT02435212|593463897|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
164347682|NCT03292588|593650852|FG001|Overall Study|Death|0|||
164347683|NCT03292588|593650851|FG000|Overall Study|Lost to Follow-up|12|||
164347684|NCT03292588|593650852|FG001|Overall Study|Lost to Follow-up|16|||
164347685|NCT03292588|593650851|FG000|Overall Study|Physician Decision|0|||
164347686|NCT03292588|593650852|FG001|Overall Study|Physician Decision|1|||
164347687|NCT03292588|593650851|FG000|Overall Study|Withdrawal by Subject|4|||
164347688|NCT03292588|593650852|FG001|Overall Study|Withdrawal by Subject|4|||
164347689|NCT03292588|593650851|FG000|Overall Study|Move out of town|1|||
164347690|NCT03292588|593650852|FG001|Overall Study|Move out of town|0|||
164347691|NCT03292588|593650851|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
164347692|NCT03292588|593650852|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
164347693|NCT05526716|593650858|FG000|Overall Study|Death|1|||
164347694|NCT05526716|593650859|FG001|Overall Study|Death|2|||
164347695|NCT05526716|593650858|FG000|Overall Study|Lost to Follow-up|17|||
164347696|NCT05526716|593650859|FG001|Overall Study|Lost to Follow-up|15|||
164347697|NCT05526716|593650858|FG000|Overall Study|Physician Decision|0|||
164347698|NCT05526716|593650859|FG001|Overall Study|Physician Decision|1|||
164347699|NCT05526716|593650858|FG000|Overall Study|Randomized by mistake without study treatment|0|||
164347700|NCT05526716|593650859|FG001|Overall Study|Randomized by mistake without study treatment|1|||
164347701|NCT05526716|593650858|FG000|Overall Study|Withdrawal by Subject|12|||
164347702|NCT05526716|593650859|FG001|Overall Study|Withdrawal by Subject|12|||
164347703|NCT05526716|593650858|FG000|Overall Study|Not reported|0|||
164347704|NCT05526716|593650859|FG001|Overall Study|Not reported|2|||
164347705|NCT03489720|593650860|FG000|Overall Study|Withdrawal by Subject|2|||
164347706|NCT03489720|593650861|FG001|Overall Study|Withdrawal by Subject|0|||
164347707|NCT01806545|593650864|FG000|Overall Study|Adverse Event|2|||
164347708|NCT01806545|593650865|FG001|Overall Study|Adverse Event|3|||
164347709|NCT01806545|593650864|FG000|Overall Study|Lost to Follow-up|1|||
164347710|NCT01806545|593650865|FG001|Overall Study|Lost to Follow-up|0|||
164297549|NCT02435212|593463898|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
164297550|NCT02435212|593463897|FG000|Optional Extension Phase|Protocol Violation|0|||
164297551|NCT02435212|593463898|FG001|Optional Extension Phase|Protocol Violation|1|||
164297552|NCT02435212|593463897|FG000|Optional Extension Phase|Recovery|1|||
164347711|NCT01806545|593650864|FG000|Overall Study|Withdrawal by Subject|3|||
164347712|NCT01806545|593650865|FG001|Overall Study|Withdrawal by Subject|2|||
164347713|NCT04932096|593650866|FG000|Overall Study|Withdrawal by Subject|1|||
164297553|NCT02435212|593463898|FG001|Optional Extension Phase|Recovery|1|||
164297554|NCT02435212|593463897|FG000|Optional Extension Phase|Death|1|||
164297555|NCT02435212|593463898|FG001|Optional Extension Phase|Death|0|||
164089529|NCT03708211|592690348|FG000|Overall Study|Other|2|||
164089530|NCT03708211|592690349|FG001|Overall Study|Other|0|||
164089531|NCT00462982|592690360|FG000|Overall Study|Adverse Event|1|||
164089532|NCT00462982|592690360|FG000|Overall Study|Patient Not Treated|2|||
164089533|NCT05328375|592691400|FG000|Overall Study|Withdrawal by Subject|0|||
164089534|NCT05328375|592691401|FG001|Overall Study|Withdrawal by Subject|1|||
164089535|NCT05514119|592691406|FG000|Overall Study|Ineligible due to disease progression|1|||
164089536|NCT02946385|592691407|FG000|Overall Study|Lost to Follow-up|0|||
164089537|NCT02946385|592691408|FG001|Overall Study|Lost to Follow-up|0|||
164089538|NCT02946385|592691409|FG002|Overall Study|Lost to Follow-up|3|||
164089539|NCT02946385|592691410|FG003|Overall Study|Lost to Follow-up|0|||
164089540|NCT02946385|592691411|FG004|Overall Study|Lost to Follow-up|2|||
164089541|NCT02946385|592691412|FG005|Overall Study|Lost to Follow-up|1|||
164089542|NCT00278200|592691423|FG000|Overall Study|Death|1|||
164089543|NCT00278200|592691424|FG001|Overall Study|Death|3|||
164089544|NCT00278200|592691423|FG000|Overall Study|Physician Decision|0|||
164089545|NCT00278200|592691424|FG001|Overall Study|Physician Decision|1|||
164089546|NCT02688400|592691430|FG000|Overall Study|Protocol Violation|2|||
164089547|NCT02688400|592691431|FG001|Overall Study|Protocol Violation|5|||
164089548|NCT02688400|592691430|FG000|Overall Study|Lack of Efficacy|7|||
164089549|NCT02688400|592691431|FG001|Overall Study|Lack of Efficacy|7|||
164089550|NCT02688400|592691430|FG000|Overall Study|Adverse Event|21|||
164089551|NCT02688400|592691431|FG001|Overall Study|Adverse Event|12|||
164089552|NCT02688400|592691430|FG000|Overall Study|Withdrawal by Subject|15|||
164089553|NCT02688400|592691431|FG001|Overall Study|Withdrawal by Subject|13|||
164089554|NCT02688400|592691430|FG000|Overall Study|No study medication intake|1|||
164089555|NCT02688400|592691431|FG001|Overall Study|No study medication intake|4|||
164089556|NCT02688400|592691430|FG000|Overall Study|Lost to Follow-up|0|||
164089557|NCT02688400|592691431|FG001|Overall Study|Lost to Follow-up|3|||
164089558|NCT03519256|592691444|FG000|Overall Study|Disease recurrence|4|||
164089559|NCT03519256|592691445|FG001|Overall Study|Disease recurrence|4|||
164089560|NCT03519256|592691446|FG002|Overall Study|Disease recurrence|5|||
164089561|NCT03519256|592691447|FG003|Overall Study|Disease recurrence|2|||
164089562|NCT03519256|592691444|FG000|Overall Study|Study drug toxicity|0|||
164089563|NCT03519256|592691445|FG001|Overall Study|Study drug toxicity|2|||
164089564|NCT03519256|592691446|FG002|Overall Study|Study drug toxicity|5|||
164089565|NCT03519256|592691447|FG003|Overall Study|Study drug toxicity|2|||
164089566|NCT03519256|592691444|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164089567|NCT03519256|592691445|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164089568|NCT03519256|592691446|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164089569|NCT03519256|592691447|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164089570|NCT03519256|592691444|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164089571|NCT03519256|592691445|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164089572|NCT03519256|592691446|FG002|Overall Study|Participant request to discontinue study treatment|0|||
164089573|NCT03519256|592691447|FG003|Overall Study|Participant request to discontinue study treatment|2|||
164089574|NCT03519256|592691444|FG000|Overall Study|Other reasons|0|||
164089575|NCT03519256|592691445|FG001|Overall Study|Other reasons|0|||
164089576|NCT03519256|592691446|FG002|Overall Study|Other reasons|2|||
164297556|NCT02435212|593463897|FG000|Optional Extension Phase|Technical problems|2|||
164297557|NCT02435212|593463898|FG001|Optional Extension Phase|Technical problems|0|||
164297558|NCT04711850|593463902|FG000|Overall Study|Graft loss|2|||
164297559|NCT04711850|593463903|FG001|Overall Study|Graft loss|1|||
164297560|NCT04711850|593463902|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
164297561|NCT04711850|593463903|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
164297562|NCT04711850|593463902|FG000|Overall Study|Study terminated by sponsor|5|||
164347714|NCT04932096|593650867|FG001|Overall Study|Withdrawal by Subject|1|||
164347715|NCT04932096|593650866|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
164347716|NCT04932096|593650867|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
164089577|NCT03519256|592691447|FG003|Overall Study|Other reasons|0|||
164089578|NCT03519256|592691444|FG000|Overall Study|Disease progression|6|||
164089579|NCT03519256|592691445|FG001|Overall Study|Disease progression|3|||
164089580|NCT03519256|592691446|FG002|Overall Study|Disease progression|2|||
164089581|NCT03519256|592691447|FG003|Overall Study|Disease progression|1|||
164089582|NCT03519256|592691444|FG000|Overall Study|Lost to Follow-up|0|||
164089583|NCT03519256|592691445|FG001|Overall Study|Lost to Follow-up|1|||
164089584|NCT03519256|592691446|FG002|Overall Study|Lost to Follow-up|0|||
164089585|NCT03519256|592691447|FG003|Overall Study|Lost to Follow-up|0|||
164297563|NCT04711850|593463903|FG001|Overall Study|Study terminated by sponsor|3|||
164297564|NCT04711850|593463902|FG000|Overall Study|Sponsor decision|0|||
164347717|NCT01438957|593650868|FG000|Overall Study|Physician Decision|1|||
164089586|NCT02207231|592691448|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
164089587|NCT02207231|592691449|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
164089588|NCT02207231|592691450|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
164089589|NCT02207231|592691451|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
164132706|NCT01986010|592850668|FG013|Overall Study|Physician Decision|0|||
164297565|NCT04711850|593463903|FG001|Overall Study|Sponsor decision|2|||
164297566|NCT01346358|593463904|FG000|Overall Study|Withdrawal by Subject|1|||
164297567|NCT01346358|593463905|FG001|Overall Study|Withdrawal by Subject|0|||
164297568|NCT01346358|593463906|FG002|Overall Study|Withdrawal by Subject|1|||
164297569|NCT01346358|593463907|FG003|Overall Study|Withdrawal by Subject|1|||
164297570|NCT01346358|593463908|FG004|Overall Study|Withdrawal by Subject|0|||
164297571|NCT01346358|593463909|FG005|Overall Study|Withdrawal by Subject|2|||
164297572|NCT01346358|593463910|FG006|Overall Study|Withdrawal by Subject|1|||
164297573|NCT01346358|593463911|FG007|Overall Study|Withdrawal by Subject|1|||
164297574|NCT01346358|593463912|FG008|Overall Study|Withdrawal by Subject|1|||
164297575|NCT01346358|593463904|FG000|Overall Study|Adverse Event|1|||
164297576|NCT01346358|593463905|FG001|Overall Study|Adverse Event|0|||
164297577|NCT01346358|593463906|FG002|Overall Study|Adverse Event|0|||
164297578|NCT01346358|593463907|FG003|Overall Study|Adverse Event|0|||
164297579|NCT01346358|593463908|FG004|Overall Study|Adverse Event|1|||
164297580|NCT01346358|593463909|FG005|Overall Study|Adverse Event|0|||
164297581|NCT01346358|593463910|FG006|Overall Study|Adverse Event|0|||
164297582|NCT01346358|593463911|FG007|Overall Study|Adverse Event|0|||
164297583|NCT01346358|593463912|FG008|Overall Study|Adverse Event|1|||
164297584|NCT01346358|593463904|FG000|Overall Study|Non-Compliance|0|||
164297585|NCT01346358|593463905|FG001|Overall Study|Non-Compliance|0|||
164297586|NCT01346358|593463906|FG002|Overall Study|Non-Compliance|0|||
164297587|NCT01346358|593463907|FG003|Overall Study|Non-Compliance|0|||
164297588|NCT01346358|593463908|FG004|Overall Study|Non-Compliance|0|||
164297589|NCT01346358|593463909|FG005|Overall Study|Non-Compliance|0|||
164297590|NCT01346358|593463910|FG006|Overall Study|Non-Compliance|0|||
164297591|NCT01346358|593463911|FG007|Overall Study|Non-Compliance|2|||
164297592|NCT01346358|593463912|FG008|Overall Study|Non-Compliance|0|||
164297593|NCT01346358|593463904|FG000|Overall Study|Physician Decision|0|||
164297594|NCT01346358|593463905|FG001|Overall Study|Physician Decision|1|||
164297595|NCT01346358|593463906|FG002|Overall Study|Physician Decision|0|||
164297596|NCT01346358|593463907|FG003|Overall Study|Physician Decision|0|||
164297597|NCT01346358|593463908|FG004|Overall Study|Physician Decision|0|||
164297598|NCT01346358|593463909|FG005|Overall Study|Physician Decision|0|||
164297599|NCT01346358|593463910|FG006|Overall Study|Physician Decision|0|||
164297600|NCT01346358|593463911|FG007|Overall Study|Physician Decision|1|||
164297601|NCT01346358|593463912|FG008|Overall Study|Physician Decision|1|||
164297602|NCT04819945|593463915|FG000|Overall Study|Lost to Follow-up|1|||
164297603|NCT04531176|593463932|FG000|Overall Study|Study was stopped early|24|||
164297604|NCT04531176|593463933|FG001|Overall Study|Study was stopped early|26|||
164297605|NCT04531176|593463934|FG002|Overall Study|Study was stopped early|24|||
164347718|NCT01438957|593650869|FG001|Overall Study|Physician Decision|1|||
164347719|NCT01438957|593650870|FG002|Overall Study|Physician Decision|0|||
164347720|NCT01438957|593650871|FG003|Overall Study|Physician Decision|1|||
164005352|NCT06400238|592385746|FG000|Overall Study|Withdrawal by Subject|2|||
164005353|NCT06400238|592385746|FG000|Overall Study|Physician Decision|2|||
164005354|NCT01009463|592385747|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
164005355|NCT01009463|592385748|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164005356|NCT01009463|592385749|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164005357|NCT01009463|592385750|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164005358|NCT01009463|592385751|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
164005359|NCT01009463|592385747|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
164005360|NCT01009463|592385748|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
164005361|NCT01009463|592385749|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
164005362|NCT01009463|592385750|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
164005363|NCT01009463|592385751|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
164005364|NCT01009463|592385747|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
164005365|NCT01009463|592385748|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164005366|NCT01009463|592385749|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164005367|NCT01009463|592385750|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164005368|NCT01009463|592385751|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
164005369|NCT01009463|592385747|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
164297606|NCT00561652|593463939|FG000|Overall Study|Withdrawal by Subject|0|||
164297607|NCT00561652|593463940|FG001|Overall Study|Withdrawal by Subject|1|||
164297608|NCT04484961|593463943|FG000|Overall Study|Lost to Follow-up|9|||
164297609|NCT04484961|593463944|FG001|Overall Study|Lost to Follow-up|9|||
164297610|NCT00685165|593463945|FG000|Washout Period of 14 Days|Adverse Event|1|||
164297611|NCT00685165|593463946|FG001|Washout Period of 14 Days|Adverse Event|0|||
164297612|NCT03155724|593463947|FG000|Overall Study|Death|3|||
164297613|NCT03155724|593463947|FG000|Overall Study|Physician Decision|1|||
164297614|NCT03155724|593463947|FG000|Overall Study|Study closure|7|||
164297615|NCT02485691|593463949|FG000|Overall Study|Adverse Event|25|||
164347721|NCT01438957|593650872|FG004|Overall Study|Physician Decision|0|||
164005370|NCT01009463|592385748|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
164297616|NCT02485691|593463950|FG001|Overall Study|Adverse Event|11|||
164347722|NCT00884312|593650874|FG000|Overall Study|Non-fatal Progressive Disease|0|||
163898563|NCT00943917|592001077|FG010|Stage II Continuation|Protocol Violation|0|||
163898564|NCT00943917|592001078|FG011|Stage II Continuation|Protocol Violation|1|||
163898565|NCT00943917|592001079|FG012|Stage II Continuation|Protocol Violation|0|||
163898566|NCT00943917|592001080|FG013|Stage II Continuation|Protocol Violation|0|||
163898567|NCT00943917|592001081|FG014|Stage II Continuation|Protocol Violation|0|||
163898568|NCT00943917|592001067|FG000|Stage II Continuation|hypoglycemia|0|||
163898569|NCT00943917|592001068|FG001|Stage II Continuation|hypoglycemia|0|||
164297617|NCT02485691|593463949|FG000|Overall Study|Poor compliance to protocol|0|||
164297618|NCT02485691|593463950|FG001|Overall Study|Poor compliance to protocol|1|||
164297619|NCT02485691|593463949|FG000|Overall Study|Disease progression|57|||
164297620|NCT02485691|593463950|FG001|Overall Study|Disease progression|92|||
164297621|NCT02485691|593463949|FG000|Overall Study|Investigator's decision|23|||
164297622|NCT02485691|593463950|FG001|Overall Study|Investigator's decision|5|||
164297623|NCT02485691|593463949|FG000|Overall Study|Participant's request|13|||
164297624|NCT02485691|593463950|FG001|Overall Study|Participant's request|6|||
164089590|NCT02207231|592691448|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
164297625|NCT02485691|593463949|FG000|Overall Study|Other reason|8|||
164089591|NCT02207231|592691449|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
164297626|NCT02485691|593463950|FG001|Overall Study|Other reason|9|||
164297627|NCT02485691|593463949|FG000|Overall Study|Randomized and not treated|3|||
164297628|NCT02485691|593463950|FG001|Overall Study|Randomized and not treated|2|||
164297629|NCT03518086|593463953|FG000|Overall Study|Adverse Event|23|||
164297630|NCT03518086|593463954|FG001|Overall Study|Adverse Event|15|||
164297631|NCT03518086|593463955|FG002|Overall Study|Adverse Event|3|||
164297632|NCT03518086|593463956|FG003|Overall Study|Adverse Event|2|||
164297633|NCT03518086|593463953|FG000|Overall Study|Withdrawal by Subject|8|||
164297634|NCT03518086|593463954|FG001|Overall Study|Withdrawal by Subject|5|||
164297635|NCT03518086|593463955|FG002|Overall Study|Withdrawal by Subject|1|||
164297636|NCT03518086|593463956|FG003|Overall Study|Withdrawal by Subject|0|||
164297637|NCT03518086|593463953|FG000|Overall Study|Lack of Efficacy|5|||
164297638|NCT03518086|593463954|FG001|Overall Study|Lack of Efficacy|5|||
164297639|NCT03518086|593463955|FG002|Overall Study|Lack of Efficacy|0|||
164297640|NCT03518086|593463956|FG003|Overall Study|Lack of Efficacy|2|||
164297641|NCT03518086|593463953|FG000|Overall Study|Protocol Violation|1|||
164297642|NCT03518086|593463954|FG001|Overall Study|Protocol Violation|5|||
164297643|NCT03518086|593463955|FG002|Overall Study|Protocol Violation|1|||
164297644|NCT03518086|593463956|FG003|Overall Study|Protocol Violation|3|||
164297645|NCT03518086|593463953|FG000|Overall Study|Lost to Follow-up|0|||
164297646|NCT03518086|593463954|FG001|Overall Study|Lost to Follow-up|3|||
164297647|NCT03518086|593463955|FG002|Overall Study|Lost to Follow-up|0|||
164297648|NCT03518086|593463956|FG003|Overall Study|Lost to Follow-up|0|||
164297649|NCT03518086|593463953|FG000|Overall Study|Insufficient Diary Data|0|||
164297650|NCT03518086|593463954|FG001|Overall Study|Insufficient Diary Data|2|||
164297651|NCT03518086|593463955|FG002|Overall Study|Insufficient Diary Data|0|||
164297652|NCT03518086|593463956|FG003|Overall Study|Insufficient Diary Data|0|||
164297653|NCT03518086|593463953|FG000|Overall Study|Non- compliance to Protocol|0|||
164297654|NCT03518086|593463954|FG001|Overall Study|Non- compliance to Protocol|1|||
164297655|NCT03518086|593463955|FG002|Overall Study|Non- compliance to Protocol|0|||
164297656|NCT03518086|593463956|FG003|Overall Study|Non- compliance to Protocol|0|||
164297657|NCT03518086|593463953|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
164297658|NCT03518086|593463954|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
164297659|NCT03518086|593463955|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
164297660|NCT03518086|593463956|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
164297661|NCT03518086|593463953|FG000|Overall Study|Site Terminated by Sponsor|0|||
164297662|NCT03518086|593463954|FG001|Overall Study|Site Terminated by Sponsor|1|||
164297663|NCT03518086|593463955|FG002|Overall Study|Site Terminated by Sponsor|0|||
164297664|NCT03518086|593463956|FG003|Overall Study|Site Terminated by Sponsor|0|||
164297665|NCT03518086|593463953|FG000|Overall Study|Pregnancy|0|||
164297666|NCT03518086|593463954|FG001|Overall Study|Pregnancy|0|||
164297667|NCT03518086|593463955|FG002|Overall Study|Pregnancy|0|||
164297668|NCT03518086|593463956|FG003|Overall Study|Pregnancy|2|||
164297669|NCT02336282|593463957|FG000|Overall Study|Unrelated illness|1|||
164297670|NCT02336282|593463957|FG000|Overall Study|Uncomfortable with technology|1|||
164297671|NCT02336282|593463957|FG000|Overall Study|Lost to Follow-up|1|||
164297672|NCT02336282|593463957|FG000|Overall Study|Not enough time to complete sessions|2|||
164297673|NCT04163341|593463958|FG000|Overall Study|Withdrawal by Subject|2|||
164297674|NCT04163341|593463959|FG001|Overall Study|Withdrawal by Subject|0|||
164297675|NCT04163341|593463958|FG000|Overall Study|Lost to Follow-up|3|||
164297676|NCT04163341|593463959|FG001|Overall Study|Lost to Follow-up|4|||
164297677|NCT00079417|593465953|FG000|Overall Study|Physician Decision|2|||
164297678|NCT00079417|593465953|FG000|Overall Study|Ineligible|7|||
164297679|NCT01615939|593465954|FG000|Overall Study|Lost to Follow-up|5|||
164297680|NCT01615939|593465955|FG001|Overall Study|Lost to Follow-up|0|||
164297681|NCT01586364|593465956|FG000|Overall Study|Withdrawal by Subject|40|||
164297682|NCT01586364|593465956|FG000|Overall Study|Adverse Event|37|||
164297683|NCT01586364|593465956|FG000|Overall Study|Lost to Follow-up|17|||
164297684|NCT01586364|593465956|FG000|Overall Study|Protocol Violation|16|||
164297685|NCT01586364|593465956|FG000|Overall Study|Lack of Efficacy|1|||
164297686|NCT01586364|593465956|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
164297687|NCT01586364|593465956|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
164297688|NCT01586364|593465956|FG000|Overall Study|Other-Site closure due to PI illness|1|||
163898570|NCT00943917|592001069|FG002|Stage II Continuation|hypoglycemia|0|||
163898571|NCT00943917|592001070|FG003|Stage II Continuation|hypoglycemia|0|||
164297689|NCT01586364|593465956|FG000|Overall Study|Other-PI discretion, site closing|2|||
164297690|NCT01586364|593465956|FG000|Overall Study|Other-Not specified|1|||
164297691|NCT02121535|593465957|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
164297692|NCT02121535|593465958|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
164297693|NCT02121535|593465957|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
164297694|NCT02121535|593465958|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
163898572|NCT00943917|592001071|FG004|Stage II Continuation|hypoglycemia|0|||
164297695|NCT05366738|593465959|FG000|Overall Study|Adverse Event|0|||
164297696|NCT05366738|593465960|FG001|Overall Study|Adverse Event|1|||
164297697|NCT05366738|593465961|FG002|Overall Study|Adverse Event|0|||
164297698|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
164297699|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297700|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297701|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297702|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297703|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297704|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164297705|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
164297706|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297707|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297708|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297709|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297710|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297711|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
164297712|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
164297713|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297714|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297715|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297716|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297717|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297718|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164297719|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
164297720|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297721|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297722|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297723|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297724|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297725|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164297726|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
164297727|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297728|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297729|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297730|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297731|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297732|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
164297733|NCT01054885|593465968|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
164297734|NCT01054885|593465969|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297735|NCT01054885|593465970|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297736|NCT01054885|593465971|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297737|NCT01054885|593465972|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297738|NCT01054885|593465973|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297739|NCT01054885|593465974|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
164297740|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164297741|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
164297742|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
164297743|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
164297744|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
164297745|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
164297746|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
164297747|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297748|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297749|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
164297750|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
164297751|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297752|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
164297753|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164297754|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
164297755|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
164297756|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
164297757|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
164299997|NCT05138653|593472964|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164299998|NCT05138653|593472965|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164297758|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
164297759|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
164297760|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
164297761|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164297762|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
164297763|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
164297764|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164297765|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164297766|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
164297767|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164297768|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
164297769|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
164297770|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
164297771|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
164297772|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
164297773|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
164297774|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
164297775|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297776|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297777|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
164297778|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297779|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297780|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
164297781|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
164297782|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164005371|NCT01009463|592385749|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
164297783|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
164297784|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164297785|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164297786|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164297787|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164297788|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164297789|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164297790|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
164297791|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
164297792|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
164297793|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
164005372|NCT01009463|592385750|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
164297794|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
164297795|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
164297796|NCT01054885|593465968|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164297797|NCT01054885|593465969|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
164297798|NCT01054885|593465970|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164297799|NCT01054885|593465971|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
164297800|NCT01054885|593465972|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
164297801|NCT01054885|593465973|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164297802|NCT01054885|593465974|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
164297803|NCT00804908|593465975|FG000|Overall Study|Other|115|||
164297804|NCT00804908|593465976|FG001|Overall Study|Other|116|||
164297805|NCT00804908|593465977|FG002|Overall Study|Other|114|||
164297806|NCT01280903|593465978|FG000|Overall Study|Lost to Follow-up|23|||
164297807|NCT01280903|593465979|FG001|Overall Study|Lost to Follow-up|16|||
164297808|NCT03829228|593465982|FG000|Overall Study|Protocol Violation|1|||
164297809|NCT02177695|593465983|FG000|ITT Analysis|Ineligible|5|||
164297810|NCT02177695|593465984|FG001|ITT Analysis|Ineligible|5|||
164297811|NCT02177695|593465983|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
164297812|NCT02177695|593465984|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
164297813|NCT02177695|593465983|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
164297814|NCT02177695|593465984|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
164297815|NCT02177695|593465983|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
164297816|NCT02177695|593465984|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
164297817|NCT02443688|593465987|FG000|Overall Study|Adverse Event|2|||
164297818|NCT02443688|593465988|FG001|Overall Study|Adverse Event|3|||
164297819|NCT02443688|593465989|FG002|Overall Study|Adverse Event|2|||
164297820|NCT02443688|593465987|FG000|Overall Study|Lost to Follow-up|1|||
164297821|NCT02443688|593465988|FG001|Overall Study|Lost to Follow-up|0|||
164297822|NCT02443688|593465989|FG002|Overall Study|Lost to Follow-up|0|||
164297823|NCT02443688|593465987|FG000|Overall Study|Physician Decision|3|||
164297824|NCT02443688|593465988|FG001|Overall Study|Physician Decision|0|||
164297825|NCT02443688|593465989|FG002|Overall Study|Physician Decision|1|||
164297826|NCT02443688|593465987|FG000|Overall Study|Pregnancy|0|||
164297827|NCT02443688|593465988|FG001|Overall Study|Pregnancy|0|||
164297828|NCT02443688|593465989|FG002|Overall Study|Pregnancy|1|||
164297829|NCT02443688|593465987|FG000|Overall Study|Withdrawal by Subject|3|||
164297830|NCT02443688|593465988|FG001|Overall Study|Withdrawal by Subject|3|||
164297831|NCT02443688|593465989|FG002|Overall Study|Withdrawal by Subject|4|||
164297832|NCT02443688|593465987|FG000|Overall Study|Non-compliance with study drug|1|||
164297833|NCT02443688|593465988|FG001|Overall Study|Non-compliance with study drug|2|||
164297834|NCT02443688|593465989|FG002|Overall Study|Non-compliance with study drug|4|||
164297835|NCT02443688|593465987|FG000|Overall Study|Sponsor Request|2|||
164297836|NCT02443688|593465988|FG001|Overall Study|Sponsor Request|1|||
164297837|NCT02443688|593465989|FG002|Overall Study|Sponsor Request|0|||
164297838|NCT03182374|593465990|FG000|Overall Study|Lost to Follow-up|3|||
164297839|NCT03182374|593465991|FG001|Overall Study|Lost to Follow-up|2|||
164297840|NCT03182374|593465990|FG000|Overall Study|Lack of Efficacy|8|||
164297841|NCT03182374|593465991|FG001|Overall Study|Lack of Efficacy|14|||
164297842|NCT03182374|593465990|FG000|Overall Study|Withdrawal by Subject|1|||
164297843|NCT03182374|593465991|FG001|Overall Study|Withdrawal by Subject|1|||
164297844|NCT03182374|593465990|FG000|Overall Study|exit for non-compliance|1|||
164297845|NCT03182374|593465991|FG001|Overall Study|exit for non-compliance|1|||
164297846|NCT03182374|593465990|FG000|Overall Study|one subject was randomized but not treated|1|||
164297847|NCT03182374|593465991|FG001|Overall Study|one subject was randomized but not treated|0|||
164297848|NCT03182374|593465990|FG000|Overall Study|Other reasons|0|||
164297849|NCT03182374|593465991|FG001|Overall Study|Other reasons|3|||
164297850|NCT01462370|593465992|FG000|Overall Study|Lack of Qualifying Event|1|||
164297851|NCT01462370|593465993|FG001|Overall Study|Lack of Qualifying Event|1|||
164297852|NCT01462370|593465992|FG000|Overall Study|Physician Decision|0|||
164297853|NCT01462370|593465993|FG001|Overall Study|Physician Decision|1|||
164297854|NCT01462370|593465992|FG000|Overall Study|Withdrawal by Subject|0|||
164297855|NCT01462370|593465993|FG001|Overall Study|Withdrawal by Subject|3|||
164347723|NCT00884312|593650875|FG001|Overall Study|Non-fatal Progressive Disease|8|||
164347724|NCT00884312|593650874|FG000|Overall Study|Fatal Progressive Disease|0|||
164347725|NCT00884312|593650875|FG001|Overall Study|Fatal Progressive Disease|1|||
164347726|NCT00884312|593650874|FG000|Overall Study|Non-fatal Adverse Event|1|||
164297856|NCT00473564|593465996|FG000|Overall Study|robot surgery aborted in OR|23|||
164297857|NCT00914316|593465999|FG000|Phase 1|Physician Decision|4|||
164347727|NCT00884312|593650875|FG001|Overall Study|Non-fatal Adverse Event|0|||
164347728|NCT00884312|593650874|FG000|Overall Study|Fatal Adverse Event|1|||
164347729|NCT00884312|593650875|FG001|Overall Study|Fatal Adverse Event|4|||
164347730|NCT00884312|593650874|FG000|Overall Study|Withdrawal by Subject|0|||
164297858|NCT00914316|593466000|FG001|Phase 1|Physician Decision|0|||
164297859|NCT00914316|593466001|FG002|Phase 1|Physician Decision|1|||
164297860|NCT00914316|593466002|FG003|Phase 1|Physician Decision|2|||
164347731|NCT00884312|593650875|FG001|Overall Study|Withdrawal by Subject|6|||
164347732|NCT00884312|593650874|FG000|Overall Study|Physician Decision|0|||
164347733|NCT00884312|593650875|FG001|Overall Study|Physician Decision|1|||
164347734|NCT00884312|593650874|FG000|Overall Study|Other|0|||
164347735|NCT00884312|593650875|FG001|Overall Study|Other|4|||
164347736|NCT00884312|593650874|FG000|Overall Study|Did Not Receive Study Drug|0|||
164347737|NCT00884312|593650875|FG001|Overall Study|Did Not Receive Study Drug|1|||
164347738|NCT03902574|593650877|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
164347739|NCT03902574|593650878|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
164347740|NCT03902574|593650879|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
164347741|NCT00133952|593650880|FG000|Overall Study|Adverse Event|1|||
164347742|NCT00133952|593650881|FG001|Overall Study|Adverse Event|2|||
164347743|NCT00133952|593650880|FG000|Overall Study|Death|3|||
164347744|NCT00133952|593650881|FG001|Overall Study|Death|2|||
164347745|NCT00133952|593650880|FG000|Overall Study|Lost to Follow-up|9|||
164347746|NCT00133952|593650881|FG001|Overall Study|Lost to Follow-up|14|||
164347747|NCT00133952|593650880|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
164347748|NCT00133952|593650881|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
164347749|NCT00133952|593650880|FG000|Overall Study|Protocol Violation|1|||
164347750|NCT00133952|593650881|FG001|Overall Study|Protocol Violation|1|||
164347751|NCT00133952|593650880|FG000|Overall Study|Withdrawal by Subject|20|||
164347752|NCT00133952|593650881|FG001|Overall Study|Withdrawal by Subject|4|||
164347753|NCT00133952|593650880|FG000|Overall Study|Physician Decision|4|||
164347754|NCT00133952|593650881|FG001|Overall Study|Physician Decision|3|||
164347755|NCT00133952|593650880|FG000|Overall Study|Sponsor Decision|0|||
164347756|NCT00133952|593650881|FG001|Overall Study|Sponsor Decision|1|||
164347757|NCT02101060|593650893|FG000|Overall Study|Adverse Event|1|||
164347758|NCT02101060|593650894|FG001|Overall Study|Adverse Event|0|||
164347759|NCT02101060|593650893|FG000|Overall Study|Withdrawal by Subject|1|||
164347760|NCT02101060|593650894|FG001|Overall Study|Withdrawal by Subject|1|||
164347761|NCT02101060|593650893|FG000|Overall Study|Lost to Follow-up|3|||
164347762|NCT02101060|593650894|FG001|Overall Study|Lost to Follow-up|3|||
164347763|NCT00545168|593650901|FG000|Overall Study|Lost to Follow-up|5|||
164347764|NCT00545168|593650902|FG001|Overall Study|Lost to Follow-up|5|||
164347765|NCT00545168|593650903|FG002|Overall Study|Lost to Follow-up|5|||
164347766|NCT00545168|593650901|FG000|Overall Study|Withdrawal by Subject|9|||
164347767|NCT00545168|593650902|FG001|Overall Study|Withdrawal by Subject|0|||
164347768|NCT00545168|593650903|FG002|Overall Study|Withdrawal by Subject|13|||
164347769|NCT00545168|593650901|FG000|Overall Study|Protocol Violation|1|||
164347770|NCT00545168|593650902|FG001|Overall Study|Protocol Violation|0|||
164347771|NCT00545168|593650903|FG002|Overall Study|Protocol Violation|1|||
164347772|NCT00545168|593650901|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
164347773|NCT00545168|593650902|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
164347774|NCT00545168|593650903|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
164347775|NCT01833520|593650908|FG000|Overall Study|Lack of Efficacy|3|||
164347776|NCT01833520|593650909|FG001|Overall Study|Lack of Efficacy|3|||
164347777|NCT01833520|593650910|FG002|Overall Study|Lack of Efficacy|8|||
164347778|NCT01833520|593650911|FG003|Overall Study|Lack of Efficacy|3|||
164347779|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
164347780|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
164347781|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
164347782|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
164347783|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
164347784|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
164347785|NCT00489541|593650912|FG000|12-Month Clinical Follow-up|Death|3|||
164347786|NCT00489541|593650913|FG001|12-Month Clinical Follow-up|Death|2|||
164347787|NCT00489541|593650912|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
164347788|NCT00489541|593650913|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
164347789|NCT00489541|593650912|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
164347790|NCT00489541|593650913|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
164347791|NCT00003479|593650917|FG000|Overall Study|Not evaluable|3|||
164347792|NCT01484197|593650918|FG000|Treatment Period 1|Adverse Event|1|||
164347793|NCT01484197|593650919|FG001|Treatment Period 1|Adverse Event|0|||
164347794|NCT01484197|593650920|FG002|Treatment Period 1|Adverse Event|0|||
164347795|NCT01484197|593650921|FG003|Treatment Period 1|Adverse Event|0|||
164347796|NCT01484197|593650918|FG000|Treatment Period 2|Subject withdrew consent|0|||
164347797|NCT01484197|593650919|FG001|Treatment Period 2|Subject withdrew consent|0|||
164347798|NCT01484197|593650920|FG002|Treatment Period 2|Subject withdrew consent|0|||
164347799|NCT01484197|593650921|FG003|Treatment Period 2|Subject withdrew consent|1|||
164347800|NCT01727297|593650922|FG000|Overall Study|Death|13|||
164347801|NCT01727297|593650923|FG001|Overall Study|Death|0|||
164347802|NCT01727297|593650922|FG000|Overall Study|Protocol Violation|1|||
164347803|NCT01727297|593650923|FG001|Overall Study|Protocol Violation|10|||
164347804|NCT01727297|593650922|FG000|Overall Study|Adverse Event|3|||
164347805|NCT01727297|593650923|FG001|Overall Study|Adverse Event|1|||
164347806|NCT01727297|593650922|FG000|Overall Study|Lost to Follow-up|11|||
163898573|NCT00943917|592001072|FG005|Stage II Continuation|hypoglycemia|0|||
163898574|NCT00943917|592001073|FG006|Stage II Continuation|hypoglycemia|0|||
163898575|NCT00943917|592001074|FG007|Stage II Continuation|hypoglycemia|0|||
163898576|NCT00943917|592001075|FG008|Stage II Continuation|hypoglycemia|0|||
164297861|NCT00914316|593465999|FG000|Phase 1|Withdrawal by Subject|0|||
164297862|NCT00914316|593466000|FG001|Phase 1|Withdrawal by Subject|2|||
164297863|NCT00914316|593466001|FG002|Phase 1|Withdrawal by Subject|4|||
164297864|NCT00914316|593466002|FG003|Phase 1|Withdrawal by Subject|0|||
164297865|NCT00914316|593465999|FG000|Phase 1|Adverse Event|1|||
164297866|NCT00914316|593466000|FG001|Phase 1|Adverse Event|0|||
164297867|NCT00914316|593466001|FG002|Phase 1|Adverse Event|0|||
164297868|NCT00914316|593466002|FG003|Phase 1|Adverse Event|0|||
164297869|NCT00914316|593465999|FG000|Phase 2|Withdrawal by Subject|1|||
164297870|NCT00914316|593466000|FG001|Phase 2|Withdrawal by Subject|0|||
164297871|NCT00914316|593466001|FG002|Phase 2|Withdrawal by Subject|1|||
164297872|NCT00914316|593466002|FG003|Phase 2|Withdrawal by Subject|0|||
164297873|NCT01391546|593466004|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
164297874|NCT01391546|593466005|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
164297875|NCT00726063|593466006|FG000|Overall Study|Adverse Event|9|||
164297876|NCT00726063|593466007|FG001|Overall Study|Adverse Event|7|||
164297877|NCT02007096|593466008|FG000|Overall Study|medication not available|2|||
164297878|NCT02007096|593466009|FG001|Overall Study|medication not available|0|||
164297879|NCT02007096|593466008|FG000|Overall Study|did not inject saline|0|||
164297880|NCT02007096|593466009|FG001|Overall Study|did not inject saline|3|||
164297881|NCT02007096|593466008|FG000|Overall Study|did not follow postoperative protocol|8|||
164297882|NCT02007096|593466009|FG001|Overall Study|did not follow postoperative protocol|11|||
164297883|NCT02007096|593466008|FG000|Overall Study|converted to open surgery|1|||
164297884|NCT02007096|593466009|FG001|Overall Study|converted to open surgery|1|||
164297885|NCT02007096|593466008|FG000|Overall Study|no mesh placed|0|||
164297886|NCT02007096|593466009|FG001|Overall Study|no mesh placed|1|||
164297887|NCT06271993|593466010|FG000|Overall Study|Not reactive to histamine|5|||
164297888|NCT06271993|593466011|FG001|Overall Study|Not reactive to histamine|5|||
164297889|NCT06271993|593466012|FG002|Overall Study|Not reactive to histamine|5|||
164297890|NCT00837434|593466018|FG000|Overall Study|Physician Decision|3|||
164297891|NCT00837434|593466019|FG001|Overall Study|Physician Decision|0|||
164297892|NCT00837434|593466018|FG000|Overall Study|Lost to Follow-up|1|||
163898577|NCT00943917|592001076|FG009|Stage II Continuation|hypoglycemia|0|||
164297893|NCT00837434|593466019|FG001|Overall Study|Lost to Follow-up|1|||
164297894|NCT00837434|593466018|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
164297895|NCT00837434|593466019|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
164297896|NCT00837434|593466018|FG000|Overall Study|Noncompliant|2|||
164297897|NCT00837434|593466019|FG001|Overall Study|Noncompliant|0|||
164297898|NCT00837434|593466018|FG000|Overall Study|Baseline assessments not done in time|1|||
164297899|NCT00837434|593466019|FG001|Overall Study|Baseline assessments not done in time|0|||
163898578|NCT00943917|592001077|FG010|Stage II Continuation|hypoglycemia|0|||
164297900|NCT00837434|593466018|FG000|Overall Study|Unable to obtain study drug|1|||
164297901|NCT00837434|593466019|FG001|Overall Study|Unable to obtain study drug|0|||
164297902|NCT01980017|593466020|FG000|Overall Study|Lost to Follow-up|30|||
164297903|NCT01980017|593466021|FG001|Overall Study|Lost to Follow-up|21|||
164297904|NCT01980017|593466020|FG000|Overall Study|Death|0|||
164297905|NCT01980017|593466021|FG001|Overall Study|Death|1|||
164297906|NCT03044106|593466022|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
164297907|NCT03044106|593466023|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
164297908|NCT01207414|593466024|FG000|Overall Study|Adverse Event|25|||
164297909|NCT01207414|593466025|FG001|Overall Study|Adverse Event|39|||
164297910|NCT01207414|593466024|FG000|Overall Study|Abnormal test procedure results|0|||
164297911|NCT01207414|593466025|FG001|Overall Study|Abnormal test procedure results|1|||
164297912|NCT01207414|593466024|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164297913|NCT01207414|593466025|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164297914|NCT01207414|593466024|FG000|Overall Study|Patient withdrew consent|14|||
164297915|NCT01207414|593466025|FG001|Overall Study|Patient withdrew consent|11|||
164297916|NCT01207414|593466024|FG000|Overall Study|Lost to Follow-up|15|||
164297917|NCT01207414|593466025|FG001|Overall Study|Lost to Follow-up|17|||
164297918|NCT01207414|593466024|FG000|Overall Study|Administrative problems|1|||
164297919|NCT01207414|593466025|FG001|Overall Study|Administrative problems|1|||
164297920|NCT01207414|593466024|FG000|Overall Study|Protocol deviation|12|||
164297921|NCT01207414|593466025|FG001|Overall Study|Protocol deviation|9|||
164297922|NCT01207414|593466024|FG000|Overall Study|Randomized in error|1|||
164297923|NCT01207414|593466025|FG001|Overall Study|Randomized in error|0|||
164297924|NCT01748292|593466026|FG000|Overall Study|Adverse Event|2|||
164297925|NCT01748292|593466027|FG001|Overall Study|Adverse Event|4|||
164297926|NCT01748292|593466026|FG000|Overall Study|Lost to Follow-up|0|||
164297927|NCT01748292|593466027|FG001|Overall Study|Lost to Follow-up|3|||
164297928|NCT01748292|593466026|FG000|Overall Study|Death|0|||
164297929|NCT01748292|593466027|FG001|Overall Study|Death|3|||
164297930|NCT01748292|593466026|FG000|Overall Study|Withdrawal by Subject|0|||
164297931|NCT01748292|593466027|FG001|Overall Study|Withdrawal by Subject|2|||
164297932|NCT02057250|593466028|FG000|AID Assessment Phase|Adverse Event|3|||
164297933|NCT02057250|593466029|FG001|AID Assessment Phase|Adverse Event|2|||
164297934|NCT02057250|593466030|FG002|AID Assessment Phase|Adverse Event|6|||
164297935|NCT02057250|593466031|FG003|AID Assessment Phase|Adverse Event|1|||
164297936|NCT02057250|593466032|FG004|AID Assessment Phase|Adverse Event|0|||
164297937|NCT02057250|593466028|FG000|AID Assessment Phase|Other than specified above|1|||
164297938|NCT02057250|593466029|FG001|AID Assessment Phase|Other than specified above|1|||
164297939|NCT02057250|593466030|FG002|AID Assessment Phase|Other than specified above|1|||
164297940|NCT02057250|593466031|FG003|AID Assessment Phase|Other than specified above|1|||
164297941|NCT02057250|593466032|FG004|AID Assessment Phase|Other than specified above|0|||
164297942|NCT02057250|593466028|FG000|Extension Phase|Adverse Event|0|||
164297943|NCT02057250|593466029|FG001|Extension Phase|Adverse Event|0|||
164297944|NCT02057250|593466030|FG002|Extension Phase|Adverse Event|0|||
164297945|NCT02057250|593466031|FG003|Extension Phase|Adverse Event|0|||
164297946|NCT02057250|593466032|FG004|Extension Phase|Adverse Event|15|||
164297947|NCT02057250|593466028|FG000|Extension Phase|Lack of Efficacy|0|||
164297948|NCT02057250|593466029|FG001|Extension Phase|Lack of Efficacy|0|||
164297949|NCT02057250|593466030|FG002|Extension Phase|Lack of Efficacy|0|||
164297950|NCT02057250|593466031|FG003|Extension Phase|Lack of Efficacy|0|||
164297951|NCT02057250|593466032|FG004|Extension Phase|Lack of Efficacy|10|||
164297952|NCT02057250|593466028|FG000|Extension Phase|Entered in this period but not treated|0|||
164297953|NCT02057250|593466029|FG001|Extension Phase|Entered in this period but not treated|0|||
164297954|NCT02057250|593466030|FG002|Extension Phase|Entered in this period but not treated|0|||
164297955|NCT02057250|593466031|FG003|Extension Phase|Entered in this period but not treated|0|||
164297956|NCT02057250|593466032|FG004|Extension Phase|Entered in this period but not treated|4|||
164297957|NCT02057250|593466028|FG000|Extension Phase|Other than specified above|0|||
164297958|NCT02057250|593466029|FG001|Extension Phase|Other than specified above|0|||
164297959|NCT02057250|593466030|FG002|Extension Phase|Other than specified above|0|||
164297960|NCT02057250|593466031|FG003|Extension Phase|Other than specified above|0|||
164297961|NCT02057250|593466032|FG004|Extension Phase|Other than specified above|7|||
164297962|NCT03199976|593466034|FG000|Overall Study|Lack of Efficacy|3|||
164347807|NCT01727297|593650923|FG001|Overall Study|Lost to Follow-up|0|||
164347808|NCT01727297|593650922|FG000|Overall Study|Withdrawal by Subject|26|||
164347809|NCT01727297|593650923|FG001|Overall Study|Withdrawal by Subject|27|||
164347810|NCT01727297|593650922|FG000|Overall Study|Physician Decision|19|||
164347811|NCT01727297|593650923|FG001|Overall Study|Physician Decision|5|||
164347812|NCT01727297|593650922|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
164347813|NCT01727297|593650923|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
164347814|NCT01192516|593650924|FG000|Overall Study|Lost to Follow-up|7|||
164347815|NCT01192516|593650925|FG001|Overall Study|Lost to Follow-up|10|||
164347816|NCT01192516|593650926|FG002|Overall Study|Lost to Follow-up|7|||
164347817|NCT01192516|593650924|FG000|Overall Study|Withdrawal by Subject|4|||
164347818|NCT01192516|593650925|FG001|Overall Study|Withdrawal by Subject|4|||
164347819|NCT01192516|593650926|FG002|Overall Study|Withdrawal by Subject|1|||
164347820|NCT01192516|593650924|FG000|Overall Study|started new treatment|5|||
164347821|NCT01192516|593650925|FG001|Overall Study|started new treatment|1|||
164347822|NCT01192516|593650926|FG002|Overall Study|started new treatment|0|||
164347823|NCT01192516|593650924|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
164347824|NCT01192516|593650925|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
164347825|NCT01192516|593650926|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
164297963|NCT03199976|593466035|FG001|Overall Study|Lack of Efficacy|6|||
164297964|NCT03199976|593466036|FG002|Overall Study|Lack of Efficacy|13|||
164297965|NCT03199976|593466034|FG000|Overall Study|Withdrawal by Subject|1|||
164297966|NCT03199976|593466035|FG001|Overall Study|Withdrawal by Subject|0|||
164297967|NCT03199976|593466036|FG002|Overall Study|Withdrawal by Subject|0|||
164297968|NCT03199976|593466034|FG000|Overall Study|Lost to Follow-up|0|||
164297969|NCT03199976|593466035|FG001|Overall Study|Lost to Follow-up|1|||
164297970|NCT03199976|593466036|FG002|Overall Study|Lost to Follow-up|1|||
164297971|NCT03367793|593466037|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297972|NCT03367793|593466038|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297973|NCT03367793|593466039|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
164297974|NCT03367793|593466040|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297975|NCT03367793|593466041|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297976|NCT03367793|593466042|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
164297977|NCT03962491|593466043|FG000|Overall Study|Lost to Follow-up|4|||
164297978|NCT03962491|593466044|FG001|Overall Study|Lost to Follow-up|5|||
164297979|NCT05058365|593466047|FG000|Overall Study|Migration|1|||
164297980|NCT05058365|593466048|FG001|Overall Study|Migration|1|||
164297981|NCT00702702|593466049|FG000|Overall Study|Study prematurely terminated|56|||
164297982|NCT02738801|593466058|FG000|Overall Study|Adverse Event|1|||
164297983|NCT02738801|593466059|FG001|Overall Study|Adverse Event|1|||
164297984|NCT02738801|593466058|FG000|Overall Study|Withdrawal by Subject|0|||
164297985|NCT02738801|593466059|FG001|Overall Study|Withdrawal by Subject|1|||
164297986|NCT03279081|593466060|FG000|Overall Study|Withdrawal by Subject|12|||
164297987|NCT03279081|593466061|FG001|Overall Study|Withdrawal by Subject|20|||
164297988|NCT03279081|593466060|FG000|Overall Study|Physician Decision|4|||
164297989|NCT03279081|593466061|FG001|Overall Study|Physician Decision|1|||
164297990|NCT03279081|593466060|FG000|Overall Study|Lost to Follow-up|8|||
164297991|NCT03279081|593466061|FG001|Overall Study|Lost to Follow-up|8|||
164297992|NCT03279081|593466060|FG000|Overall Study|Death|0|||
164297993|NCT03279081|593466061|FG001|Overall Study|Death|1|||
164347826|NCT00982878|593650930|FG000|Overall Study|Physician Decision|1|||
164347827|NCT04605484|593650931|FG000|Overall Study|Lost to Follow-up|0|||
164347828|NCT04605484|593650932|FG001|Overall Study|Lost to Follow-up|1|||
164347829|NCT04605484|593650933|FG002|Overall Study|Lost to Follow-up|1|||
164347830|NCT04605484|593650931|FG000|Overall Study|Other|0|||
164347831|NCT04605484|593650932|FG001|Overall Study|Other|1|||
164347832|NCT04605484|593650933|FG002|Overall Study|Other|0|||
164347833|NCT03366337|593650936|FG000|Overall Study|Lost to Follow-up|1|||
164347834|NCT03366337|593650937|FG001|Overall Study|Lost to Follow-up|0|||
164347835|NCT03366337|593650938|FG002|Overall Study|Lost to Follow-up|1|||
164347836|NCT03366337|593650939|FG003|Overall Study|Lost to Follow-up|0|||
164347837|NCT03366337|593650936|FG000|Overall Study|Withdrawal by Subject|2|||
164347838|NCT03366337|593650937|FG001|Overall Study|Withdrawal by Subject|0|||
164347839|NCT03366337|593650938|FG002|Overall Study|Withdrawal by Subject|1|||
164347840|NCT03366337|593650939|FG003|Overall Study|Withdrawal by Subject|1|||
164347841|NCT01578187|593650946|FG000|Usability Phase|Withdrawal by Subject|1|||
164347842|NCT02516163|593650951|FG000|Overall Study|Withdrawal by Subject|1|||
164347843|NCT02516163|593650951|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
164347844|NCT02516163|593650951|FG000|Overall Study|Unfit/delay in surgery|3|||
164347845|NCT02516163|593650951|FG000|Overall Study|Use of incorrect measurement technique|5|||
164347846|NCT02516163|593650951|FG000|Overall Study|Data not recorded|2|||
164347847|NCT02516163|593650951|FG000|Overall Study|MRI contraindication exclusion|6|||
164347848|NCT01217814|593650952|FG000|Overall Study|Adverse Event|1|||
164347849|NCT01217814|593650953|FG001|Overall Study|Adverse Event|1|||
164347850|NCT01217814|593650954|FG002|Overall Study|Adverse Event|0|||
164347851|NCT01217814|593650952|FG000|Overall Study|Lack of Efficacy|0|||
164347852|NCT01217814|593650953|FG001|Overall Study|Lack of Efficacy|0|||
164347853|NCT01217814|593650954|FG002|Overall Study|Lack of Efficacy|1|||
164347854|NCT01658072|593650957|FG000|Overall Study|Protocol Violation|4|||
164347855|NCT01658072|593650958|FG001|Overall Study|Protocol Violation|2|||
164347856|NCT00040664|593650959|FG000|Overall Study|Adverse Event|12|||
164347857|NCT00040664|593650960|FG001|Overall Study|Adverse Event|3|||
164347858|NCT00040664|593650961|FG002|Overall Study|Adverse Event|2|||
164347859|NCT00040664|593650962|FG003|Overall Study|Adverse Event|7|||
164347860|NCT00040664|593650959|FG000|Overall Study|Lack of Efficacy|9|||
164347861|NCT00040664|593650960|FG001|Overall Study|Lack of Efficacy|2|||
164347862|NCT00040664|593650961|FG002|Overall Study|Lack of Efficacy|3|||
164347863|NCT00040664|593650962|FG003|Overall Study|Lack of Efficacy|4|||
164132707|NCT01986010|592850669|FG014|Overall Study|Physician Decision|1|||
164297994|NCT03279081|593466060|FG000|Overall Study|Adverse Event|1|||
164297995|NCT03279081|593466061|FG001|Overall Study|Adverse Event|0|||
164297996|NCT03279081|593466060|FG000|Overall Study|Reason not Specified|14|||
164297997|NCT03279081|593466061|FG001|Overall Study|Reason not Specified|4|||
164347864|NCT00040664|593650959|FG000|Overall Study|Insufficient CD4 response|1|||
164297998|NCT00771914|593466062|FG000|Overall Study|Physician Decision|0|||
164297999|NCT00771914|593466063|FG001|Overall Study|Physician Decision|0|||
164347865|NCT00040664|593650960|FG001|Overall Study|Insufficient CD4 response|0|||
164089592|NCT02207231|592691450|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
164089593|NCT02207231|592691451|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
164089594|NCT02207231|592691448|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
164089595|NCT02207231|592691449|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
164089596|NCT02207231|592691450|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
164089597|NCT02207231|592691451|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
164089598|NCT02207231|592691448|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
164089599|NCT02207231|592691449|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
164089600|NCT02207231|592691450|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
164089601|NCT02207231|592691451|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
164089602|NCT02207231|592691448|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
164089603|NCT02207231|592691449|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
164089604|NCT02207231|592691450|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
164089605|NCT02207231|592691451|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
164089606|NCT02207231|592691448|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
164089607|NCT02207231|592691449|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
164089608|NCT02207231|592691450|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
164089609|NCT02207231|592691451|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
164089610|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
164089611|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
164089612|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
164089613|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
164089614|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
164089615|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
164089616|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
164089617|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
164089618|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
164089619|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
164089620|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
164089621|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
164089622|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
164089623|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
164089624|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
164089625|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
164089626|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
164089627|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
164089628|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
164089629|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
164089630|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
164089631|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
164089632|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
164089633|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
164089634|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
164089635|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
164089636|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
164089637|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
164089638|NCT02207231|592691448|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
164089639|NCT02207231|592691449|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
164089640|NCT02207231|592691450|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
164089641|NCT02207231|592691451|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
164089642|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
164089643|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
164089644|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
164298000|NCT00771914|593466064|FG002|Overall Study|Physician Decision|0|||
164298001|NCT00771914|593466065|FG003|Overall Study|Physician Decision|1|||
164298002|NCT00771914|593466062|FG000|Overall Study|Lost to Follow-up|0|||
164298003|NCT00771914|593466063|FG001|Overall Study|Lost to Follow-up|0|||
164298004|NCT00771914|593466064|FG002|Overall Study|Lost to Follow-up|0|||
164298005|NCT00771914|593466065|FG003|Overall Study|Lost to Follow-up|1|||
164298006|NCT00388349|593466074|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
164298007|NCT00388349|593466075|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
164298008|NCT01667900|593466080|FG000|Part B|Death|0|||
164298009|NCT01667900|593466081|FG001|Part B|Death|0|||
164298010|NCT01667900|593466082|FG002|Part B|Death|0|||
164298011|NCT01667900|593466083|FG003|Part B|Death|0|||
164298012|NCT01667900|593466084|FG004|Part B|Death|0|||
164298013|NCT01667900|593466085|FG005|Part B|Death|0|||
164298014|NCT01667900|593466086|FG006|Part B|Death|0|||
164298015|NCT01667900|593466087|FG007|Part B|Death|0|||
164298016|NCT01667900|593466088|FG008|Part B|Death|0|||
164298017|NCT01667900|593466089|FG009|Part B|Death|0|||
164298018|NCT01667900|593466090|FG010|Part B|Death|0|||
164298019|NCT01667900|593466091|FG011|Part B|Death|0|||
164298020|NCT01667900|593466092|FG012|Part B|Death|0|||
164298021|NCT01667900|593466093|FG013|Part B|Death|0|||
164298022|NCT01667900|593466094|FG014|Part B|Death|0|||
164298023|NCT01667900|593466095|FG015|Part B|Death|0|||
164298024|NCT01667900|593466096|FG016|Part B|Death|1|||
164298025|NCT01667900|593466097|FG017|Part B|Death|0|||
164298026|NCT01667900|593466098|FG018|Part B|Death|0|||
164298027|NCT01667900|593466099|FG019|Part B|Death|0|||
164298028|NCT00231816|593466102|FG000|Overall Study|Adverse Event|1|||
164298029|NCT00231816|593466103|FG001|Overall Study|Adverse Event|0|||
164298030|NCT00231816|593466102|FG000|Overall Study|Lost to Follow-up|8|||
164298031|NCT00231816|593466103|FG001|Overall Study|Lost to Follow-up|5|||
164298032|NCT00231816|593466102|FG000|Overall Study|Protocol Violation|2|||
164298033|NCT00231816|593466103|FG001|Overall Study|Protocol Violation|3|||
164298034|NCT00231816|593466102|FG000|Overall Study|Withdrawal by Subject|3|||
164298035|NCT00231816|593466103|FG001|Overall Study|Withdrawal by Subject|3|||
164347866|NCT00040664|593650961|FG002|Overall Study|Insufficient CD4 response|1|||
164347867|NCT00040664|593650962|FG003|Overall Study|Insufficient CD4 response|0|||
164347868|NCT00040664|593650959|FG000|Overall Study|Lost to Follow-up|4|||
164347869|NCT00040664|593650960|FG001|Overall Study|Lost to Follow-up|2|||
164347870|NCT00040664|593650961|FG002|Overall Study|Lost to Follow-up|0|||
164347871|NCT00040664|593650962|FG003|Overall Study|Lost to Follow-up|2|||
164347872|NCT00040664|593650959|FG000|Overall Study|Protocol Violation|2|||
164347873|NCT00040664|593650960|FG001|Overall Study|Protocol Violation|1|||
164347874|NCT00040664|593650961|FG002|Overall Study|Protocol Violation|0|||
164347875|NCT00040664|593650962|FG003|Overall Study|Protocol Violation|1|||
164347876|NCT00040664|593650959|FG000|Overall Study|Withdrawal by Subject|7|||
164347877|NCT00040664|593650960|FG001|Overall Study|Withdrawal by Subject|0|||
164347878|NCT00040664|593650961|FG002|Overall Study|Withdrawal by Subject|3|||
164347879|NCT00040664|593650962|FG003|Overall Study|Withdrawal by Subject|4|||
164347880|NCT00040664|593650959|FG000|Overall Study|Pregnancy|3|||
164347881|NCT00040664|593650960|FG001|Overall Study|Pregnancy|0|||
164347882|NCT00040664|593650961|FG002|Overall Study|Pregnancy|0|||
164347883|NCT00040664|593650962|FG003|Overall Study|Pregnancy|3|||
164347884|NCT00040664|593650959|FG000|Overall Study|Medication adherence/compliance problems|8|||
164347885|NCT00040664|593650960|FG001|Overall Study|Medication adherence/compliance problems|2|||
164347886|NCT00040664|593650961|FG002|Overall Study|Medication adherence/compliance problems|1|||
164347887|NCT00040664|593650962|FG003|Overall Study|Medication adherence/compliance problems|5|||
164347888|NCT00040664|593650959|FG000|Overall Study|Poor taste|2|||
164347889|NCT00040664|593650960|FG001|Overall Study|Poor taste|0|||
164347890|NCT00040664|593650961|FG002|Overall Study|Poor taste|2|||
164347891|NCT00040664|593650962|FG003|Overall Study|Poor taste|0|||
164347892|NCT00040664|593650959|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
164347893|NCT00040664|593650960|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
164089645|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
164089646|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
164089647|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
164347894|NCT00040664|593650961|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
164347895|NCT00040664|593650962|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
164347896|NCT00040664|593650959|FG000|Overall Study|Change of formulation|2|||
164298036|NCT00231816|593466102|FG000|Overall Study|Other|2|||
164298037|NCT00231816|593466103|FG001|Overall Study|Other|1|||
164298038|NCT00774046|593466104|FG000|Screening|Not eligible|56|||
164298039|NCT00774046|593466104|FG000|Enrollment|Desired other therapy/refused|28|||
164298040|NCT00774046|593466104|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
164298041|NCT00976274|593466105|FG000|Overall Study|Lost to Follow-up|5|||
164347897|NCT00040664|593650960|FG001|Overall Study|Change of formulation|2|||
164298042|NCT00976274|593466106|FG001|Overall Study|Lost to Follow-up|5|||
164298043|NCT00976274|593466105|FG000|Overall Study|Withdrawal by Subject|1|||
164298044|NCT00976274|593466106|FG001|Overall Study|Withdrawal by Subject|1|||
164298045|NCT00976274|593466105|FG000|Overall Study|Physician Decision|1|||
164298046|NCT00976274|593466106|FG001|Overall Study|Physician Decision|2|||
164298047|NCT01614249|593466108|FG000|Overall Study|Lost to Follow-up|11|||
164298048|NCT01614249|593466109|FG001|Overall Study|Lost to Follow-up|23|||
164298049|NCT02954536|593466110|FG000|Overall Study|Adverse Event|2|||
164298050|NCT02954536|593466110|FG000|Overall Study|Death|12|||
164298051|NCT05498649|593466111|FG000|Overall Study|Lost to Follow-up|1|||
164298052|NCT02946580|593466112|FG000|Overall Study|Withdrawal by Subject|1|||
164298053|NCT02946580|593466113|FG001|Overall Study|Withdrawal by Subject|2|||
164298054|NCT02946580|593466112|FG000|Overall Study|Adverse Event|0|||
164298055|NCT02946580|593466113|FG001|Overall Study|Adverse Event|2|||
164298056|NCT02946580|593466112|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
164298057|NCT02946580|593466113|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
164298058|NCT03094416|593466114|FG000|Run-in|Screening failure|8|||
164298059|NCT03094416|593466114|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
164298060|NCT03094416|593466114|FG000|Run-in|Withdrawal by Subject|3|||
164298061|NCT03094416|593466114|FG000|Treatment Period|Withdrawal by Subject|2|||
164298062|NCT00321789|593466117|FG000|Overall Study|Lost to Follow-up|4|||
164298063|NCT00321789|593466118|FG001|Overall Study|Lost to Follow-up|7|||
164298064|NCT00321789|593466117|FG000|Overall Study|Withdrawal by Subject|6|||
164298065|NCT00321789|593466118|FG001|Overall Study|Withdrawal by Subject|6|||
164298066|NCT00321789|593466117|FG000|Overall Study|Protocol Violation|5|||
164298067|NCT00321789|593466118|FG001|Overall Study|Protocol Violation|3|||
164299999|NCT05138653|593472966|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300000|NCT05138653|593472967|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
164300001|NCT05138653|593472968|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300002|NCT05138653|593472969|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300003|NCT05138653|593472970|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300004|NCT05138653|593472971|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300005|NCT05138653|593472972|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300006|NCT05138653|593472973|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300007|NCT05138653|593472974|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300008|NCT05138653|593472975|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300009|NCT05138653|593472976|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
164300010|NCT05138653|593472961|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300011|NCT05138653|593472962|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300012|NCT05138653|593472963|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300013|NCT05138653|593472964|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300014|NCT05138653|593472965|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300015|NCT05138653|593472966|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300016|NCT05138653|593472967|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300017|NCT05138653|593472968|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300018|NCT05138653|593472969|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300019|NCT05138653|593472970|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
163898579|NCT00943917|592001078|FG011|Stage II Continuation|hypoglycemia|0|||
163898580|NCT00943917|592001079|FG012|Stage II Continuation|hypoglycemia|1|||
163898581|NCT00943917|592001080|FG013|Stage II Continuation|hypoglycemia|0|||
164298068|NCT00005780|593466119|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
164298069|NCT00374140|593466120|FG000|Overall Study|Lost to Follow-up|1|||
164298070|NCT00374140|593466120|FG000|Overall Study|Protocol Violation|1|||
164298071|NCT02651675|593466121|FG000|Overall Study|Death|0|||
164298072|NCT02651675|593466122|FG001|Overall Study|Death|0|||
164298073|NCT02651675|593466123|FG002|Overall Study|Death|1|||
164298074|NCT02246530|593466124|FG000|Overall Study|Lost to Follow-up|4|||
164298075|NCT02246530|593466125|FG001|Overall Study|Lost to Follow-up|0|||
164298076|NCT05712460|593466126|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298077|NCT05712460|593466127|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298078|NCT05712460|593466128|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298079|NCT05712460|593466129|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298080|NCT05712460|593466130|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298081|NCT05712460|593466131|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298082|NCT05712460|593466132|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298083|NCT05712460|593466133|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
164298084|NCT05712460|593466134|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298085|NCT05712460|593466135|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298086|NCT05712460|593466136|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298087|NCT05712460|593466137|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
164298088|NCT04292535|593466139|FG000|Overall Study|Withdrawal by Subject|0|||
164298089|NCT04292535|593466140|FG001|Overall Study|Withdrawal by Subject|0|||
164298090|NCT04292535|593466141|FG002|Overall Study|Withdrawal by Subject|0|||
164298091|NCT04292535|593466142|FG003|Overall Study|Withdrawal by Subject|0|||
164298092|NCT04292535|593466143|FG004|Overall Study|Withdrawal by Subject|0|||
164298093|NCT04292535|593466144|FG005|Overall Study|Withdrawal by Subject|0|||
164298094|NCT04292535|593466145|FG006|Overall Study|Withdrawal by Subject|0|||
164298095|NCT04292535|593466146|FG007|Overall Study|Withdrawal by Subject|1|||
164298096|NCT04292535|593466147|FG008|Overall Study|Withdrawal by Subject|0|||
164298097|NCT04292535|593466148|FG009|Overall Study|Withdrawal by Subject|0|||
164298098|NCT04292535|593466149|FG010|Overall Study|Withdrawal by Subject|0|||
164298099|NCT04292535|593466150|FG011|Overall Study|Withdrawal by Subject|0|||
164298100|NCT04292535|593466151|FG012|Overall Study|Withdrawal by Subject|0|||
164298101|NCT04292535|593466152|FG013|Overall Study|Withdrawal by Subject|0|||
164298102|NCT04292535|593466139|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298103|NCT04292535|593466140|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298104|NCT04292535|593466141|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298105|NCT04292535|593466142|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298106|NCT04292535|593466143|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298107|NCT04292535|593466144|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298108|NCT04292535|593466145|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298109|NCT04292535|593466146|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
164298110|NCT04292535|593466147|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298111|NCT04292535|593466148|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298112|NCT04292535|593466149|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298113|NCT04292535|593466150|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
164298114|NCT04292535|593466151|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
163898582|NCT00943917|592001081|FG014|Stage II Continuation|hypoglycemia|0|||
163898583|NCT00943917|592001067|FG000|Stage II Continuation|A1C elevation|0|||
163898584|NCT00943917|592001068|FG001|Stage II Continuation|A1C elevation|0|||
163898585|NCT00943917|592001069|FG002|Stage II Continuation|A1C elevation|0|||
164298115|NCT04292535|593466152|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
164298116|NCT04292535|593466139|FG000|Overall Study|Report of Dizziness|0|||
164298117|NCT04292535|593466140|FG001|Overall Study|Report of Dizziness|0|||
164298118|NCT04292535|593466141|FG002|Overall Study|Report of Dizziness|0|||
164298119|NCT04292535|593466142|FG003|Overall Study|Report of Dizziness|0|||
164298120|NCT04292535|593466143|FG004|Overall Study|Report of Dizziness|0|||
164298121|NCT04292535|593466144|FG005|Overall Study|Report of Dizziness|0|||
164298122|NCT04292535|593466145|FG006|Overall Study|Report of Dizziness|0|||
164298123|NCT04292535|593466146|FG007|Overall Study|Report of Dizziness|0|||
164298124|NCT04292535|593466147|FG008|Overall Study|Report of Dizziness|0|||
164298125|NCT04292535|593466148|FG009|Overall Study|Report of Dizziness|0|||
164298126|NCT04292535|593466149|FG010|Overall Study|Report of Dizziness|0|||
164298127|NCT04292535|593466150|FG011|Overall Study|Report of Dizziness|0|||
164298128|NCT04292535|593466151|FG012|Overall Study|Report of Dizziness|0|||
164298129|NCT04292535|593466152|FG013|Overall Study|Report of Dizziness|1|||
164298130|NCT04292535|593466139|FG000|Overall Study|Equipment Failure|0|||
164298131|NCT04292535|593466140|FG001|Overall Study|Equipment Failure|0|||
163898586|NCT00943917|592001070|FG003|Stage II Continuation|A1C elevation|0|||
163898587|NCT00943917|592001071|FG004|Stage II Continuation|A1C elevation|0|||
163898588|NCT00943917|592001072|FG005|Stage II Continuation|A1C elevation|0|||
163898589|NCT00943917|592001073|FG006|Stage II Continuation|A1C elevation|0|||
163898590|NCT00943917|592001074|FG007|Stage II Continuation|A1C elevation|0|||
163898591|NCT00943917|592001075|FG008|Stage II Continuation|A1C elevation|0|||
163898592|NCT00943917|592001076|FG009|Stage II Continuation|A1C elevation|0|||
163898593|NCT00943917|592001077|FG010|Stage II Continuation|A1C elevation|0|||
163898594|NCT00943917|592001078|FG011|Stage II Continuation|A1C elevation|0|||
163898595|NCT00943917|592001079|FG012|Stage II Continuation|A1C elevation|0|||
163898596|NCT00943917|592001080|FG013|Stage II Continuation|A1C elevation|1|||
163898597|NCT00943917|592001081|FG014|Stage II Continuation|A1C elevation|0|||
163898598|NCT01171976|592001082|FG000|Overall Study|Protocol Violation|0|||
163898599|NCT01171976|592001083|FG001|Overall Study|Protocol Violation|0|||
163898600|NCT01171976|592001084|FG002|Overall Study|Protocol Violation|1|||
164089648|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
164089649|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
164298132|NCT04292535|593466141|FG002|Overall Study|Equipment Failure|0|||
163898601|NCT01171976|592001082|FG000|Overall Study|Death|2|||
163898602|NCT01171976|592001083|FG001|Overall Study|Death|4|||
163898603|NCT01171976|592001084|FG002|Overall Study|Death|1|||
163898604|NCT01171976|592001082|FG000|Overall Study|Lost to Follow-up|4|||
163898605|NCT01171976|592001083|FG001|Overall Study|Lost to Follow-up|0|||
163898606|NCT01171976|592001084|FG002|Overall Study|Lost to Follow-up|2|||
164298133|NCT04292535|593466142|FG003|Overall Study|Equipment Failure|0|||
164298134|NCT04292535|593466143|FG004|Overall Study|Equipment Failure|0|||
164298135|NCT04292535|593466144|FG005|Overall Study|Equipment Failure|0|||
164298136|NCT04292535|593466145|FG006|Overall Study|Equipment Failure|0|||
164298137|NCT04292535|593466146|FG007|Overall Study|Equipment Failure|0|||
164298138|NCT04292535|593466147|FG008|Overall Study|Equipment Failure|0|||
164298139|NCT04292535|593466148|FG009|Overall Study|Equipment Failure|0|||
164298140|NCT04292535|593466149|FG010|Overall Study|Equipment Failure|0|||
164298141|NCT04292535|593466150|FG011|Overall Study|Equipment Failure|1|||
164298142|NCT04292535|593466151|FG012|Overall Study|Equipment Failure|0|||
164298143|NCT04292535|593466152|FG013|Overall Study|Equipment Failure|0|||
164298144|NCT01420861|593466153|FG000|Overall Study|Adverse Event|2|||
164298145|NCT01420861|593466153|FG000|Overall Study|Study terminated by Sponsor|7|||
164298146|NCT01420861|593466153|FG000|Overall Study|Screen failure|7|||
164298147|NCT01420861|593466153|FG000|Overall Study|Randomized not Treated|2|||
164298148|NCT00303069|593467994|FG000|Overall Study|Lost to Follow-up|1|||
164298149|NCT00303069|593467995|FG001|Overall Study|Lost to Follow-up|0|||
164298150|NCT00303069|593467996|FG002|Overall Study|Lost to Follow-up|0|||
164298151|NCT00303069|593467997|FG003|Overall Study|Lost to Follow-up|2|||
163898607|NCT01171976|592001082|FG000|Overall Study|Withdrawal by Subject|1|||
163898608|NCT01171976|592001083|FG001|Overall Study|Withdrawal by Subject|5|||
163898609|NCT01171976|592001084|FG002|Overall Study|Withdrawal by Subject|6|||
163898610|NCT01171976|592001082|FG000|Overall Study|Abnormal test result|1|||
163898611|NCT01171976|592001083|FG001|Overall Study|Abnormal test result|0|||
163898612|NCT01171976|592001084|FG002|Overall Study|Abnormal test result|0|||
163898613|NCT01171976|592001082|FG000|Overall Study|Adverse Event|6|||
163898614|NCT01171976|592001083|FG001|Overall Study|Adverse Event|2|||
163898615|NCT01171976|592001084|FG002|Overall Study|Adverse Event|5|||
164298152|NCT00303069|593467994|FG000|Overall Study|subject moved|1|||
164298153|NCT00303069|593467995|FG001|Overall Study|subject moved|0|||
164298154|NCT00303069|593467996|FG002|Overall Study|subject moved|0|||
164298155|NCT00303069|593467997|FG003|Overall Study|subject moved|0|||
164298156|NCT00303069|593467994|FG000|Overall Study|Recruitment into Army Reserves|0|||
164298157|NCT00303069|593467995|FG001|Overall Study|Recruitment into Army Reserves|0|||
164298158|NCT00303069|593467996|FG002|Overall Study|Recruitment into Army Reserves|1|||
164298159|NCT00303069|593467997|FG003|Overall Study|Recruitment into Army Reserves|0|||
164298160|NCT00092417|593467998|FG000|Overall Study|Lost to Follow-up|2|||
164298161|NCT00092417|593467999|FG001|Overall Study|Lost to Follow-up|0|||
164298162|NCT00092417|593467998|FG000|Overall Study|Withdrawal by Subject|2|||
164298163|NCT00092417|593467999|FG001|Overall Study|Withdrawal by Subject|1|||
164298164|NCT00092417|593467998|FG000|Overall Study|Other|1|||
164298165|NCT00092417|593467999|FG001|Overall Study|Other|0|||
164298166|NCT00425269|593468000|FG000|Overall Study|Pregnancy|5|||
164298167|NCT00425269|593468001|FG001|Overall Study|Pregnancy|7|||
164298168|NCT00425269|593468000|FG000|Overall Study|Lost to Follow-up|9|||
164298169|NCT00425269|593468001|FG001|Overall Study|Lost to Follow-up|9|||
164298170|NCT00425269|593468000|FG000|Overall Study|moved or medical reason|5|||
164298171|NCT00425269|593468001|FG001|Overall Study|moved or medical reason|4|||
164298172|NCT01084655|593468004|FG000|Overall Study|Radiographic disease progression|3|||
164298173|NCT01084655|593468005|FG001|Overall Study|Radiographic disease progression|2|||
164298174|NCT01084655|593468006|FG002|Overall Study|Radiographic disease progression|8|||
164298175|NCT01084655|593468004|FG000|Overall Study|Withdrawal by Subject|1|||
164298176|NCT01084655|593468005|FG001|Overall Study|Withdrawal by Subject|0|||
164298177|NCT01084655|593468006|FG002|Overall Study|Withdrawal by Subject|4|||
164298178|NCT01084655|593468004|FG000|Overall Study|Adverse Event|2|||
164298179|NCT01084655|593468005|FG001|Overall Study|Adverse Event|1|||
164298180|NCT01084655|593468006|FG002|Overall Study|Adverse Event|2|||
164298181|NCT01084655|593468004|FG000|Overall Study|Other|0|||
164298182|NCT01084655|593468005|FG001|Overall Study|Other|3|||
164298183|NCT01084655|593468006|FG002|Overall Study|Other|2|||
164298184|NCT01084655|593468004|FG000|Overall Study|Symptomatic deterioration|0|||
164298185|NCT01084655|593468005|FG001|Overall Study|Symptomatic deterioration|0|||
164298186|NCT01084655|593468006|FG002|Overall Study|Symptomatic deterioration|2|||
164298187|NCT01084655|593468004|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
164301046|NCT02435992|593478415|FG004|Overall Study|Adverse Event|0|||
164301047|NCT02435992|593478411|FG000|Overall Study|Lack of Efficacy|4|||
164301048|NCT02435992|593478412|FG001|Overall Study|Lack of Efficacy|10|||
164301049|NCT02435992|593478413|FG002|Overall Study|Lack of Efficacy|9|||
164301050|NCT02435992|593478414|FG003|Overall Study|Lack of Efficacy|0|||
164301051|NCT02435992|593478415|FG004|Overall Study|Lack of Efficacy|0|||
164301052|NCT02435992|593478411|FG000|Overall Study|Withdrawal by Subject|10|||
164301053|NCT02435992|593478412|FG001|Overall Study|Withdrawal by Subject|8|||
164301054|NCT02435992|593478413|FG002|Overall Study|Withdrawal by Subject|20|||
164301055|NCT02435992|593478414|FG003|Overall Study|Withdrawal by Subject|0|||
164301056|NCT02435992|593478415|FG004|Overall Study|Withdrawal by Subject|0|||
164301057|NCT02435992|593478411|FG000|Overall Study|Other Reason|1|||
164301058|NCT02435992|593478412|FG001|Overall Study|Other Reason|0|||
164298188|NCT01084655|593468005|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
164298189|NCT01084655|593468006|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
164298190|NCT00335777|593468007|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
164298191|NCT00335777|593468007|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
164298192|NCT00335777|593468007|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
164298193|NCT00335777|593468007|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
164298194|NCT00335777|593468007|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
164298195|NCT00992108|593468008|FG000|Overall Study|Lost to Follow-up|0|||
164298196|NCT00992108|593468009|FG001|Overall Study|Lost to Follow-up|1|||
164298197|NCT04639245|593468010|FG000|Overall Study|Death|1|||
164298198|NCT01112917|593468013|FG000|Overall Study|Death|2|||
164298199|NCT01112917|593468014|FG001|Overall Study|Death|11|||
164298200|NCT01112917|593468013|FG000|Overall Study|Lost to Follow-up|1|||
164298201|NCT01112917|593468014|FG001|Overall Study|Lost to Follow-up|1|||
164298202|NCT01112917|593468013|FG000|Overall Study|Withdrawal by Subject|1|||
164298203|NCT01112917|593468014|FG001|Overall Study|Withdrawal by Subject|3|||
164298204|NCT01112917|593468013|FG000|Overall Study|Unable to Convert Filter|3|||
164298205|NCT01112917|593468014|FG001|Overall Study|Unable to Convert Filter|0|||
164298206|NCT05101122|593468015|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
164298207|NCT05101122|593468015|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
164298208|NCT05101122|593468015|FG000|AD313 80/5|Withdrawal by Subject|1|||
164298209|NCT05101122|593468015|FG000|AD313 80/10|Physician Decision|1|||
164298210|NCT03131219|593468016|FG000|Initial Evaluation Period|Adverse Event|2|||
164298211|NCT03131219|593468017|FG001|Initial Evaluation Period|Adverse Event|0|||
164298212|NCT03131219|593468016|FG000|Initial Evaluation Period|Protocol Violation|1|||
164298213|NCT03131219|593468017|FG001|Initial Evaluation Period|Protocol Violation|0|||
164298214|NCT03131219|593468016|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
164298215|NCT03131219|593468017|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
164298216|NCT03131219|593468016|FG000|Initial Evaluation Period|Physician Decision|1|||
164298217|NCT03131219|593468017|FG001|Initial Evaluation Period|Physician Decision|0|||
164298218|NCT03131219|593468016|FG000|Extension Period|Physician Decision|1|||
164298219|NCT03131219|593468017|FG001|Extension Period|Physician Decision|0|||
164298220|NCT00616759|593468019|FG000|Overall Study|Physician Decision|2|||
164298221|NCT00616759|593468020|FG001|Overall Study|Physician Decision|0|||
164298222|NCT00616759|593468019|FG000|Overall Study|Withdrawal by Subject|1|||
164298223|NCT00616759|593468020|FG001|Overall Study|Withdrawal by Subject|2|||
164298224|NCT02399163|593468023|FG000|Overall Study|Adverse Event|2|||
164298225|NCT02399163|593468023|FG000|Overall Study|Protocol Deviation|2|||
164298226|NCT02399163|593468023|FG000|Overall Study|Withdrawal by Participant|5|||
164298227|NCT02177123|593468028|FG000|Overall Study|Lost to Follow-up|6|||
164298228|NCT02177123|593468028|FG000|Overall Study|Withdrawal by Subject|4|||
164298229|NCT02177123|593468028|FG000|Overall Study|Adverse Event|4|||
164298230|NCT02177123|593468028|FG000|Overall Study|Physician Decision|3|||
164298231|NCT02177123|593468028|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
164298232|NCT02177123|593468028|FG000|Overall Study|Excluded for medical reasons|2|||
164298233|NCT02177123|593468028|FG000|Overall Study|Death|1|||
164298234|NCT02177123|593468028|FG000|Overall Study|Other|1|||
164298235|NCT02177123|593468028|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
164005373|NCT01009463|592385751|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
164005374|NCT01009463|592385747|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
164298236|NCT04613362|593468029|FG000|3 Month Follow-up|Lost to Follow-up|1|||
164298237|NCT04613362|593468030|FG001|3 Month Follow-up|Lost to Follow-up|2|||
164298238|NCT04613362|593468029|FG000|6 Month Follow-up|Lost to Follow-up|0|||
164298239|NCT04613362|593468030|FG001|6 Month Follow-up|Lost to Follow-up|1|||
164298240|NCT00074711|593468031|FG000|Overall Study|Withdrawal by Subject|1|||
164298241|NCT00074711|593468032|FG001|Overall Study|Withdrawal by Subject|1|||
164298242|NCT00074711|593468031|FG000|Overall Study|Lost to Follow-up|10|||
164298243|NCT00074711|593468032|FG001|Overall Study|Lost to Follow-up|8|||
164298244|NCT00074711|593468031|FG000|Overall Study|Participant stopped study drug|4|||
164298245|NCT00074711|593468032|FG001|Overall Study|Participant stopped study drug|6|||
164298246|NCT03466658|593468033|FG000|Overall Study|Withdrawal by Subject|3|||
164298247|NCT00886379|593468034|FG000|Overall Study|Transferred Schools|0|||
164298248|NCT00886379|593468035|FG001|Overall Study|Transferred Schools|0|||
164298249|NCT00886379|593468036|FG002|Overall Study|Transferred Schools|2|||
164298250|NCT00886379|593468037|FG003|Overall Study|Transferred Schools|1|||
164298251|NCT00886379|593468038|FG004|Overall Study|Transferred Schools|1|||
164298252|NCT00886379|593468034|FG000|Overall Study|Final blood draw not obtained|3|||
164298253|NCT00886379|593468035|FG001|Overall Study|Final blood draw not obtained|3|||
164298254|NCT00886379|593468036|FG002|Overall Study|Final blood draw not obtained|4|||
164298255|NCT00886379|593468037|FG003|Overall Study|Final blood draw not obtained|2|||
164298256|NCT00886379|593468038|FG004|Overall Study|Final blood draw not obtained|2|||
164298257|NCT01435382|593468045|FG000|Overall Study|Lost to Follow-up|1|||
164298258|NCT01435382|593468046|FG001|Overall Study|Lost to Follow-up|0|||
164298259|NCT01435382|593468047|FG002|Overall Study|Lost to Follow-up|1|||
164298260|NCT01435382|593468048|FG003|Overall Study|Lost to Follow-up|0|||
164298261|NCT01435382|593468045|FG000|Overall Study|Withdrawal by Subject|0|||
164298262|NCT01435382|593468046|FG001|Overall Study|Withdrawal by Subject|2|||
164298263|NCT01435382|593468047|FG002|Overall Study|Withdrawal by Subject|0|||
164298264|NCT01435382|593468048|FG003|Overall Study|Withdrawal by Subject|1|||
164298265|NCT00910650|593468049|FG000|Overall Study|Death|2|||
164298266|NCT00260533|593468052|FG000|Overall Study|Other|3|||
164298267|NCT00260533|593468053|FG001|Overall Study|Other|3|||
164298268|NCT01761877|593468054|FG000|Overall Study|Adverse Event|7|||
164298269|NCT01761877|593468055|FG001|Overall Study|Adverse Event|0|||
164298270|NCT01761877|593468054|FG000|Overall Study|Withdrawal by Subject|6|||
164298271|NCT01761877|593468055|FG001|Overall Study|Withdrawal by Subject|4|||
164298272|NCT01761877|593468054|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
164298273|NCT01761877|593468055|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
164298274|NCT01761877|593468054|FG000|Overall Study|Death|0|||
164298275|NCT01761877|593468055|FG001|Overall Study|Death|1|||
164298276|NCT01761877|593468054|FG000|Overall Study|MRI intolerant|1|||
164298277|NCT01761877|593468055|FG001|Overall Study|MRI intolerant|6|||
164298278|NCT01310777|593468057|FG000|Overall Study|Adverse Event|23|||
164005375|NCT01009463|592385748|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164005376|NCT01009463|592385749|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164298279|NCT01310777|593468058|FG001|Overall Study|Adverse Event|1|||
164298280|NCT01310777|593468059|FG002|Overall Study|Adverse Event|15|||
164298281|NCT01310777|593468057|FG000|Overall Study|Lost to Follow-up|0|||
164298282|NCT01310777|593468058|FG001|Overall Study|Lost to Follow-up|4|||
164298283|NCT01310777|593468059|FG002|Overall Study|Lost to Follow-up|1|||
164298284|NCT01310777|593468057|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
164298285|NCT01310777|593468058|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
164298286|NCT01310777|593468059|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
164298287|NCT01310777|593468057|FG000|Overall Study|Inadequate Control of IOP|5|||
164298288|NCT01310777|593468058|FG001|Overall Study|Inadequate Control of IOP|7|||
164298289|NCT01310777|593468059|FG002|Overall Study|Inadequate Control of IOP|10|||
164298290|NCT01310777|593468057|FG000|Overall Study|Other|4|||
164298291|NCT01310777|593468058|FG001|Overall Study|Other|1|||
164298292|NCT01310777|593468059|FG002|Overall Study|Other|2|||
164298293|NCT01780506|593468060|FG000|Double-Blind Phase|Randomized but not Treated|3|||
164298294|NCT01780506|593468061|FG001|Double-Blind Phase|Randomized but not Treated|2|||
164298295|NCT01780506|593468060|FG000|Double-Blind Phase|Adverse Event|4|||
164298296|NCT01780506|593468061|FG001|Double-Blind Phase|Adverse Event|14|||
164298297|NCT01780506|593468060|FG000|Double-Blind Phase|Death|1|||
164298298|NCT01780506|593468061|FG001|Double-Blind Phase|Death|2|||
164298299|NCT01780506|593468060|FG000|Double-Blind Phase|Pregnancy|2|||
164298300|NCT01780506|593468061|FG001|Double-Blind Phase|Pregnancy|1|||
164298301|NCT01780506|593468060|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164298302|NCT01780506|593468061|FG001|Double-Blind Phase|Lack of Efficacy|1|||
164298303|NCT01780506|593468060|FG000|Double-Blind Phase|Investigator's Discretion|5|||
164298304|NCT01780506|593468061|FG001|Double-Blind Phase|Investigator's Discretion|2|||
164298305|NCT01780506|593468060|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
164298306|NCT01780506|593468061|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
164298307|NCT01780506|593468060|FG000|Double-Blind Phase|Protocol Violation|4|||
164298308|NCT01780506|593468061|FG001|Double-Blind Phase|Protocol Violation|3|||
164298309|NCT01780506|593468060|FG000|Double-Blind Phase|Withdrew Consent|23|||
164298310|NCT01780506|593468061|FG001|Double-Blind Phase|Withdrew Consent|24|||
164298311|NCT01780506|593468060|FG000|Double-Blind Phase|Lost to Follow-up|23|||
164298312|NCT01780506|593468061|FG001|Double-Blind Phase|Lost to Follow-up|26|||
164298313|NCT01780506|593468060|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
164298314|NCT01780506|593468061|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
164298315|NCT01867671|593468064|FG000|Overall Study|Adverse Event|5|||
164298316|NCT01867671|593468065|FG001|Overall Study|Adverse Event|3|||
164298317|NCT01867671|593468064|FG000|Overall Study|Anaphylaxis|0|||
164298318|NCT01867671|593468065|FG001|Overall Study|Anaphylaxis|1|||
164298319|NCT01867671|593468064|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
164298320|NCT01867671|593468065|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
164298321|NCT01867671|593468064|FG000|Overall Study|Lost to Follow-up|0|||
164298322|NCT01867671|593468065|FG001|Overall Study|Lost to Follow-up|1|||
164298323|NCT01867671|593468064|FG000|Overall Study|Non-compliance with Study Drug|1|||
164298324|NCT01867671|593468065|FG001|Overall Study|Non-compliance with Study Drug|2|||
164298325|NCT01867671|593468064|FG000|Overall Study|Withdrawal by Subject|21|||
164298326|NCT01867671|593468065|FG001|Overall Study|Withdrawal by Subject|21|||
164298327|NCT04852302|593468066|FG000|Overall Study|Withdrawal by Subject|2|||
164089650|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
164089651|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
164089652|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
164089653|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
164089654|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
164089655|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
164089656|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
164089657|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
164089658|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
164089659|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
164089660|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
164089661|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
164089662|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
164089663|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
164089664|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
164089665|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
164089666|NCT02207231|592691448|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
164089667|NCT02207231|592691449|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
164089668|NCT02207231|592691450|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
164089669|NCT02207231|592691451|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
164089670|NCT00421174|592691452|FG000|Overall Study|Withdrawal by Subject|0|||
164089671|NCT00421174|592691453|FG001|Overall Study|Withdrawal by Subject|1|||
164089672|NCT00421174|592691452|FG000|Overall Study|Ineligible due to infection|2|||
164089673|NCT00421174|592691453|FG001|Overall Study|Ineligible due to infection|0|||
164089674|NCT01290263|592691456|FG000|Overall Study|Adverse Event|0|||
164089675|NCT01290263|592691457|FG001|Overall Study|Adverse Event|0|||
164089676|NCT01290263|592691458|FG002|Overall Study|Adverse Event|0|||
164089677|NCT01290263|592691459|FG003|Overall Study|Adverse Event|1|||
164089678|NCT01290263|592691460|FG004|Overall Study|Adverse Event|1|||
164089679|NCT01290263|592691456|FG000|Overall Study|Lack of Efficacy|8|||
164089680|NCT01290263|592691457|FG001|Overall Study|Lack of Efficacy|2|||
164089681|NCT01290263|592691458|FG002|Overall Study|Lack of Efficacy|7|||
164089682|NCT01290263|592691459|FG003|Overall Study|Lack of Efficacy|24|||
164089683|NCT01290263|592691460|FG004|Overall Study|Lack of Efficacy|33|||
164089684|NCT01290263|592691456|FG000|Overall Study|Withdrawal by Subject|3|||
164089685|NCT01290263|592691457|FG001|Overall Study|Withdrawal by Subject|1|||
164089686|NCT01290263|592691458|FG002|Overall Study|Withdrawal by Subject|0|||
164089687|NCT01290263|592691459|FG003|Overall Study|Withdrawal by Subject|1|||
164089688|NCT01290263|592691460|FG004|Overall Study|Withdrawal by Subject|2|||
164089689|NCT01290263|592691456|FG000|Overall Study|Participant Non-Compliance|0|||
164298328|NCT04852302|593468066|FG000|Overall Study|Did not complete CALM therapy.|2|||
164298329|NCT05249582|593468067|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
164298330|NCT05249582|593468068|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
164298331|NCT05249582|593468067|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
164298332|NCT05249582|593468068|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
164298333|NCT05249582|593468067|FG000|Overall Study|Declined to use virtual reality headset|1|||
164298334|NCT05249582|593468068|FG001|Overall Study|Declined to use virtual reality headset|0|||
164298335|NCT01743469|593468069|FG000|Active Treatment Phase|Adverse Event|10|||
164298336|NCT01743469|593468070|FG001|Active Treatment Phase|Adverse Event|5|||
164298337|NCT01743469|593468071|FG002|Active Treatment Phase|Adverse Event|8|||
164298338|NCT01743469|593468072|FG003|Active Treatment Phase|Adverse Event|1|||
164298339|NCT01743469|593468069|FG000|Active Treatment Phase|Disease Progression|40|||
164298340|NCT01743469|593468070|FG001|Active Treatment Phase|Disease Progression|47|||
164298341|NCT01743469|593468071|FG002|Active Treatment Phase|Disease Progression|30|||
164298342|NCT01743469|593468072|FG003|Active Treatment Phase|Disease Progression|20|||
164298343|NCT01743469|593468069|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
164298344|NCT01743469|593468070|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
164298345|NCT01743469|593468071|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
164298346|NCT01743469|593468072|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
164298347|NCT01743469|593468069|FG000|Active Treatment Phase|Missing|1|||
164298348|NCT01743469|593468070|FG001|Active Treatment Phase|Missing|0|||
164298349|NCT01743469|593468071|FG002|Active Treatment Phase|Missing|0|||
164298350|NCT01743469|593468072|FG003|Active Treatment Phase|Missing|0|||
164089690|NCT01290263|592691457|FG001|Overall Study|Participant Non-Compliance|0|||
164089691|NCT01290263|592691458|FG002|Overall Study|Participant Non-Compliance|0|||
164089692|NCT01290263|592691459|FG003|Overall Study|Participant Non-Compliance|1|||
164089693|NCT01290263|592691460|FG004|Overall Study|Participant Non-Compliance|1|||
164089694|NCT02309099|592691461|FG000|Overall Study|Adverse Event|2|||
163898616|NCT00003222|592001085|FG000|Overall Study|Physician Decision|0|||
163898617|NCT00003222|592001086|FG001|Overall Study|Physician Decision|1|||
163898618|NCT01313559|592001088|FG000|Overall Study|Withdrawal by Subject|1|||
163898619|NCT01313559|592001089|FG001|Overall Study|Withdrawal by Subject|2|||
163898620|NCT01313559|592001088|FG000|Overall Study|Disease progression|1|||
163898621|NCT01313559|592001089|FG001|Overall Study|Disease progression|0|||
163898622|NCT01313559|592001088|FG000|Overall Study|Rising PSA|2|||
163898623|NCT01313559|592001089|FG001|Overall Study|Rising PSA|0|||
163898624|NCT02466971|592001090|FG000|Overall Study|eligible and never treated|14|||
163898625|NCT02466971|592001091|FG001|Overall Study|eligible and never treated|20|||
163898626|NCT02466971|592001090|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
163898627|NCT02466971|592001091|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
163898628|NCT02466971|592001090|FG000|Overall Study|ineligible and treated|1|||
163898629|NCT02466971|592001091|FG001|Overall Study|ineligible and treated|0|||
163898630|NCT02466971|592001090|FG000|Overall Study|ineligible and never treated|0|||
163898631|NCT02466971|592001091|FG001|Overall Study|ineligible and never treated|1|||
163898632|NCT05707351|592001092|FG000|Overall Study|Withdrawal by Subject|2|||
163898633|NCT05707351|592001092|FG000|Overall Study|Reason Not Specified|1|||
163898634|NCT04174560|592001096|FG000|Overall Study|Lost to Follow-up|1|||
163898635|NCT04174560|592001097|FG001|Overall Study|Lost to Follow-up|0|||
163898636|NCT04174560|592001098|FG002|Overall Study|Lost to Follow-up|0|||
163898637|NCT04174560|592001099|FG003|Overall Study|Lost to Follow-up|0|||
163898638|NCT04174560|592001096|FG000|Overall Study|Withdrawal by Subject|0|||
163898639|NCT04174560|592001097|FG001|Overall Study|Withdrawal by Subject|0|||
164347898|NCT00040664|593650961|FG002|Overall Study|Change of formulation|0|||
164347899|NCT00040664|593650962|FG003|Overall Study|Change of formulation|0|||
164347900|NCT00040664|593650959|FG000|Overall Study|Non-viability of oral suspension|1|||
164347901|NCT00040664|593650960|FG001|Overall Study|Non-viability of oral suspension|0|||
164347902|NCT00040664|593650961|FG002|Overall Study|Non-viability of oral suspension|1|||
164347903|NCT00040664|593650962|FG003|Overall Study|Non-viability of oral suspension|0|||
164347904|NCT01709162|593650963|FG000|Overall Study|Disease progression|3|||
164347905|NCT01709162|593650964|FG001|Overall Study|Disease progression|3|||
164347906|NCT01709162|593650963|FG000|Overall Study|Study drug toxicity|2|||
164347907|NCT01709162|593650964|FG001|Overall Study|Study drug toxicity|0|||
164347908|NCT01709162|593650963|FG000|Overall Study|Administrative reason by sponsor|0|||
164347909|NCT01709162|593650964|FG001|Overall Study|Administrative reason by sponsor|1|||
164347910|NCT01709162|593650963|FG000|Overall Study|Other|1|||
164347911|NCT01709162|593650964|FG001|Overall Study|Other|0|||
164347912|NCT01709162|593650963|FG000|Overall Study|Withdrawal by Subject|0|||
164347913|NCT01709162|593650964|FG001|Overall Study|Withdrawal by Subject|1|||
164347914|NCT01637272|593650976|FG000|Overall Study|Adverse Event|6|||
164347915|NCT01637272|593650976|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164347916|NCT01637272|593650976|FG000|Overall Study|Withdrawal by Subject|3|||
164347917|NCT01637272|593650976|FG000|Overall Study|Lost to Follow-up|2|||
164347918|NCT01637272|593650976|FG000|Overall Study|completed core, did not enter ext. phase|4|||
164347919|NCT01637272|593650976|FG000|Overall Study|Administrative problems|1|||
164347920|NCT01637272|593650976|FG000|Overall Study|Protocol Violation|2|||
164347921|NCT01844518|593650977|FG000|Overall Study|Adverse Event|7|||
164347922|NCT01844518|593650978|FG001|Overall Study|Adverse Event|1|||
164347923|NCT01844518|593650977|FG000|Overall Study|Lack of Efficacy|17|||
164347924|NCT01844518|593650978|FG001|Overall Study|Lack of Efficacy|5|||
164347925|NCT01844518|593650977|FG000|Overall Study|Participant's request to discontinue|4|||
164347926|NCT01844518|593650978|FG001|Overall Study|Participant's request to discontinue|1|||
164347927|NCT01844518|593650977|FG000|Overall Study|Poor/Non-compliance|1|||
164347928|NCT01844518|593650978|FG001|Overall Study|Poor/Non-compliance|0|||
164347929|NCT01844518|593650977|FG000|Overall Study|No Longer Met Study Criteria|2|||
164347930|NCT01844518|593650978|FG001|Overall Study|No Longer Met Study Criteria|0|||
164347931|NCT01844518|593650977|FG000|Overall Study|Withdrawal by Subject|9|||
164347932|NCT01844518|593650978|FG001|Overall Study|Withdrawal by Subject|0|||
164347933|NCT01844518|593650977|FG000|Overall Study|Pregnancy|1|||
164347934|NCT01844518|593650978|FG001|Overall Study|Pregnancy|0|||
164347935|NCT05399641|593650979|FG000|Overall Study|Adverse Event|0|||
164347936|NCT05399641|593650980|FG001|Overall Study|Adverse Event|1|||
164347937|NCT05399641|593650981|FG002|Overall Study|Adverse Event|1|||
164347938|NCT05399641|593650979|FG000|Overall Study|Lost to Follow-up|1|||
164347939|NCT05399641|593650980|FG001|Overall Study|Lost to Follow-up|2|||
164347940|NCT05399641|593650981|FG002|Overall Study|Lost to Follow-up|2|||
164347941|NCT05399641|593650979|FG000|Overall Study|Physician Decision|1|||
164347942|NCT05399641|593650980|FG001|Overall Study|Physician Decision|3|||
164347943|NCT05399641|593650981|FG002|Overall Study|Physician Decision|3|||
163898640|NCT04174560|592001098|FG002|Overall Study|Withdrawal by Subject|2|||
163898641|NCT04174560|592001099|FG003|Overall Study|Withdrawal by Subject|0|||
164347944|NCT05399641|593650979|FG000|Overall Study|Withdrawal by Subject|4|||
164347945|NCT05399641|593650980|FG001|Overall Study|Withdrawal by Subject|11|||
164347946|NCT05399641|593650981|FG002|Overall Study|Withdrawal by Subject|7|||
164347947|NCT05399641|593650979|FG000|Overall Study|Reason not defined|3|||
164347948|NCT05399641|593650980|FG001|Overall Study|Reason not defined|5|||
164298351|NCT01743469|593468069|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
164298352|NCT01743469|593468070|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
164298353|NCT01743469|593468071|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
164298354|NCT01743469|593468072|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
164298355|NCT01743469|593468069|FG000|Follow-up Period - Post-Treatment|Death|43|||
164298356|NCT01743469|593468070|FG001|Follow-up Period - Post-Treatment|Death|47|||
164298357|NCT01743469|593468071|FG002|Follow-up Period - Post-Treatment|Death|22|||
164298358|NCT01743469|593468072|FG003|Follow-up Period - Post-Treatment|Death|16|||
164298359|NCT01743469|593468069|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
164298360|NCT01743469|593468070|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
164298361|NCT01743469|593468071|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
164298362|NCT01743469|593468072|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
164298363|NCT00317473|593468073|FG000|Overall Study|Withdrawal by Subject|2|||
164298364|NCT00317473|593468074|FG001|Overall Study|Withdrawal by Subject|1|||
164298365|NCT00317473|593468075|FG002|Overall Study|Withdrawal by Subject|2|||
164298366|NCT00317473|593468076|FG003|Overall Study|Withdrawal by Subject|1|||
164298367|NCT00317473|593468077|FG004|Overall Study|Withdrawal by Subject|3|||
164298368|NCT00317473|593468078|FG005|Overall Study|Withdrawal by Subject|1|||
164298369|NCT00317473|593468073|FG000|Overall Study|Relocation|1|||
164298370|NCT00317473|593468074|FG001|Overall Study|Relocation|0|||
164298371|NCT00317473|593468075|FG002|Overall Study|Relocation|1|||
164298372|NCT00317473|593468076|FG003|Overall Study|Relocation|1|||
164298373|NCT00317473|593468077|FG004|Overall Study|Relocation|5|||
164298374|NCT00317473|593468078|FG005|Overall Study|Relocation|2|||
164298375|NCT00317473|593468073|FG000|Overall Study|Death|1|||
164298376|NCT00317473|593468074|FG001|Overall Study|Death|0|||
164298377|NCT00317473|593468075|FG002|Overall Study|Death|0|||
164298378|NCT00317473|593468076|FG003|Overall Study|Death|0|||
164298379|NCT00317473|593468077|FG004|Overall Study|Death|0|||
164298380|NCT00317473|593468078|FG005|Overall Study|Death|0|||
164298381|NCT00317473|593468073|FG000|Overall Study|Other|0|||
164298382|NCT00317473|593468074|FG001|Overall Study|Other|2|||
164298383|NCT00317473|593468075|FG002|Overall Study|Other|0|||
164298384|NCT00317473|593468076|FG003|Overall Study|Other|0|||
164298385|NCT00317473|593468077|FG004|Overall Study|Other|0|||
164298386|NCT00317473|593468078|FG005|Overall Study|Other|0|||
164298387|NCT02285855|593468079|FG000|Overall Study|Withdrawal by Subject|2|||
164298388|NCT02285855|593468080|FG001|Overall Study|Withdrawal by Subject|1|||
164298389|NCT03253796|593468081|FG000|Period 1: Run-In|Adverse Event|4|||
164298390|NCT03253796|593468082|FG001|Period 1: Run-In|Adverse Event|0|||
164298391|NCT03253796|593468083|FG002|Period 1: Run-In|Adverse Event|0|||
164298392|NCT03253796|593468084|FG003|Period 1: Run-In|Adverse Event|0|||
164298393|NCT03253796|593468085|FG004|Period 1: Run-In|Adverse Event|0|||
164298394|NCT03253796|593468081|FG000|Period 1: Run-In|Lack of Efficacy|1|||
164298395|NCT03253796|593468082|FG001|Period 1: Run-In|Lack of Efficacy|0|||
164298396|NCT03253796|593468083|FG002|Period 1: Run-In|Lack of Efficacy|0|||
164298397|NCT03253796|593468084|FG003|Period 1: Run-In|Lack of Efficacy|0|||
164298398|NCT03253796|593468085|FG004|Period 1: Run-In|Lack of Efficacy|0|||
164298399|NCT03253796|593468081|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
164298400|NCT03253796|593468082|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
164298401|NCT03253796|593468083|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
164298402|NCT03253796|593468084|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
164298403|NCT03253796|593468085|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
164298404|NCT03253796|593468081|FG000|Period 1: Run-In|Protocol Violation|5|||
164298405|NCT03253796|593468082|FG001|Period 1: Run-In|Protocol Violation|0|||
164298406|NCT03253796|593468083|FG002|Period 1: Run-In|Protocol Violation|0|||
164298407|NCT03253796|593468084|FG003|Period 1: Run-In|Protocol Violation|0|||
164298408|NCT03253796|593468085|FG004|Period 1: Run-In|Protocol Violation|0|||
164298409|NCT03253796|593468081|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
164298410|NCT03253796|593468082|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
164298411|NCT03253796|593468083|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
164298412|NCT03253796|593468084|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
164298413|NCT03253796|593468085|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
164298414|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298415|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298416|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
164298417|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298418|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
164298419|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298420|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298421|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
164301059|NCT02435992|593478413|FG002|Overall Study|Other Reason|0|||
164301060|NCT02435992|593478414|FG003|Overall Study|Other Reason|0|||
164301061|NCT02435992|593478415|FG004|Overall Study|Other Reason|0|||
164301062|NCT02435992|593478411|FG000|Overall Study|Physician Decision|0|||
164301063|NCT02435992|593478412|FG001|Overall Study|Physician Decision|0|||
164089695|NCT02309099|592691462|FG001|Overall Study|Adverse Event|0|||
164089696|NCT01545076|592691463|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
164089697|NCT01545076|592691464|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
164298422|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298423|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
164298424|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
164298425|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
164298426|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
164298427|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
164298428|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
164298429|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298430|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298431|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
164298432|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298433|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
164298434|NCT03253796|593468081|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
164298435|NCT03253796|593468082|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
164298436|NCT03253796|593468083|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
164298437|NCT03253796|593468084|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
164298438|NCT03253796|593468085|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
164298439|NCT03253796|593468081|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298440|NCT03253796|593468082|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298441|NCT03253796|593468083|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298442|NCT03253796|593468084|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
164298443|NCT03253796|593468085|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
164298444|NCT00528112|593468086|FG000|Treatment up to 3 Years|Adverse Event|313|||
164298445|NCT00528112|593468087|FG001|Treatment up to 3 Years|Adverse Event|278|||
164298446|NCT00528112|593468086|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
164298447|NCT00528112|593468087|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
164298448|NCT00528112|593468086|FG000|Treatment up to 3 Years|Protocol Violation|16|||
164298449|NCT00528112|593468087|FG001|Treatment up to 3 Years|Protocol Violation|16|||
164298450|NCT00528112|593468086|FG000|Treatment up to 3 Years|Death|0|||
164298451|NCT00528112|593468087|FG001|Treatment up to 3 Years|Death|1|||
164298452|NCT00528112|593468086|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
164298453|NCT00528112|593468087|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
164298454|NCT00528112|593468086|FG000|Treatment up to 3 Years|Pregnancy|9|||
164298455|NCT00528112|593468087|FG001|Treatment up to 3 Years|Pregnancy|10|||
164298456|NCT00528112|593468086|FG000|Treatment up to 3 Years|Other reasons|186|||
164298457|NCT00528112|593468087|FG001|Treatment up to 3 Years|Other reasons|186|||
164298458|NCT00528112|593468086|FG000|Extension Phase|Withdrawal by Subject|0|||
164298459|NCT00528112|593468087|FG001|Extension Phase|Withdrawal by Subject|3|||
164298460|NCT00528112|593468086|FG000|Extension Phase|Other reasons|0|||
164298461|NCT00528112|593468087|FG001|Extension Phase|Other reasons|100|||
164298462|NCT00528112|593468086|FG000|Extension Phase|Pregnancy|0|||
164298463|NCT00528112|593468087|FG001|Extension Phase|Pregnancy|3|||
164298464|NCT00528112|593468086|FG000|Extension Phase|Lost to Follow-up|0|||
164298465|NCT00528112|593468087|FG001|Extension Phase|Lost to Follow-up|12|||
164298466|NCT00528112|593468086|FG000|Extension Phase|Death|0|||
164298467|NCT00528112|593468087|FG001|Extension Phase|Death|1|||
164298468|NCT00528112|593468086|FG000|Extension Phase|Adverse Event|0|||
164298469|NCT00528112|593468087|FG001|Extension Phase|Adverse Event|36|||
164298470|NCT00528112|593468086|FG000|Extension Phase|Protocol Violation|0|||
164298471|NCT00528112|593468087|FG001|Extension Phase|Protocol Violation|2|||
164298472|NCT02718898|593468090|FG000|Blinded Treatment Period|Adverse Event|5|||
164298473|NCT02718898|593468091|FG001|Blinded Treatment Period|Adverse Event|1|||
164298474|NCT02718898|593468092|FG002|Blinded Treatment Period|Adverse Event|0|||
164298475|NCT02718898|593468093|FG003|Blinded Treatment Period|Adverse Event|0|||
164089698|NCT01545076|592691465|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
164089699|NCT01545076|592691466|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
164089700|NCT01545076|592691467|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
164089701|NCT01545076|592691463|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
164298476|NCT02718898|593468094|FG004|Blinded Treatment Period|Adverse Event|0|||
164298477|NCT02718898|593468095|FG005|Blinded Treatment Period|Adverse Event|0|||
164347949|NCT05399641|593650981|FG002|Overall Study|Reason not defined|6|||
164347950|NCT04523220|593650989|FG000|Main Treatment Period|Physician Decision|1|||
164347951|NCT04523220|593650990|FG001|Main Treatment Period|Physician Decision|1|||
164089702|NCT01545076|592691464|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
163898642|NCT03872466|592001100|FG000|Overall Study|Withdrawal by Subject|1|||
164132708|NCT01986010|592850670|FG015|Overall Study|Physician Decision|0|||
163898643|NCT03872466|592001101|FG001|Overall Study|Withdrawal by Subject|0|||
163898644|NCT03872466|592001100|FG000|Overall Study|Physician Decision|2|||
163898645|NCT03872466|592001101|FG001|Overall Study|Physician Decision|0|||
163898646|NCT01778686|592001102|FG000|Overall Study|Adverse Event|0|||
163898647|NCT01778686|592001103|FG001|Overall Study|Adverse Event|0|||
163898648|NCT01778686|592001104|FG002|Overall Study|Adverse Event|1|||
163898649|NCT04012567|592001105|FG000|Overall Study|Lost to Follow-up|0|||
163898650|NCT04012567|592001106|FG001|Overall Study|Lost to Follow-up|1|||
163898651|NCT04012567|592001105|FG000|Overall Study|Withdrawal by Subject|1|||
164005377|NCT01009463|592385750|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164005378|NCT01009463|592385751|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
164005379|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
164005380|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
164005381|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
164005382|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
164005383|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
164005384|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164005385|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
164005386|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
164005387|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
164005388|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
164005389|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
164005390|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
164005391|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
164005392|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
164298478|NCT02718898|593468096|FG006|Blinded Treatment Period|Adverse Event|0|||
164298479|NCT02718898|593468090|FG000|Blinded Treatment Period|Physician Decision|1|||
164298480|NCT02718898|593468091|FG001|Blinded Treatment Period|Physician Decision|0|||
164298481|NCT02718898|593468092|FG002|Blinded Treatment Period|Physician Decision|0|||
163898652|NCT04012567|592001106|FG001|Overall Study|Withdrawal by Subject|0|||
164005393|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
164005394|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
164005395|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
164005396|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
164005397|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
164005398|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
164132709|NCT01986010|592850671|FG016|Overall Study|Physician Decision|0|||
163898653|NCT05714059|592001111|FG000|Overall Study|Withdrawal by Subject|2|||
164089703|NCT01545076|592691465|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
164089704|NCT01545076|592691466|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
164089705|NCT01545076|592691467|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
164089706|NCT01545076|592691463|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
164089707|NCT01545076|592691464|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
164089708|NCT01545076|592691465|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
164089709|NCT01545076|592691466|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
164089710|NCT01545076|592691467|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
164089711|NCT01545076|592691463|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
164089712|NCT01545076|592691464|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164089713|NCT01545076|592691465|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164089714|NCT01545076|592691466|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164089715|NCT01545076|592691467|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
164089716|NCT01545076|592691463|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
164089717|NCT01545076|592691464|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164089718|NCT01545076|592691465|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164089719|NCT01545076|592691466|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164089720|NCT01545076|592691467|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
164089721|NCT01545076|592691463|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164089722|NCT01545076|592691464|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164089723|NCT01545076|592691465|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164089724|NCT01545076|592691466|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
164089725|NCT01545076|592691467|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
164089726|NCT01545076|592691463|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
164089727|NCT01545076|592691464|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
164089728|NCT01545076|592691465|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
164089729|NCT01545076|592691466|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
164089730|NCT01545076|592691467|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
164089731|NCT01545076|592691463|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
164089732|NCT01545076|592691464|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
164089733|NCT01545076|592691465|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
164089734|NCT01545076|592691466|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
164089735|NCT01545076|592691467|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
164005399|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164005400|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
164005401|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
164005402|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
164005403|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
164005404|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164005405|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
164005406|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164005407|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
164005408|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
164005409|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164005410|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
164005411|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
164089736|NCT01545076|592691463|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
164089737|NCT01545076|592691464|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
164089738|NCT01545076|592691465|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
164005412|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
164005413|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
164005414|NCT01009463|592385747|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
164005415|NCT01009463|592385748|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
164005416|NCT01009463|592385749|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
164005417|NCT01009463|592385750|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
164005418|NCT01009463|592385751|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
164005419|NCT04430348|592385752|FG000|Overall Study|Death|3|||
164005420|NCT04430348|592385753|FG001|Overall Study|Death|2|||
164005421|NCT04430348|592385754|FG002|Overall Study|Death|2|||
164005422|NCT04430348|592385755|FG003|Overall Study|Death|2|||
164005423|NCT04430348|592385756|FG004|Overall Study|Death|2|||
164005424|NCT04430348|592385757|FG005|Overall Study|Death|3|||
164005425|NCT04430348|592385752|FG000|Overall Study|Lost to Follow-up|0|||
164005426|NCT04430348|592385753|FG001|Overall Study|Lost to Follow-up|0|||
164005427|NCT04430348|592385754|FG002|Overall Study|Lost to Follow-up|0|||
164005428|NCT04430348|592385755|FG003|Overall Study|Lost to Follow-up|1|||
164005429|NCT04430348|592385756|FG004|Overall Study|Lost to Follow-up|0|||
164005430|NCT04430348|592385757|FG005|Overall Study|Lost to Follow-up|0|||
164005431|NCT04430348|592385752|FG000|Overall Study|Adverse Event|0|||
164005432|NCT04430348|592385753|FG001|Overall Study|Adverse Event|0|||
164005433|NCT04430348|592385754|FG002|Overall Study|Adverse Event|0|||
164005434|NCT04430348|592385755|FG003|Overall Study|Adverse Event|0|||
164005435|NCT04430348|592385756|FG004|Overall Study|Adverse Event|0|||
164005436|NCT04430348|592385757|FG005|Overall Study|Adverse Event|1|||
164005437|NCT04430348|592385752|FG000|Overall Study|Withdrawal by Subject|0|||
164005438|NCT04430348|592385753|FG001|Overall Study|Withdrawal by Subject|1|||
164005439|NCT04430348|592385754|FG002|Overall Study|Withdrawal by Subject|0|||
164005440|NCT04430348|592385755|FG003|Overall Study|Withdrawal by Subject|0|||
164005441|NCT04430348|592385756|FG004|Overall Study|Withdrawal by Subject|0|||
164005442|NCT04430348|592385757|FG005|Overall Study|Withdrawal by Subject|1|||
164005443|NCT04430348|592385752|FG000|Overall Study|Study Terminated by Sponsor|0|||
164005444|NCT04430348|592385753|FG001|Overall Study|Study Terminated by Sponsor|0|||
164005445|NCT04430348|592385754|FG002|Overall Study|Study Terminated by Sponsor|2|||
164005446|NCT04430348|592385755|FG003|Overall Study|Study Terminated by Sponsor|0|||
164005447|NCT04430348|592385756|FG004|Overall Study|Study Terminated by Sponsor|1|||
164005448|NCT04430348|592385757|FG005|Overall Study|Study Terminated by Sponsor|1|||
164005449|NCT00384956|592385762|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
164005450|NCT01021007|592385764|FG000|Overall Study|Lost to Follow-up|1|||
164005451|NCT01021007|592385765|FG001|Overall Study|Lost to Follow-up|1|||
164005452|NCT01021007|592385764|FG000|Overall Study|Adverse Event|1|||
164298482|NCT02718898|593468093|FG003|Blinded Treatment Period|Physician Decision|0|||
164298483|NCT02718898|593468094|FG004|Blinded Treatment Period|Physician Decision|0|||
164298484|NCT02718898|593468095|FG005|Blinded Treatment Period|Physician Decision|0|||
164298485|NCT02718898|593468096|FG006|Blinded Treatment Period|Physician Decision|0|||
164298486|NCT02718898|593468090|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
164298487|NCT02718898|593468091|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
164298488|NCT02718898|593468092|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
164298489|NCT02718898|593468093|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
164298490|NCT02718898|593468094|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
164298491|NCT02718898|593468095|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
164298492|NCT02718898|593468096|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
164298493|NCT02718898|593468090|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
164298494|NCT02718898|593468091|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
164298495|NCT02718898|593468092|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
164298496|NCT02718898|593468093|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
164298497|NCT02718898|593468094|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
164298498|NCT02718898|593468095|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
164298499|NCT02718898|593468096|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
164298500|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298501|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298502|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
164298503|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
164298504|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298505|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298506|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
164298507|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298508|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298509|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298510|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
164005453|NCT01021007|592385765|FG001|Overall Study|Adverse Event|3|||
164005454|NCT00947154|592385768|FG000|Overall Study|Lost to Follow-up|1|||
164005455|NCT03293030|592385771|FG000|Overall Study|Withdrawal by Subject|3|||
164005456|NCT04899271|592385772|FG000|Overall Study|Lost to Follow-up|1|||
164005457|NCT04899271|592385773|FG001|Overall Study|Lost to Follow-up|0|||
164005458|NCT04899271|592385772|FG000|Overall Study|Subject request/consent withdrawal|2|||
164005459|NCT04899271|592385773|FG001|Overall Study|Subject request/consent withdrawal|0|||
164005460|NCT00900796|592385774|FG000|Phase 1|Lacked sufficient information|4|||
164005461|NCT00900796|592385774|FG000|Phase 1|Missing information at Week 16|7|||
164298511|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298512|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298513|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
164298514|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298515|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298516|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
164298517|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
164298518|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298519|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298520|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298521|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298522|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298523|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
164298524|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
164298525|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298526|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298527|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
164298528|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298529|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298530|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298531|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
164298532|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298533|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298534|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
164298535|NCT02718898|593468090|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298536|NCT02718898|593468091|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298537|NCT02718898|593468092|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298538|NCT02718898|593468093|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
164298539|NCT02718898|593468094|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298540|NCT02718898|593468095|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298541|NCT02718898|593468096|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
164298542|NCT02718898|593468090|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
164298543|NCT02718898|593468091|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
164298544|NCT02718898|593468092|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
164298545|NCT02718898|593468093|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
164298546|NCT02718898|593468094|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
164298547|NCT02718898|593468095|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
164298548|NCT02718898|593468096|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
164298549|NCT02718898|593468090|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298550|NCT02718898|593468091|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298551|NCT02718898|593468092|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298552|NCT02718898|593468093|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
164298553|NCT02718898|593468094|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
164347952|NCT04523220|593650991|FG002|Main Treatment Period|Physician Decision|0|||
164347953|NCT04523220|593650989|FG000|Main Treatment Period|Other|5|||
164347954|NCT04523220|593650990|FG001|Main Treatment Period|Other|2|||
164347955|NCT04523220|593650991|FG002|Main Treatment Period|Other|4|||
164347956|NCT04523220|593650989|FG000|Main Treatment Period|Subject Decision|5|||
164347957|NCT04523220|593650990|FG001|Main Treatment Period|Subject Decision|7|||
164347958|NCT04523220|593650991|FG002|Main Treatment Period|Subject Decision|3|||
164347959|NCT04523220|593650989|FG000|Main Treatment Period|Death|5|||
164347960|NCT04523220|593650990|FG001|Main Treatment Period|Death|11|||
164347961|NCT04523220|593650991|FG002|Main Treatment Period|Death|4|||
164347962|NCT04523220|593650989|FG000|Main Treatment Period|Adverse Event|11|||
164347963|NCT04523220|593650990|FG001|Main Treatment Period|Adverse Event|9|||
164347964|NCT04523220|593650991|FG002|Main Treatment Period|Adverse Event|9|||
164347965|NCT04523220|593650989|FG000|Main Treatment Period|Withdrawal by Subject|3|||
164347966|NCT04523220|593650990|FG001|Main Treatment Period|Withdrawal by Subject|3|||
164347967|NCT04523220|593650991|FG002|Main Treatment Period|Withdrawal by Subject|4|||
164347968|NCT04523220|593650989|FG000|Main Treatment Period|Study drug never adminstered|10|||
164347969|NCT04523220|593650990|FG001|Main Treatment Period|Study drug never adminstered|3|||
164347970|NCT04523220|593650991|FG002|Main Treatment Period|Study drug never adminstered|5|||
164347971|NCT04523220|593650989|FG000|Extension Treatment Period|Physician Decision|1|||
164005462|NCT00900796|592385774|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
164005463|NCT00900796|592385774|FG000|Phase 2|Lost to Follow-up|5|||
164298554|NCT02718898|593468095|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
164298555|NCT02718898|593468096|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
164298556|NCT02718898|593468090|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298557|NCT02718898|593468091|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298558|NCT02718898|593468092|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298559|NCT02718898|593468093|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298560|NCT02718898|593468094|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
164298561|NCT02718898|593468095|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
164298562|NCT02718898|593468096|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
164298563|NCT02163538|593468097|FG000|Overall Study|Protocol Violation|1|||
164298564|NCT02163538|593468098|FG001|Overall Study|Protocol Violation|0|||
164298565|NCT02163538|593468097|FG000|Overall Study|Physician Decision|0|||
164298566|NCT02163538|593468098|FG001|Overall Study|Physician Decision|1|||
164298567|NCT01345240|593468099|FG000|Overall Study|Adverse Event|3|||
164298568|NCT01345240|593468100|FG001|Overall Study|Adverse Event|5|||
164298569|NCT01345240|593468101|FG002|Overall Study|Adverse Event|4|||
164298570|NCT01345240|593468102|FG003|Overall Study|Adverse Event|2|||
164298571|NCT01345240|593468103|FG004|Overall Study|Adverse Event|1|||
164298572|NCT01345240|593468099|FG000|Overall Study|Lost to Follow-up|8|||
164298573|NCT01345240|593468100|FG001|Overall Study|Lost to Follow-up|9|||
164298574|NCT01345240|593468101|FG002|Overall Study|Lost to Follow-up|14|||
164298575|NCT01345240|593468102|FG003|Overall Study|Lost to Follow-up|7|||
164298576|NCT01345240|593468103|FG004|Overall Study|Lost to Follow-up|9|||
164298577|NCT02158442|593468107|FG000|Overall Study|Withdrawal by Subject|1|||
164298578|NCT02158442|593468108|FG001|Overall Study|Withdrawal by Subject|0|||
164298579|NCT02158442|593468107|FG000|Overall Study|Perfusion staff not available|1|||
164298580|NCT02158442|593468108|FG001|Overall Study|Perfusion staff not available|0|||
164298581|NCT00617734|593468110|FG000|Overall Study|Withdrew Consent|2|||
164298582|NCT00617734|593468111|FG001|Overall Study|Withdrew Consent|0|||
164298583|NCT00617734|593468110|FG000|Overall Study|Adverse Event|4|||
164298584|NCT00617734|593468111|FG001|Overall Study|Adverse Event|1|||
164298585|NCT00617734|593468110|FG000|Overall Study|Protocol Violation|1|||
164298586|NCT00617734|593468111|FG001|Overall Study|Protocol Violation|0|||
164298587|NCT00617734|593468110|FG000|Overall Study|Found Ineligible After Randomization|1|||
164298588|NCT00617734|593468111|FG001|Overall Study|Found Ineligible After Randomization|4|||
164298589|NCT00617734|593468110|FG000|Overall Study|Lost to Follow-up|0|||
164298590|NCT00617734|593468111|FG001|Overall Study|Lost to Follow-up|1|||
164298591|NCT05135767|593468114|FG000|Baseline|Lost to Follow-up|1|||
164298592|NCT05135767|593468115|FG001|Baseline|Lost to Follow-up|1|||
164298593|NCT05135767|593468114|FG000|Baseline|Withdrawal by Subject|0|||
164298594|NCT05135767|593468115|FG001|Baseline|Withdrawal by Subject|2|||
164298595|NCT05135767|593468114|FG000|Active Study Phase|Lost to Follow-up|2|||
164298596|NCT05135767|593468115|FG001|Active Study Phase|Lost to Follow-up|0|||
164298597|NCT02694185|593468116|FG000|Overall Study|Withdrawal by Subject|45|||
164298598|NCT02694185|593468117|FG001|Overall Study|Withdrawal by Subject|0|||
164298599|NCT05082857|593468118|FG000|Overall Study|participants relocated and could not continue|2|||
164298600|NCT05082857|593468119|FG001|Overall Study|participants relocated and could not continue|1|||
164298601|NCT05082857|593468118|FG000|Overall Study|Lost to Follow-up|1|||
164298602|NCT05082857|593468119|FG001|Overall Study|Lost to Follow-up|3|||
164298603|NCT04366349|593468120|FG000|Overall Study|Withdrawal by Subject|1|||
164298604|NCT04366349|593468121|FG001|Overall Study|Withdrawal by Subject|0|||
164298605|NCT04366349|593468122|FG002|Overall Study|Withdrawal by Subject|0|||
164298606|NCT04366349|593468123|FG003|Overall Study|Withdrawal by Subject|0|||
164298607|NCT04366349|593468124|FG004|Overall Study|Withdrawal by Subject|0|||
164298608|NCT04366349|593468125|FG005|Overall Study|Withdrawal by Subject|0|||
164298609|NCT03341299|593468126|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
164298610|NCT03341299|593468127|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
164347972|NCT04523220|593650990|FG001|Extension Treatment Period|Physician Decision|0|||
164347973|NCT04523220|593650991|FG002|Extension Treatment Period|Physician Decision|3|||
164347974|NCT04523220|593650989|FG000|Extension Treatment Period|Other|2|||
164347975|NCT04523220|593650990|FG001|Extension Treatment Period|Other|6|||
164347976|NCT04523220|593650991|FG002|Extension Treatment Period|Other|6|||
164347977|NCT04523220|593650989|FG000|Extension Treatment Period|Subject Decision|5|||
164347978|NCT04523220|593650990|FG001|Extension Treatment Period|Subject Decision|2|||
164347979|NCT04523220|593650991|FG002|Extension Treatment Period|Subject Decision|4|||
164347980|NCT04523220|593650989|FG000|Extension Treatment Period|Death|6|||
164132860|NCT00502801|592850718|FG000|Treatment Period|OTHER|30|||
164298611|NCT03341299|593468128|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
164298612|NCT03341299|593468129|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
164347981|NCT04523220|593650990|FG001|Extension Treatment Period|Death|4|||
164347982|NCT04523220|593650991|FG002|Extension Treatment Period|Death|7|||
164298613|NCT04905134|593468134|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
164347983|NCT04523220|593650989|FG000|Extension Treatment Period|Adverse Event|6|||
164347984|NCT04523220|593650990|FG001|Extension Treatment Period|Adverse Event|7|||
164298614|NCT04905134|593468134|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
164347985|NCT04523220|593650991|FG002|Extension Treatment Period|Adverse Event|9|||
164347986|NCT04523220|593650989|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
164347987|NCT04523220|593650990|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
164347988|NCT04523220|593650991|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
164347989|NCT04523220|593650989|FG000|Extension Treatment Period|Study drug never administered|0|||
164347990|NCT04523220|593650990|FG001|Extension Treatment Period|Study drug never administered|1|||
164347991|NCT04523220|593650991|FG002|Extension Treatment Period|Study drug never administered|0|||
164347992|NCT00256750|593650993|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
164347993|NCT00256750|593650994|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
164347994|NCT00256750|593650995|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
164347995|NCT00256750|593650993|FG000|Transplanted Pre-Treatment|Other|2|||
164347996|NCT00256750|593650994|FG001|Transplanted Pre-Treatment|Other|0|||
164347997|NCT00256750|593650995|FG002|Transplanted Pre-Treatment|Other|0|||
164347998|NCT00256750|593650993|FG000|Transplanted Pre-Treatment|Death|1|||
164347999|NCT00256750|593650994|FG001|Transplanted Pre-Treatment|Death|0|||
164348000|NCT00256750|593650995|FG002|Transplanted Pre-Treatment|Death|0|||
164348001|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
164348002|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
164348003|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
164348004|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Death|3|||
164348005|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Death|2|||
164348006|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Death|4|||
164348007|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
164348008|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
164348009|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
164348010|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
164348011|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
164348012|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
164348013|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Other|5|||
164348014|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Other|4|||
164348015|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Other|2|||
164348016|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
164348017|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
164348018|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
164348019|NCT00256750|593650993|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
164348020|NCT00256750|593650994|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
164348021|NCT00256750|593650995|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
164348022|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
164348023|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
164348024|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
164348025|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
164348026|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
164348027|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
164348028|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Death|3|||
164348029|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Death|0|||
164348030|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Death|0|||
164348031|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
164348032|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
164348033|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
164348034|NCT00256750|593650993|FG000|Post-Transplant Treated (24 Months)|Other|2|||
164348035|NCT00256750|593650994|FG001|Post-Transplant Treated (24 Months)|Other|0|||
164348036|NCT00256750|593650995|FG002|Post-Transplant Treated (24 Months)|Other|1|||
164348037|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
164348038|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
164348039|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
164348040|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
164348041|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
164348042|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
164348043|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Death|0|||
164348044|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Death|2|||
164348045|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Death|1|||
164348046|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
164348047|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
164348048|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
164348049|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
164348050|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
164348051|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
164348052|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
164348053|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
164005464|NCT00881205|592385776|FG000|Overall Study|Adverse Event|8|||
164005465|NCT00881205|592385777|FG001|Overall Study|Adverse Event|3|||
164005466|NCT00881205|592385776|FG000|Overall Study|Withdrawal by Subject|1|||
164005467|NCT00881205|592385777|FG001|Overall Study|Withdrawal by Subject|2|||
164005468|NCT00881205|592385776|FG000|Overall Study|Lost to Follow-up|0|||
164005469|NCT00881205|592385777|FG001|Overall Study|Lost to Follow-up|1|||
164005470|NCT00881205|592385776|FG000|Overall Study|Administrative problems|1|||
164005471|NCT00881205|592385777|FG001|Overall Study|Administrative problems|1|||
164005472|NCT00881205|592385776|FG000|Overall Study|Condition no longer requires drug|1|||
164005473|NCT00881205|592385777|FG001|Overall Study|Condition no longer requires drug|0|||
164005474|NCT02318602|592385781|FG000|Overall Study|Adverse Event|0|||
164005475|NCT02318602|592385782|FG001|Overall Study|Adverse Event|1|||
164089739|NCT01545076|592691466|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
163898654|NCT05714059|592001112|FG001|Overall Study|Withdrawal by Subject|2|||
163898655|NCT05714059|592001111|FG000|Overall Study|Adverse Event|0|||
163898656|NCT05714059|592001112|FG001|Overall Study|Adverse Event|1|||
163898657|NCT05714059|592001111|FG000|Overall Study|Lost to Follow-up|0|||
164005476|NCT02318602|592385783|FG002|Overall Study|Adverse Event|1|||
163898658|NCT05714059|592001112|FG001|Overall Study|Lost to Follow-up|1|||
163898659|NCT05714059|592001111|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
163898660|NCT05714059|592001112|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
163898661|NCT05714059|592001111|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
163898662|NCT05714059|592001112|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
163898663|NCT04899674|592001113|FG000|Test|Adverse Event|1|||
163898664|NCT04305327|592001118|FG000|Overall Study|Study early termination|2|||
163898665|NCT04305327|592001119|FG001|Overall Study|Study early termination|5|||
163898666|NCT04305327|592001120|FG002|Overall Study|Study early termination|2|||
163898667|NCT04305327|592001121|FG003|Overall Study|Study early termination|2|||
163898668|NCT04305327|592001118|FG000|Overall Study|Withdrawal by Subject|0|||
163898669|NCT04305327|592001119|FG001|Overall Study|Withdrawal by Subject|1|||
163898670|NCT04305327|592001120|FG002|Overall Study|Withdrawal by Subject|0|||
163898671|NCT04305327|592001121|FG003|Overall Study|Withdrawal by Subject|0|||
163898672|NCT05864209|592002010|FG000|Overall Study|Lost to Follow-up|2|||
163898673|NCT05864209|592002011|FG001|Overall Study|Lost to Follow-up|3|||
163898674|NCT04530487|592002012|FG000|Overall Study|Death|1|||
163898675|NCT04977583|592002013|FG000|Overall Study|Lost to Follow-up|8|||
163898676|NCT04977583|592002014|FG001|Overall Study|Lost to Follow-up|4|||
163898677|NCT04977583|592002015|FG002|Overall Study|Lost to Follow-up|13|||
163898678|NCT04977583|592002013|FG000|Overall Study|Withdrawal by Subject|3|||
164005477|NCT02318602|592385781|FG000|Overall Study|Withdrawal by Subject|0|||
164005478|NCT02318602|592385782|FG001|Overall Study|Withdrawal by Subject|3|||
164005479|NCT02318602|592385783|FG002|Overall Study|Withdrawal by Subject|0|||
164005480|NCT02318602|592385781|FG000|Overall Study|Death|1|||
164005481|NCT02318602|592385782|FG001|Overall Study|Death|0|||
164005482|NCT02318602|592385783|FG002|Overall Study|Death|0|||
164005483|NCT02318602|592385781|FG000|Overall Study|Guardian decision to withdraw|0|||
164005484|NCT02318602|592385782|FG001|Overall Study|Guardian decision to withdraw|0|||
164005485|NCT02318602|592385783|FG002|Overall Study|Guardian decision to withdraw|1|||
164005486|NCT00693706|592385784|FG000|Overall Study|Protocol Violation|0|||
164005487|NCT00693706|592385785|FG001|Overall Study|Protocol Violation|1|||
164005488|NCT01733329|592385787|FG000|Overall Study|Protocol Violation|1|||
164005489|NCT01733329|592385788|FG001|Overall Study|Protocol Violation|1|||
164005490|NCT01733329|592385787|FG000|Overall Study|Uterine artery injury|1|||
164005491|NCT01733329|592385788|FG001|Overall Study|Uterine artery injury|0|||
164005492|NCT00730236|592385789|FG000|Overall Study|Adverse Event|4|||
164005493|NCT00730236|592385789|FG000|Overall Study|Withdrawal by Subject|1|||
164005494|NCT00730236|592385789|FG000|Overall Study|Non-compliance|1|||
164005495|NCT00498173|592385795|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
164005496|NCT00498173|592385796|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
164005497|NCT00498173|592385797|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
164005498|NCT00095303|592385800|FG000|Main Study|Lost to Follow-up|91|||
164005499|NCT00095303|592385801|FG001|Main Study|Lost to Follow-up|87|||
164005500|NCT00095303|592385800|FG000|Follow Up Study|Lost to Follow-up|59|||
164005501|NCT00095303|592385801|FG001|Follow Up Study|Lost to Follow-up|58|||
164348054|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
164348055|NCT00256750|593650993|FG000|Post-Transplant Treated (36 Months)|Other|0|||
164348056|NCT00256750|593650994|FG001|Post-Transplant Treated (36 Months)|Other|1|||
164348057|NCT00256750|593650995|FG002|Post-Transplant Treated (36 Months)|Other|1|||
164348058|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
164348059|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
164348060|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
164348061|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
164348062|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
164348063|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
163898679|NCT04977583|592002014|FG001|Overall Study|Withdrawal by Subject|2|||
163898680|NCT04977583|592002015|FG002|Overall Study|Withdrawal by Subject|1|||
163898681|NCT04974047|592002020|FG000|Overall Study|Sponsor Ended Study|20|||
164005502|NCT01634243|592385804|FG000|Overall Study|Adverse Event|5|||
164348064|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
164348065|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
164348066|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
163898682|NCT04974047|592002021|FG001|Overall Study|Sponsor Ended Study|22|||
163898683|NCT04974047|592002020|FG000|Overall Study|Death|8|||
164005503|NCT01634243|592385805|FG001|Overall Study|Adverse Event|5|||
163898684|NCT04974047|592002021|FG001|Overall Study|Death|17|||
163898685|NCT04974047|592002020|FG000|Overall Study|Lost to Follow-up|2|||
164005504|NCT01634243|592385804|FG000|Overall Study|Lack of Efficacy|1|||
163898686|NCT04974047|592002021|FG001|Overall Study|Lost to Follow-up|0|||
163898687|NCT04974047|592002020|FG000|Overall Study|Withdrawal by Subject|0|||
163898688|NCT04974047|592002021|FG001|Overall Study|Withdrawal by Subject|1|||
163898689|NCT00655499|592002022|FG000|Overall Study|not eligible|4|||
163898690|NCT00146172|592002024|FG000|Overall Study|Adverse Event|0|||
163898691|NCT00146172|592002025|FG001|Overall Study|Adverse Event|0|||
163898692|NCT00146172|592002026|FG002|Overall Study|Adverse Event|1|||
163898693|NCT00146172|592002027|FG003|Overall Study|Adverse Event|1|||
163898694|NCT00146172|592002028|FG004|Overall Study|Adverse Event|0|||
163898695|NCT00146172|592002029|FG005|Overall Study|Adverse Event|2|||
163898696|NCT00146172|592002030|FG006|Overall Study|Adverse Event|3|||
164005505|NCT01634243|592385805|FG001|Overall Study|Lack of Efficacy|0|||
164005506|NCT00258154|592385806|FG000|Overall Study|Adverse Event|1|||
164348067|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
164005507|NCT00258154|592385807|FG001|Overall Study|Adverse Event|0|||
164348068|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
164348069|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
164348070|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
164348071|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
164348072|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
164348073|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
164348074|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
164348075|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
164348076|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
164348077|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
164348078|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
164348079|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
164348080|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
164348081|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
164348082|NCT00256750|593650993|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
164348083|NCT00256750|593650994|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
164348084|NCT00256750|593650995|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
164348085|NCT04659161|593651000|FG000|Overall Study|Adverse Event|10|||
164348086|NCT04659161|593651001|FG001|Overall Study|Adverse Event|6|||
164348087|NCT04659161|593651000|FG000|Overall Study|Withdrawal by Subject|13|||
164348088|NCT04659161|593651001|FG001|Overall Study|Withdrawal by Subject|12|||
164348089|NCT04659161|593651000|FG000|Overall Study|Other|9|||
164348090|NCT04659161|593651001|FG001|Overall Study|Other|8|||
164348091|NCT01929343|593651002|FG000|Overall Study|Physician Decision|0|||
164348092|NCT01929343|593651003|FG001|Overall Study|Physician Decision|2|||
164348093|NCT01929343|593651004|FG002|Overall Study|Physician Decision|0|||
164348094|NCT01929343|593651002|FG000|Overall Study|Withdrawal by Subject|1|||
164348095|NCT01929343|593651003|FG001|Overall Study|Withdrawal by Subject|0|||
164348096|NCT01929343|593651004|FG002|Overall Study|Withdrawal by Subject|0|||
164348097|NCT02197130|593651007|FG000|Overall Study|Adverse Event|13|||
164348098|NCT02197130|593651008|FG001|Overall Study|Adverse Event|4|||
164348099|NCT02197130|593651009|FG002|Overall Study|Adverse Event|23|||
164348100|NCT02197130|593651007|FG000|Overall Study|Death|0|||
164348101|NCT02197130|593651008|FG001|Overall Study|Death|1|||
164348102|NCT02197130|593651009|FG002|Overall Study|Death|0|||
164348103|NCT02197130|593651007|FG000|Overall Study|Lost to Follow-up|2|||
164348104|NCT02197130|593651008|FG001|Overall Study|Lost to Follow-up|0|||
164348105|NCT02197130|593651009|FG002|Overall Study|Lost to Follow-up|1|||
164348106|NCT02197130|593651007|FG000|Overall Study|Does not meet entrance criteria|0|||
164348107|NCT02197130|593651008|FG001|Overall Study|Does not meet entrance criteria|0|||
164348108|NCT02197130|593651009|FG002|Overall Study|Does not meet entrance criteria|1|||
164348109|NCT02197130|593651007|FG000|Overall Study|Withdrawal by Subject|0|||
164348110|NCT02197130|593651008|FG001|Overall Study|Withdrawal by Subject|3|||
164348111|NCT02197130|593651009|FG002|Overall Study|Withdrawal by Subject|4|||
164348112|NCT02197130|593651007|FG000|Overall Study|Other|1|||
164348113|NCT02197130|593651008|FG001|Overall Study|Other|0|||
163898697|NCT00146172|592002031|FG007|Overall Study|Adverse Event|10|||
164005508|NCT00258154|592385806|FG000|Overall Study|Lost to Follow-up|0|||
164005509|NCT00258154|592385807|FG001|Overall Study|Lost to Follow-up|1|||
164348114|NCT02197130|593651009|FG002|Overall Study|Other|3|||
164348115|NCT02615145|593651010|FG000|Overall Study|Did Not Start Treatment|0|||
164005510|NCT00258154|592385806|FG000|Overall Study|Protocol Violation|2|||
164005511|NCT00258154|592385807|FG001|Overall Study|Protocol Violation|1|||
164348116|NCT02615145|593651011|FG001|Overall Study|Did Not Start Treatment|0|||
164348117|NCT02615145|593651012|FG002|Overall Study|Did Not Start Treatment|1|||
164348118|NCT02615145|593651013|FG003|Overall Study|Did Not Start Treatment|1|||
163898698|NCT00146172|592002024|FG000|Overall Study|Lost to Follow-up|0|||
164348119|NCT02615145|593651010|FG000|Overall Study|Failure to Return|20|||
164348120|NCT02615145|593651011|FG001|Overall Study|Failure to Return|10|||
164348121|NCT02615145|593651012|FG002|Overall Study|Failure to Return|7|||
163898699|NCT00146172|592002025|FG001|Overall Study|Lost to Follow-up|0|||
164348122|NCT02615145|593651013|FG003|Overall Study|Failure to Return|0|||
164348123|NCT02615145|593651010|FG000|Overall Study|Death|2|||
164348124|NCT02615145|593651011|FG001|Overall Study|Death|3|||
164348125|NCT02615145|593651012|FG002|Overall Study|Death|0|||
164348126|NCT02615145|593651013|FG003|Overall Study|Death|0|||
164348127|NCT02615145|593651010|FG000|Overall Study|Other, Not Specified|5|||
164348128|NCT02615145|593651011|FG001|Overall Study|Other, Not Specified|2|||
164348129|NCT02615145|593651012|FG002|Overall Study|Other, Not Specified|0|||
164348130|NCT02615145|593651013|FG003|Overall Study|Other, Not Specified|0|||
164348131|NCT00006237|593651018|FG000|Overall Study|Adverse Event|39|||
164348132|NCT00006237|593651019|FG001|Overall Study|Adverse Event|29|||
164348133|NCT00006237|593651018|FG000|Overall Study|Death|1|||
164348134|NCT00006237|593651019|FG001|Overall Study|Death|0|||
164348135|NCT00006237|593651018|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
164348136|NCT00006237|593651019|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
164348137|NCT00006237|593651018|FG000|Overall Study|Progression/relapse|54|||
164348138|NCT00006237|593651019|FG001|Overall Study|Progression/relapse|2|||
164348139|NCT00006237|593651018|FG000|Overall Study|Not eligible|9|||
164348140|NCT00006237|593651019|FG001|Overall Study|Not eligible|20|||
164348141|NCT00006237|593651018|FG000|Overall Study|Withdrawal by Subject|0|||
164348142|NCT00006237|593651019|FG001|Overall Study|Withdrawal by Subject|1|||
164348143|NCT00006237|593651018|FG000|Overall Study|Not protocol specified|14|||
164348144|NCT00006237|593651019|FG001|Overall Study|Not protocol specified|5|||
164348145|NCT03648983|593651024|FG000|Overall Study|Study was terminated due to PI departure|95|||
164348146|NCT01943292|593652552|FG000|Overall Study|Withdrawal by Subject|1|||
164348147|NCT01943292|593652553|FG001|Overall Study|Withdrawal by Subject|0|||
164348148|NCT01943292|593652554|FG002|Overall Study|Withdrawal by Subject|0|||
164348149|NCT00911820|593652555|FG000|Overall Study|RECIST progression|12|||
164348150|NCT00911820|593652556|FG001|Overall Study|RECIST progression|8|||
164348151|NCT00911820|593652555|FG000|Overall Study|Adverse Event|8|||
164348152|NCT00911820|593652556|FG001|Overall Study|Adverse Event|8|||
164348153|NCT00911820|593652555|FG000|Overall Study|Clinical Progression|7|||
164348154|NCT00911820|593652556|FG001|Overall Study|Clinical Progression|5|||
164348155|NCT00911820|593652555|FG000|Overall Study|Physician Decision|5|||
164348156|NCT00911820|593652556|FG001|Overall Study|Physician Decision|9|||
164348157|NCT00911820|593652555|FG000|Overall Study|Decline in Performance Status|4|||
164348158|NCT00911820|593652556|FG001|Overall Study|Decline in Performance Status|2|||
164348159|NCT00911820|593652555|FG000|Overall Study|Withdrawal by Subject|3|||
164348160|NCT00911820|593652556|FG001|Overall Study|Withdrawal by Subject|4|||
164348161|NCT00911820|593652555|FG000|Overall Study|Death|1|||
164348162|NCT00911820|593652556|FG001|Overall Study|Death|2|||
164348163|NCT00911820|593652555|FG000|Overall Study|Pursue surgery|1|||
164348164|NCT00911820|593652556|FG001|Overall Study|Pursue surgery|1|||
164348165|NCT00911820|593652555|FG000|Overall Study|Pursue Radiation|1|||
164348166|NCT00911820|593652556|FG001|Overall Study|Pursue Radiation|0|||
164348167|NCT00911820|593652555|FG000|Overall Study|Still on Therapy|2|||
164348168|NCT00911820|593652556|FG001|Overall Study|Still on Therapy|2|||
164348169|NCT00911820|593652555|FG000|Overall Study|Pathology Not Confirmed|1|||
164348170|NCT00911820|593652556|FG001|Overall Study|Pathology Not Confirmed|0|||
164348171|NCT00911820|593652555|FG000|Overall Study|Withdraw before Receive Treatment|0|||
164348172|NCT00911820|593652556|FG001|Overall Study|Withdraw before Receive Treatment|2|||
164348173|NCT02674529|593652559|FG000|Overall Study|Lost to Follow-up|1|||
164348174|NCT02674529|593652560|FG001|Overall Study|Lost to Follow-up|2|||
164348175|NCT02674529|593652559|FG000|Overall Study|Withdrawal by Subject|2|||
164348176|NCT02674529|593652560|FG001|Overall Study|Withdrawal by Subject|1|||
164348177|NCT02674529|593652559|FG000|Overall Study|Physician Decision|0|||
163898700|NCT00146172|592002026|FG002|Overall Study|Lost to Follow-up|0|||
163898701|NCT00146172|592002027|FG003|Overall Study|Lost to Follow-up|0|||
163898702|NCT00146172|592002028|FG004|Overall Study|Lost to Follow-up|0|||
163898703|NCT00146172|592002029|FG005|Overall Study|Lost to Follow-up|0|||
163898704|NCT00146172|592002030|FG006|Overall Study|Lost to Follow-up|0|||
163898705|NCT00146172|592002031|FG007|Overall Study|Lost to Follow-up|1|||
163898706|NCT00146172|592002024|FG000|Overall Study|Disease Progression|2|||
164348178|NCT02674529|593652560|FG001|Overall Study|Physician Decision|1|||
164348179|NCT02674529|593652559|FG000|Overall Study|Protocol Violation|0|||
164348180|NCT02674529|593652560|FG001|Overall Study|Protocol Violation|1|||
164005512|NCT00258154|592385806|FG000|Overall Study|Withdrawal by Subject|3|||
164348181|NCT02141282|593652562|FG000|Overall Study|Adverse event, not related to progression|8|||
163898707|NCT00146172|592002025|FG001|Overall Study|Disease Progression|4|||
163898708|NCT00146172|592002026|FG002|Overall Study|Disease Progression|2|||
164348182|NCT02141282|593652563|FG001|Overall Study|Adverse event, not related to progression|1|||
164348183|NCT02141282|593652564|FG002|Overall Study|Adverse event, not related to progression|3|||
164348184|NCT02141282|593652565|FG003|Overall Study|Adverse event, not related to progression|1|||
164348185|NCT02141282|593652562|FG000|Overall Study|Adverse event, related to progression|1|||
164348186|NCT02141282|593652563|FG001|Overall Study|Adverse event, related to progression|0|||
164348187|NCT02141282|593652564|FG002|Overall Study|Adverse event, related to progression|2|||
164348188|NCT02141282|593652565|FG003|Overall Study|Adverse event, related to progression|0|||
164005513|NCT00258154|592385807|FG001|Overall Study|Withdrawal by Subject|4|||
164005514|NCT00258154|592385806|FG000|Overall Study|Patient Moved|3|||
164005515|NCT00258154|592385807|FG001|Overall Study|Patient Moved|1|||
164005516|NCT00613626|592385812|FG000|Overall Study|Ineligible|0|||
164005517|NCT00613626|592385813|FG001|Overall Study|Ineligible|1|||
164005518|NCT00613626|592385814|FG002|Overall Study|Ineligible|0|||
164005519|NCT01299025|592385815|FG000|Overall Study|Withdrawal by Subject|2|||
164005520|NCT01299025|592385816|FG001|Overall Study|Withdrawal by Subject|1|||
164005521|NCT01299025|592385815|FG000|Overall Study|Lost to Follow-up|1|||
164005522|NCT01299025|592385816|FG001|Overall Study|Lost to Follow-up|0|||
164005523|NCT05480514|592385817|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
164005524|NCT05480514|592385818|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
164005525|NCT05480514|592385817|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
164005526|NCT05480514|592385818|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
164005527|NCT05480514|592385817|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
164005528|NCT05480514|592385818|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
164005529|NCT05480514|592385817|FG000|Period 1|Covid-19 Related|1|||
164005530|NCT05480514|592385818|FG001|Period 1|Covid-19 Related|0|||
164005531|NCT05480514|592385817|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
164005532|NCT05480514|592385818|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
164005533|NCT00820040|592385819|FG000|Overall Study|Death|1|||
164005534|NCT00820040|592385819|FG000|Overall Study|Sponsor terminated study|1|||
164005535|NCT00820040|592385819|FG000|Overall Study|Screen failure|1|||
164005536|NCT00184054|592385821|FG000|Overall Study|Adverse Event|1|||
164005537|NCT00002850|592385822|FG000|Overall Study|Death|4|||
164005538|NCT00002850|592385823|FG001|Overall Study|Death|1|||
164005539|NCT00002850|592385824|FG002|Overall Study|Death|3|||
164348189|NCT02141282|593652562|FG000|Overall Study|COVID-19 infection|1|||
164348190|NCT02141282|593652563|FG001|Overall Study|COVID-19 infection|0|||
164348191|NCT02141282|593652564|FG002|Overall Study|COVID-19 infection|0|||
164348192|NCT02141282|593652565|FG003|Overall Study|COVID-19 infection|0|||
164348193|NCT02141282|593652562|FG000|Overall Study|Lost to Follow-up|0|||
164348194|NCT02141282|593652563|FG001|Overall Study|Lost to Follow-up|0|||
164348195|NCT02141282|593652564|FG002|Overall Study|Lost to Follow-up|4|||
164348196|NCT02141282|593652565|FG003|Overall Study|Lost to Follow-up|2|||
164348197|NCT02141282|593652562|FG000|Overall Study|Other, not specified|14|||
164348198|NCT02141282|593652563|FG001|Overall Study|Other, not specified|11|||
164348199|NCT02141282|593652564|FG002|Overall Study|Other, not specified|23|||
164348200|NCT02141282|593652565|FG003|Overall Study|Other, not specified|9|||
164348201|NCT02141282|593652562|FG000|Overall Study|Progressive disease, Richter's|4|||
164348202|NCT02141282|593652563|FG001|Overall Study|Progressive disease, Richter's|1|||
164348203|NCT02141282|593652564|FG002|Overall Study|Progressive disease, Richter's|1|||
164348204|NCT02141282|593652565|FG003|Overall Study|Progressive disease, Richter's|1|||
164348205|NCT02141282|593652562|FG000|Overall Study|Progressive disease per protocol|12|||
164348206|NCT02141282|593652563|FG001|Overall Study|Progressive disease per protocol|7|||
164348207|NCT02141282|593652564|FG002|Overall Study|Progressive disease per protocol|9|||
164348208|NCT02141282|593652565|FG003|Overall Study|Progressive disease per protocol|2|||
164348209|NCT02141282|593652562|FG000|Overall Study|Stem cell transplant|1|||
164348210|NCT02141282|593652563|FG001|Overall Study|Stem cell transplant|0|||
164348211|NCT02141282|593652564|FG002|Overall Study|Stem cell transplant|1|||
164348212|NCT02141282|593652565|FG003|Overall Study|Stem cell transplant|0|||
164348213|NCT02141282|593652562|FG000|Overall Study|Study terminated by Sponsor|0|||
164348214|NCT02141282|593652563|FG001|Overall Study|Study terminated by Sponsor|1|||
164348215|NCT02141282|593652564|FG002|Overall Study|Study terminated by Sponsor|0|||
164348216|NCT02141282|593652565|FG003|Overall Study|Study terminated by Sponsor|0|||
164348217|NCT02141282|593652562|FG000|Overall Study|Subject non-compliance|0|||
164348218|NCT02141282|593652563|FG001|Overall Study|Subject non-compliance|0|||
164348219|NCT02141282|593652564|FG002|Overall Study|Subject non-compliance|1|||
164348220|NCT02141282|593652565|FG003|Overall Study|Subject non-compliance|0|||
164348221|NCT02141282|593652562|FG000|Overall Study|Withdrew consent|2|||
164348222|NCT02141282|593652563|FG001|Overall Study|Withdrew consent|0|||
164005540|NCT00002850|592385822|FG000|Overall Study|Protocol Violation|1|||
164348223|NCT02141282|593652564|FG002|Overall Study|Withdrew consent|4|||
164005541|NCT00002850|592385823|FG001|Overall Study|Protocol Violation|0|||
164005542|NCT00002850|592385824|FG002|Overall Study|Protocol Violation|1|||
164005543|NCT00002850|592385822|FG000|Overall Study|Withdrawal by Subject|0|||
164005544|NCT00002850|592385823|FG001|Overall Study|Withdrawal by Subject|1|||
164005545|NCT00002850|592385824|FG002|Overall Study|Withdrawal by Subject|0|||
164348224|NCT02141282|593652565|FG003|Overall Study|Withdrew consent|0|||
164005546|NCT02006576|592385826|FG000|Overall Study|Withdrawal by Subject|4|||
164348225|NCT00963547|593652568|FG000|Overall Study|Adverse Event|0|||
164348226|NCT00963547|593652569|FG001|Overall Study|Adverse Event|1|||
164133096|NCT00616629|592852653|FG003|Overall Study|AV-block|0|||
164348227|NCT00963547|593652570|FG002|Overall Study|Adverse Event|0|||
164348228|NCT00963547|593652571|FG003|Overall Study|Adverse Event|1|||
164348229|NCT00963547|593652572|FG004|Overall Study|Adverse Event|0|||
164005547|NCT02006576|592385827|FG001|Overall Study|Withdrawal by Subject|6|||
163898709|NCT00146172|592002027|FG003|Overall Study|Disease Progression|5|||
164348230|NCT00963547|593652573|FG005|Overall Study|Adverse Event|0|||
164348231|NCT00963547|593652574|FG006|Overall Study|Adverse Event|0|||
164348232|NCT00963547|593652568|FG000|Overall Study|Physician Decision|1|||
164348233|NCT00963547|593652569|FG001|Overall Study|Physician Decision|1|||
164348234|NCT00963547|593652570|FG002|Overall Study|Physician Decision|0|||
164348235|NCT00963547|593652571|FG003|Overall Study|Physician Decision|0|||
164348236|NCT00963547|593652572|FG004|Overall Study|Physician Decision|0|||
164348237|NCT00963547|593652573|FG005|Overall Study|Physician Decision|0|||
164348238|NCT00963547|593652574|FG006|Overall Study|Physician Decision|0|||
164348239|NCT00963547|593652568|FG000|Overall Study|Progressive Disease|3|||
164348240|NCT00963547|593652569|FG001|Overall Study|Progressive Disease|8|||
164348241|NCT00963547|593652570|FG002|Overall Study|Progressive Disease|9|||
164348242|NCT00963547|593652571|FG003|Overall Study|Progressive Disease|5|||
164348243|NCT00963547|593652572|FG004|Overall Study|Progressive Disease|0|||
164348244|NCT00963547|593652573|FG005|Overall Study|Progressive Disease|0|||
164348245|NCT00963547|593652574|FG006|Overall Study|Progressive Disease|0|||
164348246|NCT00963547|593652568|FG000|Overall Study|Withdrawal by Subject|0|||
164348247|NCT00963547|593652569|FG001|Overall Study|Withdrawal by Subject|0|||
164348248|NCT00963547|593652570|FG002|Overall Study|Withdrawal by Subject|3|||
164348249|NCT00963547|593652571|FG003|Overall Study|Withdrawal by Subject|0|||
164348250|NCT00963547|593652572|FG004|Overall Study|Withdrawal by Subject|0|||
164348251|NCT00963547|593652573|FG005|Overall Study|Withdrawal by Subject|0|||
164348252|NCT00963547|593652574|FG006|Overall Study|Withdrawal by Subject|0|||
164348253|NCT00963547|593652568|FG000|Overall Study|Reason Unknown|0|||
164348254|NCT00963547|593652569|FG001|Overall Study|Reason Unknown|1|||
164348255|NCT00963547|593652570|FG002|Overall Study|Reason Unknown|0|||
164348256|NCT00963547|593652571|FG003|Overall Study|Reason Unknown|0|||
164348257|NCT00963547|593652572|FG004|Overall Study|Reason Unknown|0|||
164348258|NCT00963547|593652573|FG005|Overall Study|Reason Unknown|0|||
164348259|NCT00963547|593652574|FG006|Overall Study|Reason Unknown|0|||
164348260|NCT00331682|593652575|FG000|Overall Study|Adverse Event|1|||
164348261|NCT03761277|593652576|FG000|Enrollment to Implant|Screen Failure|17|||
164348262|NCT03761277|593652576|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
164348263|NCT03761277|593652576|FG000|Enrollment to Implant|Physician Decision|2|||
164348264|NCT03761277|593652576|FG000|Enrollment to Implant|Site Closure|3|||
164348265|NCT03761277|593652576|FG000|Enrollment to Implant|Sponsor Request|2|||
164348266|NCT03761277|593652576|FG000|Post-Implant to 6 Months|Adverse Event|2|||
164348267|NCT03761277|593652576|FG000|Post-Implant to 6 Months|Death|1|||
164348268|NCT03761277|593652576|FG000|Post-Implant to 6 Months|Site Closure|2|||
164348269|NCT03761277|593652576|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
164348270|NCT03761277|593652576|FG000|6 Months to 12 Months|Physician Decision|2|||
164348271|NCT03761277|593652576|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
164348272|NCT00187486|593652577|FG000|Overall Study|Protocol Violation|1|||
164348273|NCT00759031|593652578|FG000|First Intervention (1 Day)|Physician Decision|1|||
164348274|NCT00759031|593652579|FG001|First Intervention (1 Day)|Physician Decision|0|||
164348275|NCT00759031|593652578|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164348276|NCT00759031|593652579|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164348277|NCT00759031|593652578|FG000|First Intervention (1 Day)|Screening failure|1|||
163898710|NCT00146172|592002028|FG004|Overall Study|Disease Progression|2|||
163898711|NCT00146172|592002029|FG005|Overall Study|Disease Progression|2|||
163898712|NCT00146172|592002030|FG006|Overall Study|Disease Progression|1|||
163898713|NCT00146172|592002031|FG007|Overall Study|Disease Progression|22|||
163898714|NCT00146172|592002024|FG000|Overall Study|Death|0|||
163898715|NCT00146172|592002025|FG001|Overall Study|Death|0|||
163898716|NCT00146172|592002026|FG002|Overall Study|Death|0|||
164348278|NCT00759031|593652579|FG001|First Intervention (1 Day)|Screening failure|0|||
163898717|NCT00146172|592002027|FG003|Overall Study|Death|0|||
163898718|NCT00146172|592002028|FG004|Overall Study|Death|0|||
164348279|NCT00543140|593652580|FG000|Overall Study|Lost to Follow-up|33|||
163898719|NCT00146172|592002029|FG005|Overall Study|Death|0|||
163898720|NCT00146172|592002030|FG006|Overall Study|Death|1|||
163898721|NCT00146172|592002031|FG007|Overall Study|Death|0|||
163898722|NCT00146172|592002024|FG000|Overall Study|Physician Decision|0|||
164348280|NCT00543140|593652580|FG000|Overall Study|Withdrawal by Subject|13|||
164348281|NCT00543140|593652580|FG000|Overall Study|Protocol Violation|10|||
164005548|NCT02006576|592385828|FG002|Overall Study|Withdrawal by Subject|2|||
164005549|NCT02006576|592385826|FG000|Overall Study|Death|0|||
164005550|NCT02006576|592385827|FG001|Overall Study|Death|0|||
164298615|NCT03009058|593468135|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
164298616|NCT05556265|593468136|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298617|NCT05556265|593468137|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
164298618|NCT05556265|593468138|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298619|NCT05556265|593468139|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298620|NCT05556265|593468140|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
164298621|NCT05556265|593468136|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298622|NCT05556265|593468137|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
164298623|NCT05556265|593468138|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298624|NCT05556265|593468139|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298625|NCT05556265|593468140|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
164298626|NCT05556265|593468136|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298627|NCT05556265|593468137|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
164298628|NCT05556265|593468138|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298629|NCT05556265|593468139|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298630|NCT05556265|593468140|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
164298631|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
164298632|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
164298633|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
164298634|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
164298635|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
164298636|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
164298637|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
164298638|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
164298639|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
164298640|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
164298641|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
164298642|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
164298643|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
164298644|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
164298645|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
164298646|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
164298647|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
164298648|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
164298649|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
164298650|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
164298651|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
164298652|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
164298653|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
164298654|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
164298655|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
164298656|NCT05556265|593468136|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
164298657|NCT05556265|593468137|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
164298658|NCT05556265|593468138|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
164298659|NCT05556265|593468139|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
164298660|NCT05556265|593468140|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
164298661|NCT03137992|593468141|FG000|Washout Period 1|Adverse Event|1|||
164298662|NCT03137992|593468142|FG001|Washout Period 1|Adverse Event|1|||
164298663|NCT03137992|593468143|FG002|Washout Period 1|Adverse Event|0|||
164298664|NCT03137992|593468144|FG003|Washout Period 1|Adverse Event|0|||
164298665|NCT03137992|593468145|FG004|Washout Period 1|Adverse Event|0|||
164298666|NCT03137992|593468146|FG005|Washout Period 1|Adverse Event|1|||
164298667|NCT03137992|593468141|FG000|Washout Period 1|Withdrawal by Subject|0|||
164298668|NCT03137992|593468142|FG001|Washout Period 1|Withdrawal by Subject|1|||
164298669|NCT03137992|593468143|FG002|Washout Period 1|Withdrawal by Subject|1|||
164298670|NCT03137992|593468144|FG003|Washout Period 1|Withdrawal by Subject|0|||
164298671|NCT03137992|593468145|FG004|Washout Period 1|Withdrawal by Subject|0|||
164298672|NCT03137992|593468146|FG005|Washout Period 1|Withdrawal by Subject|0|||
164298673|NCT03137992|593468141|FG000|Washout Period 1|Principal Investigator Discretion|0|||
164298674|NCT03137992|593468142|FG001|Washout Period 1|Principal Investigator Discretion|1|||
164301064|NCT02435992|593478413|FG002|Overall Study|Physician Decision|1|||
164348282|NCT00543140|593652580|FG000|Overall Study|Insufficient weight loss|10|||
164348283|NCT00543140|593652580|FG000|Overall Study|SAE leading to explant of SAGB|3|||
164348284|NCT00543140|593652580|FG000|Overall Study|Death|1|||
164348285|NCT00543140|593652580|FG000|Overall Study|Subject moved|1|||
164348286|NCT00543140|593652580|FG000|Overall Study|Conversion to different procedure|1|||
164348287|NCT04532164|593652581|FG000|Overall Study|Adverse Event|1|||
164348288|NCT04532164|593652581|FG000|Overall Study|Protocol Violation|5|||
164348289|NCT04532164|593652581|FG000|Overall Study|Lost to Follow-up|1|||
164348290|NCT04532164|593652581|FG000|Overall Study|Found to be Ineligible|3|||
164348291|NCT04532164|593652581|FG000|Overall Study|Withdrawal by Subject|14|||
164348292|NCT02483520|593652582|FG000|Overall Study|Lost to Follow-up|3|||
164348293|NCT02483520|593652583|FG001|Overall Study|Lost to Follow-up|4|||
164348294|NCT02483520|593652582|FG000|Overall Study|Withdrawal by Subject|4|||
164348295|NCT02483520|593652583|FG001|Overall Study|Withdrawal by Subject|14|||
164348296|NCT02483520|593652582|FG000|Overall Study|Hospitalized|2|||
164348297|NCT02483520|593652583|FG001|Overall Study|Hospitalized|3|||
164348298|NCT02483520|593652582|FG000|Overall Study|Moved to LTC|2|||
164348299|NCT02483520|593652583|FG001|Overall Study|Moved to LTC|3|||
164348300|NCT01104493|593652586|FG000|Overall Study|Lost to Follow-up|0|||
164348301|NCT01104493|593652587|FG001|Overall Study|Lost to Follow-up|2|||
164348302|NCT03521934|593652598|FG000|Overall Study|Death|65|||
164348303|NCT03521934|593652599|FG001|Overall Study|Death|73|||
164348304|NCT03521934|593652598|FG000|Overall Study|Withdrawal by Subject|18|||
164348305|NCT03521934|593652599|FG001|Overall Study|Withdrawal by Subject|23|||
164348306|NCT03521934|593652598|FG000|Overall Study|Site Terminated by Sponsor|39|||
164348307|NCT03521934|593652599|FG001|Overall Study|Site Terminated by Sponsor|35|||
164348308|NCT03521934|593652598|FG000|Overall Study|Study Terminated by Sponsor|483|||
164348309|NCT03521934|593652599|FG001|Overall Study|Study Terminated by Sponsor|477|||
164348310|NCT03521934|593652598|FG000|Overall Study|Reason not Specified|3|||
164348311|NCT03521934|593652599|FG001|Overall Study|Reason not Specified|6|||
164348312|NCT00284050|593652600|FG000|Overall Study|Adverse Event|1|||
164348313|NCT00284050|593652601|FG001|Overall Study|Adverse Event|1|||
164348314|NCT00284050|593652602|FG002|Overall Study|Adverse Event|1|||
164348315|NCT00284050|593652600|FG000|Overall Study|Lack of Efficacy|0|||
164348316|NCT00284050|593652601|FG001|Overall Study|Lack of Efficacy|1|||
164348317|NCT00284050|593652602|FG002|Overall Study|Lack of Efficacy|3|||
164348318|NCT00284050|593652600|FG000|Overall Study|Protocol Violation|0|||
164348319|NCT00284050|593652601|FG001|Overall Study|Protocol Violation|1|||
164348320|NCT00284050|593652602|FG002|Overall Study|Protocol Violation|2|||
164348321|NCT00284050|593652600|FG000|Overall Study|Withdrawal by Subject|2|||
164348322|NCT00284050|593652601|FG001|Overall Study|Withdrawal by Subject|2|||
164348323|NCT00284050|593652602|FG002|Overall Study|Withdrawal by Subject|2|||
164348324|NCT00284050|593652600|FG000|Overall Study|Lost to Follow-up|1|||
164348325|NCT00284050|593652601|FG001|Overall Study|Lost to Follow-up|0|||
164348326|NCT00284050|593652602|FG002|Overall Study|Lost to Follow-up|1|||
164348327|NCT00284050|593652600|FG000|Overall Study|Death|1|||
164348328|NCT00284050|593652601|FG001|Overall Study|Death|0|||
164348329|NCT00284050|593652602|FG002|Overall Study|Death|0|||
164348330|NCT04182763|593652614|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
164005551|NCT02006576|592385828|FG002|Overall Study|Death|1|||
164005552|NCT02006576|592385826|FG000|Overall Study|Lost to Follow-up|1|||
164005553|NCT02006576|592385827|FG001|Overall Study|Lost to Follow-up|0|||
164005554|NCT02006576|592385828|FG002|Overall Study|Lost to Follow-up|1|||
164005555|NCT02006576|592385826|FG000|Overall Study|Screen Failure, too sick, other|13|||
164005556|NCT02006576|592385827|FG001|Overall Study|Screen Failure, too sick, other|1|||
164348331|NCT04182763|593652615|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
164005557|NCT02006576|592385828|FG002|Overall Study|Screen Failure, too sick, other|13|||
164005558|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
164005559|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
164348332|NCT04182763|593652616|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
164005560|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
164348333|NCT04182763|593652617|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
164348334|NCT04182763|593652618|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
164348335|NCT04182763|593652614|FG000|Double-Blind Period, initial 6 months|Death|0|||
164348336|NCT04182763|593652615|FG001|Double-Blind Period, initial 6 months|Death|1|||
164348337|NCT04182763|593652616|FG002|Double-Blind Period, initial 6 months|Death|0|||
164348338|NCT04182763|593652617|FG003|Double-Blind Period, initial 6 months|Death|0|||
164348339|NCT04182763|593652618|FG004|Double-Blind Period, initial 6 months|Death|0|||
164348340|NCT04182763|593652614|FG000|Open-Label Period, subsequent 18 months|Death|3|||
164348341|NCT04182763|593652615|FG001|Open-Label Period, subsequent 18 months|Death|2|||
164348342|NCT04182763|593652616|FG002|Open-Label Period, subsequent 18 months|Death|2|||
164348343|NCT04182763|593652617|FG003|Open-Label Period, subsequent 18 months|Death|0|||
164348344|NCT04182763|593652618|FG004|Open-Label Period, subsequent 18 months|Death|1|||
164348345|NCT04182763|593652614|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
164348346|NCT04182763|593652615|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
164348347|NCT04182763|593652616|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
164348348|NCT04182763|593652617|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
164348349|NCT04182763|593652618|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
164348350|NCT04182763|593652614|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
164348351|NCT04182763|593652615|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
164348352|NCT04182763|593652616|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
164348353|NCT04182763|593652617|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
164348354|NCT04182763|593652618|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
164348355|NCT02551731|593652620|FG000|Overall Study|Withdrawal by Subject|2|||
164348356|NCT05228132|593652637|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
164348357|NCT05228132|593652637|FG000|Overall Study|Adverse Event|3|||
164348358|NCT05228132|593652637|FG000|Overall Study|Lost to Follow-up|1|||
164348359|NCT05228132|593652637|FG000|Overall Study|Arteriovenous-fistula mature|1|||
164348360|NCT02627144|593652638|FG000|Overall Study|Serious adverse event|32|||
164348361|NCT02627144|593652638|FG000|Overall Study|Cancer progression|171|||
164348362|NCT02627144|593652638|FG000|Overall Study|Death from cancer|20|||
164348363|NCT02627144|593652638|FG000|Overall Study|Death from other cause|8|||
164348364|NCT02627144|593652638|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
164348365|NCT02627144|593652638|FG000|Overall Study|Administrative reasons|65|||
164348366|NCT02627144|593652638|FG000|Overall Study|Lost to Follow-up|8|||
164348367|NCT02627144|593652638|FG000|Overall Study|Enrolled, not treated|6|||
164348368|NCT02627144|593652638|FG000|Overall Study|Other|17|||
164348369|NCT04545385|593652643|FG000|Overall Study|Withdrawal by Subject|2|||
164348370|NCT04545385|593652644|FG001|Overall Study|Withdrawal by Subject|0|||
164348371|NCT04545385|593652643|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
164348372|NCT04545385|593652644|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
164348373|NCT04545385|593652643|FG000|Overall Study|Study termination|10|||
164348374|NCT04545385|593652644|FG001|Overall Study|Study termination|10|||
164348375|NCT04545385|593652643|FG000|Overall Study|Sponsor decision|2|||
164348376|NCT04545385|593652644|FG001|Overall Study|Sponsor decision|2|||
164348377|NCT04545385|593652643|FG000|Overall Study|Other than specified|1|||
164348378|NCT04545385|593652644|FG001|Overall Study|Other than specified|0|||
164348379|NCT01217801|593652649|FG000|Period 1|Protocol Violation|1|||
164348380|NCT01217801|593652650|FG001|Period 1|Protocol Violation|1|||
164348381|NCT01217801|593652649|FG000|Period 1|Withdrawal by Subject|0|||
164348382|NCT01217801|593652650|FG001|Period 1|Withdrawal by Subject|1|||
164348383|NCT00291577|593652652|FG000|Overall Study|Adverse Event|1|||
164348384|NCT00291577|593652652|FG000|Overall Study|Other|4|||
164348385|NCT00291577|593652652|FG000|Overall Study|Withdrawal by Subject|2|||
163898723|NCT00146172|592002025|FG001|Overall Study|Physician Decision|0|||
163898724|NCT00146172|592002026|FG002|Overall Study|Physician Decision|0|||
163898725|NCT00146172|592002027|FG003|Overall Study|Physician Decision|0|||
163898726|NCT00146172|592002028|FG004|Overall Study|Physician Decision|0|||
163898727|NCT00146172|592002029|FG005|Overall Study|Physician Decision|0|||
163898728|NCT00146172|592002030|FG006|Overall Study|Physician Decision|0|||
163898729|NCT00146172|592002031|FG007|Overall Study|Physician Decision|1|||
163898730|NCT00146172|592002024|FG000|Overall Study|Withdrawal by Subject|0|||
163898731|NCT00146172|592002025|FG001|Overall Study|Withdrawal by Subject|0|||
163898732|NCT00146172|592002026|FG002|Overall Study|Withdrawal by Subject|0|||
163898733|NCT00146172|592002027|FG003|Overall Study|Withdrawal by Subject|0|||
163898734|NCT00146172|592002028|FG004|Overall Study|Withdrawal by Subject|0|||
163898735|NCT00146172|592002029|FG005|Overall Study|Withdrawal by Subject|1|||
163898736|NCT00146172|592002030|FG006|Overall Study|Withdrawal by Subject|1|||
163898737|NCT00146172|592002031|FG007|Overall Study|Withdrawal by Subject|4|||
163898738|NCT00146172|592002024|FG000|Overall Study|Symptomatic Deterioration|1|||
163898739|NCT00146172|592002025|FG001|Overall Study|Symptomatic Deterioration|0|||
163898740|NCT00146172|592002026|FG002|Overall Study|Symptomatic Deterioration|1|||
164348386|NCT00291577|593652652|FG000|Overall Study|Lack of Efficacy|14|||
164348387|NCT04584645|593652653|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
164348388|NCT04584645|593652654|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
164348389|NCT03845985|593652661|FG000|Overall Study|Lost to Follow-up|2|||
164348390|NCT03845985|593652662|FG001|Overall Study|Lost to Follow-up|1|||
164348391|NCT03845985|593652661|FG000|Overall Study|Physician Decision|1|||
164348392|NCT03845985|593652662|FG001|Overall Study|Physician Decision|0|||
164348393|NCT03845985|593652661|FG000|Overall Study|Withdrawal by Subject|4|||
164348394|NCT03845985|593652662|FG001|Overall Study|Withdrawal by Subject|1|||
164348395|NCT02756013|593652663|FG000|Overall Study|Adverse Event|1|||
164348396|NCT02756013|593652663|FG000|Overall Study|Hypersensitivity|1|||
164348397|NCT03926169|593652664|FG000|Period A|Adverse Event|2|||
164348398|NCT03926169|593652665|FG001|Period A|Adverse Event|2|||
164348399|NCT03926169|593652666|FG002|Period A|Adverse Event|1|||
164348400|NCT03926169|593652664|FG000|Period A|Withdrawal by Subject|2|||
163898741|NCT00146172|592002027|FG003|Overall Study|Symptomatic Deterioration|0|||
164348401|NCT03926169|593652665|FG001|Period A|Withdrawal by Subject|2|||
164348402|NCT03926169|593652666|FG002|Period A|Withdrawal by Subject|2|||
164348403|NCT03926169|593652664|FG000|Period A|Lost to Follow-up|3|||
164348404|NCT03926169|593652665|FG001|Period A|Lost to Follow-up|1|||
164348405|NCT03926169|593652666|FG002|Period A|Lost to Follow-up|0|||
164348406|NCT03926169|593652664|FG000|Period A|Lack of Efficacy|0|||
164348407|NCT03926169|593652665|FG001|Period A|Lack of Efficacy|2|||
164348408|NCT03926169|593652666|FG002|Period A|Lack of Efficacy|2|||
164348409|NCT03926169|593652664|FG000|Period A|COVID-19 Infection|0|||
164348410|NCT03926169|593652665|FG001|Period A|COVID-19 Infection|1|||
164348411|NCT03926169|593652666|FG002|Period A|COVID-19 Infection|0|||
164348412|NCT03926169|593652664|FG000|Period A|COVID-19 Logistical Restrictions|0|||
164348413|NCT03926169|593652665|FG001|Period A|COVID-19 Logistical Restrictions|2|||
164348414|NCT03926169|593652666|FG002|Period A|COVID-19 Logistical Restrictions|1|||
164348415|NCT03926169|593652664|FG000|Period A|Other, Not Specified|1|||
164348416|NCT03926169|593652665|FG001|Period A|Other, Not Specified|0|||
164348417|NCT03926169|593652666|FG002|Period A|Other, Not Specified|0|||
164348418|NCT03926169|593652664|FG000|Period B|Adverse Event|3|||
164348419|NCT03926169|593652665|FG001|Period B|Adverse Event|1|||
164348420|NCT03926169|593652666|FG002|Period B|Adverse Event|1|||
164348421|NCT03926169|593652664|FG000|Period B|Withdrawal by Subject|1|||
164348422|NCT03926169|593652665|FG001|Period B|Withdrawal by Subject|3|||
164348423|NCT03926169|593652666|FG002|Period B|Withdrawal by Subject|0|||
164298675|NCT03137992|593468143|FG002|Washout Period 1|Principal Investigator Discretion|0|||
164298676|NCT03137992|593468144|FG003|Washout Period 1|Principal Investigator Discretion|0|||
164298677|NCT03137992|593468145|FG004|Washout Period 1|Principal Investigator Discretion|0|||
164298678|NCT03137992|593468146|FG005|Washout Period 1|Principal Investigator Discretion|0|||
164348424|NCT03926169|593652664|FG000|Period B|Lack of Efficacy|3|||
164348425|NCT03926169|593652665|FG001|Period B|Lack of Efficacy|1|||
164348426|NCT03926169|593652666|FG002|Period B|Lack of Efficacy|1|||
164348427|NCT03926169|593652664|FG000|Period B|Lost to Follow-up|1|||
164348428|NCT03926169|593652665|FG001|Period B|Lost to Follow-up|1|||
163898742|NCT00146172|592002028|FG004|Overall Study|Symptomatic Deterioration|1|||
164298679|NCT03137992|593468141|FG000|Washout Period 1|COPD Exacerbation|1|||
164298680|NCT03137992|593468142|FG001|Washout Period 1|COPD Exacerbation|1|||
164298681|NCT03137992|593468143|FG002|Washout Period 1|COPD Exacerbation|1|||
164298682|NCT03137992|593468144|FG003|Washout Period 1|COPD Exacerbation|0|||
164298683|NCT03137992|593468145|FG004|Washout Period 1|COPD Exacerbation|1|||
164298684|NCT03137992|593468146|FG005|Washout Period 1|COPD Exacerbation|1|||
164298685|NCT03137992|593468141|FG000|Washout Period 1|Subject Noncompliance|1|||
164298686|NCT03137992|593468142|FG001|Washout Period 1|Subject Noncompliance|0|||
164298687|NCT03137992|593468143|FG002|Washout Period 1|Subject Noncompliance|0|||
164298688|NCT03137992|593468144|FG003|Washout Period 1|Subject Noncompliance|0|||
164298689|NCT03137992|593468145|FG004|Washout Period 1|Subject Noncompliance|1|||
164298690|NCT03137992|593468146|FG005|Washout Period 1|Subject Noncompliance|0|||
164298691|NCT03137992|593468141|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
164298692|NCT03137992|593468142|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
164298693|NCT03137992|593468143|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
164298694|NCT03137992|593468144|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
164348429|NCT03926169|593652666|FG002|Period B|Lost to Follow-up|4|||
164348430|NCT03926169|593652664|FG000|Period B|Other, Not Specified|62|||
164348431|NCT03926169|593652665|FG001|Period B|Other, Not Specified|57|||
164348432|NCT03926169|593652666|FG002|Period B|Other, Not Specified|65|||
164348433|NCT03334539|593652667|FG000|Overall Study|Adverse Event|3|||
164348434|NCT03334539|593652668|FG001|Overall Study|Adverse Event|5|||
164348435|NCT03334539|593652669|FG002|Overall Study|Adverse Event|0|||
164348436|NCT03334539|593652667|FG000|Overall Study|Withdrawal by Subject|0|||
164348437|NCT03334539|593652668|FG001|Overall Study|Withdrawal by Subject|1|||
164348438|NCT03334539|593652669|FG002|Overall Study|Withdrawal by Subject|1|||
164348439|NCT03334539|593652667|FG000|Overall Study|Administrative Reasons|1|||
164348440|NCT03334539|593652668|FG001|Overall Study|Administrative Reasons|0|||
164348441|NCT03334539|593652669|FG002|Overall Study|Administrative Reasons|0|||
164348442|NCT03334539|593652667|FG000|Overall Study|Hypertension Not Controlled|0|||
164348443|NCT03334539|593652668|FG001|Overall Study|Hypertension Not Controlled|1|||
164348444|NCT03334539|593652669|FG002|Overall Study|Hypertension Not Controlled|0|||
164348445|NCT00968201|593652670|FG000|Base Study - (Period II)|Adverse Event|8|||
164348446|NCT00968201|593652671|FG001|Base Study - (Period II)|Adverse Event|0|||
164348447|NCT00968201|593652672|FG002|Base Study - (Period II)|Adverse Event|16|||
164348448|NCT00968201|593652670|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
164348449|NCT00968201|593652671|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
164348450|NCT00968201|593652672|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
164348451|NCT00968201|593652670|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
164348452|NCT00968201|593652671|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
164348453|NCT00968201|593652672|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
164348454|NCT00968201|593652670|FG000|Base Study - (Period II)|Protocol Violation|12|||
164348455|NCT00968201|593652671|FG001|Base Study - (Period II)|Protocol Violation|0|||
164348456|NCT00968201|593652672|FG002|Base Study - (Period II)|Protocol Violation|12|||
164348457|NCT00968201|593652670|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
164348458|NCT00968201|593652671|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
164348459|NCT00968201|593652672|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
164348460|NCT00968201|593652670|FG000|Base Study - (Period II)|Site Error|0|||
164348461|NCT00968201|593652671|FG001|Base Study - (Period II)|Site Error|0|||
164348462|NCT00968201|593652672|FG002|Base Study - (Period II)|Site Error|1|||
164348463|NCT00968201|593652670|FG000|Extension Study - (Period III)|Adverse Event|0|||
164348464|NCT00968201|593652671|FG001|Extension Study - (Period III)|Adverse Event|5|||
164348465|NCT00968201|593652672|FG002|Extension Study - (Period III)|Adverse Event|22|||
164348466|NCT00968201|593652670|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
164348467|NCT00968201|593652671|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
164348468|NCT00968201|593652672|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
164348469|NCT00968201|593652670|FG000|Extension Study - (Period III)|Protocol Violation|0|||
164348470|NCT00968201|593652671|FG001|Extension Study - (Period III)|Protocol Violation|17|||
164348471|NCT00968201|593652672|FG002|Extension Study - (Period III)|Protocol Violation|14|||
164348472|NCT00968201|593652670|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
164348473|NCT00968201|593652671|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
164348474|NCT00968201|593652672|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
164348475|NCT00968201|593652670|FG000|Extension Study - (Period III)|Patient Relocated|0|||
164348476|NCT00968201|593652671|FG001|Extension Study - (Period III)|Patient Relocated|1|||
164348477|NCT00968201|593652672|FG002|Extension Study - (Period III)|Patient Relocated|1|||
164348478|NCT00968201|593652670|FG000|Extension Study - (Period III)|Noncompliance|0|||
164348479|NCT00968201|593652671|FG001|Extension Study - (Period III)|Noncompliance|0|||
164348480|NCT00968201|593652672|FG002|Extension Study - (Period III)|Noncompliance|3|||
164348481|NCT00968201|593652670|FG000|Extension Study - (Period III)|Other|0|||
164348482|NCT00968201|593652671|FG001|Extension Study - (Period III)|Other|0|||
164348483|NCT00968201|593652672|FG002|Extension Study - (Period III)|Other|2|||
164348484|NCT00968201|593652670|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
164348485|NCT00968201|593652671|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
164348486|NCT00968201|593652672|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
164348487|NCT04974697|593652673|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
164348488|NCT04974697|593652673|FG000|Overall Study|Lens discomfort|1|||
164348489|NCT03706456|593652674|FG000|Overall Study|Adverse Event|1|||
164348490|NCT03706456|593652674|FG000|Overall Study|Lack of Efficacy|2|||
164348491|NCT03302234|593652676|FG000|Overall Study|Death|191|||
164348492|NCT03302234|593652677|FG001|Overall Study|Death|192|||
164348493|NCT03302234|593652676|FG000|Overall Study|Withdrawal by Subject|2|||
164348494|NCT03302234|593652677|FG001|Overall Study|Withdrawal by Subject|2|||
164348495|NCT03302234|593652676|FG000|Overall Study|Sponsor Decision|90|||
164348496|NCT03302234|593652677|FG001|Overall Study|Sponsor Decision|89|||
164348497|NCT03302234|593652676|FG000|Overall Study|Laryngeal carcinoma|0|||
164348498|NCT03302234|593652677|FG001|Overall Study|Laryngeal carcinoma|1|||
164348499|NCT03302234|593652676|FG000|Overall Study|Not Reported|1|||
164348500|NCT03302234|593652677|FG001|Overall Study|Not Reported|0|||
164348501|NCT04112784|593652678|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
164348502|NCT04112784|593652678|FG000|Overall Study|Screen Failures|4|||
164348503|NCT00221403|593652679|FG000|Overall Study|Protocol Violation|1|||
164348504|NCT00221403|593652680|FG001|Overall Study|Protocol Violation|0|||
164348505|NCT00221403|593652681|FG002|Overall Study|Protocol Violation|0|||
164348506|NCT00221403|593652679|FG000|Overall Study|Physician Decision|1|||
164348507|NCT00221403|593652680|FG001|Overall Study|Physician Decision|0|||
164348508|NCT00221403|593652681|FG002|Overall Study|Physician Decision|0|||
164348509|NCT00221403|593652679|FG000|Overall Study|Withdrawal by Subject|0|||
164348510|NCT00221403|593652680|FG001|Overall Study|Withdrawal by Subject|3|||
164348511|NCT00221403|593652681|FG002|Overall Study|Withdrawal by Subject|0|||
164348512|NCT00221403|593652679|FG000|Overall Study|Lack of Efficacy|0|||
164348513|NCT00221403|593652680|FG001|Overall Study|Lack of Efficacy|1|||
164348514|NCT00221403|593652681|FG002|Overall Study|Lack of Efficacy|0|||
164348515|NCT00221403|593652679|FG000|Overall Study|Adverse Event|0|||
164348516|NCT00221403|593652680|FG001|Overall Study|Adverse Event|1|||
164348517|NCT00221403|593652681|FG002|Overall Study|Adverse Event|0|||
164348518|NCT02439138|593652682|FG000|Overall Study|Adverse Event|1|||
164348519|NCT02439138|593652682|FG000|Overall Study|PI decision to terminate the study|2|||
164348520|NCT02216591|593652685|FG000|Overall Study|Lost to Follow-up|0|||
164348521|NCT02216591|593652686|FG001|Overall Study|Lost to Follow-up|1|||
164348522|NCT01950741|593652688|FG000|Overall Study|Lost to Follow-up|1|||
164348523|NCT01950741|593652688|FG000|Overall Study|Death|1|||
164348524|NCT01950741|593652688|FG000|Overall Study|Withdrawal by Subject|1|||
164348525|NCT00558558|593652691|FG000|Overall Study|Unable to swallow|1|||
164348526|NCT00558558|593652691|FG000|Overall Study|Withdrawal by Subject|1|||
164348527|NCT00558558|593652691|FG000|Overall Study|Lack of Efficacy|4|||
164348528|NCT02549937|593652693|FG000|Overall Study|Death|0|||
164348529|NCT02549937|593652694|FG001|Overall Study|Death|1|||
164348530|NCT02549937|593652695|FG002|Overall Study|Death|0|||
164348531|NCT02549937|593652696|FG003|Overall Study|Death|1|||
164348532|NCT02549937|593652697|FG004|Overall Study|Death|0|||
164348533|NCT02549937|593652698|FG005|Overall Study|Death|8|||
164348534|NCT02549937|593652699|FG006|Overall Study|Death|0|||
164348535|NCT02549937|593652700|FG007|Overall Study|Death|0|||
164348536|NCT02549937|593652701|FG008|Overall Study|Death|19|||
164348537|NCT02549937|593652693|FG000|Overall Study|No follow up required|3|||
164348538|NCT02549937|593652694|FG001|Overall Study|No follow up required|6|||
164348539|NCT02549937|593652695|FG002|Overall Study|No follow up required|3|||
164348540|NCT02549937|593652696|FG003|Overall Study|No follow up required|8|||
164348541|NCT02549937|593652697|FG004|Overall Study|No follow up required|12|||
164348542|NCT02549937|593652698|FG005|Overall Study|No follow up required|21|||
164348543|NCT02549937|593652699|FG006|Overall Study|No follow up required|9|||
164348544|NCT02549937|593652700|FG007|Overall Study|No follow up required|11|||
164348545|NCT02549937|593652701|FG008|Overall Study|No follow up required|0|||
164348546|NCT02549937|593652693|FG000|Overall Study|Other|0|||
164348547|NCT02549937|593652694|FG001|Overall Study|Other|0|||
164348548|NCT02549937|593652695|FG002|Overall Study|Other|0|||
164348549|NCT02549937|593652696|FG003|Overall Study|Other|0|||
164348550|NCT02549937|593652697|FG004|Overall Study|Other|1|||
164348551|NCT02549937|593652698|FG005|Overall Study|Other|0|||
164348552|NCT02549937|593652699|FG006|Overall Study|Other|3|||
164348553|NCT02549937|593652700|FG007|Overall Study|Other|2|||
164348554|NCT02549937|593652701|FG008|Overall Study|Other|3|||
164348555|NCT02549937|593652693|FG000|Overall Study|Lost to Follow-up|0|||
164348556|NCT02549937|593652694|FG001|Overall Study|Lost to Follow-up|0|||
164348557|NCT02549937|593652695|FG002|Overall Study|Lost to Follow-up|0|||
164348558|NCT02549937|593652696|FG003|Overall Study|Lost to Follow-up|0|||
164348559|NCT02549937|593652697|FG004|Overall Study|Lost to Follow-up|0|||
164348560|NCT02549937|593652698|FG005|Overall Study|Lost to Follow-up|0|||
164348561|NCT02549937|593652699|FG006|Overall Study|Lost to Follow-up|0|||
164348562|NCT02549937|593652700|FG007|Overall Study|Lost to Follow-up|0|||
164348563|NCT02549937|593652701|FG008|Overall Study|Lost to Follow-up|3|||
164348564|NCT02549937|593652693|FG000|Overall Study|Withdrawal by Subject|0|||
164348565|NCT02549937|593652694|FG001|Overall Study|Withdrawal by Subject|0|||
164348566|NCT02549937|593652695|FG002|Overall Study|Withdrawal by Subject|0|||
164348567|NCT02549937|593652696|FG003|Overall Study|Withdrawal by Subject|0|||
164348568|NCT02549937|593652697|FG004|Overall Study|Withdrawal by Subject|0|||
164348569|NCT02549937|593652698|FG005|Overall Study|Withdrawal by Subject|1|||
164348570|NCT02549937|593652699|FG006|Overall Study|Withdrawal by Subject|4|||
164133097|NCT00616629|592852654|FG004|Overall Study|AV-block|0|||
164348571|NCT02549937|593652700|FG007|Overall Study|Withdrawal by Subject|3|||
164348572|NCT02549937|593652701|FG008|Overall Study|Withdrawal by Subject|2|||
164348573|NCT02549937|593652693|FG000|Overall Study|Sponsor Decision|0|||
164348574|NCT02549937|593652694|FG001|Overall Study|Sponsor Decision|0|||
164348575|NCT02549937|593652695|FG002|Overall Study|Sponsor Decision|0|||
164348576|NCT02549937|593652696|FG003|Overall Study|Sponsor Decision|0|||
164348577|NCT02549937|593652697|FG004|Overall Study|Sponsor Decision|0|||
164348578|NCT02549937|593652698|FG005|Overall Study|Sponsor Decision|0|||
164348579|NCT02549937|593652699|FG006|Overall Study|Sponsor Decision|0|||
164348580|NCT02549937|593652700|FG007|Overall Study|Sponsor Decision|0|||
164348581|NCT02549937|593652701|FG008|Overall Study|Sponsor Decision|6|||
164348582|NCT02144012|593652704|FG000|Overall Study|Adverse Event|1|||
164348583|NCT02144012|593652705|FG001|Overall Study|Adverse Event|0|||
164348584|NCT02144012|593652704|FG000|Overall Study|Death|1|||
164298695|NCT03137992|593468145|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
164298696|NCT03137992|593468146|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
164348585|NCT02144012|593652705|FG001|Overall Study|Death|0|||
164348586|NCT02144012|593652704|FG000|Overall Study|Withdrawal by Subject|11|||
164348587|NCT02144012|593652705|FG001|Overall Study|Withdrawal by Subject|3|||
164348588|NCT02144012|593652704|FG000|Overall Study|Study Terminated by Sponsor|18|||
164348589|NCT02144012|593652705|FG001|Overall Study|Study Terminated by Sponsor|12|||
164348590|NCT02144012|593652704|FG000|Overall Study|Other|3|||
164348591|NCT02144012|593652705|FG001|Overall Study|Other|0|||
164348592|NCT00317356|593652706|FG000|Overall Study|Adverse Event|0|||
164348593|NCT00317356|593652707|FG001|Overall Study|Adverse Event|0|||
164348594|NCT00317356|593652708|FG002|Overall Study|Adverse Event|1|||
164348595|NCT00317356|593652709|FG003|Overall Study|Adverse Event|0|||
164348596|NCT00317356|593652706|FG000|Overall Study|Lack of Efficacy|1|||
164348597|NCT00317356|593652707|FG001|Overall Study|Lack of Efficacy|1|||
164348598|NCT00317356|593652708|FG002|Overall Study|Lack of Efficacy|0|||
164348599|NCT00317356|593652709|FG003|Overall Study|Lack of Efficacy|3|||
164348600|NCT00317356|593652706|FG000|Overall Study|Physician Decision|0|||
164348601|NCT00317356|593652707|FG001|Overall Study|Physician Decision|1|||
164348602|NCT00317356|593652708|FG002|Overall Study|Physician Decision|0|||
164348603|NCT00317356|593652709|FG003|Overall Study|Physician Decision|0|||
164348604|NCT04342897|593652710|FG000|Overall Study|Death|7|||
164348605|NCT04342897|593652711|FG001|Overall Study|Death|4|||
164348606|NCT04342897|593652710|FG000|Overall Study|Lost to Follow-up|6|||
164348607|NCT04342897|593652711|FG001|Overall Study|Lost to Follow-up|6|||
164348608|NCT04342897|593652710|FG000|Overall Study|Withdrawal by Subject|1|||
164348609|NCT04342897|593652711|FG001|Overall Study|Withdrawal by Subject|2|||
164348610|NCT00903695|593655266|FG000|Overall Study|medical exclusion after 1st testing|1|||
164348611|NCT00903695|593655267|FG001|Overall Study|medical exclusion after 1st testing|0|||
164348612|NCT00903695|593655266|FG000|Overall Study|lung cancer|1|||
164348613|NCT00903695|593655267|FG001|Overall Study|lung cancer|0|||
164298697|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
164298698|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
164298699|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
164298700|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
164298701|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
164298702|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
164298703|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Adverse Event|0|||
164298704|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Adverse Event|1|||
164298705|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Adverse Event|0|||
164298706|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Adverse Event|0|||
164298707|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Adverse Event|0|||
164298708|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Adverse Event|0|||
164298709|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298710|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298711|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298712|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
164298713|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298714|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
164298715|NCT03137992|593468141|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298716|NCT03137992|593468142|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
164298717|NCT03137992|593468143|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298718|NCT03137992|593468144|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298719|NCT03137992|593468145|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
164298720|NCT03137992|593468146|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
164298721|NCT03137992|593468141|FG000|Washout Period 2|COPD Exacerbation|1|||
164298722|NCT03137992|593468142|FG001|Washout Period 2|COPD Exacerbation|1|||
164298723|NCT03137992|593468143|FG002|Washout Period 2|COPD Exacerbation|0|||
164298724|NCT03137992|593468144|FG003|Washout Period 2|COPD Exacerbation|0|||
164298725|NCT03137992|593468145|FG004|Washout Period 2|COPD Exacerbation|1|||
164298726|NCT03137992|593468146|FG005|Washout Period 2|COPD Exacerbation|0|||
164298727|NCT03137992|593468141|FG000|Washout Period 2|Subject Non-compliance|0|||
164298728|NCT03137992|593468142|FG001|Washout Period 2|Subject Non-compliance|1|||
164298729|NCT03137992|593468143|FG002|Washout Period 2|Subject Non-compliance|0|||
164298730|NCT03137992|593468144|FG003|Washout Period 2|Subject Non-compliance|0|||
164298731|NCT03137992|593468145|FG004|Washout Period 2|Subject Non-compliance|0|||
164298732|NCT03137992|593468146|FG005|Washout Period 2|Subject Non-compliance|0|||
164298733|NCT03137992|593468141|FG000|Washout Period 2|Adverse Event|0|||
164298734|NCT03137992|593468142|FG001|Washout Period 2|Adverse Event|0|||
164298735|NCT03137992|593468143|FG002|Washout Period 2|Adverse Event|0|||
164298736|NCT03137992|593468144|FG003|Washout Period 2|Adverse Event|1|||
164348614|NCT01599234|593655268|FG000|Overall Study|Adverse Event|9|||
164348615|NCT01599234|593655269|FG001|Overall Study|Adverse Event|5|||
164348616|NCT01599234|593655268|FG000|Overall Study|Withdrawal by Subject|2|||
164348617|NCT01599234|593655269|FG001|Overall Study|Withdrawal by Subject|1|||
164348618|NCT01599234|593655268|FG000|Overall Study|Lost to Follow-up|1|||
164348619|NCT01599234|593655269|FG001|Overall Study|Lost to Follow-up|2|||
163898743|NCT00146172|592002029|FG005|Overall Study|Symptomatic Deterioration|2|||
163898744|NCT00146172|592002030|FG006|Overall Study|Symptomatic Deterioration|0|||
163898745|NCT00146172|592002031|FG007|Overall Study|Symptomatic Deterioration|2|||
163898746|NCT00210106|592002032|FG000|Overall Study|Death|1|||
163898747|NCT00210106|592002032|FG000|Overall Study|Protocol Violation|13|||
163898748|NCT00786864|592002033|FG000|Overall Study|Lost to Follow-up|0|||
163898749|NCT00786864|592002034|FG001|Overall Study|Lost to Follow-up|1|||
163898750|NCT00786864|592002033|FG000|Overall Study|Sustained serious back injury|1|||
163898751|NCT00786864|592002034|FG001|Overall Study|Sustained serious back injury|0|||
163898752|NCT02422615|592002035|FG000|Treatment Period|Progressive disease|314|||
163898753|NCT02422615|592002036|FG001|Treatment Period|Progressive disease|200|||
163898754|NCT02422615|592002035|FG000|Treatment Period|Adverse Event|51|||
163898755|NCT02422615|592002036|FG001|Treatment Period|Adverse Event|9|||
163898756|NCT02422615|592002035|FG000|Treatment Period|Physician Decision|32|||
163898757|NCT02422615|592002036|FG001|Treatment Period|Physician Decision|8|||
163898758|NCT02422615|592002035|FG000|Treatment Period|Subject/guardian decision|38|||
163898759|NCT02422615|592002036|FG001|Treatment Period|Subject/guardian decision|8|||
163898760|NCT02422615|592002035|FG000|Treatment Period|Death|2|||
163898761|NCT02422615|592002036|FG001|Treatment Period|Death|1|||
163898762|NCT02422615|592002035|FG000|Treatment Period|Technical problems|0|||
163898763|NCT02422615|592002036|FG001|Treatment Period|Technical problems|1|||
163898764|NCT02422615|592002035|FG000|Treatment Period|Protocol deviation|1|||
163898765|NCT02422615|592002036|FG001|Treatment Period|Protocol deviation|1|||
163898766|NCT02422615|592002035|FG000|Treatment Period|Study terminated as per protocol|46|||
163898767|NCT02422615|592002036|FG001|Treatment Period|Study terminated as per protocol|14|||
163898768|NCT02422615|592002035|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163898769|NCT02422615|592002036|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163898770|NCT02422615|592002035|FG000|Post-treatment Efficacy Follow-up|Death|2|||
163898771|NCT02422615|592002036|FG001|Post-treatment Efficacy Follow-up|Death|1|||
163898772|NCT02422615|592002035|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
163898773|NCT02422615|592002036|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163898774|NCT02422615|592002035|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
163898775|NCT02422615|592002036|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
163898776|NCT02422615|592002035|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
163898777|NCT02422615|592002036|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
163898778|NCT02422615|592002035|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
163898779|NCT02422615|592002036|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
163898780|NCT01288443|592002037|FG000|Overall Study|Adverse Event|0|||
163898781|NCT01288443|592002038|FG001|Overall Study|Adverse Event|0|||
163898782|NCT01288443|592002039|FG002|Overall Study|Adverse Event|1|||
164348620|NCT01599234|593655268|FG000|Overall Study|Lack of Efficacy|2|||
164348621|NCT01599234|593655269|FG001|Overall Study|Lack of Efficacy|4|||
164348622|NCT01599234|593655268|FG000|Overall Study|Unable to operate spray|1|||
164348623|NCT01599234|593655269|FG001|Overall Study|Unable to operate spray|0|||
164348624|NCT01599234|593655268|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
164348625|NCT01599234|593655269|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
164348626|NCT01599234|593655268|FG000|Overall Study|Death|1|||
164348627|NCT01599234|593655269|FG001|Overall Study|Death|0|||
164348628|NCT01599234|593655268|FG000|Overall Study|Patient would not stop driving|1|||
163898783|NCT01288443|592002040|FG003|Overall Study|Adverse Event|1|||
163898784|NCT01288443|592002041|FG004|Overall Study|Adverse Event|3|||
163898785|NCT01288443|592002042|FG005|Overall Study|Adverse Event|1|||
163898786|NCT01288443|592002037|FG000|Overall Study|Poor compliance to protocol|0|||
163898787|NCT01288443|592002038|FG001|Overall Study|Poor compliance to protocol|0|||
163898788|NCT01288443|592002039|FG002|Overall Study|Poor compliance to protocol|0|||
163898789|NCT01288443|592002040|FG003|Overall Study|Poor compliance to protocol|0|||
163898790|NCT01288443|592002041|FG004|Overall Study|Poor compliance to protocol|0|||
164133098|NCT01447420|592852655|FG000|Overall Study|Adverse Event|2|||
164348629|NCT01599234|593655269|FG001|Overall Study|Patient would not stop driving|0|||
164348630|NCT01599234|593655268|FG000|Overall Study|Contra-indication discovered|0|||
164348631|NCT01599234|593655269|FG001|Overall Study|Contra-indication discovered|1|||
164348632|NCT01599234|593655268|FG000|Overall Study|Pregnancy|0|||
164348633|NCT01599234|593655269|FG001|Overall Study|Pregnancy|1|||
164348634|NCT02511184|593655271|FG000|Overall Study|Death|1|||
164348635|NCT02511184|593655272|FG001|Overall Study|Death|0|||
164348636|NCT02511184|593655271|FG000|Overall Study|Lost to Follow-up|0|||
164348637|NCT02511184|593655272|FG001|Overall Study|Lost to Follow-up|1|||
164348638|NCT02511184|593655271|FG000|Overall Study|Study terminated by sponsor|1|||
164348639|NCT02511184|593655272|FG001|Overall Study|Study terminated by sponsor|5|||
164348640|NCT02511184|593655271|FG000|Overall Study|Withdrawal by Subject|0|||
164348641|NCT02511184|593655272|FG001|Overall Study|Withdrawal by Subject|1|||
164348642|NCT01513473|593655279|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
164348643|NCT01513473|593655280|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
164348644|NCT01513473|593655279|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
164348645|NCT01513473|593655280|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
164348646|NCT01513473|593655279|FG000|Main Trial (26 Weeks)|Unclassified|0|||
164348647|NCT01513473|593655280|FG001|Main Trial (26 Weeks)|Unclassified|2|||
164348648|NCT01513473|593655279|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
164348649|NCT01513473|593655280|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
164348650|NCT01513473|593655279|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
164348651|NCT01513473|593655280|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
164348652|NCT04016285|593655281|FG000|Overall Study|Did not progress to surgery|2|||
164348653|NCT04016285|593655282|FG001|Overall Study|Did not progress to surgery|5|||
164348654|NCT04016285|593655281|FG000|Overall Study|Failed to collect outcome data|5|||
164348655|NCT04016285|593655282|FG001|Overall Study|Failed to collect outcome data|3|||
164348656|NCT03462082|593655283|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348657|NCT03462082|593655284|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348658|NCT03462082|593655285|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348659|NCT03462082|593655286|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348660|NCT03462082|593655287|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348661|NCT03462082|593655288|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
164348662|NCT03462082|593655289|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
164348663|NCT03462082|593655290|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
164348664|NCT00743340|593655293|FG000|Overall Study|Study medication non-compliance|1|||
164348665|NCT00743340|593655293|FG000|Overall Study|Lost to Follow-up|1|||
164348666|NCT00743340|593655293|FG000|Overall Study|Withdrawal from the Study|5|||
164348667|NCT00743340|593655293|FG000|Overall Study|Protocol Violation|1|||
164348668|NCT00743340|593655293|FG000|Overall Study|Virologic failure|8|||
164348669|NCT00743340|593655293|FG000|Overall Study|Pregnancy|1|||
164348670|NCT00743340|593655293|FG000|Overall Study|Rolled over to other Gilead Study|23|||
164348671|NCT00743340|593655293|FG000|Overall Study|Participant Relocated|1|||
164348672|NCT00127660|593655294|FG000|Overall Study|Protocol Violation|3|||
164348673|NCT00127660|593655295|FG001|Overall Study|Protocol Violation|3|||
164348674|NCT00127660|593655296|FG002|Overall Study|Protocol Violation|5|||
164348675|NCT00127660|593655297|FG003|Overall Study|Protocol Violation|0|||
164348676|NCT01425281|593655298|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
164348677|NCT01425281|593655299|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
164348678|NCT01425281|593655298|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
164348679|NCT01425281|593655299|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
164348680|NCT01425281|593655298|FG000|At 180-day Clinical Follow-up|Death|0|||
164348681|NCT01425281|593655299|FG001|At 180-day Clinical Follow-up|Death|1|||
164348682|NCT01425281|593655298|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
164348683|NCT01425281|593655299|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
164348684|NCT01425281|593655298|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
164348685|NCT01425281|593655299|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
164348686|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
164348687|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
164348688|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Death|2|||
164348689|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Death|0|||
164348690|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
164348691|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
164348692|NCT01425281|593655298|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
164348693|NCT01425281|593655299|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
164348694|NCT01425281|593655298|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
164348695|NCT01425281|593655299|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
164089740|NCT01545076|592691467|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
164348696|NCT01425281|593655298|FG000|At 3-year Clinical Follow-up|Death|2|||
164348697|NCT01425281|593655299|FG001|At 3-year Clinical Follow-up|Death|3|||
164348698|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Death|7|||
164348699|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Death|3|||
163898791|NCT01288443|592002042|FG005|Overall Study|Poor compliance to protocol|1|||
163898792|NCT01288443|592002037|FG000|Overall Study|Participant Moved|0|||
163898793|NCT01288443|592002038|FG001|Overall Study|Participant Moved|0|||
164298737|NCT03137992|593468145|FG004|Washout Period 2|Adverse Event|1|||
164298738|NCT03137992|593468146|FG005|Washout Period 2|Adverse Event|0|||
164298739|NCT03137992|593468141|FG000|Washout Period 2|Withdrawal by Subject|1|||
164298740|NCT03137992|593468142|FG001|Washout Period 2|Withdrawal by Subject|0|||
164298741|NCT03137992|593468143|FG002|Washout Period 2|Withdrawal by Subject|0|||
164298742|NCT03137992|593468144|FG003|Washout Period 2|Withdrawal by Subject|0|||
164298743|NCT03137992|593468145|FG004|Washout Period 2|Withdrawal by Subject|1|||
164298744|NCT03137992|593468146|FG005|Washout Period 2|Withdrawal by Subject|0|||
164298745|NCT03137992|593468141|FG000|Washout Period 2|Sponsor Decision|0|||
164298746|NCT03137992|593468142|FG001|Washout Period 2|Sponsor Decision|0|||
164298747|NCT03137992|593468143|FG002|Washout Period 2|Sponsor Decision|0|||
164298748|NCT03137992|593468144|FG003|Washout Period 2|Sponsor Decision|0|||
164298749|NCT03137992|593468145|FG004|Washout Period 2|Sponsor Decision|0|||
164298750|NCT03137992|593468146|FG005|Washout Period 2|Sponsor Decision|1|||
164298751|NCT03137992|593468141|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
164298752|NCT03137992|593468142|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
164298753|NCT03137992|593468143|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
164298754|NCT03137992|593468144|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
164298755|NCT03137992|593468145|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
164298756|NCT03137992|593468146|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
164298757|NCT03137992|593468141|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
164298758|NCT03137992|593468142|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
164298759|NCT03137992|593468143|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
164298760|NCT03137992|593468144|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
164298761|NCT03137992|593468145|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
164298762|NCT03137992|593468146|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
164298763|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
164298764|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298765|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
164298766|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298767|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298768|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
164298769|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298770|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298771|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298772|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
164298773|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298774|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
164298775|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|Per study team|1|||
164298776|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|Per study team|0|||
164298777|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|Per study team|0|||
164298778|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|Per study team|0|||
164298779|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|Per study team|0|||
164298780|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|Per study team|0|||
164298781|NCT03137992|593468141|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298782|NCT03137992|593468142|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298783|NCT03137992|593468143|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298784|NCT03137992|593468144|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298785|NCT03137992|593468145|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
164298786|NCT03137992|593468146|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
164298787|NCT03221556|593468149|FG000|Allocation|post-randomization exclusion|0|||
164298788|NCT03221556|593468150|FG001|Allocation|post-randomization exclusion|1|||
164298789|NCT03221556|593468149|FG000|Follow-Up|Withdrawal by Subject|0|||
164298790|NCT03221556|593468150|FG001|Follow-Up|Withdrawal by Subject|1|||
164298791|NCT01486966|593468157|FG000|Overall Study|Adverse Event|0|||
164298792|NCT01486966|593468158|FG001|Overall Study|Adverse Event|1|||
164298793|NCT01486966|593468157|FG000|Overall Study|Withdrawal by Subject|0|||
164298794|NCT01486966|593468158|FG001|Overall Study|Withdrawal by Subject|1|||
164298795|NCT02331134|593468159|FG000|Overall Study|Withdrawal by Subject|1|||
164298796|NCT04825574|593468163|FG000|Overall Study|Commercial treatment became available|1|||
164298797|NCT04825574|593468163|FG000|Overall Study|Disease progression|1|||
164298798|NCT05967260|593468164|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
164298799|NCT05967260|593468165|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
164298800|NCT05565742|593468166|FG000|Overall Study|Withdrawal by Subject|0|||
164298801|NCT05565742|593468167|FG001|Overall Study|Withdrawal by Subject|0|||
164298802|NCT05565742|593468168|FG002|Overall Study|Withdrawal by Subject|2|||
164298803|NCT05565742|593468169|FG003|Overall Study|Withdrawal by Subject|2|||
164298804|NCT05565742|593468170|FG004|Overall Study|Withdrawal by Subject|2|||
163898794|NCT01288443|592002039|FG002|Overall Study|Participant Moved|0|||
163898795|NCT01288443|592002040|FG003|Overall Study|Participant Moved|1|||
163898796|NCT01288443|592002041|FG004|Overall Study|Participant Moved|2|||
163898797|NCT01288443|592002042|FG005|Overall Study|Participant Moved|1|||
163898798|NCT01288443|592002037|FG000|Overall Study|Consent withdrawn by Participant|0|||
163898799|NCT01288443|592002038|FG001|Overall Study|Consent withdrawn by Participant|0|||
163898800|NCT01288443|592002039|FG002|Overall Study|Consent withdrawn by Participant|0|||
163898801|NCT01288443|592002040|FG003|Overall Study|Consent withdrawn by Participant|0|||
163898802|NCT01288443|592002041|FG004|Overall Study|Consent withdrawn by Participant|0|||
163898803|NCT01288443|592002042|FG005|Overall Study|Consent withdrawn by Participant|1|||
163898804|NCT01288443|592002037|FG000|Overall Study|Lost to Follow-up|0|||
163898805|NCT01288443|592002038|FG001|Overall Study|Lost to Follow-up|1|||
163898806|NCT01288443|592002039|FG002|Overall Study|Lost to Follow-up|0|||
163898807|NCT01288443|592002040|FG003|Overall Study|Lost to Follow-up|0|||
163898808|NCT01288443|592002041|FG004|Overall Study|Lost to Follow-up|0|||
163898809|NCT01288443|592002042|FG005|Overall Study|Lost to Follow-up|0|||
163898810|NCT01288443|592002037|FG000|Overall Study|Study drug auto-injector administration|0|||
163898811|NCT01288443|592002038|FG001|Overall Study|Study drug auto-injector administration|0|||
163898812|NCT01288443|592002039|FG002|Overall Study|Study drug auto-injector administration|0|||
163898813|NCT01288443|592002040|FG003|Overall Study|Study drug auto-injector administration|0|||
163898814|NCT01288443|592002041|FG004|Overall Study|Study drug auto-injector administration|1|||
163898815|NCT01288443|592002042|FG005|Overall Study|Study drug auto-injector administration|1|||
163898816|NCT01288443|592002037|FG000|Overall Study|Other than above|0|||
163898817|NCT01288443|592002038|FG001|Overall Study|Other than above|0|||
163898818|NCT01288443|592002039|FG002|Overall Study|Other than above|0|||
163898819|NCT01288443|592002040|FG003|Overall Study|Other than above|2|||
163898820|NCT01288443|592002041|FG004|Overall Study|Other than above|1|||
163898821|NCT01288443|592002042|FG005|Overall Study|Other than above|0|||
163898822|NCT01596972|592002043|FG000|Overall Study|Physician Decision|1|||
163898823|NCT01596972|592002044|FG001|Overall Study|Physician Decision|9|||
163898824|NCT01596972|592002043|FG000|Overall Study|Lost to Follow-up|0|||
163898825|NCT01596972|592002044|FG001|Overall Study|Lost to Follow-up|4|||
163898826|NCT01596972|592002043|FG000|Overall Study|Withdrawal by Subject|0|||
163898827|NCT01596972|592002044|FG001|Overall Study|Withdrawal by Subject|1|||
163898828|NCT01639131|592002046|FG000|Overall Study|Disease Progression|6|||
163898829|NCT00945321|592002050|FG000|Period 1|Adverse Event|0|||
163898830|NCT00945321|592002051|FG001|Period 1|Adverse Event|0|||
163898831|NCT00945321|592002052|FG002|Period 1|Adverse Event|0|||
163898832|NCT00945321|592002053|FG003|Period 1|Adverse Event|0|||
163898833|NCT00945321|592002054|FG004|Period 1|Adverse Event|1|||
163898834|NCT00945321|592002055|FG005|Period 1|Adverse Event|0|||
163898835|NCT00945321|592002050|FG000|Period 4|Lost to Follow-up|0|||
163898836|NCT00945321|592002051|FG001|Period 4|Lost to Follow-up|0|||
163898837|NCT00945321|592002052|FG002|Period 4|Lost to Follow-up|0|||
163898838|NCT00945321|592002053|FG003|Period 4|Lost to Follow-up|0|||
163898839|NCT00945321|592002054|FG004|Period 4|Lost to Follow-up|0|||
163898840|NCT00945321|592002055|FG005|Period 4|Lost to Follow-up|1|||
163898841|NCT02438137|592002056|FG000|Overall Study|Lost to Follow-up|3|||
163898842|NCT02438137|592002057|FG001|Overall Study|Lost to Follow-up|2|||
163898843|NCT02438137|592002056|FG000|Overall Study|Adverse Event|1|||
163898844|NCT02438137|592002057|FG001|Overall Study|Adverse Event|0|||
163898845|NCT02438137|592002056|FG000|Overall Study|Withdrawal by Subject|4|||
163898846|NCT02438137|592002057|FG001|Overall Study|Withdrawal by Subject|3|||
163898847|NCT02438137|592002056|FG000|Overall Study|Physician Decision|0|||
163898848|NCT02438137|592002057|FG001|Overall Study|Physician Decision|1|||
163898849|NCT03248492|592002068|FG000|Overall Study|Progressive Disease|24|||
163898850|NCT03248492|592002069|FG001|Overall Study|Progressive Disease|23|||
163898851|NCT03248492|592002070|FG002|Overall Study|Progressive Disease|11|||
163898852|NCT03248492|592002071|FG003|Overall Study|Progressive Disease|66|||
163898853|NCT03248492|592002072|FG004|Overall Study|Progressive Disease|1|||
163898854|NCT03248492|592002068|FG000|Overall Study|Adverse Event|14|||
163898855|NCT03248492|592002069|FG001|Overall Study|Adverse Event|13|||
163898856|NCT03248492|592002070|FG002|Overall Study|Adverse Event|9|||
164089741|NCT00797108|592691471|FG000|Overall Study|Adverse Event|1|||
163898857|NCT03248492|592002071|FG003|Overall Study|Adverse Event|22|||
163898858|NCT03248492|592002072|FG004|Overall Study|Adverse Event|2|||
163898859|NCT03248492|592002068|FG000|Overall Study|Withdrawal by Subject|5|||
163898860|NCT03248492|592002069|FG001|Overall Study|Withdrawal by Subject|4|||
164298805|NCT05565742|593468166|FG000|Overall Study|Death|1|||
164298806|NCT05565742|593468167|FG001|Overall Study|Death|0|||
164298807|NCT05565742|593468168|FG002|Overall Study|Death|0|||
164298808|NCT05565742|593468169|FG003|Overall Study|Death|0|||
164298809|NCT05565742|593468170|FG004|Overall Study|Death|0|||
164298810|NCT05565742|593468166|FG000|Overall Study|Participant Travelled Abroad|0|||
164298811|NCT05565742|593468167|FG001|Overall Study|Participant Travelled Abroad|0|||
164298812|NCT05565742|593468168|FG002|Overall Study|Participant Travelled Abroad|0|||
164298813|NCT05565742|593468169|FG003|Overall Study|Participant Travelled Abroad|0|||
164298814|NCT05565742|593468170|FG004|Overall Study|Participant Travelled Abroad|1|||
164298815|NCT00668148|593468171|FG000|Overall Study|Adverse Event|5|||
164298816|NCT00668148|593468171|FG000|Overall Study|Subject Non-compliance|1|||
164298817|NCT00668148|593468171|FG000|Overall Study|Progressive Disease Before Treatment|2|||
164298818|NCT00668148|593468171|FG000|Overall Study|Withdrawal of Consent|2|||
164298819|NCT05472090|593468173|FG000|Overall Study|Adverse Event|2|||
164298820|NCT05472090|593468174|FG001|Overall Study|Adverse Event|3|||
164298821|NCT05472090|593468173|FG000|Overall Study|Lack of Efficacy|1|||
164298822|NCT05472090|593468174|FG001|Overall Study|Lack of Efficacy|0|||
164298823|NCT05472090|593468173|FG000|Overall Study|Physician Decision|1|||
164298824|NCT05472090|593468174|FG001|Overall Study|Physician Decision|0|||
164298825|NCT05472090|593468173|FG000|Overall Study|Withdrawal by Subject|2|||
164298826|NCT05472090|593468174|FG001|Overall Study|Withdrawal by Subject|0|||
164298827|NCT05472090|593468173|FG000|Overall Study|Lost to Follow-up|0|||
164298828|NCT05472090|593468174|FG001|Overall Study|Lost to Follow-up|3|||
164298829|NCT02419001|593471157|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
164298830|NCT02419001|593471158|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
164298831|NCT01209689|593471162|FG000|Overall Study|Insufficient Therapeutic Response|7|||
164298832|NCT01209689|593471163|FG001|Overall Study|Insufficient Therapeutic Response|2|||
164298833|NCT01209689|593471162|FG000|Overall Study|Refused Treatment|8|||
164298834|NCT01209689|593471163|FG001|Overall Study|Refused Treatment|3|||
164298835|NCT01209689|593471162|FG000|Overall Study|Adverse Event|4|||
164298836|NCT01209689|593471163|FG001|Overall Study|Adverse Event|0|||
164298837|NCT01209689|593471162|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164298838|NCT01209689|593471163|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164298839|NCT01209689|593471162|FG000|Overall Study|Failure to Return|3|||
164298840|NCT01209689|593471163|FG001|Overall Study|Failure to Return|0|||
164298841|NCT01209689|593471162|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
164298842|NCT01209689|593471163|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
164298843|NCT03780244|593471166|FG000|Overall Study|Lost to Follow-up|1|||
164298844|NCT03780244|593471167|FG001|Overall Study|Lost to Follow-up|0|||
164298845|NCT01083771|593471168|FG000|Overall Study|non-compliant|2|||
164298846|NCT01083771|593471168|FG000|Overall Study|Withdrawal by Subject|3|||
164298847|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298848|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298849|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
164298850|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
164298851|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298852|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
164298853|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
164298854|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298855|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298856|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
164298857|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
164298858|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
164298859|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298860|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
164298861|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164301065|NCT02435992|593478414|FG003|Overall Study|Physician Decision|0|||
164301066|NCT02435992|593478415|FG004|Overall Study|Physician Decision|0|||
164301067|NCT03879772|593478416|FG000|Overall Study|Adverse Event|2|||
164301068|NCT03879772|593478417|FG001|Overall Study|Adverse Event|2|||
164301069|NCT03879772|593478418|FG002|Overall Study|Adverse Event|3|||
164301070|NCT03879772|593478419|FG003|Overall Study|Adverse Event|4|||
164301071|NCT03879772|593478420|FG004|Overall Study|Adverse Event|3|||
164301072|NCT03879772|593478416|FG000|Overall Study|Treatment Failure|1|||
164301073|NCT03879772|593478417|FG001|Overall Study|Treatment Failure|0|||
164301074|NCT03879772|593478418|FG002|Overall Study|Treatment Failure|0|||
164301075|NCT03879772|593478419|FG003|Overall Study|Treatment Failure|2|||
164301076|NCT03879772|593478420|FG004|Overall Study|Treatment Failure|1|||
164301077|NCT03879772|593478416|FG000|Overall Study|Lost to Follow-up|0|||
164301078|NCT03879772|593478417|FG001|Overall Study|Lost to Follow-up|0|||
164301079|NCT03879772|593478418|FG002|Overall Study|Lost to Follow-up|0|||
164301080|NCT03879772|593478419|FG003|Overall Study|Lost to Follow-up|0|||
164301081|NCT03879772|593478420|FG004|Overall Study|Lost to Follow-up|1|||
164348700|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
164348701|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
164348702|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
164348703|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
164348704|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
164348705|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
164348706|NCT01425281|593655298|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
164348707|NCT01425281|593655299|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
164348708|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Death|2|||
164348709|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Death|0|||
164348710|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
164348711|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
164348712|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
164348713|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
164348714|NCT01425281|593655298|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
164348715|NCT01425281|593655299|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
164348716|NCT01987505|593655300|FG000|Overall Study|Other|9|||
164348717|NCT01987505|593655300|FG000|Overall Study|Withdrawal by Subject|2|||
164348718|NCT01987505|593655300|FG000|Overall Study|Other Reason|2|||
164348719|NCT01987505|593655300|FG000|Overall Study|Lost to Follow-up|15|||
164348720|NCT01987505|593655300|FG000|Overall Study|Investigator Decision|2|||
164348721|NCT01987505|593655300|FG000|Overall Study|Death|4|||
164348722|NCT01749514|593655301|FG000|Overall Study|Lost to Follow-up|0|||
164348723|NCT01749514|593655302|FG001|Overall Study|Lost to Follow-up|0|||
164348724|NCT01749514|593655303|FG002|Overall Study|Lost to Follow-up|0|||
164348725|NCT01749514|593655304|FG003|Overall Study|Lost to Follow-up|0|||
164348726|NCT01749514|593655305|FG004|Overall Study|Lost to Follow-up|0|||
164348727|NCT01749514|593655306|FG005|Overall Study|Lost to Follow-up|0|||
164348728|NCT01749514|593655307|FG006|Overall Study|Lost to Follow-up|0|||
164348729|NCT01749514|593655308|FG007|Overall Study|Lost to Follow-up|1|||
164348730|NCT01749514|593655301|FG000|Overall Study|Withdrawal by Subject|0|||
164348731|NCT01749514|593655302|FG001|Overall Study|Withdrawal by Subject|0|||
164348732|NCT01749514|593655303|FG002|Overall Study|Withdrawal by Subject|0|||
164348733|NCT01749514|593655304|FG003|Overall Study|Withdrawal by Subject|0|||
164348734|NCT01749514|593655305|FG004|Overall Study|Withdrawal by Subject|0|||
164348735|NCT01749514|593655306|FG005|Overall Study|Withdrawal by Subject|1|||
164348736|NCT01749514|593655307|FG006|Overall Study|Withdrawal by Subject|0|||
164348737|NCT01749514|593655308|FG007|Overall Study|Withdrawal by Subject|1|||
164348738|NCT01749514|593655301|FG000|Overall Study|Not Reported|0|||
164348739|NCT01749514|593655302|FG001|Overall Study|Not Reported|0|||
164348740|NCT01749514|593655303|FG002|Overall Study|Not Reported|0|||
164348741|NCT01749514|593655304|FG003|Overall Study|Not Reported|0|||
164348742|NCT01749514|593655305|FG004|Overall Study|Not Reported|0|||
164348743|NCT01749514|593655306|FG005|Overall Study|Not Reported|0|||
164348744|NCT01749514|593655307|FG006|Overall Study|Not Reported|0|||
164348745|NCT01749514|593655308|FG007|Overall Study|Not Reported|5|||
164348746|NCT02509156|593655309|FG000|Randomized Phase|Death|1|||
164348747|NCT02509156|593655310|FG001|Randomized Phase|Death|0|||
164348748|NCT02509156|593655309|FG000|Randomized Phase|Withdrawal by Subject|1|||
164348749|NCT02509156|593655310|FG001|Randomized Phase|Withdrawal by Subject|1|||
164348750|NCT05131646|593655311|FG000|Overall Study|Withdrawal by Subject|1|||
164348751|NCT05131646|593655312|FG001|Overall Study|Withdrawal by Subject|0|||
164348752|NCT05131646|593655313|FG002|Overall Study|Withdrawal by Subject|0|||
164348753|NCT02128113|593655314|FG000|Overall Study|Withdrawal by Subject|3|||
164348754|NCT02128113|593655315|FG001|Overall Study|Withdrawal by Subject|1|||
164348755|NCT02128113|593655316|FG002|Overall Study|Withdrawal by Subject|0|||
164348756|NCT02128113|593655314|FG000|Overall Study|Protocol Violation|0|||
164348757|NCT02128113|593655315|FG001|Overall Study|Protocol Violation|1|||
164348758|NCT02128113|593655316|FG002|Overall Study|Protocol Violation|0|||
164348759|NCT02128113|593655314|FG000|Overall Study|Surgery cancelled|0|||
164348760|NCT02128113|593655315|FG001|Overall Study|Surgery cancelled|1|||
164348761|NCT02128113|593655316|FG002|Overall Study|Surgery cancelled|0|||
164348762|NCT02128113|593655314|FG000|Overall Study|Adverse Event|0|||
164348763|NCT02128113|593655315|FG001|Overall Study|Adverse Event|0|||
164348764|NCT02128113|593655316|FG002|Overall Study|Adverse Event|1|||
164348765|NCT01750242|593655317|FG000|Overall Study|Unreadable Images|3|||
164348766|NCT03765918|593655318|FG000|Overall Study|Death|109|||
164348767|NCT03765918|593655319|FG001|Overall Study|Death|127|||
164348768|NCT03765918|593655318|FG000|Overall Study|Lost to Follow-up|2|||
164348769|NCT03765918|593655319|FG001|Overall Study|Lost to Follow-up|3|||
164348770|NCT03765918|593655318|FG000|Overall Study|Withdrawal by Subject|12|||
164348771|NCT03765918|593655319|FG001|Overall Study|Withdrawal by Subject|16|||
164348772|NCT03765918|593655318|FG000|Overall Study|Participants Ongoing|240|||
164348773|NCT03765918|593655319|FG001|Overall Study|Participants Ongoing|205|||
164348774|NCT04202965|593655320|FG000|Overall Study|Adverse Event|3|||
164348775|NCT04202965|593655320|FG000|Overall Study|Did not meet inclusion criteria|1|||
164348776|NCT02969369|593655321|FG000|Study|Adverse Event|1|||
164348777|NCT02969369|593655322|FG001|Study|Adverse Event|6|||
164348778|NCT02969369|593655321|FG000|Study|Lack of Efficacy|0|||
164348779|NCT02969369|593655322|FG001|Study|Lack of Efficacy|1|||
164348780|NCT02969369|593655321|FG000|Study|Lost to Follow-up|0|||
164348781|NCT02969369|593655322|FG001|Study|Lost to Follow-up|1|||
164348782|NCT02969369|593655321|FG000|Study|Withdrawal by Subject|3|||
164348783|NCT02969369|593655322|FG001|Study|Withdrawal by Subject|5|||
164348784|NCT02969369|593655321|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
164348785|NCT02969369|593655322|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
164348786|NCT02969369|593655321|FG000|Double-blind Period|Adverse Event|1|||
164348787|NCT02969369|593655322|FG001|Double-blind Period|Adverse Event|5|||
164348788|NCT02969369|593655321|FG000|Double-blind Period|Lost to Follow-up|0|||
164348789|NCT02969369|593655322|FG001|Double-blind Period|Lost to Follow-up|1|||
164348790|NCT02969369|593655321|FG000|Double-blind Period|Withdrawal by Subject|2|||
164348791|NCT02969369|593655322|FG001|Double-blind Period|Withdrawal by Subject|3|||
164348792|NCT02969369|593655321|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
164348793|NCT02969369|593655322|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
164348794|NCT02969369|593655321|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
164348795|NCT02969369|593655322|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
164348796|NCT02969369|593655321|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
164348797|NCT02969369|593655322|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
164348798|NCT02969369|593655321|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
164348799|NCT02969369|593655322|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
164348800|NCT01980992|593655325|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
164348801|NCT01980992|593655326|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
164348802|NCT01980992|593655325|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
164348803|NCT01980992|593655326|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
164348804|NCT01980992|593655325|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
164348805|NCT01980992|593655326|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
164348806|NCT01980992|593655325|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
164348807|NCT01980992|593655326|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
164348808|NCT01980992|593655325|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
164348809|NCT01980992|593655326|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
164348810|NCT01980992|593655325|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
164348811|NCT01980992|593655326|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
164348812|NCT00299975|593655327|FG000|Overall Study|Adverse Event|1|||
164348813|NCT00299975|593655328|FG001|Overall Study|Adverse Event|0|||
164348814|NCT00299975|593655329|FG002|Overall Study|Adverse Event|2|||
164348815|NCT00299975|593655327|FG000|Overall Study|Pregnancy|0|||
164348816|NCT00299975|593655328|FG001|Overall Study|Pregnancy|0|||
164348817|NCT00299975|593655329|FG002|Overall Study|Pregnancy|1|||
164348818|NCT00299975|593655327|FG000|Overall Study|Lack of Efficacy|1|||
164348819|NCT00299975|593655328|FG001|Overall Study|Lack of Efficacy|0|||
164348820|NCT00299975|593655329|FG002|Overall Study|Lack of Efficacy|1|||
164348821|NCT00299975|593655327|FG000|Overall Study|Lost to Follow-up|1|||
164348822|NCT00299975|593655328|FG001|Overall Study|Lost to Follow-up|0|||
164348823|NCT00299975|593655329|FG002|Overall Study|Lost to Follow-up|0|||
164348824|NCT00299975|593655327|FG000|Overall Study|Withdrawal by Subject|0|||
164348825|NCT00299975|593655328|FG001|Overall Study|Withdrawal by Subject|1|||
164348826|NCT00299975|593655329|FG002|Overall Study|Withdrawal by Subject|3|||
164348827|NCT00299975|593655327|FG000|Overall Study|Physician Decision|0|||
164348828|NCT00299975|593655328|FG001|Overall Study|Physician Decision|0|||
164348829|NCT00299975|593655329|FG002|Overall Study|Physician Decision|1|||
164348830|NCT01169493|593655333|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
164348831|NCT01169493|593655334|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
164348832|NCT01169493|593655335|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
164348833|NCT01169493|593655336|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
164348834|NCT01169493|593655337|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
164348835|NCT01169493|593655338|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
164348836|NCT01169493|593655333|FG000|Period 3 (6 Months)|Adverse Event|0|||
164348837|NCT01169493|593655334|FG001|Period 3 (6 Months)|Adverse Event|1|||
164348838|NCT01169493|593655335|FG002|Period 3 (6 Months)|Adverse Event|0|||
164089742|NCT00797108|592691472|FG001|Overall Study|Adverse Event|0|||
164089743|NCT00797108|592691473|FG002|Overall Study|Adverse Event|3|||
164089744|NCT00797108|592691471|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
163898861|NCT03248492|592002070|FG002|Overall Study|Withdrawal by Subject|0|||
163898862|NCT03248492|592002071|FG003|Overall Study|Withdrawal by Subject|8|||
163898863|NCT03248492|592002072|FG004|Overall Study|Withdrawal by Subject|1|||
163898864|NCT03248492|592002068|FG000|Overall Study|Physician Decision|1|||
163898865|NCT03248492|592002069|FG001|Overall Study|Physician Decision|1|||
163898866|NCT03248492|592002070|FG002|Overall Study|Physician Decision|1|||
163898867|NCT03248492|592002071|FG003|Overall Study|Physician Decision|7|||
163898868|NCT03248492|592002072|FG004|Overall Study|Physician Decision|0|||
163898869|NCT03248492|592002068|FG000|Overall Study|Death|1|||
163898870|NCT03248492|592002069|FG001|Overall Study|Death|1|||
163898871|NCT03248492|592002070|FG002|Overall Study|Death|0|||
164298862|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164298863|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
164348839|NCT01169493|593655336|FG003|Period 3 (6 Months)|Adverse Event|0|||
164348840|NCT01169493|593655337|FG004|Period 3 (6 Months)|Adverse Event|0|||
164348841|NCT01169493|593655338|FG005|Period 3 (6 Months)|Adverse Event|0|||
164348842|NCT01169493|593655333|FG000|Period 3 (6 Months)|Physician Decision|0|||
164348843|NCT01169493|593655334|FG001|Period 3 (6 Months)|Physician Decision|1|||
164348844|NCT01169493|593655335|FG002|Period 3 (6 Months)|Physician Decision|1|||
164348845|NCT01169493|593655336|FG003|Period 3 (6 Months)|Physician Decision|0|||
164348846|NCT01169493|593655337|FG004|Period 3 (6 Months)|Physician Decision|0|||
164348847|NCT01169493|593655338|FG005|Period 3 (6 Months)|Physician Decision|0|||
164348848|NCT03018704|593655343|FG000|Overall Study|Lost to Follow-up|1|||
164348849|NCT03018704|593655344|FG001|Overall Study|Lost to Follow-up|1|||
164348850|NCT00320411|593655345|FG000|Overall Study|No investigational product admin.|4|||
164348851|NCT04448171|593655348|FG000|Overall Study|Procedure Cancelled|1|||
164348852|NCT04448171|593655349|FG001|Overall Study|Procedure Cancelled|0|||
164348853|NCT04448171|593655348|FG000|Overall Study|Protocol Violation|1|||
164348854|NCT04448171|593655349|FG001|Overall Study|Protocol Violation|0|||
164348855|NCT02088047|593655350|FG000|Overall Study|Withdrawal by Subject|1|||
164348856|NCT02088047|593655351|FG001|Overall Study|Withdrawal by Subject|0|||
164348857|NCT00211809|593655354|FG000|Overall Study|Lack of Efficacy|1|||
164348858|NCT00211809|593655354|FG000|Overall Study|Lost to Follow-up|2|||
163898872|NCT03248492|592002071|FG003|Overall Study|Death|6|||
163898873|NCT03248492|592002072|FG004|Overall Study|Death|0|||
164348859|NCT00211809|593655354|FG000|Overall Study|Pregnancy|1|||
164348860|NCT00211809|593655354|FG000|Overall Study|side effects|2|||
164348861|NCT01417234|593655355|FG000|Overall Study|Subject non-compliant|3|||
164348862|NCT00023764|593655356|FG000|Overall Study|Other|1|||
164348863|NCT00023764|593655356|FG000|Overall Study|Adverse Event|4|||
164348864|NCT00023764|593655356|FG000|Overall Study|Withdrawal by Subject|1|||
164348865|NCT00023764|593655356|FG000|Overall Study|Progression of disease|6|||
164348866|NCT00023764|593655356|FG000|Overall Study|patient received other treatment|1|||
164348867|NCT00023764|593655356|FG000|Overall Study|delay in obtaining staging images|1|||
164348868|NCT01537393|593655357|FG000|Overall Study|Exclude prior to study|32|||
164348869|NCT01537393|593655358|FG001|Overall Study|Exclude prior to study|44|||
164348870|NCT01537393|593655357|FG000|Overall Study|Death|20|||
164348871|NCT01537393|593655358|FG001|Overall Study|Death|32|||
164348872|NCT01537393|593655357|FG000|Overall Study|Withdrawal by Subject|18|||
164348873|NCT01537393|593655358|FG001|Overall Study|Withdrawal by Subject|17|||
164348874|NCT01537393|593655357|FG000|Overall Study|Lost to Follow-up|53|||
164348875|NCT01537393|593655358|FG001|Overall Study|Lost to Follow-up|48|||
164348876|NCT01537393|593655357|FG000|Overall Study|Failure - Regrafted|28|||
164298864|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
164348877|NCT01537393|593655358|FG001|Overall Study|Failure - Regrafted|43|||
163898874|NCT03248492|592002068|FG000|Overall Study|Study Terminated by Sponsor|3|||
163898875|NCT03248492|592002069|FG001|Overall Study|Study Terminated by Sponsor|1|||
163898876|NCT03248492|592002070|FG002|Overall Study|Study Terminated by Sponsor|0|||
164298865|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164298866|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164298867|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164298868|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
164298869|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
164298870|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
164348878|NCT01537393|593655357|FG000|Overall Study|Failure - Not regrafted|2|||
164348879|NCT01537393|593655358|FG001|Overall Study|Failure - Not regrafted|6|||
164348880|NCT01537393|593655357|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
164348881|NCT01537393|593655358|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
164348882|NCT00459953|593655360|FG000|Overall Study|not analyzed-household member in study|1|||
164348883|NCT00459953|593655361|FG001|Overall Study|not analyzed-household member in study|1|||
164348884|NCT00036270|593655364|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
164348885|NCT00036270|593655365|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
164348886|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
164348887|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
164348888|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
164348889|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
164348890|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
164348891|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
164348892|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Other|277|||
164348893|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Other|288|||
164348894|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
164348895|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
164348896|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
164348897|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
164348898|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
164348899|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
164348900|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
164348901|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
164348902|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
164348903|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
164348904|NCT00036270|593655364|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
164348905|NCT00036270|593655365|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
164348906|NCT00496470|593655366|FG000|Overall Study|Adverse Event|8|||
164348907|NCT00496470|593655367|FG001|Overall Study|Adverse Event|10|||
164348908|NCT00496470|593655366|FG000|Overall Study|Withdrawal by Subject|5|||
164348909|NCT00496470|593655367|FG001|Overall Study|Withdrawal by Subject|12|||
164348910|NCT00496470|593655366|FG000|Overall Study|Incorrectly enrolled|13|||
164348911|NCT00496470|593655367|FG001|Overall Study|Incorrectly enrolled|5|||
164348912|NCT00496470|593655366|FG000|Overall Study|Other reason|0|||
164348913|NCT00496470|593655367|FG001|Overall Study|Other reason|2|||
164348914|NCT01370356|593655368|FG000|Overall Study|Death|1|||
164348915|NCT01370356|593655369|FG001|Overall Study|Death|0|||
164348916|NCT01370356|593655368|FG000|Overall Study|Lack of Efficacy|6|||
164348917|NCT01370356|593655369|FG001|Overall Study|Lack of Efficacy|28|||
164348918|NCT01370356|593655368|FG000|Overall Study|Lost to Follow-up|76|||
164348919|NCT01370356|593655369|FG001|Overall Study|Lost to Follow-up|81|||
164348920|NCT01370356|593655368|FG000|Overall Study|Withdrawal by Subject|54|||
164348921|NCT01370356|593655369|FG001|Overall Study|Withdrawal by Subject|59|||
164348922|NCT01370356|593655368|FG000|Overall Study|Reason not specified|39|||
164348923|NCT01370356|593655369|FG001|Overall Study|Reason not specified|43|||
164348924|NCT01370356|593655368|FG000|Overall Study|Protocol Violation|3|||
164348925|NCT01370356|593655369|FG001|Overall Study|Protocol Violation|3|||
164348926|NCT01370356|593655368|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
164348927|NCT01370356|593655369|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
164348928|NCT01370356|593655368|FG000|Overall Study|AE Not Related to Study Drug|1|||
164348929|NCT01370356|593655369|FG001|Overall Study|AE Not Related to Study Drug|4|||
164348930|NCT00799422|593655377|FG000|First Week of Wear|Lost to Follow-up|0|||
164348931|NCT00799422|593655378|FG001|First Week of Wear|Lost to Follow-up|0|||
164348932|NCT00799422|593655379|FG002|First Week of Wear|Lost to Follow-up|1|||
164348933|NCT00799422|593655380|FG003|First Week of Wear|Lost to Follow-up|0|||
164348934|NCT00799422|593655381|FG004|First Week of Wear|Lost to Follow-up|0|||
164348935|NCT00799422|593655382|FG005|First Week of Wear|Lost to Follow-up|0|||
164348936|NCT00799422|593655377|FG000|First Week of Wear|Adverse Event|0|||
164348937|NCT00799422|593655378|FG001|First Week of Wear|Adverse Event|0|||
164348938|NCT00799422|593655379|FG002|First Week of Wear|Adverse Event|0|||
164348939|NCT00799422|593655380|FG003|First Week of Wear|Adverse Event|1|||
164348940|NCT00799422|593655381|FG004|First Week of Wear|Adverse Event|0|||
164348941|NCT00799422|593655382|FG005|First Week of Wear|Adverse Event|0|||
164348942|NCT01496612|593655383|FG000|1st Intervention|Adverse Event|1|||
164348943|NCT01496612|593655384|FG001|1st Intervention|Adverse Event|0|||
164348944|NCT01496612|593655383|FG000|1st Intervention|Withdrawal by Subject|1|||
164348945|NCT01496612|593655384|FG001|1st Intervention|Withdrawal by Subject|0|||
164348946|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
164348947|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
164348948|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
164348949|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
164348950|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
164348951|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
164348952|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
164348953|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
164348954|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
164348955|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
164348956|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
164348957|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
164348958|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
164348959|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
164348960|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
164348961|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
164348962|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
164348963|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
164348964|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
164348965|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
164348966|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
164348967|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
164348968|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
163898877|NCT03248492|592002071|FG003|Overall Study|Study Terminated by Sponsor|7|||
163898878|NCT03248492|592002072|FG004|Overall Study|Study Terminated by Sponsor|0|||
163898879|NCT03248492|592002068|FG000|Overall Study|Other|2|||
163898880|NCT03248492|592002069|FG001|Overall Study|Other|5|||
163898881|NCT03248492|592002070|FG002|Overall Study|Other|0|||
163898882|NCT03248492|592002071|FG003|Overall Study|Other|14|||
163898883|NCT03248492|592002072|FG004|Overall Study|Other|0|||
163898884|NCT04495621|592002073|FG000|Overall Study|Withdrawal by Subject|0|||
163898885|NCT04495621|592002074|FG001|Overall Study|Withdrawal by Subject|3|||
163898886|NCT04495621|592002073|FG000|Overall Study|Death|7|||
163898887|NCT04495621|592002074|FG001|Overall Study|Death|11|||
163898888|NCT04495621|592002073|FG000|Overall Study|Investigator Decision|0|||
163898889|NCT04495621|592002074|FG001|Overall Study|Investigator Decision|7|||
163898890|NCT04495621|592002073|FG000|Overall Study|Lost to Follow-up|0|||
163898891|NCT04495621|592002074|FG001|Overall Study|Lost to Follow-up|1|||
163898892|NCT03774472|592002077|FG000|Overall Study|Physician Decision|1|||
163898893|NCT03774472|592002078|FG001|Overall Study|Physician Decision|0|||
163898894|NCT03774472|592002079|FG002|Overall Study|Physician Decision|0|||
163898895|NCT03774472|592002077|FG000|Overall Study|Progression prior to 4 weeks|0|||
163898896|NCT03774472|592002078|FG001|Overall Study|Progression prior to 4 weeks|1|||
163898897|NCT03774472|592002079|FG002|Overall Study|Progression prior to 4 weeks|0|||
163898898|NCT03774472|592002077|FG000|Overall Study|Withdrawal by Subject|0|||
163898899|NCT03774472|592002078|FG001|Overall Study|Withdrawal by Subject|1|||
163898900|NCT03774472|592002079|FG002|Overall Study|Withdrawal by Subject|0|||
163898901|NCT04059406|592002084|FG000|Overall Study|Early Treatment Termination|5|||
163898902|NCT04059406|592002085|FG001|Overall Study|Early Treatment Termination|5|||
163898903|NCT04059406|592002086|FG002|Overall Study|Early Treatment Termination|15|||
163898904|NCT05155306|592002087|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
163898905|NCT05155306|592002088|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
164298871|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
163898906|NCT05155306|592002089|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
163898907|NCT05155306|592002090|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
163898908|NCT05155306|592002087|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
163898909|NCT05155306|592002088|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
163898910|NCT05155306|592002089|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
163898911|NCT05155306|592002090|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
163898912|NCT04121741|592002091|FG000|Overall Study|Protocol Violation|1|||
163898913|NCT04121741|592002092|FG001|Overall Study|Protocol Violation|0|||
163898914|NCT04121741|592002093|FG002|Overall Study|Protocol Violation|0|||
163898915|NCT04121741|592002094|FG003|Overall Study|Protocol Violation|0|||
163898916|NCT04121741|592002095|FG004|Overall Study|Protocol Violation|0|||
163898917|NCT04121741|592002096|FG005|Overall Study|Protocol Violation|0|||
163898918|NCT01084863|592002097|FG000|Main Study Treatment Period|Disease progression|11|||
164298872|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164298873|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164298874|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
164298875|NCT03175367|593471169|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298876|NCT03175367|593471170|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298877|NCT03175367|593471171|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
164298878|NCT03175367|593471172|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298879|NCT03175367|593471173|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
164298880|NCT03175367|593471174|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298881|NCT03175367|593471175|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164298882|NCT03175367|593471169|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298883|NCT03175367|593471170|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298884|NCT03175367|593471171|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298885|NCT03175367|593471172|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298886|NCT03175367|593471173|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298887|NCT03175367|593471174|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
164298888|NCT03175367|593471175|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
164298889|NCT03175367|593471169|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298890|NCT03175367|593471170|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298891|NCT03175367|593471171|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298892|NCT03175367|593471172|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298893|NCT03175367|593471173|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
164298894|NCT03175367|593471174|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
164298895|NCT03175367|593471175|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
164298896|NCT02851615|593471176|FG000|Overall Study|Cognitive Issue|1|||
164298897|NCT02851615|593471177|FG001|Overall Study|Cognitive Issue|0|||
164298898|NCT02851615|593471176|FG000|Overall Study|Lost to Follow-up|0|||
163898919|NCT01084863|592002098|FG001|Main Study Treatment Period|Disease progression|7|||
164298899|NCT02851615|593471177|FG001|Overall Study|Lost to Follow-up|4|||
164298900|NCT02345070|593471179|FG000|Overall Study|Adverse Event|12|||
164298901|NCT02345070|593471180|FG001|Overall Study|Adverse Event|8|||
164298902|NCT02345070|593471181|FG002|Overall Study|Adverse Event|16|||
164005561|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
164005562|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
164005563|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164005564|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164005565|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164005566|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
164005567|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
164005568|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164005569|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164005570|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164005571|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
164005572|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
164348969|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
164348970|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
164348971|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
164348972|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
164348973|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348974|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348975|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348976|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348977|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348978|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348979|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348980|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348981|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348982|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348983|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348984|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348985|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348986|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348987|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348988|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348989|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348990|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348991|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164005573|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
164005574|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
164298903|NCT02345070|593471179|FG000|Overall Study|Poor compliance to protocol|2|||
164298904|NCT02345070|593471180|FG001|Overall Study|Poor compliance to protocol|0|||
164298905|NCT02345070|593471181|FG002|Overall Study|Poor compliance to protocol|0|||
164298906|NCT02345070|593471179|FG000|Overall Study|Other than specified above|6|||
164298907|NCT02345070|593471180|FG001|Overall Study|Other than specified above|3|||
164298908|NCT02345070|593471181|FG002|Overall Study|Other than specified above|7|||
164298909|NCT02151058|593471182|FG000|Overall Study|Withdrawal by Subject|1|||
164298910|NCT02151058|593471183|FG001|Overall Study|Withdrawal by Subject|1|||
164298911|NCT02151058|593471184|FG002|Overall Study|Withdrawal by Subject|3|||
164298912|NCT02151058|593471182|FG000|Overall Study|Lost to Follow-up|1|||
164298913|NCT02151058|593471183|FG001|Overall Study|Lost to Follow-up|0|||
164298914|NCT02151058|593471184|FG002|Overall Study|Lost to Follow-up|2|||
164298915|NCT00321620|593471186|FG000|Overall Study|Death|269|||
164298916|NCT00321620|593471187|FG001|Overall Study|Death|294|||
164298917|NCT00321620|593471186|FG000|Overall Study|Withdrawal by Subject|164|||
164298918|NCT00321620|593471187|FG001|Overall Study|Withdrawal by Subject|147|||
164298919|NCT00321620|593471186|FG000|Overall Study|Disease progression|113|||
164298920|NCT00321620|593471187|FG001|Overall Study|Disease progression|117|||
164298921|NCT00321620|593471186|FG000|Overall Study|Adverse Event|43|||
164298922|NCT00321620|593471187|FG001|Overall Study|Adverse Event|56|||
164298923|NCT00321620|593471186|FG000|Overall Study|Lost to Follow-up|13|||
164298924|NCT00321620|593471187|FG001|Overall Study|Lost to Follow-up|9|||
164298925|NCT00321620|593471186|FG000|Overall Study|Physician Decision|4|||
164298926|NCT00321620|593471187|FG001|Overall Study|Physician Decision|1|||
164298927|NCT00321620|593471186|FG000|Overall Study|Noncompliance|14|||
164298928|NCT00321620|593471187|FG001|Overall Study|Noncompliance|7|||
164298929|NCT00321620|593471186|FG000|Overall Study|Protocol deviation|4|||
164298930|NCT00321620|593471187|FG001|Overall Study|Protocol deviation|3|||
164298931|NCT00321620|593471186|FG000|Overall Study|Ineligibility determined|2|||
164298932|NCT00321620|593471187|FG001|Overall Study|Ineligibility determined|3|||
164298933|NCT00321620|593471186|FG000|Overall Study|Participant request|75|||
164298934|NCT00321620|593471187|FG001|Overall Study|Participant request|52|||
164298935|NCT00321620|593471186|FG000|Overall Study|Other|42|||
164298936|NCT00321620|593471187|FG001|Overall Study|Other|33|||
164005575|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
164298937|NCT03337477|593471188|FG000|Overall Study|not categorized into the listed ones|11|||
163898920|NCT01084863|592002097|FG000|Main Study Treatment Period|Adverse Event|5|||
163898921|NCT01084863|592002098|FG001|Main Study Treatment Period|Adverse Event|3|||
163898922|NCT01084863|592002097|FG000|Main Study Treatment Period|Other Reason|0|||
163898923|NCT01084863|592002098|FG001|Main Study Treatment Period|Other Reason|1|||
163898924|NCT01084863|592002097|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
163898925|NCT01084863|592002098|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
163898926|NCT01084863|592002097|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
163898927|NCT01084863|592002098|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
163898928|NCT01084863|592002097|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
163898929|NCT01084863|592002098|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
163898930|NCT01084863|592002097|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
163898931|NCT01084863|592002098|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
163898932|NCT01084863|592002097|FG000|Treatment Period Beyond Cycle 8|Other|0|||
163898933|NCT01084863|592002098|FG001|Treatment Period Beyond Cycle 8|Other|1|||
164005576|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
164005577|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
164005578|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
164005579|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
164005580|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
164005581|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
164005582|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
164005583|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
164005584|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
164005585|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
164005586|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
164005587|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
164005588|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
164005589|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
164005590|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
164005591|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
164005592|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
164005593|NCT00785577|592385829|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
164348992|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348993|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348994|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348995|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348996|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348997|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
164348998|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
164348999|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
164349000|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349001|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349002|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349003|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349004|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164005594|NCT00785577|592385830|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
164005595|NCT00785577|592385831|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
164349005|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349006|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349007|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349008|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349009|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349010|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349011|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349012|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349013|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349014|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349015|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349016|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349017|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349018|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349019|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349020|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349021|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349022|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349023|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
164349024|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
164349025|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
164349026|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349027|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349028|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349029|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349030|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349031|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349032|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349033|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349034|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349035|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349036|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349037|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349038|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349039|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349040|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349041|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349042|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349043|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349044|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349045|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349046|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349047|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349048|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349049|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
164349050|NCT03129100|593655386|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349051|NCT03129100|593655387|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
164349052|NCT03129100|593655388|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349053|NCT03129100|593655389|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349054|NCT03129100|593655390|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349055|NCT03129100|593655391|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349056|NCT03129100|593655392|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349057|NCT03129100|593655393|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349058|NCT03129100|593655394|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349059|NCT03129100|593655395|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349060|NCT03129100|593655396|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349061|NCT03129100|593655397|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349062|NCT03129100|593655398|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349063|NCT03129100|593655399|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349064|NCT03129100|593655400|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349065|NCT03129100|593655401|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349066|NCT03129100|593655402|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
164089745|NCT00797108|592691472|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
164089746|NCT00797108|592691473|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
164089747|NCT00797108|592691471|FG000|Overall Study|Global Deterioration of Health Status|0|||
163898934|NCT01084863|592002097|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
163898935|NCT01084863|592002098|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
163898936|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
163898937|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
163898938|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
163898939|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
163898940|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
163898941|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
163898942|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
163898943|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
163898944|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
163898945|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
163898946|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
163898947|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
163898948|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
163898949|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
163898950|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
163898951|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
163898952|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
163898953|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
163898954|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
164349067|NCT03129100|593655403|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349068|NCT03129100|593655404|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349069|NCT03129100|593655405|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349070|NCT03129100|593655406|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349071|NCT03129100|593655407|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349072|NCT03129100|593655408|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349073|NCT03129100|593655409|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349074|NCT03129100|593655410|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349075|NCT03129100|593655411|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
164349076|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349077|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349078|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
164349079|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
164349080|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349081|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
164349082|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349083|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349084|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349085|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349086|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349087|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349088|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349089|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349090|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349091|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349092|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349093|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349094|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349095|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349096|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349097|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349098|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349099|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349100|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349101|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
164349102|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Death|0|||
164349103|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Death|0|||
164349104|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Death|1|||
164349105|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Death|0|||
164349106|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Death|0|||
164349107|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Death|0|||
164349108|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Death|0|||
163898955|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
163898956|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
163898957|NCT04505722|592002100|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
163898958|NCT04505722|592002101|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
164133099|NCT01447420|592852656|FG001|Overall Study|Adverse Event|4|||
164349109|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Death|0|||
164349110|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Death|0|||
164349111|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Death|0|||
164349112|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Death|0|||
164349113|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Death|0|||
164349114|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Death|0|||
164349115|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Death|0|||
164349116|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Death|0|||
164349117|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Death|0|||
164349118|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Death|0|||
164349119|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Death|0|||
164349120|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Death|0|||
164349121|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Death|0|||
164349122|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Death|0|||
164349123|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Death|0|||
164349124|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Death|0|||
164349125|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Death|0|||
164349126|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Death|0|||
164349127|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Death|0|||
164349128|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349129|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349130|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
164349131|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
164349132|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
164349133|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
164349134|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
164349135|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349136|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349137|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349138|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349139|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349140|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349141|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349142|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349143|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349144|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349145|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349146|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349147|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349148|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349149|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349150|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349151|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349152|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349153|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
164349154|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349155|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349156|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
164349157|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349158|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349159|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349160|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349161|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349162|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
163898959|NCT04505722|592002102|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
163898960|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
163898961|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
163898962|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
164089748|NCT00797108|592691472|FG001|Overall Study|Global Deterioration of Health Status|1|||
164349163|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349164|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349165|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349166|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349167|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349168|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349169|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349170|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349171|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349172|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349173|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349174|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349175|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349176|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349177|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349178|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349179|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
164349180|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349181|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349182|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
164349183|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349184|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349185|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349186|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349187|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349188|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349189|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349190|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349191|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349192|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349193|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349194|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349195|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349196|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349197|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349198|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349199|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349200|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349201|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349202|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349203|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349204|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349205|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
164349206|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349207|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349208|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
164349209|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349210|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349211|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349212|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349213|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349214|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349215|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349216|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349217|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349218|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349219|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349220|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349221|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349222|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349223|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349224|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349225|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349226|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349227|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349228|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349229|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349230|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349231|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
164349232|NCT03129100|593655386|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349233|NCT03129100|593655387|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349234|NCT03129100|593655388|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349235|NCT03129100|593655389|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349236|NCT03129100|593655390|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
164349237|NCT03129100|593655391|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
164349238|NCT03129100|593655392|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
164349239|NCT03129100|593655393|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349240|NCT03129100|593655394|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349241|NCT03129100|593655395|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349242|NCT03129100|593655396|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349243|NCT03129100|593655397|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349244|NCT03129100|593655398|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349245|NCT03129100|593655399|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349246|NCT03129100|593655400|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349247|NCT03129100|593655401|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349248|NCT03129100|593655402|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349249|NCT03129100|593655403|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349250|NCT03129100|593655404|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349251|NCT03129100|593655405|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349252|NCT03129100|593655406|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349253|NCT03129100|593655407|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349254|NCT03129100|593655408|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164298938|NCT03337477|593471189|FG001|Overall Study|not categorized into the listed ones|9|||
164298939|NCT03337477|593471188|FG000|Overall Study|Withdrawal by Subject|0|||
164298940|NCT03337477|593471189|FG001|Overall Study|Withdrawal by Subject|1|||
164298941|NCT03337477|593471188|FG000|Overall Study|Death|0|||
164298942|NCT03337477|593471189|FG001|Overall Study|Death|1|||
164298943|NCT03337477|593471188|FG000|Overall Study|Lost to Follow-up|0|||
164298944|NCT03337477|593471189|FG001|Overall Study|Lost to Follow-up|2|||
164298945|NCT01747876|593471191|FG000|Overall Study|Adverse Event|1|||
164298946|NCT01747876|593471192|FG001|Overall Study|Adverse Event|0|||
164298947|NCT01747876|593471193|FG002|Overall Study|Adverse Event|2|||
164298948|NCT01747876|593471191|FG000|Overall Study|Withdrawal by Subject|0|||
164298949|NCT01747876|593471192|FG001|Overall Study|Withdrawal by Subject|1|||
164298950|NCT01747876|593471193|FG002|Overall Study|Withdrawal by Subject|1|||
164298951|NCT01747876|593471191|FG000|Overall Study|Disease progression|4|||
164298952|NCT01747876|593471192|FG001|Overall Study|Disease progression|13|||
164298953|NCT01747876|593471193|FG002|Overall Study|Disease progression|8|||
164298954|NCT01747876|593471191|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
164298955|NCT01747876|593471192|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
164298956|NCT01747876|593471193|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
164298957|NCT03198715|593471194|FG000|Overall Study|Death|0|||
164298958|NCT03198715|593471195|FG001|Overall Study|Death|0|||
164298959|NCT03198715|593471196|FG002|Overall Study|Death|1|||
164298960|NCT03198715|593471197|FG003|Overall Study|Death|0|||
164298961|NCT03198715|593471198|FG004|Overall Study|Death|2|||
164298962|NCT03198715|593471194|FG000|Overall Study|Other|0|||
164298963|NCT03198715|593471195|FG001|Overall Study|Other|1|||
164298964|NCT03198715|593471196|FG002|Overall Study|Other|1|||
164298965|NCT03198715|593471197|FG003|Overall Study|Other|0|||
164089749|NCT00797108|592691473|FG002|Overall Study|Global Deterioration of Health Status|0|||
164089750|NCT00797108|592691471|FG000|Overall Study|Lack of Efficacy|1|||
164298966|NCT03198715|593471198|FG004|Overall Study|Other|0|||
164298967|NCT00853307|593471199|FG000|Overall Study|Adverse Event|1|||
164298968|NCT00853307|593471200|FG001|Overall Study|Adverse Event|2|||
164298969|NCT00853307|593471199|FG000|Overall Study|Withdrawal by Subject|1|||
164298970|NCT00853307|593471200|FG001|Overall Study|Withdrawal by Subject|2|||
164298971|NCT00853307|593471199|FG000|Overall Study|Reason Not Specified|0|||
164298972|NCT00853307|593471200|FG001|Overall Study|Reason Not Specified|1|||
164298973|NCT04225897|593471207|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298974|NCT04225897|593471208|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
164298975|NCT04225897|593471209|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298976|NCT04225897|593471210|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298977|NCT04225897|593471211|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298978|NCT04225897|593471212|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298979|NCT04225897|593471213|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298980|NCT04225897|593471214|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298981|NCT04225897|593471215|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298982|NCT04225897|593471216|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298983|NCT04225897|593471217|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298984|NCT04225897|593471218|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
164298985|NCT04225897|593471207|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298986|NCT04225897|593471208|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298987|NCT04225897|593471209|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
164298988|NCT04225897|593471210|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298989|NCT04225897|593471211|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164301313|NCT05462756|593480132|FG001|Treatment Period|Death|1|||
164301314|NCT05462756|593480131|FG000|Treatment Period|Lost to Follow-up|2|||
164301315|NCT05462756|593480132|FG001|Treatment Period|Lost to Follow-up|1|||
164301316|NCT05462756|593480131|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
164301317|NCT05462756|593480132|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
164301318|NCT05462756|593480131|FG000|Treatment Period|Physician Decision|2|||
164301319|NCT05462756|593480132|FG001|Treatment Period|Physician Decision|0|||
164301320|NCT05462756|593480131|FG000|Treatment Period|Protocol Violation|0|||
164301321|NCT05462756|593480132|FG001|Treatment Period|Protocol Violation|1|||
164301322|NCT05462756|593480131|FG000|Treatment Period|Withdrawal by Subject|5|||
164301323|NCT05462756|593480132|FG001|Treatment Period|Withdrawal by Subject|12|||
164301324|NCT05462756|593480131|FG000|Follow-Up Period|Adverse Event|1|||
164301325|NCT05462756|593480132|FG001|Follow-Up Period|Adverse Event|0|||
164301326|NCT05462756|593480131|FG000|Follow-Up Period|Death|1|||
164301327|NCT05462756|593480132|FG001|Follow-Up Period|Death|0|||
164301328|NCT05462756|593480131|FG000|Follow-Up Period|Lost to Follow-up|3|||
164301329|NCT05462756|593480132|FG001|Follow-Up Period|Lost to Follow-up|1|||
164301330|NCT05462756|593480131|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164301331|NCT05462756|593480132|FG001|Follow-Up Period|Withdrawal by Subject|4|||
164301332|NCT03591406|593480133|FG000|Overall Study|Adverse Event|5|||
164301333|NCT03591406|593480134|FG001|Overall Study|Adverse Event|3|||
164301334|NCT03591406|593480133|FG000|Overall Study|Protocol Violation|2|||
164301335|NCT03591406|593480134|FG001|Overall Study|Protocol Violation|1|||
164301336|NCT03591406|593480133|FG000|Overall Study|Withdrawal by Subject|0|||
164301337|NCT03591406|593480134|FG001|Overall Study|Withdrawal by Subject|5|||
164301338|NCT01389596|593480135|FG000|Overall Study|Protocol Violation|3|||
164301339|NCT01389596|593480136|FG001|Overall Study|Protocol Violation|4|||
164301340|NCT01389596|593480137|FG002|Overall Study|Protocol Violation|3|||
164301341|NCT01389596|593480135|FG000|Overall Study|Withdrawal by Subject|1|||
164301342|NCT01389596|593480136|FG001|Overall Study|Withdrawal by Subject|2|||
164301343|NCT01389596|593480137|FG002|Overall Study|Withdrawal by Subject|2|||
164301344|NCT01389596|593480135|FG000|Overall Study|Insufficient Clinical Response|3|||
164301345|NCT01389596|593480136|FG001|Overall Study|Insufficient Clinical Response|4|||
164301346|NCT01389596|593480137|FG002|Overall Study|Insufficient Clinical Response|5|||
164301347|NCT01389596|593480135|FG000|Overall Study|Adverse Event|1|||
164301348|NCT01389596|593480136|FG001|Overall Study|Adverse Event|4|||
164301349|NCT01389596|593480137|FG002|Overall Study|Adverse Event|0|||
164301350|NCT01389596|593480135|FG000|Overall Study|Death|0|||
164301351|NCT01389596|593480136|FG001|Overall Study|Death|1|||
164301352|NCT01389596|593480137|FG002|Overall Study|Death|0|||
164301353|NCT01389596|593480135|FG000|Overall Study|Other Unspecified|2|||
164301354|NCT01389596|593480136|FG001|Overall Study|Other Unspecified|1|||
164301355|NCT01389596|593480137|FG002|Overall Study|Other Unspecified|0|||
164301356|NCT01709084|593480138|FG000|Overall Study|Lost to Follow-up|4|||
164301357|NCT01709084|593480139|FG001|Overall Study|Lost to Follow-up|7|||
164301358|NCT01709084|593480138|FG000|Overall Study|Withdrawal by Subject|2|||
164301359|NCT01709084|593480139|FG001|Overall Study|Withdrawal by Subject|2|||
164301360|NCT01709084|593480138|FG000|Overall Study|Adverse Event|5|||
164005596|NCT00785577|592385832|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
164005597|NCT00785577|592385833|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
164349255|NCT03129100|593655409|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349256|NCT03129100|593655410|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349257|NCT03129100|593655411|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
164349258|NCT03129100|593655386|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349259|NCT03129100|593655387|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349260|NCT03129100|593655388|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349261|NCT03129100|593655389|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349262|NCT03129100|593655390|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349263|NCT03129100|593655391|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349264|NCT03129100|593655392|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349265|NCT03129100|593655393|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349266|NCT03129100|593655394|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349267|NCT03129100|593655395|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
164349268|NCT03129100|593655396|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349269|NCT03129100|593655397|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349270|NCT03129100|593655398|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349271|NCT03129100|593655399|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349272|NCT03129100|593655400|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349273|NCT03129100|593655401|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349274|NCT03129100|593655402|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349275|NCT03129100|593655403|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349276|NCT03129100|593655404|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349277|NCT03129100|593655405|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349278|NCT03129100|593655406|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349279|NCT03129100|593655407|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349280|NCT03129100|593655408|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349281|NCT03129100|593655409|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349282|NCT03129100|593655410|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349283|NCT03129100|593655411|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
164349284|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349285|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349286|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349287|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349288|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349289|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349290|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349291|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349292|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349293|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349294|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349295|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
164349296|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349297|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349298|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349299|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349300|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349301|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349302|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349303|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349304|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349305|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349306|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349307|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349308|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349309|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
164349310|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349311|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164005598|NCT00785577|592385829|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164005599|NCT00785577|592385830|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164005600|NCT00785577|592385831|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164005601|NCT00785577|592385832|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
163898963|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
163898964|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
164349312|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349313|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349314|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349315|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349316|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349317|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349318|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349319|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349320|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349321|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
164349322|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
164349323|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
164349324|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
164349325|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349326|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349327|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349328|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349329|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349330|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349331|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349332|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349333|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349334|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349335|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
164349336|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349337|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349338|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349339|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349340|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349341|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349342|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349343|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349344|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349345|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349346|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349347|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
164349348|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349349|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
164349350|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
164349351|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349352|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349353|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349354|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349355|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349356|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349357|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349358|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349359|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349360|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349361|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
164349362|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349363|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349364|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349365|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349366|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349367|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349368|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349369|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349370|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349371|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349372|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164089751|NCT00797108|592691472|FG001|Overall Study|Lack of Efficacy|0|||
164349373|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349374|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349375|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349376|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349377|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
164349378|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349379|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349380|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349381|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349382|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349383|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349384|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349385|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349386|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349387|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
164349388|NCT03129100|593655386|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349389|NCT03129100|593655387|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349390|NCT03129100|593655388|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349391|NCT03129100|593655389|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349392|NCT03129100|593655390|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349393|NCT03129100|593655391|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349394|NCT03129100|593655392|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349395|NCT03129100|593655393|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349396|NCT03129100|593655394|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349397|NCT03129100|593655395|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349398|NCT03129100|593655396|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349399|NCT03129100|593655397|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349400|NCT03129100|593655398|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
164349401|NCT03129100|593655399|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349402|NCT03129100|593655400|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
164349403|NCT03129100|593655401|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
164349404|NCT03129100|593655402|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349405|NCT03129100|593655403|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349406|NCT03129100|593655404|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349407|NCT03129100|593655405|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349408|NCT03129100|593655406|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349409|NCT03129100|593655407|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349410|NCT03129100|593655408|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349411|NCT03129100|593655409|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349412|NCT03129100|593655410|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349413|NCT03129100|593655411|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
164349414|NCT03129100|593655386|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349415|NCT03129100|593655387|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349416|NCT03129100|593655388|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349417|NCT03129100|593655389|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349418|NCT03129100|593655390|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349419|NCT03129100|593655391|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349420|NCT03129100|593655392|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349421|NCT03129100|593655393|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349422|NCT03129100|593655394|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349423|NCT03129100|593655395|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349424|NCT03129100|593655396|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349425|NCT03129100|593655397|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349426|NCT03129100|593655398|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349427|NCT03129100|593655399|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349428|NCT03129100|593655400|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349429|NCT03129100|593655401|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349430|NCT03129100|593655402|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349431|NCT03129100|593655403|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
164349432|NCT03129100|593655404|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349433|NCT03129100|593655405|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
164349434|NCT03129100|593655406|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349435|NCT03129100|593655407|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349436|NCT03129100|593655408|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349437|NCT03129100|593655409|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349438|NCT03129100|593655410|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349439|NCT03129100|593655411|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
164349440|NCT03129100|593655386|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349441|NCT03129100|593655387|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349442|NCT03129100|593655388|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349443|NCT03129100|593655389|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349444|NCT03129100|593655390|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349445|NCT03129100|593655391|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349446|NCT03129100|593655392|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349447|NCT03129100|593655393|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349448|NCT03129100|593655394|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349449|NCT03129100|593655395|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349450|NCT03129100|593655396|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349451|NCT03129100|593655397|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349452|NCT03129100|593655398|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349453|NCT03129100|593655399|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349454|NCT03129100|593655400|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349455|NCT03129100|593655401|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349456|NCT03129100|593655402|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349457|NCT03129100|593655403|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349458|NCT03129100|593655404|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349459|NCT03129100|593655405|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349460|NCT03129100|593655406|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
164349461|NCT03129100|593655407|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349462|NCT03129100|593655408|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349463|NCT03129100|593655409|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349464|NCT03129100|593655410|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349465|NCT03129100|593655411|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
164349466|NCT03129100|593655386|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
164349467|NCT03129100|593655387|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
164349468|NCT03129100|593655388|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
164349469|NCT03129100|593655389|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
164349470|NCT03129100|593655390|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
164349471|NCT03129100|593655391|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
164349472|NCT03129100|593655392|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
164349473|NCT03129100|593655393|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
164349474|NCT03129100|593655394|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
164349475|NCT03129100|593655395|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
164349476|NCT03129100|593655396|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
164349477|NCT03129100|593655397|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
164349478|NCT03129100|593655398|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
164349479|NCT03129100|593655399|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
164349480|NCT03129100|593655400|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
164349481|NCT03129100|593655401|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
164349482|NCT03129100|593655402|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
164349483|NCT03129100|593655403|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
164349484|NCT03129100|593655404|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
164349485|NCT03129100|593655405|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
164349486|NCT03129100|593655406|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
164349487|NCT03129100|593655407|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
164349488|NCT03129100|593655408|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
164349489|NCT03129100|593655409|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
164349490|NCT03129100|593655410|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
164349491|NCT03129100|593655411|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
164349492|NCT03129100|593655386|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349493|NCT03129100|593655387|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349494|NCT03129100|593655388|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349495|NCT03129100|593655389|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349496|NCT03129100|593655390|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349497|NCT03129100|593655391|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349498|NCT03129100|593655392|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349499|NCT03129100|593655393|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349500|NCT03129100|593655394|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349501|NCT03129100|593655395|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349502|NCT03129100|593655396|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349503|NCT03129100|593655397|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349504|NCT03129100|593655398|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349505|NCT03129100|593655399|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349506|NCT03129100|593655400|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349507|NCT03129100|593655401|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349508|NCT03129100|593655402|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349509|NCT03129100|593655403|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349510|NCT03129100|593655404|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349511|NCT03129100|593655405|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349512|NCT03129100|593655406|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
164349513|NCT03129100|593655407|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349514|NCT03129100|593655408|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349515|NCT03129100|593655409|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349516|NCT03129100|593655410|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349517|NCT03129100|593655411|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
164349518|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
164349519|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
164349520|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
164349521|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
164349522|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
164349523|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
164349524|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
164349525|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
164349526|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
164349527|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
164349528|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
164349529|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
164349530|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
164349531|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
164349532|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
164349533|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
164349534|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
164349535|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
164349536|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
164349537|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
164349538|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
164349539|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
164349540|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
164349541|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
164349542|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
164349543|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
164349544|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349545|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349546|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349547|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349548|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349549|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349550|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349551|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349552|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349553|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349554|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349555|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349556|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349557|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349558|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349559|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349560|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349561|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349562|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349563|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349564|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349565|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349566|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349567|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
164349568|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
164349569|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
164349570|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349571|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349572|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349573|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349574|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349575|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164089752|NCT00797108|592691473|FG002|Overall Study|Lack of Efficacy|1|||
163898965|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
163898966|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
163898967|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
163898968|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
163898969|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
163898970|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
163898971|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
163898972|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
164349576|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349577|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349578|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349579|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349580|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349581|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349582|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349583|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349584|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349585|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349586|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349587|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349588|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349589|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349590|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349591|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349592|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
164349593|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
164349594|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
164349595|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
164349596|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349597|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349598|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349599|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349600|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349601|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349602|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349603|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349604|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349605|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349606|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349607|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349608|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
163898973|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
164005602|NCT00785577|592385833|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
164349609|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349610|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349611|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349612|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349613|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349614|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349615|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349616|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349617|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349618|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349619|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349620|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
164349621|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
164349622|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349623|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349624|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349625|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349626|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349627|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349628|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349629|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349630|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349631|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349632|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349633|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349634|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349635|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349636|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349637|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349638|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349639|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349640|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349641|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349642|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349643|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349644|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349645|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349646|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
164349647|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
164349648|NCT03129100|593655386|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
164349649|NCT03129100|593655387|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
164349650|NCT03129100|593655388|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
164349651|NCT03129100|593655389|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
164349652|NCT03129100|593655390|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
164349653|NCT03129100|593655391|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
164349654|NCT03129100|593655392|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
164349655|NCT03129100|593655393|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
164349656|NCT03129100|593655394|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
164349657|NCT03129100|593655395|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
164349658|NCT03129100|593655396|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
164349659|NCT03129100|593655397|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
164349660|NCT03129100|593655398|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
164349661|NCT03129100|593655399|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
164349662|NCT03129100|593655400|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
164349663|NCT03129100|593655401|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
164349664|NCT03129100|593655402|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
164349665|NCT03129100|593655403|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
164349666|NCT03129100|593655404|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
164349667|NCT03129100|593655405|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
164349668|NCT03129100|593655406|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
164349669|NCT03129100|593655407|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
164349670|NCT03129100|593655408|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
164349671|NCT03129100|593655409|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
164349672|NCT03129100|593655410|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
164349673|NCT03129100|593655411|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
164349674|NCT03708328|593655414|FG000|Overall Study|Death|3|||
164349675|NCT03708328|593655415|FG001|Overall Study|Death|3|||
164349676|NCT03708328|593655416|FG002|Overall Study|Death|4|||
164349677|NCT03708328|593655417|FG003|Overall Study|Death|2|||
164089753|NCT00797108|592691471|FG000|Overall Study|Other|0|||
164298990|NCT04225897|593471212|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298991|NCT04225897|593471213|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298992|NCT04225897|593471214|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298993|NCT04225897|593471215|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298994|NCT04225897|593471216|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298995|NCT04225897|593471217|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298996|NCT04225897|593471218|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
164298997|NCT04225897|593471207|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164298998|NCT04225897|593471208|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164298999|NCT04225897|593471209|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
164299000|NCT04225897|593471210|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299001|NCT04225897|593471211|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299002|NCT04225897|593471212|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299003|NCT04225897|593471213|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299004|NCT04225897|593471214|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299005|NCT04225897|593471215|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299006|NCT04225897|593471216|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299007|NCT04225897|593471217|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299008|NCT04225897|593471218|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
164299009|NCT04225897|593471207|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299010|NCT04225897|593471208|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299011|NCT04225897|593471209|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299012|NCT04225897|593471210|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299013|NCT04225897|593471211|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299014|NCT04225897|593471212|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299015|NCT04225897|593471213|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299016|NCT04225897|593471214|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
164299017|NCT04225897|593471215|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299018|NCT04225897|593471216|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299019|NCT04225897|593471217|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299020|NCT04225897|593471218|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
164299021|NCT02703597|593471226|FG000|Assignment to Baseline|Lost to Follow-up|17|||
164299022|NCT02703597|593471227|FG001|Assignment to Baseline|Lost to Follow-up|16|||
164299023|NCT02703597|593471226|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
164299024|NCT02703597|593471227|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
164299025|NCT02703597|593471226|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
164299026|NCT02703597|593471227|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
164299027|NCT02703597|593471226|FG000|First Post-test to First Follow-up|Site drop out|0|||
164299028|NCT02703597|593471227|FG001|First Post-test to First Follow-up|Site drop out|58|||
164299029|NCT02703597|593471226|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
164299030|NCT02703597|593471227|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
164299031|NCT02703597|593471226|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
164299032|NCT02703597|593471227|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
164299033|NCT02703597|593471226|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
164299034|NCT02703597|593471227|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
164299035|NCT00481832|593471228|FG000|Enrollment|Physician Decision|8|||
164299036|NCT00481832|593471228|FG000|Enrollment|Unable to collect enough stem cells|2|||
164299037|NCT00481832|593471228|FG000|Inter-transplant Period|Adverse Event|4|||
164299038|NCT00481832|593471228|FG000|Inter-transplant Period|Death|3|||
164299039|NCT00481832|593471228|FG000|Inter-transplant Period|Physician Decision|4|||
164299040|NCT00481832|593471228|FG000|Inter-transplant Period|Disease relapse|11|||
164299041|NCT00481832|593471228|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
164299042|NCT00456846|593471229|FG000|Overall Study|Adverse Event|2|||
164299043|NCT00456846|593471230|FG001|Overall Study|Adverse Event|15|||
164299044|NCT00456846|593471229|FG000|Overall Study|Physician Decision|11|||
164299045|NCT00456846|593471230|FG001|Overall Study|Physician Decision|6|||
164299046|NCT00456846|593471229|FG000|Overall Study|Protocol Deviation|2|||
164299047|NCT00456846|593471230|FG001|Overall Study|Protocol Deviation|0|||
164349678|NCT03708328|593655418|FG004|Overall Study|Death|2|||
164349679|NCT03708328|593655419|FG005|Overall Study|Death|13|||
164349680|NCT03708328|593655420|FG006|Overall Study|Death|26|||
164349681|NCT03708328|593655421|FG007|Overall Study|Death|18|||
164349682|NCT03708328|593655422|FG008|Overall Study|Death|13|||
164349683|NCT03708328|593655423|FG009|Overall Study|Death|8|||
164349684|NCT03708328|593655414|FG000|Overall Study|Lost to Follow-up|0|||
164349685|NCT03708328|593655415|FG001|Overall Study|Lost to Follow-up|1|||
164349686|NCT03708328|593655416|FG002|Overall Study|Lost to Follow-up|0|||
164349687|NCT03708328|593655417|FG003|Overall Study|Lost to Follow-up|1|||
164349688|NCT03708328|593655418|FG004|Overall Study|Lost to Follow-up|0|||
164349689|NCT03708328|593655419|FG005|Overall Study|Lost to Follow-up|3|||
164349690|NCT03708328|593655420|FG006|Overall Study|Lost to Follow-up|3|||
164349691|NCT03708328|593655421|FG007|Overall Study|Lost to Follow-up|0|||
164349692|NCT03708328|593655422|FG008|Overall Study|Lost to Follow-up|0|||
164349693|NCT03708328|593655423|FG009|Overall Study|Lost to Follow-up|1|||
164349694|NCT03708328|593655414|FG000|Overall Study|Physician Decision|0|||
164349695|NCT03708328|593655415|FG001|Overall Study|Physician Decision|0|||
164349696|NCT03708328|593655416|FG002|Overall Study|Physician Decision|0|||
164349697|NCT03708328|593655417|FG003|Overall Study|Physician Decision|0|||
164349698|NCT03708328|593655418|FG004|Overall Study|Physician Decision|0|||
164349699|NCT03708328|593655419|FG005|Overall Study|Physician Decision|1|||
164349700|NCT03708328|593655420|FG006|Overall Study|Physician Decision|0|||
164349701|NCT03708328|593655421|FG007|Overall Study|Physician Decision|0|||
164349702|NCT03708328|593655422|FG008|Overall Study|Physician Decision|0|||
164349703|NCT03708328|593655423|FG009|Overall Study|Physician Decision|0|||
164349704|NCT03708328|593655414|FG000|Overall Study|Withdrawal by Subject|0|||
164349705|NCT03708328|593655415|FG001|Overall Study|Withdrawal by Subject|0|||
164349706|NCT03708328|593655416|FG002|Overall Study|Withdrawal by Subject|0|||
164349707|NCT03708328|593655417|FG003|Overall Study|Withdrawal by Subject|0|||
164349708|NCT03708328|593655418|FG004|Overall Study|Withdrawal by Subject|1|||
164349709|NCT03708328|593655419|FG005|Overall Study|Withdrawal by Subject|0|||
164349710|NCT03708328|593655420|FG006|Overall Study|Withdrawal by Subject|2|||
164349711|NCT03708328|593655421|FG007|Overall Study|Withdrawal by Subject|4|||
164349712|NCT03708328|593655422|FG008|Overall Study|Withdrawal by Subject|1|||
164349713|NCT03708328|593655423|FG009|Overall Study|Withdrawal by Subject|5|||
164349714|NCT03708328|593655414|FG000|Overall Study|Study Closed Locally|0|||
164349715|NCT03708328|593655415|FG001|Overall Study|Study Closed Locally|0|||
164349716|NCT03708328|593655416|FG002|Overall Study|Study Closed Locally|0|||
164349717|NCT03708328|593655417|FG003|Overall Study|Study Closed Locally|0|||
164349718|NCT03708328|593655418|FG004|Overall Study|Study Closed Locally|0|||
164349719|NCT03708328|593655419|FG005|Overall Study|Study Closed Locally|0|||
164349720|NCT03708328|593655420|FG006|Overall Study|Study Closed Locally|0|||
164349721|NCT03708328|593655421|FG007|Overall Study|Study Closed Locally|1|||
164349722|NCT03708328|593655422|FG008|Overall Study|Study Closed Locally|0|||
164349723|NCT03708328|593655423|FG009|Overall Study|Study Closed Locally|0|||
164349724|NCT03708328|593655414|FG000|Overall Study|Study Ended By Sponsor|0|||
164349725|NCT03708328|593655415|FG001|Overall Study|Study Ended By Sponsor|0|||
164349726|NCT03708328|593655416|FG002|Overall Study|Study Ended By Sponsor|0|||
164349727|NCT03708328|593655417|FG003|Overall Study|Study Ended By Sponsor|0|||
164349728|NCT03708328|593655418|FG004|Overall Study|Study Ended By Sponsor|0|||
164349729|NCT03708328|593655419|FG005|Overall Study|Study Ended By Sponsor|1|||
164349730|NCT03708328|593655420|FG006|Overall Study|Study Ended By Sponsor|0|||
164349731|NCT03708328|593655421|FG007|Overall Study|Study Ended By Sponsor|1|||
164349732|NCT03708328|593655422|FG008|Overall Study|Study Ended By Sponsor|0|||
164349733|NCT03708328|593655423|FG009|Overall Study|Study Ended By Sponsor|0|||
164349734|NCT03708328|593655414|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349735|NCT03708328|593655415|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349736|NCT03708328|593655416|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349737|NCT03708328|593655417|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349738|NCT03708328|593655418|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349739|NCT03708328|593655419|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349740|NCT03708328|593655420|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349741|NCT03708328|593655421|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349742|NCT03708328|593655422|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
164349743|NCT03708328|593655423|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
164349744|NCT00571948|593655424|FG000|Overall Study|Lost to Follow-up|2|||
164349745|NCT00571948|593655425|FG001|Overall Study|Lost to Follow-up|0|||
164349746|NCT00571948|593655424|FG000|Overall Study|Withdrawal by Subject|1|||
164349747|NCT00571948|593655425|FG001|Overall Study|Withdrawal by Subject|2|||
164349748|NCT00571948|593655424|FG000|Overall Study|Protocol Violation|3|||
164349749|NCT00571948|593655425|FG001|Overall Study|Protocol Violation|3|||
164349750|NCT00571948|593655424|FG000|Overall Study|infant refused study meal|3|||
164349751|NCT00571948|593655425|FG001|Overall Study|infant refused study meal|4|||
164349752|NCT00571948|593655424|FG000|Overall Study|Parent were afraid of blood colection|2|||
164349753|NCT00571948|593655425|FG001|Overall Study|Parent were afraid of blood colection|5|||
164349754|NCT01845831|593655427|FG000|Inpatient Phase|Withdrawal by Subject|1|||
164349755|NCT01845831|593655428|FG001|Inpatient Phase|Withdrawal by Subject|1|||
164349756|NCT01845831|593655429|FG002|Inpatient Phase|Withdrawal by Subject|0|||
164349757|NCT01845831|593655430|FG003|Inpatient Phase|Withdrawal by Subject|0|||
164349758|NCT01845831|593655431|FG004|Inpatient Phase|Withdrawal by Subject|0|||
164349759|NCT02010775|593655432|FG000|Overall Study|Adverse Event|0|||
164349760|NCT02010775|593655433|FG001|Overall Study|Adverse Event|0|||
164349761|NCT02010775|593655434|FG002|Overall Study|Adverse Event|0|||
164349762|NCT02010775|593655435|FG003|Overall Study|Adverse Event|0|||
164349763|NCT02010775|593655436|FG004|Overall Study|Adverse Event|1|||
164349764|NCT02010775|593655432|FG000|Overall Study|Pregnancy|0|||
164349765|NCT02010775|593655433|FG001|Overall Study|Pregnancy|0|||
164349766|NCT02010775|593655434|FG002|Overall Study|Pregnancy|2|||
164349767|NCT02010775|593655435|FG003|Overall Study|Pregnancy|0|||
164349768|NCT02010775|593655436|FG004|Overall Study|Pregnancy|0|||
164349769|NCT02010775|593655432|FG000|Overall Study|Lost to Follow-up|2|||
164349770|NCT02010775|593655433|FG001|Overall Study|Lost to Follow-up|0|||
164349771|NCT02010775|593655434|FG002|Overall Study|Lost to Follow-up|0|||
164349772|NCT02010775|593655435|FG003|Overall Study|Lost to Follow-up|1|||
164349773|NCT02010775|593655436|FG004|Overall Study|Lost to Follow-up|1|||
164349774|NCT02010775|593655432|FG000|Overall Study|Personal Reasons|3|||
164349775|NCT02010775|593655433|FG001|Overall Study|Personal Reasons|3|||
164349776|NCT02010775|593655434|FG002|Overall Study|Personal Reasons|1|||
164349777|NCT02010775|593655435|FG003|Overall Study|Personal Reasons|2|||
164349778|NCT02010775|593655436|FG004|Overall Study|Personal Reasons|4|||
164349779|NCT02030041|593655438|FG000|Overall Study|Withdrawal by Subject|2|||
164349780|NCT02030041|593655439|FG001|Overall Study|Withdrawal by Subject|2|||
164349781|NCT02030041|593655440|FG002|Overall Study|Withdrawal by Subject|1|||
164349782|NCT02006719|593655441|FG000|Overall Study|Withdrawal by Subject|10|||
164349783|NCT02006719|593655442|FG001|Overall Study|Withdrawal by Subject|2|||
164349784|NCT02006719|593655441|FG000|Overall Study|Lost to Follow-up|5|||
164349785|NCT02006719|593655442|FG001|Overall Study|Lost to Follow-up|1|||
164349786|NCT02006719|593655441|FG000|Overall Study|Protocol Violation|2|||
164349787|NCT02006719|593655442|FG001|Overall Study|Protocol Violation|0|||
164349788|NCT02006719|593655441|FG000|Overall Study|Adverse Event|1|||
164349789|NCT02006719|593655442|FG001|Overall Study|Adverse Event|1|||
164349790|NCT02006719|593655441|FG000|Overall Study|Other/Unknown|0|||
164349791|NCT02006719|593655442|FG001|Overall Study|Other/Unknown|1|||
164349792|NCT00496054|593655448|FG000|Overall Study|Adverse Event|1|||
164349793|NCT00496054|593655448|FG000|Overall Study|Lost to Follow-up|7|||
164349794|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349795|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
164349796|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349797|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
164349798|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
164349799|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349800|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349801|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349802|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349803|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349804|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349805|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349806|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349807|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349808|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
164349809|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
164349810|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
164349811|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
164349812|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349813|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349814|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349815|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349816|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349817|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349818|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349819|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349820|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349821|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349822|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349823|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
164349824|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349825|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349826|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349827|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
164349828|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349829|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349830|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349831|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349832|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349833|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349834|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349835|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349836|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349837|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349838|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
164349839|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349840|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
164349841|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349842|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349843|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349844|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349845|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349846|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349847|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349848|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349849|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349850|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349851|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349852|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349853|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
164349854|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349855|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349856|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349857|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349858|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
164349859|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349860|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349861|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349862|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349863|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349864|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349865|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349866|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349867|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349868|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
164349869|NCT01737697|593655449|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349870|NCT01737697|593655450|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
164349871|NCT01737697|593655451|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
164349872|NCT01737697|593655452|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
164349873|NCT01737697|593655453|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
164349874|NCT01737697|593655454|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349875|NCT01737697|593655455|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349876|NCT01737697|593655456|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349877|NCT01737697|593655457|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349878|NCT01737697|593655458|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349879|NCT01737697|593655459|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349880|NCT01737697|593655460|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349881|NCT01737697|593655461|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164005603|NCT00785577|592385829|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
164005604|NCT00785577|592385830|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
164005605|NCT00785577|592385831|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
164349882|NCT01737697|593655462|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349883|NCT01737697|593655463|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
164349884|NCT01737697|593655449|FG000|Subacute Phase|Adverse Event|0|||
164349885|NCT01737697|593655450|FG001|Subacute Phase|Adverse Event|0|||
164349886|NCT01737697|593655451|FG002|Subacute Phase|Adverse Event|0|||
164349887|NCT01737697|593655452|FG003|Subacute Phase|Adverse Event|0|||
164349888|NCT01737697|593655453|FG004|Subacute Phase|Adverse Event|0|||
164349889|NCT01737697|593655454|FG005|Subacute Phase|Adverse Event|1|||
164349890|NCT01737697|593655455|FG006|Subacute Phase|Adverse Event|1|||
164349891|NCT01737697|593655456|FG007|Subacute Phase|Adverse Event|1|||
164349892|NCT01737697|593655457|FG008|Subacute Phase|Adverse Event|1|||
164349893|NCT01737697|593655458|FG009|Subacute Phase|Adverse Event|1|||
164349894|NCT01737697|593655459|FG010|Subacute Phase|Adverse Event|4|||
164349895|NCT01737697|593655460|FG011|Subacute Phase|Adverse Event|1|||
164349896|NCT01737697|593655461|FG012|Subacute Phase|Adverse Event|1|||
164349897|NCT01737697|593655462|FG013|Subacute Phase|Adverse Event|0|||
164349898|NCT01737697|593655463|FG014|Subacute Phase|Adverse Event|0|||
164349899|NCT01737697|593655449|FG000|Subacute Phase|Withdrawal by Subject|0|||
164349900|NCT01737697|593655450|FG001|Subacute Phase|Withdrawal by Subject|0|||
164349901|NCT01737697|593655451|FG002|Subacute Phase|Withdrawal by Subject|0|||
164349902|NCT01737697|593655452|FG003|Subacute Phase|Withdrawal by Subject|0|||
164349903|NCT01737697|593655453|FG004|Subacute Phase|Withdrawal by Subject|0|||
164349904|NCT01737697|593655454|FG005|Subacute Phase|Withdrawal by Subject|1|||
164349905|NCT01737697|593655455|FG006|Subacute Phase|Withdrawal by Subject|0|||
164349906|NCT01737697|593655456|FG007|Subacute Phase|Withdrawal by Subject|2|||
164349907|NCT01737697|593655457|FG008|Subacute Phase|Withdrawal by Subject|0|||
164349908|NCT01737697|593655458|FG009|Subacute Phase|Withdrawal by Subject|1|||
164349909|NCT01737697|593655459|FG010|Subacute Phase|Withdrawal by Subject|0|||
164349910|NCT01737697|593655460|FG011|Subacute Phase|Withdrawal by Subject|1|||
164349911|NCT01737697|593655461|FG012|Subacute Phase|Withdrawal by Subject|1|||
164349912|NCT01737697|593655462|FG013|Subacute Phase|Withdrawal by Subject|1|||
164349913|NCT01737697|593655463|FG014|Subacute Phase|Withdrawal by Subject|0|||
164349914|NCT01737697|593655449|FG000|Subacute Phase|Lost to Follow-up|0|||
164349915|NCT01737697|593655450|FG001|Subacute Phase|Lost to Follow-up|0|||
164349916|NCT01737697|593655451|FG002|Subacute Phase|Lost to Follow-up|0|||
164349917|NCT01737697|593655452|FG003|Subacute Phase|Lost to Follow-up|0|||
164349918|NCT01737697|593655453|FG004|Subacute Phase|Lost to Follow-up|0|||
164349919|NCT01737697|593655454|FG005|Subacute Phase|Lost to Follow-up|0|||
164349920|NCT01737697|593655455|FG006|Subacute Phase|Lost to Follow-up|0|||
164349921|NCT01737697|593655456|FG007|Subacute Phase|Lost to Follow-up|0|||
164349922|NCT01737697|593655457|FG008|Subacute Phase|Lost to Follow-up|0|||
164349923|NCT01737697|593655458|FG009|Subacute Phase|Lost to Follow-up|0|||
164349924|NCT01737697|593655459|FG010|Subacute Phase|Lost to Follow-up|0|||
164349925|NCT01737697|593655460|FG011|Subacute Phase|Lost to Follow-up|0|||
164349926|NCT01737697|593655461|FG012|Subacute Phase|Lost to Follow-up|0|||
164349927|NCT01737697|593655462|FG013|Subacute Phase|Lost to Follow-up|0|||
164349928|NCT01737697|593655463|FG014|Subacute Phase|Lost to Follow-up|1|||
164349929|NCT01737697|593655449|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
164349930|NCT01737697|593655450|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
164349931|NCT01737697|593655451|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
164349932|NCT01737697|593655452|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
164349933|NCT01737697|593655453|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
164349934|NCT01737697|593655454|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
164349935|NCT01737697|593655455|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
164349936|NCT01737697|593655456|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
164349937|NCT01737697|593655457|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
164349938|NCT01737697|593655458|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
164349939|NCT01737697|593655459|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
164349940|NCT01737697|593655460|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
164349941|NCT01737697|593655461|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
164349942|NCT01737697|593655462|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
164349943|NCT01737697|593655463|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
164349944|NCT01737697|593655449|FG000|Subacute Phase|Protocol Violation|0|||
164349945|NCT01737697|593655450|FG001|Subacute Phase|Protocol Violation|0|||
164349946|NCT01737697|593655451|FG002|Subacute Phase|Protocol Violation|0|||
164349947|NCT01737697|593655452|FG003|Subacute Phase|Protocol Violation|0|||
164349948|NCT01737697|593655453|FG004|Subacute Phase|Protocol Violation|0|||
164349949|NCT01737697|593655454|FG005|Subacute Phase|Protocol Violation|1|||
164349950|NCT01737697|593655455|FG006|Subacute Phase|Protocol Violation|0|||
164349951|NCT01737697|593655456|FG007|Subacute Phase|Protocol Violation|0|||
164349952|NCT01737697|593655457|FG008|Subacute Phase|Protocol Violation|0|||
164349953|NCT01737697|593655458|FG009|Subacute Phase|Protocol Violation|0|||
164349954|NCT01737697|593655459|FG010|Subacute Phase|Protocol Violation|1|||
164349955|NCT01737697|593655460|FG011|Subacute Phase|Protocol Violation|0|||
164349956|NCT01737697|593655461|FG012|Subacute Phase|Protocol Violation|0|||
164349957|NCT01737697|593655462|FG013|Subacute Phase|Protocol Violation|0|||
164349958|NCT01737697|593655463|FG014|Subacute Phase|Protocol Violation|0|||
164349959|NCT01737697|593655449|FG000|Subacute Phase|Physician Decision|0|||
164349960|NCT01737697|593655450|FG001|Subacute Phase|Physician Decision|0|||
164349961|NCT01737697|593655451|FG002|Subacute Phase|Physician Decision|0|||
164349962|NCT01737697|593655452|FG003|Subacute Phase|Physician Decision|0|||
164349963|NCT01737697|593655453|FG004|Subacute Phase|Physician Decision|0|||
164349964|NCT01737697|593655454|FG005|Subacute Phase|Physician Decision|0|||
164349965|NCT01737697|593655455|FG006|Subacute Phase|Physician Decision|0|||
164349966|NCT01737697|593655456|FG007|Subacute Phase|Physician Decision|0|||
164349967|NCT01737697|593655457|FG008|Subacute Phase|Physician Decision|1|||
164349968|NCT01737697|593655458|FG009|Subacute Phase|Physician Decision|0|||
164349969|NCT01737697|593655459|FG010|Subacute Phase|Physician Decision|0|||
164349970|NCT01737697|593655460|FG011|Subacute Phase|Physician Decision|0|||
164349971|NCT01737697|593655461|FG012|Subacute Phase|Physician Decision|0|||
164349972|NCT01737697|593655462|FG013|Subacute Phase|Physician Decision|0|||
164349973|NCT01737697|593655463|FG014|Subacute Phase|Physician Decision|0|||
164349974|NCT01737697|593655449|FG000|Subacute Phase|Death|0|||
164349975|NCT01737697|593655450|FG001|Subacute Phase|Death|0|||
164349976|NCT01737697|593655451|FG002|Subacute Phase|Death|0|||
164349977|NCT01737697|593655452|FG003|Subacute Phase|Death|0|||
164349978|NCT01737697|593655453|FG004|Subacute Phase|Death|0|||
164349979|NCT01737697|593655454|FG005|Subacute Phase|Death|0|||
164349980|NCT01737697|593655455|FG006|Subacute Phase|Death|0|||
164349981|NCT01737697|593655456|FG007|Subacute Phase|Death|0|||
164349982|NCT01737697|593655457|FG008|Subacute Phase|Death|0|||
164349983|NCT01737697|593655458|FG009|Subacute Phase|Death|0|||
164349984|NCT01737697|593655459|FG010|Subacute Phase|Death|1|||
164349985|NCT01737697|593655460|FG011|Subacute Phase|Death|0|||
164349986|NCT01737697|593655461|FG012|Subacute Phase|Death|0|||
164349987|NCT01737697|593655462|FG013|Subacute Phase|Death|0|||
164349988|NCT01737697|593655463|FG014|Subacute Phase|Death|0|||
164349989|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
164349990|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
164349991|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
164349992|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349993|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349994|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349995|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349996|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349997|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349998|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164349999|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
164350000|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
164350001|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350002|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
164350003|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350004|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350005|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350006|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350007|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350008|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350009|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350010|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
164350011|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
164350012|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
164350013|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
164350014|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350015|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350016|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350017|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350018|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350019|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350020|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350021|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
164350022|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
164350023|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
164350024|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350025|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350026|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350027|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
163898974|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
163898975|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
163898976|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
163898977|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
164350028|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350029|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350030|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350031|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350032|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
164350033|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
164350034|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
164350035|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
164350036|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350037|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350038|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350039|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350040|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350041|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350042|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350043|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
164350044|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350045|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
164350046|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
164350047|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350048|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350049|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350050|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350051|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350052|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350053|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350054|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
164350055|NCT02207244|593655464|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350056|NCT02207244|593655465|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
164350057|NCT02207244|593655466|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350058|NCT02207244|593655467|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350059|NCT02207244|593655468|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350060|NCT02207244|593655469|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350061|NCT02207244|593655470|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350062|NCT02207244|593655471|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350063|NCT02207244|593655472|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350064|NCT02207244|593655473|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350065|NCT02207244|593655474|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
164350066|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350067|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350068|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350069|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350070|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
164350071|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
164350072|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350073|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350074|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350075|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350076|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
164350077|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350078|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350079|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350080|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350081|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350082|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
164350083|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350084|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350085|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350086|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350087|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
164350088|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350089|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350090|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350091|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
164350092|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
164350093|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
164350094|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350095|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350096|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
163898978|NCT04505722|592002100|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
164350097|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350098|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
164350099|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350100|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350101|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350102|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
164350103|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
164350104|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
164350105|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350106|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350107|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350108|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350109|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
164350110|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350111|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350112|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350113|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
164350114|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350115|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
164350116|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350117|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350118|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350119|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350120|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
164350121|NCT02207244|593655464|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350122|NCT02207244|593655465|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350123|NCT02207244|593655466|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350124|NCT02207244|593655467|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
164350125|NCT02207244|593655468|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350126|NCT02207244|593655469|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350127|NCT02207244|593655470|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350128|NCT02207244|593655471|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350129|NCT02207244|593655472|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350130|NCT02207244|593655473|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350131|NCT02207244|593655474|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
164350132|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350133|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350134|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350135|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350136|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350137|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350138|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
164350139|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
164350140|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
164350141|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
164350142|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
164350143|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350144|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350145|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350146|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350147|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350148|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350149|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350150|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
164350151|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350152|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350153|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
164350154|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350155|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350156|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350157|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350158|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350159|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350160|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
164350161|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
164089754|NCT00797108|592691472|FG001|Overall Study|Other|0|||
164350162|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
164350163|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
164350164|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
164350165|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350166|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350167|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350168|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350169|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350170|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350171|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
164350172|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
164350173|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350174|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
164350175|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
164350176|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350177|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350178|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350179|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350180|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350181|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350182|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
164350183|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
164350184|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
164350185|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
164350186|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
164350187|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350188|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350189|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350190|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350191|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350192|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350193|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350194|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
164350195|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
164350196|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350197|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
164350198|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350199|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350200|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350201|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350202|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350203|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350204|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350205|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350206|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
164350207|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350208|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
164350209|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350210|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350211|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350212|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350213|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350214|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350215|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350216|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
164350217|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350218|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350219|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
164350220|NCT02207244|593655464|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350221|NCT02207244|593655465|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350222|NCT02207244|593655466|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350223|NCT02207244|593655467|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350224|NCT02207244|593655468|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350225|NCT02207244|593655469|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350226|NCT02207244|593655470|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
164350227|NCT02207244|593655471|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350228|NCT02207244|593655472|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350229|NCT02207244|593655473|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350230|NCT02207244|593655474|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
164350231|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350232|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350233|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350234|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350235|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350236|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350237|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350238|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350239|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
164350240|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
164350241|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
164350242|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350243|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350244|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
163898979|NCT04505722|592002101|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
163898980|NCT04505722|592002102|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
164350245|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350246|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350247|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350248|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350249|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350250|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
164350251|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
164350252|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
164350253|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350254|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350255|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350256|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350257|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350258|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350259|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350260|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350261|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
164350262|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
164350263|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
164350264|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350265|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350266|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350267|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350268|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350269|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350270|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350271|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350272|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
164350273|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
164350274|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
164350275|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
164350276|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
164350277|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
164350278|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
163898981|NCT03473223|592002103|FG000|Overall Study|Lost to Follow-up|1|||
164089755|NCT00797108|592691473|FG002|Overall Study|Other|2|||
164089756|NCT00797108|592691471|FG000|Overall Study|Randomized but not Treated|2|||
164350279|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
164350280|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
164350281|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
164350282|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
164350283|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
164350284|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
164350285|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
163898982|NCT03473223|592002104|FG001|Overall Study|Lost to Follow-up|1|||
164350286|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
164350287|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
164350288|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
164350289|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
164350290|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
164350291|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
164350292|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
164350293|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
164350294|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
164350295|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
164350296|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
164350297|NCT02207244|593655464|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350298|NCT02207244|593655465|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350299|NCT02207244|593655466|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350300|NCT02207244|593655467|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350301|NCT02207244|593655468|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350302|NCT02207244|593655469|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350303|NCT02207244|593655470|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350304|NCT02207244|593655471|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350305|NCT02207244|593655472|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350306|NCT02207244|593655473|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
164350307|NCT02207244|593655474|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
164350308|NCT01866930|593655477|FG000|Treatment Period|Other|1|||
164350309|NCT01866930|593655478|FG001|Treatment Period|Other|0|||
164350310|NCT01866930|593655477|FG000|Treatment Period|Death|0|||
164350311|NCT01866930|593655478|FG001|Treatment Period|Death|2|||
164350312|NCT01866930|593655477|FG000|Treatment Period|Poor/non compliance|0|||
164350313|NCT01866930|593655478|FG001|Treatment Period|Poor/non compliance|2|||
164350314|NCT01866930|593655477|FG000|Treatment Period|No longer meets study criteria|0|||
164350315|NCT01866930|593655478|FG001|Treatment Period|No longer meets study criteria|1|||
164350316|NCT01866930|593655477|FG000|Treatment Period|Withdrawal by Subject|2|||
164350317|NCT01866930|593655478|FG001|Treatment Period|Withdrawal by Subject|8|||
164350318|NCT01866930|593655477|FG000|Treatment Period|Lack of Efficacy|1|||
164350319|NCT01866930|593655478|FG001|Treatment Period|Lack of Efficacy|9|||
164350320|NCT01866930|593655477|FG000|Treatment Period|Adverse Event|4|||
164350321|NCT01866930|593655478|FG001|Treatment Period|Adverse Event|12|||
164350322|NCT01866930|593655477|FG000|Treatment Period|Lost to Follow-up|1|||
164350323|NCT01866930|593655478|FG001|Treatment Period|Lost to Follow-up|1|||
164350324|NCT01866930|593655477|FG000|Follow-up Period|Lost to Follow-up|1|||
164350325|NCT01866930|593655478|FG001|Follow-up Period|Lost to Follow-up|1|||
164350326|NCT01866930|593655477|FG000|Follow-up Period|Other|1|||
164350327|NCT01866930|593655478|FG001|Follow-up Period|Other|5|||
164350328|NCT01866930|593655477|FG000|Follow-up Period|No longer required per protocol|1|||
164350329|NCT01866930|593655478|FG001|Follow-up Period|No longer required per protocol|0|||
164350330|NCT01866930|593655477|FG000|Follow-up Period|Withdrawal by Subject|3|||
164350331|NCT01866930|593655478|FG001|Follow-up Period|Withdrawal by Subject|3|||
164350332|NCT00471328|593655483|FG000|Core Phase|Adverse Event|18|||
164350333|NCT00471328|593655484|FG001|Core Phase|Adverse Event|6|||
164350334|NCT00471328|593655483|FG000|Core Phase|Death|8|||
164350335|NCT00471328|593655484|FG001|Core Phase|Death|4|||
164350336|NCT00471328|593655483|FG000|Core Phase|Withdrawal by Subject|2|||
164350337|NCT00471328|593655484|FG001|Core Phase|Withdrawal by Subject|2|||
164350338|NCT00471328|593655483|FG000|Core Phase|Abnormal laboratory value|1|||
164350339|NCT00471328|593655484|FG001|Core Phase|Abnormal laboratory value|0|||
164350340|NCT00471328|593655483|FG000|Core Phase|Disease Progression|78|||
164350341|NCT00471328|593655484|FG001|Core Phase|Disease Progression|53|||
164350342|NCT00471328|593655483|FG000|Core Phase|Administrative Problem|0|||
163898983|NCT03473223|592002103|FG000|Overall Study|Withdrawal by Subject|47|||
163898984|NCT03473223|592002104|FG001|Overall Study|Withdrawal by Subject|42|||
163898985|NCT03473223|592002103|FG000|Overall Study|Indirect contact|32|||
163898986|NCT03473223|592002104|FG001|Overall Study|Indirect contact|29|||
163898987|NCT03473223|592002103|FG000|Overall Study|Other (Not specified)|32|||
163898988|NCT03473223|592002104|FG001|Overall Study|Other (Not specified)|20|||
163898989|NCT04755595|592002105|FG000|Overall Study|Lost to Follow-up|1|||
163898990|NCT02549352|592002109|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
163898991|NCT02549352|592002110|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
163898992|NCT02549352|592002109|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
163898993|NCT02549352|592002110|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
163898994|NCT02549352|592002109|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
163898995|NCT02549352|592002110|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
163898996|NCT02549352|592002109|FG000|12-month Follow-up|Withdrawal by Subject|4|||
163898997|NCT02549352|592002110|FG001|12-month Follow-up|Withdrawal by Subject|5|||
163898998|NCT02549352|592002109|FG000|12-month Follow-up|Lost to Follow-up|3|||
163898999|NCT02549352|592002110|FG001|12-month Follow-up|Lost to Follow-up|2|||
164350343|NCT00471328|593655484|FG001|Core Phase|Administrative Problem|1|||
164350344|NCT00471328|593655483|FG000|Core Phase|Protocol Deviation|0|||
164350345|NCT00471328|593655484|FG001|Core Phase|Protocol Deviation|1|||
164350346|NCT00471328|593655483|FG000|Extension Phase|Adverse Event|3|||
164350347|NCT00471328|593655484|FG001|Extension Phase|Adverse Event|12|||
164350348|NCT00471328|593655483|FG000|Extension Phase|Withdrawal by Subject|0|||
164350349|NCT00471328|593655484|FG001|Extension Phase|Withdrawal by Subject|2|||
164350350|NCT00471328|593655483|FG000|Extension Phase|Death|1|||
164350351|NCT00471328|593655484|FG001|Extension Phase|Death|7|||
164350352|NCT00471328|593655483|FG000|Extension Phase|Protocol Deviation|3|||
164350353|NCT00471328|593655484|FG001|Extension Phase|Protocol Deviation|1|||
164350354|NCT00471328|593655483|FG000|Extension Phase|Treatment duration as per protocol|0|||
164350355|NCT00471328|593655484|FG001|Extension Phase|Treatment duration as per protocol|1|||
164350356|NCT00471328|593655483|FG000|Extension Phase|Disease Progression|32|||
164350357|NCT00471328|593655484|FG001|Extension Phase|Disease Progression|44|||
164350358|NCT00471328|593655483|FG000|Extension Phase|New cancer Therapy|1|||
164350359|NCT00471328|593655484|FG001|Extension Phase|New cancer Therapy|0|||
164350360|NCT00471328|593655483|FG000|Extension Phase|Administrative Problem|1|||
164350361|NCT00471328|593655484|FG001|Extension Phase|Administrative Problem|0|||
164350362|NCT02854631|593655485|FG000|Overall Study|Adverse Event|1|||
164350363|NCT02854631|593655486|FG001|Overall Study|Adverse Event|2|||
164350364|NCT02854631|593655485|FG000|Overall Study|Withdrew Consent|3|||
164350365|NCT02854631|593655486|FG001|Overall Study|Withdrew Consent|2|||
164350366|NCT02854631|593655485|FG000|Overall Study|Investigator's Discretion|2|||
164350367|NCT02854631|593655486|FG001|Overall Study|Investigator's Discretion|0|||
164350368|NCT02854631|593655485|FG000|Overall Study|Death|12|||
164350369|NCT02854631|593655486|FG001|Overall Study|Death|8|||
164350370|NCT02854631|593655485|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
164350371|NCT02854631|593655486|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
164350372|NCT02854631|593655485|FG000|Overall Study|Protocol Violation|0|||
164350373|NCT02854631|593655486|FG001|Overall Study|Protocol Violation|1|||
164350374|NCT02854631|593655485|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
164350375|NCT02854631|593655486|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
164350376|NCT02854631|593655485|FG000|Overall Study|Lost to Follow-up|4|||
164350377|NCT02854631|593655486|FG001|Overall Study|Lost to Follow-up|2|||
164350378|NCT03930797|593655487|FG000|Overall Study|Lost to Follow-up|3|||
164350379|NCT03930797|593655488|FG001|Overall Study|Lost to Follow-up|10|||
164350380|NCT03727347|593655493|FG000|Overall Study|Withdrawal by Subject|2|||
164350381|NCT03727347|593655493|FG000|Overall Study|Lost to Follow-up|1|||
164350382|NCT04292743|593655494|FG000|Overall Study|Physician Decision|1|||
164350383|NCT04292743|593655495|FG001|Overall Study|Physician Decision|3|||
164350384|NCT04292743|593655496|FG002|Overall Study|Physician Decision|0|||
164350385|NCT04292743|593655497|FG003|Overall Study|Physician Decision|0|||
164350386|NCT04292743|593655494|FG000|Overall Study|Withdrawal by Subject|0|||
164350387|NCT04292743|593655495|FG001|Overall Study|Withdrawal by Subject|5|||
164350388|NCT04292743|593655496|FG002|Overall Study|Withdrawal by Subject|0|||
164350389|NCT04292743|593655497|FG003|Overall Study|Withdrawal by Subject|0|||
164350390|NCT04292743|593655494|FG000|Overall Study|Death|0|||
164350391|NCT04292743|593655495|FG001|Overall Study|Death|1|||
164350392|NCT04292743|593655496|FG002|Overall Study|Death|0|||
164350393|NCT04292743|593655497|FG003|Overall Study|Death|0|||
164350394|NCT04292743|593655494|FG000|Overall Study|Progression of Disease|2|||
164350395|NCT04292743|593655495|FG001|Overall Study|Progression of Disease|5|||
164350396|NCT04292743|593655496|FG002|Overall Study|Progression of Disease|0|||
164350397|NCT04292743|593655497|FG003|Overall Study|Progression of Disease|0|||
164350398|NCT04292743|593655494|FG000|Overall Study|No Treatment per protocol|0|||
164350399|NCT04292743|593655495|FG001|Overall Study|No Treatment per protocol|2|||
164350400|NCT04292743|593655496|FG002|Overall Study|No Treatment per protocol|0|||
164350401|NCT04292743|593655497|FG003|Overall Study|No Treatment per protocol|0|||
164350402|NCT05330702|593655498|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
164350403|NCT05330702|593655499|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
164005606|NCT00785577|592385832|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
164005607|NCT00785577|592385833|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
164005608|NCT01919411|592385834|FG000|Overall Study|Lost to Follow-up|2|||
164005609|NCT01919411|592385835|FG001|Overall Study|Lost to Follow-up|4|||
164005610|NCT01919411|592385834|FG000|Overall Study|Physician Decision|1|||
164350404|NCT05330702|593655500|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
164350405|NCT02881554|593655501|FG000|Overall Study|Withdrawal by Subject|2|||
164350406|NCT02881554|593655502|FG001|Overall Study|Withdrawal by Subject|0|||
164350407|NCT01852110|593657486|FG000|Overall Study|Adverse Event|12|||
164350408|NCT01852110|593657487|FG001|Overall Study|Adverse Event|5|||
164350409|NCT01852110|593657488|FG002|Overall Study|Adverse Event|0|||
164350410|NCT01852110|593657489|FG003|Overall Study|Adverse Event|0|||
164350411|NCT01852110|593657490|FG004|Overall Study|Adverse Event|0|||
164350412|NCT01852110|593657491|FG005|Overall Study|Adverse Event|0|||
164350413|NCT01852110|593657486|FG000|Overall Study|Lost to Follow-up|1|||
164350414|NCT01852110|593657487|FG001|Overall Study|Lost to Follow-up|3|||
164350415|NCT01852110|593657488|FG002|Overall Study|Lost to Follow-up|0|||
164350416|NCT01852110|593657489|FG003|Overall Study|Lost to Follow-up|0|||
164350417|NCT01852110|593657490|FG004|Overall Study|Lost to Follow-up|0|||
164350418|NCT01852110|593657491|FG005|Overall Study|Lost to Follow-up|0|||
163899000|NCT02549352|592002109|FG000|12-month Follow-up|Death|0|||
164350419|NCT01852110|593657486|FG000|Overall Study|Non-compliance with Study Drug|2|||
164350420|NCT01852110|593657487|FG001|Overall Study|Non-compliance with Study Drug|1|||
164350421|NCT01852110|593657488|FG002|Overall Study|Non-compliance with Study Drug|0|||
164350422|NCT01852110|593657489|FG003|Overall Study|Non-compliance with Study Drug|0|||
164350423|NCT01852110|593657490|FG004|Overall Study|Non-compliance with Study Drug|0|||
164350424|NCT01852110|593657491|FG005|Overall Study|Non-compliance with Study Drug|0|||
164350425|NCT01852110|593657486|FG000|Overall Study|Physician Decision|1|||
164350426|NCT01852110|593657487|FG001|Overall Study|Physician Decision|0|||
164350427|NCT01852110|593657488|FG002|Overall Study|Physician Decision|0|||
164350428|NCT01852110|593657489|FG003|Overall Study|Physician Decision|0|||
164350429|NCT01852110|593657490|FG004|Overall Study|Physician Decision|0|||
164350430|NCT01852110|593657491|FG005|Overall Study|Physician Decision|0|||
164350431|NCT01852110|593657486|FG000|Overall Study|Protocol Violation|0|||
164350432|NCT01852110|593657487|FG001|Overall Study|Protocol Violation|1|||
164350433|NCT01852110|593657488|FG002|Overall Study|Protocol Violation|0|||
164350434|NCT01852110|593657489|FG003|Overall Study|Protocol Violation|0|||
164350435|NCT01852110|593657490|FG004|Overall Study|Protocol Violation|0|||
164350436|NCT01852110|593657491|FG005|Overall Study|Protocol Violation|0|||
164350437|NCT01852110|593657486|FG000|Overall Study|Study Terminated by Sponsor|30|||
164350438|NCT01852110|593657487|FG001|Overall Study|Study Terminated by Sponsor|32|||
164350439|NCT01852110|593657488|FG002|Overall Study|Study Terminated by Sponsor|0|||
164350440|NCT01852110|593657489|FG003|Overall Study|Study Terminated by Sponsor|0|||
164350441|NCT01852110|593657490|FG004|Overall Study|Study Terminated by Sponsor|0|||
164350442|NCT01852110|593657491|FG005|Overall Study|Study Terminated by Sponsor|0|||
164350443|NCT01852110|593657486|FG000|Overall Study|Withdrawal by Subject|4|||
164350444|NCT01852110|593657487|FG001|Overall Study|Withdrawal by Subject|4|||
164350445|NCT01852110|593657488|FG002|Overall Study|Withdrawal by Subject|0|||
164350446|NCT01852110|593657489|FG003|Overall Study|Withdrawal by Subject|0|||
164350447|NCT01852110|593657490|FG004|Overall Study|Withdrawal by Subject|0|||
164350448|NCT01852110|593657491|FG005|Overall Study|Withdrawal by Subject|0|||
164350449|NCT01549860|593657497|FG000|Overall Study|Withdrawal by Subject|1|||
164350450|NCT01549860|593657498|FG001|Overall Study|Withdrawal by Subject|0|||
164350451|NCT01549860|593657497|FG000|Overall Study|Physician Decision|1|||
164350452|NCT01549860|593657498|FG001|Overall Study|Physician Decision|1|||
164350453|NCT01366521|593657500|FG000|Overall Study|Adverse Event|1|||
164350454|NCT01366521|593657501|FG001|Overall Study|Adverse Event|0|||
164350455|NCT01366521|593657502|FG002|Overall Study|Adverse Event|0|||
164350456|NCT01366521|593657503|FG003|Overall Study|Adverse Event|0|||
164350457|NCT01366521|593657500|FG000|Overall Study|Protocol Violation|0|||
164350458|NCT01366521|593657501|FG001|Overall Study|Protocol Violation|0|||
164350459|NCT01366521|593657502|FG002|Overall Study|Protocol Violation|1|||
164350460|NCT01366521|593657503|FG003|Overall Study|Protocol Violation|0|||
164350461|NCT01366521|593657500|FG000|Overall Study|Physician Decision|0|||
164350462|NCT01366521|593657501|FG001|Overall Study|Physician Decision|0|||
164350463|NCT01366521|593657502|FG002|Overall Study|Physician Decision|1|||
164350464|NCT01366521|593657503|FG003|Overall Study|Physician Decision|0|||
164350465|NCT01366521|593657500|FG000|Overall Study|Withdrawal by Subject|0|||
164350466|NCT01366521|593657501|FG001|Overall Study|Withdrawal by Subject|1|||
164350467|NCT01366521|593657502|FG002|Overall Study|Withdrawal by Subject|0|||
164350468|NCT01366521|593657503|FG003|Overall Study|Withdrawal by Subject|0|||
164350469|NCT02430311|593657504|FG000|Part A|Adverse Event|0|||
164350470|NCT02430311|593657505|FG001|Part A|Adverse Event|1|||
164350471|NCT02430311|593657504|FG000|Part A|Withdrawal by Subject|1|||
164350472|NCT02430311|593657505|FG001|Part A|Withdrawal by Subject|0|||
164350473|NCT02430311|593657504|FG000|Part B|Meet study-specific withdrawal criteria|6|||
164350474|NCT02430311|593657505|FG001|Part B|Meet study-specific withdrawal criteria|6|||
164350475|NCT02430311|593657504|FG000|Part B|Withdrawal by Subject|2|||
164350476|NCT02430311|593657505|FG001|Part B|Withdrawal by Subject|2|||
164350477|NCT02430311|593657504|FG000|Part B|Adverse Event|1|||
164350478|NCT02430311|593657505|FG001|Part B|Adverse Event|0|||
164350479|NCT02430311|593657504|FG000|Part B|Death|1|||
164350480|NCT02430311|593657505|FG001|Part B|Death|0|||
164350481|NCT00578812|593657506|FG000|Overall Study|Not treated|6|||
164350482|NCT00578812|593657507|FG001|Overall Study|Not treated|7|||
164350483|NCT00166114|593657522|FG000|Overall Study|Protocol Violation|2|||
164350484|NCT00166114|593657523|FG001|Overall Study|Protocol Violation|1|||
164350485|NCT00166114|593657522|FG000|Overall Study|Withdrawal by Subject|10|||
164350486|NCT00166114|593657523|FG001|Overall Study|Withdrawal by Subject|4|||
164350487|NCT00166114|593657522|FG000|Overall Study|Adverse Event|2|||
164350488|NCT00166114|593657523|FG001|Overall Study|Adverse Event|1|||
164350489|NCT02708121|593657530|FG000|Overall Study|Withdrawn by Study Team|1|||
164350490|NCT02708121|593657531|FG001|Overall Study|Withdrawn by Study Team|1|||
164350491|NCT02708121|593657530|FG000|Overall Study|Withdrawal by Subject|0|||
164350492|NCT02708121|593657531|FG001|Overall Study|Withdrawal by Subject|4|||
163899001|NCT02549352|592002110|FG001|12-month Follow-up|Death|1|||
164350493|NCT03266107|593657532|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
164350494|NCT03266107|593657532|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
163899002|NCT02549352|592002109|FG000|12-month Follow-up|Protocol Violation|0|||
163899003|NCT02549352|592002110|FG001|12-month Follow-up|Protocol Violation|1|||
163899004|NCT02549352|592002109|FG000|12-month Follow-up|Other|1|||
163899005|NCT02549352|592002110|FG001|12-month Follow-up|Other|3|||
163899006|NCT02291913|592002780|FG000|Overall Study|Progressive Disease|32|||
163899007|NCT02291913|592002780|FG000|Overall Study|Adverse Event|11|||
163899008|NCT02291913|592002780|FG000|Overall Study|Death|2|||
163899009|NCT02291913|592002780|FG000|Overall Study|Physician Decision|1|||
163899010|NCT02291913|592002780|FG000|Overall Study|Withdrawal by Subject|1|||
163899011|NCT02291913|592002780|FG000|Overall Study|Protocol Violation|1|||
163899012|NCT04876417|592002781|FG000|Overall Study|Lost to Follow-up|5|||
163899013|NCT04876417|592002782|FG001|Overall Study|Lost to Follow-up|8|||
163899014|NCT04876417|592002783|FG002|Overall Study|Lost to Follow-up|0|||
163899015|NCT04876417|592002784|FG003|Overall Study|Lost to Follow-up|0|||
163899016|NCT04334317|592002785|FG000|Overall Study|Adverse Event|1|||
163899017|NCT04334317|592002786|FG001|Overall Study|Adverse Event|2|||
163899018|NCT04334317|592002787|FG002|Overall Study|Adverse Event|0|||
163899019|NCT04334317|592002788|FG003|Overall Study|Adverse Event|0|||
163899020|NCT04334317|592002785|FG000|Overall Study|Protocol Deviation|0|||
163899021|NCT04334317|592002786|FG001|Overall Study|Protocol Deviation|1|||
163899022|NCT04334317|592002787|FG002|Overall Study|Protocol Deviation|0|||
163899023|NCT04334317|592002788|FG003|Overall Study|Protocol Deviation|0|||
163899024|NCT04334317|592002785|FG000|Overall Study|Withdrawal by Subject|2|||
163899025|NCT04334317|592002786|FG001|Overall Study|Withdrawal by Subject|2|||
163899026|NCT04334317|592002787|FG002|Overall Study|Withdrawal by Subject|0|||
163899027|NCT04334317|592002788|FG003|Overall Study|Withdrawal by Subject|0|||
163899028|NCT03621735|592002789|FG000|Overall Study|Withdrawal by Subject|13|||
163899029|NCT03621735|592002790|FG001|Overall Study|Withdrawal by Subject|13|||
163899030|NCT00605306|592002793|FG000|Overall Study|Adverse Event|0|||
163899031|NCT00605306|592002794|FG001|Overall Study|Adverse Event|1|||
163899032|NCT03875313|592002797|FG000|Overall Study|Withdrawal by Subject|1|||
163899033|NCT03875313|592002798|FG001|Overall Study|Withdrawal by Subject|3|||
163899034|NCT03875313|592002799|FG002|Overall Study|Withdrawal by Subject|0|||
163899035|NCT03875313|592002800|FG003|Overall Study|Withdrawal by Subject|0|||
163899036|NCT03875313|592002801|FG004|Overall Study|Withdrawal by Subject|0|||
163899037|NCT03875313|592002797|FG000|Overall Study|Death|0|||
163899038|NCT03875313|592002798|FG001|Overall Study|Death|0|||
163899039|NCT03875313|592002799|FG002|Overall Study|Death|0|||
163899040|NCT03875313|592002800|FG003|Overall Study|Death|0|||
163899041|NCT03875313|592002801|FG004|Overall Study|Death|1|||
163899042|NCT03875313|592002797|FG000|Overall Study|Lost to Follow-up|0|||
163899043|NCT03875313|592002798|FG001|Overall Study|Lost to Follow-up|0|||
163899044|NCT03875313|592002799|FG002|Overall Study|Lost to Follow-up|0|||
163899045|NCT03875313|592002800|FG003|Overall Study|Lost to Follow-up|0|||
163899046|NCT03875313|592002801|FG004|Overall Study|Lost to Follow-up|1|||
163899047|NCT03875313|592002797|FG000|Overall Study|Study Termination by Sponsor|0|||
163899048|NCT03875313|592002798|FG001|Overall Study|Study Termination by Sponsor|1|||
163899049|NCT03875313|592002799|FG002|Overall Study|Study Termination by Sponsor|1|||
163899050|NCT03875313|592002800|FG003|Overall Study|Study Termination by Sponsor|0|||
163899051|NCT03875313|592002801|FG004|Overall Study|Study Termination by Sponsor|1|||
163899052|NCT03875313|592002797|FG000|Overall Study|New Anticancer Treatment|0|||
164350495|NCT03266107|593657532|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
164350496|NCT03266107|593657532|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
164350497|NCT02548650|593657535|FG000|Triple Therapy|Adverse Event|1|||
164350498|NCT02548650|593657536|FG001|Triple Therapy|Adverse Event|0|||
164350499|NCT02548650|593657535|FG000|Triple Therapy|Withdrawal by Subject|0|||
164350500|NCT02548650|593657536|FG001|Triple Therapy|Withdrawal by Subject|4|||
164350501|NCT02548650|593657535|FG000|Double Therapy|Adverse Event|1|||
164350502|NCT02548650|593657536|FG001|Double Therapy|Adverse Event|1|||
164350503|NCT02548650|593657535|FG000|Double Therapy|Withdrawal by Subject|0|||
164350504|NCT02548650|593657536|FG001|Double Therapy|Withdrawal by Subject|1|||
164350505|NCT01191801|593657537|FG000|Overall Study|Death|36|||
163899053|NCT03875313|592002798|FG001|Overall Study|New Anticancer Treatment|1|||
164350506|NCT01191801|593657538|FG001|Overall Study|Death|12|||
163899054|NCT03875313|592002799|FG002|Overall Study|New Anticancer Treatment|2|||
163899055|NCT03875313|592002800|FG003|Overall Study|New Anticancer Treatment|1|||
163899056|NCT03875313|592002801|FG004|Overall Study|New Anticancer Treatment|0|||
164350507|NCT01191801|593657537|FG000|Overall Study|Lack of Efficacy|176|||
164350508|NCT01191801|593657538|FG001|Overall Study|Lack of Efficacy|258|||
163899057|NCT03875313|592002797|FG000|Overall Study|Other, Not Specified|2|||
163899058|NCT03875313|592002798|FG001|Overall Study|Other, Not Specified|11|||
163899059|NCT03875313|592002799|FG002|Overall Study|Other, Not Specified|3|||
163899060|NCT03875313|592002800|FG003|Overall Study|Other, Not Specified|3|||
163899061|NCT03875313|592002801|FG004|Overall Study|Other, Not Specified|1|||
164005611|NCT01919411|592385835|FG001|Overall Study|Physician Decision|0|||
164005612|NCT01919411|592385834|FG000|Overall Study|Protocol Violation|2|||
164350509|NCT01191801|593657537|FG000|Overall Study|Adverse Event|9|||
164350510|NCT01191801|593657538|FG001|Overall Study|Adverse Event|8|||
164350511|NCT01191801|593657537|FG000|Overall Study|Protocol Violation|2|||
164350512|NCT01191801|593657538|FG001|Overall Study|Protocol Violation|4|||
164350513|NCT01191801|593657537|FG000|Overall Study|Physician Decision|47|||
164350514|NCT01191801|593657538|FG001|Overall Study|Physician Decision|24|||
164350515|NCT01191801|593657537|FG000|Overall Study|Withdrawal by Subject|1|||
164350516|NCT01191801|593657538|FG001|Overall Study|Withdrawal by Subject|4|||
164350517|NCT01191801|593657537|FG000|Overall Study|Not Provided|45|||
164350518|NCT01191801|593657538|FG001|Overall Study|Not Provided|27|||
164350519|NCT00299104|593657539|FG000|Treatment Period|Adverse Event|14|||
164350520|NCT00299104|593657540|FG001|Treatment Period|Adverse Event|9|||
164350521|NCT00299104|593657541|FG002|Treatment Period|Adverse Event|7|||
164350522|NCT00299104|593657539|FG000|Treatment Period|Death|1|||
164350523|NCT00299104|593657540|FG001|Treatment Period|Death|1|||
164350524|NCT00299104|593657541|FG002|Treatment Period|Death|1|||
164350525|NCT00299104|593657539|FG000|Treatment Period|Insufficient therapeutic response|34|||
164350526|NCT00299104|593657540|FG001|Treatment Period|Insufficient therapeutic response|13|||
164350527|NCT00299104|593657541|FG002|Treatment Period|Insufficient therapeutic response|8|||
164350528|NCT00299104|593657539|FG000|Treatment Period|Failure to return|9|||
164350529|NCT00299104|593657540|FG001|Treatment Period|Failure to return|8|||
164350530|NCT00299104|593657541|FG002|Treatment Period|Failure to return|8|||
164350531|NCT00299104|593657539|FG000|Treatment Period|Violation of selection criteria|1|||
164350532|NCT00299104|593657540|FG001|Treatment Period|Violation of selection criteria|2|||
164350533|NCT00299104|593657541|FG002|Treatment Period|Violation of selection criteria|0|||
164350534|NCT00299104|593657539|FG000|Treatment Period|Protocol Violation|1|||
164350535|NCT00299104|593657540|FG001|Treatment Period|Protocol Violation|1|||
164350536|NCT00299104|593657541|FG002|Treatment Period|Protocol Violation|0|||
164350537|NCT00299104|593657539|FG000|Treatment Period|Refused treatment|9|||
164350538|NCT00299104|593657540|FG001|Treatment Period|Refused treatment|2|||
164350539|NCT00299104|593657541|FG002|Treatment Period|Refused treatment|2|||
164350540|NCT00299104|593657539|FG000|Treatment Period|Withdrew consent|14|||
164350541|NCT00299104|593657540|FG001|Treatment Period|Withdrew consent|19|||
164350542|NCT00299104|593657541|FG002|Treatment Period|Withdrew consent|9|||
164350543|NCT00299104|593657539|FG000|Treatment Period|Administrative reasons|106|||
164350544|NCT00299104|593657540|FG001|Treatment Period|Administrative reasons|120|||
164350545|NCT00299104|593657541|FG002|Treatment Period|Administrative reasons|137|||
164350546|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Death|3|||
164350547|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Death|2|||
164350548|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Death|1|||
164350549|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
164350550|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
164350551|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
164350552|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
164350553|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
164350554|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
164350555|NCT00299104|593657539|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
164350556|NCT00299104|593657540|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
164350557|NCT00299104|593657541|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
164350558|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
164350559|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
164350560|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
164350561|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
164350562|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
164350563|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
164350564|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
164350565|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
164350566|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
164350567|NCT00299104|593657539|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
164350568|NCT00299104|593657540|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
164350569|NCT00299104|593657541|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
164350570|NCT03167411|593657545|FG000|Overall Study|Adverse Event|0|||
164350571|NCT03167411|593657546|FG001|Overall Study|Adverse Event|1|||
164350572|NCT02651922|593657547|FG000|Overall Study|due to exclusion criteria|2|||
164350573|NCT01366209|593657548|FG000|Overall Study|Adverse Event|6|||
164350574|NCT01366209|593657549|FG001|Overall Study|Adverse Event|7|||
164350575|NCT01366209|593657548|FG000|Overall Study|Withdrawal by Subject|4|||
164350576|NCT01366209|593657549|FG001|Overall Study|Withdrawal by Subject|4|||
164350577|NCT01366209|593657548|FG000|Overall Study|Death|12|||
164350578|NCT01366209|593657549|FG001|Overall Study|Death|19|||
164350579|NCT01366209|593657548|FG000|Overall Study|Lung transplantation|6|||
164350580|NCT01366209|593657549|FG001|Overall Study|Lung transplantation|1|||
164350581|NCT01366209|593657548|FG000|Overall Study|Lost to Follow-up|2|||
164350582|NCT01366209|593657549|FG001|Overall Study|Lost to Follow-up|1|||
164350583|NCT01366209|593657548|FG000|Overall Study|Physician Decision|1|||
164350584|NCT01366209|593657549|FG001|Overall Study|Physician Decision|0|||
164350585|NCT01366209|593657548|FG000|Overall Study|Sponsors decision|0|||
164350586|NCT01366209|593657549|FG001|Overall Study|Sponsors decision|1|||
164350587|NCT01366209|593657548|FG000|Overall Study|Withdrew consent|4|||
164350588|NCT01366209|593657549|FG001|Overall Study|Withdrew consent|3|||
164350589|NCT00420927|593657550|FG000|Period 1|Adverse Event|19|||
164350590|NCT00420927|593657551|FG001|Period 1|Adverse Event|15|||
164350591|NCT00420927|593657552|FG002|Period 1|Adverse Event|0|||
164350592|NCT00420927|593657553|FG003|Period 1|Adverse Event|0|||
164350593|NCT00420927|593657554|FG004|Period 1|Adverse Event|0|||
164350594|NCT00420927|593657555|FG005|Period 1|Adverse Event|0|||
164350595|NCT00420927|593657556|FG006|Period 1|Adverse Event|0|||
164350596|NCT00420927|593657550|FG000|Period 1|Withdrawal by Subject|7|||
164350597|NCT00420927|593657551|FG001|Period 1|Withdrawal by Subject|12|||
164350598|NCT00420927|593657552|FG002|Period 1|Withdrawal by Subject|0|||
164350599|NCT00420927|593657553|FG003|Period 1|Withdrawal by Subject|0|||
164350600|NCT00420927|593657554|FG004|Period 1|Withdrawal by Subject|0|||
164350601|NCT00420927|593657555|FG005|Period 1|Withdrawal by Subject|0|||
164350602|NCT00420927|593657556|FG006|Period 1|Withdrawal by Subject|0|||
164350603|NCT00420927|593657550|FG000|Period 1|Lost to Follow-up|8|||
164350604|NCT00420927|593657551|FG001|Period 1|Lost to Follow-up|6|||
164350605|NCT00420927|593657552|FG002|Period 1|Lost to Follow-up|0|||
164350606|NCT00420927|593657553|FG003|Period 1|Lost to Follow-up|0|||
164350607|NCT00420927|593657554|FG004|Period 1|Lost to Follow-up|0|||
164005613|NCT01919411|592385835|FG001|Overall Study|Protocol Violation|1|||
164005614|NCT00957372|592385840|FG000|PART I|Lost to Follow-up|0|||
164005615|NCT00957372|592385841|FG001|PART I|Lost to Follow-up|0|||
164005616|NCT00957372|592385842|FG002|PART I|Lost to Follow-up|1|||
164005617|NCT00957372|592385843|FG003|PART I|Lost to Follow-up|0|||
164350608|NCT00420927|593657555|FG005|Period 1|Lost to Follow-up|0|||
164350609|NCT00420927|593657556|FG006|Period 1|Lost to Follow-up|0|||
164350610|NCT00420927|593657550|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
164350611|NCT00420927|593657551|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
164350612|NCT00420927|593657552|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
164005618|NCT00957372|592385840|FG000|PART II|Withdrawal by Subject|0|||
164005619|NCT00957372|592385841|FG001|PART II|Withdrawal by Subject|0|||
164350613|NCT00420927|593657553|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350614|NCT00420927|593657554|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350615|NCT00420927|593657555|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350616|NCT00420927|593657556|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
164350617|NCT00420927|593657550|FG000|Period 1|Death|2|||
164350618|NCT00420927|593657551|FG001|Period 1|Death|0|||
164350619|NCT00420927|593657552|FG002|Period 1|Death|0|||
164350620|NCT00420927|593657553|FG003|Period 1|Death|0|||
164350621|NCT00420927|593657554|FG004|Period 1|Death|0|||
164350622|NCT00420927|593657555|FG005|Period 1|Death|0|||
164350623|NCT00420927|593657556|FG006|Period 1|Death|0|||
164350624|NCT00420927|593657550|FG000|Period 1|Subject moved/relocated|0|||
164350625|NCT00420927|593657551|FG001|Period 1|Subject moved/relocated|2|||
164350626|NCT00420927|593657552|FG002|Period 1|Subject moved/relocated|0|||
164350627|NCT00420927|593657553|FG003|Period 1|Subject moved/relocated|0|||
164350628|NCT00420927|593657554|FG004|Period 1|Subject moved/relocated|0|||
164350629|NCT00420927|593657555|FG005|Period 1|Subject moved/relocated|0|||
164350630|NCT00420927|593657556|FG006|Period 1|Subject moved/relocated|0|||
164350631|NCT00420927|593657550|FG000|Period 1|Noncompliant with study drug|1|||
164350632|NCT00420927|593657551|FG001|Period 1|Noncompliant with study drug|1|||
164350633|NCT00420927|593657552|FG002|Period 1|Noncompliant with study drug|0|||
164350634|NCT00420927|593657553|FG003|Period 1|Noncompliant with study drug|0|||
164350635|NCT00420927|593657554|FG004|Period 1|Noncompliant with study drug|0|||
164350636|NCT00420927|593657555|FG005|Period 1|Noncompliant with study drug|0|||
164350637|NCT00420927|593657556|FG006|Period 1|Noncompliant with study drug|0|||
164350638|NCT00420927|593657550|FG000|Period 1|Randomization error|1|||
164350639|NCT00420927|593657551|FG001|Period 1|Randomization error|0|||
164350640|NCT00420927|593657552|FG002|Period 1|Randomization error|0|||
164350641|NCT00420927|593657553|FG003|Period 1|Randomization error|0|||
164350642|NCT00420927|593657554|FG004|Period 1|Randomization error|0|||
164350643|NCT00420927|593657555|FG005|Period 1|Randomization error|0|||
164350644|NCT00420927|593657556|FG006|Period 1|Randomization error|0|||
164350645|NCT00420927|593657550|FG000|Period 1|Suspected tuberculosis/positive test|1|||
164350646|NCT00420927|593657551|FG001|Period 1|Suspected tuberculosis/positive test|1|||
164350647|NCT00420927|593657552|FG002|Period 1|Suspected tuberculosis/positive test|0|||
164350648|NCT00420927|593657553|FG003|Period 1|Suspected tuberculosis/positive test|0|||
164350649|NCT00420927|593657554|FG004|Period 1|Suspected tuberculosis/positive test|0|||
164350650|NCT00420927|593657555|FG005|Period 1|Suspected tuberculosis/positive test|0|||
164350651|NCT00420927|593657556|FG006|Period 1|Suspected tuberculosis/positive test|0|||
164350652|NCT00420927|593657550|FG000|Period 1|Study site closure|0|||
164350653|NCT00420927|593657551|FG001|Period 1|Study site closure|1|||
164350654|NCT00420927|593657552|FG002|Period 1|Study site closure|0|||
164350655|NCT00420927|593657553|FG003|Period 1|Study site closure|0|||
164350656|NCT00420927|593657554|FG004|Period 1|Study site closure|0|||
164350657|NCT00420927|593657555|FG005|Period 1|Study site closure|0|||
164350658|NCT00420927|593657556|FG006|Period 1|Study site closure|0|||
164350659|NCT00420927|593657550|FG000|Period 1|Subject received new diagnosis|0|||
164350660|NCT00420927|593657551|FG001|Period 1|Subject received new diagnosis|2|||
164350661|NCT00420927|593657552|FG002|Period 1|Subject received new diagnosis|0|||
164350662|NCT00420927|593657553|FG003|Period 1|Subject received new diagnosis|0|||
164350663|NCT00420927|593657554|FG004|Period 1|Subject received new diagnosis|0|||
164350664|NCT00420927|593657555|FG005|Period 1|Subject received new diagnosis|0|||
164350665|NCT00420927|593657556|FG006|Period 1|Subject received new diagnosis|0|||
164350666|NCT00420927|593657550|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
164350667|NCT00420927|593657551|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
164350668|NCT00420927|593657552|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
164350669|NCT00420927|593657553|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
164350670|NCT00420927|593657554|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
164350671|NCT00420927|593657555|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
164350672|NCT00420927|593657556|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
164350673|NCT00420927|593657550|FG000|Period 1|Failed to meet entry criteria|8|||
164350674|NCT00420927|593657551|FG001|Period 1|Failed to meet entry criteria|7|||
164350675|NCT00420927|593657552|FG002|Period 1|Failed to meet entry criteria|0|||
164350676|NCT00420927|593657553|FG003|Period 1|Failed to meet entry criteria|0|||
164350677|NCT00420927|593657554|FG004|Period 1|Failed to meet entry criteria|0|||
164350678|NCT00420927|593657555|FG005|Period 1|Failed to meet entry criteria|0|||
164350679|NCT00420927|593657556|FG006|Period 1|Failed to meet entry criteria|0|||
164350680|NCT00420927|593657550|FG000|Period 1|Took prohibited medication|1|||
164350681|NCT00420927|593657551|FG001|Period 1|Took prohibited medication|3|||
164350682|NCT00420927|593657552|FG002|Period 1|Took prohibited medication|0|||
164350683|NCT00420927|593657553|FG003|Period 1|Took prohibited medication|0|||
164350684|NCT00420927|593657554|FG004|Period 1|Took prohibited medication|0|||
164350685|NCT00420927|593657555|FG005|Period 1|Took prohibited medication|0|||
164350686|NCT00420927|593657556|FG006|Period 1|Took prohibited medication|0|||
164350687|NCT00420927|593657550|FG000|Period 2|Adverse Event|0|||
164350688|NCT00420927|593657551|FG001|Period 2|Adverse Event|0|||
164350689|NCT00420927|593657552|FG002|Period 2|Adverse Event|7|||
164350690|NCT00420927|593657553|FG003|Period 2|Adverse Event|3|||
164350691|NCT00420927|593657554|FG004|Period 2|Adverse Event|17|||
164350692|NCT00420927|593657555|FG005|Period 2|Adverse Event|6|||
164350693|NCT00420927|593657556|FG006|Period 2|Adverse Event|20|||
164350694|NCT00420927|593657550|FG000|Period 2|Withdrawal by Subject|0|||
164350695|NCT00420927|593657551|FG001|Period 2|Withdrawal by Subject|0|||
164350696|NCT00420927|593657552|FG002|Period 2|Withdrawal by Subject|1|||
164350697|NCT00420927|593657553|FG003|Period 2|Withdrawal by Subject|3|||
164350698|NCT00420927|593657554|FG004|Period 2|Withdrawal by Subject|11|||
164350699|NCT00420927|593657555|FG005|Period 2|Withdrawal by Subject|2|||
164350700|NCT00420927|593657556|FG006|Period 2|Withdrawal by Subject|12|||
164350701|NCT00420927|593657550|FG000|Period 2|Lost to Follow-up|0|||
164350702|NCT00420927|593657551|FG001|Period 2|Lost to Follow-up|0|||
164350703|NCT00420927|593657552|FG002|Period 2|Lost to Follow-up|2|||
164350704|NCT00420927|593657553|FG003|Period 2|Lost to Follow-up|2|||
164350705|NCT00420927|593657554|FG004|Period 2|Lost to Follow-up|6|||
164350706|NCT00420927|593657555|FG005|Period 2|Lost to Follow-up|3|||
164350707|NCT00420927|593657556|FG006|Period 2|Lost to Follow-up|9|||
164350708|NCT00420927|593657550|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
164350709|NCT00420927|593657551|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
164350710|NCT00420927|593657552|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
164350711|NCT00420927|593657553|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
164350712|NCT00420927|593657554|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
164350713|NCT00420927|593657555|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
164350714|NCT00420927|593657556|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
164350715|NCT00420927|593657550|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
164350716|NCT00420927|593657551|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
164350717|NCT00420927|593657552|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
164350718|NCT00420927|593657553|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
164350719|NCT00420927|593657554|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
164350720|NCT00420927|593657555|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
164350721|NCT00420927|593657556|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
164350722|NCT00420927|593657550|FG000|Period 2|Subject unable to find transportation|0|||
164350723|NCT00420927|593657551|FG001|Period 2|Subject unable to find transportation|0|||
164350724|NCT00420927|593657552|FG002|Period 2|Subject unable to find transportation|0|||
164350725|NCT00420927|593657553|FG003|Period 2|Subject unable to find transportation|0|||
164350726|NCT00420927|593657554|FG004|Period 2|Subject unable to find transportation|0|||
164350727|NCT00420927|593657555|FG005|Period 2|Subject unable to find transportation|0|||
164350728|NCT00420927|593657556|FG006|Period 2|Subject unable to find transportation|1|||
164350729|NCT00420927|593657550|FG000|Period 2|Physician Decision|0|||
164350730|NCT00420927|593657551|FG001|Period 2|Physician Decision|0|||
164350731|NCT00420927|593657552|FG002|Period 2|Physician Decision|0|||
164350732|NCT00420927|593657553|FG003|Period 2|Physician Decision|0|||
164350733|NCT00420927|593657554|FG004|Period 2|Physician Decision|1|||
164350734|NCT00420927|593657555|FG005|Period 2|Physician Decision|1|||
164350735|NCT00420927|593657556|FG006|Period 2|Physician Decision|0|||
164350736|NCT00420927|593657550|FG000|Period 2|Sponsor decision|0|||
164350737|NCT00420927|593657551|FG001|Period 2|Sponsor decision|0|||
164350738|NCT00420927|593657552|FG002|Period 2|Sponsor decision|1|||
164350739|NCT00420927|593657553|FG003|Period 2|Sponsor decision|0|||
164350740|NCT00420927|593657554|FG004|Period 2|Sponsor decision|0|||
164350741|NCT00420927|593657555|FG005|Period 2|Sponsor decision|0|||
164005620|NCT00957372|592385842|FG002|PART II|Withdrawal by Subject|0|||
164005621|NCT00957372|592385843|FG003|PART II|Withdrawal by Subject|8|||
164005622|NCT00957372|592385840|FG000|PART II|Physician Decision|0|||
164005623|NCT00957372|592385841|FG001|PART II|Physician Decision|0|||
164005624|NCT00957372|592385842|FG002|PART II|Physician Decision|0|||
164005625|NCT00957372|592385843|FG003|PART II|Physician Decision|1|||
164005626|NCT00957372|592385840|FG000|PART II|Pregnancy|0|||
164005627|NCT00957372|592385841|FG001|PART II|Pregnancy|0|||
164005628|NCT00957372|592385842|FG002|PART II|Pregnancy|0|||
164005629|NCT00957372|592385843|FG003|PART II|Pregnancy|1|||
164350742|NCT00420927|593657556|FG006|Period 2|Sponsor decision|1|||
164350743|NCT00420927|593657550|FG000|Period 2|Randomization error|0|||
164350744|NCT00420927|593657551|FG001|Period 2|Randomization error|0|||
164350745|NCT00420927|593657552|FG002|Period 2|Randomization error|0|||
164350746|NCT00420927|593657553|FG003|Period 2|Randomization error|0|||
164350747|NCT00420927|593657554|FG004|Period 2|Randomization error|1|||
164350748|NCT00420927|593657555|FG005|Period 2|Randomization error|1|||
164350749|NCT00420927|593657556|FG006|Period 2|Randomization error|0|||
164005630|NCT00957372|592385840|FG000|PART II|Not Know|0|||
164005631|NCT00957372|592385841|FG001|PART II|Not Know|0|||
164005632|NCT00957372|592385842|FG002|PART II|Not Know|0|||
164005633|NCT00957372|592385843|FG003|PART II|Not Know|20|||
164005634|NCT00957372|592385840|FG000|PART II|Adverse Event|0|||
164350750|NCT00420927|593657550|FG000|Period 2|Noncompliant with study drug|0|||
163899062|NCT01092416|592002802|FG000|Enrollment|Atherectomy device not inserted|3|||
163899063|NCT01092416|592002802|FG000|30-Day Follow-up|Death|2|||
163899064|NCT01092416|592002802|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
163899065|NCT01092416|592002802|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
163899066|NCT01092416|592002802|FG000|12-Month Follow-up|Death|16|||
163899067|NCT01092416|592002802|FG000|12-Month Follow-up|Lost to Follow-up|4|||
163899068|NCT01092416|592002802|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
163899069|NCT01092416|592002802|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
163899070|NCT01092416|592002802|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
163899071|NCT03709706|592002803|FG000|Overall Study|Adverse Event|0|||
163899072|NCT03709706|592002804|FG001|Overall Study|Adverse Event|1|||
163899073|NCT03709706|592002803|FG000|Overall Study|Physician Decision|14|||
163899074|NCT03709706|592002804|FG001|Overall Study|Physician Decision|8|||
163899075|NCT03709706|592002803|FG000|Overall Study|Withdrawal by Subject|2|||
163899076|NCT03709706|592002804|FG001|Overall Study|Withdrawal by Subject|1|||
163899077|NCT03709706|592002803|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
163899078|NCT03709706|592002804|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
163899079|NCT01105975|592002805|FG000|Overall Study|Adverse Event|2|||
164299048|NCT00456846|593471229|FG000|Overall Study|Participant Discretion|1|||
164299049|NCT00456846|593471230|FG001|Overall Study|Participant Discretion|5|||
164299050|NCT00456846|593471229|FG000|Overall Study|Other|0|||
164299051|NCT00456846|593471230|FG001|Overall Study|Other|2|||
164299052|NCT00581308|593471231|FG000|Pre Discharge|Lost to Follow-up|1|||
164299053|NCT00581308|593471231|FG000|Pre Discharge|Device Removed|1|||
164299054|NCT00581308|593471231|FG000|Month 1|Lost to Follow-up|3|||
164299055|NCT00581308|593471231|FG000|Month 1|Withdrawal by Subject|2|||
164350751|NCT00420927|593657551|FG001|Period 2|Noncompliant with study drug|0|||
164350752|NCT00420927|593657552|FG002|Period 2|Noncompliant with study drug|0|||
164350753|NCT00420927|593657553|FG003|Period 2|Noncompliant with study drug|1|||
164350754|NCT00420927|593657554|FG004|Period 2|Noncompliant with study drug|0|||
164350755|NCT00420927|593657555|FG005|Period 2|Noncompliant with study drug|0|||
164350756|NCT00420927|593657556|FG006|Period 2|Noncompliant with study drug|2|||
164350757|NCT00420927|593657550|FG000|Period 2|Methotrexate intolerance|0|||
164350758|NCT00420927|593657551|FG001|Period 2|Methotrexate intolerance|0|||
164350759|NCT00420927|593657552|FG002|Period 2|Methotrexate intolerance|0|||
164350760|NCT00420927|593657553|FG003|Period 2|Methotrexate intolerance|0|||
164350761|NCT00420927|593657554|FG004|Period 2|Methotrexate intolerance|0|||
164350762|NCT00420927|593657555|FG005|Period 2|Methotrexate intolerance|0|||
164350763|NCT00420927|593657556|FG006|Period 2|Methotrexate intolerance|1|||
164350764|NCT00420927|593657550|FG000|Period 2|Took prohibited medication|0|||
164350765|NCT00420927|593657551|FG001|Period 2|Took prohibited medication|0|||
164350766|NCT00420927|593657552|FG002|Period 2|Took prohibited medication|0|||
164350767|NCT00420927|593657553|FG003|Period 2|Took prohibited medication|0|||
164350768|NCT00420927|593657554|FG004|Period 2|Took prohibited medication|1|||
164350769|NCT00420927|593657555|FG005|Period 2|Took prohibited medication|0|||
164350770|NCT00420927|593657556|FG006|Period 2|Took prohibited medication|0|||
164350771|NCT01218243|593657557|FG000|Overall Study|Lack of Efficacy|1|||
164350772|NCT01218243|593657558|FG001|Overall Study|Lack of Efficacy|1|||
164350773|NCT01218243|593657557|FG000|Overall Study|Lost to Follow-up|3|||
164350774|NCT01218243|593657558|FG001|Overall Study|Lost to Follow-up|3|||
164350775|NCT01218243|593657557|FG000|Overall Study|Protocol Violation|5|||
164350776|NCT01218243|593657558|FG001|Overall Study|Protocol Violation|10|||
164350777|NCT01032837|593657561|FG000|Overall Study|Adverse event/internal illness|0|||
164350778|NCT01032837|593657562|FG001|Overall Study|Adverse event/internal illness|1|||
164350779|NCT01032837|593657563|FG002|Overall Study|Adverse event/internal illness|0|||
164350780|NCT01032837|593657564|FG003|Overall Study|Adverse event/internal illness|1|||
164350781|NCT01032837|593657561|FG000|Overall Study|Withdrew consent|0|||
164350782|NCT01032837|593657562|FG001|Overall Study|Withdrew consent|2|||
164350783|NCT01032837|593657563|FG002|Overall Study|Withdrew consent|0|||
164350784|NCT01032837|593657564|FG003|Overall Study|Withdrew consent|1|||
164350785|NCT01032837|593657561|FG000|Overall Study|Failed to return|0|||
164350786|NCT01032837|593657562|FG001|Overall Study|Failed to return|0|||
164350787|NCT01032837|593657563|FG002|Overall Study|Failed to return|1|||
164350788|NCT01032837|593657564|FG003|Overall Study|Failed to return|0|||
164350789|NCT01032837|593657561|FG000|Overall Study|Refused treatment|0|||
164299056|NCT00581308|593471231|FG000|Month 1|Device Removed|2|||
164299057|NCT00581308|593471231|FG000|Month 1|Uknown|1|||
164350790|NCT01032837|593657562|FG001|Overall Study|Refused treatment|0|||
164350791|NCT01032837|593657563|FG002|Overall Study|Refused treatment|0|||
164350792|NCT01032837|593657564|FG003|Overall Study|Refused treatment|1|||
164350793|NCT01197560|593657565|FG000|Overall Study|Adverse Event|6|||
163899080|NCT01105975|592002806|FG001|Overall Study|Adverse Event|1|||
163899081|NCT01105975|592002807|FG002|Overall Study|Adverse Event|5|||
164350794|NCT01197560|593657566|FG001|Overall Study|Adverse Event|8|||
164350795|NCT01197560|593657565|FG000|Overall Study|Death|3|||
164350796|NCT01197560|593657566|FG001|Overall Study|Death|5|||
164350797|NCT01197560|593657565|FG000|Overall Study|Withdrawal by Subject|1|||
164299058|NCT00581308|593471231|FG000|Month 6|Lost to Follow-up|1|||
164350798|NCT01197560|593657566|FG001|Overall Study|Withdrawal by Subject|1|||
164350799|NCT01197560|593657565|FG000|Overall Study|Disease progression|40|||
164350800|NCT01197560|593657566|FG001|Overall Study|Disease progression|35|||
164350801|NCT01197560|593657565|FG000|Overall Study|Miscellaneous|4|||
164350802|NCT01197560|593657566|FG001|Overall Study|Miscellaneous|3|||
164350803|NCT01197560|593657565|FG000|Overall Study|Missing|0|||
164350804|NCT01197560|593657566|FG001|Overall Study|Missing|1|||
164350805|NCT00211510|593657569|FG000|Overall Study|Physician Decision|3|||
164350806|NCT00211510|593657570|FG001|Overall Study|Physician Decision|1|||
164350807|NCT00211510|593657569|FG000|Overall Study|Withdrawal by Subject|3|||
164350808|NCT00211510|593657570|FG001|Overall Study|Withdrawal by Subject|1|||
164350809|NCT01487200|593657571|FG000|Overall Study|Withdrawal by Subject|0|||
164350810|NCT01487200|593657572|FG001|Overall Study|Withdrawal by Subject|1|||
164350811|NCT01487200|593657573|FG002|Overall Study|Withdrawal by Subject|0|||
164350812|NCT01487200|593657574|FG003|Overall Study|Withdrawal by Subject|0|||
164350813|NCT02521870|593657580|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350814|NCT02521870|593657581|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
164350815|NCT02521870|593657582|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350816|NCT02521870|593657583|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350817|NCT02521870|593657584|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350818|NCT02521870|593657585|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350819|NCT02521870|593657586|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350820|NCT02521870|593657587|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350821|NCT02521870|593657588|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350822|NCT02521870|593657589|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350823|NCT02521870|593657590|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350824|NCT02521870|593657591|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
164350825|NCT02521870|593657580|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
164350826|NCT02521870|593657581|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
164350827|NCT02521870|593657582|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
164350828|NCT02521870|593657583|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
164350829|NCT02521870|593657584|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
164350830|NCT02521870|593657585|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
164350831|NCT02521870|593657586|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
164350832|NCT02521870|593657587|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
164350833|NCT02521870|593657588|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
164350834|NCT02521870|593657589|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
164350835|NCT02521870|593657590|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
164350836|NCT02521870|593657591|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
164350837|NCT02521870|593657580|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
164350838|NCT02521870|593657581|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
164350839|NCT02521870|593657582|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
164350840|NCT02521870|593657583|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
164350841|NCT02521870|593657584|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
164350842|NCT02521870|593657585|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
164350843|NCT02521870|593657586|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
164350844|NCT02521870|593657587|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
164350845|NCT02521870|593657588|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
164350846|NCT02521870|593657589|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
164350847|NCT02521870|593657590|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
164350848|NCT02521870|593657591|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
164350849|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350850|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350851|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350852|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350853|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
164350854|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350855|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350856|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350857|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350858|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
164350859|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
164350860|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164350861|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
164350862|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
164350863|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
164350864|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
164350865|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
164350866|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
164350867|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
164350868|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
164350869|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
164350870|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
164350871|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
164350872|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
164350873|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
164350874|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
164350875|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
164350876|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
164350877|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
164350878|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
164350879|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
164350880|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
164350881|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
164350882|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
164350883|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
164350884|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
164350885|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Death|0|||
164350886|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Death|0|||
164350887|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Death|0|||
164350888|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Death|0|||
164350889|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Death|1|||
164350890|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Death|1|||
164350891|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Death|3|||
164350892|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Death|1|||
164350893|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Death|1|||
164350894|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Death|5|||
164350895|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Death|2|||
164350896|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Death|2|||
164350897|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Other|0|||
164350898|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Other|0|||
164350899|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Other|0|||
164350900|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Other|0|||
164350901|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Other|10|||
164350902|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Other|3|||
164350903|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Other|2|||
164350904|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Other|0|||
164350905|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Other|10|||
164350906|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Other|5|||
164350907|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Other|1|||
164350908|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Other|7|||
163899082|NCT01105975|592002808|FG003|Overall Study|Adverse Event|1|||
164350909|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350910|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350911|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350912|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350913|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
164350914|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350915|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350916|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350917|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350918|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350919|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350920|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
164350921|NCT02521870|593657580|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350922|NCT02521870|593657581|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350923|NCT02521870|593657582|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350924|NCT02521870|593657583|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350925|NCT02521870|593657584|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
164350926|NCT02521870|593657585|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350927|NCT02521870|593657586|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350928|NCT02521870|593657587|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350929|NCT02521870|593657588|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350930|NCT02521870|593657589|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350931|NCT02521870|593657590|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350932|NCT02521870|593657591|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
164350933|NCT00519831|593657592|FG000|Overall Study|Adverse Event|3|||
164350934|NCT04051008|593657593|FG000|Overall Study|Withdrawal by Subject|2|||
164350935|NCT04051008|593657594|FG001|Overall Study|Withdrawal by Subject|0|||
164350936|NCT04051008|593657595|FG002|Overall Study|Withdrawal by Subject|1|||
164350937|NCT02862171|593657596|FG000|Overall Study|Death|1|||
164350938|NCT02862171|593657596|FG000|Overall Study|Lost to Follow-up|13|||
164350939|NCT02862171|593657596|FG000|Overall Study|Withdrawal by Subject|57|||
164350940|NCT02862171|593657596|FG000|Overall Study|Non-compliance|4|||
164350941|NCT02862171|593657596|FG000|Overall Study|HIV-1 seroconversion|18|||
164350942|NCT01962896|593657597|FG000|Overall Study|Lack of Efficacy|4|||
164350943|NCT00662012|593657598|FG000|Overall Study|Lost to Follow-up|85|||
164350944|NCT00662012|593657598|FG000|Overall Study|Death|1|||
164350945|NCT00662012|593657598|FG000|Overall Study|Withdrawal by Subject|1|||
164299059|NCT00581308|593471231|FG000|Month 6|Withdrawal by Subject|2|||
164299060|NCT00581308|593471231|FG000|Month 12|Death|1|||
164299061|NCT00581308|593471231|FG000|Month 12|Lost to Follow-up|14|||
164350946|NCT00844896|593657599|FG000|Overall Study|Lost to Follow-up|12|||
164350947|NCT00844896|593657600|FG001|Overall Study|Lost to Follow-up|16|||
164350948|NCT00844896|593657599|FG000|Overall Study|Parents did not have time to complete|0|||
164350949|NCT00844896|593657600|FG001|Overall Study|Parents did not have time to complete|1|||
164350950|NCT00458211|593657601|FG000|Overall Study|Lack of Efficacy|12|||
164350951|NCT00458211|593657601|FG000|Overall Study|Withdrawal by Subject|2|||
163899083|NCT01105975|592002809|FG004|Overall Study|Adverse Event|0|||
163899084|NCT01105975|592002810|FG005|Overall Study|Adverse Event|1|||
164299062|NCT00581308|593471231|FG000|Month 12|Withdrawal by Subject|3|||
164299063|NCT00581308|593471231|FG000|Month 12|Device Removed|1|||
164299064|NCT00581308|593471231|FG000|Month 12|Other|1|||
164299065|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
164299066|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
164299067|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
164299068|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
164299069|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
164299070|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299071|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299072|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
164299073|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299074|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
164299075|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
164299076|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
164299077|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
164299078|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
164299079|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
164299080|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Other|1|||
164299081|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Other|5|||
164299082|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Other|0|||
164299083|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Other|2|||
164299084|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Other|3|||
163899085|NCT01105975|592002811|FG006|Overall Study|Adverse Event|2|||
164299085|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
164299086|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
164299087|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
164299088|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
164350952|NCT00458211|593657601|FG000|Overall Study|Protocol Violation|2|||
164350953|NCT00753415|593657606|FG000|Part A|Disease progression|1|||
164350954|NCT00753415|593657607|FG001|Part A|Disease progression|0|||
164350955|NCT00753415|593657608|FG002|Part A|Disease progression|1|||
164350956|NCT00753415|593657609|FG003|Part A|Disease progression|2|||
164350957|NCT00753415|593657610|FG004|Part A|Disease progression|0|||
164350958|NCT00753415|593657611|FG005|Part A|Disease progression|0|||
164350959|NCT00753415|593657612|FG006|Part A|Disease progression|0|||
164350960|NCT00753415|593657613|FG007|Part A|Disease progression|0|||
164350961|NCT00753415|593657614|FG008|Part A|Disease progression|0|||
164350962|NCT00753415|593657615|FG009|Part A|Disease progression|0|||
164350963|NCT00753415|593657606|FG000|Part A|Withdrawal by Subject|0|||
164350964|NCT00753415|593657607|FG001|Part A|Withdrawal by Subject|0|||
164350965|NCT00753415|593657608|FG002|Part A|Withdrawal by Subject|1|||
164350966|NCT00753415|593657609|FG003|Part A|Withdrawal by Subject|0|||
164350967|NCT00753415|593657610|FG004|Part A|Withdrawal by Subject|0|||
164350968|NCT00753415|593657611|FG005|Part A|Withdrawal by Subject|0|||
164350969|NCT00753415|593657612|FG006|Part A|Withdrawal by Subject|0|||
164350970|NCT00753415|593657613|FG007|Part A|Withdrawal by Subject|0|||
164350971|NCT00753415|593657614|FG008|Part A|Withdrawal by Subject|0|||
164350972|NCT00753415|593657615|FG009|Part A|Withdrawal by Subject|0|||
164350973|NCT00753415|593657606|FG000|Part B|Lost to Follow-up|0|||
164350974|NCT00753415|593657607|FG001|Part B|Lost to Follow-up|0|||
164350975|NCT00753415|593657608|FG002|Part B|Lost to Follow-up|0|||
164350976|NCT00753415|593657609|FG003|Part B|Lost to Follow-up|0|||
164350977|NCT00753415|593657610|FG004|Part B|Lost to Follow-up|0|||
164350978|NCT00753415|593657611|FG005|Part B|Lost to Follow-up|0|||
164350979|NCT00753415|593657612|FG006|Part B|Lost to Follow-up|0|||
164350980|NCT00753415|593657613|FG007|Part B|Lost to Follow-up|1|||
164350981|NCT00753415|593657614|FG008|Part B|Lost to Follow-up|1|||
164350982|NCT00753415|593657615|FG009|Part B|Lost to Follow-up|0|||
164350983|NCT00753415|593657606|FG000|Part B|Disease progression|0|||
164350984|NCT00753415|593657607|FG001|Part B|Disease progression|0|||
164350985|NCT00753415|593657608|FG002|Part B|Disease progression|0|||
164350986|NCT00753415|593657609|FG003|Part B|Disease progression|0|||
164350987|NCT00753415|593657610|FG004|Part B|Disease progression|0|||
164350988|NCT00753415|593657611|FG005|Part B|Disease progression|0|||
164350989|NCT00753415|593657612|FG006|Part B|Disease progression|0|||
164350990|NCT00753415|593657613|FG007|Part B|Disease progression|0|||
164350991|NCT00753415|593657614|FG008|Part B|Disease progression|2|||
164350992|NCT00753415|593657615|FG009|Part B|Disease progression|1|||
164350993|NCT00621153|593657616|FG000|Overall Study|Safety Reason|8|||
164350994|NCT00621153|593657617|FG001|Overall Study|Safety Reason|7|||
164350995|NCT00621153|593657616|FG000|Overall Study|Adverse Event|3|||
164350996|NCT00621153|593657617|FG001|Overall Study|Adverse Event|2|||
164350997|NCT00621153|593657616|FG000|Overall Study|Lost to Follow-up|5|||
164350998|NCT00621153|593657617|FG001|Overall Study|Lost to Follow-up|1|||
164350999|NCT00621153|593657616|FG000|Overall Study|Withdrawal by Subject|4|||
164351000|NCT00621153|593657617|FG001|Overall Study|Withdrawal by Subject|5|||
164351001|NCT04212650|593657618|FG000|Overall Study|Withdrawal by Subject|1|||
164351002|NCT04212650|593657619|FG001|Overall Study|Withdrawal by Subject|0|||
164351003|NCT00838578|593657620|FG000|Overall Study|Protocol Violation|2|||
164351004|NCT00598832|593657621|FG000|Overall Study|Lack of Efficacy|3|||
164351005|NCT00598832|593657622|FG001|Overall Study|Lack of Efficacy|7|||
164351006|NCT00598832|593657621|FG000|Overall Study|Adverse Event|6|||
164351007|NCT00598832|593657622|FG001|Overall Study|Adverse Event|2|||
164351008|NCT00598832|593657621|FG000|Overall Study|Withdrawal by Subject|25|||
164351009|NCT00598832|593657622|FG001|Overall Study|Withdrawal by Subject|36|||
164351010|NCT00598832|593657621|FG000|Overall Study|Protocol Violation|0|||
164351011|NCT00598832|593657622|FG001|Overall Study|Protocol Violation|2|||
164351012|NCT00598832|593657621|FG000|Overall Study|Lost to Follow-up|24|||
164351013|NCT00598832|593657622|FG001|Overall Study|Lost to Follow-up|29|||
164351014|NCT00598832|593657621|FG000|Overall Study|Pregnancy|2|||
164351015|NCT00598832|593657622|FG001|Overall Study|Pregnancy|2|||
164351016|NCT00598832|593657621|FG000|Overall Study|Physician Decision|1|||
164351017|NCT00598832|593657622|FG001|Overall Study|Physician Decision|4|||
164351018|NCT00598832|593657621|FG000|Overall Study|Non compliance|1|||
164351019|NCT00598832|593657622|FG001|Overall Study|Non compliance|0|||
164351020|NCT00357968|593657623|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
164351021|NCT00357968|593657624|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
164351022|NCT00357968|593657623|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
164351023|NCT00357968|593657624|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
164351024|NCT03919799|593657629|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
164351025|NCT03919799|593657630|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
164351026|NCT03919799|593657631|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
164351027|NCT03919799|593657632|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
164005635|NCT00957372|592385841|FG001|PART II|Adverse Event|0|||
164351028|NCT03919799|593657633|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
164351029|NCT03919799|593657629|FG000|DB Period (28 Weeks)|Adverse Event|1|||
164351030|NCT03919799|593657630|FG001|DB Period (28 Weeks)|Adverse Event|1|||
164351031|NCT03919799|593657631|FG002|DB Period (28 Weeks)|Adverse Event|1|||
164351032|NCT03919799|593657632|FG003|DB Period (28 Weeks)|Adverse Event|0|||
164351033|NCT03919799|593657633|FG004|DB Period (28 Weeks)|Adverse Event|0|||
164351034|NCT03919799|593657629|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351035|NCT03919799|593657630|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
164351036|NCT03919799|593657631|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351037|NCT03919799|593657632|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351038|NCT03919799|593657633|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
164351039|NCT03919799|593657629|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351040|NCT03919799|593657630|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
164351041|NCT03919799|593657631|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351042|NCT03919799|593657632|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351043|NCT03919799|593657633|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
164351044|NCT03919799|593657629|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
164351045|NCT03919799|593657630|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
164351046|NCT03919799|593657631|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
164351047|NCT03919799|593657632|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
164351048|NCT03919799|593657633|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
164351049|NCT02142959|593657635|FG000|Overall Study|Adverse Event|1|||
164351050|NCT02142959|593657636|FG001|Overall Study|Adverse Event|0|||
164351051|NCT02142959|593657637|FG002|Overall Study|Adverse Event|0|||
164351052|NCT02142959|593657635|FG000|Overall Study|Death|0|||
164351053|NCT02142959|593657636|FG001|Overall Study|Death|1|||
164351054|NCT02142959|593657637|FG002|Overall Study|Death|0|||
164351055|NCT02142959|593657635|FG000|Overall Study|Withdrawal by Subject|3|||
164351056|NCT02142959|593657636|FG001|Overall Study|Withdrawal by Subject|1|||
164351057|NCT02142959|593657637|FG002|Overall Study|Withdrawal by Subject|3|||
164351058|NCT02142959|593657635|FG000|Overall Study|Administrative Reasons|1|||
164351059|NCT02142959|593657636|FG001|Overall Study|Administrative Reasons|0|||
164351060|NCT02142959|593657637|FG002|Overall Study|Administrative Reasons|1|||
164351061|NCT02142959|593657635|FG000|Overall Study|Missing|0|||
164351062|NCT02142959|593657636|FG001|Overall Study|Missing|1|||
164351063|NCT02142959|593657637|FG002|Overall Study|Missing|0|||
164351064|NCT02142959|593657635|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
164351065|NCT02142959|593657636|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
164351066|NCT02142959|593657637|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
164351067|NCT02142959|593657635|FG000|Overall Study|Patient didn't complete end of study visit|0|||
164351068|NCT02142959|593657636|FG001|Overall Study|Patient didn't complete end of study visit|0|||
164351069|NCT02142959|593657637|FG002|Overall Study|Patient didn't complete end of study visit|1|||
164351070|NCT00679302|593657639|FG000|Overall Study|Lost to Follow-up|8|||
164351071|NCT00679302|593657640|FG001|Overall Study|Lost to Follow-up|4|||
164351072|NCT03547687|593657641|FG000|Overall Study|Withdrawal by Subject|1|||
164351073|NCT03547687|593657641|FG000|Overall Study|Death|1|||
164351074|NCT00646776|593657642|FG000|Overall Study|Adverse Event|1|||
164351075|NCT00646776|593657643|FG001|Overall Study|Adverse Event|9|||
164351076|NCT00646776|593657642|FG000|Overall Study|Investigator discretion|0|||
164351077|NCT00646776|593657643|FG001|Overall Study|Investigator discretion|4|||
164351078|NCT04656691|593657644|FG000|Overall Study|Adverse Event|1|||
164351079|NCT01753856|593657649|FG000|Overall Study|Adverse Event|1|||
164351080|NCT01753856|593657650|FG001|Overall Study|Adverse Event|0|||
164351081|NCT01753856|593657649|FG000|Overall Study|Withdrawal by Subject|0|||
164351082|NCT01753856|593657650|FG001|Overall Study|Withdrawal by Subject|2|||
164351083|NCT01753856|593657649|FG000|Overall Study|Sponsor Decision|2|||
164351084|NCT01753856|593657650|FG001|Overall Study|Sponsor Decision|0|||
164351085|NCT00887978|593657651|FG000|Overall Study|Adverse Event|18|||
164351086|NCT00887978|593657652|FG001|Overall Study|Adverse Event|5|||
164351087|NCT00887978|593657651|FG000|Overall Study|Clinical Worsening|4|||
164351088|NCT00887978|593657652|FG001|Overall Study|Clinical Worsening|4|||
164351089|NCT00887978|593657651|FG000|Overall Study|Death|2|||
164351090|NCT00887978|593657652|FG001|Overall Study|Death|3|||
164351091|NCT00887978|593657651|FG000|Overall Study|Withdrawal by Subject|1|||
164351092|NCT00887978|593657652|FG001|Overall Study|Withdrawal by Subject|2|||
164351093|NCT00887978|593657651|FG000|Overall Study|Lost to Follow-up|0|||
164351094|NCT00887978|593657652|FG001|Overall Study|Lost to Follow-up|1|||
164351095|NCT05980182|593657653|FG000|Overall Study|Lost to Follow-up|10|||
164351096|NCT04419714|593657661|FG000|Overall Study|Technical Fault|5|||
164089757|NCT00797108|592691472|FG001|Overall Study|Randomized but not Treated|0|||
164351097|NCT04419714|593657661|FG000|Overall Study|Protocol Deviation|2|||
164351098|NCT04419714|593657661|FG000|Overall Study|Withdrawal by Subject|1|||
164351099|NCT02700815|593659003|FG000|Overall Study|Adverse Event|0|||
164351100|NCT02700815|593659004|FG001|Overall Study|Adverse Event|6|||
164351101|NCT02700815|593659005|FG002|Overall Study|Adverse Event|2|||
164351102|NCT02700815|593659006|FG003|Overall Study|Adverse Event|3|||
164351103|NCT02700815|593659003|FG000|Overall Study|Lack of Efficacy|0|||
164351104|NCT02700815|593659004|FG001|Overall Study|Lack of Efficacy|0|||
164351105|NCT02700815|593659005|FG002|Overall Study|Lack of Efficacy|1|||
163899086|NCT01105975|592002812|FG007|Overall Study|Adverse Event|4|||
164089758|NCT00797108|592691473|FG002|Overall Study|Randomized but not Treated|0|||
164351106|NCT02700815|593659006|FG003|Overall Study|Lack of Efficacy|2|||
164351107|NCT02700815|593659003|FG000|Overall Study|Lost to Follow-up|1|||
164351108|NCT02700815|593659004|FG001|Overall Study|Lost to Follow-up|0|||
164351109|NCT02700815|593659005|FG002|Overall Study|Lost to Follow-up|0|||
164351110|NCT02700815|593659006|FG003|Overall Study|Lost to Follow-up|1|||
164351111|NCT02700815|593659003|FG000|Overall Study|Refusal to continue medication|0|||
164351112|NCT02700815|593659004|FG001|Overall Study|Refusal to continue medication|1|||
164351113|NCT02700815|593659005|FG002|Overall Study|Refusal to continue medication|0|||
164351114|NCT02700815|593659006|FG003|Overall Study|Refusal to continue medication|1|||
164351115|NCT02700815|593659003|FG000|Overall Study|Withdrawal by Subject|0|||
164351116|NCT02700815|593659004|FG001|Overall Study|Withdrawal by Subject|0|||
164351117|NCT02700815|593659005|FG002|Overall Study|Withdrawal by Subject|1|||
164351118|NCT02700815|593659006|FG003|Overall Study|Withdrawal by Subject|0|||
164351119|NCT04023526|593659007|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
164351120|NCT04023526|593659008|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
164351121|NCT04023526|593659007|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
164351122|NCT04023526|593659008|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
164351123|NCT01955733|593659012|FG000|Period 1|Lost to Follow-up|1|||
164351124|NCT01955733|593659013|FG001|Period 1|Lost to Follow-up|0|||
164351125|NCT01955733|593659014|FG002|Period 1|Lost to Follow-up|0|||
164351126|NCT01955733|593659012|FG000|Period 2|Adverse Event|1|||
164351127|NCT01955733|593659013|FG001|Period 2|Adverse Event|0|||
164351128|NCT01955733|593659014|FG002|Period 2|Adverse Event|0|||
164351129|NCT01955733|593659012|FG000|Period 2|Physician Decision|0|||
164351130|NCT01955733|593659013|FG001|Period 2|Physician Decision|0|||
164351131|NCT01955733|593659014|FG002|Period 2|Physician Decision|1|||
164351132|NCT01955733|593659012|FG000|Period 2|Withdrawal by Subject|1|||
164351133|NCT01955733|593659013|FG001|Period 2|Withdrawal by Subject|3|||
164351134|NCT01955733|593659014|FG002|Period 2|Withdrawal by Subject|2|||
164351135|NCT01955733|593659012|FG000|Period 2|Study terminated by sponsor|8|||
164351136|NCT01955733|593659013|FG001|Period 2|Study terminated by sponsor|14|||
164351137|NCT01955733|593659014|FG002|Period 2|Study terminated by sponsor|16|||
164351138|NCT01955733|593659012|FG000|Period 2|Lost to Follow-up|2|||
164351139|NCT01955733|593659013|FG001|Period 2|Lost to Follow-up|0|||
164351140|NCT01955733|593659014|FG002|Period 2|Lost to Follow-up|0|||
164351141|NCT01955733|593659012|FG000|Period 2|Other not defined above|0|||
164351142|NCT01955733|593659013|FG001|Period 2|Other not defined above|2|||
164351143|NCT01955733|593659014|FG002|Period 2|Other not defined above|2|||
164351144|NCT02239978|593659017|FG000|Overall Study|Withdrawal by Subject|2|||
164351145|NCT02239978|593659018|FG001|Overall Study|Withdrawal by Subject|0|||
164351146|NCT02324569|593659026|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164351147|NCT02324569|593659027|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
164351148|NCT02324569|593659026|FG000|Overall Study|Voluntary Withdrawal|3|||
164351149|NCT02324569|593659027|FG001|Overall Study|Voluntary Withdrawal|6|||
164351150|NCT02324569|593659026|FG000|Overall Study|Lack of Efficacy|2|||
164351151|NCT02324569|593659027|FG001|Overall Study|Lack of Efficacy|3|||
164351152|NCT02324569|593659026|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
164351153|NCT02324569|593659027|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
164351154|NCT02324569|593659026|FG000|Overall Study|Inconvenient Schedule|2|||
164351155|NCT02324569|593659027|FG001|Overall Study|Inconvenient Schedule|0|||
164351156|NCT00793403|593659036|FG000|Overall Study|Other|73|||
164351157|NCT02961751|593659045|FG000|Overall Study|Lost to Follow-up|11|||
164351158|NCT02961751|593659045|FG000|Overall Study|Physician Decision|2|||
164351159|NCT02961751|593659045|FG000|Overall Study|Not Eligible at Enrollment|1|||
164351160|NCT02961751|593659045|FG000|Overall Study|Protocol Violation|1|||
164351161|NCT00842712|593659046|FG000|Safety Run-in Part|Adverse Event|0|||
164351162|NCT00842712|593659047|FG001|Safety Run-in Part|Adverse Event|1|||
164351163|NCT00842712|593659048|FG002|Safety Run-in Part|Adverse Event|0|||
164351164|NCT00842712|593659049|FG003|Safety Run-in Part|Adverse Event|0|||
164351165|NCT00842712|593659050|FG004|Safety Run-in Part|Adverse Event|0|||
164351166|NCT00842712|593659051|FG005|Safety Run-in Part|Adverse Event|0|||
164351167|NCT00842712|593659052|FG006|Safety Run-in Part|Adverse Event|0|||
164351168|NCT00842712|593659046|FG000|Safety Run-in Part|Progressive disease|3|||
164351169|NCT00842712|593659047|FG001|Safety Run-in Part|Progressive disease|1|||
164351170|NCT00842712|593659048|FG002|Safety Run-in Part|Progressive disease|0|||
164351171|NCT00842712|593659049|FG003|Safety Run-in Part|Progressive disease|1|||
164005636|NCT00957372|592385842|FG002|PART II|Adverse Event|0|||
164351172|NCT00842712|593659050|FG004|Safety Run-in Part|Progressive disease|0|||
164351173|NCT00842712|593659051|FG005|Safety Run-in Part|Progressive disease|0|||
164351174|NCT00842712|593659052|FG006|Safety Run-in Part|Progressive disease|0|||
164351175|NCT00842712|593659046|FG000|Randomized Part|Randomized but not treated|0|||
164351176|NCT00842712|593659047|FG001|Randomized Part|Randomized but not treated|0|||
164351177|NCT00842712|593659048|FG002|Randomized Part|Randomized but not treated|0|||
164351178|NCT00842712|593659049|FG003|Randomized Part|Randomized but not treated|0|||
164351179|NCT00842712|593659050|FG004|Randomized Part|Randomized but not treated|0|||
164351180|NCT00842712|593659051|FG005|Randomized Part|Randomized but not treated|1|||
164351181|NCT00842712|593659052|FG006|Randomized Part|Randomized but not treated|4|||
164351182|NCT00842712|593659046|FG000|Randomized Part|Ongoing at cut-off date|0|||
164351183|NCT00842712|593659047|FG001|Randomized Part|Ongoing at cut-off date|0|||
164351184|NCT00842712|593659048|FG002|Randomized Part|Ongoing at cut-off date|0|||
164351185|NCT00842712|593659049|FG003|Randomized Part|Ongoing at cut-off date|0|||
164351186|NCT00842712|593659050|FG004|Randomized Part|Ongoing at cut-off date|0|||
164351187|NCT00842712|593659051|FG005|Randomized Part|Ongoing at cut-off date|0|||
164351188|NCT00842712|593659052|FG006|Randomized Part|Ongoing at cut-off date|2|||
164351189|NCT03909295|593659056|FG000|Overall Study|Adverse Event|2|||
164351190|NCT03909295|593659056|FG000|Overall Study|Study terminated by sponsor|50|||
164351191|NCT03312933|593659060|FG000|Overall Study|Protocol Violation|15|||
164351192|NCT03312933|593659060|FG000|Overall Study|Lost to Follow-up|36|||
164351193|NCT03312933|593659060|FG000|Overall Study|Withdrawal by Subject|3|||
164351194|NCT00848081|593659062|FG000|Overall Study|Adverse Event|6|||
164351195|NCT00848081|593659063|FG001|Overall Study|Adverse Event|7|||
164351196|NCT00848081|593659062|FG000|Overall Study|Protocol Violation|8|||
164351197|NCT00848081|593659063|FG001|Overall Study|Protocol Violation|5|||
164351198|NCT00848081|593659062|FG000|Overall Study|Lost to Follow-up|1|||
164351199|NCT00848081|593659063|FG001|Overall Study|Lost to Follow-up|0|||
164351200|NCT00848081|593659062|FG000|Overall Study|Physician Decision|0|||
164351201|NCT00848081|593659063|FG001|Overall Study|Physician Decision|3|||
164351202|NCT00848081|593659062|FG000|Overall Study|Withdrawal by Subject|5|||
164351203|NCT00848081|593659063|FG001|Overall Study|Withdrawal by Subject|3|||
164351204|NCT01752907|593659064|FG000|Overall Study|Withdrawal by Subject|4|||
164351205|NCT01752907|593659065|FG001|Overall Study|Withdrawal by Subject|10|||
164351206|NCT01752907|593659064|FG000|Overall Study|Lost to Follow-up|2|||
164351207|NCT01752907|593659065|FG001|Overall Study|Lost to Follow-up|1|||
164351208|NCT01752907|593659064|FG000|Overall Study|Decision by Sponsor|6|||
164351209|NCT01752907|593659065|FG001|Overall Study|Decision by Sponsor|9|||
164351210|NCT03098550|593659066|FG000|Overall Study|Disease Progression|30|||
164351211|NCT03098550|593659067|FG001|Overall Study|Disease Progression|19|||
164351212|NCT03098550|593659068|FG002|Overall Study|Disease Progression|41|||
164351213|NCT03098550|593659066|FG000|Overall Study|Study Drug Toxicity|2|||
164351214|NCT03098550|593659067|FG001|Overall Study|Study Drug Toxicity|1|||
164351215|NCT03098550|593659068|FG002|Overall Study|Study Drug Toxicity|0|||
164351216|NCT03098550|593659066|FG000|Overall Study|Death|1|||
164351217|NCT03098550|593659067|FG001|Overall Study|Death|0|||
164351218|NCT03098550|593659068|FG002|Overall Study|Death|0|||
164351219|NCT03098550|593659066|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
164351220|NCT03098550|593659067|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
164351221|NCT03098550|593659068|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
164351222|NCT03098550|593659066|FG000|Overall Study|Administrative reason by sponsor|0|||
164351223|NCT03098550|593659067|FG001|Overall Study|Administrative reason by sponsor|0|||
164351224|NCT03098550|593659068|FG002|Overall Study|Administrative reason by sponsor|1|||
164351225|NCT03098550|593659066|FG000|Overall Study|Other reasons|2|||
164351226|NCT03098550|593659067|FG001|Overall Study|Other reasons|0|||
164351227|NCT03098550|593659068|FG002|Overall Study|Other reasons|0|||
164351228|NCT01384760|593659075|FG000|Overall Study|Lost to Follow-up|0|||
164351229|NCT01384760|593659076|FG001|Overall Study|Lost to Follow-up|6|||
164351230|NCT01384760|593659075|FG000|Overall Study|Protocol Violation|16|||
164351231|NCT01384760|593659076|FG001|Overall Study|Protocol Violation|0|||
164351232|NCT00309387|593659087|FG000|Overall Study|Death|72|||
164351233|NCT00309387|593659088|FG001|Overall Study|Death|73|||
164351234|NCT00309387|593659087|FG000|Overall Study|Lost to Follow-up|70|||
164351235|NCT00309387|593659088|FG001|Overall Study|Lost to Follow-up|86|||
164005637|NCT00957372|592385843|FG003|PART II|Adverse Event|10|||
164351236|NCT02899988|593659091|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
164351237|NCT02899988|593659092|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
164351238|NCT02899988|593659093|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351239|NCT02899988|593659094|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351240|NCT02899988|593659095|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351241|NCT02899988|593659096|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164005638|NCT00957372|592385840|FG000|PART II|Patient non-compliance|0|||
164351242|NCT02899988|593659097|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351243|NCT02899988|593659098|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351244|NCT02899988|593659099|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351245|NCT02899988|593659100|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351246|NCT02899988|593659101|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164351247|NCT02899988|593659091|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
164351248|NCT02899988|593659092|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
164351249|NCT02899988|593659093|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
164351250|NCT02899988|593659094|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
164351251|NCT02899988|593659095|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164351252|NCT02899988|593659096|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
164351253|NCT02899988|593659097|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
164351254|NCT02899988|593659098|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
164351255|NCT02899988|593659099|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
164351256|NCT02899988|593659100|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
164351257|NCT02899988|593659101|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
164351258|NCT02899988|593659091|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
164351259|NCT02899988|593659092|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
164351260|NCT02899988|593659093|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
164351261|NCT02899988|593659094|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
164351262|NCT02899988|593659095|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
164351263|NCT02899988|593659096|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
164351264|NCT02899988|593659097|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
164351265|NCT02899988|593659098|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
164351266|NCT02899988|593659099|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
164351267|NCT02899988|593659100|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
164351268|NCT02899988|593659101|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
164351269|NCT02899988|593659091|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351270|NCT02899988|593659092|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351271|NCT02899988|593659093|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351272|NCT02899988|593659094|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
164351273|NCT02899988|593659095|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
164351274|NCT02899988|593659096|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351275|NCT02899988|593659097|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
164351276|NCT02899988|593659098|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351277|NCT02899988|593659099|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351278|NCT02899988|593659100|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
164351279|NCT02899988|593659101|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
164351280|NCT02899988|593659091|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351281|NCT02899988|593659092|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351282|NCT02899988|593659093|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351283|NCT02899988|593659094|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351284|NCT02899988|593659095|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351285|NCT02899988|593659096|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
164351286|NCT02899988|593659097|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351287|NCT02899988|593659098|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
164351288|NCT02899988|593659099|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351289|NCT02899988|593659100|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351290|NCT02899988|593659101|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
164351291|NCT02899988|593659091|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351292|NCT02899988|593659092|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351293|NCT02899988|593659093|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351294|NCT02899988|593659094|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351295|NCT02899988|593659095|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
164351296|NCT02899988|593659096|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351297|NCT02899988|593659097|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
163899087|NCT01105975|592002813|FG008|Overall Study|Adverse Event|1|||
163899088|NCT01105975|592002814|FG009|Overall Study|Adverse Event|4|||
163899089|NCT01105975|592002805|FG000|Overall Study|Withdrawal by Subject|2|||
164351298|NCT02899988|593659098|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
164351299|NCT02899988|593659099|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
164351300|NCT02899988|593659100|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
164351301|NCT02899988|593659101|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
164351302|NCT02041286|593659102|FG000|Overall Study|Adverse Event|1|||
164351303|NCT00085631|593659106|FG000|Overall Study|Missing Data|4|||
163899090|NCT01105975|592002806|FG001|Overall Study|Withdrawal by Subject|2|||
163899091|NCT01105975|592002807|FG002|Overall Study|Withdrawal by Subject|2|||
163899092|NCT01105975|592002808|FG003|Overall Study|Withdrawal by Subject|0|||
163899093|NCT01105975|592002809|FG004|Overall Study|Withdrawal by Subject|4|||
164351304|NCT00085631|593659107|FG001|Overall Study|Missing Data|11|||
164351305|NCT00085631|593659108|FG002|Overall Study|Missing Data|7|||
164351306|NCT00411645|593659109|FG000|Overall Study|Consent Withdrawn|13|||
164351307|NCT00411645|593659110|FG001|Overall Study|Consent Withdrawn|22|||
164351308|NCT00411645|593659109|FG000|Overall Study|Death|56|||
164351309|NCT00411645|593659110|FG001|Overall Study|Death|135|||
164351310|NCT00411645|593659109|FG000|Overall Study|Investigator/Sponsor Decision|10|||
164351311|NCT00411645|593659110|FG001|Overall Study|Investigator/Sponsor Decision|7|||
164351312|NCT00411645|593659109|FG000|Overall Study|Lost to Follow-up|2|||
164351313|NCT00411645|593659110|FG001|Overall Study|Lost to Follow-up|0|||
164351314|NCT01349790|593659111|FG000|Overall Study|Investigator Judgement|3|||
164351315|NCT01349790|593659111|FG000|Overall Study|Death|2|||
164351316|NCT01349790|593659111|FG000|Overall Study|Withdrawal by Patient|2|||
164351317|NCT01349790|593659111|FG000|Overall Study|Adverse Event|1|||
164351318|NCT01349790|593659111|FG000|Overall Study|Lost to Follow-up|1|||
164351319|NCT02289690|593659112|FG000|Overall Study|Adverse Event Related to Progression|0|||
164351320|NCT02289690|593659113|FG001|Overall Study|Adverse Event Related to Progression|1|||
164351321|NCT02289690|593659114|FG002|Overall Study|Adverse Event Related to Progression|1|||
164351322|NCT02289690|593659115|FG003|Overall Study|Adverse Event Related to Progression|0|||
164351323|NCT02289690|593659116|FG004|Overall Study|Adverse Event Related to Progression|1|||
164351324|NCT02289690|593659117|FG005|Overall Study|Adverse Event Related to Progression|0|||
164351325|NCT02289690|593659118|FG006|Overall Study|Adverse Event Related to Progression|1|||
164351326|NCT02289690|593659119|FG007|Overall Study|Adverse Event Related to Progression|0|||
164351327|NCT02289690|593659120|FG008|Overall Study|Adverse Event Related to Progression|0|||
164351328|NCT02289690|593659121|FG009|Overall Study|Adverse Event Related to Progression|0|||
164351329|NCT02289690|593659112|FG000|Overall Study|Withdrawal by Subject|1|||
164351330|NCT02289690|593659113|FG001|Overall Study|Withdrawal by Subject|0|||
164351331|NCT02289690|593659114|FG002|Overall Study|Withdrawal by Subject|0|||
164351332|NCT02289690|593659115|FG003|Overall Study|Withdrawal by Subject|0|||
164351333|NCT02289690|593659116|FG004|Overall Study|Withdrawal by Subject|1|||
164351334|NCT02289690|593659117|FG005|Overall Study|Withdrawal by Subject|1|||
164351335|NCT02289690|593659118|FG006|Overall Study|Withdrawal by Subject|0|||
164351336|NCT02289690|593659119|FG007|Overall Study|Withdrawal by Subject|0|||
164351337|NCT02289690|593659120|FG008|Overall Study|Withdrawal by Subject|4|||
164351338|NCT02289690|593659121|FG009|Overall Study|Withdrawal by Subject|2|||
164351339|NCT02289690|593659112|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
164351340|NCT02289690|593659113|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
164351341|NCT02289690|593659114|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
164351342|NCT02289690|593659115|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
164351343|NCT02289690|593659116|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
164351344|NCT02289690|593659117|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
164351345|NCT02289690|593659118|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
164351346|NCT02289690|593659119|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
164351347|NCT02289690|593659120|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
164351348|NCT02289690|593659121|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
164351349|NCT02289690|593659112|FG000|Overall Study|Lost to Follow-up|0|||
164351350|NCT02289690|593659113|FG001|Overall Study|Lost to Follow-up|0|||
164351351|NCT02289690|593659114|FG002|Overall Study|Lost to Follow-up|0|||
164351352|NCT02289690|593659115|FG003|Overall Study|Lost to Follow-up|0|||
164351353|NCT02289690|593659116|FG004|Overall Study|Lost to Follow-up|0|||
164351354|NCT02289690|593659117|FG005|Overall Study|Lost to Follow-up|0|||
164351355|NCT02289690|593659118|FG006|Overall Study|Lost to Follow-up|0|||
164351356|NCT02289690|593659119|FG007|Overall Study|Lost to Follow-up|1|||
164351357|NCT02289690|593659120|FG008|Overall Study|Lost to Follow-up|0|||
164351358|NCT02289690|593659121|FG009|Overall Study|Lost to Follow-up|2|||
164351359|NCT02289690|593659112|FG000|Overall Study|Death|0|||
164351360|NCT02289690|593659113|FG001|Overall Study|Death|0|||
164351361|NCT02289690|593659114|FG002|Overall Study|Death|0|||
164351362|NCT02289690|593659115|FG003|Overall Study|Death|0|||
164351363|NCT02289690|593659116|FG004|Overall Study|Death|0|||
164351364|NCT02289690|593659117|FG005|Overall Study|Death|0|||
164351365|NCT02289690|593659118|FG006|Overall Study|Death|0|||
164351366|NCT02289690|593659119|FG007|Overall Study|Death|49|||
164351367|NCT02289690|593659120|FG008|Overall Study|Death|45|||
164351368|NCT02289690|593659121|FG009|Overall Study|Death|41|||
164351369|NCT02289690|593659112|FG000|Overall Study|Sponsor Discontinued Study|0|||
164351370|NCT02289690|593659113|FG001|Overall Study|Sponsor Discontinued Study|0|||
164351371|NCT02289690|593659114|FG002|Overall Study|Sponsor Discontinued Study|0|||
164351372|NCT02289690|593659115|FG003|Overall Study|Sponsor Discontinued Study|0|||
164351373|NCT02289690|593659116|FG004|Overall Study|Sponsor Discontinued Study|0|||
164351374|NCT02289690|593659117|FG005|Overall Study|Sponsor Discontinued Study|0|||
164351375|NCT02289690|593659118|FG006|Overall Study|Sponsor Discontinued Study|0|||
164351376|NCT02289690|593659119|FG007|Overall Study|Sponsor Discontinued Study|9|||
164351377|NCT02289690|593659120|FG008|Overall Study|Sponsor Discontinued Study|7|||
164351378|NCT02289690|593659121|FG009|Overall Study|Sponsor Discontinued Study|15|||
164351379|NCT02289690|593659112|FG000|Overall Study|Other|0|||
164351380|NCT02289690|593659113|FG001|Overall Study|Other|0|||
164351381|NCT02289690|593659114|FG002|Overall Study|Other|0|||
164351382|NCT02289690|593659115|FG003|Overall Study|Other|1|||
164351383|NCT02289690|593659116|FG004|Overall Study|Other|1|||
164351384|NCT02289690|593659117|FG005|Overall Study|Other|0|||
164351385|NCT02289690|593659118|FG006|Overall Study|Other|1|||
164351386|NCT02289690|593659119|FG007|Overall Study|Other|2|||
164351387|NCT02289690|593659120|FG008|Overall Study|Other|3|||
164351388|NCT02289690|593659121|FG009|Overall Study|Other|1|||
164351389|NCT04166435|593659124|FG000|Overall Study|2 patients ineligible for response|2|||
164351390|NCT00814164|593659128|FG000|Overall Study|Progression|7|||
164351391|NCT00814164|593659128|FG000|Overall Study|not stated|7|||
164351392|NCT00814164|593659128|FG000|Overall Study|Death|5|||
164351393|NCT01053221|593659129|FG000|Overall Study|The study was closed prematurely|5|||
164351394|NCT01053221|593659130|FG001|Overall Study|The study was closed prematurely|9|||
164351395|NCT01025752|593659131|FG000|Overall Study|Lost to Follow-up|7|||
164351396|NCT01025752|593659132|FG001|Overall Study|Lost to Follow-up|10|||
164351397|NCT01025752|593659131|FG000|Overall Study|Physician Decision|1|||
164351398|NCT01025752|593659132|FG001|Overall Study|Physician Decision|3|||
164351399|NCT00855920|593659133|FG000|Overall Study|Protocol Violation|0|||
164351400|NCT00855920|593659134|FG001|Overall Study|Protocol Violation|0|||
164351401|NCT00855920|593659135|FG002|Overall Study|Protocol Violation|2|||
164351402|NCT00855920|593659133|FG000|Overall Study|Adverse Event|2|||
164351403|NCT00855920|593659134|FG001|Overall Study|Adverse Event|1|||
164351404|NCT00855920|593659135|FG002|Overall Study|Adverse Event|1|||
164351405|NCT00855920|593659133|FG000|Overall Study|Lack of Efficacy|2|||
164351406|NCT00855920|593659134|FG001|Overall Study|Lack of Efficacy|2|||
164351407|NCT00855920|593659135|FG002|Overall Study|Lack of Efficacy|2|||
164351408|NCT00855920|593659133|FG000|Overall Study|Withdrawal by Subject|2|||
164351409|NCT00855920|593659134|FG001|Overall Study|Withdrawal by Subject|3|||
164351410|NCT00855920|593659135|FG002|Overall Study|Withdrawal by Subject|2|||
164351411|NCT00855920|593659133|FG000|Overall Study|Lost to Follow-up|1|||
164351412|NCT00855920|593659134|FG001|Overall Study|Lost to Follow-up|0|||
164351413|NCT00855920|593659135|FG002|Overall Study|Lost to Follow-up|2|||
164351414|NCT00855920|593659133|FG000|Overall Study|Death|0|||
164351415|NCT00855920|593659134|FG001|Overall Study|Death|1|||
164351416|NCT00855920|593659135|FG002|Overall Study|Death|0|||
164351417|NCT00855920|593659133|FG000|Overall Study|Decision by the sponsor|0|||
164351418|NCT00855920|593659134|FG001|Overall Study|Decision by the sponsor|1|||
164351419|NCT00855920|593659135|FG002|Overall Study|Decision by the sponsor|1|||
164351420|NCT00855920|593659133|FG000|Overall Study|Other than specified above|1|||
164351421|NCT00855920|593659134|FG001|Overall Study|Other than specified above|1|||
164351422|NCT00855920|593659135|FG002|Overall Study|Other than specified above|1|||
164351423|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
164351424|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
164351425|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351426|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351427|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351428|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
164351429|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
164351430|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
164351431|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351432|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351433|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351434|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
164351435|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
164351436|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
164351437|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164351438|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164351439|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
163899094|NCT01105975|592002810|FG005|Overall Study|Withdrawal by Subject|1|||
163899095|NCT01105975|592002811|FG006|Overall Study|Withdrawal by Subject|2|||
163899096|NCT01105975|592002812|FG007|Overall Study|Withdrawal by Subject|1|||
164351440|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
164351441|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
164351442|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
164351443|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164351444|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164351445|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
163899097|NCT01105975|592002813|FG008|Overall Study|Withdrawal by Subject|0|||
164351446|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
164351447|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
164351448|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
164351449|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351450|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351451|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351452|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
164351453|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351454|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
164351455|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351456|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351457|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351458|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
164351459|NCT00843024|593659136|FG000|Single-blind Placebo Run-In Phase|Other|0|||
164351460|NCT00843024|593659137|FG001|Single-blind Placebo Run-In Phase|Other|1|||
164351461|NCT00843024|593659138|FG002|Single-blind Placebo Run-In Phase|Other|0|||
164351462|NCT00843024|593659139|FG003|Single-blind Placebo Run-In Phase|Other|0|||
164351463|NCT00843024|593659140|FG004|Single-blind Placebo Run-In Phase|Other|0|||
164351464|NCT00843024|593659141|FG005|Single-blind Placebo Run-In Phase|Other|0|||
164351465|NCT00843024|593659136|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
164351466|NCT00843024|593659137|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
164351467|NCT00843024|593659138|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
164351468|NCT00843024|593659139|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
164351469|NCT00843024|593659140|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
164351470|NCT00843024|593659141|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
164351471|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164351472|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
164351473|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
164351474|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
164351475|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
164351476|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
164351477|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351478|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351479|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351480|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
164351481|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164351482|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
164351483|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
164351484|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
164351485|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
164351486|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
164351487|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
164351488|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
164351489|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Physician Decision|0|||
164351490|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Physician Decision|0|||
164351491|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Physician Decision|0|||
164351492|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Physician Decision|3|||
164351493|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Physician Decision|1|||
164351494|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Physician Decision|1|||
164351495|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164351496|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Adverse Event|0|||
164351497|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Adverse Event|0|||
164351498|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Adverse Event|0|||
164351499|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Adverse Event|1|||
164351500|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Adverse Event|1|||
164351501|NCT00843024|593659136|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351502|NCT00843024|593659137|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351503|NCT00843024|593659138|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351504|NCT00843024|593659139|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351505|NCT00843024|593659140|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
164351506|NCT00843024|593659141|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
164351507|NCT05201703|593659142|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
164351508|NCT05201703|593659143|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
164351509|NCT05201703|593659142|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
164351510|NCT05201703|593659143|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
164351511|NCT02132130|593659144|FG000|Overall Study|Lost to Follow-up|0|||
164351512|NCT02132130|593659145|FG001|Overall Study|Lost to Follow-up|2|||
164351513|NCT02132130|593659146|FG002|Overall Study|Lost to Follow-up|0|||
164351514|NCT02132130|593659147|FG003|Overall Study|Lost to Follow-up|0|||
164351515|NCT02132130|593659144|FG000|Overall Study|Withdrawal by Subject|0|||
164351516|NCT02132130|593659145|FG001|Overall Study|Withdrawal by Subject|0|||
164351517|NCT02132130|593659146|FG002|Overall Study|Withdrawal by Subject|0|||
164351518|NCT02132130|593659147|FG003|Overall Study|Withdrawal by Subject|1|||
164351519|NCT04600921|593659148|FG000|Overall Study|Withdrawal by Subject|3|||
164351520|NCT04600921|593659149|FG001|Overall Study|Withdrawal by Subject|5|||
164351521|NCT04600921|593659148|FG000|Overall Study|Death|0|||
164351522|NCT04600921|593659149|FG001|Overall Study|Death|1|||
164351523|NCT05425745|593659153|FG000|Overall Study|Withdrawal of Consent|3|||
164351524|NCT05425745|593659154|FG001|Overall Study|Withdrawal of Consent|3|||
164351525|NCT05425745|593659153|FG000|Overall Study|Death|2|||
164351526|NCT05425745|593659154|FG001|Overall Study|Death|3|||
164351527|NCT05425745|593659153|FG000|Overall Study|Lost to Follow-up|1|||
164351528|NCT05425745|593659154|FG001|Overall Study|Lost to Follow-up|2|||
164351529|NCT05425745|593659153|FG000|Overall Study|Adverse Event|0|||
164351530|NCT05425745|593659154|FG001|Overall Study|Adverse Event|1|||
164351531|NCT05425745|593659153|FG000|Overall Study|Did not return for end of study visit|0|||
164351532|NCT05425745|593659154|FG001|Overall Study|Did not return for end of study visit|1|||
164351533|NCT05425745|593659153|FG000|Overall Study|End of study visit completed by phone|1|||
164351534|NCT05425745|593659154|FG001|Overall Study|End of study visit completed by phone|0|||
164351535|NCT05425745|593659153|FG000|Overall Study|Subject decision|1|||
164351536|NCT05425745|593659154|FG001|Overall Study|Subject decision|0|||
164351537|NCT04221009|593660807|FG000|Overall Study|Withdrawal by Subject|4|||
164351538|NCT00793598|593660808|FG000|Overall Study|Patient Request|0|||
164351539|NCT00793598|593660809|FG001|Overall Study|Patient Request|1|||
164351540|NCT00793598|593660810|FG002|Overall Study|Patient Request|0|||
164351541|NCT00793598|593660811|FG003|Overall Study|Patient Request|0|||
164351542|NCT00793598|593660812|FG004|Overall Study|Patient Request|0|||
164351543|NCT00793598|593660813|FG005|Overall Study|Patient Request|0|||
164351544|NCT00793598|593660814|FG006|Overall Study|Patient Request|0|||
164351545|NCT00793598|593660815|FG007|Overall Study|Patient Request|0|||
164351546|NCT00793598|593660808|FG000|Overall Study|Protocol Violation|0|||
164351547|NCT00793598|593660809|FG001|Overall Study|Protocol Violation|0|||
164351548|NCT00793598|593660810|FG002|Overall Study|Protocol Violation|0|||
164351549|NCT00793598|593660811|FG003|Overall Study|Protocol Violation|0|||
164351550|NCT00793598|593660812|FG004|Overall Study|Protocol Violation|0|||
164351551|NCT00793598|593660813|FG005|Overall Study|Protocol Violation|0|||
164351552|NCT00793598|593660814|FG006|Overall Study|Protocol Violation|0|||
164351553|NCT00793598|593660815|FG007|Overall Study|Protocol Violation|1|||
164351554|NCT00793598|593660808|FG000|Overall Study|Subject not dosed|0|||
164351555|NCT00793598|593660809|FG001|Overall Study|Subject not dosed|0|||
164351556|NCT00793598|593660810|FG002|Overall Study|Subject not dosed|0|||
164351557|NCT00793598|593660811|FG003|Overall Study|Subject not dosed|0|||
164351558|NCT00793598|593660812|FG004|Overall Study|Subject not dosed|0|||
164351559|NCT00793598|593660813|FG005|Overall Study|Subject not dosed|1|||
164351560|NCT00793598|593660814|FG006|Overall Study|Subject not dosed|0|||
164351561|NCT00793598|593660815|FG007|Overall Study|Subject not dosed|0|||
164351562|NCT02762266|593660816|FG000|Overall Study|Physician Decision|2|||
164351563|NCT02762266|593660817|FG001|Overall Study|Physician Decision|0|||
164351564|NCT00630396|593660823|FG000|Overall Study|Death|4|||
164351565|NCT00630396|593660823|FG000|Overall Study|Lost to Follow-up|3|||
164351566|NCT02990910|593660827|FG000|Overall Study|Lack of Efficacy|6|||
164351567|NCT02990910|593660828|FG001|Overall Study|Lack of Efficacy|10|||
164351568|NCT02064868|593660830|FG000|Overall Study|Lost to Follow-up|14|||
164351569|NCT02064868|593660831|FG001|Overall Study|Lost to Follow-up|8|||
164351570|NCT02064868|593660830|FG000|Overall Study|Physician Decision|1|||
164351571|NCT02064868|593660831|FG001|Overall Study|Physician Decision|0|||
164351572|NCT02064868|593660830|FG000|Overall Study|Withdrawal by Subject|14|||
164351573|NCT02064868|593660831|FG001|Overall Study|Withdrawal by Subject|3|||
164351574|NCT02064868|593660830|FG000|Overall Study|Technical Problems or Missing|5|||
164351575|NCT02064868|593660831|FG001|Overall Study|Technical Problems or Missing|2|||
164351576|NCT00482612|593660832|FG000|In-treatment Period|No study medication administered|0|||
164351577|NCT00482612|593660833|FG001|In-treatment Period|No study medication administered|0|||
164351578|NCT00482612|593660834|FG002|In-treatment Period|No study medication administered|1|||
164351579|NCT00482612|593660835|FG003|In-treatment Period|No study medication administered|0|||
164351580|NCT00482612|593660832|FG000|Follow-up Period|Other|4|||
164351581|NCT00482612|593660833|FG001|Follow-up Period|Other|2|||
164351582|NCT00482612|593660834|FG002|Follow-up Period|Other|1|||
164351583|NCT00482612|593660835|FG003|Follow-up Period|Other|2|||
164351584|NCT00482612|593660832|FG000|Follow-up Period|Lack of compliance|0|||
164351585|NCT00482612|593660833|FG001|Follow-up Period|Lack of compliance|0|||
164351586|NCT00482612|593660834|FG002|Follow-up Period|Lack of compliance|1|||
164351587|NCT00482612|593660835|FG003|Follow-up Period|Lack of compliance|0|||
164351588|NCT00482612|593660832|FG000|Follow-up Period|Lost to Follow-up|0|||
164351589|NCT00482612|593660833|FG001|Follow-up Period|Lost to Follow-up|4|||
164351590|NCT00482612|593660834|FG002|Follow-up Period|Lost to Follow-up|2|||
164351591|NCT00482612|593660835|FG003|Follow-up Period|Lost to Follow-up|1|||
164351592|NCT00482612|593660832|FG000|Follow-up Period|Adverse Event|4|||
164351593|NCT00482612|593660833|FG001|Follow-up Period|Adverse Event|7|||
164351594|NCT00482612|593660834|FG002|Follow-up Period|Adverse Event|9|||
164351595|NCT00482612|593660835|FG003|Follow-up Period|Adverse Event|0|||
164351596|NCT00482612|593660832|FG000|Follow-up Period|Lack of Efficacy|2|||
164351597|NCT00482612|593660833|FG001|Follow-up Period|Lack of Efficacy|0|||
164351598|NCT00482612|593660834|FG002|Follow-up Period|Lack of Efficacy|1|||
164351599|NCT00482612|593660835|FG003|Follow-up Period|Lack of Efficacy|0|||
164351600|NCT00482612|593660832|FG000|Follow-up Period|Withdrawal by Subject|3|||
164351601|NCT00482612|593660833|FG001|Follow-up Period|Withdrawal by Subject|5|||
164351602|NCT00482612|593660834|FG002|Follow-up Period|Withdrawal by Subject|7|||
164351603|NCT00482612|593660835|FG003|Follow-up Period|Withdrawal by Subject|2|||
164351604|NCT00482612|593660832|FG000|Follow-up Period|Reasons not related to trial|1|||
164351605|NCT00482612|593660833|FG001|Follow-up Period|Reasons not related to trial|0|||
164351606|NCT00482612|593660834|FG002|Follow-up Period|Reasons not related to trial|1|||
164351607|NCT00482612|593660835|FG003|Follow-up Period|Reasons not related to trial|3|||
164351608|NCT00660023|593660836|FG000|Overall Study|Adverse Event|2|||
164351609|NCT00660023|593660836|FG000|Overall Study|Death|8|||
164351610|NCT00660023|593660836|FG000|Overall Study|Blood Transfusion|5|||
164351611|NCT00660023|593660836|FG000|Overall Study|Renal Transplantation|3|||
164351612|NCT00660023|593660836|FG000|Overall Study|Withdrawal by Subject|1|||
164351613|NCT00660023|593660836|FG000|Overall Study|Missed Pregnancy Test|1|||
164351614|NCT00660023|593660836|FG000|Overall Study|Other Screening Failure|9|||
164351615|NCT04180488|593660838|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
164351616|NCT04180488|593660839|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
164351617|NCT04180488|593660840|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
164351618|NCT04180488|593660841|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
164351619|NCT04180488|593660842|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
164351620|NCT04180488|593660843|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
164351621|NCT04180488|593660838|FG000|Overall Study|Withdrawal by Subject|8|||
164351622|NCT04180488|593660839|FG001|Overall Study|Withdrawal by Subject|4|||
164351623|NCT04180488|593660840|FG002|Overall Study|Withdrawal by Subject|5|||
164351624|NCT04180488|593660841|FG003|Overall Study|Withdrawal by Subject|2|||
164351625|NCT04180488|593660842|FG004|Overall Study|Withdrawal by Subject|8|||
164351626|NCT04180488|593660843|FG005|Overall Study|Withdrawal by Subject|6|||
164351627|NCT04180488|593660838|FG000|Overall Study|Adverse Event|3|||
164351628|NCT04180488|593660839|FG001|Overall Study|Adverse Event|2|||
164351629|NCT04180488|593660840|FG002|Overall Study|Adverse Event|0|||
164351630|NCT04180488|593660841|FG003|Overall Study|Adverse Event|0|||
164351631|NCT04180488|593660842|FG004|Overall Study|Adverse Event|0|||
164351632|NCT04180488|593660843|FG005|Overall Study|Adverse Event|0|||
164351633|NCT04180488|593660838|FG000|Overall Study|Poor compliance to protocol|0|||
164351634|NCT04180488|593660839|FG001|Overall Study|Poor compliance to protocol|0|||
164351635|NCT04180488|593660840|FG002|Overall Study|Poor compliance to protocol|1|||
164351636|NCT04180488|593660841|FG003|Overall Study|Poor compliance to protocol|0|||
164351637|NCT04180488|593660842|FG004|Overall Study|Poor compliance to protocol|0|||
164351638|NCT04180488|593660843|FG005|Overall Study|Poor compliance to protocol|0|||
164351639|NCT03506815|593660844|FG000|Overall Study|Adverse Event|8|||
164351640|NCT03506815|593660845|FG001|Overall Study|Adverse Event|0|||
164351641|NCT03506815|593660844|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
164351642|NCT03506815|593660845|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
164351643|NCT03506815|593660844|FG000|Overall Study|Protocol Violation|1|||
164351644|NCT03506815|593660845|FG001|Overall Study|Protocol Violation|0|||
164351645|NCT03506815|593660844|FG000|Overall Study|Elective Surgery|1|||
164351646|NCT03506815|593660845|FG001|Overall Study|Elective Surgery|0|||
164351647|NCT00381095|593660851|FG000|Overall Study|Death|3|||
164351648|NCT00381095|593660852|FG001|Overall Study|Death|4|||
164351649|NCT00381095|593660851|FG000|Overall Study|Lack of Efficacy|2|||
164351650|NCT00381095|593660852|FG001|Overall Study|Lack of Efficacy|4|||
164351651|NCT00381095|593660851|FG000|Overall Study|Other|2|||
164351652|NCT00381095|593660852|FG001|Overall Study|Other|2|||
164351653|NCT00381095|593660851|FG000|Overall Study|Protocol Violation|1|||
164351654|NCT00381095|593660852|FG001|Overall Study|Protocol Violation|1|||
164351655|NCT00381095|593660851|FG000|Overall Study|Withdrawal by Subject|3|||
164351656|NCT00381095|593660852|FG001|Overall Study|Withdrawal by Subject|3|||
164351657|NCT00381095|593660851|FG000|Overall Study|Adverse Event|2|||
164351658|NCT00381095|593660852|FG001|Overall Study|Adverse Event|7|||
164351659|NCT02057406|593660853|FG000|Overall Study|Physician Decision|0|||
164351660|NCT02057406|593660854|FG001|Overall Study|Physician Decision|0|||
164351661|NCT02057406|593660855|FG002|Overall Study|Physician Decision|2|||
164351662|NCT02057406|593660853|FG000|Overall Study|Withdrawal by Subject|0|||
164351663|NCT02057406|593660854|FG001|Overall Study|Withdrawal by Subject|2|||
164351664|NCT02057406|593660855|FG002|Overall Study|Withdrawal by Subject|0|||
164351665|NCT02057406|593660853|FG000|Overall Study|Lost to Follow-up|0|||
164351666|NCT02057406|593660854|FG001|Overall Study|Lost to Follow-up|0|||
164351667|NCT02057406|593660855|FG002|Overall Study|Lost to Follow-up|1|||
164351668|NCT02057406|593660853|FG000|Overall Study|Death|1|||
164351669|NCT02057406|593660854|FG001|Overall Study|Death|0|||
164351670|NCT02057406|593660855|FG002|Overall Study|Death|0|||
164351671|NCT02057406|593660853|FG000|Overall Study|Protocol Violation|0|||
164351672|NCT02057406|593660854|FG001|Overall Study|Protocol Violation|1|||
164351673|NCT02057406|593660855|FG002|Overall Study|Protocol Violation|0|||
164351674|NCT02057406|593660853|FG000|Overall Study|Patient transportation issues|0|||
164351675|NCT02057406|593660854|FG001|Overall Study|Patient transportation issues|0|||
164351676|NCT02057406|593660855|FG002|Overall Study|Patient transportation issues|1|||
164351677|NCT03562481|593660856|FG000|First Intervention|Lost to Follow-up|1|||
164351678|NCT03562481|593660857|FG001|First Intervention|Lost to Follow-up|0|||
164351679|NCT01401283|593660859|FG000|Overall Study|surgery cancelled|5|||
164351680|NCT01401283|593660860|FG001|Overall Study|surgery cancelled|8|||
164351681|NCT01401283|593660859|FG000|Overall Study|preoperative arrhythmia|5|||
164351682|NCT01401283|593660860|FG001|Overall Study|preoperative arrhythmia|0|||
164351683|NCT01401283|593660859|FG000|Overall Study|no central venous access|0|||
164351684|NCT01401283|593660860|FG001|Overall Study|no central venous access|1|||
164351685|NCT01401283|593660859|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
164351686|NCT01401283|593660860|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
164351687|NCT02433483|593660861|FG000|Overall Study|Unacceptable toxicity|1|||
164351688|NCT02433483|593660861|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
164351689|NCT00856284|593660866|FG000|Overall Study|Hyperglycemic rescue|231|||
164351690|NCT00856284|593660867|FG001|Overall Study|Hyperglycemic rescue|201|||
164351691|NCT00856284|593660868|FG002|Overall Study|Hyperglycemic rescue|235|||
164351692|NCT00856284|593660866|FG000|Overall Study|Adverse Event|60|||
164351693|NCT00856284|593660867|FG001|Overall Study|Adverse Event|74|||
164351694|NCT00856284|593660868|FG002|Overall Study|Adverse Event|82|||
164351695|NCT00856284|593660866|FG000|Overall Study|Major protocol deviation|24|||
164351696|NCT00856284|593660867|FG001|Overall Study|Major protocol deviation|16|||
164351697|NCT00856284|593660868|FG002|Overall Study|Major protocol deviation|15|||
164351698|NCT00856284|593660866|FG000|Overall Study|Lost to Follow-up|20|||
164351699|NCT00856284|593660867|FG001|Overall Study|Lost to Follow-up|22|||
164351700|NCT00856284|593660868|FG002|Overall Study|Lost to Follow-up|28|||
164351701|NCT00856284|593660866|FG000|Overall Study|Voluntary withdrawal|48|||
164351702|NCT00856284|593660867|FG001|Overall Study|Voluntary withdrawal|52|||
164351703|NCT00856284|593660868|FG002|Overall Study|Voluntary withdrawal|62|||
164351704|NCT00856284|593660866|FG000|Overall Study|Pregnancy|1|||
164351705|NCT00856284|593660867|FG001|Overall Study|Pregnancy|2|||
164351706|NCT00856284|593660868|FG002|Overall Study|Pregnancy|0|||
164351707|NCT00856284|593660866|FG000|Overall Study|Investigator discretion|9|||
164351708|NCT00856284|593660867|FG001|Overall Study|Investigator discretion|8|||
164351709|NCT00856284|593660868|FG002|Overall Study|Investigator discretion|10|||
164351710|NCT00856284|593660866|FG000|Overall Study|Other|15|||
164351711|NCT00856284|593660867|FG001|Overall Study|Other|17|||
164351712|NCT00856284|593660868|FG002|Overall Study|Other|14|||
164351713|NCT00856284|593660866|FG000|Overall Study|Randomized in error|0|||
164351714|NCT00856284|593660867|FG001|Overall Study|Randomized in error|0|||
164351715|NCT00856284|593660868|FG002|Overall Study|Randomized in error|1|||
164351716|NCT01327885|593660873|FG000|Overall Study|Disease progression-according to RECIST|173|||
164351717|NCT01327885|593660874|FG001|Overall Study|Disease progression-according to RECIST|165|||
164351718|NCT01327885|593660873|FG000|Overall Study|Clinical progression|24|||
164351719|NCT01327885|593660874|FG001|Overall Study|Clinical progression|27|||
164351720|NCT01327885|593660873|FG000|Overall Study|Adverse Event|14|||
164351721|NCT01327885|593660874|FG001|Overall Study|Adverse Event|10|||
164351722|NCT01327885|593660873|FG000|Overall Study|Subject choice|5|||
163899098|NCT01105975|592002814|FG009|Overall Study|Withdrawal by Subject|3|||
163899099|NCT01105975|592002805|FG000|Overall Study|Lost to Follow-up|1|||
163899100|NCT01105975|592002806|FG001|Overall Study|Lost to Follow-up|0|||
163899101|NCT01105975|592002807|FG002|Overall Study|Lost to Follow-up|0|||
163899102|NCT01105975|592002808|FG003|Overall Study|Lost to Follow-up|1|||
164089759|NCT02324465|592691474|FG000|Overall Study|device failure|0|||
164089760|NCT02324465|592691475|FG001|Overall Study|device failure|1|||
164351723|NCT01327885|593660874|FG001|Overall Study|Subject choice|10|||
164351724|NCT01327885|593660873|FG000|Overall Study|Other|8|||
164351725|NCT01327885|593660874|FG001|Overall Study|Other|6|||
164351726|NCT01327885|593660873|FG000|Overall Study|Withdrawal of consent from study|3|||
164351727|NCT01327885|593660874|FG001|Overall Study|Withdrawal of consent from study|4|||
164351728|NCT01327885|593660873|FG000|Overall Study|Not treated|1|||
164351729|NCT01327885|593660874|FG001|Overall Study|Not treated|1|||
164351730|NCT01327885|593660873|FG000|Overall Study|Administrative decision|0|||
164351731|NCT01327885|593660874|FG001|Overall Study|Administrative decision|1|||
164351732|NCT03824912|593660880|FG000|Overall Study|Lost to Follow-up|18|||
164351733|NCT03824912|593660881|FG001|Overall Study|Lost to Follow-up|15|||
164351734|NCT03824912|593660882|FG002|Overall Study|Lost to Follow-up|8|||
164351735|NCT03824912|593660880|FG000|Overall Study|Negative Baseline Culture Result|118|||
164351736|NCT03824912|593660881|FG001|Overall Study|Negative Baseline Culture Result|112|||
164351737|NCT03824912|593660882|FG002|Overall Study|Negative Baseline Culture Result|57|||
164351738|NCT03824912|593660880|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164351739|NCT03824912|593660881|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164351740|NCT03824912|593660882|FG002|Overall Study|Non-Compliance with Study Drug|1|||
164351741|NCT03824912|593660880|FG000|Overall Study|Protocol Violation|1|||
164351742|NCT03824912|593660881|FG001|Overall Study|Protocol Violation|4|||
164351743|NCT03824912|593660882|FG002|Overall Study|Protocol Violation|1|||
164351744|NCT03824912|593660880|FG000|Overall Study|Withdrawal by Subject|3|||
164351745|NCT03824912|593660881|FG001|Overall Study|Withdrawal by Subject|2|||
164351746|NCT03824912|593660882|FG002|Overall Study|Withdrawal by Subject|1|||
164351747|NCT03824912|593660880|FG000|Overall Study|Participation in another study|0|||
164351748|NCT03824912|593660881|FG001|Overall Study|Participation in another study|1|||
164351749|NCT03824912|593660882|FG002|Overall Study|Participation in another study|0|||
164351750|NCT04271605|593660883|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
164351751|NCT02485301|593660884|FG000|Overall Study|Serious Adverse Events|2|||
164351752|NCT02485301|593660885|FG001|Overall Study|Serious Adverse Events|1|||
164351753|NCT02485301|593660884|FG000|Overall Study|Protocol Violation|0|||
164351754|NCT02485301|593660885|FG001|Overall Study|Protocol Violation|1|||
164351755|NCT02485301|593660884|FG000|Overall Study|Withdrawal by Subject|6|||
164351756|NCT02485301|593660885|FG001|Overall Study|Withdrawal by Subject|7|||
164351757|NCT02485301|593660884|FG000|Overall Study|Migrated/moved from study area|10|||
164351758|NCT02485301|593660885|FG001|Overall Study|Migrated/moved from study area|19|||
164351759|NCT02485301|593660884|FG000|Overall Study|Lost to Follow-up|17|||
164351760|NCT02485301|593660885|FG001|Overall Study|Lost to Follow-up|17|||
164351761|NCT02485301|593660884|FG000|Overall Study|Other|3|||
164351762|NCT02485301|593660885|FG001|Overall Study|Other|4|||
164351763|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351764|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351765|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351766|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351767|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164005639|NCT00957372|592385841|FG001|PART II|Patient non-compliance|0|||
164005640|NCT00957372|592385842|FG002|PART II|Patient non-compliance|0|||
164005641|NCT00957372|592385843|FG003|PART II|Patient non-compliance|4|||
164351768|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
164351769|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
164351770|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351771|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351772|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351773|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351774|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351775|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
164351776|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
164351777|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351778|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351779|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351780|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351781|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351782|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
164351783|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
164351784|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351785|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351786|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351787|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351788|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351789|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
164351790|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
164351791|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
164351792|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
164351793|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
164351794|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
164351795|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
164351796|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
164351797|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
164351798|NCT01059825|593660889|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
164351799|NCT01059825|593660890|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
164351800|NCT01059825|593660891|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
164351801|NCT01059825|593660892|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
164351802|NCT01059825|593660893|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
164351803|NCT01059825|593660894|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
164351804|NCT01059825|593660895|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
164351805|NCT01059825|593660889|FG000|Treatment Period|Lost to Follow-up|2|||
164351806|NCT01059825|593660890|FG001|Treatment Period|Lost to Follow-up|1|||
164351807|NCT01059825|593660891|FG002|Treatment Period|Lost to Follow-up|0|||
164351808|NCT01059825|593660892|FG003|Treatment Period|Lost to Follow-up|1|||
164351809|NCT01059825|593660893|FG004|Treatment Period|Lost to Follow-up|2|||
164351810|NCT01059825|593660894|FG005|Treatment Period|Lost to Follow-up|0|||
164351811|NCT01059825|593660895|FG006|Treatment Period|Lost to Follow-up|0|||
164351812|NCT01059825|593660889|FG000|Treatment Period|Withdrawal by Subject|3|||
164351813|NCT01059825|593660890|FG001|Treatment Period|Withdrawal by Subject|0|||
164351814|NCT01059825|593660891|FG002|Treatment Period|Withdrawal by Subject|1|||
164351815|NCT01059825|593660892|FG003|Treatment Period|Withdrawal by Subject|5|||
164351816|NCT01059825|593660893|FG004|Treatment Period|Withdrawal by Subject|4|||
164351817|NCT01059825|593660894|FG005|Treatment Period|Withdrawal by Subject|1|||
164351818|NCT01059825|593660895|FG006|Treatment Period|Withdrawal by Subject|0|||
164351819|NCT01059825|593660889|FG000|Treatment Period|Other reason not specified|1|||
164351820|NCT01059825|593660890|FG001|Treatment Period|Other reason not specified|2|||
164351821|NCT01059825|593660891|FG002|Treatment Period|Other reason not specified|1|||
164351822|NCT01059825|593660892|FG003|Treatment Period|Other reason not specified|2|||
164351823|NCT01059825|593660893|FG004|Treatment Period|Other reason not specified|0|||
164351824|NCT01059825|593660894|FG005|Treatment Period|Other reason not specified|0|||
164351825|NCT01059825|593660895|FG006|Treatment Period|Other reason not specified|0|||
164351826|NCT01059825|593660889|FG000|Treatment Period|Protocol Violation|0|||
164351827|NCT01059825|593660890|FG001|Treatment Period|Protocol Violation|0|||
164351828|NCT01059825|593660891|FG002|Treatment Period|Protocol Violation|1|||
164351829|NCT01059825|593660892|FG003|Treatment Period|Protocol Violation|1|||
164351830|NCT01059825|593660893|FG004|Treatment Period|Protocol Violation|1|||
164351831|NCT01059825|593660894|FG005|Treatment Period|Protocol Violation|1|||
164351832|NCT01059825|593660895|FG006|Treatment Period|Protocol Violation|0|||
164351833|NCT01059825|593660889|FG000|Treatment Period|Adverse event related to study drug|1|||
164351834|NCT01059825|593660890|FG001|Treatment Period|Adverse event related to study drug|0|||
164351835|NCT01059825|593660891|FG002|Treatment Period|Adverse event related to study drug|1|||
164351836|NCT01059825|593660892|FG003|Treatment Period|Adverse event related to study drug|1|||
164351837|NCT01059825|593660893|FG004|Treatment Period|Adverse event related to study drug|0|||
164351838|NCT01059825|593660894|FG005|Treatment Period|Adverse event related to study drug|0|||
164351839|NCT01059825|593660895|FG006|Treatment Period|Adverse event related to study drug|0|||
164351840|NCT01059825|593660889|FG000|Treatment Period|Insufficient clinical response|3|||
164351841|NCT01059825|593660890|FG001|Treatment Period|Insufficient clinical response|0|||
164351842|NCT01059825|593660891|FG002|Treatment Period|Insufficient clinical response|0|||
164351843|NCT01059825|593660892|FG003|Treatment Period|Insufficient clinical response|0|||
164351844|NCT01059825|593660893|FG004|Treatment Period|Insufficient clinical response|0|||
164351845|NCT01059825|593660894|FG005|Treatment Period|Insufficient clinical response|0|||
164351846|NCT01059825|593660895|FG006|Treatment Period|Insufficient clinical response|0|||
164351847|NCT01059825|593660889|FG000|Treatment Period|Adverse event not related to study drug|0|||
164351848|NCT01059825|593660890|FG001|Treatment Period|Adverse event not related to study drug|1|||
164351849|NCT01059825|593660891|FG002|Treatment Period|Adverse event not related to study drug|2|||
164351850|NCT01059825|593660892|FG003|Treatment Period|Adverse event not related to study drug|1|||
164351851|NCT01059825|593660893|FG004|Treatment Period|Adverse event not related to study drug|1|||
164351852|NCT01059825|593660894|FG005|Treatment Period|Adverse event not related to study drug|1|||
164351853|NCT01059825|593660895|FG006|Treatment Period|Adverse event not related to study drug|0|||
164351854|NCT03342690|593660904|FG000|Overall Study|Missing Information|9|||
164351855|NCT03342690|593660904|FG000|Overall Study|Protocol Violation|16|||
164351856|NCT03138889|593660905|FG000|Overall Study|Withdrawal by Subject|5|||
164351857|NCT03138889|593660906|FG001|Overall Study|Withdrawal by Subject|5|||
164351858|NCT03138889|593660907|FG002|Overall Study|Withdrawal by Subject|0|||
164351859|NCT03138889|593660908|FG003|Overall Study|Withdrawal by Subject|2|||
164351860|NCT03138889|593660909|FG004|Overall Study|Withdrawal by Subject|1|||
164351861|NCT03138889|593660910|FG005|Overall Study|Withdrawal by Subject|3|||
164351862|NCT03138889|593660911|FG006|Overall Study|Withdrawal by Subject|0|||
164351863|NCT03138889|593660912|FG007|Overall Study|Withdrawal by Subject|1|||
164351864|NCT00549302|593660921|FG000|Double-Blind|Death|2|||
164351865|NCT00549302|593660922|FG001|Double-Blind|Death|9|||
164005642|NCT03750838|592385844|FG000|Overall Study|Lost to Follow-up|10|||
164351866|NCT00549302|593660923|FG002|Double-Blind|Death|0|||
164351867|NCT00549302|593660921|FG000|Double-Blind|Adverse Event|3|||
164005643|NCT03750838|592385845|FG001|Overall Study|Lost to Follow-up|6|||
164005644|NCT02032875|592385848|FG000|Treatment Period|Adverse Event|1|||
164351868|NCT00549302|593660922|FG001|Double-Blind|Adverse Event|16|||
164351869|NCT00549302|593660923|FG002|Double-Blind|Adverse Event|0|||
164351870|NCT00549302|593660921|FG000|Double-Blind|Withdrawal by Subject|3|||
164351871|NCT00549302|593660922|FG001|Double-Blind|Withdrawal by Subject|8|||
164005645|NCT02032875|592385849|FG001|Treatment Period|Adverse Event|0|||
164351872|NCT00549302|593660923|FG002|Double-Blind|Withdrawal by Subject|0|||
164351873|NCT00549302|593660921|FG000|Double-Blind|Investigator Decision|1|||
164351874|NCT00549302|593660922|FG001|Double-Blind|Investigator Decision|5|||
164351875|NCT00549302|593660923|FG002|Double-Blind|Investigator Decision|0|||
164351876|NCT00549302|593660921|FG000|Double-Blind|Sponsor Decision|0|||
164351877|NCT00549302|593660922|FG001|Double-Blind|Sponsor Decision|1|||
164351878|NCT00549302|593660923|FG002|Double-Blind|Sponsor Decision|0|||
164351879|NCT00549302|593660921|FG000|Double-Blind|Lost to Follow-up|1|||
164351880|NCT00549302|593660922|FG001|Double-Blind|Lost to Follow-up|2|||
164351881|NCT00549302|593660923|FG002|Double-Blind|Lost to Follow-up|0|||
164351882|NCT00549302|593660921|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
164351883|NCT00549302|593660922|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
164351884|NCT00549302|593660923|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
164351885|NCT00549302|593660921|FG000|Double-Blind|New condition or starts new therapy|0|||
164351886|NCT00549302|593660922|FG001|Double-Blind|New condition or starts new therapy|2|||
164351887|NCT00549302|593660923|FG002|Double-Blind|New condition or starts new therapy|0|||
164351888|NCT00549302|593660921|FG000|Open-Label|Adverse Event|0|||
164351889|NCT00549302|593660922|FG001|Open-Label|Adverse Event|0|||
164351890|NCT00549302|593660923|FG002|Open-Label|Adverse Event|11|||
164351891|NCT00549302|593660921|FG000|Open-Label|Death|0|||
164351892|NCT00549302|593660922|FG001|Open-Label|Death|0|||
164351893|NCT00549302|593660923|FG002|Open-Label|Death|40|||
164351894|NCT00549302|593660921|FG000|Open-Label|Investigator Decision|0|||
164351895|NCT00549302|593660922|FG001|Open-Label|Investigator Decision|0|||
164351896|NCT00549302|593660923|FG002|Open-Label|Investigator Decision|5|||
164351897|NCT00549302|593660921|FG000|Open-Label|Lost to Follow-up|0|||
164351898|NCT00549302|593660922|FG001|Open-Label|Lost to Follow-up|0|||
164351899|NCT00549302|593660923|FG002|Open-Label|Lost to Follow-up|2|||
164351900|NCT00549302|593660921|FG000|Open-Label|Other|0|||
164351901|NCT00549302|593660922|FG001|Open-Label|Other|0|||
164351902|NCT00549302|593660923|FG002|Open-Label|Other|3|||
164351903|NCT00549302|593660921|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
164351904|NCT00549302|593660922|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
164351905|NCT00549302|593660923|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
164351906|NCT00549302|593660921|FG000|Open-Label|Withdrawal by Subject|0|||
164351907|NCT00549302|593660922|FG001|Open-Label|Withdrawal by Subject|0|||
164351908|NCT00549302|593660923|FG002|Open-Label|Withdrawal by Subject|6|||
164351909|NCT01414114|593660924|FG000|Overall Study|Adverse Event|2|||
164351910|NCT01414114|593660924|FG000|Overall Study|Withdrawal by Subject|1|||
164351911|NCT01414114|593660924|FG000|Overall Study|Other|2|||
164351912|NCT00105482|593660929|FG000|Overall Study|Adverse Event|1|||
164351913|NCT00105482|593660930|FG001|Overall Study|Adverse Event|1|||
164351914|NCT00105482|593660929|FG000|Overall Study|Lost to Follow-up|26|||
164351915|NCT00105482|593660930|FG001|Overall Study|Lost to Follow-up|17|||
164351916|NCT00105482|593660929|FG000|Overall Study|Withdrawal by Subject|0|||
164351917|NCT00105482|593660930|FG001|Overall Study|Withdrawal by Subject|1|||
164351918|NCT00105482|593660929|FG000|Overall Study|Lost Interest|29|||
164351919|NCT00105482|593660930|FG001|Overall Study|Lost Interest|32|||
164351920|NCT00105482|593660929|FG000|Overall Study|Scheduling Conflict|2|||
164351921|NCT00105482|593660930|FG001|Overall Study|Scheduling Conflict|3|||
164351922|NCT00105482|593660929|FG000|Overall Study|Withdrawn by PI|1|||
164351923|NCT00105482|593660930|FG001|Overall Study|Withdrawn by PI|1|||
164351924|NCT02495168|593660936|FG000|Overall Study|Other than Specified|18|||
164351925|NCT02495168|593660937|FG001|Overall Study|Other than Specified|22|||
164351926|NCT02495168|593660938|FG002|Overall Study|Other than Specified|5|||
164351927|NCT02495168|593660936|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
163899103|NCT01105975|592002809|FG004|Overall Study|Lost to Follow-up|1|||
164089761|NCT01031537|592691476|FG000|Overall Study|medical reasons not related to study|3|||
164089762|NCT01031537|592691476|FG000|Overall Study|Lack of Efficacy|1|||
164089763|NCT01031537|592691476|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
164089764|NCT01031537|592691476|FG000|Overall Study|moved, met exclusion criteria|10|||
164351928|NCT02495168|593660937|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
164351929|NCT02495168|593660938|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
164351930|NCT02495168|593660936|FG000|Overall Study|Physician Decision|1|||
164351931|NCT02495168|593660937|FG001|Overall Study|Physician Decision|1|||
164351932|NCT02495168|593660938|FG002|Overall Study|Physician Decision|0|||
164351933|NCT02495168|593660936|FG000|Overall Study|Lost to Follow-up|10|||
164351934|NCT02495168|593660937|FG001|Overall Study|Lost to Follow-up|6|||
164351935|NCT02495168|593660938|FG002|Overall Study|Lost to Follow-up|1|||
164351936|NCT02495168|593660936|FG000|Overall Study|Withdrawal by Subject|1|||
164351937|NCT02495168|593660937|FG001|Overall Study|Withdrawal by Subject|4|||
164351938|NCT02495168|593660938|FG002|Overall Study|Withdrawal by Subject|2|||
164351939|NCT02495168|593660936|FG000|Overall Study|Protocol Violation|0|||
164351940|NCT02495168|593660937|FG001|Overall Study|Protocol Violation|10|||
164351941|NCT02495168|593660938|FG002|Overall Study|Protocol Violation|1|||
164351942|NCT02495168|593660936|FG000|Overall Study|Adverse Event|4|||
164351943|NCT02495168|593660937|FG001|Overall Study|Adverse Event|8|||
164351944|NCT02495168|593660938|FG002|Overall Study|Adverse Event|3|||
164351945|NCT02495168|593660936|FG000|Overall Study|Lack of Efficacy|0|||
164351946|NCT02495168|593660937|FG001|Overall Study|Lack of Efficacy|0|||
164351947|NCT02495168|593660938|FG002|Overall Study|Lack of Efficacy|3|||
164351948|NCT00644995|593660939|FG000|Overall Study|Lost to Follow-up|1|||
164351949|NCT00644995|593660940|FG001|Overall Study|Lost to Follow-up|4|||
164351950|NCT00644995|593660939|FG000|Overall Study|Refused|1|||
164351951|NCT00644995|593660940|FG001|Overall Study|Refused|0|||
164351952|NCT00865124|593660941|FG000|Overall Study|Physician Decision|2|||
164351953|NCT00865124|593660942|FG001|Overall Study|Physician Decision|1|||
164351954|NCT00865124|593660943|FG002|Overall Study|Physician Decision|0|||
164351955|NCT00865124|593660941|FG000|Overall Study|Withdrawn consent|2|||
164351956|NCT00865124|593660942|FG001|Overall Study|Withdrawn consent|0|||
164351957|NCT00865124|593660943|FG002|Overall Study|Withdrawn consent|0|||
164351958|NCT02743520|593660944|FG000|Overall Study|Withdrawal by Subject|1|||
164351959|NCT03247530|593660945|FG000|Overall Study|Withdrawal by caregiver|19|||
164351960|NCT03247530|593660946|FG001|Overall Study|Withdrawal by caregiver|8|||
164351961|NCT03247530|593660947|FG002|Overall Study|Withdrawal by caregiver|10|||
164351962|NCT03247530|593660945|FG000|Overall Study|Lost to Follow-up|3|||
164351963|NCT03247530|593660946|FG001|Overall Study|Lost to Follow-up|9|||
164351964|NCT03247530|593660947|FG002|Overall Study|Lost to Follow-up|6|||
164351965|NCT03247530|593660945|FG000|Overall Study|Adverse Event|2|||
164351966|NCT03247530|593660946|FG001|Overall Study|Adverse Event|5|||
164351967|NCT03247530|593660947|FG002|Overall Study|Adverse Event|2|||
164351968|NCT03247530|593660945|FG000|Overall Study|Failure to follow procedure|1|||
164351969|NCT03247530|593660946|FG001|Overall Study|Failure to follow procedure|1|||
164351970|NCT03247530|593660947|FG002|Overall Study|Failure to follow procedure|1|||
164351971|NCT03247530|593660945|FG000|Overall Study|Withdrawal by Subject|1|||
164351972|NCT03247530|593660946|FG001|Overall Study|Withdrawal by Subject|1|||
164351973|NCT03247530|593660947|FG002|Overall Study|Withdrawal by Subject|0|||
164351974|NCT03247530|593660945|FG000|Overall Study|Study medication misuse|0|||
164351975|NCT03247530|593660946|FG001|Overall Study|Study medication misuse|1|||
164351976|NCT03247530|593660947|FG002|Overall Study|Study medication misuse|0|||
164351977|NCT03247530|593660945|FG000|Overall Study|Other, multiple categories|1|||
164351978|NCT03247530|593660946|FG001|Overall Study|Other, multiple categories|3|||
164351979|NCT03247530|593660947|FG002|Overall Study|Other, multiple categories|1|||
164351980|NCT03042533|593660948|FG000|Overall Study|MD left program|1|||
164351981|NCT03042533|593660949|FG001|Overall Study|MD left program|4|||
164351982|NCT03042533|593660950|FG002|Overall Study|MD left program|1|||
164351983|NCT01587001|593660951|FG000|Overall Study|Lost to Follow-up|2|||
164351984|NCT01587001|593660952|FG001|Overall Study|Lost to Follow-up|0|||
164351985|NCT01587001|593660951|FG000|Overall Study|Insufficient samples to complete testing|4|||
164351986|NCT01587001|593660952|FG001|Overall Study|Insufficient samples to complete testing|1|||
164351987|NCT04786990|593660953|FG000|Overall Study|Withdrawal by Subject|1|||
164351988|NCT04786990|593660953|FG000|Overall Study|Adverse Event|1|||
164351989|NCT04786990|593660953|FG000|Overall Study|Lost to Follow-up|1|||
164351990|NCT04786990|593660953|FG000|Overall Study|Noncompliance|1|||
164351991|NCT04786990|593660953|FG000|Overall Study|Unable to complete site visits|1|||
164351992|NCT04786990|593660953|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
164351993|NCT02233647|593660954|FG000|Overall Study|Adverse Event|1|||
164351994|NCT00439244|593660960|FG000|Overall Study|Adverse Event|5|||
164351995|NCT00439244|593660961|FG001|Overall Study|Adverse Event|2|||
164351996|NCT00439244|593660962|FG002|Overall Study|Adverse Event|3|||
164351997|NCT00439244|593660960|FG000|Overall Study|Withdrawal by Subject|3|||
164351998|NCT00439244|593660961|FG001|Overall Study|Withdrawal by Subject|1|||
164351999|NCT00439244|593660962|FG002|Overall Study|Withdrawal by Subject|2|||
164352000|NCT00439244|593660960|FG000|Overall Study|Lost to Follow-up|2|||
164352001|NCT00439244|593660961|FG001|Overall Study|Lost to Follow-up|1|||
164352002|NCT00439244|593660962|FG002|Overall Study|Lost to Follow-up|2|||
164352003|NCT00439244|593660960|FG000|Overall Study|Death|0|||
164352004|NCT00439244|593660961|FG001|Overall Study|Death|1|||
164005646|NCT02032875|592385848|FG000|Treatment Period|Liver transplant, No extension needed|0|||
164352005|NCT00439244|593660962|FG002|Overall Study|Death|0|||
164352006|NCT00439244|593660960|FG000|Overall Study|Protocol Violation|0|||
164352007|NCT00439244|593660961|FG001|Overall Study|Protocol Violation|1|||
164352008|NCT00439244|593660962|FG002|Overall Study|Protocol Violation|0|||
164352009|NCT00439244|593660960|FG000|Overall Study|Administrative problems|1|||
164352010|NCT00439244|593660961|FG001|Overall Study|Administrative problems|0|||
164352011|NCT00439244|593660962|FG002|Overall Study|Administrative problems|0|||
164352012|NCT02846779|593660963|FG000|Overall Study|Lost Enrollment|83|||
164352013|NCT02846779|593660964|FG001|Overall Study|Lost Enrollment|82|||
164352014|NCT02846779|593660965|FG002|Overall Study|Lost Enrollment|86|||
164352015|NCT02846779|593660963|FG000|Overall Study|Less than 31 days of follow-up|56|||
164352016|NCT02846779|593660964|FG001|Overall Study|Less than 31 days of follow-up|45|||
164352017|NCT02846779|593660965|FG002|Overall Study|Less than 31 days of follow-up|52|||
164352018|NCT05353985|593660970|FG000|Overall Study|Adverse Event|5|||
164352019|NCT05353985|593660971|FG001|Overall Study|Adverse Event|7|||
164352020|NCT05353985|593660970|FG000|Overall Study|Lost to Follow-up|1|||
164352021|NCT05353985|593660971|FG001|Overall Study|Lost to Follow-up|1|||
164352022|NCT05353985|593660970|FG000|Overall Study|Protocol Violation|1|||
164352023|NCT05353985|593660971|FG001|Overall Study|Protocol Violation|0|||
164352024|NCT05353985|593660970|FG000|Overall Study|Withdrawal by Subject|13|||
164352025|NCT05353985|593660971|FG001|Overall Study|Withdrawal by Subject|17|||
164352026|NCT05353985|593660970|FG000|Overall Study|Reason Not Specified|1|||
164352027|NCT05353985|593660971|FG001|Overall Study|Reason Not Specified|0|||
164352028|NCT05353985|593660970|FG000|Overall Study|Randomized in Error & Not Treated|0|||
164352029|NCT05353985|593660971|FG001|Overall Study|Randomized in Error & Not Treated|1|||
164352030|NCT00524368|593662566|FG000|Overall Study|Adverse Event|10|||
164352031|NCT00524368|593662567|FG001|Overall Study|Adverse Event|12|||
164352032|NCT00524368|593662566|FG000|Overall Study|Lost to Follow-up|9|||
164352033|NCT00524368|593662567|FG001|Overall Study|Lost to Follow-up|13|||
164352034|NCT00524368|593662566|FG000|Overall Study|Withdrawal by Subject|4|||
164352035|NCT00524368|593662567|FG001|Overall Study|Withdrawal by Subject|5|||
164352036|NCT00524368|593662566|FG000|Overall Study|Non-compliant|8|||
164352037|NCT00524368|593662567|FG001|Overall Study|Non-compliant|9|||
164352038|NCT00524368|593662566|FG000|Overall Study|Reached a Virologic Endpoint|3|||
164352039|NCT00524368|593662567|FG001|Overall Study|Reached a Virologic Endpoint|2|||
164352040|NCT00524368|593662566|FG000|Overall Study|Sponsor's Decision|2|||
164352041|NCT00524368|593662567|FG001|Overall Study|Sponsor's Decision|0|||
164352042|NCT00524368|593662566|FG000|Overall Study|Ineligible to Continue the study|2|||
164352043|NCT00524368|593662567|FG001|Overall Study|Ineligible to Continue the study|5|||
164352044|NCT00524368|593662566|FG000|Overall Study|Other|3|||
164352045|NCT00524368|593662567|FG001|Overall Study|Other|2|||
164352046|NCT01438424|593662570|FG000|Overall Study|Continuing treatment|29|||
164352047|NCT01438424|593662570|FG000|Overall Study|Minimal virologic response|95|||
164352048|NCT01438424|593662570|FG000|Overall Study|Not identified|55|||
164352049|NCT01438424|593662570|FG000|Overall Study|Withdrawal by Subject|104|||
164352050|NCT01438424|593662570|FG000|Overall Study|Progression of chronic hepatitis B|22|||
164352051|NCT01438424|593662570|FG000|Overall Study|Death|22|||
164352052|NCT01438424|593662570|FG000|Overall Study|Adverse Event|17|||
164352053|NCT01438424|593662570|FG000|Overall Study|Lost to Follow-up|17|||
164352054|NCT01438424|593662570|FG000|Overall Study|Abnormal laboratory test result|14|||
164352055|NCT01438424|593662570|FG000|Overall Study|Need for drug prohibited by protocol|14|||
164352056|NCT01438424|593662570|FG000|Overall Study|Pregnancy|7|||
164352057|NCT01438424|593662570|FG000|Overall Study|No longer met inclusion criteria|1|||
164352058|NCT01438424|593662570|FG000|Overall Study|Participant noncompliance|20|||
164352059|NCT02373202|593662574|FG000|Overall Study|Adverse Event|2|||
164352060|NCT02373202|593662575|FG001|Overall Study|Adverse Event|5|||
164352061|NCT02373202|593662576|FG002|Overall Study|Adverse Event|2|||
164352062|NCT02373202|593662577|FG003|Overall Study|Adverse Event|1|||
164352063|NCT02373202|593662574|FG000|Overall Study|Lack of Efficacy|0|||
164352064|NCT02373202|593662575|FG001|Overall Study|Lack of Efficacy|0|||
164352065|NCT02373202|593662576|FG002|Overall Study|Lack of Efficacy|1|||
164352066|NCT02373202|593662577|FG003|Overall Study|Lack of Efficacy|0|||
164352067|NCT02373202|593662574|FG000|Overall Study|Other|0|||
164352068|NCT02373202|593662575|FG001|Overall Study|Other|1|||
164352069|NCT02373202|593662576|FG002|Overall Study|Other|0|||
164352070|NCT02373202|593662577|FG003|Overall Study|Other|0|||
164352071|NCT00410046|593662578|FG000|Overall Study|Adverse Event|3|||
164352072|NCT00410046|593662578|FG000|Overall Study|Withdrawal by Subject|1|||
164352073|NCT00410046|593662578|FG000|Overall Study|Lost to Follow-up|1|||
164352074|NCT03010254|593662579|FG000|Overall Study|Adverse Event|0|||
164352075|NCT03010254|593662580|FG001|Overall Study|Adverse Event|1|||
164352076|NCT03010254|593662579|FG000|Overall Study|Lost to Follow-up|4|||
164352077|NCT03010254|593662580|FG001|Overall Study|Lost to Follow-up|0|||
164352078|NCT03010254|593662579|FG000|Overall Study|Withdrawal by Subject|1|||
164352079|NCT03010254|593662580|FG001|Overall Study|Withdrawal by Subject|1|||
164352080|NCT03010254|593662579|FG000|Overall Study|Other|2|||
164352081|NCT03010254|593662580|FG001|Overall Study|Other|3|||
164352082|NCT02927080|593662587|FG000|Overall Study|Withdrawal by Subject|0|||
164352083|NCT02927080|593662588|FG001|Overall Study|Withdrawal by Subject|0|||
164352084|NCT02927080|593662589|FG002|Overall Study|Withdrawal by Subject|0|||
164352085|NCT02927080|593662590|FG003|Overall Study|Withdrawal by Subject|0|||
164352086|NCT02927080|593662591|FG004|Overall Study|Withdrawal by Subject|1|||
164352087|NCT02927080|593662592|FG005|Overall Study|Withdrawal by Subject|0|||
164352088|NCT02927080|593662593|FG006|Overall Study|Withdrawal by Subject|1|||
164352089|NCT02927080|593662594|FG007|Overall Study|Withdrawal by Subject|1|||
164352090|NCT02927080|593662595|FG008|Overall Study|Withdrawal by Subject|0|||
164352091|NCT02927080|593662596|FG009|Overall Study|Withdrawal by Subject|2|||
164352092|NCT02927080|593662587|FG000|Overall Study|Willingness to comply with protocol|0|||
164352093|NCT02927080|593662588|FG001|Overall Study|Willingness to comply with protocol|0|||
164352094|NCT02927080|593662589|FG002|Overall Study|Willingness to comply with protocol|0|||
164352095|NCT02927080|593662590|FG003|Overall Study|Willingness to comply with protocol|0|||
164352096|NCT02927080|593662591|FG004|Overall Study|Willingness to comply with protocol|0|||
164352097|NCT02927080|593662592|FG005|Overall Study|Willingness to comply with protocol|0|||
164352098|NCT02927080|593662593|FG006|Overall Study|Willingness to comply with protocol|0|||
164352099|NCT02927080|593662594|FG007|Overall Study|Willingness to comply with protocol|0|||
164352100|NCT02927080|593662595|FG008|Overall Study|Willingness to comply with protocol|0|||
164352101|NCT02927080|593662596|FG009|Overall Study|Willingness to comply with protocol|1|||
164352102|NCT02927080|593662587|FG000|Overall Study|Study terminated by Sponsor|0|||
164352103|NCT02927080|593662588|FG001|Overall Study|Study terminated by Sponsor|0|||
164352104|NCT02927080|593662589|FG002|Overall Study|Study terminated by Sponsor|0|||
164352105|NCT02927080|593662590|FG003|Overall Study|Study terminated by Sponsor|0|||
164352106|NCT02927080|593662591|FG004|Overall Study|Study terminated by Sponsor|0|||
164352107|NCT02927080|593662592|FG005|Overall Study|Study terminated by Sponsor|0|||
164352108|NCT02927080|593662593|FG006|Overall Study|Study terminated by Sponsor|6|||
164352109|NCT02927080|593662594|FG007|Overall Study|Study terminated by Sponsor|7|||
164352110|NCT02927080|593662595|FG008|Overall Study|Study terminated by Sponsor|2|||
164352111|NCT02927080|593662596|FG009|Overall Study|Study terminated by Sponsor|3|||
164352112|NCT02927080|593662587|FG000|Overall Study|Adverse Event|0|||
164352113|NCT02927080|593662588|FG001|Overall Study|Adverse Event|1|||
164352114|NCT02927080|593662589|FG002|Overall Study|Adverse Event|0|||
164352115|NCT02927080|593662590|FG003|Overall Study|Adverse Event|0|||
164352116|NCT02927080|593662591|FG004|Overall Study|Adverse Event|0|||
164352117|NCT02927080|593662592|FG005|Overall Study|Adverse Event|0|||
164352118|NCT02927080|593662593|FG006|Overall Study|Adverse Event|0|||
164352119|NCT02927080|593662594|FG007|Overall Study|Adverse Event|1|||
164352120|NCT02927080|593662595|FG008|Overall Study|Adverse Event|0|||
164352121|NCT02927080|593662596|FG009|Overall Study|Adverse Event|1|||
164352122|NCT02927080|593662587|FG000|Overall Study|Other|0|||
164352123|NCT02927080|593662588|FG001|Overall Study|Other|0|||
164352124|NCT02927080|593662589|FG002|Overall Study|Other|0|||
164352125|NCT02927080|593662590|FG003|Overall Study|Other|0|||
164352126|NCT02927080|593662591|FG004|Overall Study|Other|0|||
164352127|NCT02927080|593662592|FG005|Overall Study|Other|0|||
164352128|NCT02927080|593662593|FG006|Overall Study|Other|1|||
164352129|NCT02927080|593662594|FG007|Overall Study|Other|0|||
164352130|NCT02927080|593662595|FG008|Overall Study|Other|1|||
164352131|NCT02927080|593662596|FG009|Overall Study|Other|0|||
164352132|NCT01404325|593662597|FG000|Overall Study|Lost to Follow-up|1|||
164005647|NCT02032875|592385849|FG001|Treatment Period|Liver transplant, No extension needed|1|||
164352133|NCT01404325|593662598|FG001|Overall Study|Lost to Follow-up|0|||
164352134|NCT01404325|593662597|FG000|Overall Study|Death|2|||
164352135|NCT01404325|593662598|FG001|Overall Study|Death|0|||
164352136|NCT01404325|593662597|FG000|Overall Study|Graft loss/Retransplantation|1|||
164352137|NCT01404325|593662598|FG001|Overall Study|Graft loss/Retransplantation|0|||
164352138|NCT01404325|593662597|FG000|Overall Study|non-specified reason|0|||
164133100|NCT01447420|592852657|FG002|Overall Study|Adverse Event|2|||
164352139|NCT01404325|593662598|FG001|Overall Study|non-specified reason|2|||
164352140|NCT01411228|593662601|FG000|Overall Study|Lost to Follow-up|0|||
164352141|NCT01411228|593662602|FG001|Overall Study|Lost to Follow-up|0|||
164352142|NCT01411228|593662603|FG002|Overall Study|Lost to Follow-up|1|||
164352143|NCT01411228|593662601|FG000|Overall Study|Withdrawal by Subject|1|||
164352144|NCT01411228|593662602|FG001|Overall Study|Withdrawal by Subject|0|||
164352145|NCT01411228|593662603|FG002|Overall Study|Withdrawal by Subject|0|||
164352146|NCT00664742|593662605|FG000|Overall Study|Withdrawn due to adverse events|3|||
164352147|NCT00664742|593662605|FG000|Overall Study|Withdrawal by Subject|31|||
164352148|NCT00664742|593662605|FG000|Overall Study|Lost to Follow-up|92|||
164352149|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352150|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352151|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352152|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
164352153|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
164352154|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
164352155|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352156|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352157|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352158|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
164352159|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Other|1|||
164352160|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Other|1|||
164352161|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Other|0|||
164352162|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Other|0|||
164352163|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Other|0|||
164352164|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
164352165|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
164352166|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
164352167|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
164352168|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
164352169|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352170|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352171|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352172|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
164352173|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
164352174|NCT02310568|593662606|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352175|NCT02310568|593662607|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352176|NCT02310568|593662608|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352177|NCT02310568|593662609|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
164352178|NCT02310568|593662610|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
164352179|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
164352180|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
164352181|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
164352182|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
164352183|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
164352184|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Other|0|||
164352185|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Other|1|||
164352186|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Other|1|||
164352187|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Other|0|||
164352188|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Other|0|||
164352189|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
164352190|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
164352191|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
164352192|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
164352193|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
164352194|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352195|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352196|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352197|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
164352198|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
164352199|NCT02310568|593662606|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352200|NCT02310568|593662607|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352201|NCT02310568|593662608|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352202|NCT02310568|593662609|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
164352203|NCT02310568|593662610|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
164352204|NCT02989194|593662615|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
164352205|NCT02989194|593662616|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
164352206|NCT02989194|593662617|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
164352207|NCT02989194|593662615|FG000|Overall Study|Lost to Follow-up|0|||
164352208|NCT02989194|593662616|FG001|Overall Study|Lost to Follow-up|1|||
164352209|NCT02989194|593662617|FG002|Overall Study|Lost to Follow-up|0|||
164352210|NCT02989194|593662615|FG000|Overall Study|Withdrawal by Subject|0|||
164352211|NCT02989194|593662616|FG001|Overall Study|Withdrawal by Subject|1|||
164352212|NCT02989194|593662617|FG002|Overall Study|Withdrawal by Subject|0|||
164352213|NCT02670083|593662618|FG000|Overall Study|Adverse Event|16|||
164352214|NCT02670083|593662619|FG001|Overall Study|Adverse Event|13|||
164352215|NCT02670083|593662618|FG000|Overall Study|Death|4|||
164352216|NCT02670083|593662619|FG001|Overall Study|Death|6|||
164352217|NCT02670083|593662618|FG000|Overall Study|Lost to Follow-up|2|||
164352218|NCT02670083|593662619|FG001|Overall Study|Lost to Follow-up|2|||
164089765|NCT01031537|592691476|FG000|Overall Study|Withdrawal by Subject|5|||
164089766|NCT01031537|592691476|FG000|Overall Study|PI removal, no longer met eligibility|12|||
164089767|NCT00561730|592691485|FG000|Overall Study|Adverse Event|2|||
164089768|NCT00561730|592691485|FG000|Overall Study|Handling of the drug|1|||
164352219|NCT02670083|593662618|FG000|Overall Study|Multiple Reasons|9|||
164352220|NCT02670083|593662619|FG001|Overall Study|Multiple Reasons|9|||
164352221|NCT02670083|593662618|FG000|Overall Study|Physician Decision|0|||
164352222|NCT02670083|593662619|FG001|Overall Study|Physician Decision|2|||
164352223|NCT02670083|593662618|FG000|Overall Study|Study Terminated By Sponsor|257|||
164352224|NCT02670083|593662619|FG001|Overall Study|Study Terminated By Sponsor|254|||
164352225|NCT02670083|593662618|FG000|Overall Study|Symptomatic Deterioration|0|||
164352226|NCT02670083|593662619|FG001|Overall Study|Symptomatic Deterioration|2|||
164352227|NCT02670083|593662618|FG000|Overall Study|Withdrawal by Subject|32|||
164352228|NCT02670083|593662619|FG001|Overall Study|Withdrawal by Subject|31|||
164352229|NCT02670083|593662618|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164352230|NCT02670083|593662619|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164352231|NCT02825992|593662620|FG000|Overall Study|Withdrawal by Subject|4|||
164352232|NCT02825992|593662620|FG000|Overall Study|Lost to Follow-up|2|||
164352233|NCT02825992|593662620|FG000|Overall Study|Procedure terminated|2|||
164352234|NCT04160091|593662623|FG000|Overall Study|Terminated by Sponsor|7|||
164352235|NCT04160091|593662624|FG001|Overall Study|Terminated by Sponsor|3|||
164352236|NCT04160091|593662625|FG002|Overall Study|Terminated by Sponsor|5|||
164352237|NCT04160091|593662626|FG003|Overall Study|Terminated by Sponsor|2|||
164352238|NCT04160091|593662623|FG000|Overall Study|Noncompliance|0|||
164352239|NCT04160091|593662624|FG001|Overall Study|Noncompliance|0|||
164352240|NCT04160091|593662625|FG002|Overall Study|Noncompliance|0|||
164352241|NCT04160091|593662626|FG003|Overall Study|Noncompliance|1|||
164352242|NCT04160091|593662623|FG000|Overall Study|Withdrawal by Subject|0|||
164352243|NCT04160091|593662624|FG001|Overall Study|Withdrawal by Subject|0|||
164352244|NCT04160091|593662625|FG002|Overall Study|Withdrawal by Subject|0|||
164352245|NCT04160091|593662626|FG003|Overall Study|Withdrawal by Subject|1|||
164352246|NCT00609492|593662627|FG000|Overall Study|Withdrawal by Subject|0|||
164352247|NCT00609492|593662628|FG001|Overall Study|Withdrawal by Subject|2|||
164352248|NCT00609492|593662629|FG002|Overall Study|Withdrawal by Subject|3|||
164352249|NCT00609492|593662627|FG000|Overall Study|Lost to Follow-up|1|||
164352250|NCT00609492|593662628|FG001|Overall Study|Lost to Follow-up|1|||
164352251|NCT00609492|593662629|FG002|Overall Study|Lost to Follow-up|4|||
164352252|NCT01224431|593662630|FG000|Overall Study|not randomized|0|||
164352253|NCT01224431|593662631|FG001|Overall Study|not randomized|4|||
164352254|NCT01224431|593662630|FG000|Overall Study|no video record|0|||
164352255|NCT01224431|593662631|FG001|Overall Study|no video record|1|||
164352256|NCT04492618|593662632|FG000|Overall Study|Withdrawal by Subject|1|||
164352257|NCT05620563|593662633|FG000|Overall Study|Adverse Event|3|||
164352258|NCT05620563|593662634|FG001|Overall Study|Adverse Event|1|||
164352259|NCT05620563|593662633|FG000|Overall Study|Lost to Follow-up|0|||
164352260|NCT05620563|593662634|FG001|Overall Study|Lost to Follow-up|2|||
164352261|NCT05620563|593662633|FG000|Overall Study|Protocol Deviation|1|||
164352262|NCT05620563|593662634|FG001|Overall Study|Protocol Deviation|2|||
164352263|NCT05620563|593662633|FG000|Overall Study|Withdrawal by Subject|3|||
164352264|NCT05620563|593662634|FG001|Overall Study|Withdrawal by Subject|3|||
164352265|NCT05620563|593662633|FG000|Overall Study|Physician Decision|0|||
164352266|NCT05620563|593662634|FG001|Overall Study|Physician Decision|1|||
164352267|NCT00779467|593662635|FG000|Overall Study|Lack of Efficacy|11|||
164352268|NCT00779467|593662636|FG001|Overall Study|Lack of Efficacy|2|||
164352269|NCT00779467|593662637|FG002|Overall Study|Lack of Efficacy|6|||
164352270|NCT00779467|593662638|FG003|Overall Study|Lack of Efficacy|11|||
164352271|NCT00779467|593662635|FG000|Overall Study|failed inclusion criteria|3|||
164352272|NCT00779467|593662636|FG001|Overall Study|failed inclusion criteria|3|||
164352273|NCT00779467|593662637|FG002|Overall Study|failed inclusion criteria|1|||
164352274|NCT00779467|593662638|FG003|Overall Study|failed inclusion criteria|2|||
164352275|NCT00779467|593662635|FG000|Overall Study|missing data|1|||
164352276|NCT00779467|593662636|FG001|Overall Study|missing data|0|||
164352277|NCT00779467|593662637|FG002|Overall Study|missing data|1|||
164352278|NCT00779467|593662638|FG003|Overall Study|missing data|4|||
164352279|NCT00779467|593662635|FG000|Overall Study|technical issue|0|||
164352280|NCT00779467|593662636|FG001|Overall Study|technical issue|0|||
164352281|NCT00779467|593662637|FG002|Overall Study|technical issue|2|||
164352282|NCT00779467|593662638|FG003|Overall Study|technical issue|1|||
164352283|NCT00779467|593662635|FG000|Overall Study|unavailable research staff|0|||
164352284|NCT00779467|593662636|FG001|Overall Study|unavailable research staff|0|||
164089769|NCT00561730|592691485|FG000|Overall Study|Lost to Follow-up|5|||
164352285|NCT00779467|593662637|FG002|Overall Study|unavailable research staff|0|||
164352286|NCT00779467|593662638|FG003|Overall Study|unavailable research staff|1|||
164352287|NCT00460408|593662645|FG000|Overall Study|Adverse Event|1|||
164352288|NCT00460408|593662646|FG001|Overall Study|Adverse Event|0|||
164352289|NCT00460408|593662647|FG002|Overall Study|Adverse Event|0|||
164089770|NCT00561730|592691485|FG000|Overall Study|Not specified reasons|1|||
164089771|NCT03194464|592691486|FG000|Overall Study|data not usable|2|||
164352290|NCT00460408|593662648|FG003|Overall Study|Adverse Event|0|||
164352291|NCT00460408|593662645|FG000|Overall Study|Death|7|||
164352292|NCT00460408|593662646|FG001|Overall Study|Death|0|||
164352293|NCT00460408|593662647|FG002|Overall Study|Death|0|||
164352294|NCT00460408|593662648|FG003|Overall Study|Death|0|||
164089772|NCT03803943|592691487|FG000|Overall Study|Withdrawal by Subject|2|||
164352295|NCT00460408|593662645|FG000|Overall Study|Lost to Follow-up|11|||
164352296|NCT00460408|593662646|FG001|Overall Study|Lost to Follow-up|0|||
164352297|NCT00460408|593662647|FG002|Overall Study|Lost to Follow-up|1|||
164352298|NCT00460408|593662648|FG003|Overall Study|Lost to Follow-up|0|||
164352299|NCT00460408|593662645|FG000|Overall Study|Withdrawal by Subject|31|||
164352300|NCT00460408|593662646|FG001|Overall Study|Withdrawal by Subject|0|||
164352301|NCT00460408|593662647|FG002|Overall Study|Withdrawal by Subject|0|||
164352302|NCT00460408|593662648|FG003|Overall Study|Withdrawal by Subject|0|||
164352303|NCT00460408|593662645|FG000|Overall Study|Insufficient clinical response|5|||
164352304|NCT00460408|593662646|FG001|Overall Study|Insufficient clinical response|1|||
164352305|NCT00460408|593662647|FG002|Overall Study|Insufficient clinical response|5|||
164352306|NCT00460408|593662648|FG003|Overall Study|Insufficient clinical response|0|||
164352307|NCT00460408|593662645|FG000|Overall Study|Other|12|||
164352308|NCT00460408|593662646|FG001|Overall Study|Other|2|||
164352309|NCT00460408|593662647|FG002|Overall Study|Other|0|||
164352310|NCT00460408|593662648|FG003|Overall Study|Other|0|||
164352311|NCT02573350|593662649|FG000|Overall Study|Lost to Follow-up|2|||
164352312|NCT02573350|593662650|FG001|Overall Study|Lost to Follow-up|1|||
164352313|NCT02573350|593662649|FG000|Overall Study|Adverse Event|3|||
164352314|NCT02573350|593662650|FG001|Overall Study|Adverse Event|4|||
164352315|NCT02573350|593662649|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
164352316|NCT02573350|593662650|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
164352317|NCT02573350|593662649|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
164352318|NCT02573350|593662650|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
164352319|NCT02573350|593662649|FG000|Overall Study|Subject withdrew consent to participate|6|||
164352320|NCT02573350|593662650|FG001|Overall Study|Subject withdrew consent to participate|1|||
164352321|NCT02573350|593662649|FG000|Overall Study|Protocol Deviation|1|||
164352322|NCT02573350|593662650|FG001|Overall Study|Protocol Deviation|1|||
164352323|NCT01111149|593662657|FG000|Overall Study|Protocol Violation|1|||
164352324|NCT01111149|593662658|FG001|Overall Study|Protocol Violation|1|||
164352325|NCT01111149|593662659|FG002|Overall Study|Protocol Violation|2|||
164352326|NCT01111149|593662657|FG000|Overall Study|Withdrawal by Subject|1|||
164352327|NCT01111149|593662658|FG001|Overall Study|Withdrawal by Subject|0|||
164352328|NCT01111149|593662659|FG002|Overall Study|Withdrawal by Subject|2|||
164352329|NCT00006903|593662662|FG000|Overall Study|Still receiving treatment|0|||
164352330|NCT00006903|593662663|FG001|Overall Study|Still receiving treatment|0|||
164352331|NCT00006903|593662664|FG002|Overall Study|Still receiving treatment|1|||
164352332|NCT00006903|593662662|FG000|Overall Study|Refused further treatment|0|||
164352333|NCT00006903|593662663|FG001|Overall Study|Refused further treatment|2|||
164352334|NCT00006903|593662664|FG002|Overall Study|Refused further treatment|1|||
164352335|NCT00006903|593662662|FG000|Overall Study|Adverse Event|0|||
164352336|NCT00006903|593662663|FG001|Overall Study|Adverse Event|0|||
164352337|NCT00006903|593662664|FG002|Overall Study|Adverse Event|1|||
164089773|NCT03803943|592691488|FG001|Overall Study|Withdrawal by Subject|2|||
164352338|NCT00006903|593662662|FG000|Overall Study|Death|0|||
164352339|NCT00006903|593662663|FG001|Overall Study|Death|1|||
164352340|NCT00006903|593662664|FG002|Overall Study|Death|0|||
164352341|NCT00006903|593662662|FG000|Overall Study|Patient never treated|0|||
164352342|NCT00006903|593662663|FG001|Overall Study|Patient never treated|0|||
164352343|NCT00006903|593662664|FG002|Overall Study|Patient never treated|1|||
164352344|NCT00006903|593662662|FG000|Overall Study|Ineligible|10|||
164352345|NCT00006903|593662663|FG001|Overall Study|Ineligible|1|||
164352346|NCT00006903|593662664|FG002|Overall Study|Ineligible|2|||
164352347|NCT02794883|593662665|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
164352348|NCT02794883|593662666|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
164352349|NCT02794883|593662667|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
164352350|NCT02794883|593662665|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
164352351|NCT02794883|593662666|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
164352352|NCT02794883|593662667|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
164352353|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
164352354|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
164352355|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
164352356|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
164352357|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
164352358|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
164352359|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
164352360|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
164352361|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
164352362|NCT02794883|593662665|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
164352363|NCT02794883|593662666|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
164352364|NCT02794883|593662667|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
164352365|NCT02794883|593662665|FG000|Follow-up Period (up to 2 Years)|Death|12|||
164352366|NCT02794883|593662666|FG001|Follow-up Period (up to 2 Years)|Death|10|||
163899104|NCT01105975|592002810|FG005|Overall Study|Lost to Follow-up|0|||
163899105|NCT01105975|592002811|FG006|Overall Study|Lost to Follow-up|0|||
163899106|NCT01105975|592002812|FG007|Overall Study|Lost to Follow-up|0|||
163899107|NCT01105975|592002813|FG008|Overall Study|Lost to Follow-up|1|||
164352367|NCT02794883|593662667|FG002|Follow-up Period (up to 2 Years)|Death|10|||
164352368|NCT01906008|593662669|FG000|Overall Study|Lost to Follow-up|2|||
164352369|NCT01906008|593662670|FG001|Overall Study|Lost to Follow-up|0|||
164352370|NCT01906008|593662669|FG000|Overall Study|Oxaliplatin toxicity|2|||
164352371|NCT01906008|593662670|FG001|Overall Study|Oxaliplatin toxicity|0|||
164352372|NCT01906008|593662669|FG000|Overall Study|Protocol Violation|0|||
164352373|NCT01906008|593662670|FG001|Overall Study|Protocol Violation|1|||
164352374|NCT01906008|593662669|FG000|Overall Study|Withdrawal by Subject|1|||
164352375|NCT01906008|593662670|FG001|Overall Study|Withdrawal by Subject|5|||
164352376|NCT01906008|593662669|FG000|Overall Study|Did not start study med|3|||
164352377|NCT01906008|593662670|FG001|Overall Study|Did not start study med|4|||
164352378|NCT01906008|593662669|FG000|Overall Study|Oxaliplatin stops|10|||
164352379|NCT01906008|593662670|FG001|Overall Study|Oxaliplatin stops|8|||
164352380|NCT01906008|593662669|FG000|Overall Study|Hospice|1|||
164352381|NCT01906008|593662670|FG001|Overall Study|Hospice|0|||
164352382|NCT01906008|593662669|FG000|Overall Study|Physician Decision|3|||
164352383|NCT01906008|593662670|FG001|Overall Study|Physician Decision|3|||
164352384|NCT01906008|593662669|FG000|Overall Study|Lack of compliance of study med|5|||
164352385|NCT01906008|593662670|FG001|Overall Study|Lack of compliance of study med|3|||
164352386|NCT01906008|593662669|FG000|Overall Study|Adverse Event|0|||
164352387|NCT01906008|593662670|FG001|Overall Study|Adverse Event|3|||
164352388|NCT01574326|593662671|FG000|Overall Study|Randomized but not treated|0|||
164352389|NCT01574326|593662672|FG001|Overall Study|Randomized but not treated|1|||
164352390|NCT01574326|593662671|FG000|Overall Study|Withdrawal by Participant|2|||
164352391|NCT01574326|593662672|FG001|Overall Study|Withdrawal by Participant|4|||
164352392|NCT01574326|593662671|FG000|Overall Study|Physician Decision|5|||
164352393|NCT01574326|593662672|FG001|Overall Study|Physician Decision|3|||
164352394|NCT01574326|593662671|FG000|Overall Study|Adverse Event|1|||
164352395|NCT01574326|593662672|FG001|Overall Study|Adverse Event|3|||
164352396|NCT01574326|593662671|FG000|Overall Study|Other: Mainly kidney transplant|8|||
164352397|NCT01574326|593662672|FG001|Overall Study|Other: Mainly kidney transplant|8|||
164352398|NCT00137046|593662673|FG000|Overall Study|Death|2|||
164352399|NCT00137046|593662674|FG001|Overall Study|Death|1|||
164352400|NCT00137046|593662673|FG000|Overall Study|Adverse Event|16|||
164352401|NCT00137046|593662674|FG001|Overall Study|Adverse Event|5|||
164352402|NCT00137046|593662673|FG000|Overall Study|Laboratory Abnormality|2|||
164352403|NCT00137046|593662674|FG001|Overall Study|Laboratory Abnormality|0|||
164352404|NCT00137046|593662673|FG000|Overall Study|Lack of Efficacy|13|||
164352405|NCT00137046|593662674|FG001|Overall Study|Lack of Efficacy|1|||
164352406|NCT00137046|593662673|FG000|Overall Study|Lost to Follow-up|8|||
164352407|NCT00137046|593662674|FG001|Overall Study|Lost to Follow-up|24|||
164352408|NCT00137046|593662673|FG000|Overall Study|Other|23|||
164352409|NCT00137046|593662674|FG001|Overall Study|Other|19|||
164352410|NCT00137046|593662673|FG000|Overall Study|Withdrawal by Subject|33|||
164352411|NCT00137046|593662674|FG001|Overall Study|Withdrawal by Subject|42|||
164352412|NCT00137046|593662673|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
164352413|NCT00137046|593662674|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
164352414|NCT00137046|593662673|FG000|Overall Study|Withdrew prior to study treatment|1|||
164352415|NCT00137046|593662674|FG001|Overall Study|Withdrew prior to study treatment|1|||
164352416|NCT02268084|593662681|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
164352417|NCT02268084|593662682|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
164352418|NCT02268084|593662681|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
164352419|NCT02268084|593662682|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
164352420|NCT05227027|593662683|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
164352421|NCT05227027|593662684|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
164352422|NCT03552198|593662685|FG000|Overall Study|Lost to Follow-up|42|||
164352423|NCT03552198|593662686|FG001|Overall Study|Lost to Follow-up|48|||
164352424|NCT03552198|593662687|FG002|Overall Study|Lost to Follow-up|15|||
164352425|NCT03552198|593662688|FG003|Overall Study|Lost to Follow-up|19|||
164352426|NCT03552198|593662685|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
164352427|NCT03552198|593662686|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
164352428|NCT03552198|593662687|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
164352429|NCT03552198|593662688|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
164352430|NCT03552198|593662685|FG000|Overall Study|Did not receive air alerts|1|||
164352431|NCT03552198|593662686|FG001|Overall Study|Did not receive air alerts|0|||
164352432|NCT03552198|593662687|FG002|Overall Study|Did not receive air alerts|0|||
164352433|NCT03552198|593662688|FG003|Overall Study|Did not receive air alerts|1|||
164352434|NCT06149247|593662689|FG000|Overall Study|Adverse Event|0|||
164352435|NCT06149247|593662690|FG001|Overall Study|Adverse Event|1|||
164352436|NCT00371137|593662695|FG000|Overall Study|Adverse Event|20|||
164352437|NCT00371137|593662696|FG001|Overall Study|Adverse Event|35|||
164352438|NCT00371137|593662697|FG002|Overall Study|Adverse Event|42|||
164352439|NCT00371137|593662695|FG000|Overall Study|Withdrawal by Subject|11|||
164352440|NCT00371137|593662696|FG001|Overall Study|Withdrawal by Subject|10|||
164352441|NCT00371137|593662697|FG002|Overall Study|Withdrawal by Subject|15|||
164352442|NCT00371137|593662695|FG000|Overall Study|Lost to Follow-up|6|||
164352443|NCT00371137|593662696|FG001|Overall Study|Lost to Follow-up|3|||
164352444|NCT00371137|593662697|FG002|Overall Study|Lost to Follow-up|5|||
164352445|NCT00371137|593662695|FG000|Overall Study|Lack of Efficacy|30|||
164352446|NCT00371137|593662696|FG001|Overall Study|Lack of Efficacy|12|||
164352447|NCT00371137|593662697|FG002|Overall Study|Lack of Efficacy|13|||
164352448|NCT00371137|593662695|FG000|Overall Study|Sponsor Decision|2|||
164352449|NCT00371137|593662696|FG001|Overall Study|Sponsor Decision|1|||
164352450|NCT00371137|593662697|FG002|Overall Study|Sponsor Decision|2|||
164352451|NCT00371137|593662695|FG000|Overall Study|Physician Decision|1|||
164352452|NCT00371137|593662696|FG001|Overall Study|Physician Decision|1|||
164352453|NCT00371137|593662697|FG002|Overall Study|Physician Decision|1|||
164352454|NCT00371137|593662695|FG000|Overall Study|Protocol Violation|2|||
164352455|NCT00371137|593662696|FG001|Overall Study|Protocol Violation|1|||
164352456|NCT00371137|593662697|FG002|Overall Study|Protocol Violation|1|||
164352457|NCT01756898|593662700|FG000|Overall Study|Adverse Event|7|||
164352458|NCT01756898|593662701|FG001|Overall Study|Adverse Event|1|||
164352459|NCT01756898|593662702|FG002|Overall Study|Adverse Event|0|||
164352460|NCT01756898|593662703|FG003|Overall Study|Adverse Event|0|||
164352461|NCT01756898|593662700|FG000|Overall Study|Lack of Efficacy|4|||
164352462|NCT01756898|593662701|FG001|Overall Study|Lack of Efficacy|7|||
164352463|NCT01756898|593662702|FG002|Overall Study|Lack of Efficacy|6|||
164352464|NCT01756898|593662703|FG003|Overall Study|Lack of Efficacy|6|||
164352465|NCT01756898|593662700|FG000|Overall Study|Lost to Follow-up|2|||
164352466|NCT01756898|593662701|FG001|Overall Study|Lost to Follow-up|4|||
164352467|NCT01756898|593662702|FG002|Overall Study|Lost to Follow-up|2|||
164352468|NCT01756898|593662703|FG003|Overall Study|Lost to Follow-up|3|||
164352469|NCT01756898|593662700|FG000|Overall Study|Protocol Violation|1|||
164352470|NCT01756898|593662701|FG001|Overall Study|Protocol Violation|2|||
164352471|NCT01756898|593662702|FG002|Overall Study|Protocol Violation|2|||
164352472|NCT01756898|593662703|FG003|Overall Study|Protocol Violation|1|||
164352473|NCT01756898|593662700|FG000|Overall Study|Withdrew Consent|5|||
164352474|NCT01756898|593662701|FG001|Overall Study|Withdrew Consent|3|||
164352475|NCT01756898|593662702|FG002|Overall Study|Withdrew Consent|5|||
164352476|NCT01756898|593662703|FG003|Overall Study|Withdrew Consent|6|||
164352477|NCT01756898|593662700|FG000|Overall Study|Other|0|||
164352478|NCT01756898|593662701|FG001|Overall Study|Other|2|||
164352479|NCT01756898|593662702|FG002|Overall Study|Other|2|||
164352480|NCT01756898|593662703|FG003|Overall Study|Other|0|||
164352481|NCT01500694|593662704|FG000|Overall Study|Adverse Event|4|||
164352482|NCT01500694|593662705|FG001|Overall Study|Adverse Event|3|||
164352483|NCT01500694|593662704|FG000|Overall Study|Protocol Violation|0|||
164352484|NCT01500694|593662705|FG001|Overall Study|Protocol Violation|1|||
164352485|NCT01500694|593662704|FG000|Overall Study|Withdrawal by Subject|23|||
164352486|NCT01500694|593662705|FG001|Overall Study|Withdrawal by Subject|14|||
164352487|NCT01500694|593662704|FG000|Overall Study|Lost to Follow-up|2|||
164352488|NCT01500694|593662705|FG001|Overall Study|Lost to Follow-up|3|||
164352489|NCT01500694|593662704|FG000|Overall Study|Lack of Efficacy|14|||
164352490|NCT01500694|593662705|FG001|Overall Study|Lack of Efficacy|5|||
164352491|NCT01500694|593662704|FG000|Overall Study|Other|9|||
164352492|NCT01500694|593662705|FG001|Overall Study|Other|3|||
164352493|NCT02837783|593662706|FG000|Overall Study|Adverse Event|1|||
164352494|NCT02837783|593662707|FG001|Overall Study|Adverse Event|0|||
164352495|NCT02837783|593662706|FG000|Overall Study|Other, Not Specified|1|||
164352496|NCT02837783|593662707|FG001|Overall Study|Other, Not Specified|2|||
164352497|NCT02154490|593664379|FG000|Overall Study|No tissue submitted|23|||
164352498|NCT02154490|593664379|FG000|Overall Study|No biomarker results|167|||
164352499|NCT02154490|593664379|FG000|Overall Study|Not assigned to a sub-study|270|||
164352500|NCT02154490|593664379|FG000|Overall Study|Did not register to a sub-study|749|||
164005648|NCT02032875|592385848|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
164352501|NCT01442493|593664381|FG000|Overall Study|withdrawn from study|3|||
164352502|NCT01442493|593664382|FG001|Overall Study|withdrawn from study|2|||
164352503|NCT00938639|593664383|FG000|Overall Study|Moved away from study area|0|||
164352504|NCT00938639|593664384|FG001|Overall Study|Moved away from study area|1|||
164352505|NCT00938639|593664383|FG000|Overall Study|Lost to Follow-up|1|||
164352506|NCT00938639|593664384|FG001|Overall Study|Lost to Follow-up|2|||
164352507|NCT00938639|593664383|FG000|Overall Study|Family issues|1|||
164352508|NCT00938639|593664384|FG001|Overall Study|Family issues|1|||
164352509|NCT00938639|593664383|FG000|Overall Study|Participant noncompliance|1|||
164352510|NCT00938639|593664384|FG001|Overall Study|Participant noncompliance|0|||
164352511|NCT02547649|593664387|FG000|Overall Study|Lost to Follow-up|3|||
164352512|NCT02547649|593664388|FG001|Overall Study|Lost to Follow-up|1|||
164352513|NCT02547649|593664389|FG002|Overall Study|Lost to Follow-up|1|||
164352514|NCT02547649|593664387|FG000|Overall Study|Not vaccinated|0|||
164352515|NCT02547649|593664388|FG001|Overall Study|Not vaccinated|0|||
164352516|NCT02547649|593664389|FG002|Overall Study|Not vaccinated|1|||
164352517|NCT02547649|593664387|FG000|Overall Study|Withdrawal by Subject|0|||
163899108|NCT01105975|592002814|FG009|Overall Study|Lost to Follow-up|0|||
164352518|NCT02547649|593664388|FG001|Overall Study|Withdrawal by Subject|4|||
164352519|NCT02547649|593664389|FG002|Overall Study|Withdrawal by Subject|2|||
164352520|NCT04326231|593664391|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
164352521|NCT03303079|593664392|FG000|Overall Study|Adverse Event|0|||
164352522|NCT03303079|593664393|FG001|Overall Study|Adverse Event|1|||
164352523|NCT03303079|593664394|FG002|Overall Study|Adverse Event|3|||
164352524|NCT03303079|593664392|FG000|Overall Study|Protocol Violation|5|||
164352525|NCT03303079|593664393|FG001|Overall Study|Protocol Violation|4|||
164352526|NCT03303079|593664394|FG002|Overall Study|Protocol Violation|7|||
164352527|NCT03303079|593664392|FG000|Overall Study|Withdrawal by Subject|2|||
164352528|NCT03303079|593664393|FG001|Overall Study|Withdrawal by Subject|4|||
164352529|NCT03303079|593664394|FG002|Overall Study|Withdrawal by Subject|2|||
164352530|NCT03303079|593664392|FG000|Overall Study|Other than specified|0|||
164352531|NCT03303079|593664393|FG001|Overall Study|Other than specified|2|||
164352532|NCT03303079|593664394|FG002|Overall Study|Other than specified|0|||
164352533|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Left Oranization|1|||
164352534|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Left Oranization|1|||
164352535|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
164352536|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
164352537|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
164352538|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
164352539|NCT03454997|593664395|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
164352540|NCT03454997|593664396|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
164352541|NCT03454997|593664395|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
164352542|NCT03454997|593664396|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
164352543|NCT03454997|593664395|FG000|Overall Study|Client with SMI - Left organization|0|||
164352544|NCT03454997|593664396|FG001|Overall Study|Client with SMI - Left organization|1|||
164352545|NCT03454997|593664395|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
164352546|NCT03454997|593664396|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
164352547|NCT01909674|593664405|FG000|Overall Study|Withdrawal by Subject|5|||
164352548|NCT01909674|593664406|FG001|Overall Study|Withdrawal by Subject|2|||
164352549|NCT01678911|593664410|FG000|Second Intervention|Lost to Follow-up|2|||
164352550|NCT01678911|593664411|FG001|Second Intervention|Lost to Follow-up|0|||
164352551|NCT02706691|593664412|FG000|Overall Study|Adverse Event|1|||
164352552|NCT01830972|593664418|FG000|Part II|Withdrawal by Subject|2|||
164352553|NCT01830972|593664419|FG001|Part II|Withdrawal by Subject|2|||
164352554|NCT01830972|593664418|FG000|Part III|Withdrawal by Subject|1|||
164352555|NCT01830972|593664419|FG001|Part III|Withdrawal by Subject|0|||
164352556|NCT01830972|593664418|FG000|Part III|Noncompliance|1|||
164352557|NCT01830972|593664419|FG001|Part III|Noncompliance|0|||
164352558|NCT01830972|593664418|FG000|Part IV|Withdrawal by Subject|2|||
164352559|NCT01830972|593664419|FG001|Part IV|Withdrawal by Subject|1|||
164352560|NCT01830972|593664418|FG000|Part IV|Non-Compliance|1|||
164352561|NCT01830972|593664419|FG001|Part IV|Non-Compliance|0|||
164352562|NCT02117648|593664420|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
164352563|NCT02117648|593664420|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
164352564|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
164352565|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
164352566|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
164352567|NCT02117648|593664420|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
164352568|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
164352569|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
164352570|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
164352571|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
164352572|NCT02117648|593664420|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
164352573|NCT00171730|593664422|FG000|Overall Study|Adverse Event|3|||
164352574|NCT00171730|593664422|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
164352575|NCT00171730|593664422|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
164352576|NCT00171730|593664422|FG000|Overall Study|Withdrawal by Subject|3|||
164352577|NCT05025241|593664423|FG000|Screening|Failed Screening|5|||
164352578|NCT05025241|593664423|FG000|Treatment and Follow Up|Adverse Event|3|||
164352579|NCT02670837|593664424|FG000|Overall Study|Death|2|||
164352580|NCT02670837|593664425|FG001|Overall Study|Death|0|||
164352581|NCT02670837|593664426|FG002|Overall Study|Death|0|||
164352582|NCT01829191|593664427|FG000|Overall Study|Relocation|0|||
164352583|NCT01829191|593664428|FG001|Overall Study|Relocation|1|||
164352584|NCT01829191|593664427|FG000|Overall Study|Lens discomfort|0|||
164352585|NCT01829191|593664428|FG001|Overall Study|Lens discomfort|3|||
164352586|NCT01829191|593664427|FG000|Overall Study|Lens handling difficulty|1|||
164352587|NCT01829191|593664428|FG001|Overall Study|Lens handling difficulty|4|||
164352588|NCT01829191|593664427|FG000|Overall Study|Protocol Violation|4|||
164352589|NCT01829191|593664428|FG001|Overall Study|Protocol Violation|1|||
164352590|NCT01829191|593664427|FG000|Overall Study|Withdrawal by Subject|2|||
163899109|NCT01105975|592002805|FG000|Overall Study|Physician Decision|0|||
164352591|NCT01829191|593664428|FG001|Overall Study|Withdrawal by Subject|3|||
164352592|NCT01829191|593664427|FG000|Overall Study|Lost to Follow-up|0|||
164352593|NCT01829191|593664428|FG001|Overall Study|Lost to Follow-up|1|||
164352594|NCT01829191|593664427|FG000|Overall Study|Subject was fit for ortho - k|0|||
164352595|NCT01829191|593664428|FG001|Overall Study|Subject was fit for ortho - k|1|||
164352596|NCT02220205|593664429|FG000|Overall Study|Withdrawal by Subject|1|||
164352597|NCT02220205|593664430|FG001|Overall Study|Withdrawal by Subject|0|||
164352598|NCT01276353|593664433|FG000|Double-blind|Adverse Event|2|||
164352599|NCT01276353|593664434|FG001|Double-blind|Adverse Event|0|||
164352600|NCT01276353|593664433|FG000|Double-blind|Withdrawal by Subject|1|||
164352601|NCT01276353|593664434|FG001|Double-blind|Withdrawal by Subject|0|||
164352602|NCT01276353|593664433|FG000|Extension|Adverse Event|2|||
164352603|NCT01276353|593664434|FG001|Extension|Adverse Event|5|||
164352604|NCT01276353|593664433|FG000|Extension|Withdrawal by Subject|1|||
164352605|NCT01276353|593664434|FG001|Extension|Withdrawal by Subject|2|||
164352606|NCT01276353|593664433|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
164352607|NCT01276353|593664434|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
164352608|NCT01276353|593664433|FG000|Extension|Physician Decision|1|||
164352609|NCT01276353|593664434|FG001|Extension|Physician Decision|0|||
164352610|NCT01276353|593664433|FG000|Extension|Prohibited concomitant medications|0|||
164352611|NCT01276353|593664434|FG001|Extension|Prohibited concomitant medications|1|||
164352612|NCT02266225|593664437|FG000|Overall Study|Lost to Follow-up|2|||
164352613|NCT02266225|593664437|FG000|Overall Study|Death|1|||
164352614|NCT02266225|593664437|FG000|Overall Study|Withdrawal by Subject|13|||
164352615|NCT00553514|593664438|FG000|Overall Study|Protocol deviation|0|||
164352616|NCT00553514|593664439|FG001|Overall Study|Protocol deviation|0|||
164352617|NCT00553514|593664440|FG002|Overall Study|Protocol deviation|0|||
164352618|NCT00553514|593664441|FG003|Overall Study|Protocol deviation|1|||
164352619|NCT00553514|593664442|FG004|Overall Study|Protocol deviation|0|||
164352620|NCT00553514|593664438|FG000|Overall Study|Lack of ovarian response|4|||
164352621|NCT00553514|593664439|FG001|Overall Study|Lack of ovarian response|5|||
164352622|NCT00553514|593664440|FG002|Overall Study|Lack of ovarian response|5|||
164352623|NCT00553514|593664441|FG003|Overall Study|Lack of ovarian response|5|||
164352624|NCT00553514|593664442|FG004|Overall Study|Lack of ovarian response|6|||
164352625|NCT00553514|593664438|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
164352626|NCT00553514|593664439|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164352627|NCT00553514|593664440|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164352628|NCT00553514|593664441|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164352629|NCT00553514|593664442|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164352630|NCT00553514|593664438|FG000|Overall Study|Risk of multiple pregnancy|0|||
164352631|NCT00553514|593664439|FG001|Overall Study|Risk of multiple pregnancy|2|||
164352632|NCT00553514|593664440|FG002|Overall Study|Risk of multiple pregnancy|0|||
164352633|NCT00553514|593664441|FG003|Overall Study|Risk of multiple pregnancy|1|||
164352634|NCT00553514|593664442|FG004|Overall Study|Risk of multiple pregnancy|0|||
164352635|NCT00553514|593664438|FG000|Overall Study|Other|1|||
164352636|NCT00553514|593664439|FG001|Overall Study|Other|1|||
164352637|NCT00553514|593664440|FG002|Overall Study|Other|0|||
164352638|NCT00553514|593664441|FG003|Overall Study|Other|0|||
164352639|NCT00553514|593664442|FG004|Overall Study|Other|1|||
164352640|NCT00660309|593664446|FG000|Overall Study|Adverse Event|2|||
164352641|NCT00660309|593664447|FG001|Overall Study|Adverse Event|0|||
164352642|NCT00660309|593664446|FG000|Overall Study|Withdrawal by Subject|0|||
164352643|NCT00660309|593664447|FG001|Overall Study|Withdrawal by Subject|3|||
164352644|NCT02532972|593664451|FG000|Overall Study|Withdrawal by Subject|1|||
164352645|NCT01018186|593664452|FG000|2-week Run-in Period|Protocol Violation|1|||
164352646|NCT01018186|593664453|FG001|2-week Run-in Period|Protocol Violation|0|||
164352647|NCT01018186|593664454|FG002|2-week Run-in Period|Protocol Violation|0|||
164133101|NCT01447420|592852655|FG000|Overall Study|Protocol Violation|3|||
164352648|NCT01018186|593664455|FG003|2-week Run-in Period|Protocol Violation|0|||
164352649|NCT01018186|593664452|FG000|2-week Run-in Period|Lost to Follow-up|2|||
164352650|NCT01018186|593664453|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164352651|NCT01018186|593664454|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164352652|NCT01018186|593664455|FG003|2-week Run-in Period|Lost to Follow-up|0|||
164352653|NCT01018186|593664452|FG000|2-week Run-in Period|Physician Decision|3|||
164352654|NCT01018186|593664453|FG001|2-week Run-in Period|Physician Decision|0|||
164352655|NCT01018186|593664454|FG002|2-week Run-in Period|Physician Decision|0|||
164352656|NCT01018186|593664455|FG003|2-week Run-in Period|Physician Decision|0|||
164352657|NCT01018186|593664452|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
164352658|NCT01018186|593664453|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164352659|NCT01018186|593664454|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164352660|NCT01018186|593664455|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
164352661|NCT01018186|593664452|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
164352662|NCT01018186|593664453|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164352663|NCT01018186|593664454|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164352664|NCT01018186|593664455|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164352665|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
164352666|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
164352667|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
164352668|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
164352669|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
164352670|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
164352671|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
164352672|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
164352673|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
164352674|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
164352675|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
164352676|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
164352677|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
164352678|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
164352679|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
164352680|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
164352681|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
164352682|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
164352683|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
164352684|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
164352685|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
164352686|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
164352687|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
164352688|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
164352689|NCT01018186|593664452|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164352690|NCT01018186|593664453|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
164352691|NCT01018186|593664454|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
164352692|NCT01018186|593664455|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
164352693|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352694|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
164352695|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352696|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352697|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352698|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
164352699|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
164352700|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
164352701|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
164352702|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
164352703|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
164352704|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
164352705|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
164352706|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
164352707|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
164352708|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
164352709|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
164352710|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
164352711|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352712|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352713|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164005649|NCT02032875|592385849|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
164005650|NCT02032875|592385848|FG000|Follow-up Period|Death|0|||
164352714|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352715|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
164352716|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
164352717|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352718|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
164352719|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352720|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352721|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352722|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
164352723|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
164352724|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
164352725|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
164352726|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
164352727|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
164352728|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
164352729|NCT02603419|593664456|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352730|NCT02603419|593664457|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352731|NCT02603419|593664458|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352732|NCT02603419|593664459|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
164352733|NCT02603419|593664460|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352734|NCT02603419|593664461|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
164352735|NCT02603419|593664456|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352736|NCT02603419|593664457|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352737|NCT02603419|593664458|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352738|NCT02603419|593664459|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352739|NCT02603419|593664460|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
164352740|NCT02603419|593664461|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
164352741|NCT02603419|593664456|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352742|NCT02603419|593664457|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352743|NCT02603419|593664458|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352744|NCT02603419|593664459|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352745|NCT02603419|593664460|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
164352746|NCT02603419|593664461|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
164352747|NCT02603419|593664456|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352748|NCT02603419|593664457|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352749|NCT02603419|593664458|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352750|NCT02603419|593664459|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352751|NCT02603419|593664460|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
164352752|NCT02603419|593664461|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
164352753|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
164352754|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
164352755|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
164352756|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
164352757|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164352758|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164352759|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
164352760|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
164352761|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Other|1|||
164352762|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Other|4|||
164352763|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Other|3|||
164352764|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Other|6|||
164352765|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
164352766|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
164352767|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
164352768|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
164352769|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
164352770|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
164352771|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
164352772|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
164352773|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164352774|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164352775|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
164352776|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
164352777|NCT02925494|593664462|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
164352778|NCT02925494|593664463|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
164352779|NCT02925494|593664464|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
164352780|NCT02925494|593664465|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
164352781|NCT01666782|593664471|FG000|Overall Study|Received 2 doses of vaccine|0|||
164352782|NCT01666782|593664472|FG001|Overall Study|Received 2 doses of vaccine|1|||
164352783|NCT01666782|593664471|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
164352784|NCT01666782|593664472|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
164352785|NCT02007109|593664475|FG000|Overall Study|Diary not returned or excluded|102|||
164352786|NCT02007109|593664475|FG000|Overall Study|Excluded - Age<7yo|9|||
164352787|NCT01858389|593664476|FG000|Overall Study|Death|1|||
164352788|NCT01858389|593664477|FG001|Overall Study|Death|3|||
164352789|NCT01858389|593664476|FG000|Overall Study|Study terminated by sponsor|0|||
164352790|NCT01858389|593664477|FG001|Overall Study|Study terminated by sponsor|2|||
164352791|NCT01858389|593664476|FG000|Overall Study|Withdrawal by Subject|0|||
164352792|NCT01858389|593664477|FG001|Overall Study|Withdrawal by Subject|1|||
164352793|NCT01858389|593664476|FG000|Overall Study|Progressive disease|10|||
164352794|NCT01858389|593664477|FG001|Overall Study|Progressive disease|11|||
164352795|NCT01858389|593664476|FG000|Overall Study|Other|2|||
164352796|NCT01858389|593664477|FG001|Overall Study|Other|4|||
164352797|NCT01858389|593664476|FG000|Overall Study|Adverse Event|3|||
164352798|NCT01858389|593664477|FG001|Overall Study|Adverse Event|1|||
164352799|NCT01858389|593664476|FG000|Overall Study|Did not receive treatment|0|||
164352800|NCT01858389|593664477|FG001|Overall Study|Did not receive treatment|3|||
164352801|NCT03572062|593664478|FG000|Overall Study|Adverse Event|0|||
164352802|NCT03572062|593664479|FG001|Overall Study|Adverse Event|0|||
164352803|NCT03572062|593664480|FG002|Overall Study|Adverse Event|0|||
164352804|NCT03572062|593664481|FG003|Overall Study|Adverse Event|0|||
164352805|NCT03572062|593664482|FG004|Overall Study|Adverse Event|0|||
164352806|NCT03572062|593664483|FG005|Overall Study|Adverse Event|0|||
164352807|NCT03572062|593664484|FG006|Overall Study|Adverse Event|0|||
164352808|NCT03572062|593664485|FG007|Overall Study|Adverse Event|0|||
164352809|NCT03572062|593664486|FG008|Overall Study|Adverse Event|1|||
164352810|NCT03572062|593664487|FG009|Overall Study|Adverse Event|3|||
164352811|NCT03572062|593664478|FG000|Overall Study|Death|0|||
164352812|NCT03572062|593664479|FG001|Overall Study|Death|0|||
164352813|NCT03572062|593664480|FG002|Overall Study|Death|0|||
164352814|NCT03572062|593664481|FG003|Overall Study|Death|0|||
164352815|NCT03572062|593664482|FG004|Overall Study|Death|0|||
164352816|NCT03572062|593664483|FG005|Overall Study|Death|1|||
164352817|NCT03572062|593664484|FG006|Overall Study|Death|0|||
164352818|NCT03572062|593664485|FG007|Overall Study|Death|0|||
164352819|NCT03572062|593664486|FG008|Overall Study|Death|0|||
164352820|NCT03572062|593664487|FG009|Overall Study|Death|0|||
164352821|NCT03572062|593664478|FG000|Overall Study|Lost to Follow-up|0|||
164352822|NCT03572062|593664479|FG001|Overall Study|Lost to Follow-up|0|||
164352823|NCT03572062|593664480|FG002|Overall Study|Lost to Follow-up|0|||
164352824|NCT03572062|593664481|FG003|Overall Study|Lost to Follow-up|0|||
164352825|NCT03572062|593664482|FG004|Overall Study|Lost to Follow-up|0|||
164352826|NCT03572062|593664483|FG005|Overall Study|Lost to Follow-up|1|||
164352827|NCT03572062|593664484|FG006|Overall Study|Lost to Follow-up|1|||
164352828|NCT03572062|593664485|FG007|Overall Study|Lost to Follow-up|0|||
164352829|NCT03572062|593664486|FG008|Overall Study|Lost to Follow-up|0|||
164352830|NCT03572062|593664487|FG009|Overall Study|Lost to Follow-up|0|||
164352831|NCT03572062|593664478|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352832|NCT03572062|593664479|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352833|NCT03572062|593664480|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352834|NCT03572062|593664481|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352835|NCT03572062|593664482|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352836|NCT03572062|593664483|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352837|NCT03572062|593664484|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352838|NCT03572062|593664485|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352839|NCT03572062|593664486|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
164352840|NCT03572062|593664487|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
164352841|NCT03572062|593664478|FG000|Overall Study|Study Terminated By Sponsor|0|||
164352842|NCT03572062|593664479|FG001|Overall Study|Study Terminated By Sponsor|0|||
164352843|NCT03572062|593664480|FG002|Overall Study|Study Terminated By Sponsor|0|||
164352844|NCT03572062|593664481|FG003|Overall Study|Study Terminated By Sponsor|0|||
164352845|NCT03572062|593664482|FG004|Overall Study|Study Terminated By Sponsor|0|||
164352846|NCT03572062|593664483|FG005|Overall Study|Study Terminated By Sponsor|0|||
164352847|NCT03572062|593664484|FG006|Overall Study|Study Terminated By Sponsor|0|||
164352848|NCT03572062|593664485|FG007|Overall Study|Study Terminated By Sponsor|0|||
164352849|NCT03572062|593664486|FG008|Overall Study|Study Terminated By Sponsor|29|||
164352850|NCT03572062|593664487|FG009|Overall Study|Study Terminated By Sponsor|27|||
164352851|NCT03572062|593664478|FG000|Overall Study|Physician Decision|0|||
164352852|NCT03572062|593664479|FG001|Overall Study|Physician Decision|0|||
164352853|NCT03572062|593664480|FG002|Overall Study|Physician Decision|0|||
164352854|NCT03572062|593664481|FG003|Overall Study|Physician Decision|0|||
164352855|NCT03572062|593664482|FG004|Overall Study|Physician Decision|0|||
164352856|NCT03572062|593664483|FG005|Overall Study|Physician Decision|0|||
164352857|NCT03572062|593664484|FG006|Overall Study|Physician Decision|0|||
164352858|NCT03572062|593664485|FG007|Overall Study|Physician Decision|0|||
164352859|NCT03572062|593664486|FG008|Overall Study|Physician Decision|1|||
164352860|NCT03572062|593664487|FG009|Overall Study|Physician Decision|0|||
164352861|NCT03572062|593664478|FG000|Overall Study|Withdrawal by Subject|0|||
164352862|NCT03572062|593664479|FG001|Overall Study|Withdrawal by Subject|0|||
164352863|NCT03572062|593664480|FG002|Overall Study|Withdrawal by Subject|0|||
164352864|NCT03572062|593664481|FG003|Overall Study|Withdrawal by Subject|0|||
164352865|NCT03572062|593664482|FG004|Overall Study|Withdrawal by Subject|0|||
164352866|NCT03572062|593664483|FG005|Overall Study|Withdrawal by Subject|0|||
164352867|NCT03572062|593664484|FG006|Overall Study|Withdrawal by Subject|0|||
164352868|NCT03572062|593664485|FG007|Overall Study|Withdrawal by Subject|0|||
164352869|NCT03572062|593664486|FG008|Overall Study|Withdrawal by Subject|0|||
164352870|NCT03572062|593664487|FG009|Overall Study|Withdrawal by Subject|1|||
164352871|NCT03572062|593664478|FG000|Overall Study|Randomized But Not Treated|0|||
164352872|NCT03572062|593664479|FG001|Overall Study|Randomized But Not Treated|0|||
164352873|NCT03572062|593664480|FG002|Overall Study|Randomized But Not Treated|0|||
164352874|NCT03572062|593664481|FG003|Overall Study|Randomized But Not Treated|0|||
164352875|NCT03572062|593664482|FG004|Overall Study|Randomized But Not Treated|1|||
164352876|NCT03572062|593664483|FG005|Overall Study|Randomized But Not Treated|2|||
164352877|NCT03572062|593664484|FG006|Overall Study|Randomized But Not Treated|0|||
164352878|NCT03572062|593664485|FG007|Overall Study|Randomized But Not Treated|1|||
164352879|NCT03572062|593664486|FG008|Overall Study|Randomized But Not Treated|0|||
164352880|NCT03572062|593664487|FG009|Overall Study|Randomized But Not Treated|0|||
164352881|NCT01691781|593664488|FG000|Overall Study|Withdrawal by Subject|4|||
164352882|NCT01691781|593664489|FG001|Overall Study|Withdrawal by Subject|3|||
164352883|NCT01691781|593664488|FG000|Overall Study|Physician Decision|1|||
164352884|NCT01691781|593664489|FG001|Overall Study|Physician Decision|1|||
164352885|NCT01691781|593664488|FG000|Overall Study|Protocol Violation|2|||
164352886|NCT01691781|593664489|FG001|Overall Study|Protocol Violation|2|||
164352887|NCT01691781|593664488|FG000|Overall Study|Adverse Event|0|||
164352888|NCT01691781|593664489|FG001|Overall Study|Adverse Event|1|||
164352889|NCT03978520|593664490|FG000|Overall Study|Adverse Event|2|||
164352890|NCT03978520|593664491|FG001|Overall Study|Adverse Event|5|||
164352891|NCT03978520|593664492|FG002|Overall Study|Adverse Event|3|||
164352892|NCT03978520|593664493|FG003|Overall Study|Adverse Event|5|||
164352893|NCT03978520|593664494|FG004|Overall Study|Adverse Event|6|||
164352894|NCT03978520|593664490|FG000|Overall Study|Withdrawal by Subject|10|||
164352895|NCT03978520|593664491|FG001|Overall Study|Withdrawal by Subject|4|||
164352896|NCT03978520|593664492|FG002|Overall Study|Withdrawal by Subject|5|||
164352897|NCT03978520|593664493|FG003|Overall Study|Withdrawal by Subject|6|||
164352898|NCT03978520|593664494|FG004|Overall Study|Withdrawal by Subject|5|||
164352899|NCT03978520|593664490|FG000|Overall Study|Lost to Follow-up|2|||
164352900|NCT03978520|593664491|FG001|Overall Study|Lost to Follow-up|2|||
164352901|NCT03978520|593664492|FG002|Overall Study|Lost to Follow-up|2|||
163899110|NCT01105975|592002806|FG001|Overall Study|Physician Decision|0|||
164352902|NCT03978520|593664493|FG003|Overall Study|Lost to Follow-up|0|||
164352903|NCT03978520|593664494|FG004|Overall Study|Lost to Follow-up|1|||
164352904|NCT03978520|593664490|FG000|Overall Study|COVID-19 infection|0|||
164352905|NCT03978520|593664491|FG001|Overall Study|COVID-19 infection|1|||
164352906|NCT03978520|593664492|FG002|Overall Study|COVID-19 infection|0|||
164352907|NCT03978520|593664493|FG003|Overall Study|COVID-19 infection|0|||
164352908|NCT03978520|593664494|FG004|Overall Study|COVID-19 infection|0|||
164352909|NCT03978520|593664490|FG000|Overall Study|Other, not specified|9|||
164352910|NCT03978520|593664491|FG001|Overall Study|Other, not specified|4|||
164352911|NCT03978520|593664492|FG002|Overall Study|Other, not specified|1|||
164352912|NCT03978520|593664493|FG003|Overall Study|Other, not specified|1|||
164299089|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
164299090|NCT02006472|593471235|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
164299091|NCT02006472|593471236|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
164299092|NCT02006472|593471237|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
164299093|NCT02006472|593471238|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
164299094|NCT02006472|593471239|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
164299095|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
164299096|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
164299097|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
164299098|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
164299099|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
164299100|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
164299101|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
164299102|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
164299103|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
164299104|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
164299105|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
164299106|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
164299107|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
164299108|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
164299109|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
164299110|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Other|0|||
164299111|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Other|1|||
164299112|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Other|0|||
164299113|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Other|1|||
164299114|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Other|0|||
164299115|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Not treated|0|||
164299116|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Not treated|0|||
164299117|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Not treated|2|||
164299118|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Not treated|0|||
164299119|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Not treated|0|||
164299120|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
164299121|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
164299122|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
164299123|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
164299124|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
164299125|NCT02006472|593471235|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
164299126|NCT02006472|593471236|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
164299127|NCT02006472|593471237|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
164299128|NCT02006472|593471238|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
164299129|NCT02006472|593471239|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
164299130|NCT03219723|593471240|FG000|Overall Study|Case Report Forms Uncollected|6|||
164299131|NCT03219723|593471240|FG000|Overall Study|Protocol Deviation|4|||
164299132|NCT04558125|593471241|FG000|Overall Study|Death|1|||
164299133|NCT03137381|593471242|FG000|Overall Study|Adverse Event|3|||
164299134|NCT03137381|593471243|FG001|Overall Study|Adverse Event|0|||
164299135|NCT03137381|593471244|FG002|Overall Study|Adverse Event|2|||
164299136|NCT03137381|593471245|FG003|Overall Study|Adverse Event|0|||
164299137|NCT03137381|593471242|FG000|Overall Study|Lost to Follow-up|2|||
164299138|NCT03137381|593471243|FG001|Overall Study|Lost to Follow-up|1|||
164299139|NCT03137381|593471244|FG002|Overall Study|Lost to Follow-up|1|||
164299140|NCT03137381|593471245|FG003|Overall Study|Lost to Follow-up|0|||
164299141|NCT03137381|593471242|FG000|Overall Study|Protocol deviation|1|||
164299142|NCT03137381|593471243|FG001|Overall Study|Protocol deviation|1|||
164299143|NCT03137381|593471244|FG002|Overall Study|Protocol deviation|0|||
164299144|NCT03137381|593471245|FG003|Overall Study|Protocol deviation|1|||
164299145|NCT03137381|593471242|FG000|Overall Study|Withdrawal by Investigator|0|||
164299146|NCT03137381|593471243|FG001|Overall Study|Withdrawal by Investigator|1|||
164299147|NCT03137381|593471244|FG002|Overall Study|Withdrawal by Investigator|1|||
164299148|NCT03137381|593471245|FG003|Overall Study|Withdrawal by Investigator|0|||
164299149|NCT03137381|593471242|FG000|Overall Study|Withdrawal by Subject|3|||
164299150|NCT03137381|593471243|FG001|Overall Study|Withdrawal by Subject|4|||
164299151|NCT03137381|593471244|FG002|Overall Study|Withdrawal by Subject|3|||
164299152|NCT03137381|593471245|FG003|Overall Study|Withdrawal by Subject|0|||
164299153|NCT03137381|593471242|FG000|Overall Study|Pregnancy|0|||
164299154|NCT03137381|593471243|FG001|Overall Study|Pregnancy|0|||
164299155|NCT03137381|593471244|FG002|Overall Study|Pregnancy|1|||
164299156|NCT03137381|593471245|FG003|Overall Study|Pregnancy|0|||
164299157|NCT00459316|593471246|FG000|Steps 1 & 2|Other eligibility failure|1|||
164299158|NCT00459316|593471247|FG001|Steps 1 & 2|Other eligibility failure|1|||
164352913|NCT03978520|593664494|FG004|Overall Study|Other, not specified|2|||
164352914|NCT03978520|593664490|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
164352915|NCT03978520|593664491|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
164352916|NCT03978520|593664492|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
164352917|NCT03978520|593664493|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
164352918|NCT03978520|593664494|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
164352919|NCT02760069|593664495|FG000|Overall Study|Withdrawal by Subject|0|||
164352920|NCT02760069|593664496|FG001|Overall Study|Withdrawal by Subject|1|||
164352921|NCT02760069|593664497|FG002|Overall Study|Withdrawal by Subject|1|||
164352922|NCT00600483|593664500|FG000|Overall Study|Lost to Follow-up|26|||
164352923|NCT00600483|593664501|FG001|Overall Study|Lost to Follow-up|47|||
164352924|NCT00600483|593664500|FG000|Overall Study|Randomized but not treated|10|||
164352925|NCT00600483|593664501|FG001|Overall Study|Randomized but not treated|0|||
164352926|NCT03031678|593664507|FG000|Overall Study|Study closed prior to completion|1|||
164352927|NCT03694821|593664508|FG000|Overall Study|Study terminated|4|||
164352928|NCT03694821|593664509|FG001|Overall Study|Study terminated|8|||
164352929|NCT03694821|593664510|FG002|Overall Study|Study terminated|4|||
164352930|NCT05109442|593664515|FG000|Overall Study|Withdrawal by Subject|0|||
164352931|NCT05109442|593664516|FG001|Overall Study|Withdrawal by Subject|0|||
164352932|NCT05109442|593664517|FG002|Overall Study|Withdrawal by Subject|1|||
164352933|NCT05109442|593664518|FG003|Overall Study|Withdrawal by Subject|0|||
164352934|NCT05109442|593664519|FG004|Overall Study|Withdrawal by Subject|0|||
164352935|NCT05109442|593664520|FG005|Overall Study|Withdrawal by Subject|0|||
164352936|NCT05109442|593664515|FG000|Overall Study|Adverse Event|0|||
164352937|NCT05109442|593664516|FG001|Overall Study|Adverse Event|1|||
164352938|NCT05109442|593664517|FG002|Overall Study|Adverse Event|5|||
164352939|NCT05109442|593664518|FG003|Overall Study|Adverse Event|0|||
164352940|NCT05109442|593664519|FG004|Overall Study|Adverse Event|0|||
164352941|NCT05109442|593664520|FG005|Overall Study|Adverse Event|2|||
164352942|NCT05109442|593664515|FG000|Overall Study|Death|0|||
164352943|NCT05109442|593664516|FG001|Overall Study|Death|0|||
164352944|NCT05109442|593664517|FG002|Overall Study|Death|4|||
164352945|NCT05109442|593664518|FG003|Overall Study|Death|0|||
164352946|NCT05109442|593664519|FG004|Overall Study|Death|0|||
164352947|NCT05109442|593664520|FG005|Overall Study|Death|1|||
164352948|NCT05109442|593664515|FG000|Overall Study|Physician Decision|1|||
164352949|NCT05109442|593664516|FG001|Overall Study|Physician Decision|0|||
164352950|NCT05109442|593664517|FG002|Overall Study|Physician Decision|1|||
164352951|NCT05109442|593664518|FG003|Overall Study|Physician Decision|0|||
164352952|NCT05109442|593664519|FG004|Overall Study|Physician Decision|0|||
164352953|NCT05109442|593664520|FG005|Overall Study|Physician Decision|2|||
164352954|NCT05109442|593664515|FG000|Overall Study|Other than listed|0|||
164352955|NCT05109442|593664516|FG001|Overall Study|Other than listed|0|||
164352956|NCT05109442|593664517|FG002|Overall Study|Other than listed|9|||
164352957|NCT05109442|593664518|FG003|Overall Study|Other than listed|2|||
164352958|NCT05109442|593664519|FG004|Overall Study|Other than listed|0|||
164352959|NCT05109442|593664520|FG005|Overall Study|Other than listed|8|||
164352960|NCT05109442|593664515|FG000|Overall Study|Lack of Efficacy|3|||
164352961|NCT05109442|593664516|FG001|Overall Study|Lack of Efficacy|5|||
164352962|NCT05109442|593664517|FG002|Overall Study|Lack of Efficacy|29|||
164352963|NCT05109442|593664518|FG003|Overall Study|Lack of Efficacy|10|||
164089774|NCT03803943|592691489|FG002|Overall Study|Withdrawal by Subject|2|||
164352964|NCT05109442|593664519|FG004|Overall Study|Lack of Efficacy|11|||
164352965|NCT05109442|593664520|FG005|Overall Study|Lack of Efficacy|17|||
164352966|NCT03278613|593664526|FG000|Overall Study|Lost to Follow-up|3|||
164352967|NCT03278613|593664527|FG001|Overall Study|Lost to Follow-up|1|||
164352968|NCT01405456|593664528|FG000|Overall Study|Lost to Follow-up|2|||
164352969|NCT01405456|593664529|FG001|Overall Study|Lost to Follow-up|1|||
164352970|NCT01405456|593664528|FG000|Overall Study|Physician Decision|1|||
164089775|NCT03803943|592691490|FG003|Overall Study|Withdrawal by Subject|2|||
164089776|NCT00995410|592691491|FG000|Overall Study|Adverse Event|51|||
164089777|NCT00995410|592691491|FG000|Overall Study|Withdrawal by Subject|7|||
164089778|NCT00995410|592691491|FG000|Overall Study|Lost to Follow-up|2|||
164089779|NCT00995410|592691491|FG000|Overall Study|Misc|28|||
164089780|NCT03594123|592691492|FG000|Overall Study|Lost to Follow-up|0|||
164089781|NCT03594123|592691493|FG001|Overall Study|Lost to Follow-up|1|||
164089782|NCT03594123|592691492|FG000|Overall Study|Adverse Event|8|||
164352971|NCT01405456|593664529|FG001|Overall Study|Physician Decision|0|||
164352972|NCT05475236|593664531|FG000|Overall Study|Withdrawal by Subject|0|||
164352973|NCT05475236|593664532|FG001|Overall Study|Withdrawal by Subject|1|||
164352974|NCT05355805|593664535|FG000|Overall Study|Lost to Follow-up|6|||
164352975|NCT05355805|593664536|FG001|Overall Study|Lost to Follow-up|11|||
164352976|NCT05355805|593664537|FG002|Overall Study|Lost to Follow-up|10|||
164352977|NCT05355805|593664538|FG003|Overall Study|Lost to Follow-up|6|||
164352978|NCT05355805|593664535|FG000|Overall Study|Decision by Sponsor|0|||
164352979|NCT05355805|593664536|FG001|Overall Study|Decision by Sponsor|0|||
164352980|NCT05355805|593664537|FG002|Overall Study|Decision by Sponsor|1|||
164089783|NCT03594123|592691493|FG001|Overall Study|Adverse Event|5|||
164352981|NCT05355805|593664538|FG003|Overall Study|Decision by Sponsor|0|||
164352982|NCT05355805|593664535|FG000|Overall Study|Withdrawal by Subject|7|||
164352983|NCT05355805|593664536|FG001|Overall Study|Withdrawal by Subject|14|||
164352984|NCT05355805|593664537|FG002|Overall Study|Withdrawal by Subject|15|||
164352985|NCT05355805|593664538|FG003|Overall Study|Withdrawal by Subject|13|||
164352986|NCT02692716|593666565|FG000|Overall Study|Lost to Follow-up|2|||
164352987|NCT02692716|593666566|FG001|Overall Study|Lost to Follow-up|5|||
164352988|NCT02692716|593666565|FG000|Overall Study|Withdrawal by Subject|3|||
164352989|NCT02692716|593666566|FG001|Overall Study|Withdrawal by Subject|1|||
164352990|NCT02904512|593666576|FG000|Overall Study|Withdrawal by Subject|1|||
164352991|NCT02904512|593666577|FG001|Overall Study|Withdrawal by Subject|0|||
164352992|NCT02904512|593666576|FG000|Overall Study|Transferred to ICU|1|||
164352993|NCT02904512|593666577|FG001|Overall Study|Transferred to ICU|0|||
164352994|NCT02904512|593666576|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
164352995|NCT02904512|593666577|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
164352996|NCT01963403|593666584|FG000|Overall Study|Lost to Follow-up|2|||
164352997|NCT01963403|593666585|FG001|Overall Study|Lost to Follow-up|3|||
164352998|NCT01963403|593666584|FG000|Overall Study|Implant removal|0|||
164352999|NCT01963403|593666585|FG001|Overall Study|Implant removal|1|||
164353000|NCT03585504|593666586|FG000|Overall Study|Lost to Follow-up|26|||
164353001|NCT03585504|593666587|FG001|Overall Study|Lost to Follow-up|29|||
164353002|NCT02564042|593666588|FG000|Overall Study|Adverse Event|4|||
164353003|NCT02564042|593666589|FG001|Overall Study|Adverse Event|4|||
164353004|NCT02564042|593666590|FG002|Overall Study|Adverse Event|3|||
164353005|NCT02564042|593666591|FG003|Overall Study|Adverse Event|0|||
164353006|NCT02564042|593666592|FG004|Overall Study|Adverse Event|0|||
164353007|NCT02564042|593666593|FG005|Overall Study|Adverse Event|1|||
164353008|NCT02564042|593666588|FG000|Overall Study|Lost to Follow-up|1|||
164353009|NCT02564042|593666589|FG001|Overall Study|Lost to Follow-up|1|||
164353010|NCT02564042|593666590|FG002|Overall Study|Lost to Follow-up|1|||
164353011|NCT02564042|593666591|FG003|Overall Study|Lost to Follow-up|0|||
164353012|NCT02564042|593666592|FG004|Overall Study|Lost to Follow-up|1|||
164353013|NCT02564042|593666593|FG005|Overall Study|Lost to Follow-up|1|||
164353014|NCT02564042|593666588|FG000|Overall Study|Physician Decision|1|||
164353015|NCT02564042|593666589|FG001|Overall Study|Physician Decision|0|||
164353016|NCT02564042|593666590|FG002|Overall Study|Physician Decision|0|||
164353017|NCT02564042|593666591|FG003|Overall Study|Physician Decision|1|||
164353018|NCT02564042|593666592|FG004|Overall Study|Physician Decision|0|||
164353019|NCT02564042|593666593|FG005|Overall Study|Physician Decision|0|||
164353020|NCT02564042|593666588|FG000|Overall Study|Withdrawal by Subject|5|||
164353021|NCT02564042|593666589|FG001|Overall Study|Withdrawal by Subject|3|||
164353022|NCT02564042|593666590|FG002|Overall Study|Withdrawal by Subject|2|||
164353023|NCT02564042|593666591|FG003|Overall Study|Withdrawal by Subject|2|||
164353024|NCT02564042|593666592|FG004|Overall Study|Withdrawal by Subject|10|||
164353025|NCT02564042|593666593|FG005|Overall Study|Withdrawal by Subject|12|||
164353026|NCT01356966|593666594|FG000|Overall Study|Withdrawal by Subject|1|||
164353027|NCT01356966|593666595|FG001|Overall Study|Withdrawal by Subject|2|||
164353028|NCT01356966|593666594|FG000|Overall Study|Physician Decision|1|||
164353029|NCT01356966|593666595|FG001|Overall Study|Physician Decision|0|||
164353030|NCT02743806|593666596|FG000|Overall Study|Adverse Event|9|||
164353031|NCT02743806|593666596|FG000|Overall Study|Lost to Follow-up|8|||
164353032|NCT02743806|593666596|FG000|Overall Study|Voluntary Withdrawal|54|||
164353033|NCT02743806|593666596|FG000|Overall Study|Study Termination|65|||
164353034|NCT02743806|593666596|FG000|Overall Study|Pregnancy|6|||
164353035|NCT02743806|593666596|FG000|Overall Study|No Longer Clinically Benefiting|27|||
164353036|NCT02743806|593666596|FG000|Overall Study|Reason Not Specified|12|||
164353037|NCT00849381|593666598|FG000|Overall Study|Adverse Event|1|||
164353038|NCT00849381|593666598|FG000|Overall Study|Lost to Follow-up|129|||
164353039|NCT00849381|593666598|FG000|Overall Study|Protocol Violation|5|||
164353040|NCT00849381|593666598|FG000|Overall Study|Withdrawal by Subject|6|||
164353041|NCT00849381|593666598|FG000|Overall Study|Other|4|||
164353042|NCT04429061|593666604|FG000|Overall Study|Lost to Follow-up|62|||
164353043|NCT04429061|593666605|FG001|Overall Study|Lost to Follow-up|87|||
164353044|NCT04429061|593666604|FG000|Overall Study|Withdrawal by Subject|3|||
164353045|NCT04429061|593666605|FG001|Overall Study|Withdrawal by Subject|4|||
164353046|NCT02085785|593666606|FG000|Overall Study|Withdrawal by Subject|2|||
164353047|NCT02085785|593666607|FG001|Overall Study|Withdrawal by Subject|1|||
164353048|NCT02085785|593666606|FG000|Overall Study|Lost to Follow-up|0|||
164353049|NCT02085785|593666607|FG001|Overall Study|Lost to Follow-up|1|||
164353050|NCT03590041|593666608|FG000|Overall Study|Protocol Violation|4|||
164353051|NCT03590041|593666609|FG001|Overall Study|Protocol Violation|3|||
164353052|NCT03590041|593666608|FG000|Overall Study|No session data recorded|14|||
164353053|NCT03590041|593666609|FG001|Overall Study|No session data recorded|2|||
164353054|NCT02692703|593666610|FG000|Overall Study|Lost to Follow-up|1|||
164353055|NCT02692703|593666610|FG000|Overall Study|Other|1|||
164353056|NCT04118166|593666611|FG000|Overall Study|Adverse Event|1|||
164353057|NCT03519932|593666612|FG000|First Intervention|Adverse Event|1|||
164353058|NCT03519932|593666613|FG001|First Intervention|Adverse Event|3|||
164353059|NCT02254486|593666614|FG000|Overall Study|Adverse Event|1|||
163899111|NCT01105975|592002807|FG002|Overall Study|Physician Decision|0|||
163899112|NCT01105975|592002808|FG003|Overall Study|Physician Decision|0|||
163899113|NCT01105975|592002809|FG004|Overall Study|Physician Decision|0|||
163899114|NCT01105975|592002810|FG005|Overall Study|Physician Decision|0|||
163899115|NCT01105975|592002811|FG006|Overall Study|Physician Decision|2|||
163899116|NCT01105975|592002812|FG007|Overall Study|Physician Decision|0|||
163899117|NCT01105975|592002813|FG008|Overall Study|Physician Decision|0|||
163899118|NCT01105975|592002814|FG009|Overall Study|Physician Decision|0|||
163899119|NCT01105975|592002805|FG000|Overall Study|Protocol Violation|0|||
163899120|NCT01105975|592002806|FG001|Overall Study|Protocol Violation|2|||
163899121|NCT01105975|592002807|FG002|Overall Study|Protocol Violation|2|||
163899122|NCT01105975|592002808|FG003|Overall Study|Protocol Violation|0|||
163899123|NCT01105975|592002809|FG004|Overall Study|Protocol Violation|1|||
163899124|NCT01105975|592002810|FG005|Overall Study|Protocol Violation|1|||
163899125|NCT01105975|592002811|FG006|Overall Study|Protocol Violation|1|||
163899126|NCT01105975|592002812|FG007|Overall Study|Protocol Violation|1|||
163899127|NCT01105975|592002813|FG008|Overall Study|Protocol Violation|2|||
163899128|NCT01105975|592002814|FG009|Overall Study|Protocol Violation|2|||
163899129|NCT01105975|592002805|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163899130|NCT01105975|592002806|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163899131|NCT01105975|592002807|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163899132|NCT01105975|592002808|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163899133|NCT01105975|592002809|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163899134|NCT01105975|592002810|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
163899135|NCT01105975|592002811|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163899136|NCT01105975|592002812|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163899137|NCT01105975|592002813|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
163899138|NCT01105975|592002814|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163899139|NCT04868617|592002815|FG000|Overall Study|Death|1|||
163899140|NCT04868617|592002816|FG001|Overall Study|Death|0|||
163899141|NCT04868617|592002815|FG000|Overall Study|Adverse Event|1|||
163899142|NCT04868617|592002816|FG001|Overall Study|Adverse Event|0|||
163899143|NCT04868617|592002815|FG000|Overall Study|Withdrawal by Subject|1|||
163899144|NCT04868617|592002816|FG001|Overall Study|Withdrawal by Subject|0|||
163899145|NCT04868617|592002815|FG000|Overall Study|Device deficiency|1|||
163899146|NCT04868617|592002816|FG001|Overall Study|Device deficiency|0|||
164353060|NCT02254486|593666615|FG001|Overall Study|Adverse Event|1|||
164353061|NCT02254486|593666614|FG000|Overall Study|Lack of Efficacy|1|||
164353062|NCT02254486|593666615|FG001|Overall Study|Lack of Efficacy|0|||
164353063|NCT02254486|593666614|FG000|Overall Study|Lost to Follow-up|2|||
164353064|NCT02254486|593666615|FG001|Overall Study|Lost to Follow-up|4|||
164353065|NCT02254486|593666614|FG000|Overall Study|Protocol Violation|1|||
164353066|NCT02254486|593666615|FG001|Overall Study|Protocol Violation|2|||
164353067|NCT02254486|593666614|FG000|Overall Study|Withdrawal by Subject|17|||
164353068|NCT02254486|593666615|FG001|Overall Study|Withdrawal by Subject|15|||
164353069|NCT02254486|593666614|FG000|Overall Study|GFR<60mL/min|16|||
164353070|NCT02254486|593666615|FG001|Overall Study|GFR<60mL/min|21|||
164353071|NCT02254486|593666614|FG000|Overall Study|Various|12|||
164353072|NCT02254486|593666615|FG001|Overall Study|Various|12|||
164353073|NCT01350414|593666616|FG000|Overall Study|Lost to Follow-up|13|||
164353074|NCT01350414|593666616|FG000|Overall Study|Withdrawal by Subject|4|||
164353075|NCT01350414|593666616|FG000|Overall Study|Physician Decision|2|||
164353076|NCT00267046|593666622|FG000|Overall Study|Disease progression|4|||
164353077|NCT00267046|593666623|FG001|Overall Study|Disease progression|2|||
164353078|NCT00267046|593666622|FG000|Overall Study|Chemotoxicity|2|||
164353079|NCT00267046|593666623|FG001|Overall Study|Chemotoxicity|0|||
164353080|NCT00267046|593666622|FG000|Overall Study|Open-label palifermin|2|||
164353081|NCT00267046|593666623|FG001|Overall Study|Open-label palifermin|7|||
164353082|NCT00267046|593666622|FG000|Overall Study|Surgery|3|||
164353083|NCT00267046|593666623|FG001|Overall Study|Surgery|1|||
164353084|NCT00267046|593666622|FG000|Overall Study|Withdrawal by Subject|1|||
164353085|NCT00267046|593666623|FG001|Overall Study|Withdrawal by Subject|0|||
164353086|NCT00267046|593666622|FG000|Overall Study|Radiation|0|||
164353087|NCT00267046|593666623|FG001|Overall Study|Radiation|1|||
164353088|NCT00103142|593666624|FG000|Overall Study|Adverse Event|1|||
164353089|NCT00103142|593666625|FG001|Overall Study|Adverse Event|0|||
163899147|NCT00686595|592002819|FG000|Overall Study|Adverse Event|3|||
163899148|NCT00686595|592002819|FG000|Overall Study|Protocol Violation|1|||
163899149|NCT00686595|592002819|FG000|Overall Study|Lost to Follow-up|1|||
163899150|NCT00686595|592002819|FG000|Overall Study|Lack of Efficacy|1|||
164005651|NCT02032875|592385849|FG001|Follow-up Period|Death|1|||
164353090|NCT00103142|593666624|FG000|Overall Study|Progression of disease|2|||
163899151|NCT00686595|592002819|FG000|Overall Study|Poor Compliance|1|||
163899152|NCT01315132|592002822|FG000|Overall Study|not treated due to disease progression|1|||
163899153|NCT04158141|592002830|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
163899154|NCT04158141|592002831|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
164353091|NCT00103142|593666625|FG001|Overall Study|Progression of disease|1|||
164353092|NCT02772081|593666626|FG000|Overall Study|Physician Decision|1|||
164353093|NCT02772081|593666627|FG001|Overall Study|Physician Decision|1|||
164353094|NCT02772081|593666626|FG000|Overall Study|Death|1|||
164353095|NCT02772081|593666627|FG001|Overall Study|Death|1|||
164353096|NCT01979016|593666637|FG000|Overall Study|Withdrawal by Subject|2|||
164353097|NCT01979016|593666638|FG001|Overall Study|Withdrawal by Subject|0|||
164353098|NCT01979016|593666637|FG000|Overall Study|Adverse Event|0|||
164353099|NCT01979016|593666638|FG001|Overall Study|Adverse Event|1|||
164353100|NCT01985867|593666639|FG000|Overall Study|Lost to Follow-up|3|||
164353101|NCT01985867|593666640|FG001|Overall Study|Lost to Follow-up|4|||
164353102|NCT01985867|593666639|FG000|Overall Study|Adverse Event|3|||
164353103|NCT01985867|593666640|FG001|Overall Study|Adverse Event|2|||
164353104|NCT01985867|593666639|FG000|Overall Study|Lack of Efficacy|1|||
164353105|NCT01985867|593666640|FG001|Overall Study|Lack of Efficacy|0|||
164005652|NCT02032875|592385848|FG000|Follow-up Period|Virologic Relapse|3|||
164005653|NCT02032875|592385849|FG001|Follow-up Period|Virologic Relapse|10|||
164005654|NCT02413398|592387301|FG000|Overall Study|Lost to Follow-up|2|||
164299159|NCT00459316|593471248|FG002|Steps 1 & 2|Other eligibility failure|0|||
164299160|NCT00459316|593471246|FG000|Steps 1 & 2|Death|1|||
164299161|NCT00459316|593471247|FG001|Steps 1 & 2|Death|1|||
164299162|NCT00459316|593471248|FG002|Steps 1 & 2|Death|0|||
164299163|NCT00459316|593471246|FG000|Steps 1 & 2|Not able to get to clinic|7|||
164299164|NCT00459316|593471247|FG001|Steps 1 & 2|Not able to get to clinic|4|||
164299165|NCT00459316|593471248|FG002|Steps 1 & 2|Not able to get to clinic|0|||
164299166|NCT00459316|593471246|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
164299167|NCT00459316|593471247|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
164299168|NCT00459316|593471248|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
164299169|NCT00459316|593471246|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
164299170|NCT00459316|593471247|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
164299171|NCT00459316|593471248|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
164299172|NCT00459316|593471246|FG000|Steps 1 & 2|Lost to Follow-up|5|||
164299173|NCT00459316|593471247|FG001|Steps 1 & 2|Lost to Follow-up|0|||
164299174|NCT00459316|593471248|FG002|Steps 1 & 2|Lost to Follow-up|2|||
164299175|NCT00459316|593471246|FG000|Step 3|Withdrawal by Subject|3|||
164299176|NCT00459316|593471247|FG001|Step 3|Withdrawal by Subject|0|||
164299177|NCT00459316|593471248|FG002|Step 3|Withdrawal by Subject|1|||
164299178|NCT01614886|593471249|FG000|Overall Study|Adverse Event|15|||
164299179|NCT01614886|593471250|FG001|Overall Study|Adverse Event|20|||
164299180|NCT01614886|593471249|FG000|Overall Study|Withdrawal by Subject|4|||
164299181|NCT01614886|593471250|FG001|Overall Study|Withdrawal by Subject|4|||
164299182|NCT01614886|593471249|FG000|Overall Study|Death|1|||
164299183|NCT01614886|593471250|FG001|Overall Study|Death|0|||
164299184|NCT01614886|593471249|FG000|Overall Study|Protocol deviation|0|||
164299185|NCT01614886|593471250|FG001|Overall Study|Protocol deviation|2|||
164299186|NCT03379818|593471253|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
164299187|NCT03379818|593471254|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
164299188|NCT03379818|593471253|FG000|Overall Study|Withdrawal by Subject|2|||
164299189|NCT03379818|593471254|FG001|Overall Study|Withdrawal by Subject|3|||
164299190|NCT03379818|593471253|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
164299191|NCT03379818|593471254|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
164299192|NCT00423579|593471255|FG000|Overall Study|Lost to Follow-up|3|||
164299193|NCT00423579|593471256|FG001|Overall Study|Lost to Follow-up|0|||
164299194|NCT00423579|593471255|FG000|Overall Study|Protocol Violation|1|||
164299195|NCT00423579|593471256|FG001|Overall Study|Protocol Violation|3|||
164353106|NCT01465997|593666641|FG000|Overall Study|Adverse Event|12|||
164353107|NCT01465997|593666642|FG001|Overall Study|Adverse Event|22|||
164353108|NCT01465997|593666641|FG000|Overall Study|Lack of Efficacy|13|||
164353109|NCT01465997|593666642|FG001|Overall Study|Lack of Efficacy|1|||
164353110|NCT01465997|593666641|FG000|Overall Study|Protocol Violation|1|||
164353111|NCT01465997|593666642|FG001|Overall Study|Protocol Violation|4|||
164353112|NCT01465997|593666641|FG000|Overall Study|Lost to Follow-up|6|||
164353113|NCT01465997|593666642|FG001|Overall Study|Lost to Follow-up|9|||
164353114|NCT01465997|593666641|FG000|Overall Study|Withdrawal by Subject|32|||
164353115|NCT01465997|593666642|FG001|Overall Study|Withdrawal by Subject|35|||
164353116|NCT01465997|593666641|FG000|Overall Study|investigator's decision|1|||
164353117|NCT01465997|593666642|FG001|Overall Study|investigator's decision|1|||
164353118|NCT01465997|593666641|FG000|Overall Study|Death|0|||
164353119|NCT01465997|593666642|FG001|Overall Study|Death|1|||
164353120|NCT01465997|593666641|FG000|Overall Study|sponsor's decision|1|||
164353121|NCT01465997|593666642|FG001|Overall Study|sponsor's decision|1|||
164353122|NCT01465997|593666641|FG000|Overall Study|subject withdrew consent|1|||
164353123|NCT01465997|593666642|FG001|Overall Study|subject withdrew consent|0|||
164353124|NCT01465997|593666641|FG000|Overall Study|local lab unblinded site|1|||
164353125|NCT01465997|593666642|FG001|Overall Study|local lab unblinded site|0|||
164353126|NCT01465997|593666641|FG000|Overall Study|withdrew before follow-up|0|||
164353127|NCT01465997|593666642|FG001|Overall Study|withdrew before follow-up|13|||
164353128|NCT01465997|593666641|FG000|Overall Study|decision by site staff|0|||
164353129|NCT01465997|593666642|FG001|Overall Study|decision by site staff|1|||
164353130|NCT01465997|593666641|FG000|Overall Study|subject left participation SP0993|0|||
164353131|NCT01465997|593666642|FG001|Overall Study|subject left participation SP0993|1|||
164353132|NCT02205814|593666643|FG000|Overall Study|Lost to Follow-up|0|||
164353133|NCT02205814|593666644|FG001|Overall Study|Lost to Follow-up|0|||
164353134|NCT02205814|593666645|FG002|Overall Study|Lost to Follow-up|0|||
164353135|NCT02205814|593666646|FG003|Overall Study|Lost to Follow-up|1|||
164353136|NCT02205814|593666643|FG000|Overall Study|Lack of Efficacy|1|||
164353137|NCT02205814|593666644|FG001|Overall Study|Lack of Efficacy|0|||
164353138|NCT02205814|593666645|FG002|Overall Study|Lack of Efficacy|1|||
164353139|NCT02205814|593666646|FG003|Overall Study|Lack of Efficacy|1|||
164353140|NCT02205814|593666643|FG000|Overall Study|Physician Decision|0|||
164353141|NCT02205814|593666644|FG001|Overall Study|Physician Decision|0|||
164353142|NCT02205814|593666645|FG002|Overall Study|Physician Decision|1|||
164353143|NCT02205814|593666646|FG003|Overall Study|Physician Decision|0|||
164353144|NCT02205814|593666643|FG000|Overall Study|Protocol Violation|1|||
164089784|NCT03594123|592691492|FG000|Overall Study|Site Terminated by Sponsor|4|||
164353145|NCT02205814|593666644|FG001|Overall Study|Protocol Violation|0|||
164353146|NCT02205814|593666645|FG002|Overall Study|Protocol Violation|0|||
164353147|NCT02205814|593666646|FG003|Overall Study|Protocol Violation|1|||
164353148|NCT02205814|593666643|FG000|Overall Study|Withdrawal by Subject|0|||
164353149|NCT02205814|593666644|FG001|Overall Study|Withdrawal by Subject|1|||
164353150|NCT02205814|593666645|FG002|Overall Study|Withdrawal by Subject|2|||
164353151|NCT02205814|593666646|FG003|Overall Study|Withdrawal by Subject|1|||
164353152|NCT02205814|593666643|FG000|Overall Study|not compliant with study procedures|0|||
164353153|NCT02205814|593666644|FG001|Overall Study|not compliant with study procedures|0|||
163899155|NCT04158141|592002832|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
163899156|NCT04158141|592002830|FG000|Step 1: Registration|Adverse Event|1|||
163899157|NCT04158141|592002831|FG001|Step 1: Registration|Adverse Event|0|||
163899158|NCT04158141|592002832|FG002|Step 1: Registration|Adverse Event|0|||
163899159|NCT04158141|592002830|FG000|Step 1: Registration|Withdrawal by Subject|1|||
164353154|NCT02205814|593666645|FG002|Overall Study|not compliant with study procedures|1|||
164353155|NCT02205814|593666646|FG003|Overall Study|not compliant with study procedures|0|||
164353156|NCT01426373|593666647|FG000|Overall Study|Adverse Event|6|||
164353157|NCT01426373|593666647|FG000|Overall Study|Lost to Follow-up|14|||
164353158|NCT01426373|593666647|FG000|Overall Study|Participant Convenience|10|||
164353159|NCT01426373|593666647|FG000|Overall Study|Miscellaneous Reasons|4|||
164353160|NCT00726661|593666650|FG000|Overall Study|Lost to Follow-up|36|||
164353161|NCT00726661|593666651|FG001|Overall Study|Lost to Follow-up|11|||
163899160|NCT04158141|592002831|FG001|Step 1: Registration|Withdrawal by Subject|0|||
163899161|NCT04158141|592002832|FG002|Step 1: Registration|Withdrawal by Subject|0|||
163899162|NCT04158141|592002830|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
163899163|NCT04158141|592002831|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
163899164|NCT04158141|592002832|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
163899165|NCT00319696|592002836|FG000|Overall Study|Adverse Event|36|||
163899166|NCT00319696|592002836|FG000|Overall Study|withdrawal of consent|14|||
163899167|NCT00319696|592002836|FG000|Overall Study|administrative|7|||
163899168|NCT00319696|592002836|FG000|Overall Study|Lost to Follow-up|3|||
163899169|NCT03777657|592002837|FG000|Overall Study|Death|397|||
163899170|NCT03777657|592002838|FG001|Overall Study|Death|431|||
163899171|NCT03777657|592002837|FG000|Overall Study|Study Closed by Sponsor|77|||
163899172|NCT03777657|592002838|FG001|Overall Study|Study Closed by Sponsor|38|||
163899173|NCT03777657|592002837|FG000|Overall Study|Withdrawal by Subject|20|||
163899174|NCT03777657|592002838|FG001|Overall Study|Withdrawal by Subject|17|||
163899175|NCT03777657|592002837|FG000|Overall Study|Lost to Follow-up|6|||
163899176|NCT03777657|592002838|FG001|Overall Study|Lost to Follow-up|10|||
163899177|NCT04129450|592002841|FG000|Overall Study|Lost to Follow-up|20|||
163899178|NCT04129450|592002842|FG001|Overall Study|Lost to Follow-up|10|||
163899179|NCT04129450|592002841|FG000|Overall Study|Withdrawal by Subject|9|||
164353162|NCT00726661|593666650|FG000|Overall Study|Withdrawal by Subject|17|||
164353163|NCT00726661|593666651|FG001|Overall Study|Withdrawal by Subject|13|||
163899180|NCT04129450|592002842|FG001|Overall Study|Withdrawal by Subject|5|||
163899181|NCT04129450|592002841|FG000|Overall Study|Work Family Obligations|2|||
163899182|NCT04129450|592002842|FG001|Overall Study|Work Family Obligations|0|||
163899183|NCT04129450|592002841|FG000|Overall Study|Other|3|||
164353164|NCT00726661|593666650|FG000|Overall Study|Trial terminated by sponsor|214|||
164353165|NCT00726661|593666651|FG001|Overall Study|Trial terminated by sponsor|187|||
164353166|NCT00726661|593666650|FG000|Overall Study|Death|475|||
164353167|NCT00726661|593666651|FG001|Overall Study|Death|159|||
164353168|NCT00726661|593666650|FG000|Overall Study|Physician Decision|25|||
164353169|NCT00726661|593666651|FG001|Overall Study|Physician Decision|13|||
164353170|NCT00726661|593666650|FG000|Overall Study|Other|47|||
164353171|NCT00726661|593666651|FG001|Overall Study|Other|35|||
164353172|NCT02557646|593666654|FG000|Overall Study|Adverse Event|40|||
164353173|NCT02557646|593666654|FG000|Overall Study|Death|1|||
164353174|NCT02557646|593666654|FG000|Overall Study|Lack of Efficacy|186|||
164353175|NCT02557646|593666654|FG000|Overall Study|Withdrawal by Subject|18|||
164353176|NCT02557646|593666654|FG000|Overall Study|Lost to Follow-up|17|||
164353177|NCT02557646|593666654|FG000|Overall Study|Other|14|||
164353178|NCT00005937|593666660|FG000|Overall Study|Lack of Efficacy|5|||
164353179|NCT00160251|593666661|FG000|Prior to Amendment 2|Adverse Event|2|||
164353180|NCT00160251|593666662|FG001|Prior to Amendment 2|Adverse Event|1|||
164353181|NCT00160251|593666663|FG002|Prior to Amendment 2|Adverse Event|3|||
164353182|NCT00160251|593666664|FG003|Prior to Amendment 2|Adverse Event|1|||
164353183|NCT00160251|593666665|FG004|Prior to Amendment 2|Adverse Event|1|||
164353184|NCT00160251|593666666|FG005|Prior to Amendment 2|Adverse Event|1|||
164353185|NCT00160251|593666667|FG006|Prior to Amendment 2|Adverse Event|1|||
164353186|NCT00160251|593666668|FG007|Prior to Amendment 2|Adverse Event|0|||
164353187|NCT00160251|593666661|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
164353188|NCT00160251|593666662|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
164353189|NCT00160251|593666663|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
164353190|NCT00160251|593666664|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
164353191|NCT00160251|593666665|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
164353192|NCT00160251|593666666|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
164353193|NCT00160251|593666667|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
163899184|NCT04129450|592002842|FG001|Overall Study|Other|0|||
163899185|NCT04559698|592003559|FG000|Overall Study|Lost to Follow-up|14|||
163899186|NCT04559698|592003560|FG001|Overall Study|Lost to Follow-up|15|||
163899187|NCT04559698|592003559|FG000|Overall Study|Withdrawal by Subject|0|||
163899188|NCT04559698|592003560|FG001|Overall Study|Withdrawal by Subject|1|||
163899189|NCT01982682|592003561|FG000|Overall Study|Physician Decision|1|||
163899190|NCT02760654|592003562|FG000|Overall Study|Lost to Follow-up|3|||
164353194|NCT00160251|593666668|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
163899191|NCT02760654|592003563|FG001|Overall Study|Lost to Follow-up|3|||
163899192|NCT02760654|592003562|FG000|Overall Study|Withdrawal by Subject|4|||
163899193|NCT02760654|592003563|FG001|Overall Study|Withdrawal by Subject|3|||
163899194|NCT01574716|592003564|FG000|Part 1|Death|3|||
163899195|NCT01574716|592003565|FG001|Part 1|Death|1|||
163899196|NCT01574716|592003566|FG002|Part 1|Death|8|||
163899197|NCT01574716|592003567|FG003|Part 1|Death|0|||
163899198|NCT01574716|592003568|FG004|Part 1|Death|0|||
163899199|NCT01574716|592003564|FG000|Part 1|Discontinuation of study by sponsor|0|||
163899200|NCT01574716|592003565|FG001|Part 1|Discontinuation of study by sponsor|0|||
163899201|NCT01574716|592003566|FG002|Part 1|Discontinuation of study by sponsor|1|||
163899202|NCT01574716|592003567|FG003|Part 1|Discontinuation of study by sponsor|0|||
163899203|NCT01574716|592003568|FG004|Part 1|Discontinuation of study by sponsor|0|||
163899204|NCT01574716|592003564|FG000|Part 1|Withdrawal by Subject|0|||
163899205|NCT01574716|592003565|FG001|Part 1|Withdrawal by Subject|2|||
163899206|NCT01574716|592003566|FG002|Part 1|Withdrawal by Subject|0|||
163899207|NCT01574716|592003567|FG003|Part 1|Withdrawal by Subject|0|||
164353195|NCT00160251|593666661|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
164353196|NCT00160251|593666662|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
164353197|NCT00160251|593666663|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
164353198|NCT00160251|593666664|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
164353199|NCT00160251|593666665|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
164353200|NCT00160251|593666666|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
164353201|NCT00160251|593666667|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
164353202|NCT00160251|593666668|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
164353203|NCT00160251|593666661|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
164353204|NCT00160251|593666662|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
164353205|NCT00160251|593666663|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
164353206|NCT00160251|593666664|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
164353207|NCT00160251|593666665|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
164353208|NCT00160251|593666666|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
164353209|NCT00160251|593666667|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
164353210|NCT00160251|593666668|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
164353211|NCT00160251|593666661|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
164353212|NCT00160251|593666662|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
164353213|NCT00160251|593666663|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
164353214|NCT00160251|593666664|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
164353215|NCT00160251|593666665|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
164353216|NCT00160251|593666666|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
164353217|NCT00160251|593666667|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
164353218|NCT00160251|593666668|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
164353219|NCT00160251|593666661|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
164353220|NCT00160251|593666662|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
164353221|NCT00160251|593666663|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
164353222|NCT00160251|593666664|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
164353223|NCT00160251|593666665|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
164353224|NCT00160251|593666666|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
164353225|NCT00160251|593666667|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
164353226|NCT00160251|593666668|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
164353227|NCT00160251|593666661|FG000|Post-amendment 2|Adverse Event|0|||
164353228|NCT00160251|593666662|FG001|Post-amendment 2|Adverse Event|0|||
164353229|NCT00160251|593666663|FG002|Post-amendment 2|Adverse Event|0|||
164353230|NCT00160251|593666664|FG003|Post-amendment 2|Adverse Event|0|||
164353231|NCT00160251|593666665|FG004|Post-amendment 2|Adverse Event|0|||
164353232|NCT00160251|593666666|FG005|Post-amendment 2|Adverse Event|0|||
164353233|NCT00160251|593666667|FG006|Post-amendment 2|Adverse Event|0|||
164353234|NCT00160251|593666668|FG007|Post-amendment 2|Adverse Event|20|||
164353235|NCT00160251|593666661|FG000|Post-amendment 2|Lack of Efficacy|0|||
164353236|NCT00160251|593666662|FG001|Post-amendment 2|Lack of Efficacy|0|||
164353237|NCT00160251|593666663|FG002|Post-amendment 2|Lack of Efficacy|0|||
164353238|NCT00160251|593666664|FG003|Post-amendment 2|Lack of Efficacy|0|||
164353239|NCT00160251|593666665|FG004|Post-amendment 2|Lack of Efficacy|0|||
164353240|NCT00160251|593666666|FG005|Post-amendment 2|Lack of Efficacy|0|||
164353241|NCT00160251|593666667|FG006|Post-amendment 2|Lack of Efficacy|0|||
164353242|NCT00160251|593666668|FG007|Post-amendment 2|Lack of Efficacy|24|||
164353243|NCT00160251|593666661|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163899208|NCT01574716|592003568|FG004|Part 1|Withdrawal by Subject|0|||
163899209|NCT01574716|592003564|FG000|Part 1|Lost to Follow-up|0|||
163899210|NCT01574716|592003565|FG001|Part 1|Lost to Follow-up|1|||
164353244|NCT00160251|593666662|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353245|NCT00160251|593666663|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353246|NCT00160251|593666664|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353247|NCT00160251|593666665|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
163899211|NCT01574716|592003566|FG002|Part 1|Lost to Follow-up|0|||
163899212|NCT01574716|592003567|FG003|Part 1|Lost to Follow-up|0|||
163899213|NCT01574716|592003568|FG004|Part 1|Lost to Follow-up|0|||
164353248|NCT00160251|593666666|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353249|NCT00160251|593666667|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
164353250|NCT00160251|593666668|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
164353251|NCT01288469|593666669|FG000|Overall Study|Adverse Event|4|||
164353252|NCT01288469|593666670|FG001|Overall Study|Adverse Event|1|||
164353253|NCT01288469|593666671|FG002|Overall Study|Adverse Event|1|||
164089785|NCT03594123|592691493|FG001|Overall Study|Site Terminated by Sponsor|1|||
164353254|NCT01288469|593666669|FG000|Overall Study|Poor compliance to protocol|0|||
164353255|NCT01288469|593666670|FG001|Overall Study|Poor compliance to protocol|1|||
164353256|NCT01288469|593666671|FG002|Overall Study|Poor compliance to protocol|0|||
164353257|NCT01288469|593666669|FG000|Overall Study|Participant Moved|1|||
164353258|NCT01288469|593666670|FG001|Overall Study|Participant Moved|0|||
164353259|NCT01288469|593666671|FG002|Overall Study|Participant Moved|0|||
164353260|NCT01288469|593666669|FG000|Overall Study|Consent withdrawn by subject|1|||
164353261|NCT01288469|593666670|FG001|Overall Study|Consent withdrawn by subject|1|||
164353262|NCT01288469|593666671|FG002|Overall Study|Consent withdrawn by subject|1|||
164353263|NCT01288469|593666669|FG000|Overall Study|Exclusion criteria finally met|1|||
164353264|NCT01288469|593666670|FG001|Overall Study|Exclusion criteria finally met|0|||
164353265|NCT01288469|593666671|FG002|Overall Study|Exclusion criteria finally met|0|||
164353266|NCT01574612|593666672|FG000|Overall Study|Adverse Event|3|||
164353267|NCT01574612|593666672|FG000|Overall Study|non compliant with drug|2|||
164353268|NCT01574612|593666672|FG000|Overall Study|Withdrawal by Subject|1|||
164353269|NCT01574612|593666672|FG000|Overall Study|Lost to Follow-up|2|||
164353270|NCT00582166|593666673|FG000|Overall Study|Death|1|||
164353271|NCT00582166|593666673|FG000|Overall Study|Ineligible pathology|1|||
164353272|NCT01606436|593666676|FG000|Overall Study|Withdrawal by Subject|0|||
164353273|NCT01606436|593666677|FG001|Overall Study|Withdrawal by Subject|0|||
164353274|NCT01606436|593666678|FG002|Overall Study|Withdrawal by Subject|1|||
164353275|NCT01606436|593666679|FG003|Overall Study|Withdrawal by Subject|1|||
164353276|NCT01606436|593666680|FG004|Overall Study|Withdrawal by Subject|1|||
164353277|NCT01606436|593666681|FG005|Overall Study|Withdrawal by Subject|0|||
164353278|NCT01606436|593666676|FG000|Overall Study|Adverse Event|0|||
164353279|NCT01606436|593666677|FG001|Overall Study|Adverse Event|0|||
164353280|NCT01606436|593666678|FG002|Overall Study|Adverse Event|1|||
164353281|NCT01606436|593666679|FG003|Overall Study|Adverse Event|0|||
164353282|NCT01606436|593666680|FG004|Overall Study|Adverse Event|0|||
164353283|NCT01606436|593666681|FG005|Overall Study|Adverse Event|0|||
164353284|NCT01606436|593666676|FG000|Overall Study|Sponsor Decision|0|||
164353285|NCT01606436|593666677|FG001|Overall Study|Sponsor Decision|0|||
164353286|NCT01606436|593666678|FG002|Overall Study|Sponsor Decision|0|||
164353287|NCT01606436|593666679|FG003|Overall Study|Sponsor Decision|1|||
164353288|NCT01606436|593666680|FG004|Overall Study|Sponsor Decision|0|||
164353289|NCT01606436|593666681|FG005|Overall Study|Sponsor Decision|0|||
164353290|NCT02859454|593666682|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
164353291|NCT00110149|593666683|FG000|Overall Study|Physician Decision|3|||
164353292|NCT02452398|593666688|FG000|Overall Study|Adverse Event|1|||
164353293|NCT02452398|593666688|FG000|Overall Study|Lost to Follow-up|28|||
164353294|NCT02452398|593666688|FG000|Overall Study|Physician Decision|2|||
164353295|NCT02452398|593666688|FG000|Overall Study|Withdrawal by Subject|6|||
164353296|NCT02452398|593666688|FG000|Overall Study|Moved away|4|||
164353297|NCT00748033|593666689|FG000|Overall Study|Adverse Event|0|||
164353298|NCT00748033|593666690|FG001|Overall Study|Adverse Event|1|||
164353299|NCT03334448|593666691|FG000|Washout|Personal Reason|0|||
164353300|NCT03334448|593666692|FG001|Washout|Personal Reason|1|||
164353301|NCT03334448|593666693|FG002|Washout|Personal Reason|0|||
164353302|NCT03334448|593666694|FG003|Washout|Personal Reason|0|||
164353303|NCT03334448|593666691|FG000|Washout|Protocol Violation|0|||
164353304|NCT03334448|593666692|FG001|Washout|Protocol Violation|0|||
164353305|NCT03334448|593666693|FG002|Washout|Protocol Violation|0|||
164353306|NCT03334448|593666694|FG003|Washout|Protocol Violation|1|||
164353307|NCT02326025|593666695|FG000|Overall Study|Adverse Event|3|||
164089786|NCT03594123|592691492|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
164353308|NCT02326025|593666696|FG001|Overall Study|Adverse Event|0|||
164353309|NCT02326025|593666695|FG000|Overall Study|Physician Decision|1|||
164353310|NCT02326025|593666696|FG001|Overall Study|Physician Decision|2|||
164353311|NCT02326025|593666695|FG000|Overall Study|Physician and Participant Decision|1|||
164353312|NCT02326025|593666696|FG001|Overall Study|Physician and Participant Decision|0|||
164353313|NCT02326025|593666695|FG000|Overall Study|Withdrawal by Subject|0|||
164353314|NCT02326025|593666696|FG001|Overall Study|Withdrawal by Subject|2|||
164089787|NCT03594123|592691493|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
164353315|NCT02326025|593666695|FG000|Overall Study|Protocol Violation|0|||
164353316|NCT02326025|593666696|FG001|Overall Study|Protocol Violation|1|||
164353317|NCT01365910|593666697|FG000|Overall Study|Withdrawal by Subject|7|||
164353318|NCT01365910|593666697|FG000|Overall Study|disease progression|18|||
164353319|NCT01365910|593666697|FG000|Overall Study|Adverse Event|3|||
164353320|NCT01365910|593666697|FG000|Overall Study|other complicating disease|1|||
164353321|NCT01365910|593666697|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
163899214|NCT01574716|592003564|FG000|Part 2|Progressive disease|0|||
163899215|NCT01574716|592003565|FG001|Part 2|Progressive disease|0|||
163899216|NCT01574716|592003566|FG002|Part 2|Progressive disease|0|||
163899217|NCT01574716|592003567|FG003|Part 2|Progressive disease|1|||
163899218|NCT01574716|592003568|FG004|Part 2|Progressive disease|0|||
163899219|NCT01574716|592003564|FG000|Part 2|Death|0|||
163899220|NCT01574716|592003565|FG001|Part 2|Death|0|||
163899221|NCT01574716|592003566|FG002|Part 2|Death|0|||
163899222|NCT01574716|592003567|FG003|Part 2|Death|76|||
163899223|NCT01574716|592003568|FG004|Part 2|Death|35|||
163899224|NCT01574716|592003564|FG000|Part 2|Discontinuation of study by sponsor|0|||
163899225|NCT01574716|592003565|FG001|Part 2|Discontinuation of study by sponsor|0|||
163899226|NCT01574716|592003566|FG002|Part 2|Discontinuation of study by sponsor|0|||
163899227|NCT01574716|592003567|FG003|Part 2|Discontinuation of study by sponsor|51|||
164353322|NCT02013791|593666698|FG000|Period 1|Lost to Follow-up|0|||
164353323|NCT02013791|593666699|FG001|Period 1|Lost to Follow-up|0|||
164353324|NCT02013791|593666700|FG002|Period 1|Lost to Follow-up|0|||
164353325|NCT02013791|593666701|FG003|Period 1|Lost to Follow-up|1|||
163899228|NCT01574716|592003568|FG004|Part 2|Discontinuation of study by sponsor|31|||
163899229|NCT01574716|592003564|FG000|Part 2|Withdrawal by Subject|0|||
163899230|NCT01574716|592003565|FG001|Part 2|Withdrawal by Subject|0|||
164353326|NCT02013791|593666702|FG004|Period 1|Lost to Follow-up|0|||
164353327|NCT02013791|593666703|FG005|Period 1|Lost to Follow-up|0|||
164353328|NCT02013791|593666704|FG006|Period 1|Lost to Follow-up|1|||
164353329|NCT02013791|593666705|FG007|Period 1|Lost to Follow-up|1|||
164353330|NCT02013791|593666706|FG008|Period 1|Lost to Follow-up|0|||
164353331|NCT02013791|593666698|FG000|Period 1|Other Miscellaneous Reasons|0|||
164353332|NCT02013791|593666699|FG001|Period 1|Other Miscellaneous Reasons|2|||
164353333|NCT02013791|593666700|FG002|Period 1|Other Miscellaneous Reasons|0|||
163899231|NCT01574716|592003566|FG002|Part 2|Withdrawal by Subject|0|||
164353334|NCT02013791|593666701|FG003|Period 1|Other Miscellaneous Reasons|0|||
164353335|NCT02013791|593666702|FG004|Period 1|Other Miscellaneous Reasons|0|||
164353336|NCT02013791|593666703|FG005|Period 1|Other Miscellaneous Reasons|0|||
164353337|NCT02013791|593666704|FG006|Period 1|Other Miscellaneous Reasons|0|||
164353338|NCT02013791|593666705|FG007|Period 1|Other Miscellaneous Reasons|0|||
164353339|NCT02013791|593666706|FG008|Period 1|Other Miscellaneous Reasons|0|||
164353340|NCT03798483|593666707|FG000|Overall Study|Lost to Follow-up|2|||
164353341|NCT02643082|593666708|FG000|Period 1|Adverse Event|1|||
164353342|NCT02643082|593666709|FG001|Period 1|Adverse Event|0|||
164353343|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
164353344|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353345|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
164353346|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353347|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353348|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353349|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353350|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353351|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
164353352|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
164353353|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
164353354|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
164353355|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353356|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353357|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353358|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353359|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353360|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
164353361|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353362|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
164353363|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353364|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353365|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353366|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163899232|NCT01574716|592003567|FG003|Part 2|Withdrawal by Subject|5|||
163899233|NCT01574716|592003568|FG004|Part 2|Withdrawal by Subject|4|||
163899234|NCT01574716|592003564|FG000|Part 2|Brain metastases|0|||
164353367|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353368|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
164353369|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
163899235|NCT01574716|592003565|FG001|Part 2|Brain metastases|0|||
163899236|NCT01574716|592003566|FG002|Part 2|Brain metastases|0|||
163899237|NCT01574716|592003567|FG003|Part 2|Brain metastases|1|||
163899238|NCT01574716|592003568|FG004|Part 2|Brain metastases|0|||
163899239|NCT01574716|592003564|FG000|Part 2|Lost to Follow-up|0|||
163899240|NCT01574716|592003565|FG001|Part 2|Lost to Follow-up|0|||
164353370|NCT02289417|593666710|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
164353371|NCT02289417|593666711|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353372|NCT02289417|593666712|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353373|NCT02289417|593666713|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353374|NCT02289417|593666714|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353375|NCT02289417|593666715|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353376|NCT02289417|593666716|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353377|NCT02289417|593666717|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353378|NCT02289417|593666718|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
164353379|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353380|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
164353381|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
164353382|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
164353383|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
164353384|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
164353385|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353386|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353387|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
164353388|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353389|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353390|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
164353391|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353392|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353393|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353394|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353395|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353396|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
164353397|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353398|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
164353399|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
164353400|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
164353401|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
164353402|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
164353403|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353404|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353405|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
164353406|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353407|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353408|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
164353409|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353410|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
164353411|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
164353412|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353413|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353414|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
164353415|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353416|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353417|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353418|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353419|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353420|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353421|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
164353422|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353423|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
164353424|NCT02289417|593666710|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353425|NCT02289417|593666711|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353426|NCT02289417|593666712|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353427|NCT02289417|593666713|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
164353428|NCT02289417|593666714|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353429|NCT02289417|593666715|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353430|NCT02289417|593666716|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
164353431|NCT02289417|593666717|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353432|NCT02289417|593666718|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
164353433|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
164353434|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
164353435|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
164353436|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
164299196|NCT00423579|593471255|FG000|Overall Study|Diagnosis of diabetes|0|||
164299197|NCT00423579|593471256|FG001|Overall Study|Diagnosis of diabetes|1|||
164299198|NCT04004988|593471258|FG000|Period 1|Physician Decision|2|||
164299199|NCT04004988|593471259|FG001|Period 1|Physician Decision|0|||
164299200|NCT04004988|593471258|FG000|Period 1|Withdrawal by Subject|0|||
164299201|NCT04004988|593471259|FG001|Period 1|Withdrawal by Subject|1|||
164299202|NCT04004988|593471258|FG000|Period 1|Adverse Event|1|||
164299203|NCT04004988|593471259|FG001|Period 1|Adverse Event|2|||
164299204|NCT03873116|593471260|FG000|Part 1|Study drug discontinuation due to rash|0|||
164299205|NCT03873116|593471261|FG001|Part 1|Study drug discontinuation due to rash|0|||
164299206|NCT03873116|593471262|FG002|Part 1|Study drug discontinuation due to rash|0|||
164299207|NCT03873116|593471263|FG003|Part 1|Study drug discontinuation due to rash|0|||
164299208|NCT03873116|593471264|FG004|Part 1|Study drug discontinuation due to rash|0|||
164299209|NCT03873116|593471265|FG005|Part 1|Study drug discontinuation due to rash|1|||
164299210|NCT03873116|593471260|FG000|Part 2|Withdrawal by Subject|0|||
164299211|NCT03873116|593471261|FG001|Part 2|Withdrawal by Subject|0|||
164299212|NCT03873116|593471262|FG002|Part 2|Withdrawal by Subject|1|||
164299213|NCT03873116|593471263|FG003|Part 2|Withdrawal by Subject|0|||
164299214|NCT03873116|593471264|FG004|Part 2|Withdrawal by Subject|0|||
164299215|NCT03873116|593471265|FG005|Part 2|Withdrawal by Subject|0|||
164299216|NCT03873116|593471260|FG000|Part 2|Lab abnormality or AE|0|||
164299217|NCT03873116|593471261|FG001|Part 2|Lab abnormality or AE|0|||
164299218|NCT03873116|593471262|FG002|Part 2|Lab abnormality or AE|0|||
164299219|NCT03873116|593471263|FG003|Part 2|Lab abnormality or AE|0|||
164299220|NCT03873116|593471264|FG004|Part 2|Lab abnormality or AE|1|||
164299221|NCT03873116|593471265|FG005|Part 2|Lab abnormality or AE|0|||
164299222|NCT03873116|593471260|FG000|Part 3|Withdrawal by Subject|0|||
164299223|NCT03873116|593471261|FG001|Part 3|Withdrawal by Subject|0|||
164299224|NCT03873116|593471262|FG002|Part 3|Withdrawal by Subject|0|||
164299225|NCT03873116|593471263|FG003|Part 3|Withdrawal by Subject|0|||
164299226|NCT03873116|593471264|FG004|Part 3|Withdrawal by Subject|1|||
164299227|NCT03873116|593471265|FG005|Part 3|Withdrawal by Subject|0|||
164299228|NCT00003475|593471266|FG000|Overall Study|Not evaluable|13|||
164353437|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
164353438|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
164353439|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
164353440|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
164353441|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
164353442|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353443|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353444|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353445|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353446|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353447|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353448|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
164353449|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
164353450|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
164353451|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353452|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353453|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353454|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353455|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353456|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353457|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
164353458|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
164353459|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
164353460|NCT02289417|593666710|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353461|NCT02289417|593666711|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353462|NCT02289417|593666712|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353463|NCT02289417|593666713|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353464|NCT02289417|593666714|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353465|NCT02289417|593666715|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353466|NCT02289417|593666716|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353467|NCT02289417|593666717|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
164353468|NCT02289417|593666718|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
164353469|NCT02725710|593666719|FG000|Overall Study|Lost to Follow-up|1|||
164353470|NCT02725710|593666720|FG001|Overall Study|Lost to Follow-up|0|||
164353471|NCT02505867|593666721|FG000|Overall Study|Lack of Efficacy|6|||
164353472|NCT02505867|593666722|FG001|Overall Study|Lack of Efficacy|6|||
164353473|NCT01782222|593666723|FG000|Overall Study|Adverse Event|4|||
164353474|NCT01782222|593666724|FG001|Overall Study|Adverse Event|5|||
164353475|NCT01782222|593666725|FG002|Overall Study|Adverse Event|3|||
164353476|NCT01782222|593666723|FG000|Overall Study|Lack of Efficacy|2|||
164353477|NCT01782222|593666724|FG001|Overall Study|Lack of Efficacy|1|||
164353478|NCT01782222|593666725|FG002|Overall Study|Lack of Efficacy|0|||
164353479|NCT01782222|593666723|FG000|Overall Study|Protocol Violation|1|||
164353480|NCT01782222|593666724|FG001|Overall Study|Protocol Violation|0|||
164353481|NCT01782222|593666725|FG002|Overall Study|Protocol Violation|0|||
164353482|NCT01782222|593666723|FG000|Overall Study|Withdrawal by Subject|1|||
164353483|NCT01782222|593666724|FG001|Overall Study|Withdrawal by Subject|4|||
164353484|NCT01782222|593666725|FG002|Overall Study|Withdrawal by Subject|1|||
164353485|NCT01782222|593666723|FG000|Overall Study|Moved to other state|0|||
164353486|NCT01782222|593666724|FG001|Overall Study|Moved to other state|1|||
164353487|NCT01782222|593666725|FG002|Overall Study|Moved to other state|0|||
164353488|NCT03200860|593666726|FG000|Overall Study|Withdrawal by Subject|1|||
164353489|NCT03200860|593666727|FG001|Overall Study|Withdrawal by Subject|0|||
164353490|NCT01605877|593666728|FG000|Overall Study|Withdrawal by Subject|1|||
164353491|NCT01918085|593666733|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
164353492|NCT01918085|593666734|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
164353493|NCT02634320|593666738|FG000|Overall Study|Adverse Event|2|||
164353494|NCT02634320|593666738|FG000|Overall Study|Lost to Follow-up|3|||
164353495|NCT02634320|593666738|FG000|Overall Study|Moved out of area|2|||
164353496|NCT02634320|593666738|FG000|Overall Study|Out of window for study visits|1|||
164353497|NCT02634320|593666738|FG000|Overall Study|Protocol Violation|1|||
164353498|NCT02634320|593666738|FG000|Overall Study|Withdrawal by Subject|5|||
164353499|NCT02634320|593666738|FG000|Overall Study|Lack of Efficacy|2|||
164353500|NCT00687323|593666739|FG000|Overall Study|Death|25|||
164353501|NCT00687323|593666739|FG000|Overall Study|Withdrawal by Subject|1|||
164353502|NCT00687323|593666739|FG000|Overall Study|Excluded from efficacy evaluations|6|||
164353503|NCT00687323|593666739|FG000|Overall Study|Screen failure|148|||
164353504|NCT03655691|593666747|FG000|Overall Study|Adverse Event|0|||
164353505|NCT03655691|593666748|FG001|Overall Study|Adverse Event|0|||
164353506|NCT03655691|593666749|FG002|Overall Study|Adverse Event|1|||
164353507|NCT03655691|593666747|FG000|Overall Study|Lost to Follow-up|1|||
164353508|NCT03655691|593666748|FG001|Overall Study|Lost to Follow-up|1|||
164353509|NCT03655691|593666749|FG002|Overall Study|Lost to Follow-up|2|||
164353510|NCT03655691|593666747|FG000|Overall Study|Protocol Violation|0|||
164353511|NCT03655691|593666748|FG001|Overall Study|Protocol Violation|1|||
164353512|NCT03655691|593666749|FG002|Overall Study|Protocol Violation|0|||
164353513|NCT03655691|593666747|FG000|Overall Study|Withdrawal by Subject|1|||
164353514|NCT03655691|593666748|FG001|Overall Study|Withdrawal by Subject|1|||
164353515|NCT03655691|593666749|FG002|Overall Study|Withdrawal by Subject|0|||
164353516|NCT04557371|593666750|FG000|Overall Study|Covid-19-related|0|||
164353517|NCT04557371|593666751|FG001|Overall Study|Covid-19-related|1|||
164353518|NCT04557371|593666752|FG002|Overall Study|Covid-19-related|0|||
164353519|NCT04557371|593666750|FG000|Overall Study|Withdrawal by Subject|0|||
164353520|NCT04557371|593666751|FG001|Overall Study|Withdrawal by Subject|1|||
164353521|NCT04557371|593666752|FG002|Overall Study|Withdrawal by Subject|0|||
164353522|NCT04557371|593666750|FG000|Overall Study|Adverse Event|1|||
164353523|NCT04557371|593666751|FG001|Overall Study|Adverse Event|0|||
164353524|NCT04557371|593666752|FG002|Overall Study|Adverse Event|0|||
164353525|NCT01428453|593666755|FG000|Overall Study|Adverse Event|2|||
164353526|NCT01428453|593666756|FG001|Overall Study|Adverse Event|7|||
163899241|NCT01574716|592003566|FG002|Part 2|Lost to Follow-up|0|||
164353527|NCT01428453|593666755|FG000|Overall Study|Protocol Violation|1|||
164353528|NCT01428453|593666756|FG001|Overall Study|Protocol Violation|0|||
164353529|NCT01428453|593666755|FG000|Overall Study|Lost to Follow-up|0|||
164353530|NCT01428453|593666756|FG001|Overall Study|Lost to Follow-up|1|||
164353531|NCT01428453|593666755|FG000|Overall Study|Withdrawal by Subject|3|||
164353532|NCT01428453|593666756|FG001|Overall Study|Withdrawal by Subject|1|||
163899242|NCT01574716|592003567|FG003|Part 2|Lost to Follow-up|3|||
163899243|NCT01574716|592003568|FG004|Part 2|Lost to Follow-up|0|||
164353533|NCT01996709|593666757|FG000|Overall Study|Withdrawal by Subject|1|||
164353534|NCT01996709|593666758|FG001|Overall Study|Withdrawal by Subject|0|||
164353535|NCT01996709|593666757|FG000|Overall Study|Lost to Follow-up|3|||
163899244|NCT03183050|592003569|FG000|Overall Study|Lost to Follow-up|23|||
163899245|NCT02797132|592003571|FG000|Part A (15 Days)|Adverse Event|1|||
163899246|NCT02797132|592003571|FG000|Part B (24 Weeks)|Adverse Event|3|||
163899247|NCT02502526|592003572|FG000|Overall Study|Lost to Follow-up|2|||
163899248|NCT02502526|592003573|FG001|Overall Study|Lost to Follow-up|2|||
163899249|NCT02502526|592003574|FG002|Overall Study|Lost to Follow-up|3|||
163899250|NCT02502526|592003572|FG000|Overall Study|Withdrawal by Subject|0|||
163899251|NCT02502526|592003573|FG001|Overall Study|Withdrawal by Subject|1|||
163899252|NCT02502526|592003574|FG002|Overall Study|Withdrawal by Subject|1|||
163899253|NCT02502526|592003572|FG000|Overall Study|Disqualified due to cataract grading|0|||
163899254|NCT02502526|592003573|FG001|Overall Study|Disqualified due to cataract grading|0|||
163899255|NCT02502526|592003574|FG002|Overall Study|Disqualified due to cataract grading|1|||
163899256|NCT02502526|592003572|FG000|Overall Study|Enrollment suspension|4|||
163899257|NCT02502526|592003573|FG001|Overall Study|Enrollment suspension|1|||
163899258|NCT02502526|592003574|FG002|Overall Study|Enrollment suspension|1|||
163899259|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
163899260|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
163899261|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
163899262|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
163899263|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
163899264|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
163899265|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
163899266|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
163899267|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
163899268|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
163899269|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
163899270|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
163899271|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
163899272|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
163899273|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
163899274|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
163899275|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
163899276|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
163899277|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
163899278|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
163899279|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
163899280|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
163899281|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
163899282|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
163899283|NCT01074294|592003579|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
163899284|NCT01074294|592003580|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
164089788|NCT03594123|592691492|FG000|Overall Study|Lack of Efficacy|1|||
164089789|NCT03594123|592691493|FG001|Overall Study|Lack of Efficacy|0|||
164353536|NCT01996709|593666758|FG001|Overall Study|Lost to Follow-up|0|||
164353537|NCT01996709|593666757|FG000|Overall Study|Subject Non-Compliant|1|||
164353538|NCT01996709|593666758|FG001|Overall Study|Subject Non-Compliant|0|||
164353539|NCT01996709|593666757|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164353540|NCT01996709|593666758|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
164353541|NCT03918447|593666759|FG000|Overall Study|Death|1|||
164353542|NCT03918447|593666760|FG001|Overall Study|Death|0|||
164353543|NCT03918447|593666759|FG000|Overall Study|Lost to Follow-up|13|||
164353544|NCT03918447|593666760|FG001|Overall Study|Lost to Follow-up|6|||
164353545|NCT03918447|593666759|FG000|Overall Study|Withdrawal by Subject|19|||
164353546|NCT03918447|593666760|FG001|Overall Study|Withdrawal by Subject|17|||
164353547|NCT03918447|593666759|FG000|Overall Study|Study Terminated by Sponsor|195|||
164353548|NCT03918447|593666760|FG001|Overall Study|Study Terminated by Sponsor|197|||
164353549|NCT03918447|593666759|FG000|Overall Study|Reason not Specified|0|||
164353550|NCT03918447|593666760|FG001|Overall Study|Reason not Specified|1|||
164353551|NCT00477971|593666761|FG000|Overall Study|Disease progression|6|||
164353552|NCT00477971|593666762|FG001|Overall Study|Disease progression|0|||
164089790|NCT03594123|592691492|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
164089791|NCT03594123|592691493|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
164353553|NCT00477971|593666761|FG000|Overall Study|Withdrawal by Subject|3|||
164353554|NCT00477971|593666762|FG001|Overall Study|Withdrawal by Subject|1|||
164353555|NCT00477971|593666761|FG000|Overall Study|Adverse Event|3|||
164353556|NCT00477971|593666762|FG001|Overall Study|Adverse Event|0|||
164353557|NCT00477971|593666761|FG000|Overall Study|Death|2|||
164353558|NCT00477971|593666762|FG001|Overall Study|Death|4|||
164353559|NCT00477971|593666761|FG000|Overall Study|Alternative treatment|3|||
164353560|NCT00477971|593666762|FG001|Overall Study|Alternative treatment|1|||
164353561|NCT01774968|593666763|FG000|Overall Study|Adverse Event|4|||
163899285|NCT01074294|592003581|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
163899286|NCT01074294|592003582|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
163899287|NCT01074294|592003579|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
163899288|NCT01074294|592003580|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
163899289|NCT01074294|592003581|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
163899290|NCT01074294|592003582|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
163899291|NCT01074294|592003579|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
163899292|NCT01074294|592003580|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
163899293|NCT01074294|592003581|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
163899294|NCT01074294|592003582|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
163899295|NCT01074294|592003579|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
163899296|NCT01074294|592003580|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
163899297|NCT01074294|592003581|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
163899298|NCT01074294|592003582|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
163899299|NCT01074294|592003579|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
163899300|NCT01074294|592003580|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
163899301|NCT01074294|592003581|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
163899302|NCT01074294|592003582|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
163899303|NCT01074294|592003579|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
163899304|NCT01074294|592003580|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
163899305|NCT01074294|592003581|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
163899306|NCT01074294|592003582|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
163899307|NCT01074294|592003579|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
163899308|NCT01074294|592003580|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
163899309|NCT01074294|592003581|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
163899310|NCT01074294|592003582|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
163899311|NCT00112359|592003583|FG000|Overall Study|Unrelated adverse event|16|||
163899312|NCT00112359|592003584|FG001|Overall Study|Unrelated adverse event|8|||
163899313|NCT00112359|592003583|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
163899314|NCT00112359|592003584|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
163899315|NCT00112359|592003583|FG000|Overall Study|Related adverse event|5|||
163899316|NCT00112359|592003584|FG001|Overall Study|Related adverse event|3|||
163899317|NCT00112359|592003583|FG000|Overall Study|Lost to Follow-up|0|||
163899318|NCT00112359|592003584|FG001|Overall Study|Lost to Follow-up|1|||
163899319|NCT00112359|592003583|FG000|Overall Study|Personal/administrative|1|||
163899320|NCT00112359|592003584|FG001|Overall Study|Personal/administrative|1|||
163899321|NCT00112359|592003583|FG000|Overall Study|Other|3|||
163899322|NCT00112359|592003584|FG001|Overall Study|Other|0|||
163899323|NCT01500200|592003585|FG000|Stage 1|Adverse Event|1|||
163899324|NCT01500200|592003586|FG001|Stage 1|Adverse Event|4|||
163899325|NCT01500200|592003587|FG002|Stage 1|Adverse Event|5|||
163899326|NCT01500200|592003588|FG003|Stage 1|Adverse Event|0|||
163899327|NCT01500200|592003589|FG004|Stage 1|Adverse Event|0|||
163899328|NCT01500200|592003590|FG005|Stage 1|Adverse Event|0|||
163899329|NCT01500200|592003585|FG000|Stage 1|Lost to Follow-up|2|||
163899330|NCT01500200|592003586|FG001|Stage 1|Lost to Follow-up|2|||
163899331|NCT01500200|592003587|FG002|Stage 1|Lost to Follow-up|1|||
163899332|NCT01500200|592003588|FG003|Stage 1|Lost to Follow-up|0|||
163899333|NCT01500200|592003589|FG004|Stage 1|Lost to Follow-up|0|||
163899334|NCT01500200|592003590|FG005|Stage 1|Lost to Follow-up|0|||
163899335|NCT01500200|592003585|FG000|Stage 1|Withdrawal by Subject|3|||
163899336|NCT01500200|592003586|FG001|Stage 1|Withdrawal by Subject|0|||
163899337|NCT01500200|592003587|FG002|Stage 1|Withdrawal by Subject|0|||
163899338|NCT01500200|592003588|FG003|Stage 1|Withdrawal by Subject|0|||
163899339|NCT01500200|592003589|FG004|Stage 1|Withdrawal by Subject|0|||
163899340|NCT01500200|592003590|FG005|Stage 1|Withdrawal by Subject|0|||
164005655|NCT02413398|592387302|FG001|Overall Study|Lost to Follow-up|4|||
164005656|NCT02413398|592387301|FG000|Overall Study|Withdrawal by Subject|1|||
164005657|NCT02413398|592387302|FG001|Overall Study|Withdrawal by Subject|1|||
164005658|NCT02413398|592387301|FG000|Overall Study|Other Eligibility criteria|1|||
164005659|NCT02413398|592387302|FG001|Overall Study|Other Eligibility criteria|2|||
163899341|NCT01500200|592003585|FG000|Stage 1|Noncompliance with Study Drug|1|||
163899342|NCT01500200|592003586|FG001|Stage 1|Noncompliance with Study Drug|0|||
163899343|NCT01500200|592003587|FG002|Stage 1|Noncompliance with Study Drug|0|||
163899344|NCT01500200|592003588|FG003|Stage 1|Noncompliance with Study Drug|0|||
163899345|NCT01500200|592003589|FG004|Stage 1|Noncompliance with Study Drug|0|||
163899346|NCT01500200|592003590|FG005|Stage 1|Noncompliance with Study Drug|0|||
163899347|NCT01500200|592003585|FG000|Stage 1|Physician Decision|1|||
163899348|NCT01500200|592003586|FG001|Stage 1|Physician Decision|0|||
163899349|NCT01500200|592003587|FG002|Stage 1|Physician Decision|0|||
163899350|NCT01500200|592003588|FG003|Stage 1|Physician Decision|0|||
163899351|NCT01500200|592003589|FG004|Stage 1|Physician Decision|0|||
163899352|NCT01500200|592003590|FG005|Stage 1|Physician Decision|0|||
163899353|NCT01500200|592003585|FG000|Stage 2|Adverse Event|0|||
164005660|NCT05408858|592387303|FG000|Overall Study|no longer met eligibility criteria|1|||
164005661|NCT01184989|592387306|FG000|Overall Study|Adverse Event|11|||
164005662|NCT01184989|592387306|FG000|Overall Study|Withdrawal by Subject|1|||
164353562|NCT01774968|593666764|FG001|Overall Study|Adverse Event|4|||
164353563|NCT01774968|593666763|FG000|Overall Study|Death|0|||
164353564|NCT01774968|593666764|FG001|Overall Study|Death|1|||
164353565|NCT01774968|593666763|FG000|Overall Study|Lost to Follow-up|1|||
164353566|NCT01774968|593666764|FG001|Overall Study|Lost to Follow-up|3|||
164353567|NCT01774968|593666763|FG000|Overall Study|Physician Decision|5|||
164353568|NCT01774968|593666764|FG001|Overall Study|Physician Decision|1|||
164353569|NCT01774968|593666763|FG000|Overall Study|Protocol Violation|14|||
164353570|NCT01774968|593666764|FG001|Overall Study|Protocol Violation|13|||
164353571|NCT01774968|593666763|FG000|Overall Study|Sponsor Decision|0|||
164353572|NCT01774968|593666764|FG001|Overall Study|Sponsor Decision|2|||
164353573|NCT01774968|593666763|FG000|Overall Study|Withdrawal by Subject|6|||
164353574|NCT01774968|593666764|FG001|Overall Study|Withdrawal by Subject|11|||
164353575|NCT01986855|593668317|FG000|Overall Study|Adverse Event|1|||
164353576|NCT01986855|593668318|FG001|Overall Study|Adverse Event|0|||
164353577|NCT01986855|593668319|FG002|Overall Study|Adverse Event|0|||
164353578|NCT01986855|593668317|FG000|Overall Study|Death|3|||
164353579|NCT01986855|593668318|FG001|Overall Study|Death|4|||
164353580|NCT01986855|593668319|FG002|Overall Study|Death|4|||
164353581|NCT01986855|593668317|FG000|Overall Study|Lost to Follow-up|2|||
164353582|NCT01986855|593668318|FG001|Overall Study|Lost to Follow-up|1|||
164353583|NCT01986855|593668319|FG002|Overall Study|Lost to Follow-up|0|||
164353584|NCT01986855|593668317|FG000|Overall Study|Screen Failure|0|||
164353585|NCT01986855|593668318|FG001|Overall Study|Screen Failure|1|||
164353586|NCT01986855|593668319|FG002|Overall Study|Screen Failure|0|||
164353587|NCT01986855|593668317|FG000|Overall Study|Participant Moved|0|||
164353588|NCT01986855|593668318|FG001|Overall Study|Participant Moved|0|||
164353589|NCT01986855|593668319|FG002|Overall Study|Participant Moved|2|||
164353590|NCT01986855|593668317|FG000|Overall Study|Withdrawal by Subject|7|||
164353591|NCT01986855|593668318|FG001|Overall Study|Withdrawal by Subject|8|||
164353592|NCT01986855|593668319|FG002|Overall Study|Withdrawal by Subject|5|||
164353593|NCT04317066|593668320|FG000|Overall Study|Sponsor decision|5|||
164353594|NCT04317066|593668320|FG000|Overall Study|Death|2|||
164353595|NCT02014597|593668324|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
164353596|NCT02014597|593668325|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
164353597|NCT02279173|593668327|FG000|Overall Study|Protocol-specified Criteria|67|||
164353598|NCT02279173|593668327|FG000|Overall Study|Withdrawal by Subject|20|||
164353599|NCT02279173|593668327|FG000|Overall Study|Decision by Sponsor|4|||
164353600|NCT02279173|593668327|FG000|Overall Study|Lost to Follow-up|3|||
164353601|NCT00754624|593668329|FG000|Overall Study|Adverse Event|16|||
164353602|NCT00754624|593668329|FG000|Overall Study|Death|1|||
164353603|NCT00754624|593668329|FG000|Overall Study|Physician Decision|8|||
164353604|NCT00754624|593668329|FG000|Overall Study|Protocol Violation|1|||
164353605|NCT00754624|593668329|FG000|Overall Study|Withdrawal by Subject|28|||
164353606|NCT00754624|593668329|FG000|Overall Study|Various|12|||
164353607|NCT00754624|593668329|FG000|Overall Study|Lost to Follow-up|3|||
164353608|NCT00022633|593668337|FG000|Overall Study|Adverse Event|11|||
164353609|NCT00022633|593668338|FG001|Overall Study|Adverse Event|1|||
164353610|NCT00022633|593668337|FG000|Overall Study|Refusal unrelated to adverse event|1|||
164353611|NCT00022633|593668338|FG001|Overall Study|Refusal unrelated to adverse event|0|||
164353612|NCT00022633|593668337|FG000|Overall Study|Progression/relapse|9|||
164353613|NCT00022633|593668338|FG001|Overall Study|Progression/relapse|2|||
164353614|NCT00022633|593668337|FG000|Overall Study|Death|4|||
164353615|NCT00022633|593668338|FG001|Overall Study|Death|0|||
164353616|NCT00022633|593668337|FG000|Overall Study|Other - not protocol specified|3|||
164353617|NCT00022633|593668338|FG001|Overall Study|Other - not protocol specified|2|||
164353618|NCT00022633|593668337|FG000|Overall Study|Ineligible|4|||
164005663|NCT00465569|592387307|FG000|Overall Study|persistent eczema during dose escalation|1|||
164005664|NCT00465569|592387308|FG001|Overall Study|persistent eczema during dose escalation|0|||
164005665|NCT00482001|592387310|FG000|Overall Study|Protocol Violation|1|||
164005666|NCT00482001|592387311|FG001|Overall Study|Protocol Violation|1|||
164353619|NCT00022633|593668338|FG001|Overall Study|Ineligible|0|||
164353620|NCT01741701|593668341|FG000|Overall Study|Adverse Event|5|||
164353621|NCT01741701|593668342|FG001|Overall Study|Adverse Event|1|||
164353622|NCT01741701|593668341|FG000|Overall Study|Withdrawal by Subject|0|||
164353623|NCT01741701|593668342|FG001|Overall Study|Withdrawal by Subject|1|||
164353624|NCT00372112|593668354|FG000|Overall Study|Adverse Event|0|||
164353625|NCT00372112|593668355|FG001|Overall Study|Adverse Event|1|||
164005667|NCT04786210|592387312|FG000|Overall Study|Lost to Follow-up|2|||
164353626|NCT00372112|593668356|FG002|Overall Study|Adverse Event|1|||
164353627|NCT00372112|593668357|FG003|Overall Study|Adverse Event|1|||
164353628|NCT00372112|593668354|FG000|Overall Study|Withdrawal by Subject|0|||
164353629|NCT00372112|593668355|FG001|Overall Study|Withdrawal by Subject|0|||
164353630|NCT00372112|593668356|FG002|Overall Study|Withdrawal by Subject|2|||
164353631|NCT00372112|593668357|FG003|Overall Study|Withdrawal by Subject|1|||
164353632|NCT00372112|593668354|FG000|Overall Study|Exacerbation|0|||
164353633|NCT00372112|593668355|FG001|Overall Study|Exacerbation|0|||
164353634|NCT00372112|593668356|FG002|Overall Study|Exacerbation|0|||
164353635|NCT00372112|593668357|FG003|Overall Study|Exacerbation|1|||
164353636|NCT00372112|593668354|FG000|Overall Study|PR >240 at Visit 3|0|||
164353637|NCT00372112|593668355|FG001|Overall Study|PR >240 at Visit 3|0|||
164353638|NCT00372112|593668356|FG002|Overall Study|PR >240 at Visit 3|0|||
164353639|NCT00372112|593668357|FG003|Overall Study|PR >240 at Visit 3|1|||
164353640|NCT00372112|593668354|FG000|Overall Study|Hepatitis B|1|||
164353641|NCT00372112|593668355|FG001|Overall Study|Hepatitis B|0|||
164353642|NCT00372112|593668356|FG002|Overall Study|Hepatitis B|0|||
164353643|NCT00372112|593668357|FG003|Overall Study|Hepatitis B|0|||
164353644|NCT00372112|593668354|FG000|Overall Study|Other-protocol violation|0|||
164353645|NCT00372112|593668355|FG001|Overall Study|Other-protocol violation|0|||
164353646|NCT00372112|593668356|FG002|Overall Study|Other-protocol violation|1|||
164353647|NCT00372112|593668357|FG003|Overall Study|Other-protocol violation|0|||
163899354|NCT01500200|592003586|FG001|Stage 2|Adverse Event|0|||
163899355|NCT01500200|592003587|FG002|Stage 2|Adverse Event|0|||
163899356|NCT01500200|592003588|FG003|Stage 2|Adverse Event|0|||
164353648|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
164353649|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
164353650|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
164353651|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
164353652|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
163899357|NCT01500200|592003589|FG004|Stage 2|Adverse Event|5|||
164353653|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
164353654|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
164353655|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
164353656|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Patient Request|1|||
164353657|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Patient Request|0|||
164353658|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
164353659|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
164353660|NCT04649060|593668358|FG000|Arm A/Arm B Treatment|Other|1|||
164353661|NCT04649060|593668359|FG001|Arm A/Arm B Treatment|Other|0|||
164005668|NCT04786210|592387312|FG000|Overall Study|Withdrawal by Subject|4|||
164005669|NCT03826914|592387313|FG000|Overall Study|Withdrawal by Subject|1|||
164005670|NCT03826914|592387314|FG001|Overall Study|Withdrawal by Subject|1|||
164353662|NCT04649060|593668358|FG000|Crossover (Arm B)|Adverse Event|0|||
164353663|NCT04649060|593668359|FG001|Crossover (Arm B)|Adverse Event|1|||
164353664|NCT04649060|593668358|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
164353665|NCT04649060|593668359|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
164353666|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
164353667|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
164353668|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
164353669|NCT03033394|593668360|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
164353670|NCT03033394|593668360|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
164353671|NCT02927431|593668361|FG000|Overall Study|Withdrawal by Subject|0|||
164353672|NCT02927431|593668362|FG001|Overall Study|Withdrawal by Subject|0|||
164353673|NCT02927431|593668363|FG002|Overall Study|Withdrawal by Subject|1|||
164353674|NCT02246660|593668364|FG000|Overall Study|Withdrawal by Subject|0|||
164353675|NCT02246660|593668365|FG001|Overall Study|Withdrawal by Subject|1|||
164353676|NCT02246660|593668366|FG002|Overall Study|Withdrawal by Subject|0|||
164353677|NCT02246660|593668364|FG000|Overall Study|Death|0|||
164353678|NCT02246660|593668365|FG001|Overall Study|Death|0|||
164353679|NCT02246660|593668366|FG002|Overall Study|Death|1|||
164353680|NCT04952402|593668367|FG000|Overall Study|Lost to Follow-up|1|||
164353681|NCT04952402|593668368|FG001|Overall Study|Lost to Follow-up|3|||
164353682|NCT04952402|593668367|FG000|Overall Study|Lack Of Venous Access|0|||
164353683|NCT04952402|593668368|FG001|Overall Study|Lack Of Venous Access|1|||
164353684|NCT00143403|593668369|FG000|Overall Study|Adverse Event|3|||
164353685|NCT00143403|593668370|FG001|Overall Study|Adverse Event|8|||
164353686|NCT00143403|593668369|FG000|Overall Study|Death|1|||
164353687|NCT00143403|593668370|FG001|Overall Study|Death|0|||
164353688|NCT00143403|593668369|FG000|Overall Study|Withdrawal by Subject|3|||
164353689|NCT00143403|593668370|FG001|Overall Study|Withdrawal by Subject|12|||
164353690|NCT00143403|593668369|FG000|Overall Study|Relapse|15|||
164353691|NCT00143403|593668370|FG001|Overall Study|Relapse|7|||
164353692|NCT00143403|593668369|FG000|Overall Study|Protocol Violation|2|||
164353693|NCT00143403|593668370|FG001|Overall Study|Protocol Violation|2|||
164353694|NCT00143403|593668369|FG000|Overall Study|specified by site|4|||
164353695|NCT00143403|593668370|FG001|Overall Study|specified by site|9|||
164353696|NCT00143403|593668369|FG000|Overall Study|Randomized Not Treated|7|||
164353697|NCT00143403|593668370|FG001|Overall Study|Randomized Not Treated|8|||
164353698|NCT00587639|593668371|FG000|Overall Study|Withdrawal by Subject|1|||
164353699|NCT00533845|593668374|FG000|Overall Study|Physician Decision|1|||
164353700|NCT00533845|593668375|FG001|Overall Study|Physician Decision|0|||
164353701|NCT01442675|593668376|FG000|Overall Study|Protocol Violation|6|||
164353702|NCT01442675|593668376|FG000|Overall Study|Lost to Follow-up|2|||
164353703|NCT01442675|593668376|FG000|Overall Study|Withdrawal by Subject|4|||
164353704|NCT00667368|593668385|FG000|Overall Study|Lost to Follow-up|176|||
164353705|NCT00667368|593668386|FG001|Overall Study|Lost to Follow-up|155|||
164353706|NCT00667368|593668385|FG000|Overall Study|Discontinued early|24|||
164353707|NCT00667368|593668386|FG001|Overall Study|Discontinued early|17|||
164353708|NCT03944954|593668387|FG000|Overall Study|Withdrawal by Subject|22|||
164353709|NCT03944954|593668388|FG001|Overall Study|Withdrawal by Subject|4|||
164353710|NCT03944954|593668387|FG000|Overall Study|Lost to Follow-up|18|||
164353711|NCT03944954|593668388|FG001|Overall Study|Lost to Follow-up|0|||
164353712|NCT03944954|593668387|FG000|Overall Study|Failed Medical Screening|7|||
164353713|NCT03944954|593668388|FG001|Overall Study|Failed Medical Screening|0|||
164133102|NCT01447420|592852656|FG001|Overall Study|Protocol Violation|3|||
164353714|NCT03235154|593668392|FG000|Overall Study|Withdrawal by Subject|1|||
164353715|NCT03235154|593668392|FG000|Overall Study|Adverse Event|1|||
164353716|NCT03235154|593668392|FG000|Overall Study|Lost to Follow-up|2|||
164353717|NCT02850965|593668393|FG000|Overall Study|Other than listed|3|||
164353718|NCT02850965|593668394|FG001|Overall Study|Other than listed|4|||
164353719|NCT02850965|593668393|FG000|Overall Study|Protocol Violation|0|||
164353720|NCT02850965|593668394|FG001|Overall Study|Protocol Violation|2|||
164353721|NCT02850965|593668393|FG000|Overall Study|Lost to Follow-up|5|||
164353722|NCT02850965|593668394|FG001|Overall Study|Lost to Follow-up|3|||
164353723|NCT02850965|593668393|FG000|Overall Study|Lack of Efficacy|4|||
164353724|NCT02850965|593668394|FG001|Overall Study|Lack of Efficacy|8|||
163899358|NCT01500200|592003590|FG005|Stage 2|Adverse Event|4|||
163899359|NCT00312208|592003591|FG000|Overall Study|Adverse Event|97|||
163899360|NCT00312208|592003592|FG001|Overall Study|Adverse Event|61|||
163899361|NCT00312208|592003591|FG000|Overall Study|Protocol Violation|5|||
163899362|NCT00312208|592003592|FG001|Overall Study|Protocol Violation|3|||
163899363|NCT00312208|592003591|FG000|Overall Study|Death|2|||
163899364|NCT00312208|592003592|FG001|Overall Study|Death|1|||
163899365|NCT00312208|592003591|FG000|Overall Study|Lack of Efficacy|7|||
164133103|NCT01447420|592852657|FG002|Overall Study|Protocol Violation|0|||
163899366|NCT00312208|592003592|FG001|Overall Study|Lack of Efficacy|4|||
163899367|NCT00312208|592003591|FG000|Overall Study|Lost to Follow-up|3|||
164299229|NCT04682366|593471267|FG000|Overall Study|Lost to Follow-up|1|||
163899368|NCT00312208|592003592|FG001|Overall Study|Lost to Follow-up|5|||
163899369|NCT00312208|592003591|FG000|Overall Study|Withdrawal by Subject|53|||
163899370|NCT00312208|592003592|FG001|Overall Study|Withdrawal by Subject|42|||
163899371|NCT00312208|592003591|FG000|Overall Study|Other|5|||
163899372|NCT00312208|592003592|FG001|Overall Study|Other|7|||
163899373|NCT01218659|592003594|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
163899374|NCT01218659|592003595|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
163899375|NCT01218659|592003596|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
163899376|NCT01218659|592003594|FG000|18-Month Randomized Period|Did not receive study drug|0|||
163899377|NCT01218659|592003595|FG001|18-Month Randomized Period|Did not receive study drug|3|||
163899378|NCT01218659|592003596|FG002|18-Month Randomized Period|Did not receive study drug|0|||
163899379|NCT01218659|592003594|FG000|12-Month OLE|Withdrawal by Subject|0|||
163899380|NCT01218659|592003595|FG001|12-Month OLE|Withdrawal by Subject|0|||
163899381|NCT01218659|592003596|FG002|12-Month OLE|Withdrawal by Subject|2|||
163899382|NCT01218659|592003594|FG000|12-Month OLE|Physician Decision|0|||
163899383|NCT01218659|592003595|FG001|12-Month OLE|Physician Decision|0|||
163899384|NCT01218659|592003596|FG002|12-Month OLE|Physician Decision|1|||
163899385|NCT01218659|592003594|FG000|12-Month OLE|Lost to Follow-up|0|||
163899386|NCT01218659|592003595|FG001|12-Month OLE|Lost to Follow-up|0|||
163899387|NCT01218659|592003596|FG002|12-Month OLE|Lost to Follow-up|1|||
163899388|NCT01218659|592003594|FG000|12-Month OLE|Pregnancy|0|||
163899389|NCT01218659|592003595|FG001|12-Month OLE|Pregnancy|0|||
163899390|NCT01218659|592003596|FG002|12-Month OLE|Pregnancy|1|||
163899391|NCT01218659|592003594|FG000|12-Month OLE|Lack of Efficacy|0|||
163899392|NCT01218659|592003595|FG001|12-Month OLE|Lack of Efficacy|0|||
163899393|NCT01218659|592003596|FG002|12-Month OLE|Lack of Efficacy|1|||
163899394|NCT01218659|592003594|FG000|12-Month OLE|Declined to participate in the OLE|0|||
164299230|NCT04682366|593471268|FG001|Overall Study|Lost to Follow-up|1|||
164299231|NCT03697252|593471275|FG000|Overall Study|Adverse Event|3|||
164299232|NCT03697252|593471276|FG001|Overall Study|Adverse Event|2|||
164299233|NCT03697252|593471275|FG000|Overall Study|Withdrawal by Subject|14|||
164299234|NCT03697252|593471276|FG001|Overall Study|Withdrawal by Subject|14|||
164299235|NCT03697252|593471275|FG000|Overall Study|Lost to Follow-up|0|||
164299236|NCT03697252|593471276|FG001|Overall Study|Lost to Follow-up|1|||
164299237|NCT03697252|593471275|FG000|Overall Study|Physician Decision|1|||
164299238|NCT03697252|593471276|FG001|Overall Study|Physician Decision|1|||
164299239|NCT03697252|593471275|FG000|Overall Study|Other|0|||
164299240|NCT03697252|593471276|FG001|Overall Study|Other|1|||
164299241|NCT03125395|593471277|FG000|Overall Study|Adverse Event|2|||
164299242|NCT03125395|593471277|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
164299243|NCT03125395|593471277|FG000|Overall Study|Physician Decision|2|||
164299244|NCT03125395|593471277|FG000|Overall Study|Commercial drug is available|5|||
164299245|NCT02531802|593471278|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
164299246|NCT02531802|593471279|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
164299247|NCT02531802|593471280|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
164299248|NCT02531802|593471281|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
164299249|NCT02531802|593471282|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
164299250|NCT02531802|593471283|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
164299251|NCT02531802|593471284|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
164299252|NCT02531802|593471285|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
164299253|NCT02531802|593471286|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
164299254|NCT02531802|593471287|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
164299255|NCT02531802|593471288|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
164299256|NCT02531802|593471289|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
164299257|NCT02531802|593471290|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
164299258|NCT02531802|593471291|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
164299259|NCT02531802|593471292|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
164299260|NCT02531802|593471293|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
164299261|NCT02531802|593471294|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
164299262|NCT02531802|593471295|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
164299263|NCT02531802|593471296|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
164299264|NCT02531802|593471297|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
164353725|NCT02850965|593668393|FG000|Overall Study|Adverse Event|3|||
164353726|NCT02850965|593668394|FG001|Overall Study|Adverse Event|2|||
164353727|NCT02850965|593668393|FG000|Overall Study|Withdrawal by Subject|3|||
164353728|NCT02850965|593668394|FG001|Overall Study|Withdrawal by Subject|4|||
164353729|NCT02850965|593668393|FG000|Overall Study|Physician Decision|0|||
164353730|NCT02850965|593668394|FG001|Overall Study|Physician Decision|1|||
164353731|NCT02850965|593668393|FG000|Overall Study|Randomized but not treated|0|||
164353732|NCT02850965|593668394|FG001|Overall Study|Randomized but not treated|1|||
164353733|NCT00536198|593668395|FG000|Overall Study|Lost to Follow-up|15|||
164353734|NCT00536198|593668396|FG001|Overall Study|Lost to Follow-up|14|||
164353735|NCT00536198|593668395|FG000|Overall Study|Withdrawal by Subject|16|||
164353736|NCT00536198|593668396|FG001|Overall Study|Withdrawal by Subject|12|||
164353737|NCT00536198|593668395|FG000|Overall Study|Adverse Event|2|||
164353738|NCT00536198|593668396|FG001|Overall Study|Adverse Event|2|||
164353739|NCT00536198|593668395|FG000|Overall Study|Rescue|3|||
164353740|NCT00536198|593668396|FG001|Overall Study|Rescue|9|||
164353741|NCT00536198|593668395|FG000|Overall Study|Pregnancy|1|||
164353742|NCT00536198|593668396|FG001|Overall Study|Pregnancy|1|||
164353743|NCT00536198|593668395|FG000|Overall Study|Protocol Violation|0|||
164353744|NCT00536198|593668396|FG001|Overall Study|Protocol Violation|1|||
164353745|NCT00881712|593668397|FG000|Overall Study|Death|1|||
164353746|NCT00881712|593668398|FG001|Overall Study|Death|0|||
164353747|NCT00881712|593668399|FG002|Overall Study|Death|0|||
164353748|NCT00881712|593668397|FG000|Overall Study|Withdrawal by Subject|1|||
164353749|NCT00881712|593668398|FG001|Overall Study|Withdrawal by Subject|0|||
164353750|NCT00881712|593668399|FG002|Overall Study|Withdrawal by Subject|0|||
164353751|NCT00276744|593668400|FG000|PART A|Reason unknown|98|||
164353752|NCT00230607|593668421|FG000|Overall Study|Other|3|||
164353753|NCT03672747|593668422|FG000|Overall Study|Lost to Follow-up|1|||
164353754|NCT03672747|593668423|FG001|Overall Study|Lost to Follow-up|1|||
164353755|NCT03672747|593668424|FG002|Overall Study|Lost to Follow-up|2|||
164353756|NCT03672747|593668425|FG003|Overall Study|Lost to Follow-up|2|||
164353757|NCT03672747|593668426|FG004|Overall Study|Lost to Follow-up|2|||
164353758|NCT03672747|593668427|FG005|Overall Study|Lost to Follow-up|1|||
164353759|NCT00965718|593668430|FG000|Overall Study|Withdrawal by Subject|4|||
164353760|NCT03667924|593668431|FG000|Baseline Completed|Lost to Follow-up|0|||
164353761|NCT03667924|593668432|FG001|Baseline Completed|Lost to Follow-up|2|||
164353762|NCT03667924|593668433|FG002|Baseline Completed|Lost to Follow-up|0|||
164353763|NCT03667924|593668431|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
164353764|NCT03667924|593668432|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
164353765|NCT03667924|593668433|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
164353766|NCT03667924|593668431|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
164353767|NCT03667924|593668432|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
164353768|NCT03667924|593668433|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
164353769|NCT03667924|593668431|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
164353770|NCT03667924|593668432|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
164353771|NCT03667924|593668433|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
164353772|NCT03667924|593668431|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
164005671|NCT04334148|592387315|FG000|Overall Study|positive nasal swab at baseline|0|||
164005672|NCT04334148|592387316|FG001|Overall Study|positive nasal swab at baseline|1|||
164005673|NCT05370157|592387317|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
164005674|NCT05370157|592387318|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
164005675|NCT05370157|592387317|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
164005676|NCT05370157|592387318|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
164005677|NCT01508676|592387319|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
164005678|NCT01508676|592387320|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
164005679|NCT01508676|592387319|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
164005680|NCT01508676|592387320|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
164005681|NCT01508676|592387319|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
164005682|NCT01508676|592387320|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
164005683|NCT01508676|592387319|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
164005684|NCT01508676|592387320|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
164005685|NCT01508676|592387319|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
164353773|NCT03667924|593668432|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
164353774|NCT03667924|593668433|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
164353775|NCT03667924|593668431|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
164353776|NCT03667924|593668432|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
164353777|NCT03667924|593668433|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
164353778|NCT03667924|593668431|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
164353779|NCT03667924|593668432|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
164353780|NCT03667924|593668433|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
164005686|NCT01508676|592387320|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
164005687|NCT00542828|592387321|FG000|Overall Study|Physician Decision|1|||
164005688|NCT00542828|592387321|FG000|Overall Study|Need for Prohibited Treatment|3|||
164005689|NCT00542828|592387321|FG000|Overall Study|Study Prematurely Discontinued|7|||
164005690|NCT00542828|592387321|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
164005691|NCT06129487|592387322|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
164005692|NCT06129487|592387323|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
164005693|NCT05139030|592387324|FG000|Overall Study|Withdrawal by Subject|1|||
164005694|NCT05139030|592387325|FG001|Overall Study|Withdrawal by Subject|3|||
164005695|NCT05139030|592387324|FG000|Overall Study|Adverse Event|0|||
164005696|NCT05139030|592387325|FG001|Overall Study|Adverse Event|1|||
164005697|NCT05139030|592387324|FG000|Overall Study|Failure to meet continuation criteria|0|||
164005698|NCT05139030|592387325|FG001|Overall Study|Failure to meet continuation criteria|1|||
164005699|NCT03772327|592387326|FG000|Overall Study|Lost to Follow-up|3|||
164005700|NCT03772327|592387327|FG001|Overall Study|Lost to Follow-up|4|||
164005701|NCT03772327|592387326|FG000|Overall Study|Withdrawal by Subject|2|||
164005702|NCT03772327|592387327|FG001|Overall Study|Withdrawal by Subject|3|||
164005703|NCT04689828|592387328|FG000|Overall Study|Subject decision|5|||
164005704|NCT04689828|592387329|FG001|Overall Study|Subject decision|5|||
164005705|NCT04689828|592387328|FG000|Overall Study|Adverse Event|12|||
164005706|NCT04689828|592387329|FG001|Overall Study|Adverse Event|12|||
164005707|NCT04689828|592387328|FG000|Overall Study|Physician Decision|24|||
164005708|NCT04689828|592387329|FG001|Overall Study|Physician Decision|32|||
164005709|NCT04689828|592387328|FG000|Overall Study|Progressive disease|54|||
164005710|NCT04689828|592387329|FG001|Overall Study|Progressive disease|173|||
164005711|NCT04689828|592387328|FG000|Overall Study|Death|0|||
164005712|NCT04689828|592387329|FG001|Overall Study|Death|1|||
164005713|NCT04689828|592387328|FG000|Overall Study|Lost to Follow-up|1|||
164005714|NCT04689828|592387329|FG001|Overall Study|Lost to Follow-up|0|||
164005715|NCT04689828|592387328|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
164353781|NCT00126568|593668434|FG000|Overall Study|Death|2|||
164353782|NCT01244425|593668435|FG000|Overall Study|Withdrawal by Subject|2|||
164353783|NCT01244425|593668436|FG001|Overall Study|Withdrawal by Subject|2|||
164353784|NCT01244425|593668435|FG000|Overall Study|Adverse Event|1|||
164353785|NCT01244425|593668436|FG001|Overall Study|Adverse Event|1|||
164353786|NCT02547454|593668437|FG000|Overall Study|Due to hemodialysis|53|||
164353787|NCT02547454|593668437|FG000|Overall Study|Due to transplantation|1|||
164353788|NCT02547454|593668437|FG000|Overall Study|Due to no further need to treat|4|||
164353789|NCT02547454|593668437|FG000|Overall Study|Death|38|||
164353790|NCT02547454|593668437|FG000|Overall Study|Lost to Follow-up|26|||
164353791|NCT02547454|593668437|FG000|Overall Study|Other|39|||
164353792|NCT02547454|593668437|FG000|Overall Study|No data|11|||
164353793|NCT00733408|593669767|FG000|Overall Study|Adverse Event|4|||
164353794|NCT01134783|593669769|FG000|Overall Study|Pregnancy|16|||
164353795|NCT01134783|593669770|FG001|Overall Study|Pregnancy|8|||
164353796|NCT01134783|593669769|FG000|Overall Study|Withdrawal by Subject|15|||
164353797|NCT01134783|593669770|FG001|Overall Study|Withdrawal by Subject|9|||
164353798|NCT01134783|593669769|FG000|Overall Study|Lost to Follow-up|5|||
164353799|NCT01134783|593669770|FG001|Overall Study|Lost to Follow-up|20|||
164353800|NCT00531232|593669772|FG000|Overall Study|Investigator decision|0|||
164353801|NCT00531232|593669773|FG001|Overall Study|Investigator decision|0|||
164353802|NCT00531232|593669774|FG002|Overall Study|Investigator decision|4|||
164353803|NCT00531232|593669772|FG000|Overall Study|Participants refused further treatment|0|||
164353804|NCT00531232|593669773|FG001|Overall Study|Participants refused further treatment|1|||
164353805|NCT00531232|593669774|FG002|Overall Study|Participants refused further treatment|2|||
164353806|NCT00531232|593669772|FG000|Overall Study|Adverse events (AEs)|1|||
164353807|NCT00531232|593669773|FG001|Overall Study|Adverse events (AEs)|2|||
164353808|NCT00531232|593669774|FG002|Overall Study|Adverse events (AEs)|2|||
164353809|NCT00531232|593669772|FG000|Overall Study|Treatment failure|1|||
164353810|NCT00531232|593669773|FG001|Overall Study|Treatment failure|3|||
164353811|NCT00531232|593669774|FG002|Overall Study|Treatment failure|7|||
164353812|NCT00531232|593669772|FG000|Overall Study|Disease recurrence|0|||
164353813|NCT00531232|593669773|FG001|Overall Study|Disease recurrence|0|||
164353814|NCT00531232|593669774|FG002|Overall Study|Disease recurrence|1|||
164353815|NCT00531232|593669772|FG000|Overall Study|Deceased|2|||
164353816|NCT00531232|593669773|FG001|Overall Study|Deceased|2|||
164353817|NCT00531232|593669774|FG002|Overall Study|Deceased|2|||
164353818|NCT00531232|593669772|FG000|Overall Study|Withdrawal by Subject|0|||
164353819|NCT00531232|593669773|FG001|Overall Study|Withdrawal by Subject|1|||
164005716|NCT04689828|592387329|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
164005717|NCT04689828|592387328|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
164353820|NCT00531232|593669774|FG002|Overall Study|Withdrawal by Subject|2|||
164353821|NCT00531232|593669772|FG000|Overall Study|Other|0|||
164353822|NCT00531232|593669773|FG001|Overall Study|Other|0|||
164353823|NCT00531232|593669774|FG002|Overall Study|Other|5|||
164353824|NCT04232124|593669775|FG000|Overall Study|Lost to Follow-up|3|||
163899395|NCT01218659|592003595|FG001|12-Month OLE|Declined to participate in the OLE|0|||
163899396|NCT01218659|592003596|FG002|12-Month OLE|Declined to participate in the OLE|4|||
163899397|NCT03066609|592003599|FG000|INDUCTION|Pregnancy|0|||
163899398|NCT03066609|592003600|FG001|INDUCTION|Pregnancy|0|||
163899399|NCT03066609|592003601|FG002|INDUCTION|Pregnancy|1|||
163899400|NCT03066609|592003602|FG003|INDUCTION|Pregnancy|0|||
163899401|NCT03066609|592003599|FG000|INDUCTION|Lack of Efficacy|0|||
163899402|NCT03066609|592003600|FG001|INDUCTION|Lack of Efficacy|0|||
163899403|NCT03066609|592003601|FG002|INDUCTION|Lack of Efficacy|1|||
163899404|NCT03066609|592003602|FG003|INDUCTION|Lack of Efficacy|0|||
163899405|NCT03066609|592003599|FG000|INDUCTION|Adverse Event|2|||
163899406|NCT03066609|592003600|FG001|INDUCTION|Adverse Event|2|||
163899407|NCT03066609|592003601|FG002|INDUCTION|Adverse Event|0|||
163899408|NCT03066609|592003602|FG003|INDUCTION|Adverse Event|0|||
163899409|NCT03066609|592003599|FG000|MAINTENANCE|Adverse Event|0|||
163899410|NCT03066609|592003600|FG001|MAINTENANCE|Adverse Event|0|||
163899411|NCT03066609|592003601|FG002|MAINTENANCE|Adverse Event|0|||
163899412|NCT03066609|592003602|FG003|MAINTENANCE|Adverse Event|1|||
163899413|NCT03066609|592003599|FG000|MAINTENANCE|Withdrawal by Subject|4|||
163899414|NCT03066609|592003600|FG001|MAINTENANCE|Withdrawal by Subject|2|||
163899415|NCT03066609|592003601|FG002|MAINTENANCE|Withdrawal by Subject|1|||
163899416|NCT03066609|592003602|FG003|MAINTENANCE|Withdrawal by Subject|1|||
163899417|NCT03066609|592003599|FG000|MAINTENANCE|Lost to Follow-up|0|||
163899418|NCT03066609|592003600|FG001|MAINTENANCE|Lost to Follow-up|1|||
163899419|NCT03066609|592003601|FG002|MAINTENANCE|Lost to Follow-up|1|||
163899420|NCT03066609|592003602|FG003|MAINTENANCE|Lost to Follow-up|0|||
163899421|NCT03066609|592003599|FG000|MAINTENANCE|Pregnancy|1|||
163899422|NCT03066609|592003600|FG001|MAINTENANCE|Pregnancy|0|||
163899423|NCT03066609|592003601|FG002|MAINTENANCE|Pregnancy|0|||
163899424|NCT03066609|592003602|FG003|MAINTENANCE|Pregnancy|0|||
163899425|NCT03066609|592003599|FG000|MAINTENANCE|Lack of Efficacy|2|||
163899426|NCT03066609|592003600|FG001|MAINTENANCE|Lack of Efficacy|1|||
163899427|NCT03066609|592003601|FG002|MAINTENANCE|Lack of Efficacy|0|||
163899428|NCT03066609|592003602|FG003|MAINTENANCE|Lack of Efficacy|1|||
163899429|NCT03066609|592003599|FG000|OVERALL STUDY|Adverse Event|2|||
163899430|NCT03066609|592003600|FG001|OVERALL STUDY|Adverse Event|2|||
163899431|NCT03066609|592003601|FG002|OVERALL STUDY|Adverse Event|0|||
163899432|NCT03066609|592003602|FG003|OVERALL STUDY|Adverse Event|1|||
163899433|NCT03066609|592003599|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
163899434|NCT03066609|592003600|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
163899435|NCT03066609|592003601|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
163899436|NCT03066609|592003602|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
163899437|NCT03066609|592003599|FG000|OVERALL STUDY|Lost to Follow-up|1|||
163899438|NCT03066609|592003600|FG001|OVERALL STUDY|Lost to Follow-up|1|||
163899439|NCT03066609|592003601|FG002|OVERALL STUDY|Lost to Follow-up|1|||
163899440|NCT03066609|592003602|FG003|OVERALL STUDY|Lost to Follow-up|1|||
163899441|NCT03066609|592003599|FG000|OVERALL STUDY|Pregnancy|1|||
163899442|NCT03066609|592003600|FG001|OVERALL STUDY|Pregnancy|0|||
163899443|NCT03066609|592003601|FG002|OVERALL STUDY|Pregnancy|1|||
163899444|NCT03066609|592003602|FG003|OVERALL STUDY|Pregnancy|0|||
163899445|NCT03066609|592003599|FG000|OVERALL STUDY|Lack of Efficacy|2|||
163899446|NCT03066609|592003600|FG001|OVERALL STUDY|Lack of Efficacy|1|||
163899447|NCT03066609|592003601|FG002|OVERALL STUDY|Lack of Efficacy|1|||
163899448|NCT03066609|592003602|FG003|OVERALL STUDY|Lack of Efficacy|1|||
163899449|NCT03066609|592003599|FG000|OVERALL STUDY|discontinued follow up|0|||
163899450|NCT03066609|592003600|FG001|OVERALL STUDY|discontinued follow up|2|||
163899451|NCT03066609|592003601|FG002|OVERALL STUDY|discontinued follow up|0|||
163899452|NCT03066609|592003602|FG003|OVERALL STUDY|discontinued follow up|0|||
164089792|NCT01766921|592691494|FG000|Overall Study|Administrative Reason|5|||
164089793|NCT01766921|592691495|FG001|Overall Study|Administrative Reason|5|||
164089794|NCT01766921|592691494|FG000|Overall Study|Death|1|||
164089795|NCT01766921|592691495|FG001|Overall Study|Death|1|||
164089796|NCT01766921|592691494|FG000|Overall Study|Lost to Follow-up|1|||
164089797|NCT01766921|592691495|FG001|Overall Study|Lost to Follow-up|3|||
164089798|NCT01766921|592691494|FG000|Overall Study|Unclassified|2|||
164089799|NCT01766921|592691495|FG001|Overall Study|Unclassified|2|||
164089800|NCT01766921|592691494|FG000|Overall Study|Protocol Violation|1|||
164089801|NCT01766921|592691495|FG001|Overall Study|Protocol Violation|1|||
164089802|NCT01766921|592691494|FG000|Overall Study|Withdrawal by Subject|14|||
164089803|NCT01766921|592691495|FG001|Overall Study|Withdrawal by Subject|5|||
164089804|NCT01862328|592691507|FG000|Overall Study|Progressive Disease|3|||
164089805|NCT01862328|592691508|FG001|Overall Study|Progressive Disease|11|||
164089806|NCT01862328|592691509|FG002|Overall Study|Progressive Disease|5|||
164089807|NCT01862328|592691510|FG003|Overall Study|Progressive Disease|6|||
164089808|NCT01862328|592691511|FG004|Overall Study|Progressive Disease|7|||
164089809|NCT01862328|592691512|FG005|Overall Study|Progressive Disease|4|||
164089810|NCT01862328|592691513|FG006|Overall Study|Progressive Disease|3|||
164089811|NCT01862328|592691507|FG000|Overall Study|Adverse Event|0|||
164089812|NCT01862328|592691508|FG001|Overall Study|Adverse Event|4|||
164089813|NCT01862328|592691509|FG002|Overall Study|Adverse Event|0|||
164089814|NCT01862328|592691510|FG003|Overall Study|Adverse Event|1|||
164089815|NCT01862328|592691511|FG004|Overall Study|Adverse Event|0|||
164089816|NCT01862328|592691512|FG005|Overall Study|Adverse Event|2|||
164089817|NCT01862328|592691513|FG006|Overall Study|Adverse Event|4|||
164089818|NCT01862328|592691507|FG000|Overall Study|Other|0|||
164089819|NCT01862328|592691508|FG001|Overall Study|Other|2|||
164089820|NCT01862328|592691509|FG002|Overall Study|Other|1|||
164089821|NCT01862328|592691510|FG003|Overall Study|Other|0|||
164089822|NCT01862328|592691511|FG004|Overall Study|Other|4|||
164089823|NCT01862328|592691512|FG005|Overall Study|Other|0|||
164089824|NCT01862328|592691513|FG006|Overall Study|Other|1|||
164089825|NCT01862328|592691507|FG000|Overall Study|Withdrawal by Subject|1|||
164089826|NCT01862328|592691508|FG001|Overall Study|Withdrawal by Subject|1|||
164089827|NCT01862328|592691509|FG002|Overall Study|Withdrawal by Subject|0|||
164089828|NCT01862328|592691510|FG003|Overall Study|Withdrawal by Subject|0|||
164089829|NCT01862328|592691511|FG004|Overall Study|Withdrawal by Subject|1|||
164089830|NCT01862328|592691512|FG005|Overall Study|Withdrawal by Subject|1|||
164089831|NCT01862328|592691513|FG006|Overall Study|Withdrawal by Subject|1|||
164089832|NCT01862328|592691507|FG000|Overall Study|Symptomatic Deterioration|0|||
164353825|NCT00463346|593669778|FG000|Overall Study|Withdrawal by Subject|3|||
164353826|NCT00463346|593669779|FG001|Overall Study|Withdrawal by Subject|3|||
164353827|NCT03641651|593669780|FG000|Overall Study|organizational issues at one study site|1|||
164353828|NCT01991067|593669782|FG000|Overall Study|Lost to Follow-up|6|||
164353829|NCT01991067|593669783|FG001|Overall Study|Lost to Follow-up|5|||
163899453|NCT02284113|592003603|FG000|Overall Study|Adverse Event|1|||
163899454|NCT02284113|592003604|FG001|Overall Study|Adverse Event|0|||
163899455|NCT02284113|592003603|FG000|Overall Study|non-compliance|0|||
163899456|NCT02284113|592003604|FG001|Overall Study|non-compliance|1|||
163899457|NCT02284113|592003603|FG000|Overall Study|Withdrawal by Subject|0|||
163899458|NCT02284113|592003604|FG001|Overall Study|Withdrawal by Subject|1|||
163899459|NCT02284113|592003603|FG000|Overall Study|not provided|0|||
163899460|NCT02284113|592003604|FG001|Overall Study|not provided|1|||
163899461|NCT02284113|592003603|FG000|Overall Study|surgery cancelled|2|||
163899462|NCT02284113|592003604|FG001|Overall Study|surgery cancelled|0|||
163899463|NCT01324310|592003607|FG000|Overall Study|Adverse Event|1|||
163899464|NCT01324310|592003607|FG000|Overall Study|Disease Progression|1|||
163899465|NCT03170882|592003608|FG000|Overall Study|Death|17|||
163899466|NCT03170882|592003609|FG001|Overall Study|Death|29|||
163899467|NCT03170882|592003608|FG000|Overall Study|Lost to Follow-up|0|||
163899468|NCT03170882|592003609|FG001|Overall Study|Lost to Follow-up|1|||
163899469|NCT03170882|592003608|FG000|Overall Study|Withdrawal by Subject|4|||
163899470|NCT03170882|592003609|FG001|Overall Study|Withdrawal by Subject|7|||
163899471|NCT03170882|592003608|FG000|Overall Study|Reason not Specified|28|||
163899472|NCT03170882|592003609|FG001|Overall Study|Reason not Specified|36|||
163899473|NCT03213457|592003610|FG000|Screening Period|Withdrawal by Subject|0|||
163899474|NCT03213457|592003611|FG001|Screening Period|Withdrawal by Subject|1|||
163899475|NCT03213457|592003612|FG002|Screening Period|Withdrawal by Subject|0|||
163899476|NCT03213457|592003610|FG000|Screening Period|Other|1|||
163899477|NCT03213457|592003611|FG001|Screening Period|Other|0|||
164089833|NCT01862328|592691508|FG001|Overall Study|Symptomatic Deterioration|0|||
164089834|NCT01862328|592691509|FG002|Overall Study|Symptomatic Deterioration|0|||
164089835|NCT01862328|592691510|FG003|Overall Study|Symptomatic Deterioration|0|||
164089836|NCT01862328|592691511|FG004|Overall Study|Symptomatic Deterioration|0|||
164353830|NCT00224055|593669785|FG000|Overall Study|Adverse Event|9|||
164089837|NCT01862328|592691512|FG005|Overall Study|Symptomatic Deterioration|0|||
164089838|NCT01862328|592691513|FG006|Overall Study|Symptomatic Deterioration|1|||
164089839|NCT03276975|592691514|FG000|Overall Study|Withdrawal by Subject|1|||
164353831|NCT00224055|593669786|FG001|Overall Study|Adverse Event|3|||
164353832|NCT00224055|593669785|FG000|Overall Study|Lost to Follow-up|1|||
164353833|NCT00224055|593669786|FG001|Overall Study|Lost to Follow-up|2|||
164353834|NCT00224055|593669785|FG000|Overall Study|Protocol Violation|1|||
164353835|NCT00224055|593669786|FG001|Overall Study|Protocol Violation|1|||
164353836|NCT00224055|593669785|FG000|Overall Study|Inclusion Violation|3|||
164353837|NCT00224055|593669786|FG001|Overall Study|Inclusion Violation|6|||
164353838|NCT00224055|593669785|FG000|Overall Study|Withdrawal by Subject|0|||
164353839|NCT00224055|593669786|FG001|Overall Study|Withdrawal by Subject|2|||
164353840|NCT00224055|593669785|FG000|Overall Study|Other|1|||
164353841|NCT00224055|593669786|FG001|Overall Study|Other|0|||
164353842|NCT00127712|593669789|FG000|Overall Study|Adverse Event|3|||
164353843|NCT00127712|593669790|FG001|Overall Study|Adverse Event|0|||
164353844|NCT00127712|593669789|FG000|Overall Study|Lack of GI access to continue|2|||
164353845|NCT00127712|593669790|FG001|Overall Study|Lack of GI access to continue|0|||
164353846|NCT00407563|593669791|FG000|Overall Study|Patient continues on treatment|1|||
164353847|NCT03055260|593669792|FG000|Overall Study|Withdrawal by Subject|1|||
164353848|NCT03055260|593669793|FG001|Overall Study|Withdrawal by Subject|0|||
164353849|NCT00464087|593669794|FG000|Overall Study|No PCI per inclusion criteria|0|||
164353850|NCT00464087|593669795|FG001|Overall Study|No PCI per inclusion criteria|0|||
164353851|NCT00464087|593669796|FG002|Overall Study|No PCI per inclusion criteria|29|||
164353852|NCT01164956|593669797|FG000|Overall Study|Side Effects|1|||
164353853|NCT01164956|593669798|FG001|Overall Study|Side Effects|0|||
164353854|NCT01164956|593669799|FG002|Overall Study|Side Effects|1|||
164353855|NCT00720434|593669800|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
164353856|NCT00720434|593669801|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
164005718|NCT04689828|592387329|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
164005719|NCT04689828|592387328|FG000|Overall Study|Participants not treated|7|||
164005720|NCT04689828|592387329|FG001|Overall Study|Participants not treated|2|||
164005721|NCT00195351|592387336|FG000|Overall Study|Lost to Follow-up|9|||
164005722|NCT00195351|592387337|FG001|Overall Study|Lost to Follow-up|9|||
164005723|NCT00195351|592387336|FG000|Overall Study|Withdrawal by Subject|6|||
164005724|NCT00195351|592387337|FG001|Overall Study|Withdrawal by Subject|3|||
164005725|NCT00195351|592387336|FG000|Overall Study|Protocol Deviation|3|||
164005726|NCT00195351|592387337|FG001|Overall Study|Protocol Deviation|2|||
164005727|NCT00195351|592387336|FG000|Overall Study|Death|3|||
164005728|NCT00195351|592387337|FG001|Overall Study|Death|1|||
164005729|NCT00195351|592387336|FG000|Overall Study|Lack of Efficacy|0|||
164005730|NCT00195351|592387337|FG001|Overall Study|Lack of Efficacy|1|||
164005731|NCT04332419|592387340|FG000|Overall Study|Withdrawal by Subject|1|||
164005732|NCT02493751|592387341|FG000|Overall Study|Withdrawal by Subject|2|||
164005733|NCT02493751|592387342|FG001|Overall Study|Withdrawal by Subject|8|||
164005734|NCT02493751|592387341|FG000|Overall Study|Death|6|||
164005735|NCT02493751|592387342|FG001|Overall Study|Death|13|||
164005736|NCT02493751|592387341|FG000|Overall Study|Lost to Follow-up|2|||
164005737|NCT02493751|592387342|FG001|Overall Study|Lost to Follow-up|3|||
164005738|NCT02493751|592387341|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
164005739|NCT02493751|592387342|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
164005740|NCT01480180|592387343|FG000|Main Phase|Withdrawal criteria|12|||
164005741|NCT01480180|592387344|FG001|Main Phase|Withdrawal criteria|1|||
164005742|NCT01480180|592387345|FG002|Main Phase|Withdrawal criteria|0|||
164005743|NCT01480180|592387346|FG003|Main Phase|Withdrawal criteria|0|||
164005744|NCT01480180|592387347|FG004|Main Phase|Withdrawal criteria|0|||
164005745|NCT01480180|592387348|FG005|Main Phase|Withdrawal criteria|0|||
164005746|NCT01480180|592387343|FG000|Main Phase|Lack of Efficacy|1|||
164005747|NCT01480180|592387344|FG001|Main Phase|Lack of Efficacy|0|||
164005748|NCT01480180|592387345|FG002|Main Phase|Lack of Efficacy|0|||
164005749|NCT01480180|592387346|FG003|Main Phase|Lack of Efficacy|0|||
164299265|NCT02531802|593471298|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
164299266|NCT02531802|593471278|FG000|Received Vaccination 2|Physician Decision|0|||
164299267|NCT02531802|593471279|FG001|Received Vaccination 2|Physician Decision|0|||
164299268|NCT02531802|593471280|FG002|Received Vaccination 2|Physician Decision|0|||
164299269|NCT02531802|593471281|FG003|Received Vaccination 2|Physician Decision|0|||
164299270|NCT02531802|593471282|FG004|Received Vaccination 2|Physician Decision|0|||
164299271|NCT02531802|593471283|FG005|Received Vaccination 2|Physician Decision|1|||
164299272|NCT02531802|593471284|FG006|Received Vaccination 2|Physician Decision|0|||
164299273|NCT02531802|593471285|FG007|Received Vaccination 2|Physician Decision|0|||
164299274|NCT02531802|593471286|FG008|Received Vaccination 2|Physician Decision|0|||
164299275|NCT02531802|593471287|FG009|Received Vaccination 2|Physician Decision|2|||
164353857|NCT00720434|593669802|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
164353858|NCT00720434|593669803|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
164005750|NCT01480180|592387347|FG004|Main Phase|Lack of Efficacy|0|||
164005751|NCT01480180|592387348|FG005|Main Phase|Lack of Efficacy|0|||
164005752|NCT01480180|592387343|FG000|Main Phase|Non-compliance|3|||
164005753|NCT01480180|592387344|FG001|Main Phase|Non-compliance|0|||
164005754|NCT01480180|592387345|FG002|Main Phase|Non-compliance|0|||
164005755|NCT01480180|592387346|FG003|Main Phase|Non-compliance|0|||
164005756|NCT01480180|592387347|FG004|Main Phase|Non-compliance|0|||
164005757|NCT01480180|592387348|FG005|Main Phase|Non-compliance|0|||
164005758|NCT01480180|592387343|FG000|Main Phase|Unclassified|3|||
164005759|NCT01480180|592387344|FG001|Main Phase|Unclassified|0|||
164005760|NCT01480180|592387345|FG002|Main Phase|Unclassified|0|||
164005761|NCT01480180|592387346|FG003|Main Phase|Unclassified|0|||
164005762|NCT01480180|592387347|FG004|Main Phase|Unclassified|0|||
164353859|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
164353860|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
164353861|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
164353862|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
164353863|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
164353864|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
164353865|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
164353866|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
164353867|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
164353868|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
164353869|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
164353870|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
164353871|NCT00720434|593669800|FG000|Open-Label Period (Week 5-72)|Other|4|||
164353872|NCT00720434|593669801|FG001|Open-Label Period (Week 5-72)|Other|3|||
164353873|NCT00720434|593669802|FG002|Open-Label Period (Week 5-72)|Other|3|||
164353874|NCT00720434|593669803|FG003|Open-Label Period (Week 5-72)|Other|2|||
164353875|NCT00418314|593669804|FG000|Overall Study|Withdrawal by Subject|1|||
164353876|NCT00418314|593669805|FG001|Overall Study|Withdrawal by Subject|2|||
164353877|NCT00967798|593669806|FG000|Overall Study|Withdrawal by Subject|5|||
164353878|NCT00967798|593669807|FG001|Overall Study|Withdrawal by Subject|2|||
164353879|NCT00967798|593669806|FG000|Overall Study|Lost to Follow-up|4|||
164353880|NCT00967798|593669807|FG001|Overall Study|Lost to Follow-up|1|||
164353881|NCT02425046|593669808|FG000|Overall Study|Lost to Follow-up|52|||
164353882|NCT02425046|593669809|FG001|Overall Study|Lost to Follow-up|50|||
164353883|NCT02425046|593669810|FG002|Overall Study|Lost to Follow-up|56|||
164353884|NCT02425046|593669808|FG000|Overall Study|Withdrawal by Subject|16|||
164353885|NCT02425046|593669809|FG001|Overall Study|Withdrawal by Subject|12|||
164353886|NCT02425046|593669810|FG002|Overall Study|Withdrawal by Subject|0|||
164353887|NCT01409564|593669811|FG000|Overall Study|low medication compliance|4|||
164353888|NCT01409564|593669812|FG001|Overall Study|low medication compliance|3|||
164353889|NCT01409564|593669811|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
164353890|NCT01409564|593669812|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
164353891|NCT02782780|593669813|FG000|Overall Study|dropped out after randomization.|7|||
164353892|NCT02782780|593669814|FG001|Overall Study|dropped out after randomization.|5|||
164353893|NCT02782780|593669813|FG000|Overall Study|Protocol Violation|0|||
164353894|NCT02782780|593669814|FG001|Overall Study|Protocol Violation|2|||
164353895|NCT01413191|593669815|FG000|Overall Study|Lost to Follow-up|5|||
164353896|NCT01413191|593669815|FG000|Overall Study|Disease Progression|5|||
164353897|NCT01413191|593669815|FG000|Overall Study|Death|1|||
164353898|NCT05040386|593669816|FG000|Overall Study|Withdrawal by Subject|1|||
164005763|NCT01480180|592387348|FG005|Main Phase|Unclassified|0|||
164005764|NCT01480180|592387343|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
164005765|NCT01480180|592387344|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
164005766|NCT01480180|592387345|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
164005767|NCT01480180|592387346|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
164005768|NCT01480180|592387347|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
164005769|NCT01480180|592387348|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
164005770|NCT01480180|592387343|FG000|Extension Phase, Part 1|Unclassified|0|||
164005771|NCT01480180|592387344|FG001|Extension Phase, Part 1|Unclassified|0|||
164005772|NCT01480180|592387345|FG002|Extension Phase, Part 1|Unclassified|1|||
164005773|NCT01480180|592387346|FG003|Extension Phase, Part 1|Unclassified|0|||
164005774|NCT01480180|592387347|FG004|Extension Phase, Part 1|Unclassified|0|||
164005775|NCT01480180|592387348|FG005|Extension Phase, Part 1|Unclassified|0|||
164005776|NCT01480180|592387343|FG000|Extension Phase, Part 1|Adverse Event|0|||
164005777|NCT01480180|592387344|FG001|Extension Phase, Part 1|Adverse Event|0|||
164005778|NCT01480180|592387345|FG002|Extension Phase, Part 1|Adverse Event|4|||
164005779|NCT01480180|592387346|FG003|Extension Phase, Part 1|Adverse Event|1|||
164005780|NCT01480180|592387347|FG004|Extension Phase, Part 1|Adverse Event|0|||
164005781|NCT01480180|592387348|FG005|Extension Phase, Part 1|Adverse Event|0|||
164353899|NCT05040386|593669817|FG001|Overall Study|Withdrawal by Subject|0|||
164353900|NCT05040386|593669818|FG002|Overall Study|Withdrawal by Subject|1|||
164353901|NCT05040386|593669819|FG003|Overall Study|Withdrawal by Subject|0|||
164005782|NCT01480180|592387343|FG000|Extension Phase, Part 1|Change of treatment|0|||
164005783|NCT01480180|592387344|FG001|Extension Phase, Part 1|Change of treatment|0|||
164005784|NCT01480180|592387345|FG002|Extension Phase, Part 1|Change of treatment|0|||
164353902|NCT05040386|593669816|FG000|Overall Study|Lost to Follow-up|0|||
164353903|NCT05040386|593669817|FG001|Overall Study|Lost to Follow-up|0|||
164353904|NCT05040386|593669818|FG002|Overall Study|Lost to Follow-up|1|||
164089840|NCT03276975|592691515|FG001|Overall Study|Withdrawal by Subject|0|||
164089841|NCT00679783|592691516|FG000|Overall Study|Adverse Event|0|||
164089842|NCT00679783|592691517|FG001|Overall Study|Adverse Event|0|||
164005785|NCT01480180|592387346|FG003|Extension Phase, Part 1|Change of treatment|9|||
164005786|NCT01480180|592387347|FG004|Extension Phase, Part 1|Change of treatment|0|||
164005787|NCT01480180|592387348|FG005|Extension Phase, Part 1|Change of treatment|0|||
164005788|NCT01480180|592387343|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
164005789|NCT01480180|592387344|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
164005790|NCT01480180|592387345|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
164005791|NCT01480180|592387346|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
164005792|NCT01480180|592387347|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
164005793|NCT01480180|592387348|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
164005794|NCT01480180|592387343|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
164005795|NCT01480180|592387344|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
164005796|NCT01480180|592387345|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
164005797|NCT01480180|592387346|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
164005798|NCT01480180|592387347|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
164005799|NCT01480180|592387348|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
164005800|NCT01480180|592387343|FG000|Extension Phase, Part 2|Unclassified|0|||
164005801|NCT01480180|592387344|FG001|Extension Phase, Part 2|Unclassified|0|||
164005802|NCT01480180|592387345|FG002|Extension Phase, Part 2|Unclassified|3|||
164005803|NCT01480180|592387346|FG003|Extension Phase, Part 2|Unclassified|1|||
164005804|NCT01480180|592387347|FG004|Extension Phase, Part 2|Unclassified|1|||
164005805|NCT01480180|592387348|FG005|Extension Phase, Part 2|Unclassified|0|||
164005806|NCT00519623|592387349|FG000|Overall Study|Adverse Event|1|||
164005807|NCT01824602|592387351|FG000|Overall Study|Withdrawal by Subject|0|||
164005808|NCT01824602|592387352|FG001|Overall Study|Withdrawal by Subject|0|||
164005809|NCT01824602|592387353|FG002|Overall Study|Withdrawal by Subject|1|||
164005810|NCT01824602|592387354|FG003|Overall Study|Withdrawal by Subject|2|||
164005811|NCT01824602|592387351|FG000|Overall Study|Patient non-compliance|0|||
164005812|NCT01824602|592387352|FG001|Overall Study|Patient non-compliance|0|||
164005813|NCT01824602|592387353|FG002|Overall Study|Patient non-compliance|1|||
164005814|NCT01824602|592387354|FG003|Overall Study|Patient non-compliance|0|||
164005815|NCT01824602|592387351|FG000|Overall Study|Adverse Event|1|||
164005816|NCT01824602|592387352|FG001|Overall Study|Adverse Event|0|||
164005817|NCT01824602|592387353|FG002|Overall Study|Adverse Event|2|||
164005818|NCT01824602|592387354|FG003|Overall Study|Adverse Event|2|||
164005819|NCT01824602|592387351|FG000|Overall Study|Treatment failure|0|||
164005820|NCT01824602|592387352|FG001|Overall Study|Treatment failure|0|||
164005821|NCT01824602|592387353|FG002|Overall Study|Treatment failure|0|||
164005822|NCT01824602|592387354|FG003|Overall Study|Treatment failure|1|||
164005823|NCT04222725|592387357|FG000|Overall Study|Adverse Event|0|||
164005824|NCT04222725|592387358|FG001|Overall Study|Adverse Event|1|||
164005825|NCT04222725|592387359|FG002|Overall Study|Adverse Event|0|||
164005826|NCT04222725|592387360|FG003|Overall Study|Adverse Event|0|||
164005827|NCT03819140|592387361|FG000|Overall Study|Lost to Follow-up|1|||
164005828|NCT03819140|592387362|FG001|Overall Study|Lost to Follow-up|2|||
164005829|NCT03819140|592387361|FG000|Overall Study|Withdrawal by Subject|3|||
164005830|NCT03819140|592387362|FG001|Overall Study|Withdrawal by Subject|2|||
164005831|NCT03819140|592387361|FG000|Overall Study|Adverse Event|0|||
164005832|NCT03819140|592387362|FG001|Overall Study|Adverse Event|1|||
164005833|NCT03819140|592387361|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
164005834|NCT03819140|592387362|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
164005835|NCT03819140|592387361|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
164089843|NCT00679783|592691518|FG002|Overall Study|Adverse Event|0|||
164089844|NCT00679783|592691519|FG003|Overall Study|Adverse Event|3|||
164089845|NCT00679783|592691520|FG004|Overall Study|Adverse Event|0|||
164089846|NCT00679783|592691521|FG005|Overall Study|Adverse Event|0|||
164089847|NCT00679783|592691522|FG006|Overall Study|Adverse Event|1|||
164089848|NCT00679783|592691516|FG000|Overall Study|Lack of Efficacy|0|||
164089849|NCT00679783|592691517|FG001|Overall Study|Lack of Efficacy|1|||
164089850|NCT00679783|592691518|FG002|Overall Study|Lack of Efficacy|0|||
164089851|NCT00679783|592691519|FG003|Overall Study|Lack of Efficacy|2|||
164089852|NCT00679783|592691520|FG004|Overall Study|Lack of Efficacy|0|||
164005836|NCT03819140|592387362|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
164005837|NCT00104871|592387363|FG000|Overall Study|Not evaluable|1|||
164005838|NCT02192359|592387366|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
164005839|NCT02192359|592387367|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
164089853|NCT00679783|592691521|FG005|Overall Study|Lack of Efficacy|0|||
164089854|NCT00679783|592691522|FG006|Overall Study|Lack of Efficacy|0|||
164089855|NCT00679783|592691516|FG000|Overall Study|Withdrawal by Subject|0|||
164089856|NCT00679783|592691517|FG001|Overall Study|Withdrawal by Subject|0|||
164089857|NCT00679783|592691518|FG002|Overall Study|Withdrawal by Subject|1|||
164005840|NCT02192359|592387368|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
164005841|NCT02192359|592387369|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
164005842|NCT02192359|592387366|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
164005843|NCT02192359|592387367|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
164005844|NCT02192359|592387368|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
164005845|NCT02192359|592387369|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
164005846|NCT02192359|592387366|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
164005847|NCT02192359|592387367|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
164005848|NCT02192359|592387368|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
164005849|NCT02192359|592387369|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
164005850|NCT00658333|592387372|FG000|Overall Study|Adverse Event|2|||
164005851|NCT00658333|592387373|FG001|Overall Study|Adverse Event|1|||
164005852|NCT00828451|592387376|FG000|Overall Study|Death|2|||
164005853|NCT00828451|592387376|FG000|Overall Study|Lack of intravenous line|7|||
164005854|NCT00828451|592387376|FG000|Overall Study|Withdrawal by Subject|1|||
164089858|NCT00679783|592691519|FG003|Overall Study|Withdrawal by Subject|1|||
164089859|NCT00679783|592691520|FG004|Overall Study|Withdrawal by Subject|0|||
164089860|NCT00679783|592691521|FG005|Overall Study|Withdrawal by Subject|0|||
164089861|NCT00679783|592691522|FG006|Overall Study|Withdrawal by Subject|0|||
164089862|NCT00679783|592691516|FG000|Overall Study|Not Captured|0|||
164089863|NCT00679783|592691517|FG001|Overall Study|Not Captured|0|||
164089864|NCT00679783|592691518|FG002|Overall Study|Not Captured|0|||
164089865|NCT00679783|592691519|FG003|Overall Study|Not Captured|5|||
164089866|NCT00679783|592691520|FG004|Overall Study|Not Captured|0|||
164089867|NCT00679783|592691521|FG005|Overall Study|Not Captured|0|||
164089868|NCT00679783|592691522|FG006|Overall Study|Not Captured|0|||
164089869|NCT00679783|592691516|FG000|Overall Study|Ongoing at data cut-off|2|||
164089870|NCT00679783|592691517|FG001|Overall Study|Ongoing at data cut-off|2|||
164089871|NCT00679783|592691518|FG002|Overall Study|Ongoing at data cut-off|0|||
164089872|NCT00679783|592691519|FG003|Overall Study|Ongoing at data cut-off|9|||
164089873|NCT00679783|592691520|FG004|Overall Study|Ongoing at data cut-off|1|||
164005855|NCT00828451|592387376|FG000|Overall Study|Deterioration in clinical status|1|||
164005856|NCT03256539|592387377|FG000|Overall Study|Withdrawal by Subject|0|||
164005857|NCT03256539|592387378|FG001|Overall Study|Withdrawal by Subject|3|||
164089874|NCT00679783|592691521|FG005|Overall Study|Ongoing at data cut-off|0|||
164353905|NCT05040386|593669819|FG003|Overall Study|Lost to Follow-up|0|||
164089875|NCT00679783|592691522|FG006|Overall Study|Ongoing at data cut-off|0|||
164353906|NCT03654651|593669820|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164353907|NCT03654651|593669821|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
164353908|NCT03045328|593669822|FG000|Overall Study|Withdrawal by Subject|2|||
164353909|NCT00592839|593669825|FG000|Overall Study|Withdrawal by Subject|1|||
164353910|NCT00592839|593669826|FG001|Overall Study|Withdrawal by Subject|1|||
164353911|NCT00592839|593669827|FG002|Overall Study|Withdrawal by Subject|3|||
164353912|NCT00592839|593669825|FG000|Overall Study|Protocol Violation|1|||
164353913|NCT00592839|593669826|FG001|Overall Study|Protocol Violation|1|||
164353914|NCT00592839|593669827|FG002|Overall Study|Protocol Violation|2|||
164353915|NCT00592839|593669825|FG000|Overall Study|Adverse Event|0|||
164353916|NCT00592839|593669826|FG001|Overall Study|Adverse Event|1|||
164353917|NCT00592839|593669827|FG002|Overall Study|Adverse Event|0|||
164353918|NCT00592839|593669825|FG000|Overall Study|Lost to Follow-up|0|||
164353919|NCT00592839|593669826|FG001|Overall Study|Lost to Follow-up|1|||
164353920|NCT00592839|593669827|FG002|Overall Study|Lost to Follow-up|1|||
164353921|NCT00589914|593669830|FG000|Overall Study|Adverse Event|19|||
164353922|NCT00589914|593669831|FG001|Overall Study|Adverse Event|10|||
164353923|NCT00589914|593669830|FG000|Overall Study|Death|2|||
164353924|NCT00589914|593669831|FG001|Overall Study|Death|0|||
164353925|NCT00589914|593669830|FG000|Overall Study|Lack of Efficacy|40|||
164353926|NCT00589914|593669831|FG001|Overall Study|Lack of Efficacy|43|||
164353927|NCT00589914|593669830|FG000|Overall Study|Lost to Follow-up|11|||
164353928|NCT00589914|593669831|FG001|Overall Study|Lost to Follow-up|18|||
164353929|NCT00589914|593669830|FG000|Overall Study|Pregnancy|1|||
164353930|NCT00589914|593669831|FG001|Overall Study|Pregnancy|0|||
164353931|NCT00589914|593669830|FG000|Overall Study|Withdrawal by Subject|55|||
164353932|NCT00589914|593669831|FG001|Overall Study|Withdrawal by Subject|49|||
164353933|NCT00589914|593669830|FG000|Overall Study|Other|22|||
164353934|NCT00589914|593669831|FG001|Overall Study|Other|17|||
164089876|NCT01485536|592691523|FG000|Overall Study|Withdrawal by Subject|3|||
164089877|NCT01485536|592691523|FG000|Overall Study|Adverse Event|1|||
164089878|NCT02626949|592691524|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
164353935|NCT00799487|593669833|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
164353936|NCT00799487|593669834|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
164353937|NCT00799487|593669835|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
164353938|NCT00799487|593669833|FG000|Dose Adjustment Period|Adverse Event|2|||
163899478|NCT03213457|592003612|FG002|Screening Period|Other|0|||
163899479|NCT03213457|592003610|FG000|Double-Blind Period|Adverse Event|3|||
163899480|NCT03213457|592003611|FG001|Double-Blind Period|Adverse Event|2|||
163899481|NCT03213457|592003612|FG002|Double-Blind Period|Adverse Event|7|||
163899482|NCT03213457|592003610|FG000|Double-Blind Period|Withdrawal by Subject|14|||
163899483|NCT03213457|592003611|FG001|Double-Blind Period|Withdrawal by Subject|2|||
163899484|NCT03213457|592003612|FG002|Double-Blind Period|Withdrawal by Subject|14|||
163899485|NCT03213457|592003610|FG000|Double-Blind Period|Lost to Follow-up|2|||
163899486|NCT03213457|592003611|FG001|Double-Blind Period|Lost to Follow-up|3|||
163899487|NCT03213457|592003612|FG002|Double-Blind Period|Lost to Follow-up|9|||
163899488|NCT03213457|592003610|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
163899489|NCT03213457|592003611|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
163899490|NCT03213457|592003612|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
163899491|NCT03213457|592003610|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
163899492|NCT03213457|592003611|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
163899493|NCT03213457|592003612|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
163899494|NCT03213457|592003610|FG000|Double-Blind Period|Pregnancy|5|||
163899495|NCT03213457|592003611|FG001|Double-Blind Period|Pregnancy|0|||
163899496|NCT03213457|592003612|FG002|Double-Blind Period|Pregnancy|0|||
163899497|NCT03213457|592003610|FG000|Double-Blind Period|Other|10|||
163899498|NCT03213457|592003611|FG001|Double-Blind Period|Other|3|||
163899499|NCT03213457|592003612|FG002|Double-Blind Period|Other|17|||
163899500|NCT03213457|592003610|FG000|Open-Label Period|Adverse Event|1|||
163899501|NCT03213457|592003611|FG001|Open-Label Period|Adverse Event|2|||
163899502|NCT03213457|592003612|FG002|Open-Label Period|Adverse Event|2|||
163899503|NCT03213457|592003610|FG000|Open-Label Period|Withdrawal by Subject|12|||
163899504|NCT03213457|592003611|FG001|Open-Label Period|Withdrawal by Subject|5|||
163899505|NCT03213457|592003612|FG002|Open-Label Period|Withdrawal by Subject|24|||
163899506|NCT03213457|592003610|FG000|Open-Label Period|Lost to Follow-up|1|||
163899507|NCT03213457|592003611|FG001|Open-Label Period|Lost to Follow-up|2|||
164005858|NCT03256539|592387377|FG000|Overall Study|Unexpected closure of study components|8|||
164005859|NCT03256539|592387378|FG001|Overall Study|Unexpected closure of study components|4|||
164005860|NCT05755438|592387382|FG000|12-week DBVC Period|Adverse Event|4|||
164005861|NCT05755438|592387383|FG001|12-week DBVC Period|Adverse Event|1|||
164005862|NCT05755438|592387382|FG000|12-week DBVC Period|Physician Decision|1|||
164005863|NCT05755438|592387383|FG001|12-week DBVC Period|Physician Decision|1|||
164005864|NCT05755438|592387382|FG000|12-week DBVC Period|Protocol Violation|4|||
164005865|NCT05755438|592387383|FG001|12-week DBVC Period|Protocol Violation|2|||
164005866|NCT05755438|592387382|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
164005867|NCT05755438|592387383|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
164005868|NCT05755438|592387382|FG000|12-week DBVC Period|Sponsor Decision|1|||
164005869|NCT05755438|592387383|FG001|12-week DBVC Period|Sponsor Decision|0|||
164005870|NCT05755438|592387382|FG000|40-week OLE Period|Adverse Event|0|||
164005871|NCT05755438|592387383|FG001|40-week OLE Period|Adverse Event|2|||
164005872|NCT05755438|592387382|FG000|40-week OLE Period|Lack of Efficacy|1|||
164005873|NCT05755438|592387383|FG001|40-week OLE Period|Lack of Efficacy|1|||
164005874|NCT05755438|592387382|FG000|40-week OLE Period|Lost to Follow-up|1|||
164005875|NCT05755438|592387383|FG001|40-week OLE Period|Lost to Follow-up|0|||
164005876|NCT05755438|592387382|FG000|40-week OLE Period|Physician Decision|1|||
164005877|NCT05755438|592387383|FG001|40-week OLE Period|Physician Decision|1|||
164005878|NCT05755438|592387382|FG000|40-week OLE Period|Protocol Violation|1|||
164005879|NCT05755438|592387383|FG001|40-week OLE Period|Protocol Violation|1|||
164005880|NCT05755438|592387382|FG000|40-week OLE Period|Withdrawal by Subject|6|||
163899508|NCT03213457|592003612|FG002|Open-Label Period|Lost to Follow-up|8|||
163899509|NCT03213457|592003610|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
163899510|NCT03213457|592003611|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
163899511|NCT03213457|592003612|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
163899512|NCT03213457|592003610|FG000|Open-Label Period|Non-compliance with study procedures|1|||
163899513|NCT03213457|592003611|FG001|Open-Label Period|Non-compliance with study procedures|1|||
163899514|NCT03213457|592003612|FG002|Open-Label Period|Non-compliance with study procedures|2|||
163899515|NCT03213457|592003610|FG000|Open-Label Period|Exclusionary medications|0|||
163899516|NCT03213457|592003611|FG001|Open-Label Period|Exclusionary medications|0|||
164005881|NCT05755438|592387383|FG001|40-week OLE Period|Withdrawal by Subject|6|||
164005882|NCT05755438|592387382|FG000|40-week OLE Period|Sponsor Decision|3|||
163899517|NCT03213457|592003612|FG002|Open-Label Period|Exclusionary medications|1|||
163899518|NCT03213457|592003610|FG000|Open-Label Period|Other|1|||
163899519|NCT03213457|592003611|FG001|Open-Label Period|Other|1|||
163899520|NCT03213457|592003612|FG002|Open-Label Period|Other|6|||
163899521|NCT03213457|592003610|FG000|Follow-Up Period|Adverse Event|16|||
164005883|NCT05755438|592387383|FG001|40-week OLE Period|Sponsor Decision|0|||
164005884|NCT05755438|592387382|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
164133182|NCT04126213|592852702|FG003|Overall Study|Other|2|||
164005885|NCT05755438|592387383|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
164005886|NCT05755438|592387382|FG000|40-week OLE Period|Ongoing|46|||
164005887|NCT05755438|592387383|FG001|40-week OLE Period|Ongoing|58|||
164005888|NCT01548638|592387390|FG000|Overall Study|Protocol Violation|3|||
164005889|NCT01548638|592387390|FG000|Overall Study|Withdrawal by Subject|1|||
164005890|NCT02117687|592387394|FG000|Overall Study|Lost to Follow-up|0|||
164005891|NCT02117687|592387395|FG001|Overall Study|Lost to Follow-up|1|||
164005892|NCT02117687|592387394|FG000|Overall Study|Adverse Event|0|||
164005893|NCT02117687|592387395|FG001|Overall Study|Adverse Event|2|||
164005894|NCT02117687|592387394|FG000|Overall Study|Other Reasons|1|||
164005895|NCT02117687|592387395|FG001|Overall Study|Other Reasons|1|||
164005896|NCT01687673|592387402|FG000|Overall Study|Physician Decision|1|||
164005897|NCT03476239|592387403|FG000|Overall Study|Withdrawal by Subject|10|||
164005898|NCT03476239|592387403|FG000|Overall Study|Death|80|||
164005899|NCT03476239|592387403|FG000|Overall Study|Lost to Follow-up|8|||
164005900|NCT00618956|592387404|FG000|Overall Study|Adverse Event|10|||
164005901|NCT00618956|592387405|FG001|Overall Study|Adverse Event|34|||
164005902|NCT00618956|592387404|FG000|Overall Study|Lack of Efficacy|2|||
164005903|NCT00618956|592387405|FG001|Overall Study|Lack of Efficacy|1|||
164299276|NCT02531802|593471288|FG010|Received Vaccination 2|Physician Decision|0|||
164299277|NCT02531802|593471289|FG011|Received Vaccination 2|Physician Decision|0|||
164299278|NCT02531802|593471290|FG012|Received Vaccination 2|Physician Decision|0|||
164299279|NCT02531802|593471291|FG013|Received Vaccination 2|Physician Decision|1|||
164299280|NCT02531802|593471292|FG014|Received Vaccination 2|Physician Decision|0|||
164299281|NCT02531802|593471293|FG015|Received Vaccination 2|Physician Decision|0|||
164299282|NCT02531802|593471294|FG016|Received Vaccination 2|Physician Decision|0|||
164299283|NCT02531802|593471295|FG017|Received Vaccination 2|Physician Decision|1|||
164299284|NCT02531802|593471296|FG018|Received Vaccination 2|Physician Decision|0|||
164299285|NCT02531802|593471297|FG019|Received Vaccination 2|Physician Decision|0|||
164299286|NCT02531802|593471298|FG020|Received Vaccination 2|Physician Decision|0|||
164299287|NCT02531802|593471278|FG000|Received Vaccination 2|Adverse Event|0|||
164299288|NCT02531802|593471279|FG001|Received Vaccination 2|Adverse Event|0|||
164299289|NCT02531802|593471280|FG002|Received Vaccination 2|Adverse Event|0|||
164299290|NCT02531802|593471281|FG003|Received Vaccination 2|Adverse Event|0|||
164299291|NCT02531802|593471282|FG004|Received Vaccination 2|Adverse Event|0|||
164299292|NCT02531802|593471283|FG005|Received Vaccination 2|Adverse Event|2|||
164299293|NCT02531802|593471284|FG006|Received Vaccination 2|Adverse Event|0|||
164299294|NCT02531802|593471285|FG007|Received Vaccination 2|Adverse Event|0|||
164299295|NCT02531802|593471286|FG008|Received Vaccination 2|Adverse Event|0|||
164299296|NCT02531802|593471287|FG009|Received Vaccination 2|Adverse Event|0|||
164299297|NCT02531802|593471288|FG010|Received Vaccination 2|Adverse Event|0|||
164299298|NCT02531802|593471289|FG011|Received Vaccination 2|Adverse Event|0|||
164299299|NCT02531802|593471290|FG012|Received Vaccination 2|Adverse Event|0|||
164299300|NCT02531802|593471291|FG013|Received Vaccination 2|Adverse Event|0|||
164299301|NCT02531802|593471292|FG014|Received Vaccination 2|Adverse Event|0|||
164299302|NCT02531802|593471293|FG015|Received Vaccination 2|Adverse Event|0|||
164299303|NCT02531802|593471294|FG016|Received Vaccination 2|Adverse Event|0|||
164299304|NCT02531802|593471295|FG017|Received Vaccination 2|Adverse Event|2|||
164299305|NCT02531802|593471296|FG018|Received Vaccination 2|Adverse Event|1|||
164299306|NCT02531802|593471297|FG019|Received Vaccination 2|Adverse Event|0|||
164299307|NCT02531802|593471298|FG020|Received Vaccination 2|Adverse Event|1|||
164299308|NCT02531802|593471278|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
164299309|NCT02531802|593471279|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
164299310|NCT02531802|593471280|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
164299311|NCT02531802|593471281|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
164299312|NCT02531802|593471282|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
164299313|NCT02531802|593471283|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
164299314|NCT02531802|593471284|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
164299315|NCT02531802|593471285|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
164299316|NCT02531802|593471286|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
164299317|NCT02531802|593471287|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
164299318|NCT02531802|593471288|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
164299319|NCT02531802|593471289|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
164299320|NCT02531802|593471290|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
164299321|NCT02531802|593471291|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
164299322|NCT02531802|593471292|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
164299323|NCT02531802|593471293|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
164299324|NCT02531802|593471294|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
164299325|NCT02531802|593471295|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
164299326|NCT02531802|593471296|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
164299327|NCT02531802|593471297|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
164005904|NCT00618956|592387404|FG000|Overall Study|Withdrawal by Subject|5|||
164005905|NCT00618956|592387405|FG001|Overall Study|Withdrawal by Subject|7|||
164005906|NCT00618956|592387404|FG000|Overall Study|Lost to Follow-up|4|||
164005907|NCT00618956|592387405|FG001|Overall Study|Lost to Follow-up|5|||
163899522|NCT03213457|592003611|FG001|Follow-Up Period|Adverse Event|8|||
163899523|NCT03213457|592003612|FG002|Follow-Up Period|Adverse Event|37|||
163899524|NCT03213457|592003610|FG000|Follow-Up Period|Withdrawal by Subject|18|||
163899525|NCT03213457|592003611|FG001|Follow-Up Period|Withdrawal by Subject|11|||
163899526|NCT03213457|592003612|FG002|Follow-Up Period|Withdrawal by Subject|55|||
163899527|NCT03213457|592003610|FG000|Follow-Up Period|Lost to Follow-up|28|||
163899528|NCT03213457|592003611|FG001|Follow-Up Period|Lost to Follow-up|15|||
163899529|NCT03213457|592003612|FG002|Follow-Up Period|Lost to Follow-up|50|||
163899530|NCT03213457|592003610|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
163899531|NCT03213457|592003611|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
163899532|NCT03213457|592003612|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
163899533|NCT03213457|592003610|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
163899534|NCT03213457|592003611|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
163899535|NCT03213457|592003612|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
163899536|NCT03213457|592003610|FG000|Follow-Up Period|Pregnancy|7|||
163899537|NCT03213457|592003611|FG001|Follow-Up Period|Pregnancy|0|||
163899538|NCT03213457|592003612|FG002|Follow-Up Period|Pregnancy|18|||
163899539|NCT03213457|592003610|FG000|Follow-Up Period|Exclusionary medications|1|||
163899540|NCT03213457|592003611|FG001|Follow-Up Period|Exclusionary medications|1|||
163899541|NCT03213457|592003612|FG002|Follow-Up Period|Exclusionary medications|5|||
163899542|NCT03213457|592003610|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
163899543|NCT03213457|592003611|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
163899544|NCT03213457|592003612|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
163899545|NCT03213457|592003610|FG000|Follow-Up Period|Other|14|||
163899546|NCT03213457|592003611|FG001|Follow-Up Period|Other|10|||
163899547|NCT03213457|592003612|FG002|Follow-Up Period|Other|31|||
163899548|NCT05116774|592003613|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
163899549|NCT05116774|592003614|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
163899550|NCT05116774|592003613|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
163899551|NCT05116774|592003614|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
163899552|NCT05116774|592003613|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
163899553|NCT05116774|592003614|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
163899554|NCT05116774|592003613|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
163899555|NCT05116774|592003614|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
163899556|NCT03150862|592003615|FG000|Overall Study|Death|2|||
163899557|NCT03150862|592003616|FG001|Overall Study|Death|7|||
163899558|NCT03150862|592003617|FG002|Overall Study|Death|8|||
163899559|NCT03150862|592003618|FG003|Overall Study|Death|27|||
163899560|NCT03150862|592003619|FG004|Overall Study|Death|4|||
163899561|NCT03150862|592003620|FG005|Overall Study|Death|8|||
163899562|NCT03150862|592003621|FG006|Overall Study|Death|6|||
163899563|NCT03150862|592003622|FG007|Overall Study|Death|21|||
163899564|NCT03150862|592003615|FG000|Overall Study|Withdrawal by Subject|1|||
163899565|NCT03150862|592003616|FG001|Overall Study|Withdrawal by Subject|1|||
163899566|NCT03150862|592003617|FG002|Overall Study|Withdrawal by Subject|0|||
164005908|NCT00618956|592387404|FG000|Overall Study|Protocol Violation|2|||
164005909|NCT00618956|592387405|FG001|Overall Study|Protocol Violation|2|||
164005910|NCT00618956|592387404|FG000|Overall Study|did not meet criteria, non-compliance|2|||
164005911|NCT00618956|592387405|FG001|Overall Study|did not meet criteria, non-compliance|1|||
164005912|NCT03598777|592387406|FG000|Overall Study|Study Terminated by Sponsor|3|||
164005913|NCT03598777|592387407|FG001|Overall Study|Study Terminated by Sponsor|0|||
164005914|NCT03598777|592387408|FG002|Overall Study|Study Terminated by Sponsor|0|||
164353939|NCT00799487|593669834|FG001|Dose Adjustment Period|Adverse Event|0|||
164353940|NCT00799487|593669835|FG002|Dose Adjustment Period|Adverse Event|0|||
164353941|NCT00799487|593669833|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
164353942|NCT00799487|593669834|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
164353943|NCT00799487|593669835|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
164353944|NCT00799487|593669833|FG000|Dose Adjustment Period|Investigator Discretion|2|||
164353945|NCT00799487|593669834|FG001|Dose Adjustment Period|Investigator Discretion|0|||
164353946|NCT00799487|593669835|FG002|Dose Adjustment Period|Investigator Discretion|0|||
164353947|NCT00799487|593669833|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
164353948|NCT00799487|593669834|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
163899567|NCT03150862|592003618|FG003|Overall Study|Withdrawal by Subject|3|||
163899568|NCT03150862|592003619|FG004|Overall Study|Withdrawal by Subject|1|||
164353949|NCT00799487|593669835|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
163899569|NCT03150862|592003620|FG005|Overall Study|Withdrawal by Subject|1|||
163899570|NCT03150862|592003621|FG006|Overall Study|Withdrawal by Subject|1|||
163899571|NCT03150862|592003622|FG007|Overall Study|Withdrawal by Subject|3|||
163899572|NCT03150862|592003615|FG000|Overall Study|Lost to Follow-up|0|||
163899573|NCT03150862|592003616|FG001|Overall Study|Lost to Follow-up|0|||
163899574|NCT03150862|592003617|FG002|Overall Study|Lost to Follow-up|1|||
163899575|NCT03150862|592003618|FG003|Overall Study|Lost to Follow-up|0|||
163899576|NCT03150862|592003619|FG004|Overall Study|Lost to Follow-up|0|||
163899577|NCT03150862|592003620|FG005|Overall Study|Lost to Follow-up|0|||
164353950|NCT00799487|593669833|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
164353951|NCT00799487|593669834|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
164353952|NCT00799487|593669835|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
164353953|NCT00799487|593669833|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
164353954|NCT00799487|593669834|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
164353955|NCT00799487|593669835|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
164353956|NCT00799487|593669833|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
163899578|NCT03150862|592003621|FG006|Overall Study|Lost to Follow-up|0|||
163899579|NCT03150862|592003622|FG007|Overall Study|Lost to Follow-up|2|||
163899580|NCT03150862|592003615|FG000|Overall Study|Sponsor's decision|0|||
163899581|NCT03150862|592003616|FG001|Overall Study|Sponsor's decision|0|||
163899582|NCT03150862|592003617|FG002|Overall Study|Sponsor's decision|0|||
163899583|NCT03150862|592003618|FG003|Overall Study|Sponsor's decision|10|||
163899584|NCT03150862|592003619|FG004|Overall Study|Sponsor's decision|3|||
163899585|NCT03150862|592003620|FG005|Overall Study|Sponsor's decision|0|||
163899586|NCT03150862|592003621|FG006|Overall Study|Sponsor's decision|1|||
163899587|NCT03150862|592003622|FG007|Overall Study|Sponsor's decision|1|||
163899588|NCT03150862|592003615|FG000|Overall Study|Change in Methylation status|0|||
163899589|NCT03150862|592003616|FG001|Overall Study|Change in Methylation status|0|||
163899590|NCT03150862|592003617|FG002|Overall Study|Change in Methylation status|0|||
163899591|NCT03150862|592003618|FG003|Overall Study|Change in Methylation status|0|||
163899592|NCT03150862|592003619|FG004|Overall Study|Change in Methylation status|1|||
163899593|NCT03150862|592003620|FG005|Overall Study|Change in Methylation status|0|||
163899594|NCT03150862|592003621|FG006|Overall Study|Change in Methylation status|0|||
163899595|NCT03150862|592003622|FG007|Overall Study|Change in Methylation status|0|||
163899596|NCT03150862|592003615|FG000|Overall Study|Roll over in to Long Term Extension|0|||
163899597|NCT03150862|592003616|FG001|Overall Study|Roll over in to Long Term Extension|0|||
163899598|NCT03150862|592003617|FG002|Overall Study|Roll over in to Long Term Extension|0|||
163899599|NCT03150862|592003618|FG003|Overall Study|Roll over in to Long Term Extension|0|||
163899600|NCT03150862|592003619|FG004|Overall Study|Roll over in to Long Term Extension|0|||
163899601|NCT03150862|592003620|FG005|Overall Study|Roll over in to Long Term Extension|0|||
163899602|NCT03150862|592003621|FG006|Overall Study|Roll over in to Long Term Extension|0|||
163899603|NCT03150862|592003622|FG007|Overall Study|Roll over in to Long Term Extension|1|||
163899604|NCT03150862|592003615|FG000|Overall Study|Progressive Disease|0|||
163899605|NCT03150862|592003616|FG001|Overall Study|Progressive Disease|0|||
163899606|NCT03150862|592003617|FG002|Overall Study|Progressive Disease|0|||
163899607|NCT03150862|592003618|FG003|Overall Study|Progressive Disease|0|||
163899608|NCT03150862|592003619|FG004|Overall Study|Progressive Disease|0|||
163899609|NCT03150862|592003620|FG005|Overall Study|Progressive Disease|0|||
163899610|NCT03150862|592003621|FG006|Overall Study|Progressive Disease|0|||
163899611|NCT03150862|592003622|FG007|Overall Study|Progressive Disease|2|||
163899612|NCT05139992|592003623|FG000|Overall Study|Withdrawal by Subject|12|||
163899613|NCT05139992|592003623|FG000|Overall Study|Lost to Follow-up|6|||
163899614|NCT05521516|592003624|FG000|Overall Study|Withdrawal by Subject|1|||
163899615|NCT05521516|592003625|FG001|Overall Study|Withdrawal by Subject|1|||
163899616|NCT00747565|592003626|FG000|Overall Study|Withdrawal by Subject|10|||
163899617|NCT00747565|592003627|FG001|Overall Study|Withdrawal by Subject|6|||
163899618|NCT00747565|592003626|FG000|Overall Study|Lost to Follow-up|4|||
163899619|NCT00747565|592003627|FG001|Overall Study|Lost to Follow-up|1|||
163899620|NCT03437733|592004300|FG000|Overall Study|Eligibility criteria not met|0|||
163899621|NCT03437733|592004301|FG001|Overall Study|Eligibility criteria not met|3|||
163899622|NCT04017611|592004305|FG000|Overall Study|Withdrawn prior to completion|1|||
163899623|NCT01128595|592004316|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163899624|NCT01128595|592004317|FG001|Treatment Period 3|Withdrawal by Subject|1|||
163899625|NCT01128595|592004318|FG002|Treatment Period 3|Withdrawal by Subject|0|||
163899626|NCT01128595|592004319|FG003|Treatment Period 3|Withdrawal by Subject|0|||
163899627|NCT00366249|592004322|FG000|Overall Study|Adverse Event|53|||
163899628|NCT00366249|592004323|FG001|Overall Study|Adverse Event|28|||
163899629|NCT00366249|592004322|FG000|Overall Study|Death|0|||
163899630|NCT00366249|592004323|FG001|Overall Study|Death|1|||
163899631|NCT00366249|592004322|FG000|Overall Study|Physician Decision|5|||
163899632|NCT00366249|592004323|FG001|Overall Study|Physician Decision|2|||
163899633|NCT00366249|592004322|FG000|Overall Study|Lost to Follow-up|2|||
163899634|NCT00366249|592004323|FG001|Overall Study|Lost to Follow-up|0|||
163899635|NCT00366249|592004322|FG000|Overall Study|Protocol Violation|1|||
163899636|NCT00366249|592004323|FG001|Overall Study|Protocol Violation|2|||
163899637|NCT00366249|592004322|FG000|Overall Study|Withdrawal by Subject|18|||
163899638|NCT00366249|592004323|FG001|Overall Study|Withdrawal by Subject|4|||
163899639|NCT00366249|592004322|FG000|Overall Study|Lack of Efficacy|21|||
163899640|NCT00366249|592004323|FG001|Overall Study|Lack of Efficacy|21|||
163899641|NCT00366249|592004322|FG000|Overall Study|Most due to osteomylitis status|31|||
163899642|NCT00366249|592004323|FG001|Overall Study|Most due to osteomylitis status|20|||
163899643|NCT00246805|592004324|FG000|Phase 1|Lost to Follow-up|1|||
163899644|NCT00246805|592004325|FG001|Phase 1|Lost to Follow-up|0|||
163899645|NCT00609869|592004326|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
163899646|NCT00609869|592004326|FG000|Overall Study|Severe hematologic toxicity|1|||
163899647|NCT00609869|592004326|FG000|Overall Study|Withdrawal by Subject|1|||
163899648|NCT00609869|592004326|FG000|Overall Study|Seizures|1|||
163899649|NCT00609869|592004326|FG000|Overall Study|Severe tumor flare reaction|1|||
163899650|NCT00609869|592004326|FG000|Overall Study|Hepatitis B infection|1|||
163899651|NCT00609869|592004326|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
164089879|NCT02626949|592691525|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
164089880|NCT02626949|592691524|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
164089881|NCT02626949|592691525|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
164089882|NCT02626949|592691524|FG000|Enrolled|Lost to Follow-up|7|||
164089883|NCT02626949|592691525|FG001|Enrolled|Lost to Follow-up|6|||
164089884|NCT02626949|592691524|FG000|Enrolled|Withdrawal by Subject|3|||
164089885|NCT02626949|592691525|FG001|Enrolled|Withdrawal by Subject|2|||
164089886|NCT00576199|592691526|FG000|Overall Study|Adverse Event|12|||
164089887|NCT00576199|592691526|FG000|Overall Study|Insufficient Therapeutic Response|14|||
164089888|NCT00576199|592691526|FG000|Overall Study|Refused Treatment|2|||
164089889|NCT00576199|592691526|FG000|Overall Study|Reason Unspecified|2|||
164089890|NCT01463683|592691527|FG000|Overall Study|Adverse Event|2|||
164089891|NCT01463683|592691528|FG001|Overall Study|Adverse Event|0|||
164089892|NCT01463683|592691529|FG002|Overall Study|Adverse Event|0|||
164089893|NCT01463683|592691527|FG000|Overall Study|Lost to Follow-up|10|||
164089894|NCT01463683|592691528|FG001|Overall Study|Lost to Follow-up|9|||
164089895|NCT01463683|592691529|FG002|Overall Study|Lost to Follow-up|7|||
164089896|NCT01463683|592691527|FG000|Overall Study|Physician Decision|0|||
164089897|NCT01463683|592691528|FG001|Overall Study|Physician Decision|3|||
164089898|NCT01463683|592691529|FG002|Overall Study|Physician Decision|1|||
164089899|NCT01463683|592691527|FG000|Overall Study|Pregnancy|2|||
164089900|NCT01463683|592691528|FG001|Overall Study|Pregnancy|2|||
164089901|NCT01463683|592691529|FG002|Overall Study|Pregnancy|1|||
164089902|NCT01463683|592691527|FG000|Overall Study|Withdrawal by Subject|5|||
164089903|NCT01463683|592691528|FG001|Overall Study|Withdrawal by Subject|17|||
164299328|NCT02531802|593471298|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
164299329|NCT00106704|593471299|FG000|Overall Study|Adverse Event|10|||
164299330|NCT00106704|593471300|FG001|Overall Study|Adverse Event|7|||
164299331|NCT00106704|593471299|FG000|Overall Study|Death|2|||
163899652|NCT00609869|592004326|FG000|Overall Study|Mantle cell: not evaluable|4|||
163899653|NCT01342367|592004327|FG000|Overall Study|Death|1|||
163899654|NCT01342367|592004328|FG001|Overall Study|Death|0|||
163899655|NCT01342367|592004327|FG000|Overall Study|Withdrawal by Subject|1|||
163899656|NCT01342367|592004328|FG001|Overall Study|Withdrawal by Subject|2|||
163899657|NCT02964741|592004329|FG000|Overall Study|Protocol Violation|1|||
163899658|NCT02964741|592004330|FG001|Overall Study|Protocol Violation|0|||
163899659|NCT02964741|592004331|FG002|Overall Study|Protocol Violation|0|||
163899660|NCT02964741|592004329|FG000|Overall Study|Withdrawal by Subject|0|||
163899661|NCT02964741|592004330|FG001|Overall Study|Withdrawal by Subject|1|||
163899662|NCT02964741|592004331|FG002|Overall Study|Withdrawal by Subject|0|||
163899663|NCT02964741|592004329|FG000|Overall Study|claustrophobia|1|||
163899664|NCT02964741|592004330|FG001|Overall Study|claustrophobia|0|||
163899665|NCT02964741|592004331|FG002|Overall Study|claustrophobia|0|||
163899666|NCT00640159|592004332|FG000|Overall Study|Lost to Follow-up|2|||
163899667|NCT03355573|592004333|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
163899668|NCT03355573|592004333|FG000|Overall Study|Sponsor's decision|1|||
163899669|NCT03355573|592004333|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
163899670|NCT03355573|592004333|FG000|Overall Study|PI's decision|2|||
163899671|NCT03355573|592004333|FG000|Overall Study|Withdrawal by Subject|23|||
163899672|NCT03355573|592004333|FG000|Overall Study|Lost to Follow-up|4|||
163899673|NCT03355573|592004333|FG000|Overall Study|Lack of Efficacy|2|||
163899674|NCT03355573|592004333|FG000|Overall Study|Adverse Event, non-fatal|17|||
163899675|NCT03355573|592004333|FG000|Overall Study|Adverse Event, serious fatal|2|||
163899676|NCT04191824|592004334|FG000|Overall Study|Death|13|||
163899677|NCT04191824|592004335|FG001|Overall Study|Death|12|||
163899678|NCT04191824|592004334|FG000|Overall Study|Lost to Follow-up|456|||
163899679|NCT04191824|592004335|FG001|Overall Study|Lost to Follow-up|435|||
163899680|NCT04191824|592004334|FG000|Overall Study|Physician Decision|2|||
163899681|NCT04191824|592004335|FG001|Overall Study|Physician Decision|1|||
163899682|NCT04191824|592004334|FG000|Overall Study|Protocol Violation|0|||
163899683|NCT04191824|592004335|FG001|Overall Study|Protocol Violation|2|||
163899684|NCT04191824|592004334|FG000|Overall Study|Withdrawal by Subject|16|||
163899685|NCT04191824|592004335|FG001|Overall Study|Withdrawal by Subject|18|||
163899686|NCT04191824|592004334|FG000|Overall Study|Early site closure|24|||
163899687|NCT04191824|592004335|FG001|Overall Study|Early site closure|22|||
163899688|NCT01218009|592004336|FG000|Overall Study|Protocol Violation|2|||
163899689|NCT01218009|592004337|FG001|Overall Study|Protocol Violation|1|||
163899690|NCT01218009|592004336|FG000|Overall Study|Withdrawal by Subject|3|||
163899691|NCT01218009|592004337|FG001|Overall Study|Withdrawal by Subject|1|||
163899692|NCT01218009|592004336|FG000|Overall Study|Sponsor terminated study|161|||
163899693|NCT01218009|592004337|FG001|Overall Study|Sponsor terminated study|163|||
163899694|NCT01371994|592004341|FG000|Overall Study|Adverse Event|3|||
164299332|NCT00106704|593471300|FG001|Overall Study|Death|1|||
163899695|NCT01371994|592004342|FG001|Overall Study|Adverse Event|6|||
163899696|NCT01371994|592004341|FG000|Overall Study|Lack of Efficacy|3|||
163899697|NCT01371994|592004342|FG001|Overall Study|Lack of Efficacy|0|||
163899698|NCT01371994|592004341|FG000|Overall Study|Withdrawal by Subject|13|||
163899699|NCT01371994|592004342|FG001|Overall Study|Withdrawal by Subject|7|||
163899700|NCT01371994|592004341|FG000|Overall Study|Lost to Follow-up|1|||
163899701|NCT01371994|592004342|FG001|Overall Study|Lost to Follow-up|1|||
163899702|NCT01371994|592004341|FG000|Overall Study|Protocol Violation|24|||
163899703|NCT01371994|592004342|FG001|Overall Study|Protocol Violation|17|||
163899704|NCT01371994|592004341|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
163899705|NCT01371994|592004342|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
163899706|NCT01371994|592004341|FG000|Overall Study|Physician Decision|1|||
163899707|NCT01371994|592004342|FG001|Overall Study|Physician Decision|1|||
163899708|NCT01371994|592004341|FG000|Overall Study|Miscellaneous Reasons|6|||
163899709|NCT01371994|592004342|FG001|Overall Study|Miscellaneous Reasons|4|||
163899710|NCT00087685|592004343|FG000|Overall Study|Adverse Event|5|||
163899711|NCT00087685|592004343|FG000|Overall Study|Non-Compliance|1|||
163899712|NCT00087685|592004343|FG000|Overall Study|Progressive Disease|5|||
163899713|NCT00087685|592004343|FG000|Overall Study|Withdrawal by Subject|3|||
163899714|NCT01830595|592004344|FG000|First Period|Withdrawal by Subject|1|||
163899715|NCT01830595|592004345|FG001|First Period|Withdrawal by Subject|3|||
163899716|NCT01830595|592004344|FG000|Washout|Withdrawal by Subject|2|||
163899717|NCT01830595|592004345|FG001|Washout|Withdrawal by Subject|2|||
163899718|NCT03280030|592004353|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
163899719|NCT03280030|592004354|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
163899720|NCT03280030|592004355|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
163899721|NCT03280030|592004353|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
163899722|NCT03280030|592004354|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
163899723|NCT03280030|592004355|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
163899724|NCT03280030|592004353|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
163899725|NCT03280030|592004354|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
163899726|NCT03280030|592004355|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
163899727|NCT03280030|592004353|FG000|Part 2 - Efficacy|Adverse Event|0|||
163899728|NCT03280030|592004354|FG001|Part 2 - Efficacy|Adverse Event|4|||
163899729|NCT03280030|592004355|FG002|Part 2 - Efficacy|Adverse Event|6|||
163899730|NCT03280030|592004353|FG000|Part 2 - Efficacy|Death|0|||
163899731|NCT03280030|592004354|FG001|Part 2 - Efficacy|Death|3|||
163899732|NCT03280030|592004355|FG002|Part 2 - Efficacy|Death|0|||
163899733|NCT03280030|592004353|FG000|Part 2 - Efficacy|Physician Decision|0|||
163899734|NCT03280030|592004354|FG001|Part 2 - Efficacy|Physician Decision|10|||
163899735|NCT03280030|592004355|FG002|Part 2 - Efficacy|Physician Decision|16|||
163899736|NCT03280030|592004353|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
163899737|NCT03280030|592004354|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
163899738|NCT03280030|592004355|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
164353957|NCT00799487|593669834|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
164353958|NCT00799487|593669835|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
164353959|NCT00799487|593669833|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
164005915|NCT03598777|592387409|FG003|Overall Study|Study Terminated by Sponsor|0|||
164005916|NCT03598777|592387410|FG004|Overall Study|Study Terminated by Sponsor|15|||
164005917|NCT03598777|592387406|FG000|Overall Study|Withdrawal by Subject|1|||
164353960|NCT00799487|593669834|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
164353961|NCT00799487|593669835|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
164353962|NCT00799487|593669833|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
164353963|NCT00799487|593669834|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
164353964|NCT00799487|593669835|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
164353965|NCT00799487|593669833|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
164353966|NCT00799487|593669834|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
164353967|NCT00799487|593669835|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
164353968|NCT00799487|593669833|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
164353969|NCT00799487|593669834|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
164353970|NCT00799487|593669835|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
164353971|NCT02618434|593669840|FG000|Overall Study|Withdrawal by Subject|0|||
164353972|NCT02618434|593669841|FG001|Overall Study|Withdrawal by Subject|2|||
164299333|NCT00106704|593471299|FG000|Overall Study|Lack of Efficacy|67|||
164299334|NCT00106704|593471300|FG001|Overall Study|Lack of Efficacy|69|||
164299335|NCT00106704|593471299|FG000|Overall Study|Lost to Follow-up|7|||
164299336|NCT00106704|593471300|FG001|Overall Study|Lost to Follow-up|3|||
164299337|NCT00106704|593471299|FG000|Overall Study|Pregnancy|1|||
164299338|NCT00106704|593471300|FG001|Overall Study|Pregnancy|0|||
164299339|NCT00106704|593471299|FG000|Overall Study|Protocol Violation|4|||
164299340|NCT00106704|593471300|FG001|Overall Study|Protocol Violation|7|||
164299341|NCT00106704|593471299|FG000|Overall Study|Withdrawal by Subject|14|||
164299342|NCT00106704|593471300|FG001|Overall Study|Withdrawal by Subject|21|||
164299343|NCT00106704|593471299|FG000|Overall Study|Patient moved|1|||
164299344|NCT00106704|593471300|FG001|Overall Study|Patient moved|0|||
164299345|NCT00106704|593471299|FG000|Overall Study|Site terminated|0|||
164299346|NCT00106704|593471300|FG001|Overall Study|Site terminated|1|||
164299347|NCT00106704|593471299|FG000|Overall Study|Planned major surgery|1|||
164299348|NCT00106704|593471300|FG001|Overall Study|Planned major surgery|0|||
164299349|NCT00106704|593471299|FG000|Overall Study|Patient Received Glycemic Medication|22|||
164299350|NCT00106704|593471300|FG001|Overall Study|Patient Received Glycemic Medication|41|||
164299351|NCT00106704|593471299|FG000|Overall Study|Unable to re-enter US|1|||
164299352|NCT00106704|593471300|FG001|Overall Study|Unable to re-enter US|0|||
164299353|NCT00106704|593471299|FG000|Overall Study|Laboratory test|1|||
164299354|NCT00106704|593471300|FG001|Overall Study|Laboratory test|1|||
164299355|NCT00482053|593471302|FG000|Inter-treatment Period|Disease progression|1|||
164299356|NCT04842747|593471306|FG000|Overall Study|Withdrawal by Subject|6|||
164299357|NCT04842747|593471307|FG001|Overall Study|Withdrawal by Subject|2|||
164299358|NCT04842747|593471306|FG000|Overall Study|Lost to Follow-up|1|||
164299359|NCT04842747|593471307|FG001|Overall Study|Lost to Follow-up|2|||
164299360|NCT04842747|593471306|FG000|Overall Study|Physician Decision|1|||
164299361|NCT04842747|593471307|FG001|Overall Study|Physician Decision|0|||
164299362|NCT04842747|593471306|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
164299363|NCT04842747|593471307|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
164299364|NCT02559622|593471309|FG000|Overall Study|Progressive disease|0|||
164299365|NCT02559622|593471310|FG001|Overall Study|Progressive disease|1|||
164299366|NCT02559622|593471311|FG002|Overall Study|Progressive disease|0|||
164299367|NCT02559622|593471312|FG003|Overall Study|Progressive disease|0|||
164299368|NCT02559622|593471309|FG000|Overall Study|Adverse Event|0|||
164299369|NCT02559622|593471310|FG001|Overall Study|Adverse Event|2|||
164299370|NCT02559622|593471311|FG002|Overall Study|Adverse Event|2|||
164299371|NCT02559622|593471312|FG003|Overall Study|Adverse Event|2|||
164299372|NCT02559622|593471309|FG000|Overall Study|Patient/guardian decision|1|||
164299373|NCT02559622|593471310|FG001|Overall Study|Patient/guardian decision|2|||
164299374|NCT02559622|593471311|FG002|Overall Study|Patient/guardian decision|0|||
164299375|NCT02559622|593471312|FG003|Overall Study|Patient/guardian decision|1|||
164299376|NCT01710345|593471313|FG000|Overall Study|Adverse Event|0|||
164299377|NCT01710345|593471314|FG001|Overall Study|Adverse Event|2|||
164299378|NCT01710345|593471315|FG002|Overall Study|Adverse Event|0|||
164299379|NCT01710345|593471313|FG000|Overall Study|Lack of Efficacy|2|||
164299380|NCT01710345|593471314|FG001|Overall Study|Lack of Efficacy|3|||
164299381|NCT01710345|593471315|FG002|Overall Study|Lack of Efficacy|1|||
164299382|NCT01710345|593471313|FG000|Overall Study|Drug Dosing Error|1|||
164299383|NCT01710345|593471314|FG001|Overall Study|Drug Dosing Error|0|||
164299384|NCT01710345|593471315|FG002|Overall Study|Drug Dosing Error|0|||
164299385|NCT04011540|593471317|FG000|Overall Study|Lost to Follow-up|9|||
164299386|NCT04011540|593471318|FG001|Overall Study|Lost to Follow-up|6|||
164299387|NCT01033019|593471319|FG000|Overall Study|Withdrawal by Subject|1|||
164005918|NCT03598777|592387407|FG001|Overall Study|Withdrawal by Subject|1|||
164005919|NCT03598777|592387408|FG002|Overall Study|Withdrawal by Subject|0|||
164005920|NCT03598777|592387409|FG003|Overall Study|Withdrawal by Subject|0|||
164005921|NCT03598777|592387410|FG004|Overall Study|Withdrawal by Subject|0|||
164005922|NCT03598777|592387406|FG000|Overall Study|Adverse Event|1|||
164005923|NCT03598777|592387407|FG001|Overall Study|Adverse Event|0|||
164005924|NCT03598777|592387408|FG002|Overall Study|Adverse Event|0|||
164005925|NCT03598777|592387409|FG003|Overall Study|Adverse Event|0|||
164005926|NCT03598777|592387410|FG004|Overall Study|Adverse Event|0|||
164005927|NCT03598777|592387406|FG000|Overall Study|Lost to Follow-up|1|||
164005928|NCT03598777|592387407|FG001|Overall Study|Lost to Follow-up|0|||
164005929|NCT03598777|592387408|FG002|Overall Study|Lost to Follow-up|0|||
164005930|NCT03598777|592387409|FG003|Overall Study|Lost to Follow-up|0|||
164005931|NCT03598777|592387410|FG004|Overall Study|Lost to Follow-up|0|||
164005932|NCT00630032|592387412|FG000|Overall Study|Death|55|||
164005933|NCT00630032|592387413|FG001|Overall Study|Death|49|||
164005934|NCT00630032|592387412|FG000|Overall Study|Withdrawal by Subject|3|||
164005935|NCT00630032|592387413|FG001|Overall Study|Withdrawal by Subject|2|||
164005936|NCT00630032|592387412|FG000|Overall Study|Lost to Follow-up|18|||
164005937|NCT00630032|592387413|FG001|Overall Study|Lost to Follow-up|31|||
164005938|NCT00630032|592387412|FG000|Overall Study|Protocol Violation|1|||
164005939|NCT00630032|592387413|FG001|Overall Study|Protocol Violation|0|||
164005940|NCT00630032|592387412|FG000|Overall Study|Patient has moved|1|||
164005941|NCT00630032|592387413|FG001|Overall Study|Patient has moved|1|||
164005942|NCT00630032|592387412|FG000|Overall Study|Disease progression|1|||
164005943|NCT00630032|592387413|FG001|Overall Study|Disease progression|1|||
164005944|NCT00630032|592387412|FG000|Overall Study|End of monitoring in US centers|11|||
164005945|NCT00630032|592387413|FG001|Overall Study|End of monitoring in US centers|11|||
164005946|NCT02332915|592387416|FG000|Overall Study|Moved out of region|3|||
164005947|NCT02332915|592387417|FG001|Overall Study|Moved out of region|0|||
164005948|NCT02332915|592387416|FG000|Overall Study|Unrelated illness|1|||
164005949|NCT02332915|592387417|FG001|Overall Study|Unrelated illness|1|||
164005950|NCT02332915|592387416|FG000|Overall Study|Travel distance prohibitive|0|||
164005951|NCT02332915|592387417|FG001|Overall Study|Travel distance prohibitive|1|||
164005952|NCT02332915|592387416|FG000|Overall Study|did not meet inclusion criteria|2|||
164005953|NCT02332915|592387417|FG001|Overall Study|did not meet inclusion criteria|4|||
164005954|NCT01901328|592387421|FG000|Overall Study|Lost to Follow-up|1|||
164005955|NCT01901328|592387422|FG001|Overall Study|Lost to Follow-up|0|||
164005956|NCT01901328|592387421|FG000|Overall Study|Physician Decision|0|||
164005957|NCT01901328|592387422|FG001|Overall Study|Physician Decision|1|||
164005958|NCT01901328|592387421|FG000|Overall Study|Protocol Violation|1|||
164005959|NCT01901328|592387422|FG001|Overall Study|Protocol Violation|1|||
164005960|NCT01901328|592387421|FG000|Overall Study|Study Terminated by Sponsor|19|||
164005961|NCT01901328|592387422|FG001|Overall Study|Study Terminated by Sponsor|16|||
164005962|NCT01901328|592387421|FG000|Overall Study|Withdrawal by Subject|1|||
164005963|NCT01901328|592387422|FG001|Overall Study|Withdrawal by Subject|2|||
164005964|NCT01901328|592387421|FG000|Overall Study|Lack of Efficacy|0|||
164005965|NCT01901328|592387422|FG001|Overall Study|Lack of Efficacy|1|||
164005966|NCT03232073|592387423|FG000|Overall Study|Death|1|||
164005967|NCT03232073|592387424|FG001|Overall Study|Death|0|||
164005968|NCT03232073|592387423|FG000|Overall Study|Adverse Event|7|||
164005969|NCT03232073|592387424|FG001|Overall Study|Adverse Event|12|||
164005970|NCT03232073|592387423|FG000|Overall Study|Lost to Follow-up|6|||
164005971|NCT03232073|592387424|FG001|Overall Study|Lost to Follow-up|6|||
164005972|NCT03232073|592387423|FG000|Overall Study|Lack of Efficacy|10|||
164005973|NCT03232073|592387424|FG001|Overall Study|Lack of Efficacy|8|||
164005974|NCT03232073|592387423|FG000|Overall Study|Physician Decision|9|||
164353973|NCT02618434|593669842|FG002|Overall Study|Withdrawal by Subject|3|||
164353974|NCT02618434|593669840|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
164353975|NCT02618434|593669841|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
164005975|NCT03232073|592387424|FG001|Overall Study|Physician Decision|2|||
164005976|NCT03232073|592387423|FG000|Overall Study|Withdrawal by Subject|54|||
164005977|NCT03232073|592387424|FG001|Overall Study|Withdrawal by Subject|39|||
164353976|NCT02618434|593669842|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
164353977|NCT02618434|593669840|FG000|Overall Study|Lost to Follow-up|3|||
164005978|NCT04358458|592387425|FG000|Overall Study|Death|1|||
164353978|NCT02618434|593669841|FG001|Overall Study|Lost to Follow-up|1|||
164005979|NCT04358458|592387426|FG001|Overall Study|Death|1|||
164005980|NCT04358458|592387427|FG002|Overall Study|Death|3|||
164005981|NCT04358458|592387428|FG003|Overall Study|Death|8|||
164005982|NCT04358458|592387429|FG004|Overall Study|Death|1|||
164005983|NCT04358458|592387430|FG005|Overall Study|Death|6|||
164005984|NCT04358458|592387431|FG006|Overall Study|Death|2|||
164005985|NCT04358458|592387432|FG007|Overall Study|Death|3|||
164005986|NCT04358458|592387425|FG000|Overall Study|Lost to Follow-up|0|||
164005987|NCT04358458|592387426|FG001|Overall Study|Lost to Follow-up|0|||
164005988|NCT04358458|592387427|FG002|Overall Study|Lost to Follow-up|0|||
164005989|NCT04358458|592387428|FG003|Overall Study|Lost to Follow-up|0|||
164005990|NCT04358458|592387429|FG004|Overall Study|Lost to Follow-up|0|||
164005991|NCT04358458|592387430|FG005|Overall Study|Lost to Follow-up|0|||
164353979|NCT02618434|593669842|FG002|Overall Study|Lost to Follow-up|3|||
164353980|NCT02618434|593669840|FG000|Overall Study|Adverse Event|1|||
164353981|NCT02618434|593669841|FG001|Overall Study|Adverse Event|0|||
164353982|NCT02618434|593669842|FG002|Overall Study|Adverse Event|12|||
164353983|NCT02618434|593669840|FG000|Overall Study|Physician Decision|0|||
164353984|NCT02618434|593669841|FG001|Overall Study|Physician Decision|1|||
164353985|NCT02618434|593669842|FG002|Overall Study|Physician Decision|0|||
163899739|NCT03280030|592004353|FG000|Part 2 - Efficacy|Progressive disease|0|||
163899740|NCT03280030|592004354|FG001|Part 2 - Efficacy|Progressive disease|7|||
163899741|NCT03280030|592004355|FG002|Part 2 - Efficacy|Progressive disease|5|||
163899742|NCT01983683|592004357|FG000|Overall Study|Withdrawal by Subject|14|||
163899743|NCT01983683|592004358|FG001|Overall Study|Withdrawal by Subject|18|||
163899744|NCT01983683|592004357|FG000|Overall Study|Death|11|||
163899745|NCT01983683|592004358|FG001|Overall Study|Death|15|||
163899746|NCT01983683|592004357|FG000|Overall Study|Physician Decision|8|||
163899747|NCT01983683|592004358|FG001|Overall Study|Physician Decision|9|||
163899748|NCT01983683|592004357|FG000|Overall Study|Lost to Follow-up|4|||
163899749|NCT01983683|592004358|FG001|Overall Study|Lost to Follow-up|8|||
163899750|NCT01983683|592004357|FG000|Overall Study|Sponsor Decision|1|||
163899751|NCT01983683|592004358|FG001|Overall Study|Sponsor Decision|1|||
163899752|NCT04882917|592004361|FG000|Overall Study|Adverse Event|0|||
163899753|NCT04882917|592004362|FG001|Overall Study|Adverse Event|1|||
163899754|NCT04882917|592004363|FG002|Overall Study|Adverse Event|2|||
163899755|NCT04882917|592004364|FG003|Overall Study|Adverse Event|2|||
163899756|NCT04882917|592004361|FG000|Overall Study|Withdrawal by Subject|1|||
163899757|NCT04882917|592004362|FG001|Overall Study|Withdrawal by Subject|0|||
163899758|NCT04882917|592004363|FG002|Overall Study|Withdrawal by Subject|2|||
163899759|NCT04882917|592004364|FG003|Overall Study|Withdrawal by Subject|1|||
163899760|NCT04882917|592004361|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
163899761|NCT04882917|592004362|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
163899762|NCT04882917|592004363|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
163899763|NCT04882917|592004364|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
163899764|NCT00319020|592004365|FG000|Overall Study|Death|2|||
163899765|NCT00319020|592004366|FG001|Overall Study|Death|2|||
163899766|NCT00319020|592004365|FG000|Overall Study|Withdrawal by Subject|4|||
163899767|NCT00319020|592004366|FG001|Overall Study|Withdrawal by Subject|1|||
163899768|NCT00319020|592004365|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
163899769|NCT00319020|592004366|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
163899770|NCT00319020|592004365|FG000|Overall Study|Administrative reason|0|||
163899771|NCT00319020|592004366|FG001|Overall Study|Administrative reason|5|||
163899772|NCT00319020|592004365|FG000|Overall Study|Disease progression|0|||
163899773|NCT00319020|592004366|FG001|Overall Study|Disease progression|2|||
163899774|NCT00319020|592004365|FG000|Overall Study|Transplant|0|||
163899775|NCT00319020|592004366|FG001|Overall Study|Transplant|1|||
163899776|NCT00319020|592004365|FG000|Overall Study|Treatment failure|0|||
163899777|NCT00319020|592004366|FG001|Overall Study|Treatment failure|1|||
163899778|NCT00319020|592004365|FG000|Overall Study|Adverse Event|0|||
163899779|NCT00319020|592004366|FG001|Overall Study|Adverse Event|1|||
163899780|NCT04926740|592004367|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
163899781|NCT04926740|592004368|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
163899782|NCT04926740|592004367|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
163899783|NCT04926740|592004368|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
163899784|NCT04980300|592004369|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
163899785|NCT04980300|592004370|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
163899786|NCT04980300|592004369|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
163899787|NCT04980300|592004370|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
163899788|NCT04980300|592004369|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
163899789|NCT04980300|592004370|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
163899790|NCT04980300|592004369|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
163899791|NCT04980300|592004370|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
163899792|NCT06056310|592005533|FG000|Overall Study|Other Reasons|2|||
163899793|NCT06056310|592005533|FG000|Overall Study|Sponsor Request|16|||
163899794|NCT00536120|592005544|FG000|Overall Study|Lost to Follow-up|1|||
163899795|NCT00536120|592005545|FG001|Overall Study|Lost to Follow-up|0|||
163899796|NCT00536120|592005544|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
163899797|NCT00536120|592005545|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
164353986|NCT02618434|593669840|FG000|Overall Study|Protocol Violation|0|||
163899798|NCT00536120|592005544|FG000|Overall Study|Non-compliance|1|||
163899799|NCT00536120|592005545|FG001|Overall Study|Non-compliance|0|||
163899800|NCT00536120|592005544|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
163899801|NCT00536120|592005545|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
163899802|NCT00536120|592005544|FG000|Overall Study|Steroid Use|0|||
163899803|NCT00536120|592005545|FG001|Overall Study|Steroid Use|2|||
163899804|NCT00536120|592005544|FG000|Overall Study|Missed Study Visit|0|||
164353987|NCT02618434|593669841|FG001|Overall Study|Protocol Violation|0|||
164005992|NCT04358458|592387431|FG006|Overall Study|Lost to Follow-up|0|||
164005993|NCT04358458|592387432|FG007|Overall Study|Lost to Follow-up|1|||
164005994|NCT04358458|592387425|FG000|Overall Study|Site is closing study participation|0|||
164005995|NCT04358458|592387426|FG001|Overall Study|Site is closing study participation|0|||
164005996|NCT04358458|592387427|FG002|Overall Study|Site is closing study participation|0|||
164005997|NCT04358458|592387428|FG003|Overall Study|Site is closing study participation|1|||
164005998|NCT04358458|592387429|FG004|Overall Study|Site is closing study participation|0|||
164005999|NCT04358458|592387430|FG005|Overall Study|Site is closing study participation|0|||
164006000|NCT04358458|592387431|FG006|Overall Study|Site is closing study participation|0|||
164006001|NCT04358458|592387432|FG007|Overall Study|Site is closing study participation|0|||
164006002|NCT04358458|592387425|FG000|Overall Study|Sponsor request|2|||
164006003|NCT04358458|592387426|FG001|Overall Study|Sponsor request|3|||
164006004|NCT04358458|592387427|FG002|Overall Study|Sponsor request|3|||
164006005|NCT04358458|592387428|FG003|Overall Study|Sponsor request|0|||
164006006|NCT04358458|592387429|FG004|Overall Study|Sponsor request|2|||
164006007|NCT04358458|592387430|FG005|Overall Study|Sponsor request|3|||
164006008|NCT04358458|592387431|FG006|Overall Study|Sponsor request|1|||
164006009|NCT04358458|592387432|FG007|Overall Study|Sponsor request|1|||
164006010|NCT04358458|592387425|FG000|Overall Study|Withdrawal by Subject|0|||
164006011|NCT04358458|592387426|FG001|Overall Study|Withdrawal by Subject|0|||
164006012|NCT04358458|592387427|FG002|Overall Study|Withdrawal by Subject|1|||
164006013|NCT04358458|592387428|FG003|Overall Study|Withdrawal by Subject|1|||
164006014|NCT04358458|592387429|FG004|Overall Study|Withdrawal by Subject|0|||
164006015|NCT04358458|592387430|FG005|Overall Study|Withdrawal by Subject|1|||
164006016|NCT04358458|592387431|FG006|Overall Study|Withdrawal by Subject|0|||
164006017|NCT04358458|592387432|FG007|Overall Study|Withdrawal by Subject|1|||
164006018|NCT01981187|592388696|FG000|Overall Study|Participant/guardian decision|2|||
164006019|NCT01981187|592388696|FG000|Overall Study|Physician Decision|1|||
164006020|NCT01981187|592388696|FG000|Overall Study|Disease progression|2|||
164006021|NCT01981187|592388696|FG000|Overall Study|Adverse Event|7|||
164006022|NCT02082184|592388701|FG000|Overall Study|Adverse Event|1|||
164006023|NCT02082184|592388702|FG001|Overall Study|Adverse Event|0|||
164006024|NCT02082184|592388701|FG000|Overall Study|Medical diagnosis|1|||
164006025|NCT02082184|592388702|FG001|Overall Study|Medical diagnosis|2|||
164006026|NCT02082184|592388701|FG000|Overall Study|Device associated symptoms|5|||
164006027|NCT02082184|592388702|FG001|Overall Study|Device associated symptoms|0|||
164006028|NCT02082184|592388701|FG000|Overall Study|Withdrawal by Subject|3|||
164006029|NCT02082184|592388702|FG001|Overall Study|Withdrawal by Subject|2|||
164006030|NCT02082184|592388701|FG000|Overall Study|Protocol Violation|0|||
164006031|NCT02082184|592388702|FG001|Overall Study|Protocol Violation|6|||
164006032|NCT02082184|592388701|FG000|Overall Study|Lost to Follow-up|0|||
164006033|NCT02082184|592388702|FG001|Overall Study|Lost to Follow-up|2|||
164006034|NCT02082184|592388701|FG000|Overall Study|Subject non-compliance|0|||
164006035|NCT02082184|592388702|FG001|Overall Study|Subject non-compliance|1|||
164006036|NCT00443560|592388703|FG000|Overall Study|No intrathecal dose|58|||
164006037|NCT00443560|592388704|FG001|Overall Study|No intrathecal dose|26|||
164006038|NCT00443560|592388703|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
164006039|NCT00443560|592388704|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
164006040|NCT01943539|592388711|FG000|Overall Study|Non-compliance with at-home intervention|4|||
164006041|NCT01943539|592388712|FG001|Overall Study|Non-compliance with at-home intervention|0|||
164006042|NCT01362322|592388713|FG000|Overall Study|Withdrawal by Subject|3|||
164006043|NCT01362322|592388714|FG001|Overall Study|Withdrawal by Subject|1|||
164006044|NCT01362322|592388713|FG000|Overall Study|Lost to Follow-up|2|||
164006045|NCT01362322|592388714|FG001|Overall Study|Lost to Follow-up|6|||
164006046|NCT03715465|592388718|FG000|Overall Study|Withdrawal by Subject|1|||
164006047|NCT03715465|592388719|FG001|Overall Study|Withdrawal by Subject|2|||
164006048|NCT00174941|592388721|FG000|Overall Study|Adverse Event|1|||
164006049|NCT00174941|592388722|FG001|Overall Study|Adverse Event|10|||
164006050|NCT00174941|592388723|FG002|Overall Study|Adverse Event|2|||
164006051|NCT00174941|592388724|FG003|Overall Study|Adverse Event|13|||
164006052|NCT00174941|592388721|FG000|Overall Study|Protocol Violation|0|||
164089904|NCT01463683|592691529|FG002|Overall Study|Withdrawal by Subject|2|||
164353988|NCT02618434|593669842|FG002|Overall Study|Protocol Violation|1|||
164006053|NCT00174941|592388722|FG001|Overall Study|Protocol Violation|1|||
164006054|NCT00174941|592388723|FG002|Overall Study|Protocol Violation|0|||
164006055|NCT00174941|592388724|FG003|Overall Study|Protocol Violation|1|||
164006056|NCT00174941|592388721|FG000|Overall Study|Lost to Follow-up|0|||
164006057|NCT00174941|592388722|FG001|Overall Study|Lost to Follow-up|3|||
164006058|NCT00174941|592388723|FG002|Overall Study|Lost to Follow-up|2|||
164006059|NCT00174941|592388724|FG003|Overall Study|Lost to Follow-up|5|||
164006060|NCT00174941|592388721|FG000|Overall Study|Personal Reason(s)|0|||
164006061|NCT00174941|592388722|FG001|Overall Study|Personal Reason(s)|14|||
164006062|NCT00174941|592388723|FG002|Overall Study|Personal Reason(s)|8|||
164006063|NCT00174941|592388724|FG003|Overall Study|Personal Reason(s)|22|||
164006064|NCT00174941|592388721|FG000|Overall Study|Gout Flare|0|||
164006065|NCT00174941|592388722|FG001|Overall Study|Gout Flare|4|||
164353989|NCT02618434|593669840|FG000|Overall Study|Other, Multiple categories|1|||
164353990|NCT02618434|593669841|FG001|Overall Study|Other, Multiple categories|1|||
164353991|NCT02618434|593669842|FG002|Overall Study|Other, Multiple categories|1|||
164353992|NCT02289898|593669848|FG000|Overall Study|Death|5|||
164353993|NCT02289898|593669849|FG001|Overall Study|Death|4|||
164353994|NCT02289898|593669850|FG002|Overall Study|Death|3|||
164353995|NCT02289898|593669848|FG000|Overall Study|Physician Decision|2|||
164006066|NCT00174941|592388723|FG002|Overall Study|Gout Flare|4|||
164006067|NCT00174941|592388724|FG003|Overall Study|Gout Flare|8|||
164006068|NCT00174941|592388721|FG000|Overall Study|Reason Not Specified|1|||
164006069|NCT00174941|592388722|FG001|Overall Study|Reason Not Specified|6|||
164006070|NCT00174941|592388723|FG002|Overall Study|Reason Not Specified|2|||
164006071|NCT00174941|592388724|FG003|Overall Study|Reason Not Specified|9|||
164006072|NCT03230097|592388727|FG000|Overall Study|Adverse Event|2|||
164006073|NCT03230097|592388728|FG001|Overall Study|Adverse Event|1|||
164006074|NCT03230097|592388727|FG000|Overall Study|non-compliance|0|||
164006075|NCT03230097|592388728|FG001|Overall Study|non-compliance|1|||
164006076|NCT03230097|592388727|FG000|Overall Study|Lost to Follow-up|2|||
164006077|NCT03230097|592388728|FG001|Overall Study|Lost to Follow-up|4|||
164006078|NCT03230097|592388727|FG000|Overall Study|Withdrawal by Subject|7|||
164006079|NCT03230097|592388728|FG001|Overall Study|Withdrawal by Subject|3|||
164006080|NCT03230097|592388727|FG000|Overall Study|Trial termination|4|||
164006081|NCT03230097|592388728|FG001|Overall Study|Trial termination|5|||
164006082|NCT03230097|592388727|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
164006083|NCT03230097|592388728|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
164006084|NCT03230097|592388727|FG000|Overall Study|outcome event|0|||
164006085|NCT03230097|592388728|FG001|Overall Study|outcome event|1|||
164006086|NCT00635102|592388744|FG000|Overall Study|Withdrawal by Subject|7|||
164006087|NCT00635102|592388745|FG001|Overall Study|Withdrawal by Subject|8|||
164006088|NCT00440401|592388750|FG000|Overall Study|Adverse Event|2|||
164006089|NCT00440401|592388751|FG001|Overall Study|Adverse Event|1|||
164006090|NCT00440401|592388750|FG000|Overall Study|Other|2|||
164006091|NCT00440401|592388751|FG001|Overall Study|Other|5|||
164006092|NCT01925703|592388752|FG000|Overall Study|Physician Decision|1|||
164006093|NCT01925703|592388752|FG000|Overall Study|Lost to Follow-up|2|||
164006094|NCT01925703|592388752|FG000|Overall Study|Discharge prior to full iron repletion|1|||
164006095|NCT01938625|592388753|FG000|Overall Study|Withdrawal by Subject|0|||
164006096|NCT01938625|592388754|FG001|Overall Study|Withdrawal by Subject|1|||
164006097|NCT01938625|592388753|FG000|Overall Study|Adverse Event|0|||
164006098|NCT01938625|592388754|FG001|Overall Study|Adverse Event|1|||
164006099|NCT02088034|592388755|FG000|Overall Study|Lost to Follow-up|1|||
164006100|NCT02088034|592388756|FG001|Overall Study|Lost to Follow-up|1|||
164006101|NCT02088034|592388757|FG002|Overall Study|Lost to Follow-up|0|||
164006102|NCT02088034|592388755|FG000|Overall Study|Pregnancy|2|||
164006103|NCT02088034|592388756|FG001|Overall Study|Pregnancy|1|||
164006104|NCT02088034|592388757|FG002|Overall Study|Pregnancy|2|||
164006105|NCT00308620|592388758|FG000|Overall Study|Death|1|||
164006106|NCT00308620|592388759|FG001|Overall Study|Death|1|||
164006107|NCT00308620|592388760|FG002|Overall Study|Death|0|||
164006108|NCT00308620|592388758|FG000|Overall Study|Lost to Follow-up|0|||
164006109|NCT00308620|592388759|FG001|Overall Study|Lost to Follow-up|0|||
164006110|NCT00308620|592388760|FG002|Overall Study|Lost to Follow-up|1|||
164006111|NCT00091793|592388761|FG000|Overall Study|Adverse Event|1|||
164006112|NCT00091793|592388762|FG001|Overall Study|Adverse Event|2|||
164006113|NCT00091793|592388761|FG000|Overall Study|Withdrawal by Subject|10|||
164006114|NCT00091793|592388762|FG001|Overall Study|Withdrawal by Subject|15|||
164006115|NCT00091793|592388761|FG000|Overall Study|Ineligibility determined|2|||
164006116|NCT00091793|592388762|FG001|Overall Study|Ineligibility determined|0|||
164006117|NCT00091793|592388761|FG000|Overall Study|Lost to Follow-up|7|||
164006118|NCT00091793|592388762|FG001|Overall Study|Lost to Follow-up|5|||
164006119|NCT00091793|592388761|FG000|Overall Study|Noncompliance|2|||
164353996|NCT02289898|593669849|FG001|Overall Study|Physician Decision|5|||
164353997|NCT02289898|593669850|FG002|Overall Study|Physician Decision|2|||
164006120|NCT00091793|592388762|FG001|Overall Study|Noncompliance|0|||
164353998|NCT02289898|593669848|FG000|Overall Study|Withdrawal by Subject|0|||
164353999|NCT02289898|593669849|FG001|Overall Study|Withdrawal by Subject|4|||
164006121|NCT00091793|592388761|FG000|Overall Study|Other|2|||
164006122|NCT00091793|592388762|FG001|Overall Study|Other|0|||
164006123|NCT02424149|592388766|FG000|Overall Study|surgery cancelled|2|||
164006124|NCT02424149|592388767|FG001|Overall Study|surgery cancelled|0|||
164006125|NCT02424149|592388766|FG000|Overall Study|Withdrawal by Subject|0|||
164006126|NCT02424149|592388767|FG001|Overall Study|Withdrawal by Subject|1|||
164006127|NCT05309083|592388768|FG000|Overall Study|Withdrawal by Subject|2|||
164006128|NCT01238120|592388769|FG000|Overall Study|Withdrawal by Subject|4|||
164006129|NCT01238120|592388770|FG001|Overall Study|Withdrawal by Subject|1|||
164006130|NCT01238120|592388771|FG002|Overall Study|Withdrawal by Subject|2|||
164006131|NCT01238120|592388772|FG003|Overall Study|Withdrawal by Subject|5|||
164006132|NCT01238120|592388769|FG000|Overall Study|Lost to Follow-up|2|||
164006133|NCT01238120|592388770|FG001|Overall Study|Lost to Follow-up|0|||
164006134|NCT01238120|592388771|FG002|Overall Study|Lost to Follow-up|1|||
164354000|NCT02289898|593669850|FG002|Overall Study|Withdrawal by Subject|1|||
164354001|NCT02289898|593669848|FG000|Overall Study|Adverse Event|3|||
164299388|NCT01033019|593471320|FG001|Overall Study|Withdrawal by Subject|0|||
164299389|NCT01339832|593471321|FG000|Overall Study|Lost to Follow-up|3|||
164299390|NCT01339832|593471321|FG000|Overall Study|Death|11|||
164299391|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
164299392|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
164299393|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
164299394|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
164299395|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
164299396|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
164299397|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
164299398|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
164299399|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
164299400|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
164299401|NCT01668784|593471335|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
164299402|NCT01668784|593471336|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
164299403|NCT01668784|593471335|FG000|Treatment Period|Disease Progression|316|||
164299404|NCT01668784|593471336|FG001|Treatment Period|Disease Progression|293|||
164299405|NCT01668784|593471335|FG000|Treatment Period|Study Drug Toxicity|46|||
164299406|NCT01668784|593471336|FG001|Treatment Period|Study Drug Toxicity|53|||
164299407|NCT01668784|593471335|FG000|Treatment Period|Death|1|||
164299408|NCT01668784|593471336|FG001|Treatment Period|Death|1|||
164299409|NCT01668784|593471335|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
164354002|NCT02289898|593669849|FG001|Overall Study|Adverse Event|5|||
164354003|NCT02289898|593669850|FG002|Overall Study|Adverse Event|5|||
164354004|NCT02289898|593669848|FG000|Overall Study|Disease progression|34|||
163899805|NCT00536120|592005545|FG001|Overall Study|Missed Study Visit|1|||
163899806|NCT02722434|592005546|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
163899807|NCT02722434|592005547|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
164299410|NCT01668784|593471336|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
164299411|NCT01668784|593471335|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
164299412|NCT01668784|593471336|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
164299413|NCT01668784|593471335|FG000|Treatment Period|Withdrawal by Subject|5|||
164299414|NCT01668784|593471336|FG001|Treatment Period|Withdrawal by Subject|3|||
164299415|NCT01668784|593471335|FG000|Treatment Period|Maximal Clinical Benefit|3|||
164299416|NCT01668784|593471336|FG001|Treatment Period|Maximal Clinical Benefit|3|||
164299417|NCT01668784|593471335|FG000|Treatment Period|Other|2|||
164299418|NCT01668784|593471336|FG001|Treatment Period|Other|8|||
164299419|NCT01668784|593471335|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
164299420|NCT01668784|593471336|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
164299421|NCT02761330|593471337|FG000|Treatment Week 1|Withdrawal by Subject|0|||
164299422|NCT02761330|593471338|FG001|Treatment Week 1|Withdrawal by Subject|0|||
164299423|NCT02761330|593471339|FG002|Treatment Week 1|Withdrawal by Subject|0|||
164299424|NCT02761330|593471340|FG003|Treatment Week 1|Withdrawal by Subject|1|||
164299425|NCT02761330|593471341|FG004|Treatment Week 1|Withdrawal by Subject|0|||
164299426|NCT02761330|593471342|FG005|Treatment Week 1|Withdrawal by Subject|1|||
164354005|NCT02289898|593669849|FG001|Overall Study|Disease progression|28|||
163899808|NCT02722434|592005546|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
163899809|NCT02722434|592005547|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
163899810|NCT03876457|592005554|FG000|Overall Study|Lost to Follow-up|1|||
163899811|NCT03876457|592005555|FG001|Overall Study|Lost to Follow-up|3|||
163899812|NCT01084694|592005556|FG000|Overall Study|Withdrawal by Subject|2|||
163899813|NCT01084694|592005557|FG001|Overall Study|Withdrawal by Subject|1|||
163899814|NCT01084694|592005556|FG000|Overall Study|Death|2|||
163899815|NCT01084694|592005557|FG001|Overall Study|Death|12|||
163899816|NCT01084694|592005556|FG000|Overall Study|eligibility not maintained|2|||
163899817|NCT01084694|592005557|FG001|Overall Study|eligibility not maintained|7|||
163899818|NCT02185794|592005562|FG000|Overall Study|Enrolled but Never Dosed|1|||
163899819|NCT02185794|592005563|FG001|Overall Study|Enrolled but Never Dosed|6|||
163899820|NCT02185794|592005564|FG002|Overall Study|Enrolled but Never Dosed|3|||
163899821|NCT02185794|592005565|FG003|Overall Study|Enrolled but Never Dosed|1|||
163899822|NCT02185794|592005566|FG004|Overall Study|Enrolled but Never Dosed|1|||
163899823|NCT02185794|592005567|FG005|Overall Study|Enrolled but Never Dosed|0|||
163899824|NCT02185794|592005562|FG000|Overall Study|Investigator's Discretion|1|||
163899825|NCT02185794|592005563|FG001|Overall Study|Investigator's Discretion|0|||
163899826|NCT02185794|592005564|FG002|Overall Study|Investigator's Discretion|1|||
163899827|NCT02185794|592005565|FG003|Overall Study|Investigator's Discretion|2|||
163899828|NCT02185794|592005566|FG004|Overall Study|Investigator's Discretion|2|||
163899829|NCT02185794|592005567|FG005|Overall Study|Investigator's Discretion|15|||
163899830|NCT02185794|592005562|FG000|Overall Study|Withdrew Consent|2|||
163899831|NCT02185794|592005563|FG001|Overall Study|Withdrew Consent|5|||
163899832|NCT02185794|592005564|FG002|Overall Study|Withdrew Consent|10|||
163899833|NCT02185794|592005565|FG003|Overall Study|Withdrew Consent|2|||
163899834|NCT02185794|592005566|FG004|Overall Study|Withdrew Consent|0|||
164006135|NCT01238120|592388772|FG003|Overall Study|Lost to Follow-up|1|||
164006136|NCT01238120|592388769|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
164354006|NCT02289898|593669850|FG002|Overall Study|Disease progression|34|||
164354007|NCT02289898|593669848|FG000|Overall Study|Use of another anticancer therapy|0|||
164354008|NCT02289898|593669849|FG001|Overall Study|Use of another anticancer therapy|0|||
164354009|NCT02289898|593669850|FG002|Overall Study|Use of another anticancer therapy|1|||
164006137|NCT01238120|592388770|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
164006138|NCT01238120|592388771|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
164006139|NCT01238120|592388772|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
164006140|NCT02498652|592388776|FG000|Overall Study|Protocol Violation|0|||
164006141|NCT02498652|592388777|FG001|Overall Study|Protocol Violation|1|||
164006142|NCT02388776|592388780|FG000|Overall Study|Death|1|||
164006143|NCT02388776|592388780|FG000|Overall Study|Lost to Follow-up|1|||
164006144|NCT00845429|592388795|FG000|Overall Study|Protocol Violation|5|||
164006145|NCT00845429|592388796|FG001|Overall Study|Protocol Violation|4|||
164006146|NCT00845429|592388797|FG002|Overall Study|Protocol Violation|7|||
164006147|NCT00845429|592388795|FG000|Overall Study|Lost to Follow-up|7|||
164006148|NCT00845429|592388796|FG001|Overall Study|Lost to Follow-up|9|||
164006149|NCT00845429|592388797|FG002|Overall Study|Lost to Follow-up|10|||
164006150|NCT00845429|592388795|FG000|Overall Study|Withdrawal by Subject|2|||
164006151|NCT00845429|592388796|FG001|Overall Study|Withdrawal by Subject|2|||
164006152|NCT00845429|592388797|FG002|Overall Study|Withdrawal by Subject|2|||
164006153|NCT00845429|592388795|FG000|Overall Study|Serious adverse event|0|||
164006154|NCT00845429|592388796|FG001|Overall Study|Serious adverse event|0|||
164006155|NCT00845429|592388797|FG002|Overall Study|Serious adverse event|1|||
164006156|NCT01476787|592388798|FG000|Treatment|Progression|64|||
164006157|NCT01476787|592388799|FG001|Treatment|Progression|71|||
164006158|NCT01476787|592388798|FG000|Treatment|Toxicity|44|||
164006159|NCT01476787|592388799|FG001|Treatment|Toxicity|16|||
164006160|NCT01476787|592388798|FG000|Treatment|Death|0|||
164006161|NCT01476787|592388799|FG001|Treatment|Death|1|||
164006162|NCT01476787|592388798|FG000|Treatment|Withdrawal by Subject|3|||
164006163|NCT01476787|592388799|FG001|Treatment|Withdrawal by Subject|14|||
164006164|NCT01476787|592388798|FG000|Treatment|Major protocol violation|1|||
164006165|NCT01476787|592388799|FG001|Treatment|Major protocol violation|6|||
164006166|NCT01476787|592388798|FG000|Treatment|Other reasons|10|||
164006167|NCT01476787|592388799|FG001|Treatment|Other reasons|22|||
164006168|NCT01476787|592388798|FG000|Treatment|Concurrent illness|12|||
164354010|NCT02289898|593669848|FG000|Overall Study|Other|8|||
164354011|NCT02289898|593669849|FG001|Overall Study|Other|7|||
164354012|NCT02289898|593669850|FG002|Overall Study|Other|10|||
164354013|NCT04626297|593669851|FG000|Overall Study|Adverse Event|5|||
164354014|NCT04626297|593669852|FG001|Overall Study|Adverse Event|3|||
164354015|NCT04626297|593669851|FG000|Overall Study|Lost to Follow-up|7|||
164354016|NCT04626297|593669852|FG001|Overall Study|Lost to Follow-up|3|||
164354017|NCT04626297|593669851|FG000|Overall Study|Protocol Violation|5|||
164354018|NCT04626297|593669852|FG001|Overall Study|Protocol Violation|1|||
164354019|NCT04626297|593669851|FG000|Overall Study|Withdrawal by Subject|20|||
164354020|NCT04626297|593669852|FG001|Overall Study|Withdrawal by Subject|6|||
164354021|NCT04626297|593669851|FG000|Overall Study|Sponsor decision|2|||
164354022|NCT04626297|593669852|FG001|Overall Study|Sponsor decision|1|||
164354023|NCT00885105|593669855|FG000|Overall Study|Withdrawal by Subject|0|||
164354024|NCT00885105|593669856|FG001|Overall Study|Withdrawal by Subject|8|||
164354025|NCT00885105|593669855|FG000|Overall Study|Adverse Event|1|||
164354026|NCT00885105|593669856|FG001|Overall Study|Adverse Event|0|||
164354027|NCT00885105|593669855|FG000|Overall Study|Protocol Violation|0|||
164354028|NCT00885105|593669856|FG001|Overall Study|Protocol Violation|2|||
164354029|NCT02066233|593669857|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
164354030|NCT02066233|593669858|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
164354031|NCT02598076|593669859|FG000|Overall Study|Lost to Follow-up|2|||
164354032|NCT02598076|593669860|FG001|Overall Study|Lost to Follow-up|3|||
164354033|NCT02005445|593669861|FG000|Overall Study|Dual study enrollment|0|||
164354034|NCT02005445|593669862|FG001|Overall Study|Dual study enrollment|1|||
164006169|NCT01476787|592388799|FG001|Treatment|Concurrent illness|9|||
164006170|NCT01476787|592388798|FG000|Treatment|Insufficient response|15|||
164006171|NCT01476787|592388799|FG001|Treatment|Insufficient response|3|||
164006172|NCT01476787|592388798|FG000|Treatment|Voluntary treatment discontinuation|8|||
164006173|NCT01476787|592388799|FG001|Treatment|Voluntary treatment discontinuation|4|||
164006174|NCT02234622|592388806|FG000|Overall Study|Withdrawal by Subject|16|||
164006175|NCT02234622|592388807|FG001|Overall Study|Withdrawal by Subject|22|||
164006176|NCT02234622|592388806|FG000|Overall Study|Lost to Follow-up|27|||
164006177|NCT02234622|592388807|FG001|Overall Study|Lost to Follow-up|14|||
164006178|NCT00144300|592388808|FG000|Overall Study|Adverse Event|18|||
164006179|NCT00144300|592388809|FG001|Overall Study|Adverse Event|16|||
164006180|NCT00144300|592388808|FG000|Overall Study|Protocol Violation|1|||
164354035|NCT00759954|593669863|FG000|Overall Study|Personal reason|1|||
164354036|NCT00759954|593669864|FG001|Overall Study|Personal reason|0|||
164354037|NCT00759954|593669863|FG000|Overall Study|Adverse Event|1|||
164354038|NCT00759954|593669864|FG001|Overall Study|Adverse Event|2|||
163899835|NCT02185794|592005567|FG005|Overall Study|Withdrew Consent|0|||
163899836|NCT02185794|592005562|FG000|Overall Study|Lost to Follow-up|1|||
163899837|NCT02185794|592005563|FG001|Overall Study|Lost to Follow-up|2|||
163899838|NCT02185794|592005564|FG002|Overall Study|Lost to Follow-up|2|||
163899839|NCT02185794|592005565|FG003|Overall Study|Lost to Follow-up|3|||
163899840|NCT02185794|592005566|FG004|Overall Study|Lost to Follow-up|0|||
163899841|NCT02185794|592005567|FG005|Overall Study|Lost to Follow-up|1|||
163899842|NCT00336505|592005568|FG000|Overall Study|Adverse Event|10|||
163899843|NCT00336505|592005569|FG001|Overall Study|Adverse Event|9|||
163899844|NCT00336505|592005568|FG000|Overall Study|Lack of Efficacy|8|||
163899845|NCT00336505|592005569|FG001|Overall Study|Lack of Efficacy|4|||
163899846|NCT00336505|592005568|FG000|Overall Study|Lost to Follow-up|7|||
163899847|NCT00336505|592005569|FG001|Overall Study|Lost to Follow-up|4|||
163899848|NCT00336505|592005568|FG000|Overall Study|Withdrawal by Subject|5|||
163899849|NCT00336505|592005569|FG001|Overall Study|Withdrawal by Subject|3|||
163899850|NCT00336505|592005568|FG000|Overall Study|Other|7|||
163899851|NCT00336505|592005569|FG001|Overall Study|Other|7|||
163899852|NCT03478969|592005570|FG000|Overall Study|Withdrawal by Subject|4|||
163899853|NCT03478969|592005571|FG001|Overall Study|Withdrawal by Subject|7|||
163899854|NCT03478969|592005572|FG002|Overall Study|Withdrawal by Subject|6|||
164089905|NCT03111147|592691530|FG000|Overall Study|Lost to Follow-up|2|||
164089906|NCT03111147|592691531|FG001|Overall Study|Lost to Follow-up|5|||
164089907|NCT03111147|592691530|FG000|Overall Study|Withdrawal by Subject|4|||
164089908|NCT03111147|592691531|FG001|Overall Study|Withdrawal by Subject|3|||
164089909|NCT03111147|592691530|FG000|Overall Study|Protocol Violation|2|||
164089910|NCT03111147|592691531|FG001|Overall Study|Protocol Violation|1|||
164089911|NCT03111147|592691530|FG000|Overall Study|Death|1|||
164089912|NCT03111147|592691531|FG001|Overall Study|Death|1|||
164089913|NCT01058421|592691532|FG000|1 Month Outcomes|Death|10|||
164089914|NCT01058421|592691533|FG001|1 Month Outcomes|Death|6|||
164089915|NCT01058421|592691532|FG000|1 Month Outcomes|Lost to Follow-up|8|||
164089916|NCT01058421|592691533|FG001|1 Month Outcomes|Lost to Follow-up|7|||
164089917|NCT01058421|592691532|FG000|1 Month Outcomes|Remained in Hospital|5|||
164089918|NCT01058421|592691533|FG001|1 Month Outcomes|Remained in Hospital|12|||
164089919|NCT01058421|592691532|FG000|1 Month Outcomes|Remained in Other Facility|16|||
164089920|NCT01058421|592691533|FG001|1 Month Outcomes|Remained in Other Facility|17|||
164089921|NCT01058421|592691532|FG000|3 Month Outcomes|Death|3|||
164089922|NCT01058421|592691533|FG001|3 Month Outcomes|Death|5|||
164089923|NCT01058421|592691532|FG000|3 Month Outcomes|Lost to Follow-up|12|||
164089924|NCT01058421|592691533|FG001|3 Month Outcomes|Lost to Follow-up|11|||
164089925|NCT01058421|592691532|FG000|3 Month Outcomes|Remained in Hospital|0|||
164089926|NCT01058421|592691533|FG001|3 Month Outcomes|Remained in Hospital|2|||
164354039|NCT00010374|593669865|FG000|Overall Study|False positive phrenic nerve test|1|||
164354040|NCT02407704|593669870|FG000|Overall Study|Lost to Follow-up|0|||
164354041|NCT02407704|593669871|FG001|Overall Study|Lost to Follow-up|0|||
164354042|NCT02407704|593669872|FG002|Overall Study|Lost to Follow-up|0|||
164354043|NCT02407704|593669873|FG003|Overall Study|Lost to Follow-up|2|||
164354044|NCT02407704|593669870|FG000|Overall Study|Protocol Violation|0|||
164354045|NCT02407704|593669871|FG001|Overall Study|Protocol Violation|0|||
164354046|NCT02407704|593669872|FG002|Overall Study|Protocol Violation|0|||
164354047|NCT02407704|593669873|FG003|Overall Study|Protocol Violation|1|||
164354048|NCT02407704|593669870|FG000|Overall Study|Withdrawal by Subject|0|||
164354049|NCT02407704|593669871|FG001|Overall Study|Withdrawal by Subject|0|||
164354050|NCT02407704|593669872|FG002|Overall Study|Withdrawal by Subject|1|||
164354051|NCT02407704|593669873|FG003|Overall Study|Withdrawal by Subject|0|||
164354052|NCT01683383|593669874|FG000|Overall Study|Infant was not transported|1|||
164354053|NCT01683383|593669875|FG001|Overall Study|Infant was not transported|0|||
164354054|NCT02496611|593669876|FG000|Overall Study|Lost to Follow-up|2|||
164354055|NCT02496611|593669877|FG001|Overall Study|Lost to Follow-up|1|||
164354056|NCT02496611|593669876|FG000|Overall Study|Withdrawal by Subject|5|||
164354057|NCT02496611|593669877|FG001|Overall Study|Withdrawal by Subject|2|||
163899855|NCT03478969|592005570|FG000|Overall Study|Adverse Event|2|||
163899856|NCT03478969|592005571|FG001|Overall Study|Adverse Event|0|||
163899857|NCT03478969|592005572|FG002|Overall Study|Adverse Event|1|||
163899858|NCT03478969|592005570|FG000|Overall Study|Pregnancy|1|||
163899859|NCT03478969|592005571|FG001|Overall Study|Pregnancy|0|||
163899860|NCT03478969|592005572|FG002|Overall Study|Pregnancy|0|||
163899861|NCT03478969|592005570|FG000|Overall Study|Personal Reasons|1|||
163899862|NCT03478969|592005571|FG001|Overall Study|Personal Reasons|0|||
164089927|NCT01058421|592691532|FG000|3 Month Outcomes|Remained in Other Facility|5|||
164089928|NCT01058421|592691533|FG001|3 Month Outcomes|Remained in Other Facility|8|||
164089929|NCT01058421|592691532|FG000|6 Month Outcomes|Death|2|||
164089930|NCT01058421|592691533|FG001|6 Month Outcomes|Death|2|||
164089931|NCT01058421|592691532|FG000|6 Month Outcomes|Lost to Follow-up|16|||
164089932|NCT01058421|592691533|FG001|6 Month Outcomes|Lost to Follow-up|21|||
164133183|NCT04126213|592852703|FG004|Overall Study|Other|0|||
164354058|NCT03228537|593669884|FG000|Neoadjuvant|Adverse Event|2|||
164354059|NCT03228537|593669884|FG000|Neoadjuvant|Progression/Relapse|4|||
164354060|NCT03228537|593669884|FG000|Neoadjuvant|Death|1|||
164089933|NCT01058421|592691532|FG000|6 Month Outcomes|Remained in Other Facility|1|||
164354061|NCT03228537|593669884|FG000|Surgery|Death|1|||
164089934|NCT01058421|592691533|FG001|6 Month Outcomes|Remained in Other Facility|3|||
164089935|NCT01497938|592691534|FG000|Overall Study|Adverse Event|0|||
164089936|NCT01497938|592691535|FG001|Overall Study|Adverse Event|1|||
164089937|NCT01497938|592691534|FG000|Overall Study|Physician Decision|0|||
164089938|NCT01497938|592691535|FG001|Overall Study|Physician Decision|1|||
164089939|NCT01497938|592691534|FG000|Overall Study|Withdrawal by Subject|4|||
164089940|NCT01497938|592691535|FG001|Overall Study|Withdrawal by Subject|0|||
164089941|NCT01497938|592691534|FG000|Overall Study|Device Violation|1|||
164089942|NCT01497938|592691535|FG001|Overall Study|Device Violation|0|||
164089943|NCT05665595|592693284|FG000|Overall Study|Ongoing|692|||
164089944|NCT05665595|592693285|FG001|Overall Study|Ongoing|698|||
164089945|NCT05665595|592693284|FG000|Overall Study|Withdrawal by Subject|2|||
164089946|NCT05665595|592693285|FG001|Overall Study|Withdrawal by Subject|2|||
164089947|NCT05665595|592693284|FG000|Overall Study|Lost to Follow-up|1|||
164089948|NCT05665595|592693285|FG001|Overall Study|Lost to Follow-up|0|||
164089949|NCT05665595|592693284|FG000|Overall Study|Death|6|||
164089950|NCT05665595|592693285|FG001|Overall Study|Death|1|||
164089951|NCT02581345|592693286|FG000|Part 1: up to Week 16|Adverse Event|3|||
164089952|NCT02581345|592693287|FG001|Part 1: up to Week 16|Adverse Event|8|||
164089953|NCT02581345|592693288|FG002|Part 1: up to Week 16|Adverse Event|0|||
164089954|NCT02581345|592693289|FG003|Part 1: up to Week 16|Adverse Event|0|||
164089955|NCT02581345|592693286|FG000|Part 1: up to Week 16|Physician Decision|2|||
164089956|NCT02581345|592693287|FG001|Part 1: up to Week 16|Physician Decision|4|||
164089957|NCT02581345|592693288|FG002|Part 1: up to Week 16|Physician Decision|0|||
164089958|NCT02581345|592693289|FG003|Part 1: up to Week 16|Physician Decision|0|||
164089959|NCT02581345|592693286|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
164089960|NCT02581345|592693287|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
164089961|NCT02581345|592693288|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
164089962|NCT02581345|592693289|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
164089963|NCT02581345|592693286|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
164089964|NCT02581345|592693287|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
164089965|NCT02581345|592693288|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
164089966|NCT02581345|592693289|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
164089967|NCT02581345|592693286|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
164089968|NCT02581345|592693287|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
164089969|NCT02581345|592693288|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
164089970|NCT02581345|592693289|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
164089971|NCT02581345|592693286|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
164089972|NCT02581345|592693287|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
164089973|NCT02581345|592693288|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
164089974|NCT02581345|592693289|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
164089975|NCT02581345|592693286|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
164089976|NCT02581345|592693287|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
164089977|NCT02581345|592693288|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
164089978|NCT02581345|592693289|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
164089979|NCT02581345|592693286|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
164089980|NCT02581345|592693287|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
164089981|NCT02581345|592693288|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
164354062|NCT03228537|593669884|FG000|Surgery|Other - Not Protocol Specified|2|||
164354063|NCT03228537|593669884|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
164354064|NCT03228537|593669884|FG000|Maintenance|Progression/Relapse|10|||
164354065|NCT00580606|593669888|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
164354066|NCT00580606|593669889|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
164354067|NCT00580606|593669888|FG000|Open Label (OL)|Withdrawal by Subject|4|||
164354068|NCT00580606|593669889|FG001|Open Label (OL)|Withdrawal by Subject|6|||
164354069|NCT00580606|593669888|FG000|Open Label (OL)|Dosing Symptoms|0|||
164354070|NCT00580606|593669889|FG001|Open Label (OL)|Dosing Symptoms|1|||
164354071|NCT00580606|593669888|FG000|Open Label (OL)|Lost to Follow-up|0|||
164354072|NCT00580606|593669889|FG001|Open Label (OL)|Lost to Follow-up|1|||
164354073|NCT00580606|593669888|FG000|Open Label (OL)|Pregnancy|0|||
164354074|NCT00580606|593669889|FG001|Open Label (OL)|Pregnancy|1|||
164089982|NCT02581345|592693289|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
164089983|NCT02581345|592693286|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
164089984|NCT02581345|592693287|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
164354075|NCT00580606|593669888|FG000|Open Label (OL)|Non-compliance|2|||
164089985|NCT02581345|592693288|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
164089986|NCT02581345|592693289|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
164089987|NCT02581345|592693286|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
164089988|NCT02581345|592693287|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
164089989|NCT02581345|592693288|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
164354076|NCT00580606|593669889|FG001|Open Label (OL)|Non-compliance|0|||
164006181|NCT00144300|592388809|FG001|Overall Study|Protocol Violation|3|||
164354077|NCT00580606|593669888|FG000|Open Label (OL)|Physician Decision|1|||
164354078|NCT00580606|593669889|FG001|Open Label (OL)|Physician Decision|1|||
164354079|NCT00580606|593669888|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
164354080|NCT00580606|593669889|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
164354081|NCT03358290|593669891|FG000|Overall Study|Study discontinued by Sponsor|0|||
164006182|NCT00144300|592388808|FG000|Overall Study|Lost to Follow-up|3|||
164354082|NCT03358290|593669892|FG001|Overall Study|Study discontinued by Sponsor|1|||
164354083|NCT03358290|593669893|FG002|Overall Study|Study discontinued by Sponsor|1|||
164354084|NCT03358290|593669894|FG003|Overall Study|Study discontinued by Sponsor|0|||
164354085|NCT03358290|593669895|FG004|Overall Study|Study discontinued by Sponsor|0|||
164354086|NCT03358290|593669891|FG000|Overall Study|Adverse Event|0|||
164354087|NCT03358290|593669892|FG001|Overall Study|Adverse Event|0|||
164354088|NCT03358290|593669893|FG002|Overall Study|Adverse Event|1|||
164354089|NCT03358290|593669894|FG003|Overall Study|Adverse Event|2|||
164354090|NCT03358290|593669895|FG004|Overall Study|Adverse Event|0|||
164354091|NCT03358290|593669891|FG000|Overall Study|Withdrawal by Subject|0|||
164354092|NCT03358290|593669892|FG001|Overall Study|Withdrawal by Subject|0|||
164354093|NCT03358290|593669893|FG002|Overall Study|Withdrawal by Subject|0|||
164354094|NCT03358290|593669894|FG003|Overall Study|Withdrawal by Subject|0|||
164354095|NCT03358290|593669895|FG004|Overall Study|Withdrawal by Subject|1|||
164354096|NCT01482884|593669896|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
164354097|NCT01482884|593669897|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
164354098|NCT01482884|593669896|FG000|Overall Study|Protocol Violation|1|||
164354099|NCT01482884|593669897|FG001|Overall Study|Protocol Violation|0|||
164354100|NCT01482884|593669896|FG000|Overall Study|Lost to Follow-up|2|||
164354101|NCT01482884|593669897|FG001|Overall Study|Lost to Follow-up|2|||
164354102|NCT01482884|593669896|FG000|Overall Study|Lack of Efficacy|0|||
164354103|NCT01482884|593669897|FG001|Overall Study|Lack of Efficacy|1|||
164354104|NCT01482884|593669896|FG000|Overall Study|Adverse Event|2|||
164006183|NCT00144300|592388809|FG001|Overall Study|Lost to Follow-up|0|||
164006184|NCT00144300|592388808|FG000|Overall Study|Withdrawal by Subject|6|||
164006185|NCT00144300|592388809|FG001|Overall Study|Withdrawal by Subject|6|||
164006186|NCT00144300|592388808|FG000|Overall Study|Other reason (not specified)|1|||
164006187|NCT00144300|592388809|FG001|Overall Study|Other reason (not specified)|3|||
164006188|NCT01650805|592388810|FG000|Overall Study|Withdrawal by Subject|1|||
164006189|NCT01650805|592388811|FG001|Overall Study|Withdrawal by Subject|0|||
164006190|NCT02403206|592388812|FG000|Overall Study|Lost to Follow-up|4|||
164006191|NCT02403206|592388813|FG001|Overall Study|Lost to Follow-up|3|||
164006192|NCT02403206|592388812|FG000|Overall Study|Physician Decision|2|||
164006193|NCT02403206|592388813|FG001|Overall Study|Physician Decision|0|||
164006194|NCT02403206|592388812|FG000|Overall Study|Withdrawal by Subject|3|||
164089990|NCT02581345|592693289|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
164089991|NCT02581345|592693286|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
164089992|NCT02581345|592693287|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
164089993|NCT02581345|592693288|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
164089994|NCT02581345|592693289|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
164089995|NCT02581345|592693286|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
164354105|NCT01482884|593669897|FG001|Overall Study|Adverse Event|1|||
164354106|NCT01482884|593669896|FG000|Overall Study|Withdrawal by Subject|8|||
164354107|NCT01482884|593669897|FG001|Overall Study|Withdrawal by Subject|13|||
164354108|NCT04102020|593669898|FG000|Overall Study|Adverse Event|1|||
164354109|NCT04102020|593669899|FG001|Overall Study|Adverse Event|0|||
164354110|NCT04102020|593669900|FG002|Overall Study|Adverse Event|0|||
164354111|NCT04102020|593669901|FG003|Overall Study|Adverse Event|1|||
164354112|NCT04102020|593669902|FG004|Overall Study|Adverse Event|0|||
164354113|NCT04102020|593669898|FG000|Overall Study|Withdrawal by Subject|0|||
164354114|NCT04102020|593669899|FG001|Overall Study|Withdrawal by Subject|1|||
164354115|NCT04102020|593669900|FG002|Overall Study|Withdrawal by Subject|1|||
164354116|NCT04102020|593669901|FG003|Overall Study|Withdrawal by Subject|1|||
164006195|NCT02403206|592388813|FG001|Overall Study|Withdrawal by Subject|3|||
164354117|NCT04102020|593669902|FG004|Overall Study|Withdrawal by Subject|1|||
164354118|NCT04102020|593669898|FG000|Overall Study|Death|1|||
164354119|NCT04102020|593669899|FG001|Overall Study|Death|4|||
164354120|NCT04102020|593669900|FG002|Overall Study|Death|1|||
164354121|NCT04102020|593669901|FG003|Overall Study|Death|1|||
164354122|NCT04102020|593669902|FG004|Overall Study|Death|0|||
164354123|NCT04102020|593669898|FG000|Overall Study|Physician Decision|1|||
164354124|NCT04102020|593669899|FG001|Overall Study|Physician Decision|2|||
164006196|NCT02403206|592388812|FG000|Overall Study|Reason not given|2|||
164006197|NCT02403206|592388813|FG001|Overall Study|Reason not given|4|||
164006198|NCT04070378|592388816|FG000|Overall Study|Withdrawal by Subject|2|||
164006199|NCT04070378|592388816|FG000|Overall Study|Screen Failure|6|||
164006200|NCT04070378|592388816|FG000|Overall Study|Physician Decision|1|||
164006201|NCT04070378|592388816|FG000|Overall Study|Adverse Event|1|||
164089996|NCT02581345|592693287|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
164354125|NCT04102020|593669900|FG002|Overall Study|Physician Decision|2|||
164089997|NCT02581345|592693288|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
164354126|NCT04102020|593669901|FG003|Overall Study|Physician Decision|0|||
164354127|NCT04102020|593669902|FG004|Overall Study|Physician Decision|1|||
164354128|NCT04102020|593669898|FG000|Overall Study|COVID-19 Infection|1|||
164354129|NCT04102020|593669899|FG001|Overall Study|COVID-19 Infection|0|||
164354130|NCT04102020|593669900|FG002|Overall Study|COVID-19 Infection|0|||
164354131|NCT04102020|593669901|FG003|Overall Study|COVID-19 Infection|0|||
164354132|NCT04102020|593669902|FG004|Overall Study|COVID-19 Infection|0|||
163899863|NCT03478969|592005572|FG002|Overall Study|Personal Reasons|1|||
163899864|NCT03478969|592005570|FG000|Overall Study|Covid-19|1|||
163899865|NCT03478969|592005571|FG001|Overall Study|Covid-19|4|||
163899866|NCT03478969|592005572|FG002|Overall Study|Covid-19|3|||
163899867|NCT03478969|592005570|FG000|Overall Study|Multiple Reasons|0|||
163899868|NCT03478969|592005571|FG001|Overall Study|Multiple Reasons|1|||
163899869|NCT03478969|592005572|FG002|Overall Study|Multiple Reasons|1|||
163899870|NCT03478969|592005570|FG000|Overall Study|Eligibility Criteria|0|||
163899871|NCT03478969|592005571|FG001|Overall Study|Eligibility Criteria|0|||
163899872|NCT03478969|592005572|FG002|Overall Study|Eligibility Criteria|5|||
163899873|NCT03478969|592005570|FG000|Overall Study|Lost to Follow-up|0|||
163899874|NCT03478969|592005571|FG001|Overall Study|Lost to Follow-up|0|||
163899875|NCT03478969|592005572|FG002|Overall Study|Lost to Follow-up|1|||
163899876|NCT01185600|592005573|FG000|Overall Study|Adverse Event|1|||
163899877|NCT01185600|592005574|FG001|Overall Study|Adverse Event|1|||
163899878|NCT01185600|592005573|FG000|Overall Study|Death|0|||
163899879|NCT01185600|592005574|FG001|Overall Study|Death|1|||
163899880|NCT01185600|592005573|FG000|Overall Study|Lost to Follow-up|0|||
163899881|NCT01185600|592005574|FG001|Overall Study|Lost to Follow-up|5|||
163899882|NCT01185600|592005573|FG000|Overall Study|Physician Decision|29|||
163899883|NCT01185600|592005574|FG001|Overall Study|Physician Decision|35|||
163899884|NCT01185600|592005573|FG000|Overall Study|Withdrawal by Subject|1|||
163899885|NCT01185600|592005574|FG001|Overall Study|Withdrawal by Subject|1|||
163899886|NCT01185600|592005573|FG000|Overall Study|Hold by DSMB|1|||
163899887|NCT01185600|592005574|FG001|Overall Study|Hold by DSMB|2|||
163899888|NCT05405244|592005575|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
163899889|NCT05405244|592005576|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
163899890|NCT05405244|592005575|FG000|Washout (2 Weeks)|Adverse Event|2|||
163899891|NCT05405244|592005576|FG001|Washout (2 Weeks)|Adverse Event|0|||
163899892|NCT05405244|592005575|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
163899893|NCT05405244|592005576|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
163899894|NCT00739934|592005577|FG000|Voriconazole IV|Adverse Event|6|||
163899895|NCT00739934|592005577|FG000|Voriconazole Oral|Other|3|||
163899896|NCT00754065|592005580|FG000|Overall Study|Never received treatment|12|||
163899897|NCT00754065|592005581|FG001|Overall Study|Never received treatment|2|||
163899898|NCT00754065|592005580|FG000|Overall Study|Adverse Event|19|||
163899899|NCT00754065|592005581|FG001|Overall Study|Adverse Event|25|||
163899900|NCT00754065|592005580|FG000|Overall Study|Lost to Follow-up|7|||
163899901|NCT00754065|592005581|FG001|Overall Study|Lost to Follow-up|11|||
163899902|NCT00754065|592005580|FG000|Overall Study|Protocol Violation|12|||
163899903|NCT00754065|592005581|FG001|Overall Study|Protocol Violation|10|||
163899904|NCT00754065|592005580|FG000|Overall Study|Withdrawal by Subject|4|||
163899905|NCT00754065|592005581|FG001|Overall Study|Withdrawal by Subject|5|||
163899906|NCT00754065|592005580|FG000|Overall Study|Pregnancy|6|||
163899907|NCT00754065|592005581|FG001|Overall Study|Pregnancy|0|||
163899908|NCT00754065|592005580|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
163899909|NCT00754065|592005581|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
163899910|NCT04353492|592005584|FG000|Overall Study|Subject decision|24|||
163899911|NCT04353492|592005584|FG000|Overall Study|Physician Decision|5|||
163899912|NCT04353492|592005584|FG000|Overall Study|Adverse Event|3|||
163899913|NCT04353492|592005584|FG000|Overall Study|Pregnancy|3|||
163899914|NCT04353492|592005584|FG000|Overall Study|Lost to Follow-up|2|||
163899915|NCT04353492|592005584|FG000|Overall Study|Protocol deviation|1|||
163899916|NCT04353492|592005584|FG000|Overall Study|Technical problems|1|||
163899917|NCT01952366|592005587|FG000|Overall Study|Death|22|||
163899918|NCT01952366|592005587|FG000|Overall Study|Withdrawal by Subject|9|||
163899919|NCT00623194|592005588|FG000|Overall Study|Lack of Efficacy|1|||
163899920|NCT00623194|592005588|FG000|Overall Study|Protocol Violation|3|||
163899921|NCT00623194|592005588|FG000|Overall Study|Unclassified|1|||
164089998|NCT02581345|592693289|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
163899922|NCT00857766|592005589|FG000|Overall Study|Adverse Event|13|||
163899923|NCT00857766|592005590|FG001|Overall Study|Adverse Event|12|||
163899924|NCT00857766|592005589|FG000|Overall Study|Protocol Violation|11|||
163899925|NCT00857766|592005590|FG001|Overall Study|Protocol Violation|11|||
163899926|NCT00857766|592005589|FG000|Overall Study|Lost to Follow-up|1|||
163899927|NCT00857766|592005590|FG001|Overall Study|Lost to Follow-up|0|||
163899928|NCT00857766|592005589|FG000|Overall Study|Investigator Discretion|2|||
163899929|NCT00857766|592005590|FG001|Overall Study|Investigator Discretion|3|||
163899930|NCT00857766|592005589|FG000|Overall Study|Participant Withdrew Consent|4|||
163899931|NCT00857766|592005590|FG001|Overall Study|Participant Withdrew Consent|4|||
164089999|NCT01768858|592693292|FG000|Overall Study|Lost to Follow-up|9|||
164354133|NCT04102020|593669898|FG000|Overall Study|Not disclosed|5|||
164006202|NCT02462889|592388817|FG000|Overall Study|Withdrawal by Subject|2|||
164006203|NCT02462889|592388818|FG001|Overall Study|Withdrawal by Subject|6|||
164006204|NCT02462889|592388817|FG000|Overall Study|Death|1|||
164006205|NCT02462889|592388818|FG001|Overall Study|Death|5|||
164006206|NCT04636177|592388821|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
164006207|NCT04636177|592388822|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
164006208|NCT04636177|592388821|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
164006209|NCT04636177|592388822|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
164006210|NCT04636177|592388821|FG000|Single-arm portion|Withdrawal by Subject|1|||
164006211|NCT04636177|592388822|FG001|Single-arm portion|Withdrawal by Subject|0|||
164006212|NCT04636177|592388821|FG000|Single-arm portion|Adverse Event|1|||
164006213|NCT04636177|592388822|FG001|Single-arm portion|Adverse Event|0|||
164006214|NCT05165394|592390924|FG000|Overall Study|Withdrawal by Subject|5|||
164006215|NCT05165394|592390925|FG001|Overall Study|Withdrawal by Subject|1|||
164006216|NCT05165394|592390924|FG000|Overall Study|Lost to Follow-up|1|||
164006217|NCT05165394|592390925|FG001|Overall Study|Lost to Follow-up|2|||
164006218|NCT05165394|592390924|FG000|Overall Study|Other Than Specified|0|||
164006219|NCT05165394|592390925|FG001|Overall Study|Other Than Specified|1|||
164006220|NCT03705494|592390926|FG000|Overall Study|Lost to Follow-up|2|||
164006221|NCT03705494|592390927|FG001|Overall Study|Lost to Follow-up|1|||
164006222|NCT03705494|592390926|FG000|Overall Study|Withdrawal by Subject|5|||
164006223|NCT03705494|592390927|FG001|Overall Study|Withdrawal by Subject|2|||
164006224|NCT02495077|592390928|FG000|Overall Study|Adverse Event|0|||
164006225|NCT02495077|592390929|FG001|Overall Study|Adverse Event|1|||
164006226|NCT02495077|592390930|FG002|Overall Study|Adverse Event|1|||
164006227|NCT02495077|592390931|FG003|Overall Study|Adverse Event|0|||
164006228|NCT02495077|592390928|FG000|Overall Study|Death|3|||
164006229|NCT02495077|592390929|FG001|Overall Study|Death|5|||
164006230|NCT02495077|592390930|FG002|Overall Study|Death|0|||
164006231|NCT02495077|592390931|FG003|Overall Study|Death|0|||
164006232|NCT02495077|592390928|FG000|Overall Study|Lost to Follow-up|6|||
164006233|NCT02495077|592390929|FG001|Overall Study|Lost to Follow-up|4|||
164006234|NCT02495077|592390930|FG002|Overall Study|Lost to Follow-up|0|||
164006235|NCT02495077|592390931|FG003|Overall Study|Lost to Follow-up|0|||
164006236|NCT02495077|592390928|FG000|Overall Study|Physician Decision|2|||
164006237|NCT02495077|592390929|FG001|Overall Study|Physician Decision|1|||
164006238|NCT02495077|592390930|FG002|Overall Study|Physician Decision|4|||
164006239|NCT02495077|592390931|FG003|Overall Study|Physician Decision|0|||
164354134|NCT04102020|593669899|FG001|Overall Study|Not disclosed|3|||
164354135|NCT04102020|593669900|FG002|Overall Study|Not disclosed|8|||
164354136|NCT04102020|593669901|FG003|Overall Study|Not disclosed|0|||
164354137|NCT04102020|593669902|FG004|Overall Study|Not disclosed|1|||
164354138|NCT04102020|593669898|FG000|Overall Study|MIssing|1|||
164354139|NCT04102020|593669899|FG001|Overall Study|MIssing|0|||
164354140|NCT04102020|593669900|FG002|Overall Study|MIssing|1|||
164354141|NCT04102020|593669901|FG003|Overall Study|MIssing|1|||
164354142|NCT04102020|593669902|FG004|Overall Study|MIssing|1|||
164354143|NCT04102020|593669898|FG000|Overall Study|Continuing in ongoing study|13|||
164354144|NCT04102020|593669899|FG001|Overall Study|Continuing in ongoing study|13|||
164354145|NCT04102020|593669900|FG002|Overall Study|Continuing in ongoing study|7|||
164354146|NCT04102020|593669901|FG003|Overall Study|Continuing in ongoing study|26|||
164354147|NCT04102020|593669902|FG004|Overall Study|Continuing in ongoing study|12|||
164354148|NCT04853225|593669903|FG000|Overall Study|Withdrawal by Subject|81|||
164354149|NCT04853225|593669904|FG001|Overall Study|Withdrawal by Subject|4|||
164354150|NCT04853225|593669905|FG002|Overall Study|Withdrawal by Subject|1|||
164354151|NCT04853225|593669903|FG000|Overall Study|Physician Decision|12|||
164354152|NCT04853225|593669904|FG001|Overall Study|Physician Decision|4|||
164354153|NCT04853225|593669905|FG002|Overall Study|Physician Decision|1|||
164354154|NCT04853225|593669903|FG000|Overall Study|Lost to Follow-up|50|||
164006240|NCT02495077|592390928|FG000|Overall Study|Protocol Violation|0|||
164354155|NCT04853225|593669904|FG001|Overall Study|Lost to Follow-up|0|||
164354156|NCT04853225|593669905|FG002|Overall Study|Lost to Follow-up|0|||
164354157|NCT04853225|593669903|FG000|Overall Study|Other|102|||
164006241|NCT02495077|592390929|FG001|Overall Study|Protocol Violation|1|||
164006242|NCT02495077|592390930|FG002|Overall Study|Protocol Violation|0|||
164006243|NCT02495077|592390931|FG003|Overall Study|Protocol Violation|0|||
164006244|NCT02495077|592390928|FG000|Overall Study|Screen Failure|0|||
164006245|NCT02495077|592390929|FG001|Overall Study|Screen Failure|0|||
164006246|NCT02495077|592390930|FG002|Overall Study|Screen Failure|0|||
164006247|NCT02495077|592390931|FG003|Overall Study|Screen Failure|48|||
164006248|NCT02495077|592390928|FG000|Overall Study|Withdrawal by Subject|7|||
164006249|NCT02495077|592390929|FG001|Overall Study|Withdrawal by Subject|7|||
164006250|NCT02495077|592390930|FG002|Overall Study|Withdrawal by Subject|7|||
164006251|NCT02495077|592390931|FG003|Overall Study|Withdrawal by Subject|0|||
164354158|NCT04853225|593669904|FG001|Overall Study|Other|11|||
164354159|NCT04853225|593669905|FG002|Overall Study|Other|5|||
164354160|NCT04853225|593669903|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
164354161|NCT04853225|593669904|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
164354162|NCT04853225|593669905|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
164354163|NCT04853225|593669903|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
164354164|NCT04853225|593669904|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
164354165|NCT04853225|593669905|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
164354166|NCT03789318|593669906|FG000|Overall Study|Adverse Event|0|||
164354167|NCT03789318|593669907|FG001|Overall Study|Adverse Event|0|||
164354168|NCT03789318|593669908|FG002|Overall Study|Adverse Event|1|||
164354169|NCT03789318|593669909|FG003|Overall Study|Adverse Event|1|||
164354170|NCT03789318|593669910|FG004|Overall Study|Adverse Event|0|||
164354171|NCT03789318|593669906|FG000|Overall Study|Lost to Follow-up|0|||
164354172|NCT03789318|593669907|FG001|Overall Study|Lost to Follow-up|0|||
164354173|NCT03789318|593669908|FG002|Overall Study|Lost to Follow-up|1|||
164354174|NCT03789318|593669909|FG003|Overall Study|Lost to Follow-up|0|||
164354175|NCT03789318|593669910|FG004|Overall Study|Lost to Follow-up|0|||
164354176|NCT03789318|593669906|FG000|Overall Study|Withdrawal by Subject|0|||
164354177|NCT03789318|593669907|FG001|Overall Study|Withdrawal by Subject|0|||
164354178|NCT03789318|593669908|FG002|Overall Study|Withdrawal by Subject|1|||
164354179|NCT03789318|593669909|FG003|Overall Study|Withdrawal by Subject|0|||
164354180|NCT03789318|593669910|FG004|Overall Study|Withdrawal by Subject|0|||
164354181|NCT01463878|593672278|FG000|Overall Study|no longer met criteria for tube feed|2|||
164354182|NCT01463878|593672279|FG001|Overall Study|no longer met criteria for tube feed|2|||
164354183|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Death|3|||
164354184|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Death|3|||
164354185|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Death|0|||
164354186|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Death|0|||
164354187|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
164354188|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
164354189|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
164354190|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
164354191|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
164354192|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
164354193|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
164354194|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
164354195|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
164354196|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
164354197|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
164354198|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
164354199|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
164354200|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
164354201|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
164354202|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
164354203|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
164354204|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
164354205|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
164354206|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
164006252|NCT02495077|592390928|FG000|Overall Study|Covid-19 research restrictions|1|||
164006253|NCT02495077|592390929|FG001|Overall Study|Covid-19 research restrictions|0|||
164006254|NCT02495077|592390930|FG002|Overall Study|Covid-19 research restrictions|0|||
164006255|NCT02495077|592390931|FG003|Overall Study|Covid-19 research restrictions|0|||
164006256|NCT02495077|592390928|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
164006257|NCT02495077|592390929|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
164006258|NCT02495077|592390930|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
164006259|NCT02495077|592390931|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
164006260|NCT02495077|592390928|FG000|Overall Study|Incarcerated|0|||
164006261|NCT02495077|592390929|FG001|Overall Study|Incarcerated|1|||
164354207|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
164354208|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
164354209|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
164354210|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
164354211|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Other|6|||
164354212|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Other|3|||
164354213|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Other|0|||
164006262|NCT02495077|592390930|FG002|Overall Study|Incarcerated|0|||
164006263|NCT02495077|592390931|FG003|Overall Study|Incarcerated|0|||
164354214|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Other|0|||
164354215|NCT02051608|593672282|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
164006264|NCT02495077|592390928|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
164006265|NCT02495077|592390929|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
164354216|NCT02051608|593672283|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
164354217|NCT02051608|593672284|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
164354218|NCT02051608|593672285|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
164354219|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Adverse Event|0|||
164354220|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Adverse Event|0|||
164354221|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Adverse Event|6|||
164354222|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Adverse Event|8|||
164354223|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Death|0|||
164354224|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Death|0|||
164354225|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Death|7|||
164354226|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Death|4|||
164354227|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
164354228|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
164354229|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
164354230|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
164354231|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
164354232|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
164354233|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
164354234|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
164354235|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164354236|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164354237|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
164354238|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
164354239|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
164354240|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
164354241|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
164354242|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
164354243|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Physician Decision|0|||
164354244|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Physician Decision|0|||
164354245|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Physician Decision|8|||
164354246|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Physician Decision|5|||
164354247|NCT02051608|593672282|FG000|Part 2: Open-label Extension|Other|0|||
164354248|NCT02051608|593672283|FG001|Part 2: Open-label Extension|Other|0|||
164354249|NCT02051608|593672284|FG002|Part 2: Open-label Extension|Other|9|||
164354250|NCT02051608|593672285|FG003|Part 2: Open-label Extension|Other|9|||
164354251|NCT00142584|593672286|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
164354252|NCT00142584|593672287|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
164354253|NCT00142584|593672286|FG000|Overall Study|Withdrawal by Subject|30|||
164354254|NCT00142584|593672287|FG001|Overall Study|Withdrawal by Subject|16|||
164354255|NCT00142584|593672286|FG000|Overall Study|Lost to Follow-up|22|||
164354256|NCT00142584|593672287|FG001|Overall Study|Lost to Follow-up|12|||
164354257|NCT00142584|593672286|FG000|Overall Study|Adverse Event|14|||
164354258|NCT00142584|593672287|FG001|Overall Study|Adverse Event|5|||
164354259|NCT00142584|593672286|FG000|Overall Study|Protocol Violation|4|||
164354260|NCT00142584|593672287|FG001|Overall Study|Protocol Violation|7|||
164354261|NCT00142584|593672286|FG000|Overall Study|Treatment Failure|2|||
164354262|NCT00142584|593672287|FG001|Overall Study|Treatment Failure|0|||
164354263|NCT01083576|593672288|FG000|Overall Study|Treatment Failure|6|||
164354264|NCT01083576|593672289|FG001|Overall Study|Treatment Failure|1|||
164354265|NCT01986985|593672290|FG000|Overall Study|Withdrawal by Subject|4|||
164354266|NCT01986985|593672290|FG000|Overall Study|Scan not completed due to malfunction|3|||
164354267|NCT00449540|593672291|FG000|Pretreatment Phase|No migraine experienced|66|||
164354268|NCT00449540|593672292|FG001|Pretreatment Phase|No migraine experienced|0|||
164354269|NCT00449540|593672293|FG002|Pretreatment Phase|No migraine experienced|0|||
164354270|NCT00449540|593672291|FG000|Treatment Phase|did not experience or treat migraine|0|||
164354271|NCT00449540|593672292|FG001|Treatment Phase|did not experience or treat migraine|20|||
164354272|NCT00449540|593672293|FG002|Treatment Phase|did not experience or treat migraine|17|||
164354273|NCT04577118|593672294|FG000|Overall Study|Withdrawal by Subject|4|||
164354274|NCT02036294|593672295|FG000|Overall Study|Death|7|||
164354275|NCT02036294|593672296|FG001|Overall Study|Death|8|||
164354276|NCT02036294|593672295|FG000|Overall Study|Withdrawal by Subject|2|||
164354277|NCT02036294|593672296|FG001|Overall Study|Withdrawal by Subject|3|||
164354278|NCT00356369|593672297|FG000|Active Phase|Withdrawal by Subject|2|||
164354279|NCT00356369|593672298|FG001|Active Phase|Withdrawal by Subject|1|||
164354280|NCT00673465|593672301|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354281|NCT00673465|593672302|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354282|NCT00673465|593672303|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354283|NCT00673465|593672304|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354284|NCT00673465|593672305|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
164354285|NCT00673465|593672306|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
164354286|NCT00673465|593672307|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
164006266|NCT02495077|592390930|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
164006267|NCT02495077|592390931|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
164006268|NCT02495077|592390928|FG000|Overall Study|Timing of transplant and randomization|0|||
164006269|NCT02495077|592390929|FG001|Overall Study|Timing of transplant and randomization|0|||
164006270|NCT02495077|592390930|FG002|Overall Study|Timing of transplant and randomization|5|||
164006271|NCT02495077|592390931|FG003|Overall Study|Timing of transplant and randomization|0|||
164090000|NCT01768858|592693292|FG000|Overall Study|Lack of Efficacy|8|||
164354287|NCT00673465|593672308|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354288|NCT00673465|593672309|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354289|NCT00673465|593672310|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354290|NCT00673465|593672311|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354291|NCT00673465|593672312|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
164354292|NCT00673465|593672301|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354293|NCT00673465|593672302|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354294|NCT00673465|593672303|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354295|NCT00673465|593672304|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354296|NCT00673465|593672305|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
164354297|NCT00673465|593672306|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354298|NCT00673465|593672307|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354299|NCT00673465|593672308|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354300|NCT00673465|593672309|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354301|NCT00673465|593672310|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354302|NCT00673465|593672311|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354303|NCT00673465|593672312|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
164354304|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
164354305|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
164354306|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
164354307|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
164354308|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
164354309|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
164354310|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
164354311|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
164354312|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
164354313|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
164354314|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
164354315|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
164354316|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
164354317|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
164354318|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
164354319|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
164354320|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
164354321|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
164354322|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
164354323|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
164354324|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
164354325|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
164354326|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
164354327|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
164354328|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
164354329|NCT01285310|593672313|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
164354330|NCT01285310|593672314|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
164354331|NCT01285310|593672315|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
164354332|NCT01285310|593672316|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
164354333|NCT01285310|593672317|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
164354334|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
164354335|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
164354336|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
164354337|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
164354338|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
164354339|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
164354340|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
164354341|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
164354342|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
164354343|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
164354344|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
164354345|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
164354346|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
164354347|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
164354348|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
164354349|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
164354350|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
164354351|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
164354352|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
164354353|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
164354354|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
164354355|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
164354356|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
164354357|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
164354358|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
164354359|NCT01285310|593672313|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
164354360|NCT01285310|593672314|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
164354361|NCT01285310|593672315|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
164354362|NCT01285310|593672316|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
164354363|NCT01285310|593672317|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
164354364|NCT00514540|593672318|FG000|First-Line Chemo|Withdrawal by Subject|1|||
164354365|NCT00514540|593672318|FG000|First-Line Chemo|Protocol Violation|7|||
164354366|NCT00514540|593672318|FG000|Second-Line|Physician/Patient Decision|31|||
164354367|NCT01996982|593672321|FG000|Overall Study|PI/team left institution|7|||
164354368|NCT01195415|593672340|FG000|Overall Study|No repeat biopsy due to progression|2|||
164354369|NCT01919723|593672341|FG000|Overall Study|Blood Samples Hemolyzed|2|||
164354370|NCT01919723|593672342|FG001|Overall Study|Blood Samples Hemolyzed|2|||
164354371|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
164354372|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
164354373|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
164354374|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
164354375|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
164354376|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
164354377|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
164354378|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
164354379|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
164354380|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
164354381|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Death|2|||
164354382|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Death|1|||
164354383|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Death|4|||
164354384|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Death|0|||
164354385|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Death|0|||
164354386|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
164354387|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
164354388|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
164354389|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
164354390|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
164354391|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Other Reason|1|||
164354392|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Other Reason|3|||
164354393|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Other Reason|2|||
164354394|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Other Reason|0|||
164354395|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Other Reason|0|||
164354396|NCT00555321|593672343|FG000|Treatment Phase up to 12-months|Never treated|2|||
164354397|NCT00555321|593672344|FG001|Treatment Phase up to 12-months|Never treated|3|||
164006272|NCT02742649|592390932|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
164006273|NCT02742649|592390933|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164006274|NCT02742649|592390934|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164006275|NCT02742649|592390935|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164006276|NCT02742649|592390936|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
164006277|NCT02742649|592390932|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164354398|NCT00555321|593672345|FG002|Treatment Phase up to 12-months|Never treated|1|||
164354399|NCT00555321|593672346|FG003|Treatment Phase up to 12-months|Never treated|0|||
164354400|NCT00555321|593672347|FG004|Treatment Phase up to 12-months|Never treated|4|||
164354401|NCT00555321|593672343|FG000|Long-term Extension Phase|Adverse Event|2|||
164354402|NCT00555321|593672344|FG001|Long-term Extension Phase|Adverse Event|5|||
164354403|NCT00555321|593672345|FG002|Long-term Extension Phase|Adverse Event|2|||
164354404|NCT00555321|593672346|FG003|Long-term Extension Phase|Adverse Event|1|||
164354405|NCT00555321|593672347|FG004|Long-term Extension Phase|Adverse Event|0|||
164354406|NCT00555321|593672343|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
164354407|NCT00555321|593672344|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
164354408|NCT00555321|593672345|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
164354409|NCT00555321|593672346|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
164354410|NCT00555321|593672347|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
164354411|NCT00555321|593672343|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
164354412|NCT00555321|593672344|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
164354413|NCT00555321|593672345|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
164354414|NCT00555321|593672346|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
164354415|NCT00555321|593672347|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
164354416|NCT00555321|593672343|FG000|Long-term Extension Phase|Death|2|||
164354417|NCT00555321|593672344|FG001|Long-term Extension Phase|Death|0|||
164354418|NCT00555321|593672345|FG002|Long-term Extension Phase|Death|0|||
164354419|NCT00555321|593672346|FG003|Long-term Extension Phase|Death|3|||
164354420|NCT00555321|593672347|FG004|Long-term Extension Phase|Death|0|||
164354421|NCT00555321|593672343|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354422|NCT00555321|593672344|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354423|NCT00555321|593672345|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354424|NCT00555321|593672346|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
164354425|NCT00555321|593672347|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
164354426|NCT00555321|593672343|FG000|Long-term Extension Phase|Other Reason|1|||
164354427|NCT00555321|593672344|FG001|Long-term Extension Phase|Other Reason|0|||
164354428|NCT00555321|593672345|FG002|Long-term Extension Phase|Other Reason|2|||
164006278|NCT02742649|592390933|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164006279|NCT02742649|592390934|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164006280|NCT02742649|592390935|FG003|Double-Blind Treatment Period|Adverse Event|0|||
164006281|NCT02742649|592390936|FG004|Double-Blind Treatment Period|Adverse Event|0|||
164006282|NCT02742649|592390932|FG000|Open-Label Period|Lost to Follow-up|0|||
164006283|NCT02742649|592390933|FG001|Open-Label Period|Lost to Follow-up|0|||
164354429|NCT00555321|593672346|FG003|Long-term Extension Phase|Other Reason|0|||
164354430|NCT00555321|593672347|FG004|Long-term Extension Phase|Other Reason|0|||
164354431|NCT04294472|593672348|FG000|Overall Study|Adverse Event|0|||
164354432|NCT04294472|593672349|FG001|Overall Study|Adverse Event|1|||
164354433|NCT04294472|593672350|FG002|Overall Study|Adverse Event|1|||
164354434|NCT04294472|593672348|FG000|Overall Study|Randomized but not treated|0|||
164354435|NCT04294472|593672349|FG001|Overall Study|Randomized but not treated|1|||
164090001|NCT01768858|592693292|FG000|Overall Study|Serious Adverse Event|1|||
164354436|NCT04294472|593672350|FG002|Overall Study|Randomized but not treated|1|||
164354437|NCT00563381|593672351|FG000|Overall Study|Adverse Event|264|||
164354438|NCT00563381|593672352|FG001|Overall Study|Adverse Event|292|||
164354439|NCT00563381|593672351|FG000|Overall Study|Protocol Violation|66|||
164006284|NCT02742649|592390934|FG002|Open-Label Period|Lost to Follow-up|0|||
164006285|NCT02742649|592390935|FG003|Open-Label Period|Lost to Follow-up|0|||
164354440|NCT00563381|593672352|FG001|Overall Study|Protocol Violation|74|||
164354441|NCT00563381|593672351|FG000|Overall Study|Lost to Follow-up|7|||
164354442|NCT00563381|593672352|FG001|Overall Study|Lost to Follow-up|15|||
164133184|NCT04126213|592852704|FG005|Overall Study|Other|1|||
163899932|NCT01988402|592005591|FG000|Overall Study|Adverse Event|1|||
163899933|NCT01988402|592005592|FG001|Overall Study|Adverse Event|2|||
163899934|NCT01988402|592005591|FG000|Overall Study|Withdrawal by Subject|1|||
163899935|NCT01988402|592005592|FG001|Overall Study|Withdrawal by Subject|0|||
163899936|NCT01961609|592005593|FG000|Initiation|Missing|3|||
163899937|NCT01961609|592005594|FG001|Initiation|Missing|2|||
163899938|NCT01961609|592005595|FG002|Initiation|Missing|0|||
163899939|NCT01961609|592005596|FG003|Initiation|Missing|0|||
163899940|NCT01961609|592005593|FG000|Initiation|Protocol deviation|1|||
163899941|NCT01961609|592005594|FG001|Initiation|Protocol deviation|0|||
163899942|NCT01961609|592005595|FG002|Initiation|Protocol deviation|0|||
163899943|NCT01961609|592005596|FG003|Initiation|Protocol deviation|0|||
163899944|NCT01961609|592005593|FG000|Initiation|Death|0|||
163899945|NCT01961609|592005594|FG001|Initiation|Death|1|||
163899946|NCT01961609|592005595|FG002|Initiation|Death|0|||
163899947|NCT01961609|592005596|FG003|Initiation|Death|0|||
163899948|NCT01961609|592005593|FG000|Initiation|Administrative problems|1|||
163899949|NCT01961609|592005594|FG001|Initiation|Administrative problems|0|||
163899950|NCT01961609|592005595|FG002|Initiation|Administrative problems|0|||
163899951|NCT01961609|592005596|FG003|Initiation|Administrative problems|0|||
163899952|NCT01961609|592005593|FG000|Initiation|Withdrawal by Subject|1|||
163899953|NCT01961609|592005594|FG001|Initiation|Withdrawal by Subject|2|||
163899954|NCT01961609|592005595|FG002|Initiation|Withdrawal by Subject|0|||
163899955|NCT01961609|592005596|FG003|Initiation|Withdrawal by Subject|0|||
163899956|NCT01961609|592005593|FG000|Initiation|Lack of Efficacy|2|||
163899957|NCT01961609|592005594|FG001|Initiation|Lack of Efficacy|1|||
163899958|NCT01961609|592005595|FG002|Initiation|Lack of Efficacy|0|||
163899959|NCT01961609|592005596|FG003|Initiation|Lack of Efficacy|0|||
163899960|NCT01961609|592005593|FG000|Initiation|Abnormal lab values|0|||
163899961|NCT01961609|592005594|FG001|Initiation|Abnormal lab values|1|||
163899962|NCT01961609|592005595|FG002|Initiation|Abnormal lab values|0|||
163899963|NCT01961609|592005596|FG003|Initiation|Abnormal lab values|0|||
163899964|NCT01961609|592005593|FG000|Initiation|Adverse Event|3|||
163899965|NCT01961609|592005594|FG001|Initiation|Adverse Event|5|||
163899966|NCT01961609|592005595|FG002|Initiation|Adverse Event|0|||
163899967|NCT01961609|592005596|FG003|Initiation|Adverse Event|0|||
163899968|NCT01961609|592005593|FG000|Initiation|Randomized but not treated|1|||
163899969|NCT01961609|592005594|FG001|Initiation|Randomized but not treated|1|||
163899970|NCT01961609|592005595|FG002|Initiation|Randomized but not treated|0|||
163899971|NCT01961609|592005596|FG003|Initiation|Randomized but not treated|0|||
164090002|NCT01768858|592693292|FG000|Overall Study|Participant moved to Germany|1|||
164090003|NCT01768858|592693292|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
164090004|NCT01768858|592693292|FG000|Overall Study|Exanthema|1|||
164299427|NCT05386329|593471343|FG000|Overall Study|Lost to Follow-up|3|||
163899972|NCT01961609|592005593|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
163899973|NCT01961609|592005594|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
163899974|NCT01961609|592005595|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
163899975|NCT01961609|592005596|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
163899976|NCT01961609|592005593|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
163899977|NCT01961609|592005594|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
164299428|NCT03043313|593471346|FG000|Overall Study|Withdrawal by Subject|5|||
164299429|NCT03043313|593471347|FG001|Overall Study|Withdrawal by Subject|1|||
164299430|NCT03043313|593471348|FG002|Overall Study|Withdrawal by Subject|1|||
164299431|NCT03043313|593471346|FG000|Overall Study|Lost to Follow-up|1|||
164299432|NCT03043313|593471347|FG001|Overall Study|Lost to Follow-up|1|||
164299433|NCT03043313|593471348|FG002|Overall Study|Lost to Follow-up|0|||
164299434|NCT03043313|593471346|FG000|Overall Study|Death|28|||
164299435|NCT03043313|593471347|FG001|Overall Study|Death|26|||
164299436|NCT03043313|593471348|FG002|Overall Study|Death|17|||
164299437|NCT03043313|593471346|FG000|Overall Study|Participation terminated by sponsor|11|||
164299438|NCT03043313|593471347|FG001|Overall Study|Participation terminated by sponsor|13|||
164299439|NCT03043313|593471348|FG002|Overall Study|Participation terminated by sponsor|13|||
164299440|NCT04973449|593471351|FG000|Overall Study|Withdrawal by Subject|3|||
164299441|NCT04973449|593471352|FG001|Overall Study|Withdrawal by Subject|3|||
164299442|NCT04973449|593471353|FG002|Overall Study|Withdrawal by Subject|2|||
164299443|NCT04973449|593471354|FG003|Overall Study|Withdrawal by Subject|5|||
164299444|NCT04973449|593471355|FG004|Overall Study|Withdrawal by Subject|5|||
164299445|NCT04973449|593471356|FG005|Overall Study|Withdrawal by Subject|4|||
164299446|NCT04973449|593471357|FG006|Overall Study|Withdrawal by Subject|7|||
164299447|NCT04973449|593471358|FG007|Overall Study|Withdrawal by Subject|5|||
164299448|NCT04973449|593471351|FG000|Overall Study|Lost to Follow-up|15|||
164299449|NCT04973449|593471352|FG001|Overall Study|Lost to Follow-up|16|||
164299450|NCT04973449|593471353|FG002|Overall Study|Lost to Follow-up|16|||
163899978|NCT01961609|592005595|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
163899979|NCT01961609|592005596|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
164090005|NCT01768858|592693292|FG000|Overall Study|Withdrawal by Subject|1|||
164299451|NCT04973449|593471354|FG003|Overall Study|Lost to Follow-up|13|||
164299452|NCT04973449|593471355|FG004|Overall Study|Lost to Follow-up|5|||
164354443|NCT00563381|593672351|FG000|Overall Study|Withdrawal by Subject|192|||
164354444|NCT00563381|593672352|FG001|Overall Study|Withdrawal by Subject|209|||
164354445|NCT00563381|593672351|FG000|Overall Study|Lack of Efficacy|32|||
164354446|NCT00563381|593672352|FG001|Overall Study|Lack of Efficacy|24|||
164354447|NCT00563381|593672351|FG000|Overall Study|Individual different reasons|24|||
164354448|NCT00563381|593672352|FG001|Overall Study|Individual different reasons|34|||
164354449|NCT01957644|593672353|FG000|Overall Study|Adverse Event|4|||
164354450|NCT01957644|593672354|FG001|Overall Study|Adverse Event|2|||
164354451|NCT01957644|593672355|FG002|Overall Study|Adverse Event|0|||
164354452|NCT01957644|593672356|FG003|Overall Study|Adverse Event|0|||
164354453|NCT01957644|593672357|FG004|Overall Study|Adverse Event|1|||
164354454|NCT01957644|593672353|FG000|Overall Study|Progressive disease / relapse|0|||
164354455|NCT01957644|593672354|FG001|Overall Study|Progressive disease / relapse|1|||
164354456|NCT01957644|593672355|FG002|Overall Study|Progressive disease / relapse|0|||
164354457|NCT01957644|593672356|FG003|Overall Study|Progressive disease / relapse|1|||
164354458|NCT01957644|593672357|FG004|Overall Study|Progressive disease / relapse|0|||
164354459|NCT01957644|593672353|FG000|Overall Study|Other reason|1|||
164354460|NCT01957644|593672354|FG001|Overall Study|Other reason|2|||
164354461|NCT01957644|593672355|FG002|Overall Study|Other reason|1|||
164354462|NCT01957644|593672356|FG003|Overall Study|Other reason|1|||
164354463|NCT01957644|593672357|FG004|Overall Study|Other reason|0|||
164354464|NCT01957644|593672353|FG000|Overall Study|Withdrawal by Subject|1|||
164354465|NCT01957644|593672354|FG001|Overall Study|Withdrawal by Subject|0|||
164354466|NCT01957644|593672355|FG002|Overall Study|Withdrawal by Subject|0|||
164354467|NCT01957644|593672356|FG003|Overall Study|Withdrawal by Subject|0|||
164354468|NCT01957644|593672357|FG004|Overall Study|Withdrawal by Subject|0|||
164354469|NCT01957644|593672353|FG000|Overall Study|Protocol Violation|0|||
164354470|NCT01957644|593672354|FG001|Overall Study|Protocol Violation|1|||
164354471|NCT01957644|593672355|FG002|Overall Study|Protocol Violation|0|||
164354472|NCT01957644|593672356|FG003|Overall Study|Protocol Violation|0|||
164354473|NCT01957644|593672357|FG004|Overall Study|Protocol Violation|0|||
164354474|NCT04044716|593672358|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
164354475|NCT04044716|593672359|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
164354476|NCT04044716|593672360|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
164354477|NCT04044716|593672358|FG000|Overall Study|Lost to Follow-up|2|||
164354478|NCT04044716|593672359|FG001|Overall Study|Lost to Follow-up|3|||
164354479|NCT04044716|593672360|FG002|Overall Study|Lost to Follow-up|0|||
164354480|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
164354481|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
164354482|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
164354483|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
164354484|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
164354485|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
164354486|NCT01957553|593672361|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
164354487|NCT01957553|593672362|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
164354488|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
164354489|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
164354490|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
164354491|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
164354492|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
164354493|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
164354494|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
164354495|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
164354496|NCT01957553|593672361|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
164354497|NCT01957553|593672362|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
164354498|NCT01348347|593672363|FG000|Overall Study|Withdrawal by Subject|1|||
164354499|NCT01348347|593672364|FG001|Overall Study|Withdrawal by Subject|1|||
164354500|NCT01348347|593672365|FG002|Overall Study|Withdrawal by Subject|1|||
164354501|NCT01348347|593672363|FG000|Overall Study|Progressive disease|2|||
164354502|NCT01348347|593672364|FG001|Overall Study|Progressive disease|5|||
164354503|NCT01348347|593672365|FG002|Overall Study|Progressive disease|5|||
164354504|NCT00996307|593672375|FG000|Overall Study|Adverse Event|0|||
164354505|NCT00996307|593672376|FG001|Overall Study|Adverse Event|1|||
164354506|NCT00996307|593672377|FG002|Overall Study|Adverse Event|0|||
164354507|NCT00996307|593672378|FG003|Overall Study|Adverse Event|0|||
164354508|NCT00996307|593672375|FG000|Overall Study|Withdrawal by Subject|3|||
164354509|NCT00996307|593672376|FG001|Overall Study|Withdrawal by Subject|2|||
164354510|NCT00996307|593672377|FG002|Overall Study|Withdrawal by Subject|5|||
164354511|NCT00996307|593672378|FG003|Overall Study|Withdrawal by Subject|5|||
164354512|NCT00996307|593672375|FG000|Overall Study|Lost to Follow-up|13|||
164354513|NCT00996307|593672376|FG001|Overall Study|Lost to Follow-up|13|||
164006286|NCT02742649|592390936|FG004|Open-Label Period|Lost to Follow-up|1|||
164006287|NCT03937986|592390937|FG000|Overall Study|COVID-19 Pandemic|1|||
164006288|NCT02839746|592390938|FG000|Overall Study|Not met selection criteria|12|||
164006289|NCT02333331|592390939|FG000|Overall Study|Adverse Event|1|||
164006290|NCT02333331|592390940|FG001|Overall Study|Adverse Event|0|||
164006291|NCT02333331|592390941|FG002|Overall Study|Adverse Event|4|||
164006292|NCT02333331|592390942|FG003|Overall Study|Adverse Event|1|||
164006293|NCT02333331|592390939|FG000|Overall Study|Death|0|||
164006294|NCT02333331|592390940|FG001|Overall Study|Death|0|||
164006295|NCT02333331|592390941|FG002|Overall Study|Death|2|||
164006296|NCT02333331|592390942|FG003|Overall Study|Death|0|||
164006297|NCT02333331|592390939|FG000|Overall Study|Lost to Follow-up|0|||
164006298|NCT02333331|592390940|FG001|Overall Study|Lost to Follow-up|0|||
164006299|NCT02333331|592390941|FG002|Overall Study|Lost to Follow-up|1|||
164006300|NCT02333331|592390942|FG003|Overall Study|Lost to Follow-up|0|||
164006301|NCT02333331|592390939|FG000|Overall Study|Physician Decision|0|||
164006302|NCT02333331|592390940|FG001|Overall Study|Physician Decision|1|||
164006303|NCT02333331|592390941|FG002|Overall Study|Physician Decision|0|||
164006304|NCT02333331|592390942|FG003|Overall Study|Physician Decision|0|||
164006305|NCT02333331|592390939|FG000|Overall Study|Protocol Deviation|0|||
164006306|NCT02333331|592390940|FG001|Overall Study|Protocol Deviation|3|||
164006307|NCT02333331|592390941|FG002|Overall Study|Protocol Deviation|2|||
164006308|NCT02333331|592390942|FG003|Overall Study|Protocol Deviation|1|||
164006309|NCT02333331|592390939|FG000|Overall Study|Patient/Guardian Decision|1|||
164006310|NCT02333331|592390940|FG001|Overall Study|Patient/Guardian Decision|2|||
164006311|NCT02333331|592390941|FG002|Overall Study|Patient/Guardian Decision|9|||
164006312|NCT02333331|592390942|FG003|Overall Study|Patient/Guardian Decision|1|||
164006313|NCT01494038|592390943|FG000|Overall Study|Protocol Violation|1|||
164006314|NCT01494038|592390944|FG001|Overall Study|Protocol Violation|1|||
164006315|NCT01494038|592390943|FG000|Overall Study|Lost to Follow-up|18|||
164006316|NCT01494038|592390944|FG001|Overall Study|Lost to Follow-up|20|||
164006317|NCT01494038|592390943|FG000|Overall Study|Withdrawal by Subject|44|||
164006318|NCT01494038|592390944|FG001|Overall Study|Withdrawal by Subject|34|||
164006319|NCT01494038|592390943|FG000|Overall Study|Not able to get to clinic|21|||
164006320|NCT01494038|592390944|FG001|Overall Study|Not able to get to clinic|15|||
164006321|NCT01494038|592390943|FG000|Overall Study|Not willing to adhere to reqs|2|||
164006322|NCT01494038|592390944|FG001|Overall Study|Not willing to adhere to reqs|9|||
164006323|NCT01494038|592390943|FG000|Overall Study|Death|2|||
164006324|NCT01494038|592390944|FG001|Overall Study|Death|4|||
164006325|NCT00537940|592390945|FG000|Overall Study|Adverse Event|20|||
164006326|NCT00537940|592390946|FG001|Overall Study|Adverse Event|19|||
164006327|NCT00537940|592390945|FG000|Overall Study|Lack of Efficacy|8|||
164006328|NCT00537940|592390946|FG001|Overall Study|Lack of Efficacy|16|||
164006329|NCT00537940|592390945|FG000|Overall Study|Lost to Follow-up|23|||
164006330|NCT00537940|592390946|FG001|Overall Study|Lost to Follow-up|29|||
164006331|NCT00537940|592390945|FG000|Overall Study|Withdrawal by Subject|113|||
164006332|NCT00537940|592390946|FG001|Overall Study|Withdrawal by Subject|95|||
164006333|NCT00537940|592390945|FG000|Overall Study|Protocol Violation|6|||
164354514|NCT00996307|593672377|FG002|Overall Study|Lost to Follow-up|7|||
164354515|NCT00996307|593672378|FG003|Overall Study|Lost to Follow-up|15|||
164354516|NCT00996307|593672375|FG000|Overall Study|Administrative reason|0|||
164354517|NCT00996307|593672376|FG001|Overall Study|Administrative reason|1|||
164354518|NCT00996307|593672377|FG002|Overall Study|Administrative reason|0|||
164354519|NCT00996307|593672378|FG003|Overall Study|Administrative reason|0|||
164354520|NCT00996307|593672375|FG000|Overall Study|Unable to classify|4|||
164354521|NCT00996307|593672376|FG001|Overall Study|Unable to classify|0|||
164354522|NCT00996307|593672377|FG002|Overall Study|Unable to classify|2|||
164354523|NCT00996307|593672378|FG003|Overall Study|Unable to classify|1|||
164354524|NCT02788357|593672379|FG000|Overall Study|Lost to Follow-up|3|||
164354525|NCT02788357|593672380|FG001|Overall Study|Lost to Follow-up|0|||
164354526|NCT00640601|593672381|FG000|Overall Study|Adverse Event|43|||
164354527|NCT00640601|593672381|FG000|Overall Study|Withdrawal by Subject|20|||
164354528|NCT00640601|593672381|FG000|Overall Study|Protocol Violation|6|||
164354529|NCT00640601|593672381|FG000|Overall Study|Lack of Efficacy|16|||
164006334|NCT00537940|592390946|FG001|Overall Study|Protocol Violation|4|||
164006335|NCT00537940|592390945|FG000|Overall Study|Pregnancy|1|||
164006336|NCT00537940|592390946|FG001|Overall Study|Pregnancy|1|||
164354530|NCT00640601|593672381|FG000|Overall Study|Lost to Follow-up|9|||
164354531|NCT00640601|593672381|FG000|Overall Study|Physician Decision|8|||
164354532|NCT00640601|593672381|FG000|Overall Study|treatment naive, combination therapy|10|||
164354533|NCT03198234|593672382|FG000|Overall Study|Relapse of primary disease|0|||
164354534|NCT03198234|593672383|FG001|Overall Study|Relapse of primary disease|1|||
164006337|NCT00537940|592390945|FG000|Overall Study|Study terminated by sponsor|2|||
164006338|NCT00537940|592390946|FG001|Overall Study|Study terminated by sponsor|3|||
164006339|NCT00537940|592390945|FG000|Overall Study|Other|10|||
164006340|NCT00537940|592390946|FG001|Overall Study|Other|12|||
164006341|NCT02138110|592390957|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
164006342|NCT02138110|592390957|FG000|Overall Scaffold Implantation|Death|3|||
164006343|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
164006344|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
164354535|NCT03198234|593672384|FG002|Overall Study|Relapse of primary disease|0|||
164354536|NCT00165776|593672386|FG000|Overall Study|Lack of Efficacy|0|||
164354537|NCT00165776|593672387|FG001|Overall Study|Lack of Efficacy|0|||
164354538|NCT00165776|593672388|FG002|Overall Study|Lack of Efficacy|0|||
164354539|NCT00165776|593672389|FG003|Overall Study|Lack of Efficacy|1|||
164354540|NCT00165776|593672386|FG000|Overall Study|Withdrawal by Subject|4|||
164354541|NCT00165776|593672387|FG001|Overall Study|Withdrawal by Subject|1|||
164354542|NCT00165776|593672388|FG002|Overall Study|Withdrawal by Subject|2|||
164354543|NCT00165776|593672389|FG003|Overall Study|Withdrawal by Subject|0|||
164354544|NCT00165776|593672386|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
164354545|NCT00165776|593672387|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
164354546|NCT00165776|593672388|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
164354547|NCT00165776|593672389|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
164354548|NCT04285879|593672390|FG000|Overall Study|Lost to Follow-up|1|||
164354549|NCT04285879|593672391|FG001|Overall Study|Lost to Follow-up|8|||
164354550|NCT04285879|593672390|FG000|Overall Study|medical/surgical exclusion|16|||
164354551|NCT04285879|593672391|FG001|Overall Study|medical/surgical exclusion|0|||
164354552|NCT01835587|593672394|FG000|Overall Study|Disease Recurrence or Relapse|0|||
164354553|NCT01835587|593672395|FG001|Overall Study|Disease Recurrence or Relapse|3|||
164354554|NCT01835587|593672396|FG002|Overall Study|Disease Recurrence or Relapse|0|||
164354555|NCT01835587|593672397|FG003|Overall Study|Disease Recurrence or Relapse|3|||
164354556|NCT01835587|593672394|FG000|Overall Study|Withdrawal by Subject|2|||
164354557|NCT01835587|593672395|FG001|Overall Study|Withdrawal by Subject|0|||
164354558|NCT01835587|593672396|FG002|Overall Study|Withdrawal by Subject|0|||
164354559|NCT01835587|593672397|FG003|Overall Study|Withdrawal by Subject|3|||
164354560|NCT01835587|593672394|FG000|Overall Study|Adverse Event|0|||
164354561|NCT01835587|593672395|FG001|Overall Study|Adverse Event|0|||
164354562|NCT01835587|593672396|FG002|Overall Study|Adverse Event|2|||
164354563|NCT01835587|593672397|FG003|Overall Study|Adverse Event|2|||
164354564|NCT01835587|593672394|FG000|Overall Study|Death|0|||
164354565|NCT01835587|593672395|FG001|Overall Study|Death|0|||
164354566|NCT01835587|593672396|FG002|Overall Study|Death|0|||
164354567|NCT01835587|593672397|FG003|Overall Study|Death|1|||
164354568|NCT01835587|593672394|FG000|Overall Study|Miscellaneous|0|||
164354569|NCT01835587|593672395|FG001|Overall Study|Miscellaneous|1|||
164354570|NCT01835587|593672396|FG002|Overall Study|Miscellaneous|0|||
164354571|NCT01835587|593672397|FG003|Overall Study|Miscellaneous|0|||
164354572|NCT03310775|593672404|FG000|Overall Study|Lost to Follow-up|2|||
164354573|NCT03310775|593672405|FG001|Overall Study|Lost to Follow-up|3|||
164354574|NCT03310775|593672404|FG000|Overall Study|aggravation of depression|0|||
164354575|NCT03310775|593672405|FG001|Overall Study|aggravation of depression|1|||
164354576|NCT01648205|593672408|FG000|Placebo|Pregnancy|1|||
164354577|NCT01648205|593672408|FG000|Placebo|Withdrawal by Subject|1|||
164354578|NCT01648205|593672408|FG000|Placebo|Protocol Violation|2|||
164354579|NCT01648205|593672408|FG000|Ranolazine|Death|1|||
164354580|NCT01648205|593672408|FG000|Ranolazine|Withdrawal by Subject|1|||
164354581|NCT01648205|593672408|FG000|Ranolazine|Protocol Violation|3|||
164354582|NCT02622321|593672409|FG000|Overall Study|Withdrawal by Subject|2|||
164354583|NCT02622321|593672410|FG001|Overall Study|Withdrawal by Subject|0|||
164354584|NCT02622321|593672411|FG002|Overall Study|Withdrawal by Subject|0|||
164354585|NCT02622321|593672412|FG003|Overall Study|Withdrawal by Subject|0|||
164354586|NCT02622321|593672409|FG000|Overall Study|Death|0|||
164354587|NCT02622321|593672410|FG001|Overall Study|Death|0|||
164354588|NCT02622321|593672411|FG002|Overall Study|Death|1|||
164354589|NCT02622321|593672412|FG003|Overall Study|Death|0|||
164354590|NCT02622321|593672409|FG000|Overall Study|Physician Decision|1|||
164354591|NCT02622321|593672410|FG001|Overall Study|Physician Decision|0|||
164354592|NCT02622321|593672411|FG002|Overall Study|Physician Decision|0|||
164354593|NCT02622321|593672412|FG003|Overall Study|Physician Decision|0|||
164354594|NCT01958008|593672414|FG000|Overall Study|Worsening of disease under study|0|||
164354595|NCT01958008|593672415|FG001|Overall Study|Worsening of disease under study|0|||
164354596|NCT01958008|593672416|FG002|Overall Study|Worsening of disease under study|1|||
164354597|NCT01958008|593672417|FG003|Overall Study|Worsening of disease under study|0|||
164354598|NCT01958008|593672414|FG000|Overall Study|Other adverse event|1|||
164354599|NCT01958008|593672415|FG001|Overall Study|Other adverse event|0|||
164354600|NCT01958008|593672416|FG002|Overall Study|Other adverse event|0|||
163899980|NCT01961609|592005593|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
164354601|NCT01958008|593672417|FG003|Overall Study|Other adverse event|0|||
164354602|NCT00241280|593672418|FG000|Overall Study|Adverse Event|2|||
164354603|NCT00241280|593672419|FG001|Overall Study|Adverse Event|6|||
164354604|NCT00241280|593672418|FG000|Overall Study|Discomfort|11|||
164354605|NCT00241280|593672419|FG001|Overall Study|Discomfort|16|||
164354606|NCT00241280|593672418|FG000|Overall Study|Pregnancy|1|||
164354607|NCT00241280|593672419|FG001|Overall Study|Pregnancy|5|||
164354608|NCT00241280|593672418|FG000|Overall Study|Lost to Follow-up|5|||
164354609|NCT00241280|593672419|FG001|Overall Study|Lost to Follow-up|8|||
164354610|NCT00241280|593672418|FG000|Overall Study|Withdrawal by Subject|7|||
164354611|NCT00241280|593672419|FG001|Overall Study|Withdrawal by Subject|4|||
164354612|NCT00241280|593672418|FG000|Overall Study|Protocol Violation|4|||
164354613|NCT00241280|593672419|FG001|Overall Study|Protocol Violation|10|||
164354614|NCT00241280|593672418|FG000|Overall Study|Relocation|4|||
164354615|NCT00241280|593672419|FG001|Overall Study|Relocation|4|||
164354616|NCT00241280|593672418|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
164354617|NCT00241280|593672419|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
164354618|NCT00241280|593672418|FG000|Overall Study|Unsatisfactory Visual Response|1|||
164354619|NCT00241280|593672419|FG001|Overall Study|Unsatisfactory Visual Response|1|||
164354620|NCT00241280|593672418|FG000|Overall Study|Diabetic|1|||
164354621|NCT00241280|593672419|FG001|Overall Study|Diabetic|0|||
164354622|NCT00241280|593672418|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
164354623|NCT00241280|593672419|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
164354624|NCT00241280|593672418|FG000|Overall Study|Dispensed incorrect test article|1|||
164354625|NCT00241280|593672419|FG001|Overall Study|Dispensed incorrect test article|2|||
164354626|NCT00241280|593672418|FG000|Overall Study|Unacceptable Fit|0|||
164354627|NCT00241280|593672419|FG001|Overall Study|Unacceptable Fit|1|||
164354628|NCT00241280|593672418|FG000|Overall Study|Scheduling Conflict|0|||
164354629|NCT00241280|593672419|FG001|Overall Study|Scheduling Conflict|2|||
164354630|NCT00241280|593672418|FG000|Overall Study|History of Ocular Surgery|0|||
164354631|NCT00241280|593672419|FG001|Overall Study|History of Ocular Surgery|1|||
164354632|NCT00241280|593672418|FG000|Overall Study|Coating on Lens|1|||
164354633|NCT00241280|593672419|FG001|Overall Study|Coating on Lens|0|||
164354634|NCT00241280|593672418|FG000|Overall Study|Excessive Dryness|0|||
164354635|NCT00241280|593672419|FG001|Overall Study|Excessive Dryness|1|||
164354636|NCT02260921|593672426|FG000|Overall Study|Adverse Event|1|||
164354637|NCT02260921|593672427|FG001|Overall Study|Adverse Event|0|||
164354638|NCT02260921|593672426|FG000|Overall Study|Lost to Follow-up|4|||
164354639|NCT02260921|593672427|FG001|Overall Study|Lost to Follow-up|3|||
164354640|NCT02260921|593672426|FG000|Overall Study|Withdraw Consent|4|||
164354641|NCT02260921|593672427|FG001|Overall Study|Withdraw Consent|1|||
164354642|NCT02260921|593672426|FG000|Overall Study|Death|1|||
164354643|NCT02260921|593672427|FG001|Overall Study|Death|0|||
164354644|NCT02260921|593672426|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
164354645|NCT02260921|593672427|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
164354646|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
164354647|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
164354648|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
164354649|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
164354650|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Death|7|||
164354651|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Death|5|||
164354652|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
164354653|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
164354654|NCT02999854|593672437|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
164354655|NCT02999854|593672438|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
164354656|NCT02999854|593672437|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
164354657|NCT02999854|593672438|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
164354658|NCT02999854|593672437|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
164354659|NCT02999854|593672438|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
164354660|NCT02999854|593672437|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
164354661|NCT02999854|593672438|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
164354662|NCT00203996|593672439|FG000|Overall Study|Lost to Follow-up|0|||
164354663|NCT00203996|593672440|FG001|Overall Study|Lost to Follow-up|0|||
164354664|NCT00203996|593672441|FG002|Overall Study|Lost to Follow-up|0|||
164354665|NCT00203996|593672442|FG003|Overall Study|Lost to Follow-up|1|||
164354666|NCT00203996|593672443|FG004|Overall Study|Lost to Follow-up|0|||
164354667|NCT00203996|593672444|FG005|Overall Study|Lost to Follow-up|0|||
164354668|NCT00203996|593672445|FG006|Overall Study|Lost to Follow-up|0|||
164354669|NCT00203996|593672446|FG007|Overall Study|Lost to Follow-up|0|||
164354670|NCT00203996|593672447|FG008|Overall Study|Lost to Follow-up|0|||
164354671|NCT00203996|593672448|FG009|Overall Study|Lost to Follow-up|0|||
164354672|NCT00203996|593672439|FG000|Overall Study|Protocol Violation|0|||
164354673|NCT00203996|593672440|FG001|Overall Study|Protocol Violation|0|||
164354674|NCT00203996|593672441|FG002|Overall Study|Protocol Violation|0|||
164354675|NCT00203996|593672442|FG003|Overall Study|Protocol Violation|6|||
164354676|NCT00203996|593672443|FG004|Overall Study|Protocol Violation|1|||
164354677|NCT00203996|593672444|FG005|Overall Study|Protocol Violation|0|||
164354678|NCT00203996|593672445|FG006|Overall Study|Protocol Violation|0|||
164354679|NCT00203996|593672446|FG007|Overall Study|Protocol Violation|0|||
164354680|NCT00203996|593672447|FG008|Overall Study|Protocol Violation|0|||
164354681|NCT00203996|593672448|FG009|Overall Study|Protocol Violation|0|||
164354682|NCT00203996|593672439|FG000|Overall Study|Physician Decision|0|||
164354683|NCT00203996|593672440|FG001|Overall Study|Physician Decision|0|||
164354684|NCT00203996|593672441|FG002|Overall Study|Physician Decision|0|||
164354685|NCT00203996|593672442|FG003|Overall Study|Physician Decision|2|||
164354686|NCT00203996|593672443|FG004|Overall Study|Physician Decision|0|||
164354687|NCT00203996|593672444|FG005|Overall Study|Physician Decision|0|||
164006345|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
164006346|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
164006347|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
164006348|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
164006349|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
164006350|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
164006351|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
164006352|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
164006353|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
164006354|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
164006355|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
164006356|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
164006357|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
164006358|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
164006359|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
164006360|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
164006361|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Death|0|||
164006362|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Death|1|||
164006363|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Death|0|||
164006364|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
164006365|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
164006366|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
164006367|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
164006368|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
164006369|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
164006370|NCT00430781|592390958|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
164006371|NCT00430781|592390959|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
164354688|NCT00203996|593672445|FG006|Overall Study|Physician Decision|0|||
164354689|NCT00203996|593672446|FG007|Overall Study|Physician Decision|0|||
164354690|NCT00203996|593672447|FG008|Overall Study|Physician Decision|0|||
164354691|NCT00203996|593672448|FG009|Overall Study|Physician Decision|1|||
164354692|NCT00203996|593672439|FG000|Overall Study|CPAP machine malfunction|0|||
164354693|NCT00203996|593672440|FG001|Overall Study|CPAP machine malfunction|0|||
164354694|NCT00203996|593672441|FG002|Overall Study|CPAP machine malfunction|0|||
164354695|NCT00203996|593672442|FG003|Overall Study|CPAP machine malfunction|1|||
164354696|NCT00203996|593672443|FG004|Overall Study|CPAP machine malfunction|0|||
164354697|NCT00203996|593672444|FG005|Overall Study|CPAP machine malfunction|0|||
164354698|NCT00203996|593672445|FG006|Overall Study|CPAP machine malfunction|0|||
164354699|NCT00203996|593672446|FG007|Overall Study|CPAP machine malfunction|0|||
164354700|NCT00203996|593672447|FG008|Overall Study|CPAP machine malfunction|0|||
164354701|NCT00203996|593672448|FG009|Overall Study|CPAP machine malfunction|0|||
164354702|NCT00203996|593672439|FG000|Overall Study|Scheduling issue|0|||
164354703|NCT00203996|593672440|FG001|Overall Study|Scheduling issue|0|||
164354704|NCT00203996|593672441|FG002|Overall Study|Scheduling issue|0|||
164354705|NCT00203996|593672442|FG003|Overall Study|Scheduling issue|0|||
164354706|NCT00203996|593672443|FG004|Overall Study|Scheduling issue|0|||
164354707|NCT00203996|593672444|FG005|Overall Study|Scheduling issue|0|||
164354708|NCT00203996|593672445|FG006|Overall Study|Scheduling issue|0|||
164354709|NCT00203996|593672446|FG007|Overall Study|Scheduling issue|2|||
164354710|NCT00203996|593672447|FG008|Overall Study|Scheduling issue|0|||
164354711|NCT00203996|593672448|FG009|Overall Study|Scheduling issue|0|||
164354712|NCT03064451|593672449|FG000|Overall Study|Lost to Follow-up|1|||
164354713|NCT03064451|593672449|FG000|Overall Study|Mapping Failure|4|||
164354714|NCT03064451|593672449|FG000|Overall Study|Exited prior to procedure|8|||
164354715|NCT03064451|593672449|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
164354716|NCT00897104|593672450|FG000|Overall Study|Lost to Follow-up|12|||
164354717|NCT00897104|593672451|FG001|Overall Study|Lost to Follow-up|17|||
164354718|NCT00897104|593672452|FG002|Overall Study|Lost to Follow-up|2|||
164354719|NCT00897104|593672450|FG000|Overall Study|Pregnancy|0|||
164354720|NCT00897104|593672451|FG001|Overall Study|Pregnancy|1|||
164354721|NCT00897104|593672452|FG002|Overall Study|Pregnancy|0|||
164354722|NCT00897104|593672450|FG000|Overall Study|Protocol Violation|0|||
164354723|NCT00897104|593672451|FG001|Overall Study|Protocol Violation|1|||
164354724|NCT00897104|593672452|FG002|Overall Study|Protocol Violation|0|||
164354725|NCT00897104|593672450|FG000|Overall Study|Withdrawal by Subject|23|||
164354726|NCT00897104|593672451|FG001|Overall Study|Withdrawal by Subject|27|||
164354727|NCT00897104|593672452|FG002|Overall Study|Withdrawal by Subject|3|||
164354728|NCT00897104|593672450|FG000|Overall Study|Abnormal Prestudy Labs|2|||
164006372|NCT00430781|592390960|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
164354729|NCT00897104|593672451|FG001|Overall Study|Abnormal Prestudy Labs|0|||
164354730|NCT00897104|593672452|FG002|Overall Study|Abnormal Prestudy Labs|0|||
164354731|NCT00897104|593672450|FG000|Overall Study|Abnormal Baseline ECG|2|||
164354732|NCT00897104|593672451|FG001|Overall Study|Abnormal Baseline ECG|2|||
164354733|NCT00897104|593672452|FG002|Overall Study|Abnormal Baseline ECG|0|||
164354734|NCT00897104|593672450|FG000|Overall Study|Need for Concom. Med.|0|||
164354735|NCT00897104|593672451|FG001|Overall Study|Need for Concom. Med.|1|||
164354736|NCT00897104|593672452|FG002|Overall Study|Need for Concom. Med.|1|||
164354737|NCT00897104|593672450|FG000|Overall Study|Lack of Migraine Attack|20|||
164354738|NCT00897104|593672451|FG001|Overall Study|Lack of Migraine Attack|22|||
164006373|NCT00430781|592390958|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
164006374|NCT00430781|592390959|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
164006375|NCT00430781|592390960|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
164006376|NCT00430781|592390958|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
164006377|NCT00430781|592390959|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
164354739|NCT00897104|593672452|FG002|Overall Study|Lack of Migraine Attack|1|||
164354740|NCT00897104|593672450|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
164354741|NCT00897104|593672451|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164354742|NCT00897104|593672452|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164354743|NCT00897104|593672450|FG000|Overall Study|Other|3|||
164354744|NCT00897104|593672451|FG001|Overall Study|Other|0|||
164354745|NCT00897104|593672452|FG002|Overall Study|Other|0|||
164354746|NCT00897104|593672450|FG000|Overall Study|Protocol Violation|1|||
164354747|NCT00897104|593672451|FG001|Overall Study|Protocol Violation|0|||
164354748|NCT00897104|593672452|FG002|Overall Study|Protocol Violation|0|||
164354749|NCT00897104|593672450|FG000|Overall Study|Withdrawal by Subject|0|||
164354750|NCT00897104|593672451|FG001|Overall Study|Withdrawal by Subject|0|||
164354751|NCT00897104|593672452|FG002|Overall Study|Withdrawal by Subject|1|||
164354752|NCT00750204|593672453|FG000|Overall Study|study halted prematurely|1|||
164354753|NCT00750204|593672454|FG001|Overall Study|study halted prematurely|1|||
164354754|NCT00434330|593672457|FG000|Overall Study|Adverse Event|0|||
164354755|NCT00434330|593672458|FG001|Overall Study|Adverse Event|0|||
164354756|NCT00434330|593672459|FG002|Overall Study|Adverse Event|1|||
164354757|NCT00434330|593672460|FG003|Overall Study|Adverse Event|0|||
164354758|NCT00434330|593672461|FG004|Overall Study|Adverse Event|0|||
164354759|NCT00434330|593672462|FG005|Overall Study|Adverse Event|0|||
164354760|NCT00434330|593672457|FG000|Overall Study|Death|1|||
164354761|NCT00434330|593672458|FG001|Overall Study|Death|0|||
164354762|NCT00434330|593672459|FG002|Overall Study|Death|0|||
164354763|NCT00434330|593672460|FG003|Overall Study|Death|0|||
164354764|NCT00434330|593672461|FG004|Overall Study|Death|1|||
164354765|NCT00434330|593672462|FG005|Overall Study|Death|1|||
164354766|NCT00434330|593672457|FG000|Overall Study|Withdrawal by Subject|0|||
164354767|NCT00434330|593672458|FG001|Overall Study|Withdrawal by Subject|0|||
164354768|NCT00434330|593672459|FG002|Overall Study|Withdrawal by Subject|1|||
164354769|NCT00434330|593672460|FG003|Overall Study|Withdrawal by Subject|1|||
164354770|NCT00434330|593672461|FG004|Overall Study|Withdrawal by Subject|0|||
164354771|NCT00434330|593672462|FG005|Overall Study|Withdrawal by Subject|0|||
164354772|NCT00434330|593672457|FG000|Overall Study|Renal transplant|0|||
164354773|NCT00434330|593672458|FG001|Overall Study|Renal transplant|0|||
164354774|NCT00434330|593672459|FG002|Overall Study|Renal transplant|0|||
164354775|NCT00434330|593672460|FG003|Overall Study|Renal transplant|1|||
164354776|NCT00434330|593672461|FG004|Overall Study|Renal transplant|0|||
164354777|NCT00434330|593672462|FG005|Overall Study|Renal transplant|0|||
164354778|NCT00434330|593672457|FG000|Overall Study|Subject Not Compliant With Study|0|||
164354779|NCT00434330|593672458|FG001|Overall Study|Subject Not Compliant With Study|0|||
164354780|NCT00434330|593672459|FG002|Overall Study|Subject Not Compliant With Study|1|||
164354781|NCT00434330|593672460|FG003|Overall Study|Subject Not Compliant With Study|0|||
164354782|NCT00434330|593672461|FG004|Overall Study|Subject Not Compliant With Study|0|||
164354783|NCT00434330|593672462|FG005|Overall Study|Subject Not Compliant With Study|0|||
164354784|NCT00850564|593672463|FG000|Overall Study|Withdrawal by Subject|2|||
164354785|NCT03032705|593672464|FG000|Overall Study|Lost to Follow-up|16|||
164354786|NCT03032705|593672465|FG001|Overall Study|Lost to Follow-up|17|||
164354787|NCT03032705|593672464|FG000|Overall Study|did not quality|6|||
164354788|NCT03032705|593672465|FG001|Overall Study|did not quality|6|||
164354789|NCT02167893|593672468|FG000|Overall Study|Investigator transferred|85|||
164354790|NCT02167893|593672468|FG000|Overall Study|Investigator health reasons|10|||
164354791|NCT02167893|593672468|FG000|Overall Study|Case report forms not collected|68|||
164354792|NCT04818840|593672469|FG000|Overall Study|Lost to Follow-up|0|||
164354793|NCT04818840|593672470|FG001|Overall Study|Lost to Follow-up|5|||
164354794|NCT04818840|593672469|FG000|Overall Study|Physician Decision|1|||
164354795|NCT04818840|593672470|FG001|Overall Study|Physician Decision|0|||
164354796|NCT04818840|593672469|FG000|Overall Study|Site Terminated by Sponsor|0|||
164006378|NCT00430781|592390960|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
164354797|NCT04818840|593672470|FG001|Overall Study|Site Terminated by Sponsor|3|||
164354798|NCT04818840|593672469|FG000|Overall Study|Study Terminated by Sponsor|43|||
164354799|NCT04818840|593672470|FG001|Overall Study|Study Terminated by Sponsor|7|||
164354800|NCT04818840|593672469|FG000|Overall Study|Withdrawal by Subject|0|||
164354801|NCT04818840|593672470|FG001|Overall Study|Withdrawal by Subject|1|||
164354802|NCT04847557|593672475|FG000|Overall Study|Adverse Event|1|||
164354803|NCT04847557|593672476|FG001|Overall Study|Adverse Event|0|||
164354804|NCT04847557|593672475|FG000|Overall Study|Death|19|||
164354805|NCT04847557|593672476|FG001|Overall Study|Death|15|||
164354806|NCT04847557|593672475|FG000|Overall Study|Lost to Follow-up|3|||
164354807|NCT04847557|593672476|FG001|Overall Study|Lost to Follow-up|6|||
164354808|NCT04847557|593672475|FG000|Overall Study|Physician Decision|1|||
164354809|NCT04847557|593672476|FG001|Overall Study|Physician Decision|0|||
164354810|NCT04847557|593672475|FG000|Overall Study|Protocol Violation|0|||
164354811|NCT04847557|593672476|FG001|Overall Study|Protocol Violation|1|||
164354812|NCT04847557|593672475|FG000|Overall Study|Withdrawal by Subject|8|||
164354813|NCT04847557|593672476|FG001|Overall Study|Withdrawal by Subject|14|||
164354814|NCT01325584|593672477|FG000|Overall Study|Death|1|||
164354815|NCT01853826|593674326|FG000|Overall Study|Patients who switched to commercial drug|11|||
164354816|NCT01853826|593674326|FG000|Overall Study|Patient refused to continue medication|21|||
164354817|NCT01853826|593674326|FG000|Overall Study|Lost to Follow-up|2|||
164354818|NCT01853826|593674326|FG000|Overall Study|Non-compliant with protocol|4|||
164354819|NCT01853826|593674326|FG000|Overall Study|Other adverse events (AE)|62|||
164354820|NCT01853826|593674326|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
164354821|NCT01853826|593674326|FG000|Overall Study|Progressive disease|342|||
164354822|NCT01853826|593674326|FG000|Overall Study|Other than listed|13|||
164354823|NCT01853826|593674326|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
164354824|NCT00397982|593674327|FG000|Overall Study|Withdrawal by Subject|1|||
164354825|NCT00397982|593674327|FG000|Overall Study|Adverse Event|1|||
164354826|NCT00397982|593674327|FG000|Overall Study|noncompliance|1|||
164354827|NCT00397982|593674327|FG000|Overall Study|Unrelated health issues|1|||
164354828|NCT02329730|593674333|FG000|Overall Study|Protocol Violation|0|||
164354829|NCT02329730|593674334|FG001|Overall Study|Protocol Violation|0|||
164354830|NCT02329730|593674335|FG002|Overall Study|Protocol Violation|0|||
164354831|NCT02329730|593674336|FG003|Overall Study|Protocol Violation|0|||
164354832|NCT02329730|593674337|FG004|Overall Study|Protocol Violation|2|||
164354833|NCT02329730|593674338|FG005|Overall Study|Protocol Violation|2|||
164354834|NCT02329730|593674339|FG006|Overall Study|Protocol Violation|0|||
164354835|NCT02329730|593674340|FG007|Overall Study|Protocol Violation|0|||
164354836|NCT02329730|593674341|FG008|Overall Study|Protocol Violation|0|||
164354837|NCT02329730|593674342|FG009|Overall Study|Protocol Violation|0|||
164354838|NCT02329730|593674343|FG010|Overall Study|Protocol Violation|0|||
164354839|NCT02329730|593674344|FG011|Overall Study|Protocol Violation|0|||
164354840|NCT02329730|593674333|FG000|Overall Study|Withdrawal by Subject|0|||
164354841|NCT02329730|593674334|FG001|Overall Study|Withdrawal by Subject|0|||
164354842|NCT02329730|593674335|FG002|Overall Study|Withdrawal by Subject|0|||
164354843|NCT02329730|593674336|FG003|Overall Study|Withdrawal by Subject|0|||
164354844|NCT02329730|593674337|FG004|Overall Study|Withdrawal by Subject|1|||
164354845|NCT02329730|593674338|FG005|Overall Study|Withdrawal by Subject|0|||
164354846|NCT02329730|593674339|FG006|Overall Study|Withdrawal by Subject|1|||
164354847|NCT02329730|593674340|FG007|Overall Study|Withdrawal by Subject|1|||
164354848|NCT02329730|593674341|FG008|Overall Study|Withdrawal by Subject|1|||
164354849|NCT02329730|593674342|FG009|Overall Study|Withdrawal by Subject|1|||
164354850|NCT02329730|593674343|FG010|Overall Study|Withdrawal by Subject|0|||
164354851|NCT02329730|593674344|FG011|Overall Study|Withdrawal by Subject|0|||
164354852|NCT02345850|593674348|FG000|Overall Study|Not transplanted|10|||
164354853|NCT02345850|593674349|FG001|Overall Study|Not transplanted|5|||
164354854|NCT02345850|593674350|FG002|Overall Study|Not transplanted|4|||
164354855|NCT02345850|593674348|FG000|Overall Study|Lost to Follow-up|2|||
164354856|NCT02345850|593674349|FG001|Overall Study|Lost to Follow-up|3|||
164354857|NCT02345850|593674350|FG002|Overall Study|Lost to Follow-up|2|||
164354858|NCT02345850|593674348|FG000|Overall Study|Withdrawal by Subject|1|||
164354859|NCT02345850|593674349|FG001|Overall Study|Withdrawal by Subject|0|||
164354860|NCT02345850|593674350|FG002|Overall Study|Withdrawal by Subject|0|||
164354861|NCT02392247|593674354|FG000|Overall Study|Withdrawal by Subject|1|||
164354862|NCT02392247|593674354|FG000|Overall Study|Surgery cancelled; no data|1|||
164354863|NCT04779489|593674355|FG000|Overall Study|Physician Decision|1|||
164354864|NCT00951665|593674356|FG000|Phase 1b|Adverse Event|2|||
164354865|NCT00951665|593674357|FG001|Phase 1b|Adverse Event|1|||
164354866|NCT00951665|593674358|FG002|Phase 1b|Adverse Event|0|||
164354867|NCT00951665|593674359|FG003|Phase 1b|Adverse Event|1|||
164354868|NCT00951665|593674360|FG004|Phase 1b|Adverse Event|0|||
164354869|NCT00951665|593674361|FG005|Phase 1b|Adverse Event|0|||
164354870|NCT00951665|593674356|FG000|Phase 1b|Death|1|||
164354871|NCT00951665|593674357|FG001|Phase 1b|Death|0|||
164354872|NCT00951665|593674358|FG002|Phase 1b|Death|2|||
164354873|NCT00951665|593674359|FG003|Phase 1b|Death|0|||
164354874|NCT00951665|593674360|FG004|Phase 1b|Death|0|||
164354875|NCT00951665|593674361|FG005|Phase 1b|Death|0|||
164354876|NCT00951665|593674356|FG000|Phase 1b|Physician Decision|4|||
164354877|NCT00951665|593674357|FG001|Phase 1b|Physician Decision|0|||
164354878|NCT00951665|593674358|FG002|Phase 1b|Physician Decision|1|||
164354879|NCT00951665|593674359|FG003|Phase 1b|Physician Decision|0|||
164354880|NCT00951665|593674360|FG004|Phase 1b|Physician Decision|0|||
164354881|NCT00951665|593674361|FG005|Phase 1b|Physician Decision|0|||
164354882|NCT00951665|593674356|FG000|Phase 1b|Withdrawal by Subject|0|||
164006379|NCT00430781|592390958|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
164006380|NCT00430781|592390959|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
164006381|NCT00430781|592390960|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
164006382|NCT00430781|592390958|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
164006383|NCT00430781|592390959|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
164006384|NCT00430781|592390960|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
164006385|NCT00430781|592390958|FG000|Final Analysis; 31 July 2008|Other|0|||
164006386|NCT00430781|592390959|FG001|Final Analysis; 31 July 2008|Other|1|||
164006387|NCT00430781|592390960|FG002|Final Analysis; 31 July 2008|Other|0|||
164006388|NCT00430781|592390958|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
164006389|NCT00430781|592390959|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
164006390|NCT00430781|592390960|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
164299453|NCT04973449|593471356|FG005|Overall Study|Lost to Follow-up|6|||
164299454|NCT04973449|593471357|FG006|Overall Study|Lost to Follow-up|10|||
164299455|NCT04973449|593471358|FG007|Overall Study|Lost to Follow-up|6|||
164299456|NCT04973449|593471351|FG000|Overall Study|Death|1|||
164299457|NCT04973449|593471352|FG001|Overall Study|Death|0|||
164299458|NCT04973449|593471353|FG002|Overall Study|Death|0|||
164299459|NCT04973449|593471354|FG003|Overall Study|Death|0|||
164299460|NCT04973449|593471355|FG004|Overall Study|Death|0|||
164299461|NCT04973449|593471356|FG005|Overall Study|Death|1|||
164299462|NCT04973449|593471357|FG006|Overall Study|Death|0|||
164299463|NCT04973449|593471358|FG007|Overall Study|Death|0|||
164299464|NCT04973449|593471351|FG000|Overall Study|Other|1|||
164299465|NCT04973449|593471352|FG001|Overall Study|Other|1|||
164299466|NCT04973449|593471353|FG002|Overall Study|Other|2|||
164299467|NCT04973449|593471354|FG003|Overall Study|Other|1|||
164299468|NCT04973449|593471355|FG004|Overall Study|Other|4|||
164299469|NCT04973449|593471356|FG005|Overall Study|Other|0|||
164299470|NCT04973449|593471357|FG006|Overall Study|Other|2|||
164299471|NCT04973449|593471358|FG007|Overall Study|Other|2|||
164299472|NCT01506596|593471359|FG000|Overall Study|ineligible pathology|1|||
164299473|NCT04408989|593471361|FG000|Overall Study|Lost to Follow-up|0|||
164299474|NCT04408989|593471362|FG001|Overall Study|Lost to Follow-up|0|||
164299475|NCT04408989|593471363|FG002|Overall Study|Lost to Follow-up|1|||
164299476|NCT04408989|593471361|FG000|Overall Study|Withdrawal by Subject|0|||
164299477|NCT04408989|593471362|FG001|Overall Study|Withdrawal by Subject|0|||
164299478|NCT04408989|593471363|FG002|Overall Study|Withdrawal by Subject|2|||
164299479|NCT02260934|593471378|FG000|Overall Study|Lost to Follow-up|2|||
164299480|NCT02260934|593471379|FG001|Overall Study|Lost to Follow-up|1|||
164299481|NCT02260934|593471378|FG000|Overall Study|Withdrawal by Subject|0|||
164299482|NCT02260934|593471379|FG001|Overall Study|Withdrawal by Subject|2|||
164299483|NCT02260934|593471378|FG000|Overall Study|Participant Relocated|1|||
164299484|NCT02260934|593471379|FG001|Overall Study|Participant Relocated|0|||
164299485|NCT02260934|593471378|FG000|Overall Study|Site error|0|||
164299486|NCT02260934|593471379|FG001|Overall Study|Site error|1|||
164299487|NCT04609319|593471382|FG000|Overall Study|Death|64|||
164299488|NCT04609319|593471383|FG001|Overall Study|Death|49|||
164299489|NCT04609319|593471384|FG002|Overall Study|Death|1|||
164299490|NCT04609319|593471382|FG000|Overall Study|Withdrawal of consent|15|||
164299491|NCT04609319|593471383|FG001|Overall Study|Withdrawal of consent|3|||
164299492|NCT04609319|593471384|FG002|Overall Study|Withdrawal of consent|0|||
164299493|NCT04609319|593471382|FG000|Overall Study|Lost to Follow-up|20|||
164299494|NCT04609319|593471383|FG001|Overall Study|Lost to Follow-up|33|||
164299495|NCT04609319|593471384|FG002|Overall Study|Lost to Follow-up|0|||
164299496|NCT04609319|593471382|FG000|Overall Study|Alive until end of follow-up|60|||
164299497|NCT04609319|593471383|FG001|Overall Study|Alive until end of follow-up|53|||
164299498|NCT04609319|593471384|FG002|Overall Study|Alive until end of follow-up|1|||
164299499|NCT04272242|593471387|FG000|Overall Study|Withdrawal by Subject|3|||
164299500|NCT04272242|593471387|FG000|Overall Study|Lost to Follow-up|1|||
164299501|NCT04272242|593471387|FG000|Overall Study|Adverse Event|1|||
164299502|NCT01520506|593472823|FG000|Overall Study|Missed Visit|4|||
164299503|NCT01520506|593472823|FG000|Overall Study|Lost to Follow-up|1|||
164299504|NCT01520506|593472823|FG000|Overall Study|Withdrawal by Subject|1|||
164299505|NCT00906204|593472824|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
164299506|NCT00906204|593472825|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
164299507|NCT00906204|593472824|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
164299508|NCT00906204|593472825|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
164299509|NCT00906204|593472824|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
164299510|NCT00906204|593472825|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
164299511|NCT00906204|593472824|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
164299512|NCT00906204|593472825|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
164301361|NCT01709084|593480139|FG001|Overall Study|Adverse Event|0|||
164301362|NCT01709084|593480138|FG000|Overall Study|Other|5|||
164301363|NCT01709084|593480139|FG001|Overall Study|Other|3|||
164301364|NCT01709084|593480138|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
164301365|NCT01709084|593480139|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
164354883|NCT00951665|593674357|FG001|Phase 1b|Withdrawal by Subject|1|||
164354884|NCT00951665|593674358|FG002|Phase 1b|Withdrawal by Subject|0|||
164354885|NCT00951665|593674359|FG003|Phase 1b|Withdrawal by Subject|0|||
164354886|NCT00951665|593674360|FG004|Phase 1b|Withdrawal by Subject|0|||
164354887|NCT00951665|593674361|FG005|Phase 1b|Withdrawal by Subject|0|||
164354888|NCT00951665|593674356|FG000|Phase 1b|Disease Progression|13|||
164354889|NCT00951665|593674357|FG001|Phase 1b|Disease Progression|2|||
164354890|NCT00951665|593674358|FG002|Phase 1b|Disease Progression|14|||
164354891|NCT00951665|593674359|FG003|Phase 1b|Disease Progression|0|||
164006391|NCT00430781|592390958|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
164006392|NCT00430781|592390959|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
164006393|NCT00430781|592390960|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
164006394|NCT00430781|592390958|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
164006395|NCT00430781|592390959|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
164006396|NCT00430781|592390960|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
164006397|NCT00430781|592390958|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
164006398|NCT00430781|592390959|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
164006399|NCT00430781|592390960|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
164006400|NCT00430781|592390958|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
164354892|NCT00951665|593674360|FG004|Phase 1b|Disease Progression|0|||
164354893|NCT00951665|593674361|FG005|Phase 1b|Disease Progression|0|||
164354894|NCT00951665|593674356|FG000|Phase 1b|Protocol Violation|2|||
164354895|NCT00951665|593674357|FG001|Phase 1b|Protocol Violation|0|||
164354896|NCT00951665|593674358|FG002|Phase 1b|Protocol Violation|0|||
164354897|NCT00951665|593674359|FG003|Phase 1b|Protocol Violation|0|||
164354898|NCT00951665|593674360|FG004|Phase 1b|Protocol Violation|0|||
164354899|NCT00951665|593674361|FG005|Phase 1b|Protocol Violation|0|||
164354900|NCT00951665|593674356|FG000|Phase 2a|Adverse Event|0|||
164354901|NCT00951665|593674357|FG001|Phase 2a|Adverse Event|0|||
164354902|NCT00951665|593674358|FG002|Phase 2a|Adverse Event|0|||
164354903|NCT00951665|593674359|FG003|Phase 2a|Adverse Event|0|||
164354904|NCT00951665|593674360|FG004|Phase 2a|Adverse Event|2|||
164354905|NCT00951665|593674361|FG005|Phase 2a|Adverse Event|0|||
164354906|NCT00951665|593674356|FG000|Phase 2a|Death|0|||
164354907|NCT00951665|593674357|FG001|Phase 2a|Death|0|||
164354908|NCT00951665|593674358|FG002|Phase 2a|Death|0|||
164354909|NCT00951665|593674359|FG003|Phase 2a|Death|0|||
164354910|NCT00951665|593674360|FG004|Phase 2a|Death|1|||
164354911|NCT00951665|593674361|FG005|Phase 2a|Death|1|||
164354912|NCT00951665|593674356|FG000|Phase 2a|Lost to Follow-up|0|||
164354913|NCT00951665|593674357|FG001|Phase 2a|Lost to Follow-up|0|||
164354914|NCT00951665|593674358|FG002|Phase 2a|Lost to Follow-up|0|||
164354915|NCT00951665|593674359|FG003|Phase 2a|Lost to Follow-up|0|||
164354916|NCT00951665|593674360|FG004|Phase 2a|Lost to Follow-up|1|||
164354917|NCT00951665|593674361|FG005|Phase 2a|Lost to Follow-up|0|||
164354918|NCT00951665|593674356|FG000|Phase 2a|Physician Decision|0|||
164354919|NCT00951665|593674357|FG001|Phase 2a|Physician Decision|0|||
164354920|NCT00951665|593674358|FG002|Phase 2a|Physician Decision|0|||
164354921|NCT00951665|593674359|FG003|Phase 2a|Physician Decision|0|||
164354922|NCT00951665|593674360|FG004|Phase 2a|Physician Decision|0|||
164354923|NCT00951665|593674361|FG005|Phase 2a|Physician Decision|1|||
164354924|NCT00951665|593674356|FG000|Phase 2a|Withdrawal by Subject|0|||
164354925|NCT00951665|593674357|FG001|Phase 2a|Withdrawal by Subject|0|||
164354926|NCT00951665|593674358|FG002|Phase 2a|Withdrawal by Subject|0|||
164354927|NCT00951665|593674359|FG003|Phase 2a|Withdrawal by Subject|0|||
164354928|NCT00951665|593674360|FG004|Phase 2a|Withdrawal by Subject|2|||
164354929|NCT00951665|593674361|FG005|Phase 2a|Withdrawal by Subject|0|||
164354930|NCT00951665|593674356|FG000|Phase 2a|Disease Progression|0|||
164354931|NCT00951665|593674357|FG001|Phase 2a|Disease Progression|0|||
164354932|NCT00951665|593674358|FG002|Phase 2a|Disease Progression|0|||
164354933|NCT00951665|593674359|FG003|Phase 2a|Disease Progression|0|||
164006401|NCT00430781|592390959|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
164006402|NCT00430781|592390960|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
164006403|NCT00430781|592390958|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
164354934|NCT00951665|593674360|FG004|Phase 2a|Disease Progression|6|||
164354935|NCT00951665|593674361|FG005|Phase 2a|Disease Progression|5|||
164354936|NCT02450903|593674364|FG000|Overall Study|Adverse Event|3|||
164354937|NCT02450903|593674364|FG000|Overall Study|Progressive disease|15|||
164354938|NCT02450903|593674364|FG000|Overall Study|Switched to commercial drug|1|||
164354939|NCT02450903|593674364|FG000|Overall Study|Subject/guardian decision|1|||
164354940|NCT05126901|593674365|FG000|Overall Study|Withdrawal by Subject|1|||
164354941|NCT05126901|593674366|FG001|Overall Study|Withdrawal by Subject|1|||
164354942|NCT05126901|593674367|FG002|Overall Study|Withdrawal by Subject|4|||
164354943|NCT05126901|593674365|FG000|Overall Study|Adverse Event|0|||
164354944|NCT05126901|593674366|FG001|Overall Study|Adverse Event|0|||
164354945|NCT05126901|593674367|FG002|Overall Study|Adverse Event|1|||
164354946|NCT05126901|593674365|FG000|Overall Study|Lost to Follow-up|0|||
164006404|NCT00430781|592390959|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
164006405|NCT00430781|592390960|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
164006406|NCT00430781|592390958|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
164006407|NCT00430781|592390959|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
164006408|NCT00430781|592390960|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
164006409|NCT02158533|592390962|FG000|Stage 1|Adverse Event|6|||
164006410|NCT02158533|592390963|FG001|Stage 1|Adverse Event|4|||
164006411|NCT02158533|592390964|FG002|Stage 1|Adverse Event|7|||
164354947|NCT05126901|593674366|FG001|Overall Study|Lost to Follow-up|2|||
164354948|NCT05126901|593674367|FG002|Overall Study|Lost to Follow-up|0|||
164354949|NCT00254540|593674368|FG000|Overall Study|Adverse Event|6|||
164354950|NCT00254540|593674369|FG001|Overall Study|Adverse Event|7|||
164354951|NCT00254540|593674368|FG000|Overall Study|Lack of Efficacy|13|||
164354952|NCT00254540|593674369|FG001|Overall Study|Lack of Efficacy|13|||
164354953|NCT00254540|593674368|FG000|Overall Study|Death|0|||
164354954|NCT00254540|593674369|FG001|Overall Study|Death|1|||
164354955|NCT00254540|593674368|FG000|Overall Study|Laboratory Test Abnormality|0|||
164354956|NCT00254540|593674369|FG001|Overall Study|Laboratory Test Abnormality|1|||
164354957|NCT00710710|593674370|FG000|Overall Study|Consent withdrawn|2|||
164354958|NCT00710710|593674371|FG001|Overall Study|Consent withdrawn|2|||
164354959|NCT00710710|593674370|FG000|Overall Study|Protocol Violation|0|||
164354960|NCT00710710|593674371|FG001|Overall Study|Protocol Violation|1|||
164354961|NCT00710710|593674370|FG000|Overall Study|Adverse Event|3|||
164354962|NCT00710710|593674371|FG001|Overall Study|Adverse Event|3|||
164354963|NCT00710710|593674370|FG000|Overall Study|Progressive disease|40|||
164354964|NCT00710710|593674371|FG001|Overall Study|Progressive disease|38|||
164354965|NCT00715078|593674372|FG000|Overall Study|Death|29|||
164354966|NCT00715078|593674373|FG001|Overall Study|Death|36|||
164354967|NCT00715078|593674374|FG002|Overall Study|Death|36|||
164354968|NCT00715078|593674372|FG000|Overall Study|Withdrawal by Subject|1|||
164354969|NCT00715078|593674373|FG001|Overall Study|Withdrawal by Subject|0|||
164354970|NCT00715078|593674374|FG002|Overall Study|Withdrawal by Subject|1|||
164354971|NCT00715078|593674372|FG000|Overall Study|Unable to start due to disease prog.|0|||
164354972|NCT00715078|593674373|FG001|Overall Study|Unable to start due to disease prog.|0|||
164354973|NCT00715078|593674374|FG002|Overall Study|Unable to start due to disease prog.|1|||
164354974|NCT01313767|593674375|FG000|Overall Study|Adverse Event|1|||
164354975|NCT01313767|593674376|FG001|Overall Study|Adverse Event|0|||
164354976|NCT01313767|593674375|FG000|Overall Study|Lost to Follow-up|1|||
164354977|NCT01313767|593674376|FG001|Overall Study|Lost to Follow-up|0|||
164354978|NCT01313767|593674375|FG000|Overall Study|Withdrawal by Subject|2|||
164354979|NCT01313767|593674376|FG001|Overall Study|Withdrawal by Subject|1|||
164354980|NCT01313767|593674375|FG000|Overall Study|Protocol Violation|3|||
164006412|NCT02158533|592390965|FG003|Stage 1|Adverse Event|0|||
164006413|NCT02158533|592390966|FG004|Stage 1|Adverse Event|0|||
164006414|NCT02158533|592390967|FG005|Stage 1|Adverse Event|0|||
164006415|NCT02158533|592390962|FG000|Stage 1|Withdrawal by Subject|3|||
164006416|NCT02158533|592390963|FG001|Stage 1|Withdrawal by Subject|2|||
164006417|NCT02158533|592390964|FG002|Stage 1|Withdrawal by Subject|1|||
164006418|NCT02158533|592390965|FG003|Stage 1|Withdrawal by Subject|0|||
164006419|NCT02158533|592390966|FG004|Stage 1|Withdrawal by Subject|0|||
164354981|NCT01313767|593674376|FG001|Overall Study|Protocol Violation|1|||
164354982|NCT01529346|593674377|FG000|Overall Study|Lost to Follow-up|2|||
164354983|NCT01529346|593674378|FG001|Overall Study|Lost to Follow-up|0|||
164354984|NCT01529346|593674379|FG002|Overall Study|Lost to Follow-up|1|||
164354985|NCT01529346|593674380|FG003|Overall Study|Lost to Follow-up|0|||
164354986|NCT01529346|593674381|FG004|Overall Study|Lost to Follow-up|0|||
164354987|NCT01529346|593674377|FG000|Overall Study|Other|0|||
164354988|NCT01529346|593674378|FG001|Overall Study|Other|1|||
164354989|NCT01529346|593674379|FG002|Overall Study|Other|1|||
164354990|NCT01529346|593674380|FG003|Overall Study|Other|0|||
164354991|NCT01529346|593674381|FG004|Overall Study|Other|0|||
164354992|NCT02282020|593674388|FG000|Overall Study|Objective Disease Progression|128|||
164354993|NCT02282020|593674389|FG001|Overall Study|Objective Disease Progression|30|||
164354994|NCT02282020|593674388|FG000|Overall Study|Adverse Event|18|||
164354995|NCT02282020|593674389|FG001|Overall Study|Adverse Event|15|||
164354996|NCT02282020|593674388|FG000|Overall Study|Withdrawal by Subject|7|||
164354997|NCT02282020|593674389|FG001|Overall Study|Withdrawal by Subject|10|||
164354998|NCT02282020|593674388|FG000|Overall Study|Miscellaneous|5|||
164354999|NCT02282020|593674389|FG001|Overall Study|Miscellaneous|19|||
164355000|NCT02282020|593674388|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
164006420|NCT02158533|592390967|FG005|Stage 1|Withdrawal by Subject|0|||
164006421|NCT02158533|592390962|FG000|Stage 1|Lack of Efficacy|1|||
164006422|NCT02158533|592390963|FG001|Stage 1|Lack of Efficacy|0|||
164355001|NCT02282020|593674389|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
164355002|NCT02282020|593674388|FG000|Overall Study|Developed Discontinuation Criteria|0|||
164355003|NCT02282020|593674389|FG001|Overall Study|Developed Discontinuation Criteria|2|||
164355004|NCT02282020|593674388|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
164355005|NCT02282020|593674389|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
164355006|NCT00588848|593674390|FG000|Overall Study|Physician Decision|0|||
164355007|NCT00588848|593674391|FG001|Overall Study|Physician Decision|3|||
164355008|NCT00249444|593674392|FG000|Overall Study|Lost to Follow-up|2|||
164355009|NCT00249444|593674393|FG001|Overall Study|Lost to Follow-up|2|||
164355010|NCT00249444|593674392|FG000|Overall Study|non-compliant|9|||
164355011|NCT00249444|593674393|FG001|Overall Study|non-compliant|11|||
164355012|NCT00249444|593674392|FG000|Overall Study|Adverse Event|1|||
164355013|NCT00249444|593674393|FG001|Overall Study|Adverse Event|1|||
164355014|NCT00249444|593674392|FG000|Overall Study|life event|0|||
164355015|NCT00249444|593674393|FG001|Overall Study|life event|1|||
164355016|NCT01499667|593674394|FG000|Overall Study|administrative problems|4|||
164355017|NCT01499667|593674395|FG001|Overall Study|administrative problems|5|||
164355018|NCT01499667|593674396|FG002|Overall Study|administrative problems|5|||
164355019|NCT01499667|593674394|FG000|Overall Study|Protocol Violation|1|||
164355020|NCT01499667|593674395|FG001|Overall Study|Protocol Violation|3|||
164355021|NCT01499667|593674396|FG002|Overall Study|Protocol Violation|2|||
164355022|NCT01499667|593674394|FG000|Overall Study|Adverse Event|0|||
164355023|NCT01499667|593674395|FG001|Overall Study|Adverse Event|2|||
164355024|NCT01499667|593674396|FG002|Overall Study|Adverse Event|2|||
164355025|NCT01499667|593674394|FG000|Overall Study|Withdrawal by Subject|2|||
164355026|NCT01499667|593674395|FG001|Overall Study|Withdrawal by Subject|1|||
164355027|NCT01499667|593674396|FG002|Overall Study|Withdrawal by Subject|1|||
164355028|NCT01499667|593674394|FG000|Overall Study|Lack of Efficacy|2|||
164355029|NCT01499667|593674395|FG001|Overall Study|Lack of Efficacy|0|||
164355030|NCT01499667|593674396|FG002|Overall Study|Lack of Efficacy|0|||
164355031|NCT02673489|593674397|FG000|Treatment Period|Lost to Follow-up|3|||
164355032|NCT02673489|593674398|FG001|Treatment Period|Lost to Follow-up|0|||
164355033|NCT02673489|593674397|FG000|Treatment Period|Participant request to discontinue|1|||
164355034|NCT02673489|593674398|FG001|Treatment Period|Participant request to discontinue|1|||
164355035|NCT02673489|593674397|FG000|Treatment Period|Participant moved to another province|1|||
164355036|NCT02673489|593674398|FG001|Treatment Period|Participant moved to another province|0|||
164355037|NCT02673489|593674397|FG000|Treatment Period|Participant was incarcerated|0|||
164355038|NCT02673489|593674398|FG001|Treatment Period|Participant was incarcerated|1|||
164355039|NCT02673489|593674397|FG000|Treatment Period|Adverse Event|0|||
164355040|NCT02673489|593674398|FG001|Treatment Period|Adverse Event|1|||
164355041|NCT02673489|593674397|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
164355042|NCT02673489|593674398|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
164355043|NCT02673489|593674397|FG000|Follow Up Period|Unable to return for follow-up|0|||
164355044|NCT02673489|593674398|FG001|Follow Up Period|Unable to return for follow-up|1|||
164355045|NCT00232817|593674399|FG000|Overall Study|Protocol Violation|2|||
164355046|NCT00232817|593674400|FG001|Overall Study|Protocol Violation|1|||
164355047|NCT01084174|593674404|FG000|Overall Study|gastrointestinal symptoms|1|||
164355048|NCT01084174|593674405|FG001|Overall Study|gastrointestinal symptoms|1|||
164355049|NCT01084174|593674404|FG000|Overall Study|Eosinophilic esophagitis|0|||
164355050|NCT01084174|593674405|FG001|Overall Study|Eosinophilic esophagitis|1|||
164355051|NCT01084174|593674404|FG000|Overall Study|Anaphylaxis|0|||
164355052|NCT01084174|593674405|FG001|Overall Study|Anaphylaxis|1|||
164355053|NCT01084174|593674404|FG000|Overall Study|Participant noncompliance|0|||
164355054|NCT01084174|593674405|FG001|Overall Study|Participant noncompliance|1|||
164355055|NCT04273217|593674406|FG000|Overall Study|Lost to Follow-up|0|||
164355056|NCT04273217|593674407|FG001|Overall Study|Lost to Follow-up|0|||
164355057|NCT04273217|593674408|FG002|Overall Study|Lost to Follow-up|0|||
164355058|NCT04273217|593674409|FG003|Overall Study|Lost to Follow-up|0|||
164355059|NCT04273217|593674410|FG004|Overall Study|Lost to Follow-up|0|||
164355060|NCT04273217|593674411|FG005|Overall Study|Lost to Follow-up|1|||
164355061|NCT04273217|593674406|FG000|Overall Study|Participant non-compliance|0|||
164355062|NCT04273217|593674407|FG001|Overall Study|Participant non-compliance|0|||
164355063|NCT04273217|593674408|FG002|Overall Study|Participant non-compliance|0|||
164355064|NCT04273217|593674409|FG003|Overall Study|Participant non-compliance|0|||
164355065|NCT04273217|593674410|FG004|Overall Study|Participant non-compliance|1|||
164355066|NCT04273217|593674411|FG005|Overall Study|Participant non-compliance|0|||
164355067|NCT04273217|593674406|FG000|Overall Study|Positive urine drug screen|1|||
164355068|NCT04273217|593674407|FG001|Overall Study|Positive urine drug screen|0|||
164355069|NCT04273217|593674408|FG002|Overall Study|Positive urine drug screen|1|||
164355070|NCT04273217|593674409|FG003|Overall Study|Positive urine drug screen|0|||
164355071|NCT04273217|593674410|FG004|Overall Study|Positive urine drug screen|0|||
164355072|NCT04273217|593674411|FG005|Overall Study|Positive urine drug screen|1|||
164355073|NCT04532099|593674412|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
164355074|NCT04532099|593674413|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
164355075|NCT04532099|593674414|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
164355076|NCT05492942|593674415|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
164355077|NCT05492942|593674416|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
164355078|NCT05492942|593674417|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
164355079|NCT05492942|593674418|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
164006423|NCT02158533|592390964|FG002|Stage 1|Lack of Efficacy|0|||
164355080|NCT02506153|593674419|FG000|Overall Study|Adverse Event|359|||
164355081|NCT02506153|593674420|FG001|Overall Study|Adverse Event|114|||
164355082|NCT02506153|593674419|FG000|Overall Study|Refused unrelated to adverse event|127|||
164006424|NCT02158533|592390965|FG003|Stage 1|Lack of Efficacy|0|||
164355083|NCT02506153|593674420|FG001|Overall Study|Refused unrelated to adverse event|18|||
164355084|NCT02506153|593674419|FG000|Overall Study|Progression/relapse|91|||
164355085|NCT02506153|593674420|FG001|Overall Study|Progression/relapse|136|||
164355086|NCT02506153|593674419|FG000|Overall Study|Death|2|||
164355087|NCT02506153|593674420|FG001|Overall Study|Death|1|||
164355088|NCT02506153|593674419|FG000|Overall Study|Other - not protocol specified|23|||
164355089|NCT02506153|593674420|FG001|Overall Study|Other - not protocol specified|12|||
164355090|NCT03103919|593674421|FG000|Overall Study|Adverse Event|2|||
164355091|NCT03103919|593674422|FG001|Overall Study|Adverse Event|2|||
164355092|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
164355093|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
164355094|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
164355095|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
164355096|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
164355097|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
164355098|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
164355099|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
164355100|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
164355101|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
164355102|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
164355103|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
164355104|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
164355105|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
164355106|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
164355107|NCT01124422|593674423|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
164355108|NCT01124422|593674424|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
164355109|NCT01124422|593674425|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
164355110|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
164355111|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
164355112|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
164355113|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
164355114|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
164355115|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
164355116|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
164355117|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
164355118|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
164355119|NCT01124422|593674423|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
164355120|NCT01124422|593674424|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
164355121|NCT01124422|593674425|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
164355122|NCT01828281|593674426|FG000|Overall Study|Withdrawal by Subject|1|||
164355123|NCT01828281|593674427|FG001|Overall Study|Withdrawal by Subject|0|||
164355124|NCT03454893|593674430|FG000|Overall Study|Study Terminated by the Sponsor|5|||
164355125|NCT03454893|593674430|FG000|Overall Study|Did not pass screening|4|||
164355126|NCT04876274|593674431|FG000|Overall Study|Lost to Follow-up|9|||
164355127|NCT04876274|593674432|FG001|Overall Study|Lost to Follow-up|12|||
164355128|NCT03070782|593674435|FG000|Overall Study|Adverse Event|3|||
164355129|NCT03070782|593674436|FG001|Overall Study|Adverse Event|0|||
164355130|NCT03070782|593674437|FG002|Overall Study|Adverse Event|3|||
164355131|NCT03070782|593674438|FG003|Overall Study|Adverse Event|1|||
164355132|NCT03070782|593674439|FG004|Overall Study|Adverse Event|6|||
164355133|NCT03070782|593674440|FG005|Overall Study|Adverse Event|2|||
164355134|NCT03070782|593674435|FG000|Overall Study|Withdrawal by Subject|2|||
164355135|NCT03070782|593674436|FG001|Overall Study|Withdrawal by Subject|1|||
164355136|NCT03070782|593674437|FG002|Overall Study|Withdrawal by Subject|1|||
164355137|NCT03070782|593674438|FG003|Overall Study|Withdrawal by Subject|0|||
164355138|NCT03070782|593674439|FG004|Overall Study|Withdrawal by Subject|4|||
164355139|NCT03070782|593674440|FG005|Overall Study|Withdrawal by Subject|3|||
164355140|NCT03070782|593674435|FG000|Overall Study|Reason Not Specified|2|||
164355141|NCT03070782|593674436|FG001|Overall Study|Reason Not Specified|0|||
164355142|NCT03070782|593674437|FG002|Overall Study|Reason Not Specified|0|||
164006425|NCT02158533|592390966|FG004|Stage 1|Lack of Efficacy|0|||
164006426|NCT02158533|592390967|FG005|Stage 1|Lack of Efficacy|0|||
164006427|NCT02158533|592390962|FG000|Stage 1|Lost to Follow-up|3|||
164355143|NCT03070782|593674438|FG003|Overall Study|Reason Not Specified|1|||
164355144|NCT03070782|593674439|FG004|Overall Study|Reason Not Specified|2|||
164355145|NCT03070782|593674440|FG005|Overall Study|Reason Not Specified|1|||
164006428|NCT02158533|592390963|FG001|Stage 1|Lost to Follow-up|1|||
164355146|NCT03070782|593674435|FG000|Overall Study|Ineligibility|0|||
164355147|NCT03070782|593674436|FG001|Overall Study|Ineligibility|0|||
164355148|NCT03070782|593674437|FG002|Overall Study|Ineligibility|0|||
164090006|NCT03471078|592693293|FG000|Overall Study|Withdrawal by Subject|9|||
164090007|NCT03471078|592693294|FG001|Overall Study|Withdrawal by Subject|1|||
164090008|NCT03471078|592693293|FG000|Overall Study|Adverse Event|4|||
164090009|NCT03471078|592693294|FG001|Overall Study|Adverse Event|1|||
164090010|NCT03471078|592693293|FG000|Overall Study|Physician Decision|3|||
164090011|NCT03471078|592693294|FG001|Overall Study|Physician Decision|2|||
164090012|NCT03471078|592693293|FG000|Overall Study|Death|2|||
164090013|NCT03471078|592693294|FG001|Overall Study|Death|0|||
164090014|NCT03471078|592693293|FG000|Overall Study|Other|3|||
164090015|NCT03471078|592693294|FG001|Overall Study|Other|2|||
164090016|NCT02819362|592693306|FG000|Overall Study|On-site MRI could not be performed|70|||
164090017|NCT05456529|592693307|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
164090018|NCT05456529|592693307|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
164090019|NCT05456529|592693307|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
164090020|NCT05456529|592693307|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
164090021|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
164090022|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
164090023|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Physician Decision|2|||
164090024|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
164090025|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
164090026|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
164090027|NCT05456529|592693307|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
164090028|NCT02710123|592693308|FG000|Overall Study|Lost to Follow-up|3|||
164090029|NCT02710123|592693309|FG001|Overall Study|Lost to Follow-up|4|||
164090030|NCT02710123|592693308|FG000|Overall Study|Withdrawal by Subject|1|||
164090031|NCT02710123|592693309|FG001|Overall Study|Withdrawal by Subject|1|||
164090032|NCT02710123|592693308|FG000|Overall Study|Illness unrelated to study intervention|1|||
164090033|NCT02710123|592693309|FG001|Overall Study|Illness unrelated to study intervention|0|||
164090034|NCT05381948|592693310|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
164090035|NCT05381948|592693311|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
164090036|NCT05381948|592693312|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
164090037|NCT05381948|592693310|FG000|Overall Study|Adverse Event: Non-ocular|0|||
164090038|NCT05381948|592693311|FG001|Overall Study|Adverse Event: Non-ocular|1|||
164090039|NCT05381948|592693312|FG002|Overall Study|Adverse Event: Non-ocular|0|||
164090040|NCT05381948|592693310|FG000|Overall Study|Lost to Follow-up|1|||
164090041|NCT05381948|592693311|FG001|Overall Study|Lost to Follow-up|0|||
164090042|NCT05381948|592693312|FG002|Overall Study|Lost to Follow-up|0|||
164090043|NCT05381948|592693310|FG000|Overall Study|Protocol Deviation|0|||
164090044|NCT05381948|592693311|FG001|Overall Study|Protocol Deviation|2|||
164090045|NCT05381948|592693312|FG002|Overall Study|Protocol Deviation|0|||
164090046|NCT05381948|592693310|FG000|Overall Study|Withdrawal by Subject|1|||
164090047|NCT05381948|592693311|FG001|Overall Study|Withdrawal by Subject|0|||
164090048|NCT05381948|592693312|FG002|Overall Study|Withdrawal by Subject|1|||
164090049|NCT05381948|592693310|FG000|Overall Study|Death|0|||
164090050|NCT05381948|592693311|FG001|Overall Study|Death|2|||
164090051|NCT05381948|592693312|FG002|Overall Study|Death|0|||
164090052|NCT05381948|592693310|FG000|Overall Study|Discontinued study without receiving study drug|0|||
164090053|NCT05381948|592693311|FG001|Overall Study|Discontinued study without receiving study drug|0|||
164090054|NCT05381948|592693312|FG002|Overall Study|Discontinued study without receiving study drug|1|||
164090055|NCT04471207|592693313|FG000|Overall Study|Lost to Follow-up|4|||
164090056|NCT04471207|592693314|FG001|Overall Study|Lost to Follow-up|1|||
164090057|NCT04471207|592693313|FG000|Overall Study|Medication Contraindication|0|||
164090058|NCT04471207|592693314|FG001|Overall Study|Medication Contraindication|1|||
164090059|NCT04471207|592693313|FG000|Overall Study|Loss of Interest|2|||
164090060|NCT04471207|592693314|FG001|Overall Study|Loss of Interest|1|||
164090061|NCT04471207|592693313|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
164090062|NCT04471207|592693314|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
164090063|NCT04471207|592693313|FG000|Overall Study|Scheduling Conflicts|3|||
164090064|NCT04471207|592693314|FG001|Overall Study|Scheduling Conflicts|1|||
164090065|NCT04471207|592693313|FG000|Overall Study|Physician Decision|1|||
164090066|NCT04471207|592693314|FG001|Overall Study|Physician Decision|0|||
164090067|NCT04471207|592693313|FG000|Overall Study|Unwilling to Use System|0|||
164090068|NCT04471207|592693314|FG001|Overall Study|Unwilling to Use System|1|||
164090069|NCT02750761|592693322|FG000|Overall Study|Lost to Follow-up|0|||
164090070|NCT02750761|592693323|FG001|Overall Study|Lost to Follow-up|0|||
164090071|NCT02750761|592693324|FG002|Overall Study|Lost to Follow-up|1|||
164355149|NCT03070782|593674438|FG003|Overall Study|Ineligibility|1|||
163899981|NCT01961609|592005594|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
164090072|NCT02750761|592693325|FG003|Overall Study|Lost to Follow-up|0|||
164090073|NCT02750761|592693326|FG004|Overall Study|Lost to Follow-up|0|||
164090074|NCT02750761|592693327|FG005|Overall Study|Lost to Follow-up|0|||
164090075|NCT01860976|592693328|FG000|Blinded Treatment|Adverse Event|1|||
164090076|NCT01860976|592693329|FG001|Blinded Treatment|Adverse Event|3|||
164090077|NCT01860976|592693328|FG000|Blinded Treatment|Lack of Efficacy|5|||
164090078|NCT01860976|592693329|FG001|Blinded Treatment|Lack of Efficacy|12|||
164355150|NCT03070782|593674439|FG004|Overall Study|Ineligibility|0|||
164355151|NCT03070782|593674440|FG005|Overall Study|Ineligibility|1|||
164355152|NCT03070782|593674435|FG000|Overall Study|Pregnancy|0|||
164355153|NCT03070782|593674436|FG001|Overall Study|Pregnancy|0|||
164355154|NCT03070782|593674437|FG002|Overall Study|Pregnancy|0|||
164355155|NCT03070782|593674438|FG003|Overall Study|Pregnancy|1|||
164355156|NCT03070782|593674439|FG004|Overall Study|Pregnancy|0|||
164355157|NCT03070782|593674440|FG005|Overall Study|Pregnancy|0|||
164355158|NCT03070782|593674435|FG000|Overall Study|Investigator Judgement|0|||
164355159|NCT03070782|593674436|FG001|Overall Study|Investigator Judgement|0|||
164355160|NCT03070782|593674437|FG002|Overall Study|Investigator Judgement|0|||
164355161|NCT03070782|593674438|FG003|Overall Study|Investigator Judgement|1|||
164355162|NCT03070782|593674439|FG004|Overall Study|Investigator Judgement|0|||
164355163|NCT03070782|593674440|FG005|Overall Study|Investigator Judgement|0|||
164355164|NCT03527966|593674443|FG000|Overall Study|Lost to Follow-up|3|||
164355165|NCT03527966|593674444|FG001|Overall Study|Lost to Follow-up|0|||
164355166|NCT01948050|593674445|FG000|Overall Study|Withdrawal by Subject|0|||
163899982|NCT01961609|592005595|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
164299513|NCT00906204|593472824|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
164355167|NCT01948050|593674446|FG001|Overall Study|Withdrawal by Subject|1|||
164355168|NCT02288559|593674447|FG000|Overall Study|Adverse Event|1|||
164355169|NCT02288559|593674448|FG001|Overall Study|Adverse Event|1|||
164355170|NCT02288559|593674449|FG002|Overall Study|Adverse Event|5|||
164355171|NCT02288559|593674450|FG003|Overall Study|Adverse Event|0|||
164355172|NCT02288559|593674447|FG000|Overall Study|Death|0|||
164355173|NCT02288559|593674448|FG001|Overall Study|Death|0|||
164355174|NCT02288559|593674449|FG002|Overall Study|Death|1|||
164355175|NCT02288559|593674450|FG003|Overall Study|Death|0|||
164355176|NCT02288559|593674447|FG000|Overall Study|Lost to Follow-up|0|||
164355177|NCT02288559|593674448|FG001|Overall Study|Lost to Follow-up|0|||
164355178|NCT02288559|593674449|FG002|Overall Study|Lost to Follow-up|0|||
164355179|NCT02288559|593674450|FG003|Overall Study|Lost to Follow-up|1|||
164299514|NCT00906204|593472825|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
164299515|NCT00696072|593472826|FG000|Overall Study|continuing active treatment|10|||
164299516|NCT00696072|593472827|FG001|Overall Study|continuing active treatment|13|||
164299517|NCT00696072|593472826|FG000|Overall Study|Adverse Event|10|||
164299518|NCT00696072|593472827|FG001|Overall Study|Adverse Event|6|||
164299519|NCT00696072|593472826|FG000|Overall Study|Patient Request|3|||
164299520|NCT00696072|593472827|FG001|Overall Study|Patient Request|7|||
164299521|NCT00696072|593472826|FG000|Overall Study|Investigator Request|1|||
164299522|NCT00696072|593472827|FG001|Overall Study|Investigator Request|4|||
164299523|NCT00696072|593472826|FG000|Overall Study|Sponsor Request|0|||
164299524|NCT00696072|593472827|FG001|Overall Study|Sponsor Request|1|||
164299525|NCT00696072|593472826|FG000|Overall Study|Disease Progression|32|||
164299526|NCT00696072|593472827|FG001|Overall Study|Disease Progression|30|||
164299527|NCT00696072|593472826|FG000|Overall Study|Non-specified|1|||
164299528|NCT00696072|593472827|FG001|Overall Study|Non-specified|2|||
164299529|NCT00535496|593472828|FG000|Overall Study|Lost to Follow-up|0|||
164299530|NCT00535496|593472829|FG001|Overall Study|Lost to Follow-up|1|||
164299531|NCT00535496|593472830|FG002|Overall Study|Lost to Follow-up|0|||
164299532|NCT00535496|593472831|FG003|Overall Study|Lost to Follow-up|0|||
164299533|NCT00535496|593472828|FG000|Overall Study|Not treated with sugammadex|0|||
164299534|NCT00535496|593472829|FG001|Overall Study|Not treated with sugammadex|1|||
164299535|NCT00535496|593472830|FG002|Overall Study|Not treated with sugammadex|0|||
164299536|NCT00535496|593472831|FG003|Overall Study|Not treated with sugammadex|0|||
164299537|NCT00371150|593472832|FG000|Overall Study|Lost to Follow-up|3|||
164299538|NCT00371150|593472833|FG001|Overall Study|Lost to Follow-up|2|||
164299539|NCT00124943|593472834|FG000|Phase II|Adverse Event|0|||
164299540|NCT00124943|593472835|FG001|Phase II|Adverse Event|2|||
164299541|NCT00124943|593472836|FG002|Phase II|Adverse Event|0|||
164299542|NCT00124943|593472837|FG003|Phase II|Adverse Event|1|||
164299543|NCT00124943|593472834|FG000|Phase II|Protocol Violation|0|||
164299544|NCT00124943|593472835|FG001|Phase II|Protocol Violation|0|||
164299545|NCT00124943|593472836|FG002|Phase II|Protocol Violation|0|||
164299546|NCT00124943|593472837|FG003|Phase II|Protocol Violation|1|||
164299547|NCT00124943|593472834|FG000|Phase II|Lost to Follow-up|0|||
164355180|NCT02288559|593674447|FG000|Overall Study|Withdrawal by Subject|0|||
164355181|NCT02288559|593674448|FG001|Overall Study|Withdrawal by Subject|0|||
164355182|NCT02288559|593674449|FG002|Overall Study|Withdrawal by Subject|2|||
164355183|NCT02288559|593674450|FG003|Overall Study|Withdrawal by Subject|1|||
164355184|NCT02288559|593674447|FG000|Overall Study|Reason Not Specified|0|||
164355185|NCT02288559|593674448|FG001|Overall Study|Reason Not Specified|0|||
164299548|NCT00124943|593472835|FG001|Phase II|Lost to Follow-up|0|||
164299549|NCT00124943|593472836|FG002|Phase II|Lost to Follow-up|0|||
164299550|NCT00124943|593472837|FG003|Phase II|Lost to Follow-up|1|||
164299551|NCT00124943|593472834|FG000|Phase II|Withdrawal by Subject|0|||
164299552|NCT00124943|593472835|FG001|Phase II|Withdrawal by Subject|0|||
164299553|NCT00124943|593472836|FG002|Phase II|Withdrawal by Subject|0|||
164299554|NCT00124943|593472837|FG003|Phase II|Withdrawal by Subject|2|||
164355186|NCT02288559|593674449|FG002|Overall Study|Reason Not Specified|3|||
164355187|NCT02288559|593674450|FG003|Overall Study|Reason Not Specified|0|||
164355188|NCT02709785|593674453|FG000|Overall Study|Withdrawal by Subject|1|||
164355189|NCT02709785|593674454|FG001|Overall Study|Withdrawal by Subject|2|||
164355190|NCT02709785|593674455|FG002|Overall Study|Withdrawal by Subject|1|||
164355191|NCT01961323|593674458|FG000|Overall Study|Withdrawal by Subject|7|||
164355192|NCT01961323|593674458|FG000|Overall Study|Lost to Follow-up|8|||
164355193|NCT01961323|593674458|FG000|Overall Study|screen failure|34|||
164355194|NCT00810407|593674459|FG000|Overall Study|Protocol Violation|3|||
164355195|NCT00810407|593674459|FG000|Overall Study|No Visit After First Day of Treatment|3|||
164355196|NCT02320149|593674463|FG000|Overall Study|Adverse Event|3|||
164355197|NCT02320149|593674464|FG001|Overall Study|Adverse Event|7|||
164355198|NCT02320149|593674463|FG000|Overall Study|Withdrawal of Consent|28|||
164355199|NCT02320149|593674464|FG001|Overall Study|Withdrawal of Consent|32|||
164355200|NCT02320149|593674463|FG000|Overall Study|Lost to Follow-up|21|||
164355201|NCT02320149|593674464|FG001|Overall Study|Lost to Follow-up|34|||
164355202|NCT02320149|593674463|FG000|Overall Study|Protocol Violation|2|||
164355203|NCT02320149|593674464|FG001|Overall Study|Protocol Violation|1|||
164355204|NCT02320149|593674463|FG000|Overall Study|Noncompliance with Study Treatment|7|||
164355205|NCT02320149|593674464|FG001|Overall Study|Noncompliance with Study Treatment|2|||
164355206|NCT02320149|593674463|FG000|Overall Study|Lack of Efficacy|0|||
164355207|NCT02320149|593674464|FG001|Overall Study|Lack of Efficacy|1|||
164355208|NCT02320149|593674463|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164355209|NCT02320149|593674464|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164355210|NCT00276159|593674465|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
164355211|NCT00333866|593674468|FG000|Overall Study|Adverse Event|23|||
164355212|NCT00333866|593674469|FG001|Overall Study|Adverse Event|37|||
164355213|NCT00333866|593674470|FG002|Overall Study|Adverse Event|38|||
164355214|NCT00333866|593674471|FG003|Overall Study|Adverse Event|47|||
164355215|NCT00333866|593674468|FG000|Overall Study|Other|3|||
164355216|NCT00333866|593674469|FG001|Overall Study|Other|2|||
164355217|NCT00333866|593674470|FG002|Overall Study|Other|2|||
164355218|NCT00333866|593674471|FG003|Overall Study|Other|2|||
164355219|NCT00333866|593674468|FG000|Overall Study|Lack of Efficacy|8|||
164355220|NCT00333866|593674469|FG001|Overall Study|Lack of Efficacy|6|||
164355221|NCT00333866|593674470|FG002|Overall Study|Lack of Efficacy|3|||
164355222|NCT00333866|593674471|FG003|Overall Study|Lack of Efficacy|5|||
164355223|NCT00333866|593674468|FG000|Overall Study|Lost to Follow-up|1|||
164355224|NCT00333866|593674469|FG001|Overall Study|Lost to Follow-up|2|||
164355225|NCT00333866|593674470|FG002|Overall Study|Lost to Follow-up|2|||
164355226|NCT00333866|593674471|FG003|Overall Study|Lost to Follow-up|2|||
164355227|NCT00333866|593674468|FG000|Overall Study|Withdrawal by Subject|8|||
164355228|NCT00333866|593674469|FG001|Overall Study|Withdrawal by Subject|14|||
164355229|NCT00333866|593674470|FG002|Overall Study|Withdrawal by Subject|4|||
164355230|NCT00333866|593674471|FG003|Overall Study|Withdrawal by Subject|9|||
164355231|NCT00333866|593674468|FG000|Overall Study|Randomized but not Treated|5|||
164355232|NCT00333866|593674469|FG001|Overall Study|Randomized but not Treated|3|||
164355233|NCT00333866|593674470|FG002|Overall Study|Randomized but not Treated|2|||
164355234|NCT00333866|593674471|FG003|Overall Study|Randomized but not Treated|1|||
164355235|NCT06073119|593674472|FG000|Overall Study|Adverse Event|1|||
164355236|NCT06073119|593674473|FG001|Overall Study|Adverse Event|3|||
164355237|NCT06073119|593674474|FG002|Overall Study|Adverse Event|0|||
164355238|NCT06073119|593674475|FG003|Overall Study|Adverse Event|0|||
164355239|NCT06073119|593674476|FG004|Overall Study|Adverse Event|1|||
164355240|NCT06073119|593674477|FG005|Overall Study|Adverse Event|0|||
164090079|NCT01860976|592693328|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
164090080|NCT01860976|592693329|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
164090081|NCT01860976|592693328|FG000|Blinded Treatment|Withdrawal by Subject|3|||
164090082|NCT01860976|592693329|FG001|Blinded Treatment|Withdrawal by Subject|5|||
164090083|NCT01860976|592693328|FG000|Blinded Treatment|Subject no longer met criteria|1|||
164090084|NCT01860976|592693329|FG001|Blinded Treatment|Subject no longer met criteria|0|||
164090085|NCT01860976|592693328|FG000|Blinded Treatment|Entered Open-Label in error|0|||
164090086|NCT01860976|592693329|FG001|Blinded Treatment|Entered Open-Label in error|1|||
164090087|NCT01860976|592693328|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
164090088|NCT01860976|592693329|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
164090089|NCT01860976|592693328|FG000|Open-Label|Adverse Event|2|||
164090090|NCT01860976|592693329|FG001|Open-Label|Adverse Event|4|||
164090091|NCT01860976|592693328|FG000|Open-Label|Lack of Efficacy|16|||
164090092|NCT01860976|592693329|FG001|Open-Label|Lack of Efficacy|8|||
164090093|NCT01860976|592693328|FG000|Open-Label|Lost to Follow-up|1|||
164090094|NCT01860976|592693329|FG001|Open-Label|Lost to Follow-up|2|||
164090095|NCT01860976|592693328|FG000|Open-Label|Subject request discontinue treatment|4|||
164090096|NCT01860976|592693329|FG001|Open-Label|Subject request discontinue treatment|3|||
164090097|NCT01860976|592693328|FG000|Open-Label|Withdrawal by Subject|4|||
164090098|NCT01860976|592693329|FG001|Open-Label|Withdrawal by Subject|1|||
164090099|NCT01860976|592693328|FG000|Open-Label|Other Reasons|1|||
164090100|NCT01860976|592693329|FG001|Open-Label|Other Reasons|1|||
164090101|NCT01860976|592693328|FG000|Long Term Extension|Adverse Event|4|||
164090102|NCT01860976|592693329|FG001|Long Term Extension|Adverse Event|0|||
164355241|NCT06073119|593674472|FG000|Overall Study|Non-compliance with study schedule|1|||
164355242|NCT06073119|593674473|FG001|Overall Study|Non-compliance with study schedule|0|||
164355243|NCT06073119|593674474|FG002|Overall Study|Non-compliance with study schedule|0|||
164355244|NCT06073119|593674475|FG003|Overall Study|Non-compliance with study schedule|0|||
164355245|NCT06073119|593674476|FG004|Overall Study|Non-compliance with study schedule|1|||
164355246|NCT06073119|593674477|FG005|Overall Study|Non-compliance with study schedule|0|||
164355247|NCT06073119|593674472|FG000|Overall Study|Withdrawal by Subject|4|||
164355248|NCT06073119|593674473|FG001|Overall Study|Withdrawal by Subject|4|||
164355249|NCT06073119|593674474|FG002|Overall Study|Withdrawal by Subject|3|||
164355250|NCT06073119|593674475|FG003|Overall Study|Withdrawal by Subject|5|||
164355251|NCT06073119|593674476|FG004|Overall Study|Withdrawal by Subject|3|||
164355252|NCT06073119|593674477|FG005|Overall Study|Withdrawal by Subject|1|||
164355253|NCT06073119|593674472|FG000|Overall Study|Other|2|||
164355254|NCT06073119|593674473|FG001|Overall Study|Other|4|||
164355255|NCT06073119|593674474|FG002|Overall Study|Other|1|||
164355256|NCT06073119|593674475|FG003|Overall Study|Other|0|||
164355257|NCT06073119|593674476|FG004|Overall Study|Other|1|||
164355258|NCT06073119|593674477|FG005|Overall Study|Other|0|||
163899983|NCT01961609|592005596|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
164355259|NCT01359449|593674480|FG000|Overall Study|Lost to Follow-up|1|||
164355260|NCT01359449|593674481|FG001|Overall Study|Lost to Follow-up|0|||
164355261|NCT01359449|593674480|FG000|Overall Study|Protocol Violation|0|||
164355262|NCT01359449|593674481|FG001|Overall Study|Protocol Violation|2|||
164355263|NCT01359449|593674480|FG000|Overall Study|Withdrawal by Subject|3|||
164355264|NCT01359449|593674481|FG001|Overall Study|Withdrawal by Subject|2|||
164355265|NCT01907815|593674485|FG000|Overall Study|Withdrawal by Subject|1|||
164355266|NCT01907815|593674486|FG001|Overall Study|Withdrawal by Subject|0|||
164355267|NCT00191789|593674487|FG000|Overall Study|Adverse Event|5|||
164355268|NCT00191789|593674487|FG000|Overall Study|Patient: Satisfactory Response|5|||
164355269|NCT00191789|593674487|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
164355270|NCT00191789|593674487|FG000|Overall Study|Withdrawal by Subject|4|||
164355271|NCT00191789|593674487|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
164355272|NCT00191789|593674487|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
164355273|NCT00191789|593674487|FG000|Overall Study|Death - Not Study-Drug Related|1|||
164355274|NCT01414855|593674488|FG000|Overall Study|Death|17|||
164355275|NCT01414855|593674488|FG000|Overall Study|Lost to Follow-up|5|||
164090103|NCT01860976|592693328|FG000|Long Term Extension|Lack of Efficacy|2|||
164355276|NCT01414855|593674488|FG000|Overall Study|Withdrawal by Subject|7|||
164355277|NCT01937559|593674491|FG000|Overall Study|Physician Decision|3|||
164355278|NCT01937559|593674492|FG001|Overall Study|Physician Decision|3|||
164355279|NCT01937559|593674493|FG002|Overall Study|Physician Decision|0|||
164355280|NCT01937559|593674491|FG000|Overall Study|Withdrawal by Subject|6|||
164355281|NCT01937559|593674492|FG001|Overall Study|Withdrawal by Subject|4|||
164355282|NCT01937559|593674493|FG002|Overall Study|Withdrawal by Subject|0|||
164355283|NCT01937559|593674491|FG000|Overall Study|screen fail|2|||
164090104|NCT01860976|592693329|FG001|Long Term Extension|Lack of Efficacy|0|||
164090105|NCT01860976|592693328|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
164090106|NCT01860976|592693329|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
164090107|NCT01860976|592693328|FG000|Long Term Extension|Lost to Follow-up|2|||
164090108|NCT01860976|592693329|FG001|Long Term Extension|Lost to Follow-up|0|||
164355284|NCT01937559|593674492|FG001|Overall Study|screen fail|4|||
164355285|NCT01937559|593674493|FG002|Overall Study|screen fail|0|||
163899984|NCT01961609|592005593|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
163899985|NCT01961609|592005594|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
164299555|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
164299556|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
164299557|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
164299558|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
164299559|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
164299560|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
164299561|NCT03181932|593472838|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
164299562|NCT03181932|593472839|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
164299563|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
164299564|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
164299565|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
164299566|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
164299567|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
164299568|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
164299569|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
164299570|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
164299571|NCT03181932|593472838|FG000|Period 2 (Open-label Period)|Reason missing|2|||
164299572|NCT03181932|593472839|FG001|Period 2 (Open-label Period)|Reason missing|0|||
164299573|NCT03304626|593472840|FG000|Overall Study|Adverse Event|1|||
164299574|NCT03304626|593472841|FG001|Overall Study|Adverse Event|0|||
164299575|NCT03304626|593472840|FG000|Overall Study|Lack of Efficacy|1|||
164299576|NCT03304626|593472841|FG001|Overall Study|Lack of Efficacy|1|||
164299577|NCT00408317|593472848|FG000|First Intervention Period|Adverse Event|0|||
164299578|NCT00408317|593472849|FG001|First Intervention Period|Adverse Event|1|||
164299579|NCT00408317|593472848|FG000|Second Intervention Period|Adverse Event|2|||
164299580|NCT00408317|593472849|FG001|Second Intervention Period|Adverse Event|0|||
164299581|NCT00408317|593472848|FG000|Second Intervention Period|Protocol Violation|0|||
164299582|NCT00408317|593472849|FG001|Second Intervention Period|Protocol Violation|1|||
164299583|NCT00408317|593472848|FG000|Second Intervention Period|Withdrawal of consent|0|||
164299584|NCT00408317|593472849|FG001|Second Intervention Period|Withdrawal of consent|1|||
164299585|NCT02379728|593472852|FG000|Overall Study|Lost to Follow-up|1|||
164299586|NCT02379728|593472853|FG001|Overall Study|Lost to Follow-up|0|||
164299587|NCT02379728|593472854|FG002|Overall Study|Lost to Follow-up|3|||
164299588|NCT02379728|593472855|FG003|Overall Study|Lost to Follow-up|0|||
164299589|NCT02379728|593472852|FG000|Overall Study|Withdrawal by Subject|5|||
164299590|NCT02379728|593472853|FG001|Overall Study|Withdrawal by Subject|0|||
164299591|NCT02379728|593472854|FG002|Overall Study|Withdrawal by Subject|5|||
164299592|NCT02379728|593472855|FG003|Overall Study|Withdrawal by Subject|3|||
164299593|NCT02379728|593472852|FG000|Overall Study|Protocol Violation|0|||
164299594|NCT02379728|593472853|FG001|Overall Study|Protocol Violation|0|||
164299595|NCT02379728|593472854|FG002|Overall Study|Protocol Violation|2|||
164299596|NCT02379728|593472855|FG003|Overall Study|Protocol Violation|0|||
164299597|NCT01921205|593472856|FG000|Overall Study|Adverse Event|12|||
164299598|NCT01921205|593472857|FG001|Overall Study|Adverse Event|7|||
164299599|NCT01921205|593472856|FG000|Overall Study|Lack of Efficacy|1|||
164299600|NCT01921205|593472857|FG001|Overall Study|Lack of Efficacy|0|||
164299601|NCT01921205|593472856|FG000|Overall Study|Protocol Violation|1|||
164299602|NCT01921205|593472857|FG001|Overall Study|Protocol Violation|3|||
164299603|NCT01921205|593472856|FG000|Overall Study|Lost to Follow-up|1|||
164299604|NCT01921205|593472857|FG001|Overall Study|Lost to Follow-up|1|||
164299605|NCT01921205|593472856|FG000|Overall Study|Withdrawal by Subject|6|||
164299606|NCT01921205|593472857|FG001|Overall Study|Withdrawal by Subject|5|||
164299607|NCT01921205|593472856|FG000|Overall Study|Use Of Prohibited Medication|0|||
164299608|NCT01921205|593472857|FG001|Overall Study|Use Of Prohibited Medication|1|||
164299609|NCT01921205|593472856|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
164299610|NCT01921205|593472857|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
164299611|NCT01921205|593472856|FG000|Overall Study|Non Compliance Of The Parent|0|||
164299612|NCT01921205|593472857|FG001|Overall Study|Non Compliance Of The Parent|1|||
164299613|NCT01921205|593472856|FG000|Overall Study|Non Compliance Of Child|0|||
164299614|NCT01921205|593472857|FG001|Overall Study|Non Compliance Of Child|1|||
164299615|NCT03331315|593472858|FG000|Overall Study|Physician Decision|18|||
164299616|NCT03331315|593472859|FG001|Overall Study|Physician Decision|14|||
164299617|NCT00360230|593472860|FG000|Overall Study|Withdrawal by Subject|1|||
164299618|NCT00360230|593472861|FG001|Overall Study|Withdrawal by Subject|1|||
164299619|NCT00360230|593472862|FG002|Overall Study|Withdrawal by Subject|0|||
164299620|NCT00360230|593472863|FG003|Overall Study|Withdrawal by Subject|1|||
163899986|NCT01961609|592005595|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
164299621|NCT00360230|593472864|FG004|Overall Study|Withdrawal by Subject|1|||
164299622|NCT00360230|593472865|FG005|Overall Study|Withdrawal by Subject|1|||
164299623|NCT00360230|593472866|FG006|Overall Study|Withdrawal by Subject|0|||
164299624|NCT00360230|593472860|FG000|Overall Study|Migrated|4|||
164355286|NCT03653637|593676318|FG000|Overall Study|Death|1|||
164355287|NCT03653637|593676319|FG001|Overall Study|Death|3|||
164355288|NCT03653637|593676318|FG000|Overall Study|Lost to Follow-up|29|||
164355289|NCT03653637|593676319|FG001|Overall Study|Lost to Follow-up|30|||
164355290|NCT03653637|593676318|FG000|Overall Study|Physician Decision|1|||
164355291|NCT03653637|593676319|FG001|Overall Study|Physician Decision|1|||
164355292|NCT03653637|593676318|FG000|Overall Study|Withdrawal by Subject|7|||
164355293|NCT03653637|593676319|FG001|Overall Study|Withdrawal by Subject|4|||
164355294|NCT02068443|593676322|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164355295|NCT02068443|593676323|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
164355296|NCT02068443|593676324|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
164355297|NCT02068443|593676322|FG000|Overall Study|Voluntary Withdrawal|4|||
164355298|NCT02068443|593676323|FG001|Overall Study|Voluntary Withdrawal|0|||
164355299|NCT02068443|593676324|FG002|Overall Study|Voluntary Withdrawal|1|||
164355300|NCT02068443|593676322|FG000|Overall Study|Lack of Efficacy|2|||
164355301|NCT02068443|593676323|FG001|Overall Study|Lack of Efficacy|1|||
164355302|NCT02068443|593676324|FG002|Overall Study|Lack of Efficacy|0|||
164355303|NCT02068443|593676322|FG000|Overall Study|Other Reason Not Specified|1|||
164355304|NCT02068443|593676323|FG001|Overall Study|Other Reason Not Specified|0|||
164355305|NCT02068443|593676324|FG002|Overall Study|Other Reason Not Specified|0|||
164355306|NCT02723084|593676326|FG000|Overall Study|Withdrawal by Subject|1|||
164355307|NCT02723084|593676327|FG001|Overall Study|Withdrawal by Subject|1|||
164355308|NCT02723084|593676326|FG000|Overall Study|Lost to Follow-up|3|||
164355309|NCT02723084|593676327|FG001|Overall Study|Lost to Follow-up|0|||
164355310|NCT04067544|593676330|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
164355311|NCT01320085|593676331|FG000|Overall Study|Disease Progression|26|||
164355312|NCT01320085|593676332|FG001|Overall Study|Disease Progression|93|||
164355313|NCT01320085|593676333|FG002|Overall Study|Disease Progression|17|||
164355314|NCT01320085|593676331|FG000|Overall Study|Adverse Event|12|||
164355315|NCT01320085|593676332|FG001|Overall Study|Adverse Event|20|||
164355316|NCT01320085|593676333|FG002|Overall Study|Adverse Event|5|||
164355317|NCT01320085|593676331|FG000|Overall Study|Withdrawal by Subject|2|||
164355318|NCT01320085|593676332|FG001|Overall Study|Withdrawal by Subject|4|||
164355319|NCT01320085|593676333|FG002|Overall Study|Withdrawal by Subject|1|||
164355320|NCT01320085|593676331|FG000|Overall Study|Protocol Deviation|1|||
164355321|NCT01320085|593676332|FG001|Overall Study|Protocol Deviation|0|||
164355322|NCT01320085|593676333|FG002|Overall Study|Protocol Deviation|1|||
164355323|NCT01320085|593676331|FG000|Overall Study|Administrative problems|0|||
164355324|NCT01320085|593676332|FG001|Overall Study|Administrative problems|0|||
164355325|NCT01320085|593676333|FG002|Overall Study|Administrative problems|1|||
164355326|NCT00225251|593676336|FG000|Overall Study|Withdrawal by Subject|1|||
164355327|NCT00225251|593676337|FG001|Overall Study|Withdrawal by Subject|1|||
164355328|NCT01702454|593676338|FG000|Overall Study|Consent withdrawal|0|||
164355329|NCT01702454|593676339|FG001|Overall Study|Consent withdrawal|1|||
164355330|NCT01702454|593676338|FG000|Overall Study|Migrated/moved from study area|0|||
164355331|NCT01702454|593676339|FG001|Overall Study|Migrated/moved from study area|1|||
164355332|NCT01702454|593676338|FG000|Overall Study|Lost to Follow-up|3|||
164355333|NCT01702454|593676339|FG001|Overall Study|Lost to Follow-up|6|||
164355334|NCT00082355|593676340|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
164355335|NCT00082355|593676340|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
164355336|NCT00082355|593676340|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
164355337|NCT02233309|593676343|FG000|Overall Study|Physician Decision|5|||
164355338|NCT00475176|593676348|FG000|Overall Study|Adverse Event|2|||
164355339|NCT00475176|593676348|FG000|Overall Study|Withdrawal by Subject|1|||
164355340|NCT00475176|593676348|FG000|Overall Study|Protocol Violation|1|||
164355341|NCT01484873|593676349|FG000|Overall Study|Withdrawal by Subject|2|||
164355342|NCT01549392|593676350|FG000|Overall Study|Withdrawal by Subject|1|||
164355343|NCT01549392|593676351|FG001|Overall Study|Withdrawal by Subject|0|||
164355344|NCT00227903|593676352|FG000|Overall Study|Withdrawal by Subject|2|||
164355345|NCT00227903|593676353|FG001|Overall Study|Withdrawal by Subject|5|||
164355346|NCT00227903|593676352|FG000|Overall Study|Subject moved out of area|1|||
164355347|NCT00227903|593676353|FG001|Overall Study|Subject moved out of area|2|||
164355348|NCT00227903|593676352|FG000|Overall Study|Lost to Follow-up|1|||
164355349|NCT00227903|593676353|FG001|Overall Study|Lost to Follow-up|3|||
164355350|NCT00227903|593676352|FG000|Overall Study|Miscarriage|1|||
164355351|NCT00227903|593676353|FG001|Overall Study|Miscarriage|0|||
164355352|NCT01475331|593676354|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
164355353|NCT01475331|593676355|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
164355354|NCT01475331|593676354|FG000|Overall Study|excessive main duct communication|1|||
164355355|NCT01475331|593676355|FG001|Overall Study|excessive main duct communication|1|||
164355356|NCT01475331|593676354|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
164355357|NCT01475331|593676355|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
164355358|NCT01475331|593676354|FG000|Overall Study|Sign of malignancy during the procedure|2|||
164355359|NCT01475331|593676355|FG001|Overall Study|Sign of malignancy during the procedure|0|||
164355360|NCT01475331|593676354|FG000|Overall Study|cyst found to be prohibitively small|0|||
164355361|NCT01475331|593676355|FG001|Overall Study|cyst found to be prohibitively small|1|||
164355362|NCT00462761|593676356|FG000|Overall Study|Adverse Event|6|||
164355363|NCT00462761|593676356|FG000|Overall Study|Withdrawal by Subject|9|||
164355364|NCT00462761|593676356|FG000|Overall Study|Physician Decision|5|||
164355365|NCT00462761|593676356|FG000|Overall Study|Disease progression|43|||
164355366|NCT00462761|593676356|FG000|Overall Study|Death|12|||
164355367|NCT00462761|593676356|FG000|Overall Study|Other|1|||
164355368|NCT02877082|593676357|FG000|Overall Study|Trial was closed early|5|||
164355369|NCT00311623|593676360|FG000|Overall Study|Physician Decision|0|||
164355370|NCT00311623|593676361|FG001|Overall Study|Physician Decision|0|||
164355371|NCT00311623|593676362|FG002|Overall Study|Physician Decision|2|||
164355372|NCT03998189|593676363|FG000|Overall Study|Lack of Efficacy|0|||
164355373|NCT03998189|593676364|FG001|Overall Study|Lack of Efficacy|1|||
164355374|NCT04983264|593676365|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
164355375|NCT04983264|593676366|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
163899987|NCT01961609|592005596|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
163899988|NCT01961609|592005593|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
163899989|NCT01961609|592005594|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
164355376|NCT04983264|593676367|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
164355377|NCT04983264|593676365|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
164355378|NCT04983264|593676366|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
164355379|NCT04983264|593676367|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
164355380|NCT00558025|593676370|FG000|Overall Study|Adverse Event|1|||
164355381|NCT00558025|593676371|FG001|Overall Study|Adverse Event|1|||
164355382|NCT00558025|593676370|FG000|Overall Study|Withdrawal by Subject|2|||
164355383|NCT00558025|593676371|FG001|Overall Study|Withdrawal by Subject|2|||
164355384|NCT00558025|593676370|FG000|Overall Study|Protocol Violation|1|||
164355385|NCT00558025|593676371|FG001|Overall Study|Protocol Violation|0|||
164355386|NCT01506479|593676372|FG000|Overall Study|Lost to Follow-up|1|||
164355387|NCT01506479|593676373|FG001|Overall Study|Lost to Follow-up|2|||
164355388|NCT01506479|593676374|FG002|Overall Study|Lost to Follow-up|2|||
164355389|NCT01506479|593676372|FG000|Overall Study|Withdrawal by Subject|1|||
163899990|NCT01961609|592005595|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
164355390|NCT01506479|593676373|FG001|Overall Study|Withdrawal by Subject|2|||
164355391|NCT01506479|593676374|FG002|Overall Study|Withdrawal by Subject|1|||
164090109|NCT01860976|592693328|FG000|Long Term Extension|subject withdrew consent|7|||
164090110|NCT01860976|592693329|FG001|Long Term Extension|subject withdrew consent|0|||
164090111|NCT02153398|592693331|FG000|Overall Study|Withdrawal by Subject|1|||
164090112|NCT02153398|592693332|FG001|Overall Study|Withdrawal by Subject|0|||
164090113|NCT02153398|592693333|FG002|Overall Study|Withdrawal by Subject|0|||
164090114|NCT02153398|592693334|FG003|Overall Study|Withdrawal by Subject|0|||
164090115|NCT02153398|592693335|FG004|Overall Study|Withdrawal by Subject|0|||
164090116|NCT02153398|592693331|FG000|Overall Study|Adverse Event|0|||
164090117|NCT02153398|592693332|FG001|Overall Study|Adverse Event|0|||
164090118|NCT02153398|592693333|FG002|Overall Study|Adverse Event|1|||
164090119|NCT02153398|592693334|FG003|Overall Study|Adverse Event|1|||
164090120|NCT02153398|592693335|FG004|Overall Study|Adverse Event|0|||
164090121|NCT02204371|592693337|FG000|Overall Study|Adverse Event|1|||
164090122|NCT00810368|592693338|FG000|Overall Study|Lost to Follow-up|4|||
164090123|NCT00810368|592693339|FG001|Overall Study|Lost to Follow-up|2|||
164090124|NCT00810368|592693338|FG000|Overall Study|Lack of Efficacy|2|||
164090125|NCT00810368|592693339|FG001|Overall Study|Lack of Efficacy|0|||
164090126|NCT01506947|592693340|FG000|Overall Study|Lost to Follow-up|7|||
164090127|NCT01506947|592693340|FG000|Overall Study|Adverse Event|5|||
164090128|NCT01506947|592693340|FG000|Overall Study|Death|1|||
164090129|NCT01506947|592693340|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
164090130|NCT01781286|592693345|FG000|Overall Study|Lost to Follow-up|0|||
164090131|NCT01781286|592693346|FG001|Overall Study|Lost to Follow-up|0|||
164090132|NCT01781286|592693347|FG002|Overall Study|Lost to Follow-up|0|||
164090133|NCT01781286|592693348|FG003|Overall Study|Lost to Follow-up|0|||
164090134|NCT01781286|592693349|FG004|Overall Study|Lost to Follow-up|0|||
164090135|NCT01781286|592693350|FG005|Overall Study|Lost to Follow-up|1|||
164090136|NCT01781286|592693345|FG000|Overall Study|Time Constraints|2|||
164090137|NCT01781286|592693346|FG001|Overall Study|Time Constraints|0|||
164090138|NCT01781286|592693347|FG002|Overall Study|Time Constraints|2|||
164090139|NCT01781286|592693348|FG003|Overall Study|Time Constraints|0|||
164090140|NCT01781286|592693349|FG004|Overall Study|Time Constraints|0|||
164090141|NCT01781286|592693350|FG005|Overall Study|Time Constraints|0|||
164090142|NCT01781286|592693345|FG000|Overall Study|Noncompliance|0|||
164090143|NCT01781286|592693346|FG001|Overall Study|Noncompliance|0|||
164090144|NCT01781286|592693347|FG002|Overall Study|Noncompliance|0|||
164090145|NCT01781286|592693348|FG003|Overall Study|Noncompliance|1|||
164090146|NCT01781286|592693349|FG004|Overall Study|Noncompliance|0|||
164090147|NCT01781286|592693350|FG005|Overall Study|Noncompliance|0|||
164090148|NCT03365375|592693351|FG000|Overall Study|Withdrawal by Subject|0|||
164090149|NCT03365375|592693352|FG001|Overall Study|Withdrawal by Subject|1|||
164090150|NCT03365375|592693351|FG000|Overall Study|Lost to Follow-up|0|||
164090151|NCT03365375|592693352|FG001|Overall Study|Lost to Follow-up|4|||
164090152|NCT02187042|592693353|FG000|Overall Study|Death|1|||
164090153|NCT02187042|592693354|FG001|Overall Study|Death|1|||
164090154|NCT02187042|592693353|FG000|Overall Study|Toxicity|6|||
164090155|NCT02187042|592693354|FG001|Overall Study|Toxicity|5|||
164090156|NCT02187042|592693353|FG000|Overall Study|Participant choice|1|||
164090157|NCT02187042|592693354|FG001|Overall Study|Participant choice|0|||
164090158|NCT02187042|592693353|FG000|Overall Study|Doctor choice|1|||
164090159|NCT02187042|592693354|FG001|Overall Study|Doctor choice|0|||
164090160|NCT02187042|592693353|FG000|Overall Study|Progressive disease|4|||
164090161|NCT02187042|592693354|FG001|Overall Study|Progressive disease|8|||
164090162|NCT01659567|592693361|FG000|Overall Study|Lack of Efficacy|22|||
164090163|NCT01659567|592693361|FG000|Overall Study|Switched to Pegferon|6|||
164090164|NCT01659567|592693361|FG000|Overall Study|Adverse Event|12|||
164090165|NCT01659567|592693361|FG000|Overall Study|Good result at early stage of treatment|5|||
164090166|NCT01659567|592693361|FG000|Overall Study|Withdrawal by Subject|64|||
164090167|NCT01659567|592693361|FG000|Overall Study|Progression of the main disease|1|||
164090168|NCT01659567|592693361|FG000|Overall Study|Other|13|||
164090169|NCT01179919|592693364|FG000|Overall Study|Protocol Violation|1|||
164355392|NCT01506479|593676372|FG000|Overall Study|Missing assessment|1|||
164355393|NCT01506479|593676373|FG001|Overall Study|Missing assessment|0|||
164355394|NCT01506479|593676374|FG002|Overall Study|Missing assessment|0|||
164355395|NCT01506479|593676372|FG000|Overall Study|Adverse Event|0|||
164090170|NCT01179919|592693364|FG000|Overall Study|Adverse Event|1|||
164090171|NCT01915732|592693375|FG000|Overall Study|Withdrawal by Subject|18|||
164090172|NCT01915732|592693376|FG001|Overall Study|Withdrawal by Subject|18|||
164090173|NCT01915732|592693375|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
164090174|NCT01915732|592693376|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164090175|NCT01915732|592693375|FG000|Overall Study|Adverse Event|12|||
164090176|NCT01915732|592693376|FG001|Overall Study|Adverse Event|4|||
164090177|NCT01915732|592693375|FG000|Overall Study|Protocol Violation|5|||
164090178|NCT01915732|592693376|FG001|Overall Study|Protocol Violation|5|||
164090179|NCT01915732|592693375|FG000|Overall Study|Lack of Efficacy|6|||
164090180|NCT01915732|592693376|FG001|Overall Study|Lack of Efficacy|11|||
164090181|NCT01915732|592693375|FG000|Overall Study|Lost to Follow-up|22|||
164090182|NCT01915732|592693376|FG001|Overall Study|Lost to Follow-up|26|||
164090183|NCT01915732|592693375|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
164090184|NCT01915732|592693376|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
164090185|NCT01915732|592693375|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
164090186|NCT01915732|592693376|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
164090187|NCT01915732|592693375|FG000|Overall Study|Drug Release Error|1|||
164090188|NCT01915732|592693376|FG001|Overall Study|Drug Release Error|0|||
164090189|NCT01915732|592693375|FG000|Overall Study|Recovered|1|||
164090190|NCT01915732|592693376|FG001|Overall Study|Recovered|0|||
164090191|NCT01915732|592693375|FG000|Overall Study|Pregnancy|1|||
164090192|NCT01915732|592693376|FG001|Overall Study|Pregnancy|0|||
164090193|NCT01915732|592693375|FG000|Overall Study|Poor Perceived Efficacy|1|||
164090194|NCT01915732|592693376|FG001|Overall Study|Poor Perceived Efficacy|0|||
164090195|NCT01915732|592693375|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
164355396|NCT01506479|593676373|FG001|Overall Study|Adverse Event|1|||
164355397|NCT01506479|593676374|FG002|Overall Study|Adverse Event|0|||
164355398|NCT05247866|593676376|FG000|Overall Study|Adverse Event|2|||
164355399|NCT05247866|593676376|FG000|Overall Study|Lack of Efficacy|1|||
164355400|NCT05247866|593676376|FG000|Overall Study|Protocol Violation|1|||
164355401|NCT05247866|593676376|FG000|Overall Study|Withdrawal by Subject|3|||
164355402|NCT03315208|593676379|FG000|Overall Study|Lost to Follow-up|11|||
164355403|NCT03315208|593676380|FG001|Overall Study|Lost to Follow-up|6|||
164355404|NCT03315208|593676379|FG000|Overall Study|Withdrawal by Subject|2|||
164355405|NCT03315208|593676380|FG001|Overall Study|Withdrawal by Subject|0|||
164355406|NCT02746874|593676381|FG000|Overall Study|Withdrawal by Subject|0|||
164355407|NCT02746874|593676382|FG001|Overall Study|Withdrawal by Subject|1|||
164355408|NCT02746874|593676381|FG000|Overall Study|Surgery Date Changed|0|||
164355409|NCT02746874|593676382|FG001|Overall Study|Surgery Date Changed|2|||
164355410|NCT01156311|593676386|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
164355411|NCT01156311|593676387|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
164355412|NCT01156311|593676388|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
164355413|NCT01156311|593676389|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
164355414|NCT01156311|593676386|FG000|2-Month Monotherapy Period|Physician Decision|0|||
164355415|NCT01156311|593676387|FG001|2-Month Monotherapy Period|Physician Decision|1|||
164355416|NCT01156311|593676388|FG002|2-Month Monotherapy Period|Physician Decision|0|||
164355417|NCT01156311|593676389|FG003|2-Month Monotherapy Period|Physician Decision|0|||
164090196|NCT01915732|592693376|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
164355418|NCT01156311|593676386|FG000|2-Month Monotherapy Period|Other|1|||
164090197|NCT01915732|592693375|FG000|Overall Study|Got Well|0|||
164090198|NCT01915732|592693376|FG001|Overall Study|Got Well|1|||
164090199|NCT01915732|592693375|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
164355419|NCT01156311|593676387|FG001|2-Month Monotherapy Period|Other|0|||
164090200|NCT01915732|592693376|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
164090201|NCT01915732|592693375|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
164355420|NCT01156311|593676388|FG002|2-Month Monotherapy Period|Other|0|||
164355421|NCT01156311|593676389|FG003|2-Month Monotherapy Period|Other|0|||
164355422|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
164006429|NCT02158533|592390964|FG002|Stage 1|Lost to Follow-up|0|||
164355423|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
164355424|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
164355425|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
164355426|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
164355427|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
164355428|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
164355429|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
164355430|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
164355431|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
164355432|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
164355433|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
164355434|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
164355435|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
164355436|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
164355437|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
164355438|NCT01156311|593676386|FG000|6-month Add-on Therapy Period|Other|0|||
164355439|NCT01156311|593676387|FG001|6-month Add-on Therapy Period|Other|0|||
164355440|NCT01156311|593676388|FG002|6-month Add-on Therapy Period|Other|1|||
164355441|NCT01156311|593676389|FG003|6-month Add-on Therapy Period|Other|2|||
164355442|NCT06133348|593676392|FG000|Overall Study|Death|3|||
164355443|NCT06133348|593676392|FG000|Overall Study|Lost to Follow-up|1|||
164355444|NCT06133348|593676392|FG000|Overall Study|Physician Decision|1|||
164355445|NCT06133348|593676392|FG000|Overall Study|Withdrawal by Subject|5|||
164355446|NCT02393547|593676395|FG000|Overall Study|Adverse Event|2|||
164355447|NCT02393547|593676395|FG000|Overall Study|Withdrawal by Subject|3|||
164355448|NCT02393547|593676395|FG000|Overall Study|Lost to Follow-up|1|||
164355449|NCT00429104|593676397|FG000|Overall Study|Protocol Violation|1|||
164355450|NCT04997161|593676414|FG000|Overall Study|Study terminated by sponsor|3|||
164355451|NCT00752232|593676415|FG000|Overall Study|Protocol Violation|0|||
164355452|NCT00752232|593676416|FG001|Overall Study|Protocol Violation|0|||
164355453|NCT00752232|593676417|FG002|Overall Study|Protocol Violation|0|||
164355454|NCT00752232|593676418|FG003|Overall Study|Protocol Violation|0|||
164355455|NCT00752232|593676419|FG004|Overall Study|Protocol Violation|0|||
164355456|NCT00752232|593676420|FG005|Overall Study|Protocol Violation|1|||
164355457|NCT00752232|593676421|FG006|Overall Study|Protocol Violation|0|||
164355458|NCT00752232|593676415|FG000|Overall Study|Caregiver request|2|||
164355459|NCT00752232|593676416|FG001|Overall Study|Caregiver request|0|||
164355460|NCT00752232|593676417|FG002|Overall Study|Caregiver request|0|||
164355461|NCT00752232|593676418|FG003|Overall Study|Caregiver request|0|||
164355462|NCT00752232|593676419|FG004|Overall Study|Caregiver request|1|||
164355463|NCT00752232|593676420|FG005|Overall Study|Caregiver request|0|||
164355464|NCT00752232|593676421|FG006|Overall Study|Caregiver request|0|||
164355465|NCT00752232|593676415|FG000|Overall Study|Investigator request|0|||
164355466|NCT00752232|593676416|FG001|Overall Study|Investigator request|0|||
164355467|NCT00752232|593676417|FG002|Overall Study|Investigator request|0|||
164355468|NCT00752232|593676418|FG003|Overall Study|Investigator request|0|||
164355469|NCT00752232|593676419|FG004|Overall Study|Investigator request|1|||
164355470|NCT00752232|593676420|FG005|Overall Study|Investigator request|0|||
164355471|NCT00752232|593676421|FG006|Overall Study|Investigator request|0|||
164355472|NCT00752232|593676415|FG000|Overall Study|Subject request|0|||
164355473|NCT00752232|593676416|FG001|Overall Study|Subject request|0|||
164355474|NCT00752232|593676417|FG002|Overall Study|Subject request|1|||
164355475|NCT00752232|593676418|FG003|Overall Study|Subject request|0|||
164355476|NCT00752232|593676419|FG004|Overall Study|Subject request|0|||
164355477|NCT00752232|593676420|FG005|Overall Study|Subject request|0|||
164355478|NCT00752232|593676421|FG006|Overall Study|Subject request|0|||
164355479|NCT00752232|593676415|FG000|Overall Study|Group home admission|0|||
164355480|NCT00752232|593676416|FG001|Overall Study|Group home admission|0|||
164355481|NCT00752232|593676417|FG002|Overall Study|Group home admission|0|||
164355482|NCT00752232|593676418|FG003|Overall Study|Group home admission|1|||
164355483|NCT00752232|593676419|FG004|Overall Study|Group home admission|0|||
164355484|NCT00752232|593676420|FG005|Overall Study|Group home admission|0|||
164355485|NCT00752232|593676421|FG006|Overall Study|Group home admission|0|||
164355486|NCT00752232|593676415|FG000|Overall Study|Caregiver could not attend the subject|0|||
164355487|NCT00752232|593676416|FG001|Overall Study|Caregiver could not attend the subject|0|||
164355488|NCT00752232|593676417|FG002|Overall Study|Caregiver could not attend the subject|0|||
164355489|NCT00752232|593676418|FG003|Overall Study|Caregiver could not attend the subject|0|||
164355490|NCT00752232|593676419|FG004|Overall Study|Caregiver could not attend the subject|1|||
164355491|NCT00752232|593676420|FG005|Overall Study|Caregiver could not attend the subject|0|||
164355492|NCT00752232|593676421|FG006|Overall Study|Caregiver could not attend the subject|0|||
164355493|NCT04502589|593676422|FG000|Overall Study|Physician Decision|1|||
164355494|NCT04502589|593676423|FG001|Overall Study|Physician Decision|0|||
164355495|NCT02730455|593676425|FG000|Overall Study|Death|5|||
164355496|NCT02730455|593676426|FG001|Overall Study|Death|6|||
164355497|NCT02730455|593676427|FG002|Overall Study|Death|4|||
164090202|NCT01915732|592693376|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
164090203|NCT01915732|592693375|FG000|Overall Study|Job Transfer|0|||
164090204|NCT01915732|592693376|FG001|Overall Study|Job Transfer|1|||
164090205|NCT01915732|592693375|FG000|Overall Study|Improper Facial Procedure|0|||
164090206|NCT01915732|592693376|FG001|Overall Study|Improper Facial Procedure|1|||
164090207|NCT01915732|592693375|FG000|Overall Study|Poor Conscious Effect|0|||
164090208|NCT01915732|592693376|FG001|Overall Study|Poor Conscious Effect|1|||
164090209|NCT01325207|592693377|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164090210|NCT01325207|592693378|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164090211|NCT01325207|592693379|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164090212|NCT01325207|592693380|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164090213|NCT01325207|592693381|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
164090214|NCT01325207|592693382|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
164090215|NCT01325207|592693377|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
164090216|NCT01325207|592693378|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
164090217|NCT01325207|592693379|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
164133262|NCT02283983|592852718|FG001|Overall Study|Lost to Follow-up|8|||
164090218|NCT01325207|592693380|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
164090219|NCT01325207|592693381|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
164090220|NCT01325207|592693382|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
164090221|NCT01325207|592693377|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164090222|NCT01325207|592693378|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164090223|NCT01325207|592693379|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164090224|NCT01325207|592693380|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
164090225|NCT01325207|592693381|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
164090226|NCT01325207|592693382|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
164090227|NCT01325207|592693377|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164090228|NCT01325207|592693378|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
164090229|NCT01325207|592693379|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164090230|NCT01325207|592693380|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164090231|NCT01325207|592693381|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164090232|NCT01325207|592693382|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
164090233|NCT01325207|592693377|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164090234|NCT01325207|592693378|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164090235|NCT01325207|592693379|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164090236|NCT01325207|592693380|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164090237|NCT01325207|592693381|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
164090238|NCT01325207|592693382|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
164090239|NCT01325207|592693377|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164090240|NCT01325207|592693378|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164090241|NCT01325207|592693379|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164090242|NCT01325207|592693380|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164090243|NCT01325207|592693381|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
164090244|NCT01325207|592693382|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
164090245|NCT01325207|592693377|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164090246|NCT01325207|592693378|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164090247|NCT01325207|592693379|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164090248|NCT01325207|592693380|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164090249|NCT01325207|592693381|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
164090250|NCT01325207|592693382|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
164090251|NCT00698685|592693383|FG000|Overall Study|Sister withdrew as donor|1|||
164090252|NCT00698685|592693383|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
164090253|NCT00337571|592693384|FG000|Overall Study|Lack of Efficacy|3|||
164090254|NCT00337571|592693385|FG001|Overall Study|Lack of Efficacy|0|||
164090255|NCT00337571|592693386|FG002|Overall Study|Lack of Efficacy|0|||
164090256|NCT00337571|592693387|FG003|Overall Study|Lack of Efficacy|0|||
164090257|NCT00337571|592693384|FG000|Overall Study|Adverse Event|4|||
164090258|NCT00337571|592693385|FG001|Overall Study|Adverse Event|5|||
164090259|NCT00337571|592693386|FG002|Overall Study|Adverse Event|8|||
164090260|NCT00337571|592693387|FG003|Overall Study|Adverse Event|4|||
164090261|NCT00337571|592693384|FG000|Overall Study|Withdrawal by Subject|2|||
164090262|NCT00337571|592693385|FG001|Overall Study|Withdrawal by Subject|2|||
164090263|NCT00337571|592693386|FG002|Overall Study|Withdrawal by Subject|1|||
164090264|NCT00337571|592693387|FG003|Overall Study|Withdrawal by Subject|0|||
164090265|NCT00337571|592693384|FG000|Overall Study|Lost to Follow-up|3|||
164090266|NCT00337571|592693385|FG001|Overall Study|Lost to Follow-up|1|||
164090267|NCT00337571|592693386|FG002|Overall Study|Lost to Follow-up|0|||
164090268|NCT00337571|592693387|FG003|Overall Study|Lost to Follow-up|1|||
164090269|NCT00337571|592693384|FG000|Overall Study|Poor/noncompliance|1|||
164090270|NCT00337571|592693385|FG001|Overall Study|Poor/noncompliance|1|||
164090271|NCT00337571|592693386|FG002|Overall Study|Poor/noncompliance|1|||
164090272|NCT00337571|592693387|FG003|Overall Study|Poor/noncompliance|1|||
164090273|NCT00337571|592693384|FG000|Overall Study|No longer met study criteria|1|||
164090274|NCT00337571|592693385|FG001|Overall Study|No longer met study criteria|0|||
164090275|NCT00337571|592693386|FG002|Overall Study|No longer met study criteria|0|||
164090276|NCT00337571|592693387|FG003|Overall Study|No longer met study criteria|0|||
164090277|NCT00337571|592693384|FG000|Overall Study|High Potassium level|0|||
164090278|NCT00337571|592693385|FG001|Overall Study|High Potassium level|0|||
164090279|NCT00337571|592693386|FG002|Overall Study|High Potassium level|0|||
164090280|NCT00337571|592693387|FG003|Overall Study|High Potassium level|1|||
164090281|NCT01890915|592693388|FG000|Overall Study|Adverse Event|1|||
164090282|NCT01890915|592693389|FG001|Overall Study|Adverse Event|0|||
164090283|NCT01890915|592693388|FG000|Overall Study|Protocol Violation|2|||
164090284|NCT01890915|592693389|FG001|Overall Study|Protocol Violation|0|||
164090285|NCT01890915|592693388|FG000|Overall Study|Equipment Malfunction|0|||
164090286|NCT01890915|592693389|FG001|Overall Study|Equipment Malfunction|1|||
164090287|NCT01974895|592693396|FG000|Overall Study|Protocol Violation|1|||
164090288|NCT01974895|592693397|FG001|Overall Study|Protocol Violation|0|||
164090289|NCT01974895|592693396|FG000|Overall Study|Lost to Follow-up|4|||
164090290|NCT01974895|592693397|FG001|Overall Study|Lost to Follow-up|6|||
164090291|NCT01974895|592693396|FG000|Overall Study|Withdrawal by Subject|0|||
164090292|NCT01974895|592693397|FG001|Overall Study|Withdrawal by Subject|1|||
164090293|NCT01974895|592693396|FG000|Overall Study|Other (Missed Visit)|1|||
164090294|NCT01974895|592693397|FG001|Overall Study|Other (Missed Visit)|0|||
164090295|NCT01974895|592693396|FG000|Overall Study|Other (Reason unknown)|9|||
164090296|NCT01974895|592693397|FG001|Overall Study|Other (Reason unknown)|8|||
163899991|NCT01961609|592005596|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
164090297|NCT01513148|592693398|FG000|Overall Study|Protocol Violation|2|||
164090298|NCT01513148|592693399|FG001|Overall Study|Protocol Violation|2|||
164090299|NCT03552757|592693400|FG000|Overall Study|Withdrawal by Subject|10|||
164090300|NCT03552757|592693401|FG001|Overall Study|Withdrawal by Subject|5|||
164090301|NCT03552757|592693402|FG002|Overall Study|Withdrawal by Subject|12|||
164090302|NCT03552757|592693400|FG000|Overall Study|Lost to Follow-up|2|||
164090303|NCT03552757|592693401|FG001|Overall Study|Lost to Follow-up|7|||
164090304|NCT03552757|592693402|FG002|Overall Study|Lost to Follow-up|7|||
164090305|NCT03552757|592693400|FG000|Overall Study|Death|1|||
164090306|NCT03552757|592693401|FG001|Overall Study|Death|1|||
164090307|NCT03552757|592693402|FG002|Overall Study|Death|1|||
164090308|NCT02192099|592693405|FG000|Overall Study|Adverse Event|1|||
164090309|NCT02192099|592693405|FG000|Overall Study|Lost to Follow-up|2|||
164090310|NCT02192099|592693405|FG000|Overall Study|Physician Decision|1|||
164090311|NCT02192099|592693405|FG000|Overall Study|Pregnancy|1|||
164090312|NCT02192099|592693405|FG000|Overall Study|Protocol Violation|8|||
164090313|NCT02192099|592693405|FG000|Overall Study|Study Terminated by Sponsor|32|||
164090314|NCT02192099|592693405|FG000|Overall Study|Withdrawal by Subject|11|||
164090315|NCT02192099|592693405|FG000|Overall Study|Miscellaneous Reasons|5|||
164090316|NCT00386009|592693406|FG000|Overall Study|Adverse Event|0|||
164090317|NCT00386009|592693407|FG001|Overall Study|Adverse Event|2|||
164090318|NCT00386009|592693406|FG000|Overall Study|Death|1|||
164090319|NCT00386009|592693407|FG001|Overall Study|Death|0|||
164090320|NCT00386009|592693406|FG000|Overall Study|Entry Criteria Not Met|0|||
164090321|NCT00386009|592693407|FG001|Overall Study|Entry Criteria Not Met|2|||
164090322|NCT00386009|592693406|FG000|Overall Study|Lost to Follow-up|1|||
164090323|NCT00386009|592693407|FG001|Overall Study|Lost to Follow-up|1|||
164090324|NCT00386009|592693406|FG000|Overall Study|Protocol Violation|1|||
164090325|NCT00386009|592693407|FG001|Overall Study|Protocol Violation|0|||
164090326|NCT00386009|592693406|FG000|Overall Study|Sponsor Decision|1|||
164090327|NCT00386009|592693407|FG001|Overall Study|Sponsor Decision|1|||
164090328|NCT00386009|592693406|FG000|Overall Study|Withdrawal by Subject|5|||
164090329|NCT00386009|592693407|FG001|Overall Study|Withdrawal by Subject|4|||
164090330|NCT00536575|592693408|FG000|Overall Study|Withdrawal by Subject|1|||
164090331|NCT00536575|592693408|FG000|Overall Study|Death|1|||
163899992|NCT01961609|592005593|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
164090332|NCT02549495|592693414|FG000|Overall Study|Death|2|||
164090333|NCT02549495|592693414|FG000|Overall Study|Withdrawal by Subject|5|||
164090334|NCT02549495|592693414|FG000|Overall Study|Physician Decision|22|||
164090335|NCT02549495|592693414|FG000|Overall Study|Lost to Follow-up|6|||
164090336|NCT02549495|592693414|FG000|Overall Study|Protocol Violation|6|||
164090337|NCT00936975|592693415|FG000|Overall Study|Withdrawal by Subject|1|||
164090338|NCT00936975|592693415|FG000|Overall Study|Disease progression|3|||
164090339|NCT00936975|592693415|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
164090340|NCT01656889|592693419|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
164133263|NCT02283983|592852717|FG000|Overall Study|Relapse|1|||
164299625|NCT00360230|593472861|FG001|Overall Study|Migrated|1|||
164006430|NCT02158533|592390965|FG003|Stage 1|Lost to Follow-up|0|||
164006431|NCT02158533|592390966|FG004|Stage 1|Lost to Follow-up|0|||
164006432|NCT02158533|592390967|FG005|Stage 1|Lost to Follow-up|0|||
164090341|NCT01656889|592693420|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
164090342|NCT01656889|592693419|FG000|Treatment Period, 12 Weeks|Death|0|||
164090343|NCT01656889|592693420|FG001|Treatment Period, 12 Weeks|Death|1|||
164355498|NCT02730455|593676425|FG000|Overall Study|Consent withdrawn|2|||
164355499|NCT02730455|593676426|FG001|Overall Study|Consent withdrawn|4|||
164355500|NCT02730455|593676427|FG002|Overall Study|Consent withdrawn|1|||
164355501|NCT02730455|593676425|FG000|Overall Study|Lost to Follow-up|3|||
164355502|NCT02730455|593676426|FG001|Overall Study|Lost to Follow-up|1|||
164355503|NCT02730455|593676427|FG002|Overall Study|Lost to Follow-up|4|||
164355504|NCT02730455|593676425|FG000|Overall Study|Other|1|||
164355505|NCT02730455|593676426|FG001|Overall Study|Other|1|||
164355506|NCT02730455|593676427|FG002|Overall Study|Other|2|||
164355507|NCT02730455|593676425|FG000|Overall Study|Other|2|||
164355508|NCT02730455|593676426|FG001|Overall Study|Other|2|||
164355509|NCT02730455|593676427|FG002|Overall Study|Other|0|||
164355510|NCT02733367|593676428|FG000|Overall Study|Withdrawal by Subject|6|||
164355511|NCT01922089|593676431|FG000|Overall Study|Adverse Event|18|||
164355512|NCT01922089|593676432|FG001|Overall Study|Adverse Event|13|||
164355513|NCT01922089|593676431|FG000|Overall Study|Protocol Deviation|10|||
164355514|NCT01922089|593676432|FG001|Overall Study|Protocol Deviation|7|||
164355515|NCT01922089|593676431|FG000|Overall Study|Withdrawal by Subject|3|||
164355516|NCT01922089|593676432|FG001|Overall Study|Withdrawal by Subject|4|||
164355517|NCT01922089|593676431|FG000|Overall Study|administrative problems|4|||
164355518|NCT01922089|593676432|FG001|Overall Study|administrative problems|1|||
164355519|NCT01922089|593676431|FG000|Overall Study|Physician Decision|2|||
164355520|NCT01922089|593676432|FG001|Overall Study|Physician Decision|3|||
164355521|NCT01922089|593676431|FG000|Overall Study|Death|2|||
164355522|NCT01922089|593676432|FG001|Overall Study|Death|1|||
164355523|NCT01922089|593676431|FG000|Overall Study|Lost to Follow-up|0|||
164355524|NCT01922089|593676432|FG001|Overall Study|Lost to Follow-up|1|||
164355525|NCT05582889|593676434|FG000|Overall Study|Health event|3|||
164355526|NCT05582889|593676435|FG001|Overall Study|Health event|2|||
164355527|NCT05582889|593676434|FG000|Overall Study|Lost to Follow-up|2|||
164355528|NCT05582889|593676435|FG001|Overall Study|Lost to Follow-up|4|||
164355529|NCT00001723|593676436|FG000|Overall Study|Lack of Efficacy|6|||
164355530|NCT00001723|593676437|FG001|Overall Study|Lack of Efficacy|7|||
164355531|NCT00001723|593676436|FG000|Overall Study|Lack of family interest|4|||
164355532|NCT00001723|593676437|FG001|Overall Study|Lack of family interest|5|||
164355533|NCT00001723|593676436|FG000|Overall Study|Lost to Follow-up|2|||
164355534|NCT00001723|593676437|FG001|Overall Study|Lost to Follow-up|2|||
164355535|NCT00001723|593676436|FG000|Overall Study|medication intolerance|1|||
164355536|NCT00001723|593676437|FG001|Overall Study|medication intolerance|2|||
164355537|NCT02170051|593676438|FG000|Overall Study|Withdrawal by Subject|10|||
164355538|NCT02170051|593676439|FG001|Overall Study|Withdrawal by Subject|10|||
164355539|NCT02170051|593676438|FG000|Overall Study|Lost to Follow-up|1|||
164355540|NCT02170051|593676439|FG001|Overall Study|Lost to Follow-up|3|||
164355541|NCT04551092|593676440|FG000|Overall Study|Lost to Follow-up|7|||
164355542|NCT04551092|593676440|FG000|Overall Study|Withdrawal by Subject|4|||
164355543|NCT01324999|593676441|FG000|Overall Study|Adverse Event|3|||
164355544|NCT01324999|593676441|FG000|Overall Study|Withdrawal by Subject|2|||
164355545|NCT01712490|593676442|FG000|Overall Study|Ongoing|601|||
164355546|NCT01712490|593676443|FG001|Overall Study|Ongoing|586|||
164355547|NCT01712490|593676442|FG000|Overall Study|Other|11|||
164355548|NCT01712490|593676443|FG001|Overall Study|Other|11|||
164355549|NCT01712490|593676442|FG000|Overall Study|Withdrawal by Subject|36|||
164355550|NCT01712490|593676443|FG001|Overall Study|Withdrawal by Subject|44|||
164355551|NCT01712490|593676442|FG000|Overall Study|Lost to Follow-up|16|||
164355552|NCT01712490|593676443|FG001|Overall Study|Lost to Follow-up|29|||
164355553|NCT01714635|593676456|FG000|Overall Study|Discontinued|1|||
164355554|NCT01714635|593676457|FG001|Overall Study|Discontinued|0|||
164355555|NCT01714635|593676458|FG002|Overall Study|Discontinued|2|||
164355556|NCT01714635|593676456|FG000|Overall Study|Missed 6-month exam|1|||
164355557|NCT01714635|593676457|FG001|Overall Study|Missed 6-month exam|0|||
164355558|NCT01714635|593676458|FG002|Overall Study|Missed 6-month exam|0|||
164355559|NCT02860169|593676459|FG000|Part A|Withdrawal by Subject|1|||
164355560|NCT02860169|593676459|FG000|Part A|Other (Screening failure)|6|||
164355561|NCT02860169|593676459|FG000|Part A|Other (Survey not completed)|3|||
164355562|NCT02860169|593676459|FG000|Part A|Other (did not completed consent)|1|||
164355563|NCT02860169|593676459|FG000|Part B|Other (Screening failure)|10|||
164355564|NCT02860169|593676459|FG000|Part B|Withdrawal by Subject|1|||
164355565|NCT02860169|593676459|FG000|Part C|Other (Screening failure)|1|||
164355566|NCT01782495|593676460|FG000|Overall Study|Adverse Event|0|||
164355567|NCT01782495|593676461|FG001|Overall Study|Adverse Event|0|||
164355568|NCT01782495|593676462|FG002|Overall Study|Adverse Event|0|||
164355569|NCT01782495|593676463|FG003|Overall Study|Adverse Event|0|||
164355570|NCT01782495|593676464|FG004|Overall Study|Adverse Event|0|||
164355571|NCT01782495|593676465|FG005|Overall Study|Adverse Event|0|||
164355572|NCT01782495|593676466|FG006|Overall Study|Adverse Event|0|||
164355573|NCT01782495|593676467|FG007|Overall Study|Adverse Event|2|||
164355574|NCT01782495|593676468|FG008|Overall Study|Adverse Event|0|||
164355575|NCT01782495|593676469|FG009|Overall Study|Adverse Event|0|||
164090344|NCT01656889|592693419|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
164090345|NCT01656889|592693420|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
164090346|NCT01656889|592693419|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
164090347|NCT01656889|592693420|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
164090348|NCT01656889|592693419|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
164090349|NCT01656889|592693420|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
164090350|NCT01656889|592693419|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
164090351|NCT01656889|592693420|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
164090352|NCT01656889|592693419|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
164090353|NCT01656889|592693420|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
164090354|NCT01656889|592693419|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
164090355|NCT01656889|592693420|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
164090356|NCT01656889|592693419|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
164090357|NCT01656889|592693420|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
164090358|NCT01656889|592693419|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
164090359|NCT01656889|592693420|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
164090360|NCT02486796|592693421|FG000|Overall Study|Withdrawal by Subject|1|||
164090361|NCT02486796|592693422|FG001|Overall Study|Withdrawal by Subject|1|||
164090362|NCT02486796|592693421|FG000|Overall Study|Physician Decision|1|||
164090363|NCT02486796|592693422|FG001|Overall Study|Physician Decision|0|||
164090364|NCT00306384|592693425|FG000|Overall Study|Adverse Event|103|||
164090365|NCT00306384|592693426|FG001|Overall Study|Adverse Event|87|||
164090366|NCT00306384|592693427|FG002|Overall Study|Adverse Event|40|||
164090367|NCT00306384|592693425|FG000|Overall Study|Major protocol deviation|43|||
164299626|NCT00360230|593472862|FG002|Overall Study|Migrated|3|||
163899993|NCT01961609|592005594|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
164090368|NCT00306384|592693426|FG001|Overall Study|Major protocol deviation|51|||
164090369|NCT00306384|592693427|FG002|Overall Study|Major protocol deviation|18|||
164090370|NCT00306384|592693425|FG000|Overall Study|Lost to Follow-up|57|||
164090371|NCT00306384|592693426|FG001|Overall Study|Lost to Follow-up|41|||
164090372|NCT00306384|592693427|FG002|Overall Study|Lost to Follow-up|35|||
164090373|NCT00306384|592693425|FG000|Overall Study|Voluntary withdrawal|199|||
164090374|NCT00306384|592693426|FG001|Overall Study|Voluntary withdrawal|187|||
164090375|NCT00306384|592693427|FG002|Overall Study|Voluntary withdrawal|91|||
164090376|NCT00306384|592693425|FG000|Overall Study|Study termination|1|||
164299627|NCT00360230|593472863|FG003|Overall Study|Migrated|1|||
164299628|NCT00360230|593472864|FG004|Overall Study|Migrated|4|||
164299629|NCT00360230|593472865|FG005|Overall Study|Migrated|1|||
164299630|NCT00360230|593472866|FG006|Overall Study|Migrated|1|||
164299631|NCT00360230|593472860|FG000|Overall Study|Other|1|||
164299632|NCT00360230|593472861|FG001|Overall Study|Other|0|||
164355576|NCT01782495|593676470|FG010|Overall Study|Adverse Event|0|||
164355577|NCT01782495|593676460|FG000|Overall Study|Withdrew Consent|0|||
164355578|NCT01782495|593676461|FG001|Overall Study|Withdrew Consent|1|||
164355579|NCT01782495|593676462|FG002|Overall Study|Withdrew Consent|0|||
164355580|NCT01782495|593676463|FG003|Overall Study|Withdrew Consent|0|||
164355581|NCT01782495|593676464|FG004|Overall Study|Withdrew Consent|0|||
164355582|NCT01782495|593676465|FG005|Overall Study|Withdrew Consent|0|||
164355583|NCT01782495|593676466|FG006|Overall Study|Withdrew Consent|0|||
164355584|NCT01782495|593676467|FG007|Overall Study|Withdrew Consent|1|||
164355585|NCT01782495|593676468|FG008|Overall Study|Withdrew Consent|0|||
164355586|NCT01782495|593676469|FG009|Overall Study|Withdrew Consent|0|||
164355587|NCT01782495|593676470|FG010|Overall Study|Withdrew Consent|0|||
164355588|NCT00396591|593676475|FG000|Overall Study|Disease Progression|13|||
164355589|NCT00396591|593676475|FG000|Overall Study|Adverse Event|2|||
164355590|NCT00396591|593676475|FG000|Overall Study|Participant request|1|||
164355591|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
164355592|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
164355593|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
164355594|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
164355595|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
164355596|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
164355597|NCT01962207|593676478|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
164355598|NCT01962207|593676479|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
164355599|NCT01962207|593676476|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
164355600|NCT01962207|593676477|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
164090377|NCT00306384|592693426|FG001|Overall Study|Study termination|0|||
164090378|NCT00306384|592693427|FG002|Overall Study|Study termination|1|||
164299633|NCT00360230|593472862|FG002|Overall Study|Other|0|||
164299634|NCT00360230|593472863|FG003|Overall Study|Other|0|||
164299635|NCT00360230|593472864|FG004|Overall Study|Other|0|||
164299636|NCT00360230|593472865|FG005|Overall Study|Other|0|||
164299637|NCT00360230|593472866|FG006|Overall Study|Other|0|||
164299638|NCT00360230|593472860|FG000|Overall Study|Protocol Violation|0|||
164299639|NCT00360230|593472861|FG001|Overall Study|Protocol Violation|0|||
164299640|NCT00360230|593472862|FG002|Overall Study|Protocol Violation|0|||
164299641|NCT00360230|593472863|FG003|Overall Study|Protocol Violation|0|||
164299642|NCT00360230|593472864|FG004|Overall Study|Protocol Violation|0|||
164299643|NCT00360230|593472865|FG005|Overall Study|Protocol Violation|1|||
164299644|NCT00360230|593472866|FG006|Overall Study|Protocol Violation|0|||
164299645|NCT00360230|593472860|FG000|Overall Study|Death|0|||
164299646|NCT00360230|593472861|FG001|Overall Study|Death|1|||
164299647|NCT00360230|593472862|FG002|Overall Study|Death|0|||
164299648|NCT00360230|593472863|FG003|Overall Study|Death|0|||
164299649|NCT00360230|593472864|FG004|Overall Study|Death|0|||
164299650|NCT00360230|593472865|FG005|Overall Study|Death|1|||
164299651|NCT00360230|593472866|FG006|Overall Study|Death|1|||
164299652|NCT01052493|593472873|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
164299653|NCT01052493|593472874|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
164299654|NCT01052493|593472875|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
164090379|NCT00306384|592693425|FG000|Overall Study|Pregnancy|3|||
164299655|NCT01075243|593472884|FG000|Overall Study|Lost to Follow-up|5|||
164299656|NCT01075243|593472885|FG001|Overall Study|Lost to Follow-up|2|||
164299657|NCT01075243|593472886|FG002|Overall Study|Lost to Follow-up|0|||
164299658|NCT01075243|593472884|FG000|Overall Study|Withdrawal by Subject|1|||
164299659|NCT01075243|593472885|FG001|Overall Study|Withdrawal by Subject|1|||
164090470|NCT03131999|592693442|FG000|Overall Study|Withdrawal by Subject|0|||
164090471|NCT03131999|592693443|FG001|Overall Study|Withdrawal by Subject|1|||
164090472|NCT02260492|592693444|FG000|Overall Study|Adverse Event|6|||
164090473|NCT02260492|592693445|FG001|Overall Study|Adverse Event|1|||
164090474|NCT02260492|592693446|FG002|Overall Study|Adverse Event|2|||
164090475|NCT02260492|592693444|FG000|Overall Study|Death|0|||
164090476|NCT02260492|592693445|FG001|Overall Study|Death|1|||
164090477|NCT02260492|592693446|FG002|Overall Study|Death|0|||
164090478|NCT02260492|592693444|FG000|Overall Study|Lost to Follow-up|12|||
164090479|NCT02260492|592693445|FG001|Overall Study|Lost to Follow-up|9|||
164090480|NCT02260492|592693446|FG002|Overall Study|Lost to Follow-up|0|||
164090481|NCT02260492|592693444|FG000|Overall Study|Physician Decision|2|||
164090482|NCT02260492|592693445|FG001|Overall Study|Physician Decision|0|||
164090483|NCT02260492|592693446|FG002|Overall Study|Physician Decision|1|||
164090484|NCT02260492|592693444|FG000|Overall Study|Withdrawal by Subject|3|||
164090485|NCT02260492|592693445|FG001|Overall Study|Withdrawal by Subject|2|||
164090486|NCT02260492|592693446|FG002|Overall Study|Withdrawal by Subject|2|||
164090487|NCT04634409|592693447|FG000|Overall Study|Death|0|||
164090488|NCT04634409|592693448|FG001|Overall Study|Death|0|||
164090489|NCT04634409|592693449|FG002|Overall Study|Death|0|||
164090490|NCT04634409|592693450|FG003|Overall Study|Death|0|||
164090491|NCT04634409|592693451|FG004|Overall Study|Death|0|||
164090492|NCT04634409|592693452|FG005|Overall Study|Death|0|||
164090493|NCT04634409|592693453|FG006|Overall Study|Death|0|||
164090494|NCT04634409|592693454|FG007|Overall Study|Death|0|||
164090495|NCT04634409|592693455|FG008|Overall Study|Death|0|||
164090496|NCT04634409|592693456|FG009|Overall Study|Death|0|||
164090497|NCT04634409|592693457|FG010|Overall Study|Death|1|||
164090498|NCT04634409|592693458|FG011|Overall Study|Death|0|||
164090499|NCT04634409|592693459|FG012|Overall Study|Death|1|||
164090500|NCT04634409|592693460|FG013|Overall Study|Death|0|||
164090501|NCT04634409|592693461|FG014|Overall Study|Death|0|||
164090502|NCT04634409|592693462|FG015|Overall Study|Death|0|||
164090503|NCT04634409|592693463|FG016|Overall Study|Death|0|||
164090504|NCT04634409|592693464|FG017|Overall Study|Death|0|||
164090505|NCT04634409|592693465|FG018|Overall Study|Death|0|||
164090506|NCT04634409|592693466|FG019|Overall Study|Death|0|||
164090507|NCT04634409|592693467|FG020|Overall Study|Death|0|||
164090508|NCT04634409|592693468|FG021|Overall Study|Death|0|||
164090509|NCT04634409|592693469|FG022|Overall Study|Death|0|||
164090510|NCT04634409|592693470|FG023|Overall Study|Death|0|||
164090511|NCT04634409|592693471|FG024|Overall Study|Death|0|||
164090512|NCT04634409|592693472|FG025|Overall Study|Death|0|||
164090513|NCT04634409|592693473|FG026|Overall Study|Death|0|||
164090514|NCT04634409|592693447|FG000|Overall Study|Adverse Event|0|||
164090515|NCT04634409|592693448|FG001|Overall Study|Adverse Event|0|||
164090516|NCT04634409|592693449|FG002|Overall Study|Adverse Event|1|||
164090517|NCT04634409|592693450|FG003|Overall Study|Adverse Event|0|||
164090518|NCT04634409|592693451|FG004|Overall Study|Adverse Event|0|||
164090519|NCT04634409|592693452|FG005|Overall Study|Adverse Event|1|||
164090520|NCT04634409|592693453|FG006|Overall Study|Adverse Event|0|||
164090521|NCT04634409|592693454|FG007|Overall Study|Adverse Event|0|||
164090522|NCT04634409|592693455|FG008|Overall Study|Adverse Event|0|||
164090523|NCT04634409|592693456|FG009|Overall Study|Adverse Event|0|||
164090524|NCT04634409|592693457|FG010|Overall Study|Adverse Event|0|||
164090525|NCT04634409|592693458|FG011|Overall Study|Adverse Event|0|||
164090526|NCT04634409|592693459|FG012|Overall Study|Adverse Event|0|||
164090527|NCT04634409|592693460|FG013|Overall Study|Adverse Event|0|||
164090528|NCT04634409|592693461|FG014|Overall Study|Adverse Event|0|||
164090529|NCT04634409|592693462|FG015|Overall Study|Adverse Event|0|||
164090530|NCT04634409|592693463|FG016|Overall Study|Adverse Event|0|||
164090531|NCT04634409|592693464|FG017|Overall Study|Adverse Event|0|||
164090532|NCT04634409|592693465|FG018|Overall Study|Adverse Event|0|||
164090533|NCT04634409|592693466|FG019|Overall Study|Adverse Event|0|||
164090534|NCT04634409|592693467|FG020|Overall Study|Adverse Event|0|||
164090535|NCT04634409|592693468|FG021|Overall Study|Adverse Event|0|||
164090536|NCT04634409|592693469|FG022|Overall Study|Adverse Event|0|||
164090537|NCT04634409|592693470|FG023|Overall Study|Adverse Event|0|||
164090538|NCT04634409|592693471|FG024|Overall Study|Adverse Event|0|||
164090539|NCT04634409|592693472|FG025|Overall Study|Adverse Event|0|||
164090540|NCT04634409|592693473|FG026|Overall Study|Adverse Event|0|||
164090541|NCT04634409|592693447|FG000|Overall Study|Lost to Follow-up|3|||
164090542|NCT04634409|592693448|FG001|Overall Study|Lost to Follow-up|1|||
164090543|NCT04634409|592693449|FG002|Overall Study|Lost to Follow-up|1|||
164090544|NCT04634409|592693450|FG003|Overall Study|Lost to Follow-up|3|||
164090545|NCT04634409|592693451|FG004|Overall Study|Lost to Follow-up|1|||
164090546|NCT04634409|592693452|FG005|Overall Study|Lost to Follow-up|1|||
164090547|NCT04634409|592693453|FG006|Overall Study|Lost to Follow-up|1|||
164090548|NCT04634409|592693454|FG007|Overall Study|Lost to Follow-up|3|||
164090549|NCT04634409|592693455|FG008|Overall Study|Lost to Follow-up|3|||
164090550|NCT04634409|592693456|FG009|Overall Study|Lost to Follow-up|11|||
164090551|NCT04634409|592693457|FG010|Overall Study|Lost to Follow-up|8|||
164090552|NCT04634409|592693458|FG011|Overall Study|Lost to Follow-up|15|||
164090553|NCT04634409|592693459|FG012|Overall Study|Lost to Follow-up|3|||
164090554|NCT04634409|592693460|FG013|Overall Study|Lost to Follow-up|2|||
164090555|NCT04634409|592693461|FG014|Overall Study|Lost to Follow-up|7|||
164090556|NCT04634409|592693462|FG015|Overall Study|Lost to Follow-up|0|||
164090557|NCT04634409|592693463|FG016|Overall Study|Lost to Follow-up|0|||
164090558|NCT04634409|592693464|FG017|Overall Study|Lost to Follow-up|0|||
164090559|NCT04634409|592693465|FG018|Overall Study|Lost to Follow-up|0|||
164090560|NCT04634409|592693466|FG019|Overall Study|Lost to Follow-up|0|||
164090561|NCT04634409|592693467|FG020|Overall Study|Lost to Follow-up|0|||
164090562|NCT04634409|592693468|FG021|Overall Study|Lost to Follow-up|0|||
164090563|NCT04634409|592693469|FG022|Overall Study|Lost to Follow-up|0|||
164090564|NCT04634409|592693470|FG023|Overall Study|Lost to Follow-up|0|||
164090565|NCT04634409|592693471|FG024|Overall Study|Lost to Follow-up|0|||
164090566|NCT04634409|592693472|FG025|Overall Study|Lost to Follow-up|0|||
164090567|NCT04634409|592693473|FG026|Overall Study|Lost to Follow-up|0|||
164090568|NCT04634409|592693447|FG000|Overall Study|Withdrawal by Subject|3|||
164090569|NCT04634409|592693448|FG001|Overall Study|Withdrawal by Subject|1|||
164090570|NCT04634409|592693449|FG002|Overall Study|Withdrawal by Subject|6|||
164090571|NCT04634409|592693450|FG003|Overall Study|Withdrawal by Subject|4|||
164090572|NCT04634409|592693451|FG004|Overall Study|Withdrawal by Subject|2|||
164090573|NCT04634409|592693452|FG005|Overall Study|Withdrawal by Subject|0|||
164090574|NCT04634409|592693453|FG006|Overall Study|Withdrawal by Subject|0|||
164090575|NCT04634409|592693454|FG007|Overall Study|Withdrawal by Subject|2|||
164090576|NCT04634409|592693455|FG008|Overall Study|Withdrawal by Subject|3|||
164090577|NCT04634409|592693456|FG009|Overall Study|Withdrawal by Subject|2|||
164090578|NCT04634409|592693457|FG010|Overall Study|Withdrawal by Subject|3|||
164090579|NCT04634409|592693458|FG011|Overall Study|Withdrawal by Subject|2|||
164090580|NCT04634409|592693459|FG012|Overall Study|Withdrawal by Subject|2|||
164090581|NCT04634409|592693460|FG013|Overall Study|Withdrawal by Subject|1|||
164090582|NCT04634409|592693461|FG014|Overall Study|Withdrawal by Subject|5|||
164090583|NCT04634409|592693462|FG015|Overall Study|Withdrawal by Subject|0|||
164090584|NCT04634409|592693463|FG016|Overall Study|Withdrawal by Subject|0|||
164090585|NCT04634409|592693464|FG017|Overall Study|Withdrawal by Subject|1|||
164090586|NCT04634409|592693465|FG018|Overall Study|Withdrawal by Subject|0|||
164090587|NCT04634409|592693466|FG019|Overall Study|Withdrawal by Subject|0|||
164090588|NCT04634409|592693467|FG020|Overall Study|Withdrawal by Subject|0|||
164090589|NCT04634409|592693468|FG021|Overall Study|Withdrawal by Subject|0|||
164090590|NCT04634409|592693469|FG022|Overall Study|Withdrawal by Subject|0|||
164090591|NCT04634409|592693470|FG023|Overall Study|Withdrawal by Subject|1|||
164090592|NCT04634409|592693471|FG024|Overall Study|Withdrawal by Subject|0|||
164090593|NCT04634409|592693472|FG025|Overall Study|Withdrawal by Subject|0|||
164090594|NCT04634409|592693473|FG026|Overall Study|Withdrawal by Subject|0|||
164090595|NCT04634409|592693447|FG000|Overall Study|Other - As reported by Investigator|1|||
164090596|NCT04634409|592693448|FG001|Overall Study|Other - As reported by Investigator|0|||
164090597|NCT04634409|592693449|FG002|Overall Study|Other - As reported by Investigator|0|||
164090598|NCT04634409|592693450|FG003|Overall Study|Other - As reported by Investigator|0|||
164090599|NCT04634409|592693451|FG004|Overall Study|Other - As reported by Investigator|0|||
164090600|NCT04634409|592693452|FG005|Overall Study|Other - As reported by Investigator|0|||
163900168|NCT03789110|592005624|FG000|Overall Study|Withdrawal by Subject|2|||
163900169|NCT03789110|592005624|FG000|Overall Study|Lack of Efficacy|22|||
163900170|NCT03789110|592005624|FG000|Overall Study|still on treatment|3|||
163900171|NCT03959423|592005628|FG000|Overall Study|Withdrawal by Subject|2|||
163900172|NCT03959423|592005629|FG001|Overall Study|Withdrawal by Subject|3|||
163900173|NCT03959423|592005628|FG000|Overall Study|Physician Decision|0|||
163900174|NCT03959423|592005629|FG001|Overall Study|Physician Decision|1|||
163900175|NCT03959423|592005628|FG000|Overall Study|Lost to Follow-up|1|||
163900176|NCT03959423|592005629|FG001|Overall Study|Lost to Follow-up|0|||
163900177|NCT03959423|592005628|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
163900178|NCT03959423|592005629|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164090601|NCT04634409|592693453|FG006|Overall Study|Other - As reported by Investigator|0|||
164090602|NCT04634409|592693454|FG007|Overall Study|Other - As reported by Investigator|6|||
164090603|NCT04634409|592693455|FG008|Overall Study|Other - As reported by Investigator|4|||
164090604|NCT04634409|592693456|FG009|Overall Study|Other - As reported by Investigator|0|||
164090605|NCT04634409|592693457|FG010|Overall Study|Other - As reported by Investigator|1|||
164090606|NCT04634409|592693458|FG011|Overall Study|Other - As reported by Investigator|2|||
164090607|NCT04634409|592693459|FG012|Overall Study|Other - As reported by Investigator|2|||
164090608|NCT04634409|592693460|FG013|Overall Study|Other - As reported by Investigator|1|||
164090609|NCT04634409|592693461|FG014|Overall Study|Other - As reported by Investigator|0|||
164090610|NCT04634409|592693462|FG015|Overall Study|Other - As reported by Investigator|0|||
163900179|NCT00593840|592005632|FG000|Overall Study|Withdrawal by Subject|1|||
164090611|NCT04634409|592693463|FG016|Overall Study|Other - As reported by Investigator|0|||
164090612|NCT04634409|592693464|FG017|Overall Study|Other - As reported by Investigator|0|||
164090613|NCT04634409|592693465|FG018|Overall Study|Other - As reported by Investigator|0|||
164090614|NCT04634409|592693466|FG019|Overall Study|Other - As reported by Investigator|0|||
164090615|NCT04634409|592693467|FG020|Overall Study|Other - As reported by Investigator|0|||
164090616|NCT04634409|592693468|FG021|Overall Study|Other - As reported by Investigator|0|||
164090617|NCT04634409|592693469|FG022|Overall Study|Other - As reported by Investigator|0|||
164090618|NCT04634409|592693470|FG023|Overall Study|Other - As reported by Investigator|0|||
164090619|NCT04634409|592693471|FG024|Overall Study|Other - As reported by Investigator|0|||
164090620|NCT04634409|592693472|FG025|Overall Study|Other - As reported by Investigator|0|||
164090621|NCT04634409|592693473|FG026|Overall Study|Other - As reported by Investigator|0|||
164090622|NCT02683187|592693474|FG000|Overall Study|Failed IV access|3|||
164090623|NCT02683187|592693474|FG000|Overall Study|Withdrawal by Subject|5|||
164090624|NCT02785913|592695771|FG000|Overall Study|Adverse Event|5|||
164090625|NCT02785913|592695771|FG000|Overall Study|Death|2|||
164090626|NCT02785913|592695771|FG000|Overall Study|Progression|18|||
164090627|NCT02785913|592695771|FG000|Overall Study|Not protocol specified|1|||
164090628|NCT03717064|592695772|FG000|Period 2|Adverse Event|1|||
164090629|NCT01298570|592695773|FG000|Overall Study|Disease progression, relapse during acti|64|||
164090630|NCT01298570|592695774|FG001|Overall Study|Disease progression, relapse during acti|40|||
164090631|NCT01298570|592695773|FG000|Overall Study|Adverse Event|20|||
164090632|NCT01298570|592695774|FG001|Overall Study|Adverse Event|2|||
164090633|NCT01298570|592695773|FG000|Overall Study|Withdrawal by Subject|21|||
164090634|NCT01298570|592695774|FG001|Overall Study|Withdrawal by Subject|6|||
164090635|NCT01298570|592695773|FG000|Overall Study|Treatment delay > 4 weeks|4|||
164090636|NCT01298570|592695774|FG001|Overall Study|Treatment delay > 4 weeks|5|||
164090637|NCT01298570|592695773|FG000|Overall Study|Physician Decision|4|||
164090638|NCT01298570|592695774|FG001|Overall Study|Physician Decision|2|||
164090639|NCT01298570|592695773|FG000|Overall Study|Other complicating disease|2|||
164090640|NCT01298570|592695774|FG001|Overall Study|Other complicating disease|1|||
164090641|NCT01298570|592695773|FG000|Overall Study|Surgery|2|||
164090642|NCT01298570|592695774|FG001|Overall Study|Surgery|1|||
164090643|NCT01298570|592695773|FG000|Overall Study|Symptomatic progression/deterioration|3|||
164090644|NCT01298570|592695774|FG001|Overall Study|Symptomatic progression/deterioration|2|||
164090645|NCT01298570|592695773|FG000|Overall Study|Death|0|||
164090646|NCT01298570|592695774|FG001|Overall Study|Death|1|||
164090647|NCT01298570|592695773|FG000|Overall Study|Ineligibility|0|||
164090648|NCT01298570|592695774|FG001|Overall Study|Ineligibility|1|||
164090649|NCT01929109|592695775|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
164090650|NCT01929109|592695776|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
164090651|NCT01929109|592695777|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
164090652|NCT01929109|592695778|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
164090653|NCT01929109|592695779|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
164090654|NCT00076102|592695780|FG000|Overall Study|Clinical progression|1|||
164090655|NCT00076102|592695780|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
164090656|NCT00076102|592695780|FG000|Overall Study|plexiform neurofibroma surgery|1|||
164090657|NCT00076102|592695780|FG000|Overall Study|refusal of further therapy|2|||
164090658|NCT01052116|592695781|FG000|Overall Study|Lost to Follow-up|11|||
164090659|NCT01052116|592695782|FG001|Overall Study|Lost to Follow-up|17|||
164090660|NCT01052116|592695781|FG000|Overall Study|Withdrawal by Subject|3|||
164090661|NCT01052116|592695782|FG001|Overall Study|Withdrawal by Subject|6|||
164090662|NCT01052116|592695781|FG000|Overall Study|Spirometry not performed|0|||
164090663|NCT01052116|592695782|FG001|Overall Study|Spirometry not performed|4|||
164090664|NCT02180711|592695784|FG000|Overall Study|Death|0|||
164090665|NCT02180711|592695785|FG001|Overall Study|Death|1|||
164090666|NCT02180711|592695786|FG002|Overall Study|Death|0|||
164090667|NCT02180711|592695787|FG003|Overall Study|Death|0|||
164090668|NCT02180711|592695788|FG004|Overall Study|Death|7|||
164090669|NCT02180711|592695789|FG005|Overall Study|Death|0|||
164090670|NCT02180711|592695790|FG006|Overall Study|Death|1|||
164090671|NCT02180711|592695791|FG007|Overall Study|Death|3|||
164090672|NCT02180711|592695784|FG000|Overall Study|Lost to Follow-up|0|||
164090673|NCT02180711|592695785|FG001|Overall Study|Lost to Follow-up|1|||
164090674|NCT02180711|592695786|FG002|Overall Study|Lost to Follow-up|0|||
164090675|NCT02180711|592695787|FG003|Overall Study|Lost to Follow-up|0|||
164090676|NCT02180711|592695788|FG004|Overall Study|Lost to Follow-up|1|||
164090677|NCT02180711|592695789|FG005|Overall Study|Lost to Follow-up|1|||
164090678|NCT02180711|592695790|FG006|Overall Study|Lost to Follow-up|0|||
164090679|NCT02180711|592695791|FG007|Overall Study|Lost to Follow-up|3|||
164090680|NCT02180711|592695784|FG000|Overall Study|Withdrawal by Subject|2|||
164090681|NCT02180711|592695785|FG001|Overall Study|Withdrawal by Subject|1|||
164090682|NCT02180711|592695786|FG002|Overall Study|Withdrawal by Subject|0|||
164090683|NCT02180711|592695787|FG003|Overall Study|Withdrawal by Subject|4|||
164090684|NCT02180711|592695788|FG004|Overall Study|Withdrawal by Subject|3|||
164090685|NCT02180711|592695789|FG005|Overall Study|Withdrawal by Subject|0|||
164090686|NCT02180711|592695790|FG006|Overall Study|Withdrawal by Subject|3|||
164090687|NCT02180711|592695791|FG007|Overall Study|Withdrawal by Subject|2|||
164090688|NCT02180711|592695784|FG000|Overall Study|- Disease Progression|0|||
164090689|NCT02180711|592695785|FG001|Overall Study|- Disease Progression|1|||
164090690|NCT02180711|592695786|FG002|Overall Study|- Disease Progression|0|||
164090691|NCT02180711|592695787|FG003|Overall Study|- Disease Progression|0|||
164090692|NCT02180711|592695788|FG004|Overall Study|- Disease Progression|0|||
164090693|NCT02180711|592695789|FG005|Overall Study|- Disease Progression|0|||
164090694|NCT02180711|592695790|FG006|Overall Study|- Disease Progression|0|||
164090695|NCT02180711|592695791|FG007|Overall Study|- Disease Progression|0|||
164090696|NCT02180711|592695784|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
164090697|NCT02180711|592695785|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
164090698|NCT02180711|592695786|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
164090699|NCT02180711|592695787|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
164090700|NCT02180711|592695788|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164090701|NCT02180711|592695789|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164090702|NCT02180711|592695790|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164090703|NCT02180711|592695791|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
164090704|NCT02180711|592695784|FG000|Overall Study|- Study Terminated by Sponsor|2|||
164090705|NCT02180711|592695785|FG001|Overall Study|- Study Terminated by Sponsor|3|||
164090706|NCT02180711|592695786|FG002|Overall Study|- Study Terminated by Sponsor|0|||
164090707|NCT02180711|592695787|FG003|Overall Study|- Study Terminated by Sponsor|5|||
164090708|NCT02180711|592695788|FG004|Overall Study|- Study Terminated by Sponsor|32|||
164090709|NCT02180711|592695789|FG005|Overall Study|- Study Terminated by Sponsor|0|||
164090710|NCT02180711|592695790|FG006|Overall Study|- Study Terminated by Sponsor|4|||
164090711|NCT02180711|592695791|FG007|Overall Study|- Study Terminated by Sponsor|13|||
164090712|NCT02180711|592695784|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
164090713|NCT02180711|592695785|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
164090714|NCT02180711|592695786|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
164090715|NCT02180711|592695787|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
164090716|NCT02180711|592695788|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
164090717|NCT02180711|592695789|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
164090718|NCT02180711|592695790|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
164090719|NCT02180711|592695791|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
164090720|NCT02180711|592695784|FG000|Overall Study|- Other|1|||
164090721|NCT02180711|592695785|FG001|Overall Study|- Other|0|||
164090722|NCT02180711|592695786|FG002|Overall Study|- Other|0|||
164090723|NCT02180711|592695787|FG003|Overall Study|- Other|1|||
164090724|NCT02180711|592695788|FG004|Overall Study|- Other|0|||
164090725|NCT02180711|592695789|FG005|Overall Study|- Other|0|||
164090726|NCT02180711|592695790|FG006|Overall Study|- Other|0|||
164090727|NCT02180711|592695791|FG007|Overall Study|- Other|0|||
164090728|NCT00444145|592695792|FG000|Overall Study|Withdrawal by Subject|2|||
164090729|NCT00444145|592695792|FG000|Overall Study|Lost to Follow-up|1|||
164090730|NCT00444145|592695792|FG000|Overall Study|non-compliant|11|||
164090731|NCT00444145|592695792|FG000|Overall Study|Screen Failures|5|||
164090732|NCT01619800|592695793|FG000|Overall Study|study terminated|2|||
164090733|NCT01619800|592695794|FG001|Overall Study|study terminated|0|||
164090734|NCT00502775|592695801|FG000|Overall Study|Adverse Event|1|||
164090735|NCT00502775|592695802|FG001|Overall Study|Adverse Event|2|||
164090736|NCT00502775|592695803|FG002|Overall Study|Adverse Event|1|||
164090737|NCT00502775|592695801|FG000|Overall Study|Protocol Violation|1|||
164090738|NCT00502775|592695802|FG001|Overall Study|Protocol Violation|5|||
164090739|NCT00502775|592695803|FG002|Overall Study|Protocol Violation|2|||
164090740|NCT00502775|592695801|FG000|Overall Study|Withdrawal by Subject|1|||
164090741|NCT00502775|592695802|FG001|Overall Study|Withdrawal by Subject|1|||
164090742|NCT00502775|592695803|FG002|Overall Study|Withdrawal by Subject|2|||
164090743|NCT00502775|592695801|FG000|Overall Study|Sponsor Terminated Study|1|||
164090744|NCT00502775|592695802|FG001|Overall Study|Sponsor Terminated Study|0|||
164090745|NCT00502775|592695803|FG002|Overall Study|Sponsor Terminated Study|1|||
164090746|NCT00502775|592695801|FG000|Overall Study|Non-compliance with eDiary|4|||
164090747|NCT00502775|592695802|FG001|Overall Study|Non-compliance with eDiary|1|||
164090748|NCT00502775|592695803|FG002|Overall Study|Non-compliance with eDiary|1|||
164090749|NCT00502775|592695801|FG000|Overall Study|Subject unable to swallow capsule|1|||
164090750|NCT00502775|592695802|FG001|Overall Study|Subject unable to swallow capsule|0|||
164090751|NCT00502775|592695803|FG002|Overall Study|Subject unable to swallow capsule|1|||
164090752|NCT00502775|592695801|FG000|Overall Study|Logpad compliance <80%|1|||
164355673|NCT03720470|593678625|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355674|NCT03720470|593678626|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355675|NCT03720470|593678627|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
163900180|NCT05802173|592006687|FG000|Overall Study|Withdrawal by Subject|2|||
164090753|NCT00502775|592695802|FG001|Overall Study|Logpad compliance <80%|0|||
164090754|NCT00502775|592695803|FG002|Overall Study|Logpad compliance <80%|0|||
164090755|NCT00502775|592695801|FG000|Overall Study|Randomized in error|0|||
164090756|NCT00502775|592695802|FG001|Overall Study|Randomized in error|1|||
164090757|NCT00502775|592695803|FG002|Overall Study|Randomized in error|1|||
164090758|NCT00502775|592695801|FG000|Overall Study|Non-compliance|0|||
164090759|NCT00502775|592695802|FG001|Overall Study|Non-compliance|2|||
164090760|NCT00502775|592695803|FG002|Overall Study|Non-compliance|2|||
164355676|NCT03720470|593678628|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355677|NCT03720470|593678629|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
164355678|NCT03720470|593678630|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
164355679|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
164355680|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
164355681|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
164355682|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
164355683|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
164355684|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
164355685|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355686|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355687|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
164355688|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164006738|NCT03519178|592391062|FG013|PF-06873600 Treatment|Progressive disease|28|||
164006739|NCT03519178|592391063|FG014|PF-06873600 Treatment|Progressive disease|8|||
164006740|NCT03519178|592391049|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
164006741|NCT03519178|592391050|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
164006742|NCT03519178|592391051|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
164006743|NCT03519178|592391052|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
164006744|NCT03519178|592391053|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
164006745|NCT03519178|592391054|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
164006746|NCT03519178|592391055|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
164006747|NCT03519178|592391056|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
164006748|NCT03519178|592391057|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
164006749|NCT03519178|592391058|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
164006750|NCT03519178|592391059|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
164006751|NCT03519178|592391060|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
164006752|NCT03519178|592391061|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
164006753|NCT03519178|592391062|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
164090761|NCT00502775|592695801|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
164090762|NCT00502775|592695802|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
164090763|NCT00502775|592695803|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
164090764|NCT00502775|592695801|FG000|Overall Study|Declining pollen counts|0|||
164090765|NCT00502775|592695802|FG001|Overall Study|Declining pollen counts|1|||
164090766|NCT00502775|592695803|FG002|Overall Study|Declining pollen counts|1|||
164090767|NCT00502775|592695801|FG000|Overall Study|Subject in jail|0|||
164090768|NCT00502775|592695802|FG001|Overall Study|Subject in jail|1|||
164090769|NCT00502775|592695803|FG002|Overall Study|Subject in jail|0|||
164090770|NCT00502775|592695801|FG000|Overall Study|Subject took disallowed drug|0|||
164090771|NCT00502775|592695802|FG001|Overall Study|Subject took disallowed drug|0|||
164090772|NCT00502775|592695803|FG002|Overall Study|Subject took disallowed drug|1|||
164090773|NCT02518113|592695804|FG000|Overall Study|Adverse Event|1|||
164090774|NCT02518113|592695805|FG001|Overall Study|Adverse Event|0|||
164090775|NCT02518113|592695806|FG002|Overall Study|Adverse Event|1|||
164090776|NCT02518113|592695807|FG003|Overall Study|Adverse Event|0|||
164355689|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355690|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
164355691|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355692|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355693|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355694|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
164355695|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
164355696|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
164355697|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355698|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164090777|NCT02518113|592695804|FG000|Overall Study|Death|1|||
164355699|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355700|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355701|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
164355702|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
164355703|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355704|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355705|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
164355706|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355707|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355708|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
164355709|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
164355710|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
164355711|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
164355712|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
164355713|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
164355714|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
164355715|NCT03720470|593678625|FG000|Treatment Period: Final 4 Weeks|Other|0|||
164355716|NCT03720470|593678626|FG001|Treatment Period: Final 4 Weeks|Other|1|||
164355717|NCT03720470|593678627|FG002|Treatment Period: Final 4 Weeks|Other|0|||
164355718|NCT03720470|593678628|FG003|Treatment Period: Final 4 Weeks|Other|2|||
164355719|NCT03720470|593678629|FG004|Treatment Period: Final 4 Weeks|Other|1|||
164355720|NCT03720470|593678630|FG005|Treatment Period: Final 4 Weeks|Other|0|||
164355721|NCT01988103|593678631|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
164355722|NCT01988103|593678632|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
164355723|NCT01988103|593678633|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
164355724|NCT01988103|593678634|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
164355725|NCT01988103|593678635|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
164355726|NCT01988103|593678631|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
164355727|NCT01988103|593678632|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
164355728|NCT01988103|593678633|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
164355729|NCT01988103|593678634|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
164355730|NCT01988103|593678635|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
164355731|NCT01988103|593678631|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
164355732|NCT01988103|593678632|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
164355733|NCT01988103|593678633|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
164355734|NCT01988103|593678634|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164355735|NCT01988103|593678635|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164090778|NCT02518113|592695805|FG001|Overall Study|Death|2|||
164090779|NCT02518113|592695806|FG002|Overall Study|Death|0|||
164090780|NCT02518113|592695807|FG003|Overall Study|Death|0|||
164090781|NCT02518113|592695804|FG000|Overall Study|Physician Decision|0|||
164090782|NCT02518113|592695805|FG001|Overall Study|Physician Decision|1|||
164090783|NCT02518113|592695806|FG002|Overall Study|Physician Decision|0|||
164090784|NCT02518113|592695807|FG003|Overall Study|Physician Decision|0|||
164090785|NCT02518113|592695804|FG000|Overall Study|Progressive Disease|1|||
164090786|NCT02518113|592695805|FG001|Overall Study|Progressive Disease|2|||
164090787|NCT02518113|592695806|FG002|Overall Study|Progressive Disease|3|||
164090788|NCT02518113|592695807|FG003|Overall Study|Progressive Disease|0|||
164090789|NCT00520741|592695808|FG000|Overall Study|Adverse Event|16|||
164090790|NCT00520741|592695809|FG001|Overall Study|Adverse Event|56|||
164090791|NCT00520741|592695808|FG000|Overall Study|Lack of Efficacy|11|||
164090792|NCT00520741|592695809|FG001|Overall Study|Lack of Efficacy|30|||
164090793|NCT00520741|592695808|FG000|Overall Study|Withdrawal by Subject|0|||
164090794|NCT00520741|592695809|FG001|Overall Study|Withdrawal by Subject|11|||
164090795|NCT00520741|592695808|FG000|Overall Study|Protocol Violation|2|||
164090796|NCT00520741|592695809|FG001|Overall Study|Protocol Violation|15|||
164090797|NCT00520741|592695808|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
164090798|NCT00520741|592695809|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
164090799|NCT00520741|592695808|FG000|Overall Study|Lost to Follow-up|4|||
164090800|NCT00520741|592695809|FG001|Overall Study|Lost to Follow-up|4|||
164090801|NCT00520741|592695808|FG000|Overall Study|Other reasons for premature termination|0|||
164090802|NCT00520741|592695809|FG001|Overall Study|Other reasons for premature termination|6|||
164090803|NCT03702621|592695810|FG000|Overall Study|Physician Decision|6|||
164090804|NCT03702621|592695811|FG001|Overall Study|Physician Decision|6|||
164090805|NCT00419926|592695812|FG000|Overall Study|Withdrawal by Subject|7|||
164090806|NCT00419926|592695813|FG001|Overall Study|Withdrawal by Subject|3|||
164090807|NCT00419926|592695812|FG000|Overall Study|Administrative Problem|4|||
164090808|NCT00419926|592695813|FG001|Overall Study|Administrative Problem|4|||
164090809|NCT00419926|592695812|FG000|Overall Study|Lost to Follow-up|1|||
164090810|NCT00419926|592695813|FG001|Overall Study|Lost to Follow-up|2|||
164090811|NCT00419926|592695812|FG000|Overall Study|Death|2|||
164090812|NCT00419926|592695813|FG001|Overall Study|Death|1|||
164090813|NCT02374918|592695814|FG000|Overall Study|Protocol Violation|2|||
164090814|NCT02374918|592695815|FG001|Overall Study|Protocol Violation|0|||
164090815|NCT02374918|592695816|FG002|Overall Study|Protocol Violation|2|||
164090816|NCT02374918|592695817|FG003|Overall Study|Protocol Violation|1|||
164090817|NCT02374918|592695814|FG000|Overall Study|Withdrawal by Subject|1|||
164090818|NCT02374918|592695815|FG001|Overall Study|Withdrawal by Subject|1|||
164090819|NCT02374918|592695816|FG002|Overall Study|Withdrawal by Subject|1|||
164090820|NCT02374918|592695817|FG003|Overall Study|Withdrawal by Subject|0|||
164090821|NCT02374918|592695814|FG000|Overall Study|Lack of Efficacy|0|||
164090822|NCT02374918|592695815|FG001|Overall Study|Lack of Efficacy|0|||
164090823|NCT02374918|592695816|FG002|Overall Study|Lack of Efficacy|1|||
164090824|NCT02374918|592695817|FG003|Overall Study|Lack of Efficacy|1|||
164090825|NCT02402166|592695818|FG000|Overall Study|Adverse Event|2|||
164090826|NCT02402166|592695818|FG000|Overall Study|Withdrawal by Subject|2|||
164090827|NCT02402166|592695818|FG000|Overall Study|Lost to Follow-up|1|||
164090828|NCT00623103|592695819|FG000|Overall Study|Adverse Event|70|||
164090829|NCT00623103|592695820|FG001|Overall Study|Adverse Event|60|||
164090830|NCT00623103|592695819|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164090831|NCT00623103|592695820|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
164090832|NCT00623103|592695819|FG000|Overall Study|Withdrawal by Subject|18|||
164090833|NCT00623103|592695820|FG001|Overall Study|Withdrawal by Subject|24|||
164090834|NCT00623103|592695819|FG000|Overall Study|Lost to Follow-up|4|||
164090835|NCT00623103|592695820|FG001|Overall Study|Lost to Follow-up|1|||
164090836|NCT00623103|592695819|FG000|Overall Study|Administrative problems|2|||
163900181|NCT05802173|592006688|FG001|Overall Study|Withdrawal by Subject|0|||
163900182|NCT05802173|592006689|FG002|Overall Study|Withdrawal by Subject|0|||
163900183|NCT05802173|592006687|FG000|Overall Study|Protocol Violation|1|||
163900184|NCT05802173|592006688|FG001|Overall Study|Protocol Violation|0|||
163900185|NCT05802173|592006689|FG002|Overall Study|Protocol Violation|0|||
163900186|NCT05802173|592006687|FG000|Overall Study|Lost to Follow-up|0|||
163900187|NCT05802173|592006688|FG001|Overall Study|Lost to Follow-up|6|||
163900188|NCT05802173|592006689|FG002|Overall Study|Lost to Follow-up|4|||
163900189|NCT05802173|592006687|FG000|Overall Study|non-compliance|0|||
163900190|NCT05802173|592006688|FG001|Overall Study|non-compliance|1|||
163900191|NCT05802173|592006689|FG002|Overall Study|non-compliance|0|||
163900192|NCT04503681|592006690|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
163900193|NCT04503681|592006691|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
164090837|NCT00623103|592695820|FG001|Overall Study|Administrative problems|4|||
164090838|NCT00623103|592695819|FG000|Overall Study|Death|11|||
164090839|NCT00623103|592695820|FG001|Overall Study|Death|11|||
164090840|NCT00623103|592695819|FG000|Overall Study|Protocol deviation|2|||
164090841|NCT00623103|592695820|FG001|Overall Study|Protocol deviation|1|||
164090842|NCT02433678|592695825|FG000|Overall Study|Lost to Follow-up|1|||
164090843|NCT02433678|592695826|FG001|Overall Study|Lost to Follow-up|2|||
164090844|NCT01424722|592695830|FG000|Overall Study|Sponsor terminated investigation|2258|||
164090845|NCT02483975|592695831|FG000|Overall Study|Adverse Event|0|||
164090846|NCT02483975|592695832|FG001|Overall Study|Adverse Event|1|||
163900194|NCT03352713|592006692|FG000|Overall Study|Lost to Follow-up|8|||
164090847|NCT02483975|592695831|FG000|Overall Study|Lost to Follow-up|0|||
164090848|NCT02483975|592695832|FG001|Overall Study|Lost to Follow-up|1|||
164090849|NCT02483975|592695831|FG000|Overall Study|Physician Decision|2|||
164090850|NCT02483975|592695832|FG001|Overall Study|Physician Decision|0|||
164090851|NCT00818883|592695833|FG000|Overall Study|Adverse Event|28|||
164090852|NCT00818883|592695834|FG001|Overall Study|Adverse Event|19|||
164090853|NCT00818883|592695833|FG000|Overall Study|Protocol Violation|2|||
164090854|NCT00818883|592695834|FG001|Overall Study|Protocol Violation|2|||
164090855|NCT00818883|592695833|FG000|Overall Study|Lost to Follow-up|3|||
164090856|NCT00818883|592695834|FG001|Overall Study|Lost to Follow-up|2|||
164090857|NCT00818883|592695833|FG000|Overall Study|Withdrawal by Subject|16|||
164090858|NCT00818883|592695834|FG001|Overall Study|Withdrawal by Subject|14|||
164090859|NCT00818883|592695833|FG000|Overall Study|Lack of Efficacy|0|||
164090860|NCT00818883|592695834|FG001|Overall Study|Lack of Efficacy|2|||
164090861|NCT00818883|592695833|FG000|Overall Study|Other|2|||
164090862|NCT00818883|592695834|FG001|Overall Study|Other|7|||
164090863|NCT02166697|592695835|FG000|Overall Study|Protocol Violation|347|||
164090864|NCT02684578|592695839|FG000|Overall Study|Withdrawal by Subject|10|||
164090865|NCT02684578|592695840|FG001|Overall Study|Withdrawal by Subject|7|||
164090866|NCT02684578|592695839|FG000|Overall Study|Lost to Follow-up|0|||
164090867|NCT02684578|592695840|FG001|Overall Study|Lost to Follow-up|3|||
164090868|NCT02684578|592695839|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
164090869|NCT02684578|592695840|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
164090870|NCT02684578|592695839|FG000|Overall Study|Missing follow-up data|0|||
164090871|NCT02684578|592695840|FG001|Overall Study|Missing follow-up data|1|||
164090872|NCT01505530|592695841|FG000|Overall Study|Progressive Disease|19|||
164090873|NCT01505530|592695842|FG001|Overall Study|Progressive Disease|17|||
164090874|NCT01505530|592695843|FG002|Overall Study|Progressive Disease|18|||
164090875|NCT01505530|592695841|FG000|Overall Study|Adverse Event|1|||
164090876|NCT01505530|592695842|FG001|Overall Study|Adverse Event|1|||
164090877|NCT01505530|592695843|FG002|Overall Study|Adverse Event|0|||
164090878|NCT01505530|592695841|FG000|Overall Study|Withdrawal by Subject|7|||
164090879|NCT01505530|592695842|FG001|Overall Study|Withdrawal by Subject|8|||
164090880|NCT01505530|592695843|FG002|Overall Study|Withdrawal by Subject|6|||
164090881|NCT01505530|592695841|FG000|Overall Study|Physician Decision|6|||
164090882|NCT01505530|592695842|FG001|Overall Study|Physician Decision|2|||
164090883|NCT01505530|592695843|FG002|Overall Study|Physician Decision|5|||
164090884|NCT01505530|592695841|FG000|Overall Study|Sponsor Decision|1|||
164090885|NCT01505530|592695842|FG001|Overall Study|Sponsor Decision|8|||
164090886|NCT01505530|592695843|FG002|Overall Study|Sponsor Decision|7|||
164090887|NCT01505530|592695841|FG000|Overall Study|Death|7|||
164090888|NCT01505530|592695842|FG001|Overall Study|Death|6|||
164090889|NCT01505530|592695843|FG002|Overall Study|Death|5|||
164090890|NCT01505530|592695841|FG000|Overall Study|entry criteria not met|0|||
164090891|NCT01505530|592695842|FG001|Overall Study|entry criteria not met|1|||
164090892|NCT01505530|592695843|FG002|Overall Study|entry criteria not met|0|||
164090893|NCT00625807|592695846|FG000|Overall Study|schedule conflict|2|||
164090894|NCT00625807|592695847|FG001|Overall Study|schedule conflict|8|||
164090895|NCT01966042|592695848|FG000|Overall Study|Death|2|||
164090896|NCT01802879|592695849|FG000|Overall Study|Administrative problems|2|||
164090897|NCT01802879|592695849|FG000|Overall Study|Disease progression|6|||
164090898|NCT00266409|592695850|FG000|Overall Study|Lack of Efficacy|2|||
164090899|NCT00266409|592695851|FG001|Overall Study|Lack of Efficacy|6|||
164090900|NCT00266409|592695852|FG002|Overall Study|Lack of Efficacy|1|||
164090901|NCT00266409|592695853|FG003|Overall Study|Lack of Efficacy|2|||
164090902|NCT00266409|592695850|FG000|Overall Study|Adverse Event|7|||
164090903|NCT00266409|592695851|FG001|Overall Study|Adverse Event|2|||
164090904|NCT00266409|592695852|FG002|Overall Study|Adverse Event|1|||
164090905|NCT00266409|592695853|FG003|Overall Study|Adverse Event|1|||
164090906|NCT00266409|592695850|FG000|Overall Study|Lost to Follow-up|18|||
164090907|NCT00266409|592695851|FG001|Overall Study|Lost to Follow-up|21|||
164090908|NCT00266409|592695852|FG002|Overall Study|Lost to Follow-up|6|||
164090909|NCT00266409|592695853|FG003|Overall Study|Lost to Follow-up|8|||
164090910|NCT00266409|592695850|FG000|Overall Study|Withdrawal by Subject|6|||
164090911|NCT00266409|592695851|FG001|Overall Study|Withdrawal by Subject|10|||
164090912|NCT00266409|592695852|FG002|Overall Study|Withdrawal by Subject|3|||
164090913|NCT00266409|592695853|FG003|Overall Study|Withdrawal by Subject|9|||
164090914|NCT00266409|592695850|FG000|Overall Study|Protocol Violation|5|||
164090915|NCT00266409|592695851|FG001|Overall Study|Protocol Violation|3|||
164090916|NCT00266409|592695852|FG002|Overall Study|Protocol Violation|4|||
164090917|NCT00266409|592695853|FG003|Overall Study|Protocol Violation|2|||
164090918|NCT00266409|592695850|FG000|Overall Study|Other|7|||
164090919|NCT00266409|592695851|FG001|Overall Study|Other|4|||
164090920|NCT00266409|592695852|FG002|Overall Study|Other|2|||
164090921|NCT00266409|592695853|FG003|Overall Study|Other|0|||
164090922|NCT00108732|592695861|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
164090923|NCT00108732|592695861|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
164090924|NCT00108732|592695861|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
164090925|NCT00108732|592695861|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
164090926|NCT00108732|592695861|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
164090927|NCT00108732|592695861|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
164090928|NCT00108732|592695861|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
164090929|NCT01946165|592695863|FG000|Overall Study|Physician Decision|2|||
164090930|NCT01946165|592695864|FG001|Overall Study|Physician Decision|0|||
164090931|NCT01946165|592695863|FG000|Overall Study|Withdrawal by Subject|0|||
164090932|NCT01946165|592695864|FG001|Overall Study|Withdrawal by Subject|2|||
164090933|NCT01901055|592695865|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
164090934|NCT01901055|592695866|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
164090935|NCT01901055|592695865|FG000|Randomization But Not Titrated|Physician Decision|0|||
164090936|NCT01901055|592695866|FG001|Randomization But Not Titrated|Physician Decision|1|||
164090937|NCT01901055|592695865|FG000|Started Protocol to Week 6|Physician Decision|2|||
164090938|NCT01901055|592695866|FG001|Started Protocol to Week 6|Physician Decision|1|||
164090939|NCT01901055|592695865|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
164090940|NCT01901055|592695866|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
164090941|NCT01901055|592695865|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
164090942|NCT01901055|592695866|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
164090943|NCT01901055|592695865|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
164090944|NCT01901055|592695866|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
164090945|NCT01901055|592695865|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
164090946|NCT01901055|592695866|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
164090947|NCT01901055|592695865|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
164090948|NCT01901055|592695866|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
164090949|NCT01901055|592695865|FG000|Week 24|Withdrawal by Subject|13|||
164090950|NCT01901055|592695866|FG001|Week 24|Withdrawal by Subject|19|||
164090951|NCT01901055|592695865|FG000|Week 24|Physician Decision|1|||
164090952|NCT01901055|592695866|FG001|Week 24|Physician Decision|0|||
164090953|NCT01901055|592695865|FG000|Week 36|Withdrawal by Subject|0|||
164090954|NCT01901055|592695866|FG001|Week 36|Withdrawal by Subject|5|||
164090955|NCT03019965|592695867|FG000|Overall Study|Withdrawal by Subject|1|||
164090956|NCT03019965|592695868|FG001|Overall Study|Withdrawal by Subject|0|||
164090957|NCT03019965|592695867|FG000|Overall Study|Protocol Violation|1|||
164090958|NCT03019965|592695868|FG001|Overall Study|Protocol Violation|3|||
164090959|NCT03019965|592695867|FG000|Overall Study|viral or fungal infection|3|||
164090960|NCT03019965|592695868|FG001|Overall Study|viral or fungal infection|4|||
164090961|NCT03019965|592695867|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
164090962|NCT03019965|592695868|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
164090963|NCT03019965|592695867|FG000|Overall Study|Physician Decision|1|||
164090964|NCT03019965|592695868|FG001|Overall Study|Physician Decision|1|||
164090965|NCT00708422|592695869|FG000|Overall Study|Adverse Event|3|||
164090966|NCT00708422|592695870|FG001|Overall Study|Adverse Event|1|||
164090967|NCT00708422|592695869|FG000|Overall Study|Withdrawal by Subject|1|||
164090968|NCT00708422|592695870|FG001|Overall Study|Withdrawal by Subject|0|||
164090969|NCT01254409|592695871|FG000|Overall Study|Adverse Event|0|||
164090970|NCT01254409|592695872|FG001|Overall Study|Adverse Event|1|||
164090971|NCT01254409|592695873|FG002|Overall Study|Adverse Event|0|||
164090972|NCT01254409|592695874|FG003|Overall Study|Adverse Event|0|||
164090973|NCT00635154|592695881|FG000|Overall Study|Alternative Treatment|8|||
164090974|NCT00635154|592695881|FG000|Overall Study|Other|4|||
164090975|NCT00635154|592695881|FG000|Overall Study|Still on treatment|21|||
164090976|NCT02114697|592695882|FG000|Overall Study|Study terminated|5|||
164090977|NCT02114697|592695883|FG001|Overall Study|Study terminated|4|||
164090978|NCT02660242|592695888|FG000|Glucose Tabs|Lost to Follow-up|1|||
164090979|NCT02660242|592695888|FG000|Glucagon Injection|Lost to Follow-up|1|||
164090980|NCT02796664|592695891|FG000|Overall Study|Withdrawal by Subject|0|||
164090981|NCT02796664|592695892|FG001|Overall Study|Withdrawal by Subject|3|||
164090982|NCT02796664|592695891|FG000|Overall Study|Noncompliance|1|||
164090983|NCT02796664|592695892|FG001|Overall Study|Noncompliance|1|||
164090984|NCT02796664|592695891|FG000|Overall Study|Death|0|||
164090985|NCT02796664|592695892|FG001|Overall Study|Death|1|||
164090986|NCT01626079|592695893|FG000|Overall Study|Death|167|||
164090987|NCT01626079|592695894|FG001|Overall Study|Death|192|||
164090988|NCT01626079|592695895|FG002|Overall Study|Death|39|||
164090989|NCT01626079|592695893|FG000|Overall Study|Withdrawal by Subject|23|||
164090990|NCT01626079|592695894|FG001|Overall Study|Withdrawal by Subject|37|||
164090991|NCT01626079|592695895|FG002|Overall Study|Withdrawal by Subject|5|||
164090992|NCT01626079|592695893|FG000|Overall Study|Lost to Follow-up|7|||
164090993|NCT01626079|592695894|FG001|Overall Study|Lost to Follow-up|4|||
163900195|NCT03352713|592006692|FG000|Overall Study|Withdrawn by investigator|5|||
163900196|NCT03352713|592006692|FG000|Overall Study|Completed 0 EMAs|8|||
163900197|NCT03352713|592006692|FG000|Overall Study|Device incompatible/stolen|5|||
163900198|NCT01812759|592006693|FG000|Overall Study|Physician Decision|0|||
163900199|NCT01812759|592006694|FG001|Overall Study|Physician Decision|0|||
163900200|NCT01812759|592006695|FG002|Overall Study|Physician Decision|1|||
163900201|NCT00360269|592006696|FG000|Overall Study|Lost to Follow-up|7|||
163900202|NCT00360269|592006697|FG001|Overall Study|Lost to Follow-up|9|||
163900203|NCT00360269|592006696|FG000|Overall Study|Physician Decision|1|||
163900204|NCT00360269|592006697|FG001|Overall Study|Physician Decision|2|||
163900205|NCT00360269|592006696|FG000|Overall Study|Adverse Event|1|||
163900206|NCT00360269|592006697|FG001|Overall Study|Adverse Event|0|||
163900207|NCT00360269|592006696|FG000|Overall Study|Withdrawal by Subject|1|||
163900208|NCT00360269|592006697|FG001|Overall Study|Withdrawal by Subject|1|||
163900209|NCT04989816|592006700|FG000|Overall Study|Death|77|||
163900210|NCT04989816|592006700|FG000|Overall Study|Lost to Follow-up|3|||
163900211|NCT03758638|592006701|FG000|Overall Study|Pregnancy|17|||
163900212|NCT03758638|592006702|FG001|Overall Study|Pregnancy|25|||
163900213|NCT03758638|592006701|FG000|Overall Study|Lost to Follow-up|60|||
163900214|NCT03758638|592006702|FG001|Overall Study|Lost to Follow-up|54|||
163900215|NCT03758638|592006701|FG000|Overall Study|Protocol Violation|2|||
163900216|NCT03758638|592006702|FG001|Overall Study|Protocol Violation|0|||
163900217|NCT03758638|592006701|FG000|Overall Study|Withdrawal by Subject|8|||
163900218|NCT03758638|592006702|FG001|Overall Study|Withdrawal by Subject|2|||
163900219|NCT03758638|592006701|FG000|Overall Study|Providers not included in the primary outcome.|183|||
163900220|NCT03758638|592006702|FG001|Overall Study|Providers not included in the primary outcome.|128|||
163900221|NCT01184326|592006703|FG000|Overall Study|Adverse Event|1|||
163900222|NCT01184326|592006704|FG001|Overall Study|Adverse Event|2|||
163900223|NCT01184326|592006705|FG002|Overall Study|Adverse Event|0|||
163900224|NCT01184326|592006703|FG000|Overall Study|Death|0|||
163900225|NCT01184326|592006704|FG001|Overall Study|Death|0|||
163900226|NCT01184326|592006705|FG002|Overall Study|Death|1|||
163900227|NCT01184326|592006703|FG000|Overall Study|Withdrawal by Subject|0|||
163900228|NCT01184326|592006704|FG001|Overall Study|Withdrawal by Subject|0|||
163900229|NCT01184326|592006705|FG002|Overall Study|Withdrawal by Subject|1|||
163900230|NCT01184326|592006703|FG000|Overall Study|Physician Decision|1|||
163900231|NCT01184326|592006704|FG001|Overall Study|Physician Decision|1|||
163900232|NCT01184326|592006705|FG002|Overall Study|Physician Decision|0|||
163900233|NCT01184326|592006703|FG000|Overall Study|Disease Progression|1|||
163900234|NCT01184326|592006704|FG001|Overall Study|Disease Progression|3|||
163900235|NCT01184326|592006705|FG002|Overall Study|Disease Progression|12|||
163900236|NCT01036724|592006706|FG000|Overall Study|Adverse Event|1|||
163900237|NCT01036724|592006707|FG001|Overall Study|Adverse Event|2|||
163900238|NCT01036724|592006706|FG000|Overall Study|Lack of Efficacy|1|||
164355736|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
164355737|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
164355738|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
164355739|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
164355740|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
164355741|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
164355742|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
164355743|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
164355744|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
164355745|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
164355746|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
164355747|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
164355748|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
164355749|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
164355750|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
163900239|NCT01036724|592006707|FG001|Overall Study|Lack of Efficacy|1|||
163900240|NCT01036724|592006706|FG000|Overall Study|Protocol Violation|4|||
163900241|NCT01036724|592006707|FG001|Overall Study|Protocol Violation|5|||
163900242|NCT03442777|592006710|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
163900243|NCT03442777|592006711|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
163900244|NCT03442777|592006712|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
163900245|NCT02866942|592006713|FG000|Overall Study|Invalid consent|1|||
163900246|NCT00372775|592006714|FG000|Overall Study|Adverse Event|8|||
163900247|NCT00372775|592006714|FG000|Overall Study|Death|15|||
163900248|NCT00372775|592006714|FG000|Overall Study|Objective progression or relapse|30|||
163900249|NCT00372775|592006714|FG000|Overall Study|Global deterioration of health status|6|||
163900250|NCT00372775|592006714|FG000|Overall Study|Withdrawal by Subject|1|||
163900251|NCT00372775|592006714|FG000|Overall Study|Other|1|||
163900252|NCT00372775|592006714|FG000|Overall Study|Not Treated|2|||
163900253|NCT01750684|592006715|FG000|Overall Study|Death|1|||
163900254|NCT01750684|592006716|FG001|Overall Study|Death|0|||
163900255|NCT01750684|592006715|FG000|Overall Study|Non-compliance with Study Drug|0|||
163900256|NCT01750684|592006716|FG001|Overall Study|Non-compliance with Study Drug|1|||
163900257|NCT01750684|592006715|FG000|Overall Study|Withdrawn by Sponsor|0|||
163900258|NCT01750684|592006716|FG001|Overall Study|Withdrawn by Sponsor|1|||
163900259|NCT01750684|592006715|FG000|Overall Study|Protocol Violation|1|||
163900260|NCT01750684|592006716|FG001|Overall Study|Protocol Violation|0|||
163900261|NCT01561300|592006717|FG000|Run in on Placebo|Adverse Event|1|||
163900262|NCT01561300|592006718|FG001|Run in on Placebo|Adverse Event|0|||
163900263|NCT00777049|592006719|FG000|Overall Study|Withdrawal by Subject|1|||
163900264|NCT00777049|592006720|FG001|Overall Study|Withdrawal by Subject|0|||
163900265|NCT00777049|592006719|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
163900266|NCT00777049|592006720|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
163900267|NCT00790569|592006721|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
163900268|NCT00790569|592006722|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
163900269|NCT00790569|592006723|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
164006754|NCT03519178|592391063|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
164006755|NCT03519178|592391049|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
164006756|NCT03519178|592391050|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
164006757|NCT03519178|592391051|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
164006758|NCT03519178|592391052|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
164006759|NCT03519178|592391053|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
164006760|NCT03519178|592391054|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
164006761|NCT03519178|592391055|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
164006762|NCT03519178|592391056|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
164006763|NCT03519178|592391057|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
164006764|NCT03519178|592391058|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
164006765|NCT03519178|592391059|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
164355751|NCT01988103|593678631|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
164355752|NCT01988103|593678632|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
164006766|NCT03519178|592391060|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
164006767|NCT03519178|592391061|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
164006768|NCT03519178|592391062|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
164006769|NCT03519178|592391063|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
164006770|NCT03519178|592391049|FG000|PF-06873600 Treatment|Refused further treatment|0|||
164006771|NCT03519178|592391050|FG001|PF-06873600 Treatment|Refused further treatment|1|||
164006772|NCT03519178|592391051|FG002|PF-06873600 Treatment|Refused further treatment|0|||
164006773|NCT03519178|592391052|FG003|PF-06873600 Treatment|Refused further treatment|0|||
164006774|NCT03519178|592391053|FG004|PF-06873600 Treatment|Refused further treatment|1|||
164006775|NCT03519178|592391054|FG005|PF-06873600 Treatment|Refused further treatment|0|||
164006776|NCT03519178|592391055|FG006|PF-06873600 Treatment|Refused further treatment|0|||
164006777|NCT03519178|592391056|FG007|PF-06873600 Treatment|Refused further treatment|0|||
164006778|NCT03519178|592391057|FG008|PF-06873600 Treatment|Refused further treatment|0|||
164006779|NCT03519178|592391058|FG009|PF-06873600 Treatment|Refused further treatment|0|||
164006780|NCT03519178|592391059|FG010|PF-06873600 Treatment|Refused further treatment|0|||
164006781|NCT03519178|592391060|FG011|PF-06873600 Treatment|Refused further treatment|0|||
164006782|NCT03519178|592391061|FG012|PF-06873600 Treatment|Refused further treatment|0|||
164006783|NCT03519178|592391062|FG013|PF-06873600 Treatment|Refused further treatment|0|||
164006784|NCT03519178|592391063|FG014|PF-06873600 Treatment|Refused further treatment|1|||
164006785|NCT03519178|592391049|FG000|PF-06873600 Treatment|Other|0|||
164006786|NCT03519178|592391050|FG001|PF-06873600 Treatment|Other|0|||
163900270|NCT00790569|592006721|FG000|End of Treatment (6 Month Interview)|Death|0|||
163900271|NCT00790569|592006722|FG001|End of Treatment (6 Month Interview)|Death|2|||
163900272|NCT00790569|592006723|FG002|End of Treatment (6 Month Interview)|Death|1|||
163900273|NCT00790569|592006721|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
163900274|NCT00790569|592006722|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
163900275|NCT00790569|592006723|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
163900276|NCT00790569|592006721|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
163900277|NCT00790569|592006722|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
163900278|NCT00790569|592006723|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
163900279|NCT00790569|592006721|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
163900280|NCT00790569|592006722|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
163900281|NCT00790569|592006723|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
164006787|NCT03519178|592391051|FG002|PF-06873600 Treatment|Other|0|||
164006788|NCT03519178|592391052|FG003|PF-06873600 Treatment|Other|0|||
164006789|NCT03519178|592391053|FG004|PF-06873600 Treatment|Other|0|||
164006790|NCT03519178|592391054|FG005|PF-06873600 Treatment|Other|0|||
163900282|NCT00790569|592006721|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
163900283|NCT00790569|592006722|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
163900284|NCT00790569|592006723|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
163900285|NCT01627561|592006724|FG000|Overall Study|Lost to Follow-up|1|||
163900286|NCT01627561|592006725|FG001|Overall Study|Lost to Follow-up|0|||
163900287|NCT01627561|592006724|FG000|Overall Study|Withdrawal by Subject|0|||
163900288|NCT01627561|592006725|FG001|Overall Study|Withdrawal by Subject|1|||
163900289|NCT01627561|592006724|FG000|Overall Study|Migrated/moved from study area|0|||
163900290|NCT01627561|592006725|FG001|Overall Study|Migrated/moved from study area|2|||
163900291|NCT00724126|592006726|FG000|Overall Study|Adverse Event|2|||
163900292|NCT00724126|592006727|FG001|Overall Study|Adverse Event|0|||
163900293|NCT00724126|592006726|FG000|Overall Study|Withdrawal by Subject|8|||
163900294|NCT00724126|592006727|FG001|Overall Study|Withdrawal by Subject|6|||
163900295|NCT00724126|592006726|FG000|Overall Study|Lost to Follow-up|6|||
163900296|NCT00724126|592006727|FG001|Overall Study|Lost to Follow-up|6|||
163900297|NCT00724126|592006726|FG000|Overall Study|Noncompliance|2|||
163900298|NCT00724126|592006727|FG001|Overall Study|Noncompliance|1|||
163900299|NCT00724126|592006726|FG000|Overall Study|Subject randomized although ineligible|1|||
163900300|NCT00724126|592006727|FG001|Overall Study|Subject randomized although ineligible|1|||
163900301|NCT00724126|592006726|FG000|Overall Study|Subject had to leave vicinity of site|0|||
163900302|NCT00724126|592006727|FG001|Overall Study|Subject had to leave vicinity of site|1|||
163900303|NCT01436175|592006728|FG000|Overall Study|Adverse Event|111|||
163900304|NCT01436175|592006728|FG000|Overall Study|Protocol Violation|49|||
163900305|NCT01436175|592006728|FG000|Overall Study|Withdrawal by Subject|108|||
163900306|NCT01436175|592006728|FG000|Overall Study|Lost to Follow-up|89|||
163900307|NCT01436175|592006728|FG000|Overall Study|Lack of Efficacy|24|||
163900308|NCT01436175|592006728|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
163900309|NCT01436175|592006728|FG000|Overall Study|Other|826|||
163900310|NCT03577106|592006732|FG000|Overall Study|Withdrawal by Subject|3|||
163900311|NCT01579318|592006733|FG000|Overall Study|Disease Progression|1|||
163900312|NCT03601715|592006736|FG000|Second Intervention|Lost to Follow-up|1|||
163900313|NCT03601715|592006737|FG001|Second Intervention|Lost to Follow-up|1|||
163900314|NCT03601715|592006738|FG002|Second Intervention|Lost to Follow-up|0|||
163900315|NCT01478594|592006740|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
163900316|NCT01478594|592006741|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
163900317|NCT01478594|592006740|FG000|Overall Study|Death|45|||
163900318|NCT01478594|592006741|FG001|Overall Study|Death|18|||
163900319|NCT01478594|592006740|FG000|Overall Study|Lost to Follow-up|3|||
163900320|NCT01478594|592006741|FG001|Overall Study|Lost to Follow-up|1|||
163900321|NCT01478594|592006740|FG000|Overall Study|Withdrawal by Subject|9|||
163900322|NCT01478594|592006741|FG001|Overall Study|Withdrawal by Subject|3|||
163900323|NCT01478594|592006740|FG000|Overall Study|Study Closed by Sponsor|8|||
163900324|NCT01478594|592006741|FG001|Overall Study|Study Closed by Sponsor|5|||
163900325|NCT01313884|592006743|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
163900326|NCT01970007|592006744|FG000|Overall Study|Death|5|||
163900327|NCT01970007|592006744|FG000|Overall Study|Withdrawal by Subject|23|||
163900328|NCT01970007|592006744|FG000|Overall Study|Lost to Follow-up|24|||
163900329|NCT01970007|592006744|FG000|Overall Study|"Other endpoint"|3|||
163900330|NCT04250194|592006748|FG000|Overall Study|Declined to schedule biopsy|6|||
163900331|NCT04250194|592006749|FG001|Overall Study|Declined to schedule biopsy|10|||
163900332|NCT04250194|592006748|FG000|Overall Study|Medically Unfit for Biopsy|2|||
163900333|NCT04250194|592006749|FG001|Overall Study|Medically Unfit for Biopsy|1|||
163900334|NCT04250194|592006748|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
163900335|NCT04250194|592006749|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
163900336|NCT04250194|592006748|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
163900337|NCT04250194|592006749|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
163900338|NCT04250194|592006748|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
163900339|NCT04250194|592006749|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
163900340|NCT00274261|592006750|FG000|Overall Study|Adverse Event|19|||
163900341|NCT00274261|592006751|FG001|Overall Study|Adverse Event|11|||
163900342|NCT00274261|592006750|FG000|Overall Study|Pregnancy|114|||
163900343|NCT00274261|592006751|FG001|Overall Study|Pregnancy|83|||
164090994|NCT01626079|592695895|FG002|Overall Study|Lost to Follow-up|2|||
164090995|NCT01626079|592695893|FG000|Overall Study|Missed Visits|1|||
164090996|NCT01626079|592695894|FG001|Overall Study|Missed Visits|4|||
164006791|NCT03519178|592391055|FG006|PF-06873600 Treatment|Other|0|||
164006792|NCT03519178|592391056|FG007|PF-06873600 Treatment|Other|0|||
164006793|NCT03519178|592391057|FG008|PF-06873600 Treatment|Other|1|||
164006794|NCT03519178|592391058|FG009|PF-06873600 Treatment|Other|0|||
164006795|NCT03519178|592391059|FG010|PF-06873600 Treatment|Other|0|||
164006796|NCT03519178|592391060|FG011|PF-06873600 Treatment|Other|0|||
164006797|NCT03519178|592391061|FG012|PF-06873600 Treatment|Other|0|||
164006798|NCT03519178|592391062|FG013|PF-06873600 Treatment|Other|1|||
164006799|NCT03519178|592391063|FG014|PF-06873600 Treatment|Other|3|||
164006800|NCT03519178|592391049|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
164006801|NCT03519178|592391050|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
164006802|NCT03519178|592391051|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
164006803|NCT03519178|592391052|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
164006804|NCT03519178|592391053|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
164006805|NCT03519178|592391054|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
164006806|NCT03519178|592391055|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
164006807|NCT03519178|592391056|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
164006808|NCT03519178|592391057|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
164006809|NCT03519178|592391058|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
164006810|NCT03519178|592391059|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
164006811|NCT03519178|592391060|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
164006812|NCT03519178|592391061|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
164006813|NCT03519178|592391062|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
164006814|NCT03519178|592391063|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
164006815|NCT03519178|592391049|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006816|NCT03519178|592391050|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006817|NCT03519178|592391051|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006818|NCT03519178|592391052|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006819|NCT03519178|592391053|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006820|NCT03519178|592391054|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006821|NCT03519178|592391055|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006822|NCT03519178|592391056|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006823|NCT03519178|592391057|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006824|NCT03519178|592391058|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006825|NCT03519178|592391059|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006826|NCT03519178|592391060|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006827|NCT03519178|592391061|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
164006828|NCT03519178|592391062|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
164006829|NCT03519178|592391063|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
164006830|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Adverse Event|0|||
164006831|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Adverse Event|0|||
164006832|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Adverse Event|0|||
164006833|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Adverse Event|0|||
164006834|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Adverse Event|0|||
164006835|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Adverse Event|0|||
164006836|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Adverse Event|0|||
164006837|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Adverse Event|0|||
164006838|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Adverse Event|0|||
164006839|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Adverse Event|0|||
164006840|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Adverse Event|0|||
164006841|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Adverse Event|0|||
164006842|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Adverse Event|0|||
164006843|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Adverse Event|1|||
164006844|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Adverse Event|0|||
164006845|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Death|0|||
164006846|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Death|0|||
164006847|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Death|0|||
164006848|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Death|0|||
164006849|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Death|0|||
164006850|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Death|0|||
164006851|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Death|0|||
164006852|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Death|0|||
164006853|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Death|0|||
164006854|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Death|1|||
164006855|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Death|0|||
164006856|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Death|0|||
164006857|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Death|0|||
164006858|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Death|0|||
164006859|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Death|1|||
164006860|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006861|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006862|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006863|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006864|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006865|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
164355753|NCT01988103|593678633|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
164355754|NCT01988103|593678634|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
164355755|NCT01988103|593678635|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
164355756|NCT01946425|593678637|FG000|Overall Study|Protocol Violation|1|||
164355757|NCT01946425|593678638|FG001|Overall Study|Protocol Violation|0|||
164355758|NCT01946425|593678637|FG000|Overall Study|Withdrawal by Subject|1|||
164355759|NCT01946425|593678638|FG001|Overall Study|Withdrawal by Subject|0|||
164355760|NCT05682326|593678642|FG000|Overall Study|Withdrawal by Subject|1|||
164355761|NCT05682326|593678643|FG001|Overall Study|Withdrawal by Subject|0|||
164355762|NCT01402544|593678644|FG000|Overall Study|Withdrawal by Subject|6|||
164355763|NCT01113801|593678645|FG000|Overall Study|Adverse Event|4|||
164355764|NCT01113801|593678646|FG001|Overall Study|Adverse Event|0|||
164355765|NCT01113801|593678647|FG002|Overall Study|Adverse Event|2|||
164355766|NCT01113801|593678648|FG003|Overall Study|Adverse Event|6|||
164355767|NCT01113801|593678645|FG000|Overall Study|Death|4|||
164355768|NCT01113801|593678646|FG001|Overall Study|Death|5|||
164355769|NCT01113801|593678647|FG002|Overall Study|Death|3|||
164355770|NCT01113801|593678648|FG003|Overall Study|Death|4|||
164355771|NCT01113801|593678645|FG000|Overall Study|Protocol Violation|0|||
164355772|NCT01113801|593678646|FG001|Overall Study|Protocol Violation|1|||
164355773|NCT01113801|593678647|FG002|Overall Study|Protocol Violation|0|||
164355774|NCT01113801|593678648|FG003|Overall Study|Protocol Violation|0|||
164355775|NCT01113801|593678645|FG000|Overall Study|Withdrawal by Subject|9|||
164355776|NCT01113801|593678646|FG001|Overall Study|Withdrawal by Subject|7|||
164355777|NCT01113801|593678647|FG002|Overall Study|Withdrawal by Subject|7|||
164355778|NCT01113801|593678648|FG003|Overall Study|Withdrawal by Subject|8|||
164355779|NCT01113801|593678645|FG000|Overall Study|Physician Decision|2|||
163900344|NCT00274261|592006750|FG000|Overall Study|Withdrawal by Subject|179|||
163900345|NCT00274261|592006751|FG001|Overall Study|Withdrawal by Subject|126|||
163900346|NCT00274261|592006750|FG000|Overall Study|Protocol Violation|71|||
163900347|NCT00274261|592006751|FG001|Overall Study|Protocol Violation|42|||
163900348|NCT00274261|592006750|FG000|Overall Study|Lost to Follow-up|106|||
163900349|NCT00274261|592006751|FG001|Overall Study|Lost to Follow-up|75|||
163900350|NCT03500549|592006752|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
163900351|NCT03500549|592006753|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
163900352|NCT03500549|592006752|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
163900353|NCT03500549|592006753|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
163900354|NCT02016872|592006756|FG000|Overall Study|Withdrawal by Subject|10|||
163900355|NCT02016872|592006756|FG000|Overall Study|Death Progression|2|||
163900356|NCT02016872|592006756|FG000|Overall Study|No FMISO scan|1|||
163900357|NCT02016872|592006756|FG000|Overall Study|Ineligible|2|||
163900358|NCT05018143|592006757|FG000|Overall Study|Lost to Follow-up|5|||
163900359|NCT05018143|592006758|FG001|Overall Study|Lost to Follow-up|4|||
163900360|NCT05018143|592006757|FG000|Overall Study|Withdrawal by Subject|0|||
163900361|NCT05018143|592006758|FG001|Overall Study|Withdrawal by Subject|1|||
163900362|NCT06688357|592006759|FG000|Overall Study|Adverse Event|0|||
163900363|NCT06688357|592006760|FG001|Overall Study|Adverse Event|1|||
163900364|NCT00545545|592006761|FG000|Overall Study|Progressive Neoplastic Disease|1|||
163900365|NCT00545545|592006762|FG001|Overall Study|Progressive Neoplastic Disease|5|||
163900366|NCT00545545|592006763|FG002|Overall Study|Progressive Neoplastic Disease|0|||
163900367|NCT00545545|592006764|FG003|Overall Study|Progressive Neoplastic Disease|4|||
163900368|NCT00545545|592006765|FG004|Overall Study|Progressive Neoplastic Disease|8|||
163900369|NCT00545545|592006766|FG005|Overall Study|Progressive Neoplastic Disease|7|||
163900370|NCT00545545|592006761|FG000|Overall Study|Withdrawal by Subject|0|||
163900371|NCT00545545|592006762|FG001|Overall Study|Withdrawal by Subject|1|||
163900372|NCT00545545|592006763|FG002|Overall Study|Withdrawal by Subject|0|||
163900373|NCT00545545|592006764|FG003|Overall Study|Withdrawal by Subject|0|||
163900374|NCT00545545|592006765|FG004|Overall Study|Withdrawal by Subject|0|||
163900375|NCT00545545|592006766|FG005|Overall Study|Withdrawal by Subject|0|||
163900376|NCT00545545|592006761|FG000|Overall Study|Physician Decision|1|||
163900377|NCT00545545|592006762|FG001|Overall Study|Physician Decision|0|||
163900378|NCT00545545|592006763|FG002|Overall Study|Physician Decision|0|||
163900379|NCT00545545|592006764|FG003|Overall Study|Physician Decision|0|||
163900380|NCT00545545|592006765|FG004|Overall Study|Physician Decision|0|||
163900381|NCT00545545|592006766|FG005|Overall Study|Physician Decision|1|||
163900382|NCT00545545|592006761|FG000|Overall Study|Irinotecan intolerance|1|||
163900383|NCT00545545|592006762|FG001|Overall Study|Irinotecan intolerance|1|||
163900384|NCT00545545|592006763|FG002|Overall Study|Irinotecan intolerance|0|||
163900385|NCT00545545|592006764|FG003|Overall Study|Irinotecan intolerance|0|||
164355780|NCT01113801|593678646|FG001|Overall Study|Physician Decision|2|||
164355781|NCT01113801|593678647|FG002|Overall Study|Physician Decision|3|||
164355782|NCT01113801|593678648|FG003|Overall Study|Physician Decision|3|||
164355783|NCT01113801|593678645|FG000|Overall Study|Sponsor Decision|15|||
164355784|NCT01113801|593678646|FG001|Overall Study|Sponsor Decision|21|||
164355785|NCT01113801|593678647|FG002|Overall Study|Sponsor Decision|20|||
164355786|NCT01113801|593678648|FG003|Overall Study|Sponsor Decision|15|||
164355787|NCT01113801|593678645|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
164006866|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006867|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006868|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
164355788|NCT01113801|593678646|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
164355789|NCT01113801|593678647|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
163900386|NCT00545545|592006765|FG004|Overall Study|Irinotecan intolerance|0|||
163900387|NCT00545545|592006766|FG005|Overall Study|Irinotecan intolerance|0|||
163900388|NCT00545545|592006761|FG000|Overall Study|No target lesions to track post surgery|0|||
164006869|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006870|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006871|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006872|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006873|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
164006874|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
164006875|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Physician Decision|0|||
164006876|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Physician Decision|0|||
164006877|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Physician Decision|0|||
164006878|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Physician Decision|0|||
164006879|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Physician Decision|0|||
164006880|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Physician Decision|0|||
164006881|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Physician Decision|0|||
164006882|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Physician Decision|0|||
164006883|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Physician Decision|0|||
164006884|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Physician Decision|0|||
164006885|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Physician Decision|0|||
164006886|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Physician Decision|0|||
164006887|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Physician Decision|0|||
164006888|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Physician Decision|4|||
164006889|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Physician Decision|2|||
164006890|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Progressive disease|0|||
164006891|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Progressive disease|0|||
164006892|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Progressive disease|0|||
164006893|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Progressive disease|0|||
164006894|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Progressive disease|0|||
164006895|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Progressive disease|0|||
164006896|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Progressive disease|0|||
164006897|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Progressive disease|0|||
164006898|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Progressive disease|0|||
164006899|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Progressive disease|5|||
164006900|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Progressive disease|0|||
164006901|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Progressive disease|0|||
164006902|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Progressive disease|0|||
164006903|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Progressive disease|30|||
164006904|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Progressive disease|8|||
164006905|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006906|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006907|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006908|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006909|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006910|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
163900389|NCT00545545|592006762|FG001|Overall Study|No target lesions to track post surgery|0|||
163900390|NCT00545545|592006763|FG002|Overall Study|No target lesions to track post surgery|0|||
163900391|NCT00545545|592006764|FG003|Overall Study|No target lesions to track post surgery|0|||
163900392|NCT00545545|592006765|FG004|Overall Study|No target lesions to track post surgery|1|||
163900393|NCT00545545|592006766|FG005|Overall Study|No target lesions to track post surgery|1|||
163900394|NCT00227266|592006770|FG000|Overall Study|Withdrawal by Subject|0|||
163900395|NCT00227266|592006771|FG001|Overall Study|Withdrawal by Subject|0|||
163900396|NCT00227266|592006772|FG002|Overall Study|Withdrawal by Subject|1|||
163900397|NCT00227266|592006770|FG000|Overall Study|Protocol Violation|1|||
163900398|NCT00227266|592006771|FG001|Overall Study|Protocol Violation|0|||
163900399|NCT00227266|592006772|FG002|Overall Study|Protocol Violation|1|||
163900400|NCT00227266|592006770|FG000|Overall Study|Excessive weight gain|0|||
163900401|NCT00227266|592006771|FG001|Overall Study|Excessive weight gain|0|||
163900402|NCT00227266|592006772|FG002|Overall Study|Excessive weight gain|2|||
163900403|NCT02761187|592006776|FG000|Overall Study|Too ill to Participate|13|||
163900404|NCT02761187|592006777|FG001|Overall Study|Too ill to Participate|8|||
163900405|NCT02761187|592006776|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
163900406|NCT02761187|592006777|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
163900407|NCT02761187|592006776|FG000|Overall Study|Patient withdrew consent|64|||
163900408|NCT02761187|592006777|FG001|Overall Study|Patient withdrew consent|58|||
164006911|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164355790|NCT01113801|593678648|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
163900409|NCT02761187|592006776|FG000|Overall Study|Physician discretion|4|||
163900410|NCT02761187|592006777|FG001|Overall Study|Physician discretion|8|||
163900411|NCT02761187|592006776|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
163900412|NCT02761187|592006777|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
163900413|NCT02761187|592006776|FG000|Overall Study|On Hospice|20|||
163900414|NCT02761187|592006777|FG001|Overall Study|On Hospice|26|||
163900415|NCT02761187|592006776|FG000|Overall Study|Deceased|474|||
163900416|NCT02761187|592006777|FG001|Overall Study|Deceased|642|||
163900417|NCT02761187|592006776|FG000|Overall Study|Lost to Follow-up|73|||
163900418|NCT02761187|592006777|FG001|Overall Study|Lost to Follow-up|63|||
163900419|NCT02761187|592006776|FG000|Overall Study|Due to study discontinued at site|100|||
163900420|NCT02761187|592006777|FG001|Overall Study|Due to study discontinued at site|85|||
163900421|NCT02761187|592006776|FG000|Overall Study|Reason not Specified|1484|||
163900422|NCT02761187|592006777|FG001|Overall Study|Reason not Specified|937|||
163900423|NCT05786612|592006780|FG000|Overall Study|Adverse Event|1|||
163900424|NCT05786612|592006781|FG001|Overall Study|Adverse Event|2|||
163900425|NCT05786612|592006780|FG000|Overall Study|one screening failure|0|||
163900426|NCT05786612|592006781|FG001|Overall Study|one screening failure|2|||
163900427|NCT05704725|592006786|FG000|Overall Study|Lost to Follow-up|0|||
163900428|NCT05704725|592006787|FG001|Overall Study|Lost to Follow-up|1|||
163900429|NCT05704725|592006786|FG000|Overall Study|Withdrawal by Subject|1|||
163900430|NCT05704725|592006787|FG001|Overall Study|Withdrawal by Subject|0|||
163900431|NCT01470144|592006788|FG000|Overall Study|Adverse Event|2|||
163900432|NCT01470144|592006788|FG000|Overall Study|Death|1|||
163900433|NCT01470144|592006788|FG000|Overall Study|Lung transplant|6|||
163900434|NCT01470144|592006788|FG000|Overall Study|Patient's and investigator's decision|1|||
163900435|NCT03752684|592007920|FG000|Overall Study|Lost to Follow-up|4|||
163900436|NCT00048932|592007923|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
163900437|NCT00048932|592007924|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
163900438|NCT00048932|592007925|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
163900439|NCT00048932|592007923|FG000|Double Blind Period (DB)|Adverse Event|51|||
163900440|NCT00048932|592007924|FG001|Double Blind Period (DB)|Adverse Event|19|||
163900441|NCT00048932|592007925|FG002|Double Blind Period (DB)|Adverse Event|0|||
163900442|NCT00048932|592007923|FG000|Double Blind Period (DB)|Death|5|||
163900443|NCT00048932|592007924|FG001|Double Blind Period (DB)|Death|3|||
163900444|NCT00048932|592007925|FG002|Double Blind Period (DB)|Death|0|||
163900445|NCT00048932|592007923|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
163900446|NCT00048932|592007924|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
163900447|NCT00048932|592007925|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
163900448|NCT00048932|592007923|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
163900449|NCT00048932|592007924|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
163900450|NCT00048932|592007925|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
163900451|NCT00048932|592007923|FG000|Double Blind Period (DB)|Relocation|1|||
163900452|NCT00048932|592007924|FG001|Double Blind Period (DB)|Relocation|0|||
163900453|NCT00048932|592007925|FG002|Double Blind Period (DB)|Relocation|0|||
163900454|NCT00048932|592007923|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
163900455|NCT00048932|592007924|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
163900456|NCT00048932|592007925|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
163900457|NCT00048932|592007923|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
163900458|NCT00048932|592007924|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
163900459|NCT00048932|592007925|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
163900460|NCT00048932|592007923|FG000|Double Blind Period (DB)|Pregnancy|1|||
163900461|NCT00048932|592007924|FG001|Double Blind Period (DB)|Pregnancy|0|||
163900462|NCT00048932|592007925|FG002|Double Blind Period (DB)|Pregnancy|0|||
163900463|NCT00048932|592007923|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
163900464|NCT00048932|592007924|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
163900465|NCT00048932|592007925|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
163900466|NCT00048932|592007923|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
163900467|NCT00048932|592007924|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
163900468|NCT00048932|592007925|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
163900469|NCT00048932|592007923|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
163900470|NCT00048932|592007924|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
163900471|NCT00048932|592007925|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
163900472|NCT00048932|592007923|FG000|Open Label Period (OL)|Death|0|||
163900473|NCT00048932|592007924|FG001|Open Label Period (OL)|Death|0|||
163900474|NCT00048932|592007925|FG002|Open Label Period (OL)|Death|25|||
163900475|NCT00048932|592007923|FG000|Open Label Period (OL)|Adverse Event|0|||
163900476|NCT00048932|592007924|FG001|Open Label Period (OL)|Adverse Event|0|||
163900477|NCT00048932|592007925|FG002|Open Label Period (OL)|Adverse Event|103|||
163900478|NCT00048932|592007923|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
163900479|NCT00048932|592007924|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
163900480|NCT00048932|592007925|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
164006912|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006913|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164355791|NCT01949051|593678652|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
164355792|NCT01949051|593678653|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355793|NCT01949051|593678654|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355794|NCT01949051|593678655|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
164355795|NCT01949051|593678656|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355796|NCT01949051|593678657|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
164355797|NCT01949051|593678652|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
164355798|NCT01949051|593678653|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164355799|NCT01949051|593678654|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164355800|NCT01949051|593678655|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164355801|NCT01949051|593678656|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
164006914|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006915|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006916|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006917|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
164006918|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
164006919|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
164006920|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006921|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006922|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006923|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006924|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006925|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006926|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006927|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006928|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006929|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
164006930|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006931|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006932|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
164006933|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
164006934|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
164006935|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006936|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006937|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006938|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006939|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006940|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006941|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
164355802|NCT01949051|593678657|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
163900481|NCT00048932|592007923|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
163900482|NCT00048932|592007924|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
163900483|NCT00048932|592007925|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
163900484|NCT00048932|592007923|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
163900485|NCT00048932|592007924|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
163900486|NCT00048932|592007925|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
163900487|NCT00048932|592007923|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
163900488|NCT00048932|592007924|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
163900489|NCT00048932|592007925|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
163900490|NCT00048932|592007923|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
163900491|NCT00048932|592007924|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
163900492|NCT00048932|592007925|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
163900493|NCT00048932|592007923|FG000|Open Label Period (OL)|Pregnancy|0|||
163900494|NCT00048932|592007924|FG001|Open Label Period (OL)|Pregnancy|0|||
163900495|NCT00048932|592007925|FG002|Open Label Period (OL)|Pregnancy|6|||
163900496|NCT00048932|592007923|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
163900497|NCT00048932|592007924|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
163900498|NCT00048932|592007925|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
163900499|NCT00048932|592007923|FG000|Open Label Period (OL)|Investigator Retiring|0|||
163900500|NCT00048932|592007924|FG001|Open Label Period (OL)|Investigator Retiring|0|||
163900501|NCT00048932|592007925|FG002|Open Label Period (OL)|Investigator Retiring|2|||
163900502|NCT00048932|592007923|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
163900503|NCT00048932|592007924|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
163900504|NCT00048932|592007925|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
163900505|NCT00048932|592007923|FG000|Open Label Period (OL)|Participant Relocated|0|||
163900506|NCT00048932|592007924|FG001|Open Label Period (OL)|Participant Relocated|0|||
163900507|NCT00048932|592007925|FG002|Open Label Period (OL)|Participant Relocated|6|||
163900508|NCT00048932|592007923|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
163900509|NCT00048932|592007924|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
163900510|NCT00048932|592007925|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
163900511|NCT00048932|592007923|FG000|Open Label Period (OL)|Site Closure|0|||
163900512|NCT00048932|592007924|FG001|Open Label Period (OL)|Site Closure|0|||
163900513|NCT00048932|592007925|FG002|Open Label Period (OL)|Site Closure|3|||
163900514|NCT00048932|592007923|FG000|Open Label Period (OL)|Trial Terminated|0|||
163900515|NCT00048932|592007924|FG001|Open Label Period (OL)|Trial Terminated|0|||
163900516|NCT00048932|592007925|FG002|Open Label Period (OL)|Trial Terminated|1|||
163900517|NCT00048932|592007923|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
163900518|NCT00048932|592007924|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
163900519|NCT00048932|592007925|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
163900520|NCT00048932|592007923|FG000|Open Label Period (OL)|Patient Decision|0|||
163900521|NCT00048932|592007924|FG001|Open Label Period (OL)|Patient Decision|0|||
163900522|NCT00048932|592007925|FG002|Open Label Period (OL)|Patient Decision|4|||
163900523|NCT00048932|592007923|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
163900524|NCT00048932|592007924|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
163900525|NCT00048932|592007925|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
163900526|NCT00048932|592007923|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
163900527|NCT00048932|592007924|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
163900528|NCT00048932|592007925|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
163900529|NCT00048932|592007923|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
163900530|NCT00048932|592007924|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
163900531|NCT00048932|592007925|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
163900532|NCT00048932|592007923|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
163900533|NCT00048932|592007924|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
163900534|NCT00048932|592007925|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
163900535|NCT00048932|592007923|FG000|Open Label Period (OL)|Investigator Decision|0|||
163900536|NCT00048932|592007924|FG001|Open Label Period (OL)|Investigator Decision|0|||
163900537|NCT00048932|592007925|FG002|Open Label Period (OL)|Investigator Decision|4|||
163900538|NCT00048932|592007923|FG000|Open Label Period (OL)|Site Staff Issues|0|||
163900539|NCT00048932|592007924|FG001|Open Label Period (OL)|Site Staff Issues|0|||
163900540|NCT00048932|592007925|FG002|Open Label Period (OL)|Site Staff Issues|2|||
163900541|NCT00048932|592007923|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
163900542|NCT00048932|592007924|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
163900543|NCT00048932|592007925|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
163900544|NCT00048932|592007923|FG000|Open Label Period (OL)|Participant Surgery|0|||
163900545|NCT00048932|592007924|FG001|Open Label Period (OL)|Participant Surgery|0|||
163900546|NCT00048932|592007925|FG002|Open Label Period (OL)|Participant Surgery|1|||
163900547|NCT04213807|592007928|FG000|Overall Study|Physician Decision|0|||
163900548|NCT04213807|592007929|FG001|Overall Study|Physician Decision|0|||
163900549|NCT04213807|592007930|FG002|Overall Study|Physician Decision|1|||
163900550|NCT03418922|592007931|FG000|Overall Study|Withdrawal by Subject|0|||
163900551|NCT03418922|592007932|FG001|Overall Study|Withdrawal by Subject|2|||
163900552|NCT03418922|592007931|FG000|Overall Study|Adverse Event|2|||
163900553|NCT03418922|592007932|FG001|Overall Study|Adverse Event|2|||
163900554|NCT03418922|592007931|FG000|Overall Study|Death|0|||
163900555|NCT03418922|592007932|FG001|Overall Study|Death|1|||
163900556|NCT03418922|592007931|FG000|Overall Study|Physician Decision|0|||
163900557|NCT03418922|592007932|FG001|Overall Study|Physician Decision|1|||
163900558|NCT03451422|592007933|FG000|Overall Study|Lost to Follow-up|0|||
163900559|NCT03451422|592007934|FG001|Overall Study|Lost to Follow-up|0|||
163900560|NCT03451422|592007935|FG002|Overall Study|Lost to Follow-up|0|||
163900561|NCT03451422|592007936|FG003|Overall Study|Lost to Follow-up|0|||
163900562|NCT03451422|592007937|FG004|Overall Study|Lost to Follow-up|0|||
163900563|NCT03451422|592007938|FG005|Overall Study|Lost to Follow-up|1|||
163900564|NCT03451422|592007933|FG000|Overall Study|Decision by sponsor|1|||
163900565|NCT03451422|592007934|FG001|Overall Study|Decision by sponsor|0|||
163900566|NCT03451422|592007935|FG002|Overall Study|Decision by sponsor|1|||
163900567|NCT03451422|592007936|FG003|Overall Study|Decision by sponsor|0|||
163900568|NCT03451422|592007937|FG004|Overall Study|Decision by sponsor|0|||
163900569|NCT03451422|592007938|FG005|Overall Study|Decision by sponsor|0|||
163900570|NCT03451422|592007933|FG000|Overall Study|Withdrawal by Subject|0|||
163900571|NCT03451422|592007934|FG001|Overall Study|Withdrawal by Subject|0|||
163900572|NCT03451422|592007935|FG002|Overall Study|Withdrawal by Subject|2|||
163900573|NCT03451422|592007936|FG003|Overall Study|Withdrawal by Subject|3|||
163900574|NCT03451422|592007937|FG004|Overall Study|Withdrawal by Subject|2|||
163900575|NCT03451422|592007938|FG005|Overall Study|Withdrawal by Subject|1|||
163900576|NCT02347332|592007939|FG000|Overall Study|Not treated|5|||
163900577|NCT02347332|592007940|FG001|Overall Study|Not treated|2|||
163900578|NCT02347332|592007939|FG000|Overall Study|Progressive disease|141|||
164355803|NCT01949051|593678652|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355804|NCT01949051|593678653|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355805|NCT01949051|593678654|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355806|NCT01949051|593678655|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355807|NCT01949051|593678656|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
164355808|NCT01949051|593678657|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
164006942|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006943|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006944|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
164006945|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006946|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006947|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006948|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
164006949|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
164006950|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
164006951|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
164006952|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
164006953|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
164006954|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
164006955|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
164006956|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
164006957|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
164006958|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
164006959|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
164006960|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
164006961|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
164006962|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
164006963|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
164006964|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
164006965|NCT03519178|592391049|FG000|Fulvestrant. Treatment|Other|0|||
164006966|NCT03519178|592391050|FG001|Fulvestrant. Treatment|Other|0|||
164006967|NCT03519178|592391051|FG002|Fulvestrant. Treatment|Other|0|||
164006968|NCT03519178|592391052|FG003|Fulvestrant. Treatment|Other|0|||
164006969|NCT03519178|592391053|FG004|Fulvestrant. Treatment|Other|0|||
164006970|NCT03519178|592391054|FG005|Fulvestrant. Treatment|Other|0|||
164006971|NCT03519178|592391055|FG006|Fulvestrant. Treatment|Other|0|||
164006972|NCT03519178|592391056|FG007|Fulvestrant. Treatment|Other|0|||
164006973|NCT03519178|592391057|FG008|Fulvestrant. Treatment|Other|0|||
164006974|NCT03519178|592391058|FG009|Fulvestrant. Treatment|Other|0|||
164006975|NCT03519178|592391059|FG010|Fulvestrant. Treatment|Other|0|||
164006976|NCT03519178|592391060|FG011|Fulvestrant. Treatment|Other|0|||
164006977|NCT03519178|592391061|FG012|Fulvestrant. Treatment|Other|0|||
164006978|NCT03519178|592391062|FG013|Fulvestrant. Treatment|Other|1|||
164006979|NCT03519178|592391063|FG014|Fulvestrant. Treatment|Other|3|||
164006980|NCT03519178|592391049|FG000|Letrozole Treatment|Physician Decision|0|||
164006981|NCT03519178|592391050|FG001|Letrozole Treatment|Physician Decision|0|||
164006982|NCT03519178|592391051|FG002|Letrozole Treatment|Physician Decision|0|||
164006983|NCT03519178|592391052|FG003|Letrozole Treatment|Physician Decision|0|||
164006984|NCT03519178|592391053|FG004|Letrozole Treatment|Physician Decision|0|||
164006985|NCT03519178|592391054|FG005|Letrozole Treatment|Physician Decision|0|||
164006986|NCT03519178|592391055|FG006|Letrozole Treatment|Physician Decision|0|||
164006987|NCT03519178|592391056|FG007|Letrozole Treatment|Physician Decision|0|||
164006988|NCT03519178|592391057|FG008|Letrozole Treatment|Physician Decision|0|||
164006989|NCT03519178|592391058|FG009|Letrozole Treatment|Physician Decision|0|||
164006990|NCT03519178|592391059|FG010|Letrozole Treatment|Physician Decision|1|||
164006991|NCT03519178|592391060|FG011|Letrozole Treatment|Physician Decision|0|||
164006992|NCT03519178|592391061|FG012|Letrozole Treatment|Physician Decision|0|||
164006993|NCT03519178|592391062|FG013|Letrozole Treatment|Physician Decision|0|||
164006994|NCT03519178|592391063|FG014|Letrozole Treatment|Physician Decision|0|||
164006995|NCT03519178|592391049|FG000|Letrozole Treatment|Progressive disease|0|||
164006996|NCT03519178|592391050|FG001|Letrozole Treatment|Progressive disease|0|||
164006997|NCT03519178|592391051|FG002|Letrozole Treatment|Progressive disease|0|||
164006998|NCT03519178|592391052|FG003|Letrozole Treatment|Progressive disease|0|||
164006999|NCT03519178|592391053|FG004|Letrozole Treatment|Progressive disease|0|||
164007000|NCT03519178|592391054|FG005|Letrozole Treatment|Progressive disease|0|||
164007001|NCT03519178|592391055|FG006|Letrozole Treatment|Progressive disease|0|||
164007002|NCT03519178|592391056|FG007|Letrozole Treatment|Progressive disease|0|||
164007003|NCT03519178|592391057|FG008|Letrozole Treatment|Progressive disease|0|||
164355809|NCT01949051|593678652|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164007004|NCT03519178|592391058|FG009|Letrozole Treatment|Progressive disease|0|||
164007005|NCT03519178|592391059|FG010|Letrozole Treatment|Progressive disease|4|||
164007006|NCT03519178|592391060|FG011|Letrozole Treatment|Progressive disease|0|||
164007007|NCT03519178|592391061|FG012|Letrozole Treatment|Progressive disease|0|||
164355810|NCT01949051|593678653|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
164355811|NCT01949051|593678654|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355812|NCT01949051|593678655|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355813|NCT01949051|593678656|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355814|NCT01949051|593678657|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
164355815|NCT01949051|593678652|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355816|NCT01949051|593678653|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355817|NCT01949051|593678654|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
164355818|NCT01949051|593678655|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355819|NCT01949051|593678656|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355820|NCT01949051|593678657|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
164355821|NCT04545866|593678659|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
164355822|NCT04545866|593678660|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
164355823|NCT04545866|593678659|FG000|Overall Study|Withdrawal by Physician|1|||
164355824|NCT04545866|593678660|FG001|Overall Study|Withdrawal by Physician|0|||
164355825|NCT04463719|593678663|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
164355826|NCT04463719|593678664|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
163900579|NCT02347332|592007940|FG001|Overall Study|Progressive disease|159|||
163900580|NCT02347332|592007939|FG000|Overall Study|Adverse Event|50|||
163900581|NCT02347332|592007940|FG001|Overall Study|Adverse Event|41|||
163900582|NCT02347332|592007939|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
163900583|NCT02347332|592007940|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
163900584|NCT02347332|592007939|FG000|Overall Study|Protocol Violation|1|||
163900585|NCT02347332|592007940|FG001|Overall Study|Protocol Violation|1|||
163900586|NCT02347332|592007939|FG000|Overall Study|Lost to Follow-up|2|||
163900587|NCT02347332|592007940|FG001|Overall Study|Lost to Follow-up|1|||
163900588|NCT02347332|592007939|FG000|Overall Study|Physician Decision|4|||
164355827|NCT04463719|593678665|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
164355828|NCT02436356|593678666|FG000|Overall Study|Excluded by MRI Screening|0|||
164355829|NCT02436356|593678667|FG001|Overall Study|Excluded by MRI Screening|0|||
164355830|NCT02436356|593678668|FG002|Overall Study|Excluded by MRI Screening|2|||
164355831|NCT02436356|593678666|FG000|Overall Study|Lost to Follow-up|0|||
164355832|NCT02436356|593678667|FG001|Overall Study|Lost to Follow-up|1|||
164355833|NCT02436356|593678668|FG002|Overall Study|Lost to Follow-up|0|||
164355834|NCT02436356|593678666|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
164355835|NCT02436356|593678667|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
164355836|NCT02436356|593678668|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
164355837|NCT02436356|593678666|FG000|Overall Study|Excluded due to other medical conditions|3|||
164355838|NCT02436356|593678667|FG001|Overall Study|Excluded due to other medical conditions|0|||
164355839|NCT02436356|593678668|FG002|Overall Study|Excluded due to other medical conditions|0|||
164355840|NCT02436356|593678666|FG000|Overall Study|Withdrawal by Subject|1|||
164355841|NCT02436356|593678667|FG001|Overall Study|Withdrawal by Subject|0|||
164355842|NCT02436356|593678668|FG002|Overall Study|Withdrawal by Subject|0|||
163900589|NCT02347332|592007940|FG001|Overall Study|Physician Decision|3|||
163900590|NCT02347332|592007939|FG000|Overall Study|Withdrawal by Subject|20|||
163900591|NCT02347332|592007940|FG001|Overall Study|Withdrawal by Subject|14|||
163900592|NCT02347332|592007939|FG000|Overall Study|Protocol requirement|1|||
163900593|NCT02347332|592007940|FG001|Overall Study|Protocol requirement|1|||
163900594|NCT02347332|592007939|FG000|Overall Study|Switch Post-Trial program|0|||
163900595|NCT02347332|592007940|FG001|Overall Study|Switch Post-Trial program|1|||
163900596|NCT04384172|592007942|FG000|Overall Study|Lost to Follow-up|0|||
163900597|NCT04384172|592007943|FG001|Overall Study|Lost to Follow-up|2|||
163900598|NCT04384172|592007942|FG000|Overall Study|Pregnancy|1|||
163900599|NCT04384172|592007943|FG001|Overall Study|Pregnancy|0|||
163900600|NCT04384172|592007942|FG000|Overall Study|Withdrawal by Subject|0|||
163900601|NCT04384172|592007943|FG001|Overall Study|Withdrawal by Subject|1|||
163900602|NCT04860505|592007944|FG000|Overall Study|Lost to Follow-up|2|||
163900603|NCT01640951|592007945|FG000|Overall Study|Adverse Event|8|||
163900604|NCT01640951|592007946|FG001|Overall Study|Adverse Event|3|||
163900605|NCT01640951|592007947|FG002|Overall Study|Adverse Event|10|||
163900606|NCT01640951|592007948|FG003|Overall Study|Adverse Event|6|||
163900607|NCT01640951|592007949|FG004|Overall Study|Adverse Event|1|||
163900608|NCT01640951|592007950|FG005|Overall Study|Adverse Event|11|||
163900609|NCT01640951|592007951|FG006|Overall Study|Adverse Event|1|||
163900610|NCT01640951|592007952|FG007|Overall Study|Adverse Event|3|||
163900611|NCT01640951|592007945|FG000|Overall Study|Lack of Efficacy|20|||
163900612|NCT01640951|592007946|FG001|Overall Study|Lack of Efficacy|1|||
163900613|NCT01640951|592007947|FG002|Overall Study|Lack of Efficacy|7|||
163900614|NCT01640951|592007948|FG003|Overall Study|Lack of Efficacy|14|||
163900615|NCT01640951|592007949|FG004|Overall Study|Lack of Efficacy|0|||
163900616|NCT01640951|592007950|FG005|Overall Study|Lack of Efficacy|6|||
163900617|NCT01640951|592007951|FG006|Overall Study|Lack of Efficacy|5|||
163900618|NCT01640951|592007952|FG007|Overall Study|Lack of Efficacy|6|||
163900619|NCT01640951|592007945|FG000|Overall Study|Lost to Follow-up|1|||
163900620|NCT01640951|592007946|FG001|Overall Study|Lost to Follow-up|0|||
163900621|NCT01640951|592007947|FG002|Overall Study|Lost to Follow-up|6|||
163900622|NCT01640951|592007948|FG003|Overall Study|Lost to Follow-up|2|||
163900623|NCT01640951|592007949|FG004|Overall Study|Lost to Follow-up|2|||
163900624|NCT01640951|592007950|FG005|Overall Study|Lost to Follow-up|3|||
163900625|NCT01640951|592007951|FG006|Overall Study|Lost to Follow-up|1|||
163900626|NCT01640951|592007952|FG007|Overall Study|Lost to Follow-up|1|||
163900627|NCT01640951|592007945|FG000|Overall Study|Non-compliance with study treatment|0|||
163900628|NCT01640951|592007946|FG001|Overall Study|Non-compliance with study treatment|0|||
163900629|NCT01640951|592007947|FG002|Overall Study|Non-compliance with study treatment|1|||
163900630|NCT01640951|592007948|FG003|Overall Study|Non-compliance with study treatment|1|||
164355843|NCT02875860|593678669|FG000|Overall Study|Withdrawal by Subject|0|||
164355844|NCT02875860|593678670|FG001|Overall Study|Withdrawal by Subject|1|||
164355845|NCT03287804|593678671|FG000|Overall Study|Death|1|||
164355846|NCT03287804|593678671|FG000|Overall Study|Physician Decision|2|||
164355847|NCT03287804|593678671|FG000|Overall Study|Progressive disease|8|||
164355848|NCT01881776|593678672|FG000|Overall Study|Lost to Follow-up|1|||
164355849|NCT01881776|593678673|FG001|Overall Study|Lost to Follow-up|2|||
164355850|NCT01881776|593678674|FG002|Overall Study|Lost to Follow-up|1|||
164355851|NCT01881776|593678672|FG000|Overall Study|Protocol Violation|0|||
164355852|NCT01881776|593678673|FG001|Overall Study|Protocol Violation|2|||
164355853|NCT01881776|593678674|FG002|Overall Study|Protocol Violation|1|||
164355854|NCT00487747|593678675|FG000|Overall Study|Adverse Event|1|||
164355855|NCT00487747|593678675|FG000|Overall Study|Lost to Follow-up|9|||
164355856|NCT00487747|593678675|FG000|Overall Study|Lack of Efficacy|1|||
164355857|NCT04483011|593678676|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
164355858|NCT04483011|593678677|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
164007008|NCT03519178|592391062|FG013|Letrozole Treatment|Progressive disease|0|||
164007009|NCT03519178|592391063|FG014|Letrozole Treatment|Progressive disease|0|||
164007010|NCT03519178|592391049|FG000|Letrozole Treatment|Global deterioration of health status|0|||
164007011|NCT03519178|592391050|FG001|Letrozole Treatment|Global deterioration of health status|0|||
164007012|NCT03519178|592391051|FG002|Letrozole Treatment|Global deterioration of health status|0|||
164007013|NCT03519178|592391052|FG003|Letrozole Treatment|Global deterioration of health status|0|||
164007014|NCT03519178|592391053|FG004|Letrozole Treatment|Global deterioration of health status|0|||
164007015|NCT03519178|592391054|FG005|Letrozole Treatment|Global deterioration of health status|0|||
164007016|NCT03519178|592391055|FG006|Letrozole Treatment|Global deterioration of health status|0|||
164007017|NCT03519178|592391056|FG007|Letrozole Treatment|Global deterioration of health status|0|||
164007018|NCT03519178|592391057|FG008|Letrozole Treatment|Global deterioration of health status|0|||
164007019|NCT03519178|592391058|FG009|Letrozole Treatment|Global deterioration of health status|0|||
164007020|NCT03519178|592391059|FG010|Letrozole Treatment|Global deterioration of health status|2|||
164007021|NCT03519178|592391060|FG011|Letrozole Treatment|Global deterioration of health status|0|||
164007022|NCT03519178|592391061|FG012|Letrozole Treatment|Global deterioration of health status|0|||
164007023|NCT03519178|592391062|FG013|Letrozole Treatment|Global deterioration of health status|0|||
164007024|NCT03519178|592391063|FG014|Letrozole Treatment|Global deterioration of health status|0|||
164007025|NCT03519178|592391049|FG000|Follow-Up|Death|0|||
164007026|NCT03519178|592391050|FG001|Follow-Up|Death|0|||
164007027|NCT03519178|592391051|FG002|Follow-Up|Death|0|||
164007028|NCT03519178|592391052|FG003|Follow-Up|Death|0|||
164007029|NCT03519178|592391053|FG004|Follow-Up|Death|0|||
164007030|NCT03519178|592391054|FG005|Follow-Up|Death|0|||
164007031|NCT03519178|592391055|FG006|Follow-Up|Death|0|||
164007032|NCT03519178|592391056|FG007|Follow-Up|Death|0|||
164007033|NCT03519178|592391057|FG008|Follow-Up|Death|3|||
164007034|NCT03519178|592391058|FG009|Follow-Up|Death|1|||
164007035|NCT03519178|592391059|FG010|Follow-Up|Death|0|||
164007036|NCT03519178|592391060|FG011|Follow-Up|Death|0|||
164007037|NCT03519178|592391061|FG012|Follow-Up|Death|2|||
164007038|NCT03519178|592391062|FG013|Follow-Up|Death|0|||
164007039|NCT03519178|592391063|FG014|Follow-Up|Death|0|||
164007040|NCT03519178|592391049|FG000|Follow-Up|Lost to Follow-up|0|||
164007041|NCT03519178|592391050|FG001|Follow-Up|Lost to Follow-up|0|||
164007042|NCT03519178|592391051|FG002|Follow-Up|Lost to Follow-up|0|||
164007043|NCT03519178|592391052|FG003|Follow-Up|Lost to Follow-up|0|||
164007044|NCT03519178|592391053|FG004|Follow-Up|Lost to Follow-up|0|||
164007045|NCT03519178|592391054|FG005|Follow-Up|Lost to Follow-up|3|||
164007046|NCT03519178|592391055|FG006|Follow-Up|Lost to Follow-up|1|||
164007047|NCT03519178|592391056|FG007|Follow-Up|Lost to Follow-up|4|||
164007048|NCT03519178|592391057|FG008|Follow-Up|Lost to Follow-up|1|||
164007049|NCT03519178|592391058|FG009|Follow-Up|Lost to Follow-up|0|||
164007050|NCT03519178|592391059|FG010|Follow-Up|Lost to Follow-up|0|||
164007051|NCT03519178|592391060|FG011|Follow-Up|Lost to Follow-up|0|||
164007052|NCT03519178|592391061|FG012|Follow-Up|Lost to Follow-up|0|||
164007053|NCT03519178|592391062|FG013|Follow-Up|Lost to Follow-up|0|||
164007054|NCT03519178|592391063|FG014|Follow-Up|Lost to Follow-up|0|||
164007055|NCT03519178|592391049|FG000|Follow-Up|Withdrawal by Subject|1|||
164007056|NCT03519178|592391050|FG001|Follow-Up|Withdrawal by Subject|2|||
164355859|NCT02979522|593678700|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
164355860|NCT02979522|593678701|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
164007057|NCT03519178|592391051|FG002|Follow-Up|Withdrawal by Subject|2|||
164007058|NCT03519178|592391052|FG003|Follow-Up|Withdrawal by Subject|3|||
164355861|NCT02979522|593678700|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
164355862|NCT02979522|593678701|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
164007059|NCT03519178|592391053|FG004|Follow-Up|Withdrawal by Subject|5|||
164007060|NCT03519178|592391054|FG005|Follow-Up|Withdrawal by Subject|1|||
164007061|NCT03519178|592391055|FG006|Follow-Up|Withdrawal by Subject|2|||
164007062|NCT03519178|592391056|FG007|Follow-Up|Withdrawal by Subject|6|||
164007063|NCT03519178|592391057|FG008|Follow-Up|Withdrawal by Subject|5|||
164007064|NCT03519178|592391058|FG009|Follow-Up|Withdrawal by Subject|2|||
164007065|NCT03519178|592391059|FG010|Follow-Up|Withdrawal by Subject|3|||
164355863|NCT01896531|593678704|FG000|Overall Study|Death|57|||
164355864|NCT01896531|593678705|FG001|Overall Study|Death|59|||
164355865|NCT01896531|593678704|FG000|Overall Study|Lost to Follow-up|3|||
164355866|NCT01896531|593678705|FG001|Overall Study|Lost to Follow-up|0|||
164355867|NCT01896531|593678704|FG000|Overall Study|Non-compliance|0|||
164355868|NCT01896531|593678705|FG001|Overall Study|Non-compliance|1|||
164355869|NCT01896531|593678704|FG000|Overall Study|Study Ended by Sponsor|7|||
164355870|NCT01896531|593678705|FG001|Overall Study|Study Ended by Sponsor|20|||
164355871|NCT01896531|593678704|FG000|Overall Study|Withdrawal by Subject|3|||
164355872|NCT01896531|593678705|FG001|Overall Study|Withdrawal by Subject|2|||
164355873|NCT01896531|593678704|FG000|Overall Study|Death Prior to Treatment|1|||
164355874|NCT01896531|593678705|FG001|Overall Study|Death Prior to Treatment|0|||
164355875|NCT05185089|593678706|FG000|First Intervention (4 weeks)|Adverse Event|0|||
164007066|NCT03519178|592391060|FG011|Follow-Up|Withdrawal by Subject|5|||
164007067|NCT03519178|592391061|FG012|Follow-Up|Withdrawal by Subject|2|||
164007068|NCT03519178|592391062|FG013|Follow-Up|Withdrawal by Subject|0|||
164007069|NCT03519178|592391063|FG014|Follow-Up|Withdrawal by Subject|0|||
164007070|NCT03519178|592391049|FG000|Follow-Up|Other|0|||
164007071|NCT03519178|592391050|FG001|Follow-Up|Other|0|||
164007072|NCT03519178|592391051|FG002|Follow-Up|Other|0|||
164007073|NCT03519178|592391052|FG003|Follow-Up|Other|0|||
164007074|NCT03519178|592391053|FG004|Follow-Up|Other|0|||
164007075|NCT03519178|592391054|FG005|Follow-Up|Other|0|||
164007076|NCT03519178|592391055|FG006|Follow-Up|Other|0|||
164007077|NCT03519178|592391056|FG007|Follow-Up|Other|1|||
164007078|NCT03519178|592391057|FG008|Follow-Up|Other|0|||
164007079|NCT03519178|592391058|FG009|Follow-Up|Other|0|||
164007080|NCT03519178|592391059|FG010|Follow-Up|Other|0|||
164007081|NCT03519178|592391060|FG011|Follow-Up|Other|0|||
164007082|NCT03519178|592391061|FG012|Follow-Up|Other|0|||
164007083|NCT03519178|592391062|FG013|Follow-Up|Other|0|||
164007084|NCT03519178|592391063|FG014|Follow-Up|Other|0|||
164007085|NCT03519178|592391049|FG000|Long-term Follow-up|Death|0|||
164007086|NCT03519178|592391050|FG001|Long-term Follow-up|Death|0|||
164007087|NCT03519178|592391051|FG002|Long-term Follow-up|Death|0|||
164007088|NCT03519178|592391052|FG003|Long-term Follow-up|Death|0|||
164007089|NCT03519178|592391053|FG004|Long-term Follow-up|Death|0|||
164007090|NCT03519178|592391054|FG005|Long-term Follow-up|Death|0|||
164007091|NCT03519178|592391055|FG006|Long-term Follow-up|Death|0|||
164007092|NCT03519178|592391056|FG007|Long-term Follow-up|Death|0|||
164007093|NCT03519178|592391057|FG008|Long-term Follow-up|Death|0|||
164007094|NCT03519178|592391058|FG009|Long-term Follow-up|Death|0|||
164007095|NCT03519178|592391059|FG010|Long-term Follow-up|Death|0|||
164007096|NCT03519178|592391060|FG011|Long-term Follow-up|Death|0|||
164007097|NCT03519178|592391061|FG012|Long-term Follow-up|Death|0|||
164007098|NCT03519178|592391062|FG013|Long-term Follow-up|Death|4|||
164007099|NCT03519178|592391063|FG014|Long-term Follow-up|Death|4|||
164007100|NCT03519178|592391049|FG000|Long-term Follow-up|Lost to Follow-up|0|||
164007101|NCT03519178|592391050|FG001|Long-term Follow-up|Lost to Follow-up|0|||
164007102|NCT03519178|592391051|FG002|Long-term Follow-up|Lost to Follow-up|0|||
164007103|NCT03519178|592391052|FG003|Long-term Follow-up|Lost to Follow-up|0|||
164007104|NCT03519178|592391053|FG004|Long-term Follow-up|Lost to Follow-up|0|||
164007105|NCT03519178|592391054|FG005|Long-term Follow-up|Lost to Follow-up|0|||
164007106|NCT03519178|592391055|FG006|Long-term Follow-up|Lost to Follow-up|0|||
164007107|NCT03519178|592391056|FG007|Long-term Follow-up|Lost to Follow-up|0|||
164007108|NCT03519178|592391057|FG008|Long-term Follow-up|Lost to Follow-up|0|||
164007109|NCT03519178|592391058|FG009|Long-term Follow-up|Lost to Follow-up|0|||
164007110|NCT03519178|592391059|FG010|Long-term Follow-up|Lost to Follow-up|0|||
164007111|NCT03519178|592391060|FG011|Long-term Follow-up|Lost to Follow-up|0|||
164007112|NCT03519178|592391061|FG012|Long-term Follow-up|Lost to Follow-up|0|||
164007113|NCT03519178|592391062|FG013|Long-term Follow-up|Lost to Follow-up|1|||
164007114|NCT03519178|592391063|FG014|Long-term Follow-up|Lost to Follow-up|1|||
164007115|NCT03519178|592391049|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
164007116|NCT03519178|592391050|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
164007117|NCT03519178|592391051|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
164007118|NCT03519178|592391052|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
164007119|NCT03519178|592391053|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
164007120|NCT03519178|592391054|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
164007121|NCT03519178|592391055|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
164007122|NCT03519178|592391056|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
164007123|NCT03519178|592391057|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
164007124|NCT03519178|592391058|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
164355876|NCT05185089|593678707|FG001|First Intervention (4 weeks)|Adverse Event|0|||
164007125|NCT03519178|592391059|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
164007126|NCT03519178|592391060|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
164007127|NCT03519178|592391061|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
164007128|NCT03519178|592391062|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
164007129|NCT03519178|592391063|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
164007130|NCT03519178|592391049|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
164355877|NCT05185089|593678708|FG002|First Intervention (4 weeks)|Adverse Event|0|||
163900631|NCT01640951|592007949|FG004|Overall Study|Non-compliance with study treatment|1|||
164007131|NCT03519178|592391050|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
164007132|NCT03519178|592391051|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
164007133|NCT03519178|592391052|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
164007134|NCT03519178|592391053|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
164007135|NCT03519178|592391054|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
164007136|NCT03519178|592391055|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
164007137|NCT03519178|592391056|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
164007138|NCT03519178|592391057|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
164007139|NCT03519178|592391058|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
164007140|NCT03519178|592391059|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
164007141|NCT03519178|592391060|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
164007142|NCT03519178|592391061|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
164007143|NCT03519178|592391062|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
164007144|NCT03519178|592391063|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
164007145|NCT03519178|592391049|FG000|Long-term Follow-up|Other|0|||
164007146|NCT03519178|592391050|FG001|Long-term Follow-up|Other|0|||
164007147|NCT03519178|592391051|FG002|Long-term Follow-up|Other|0|||
164007148|NCT03519178|592391052|FG003|Long-term Follow-up|Other|0|||
164007149|NCT03519178|592391053|FG004|Long-term Follow-up|Other|0|||
164007150|NCT03519178|592391054|FG005|Long-term Follow-up|Other|0|||
164007151|NCT03519178|592391055|FG006|Long-term Follow-up|Other|0|||
164007152|NCT03519178|592391056|FG007|Long-term Follow-up|Other|0|||
164007153|NCT03519178|592391057|FG008|Long-term Follow-up|Other|0|||
164007154|NCT03519178|592391058|FG009|Long-term Follow-up|Other|0|||
164007155|NCT03519178|592391059|FG010|Long-term Follow-up|Other|0|||
164007156|NCT03519178|592391060|FG011|Long-term Follow-up|Other|0|||
164007157|NCT03519178|592391061|FG012|Long-term Follow-up|Other|0|||
164007158|NCT03519178|592391062|FG013|Long-term Follow-up|Other|0|||
164007159|NCT03519178|592391063|FG014|Long-term Follow-up|Other|1|||
164007160|NCT03519178|592391049|FG000|Long-term Follow-up|Global deterioration of health status|0|||
164007161|NCT03519178|592391050|FG001|Long-term Follow-up|Global deterioration of health status|0|||
164007162|NCT03519178|592391051|FG002|Long-term Follow-up|Global deterioration of health status|0|||
164007163|NCT03519178|592391052|FG003|Long-term Follow-up|Global deterioration of health status|0|||
164007164|NCT03519178|592391053|FG004|Long-term Follow-up|Global deterioration of health status|0|||
164007165|NCT03519178|592391054|FG005|Long-term Follow-up|Global deterioration of health status|0|||
164007166|NCT03519178|592391055|FG006|Long-term Follow-up|Global deterioration of health status|0|||
164007167|NCT03519178|592391056|FG007|Long-term Follow-up|Global deterioration of health status|0|||
164007168|NCT03519178|592391057|FG008|Long-term Follow-up|Global deterioration of health status|0|||
164007169|NCT03519178|592391058|FG009|Long-term Follow-up|Global deterioration of health status|0|||
164007170|NCT03519178|592391059|FG010|Long-term Follow-up|Global deterioration of health status|0|||
164007171|NCT03519178|592391060|FG011|Long-term Follow-up|Global deterioration of health status|0|||
164007172|NCT03519178|592391061|FG012|Long-term Follow-up|Global deterioration of health status|0|||
164007173|NCT03519178|592391062|FG013|Long-term Follow-up|Global deterioration of health status|1|||
164007174|NCT03519178|592391063|FG014|Long-term Follow-up|Global deterioration of health status|0|||
164007175|NCT00072189|592391070|FG000|Overall Study|Withdrawal by Subject|1|||
164007176|NCT00970294|592391075|FG000|Overall Study|Physician Decision|4|||
164007177|NCT00970294|592391075|FG000|Overall Study|Withdrawal by Subject|1|||
164007178|NCT01877655|592391078|FG000|Overall Study|Death|57|||
164090997|NCT01626079|592695895|FG002|Overall Study|Missed Visits|6|||
163900632|NCT01640951|592007950|FG005|Overall Study|Non-compliance with study treatment|4|||
163900633|NCT01640951|592007951|FG006|Overall Study|Non-compliance with study treatment|1|||
163900634|NCT01640951|592007952|FG007|Overall Study|Non-compliance with study treatment|0|||
163900635|NCT01640951|592007945|FG000|Overall Study|Physician Decision|2|||
163900636|NCT01640951|592007946|FG001|Overall Study|Physician Decision|5|||
163900637|NCT01640951|592007947|FG002|Overall Study|Physician Decision|2|||
163900638|NCT01640951|592007948|FG003|Overall Study|Physician Decision|2|||
163900639|NCT01640951|592007949|FG004|Overall Study|Physician Decision|2|||
163900640|NCT01640951|592007950|FG005|Overall Study|Physician Decision|3|||
163900641|NCT01640951|592007951|FG006|Overall Study|Physician Decision|3|||
163900642|NCT01640951|592007952|FG007|Overall Study|Physician Decision|0|||
163900643|NCT01640951|592007945|FG000|Overall Study|Pregnancy|3|||
163900644|NCT01640951|592007946|FG001|Overall Study|Pregnancy|0|||
163900645|NCT01640951|592007947|FG002|Overall Study|Pregnancy|0|||
164090998|NCT02430870|592695897|FG000|Part 2|Voluntary Withdrawal|0|||
164090999|NCT02430870|592695898|FG001|Part 2|Voluntary Withdrawal|0|||
164091000|NCT02430870|592695899|FG002|Part 2|Voluntary Withdrawal|0|||
164091001|NCT02430870|592695900|FG003|Part 2|Voluntary Withdrawal|0|||
164091002|NCT02430870|592695901|FG004|Part 2|Voluntary Withdrawal|0|||
164091003|NCT02430870|592695902|FG005|Part 2|Voluntary Withdrawal|0|||
164091004|NCT02430870|592695903|FG006|Part 2|Voluntary Withdrawal|1|||
164091005|NCT02430870|592695904|FG007|Part 2|Voluntary Withdrawal|0|||
164091006|NCT02430870|592695897|FG000|Part 2|Other Reason Not Specified|0|||
164091007|NCT02430870|592695898|FG001|Part 2|Other Reason Not Specified|0|||
164091008|NCT02430870|592695899|FG002|Part 2|Other Reason Not Specified|0|||
164091009|NCT02430870|592695900|FG003|Part 2|Other Reason Not Specified|0|||
164091010|NCT02430870|592695901|FG004|Part 2|Other Reason Not Specified|0|||
164091011|NCT02430870|592695902|FG005|Part 2|Other Reason Not Specified|0|||
164091012|NCT02430870|592695903|FG006|Part 2|Other Reason Not Specified|0|||
164091013|NCT02430870|592695904|FG007|Part 2|Other Reason Not Specified|1|||
164355878|NCT05185089|593678709|FG003|First Intervention (4 weeks)|Adverse Event|1|||
164355879|NCT05185089|593678706|FG000|Second Intervention (4 weeks)|Death|0|||
164355880|NCT05185089|593678707|FG001|Second Intervention (4 weeks)|Death|1|||
164355881|NCT05185089|593678708|FG002|Second Intervention (4 weeks)|Death|0|||
164355882|NCT05185089|593678709|FG003|Second Intervention (4 weeks)|Death|0|||
164355883|NCT05185089|593678706|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
164355884|NCT05185089|593678707|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
164355885|NCT05185089|593678708|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
164355886|NCT05185089|593678709|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
164355887|NCT00770289|593678710|FG000|Overall Study|Other|6|||
164355888|NCT02733991|593678711|FG000|Overall Study|Adverse Event|1|||
164355889|NCT02733991|593678712|FG001|Overall Study|Adverse Event|0|||
164355890|NCT02733991|593678711|FG000|Overall Study|Withdrawal by Subject|0|||
164355891|NCT02733991|593678712|FG001|Overall Study|Withdrawal by Subject|5|||
164355892|NCT02956486|593678715|FG000|Core Phase|Adverse Event|51|||
164355893|NCT02956486|593678716|FG001|Core Phase|Adverse Event|88|||
164355894|NCT02956486|593678717|FG002|Core Phase|Adverse Event|0|||
164355895|NCT02956486|593678715|FG000|Core Phase|Lost to Follow-up|8|||
164355896|NCT02956486|593678716|FG001|Core Phase|Lost to Follow-up|6|||
164355897|NCT02956486|593678717|FG002|Core Phase|Lost to Follow-up|0|||
164355898|NCT02956486|593678715|FG000|Core Phase|Inadequate therapeutic effect|4|||
164355899|NCT02956486|593678716|FG001|Core Phase|Inadequate therapeutic effect|5|||
164355900|NCT02956486|593678717|FG002|Core Phase|Inadequate therapeutic effect|0|||
164355901|NCT02956486|593678715|FG000|Core Phase|Withdrawal by Subject|101|||
163900646|NCT01640951|592007948|FG003|Overall Study|Pregnancy|4|||
163900647|NCT01640951|592007949|FG004|Overall Study|Pregnancy|0|||
163900648|NCT01640951|592007950|FG005|Overall Study|Pregnancy|0|||
163900649|NCT01640951|592007951|FG006|Overall Study|Pregnancy|2|||
163900650|NCT01640951|592007952|FG007|Overall Study|Pregnancy|0|||
163900651|NCT01640951|592007945|FG000|Overall Study|Protocol Deviation|0|||
163900652|NCT01640951|592007946|FG001|Overall Study|Protocol Deviation|1|||
163900653|NCT01640951|592007947|FG002|Overall Study|Protocol Deviation|2|||
163900654|NCT01640951|592007948|FG003|Overall Study|Protocol Deviation|1|||
163900655|NCT01640951|592007949|FG004|Overall Study|Protocol Deviation|0|||
163900656|NCT01640951|592007950|FG005|Overall Study|Protocol Deviation|1|||
163900657|NCT01640951|592007951|FG006|Overall Study|Protocol Deviation|0|||
163900658|NCT01640951|592007952|FG007|Overall Study|Protocol Deviation|0|||
163900659|NCT01640951|592007945|FG000|Overall Study|Subject/Guardian decision|12|||
163900660|NCT01640951|592007946|FG001|Overall Study|Subject/Guardian decision|4|||
163900661|NCT01640951|592007947|FG002|Overall Study|Subject/Guardian decision|13|||
163900662|NCT01640951|592007948|FG003|Overall Study|Subject/Guardian decision|15|||
163900663|NCT01640951|592007949|FG004|Overall Study|Subject/Guardian decision|7|||
163900664|NCT01640951|592007950|FG005|Overall Study|Subject/Guardian decision|19|||
163900665|NCT01640951|592007951|FG006|Overall Study|Subject/Guardian decision|5|||
163900666|NCT01640951|592007952|FG007|Overall Study|Subject/Guardian decision|4|||
163900667|NCT01640951|592007945|FG000|Overall Study|Death|0|||
163900668|NCT01640951|592007946|FG001|Overall Study|Death|1|||
163900669|NCT01640951|592007947|FG002|Overall Study|Death|1|||
163900670|NCT01640951|592007948|FG003|Overall Study|Death|0|||
163900671|NCT01640951|592007949|FG004|Overall Study|Death|0|||
163900672|NCT01640951|592007950|FG005|Overall Study|Death|0|||
163900673|NCT01640951|592007951|FG006|Overall Study|Death|0|||
163900674|NCT01640951|592007952|FG007|Overall Study|Death|2|||
163900675|NCT00582972|592007953|FG000|Overall Study|Protocol Violation|2|||
163900676|NCT00293397|592007956|FG000|Overall Study|Death|2|||
163900677|NCT00523419|592007958|FG000|Overall Study|Adverse Event|1|||
163900678|NCT00523419|592007958|FG000|Overall Study|Withdrawal by Subject|1|||
163900679|NCT00523419|592007958|FG000|Overall Study|Physician Decision|2|||
163900680|NCT00523419|592007958|FG000|Overall Study|Progressive Disease|22|||
163900681|NCT00523419|592007958|FG000|Overall Study|Death due to Study Disease|4|||
163900682|NCT00523419|592007958|FG000|Overall Study|Death due to Adverse Event|2|||
164091014|NCT00865709|592695907|FG000|Treatment|Adverse Event|9|||
164355902|NCT02956486|593678716|FG001|Core Phase|Withdrawal by Subject|104|||
164355903|NCT02956486|593678717|FG002|Core Phase|Withdrawal by Subject|0|||
164007179|NCT01877655|592391079|FG001|Overall Study|Death|52|||
164007180|NCT01877655|592391078|FG000|Overall Study|Withdrawal by Subject|18|||
164007181|NCT01877655|592391079|FG001|Overall Study|Withdrawal by Subject|26|||
164007182|NCT01877655|592391078|FG000|Overall Study|Physician Decision|11|||
164007183|NCT01877655|592391079|FG001|Overall Study|Physician Decision|10|||
164007184|NCT01877655|592391078|FG000|Overall Study|Miscellaneous|4|||
164007185|NCT01877655|592391079|FG001|Overall Study|Miscellaneous|4|||
164007186|NCT01877655|592391078|FG000|Overall Study|Randomized but Never Received Drug|8|||
164007187|NCT01877655|592391079|FG001|Overall Study|Randomized but Never Received Drug|5|||
164007188|NCT02562235|592392355|FG000|Overall Study|Adverse Event|3|||
164007189|NCT02089737|592392356|FG000|Overall Study|Survey form not completed|5|||
164007190|NCT02089737|592392356|FG000|Overall Study|Not treated|1|||
164007191|NCT00744055|592392357|FG000|Overall Study|Withdrawal by Subject|6|||
164007192|NCT00744055|592392358|FG001|Overall Study|Withdrawal by Subject|9|||
164007193|NCT00744055|592392357|FG000|Overall Study|Lack of Efficacy|0|||
164007194|NCT00744055|592392358|FG001|Overall Study|Lack of Efficacy|1|||
164007195|NCT00744055|592392357|FG000|Overall Study|Physician Decision|0|||
164007196|NCT00744055|592392358|FG001|Overall Study|Physician Decision|2|||
164007197|NCT00744055|592392357|FG000|Overall Study|Protocol Violation|1|||
164007198|NCT00744055|592392358|FG001|Overall Study|Protocol Violation|1|||
164007199|NCT00744055|592392357|FG000|Overall Study|Lost to Follow-up|0|||
164007200|NCT00744055|592392358|FG001|Overall Study|Lost to Follow-up|1|||
164007201|NCT05248945|592392359|FG000|Overall Study|Adverse Event|1|||
164007202|NCT05248945|592392359|FG000|Overall Study|Elevated Gamma-Glutamyl Transferase (GGT)|1|||
164007203|NCT05525975|592392360|FG000|Overall Study|Surgery cancellation|4|||
164007204|NCT05525975|592392361|FG001|Overall Study|Surgery cancellation|5|||
164007205|NCT05525975|592392360|FG000|Overall Study|didn't fill prescription|1|||
164007206|NCT05525975|592392361|FG001|Overall Study|didn't fill prescription|0|||
164007207|NCT05525975|592392360|FG000|Overall Study|Withdrawal by Subject|0|||
164007208|NCT05525975|592392361|FG001|Overall Study|Withdrawal by Subject|3|||
164007209|NCT01123889|592392362|FG000|Overall Study|Lost to Follow-up|3|||
164007210|NCT01123889|592392363|FG001|Overall Study|Lost to Follow-up|1|||
164007211|NCT05090423|592392364|FG000|Overall Study|Because of the covid-19|3|||
164007212|NCT05090423|592392365|FG001|Overall Study|Because of the covid-19|2|||
164007213|NCT05090423|592392364|FG000|Overall Study|repeated ankle sprain in daily of life|0|||
164007214|NCT05090423|592392365|FG001|Overall Study|repeated ankle sprain in daily of life|1|||
164007215|NCT05733286|592392366|FG000|Overall Study|Never received study drug|2|||
164007216|NCT05733286|592392367|FG001|Overall Study|Never received study drug|3|||
164007217|NCT00685178|592392368|FG000|Overall Study|Adverse Event|1|||
164007218|NCT00685178|592392369|FG001|Overall Study|Adverse Event|5|||
164007219|NCT00685178|592392370|FG002|Overall Study|Adverse Event|2|||
164007220|NCT00685178|592392371|FG003|Overall Study|Adverse Event|4|||
164007221|NCT00685178|592392368|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
164007222|NCT00685178|592392369|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
164007223|NCT00685178|592392370|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
164007224|NCT00685178|592392371|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
164007225|NCT00685178|592392368|FG000|Overall Study|voluntary study discharge|4|||
164007226|NCT00685178|592392369|FG001|Overall Study|voluntary study discharge|5|||
164007227|NCT00685178|592392370|FG002|Overall Study|voluntary study discharge|1|||
164007228|NCT00685178|592392371|FG003|Overall Study|voluntary study discharge|1|||
164007229|NCT00685178|592392368|FG000|Overall Study|incarcerated|1|||
164007230|NCT00685178|592392369|FG001|Overall Study|incarcerated|3|||
164007231|NCT00685178|592392370|FG002|Overall Study|incarcerated|7|||
164007232|NCT00685178|592392371|FG003|Overall Study|incarcerated|0|||
164007233|NCT00685178|592392368|FG000|Overall Study|administrative (disciplinary) discharge|0|||
164007234|NCT00685178|592392369|FG001|Overall Study|administrative (disciplinary) discharge|1|||
164007235|NCT00685178|592392370|FG002|Overall Study|administrative (disciplinary) discharge|0|||
164007236|NCT00685178|592392371|FG003|Overall Study|administrative (disciplinary) discharge|2|||
164007237|NCT00685178|592392368|FG000|Overall Study|Pregnancy|0|||
164007238|NCT00685178|592392369|FG001|Overall Study|Pregnancy|0|||
164007239|NCT00685178|592392370|FG002|Overall Study|Pregnancy|0|||
164007240|NCT00685178|592392371|FG003|Overall Study|Pregnancy|1|||
164007241|NCT05098015|592392377|FG000|Overall Study|Death|1|||
164091015|NCT00865709|592695908|FG001|Treatment|Adverse Event|6|||
164091016|NCT00865709|592695907|FG000|Treatment|Withdrawal by Subject|10|||
164007242|NCT05098015|592392378|FG001|Overall Study|Death|1|||
164007243|NCT05098015|592392379|FG002|Overall Study|Death|3|||
164007244|NCT05098015|592392380|FG003|Overall Study|Death|0|||
164007245|NCT05098015|592392377|FG000|Overall Study|Lost to Follow-up|1|||
164007246|NCT05098015|592392378|FG001|Overall Study|Lost to Follow-up|1|||
164355904|NCT02956486|593678715|FG000|Core Phase|Study terminated by sponsor|888|||
164355905|NCT02956486|593678716|FG001|Core Phase|Study terminated by sponsor|848|||
164355906|NCT02956486|593678717|FG002|Core Phase|Study terminated by sponsor|0|||
164355907|NCT02956486|593678715|FG000|Core Phase|Other|27|||
164007247|NCT05098015|592392379|FG002|Overall Study|Lost to Follow-up|3|||
164007248|NCT05098015|592392380|FG003|Overall Study|Lost to Follow-up|3|||
164007249|NCT05098015|592392377|FG000|Overall Study|Withdrawal by Subject|0|||
164355908|NCT02956486|593678716|FG001|Core Phase|Other|18|||
163900683|NCT00822120|592007959|FG000|Initial Registration|Adverse Event|1|||
163900684|NCT00822120|592007960|FG001|Initial Registration|Adverse Event|0|||
163900685|NCT00822120|592007961|FG002|Initial Registration|Adverse Event|0|||
163900686|NCT00822120|592007962|FG003|Initial Registration|Adverse Event|0|||
163900687|NCT00822120|592007963|FG004|Initial Registration|Adverse Event|0|||
163900688|NCT00822120|592007964|FG005|Initial Registration|Adverse Event|0|||
163900689|NCT00822120|592007959|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
163900690|NCT00822120|592007960|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163900691|NCT00822120|592007961|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163900692|NCT00822120|592007962|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163900693|NCT00822120|592007963|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163900694|NCT00822120|592007964|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
163900695|NCT00822120|592007959|FG000|Initial Registration|Reasons not Protocol Specified|2|||
163900696|NCT00822120|592007960|FG001|Initial Registration|Reasons not Protocol Specified|0|||
163900697|NCT00822120|592007961|FG002|Initial Registration|Reasons not Protocol Specified|0|||
163900698|NCT00822120|592007962|FG003|Initial Registration|Reasons not Protocol Specified|0|||
163900699|NCT00822120|592007963|FG004|Initial Registration|Reasons not Protocol Specified|0|||
163900700|NCT00822120|592007964|FG005|Initial Registration|Reasons not Protocol Specified|0|||
163900701|NCT00822120|592007959|FG000|Initial Registration|Ineligible|22|||
163900702|NCT00822120|592007960|FG001|Initial Registration|Ineligible|1|||
163900703|NCT00822120|592007961|FG002|Initial Registration|Ineligible|0|||
163900704|NCT00822120|592007962|FG003|Initial Registration|Ineligible|0|||
163900705|NCT00822120|592007963|FG004|Initial Registration|Ineligible|0|||
163900706|NCT00822120|592007964|FG005|Initial Registration|Ineligible|0|||
163900707|NCT00822120|592007959|FG000|PET-directed Therapy|Adverse Event|0|||
163900708|NCT00822120|592007960|FG001|PET-directed Therapy|Adverse Event|0|||
163900709|NCT00822120|592007961|FG002|PET-directed Therapy|Adverse Event|0|||
163900710|NCT00822120|592007962|FG003|PET-directed Therapy|Adverse Event|1|||
163900711|NCT00822120|592007963|FG004|PET-directed Therapy|Adverse Event|0|||
163900712|NCT00822120|592007964|FG005|PET-directed Therapy|Adverse Event|0|||
163900713|NCT00822120|592007959|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163900714|NCT00822120|592007960|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163900715|NCT00822120|592007961|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163900716|NCT00822120|592007962|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
163900717|NCT00822120|592007963|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163900718|NCT00822120|592007964|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
163900719|NCT00822120|592007959|FG000|PET-directed Therapy|Death|0|||
163900720|NCT00822120|592007960|FG001|PET-directed Therapy|Death|0|||
163900721|NCT00822120|592007961|FG002|PET-directed Therapy|Death|0|||
163900722|NCT00822120|592007962|FG003|PET-directed Therapy|Death|2|||
163900723|NCT00822120|592007963|FG004|PET-directed Therapy|Death|0|||
163900724|NCT00822120|592007964|FG005|PET-directed Therapy|Death|0|||
163900725|NCT00822120|592007959|FG000|PET-directed Therapy|Protocol Violation|0|||
163900726|NCT00822120|592007960|FG001|PET-directed Therapy|Protocol Violation|0|||
163900727|NCT00822120|592007961|FG002|PET-directed Therapy|Protocol Violation|0|||
163900728|NCT00822120|592007962|FG003|PET-directed Therapy|Protocol Violation|6|||
163900729|NCT00822120|592007963|FG004|PET-directed Therapy|Protocol Violation|0|||
163900730|NCT00822120|592007964|FG005|PET-directed Therapy|Protocol Violation|0|||
163900731|NCT01759862|592007965|FG000|Overall Study|Physician Decision|3|||
163900732|NCT01759862|592007966|FG001|Overall Study|Physician Decision|1|||
163900733|NCT01759862|592007965|FG000|Overall Study|Adverse Event|0|||
163900734|NCT01759862|592007966|FG001|Overall Study|Adverse Event|1|||
163900735|NCT04060212|592007968|FG000|Overall Study|Withdrawal by Subject|7|||
163900736|NCT01499849|592007969|FG000|Overall Study|Adverse Event|28|||
163900737|NCT01499849|592007970|FG001|Overall Study|Adverse Event|32|||
163900738|NCT01499849|592007969|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
163900739|NCT01499849|592007970|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
163900740|NCT01499849|592007969|FG000|Overall Study|Withdrawal by Subject|43|||
163900741|NCT01499849|592007970|FG001|Overall Study|Withdrawal by Subject|43|||
163900742|NCT01499849|592007969|FG000|Overall Study|Death|5|||
163900743|NCT01499849|592007970|FG001|Overall Study|Death|7|||
163900744|NCT01499849|592007969|FG000|Overall Study|Disease Progression|11|||
163900745|NCT01499849|592007970|FG001|Overall Study|Disease Progression|10|||
163900746|NCT01499849|592007969|FG000|Overall Study|Protocol Violation|11|||
163900747|NCT01499849|592007970|FG001|Overall Study|Protocol Violation|11|||
163900748|NCT01499849|592007969|FG000|Overall Study|Physician Decision|20|||
163900749|NCT01499849|592007970|FG001|Overall Study|Physician Decision|19|||
164007250|NCT05098015|592392378|FG001|Overall Study|Withdrawal by Subject|1|||
164007251|NCT05098015|592392379|FG002|Overall Study|Withdrawal by Subject|0|||
164007252|NCT05098015|592392380|FG003|Overall Study|Withdrawal by Subject|2|||
164007253|NCT03334214|592392387|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164007254|NCT03334214|592392388|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
164007255|NCT03334214|592392387|FG000|Overall Study|Withdrawal by Subject|0|||
164007256|NCT03334214|592392388|FG001|Overall Study|Withdrawal by Subject|1|||
164007257|NCT03334214|592392387|FG000|Overall Study|Other|1|||
164007258|NCT03334214|592392388|FG001|Overall Study|Other|0|||
164007259|NCT05655832|592392392|FG000|Overall Study|Not mentioned|0|||
164007260|NCT05655832|592392393|FG001|Overall Study|Not mentioned|1|||
164007261|NCT05655832|592392392|FG000|Overall Study|Withdrawal by Subject|0|||
164007262|NCT05655832|592392393|FG001|Overall Study|Withdrawal by Subject|1|||
164007263|NCT05655832|592392392|FG000|Overall Study|Protocol non-compliance|0|||
164007264|NCT05655832|592392393|FG001|Overall Study|Protocol non-compliance|1|||
164007265|NCT04516967|592392396|FG000|Core Phase|Adverse Event|2|||
164007266|NCT04516967|592392397|FG001|Core Phase|Adverse Event|1|||
164007267|NCT04516967|592392398|FG002|Core Phase|Adverse Event|0|||
164007268|NCT04516967|592392396|FG000|Core Phase|Physician Decision|1|||
164007269|NCT04516967|592392397|FG001|Core Phase|Physician Decision|1|||
164007270|NCT04516967|592392398|FG002|Core Phase|Physician Decision|0|||
164007271|NCT04516967|592392396|FG000|Core Phase|Lack of Efficacy|7|||
164007272|NCT04516967|592392397|FG001|Core Phase|Lack of Efficacy|18|||
164007273|NCT04516967|592392398|FG002|Core Phase|Lack of Efficacy|0|||
164007274|NCT05916170|592392399|FG000|No Warning Control|Lost to Follow-up|12|||
164007275|NCT05916170|592392399|FG000|No Warning Control|Withdrawal by Subject|15|||
164007276|NCT05916170|592392399|FG000|No Warning Control|Noncompliance with protocol|1|||
164007277|NCT05916170|592392399|FG000|Health Warning Intervention|Lost to Follow-up|15|||
164007278|NCT05916170|592392399|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
164007279|NCT05916170|592392399|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
164007280|NCT04576949|592392400|FG000|Overall Study|Adverse Event|1|||
164007281|NCT04576949|592392401|FG001|Overall Study|Adverse Event|3|||
164007282|NCT04576949|592392402|FG002|Overall Study|Adverse Event|2|||
164007283|NCT04576949|592392400|FG000|Overall Study|Withdrawal by Subject|41|||
164007284|NCT04576949|592392401|FG001|Overall Study|Withdrawal by Subject|26|||
164007285|NCT04576949|592392402|FG002|Overall Study|Withdrawal by Subject|18|||
164007286|NCT04576949|592392400|FG000|Overall Study|Physician Decision|3|||
164007287|NCT04576949|592392401|FG001|Overall Study|Physician Decision|0|||
164007288|NCT04576949|592392402|FG002|Overall Study|Physician Decision|0|||
164007289|NCT04576949|592392400|FG000|Overall Study|Death|0|||
164007290|NCT04576949|592392401|FG001|Overall Study|Death|1|||
164007291|NCT04576949|592392402|FG002|Overall Study|Death|0|||
164007292|NCT04576949|592392400|FG000|Overall Study|Lost to Follow-up|29|||
164007293|NCT04576949|592392401|FG001|Overall Study|Lost to Follow-up|37|||
164007294|NCT04576949|592392402|FG002|Overall Study|Lost to Follow-up|24|||
164007295|NCT04576949|592392400|FG000|Overall Study|Other, Not Specified|2|||
164007296|NCT04576949|592392401|FG001|Overall Study|Other, Not Specified|3|||
164007297|NCT04576949|592392402|FG002|Overall Study|Other, Not Specified|1|||
164007298|NCT04576949|592392400|FG000|Overall Study|Other|1|||
164007299|NCT04576949|592392401|FG001|Overall Study|Other|0|||
164007300|NCT04576949|592392402|FG002|Overall Study|Other|0|||
164007301|NCT03556904|592392405|FG000|Overall Study|Disease Progression after treatment started|3|||
164007302|NCT03556904|592392406|FG001|Overall Study|Disease Progression after treatment started|3|||
164007303|NCT03556904|592392405|FG000|Overall Study|Sponsor Termination|2|||
164091017|NCT00865709|592695908|FG001|Treatment|Withdrawal by Subject|7|||
164007304|NCT03556904|592392406|FG001|Overall Study|Sponsor Termination|2|||
164007305|NCT03556904|592392405|FG000|Overall Study|Physician Decision|2|||
164007306|NCT03556904|592392406|FG001|Overall Study|Physician Decision|0|||
163900750|NCT01499849|592007969|FG000|Overall Study|Lack of Efficacy|3|||
163900751|NCT01499849|592007970|FG001|Overall Study|Lack of Efficacy|4|||
163900752|NCT01499849|592007969|FG000|Overall Study|Lost to Follow-up|6|||
164007307|NCT03556904|592392405|FG000|Overall Study|Withdrawal by Subject|1|||
164007308|NCT03556904|592392406|FG001|Overall Study|Withdrawal by Subject|0|||
164007309|NCT05243680|592392407|FG000|Overall Study|Adverse Event|1|||
164007310|NCT05243680|592392408|FG001|Overall Study|Adverse Event|1|||
164007311|NCT05243680|592392407|FG000|Overall Study|Lack of Efficacy|1|||
164007312|NCT05243680|592392408|FG001|Overall Study|Lack of Efficacy|1|||
164007313|NCT05243680|592392407|FG000|Overall Study|Lost to Follow-up|5|||
163900753|NCT01499849|592007970|FG001|Overall Study|Lost to Follow-up|3|||
163900754|NCT01499849|592007969|FG000|Overall Study|Other Reasons|27|||
163900755|NCT01499849|592007970|FG001|Overall Study|Other Reasons|30|||
163900756|NCT02646618|592007971|FG000|Overall Study|Lost to Follow-up|10|||
163900757|NCT02646618|592007972|FG001|Overall Study|Lost to Follow-up|14|||
163900758|NCT03885232|592007973|FG000|Overall Study|Lost to Follow-up|74|||
163900759|NCT03885232|592007974|FG001|Overall Study|Lost to Follow-up|32|||
163900760|NCT03885232|592007973|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
163900761|NCT03885232|592007974|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
163900762|NCT00918203|592007976|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
163900763|NCT00918203|592007977|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
163900764|NCT00918203|592007978|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
163900765|NCT00918203|592007976|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
163900766|NCT00918203|592007977|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
163900767|NCT00918203|592007978|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
163900768|NCT00918203|592007976|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
163900769|NCT00918203|592007977|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
163900770|NCT00918203|592007978|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
163900771|NCT00918203|592007976|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
163900772|NCT00918203|592007977|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
163900773|NCT00918203|592007978|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
163900774|NCT04066075|592007979|FG000|Overall Study|Lost to Follow-up|3|||
163900775|NCT04066075|592007980|FG001|Overall Study|Lost to Follow-up|3|||
164007314|NCT05243680|592392408|FG001|Overall Study|Lost to Follow-up|4|||
164007315|NCT05243680|592392407|FG000|Overall Study|Physician Decision|1|||
164007316|NCT05243680|592392408|FG001|Overall Study|Physician Decision|0|||
164007317|NCT05243680|592392407|FG000|Overall Study|Withdrawal by Subject|3|||
164007318|NCT05243680|592392408|FG001|Overall Study|Withdrawal by Subject|10|||
164007319|NCT05243680|592392407|FG000|Overall Study|Data integrity and GCP violations|4|||
164007320|NCT05243680|592392408|FG001|Overall Study|Data integrity and GCP violations|8|||
164007321|NCT01025336|592392410|FG000|Overall Study|Protocol Violation|0|||
164007322|NCT01025336|592392411|FG001|Overall Study|Protocol Violation|0|||
164007323|NCT01025336|592392412|FG002|Overall Study|Protocol Violation|0|||
164007324|NCT01025336|592392413|FG003|Overall Study|Protocol Violation|2|||
163900776|NCT04066075|592007979|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
163900777|NCT04066075|592007980|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
164007325|NCT01025336|592392414|FG004|Overall Study|Protocol Violation|0|||
164007326|NCT03794986|592392415|FG000|Overall Study|0 Sessions Attended|34|||
164007327|NCT03794986|592392416|FG001|Overall Study|0 Sessions Attended|37|||
164007328|NCT03794986|592392415|FG000|Overall Study|Withdrawal by Subject|4|||
164091018|NCT00865709|592695907|FG000|Treatment|Physician Decision|3|||
164091019|NCT00865709|592695908|FG001|Treatment|Physician Decision|2|||
164091020|NCT00865709|592695907|FG000|Treatment|Surgery|8|||
164091021|NCT00865709|592695908|FG001|Treatment|Surgery|3|||
164007329|NCT03794986|592392416|FG001|Overall Study|Withdrawal by Subject|6|||
164007330|NCT03794986|592392415|FG000|Overall Study|Protocol Violation|1|||
164007331|NCT03794986|592392416|FG001|Overall Study|Protocol Violation|0|||
164007332|NCT00550238|592392422|FG000|Overall Study|Adverse Event|88|||
164007333|NCT00550238|592392422|FG000|Overall Study|Death|34|||
164007334|NCT00550238|592392422|FG000|Overall Study|Disease progression|46|||
164007335|NCT00550238|592392422|FG000|Overall Study|Withdrawal by Subject|167|||
164007336|NCT00550238|592392422|FG000|Overall Study|Physician Decision|31|||
164007337|NCT00550238|592392422|FG000|Overall Study|Patient noncompliance|25|||
164007338|NCT00550238|592392422|FG000|Overall Study|Lost to Follow-up|13|||
164007339|NCT00550238|592392422|FG000|Overall Study|Sponsor decision|55|||
164007340|NCT00923091|592392433|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
164007341|NCT00923091|592392434|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
164007342|NCT00923091|592392435|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
164007343|NCT00923091|592392436|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
164007344|NCT00923091|592392437|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
164007345|NCT00923091|592392438|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
164007346|NCT00923091|592392439|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
164007347|NCT00923091|592392440|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
164091022|NCT00429923|592695909|FG000|Overall Study|Adverse Event|0|||
164007348|NCT00923091|592392441|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164007349|NCT00923091|592392442|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164007350|NCT00923091|592392443|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164007351|NCT00923091|592392444|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164007352|NCT00923091|592392445|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
164007353|NCT00923091|592392433|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
164007354|NCT00923091|592392434|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
164007355|NCT00923091|592392435|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
164007356|NCT00923091|592392436|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
164007357|NCT00923091|592392437|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
164007358|NCT00923091|592392438|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
164007359|NCT00923091|592392439|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
164007360|NCT00923091|592392440|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
164007361|NCT00923091|592392441|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164007362|NCT00923091|592392442|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164007363|NCT00923091|592392443|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164007364|NCT00923091|592392444|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164007365|NCT00923091|592392445|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
164007366|NCT00923091|592392433|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
164007367|NCT00923091|592392434|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
164007368|NCT00923091|592392435|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
164007369|NCT00923091|592392436|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
164007370|NCT00923091|592392437|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
164007371|NCT00923091|592392438|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
164007372|NCT00923091|592392439|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
164007373|NCT00923091|592392440|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
164007374|NCT00923091|592392441|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164007375|NCT00923091|592392442|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164007376|NCT00923091|592392443|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164007377|NCT00923091|592392444|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164091023|NCT00429923|592695910|FG001|Overall Study|Adverse Event|2|||
164007378|NCT00923091|592392445|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
164007379|NCT00923091|592392433|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007380|NCT00923091|592392434|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007381|NCT00923091|592392435|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007382|NCT00923091|592392436|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007383|NCT00923091|592392437|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007384|NCT00923091|592392438|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
164007385|NCT00923091|592392439|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164091024|NCT00429923|592695911|FG002|Overall Study|Adverse Event|3|||
164007386|NCT00923091|592392440|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007387|NCT00923091|592392441|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007388|NCT00923091|592392442|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007389|NCT00923091|592392443|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007390|NCT00923091|592392444|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007391|NCT00923091|592392445|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
164007392|NCT00923091|592392433|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007393|NCT00923091|592392434|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
164007394|NCT00923091|592392435|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007395|NCT00923091|592392436|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
164007396|NCT00923091|592392437|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007397|NCT00923091|592392438|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
164007398|NCT00923091|592392439|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007399|NCT00923091|592392440|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007400|NCT00923091|592392441|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007401|NCT00923091|592392442|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007402|NCT00923091|592392443|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007403|NCT00923091|592392444|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007404|NCT00923091|592392445|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
164007405|NCT00923091|592392433|FG000|Period III (Single-Blind)|Adverse Event|5|||
164007406|NCT00923091|592392434|FG001|Period III (Single-Blind)|Adverse Event|0|||
164007407|NCT00923091|592392435|FG002|Period III (Single-Blind)|Adverse Event|0|||
164007408|NCT00923091|592392436|FG003|Period III (Single-Blind)|Adverse Event|0|||
164007409|NCT00923091|592392437|FG004|Period III (Single-Blind)|Adverse Event|0|||
164007410|NCT00923091|592392438|FG005|Period III (Single-Blind)|Adverse Event|0|||
164007411|NCT00923091|592392439|FG006|Period III (Single-Blind)|Adverse Event|0|||
164007412|NCT00923091|592392440|FG007|Period III (Single-Blind)|Adverse Event|0|||
164007413|NCT00923091|592392441|FG008|Period III (Single-Blind)|Adverse Event|0|||
164007414|NCT00923091|592392442|FG009|Period III (Single-Blind)|Adverse Event|0|||
164007415|NCT00923091|592392443|FG010|Period III (Single-Blind)|Adverse Event|0|||
164007416|NCT00923091|592392444|FG011|Period III (Single-Blind)|Adverse Event|0|||
164007417|NCT00923091|592392445|FG012|Period III (Single-Blind)|Adverse Event|0|||
164007418|NCT00923091|592392433|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
164007419|NCT00923091|592392434|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007420|NCT00923091|592392435|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007421|NCT00923091|592392436|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007422|NCT00923091|592392437|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007423|NCT00923091|592392438|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007424|NCT00923091|592392439|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007425|NCT00923091|592392440|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007426|NCT00923091|592392441|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007427|NCT00923091|592392442|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007428|NCT00923091|592392443|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007429|NCT00923091|592392444|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007430|NCT00923091|592392445|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
164007431|NCT00923091|592392433|FG000|Period III (Single-Blind)|Protocol Violation|3|||
164007432|NCT00923091|592392434|FG001|Period III (Single-Blind)|Protocol Violation|0|||
164007433|NCT00923091|592392435|FG002|Period III (Single-Blind)|Protocol Violation|0|||
164007434|NCT00923091|592392436|FG003|Period III (Single-Blind)|Protocol Violation|0|||
164007435|NCT00923091|592392437|FG004|Period III (Single-Blind)|Protocol Violation|0|||
164007436|NCT00923091|592392438|FG005|Period III (Single-Blind)|Protocol Violation|0|||
164007437|NCT00923091|592392439|FG006|Period III (Single-Blind)|Protocol Violation|0|||
164007438|NCT00923091|592392440|FG007|Period III (Single-Blind)|Protocol Violation|0|||
164007439|NCT00923091|592392441|FG008|Period III (Single-Blind)|Protocol Violation|0|||
164007440|NCT00923091|592392442|FG009|Period III (Single-Blind)|Protocol Violation|0|||
164007441|NCT00923091|592392443|FG010|Period III (Single-Blind)|Protocol Violation|0|||
164007442|NCT00923091|592392444|FG011|Period III (Single-Blind)|Protocol Violation|0|||
164007443|NCT00923091|592392445|FG012|Period III (Single-Blind)|Protocol Violation|0|||
164007444|NCT00923091|592392433|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
164007445|NCT00923091|592392434|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
164007446|NCT00923091|592392435|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
164007447|NCT00923091|592392436|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
164007448|NCT00923091|592392437|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
164007449|NCT00923091|592392438|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
164007450|NCT00923091|592392439|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
164007451|NCT00923091|592392440|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
164007452|NCT00923091|592392441|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
164007453|NCT00923091|592392442|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
164007454|NCT00923091|592392443|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
164007455|NCT00923091|592392444|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
163900778|NCT04066075|592007979|FG000|Overall Study|Withdrawal by Subject|2|||
163900779|NCT04066075|592007980|FG001|Overall Study|Withdrawal by Subject|2|||
163900780|NCT00309166|592007981|FG000|Overall Study|Adverse event, non-fatal|1|||
163900781|NCT00309166|592007982|FG001|Overall Study|Adverse event, non-fatal|0|||
163900782|NCT00309166|592007981|FG000|Overall Study|Withdrawal by Subject|4|||
164007456|NCT00923091|592392445|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
164007457|NCT00923091|592392433|FG000|Period IV (Double-Blind)|Adverse Event|2|||
164007458|NCT00923091|592392434|FG001|Period IV (Double-Blind)|Adverse Event|0|||
164007459|NCT00923091|592392435|FG002|Period IV (Double-Blind)|Adverse Event|0|||
164007460|NCT00923091|592392436|FG003|Period IV (Double-Blind)|Adverse Event|0|||
164007461|NCT00923091|592392437|FG004|Period IV (Double-Blind)|Adverse Event|0|||
164007462|NCT00923091|592392438|FG005|Period IV (Double-Blind)|Adverse Event|0|||
164007463|NCT00923091|592392439|FG006|Period IV (Double-Blind)|Adverse Event|0|||
164007464|NCT00923091|592392440|FG007|Period IV (Double-Blind)|Adverse Event|0|||
164007465|NCT00923091|592392441|FG008|Period IV (Double-Blind)|Adverse Event|0|||
163900783|NCT00309166|592007982|FG001|Overall Study|Withdrawal by Subject|3|||
163900784|NCT00701701|592007985|FG000|Overall Study|Withdrawal by Subject|0|||
163900785|NCT00701701|592007986|FG001|Overall Study|Withdrawal by Subject|1|||
163900786|NCT00701701|592007985|FG000|Overall Study|Adverse Event|0|||
163900787|NCT00701701|592007986|FG001|Overall Study|Adverse Event|1|||
163900788|NCT05601882|592007987|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
163900789|NCT05601882|592007988|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
163900790|NCT05601882|592007989|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
163900791|NCT05601882|592007990|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
163900792|NCT05601882|592007987|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
163900793|NCT05601882|592007988|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
163900794|NCT05601882|592007989|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
163900795|NCT05601882|592007990|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
163900796|NCT05601882|592007987|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
163900797|NCT05601882|592007988|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
163900798|NCT05601882|592007989|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
164007466|NCT00923091|592392442|FG009|Period IV (Double-Blind)|Adverse Event|0|||
164007467|NCT00923091|592392443|FG010|Period IV (Double-Blind)|Adverse Event|0|||
163900799|NCT05601882|592007990|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
164007468|NCT00923091|592392444|FG011|Period IV (Double-Blind)|Adverse Event|0|||
164007469|NCT00923091|592392445|FG012|Period IV (Double-Blind)|Adverse Event|0|||
164007470|NCT00923091|592392433|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007471|NCT00923091|592392434|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
164007472|NCT00923091|592392435|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007473|NCT00923091|592392436|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007474|NCT00923091|592392437|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007475|NCT00923091|592392438|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007476|NCT00923091|592392439|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
163900800|NCT05601882|592007987|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
163900801|NCT05601882|592007988|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
163900802|NCT05601882|592007989|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
163900803|NCT05601882|592007990|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
163900804|NCT05601882|592007987|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
163900805|NCT05601882|592007988|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
163900806|NCT05601882|592007989|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
163900807|NCT05601882|592007990|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
163900808|NCT05601882|592007987|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
163900809|NCT05601882|592007988|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
163900810|NCT05601882|592007989|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
164007477|NCT00923091|592392440|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007478|NCT00923091|592392441|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007479|NCT00923091|592392442|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007480|NCT00923091|592392443|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007481|NCT00923091|592392444|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007482|NCT00923091|592392445|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
164007483|NCT00923091|592392433|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
164007484|NCT00923091|592392434|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
164007485|NCT00923091|592392435|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
164007486|NCT00923091|592392436|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
164007487|NCT00923091|592392437|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
164007488|NCT00923091|592392438|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
164007489|NCT00923091|592392439|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
164007490|NCT00923091|592392440|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
164007491|NCT00923091|592392441|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
164007492|NCT00923091|592392442|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
164007493|NCT00923091|592392443|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
164007494|NCT00923091|592392444|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
164007495|NCT00923091|592392445|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
164007496|NCT00923091|592392433|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007497|NCT00923091|592392434|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
163900811|NCT05601882|592007990|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
163900812|NCT03834740|592007991|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
163900813|NCT03834740|592007992|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
163900814|NCT03834740|592007993|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
163900815|NCT01208974|592007994|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
163900816|NCT01208974|592007995|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
163900817|NCT01208974|592007996|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
163900818|NCT01208974|592007997|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
163900819|NCT01208974|592007994|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
163900820|NCT01208974|592007995|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
163900821|NCT01208974|592007996|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
163900822|NCT01208974|592007997|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
163900823|NCT01208974|592007994|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
163900824|NCT01208974|592007995|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
164007498|NCT00923091|592392435|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007499|NCT00923091|592392436|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007500|NCT00923091|592392437|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
164091025|NCT00429923|592695909|FG000|Overall Study|Lack of Efficacy|4|||
164355909|NCT02956486|593678717|FG002|Core Phase|Other|0|||
164355910|NCT02956486|593678715|FG000|Core Phase|Not treated|0|||
164355911|NCT02956486|593678716|FG001|Core Phase|Not treated|3|||
164355912|NCT02956486|593678717|FG002|Core Phase|Not treated|0|||
164355913|NCT02956486|593678715|FG000|Extension Phase|Adverse Event|0|||
164355914|NCT02956486|593678716|FG001|Extension Phase|Adverse Event|0|||
164355915|NCT02956486|593678717|FG002|Extension Phase|Adverse Event|2|||
163900825|NCT01208974|592007996|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
163900826|NCT01208974|592007997|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
163900827|NCT03593226|592007998|FG000|Overall Study|Disease progression|6|||
164007501|NCT00923091|592392438|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007502|NCT00923091|592392439|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007503|NCT00923091|592392440|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
164355916|NCT02956486|593678715|FG000|Extension Phase|Study terminated by sponsor|0|||
164355917|NCT02956486|593678716|FG001|Extension Phase|Study terminated by sponsor|0|||
164355918|NCT02956486|593678717|FG002|Extension Phase|Study terminated by sponsor|16|||
164007504|NCT00923091|592392441|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
164007505|NCT00923091|592392442|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007506|NCT00923091|592392443|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007507|NCT00923091|592392444|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
164007508|NCT00923091|592392445|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
164007509|NCT00923091|592392433|FG000|Period V (Double -Blind)|Protocol Violation|0|||
164007510|NCT00923091|592392434|FG001|Period V (Double -Blind)|Protocol Violation|0|||
164007511|NCT00923091|592392435|FG002|Period V (Double -Blind)|Protocol Violation|0|||
164007512|NCT00923091|592392436|FG003|Period V (Double -Blind)|Protocol Violation|0|||
164007513|NCT00923091|592392437|FG004|Period V (Double -Blind)|Protocol Violation|0|||
164007514|NCT00923091|592392438|FG005|Period V (Double -Blind)|Protocol Violation|0|||
164007515|NCT00923091|592392439|FG006|Period V (Double -Blind)|Protocol Violation|0|||
164007516|NCT00923091|592392440|FG007|Period V (Double -Blind)|Protocol Violation|0|||
164007517|NCT00923091|592392441|FG008|Period V (Double -Blind)|Protocol Violation|0|||
164007518|NCT00923091|592392442|FG009|Period V (Double -Blind)|Protocol Violation|0|||
164007519|NCT00923091|592392443|FG010|Period V (Double -Blind)|Protocol Violation|0|||
164007520|NCT00923091|592392444|FG011|Period V (Double -Blind)|Protocol Violation|0|||
164007521|NCT00923091|592392445|FG012|Period V (Double -Blind)|Protocol Violation|1|||
164007522|NCT00923091|592392433|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
164007523|NCT00923091|592392434|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
164007524|NCT00923091|592392435|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
164007525|NCT00923091|592392436|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
164007526|NCT00923091|592392437|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
164007527|NCT00923091|592392438|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
164007528|NCT00923091|592392439|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
164007529|NCT00923091|592392440|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
164007530|NCT00923091|592392441|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
164007531|NCT00923091|592392442|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
164007532|NCT00923091|592392443|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
164007533|NCT00923091|592392444|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
164007534|NCT00923091|592392445|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
164007535|NCT00923091|592392433|FG000|Period VI (Open-Label)|Adverse Event|17|||
164007536|NCT00923091|592392434|FG001|Period VI (Open-Label)|Adverse Event|0|||
164007537|NCT00923091|592392435|FG002|Period VI (Open-Label)|Adverse Event|4|||
164007538|NCT00923091|592392436|FG003|Period VI (Open-Label)|Adverse Event|1|||
164007539|NCT00923091|592392437|FG004|Period VI (Open-Label)|Adverse Event|1|||
164007540|NCT00923091|592392438|FG005|Period VI (Open-Label)|Adverse Event|0|||
164007541|NCT00923091|592392439|FG006|Period VI (Open-Label)|Adverse Event|0|||
164007542|NCT00923091|592392440|FG007|Period VI (Open-Label)|Adverse Event|0|||
164007543|NCT00923091|592392441|FG008|Period VI (Open-Label)|Adverse Event|0|||
164007544|NCT00923091|592392442|FG009|Period VI (Open-Label)|Adverse Event|0|||
164007545|NCT00923091|592392443|FG010|Period VI (Open-Label)|Adverse Event|0|||
164007546|NCT00923091|592392444|FG011|Period VI (Open-Label)|Adverse Event|0|||
164007547|NCT00923091|592392445|FG012|Period VI (Open-Label)|Adverse Event|0|||
164007548|NCT00923091|592392433|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
164007549|NCT00923091|592392434|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
164007550|NCT00923091|592392435|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
164007551|NCT00923091|592392436|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007552|NCT00923091|592392437|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
164007553|NCT00923091|592392438|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007554|NCT00923091|592392439|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007555|NCT00923091|592392440|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007556|NCT00923091|592392441|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007557|NCT00923091|592392442|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007558|NCT00923091|592392443|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007559|NCT00923091|592392444|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007560|NCT00923091|592392445|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
164007561|NCT00923091|592392433|FG000|Period VI (Open-Label)|Protocol Violation|6|||
164007562|NCT00923091|592392434|FG001|Period VI (Open-Label)|Protocol Violation|1|||
164007563|NCT00923091|592392435|FG002|Period VI (Open-Label)|Protocol Violation|3|||
164007564|NCT00923091|592392436|FG003|Period VI (Open-Label)|Protocol Violation|1|||
164007565|NCT00923091|592392437|FG004|Period VI (Open-Label)|Protocol Violation|4|||
164007566|NCT00923091|592392438|FG005|Period VI (Open-Label)|Protocol Violation|0|||
164355919|NCT02956486|593678715|FG000|Extension Phase|Not Treated|0|||
164007567|NCT00923091|592392439|FG006|Period VI (Open-Label)|Protocol Violation|0|||
164007568|NCT00923091|592392440|FG007|Period VI (Open-Label)|Protocol Violation|0|||
164007569|NCT00923091|592392441|FG008|Period VI (Open-Label)|Protocol Violation|0|||
164007570|NCT00923091|592392442|FG009|Period VI (Open-Label)|Protocol Violation|0|||
164007571|NCT00923091|592392443|FG010|Period VI (Open-Label)|Protocol Violation|0|||
164355920|NCT02956486|593678716|FG001|Extension Phase|Not Treated|0|||
164355921|NCT02956486|593678717|FG002|Extension Phase|Not Treated|1|||
164355922|NCT02485574|593678724|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
164355923|NCT00255047|593678726|FG000|Overall Study|Serious Adverse Events|2|||
164355924|NCT00255047|593678727|FG001|Overall Study|Serious Adverse Events|1|||
164355925|NCT00255047|593678728|FG002|Overall Study|Serious Adverse Events|2|||
164355926|NCT00255047|593678729|FG003|Overall Study|Serious Adverse Events|1|||
164355927|NCT00255047|593678726|FG000|Overall Study|Adverse Event|0|||
164355928|NCT00255047|593678727|FG001|Overall Study|Adverse Event|3|||
164355929|NCT00255047|593678728|FG002|Overall Study|Adverse Event|2|||
164355930|NCT00255047|593678729|FG003|Overall Study|Adverse Event|1|||
164355931|NCT00255047|593678726|FG000|Overall Study|Protocol Violation|13|||
164355932|NCT00255047|593678727|FG001|Overall Study|Protocol Violation|13|||
164355933|NCT00255047|593678728|FG002|Overall Study|Protocol Violation|16|||
164355934|NCT00255047|593678729|FG003|Overall Study|Protocol Violation|20|||
164355935|NCT00255047|593678726|FG000|Overall Study|Lost to Follow-up|9|||
164355936|NCT00255047|593678727|FG001|Overall Study|Lost to Follow-up|8|||
164355937|NCT00255047|593678728|FG002|Overall Study|Lost to Follow-up|5|||
164355938|NCT00255047|593678729|FG003|Overall Study|Lost to Follow-up|6|||
164355939|NCT00255047|593678726|FG000|Overall Study|Withdrawal by Subject|24|||
164355940|NCT00255047|593678727|FG001|Overall Study|Withdrawal by Subject|23|||
164355941|NCT00255047|593678728|FG002|Overall Study|Withdrawal by Subject|25|||
164355942|NCT00255047|593678729|FG003|Overall Study|Withdrawal by Subject|18|||
164355943|NCT01585194|593678736|FG000|Overall Study|Withdrawal by Subject|1|||
164355944|NCT01585194|593678736|FG000|Overall Study|Physician Decision|2|||
164355945|NCT01585194|593678736|FG000|Overall Study|Lack of insurance|1|||
164355946|NCT00993291|593678737|FG000|Overall Study|Withdrawal by Subject|1|||
164355947|NCT00003492|593678738|FG000|Overall Study|Not evaluable|6|||
164355948|NCT04446377|593678739|FG000|Overall Study|Withdrawal by Subject|6|||
164355949|NCT04446377|593678740|FG001|Overall Study|Withdrawal by Subject|1|||
164355950|NCT04446377|593678739|FG000|Overall Study|Physician Decision|1|||
164355951|NCT04446377|593678740|FG001|Overall Study|Physician Decision|1|||
164355952|NCT04446377|593678739|FG000|Overall Study|Lost to Follow-up|0|||
164355953|NCT04446377|593678740|FG001|Overall Study|Lost to Follow-up|2|||
164355954|NCT04446377|593678739|FG000|Overall Study|Not eligible|0|||
164355955|NCT04446377|593678740|FG001|Overall Study|Not eligible|1|||
164355956|NCT03049280|593678746|FG000|Overall Study|Physician Decision|1|||
164355957|NCT01867021|593678747|FG000|Overall Study|Adverse Event|0|||
164355958|NCT01867021|593678748|FG001|Overall Study|Adverse Event|1|||
164355959|NCT01867021|593678747|FG000|Overall Study|Not Eligible|0|||
164355960|NCT01867021|593678748|FG001|Overall Study|Not Eligible|1|||
164355961|NCT01867021|593678747|FG000|Overall Study|Death|1|||
164355962|NCT01867021|593678748|FG001|Overall Study|Death|0|||
164355963|NCT01867021|593678747|FG000|Overall Study|Lost to Follow-up|0|||
164355964|NCT01867021|593678748|FG001|Overall Study|Lost to Follow-up|2|||
164355965|NCT01867021|593678747|FG000|Overall Study|Withdrawal by Subject|1|||
164355966|NCT01867021|593678748|FG001|Overall Study|Withdrawal by Subject|6|||
164355967|NCT01129960|593678752|FG000|Overall Study|Withdrawal by Subject|3|||
164355968|NCT01129960|593678753|FG001|Overall Study|Withdrawal by Subject|0|||
164355969|NCT01129960|593678754|FG002|Overall Study|Withdrawal by Subject|3|||
164091026|NCT00429923|592695910|FG001|Overall Study|Lack of Efficacy|1|||
163900828|NCT03593226|592007999|FG001|Overall Study|Disease progression|13|||
163900829|NCT03593226|592008000|FG002|Overall Study|Disease progression|5|||
163900830|NCT03593226|592008001|FG003|Overall Study|Disease progression|6|||
163900831|NCT03593226|592007998|FG000|Overall Study|Adverse Event|0|||
164091027|NCT00429923|592695911|FG002|Overall Study|Lack of Efficacy|33|||
163900832|NCT03593226|592007999|FG001|Overall Study|Adverse Event|1|||
163900833|NCT03593226|592008000|FG002|Overall Study|Adverse Event|0|||
163900834|NCT03593226|592008001|FG003|Overall Study|Adverse Event|0|||
163900835|NCT03593226|592007998|FG000|Overall Study|Withdrawal by Subject|0|||
163900836|NCT03593226|592007999|FG001|Overall Study|Withdrawal by Subject|4|||
163900837|NCT03593226|592008000|FG002|Overall Study|Withdrawal by Subject|1|||
163900838|NCT03593226|592008001|FG003|Overall Study|Withdrawal by Subject|0|||
163900839|NCT03593226|592007998|FG000|Overall Study|Physician Decision|0|||
163900840|NCT03593226|592007999|FG001|Overall Study|Physician Decision|1|||
163900841|NCT03593226|592008000|FG002|Overall Study|Physician Decision|0|||
163900842|NCT03593226|592008001|FG003|Overall Study|Physician Decision|0|||
163900843|NCT03593226|592007998|FG000|Overall Study|Clinical disease progression|0|||
164355970|NCT01129960|593678755|FG003|Overall Study|Withdrawal by Subject|2|||
164355971|NCT01129960|593678752|FG000|Overall Study|Lack of Efficacy|1|||
164355972|NCT01129960|593678753|FG001|Overall Study|Lack of Efficacy|1|||
164355973|NCT01129960|593678754|FG002|Overall Study|Lack of Efficacy|1|||
164355974|NCT01129960|593678755|FG003|Overall Study|Lack of Efficacy|1|||
164355975|NCT01129960|593678752|FG000|Overall Study|Adverse Event|23|||
164355976|NCT01129960|593678753|FG001|Overall Study|Adverse Event|16|||
164355977|NCT01129960|593678754|FG002|Overall Study|Adverse Event|16|||
164355978|NCT01129960|593678755|FG003|Overall Study|Adverse Event|7|||
164355979|NCT01129960|593678752|FG000|Overall Study|Protocol Violation|1|||
164355980|NCT01129960|593678753|FG001|Overall Study|Protocol Violation|2|||
164355981|NCT01129960|593678754|FG002|Overall Study|Protocol Violation|3|||
164355982|NCT01129960|593678755|FG003|Overall Study|Protocol Violation|0|||
164355983|NCT01129960|593678752|FG000|Overall Study|Lost to Follow-up|0|||
164355984|NCT01129960|593678753|FG001|Overall Study|Lost to Follow-up|2|||
164355985|NCT01129960|593678754|FG002|Overall Study|Lost to Follow-up|3|||
164355986|NCT01129960|593678755|FG003|Overall Study|Lost to Follow-up|3|||
164355987|NCT01129960|593678752|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
164091028|NCT00429923|592695909|FG000|Overall Study|Lost to Follow-up|0|||
164091029|NCT00429923|592695910|FG001|Overall Study|Lost to Follow-up|0|||
164091030|NCT00429923|592695911|FG002|Overall Study|Lost to Follow-up|2|||
164091031|NCT00429923|592695909|FG000|Overall Study|Withdrew Consent|1|||
164091032|NCT00429923|592695910|FG001|Overall Study|Withdrew Consent|0|||
164091033|NCT00429923|592695911|FG002|Overall Study|Withdrew Consent|1|||
164091034|NCT00429923|592695909|FG000|Overall Study|Early Termination|0|||
164091035|NCT00429923|592695910|FG001|Overall Study|Early Termination|1|||
164091036|NCT00429923|592695911|FG002|Overall Study|Early Termination|0|||
164091037|NCT01265784|592695912|FG000|Overall Study|Lost to Follow-up|5|||
164091038|NCT01265784|592695913|FG001|Overall Study|Lost to Follow-up|3|||
164091039|NCT01265784|592695914|FG002|Overall Study|Lost to Follow-up|2|||
164091040|NCT01265784|592695912|FG000|Overall Study|Withdrawal by Subject|0|||
164091041|NCT01265784|592695913|FG001|Overall Study|Withdrawal by Subject|5|||
164355988|NCT01129960|593678753|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
164355989|NCT01129960|593678754|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
164355990|NCT01129960|593678755|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
164091042|NCT01265784|592695914|FG002|Overall Study|Withdrawal by Subject|0|||
164091043|NCT01265784|592695912|FG000|Overall Study|Physician Decision|1|||
164091044|NCT01265784|592695913|FG001|Overall Study|Physician Decision|0|||
164091045|NCT01265784|592695914|FG002|Overall Study|Physician Decision|1|||
164091046|NCT01265784|592695912|FG000|Overall Study|Adverse Event|1|||
164091047|NCT01265784|592695913|FG001|Overall Study|Adverse Event|0|||
164091048|NCT01265784|592695914|FG002|Overall Study|Adverse Event|0|||
164091049|NCT01265784|592695912|FG000|Overall Study|Death|3|||
164091050|NCT01265784|592695913|FG001|Overall Study|Death|0|||
164091051|NCT01265784|592695914|FG002|Overall Study|Death|0|||
164091052|NCT01265784|592695912|FG000|Overall Study|Protocol Violation|2|||
164091053|NCT01265784|592695913|FG001|Overall Study|Protocol Violation|0|||
164091054|NCT01265784|592695914|FG002|Overall Study|Protocol Violation|0|||
164091055|NCT01265784|592695912|FG000|Overall Study|Incorrectly Randomized|0|||
164091056|NCT01265784|592695913|FG001|Overall Study|Incorrectly Randomized|0|||
164355991|NCT01129960|593678752|FG000|Overall Study|Physician Decision|1|||
164355992|NCT01129960|593678753|FG001|Overall Study|Physician Decision|0|||
164355993|NCT01129960|593678754|FG002|Overall Study|Physician Decision|0|||
164355994|NCT01129960|593678755|FG003|Overall Study|Physician Decision|0|||
164355995|NCT01129960|593678752|FG000|Overall Study|Pregnancy|1|||
164355996|NCT01129960|593678753|FG001|Overall Study|Pregnancy|0|||
164355997|NCT01129960|593678754|FG002|Overall Study|Pregnancy|0|||
164355998|NCT01129960|593678755|FG003|Overall Study|Pregnancy|0|||
164355999|NCT02056340|593678757|FG000|Overall Study|Lost to Follow-up|5|||
164356000|NCT02056340|593678758|FG001|Overall Study|Lost to Follow-up|5|||
164356001|NCT02056340|593678757|FG000|Overall Study|Withdrawal by Subject|2|||
164356002|NCT02056340|593678758|FG001|Overall Study|Withdrawal by Subject|6|||
164356003|NCT01927367|593678761|FG000|Overall Study|Withdrawal by Subject|7|||
164356004|NCT01927367|593678762|FG001|Overall Study|Withdrawal by Subject|4|||
164356005|NCT01927367|593678761|FG000|Overall Study|No baseline data|0|||
164356006|NCT01927367|593678762|FG001|Overall Study|No baseline data|1|||
164356007|NCT00071513|593678763|FG000|Intervention Component|Withdrawal by Subject|2|||
164356008|NCT00071513|593678764|FG001|Intervention Component|Withdrawal by Subject|3|||
164356009|NCT00071513|593678763|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
164356010|NCT00071513|593678764|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
164356011|NCT01634360|593678765|FG000|Overall Study|Adverse Event|10|||
164356012|NCT01634360|593678766|FG001|Overall Study|Adverse Event|34|||
164356013|NCT01634360|593678765|FG000|Overall Study|subject withdrew consent|13|||
164356014|NCT01634360|593678766|FG001|Overall Study|subject withdrew consent|23|||
164356015|NCT01634360|593678765|FG000|Overall Study|Protocol Violation|1|||
164356016|NCT01634360|593678766|FG001|Overall Study|Protocol Violation|1|||
164356017|NCT01634360|593678765|FG000|Overall Study|Lack of Efficacy|4|||
164356018|NCT01634360|593678766|FG001|Overall Study|Lack of Efficacy|14|||
164356019|NCT01634360|593678765|FG000|Overall Study|Other|3|||
164356020|NCT01634360|593678766|FG001|Overall Study|Other|20|||
164091057|NCT01265784|592695914|FG002|Overall Study|Incorrectly Randomized|1|||
164091058|NCT03740165|592695917|FG000|Overall Study|Death|232|||
164091059|NCT03740165|592695918|FG001|Overall Study|Death|242|||
164091060|NCT03740165|592695919|FG002|Overall Study|Death|229|||
164356021|NCT01634360|593678765|FG000|Overall Study|Study termination by sponsor|18|||
164356022|NCT01634360|593678766|FG001|Overall Study|Study termination by sponsor|44|||
164091061|NCT03740165|592695917|FG000|Overall Study|Lost to Follow-up|0|||
164091062|NCT03740165|592695918|FG001|Overall Study|Lost to Follow-up|0|||
164091063|NCT03740165|592695919|FG002|Overall Study|Lost to Follow-up|1|||
164356023|NCT02743871|593678767|FG000|Overall Study|Lost to Follow-up|0|||
164356024|NCT02743871|593678768|FG001|Overall Study|Lost to Follow-up|0|||
164356025|NCT02743871|593678769|FG002|Overall Study|Lost to Follow-up|0|||
164356026|NCT02743871|593678770|FG003|Overall Study|Lost to Follow-up|1|||
164356027|NCT02743871|593678771|FG004|Overall Study|Lost to Follow-up|0|||
164356028|NCT02743871|593678772|FG005|Overall Study|Lost to Follow-up|0|||
164356029|NCT02743871|593678773|FG006|Overall Study|Lost to Follow-up|1|||
164356030|NCT02743871|593678774|FG007|Overall Study|Lost to Follow-up|0|||
164356031|NCT02743871|593678775|FG008|Overall Study|Lost to Follow-up|0|||
164356032|NCT02743871|593678776|FG009|Overall Study|Lost to Follow-up|0|||
164356033|NCT02743871|593678777|FG010|Overall Study|Lost to Follow-up|0|||
164007572|NCT00923091|592392444|FG011|Period VI (Open-Label)|Protocol Violation|0|||
164007573|NCT00923091|592392445|FG012|Period VI (Open-Label)|Protocol Violation|0|||
164007574|NCT00923091|592392433|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
164007575|NCT00923091|592392434|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
164007576|NCT00923091|592392435|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
164007577|NCT00923091|592392436|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
164007578|NCT00923091|592392437|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
164007579|NCT00923091|592392438|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
164007580|NCT00923091|592392439|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
164007581|NCT00923091|592392440|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
164007582|NCT00923091|592392441|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
164007583|NCT00923091|592392442|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
164007584|NCT00923091|592392443|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
164007585|NCT00923091|592392444|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
164007586|NCT00923091|592392445|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
164007587|NCT00923091|592392433|FG000|Period VI (Open-Label)|Other Reason|0|||
164007588|NCT00923091|592392434|FG001|Period VI (Open-Label)|Other Reason|0|||
164007589|NCT00923091|592392435|FG002|Period VI (Open-Label)|Other Reason|0|||
164007590|NCT00923091|592392436|FG003|Period VI (Open-Label)|Other Reason|1|||
164007591|NCT00923091|592392437|FG004|Period VI (Open-Label)|Other Reason|1|||
164007592|NCT00923091|592392438|FG005|Period VI (Open-Label)|Other Reason|0|||
164007593|NCT00923091|592392439|FG006|Period VI (Open-Label)|Other Reason|0|||
164007594|NCT00923091|592392440|FG007|Period VI (Open-Label)|Other Reason|0|||
164007595|NCT00923091|592392441|FG008|Period VI (Open-Label)|Other Reason|0|||
164007596|NCT00923091|592392442|FG009|Period VI (Open-Label)|Other Reason|0|||
164007597|NCT00923091|592392443|FG010|Period VI (Open-Label)|Other Reason|0|||
164007598|NCT00923091|592392444|FG011|Period VI (Open-Label)|Other Reason|0|||
164007599|NCT00923091|592392445|FG012|Period VI (Open-Label)|Other Reason|0|||
164007600|NCT04246047|592392449|FG000|Overall Study|Death|50|||
164007601|NCT04246047|592392450|FG001|Overall Study|Death|77|||
164007602|NCT04246047|592392449|FG000|Overall Study|Lost to Follow-up|1|||
164007603|NCT04246047|592392450|FG001|Overall Study|Lost to Follow-up|3|||
164007604|NCT04246047|592392449|FG000|Overall Study|Physician Decision|4|||
164007605|NCT04246047|592392450|FG001|Overall Study|Physician Decision|10|||
164007606|NCT04246047|592392449|FG000|Overall Study|Withdrawal by Subject|19|||
164007607|NCT04246047|592392450|FG001|Overall Study|Withdrawal by Subject|26|||
164007608|NCT04246047|592392449|FG000|Overall Study|Ongoing|169|||
164007609|NCT04246047|592392450|FG001|Overall Study|Ongoing|135|||
164007610|NCT02111369|592392452|FG000|Overall Study|Lost to Follow-up|2|||
164007611|NCT02111369|592392452|FG000|Overall Study|Withdrawal by Subject|1|||
164007612|NCT05270265|592392453|FG000|Overall Study|Lost to Follow-up|0|||
164007613|NCT05270265|592392454|FG001|Overall Study|Lost to Follow-up|1|||
164007614|NCT05270265|592392455|FG002|Overall Study|Lost to Follow-up|0|||
164007615|NCT00624338|592392458|FG000|Overall Study|Adverse Event|14|||
164007616|NCT00624338|592392459|FG001|Overall Study|Adverse Event|14|||
164007617|NCT00624338|592392460|FG002|Overall Study|Adverse Event|18|||
164007618|NCT00624338|592392458|FG000|Overall Study|Lost to Follow-up|1|||
164356034|NCT02743871|593678778|FG011|Overall Study|Lost to Follow-up|2|||
164356035|NCT02743871|593678779|FG012|Overall Study|Lost to Follow-up|0|||
164356036|NCT02743871|593678780|FG013|Overall Study|Lost to Follow-up|0|||
164356037|NCT02743871|593678767|FG000|Overall Study|Withdrawal by Subject|0|||
164356038|NCT02743871|593678768|FG001|Overall Study|Withdrawal by Subject|0|||
164356039|NCT02743871|593678769|FG002|Overall Study|Withdrawal by Subject|0|||
164356040|NCT02743871|593678770|FG003|Overall Study|Withdrawal by Subject|0|||
164356041|NCT02743871|593678771|FG004|Overall Study|Withdrawal by Subject|0|||
164356042|NCT02743871|593678772|FG005|Overall Study|Withdrawal by Subject|0|||
164356043|NCT02743871|593678773|FG006|Overall Study|Withdrawal by Subject|0|||
164356044|NCT02743871|593678774|FG007|Overall Study|Withdrawal by Subject|0|||
164007619|NCT00624338|592392459|FG001|Overall Study|Lost to Follow-up|0|||
164007620|NCT00624338|592392460|FG002|Overall Study|Lost to Follow-up|0|||
164007621|NCT00624338|592392458|FG000|Overall Study|Lack of Efficacy|11|||
164007622|NCT00624338|592392459|FG001|Overall Study|Lack of Efficacy|3|||
164007623|NCT00624338|592392460|FG002|Overall Study|Lack of Efficacy|14|||
164007624|NCT00624338|592392458|FG000|Overall Study|Protocol Violation|3|||
164007625|NCT00624338|592392459|FG001|Overall Study|Protocol Violation|3|||
164007626|NCT00624338|592392460|FG002|Overall Study|Protocol Violation|2|||
164007627|NCT00624338|592392458|FG000|Overall Study|Death|0|||
164356045|NCT02743871|593678775|FG008|Overall Study|Withdrawal by Subject|0|||
164356046|NCT02743871|593678776|FG009|Overall Study|Withdrawal by Subject|0|||
164356047|NCT02743871|593678777|FG010|Overall Study|Withdrawal by Subject|1|||
164356048|NCT02743871|593678778|FG011|Overall Study|Withdrawal by Subject|0|||
164356049|NCT02743871|593678779|FG012|Overall Study|Withdrawal by Subject|12|||
164007628|NCT00624338|592392459|FG001|Overall Study|Death|2|||
164007629|NCT00624338|592392460|FG002|Overall Study|Death|0|||
164007630|NCT00624338|592392458|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
164007631|NCT00624338|592392459|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
164007632|NCT00624338|592392460|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
164007633|NCT00624338|592392458|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
164007634|NCT00624338|592392459|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
164007635|NCT00624338|592392460|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
164007636|NCT00624338|592392458|FG000|Overall Study|Other|15|||
164007637|NCT00624338|592392459|FG001|Overall Study|Other|5|||
164007638|NCT00624338|592392460|FG002|Overall Study|Other|9|||
164007639|NCT00624338|592392458|FG000|Overall Study|Randomized but not treated|2|||
164007640|NCT00624338|592392459|FG001|Overall Study|Randomized but not treated|1|||
164007641|NCT00624338|592392460|FG002|Overall Study|Randomized but not treated|3|||
164007642|NCT01933672|592392465|FG000|Metformin Run-in Period|Adverse Event|1|||
164007643|NCT01933672|592392466|FG001|Metformin Run-in Period|Adverse Event|0|||
164007644|NCT01933672|592392467|FG002|Metformin Run-in Period|Adverse Event|0|||
164007645|NCT01933672|592392468|FG003|Metformin Run-in Period|Adverse Event|0|||
164007646|NCT01933672|592392469|FG004|Metformin Run-in Period|Adverse Event|0|||
164356050|NCT02743871|593678780|FG013|Overall Study|Withdrawal by Subject|6|||
164356051|NCT02743871|593678767|FG000|Overall Study|Adverse Event|1|||
164356052|NCT02743871|593678768|FG001|Overall Study|Adverse Event|0|||
164356053|NCT02743871|593678769|FG002|Overall Study|Adverse Event|0|||
164356054|NCT02743871|593678770|FG003|Overall Study|Adverse Event|0|||
164356055|NCT02743871|593678771|FG004|Overall Study|Adverse Event|0|||
164356056|NCT02743871|593678772|FG005|Overall Study|Adverse Event|0|||
164356057|NCT02743871|593678773|FG006|Overall Study|Adverse Event|0|||
164356058|NCT02743871|593678774|FG007|Overall Study|Adverse Event|0|||
164356059|NCT02743871|593678775|FG008|Overall Study|Adverse Event|0|||
164356060|NCT02743871|593678776|FG009|Overall Study|Adverse Event|0|||
164356061|NCT02743871|593678777|FG010|Overall Study|Adverse Event|0|||
164356062|NCT02743871|593678778|FG011|Overall Study|Adverse Event|0|||
164356063|NCT02743871|593678779|FG012|Overall Study|Adverse Event|0|||
164356064|NCT02743871|593678780|FG013|Overall Study|Adverse Event|0|||
164356065|NCT02743871|593678767|FG000|Overall Study|Other|0|||
164356066|NCT02743871|593678768|FG001|Overall Study|Other|0|||
164356067|NCT02743871|593678769|FG002|Overall Study|Other|0|||
164356068|NCT02743871|593678770|FG003|Overall Study|Other|0|||
164356069|NCT02743871|593678771|FG004|Overall Study|Other|0|||
164356070|NCT02743871|593678772|FG005|Overall Study|Other|0|||
164356071|NCT02743871|593678773|FG006|Overall Study|Other|0|||
164356072|NCT02743871|593678774|FG007|Overall Study|Other|0|||
164356073|NCT02743871|593678775|FG008|Overall Study|Other|0|||
164356074|NCT02743871|593678776|FG009|Overall Study|Other|0|||
164356075|NCT02743871|593678777|FG010|Overall Study|Other|0|||
164356076|NCT02743871|593678778|FG011|Overall Study|Other|1|||
164356077|NCT02743871|593678779|FG012|Overall Study|Other|1|||
164356078|NCT02743871|593678780|FG013|Overall Study|Other|1|||
164356079|NCT02743871|593678767|FG000|Overall Study|Protocol Violation|0|||
164356080|NCT02743871|593678768|FG001|Overall Study|Protocol Violation|0|||
164356081|NCT02743871|593678769|FG002|Overall Study|Protocol Violation|0|||
164356082|NCT02743871|593678770|FG003|Overall Study|Protocol Violation|0|||
164007647|NCT01933672|592392470|FG005|Metformin Run-in Period|Adverse Event|0|||
164007648|NCT01933672|592392471|FG006|Metformin Run-in Period|Adverse Event|0|||
164007649|NCT01933672|592392465|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
164007650|NCT01933672|592392466|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164007651|NCT01933672|592392467|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164007652|NCT01933672|592392468|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164007653|NCT01933672|592392469|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164007654|NCT01933672|592392470|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164356083|NCT02743871|593678771|FG004|Overall Study|Protocol Violation|0|||
164356084|NCT02743871|593678772|FG005|Overall Study|Protocol Violation|0|||
164356085|NCT02743871|593678773|FG006|Overall Study|Protocol Violation|0|||
164356086|NCT02743871|593678774|FG007|Overall Study|Protocol Violation|0|||
164356087|NCT02743871|593678775|FG008|Overall Study|Protocol Violation|0|||
164356088|NCT02743871|593678776|FG009|Overall Study|Protocol Violation|0|||
164356089|NCT02743871|593678777|FG010|Overall Study|Protocol Violation|0|||
164007655|NCT01933672|592392471|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
164007656|NCT01933672|592392465|FG000|Metformin Run-in Period|Other|5|||
164356090|NCT02743871|593678778|FG011|Overall Study|Protocol Violation|0|||
164356091|NCT02743871|593678779|FG012|Overall Study|Protocol Violation|2|||
164356092|NCT02743871|593678780|FG013|Overall Study|Protocol Violation|0|||
164007657|NCT01933672|592392466|FG001|Metformin Run-in Period|Other|0|||
164007658|NCT01933672|592392467|FG002|Metformin Run-in Period|Other|0|||
164007659|NCT01933672|592392468|FG003|Metformin Run-in Period|Other|0|||
164007660|NCT01933672|592392469|FG004|Metformin Run-in Period|Other|0|||
164007661|NCT01933672|592392470|FG005|Metformin Run-in Period|Other|0|||
164007662|NCT01933672|592392471|FG006|Metformin Run-in Period|Other|0|||
164007663|NCT01933672|592392465|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007664|NCT01933672|592392466|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007665|NCT01933672|592392467|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007666|NCT01933672|592392468|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007667|NCT01933672|592392469|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
164007668|NCT01933672|592392470|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007669|NCT01933672|592392471|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007670|NCT01933672|592392465|FG000|First Intervention Period (12-16 Days)|Other|0|||
164007671|NCT01933672|592392466|FG001|First Intervention Period (12-16 Days)|Other|0|||
164007672|NCT01933672|592392467|FG002|First Intervention Period (12-16 Days)|Other|1|||
164007673|NCT01933672|592392468|FG003|First Intervention Period (12-16 Days)|Other|0|||
164007674|NCT01933672|592392469|FG004|First Intervention Period (12-16 Days)|Other|0|||
164007675|NCT01933672|592392470|FG005|First Intervention Period (12-16 Days)|Other|1|||
164007676|NCT01933672|592392471|FG006|First Intervention Period (12-16 Days)|Other|0|||
164007677|NCT01933672|592392465|FG000|Second Intervention Period (12-16 Days)|Other|0|||
164007678|NCT01933672|592392466|FG001|Second Intervention Period (12-16 Days)|Other|1|||
164007679|NCT01933672|592392467|FG002|Second Intervention Period (12-16 Days)|Other|1|||
164007680|NCT01933672|592392468|FG003|Second Intervention Period (12-16 Days)|Other|0|||
164007681|NCT01933672|592392469|FG004|Second Intervention Period (12-16 Days)|Other|0|||
164007682|NCT01933672|592392470|FG005|Second Intervention Period (12-16 Days)|Other|0|||
164007683|NCT01933672|592392471|FG006|Second Intervention Period (12-16 Days)|Other|0|||
164007684|NCT01933672|592392465|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007685|NCT01933672|592392466|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007686|NCT01933672|592392467|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007687|NCT01933672|592392468|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
164007688|NCT01933672|592392469|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007689|NCT01933672|592392470|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007690|NCT01933672|592392471|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
164007691|NCT01933672|592392465|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164007692|NCT01933672|592392466|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
164007693|NCT01933672|592392467|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164007694|NCT01933672|592392468|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164007695|NCT01933672|592392469|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164007696|NCT01933672|592392470|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164007697|NCT01933672|592392471|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
164007698|NCT00524303|592392472|FG000|Overall Study|Lost to Follow-up|6|||
164007699|NCT00524303|592392473|FG001|Overall Study|Lost to Follow-up|0|||
164007700|NCT00524303|592392474|FG002|Overall Study|Lost to Follow-up|3|||
164007701|NCT00524303|592392472|FG000|Overall Study|Protocol Violation|0|||
164007702|NCT00524303|592392473|FG001|Overall Study|Protocol Violation|1|||
164007703|NCT00524303|592392474|FG002|Overall Study|Protocol Violation|1|||
164007704|NCT00524303|592392472|FG000|Overall Study|Withdrawal by Subject|3|||
164007705|NCT00524303|592392473|FG001|Overall Study|Withdrawal by Subject|0|||
164007706|NCT00524303|592392474|FG002|Overall Study|Withdrawal by Subject|4|||
164007707|NCT00524303|592392472|FG000|Overall Study|Death|0|||
164007708|NCT00524303|592392473|FG001|Overall Study|Death|2|||
164007709|NCT00524303|592392474|FG002|Overall Study|Death|3|||
164007710|NCT00524303|592392472|FG000|Overall Study|Adverse Event|1|||
164007711|NCT00524303|592392473|FG001|Overall Study|Adverse Event|2|||
164356093|NCT03171415|593678782|FG000|Overall Study|Lost to Follow-up|0|||
164356094|NCT03171415|593678783|FG001|Overall Study|Lost to Follow-up|0|||
164356095|NCT03171415|593678784|FG002|Overall Study|Lost to Follow-up|0|||
164356096|NCT03171415|593678785|FG003|Overall Study|Lost to Follow-up|0|||
164356097|NCT03171415|593678786|FG004|Overall Study|Lost to Follow-up|2|||
164356098|NCT02848651|593678787|FG000|Overall Study|Death|85|||
164356099|NCT02848651|593678787|FG000|Overall Study|Lost to Follow-up|1|||
164356100|NCT02848651|593678787|FG000|Overall Study|Non-Compliance|1|||
164007712|NCT00524303|592392474|FG002|Overall Study|Adverse Event|3|||
164007713|NCT00524303|592392472|FG000|Overall Study|Did not Complete Study Dosing|1|||
164007714|NCT00524303|592392473|FG001|Overall Study|Did not Complete Study Dosing|0|||
164007715|NCT00524303|592392474|FG002|Overall Study|Did not Complete Study Dosing|0|||
164007716|NCT00524303|592392472|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
164007717|NCT00524303|592392473|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
164007718|NCT00524303|592392474|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
164007719|NCT00524303|592392472|FG000|Overall Study|Disease Progression|0|||
164007720|NCT00524303|592392473|FG001|Overall Study|Disease Progression|4|||
164007721|NCT00524303|592392474|FG002|Overall Study|Disease Progression|1|||
164007722|NCT00524303|592392472|FG000|Overall Study|Disease Recurrence|0|||
164007723|NCT00524303|592392473|FG001|Overall Study|Disease Recurrence|1|||
164007724|NCT00524303|592392474|FG002|Overall Study|Disease Recurrence|0|||
164007725|NCT00524303|592392472|FG000|Overall Study|Sponsor Request|0|||
164007726|NCT00524303|592392473|FG001|Overall Study|Sponsor Request|0|||
164007727|NCT00524303|592392474|FG002|Overall Study|Sponsor Request|1|||
164007728|NCT00524303|592392472|FG000|Overall Study|Physician Decision|0|||
164007729|NCT00524303|592392473|FG001|Overall Study|Physician Decision|0|||
164007730|NCT00524303|592392474|FG002|Overall Study|Physician Decision|1|||
164007731|NCT00524303|592392472|FG000|Overall Study|Completed 5 years|0|||
164007732|NCT00524303|592392473|FG001|Overall Study|Completed 5 years|0|||
164007733|NCT00524303|592392474|FG002|Overall Study|Completed 5 years|1|||
164007734|NCT00095121|592392475|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
164007735|NCT00095121|592392476|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
164007736|NCT00095121|592392475|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
164007737|NCT00095121|592392476|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
164007738|NCT03497689|592392480|FG000|Overall Study|Adverse Event|2|||
164007739|NCT03497689|592392480|FG000|Overall Study|Death|1|||
164007740|NCT03497689|592392480|FG000|Overall Study|Physician Decision|1|||
164007741|NCT03497689|592392480|FG000|Overall Study|Withdrawal by Subject|1|||
164007742|NCT03497689|592392480|FG000|Overall Study|Protocol Violation|2|||
164007743|NCT03567187|592392481|FG000|Overall Study|Lost to Follow-up|18|||
164007744|NCT05176847|592392934|FG000|Overall Study|Lost to Follow-up|23|||
164007745|NCT05176847|592392935|FG001|Overall Study|Lost to Follow-up|36|||
164007746|NCT05176847|592392934|FG000|Overall Study|Withdrawal by Subject|7|||
164007747|NCT05176847|592392935|FG001|Overall Study|Withdrawal by Subject|12|||
164007748|NCT05176847|592392934|FG000|Overall Study|Removed from analysis|1|||
164007749|NCT05176847|592392935|FG001|Overall Study|Removed from analysis|0|||
164007750|NCT05369208|592392936|FG000|Core Phase|Prohibited Medication Required|2|||
164007751|NCT05369208|592392936|FG000|Core Phase|Adverse Event|1|||
164007752|NCT05369208|592392936|FG000|Core Phase|Lack of Efficacy|1|||
164007753|NCT05441670|592392937|FG000|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|0|||
164007754|NCT05441670|592392938|FG001|Overall Study|Two participants completed intervention but not post-test due to ICU admit and family challenges.|2|||
164007755|NCT01059812|592392947|FG000|Overall Study|Adverse Event|9|||
164007756|NCT01059812|592392948|FG001|Overall Study|Adverse Event|5|||
164007757|NCT01059812|592392947|FG000|Overall Study|Lack of Efficacy|2|||
164007758|NCT01059812|592392948|FG001|Overall Study|Lack of Efficacy|2|||
164007759|NCT01059812|592392947|FG000|Overall Study|Protocol Violation|3|||
164007760|NCT01059812|592392948|FG001|Overall Study|Protocol Violation|1|||
164007761|NCT01059812|592392947|FG000|Overall Study|Withdrawal Criteria|9|||
164007762|NCT01059812|592392948|FG001|Overall Study|Withdrawal Criteria|4|||
164007763|NCT01059812|592392947|FG000|Overall Study|Unclassified|14|||
164007764|NCT01059812|592392948|FG001|Overall Study|Unclassified|4|||
164007765|NCT05299892|592392949|FG000|Overall Study|Withdrawal by Subject|2|||
164007766|NCT00149214|592392950|FG000|Overall Study|Adverse Event|12|||
164007767|NCT00149214|592392951|FG001|Overall Study|Adverse Event|9|||
164007768|NCT00149214|592392950|FG000|Overall Study|Withdrawal by Subject|4|||
164007769|NCT00149214|592392951|FG001|Overall Study|Withdrawal by Subject|1|||
164007770|NCT00149214|592392950|FG000|Overall Study|Physician Decision|3|||
164007771|NCT00149214|592392951|FG001|Overall Study|Physician Decision|3|||
164007772|NCT00149214|592392950|FG000|Overall Study|Sponsor Decision|0|||
164007773|NCT00149214|592392951|FG001|Overall Study|Sponsor Decision|1|||
164007774|NCT00149214|592392950|FG000|Overall Study|Progressive Disease|7|||
164007775|NCT00149214|592392951|FG001|Overall Study|Progressive Disease|3|||
164007776|NCT05642442|592392952|FG000|Overall Study|Adverse Event|0|||
164007777|NCT05642442|592392953|FG001|Overall Study|Adverse Event|1|||
164007778|NCT05642442|592392952|FG000|Overall Study|Lack of Efficacy|0|||
164007779|NCT05642442|592392953|FG001|Overall Study|Lack of Efficacy|1|||
164007780|NCT05642442|592392952|FG000|Overall Study|Withdrawal by Subject|13|||
164007781|NCT05642442|592392953|FG001|Overall Study|Withdrawal by Subject|9|||
164007782|NCT05642442|592392952|FG000|Overall Study|Other|5|||
164007783|NCT05642442|592392953|FG001|Overall Study|Other|2|||
164007784|NCT05642442|592392952|FG000|Overall Study|Lost to Follow-up|0|||
164007785|NCT05642442|592392953|FG001|Overall Study|Lost to Follow-up|1|||
164007786|NCT02296684|592392958|FG000|Overall Study|Withdrawal by Subject|0|||
164007787|NCT02296684|592392959|FG001|Overall Study|Withdrawal by Subject|1|||
164007788|NCT02296684|592392960|FG002|Overall Study|Withdrawal by Subject|1|||
164007789|NCT02296684|592392958|FG000|Overall Study|Death|2|||
164007790|NCT02296684|592392959|FG001|Overall Study|Death|0|||
164007791|NCT02296684|592392960|FG002|Overall Study|Death|0|||
164007792|NCT05561673|592392968|FG000|Overall Study|Lost to Follow-up|0|||
164007793|NCT05561673|592392969|FG001|Overall Study|Lost to Follow-up|1|||
164007794|NCT05561673|592392970|FG002|Overall Study|Lost to Follow-up|0|||
164007795|NCT05561673|592392971|FG003|Overall Study|Lost to Follow-up|1|||
164007796|NCT05561673|592392972|FG004|Overall Study|Lost to Follow-up|0|||
164007797|NCT05561673|592392968|FG000|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164007798|NCT05561673|592392969|FG001|Overall Study|Consent withdrawal, not due to (S)AE|1|||
164091064|NCT03740165|592695917|FG000|Overall Study|Withdrawal by Subject|7|||
164091065|NCT03740165|592695918|FG001|Overall Study|Withdrawal by Subject|4|||
164091066|NCT03740165|592695919|FG002|Overall Study|Withdrawal by Subject|3|||
164091067|NCT03740165|592695917|FG000|Overall Study|Ongoing in Study|216|||
164091068|NCT03740165|592695918|FG001|Overall Study|Ongoing in Study|212|||
164091069|NCT03740165|592695919|FG002|Overall Study|Ongoing in Study|221|||
164091070|NCT03049618|592695920|FG000|Overall Study|Death|1|||
164091071|NCT03049618|592695921|FG001|Overall Study|Death|0|||
164091072|NCT03049618|592695920|FG000|Overall Study|Lack of Efficacy|1|||
164091073|NCT03049618|592695921|FG001|Overall Study|Lack of Efficacy|2|||
164091074|NCT00788125|592697774|FG000|Overall Study|Death|6|||
164091075|NCT00414466|592697777|FG000|Overall Study|Adverse Event|0|||
164091076|NCT00414466|592697778|FG001|Overall Study|Adverse Event|0|||
164091077|NCT00414466|592697779|FG002|Overall Study|Adverse Event|1|||
164091078|NCT00414466|592697780|FG003|Overall Study|Adverse Event|1|||
164091079|NCT00414466|592697777|FG000|Overall Study|Lack of Efficacy|1|||
164091080|NCT00414466|592697778|FG001|Overall Study|Lack of Efficacy|0|||
164091081|NCT00414466|592697779|FG002|Overall Study|Lack of Efficacy|0|||
164091082|NCT00414466|592697780|FG003|Overall Study|Lack of Efficacy|0|||
164091083|NCT00414466|592697777|FG000|Overall Study|Withdrawn by Sponsor|1|||
164091084|NCT00414466|592697778|FG001|Overall Study|Withdrawn by Sponsor|0|||
164091085|NCT00414466|592697779|FG002|Overall Study|Withdrawn by Sponsor|0|||
164091086|NCT00414466|592697780|FG003|Overall Study|Withdrawn by Sponsor|0|||
164091087|NCT03480425|592697781|FG000|Overall Study|Force transducer technical failure|1|||
164091088|NCT02742090|592697784|FG000|Overall Study|Adverse Event|10|||
164091089|NCT02742090|592697784|FG000|Overall Study|Death|3|||
164091090|NCT02742090|592697784|FG000|Overall Study|Disease Progression|25|||
164091091|NCT02742090|592697784|FG000|Overall Study|Investigator's Decision|1|||
164091092|NCT02742090|592697784|FG000|Overall Study|Lost to Follow-up|1|||
164091093|NCT02742090|592697784|FG000|Overall Study|Non-compliance with Study|1|||
164091094|NCT02742090|592697784|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
164091095|NCT02742090|592697784|FG000|Overall Study|Withdrawal by Subject|4|||
164091096|NCT02742090|592697784|FG000|Overall Study|Reason Not Specified|1|||
164091097|NCT02473640|592697796|FG000|Treatment Period 1|Adverse Event|1|||
164091098|NCT04720664|592697797|FG000|Overall Study|Adverse Event|2|||
164091099|NCT04720664|592697797|FG000|Overall Study|Lack of Efficacy|9|||
164091100|NCT02016300|592697804|FG000|Overall Study|Lost to Follow-up|0|||
164091101|NCT02016300|592697805|FG001|Overall Study|Lost to Follow-up|3|||
164091102|NCT05301751|592697806|FG000|Overall Study|Withdrawal by Subject|0|||
164091103|NCT05301751|592697807|FG001|Overall Study|Withdrawal by Subject|0|||
164007799|NCT05561673|592392970|FG002|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164007800|NCT05561673|592392971|FG003|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164007801|NCT05561673|592392972|FG004|Overall Study|Consent withdrawal, not due to (S)AE|0|||
164007802|NCT05561673|592392968|FG000|Overall Study|Other|1|||
164007803|NCT05561673|592392969|FG001|Overall Study|Other|0|||
164007804|NCT05561673|592392970|FG002|Overall Study|Other|1|||
164007805|NCT05561673|592392971|FG003|Overall Study|Other|0|||
164007806|NCT05561673|592392972|FG004|Overall Study|Other|0|||
164007807|NCT01582282|592394728|FG000|Overall Study|Adverse Event|1|||
164007808|NCT01582282|592394729|FG001|Overall Study|Adverse Event|1|||
164007809|NCT01582282|592394730|FG002|Overall Study|Adverse Event|0|||
164007810|NCT01582282|592394728|FG000|Overall Study|Lost to Follow-up|1|||
164007811|NCT01582282|592394729|FG001|Overall Study|Lost to Follow-up|0|||
164007812|NCT01582282|592394730|FG002|Overall Study|Lost to Follow-up|0|||
164007813|NCT01582282|592394728|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
164007814|NCT01582282|592394729|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
164091104|NCT05301751|592697808|FG002|Overall Study|Withdrawal by Subject|1|||
164091105|NCT05301751|592697809|FG003|Overall Study|Withdrawal by Subject|0|||
164091106|NCT06165744|592697812|FG000|Overall Study|Non device-related adverse event|1|||
164091107|NCT01546987|592697813|FG000|Overall Study|Protocol Violation|3|||
164091108|NCT01546987|592697814|FG001|Overall Study|Protocol Violation|4|||
164091109|NCT02270736|592697815|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164356101|NCT02848651|593678787|FG000|Overall Study|Symptomatic Deterioration|1|||
164356102|NCT02848651|593678787|FG000|Overall Study|Physician Decision|4|||
164356103|NCT02848651|593678787|FG000|Overall Study|Withdrawal by Subject|14|||
164356104|NCT00883116|593678788|FG000|Overall Study|Adverse event unrelated to study drug|5|||
164007815|NCT01582282|592394730|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
164007816|NCT04426630|592394731|FG000|Overall Study|Death|4|||
164007817|NCT04426630|592394731|FG000|Overall Study|Lost to Follow-up|2|||
164091110|NCT02270736|592697816|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
164091111|NCT02270736|592697817|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164091112|NCT02270736|592697818|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164091113|NCT02270736|592697819|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
164091114|NCT02270736|592697815|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
164091115|NCT02270736|592697816|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
164091116|NCT02270736|592697817|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
164091117|NCT02270736|592697818|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
164091118|NCT02270736|592697819|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
164091119|NCT02270736|592697815|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164091120|NCT02270736|592697816|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
164356105|NCT00883116|593678789|FG001|Overall Study|Adverse event unrelated to study drug|10|||
164356106|NCT00883116|593678788|FG000|Overall Study|Death|6|||
164356107|NCT00883116|593678789|FG001|Overall Study|Death|2|||
164356108|NCT00883116|593678788|FG000|Overall Study|Disease progression|130|||
164356109|NCT00883116|593678789|FG001|Overall Study|Disease progression|128|||
164356110|NCT00883116|593678788|FG000|Overall Study|Lost to Follow-up|0|||
164356111|NCT00883116|593678789|FG001|Overall Study|Lost to Follow-up|1|||
164356112|NCT00883116|593678788|FG000|Overall Study|Maximum clinical benefit|13|||
164356113|NCT00883116|593678789|FG001|Overall Study|Maximum clinical benefit|46|||
164356114|NCT00883116|593678788|FG000|Overall Study|Not identified|3|||
164356115|NCT00883116|593678789|FG001|Overall Study|Not identified|6|||
164356116|NCT00883116|593678788|FG000|Overall Study|Study drug toxicity|36|||
164356117|NCT00883116|593678789|FG001|Overall Study|Study drug toxicity|16|||
164356118|NCT00883116|593678788|FG000|Overall Study|Withdrawal by Subject|14|||
164356119|NCT00883116|593678789|FG001|Overall Study|Withdrawal by Subject|8|||
164356120|NCT00883116|593678788|FG000|Overall Study|No longer meets study criteria|2|||
164356121|NCT00883116|593678789|FG001|Overall Study|No longer meets study criteria|2|||
164356122|NCT04140292|593678790|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
164356123|NCT04140292|593678791|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
164356124|NCT00680043|593678795|FG000|Overall Study|Withdrawal by Subject|1|||
164356125|NCT00680043|593678796|FG001|Overall Study|Withdrawal by Subject|0|||
164356126|NCT00680043|593678797|FG002|Overall Study|Withdrawal by Subject|0|||
164356127|NCT00680043|593678795|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
164356128|NCT00680043|593678796|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
164356129|NCT00680043|593678797|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
164356130|NCT00680043|593678795|FG000|Overall Study|Renal Transplant|1|||
164356131|NCT00680043|593678796|FG001|Overall Study|Renal Transplant|0|||
164356132|NCT00680043|593678797|FG002|Overall Study|Renal Transplant|4|||
164356133|NCT02484729|593678798|FG000|Overall Study|Failure of IntelliCap Error|0|||
164356134|NCT02484729|593678799|FG001|Overall Study|Failure of IntelliCap Error|0|||
164356135|NCT02484729|593678800|FG002|Overall Study|Failure of IntelliCap Error|0|||
164356136|NCT02484729|593678801|FG003|Overall Study|Failure of IntelliCap Error|0|||
164356137|NCT02484729|593678802|FG004|Overall Study|Failure of IntelliCap Error|0|||
164356138|NCT02484729|593678803|FG005|Overall Study|Failure of IntelliCap Error|0|||
164356139|NCT02484729|593678804|FG006|Overall Study|Failure of IntelliCap Error|0|||
164356140|NCT02484729|593678805|FG007|Overall Study|Failure of IntelliCap Error|0|||
164356141|NCT02484729|593678806|FG008|Overall Study|Failure of IntelliCap Error|0|||
164356142|NCT02484729|593678807|FG009|Overall Study|Failure of IntelliCap Error|1|||
164356143|NCT02480114|593678808|FG000|Overall Study|Not completing surveys|3|||
164356144|NCT02480114|593678809|FG001|Overall Study|Not completing surveys|2|||
164356145|NCT02480114|593678808|FG000|Overall Study|Withdrawal by Subject|2|||
164356146|NCT02480114|593678809|FG001|Overall Study|Withdrawal by Subject|4|||
164356147|NCT02480114|593678808|FG000|Overall Study|Disease progression|3|||
164356148|NCT02480114|593678809|FG001|Overall Study|Disease progression|0|||
164356149|NCT02480114|593678808|FG000|Overall Study|Improper completion of survey|1|||
164356150|NCT02480114|593678809|FG001|Overall Study|Improper completion of survey|1|||
164356151|NCT02480114|593678808|FG000|Overall Study|Not eligible|0|||
164356152|NCT02480114|593678809|FG001|Overall Study|Not eligible|1|||
164356153|NCT01031069|593678810|FG000|Overall Study|Serious Adverse Event|0|||
164356154|NCT01031069|593678811|FG001|Overall Study|Serious Adverse Event|1|||
164356155|NCT01031069|593678812|FG002|Overall Study|Serious Adverse Event|0|||
164356156|NCT01031069|593678813|FG003|Overall Study|Serious Adverse Event|0|||
164356157|NCT01031069|593678810|FG000|Overall Study|Withdrawal by Subject|2|||
164356158|NCT01031069|593678811|FG001|Overall Study|Withdrawal by Subject|3|||
164356159|NCT01031069|593678812|FG002|Overall Study|Withdrawal by Subject|18|||
164356160|NCT01031069|593678813|FG003|Overall Study|Withdrawal by Subject|18|||
164356161|NCT01031069|593678810|FG000|Overall Study|Migrated/moved from study area|1|||
164356162|NCT01031069|593678811|FG001|Overall Study|Migrated/moved from study area|2|||
164356163|NCT01031069|593678812|FG002|Overall Study|Migrated/moved from study area|1|||
164356164|NCT01031069|593678813|FG003|Overall Study|Migrated/moved from study area|1|||
164091121|NCT02270736|592697817|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164091122|NCT02270736|592697818|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164356165|NCT01031069|593678810|FG000|Overall Study|Lost to Follow-up|9|||
164356166|NCT01031069|593678811|FG001|Overall Study|Lost to Follow-up|5|||
164356167|NCT01031069|593678812|FG002|Overall Study|Lost to Follow-up|21|||
164356168|NCT01031069|593678813|FG003|Overall Study|Lost to Follow-up|15|||
164356169|NCT01031069|593678810|FG000|Overall Study|Other|0|||
164356170|NCT01031069|593678811|FG001|Overall Study|Other|0|||
164356171|NCT01031069|593678812|FG002|Overall Study|Other|1|||
164356172|NCT01031069|593678813|FG003|Overall Study|Other|0|||
164356173|NCT01317160|593678814|FG000|Overall Study|Incorrect inclusion|1|||
164007818|NCT02786537|592394732|FG000|As Randomized|Adverse Event|0|||
164007819|NCT02786537|592394733|FG001|As Randomized|Adverse Event|11|||
164007820|NCT02786537|592394734|FG002|As Randomized|Adverse Event|0|||
164007821|NCT02786537|592394735|FG003|As Randomized|Adverse Event|4|||
164007822|NCT02786537|592394736|FG004|As Randomized|Adverse Event|6|||
164007823|NCT02786537|592394737|FG005|As Randomized|Adverse Event|2|||
164007824|NCT02786537|592394732|FG000|As Randomized|Lack of Efficacy|0|||
164007825|NCT02786537|592394733|FG001|As Randomized|Lack of Efficacy|0|||
164007826|NCT02786537|592394734|FG002|As Randomized|Lack of Efficacy|0|||
164007827|NCT02786537|592394735|FG003|As Randomized|Lack of Efficacy|1|||
164007828|NCT02786537|592394736|FG004|As Randomized|Lack of Efficacy|0|||
164007829|NCT02786537|592394737|FG005|As Randomized|Lack of Efficacy|0|||
164007830|NCT02786537|592394732|FG000|As Randomized|Withdrawal by Subject|1|||
164007831|NCT02786537|592394733|FG001|As Randomized|Withdrawal by Subject|2|||
164007832|NCT02786537|592394734|FG002|As Randomized|Withdrawal by Subject|0|||
164007833|NCT02786537|592394735|FG003|As Randomized|Withdrawal by Subject|1|||
164007834|NCT02786537|592394736|FG004|As Randomized|Withdrawal by Subject|1|||
164007835|NCT02786537|592394737|FG005|As Randomized|Withdrawal by Subject|0|||
164007836|NCT02786537|592394732|FG000|As Randomized|Death|0|||
164007837|NCT02786537|592394733|FG001|As Randomized|Death|2|||
164007838|NCT02786537|592394734|FG002|As Randomized|Death|0|||
164007839|NCT02786537|592394735|FG003|As Randomized|Death|3|||
164007840|NCT02786537|592394736|FG004|As Randomized|Death|1|||
164007841|NCT02786537|592394737|FG005|As Randomized|Death|0|||
164007842|NCT02786537|592394732|FG000|As Randomized|Non-compliance with study drug|1|||
164007843|NCT02786537|592394733|FG001|As Randomized|Non-compliance with study drug|11|||
164007844|NCT02786537|592394734|FG002|As Randomized|Non-compliance with study drug|0|||
164007845|NCT02786537|592394735|FG003|As Randomized|Non-compliance with study drug|1|||
164007846|NCT02786537|592394736|FG004|As Randomized|Non-compliance with study drug|0|||
164007847|NCT02786537|592394737|FG005|As Randomized|Non-compliance with study drug|1|||
164007848|NCT02786537|592394732|FG000|As Randomized|Lost to treatment follow-up|4|||
164007849|NCT02786537|592394733|FG001|As Randomized|Lost to treatment follow-up|32|||
164007850|NCT02786537|592394734|FG002|As Randomized|Lost to treatment follow-up|0|||
164007851|NCT02786537|592394735|FG003|As Randomized|Lost to treatment follow-up|24|||
164007852|NCT02786537|592394736|FG004|As Randomized|Lost to treatment follow-up|4|||
164007853|NCT02786537|592394737|FG005|As Randomized|Lost to treatment follow-up|4|||
164007854|NCT02786537|592394732|FG000|As Randomized|Incarceration|0|||
164007855|NCT02786537|592394733|FG001|As Randomized|Incarceration|1|||
164007856|NCT02786537|592394734|FG002|As Randomized|Incarceration|0|||
164007857|NCT02786537|592394735|FG003|As Randomized|Incarceration|0|||
164007858|NCT02786537|592394736|FG004|As Randomized|Incarceration|0|||
164007859|NCT02786537|592394737|FG005|As Randomized|Incarceration|0|||
164007860|NCT02786537|592394732|FG000|As Randomized|Opiate Dependency Relapse|0|||
164007861|NCT02786537|592394733|FG001|As Randomized|Opiate Dependency Relapse|1|||
164007862|NCT02786537|592394734|FG002|As Randomized|Opiate Dependency Relapse|0|||
164007863|NCT02786537|592394735|FG003|As Randomized|Opiate Dependency Relapse|0|||
164007864|NCT02786537|592394736|FG004|As Randomized|Opiate Dependency Relapse|0|||
164007865|NCT02786537|592394737|FG005|As Randomized|Opiate Dependency Relapse|0|||
164007866|NCT02786537|592394732|FG000|As Randomized|HCV drugs stolen from pt|0|||
164007867|NCT02786537|592394733|FG001|As Randomized|HCV drugs stolen from pt|1|||
164007868|NCT02786537|592394734|FG002|As Randomized|HCV drugs stolen from pt|0|||
164007869|NCT02786537|592394735|FG003|As Randomized|HCV drugs stolen from pt|0|||
164007870|NCT02786537|592394736|FG004|As Randomized|HCV drugs stolen from pt|0|||
164007871|NCT02786537|592394737|FG005|As Randomized|HCV drugs stolen from pt|0|||
164007872|NCT02786537|592394732|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
164007873|NCT02786537|592394733|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
164007874|NCT02786537|592394734|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
164007875|NCT02786537|592394735|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
164007876|NCT02786537|592394736|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
164007877|NCT02786537|592394737|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
164007878|NCT02786537|592394732|FG000|As Randomized|Subject lost insurance|0|||
164007879|NCT02786537|592394733|FG001|As Randomized|Subject lost insurance|0|||
164007880|NCT02786537|592394734|FG002|As Randomized|Subject lost insurance|0|||
164091123|NCT02270736|592697819|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
164091124|NCT02270736|592697815|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164007881|NCT02786537|592394735|FG003|As Randomized|Subject lost insurance|1|||
164007882|NCT02786537|592394736|FG004|As Randomized|Subject lost insurance|0|||
164007883|NCT02786537|592394737|FG005|As Randomized|Subject lost insurance|0|||
164007884|NCT02786537|592394732|FG000|As Treated|Adverse Event|0|||
164007885|NCT02786537|592394733|FG001|As Treated|Adverse Event|11|||
164007886|NCT02786537|592394734|FG002|As Treated|Adverse Event|0|||
164007887|NCT02786537|592394735|FG003|As Treated|Adverse Event|4|||
164007888|NCT02786537|592394736|FG004|As Treated|Adverse Event|6|||
164007889|NCT02786537|592394737|FG005|As Treated|Adverse Event|2|||
164007890|NCT02786537|592394732|FG000|As Treated|Death|0|||
164007891|NCT02786537|592394733|FG001|As Treated|Death|2|||
164007892|NCT02786537|592394734|FG002|As Treated|Death|0|||
164356174|NCT01317160|593678815|FG001|Overall Study|Incorrect inclusion|1|||
164356175|NCT01317160|593678814|FG000|Overall Study|Lost to Follow-up|3|||
164356176|NCT01317160|593678815|FG001|Overall Study|Lost to Follow-up|3|||
164356177|NCT01317160|593678814|FG000|Overall Study|Withdrawal by Subject|0|||
164356178|NCT01317160|593678815|FG001|Overall Study|Withdrawal by Subject|2|||
164356179|NCT03578367|593678817|FG000|Overall Study|Adverse Event|0|||
164356180|NCT03578367|593678818|FG001|Overall Study|Adverse Event|3|||
164356181|NCT03578367|593678819|FG002|Overall Study|Adverse Event|0|||
164356182|NCT03578367|593678820|FG003|Overall Study|Adverse Event|5|||
164356183|NCT03578367|593678817|FG000|Overall Study|Withdrawal by Subject|2|||
164356184|NCT03578367|593678818|FG001|Overall Study|Withdrawal by Subject|2|||
164356185|NCT03578367|593678819|FG002|Overall Study|Withdrawal by Subject|1|||
164356186|NCT03578367|593678820|FG003|Overall Study|Withdrawal by Subject|3|||
164356187|NCT03578367|593678817|FG000|Overall Study|Physician Decision|0|||
164356188|NCT03578367|593678818|FG001|Overall Study|Physician Decision|0|||
164356189|NCT03578367|593678819|FG002|Overall Study|Physician Decision|14|||
164356190|NCT03578367|593678820|FG003|Overall Study|Physician Decision|0|||
164356191|NCT03578367|593678817|FG000|Overall Study|Death|1|||
164356192|NCT03578367|593678818|FG001|Overall Study|Death|0|||
164356193|NCT03578367|593678819|FG002|Overall Study|Death|0|||
164356194|NCT03578367|593678820|FG003|Overall Study|Death|0|||
164356195|NCT03578367|593678817|FG000|Overall Study|Not treated|0|||
164356196|NCT03578367|593678818|FG001|Overall Study|Not treated|0|||
164356197|NCT03578367|593678819|FG002|Overall Study|Not treated|1|||
164356198|NCT03578367|593678820|FG003|Overall Study|Not treated|0|||
164356199|NCT00670800|593680906|FG000|Overall Study|2 controls were insulin resistant|0|||
164356200|NCT00670800|593680907|FG001|Overall Study|2 controls were insulin resistant|2|||
164356201|NCT00587561|593680908|FG000|Overall Study|Lost to Follow-up|6|||
164356202|NCT00587561|593680909|FG001|Overall Study|Lost to Follow-up|4|||
164356203|NCT05661942|593680910|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
164356204|NCT05661942|593680911|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
164356205|NCT02081690|593680915|FG000|Overall Study|Death|3|||
164356206|NCT02081690|593680915|FG000|Overall Study|Physician Decision|3|||
164356207|NCT02081690|593680915|FG000|Overall Study|Withdrawal by Subject|1|||
164356208|NCT00982488|593680917|FG000|Overall Study|Administrative reason by sponsor|81|||
164356209|NCT00982488|593680918|FG001|Overall Study|Administrative reason by sponsor|3|||
164356210|NCT00982488|593680919|FG002|Overall Study|Administrative reason by sponsor|11|||
164356211|NCT00982488|593680920|FG003|Overall Study|Administrative reason by sponsor|0|||
164356212|NCT00982488|593680921|FG004|Overall Study|Administrative reason by sponsor|0|||
164356213|NCT00982488|593680917|FG000|Overall Study|Adverse event unrelated to study drug|5|||
164356214|NCT00982488|593680918|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164356215|NCT00982488|593680919|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164356216|NCT00982488|593680920|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164356217|NCT00982488|593680921|FG004|Overall Study|Adverse event unrelated to study drug|0|||
164356218|NCT00982488|593680917|FG000|Overall Study|Death|11|||
164356219|NCT00982488|593680918|FG001|Overall Study|Death|0|||
164356220|NCT00982488|593680919|FG002|Overall Study|Death|2|||
164356221|NCT00982488|593680920|FG003|Overall Study|Death|0|||
164356222|NCT00982488|593680921|FG004|Overall Study|Death|0|||
164356223|NCT00982488|593680917|FG000|Overall Study|Disease progression|30|||
164356224|NCT00982488|593680918|FG001|Overall Study|Disease progression|5|||
164356225|NCT00982488|593680919|FG002|Overall Study|Disease progression|10|||
164356226|NCT00982488|593680920|FG003|Overall Study|Disease progression|1|||
164356227|NCT00982488|593680921|FG004|Overall Study|Disease progression|1|||
164356228|NCT00982488|593680917|FG000|Overall Study|Lost to Follow-up|1|||
164356229|NCT00982488|593680918|FG001|Overall Study|Lost to Follow-up|0|||
164356230|NCT00982488|593680919|FG002|Overall Study|Lost to Follow-up|0|||
164356231|NCT00982488|593680920|FG003|Overall Study|Lost to Follow-up|0|||
164356232|NCT00982488|593680921|FG004|Overall Study|Lost to Follow-up|0|||
164356233|NCT00982488|593680917|FG000|Overall Study|Maximum clinical benefit|1|||
164356234|NCT00982488|593680918|FG001|Overall Study|Maximum clinical benefit|1|||
164356235|NCT00982488|593680919|FG002|Overall Study|Maximum clinical benefit|1|||
164356236|NCT00982488|593680920|FG003|Overall Study|Maximum clinical benefit|0|||
164356237|NCT00982488|593680921|FG004|Overall Study|Maximum clinical benefit|0|||
164356238|NCT00982488|593680917|FG000|Overall Study|Other|15|||
164356239|NCT00982488|593680918|FG001|Overall Study|Other|1|||
164356240|NCT00982488|593680919|FG002|Overall Study|Other|3|||
164356241|NCT00982488|593680920|FG003|Overall Study|Other|1|||
164356242|NCT00982488|593680921|FG004|Overall Study|Other|0|||
164356243|NCT00982488|593680917|FG000|Overall Study|Poor compliance/noncompliance|0|||
164356244|NCT00982488|593680918|FG001|Overall Study|Poor compliance/noncompliance|1|||
164356245|NCT00982488|593680919|FG002|Overall Study|Poor compliance/noncompliance|0|||
164356246|NCT00982488|593680920|FG003|Overall Study|Poor compliance/noncompliance|0|||
164356247|NCT00982488|593680921|FG004|Overall Study|Poor compliance/noncompliance|0|||
164356248|NCT00982488|593680917|FG000|Overall Study|Stem cell transplant|2|||
164356249|NCT00982488|593680918|FG001|Overall Study|Stem cell transplant|0|||
164007893|NCT02786537|592394735|FG003|As Treated|Death|3|||
164007894|NCT02786537|592394736|FG004|As Treated|Death|1|||
164007895|NCT02786537|592394737|FG005|As Treated|Death|0|||
164007896|NCT02786537|592394732|FG000|As Treated|Lack of Efficacy|0|||
164007897|NCT02786537|592394733|FG001|As Treated|Lack of Efficacy|0|||
164007898|NCT02786537|592394734|FG002|As Treated|Lack of Efficacy|0|||
164007899|NCT02786537|592394735|FG003|As Treated|Lack of Efficacy|1|||
164007900|NCT02786537|592394736|FG004|As Treated|Lack of Efficacy|0|||
164007901|NCT02786537|592394737|FG005|As Treated|Lack of Efficacy|0|||
164007902|NCT02786537|592394732|FG000|As Treated|Lost to Follow-up|4|||
164007903|NCT02786537|592394733|FG001|As Treated|Lost to Follow-up|32|||
164007904|NCT02786537|592394734|FG002|As Treated|Lost to Follow-up|0|||
164007905|NCT02786537|592394735|FG003|As Treated|Lost to Follow-up|25|||
164007906|NCT02786537|592394736|FG004|As Treated|Lost to Follow-up|4|||
164007907|NCT02786537|592394737|FG005|As Treated|Lost to Follow-up|4|||
164007908|NCT02786537|592394732|FG000|As Treated|Non-compliance with study drug|1|||
164007909|NCT02786537|592394733|FG001|As Treated|Non-compliance with study drug|11|||
164007910|NCT02786537|592394734|FG002|As Treated|Non-compliance with study drug|0|||
164007911|NCT02786537|592394735|FG003|As Treated|Non-compliance with study drug|1|||
164007912|NCT02786537|592394736|FG004|As Treated|Non-compliance with study drug|0|||
164007913|NCT02786537|592394737|FG005|As Treated|Non-compliance with study drug|1|||
164007914|NCT02786537|592394732|FG000|As Treated|Lost insurance|0|||
164007915|NCT02786537|592394733|FG001|As Treated|Lost insurance|0|||
164007916|NCT02786537|592394734|FG002|As Treated|Lost insurance|0|||
164007917|NCT02786537|592394735|FG003|As Treated|Lost insurance|1|||
164007918|NCT02786537|592394736|FG004|As Treated|Lost insurance|0|||
164007919|NCT02786537|592394737|FG005|As Treated|Lost insurance|0|||
164007920|NCT02786537|592394732|FG000|As Treated|Withdrawal by Subject|1|||
164356250|NCT00982488|593680919|FG002|Overall Study|Stem cell transplant|0|||
164356251|NCT00982488|593680920|FG003|Overall Study|Stem cell transplant|1|||
164356252|NCT00982488|593680921|FG004|Overall Study|Stem cell transplant|0|||
164356253|NCT00982488|593680917|FG000|Overall Study|Study drug toxicity|34|||
164007921|NCT02786537|592394733|FG001|As Treated|Withdrawal by Subject|2|||
164356254|NCT00982488|593680918|FG001|Overall Study|Study drug toxicity|1|||
164356255|NCT00982488|593680919|FG002|Overall Study|Study drug toxicity|6|||
164007922|NCT02786537|592394734|FG002|As Treated|Withdrawal by Subject|0|||
164007923|NCT02786537|592394735|FG003|As Treated|Withdrawal by Subject|0|||
164007924|NCT02786537|592394736|FG004|As Treated|Withdrawal by Subject|1|||
164007925|NCT02786537|592394737|FG005|As Treated|Withdrawal by Subject|0|||
164007926|NCT02786537|592394732|FG000|As Treated|Incarceration|0|||
164007927|NCT02786537|592394733|FG001|As Treated|Incarceration|1|||
164007928|NCT02786537|592394734|FG002|As Treated|Incarceration|0|||
164007929|NCT02786537|592394735|FG003|As Treated|Incarceration|0|||
164007930|NCT02786537|592394736|FG004|As Treated|Incarceration|0|||
164007931|NCT02786537|592394737|FG005|As Treated|Incarceration|0|||
164007932|NCT02786537|592394732|FG000|As Treated|Opiate dependency relapse|0|||
164007933|NCT02786537|592394733|FG001|As Treated|Opiate dependency relapse|1|||
164007934|NCT02786537|592394734|FG002|As Treated|Opiate dependency relapse|0|||
164007935|NCT02786537|592394735|FG003|As Treated|Opiate dependency relapse|0|||
164007936|NCT02786537|592394736|FG004|As Treated|Opiate dependency relapse|0|||
164007937|NCT02786537|592394737|FG005|As Treated|Opiate dependency relapse|0|||
164007938|NCT02786537|592394732|FG000|As Treated|Drugs stolen from patient|0|||
164007939|NCT02786537|592394733|FG001|As Treated|Drugs stolen from patient|1|||
164007940|NCT02786537|592394734|FG002|As Treated|Drugs stolen from patient|0|||
164356256|NCT00982488|593680920|FG003|Overall Study|Study drug toxicity|0|||
164356257|NCT00982488|593680921|FG004|Overall Study|Study drug toxicity|0|||
164356258|NCT00982488|593680917|FG000|Overall Study|Withdrawal by Subject|5|||
164356259|NCT00982488|593680918|FG001|Overall Study|Withdrawal by Subject|1|||
164356260|NCT00982488|593680919|FG002|Overall Study|Withdrawal by Subject|1|||
164356261|NCT00982488|593680920|FG003|Overall Study|Withdrawal by Subject|0|||
164356262|NCT00982488|593680921|FG004|Overall Study|Withdrawal by Subject|0|||
164356263|NCT03204981|593680922|FG000|Overall Study|Physician Decision|2|||
164356264|NCT03204981|593680922|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
164007941|NCT02786537|592394735|FG003|As Treated|Drugs stolen from patient|0|||
164007942|NCT02786537|592394736|FG004|As Treated|Drugs stolen from patient|0|||
164007943|NCT02786537|592394737|FG005|As Treated|Drugs stolen from patient|0|||
164007944|NCT02786537|592394732|FG000|As Treated|Advised to stop tx after loss of meds|0|||
164007945|NCT02786537|592394733|FG001|As Treated|Advised to stop tx after loss of meds|1|||
164007946|NCT02786537|592394734|FG002|As Treated|Advised to stop tx after loss of meds|0|||
164007947|NCT02786537|592394735|FG003|As Treated|Advised to stop tx after loss of meds|0|||
164007948|NCT02786537|592394736|FG004|As Treated|Advised to stop tx after loss of meds|0|||
164007949|NCT02786537|592394737|FG005|As Treated|Advised to stop tx after loss of meds|0|||
164007950|NCT02413255|592394740|FG000|Overall Study|Voluntary Withdrawal|0|||
164007951|NCT02413255|592394741|FG001|Overall Study|Voluntary Withdrawal|0|||
164007952|NCT02413255|592394742|FG002|Overall Study|Voluntary Withdrawal|0|||
164007953|NCT02413255|592394743|FG003|Overall Study|Voluntary Withdrawal|0|||
164007954|NCT02413255|592394744|FG004|Overall Study|Voluntary Withdrawal|0|||
164356265|NCT04203238|593680923|FG000|Overall Study|Withdrawal by Subject|1|||
164356266|NCT04203238|593680924|FG001|Overall Study|Withdrawal by Subject|1|||
163900844|NCT03593226|592007999|FG001|Overall Study|Clinical disease progression|0|||
163900845|NCT03593226|592008000|FG002|Overall Study|Clinical disease progression|1|||
163900846|NCT03593226|592008001|FG003|Overall Study|Clinical disease progression|0|||
163900847|NCT02500576|592008002|FG000|Overall Study|Adverse Event|0|||
163900848|NCT02500576|592008003|FG001|Overall Study|Adverse Event|1|||
163900849|NCT02500576|592008002|FG000|Overall Study|Death|2|||
163900850|NCT02500576|592008003|FG001|Overall Study|Death|1|||
163900851|NCT02500576|592008002|FG000|Overall Study|Lack of Efficacy|5|||
163900852|NCT02500576|592008003|FG001|Overall Study|Lack of Efficacy|5|||
163900853|NCT02500576|592008002|FG000|Overall Study|Withdrawal by Subject|1|||
163900854|NCT02500576|592008003|FG001|Overall Study|Withdrawal by Subject|1|||
163900855|NCT03691493|592008004|FG000|Overall Study|Withdrawal by Subject|1|||
163900856|NCT02798471|592008019|FG000|Overall Study|Adverse Event|7|||
163900857|NCT02798471|592008020|FG001|Overall Study|Adverse Event|2|||
163900858|NCT02798471|592008019|FG000|Overall Study|Physician Decision|3|||
163900859|NCT02798471|592008020|FG001|Overall Study|Physician Decision|7|||
163900860|NCT02798471|592008019|FG000|Overall Study|Death|2|||
163900861|NCT02798471|592008020|FG001|Overall Study|Death|3|||
163900862|NCT02798471|592008019|FG000|Overall Study|Lost to Follow-up|0|||
163900863|NCT02798471|592008020|FG001|Overall Study|Lost to Follow-up|1|||
163900864|NCT02798471|592008019|FG000|Overall Study|Other|5|||
163900865|NCT02798471|592008020|FG001|Overall Study|Other|3|||
163900866|NCT02798471|592008019|FG000|Overall Study|Subject withdrew consent|0|||
163900867|NCT02798471|592008020|FG001|Overall Study|Subject withdrew consent|6|||
163900868|NCT02798471|592008019|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
163900869|NCT02798471|592008020|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
163900870|NCT02798471|592008019|FG000|Overall Study|Randomized, but not treated|0|||
163900871|NCT02798471|592008020|FG001|Overall Study|Randomized, but not treated|2|||
163900872|NCT03459196|592009561|FG000|Overall Study|Subject didn't receive study catheter|2|||
163900873|NCT03367156|592009562|FG000|Overall Study|Lack of interest|3|||
163900874|NCT03367156|592009563|FG001|Overall Study|Lack of interest|1|||
163900875|NCT03367156|592009562|FG000|Overall Study|Death|2|||
164091125|NCT02270736|592697816|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164356267|NCT04203238|593680923|FG000|Overall Study|Covid-19|3|||
164356268|NCT04203238|593680924|FG001|Overall Study|Covid-19|0|||
164356269|NCT04244786|593680927|FG000|Overall Study|Adverse Event|0|||
164356270|NCT04244786|593680928|FG001|Overall Study|Adverse Event|0|||
164356271|NCT04244786|593680929|FG002|Overall Study|Adverse Event|2|||
164356272|NCT04244786|593680927|FG000|Overall Study|Withdrawal by Subject|0|||
164356273|NCT04244786|593680928|FG001|Overall Study|Withdrawal by Subject|0|||
164356274|NCT04244786|593680929|FG002|Overall Study|Withdrawal by Subject|5|||
164356275|NCT03274687|593680930|FG000|Overall Study|Protocol Violation|1|||
164356276|NCT03274687|593680931|FG001|Overall Study|Protocol Violation|1|||
164356277|NCT01572909|593680934|FG000|Overall Study|Adverse Event|7|||
164356278|NCT01572909|593680935|FG001|Overall Study|Adverse Event|2|||
164356279|NCT01572909|593680934|FG000|Overall Study|Death|3|||
164356280|NCT01572909|593680935|FG001|Overall Study|Death|1|||
164356281|NCT01572909|593680934|FG000|Overall Study|Lost to Follow-up|8|||
164356282|NCT01572909|593680935|FG001|Overall Study|Lost to Follow-up|7|||
164356283|NCT01572909|593680934|FG000|Overall Study|Physician Decision|1|||
164356284|NCT01572909|593680935|FG001|Overall Study|Physician Decision|1|||
164356285|NCT01572909|593680934|FG000|Overall Study|Technical Issues|1|||
164356286|NCT01572909|593680935|FG001|Overall Study|Technical Issues|0|||
164356287|NCT01572909|593680934|FG000|Overall Study|Withdrawal by Subject|12|||
164356288|NCT01572909|593680935|FG001|Overall Study|Withdrawal by Subject|11|||
164356289|NCT01572909|593680934|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
164356290|NCT01572909|593680935|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
164356291|NCT01199289|593680936|FG000|Overall Study|Ineligibility determined|2|||
164356292|NCT01199289|593680937|FG001|Overall Study|Ineligibility determined|1|||
164356293|NCT01199289|593680938|FG002|Overall Study|Ineligibility determined|0|||
164356294|NCT01199289|593680939|FG003|Overall Study|Ineligibility determined|0|||
164356295|NCT01199289|593680936|FG000|Overall Study|Protocol Violation|1|||
164356296|NCT01199289|593680937|FG001|Overall Study|Protocol Violation|0|||
164356297|NCT01199289|593680938|FG002|Overall Study|Protocol Violation|0|||
164356298|NCT01199289|593680939|FG003|Overall Study|Protocol Violation|1|||
164356299|NCT01199289|593680936|FG000|Overall Study|Noncompliance|1|||
164356300|NCT01199289|593680937|FG001|Overall Study|Noncompliance|0|||
164356301|NCT01199289|593680938|FG002|Overall Study|Noncompliance|2|||
164356302|NCT01199289|593680939|FG003|Overall Study|Noncompliance|0|||
164356303|NCT01199289|593680936|FG000|Overall Study|Adverse Event|0|||
163900876|NCT03367156|592009563|FG001|Overall Study|Death|0|||
163900877|NCT03367156|592009562|FG000|Overall Study|Lost to Follow-up|2|||
164356304|NCT01199289|593680937|FG001|Overall Study|Adverse Event|3|||
163900878|NCT03367156|592009563|FG001|Overall Study|Lost to Follow-up|1|||
163900879|NCT03367156|592009562|FG000|Overall Study|Became ineligible|1|||
164356305|NCT01199289|593680938|FG002|Overall Study|Adverse Event|1|||
164356306|NCT01199289|593680939|FG003|Overall Study|Adverse Event|4|||
164356307|NCT01199289|593680936|FG000|Overall Study|Full consent withdrawn|2|||
164356308|NCT01199289|593680937|FG001|Overall Study|Full consent withdrawn|2|||
164356309|NCT01199289|593680938|FG002|Overall Study|Full consent withdrawn|2|||
164356310|NCT01199289|593680939|FG003|Overall Study|Full consent withdrawn|3|||
164007955|NCT02413255|592394745|FG005|Overall Study|Voluntary Withdrawal|0|||
164007956|NCT02413255|592394746|FG006|Overall Study|Voluntary Withdrawal|0|||
164007957|NCT02413255|592394747|FG007|Overall Study|Voluntary Withdrawal|0|||
164007958|NCT02413255|592394748|FG008|Overall Study|Voluntary Withdrawal|0|||
164007959|NCT02413255|592394749|FG009|Overall Study|Voluntary Withdrawal|0|||
164007960|NCT02413255|592394750|FG010|Overall Study|Voluntary Withdrawal|0|||
164007961|NCT02413255|592394751|FG011|Overall Study|Voluntary Withdrawal|0|||
164007962|NCT02413255|592394752|FG012|Overall Study|Voluntary Withdrawal|0|||
164007963|NCT02413255|592394753|FG013|Overall Study|Voluntary Withdrawal|0|||
164007964|NCT02413255|592394754|FG014|Overall Study|Voluntary Withdrawal|1|||
164007965|NCT02413255|592394755|FG015|Overall Study|Voluntary Withdrawal|0|||
164007966|NCT02413255|592394756|FG016|Overall Study|Voluntary Withdrawal|0|||
164007967|NCT00077623|592394757|FG000|Overall Study|Adverse Event|1|||
164007968|NCT00077623|592394758|FG001|Overall Study|Adverse Event|0|||
164007969|NCT00077623|592394759|FG002|Overall Study|Adverse Event|1|||
164007970|NCT00077623|592394757|FG000|Overall Study|Withdrawal by Subject|2|||
164007971|NCT00077623|592394758|FG001|Overall Study|Withdrawal by Subject|10|||
164007972|NCT00077623|592394759|FG002|Overall Study|Withdrawal by Subject|1|||
164007973|NCT00077623|592394757|FG000|Overall Study|Other-Non safety reason|18|||
164007974|NCT00077623|592394758|FG001|Overall Study|Other-Non safety reason|15|||
164007975|NCT00077623|592394759|FG002|Overall Study|Other-Non safety reason|19|||
164007976|NCT00077623|592394757|FG000|Overall Study|Insufficient therapeutic response|2|||
164007977|NCT00077623|592394758|FG001|Overall Study|Insufficient therapeutic response|0|||
164007978|NCT00077623|592394759|FG002|Overall Study|Insufficient therapeutic response|0|||
164007979|NCT00077623|592394757|FG000|Overall Study|Death|12|||
164007980|NCT00077623|592394758|FG001|Overall Study|Death|18|||
164007981|NCT00077623|592394759|FG002|Overall Study|Death|11|||
164007982|NCT00077623|592394757|FG000|Overall Study|Failure to return|1|||
164007983|NCT00077623|592394758|FG001|Overall Study|Failure to return|0|||
164007984|NCT00077623|592394759|FG002|Overall Study|Failure to return|0|||
164007985|NCT00401973|592394760|FG000|Overall Study|Adverse Event|2|||
164007986|NCT00401973|592394761|FG001|Overall Study|Adverse Event|8|||
164007987|NCT00401973|592394762|FG002|Overall Study|Adverse Event|4|||
164007988|NCT00401973|592394760|FG000|Overall Study|Clinical Relapse|0|||
164007989|NCT00401973|592394761|FG001|Overall Study|Clinical Relapse|1|||
164007990|NCT00401973|592394762|FG002|Overall Study|Clinical Relapse|1|||
164356311|NCT01199289|593680936|FG000|Overall Study|Administrative decision|0|||
164356312|NCT01199289|593680937|FG001|Overall Study|Administrative decision|0|||
164356313|NCT01199289|593680938|FG002|Overall Study|Administrative decision|0|||
164356314|NCT01199289|593680939|FG003|Overall Study|Administrative decision|1|||
164356315|NCT01199289|593680936|FG000|Overall Study|Lost to Follow-up|0|||
164356316|NCT01199289|593680937|FG001|Overall Study|Lost to Follow-up|0|||
164356317|NCT01199289|593680938|FG002|Overall Study|Lost to Follow-up|0|||
164356318|NCT01199289|593680939|FG003|Overall Study|Lost to Follow-up|1|||
164356319|NCT01199289|593680936|FG000|Overall Study|Protocol-specified criteria|3|||
164356320|NCT01199289|593680937|FG001|Overall Study|Protocol-specified criteria|0|||
164356321|NCT01199289|593680938|FG002|Overall Study|Protocol-specified criteria|0|||
164356322|NCT01199289|593680939|FG003|Overall Study|Protocol-specified criteria|1|||
164356323|NCT01199289|593680936|FG000|Overall Study|Pregnancy|0|||
164356324|NCT01199289|593680937|FG001|Overall Study|Pregnancy|1|||
164356325|NCT01199289|593680938|FG002|Overall Study|Pregnancy|0|||
164356326|NCT01199289|593680939|FG003|Overall Study|Pregnancy|1|||
164356327|NCT02636868|593680940|FG000|Overall Study|Death|0|||
164356328|NCT02636868|593680941|FG001|Overall Study|Death|1|||
164356329|NCT02636868|593680942|FG002|Overall Study|Death|2|||
164356330|NCT00415909|593680946|FG000|Overall Study|Withdrawal by Subject|2|||
164356331|NCT00415909|593680946|FG000|Overall Study|Death|1|||
164356332|NCT05024058|593680947|FG000|Treatment|Study terminated by sponsor|5|||
164356333|NCT05024058|593680948|FG001|Treatment|Study terminated by sponsor|6|||
164356334|NCT05024058|593680949|FG002|Treatment|Study terminated by sponsor|4|||
164356335|NCT05024058|593680950|FG003|Treatment|Study terminated by sponsor|2|||
164356336|NCT05024058|593680951|FG004|Treatment|Study terminated by sponsor|3|||
164356337|NCT05024058|593680952|FG005|Treatment|Study terminated by sponsor|3|||
164356338|NCT05024058|593680953|FG006|Treatment|Study terminated by sponsor|1|||
164356339|NCT05024058|593680954|FG007|Treatment|Study terminated by sponsor|3|||
164356340|NCT05024058|593680955|FG008|Treatment|Study terminated by sponsor|6|||
164007991|NCT00401973|592394760|FG000|Overall Study|Lack of Efficacy|0|||
164356341|NCT05024058|593680956|FG009|Treatment|Study terminated by sponsor|6|||
164356342|NCT05024058|593680947|FG000|Follow-up|Withdrawal by Subject|1|||
164007992|NCT00401973|592394761|FG001|Overall Study|Lack of Efficacy|0|||
164007993|NCT00401973|592394762|FG002|Overall Study|Lack of Efficacy|3|||
164007994|NCT00401973|592394760|FG000|Overall Study|Lost to Follow-up|2|||
164356343|NCT05024058|593680948|FG001|Follow-up|Withdrawal by Subject|0|||
164356344|NCT05024058|593680949|FG002|Follow-up|Withdrawal by Subject|1|||
164356345|NCT05024058|593680950|FG003|Follow-up|Withdrawal by Subject|0|||
164356346|NCT05024058|593680951|FG004|Follow-up|Withdrawal by Subject|0|||
164356347|NCT05024058|593680952|FG005|Follow-up|Withdrawal by Subject|0|||
164356348|NCT05024058|593680953|FG006|Follow-up|Withdrawal by Subject|0|||
164356349|NCT05024058|593680954|FG007|Follow-up|Withdrawal by Subject|1|||
164356350|NCT05024058|593680955|FG008|Follow-up|Withdrawal by Subject|0|||
164356351|NCT05024058|593680956|FG009|Follow-up|Withdrawal by Subject|1|||
164356352|NCT02734810|593680958|FG000|Overall Study|Adverse Event|1|||
164356353|NCT02734810|593680959|FG001|Overall Study|Adverse Event|0|||
164356354|NCT02734810|593680958|FG000|Overall Study|Lack of Efficacy|1|||
164356355|NCT02734810|593680959|FG001|Overall Study|Lack of Efficacy|0|||
164356356|NCT02507505|593680963|FG000|Overall Study|Withdrawal by Subject|13|||
164356357|NCT02507505|593680964|FG001|Overall Study|Withdrawal by Subject|11|||
164356358|NCT02507505|593680963|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
164356359|NCT02507505|593680964|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
164356360|NCT02507505|593680963|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
164356361|NCT02507505|593680964|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
164356362|NCT02507505|593680963|FG000|Overall Study|Death before receipt of anesthesia|0|||
164356363|NCT02507505|593680964|FG001|Overall Study|Death before receipt of anesthesia|1|||
164356364|NCT00931762|593680965|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
164356365|NCT00931762|593680965|FG000|Overall Study|Administrative Problems|5|||
164356366|NCT00931762|593680965|FG000|Overall Study|Death|1|||
164356367|NCT00931762|593680965|FG000|Overall Study|Disease Progression|3|||
164356368|NCT00931762|593680965|FG000|Overall Study|Adverse Event (s)|11|||
164356369|NCT00931762|593680965|FG000|Overall Study|Subject withdrew consent|13|||
164356370|NCT03182829|593680966|FG000|Overall Study|Protocol Violation|12|||
164356371|NCT03182829|593680967|FG001|Overall Study|Protocol Violation|12|||
164356372|NCT03182829|593680966|FG000|Overall Study|Other|4|||
164356373|NCT03182829|593680967|FG001|Overall Study|Other|3|||
164356374|NCT03316131|593680968|FG000|Treatment Period 2|Protocol deviation|1|||
163900880|NCT03367156|592009563|FG001|Overall Study|Became ineligible|2|||
163900881|NCT03367156|592009562|FG000|Overall Study|Hospitalization|1|||
163900882|NCT03367156|592009563|FG001|Overall Study|Hospitalization|0|||
163900883|NCT03367156|592009562|FG000|Overall Study|Concerned about Treatment|11|||
163900884|NCT03367156|592009563|FG001|Overall Study|Concerned about Treatment|3|||
163900885|NCT03367156|592009562|FG000|Overall Study|Started new treatment|4|||
163900886|NCT03367156|592009563|FG001|Overall Study|Started new treatment|1|||
163900887|NCT03762850|592009564|FG000|Overall Study|Death|0|||
163900888|NCT03762850|592009565|FG001|Overall Study|Death|1|||
163900889|NCT03762850|592009564|FG000|Overall Study|Lost to Follow-up|0|||
163900890|NCT03762850|592009565|FG001|Overall Study|Lost to Follow-up|1|||
163900891|NCT03762850|592009564|FG000|Overall Study|Physician Decision|0|||
163900892|NCT03762850|592009565|FG001|Overall Study|Physician Decision|1|||
163900893|NCT03762850|592009564|FG000|Overall Study|Withdrawal by Subject|4|||
163900894|NCT03762850|592009565|FG001|Overall Study|Withdrawal by Subject|9|||
163900895|NCT00092534|592009568|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
164007995|NCT00401973|592394761|FG001|Overall Study|Lost to Follow-up|2|||
164007996|NCT00401973|592394762|FG002|Overall Study|Lost to Follow-up|2|||
163900896|NCT00092534|592009569|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
163900897|NCT00092534|592009570|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163900898|NCT00092534|592009571|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164007997|NCT00401973|592394760|FG000|Overall Study|Physician Decision|2|||
164007998|NCT00401973|592394761|FG001|Overall Study|Physician Decision|0|||
164007999|NCT00401973|592394762|FG002|Overall Study|Physician Decision|1|||
164008000|NCT00401973|592394760|FG000|Overall Study|Protocol Violation|1|||
164008001|NCT00401973|592394761|FG001|Overall Study|Protocol Violation|2|||
164008002|NCT00401973|592394762|FG002|Overall Study|Protocol Violation|3|||
164008003|NCT00401973|592394760|FG000|Overall Study|Sponsor Decision|0|||
164008004|NCT00401973|592394761|FG001|Overall Study|Sponsor Decision|1|||
164008005|NCT00401973|592394762|FG002|Overall Study|Sponsor Decision|0|||
164008006|NCT00401973|592394760|FG000|Overall Study|Withdrawal by Subject|4|||
164008007|NCT00401973|592394761|FG001|Overall Study|Withdrawal by Subject|12|||
164008008|NCT00401973|592394762|FG002|Overall Study|Withdrawal by Subject|9|||
164008009|NCT02584634|592394763|FG000|Overall Study|Adverse Event|3|||
164008010|NCT02584634|592394764|FG001|Overall Study|Adverse Event|5|||
164008011|NCT02584634|592394763|FG000|Overall Study|Death|0|||
164008012|NCT02584634|592394764|FG001|Overall Study|Death|1|||
164008013|NCT02584634|592394763|FG000|Overall Study|Lost to Follow-up|0|||
164008014|NCT02584634|592394764|FG001|Overall Study|Lost to Follow-up|1|||
164008015|NCT02584634|592394763|FG000|Overall Study|Physician Decision|1|||
164008016|NCT02584634|592394764|FG001|Overall Study|Physician Decision|2|||
164008017|NCT02584634|592394763|FG000|Overall Study|Progressive disease|7|||
164008018|NCT02584634|592394764|FG001|Overall Study|Progressive disease|15|||
164008019|NCT02584634|592394763|FG000|Overall Study|Withdrawal by Subject|1|||
164008020|NCT02584634|592394764|FG001|Overall Study|Withdrawal by Subject|1|||
164008021|NCT02584634|592394763|FG000|Overall Study|Other|0|||
164008022|NCT02584634|592394764|FG001|Overall Study|Other|6|||
164008023|NCT04075604|592394766|FG000|Overall Study|Adverse Event|0|||
164008024|NCT04075604|592394767|FG001|Overall Study|Adverse Event|0|||
164008025|NCT04075604|592394768|FG002|Overall Study|Adverse Event|3|||
164008026|NCT04075604|592394766|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164008027|NCT04075604|592394767|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164008028|NCT04075604|592394768|FG002|Overall Study|Participant request to discontinue study treatment|1|||
164008029|NCT04075604|592394766|FG000|Overall Study|Participant withdrew consent|0|||
164008030|NCT04075604|592394767|FG001|Overall Study|Participant withdrew consent|0|||
164008031|NCT04075604|592394768|FG002|Overall Study|Participant withdrew consent|1|||
164008032|NCT04075604|592394766|FG000|Overall Study|Other reasons|1|||
164008033|NCT04075604|592394767|FG001|Overall Study|Other reasons|0|||
164008034|NCT04075604|592394768|FG002|Overall Study|Other reasons|0|||
164008035|NCT04075604|592394766|FG000|Overall Study|Disease progression|0|||
164008036|NCT04075604|592394767|FG001|Overall Study|Disease progression|1|||
164008037|NCT04075604|592394768|FG002|Overall Study|Disease progression|0|||
164008038|NCT04075604|592394766|FG000|Overall Study|Study drug toxicity|0|||
164008039|NCT04075604|592394767|FG001|Overall Study|Study drug toxicity|5|||
164356375|NCT03316131|593680969|FG001|Treatment Period 2|Protocol deviation|0|||
164356376|NCT02664441|593680970|FG000|Randomization|Withdrawal by Subject|0|||
164356377|NCT02664441|593680971|FG001|Randomization|Withdrawal by Subject|1|||
164356378|NCT02664441|593680970|FG000|36-week Randomized Trial|Adverse Event|2|||
164356379|NCT02664441|593680971|FG001|36-week Randomized Trial|Adverse Event|0|||
164356380|NCT02664441|593680970|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
164356381|NCT02664441|593680971|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
164356382|NCT02664441|593680970|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
164356383|NCT02664441|593680971|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
164356384|NCT02664441|593680970|FG000|18-week Open Label Extension|Adverse Event|1|||
164356385|NCT02664441|593680971|FG001|18-week Open Label Extension|Adverse Event|0|||
164356386|NCT02664441|593680970|FG000|18-week Open Label Extension|Physician Decision|1|||
164356387|NCT02664441|593680971|FG001|18-week Open Label Extension|Physician Decision|0|||
164356388|NCT02664441|593680970|FG000|18-week Open Label Extension|Death|1|||
164356389|NCT02664441|593680971|FG001|18-week Open Label Extension|Death|0|||
164356390|NCT02664441|593680970|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
164356391|NCT02664441|593680971|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
164008040|NCT04075604|592394768|FG002|Overall Study|Study drug toxicity|1|||
164008041|NCT01050062|592394772|FG000|Overall Study|Adverse Event|75|||
164008042|NCT01050062|592394773|FG001|Overall Study|Adverse Event|22|||
164008043|NCT01050062|592394772|FG000|Overall Study|Lost to Follow-up|83|||
164356392|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
164356393|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
164356394|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
164356395|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
164008044|NCT01050062|592394773|FG001|Overall Study|Lost to Follow-up|35|||
164008045|NCT01050062|592394772|FG000|Overall Study|Lack of Efficacy|22|||
164008046|NCT01050062|592394773|FG001|Overall Study|Lack of Efficacy|35|||
164008047|NCT01050062|592394772|FG000|Overall Study|Physician Decision|74|||
164008048|NCT01050062|592394773|FG001|Overall Study|Physician Decision|9|||
164008049|NCT01050062|592394772|FG000|Overall Study|Others|17|||
164008050|NCT01050062|592394773|FG001|Overall Study|Others|11|||
164008051|NCT03894540|592394774|FG000|Overall Study|Adverse Event|0|||
164008052|NCT03894540|592394775|FG001|Overall Study|Adverse Event|0|||
164008053|NCT03894540|592394776|FG002|Overall Study|Adverse Event|0|||
164008054|NCT03894540|592394777|FG003|Overall Study|Adverse Event|0|||
164008055|NCT03894540|592394778|FG004|Overall Study|Adverse Event|1|||
164008056|NCT03894540|592394779|FG005|Overall Study|Adverse Event|0|||
164008057|NCT03894540|592394774|FG000|Overall Study|Withdrawal by Subject|0|||
164008058|NCT03894540|592394775|FG001|Overall Study|Withdrawal by Subject|0|||
164008059|NCT03894540|592394776|FG002|Overall Study|Withdrawal by Subject|0|||
164008060|NCT03894540|592394777|FG003|Overall Study|Withdrawal by Subject|0|||
164008061|NCT03894540|592394778|FG004|Overall Study|Withdrawal by Subject|1|||
164008062|NCT03894540|592394779|FG005|Overall Study|Withdrawal by Subject|0|||
164008063|NCT03894540|592394774|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
164008064|NCT03894540|592394775|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
164008065|NCT03894540|592394776|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
164008066|NCT03894540|592394777|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
164008067|NCT03894540|592394778|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
164008068|NCT03894540|592394779|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
164008069|NCT03894540|592394774|FG000|Overall Study|Progressive Disease Clinical|1|||
164008070|NCT03894540|592394775|FG001|Overall Study|Progressive Disease Clinical|1|||
164008071|NCT03894540|592394776|FG002|Overall Study|Progressive Disease Clinical|0|||
164008072|NCT03894540|592394777|FG003|Overall Study|Progressive Disease Clinical|1|||
164008073|NCT03894540|592394778|FG004|Overall Study|Progressive Disease Clinical|5|||
164008074|NCT03894540|592394779|FG005|Overall Study|Progressive Disease Clinical|1|||
164008075|NCT03894540|592394774|FG000|Overall Study|Study termination by sponsor|0|||
164008076|NCT03894540|592394775|FG001|Overall Study|Study termination by sponsor|0|||
164008077|NCT03894540|592394776|FG002|Overall Study|Study termination by sponsor|0|||
164008078|NCT03894540|592394777|FG003|Overall Study|Study termination by sponsor|0|||
164008079|NCT03894540|592394778|FG004|Overall Study|Study termination by sponsor|2|||
164008080|NCT03894540|592394779|FG005|Overall Study|Study termination by sponsor|0|||
164008081|NCT00852930|592394780|FG000|Overall Study|Withdrawal by Subject|1|||
164008082|NCT00852930|592394781|FG001|Overall Study|Withdrawal by Subject|1|||
164008083|NCT00852930|592394782|FG002|Overall Study|Withdrawal by Subject|1|||
164008084|NCT00852930|592394780|FG000|Overall Study|Physician Decision|0|||
164008085|NCT00852930|592394781|FG001|Overall Study|Physician Decision|0|||
164008086|NCT00852930|592394782|FG002|Overall Study|Physician Decision|1|||
164008087|NCT00537745|592394783|FG000|Overall Study|Did not meet eligibility criteria|2|||
164008088|NCT00537745|592394783|FG000|Overall Study|Withdrawal by Subject|2|||
164008089|NCT00537745|592394783|FG000|Overall Study|Subject unable to provide Interlock info|1|||
164008090|NCT03700892|592394785|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
164008091|NCT03700892|592394786|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
164008092|NCT03700892|592394787|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
164008093|NCT00650585|592394788|FG000|Overall Study|Lost to Follow-up|505|||
164008094|NCT00650585|592394789|FG001|Overall Study|Lost to Follow-up|482|||
164008095|NCT00650585|592394788|FG000|Overall Study|No parental consent|935|||
164008096|NCT00650585|592394789|FG001|Overall Study|No parental consent|866|||
164008097|NCT00650585|592394788|FG000|Overall Study|Excluded/ruled ineligible|357|||
164008098|NCT00650585|592394789|FG001|Overall Study|Excluded/ruled ineligible|129|||
164008099|NCT02532543|592394790|FG000|Overall Study|Lost to Follow-up|0|||
164008100|NCT02532543|592394791|FG001|Overall Study|Lost to Follow-up|0|||
164008101|NCT02532543|592394792|FG002|Overall Study|Lost to Follow-up|1|||
164008102|NCT02532543|592394793|FG003|Overall Study|Lost to Follow-up|0|||
164356396|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
164356397|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
164356398|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
164356399|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
164356400|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
164356401|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
164356402|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
164356403|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
164008103|NCT02640612|592394794|FG000|Overall Study|Adverse Event|6|||
164008104|NCT02640612|592394795|FG001|Overall Study|Adverse Event|7|||
164008105|NCT02640612|592394796|FG002|Overall Study|Adverse Event|2|||
164008106|NCT02640612|592394794|FG000|Overall Study|Death|1|||
164008107|NCT02640612|592394795|FG001|Overall Study|Death|0|||
164008108|NCT02640612|592394796|FG002|Overall Study|Death|0|||
164112583|NCT03686215|592774027|FG001|Overall Study|Device issue|0|||
164356404|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
164356405|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
164356406|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
164356407|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
164356408|NCT03510884|593680972|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
164356409|NCT03510884|593680973|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
164356410|NCT03510884|593680974|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
164356411|NCT03510884|593680975|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
164356412|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
164356413|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
164356414|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
164356415|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
164356416|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
164356417|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
164356418|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
164356419|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
164356420|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
164356421|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
164356422|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
164356423|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
164356424|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
164356425|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
164356426|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
164356427|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
164356428|NCT03510884|593680972|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
164356429|NCT03510884|593680973|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
164356430|NCT03510884|593680974|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
164356431|NCT03510884|593680975|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
164356432|NCT05608005|593680976|FG000|Overall Study|Adverse Event|2|||
164356433|NCT05608005|593680977|FG001|Overall Study|Adverse Event|1|||
164356434|NCT05608005|593680978|FG002|Overall Study|Adverse Event|3|||
164356435|NCT05608005|593680976|FG000|Overall Study|Protocol Violation|2|||
164356436|NCT05608005|593680977|FG001|Overall Study|Protocol Violation|3|||
164356437|NCT05608005|593680978|FG002|Overall Study|Protocol Violation|0|||
164356438|NCT05608005|593680976|FG000|Overall Study|Withdrawal by Subject|10|||
164356439|NCT05608005|593680977|FG001|Overall Study|Withdrawal by Subject|12|||
164356440|NCT05608005|593680978|FG002|Overall Study|Withdrawal by Subject|4|||
164356441|NCT05608005|593680976|FG000|Overall Study|Lost to Follow-up|25|||
164008109|NCT02640612|592394794|FG000|Overall Study|Withdrawal by Subject|10|||
164008110|NCT02640612|592394795|FG001|Overall Study|Withdrawal by Subject|3|||
164008111|NCT02640612|592394796|FG002|Overall Study|Withdrawal by Subject|3|||
164091126|NCT02270736|592697817|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
164091127|NCT02270736|592697818|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164091128|NCT02270736|592697819|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
164091129|NCT02270736|592697815|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164091130|NCT02270736|592697816|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164091131|NCT02270736|592697817|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164091132|NCT02270736|592697818|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
164091133|NCT02270736|592697819|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
164091134|NCT02270736|592697815|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164008112|NCT02640612|592394794|FG000|Overall Study|Lost to Follow-up|4|||
164008113|NCT02640612|592394795|FG001|Overall Study|Lost to Follow-up|1|||
164091135|NCT02270736|592697816|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164091136|NCT02270736|592697817|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164008114|NCT02640612|592394796|FG002|Overall Study|Lost to Follow-up|1|||
164008115|NCT02640612|592394794|FG000|Overall Study|Protocol Violation|0|||
164008116|NCT02640612|592394795|FG001|Overall Study|Protocol Violation|2|||
164008117|NCT02640612|592394796|FG002|Overall Study|Protocol Violation|0|||
164008118|NCT02640612|592394794|FG000|Overall Study|Lack of Efficacy|1|||
164008119|NCT02640612|592394795|FG001|Overall Study|Lack of Efficacy|1|||
164008120|NCT02640612|592394796|FG002|Overall Study|Lack of Efficacy|0|||
164008121|NCT00849212|592394797|FG000|Overall Study|Lack of Efficacy|1|||
164008122|NCT00849212|592394797|FG000|Overall Study|Withdrawal by Subject|3|||
164008123|NCT00849212|592394797|FG000|Overall Study|Adverse Event|2|||
164008124|NCT00849212|592394797|FG000|Overall Study|Miscellaneous|1|||
164008125|NCT03472534|592394806|FG000|Overall Study|Withdrawal by Subject|9|||
164008126|NCT03472534|592394806|FG000|Overall Study|Adverse Event|2|||
164008127|NCT02614794|592394807|FG000|Overall Study|Death|258|||
164091137|NCT02270736|592697818|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
164091138|NCT02270736|592697819|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
164091139|NCT02270736|592697815|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164091140|NCT02270736|592697816|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164091141|NCT02270736|592697817|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164091142|NCT02270736|592697818|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
164091143|NCT02270736|592697819|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
164091144|NCT02270736|592697815|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164091145|NCT02270736|592697816|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164091146|NCT02270736|592697817|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164091147|NCT02270736|592697818|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
164091148|NCT02270736|592697819|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
164091149|NCT02270736|592697815|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164356442|NCT05608005|593680977|FG001|Overall Study|Lost to Follow-up|27|||
164356443|NCT05608005|593680978|FG002|Overall Study|Lost to Follow-up|15|||
164356444|NCT05608005|593680976|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
164008128|NCT02614794|592394808|FG001|Overall Study|Death|151|||
164008129|NCT02614794|592394807|FG000|Overall Study|Study closure by Sponsor|119|||
164008130|NCT02614794|592394808|FG001|Overall Study|Study closure by Sponsor|45|||
164008131|NCT02614794|592394807|FG000|Overall Study|Withdrawal by Subject|24|||
164008132|NCT02614794|592394808|FG001|Overall Study|Withdrawal by Subject|5|||
164008133|NCT02614794|592394807|FG000|Overall Study|Lost to Follow-up|7|||
164008134|NCT02614794|592394808|FG001|Overall Study|Lost to Follow-up|0|||
164356445|NCT05608005|593680977|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
164356446|NCT05608005|593680978|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
164356447|NCT00157950|593680979|FG000|Overall Study|Death|1|||
164356448|NCT00157950|593680980|FG001|Overall Study|Death|0|||
164356449|NCT01287897|593680984|FG000|Overall Study|Adverse Event|5|||
164356450|NCT01287897|593680985|FG001|Overall Study|Adverse Event|3|||
164356451|NCT01287897|593680986|FG002|Overall Study|Adverse Event|6|||
164356452|NCT01287897|593680987|FG003|Overall Study|Adverse Event|4|||
164356453|NCT01287897|593680984|FG000|Overall Study|Lack of Efficacy|2|||
164356454|NCT01287897|593680985|FG001|Overall Study|Lack of Efficacy|0|||
164356455|NCT01287897|593680986|FG002|Overall Study|Lack of Efficacy|0|||
164356456|NCT01287897|593680987|FG003|Overall Study|Lack of Efficacy|0|||
164356457|NCT01287897|593680984|FG000|Overall Study|Protocol Violation|1|||
164356458|NCT01287897|593680985|FG001|Overall Study|Protocol Violation|1|||
164356459|NCT01287897|593680986|FG002|Overall Study|Protocol Violation|0|||
164356460|NCT01287897|593680987|FG003|Overall Study|Protocol Violation|1|||
164356461|NCT01287897|593680984|FG000|Overall Study|Lost to Follow-up|0|||
164356462|NCT01287897|593680985|FG001|Overall Study|Lost to Follow-up|0|||
164356463|NCT01287897|593680986|FG002|Overall Study|Lost to Follow-up|2|||
164356464|NCT01287897|593680987|FG003|Overall Study|Lost to Follow-up|0|||
164356465|NCT01287897|593680984|FG000|Overall Study|Withdrawal by Subject|1|||
164356466|NCT01287897|593680985|FG001|Overall Study|Withdrawal by Subject|5|||
164356467|NCT01287897|593680986|FG002|Overall Study|Withdrawal by Subject|3|||
164356468|NCT01287897|593680987|FG003|Overall Study|Withdrawal by Subject|2|||
164356469|NCT01287897|593680984|FG000|Overall Study|Not consented properly|0|||
164356470|NCT01287897|593680985|FG001|Overall Study|Not consented properly|1|||
164356471|NCT01287897|593680986|FG002|Overall Study|Not consented properly|0|||
164356472|NCT01287897|593680987|FG003|Overall Study|Not consented properly|0|||
164356473|NCT01287897|593680984|FG000|Overall Study|Not meeting entrance criteria|1|||
164356474|NCT01287897|593680985|FG001|Overall Study|Not meeting entrance criteria|1|||
164356475|NCT01287897|593680986|FG002|Overall Study|Not meeting entrance criteria|0|||
164356476|NCT01287897|593680987|FG003|Overall Study|Not meeting entrance criteria|0|||
164356477|NCT01287897|593680984|FG000|Overall Study|Other|1|||
164356478|NCT01287897|593680985|FG001|Overall Study|Other|0|||
164356479|NCT01287897|593680986|FG002|Overall Study|Other|1|||
164356480|NCT01287897|593680987|FG003|Overall Study|Other|0|||
164356481|NCT02892760|593680988|FG000|Overall Study|Withdrawal by Subject|3|||
164356482|NCT00386776|593680989|FG000|Overall Study|Withdrawal by Subject|8|||
164356483|NCT01500629|593680994|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
164356484|NCT01500629|593680995|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
164356485|NCT02902965|593680996|FG000|Overall Study|Withdrawal by Subject|10|||
164356486|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
164356487|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
164356488|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
164356489|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
164356490|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
164356491|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
164356492|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
164356493|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
164356494|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
164356495|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
164356496|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
164356497|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
164356498|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
164356499|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
164356500|NCT00293254|593680997|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
164356501|NCT00293254|593680998|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
164356502|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
164008135|NCT02614794|592394807|FG000|Overall Study|Physician Decision|1|||
164008136|NCT02614794|592394808|FG001|Overall Study|Physician Decision|1|||
164008137|NCT02614794|592394807|FG000|Overall Study|Hospital closure|1|||
164356503|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
164356504|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Death|4|||
164008138|NCT02614794|592394808|FG001|Overall Study|Hospital closure|0|||
164008139|NCT02117050|592394811|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
164356505|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Death|1|||
164356506|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
164356507|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
164356508|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
164356509|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
164008140|NCT01591330|592394812|FG000|Period 1|Adverse Event|1|||
164008141|NCT01591330|592394813|FG001|Period 1|Adverse Event|0|||
164356510|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
164356511|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
164356512|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
164356513|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
164356514|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
164356515|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
164356516|NCT00293254|593680997|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
164356517|NCT00293254|593680998|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
164356518|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
164356519|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
164356520|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
164356521|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
164356522|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
164356523|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
164356524|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
163900899|NCT00092534|592009572|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
163900900|NCT00092534|592009568|FG000|Base Study Vaccination Period|Adverse Event|3|||
163900901|NCT00092534|592009569|FG001|Base Study Vaccination Period|Adverse Event|1|||
163900902|NCT00092534|592009570|FG002|Base Study Vaccination Period|Adverse Event|0|||
164356525|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
164356526|NCT00293254|593680997|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
164356527|NCT00293254|593680998|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
164356528|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
164356529|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
164356530|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
164356531|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
164356532|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
164356533|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
164356534|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
164356535|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
164356536|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
164356537|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
164356538|NCT00293254|593680997|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
164356539|NCT00293254|593680998|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
164356540|NCT02259582|593680999|FG000|Overall Study|Physician Decision|0|||
164356541|NCT02259582|593681000|FG001|Overall Study|Physician Decision|1|||
164356542|NCT02259582|593681001|FG002|Overall Study|Physician Decision|0|||
164356543|NCT02259582|593680999|FG000|Overall Study|Death|0|||
164356544|NCT02259582|593681000|FG001|Overall Study|Death|0|||
164356545|NCT02259582|593681001|FG002|Overall Study|Death|1|||
164356546|NCT02259582|593680999|FG000|Overall Study|Adverse Event|1|||
164356547|NCT02259582|593681000|FG001|Overall Study|Adverse Event|0|||
164356548|NCT02259582|593681001|FG002|Overall Study|Adverse Event|1|||
164356549|NCT02259582|593680999|FG000|Overall Study|Withdrawal by Subject|0|||
164356550|NCT02259582|593681000|FG001|Overall Study|Withdrawal by Subject|0|||
164356551|NCT02259582|593681001|FG002|Overall Study|Withdrawal by Subject|1|||
164356552|NCT02259582|593680999|FG000|Overall Study|Disease progression|14|||
164356553|NCT02259582|593681000|FG001|Overall Study|Disease progression|15|||
164356554|NCT02259582|593681001|FG002|Overall Study|Disease progression|17|||
164356555|NCT02259582|593680999|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
164356556|NCT02259582|593681000|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
164356557|NCT02259582|593681001|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
164356558|NCT02335489|593681002|FG000|Overall Study|Sponsor terminated study|4|||
164356559|NCT02335489|593681002|FG000|Overall Study|Lost to Follow-up|1|||
164356560|NCT02335489|593681002|FG000|Overall Study|Withdrawal by Subject|2|||
164356561|NCT02335489|593681002|FG000|Overall Study|Physician Decision|2|||
164356562|NCT02335489|593681002|FG000|Overall Study|Lack of Efficacy|1|||
164356563|NCT00759863|593681005|FG000|Overall Study|Death, moved, or lost contact|20|||
164356564|NCT00759863|593681006|FG001|Overall Study|Death, moved, or lost contact|18|||
164356565|NCT00503308|593681010|FG000|Overall Study|Protocol Violation|2|||
164356566|NCT00503308|593681011|FG001|Overall Study|Protocol Violation|1|||
164356567|NCT00531050|593681013|FG000|Part 1: Period 1|Adverse Event|0|||
164356568|NCT00531050|593681014|FG001|Part 1: Period 1|Adverse Event|1|||
164356569|NCT00531050|593681015|FG002|Part 1: Period 1|Adverse Event|0|||
164356570|NCT00531050|593681016|FG003|Part 1: Period 1|Adverse Event|0|||
164356571|NCT00531050|593681017|FG004|Part 1: Period 1|Adverse Event|0|||
164356572|NCT00531050|593681018|FG005|Part 1: Period 1|Adverse Event|0|||
164356573|NCT00531050|593681013|FG000|Part 1: Period 1|Protocol Deviation|0|||
164356574|NCT00531050|593681014|FG001|Part 1: Period 1|Protocol Deviation|0|||
164356575|NCT00531050|593681015|FG002|Part 1: Period 1|Protocol Deviation|0|||
164356576|NCT00531050|593681016|FG003|Part 1: Period 1|Protocol Deviation|1|||
164008142|NCT01591330|592394814|FG002|Period 1|Adverse Event|0|||
164008143|NCT01591330|592394815|FG003|Period 1|Adverse Event|0|||
164008144|NCT01591330|592394812|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
164008145|NCT01591330|592394813|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
164008146|NCT01591330|592394814|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
164008147|NCT01591330|592394815|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
164008148|NCT01591330|592394812|FG000|Period 2|Adverse Event|1|||
164356577|NCT00531050|593681017|FG004|Part 1: Period 1|Protocol Deviation|0|||
164356578|NCT00531050|593681018|FG005|Part 1: Period 1|Protocol Deviation|0|||
164356579|NCT00531050|593681013|FG000|Part 1: Period 3|Adverse Event|1|||
164356580|NCT00531050|593681014|FG001|Part 1: Period 3|Adverse Event|0|||
164356581|NCT00531050|593681015|FG002|Part 1: Period 3|Adverse Event|0|||
164356582|NCT00531050|593681016|FG003|Part 1: Period 3|Adverse Event|0|||
164356583|NCT00531050|593681017|FG004|Part 1: Period 3|Adverse Event|0|||
164356584|NCT00531050|593681018|FG005|Part 1: Period 3|Adverse Event|0|||
164356585|NCT00531050|593681013|FG000|Part 2: Period 1|Adverse Event|0|||
164356586|NCT00531050|593681014|FG001|Part 2: Period 1|Adverse Event|0|||
164356587|NCT00531050|593681015|FG002|Part 2: Period 1|Adverse Event|0|||
164356588|NCT00531050|593681016|FG003|Part 2: Period 1|Adverse Event|0|||
164356589|NCT00531050|593681017|FG004|Part 2: Period 1|Adverse Event|0|||
164356590|NCT00531050|593681018|FG005|Part 2: Period 1|Adverse Event|1|||
164356591|NCT00531050|593681013|FG000|Part 2: Period 3|Abnormal test procedure|1|||
164356592|NCT00531050|593681014|FG001|Part 2: Period 3|Abnormal test procedure|0|||
164356593|NCT00531050|593681015|FG002|Part 2: Period 3|Abnormal test procedure|0|||
164356594|NCT00531050|593681016|FG003|Part 2: Period 3|Abnormal test procedure|0|||
164356595|NCT00531050|593681017|FG004|Part 2: Period 3|Abnormal test procedure|0|||
164356596|NCT00531050|593681018|FG005|Part 2: Period 3|Abnormal test procedure|1|||
164356597|NCT03263442|593681019|FG000|Inpatient Phase|Death|1|||
164356598|NCT03263442|593681020|FG001|Inpatient Phase|Death|0|||
164356599|NCT03263442|593681019|FG000|Inpatient Phase|Withdrawal by Subject|1|||
164356600|NCT03263442|593681020|FG001|Inpatient Phase|Withdrawal by Subject|0|||
164356601|NCT03263442|593681019|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
164356602|NCT03263442|593681020|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
164356603|NCT03263442|593681019|FG000|1-month Follow-Up|Lost to Follow-up|1|||
164356604|NCT03263442|593681020|FG001|1-month Follow-Up|Lost to Follow-up|0|||
164356605|NCT03263442|593681019|FG000|3-month Follow-Up|Lost to Follow-up|1|||
164356606|NCT03263442|593681020|FG001|3-month Follow-Up|Lost to Follow-up|3|||
164356607|NCT03263442|593681019|FG000|6-month Follow-Up|Lost to Follow-up|2|||
164356608|NCT03263442|593681020|FG001|6-month Follow-Up|Lost to Follow-up|2|||
164356609|NCT01594125|593681021|FG000|Overall Study|Withdrawal by Subject|1|||
164356610|NCT01594125|593681022|FG001|Overall Study|Withdrawal by Subject|0|||
164356611|NCT01594125|593681023|FG002|Overall Study|Withdrawal by Subject|0|||
164356612|NCT01594125|593681024|FG003|Overall Study|Withdrawal by Subject|1|||
164356613|NCT01594125|593681025|FG004|Overall Study|Withdrawal by Subject|0|||
164356614|NCT01594125|593681021|FG000|Overall Study|Progressive Disease|3|||
164356615|NCT01594125|593681022|FG001|Overall Study|Progressive Disease|12|||
164356616|NCT01594125|593681023|FG002|Overall Study|Progressive Disease|3|||
164356617|NCT01594125|593681024|FG003|Overall Study|Progressive Disease|3|||
164356618|NCT01594125|593681025|FG004|Overall Study|Progressive Disease|7|||
164356619|NCT00708643|593681026|FG000|Overall Study|Adverse Event|0|||
164356620|NCT00708643|593681027|FG001|Overall Study|Adverse Event|1|||
164356621|NCT03635957|593681030|FG000|Run-In Period|Lost to Follow-up|1|||
164356622|NCT03635957|593681030|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
164356623|NCT01710033|593681031|FG000|Stage 2|Adverse Event|0|||
164356624|NCT01710033|593681032|FG001|Stage 2|Adverse Event|0|||
164356625|NCT01710033|593681033|FG002|Stage 2|Adverse Event|0|||
164008149|NCT01591330|592394813|FG001|Period 2|Adverse Event|0|||
164008150|NCT01591330|592394814|FG002|Period 2|Adverse Event|0|||
164008151|NCT01591330|592394815|FG003|Period 2|Adverse Event|0|||
164008152|NCT01662999|592394816|FG000|Period 3|Withdrawal by Subject|0|||
164356626|NCT01710033|593681034|FG003|Stage 2|Adverse Event|0|||
164356627|NCT01710033|593681035|FG004|Stage 2|Adverse Event|1|||
164356628|NCT01525550|593681037|FG000|Overall Study|Lost to Follow-up|8|||
164356629|NCT01525550|593681038|FG001|Overall Study|Lost to Follow-up|2|||
164356630|NCT01525550|593681037|FG000|Overall Study|Death|19|||
164356631|NCT01525550|593681038|FG001|Overall Study|Death|28|||
164356632|NCT01525550|593681037|FG000|Overall Study|Other|0|||
164356633|NCT01525550|593681038|FG001|Overall Study|Other|4|||
164356634|NCT01525550|593681037|FG000|Overall Study|Sponsor's Decision|30|||
164356635|NCT01525550|593681038|FG001|Overall Study|Sponsor's Decision|11|||
164008153|NCT01662999|592394817|FG001|Period 3|Withdrawal by Subject|1|||
164356636|NCT01525550|593681037|FG000|Overall Study|Withdrawal by Subject|4|||
164356637|NCT01525550|593681038|FG001|Overall Study|Withdrawal by Subject|0|||
164356638|NCT00460031|593681041|FG000|Overall Study|Adverse Event|5|||
164356639|NCT00460031|593681041|FG000|Overall Study|Withdrawal by Subject|5|||
164008154|NCT01662999|592394818|FG002|Period 3|Withdrawal by Subject|0|||
164356640|NCT00460031|593681041|FG000|Overall Study|Death|1|||
164356641|NCT03045887|593681050|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
164356642|NCT03045887|593681051|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356643|NCT03045887|593681052|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356644|NCT03045887|593681053|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356645|NCT03045887|593681054|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164008155|NCT01662999|592394819|FG003|Period 3|Withdrawal by Subject|0|||
164008156|NCT01662999|592394820|FG004|Period 3|Withdrawal by Subject|0|||
164008157|NCT01662999|592394821|FG005|Period 3|Withdrawal by Subject|0|||
164008158|NCT00196937|592394822|FG000|Overall Study|Serious Adverse Event|1|||
164008159|NCT00196937|592394823|FG001|Overall Study|Serious Adverse Event|0|||
164008160|NCT00196937|592394824|FG002|Overall Study|Serious Adverse Event|0|||
164008161|NCT00196937|592394822|FG000|Overall Study|Non-serious adverse event|1|||
164008162|NCT00196937|592394823|FG001|Overall Study|Non-serious adverse event|1|||
164008163|NCT00196937|592394824|FG002|Overall Study|Non-serious adverse event|1|||
164008164|NCT00196937|592394822|FG000|Overall Study|Withdrawal by Subject|0|||
164008165|NCT00196937|592394823|FG001|Overall Study|Withdrawal by Subject|0|||
164008166|NCT00196937|592394824|FG002|Overall Study|Withdrawal by Subject|2|||
164008167|NCT00196937|592394822|FG000|Overall Study|Lost to Follow-up|4|||
164008168|NCT00196937|592394823|FG001|Overall Study|Lost to Follow-up|3|||
164008169|NCT00196937|592394824|FG002|Overall Study|Lost to Follow-up|3|||
164008170|NCT00196937|592394822|FG000|Overall Study|Other|3|||
164008171|NCT00196937|592394823|FG001|Overall Study|Other|1|||
164008172|NCT00196937|592394824|FG002|Overall Study|Other|1|||
164008173|NCT03368404|592394827|FG000|Overall Study|Adverse Event|2|||
164008174|NCT03368404|592394828|FG001|Overall Study|Adverse Event|1|||
164008175|NCT03368404|592394827|FG000|Overall Study|Withdrawal by Subject|1|||
164008176|NCT03368404|592394828|FG001|Overall Study|Withdrawal by Subject|1|||
164008177|NCT04725682|592394829|FG000|Overall Study|Withdrawal by Subject|7|||
164008178|NCT04725682|592394830|FG001|Overall Study|Withdrawal by Subject|5|||
164008179|NCT04725682|592394829|FG000|Overall Study|Failed to comply with the requirements|2|||
164008180|NCT04725682|592394830|FG001|Overall Study|Failed to comply with the requirements|1|||
164008181|NCT04725682|592394829|FG000|Overall Study|Adverse Event|1|||
164008182|NCT04725682|592394830|FG001|Overall Study|Adverse Event|1|||
164008183|NCT04725682|592394829|FG000|Overall Study|Death|0|||
164008184|NCT04725682|592394830|FG001|Overall Study|Death|1|||
164008185|NCT00964795|592394831|FG000|Overall Study|Withdrawal by Subject|79|||
164008186|NCT00964795|592394831|FG000|Overall Study|Adverse Event|12|||
164008187|NCT00964795|592394831|FG000|Overall Study|Death|14|||
164008188|NCT00964795|592394831|FG000|Overall Study|Lost to Follow-up|7|||
164091150|NCT02270736|592697816|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164091151|NCT02270736|592697817|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164356646|NCT03045887|593681055|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356647|NCT03045887|593681056|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356648|NCT03045887|593681057|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356649|NCT03045887|593681058|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356650|NCT03045887|593681059|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
164356651|NCT03045887|593681050|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356652|NCT03045887|593681051|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356653|NCT03045887|593681052|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356654|NCT03045887|593681053|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
164356655|NCT03045887|593681054|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356656|NCT03045887|593681055|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356657|NCT03045887|593681056|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356658|NCT03045887|593681057|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356659|NCT03045887|593681058|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356660|NCT03045887|593681059|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
164356661|NCT03045887|593681050|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
164356662|NCT03045887|593681051|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356663|NCT03045887|593681052|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356664|NCT03045887|593681053|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
164091152|NCT02270736|592697818|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
164091153|NCT02270736|592697819|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
164356665|NCT03045887|593681054|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356666|NCT03045887|593681055|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
164091154|NCT00262600|592697820|FG000|Overall Study|Lost to Follow-up|17|||
164356667|NCT03045887|593681056|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
164008189|NCT00964795|592394831|FG000|Overall Study|Termination of Study by Sponsor|169|||
164008190|NCT00964795|592394831|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
164008191|NCT00964795|592394831|FG000|Overall Study|Other|23|||
164008192|NCT02973815|592394832|FG000|Post Intervention|Death|1|||
164008193|NCT02973815|592394833|FG001|Post Intervention|Death|0|||
164008194|NCT02973815|592394832|FG000|Post Intervention|Lost to Follow-up|7|||
164356668|NCT03045887|593681057|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356669|NCT03045887|593681058|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356670|NCT03045887|593681059|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
164356671|NCT03045887|593681050|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356672|NCT03045887|593681051|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356673|NCT03045887|593681052|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
164356674|NCT03045887|593681053|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
164356675|NCT03045887|593681054|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356676|NCT03045887|593681055|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356677|NCT03045887|593681056|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356678|NCT03045887|593681057|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356679|NCT03045887|593681058|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356680|NCT03045887|593681059|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
164356681|NCT03045887|593681050|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356682|NCT03045887|593681051|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356683|NCT03045887|593681052|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356684|NCT03045887|593681053|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
164356685|NCT03045887|593681054|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356686|NCT03045887|593681055|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356687|NCT03045887|593681056|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164008195|NCT02973815|592394833|FG001|Post Intervention|Lost to Follow-up|24|||
164008196|NCT02973815|592394832|FG000|Follow-up|Lost to Follow-up|2|||
164008197|NCT02973815|592394833|FG001|Follow-up|Lost to Follow-up|0|||
164008198|NCT03734666|592394834|FG000|Overall Study|Other|7|||
164008199|NCT03734666|592394835|FG001|Overall Study|Other|4|||
164008200|NCT03734666|592394834|FG000|Overall Study|Lost to Follow-up|12|||
164008201|NCT03734666|592394835|FG001|Overall Study|Lost to Follow-up|12|||
164008202|NCT05866185|592394836|FG000|Overall Study|Lost to Follow-up|2|||
164008203|NCT05866185|592394837|FG001|Overall Study|Lost to Follow-up|4|||
164008204|NCT05866185|592394838|FG002|Overall Study|Lost to Follow-up|4|||
164008205|NCT05866185|592394839|FG003|Overall Study|Lost to Follow-up|6|||
164008206|NCT01607892|592394842|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
164008207|NCT01607892|592394843|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
164008208|NCT01607892|592394844|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
164008209|NCT01607892|592394845|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
164008210|NCT01607892|592394846|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
164008211|NCT01607892|592394842|FG000|Overall Study|Death|4|||
164008212|NCT01607892|592394843|FG001|Overall Study|Death|2|||
164008213|NCT01607892|592394844|FG002|Overall Study|Death|8|||
164008214|NCT01607892|592394845|FG003|Overall Study|Death|10|||
164008215|NCT01607892|592394846|FG004|Overall Study|Death|3|||
164008216|NCT01607892|592394842|FG000|Overall Study|Investigator discretion|2|||
164008217|NCT01607892|592394843|FG001|Overall Study|Investigator discretion|4|||
164008218|NCT01607892|592394844|FG002|Overall Study|Investigator discretion|4|||
164008219|NCT01607892|592394845|FG003|Overall Study|Investigator discretion|8|||
164008220|NCT01607892|592394846|FG004|Overall Study|Investigator discretion|0|||
164008221|NCT01607892|592394842|FG000|Overall Study|Other treatments became available|1|||
164008222|NCT01607892|592394843|FG001|Overall Study|Other treatments became available|1|||
164008223|NCT01607892|592394844|FG002|Overall Study|Other treatments became available|0|||
164008224|NCT01607892|592394845|FG003|Overall Study|Other treatments became available|0|||
164008225|NCT01607892|592394846|FG004|Overall Study|Other treatments became available|2|||
164008226|NCT01607892|592394842|FG000|Overall Study|Intercurrent illness|1|||
164008227|NCT01607892|592394843|FG001|Overall Study|Intercurrent illness|0|||
164008228|NCT01607892|592394844|FG002|Overall Study|Intercurrent illness|0|||
164008229|NCT01607892|592394845|FG003|Overall Study|Intercurrent illness|3|||
164008230|NCT01607892|592394846|FG004|Overall Study|Intercurrent illness|0|||
164356688|NCT03045887|593681057|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356689|NCT03045887|593681058|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356690|NCT03045887|593681059|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164356691|NCT03414424|593681060|FG000|Overall Study|Screened out after consent|0|||
164356692|NCT03414424|593681061|FG001|Overall Study|Screened out after consent|2|||
164356693|NCT03414424|593681060|FG000|Overall Study|Lost to Follow-up|0|||
164356694|NCT03414424|593681061|FG001|Overall Study|Lost to Follow-up|1|||
164008231|NCT01607892|592394842|FG000|Overall Study|Non-Compliance with study procedures|0|||
164008232|NCT01607892|592394843|FG001|Overall Study|Non-Compliance with study procedures|0|||
164008233|NCT01607892|592394844|FG002|Overall Study|Non-Compliance with study procedures|1|||
164091155|NCT00262600|592697821|FG001|Overall Study|Lost to Follow-up|31|||
164008234|NCT01607892|592394845|FG003|Overall Study|Non-Compliance with study procedures|0|||
164008235|NCT01607892|592394846|FG004|Overall Study|Non-Compliance with study procedures|0|||
164008236|NCT01607892|592394842|FG000|Overall Study|Consent withdrawn by participant|9|||
164356695|NCT01846507|593681062|FG000|Overall Study|Lost to Follow-up|4|||
164356696|NCT01846507|593681062|FG000|Overall Study|Protocol Violation|1|||
164356697|NCT01846507|593681062|FG000|Overall Study|Missing data|2|||
164356698|NCT01314443|593681063|FG000|Overall Study|Withdrawal by Subject|2|||
164356699|NCT01314443|593681064|FG001|Overall Study|Withdrawal by Subject|1|||
164008237|NCT01607892|592394843|FG001|Overall Study|Consent withdrawn by participant|4|||
164008238|NCT01607892|592394844|FG002|Overall Study|Consent withdrawn by participant|24|||
164008239|NCT01607892|592394845|FG003|Overall Study|Consent withdrawn by participant|14|||
164008240|NCT01607892|592394846|FG004|Overall Study|Consent withdrawn by participant|4|||
164008241|NCT01607892|592394842|FG000|Overall Study|Disease progression|38|||
164008242|NCT01607892|592394843|FG001|Overall Study|Disease progression|13|||
164008243|NCT01607892|592394844|FG002|Overall Study|Disease progression|37|||
164008244|NCT01607892|592394845|FG003|Overall Study|Disease progression|57|||
164008245|NCT01607892|592394846|FG004|Overall Study|Disease progression|9|||
164008246|NCT01607892|592394842|FG000|Overall Study|Incidence or severity of Adverse events|3|||
164008247|NCT01607892|592394843|FG001|Overall Study|Incidence or severity of Adverse events|3|||
164008248|NCT01607892|592394844|FG002|Overall Study|Incidence or severity of Adverse events|7|||
164008249|NCT01607892|592394845|FG003|Overall Study|Incidence or severity of Adverse events|2|||
164008250|NCT01607892|592394846|FG004|Overall Study|Incidence or severity of Adverse events|6|||
164008251|NCT03022422|592394849|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
164008252|NCT03022422|592394850|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
164008253|NCT03022422|592394851|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
164008254|NCT03022422|592394852|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
164008255|NCT03022422|592394853|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
164008256|NCT03022422|592394854|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
164008257|NCT02104180|592394855|FG000|Overall Study|Protocol Violation|1|||
164008258|NCT02104180|592394856|FG001|Overall Study|Protocol Violation|0|||
164008259|NCT03246529|592394857|FG000|Core Study (until 100 d post-transplant)|Adverse Event|0|||
164008260|NCT03246529|592394858|FG001|Core Study (until 100 d post-transplant)|Adverse Event|2|||
164008261|NCT03246529|592394859|FG002|Core Study (until 100 d post-transplant)|Adverse Event|0|||
164008262|NCT03246529|592394857|FG000|Core Study (until 100 d post-transplant)|Lost to Follow-up|0|||
164008263|NCT03246529|592394858|FG001|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
164008264|NCT03246529|592394859|FG002|Core Study (until 100 d post-transplant)|Lost to Follow-up|1|||
164008265|NCT03246529|592394857|FG000|Core Study (until 100 d post-transplant)|Other Reasons|0|||
164008266|NCT03246529|592394858|FG001|Core Study (until 100 d post-transplant)|Other Reasons|2|||
164008267|NCT03246529|592394859|FG002|Core Study (until 100 d post-transplant)|Other Reasons|2|||
164008268|NCT03246529|592394857|FG000|Core Study (until 100 d post-transplant)|Physician Decision|0|||
164008269|NCT03246529|592394858|FG001|Core Study (until 100 d post-transplant)|Physician Decision|0|||
164008270|NCT03246529|592394859|FG002|Core Study (until 100 d post-transplant)|Physician Decision|1|||
164008271|NCT03246529|592394857|FG000|Core Study (until 100 d post-transplant)|Withdrawal by Subject|0|||
164008272|NCT03246529|592394858|FG001|Core Study (until 100 d post-transplant)|Withdrawal by Subject|1|||
164008273|NCT03246529|592394859|FG002|Core Study (until 100 d post-transplant)|Withdrawal by Subject|4|||
164008274|NCT03246529|592394857|FG000|Follow-up period at 1 year FU Completion|Disease progression|2|||
164008275|NCT03246529|592394858|FG001|Follow-up period at 1 year FU Completion|Disease progression|1|||
164008276|NCT03246529|592394859|FG002|Follow-up period at 1 year FU Completion|Disease progression|1|||
164008277|NCT03246529|592394857|FG000|Follow-up period at 1 year FU Completion|Lost to Follow-up|1|||
164008278|NCT03246529|592394858|FG001|Follow-up period at 1 year FU Completion|Lost to Follow-up|3|||
164008279|NCT03246529|592394859|FG002|Follow-up period at 1 year FU Completion|Lost to Follow-up|0|||
164008280|NCT03246529|592394857|FG000|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
164008281|NCT03246529|592394858|FG001|Follow-up period at 1 year FU Completion|Withdrawal by Subject|3|||
164008282|NCT03246529|592394859|FG002|Follow-up period at 1 year FU Completion|Withdrawal by Subject|0|||
164008283|NCT03246529|592394857|FG000|Follow-up period at 1 year FU Completion|Death|0|||
164008284|NCT03246529|592394858|FG001|Follow-up period at 1 year FU Completion|Death|0|||
164008285|NCT03246529|592394859|FG002|Follow-up period at 1 year FU Completion|Death|1|||
164008286|NCT01676116|592394860|FG000|Overall Study|Withdrawal criteria|2|||
164008287|NCT01676116|592394861|FG001|Overall Study|Withdrawal criteria|14|||
164008288|NCT01676116|592394860|FG000|Overall Study|Adverse Event|1|||
164008289|NCT01676116|592394861|FG001|Overall Study|Adverse Event|2|||
164008290|NCT01676116|592394860|FG000|Overall Study|Unclassified|4|||
164008291|NCT01676116|592394861|FG001|Overall Study|Unclassified|10|||
164008292|NCT01676116|592394860|FG000|Overall Study|Protocol Violation|9|||
164008293|NCT01676116|592394861|FG001|Overall Study|Protocol Violation|3|||
164008294|NCT00793585|592394862|FG000|Overall Study|Adverse Event|1|||
164008295|NCT00793585|592394863|FG001|Overall Study|Adverse Event|1|||
164008296|NCT00793585|592394862|FG000|Overall Study|Protocol Violation|1|||
164008297|NCT00793585|592394863|FG001|Overall Study|Protocol Violation|2|||
164091156|NCT00262600|592697822|FG002|Overall Study|Lost to Follow-up|41|||
164091157|NCT00262600|592697820|FG000|Overall Study|Withdrawal by Subject|128|||
164356700|NCT01314443|593681065|FG002|Overall Study|Withdrawal by Subject|1|||
164356701|NCT01314443|593681066|FG003|Overall Study|Withdrawal by Subject|1|||
164356702|NCT01314443|593681063|FG000|Overall Study|Protocol Violation|2|||
164356703|NCT01314443|593681064|FG001|Overall Study|Protocol Violation|2|||
164356704|NCT01314443|593681065|FG002|Overall Study|Protocol Violation|1|||
164356705|NCT01314443|593681066|FG003|Overall Study|Protocol Violation|1|||
164356706|NCT01782859|593681067|FG000|Overall Study|Protocol Violation|6|||
164356707|NCT01782859|593681068|FG001|Overall Study|Protocol Violation|6|||
164356708|NCT01782859|593681067|FG000|Overall Study|Withdrawal by Subject|0|||
164356709|NCT01782859|593681068|FG001|Overall Study|Withdrawal by Subject|1|||
164356710|NCT00680745|593681072|FG000|Overall Study|Withdrawal by Subject|8|||
164356711|NCT00680745|593681073|FG001|Overall Study|Withdrawal by Subject|3|||
164356712|NCT00680745|593681074|FG002|Overall Study|Withdrawal by Subject|2|||
164356713|NCT00680745|593681075|FG003|Overall Study|Withdrawal by Subject|8|||
164356714|NCT00680745|593681072|FG000|Overall Study|Lost to Follow-up|0|||
164356715|NCT00680745|593681073|FG001|Overall Study|Lost to Follow-up|1|||
164356716|NCT00680745|593681074|FG002|Overall Study|Lost to Follow-up|1|||
164356717|NCT00680745|593681075|FG003|Overall Study|Lost to Follow-up|0|||
164356718|NCT00680745|593681072|FG000|Overall Study|Death|1|||
164356719|NCT00680745|593681073|FG001|Overall Study|Death|0|||
164356720|NCT00680745|593681074|FG002|Overall Study|Death|1|||
164356721|NCT00680745|593681075|FG003|Overall Study|Death|0|||
164356722|NCT00680745|593681072|FG000|Overall Study|Adverse Event|5|||
164356723|NCT00680745|593681073|FG001|Overall Study|Adverse Event|3|||
164356724|NCT00680745|593681074|FG002|Overall Study|Adverse Event|3|||
164356725|NCT00680745|593681075|FG003|Overall Study|Adverse Event|3|||
164356726|NCT00680745|593681072|FG000|Overall Study|Poor/Non-compliance|0|||
164356727|NCT00680745|593681073|FG001|Overall Study|Poor/Non-compliance|3|||
164356728|NCT00680745|593681074|FG002|Overall Study|Poor/Non-compliance|0|||
164356729|NCT00680745|593681075|FG003|Overall Study|Poor/Non-compliance|0|||
164356730|NCT00680745|593681072|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
164356731|NCT00680745|593681073|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
164356732|NCT00680745|593681074|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
164356733|NCT00680745|593681075|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
164356734|NCT00680745|593681072|FG000|Overall Study|False Treatment|0|||
164356735|NCT00680745|593681073|FG001|Overall Study|False Treatment|1|||
164356736|NCT00680745|593681074|FG002|Overall Study|False Treatment|3|||
164356737|NCT00680745|593681075|FG003|Overall Study|False Treatment|0|||
164356738|NCT01408914|593681076|FG000|Overall Study|Could not complete tx in protocol period|5|||
164356739|NCT01408914|593681077|FG001|Overall Study|Could not complete tx in protocol period|5|||
164356740|NCT01408914|593681078|FG002|Overall Study|Could not complete tx in protocol period|6|||
164356741|NCT01408914|593681076|FG000|Overall Study|Lost to Follow-up|4|||
164356742|NCT01408914|593681077|FG001|Overall Study|Lost to Follow-up|1|||
164356743|NCT01408914|593681078|FG002|Overall Study|Lost to Follow-up|2|||
164356744|NCT01408914|593681076|FG000|Overall Study|Physician Decision|1|||
164356745|NCT01408914|593681077|FG001|Overall Study|Physician Decision|1|||
164356746|NCT01408914|593681078|FG002|Overall Study|Physician Decision|0|||
164356747|NCT01408914|593681076|FG000|Overall Study|Withdrawal by Subject|1|||
164356748|NCT01408914|593681077|FG001|Overall Study|Withdrawal by Subject|0|||
164356749|NCT01408914|593681078|FG002|Overall Study|Withdrawal by Subject|1|||
164356750|NCT01408914|593681076|FG000|Overall Study|Moved out of study jurisdiction|1|||
164356751|NCT01408914|593681077|FG001|Overall Study|Moved out of study jurisdiction|1|||
164356752|NCT01408914|593681078|FG002|Overall Study|Moved out of study jurisdiction|0|||
164356753|NCT01408914|593681076|FG000|Overall Study|Late exclusion|0|||
164356754|NCT01408914|593681077|FG001|Overall Study|Late exclusion|3|||
164356755|NCT01408914|593681078|FG002|Overall Study|Late exclusion|3|||
164356756|NCT01408914|593681076|FG000|Overall Study|Change in local TB/HIV norms|0|||
164356757|NCT01408914|593681077|FG001|Overall Study|Change in local TB/HIV norms|1|||
164356758|NCT01408914|593681078|FG002|Overall Study|Change in local TB/HIV norms|1|||
164356759|NCT04903626|593681082|FG000|Overall Study|Lost to Follow-up|6|||
164356760|NCT04903626|593681082|FG000|Overall Study|Withdrawal by Subject|1|||
164356761|NCT04903626|593681082|FG000|Overall Study|Other, Not Specified|1|||
164356762|NCT06112756|593681085|FG000|Overall Study|Withdrawal by Subject|0|||
164356763|NCT06112756|593681086|FG001|Overall Study|Withdrawal by Subject|2|||
164356764|NCT06112756|593681085|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
164356765|NCT06112756|593681086|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
164356766|NCT06112756|593681085|FG000|Overall Study|Adverse Event|2|||
164356767|NCT06112756|593681086|FG001|Overall Study|Adverse Event|2|||
164356768|NCT03060629|593681087|FG000|Overall Study|Death|4|||
164356769|NCT03060629|593681088|FG001|Overall Study|Death|5|||
164356770|NCT03060629|593681087|FG000|Overall Study|Withdrawal by Subject|50|||
164356771|NCT03060629|593681088|FG001|Overall Study|Withdrawal by Subject|35|||
164356772|NCT03060629|593681087|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
164356773|NCT03060629|593681088|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
164356774|NCT03060629|593681087|FG000|Overall Study|Participant Relocate|15|||
164356775|NCT03060629|593681088|FG001|Overall Study|Participant Relocate|15|||
164008298|NCT01821677|592394864|FG000|Overall Study|Adverse Event|4|||
164356776|NCT03060629|593681087|FG000|Overall Study|Unable to Contact Participant|34|||
164356777|NCT03060629|593681088|FG001|Overall Study|Unable to Contact Participant|23|||
164356778|NCT03060629|593681087|FG000|Overall Study|Investigator Decision|7|||
164356779|NCT03060629|593681088|FG001|Overall Study|Investigator Decision|7|||
164356780|NCT03060629|593681087|FG000|Overall Study|Study Terminated by Sponsor|1100|||
164356781|NCT03060629|593681088|FG001|Overall Study|Study Terminated by Sponsor|1123|||
164356782|NCT03060629|593681087|FG000|Overall Study|Other|4|||
164356783|NCT03060629|593681088|FG001|Overall Study|Other|4|||
164356784|NCT01862874|593681089|FG000|Overall Study|Randomized not treated|1|||
164356785|NCT01862874|593681090|FG001|Overall Study|Randomized not treated|0|||
164356786|NCT01862874|593681089|FG000|Overall Study|Adverse Event|0|||
164356787|NCT01862874|593681090|FG001|Overall Study|Adverse Event|3|||
164356788|NCT01862874|593681089|FG000|Overall Study|Lost to Follow-up|26|||
164356789|NCT01862874|593681090|FG001|Overall Study|Lost to Follow-up|29|||
164356790|NCT01862874|593681089|FG000|Overall Study|Physician Decision|5|||
164356791|NCT01862874|593681090|FG001|Overall Study|Physician Decision|3|||
164356792|NCT01862874|593681089|FG000|Overall Study|Withdrawn by parent/guardian|1|||
164356793|NCT01862874|593681090|FG001|Overall Study|Withdrawn by parent/guardian|1|||
164356794|NCT01862874|593681089|FG000|Overall Study|Withdrawal by Subject|46|||
164356795|NCT01862874|593681090|FG001|Overall Study|Withdrawal by Subject|40|||
164356796|NCT01862874|593681089|FG000|Overall Study|Death|0|||
164356797|NCT01862874|593681090|FG001|Overall Study|Death|1|||
164356798|NCT03681405|593681091|FG000|Overall Study|Found to be ineligible after randomized|1|||
164356799|NCT03681405|593681092|FG001|Overall Study|Found to be ineligible after randomized|0|||
164356800|NCT00412854|593682649|FG000|Overall Study|Withdrawn due to adverse events|1|||
164356801|NCT00412854|593682650|FG001|Overall Study|Withdrawn due to adverse events|5|||
164356802|NCT00412854|593682649|FG000|Overall Study|Withdrawn for other reasons|13|||
164356803|NCT00412854|593682650|FG001|Overall Study|Withdrawn for other reasons|11|||
164356804|NCT03518073|593682651|FG000|Overall Study|Adverse Event|2|||
164356805|NCT03518073|593682652|FG001|Overall Study|Adverse Event|4|||
164356806|NCT03518073|593682653|FG002|Overall Study|Adverse Event|2|||
164356807|NCT03518073|593682651|FG000|Overall Study|Death|2|||
164356808|NCT03518073|593682652|FG001|Overall Study|Death|1|||
164356809|NCT03518073|593682653|FG002|Overall Study|Death|3|||
164356810|NCT03518073|593682651|FG000|Overall Study|Lost to Follow-up|1|||
164356811|NCT03518073|593682652|FG001|Overall Study|Lost to Follow-up|0|||
164356812|NCT03518073|593682653|FG002|Overall Study|Lost to Follow-up|1|||
164356813|NCT03518073|593682651|FG000|Overall Study|Physician Decision|5|||
164356814|NCT03518073|593682652|FG001|Overall Study|Physician Decision|0|||
164356815|NCT03518073|593682653|FG002|Overall Study|Physician Decision|2|||
164356816|NCT03518073|593682651|FG000|Overall Study|Progressive disease|1|||
164356817|NCT03518073|593682652|FG001|Overall Study|Progressive disease|1|||
164356818|NCT03518073|593682653|FG002|Overall Study|Progressive disease|1|||
164356819|NCT03518073|593682651|FG000|Overall Study|Protocol Violation|1|||
164356820|NCT03518073|593682652|FG001|Overall Study|Protocol Violation|0|||
164356821|NCT03518073|593682653|FG002|Overall Study|Protocol Violation|0|||
164356822|NCT03518073|593682651|FG000|Overall Study|Withdrawal by Subject|30|||
164356823|NCT03518073|593682652|FG001|Overall Study|Withdrawal by Subject|34|||
164356824|NCT03518073|593682653|FG002|Overall Study|Withdrawal by Subject|29|||
164356825|NCT03518073|593682651|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
164008299|NCT01821677|592394865|FG001|Overall Study|Adverse Event|6|||
164008300|NCT01821677|592394866|FG002|Overall Study|Adverse Event|5|||
164008301|NCT01821677|592394864|FG000|Overall Study|Physician Decision|1|||
164008302|NCT01821677|592394865|FG001|Overall Study|Physician Decision|4|||
164356826|NCT03518073|593682652|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
164356827|NCT03518073|593682653|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
164356828|NCT03518073|593682651|FG000|Overall Study|Covid-19|1|||
164356829|NCT03518073|593682652|FG001|Overall Study|Covid-19|2|||
164356830|NCT03518073|593682653|FG002|Overall Study|Covid-19|1|||
164356831|NCT03045081|593682654|FG000|Overall Study|Withdrawal by Subject|6|||
164356832|NCT03045081|593682655|FG001|Overall Study|Withdrawal by Subject|11|||
164356833|NCT03804879|593682656|FG000|Overall Study|Adverse Event|3|||
164356834|NCT03804879|593682657|FG001|Overall Study|Adverse Event|0|||
164356835|NCT03804879|593682656|FG000|Overall Study|Study Terminated By Sponsor|10|||
164356836|NCT03804879|593682657|FG001|Overall Study|Study Terminated By Sponsor|12|||
164008303|NCT01821677|592394866|FG002|Overall Study|Physician Decision|1|||
164356837|NCT03804879|593682656|FG000|Overall Study|Withdrawal by Subject|3|||
164356838|NCT03804879|593682657|FG001|Overall Study|Withdrawal by Subject|1|||
164356839|NCT02436889|593682658|FG000|Overall Study|No improvement in symptoms|1|||
164356840|NCT02436889|593682659|FG001|Overall Study|No improvement in symptoms|0|||
164356841|NCT02436889|593682658|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
164356842|NCT02436889|593682659|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
164356843|NCT01034462|593682660|FG000|Overall Study|Adverse Event|7|||
164356844|NCT01034462|593682661|FG001|Overall Study|Adverse Event|17|||
164356845|NCT01034462|593682660|FG000|Overall Study|Lack of Efficacy|4|||
164356846|NCT01034462|593682661|FG001|Overall Study|Lack of Efficacy|4|||
164356847|NCT01034462|593682660|FG000|Overall Study|Protocol Violation|10|||
164356848|NCT01034462|593682661|FG001|Overall Study|Protocol Violation|7|||
164356849|NCT01034462|593682660|FG000|Overall Study|Withdrawal by Subject|9|||
164356850|NCT01034462|593682661|FG001|Overall Study|Withdrawal by Subject|8|||
164356851|NCT01034462|593682660|FG000|Overall Study|Lost to Follow-up|14|||
164356852|NCT01034462|593682661|FG001|Overall Study|Lost to Follow-up|16|||
164356853|NCT01034462|593682660|FG000|Overall Study|Other reasons|1|||
164356854|NCT01034462|593682661|FG001|Overall Study|Other reasons|2|||
164356855|NCT02169739|593682663|FG000|Overall Study|Lost to Follow-up|0|||
164356856|NCT02169739|593682664|FG001|Overall Study|Lost to Follow-up|4|||
164356857|NCT03480750|593682665|FG000|Overall Study|Withdrawal by Subject|0|||
164356858|NCT03480750|593682666|FG001|Overall Study|Withdrawal by Subject|1|||
164356859|NCT03480750|593682667|FG002|Overall Study|Withdrawal by Subject|0|||
164356860|NCT03480750|593682668|FG003|Overall Study|Withdrawal by Subject|0|||
164356861|NCT03480750|593682669|FG004|Overall Study|Withdrawal by Subject|0|||
164356862|NCT03480750|593682670|FG005|Overall Study|Withdrawal by Subject|0|||
164356863|NCT03480750|593682665|FG000|Overall Study|The interruption in Trientine shippment|0|||
164356864|NCT03480750|593682666|FG001|Overall Study|The interruption in Trientine shippment|0|||
164356865|NCT03480750|593682667|FG002|Overall Study|The interruption in Trientine shippment|0|||
164356866|NCT03480750|593682668|FG003|Overall Study|The interruption in Trientine shippment|0|||
164356867|NCT03480750|593682669|FG004|Overall Study|The interruption in Trientine shippment|0|||
164356868|NCT03480750|593682670|FG005|Overall Study|The interruption in Trientine shippment|1|||
164356869|NCT03683758|593682675|FG000|Overall Study|Non-study commitment conflict|1|||
164356870|NCT03683758|593682676|FG001|Overall Study|Non-study commitment conflict|3|||
164356871|NCT03683758|593682675|FG000|Overall Study|Illness preventing participation|1|||
164356872|NCT03683758|593682676|FG001|Overall Study|Illness preventing participation|0|||
164356873|NCT03683758|593682675|FG000|Overall Study|Adverse Event|1|||
164356874|NCT03683758|593682676|FG001|Overall Study|Adverse Event|0|||
164356875|NCT00723892|593682677|FG000|Overall Study|Participant not tracked|33|||
164356876|NCT00723892|593682678|FG001|Overall Study|Participant not tracked|35|||
164356877|NCT00723892|593682677|FG000|Overall Study|Virological criterion|24|||
164356878|NCT00723892|593682678|FG001|Overall Study|Virological criterion|9|||
164356879|NCT00723892|593682677|FG000|Overall Study|Withdrawal by Subject|6|||
164356880|NCT00723892|593682678|FG001|Overall Study|Withdrawal by Subject|9|||
164356881|NCT00723892|593682677|FG000|Overall Study|End planned|11|||
164356882|NCT00723892|593682678|FG001|Overall Study|End planned|7|||
164356883|NCT00723892|593682677|FG000|Overall Study|Bad tolerance|5|||
164356884|NCT00723892|593682678|FG001|Overall Study|Bad tolerance|5|||
163900903|NCT00092534|592009571|FG003|Base Study Vaccination Period|Adverse Event|0|||
163900904|NCT00092534|592009572|FG004|Base Study Vaccination Period|Adverse Event|0|||
163900905|NCT00092534|592009568|FG000|Base Study Vaccination Period|Death|5|||
163900906|NCT00092534|592009569|FG001|Base Study Vaccination Period|Death|4|||
163900907|NCT00092534|592009570|FG002|Base Study Vaccination Period|Death|0|||
163900908|NCT00092534|592009571|FG003|Base Study Vaccination Period|Death|0|||
163900909|NCT00092534|592009572|FG004|Base Study Vaccination Period|Death|0|||
163900910|NCT00092534|592009568|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
163900911|NCT00092534|592009569|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
163900912|NCT00092534|592009570|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
163900913|NCT00092534|592009571|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
163900914|NCT00092534|592009572|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163900915|NCT00092534|592009568|FG000|Base Study Vaccination Period|Physician Decision|1|||
163900916|NCT00092534|592009569|FG001|Base Study Vaccination Period|Physician Decision|0|||
163900917|NCT00092534|592009570|FG002|Base Study Vaccination Period|Physician Decision|0|||
163900918|NCT00092534|592009571|FG003|Base Study Vaccination Period|Physician Decision|0|||
163900919|NCT00092534|592009572|FG004|Base Study Vaccination Period|Physician Decision|0|||
164356885|NCT00723892|593682677|FG000|Overall Study|Multiple reasons|17|||
164356886|NCT00723892|593682678|FG001|Overall Study|Multiple reasons|12|||
164356887|NCT00723892|593682677|FG000|Overall Study|Other|6|||
164356888|NCT00723892|593682678|FG001|Overall Study|Other|3|||
164356889|NCT00723892|593682677|FG000|Overall Study|Study end|1|||
164356890|NCT00723892|593682678|FG001|Overall Study|Study end|3|||
164356891|NCT00723892|593682677|FG000|Overall Study|Weight loss|1|||
164356892|NCT00723892|593682678|FG001|Overall Study|Weight loss|3|||
164091158|NCT00262600|592697821|FG001|Overall Study|Withdrawal by Subject|145|||
164091159|NCT00262600|592697822|FG002|Overall Study|Withdrawal by Subject|139|||
164091160|NCT00262600|592697820|FG000|Overall Study|Not Treated|32|||
164091161|NCT00262600|592697821|FG001|Overall Study|Not Treated|17|||
164091162|NCT00262600|592697822|FG002|Overall Study|Not Treated|24|||
164091163|NCT00262600|592697820|FG000|Overall Study|Other|58|||
164091164|NCT00262600|592697821|FG001|Overall Study|Other|59|||
164091165|NCT00262600|592697822|FG002|Overall Study|Other|62|||
164091166|NCT02132247|592697829|FG000|Overall Study|Protocol Violation|1|||
164091167|NCT02132247|592697830|FG001|Overall Study|Protocol Violation|0|||
164091168|NCT04373434|592697835|FG000|Overall Study|Lost to Follow-up|37|||
164091169|NCT04373434|592697836|FG001|Overall Study|Lost to Follow-up|32|||
164091170|NCT04373434|592697835|FG000|Overall Study|Refused at 9 months|1|||
164091171|NCT04373434|592697836|FG001|Overall Study|Refused at 9 months|2|||
164091172|NCT04373434|592697835|FG000|Overall Study|Refused at 4 months|7|||
164091173|NCT04373434|592697836|FG001|Overall Study|Refused at 4 months|3|||
164091174|NCT04373434|592697835|FG000|Overall Study|Excluded|2|||
164091175|NCT04373434|592697836|FG001|Overall Study|Excluded|0|||
164091176|NCT00527423|592697837|FG000|Overall Study|Protocol Violation|1|||
164091177|NCT00527423|592697837|FG000|Overall Study|Adverse Event|5|||
164091178|NCT00527423|592697837|FG000|Overall Study|Physician Decision|4|||
164091179|NCT00527423|592697837|FG000|Overall Study|Withdrawal by Subject|10|||
164091180|NCT00527423|592697837|FG000|Overall Study|Lost to Follow-up|4|||
164356893|NCT00723892|593682677|FG000|Overall Study|Alcohol abuse|0|||
164356894|NCT00723892|593682678|FG001|Overall Study|Alcohol abuse|1|||
164356895|NCT00723892|593682677|FG000|Overall Study|Intercurrent infection|2|||
164356896|NCT00723892|593682678|FG001|Overall Study|Intercurrent infection|0|||
164356897|NCT00723892|593682677|FG000|Overall Study|Drug addiction|1|||
164356898|NCT00723892|593682678|FG001|Overall Study|Drug addiction|0|||
164356899|NCT02411292|593682679|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
164356900|NCT02411292|593682679|FG000|Overall Study|Death|2|||
164356901|NCT02411292|593682679|FG000|Overall Study|Lost to Follow-up|3|||
164356902|NCT00453921|593682680|FG000|Overall Study|Withdrawal by Subject|1|||
164356903|NCT00453921|593682681|FG001|Overall Study|Withdrawal by Subject|1|||
164356904|NCT00453921|593682682|FG002|Overall Study|Withdrawal by Subject|1|||
164356905|NCT00453921|593682683|FG003|Overall Study|Withdrawal by Subject|1|||
164356906|NCT00453921|593682680|FG000|Overall Study|Lost to Follow-up|0|||
164356907|NCT00453921|593682681|FG001|Overall Study|Lost to Follow-up|0|||
164356908|NCT00453921|593682682|FG002|Overall Study|Lost to Follow-up|1|||
164356909|NCT00453921|593682683|FG003|Overall Study|Lost to Follow-up|0|||
164356910|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
164356911|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
164356912|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
164356913|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
164356914|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
164356915|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
164356916|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
164356917|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
164356918|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Other|4|||
164356919|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Other|1|||
164356920|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
164356921|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
164356922|NCT00303498|593682684|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
164356923|NCT00303498|593682685|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
164356924|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
164356925|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
164356926|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Death|1|||
164356927|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Death|0|||
164356928|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
164356929|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
164356930|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
164356931|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
164356932|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
164356933|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
164356934|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
164356935|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
164356936|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Other|1|||
164356937|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Other|0|||
164356938|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
164091181|NCT00527423|592697837|FG000|Overall Study|OTHER|4|||
164091182|NCT00527423|592697837|FG000|Overall Study|Death|9|||
164356939|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
164091183|NCT03103100|592697838|FG000|Overall Study|Adverse Event|1|||
164091184|NCT03103100|592697839|FG001|Overall Study|Adverse Event|0|||
164091185|NCT03103100|592697840|FG002|Overall Study|Adverse Event|0|||
164356940|NCT00303498|593682684|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
164356941|NCT00303498|593682685|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
164356942|NCT00174915|593682686|FG000|Overall Study|Lost to Follow-up|19|||
164356943|NCT00174915|593682687|FG001|Overall Study|Lost to Follow-up|17|||
164356944|NCT00174915|593682688|FG002|Overall Study|Lost to Follow-up|9|||
164356945|NCT00174915|593682689|FG003|Overall Study|Lost to Follow-up|17|||
164356946|NCT00174915|593682690|FG004|Overall Study|Lost to Follow-up|10|||
164356947|NCT00174915|593682686|FG000|Overall Study|Adverse Event|18|||
164356948|NCT00174915|593682687|FG001|Overall Study|Adverse Event|16|||
164356949|NCT00174915|593682688|FG002|Overall Study|Adverse Event|11|||
164356950|NCT00174915|593682689|FG003|Overall Study|Adverse Event|18|||
164356951|NCT00174915|593682690|FG004|Overall Study|Adverse Event|5|||
164356952|NCT00174915|593682686|FG000|Overall Study|Personal Reason(s)|16|||
164356953|NCT00174915|593682687|FG001|Overall Study|Personal Reason(s)|16|||
164356954|NCT00174915|593682688|FG002|Overall Study|Personal Reason(s)|9|||
164356955|NCT00174915|593682689|FG003|Overall Study|Personal Reason(s)|9|||
164356956|NCT00174915|593682690|FG004|Overall Study|Personal Reason(s)|9|||
164356957|NCT00174915|593682686|FG000|Overall Study|Other|15|||
164356958|NCT00174915|593682687|FG001|Overall Study|Other|8|||
164356959|NCT00174915|593682688|FG002|Overall Study|Other|6|||
164356960|NCT00174915|593682689|FG003|Overall Study|Other|5|||
164356961|NCT00174915|593682690|FG004|Overall Study|Other|3|||
164356962|NCT00174915|593682686|FG000|Overall Study|Gout Flare|13|||
164356963|NCT00174915|593682687|FG001|Overall Study|Gout Flare|6|||
164356964|NCT00174915|593682688|FG002|Overall Study|Gout Flare|8|||
164356965|NCT00174915|593682689|FG003|Overall Study|Gout Flare|1|||
164356966|NCT00174915|593682690|FG004|Overall Study|Gout Flare|0|||
164356967|NCT00174915|593682686|FG000|Overall Study|Protocol Violation|6|||
164356968|NCT00174915|593682687|FG001|Overall Study|Protocol Violation|3|||
164356969|NCT00174915|593682688|FG002|Overall Study|Protocol Violation|3|||
164356970|NCT00174915|593682689|FG003|Overall Study|Protocol Violation|6|||
164356971|NCT00174915|593682690|FG004|Overall Study|Protocol Violation|3|||
164356972|NCT00174915|593682686|FG000|Overall Study|Therapeutic Failure|6|||
164356973|NCT00174915|593682687|FG001|Overall Study|Therapeutic Failure|3|||
164356974|NCT00174915|593682688|FG002|Overall Study|Therapeutic Failure|2|||
164356975|NCT00174915|593682689|FG003|Overall Study|Therapeutic Failure|1|||
164356976|NCT00174915|593682690|FG004|Overall Study|Therapeutic Failure|3|||
164356977|NCT02232425|593682691|FG000|Overall Study|Lost to Follow-up|6|||
164356978|NCT02232425|593682692|FG001|Overall Study|Lost to Follow-up|2|||
164356979|NCT02232425|593682691|FG000|Overall Study|Adverse Event|2|||
164356980|NCT02232425|593682692|FG001|Overall Study|Adverse Event|0|||
164356981|NCT02232425|593682691|FG000|Overall Study|Withdrawal by Subject|5|||
164356982|NCT02232425|593682692|FG001|Overall Study|Withdrawal by Subject|6|||
164356983|NCT02232425|593682691|FG000|Overall Study|Lack of Efficacy|1|||
164356984|NCT02232425|593682692|FG001|Overall Study|Lack of Efficacy|0|||
164356985|NCT03060447|593682693|FG000|Overall Study|Withdrawal by Subject|2|||
164356986|NCT03060447|593682694|FG001|Overall Study|Withdrawal by Subject|0|||
164356987|NCT01601626|593682697|FG000|Overall Study|Death|1|||
164356988|NCT01601626|593682698|FG001|Overall Study|Death|1|||
164356989|NCT01601626|593682699|FG002|Overall Study|Death|1|||
164356990|NCT01601626|593682697|FG000|Overall Study|Lost to Follow-up|1|||
164356991|NCT01601626|593682698|FG001|Overall Study|Lost to Follow-up|2|||
164356992|NCT01601626|593682699|FG002|Overall Study|Lost to Follow-up|0|||
164356993|NCT01601626|593682697|FG000|Overall Study|Unable to Get to Clinic|0|||
164356994|NCT01601626|593682698|FG001|Overall Study|Unable to Get to Clinic|1|||
164356995|NCT01601626|593682699|FG002|Overall Study|Unable to Get to Clinic|0|||
164356996|NCT01601626|593682697|FG000|Overall Study|Withdrawal by Subject|0|||
164356997|NCT01601626|593682698|FG001|Overall Study|Withdrawal by Subject|1|||
164356998|NCT01601626|593682699|FG002|Overall Study|Withdrawal by Subject|1|||
164356999|NCT01601626|593682697|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
164357000|NCT01601626|593682698|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
164357001|NCT01601626|593682699|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
164357002|NCT00498602|593682700|FG000|Overall Study|Death|0|||
164357003|NCT00498602|593682701|FG001|Overall Study|Death|0|||
164357004|NCT00498602|593682702|FG002|Overall Study|Death|0|||
164357005|NCT00498602|593682703|FG003|Overall Study|Death|0|||
164357006|NCT00498602|593682704|FG004|Overall Study|Death|0|||
164357007|NCT00498602|593682705|FG005|Overall Study|Death|1|||
164357008|NCT00498602|593682706|FG006|Overall Study|Death|0|||
164357009|NCT00498602|593682700|FG000|Overall Study|Lack of Efficacy|1|||
164357010|NCT00498602|593682701|FG001|Overall Study|Lack of Efficacy|0|||
164357011|NCT00498602|593682702|FG002|Overall Study|Lack of Efficacy|0|||
164357012|NCT00498602|593682703|FG003|Overall Study|Lack of Efficacy|0|||
164357013|NCT00498602|593682704|FG004|Overall Study|Lack of Efficacy|0|||
164357014|NCT00498602|593682705|FG005|Overall Study|Lack of Efficacy|0|||
164357015|NCT00498602|593682706|FG006|Overall Study|Lack of Efficacy|0|||
164357016|NCT00498602|593682700|FG000|Overall Study|Lost to Follow-up|0|||
164357017|NCT00498602|593682701|FG001|Overall Study|Lost to Follow-up|2|||
164357018|NCT00498602|593682702|FG002|Overall Study|Lost to Follow-up|0|||
164357019|NCT00498602|593682703|FG003|Overall Study|Lost to Follow-up|2|||
164357020|NCT00498602|593682704|FG004|Overall Study|Lost to Follow-up|0|||
164357021|NCT00498602|593682705|FG005|Overall Study|Lost to Follow-up|0|||
164357022|NCT00498602|593682706|FG006|Overall Study|Lost to Follow-up|0|||
164357023|NCT00498602|593682700|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164357024|NCT00498602|593682701|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164357025|NCT00498602|593682702|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
164357026|NCT00498602|593682703|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
164357027|NCT00498602|593682704|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164357028|NCT00498602|593682705|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164357029|NCT00498602|593682706|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164357030|NCT00498602|593682700|FG000|Overall Study|AE not related to Study Drug|1|||
164357031|NCT00498602|593682701|FG001|Overall Study|AE not related to Study Drug|3|||
164357032|NCT00498602|593682702|FG002|Overall Study|AE not related to Study Drug|0|||
164357033|NCT00498602|593682703|FG003|Overall Study|AE not related to Study Drug|0|||
164357034|NCT00498602|593682704|FG004|Overall Study|AE not related to Study Drug|2|||
164357035|NCT00498602|593682705|FG005|Overall Study|AE not related to Study Drug|2|||
164357036|NCT00498602|593682706|FG006|Overall Study|AE not related to Study Drug|1|||
164357037|NCT00498602|593682700|FG000|Overall Study|Caregiver Request|2|||
164357038|NCT00498602|593682701|FG001|Overall Study|Caregiver Request|2|||
164091186|NCT03103100|592697838|FG000|Overall Study|Physician Decision|1|||
164357039|NCT00498602|593682702|FG002|Overall Study|Caregiver Request|2|||
164357040|NCT00498602|593682703|FG003|Overall Study|Caregiver Request|0|||
164357041|NCT00498602|593682704|FG004|Overall Study|Caregiver Request|1|||
164357042|NCT00498602|593682705|FG005|Overall Study|Caregiver Request|2|||
164357043|NCT00498602|593682706|FG006|Overall Study|Caregiver Request|0|||
164357044|NCT00498602|593682700|FG000|Overall Study|Investigator Request|0|||
164357045|NCT00498602|593682701|FG001|Overall Study|Investigator Request|0|||
164357046|NCT00498602|593682702|FG002|Overall Study|Investigator Request|1|||
164357047|NCT00498602|593682703|FG003|Overall Study|Investigator Request|0|||
164357048|NCT00498602|593682704|FG004|Overall Study|Investigator Request|0|||
164357049|NCT00498602|593682705|FG005|Overall Study|Investigator Request|0|||
164357050|NCT00498602|593682706|FG006|Overall Study|Investigator Request|0|||
164357051|NCT00498602|593682700|FG000|Overall Study|Subject Request|3|||
164357052|NCT00498602|593682701|FG001|Overall Study|Subject Request|0|||
164357053|NCT00498602|593682702|FG002|Overall Study|Subject Request|1|||
164357054|NCT00498602|593682703|FG003|Overall Study|Subject Request|1|||
164357055|NCT00498602|593682704|FG004|Overall Study|Subject Request|1|||
164357056|NCT00498602|593682705|FG005|Overall Study|Subject Request|4|||
164357057|NCT00498602|593682706|FG006|Overall Study|Subject Request|1|||
164357058|NCT00498602|593682700|FG000|Overall Study|Other|2|||
164357059|NCT00498602|593682701|FG001|Overall Study|Other|3|||
164357060|NCT00498602|593682702|FG002|Overall Study|Other|1|||
164357061|NCT00498602|593682703|FG003|Overall Study|Other|0|||
164357062|NCT00498602|593682704|FG004|Overall Study|Other|0|||
164357063|NCT00498602|593682705|FG005|Overall Study|Other|3|||
164357064|NCT00498602|593682706|FG006|Overall Study|Other|0|||
164357065|NCT00546637|593682707|FG000|Overall Study|Adverse Event|46|||
164357066|NCT00546637|593682708|FG001|Overall Study|Adverse Event|20|||
164357067|NCT00546637|593682707|FG000|Overall Study|Lack of Efficacy|5|||
164357068|NCT00546637|593682708|FG001|Overall Study|Lack of Efficacy|5|||
164357069|NCT00546637|593682707|FG000|Overall Study|Lost to Follow-up|2|||
164357070|NCT00546637|593682708|FG001|Overall Study|Lost to Follow-up|2|||
164357071|NCT00546637|593682707|FG000|Overall Study|Other|10|||
164357072|NCT00546637|593682708|FG001|Overall Study|Other|12|||
164357073|NCT00546637|593682707|FG000|Overall Study|Withdrawal by Subject|7|||
164357074|NCT00546637|593682708|FG001|Overall Study|Withdrawal by Subject|9|||
164357075|NCT00546637|593682707|FG000|Overall Study|Randomized, but not treated|3|||
164357076|NCT00546637|593682708|FG001|Overall Study|Randomized, but not treated|1|||
164357077|NCT04984993|593682715|FG000|Overall Study|Withdrawal by Subject|8|||
164357078|NCT04984993|593682716|FG001|Overall Study|Withdrawal by Subject|2|||
164357079|NCT04984993|593682715|FG000|Overall Study|Lost to Follow-up|2|||
164357080|NCT04984993|593682716|FG001|Overall Study|Lost to Follow-up|2|||
164357081|NCT04984993|593682715|FG000|Overall Study|Both patients moved to another country|4|||
164357082|NCT04984993|593682716|FG001|Overall Study|Both patients moved to another country|0|||
164357083|NCT01110707|593682717|FG000|Overall Study|Protocol Violation|0|||
164357084|NCT01110707|593682718|FG001|Overall Study|Protocol Violation|3|||
164357085|NCT03108027|593682731|FG000|Period 1|Subject/Guardian Decision|0|||
164357086|NCT03108027|593682732|FG001|Period 1|Subject/Guardian Decision|0|||
164357087|NCT03108027|593682733|FG002|Period 1|Subject/Guardian Decision|0|||
164357088|NCT03108027|593682734|FG003|Period 1|Subject/Guardian Decision|2|||
164357089|NCT03108027|593682735|FG004|Period 1|Subject/Guardian Decision|0|||
164357090|NCT03108027|593682736|FG005|Period 1|Subject/Guardian Decision|0|||
164357091|NCT03108027|593682731|FG000|Period 3|Adverse Event|0|||
164357092|NCT03108027|593682732|FG001|Period 3|Adverse Event|1|||
164357093|NCT03108027|593682733|FG002|Period 3|Adverse Event|0|||
164357094|NCT03108027|593682734|FG003|Period 3|Adverse Event|0|||
164357095|NCT03108027|593682735|FG004|Period 3|Adverse Event|0|||
164357096|NCT03108027|593682736|FG005|Period 3|Adverse Event|0|||
164357097|NCT02426892|593682737|FG000|Overall Study|Adverse Event|2|||
164357098|NCT02426892|593682737|FG000|Overall Study|Lack of Efficacy|17|||
164357099|NCT02426892|593682737|FG000|Overall Study|Withdrawal by Subject|1|||
164357100|NCT03178773|593682738|FG000|Overall Study|Death|0|||
164357101|NCT03178773|593682739|FG001|Overall Study|Death|1|||
164357102|NCT03178773|593682738|FG000|Overall Study|Lost to Follow-up|29|||
164357103|NCT03178773|593682739|FG001|Overall Study|Lost to Follow-up|25|||
164357104|NCT03178773|593682738|FG000|Overall Study|Withdrawal by Subject|10|||
164357105|NCT03178773|593682739|FG001|Overall Study|Withdrawal by Subject|14|||
164357106|NCT01382446|593682740|FG000|Overall Study|Withdrawal by Subject|0|||
164357107|NCT01382446|593682741|FG001|Overall Study|Withdrawal by Subject|1|||
164357108|NCT01382446|593682740|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
164357109|NCT01382446|593682741|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
164357110|NCT00003901|593682742|FG000|Overall Study|Adverse Event|1|||
164357111|NCT00003901|593682742|FG000|Overall Study|Withdrawal by Subject|1|||
164357112|NCT00003901|593682742|FG000|Overall Study|Ineligible|6|||
164357113|NCT00003901|593682742|FG000|Overall Study|CT Scan not within protocol requirement|2|||
164357114|NCT00003901|593682742|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
164357115|NCT00003901|593682742|FG000|Overall Study|Medical problems|6|||
164357116|NCT00268996|593682745|FG000|Overall Study|Adverse Event|11|||
164357117|NCT00268996|593682746|FG001|Overall Study|Adverse Event|7|||
164357118|NCT00268996|593682745|FG000|Overall Study|Lost to Follow-up|3|||
164357119|NCT00268996|593682746|FG001|Overall Study|Lost to Follow-up|1|||
164357120|NCT00268996|593682745|FG000|Overall Study|Withdrawal by Subject|5|||
164357121|NCT00268996|593682746|FG001|Overall Study|Withdrawal by Subject|11|||
164357122|NCT00268996|593682745|FG000|Overall Study|Non-compliance|1|||
164357123|NCT00268996|593682746|FG001|Overall Study|Non-compliance|0|||
164357124|NCT00268996|593682745|FG000|Overall Study|Other|1|||
164357125|NCT00268996|593682746|FG001|Overall Study|Other|1|||
164357126|NCT03325075|593682749|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
164008304|NCT01821677|592394864|FG000|Overall Study|Non-compliance|0|||
164357127|NCT03325075|593682750|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
164357128|NCT03325075|593682751|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
164357129|NCT03325075|593682752|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
164357130|NCT03325075|593682749|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
164357131|NCT03325075|593682750|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
164357132|NCT03325075|593682751|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
164357133|NCT03325075|593682752|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
164357134|NCT03325075|593682749|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
164357135|NCT03325075|593682750|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
164357136|NCT03325075|593682751|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
164357137|NCT03325075|593682752|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
164357138|NCT00422591|593682753|FG000|Overall Study|Physician Decision|4|||
163900920|NCT00092534|592009568|FG000|Base Study Vaccination Period|Pregnancy|9|||
163900921|NCT00092534|592009569|FG001|Base Study Vaccination Period|Pregnancy|7|||
163900922|NCT00092534|592009570|FG002|Base Study Vaccination Period|Pregnancy|0|||
163900923|NCT00092534|592009571|FG003|Base Study Vaccination Period|Pregnancy|0|||
163900924|NCT00092534|592009572|FG004|Base Study Vaccination Period|Pregnancy|0|||
163900925|NCT00092534|592009568|FG000|Base Study Vaccination Period|Protocol Violation|2|||
163900926|NCT00092534|592009569|FG001|Base Study Vaccination Period|Protocol Violation|1|||
163900927|NCT00092534|592009570|FG002|Base Study Vaccination Period|Protocol Violation|0|||
163900928|NCT00092534|592009571|FG003|Base Study Vaccination Period|Protocol Violation|0|||
163900929|NCT00092534|592009572|FG004|Base Study Vaccination Period|Protocol Violation|0|||
163900930|NCT00092534|592009568|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
163900931|NCT00092534|592009569|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
163900932|NCT00092534|592009570|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
163900933|NCT00092534|592009571|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
163900934|NCT00092534|592009572|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164008305|NCT01821677|592394865|FG001|Overall Study|Non-compliance|1|||
164008306|NCT01821677|592394866|FG002|Overall Study|Non-compliance|2|||
164008307|NCT01821677|592394864|FG000|Overall Study|Lost to Follow-up|2|||
164008308|NCT01821677|592394865|FG001|Overall Study|Lost to Follow-up|1|||
164008309|NCT01821677|592394866|FG002|Overall Study|Lost to Follow-up|3|||
164008310|NCT01821677|592394864|FG000|Overall Study|Protocol Violation|0|||
164008311|NCT01821677|592394865|FG001|Overall Study|Protocol Violation|0|||
164008312|NCT01821677|592394866|FG002|Overall Study|Protocol Violation|2|||
164008313|NCT01821677|592394864|FG000|Overall Study|Withdrawal by Subject|7|||
164008314|NCT01821677|592394865|FG001|Overall Study|Withdrawal by Subject|3|||
164008315|NCT01821677|592394866|FG002|Overall Study|Withdrawal by Subject|2|||
164008316|NCT01821677|592394864|FG000|Overall Study|Other|9|||
164008317|NCT01821677|592394865|FG001|Overall Study|Other|0|||
164008318|NCT01821677|592394866|FG002|Overall Study|Other|0|||
164008319|NCT01769404|592394867|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
164008320|NCT01769404|592394868|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
164008321|NCT01769404|592394867|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164008322|NCT01769404|592394868|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164008323|NCT01769404|592394867|FG000|Treatment Period 1|Sponsor decision|1|||
164008324|NCT01769404|592394868|FG001|Treatment Period 1|Sponsor decision|0|||
164008325|NCT01769404|592394867|FG000|Treatment Period 2|Sponsor decision|7|||
164008326|NCT01769404|592394868|FG001|Treatment Period 2|Sponsor decision|0|||
164008327|NCT00538733|592394869|FG000|Overall Study|Adverse Event|8|||
164008328|NCT00538733|592394869|FG000|Overall Study|Death|1|||
164008329|NCT00538733|592394869|FG000|Overall Study|declined to participate|2|||
163900935|NCT00092534|592009568|FG000|Base Study Vaccination Period|Moved|14|||
163900936|NCT00092534|592009569|FG001|Base Study Vaccination Period|Moved|12|||
163900937|NCT00092534|592009570|FG002|Base Study Vaccination Period|Moved|0|||
163900938|NCT00092534|592009571|FG003|Base Study Vaccination Period|Moved|0|||
164008330|NCT00538733|592394869|FG000|Overall Study|still on therapy|1|||
163900939|NCT00092534|592009572|FG004|Base Study Vaccination Period|Moved|0|||
164008331|NCT05278104|592394885|FG000|Overall Study|Not treated|1|||
164008332|NCT05278104|592394886|FG001|Overall Study|Not treated|0|||
164357139|NCT00422591|593682753|FG000|Overall Study|Withdrawal by Subject|2|||
164357140|NCT01414075|593682758|FG000|Overall Study|Adverse Event|1|||
164357141|NCT01414075|593682759|FG001|Overall Study|Adverse Event|0|||
164357142|NCT01414075|593682760|FG002|Overall Study|Adverse Event|1|||
164357143|NCT01414075|593682761|FG003|Overall Study|Adverse Event|0|||
164357144|NCT01414075|593682758|FG000|Overall Study|Death|1|||
164357145|NCT01414075|593682759|FG001|Overall Study|Death|0|||
164357146|NCT01414075|593682760|FG002|Overall Study|Death|0|||
164357147|NCT01414075|593682761|FG003|Overall Study|Death|1|||
164357148|NCT01414075|593682758|FG000|Overall Study|Withdrawal by Subject|0|||
164357149|NCT01414075|593682759|FG001|Overall Study|Withdrawal by Subject|0|||
164357150|NCT01414075|593682760|FG002|Overall Study|Withdrawal by Subject|0|||
164357151|NCT01414075|593682761|FG003|Overall Study|Withdrawal by Subject|1|||
164357152|NCT01414075|593682758|FG000|Overall Study|Other than specified|1|||
164357153|NCT01414075|593682759|FG001|Overall Study|Other than specified|0|||
164357154|NCT01414075|593682760|FG002|Overall Study|Other than specified|1|||
164357155|NCT01414075|593682761|FG003|Overall Study|Other than specified|0|||
164357156|NCT00573534|593682763|FG000|Overall Study|oppositional behavior|3|||
164357157|NCT04851314|593682768|FG000|Overall Study|Unable to complete research set-up procedures|0|||
164357158|NCT04851314|593682769|FG001|Overall Study|Unable to complete research set-up procedures|2|||
164357159|NCT04851314|593682768|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
164357160|NCT04851314|593682769|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
164357161|NCT00867009|593682770|FG000|Induction Period|Nonserious Adverse Event|5|||
164357162|NCT00867009|593682770|FG000|Induction Period|Serious Adverse Event|10|||
164357163|NCT00867009|593682770|FG000|Induction Period|Death due to serious adverse event|6|||
164357164|NCT00867009|593682770|FG000|Induction Period|Death due to Study Disease|4|||
164357165|NCT00867009|593682770|FG000|Induction Period|Protocol Violation|1|||
164357166|NCT00867009|593682770|FG000|Induction Period|Withdrawal by Subject|8|||
164357167|NCT00867009|593682770|FG000|Induction Period|Physician Decision|3|||
164357168|NCT00867009|593682770|FG000|Induction Period|Progressive Disease (PD)|25|||
164357169|NCT00867009|593682770|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
164357170|NCT03266094|593682773|FG000|Overall Study|Lost to Follow-up|1|||
164357171|NCT03266094|593682773|FG000|Overall Study|Withdrawal by Subject|1|||
164357172|NCT03241342|593682778|FG000|Overall Study|Adverse Event|5|||
164357173|NCT03241342|593682779|FG001|Overall Study|Adverse Event|8|||
164008333|NCT05278104|592394885|FG000|Overall Study|Adverse Event|2|||
164008334|NCT05278104|592394886|FG001|Overall Study|Adverse Event|1|||
164008335|NCT05278104|592394885|FG000|Overall Study|Exclusion criteria not met|1|||
164008336|NCT05278104|592394886|FG001|Overall Study|Exclusion criteria not met|0|||
164008337|NCT00001259|592396681|FG000|Study 2|Adverse Event|0|||
164008338|NCT00001259|592396682|FG001|Study 2|Adverse Event|0|||
164008339|NCT00001259|592396683|FG002|Study 2|Adverse Event|0|||
164008340|NCT00001259|592396684|FG003|Study 2|Adverse Event|0|||
164008341|NCT00001259|592396685|FG004|Study 2|Adverse Event|2|||
164008342|NCT00001259|592396686|FG005|Study 2|Adverse Event|0|||
164008343|NCT00001259|592396687|FG006|Study 2|Adverse Event|0|||
164008344|NCT02629393|592396689|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
164008345|NCT02629393|592396689|FG000|Overall Study|Physician Decision|1|||
164008346|NCT01269125|592396690|FG000|Overall Study|Adverse Event|3|||
164357174|NCT03241342|593682780|FG002|Overall Study|Adverse Event|4|||
164357175|NCT03241342|593682778|FG000|Overall Study|Lack of Efficacy|0|||
164357176|NCT03241342|593682779|FG001|Overall Study|Lack of Efficacy|0|||
164357177|NCT03241342|593682780|FG002|Overall Study|Lack of Efficacy|1|||
164357178|NCT03241342|593682778|FG000|Overall Study|noncompliance with study drug|2|||
164357179|NCT03241342|593682779|FG001|Overall Study|noncompliance with study drug|1|||
164357180|NCT03241342|593682780|FG002|Overall Study|noncompliance with study drug|1|||
164357181|NCT03241342|593682778|FG000|Overall Study|sponsor decision|0|||
164357182|NCT03241342|593682779|FG001|Overall Study|sponsor decision|1|||
164357183|NCT03241342|593682780|FG002|Overall Study|sponsor decision|2|||
164357184|NCT03241342|593682778|FG000|Overall Study|not reported|15|||
164357185|NCT03241342|593682779|FG001|Overall Study|not reported|21|||
164357186|NCT03241342|593682780|FG002|Overall Study|not reported|19|||
164357187|NCT03036072|593682784|FG000|Overall Study|Death|0|||
164357188|NCT03036072|593682785|FG001|Overall Study|Death|1|||
164357189|NCT03036072|593682784|FG000|Overall Study|Withdrawal by Subject|0|||
164357190|NCT03036072|593682785|FG001|Overall Study|Withdrawal by Subject|1|||
164357191|NCT03036072|593682784|FG000|Overall Study|Physician Decision|0|||
164357192|NCT03036072|593682785|FG001|Overall Study|Physician Decision|1|||
164357193|NCT03334903|593682786|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
164008347|NCT01269125|592396691|FG001|Overall Study|Adverse Event|5|||
164008348|NCT01269125|592396692|FG002|Overall Study|Adverse Event|0|||
164008349|NCT01269125|592396690|FG000|Overall Study|Lost to Follow-up|4|||
164008350|NCT01269125|592396691|FG001|Overall Study|Lost to Follow-up|0|||
164091187|NCT03103100|592697839|FG001|Overall Study|Physician Decision|0|||
164357194|NCT03334903|593682787|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
164357195|NCT03334903|593682786|FG000|Overall Study|Protocol Violation|1|||
164008351|NCT01269125|592396692|FG002|Overall Study|Lost to Follow-up|0|||
164008352|NCT00151411|592396693|FG000|Overall Study|Lost to Follow-up|15|||
164008353|NCT00151411|592396694|FG001|Overall Study|Lost to Follow-up|19|||
164008354|NCT00151411|592396693|FG000|Overall Study|Withdrawal by Subject|12|||
164008355|NCT00151411|592396694|FG001|Overall Study|Withdrawal by Subject|20|||
164008356|NCT00151411|592396693|FG000|Overall Study|Adverse Event|6|||
164008357|NCT00151411|592396694|FG001|Overall Study|Adverse Event|0|||
164008358|NCT00151411|592396693|FG000|Overall Study|Pregnancy|0|||
164008359|NCT00151411|592396694|FG001|Overall Study|Pregnancy|4|||
164008360|NCT00417612|592396695|FG000|Overall Study|Errant diagnosis|0|||
164008361|NCT00417612|592396696|FG001|Overall Study|Errant diagnosis|1|||
164008362|NCT00417612|592396695|FG000|Overall Study|Adverse Event|2|||
164008363|NCT00417612|592396696|FG001|Overall Study|Adverse Event|0|||
164008364|NCT00417612|592396695|FG000|Overall Study|Protocol Violation|0|||
164008365|NCT00417612|592396696|FG001|Overall Study|Protocol Violation|2|||
164008366|NCT00417612|592396695|FG000|Overall Study|Lost to Follow-up|1|||
164008367|NCT00417612|592396696|FG001|Overall Study|Lost to Follow-up|0|||
164008368|NCT01283581|592396697|FG000|Overall Study|Lost to Follow-up|8|||
164008369|NCT01283581|592396698|FG001|Overall Study|Lost to Follow-up|6|||
164008370|NCT01283581|592396699|FG002|Overall Study|Lost to Follow-up|8|||
164008371|NCT01283581|592396697|FG000|Overall Study|Withdrawal by Subject|2|||
164008372|NCT01283581|592396698|FG001|Overall Study|Withdrawal by Subject|5|||
164008373|NCT01283581|592396699|FG002|Overall Study|Withdrawal by Subject|2|||
164008374|NCT01283581|592396697|FG000|Overall Study|Adverse Event|1|||
164008375|NCT01283581|592396698|FG001|Overall Study|Adverse Event|1|||
164008376|NCT01283581|592396699|FG002|Overall Study|Adverse Event|4|||
164008377|NCT01283581|592396697|FG000|Overall Study|Physician Decision|0|||
164008378|NCT01283581|592396698|FG001|Overall Study|Physician Decision|1|||
164008379|NCT01283581|592396699|FG002|Overall Study|Physician Decision|2|||
164008380|NCT01283581|592396697|FG000|Overall Study|Protocol Violation|0|||
164008381|NCT01283581|592396698|FG001|Overall Study|Protocol Violation|1|||
164008382|NCT01283581|592396699|FG002|Overall Study|Protocol Violation|2|||
164008383|NCT01283581|592396697|FG000|Overall Study|Noncompliance|1|||
164008384|NCT01283581|592396698|FG001|Overall Study|Noncompliance|0|||
164008385|NCT01283581|592396699|FG002|Overall Study|Noncompliance|0|||
164008386|NCT01283581|592396697|FG000|Overall Study|Investigator unblinded|0|||
164008387|NCT01283581|592396698|FG001|Overall Study|Investigator unblinded|0|||
164008388|NCT01283581|592396699|FG002|Overall Study|Investigator unblinded|1|||
164008389|NCT01283581|592396697|FG000|Overall Study|"Early termination"|0|||
164008390|NCT01283581|592396698|FG001|Overall Study|"Early termination"|0|||
164008391|NCT01283581|592396699|FG002|Overall Study|"Early termination"|1|||
164008392|NCT01334125|592396700|FG000|Overall Study|Lost to Follow-up|3|||
164008393|NCT01334125|592396701|FG001|Overall Study|Lost to Follow-up|3|||
164008394|NCT00882713|592396704|FG000|Overall Study|Adverse Event|2|||
164008395|NCT00882713|592396704|FG000|Overall Study|Death|3|||
164008396|NCT00882713|592396704|FG000|Overall Study|Administrative reasons|4|||
164008397|NCT00882713|592396704|FG000|Overall Study|refused treatment/withdrew consent|4|||
164008398|NCT00882713|592396704|FG000|Overall Study|Blood transfusion|2|||
164008399|NCT00882713|592396704|FG000|Overall Study|Insufficient therapeutic response|3|||
164008400|NCT00882713|592396704|FG000|Overall Study|Failure to return|2|||
164008401|NCT00882713|592396704|FG000|Overall Study|Other - Reasons|2|||
164008402|NCT05523362|592396707|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
164091188|NCT03103100|592697840|FG002|Overall Study|Physician Decision|2|||
164091189|NCT02354586|592697842|FG000|Overall Study|Death|230|||
164357196|NCT03334903|593682787|FG001|Overall Study|Protocol Violation|3|||
164357197|NCT03334903|593682786|FG000|Overall Study|Surgery postponed|1|||
164357198|NCT03334903|593682787|FG001|Overall Study|Surgery postponed|0|||
164357199|NCT03334903|593682786|FG000|Overall Study|Adverse Event|1|||
164357200|NCT03334903|593682787|FG001|Overall Study|Adverse Event|1|||
164357201|NCT03334903|593682786|FG000|Overall Study|Withdrawal by Subject|0|||
164357202|NCT03334903|593682787|FG001|Overall Study|Withdrawal by Subject|1|||
164357203|NCT00001596|593684258|FG000|Overall Study|Death|1|||
164008403|NCT05523362|592396707|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
164008404|NCT05523362|592396707|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
164008405|NCT05523362|592396707|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
164008406|NCT02760602|592396708|FG000|Overall Study|Withdrawal by Subject|1|||
164008407|NCT02760602|592396709|FG001|Overall Study|Withdrawal by Subject|0|||
164008408|NCT02760602|592396708|FG000|Overall Study|Terminated by sponsor|12|||
164008409|NCT02760602|592396709|FG001|Overall Study|Terminated by sponsor|13|||
164008410|NCT00474253|592396713|FG000|Overall Study|Withdrew consent|2|||
164008411|NCT00474253|592396714|FG001|Overall Study|Withdrew consent|0|||
164008412|NCT00474253|592396713|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
164008413|NCT00474253|592396714|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
164357204|NCT00001596|593684259|FG001|Overall Study|Death|0|||
164008414|NCT00474253|592396713|FG000|Overall Study|Lost to Follow-up|1|||
164008415|NCT00474253|592396714|FG001|Overall Study|Lost to Follow-up|0|||
164008416|NCT00474253|592396713|FG000|Overall Study|Discharged prior to study completion|0|||
164008417|NCT00474253|592396714|FG001|Overall Study|Discharged prior to study completion|1|||
164357205|NCT00001596|593684258|FG000|Overall Study|Withdrawal by Subject|3|||
164357206|NCT00001596|593684259|FG001|Overall Study|Withdrawal by Subject|1|||
164357207|NCT00001596|593684258|FG000|Overall Study|Study Termination|12|||
164357208|NCT00001596|593684259|FG001|Overall Study|Study Termination|9|||
164357209|NCT00001596|593684258|FG000|Overall Study|Adverse Event|1|||
164357210|NCT00001596|593684259|FG001|Overall Study|Adverse Event|0|||
164357211|NCT00903617|593684265|FG000|Overall Study|Adverse Event|0|||
164357212|NCT00903617|593684266|FG001|Overall Study|Adverse Event|1|||
164357213|NCT00903617|593684267|FG002|Overall Study|Adverse Event|1|||
164357214|NCT00903617|593684268|FG003|Overall Study|Adverse Event|0|||
164357215|NCT00903617|593684265|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164357216|NCT00903617|593684266|FG001|Overall Study|Protocol-defined stopping criteria|2|||
164357217|NCT00903617|593684267|FG002|Overall Study|Protocol-defined stopping criteria|0|||
164357218|NCT00903617|593684268|FG003|Overall Study|Protocol-defined stopping criteria|0|||
164357219|NCT00903617|593684265|FG000|Overall Study|Lost to Follow-up|2|||
164357220|NCT00903617|593684266|FG001|Overall Study|Lost to Follow-up|0|||
164357221|NCT00903617|593684267|FG002|Overall Study|Lost to Follow-up|1|||
164357222|NCT00903617|593684268|FG003|Overall Study|Lost to Follow-up|1|||
164357223|NCT00903617|593684265|FG000|Overall Study|Withdrawal by Subject|1|||
164357224|NCT00903617|593684266|FG001|Overall Study|Withdrawal by Subject|2|||
164357225|NCT00903617|593684267|FG002|Overall Study|Withdrawal by Subject|3|||
164357226|NCT00903617|593684268|FG003|Overall Study|Withdrawal by Subject|0|||
164357227|NCT01104636|593684269|FG000|Overall Study|Lack of Efficacy|43|||
164357228|NCT01104636|593684269|FG000|Overall Study|Lost to Follow-up|24|||
164357229|NCT01104636|593684269|FG000|Overall Study|Withdrawal by Subject|4|||
164357230|NCT01104636|593684269|FG000|Overall Study|Other|43|||
164357231|NCT01104636|593684269|FG000|Overall Study|Study terminated by sponsor|1|||
164357232|NCT01104636|593684269|FG000|Overall Study|Pregnancy|2|||
164357233|NCT01104636|593684269|FG000|Overall Study|Adverse Event|40|||
164357234|NCT01104636|593684269|FG000|Overall Study|Ongoing|21|||
164357235|NCT01706003|593684270|FG000|Overall Study|Withdrawal by Subject|2|||
164357236|NCT01706003|593684271|FG001|Overall Study|Withdrawal by Subject|0|||
164357237|NCT01706003|593684270|FG000|Overall Study|Not scheduled|3|||
164357238|NCT01706003|593684271|FG001|Overall Study|Not scheduled|0|||
164357239|NCT01706003|593684270|FG000|Overall Study|Lost to Follow-up|6|||
164357240|NCT01706003|593684271|FG001|Overall Study|Lost to Follow-up|4|||
164357241|NCT01244906|593684274|FG000|Overall Study|Death|2|||
164357242|NCT01244906|593684274|FG000|Overall Study|Progression of disease post treatment|6|||
164357243|NCT02865187|593684277|FG000|Overall Study|Lost to Follow-up|12|||
164357244|NCT02865187|593684278|FG001|Overall Study|Lost to Follow-up|7|||
164357245|NCT02865187|593684277|FG000|Overall Study|Adverse Event|1|||
164357246|NCT02865187|593684278|FG001|Overall Study|Adverse Event|0|||
164357247|NCT04267133|593684279|FG000|Overall Study|Withdrawal by Subject|1|||
164357248|NCT04267133|593684279|FG000|Overall Study|Adverse Event|4|||
164357249|NCT03318315|593684280|FG000|Overall Study|Lost to Follow-up|3|||
164357250|NCT03318315|593684281|FG001|Overall Study|Lost to Follow-up|2|||
164357251|NCT03318315|593684282|FG002|Overall Study|Lost to Follow-up|1|||
164357252|NCT03318315|593684280|FG000|Overall Study|Protocol Violation|1|||
164357253|NCT03318315|593684281|FG001|Overall Study|Protocol Violation|1|||
164357254|NCT03318315|593684282|FG002|Overall Study|Protocol Violation|1|||
164357255|NCT03318315|593684280|FG000|Overall Study|Withdrawal by Subject|0|||
164357256|NCT03318315|593684281|FG001|Overall Study|Withdrawal by Subject|0|||
164357257|NCT03318315|593684282|FG002|Overall Study|Withdrawal by Subject|2|||
164357258|NCT02968563|593684283|FG000|Overall Study|Adverse Event|0|||
164357259|NCT02968563|593684284|FG001|Overall Study|Adverse Event|6|||
164357260|NCT02968563|593684283|FG000|Overall Study|Death|1|||
164357261|NCT02968563|593684284|FG001|Overall Study|Death|1|||
164357262|NCT02968563|593684283|FG000|Overall Study|Lost to Follow-up|0|||
164357263|NCT02968563|593684284|FG001|Overall Study|Lost to Follow-up|1|||
164357264|NCT00674661|593684285|FG000|Overall Study|Other|5|||
164357265|NCT00674661|593684286|FG001|Overall Study|Other|7|||
164357266|NCT00674661|593684285|FG000|Overall Study|Lost to Follow-up|6|||
164357267|NCT00674661|593684286|FG001|Overall Study|Lost to Follow-up|3|||
164357268|NCT00674661|593684285|FG000|Overall Study|Withdrawal by Subject|0|||
164357269|NCT00674661|593684286|FG001|Overall Study|Withdrawal by Subject|5|||
164357270|NCT02617511|593684291|FG000|Overall Study|Withdrawal by Subject|1|||
164357271|NCT02617511|593684292|FG001|Overall Study|Withdrawal by Subject|0|||
164357272|NCT00811473|593684293|FG000|Overall Study|Adverse Event|3|||
164357273|NCT00811473|593684294|FG001|Overall Study|Adverse Event|12|||
164357274|NCT00811473|593684293|FG000|Overall Study|Lost to Follow-up|5|||
164357275|NCT00811473|593684294|FG001|Overall Study|Lost to Follow-up|1|||
164357276|NCT00811473|593684293|FG000|Overall Study|Withdrawal by Subject|2|||
164357277|NCT00811473|593684294|FG001|Overall Study|Withdrawal by Subject|4|||
164357278|NCT00811473|593684293|FG000|Overall Study|Severe non-compliance to protocol|2|||
164357279|NCT00811473|593684294|FG001|Overall Study|Severe non-compliance to protocol|4|||
164357280|NCT00811473|593684293|FG000|Overall Study|Lack of therapeutic response|4|||
164357281|NCT00811473|593684294|FG001|Overall Study|Lack of therapeutic response|1|||
164357282|NCT00811473|593684293|FG000|Overall Study|Condition under investigation worsened|1|||
164357283|NCT00811473|593684294|FG001|Overall Study|Condition under investigation worsened|3|||
164357284|NCT00811473|593684293|FG000|Overall Study|Other 2|4|||
164357285|NCT00811473|593684294|FG001|Overall Study|Other 2|1|||
164357286|NCT00811473|593684293|FG000|Overall Study|Incorrect Enrollment|1|||
164357287|NCT00811473|593684294|FG001|Overall Study|Incorrect Enrollment|0|||
164357288|NCT00811473|593684293|FG000|Overall Study|Safety Reasons|1|||
164357289|NCT00811473|593684294|FG001|Overall Study|Safety Reasons|0|||
164357290|NCT01119131|593684298|FG000|Overall Study|Adverse Event|1|||
164357291|NCT01119131|593684299|FG001|Overall Study|Adverse Event|1|||
164357292|NCT01119131|593684300|FG002|Overall Study|Adverse Event|1|||
164357293|NCT01119131|593684298|FG000|Overall Study|Non-Compliance|1|||
164357294|NCT01119131|593684299|FG001|Overall Study|Non-Compliance|0|||
164357295|NCT01119131|593684300|FG002|Overall Study|Non-Compliance|4|||
164357296|NCT01119131|593684298|FG000|Overall Study|Physician Decision|0|||
164357297|NCT01119131|593684299|FG001|Overall Study|Physician Decision|0|||
164357298|NCT01119131|593684300|FG002|Overall Study|Physician Decision|1|||
164357299|NCT01909479|593684301|FG000|From Baseline to Week 26|Adverse Event|3|||
164357300|NCT01909479|593684302|FG001|From Baseline to Week 26|Adverse Event|2|||
164357301|NCT01909479|593684301|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
164357302|NCT01909479|593684302|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
164357303|NCT01909479|593684301|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
164357304|NCT01909479|593684302|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
164357305|NCT01909479|593684301|FG000|26 - 52 Weeks|Adverse Event|0|||
164357306|NCT01909479|593684302|FG001|26 - 52 Weeks|Adverse Event|1|||
164357307|NCT01909479|593684301|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
164357308|NCT01909479|593684302|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
164357309|NCT01909479|593684301|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
164357310|NCT01909479|593684302|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
164357311|NCT01909479|593684301|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
164357312|NCT01909479|593684302|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
164357313|NCT01909479|593684301|FG000|52 Weeks to End of Study|Adverse Event|2|||
164357314|NCT01909479|593684302|FG001|52 Weeks to End of Study|Adverse Event|1|||
164357315|NCT01909479|593684301|FG000|52 Weeks to End of Study|Death|0|||
164357316|NCT01909479|593684302|FG001|52 Weeks to End of Study|Death|1|||
164357317|NCT01909479|593684301|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
164357318|NCT01909479|593684302|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
164357319|NCT01909479|593684301|FG000|52 Weeks to End of Study|Protocol Violation|1|||
164357320|NCT01909479|593684302|FG001|52 Weeks to End of Study|Protocol Violation|0|||
164357321|NCT01909479|593684301|FG000|52 Weeks to End of Study|Progressive disease|1|||
164357322|NCT01909479|593684302|FG001|52 Weeks to End of Study|Progressive disease|1|||
164357323|NCT01909479|593684301|FG000|52 Weeks to End of Study|Personal reasons|2|||
164357324|NCT01909479|593684302|FG001|52 Weeks to End of Study|Personal reasons|1|||
164357325|NCT01909479|593684301|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
164357326|NCT01909479|593684302|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
164357327|NCT01909479|593684301|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
164357328|NCT01909479|593684302|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
164357329|NCT01909479|593684301|FG000|52 Weeks to End of Study|Lack of contact|1|||
164357330|NCT01909479|593684302|FG001|52 Weeks to End of Study|Lack of contact|0|||
164357331|NCT01909479|593684301|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
164357332|NCT01909479|593684302|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
164357333|NCT01909479|593684301|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
164357334|NCT01909479|593684302|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
164357335|NCT01187043|593684304|FG000|Overall Study|Adverse Event|0|||
164357336|NCT01187043|593684305|FG001|Overall Study|Adverse Event|0|||
164357337|NCT01187043|593684306|FG002|Overall Study|Adverse Event|0|||
164357338|NCT01187043|593684307|FG003|Overall Study|Adverse Event|0|||
164357339|NCT01187043|593684308|FG004|Overall Study|Adverse Event|1|||
164357340|NCT01187043|593684304|FG000|Overall Study|Unable to make scheduled visits|1|||
164357341|NCT01187043|593684305|FG001|Overall Study|Unable to make scheduled visits|0|||
164357342|NCT01187043|593684306|FG002|Overall Study|Unable to make scheduled visits|4|||
164357343|NCT01187043|593684307|FG003|Overall Study|Unable to make scheduled visits|0|||
164091190|NCT02354586|592697842|FG000|Overall Study|Withdrawal by Subject|59|||
164091191|NCT02354586|592697842|FG000|Overall Study|Lost to Follow-up|11|||
164357344|NCT01187043|593684308|FG004|Overall Study|Unable to make scheduled visits|1|||
164357345|NCT00927784|593684313|FG000|Overall Study|Death|1|||
164357346|NCT00927784|593684314|FG001|Overall Study|Death|0|||
164357347|NCT00927784|593684313|FG000|Overall Study|Withdrawal by Subject|1|||
164091192|NCT02354586|592697842|FG000|Overall Study|Sponsor decision|51|||
164357348|NCT00927784|593684314|FG001|Overall Study|Withdrawal by Subject|0|||
164357349|NCT02457910|593684315|FG000|Overall Study|Withdrawal by Subject|0|||
164357350|NCT02457910|593684316|FG001|Overall Study|Withdrawal by Subject|0|||
164357351|NCT02457910|593684317|FG002|Overall Study|Withdrawal by Subject|0|||
164357352|NCT02457910|593684318|FG003|Overall Study|Withdrawal by Subject|0|||
164357353|NCT02457910|593684319|FG004|Overall Study|Withdrawal by Subject|0|||
164357354|NCT02457910|593684320|FG005|Overall Study|Withdrawal by Subject|1|||
164357355|NCT02457910|593684315|FG000|Overall Study|Adverse Event|0|||
164357356|NCT02457910|593684316|FG001|Overall Study|Adverse Event|2|||
164357357|NCT02457910|593684317|FG002|Overall Study|Adverse Event|1|||
164357358|NCT02457910|593684318|FG003|Overall Study|Adverse Event|1|||
164357359|NCT02457910|593684319|FG004|Overall Study|Adverse Event|1|||
164357360|NCT02457910|593684320|FG005|Overall Study|Adverse Event|3|||
164357361|NCT02457910|593684315|FG000|Overall Study|Disease progression|3|||
164357362|NCT02457910|593684316|FG001|Overall Study|Disease progression|3|||
164357363|NCT02457910|593684317|FG002|Overall Study|Disease progression|1|||
164357364|NCT02457910|593684318|FG003|Overall Study|Disease progression|1|||
164357365|NCT02457910|593684319|FG004|Overall Study|Disease progression|4|||
164357366|NCT02457910|593684320|FG005|Overall Study|Disease progression|6|||
164357367|NCT02457910|593684315|FG000|Overall Study|Other complicating illness|0|||
164357368|NCT02457910|593684316|FG001|Overall Study|Other complicating illness|0|||
164357369|NCT02457910|593684317|FG002|Overall Study|Other complicating illness|0|||
164357370|NCT02457910|593684318|FG003|Overall Study|Other complicating illness|0|||
164357371|NCT02457910|593684319|FG004|Overall Study|Other complicating illness|0|||
164357372|NCT02457910|593684320|FG005|Overall Study|Other complicating illness|1|||
164357373|NCT02457910|593684315|FG000|Overall Study|Death|0|||
164357374|NCT02457910|593684316|FG001|Overall Study|Death|0|||
164357375|NCT02457910|593684317|FG002|Overall Study|Death|1|||
164357376|NCT02457910|593684318|FG003|Overall Study|Death|0|||
164357377|NCT02457910|593684319|FG004|Overall Study|Death|0|||
164357378|NCT02457910|593684320|FG005|Overall Study|Death|0|||
164357379|NCT00467259|593684321|FG000|Overall Study|Adverse Event|24|||
164357380|NCT00467259|593684322|FG001|Overall Study|Adverse Event|90|||
164357381|NCT00467259|593684321|FG000|Overall Study|Protocol Violation|1|||
164357382|NCT00467259|593684322|FG001|Overall Study|Protocol Violation|7|||
164357383|NCT00467259|593684321|FG000|Overall Study|Withdrawal by Subject|34|||
164357384|NCT00467259|593684322|FG001|Overall Study|Withdrawal by Subject|108|||
164357385|NCT00467259|593684321|FG000|Overall Study|Physician Decision|0|||
164357386|NCT00467259|593684322|FG001|Overall Study|Physician Decision|2|||
164357387|NCT00467259|593684321|FG000|Overall Study|Lost to Follow-up|14|||
164357388|NCT00467259|593684322|FG001|Overall Study|Lost to Follow-up|34|||
164357389|NCT00467259|593684321|FG000|Overall Study|Site Closed|2|||
164357390|NCT00467259|593684322|FG001|Overall Study|Site Closed|1|||
164357391|NCT02196558|593684323|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
164357392|NCT02196558|593684324|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
164357393|NCT02196558|593684325|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
164357394|NCT02196558|593684323|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
164357395|NCT02196558|593684324|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
164357396|NCT02196558|593684325|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
164357397|NCT02196558|593684323|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
164357398|NCT02196558|593684324|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
164357399|NCT02196558|593684325|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
164357400|NCT02196558|593684323|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
164357401|NCT02196558|593684324|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
164357402|NCT02196558|593684325|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
164357403|NCT02196558|593684323|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
164357404|NCT02196558|593684324|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
164357405|NCT02196558|593684325|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
164357406|NCT01339429|593684329|FG000|Overall Study|Withdrawal by Subject|1|||
164357407|NCT01339429|593684329|FG000|Overall Study|Physician Decision|3|||
164008418|NCT01165229|592396715|FG000|Overall Study|Serious Adverse Event|456|||
164008419|NCT01165229|592396716|FG001|Overall Study|Serious Adverse Event|487|||
164008420|NCT01165229|592396715|FG000|Overall Study|Non-Serious Adverse Event|47|||
164008421|NCT01165229|592396716|FG001|Overall Study|Non-Serious Adverse Event|15|||
164008422|NCT01165229|592396715|FG000|Overall Study|Protocol Violation|6|||
164008423|NCT01165229|592396716|FG001|Overall Study|Protocol Violation|8|||
164357408|NCT00459667|593684330|FG000|Overall Study|Adverse Event|9|||
164357409|NCT00459667|593684331|FG001|Overall Study|Adverse Event|12|||
164357410|NCT00459667|593684332|FG002|Overall Study|Adverse Event|8|||
164357411|NCT00459667|593684330|FG000|Overall Study|Lost to Follow-up|5|||
164357412|NCT00459667|593684331|FG001|Overall Study|Lost to Follow-up|9|||
164357413|NCT00459667|593684332|FG002|Overall Study|Lost to Follow-up|3|||
164357414|NCT00459667|593684330|FG000|Overall Study|Pregnancy|1|||
164357415|NCT00459667|593684331|FG001|Overall Study|Pregnancy|1|||
164357416|NCT00459667|593684332|FG002|Overall Study|Pregnancy|1|||
164357417|NCT00459667|593684330|FG000|Overall Study|Protocol Violation|1|||
164008424|NCT01165229|592396715|FG000|Overall Study|Withdrawal by Subject|387|||
164008425|NCT01165229|592396716|FG001|Overall Study|Withdrawal by Subject|396|||
164357418|NCT00459667|593684331|FG001|Overall Study|Protocol Violation|0|||
164357419|NCT00459667|593684332|FG002|Overall Study|Protocol Violation|0|||
164357420|NCT00459667|593684330|FG000|Overall Study|Withdrawal by Subject|3|||
164357421|NCT00459667|593684331|FG001|Overall Study|Withdrawal by Subject|5|||
164357422|NCT00459667|593684332|FG002|Overall Study|Withdrawal by Subject|5|||
164357423|NCT00459667|593684330|FG000|Overall Study|Other disease modifying treatment|1|||
164357424|NCT00459667|593684331|FG001|Overall Study|Other disease modifying treatment|2|||
164357425|NCT00459667|593684332|FG002|Overall Study|Other disease modifying treatment|1|||
164357426|NCT00459667|593684330|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
164357427|NCT00459667|593684331|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
164357428|NCT00459667|593684332|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
164357429|NCT00459667|593684330|FG000|Overall Study|No treatment administered|6|||
164357430|NCT00459667|593684331|FG001|Overall Study|No treatment administered|3|||
164357431|NCT00459667|593684332|FG002|Overall Study|No treatment administered|1|||
164357432|NCT01013701|593684333|FG000|Overall Study|study prematurely terminated|7|||
164357433|NCT00556712|593684335|FG000|Overall Study|Adverse Event|7|||
164357434|NCT00556712|593684336|FG001|Overall Study|Adverse Event|19|||
164357435|NCT00556712|593684335|FG000|Overall Study|Death|5|||
164357436|NCT00556712|593684336|FG001|Overall Study|Death|10|||
164357437|NCT00556712|593684335|FG000|Overall Study|Progressive Disease|383|||
164357438|NCT00556712|593684336|FG001|Overall Study|Progressive Disease|320|||
164357439|NCT00556712|593684335|FG000|Overall Study|Protocol Violation|3|||
164357440|NCT00556712|593684336|FG001|Overall Study|Protocol Violation|2|||
164357441|NCT00556712|593684335|FG000|Overall Study|Refused Treatment|17|||
164357442|NCT00556712|593684336|FG001|Overall Study|Refused Treatment|16|||
164357443|NCT00556712|593684335|FG000|Overall Study|Failure to Return|2|||
164357444|NCT00556712|593684336|FG001|Overall Study|Failure to Return|3|||
164357445|NCT00556712|593684335|FG000|Overall Study|Other|2|||
164357446|NCT00556712|593684336|FG001|Overall Study|Other|2|||
164357447|NCT00556712|593684335|FG000|Overall Study|Ongoing at Data Cutoff|32|||
164357448|NCT00556712|593684336|FG001|Overall Study|Ongoing at Data Cutoff|66|||
164357449|NCT01059799|593684339|FG000|Overall Study|Adverse Event|2|||
164357450|NCT01059799|593684340|FG001|Overall Study|Adverse Event|3|||
164357451|NCT01059799|593684339|FG000|Overall Study|Lack of Efficacy|1|||
164357452|NCT01059799|593684340|FG001|Overall Study|Lack of Efficacy|0|||
164357453|NCT01059799|593684339|FG000|Overall Study|Protocol Violation|3|||
164357454|NCT01059799|593684340|FG001|Overall Study|Protocol Violation|2|||
164357455|NCT01059799|593684339|FG000|Overall Study|Withdrawal criteria|13|||
164357456|NCT01059799|593684340|FG001|Overall Study|Withdrawal criteria|2|||
164357457|NCT01059799|593684339|FG000|Overall Study|Other|12|||
164357458|NCT01059799|593684340|FG001|Overall Study|Other|3|||
164357459|NCT01361464|593684341|FG000|Overall Study|Death|1|||
164357460|NCT01361464|593684341|FG000|Overall Study|Withdrawal by Subject|2|||
164357461|NCT01722071|593684346|FG000|Overall Study|Protocol Violation|1|||
164357462|NCT01722071|593684347|FG001|Overall Study|Protocol Violation|0|||
164357463|NCT01106898|593684348|FG000|Overall Study|Adverse Event|6|||
164357464|NCT03021265|593684349|FG000|Overall Study|Adverse Event|29|||
164357465|NCT03021265|593684349|FG000|Overall Study|Lack of Efficacy|3|||
164357466|NCT03021265|593684349|FG000|Overall Study|Improved|17|||
164357467|NCT03021265|593684349|FG000|Overall Study|Lost to Follow-up|67|||
164357468|NCT03021265|593684349|FG000|Overall Study|No reason given|2|||
164357469|NCT03021265|593684349|FG000|Overall Study|No visit since the first visit|4|||
164357470|NCT00818662|593684350|FG000|Overall Study|Adverse Event|5|||
164357471|NCT00818662|593684351|FG001|Overall Study|Adverse Event|14|||
164357472|NCT00818662|593684352|FG002|Overall Study|Adverse Event|4|||
164357473|NCT00818662|593684353|FG003|Overall Study|Adverse Event|3|||
164357474|NCT00818662|593684350|FG000|Overall Study|Withdrawal by Subject|5|||
164357475|NCT00818662|593684351|FG001|Overall Study|Withdrawal by Subject|4|||
164357476|NCT00818662|593684352|FG002|Overall Study|Withdrawal by Subject|2|||
164008426|NCT01165229|592396715|FG000|Overall Study|Migrated/moved from study area|51|||
164008427|NCT01165229|592396716|FG001|Overall Study|Migrated/moved from study area|46|||
164008428|NCT01165229|592396715|FG000|Overall Study|Lost to Follow-up|123|||
164357477|NCT00818662|593684353|FG003|Overall Study|Withdrawal by Subject|2|||
164357478|NCT00818662|593684350|FG000|Overall Study|Death|1|||
164357479|NCT00818662|593684351|FG001|Overall Study|Death|3|||
164357480|NCT00818662|593684352|FG002|Overall Study|Death|0|||
164357481|NCT00818662|593684353|FG003|Overall Study|Death|0|||
164357482|NCT00818662|593684350|FG000|Overall Study|Physician Decision|1|||
164008429|NCT01165229|592396716|FG001|Overall Study|Lost to Follow-up|133|||
164357483|NCT00818662|593684351|FG001|Overall Study|Physician Decision|0|||
164357484|NCT00818662|593684352|FG002|Overall Study|Physician Decision|0|||
164357485|NCT00818662|593684353|FG003|Overall Study|Physician Decision|0|||
164357486|NCT00818662|593684350|FG000|Overall Study|Lost to Follow-up|0|||
164357487|NCT00818662|593684351|FG001|Overall Study|Lost to Follow-up|0|||
164357488|NCT00818662|593684352|FG002|Overall Study|Lost to Follow-up|0|||
164357489|NCT00818662|593684353|FG003|Overall Study|Lost to Follow-up|1|||
164357490|NCT00818662|593684350|FG000|Overall Study|Unwilling or Unable to Participate|4|||
164357491|NCT00818662|593684351|FG001|Overall Study|Unwilling or Unable to Participate|6|||
164357492|NCT00818662|593684352|FG002|Overall Study|Unwilling or Unable to Participate|2|||
164357493|NCT00818662|593684353|FG003|Overall Study|Unwilling or Unable to Participate|4|||
164357494|NCT00818662|593684350|FG000|Overall Study|Protocol Violation|1|||
164357495|NCT00818662|593684351|FG001|Overall Study|Protocol Violation|1|||
164357496|NCT00818662|593684352|FG002|Overall Study|Protocol Violation|0|||
164357497|NCT00818662|593684353|FG003|Overall Study|Protocol Violation|0|||
164357498|NCT00818662|593684350|FG000|Overall Study|Requires a Prohibited Medication|1|||
164357499|NCT00818662|593684351|FG001|Overall Study|Requires a Prohibited Medication|0|||
164357500|NCT00818662|593684352|FG002|Overall Study|Requires a Prohibited Medication|0|||
164357501|NCT00818662|593684353|FG003|Overall Study|Requires a Prohibited Medication|0|||
164357502|NCT00818662|593684350|FG000|Overall Study|Safety Risk|1|||
164357503|NCT00818662|593684351|FG001|Overall Study|Safety Risk|1|||
164357504|NCT00818662|593684352|FG002|Overall Study|Safety Risk|0|||
164357505|NCT00818662|593684353|FG003|Overall Study|Safety Risk|1|||
164357506|NCT00818662|593684350|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
164357507|NCT00818662|593684351|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
164357508|NCT00818662|593684352|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
164357509|NCT00818662|593684353|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
164357510|NCT00818662|593684350|FG000|Overall Study|Participant's health declined|0|||
164357511|NCT00818662|593684351|FG001|Overall Study|Participant's health declined|0|||
164357512|NCT00818662|593684352|FG002|Overall Study|Participant's health declined|0|||
164357513|NCT00818662|593684353|FG003|Overall Study|Participant's health declined|1|||
164357514|NCT00818662|593684350|FG000|Overall Study|Caregiver to pursue other treatment|0|||
164357515|NCT00818662|593684351|FG001|Overall Study|Caregiver to pursue other treatment|1|||
164357516|NCT00818662|593684352|FG002|Overall Study|Caregiver to pursue other treatment|0|||
164357517|NCT00818662|593684353|FG003|Overall Study|Caregiver to pursue other treatment|0|||
164357518|NCT00818662|593684350|FG000|Overall Study|Moving out of state|0|||
164357519|NCT00818662|593684351|FG001|Overall Study|Moving out of state|0|||
164357520|NCT00818662|593684352|FG002|Overall Study|Moving out of state|0|||
164357521|NCT00818662|593684353|FG003|Overall Study|Moving out of state|1|||
164357522|NCT00818662|593684350|FG000|Overall Study|Declined move to another study site|1|||
164357523|NCT00818662|593684351|FG001|Overall Study|Declined move to another study site|0|||
164357524|NCT00818662|593684352|FG002|Overall Study|Declined move to another study site|0|||
164357525|NCT00818662|593684353|FG003|Overall Study|Declined move to another study site|0|||
164357526|NCT00818662|593684350|FG000|Overall Study|Change in living situation|0|||
164357527|NCT00818662|593684351|FG001|Overall Study|Change in living situation|0|||
164357528|NCT00818662|593684352|FG002|Overall Study|Change in living situation|0|||
164357529|NCT00818662|593684353|FG003|Overall Study|Change in living situation|1|||
164357530|NCT00818662|593684350|FG000|Overall Study|Study partner decision|0|||
164357531|NCT00818662|593684351|FG001|Overall Study|Study partner decision|0|||
164357532|NCT00818662|593684352|FG002|Overall Study|Study partner decision|0|||
164357533|NCT00818662|593684353|FG003|Overall Study|Study partner decision|1|||
164357534|NCT00818662|593684350|FG000|Overall Study|Admitted to long term nursing care|0|||
164357535|NCT00818662|593684351|FG001|Overall Study|Admitted to long term nursing care|1|||
164357536|NCT00818662|593684352|FG002|Overall Study|Admitted to long term nursing care|0|||
164357537|NCT00818662|593684353|FG003|Overall Study|Admitted to long term nursing care|0|||
164357538|NCT01338493|593684354|FG000|Enrolled|Withdrawal by Subject|1|||
164357539|NCT01338493|593684354|FG000|Enrolled|Patient not implanted|4|||
164357540|NCT01338493|593684354|FG000|Discharge|Death|1|||
164357541|NCT01338493|593684354|FG000|Discharge|Missed visit|1|||
164357542|NCT01338493|593684354|FG000|6 Months Follow up|Lost to Follow-up|11|||
164357543|NCT01338493|593684354|FG000|6 Months Follow up|Missed visit|8|||
164357544|NCT01338493|593684354|FG000|12 Months Follow up|Lost to Follow-up|9|||
164357545|NCT01846611|593684355|FG000|Overall Study|Lost to Follow-up|4|||
164357546|NCT01846611|593684356|FG001|Overall Study|Lost to Follow-up|6|||
164357547|NCT01846611|593684355|FG000|Overall Study|Withdrawal by Subject|15|||
164357548|NCT01846611|593684356|FG001|Overall Study|Withdrawal by Subject|19|||
164357549|NCT01846611|593684355|FG000|Overall Study|Other|19|||
164008430|NCT01165229|592396715|FG000|Overall Study|Suspected HZ Episode|2|||
164008431|NCT01165229|592396716|FG001|Overall Study|Suspected HZ Episode|2|||
164008432|NCT01165229|592396715|FG000|Overall Study|No reason from the subject|108|||
164008433|NCT01165229|592396716|FG001|Overall Study|No reason from the subject|102|||
164008434|NCT01165229|592396715|FG000|Overall Study|Unknown completion status|0|||
164008435|NCT01165229|592396716|FG001|Overall Study|Unknown completion status|1|||
164357550|NCT01846611|593684356|FG001|Overall Study|Other|18|||
164357551|NCT00541034|593684357|FG000|Overall Study|Non-Compliance|3|||
164357552|NCT01614067|593684358|FG000|Overall Study|Pregnancy|1|||
164357553|NCT01614067|593684359|FG001|Overall Study|Pregnancy|0|||
164357554|NCT01614067|593684358|FG000|Overall Study|Physician Decision|6|||
164357555|NCT01614067|593684359|FG001|Overall Study|Physician Decision|5|||
164357556|NCT01614067|593684358|FG000|Overall Study|Withdrawal by Subject|0|||
164357557|NCT01614067|593684359|FG001|Overall Study|Withdrawal by Subject|1|||
164357558|NCT01614067|593684358|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
164357559|NCT01614067|593684359|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
164357560|NCT00847704|593684360|FG000|Overall Study|Withdrawal by Subject|1|||
164357561|NCT02289079|593684366|FG000|Overall Study|Physician Decision|2|||
164357562|NCT02289079|593684367|FG001|Overall Study|Physician Decision|0|||
164357563|NCT02289079|593684366|FG000|Overall Study|Lost to Follow-up|0|||
164357564|NCT02289079|593684367|FG001|Overall Study|Lost to Follow-up|1|||
164357565|NCT02671422|593684368|FG000|Overall Study|Lost to Follow-up|1|||
164357566|NCT02671422|593684368|FG000|Overall Study|Adverse Event|68|||
164357567|NCT02671422|593684368|FG000|Overall Study|Lack of Efficacy|1|||
164357568|NCT02671422|593684368|FG000|Overall Study|Lost to Follow-up|4|||
164357569|NCT02671422|593684368|FG000|Overall Study|Withdrawal by Subject|7|||
164357570|NCT02671422|593684368|FG000|Overall Study|Progressive Disease|156|||
164357571|NCT02671422|593684368|FG000|Overall Study|Worsening of Disease|4|||
164357572|NCT02671422|593684368|FG000|Overall Study|Sponsor decision|5|||
164357573|NCT02671422|593684368|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
164357574|NCT02671422|593684368|FG000|Overall Study|Not treated with Vargatef®|3|||
164357575|NCT02671422|593684368|FG000|Overall Study|Other not defined above|3|||
164357576|NCT02111850|593684369|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357577|NCT02111850|593684370|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357578|NCT02111850|593684371|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357579|NCT02111850|593684372|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357580|NCT02111850|593684373|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
164357581|NCT02111850|593684374|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357582|NCT02111850|593684375|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357583|NCT02111850|593684376|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357584|NCT02111850|593684377|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357585|NCT02111850|593684378|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357586|NCT02111850|593684379|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
164357587|NCT03061331|593684380|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
164357588|NCT03061331|593684381|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
164357589|NCT02625259|593684382|FG000|First Intervention (Day 1)|Other|0|||
164357590|NCT02625259|593684383|FG001|First Intervention (Day 1)|Other|0|||
164357591|NCT02625259|593684384|FG002|First Intervention (Day 1)|Other|1|||
164357592|NCT02625259|593684385|FG003|First Intervention (Day 1)|Other|0|||
164357593|NCT02625259|593684386|FG004|First Intervention (Day 1)|Other|0|||
164357594|NCT02625259|593684382|FG000|First Intervention (Day 1)|Adverse Event|2|||
164357595|NCT02625259|593684383|FG001|First Intervention (Day 1)|Adverse Event|1|||
164357596|NCT02625259|593684384|FG002|First Intervention (Day 1)|Adverse Event|0|||
164357597|NCT02625259|593684385|FG003|First Intervention (Day 1)|Adverse Event|0|||
164357598|NCT02625259|593684386|FG004|First Intervention (Day 1)|Adverse Event|0|||
164357599|NCT02625259|593684382|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357600|NCT02625259|593684383|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357601|NCT02625259|593684384|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357602|NCT02625259|593684385|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
164357603|NCT02625259|593684386|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
164357604|NCT00513474|593684387|FG000|Overall Study|Death|6|||
164357605|NCT00513474|593684388|FG001|Overall Study|Death|9|||
164357606|NCT00513474|593684387|FG000|Overall Study|Participant Withdrew Consent|1|||
164357607|NCT00513474|593684388|FG001|Overall Study|Participant Withdrew Consent|0|||
163900940|NCT00092534|592009568|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
163900941|NCT00092534|592009569|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164357608|NCT04772755|593684389|FG000|Overall Study|Withdrawal by Subject|1|||
163900942|NCT00092534|592009570|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164357609|NCT04772755|593684390|FG001|Overall Study|Withdrawal by Subject|0|||
164357610|NCT04772755|593684389|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
164357611|NCT04772755|593684390|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
164357612|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Adverse Event|82|||
164357613|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Death|6|||
164357614|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
164357615|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
164357616|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
164357617|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
164357618|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
164357619|NCT00195676|593684392|FG000|Period O - Open-label Treatment|Other reasons|68|||
164357620|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
164357621|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
164357622|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
164357623|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
164357624|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
164357625|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
164357626|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
164357627|NCT00195676|593684392|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
164357628|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
164357629|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
164357630|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
164357631|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
164357632|NCT00195676|593684392|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
164357633|NCT01189812|593684393|FG000|Overall Study|Withdrawal by Subject|2|||
164357634|NCT01189812|593684394|FG001|Overall Study|Withdrawal by Subject|3|||
164357635|NCT01189812|593684393|FG000|Overall Study|Adverse Event|1|||
164357636|NCT01189812|593684394|FG001|Overall Study|Adverse Event|0|||
164357637|NCT01189812|593684393|FG000|Overall Study|Out of Window|4|||
164357638|NCT01189812|593684394|FG001|Overall Study|Out of Window|3|||
164357639|NCT01189812|593684393|FG000|Overall Study|Moved out of State|1|||
164357640|NCT01189812|593684394|FG001|Overall Study|Moved out of State|2|||
164357641|NCT03761147|593684395|FG000|Overall Study|Withdrawal by Subject|6|||
164357642|NCT03761147|593684396|FG001|Overall Study|Withdrawal by Subject|1|||
164357643|NCT03761147|593684395|FG000|Overall Study|Adverse Event|1|||
164357644|NCT03761147|593684396|FG001|Overall Study|Adverse Event|3|||
164357645|NCT04080297|593684397|FG000|Overall Study|Adverse Event|1|||
164357646|NCT04080297|593684398|FG001|Overall Study|Adverse Event|3|||
164357647|NCT04080297|593684397|FG000|Overall Study|concurrent illness|1|||
164357648|NCT04080297|593684398|FG001|Overall Study|concurrent illness|0|||
164357649|NCT02744391|593684399|FG000|Overall Study|Lost to Follow-up|9|||
164357650|NCT02744391|593684399|FG000|Overall Study|Physician Decision|2|||
164357651|NCT02744391|593684399|FG000|Overall Study|Withdrawal by Subject|3|||
164357652|NCT05838742|593684400|FG000|Overall Study|Adverse Event|2|||
164357653|NCT05838742|593684401|FG001|Overall Study|Adverse Event|0|||
164357654|NCT05838742|593684402|FG002|Overall Study|Adverse Event|1|||
164357655|NCT05838742|593684403|FG003|Overall Study|Adverse Event|0|||
164357656|NCT05838742|593684404|FG004|Overall Study|Adverse Event|1|||
164357657|NCT05838742|593684400|FG000|Overall Study|Lost to Follow-up|1|||
164357658|NCT05838742|593684401|FG001|Overall Study|Lost to Follow-up|1|||
164357659|NCT05838742|593684402|FG002|Overall Study|Lost to Follow-up|1|||
164357660|NCT05838742|593684403|FG003|Overall Study|Lost to Follow-up|0|||
164357661|NCT05838742|593684404|FG004|Overall Study|Lost to Follow-up|0|||
164357662|NCT05838742|593684400|FG000|Overall Study|Physician Decision|0|||
164357663|NCT05838742|593684401|FG001|Overall Study|Physician Decision|0|||
164357664|NCT05838742|593684402|FG002|Overall Study|Physician Decision|0|||
164357665|NCT05838742|593684403|FG003|Overall Study|Physician Decision|0|||
164357666|NCT05838742|593684404|FG004|Overall Study|Physician Decision|1|||
164357667|NCT05838742|593684400|FG000|Overall Study|Withdrawal by Subject|8|||
164357668|NCT05838742|593684401|FG001|Overall Study|Withdrawal by Subject|3|||
164357669|NCT05838742|593684402|FG002|Overall Study|Withdrawal by Subject|3|||
164357670|NCT05838742|593684403|FG003|Overall Study|Withdrawal by Subject|1|||
164357671|NCT05838742|593684404|FG004|Overall Study|Withdrawal by Subject|4|||
164357672|NCT05838742|593684400|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
164357673|NCT05838742|593684401|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
164357674|NCT05838742|593684402|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
164357675|NCT05838742|593684403|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
164357676|NCT05838742|593684404|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
164357677|NCT05838742|593684400|FG000|Overall Study|Lack of Efficacy|0|||
164357678|NCT05838742|593684401|FG001|Overall Study|Lack of Efficacy|0|||
164357679|NCT05838742|593684402|FG002|Overall Study|Lack of Efficacy|0|||
164357680|NCT05838742|593684403|FG003|Overall Study|Lack of Efficacy|1|||
164357681|NCT05838742|593684404|FG004|Overall Study|Lack of Efficacy|0|||
164357682|NCT05838742|593684400|FG000|Overall Study|Randomized, not treated|2|||
164357683|NCT05838742|593684401|FG001|Overall Study|Randomized, not treated|1|||
164357684|NCT05838742|593684402|FG002|Overall Study|Randomized, not treated|0|||
164357685|NCT05838742|593684403|FG003|Overall Study|Randomized, not treated|1|||
164357686|NCT05838742|593684404|FG004|Overall Study|Randomized, not treated|0|||
164357687|NCT02045797|593684405|FG000|Overall Study|Adverse Event|3|||
164357688|NCT02045797|593684406|FG001|Overall Study|Adverse Event|1|||
164357689|NCT02045797|593684407|FG002|Overall Study|Adverse Event|0|||
164357690|NCT02045797|593684405|FG000|Overall Study|Lack of Efficacy|1|||
164357691|NCT02045797|593684406|FG001|Overall Study|Lack of Efficacy|0|||
164357692|NCT02045797|593684407|FG002|Overall Study|Lack of Efficacy|0|||
164357693|NCT02045797|593684405|FG000|Overall Study|Lost to Follow-up|2|||
164357694|NCT02045797|593684406|FG001|Overall Study|Lost to Follow-up|3|||
164357695|NCT02045797|593684407|FG002|Overall Study|Lost to Follow-up|1|||
164357696|NCT02045797|593684405|FG000|Overall Study|Physician Decision|0|||
164357697|NCT02045797|593684406|FG001|Overall Study|Physician Decision|1|||
164357698|NCT02045797|593684407|FG002|Overall Study|Physician Decision|0|||
164357699|NCT02045797|593684405|FG000|Overall Study|Withdrawal by Subject|1|||
164357700|NCT02045797|593684406|FG001|Overall Study|Withdrawal by Subject|2|||
164357701|NCT02045797|593684407|FG002|Overall Study|Withdrawal by Subject|0|||
164357702|NCT03851302|593684408|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
164357703|NCT03851302|593684409|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
164357704|NCT03851302|593684410|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
164357705|NCT03851302|593684411|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
164357706|NCT03851302|593684412|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
164357707|NCT03851302|593684413|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
164357708|NCT03851302|593684408|FG000|Screening (1 Day)|Screened out|0|||
164357709|NCT03851302|593684409|FG001|Screening (1 Day)|Screened out|0|||
164357710|NCT03851302|593684410|FG002|Screening (1 Day)|Screened out|1|||
164357711|NCT03851302|593684411|FG003|Screening (1 Day)|Screened out|1|||
164357712|NCT03851302|593684412|FG004|Screening (1 Day)|Screened out|0|||
164357713|NCT03851302|593684413|FG005|Screening (1 Day)|Screened out|0|||
164357714|NCT03851302|593684408|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
164357715|NCT03851302|593684409|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357716|NCT03851302|593684410|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357717|NCT03851302|593684411|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357718|NCT03851302|593684412|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357719|NCT03851302|593684413|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
164357720|NCT00501293|593686277|FG000|Optimization Period|Enrolled in error|1|||
164357721|NCT00501293|593686278|FG001|Optimization Period|Enrolled in error|0|||
164357722|NCT00501293|593686277|FG000|Maintenance Period|Withdrawal by Subject|14|||
164357723|NCT00501293|593686278|FG001|Maintenance Period|Withdrawal by Subject|13|||
164357724|NCT00501293|593686277|FG000|Maintenance Period|Lost to Follow-up|12|||
164357725|NCT00501293|593686278|FG001|Maintenance Period|Lost to Follow-up|7|||
164357726|NCT00501293|593686277|FG000|Maintenance Period|Adverse Event|6|||
164357727|NCT00501293|593686278|FG001|Maintenance Period|Adverse Event|6|||
164357728|NCT00501293|593686277|FG000|Maintenance Period|Protocol Violation|2|||
164357729|NCT00501293|593686278|FG001|Maintenance Period|Protocol Violation|1|||
164357730|NCT00501293|593686277|FG000|Maintenance Period|Lack of Efficacy|4|||
164357731|NCT00501293|593686278|FG001|Maintenance Period|Lack of Efficacy|1|||
164357732|NCT00501293|593686277|FG000|Maintenance Period|Noncompliant with study medication|5|||
164357733|NCT00501293|593686278|FG001|Maintenance Period|Noncompliant with study medication|0|||
164357734|NCT00501293|593686277|FG000|Maintenance Period|Went into rehabilitation|1|||
164357735|NCT00501293|593686278|FG001|Maintenance Period|Went into rehabilitation|0|||
164357736|NCT00501293|593686277|FG000|Maintenance Period|Would not wear patch|1|||
164357737|NCT00501293|593686278|FG001|Maintenance Period|Would not wear patch|0|||
164357738|NCT00501293|593686277|FG000|Maintenance Period|Application site reaction|1|||
164357739|NCT00501293|593686278|FG001|Maintenance Period|Application site reaction|0|||
164357740|NCT02355691|593686282|FG000|Overall Study|Loss of Research Personnel|7|||
164357741|NCT02355691|593686283|FG001|Overall Study|Loss of Research Personnel|9|||
164357742|NCT01042236|593686287|FG000|Treatment Period 1|Adverse Event|0|||
164357743|NCT01042236|593686288|FG001|Treatment Period 1|Adverse Event|1|||
164357744|NCT01042236|593686289|FG002|Treatment Period 1|Adverse Event|0|||
163900943|NCT00092534|592009571|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164357745|NCT01042236|593686290|FG003|Treatment Period 1|Adverse Event|0|||
164357746|NCT01042236|593686291|FG004|Treatment Period 1|Adverse Event|1|||
164357747|NCT01042236|593686292|FG005|Treatment Period 1|Adverse Event|0|||
164357748|NCT01042236|593686287|FG000|Treatment Period 3|Adverse Event|0|||
164357749|NCT01042236|593686288|FG001|Treatment Period 3|Adverse Event|0|||
164357750|NCT01042236|593686289|FG002|Treatment Period 3|Adverse Event|0|||
164357751|NCT01042236|593686290|FG003|Treatment Period 3|Adverse Event|1|||
163900944|NCT00092534|592009572|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
164357752|NCT01042236|593686291|FG004|Treatment Period 3|Adverse Event|0|||
164357753|NCT01042236|593686292|FG005|Treatment Period 3|Adverse Event|0|||
164357754|NCT01042236|593686287|FG000|Treatment Period 3|Protocol Violation|0|||
164357755|NCT01042236|593686288|FG001|Treatment Period 3|Protocol Violation|0|||
164357756|NCT01042236|593686289|FG002|Treatment Period 3|Protocol Violation|0|||
164357757|NCT01042236|593686290|FG003|Treatment Period 3|Protocol Violation|1|||
164357758|NCT01042236|593686291|FG004|Treatment Period 3|Protocol Violation|0|||
164357759|NCT01042236|593686292|FG005|Treatment Period 3|Protocol Violation|0|||
164357760|NCT01172847|593686295|FG000|Overall Study|Withdrawal by Subject|3|||
164357761|NCT02132767|593686300|FG000|Overall Study|Death|3|||
164357762|NCT02132767|593686301|FG001|Overall Study|Death|2|||
164357763|NCT02132767|593686300|FG000|Overall Study|Withdrawal by Subject|10|||
164357764|NCT02132767|593686301|FG001|Overall Study|Withdrawal by Subject|9|||
164357765|NCT02132767|593686300|FG000|Overall Study|Lost to Follow-up|4|||
164357766|NCT02132767|593686301|FG001|Overall Study|Lost to Follow-up|4|||
164008436|NCT01357239|592396717|FG000|Stratum: All Patients|Adverse Event|0|||
164008437|NCT01357239|592396718|FG001|Stratum: All Patients|Adverse Event|0|||
164357767|NCT00390858|593686302|FG000|Overall Study|Adverse Event|6|||
164357768|NCT00390858|593686303|FG001|Overall Study|Adverse Event|2|||
164357769|NCT00390858|593686302|FG000|Overall Study|Lack of Efficacy|0|||
164357770|NCT00390858|593686303|FG001|Overall Study|Lack of Efficacy|1|||
164357771|NCT00390858|593686302|FG000|Overall Study|Withdrawal by Subject|3|||
164357772|NCT00390858|593686303|FG001|Overall Study|Withdrawal by Subject|4|||
164357773|NCT00937157|593686304|FG000|Overall Study|Pregnancy|1|||
164357774|NCT00937157|593686304|FG000|Overall Study|Lost to Follow-up|3|||
164357775|NCT02141997|593686305|FG000|Overall Study|Adverse Event|0|||
164357776|NCT02141997|593686306|FG001|Overall Study|Adverse Event|2|||
164357777|NCT02141997|593686307|FG002|Overall Study|Adverse Event|0|||
164357778|NCT02141997|593686308|FG003|Overall Study|Adverse Event|1|||
164357779|NCT02141997|593686305|FG000|Overall Study|Participant noncompliance|1|||
164357780|NCT02141997|593686306|FG001|Overall Study|Participant noncompliance|0|||
164357781|NCT02141997|593686307|FG002|Overall Study|Participant noncompliance|0|||
164357782|NCT02141997|593686308|FG003|Overall Study|Participant noncompliance|0|||
164357783|NCT02141997|593686305|FG000|Overall Study|Withdrew consent|1|||
164357784|NCT02141997|593686306|FG001|Overall Study|Withdrew consent|0|||
164357785|NCT02141997|593686307|FG002|Overall Study|Withdrew consent|3|||
164357786|NCT02141997|593686308|FG003|Overall Study|Withdrew consent|0|||
164357787|NCT02141997|593686305|FG000|Overall Study|Other|1|||
164357788|NCT02141997|593686306|FG001|Overall Study|Other|4|||
164357789|NCT02141997|593686307|FG002|Overall Study|Other|0|||
164357790|NCT02141997|593686308|FG003|Overall Study|Other|0|||
164357791|NCT00451321|593686309|FG000|Overall Study|Lost to Follow-up|3|||
164357792|NCT00451321|593686310|FG001|Overall Study|Lost to Follow-up|3|||
164357793|NCT00451321|593686311|FG002|Overall Study|Lost to Follow-up|1|||
164357794|NCT00451321|593686312|FG003|Overall Study|Lost to Follow-up|3|||
164357795|NCT00451321|593686313|FG004|Overall Study|Lost to Follow-up|0|||
164357796|NCT00451321|593686314|FG005|Overall Study|Lost to Follow-up|1|||
164357797|NCT00451321|593686315|FG006|Overall Study|Lost to Follow-up|0|||
164357798|NCT00451321|593686316|FG007|Overall Study|Lost to Follow-up|0|||
164357799|NCT00451321|593686309|FG000|Overall Study|Withdrawal by Subject|3|||
164357800|NCT00451321|593686310|FG001|Overall Study|Withdrawal by Subject|1|||
164357801|NCT00451321|593686311|FG002|Overall Study|Withdrawal by Subject|0|||
164357802|NCT00451321|593686312|FG003|Overall Study|Withdrawal by Subject|4|||
164357803|NCT00451321|593686313|FG004|Overall Study|Withdrawal by Subject|0|||
164357804|NCT00451321|593686314|FG005|Overall Study|Withdrawal by Subject|0|||
164357805|NCT00451321|593686315|FG006|Overall Study|Withdrawal by Subject|0|||
164357806|NCT00451321|593686316|FG007|Overall Study|Withdrawal by Subject|0|||
164357807|NCT00451321|593686309|FG000|Overall Study|Study closed/terminated|1|||
164357808|NCT00451321|593686310|FG001|Overall Study|Study closed/terminated|1|||
164357809|NCT00451321|593686311|FG002|Overall Study|Study closed/terminated|17|||
164357810|NCT00451321|593686312|FG003|Overall Study|Study closed/terminated|5|||
164357811|NCT00451321|593686313|FG004|Overall Study|Study closed/terminated|7|||
164357812|NCT00451321|593686314|FG005|Overall Study|Study closed/terminated|7|||
164357813|NCT00451321|593686315|FG006|Overall Study|Study closed/terminated|5|||
164357814|NCT00451321|593686316|FG007|Overall Study|Study closed/terminated|3|||
164008438|NCT01357239|592396719|FG002|Stratum: All Patients|Adverse Event|1|||
164008439|NCT01357239|592396720|FG003|Stratum: All Patients|Adverse Event|1|||
164008440|NCT01357239|592396717|FG000|Stratum: All Patients|Subject withdrew consent|0|||
164008441|NCT01357239|592396718|FG001|Stratum: All Patients|Subject withdrew consent|0|||
164357815|NCT00451321|593686309|FG000|Overall Study|Sponsor decision to amend protocol|0|||
164357816|NCT00451321|593686310|FG001|Overall Study|Sponsor decision to amend protocol|0|||
164357817|NCT00451321|593686311|FG002|Overall Study|Sponsor decision to amend protocol|0|||
164008442|NCT01357239|592396719|FG002|Stratum: All Patients|Subject withdrew consent|1|||
164357818|NCT00451321|593686312|FG003|Overall Study|Sponsor decision to amend protocol|0|||
164357819|NCT00451321|593686313|FG004|Overall Study|Sponsor decision to amend protocol|0|||
164357820|NCT00451321|593686314|FG005|Overall Study|Sponsor decision to amend protocol|1|||
164357821|NCT00451321|593686315|FG006|Overall Study|Sponsor decision to amend protocol|1|||
164357822|NCT00451321|593686316|FG007|Overall Study|Sponsor decision to amend protocol|3|||
164357823|NCT00732615|593686319|FG000|Overall Study|Withdrawal by Subject|3|||
164357824|NCT00732615|593686320|FG001|Overall Study|Withdrawal by Subject|1|||
164357825|NCT00732615|593686319|FG000|Overall Study|Lost to Follow-up|0|||
164357826|NCT00732615|593686320|FG001|Overall Study|Lost to Follow-up|1|||
164357827|NCT00732615|593686319|FG000|Overall Study|Adverse Event|0|||
164008443|NCT01357239|592396720|FG003|Stratum: All Patients|Subject withdrew consent|1|||
164357828|NCT00732615|593686320|FG001|Overall Study|Adverse Event|2|||
164357829|NCT00732615|593686319|FG000|Overall Study|Physician Decision|3|||
164357830|NCT00732615|593686320|FG001|Overall Study|Physician Decision|0|||
164357831|NCT00732615|593686319|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
164357832|NCT00732615|593686320|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
164357833|NCT00909389|593686323|FG000|Overall Study|Adverse Event|6|||
164357834|NCT00909389|593686323|FG000|Overall Study|Death|4|||
164357835|NCT00909389|593686323|FG000|Overall Study|Poor Compliance|16|||
164357836|NCT00909389|593686323|FG000|Overall Study|Lost to Follow-up|4|||
164357837|NCT00909389|593686323|FG000|Overall Study|No Information|103|||
164357838|NCT03566823|593686326|FG000|Overall Study|Lack of Efficacy|0|||
164357839|NCT03566823|593686327|FG001|Overall Study|Lack of Efficacy|1|||
164357840|NCT03566823|593686328|FG002|Overall Study|Lack of Efficacy|0|||
164357841|NCT03566823|593686326|FG000|Overall Study|Withdrawal by Subject|1|||
164357842|NCT03566823|593686327|FG001|Overall Study|Withdrawal by Subject|2|||
164357843|NCT03566823|593686328|FG002|Overall Study|Withdrawal by Subject|0|||
164357844|NCT03566823|593686326|FG000|Overall Study|Adverse Event|1|||
164357845|NCT03566823|593686327|FG001|Overall Study|Adverse Event|0|||
164357846|NCT03566823|593686328|FG002|Overall Study|Adverse Event|2|||
164357847|NCT01166763|593686329|FG000|Overall Study|Withdrawal by Subject|3|||
164357848|NCT03557151|593686330|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
164357849|NCT03557151|593686331|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
164357850|NCT03557151|593686330|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
164357851|NCT03557151|593686331|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
164357852|NCT03557151|593686330|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
164357853|NCT03557151|593686331|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
164357854|NCT02810392|593686332|FG000|Overall Study|Subject too ill to continue|1|||
164357855|NCT02810392|593686333|FG001|Overall Study|Subject too ill to continue|0|||
164357856|NCT02810392|593686332|FG000|Overall Study|COVID 19 research restrictions|0|||
164357857|NCT02810392|593686333|FG001|Overall Study|COVID 19 research restrictions|1|||
164357858|NCT03035409|593686335|FG000|Overall Study|Adverse Event|5|||
164357859|NCT03035409|593686335|FG000|Overall Study|Death|2|||
164357860|NCT03035409|593686335|FG000|Overall Study|Withdrawal by Subject|2|||
164357861|NCT03035409|593686335|FG000|Overall Study|Non compliance|4|||
164357862|NCT03035409|593686335|FG000|Overall Study|Patient was jittery|1|||
164357863|NCT03035409|593686335|FG000|Overall Study|Did not like Questionnaire|1|||
164357864|NCT03035409|593686335|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
164357865|NCT03035409|593686335|FG000|Overall Study|Did not like taking drugs|1|||
164357866|NCT06079320|593686336|FG000|Follow up Phase|Lost to Follow-up|1|||
164357867|NCT06079320|593686337|FG001|Follow up Phase|Lost to Follow-up|0|||
164357868|NCT03428360|593686338|FG000|Overall Study|Informed consent withdrawn|5|||
164357869|NCT03428360|593686338|FG000|Overall Study|Withdrawal by Subject|4|||
164357870|NCT03428360|593686338|FG000|Overall Study|Lost to Follow-up|5|||
164357871|NCT03428360|593686338|FG000|Overall Study|Physician Decision|2|||
164357872|NCT03428360|593686338|FG000|Overall Study|Informed consent withdrawn|5|||
164357873|NCT03428360|593686338|FG000|Overall Study|Study terminated by sponsor|10|||
164357874|NCT03428360|593686338|FG000|Overall Study|Non-compliant with study|1|||
164357875|NCT03428360|593686338|FG000|Overall Study|Non-compliant with study drug|3|||
164008444|NCT01357239|592396717|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
164008445|NCT01357239|592396718|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
164008446|NCT01357239|592396719|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
164008447|NCT01357239|592396720|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
164008448|NCT01357239|592396717|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
164008449|NCT01357239|592396718|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
164357876|NCT03428360|593686338|FG000|Overall Study|Death|3|||
164357877|NCT03428360|593686338|FG000|Overall Study|Adverse Event|1|||
164357878|NCT03428360|593686338|FG000|Overall Study|Not on antiepileptic drug|1|||
164008450|NCT01357239|592396719|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
164008451|NCT01357239|592396720|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
164008452|NCT01357239|592396717|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
164008453|NCT01357239|592396718|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
164008454|NCT01357239|592396719|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
164008455|NCT01357239|592396720|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
164008456|NCT03133481|592396723|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
164008457|NCT03133481|592396724|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
164008458|NCT00637728|592396728|FG000|Double-blind Phase|Adverse Event|1|||
164357879|NCT02107482|593686344|FG000|Overall Study|inconveinence|2|||
164357880|NCT02107482|593686344|FG000|Overall Study|Lost to Follow-up|1|||
164357881|NCT02107482|593686344|FG000|Overall Study|Lack of Efficacy|1|||
164357882|NCT04868890|593686345|FG000|Overall Study|Death|2|||
164357883|NCT04868890|593686346|FG001|Overall Study|Death|1|||
164008459|NCT00637728|592396729|FG001|Double-blind Phase|Adverse Event|0|||
164008460|NCT00637728|592396730|FG002|Double-blind Phase|Adverse Event|0|||
164357884|NCT04868890|593686345|FG000|Overall Study|Withdrawal by Subject|1|||
164357885|NCT04868890|593686346|FG001|Overall Study|Withdrawal by Subject|5|||
164357886|NCT02669433|593686349|FG000|Overall Study|Protocol Violation|0|||
164357887|NCT02669433|593686350|FG001|Overall Study|Protocol Violation|4|||
164357888|NCT02669433|593686351|FG002|Overall Study|Protocol Violation|1|||
164357889|NCT02669433|593686349|FG000|Overall Study|Disease Progression|1|||
164357890|NCT02669433|593686350|FG001|Overall Study|Disease Progression|0|||
164357891|NCT02669433|593686351|FG002|Overall Study|Disease Progression|0|||
164357892|NCT02669433|593686349|FG000|Overall Study|Physician Decision|1|||
164357893|NCT02669433|593686350|FG001|Overall Study|Physician Decision|1|||
164357894|NCT02669433|593686351|FG002|Overall Study|Physician Decision|0|||
164357895|NCT02669433|593686349|FG000|Overall Study|Adverse Event|6|||
164357896|NCT02669433|593686350|FG001|Overall Study|Adverse Event|7|||
164357897|NCT02669433|593686351|FG002|Overall Study|Adverse Event|10|||
164357898|NCT02669433|593686349|FG000|Overall Study|Sponsor Termination|1|||
164357899|NCT02669433|593686350|FG001|Overall Study|Sponsor Termination|0|||
164357900|NCT02669433|593686351|FG002|Overall Study|Sponsor Termination|1|||
164357901|NCT02669433|593686349|FG000|Overall Study|Withdrawal by Subject|5|||
164357902|NCT02669433|593686350|FG001|Overall Study|Withdrawal by Subject|1|||
164357903|NCT02669433|593686351|FG002|Overall Study|Withdrawal by Subject|0|||
164357904|NCT02669433|593686349|FG000|Overall Study|Withdrawal by Caregiver|1|||
164357905|NCT02669433|593686350|FG001|Overall Study|Withdrawal by Caregiver|0|||
164357906|NCT02669433|593686351|FG002|Overall Study|Withdrawal by Caregiver|2|||
164357907|NCT02669433|593686349|FG000|Overall Study|Death|0|||
164357908|NCT02669433|593686350|FG001|Overall Study|Death|1|||
164357909|NCT02669433|593686351|FG002|Overall Study|Death|1|||
164357910|NCT00576927|593686352|FG000|Clinical Assessment|Lack of Efficacy|24|||
164357911|NCT00576927|593686352|FG000|Clinical Assessment|Death|1|||
164357912|NCT00576927|593686352|FG000|Clinical Assessment|Withdrawal by Subject|10|||
164357913|NCT00576927|593686352|FG000|Clinical Assessment|Physician Decision|1|||
164357914|NCT00576927|593686352|FG000|Baseline|Physician Decision|9|||
164357915|NCT00576927|593686352|FG000|Baseline|Medication Change by PCP of subject|1|||
164357916|NCT00576927|593686352|FG000|Baseline|Withdrawal by Subject|3|||
164357917|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
164357918|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
164357919|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
164357920|NCT00576927|593686352|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
164357921|NCT00576927|593686352|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
164357922|NCT03128892|593686353|FG000|Overall Study|Withdrawal by Subject|2|||
164357923|NCT03128892|593686353|FG000|Overall Study|Physician Decision|1|||
164357924|NCT01850524|593686357|FG000|Overall Study|Lost to Follow-up|5|||
164357925|NCT01850524|593686358|FG001|Overall Study|Lost to Follow-up|10|||
164357926|NCT01850524|593686357|FG000|Overall Study|Withdrawal by Subject|24|||
164357927|NCT01850524|593686358|FG001|Overall Study|Withdrawal by Subject|22|||
164357928|NCT01850524|593686357|FG000|Overall Study|Reason not Specified|142|||
164357929|NCT01850524|593686358|FG001|Overall Study|Reason not Specified|141|||
164357930|NCT00368355|593686360|FG000|Overall Study|Adverse Event|1|||
164357931|NCT00368355|593686361|FG001|Overall Study|Adverse Event|0|||
164357932|NCT00368355|593686360|FG000|Overall Study|Death|2|||
164357933|NCT00368355|593686361|FG001|Overall Study|Death|4|||
164357934|NCT00368355|593686360|FG000|Overall Study|Relapse|6|||
164008461|NCT00637728|592396728|FG000|Double-blind Phase|Non-compliance|2|||
164008462|NCT00637728|592396729|FG001|Double-blind Phase|Non-compliance|0|||
164008463|NCT00637728|592396730|FG002|Double-blind Phase|Non-compliance|0|||
164008464|NCT00637728|592396728|FG000|Double-blind Phase|Study Discontinued|1|||
164008465|NCT00637728|592396729|FG001|Double-blind Phase|Study Discontinued|1|||
164008466|NCT00637728|592396730|FG002|Double-blind Phase|Study Discontinued|0|||
164008467|NCT01873950|592396733|FG000|Period 5|Withdrawal by Subject|0|||
164008468|NCT01873950|592396734|FG001|Period 5|Withdrawal by Subject|0|||
164008469|NCT01873950|592396735|FG002|Period 5|Withdrawal by Subject|0|||
164357935|NCT00368355|593686361|FG001|Overall Study|Relapse|10|||
164357936|NCT00368355|593686360|FG000|Overall Study|Subsequent transplant|0|||
164357937|NCT00368355|593686361|FG001|Overall Study|Subsequent transplant|3|||
164357938|NCT00368355|593686360|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
164357939|NCT00368355|593686361|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
164357940|NCT03473808|593686370|FG000|Overall Study|Withdrawal by Subject|1|||
164357941|NCT02157298|593686373|FG000|Overall Study|Adverse Event|1|||
164008470|NCT01873950|592396736|FG003|Period 5|Withdrawal by Subject|1|||
164357942|NCT02157298|593686374|FG001|Overall Study|Adverse Event|0|||
164008471|NCT01873950|592396737|FG004|Period 5|Withdrawal by Subject|0|||
164357943|NCT02157298|593686373|FG000|Overall Study|Subject no longer meets study criteria|1|||
164357944|NCT02157298|593686374|FG001|Overall Study|Subject no longer meets study criteria|2|||
164357945|NCT02157298|593686373|FG000|Overall Study|Poor/Non-compliance|1|||
164357946|NCT02157298|593686374|FG001|Overall Study|Poor/Non-compliance|0|||
164357947|NCT02157298|593686373|FG000|Overall Study|Withdrawal by Subject|1|||
164357948|NCT02157298|593686374|FG001|Overall Study|Withdrawal by Subject|0|||
164357949|NCT04059094|593686375|FG000|Overall Study|Adverse Event|0|||
164357950|NCT04059094|593686376|FG001|Overall Study|Adverse Event|0|||
164357951|NCT04059094|593686377|FG002|Overall Study|Adverse Event|0|||
164357952|NCT04059094|593686378|FG003|Overall Study|Adverse Event|0|||
164357953|NCT04059094|593686379|FG004|Overall Study|Adverse Event|1|||
164357954|NCT04059094|593686375|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357955|NCT04059094|593686376|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
164357956|NCT04059094|593686377|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357957|NCT04059094|593686378|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357958|NCT04059094|593686379|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
164357959|NCT01085591|593686380|FG000|Overall Study|Adverse Event|0|||
164357960|NCT01085591|593686381|FG001|Overall Study|Adverse Event|1|||
164357961|NCT01085591|593686382|FG002|Overall Study|Adverse Event|3|||
164357962|NCT01085591|593686380|FG000|Overall Study|Physician Decision|1|||
164357963|NCT01085591|593686381|FG001|Overall Study|Physician Decision|0|||
164357964|NCT01085591|593686382|FG002|Overall Study|Physician Decision|1|||
164357965|NCT01085591|593686380|FG000|Overall Study|Withdrawal by Subject|0|||
164357966|NCT01085591|593686381|FG001|Overall Study|Withdrawal by Subject|2|||
164357967|NCT01085591|593686382|FG002|Overall Study|Withdrawal by Subject|1|||
164357968|NCT01085591|593686380|FG000|Overall Study|Lost to Follow-up|0|||
164357969|NCT01085591|593686381|FG001|Overall Study|Lost to Follow-up|1|||
164357970|NCT01085591|593686382|FG002|Overall Study|Lost to Follow-up|1|||
164357971|NCT01085591|593686380|FG000|Overall Study|Protocol Violation|1|||
164357972|NCT01085591|593686381|FG001|Overall Study|Protocol Violation|1|||
164357973|NCT01085591|593686382|FG002|Overall Study|Protocol Violation|1|||
164357974|NCT01085591|593686380|FG000|Overall Study|Other|0|||
164357975|NCT01085591|593686381|FG001|Overall Study|Other|1|||
164357976|NCT01085591|593686382|FG002|Overall Study|Other|0|||
164357977|NCT01085591|593686380|FG000|Overall Study|Not Properly Consented|1|||
164357978|NCT01085591|593686381|FG001|Overall Study|Not Properly Consented|0|||
164357979|NCT01085591|593686382|FG002|Overall Study|Not Properly Consented|0|||
164357980|NCT03715764|593686383|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
164008472|NCT03000452|592396739|FG000|Treatment Period|Death|1|||
164008473|NCT03000452|592396739|FG000|Treatment Period|Progressive Disease (PD)|14|||
164008474|NCT03000452|592396739|FG000|Treatment Period|Physician Decision|1|||
164008475|NCT03000452|592396739|FG000|Treatment Period|Miscellaneous|2|||
164008476|NCT03000452|592396739|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
164008477|NCT03000452|592396739|FG000|Follow-Up Period|Death|3|||
164357981|NCT03715764|593686384|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
164357982|NCT03715764|593686383|FG000|3 Month Follow-up|Lost to Follow-up|2|||
164357983|NCT03715764|593686384|FG001|3 Month Follow-up|Lost to Follow-up|2|||
164357984|NCT03715764|593686383|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
164357985|NCT03715764|593686384|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
164357986|NCT03715764|593686383|FG000|6 Month Follow-up|Lost to Follow-up|3|||
164357987|NCT03715764|593686384|FG001|6 Month Follow-up|Lost to Follow-up|0|||
164357988|NCT03715764|593686383|FG000|12 Month Follow-up|Lost to Follow-up|2|||
164357989|NCT03715764|593686384|FG001|12 Month Follow-up|Lost to Follow-up|3|||
164357990|NCT03715764|593686383|FG000|12 Month Follow-up|Pregnancy|0|||
164357991|NCT03715764|593686384|FG001|12 Month Follow-up|Pregnancy|1|||
164357992|NCT03715764|593686383|FG000|12 Month Follow-up|Surgery|2|||
164357993|NCT03715764|593686384|FG001|12 Month Follow-up|Surgery|0|||
164357994|NCT03715764|593686383|FG000|12 Month Follow-up|Wrong address|1|||
164357995|NCT03715764|593686384|FG001|12 Month Follow-up|Wrong address|0|||
164357996|NCT03715764|593686383|FG000|12 Month Follow-up|No symptoms|1|||
164357997|NCT03715764|593686384|FG001|12 Month Follow-up|No symptoms|0|||
164357998|NCT03715764|593686383|FG000|12 Month Follow-up|Changed primary care centre|0|||
164357999|NCT03715764|593686384|FG001|12 Month Follow-up|Changed primary care centre|1|||
164358000|NCT01980875|593686386|FG000|Overall Study|Withdrew Consent|1|||
164358001|NCT01980875|593686387|FG001|Overall Study|Withdrew Consent|1|||
164358002|NCT01980875|593686388|FG002|Overall Study|Withdrew Consent|1|||
164358003|NCT01980875|593686386|FG000|Overall Study|Study Terminated by Sponsor|7|||
164358004|NCT01980875|593686387|FG001|Overall Study|Study Terminated by Sponsor|24|||
164358005|NCT01980875|593686388|FG002|Overall Study|Study Terminated by Sponsor|22|||
164358006|NCT01980875|593686386|FG000|Overall Study|Lost to Follow-up|0|||
164358007|NCT01980875|593686387|FG001|Overall Study|Lost to Follow-up|0|||
164358008|NCT01980875|593686388|FG002|Overall Study|Lost to Follow-up|1|||
164008478|NCT03000452|592396739|FG000|Follow-Up Period|Withdrawal by Subject|3|||
164358009|NCT00662363|593686389|FG000|Overall Study|Withdrawal by Subject|6|||
164358010|NCT00662363|593686390|FG001|Overall Study|Withdrawal by Subject|5|||
164358011|NCT00662363|593686389|FG000|Overall Study|Adverse Event|0|||
164358012|NCT00662363|593686390|FG001|Overall Study|Adverse Event|3|||
164358013|NCT00662363|593686389|FG000|Overall Study|Discharged early from rehab|4|||
164008479|NCT00593112|592396740|FG000|Overall Study|Scan Anxiety|3|||
164008480|NCT00593112|592396741|FG001|Overall Study|Scan Anxiety|0|||
164358014|NCT00662363|593686390|FG001|Overall Study|Discharged early from rehab|1|||
164358015|NCT00662363|593686389|FG000|Overall Study|Protocol Violation|1|||
164008481|NCT00593112|592396740|FG000|Overall Study|Abnormal Scan|1|||
164008482|NCT00593112|592396741|FG001|Overall Study|Abnormal Scan|0|||
164008483|NCT00593112|592396740|FG000|Overall Study|Unreadable Scan|1|||
164358016|NCT00662363|593686390|FG001|Overall Study|Protocol Violation|1|||
164358017|NCT01905657|593686391|FG000|Overall Study|Adverse Event|23|||
164358018|NCT01905657|593686392|FG001|Overall Study|Adverse Event|17|||
164358019|NCT01905657|593686393|FG002|Overall Study|Adverse Event|18|||
164358020|NCT01905657|593686391|FG000|Overall Study|Clinical Progression|103|||
164358021|NCT01905657|593686392|FG001|Overall Study|Clinical Progression|78|||
164358022|NCT01905657|593686393|FG002|Overall Study|Clinical Progression|59|||
164358023|NCT01905657|593686391|FG000|Overall Study|Death|40|||
164358024|NCT01905657|593686392|FG001|Overall Study|Death|43|||
164358025|NCT01905657|593686393|FG002|Overall Study|Death|47|||
164358026|NCT01905657|593686391|FG000|Overall Study|Excluded Medication|13|||
164358027|NCT01905657|593686392|FG001|Overall Study|Excluded Medication|16|||
164358028|NCT01905657|593686393|FG002|Overall Study|Excluded Medication|9|||
164358029|NCT01905657|593686391|FG000|Overall Study|Lost to Follow-up|1|||
164358030|NCT01905657|593686392|FG001|Overall Study|Lost to Follow-up|2|||
164358031|NCT01905657|593686393|FG002|Overall Study|Lost to Follow-up|1|||
164358032|NCT01905657|593686391|FG000|Overall Study|Physician Decision|5|||
164358033|NCT01905657|593686392|FG001|Overall Study|Physician Decision|8|||
164358034|NCT01905657|593686393|FG002|Overall Study|Physician Decision|12|||
164358035|NCT01905657|593686391|FG000|Overall Study|Protocol Violation|2|||
164358036|NCT01905657|593686392|FG001|Overall Study|Protocol Violation|1|||
164358037|NCT01905657|593686393|FG002|Overall Study|Protocol Violation|1|||
164358038|NCT01905657|593686391|FG000|Overall Study|Screen Failure|0|||
164358039|NCT01905657|593686392|FG001|Overall Study|Screen Failure|1|||
164358040|NCT01905657|593686393|FG002|Overall Study|Screen Failure|0|||
164358041|NCT01905657|593686391|FG000|Overall Study|Withdrawal by Subject|15|||
164358042|NCT01905657|593686392|FG001|Overall Study|Withdrawal by Subject|21|||
164358043|NCT01905657|593686393|FG002|Overall Study|Withdrawal by Subject|53|||
164358044|NCT01905657|593686391|FG000|Overall Study|Sponsor Decision|1|||
164358045|NCT01905657|593686392|FG001|Overall Study|Sponsor Decision|0|||
164358046|NCT01905657|593686393|FG002|Overall Study|Sponsor Decision|0|||
164358047|NCT05119569|593686398|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
164358048|NCT05119569|593686399|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
164358049|NCT05119569|593686400|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164358050|NCT05119569|593686401|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164358051|NCT05119569|593686398|FG000|Double Blind Treatment Phase|Adverse Event|6|||
164358052|NCT05119569|593686399|FG001|Double Blind Treatment Phase|Adverse Event|0|||
164358053|NCT05119569|593686400|FG002|Double Blind Treatment Phase|Adverse Event|0|||
164358054|NCT05119569|593686401|FG003|Double Blind Treatment Phase|Adverse Event|0|||
164358055|NCT05119569|593686398|FG000|Open Label Extension Phase|Ongoing in the study|0|||
164358056|NCT05119569|593686399|FG001|Open Label Extension Phase|Ongoing in the study|0|||
164358057|NCT05119569|593686400|FG002|Open Label Extension Phase|Ongoing in the study|65|||
164358058|NCT05119569|593686401|FG003|Open Label Extension Phase|Ongoing in the study|34|||
164358059|NCT02623439|593686404|FG000|Overall Study|Withdrawal by Subject|1|||
164358060|NCT02623439|593686404|FG000|Overall Study|Screen Failure|1|||
164358061|NCT02200445|593686407|FG000|Overall Study|Lack of Efficacy|1|||
164358062|NCT02200445|593686408|FG001|Overall Study|Lack of Efficacy|2|||
164358063|NCT02200445|593686409|FG002|Overall Study|Lack of Efficacy|2|||
164358064|NCT02200445|593686407|FG000|Overall Study|Adverse Event|0|||
164358065|NCT02200445|593686408|FG001|Overall Study|Adverse Event|2|||
164358066|NCT02200445|593686409|FG002|Overall Study|Adverse Event|0|||
164358067|NCT04484142|593686410|FG000|Overall Study|Adverse Event|13|||
164358068|NCT04484142|593686410|FG000|Overall Study|Progressive Disease|87|||
164358069|NCT04484142|593686410|FG000|Overall Study|Clinical Progression|10|||
164008484|NCT00593112|592396741|FG001|Overall Study|Unreadable Scan|0|||
164008485|NCT00593112|592396740|FG000|Overall Study|Withdrawal by Subject|5|||
164008486|NCT00593112|592396741|FG001|Overall Study|Withdrawal by Subject|0|||
164008487|NCT05372315|592396742|FG000|Overall Study|Withdrawal by Subject|1|||
164008488|NCT05372315|592396743|FG001|Overall Study|Withdrawal by Subject|0|||
164008489|NCT01512368|592396745|FG000|Overall Study|Protocol Violation|3|||
164008490|NCT00328198|592396746|FG000|Treatment|Adverse Event|21|||
164008491|NCT00328198|592396746|FG000|Treatment|Death|1|||
164008492|NCT00328198|592396746|FG000|Treatment|Physician Decision|5|||
164358070|NCT04484142|593686410|FG000|Overall Study|Withdrawal by Subject|6|||
164358071|NCT04484142|593686410|FG000|Overall Study|Physician Decision|1|||
164358072|NCT03700671|593686411|FG000|Overall Study|Lack of Efficacy|1|||
164358073|NCT03700671|593686412|FG001|Overall Study|Lack of Efficacy|2|||
164358074|NCT05371509|593686413|FG000|Overall Study|Physician Decision|1|||
164358075|NCT05371509|593686414|FG001|Overall Study|Physician Decision|0|||
164358076|NCT04405037|593686421|FG000|Overall Study|Withdrawal by Subject|1|||
164358077|NCT04405037|593686422|FG001|Overall Study|Withdrawal by Subject|0|||
164358078|NCT04405037|593686421|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
164358079|NCT04405037|593686422|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
164008493|NCT00328198|592396746|FG000|Treatment|Withdrawal by Subject|5|||
164008494|NCT00328198|592396746|FG000|Treatment|Evidence of disease progression|2|||
164008495|NCT00328198|592396746|FG000|Treatment|Non-compliance|1|||
164008496|NCT00328198|592396746|FG000|Treatment|Confirmed complete response, MRD -|3|||
164008497|NCT00328198|592396746|FG000|Follow-up|Lost to Follow-up|4|||
164008498|NCT00328198|592396746|FG000|Follow-up|Death|31|||
164008499|NCT01570491|592396747|FG000|Overall Study|Lost to Follow-up|3|||
164008500|NCT01570491|592396748|FG001|Overall Study|Lost to Follow-up|1|||
164008501|NCT01570491|592396747|FG000|Overall Study|treatment: not given or discontinued|2|||
164008502|NCT01570491|592396748|FG001|Overall Study|treatment: not given or discontinued|0|||
164008503|NCT01720667|592396754|FG000|Overall Study|Adverse Event|1|||
164008504|NCT01720667|592396755|FG001|Overall Study|Adverse Event|1|||
164008505|NCT01720667|592396754|FG000|Overall Study|Withdrawal by Subject|3|||
164008506|NCT01720667|592396755|FG001|Overall Study|Withdrawal by Subject|0|||
164008507|NCT04407507|592396756|FG000|Overall Study|Withdrawal by Subject|0|||
164008508|NCT04407507|592396757|FG001|Overall Study|Withdrawal by Subject|1|||
164008509|NCT00234104|592396760|FG000|Overall Study|Adverse Event|4|||
164008510|NCT00234104|592396761|FG001|Overall Study|Adverse Event|0|||
164008511|NCT00234104|592396762|FG002|Overall Study|Adverse Event|3|||
164008512|NCT00234104|592396763|FG003|Overall Study|Adverse Event|5|||
164091193|NCT02354586|592697842|FG000|Overall Study|Site closure|2|||
164091194|NCT02354586|592697842|FG000|Overall Study|Intercurrent illness|1|||
164091195|NCT02354586|592697842|FG000|Overall Study|Protocol Violation|3|||
164358080|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
164358081|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
164358082|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
164358083|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
164358084|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
164358085|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
164358086|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
164358087|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
164358088|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
164358089|NCT04434092|593686423|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
164358090|NCT04434092|593686424|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
164358091|NCT04434092|593686425|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
164358092|NCT04434092|593686423|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
164358093|NCT04434092|593686424|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
164358094|NCT04434092|593686425|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
164358095|NCT04434092|593686423|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
164358096|NCT04434092|593686424|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
164358097|NCT04434092|593686425|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
164358098|NCT04434092|593686423|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
164358099|NCT04434092|593686424|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
164358100|NCT04434092|593686425|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
164358101|NCT02554812|593686426|FG000|Overall Study|Adverse Event|2|||
164358102|NCT02554812|593686427|FG001|Overall Study|Adverse Event|5|||
164358103|NCT02554812|593686428|FG002|Overall Study|Adverse Event|3|||
164358104|NCT02554812|593686429|FG003|Overall Study|Adverse Event|0|||
164358105|NCT02554812|593686430|FG004|Overall Study|Adverse Event|5|||
164358106|NCT02554812|593686431|FG005|Overall Study|Adverse Event|0|||
164358107|NCT02554812|593686432|FG006|Overall Study|Adverse Event|1|||
164358108|NCT02554812|593686433|FG007|Overall Study|Adverse Event|6|||
164358109|NCT02554812|593686434|FG008|Overall Study|Adverse Event|2|||
164358110|NCT02554812|593686435|FG009|Overall Study|Adverse Event|2|||
164358111|NCT02554812|593686436|FG010|Overall Study|Adverse Event|1|||
164358112|NCT02554812|593686437|FG011|Overall Study|Adverse Event|2|||
164358113|NCT02554812|593686438|FG012|Overall Study|Adverse Event|0|||
164358114|NCT02554812|593686439|FG013|Overall Study|Adverse Event|3|||
164008513|NCT00234104|592396760|FG000|Overall Study|Protocol Violation|0|||
164008514|NCT00234104|592396761|FG001|Overall Study|Protocol Violation|0|||
164008515|NCT00234104|592396762|FG002|Overall Study|Protocol Violation|0|||
164008516|NCT00234104|592396763|FG003|Overall Study|Protocol Violation|1|||
164008517|NCT00234104|592396760|FG000|Overall Study|Physician Decision|0|||
164008518|NCT00234104|592396761|FG001|Overall Study|Physician Decision|1|||
164008519|NCT00234104|592396762|FG002|Overall Study|Physician Decision|2|||
164008520|NCT00234104|592396763|FG003|Overall Study|Physician Decision|2|||
164091196|NCT02354586|592697842|FG000|Overall Study|Physician Decision|13|||
164091197|NCT02354586|592697842|FG000|Overall Study|Lack of Efficacy|86|||
164358115|NCT02554812|593686440|FG014|Overall Study|Adverse Event|2|||
164358116|NCT02554812|593686441|FG015|Overall Study|Adverse Event|1|||
164358117|NCT02554812|593686442|FG016|Overall Study|Adverse Event|0|||
164008521|NCT00546819|592396764|FG000|Overall Study|Adverse Event|2|||
164358118|NCT02554812|593686443|FG017|Overall Study|Adverse Event|1|||
164358119|NCT02554812|593686444|FG018|Overall Study|Adverse Event|0|||
164358120|NCT02554812|593686445|FG019|Overall Study|Adverse Event|0|||
164358121|NCT02554812|593686446|FG020|Overall Study|Adverse Event|0|||
164358122|NCT02554812|593686447|FG021|Overall Study|Adverse Event|2|||
164358123|NCT02554812|593686448|FG022|Overall Study|Adverse Event|1|||
164358124|NCT02554812|593686449|FG023|Overall Study|Adverse Event|1|||
164358125|NCT02554812|593686450|FG024|Overall Study|Adverse Event|1|||
164008522|NCT00546819|592396765|FG001|Overall Study|Adverse Event|3|||
164008523|NCT00546819|592396764|FG000|Overall Study|Lost to Follow-up|2|||
164358126|NCT02554812|593686451|FG025|Overall Study|Adverse Event|2|||
164358127|NCT02554812|593686452|FG026|Overall Study|Adverse Event|1|||
164358128|NCT02554812|593686426|FG000|Overall Study|Death|1|||
164358129|NCT02554812|593686427|FG001|Overall Study|Death|2|||
164358130|NCT02554812|593686428|FG002|Overall Study|Death|2|||
164358131|NCT02554812|593686429|FG003|Overall Study|Death|2|||
164358132|NCT02554812|593686430|FG004|Overall Study|Death|0|||
164358133|NCT02554812|593686431|FG005|Overall Study|Death|1|||
164358134|NCT02554812|593686432|FG006|Overall Study|Death|1|||
164358135|NCT02554812|593686433|FG007|Overall Study|Death|1|||
164358136|NCT02554812|593686434|FG008|Overall Study|Death|0|||
164358137|NCT02554812|593686435|FG009|Overall Study|Death|0|||
164358138|NCT02554812|593686436|FG010|Overall Study|Death|0|||
164358139|NCT02554812|593686437|FG011|Overall Study|Death|0|||
164358140|NCT02554812|593686438|FG012|Overall Study|Death|0|||
164358141|NCT02554812|593686439|FG013|Overall Study|Death|0|||
164358142|NCT02554812|593686440|FG014|Overall Study|Death|1|||
164358143|NCT02554812|593686441|FG015|Overall Study|Death|1|||
164358144|NCT02554812|593686442|FG016|Overall Study|Death|1|||
164358145|NCT02554812|593686443|FG017|Overall Study|Death|0|||
164358146|NCT02554812|593686444|FG018|Overall Study|Death|1|||
164358147|NCT02554812|593686445|FG019|Overall Study|Death|2|||
164358148|NCT02554812|593686446|FG020|Overall Study|Death|0|||
164358149|NCT02554812|593686447|FG021|Overall Study|Death|1|||
164358150|NCT02554812|593686448|FG022|Overall Study|Death|1|||
164358151|NCT02554812|593686449|FG023|Overall Study|Death|0|||
164358152|NCT02554812|593686450|FG024|Overall Study|Death|0|||
164358153|NCT02554812|593686451|FG025|Overall Study|Death|0|||
164358154|NCT02554812|593686452|FG026|Overall Study|Death|0|||
164358155|NCT02554812|593686426|FG000|Overall Study|Lost to Follow-up|0|||
164358156|NCT02554812|593686427|FG001|Overall Study|Lost to Follow-up|1|||
164358157|NCT02554812|593686428|FG002|Overall Study|Lost to Follow-up|0|||
164358158|NCT02554812|593686429|FG003|Overall Study|Lost to Follow-up|0|||
164358159|NCT02554812|593686430|FG004|Overall Study|Lost to Follow-up|0|||
164358160|NCT02554812|593686431|FG005|Overall Study|Lost to Follow-up|0|||
164358161|NCT02554812|593686432|FG006|Overall Study|Lost to Follow-up|0|||
164358162|NCT02554812|593686433|FG007|Overall Study|Lost to Follow-up|0|||
164358163|NCT02554812|593686434|FG008|Overall Study|Lost to Follow-up|0|||
164358164|NCT02554812|593686435|FG009|Overall Study|Lost to Follow-up|0|||
164358165|NCT02554812|593686436|FG010|Overall Study|Lost to Follow-up|0|||
164358166|NCT02554812|593686437|FG011|Overall Study|Lost to Follow-up|0|||
164358167|NCT02554812|593686438|FG012|Overall Study|Lost to Follow-up|0|||
164358168|NCT02554812|593686439|FG013|Overall Study|Lost to Follow-up|0|||
164358169|NCT02554812|593686440|FG014|Overall Study|Lost to Follow-up|0|||
164358170|NCT02554812|593686441|FG015|Overall Study|Lost to Follow-up|0|||
164358171|NCT02554812|593686442|FG016|Overall Study|Lost to Follow-up|0|||
164358172|NCT02554812|593686443|FG017|Overall Study|Lost to Follow-up|0|||
164358173|NCT02554812|593686444|FG018|Overall Study|Lost to Follow-up|0|||
164358174|NCT02554812|593686445|FG019|Overall Study|Lost to Follow-up|0|||
164358175|NCT02554812|593686446|FG020|Overall Study|Lost to Follow-up|0|||
164358176|NCT02554812|593686447|FG021|Overall Study|Lost to Follow-up|0|||
164358177|NCT02554812|593686448|FG022|Overall Study|Lost to Follow-up|0|||
164008524|NCT00546819|592396765|FG001|Overall Study|Lost to Follow-up|1|||
164008525|NCT00546819|592396764|FG000|Overall Study|Withdrawal by Subject|4|||
164358178|NCT02554812|593686449|FG023|Overall Study|Lost to Follow-up|0|||
164358179|NCT02554812|593686450|FG024|Overall Study|Lost to Follow-up|0|||
164358180|NCT02554812|593686451|FG025|Overall Study|Lost to Follow-up|0|||
164358181|NCT02554812|593686452|FG026|Overall Study|Lost to Follow-up|0|||
164358182|NCT02554812|593686426|FG000|Overall Study|Global deterioration of health status|4|||
164358183|NCT02554812|593686427|FG001|Overall Study|Global deterioration of health status|3|||
164008526|NCT00546819|592396765|FG001|Overall Study|Withdrawal by Subject|2|||
164358184|NCT02554812|593686428|FG002|Overall Study|Global deterioration of health status|3|||
164358185|NCT02554812|593686429|FG003|Overall Study|Global deterioration of health status|2|||
164358186|NCT02554812|593686430|FG004|Overall Study|Global deterioration of health status|5|||
164358187|NCT02554812|593686431|FG005|Overall Study|Global deterioration of health status|0|||
164358188|NCT02554812|593686432|FG006|Overall Study|Global deterioration of health status|2|||
164358189|NCT02554812|593686433|FG007|Overall Study|Global deterioration of health status|1|||
164358190|NCT02554812|593686434|FG008|Overall Study|Global deterioration of health status|1|||
164358191|NCT02554812|593686435|FG009|Overall Study|Global deterioration of health status|1|||
164358192|NCT02554812|593686436|FG010|Overall Study|Global deterioration of health status|2|||
164358193|NCT02554812|593686437|FG011|Overall Study|Global deterioration of health status|1|||
164358194|NCT02554812|593686438|FG012|Overall Study|Global deterioration of health status|0|||
164358195|NCT02554812|593686439|FG013|Overall Study|Global deterioration of health status|0|||
164358196|NCT02554812|593686440|FG014|Overall Study|Global deterioration of health status|0|||
164358197|NCT02554812|593686441|FG015|Overall Study|Global deterioration of health status|1|||
164358198|NCT02554812|593686442|FG016|Overall Study|Global deterioration of health status|0|||
164358199|NCT02554812|593686443|FG017|Overall Study|Global deterioration of health status|0|||
164358200|NCT02554812|593686444|FG018|Overall Study|Global deterioration of health status|0|||
164358201|NCT02554812|593686445|FG019|Overall Study|Global deterioration of health status|0|||
164358202|NCT02554812|593686446|FG020|Overall Study|Global deterioration of health status|0|||
164358203|NCT02554812|593686447|FG021|Overall Study|Global deterioration of health status|0|||
164358204|NCT02554812|593686448|FG022|Overall Study|Global deterioration of health status|0|||
164358205|NCT02554812|593686449|FG023|Overall Study|Global deterioration of health status|0|||
164358206|NCT02554812|593686450|FG024|Overall Study|Global deterioration of health status|0|||
164358207|NCT02554812|593686451|FG025|Overall Study|Global deterioration of health status|0|||
164358208|NCT02554812|593686452|FG026|Overall Study|Global deterioration of health status|0|||
164358209|NCT02554812|593686426|FG000|Overall Study|Progressive disease|20|||
164358210|NCT02554812|593686427|FG001|Overall Study|Progressive disease|16|||
164358211|NCT02554812|593686428|FG002|Overall Study|Progressive disease|19|||
164358212|NCT02554812|593686429|FG003|Overall Study|Progressive disease|18|||
164358213|NCT02554812|593686430|FG004|Overall Study|Progressive disease|21|||
164358214|NCT02554812|593686431|FG005|Overall Study|Progressive disease|15|||
164358215|NCT02554812|593686432|FG006|Overall Study|Progressive disease|6|||
164358216|NCT02554812|593686433|FG007|Overall Study|Progressive disease|13|||
164358217|NCT02554812|593686434|FG008|Overall Study|Progressive disease|6|||
164358218|NCT02554812|593686435|FG009|Overall Study|Progressive disease|6|||
164358219|NCT02554812|593686436|FG010|Overall Study|Progressive disease|8|||
164358220|NCT02554812|593686437|FG011|Overall Study|Progressive disease|8|||
164358221|NCT02554812|593686438|FG012|Overall Study|Progressive disease|6|||
164358222|NCT02554812|593686439|FG013|Overall Study|Progressive disease|10|||
164358223|NCT02554812|593686440|FG014|Overall Study|Progressive disease|20|||
164358224|NCT02554812|593686441|FG015|Overall Study|Progressive disease|6|||
164358225|NCT02554812|593686442|FG016|Overall Study|Progressive disease|3|||
164358226|NCT02554812|593686443|FG017|Overall Study|Progressive disease|3|||
164358227|NCT02554812|593686444|FG018|Overall Study|Progressive disease|11|||
164358228|NCT02554812|593686445|FG019|Overall Study|Progressive disease|7|||
164358229|NCT02554812|593686446|FG020|Overall Study|Progressive disease|11|||
164358230|NCT02554812|593686447|FG021|Overall Study|Progressive disease|6|||
164358231|NCT02554812|593686448|FG022|Overall Study|Progressive disease|9|||
164358232|NCT02554812|593686449|FG023|Overall Study|Progressive disease|9|||
164358233|NCT02554812|593686450|FG024|Overall Study|Progressive disease|4|||
164358234|NCT02554812|593686451|FG025|Overall Study|Progressive disease|5|||
164358235|NCT02554812|593686452|FG026|Overall Study|Progressive disease|5|||
164358236|NCT02554812|593686426|FG000|Overall Study|Other|0|||
164358237|NCT02554812|593686427|FG001|Overall Study|Other|0|||
164358238|NCT02554812|593686428|FG002|Overall Study|Other|2|||
164358239|NCT02554812|593686429|FG003|Overall Study|Other|3|||
164358240|NCT02554812|593686430|FG004|Overall Study|Other|2|||
164358241|NCT02554812|593686431|FG005|Overall Study|Other|1|||
164358242|NCT02554812|593686432|FG006|Overall Study|Other|0|||
164358243|NCT02554812|593686433|FG007|Overall Study|Other|0|||
164008527|NCT04045613|592396766|FG000|Overall Study|Adverse Event|2|||
164008528|NCT04045613|592396767|FG001|Overall Study|Adverse Event|2|||
164008529|NCT04045613|592396768|FG002|Overall Study|Adverse Event|1|||
164008530|NCT04045613|592396769|FG003|Overall Study|Adverse Event|1|||
164008531|NCT04045613|592396770|FG004|Overall Study|Adverse Event|0|||
164358244|NCT02554812|593686434|FG008|Overall Study|Other|1|||
164358245|NCT02554812|593686435|FG009|Overall Study|Other|1|||
164358246|NCT02554812|593686436|FG010|Overall Study|Other|0|||
164358247|NCT02554812|593686437|FG011|Overall Study|Other|0|||
164008532|NCT04045613|592396771|FG005|Overall Study|Adverse Event|0|||
164008533|NCT04045613|592396772|FG006|Overall Study|Adverse Event|1|||
164358248|NCT02554812|593686438|FG012|Overall Study|Other|1|||
164358249|NCT02554812|593686439|FG013|Overall Study|Other|0|||
164358250|NCT02554812|593686440|FG014|Overall Study|Other|1|||
164358251|NCT02554812|593686441|FG015|Overall Study|Other|0|||
164358252|NCT02554812|593686442|FG016|Overall Study|Other|0|||
164358253|NCT02554812|593686443|FG017|Overall Study|Other|0|||
164008534|NCT04045613|592396766|FG000|Overall Study|Withdrawal by Subject|0|||
164358254|NCT02554812|593686444|FG018|Overall Study|Other|0|||
164358255|NCT02554812|593686445|FG019|Overall Study|Other|0|||
164358256|NCT02554812|593686446|FG020|Overall Study|Other|0|||
164358257|NCT02554812|593686447|FG021|Overall Study|Other|2|||
164358258|NCT02554812|593686448|FG022|Overall Study|Other|0|||
164008535|NCT04045613|592396767|FG001|Overall Study|Withdrawal by Subject|5|||
164008536|NCT04045613|592396768|FG002|Overall Study|Withdrawal by Subject|0|||
164008537|NCT04045613|592396769|FG003|Overall Study|Withdrawal by Subject|0|||
164008538|NCT04045613|592396770|FG004|Overall Study|Withdrawal by Subject|0|||
164008539|NCT04045613|592396771|FG005|Overall Study|Withdrawal by Subject|1|||
164008540|NCT04045613|592396772|FG006|Overall Study|Withdrawal by Subject|0|||
164008541|NCT04045613|592396766|FG000|Overall Study|Physician Decision|2|||
164008542|NCT04045613|592396767|FG001|Overall Study|Physician Decision|0|||
164008543|NCT04045613|592396768|FG002|Overall Study|Physician Decision|0|||
164008544|NCT04045613|592396769|FG003|Overall Study|Physician Decision|0|||
164008545|NCT04045613|592396770|FG004|Overall Study|Physician Decision|1|||
164008546|NCT04045613|592396771|FG005|Overall Study|Physician Decision|0|||
164008547|NCT04045613|592396772|FG006|Overall Study|Physician Decision|0|||
164008548|NCT04045613|592396766|FG000|Overall Study|Death|3|||
164008549|NCT04045613|592396767|FG001|Overall Study|Death|0|||
164008550|NCT04045613|592396768|FG002|Overall Study|Death|0|||
164008551|NCT04045613|592396769|FG003|Overall Study|Death|0|||
164008552|NCT04045613|592396770|FG004|Overall Study|Death|0|||
164008553|NCT04045613|592396771|FG005|Overall Study|Death|0|||
164008554|NCT04045613|592396772|FG006|Overall Study|Death|1|||
164008555|NCT04045613|592396766|FG000|Overall Study|Other reasons|0|||
164008556|NCT04045613|592396767|FG001|Overall Study|Other reasons|1|||
164008557|NCT04045613|592396768|FG002|Overall Study|Other reasons|0|||
164008558|NCT04045613|592396769|FG003|Overall Study|Other reasons|0|||
164008559|NCT04045613|592396770|FG004|Overall Study|Other reasons|0|||
164008560|NCT04045613|592396771|FG005|Overall Study|Other reasons|0|||
164008561|NCT04045613|592396772|FG006|Overall Study|Other reasons|1|||
164008562|NCT04045613|592396766|FG000|Overall Study|Progressive disease: Clinical progression|1|||
164008563|NCT04045613|592396767|FG001|Overall Study|Progressive disease: Clinical progression|0|||
164008564|NCT04045613|592396768|FG002|Overall Study|Progressive disease: Clinical progression|3|||
164008565|NCT04045613|592396769|FG003|Overall Study|Progressive disease: Clinical progression|1|||
164008566|NCT04045613|592396770|FG004|Overall Study|Progressive disease: Clinical progression|1|||
164008567|NCT04045613|592396771|FG005|Overall Study|Progressive disease: Clinical progression|3|||
164008568|NCT04045613|592396772|FG006|Overall Study|Progressive disease: Clinical progression|3|||
164008569|NCT04045613|592396766|FG000|Overall Study|Progressive disease: Radiological progression|24|||
164008570|NCT04045613|592396767|FG001|Overall Study|Progressive disease: Radiological progression|6|||
164008571|NCT04045613|592396768|FG002|Overall Study|Progressive disease: Radiological progression|8|||
164008572|NCT04045613|592396769|FG003|Overall Study|Progressive disease: Radiological progression|0|||
164008573|NCT04045613|592396770|FG004|Overall Study|Progressive disease: Radiological progression|6|||
164008574|NCT04045613|592396771|FG005|Overall Study|Progressive disease: Radiological progression|6|||
164008575|NCT04045613|592396772|FG006|Overall Study|Progressive disease: Radiological progression|11|||
164008576|NCT01254344|592396779|FG000|Overall Study|Adverse Event|2|||
164008577|NCT01254344|592396780|FG001|Overall Study|Adverse Event|5|||
164008578|NCT01254344|592396779|FG000|Overall Study|Physician Decision|7|||
164008579|NCT01254344|592396780|FG001|Overall Study|Physician Decision|4|||
164008580|NCT01254344|592396779|FG000|Overall Study|Protocol Violation|1|||
164008581|NCT01254344|592396780|FG001|Overall Study|Protocol Violation|4|||
164008582|NCT01254344|592396779|FG000|Overall Study|Withdrawal by Subject|3|||
164008583|NCT01254344|592396780|FG001|Overall Study|Withdrawal by Subject|6|||
164008584|NCT00467649|592396781|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
164008585|NCT00467649|592396782|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
164008586|NCT00467649|592396783|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
164008587|NCT00467649|592396784|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
164008588|NCT00467649|592396785|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
164008589|NCT00467649|592396786|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
164008590|NCT00467649|592396781|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
164358259|NCT02554812|593686449|FG023|Overall Study|Other|0|||
164358260|NCT02554812|593686450|FG024|Overall Study|Other|0|||
164358261|NCT02554812|593686451|FG025|Overall Study|Other|0|||
164358262|NCT02554812|593686452|FG026|Overall Study|Other|0|||
164358263|NCT02554812|593686426|FG000|Overall Study|Withdrawal by Subject|1|||
164008591|NCT00467649|592396782|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
164008592|NCT00467649|592396783|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
164008593|NCT00467649|592396784|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
164008594|NCT00467649|592396785|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
164008595|NCT00467649|592396786|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
164008596|NCT00467649|592396781|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
164008597|NCT00467649|592396782|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
164008598|NCT00467649|592396783|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164008599|NCT00467649|592396784|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164008600|NCT00467649|592396785|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164008601|NCT00467649|592396786|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
164008602|NCT00467649|592396781|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
164358264|NCT02554812|593686427|FG001|Overall Study|Withdrawal by Subject|0|||
164008603|NCT00467649|592396782|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
164008604|NCT00467649|592396783|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164008605|NCT00467649|592396784|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164008606|NCT00467649|592396785|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164008607|NCT00467649|592396786|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
164008608|NCT00467649|592396781|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164008609|NCT00467649|592396782|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164008610|NCT00467649|592396783|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164008611|NCT00467649|592396784|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
164008612|NCT00467649|592396785|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164008613|NCT00467649|592396786|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
164008614|NCT00467649|592396781|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164008615|NCT00467649|592396782|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164008616|NCT00467649|592396783|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164008617|NCT00467649|592396784|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
164008618|NCT00467649|592396785|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164008619|NCT00467649|592396786|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
164008620|NCT00467649|592396781|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164008621|NCT00467649|592396782|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164008622|NCT00467649|592396783|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164008623|NCT00467649|592396784|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164008624|NCT00467649|592396785|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
164008625|NCT00467649|592396786|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
164008626|NCT03233048|592396789|FG000|Overall Study|Withdrawal by Subject|1|||
164008627|NCT01856673|592396790|FG000|Overall Study|Withdrawal by Subject|44|||
164008628|NCT01856673|592396791|FG001|Overall Study|Withdrawal by Subject|50|||
164008629|NCT01856673|592396792|FG002|Overall Study|Withdrawal by Subject|33|||
164008630|NCT01856673|592396790|FG000|Overall Study|Lost to Follow-up|31|||
164008631|NCT01856673|592396791|FG001|Overall Study|Lost to Follow-up|34|||
164008632|NCT01856673|592396792|FG002|Overall Study|Lost to Follow-up|0|||
164008633|NCT01856673|592396790|FG000|Overall Study|Unknown reasons|9|||
164008634|NCT01856673|592396791|FG001|Overall Study|Unknown reasons|0|||
164008635|NCT01856673|592396792|FG002|Overall Study|Unknown reasons|0|||
164008636|NCT01856673|592396790|FG000|Overall Study|Psychologist decision|1|||
164008637|NCT01856673|592396791|FG001|Overall Study|Psychologist decision|0|||
164008638|NCT01856673|592396792|FG002|Overall Study|Psychologist decision|0|||
164008639|NCT01856673|592396790|FG000|Overall Study|Paperwork errors|8|||
164008640|NCT01856673|592396791|FG001|Overall Study|Paperwork errors|0|||
164008641|NCT01856673|592396792|FG002|Overall Study|Paperwork errors|0|||
164008642|NCT01856673|592396790|FG000|Overall Study|Death|1|||
164008643|NCT01856673|592396791|FG001|Overall Study|Death|1|||
164008644|NCT01856673|592396792|FG002|Overall Study|Death|0|||
164008645|NCT01856673|592396790|FG000|Overall Study|Protocol Violation|1|||
164008646|NCT01856673|592396791|FG001|Overall Study|Protocol Violation|0|||
164008647|NCT01856673|592396792|FG002|Overall Study|Protocol Violation|1|||
164008648|NCT00491530|592396793|FG000|Overall Study|Adverse Event|6|||
164008649|NCT00491530|592396794|FG001|Overall Study|Adverse Event|1|||
164008650|NCT00491530|592396795|FG002|Overall Study|Adverse Event|2|||
164008651|NCT00491530|592396793|FG000|Overall Study|Withdrawal by Subject|3|||
164008652|NCT00491530|592396794|FG001|Overall Study|Withdrawal by Subject|0|||
164008653|NCT00491530|592396795|FG002|Overall Study|Withdrawal by Subject|0|||
164008654|NCT00491530|592396793|FG000|Overall Study|Lost to Follow-up|3|||
164008655|NCT00491530|592396794|FG001|Overall Study|Lost to Follow-up|2|||
164008656|NCT00491530|592396795|FG002|Overall Study|Lost to Follow-up|2|||
164008657|NCT00491530|592396793|FG000|Overall Study|Lack of Efficacy|0|||
164008658|NCT00491530|592396794|FG001|Overall Study|Lack of Efficacy|1|||
164008659|NCT00491530|592396795|FG002|Overall Study|Lack of Efficacy|0|||
164008660|NCT00491530|592396793|FG000|Overall Study|Investigator Discretion|0|||
164008661|NCT00491530|592396794|FG001|Overall Study|Investigator Discretion|1|||
164008662|NCT00491530|592396795|FG002|Overall Study|Investigator Discretion|0|||
164008663|NCT00491530|592396793|FG000|Overall Study|Patient Request|0|||
164008664|NCT00491530|592396794|FG001|Overall Study|Patient Request|1|||
164008665|NCT00491530|592396795|FG002|Overall Study|Patient Request|0|||
164008666|NCT00491530|592396793|FG000|Overall Study|Use of Prohibited Medication|0|||
164008667|NCT00491530|592396794|FG001|Overall Study|Use of Prohibited Medication|0|||
164091198|NCT02354586|592697842|FG000|Overall Study|Adverse Event|7|||
164358265|NCT02554812|593686428|FG002|Overall Study|Withdrawal by Subject|0|||
164358266|NCT02554812|593686429|FG003|Overall Study|Withdrawal by Subject|2|||
164008668|NCT00491530|592396795|FG002|Overall Study|Use of Prohibited Medication|1|||
164008669|NCT03114969|592396796|FG000|Overall Study|Lost to Follow-up|0|||
164008670|NCT03114969|592396797|FG001|Overall Study|Lost to Follow-up|0|||
164008671|NCT03114969|592396798|FG002|Overall Study|Lost to Follow-up|3|||
164008672|NCT03114969|592396799|FG003|Overall Study|Lost to Follow-up|2|||
164358267|NCT02554812|593686430|FG004|Overall Study|Withdrawal by Subject|2|||
164358268|NCT02554812|593686431|FG005|Overall Study|Withdrawal by Subject|3|||
164358269|NCT02554812|593686432|FG006|Overall Study|Withdrawal by Subject|0|||
164358270|NCT02554812|593686433|FG007|Overall Study|Withdrawal by Subject|0|||
164358271|NCT02554812|593686434|FG008|Overall Study|Withdrawal by Subject|1|||
164358272|NCT02554812|593686435|FG009|Overall Study|Withdrawal by Subject|1|||
164358273|NCT02554812|593686436|FG010|Overall Study|Withdrawal by Subject|0|||
164358274|NCT02554812|593686437|FG011|Overall Study|Withdrawal by Subject|1|||
164358275|NCT02554812|593686438|FG012|Overall Study|Withdrawal by Subject|1|||
164358276|NCT02554812|593686439|FG013|Overall Study|Withdrawal by Subject|1|||
164358277|NCT02554812|593686440|FG014|Overall Study|Withdrawal by Subject|1|||
164358278|NCT02554812|593686441|FG015|Overall Study|Withdrawal by Subject|1|||
164358279|NCT02554812|593686442|FG016|Overall Study|Withdrawal by Subject|3|||
164358280|NCT02554812|593686443|FG017|Overall Study|Withdrawal by Subject|1|||
164358281|NCT02554812|593686444|FG018|Overall Study|Withdrawal by Subject|0|||
164358282|NCT02554812|593686445|FG019|Overall Study|Withdrawal by Subject|2|||
164358283|NCT02554812|593686446|FG020|Overall Study|Withdrawal by Subject|0|||
164358284|NCT02554812|593686447|FG021|Overall Study|Withdrawal by Subject|1|||
164358285|NCT02554812|593686448|FG022|Overall Study|Withdrawal by Subject|0|||
164358286|NCT02554812|593686449|FG023|Overall Study|Withdrawal by Subject|1|||
164358287|NCT02554812|593686450|FG024|Overall Study|Withdrawal by Subject|0|||
164358288|NCT02554812|593686451|FG025|Overall Study|Withdrawal by Subject|0|||
164358289|NCT02554812|593686452|FG026|Overall Study|Withdrawal by Subject|1|||
164358290|NCT02554812|593686426|FG000|Overall Study|Physician Decision|1|||
164358291|NCT02554812|593686427|FG001|Overall Study|Physician Decision|0|||
164358292|NCT02554812|593686428|FG002|Overall Study|Physician Decision|0|||
164358293|NCT02554812|593686429|FG003|Overall Study|Physician Decision|1|||
164358294|NCT02554812|593686430|FG004|Overall Study|Physician Decision|0|||
164358295|NCT02554812|593686431|FG005|Overall Study|Physician Decision|1|||
164358296|NCT02554812|593686432|FG006|Overall Study|Physician Decision|0|||
164358297|NCT02554812|593686433|FG007|Overall Study|Physician Decision|0|||
164358298|NCT02554812|593686434|FG008|Overall Study|Physician Decision|0|||
164358299|NCT02554812|593686435|FG009|Overall Study|Physician Decision|0|||
164358300|NCT02554812|593686436|FG010|Overall Study|Physician Decision|1|||
164358301|NCT02554812|593686437|FG011|Overall Study|Physician Decision|0|||
164358302|NCT02554812|593686438|FG012|Overall Study|Physician Decision|0|||
164358303|NCT02554812|593686439|FG013|Overall Study|Physician Decision|0|||
164358304|NCT02554812|593686440|FG014|Overall Study|Physician Decision|0|||
164358305|NCT02554812|593686441|FG015|Overall Study|Physician Decision|0|||
164358306|NCT02554812|593686442|FG016|Overall Study|Physician Decision|1|||
164358307|NCT02554812|593686443|FG017|Overall Study|Physician Decision|1|||
164358308|NCT02554812|593686444|FG018|Overall Study|Physician Decision|0|||
164358309|NCT02554812|593686445|FG019|Overall Study|Physician Decision|1|||
164358310|NCT02554812|593686446|FG020|Overall Study|Physician Decision|1|||
164358311|NCT02554812|593686447|FG021|Overall Study|Physician Decision|0|||
164358312|NCT02554812|593686448|FG022|Overall Study|Physician Decision|1|||
164358313|NCT02554812|593686449|FG023|Overall Study|Physician Decision|0|||
164358314|NCT02554812|593686450|FG024|Overall Study|Physician Decision|0|||
164358315|NCT02554812|593686451|FG025|Overall Study|Physician Decision|0|||
164358316|NCT02554812|593686452|FG026|Overall Study|Physician Decision|0|||
164358317|NCT02554812|593686426|FG000|Overall Study|Study terminated by sponsor|0|||
164358318|NCT02554812|593686427|FG001|Overall Study|Study terminated by sponsor|0|||
164358319|NCT02554812|593686428|FG002|Overall Study|Study terminated by sponsor|0|||
164358320|NCT02554812|593686429|FG003|Overall Study|Study terminated by sponsor|0|||
164358321|NCT02554812|593686430|FG004|Overall Study|Study terminated by sponsor|0|||
164358322|NCT02554812|593686431|FG005|Overall Study|Study terminated by sponsor|0|||
164358323|NCT02554812|593686432|FG006|Overall Study|Study terminated by sponsor|0|||
164358324|NCT02554812|593686433|FG007|Overall Study|Study terminated by sponsor|0|||
164358325|NCT02554812|593686434|FG008|Overall Study|Study terminated by sponsor|0|||
164358326|NCT02554812|593686435|FG009|Overall Study|Study terminated by sponsor|0|||
164358327|NCT02554812|593686436|FG010|Overall Study|Study terminated by sponsor|0|||
164358328|NCT02554812|593686437|FG011|Overall Study|Study terminated by sponsor|0|||
164358329|NCT02554812|593686438|FG012|Overall Study|Study terminated by sponsor|0|||
164008673|NCT03114969|592396800|FG004|Overall Study|Lost to Follow-up|0|||
164358330|NCT02554812|593686439|FG013|Overall Study|Study terminated by sponsor|0|||
164358331|NCT02554812|593686440|FG014|Overall Study|Study terminated by sponsor|0|||
164358332|NCT02554812|593686441|FG015|Overall Study|Study terminated by sponsor|0|||
164358333|NCT02554812|593686442|FG016|Overall Study|Study terminated by sponsor|0|||
164358334|NCT02554812|593686443|FG017|Overall Study|Study terminated by sponsor|0|||
164358335|NCT02554812|593686444|FG018|Overall Study|Study terminated by sponsor|0|||
164358336|NCT02554812|593686445|FG019|Overall Study|Study terminated by sponsor|0|||
164358337|NCT02554812|593686446|FG020|Overall Study|Study terminated by sponsor|0|||
164358338|NCT02554812|593686447|FG021|Overall Study|Study terminated by sponsor|0|||
164358339|NCT02554812|593686448|FG022|Overall Study|Study terminated by sponsor|0|||
164358340|NCT02554812|593686449|FG023|Overall Study|Study terminated by sponsor|0|||
164358341|NCT02554812|593686450|FG024|Overall Study|Study terminated by sponsor|1|||
164358342|NCT02554812|593686451|FG025|Overall Study|Study terminated by sponsor|0|||
164358343|NCT02554812|593686452|FG026|Overall Study|Study terminated by sponsor|0|||
164008674|NCT03114969|592396801|FG005|Overall Study|Lost to Follow-up|0|||
164008675|NCT03114969|592396802|FG006|Overall Study|Lost to Follow-up|0|||
164008676|NCT03114969|592396803|FG007|Overall Study|Lost to Follow-up|0|||
164008677|NCT03114969|592396804|FG008|Overall Study|Lost to Follow-up|0|||
164008678|NCT03114969|592396796|FG000|Overall Study|Adverse Event|0|||
164008679|NCT03114969|592396797|FG001|Overall Study|Adverse Event|0|||
164008680|NCT03114969|592396798|FG002|Overall Study|Adverse Event|1|||
164008681|NCT03114969|592396799|FG003|Overall Study|Adverse Event|0|||
164008682|NCT03114969|592396800|FG004|Overall Study|Adverse Event|0|||
164008683|NCT03114969|592396801|FG005|Overall Study|Adverse Event|1|||
164008684|NCT03114969|592396802|FG006|Overall Study|Adverse Event|1|||
164008685|NCT03114969|592396803|FG007|Overall Study|Adverse Event|0|||
164008686|NCT03114969|592396804|FG008|Overall Study|Adverse Event|2|||
164008687|NCT00971321|592396805|FG000|Up to Month 7|Withdrawal by Subject|1|||
164008688|NCT00971321|592396806|FG001|Up to Month 7|Withdrawal by Subject|0|||
164008689|NCT00971321|592396805|FG000|Up to Month 7|Migrated/moved from study area|3|||
164008690|NCT00971321|592396806|FG001|Up to Month 7|Migrated/moved from study area|2|||
164008691|NCT00971321|592396805|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
164008692|NCT00971321|592396806|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
164008693|NCT00971321|592396805|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
164008694|NCT00971321|592396806|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
164008695|NCT00971321|592396805|FG000|Up to Month 11-12|Lost to Follow-up|1|||
164008696|NCT00971321|592396806|FG001|Up to Month 11-12|Lost to Follow-up|0|||
164008697|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Adverse Event|12|||
164008698|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Adverse Event|3|||
164008699|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Adverse Event|4|||
164008700|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Adverse Event|2|||
164008701|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
164008702|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
164008703|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
164008704|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
164008705|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
164008706|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
164008707|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
164008708|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
164008709|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
164008710|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
164008711|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
164008712|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
164008713|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
164008714|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
164008715|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
164008716|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
164008717|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
164008718|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
164008719|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
164008720|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
164358344|NCT02554812|593686426|FG000|Overall Study|No longer meets eligibility criteria|0|||
164358345|NCT02554812|593686427|FG001|Overall Study|No longer meets eligibility criteria|1|||
163900945|NCT00092534|592009568|FG000|Base Study Vaccination Period|Travel|1|||
163900946|NCT00092534|592009569|FG001|Base Study Vaccination Period|Travel|0|||
163900947|NCT00092534|592009570|FG002|Base Study Vaccination Period|Travel|0|||
163900948|NCT00092534|592009571|FG003|Base Study Vaccination Period|Travel|0|||
163900949|NCT00092534|592009572|FG004|Base Study Vaccination Period|Travel|0|||
163900950|NCT00092534|592009568|FG000|Base Study Vaccination Period|Site Closed|0|||
163900951|NCT00092534|592009569|FG001|Base Study Vaccination Period|Site Closed|1|||
163900952|NCT00092534|592009570|FG002|Base Study Vaccination Period|Site Closed|0|||
163900953|NCT00092534|592009571|FG003|Base Study Vaccination Period|Site Closed|0|||
163900954|NCT00092534|592009572|FG004|Base Study Vaccination Period|Site Closed|0|||
163900955|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Adverse Event|2|||
163900956|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Adverse Event|4|||
163900957|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Adverse Event|0|||
163900958|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Adverse Event|0|||
163900959|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Adverse Event|0|||
163900960|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Death|2|||
163900961|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Death|1|||
163900962|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Death|0|||
163900963|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Death|0|||
163900964|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Death|0|||
164008721|NCT02436239|592396809|FG000|Open-Lable Treatment Period|Other Reason|1|||
164008722|NCT02436239|592396810|FG001|Open-Lable Treatment Period|Other Reason|1|||
164008723|NCT02436239|592396811|FG002|Open-Lable Treatment Period|Other Reason|0|||
164008724|NCT02436239|592396812|FG003|Open-Lable Treatment Period|Other Reason|0|||
164008725|NCT02436239|592396809|FG000|Down-Taper Period|Withdrawal by Subject|4|||
164008726|NCT02436239|592396810|FG001|Down-Taper Period|Withdrawal by Subject|4|||
164008727|NCT02436239|592396811|FG002|Down-Taper Period|Withdrawal by Subject|1|||
164008728|NCT02436239|592396812|FG003|Down-Taper Period|Withdrawal by Subject|2|||
164008729|NCT02168946|592396813|FG000|Overall Study|Adverse Event|8|||
164008730|NCT02168946|592396814|FG001|Overall Study|Adverse Event|5|||
164008731|NCT02168946|592396813|FG000|Overall Study|Lost to Follow-up|3|||
164008732|NCT02168946|592396814|FG001|Overall Study|Lost to Follow-up|0|||
164008733|NCT02168946|592396813|FG000|Overall Study|Subject unable to come back for visits|1|||
164008734|NCT02168946|592396814|FG001|Overall Study|Subject unable to come back for visits|0|||
164008735|NCT00450866|592396819|FG000|Overall Study|Adverse Event|0|||
164008736|NCT00450866|592396820|FG001|Overall Study|Adverse Event|1|||
164008737|NCT00450866|592396819|FG000|Overall Study|Withdrawal by Subject|5|||
164008738|NCT00450866|592396820|FG001|Overall Study|Withdrawal by Subject|2|||
164008739|NCT00450866|592396819|FG000|Overall Study|Death|1|||
164008740|NCT00450866|592396820|FG001|Overall Study|Death|0|||
164008741|NCT00450866|592396819|FG000|Overall Study|Physician Decision|1|||
164008742|NCT00450866|592396820|FG001|Overall Study|Physician Decision|0|||
164008743|NCT02675517|592396821|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
164008744|NCT02675517|592396821|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
164008745|NCT03443024|592396824|FG000|Overall Study|Adverse Event|2|||
164008746|NCT03443024|592396825|FG001|Overall Study|Adverse Event|4|||
164008747|NCT03443024|592396826|FG002|Overall Study|Adverse Event|3|||
164008748|NCT03443024|592396827|FG003|Overall Study|Adverse Event|1|||
164008749|NCT03443024|592396824|FG000|Overall Study|Lost to Follow-up|9|||
164008750|NCT03443024|592396825|FG001|Overall Study|Lost to Follow-up|9|||
164008751|NCT03443024|592396826|FG002|Overall Study|Lost to Follow-up|7|||
164008752|NCT03443024|592396827|FG003|Overall Study|Lost to Follow-up|5|||
164008753|NCT03443024|592396824|FG000|Overall Study|Withdrawal by Subject|8|||
164008754|NCT03443024|592396825|FG001|Overall Study|Withdrawal by Subject|15|||
164008755|NCT03443024|592396826|FG002|Overall Study|Withdrawal by Subject|9|||
164008756|NCT03443024|592396827|FG003|Overall Study|Withdrawal by Subject|23|||
164008757|NCT03443024|592396824|FG000|Overall Study|Physician Decision|1|||
164008758|NCT03443024|592396825|FG001|Overall Study|Physician Decision|2|||
164008759|NCT03443024|592396826|FG002|Overall Study|Physician Decision|0|||
164008760|NCT03443024|592396827|FG003|Overall Study|Physician Decision|1|||
164008761|NCT03443024|592396824|FG000|Overall Study|Sponsor Decision|1|||
164008762|NCT03443024|592396825|FG001|Overall Study|Sponsor Decision|1|||
164008763|NCT03443024|592396826|FG002|Overall Study|Sponsor Decision|0|||
164008764|NCT03443024|592396827|FG003|Overall Study|Sponsor Decision|0|||
164008765|NCT03443024|592396824|FG000|Overall Study|Protocol Deviation|0|||
164008766|NCT03443024|592396825|FG001|Overall Study|Protocol Deviation|0|||
164008767|NCT03443024|592396826|FG002|Overall Study|Protocol Deviation|0|||
164008768|NCT03443024|592396827|FG003|Overall Study|Protocol Deviation|2|||
164008769|NCT02782715|592396828|FG000|Overall Study|Withdrawal by Subject|1|||
164008770|NCT00586690|592396850|FG000|Overall Study|Death|2|||
164008771|NCT00586690|592396851|FG001|Overall Study|Death|0|||
164008772|NCT00586690|592396850|FG000|Overall Study|Disease Progression|10|||
164008773|NCT00586690|592396851|FG001|Overall Study|Disease Progression|0|||
164008774|NCT00586690|592396850|FG000|Overall Study|Adverse Event|1|||
164008775|NCT00586690|592396851|FG001|Overall Study|Adverse Event|0|||
164008776|NCT00586690|592396850|FG000|Overall Study|Lack of Efficacy|2|||
164008777|NCT00586690|592396851|FG001|Overall Study|Lack of Efficacy|0|||
164008778|NCT00586690|592396850|FG000|Overall Study|Lab can't accommodate|1|||
164008779|NCT00586690|592396851|FG001|Overall Study|Lab can't accommodate|0|||
164008780|NCT02453841|592396852|FG000|Overall Study|Protocol Violation|1|||
164008781|NCT02453841|592396852|FG000|Overall Study|Unable to obtain blood samples|2|||
164008782|NCT01751646|592396853|FG000|Overall Study|Lost to Follow-up|5|||
164008783|NCT01751646|592396854|FG001|Overall Study|Lost to Follow-up|1|||
164008784|NCT01751646|592396853|FG000|Overall Study|Withdrawal by Subject|0|||
164008785|NCT01751646|592396854|FG001|Overall Study|Withdrawal by Subject|4|||
164008786|NCT01751646|592396853|FG000|Overall Study|Starting hormone therapy|1|||
164008787|NCT01751646|592396854|FG001|Overall Study|Starting hormone therapy|0|||
164008788|NCT01751646|592396853|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
164008789|NCT01751646|592396854|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
164008790|NCT01751646|592396853|FG000|Overall Study|Inadvertent enrollment|1|||
164008791|NCT01751646|592396854|FG001|Overall Study|Inadvertent enrollment|1|||
164008792|NCT01751646|592396853|FG000|Overall Study|Moved out of the area|1|||
164008793|NCT01751646|592396854|FG001|Overall Study|Moved out of the area|5|||
164008794|NCT01751646|592396853|FG000|Overall Study|Inability to attend required visits|0|||
164008795|NCT01751646|592396854|FG001|Overall Study|Inability to attend required visits|1|||
164008796|NCT01751646|592396853|FG000|Overall Study|Off study due to multiple obligations|0|||
164008797|NCT01751646|592396854|FG001|Overall Study|Off study due to multiple obligations|1|||
164008798|NCT01751646|592396853|FG000|Overall Study|Fails to comply with study requirements|0|||
164008799|NCT01751646|592396854|FG001|Overall Study|Fails to comply with study requirements|1|||
164008800|NCT01751646|592396853|FG000|Overall Study|Childcare issues|1|||
164008801|NCT01751646|592396854|FG001|Overall Study|Childcare issues|1|||
164008802|NCT02190591|592396855|FG000|Overall Study|Withdrawal by Subject|1|||
164008803|NCT02190591|592396856|FG001|Overall Study|Withdrawal by Subject|8|||
164008804|NCT02190591|592396855|FG000|Overall Study|Protocol Violation|1|||
164008805|NCT02190591|592396856|FG001|Overall Study|Protocol Violation|0|||
164008806|NCT02190591|592396855|FG000|Overall Study|did not use peanut ball as instructed|0|||
164008807|NCT02190591|592396856|FG001|Overall Study|did not use peanut ball as instructed|2|||
164008808|NCT02190591|592396855|FG000|Overall Study|face presentation so she was ineligible|0|||
164008809|NCT02190591|592396856|FG001|Overall Study|face presentation so she was ineligible|1|||
164008810|NCT01151137|592396859|FG000|Overall Study|Death|15|||
164008811|NCT01151137|592396860|FG001|Overall Study|Death|27|||
164008812|NCT01151137|592396859|FG000|Overall Study|Lost to Follow-up|1|||
164008813|NCT01151137|592396860|FG001|Overall Study|Lost to Follow-up|1|||
164008814|NCT03478683|592396863|FG000|Overall Study|Adverse Event|5|||
164008815|NCT03478683|592396864|FG001|Overall Study|Adverse Event|3|||
164008816|NCT03478683|592396863|FG000|Overall Study|Lost to Follow-up|0|||
164008817|NCT03478683|592396864|FG001|Overall Study|Lost to Follow-up|5|||
164008818|NCT03478683|592396863|FG000|Overall Study|Physician Decision|1|||
164008819|NCT03478683|592396864|FG001|Overall Study|Physician Decision|3|||
164008820|NCT03478683|592396863|FG000|Overall Study|Withdrawal by Subject|7|||
164008821|NCT03478683|592396864|FG001|Overall Study|Withdrawal by Subject|7|||
164008822|NCT02273973|592396871|FG000|Overall Study|Adverse Event|4|||
164008823|NCT02273973|592396872|FG001|Overall Study|Adverse Event|0|||
164008824|NCT02273973|592396871|FG000|Overall Study|Withdrawal by Subject|2|||
164008825|NCT02273973|592396872|FG001|Overall Study|Withdrawal by Subject|3|||
164008826|NCT02273973|592396871|FG000|Overall Study|Death|1|||
164008827|NCT02273973|592396872|FG001|Overall Study|Death|0|||
164008828|NCT02273973|592396871|FG000|Overall Study|Non-compliance|1|||
164008829|NCT02273973|592396872|FG001|Overall Study|Non-compliance|0|||
164008830|NCT02273973|592396871|FG000|Overall Study|Protocol Violation|1|||
164008831|NCT02273973|592396872|FG001|Overall Study|Protocol Violation|0|||
164008832|NCT02273973|592396871|FG000|Overall Study|Progression of disease|0|||
164008833|NCT02273973|592396872|FG001|Overall Study|Progression of disease|2|||
164008834|NCT02273973|592396871|FG000|Overall Study|Lost to Follow-up|0|||
164008835|NCT02273973|592396872|FG001|Overall Study|Lost to Follow-up|1|||
164008836|NCT02273973|592396871|FG000|Overall Study|Physician Decision|0|||
164008837|NCT02273973|592396872|FG001|Overall Study|Physician Decision|1|||
164008838|NCT02273973|592396871|FG000|Overall Study|Reason not specified|0|||
164008839|NCT02273973|592396872|FG001|Overall Study|Reason not specified|1|||
164008840|NCT04513158|592396875|FG000|Overall Study|Screen Failure|1|||
164008841|NCT02452970|592398247|FG000|Overall Study|Adverse Event|1|||
164008842|NCT02100657|592398248|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
164008843|NCT02100657|592398249|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
164008844|NCT02100657|592398250|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
164008845|NCT02100657|592398248|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
164008846|NCT02100657|592398249|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
164008847|NCT02100657|592398250|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
164008848|NCT02100657|592398248|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
164008849|NCT02100657|592398249|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
164008850|NCT02100657|592398250|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
164008851|NCT02100657|592398248|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
164008852|NCT02100657|592398249|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
164008853|NCT02100657|592398250|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
164008854|NCT02100657|592398248|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
164008855|NCT02100657|592398249|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
164008856|NCT02100657|592398250|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
164008857|NCT02100657|592398248|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
164008858|NCT02100657|592398249|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
164008859|NCT02100657|592398250|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
164008860|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
164008861|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
164008862|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
164008863|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Death|0|||
164008864|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Death|0|||
164091199|NCT00436007|592697843|FG000|Overall Study|Withdrawal by Subject|5|||
164091200|NCT00436007|592697844|FG001|Overall Study|Withdrawal by Subject|3|||
164008865|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Death|1|||
164008866|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
164008867|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
164008868|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
164008869|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
164008870|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
164008871|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
164008872|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
164008873|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
164008874|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
164091201|NCT00436007|592697845|FG002|Overall Study|Withdrawal by Subject|4|||
164008875|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
164008876|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
164008877|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
164008878|NCT02100657|592398248|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
164008879|NCT02100657|592398249|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
164008880|NCT02100657|592398250|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
164008881|NCT02531035|592398251|FG000|Overall Study|Death|0|||
164008882|NCT02531035|592398252|FG001|Overall Study|Death|1|||
164008883|NCT02531035|592398251|FG000|Overall Study|Protocol Violation|1|||
164008884|NCT02531035|592398252|FG001|Overall Study|Protocol Violation|1|||
164008885|NCT02531035|592398251|FG000|Overall Study|Noncompliance with study drug|8|||
164008886|NCT02531035|592398252|FG001|Overall Study|Noncompliance with study drug|3|||
164008887|NCT02531035|592398251|FG000|Overall Study|Physician Decision|1|||
164008888|NCT02531035|592398252|FG001|Overall Study|Physician Decision|0|||
164008889|NCT02531035|592398251|FG000|Overall Study|Adverse Event|16|||
164008890|NCT02531035|592398252|FG001|Overall Study|Adverse Event|45|||
164358346|NCT02554812|593686428|FG002|Overall Study|No longer meets eligibility criteria|0|||
164358347|NCT02554812|593686429|FG003|Overall Study|No longer meets eligibility criteria|0|||
164358348|NCT02554812|593686430|FG004|Overall Study|No longer meets eligibility criteria|0|||
164358349|NCT02554812|593686431|FG005|Overall Study|No longer meets eligibility criteria|0|||
164358350|NCT02554812|593686432|FG006|Overall Study|No longer meets eligibility criteria|0|||
164358351|NCT02554812|593686433|FG007|Overall Study|No longer meets eligibility criteria|0|||
164358352|NCT02554812|593686434|FG008|Overall Study|No longer meets eligibility criteria|0|||
164358353|NCT02554812|593686435|FG009|Overall Study|No longer meets eligibility criteria|0|||
164358354|NCT02554812|593686436|FG010|Overall Study|No longer meets eligibility criteria|0|||
164358355|NCT02554812|593686437|FG011|Overall Study|No longer meets eligibility criteria|0|||
164358356|NCT02554812|593686438|FG012|Overall Study|No longer meets eligibility criteria|0|||
164358357|NCT02554812|593686439|FG013|Overall Study|No longer meets eligibility criteria|0|||
164358358|NCT02554812|593686440|FG014|Overall Study|No longer meets eligibility criteria|0|||
163900965|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
163900966|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
163900967|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
163900968|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
163900969|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
163900970|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Pregnancy|6|||
163900971|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Pregnancy|10|||
163900972|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Pregnancy|0|||
163900973|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Pregnancy|0|||
163900974|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Pregnancy|0|||
163900975|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
163900976|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
163900977|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
163900978|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
163900979|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
163900980|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
163900981|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
163900982|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
163900983|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
163900984|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
163900985|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Moved|62|||
163900986|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Moved|58|||
163900987|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Moved|0|||
163900988|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Moved|0|||
163900989|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Moved|0|||
163900990|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Travel|10|||
163900991|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Travel|7|||
163900992|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Travel|0|||
163900993|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Travel|0|||
163900994|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Travel|0|||
163900995|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Site Closed|0|||
163900996|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Site Closed|2|||
163900997|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Site Closed|0|||
163900998|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Site Closed|0|||
163900999|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Site Closed|0|||
163901000|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
163901001|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
163901002|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
163901003|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
163901004|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
163901005|NCT00092534|592009568|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
164008891|NCT02531035|592398251|FG000|Overall Study|Other|3|||
164358359|NCT02554812|593686441|FG015|Overall Study|No longer meets eligibility criteria|0|||
164091202|NCT00436007|592697843|FG000|Overall Study|Lost to Follow-up|14|||
164091203|NCT00436007|592697844|FG001|Overall Study|Lost to Follow-up|10|||
164091204|NCT00436007|592697845|FG002|Overall Study|Lost to Follow-up|13|||
164091205|NCT00436007|592697843|FG000|Overall Study|Physician Decision|0|||
164091206|NCT00436007|592697844|FG001|Overall Study|Physician Decision|0|||
164091207|NCT00436007|592697845|FG002|Overall Study|Physician Decision|2|||
164091208|NCT00436007|592697843|FG000|Overall Study|Death|0|||
164091209|NCT00436007|592697844|FG001|Overall Study|Death|1|||
164091210|NCT00436007|592697845|FG002|Overall Study|Death|3|||
164091211|NCT00436007|592697843|FG000|Overall Study|Other|0|||
164091212|NCT00436007|592697844|FG001|Overall Study|Other|0|||
164091213|NCT00436007|592697845|FG002|Overall Study|Other|1|||
164091214|NCT00721409|592697846|FG000|Overall Study|Global deterioration of health status|2|||
164091215|NCT00721409|592697847|FG001|Overall Study|Global deterioration of health status|6|||
164358360|NCT02554812|593686442|FG016|Overall Study|No longer meets eligibility criteria|0|||
164358361|NCT02554812|593686443|FG017|Overall Study|No longer meets eligibility criteria|0|||
163901006|NCT00092534|592009569|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
163901007|NCT00092534|592009570|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
164008892|NCT02531035|592398252|FG001|Overall Study|Other|2|||
164008893|NCT02531035|592398251|FG000|Overall Study|Withdrawal by Subject|42|||
164008894|NCT02531035|592398252|FG001|Overall Study|Withdrawal by Subject|32|||
164008895|NCT02531035|592398251|FG000|Overall Study|Lost to Follow-up|8|||
164008896|NCT02531035|592398252|FG001|Overall Study|Lost to Follow-up|10|||
164008897|NCT02531035|592398251|FG000|Overall Study|Randomized, not treated|2|||
164008898|NCT02531035|592398252|FG001|Overall Study|Randomized, not treated|1|||
164008899|NCT01543490|592398254|FG000|Overall Study|Adverse Event|4|||
164008900|NCT01543490|592398255|FG001|Overall Study|Adverse Event|0|||
164008901|NCT01543490|592398254|FG000|Overall Study|Physician Decision|1|||
164008902|NCT01543490|592398255|FG001|Overall Study|Physician Decision|0|||
164008903|NCT01543490|592398254|FG000|Overall Study|Lack of Efficacy|3|||
164008904|NCT01543490|592398255|FG001|Overall Study|Lack of Efficacy|3|||
164008905|NCT01543490|592398254|FG000|Overall Study|Lost to Follow-up|5|||
164008906|NCT01543490|592398255|FG001|Overall Study|Lost to Follow-up|0|||
164008907|NCT01543490|592398254|FG000|Overall Study|Withdrawal by Subject|2|||
164091216|NCT00721409|592697848|FG002|Overall Study|Global deterioration of health status|3|||
164091217|NCT00721409|592697846|FG000|Overall Study|Death|0|||
164091218|NCT00721409|592697847|FG001|Overall Study|Death|1|||
164091219|NCT00721409|592697848|FG002|Overall Study|Death|0|||
164091220|NCT00721409|592697846|FG000|Overall Study|Randomized not Treated|0|||
163901008|NCT00092534|592009571|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
163901009|NCT00092534|592009572|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
163901010|NCT00092534|592009568|FG000|Base Study EXT|Lost to Follow-up|0|||
163901011|NCT00092534|592009569|FG001|Base Study EXT|Lost to Follow-up|0|||
163901012|NCT00092534|592009570|FG002|Base Study EXT|Lost to Follow-up|41|||
163901013|NCT00092534|592009571|FG003|Base Study EXT|Lost to Follow-up|0|||
163901014|NCT00092534|592009572|FG004|Base Study EXT|Lost to Follow-up|0|||
163901015|NCT00092534|592009568|FG000|Base Study EXT|Physician Decision|0|||
163901016|NCT00092534|592009569|FG001|Base Study EXT|Physician Decision|0|||
163901017|NCT00092534|592009570|FG002|Base Study EXT|Physician Decision|1|||
163901018|NCT00092534|592009571|FG003|Base Study EXT|Physician Decision|0|||
163901019|NCT00092534|592009572|FG004|Base Study EXT|Physician Decision|0|||
163901020|NCT00092534|592009568|FG000|Base Study EXT|Pregnancy|0|||
163901021|NCT00092534|592009569|FG001|Base Study EXT|Pregnancy|0|||
163901022|NCT00092534|592009570|FG002|Base Study EXT|Pregnancy|12|||
163901023|NCT00092534|592009571|FG003|Base Study EXT|Pregnancy|0|||
163901024|NCT00092534|592009572|FG004|Base Study EXT|Pregnancy|0|||
163901025|NCT00092534|592009568|FG000|Base Study EXT|Withdrawal by Subject|0|||
163901026|NCT00092534|592009569|FG001|Base Study EXT|Withdrawal by Subject|0|||
163901027|NCT00092534|592009570|FG002|Base Study EXT|Withdrawal by Subject|18|||
163901028|NCT00092534|592009571|FG003|Base Study EXT|Withdrawal by Subject|0|||
163901029|NCT00092534|592009572|FG004|Base Study EXT|Withdrawal by Subject|0|||
163901030|NCT00092534|592009568|FG000|Base Study EXT|Participant moved|0|||
163901031|NCT00092534|592009569|FG001|Base Study EXT|Participant moved|0|||
163901032|NCT00092534|592009570|FG002|Base Study EXT|Participant moved|6|||
163901033|NCT00092534|592009571|FG003|Base Study EXT|Participant moved|0|||
163901034|NCT00092534|592009572|FG004|Base Study EXT|Participant moved|0|||
163901035|NCT00092534|592009568|FG000|Base Study EXT|Travel|0|||
163901036|NCT00092534|592009569|FG001|Base Study EXT|Travel|0|||
163901037|NCT00092534|592009570|FG002|Base Study EXT|Travel|2|||
163901038|NCT00092534|592009571|FG003|Base Study EXT|Travel|0|||
163901039|NCT00092534|592009572|FG004|Base Study EXT|Travel|0|||
163901040|NCT00092534|592009568|FG000|Base Study EXT|Site closed|0|||
164008908|NCT01543490|592398255|FG001|Overall Study|Withdrawal by Subject|0|||
163901041|NCT00092534|592009569|FG001|Base Study EXT|Site closed|0|||
163901042|NCT00092534|592009570|FG002|Base Study EXT|Site closed|21|||
164091221|NCT00721409|592697847|FG001|Overall Study|Randomized not Treated|1|||
164091222|NCT00721409|592697848|FG002|Overall Study|Randomized not Treated|4|||
164091223|NCT00721409|592697846|FG000|Overall Study|Reason not specified|1|||
164091224|NCT00721409|592697847|FG001|Overall Study|Reason not specified|0|||
164358362|NCT02554812|593686444|FG018|Overall Study|No longer meets eligibility criteria|0|||
164008909|NCT01543490|592398254|FG000|Overall Study|Other-Various Administrative Reasons|1|||
164008910|NCT01543490|592398255|FG001|Overall Study|Other-Various Administrative Reasons|2|||
164008911|NCT01335971|592398259|FG000|Overall Study|Withdrawal by Subject|1|||
164008912|NCT01335971|592398260|FG001|Overall Study|Withdrawal by Subject|0|||
164008913|NCT01335971|592398261|FG002|Overall Study|Withdrawal by Subject|0|||
164008914|NCT01335971|592398259|FG000|Overall Study|Did not complete bronchoscopy|1|||
164008915|NCT01335971|592398260|FG001|Overall Study|Did not complete bronchoscopy|1|||
164008916|NCT01335971|592398261|FG002|Overall Study|Did not complete bronchoscopy|1|||
164358363|NCT02554812|593686445|FG019|Overall Study|No longer meets eligibility criteria|0|||
164358364|NCT02554812|593686446|FG020|Overall Study|No longer meets eligibility criteria|0|||
164358365|NCT02554812|593686447|FG021|Overall Study|No longer meets eligibility criteria|0|||
164358366|NCT02554812|593686448|FG022|Overall Study|No longer meets eligibility criteria|0|||
164358367|NCT02554812|593686449|FG023|Overall Study|No longer meets eligibility criteria|0|||
164358368|NCT02554812|593686450|FG024|Overall Study|No longer meets eligibility criteria|0|||
164358369|NCT02554812|593686451|FG025|Overall Study|No longer meets eligibility criteria|0|||
164358370|NCT02554812|593686452|FG026|Overall Study|No longer meets eligibility criteria|0|||
164358371|NCT02879305|593686453|FG000|Overall Study|Investigator Site Closed|55|||
164358372|NCT02879305|593686454|FG001|Overall Study|Investigator Site Closed|57|||
164358373|NCT02879305|593686453|FG000|Overall Study|Withdrawal by Subject|44|||
164358374|NCT02879305|593686454|FG001|Overall Study|Withdrawal by Subject|42|||
164358375|NCT02879305|593686453|FG000|Overall Study|Lost to Follow-up|17|||
164358376|NCT02879305|593686454|FG001|Overall Study|Lost to Follow-up|12|||
164358377|NCT02879305|593686453|FG000|Overall Study|Other|1|||
164358378|NCT02879305|593686454|FG001|Overall Study|Other|0|||
164358379|NCT01786629|593688141|FG000|Overall Study|Lack of Efficacy|0|||
164358380|NCT01786629|593688142|FG001|Overall Study|Lack of Efficacy|4|||
164358381|NCT01786629|593688141|FG000|Overall Study|Adverse Event|0|||
164358382|NCT01786629|593688142|FG001|Overall Study|Adverse Event|1|||
164358383|NCT00180414|593688143|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
164358384|NCT00180414|593688144|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
164358385|NCT00613938|593688145|FG000|Overall Study|Withdrawal by Subject|2|||
164358386|NCT00613938|593688146|FG001|Overall Study|Withdrawal by Subject|4|||
164358387|NCT00613938|593688147|FG002|Overall Study|Withdrawal by Subject|9|||
164358388|NCT00613938|593688148|FG003|Overall Study|Withdrawal by Subject|9|||
164358389|NCT00613938|593688145|FG000|Overall Study|Adverse Event|1|||
164358390|NCT00613938|593688146|FG001|Overall Study|Adverse Event|4|||
164358391|NCT00613938|593688147|FG002|Overall Study|Adverse Event|8|||
164358392|NCT00613938|593688148|FG003|Overall Study|Adverse Event|5|||
164358393|NCT00613938|593688145|FG000|Overall Study|Lack of Efficacy|16|||
164358394|NCT00613938|593688146|FG001|Overall Study|Lack of Efficacy|18|||
164358395|NCT00613938|593688147|FG002|Overall Study|Lack of Efficacy|5|||
164358396|NCT00613938|593688148|FG003|Overall Study|Lack of Efficacy|9|||
164358397|NCT00613938|593688145|FG000|Overall Study|Other|1|||
164358398|NCT00613938|593688146|FG001|Overall Study|Other|2|||
164358399|NCT00613938|593688147|FG002|Overall Study|Other|1|||
164358400|NCT00613938|593688148|FG003|Overall Study|Other|3|||
164358401|NCT00623727|593688149|FG000|Double Blind (DB)|Adverse Event|1|||
164358402|NCT00623727|593688150|FG001|Double Blind (DB)|Adverse Event|3|||
164358403|NCT00623727|593688149|FG000|Double Blind (DB)|Physician Decision|0|||
164358404|NCT00623727|593688150|FG001|Double Blind (DB)|Physician Decision|1|||
164358405|NCT00623727|593688149|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
164358406|NCT00623727|593688150|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
164358407|NCT00623727|593688149|FG000|Double Blind (DB)|Lack of Efficacy|2|||
164358408|NCT00623727|593688150|FG001|Double Blind (DB)|Lack of Efficacy|2|||
164358409|NCT00623727|593688149|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
164358410|NCT00623727|593688150|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
164358411|NCT00623727|593688149|FG000|Double Blind (DB)|Lost to Follow-up|1|||
164358412|NCT00623727|593688150|FG001|Double Blind (DB)|Lost to Follow-up|1|||
164008917|NCT01260181|592398262|FG000|Overall Study|Decision of Investigator|1|||
164008918|NCT03351244|592398263|FG000|Overall Study|Adverse Event|7|||
164091225|NCT00721409|592697848|FG002|Overall Study|Reason not specified|2|||
164358413|NCT00623727|593688149|FG000|Double Blind (DB)|Protocol Violation|2|||
164358414|NCT00623727|593688150|FG001|Double Blind (DB)|Protocol Violation|2|||
164358415|NCT00623727|593688149|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
164358416|NCT00623727|593688150|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
164358417|NCT00623727|593688149|FG000|Open Label Follow-up|Study termination|0|||
164008919|NCT03351244|592398264|FG001|Overall Study|Adverse Event|11|||
164008920|NCT03351244|592398265|FG002|Overall Study|Adverse Event|12|||
164358418|NCT00623727|593688150|FG001|Open Label Follow-up|Study termination|6|||
164358419|NCT00623727|593688149|FG000|Open Label Follow-up|Participant convenience|0|||
164358420|NCT00623727|593688150|FG001|Open Label Follow-up|Participant convenience|1|||
164358421|NCT01852942|593688151|FG000|Overall Study|Physician Decision|1|||
164358422|NCT01852942|593688152|FG001|Overall Study|Physician Decision|0|||
164358423|NCT01852942|593688151|FG000|Overall Study|Death|1|||
164091226|NCT00721409|592697846|FG000|Overall Study|Adverse Event|0|||
164091227|NCT00721409|592697847|FG001|Overall Study|Adverse Event|13|||
164091228|NCT00721409|592697848|FG002|Overall Study|Adverse Event|2|||
164091229|NCT00721409|592697846|FG000|Overall Study|Lost to Follow-up|0|||
164008921|NCT03351244|592398263|FG000|Overall Study|Investigator's decision|0|||
164008922|NCT03351244|592398264|FG001|Overall Study|Investigator's decision|0|||
164008923|NCT03351244|592398265|FG002|Overall Study|Investigator's decision|2|||
164008924|NCT03351244|592398263|FG000|Overall Study|System error|0|||
164008925|NCT03351244|592398264|FG001|Overall Study|System error|0|||
164008926|NCT03351244|592398265|FG002|Overall Study|System error|2|||
164008927|NCT03351244|592398263|FG000|Overall Study|COVID-19 restrictions|3|||
164008928|NCT03351244|592398264|FG001|Overall Study|COVID-19 restrictions|0|||
164008929|NCT03351244|592398265|FG002|Overall Study|COVID-19 restrictions|1|||
164008930|NCT03351244|592398263|FG000|Overall Study|Non-compliance|2|||
164008931|NCT03351244|592398264|FG001|Overall Study|Non-compliance|5|||
164008932|NCT03351244|592398265|FG002|Overall Study|Non-compliance|0|||
164008933|NCT03351244|592398263|FG000|Overall Study|Withdrawal by Subject|11|||
164008934|NCT03351244|592398264|FG001|Overall Study|Withdrawal by Subject|16|||
164008935|NCT03351244|592398265|FG002|Overall Study|Withdrawal by Subject|13|||
164008936|NCT03351244|592398263|FG000|Overall Study|Lost to Follow-up|2|||
164008937|NCT03351244|592398264|FG001|Overall Study|Lost to Follow-up|6|||
164008938|NCT03351244|592398265|FG002|Overall Study|Lost to Follow-up|4|||
164008939|NCT03351244|592398263|FG000|Overall Study|Protocol Violation|2|||
164008940|NCT03351244|592398264|FG001|Overall Study|Protocol Violation|2|||
164008941|NCT03351244|592398265|FG002|Overall Study|Protocol Violation|0|||
164008942|NCT01499576|592398268|FG000|Overall Study|Physician Decision|12|||
164008943|NCT01499576|592398268|FG000|Overall Study|Withdrawal by Subject|9|||
164008944|NCT03396471|592398276|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
164091230|NCT00721409|592697847|FG001|Overall Study|Lost to Follow-up|0|||
164091231|NCT00721409|592697848|FG002|Overall Study|Lost to Follow-up|1|||
163901043|NCT00092534|592009571|FG003|Base Study EXT|Site closed|0|||
163901044|NCT00092534|592009572|FG004|Base Study EXT|Site closed|0|||
163901045|NCT00092534|592009568|FG000|Base Study EXT|Study ended|0|||
163901046|NCT00092534|592009569|FG001|Base Study EXT|Study ended|0|||
163901047|NCT00092534|592009570|FG002|Base Study EXT|Study ended|29|||
163901048|NCT00092534|592009571|FG003|Base Study EXT|Study ended|0|||
163901049|NCT00092534|592009572|FG004|Base Study EXT|Study ended|0|||
163901050|NCT00092534|592009568|FG000|Base Study EXT|Protocol Violation|0|||
163901051|NCT00092534|592009569|FG001|Base Study EXT|Protocol Violation|0|||
163901052|NCT00092534|592009570|FG002|Base Study EXT|Protocol Violation|15|||
163901053|NCT00092534|592009571|FG003|Base Study EXT|Protocol Violation|0|||
163901054|NCT00092534|592009572|FG004|Base Study EXT|Protocol Violation|0|||
163901055|NCT00092534|592009568|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163901056|NCT00092534|592009569|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163901057|NCT00092534|592009570|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163901058|NCT00092534|592009571|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
163901059|NCT00092534|592009572|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
163901060|NCT03083366|592009573|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
163901061|NCT03083366|592009574|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
163901062|NCT03083366|592009573|FG000|Enrollment Period|Lack of Efficacy|1|||
163901063|NCT03083366|592009574|FG001|Enrollment Period|Lack of Efficacy|0|||
163901064|NCT05250115|592009575|FG000|Overall Study|Premature study end|40|||
163901065|NCT05250115|592009575|FG000|Overall Study|Adverse Event|8|||
163901066|NCT05250115|592009575|FG000|Overall Study|Lost to Follow-up|7|||
163901067|NCT05250115|592009575|FG000|Overall Study|Withdrawal by Subject|6|||
163901068|NCT05250115|592009575|FG000|Overall Study|Withdrawal of informed consent|1|||
163901069|NCT05250115|592009575|FG000|Overall Study|Other|7|||
163901070|NCT03244800|592009577|FG000|Overall Study|Adverse Event|0|||
163901071|NCT03244800|592009578|FG001|Overall Study|Adverse Event|1|||
163901072|NCT03244800|592009579|FG002|Overall Study|Adverse Event|0|||
163901073|NCT03244800|592009580|FG003|Overall Study|Adverse Event|1|||
163901074|NCT03244800|592009577|FG000|Overall Study|Withdrew treatment|0|||
163901075|NCT03244800|592009578|FG001|Overall Study|Withdrew treatment|0|||
163901076|NCT03244800|592009579|FG002|Overall Study|Withdrew treatment|0|||
163901077|NCT03244800|592009580|FG003|Overall Study|Withdrew treatment|1|||
163901078|NCT00890591|592009589|FG000|Overall Study|Lack of Efficacy|20|||
163901079|NCT02275611|592009594|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
163901080|NCT02275611|592009595|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
163901081|NCT02275611|592009596|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
163901082|NCT02275611|592009597|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
163901083|NCT01437319|592009600|FG000|Phase I|Lost to Follow-up|2|||
163901084|NCT01437319|592009601|FG001|Phase I|Lost to Follow-up|0|||
163901085|NCT01437319|592009602|FG002|Phase I|Lost to Follow-up|0|||
163901086|NCT01437319|592009600|FG000|Phase I|Protocol Violation|1|||
163901087|NCT01437319|592009601|FG001|Phase I|Protocol Violation|0|||
164008945|NCT03396471|592398276|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
164008946|NCT03396471|592398276|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
164008947|NCT03396471|592398276|FG000|Study Treatment - Up to 22 Months|Death|2|||
164091232|NCT00721409|592697846|FG000|Overall Study|Withdrawal by Subject|1|||
164091233|NCT00721409|592697847|FG001|Overall Study|Withdrawal by Subject|6|||
164091234|NCT00721409|592697848|FG002|Overall Study|Withdrawal by Subject|5|||
164091235|NCT00721409|592697846|FG000|Overall Study|Objective progression or relapse|8|||
164091236|NCT00721409|592697847|FG001|Overall Study|Objective progression or relapse|55|||
164091237|NCT00721409|592697848|FG002|Overall Study|Objective progression or relapse|62|||
164091238|NCT01957488|592697849|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
164091239|NCT01957488|592697850|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
164091240|NCT01957488|592697851|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
164091241|NCT01957488|592697852|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
164091242|NCT01957488|592697853|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
164091243|NCT01957488|592697854|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
164091244|NCT01957488|592697849|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
164091245|NCT01957488|592697850|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
164091246|NCT01957488|592697851|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
164091247|NCT01957488|592697852|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
164091248|NCT01957488|592697853|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
164091249|NCT01957488|592697854|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
164091250|NCT01957488|592697849|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
164091251|NCT01957488|592697850|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
164091252|NCT01957488|592697851|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
164091253|NCT01957488|592697852|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
164091254|NCT01957488|592697853|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
164091255|NCT01957488|592697854|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
164091256|NCT01957488|592697849|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164091257|NCT01957488|592697850|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164091258|NCT01957488|592697851|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
164008948|NCT03396471|592398276|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
164008949|NCT03396471|592398276|FG000|Follow up - Up to 2 Years|Death|9|||
164008950|NCT03396471|592398276|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
164008951|NCT03396471|592398276|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
164008952|NCT03396471|592398276|FG000|Follow up - Up to 2 Years|study terminated|1|||
164008953|NCT03396471|592398276|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
164008954|NCT03396471|592398276|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
164008955|NCT01319929|592398277|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
164008956|NCT01319929|592398278|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
164008957|NCT01319929|592398277|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
164008958|NCT01319929|592398278|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
164008959|NCT01319929|592398277|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
164008960|NCT01319929|592398278|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
164008961|NCT01319929|592398277|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
164008962|NCT01319929|592398278|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
164008963|NCT01319929|592398277|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
164008964|NCT01319929|592398278|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
164008965|NCT03237845|592398279|FG000|Overall Study|Adverse Event|0|||
164091259|NCT01957488|592697852|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164091260|NCT01957488|592697853|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
164091261|NCT01957488|592697854|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
164091262|NCT01957488|592697849|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164091263|NCT01957488|592697850|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164091264|NCT01957488|592697851|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164008966|NCT03237845|592398280|FG001|Overall Study|Adverse Event|1|||
164008967|NCT03237845|592398279|FG000|Overall Study|Lost to Follow-up|13|||
164008968|NCT03237845|592398280|FG001|Overall Study|Lost to Follow-up|10|||
164008969|NCT03237845|592398279|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
164008970|NCT03237845|592398280|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
164008971|NCT03237845|592398279|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
164008972|NCT03237845|592398280|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
164008973|NCT03237845|592398279|FG000|Overall Study|Physician Decision|1|||
164008974|NCT03237845|592398280|FG001|Overall Study|Physician Decision|2|||
164008975|NCT03237845|592398279|FG000|Overall Study|Pregnancy|1|||
164008976|NCT03237845|592398280|FG001|Overall Study|Pregnancy|0|||
164008977|NCT03237845|592398279|FG000|Overall Study|Protocol Deviation|0|||
164008978|NCT03237845|592398280|FG001|Overall Study|Protocol Deviation|1|||
164008979|NCT03237845|592398279|FG000|Overall Study|Technical Problems|8|||
164008980|NCT03237845|592398280|FG001|Overall Study|Technical Problems|1|||
164008981|NCT03237845|592398279|FG000|Overall Study|Withdrawal by Subject|3|||
164008982|NCT03237845|592398280|FG001|Overall Study|Withdrawal by Subject|3|||
164008983|NCT03237845|592398279|FG000|Overall Study|Other Reasons|4|||
164008984|NCT03237845|592398280|FG001|Overall Study|Other Reasons|0|||
164008985|NCT01221233|592398281|FG000|Overall Study|Withdrawal by Subject|3|||
164008986|NCT01221233|592398282|FG001|Overall Study|Withdrawal by Subject|1|||
164008987|NCT03865407|592398284|FG000|Overall Study|Adverse Event|1|||
164008988|NCT03865407|592398285|FG001|Overall Study|Adverse Event|0|||
164008989|NCT03865407|592398284|FG000|Overall Study|Withdrawal by Subject|1|||
164008990|NCT03865407|592398285|FG001|Overall Study|Withdrawal by Subject|0|||
164008991|NCT03865407|592398284|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
164008992|NCT03865407|592398285|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
164008993|NCT01645280|592398286|FG000|Overall Study|Death|0|||
164008994|NCT01645280|592398287|FG001|Overall Study|Death|1|||
164008995|NCT01645280|592398288|FG002|Overall Study|Death|0|||
164008996|NCT01645280|592398289|FG003|Overall Study|Death|0|||
164008997|NCT01645280|592398290|FG004|Overall Study|Death|0|||
164008998|NCT01645280|592398286|FG000|Overall Study|Withdrawal by Subject|4|||
164008999|NCT01645280|592398287|FG001|Overall Study|Withdrawal by Subject|0|||
164009000|NCT01645280|592398288|FG002|Overall Study|Withdrawal by Subject|2|||
164009001|NCT01645280|592398289|FG003|Overall Study|Withdrawal by Subject|4|||
164009002|NCT01645280|592398290|FG004|Overall Study|Withdrawal by Subject|5|||
164009003|NCT01645280|592398286|FG000|Overall Study|Lost to Follow-up|0|||
164009004|NCT01645280|592398287|FG001|Overall Study|Lost to Follow-up|0|||
164009005|NCT01645280|592398288|FG002|Overall Study|Lost to Follow-up|0|||
164009006|NCT01645280|592398289|FG003|Overall Study|Lost to Follow-up|2|||
164009007|NCT01645280|592398290|FG004|Overall Study|Lost to Follow-up|1|||
164009008|NCT01645280|592398286|FG000|Overall Study|Other|1|||
164009009|NCT01645280|592398287|FG001|Overall Study|Other|1|||
164009010|NCT01645280|592398288|FG002|Overall Study|Other|2|||
164009011|NCT01645280|592398289|FG003|Overall Study|Other|0|||
164009012|NCT01645280|592398290|FG004|Overall Study|Other|0|||
164091265|NCT01957488|592697852|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164358424|NCT01852942|593688152|FG001|Overall Study|Death|1|||
164358425|NCT01852942|593688151|FG000|Overall Study|Withdrawal by Subject|2|||
164358426|NCT01852942|593688152|FG001|Overall Study|Withdrawal by Subject|3|||
164358427|NCT01852942|593688151|FG000|Overall Study|Lost to Follow-up|1|||
164358428|NCT01852942|593688152|FG001|Overall Study|Lost to Follow-up|2|||
164358429|NCT03220217|593688154|FG000|Overall Study|Withdrawal by Subject|0|||
164358430|NCT03220217|593688155|FG001|Overall Study|Withdrawal by Subject|1|||
164358431|NCT03220217|593688156|FG002|Overall Study|Withdrawal by Subject|0|||
164358432|NCT03220217|593688154|FG000|Overall Study|Subject Missed Procedure|0|||
164358433|NCT03220217|593688155|FG001|Overall Study|Subject Missed Procedure|0|||
164358434|NCT03220217|593688156|FG002|Overall Study|Subject Missed Procedure|1|||
164358435|NCT03025542|593688157|FG000|Overall Study|Adverse Event|0|||
164358436|NCT03025542|593688158|FG001|Overall Study|Adverse Event|2|||
164358437|NCT03025542|593688157|FG000|Overall Study|Lost to Follow-up|1|||
164358438|NCT03025542|593688158|FG001|Overall Study|Lost to Follow-up|0|||
164358439|NCT03025542|593688157|FG000|Overall Study|Withdrawal by Subject|1|||
164358440|NCT03025542|593688158|FG001|Overall Study|Withdrawal by Subject|0|||
164009013|NCT01645280|592398286|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
164009014|NCT01645280|592398287|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
164358441|NCT00312494|593688161|FG000|Overall Study|Randomized; not treated with study drug|9|||
164358442|NCT00312494|593688162|FG001|Overall Study|Randomized; not treated with study drug|10|||
164009015|NCT01645280|592398288|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
164009016|NCT01645280|592398289|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
164009017|NCT01645280|592398290|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
164009018|NCT02052960|592398296|FG000|Overall Study|Adverse Event|19|||
164009019|NCT02052960|592398297|FG001|Overall Study|Adverse Event|17|||
164358443|NCT00312494|593688163|FG002|Overall Study|Randomized; not treated with study drug|5|||
163901088|NCT01437319|592009602|FG002|Phase I|Protocol Violation|0|||
163901089|NCT01437319|592009600|FG000|Phase I|Study related symptoms/complaints|27|||
163901090|NCT01437319|592009601|FG001|Phase I|Study related symptoms/complaints|0|||
163901091|NCT01437319|592009602|FG002|Phase I|Study related symptoms/complaints|0|||
164009020|NCT02052960|592398296|FG000|Overall Study|Protocol Violation|4|||
164009021|NCT02052960|592398297|FG001|Overall Study|Protocol Violation|3|||
164009022|NCT02052960|592398296|FG000|Overall Study|Withdrawal by Subject|6|||
163901092|NCT01437319|592009600|FG000|Phase I|Withdrawal by Subject|25|||
163901093|NCT01437319|592009601|FG001|Phase I|Withdrawal by Subject|0|||
163901094|NCT01437319|592009602|FG002|Phase I|Withdrawal by Subject|0|||
163901095|NCT01437319|592009600|FG000|Phase II|Withdrawal by Subject|0|||
163901096|NCT01437319|592009601|FG001|Phase II|Withdrawal by Subject|8|||
163901097|NCT01437319|592009602|FG002|Phase II|Withdrawal by Subject|16|||
163901098|NCT01437319|592009600|FG000|Phase II|Lost to Follow-up|0|||
163901099|NCT01437319|592009601|FG001|Phase II|Lost to Follow-up|7|||
163901100|NCT01437319|592009602|FG002|Phase II|Lost to Follow-up|2|||
163901101|NCT01437319|592009600|FG000|Phase II|Study related symptoms/complaints|0|||
163901102|NCT01437319|592009601|FG001|Phase II|Study related symptoms/complaints|28|||
163901103|NCT01437319|592009602|FG002|Phase II|Study related symptoms/complaints|19|||
163901104|NCT01437319|592009600|FG000|Phase II|Protocol Violation|0|||
163901105|NCT01437319|592009601|FG001|Phase II|Protocol Violation|1|||
163901106|NCT01437319|592009602|FG002|Phase II|Protocol Violation|0|||
163901107|NCT00983294|592009603|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
163901108|NCT00983294|592009603|FG000|Colchicine With Azithromycin|Adverse Event|1|||
163901109|NCT00622700|592009604|FG000|Core Treatment Period|Randomized but Not Treated|0|||
163901110|NCT00622700|592009605|FG001|Core Treatment Period|Randomized but Not Treated|2|||
163901111|NCT00622700|592009606|FG002|Core Treatment Period|Randomized but Not Treated|2|||
163901112|NCT00622700|592009607|FG003|Core Treatment Period|Randomized but Not Treated|0|||
163901113|NCT00622700|592009608|FG004|Core Treatment Period|Randomized but Not Treated|0|||
163901114|NCT00622700|592009609|FG005|Core Treatment Period|Randomized but Not Treated|0|||
163901115|NCT00622700|592009610|FG006|Core Treatment Period|Randomized but Not Treated|0|||
163901116|NCT00622700|592009604|FG000|Core Treatment Period|Adverse Event|18|||
163901117|NCT00622700|592009605|FG001|Core Treatment Period|Adverse Event|25|||
163901118|NCT00622700|592009606|FG002|Core Treatment Period|Adverse Event|18|||
163901119|NCT00622700|592009607|FG003|Core Treatment Period|Adverse Event|0|||
163901120|NCT00622700|592009608|FG004|Core Treatment Period|Adverse Event|0|||
163901121|NCT00622700|592009609|FG005|Core Treatment Period|Adverse Event|0|||
163901122|NCT00622700|592009610|FG006|Core Treatment Period|Adverse Event|0|||
163901123|NCT00622700|592009604|FG000|Core Treatment Period|Lack of Efficacy|19|||
163901124|NCT00622700|592009605|FG001|Core Treatment Period|Lack of Efficacy|6|||
163901125|NCT00622700|592009606|FG002|Core Treatment Period|Lack of Efficacy|12|||
163901126|NCT00622700|592009607|FG003|Core Treatment Period|Lack of Efficacy|0|||
163901127|NCT00622700|592009608|FG004|Core Treatment Period|Lack of Efficacy|0|||
163901128|NCT00622700|592009609|FG005|Core Treatment Period|Lack of Efficacy|0|||
163901129|NCT00622700|592009610|FG006|Core Treatment Period|Lack of Efficacy|0|||
163901130|NCT00622700|592009604|FG000|Core Treatment Period|Lost to Follow-up|1|||
163901131|NCT00622700|592009605|FG001|Core Treatment Period|Lost to Follow-up|1|||
163901132|NCT00622700|592009606|FG002|Core Treatment Period|Lost to Follow-up|1|||
163901133|NCT00622700|592009607|FG003|Core Treatment Period|Lost to Follow-up|0|||
163901134|NCT00622700|592009608|FG004|Core Treatment Period|Lost to Follow-up|0|||
163901135|NCT00622700|592009609|FG005|Core Treatment Period|Lost to Follow-up|0|||
163901136|NCT00622700|592009610|FG006|Core Treatment Period|Lost to Follow-up|0|||
163901137|NCT00622700|592009604|FG000|Core Treatment Period|Death|1|||
163901138|NCT00622700|592009605|FG001|Core Treatment Period|Death|0|||
163901139|NCT00622700|592009606|FG002|Core Treatment Period|Death|0|||
163901140|NCT00622700|592009607|FG003|Core Treatment Period|Death|0|||
163901141|NCT00622700|592009608|FG004|Core Treatment Period|Death|0|||
163901142|NCT00622700|592009609|FG005|Core Treatment Period|Death|0|||
163901143|NCT00622700|592009610|FG006|Core Treatment Period|Death|0|||
163901144|NCT00622700|592009604|FG000|Core Treatment Period|Progressive Disease|3|||
163901145|NCT00622700|592009605|FG001|Core Treatment Period|Progressive Disease|1|||
163901146|NCT00622700|592009606|FG002|Core Treatment Period|Progressive Disease|0|||
163901147|NCT00622700|592009607|FG003|Core Treatment Period|Progressive Disease|0|||
163901148|NCT00622700|592009608|FG004|Core Treatment Period|Progressive Disease|0|||
163901149|NCT00622700|592009609|FG005|Core Treatment Period|Progressive Disease|0|||
163901150|NCT00622700|592009610|FG006|Core Treatment Period|Progressive Disease|0|||
164009023|NCT02052960|592398297|FG001|Overall Study|Withdrawal by Subject|11|||
164009024|NCT02052960|592398296|FG000|Overall Study|Other|25|||
164009025|NCT02052960|592398297|FG001|Overall Study|Other|15|||
164009026|NCT02460822|592398298|FG000|Overall Study|Withdrawal by Subject|1|||
164009027|NCT03849560|592398299|FG000|Overall Study|Withdrawal by Subject|1|||
164009028|NCT03849560|592398300|FG001|Overall Study|Withdrawal by Subject|0|||
164009029|NCT03849560|592398301|FG002|Overall Study|Withdrawal by Subject|0|||
164009030|NCT01633060|592398305|FG000|Randomization Phase|Protocol deviation|1|||
164009031|NCT01633060|592398306|FG001|Randomization Phase|Protocol deviation|2|||
164009032|NCT01633060|592398305|FG000|Randomization Phase|Technical problem|0|||
164009033|NCT01633060|592398306|FG001|Randomization Phase|Technical problem|1|||
164009034|NCT01633060|592398305|FG000|Treatment Phase|Adverse Event|24|||
164009035|NCT01633060|592398306|FG001|Treatment Phase|Adverse Event|3|||
164009036|NCT01633060|592398305|FG000|Treatment Phase|Lost to Follow-up|1|||
164009037|NCT01633060|592398306|FG001|Treatment Phase|Lost to Follow-up|0|||
164009038|NCT01633060|592398305|FG000|Treatment Phase|Physician Decision|16|||
164009039|NCT01633060|592398306|FG001|Treatment Phase|Physician Decision|7|||
164009040|NCT01633060|592398305|FG000|Treatment Phase|Progressive Disease|210|||
164009041|NCT01633060|592398306|FG001|Treatment Phase|Progressive Disease|120|||
164009042|NCT01633060|592398305|FG000|Treatment Phase|Protocol Deviation|1|||
164009043|NCT01633060|592398306|FG001|Treatment Phase|Protocol Deviation|0|||
164009044|NCT01633060|592398305|FG000|Treatment Phase|Study Terminated by sponsor|7|||
164009045|NCT01633060|592398306|FG001|Treatment Phase|Study Terminated by sponsor|3|||
164009046|NCT01633060|592398305|FG000|Treatment Phase|Subject/guardian decision|25|||
164009047|NCT01633060|592398306|FG001|Treatment Phase|Subject/guardian decision|4|||
164009048|NCT01633060|592398305|FG000|Treatment Phase|Death|4|||
164009049|NCT01633060|592398306|FG001|Treatment Phase|Death|3|||
164009050|NCT01633060|592398305|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
164358444|NCT00312494|593688161|FG000|Overall Study|Adverse Event|33|||
164358445|NCT00312494|593688162|FG001|Overall Study|Adverse Event|15|||
164358446|NCT00312494|593688163|FG002|Overall Study|Adverse Event|11|||
164358447|NCT00312494|593688161|FG000|Overall Study|Lack of Efficacy|4|||
164358448|NCT00312494|593688162|FG001|Overall Study|Lack of Efficacy|6|||
164358449|NCT00312494|593688163|FG002|Overall Study|Lack of Efficacy|8|||
164358450|NCT00312494|593688161|FG000|Overall Study|Laboratory abnormality|1|||
164358451|NCT00312494|593688162|FG001|Overall Study|Laboratory abnormality|0|||
164358452|NCT00312494|593688163|FG002|Overall Study|Laboratory abnormality|0|||
164358453|NCT00312494|593688161|FG000|Overall Study|Lost to Follow-up|8|||
164358454|NCT00312494|593688162|FG001|Overall Study|Lost to Follow-up|8|||
164358455|NCT00312494|593688163|FG002|Overall Study|Lost to Follow-up|8|||
164358456|NCT00312494|593688161|FG000|Overall Study|Withdrawal by Subject|6|||
164358457|NCT00312494|593688162|FG001|Overall Study|Withdrawal by Subject|9|||
164358458|NCT00312494|593688163|FG002|Overall Study|Withdrawal by Subject|10|||
164358459|NCT00312494|593688161|FG000|Overall Study|Other|10|||
164358460|NCT00312494|593688162|FG001|Overall Study|Other|10|||
164358461|NCT00312494|593688163|FG002|Overall Study|Other|1|||
164358462|NCT00488345|593688164|FG000|Overall Study|Adverse Event|0|||
164358463|NCT00488345|593688165|FG001|Overall Study|Adverse Event|1|||
164358464|NCT00488345|593688166|FG002|Overall Study|Adverse Event|1|||
164358465|NCT00488345|593688164|FG000|Overall Study|Unable to administer antibiotics at home|0|||
164358466|NCT00488345|593688165|FG001|Overall Study|Unable to administer antibiotics at home|1|||
164358467|NCT00488345|593688166|FG002|Overall Study|Unable to administer antibiotics at home|0|||
164358468|NCT00488345|593688164|FG000|Overall Study|Institutional Review Board review|0|||
164358469|NCT00488345|593688165|FG001|Overall Study|Institutional Review Board review|0|||
164358470|NCT00488345|593688166|FG002|Overall Study|Institutional Review Board review|1|||
164358471|NCT00488345|593688164|FG000|Overall Study|Surgical team recommendation|0|||
164358472|NCT00488345|593688165|FG001|Overall Study|Surgical team recommendation|1|||
164358473|NCT00488345|593688166|FG002|Overall Study|Surgical team recommendation|0|||
164358474|NCT00488345|593688164|FG000|Overall Study|Parent/legal guardian request|0|||
164358475|NCT00488345|593688165|FG001|Overall Study|Parent/legal guardian request|1|||
164358476|NCT00488345|593688166|FG002|Overall Study|Parent/legal guardian request|1|||
164009051|NCT01633060|592398306|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164009052|NCT01633060|592398305|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
164009053|NCT01633060|592398306|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
164009054|NCT01633060|592398305|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
164009055|NCT01633060|592398306|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
164009056|NCT01633060|592398305|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
164358477|NCT00696696|593688169|FG000|Overall Study|Adverse Event|5|||
164358478|NCT00696696|593688169|FG000|Overall Study|Withdrawal by Subject|8|||
164358479|NCT00696696|593688169|FG000|Overall Study|Physician Decision|2|||
164358480|NCT00696696|593688169|FG000|Overall Study|Death|3|||
164358481|NCT02642614|593688170|FG000|Overall Study|Adverse Event|1|||
164358482|NCT02642614|593688171|FG001|Overall Study|Adverse Event|1|||
164358483|NCT02642614|593688172|FG002|Overall Study|Adverse Event|2|||
164358484|NCT02642614|593688173|FG003|Overall Study|Adverse Event|2|||
164009057|NCT01633060|592398306|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
164009058|NCT01633060|592398305|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
164009059|NCT01633060|592398306|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
164009060|NCT01633060|592398305|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
164009061|NCT01633060|592398306|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
164009062|NCT00883753|592398307|FG000|Overall Study|Adverse Event|37|||
164009063|NCT00883753|592398307|FG000|Overall Study|Death|2|||
164009064|NCT00883753|592398307|FG000|Overall Study|Insufficient therapeutic response|16|||
164009065|NCT00883753|592398307|FG000|Overall Study|Lost to Follow-up|4|||
164009066|NCT00883753|592398307|FG000|Overall Study|Violation of selection criteria at entry|7|||
164091266|NCT01957488|592697853|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
164091267|NCT01957488|592697854|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
164091268|NCT01957488|592697849|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
164091269|NCT01957488|592697850|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
164009067|NCT00883753|592398307|FG000|Overall Study|Protocol Violation|2|||
164009068|NCT00883753|592398307|FG000|Overall Study|Refused treatment|4|||
164009069|NCT00883753|592398307|FG000|Overall Study|Withdrew consent|10|||
164009070|NCT00883753|592398307|FG000|Overall Study|Investigator's decision|17|||
164009071|NCT00883753|592398307|FG000|Overall Study|Administrative/Other|8|||
164009072|NCT02859415|592398308|FG000|Overall Study|Physician Decision|1|||
164009073|NCT02859415|592398309|FG001|Overall Study|Physician Decision|0|||
164009074|NCT02859415|592398308|FG000|Overall Study|Off treatment due to cardiac event|0|||
164009075|NCT02859415|592398309|FG001|Overall Study|Off treatment due to cardiac event|1|||
164009076|NCT01396525|592398312|FG000|Overall Study|Withdrawal by Subject|8|||
164009077|NCT01396525|592398312|FG000|Overall Study|Death|14|||
164009078|NCT01396525|592398312|FG000|Overall Study|Lost to Follow-up|4|||
164009079|NCT00414440|592398314|FG000|Core Period|Withdrawal by Subject|70|||
164009080|NCT00414440|592398315|FG001|Core Period|Withdrawal by Subject|32|||
164009081|NCT00414440|592398314|FG000|Extension Period|Lost to Follow-up|44|||
164009082|NCT00414440|592398315|FG001|Extension Period|Lost to Follow-up|52|||
164009083|NCT00414440|592398314|FG000|Extension Period|Did not consent to continue follow up|61|||
164009084|NCT00414440|592398315|FG001|Extension Period|Did not consent to continue follow up|54|||
164009085|NCT00414440|592398314|FG000|Extension Period|Other|1|||
164009086|NCT00414440|592398315|FG001|Extension Period|Other|1|||
164009087|NCT00414440|592398314|FG000|Extension Period|Administrative|16|||
164009088|NCT00414440|592398315|FG001|Extension Period|Administrative|16|||
164009089|NCT00414440|592398314|FG000|Extension Period|Death|1|||
164009090|NCT00414440|592398315|FG001|Extension Period|Death|2|||
164009091|NCT00414440|592398314|FG000|Extension Period|Withdrawal by Subject|9|||
164009092|NCT00414440|592398315|FG001|Extension Period|Withdrawal by Subject|7|||
164009093|NCT00414440|592398314|FG000|Extension Period|Not included in follow up period|18|||
164009094|NCT00414440|592398315|FG001|Extension Period|Not included in follow up period|8|||
164009095|NCT01743027|592398319|FG000|Overall Study|Adverse Event|2|||
164009096|NCT01743027|592398320|FG001|Overall Study|Adverse Event|0|||
164009097|NCT01743027|592398321|FG002|Overall Study|Adverse Event|0|||
164009098|NCT01743027|592398322|FG003|Overall Study|Adverse Event|0|||
164009099|NCT01743027|592398319|FG000|Overall Study|Lost to Follow-up|0|||
164009100|NCT01743027|592398320|FG001|Overall Study|Lost to Follow-up|0|||
164009101|NCT01743027|592398321|FG002|Overall Study|Lost to Follow-up|2|||
164009102|NCT01743027|592398322|FG003|Overall Study|Lost to Follow-up|0|||
164009103|NCT01743027|592398319|FG000|Overall Study|Progressive Disease|1|||
164009104|NCT01743027|592398320|FG001|Overall Study|Progressive Disease|4|||
164009105|NCT01743027|592398321|FG002|Overall Study|Progressive Disease|3|||
164009106|NCT01743027|592398322|FG003|Overall Study|Progressive Disease|0|||
164009107|NCT01743027|592398319|FG000|Overall Study|Protocol Violation|1|||
164009108|NCT01743027|592398320|FG001|Overall Study|Protocol Violation|1|||
164009109|NCT01743027|592398321|FG002|Overall Study|Protocol Violation|1|||
164009110|NCT01743027|592398322|FG003|Overall Study|Protocol Violation|0|||
164009111|NCT01743027|592398319|FG000|Overall Study|Withdrawal by Subject|1|||
164009112|NCT01743027|592398320|FG001|Overall Study|Withdrawal by Subject|0|||
164009113|NCT01743027|592398321|FG002|Overall Study|Withdrawal by Subject|3|||
164009114|NCT01743027|592398322|FG003|Overall Study|Withdrawal by Subject|1|||
164009115|NCT00138151|592398323|FG000|Overall Study|Withdrawal by Subject|3|||
164009116|NCT00138151|592398323|FG000|Overall Study|Physician Decision|1|||
164009117|NCT04925570|592398326|FG000|Overall Study|Protocol Violation|24|||
164009118|NCT04925570|592398327|FG001|Overall Study|Protocol Violation|30|||
164009119|NCT04925570|592398326|FG000|Overall Study|Withdrawal by Subject|0|||
164009120|NCT04925570|592398327|FG001|Overall Study|Withdrawal by Subject|2|||
164009121|NCT03494725|592398330|FG000|Overall Study|Withdrawal by Subject|0|||
164009122|NCT03494725|592398331|FG001|Overall Study|Withdrawal by Subject|2|||
164009123|NCT03494725|592398330|FG000|Overall Study|Antibiotic use|1|||
164009124|NCT03494725|592398331|FG001|Overall Study|Antibiotic use|0|||
164009125|NCT02619253|592398332|FG000|Overall Study|Adverse Event|0|||
164009126|NCT02619253|592398333|FG001|Overall Study|Adverse Event|0|||
164009127|NCT02619253|592398334|FG002|Overall Study|Adverse Event|1|||
164009128|NCT02619253|592398335|FG003|Overall Study|Adverse Event|1|||
164009129|NCT02619253|592398336|FG004|Overall Study|Adverse Event|3|||
164009130|NCT02619253|592398332|FG000|Overall Study|Alternative Therapy|0|||
164009131|NCT02619253|592398333|FG001|Overall Study|Alternative Therapy|0|||
164009132|NCT02619253|592398334|FG002|Overall Study|Alternative Therapy|1|||
164009133|NCT02619253|592398335|FG003|Overall Study|Alternative Therapy|0|||
164009134|NCT02619253|592398336|FG004|Overall Study|Alternative Therapy|0|||
164009135|NCT02619253|592398332|FG000|Overall Study|Death|0|||
164358485|NCT02642614|593688170|FG000|Overall Study|Lost to Follow-up|1|||
164358486|NCT02642614|593688171|FG001|Overall Study|Lost to Follow-up|0|||
164358487|NCT02642614|593688172|FG002|Overall Study|Lost to Follow-up|0|||
164009136|NCT02619253|592398333|FG001|Overall Study|Death|0|||
164009137|NCT02619253|592398334|FG002|Overall Study|Death|0|||
164009138|NCT02619253|592398335|FG003|Overall Study|Death|1|||
164009139|NCT02619253|592398336|FG004|Overall Study|Death|0|||
164009140|NCT02619253|592398332|FG000|Overall Study|Disease Progression|4|||
164009141|NCT02619253|592398333|FG001|Overall Study|Disease Progression|2|||
164009142|NCT02619253|592398334|FG002|Overall Study|Disease Progression|8|||
164358488|NCT02642614|593688173|FG003|Overall Study|Lost to Follow-up|0|||
164358489|NCT02642614|593688170|FG000|Overall Study|Withdrawal by Subject|1|||
164009143|NCT02619253|592398335|FG003|Overall Study|Disease Progression|9|||
164009144|NCT02619253|592398336|FG004|Overall Study|Disease Progression|10|||
164009145|NCT02619253|592398332|FG000|Overall Study|Needed a disqualifying therapy|0|||
164009146|NCT02619253|592398333|FG001|Overall Study|Needed a disqualifying therapy|0|||
164009147|NCT02619253|592398334|FG002|Overall Study|Needed a disqualifying therapy|1|||
164009148|NCT02619253|592398335|FG003|Overall Study|Needed a disqualifying therapy|0|||
164009149|NCT02619253|592398336|FG004|Overall Study|Needed a disqualifying therapy|0|||
164009150|NCT02619253|592398332|FG000|Overall Study|Transferred to hospice|0|||
164009151|NCT02619253|592398333|FG001|Overall Study|Transferred to hospice|0|||
164009152|NCT02619253|592398334|FG002|Overall Study|Transferred to hospice|1|||
164009153|NCT02619253|592398335|FG003|Overall Study|Transferred to hospice|0|||
164009154|NCT02619253|592398336|FG004|Overall Study|Transferred to hospice|0|||
164009155|NCT02619253|592398332|FG000|Overall Study|Physician Decision|0|||
164009156|NCT02619253|592398333|FG001|Overall Study|Physician Decision|1|||
164009157|NCT02619253|592398334|FG002|Overall Study|Physician Decision|2|||
164009158|NCT02619253|592398335|FG003|Overall Study|Physician Decision|3|||
164009159|NCT02619253|592398336|FG004|Overall Study|Physician Decision|0|||
164009160|NCT02619253|592398332|FG000|Overall Study|Withdrawal by Subject|0|||
164009161|NCT02619253|592398333|FG001|Overall Study|Withdrawal by Subject|1|||
164009162|NCT02619253|592398334|FG002|Overall Study|Withdrawal by Subject|0|||
164009163|NCT02619253|592398335|FG003|Overall Study|Withdrawal by Subject|0|||
164009164|NCT02619253|592398336|FG004|Overall Study|Withdrawal by Subject|2|||
164009165|NCT02111811|592398337|FG000|Treatment Phase|Lost to Follow-up|22|||
164009166|NCT02111811|592398338|FG001|Treatment Phase|Lost to Follow-up|18|||
164009167|NCT02111811|592398337|FG000|Treatment Phase|Death|2|||
164009168|NCT02111811|592398338|FG001|Treatment Phase|Death|0|||
164009169|NCT02111811|592398337|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
164009170|NCT02111811|592398338|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
164009171|NCT02111811|592398337|FG000|Follow up Period (Aim 2)|Death|2|||
164009172|NCT02111811|592398338|FG001|Follow up Period (Aim 2)|Death|0|||
164009173|NCT01359982|592398339|FG000|Overall Study|Adverse Event|2|||
164009174|NCT01359982|592398340|FG001|Overall Study|Adverse Event|0|||
164009175|NCT01359982|592398341|FG002|Overall Study|Adverse Event|0|||
164009176|NCT01359982|592398342|FG003|Overall Study|Adverse Event|1|||
164009177|NCT01359982|592398343|FG004|Overall Study|Adverse Event|0|||
164009178|NCT01359982|592398344|FG005|Overall Study|Adverse Event|0|||
164009179|NCT01359982|592398339|FG000|Overall Study|Death|1|||
164009180|NCT01359982|592398340|FG001|Overall Study|Death|0|||
164009181|NCT01359982|592398341|FG002|Overall Study|Death|0|||
164009182|NCT01359982|592398342|FG003|Overall Study|Death|0|||
164009183|NCT01359982|592398343|FG004|Overall Study|Death|0|||
164009184|NCT01359982|592398344|FG005|Overall Study|Death|0|||
164009185|NCT05593432|592398345|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
164009186|NCT05593432|592398346|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
164009187|NCT05593432|592398347|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
164009188|NCT05593432|592398348|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
164009189|NCT05593432|592398345|FG000|16-Week OLE Period|Lack of Efficacy|0|||
164009190|NCT05593432|592398346|FG001|16-Week OLE Period|Lack of Efficacy|0|||
164009191|NCT05593432|592398347|FG002|16-Week OLE Period|Lack of Efficacy|0|||
164009192|NCT05593432|592398348|FG003|16-Week OLE Period|Lack of Efficacy|1|||
164009193|NCT05593432|592398345|FG000|16-Week OLE Period|Lost to Follow-up|0|||
164009194|NCT05593432|592398346|FG001|16-Week OLE Period|Lost to Follow-up|0|||
164009195|NCT05593432|592398347|FG002|16-Week OLE Period|Lost to Follow-up|1|||
164009196|NCT05593432|592398348|FG003|16-Week OLE Period|Lost to Follow-up|2|||
164009197|NCT05593432|592398345|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
164009198|NCT05593432|592398346|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
164009199|NCT05593432|592398347|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
164009200|NCT05593432|592398348|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
164009201|NCT00069121|592398350|FG000|Overall Study|Death|286|||
164009202|NCT00069121|592398351|FG001|Overall Study|Death|242|||
164009203|NCT00069121|592398350|FG000|Overall Study|Withdrawal by Subject|18|||
164009204|NCT00069121|592398351|FG001|Overall Study|Withdrawal by Subject|20|||
164009205|NCT00069121|592398350|FG000|Overall Study|Lost to Follow-up|63|||
164009206|NCT00069121|592398351|FG001|Overall Study|Lost to Follow-up|63|||
164009207|NCT03851510|592398352|FG000|Overall Study|Screen Fail|1|||
164009208|NCT03851510|592398352|FG000|Overall Study|Adverse Event|1|||
164009209|NCT03851510|592398352|FG000|Overall Study|Withdrawal by Subject|1|||
164009210|NCT02426086|592398353|FG000|Overall Study|Death|33|||
164009211|NCT02426086|592398354|FG001|Overall Study|Death|36|||
164009212|NCT02426086|592398353|FG000|Overall Study|Lost to Follow-up|2|||
164009213|NCT02426086|592398354|FG001|Overall Study|Lost to Follow-up|0|||
164009214|NCT02426086|592398353|FG000|Overall Study|Study Terminated by Sponsor|5|||
164009215|NCT02426086|592398354|FG001|Overall Study|Study Terminated by Sponsor|14|||
164009216|NCT02426086|592398353|FG000|Overall Study|Withdrawal by Subject|8|||
164009217|NCT02426086|592398354|FG001|Overall Study|Withdrawal by Subject|9|||
164009218|NCT04542291|592398355|FG000|Overall Study|Adverse Event|1|||
164009219|NCT04542291|592398355|FG000|Overall Study|Physician Decision|2|||
164009220|NCT01287117|592398356|FG000|Overall Study|Adverse Event|2|||
163901151|NCT00622700|592009604|FG000|Core Treatment Period|Withdrawal by Subject|12|||
163901152|NCT00622700|592009605|FG001|Core Treatment Period|Withdrawal by Subject|18|||
163901153|NCT00622700|592009606|FG002|Core Treatment Period|Withdrawal by Subject|15|||
163901154|NCT00622700|592009607|FG003|Core Treatment Period|Withdrawal by Subject|0|||
163901155|NCT00622700|592009608|FG004|Core Treatment Period|Withdrawal by Subject|0|||
163901156|NCT00622700|592009609|FG005|Core Treatment Period|Withdrawal by Subject|0|||
163901157|NCT00622700|592009610|FG006|Core Treatment Period|Withdrawal by Subject|0|||
163901158|NCT00622700|592009604|FG000|Core Treatment Period|Other than specified above|2|||
163901159|NCT00622700|592009605|FG001|Core Treatment Period|Other than specified above|2|||
163901160|NCT00622700|592009606|FG002|Core Treatment Period|Other than specified above|5|||
163901161|NCT00622700|592009607|FG003|Core Treatment Period|Other than specified above|0|||
163901162|NCT00622700|592009608|FG004|Core Treatment Period|Other than specified above|0|||
163901163|NCT00622700|592009609|FG005|Core Treatment Period|Other than specified above|0|||
163901164|NCT00622700|592009610|FG006|Core Treatment Period|Other than specified above|0|||
163901165|NCT00622700|592009604|FG000|Extension Treatment Period|Adverse Event|0|||
163901166|NCT00622700|592009605|FG001|Extension Treatment Period|Adverse Event|0|||
163901167|NCT00622700|592009606|FG002|Extension Treatment Period|Adverse Event|0|||
163901168|NCT00622700|592009607|FG003|Extension Treatment Period|Adverse Event|5|||
163901169|NCT00622700|592009608|FG004|Extension Treatment Period|Adverse Event|9|||
163901170|NCT00622700|592009609|FG005|Extension Treatment Period|Adverse Event|6|||
163901171|NCT00622700|592009610|FG006|Extension Treatment Period|Adverse Event|8|||
163901172|NCT00622700|592009604|FG000|Extension Treatment Period|Lack of Efficacy|0|||
163901173|NCT00622700|592009605|FG001|Extension Treatment Period|Lack of Efficacy|0|||
163901174|NCT00622700|592009606|FG002|Extension Treatment Period|Lack of Efficacy|0|||
163901175|NCT00622700|592009607|FG003|Extension Treatment Period|Lack of Efficacy|2|||
163901176|NCT00622700|592009608|FG004|Extension Treatment Period|Lack of Efficacy|8|||
163901177|NCT00622700|592009609|FG005|Extension Treatment Period|Lack of Efficacy|1|||
163901178|NCT00622700|592009610|FG006|Extension Treatment Period|Lack of Efficacy|9|||
163901179|NCT00622700|592009604|FG000|Extension Treatment Period|Protocol Violation|0|||
163901180|NCT00622700|592009605|FG001|Extension Treatment Period|Protocol Violation|0|||
163901181|NCT00622700|592009606|FG002|Extension Treatment Period|Protocol Violation|0|||
163901182|NCT00622700|592009607|FG003|Extension Treatment Period|Protocol Violation|0|||
163901183|NCT00622700|592009608|FG004|Extension Treatment Period|Protocol Violation|0|||
163901184|NCT00622700|592009609|FG005|Extension Treatment Period|Protocol Violation|2|||
163901185|NCT00622700|592009610|FG006|Extension Treatment Period|Protocol Violation|0|||
163901186|NCT00622700|592009604|FG000|Extension Treatment Period|Lost to Follow-up|0|||
163901187|NCT00622700|592009605|FG001|Extension Treatment Period|Lost to Follow-up|0|||
163901188|NCT00622700|592009606|FG002|Extension Treatment Period|Lost to Follow-up|0|||
163901189|NCT00622700|592009607|FG003|Extension Treatment Period|Lost to Follow-up|0|||
163901190|NCT00622700|592009608|FG004|Extension Treatment Period|Lost to Follow-up|1|||
163901191|NCT00622700|592009609|FG005|Extension Treatment Period|Lost to Follow-up|0|||
163901192|NCT00622700|592009610|FG006|Extension Treatment Period|Lost to Follow-up|0|||
163901193|NCT00622700|592009604|FG000|Extension Treatment Period|Progressive Disease|0|||
163901194|NCT00622700|592009605|FG001|Extension Treatment Period|Progressive Disease|0|||
163901195|NCT00622700|592009606|FG002|Extension Treatment Period|Progressive Disease|0|||
163901196|NCT00622700|592009607|FG003|Extension Treatment Period|Progressive Disease|1|||
163901197|NCT00622700|592009608|FG004|Extension Treatment Period|Progressive Disease|2|||
163901198|NCT00622700|592009609|FG005|Extension Treatment Period|Progressive Disease|0|||
163901199|NCT00622700|592009610|FG006|Extension Treatment Period|Progressive Disease|2|||
163901200|NCT00622700|592009604|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
163901201|NCT00622700|592009605|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164358490|NCT02642614|593688171|FG001|Overall Study|Withdrawal by Subject|1|||
164358491|NCT02642614|593688172|FG002|Overall Study|Withdrawal by Subject|0|||
164358492|NCT02642614|593688173|FG003|Overall Study|Withdrawal by Subject|0|||
164358493|NCT01585428|593688174|FG000|Overall Study|Death during treatment|1|||
164358494|NCT01585428|593688175|FG001|Overall Study|Death during treatment|0|||
164358495|NCT02057198|593688178|FG000|Overall Study|Death|0|||
164358496|NCT02057198|593688179|FG001|Overall Study|Death|0|||
164358497|NCT02057198|593688180|FG002|Overall Study|Death|1|||
164358498|NCT02057198|593688178|FG000|Overall Study|Discharged early; lost to followup|0|||
164358499|NCT02057198|593688179|FG001|Overall Study|Discharged early; lost to followup|1|||
164358500|NCT02057198|593688180|FG002|Overall Study|Discharged early; lost to followup|0|||
164358501|NCT00065507|593688182|FG000|Overall Study|Death|16|||
164358502|NCT00065507|593688183|FG001|Overall Study|Death|17|||
164358503|NCT00065507|593688182|FG000|Overall Study|Adverse Event|4|||
164358504|NCT00065507|593688183|FG001|Overall Study|Adverse Event|3|||
164358505|NCT00065507|593688182|FG000|Overall Study|Lack of Efficacy|0|||
164358506|NCT00065507|593688183|FG001|Overall Study|Lack of Efficacy|6|||
163901202|NCT00622700|592009606|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163901203|NCT00622700|592009607|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
163901204|NCT00622700|592009608|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
163901205|NCT00622700|592009609|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
163901206|NCT00622700|592009610|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
163901207|NCT00622700|592009604|FG000|Extension Treatment Period|Missing|0|||
163901208|NCT00622700|592009605|FG001|Extension Treatment Period|Missing|0|||
163901209|NCT00622700|592009606|FG002|Extension Treatment Period|Missing|0|||
163901210|NCT00622700|592009607|FG003|Extension Treatment Period|Missing|2|||
163901211|NCT00622700|592009608|FG004|Extension Treatment Period|Missing|3|||
164112584|NCT03686215|592774028|FG002|Overall Study|Device issue|2|||
164358507|NCT00065507|593688182|FG000|Overall Study|Poor/Non-compliance|3|||
164358508|NCT00065507|593688183|FG001|Overall Study|Poor/Non-compliance|2|||
164358509|NCT00065507|593688182|FG000|Overall Study|Lost to Follow-up|3|||
164358510|NCT00065507|593688183|FG001|Overall Study|Lost to Follow-up|0|||
164091270|NCT01957488|592697851|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
164091271|NCT01957488|592697852|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
164091272|NCT01957488|592697853|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
164091273|NCT01957488|592697854|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
164091274|NCT01957488|592697849|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
164091275|NCT01957488|592697850|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
164091276|NCT01957488|592697851|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
164091277|NCT01957488|592697852|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
164091278|NCT01957488|592697853|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
164091279|NCT01957488|592697854|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
164091280|NCT01957488|592697849|FG000|Test Period 2 (2 Weeks)|Other|1|||
164091281|NCT01957488|592697850|FG001|Test Period 2 (2 Weeks)|Other|0|||
164091282|NCT01957488|592697851|FG002|Test Period 2 (2 Weeks)|Other|0|||
164091283|NCT01957488|592697852|FG003|Test Period 2 (2 Weeks)|Other|0|||
164091284|NCT01957488|592697853|FG004|Test Period 2 (2 Weeks)|Other|0|||
164091285|NCT01957488|592697854|FG005|Test Period 2 (2 Weeks)|Other|0|||
164091286|NCT01957488|592697849|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
163901212|NCT00622700|592009609|FG005|Extension Treatment Period|Missing|1|||
164091287|NCT01957488|592697850|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
164091288|NCT01957488|592697851|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
163901213|NCT00622700|592009610|FG006|Extension Treatment Period|Missing|0|||
163901214|NCT00622700|592009604|FG000|Extension Treatment Period|Other than specified above|0|||
163901215|NCT00622700|592009605|FG001|Extension Treatment Period|Other than specified above|0|||
163901216|NCT00622700|592009606|FG002|Extension Treatment Period|Other than specified above|0|||
163901217|NCT00622700|592009607|FG003|Extension Treatment Period|Other than specified above|0|||
163901218|NCT00622700|592009608|FG004|Extension Treatment Period|Other than specified above|0|||
163901219|NCT00622700|592009609|FG005|Extension Treatment Period|Other than specified above|1|||
163901220|NCT00622700|592009610|FG006|Extension Treatment Period|Other than specified above|1|||
163901221|NCT03611556|592009611|FG000|Overall Study|Death|7|||
163901222|NCT03611556|592009612|FG001|Overall Study|Death|7|||
163901223|NCT03611556|592009613|FG002|Overall Study|Death|3|||
163901224|NCT03611556|592009614|FG003|Overall Study|Death|8|||
163901225|NCT03611556|592009615|FG004|Overall Study|Death|47|||
163901226|NCT03611556|592009616|FG005|Overall Study|Death|32|||
163901227|NCT03611556|592009617|FG006|Overall Study|Death|53|||
163901228|NCT03611556|592009611|FG000|Overall Study|Withdrawal by Subject|0|||
163901229|NCT03611556|592009612|FG001|Overall Study|Withdrawal by Subject|0|||
163901230|NCT03611556|592009613|FG002|Overall Study|Withdrawal by Subject|0|||
163901231|NCT03611556|592009614|FG003|Overall Study|Withdrawal by Subject|0|||
163901232|NCT03611556|592009615|FG004|Overall Study|Withdrawal by Subject|4|||
163901233|NCT03611556|592009616|FG005|Overall Study|Withdrawal by Subject|2|||
163901234|NCT03611556|592009617|FG006|Overall Study|Withdrawal by Subject|4|||
163901235|NCT03611556|592009611|FG000|Overall Study|Sponsor decision|0|||
163901236|NCT03611556|592009612|FG001|Overall Study|Sponsor decision|0|||
163901237|NCT03611556|592009613|FG002|Overall Study|Sponsor decision|0|||
163901238|NCT03611556|592009614|FG003|Overall Study|Sponsor decision|0|||
163901239|NCT03611556|592009615|FG004|Overall Study|Sponsor decision|9|||
163901240|NCT03611556|592009616|FG005|Overall Study|Sponsor decision|4|||
163901241|NCT03611556|592009617|FG006|Overall Study|Sponsor decision|12|||
163901242|NCT03611556|592009611|FG000|Overall Study|Reasons|0|||
163901243|NCT03611556|592009612|FG001|Overall Study|Reasons|0|||
163901244|NCT03611556|592009613|FG002|Overall Study|Reasons|0|||
163901245|NCT03611556|592009614|FG003|Overall Study|Reasons|0|||
163901246|NCT03611556|592009615|FG004|Overall Study|Reasons|2|||
163901247|NCT03611556|592009616|FG005|Overall Study|Reasons|0|||
163901248|NCT03611556|592009617|FG006|Overall Study|Reasons|1|||
163901249|NCT02844439|592009635|FG000|Overall Study|Withdrawal by Subject|1|||
163901250|NCT02844439|592009635|FG000|Overall Study|Lost to Follow-up|2|||
163901251|NCT02844439|592009635|FG000|Overall Study|Termination by Sponsor|4|||
163901252|NCT02844439|592009635|FG000|Overall Study|Death|28|||
163901253|NCT02844439|592009635|FG000|Overall Study|Other|5|||
163901254|NCT00390884|592009638|FG000|Overall Study|Withdrawal by Subject|2|||
163901255|NCT00390884|592009639|FG001|Overall Study|Withdrawal by Subject|2|||
163901256|NCT00756574|592009640|FG000|Overall Study|Withdrawal by Subject|9|||
163901257|NCT00756574|592009641|FG001|Overall Study|Withdrawal by Subject|7|||
163901258|NCT00756574|592009640|FG000|Overall Study|Lost to Follow-up|4|||
163901259|NCT00756574|592009641|FG001|Overall Study|Lost to Follow-up|4|||
163901260|NCT04035447|592009642|FG000|Treatment Period|Lost to Follow-up|6|||
163901261|NCT04035447|592009643|FG001|Treatment Period|Lost to Follow-up|5|||
163901262|NCT04035447|592009642|FG000|Treatment Period|Physician Decision|0|||
163901263|NCT04035447|592009643|FG001|Treatment Period|Physician Decision|2|||
163901264|NCT04622332|592009644|FG000|Overall Study|Withdrawal by Subject|4|||
163901265|NCT04622332|592009645|FG001|Overall Study|Withdrawal by Subject|2|||
163901266|NCT04622332|592009644|FG000|Overall Study|Physician Decision|1|||
164091289|NCT01957488|592697852|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164091290|NCT01957488|592697853|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164091291|NCT01957488|592697854|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
164091292|NCT01957488|592697849|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
164091293|NCT01957488|592697850|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
164091294|NCT01957488|592697851|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
164091295|NCT01957488|592697852|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
164091296|NCT01957488|592697853|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
164091297|NCT01957488|592697854|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
164091298|NCT01957488|592697849|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164091299|NCT01957488|592697850|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164091300|NCT01957488|592697851|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164091301|NCT01957488|592697852|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164091302|NCT01957488|592697853|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
164091303|NCT01957488|592697854|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
164091304|NCT01957488|592697849|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
164091305|NCT01957488|592697850|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164091306|NCT01957488|592697851|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164091307|NCT01957488|592697852|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164091308|NCT01957488|592697853|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164091309|NCT01957488|592697854|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
164091310|NCT01957488|592697849|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164091311|NCT01957488|592697850|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
164091312|NCT01957488|592697851|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164091313|NCT01957488|592697852|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164091314|NCT01957488|592697853|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164091315|NCT01957488|592697854|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
164091316|NCT00973700|592697858|FG000|Overall Study|Withdrawal by Subject|2|||
164091317|NCT00973700|592697859|FG001|Overall Study|Withdrawal by Subject|2|||
164091318|NCT00973700|592697860|FG002|Overall Study|Withdrawal by Subject|8|||
164091319|NCT00973700|592697861|FG003|Overall Study|Withdrawal by Subject|4|||
164091320|NCT00973700|592697862|FG004|Overall Study|Withdrawal by Subject|4|||
164091321|NCT00973700|592697858|FG000|Overall Study|Lost to Follow-up|5|||
164091322|NCT00973700|592697859|FG001|Overall Study|Lost to Follow-up|0|||
164091323|NCT00973700|592697860|FG002|Overall Study|Lost to Follow-up|1|||
164091324|NCT00973700|592697861|FG003|Overall Study|Lost to Follow-up|8|||
164091325|NCT00973700|592697862|FG004|Overall Study|Lost to Follow-up|5|||
164091326|NCT00973700|592697858|FG000|Overall Study|Inappropriate enrolment|0|||
164091327|NCT00973700|592697859|FG001|Overall Study|Inappropriate enrolment|0|||
164091328|NCT00973700|592697860|FG002|Overall Study|Inappropriate enrolment|0|||
164091329|NCT00973700|592697861|FG003|Overall Study|Inappropriate enrolment|4|||
164091330|NCT00973700|592697862|FG004|Overall Study|Inappropriate enrolment|0|||
164091331|NCT00973700|592697858|FG000|Overall Study|Unable to Classify|0|||
164091332|NCT00973700|592697859|FG001|Overall Study|Unable to Classify|0|||
164091333|NCT00973700|592697860|FG002|Overall Study|Unable to Classify|1|||
164091334|NCT00973700|592697861|FG003|Overall Study|Unable to Classify|2|||
164091335|NCT00973700|592697862|FG004|Overall Study|Unable to Classify|1|||
164091336|NCT01618266|592697870|FG000|Overall Study|Lost to Follow-up|9|||
164091337|NCT01618266|592697870|FG000|Overall Study|Treatment satisfaction|10|||
164091338|NCT01618266|592697870|FG000|Overall Study|Other reasons|11|||
164091339|NCT01618266|592697870|FG000|Overall Study|Lack of Efficacy|23|||
164009221|NCT01287117|592398357|FG001|Overall Study|Adverse Event|1|||
164009222|NCT01287117|592398358|FG002|Overall Study|Adverse Event|1|||
164009223|NCT01287117|592398359|FG003|Overall Study|Adverse Event|1|||
164009224|NCT01287117|592398356|FG000|Overall Study|Lost to Follow-up|1|||
164009225|NCT01287117|592398357|FG001|Overall Study|Lost to Follow-up|1|||
164009226|NCT01287117|592398358|FG002|Overall Study|Lost to Follow-up|0|||
164009227|NCT01287117|592398359|FG003|Overall Study|Lost to Follow-up|0|||
164009228|NCT01287117|592398356|FG000|Overall Study|Physician Decision|0|||
164009229|NCT01287117|592398357|FG001|Overall Study|Physician Decision|1|||
164009230|NCT01287117|592398358|FG002|Overall Study|Physician Decision|1|||
164009231|NCT01287117|592398359|FG003|Overall Study|Physician Decision|1|||
164009232|NCT01287117|592398356|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
164091340|NCT01618266|592697870|FG000|Overall Study|Protocol Violation|43|||
164091341|NCT00290745|592697871|FG000|Overall Study|Withdrawal by Subject|4|||
164091342|NCT00290745|592697871|FG000|Overall Study|Physician Decision|2|||
164091343|NCT00290745|592697871|FG000|Overall Study|Surgery after 3 months for progression|3|||
164091344|NCT00290745|592697871|FG000|Overall Study|Baseline MRI not available|3|||
164091345|NCT00626925|592697872|FG000|Overall Study|Lost to Follow-up|1|||
164091346|NCT00626925|592697873|FG001|Overall Study|Lost to Follow-up|2|||
164091347|NCT00626925|592697872|FG000|Overall Study|relapse|1|||
164091348|NCT00626925|592697873|FG001|Overall Study|relapse|0|||
164091349|NCT00626925|592697872|FG000|Overall Study|Adverse effect|6|||
164009233|NCT01287117|592398357|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
164009234|NCT01287117|592398358|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
164009235|NCT01287117|592398359|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
164009236|NCT01287117|592398356|FG000|Overall Study|Disease Progression|10|||
164009237|NCT01287117|592398357|FG001|Overall Study|Disease Progression|5|||
164009238|NCT01287117|592398358|FG002|Overall Study|Disease Progression|6|||
164009239|NCT01287117|592398359|FG003|Overall Study|Disease Progression|5|||
164009240|NCT00035815|592398367|FG000|Overall Study|Withdrawal by Subject|17|||
164009241|NCT00035815|592398368|FG001|Overall Study|Withdrawal by Subject|11|||
164009242|NCT02606877|592398376|FG000|Overall Study|Adverse Event|3|||
164009243|NCT02606877|592398377|FG001|Overall Study|Adverse Event|0|||
164009244|NCT02606877|592398376|FG000|Overall Study|Non-compliance with protocol|0|||
164009245|NCT02606877|592398377|FG001|Overall Study|Non-compliance with protocol|1|||
164009246|NCT02606877|592398376|FG000|Overall Study|Other than listed above|1|||
164009247|NCT02606877|592398377|FG001|Overall Study|Other than listed above|0|||
164009248|NCT04952389|592398378|FG000|Overall Study|Withdrawal by Subject|8|||
164009249|NCT04952389|592398379|FG001|Overall Study|Withdrawal by Subject|4|||
164009250|NCT02277444|592398381|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
164009251|NCT02277444|592398381|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
164009252|NCT02277444|592398381|FG000|Treatment Period (Week 0-52)|Other|1|||
164009253|NCT02277444|592398381|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
164009254|NCT02277444|592398381|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
164009255|NCT02277444|592398381|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
164009256|NCT02277444|592398381|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
164009257|NCT02277444|592398381|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
164009258|NCT02277444|592398381|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
164009259|NCT05635838|592399588|FG000|16-Week DBVC Period|Adverse Event|2|||
164009260|NCT05635838|592399589|FG001|16-Week DBVC Period|Adverse Event|0|||
164009261|NCT05635838|592399590|FG002|16-Week DBVC Period|Adverse Event|0|||
164009262|NCT05635838|592399591|FG003|16-Week DBVC Period|Adverse Event|0|||
164009263|NCT05635838|592399588|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
164009264|NCT05635838|592399589|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
164009265|NCT05635838|592399590|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
164009266|NCT05635838|592399591|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
164009267|NCT05635838|592399588|FG000|16-Week DBVC Period|Physician Decision|0|||
164009268|NCT05635838|592399589|FG001|16-Week DBVC Period|Physician Decision|1|||
164009269|NCT05635838|592399590|FG002|16-Week DBVC Period|Physician Decision|0|||
164009270|NCT05635838|592399591|FG003|16-Week DBVC Period|Physician Decision|0|||
164009271|NCT05635838|592399588|FG000|16-Week DBVC Period|Protocol Violation|1|||
164009272|NCT05635838|592399589|FG001|16-Week DBVC Period|Protocol Violation|0|||
164009273|NCT05635838|592399590|FG002|16-Week DBVC Period|Protocol Violation|0|||
164009274|NCT05635838|592399591|FG003|16-Week DBVC Period|Protocol Violation|0|||
164009275|NCT05635838|592399588|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
164009276|NCT05635838|592399589|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
164009277|NCT05635838|592399590|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
164009278|NCT05635838|592399591|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
164009279|NCT05635838|592399588|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
164009280|NCT05635838|592399589|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
164009281|NCT05635838|592399590|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
164009282|NCT05635838|592399591|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
164009283|NCT05635838|592399588|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
164009284|NCT05635838|592399589|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
164009285|NCT05635838|592399590|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
164009286|NCT05635838|592399591|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
164009287|NCT05635838|592399588|FG000|16-Week OLE Period|Adverse Event|0|||
164009288|NCT05635838|592399589|FG001|16-Week OLE Period|Adverse Event|0|||
164009289|NCT05635838|592399590|FG002|16-Week OLE Period|Adverse Event|0|||
164009290|NCT05635838|592399591|FG003|16-Week OLE Period|Adverse Event|2|||
164009291|NCT05635838|592399588|FG000|16-Week OLE Period|Lost to Follow-up|0|||
164009292|NCT05635838|592399589|FG001|16-Week OLE Period|Lost to Follow-up|0|||
164009293|NCT05635838|592399590|FG002|16-Week OLE Period|Lost to Follow-up|1|||
164009294|NCT05635838|592399591|FG003|16-Week OLE Period|Lost to Follow-up|3|||
164009295|NCT05635838|592399588|FG000|16-Week OLE Period|Physician Decision|0|||
164009296|NCT05635838|592399589|FG001|16-Week OLE Period|Physician Decision|0|||
164009297|NCT05635838|592399590|FG002|16-Week OLE Period|Physician Decision|0|||
164009298|NCT05635838|592399591|FG003|16-Week OLE Period|Physician Decision|1|||
164009299|NCT05635838|592399588|FG000|16-Week OLE Period|Protocol Violation|0|||
164009300|NCT05635838|592399589|FG001|16-Week OLE Period|Protocol Violation|0|||
164009301|NCT05635838|592399590|FG002|16-Week OLE Period|Protocol Violation|1|||
164009302|NCT05635838|592399591|FG003|16-Week OLE Period|Protocol Violation|1|||
164009303|NCT05635838|592399588|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
164009304|NCT05635838|592399589|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
164091350|NCT00626925|592697873|FG001|Overall Study|Adverse effect|2|||
164091351|NCT00626925|592697872|FG000|Overall Study|Lack of Efficacy|1|||
164009305|NCT05635838|592399590|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
164009306|NCT05635838|592399591|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
164009307|NCT05635838|592399588|FG000|16-Week OLE Period|Pregnancy|0|||
164091352|NCT00626925|592697873|FG001|Overall Study|Lack of Efficacy|4|||
164091353|NCT00626925|592697872|FG000|Overall Study|Time constraints|3|||
164091354|NCT00626925|592697873|FG001|Overall Study|Time constraints|1|||
164091355|NCT03267264|592697876|FG000|Overall Study|Withdrawal by Subject|1|||
164091356|NCT03267264|592697877|FG001|Overall Study|Withdrawal by Subject|0|||
164091357|NCT03267264|592697878|FG002|Overall Study|Withdrawal by Subject|2|||
164091358|NCT03267264|592697879|FG003|Overall Study|Withdrawal by Subject|4|||
164091359|NCT02224391|592697880|FG000|Overall Study|Lost to Follow-up|26|||
164091360|NCT02224391|592697881|FG001|Overall Study|Lost to Follow-up|19|||
164091361|NCT02224391|592697880|FG000|Overall Study|Withdrawal by Subject|6|||
164091362|NCT02224391|592697881|FG001|Overall Study|Withdrawal by Subject|5|||
164091363|NCT02492958|592697882|FG000|Overall Study|Withdrawal by Subject|0|||
164091364|NCT02492958|592697883|FG001|Overall Study|Withdrawal by Subject|0|||
164091365|NCT02492958|592697884|FG002|Overall Study|Withdrawal by Subject|1|||
164091366|NCT02492958|592697885|FG003|Overall Study|Withdrawal by Subject|0|||
164091367|NCT02492958|592697882|FG000|Overall Study|Adverse Event|1|||
164091368|NCT02492958|592697883|FG001|Overall Study|Adverse Event|0|||
164091369|NCT02492958|592697884|FG002|Overall Study|Adverse Event|1|||
164091370|NCT02492958|592697885|FG003|Overall Study|Adverse Event|0|||
164091371|NCT03522948|592697886|FG000|Overall Study|Lost to Follow-up|1|||
164091372|NCT02236130|592697888|FG000|Overall Study|Lost to Follow-up|7|||
164091373|NCT02236130|592697889|FG001|Overall Study|Lost to Follow-up|12|||
164091374|NCT00424489|592697892|FG000|Overall Study|Death|3|||
164091375|NCT01984242|592697893|FG000|Overall Study|Death|52|||
164091376|NCT01984242|592697894|FG001|Overall Study|Death|50|||
164091377|NCT01984242|592697895|FG002|Overall Study|Death|52|||
164091378|NCT01984242|592697893|FG000|Overall Study|Withdrawal by Subject|5|||
164091379|NCT01984242|592697894|FG001|Overall Study|Withdrawal by Subject|3|||
164091380|NCT01984242|592697895|FG002|Overall Study|Withdrawal by Subject|10|||
164091381|NCT01984242|592697893|FG000|Overall Study|Physician Decision|0|||
164358511|NCT00065507|593688182|FG000|Overall Study|Subject Withdrew Consent|2|||
164358512|NCT00065507|593688183|FG001|Overall Study|Subject Withdrew Consent|1|||
164358513|NCT00065507|593688182|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
164358514|NCT00065507|593688183|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
164358515|NCT00350636|593688184|FG000|Overall Study|Adverse Event|19|||
164358516|NCT00350636|593688185|FG001|Overall Study|Adverse Event|13|||
164358517|NCT00350636|593688184|FG000|Overall Study|Protocol Violation|1|||
164358518|NCT00350636|593688185|FG001|Overall Study|Protocol Violation|3|||
164358519|NCT00350636|593688184|FG000|Overall Study|Withdrawal by Subject|13|||
164358520|NCT00350636|593688185|FG001|Overall Study|Withdrawal by Subject|17|||
164358521|NCT00350636|593688184|FG000|Overall Study|Lost to Follow-up|9|||
164358522|NCT00350636|593688185|FG001|Overall Study|Lost to Follow-up|8|||
164358523|NCT00350636|593688184|FG000|Overall Study|Physician Decision|0|||
164358524|NCT00350636|593688185|FG001|Overall Study|Physician Decision|2|||
164358525|NCT00350636|593688184|FG000|Overall Study|Other|1|||
164358526|NCT00350636|593688185|FG001|Overall Study|Other|2|||
164358527|NCT00100815|593688186|FG000|Overall Study|Progression|24|||
164358528|NCT00100815|593688186|FG000|Overall Study|Adverse Event|18|||
164358529|NCT00100815|593688186|FG000|Overall Study|Death|4|||
164358530|NCT00100815|593688186|FG000|Overall Study|Other|3|||
164358531|NCT01647282|593688189|FG000|Overall Study|Physician Decision|7|||
164358532|NCT01647282|593688190|FG001|Overall Study|Physician Decision|5|||
164358533|NCT00665353|593688191|FG000|Study Step 1|Adverse Event|1|||
164358534|NCT00665353|593688191|FG000|Study Step 1|Withdrawal by Subject|2|||
164358535|NCT00665353|593688191|FG000|Study Step 2|Lost to Follow-up|2|||
164358536|NCT00665353|593688191|FG000|Study Step 2|Lack of Efficacy|12|||
164091382|NCT01984242|592697894|FG001|Overall Study|Physician Decision|0|||
164091383|NCT01984242|592697895|FG002|Overall Study|Physician Decision|1|||
164091384|NCT01984242|592697893|FG000|Overall Study|Lost to Follow-up|4|||
164091385|NCT01984242|592697894|FG001|Overall Study|Lost to Follow-up|0|||
164091386|NCT01984242|592697895|FG002|Overall Study|Lost to Follow-up|3|||
164091387|NCT01984242|592697893|FG000|Overall Study|Sponsor Decision|1|||
164091388|NCT01984242|592697894|FG001|Overall Study|Sponsor Decision|0|||
164091389|NCT01984242|592697895|FG002|Overall Study|Sponsor Decision|0|||
164091390|NCT01984242|592697893|FG000|Overall Study|Non-Compliance|1|||
164091391|NCT01984242|592697894|FG001|Overall Study|Non-Compliance|0|||
164091392|NCT01984242|592697895|FG002|Overall Study|Non-Compliance|0|||
164358537|NCT01851720|593688192|FG000|Overall Study|Lost to Follow-up|0|||
164358538|NCT01851720|593688193|FG001|Overall Study|Lost to Follow-up|1|||
164358539|NCT01870583|593688198|FG000|Overall Study|Protocol Violation|0|||
164358540|NCT01870583|593688199|FG001|Overall Study|Protocol Violation|5|||
164358541|NCT01870583|593688200|FG002|Overall Study|Protocol Violation|3|||
164358542|NCT01870583|593688198|FG000|Overall Study|Lost to Follow-up|11|||
164358543|NCT01870583|593688199|FG001|Overall Study|Lost to Follow-up|13|||
164358544|NCT01870583|593688200|FG002|Overall Study|Lost to Follow-up|5|||
164358545|NCT02389998|593688201|FG000|Overall Study|car accident|1|||
164358546|NCT02389998|593688202|FG001|Overall Study|car accident|0|||
164358547|NCT02632552|593688204|FG000|Overall Study|Lost to Follow-up|14|||
163901267|NCT04622332|592009645|FG001|Overall Study|Physician Decision|1|||
163901268|NCT04622332|592009644|FG000|Overall Study|Adverse Event|0|||
164358548|NCT02632552|593688205|FG001|Overall Study|Lost to Follow-up|8|||
164358549|NCT02632552|593688204|FG000|Overall Study|Withdrawal by Subject|2|||
164358550|NCT02632552|593688205|FG001|Overall Study|Withdrawal by Subject|0|||
164358551|NCT02632552|593688204|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
164358552|NCT02632552|593688205|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
164358553|NCT00450450|593688212|FG000|Overall Study|Death|1|||
164358554|NCT00450450|593688213|FG001|Overall Study|Death|3|||
164358555|NCT00450450|593688212|FG000|Overall Study|Relapse|2|||
164358556|NCT00450450|593688213|FG001|Overall Study|Relapse|0|||
164358557|NCT00450450|593688212|FG000|Overall Study|Missing Data|2|||
164358558|NCT00450450|593688213|FG001|Overall Study|Missing Data|0|||
164358559|NCT02150954|593688216|FG000|Overall Study|Protocol Violation|1|||
164358560|NCT02150954|593688217|FG001|Overall Study|Protocol Violation|0|||
164358561|NCT02377466|593688227|FG000|Overall Study|Other: Randomized and not treated|0|||
164358562|NCT02377466|593688228|FG001|Overall Study|Other: Randomized and not treated|2|||
164358563|NCT04210310|593688229|FG000|Overall Study|Lost to Follow-up|32|||
164358564|NCT04210310|593688230|FG001|Overall Study|Lost to Follow-up|1|||
164358565|NCT00495170|593688231|FG000|Overall Study|Lost to Follow-up|9|||
164358566|NCT00495170|593688231|FG000|Overall Study|Withdrawal by Subject|3|||
164358567|NCT00495170|593688231|FG000|Overall Study|Inappropriate staging|8|||
164358568|NCT00330616|593688232|FG000|Overall Study|Adverse Event|13|||
164358569|NCT00330616|593688232|FG000|Overall Study|Lack of Efficacy|1|||
164358570|NCT00330616|593688232|FG000|Overall Study|Lost to Follow-up|2|||
164358571|NCT00330616|593688232|FG000|Overall Study|Withdrawal by Subject|4|||
164358572|NCT00330616|593688232|FG000|Overall Study|Other|1|||
164358573|NCT00597766|593688239|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
164358574|NCT00597766|593688240|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
164358575|NCT00597766|593688241|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
164358576|NCT00597766|593688239|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
164358577|NCT00597766|593688240|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
164358578|NCT00597766|593688241|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
164358579|NCT01333059|593688242|FG000|Overall Study|Physician Decision|3|||
164358580|NCT01333059|593688243|FG001|Overall Study|Physician Decision|3|||
164358581|NCT01333059|593688242|FG000|Overall Study|Protocol Violation|3|||
164358582|NCT01333059|593688243|FG001|Overall Study|Protocol Violation|0|||
163901269|NCT04622332|592009645|FG001|Overall Study|Adverse Event|2|||
163901270|NCT04622332|592009644|FG000|Overall Study|Protocol Violation|0|||
163901271|NCT04622332|592009645|FG001|Overall Study|Protocol Violation|1|||
163901272|NCT05966155|592009646|FG000|Overall Study|Death|1|||
163901273|NCT05966155|592009647|FG001|Overall Study|Death|2|||
163901274|NCT05966155|592009646|FG000|Overall Study|Lost to Follow-up|63|||
163901275|NCT05966155|592009647|FG001|Overall Study|Lost to Follow-up|67|||
163901276|NCT05966155|592009646|FG000|Overall Study|Protocol Violation|1|||
163901277|NCT05966155|592009647|FG001|Overall Study|Protocol Violation|0|||
163901278|NCT05966155|592009646|FG000|Overall Study|Withdrawal by Subject|8|||
163901279|NCT05966155|592009647|FG001|Overall Study|Withdrawal by Subject|9|||
163901280|NCT05966155|592009646|FG000|Overall Study|Enrolled Erroneously|0|||
163901281|NCT05966155|592009647|FG001|Overall Study|Enrolled Erroneously|1|||
163901282|NCT05966155|592009646|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
163901283|NCT05966155|592009647|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
163901284|NCT03304587|592009651|FG000|Overall Study|Headache after intervention|0|||
163901285|NCT03304587|592009652|FG001|Overall Study|Headache after intervention|1|||
163901286|NCT03304587|592009651|FG000|Overall Study|Withdrawal by Subject|1|||
163901287|NCT03304587|592009652|FG001|Overall Study|Withdrawal by Subject|0|||
163901288|NCT05036278|592009655|FG000|Overall Study|Withdrawal by Subject|1|||
163901289|NCT05036278|592009655|FG000|Overall Study|Adverse Event|1|||
163901290|NCT01458366|592009657|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
163901291|NCT01458366|592009658|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
163901292|NCT01458366|592009659|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
163901293|NCT01458366|592009660|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
163901294|NCT01458366|592009661|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
163901295|NCT01458366|592009657|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163901296|NCT01458366|592009658|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163901297|NCT01458366|592009659|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163901298|NCT01458366|592009660|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
163901299|NCT01458366|592009661|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
163901300|NCT04647487|592009662|FG000|Overall Study|Protocol Deviation|0|||
163901301|NCT04647487|592009663|FG001|Overall Study|Protocol Deviation|0|||
163901302|NCT04647487|592009664|FG002|Overall Study|Protocol Deviation|1|||
163901303|NCT04647487|592009662|FG000|Overall Study|Withdrawal by Subject|1|||
163901304|NCT04647487|592009663|FG001|Overall Study|Withdrawal by Subject|0|||
163901305|NCT04647487|592009664|FG002|Overall Study|Withdrawal by Subject|2|||
163901306|NCT02787005|592009665|FG000|Overall Study|Adverse Event|24|||
163901307|NCT02787005|592009666|FG001|Overall Study|Adverse Event|9|||
163901308|NCT02787005|592009667|FG002|Overall Study|Adverse Event|9|||
163901309|NCT02787005|592009668|FG003|Overall Study|Adverse Event|7|||
163901310|NCT02787005|592009669|FG004|Overall Study|Adverse Event|2|||
163901311|NCT02787005|592009665|FG000|Overall Study|Death|100|||
163901312|NCT02787005|592009666|FG001|Overall Study|Death|53|||
163901313|NCT02787005|592009667|FG002|Overall Study|Death|48|||
163901314|NCT02787005|592009668|FG003|Overall Study|Death|69|||
163901315|NCT02787005|592009669|FG004|Overall Study|Death|38|||
163901316|NCT02787005|592009665|FG000|Overall Study|Sponsor Decision|7|||
163901317|NCT02787005|592009666|FG001|Overall Study|Sponsor Decision|4|||
163901318|NCT02787005|592009667|FG002|Overall Study|Sponsor Decision|0|||
163901319|NCT02787005|592009668|FG003|Overall Study|Sponsor Decision|4|||
163901320|NCT02787005|592009669|FG004|Overall Study|Sponsor Decision|5|||
163901321|NCT02787005|592009665|FG000|Overall Study|Withdrawal by Subject|2|||
164358583|NCT00737282|593688245|FG000|Overall Study|Study prematurely terminated|175|||
164358584|NCT02763189|593688246|FG000|Overall Study|Device failure|0|||
164358585|NCT02763189|593688247|FG001|Overall Study|Device failure|2|||
164358586|NCT02049957|593688252|FG000|Overall Study|Progressive Disease|5|||
164358587|NCT02049957|593688253|FG001|Overall Study|Progressive Disease|4|||
164358588|NCT02049957|593688254|FG002|Overall Study|Progressive Disease|2|||
164358589|NCT02049957|593688255|FG003|Overall Study|Progressive Disease|2|||
164358590|NCT02049957|593688256|FG004|Overall Study|Progressive Disease|6|||
163901322|NCT02787005|592009666|FG001|Overall Study|Withdrawal by Subject|1|||
163901323|NCT02787005|592009667|FG002|Overall Study|Withdrawal by Subject|1|||
163901324|NCT02787005|592009668|FG003|Overall Study|Withdrawal by Subject|0|||
163901325|NCT02787005|592009669|FG004|Overall Study|Withdrawal by Subject|1|||
163901326|NCT02787005|592009665|FG000|Overall Study|Screen Failure|0|||
163901327|NCT02787005|592009666|FG001|Overall Study|Screen Failure|2|||
163901328|NCT02787005|592009667|FG002|Overall Study|Screen Failure|0|||
163901329|NCT02787005|592009668|FG003|Overall Study|Screen Failure|0|||
163901330|NCT02787005|592009669|FG004|Overall Study|Screen Failure|1|||
163901331|NCT02787005|592009665|FG000|Overall Study|Lost to Follow-up|0|||
163901332|NCT02787005|592009666|FG001|Overall Study|Lost to Follow-up|0|||
163901333|NCT02787005|592009667|FG002|Overall Study|Lost to Follow-up|0|||
163901334|NCT02787005|592009668|FG003|Overall Study|Lost to Follow-up|1|||
163901335|NCT02787005|592009669|FG004|Overall Study|Lost to Follow-up|0|||
163901336|NCT01753999|592009675|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
163901337|NCT01753999|592009676|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
163901338|NCT01753999|592009675|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
163901339|NCT01753999|592009676|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
163901340|NCT01753999|592009675|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
163901341|NCT01753999|592009676|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
163901342|NCT01753999|592009675|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
163901343|NCT01753999|592009676|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
163901344|NCT01753999|592009675|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
163901345|NCT01753999|592009676|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
163901346|NCT01753999|592009675|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
163901347|NCT01753999|592009676|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
163901348|NCT03890289|592009677|FG000|Overall Study|Adverse Event|1|||
163901349|NCT03890289|592009677|FG000|Overall Study|Physician Decision|1|||
163901350|NCT03890289|592009677|FG000|Overall Study|Lack of Efficacy|2|||
163901351|NCT00174252|592009684|FG000|Overall Study|Protocol Violation|2|||
163901352|NCT02744066|592009685|FG000|Overall Study|Withdrawal by parent|0|||
163901353|NCT02744066|592009686|FG001|Overall Study|Withdrawal by parent|1|||
163901354|NCT02744066|592009685|FG000|Overall Study|Discharged from NICU prior to completion|0|||
163901355|NCT02744066|592009686|FG001|Overall Study|Discharged from NICU prior to completion|4|||
163901356|NCT05509816|592009687|FG000|Overall Study|Lost to Follow-up|1|||
163901357|NCT02107261|592009694|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
163901358|NCT02107261|592009695|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
163901359|NCT02107261|592009694|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
163901360|NCT02107261|592009695|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
164009308|NCT05635838|592399589|FG001|16-Week OLE Period|Pregnancy|0|||
164009309|NCT05635838|592399590|FG002|16-Week OLE Period|Pregnancy|1|||
164009310|NCT05635838|592399591|FG003|16-Week OLE Period|Pregnancy|0|||
164358591|NCT02049957|593688257|FG005|Overall Study|Progressive Disease|35|||
164358592|NCT02049957|593688258|FG006|Overall Study|Progressive Disease|7|||
164358593|NCT02049957|593688259|FG007|Overall Study|Progressive Disease|26|||
164358594|NCT02049957|593688260|FG008|Overall Study|Progressive Disease|6|||
164358595|NCT02049957|593688252|FG000|Overall Study|Adverse Event|1|||
164358596|NCT02049957|593688253|FG001|Overall Study|Adverse Event|1|||
164358597|NCT02049957|593688254|FG002|Overall Study|Adverse Event|1|||
164358598|NCT02049957|593688255|FG003|Overall Study|Adverse Event|0|||
164358599|NCT02049957|593688256|FG004|Overall Study|Adverse Event|0|||
164009311|NCT02699515|592399598|FG000|Overall Study|Death|3|||
164009312|NCT02699515|592399599|FG001|Overall Study|Death|3|||
164009313|NCT02699515|592399600|FG002|Overall Study|Death|3|||
164009314|NCT02699515|592399601|FG003|Overall Study|Death|23|||
164009315|NCT02699515|592399602|FG004|Overall Study|Death|22|||
164009316|NCT02699515|592399603|FG005|Overall Study|Death|23|||
164009317|NCT02699515|592399604|FG006|Overall Study|Death|3|||
164009318|NCT02699515|592399605|FG007|Overall Study|Death|5|||
164009319|NCT02699515|592399598|FG000|Overall Study|Withdrawal by Subject|0|||
164009320|NCT02699515|592399599|FG001|Overall Study|Withdrawal by Subject|0|||
164009321|NCT02699515|592399600|FG002|Overall Study|Withdrawal by Subject|3|||
164009322|NCT02699515|592399601|FG003|Overall Study|Withdrawal by Subject|1|||
164009323|NCT02699515|592399602|FG004|Overall Study|Withdrawal by Subject|5|||
164009324|NCT02699515|592399603|FG005|Overall Study|Withdrawal by Subject|3|||
164009325|NCT02699515|592399604|FG006|Overall Study|Withdrawal by Subject|0|||
164009326|NCT02699515|592399605|FG007|Overall Study|Withdrawal by Subject|1|||
164009327|NCT02699515|592399598|FG000|Overall Study|Other|1|||
164009328|NCT02699515|592399599|FG001|Overall Study|Other|0|||
164009329|NCT02699515|592399600|FG002|Overall Study|Other|1|||
164009330|NCT02699515|592399601|FG003|Overall Study|Other|6|||
164009331|NCT02699515|592399602|FG004|Overall Study|Other|4|||
164009332|NCT02699515|592399603|FG005|Overall Study|Other|3|||
164009333|NCT02699515|592399604|FG006|Overall Study|Other|0|||
164009334|NCT02699515|592399605|FG007|Overall Study|Other|0|||
164009335|NCT05243550|592399606|FG000|Overall Study|Ongoing in the Study|171|||
164009336|NCT05243550|592399606|FG000|Overall Study|Withdrawal by Subject|10|||
164009337|NCT05243550|592399606|FG000|Overall Study|Lost to Follow-up|7|||
164009338|NCT05243550|592399606|FG000|Overall Study|Adverse Event|3|||
164009339|NCT05243550|592399606|FG000|Overall Study|Noncompliance|1|||
164009340|NCT05243550|592399606|FG000|Overall Study|Physician Decision|1|||
164009341|NCT05243550|592399606|FG000|Overall Study|Other Reason|4|||
164009342|NCT02031146|592399609|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
164009343|NCT02031146|592399610|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
164009344|NCT02031146|592399611|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
164009345|NCT02031146|592399612|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
164009346|NCT02031146|592399613|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
164009347|NCT02031146|592399614|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
164009348|NCT02031146|592399615|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
164009349|NCT01486316|592399616|FG000|Overall Study|Device explanted with/without re-implant|3|||
164009350|NCT01486316|592399617|FG001|Overall Study|Device explanted with/without re-implant|2|||
164009351|NCT01486316|592399618|FG002|Overall Study|Device explanted with/without re-implant|0|||
164009352|NCT01486316|592399619|FG003|Overall Study|Device explanted with/without re-implant|2|||
164009353|NCT01486316|592399616|FG000|Overall Study|Not meeting eligibility criteria|0|||
164009354|NCT01486316|592399617|FG001|Overall Study|Not meeting eligibility criteria|0|||
164009355|NCT01486316|592399618|FG002|Overall Study|Not meeting eligibility criteria|1|||
164009356|NCT01486316|592399619|FG003|Overall Study|Not meeting eligibility criteria|0|||
164009357|NCT01486316|592399616|FG000|Overall Study|Withdrawal by Subject|1|||
164009358|NCT01486316|592399617|FG001|Overall Study|Withdrawal by Subject|0|||
164009359|NCT01486316|592399618|FG002|Overall Study|Withdrawal by Subject|3|||
164009360|NCT01486316|592399619|FG003|Overall Study|Withdrawal by Subject|0|||
164009361|NCT01486316|592399616|FG000|Overall Study|Physician Decision|0|||
164009362|NCT01486316|592399617|FG001|Overall Study|Physician Decision|0|||
164009363|NCT01486316|592399618|FG002|Overall Study|Physician Decision|1|||
164009364|NCT01486316|592399619|FG003|Overall Study|Physician Decision|0|||
164009365|NCT01486316|592399616|FG000|Overall Study|Death|0|||
164009366|NCT01486316|592399617|FG001|Overall Study|Death|1|||
164009367|NCT01486316|592399618|FG002|Overall Study|Death|0|||
164009368|NCT01486316|592399619|FG003|Overall Study|Death|0|||
164009369|NCT05094154|592399627|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
164009370|NCT05094154|592399628|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
164009371|NCT05094154|592399627|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
164009372|NCT05094154|592399628|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
164009373|NCT02400346|592399637|FG000|Overall Study|Adverse Event|24|||
164009374|NCT02400346|592399637|FG000|Overall Study|Lack of Efficacy|9|||
164009375|NCT02400346|592399637|FG000|Overall Study|Non-compliance with IMP|1|||
164009376|NCT02400346|592399637|FG000|Overall Study|Withdrawal by Subject|7|||
164009377|NCT02400346|592399637|FG000|Overall Study|Administrative or other reason(s)|2|||
164009378|NCT02400346|592399637|FG000|Overall Study|Lost to Follow-up|1|||
164009379|NCT01040832|592399639|FG000|Overall Study|Adverse Event|4|||
164009380|NCT01040832|592399640|FG001|Overall Study|Adverse Event|5|||
164009381|NCT01040832|592399639|FG000|Overall Study|Death|4|||
164009382|NCT01040832|592399640|FG001|Overall Study|Death|6|||
164009383|NCT01040832|592399639|FG000|Overall Study|Withdrawal by Subject|2|||
164009384|NCT01040832|592399640|FG001|Overall Study|Withdrawal by Subject|3|||
164009385|NCT01040832|592399639|FG000|Overall Study|Progressive disease|32|||
164009386|NCT01040832|592399640|FG001|Overall Study|Progressive disease|17|||
163901361|NCT04337931|592009697|FG000|Overall Study|Death|4|||
163901362|NCT04337931|592009698|FG001|Overall Study|Death|1|||
163901363|NCT04337931|592009699|FG002|Overall Study|Death|7|||
163901364|NCT04337931|592009697|FG000|Overall Study|Withdrawal by Subject|0|||
163901365|NCT04337931|592009698|FG001|Overall Study|Withdrawal by Subject|1|||
163901366|NCT04337931|592009699|FG002|Overall Study|Withdrawal by Subject|0|||
163901367|NCT04337931|592009697|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
163901368|NCT04337931|592009698|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
163901369|NCT04337931|592009699|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
163901370|NCT04337931|592009697|FG000|Overall Study|Study terminated by sponsor|3|||
163901371|NCT04337931|592009698|FG001|Overall Study|Study terminated by sponsor|6|||
163901372|NCT04337931|592009699|FG002|Overall Study|Study terminated by sponsor|2|||
163901373|NCT04337931|592009697|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
163901374|NCT04337931|592009698|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
163901375|NCT04337931|592009699|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
163901376|NCT04337931|592009697|FG000|Overall Study|Colorectal cancer treatment|1|||
163901377|NCT04337931|592009698|FG001|Overall Study|Colorectal cancer treatment|0|||
163901378|NCT04337931|592009699|FG002|Overall Study|Colorectal cancer treatment|0|||
163901379|NCT04337931|592009697|FG000|Overall Study|Participant decision|0|||
163901380|NCT04337931|592009698|FG001|Overall Study|Participant decision|1|||
163901381|NCT04337931|592009699|FG002|Overall Study|Participant decision|0|||
163901382|NCT01738438|592009701|FG000|Overall Study|Disease Progression|32|||
163901383|NCT01738438|592009701|FG000|Overall Study|Adverse Event|3|||
163901384|NCT02130557|592009703|FG000|Overall Study|Withdrawal by Subject|12|||
163901385|NCT02130557|592009704|FG001|Overall Study|Withdrawal by Subject|12|||
163901386|NCT02130557|592009703|FG000|Overall Study|Investigator Request|0|||
163901387|NCT02130557|592009704|FG001|Overall Study|Investigator Request|2|||
163901388|NCT02130557|592009703|FG000|Overall Study|Deceased|14|||
163901389|NCT02130557|592009704|FG001|Overall Study|Deceased|14|||
163901390|NCT02130557|592009703|FG000|Overall Study|Lost to Follow-up|6|||
163901391|NCT02130557|592009704|FG001|Overall Study|Lost to Follow-up|7|||
163901392|NCT02130557|592009703|FG000|Overall Study|Other|2|||
163901393|NCT02130557|592009704|FG001|Overall Study|Other|1|||
163901394|NCT02130557|592009703|FG000|Overall Study|Missing|2|||
163901395|NCT02130557|592009704|FG001|Overall Study|Missing|1|||
163901396|NCT01532999|592009705|FG000|Overall Study|Lost to Follow-up|14|||
163901397|NCT01532999|592009706|FG001|Overall Study|Lost to Follow-up|8|||
163901398|NCT01532999|592009705|FG000|Overall Study|Physician Decision|1|||
163901399|NCT01532999|592009706|FG001|Overall Study|Physician Decision|2|||
163901400|NCT01532999|592009705|FG000|Overall Study|Withdrawal by Subject|5|||
163901401|NCT01532999|592009706|FG001|Overall Study|Withdrawal by Subject|0|||
163901402|NCT01532999|592009705|FG000|Overall Study|Relocated|2|||
163901403|NCT01532999|592009706|FG001|Overall Study|Relocated|0|||
163901404|NCT01532999|592009705|FG000|Overall Study|should not have been randomized|1|||
163901405|NCT01532999|592009706|FG001|Overall Study|should not have been randomized|0|||
163901406|NCT01532999|592009705|FG000|Overall Study|substantial noncompliance|2|||
163901407|NCT01532999|592009706|FG001|Overall Study|substantial noncompliance|0|||
163901408|NCT01532999|592009705|FG000|Overall Study|no show for week 9 assessments|6|||
164009387|NCT01040832|592399639|FG000|Overall Study|Symptomatic deterioration|2|||
164009388|NCT01040832|592399640|FG001|Overall Study|Symptomatic deterioration|5|||
164009389|NCT01040832|592399639|FG000|Overall Study|Other|2|||
164009390|NCT01040832|592399640|FG001|Overall Study|Other|1|||
164009391|NCT02767570|592399643|FG000|Overall Study|Lost to Follow-up|3|||
164009392|NCT02767570|592399644|FG001|Overall Study|Lost to Follow-up|0|||
164009393|NCT02767570|592399643|FG000|Overall Study|COVID shutdown|2|||
164009394|NCT02767570|592399644|FG001|Overall Study|COVID shutdown|5|||
164009395|NCT02767570|592399643|FG000|Overall Study|Increased pain|2|||
164009396|NCT02767570|592399644|FG001|Overall Study|Increased pain|0|||
164009397|NCT02767570|592399643|FG000|Overall Study|Withdrawal by Subject|1|||
164009398|NCT02767570|592399644|FG001|Overall Study|Withdrawal by Subject|3|||
164009399|NCT02767570|592399643|FG000|Overall Study|Unrelated medical issue|1|||
164009400|NCT02767570|592399644|FG001|Overall Study|Unrelated medical issue|1|||
164009401|NCT02767570|592399643|FG000|Overall Study|Received intra-articular injection|0|||
164009402|NCT02767570|592399644|FG001|Overall Study|Received intra-articular injection|1|||
164009403|NCT01712438|592399648|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
164009404|NCT01712438|592399648|FG000|Overall Study|Ongoing ITI treatment|6|||
164009405|NCT01712438|592399648|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
164009406|NCT01712438|592399648|FG000|Overall Study|Prematurely Discontinued|25|||
164009407|NCT01981122|592399649|FG000|Overall Study|Withdrawal by Subject|0|||
164009408|NCT01981122|592399650|FG001|Overall Study|Withdrawal by Subject|2|||
164009409|NCT01981122|592399649|FG000|Overall Study|Protocol Violation|0|||
164009410|NCT01981122|592399650|FG001|Overall Study|Protocol Violation|1|||
164009411|NCT01981122|592399649|FG000|Overall Study|Lost to Follow-up|0|||
164009412|NCT01981122|592399650|FG001|Overall Study|Lost to Follow-up|1|||
164009413|NCT01981122|592399649|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
164009414|NCT01981122|592399650|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
164009415|NCT01981122|592399649|FG000|Overall Study|Death|14|||
164009416|NCT01981122|592399650|FG001|Overall Study|Death|15|||
164009417|NCT00089843|592399651|FG000|Overall Study|Withdrawal by Subject|1|||
164009418|NCT00089843|592399652|FG001|Overall Study|Withdrawal by Subject|4|||
164358600|NCT02049957|593688257|FG005|Overall Study|Adverse Event|5|||
164358601|NCT02049957|593688258|FG006|Overall Study|Adverse Event|0|||
164358602|NCT02049957|593688259|FG007|Overall Study|Adverse Event|6|||
164358603|NCT02049957|593688260|FG008|Overall Study|Adverse Event|1|||
164358604|NCT02049957|593688252|FG000|Overall Study|Study Terminated by Sponsor|0|||
164358605|NCT02049957|593688253|FG001|Overall Study|Study Terminated by Sponsor|1|||
164358606|NCT02049957|593688254|FG002|Overall Study|Study Terminated by Sponsor|0|||
164358607|NCT02049957|593688255|FG003|Overall Study|Study Terminated by Sponsor|0|||
164358608|NCT02049957|593688256|FG004|Overall Study|Study Terminated by Sponsor|0|||
164358609|NCT02049957|593688257|FG005|Overall Study|Study Terminated by Sponsor|0|||
164358610|NCT02049957|593688258|FG006|Overall Study|Study Terminated by Sponsor|1|||
164358611|NCT02049957|593688259|FG007|Overall Study|Study Terminated by Sponsor|0|||
164358612|NCT02049957|593688260|FG008|Overall Study|Study Terminated by Sponsor|0|||
164358613|NCT02049957|593688252|FG000|Overall Study|Withdrawal by Subject|0|||
164358614|NCT02049957|593688253|FG001|Overall Study|Withdrawal by Subject|0|||
164358615|NCT02049957|593688254|FG002|Overall Study|Withdrawal by Subject|0|||
164358616|NCT02049957|593688255|FG003|Overall Study|Withdrawal by Subject|1|||
164358617|NCT02049957|593688256|FG004|Overall Study|Withdrawal by Subject|0|||
164358618|NCT02049957|593688257|FG005|Overall Study|Withdrawal by Subject|2|||
164358619|NCT02049957|593688258|FG006|Overall Study|Withdrawal by Subject|0|||
164358620|NCT02049957|593688259|FG007|Overall Study|Withdrawal by Subject|3|||
164358621|NCT02049957|593688260|FG008|Overall Study|Withdrawal by Subject|1|||
164358622|NCT02049957|593688252|FG000|Overall Study|Physician Decision|0|||
164358623|NCT02049957|593688253|FG001|Overall Study|Physician Decision|0|||
164358624|NCT02049957|593688254|FG002|Overall Study|Physician Decision|0|||
164358625|NCT02049957|593688255|FG003|Overall Study|Physician Decision|0|||
164358626|NCT02049957|593688256|FG004|Overall Study|Physician Decision|0|||
164358627|NCT02049957|593688257|FG005|Overall Study|Physician Decision|1|||
164358628|NCT02049957|593688258|FG006|Overall Study|Physician Decision|0|||
164358629|NCT02049957|593688259|FG007|Overall Study|Physician Decision|0|||
164358630|NCT02049957|593688260|FG008|Overall Study|Physician Decision|0|||
164358631|NCT04447755|593688261|FG000|Overall Study|Death|9|||
164358632|NCT04447755|593688262|FG001|Overall Study|Death|16|||
164358633|NCT04447755|593688263|FG002|Overall Study|Death|8|||
164358634|NCT04447755|593688264|FG003|Overall Study|Death|9|||
164358635|NCT04447755|593688265|FG004|Overall Study|Death|8|||
164009419|NCT00089843|592399653|FG002|Overall Study|Withdrawal by Subject|5|||
164009420|NCT00089843|592399654|FG003|Overall Study|Withdrawal by Subject|6|||
164009421|NCT00089843|592399651|FG000|Overall Study|Physician Decision|1|||
164009422|NCT00089843|592399652|FG001|Overall Study|Physician Decision|0|||
164009423|NCT00089843|592399653|FG002|Overall Study|Physician Decision|0|||
164009424|NCT00089843|592399654|FG003|Overall Study|Physician Decision|1|||
164009425|NCT01330381|592399655|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
164358636|NCT04447755|593688266|FG005|Overall Study|Death|9|||
164358637|NCT04447755|593688267|FG006|Overall Study|Death|55|||
164358638|NCT04447755|593688261|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164091393|NCT01984242|592697893|FG000|Overall Study|Study terminated by Sponsor|38|||
164091394|NCT01984242|592697894|FG001|Overall Study|Study terminated by Sponsor|50|||
164091395|NCT01984242|592697895|FG002|Overall Study|Study terminated by Sponsor|34|||
164091396|NCT01984242|592697893|FG000|Overall Study|Disease Progression|0|||
164091397|NCT01984242|592697894|FG001|Overall Study|Disease Progression|0|||
164091398|NCT01984242|592697895|FG002|Overall Study|Disease Progression|1|||
164091399|NCT00449150|592697898|FG000|Overall Study|Adverse Event|11|||
164091400|NCT00449150|592697899|FG001|Overall Study|Adverse Event|18|||
164091401|NCT00449150|592697900|FG002|Overall Study|Adverse Event|9|||
164091402|NCT00449150|592697898|FG000|Overall Study|Lack of Efficacy|1|||
164091403|NCT00449150|592697899|FG001|Overall Study|Lack of Efficacy|2|||
164091404|NCT00449150|592697900|FG002|Overall Study|Lack of Efficacy|2|||
164091405|NCT00449150|592697898|FG000|Overall Study|Other|16|||
164091406|NCT00449150|592697899|FG001|Overall Study|Other|13|||
164091407|NCT00449150|592697900|FG002|Overall Study|Other|14|||
164091408|NCT00449150|592697898|FG000|Overall Study|Withdrawal by Subject|17|||
164091409|NCT00449150|592697899|FG001|Overall Study|Withdrawal by Subject|18|||
164091410|NCT00449150|592697900|FG002|Overall Study|Withdrawal by Subject|21|||
164091411|NCT00449150|592697898|FG000|Overall Study|Protocol Violation|1|||
164091412|NCT00449150|592697899|FG001|Overall Study|Protocol Violation|2|||
164091413|NCT00449150|592697900|FG002|Overall Study|Protocol Violation|1|||
164091414|NCT00770510|592697901|FG000|Overall Study|Lost to Follow-up|2|||
164091415|NCT00770510|592697901|FG000|Overall Study|Pregnancy|1|||
164091416|NCT00770510|592697901|FG000|Overall Study|Withdrawal by Subject|2|||
164091417|NCT02246478|592697904|FG000|Multiple-dose Phase|Protocol Violation|1|||
164091418|NCT02246478|592697905|FG001|Multiple-dose Phase|Protocol Violation|0|||
164091419|NCT02246478|592697906|FG002|Multiple-dose Phase|Protocol Violation|0|||
164091420|NCT02246478|592697907|FG003|Multiple-dose Phase|Protocol Violation|1|||
164091421|NCT01089647|592697911|FG000|Overall Study|Lost to Follow-up|2|||
164091422|NCT01089647|592697912|FG001|Overall Study|Lost to Follow-up|2|||
164091423|NCT01089647|592697911|FG000|Overall Study|Withdrawal by Subject|2|||
164091424|NCT01089647|592697912|FG001|Overall Study|Withdrawal by Subject|1|||
164091425|NCT01089647|592697911|FG000|Overall Study|Adverse Event|0|||
164091426|NCT01089647|592697912|FG001|Overall Study|Adverse Event|1|||
164091427|NCT00198029|592697915|FG000|Overall Study|Withdrawal by Subject|4|||
164091428|NCT02001558|592697916|FG000|Overall Study|Lost to Follow-up|8|||
164091429|NCT02001558|592697917|FG001|Overall Study|Lost to Follow-up|14|||
164091430|NCT04117607|592697918|FG000|Overall Study|Early Termination|0|||
164091431|NCT04117607|592697919|FG001|Overall Study|Early Termination|1|||
164091432|NCT04117607|592697920|FG002|Overall Study|Early Termination|0|||
164091433|NCT04117607|592697921|FG003|Overall Study|Early Termination|0|||
164091434|NCT04117607|592697922|FG004|Overall Study|Early Termination|0|||
164091435|NCT04117607|592697923|FG005|Overall Study|Early Termination|0|||
164091436|NCT04117607|592697924|FG006|Overall Study|Early Termination|1|||
164091437|NCT04117607|592697925|FG007|Overall Study|Early Termination|0|||
164091438|NCT04117607|592697926|FG008|Overall Study|Early Termination|0|||
164091439|NCT04117607|592697927|FG009|Overall Study|Early Termination|0|||
164091440|NCT04117607|592697928|FG010|Overall Study|Early Termination|0|||
164358639|NCT04447755|593688262|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164358640|NCT04447755|593688263|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164358641|NCT04447755|593688264|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164358642|NCT04447755|593688265|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164358643|NCT04447755|593688266|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164358644|NCT04447755|593688267|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
164358645|NCT04447755|593688261|FG000|Overall Study|Sponsor Decision|0|||
164358646|NCT04447755|593688262|FG001|Overall Study|Sponsor Decision|0|||
164358647|NCT04447755|593688263|FG002|Overall Study|Sponsor Decision|0|||
164358648|NCT04447755|593688264|FG003|Overall Study|Sponsor Decision|0|||
164358649|NCT04447755|593688265|FG004|Overall Study|Sponsor Decision|1|||
164358650|NCT04447755|593688266|FG005|Overall Study|Sponsor Decision|0|||
164358651|NCT04447755|593688267|FG006|Overall Study|Sponsor Decision|10|||
164358652|NCT04447755|593688261|FG000|Overall Study|Lost to Follow-up|0|||
164091441|NCT04117607|592697929|FG011|Overall Study|Early Termination|0|||
164091442|NCT04117607|592697930|FG012|Overall Study|Early Termination|0|||
164091443|NCT04117607|592697931|FG013|Overall Study|Early Termination|0|||
164091444|NCT01457053|592697935|FG000|Overall Study|Unable to undergo selected treatment|1|||
164358653|NCT04447755|593688262|FG001|Overall Study|Lost to Follow-up|0|||
164358654|NCT04447755|593688263|FG002|Overall Study|Lost to Follow-up|0|||
164358655|NCT04447755|593688264|FG003|Overall Study|Lost to Follow-up|0|||
164091445|NCT01457053|592697936|FG001|Overall Study|Unable to undergo selected treatment|1|||
164091446|NCT04333095|592697939|FG000|Overall Study|Protocol Violation|4|||
164091447|NCT04333095|592697940|FG001|Overall Study|Protocol Violation|0|||
164091448|NCT04333095|592697939|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
164091449|NCT04333095|592697940|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
164091450|NCT04333095|592697939|FG000|Overall Study|Mini Sternotomy|4|||
164091451|NCT04333095|592697940|FG001|Overall Study|Mini Sternotomy|5|||
164091452|NCT02364557|592697941|FG000|Overall Study|Protocol Violation|3|||
164358656|NCT04447755|593688265|FG004|Overall Study|Lost to Follow-up|0|||
164091453|NCT02364557|592697942|FG001|Overall Study|Protocol Violation|1|||
164091454|NCT04347239|592697943|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
164091455|NCT04347239|592697944|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
164091456|NCT04347239|592697945|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
164091457|NCT04347239|592697943|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
164091458|NCT04347239|592697944|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
164091459|NCT04347239|592697945|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
164091460|NCT04582539|592697946|FG000|Overall Study|Death|1|||
164091461|NCT04582539|592697947|FG001|Overall Study|Death|1|||
164091462|NCT04582539|592697948|FG002|Overall Study|Death|0|||
164091463|NCT04582539|592697949|FG003|Overall Study|Death|1|||
164091464|NCT04582539|592697950|FG004|Overall Study|Death|0|||
164091465|NCT04582539|592697946|FG000|Overall Study|Lost to Follow-up|1|||
164091466|NCT04582539|592697947|FG001|Overall Study|Lost to Follow-up|0|||
164091467|NCT04582539|592697948|FG002|Overall Study|Lost to Follow-up|0|||
164091468|NCT04582539|592697949|FG003|Overall Study|Lost to Follow-up|0|||
164091469|NCT04582539|592697950|FG004|Overall Study|Lost to Follow-up|0|||
164091470|NCT04582539|592697946|FG000|Overall Study|Study Terminated by Sponsor|1|||
164091471|NCT04582539|592697947|FG001|Overall Study|Study Terminated by Sponsor|3|||
164091472|NCT04582539|592697948|FG002|Overall Study|Study Terminated by Sponsor|2|||
164091473|NCT04582539|592697949|FG003|Overall Study|Study Terminated by Sponsor|2|||
164091474|NCT04582539|592697950|FG004|Overall Study|Study Terminated by Sponsor|3|||
164091475|NCT04582539|592697946|FG000|Overall Study|Physician Decision|0|||
164091476|NCT04582539|592697947|FG001|Overall Study|Physician Decision|1|||
164091477|NCT04582539|592697948|FG002|Overall Study|Physician Decision|0|||
164091478|NCT04582539|592697949|FG003|Overall Study|Physician Decision|0|||
164091479|NCT04582539|592697950|FG004|Overall Study|Physician Decision|0|||
164091480|NCT04582539|592697946|FG000|Overall Study|Withdrawal by Subject|1|||
164091481|NCT04582539|592697947|FG001|Overall Study|Withdrawal by Subject|0|||
164091482|NCT04582539|592697948|FG002|Overall Study|Withdrawal by Subject|2|||
164091483|NCT04582539|592697949|FG003|Overall Study|Withdrawal by Subject|1|||
164091484|NCT04582539|592697950|FG004|Overall Study|Withdrawal by Subject|0|||
164091485|NCT04582539|592697946|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164091486|NCT04582539|592697947|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164091487|NCT04582539|592697948|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164091488|NCT04582539|592697949|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
164091489|NCT04582539|592697950|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
164091490|NCT00788957|592697956|FG000|Part 1|Death|8|||
164091491|NCT00788957|592697957|FG001|Part 1|Death|0|||
164091492|NCT00788957|592697958|FG002|Part 1|Death|0|||
164091493|NCT00788957|592697959|FG003|Part 1|Death|0|||
164091494|NCT00788957|592697960|FG004|Part 1|Death|0|||
164091495|NCT00788957|592697961|FG005|Part 1|Death|0|||
164091496|NCT00788957|592697956|FG000|Part 1|Lost to Follow-up|1|||
164091497|NCT00788957|592697957|FG001|Part 1|Lost to Follow-up|0|||
164091498|NCT00788957|592697958|FG002|Part 1|Lost to Follow-up|0|||
164091499|NCT00788957|592697959|FG003|Part 1|Lost to Follow-up|0|||
163901409|NCT01532999|592009706|FG001|Overall Study|no show for week 9 assessments|4|||
163901410|NCT01532999|592009705|FG000|Overall Study|Adverse Event|0|||
164091500|NCT00788957|592697960|FG004|Part 1|Lost to Follow-up|0|||
164091501|NCT00788957|592697961|FG005|Part 1|Lost to Follow-up|0|||
164091502|NCT00788957|592697956|FG000|Part 2|Withdrawal by Subject|0|||
164091503|NCT00788957|592697957|FG001|Part 2|Withdrawal by Subject|9|||
164091504|NCT00788957|592697958|FG002|Part 2|Withdrawal by Subject|5|||
164091505|NCT00788957|592697959|FG003|Part 2|Withdrawal by Subject|3|||
163901411|NCT01532999|592009706|FG001|Overall Study|Adverse Event|1|||
163901412|NCT01532999|592009705|FG000|Overall Study|incarcerated|0|||
163901413|NCT01532999|592009706|FG001|Overall Study|incarcerated|1|||
163901414|NCT01532999|592009705|FG000|Overall Study|New job|0|||
163901415|NCT01532999|592009706|FG001|Overall Study|New job|2|||
163901416|NCT02928172|592009707|FG000|Overall Study|Device did not record data|1|||
163901417|NCT02408887|592009708|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
163901418|NCT02408887|592009709|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
163901419|NCT02408887|592009708|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
163901420|NCT02408887|592009709|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
163901421|NCT03333109|592009710|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163901422|NCT03333109|592009711|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
163901423|NCT03333109|592009712|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
163901424|NCT03333109|592009710|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
163901425|NCT03333109|592009711|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
164091506|NCT00788957|592697960|FG004|Part 2|Withdrawal by Subject|0|||
164091507|NCT00788957|592697961|FG005|Part 2|Withdrawal by Subject|0|||
164091508|NCT00788957|592697956|FG000|Part 2|Death|0|||
164091509|NCT00788957|592697957|FG001|Part 2|Death|32|||
164091510|NCT00788957|592697958|FG002|Part 2|Death|35|||
164009426|NCT01330381|592399656|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
164009427|NCT01330381|592399657|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
164009428|NCT01330381|592399655|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
164009429|NCT01330381|592399656|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
164009430|NCT01330381|592399657|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
164009431|NCT01330381|592399655|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
164009432|NCT01330381|592399656|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
164009433|NCT01330381|592399657|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
164009434|NCT01330381|592399655|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
164009435|NCT01330381|592399656|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
164009436|NCT01330381|592399657|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
164009437|NCT01330381|592399655|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
164009438|NCT01330381|592399656|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
164009439|NCT01330381|592399657|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
164009440|NCT01330381|592399655|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
164009441|NCT01330381|592399656|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
164009442|NCT01330381|592399657|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
164009443|NCT01330381|592399655|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
164009444|NCT01330381|592399656|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
164009445|NCT01330381|592399657|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
164009446|NCT01330381|592399655|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
164009447|NCT01330381|592399656|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
164009448|NCT01330381|592399657|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
164009449|NCT01330381|592399655|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
164009450|NCT01330381|592399656|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
164009451|NCT01330381|592399657|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
164009452|NCT01330381|592399655|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
164009453|NCT01330381|592399656|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
164009454|NCT01330381|592399657|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
164009455|NCT03846947|592399658|FG000|Overall Study|technical issues with imaging sequence|2|||
164009456|NCT03060577|592399659|FG000|Overall Study|Withdrawal by Subject|25|||
164358657|NCT04447755|593688266|FG005|Overall Study|Lost to Follow-up|0|||
164358658|NCT04447755|593688267|FG006|Overall Study|Lost to Follow-up|1|||
164358659|NCT00840294|593688268|FG000|Overall Study|Withdrawal by Subject|2|||
164358660|NCT00840294|593688269|FG001|Overall Study|Withdrawal by Subject|1|||
164358661|NCT00840294|593688268|FG000|Overall Study|Protocol Violation|1|||
164358662|NCT00840294|593688269|FG001|Overall Study|Protocol Violation|3|||
164358663|NCT00840294|593688268|FG000|Overall Study|Illness|0|||
164358664|NCT00840294|593688269|FG001|Overall Study|Illness|1|||
164358665|NCT03721276|593688271|FG000|Overall Study|Lost to Follow-up|5|||
164358666|NCT03721276|593688272|FG001|Overall Study|Lost to Follow-up|3|||
164358667|NCT03721276|593688271|FG000|Overall Study|Adverse Event|0|||
164358668|NCT03721276|593688272|FG001|Overall Study|Adverse Event|1|||
164358669|NCT01405742|593688275|FG000|Overall Study|Lost to Follow-up|1|||
164358670|NCT01405742|593688276|FG001|Overall Study|Lost to Follow-up|0|||
164358671|NCT01340898|593688277|FG000|Primary Phase|Serious Adverse Events|0|||
164358672|NCT01340898|593688278|FG001|Primary Phase|Serious Adverse Events|0|||
164358673|NCT01340898|593688279|FG002|Primary Phase|Serious Adverse Events|1|||
164358674|NCT01340898|593688277|FG000|Primary Phase|Withdrawal by Subject|8|||
164358675|NCT01340898|593688278|FG001|Primary Phase|Withdrawal by Subject|7|||
164358676|NCT01340898|593688279|FG002|Primary Phase|Withdrawal by Subject|5|||
164358677|NCT01340898|593688277|FG000|Primary Phase|Migrated/moved from study area|4|||
164358678|NCT01340898|593688278|FG001|Primary Phase|Migrated/moved from study area|1|||
164358679|NCT01340898|593688279|FG002|Primary Phase|Migrated/moved from study area|0|||
164358680|NCT01340898|593688277|FG000|Primary Phase|Lost to Follow-up|4|||
164358681|NCT01340898|593688278|FG001|Primary Phase|Lost to Follow-up|1|||
164358682|NCT01340898|593688279|FG002|Primary Phase|Lost to Follow-up|0|||
164358683|NCT01340898|593688277|FG000|Booster Phase|Withdrawal by Subject|3|||
164358684|NCT01340898|593688278|FG001|Booster Phase|Withdrawal by Subject|0|||
164358685|NCT01340898|593688279|FG002|Booster Phase|Withdrawal by Subject|4|||
164358686|NCT01340898|593688277|FG000|Booster Phase|Migrated/moved from study area|3|||
164358687|NCT01340898|593688278|FG001|Booster Phase|Migrated/moved from study area|0|||
164358688|NCT01340898|593688279|FG002|Booster Phase|Migrated/moved from study area|0|||
164358689|NCT01340898|593688277|FG000|Booster Phase|Lost to Follow-up|4|||
164358690|NCT01340898|593688278|FG001|Booster Phase|Lost to Follow-up|2|||
164358691|NCT01340898|593688279|FG002|Booster Phase|Lost to Follow-up|3|||
164358692|NCT04900220|593688280|FG000|Overall Study|Lost to Follow-up|1|||
164358693|NCT04900220|593688281|FG001|Overall Study|Lost to Follow-up|1|||
164358694|NCT02028065|593688282|FG000|Randomization Through Start Treatment|Not treated|1|||
164358695|NCT02028065|593688283|FG001|Randomization Through Start Treatment|Not treated|3|||
164358696|NCT02028065|593688284|FG002|Randomization Through Start Treatment|Not treated|3|||
164358697|NCT02028065|593688282|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
164358698|NCT02028065|593688283|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
164358699|NCT02028065|593688284|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
164358700|NCT02028065|593688282|FG000|Treatment Through Study Completion|Physician Decision|1|||
164358701|NCT02028065|593688283|FG001|Treatment Through Study Completion|Physician Decision|0|||
164358702|NCT02028065|593688284|FG002|Treatment Through Study Completion|Physician Decision|0|||
164358703|NCT02028065|593688282|FG000|Treatment Through Study Completion|Protocol Violation|1|||
164358704|NCT02028065|593688283|FG001|Treatment Through Study Completion|Protocol Violation|4|||
164358705|NCT02028065|593688284|FG002|Treatment Through Study Completion|Protocol Violation|0|||
164358706|NCT02028065|593688282|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
164358707|NCT02028065|593688283|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
164358708|NCT02028065|593688284|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
164358709|NCT02028065|593688282|FG000|Treatment Through Study Completion|Adverse Event|3|||
164358710|NCT02028065|593688283|FG001|Treatment Through Study Completion|Adverse Event|3|||
164358711|NCT02028065|593688284|FG002|Treatment Through Study Completion|Adverse Event|5|||
164358712|NCT01698801|593688289|FG000|Treatment Phase|Adverse Event|4|||
164358713|NCT01698801|593688289|FG000|Treatment Phase|Protocol Violation|1|||
164358714|NCT01698801|593688289|FG000|Treatment Phase|Other|4|||
164358715|NCT01698801|593688289|FG000|Treatment Phase|Withdrawal by Subject|1|||
164358716|NCT01698801|593688289|FG000|Treatment Phase|Disease progression|1|||
164358717|NCT01698801|593688289|FG000|Follow Up Phase|Withdrawal by Subject|1|||
164358718|NCT01698801|593688289|FG000|Follow Up Phase|Death|4|||
164358719|NCT00656474|593688290|FG000|Overall Study|Other Reason|1|||
164358720|NCT02062879|593688291|FG000|Overall Study|Withdrawal by Subject|4|||
164358721|NCT02062879|593688292|FG001|Overall Study|Withdrawal by Subject|1|||
164358722|NCT00665847|593688296|FG000|Overall Study|Adverse Event|8|||
164358723|NCT00665847|593688296|FG000|Overall Study|Withdrawal by Subject|2|||
164358724|NCT00665847|593688296|FG000|Overall Study|Subject non-compliant|8|||
164358725|NCT00665847|593688296|FG000|Overall Study|Subject reached a virologic endpoint|4|||
164358726|NCT00665847|593688296|FG000|Overall Study|Resistance to TMC125|1|||
164358727|NCT00665847|593688296|FG000|Overall Study|Subject ineligible to continue the trial|1|||
164358728|NCT00665847|593688296|FG000|Overall Study|Switch to Commercial Medication|1|||
164358729|NCT00410761|593689921|FG000|Randomized Treatment Period|Adverse Event|34|||
164358730|NCT00410761|593689922|FG001|Randomized Treatment Period|Adverse Event|3|||
164358731|NCT00410761|593689921|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
164358732|NCT00410761|593689922|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
164358733|NCT00410761|593689921|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
164358734|NCT00410761|593689922|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
164358735|NCT00410761|593689921|FG000|Randomized Treatment Period|Other|69|||
164358736|NCT00410761|593689922|FG001|Randomized Treatment Period|Other|21|||
164358737|NCT00410761|593689921|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
164358738|NCT00410761|593689922|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
164358739|NCT00410761|593689921|FG000|Open-Label Treatment Period|Adverse Event|13|||
164358740|NCT00410761|593689922|FG001|Open-Label Treatment Period|Adverse Event|15|||
164358741|NCT00410761|593689921|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
164358742|NCT00410761|593689922|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
164358743|NCT00410761|593689921|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
164358744|NCT00410761|593689922|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
164009457|NCT03060577|592399660|FG001|Overall Study|Withdrawal by Subject|5|||
164009458|NCT03060577|592399659|FG000|Overall Study|Physician Decision|4|||
164009459|NCT03060577|592399660|FG001|Overall Study|Physician Decision|3|||
164009460|NCT03060577|592399659|FG000|Overall Study|Lost to Follow-up|3|||
164009461|NCT03060577|592399660|FG001|Overall Study|Lost to Follow-up|0|||
164009462|NCT03060577|592399659|FG000|Overall Study|Death|7|||
164009463|NCT03060577|592399660|FG001|Overall Study|Death|1|||
164009464|NCT03060577|592399659|FG000|Overall Study|Adverse Event|9|||
164009465|NCT03060577|592399660|FG001|Overall Study|Adverse Event|1|||
164009466|NCT03060577|592399659|FG000|Overall Study|Inclusion/Exclusion|1|||
164358745|NCT00410761|593689921|FG000|Open-Label Treatment Period|Other|18|||
164358746|NCT00410761|593689922|FG001|Open-Label Treatment Period|Other|9|||
164009467|NCT03060577|592399660|FG001|Overall Study|Inclusion/Exclusion|0|||
164009468|NCT03060577|592399659|FG000|Overall Study|Other|8|||
164009469|NCT03060577|592399660|FG001|Overall Study|Other|2|||
164009470|NCT03216265|592399661|FG000|Overall Study|Adverse Event|2|||
164358747|NCT04708886|593689931|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
164358748|NCT04708886|593689931|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
164009471|NCT03216265|592399662|FG001|Overall Study|Adverse Event|0|||
164009472|NCT03216265|592399663|FG002|Overall Study|Adverse Event|2|||
164358749|NCT01729754|593689932|FG000|Part 1|Adverse Event|2|||
164358750|NCT01729754|593689933|FG001|Part 1|Adverse Event|0|||
164358751|NCT01729754|593689934|FG002|Part 1|Adverse Event|0|||
164358752|NCT01729754|593689935|FG003|Part 1|Adverse Event|1|||
164009473|NCT03216265|592399661|FG000|Overall Study|Lost to Follow-up|0|||
164358753|NCT01729754|593689936|FG004|Part 1|Adverse Event|0|||
164358754|NCT01729754|593689937|FG005|Part 1|Adverse Event|0|||
164358755|NCT01729754|593689938|FG006|Part 1|Adverse Event|2|||
164358756|NCT01729754|593689939|FG007|Part 1|Adverse Event|0|||
164358757|NCT01729754|593689940|FG008|Part 1|Adverse Event|0|||
164358758|NCT01729754|593689941|FG009|Part 1|Adverse Event|5|||
164358759|NCT01729754|593689932|FG000|Part 1|Lack of Efficacy|1|||
164358760|NCT01729754|593689933|FG001|Part 1|Lack of Efficacy|0|||
164358761|NCT01729754|593689934|FG002|Part 1|Lack of Efficacy|0|||
164358762|NCT01729754|593689935|FG003|Part 1|Lack of Efficacy|0|||
164009474|NCT03216265|592399662|FG001|Overall Study|Lost to Follow-up|1|||
164009475|NCT03216265|592399663|FG002|Overall Study|Lost to Follow-up|0|||
164009476|NCT03216265|592399661|FG000|Overall Study|Withdrawal by Subject|0|||
164358763|NCT01729754|593689936|FG004|Part 1|Lack of Efficacy|0|||
164358764|NCT01729754|593689937|FG005|Part 1|Lack of Efficacy|0|||
164358765|NCT01729754|593689938|FG006|Part 1|Lack of Efficacy|2|||
164358766|NCT01729754|593689939|FG007|Part 1|Lack of Efficacy|0|||
164358767|NCT01729754|593689940|FG008|Part 1|Lack of Efficacy|0|||
164358768|NCT01729754|593689941|FG009|Part 1|Lack of Efficacy|0|||
164358769|NCT01729754|593689932|FG000|Part 1|Lost to Follow-up|1|||
164358770|NCT01729754|593689933|FG001|Part 1|Lost to Follow-up|0|||
164358771|NCT01729754|593689934|FG002|Part 1|Lost to Follow-up|0|||
164358772|NCT01729754|593689935|FG003|Part 1|Lost to Follow-up|2|||
164358773|NCT01729754|593689936|FG004|Part 1|Lost to Follow-up|0|||
164358774|NCT01729754|593689937|FG005|Part 1|Lost to Follow-up|0|||
164358775|NCT01729754|593689938|FG006|Part 1|Lost to Follow-up|3|||
164358776|NCT01729754|593689939|FG007|Part 1|Lost to Follow-up|0|||
164358777|NCT01729754|593689940|FG008|Part 1|Lost to Follow-up|0|||
164358778|NCT01729754|593689941|FG009|Part 1|Lost to Follow-up|3|||
164358779|NCT01729754|593689932|FG000|Part 1|Non-compliance with Study Drug|1|||
164358780|NCT01729754|593689933|FG001|Part 1|Non-compliance with Study Drug|0|||
164358781|NCT01729754|593689934|FG002|Part 1|Non-compliance with Study Drug|0|||
164358782|NCT01729754|593689935|FG003|Part 1|Non-compliance with Study Drug|0|||
164358783|NCT01729754|593689936|FG004|Part 1|Non-compliance with Study Drug|0|||
164358784|NCT01729754|593689937|FG005|Part 1|Non-compliance with Study Drug|0|||
164358785|NCT01729754|593689938|FG006|Part 1|Non-compliance with Study Drug|0|||
164358786|NCT01729754|593689939|FG007|Part 1|Non-compliance with Study Drug|0|||
164358787|NCT01729754|593689940|FG008|Part 1|Non-compliance with Study Drug|0|||
164358788|NCT01729754|593689941|FG009|Part 1|Non-compliance with Study Drug|0|||
164358789|NCT01729754|593689932|FG000|Part 1|Physician Decision|0|||
164358790|NCT01729754|593689933|FG001|Part 1|Physician Decision|0|||
164358791|NCT01729754|593689934|FG002|Part 1|Physician Decision|0|||
164358792|NCT01729754|593689935|FG003|Part 1|Physician Decision|0|||
164358793|NCT01729754|593689936|FG004|Part 1|Physician Decision|0|||
164358794|NCT01729754|593689937|FG005|Part 1|Physician Decision|0|||
164358795|NCT01729754|593689938|FG006|Part 1|Physician Decision|0|||
164358796|NCT01729754|593689939|FG007|Part 1|Physician Decision|0|||
164358797|NCT01729754|593689940|FG008|Part 1|Physician Decision|0|||
164358798|NCT01729754|593689941|FG009|Part 1|Physician Decision|4|||
164358799|NCT01729754|593689932|FG000|Part 1|Pregnancy|0|||
164358800|NCT01729754|593689933|FG001|Part 1|Pregnancy|0|||
164358801|NCT01729754|593689934|FG002|Part 1|Pregnancy|0|||
164358802|NCT01729754|593689935|FG003|Part 1|Pregnancy|1|||
164358803|NCT01729754|593689936|FG004|Part 1|Pregnancy|0|||
164358804|NCT01729754|593689937|FG005|Part 1|Pregnancy|0|||
164358805|NCT01729754|593689938|FG006|Part 1|Pregnancy|0|||
164358806|NCT01729754|593689939|FG007|Part 1|Pregnancy|0|||
164358807|NCT01729754|593689940|FG008|Part 1|Pregnancy|0|||
164358808|NCT01729754|593689941|FG009|Part 1|Pregnancy|1|||
164358809|NCT01729754|593689932|FG000|Part 1|Progressive Disease|0|||
164358810|NCT01729754|593689933|FG001|Part 1|Progressive Disease|0|||
164358811|NCT01729754|593689934|FG002|Part 1|Progressive Disease|0|||
164358812|NCT01729754|593689935|FG003|Part 1|Progressive Disease|0|||
164358813|NCT01729754|593689936|FG004|Part 1|Progressive Disease|0|||
164358814|NCT01729754|593689937|FG005|Part 1|Progressive Disease|0|||
164358815|NCT01729754|593689938|FG006|Part 1|Progressive Disease|0|||
164358816|NCT01729754|593689939|FG007|Part 1|Progressive Disease|0|||
164358817|NCT01729754|593689940|FG008|Part 1|Progressive Disease|0|||
164358818|NCT01729754|593689941|FG009|Part 1|Progressive Disease|1|||
164358819|NCT01729754|593689932|FG000|Part 1|Protocol Violation|2|||
164358820|NCT01729754|593689933|FG001|Part 1|Protocol Violation|0|||
164358821|NCT01729754|593689934|FG002|Part 1|Protocol Violation|0|||
164358822|NCT01729754|593689935|FG003|Part 1|Protocol Violation|1|||
164358823|NCT01729754|593689936|FG004|Part 1|Protocol Violation|0|||
164358824|NCT01729754|593689937|FG005|Part 1|Protocol Violation|0|||
164358825|NCT01729754|593689938|FG006|Part 1|Protocol Violation|1|||
164358826|NCT01729754|593689939|FG007|Part 1|Protocol Violation|0|||
164358827|NCT01729754|593689940|FG008|Part 1|Protocol Violation|0|||
164358828|NCT01729754|593689941|FG009|Part 1|Protocol Violation|0|||
164358829|NCT01729754|593689932|FG000|Part 1|Withdrawal by Subject|5|||
164358830|NCT01729754|593689933|FG001|Part 1|Withdrawal by Subject|0|||
164358831|NCT01729754|593689934|FG002|Part 1|Withdrawal by Subject|0|||
164358832|NCT01729754|593689935|FG003|Part 1|Withdrawal by Subject|7|||
164358833|NCT01729754|593689936|FG004|Part 1|Withdrawal by Subject|0|||
164358834|NCT01729754|593689937|FG005|Part 1|Withdrawal by Subject|0|||
164358835|NCT01729754|593689938|FG006|Part 1|Withdrawal by Subject|5|||
164358836|NCT01729754|593689939|FG007|Part 1|Withdrawal by Subject|0|||
164358837|NCT01729754|593689940|FG008|Part 1|Withdrawal by Subject|0|||
164358838|NCT01729754|593689941|FG009|Part 1|Withdrawal by Subject|6|||
164358839|NCT01729754|593689932|FG000|Part 1|Other Protocol Specified Criteria|2|||
164358840|NCT01729754|593689933|FG001|Part 1|Other Protocol Specified Criteria|0|||
164358841|NCT01729754|593689934|FG002|Part 1|Other Protocol Specified Criteria|0|||
164358842|NCT01729754|593689935|FG003|Part 1|Other Protocol Specified Criteria|0|||
164358843|NCT01729754|593689936|FG004|Part 1|Other Protocol Specified Criteria|0|||
164358844|NCT01729754|593689937|FG005|Part 1|Other Protocol Specified Criteria|0|||
164358845|NCT01729754|593689938|FG006|Part 1|Other Protocol Specified Criteria|1|||
164358846|NCT01729754|593689939|FG007|Part 1|Other Protocol Specified Criteria|0|||
164358847|NCT01729754|593689940|FG008|Part 1|Other Protocol Specified Criteria|0|||
164358848|NCT01729754|593689941|FG009|Part 1|Other Protocol Specified Criteria|4|||
164358849|NCT01729754|593689932|FG000|Part 2|Adverse Event|2|||
164358850|NCT01729754|593689933|FG001|Part 2|Adverse Event|0|||
164358851|NCT01729754|593689934|FG002|Part 2|Adverse Event|0|||
164358852|NCT01729754|593689935|FG003|Part 2|Adverse Event|0|||
164358853|NCT01729754|593689936|FG004|Part 2|Adverse Event|0|||
164358854|NCT01729754|593689937|FG005|Part 2|Adverse Event|0|||
164358855|NCT01729754|593689938|FG006|Part 2|Adverse Event|0|||
164358856|NCT01729754|593689939|FG007|Part 2|Adverse Event|0|||
164358857|NCT01729754|593689940|FG008|Part 2|Adverse Event|1|||
164358858|NCT01729754|593689941|FG009|Part 2|Adverse Event|2|||
164358859|NCT01729754|593689932|FG000|Part 2|Lack of Efficacy|0|||
164358860|NCT01729754|593689933|FG001|Part 2|Lack of Efficacy|0|||
164358861|NCT01729754|593689934|FG002|Part 2|Lack of Efficacy|0|||
164358862|NCT01729754|593689935|FG003|Part 2|Lack of Efficacy|0|||
164358863|NCT01729754|593689936|FG004|Part 2|Lack of Efficacy|0|||
164358864|NCT01729754|593689937|FG005|Part 2|Lack of Efficacy|0|||
164358865|NCT01729754|593689938|FG006|Part 2|Lack of Efficacy|0|||
164358866|NCT01729754|593689939|FG007|Part 2|Lack of Efficacy|0|||
164358867|NCT01729754|593689940|FG008|Part 2|Lack of Efficacy|2|||
164358868|NCT01729754|593689941|FG009|Part 2|Lack of Efficacy|2|||
164358869|NCT01729754|593689932|FG000|Part 2|Lost to Follow-up|0|||
164358870|NCT01729754|593689933|FG001|Part 2|Lost to Follow-up|0|||
164358871|NCT01729754|593689934|FG002|Part 2|Lost to Follow-up|0|||
164358872|NCT01729754|593689935|FG003|Part 2|Lost to Follow-up|2|||
164358873|NCT01729754|593689936|FG004|Part 2|Lost to Follow-up|0|||
164358874|NCT01729754|593689937|FG005|Part 2|Lost to Follow-up|0|||
164358875|NCT01729754|593689938|FG006|Part 2|Lost to Follow-up|0|||
164358876|NCT01729754|593689939|FG007|Part 2|Lost to Follow-up|1|||
164358877|NCT01729754|593689940|FG008|Part 2|Lost to Follow-up|0|||
164358878|NCT01729754|593689941|FG009|Part 2|Lost to Follow-up|2|||
164358879|NCT01729754|593689932|FG000|Part 2|Non-Compliance with Study Drug|0|||
164358880|NCT01729754|593689933|FG001|Part 2|Non-Compliance with Study Drug|0|||
164358881|NCT01729754|593689934|FG002|Part 2|Non-Compliance with Study Drug|0|||
164358882|NCT01729754|593689935|FG003|Part 2|Non-Compliance with Study Drug|0|||
164358883|NCT01729754|593689936|FG004|Part 2|Non-Compliance with Study Drug|0|||
164358884|NCT01729754|593689937|FG005|Part 2|Non-Compliance with Study Drug|0|||
164358885|NCT01729754|593689938|FG006|Part 2|Non-Compliance with Study Drug|0|||
164358886|NCT01729754|593689939|FG007|Part 2|Non-Compliance with Study Drug|0|||
164358887|NCT01729754|593689940|FG008|Part 2|Non-Compliance with Study Drug|0|||
164358888|NCT01729754|593689941|FG009|Part 2|Non-Compliance with Study Drug|1|||
164358889|NCT01729754|593689932|FG000|Part 2|Pregnancy|0|||
164358890|NCT01729754|593689933|FG001|Part 2|Pregnancy|0|||
164358891|NCT01729754|593689934|FG002|Part 2|Pregnancy|0|||
164358892|NCT01729754|593689935|FG003|Part 2|Pregnancy|1|||
164358893|NCT01729754|593689936|FG004|Part 2|Pregnancy|0|||
164358894|NCT01729754|593689937|FG005|Part 2|Pregnancy|0|||
164358895|NCT01729754|593689938|FG006|Part 2|Pregnancy|0|||
164358896|NCT01729754|593689939|FG007|Part 2|Pregnancy|0|||
164358897|NCT01729754|593689940|FG008|Part 2|Pregnancy|0|||
164358898|NCT01729754|593689941|FG009|Part 2|Pregnancy|1|||
164358899|NCT01729754|593689932|FG000|Part 2|Withdrawal by Subject|3|||
164358900|NCT01729754|593689933|FG001|Part 2|Withdrawal by Subject|0|||
164358901|NCT01729754|593689934|FG002|Part 2|Withdrawal by Subject|0|||
164358902|NCT01729754|593689935|FG003|Part 2|Withdrawal by Subject|2|||
164358903|NCT01729754|593689936|FG004|Part 2|Withdrawal by Subject|0|||
164358904|NCT01729754|593689937|FG005|Part 2|Withdrawal by Subject|0|||
164358905|NCT01729754|593689938|FG006|Part 2|Withdrawal by Subject|0|||
164358906|NCT01729754|593689939|FG007|Part 2|Withdrawal by Subject|1|||
164358907|NCT01729754|593689940|FG008|Part 2|Withdrawal by Subject|1|||
164358908|NCT01729754|593689941|FG009|Part 2|Withdrawal by Subject|4|||
164358909|NCT01729754|593689932|FG000|Part 2|Other Protocol Specified Criteria|1|||
164358910|NCT01729754|593689933|FG001|Part 2|Other Protocol Specified Criteria|0|||
164358911|NCT01729754|593689934|FG002|Part 2|Other Protocol Specified Criteria|0|||
164358912|NCT01729754|593689935|FG003|Part 2|Other Protocol Specified Criteria|0|||
164358913|NCT01729754|593689936|FG004|Part 2|Other Protocol Specified Criteria|0|||
164358914|NCT01729754|593689937|FG005|Part 2|Other Protocol Specified Criteria|0|||
164358915|NCT01729754|593689938|FG006|Part 2|Other Protocol Specified Criteria|0|||
164358916|NCT01729754|593689939|FG007|Part 2|Other Protocol Specified Criteria|1|||
164358917|NCT01729754|593689940|FG008|Part 2|Other Protocol Specified Criteria|0|||
164358918|NCT01729754|593689941|FG009|Part 2|Other Protocol Specified Criteria|0|||
164358919|NCT01729754|593689932|FG000|Part 3|Adverse Event|0|||
164358920|NCT01729754|593689933|FG001|Part 3|Adverse Event|0|||
164358921|NCT01729754|593689934|FG002|Part 3|Adverse Event|1|||
164358922|NCT01729754|593689935|FG003|Part 3|Adverse Event|0|||
164358923|NCT01729754|593689936|FG004|Part 3|Adverse Event|0|||
164358924|NCT01729754|593689937|FG005|Part 3|Adverse Event|5|||
164358925|NCT01729754|593689938|FG006|Part 3|Adverse Event|0|||
164358926|NCT01729754|593689939|FG007|Part 3|Adverse Event|0|||
164358927|NCT01729754|593689940|FG008|Part 3|Adverse Event|0|||
164358928|NCT01729754|593689941|FG009|Part 3|Adverse Event|3|||
164358929|NCT01729754|593689932|FG000|Part 3|Death|0|||
164358930|NCT01729754|593689933|FG001|Part 3|Death|0|||
164358931|NCT01729754|593689934|FG002|Part 3|Death|0|||
164358932|NCT01729754|593689935|FG003|Part 3|Death|0|||
164358933|NCT01729754|593689936|FG004|Part 3|Death|0|||
164358934|NCT01729754|593689937|FG005|Part 3|Death|2|||
164358935|NCT01729754|593689938|FG006|Part 3|Death|0|||
164358936|NCT01729754|593689939|FG007|Part 3|Death|0|||
164358937|NCT01729754|593689940|FG008|Part 3|Death|0|||
164358938|NCT01729754|593689941|FG009|Part 3|Death|0|||
164358939|NCT01729754|593689932|FG000|Part 3|Lack of Efficacy|0|||
164358940|NCT01729754|593689933|FG001|Part 3|Lack of Efficacy|0|||
164358941|NCT01729754|593689934|FG002|Part 3|Lack of Efficacy|0|||
164358942|NCT01729754|593689935|FG003|Part 3|Lack of Efficacy|0|||
164358943|NCT01729754|593689936|FG004|Part 3|Lack of Efficacy|2|||
164358944|NCT01729754|593689937|FG005|Part 3|Lack of Efficacy|0|||
164358945|NCT01729754|593689938|FG006|Part 3|Lack of Efficacy|0|||
164358946|NCT01729754|593689939|FG007|Part 3|Lack of Efficacy|0|||
164358947|NCT01729754|593689940|FG008|Part 3|Lack of Efficacy|0|||
164358948|NCT01729754|593689941|FG009|Part 3|Lack of Efficacy|4|||
164358949|NCT01729754|593689932|FG000|Part 3|Lost to Follow-up|0|||
164358950|NCT01729754|593689933|FG001|Part 3|Lost to Follow-up|1|||
164358951|NCT01729754|593689934|FG002|Part 3|Lost to Follow-up|2|||
164358952|NCT01729754|593689935|FG003|Part 3|Lost to Follow-up|0|||
164358953|NCT01729754|593689936|FG004|Part 3|Lost to Follow-up|0|||
164358954|NCT01729754|593689937|FG005|Part 3|Lost to Follow-up|3|||
164358955|NCT01729754|593689938|FG006|Part 3|Lost to Follow-up|0|||
164358956|NCT01729754|593689939|FG007|Part 3|Lost to Follow-up|0|||
164358957|NCT01729754|593689940|FG008|Part 3|Lost to Follow-up|1|||
164358958|NCT01729754|593689941|FG009|Part 3|Lost to Follow-up|0|||
164358959|NCT01729754|593689932|FG000|Part 3|Physician Decision|0|||
164358960|NCT01729754|593689933|FG001|Part 3|Physician Decision|0|||
164358961|NCT01729754|593689934|FG002|Part 3|Physician Decision|1|||
164358962|NCT01729754|593689935|FG003|Part 3|Physician Decision|0|||
164358963|NCT01729754|593689936|FG004|Part 3|Physician Decision|0|||
164358964|NCT01729754|593689937|FG005|Part 3|Physician Decision|0|||
164358965|NCT01729754|593689938|FG006|Part 3|Physician Decision|0|||
164358966|NCT01729754|593689939|FG007|Part 3|Physician Decision|0|||
164358967|NCT01729754|593689940|FG008|Part 3|Physician Decision|0|||
164358968|NCT01729754|593689941|FG009|Part 3|Physician Decision|0|||
164358969|NCT01729754|593689932|FG000|Part 3|Withdrawal by Subject|0|||
164358970|NCT01729754|593689933|FG001|Part 3|Withdrawal by Subject|4|||
164358971|NCT01729754|593689934|FG002|Part 3|Withdrawal by Subject|1|||
164358972|NCT01729754|593689935|FG003|Part 3|Withdrawal by Subject|0|||
164358973|NCT01729754|593689936|FG004|Part 3|Withdrawal by Subject|2|||
164358974|NCT01729754|593689937|FG005|Part 3|Withdrawal by Subject|1|||
164358975|NCT01729754|593689938|FG006|Part 3|Withdrawal by Subject|0|||
164358976|NCT01729754|593689939|FG007|Part 3|Withdrawal by Subject|2|||
164358977|NCT01729754|593689940|FG008|Part 3|Withdrawal by Subject|0|||
164358978|NCT01729754|593689941|FG009|Part 3|Withdrawal by Subject|0|||
164358979|NCT01729754|593689932|FG000|Part 3|Other Protocol Specified Criteria|0|||
164358980|NCT01729754|593689933|FG001|Part 3|Other Protocol Specified Criteria|0|||
164358981|NCT01729754|593689934|FG002|Part 3|Other Protocol Specified Criteria|0|||
164358982|NCT01729754|593689935|FG003|Part 3|Other Protocol Specified Criteria|0|||
164358983|NCT01729754|593689936|FG004|Part 3|Other Protocol Specified Criteria|0|||
164358984|NCT01729754|593689937|FG005|Part 3|Other Protocol Specified Criteria|2|||
164358985|NCT01729754|593689938|FG006|Part 3|Other Protocol Specified Criteria|0|||
164358986|NCT01729754|593689939|FG007|Part 3|Other Protocol Specified Criteria|1|||
164358987|NCT01729754|593689940|FG008|Part 3|Other Protocol Specified Criteria|0|||
164358988|NCT01729754|593689941|FG009|Part 3|Other Protocol Specified Criteria|0|||
164009477|NCT03216265|592399662|FG001|Overall Study|Withdrawal by Subject|0|||
164009478|NCT03216265|592399663|FG002|Overall Study|Withdrawal by Subject|1|||
164358989|NCT00936910|593689942|FG000|Overall Study|Lack of Efficacy|3|||
164358990|NCT00773292|593689943|FG000|Treatment 48 Weeks|Adverse Event|1|||
164358991|NCT00773292|593689943|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
164358992|NCT01853046|593689944|FG000|Overall Study|Withdrawal by Subject|1|||
164358993|NCT01853046|593689945|FG001|Overall Study|Withdrawal by Subject|1|||
164358994|NCT01853046|593689944|FG000|Overall Study|Adverse Event|4|||
164358995|NCT01853046|593689945|FG001|Overall Study|Adverse Event|2|||
164358996|NCT01853046|593689944|FG000|Overall Study|Disease progression|13|||
164358997|NCT01853046|593689945|FG001|Overall Study|Disease progression|3|||
164358998|NCT03020407|593689947|FG000|Overall Study|Withdrawal by Subject|2|||
164358999|NCT03020407|593689948|FG001|Overall Study|Withdrawal by Subject|1|||
164359000|NCT03020407|593689947|FG000|Overall Study|Lost to Follow-up|2|||
164359001|NCT03020407|593689948|FG001|Overall Study|Lost to Follow-up|3|||
164359002|NCT03020407|593689947|FG000|Overall Study|Protocol Violation|0|||
164359003|NCT03020407|593689948|FG001|Overall Study|Protocol Violation|1|||
164359004|NCT00708162|593689949|FG000|Randomized Phase|Randomized but Not Treated|7|||
164359005|NCT00708162|593689950|FG001|Randomized Phase|Randomized but Not Treated|5|||
164359006|NCT00708162|593689949|FG000|Randomized Phase|Participant Noncompliance|40|||
164359007|NCT00708162|593689950|FG001|Randomized Phase|Participant Noncompliance|32|||
164359008|NCT00708162|593689949|FG000|Randomized Phase|Lost to Follow-up|34|||
164359009|NCT00708162|593689950|FG001|Randomized Phase|Lost to Follow-up|34|||
164359010|NCT00708162|593689949|FG000|Randomized Phase|Withdrew Consent|31|||
164359011|NCT00708162|593689950|FG001|Randomized Phase|Withdrew Consent|22|||
164359012|NCT00708162|593689949|FG000|Randomized Phase|Lack of Efficacy|14|||
164359013|NCT00708162|593689950|FG001|Randomized Phase|Lack of Efficacy|19|||
164359014|NCT00708162|593689949|FG000|Randomized Phase|Protocol Violation|10|||
164359015|NCT00708162|593689950|FG001|Randomized Phase|Protocol Violation|11|||
164359016|NCT00708162|593689949|FG000|Randomized Phase|Adverse Event|8|||
164359017|NCT00708162|593689950|FG001|Randomized Phase|Adverse Event|12|||
164359018|NCT00708162|593689949|FG000|Randomized Phase|Investigator's Discretion|7|||
164009479|NCT01306058|592399664|FG000|Overall Study|Death|1|||
164359019|NCT00708162|593689950|FG001|Randomized Phase|Investigator's Discretion|10|||
164359020|NCT00708162|593689949|FG000|Randomized Phase|Death|2|||
164359021|NCT00708162|593689950|FG001|Randomized Phase|Death|9|||
164359022|NCT00708162|593689949|FG000|Randomized Phase|Pregnancy|3|||
164359023|NCT00708162|593689950|FG001|Randomized Phase|Pregnancy|0|||
164359024|NCT00708162|593689949|FG000|Open-Label Phase|Lost to Follow-up|10|||
164359025|NCT00708162|593689950|FG001|Open-Label Phase|Lost to Follow-up|8|||
164359026|NCT00708162|593689949|FG000|Open-Label Phase|Withdrew Consent|12|||
164359027|NCT00708162|593689950|FG001|Open-Label Phase|Withdrew Consent|6|||
164359028|NCT00708162|593689949|FG000|Open-Label Phase|Participant Noncompliance|7|||
164359029|NCT00708162|593689950|FG001|Open-Label Phase|Participant Noncompliance|7|||
164359030|NCT00708162|593689949|FG000|Open-Label Phase|Lack of Efficacy|7|||
164359031|NCT00708162|593689950|FG001|Open-Label Phase|Lack of Efficacy|4|||
164359032|NCT00708162|593689949|FG000|Open-Label Phase|Investigator's Discretion|3|||
164359033|NCT00708162|593689950|FG001|Open-Label Phase|Investigator's Discretion|2|||
164359034|NCT00708162|593689949|FG000|Open-Label Phase|Death|3|||
164359035|NCT00708162|593689950|FG001|Open-Label Phase|Death|1|||
164359036|NCT00708162|593689949|FG000|Open-Label Phase|Adverse Event|1|||
164359037|NCT00708162|593689950|FG001|Open-Label Phase|Adverse Event|2|||
164359038|NCT00708162|593689949|FG000|Open-Label Phase|Other|1|||
164359039|NCT00708162|593689950|FG001|Open-Label Phase|Other|0|||
164359040|NCT02699554|593689951|FG000|Overall Study|Lost to Follow-up|9|||
164359041|NCT00788151|593689952|FG000|Overall Study|Other adverse event|0|||
164359042|NCT00788151|593689953|FG001|Overall Study|Other adverse event|2|||
164359043|NCT00788151|593689952|FG000|Overall Study|Protocol Violation|0|||
164359044|NCT00788151|593689953|FG001|Overall Study|Protocol Violation|1|||
164359045|NCT00788151|593689952|FG000|Overall Study|Withdrawal by Subject|13|||
164359046|NCT00788151|593689953|FG001|Overall Study|Withdrawal by Subject|6|||
164359047|NCT00788151|593689952|FG000|Overall Study|Enrolled but not treated|1|||
164359048|NCT00788151|593689953|FG001|Overall Study|Enrolled but not treated|1|||
164359049|NCT00503009|593689954|FG000|Overall Study|Protocol Violation|1|||
164359050|NCT00503009|593689955|FG001|Overall Study|Protocol Violation|0|||
164009480|NCT01306058|592399664|FG000|Overall Study|Enrolled but did not get treatment|1|||
164009481|NCT01539837|592399665|FG000|Overall Study|reduce neutrophil level|0|||
164009482|NCT01539837|592399666|FG001|Overall Study|reduce neutrophil level|1|||
164009483|NCT01539837|592399667|FG002|Overall Study|reduce neutrophil level|1|||
164009484|NCT01539837|592399665|FG000|Overall Study|bad compliance|0|||
164359051|NCT00503009|593689956|FG002|Overall Study|Protocol Violation|1|||
164359052|NCT00503009|593689954|FG000|Overall Study|Withdrawal by Subject|0|||
164359053|NCT00503009|593689955|FG001|Overall Study|Withdrawal by Subject|1|||
164359054|NCT00503009|593689956|FG002|Overall Study|Withdrawal by Subject|1|||
164359055|NCT00503009|593689954|FG000|Overall Study|Physician Decision|0|||
164359056|NCT00503009|593689955|FG001|Overall Study|Physician Decision|1|||
164359057|NCT00503009|593689956|FG002|Overall Study|Physician Decision|1|||
164009485|NCT01539837|592399666|FG001|Overall Study|bad compliance|0|||
164009486|NCT01539837|592399667|FG002|Overall Study|bad compliance|1|||
164009487|NCT00849693|592399668|FG000|Acute Treatment Phase|Adverse Event|12|||
164009488|NCT00849693|592399669|FG001|Acute Treatment Phase|Adverse Event|7|||
164009489|NCT00849693|592399670|FG002|Acute Treatment Phase|Adverse Event|6|||
164359058|NCT01349803|593689958|FG000|Overall Study|Adverse Event|0|||
164359059|NCT01349803|593689959|FG001|Overall Study|Adverse Event|0|||
164359060|NCT01349803|593689960|FG002|Overall Study|Adverse Event|0|||
164359061|NCT01349803|593689961|FG003|Overall Study|Adverse Event|2|||
164359062|NCT01349803|593689958|FG000|Overall Study|Withdrawal by Subject|1|||
164359063|NCT01349803|593689959|FG001|Overall Study|Withdrawal by Subject|0|||
164359064|NCT01349803|593689960|FG002|Overall Study|Withdrawal by Subject|0|||
164359065|NCT01349803|593689961|FG003|Overall Study|Withdrawal by Subject|0|||
164359066|NCT01349803|593689958|FG000|Overall Study|Protocol-specified criteria|0|||
164359067|NCT01349803|593689959|FG001|Overall Study|Protocol-specified criteria|1|||
164359068|NCT01349803|593689960|FG002|Overall Study|Protocol-specified criteria|3|||
164359069|NCT01349803|593689961|FG003|Overall Study|Protocol-specified criteria|0|||
164359070|NCT02345811|593689962|FG000|First Intervention|Withdrawal by Subject|1|||
164359071|NCT02345811|593689963|FG001|First Intervention|Withdrawal by Subject|1|||
164359072|NCT02522286|593689964|FG000|Overall Study|Withdrawal by Subject|3|||
164359073|NCT02522286|593689965|FG001|Overall Study|Withdrawal by Subject|0|||
164359074|NCT02522286|593689966|FG002|Overall Study|Withdrawal by Subject|0|||
164359075|NCT02522286|593689967|FG003|Overall Study|Withdrawal by Subject|3|||
164359076|NCT00605813|593689969|FG000|Overall Study|Protocol Violation|25|||
164359077|NCT01163279|593689971|FG000|Overall Study|Withdrawal by Subject|2|||
164359078|NCT01163279|593689972|FG001|Overall Study|Withdrawal by Subject|0|||
164359079|NCT01394523|593689976|FG000|Overall Study|Unable to place block|1|||
164359080|NCT01394523|593689977|FG001|Overall Study|Unable to place block|0|||
164359081|NCT01394523|593689978|FG002|Overall Study|Unable to place block|0|||
164359082|NCT03525574|593689984|FG000|Overall Study|Adverse Event|15|||
164359083|NCT03525574|593689985|FG001|Overall Study|Adverse Event|0|||
164359084|NCT03525574|593689984|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
164359085|NCT03525574|593689985|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
164359086|NCT03525574|593689984|FG000|Overall Study|Lost to Follow-up|4|||
164359087|NCT03525574|593689985|FG001|Overall Study|Lost to Follow-up|0|||
164359088|NCT03525574|593689984|FG000|Overall Study|Commercial drug is Available for participant|48|||
164359089|NCT03525574|593689985|FG001|Overall Study|Commercial drug is Available for participant|0|||
164359090|NCT03525574|593689984|FG000|Overall Study|Death|1|||
164359091|NCT03525574|593689985|FG001|Overall Study|Death|0|||
164359092|NCT03525574|593689984|FG000|Overall Study|Other non-compliance|2|||
164359093|NCT03525574|593689985|FG001|Overall Study|Other non-compliance|0|||
164359094|NCT03525574|593689984|FG000|Overall Study|Physician Decision|6|||
164359095|NCT03525574|593689985|FG001|Overall Study|Physician Decision|0|||
164359096|NCT03525574|593689984|FG000|Overall Study|Other|58|||
164359097|NCT03525574|593689985|FG001|Overall Study|Other|0|||
164359098|NCT03525574|593689984|FG000|Overall Study|Enrolled but never dosed|1|||
164359099|NCT03525574|593689985|FG001|Overall Study|Enrolled but never dosed|0|||
164359100|NCT03525574|593689984|FG000|Overall Study|Not enrolled in 105 study|0|||
164359101|NCT03525574|593689985|FG001|Overall Study|Not enrolled in 105 study|3|||
164359102|NCT04741074|593689988|FG000|Overall Study|Withdrawal by Subject|1|||
164359103|NCT04741074|593689989|FG001|Overall Study|Withdrawal by Subject|1|||
164359104|NCT04741074|593689988|FG000|Overall Study|Study terminated prematurely|1|||
164359105|NCT04741074|593689989|FG001|Overall Study|Study terminated prematurely|0|||
164359106|NCT01770379|593689990|FG000|Overall Study|Technical issues|1|||
164359107|NCT01770379|593689991|FG001|Overall Study|Technical issues|0|||
164359108|NCT01770379|593689992|FG002|Overall Study|Technical issues|0|||
164359109|NCT01770379|593689990|FG000|Overall Study|Withdrawal by Subject|7|||
164359110|NCT01770379|593689991|FG001|Overall Study|Withdrawal by Subject|10|||
164359111|NCT01770379|593689992|FG002|Overall Study|Withdrawal by Subject|7|||
164359112|NCT01770379|593689990|FG000|Overall Study|study terminated by sponsor|22|||
164009490|NCT00849693|592399671|FG003|Acute Treatment Phase|Adverse Event|4|||
164009491|NCT00849693|592399668|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
164009492|NCT00849693|592399669|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
164009493|NCT00849693|592399670|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
164359113|NCT01770379|593689991|FG001|Overall Study|study terminated by sponsor|23|||
164359114|NCT01770379|593689992|FG002|Overall Study|study terminated by sponsor|22|||
164359115|NCT01770379|593689990|FG000|Overall Study|Protocol Violation|0|||
164359116|NCT01770379|593689991|FG001|Overall Study|Protocol Violation|1|||
164359117|NCT01770379|593689992|FG002|Overall Study|Protocol Violation|1|||
164359118|NCT01770379|593689990|FG000|Overall Study|Physician Decision|0|||
164359119|NCT01770379|593689991|FG001|Overall Study|Physician Decision|1|||
164359120|NCT01770379|593689992|FG002|Overall Study|Physician Decision|2|||
164359121|NCT01770379|593689990|FG000|Overall Study|Lost to Follow-up|0|||
164359122|NCT01770379|593689991|FG001|Overall Study|Lost to Follow-up|0|||
164359123|NCT01770379|593689992|FG002|Overall Study|Lost to Follow-up|2|||
164359124|NCT01770379|593689990|FG000|Overall Study|Lack of Efficacy|8|||
164359125|NCT01770379|593689991|FG001|Overall Study|Lack of Efficacy|6|||
164359126|NCT01770379|593689992|FG002|Overall Study|Lack of Efficacy|6|||
164359127|NCT01770379|593689990|FG000|Overall Study|Adverse Event|1|||
164359128|NCT01770379|593689991|FG001|Overall Study|Adverse Event|3|||
164359129|NCT01770379|593689992|FG002|Overall Study|Adverse Event|2|||
164359130|NCT00778700|593689993|FG000|Overall Study|Adverse Event|6|||
164359131|NCT00778700|593689994|FG001|Overall Study|Adverse Event|1|||
164359132|NCT00778700|593689995|FG002|Overall Study|Adverse Event|3|||
164359133|NCT00778700|593689996|FG003|Overall Study|Adverse Event|5|||
164359134|NCT00778700|593689993|FG000|Overall Study|Protocol Violation|1|||
164359135|NCT00778700|593689994|FG001|Overall Study|Protocol Violation|1|||
164359136|NCT00778700|593689995|FG002|Overall Study|Protocol Violation|0|||
164359137|NCT00778700|593689996|FG003|Overall Study|Protocol Violation|0|||
164359138|NCT00778700|593689993|FG000|Overall Study|Subject Withdrew Consent|6|||
164359139|NCT00778700|593689994|FG001|Overall Study|Subject Withdrew Consent|4|||
164359140|NCT00778700|593689995|FG002|Overall Study|Subject Withdrew Consent|1|||
164359141|NCT00778700|593689996|FG003|Overall Study|Subject Withdrew Consent|4|||
164359142|NCT00778700|593689993|FG000|Overall Study|Lost to Follow-up|3|||
164359143|NCT00778700|593689994|FG001|Overall Study|Lost to Follow-up|1|||
164359144|NCT00778700|593689995|FG002|Overall Study|Lost to Follow-up|0|||
164359145|NCT00778700|593689996|FG003|Overall Study|Lost to Follow-up|1|||
164359146|NCT00778700|593689993|FG000|Overall Study|Reason not Specified|2|||
164359147|NCT00778700|593689994|FG001|Overall Study|Reason not Specified|0|||
164359148|NCT00778700|593689995|FG002|Overall Study|Reason not Specified|1|||
164359149|NCT00778700|593689996|FG003|Overall Study|Reason not Specified|3|||
164359150|NCT00778700|593689993|FG000|Overall Study|Other|0|||
164359151|NCT00778700|593689994|FG001|Overall Study|Other|0|||
164359152|NCT00778700|593689995|FG002|Overall Study|Other|1|||
164359153|NCT00778700|593689996|FG003|Overall Study|Other|0|||
164359154|NCT03274440|593690002|FG000|Overall Study|Time commitment too great|1|||
164359155|NCT03274440|593690003|FG001|Overall Study|Time commitment too great|0|||
164359156|NCT03274440|593690004|FG002|Overall Study|Time commitment too great|0|||
164359157|NCT03274440|593690005|FG003|Overall Study|Time commitment too great|1|||
164359158|NCT03274440|593690006|FG004|Overall Study|Time commitment too great|0|||
164359159|NCT03274440|593690007|FG005|Overall Study|Time commitment too great|0|||
164359160|NCT02611778|593690008|FG000|Overall Study|Withdrawal by Subject|2|||
164359161|NCT02611778|593690009|FG001|Overall Study|Withdrawal by Subject|8|||
164359162|NCT02611778|593690008|FG000|Overall Study|Adverse Event|1|||
164359163|NCT02611778|593690009|FG001|Overall Study|Adverse Event|2|||
164359164|NCT02611778|593690008|FG000|Overall Study|Death|2|||
164359165|NCT02611778|593690009|FG001|Overall Study|Death|1|||
164359166|NCT02611778|593690008|FG000|Overall Study|Protocol Violation|1|||
164359167|NCT02611778|593690009|FG001|Overall Study|Protocol Violation|0|||
164359168|NCT02611778|593690008|FG000|Overall Study|Lost to Follow-up|3|||
164359169|NCT02611778|593690009|FG001|Overall Study|Lost to Follow-up|1|||
164359170|NCT02611778|593690008|FG000|Overall Study|Need for alternative treatment|1|||
164359171|NCT02611778|593690009|FG001|Overall Study|Need for alternative treatment|0|||
164359172|NCT02611778|593690008|FG000|Overall Study|Other Reason|2|||
164359173|NCT02611778|593690009|FG001|Overall Study|Other Reason|1|||
164359174|NCT04008030|593690011|FG000|Pre-Treatment|Withdrawal by Subject|0|||
164359175|NCT04008030|593690012|FG001|Pre-Treatment|Withdrawal by Subject|0|||
164359176|NCT04008030|593690013|FG002|Pre-Treatment|Withdrawal by Subject|9|||
164359177|NCT04008030|593690011|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164359178|NCT04008030|593690012|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
164359179|NCT04008030|593690013|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
164359180|NCT04008030|593690011|FG000|Pre-Treatment|Other reasons|0|||
164359181|NCT04008030|593690012|FG001|Pre-Treatment|Other reasons|1|||
164359182|NCT04008030|593690013|FG002|Pre-Treatment|Other reasons|6|||
164359183|NCT04008030|593690011|FG000|Treatment|Withdrawal by Subject|1|||
164359184|NCT04008030|593690012|FG001|Treatment|Withdrawal by Subject|1|||
164359185|NCT04008030|593690013|FG002|Treatment|Withdrawal by Subject|1|||
163901426|NCT03333109|592009712|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
163901427|NCT03333109|592009710|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
164359186|NCT04008030|593690011|FG000|Treatment|Death|2|||
164359187|NCT04008030|593690012|FG001|Treatment|Death|4|||
164359188|NCT04008030|593690013|FG002|Treatment|Death|0|||
164359189|NCT04008030|593690011|FG000|Treatment|Pregnancy|0|||
164359190|NCT04008030|593690012|FG001|Treatment|Pregnancy|1|||
164359191|NCT04008030|593690013|FG002|Treatment|Pregnancy|0|||
164359192|NCT04008030|593690011|FG000|Treatment|Participant no longer meets study criteria|0|||
164359193|NCT04008030|593690012|FG001|Treatment|Participant no longer meets study criteria|1|||
164359194|NCT04008030|593690013|FG002|Treatment|Participant no longer meets study criteria|0|||
164359195|NCT04008030|593690011|FG000|Treatment|Other reasons|5|||
163901428|NCT03333109|592009711|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
163901429|NCT03333109|592009712|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
164359196|NCT04008030|593690012|FG001|Treatment|Other reasons|13|||
164359197|NCT04008030|593690013|FG002|Treatment|Other reasons|6|||
164359198|NCT04008030|593690011|FG000|Treatment|Disease Progression|137|||
164359199|NCT04008030|593690012|FG001|Treatment|Disease Progression|82|||
164359200|NCT04008030|593690013|FG002|Treatment|Disease Progression|85|||
164359201|NCT04008030|593690011|FG000|Treatment|Study drug toxicity|28|||
164359202|NCT04008030|593690012|FG001|Treatment|Study drug toxicity|48|||
164359203|NCT04008030|593690013|FG002|Treatment|Study drug toxicity|8|||
164359204|NCT04008030|593690011|FG000|Treatment|Adverse Event unrelated to study drug|28|||
164359205|NCT04008030|593690012|FG001|Treatment|Adverse Event unrelated to study drug|22|||
164359206|NCT04008030|593690013|FG002|Treatment|Adverse Event unrelated to study drug|6|||
164359207|NCT04008030|593690011|FG000|Treatment|Maximum Clinical Benefit|0|||
164359208|NCT04008030|593690012|FG001|Treatment|Maximum Clinical Benefit|1|||
164359209|NCT04008030|593690013|FG002|Treatment|Maximum Clinical Benefit|9|||
164359210|NCT04008030|593690011|FG000|Treatment|On-going treatment|13|||
164359211|NCT04008030|593690012|FG001|Treatment|On-going treatment|20|||
164359212|NCT04008030|593690013|FG002|Treatment|On-going treatment|0|||
164359213|NCT02574247|593690020|FG000|Overall Study|Withdrawal by Subject|1|||
164359214|NCT02574247|593690021|FG001|Overall Study|Withdrawal by Subject|0|||
164359215|NCT02574247|593690022|FG002|Overall Study|Withdrawal by Subject|0|||
164359216|NCT02574247|593690020|FG000|Overall Study|Did not meet inclusion criteria|4|||
164359217|NCT02574247|593690021|FG001|Overall Study|Did not meet inclusion criteria|3|||
164359218|NCT02574247|593690022|FG002|Overall Study|Did not meet inclusion criteria|5|||
164359219|NCT02268864|593690023|FG000|Overall Study|Withdrawal by Subject|2|||
164359220|NCT02268864|593690024|FG001|Overall Study|Withdrawal by Subject|0|||
164359221|NCT02268864|593690025|FG002|Overall Study|Withdrawal by Subject|0|||
163901430|NCT03333109|592009710|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
164359222|NCT02268864|593690023|FG000|Overall Study|Death|0|||
164359223|NCT02268864|593690024|FG001|Overall Study|Death|1|||
164359224|NCT02268864|593690025|FG002|Overall Study|Death|0|||
164359225|NCT01528254|593690030|FG000|Overall Study|Administrative problems|96|||
163901431|NCT03333109|592009711|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
164359226|NCT01528254|593690031|FG001|Overall Study|Administrative problems|94|||
164359227|NCT01528254|593690030|FG000|Overall Study|Adverse Event|28|||
164009494|NCT00849693|592399671|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
164009495|NCT00849693|592399668|FG000|Acute Treatment Phase|Protocol Violation|1|||
164009496|NCT00849693|592399669|FG001|Acute Treatment Phase|Protocol Violation|5|||
164009497|NCT00849693|592399670|FG002|Acute Treatment Phase|Protocol Violation|2|||
164009498|NCT00849693|592399671|FG003|Acute Treatment Phase|Protocol Violation|6|||
164009499|NCT00849693|592399668|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
164009500|NCT00849693|592399669|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
164009501|NCT00849693|592399670|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
164009502|NCT00849693|592399671|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
164009503|NCT00849693|592399668|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
164009504|NCT00849693|592399669|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
164009505|NCT00849693|592399670|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
164009506|NCT00849693|592399671|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
164009507|NCT00849693|592399668|FG000|Acute Treatment Phase|Physician Decision|2|||
164009508|NCT00849693|592399669|FG001|Acute Treatment Phase|Physician Decision|1|||
164009509|NCT00849693|592399670|FG002|Acute Treatment Phase|Physician Decision|2|||
164009510|NCT00849693|592399671|FG003|Acute Treatment Phase|Physician Decision|1|||
164009511|NCT00849693|592399668|FG000|Acute Treatment Phase|Sponsor decision|0|||
164009512|NCT00849693|592399669|FG001|Acute Treatment Phase|Sponsor decision|0|||
164009513|NCT00849693|592399670|FG002|Acute Treatment Phase|Sponsor decision|1|||
164009514|NCT00849693|592399671|FG003|Acute Treatment Phase|Sponsor decision|0|||
164009515|NCT00849693|592399668|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
164009516|NCT00849693|592399669|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
164359228|NCT01528254|593690031|FG001|Overall Study|Adverse Event|44|||
164009517|NCT00849693|592399670|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
164009518|NCT00849693|592399671|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
164009519|NCT00849693|592399668|FG000|Extension Phase|Adverse Event|4|||
164009520|NCT00849693|592399669|FG001|Extension Phase|Adverse Event|6|||
164009521|NCT00849693|592399670|FG002|Extension Phase|Adverse Event|3|||
164009522|NCT00849693|592399671|FG003|Extension Phase|Adverse Event|7|||
164009523|NCT00849693|592399668|FG000|Extension Phase|Lost to Follow-up|7|||
164009524|NCT00849693|592399669|FG001|Extension Phase|Lost to Follow-up|5|||
164009525|NCT00849693|592399670|FG002|Extension Phase|Lost to Follow-up|6|||
164009526|NCT00849693|592399671|FG003|Extension Phase|Lost to Follow-up|6|||
164009527|NCT00849693|592399668|FG000|Extension Phase|Protocol Violation|0|||
164009528|NCT00849693|592399669|FG001|Extension Phase|Protocol Violation|3|||
164009529|NCT00849693|592399670|FG002|Extension Phase|Protocol Violation|2|||
164009530|NCT00849693|592399671|FG003|Extension Phase|Protocol Violation|3|||
164009531|NCT00849693|592399668|FG000|Extension Phase|Withdrawal by Subject|6|||
164359229|NCT01528254|593690030|FG000|Overall Study|Lost to Follow-up|17|||
164359230|NCT01528254|593690031|FG001|Overall Study|Lost to Follow-up|24|||
164359231|NCT01528254|593690030|FG000|Overall Study|Death|13|||
164359232|NCT01528254|593690031|FG001|Overall Study|Death|9|||
164359233|NCT01528254|593690030|FG000|Overall Study|Protocol deviation|9|||
164359234|NCT01528254|593690031|FG001|Overall Study|Protocol deviation|19|||
164359235|NCT01528254|593690030|FG000|Overall Study|New therapy for study indication|8|||
164359236|NCT01528254|593690031|FG001|Overall Study|New therapy for study indication|6|||
164359237|NCT01528254|593690030|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164009532|NCT00849693|592399669|FG001|Extension Phase|Withdrawal by Subject|9|||
164009533|NCT00849693|592399670|FG002|Extension Phase|Withdrawal by Subject|10|||
164009534|NCT00849693|592399671|FG003|Extension Phase|Withdrawal by Subject|15|||
164009535|NCT00849693|592399668|FG000|Extension Phase|Parent or caregiver decision|9|||
164009536|NCT00849693|592399669|FG001|Extension Phase|Parent or caregiver decision|4|||
164009537|NCT00849693|592399670|FG002|Extension Phase|Parent or caregiver decision|10|||
164009538|NCT00849693|592399671|FG003|Extension Phase|Parent or caregiver decision|5|||
164009539|NCT00849693|592399668|FG000|Extension Phase|Physician Decision|1|||
164009540|NCT00849693|592399669|FG001|Extension Phase|Physician Decision|1|||
164009541|NCT00849693|592399670|FG002|Extension Phase|Physician Decision|2|||
164009542|NCT00849693|592399671|FG003|Extension Phase|Physician Decision|0|||
164009543|NCT00849693|592399668|FG000|Extension Phase|Sponsor decision|1|||
164009544|NCT00849693|592399669|FG001|Extension Phase|Sponsor decision|0|||
164009545|NCT00849693|592399670|FG002|Extension Phase|Sponsor decision|0|||
164009546|NCT00849693|592399671|FG003|Extension Phase|Sponsor decision|1|||
164009547|NCT00849693|592399668|FG000|Extension Phase|Lack of Efficacy|2|||
164009548|NCT00849693|592399669|FG001|Extension Phase|Lack of Efficacy|2|||
164009549|NCT00849693|592399670|FG002|Extension Phase|Lack of Efficacy|2|||
164009550|NCT00849693|592399671|FG003|Extension Phase|Lack of Efficacy|1|||
164009551|NCT00098345|592399674|FG000|Overall Study|Adverse Event|7|||
164009552|NCT00098345|592399674|FG000|Overall Study|Withdrawal by Subject|2|||
164091511|NCT00788957|592697959|FG003|Part 2|Death|37|||
164091512|NCT00788957|592697960|FG004|Part 2|Death|0|||
164009553|NCT00098345|592399674|FG000|Overall Study|progression|4|||
164091513|NCT00788957|592697961|FG005|Part 2|Death|0|||
164359238|NCT01528254|593690031|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164359239|NCT01528254|593690030|FG000|Overall Study|Withdrawal by Subject|5|||
164359240|NCT01528254|593690031|FG001|Overall Study|Withdrawal by Subject|4|||
164009554|NCT01183858|592399675|FG000|Overall Study|Death not related to Progressive Disease|5|||
164009555|NCT01183858|592399676|FG001|Overall Study|Death not related to Progressive Disease|6|||
164009556|NCT01183858|592399675|FG000|Overall Study|Adverse Event|14|||
164009557|NCT01183858|592399676|FG001|Overall Study|Adverse Event|11|||
164009558|NCT01183858|592399675|FG000|Overall Study|Investigator's Decision|0|||
164009559|NCT01183858|592399676|FG001|Overall Study|Investigator's Decision|3|||
164009560|NCT01183858|592399675|FG000|Overall Study|Insufficient Therapeutic Response|2|||
164009561|NCT01183858|592399676|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164009562|NCT01183858|592399675|FG000|Overall Study|Refused Treatment|1|||
164009563|NCT01183858|592399676|FG001|Overall Study|Refused Treatment|4|||
164009564|NCT01183858|592399675|FG000|Overall Study|Withdrew Consent|4|||
164009565|NCT01183858|592399676|FG001|Overall Study|Withdrew Consent|4|||
164009566|NCT01183858|592399675|FG000|Overall Study|Discontinued Smoking|3|||
164009567|NCT01183858|592399676|FG001|Overall Study|Discontinued Smoking|1|||
164009568|NCT01183858|592399675|FG000|Overall Study|Protocol Violation|1|||
164009569|NCT01183858|592399676|FG001|Overall Study|Protocol Violation|0|||
164009570|NCT01183858|592399675|FG000|Overall Study|Administrative/Other|6|||
164009571|NCT01183858|592399676|FG001|Overall Study|Administrative/Other|6|||
164009572|NCT01183858|592399675|FG000|Overall Study|Progressive Disease|112|||
164009573|NCT01183858|592399676|FG001|Overall Study|Progressive Disease|115|||
164009574|NCT01183858|592399675|FG000|Overall Study|Death related to Progressive Disease|4|||
164009575|NCT01183858|592399676|FG001|Overall Study|Death related to Progressive Disease|5|||
164009576|NCT01183858|592399675|FG000|Overall Study|Lost to Follow-up|1|||
164009577|NCT01183858|592399676|FG001|Overall Study|Lost to Follow-up|1|||
164009578|NCT00553059|592399677|FG000|Overall Study|Deemed ineligible|1|||
164009579|NCT00553059|592399678|FG001|Overall Study|Deemed ineligible|1|||
164009580|NCT00553059|592399677|FG000|Overall Study|Drug supply not available|0|||
164009581|NCT00553059|592399678|FG001|Overall Study|Drug supply not available|1|||
164009582|NCT00984659|592399679|FG000|2-week Run-in Period|Adverse Event|8|||
164009583|NCT00984659|592399680|FG001|2-week Run-in Period|Adverse Event|0|||
164009584|NCT00984659|592399681|FG002|2-week Run-in Period|Adverse Event|0|||
164009585|NCT00984659|592399682|FG003|2-week Run-in Period|Adverse Event|0|||
164009586|NCT00984659|592399679|FG000|2-week Run-in Period|Protocol Violation|5|||
164009587|NCT00984659|592399680|FG001|2-week Run-in Period|Protocol Violation|0|||
164009588|NCT00984659|592399681|FG002|2-week Run-in Period|Protocol Violation|0|||
164009589|NCT00984659|592399682|FG003|2-week Run-in Period|Protocol Violation|0|||
164009590|NCT00984659|592399679|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
164009591|NCT00984659|592399680|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
164009592|NCT00984659|592399681|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
164009593|NCT00984659|592399682|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
164009594|NCT00984659|592399679|FG000|2-week Run-in Period|Lost to Follow-up|3|||
164009595|NCT00984659|592399680|FG001|2-week Run-in Period|Lost to Follow-up|0|||
164009596|NCT00984659|592399681|FG002|2-week Run-in Period|Lost to Follow-up|0|||
164009597|NCT00984659|592399682|FG003|2-week Run-in Period|Lost to Follow-up|0|||
164009598|NCT00984659|592399679|FG000|2-week Run-in Period|Physician Decision|10|||
164009599|NCT00984659|592399680|FG001|2-week Run-in Period|Physician Decision|0|||
164009600|NCT00984659|592399681|FG002|2-week Run-in Period|Physician Decision|0|||
164009601|NCT00984659|592399682|FG003|2-week Run-in Period|Physician Decision|0|||
164009602|NCT00984659|592399679|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
164009603|NCT00984659|592399680|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
164009604|NCT00984659|592399681|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
164009605|NCT00984659|592399682|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
164009606|NCT00984659|592399679|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
164009607|NCT00984659|592399680|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164009608|NCT00984659|592399681|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164009609|NCT00984659|592399682|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
164009610|NCT00984659|592399679|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
164009611|NCT00984659|592399680|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
164009612|NCT00984659|592399681|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
164091514|NCT00788957|592697956|FG000|Part 2|Lost to Follow-up|0|||
164009613|NCT00984659|592399682|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
164009614|NCT00984659|592399679|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
164009615|NCT00984659|592399680|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
164009616|NCT00984659|592399681|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
164009617|NCT00984659|592399682|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
164009618|NCT00984659|592399679|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
164009619|NCT00984659|592399680|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
164009620|NCT00984659|592399681|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
164009621|NCT00984659|592399682|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
164091515|NCT00788957|592697957|FG001|Part 2|Lost to Follow-up|0|||
164091516|NCT00788957|592697958|FG002|Part 2|Lost to Follow-up|3|||
164091517|NCT00788957|592697959|FG003|Part 2|Lost to Follow-up|0|||
164091518|NCT00788957|592697960|FG004|Part 2|Lost to Follow-up|0|||
164091519|NCT00788957|592697961|FG005|Part 2|Lost to Follow-up|0|||
164091520|NCT00788957|592697956|FG000|Part 2|On-study at time of data cut-off|0|||
164091521|NCT00788957|592697957|FG001|Part 2|On-study at time of data cut-off|1|||
164091522|NCT00788957|592697958|FG002|Part 2|On-study at time of data cut-off|1|||
164091523|NCT00788957|592697959|FG003|Part 2|On-study at time of data cut-off|1|||
164091524|NCT00788957|592697960|FG004|Part 2|On-study at time of data cut-off|0|||
164091525|NCT00788957|592697961|FG005|Part 2|On-study at time of data cut-off|0|||
164091526|NCT00788957|592697956|FG000|Part 3|Withdrawal by Subject|0|||
164091527|NCT00788957|592697957|FG001|Part 3|Withdrawal by Subject|0|||
164091528|NCT00788957|592697958|FG002|Part 3|Withdrawal by Subject|0|||
164091529|NCT00788957|592697959|FG003|Part 3|Withdrawal by Subject|0|||
164091530|NCT00788957|592697960|FG004|Part 3|Withdrawal by Subject|0|||
164091531|NCT00788957|592697961|FG005|Part 3|Withdrawal by Subject|2|||
164091532|NCT00788957|592697956|FG000|Part 3|Death|0|||
164091533|NCT00788957|592697957|FG001|Part 3|Death|0|||
164091534|NCT00788957|592697958|FG002|Part 3|Death|0|||
164091535|NCT00788957|592697959|FG003|Part 3|Death|0|||
164091536|NCT00788957|592697960|FG004|Part 3|Death|8|||
164091537|NCT00788957|592697961|FG005|Part 3|Death|8|||
164091538|NCT00788957|592697956|FG000|Part 3|On-study at time of data cut-off|0|||
164091539|NCT00788957|592697957|FG001|Part 3|On-study at time of data cut-off|0|||
164091540|NCT00788957|592697958|FG002|Part 3|On-study at time of data cut-off|0|||
164091541|NCT00788957|592697959|FG003|Part 3|On-study at time of data cut-off|0|||
164091542|NCT00788957|592697960|FG004|Part 3|On-study at time of data cut-off|1|||
164091543|NCT00788957|592697961|FG005|Part 3|On-study at time of data cut-off|0|||
164091544|NCT00662129|592697962|FG000|Overall Study|Protocol Violation|1|||
164091545|NCT00662129|592697962|FG000|Overall Study|Cancel prior to beginning treatment|1|||
164091546|NCT00662129|592697962|FG000|Overall Study|Ineligible|1|||
164091547|NCT00796510|592697971|FG000|Overall Study|Death|1|||
164091548|NCT00796510|592697972|FG001|Overall Study|Death|0|||
164091549|NCT00796510|592697971|FG000|Overall Study|Study Terminated|2|||
164091550|NCT00796510|592697972|FG001|Overall Study|Study Terminated|0|||
164091551|NCT03072459|592697973|FG000|Overall Study|Device revised/removed|1|||
164091552|NCT03072459|592697973|FG000|Overall Study|Subject not able to return|1|||
164091553|NCT02841709|592699933|FG000|5th Intervention|Adverse Event|2|||
164091554|NCT02841709|592699934|FG001|5th Intervention|Adverse Event|0|||
164091555|NCT02841709|592699935|FG002|5th Intervention|Adverse Event|0|||
164091556|NCT02841709|592699936|FG003|5th Intervention|Adverse Event|0|||
164091557|NCT02841709|592699937|FG004|5th Intervention|Adverse Event|2|||
164091558|NCT01210001|592699938|FG000|Overall Study|Not treated|1|||
164091559|NCT01210001|592699939|FG001|Overall Study|Not treated|0|||
164091560|NCT01210001|592699940|FG002|Overall Study|Not treated|0|||
164091561|NCT01210001|592699938|FG000|Overall Study|Adverse Event|4|||
164091562|NCT01210001|592699939|FG001|Overall Study|Adverse Event|2|||
164091563|NCT01210001|592699940|FG002|Overall Study|Adverse Event|5|||
164091564|NCT01210001|592699938|FG000|Overall Study|Non compliant with protocol|2|||
164091565|NCT01210001|592699939|FG001|Overall Study|Non compliant with protocol|2|||
164091566|NCT01210001|592699940|FG002|Overall Study|Non compliant with protocol|3|||
164091567|NCT01210001|592699938|FG000|Overall Study|Lost to Follow-up|4|||
164091568|NCT01210001|592699939|FG001|Overall Study|Lost to Follow-up|3|||
164091569|NCT01210001|592699940|FG002|Overall Study|Lost to Follow-up|2|||
164091570|NCT01210001|592699938|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
164091571|NCT01210001|592699939|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
164091572|NCT01210001|592699940|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
164091573|NCT01210001|592699938|FG000|Overall Study|Other reason not defined above|2|||
164091574|NCT01210001|592699939|FG001|Overall Study|Other reason not defined above|2|||
164091575|NCT01210001|592699940|FG002|Overall Study|Other reason not defined above|1|||
164091576|NCT04526210|592699951|FG000|Overall Study|Sponsor decision|7|||
164091577|NCT04526210|592699952|FG001|Overall Study|Sponsor decision|5|||
164091578|NCT04526210|592699951|FG000|Overall Study|Withdrawal by Subject|3|||
164091579|NCT04526210|592699952|FG001|Overall Study|Withdrawal by Subject|2|||
164091580|NCT01781637|592699953|FG000|Overall Study|Adverse Event|1|||
164091581|NCT01781637|592699954|FG001|Overall Study|Adverse Event|0|||
164091582|NCT01781637|592699953|FG000|Overall Study|Lack of Efficacy|2|||
164091583|NCT01781637|592699954|FG001|Overall Study|Lack of Efficacy|6|||
164091584|NCT01781637|592699953|FG000|Overall Study|Withdrawal by Subject|1|||
164091585|NCT01781637|592699954|FG001|Overall Study|Withdrawal by Subject|0|||
164091586|NCT02637232|592699955|FG000|Overall Study|Lost to Follow-up|42|||
164091587|NCT02637232|592699955|FG000|Overall Study|Adverse Event|11|||
164091588|NCT02637232|592699955|FG000|Overall Study|patient 's decision|2|||
164091589|NCT02999178|592699956|FG000|Overall Study|Adverse Event|85|||
164091590|NCT02999178|592699957|FG001|Overall Study|Adverse Event|62|||
164091591|NCT02999178|592699956|FG000|Overall Study|Protocol Violation|1|||
164091592|NCT02999178|592699957|FG001|Overall Study|Protocol Violation|2|||
164091593|NCT02999178|592699956|FG000|Overall Study|Lost to Follow-up|0|||
164091594|NCT02999178|592699957|FG001|Overall Study|Lost to Follow-up|2|||
164091595|NCT02999178|592699956|FG000|Overall Study|Withdrawal by Subject|21|||
164009622|NCT00984659|592399679|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
164009623|NCT00984659|592399680|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
164009624|NCT00984659|592399681|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
164009625|NCT00984659|592399682|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
164009626|NCT00984659|592399679|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
163901432|NCT03333109|592009712|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
163901433|NCT03333109|592009710|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
163901434|NCT03333109|592009711|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
164009627|NCT00984659|592399680|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
164009628|NCT00984659|592399681|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
164009629|NCT00984659|592399682|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
164091596|NCT02999178|592699957|FG001|Overall Study|Withdrawal by Subject|21|||
163901435|NCT03333109|592009712|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
163901436|NCT03333109|592009710|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
163901437|NCT03333109|592009711|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
163901438|NCT03333109|592009712|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
163901439|NCT03333109|592009710|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
163901440|NCT03333109|592009711|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
163901441|NCT03333109|592009712|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
163901442|NCT03333109|592009710|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
163901443|NCT03333109|592009711|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
163901444|NCT03333109|592009712|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
163901445|NCT00589875|592009715|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
163901446|NCT00589875|592009715|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
163901447|NCT03598907|592009716|FG000|Overall Study|Physician Decision|14|||
163901448|NCT03598907|592009717|FG001|Overall Study|Physician Decision|19|||
163901449|NCT02678689|592009718|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
163901450|NCT02678689|592009719|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
163901451|NCT05071430|592009723|FG000|Overall Study|Adverse Event|1|||
163901452|NCT05071430|592009724|FG001|Overall Study|Adverse Event|2|||
163901453|NCT05071430|592009723|FG000|Overall Study|Lost to Follow-up|4|||
163901454|NCT05071430|592009724|FG001|Overall Study|Lost to Follow-up|4|||
163901455|NCT05071430|592009723|FG000|Overall Study|Protocol Violation|1|||
163901456|NCT05071430|592009724|FG001|Overall Study|Protocol Violation|0|||
163901457|NCT05071430|592009723|FG000|Overall Study|Withdrawal by Subject|3|||
163901458|NCT05071430|592009724|FG001|Overall Study|Withdrawal by Subject|2|||
163901459|NCT05071430|592009723|FG000|Overall Study|Other|1|||
163901460|NCT05071430|592009724|FG001|Overall Study|Other|1|||
163901461|NCT01958021|592009725|FG000|Treatment|Progressive disease|206|||
163901462|NCT01958021|592009726|FG001|Treatment|Progressive disease|265|||
163901463|NCT01958021|592009725|FG000|Treatment|Adverse Event|38|||
163901464|NCT01958021|592009726|FG001|Treatment|Adverse Event|10|||
163901465|NCT01958021|592009725|FG000|Treatment|Subject/guardian decision|29|||
163901466|NCT01958021|592009726|FG001|Treatment|Subject/guardian decision|25|||
163901467|NCT01958021|592009725|FG000|Treatment|Physician Decision|28|||
163901468|NCT01958021|592009726|FG001|Treatment|Physician Decision|21|||
163901469|NCT01958021|592009725|FG000|Treatment|Death|6|||
163901470|NCT01958021|592009726|FG001|Treatment|Death|1|||
163901471|NCT01958021|592009725|FG000|Treatment|Protocol deviation|3|||
163901472|NCT01958021|592009726|FG001|Treatment|Protocol deviation|1|||
163901473|NCT01958021|592009725|FG000|Treatment|Sponsor decision|24|||
163901474|NCT01958021|592009726|FG001|Treatment|Sponsor decision|11|||
163901475|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
163901476|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
163901477|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Death|1|||
163901478|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Death|0|||
163901479|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
163901480|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
163901481|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
163901482|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
163901483|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
163901484|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
163901485|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
163901486|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
163901487|NCT01958021|592009725|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
163901488|NCT01958021|592009726|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
163901489|NCT00490139|592009727|FG000|Overall Study|Lost to Follow-up|249|||
163901490|NCT00490139|592009728|FG001|Overall Study|Lost to Follow-up|216|||
163901491|NCT00490139|592009729|FG002|Overall Study|Lost to Follow-up|205|||
163901492|NCT00490139|592009730|FG003|Overall Study|Lost to Follow-up|229|||
163901493|NCT00490139|592009727|FG000|Overall Study|Withdrawal by Subject|333|||
164009630|NCT01966731|592399683|FG000|Overall Study|Death|2|||
164009631|NCT01966731|592399683|FG000|Overall Study|Lost to Follow-up|1|||
164009632|NCT01966731|592399683|FG000|Overall Study|Physician Decision|2|||
164009633|NCT01966731|592399683|FG000|Overall Study|Follow up is not complete|600|||
164009634|NCT01966731|592399683|FG000|Overall Study|Screening Failure|29|||
164009635|NCT01966731|592399683|FG000|Overall Study|Found to be ineligible|1|||
164009636|NCT00779038|592399685|FG000|Overall Study|Study Prematurely Terminated|13|||
164009637|NCT02717546|592399689|FG000|Overall Study|Lost to Follow-up|12|||
164009638|NCT00909090|592399690|FG000|Overall Study|Lost to Follow-up|17|||
164009639|NCT00909090|592399691|FG001|Overall Study|Lost to Follow-up|17|||
164009640|NCT02926573|592399693|FG000|Overall Study|Nausea|1|||
164009641|NCT02926573|592399694|FG001|Overall Study|Nausea|0|||
164009642|NCT02926573|592399693|FG000|Overall Study|Remain intubated|2|||
164009643|NCT02926573|592399694|FG001|Overall Study|Remain intubated|2|||
164009644|NCT02926573|592399693|FG000|Overall Study|Change in surgery plan|3|||
164009645|NCT02926573|592399694|FG001|Overall Study|Change in surgery plan|1|||
164009646|NCT02926573|592399693|FG000|Overall Study|Change to outpatient status|5|||
164009647|NCT02926573|592399694|FG001|Overall Study|Change to outpatient status|1|||
164009648|NCT02926573|592399693|FG000|Overall Study|Withdrawal by Subject|0|||
164009649|NCT02926573|592399694|FG001|Overall Study|Withdrawal by Subject|2|||
164009650|NCT02926573|592399693|FG000|Overall Study|Return to operating room|0|||
164009651|NCT02926573|592399694|FG001|Overall Study|Return to operating room|2|||
164009652|NCT02926573|592399693|FG000|Overall Study|Delirium|0|||
164009653|NCT02926573|592399694|FG001|Overall Study|Delirium|1|||
164009654|NCT03633331|592399704|FG000|Overall Study|Withdrawal by Subject|1|||
164009655|NCT01009294|592399705|FG000|Overall Study|Study discontinued by Sponsor|6|||
164009656|NCT03240081|592399706|FG000|Overall Study|Withdrawal by Subject|0|||
164009657|NCT03240081|592399707|FG001|Overall Study|Withdrawal by Subject|2|||
164009658|NCT03240081|592399706|FG000|Overall Study|Lost to Follow-up|0|||
164009659|NCT03240081|592399707|FG001|Overall Study|Lost to Follow-up|1|||
164009660|NCT00949650|592399708|FG000|Overall Study|Progressive disease|188|||
164009661|NCT00949650|592399709|FG001|Overall Study|Progressive disease|19|||
164009662|NCT00949650|592399708|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
164009663|NCT00949650|592399709|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
164009664|NCT00949650|592399708|FG000|Overall Study|Other Adverse Event (AE)|28|||
164009665|NCT00949650|592399709|FG001|Overall Study|Other Adverse Event (AE)|17|||
164009666|NCT00949650|592399708|FG000|Overall Study|Protocol Violation|1|||
164009667|NCT00949650|592399709|FG001|Overall Study|Protocol Violation|4|||
164009668|NCT00949650|592399708|FG000|Overall Study|Refusal to continue medication|7|||
164009669|NCT00949650|592399709|FG001|Overall Study|Refusal to continue medication|11|||
164009670|NCT00949650|592399708|FG000|Overall Study|Not treated|1|||
164009671|NCT00949650|592399709|FG001|Overall Study|Not treated|4|||
164009672|NCT00949650|592399708|FG000|Overall Study|Other not specified above|5|||
164009673|NCT00949650|592399709|FG001|Overall Study|Other not specified above|0|||
164009674|NCT04601272|592399710|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
164009675|NCT04601272|592399711|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
164009676|NCT04601272|592399712|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
164009677|NCT01088412|592399717|FG000|Overall Study|Adverse Event|38|||
164009678|NCT01088412|592399718|FG001|Overall Study|Adverse Event|0|||
164009679|NCT01088412|592399719|FG002|Overall Study|Adverse Event|0|||
164009680|NCT01088412|592399717|FG000|Overall Study|Death|42|||
164009681|NCT01088412|592399718|FG001|Overall Study|Death|6|||
164009682|NCT01088412|592399719|FG002|Overall Study|Death|0|||
164009683|NCT01088412|592399717|FG000|Overall Study|Other Reason per Case Report Form|2089|||
164009684|NCT01088412|592399718|FG001|Overall Study|Other Reason per Case Report Form|103|||
164009685|NCT01088412|592399719|FG002|Overall Study|Other Reason per Case Report Form|9|||
164009686|NCT01088412|592399717|FG000|Overall Study|Withdrawal by Subject|1761|||
164009687|NCT01088412|592399718|FG001|Overall Study|Withdrawal by Subject|25|||
164009688|NCT01088412|592399719|FG002|Overall Study|Withdrawal by Subject|1|||
164009689|NCT01088412|592399717|FG000|Overall Study|Received Another GH Product|79|||
164009690|NCT01088412|592399718|FG001|Overall Study|Received Another GH Product|0|||
164009691|NCT01088412|592399719|FG002|Overall Study|Received Another GH Product|0|||
164009692|NCT01088412|592399717|FG000|Overall Study|Participant Moved|601|||
164009693|NCT01088412|592399718|FG001|Overall Study|Participant Moved|21|||
164009694|NCT01088412|592399719|FG002|Overall Study|Participant Moved|2|||
164009695|NCT01088412|592399717|FG000|Overall Study|Physician Decision|1041|||
164009696|NCT01088412|592399718|FG001|Overall Study|Physician Decision|8|||
164009697|NCT01088412|592399719|FG002|Overall Study|Physician Decision|4|||
164009698|NCT01088412|592399717|FG000|Overall Study|Sponsor Decision|4467|||
164009699|NCT01088412|592399718|FG001|Overall Study|Sponsor Decision|79|||
164009700|NCT01088412|592399719|FG002|Overall Study|Sponsor Decision|23|||
164009701|NCT01088412|592399717|FG000|Overall Study|Third Party Required to Change Brand|487|||
164009702|NCT01088412|592399718|FG001|Overall Study|Third Party Required to Change Brand|0|||
164009703|NCT01088412|592399719|FG002|Overall Study|Third Party Required to Change Brand|0|||
164009704|NCT01088412|592399717|FG000|Overall Study|Lost to Follow-up|3052|||
164009705|NCT01088412|592399718|FG001|Overall Study|Lost to Follow-up|130|||
164009706|NCT01088412|592399719|FG002|Overall Study|Lost to Follow-up|11|||
164009707|NCT01088412|592399717|FG000|Overall Study|Study Summary Not Completed|4360|||
164009708|NCT01088412|592399718|FG001|Overall Study|Study Summary Not Completed|64|||
164009709|NCT01088412|592399719|FG002|Overall Study|Study Summary Not Completed|22|||
164009710|NCT00793104|592399720|FG000|Overall Study|Lost to Follow-up|1|||
164009711|NCT01450137|592399721|FG000|Up to Week 12|Adverse Event|2|||
164009712|NCT01450137|592399722|FG001|Up to Week 12|Adverse Event|1|||
164009713|NCT01450137|592399721|FG000|Up to Week 12|Withdrawal by Subject|0|||
164009714|NCT01450137|592399722|FG001|Up to Week 12|Withdrawal by Subject|2|||
164009715|NCT01450137|592399721|FG000|Week 12 to Study End|Death|0|||
164009716|NCT01450137|592399722|FG001|Week 12 to Study End|Death|1|||
164009717|NCT01450137|592399721|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
164009718|NCT01450137|592399722|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
164009719|NCT01926886|592399723|FG000|Overall Study|Administrative/other|1|||
164009720|NCT01926886|592399724|FG001|Overall Study|Administrative/other|0|||
164009721|NCT01926886|592399723|FG000|Overall Study|Adverse event/intercurrent illness|4|||
164009722|NCT01926886|592399724|FG001|Overall Study|Adverse event/intercurrent illness|0|||
164009723|NCT01926886|592399723|FG000|Overall Study|Disease progression/recurrence|4|||
164009724|NCT01926886|592399724|FG001|Overall Study|Disease progression/recurrence|0|||
164009725|NCT01926886|592399723|FG000|Overall Study|Withdrawal by Subject|15|||
164009726|NCT01926886|592399724|FG001|Overall Study|Withdrawal by Subject|0|||
164009727|NCT01926886|592399723|FG000|Overall Study|Failure to return|3|||
164009728|NCT01926886|592399724|FG001|Overall Study|Failure to return|0|||
164009729|NCT01926886|592399723|FG000|Overall Study|Recurrence of disease|1|||
164009730|NCT01926886|592399724|FG001|Overall Study|Recurrence of disease|0|||
164009731|NCT01926886|592399723|FG000|Overall Study|Progression of disease|2|||
164009732|NCT01926886|592399724|FG001|Overall Study|Progression of disease|0|||
164009733|NCT01926886|592399723|FG000|Overall Study|Death|1|||
164009734|NCT01926886|592399724|FG001|Overall Study|Death|0|||
164009735|NCT01926886|592399723|FG000|Overall Study|Did not cooperate|1|||
164009736|NCT01926886|592399724|FG001|Overall Study|Did not cooperate|0|||
164009737|NCT02986373|592399725|FG000|Overall Study|Adverse Event|4|||
164009738|NCT02986373|592399725|FG000|Overall Study|Lost to Follow-up|1|||
164009739|NCT02986373|592399725|FG000|Overall Study|Withdrawal by Subject|10|||
164009740|NCT02986373|592399725|FG000|Overall Study|Other|24|||
164009741|NCT04800315|592399726|FG000|Randomization|Did not receive study treatment|1|||
164009742|NCT04800315|592399727|FG001|Randomization|Did not receive study treatment|0|||
164009743|NCT04800315|592399728|FG002|Randomization|Did not receive study treatment|0|||
164009744|NCT04800315|592399729|FG003|Randomization|Did not receive study treatment|0|||
164009745|NCT04800315|592399726|FG000|Treatment Period|Adverse Event|4|||
164009746|NCT04800315|592399727|FG001|Treatment Period|Adverse Event|2|||
164009747|NCT04800315|592399728|FG002|Treatment Period|Adverse Event|1|||
164009748|NCT04800315|592399729|FG003|Treatment Period|Adverse Event|2|||
164009749|NCT04800315|592399726|FG000|Treatment Period|Lack of Efficacy|1|||
164009750|NCT04800315|592399727|FG001|Treatment Period|Lack of Efficacy|0|||
164009751|NCT04800315|592399728|FG002|Treatment Period|Lack of Efficacy|0|||
164009752|NCT04800315|592399729|FG003|Treatment Period|Lack of Efficacy|3|||
164009753|NCT04800315|592399726|FG000|Treatment Period|Lost to Follow-up|0|||
164009754|NCT04800315|592399727|FG001|Treatment Period|Lost to Follow-up|1|||
164009755|NCT04800315|592399728|FG002|Treatment Period|Lost to Follow-up|2|||
164009756|NCT04800315|592399729|FG003|Treatment Period|Lost to Follow-up|2|||
164009757|NCT04800315|592399726|FG000|Treatment Period|Withdrawal by participant|0|||
164009758|NCT04800315|592399727|FG001|Treatment Period|Withdrawal by participant|0|||
164009759|NCT04800315|592399728|FG002|Treatment Period|Withdrawal by participant|0|||
164009760|NCT04800315|592399729|FG003|Treatment Period|Withdrawal by participant|4|||
164009761|NCT04800315|592399726|FG000|Treatment Period|Other Reasons|0|||
164009762|NCT04800315|592399727|FG001|Treatment Period|Other Reasons|2|||
164009763|NCT04800315|592399728|FG002|Treatment Period|Other Reasons|0|||
164009764|NCT04800315|592399729|FG003|Treatment Period|Other Reasons|1|||
164009765|NCT00753922|592399730|FG000|Overall Study|Lost to Follow-up|155|||
164009766|NCT00753922|592399731|FG001|Overall Study|Lost to Follow-up|24|||
164009767|NCT00753922|592399732|FG002|Overall Study|Lost to Follow-up|28|||
164009768|NCT00753922|592399733|FG003|Overall Study|Lost to Follow-up|5|||
164009769|NCT00753922|592399730|FG000|Overall Study|Withdrawal by Subject|9|||
164009770|NCT00753922|592399731|FG001|Overall Study|Withdrawal by Subject|11|||
164009771|NCT00753922|592399732|FG002|Overall Study|Withdrawal by Subject|4|||
164009772|NCT00753922|592399733|FG003|Overall Study|Withdrawal by Subject|2|||
164009773|NCT00753922|592399730|FG000|Overall Study|Patient Non-compliance|55|||
164009774|NCT00753922|592399731|FG001|Overall Study|Patient Non-compliance|22|||
164009775|NCT00753922|592399732|FG002|Overall Study|Patient Non-compliance|14|||
164009776|NCT00753922|592399733|FG003|Overall Study|Patient Non-compliance|11|||
164009777|NCT00753922|592399730|FG000|Overall Study|Patients Not Completing Visit|11|||
164009778|NCT00753922|592399731|FG001|Overall Study|Patients Not Completing Visit|0|||
164009779|NCT00753922|592399732|FG002|Overall Study|Patients Not Completing Visit|1|||
164009780|NCT00753922|592399733|FG003|Overall Study|Patients Not Completing Visit|0|||
164009781|NCT00753922|592399730|FG000|Overall Study|Death|2|||
164009782|NCT00753922|592399731|FG001|Overall Study|Death|23|||
164009783|NCT00753922|592399732|FG002|Overall Study|Death|2|||
164009784|NCT00753922|592399733|FG003|Overall Study|Death|1|||
164009785|NCT00753922|592399730|FG000|Overall Study|Discontinuation Due to Explantation|14|||
164009786|NCT00753922|592399731|FG001|Overall Study|Discontinuation Due to Explantation|14|||
164009787|NCT00753922|592399732|FG002|Overall Study|Discontinuation Due to Explantation|14|||
164009788|NCT00753922|592399733|FG003|Overall Study|Discontinuation Due to Explantation|4|||
164009789|NCT02983292|592399738|FG000|Overall Study|Participant unwell & cannot travel|2|||
164009790|NCT02983292|592399738|FG000|Overall Study|Lost to Follow-up|3|||
164009791|NCT02983292|592399738|FG000|Overall Study|Participant withdrew consent|2|||
164009792|NCT02983292|592399738|FG000|Overall Study|Revision|7|||
164009793|NCT02983292|592399738|FG000|Overall Study|Death|1|||
164009794|NCT02983292|592399738|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
164009795|NCT02983292|592399738|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
164009796|NCT02983292|592399738|FG000|Overall Study|Participant relocation|1|||
164009797|NCT00857246|592399739|FG000|Induction Regimen|Adverse Event|1|||
164009798|NCT00857246|592399739|FG000|Induction Regimen|disease-related complications|1|||
164009799|NCT00857246|592399739|FG000|Induction Regimen|Withdrawal by Subject|1|||
164009800|NCT00857246|592399739|FG000|Surgery (Curative)|disease progression|6|||
164009801|NCT00857246|592399739|FG000|ChemoRT|Withdrawal by Subject|1|||
164009802|NCT00857246|592399739|FG000|ChemoRT|Adverse Event|2|||
164009803|NCT01266148|592401299|FG000|Overall Study|Adverse Event|2|||
164009804|NCT01266148|592401300|FG001|Overall Study|Adverse Event|0|||
164009805|NCT01266148|592401299|FG000|Overall Study|Ongoing rejection|1|||
164009806|NCT01266148|592401300|FG001|Overall Study|Ongoing rejection|0|||
164009807|NCT01266148|592401299|FG000|Overall Study|2 2R rejections|1|||
164009808|NCT01266148|592401300|FG001|Overall Study|2 2R rejections|0|||
164009809|NCT01266148|592401299|FG000|Overall Study|Death|2|||
164009810|NCT01266148|592401300|FG001|Overall Study|Death|3|||
164009811|NCT01266148|592401299|FG000|Overall Study|missing mGFR value + AE|1|||
164009812|NCT01266148|592401300|FG001|Overall Study|missing mGFR value + AE|0|||
164009813|NCT04168645|592401302|FG000|Overall Study|Lost to Follow-up|23|||
164009814|NCT04168645|592401303|FG001|Overall Study|Lost to Follow-up|28|||
164009815|NCT04168645|592401304|FG002|Overall Study|Lost to Follow-up|15|||
164009816|NCT04168645|592401305|FG003|Overall Study|Lost to Follow-up|12|||
164009817|NCT04168645|592401302|FG000|Overall Study|Death|1|||
164009818|NCT04168645|592401303|FG001|Overall Study|Death|1|||
164009819|NCT04168645|592401304|FG002|Overall Study|Death|0|||
164009820|NCT04168645|592401305|FG003|Overall Study|Death|0|||
164009821|NCT04168645|592401302|FG000|Overall Study|Withdrawal by Subject|5|||
164009822|NCT04168645|592401303|FG001|Overall Study|Withdrawal by Subject|2|||
164009823|NCT04168645|592401304|FG002|Overall Study|Withdrawal by Subject|2|||
164009824|NCT04168645|592401305|FG003|Overall Study|Withdrawal by Subject|2|||
164009825|NCT04168645|592401302|FG000|Overall Study|Administrative Withdrawal|3|||
164009826|NCT04168645|592401303|FG001|Overall Study|Administrative Withdrawal|1|||
164009827|NCT04168645|592401304|FG002|Overall Study|Administrative Withdrawal|1|||
164009828|NCT04168645|592401305|FG003|Overall Study|Administrative Withdrawal|3|||
164009829|NCT01978912|592401313|FG000|Overall Study|Adverse Event|0|||
164009830|NCT01978912|592401314|FG001|Overall Study|Adverse Event|1|||
164009831|NCT01978912|592401315|FG002|Overall Study|Adverse Event|0|||
164009832|NCT01978912|592401316|FG003|Overall Study|Adverse Event|0|||
164009833|NCT01978912|592401313|FG000|Overall Study|Lost to Follow-up|1|||
164009834|NCT01978912|592401314|FG001|Overall Study|Lost to Follow-up|1|||
164009835|NCT01978912|592401315|FG002|Overall Study|Lost to Follow-up|0|||
164009836|NCT01978912|592401316|FG003|Overall Study|Lost to Follow-up|1|||
164009837|NCT01978912|592401313|FG000|Overall Study|Withdrawal by Subject|1|||
164009838|NCT01978912|592401314|FG001|Overall Study|Withdrawal by Subject|0|||
164009839|NCT01978912|592401315|FG002|Overall Study|Withdrawal by Subject|2|||
164009840|NCT01978912|592401316|FG003|Overall Study|Withdrawal by Subject|2|||
164009841|NCT01978912|592401313|FG000|Overall Study|Lumbar Surgery|1|||
164009842|NCT01978912|592401314|FG001|Overall Study|Lumbar Surgery|0|||
164009843|NCT01978912|592401315|FG002|Overall Study|Lumbar Surgery|1|||
164009844|NCT01978912|592401316|FG003|Overall Study|Lumbar Surgery|0|||
164009845|NCT01978912|592401313|FG000|Overall Study|Intradiscal Steroid Injection|0|||
164009846|NCT01978912|592401314|FG001|Overall Study|Intradiscal Steroid Injection|1|||
164009847|NCT01978912|592401315|FG002|Overall Study|Intradiscal Steroid Injection|0|||
164009848|NCT01978912|592401316|FG003|Overall Study|Intradiscal Steroid Injection|0|||
164009849|NCT00224107|592401317|FG000|Overall Study|Adverse Event|20|||
164009850|NCT00224107|592401318|FG001|Overall Study|Adverse Event|6|||
164009851|NCT00224107|592401317|FG000|Overall Study|Protocol Violation|2|||
164009852|NCT00224107|592401318|FG001|Overall Study|Protocol Violation|3|||
164009853|NCT00224107|592401317|FG000|Overall Study|Withdrawal by Subject|1|||
164009854|NCT00224107|592401318|FG001|Overall Study|Withdrawal by Subject|4|||
164009855|NCT00224107|592401317|FG000|Overall Study|Lack of Efficacy|2|||
164009856|NCT00224107|592401318|FG001|Overall Study|Lack of Efficacy|0|||
164009857|NCT00224107|592401317|FG000|Overall Study|Lost to Follow-up|4|||
164091597|NCT02999178|592699956|FG000|Overall Study|Other reason not defined above|7|||
164091598|NCT02999178|592699957|FG001|Overall Study|Other reason not defined above|13|||
164091599|NCT00090857|592699958|FG000|Overall Study|Lost to Follow-up|0|||
164091600|NCT00090857|592699959|FG001|Overall Study|Lost to Follow-up|1|||
164091601|NCT00090857|592699958|FG000|Overall Study|Withdrawal by Subject|2|||
164091602|NCT00090857|592699959|FG001|Overall Study|Withdrawal by Subject|0|||
164091603|NCT00090857|592699958|FG000|Overall Study|Adverse Event|2|||
164091604|NCT00090857|592699959|FG001|Overall Study|Adverse Event|2|||
164091605|NCT05097326|592699961|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
164091606|NCT05097326|592699962|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
164091607|NCT01244126|592699964|FG000|Overall Study|Protocol Violation|3|||
164091608|NCT01244126|592699965|FG001|Overall Study|Protocol Violation|3|||
164091609|NCT01244126|592699966|FG002|Overall Study|Protocol Violation|9|||
164091610|NCT00630305|592699967|FG000|Overall Study|Withdrawal by Subject|1|||
164091611|NCT00630305|592699967|FG000|Overall Study|Inability to insert contact lens|1|||
164091612|NCT01085045|592699968|FG000|Part A|Withdrawal by Subject|4|||
164091613|NCT01085045|592699968|FG000|Part A|Adverse Event|6|||
164091614|NCT01085045|592699968|FG000|Part A|Protocol Violation|1|||
164091615|NCT01085045|592699968|FG000|Part A|Protocol Specified Criteria|7|||
164091616|NCT01085045|592699968|FG000|Part B|Withdrawal by Subject|2|||
164091617|NCT01085045|592699968|FG000|Part B|Protocol Specified Criteria|6|||
164091618|NCT01085045|592699968|FG000|Part B|Lost to Follow-up|1|||
164091619|NCT01085045|592699968|FG000|Part B|Adverse Event|6|||
164091620|NCT00863746|592699969|FG000|Treatment|Not treated|4|||
164091621|NCT00863746|592699970|FG001|Treatment|Not treated|2|||
164091622|NCT00863746|592699969|FG000|Treatment|Adverse Event|41|||
164091623|NCT00863746|592699970|FG001|Treatment|Adverse Event|16|||
164091624|NCT00863746|592699969|FG000|Treatment|non-compliant with study medication|4|||
164091625|NCT00863746|592699970|FG001|Treatment|non-compliant with study medication|0|||
164091626|NCT00863746|592699969|FG000|Treatment|Consent withdrawn|15|||
164091627|NCT00863746|592699970|FG001|Treatment|Consent withdrawn|14|||
164091628|NCT00863746|592699969|FG000|Treatment|Lost to Follow-up|1|||
164091629|NCT00863746|592699970|FG001|Treatment|Lost to Follow-up|0|||
164091630|NCT00863746|592699969|FG000|Treatment|Protocol Violation|5|||
164091631|NCT00863746|592699970|FG001|Treatment|Protocol Violation|3|||
164091632|NCT00863746|592699969|FG000|Treatment|Other|1|||
164091633|NCT00863746|592699970|FG001|Treatment|Other|0|||
164091634|NCT00863746|592699969|FG000|Survival Follow up|Death|244|||
164091635|NCT00863746|592699970|FG001|Survival Follow up|Death|271|||
164091636|NCT00863746|592699969|FG000|Survival Follow up|Lost to Follow-up|2|||
164091637|NCT00863746|592699970|FG001|Survival Follow up|Lost to Follow-up|1|||
164091638|NCT00863746|592699969|FG000|Survival Follow up|Consent Withdrawn|7|||
164091639|NCT00863746|592699970|FG001|Survival Follow up|Consent Withdrawn|8|||
164091640|NCT02924038|592699971|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
164091641|NCT02924038|592699972|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
164091642|NCT02395822|592699973|FG000|Overall Study|Withdrawal by Subject|1|||
164091643|NCT02395822|592699973|FG000|Overall Study|Death|1|||
164091644|NCT03292653|592699974|FG000|Overall Study|Adverse Event|0|||
164091645|NCT03292653|592699975|FG001|Overall Study|Adverse Event|0|||
164091646|NCT03292653|592699976|FG002|Overall Study|Adverse Event|1|||
164091647|NCT03292653|592699974|FG000|Overall Study|Did not Receive Treatment|1|||
164091648|NCT03292653|592699975|FG001|Overall Study|Did not Receive Treatment|0|||
164091649|NCT03292653|592699976|FG002|Overall Study|Did not Receive Treatment|0|||
164091650|NCT02446132|592699979|FG000|Overall Study|Adverse Event|10|||
164091651|NCT02446132|592699980|FG001|Overall Study|Adverse Event|27|||
164091652|NCT02446132|592699981|FG002|Overall Study|Adverse Event|27|||
164091653|NCT02446132|592699979|FG000|Overall Study|Death|2|||
164091654|NCT02446132|592699980|FG001|Overall Study|Death|13|||
164091655|NCT02446132|592699981|FG002|Overall Study|Death|10|||
164091656|NCT02446132|592699979|FG000|Overall Study|Lack of Efficacy|1|||
164091657|NCT02446132|592699980|FG001|Overall Study|Lack of Efficacy|10|||
164091658|NCT02446132|592699981|FG002|Overall Study|Lack of Efficacy|6|||
164091659|NCT02446132|592699979|FG000|Overall Study|Lost to Follow-up|2|||
164091660|NCT02446132|592699980|FG001|Overall Study|Lost to Follow-up|4|||
164091661|NCT02446132|592699981|FG002|Overall Study|Lost to Follow-up|5|||
164091662|NCT02446132|592699979|FG000|Overall Study|Non-compliance With Study Drug|2|||
164091663|NCT02446132|592699980|FG001|Overall Study|Non-compliance With Study Drug|2|||
164091664|NCT02446132|592699981|FG002|Overall Study|Non-compliance With Study Drug|3|||
164091665|NCT02446132|592699979|FG000|Overall Study|Physician Decision|1|||
164091666|NCT02446132|592699980|FG001|Overall Study|Physician Decision|8|||
164091667|NCT02446132|592699981|FG002|Overall Study|Physician Decision|13|||
164091668|NCT02446132|592699979|FG000|Overall Study|Protocol Deviation|0|||
164091669|NCT02446132|592699980|FG001|Overall Study|Protocol Deviation|0|||
164091670|NCT02446132|592699981|FG002|Overall Study|Protocol Deviation|1|||
164091671|NCT02446132|592699979|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
164112585|NCT01456962|592774033|FG000|Overall Study|Lost to Follow-up|2|||
163901494|NCT00490139|592009728|FG001|Overall Study|Withdrawal by Subject|322|||
164009858|NCT00224107|592401318|FG001|Overall Study|Lost to Follow-up|0|||
164009859|NCT00224107|592401317|FG000|Overall Study|Physician Decision|1|||
164009860|NCT00224107|592401318|FG001|Overall Study|Physician Decision|0|||
164009861|NCT00224107|592401317|FG000|Overall Study|Other|1|||
164009862|NCT00224107|592401318|FG001|Overall Study|Other|1|||
164009863|NCT01408537|592401321|FG000|Overall Study|Withdrawal by Subject|2|||
164009864|NCT01408537|592401321|FG000|Overall Study|Protocol Violation|3|||
164009865|NCT01408537|592401321|FG000|Overall Study|Lost to Follow-up|3|||
164009866|NCT01295905|592401328|FG000|Overall Study|Did not meet inclusion criteria|1|||
164009867|NCT01295905|592401329|FG001|Overall Study|Did not meet inclusion criteria|0|||
164009868|NCT01295905|592401328|FG000|Overall Study|Met exclusion criteria|1|||
164009869|NCT01295905|592401329|FG001|Overall Study|Met exclusion criteria|0|||
164009870|NCT03707977|592401330|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
164009871|NCT03707977|592401331|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
164009872|NCT03707977|592401332|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
164009873|NCT03707977|592401330|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
164009874|NCT03707977|592401331|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
164009875|NCT03707977|592401332|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
164009876|NCT03069690|592401333|FG000|Pregnancy Intervention|Pregnancy loss|9|||
164009877|NCT03069690|592401334|FG001|Pregnancy Intervention|Pregnancy loss|4|||
164009878|NCT03069690|592401335|FG002|Pregnancy Intervention|Pregnancy loss|0|||
164009879|NCT03069690|592401336|FG003|Pregnancy Intervention|Pregnancy loss|0|||
164009880|NCT03069690|592401337|FG004|Pregnancy Intervention|Pregnancy loss|0|||
164009881|NCT03069690|592401338|FG005|Pregnancy Intervention|Pregnancy loss|0|||
164009882|NCT03069690|592401333|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
164009883|NCT03069690|592401334|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
164009884|NCT03069690|592401335|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
164009885|NCT03069690|592401336|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
164009886|NCT03069690|592401337|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
164009887|NCT03069690|592401338|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
164009888|NCT03069690|592401333|FG000|Postpartum Intervention|Lost to Follow-up|0|||
163901495|NCT00490139|592009729|FG002|Overall Study|Withdrawal by Subject|396|||
163901496|NCT00490139|592009730|FG003|Overall Study|Withdrawal by Subject|295|||
163901497|NCT00490139|592009727|FG000|Overall Study|Patient did not sign ICF 12|169|||
163901498|NCT00490139|592009728|FG001|Overall Study|Patient did not sign ICF 12|176|||
163901499|NCT00490139|592009729|FG002|Overall Study|Patient did not sign ICF 12|139|||
163901500|NCT00490139|592009730|FG003|Overall Study|Patient did not sign ICF 12|167|||
163901501|NCT00490139|592009727|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
163901502|NCT00490139|592009728|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
163901503|NCT00490139|592009729|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
163901504|NCT00490139|592009730|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
163901505|NCT00490139|592009727|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
163901506|NCT00490139|592009728|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
163901507|NCT00490139|592009729|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
163901508|NCT00490139|592009730|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
163901509|NCT00490139|592009727|FG000|Overall Study|Other reasons as defined per protocol|98|||
163901510|NCT00490139|592009728|FG001|Overall Study|Other reasons as defined per protocol|84|||
163901511|NCT00490139|592009729|FG002|Overall Study|Other reasons as defined per protocol|82|||
164009889|NCT03069690|592401334|FG001|Postpartum Intervention|Lost to Follow-up|0|||
164009890|NCT03069690|592401335|FG002|Postpartum Intervention|Lost to Follow-up|5|||
163901512|NCT00490139|592009730|FG003|Overall Study|Other reasons as defined per protocol|105|||
164091672|NCT02446132|592699980|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
164091673|NCT02446132|592699981|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
164091674|NCT02446132|592699979|FG000|Overall Study|Study Terminated by Sponsor|4|||
164091675|NCT02446132|592699980|FG001|Overall Study|Study Terminated by Sponsor|35|||
164091676|NCT02446132|592699981|FG002|Overall Study|Study Terminated by Sponsor|58|||
164091677|NCT02446132|592699979|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
164091678|NCT02446132|592699980|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
164091679|NCT02446132|592699981|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
164091680|NCT02446132|592699979|FG000|Overall Study|Withdrawal by Subject|11|||
164091681|NCT02446132|592699980|FG001|Overall Study|Withdrawal by Subject|29|||
164091682|NCT02446132|592699981|FG002|Overall Study|Withdrawal by Subject|25|||
164091683|NCT02446132|592699979|FG000|Overall Study|Reason not Specified|4|||
164091684|NCT02446132|592699980|FG001|Overall Study|Reason not Specified|16|||
164091685|NCT02446132|592699981|FG002|Overall Study|Reason not Specified|10|||
164091686|NCT02446132|592699979|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
164091687|NCT02446132|592699980|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
164091688|NCT02446132|592699981|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
164091689|NCT03444038|592699982|FG000|Overall Study|Adverse Event|12|||
164091690|NCT03444038|592699982|FG000|Overall Study|Withdrawal by Subject|7|||
164091691|NCT03444038|592699982|FG000|Overall Study|Lost to Follow-up|1|||
164091692|NCT03444038|592699982|FG000|Overall Study|Physician Decision|2|||
164091693|NCT03444038|592699982|FG000|Overall Study|Lack of Efficacy|7|||
164091694|NCT02720510|592699994|FG000|Overall Study|Study Terminated by the sponsor|2|||
164091695|NCT02720510|592699995|FG001|Overall Study|Study Terminated by the sponsor|0|||
164091696|NCT02720510|592699994|FG000|Overall Study|Adverse Event|0|||
164091697|NCT02720510|592699995|FG001|Overall Study|Adverse Event|1|||
164091698|NCT02720510|592699994|FG000|Overall Study|Physician Decision|1|||
164091699|NCT02720510|592699995|FG001|Overall Study|Physician Decision|2|||
164091700|NCT01153984|592699996|FG000|Overall Study|Withdrawal by Subject|1|||
164091701|NCT01153984|592699996|FG000|Overall Study|Adverse Event|1|||
164091702|NCT02460159|592699997|FG000|Overall Study|Adverse Event|4|||
164091703|NCT02460159|592699998|FG001|Overall Study|Adverse Event|1|||
164091704|NCT02460159|592699997|FG000|Overall Study|Withdrawal by Subject|2|||
164091705|NCT02460159|592699998|FG001|Overall Study|Withdrawal by Subject|0|||
164091706|NCT00084084|592700003|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
164091707|NCT00084084|592700003|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
164091708|NCT01531205|592700007|FG000|Overall Study|Did not proceed to surgery|1|||
164091709|NCT02465567|592700008|FG000|Overall Study|Adverse Event|118|||
164091710|NCT02465567|592700009|FG001|Overall Study|Adverse Event|113|||
164091711|NCT02465567|592700010|FG002|Overall Study|Adverse Event|147|||
164091712|NCT02465567|592700011|FG003|Overall Study|Adverse Event|138|||
164091713|NCT02465567|592700008|FG000|Overall Study|Lack of Efficacy|103|||
164091714|NCT02465567|592700009|FG001|Overall Study|Lack of Efficacy|102|||
164091715|NCT02465567|592700010|FG002|Overall Study|Lack of Efficacy|171|||
164091716|NCT02465567|592700011|FG003|Overall Study|Lack of Efficacy|135|||
164091717|NCT02465567|592700008|FG000|Overall Study|Withdrawal by Subject|104|||
164091718|NCT02465567|592700009|FG001|Overall Study|Withdrawal by Subject|94|||
164091719|NCT02465567|592700010|FG002|Overall Study|Withdrawal by Subject|123|||
164091720|NCT02465567|592700011|FG003|Overall Study|Withdrawal by Subject|130|||
164091721|NCT02465567|592700008|FG000|Overall Study|Physician Decision|23|||
164091722|NCT02465567|592700009|FG001|Overall Study|Physician Decision|33|||
164091723|NCT02465567|592700010|FG002|Overall Study|Physician Decision|38|||
164091724|NCT02465567|592700011|FG003|Overall Study|Physician Decision|28|||
164091725|NCT02465567|592700008|FG000|Overall Study|Major Protocol Deviation|24|||
164091726|NCT02465567|592700009|FG001|Overall Study|Major Protocol Deviation|26|||
164091727|NCT02465567|592700010|FG002|Overall Study|Major Protocol Deviation|22|||
164091728|NCT02465567|592700011|FG003|Overall Study|Major Protocol Deviation|25|||
164091729|NCT02465567|592700008|FG000|Overall Study|Lost to Follow-up|25|||
164091730|NCT02465567|592700009|FG001|Overall Study|Lost to Follow-up|21|||
164091731|NCT02465567|592700010|FG002|Overall Study|Lost to Follow-up|19|||
164091732|NCT02465567|592700011|FG003|Overall Study|Lost to Follow-up|15|||
164091733|NCT02465567|592700008|FG000|Overall Study|Protocol Specified Criteria|20|||
164091734|NCT02465567|592700009|FG001|Overall Study|Protocol Specified Criteria|10|||
164091735|NCT02465567|592700010|FG002|Overall Study|Protocol Specified Criteria|9|||
164091736|NCT02465567|592700011|FG003|Overall Study|Protocol Specified Criteria|12|||
164091737|NCT02465567|592700008|FG000|Overall Study|Administrative Reasons|12|||
164091738|NCT02465567|592700009|FG001|Overall Study|Administrative Reasons|9|||
163901513|NCT00754325|592011358|FG000|Initial Treatment|Continuing Active Treatment|4|||
164091739|NCT02465567|592700010|FG002|Overall Study|Administrative Reasons|11|||
164091740|NCT02465567|592700011|FG003|Overall Study|Administrative Reasons|5|||
164091741|NCT02465567|592700008|FG000|Overall Study|Randomized but not treated|1|||
164091742|NCT02465567|592700009|FG001|Overall Study|Randomized but not treated|5|||
164091743|NCT02465567|592700010|FG002|Overall Study|Randomized but not treated|4|||
164091744|NCT02465567|592700011|FG003|Overall Study|Randomized but not treated|5|||
164009891|NCT03069690|592401336|FG003|Postpartum Intervention|Lost to Follow-up|5|||
164009892|NCT03069690|592401337|FG004|Postpartum Intervention|Lost to Follow-up|2|||
164009893|NCT03069690|592401338|FG005|Postpartum Intervention|Lost to Follow-up|4|||
164009894|NCT02564120|592401339|FG000|Overall Study|Did not return release forms|160|||
164009895|NCT02564120|592401339|FG000|Overall Study|Death|58|||
164009896|NCT02564120|592401339|FG000|Overall Study|Withdrawal by Subject|204|||
164009897|NCT02564120|592401339|FG000|Overall Study|Other medical condition|24|||
164009898|NCT03842709|592401340|FG000|Overall Study|Withdrawal by Subject|3|||
164009899|NCT03842709|592401341|FG001|Overall Study|Withdrawal by Subject|3|||
164009900|NCT03842709|592401340|FG000|Overall Study|Lost to Follow-up|1|||
164009901|NCT03842709|592401341|FG001|Overall Study|Lost to Follow-up|0|||
164009902|NCT00641147|592401342|FG000|Completed 4 Months.|Physician Decision|1|||
164009903|NCT00641147|592401343|FG001|Completed 4 Months.|Physician Decision|0|||
164009904|NCT00641147|592401342|FG000|Completed 4 Months.|Adverse Event|1|||
164009905|NCT00641147|592401343|FG001|Completed 4 Months.|Adverse Event|0|||
164009906|NCT00641147|592401342|FG000|Completed 8 Months.|Physician Decision|2|||
164009907|NCT00641147|592401343|FG001|Completed 8 Months.|Physician Decision|1|||
164009908|NCT00641147|592401342|FG000|Completed 8 Months.|non compliance|1|||
164009909|NCT00641147|592401343|FG001|Completed 8 Months.|non compliance|0|||
164009910|NCT00641147|592401342|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
164009911|NCT00641147|592401343|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
164009912|NCT00641147|592401342|FG000|Completed 12 Months.|Physician Decision|1|||
164009913|NCT00641147|592401343|FG001|Completed 12 Months.|Physician Decision|1|||
164009914|NCT00641147|592401342|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
164009915|NCT00641147|592401343|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
164009916|NCT00641147|592401342|FG000|Completed 16 Months.|Physician Decision|1|||
164009917|NCT00641147|592401343|FG001|Completed 16 Months.|Physician Decision|0|||
164009918|NCT00641147|592401342|FG000|Completed 16 Months.|Lost to Follow-up|1|||
164009919|NCT00641147|592401343|FG001|Completed 16 Months.|Lost to Follow-up|0|||
164009920|NCT00791128|592401344|FG000|Overall Study|Adverse Event|4|||
164009921|NCT00791128|592401344|FG000|Overall Study|Device migration|2|||
164009922|NCT00791128|592401344|FG000|Overall Study|non-compliance by subject|2|||
164009923|NCT00791128|592401344|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
164009924|NCT01629667|592401345|FG000|Overall Study|Lost to Follow-up|0|||
164009925|NCT01629667|592401346|FG001|Overall Study|Lost to Follow-up|1|||
164009926|NCT01629667|592401347|FG002|Overall Study|Lost to Follow-up|1|||
164009927|NCT01629667|592401345|FG000|Overall Study|Withdrawal by Subject|31|||
164009928|NCT01629667|592401346|FG001|Overall Study|Withdrawal by Subject|20|||
164009929|NCT01629667|592401347|FG002|Overall Study|Withdrawal by Subject|28|||
164009930|NCT01629667|592401345|FG000|Overall Study|Death|1|||
164009931|NCT01629667|592401346|FG001|Overall Study|Death|5|||
164009932|NCT01629667|592401347|FG002|Overall Study|Death|3|||
164009933|NCT01629667|592401345|FG000|Overall Study|Randomized, not treated|2|||
164009934|NCT01629667|592401346|FG001|Overall Study|Randomized, not treated|1|||
164009935|NCT01629667|592401347|FG002|Overall Study|Randomized, not treated|0|||
164009936|NCT01629667|592401345|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
164009937|NCT01629667|592401346|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
164009938|NCT01629667|592401347|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
164009939|NCT01629667|592401345|FG000|Overall Study|Requiring lung transplant|2|||
164009940|NCT01629667|592401346|FG001|Overall Study|Requiring lung transplant|1|||
164009941|NCT01629667|592401347|FG002|Overall Study|Requiring lung transplant|3|||
164009942|NCT01629667|592401345|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
164009943|NCT01629667|592401346|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
164009944|NCT01629667|592401347|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
164009945|NCT01629667|592401345|FG000|Overall Study|Started other medicine|1|||
164009946|NCT01629667|592401346|FG001|Overall Study|Started other medicine|0|||
164009947|NCT01629667|592401347|FG002|Overall Study|Started other medicine|1|||
164009948|NCT01629667|592401345|FG000|Overall Study|Site error in safety follow-up|0|||
164009949|NCT01629667|592401346|FG001|Overall Study|Site error in safety follow-up|0|||
164009950|NCT01629667|592401347|FG002|Overall Study|Site error in safety follow-up|1|||
164009951|NCT01629667|592401345|FG000|Overall Study|Enrolled in another clinical study|0|||
164009952|NCT01629667|592401346|FG001|Overall Study|Enrolled in another clinical study|1|||
164009953|NCT01629667|592401347|FG002|Overall Study|Enrolled in another clinical study|0|||
164009954|NCT01629667|592401345|FG000|Overall Study|Code break|1|||
164009955|NCT01629667|592401346|FG001|Overall Study|Code break|0|||
164009956|NCT01629667|592401347|FG002|Overall Study|Code break|0|||
164009957|NCT00592683|592401349|FG000|Overall Study|Found ineligible|0|||
164112586|NCT01456962|592774034|FG001|Overall Study|Lost to Follow-up|1|||
164009958|NCT00592683|592401350|FG001|Overall Study|Found ineligible|1|||
164009959|NCT00592683|592401349|FG000|Overall Study|Withdrawal by Subject|1|||
164009960|NCT00592683|592401350|FG001|Overall Study|Withdrawal by Subject|0|||
164009961|NCT00592683|592401349|FG000|Overall Study|Adverse Event|0|||
164009962|NCT00592683|592401350|FG001|Overall Study|Adverse Event|2|||
164009963|NCT00592683|592401349|FG000|Overall Study|Protocol Violation|1|||
164009964|NCT00592683|592401350|FG001|Overall Study|Protocol Violation|0|||
164009965|NCT00592683|592401349|FG000|Overall Study|Study drug expired|1|||
164009966|NCT00592683|592401350|FG001|Overall Study|Study drug expired|0|||
164009967|NCT00592683|592401349|FG000|Overall Study|Other|1|||
164009968|NCT00592683|592401350|FG001|Overall Study|Other|0|||
164009969|NCT00592683|592401349|FG000|Overall Study|Lost to Follow-up|0|||
164009970|NCT00592683|592401350|FG001|Overall Study|Lost to Follow-up|1|||
164009971|NCT00201201|592401351|FG000|Overall Study|Death|0|||
164009972|NCT00201201|592401352|FG001|Overall Study|Death|2|||
164009973|NCT00201201|592401351|FG000|Overall Study|Withdrawal by Subject|5|||
164009974|NCT00201201|592401352|FG001|Overall Study|Withdrawal by Subject|5|||
164009975|NCT00891657|592401358|FG000|Overall Study|Withdrawal by Subject|1|||
164009976|NCT00891657|592401359|FG001|Overall Study|Withdrawal by Subject|1|||
164009977|NCT00537823|592401369|FG000|Overall Study|Adverse Event|2|||
164009978|NCT00537823|592401370|FG001|Overall Study|Adverse Event|0|||
164009979|NCT03455543|592401371|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
164009980|NCT03455543|592401372|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
164009981|NCT03455543|592401373|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
164009982|NCT03455543|592401371|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
164009983|NCT03455543|592401372|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
164009984|NCT03455543|592401373|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
164009985|NCT03455543|592401371|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
164009986|NCT03455543|592401372|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
164009987|NCT03455543|592401373|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
164009988|NCT03455543|592401371|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
164009989|NCT03455543|592401372|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
164009990|NCT03455543|592401373|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
164009991|NCT03455543|592401371|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
164009992|NCT03455543|592401372|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
164009993|NCT03455543|592401373|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
164009994|NCT03455543|592401371|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
164009995|NCT03455543|592401372|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
164009996|NCT03455543|592401373|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
164009997|NCT03455543|592401371|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
164009998|NCT03455543|592401372|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
164009999|NCT03455543|592401373|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
164010000|NCT03455543|592401371|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
164010001|NCT03455543|592401372|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
164010002|NCT03455543|592401373|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
164010003|NCT03455543|592401371|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
164010004|NCT03455543|592401372|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
164010005|NCT03455543|592401373|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
164010006|NCT04382651|592401374|FG000|Overall Study|Death|26|||
164010007|NCT04382651|592401375|FG001|Overall Study|Death|23|||
164010008|NCT04382651|592401374|FG000|Overall Study|Lost to Follow-up|3|||
164010009|NCT04382651|592401375|FG001|Overall Study|Lost to Follow-up|4|||
164010010|NCT04382651|592401374|FG000|Overall Study|Withdrawal by Subject|2|||
164010011|NCT04382651|592401375|FG001|Overall Study|Withdrawal by Subject|0|||
164010012|NCT04382651|592401374|FG000|Overall Study|Physician Decision|0|||
164010013|NCT04382651|592401375|FG001|Overall Study|Physician Decision|1|||
164010014|NCT02612077|592401376|FG000|Overall Study|Adverse Event|3|||
164010015|NCT02612077|592401376|FG000|Overall Study|Withdrawal by Subject|9|||
164010016|NCT02612077|592401376|FG000|Overall Study|Protocol Violation|28|||
164010017|NCT02612077|592401376|FG000|Overall Study|Lost to Follow-up|20|||
164010018|NCT02612077|592401376|FG000|Overall Study|Death|377|||
164010019|NCT02612077|592401376|FG000|Overall Study|Moved or Changed Medical Team|23|||
164010020|NCT02612077|592401376|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
164010021|NCT02612077|592401376|FG000|Overall Study|Disease Progression|3|||
164010022|NCT02612077|592401376|FG000|Overall Study|Unknown reason|2|||
164010023|NCT01753518|592401377|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
164010024|NCT01753518|592401378|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
164010025|NCT01753518|592401377|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
164010026|NCT01753518|592401378|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
164010027|NCT01753518|592401377|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
164010028|NCT01753518|592401378|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
164010029|NCT01753518|592401377|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
164010030|NCT01753518|592401378|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
164010031|NCT00940342|592401379|FG000|Overall Study|Adverse Event|0|||
164010032|NCT00940342|592401380|FG001|Overall Study|Adverse Event|2|||
164010033|NCT00940342|592401381|FG002|Overall Study|Adverse Event|1|||
164010034|NCT03249350|592401384|FG000|Overall Study|Participant did not initiate treatment|5|||
164010035|NCT03249350|592401385|FG001|Overall Study|Participant did not initiate treatment|8|||
164359241|NCT01528254|593690030|FG000|Overall Study|Abnormal laboratory value(s)|3|||
164359242|NCT01528254|593690031|FG001|Overall Study|Abnormal laboratory value(s)|7|||
164359243|NCT01528254|593690030|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164359244|NCT01528254|593690031|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164359245|NCT01528254|593690030|FG000|Overall Study|No longer requires study drug|1|||
164359246|NCT01528254|593690031|FG001|Overall Study|No longer requires study drug|1|||
164359247|NCT00383149|593690032|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
164359248|NCT00383149|593690032|FG000|Overall Study|Death|2|||
164359249|NCT00383149|593690032|FG000|Overall Study|Disease Progression|38|||
164359250|NCT00383149|593690032|FG000|Overall Study|Lost to Follow-up|1|||
164359251|NCT00383149|593690032|FG000|Overall Study|Other|1|||
164359252|NCT00383149|593690032|FG000|Overall Study|Study Drug Toxicity|4|||
164359253|NCT00383149|593690032|FG000|Overall Study|Request to Discontinue Treatment|4|||
164359254|NCT00383149|593690032|FG000|Overall Study|Participant Withdrew Consent|1|||
164359255|NCT00416078|593690039|FG000|Overall Study|Death|3|||
164359256|NCT00416078|593690040|FG001|Overall Study|Death|4|||
164359257|NCT00416078|593690039|FG000|Overall Study|Withdrawal by Subject|3|||
164359258|NCT00416078|593690040|FG001|Overall Study|Withdrawal by Subject|2|||
164359259|NCT00416078|593690039|FG000|Overall Study|Physician Decision|1|||
164359260|NCT00416078|593690040|FG001|Overall Study|Physician Decision|0|||
164359261|NCT00416078|593690039|FG000|Overall Study|Lost to Follow-up|4|||
164359262|NCT00416078|593690040|FG001|Overall Study|Lost to Follow-up|2|||
164359263|NCT02998840|593690049|FG000|Overall Study|Lost to Follow-up|1|||
164359264|NCT02998840|593690050|FG001|Overall Study|Lost to Follow-up|1|||
164359265|NCT02998840|593690051|FG002|Overall Study|Lost to Follow-up|2|||
164359266|NCT02998840|593690052|FG003|Overall Study|Lost to Follow-up|3|||
164359267|NCT02998840|593690049|FG000|Overall Study|Withdrawal by Subject|1|||
164359268|NCT02998840|593690050|FG001|Overall Study|Withdrawal by Subject|1|||
164359269|NCT02998840|593690051|FG002|Overall Study|Withdrawal by Subject|0|||
164359270|NCT02998840|593690052|FG003|Overall Study|Withdrawal by Subject|1|||
164359271|NCT02998840|593690049|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
164359272|NCT02998840|593690050|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
164359273|NCT02998840|593690051|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
164359274|NCT02998840|593690052|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
164359275|NCT01686633|593690053|FG000|Overall Study|Lack of Efficacy|33|||
164359276|NCT01686633|593690054|FG001|Overall Study|Lack of Efficacy|13|||
164359277|NCT01686633|593690055|FG002|Overall Study|Lack of Efficacy|11|||
164359278|NCT01686633|593690053|FG000|Overall Study|Withdrawal by Subject|8|||
164359279|NCT01686633|593690054|FG001|Overall Study|Withdrawal by Subject|8|||
164359280|NCT01686633|593690055|FG002|Overall Study|Withdrawal by Subject|5|||
164359281|NCT01686633|593690053|FG000|Overall Study|Physician Decision|3|||
164359282|NCT01686633|593690054|FG001|Overall Study|Physician Decision|4|||
164359283|NCT01686633|593690055|FG002|Overall Study|Physician Decision|4|||
164359284|NCT01686633|593690053|FG000|Overall Study|Adverse Event|4|||
164359285|NCT01686633|593690054|FG001|Overall Study|Adverse Event|3|||
164010036|NCT01716169|592401386|FG000|Overall Study|Adverse Event|1|||
164010037|NCT01716169|592401386|FG000|Overall Study|Lost to Follow-up|1|||
164010038|NCT01716169|592401386|FG000|Overall Study|Withdrawal by Subject|1|||
164010039|NCT01716169|592401386|FG000|Overall Study|inconsistent dressing application|1|||
164010040|NCT00553787|592401387|FG000|Overall Study|Adverse Event|34|||
164010041|NCT00553787|592401388|FG001|Overall Study|Adverse Event|21|||
164010042|NCT00553787|592401389|FG002|Overall Study|Adverse Event|67|||
164010043|NCT00553787|592401387|FG000|Overall Study|Lost to Follow-up|132|||
164010044|NCT00553787|592401388|FG001|Overall Study|Lost to Follow-up|44|||
164010045|NCT00553787|592401389|FG002|Overall Study|Lost to Follow-up|78|||
164010046|NCT00553787|592401387|FG000|Overall Study|Withdrawal by Subject|151|||
164010047|NCT00553787|592401388|FG001|Overall Study|Withdrawal by Subject|40|||
164010048|NCT00553787|592401389|FG002|Overall Study|Withdrawal by Subject|83|||
164010049|NCT00553787|592401387|FG000|Overall Study|Lack of Efficacy|31|||
164010050|NCT00553787|592401388|FG001|Overall Study|Lack of Efficacy|1|||
164010051|NCT00553787|592401389|FG002|Overall Study|Lack of Efficacy|3|||
164010052|NCT00553787|592401387|FG000|Overall Study|Pregnancy|0|||
164010053|NCT00553787|592401388|FG001|Overall Study|Pregnancy|1|||
164010054|NCT00553787|592401389|FG002|Overall Study|Pregnancy|2|||
164010055|NCT00553787|592401387|FG000|Overall Study|non compliance|4|||
164359286|NCT01686633|593690055|FG002|Overall Study|Adverse Event|3|||
164359287|NCT01686633|593690053|FG000|Overall Study|Protocol Violation|2|||
164359288|NCT01686633|593690054|FG001|Overall Study|Protocol Violation|3|||
164359289|NCT01686633|593690055|FG002|Overall Study|Protocol Violation|0|||
164010056|NCT00553787|592401388|FG001|Overall Study|non compliance|0|||
164010057|NCT00553787|592401389|FG002|Overall Study|non compliance|11|||
164359290|NCT01686633|593690053|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
164359291|NCT01686633|593690054|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
164359292|NCT01686633|593690055|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
164010058|NCT00553787|592401387|FG000|Overall Study|Requirement for restricted medication|8|||
164112587|NCT02483416|592774035|FG000|Overall Study|Other reason|0|||
164359293|NCT01686633|593690053|FG000|Overall Study|Lost to Follow-up|0|||
164359294|NCT01686633|593690054|FG001|Overall Study|Lost to Follow-up|1|||
164359295|NCT01686633|593690055|FG002|Overall Study|Lost to Follow-up|1|||
164359296|NCT00511667|593690060|FG000|Overall Study|Adverse Event|1|||
164359297|NCT00511667|593690061|FG001|Overall Study|Adverse Event|0|||
164359298|NCT00511667|593690060|FG000|Overall Study|Protocol Violation|1|||
164359299|NCT00511667|593690061|FG001|Overall Study|Protocol Violation|1|||
164359300|NCT00511667|593690060|FG000|Overall Study|Withdrawal by Subject|2|||
164359301|NCT00511667|593690061|FG001|Overall Study|Withdrawal by Subject|0|||
164359302|NCT00511667|593690060|FG000|Overall Study|Site terminated|6|||
164359303|NCT00511667|593690061|FG001|Overall Study|Site terminated|1|||
164359304|NCT00511667|593690060|FG000|Overall Study|Other|2|||
164010059|NCT00553787|592401388|FG001|Overall Study|Requirement for restricted medication|7|||
164010060|NCT00553787|592401389|FG002|Overall Study|Requirement for restricted medication|5|||
164010061|NCT00553787|592401387|FG000|Overall Study|Other|18|||
164010062|NCT00553787|592401388|FG001|Overall Study|Other|10|||
164359305|NCT00511667|593690061|FG001|Overall Study|Other|1|||
164359306|NCT03564145|593690062|FG000|Overall Study|Adverse Event|4|||
164359307|NCT03564145|593690062|FG000|Overall Study|Lost to Follow-up|21|||
164359308|NCT03564145|593690062|FG000|Overall Study|Protocol Violation|2|||
164359309|NCT03564145|593690062|FG000|Overall Study|Withdrawal by Subject|48|||
164359310|NCT03564145|593690062|FG000|Overall Study|Study Terminated by Sponsor|146|||
164359311|NCT03564145|593690062|FG000|Overall Study|Physician Decision|1|||
164359312|NCT03564145|593690062|FG000|Overall Study|Other Than Specified|1|||
164359313|NCT03564145|593690062|FG000|Overall Study|Pregnancy|1|||
164359314|NCT04219891|593690065|FG000|Overall Study|Lost to Follow-up|3|||
164359315|NCT04219891|593690065|FG000|Overall Study|Withdrawal by Subject|2|||
164359316|NCT03724812|593691633|FG000|Overall Study|Missed Visit|1|||
164359317|NCT03724812|593691633|FG000|Overall Study|Death|2|||
164359318|NCT03724812|593691633|FG000|Overall Study|Withdrawal by Subject|1|||
164359319|NCT03227029|593691634|FG000|Overall Study|Child Wheezed (no treatment)|0|||
164359320|NCT03227029|593691635|FG001|Overall Study|Child Wheezed (no treatment)|1|||
164359321|NCT03227029|593691636|FG002|Overall Study|Child Wheezed (no treatment)|0|||
164359322|NCT03227029|593691634|FG000|Overall Study|No post RSV season visit due to COVID|3|||
164359323|NCT03227029|593691635|FG001|Overall Study|No post RSV season visit due to COVID|3|||
164359324|NCT03227029|593691636|FG002|Overall Study|No post RSV season visit due to COVID|2|||
164359325|NCT03227029|593691634|FG000|Overall Study|Not able to get to clinic|0|||
164359326|NCT03227029|593691635|FG001|Overall Study|Not able to get to clinic|0|||
164359327|NCT03227029|593691636|FG002|Overall Study|Not able to get to clinic|1|||
164359328|NCT03227029|593691634|FG000|Overall Study|Withdrawal by Subject|1|||
164359329|NCT03227029|593691635|FG001|Overall Study|Withdrawal by Subject|0|||
164359330|NCT03227029|593691636|FG002|Overall Study|Withdrawal by Subject|0|||
164359331|NCT03227029|593691634|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
164359332|NCT03227029|593691635|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
164359333|NCT03227029|593691636|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
164359334|NCT01291173|593691637|FG000|Overall Study|Adverse Event|0|||
164359335|NCT01291173|593691638|FG001|Overall Study|Adverse Event|3|||
164359336|NCT01291173|593691639|FG002|Overall Study|Adverse Event|1|||
164359337|NCT01291173|593691640|FG003|Overall Study|Adverse Event|3|||
164359338|NCT01291173|593691637|FG000|Overall Study|Protocol Violation|7|||
164359339|NCT01291173|593691638|FG001|Overall Study|Protocol Violation|2|||
164359340|NCT01291173|593691639|FG002|Overall Study|Protocol Violation|2|||
164359341|NCT01291173|593691640|FG003|Overall Study|Protocol Violation|5|||
164359342|NCT01291173|593691637|FG000|Overall Study|Withdrawal by Subject|6|||
164359343|NCT01291173|593691638|FG001|Overall Study|Withdrawal by Subject|4|||
164359344|NCT01291173|593691639|FG002|Overall Study|Withdrawal by Subject|4|||
164359345|NCT01291173|593691640|FG003|Overall Study|Withdrawal by Subject|2|||
164359346|NCT01291173|593691637|FG000|Overall Study|Lost to Follow-up|4|||
164359347|NCT01291173|593691638|FG001|Overall Study|Lost to Follow-up|6|||
164359348|NCT01291173|593691639|FG002|Overall Study|Lost to Follow-up|3|||
164359349|NCT01291173|593691640|FG003|Overall Study|Lost to Follow-up|2|||
164359350|NCT01291173|593691637|FG000|Overall Study|Unable to meet visit schedule|0|||
164359351|NCT01291173|593691638|FG001|Overall Study|Unable to meet visit schedule|0|||
164359352|NCT01291173|593691639|FG002|Overall Study|Unable to meet visit schedule|1|||
164359353|NCT01291173|593691640|FG003|Overall Study|Unable to meet visit schedule|0|||
164359354|NCT01291173|593691637|FG000|Overall Study|Lack of compliance|0|||
164359355|NCT01291173|593691638|FG001|Overall Study|Lack of compliance|0|||
164359356|NCT01291173|593691639|FG002|Overall Study|Lack of compliance|0|||
164359357|NCT01291173|593691640|FG003|Overall Study|Lack of compliance|1|||
164359358|NCT01291173|593691637|FG000|Overall Study|Subject was unblinded|0|||
164359359|NCT01291173|593691638|FG001|Overall Study|Subject was unblinded|0|||
164359360|NCT01291173|593691639|FG002|Overall Study|Subject was unblinded|1|||
164359361|NCT01291173|593691640|FG003|Overall Study|Subject was unblinded|0|||
164359362|NCT01291173|593691637|FG000|Overall Study|Excluded therapy|0|||
164359363|NCT01291173|593691638|FG001|Overall Study|Excluded therapy|0|||
164010063|NCT00553787|592401389|FG002|Overall Study|Other|13|||
164010064|NCT05121103|592401392|FG000|Overall Study|Progressive disease|2|||
164010065|NCT05121103|592401393|FG001|Overall Study|Progressive disease|1|||
164010066|NCT05121103|592401394|FG002|Overall Study|Progressive disease|6|||
164010067|NCT05121103|592401392|FG000|Overall Study|Physician Decision|2|||
164010068|NCT05121103|592401393|FG001|Overall Study|Physician Decision|1|||
164010069|NCT05121103|592401394|FG002|Overall Study|Physician Decision|0|||
164359364|NCT01291173|593691639|FG002|Overall Study|Excluded therapy|1|||
164359365|NCT01291173|593691640|FG003|Overall Study|Excluded therapy|0|||
164359366|NCT01074450|593691646|FG000|First Intervention|Emesis in Dosing Interval|0|||
164359367|NCT01074450|593691647|FG001|First Intervention|Emesis in Dosing Interval|2|||
164359368|NCT01074450|593691646|FG000|Second Intervention|Protocol Violation|1|||
164359369|NCT01074450|593691647|FG001|Second Intervention|Protocol Violation|0|||
164359370|NCT01074450|593691646|FG000|Second Intervention|Physician Decision|0|||
164359371|NCT01074450|593691647|FG001|Second Intervention|Physician Decision|1|||
164359372|NCT02728895|593691648|FG000|Overall Study|Other|1|||
164359373|NCT02728895|593691649|FG001|Overall Study|Other|2|||
164359374|NCT02728895|593691648|FG000|Overall Study|Withdrawal by Subject|0|||
164359375|NCT02728895|593691649|FG001|Overall Study|Withdrawal by Subject|3|||
164359376|NCT02769247|593691650|FG000|Overall Study|Withdrawal by Subject|1|||
164359377|NCT02769247|593691651|FG001|Overall Study|Withdrawal by Subject|0|||
164359378|NCT02769247|593691652|FG002|Overall Study|Withdrawal by Subject|0|||
164359379|NCT02769247|593691653|FG003|Overall Study|Withdrawal by Subject|1|||
164359380|NCT02769247|593691650|FG000|Overall Study|Protocol Violation|0|||
164359381|NCT02769247|593691651|FG001|Overall Study|Protocol Violation|0|||
164359382|NCT02769247|593691652|FG002|Overall Study|Protocol Violation|1|||
164359383|NCT02769247|593691653|FG003|Overall Study|Protocol Violation|0|||
164359384|NCT02769247|593691650|FG000|Overall Study|Physician Decision|1|||
164359385|NCT02769247|593691651|FG001|Overall Study|Physician Decision|0|||
164359386|NCT02769247|593691652|FG002|Overall Study|Physician Decision|0|||
164359387|NCT02769247|593691653|FG003|Overall Study|Physician Decision|0|||
164359388|NCT04788953|593691654|FG000|Overall Study|Adverse Event|1|||
164359389|NCT04788953|593691655|FG001|Overall Study|Adverse Event|1|||
164359390|NCT04788953|593691654|FG000|Overall Study|Withdrawal by Subject|1|||
164359391|NCT04788953|593691655|FG001|Overall Study|Withdrawal by Subject|0|||
164359392|NCT04788953|593691654|FG000|Overall Study|Protocol Violation|0|||
164359393|NCT04788953|593691655|FG001|Overall Study|Protocol Violation|1|||
164359394|NCT00469092|593691656|FG000|Overall Study|Adverse Event|5|||
164359395|NCT00469092|593691657|FG001|Overall Study|Adverse Event|4|||
164359396|NCT00469092|593691656|FG000|Overall Study|Lack of Efficacy|1|||
164359397|NCT00469092|593691657|FG001|Overall Study|Lack of Efficacy|0|||
164359398|NCT00469092|593691656|FG000|Overall Study|Lost to Follow-up|1|||
164359399|NCT00469092|593691657|FG001|Overall Study|Lost to Follow-up|2|||
164359400|NCT00469092|593691656|FG000|Overall Study|Protocol Violation|3|||
164359401|NCT00469092|593691657|FG001|Overall Study|Protocol Violation|3|||
164359402|NCT00469092|593691656|FG000|Overall Study|Withdrawal by Subject|4|||
164359403|NCT00469092|593691657|FG001|Overall Study|Withdrawal by Subject|4|||
164359404|NCT00469092|593691656|FG000|Overall Study|Withdrawal Criteria|3|||
164359405|NCT00469092|593691657|FG001|Overall Study|Withdrawal Criteria|4|||
164359406|NCT00469092|593691656|FG000|Overall Study|Incorrectly Randomised|4|||
164359407|NCT00469092|593691657|FG001|Overall Study|Incorrectly Randomised|3|||
164359408|NCT00469092|593691656|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
164359409|NCT00469092|593691657|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
163901514|NCT00754325|592011359|FG001|Initial Treatment|Continuing Active Treatment|5|||
163901515|NCT00754325|592011358|FG000|Initial Treatment|Adverse Event|7|||
163901516|NCT00754325|592011359|FG001|Initial Treatment|Adverse Event|6|||
163901517|NCT00754325|592011358|FG000|Initial Treatment|Withdrawal by Subject|2|||
163901518|NCT00754325|592011359|FG001|Initial Treatment|Withdrawal by Subject|2|||
163901519|NCT00754325|592011358|FG000|Initial Treatment|Physician Decision|2|||
163901520|NCT00754325|592011359|FG001|Initial Treatment|Physician Decision|0|||
163901521|NCT00754325|592011358|FG000|Initial Treatment|Sponsor Request|0|||
163901522|NCT00754325|592011359|FG001|Initial Treatment|Sponsor Request|1|||
163901523|NCT00754325|592011358|FG000|Initial Treatment|Disease Progression|35|||
163901524|NCT00754325|592011359|FG001|Initial Treatment|Disease Progression|35|||
163901525|NCT03738228|592011360|FG000|Overall Study|Never received study treatment|2|||
163901526|NCT03738228|592011361|FG001|Overall Study|Never received study treatment|2|||
164359410|NCT00469092|593691656|FG000|Overall Study|Use of lipid lowering drug|1|||
164359411|NCT00469092|593691657|FG001|Overall Study|Use of lipid lowering drug|0|||
164359412|NCT00469092|593691656|FG000|Overall Study|Hypoglycaemic Episodes|1|||
164359413|NCT00469092|593691657|FG001|Overall Study|Hypoglycaemic Episodes|1|||
164010070|NCT05121103|592401392|FG000|Overall Study|Withdrawal by Subject|0|||
164010071|NCT05121103|592401393|FG001|Overall Study|Withdrawal by Subject|1|||
164010072|NCT05121103|592401394|FG002|Overall Study|Withdrawal by Subject|0|||
164010073|NCT00514449|592401395|FG000|Overall Study|Withdrawal by Subject|1|||
164010074|NCT00514449|592401396|FG001|Overall Study|Withdrawal by Subject|2|||
164010075|NCT00514449|592401395|FG000|Overall Study|Protocol Violation|1|||
164010076|NCT00514449|592401396|FG001|Overall Study|Protocol Violation|2|||
164010077|NCT00514449|592401395|FG000|Overall Study|Lost to Follow-up|1|||
163901527|NCT03801148|592011362|FG000|Period 1 (2 Days)|Adverse Event|1|||
163901528|NCT03801148|592011363|FG001|Period 1 (2 Days)|Adverse Event|1|||
163901529|NCT03801148|592011364|FG002|Period 1 (2 Days)|Adverse Event|0|||
163901530|NCT03801148|592011365|FG003|Period 1 (2 Days)|Adverse Event|0|||
163901531|NCT03801148|592011362|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
163901532|NCT03801148|592011363|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
163901533|NCT03801148|592011364|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
164010078|NCT00514449|592401396|FG001|Overall Study|Lost to Follow-up|0|||
164010079|NCT00301067|592401406|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
164359414|NCT00469092|593691656|FG000|Overall Study|Abnormal lab value|1|||
164359415|NCT00469092|593691657|FG001|Overall Study|Abnormal lab value|0|||
164359416|NCT00469092|593691656|FG000|Overall Study|Use of Corticosteroid|1|||
164359417|NCT00469092|593691657|FG001|Overall Study|Use of Corticosteroid|0|||
164359418|NCT01462084|593691659|FG000|Overall Study|Withdrawal by Subject|1|||
164359419|NCT01462084|593691660|FG001|Overall Study|Withdrawal by Subject|0|||
164359420|NCT01462084|593691659|FG000|Overall Study|Protocol Violation|1|||
164359421|NCT01462084|593691660|FG001|Overall Study|Protocol Violation|1|||
164359422|NCT01086540|593691661|FG000|Overall Study|Death|3|||
164359423|NCT01086540|593691662|FG001|Overall Study|Death|1|||
164359424|NCT01086540|593691661|FG000|Overall Study|Physician Decision|2|||
164359425|NCT01086540|593691662|FG001|Overall Study|Physician Decision|1|||
164359426|NCT01086540|593691661|FG000|Overall Study|Addition of new therapy for PAH|1|||
164359427|NCT01086540|593691662|FG001|Overall Study|Addition of new therapy for PAH|0|||
164359428|NCT02278263|593691663|FG000|Overall Study|Protocol Violation|7|||
164359429|NCT02278263|593691664|FG001|Overall Study|Protocol Violation|0|||
164359430|NCT02278263|593691665|FG002|Overall Study|Protocol Violation|9|||
164359431|NCT01998737|593691666|FG000|Overall Study|Corrupted database|23|||
164359432|NCT01998737|593691667|FG001|Overall Study|Corrupted database|0|||
164359433|NCT02092662|593691669|FG000|Overall Study|Lost to Follow-up|13|||
164359434|NCT02092662|593691670|FG001|Overall Study|Lost to Follow-up|0|||
164359435|NCT02707991|593691671|FG000|Overall Study|Protocol Violation|1|||
164359436|NCT02707991|593691672|FG001|Overall Study|Protocol Violation|0|||
164359437|NCT02707991|593691671|FG000|Overall Study|Became ineligible|0|||
164359438|NCT02707991|593691672|FG001|Overall Study|Became ineligible|1|||
164359439|NCT02659631|593691675|FG000|Overall Study|Lost to Follow-up|0|||
164359440|NCT02659631|593691676|FG001|Overall Study|Lost to Follow-up|0|||
164359441|NCT02659631|593691677|FG002|Overall Study|Lost to Follow-up|2|||
164359442|NCT02659631|593691678|FG003|Overall Study|Lost to Follow-up|0|||
164359443|NCT02659631|593691679|FG004|Overall Study|Lost to Follow-up|0|||
164359444|NCT02659631|593691680|FG005|Overall Study|Lost to Follow-up|1|||
164359445|NCT02659631|593691681|FG006|Overall Study|Lost to Follow-up|0|||
164359446|NCT02659631|593691682|FG007|Overall Study|Lost to Follow-up|0|||
164359447|NCT02659631|593691683|FG008|Overall Study|Lost to Follow-up|0|||
164359448|NCT02659631|593691684|FG009|Overall Study|Lost to Follow-up|0|||
164359449|NCT02659631|593691675|FG000|Overall Study|Withdrawal prior to treatment|0|||
164359450|NCT02659631|593691676|FG001|Overall Study|Withdrawal prior to treatment|0|||
164359451|NCT02659631|593691677|FG002|Overall Study|Withdrawal prior to treatment|0|||
164359452|NCT02659631|593691678|FG003|Overall Study|Withdrawal prior to treatment|0|||
164359453|NCT02659631|593691679|FG004|Overall Study|Withdrawal prior to treatment|1|||
164359454|NCT02659631|593691680|FG005|Overall Study|Withdrawal prior to treatment|0|||
164359455|NCT02659631|593691681|FG006|Overall Study|Withdrawal prior to treatment|0|||
164359456|NCT02659631|593691682|FG007|Overall Study|Withdrawal prior to treatment|0|||
164359457|NCT02659631|593691683|FG008|Overall Study|Withdrawal prior to treatment|0|||
164359458|NCT02659631|593691684|FG009|Overall Study|Withdrawal prior to treatment|0|||
164359459|NCT02659631|593691675|FG000|Overall Study|Participant refused further follow-up|0|||
164359460|NCT02659631|593691676|FG001|Overall Study|Participant refused further follow-up|0|||
164359461|NCT02659631|593691677|FG002|Overall Study|Participant refused further follow-up|0|||
164359462|NCT02659631|593691678|FG003|Overall Study|Participant refused further follow-up|1|||
164359463|NCT02659631|593691679|FG004|Overall Study|Participant refused further follow-up|0|||
164359464|NCT02659631|593691680|FG005|Overall Study|Participant refused further follow-up|0|||
164359465|NCT02659631|593691681|FG006|Overall Study|Participant refused further follow-up|0|||
164359466|NCT02659631|593691682|FG007|Overall Study|Participant refused further follow-up|0|||
164359467|NCT02659631|593691683|FG008|Overall Study|Participant refused further follow-up|1|||
164359468|NCT02659631|593691684|FG009|Overall Study|Participant refused further follow-up|0|||
164359469|NCT02659631|593691675|FG000|Overall Study|Death (follow-up phase)|1|||
164359470|NCT02659631|593691676|FG001|Overall Study|Death (follow-up phase)|2|||
163901534|NCT03801148|592011365|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
164359471|NCT02659631|593691677|FG002|Overall Study|Death (follow-up phase)|1|||
164359472|NCT02659631|593691678|FG003|Overall Study|Death (follow-up phase)|1|||
164359473|NCT02659631|593691679|FG004|Overall Study|Death (follow-up phase)|3|||
164359474|NCT02659631|593691680|FG005|Overall Study|Death (follow-up phase)|2|||
164359475|NCT02659631|593691681|FG006|Overall Study|Death (follow-up phase)|0|||
164359476|NCT02659631|593691682|FG007|Overall Study|Death (follow-up phase)|3|||
164359477|NCT02659631|593691683|FG008|Overall Study|Death (follow-up phase)|1|||
164359478|NCT02659631|593691684|FG009|Overall Study|Death (follow-up phase)|0|||
164359479|NCT02659631|593691675|FG000|Overall Study|Death (treatment phase)|0|||
164359480|NCT02659631|593691676|FG001|Overall Study|Death (treatment phase)|0|||
164359481|NCT02659631|593691677|FG002|Overall Study|Death (treatment phase)|0|||
164359482|NCT02659631|593691678|FG003|Overall Study|Death (treatment phase)|0|||
164359483|NCT02659631|593691679|FG004|Overall Study|Death (treatment phase)|1|||
164359484|NCT02659631|593691680|FG005|Overall Study|Death (treatment phase)|0|||
164359485|NCT02659631|593691681|FG006|Overall Study|Death (treatment phase)|1|||
164359486|NCT02659631|593691682|FG007|Overall Study|Death (treatment phase)|0|||
164359487|NCT02659631|593691683|FG008|Overall Study|Death (treatment phase)|0|||
164359488|NCT02659631|593691684|FG009|Overall Study|Death (treatment phase)|0|||
164359489|NCT05407675|593691685|FG000|Overall Study|Withdrawal by Subject|0|||
164359490|NCT05407675|593691686|FG001|Overall Study|Withdrawal by Subject|2|||
164359491|NCT05407675|593691687|FG002|Overall Study|Withdrawal by Subject|3|||
164359492|NCT05407675|593691688|FG003|Overall Study|Withdrawal by Subject|5|||
164359493|NCT05407675|593691689|FG004|Overall Study|Withdrawal by Subject|0|||
164359494|NCT05407675|593691690|FG005|Overall Study|Withdrawal by Subject|2|||
164359495|NCT05407675|593691691|FG006|Overall Study|Withdrawal by Subject|0|||
164010080|NCT00301067|592401407|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
164010081|NCT00301067|592401408|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
164359496|NCT05407675|593691692|FG007|Overall Study|Withdrawal by Subject|0|||
164359497|NCT05407675|593691693|FG008|Overall Study|Withdrawal by Subject|2|||
164359498|NCT05407675|593691694|FG009|Overall Study|Withdrawal by Subject|0|||
164359499|NCT05407675|593691695|FG010|Overall Study|Withdrawal by Subject|1|||
164359500|NCT05407675|593691696|FG011|Overall Study|Withdrawal by Subject|0|||
164359501|NCT05407675|593691697|FG012|Overall Study|Withdrawal by Subject|0|||
164359502|NCT05407675|593691685|FG000|Overall Study|Site terminated by sponsor|0|||
164359503|NCT05407675|593691686|FG001|Overall Study|Site terminated by sponsor|0|||
164359504|NCT05407675|593691687|FG002|Overall Study|Site terminated by sponsor|1|||
164359505|NCT05407675|593691688|FG003|Overall Study|Site terminated by sponsor|0|||
164359506|NCT05407675|593691689|FG004|Overall Study|Site terminated by sponsor|2|||
164359507|NCT05407675|593691690|FG005|Overall Study|Site terminated by sponsor|0|||
164359508|NCT05407675|593691691|FG006|Overall Study|Site terminated by sponsor|1|||
164359509|NCT05407675|593691692|FG007|Overall Study|Site terminated by sponsor|0|||
164359510|NCT05407675|593691693|FG008|Overall Study|Site terminated by sponsor|0|||
164010082|NCT00301067|592401409|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
164359511|NCT05407675|593691694|FG009|Overall Study|Site terminated by sponsor|2|||
164359512|NCT05407675|593691695|FG010|Overall Study|Site terminated by sponsor|2|||
164359513|NCT05407675|593691696|FG011|Overall Study|Site terminated by sponsor|2|||
164359514|NCT05407675|593691697|FG012|Overall Study|Site terminated by sponsor|1|||
164359515|NCT05407675|593691685|FG000|Overall Study|Disease Progression|0|||
164359516|NCT05407675|593691686|FG001|Overall Study|Disease Progression|0|||
164359517|NCT05407675|593691687|FG002|Overall Study|Disease Progression|0|||
164359518|NCT05407675|593691688|FG003|Overall Study|Disease Progression|0|||
164359519|NCT05407675|593691689|FG004|Overall Study|Disease Progression|0|||
164359520|NCT05407675|593691690|FG005|Overall Study|Disease Progression|0|||
164359521|NCT05407675|593691691|FG006|Overall Study|Disease Progression|0|||
164359522|NCT05407675|593691692|FG007|Overall Study|Disease Progression|0|||
164359523|NCT05407675|593691693|FG008|Overall Study|Disease Progression|0|||
164359524|NCT05407675|593691694|FG009|Overall Study|Disease Progression|0|||
164359525|NCT05407675|593691695|FG010|Overall Study|Disease Progression|1|||
164359526|NCT05407675|593691696|FG011|Overall Study|Disease Progression|0|||
164359527|NCT05407675|593691697|FG012|Overall Study|Disease Progression|0|||
164359528|NCT05407675|593691685|FG000|Overall Study|Physician Decision|0|||
164359529|NCT05407675|593691686|FG001|Overall Study|Physician Decision|0|||
164359530|NCT05407675|593691687|FG002|Overall Study|Physician Decision|0|||
164359531|NCT05407675|593691688|FG003|Overall Study|Physician Decision|0|||
164010083|NCT00301067|592401406|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
164010084|NCT00301067|592401407|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
164010085|NCT00301067|592401408|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
164359532|NCT05407675|593691689|FG004|Overall Study|Physician Decision|0|||
164359533|NCT05407675|593691690|FG005|Overall Study|Physician Decision|0|||
164359534|NCT05407675|593691691|FG006|Overall Study|Physician Decision|0|||
164359535|NCT05407675|593691692|FG007|Overall Study|Physician Decision|0|||
164359536|NCT05407675|593691693|FG008|Overall Study|Physician Decision|0|||
164359537|NCT05407675|593691694|FG009|Overall Study|Physician Decision|0|||
164359538|NCT05407675|593691695|FG010|Overall Study|Physician Decision|1|||
164359539|NCT05407675|593691696|FG011|Overall Study|Physician Decision|0|||
164359540|NCT05407675|593691697|FG012|Overall Study|Physician Decision|0|||
164359541|NCT05407675|593691685|FG000|Overall Study|Other reasons|0|||
164359542|NCT05407675|593691686|FG001|Overall Study|Other reasons|0|||
164359543|NCT05407675|593691687|FG002|Overall Study|Other reasons|0|||
164359544|NCT05407675|593691688|FG003|Overall Study|Other reasons|0|||
164359545|NCT05407675|593691689|FG004|Overall Study|Other reasons|0|||
164359546|NCT05407675|593691690|FG005|Overall Study|Other reasons|0|||
164359547|NCT05407675|593691691|FG006|Overall Study|Other reasons|0|||
164359548|NCT05407675|593691692|FG007|Overall Study|Other reasons|0|||
164359549|NCT05407675|593691693|FG008|Overall Study|Other reasons|1|||
164359550|NCT05407675|593691694|FG009|Overall Study|Other reasons|1|||
164359551|NCT05407675|593691695|FG010|Overall Study|Other reasons|1|||
164359552|NCT05407675|593691696|FG011|Overall Study|Other reasons|1|||
164359553|NCT05407675|593691697|FG012|Overall Study|Other reasons|0|||
164359554|NCT05407675|593691685|FG000|Overall Study|Death|3|||
164359555|NCT05407675|593691686|FG001|Overall Study|Death|4|||
164359556|NCT05407675|593691687|FG002|Overall Study|Death|3|||
164359557|NCT05407675|593691688|FG003|Overall Study|Death|6|||
164359558|NCT05407675|593691689|FG004|Overall Study|Death|0|||
164359559|NCT05407675|593691690|FG005|Overall Study|Death|2|||
164359560|NCT05407675|593691691|FG006|Overall Study|Death|4|||
164359561|NCT05407675|593691692|FG007|Overall Study|Death|2|||
164359562|NCT05407675|593691693|FG008|Overall Study|Death|2|||
164359563|NCT05407675|593691694|FG009|Overall Study|Death|4|||
164359564|NCT05407675|593691695|FG010|Overall Study|Death|2|||
164359565|NCT05407675|593691696|FG011|Overall Study|Death|1|||
164359566|NCT05407675|593691697|FG012|Overall Study|Death|0|||
164359567|NCT05407675|593691685|FG000|Overall Study|Adverse Event|0|||
164359568|NCT05407675|593691686|FG001|Overall Study|Adverse Event|0|||
164359569|NCT05407675|593691687|FG002|Overall Study|Adverse Event|0|||
164359570|NCT05407675|593691688|FG003|Overall Study|Adverse Event|0|||
164359571|NCT05407675|593691689|FG004|Overall Study|Adverse Event|1|||
164359572|NCT05407675|593691690|FG005|Overall Study|Adverse Event|0|||
164359573|NCT05407675|593691691|FG006|Overall Study|Adverse Event|0|||
164359574|NCT05407675|593691692|FG007|Overall Study|Adverse Event|0|||
164359575|NCT05407675|593691693|FG008|Overall Study|Adverse Event|0|||
164359576|NCT05407675|593691694|FG009|Overall Study|Adverse Event|0|||
164359577|NCT05407675|593691695|FG010|Overall Study|Adverse Event|0|||
164359578|NCT05407675|593691696|FG011|Overall Study|Adverse Event|1|||
164359579|NCT05407675|593691697|FG012|Overall Study|Adverse Event|0|||
164359580|NCT05407675|593691685|FG000|Overall Study|Ongoing Treatment|0|||
164359581|NCT05407675|593691686|FG001|Overall Study|Ongoing Treatment|0|||
164359582|NCT05407675|593691687|FG002|Overall Study|Ongoing Treatment|0|||
164359583|NCT05407675|593691688|FG003|Overall Study|Ongoing Treatment|0|||
164359584|NCT05407675|593691689|FG004|Overall Study|Ongoing Treatment|0|||
164359585|NCT05407675|593691690|FG005|Overall Study|Ongoing Treatment|0|||
164359586|NCT05407675|593691691|FG006|Overall Study|Ongoing Treatment|0|||
164359587|NCT05407675|593691692|FG007|Overall Study|Ongoing Treatment|0|||
164359588|NCT05407675|593691693|FG008|Overall Study|Ongoing Treatment|1|||
164359589|NCT05407675|593691694|FG009|Overall Study|Ongoing Treatment|0|||
164359590|NCT05407675|593691695|FG010|Overall Study|Ongoing Treatment|0|||
164359591|NCT05407675|593691696|FG011|Overall Study|Ongoing Treatment|0|||
164359592|NCT05407675|593691697|FG012|Overall Study|Ongoing Treatment|0|||
164359593|NCT00857220|593691698|FG000|Overall Study|Adverse Event|35|||
163901535|NCT03801148|592011362|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164359594|NCT00857220|593691698|FG000|Overall Study|Death|1|||
164359595|NCT00857220|593691698|FG000|Overall Study|Lack of Efficacy|11|||
164359596|NCT00857220|593691698|FG000|Overall Study|Lost to Follow-up|30|||
164359597|NCT00857220|593691698|FG000|Overall Study|Physician Decision|4|||
164359598|NCT00857220|593691698|FG000|Overall Study|Protocol Violation|16|||
164359599|NCT00857220|593691698|FG000|Overall Study|Withdrawal by Subject|67|||
164359600|NCT00857220|593691698|FG000|Overall Study|Clinical Hold|6|||
164359601|NCT00857220|593691698|FG000|Overall Study|Site Closed|5|||
164359602|NCT00857220|593691698|FG000|Overall Study|Miscellaneous|8|||
164359603|NCT02612428|593691699|FG000|VTL-308|Death|14|||
164359604|NCT02612428|593691700|FG001|VTL-308|Death|16|||
163901536|NCT03801148|592011363|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
163901537|NCT03801148|592011364|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164359605|NCT02612428|593691699|FG000|VTL-308|Withdrawal by Subject|0|||
164359606|NCT02612428|593691700|FG001|VTL-308|Withdrawal by Subject|1|||
164359607|NCT02612428|593691699|FG000|VTL-308E|Death|9|||
164359608|NCT02612428|593691700|FG001|VTL-308E|Death|7|||
164359609|NCT02612428|593691699|FG000|VTL-308E|Lost to Follow-up|2|||
164359610|NCT02612428|593691700|FG001|VTL-308E|Lost to Follow-up|0|||
164359611|NCT00742001|593691701|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
164359612|NCT00742001|593691702|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
164359613|NCT00742001|593691703|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
164010086|NCT00301067|592401409|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
164010087|NCT00301067|592401406|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
164010088|NCT00301067|592401407|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
164359614|NCT00137423|593691706|FG000|Overall Study|Adverse Event|7|||
164359615|NCT00137423|593691707|FG001|Overall Study|Adverse Event|9|||
164359616|NCT00137423|593691706|FG000|Overall Study|consent withdrawn|1|||
164359617|NCT00137423|593691707|FG001|Overall Study|consent withdrawn|1|||
164359618|NCT00137423|593691706|FG000|Overall Study|Lack of Efficacy|31|||
164359619|NCT00137423|593691707|FG001|Overall Study|Lack of Efficacy|33|||
164359620|NCT00137423|593691706|FG000|Overall Study|Death|0|||
164359621|NCT00137423|593691707|FG001|Overall Study|Death|1|||
164359622|NCT01928329|593691708|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
164359623|NCT01928329|593691709|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
164359624|NCT01928329|593691708|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
164359625|NCT01928329|593691709|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
164359626|NCT01928329|593691708|FG000|Overall Study|Adverse Event|5|||
164359627|NCT01928329|593691709|FG001|Overall Study|Adverse Event|3|||
164359628|NCT01928329|593691708|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
164359629|NCT01928329|593691709|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
164359630|NCT01928329|593691708|FG000|Overall Study|Withdrawal by Subject|1|||
164359631|NCT01928329|593691709|FG001|Overall Study|Withdrawal by Subject|5|||
164359632|NCT01928329|593691708|FG000|Overall Study|Physician Decision|1|||
164359633|NCT01928329|593691709|FG001|Overall Study|Physician Decision|1|||
164359634|NCT03187262|593691710|FG000|Induction|Lack of Efficacy|2|||
164359635|NCT03187262|593691710|FG000|Induction|Progressive Disease|4|||
164359636|NCT03187262|593691710|FG000|Consolidation|Progressive Disease|5|||
164359637|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
164359638|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
164359639|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
164359640|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
164010089|NCT00301067|592401408|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
164010090|NCT00301067|592401409|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
164010091|NCT00301067|592401406|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
164010092|NCT00301067|592401407|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
164010093|NCT00301067|592401408|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
164010094|NCT00301067|592401409|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
164010095|NCT00301067|592401406|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
164010096|NCT00301067|592401407|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
164091745|NCT02465567|592700008|FG000|Overall Study|enrolled in >1 studies|18|||
164091746|NCT02465567|592700009|FG001|Overall Study|enrolled in >1 studies|11|||
164091747|NCT02465567|592700010|FG002|Overall Study|enrolled in >1 studies|19|||
164091748|NCT02465567|592700011|FG003|Overall Study|enrolled in >1 studies|15|||
164091749|NCT02465567|592700008|FG000|Overall Study|missing PI Signature|1|||
164091750|NCT02465567|592700009|FG001|Overall Study|missing PI Signature|0|||
164091751|NCT02465567|592700010|FG002|Overall Study|missing PI Signature|0|||
164091752|NCT02465567|592700011|FG003|Overall Study|missing PI Signature|0|||
164091753|NCT00337077|592700015|FG000|Overall Study|Progressive disease|25|||
164359641|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
164359642|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
164010097|NCT00301067|592401408|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
164010098|NCT00301067|592401409|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
164010099|NCT00301067|592401406|FG000|Follow up Until Death|Alive at last data cut point|1|||
164010100|NCT00301067|592401407|FG001|Follow up Until Death|Alive at last data cut point|0|||
164010101|NCT00301067|592401408|FG002|Follow up Until Death|Alive at last data cut point|0|||
164010102|NCT00301067|592401409|FG003|Follow up Until Death|Alive at last data cut point|1|||
164010103|NCT00149825|592401410|FG000|Overall Study|Intolerance to medication side effects|1|||
164010104|NCT00149825|592401411|FG001|Overall Study|Intolerance to medication side effects|2|||
164091754|NCT00337077|592700016|FG001|Overall Study|Progressive disease|37|||
164091755|NCT00337077|592700017|FG002|Overall Study|Progressive disease|19|||
164091756|NCT00337077|592700015|FG000|Overall Study|Adverse Event|7|||
164359643|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
164359644|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
164359645|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164359646|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164359647|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164359648|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
164010105|NCT00149825|592401410|FG000|Overall Study|Time commitments|2|||
164010106|NCT00149825|592401411|FG001|Overall Study|Time commitments|1|||
164010107|NCT00149825|592401410|FG000|Overall Study|Not liking insomnia therapy|1|||
164091757|NCT00337077|592700016|FG001|Overall Study|Adverse Event|7|||
164091758|NCT00337077|592700017|FG002|Overall Study|Adverse Event|1|||
164359649|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359650|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
164359651|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359652|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359653|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359654|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
164359655|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
164359656|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
164359657|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359658|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359659|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359660|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
164359661|NCT01496313|593691712|FG000|Randomized Period (up to 14 Months)|Other|1|||
164359662|NCT01496313|593691713|FG001|Randomized Period (up to 14 Months)|Other|2|||
164359663|NCT01496313|593691714|FG002|Randomized Period (up to 14 Months)|Other|0|||
164359664|NCT01496313|593691715|FG003|Randomized Period (up to 14 Months)|Other|0|||
164359665|NCT01496313|593691716|FG004|Randomized Period (up to 14 Months)|Other|0|||
164359666|NCT01496313|593691717|FG005|Randomized Period (up to 14 Months)|Other|0|||
164359667|NCT01496313|593691712|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359668|NCT01496313|593691713|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359669|NCT01496313|593691714|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359670|NCT01496313|593691715|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359671|NCT01496313|593691716|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
164359672|NCT01496313|593691717|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
164359673|NCT01496313|593691712|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359674|NCT01496313|593691713|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359675|NCT01496313|593691714|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359676|NCT01496313|593691715|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359677|NCT01496313|593691716|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
164359678|NCT01496313|593691717|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
164359679|NCT01496313|593691712|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
164359680|NCT01496313|593691713|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
164359681|NCT01496313|593691714|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
164359682|NCT01496313|593691715|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
164359683|NCT01496313|593691716|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
164359684|NCT01496313|593691717|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
164359685|NCT01050257|593691725|FG000|Overall Study|Adverse Event|4|||
164359686|NCT01050257|593691726|FG001|Overall Study|Adverse Event|4|||
164359687|NCT01050257|593691727|FG002|Overall Study|Adverse Event|2|||
164359688|NCT01050257|593691725|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
164359689|NCT01050257|593691726|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
164359690|NCT01050257|593691727|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
164359691|NCT01050257|593691725|FG000|Overall Study|Withdrawal by Subject|0|||
164359692|NCT01050257|593691726|FG001|Overall Study|Withdrawal by Subject|3|||
164359693|NCT01050257|593691727|FG002|Overall Study|Withdrawal by Subject|0|||
164359694|NCT01050257|593691725|FG000|Overall Study|No reason specified|0|||
164359695|NCT01050257|593691726|FG001|Overall Study|No reason specified|0|||
164359696|NCT01050257|593691727|FG002|Overall Study|No reason specified|2|||
164359697|NCT01050257|593691725|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
164359698|NCT01050257|593691726|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
164359699|NCT01050257|593691727|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
164359700|NCT01050257|593691725|FG000|Overall Study|Violation criteria|0|||
164359701|NCT01050257|593691726|FG001|Overall Study|Violation criteria|1|||
164359702|NCT01050257|593691727|FG002|Overall Study|Violation criteria|0|||
164359703|NCT01050257|593691725|FG000|Overall Study|Failure to return|0|||
164359704|NCT01050257|593691726|FG001|Overall Study|Failure to return|2|||
164359705|NCT01050257|593691727|FG002|Overall Study|Failure to return|0|||
164359706|NCT01050257|593691725|FG000|Overall Study|Death|0|||
164359707|NCT01050257|593691726|FG001|Overall Study|Death|0|||
164359708|NCT01050257|593691727|FG002|Overall Study|Death|1|||
164359709|NCT00171223|593691728|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
164359710|NCT00171223|593691729|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
164359711|NCT00171223|593691730|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
164010108|NCT00149825|592401411|FG001|Overall Study|Not liking insomnia therapy|0|||
164010109|NCT00149825|592401410|FG000|Overall Study|Other|1|||
164359712|NCT00171223|593691728|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
164359713|NCT00171223|593691729|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
164359714|NCT00171223|593691730|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
164359715|NCT00171223|593691728|FG000|Overall Study|Abnormal Procedure|1|||
164359716|NCT00171223|593691729|FG001|Overall Study|Abnormal Procedure|0|||
164359717|NCT00171223|593691730|FG002|Overall Study|Abnormal Procedure|0|||
163901538|NCT03801148|592011365|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
163901539|NCT03801148|592011362|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
163901540|NCT03801148|592011363|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
163901541|NCT03801148|592011364|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
163901542|NCT03801148|592011365|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
163901543|NCT06212752|592011366|FG000|Overall Study|Death|5|||
163901544|NCT06212752|592011367|FG001|Overall Study|Death|3|||
163901545|NCT06212752|592011366|FG000|Overall Study|Participants ongoing|23|||
163901546|NCT06212752|592011367|FG001|Overall Study|Participants ongoing|8|||
163901547|NCT04162210|592011368|FG000|Overall Study|Lost to Follow-up|4|||
164010110|NCT00149825|592401411|FG001|Overall Study|Other|0|||
164010111|NCT05897853|592401412|FG000|Overall Study|Lost to Follow-up|2|||
164010112|NCT05897853|592401413|FG001|Overall Study|Lost to Follow-up|0|||
164010113|NCT05897853|592401412|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
164010114|NCT05897853|592401413|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
164010115|NCT02609399|592401414|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
164010116|NCT02609399|592401415|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
164091759|NCT00337077|592700015|FG000|Overall Study|Death|0|||
164359718|NCT00171223|593691728|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
164359719|NCT00171223|593691729|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
164359720|NCT00171223|593691730|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
164359721|NCT00171223|593691728|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
164359722|NCT00171223|593691729|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
164359723|NCT00171223|593691730|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
164359724|NCT00171223|593691728|FG000|Overall Study|Protocol Violation|2|||
164359725|NCT00171223|593691729|FG001|Overall Study|Protocol Violation|2|||
164359726|NCT00171223|593691730|FG002|Overall Study|Protocol Violation|3|||
164359727|NCT00171223|593691728|FG000|Overall Study|Participant Withdrew Consent|12|||
164359728|NCT00171223|593691729|FG001|Overall Study|Participant Withdrew Consent|21|||
164359729|NCT00171223|593691730|FG002|Overall Study|Participant Withdrew Consent|15|||
164359730|NCT00171223|593691728|FG000|Overall Study|Lost to Follow-up|5|||
164359731|NCT00171223|593691729|FG001|Overall Study|Lost to Follow-up|2|||
164359732|NCT00171223|593691730|FG002|Overall Study|Lost to Follow-up|3|||
164359733|NCT00171223|593691728|FG000|Overall Study|Administrative Problems|4|||
164359734|NCT00171223|593691729|FG001|Overall Study|Administrative Problems|7|||
164359735|NCT00171223|593691730|FG002|Overall Study|Administrative Problems|6|||
164359736|NCT00171223|593691728|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
164359737|NCT00171223|593691729|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
164359738|NCT00171223|593691730|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
164359739|NCT00171223|593691728|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
164359740|NCT00171223|593691729|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
164359741|NCT00171223|593691730|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
164359742|NCT02064166|593691731|FG000|Overall Study|Adverse Event|1|||
164359743|NCT02064166|593691732|FG001|Overall Study|Adverse Event|0|||
164359744|NCT04339296|593691736|FG000|Overall Study|Refuse to participate after allocation|1|||
164359745|NCT04339296|593691737|FG001|Overall Study|Refuse to participate after allocation|1|||
164359746|NCT04339296|593691736|FG000|Overall Study|Withdrew after completion of baseline|2|||
164359747|NCT04339296|593691737|FG001|Overall Study|Withdrew after completion of baseline|1|||
164359748|NCT04339296|593691736|FG000|Overall Study|Lost to Follow-up|0|||
164359749|NCT04339296|593691737|FG001|Overall Study|Lost to Follow-up|4|||
164359750|NCT04339296|593691736|FG000|Overall Study|Discontinued intervention|5|||
164359751|NCT04339296|593691737|FG001|Overall Study|Discontinued intervention|3|||
164359752|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359753|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
164359754|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359755|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359756|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359757|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359758|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
164359759|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
164359760|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
164359761|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
164359762|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
164359763|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
164359764|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
164010117|NCT02609399|592401414|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
164010118|NCT02609399|592401415|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
164010119|NCT02609399|592401414|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
164010120|NCT02609399|592401415|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
164010121|NCT04458857|592401416|FG000|Overall Study|Adverse Event|0|||
164010122|NCT04458857|592401417|FG001|Overall Study|Adverse Event|1|||
164010123|NCT04458857|592401418|FG002|Overall Study|Adverse Event|0|||
164010124|NCT04458857|592401416|FG000|Overall Study|Withdrawal by Subject|2|||
164010125|NCT04458857|592401417|FG001|Overall Study|Withdrawal by Subject|0|||
164010126|NCT04458857|592401418|FG002|Overall Study|Withdrawal by Subject|0|||
164010127|NCT04458857|592401416|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164010128|NCT04458857|592401417|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164010129|NCT04458857|592401418|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164010130|NCT04458857|592401416|FG000|Overall Study|Non-compliance with study drug|0|||
164010131|NCT04458857|592401417|FG001|Overall Study|Non-compliance with study drug|1|||
164010132|NCT04458857|592401418|FG002|Overall Study|Non-compliance with study drug|0|||
164010133|NCT04458857|592401416|FG000|Overall Study|Lost to Follow-up|4|||
164010134|NCT04458857|592401417|FG001|Overall Study|Lost to Follow-up|1|||
164010135|NCT04458857|592401418|FG002|Overall Study|Lost to Follow-up|0|||
164010136|NCT00853905|592401420|FG000|Overall Study|Lost to Follow-up|1|||
164010137|NCT00853905|592401421|FG001|Overall Study|Lost to Follow-up|3|||
164010138|NCT00853905|592401420|FG000|Overall Study|Withdrawal by Subject|0|||
164010139|NCT00853905|592401421|FG001|Overall Study|Withdrawal by Subject|1|||
164010140|NCT00853905|592401420|FG000|Overall Study|never had surgery|1|||
164010141|NCT00853905|592401421|FG001|Overall Study|never had surgery|0|||
164010142|NCT00847561|592401424|FG000|Overall Study|Withdrawal by Subject|4|||
164010143|NCT00847561|592401425|FG001|Overall Study|Withdrawal by Subject|3|||
164010144|NCT00847561|592401424|FG000|Overall Study|Unable to schedule|9|||
164010145|NCT00847561|592401425|FG001|Overall Study|Unable to schedule|1|||
164010146|NCT01333189|592401426|FG000|Overall Study|Time constraints|1|||
164010147|NCT01333189|592401427|FG001|Overall Study|Time constraints|0|||
164010148|NCT01333189|592401426|FG000|Overall Study|Adverse Event|1|||
164010149|NCT01333189|592401427|FG001|Overall Study|Adverse Event|0|||
164010150|NCT01333189|592401426|FG000|Overall Study|Transportation difficulties|0|||
164010151|NCT01333189|592401427|FG001|Overall Study|Transportation difficulties|1|||
164010152|NCT01333189|592401426|FG000|Overall Study|Moved from region|0|||
164010153|NCT01333189|592401427|FG001|Overall Study|Moved from region|1|||
164010154|NCT01739595|592401429|FG000|Overall Study|Adverse Event|3|||
164010155|NCT01739595|592401430|FG001|Overall Study|Adverse Event|0|||
164010156|NCT01739595|592401431|FG002|Overall Study|Adverse Event|0|||
164010157|NCT01739595|592401429|FG000|Overall Study|Lost to Follow-up|2|||
164010158|NCT01739595|592401430|FG001|Overall Study|Lost to Follow-up|0|||
164010159|NCT01739595|592401431|FG002|Overall Study|Lost to Follow-up|0|||
164010160|NCT01739595|592401429|FG000|Overall Study|Withdrawal by Subject|2|||
164359765|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
164359766|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
164359767|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
164359768|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
164359769|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
164359770|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
164359771|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
164359772|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
164359773|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359774|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
164359775|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359776|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359777|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164359778|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
164359779|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
164010161|NCT01739595|592401430|FG001|Overall Study|Withdrawal by Subject|1|||
164010162|NCT01739595|592401431|FG002|Overall Study|Withdrawal by Subject|2|||
164010163|NCT01739595|592401429|FG000|Overall Study|Eligibility issue|3|||
164010164|NCT01739595|592401430|FG001|Overall Study|Eligibility issue|0|||
164010165|NCT01739595|592401431|FG002|Overall Study|Eligibility issue|0|||
164010166|NCT01739595|592401429|FG000|Overall Study|Protocol Violation|1|||
164010167|NCT01739595|592401430|FG001|Overall Study|Protocol Violation|0|||
164010168|NCT01739595|592401431|FG002|Overall Study|Protocol Violation|0|||
164010169|NCT01739595|592401429|FG000|Overall Study|Lab assessment|1|||
164010170|NCT01739595|592401430|FG001|Overall Study|Lab assessment|0|||
164010171|NCT01739595|592401431|FG002|Overall Study|Lab assessment|0|||
164010172|NCT01739595|592401429|FG000|Overall Study|Drug discrepancy|1|||
164010173|NCT01739595|592401430|FG001|Overall Study|Drug discrepancy|0|||
164010174|NCT01739595|592401431|FG002|Overall Study|Drug discrepancy|0|||
164010175|NCT04285723|592401437|FG000|Overall Study|Subject decision|1|||
164359780|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
164359781|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
164359782|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
164359783|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
164359784|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
164359785|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
164359786|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
164359787|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359788|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359789|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359790|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359791|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359792|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
164359793|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
164359794|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
164359795|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
164359796|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
164359797|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
164359798|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
164359799|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
164359800|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
164359801|NCT03742037|593691739|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359802|NCT03742037|593691740|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359803|NCT03742037|593691741|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359804|NCT03742037|593691742|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359805|NCT03742037|593691743|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359806|NCT03742037|593691744|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
164359807|NCT03742037|593691745|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
164359808|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
163901548|NCT04162210|592011369|FG001|Overall Study|Lost to Follow-up|1|||
163901549|NCT04162210|592011368|FG000|Overall Study|Withdrawal by Subject|17|||
164359809|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
164359810|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
164359811|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
164359812|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
164359813|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
164359814|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
164359815|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359816|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359817|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
164359818|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
164359819|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359820|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
164359821|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
164359822|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359823|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
164359824|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
164359825|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359826|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359827|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359828|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
164359829|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
164359830|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359831|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359832|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359833|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359834|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
164359835|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
164359836|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
164359837|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
164359838|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
164359839|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
164359840|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
164359841|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
164359842|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
164359843|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
164359844|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359845|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
164359846|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359847|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359848|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
164359849|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
164359850|NCT03742037|593691739|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359851|NCT03742037|593691740|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359852|NCT03742037|593691741|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
164359853|NCT03742037|593691742|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359854|NCT03742037|593691743|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359855|NCT03742037|593691744|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359856|NCT03742037|593691745|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
164359857|NCT00453544|593691746|FG000|Overall Study|Withdrawal by Subject|1|||
164359858|NCT00453544|593691747|FG001|Overall Study|Withdrawal by Subject|0|||
164359859|NCT00453544|593691748|FG002|Overall Study|Withdrawal by Subject|0|||
164359860|NCT00453544|593691749|FG003|Overall Study|Withdrawal by Subject|0|||
164359861|NCT00453544|593691746|FG000|Overall Study|Primary outcome measure not completed|1|||
164359862|NCT00453544|593691747|FG001|Overall Study|Primary outcome measure not completed|1|||
164359863|NCT00453544|593691748|FG002|Overall Study|Primary outcome measure not completed|0|||
163901550|NCT04162210|592011369|FG001|Overall Study|Withdrawal by Subject|9|||
163901551|NCT04162210|592011368|FG000|Overall Study|Ongoing|113|||
163901552|NCT04162210|592011369|FG001|Overall Study|Ongoing|59|||
163901553|NCT02941549|592011370|FG000|Overall Study|Adverse Event|1|||
163901554|NCT02941549|592011371|FG001|Overall Study|Adverse Event|0|||
164359864|NCT00453544|593691749|FG003|Overall Study|Primary outcome measure not completed|1|||
164359865|NCT01558752|593691750|FG000|Overall Study|Physician Decision|2|||
164359866|NCT01558752|593691751|FG001|Overall Study|Physician Decision|0|||
164359867|NCT00969150|593691752|FG000|Overall Study|Adverse Event|4|||
164359868|NCT00969150|593691753|FG001|Overall Study|Adverse Event|14|||
164359869|NCT00969150|593691752|FG000|Overall Study|Lack of Efficacy|1|||
164359870|NCT00969150|593691753|FG001|Overall Study|Lack of Efficacy|1|||
163901555|NCT02941549|592011372|FG002|Overall Study|Adverse Event|0|||
163901556|NCT02941549|592011370|FG000|Overall Study|Withdrawal by Subject|2|||
163901557|NCT02941549|592011371|FG001|Overall Study|Withdrawal by Subject|1|||
163901558|NCT02941549|592011372|FG002|Overall Study|Withdrawal by Subject|2|||
163901559|NCT00776009|592011373|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
163901560|NCT00776009|592011374|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
164359871|NCT00969150|593691752|FG000|Overall Study|Protocol Violation|9|||
164359872|NCT00969150|593691753|FG001|Overall Study|Protocol Violation|12|||
164359873|NCT00969150|593691752|FG000|Overall Study|Withdrawal by Subject|13|||
164359874|NCT00969150|593691753|FG001|Overall Study|Withdrawal by Subject|9|||
164359875|NCT00969150|593691752|FG000|Overall Study|Lost to Follow-up|5|||
164359876|NCT00969150|593691753|FG001|Overall Study|Lost to Follow-up|4|||
164359877|NCT00969150|593691752|FG000|Overall Study|Other reasons|1|||
164359878|NCT00969150|593691753|FG001|Overall Study|Other reasons|0|||
164359879|NCT00461682|593691754|FG000|Overall Study|Protocol Violation|1|||
164359880|NCT04128267|593691757|FG000|Overall Study|Withdrawal by Subject|6|||
164359881|NCT04128267|593691757|FG000|Overall Study|Death|2|||
164359882|NCT04128267|593691757|FG000|Overall Study|Disease progression|1|||
164359883|NCT04128267|593691757|FG000|Overall Study|Participant had other medical issues|4|||
164359884|NCT04128267|593691757|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
164359885|NCT01705652|593691759|FG000|Overall Study|Adverse Event|1|||
164359886|NCT01705652|593691760|FG001|Overall Study|Adverse Event|0|||
164359887|NCT01705652|593691759|FG000|Overall Study|Withdrawal by Subject|1|||
164359888|NCT01705652|593691760|FG001|Overall Study|Withdrawal by Subject|2|||
164359889|NCT01705652|593691759|FG000|Overall Study|non-compliance|1|||
164359890|NCT01705652|593691760|FG001|Overall Study|non-compliance|1|||
164359891|NCT00056407|593691762|FG000|Overall Study|Adverse Event|282|||
164359892|NCT00056407|593691763|FG001|Overall Study|Adverse Event|364|||
164359893|NCT00056407|593691762|FG000|Overall Study|Withdrawal by Subject|377|||
164359894|NCT00056407|593691763|FG001|Overall Study|Withdrawal by Subject|361|||
164359895|NCT00056407|593691762|FG000|Overall Study|Lost to Follow-up|123|||
164359896|NCT00056407|593691763|FG001|Overall Study|Lost to Follow-up|113|||
164359897|NCT00056407|593691762|FG000|Overall Study|Protocol Violation|104|||
164359898|NCT00056407|593691763|FG001|Overall Study|Protocol Violation|95|||
164359899|NCT00056407|593691762|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
164359900|NCT00056407|593691763|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
164359901|NCT00056407|593691762|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
164359902|NCT00056407|593691763|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
164359903|NCT00056407|593691762|FG000|Overall Study|Missing|25|||
164359904|NCT00056407|593691763|FG001|Overall Study|Missing|34|||
164359905|NCT00616655|593691764|FG000|Overall Study|Adverse Event|10|||
164359906|NCT00616655|593691765|FG001|Overall Study|Adverse Event|7|||
164359907|NCT00616655|593691766|FG002|Overall Study|Adverse Event|12|||
164359908|NCT00616655|593691764|FG000|Overall Study|Lack of Efficacy|5|||
164359909|NCT00616655|593691765|FG001|Overall Study|Lack of Efficacy|5|||
164359910|NCT00616655|593691766|FG002|Overall Study|Lack of Efficacy|5|||
164359911|NCT00616655|593691764|FG000|Overall Study|Lost to Follow-up|3|||
164359912|NCT00616655|593691765|FG001|Overall Study|Lost to Follow-up|12|||
164359913|NCT00616655|593691766|FG002|Overall Study|Lost to Follow-up|10|||
164359914|NCT00616655|593691764|FG000|Overall Study|Protocol Violation|2|||
164359915|NCT00616655|593691765|FG001|Overall Study|Protocol Violation|4|||
164359916|NCT00616655|593691766|FG002|Overall Study|Protocol Violation|3|||
164359917|NCT00616655|593691764|FG000|Overall Study|Withdrawal by Subject|9|||
164359918|NCT00616655|593691765|FG001|Overall Study|Withdrawal by Subject|7|||
164359919|NCT00616655|593691766|FG002|Overall Study|Withdrawal by Subject|11|||
164359920|NCT00616655|593691764|FG000|Overall Study|Does not meet in/ex criteria|0|||
164359921|NCT00616655|593691765|FG001|Overall Study|Does not meet in/ex criteria|0|||
164359922|NCT00616655|593691766|FG002|Overall Study|Does not meet in/ex criteria|2|||
164359923|NCT00616655|593691764|FG000|Overall Study|Other|6|||
164359924|NCT00616655|593691765|FG001|Overall Study|Other|6|||
164359925|NCT00616655|593691766|FG002|Overall Study|Other|5|||
164359926|NCT00309842|593691767|FG000|Overall Study|Lost to Follow-up|1|||
164359927|NCT01026792|593691768|FG000|Overall Study|Protocol Violation|1|||
164359928|NCT02335099|593691771|FG000|Treatment|Withdrawal by Subject|1|||
164359929|NCT02335099|593691772|FG001|Treatment|Withdrawal by Subject|3|||
164359930|NCT02335099|593691771|FG000|Treatment|Lost to Follow-up|2|||
164359931|NCT02335099|593691772|FG001|Treatment|Lost to Follow-up|0|||
164359932|NCT02335099|593691771|FG000|Treatment|Death|1|||
164359933|NCT02335099|593691772|FG001|Treatment|Death|0|||
164359934|NCT02335099|593691771|FG000|Treatment|Adverse Event|1|||
164359935|NCT02335099|593691772|FG001|Treatment|Adverse Event|2|||
164359936|NCT02335099|593691771|FG000|Follow-up|Death|0|||
164359937|NCT02335099|593691772|FG001|Follow-up|Death|1|||
164359938|NCT01472081|593691773|FG000|Overall Study|Continuing treatment at time of analysis|1|||
164359939|NCT01472081|593691774|FG001|Overall Study|Continuing treatment at time of analysis|4|||
164359940|NCT01472081|593691775|FG002|Overall Study|Continuing treatment at time of analysis|1|||
164359941|NCT01472081|593691776|FG003|Overall Study|Continuing treatment at time of analysis|8|||
164359942|NCT01472081|593691777|FG004|Overall Study|Continuing treatment at time of analysis|9|||
164359943|NCT01472081|593691778|FG005|Overall Study|Continuing treatment at time of analysis|0|||
164359944|NCT01472081|593691773|FG000|Overall Study|Disease Progression|4|||
164359945|NCT01472081|593691774|FG001|Overall Study|Disease Progression|10|||
164359946|NCT01472081|593691775|FG002|Overall Study|Disease Progression|12|||
164359947|NCT01472081|593691776|FG003|Overall Study|Disease Progression|31|||
164359948|NCT01472081|593691777|FG004|Overall Study|Disease Progression|22|||
164359949|NCT01472081|593691778|FG005|Overall Study|Disease Progression|3|||
164359950|NCT01472081|593691773|FG000|Overall Study|Study drug toxicity|2|||
164359951|NCT01472081|593691774|FG001|Overall Study|Study drug toxicity|9|||
164359952|NCT01472081|593691775|FG002|Overall Study|Study drug toxicity|4|||
164359953|NCT01472081|593691776|FG003|Overall Study|Study drug toxicity|6|||
164359954|NCT01472081|593691777|FG004|Overall Study|Study drug toxicity|13|||
164359955|NCT01472081|593691778|FG005|Overall Study|Study drug toxicity|2|||
164359956|NCT01472081|593691773|FG000|Overall Study|Death|0|||
164359957|NCT01472081|593691774|FG001|Overall Study|Death|0|||
164359958|NCT01472081|593691775|FG002|Overall Study|Death|0|||
164359959|NCT01472081|593691776|FG003|Overall Study|Death|0|||
164359960|NCT01472081|593691777|FG004|Overall Study|Death|1|||
164359961|NCT01472081|593691778|FG005|Overall Study|Death|0|||
164359962|NCT01472081|593691773|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
164359963|NCT01472081|593691774|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
164359964|NCT01472081|593691775|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
164359965|NCT01472081|593691776|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
164359966|NCT01472081|593691777|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
164359967|NCT01472081|593691778|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
164359968|NCT01472081|593691773|FG000|Overall Study|Withdrawal by Subject|0|||
164359969|NCT01472081|593691774|FG001|Overall Study|Withdrawal by Subject|0|||
164359970|NCT01472081|593691775|FG002|Overall Study|Withdrawal by Subject|0|||
164359971|NCT01472081|593691776|FG003|Overall Study|Withdrawal by Subject|0|||
164359972|NCT01472081|593691777|FG004|Overall Study|Withdrawal by Subject|0|||
164359973|NCT01472081|593691778|FG005|Overall Study|Withdrawal by Subject|1|||
164359974|NCT01472081|593691773|FG000|Overall Study|Poor/non-compliance|0|||
164359975|NCT01472081|593691774|FG001|Overall Study|Poor/non-compliance|0|||
164359976|NCT01472081|593691775|FG002|Overall Study|Poor/non-compliance|1|||
164359977|NCT01472081|593691776|FG003|Overall Study|Poor/non-compliance|0|||
164359978|NCT01472081|593691777|FG004|Overall Study|Poor/non-compliance|1|||
164359979|NCT01472081|593691778|FG005|Overall Study|Poor/non-compliance|0|||
164359980|NCT01472081|593691773|FG000|Overall Study|No longer meets study criteria|0|||
164359981|NCT01472081|593691774|FG001|Overall Study|No longer meets study criteria|0|||
164010176|NCT04285723|592401438|FG001|Overall Study|Subject decision|2|||
164010177|NCT04285723|592401437|FG000|Overall Study|Physician Decision|1|||
164010178|NCT04285723|592401438|FG001|Overall Study|Physician Decision|0|||
164010179|NCT04285723|592401437|FG000|Overall Study|No efficiency|1|||
164010180|NCT04285723|592401438|FG001|Overall Study|No efficiency|0|||
164010181|NCT00778999|592401439|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
164010182|NCT00778999|592401440|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
164010183|NCT00778999|592401439|FG000|Overall Study|Did not receive recFSH|14|||
164010184|NCT00778999|592401440|FG001|Overall Study|Did not receive recFSH|20|||
164010185|NCT02032524|592401441|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
164010186|NCT02032524|592401442|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
164010187|NCT02032524|592401443|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
164010188|NCT02032524|592401444|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
164010189|NCT02032524|592401445|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
164010190|NCT02032524|592401446|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
164010191|NCT02032524|592401441|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164359982|NCT01472081|593691775|FG002|Overall Study|No longer meets study criteria|1|||
164359983|NCT01472081|593691776|FG003|Overall Study|No longer meets study criteria|0|||
164359984|NCT01472081|593691777|FG004|Overall Study|No longer meets study criteria|0|||
164010192|NCT02032524|592401442|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164010193|NCT02032524|592401443|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164010194|NCT02032524|592401444|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
164359985|NCT01472081|593691778|FG005|Overall Study|No longer meets study criteria|0|||
164359986|NCT01472081|593691773|FG000|Overall Study|Subject request to discontinue treatment|0|||
164359987|NCT01472081|593691774|FG001|Overall Study|Subject request to discontinue treatment|3|||
164359988|NCT01472081|593691775|FG002|Overall Study|Subject request to discontinue treatment|1|||
164359989|NCT01472081|593691776|FG003|Overall Study|Subject request to discontinue treatment|1|||
164091760|NCT00337077|592700016|FG001|Overall Study|Death|1|||
164359990|NCT01472081|593691777|FG004|Overall Study|Subject request to discontinue treatment|0|||
164359991|NCT01472081|593691778|FG005|Overall Study|Subject request to discontinue treatment|0|||
164359992|NCT01367158|593691779|FG000|Overall Study|Withdrew consent|0|||
164359993|NCT01367158|593691780|FG001|Overall Study|Withdrew consent|2|||
164359994|NCT01367158|593691781|FG002|Overall Study|Withdrew consent|1|||
164359995|NCT01367158|593691782|FG003|Overall Study|Withdrew consent|0|||
164359996|NCT01367158|593691783|FG004|Overall Study|Withdrew consent|2|||
164359997|NCT01367158|593691784|FG005|Overall Study|Withdrew consent|0|||
164010195|NCT02032524|592401445|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
164010196|NCT02032524|592401446|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
164010197|NCT02032524|592401441|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
164359998|NCT01367158|593691785|FG006|Overall Study|Withdrew consent|0|||
164359999|NCT01367158|593691786|FG007|Overall Study|Withdrew consent|1|||
164360000|NCT01367158|593691787|FG008|Overall Study|Withdrew consent|0|||
164360001|NCT01367158|593691788|FG009|Overall Study|Withdrew consent|0|||
164360002|NCT01367158|593691789|FG010|Overall Study|Withdrew consent|0|||
164360003|NCT01367158|593691779|FG000|Overall Study|Lost to Follow-up|0|||
164360004|NCT01367158|593691780|FG001|Overall Study|Lost to Follow-up|0|||
164360005|NCT01367158|593691781|FG002|Overall Study|Lost to Follow-up|0|||
164360006|NCT01367158|593691782|FG003|Overall Study|Lost to Follow-up|1|||
164360007|NCT01367158|593691783|FG004|Overall Study|Lost to Follow-up|0|||
164360008|NCT01367158|593691784|FG005|Overall Study|Lost to Follow-up|2|||
164360009|NCT01367158|593691785|FG006|Overall Study|Lost to Follow-up|0|||
164360010|NCT01367158|593691786|FG007|Overall Study|Lost to Follow-up|1|||
164360011|NCT01367158|593691787|FG008|Overall Study|Lost to Follow-up|0|||
164360012|NCT01367158|593691788|FG009|Overall Study|Lost to Follow-up|0|||
164360013|NCT01367158|593691789|FG010|Overall Study|Lost to Follow-up|1|||
164360014|NCT01367158|593691779|FG000|Overall Study|Protocol Violation|0|||
164360015|NCT01367158|593691780|FG001|Overall Study|Protocol Violation|1|||
164360016|NCT01367158|593691781|FG002|Overall Study|Protocol Violation|0|||
164360017|NCT01367158|593691782|FG003|Overall Study|Protocol Violation|0|||
164360018|NCT01367158|593691783|FG004|Overall Study|Protocol Violation|0|||
164360019|NCT01367158|593691784|FG005|Overall Study|Protocol Violation|0|||
164360020|NCT01367158|593691785|FG006|Overall Study|Protocol Violation|0|||
164360021|NCT01367158|593691786|FG007|Overall Study|Protocol Violation|0|||
164360022|NCT01367158|593691787|FG008|Overall Study|Protocol Violation|0|||
164360023|NCT01367158|593691788|FG009|Overall Study|Protocol Violation|0|||
164360024|NCT01367158|593691789|FG010|Overall Study|Protocol Violation|0|||
164360025|NCT04702997|593691790|FG000|Overall Study|Withdrawal by Subject|1|||
164360026|NCT04702997|593691791|FG001|Overall Study|Withdrawal by Subject|1|||
164360027|NCT03915496|593691792|FG000|Overall Study|Adverse Event|2|||
164360028|NCT03915496|593691793|FG001|Overall Study|Adverse Event|1|||
164360029|NCT03915496|593691794|FG002|Overall Study|Adverse Event|2|||
164360030|NCT02759471|593691795|FG000|Overall Study|discomfort|2|||
164360031|NCT01103284|593691796|FG000|Overall Study|Death|2|||
164360032|NCT01103284|593691797|FG001|Overall Study|Death|0|||
164360033|NCT01103284|593691796|FG000|Overall Study|Lost to Follow-up|9|||
164360034|NCT01103284|593691797|FG001|Overall Study|Lost to Follow-up|10|||
164360035|NCT01103284|593691796|FG000|Overall Study|Pregnancy|3|||
164360036|NCT01103284|593691797|FG001|Overall Study|Pregnancy|1|||
164360037|NCT01103284|593691796|FG000|Overall Study|Protocol Violation|12|||
164360038|NCT01103284|593691797|FG001|Overall Study|Protocol Violation|5|||
164360039|NCT01103284|593691796|FG000|Overall Study|Adverse Event|0|||
164360040|NCT01103284|593691797|FG001|Overall Study|Adverse Event|5|||
164360041|NCT01103284|593691796|FG000|Overall Study|Withdrawal by Subject|14|||
164360042|NCT01103284|593691797|FG001|Overall Study|Withdrawal by Subject|18|||
164360043|NCT01103284|593691796|FG000|Overall Study|Dermal Hypersensitivity|0|||
164360044|NCT01103284|593691797|FG001|Overall Study|Dermal Hypersensitivity|1|||
164360045|NCT01103284|593691796|FG000|Overall Study|Termination by the Sponsor|0|||
164360046|NCT01103284|593691797|FG001|Overall Study|Termination by the Sponsor|1|||
164360047|NCT01103284|593691796|FG000|Overall Study|Not described|2|||
164360048|NCT01103284|593691797|FG001|Overall Study|Not described|1|||
164360049|NCT01103284|593691796|FG000|Overall Study|Missing CRF entries for study completion|0|||
164360050|NCT01103284|593691797|FG001|Overall Study|Missing CRF entries for study completion|2|||
164360051|NCT03712904|593693157|FG000|Overall Study|Death|0|||
164360052|NCT03712904|593693158|FG001|Overall Study|Death|1|||
164360053|NCT03712904|593693157|FG000|Overall Study|Withdrawal by Subject|0|||
164360054|NCT03712904|593693158|FG001|Overall Study|Withdrawal by Subject|1|||
164360055|NCT03712904|593693157|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
164360056|NCT03712904|593693158|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
164360057|NCT04568590|593693159|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
164360058|NCT03745937|593693160|FG000|Overall Study|Withdrawal by Subject|0|||
164360059|NCT03745937|593693161|FG001|Overall Study|Withdrawal by Subject|0|||
164360060|NCT03745937|593693162|FG002|Overall Study|Withdrawal by Subject|0|||
164360061|NCT03745937|593693163|FG003|Overall Study|Withdrawal by Subject|1|||
164360062|NCT03745937|593693160|FG000|Overall Study|Not-specifed|0|||
164360063|NCT03745937|593693161|FG001|Overall Study|Not-specifed|1|||
164360064|NCT03745937|593693162|FG002|Overall Study|Not-specifed|0|||
164360065|NCT03745937|593693163|FG003|Overall Study|Not-specifed|1|||
164360066|NCT01190254|593693166|FG000|Overall Study|Adverse Event|3|||
164360067|NCT01190254|593693167|FG001|Overall Study|Adverse Event|6|||
164360068|NCT01190254|593693168|FG002|Overall Study|Adverse Event|8|||
164360069|NCT01190254|593693166|FG000|Overall Study|Lack of Efficacy|7|||
164360070|NCT01190254|593693167|FG001|Overall Study|Lack of Efficacy|4|||
164360071|NCT01190254|593693168|FG002|Overall Study|Lack of Efficacy|5|||
164360072|NCT01190254|593693166|FG000|Overall Study|Lost to Follow-up|4|||
164360073|NCT01190254|593693167|FG001|Overall Study|Lost to Follow-up|2|||
164360074|NCT01190254|593693168|FG002|Overall Study|Lost to Follow-up|0|||
164360075|NCT01190254|593693166|FG000|Overall Study|Withdrawal by Subject|4|||
164360076|NCT01190254|593693167|FG001|Overall Study|Withdrawal by Subject|5|||
164360077|NCT01190254|593693168|FG002|Overall Study|Withdrawal by Subject|7|||
164360078|NCT01190254|593693166|FG000|Overall Study|Protocol Violation|2|||
164360079|NCT01190254|593693167|FG001|Overall Study|Protocol Violation|0|||
164360080|NCT01190254|593693168|FG002|Overall Study|Protocol Violation|2|||
164360081|NCT01190254|593693166|FG000|Overall Study|Did not meet protocol eligibility|1|||
164360082|NCT01190254|593693167|FG001|Overall Study|Did not meet protocol eligibility|0|||
164360083|NCT01190254|593693168|FG002|Overall Study|Did not meet protocol eligibility|0|||
164360084|NCT02356783|593693169|FG000|Overall Study|Lost to Follow-up|1|||
164360085|NCT02356783|593693170|FG001|Overall Study|Lost to Follow-up|3|||
164360086|NCT01485640|593693171|FG000|Overall Study|Adverse Event|10|||
164360087|NCT01485640|593693171|FG000|Overall Study|Lack of Efficacy|2|||
164360088|NCT01485640|593693171|FG000|Overall Study|Protocol Violation|1|||
164360089|NCT01485640|593693171|FG000|Overall Study|Withdrawal by Subject|14|||
164360090|NCT01485640|593693171|FG000|Overall Study|Terminated by Sponsor|95|||
164360091|NCT00202644|593693174|FG000|Overall Study|Adverse Event|12|||
164360092|NCT00202644|593693175|FG001|Overall Study|Adverse Event|13|||
164360093|NCT00202644|593693174|FG000|Overall Study|Withdrawal by Subject|8|||
164360094|NCT00202644|593693175|FG001|Overall Study|Withdrawal by Subject|6|||
164360095|NCT00202644|593693174|FG000|Overall Study|Lack of Efficacy|6|||
164360096|NCT00202644|593693175|FG001|Overall Study|Lack of Efficacy|6|||
164360097|NCT00202644|593693174|FG000|Overall Study|Lost to Follow-up|0|||
164360098|NCT00202644|593693175|FG001|Overall Study|Lost to Follow-up|1|||
164360099|NCT00202644|593693174|FG000|Overall Study|Other|9|||
164360100|NCT00202644|593693175|FG001|Overall Study|Other|1|||
164360101|NCT03232281|593693181|FG000|Overall Study|Adverse Event|1|||
164360102|NCT03232281|593693182|FG001|Overall Study|Adverse Event|1|||
164360103|NCT03232281|593693181|FG000|Overall Study|Withdrawal by Subject|5|||
164360104|NCT03232281|593693182|FG001|Overall Study|Withdrawal by Subject|4|||
164360105|NCT03232281|593693181|FG000|Overall Study|Protocol Deviation|1|||
164360106|NCT03232281|593693182|FG001|Overall Study|Protocol Deviation|1|||
164360107|NCT01372501|593693186|FG000|Overall Study|Adverse Event|4|||
164360108|NCT01372501|593693186|FG000|Overall Study|Device migration|1|||
164360109|NCT05333900|593693187|FG000|Overall Study|Protocol Violation|0|||
164360110|NCT05333900|593693188|FG001|Overall Study|Protocol Violation|1|||
164360111|NCT05333900|593693187|FG000|Overall Study|Withdrawal by Subject|0|||
164360112|NCT05333900|593693188|FG001|Overall Study|Withdrawal by Subject|1|||
164360113|NCT05333900|593693187|FG000|Overall Study|COVID-19 Pandemic|1|||
163901561|NCT00776009|592011375|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
163901562|NCT00776009|592011376|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
164360114|NCT05333900|593693188|FG001|Overall Study|COVID-19 Pandemic|1|||
163901563|NCT00776009|592011377|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
164360115|NCT00573755|593693189|FG000|Overall Study|Still receiving treatment|1|||
164360116|NCT00573755|593693190|FG001|Overall Study|Still receiving treatment|0|||
164360117|NCT02024867|593693191|FG000|Overall Study|Protocol Violation|3|||
164360118|NCT02024867|593693192|FG001|Overall Study|Protocol Violation|3|||
164360119|NCT02024867|593693191|FG000|Overall Study|Lost to Follow-up|6|||
164360120|NCT02024867|593693192|FG001|Overall Study|Lost to Follow-up|4|||
164360121|NCT02369341|593693194|FG000|Overall Study|Migrated/moved from study area|1|||
163901564|NCT00776009|592011378|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
164010198|NCT02032524|592401442|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
164010199|NCT02032524|592401443|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
164010200|NCT02032524|592401444|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
164010201|NCT02032524|592401445|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
164360122|NCT02369341|593693195|FG001|Overall Study|Migrated/moved from study area|0|||
164360123|NCT00772707|593693198|FG000|Overall Study|Withdrawn|3|||
164360124|NCT01266460|593693200|FG000|Overall Study|Adverse Event|3|||
164360125|NCT01266460|593693200|FG000|Overall Study|Withdrawal by Subject|5|||
164360126|NCT01266460|593693200|FG000|Overall Study|Disease Progression|18|||
164360127|NCT01266460|593693200|FG000|Overall Study|Not otherwise specified|8|||
164360128|NCT01132547|593693201|FG000|Overall Study|Withdrawal by Subject|3|||
164360129|NCT01132547|593693202|FG001|Overall Study|Withdrawal by Subject|1|||
164360130|NCT01132547|593693201|FG000|Overall Study|Death|1|||
164360131|NCT01132547|593693202|FG001|Overall Study|Death|0|||
164360132|NCT05811234|593693203|FG000|Overall Study|Loss of Effectiveness|2|||
164360133|NCT05811234|593693203|FG000|Overall Study|Adverse Event|4|||
164360134|NCT05811234|593693203|FG000|Overall Study|Pregnancy|1|||
164360135|NCT05811234|593693203|FG000|Overall Study|Disease progression|1|||
164360136|NCT05811234|593693203|FG000|Overall Study|Withdrawal by Subject|4|||
164360137|NCT05811234|593693203|FG000|Overall Study|Lost to Follow-up|13|||
164360138|NCT05811234|593693203|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
164360139|NCT02710045|593693204|FG000|Overall Study|Death|1|||
164360140|NCT02710045|593693205|FG001|Overall Study|Death|2|||
164360141|NCT02710045|593693206|FG002|Overall Study|Death|0|||
164360142|NCT02710045|593693204|FG000|Overall Study|Withdrawal by Subject|6|||
164360143|NCT02710045|593693205|FG001|Overall Study|Withdrawal by Subject|6|||
164360144|NCT02710045|593693206|FG002|Overall Study|Withdrawal by Subject|2|||
164360145|NCT02710045|593693204|FG000|Overall Study|Protocol Violation|1|||
164360146|NCT02710045|593693205|FG001|Overall Study|Protocol Violation|2|||
164360147|NCT02710045|593693206|FG002|Overall Study|Protocol Violation|3|||
164360148|NCT02710045|593693204|FG000|Overall Study|Lost to Follow-up|3|||
164360149|NCT02710045|593693205|FG001|Overall Study|Lost to Follow-up|6|||
164360150|NCT02710045|593693206|FG002|Overall Study|Lost to Follow-up|7|||
164360151|NCT02710045|593693204|FG000|Overall Study|Physician Decision|0|||
164360152|NCT02710045|593693205|FG001|Overall Study|Physician Decision|0|||
164360153|NCT02710045|593693206|FG002|Overall Study|Physician Decision|1|||
164360154|NCT02710045|593693204|FG000|Overall Study|Poor Attendance|0|||
164360155|NCT02710045|593693205|FG001|Overall Study|Poor Attendance|1|||
164360156|NCT02710045|593693206|FG002|Overall Study|Poor Attendance|0|||
164360157|NCT00227305|593693207|FG000|Overall Study|Adverse Event|40|||
164360158|NCT00227305|593693207|FG000|Overall Study|Withdrawal by Subject|42|||
164360159|NCT00227305|593693207|FG000|Overall Study|Lost to Follow-up|33|||
164360160|NCT00227305|593693207|FG000|Overall Study|Study specific discontinuation|13|||
164360161|NCT00227305|593693207|FG000|Overall Study|MOVED OUT OF AREA|3|||
164360162|NCT00227305|593693207|FG000|Overall Study|Lack of Efficacy|7|||
164360163|NCT00227305|593693207|FG000|Overall Study|Physician Decision|3|||
164360164|NCT00227305|593693207|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
164360165|NCT00227305|593693207|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
164360166|NCT00227305|593693207|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
164360167|NCT00278109|593693211|FG000|Overall Study|Adverse Event|3|||
164360168|NCT00278109|593693211|FG000|Overall Study|social circumstances|1|||
164360169|NCT02580357|593693212|FG000|Overall Study|Lost to Follow-up|2|||
164360170|NCT02580357|593693213|FG001|Overall Study|Lost to Follow-up|0|||
164360171|NCT02580357|593693214|FG002|Overall Study|Lost to Follow-up|0|||
164360172|NCT02580357|593693212|FG000|Overall Study|Protocol Violation|1|||
164010202|NCT02032524|592401446|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
164010203|NCT02032524|592401441|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164010204|NCT02032524|592401442|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
164010205|NCT02032524|592401443|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164010206|NCT02032524|592401444|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164010207|NCT02032524|592401445|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
164010208|NCT02032524|592401446|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
164010209|NCT02032524|592401441|FG000|Period 2: LTS13769 Study|Other|0|||
164010210|NCT02032524|592401442|FG001|Period 2: LTS13769 Study|Other|0|||
164010211|NCT02032524|592401443|FG002|Period 2: LTS13769 Study|Other|0|||
164010212|NCT02032524|592401444|FG003|Period 2: LTS13769 Study|Other|0|||
164360173|NCT02580357|593693213|FG001|Overall Study|Protocol Violation|0|||
164360174|NCT02580357|593693214|FG002|Overall Study|Protocol Violation|0|||
164360175|NCT03424265|593693215|FG000|Overall Study|screening failure|1|||
164010213|NCT02032524|592401445|FG004|Period 2: LTS13769 Study|Other|0|||
164360176|NCT03424265|593693216|FG001|Overall Study|screening failure|0|||
164360177|NCT03424265|593693215|FG000|Overall Study|Withdrawal by Subject|0|||
164360178|NCT03424265|593693216|FG001|Overall Study|Withdrawal by Subject|2|||
164360179|NCT01829230|593693217|FG000|Overall Study|Protocol Violation|0|||
164360180|NCT01829230|593693218|FG001|Overall Study|Protocol Violation|2|||
164360181|NCT01829230|593693217|FG000|Overall Study|Withdrawal by Subject|0|||
164360182|NCT01829230|593693218|FG001|Overall Study|Withdrawal by Subject|1|||
164091761|NCT00337077|592700017|FG002|Overall Study|Death|0|||
164091762|NCT00337077|592700015|FG000|Overall Study|Withdrawal by Subject|7|||
164091763|NCT00337077|592700016|FG001|Overall Study|Withdrawal by Subject|2|||
164010214|NCT02032524|592401446|FG005|Period 2: LTS13769 Study|Other|1|||
164010215|NCT02903511|592401450|FG000|Overall Study|Withdrawal by Subject|1|||
164010216|NCT02903511|592401451|FG001|Overall Study|Withdrawal by Subject|0|||
164010217|NCT02903511|592401450|FG000|Overall Study|Lost to Follow-up|3|||
164091764|NCT00337077|592700017|FG002|Overall Study|Withdrawal by Subject|2|||
164091765|NCT00337077|592700015|FG000|Overall Study|Alternative therapy|1|||
164091766|NCT00337077|592700016|FG001|Overall Study|Alternative therapy|0|||
164091767|NCT00337077|592700017|FG002|Overall Study|Alternative therapy|0|||
164091768|NCT00337077|592700015|FG000|Overall Study|Physician Decision|1|||
164091769|NCT00337077|592700016|FG001|Overall Study|Physician Decision|4|||
164091770|NCT00337077|592700017|FG002|Overall Study|Physician Decision|2|||
164091771|NCT00337077|592700015|FG000|Overall Study|Never started treatment|1|||
164091772|NCT00337077|592700016|FG001|Overall Study|Never started treatment|1|||
164091773|NCT00337077|592700017|FG002|Overall Study|Never started treatment|0|||
164091774|NCT00337077|592700015|FG000|Overall Study|Ineligible|1|||
164091775|NCT00337077|592700016|FG001|Overall Study|Ineligible|1|||
164091776|NCT00337077|592700017|FG002|Overall Study|Ineligible|1|||
164360183|NCT01829230|593693217|FG000|Overall Study|Lost to Follow-up|1|||
163901565|NCT00776009|592011373|FG000|Period 1: First Intervention|Protocol Violation|0|||
163901566|NCT00776009|592011374|FG001|Period 1: First Intervention|Protocol Violation|1|||
163901567|NCT00776009|592011375|FG002|Period 1: First Intervention|Protocol Violation|0|||
163901568|NCT00776009|592011376|FG003|Period 1: First Intervention|Protocol Violation|0|||
163901569|NCT00776009|592011377|FG004|Period 1: First Intervention|Protocol Violation|1|||
163901570|NCT00776009|592011378|FG005|Period 1: First Intervention|Protocol Violation|0|||
163901571|NCT00776009|592011373|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
164010218|NCT02903511|592401451|FG001|Overall Study|Lost to Follow-up|2|||
164360184|NCT01829230|593693218|FG001|Overall Study|Lost to Follow-up|1|||
164360185|NCT04501666|593693221|FG000|Overall Study|Physician Decision|0|||
164360186|NCT04501666|593693222|FG001|Overall Study|Physician Decision|1|||
164360187|NCT04501666|593693221|FG000|Overall Study|Adverse Event|12|||
164360188|NCT04501666|593693222|FG001|Overall Study|Adverse Event|4|||
164360189|NCT04501666|593693221|FG000|Overall Study|Subject's request|10|||
164360190|NCT04501666|593693222|FG001|Overall Study|Subject's request|6|||
164360191|NCT04501666|593693221|FG000|Overall Study|Protocol Deviation|2|||
164360192|NCT04501666|593693222|FG001|Overall Study|Protocol Deviation|1|||
164360193|NCT04501666|593693221|FG000|Overall Study|Other-- site permanently closing|0|||
164360194|NCT04501666|593693222|FG001|Overall Study|Other-- site permanently closing|1|||
164360195|NCT03338855|593693223|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
164360196|NCT03338855|593693224|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
164360197|NCT03605303|593693232|FG000|Period 1|Study Terminated|2|||
164360198|NCT03605303|593693233|FG001|Period 1|Study Terminated|1|||
164360199|NCT00399360|593693234|FG000|Overall Study|Lost to Follow-up|2|||
164360200|NCT00399360|593693235|FG001|Overall Study|Lost to Follow-up|1|||
164360201|NCT00399360|593693236|FG002|Overall Study|Lost to Follow-up|2|||
164360202|NCT00399360|593693237|FG003|Overall Study|Lost to Follow-up|4|||
164360203|NCT00399360|593693234|FG000|Overall Study|Adverse Event|0|||
164360204|NCT00399360|593693235|FG001|Overall Study|Adverse Event|0|||
164360205|NCT00399360|593693236|FG002|Overall Study|Adverse Event|1|||
164360206|NCT00399360|593693237|FG003|Overall Study|Adverse Event|0|||
164360207|NCT00399360|593693234|FG000|Overall Study|Withdrawal by Subject|0|||
164360208|NCT00399360|593693235|FG001|Overall Study|Withdrawal by Subject|2|||
164360209|NCT00399360|593693236|FG002|Overall Study|Withdrawal by Subject|0|||
164360210|NCT00399360|593693237|FG003|Overall Study|Withdrawal by Subject|2|||
164360211|NCT01765153|593693238|FG000|Training Phase 1|Format of intervention differed|1|||
164360212|NCT01765153|593693239|FG001|Training Phase 1|Format of intervention differed|0|||
164360213|NCT01765153|593693238|FG000|Training Phase 1|Poor participation in intervention|0|||
164010219|NCT00969618|592401452|FG000|Overall Study|Adverse Event|29|||
164010220|NCT00969618|592401452|FG000|Overall Study|Entry Criteria Not Met|3|||
164010221|NCT00969618|592401452|FG000|Overall Study|Lack of Efficacy|2|||
164010222|NCT00969618|592401452|FG000|Overall Study|Lost to Follow-up|7|||
164010223|NCT00969618|592401452|FG000|Overall Study|Physician Decision|1|||
164010224|NCT00969618|592401452|FG000|Overall Study|Protocol Violation|9|||
164091777|NCT02073643|592700018|FG000|Overall Study|Lost to Follow-up|24|||
164091778|NCT00984295|592700020|FG000|Overall Study|Lost to Follow-up|31|||
164091779|NCT00984295|592700021|FG001|Overall Study|Lost to Follow-up|12|||
164360214|NCT01765153|593693239|FG001|Training Phase 1|Poor participation in intervention|1|||
164360215|NCT01765153|593693238|FG000|Rest Phase 1|Withdrawal by Subject|0|||
164360216|NCT01765153|593693239|FG001|Rest Phase 1|Withdrawal by Subject|1|||
163901572|NCT00776009|592011374|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
164091780|NCT00984295|592700022|FG002|Overall Study|Lost to Follow-up|13|||
164091781|NCT00984295|592700020|FG000|Overall Study|Protocol Violation|2|||
164091782|NCT00984295|592700021|FG001|Overall Study|Protocol Violation|1|||
164091783|NCT00984295|592700022|FG002|Overall Study|Protocol Violation|4|||
164360217|NCT01765153|593693238|FG000|Training Phase 2|Withdrawal by Subject|0|||
164360218|NCT01765153|593693239|FG001|Training Phase 2|Withdrawal by Subject|1|||
164360219|NCT01765153|593693238|FG000|Rest Phase 2|Lost to Follow-up|2|||
164360220|NCT01765153|593693239|FG001|Rest Phase 2|Lost to Follow-up|1|||
164360221|NCT02663674|593693240|FG000|Overall Study|Lost to Follow-up|5|||
164360222|NCT02663674|593693241|FG001|Overall Study|Lost to Follow-up|4|||
164360223|NCT02663674|593693240|FG000|Overall Study|Withdrawal by Subject|1|||
164360224|NCT02663674|593693241|FG001|Overall Study|Withdrawal by Subject|4|||
164360225|NCT02663674|593693240|FG000|Overall Study|Physician Decision|1|||
164360226|NCT02663674|593693241|FG001|Overall Study|Physician Decision|1|||
164360227|NCT02663674|593693240|FG000|Overall Study|Other Event (Health Related)|0|||
164360228|NCT02663674|593693241|FG001|Overall Study|Other Event (Health Related)|1|||
164360229|NCT01386554|593693244|FG000|Overall Study|Lost to Follow-up|0|||
164360230|NCT01386554|593693245|FG001|Overall Study|Lost to Follow-up|0|||
164360231|NCT01386554|593693246|FG002|Overall Study|Lost to Follow-up|1|||
164360232|NCT01386554|593693244|FG000|Overall Study|Adverse Event|2|||
164360233|NCT01386554|593693245|FG001|Overall Study|Adverse Event|5|||
164360234|NCT01386554|593693246|FG002|Overall Study|Adverse Event|2|||
164360235|NCT01386554|593693244|FG000|Overall Study|Progressive disease|1|||
164360236|NCT01386554|593693245|FG001|Overall Study|Progressive disease|2|||
164360237|NCT01386554|593693246|FG002|Overall Study|Progressive disease|2|||
164360238|NCT01386554|593693244|FG000|Overall Study|Administration of live vaccines|0|||
164360239|NCT01386554|593693245|FG001|Overall Study|Administration of live vaccines|1|||
164360240|NCT01386554|593693246|FG002|Overall Study|Administration of live vaccines|0|||
164360241|NCT01386554|593693244|FG000|Overall Study|Investigator discretion|0|||
164360242|NCT01386554|593693245|FG001|Overall Study|Investigator discretion|0|||
164360243|NCT01386554|593693246|FG002|Overall Study|Investigator discretion|1|||
164360244|NCT01386554|593693244|FG000|Overall Study|Reason not collected|0|||
164360245|NCT01386554|593693245|FG001|Overall Study|Reason not collected|1|||
164360246|NCT01386554|593693246|FG002|Overall Study|Reason not collected|0|||
164360247|NCT00353262|593693247|FG000|Overall Study|Adverse Event|8|||
164360248|NCT00353262|593693247|FG000|Overall Study|Withdrawal by Subject|2|||
164360249|NCT00353262|593693247|FG000|Overall Study|Insufficient Therapeutic Response|13|||
164360250|NCT00353262|593693247|FG000|Overall Study|Progression|1|||
164360251|NCT00353262|593693247|FG000|Overall Study|Surgery|4|||
164360252|NCT00353262|593693247|FG000|Overall Study|Break from Chemotherapy|1|||
164360253|NCT04166513|593693248|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
164360254|NCT04166513|593693249|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
164360255|NCT04166513|593693250|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
164360256|NCT04166513|593693251|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
164360257|NCT04166513|593693248|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
164360258|NCT04166513|593693249|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
164360259|NCT04166513|593693250|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
164360260|NCT04166513|593693251|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
164360261|NCT04166513|593693248|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
164360262|NCT04166513|593693249|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
164360263|NCT04166513|593693250|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
164360264|NCT04166513|593693251|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
164360265|NCT04166513|593693248|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
164360266|NCT04166513|593693249|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
164360267|NCT04166513|593693250|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
164360268|NCT04166513|593693251|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
164360269|NCT04166513|593693248|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
164360270|NCT04166513|593693249|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
164360271|NCT04166513|593693250|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
164360272|NCT04166513|593693251|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
164360273|NCT05286307|593693252|FG000|Overall Study|Incomplete outcome assessments|2|||
164360274|NCT05286307|593693253|FG001|Overall Study|Incomplete outcome assessments|1|||
164360275|NCT05286307|593693252|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
164360276|NCT05286307|593693253|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
164360277|NCT05286307|593693252|FG000|Overall Study|Lost to follow up at 6 months|25|||
164360278|NCT05286307|593693253|FG001|Overall Study|Lost to follow up at 6 months|35|||
164360279|NCT05286307|593693252|FG000|Overall Study|Study medication not available|1|||
164091784|NCT00984295|592700020|FG000|Overall Study|Withdrawal by Subject|18|||
164360280|NCT05286307|593693253|FG001|Overall Study|Study medication not available|1|||
164360281|NCT02489344|593694623|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
164360282|NCT02489344|593694623|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
164360283|NCT02489344|593694623|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
164360284|NCT02489344|593694623|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
164360285|NCT01132482|593694624|FG000|Overall Study|Adverse Event|1|||
164091785|NCT00984295|592700021|FG001|Overall Study|Withdrawal by Subject|9|||
164360286|NCT01132482|593694625|FG001|Overall Study|Adverse Event|0|||
164360287|NCT04499781|593694626|FG000|Overall Study|Lost to Follow-up|2|||
164360288|NCT04499781|593694627|FG001|Overall Study|Lost to Follow-up|3|||
164360289|NCT04499781|593694626|FG000|Overall Study|Withdrawal by Subject|2|||
164360290|NCT04499781|593694627|FG001|Overall Study|Withdrawal by Subject|0|||
164360291|NCT04105998|593694635|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
164360292|NCT04105998|593694636|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
164360293|NCT00613015|593694640|FG000|Overall Study|Lost to Follow-up|0|||
164360294|NCT00613015|593694641|FG001|Overall Study|Lost to Follow-up|1|||
164360295|NCT00613015|593694642|FG002|Overall Study|Lost to Follow-up|3|||
164360296|NCT00613015|593694643|FG003|Overall Study|Lost to Follow-up|3|||
164360297|NCT00613015|593694644|FG004|Overall Study|Lost to Follow-up|2|||
164360298|NCT00613015|593694645|FG005|Overall Study|Lost to Follow-up|3|||
164360299|NCT00071760|593694648|FG000|Overall Study|Adverse Event|2|||
164360300|NCT00071760|593694649|FG001|Overall Study|Adverse Event|1|||
164360301|NCT00071760|593694648|FG000|Overall Study|Lost to Follow-up|0|||
164360302|NCT00071760|593694649|FG001|Overall Study|Lost to Follow-up|3|||
164360303|NCT00071760|593694648|FG000|Overall Study|Protocol Violation|1|||
164360304|NCT00071760|593694649|FG001|Overall Study|Protocol Violation|0|||
164360305|NCT00071760|593694648|FG000|Overall Study|Withdrawal by Subject|0|||
164360306|NCT00071760|593694649|FG001|Overall Study|Withdrawal by Subject|1|||
164360307|NCT00071760|593694648|FG000|Overall Study|Insufficient Viral Load Response|1|||
164360308|NCT00071760|593694649|FG001|Overall Study|Insufficient Viral Load Response|1|||
164360309|NCT00071760|593694648|FG000|Overall Study|Lack of availability of RTV|1|||
164360310|NCT00071760|593694649|FG001|Overall Study|Lack of availability of RTV|0|||
164360311|NCT00071760|593694648|FG000|Overall Study|Physician Decision|2|||
164360312|NCT00071760|593694649|FG001|Overall Study|Physician Decision|1|||
164360313|NCT00071760|593694648|FG000|Overall Study|Relocation|0|||
164360314|NCT00071760|593694649|FG001|Overall Study|Relocation|1|||
164360315|NCT02073279|593694650|FG000|Double-blind Period|Adverse Event|1|||
164360316|NCT02073279|593694651|FG001|Double-blind Period|Adverse Event|1|||
164360317|NCT02073279|593694650|FG000|Double-blind Period|Switched to another treatment|1|||
164360318|NCT02073279|593694651|FG001|Double-blind Period|Switched to another treatment|2|||
164360319|NCT02073279|593694650|FG000|Double-blind Period|Protocol Violation|0|||
164360320|NCT02073279|593694651|FG001|Double-blind Period|Protocol Violation|1|||
164360321|NCT02073279|593694650|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
164360322|NCT02073279|593694651|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
164360323|NCT02073279|593694650|FG000|Double-blind Period|Withdrawal by Subject|2|||
164360324|NCT02073279|593694651|FG001|Double-blind Period|Withdrawal by Subject|2|||
164360325|NCT02073279|593694650|FG000|Open-label Extension Period|Adverse Event|1|||
164360326|NCT02073279|593694651|FG001|Open-label Extension Period|Adverse Event|0|||
164360327|NCT02073279|593694650|FG000|Open-label Extension Period|Lack of Efficacy|1|||
164360328|NCT02073279|593694651|FG001|Open-label Extension Period|Lack of Efficacy|0|||
164360329|NCT02073279|593694650|FG000|Open-label Extension Period|Lost to Follow-up|0|||
164360330|NCT02073279|593694651|FG001|Open-label Extension Period|Lost to Follow-up|4|||
164360331|NCT02073279|593694650|FG000|Open-label Extension Period|Switched to another treatment|1|||
164360332|NCT02073279|593694651|FG001|Open-label Extension Period|Switched to another treatment|4|||
164360333|NCT02073279|593694650|FG000|Open-label Extension Period|Protocol Violation|0|||
164360334|NCT02073279|593694651|FG001|Open-label Extension Period|Protocol Violation|1|||
164360335|NCT02073279|593694650|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
164360336|NCT02073279|593694651|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
164360337|NCT02073279|593694650|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
164360338|NCT02073279|593694651|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
164360339|NCT01994629|593694652|FG000|Overall Study|Withdrawal by Subject|1|||
164360340|NCT01994629|593694653|FG001|Overall Study|Withdrawal by Subject|0|||
164360341|NCT01994629|593694652|FG000|Overall Study|Lost to Follow-up|0|||
164360342|NCT01994629|593694653|FG001|Overall Study|Lost to Follow-up|3|||
164360343|NCT03338062|593694656|FG000|Overall Study|Alternative Therapy|1|||
164360344|NCT03338062|593694657|FG001|Overall Study|Alternative Therapy|0|||
164360345|NCT04340362|593694659|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
164360346|NCT02375113|593694663|FG000|Overall Study|Undisclosed Reason(s).|1|||
164360347|NCT02375113|593694664|FG001|Overall Study|Undisclosed Reason(s).|1|||
164360348|NCT02375113|593694663|FG000|Overall Study|Poor adherence (<70%).|1|||
164360349|NCT02375113|593694664|FG001|Overall Study|Poor adherence (<70%).|0|||
164360350|NCT02375113|593694663|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
164360351|NCT02375113|593694664|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
164360352|NCT01214629|593694665|FG000|Overall Study|Progressive Disease|1|||
164360353|NCT01214629|593694666|FG001|Overall Study|Progressive Disease|1|||
164360354|NCT01214629|593694667|FG002|Overall Study|Progressive Disease|0|||
164360355|NCT01214629|593694668|FG003|Overall Study|Progressive Disease|1|||
164360356|NCT01214629|593694669|FG004|Overall Study|Progressive Disease|2|||
164360357|NCT01214629|593694670|FG005|Overall Study|Progressive Disease|3|||
164360358|NCT01214629|593694671|FG006|Overall Study|Progressive Disease|1|||
164360359|NCT01214629|593694672|FG007|Overall Study|Progressive Disease|1|||
164360360|NCT01214629|593694673|FG008|Overall Study|Progressive Disease|1|||
164360361|NCT01214629|593694674|FG009|Overall Study|Progressive Disease|5|||
164112588|NCT02483416|592774036|FG001|Overall Study|Other reason|1|||
164360362|NCT01214629|593694675|FG010|Overall Study|Progressive Disease|1|||
164360363|NCT01214629|593694665|FG000|Overall Study|Adverse Event|0|||
164360364|NCT01214629|593694666|FG001|Overall Study|Adverse Event|0|||
164360365|NCT01214629|593694667|FG002|Overall Study|Adverse Event|0|||
164360366|NCT01214629|593694668|FG003|Overall Study|Adverse Event|1|||
164360367|NCT01214629|593694669|FG004|Overall Study|Adverse Event|0|||
164360368|NCT01214629|593694670|FG005|Overall Study|Adverse Event|1|||
164360369|NCT01214629|593694671|FG006|Overall Study|Adverse Event|0|||
164360370|NCT01214629|593694672|FG007|Overall Study|Adverse Event|0|||
164360371|NCT01214629|593694673|FG008|Overall Study|Adverse Event|0|||
164360372|NCT01214629|593694674|FG009|Overall Study|Adverse Event|1|||
164360373|NCT01214629|593694675|FG010|Overall Study|Adverse Event|0|||
164360374|NCT01214629|593694665|FG000|Overall Study|Physician Decision|0|||
164360375|NCT01214629|593694666|FG001|Overall Study|Physician Decision|0|||
164360376|NCT01214629|593694667|FG002|Overall Study|Physician Decision|0|||
164360377|NCT01214629|593694668|FG003|Overall Study|Physician Decision|0|||
164360378|NCT01214629|593694669|FG004|Overall Study|Physician Decision|0|||
164360379|NCT01214629|593694670|FG005|Overall Study|Physician Decision|0|||
164360380|NCT01214629|593694671|FG006|Overall Study|Physician Decision|0|||
164360381|NCT01214629|593694672|FG007|Overall Study|Physician Decision|0|||
164360382|NCT01214629|593694673|FG008|Overall Study|Physician Decision|0|||
164360383|NCT01214629|593694674|FG009|Overall Study|Physician Decision|0|||
164360384|NCT01214629|593694675|FG010|Overall Study|Physician Decision|1|||
164360385|NCT01214629|593694665|FG000|Overall Study|Withdrawal by Subject|0|||
164360386|NCT01214629|593694666|FG001|Overall Study|Withdrawal by Subject|0|||
164360387|NCT01214629|593694667|FG002|Overall Study|Withdrawal by Subject|0|||
164360388|NCT01214629|593694668|FG003|Overall Study|Withdrawal by Subject|0|||
164360389|NCT01214629|593694669|FG004|Overall Study|Withdrawal by Subject|0|||
164360390|NCT01214629|593694670|FG005|Overall Study|Withdrawal by Subject|0|||
164360391|NCT01214629|593694671|FG006|Overall Study|Withdrawal by Subject|0|||
164360392|NCT01214629|593694672|FG007|Overall Study|Withdrawal by Subject|0|||
164360393|NCT01214629|593694673|FG008|Overall Study|Withdrawal by Subject|0|||
164360394|NCT01214629|593694674|FG009|Overall Study|Withdrawal by Subject|1|||
164360395|NCT01214629|593694675|FG010|Overall Study|Withdrawal by Subject|0|||
164360396|NCT00877383|593694678|FG000|Overall Study|Adverse Event|13|||
164360397|NCT00877383|593694679|FG001|Overall Study|Adverse Event|14|||
164360398|NCT00877383|593694678|FG000|Overall Study|Lost to Follow-up|5|||
164360399|NCT00877383|593694679|FG001|Overall Study|Lost to Follow-up|3|||
164360400|NCT00877383|593694678|FG000|Overall Study|Subject withdrew consent|3|||
164360401|NCT00877383|593694679|FG001|Overall Study|Subject withdrew consent|12|||
164360402|NCT00877383|593694678|FG000|Overall Study|Subject no longer requires study drug|2|||
164360403|NCT00877383|593694679|FG001|Overall Study|Subject no longer requires study drug|0|||
164010225|NCT00969618|592401452|FG000|Overall Study|Withdrawal by Subject|27|||
164010226|NCT01089725|592401453|FG000|Overall Study|Adverse Event|1|||
164010227|NCT01089725|592401454|FG001|Overall Study|Adverse Event|1|||
164010228|NCT01089725|592401455|FG002|Overall Study|Adverse Event|0|||
164010229|NCT01089725|592401456|FG003|Overall Study|Adverse Event|0|||
164010230|NCT01089725|592401457|FG004|Overall Study|Adverse Event|2|||
164010231|NCT01089725|592401453|FG000|Overall Study|Lack of Efficacy|4|||
164360404|NCT00877383|593694678|FG000|Overall Study|Administrative problems|2|||
164360405|NCT00877383|593694679|FG001|Overall Study|Administrative problems|0|||
164360406|NCT00877383|593694678|FG000|Overall Study|Protocol deviation|2|||
164360407|NCT00877383|593694679|FG001|Overall Study|Protocol deviation|6|||
164360408|NCT00877383|593694678|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164360409|NCT00877383|593694679|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164360410|NCT00877383|593694678|FG000|Overall Study|Death|1|||
164360411|NCT00877383|593694679|FG001|Overall Study|Death|2|||
164360412|NCT00459108|593694681|FG000|Overall Study|Withdrawal by Subject|5|||
164360413|NCT00459108|593694681|FG000|Overall Study|Adverse Event|3|||
164360414|NCT00459108|593694681|FG000|Overall Study|Death|2|||
164360415|NCT00459108|593694681|FG000|Overall Study|Progression|1|||
164360416|NCT04387435|593694690|FG000|Overall Study|Physician Decision|1|||
164360417|NCT00391274|593694693|FG000|Overall Study|Death Due to Study Disease|55|||
164360418|NCT00391274|593694694|FG001|Overall Study|Death Due to Study Disease|45|||
164360419|NCT00391274|593694693|FG000|Overall Study|Lost to Follow-up|0|||
164360420|NCT00391274|593694694|FG001|Overall Study|Lost to Follow-up|3|||
164360421|NCT00391274|593694693|FG000|Overall Study|Physician Decision|4|||
164360422|NCT00391274|593694694|FG001|Overall Study|Physician Decision|2|||
164360423|NCT00391274|593694693|FG000|Overall Study|Withdrawal by Subject|0|||
164360424|NCT00391274|593694694|FG001|Overall Study|Withdrawal by Subject|3|||
164360425|NCT00391274|593694693|FG000|Overall Study|Death Due to Adverse Event|1|||
164360426|NCT00391274|593694694|FG001|Overall Study|Death Due to Adverse Event|3|||
164360427|NCT00391274|593694693|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
164360428|NCT00391274|593694694|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
164360429|NCT00391274|593694693|FG000|Overall Study|Death Not Study Related|0|||
164360430|NCT00391274|593694694|FG001|Overall Study|Death Not Study Related|1|||
164360431|NCT00642941|593694696|FG000|Overall Study|Physician Decision|3|||
164360432|NCT00642941|593694697|FG001|Overall Study|Physician Decision|1|||
164360433|NCT00642941|593694698|FG002|Overall Study|Physician Decision|0|||
164360434|NCT00642941|593694699|FG003|Overall Study|Physician Decision|0|||
164360435|NCT00642941|593694700|FG004|Overall Study|Physician Decision|0|||
164360436|NCT00642941|593694701|FG005|Overall Study|Physician Decision|0|||
164360437|NCT00642941|593694702|FG006|Overall Study|Physician Decision|1|||
164360438|NCT00642941|593694703|FG007|Overall Study|Physician Decision|0|||
164360439|NCT00642941|593694704|FG008|Overall Study|Physician Decision|0|||
164360440|NCT00642941|593694705|FG009|Overall Study|Physician Decision|1|||
164360441|NCT00642941|593694706|FG010|Overall Study|Physician Decision|0|||
164360442|NCT00642941|593694707|FG011|Overall Study|Physician Decision|1|||
164360443|NCT00642941|593694696|FG000|Overall Study|Death|4|||
164360444|NCT00642941|593694697|FG001|Overall Study|Death|0|||
164360445|NCT00642941|593694698|FG002|Overall Study|Death|1|||
164360446|NCT00642941|593694699|FG003|Overall Study|Death|1|||
164360447|NCT00642941|593694700|FG004|Overall Study|Death|2|||
164360448|NCT00642941|593694701|FG005|Overall Study|Death|1|||
164360449|NCT00642941|593694702|FG006|Overall Study|Death|0|||
164360450|NCT00642941|593694703|FG007|Overall Study|Death|0|||
164360451|NCT00642941|593694704|FG008|Overall Study|Death|0|||
164360452|NCT00642941|593694705|FG009|Overall Study|Death|0|||
164360453|NCT00642941|593694706|FG010|Overall Study|Death|0|||
164360454|NCT00642941|593694707|FG011|Overall Study|Death|1|||
164360455|NCT00642941|593694696|FG000|Overall Study|Study closed by Sponsor|0|||
164360456|NCT00642941|593694697|FG001|Overall Study|Study closed by Sponsor|1|||
164360457|NCT00642941|593694698|FG002|Overall Study|Study closed by Sponsor|0|||
164360458|NCT00642941|593694699|FG003|Overall Study|Study closed by Sponsor|0|||
164360459|NCT00642941|593694700|FG004|Overall Study|Study closed by Sponsor|0|||
164360460|NCT00642941|593694701|FG005|Overall Study|Study closed by Sponsor|0|||
164360461|NCT00642941|593694702|FG006|Overall Study|Study closed by Sponsor|0|||
164360462|NCT00642941|593694703|FG007|Overall Study|Study closed by Sponsor|0|||
164360463|NCT00642941|593694704|FG008|Overall Study|Study closed by Sponsor|0|||
164360464|NCT00642941|593694705|FG009|Overall Study|Study closed by Sponsor|0|||
164360465|NCT00642941|593694706|FG010|Overall Study|Study closed by Sponsor|0|||
164360466|NCT00642941|593694707|FG011|Overall Study|Study closed by Sponsor|0|||
164360467|NCT00642941|593694696|FG000|Overall Study|Withdrawal by Subject|1|||
164360468|NCT00642941|593694697|FG001|Overall Study|Withdrawal by Subject|0|||
164010232|NCT01089725|592401454|FG001|Overall Study|Lack of Efficacy|3|||
164360469|NCT00642941|593694698|FG002|Overall Study|Withdrawal by Subject|0|||
164360470|NCT00642941|593694699|FG003|Overall Study|Withdrawal by Subject|2|||
164360471|NCT00642941|593694700|FG004|Overall Study|Withdrawal by Subject|0|||
164360472|NCT00642941|593694701|FG005|Overall Study|Withdrawal by Subject|0|||
164360473|NCT00642941|593694702|FG006|Overall Study|Withdrawal by Subject|2|||
164360474|NCT00642941|593694703|FG007|Overall Study|Withdrawal by Subject|0|||
164360475|NCT00642941|593694704|FG008|Overall Study|Withdrawal by Subject|1|||
164360476|NCT00642941|593694705|FG009|Overall Study|Withdrawal by Subject|0|||
164360477|NCT00642941|593694706|FG010|Overall Study|Withdrawal by Subject|0|||
164360478|NCT00642941|593694707|FG011|Overall Study|Withdrawal by Subject|1|||
164360479|NCT00642941|593694696|FG000|Overall Study|Protocol Violation|0|||
164360480|NCT00642941|593694697|FG001|Overall Study|Protocol Violation|0|||
164360481|NCT00642941|593694698|FG002|Overall Study|Protocol Violation|0|||
164360482|NCT00642941|593694699|FG003|Overall Study|Protocol Violation|0|||
164360483|NCT00642941|593694700|FG004|Overall Study|Protocol Violation|0|||
164360484|NCT00642941|593694701|FG005|Overall Study|Protocol Violation|0|||
164360485|NCT00642941|593694702|FG006|Overall Study|Protocol Violation|1|||
164360486|NCT00642941|593694703|FG007|Overall Study|Protocol Violation|0|||
164360487|NCT00642941|593694704|FG008|Overall Study|Protocol Violation|0|||
164360488|NCT00642941|593694705|FG009|Overall Study|Protocol Violation|0|||
164360489|NCT00642941|593694706|FG010|Overall Study|Protocol Violation|0|||
164360490|NCT00642941|593694707|FG011|Overall Study|Protocol Violation|0|||
164360491|NCT00642941|593694696|FG000|Overall Study|Adverse Event|1|||
164360492|NCT00642941|593694697|FG001|Overall Study|Adverse Event|1|||
164360493|NCT00642941|593694698|FG002|Overall Study|Adverse Event|0|||
164360494|NCT00642941|593694699|FG003|Overall Study|Adverse Event|0|||
164360495|NCT00642941|593694700|FG004|Overall Study|Adverse Event|0|||
164360496|NCT00642941|593694701|FG005|Overall Study|Adverse Event|0|||
164360497|NCT00642941|593694702|FG006|Overall Study|Adverse Event|1|||
164360498|NCT00642941|593694703|FG007|Overall Study|Adverse Event|1|||
164360499|NCT00642941|593694704|FG008|Overall Study|Adverse Event|0|||
164360500|NCT00642941|593694705|FG009|Overall Study|Adverse Event|1|||
164360501|NCT00642941|593694706|FG010|Overall Study|Adverse Event|0|||
164360502|NCT00642941|593694707|FG011|Overall Study|Adverse Event|0|||
164360503|NCT00642941|593694696|FG000|Overall Study|Other|1|||
164360504|NCT00642941|593694697|FG001|Overall Study|Other|1|||
164360505|NCT00642941|593694698|FG002|Overall Study|Other|1|||
164360506|NCT00642941|593694699|FG003|Overall Study|Other|1|||
164360507|NCT00642941|593694700|FG004|Overall Study|Other|0|||
164360508|NCT00642941|593694701|FG005|Overall Study|Other|1|||
164360509|NCT00642941|593694702|FG006|Overall Study|Other|0|||
164360510|NCT00642941|593694703|FG007|Overall Study|Other|1|||
164360511|NCT00642941|593694704|FG008|Overall Study|Other|0|||
164360512|NCT00642941|593694705|FG009|Overall Study|Other|0|||
164360513|NCT00642941|593694706|FG010|Overall Study|Other|0|||
164360514|NCT00642941|593694707|FG011|Overall Study|Other|1|||
164360515|NCT00642941|593694696|FG000|Overall Study|Disease progression|60|||
164360516|NCT00642941|593694697|FG001|Overall Study|Disease progression|50|||
164360517|NCT00642941|593694698|FG002|Overall Study|Disease progression|5|||
164360518|NCT00642941|593694699|FG003|Overall Study|Disease progression|36|||
164360519|NCT00642941|593694700|FG004|Overall Study|Disease progression|23|||
164360520|NCT00642941|593694701|FG005|Overall Study|Disease progression|39|||
164360521|NCT00642941|593694702|FG006|Overall Study|Disease progression|18|||
164360522|NCT00642941|593694703|FG007|Overall Study|Disease progression|12|||
164360523|NCT00642941|593694704|FG008|Overall Study|Disease progression|10|||
164360524|NCT00642941|593694705|FG009|Overall Study|Disease progression|7|||
164360525|NCT00642941|593694706|FG010|Overall Study|Disease progression|12|||
164360526|NCT00642941|593694707|FG011|Overall Study|Disease progression|7|||
164010233|NCT01089725|592401455|FG002|Overall Study|Lack of Efficacy|1|||
164360527|NCT03051607|593694709|FG000|Overall Study|Adverse Event|66|||
164360528|NCT01505868|593694710|FG000|Overall Study|Withdrawal by Subject|1|||
164360529|NCT01505868|593694711|FG001|Overall Study|Withdrawal by Subject|0|||
164360530|NCT01505868|593694712|FG002|Overall Study|Withdrawal by Subject|0|||
164360531|NCT01505868|593694713|FG003|Overall Study|Withdrawal by Subject|0|||
164360532|NCT01505868|593694714|FG004|Overall Study|Withdrawal by Subject|0|||
164360533|NCT00894322|593694715|FG000|Overall Study|Withdrawal by Subject|1|||
164360534|NCT00894322|593694716|FG001|Overall Study|Withdrawal by Subject|0|||
164360535|NCT00894322|593694717|FG002|Overall Study|Withdrawal by Subject|0|||
164360536|NCT02626520|593694727|FG000|Overall Study|Physician Decision|1|||
164360537|NCT02626520|593694728|FG001|Overall Study|Physician Decision|1|||
164360538|NCT02626520|593694727|FG000|Overall Study|Adverse Event|0|||
164360539|NCT02626520|593694728|FG001|Overall Study|Adverse Event|4|||
164360540|NCT02626520|593694727|FG000|Overall Study|Lack of Efficacy|0|||
164360541|NCT02626520|593694728|FG001|Overall Study|Lack of Efficacy|2|||
164360542|NCT02626520|593694727|FG000|Overall Study|Did not start protocol therapy|0|||
164360543|NCT02626520|593694728|FG001|Overall Study|Did not start protocol therapy|2|||
164360544|NCT02626520|593694727|FG000|Overall Study|Study terminated|0|||
164360545|NCT02626520|593694728|FG001|Overall Study|Study terminated|1|||
164360546|NCT00535223|593694729|FG000|Overall Study|Withdrawal by Subject|4|||
164360547|NCT00535223|593694730|FG001|Overall Study|Withdrawal by Subject|1|||
164360548|NCT02953314|593694731|FG000|Overall Study|Adverse Event|0|||
164360549|NCT02953314|593694732|FG001|Overall Study|Adverse Event|1|||
164360550|NCT02953314|593694731|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
164360551|NCT02953314|593694732|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
164360552|NCT01288287|593694733|FG000|Overall Study|Lost to Follow-up|8|||
164360553|NCT01288287|593694733|FG000|Overall Study|Withdrawal by Subject|4|||
164360554|NCT01288287|593694733|FG000|Overall Study|Lack of Efficacy|13|||
164360555|NCT01288287|593694733|FG000|Overall Study|Other Reason|13|||
164360556|NCT01288287|593694733|FG000|Overall Study|Unknown Reason|1|||
164360557|NCT01288287|593694733|FG000|Overall Study|Unknown Status|7|||
164360558|NCT00238121|593694739|FG000|Overall Study|Withdrawal by Subject|1|||
164360559|NCT00238121|593694740|FG001|Overall Study|Withdrawal by Subject|1|||
164360560|NCT00238121|593694739|FG000|Overall Study|Adverse Event|2|||
164360561|NCT00238121|593694740|FG001|Overall Study|Adverse Event|1|||
164360562|NCT02221284|593694741|FG000|Overall Study|Case Report Forms Uncollected|56|||
164360563|NCT02221284|593694741|FG000|Overall Study|Protocol Deviation|5|||
164360564|NCT00101907|593694743|FG000|Overall Study|Adverse Event|1|||
164360565|NCT00101907|593694744|FG001|Overall Study|Adverse Event|0|||
164360566|NCT00101907|593694745|FG002|Overall Study|Adverse Event|0|||
164360567|NCT00101907|593694746|FG003|Overall Study|Adverse Event|0|||
164360568|NCT00101907|593694747|FG004|Overall Study|Adverse Event|0|||
164360569|NCT00101907|593694748|FG005|Overall Study|Adverse Event|0|||
164360570|NCT00101907|593694743|FG000|Overall Study|Death|0|||
164360571|NCT00101907|593694744|FG001|Overall Study|Death|1|||
164360572|NCT00101907|593694745|FG002|Overall Study|Death|0|||
164360573|NCT00101907|593694746|FG003|Overall Study|Death|0|||
164360574|NCT00101907|593694747|FG004|Overall Study|Death|3|||
164360575|NCT00101907|593694748|FG005|Overall Study|Death|0|||
164360576|NCT00101907|593694743|FG000|Overall Study|Physician Decision|0|||
164360577|NCT00101907|593694744|FG001|Overall Study|Physician Decision|0|||
164360578|NCT00101907|593694745|FG002|Overall Study|Physician Decision|0|||
164360579|NCT00101907|593694746|FG003|Overall Study|Physician Decision|1|||
164360580|NCT00101907|593694747|FG004|Overall Study|Physician Decision|1|||
164360581|NCT00101907|593694748|FG005|Overall Study|Physician Decision|0|||
164360582|NCT00101907|593694743|FG000|Overall Study|Withdrawal by Subject|1|||
164360583|NCT00101907|593694744|FG001|Overall Study|Withdrawal by Subject|0|||
164360584|NCT00101907|593694745|FG002|Overall Study|Withdrawal by Subject|1|||
164360585|NCT00101907|593694746|FG003|Overall Study|Withdrawal by Subject|0|||
164360586|NCT00101907|593694747|FG004|Overall Study|Withdrawal by Subject|1|||
164360587|NCT00101907|593694748|FG005|Overall Study|Withdrawal by Subject|0|||
164360588|NCT01474876|593694751|FG000|Overall Study|Adverse Event|11|||
164360589|NCT01474876|593694752|FG001|Overall Study|Adverse Event|5|||
164360590|NCT01474876|593694753|FG002|Overall Study|Adverse Event|0|||
164360591|NCT01474876|593694751|FG000|Overall Study|Serious Adverse Event|2|||
164360592|NCT01474876|593694752|FG001|Overall Study|Serious Adverse Event|3|||
164360593|NCT01474876|593694753|FG002|Overall Study|Serious Adverse Event|0|||
164360594|NCT01474876|593694751|FG000|Overall Study|Lost to Follow-up|5|||
164360595|NCT01474876|593694752|FG001|Overall Study|Lost to Follow-up|4|||
164360596|NCT01474876|593694753|FG002|Overall Study|Lost to Follow-up|0|||
164360597|NCT01474876|593694751|FG000|Overall Study|Investigator's decision|28|||
164360598|NCT01474876|593694752|FG001|Overall Study|Investigator's decision|6|||
164360599|NCT01474876|593694753|FG002|Overall Study|Investigator's decision|0|||
164360600|NCT01474876|593694751|FG000|Overall Study|Patient's request|19|||
164360601|NCT01474876|593694752|FG001|Overall Study|Patient's request|5|||
164360602|NCT01474876|593694753|FG002|Overall Study|Patient's request|0|||
164360603|NCT01474876|593694751|FG000|Overall Study|Investigator's decision and pt request|1|||
164360604|NCT01474876|593694752|FG001|Overall Study|Investigator's decision and pt request|0|||
164360605|NCT01474876|593694753|FG002|Overall Study|Investigator's decision and pt request|0|||
164360606|NCT03839212|593694755|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
164360607|NCT00733746|593694756|FG000|Overall Study|Ineligible|5|||
164360608|NCT02113956|593694757|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
163901573|NCT00776009|592011375|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
163901574|NCT00776009|592011376|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
163901575|NCT00776009|592011377|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
164010234|NCT01089725|592401456|FG003|Overall Study|Lack of Efficacy|0|||
164360609|NCT02113956|593694758|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
164360610|NCT02113956|593694757|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
164360611|NCT02113956|593694758|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
164360612|NCT02113956|593694757|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
164360613|NCT02113956|593694758|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
164360614|NCT02472795|593694759|FG000|Overall Study|Adverse Event|0|||
164360615|NCT02472795|593694760|FG001|Overall Study|Adverse Event|1|||
164360616|NCT02472795|593694761|FG002|Overall Study|Adverse Event|0|||
164360617|NCT02472795|593694762|FG003|Overall Study|Adverse Event|0|||
164360618|NCT02472795|593694763|FG004|Overall Study|Adverse Event|2|||
164360619|NCT02472795|593694759|FG000|Overall Study|Withdrawal by Subject|0|||
164360620|NCT02472795|593694760|FG001|Overall Study|Withdrawal by Subject|0|||
164360621|NCT02472795|593694761|FG002|Overall Study|Withdrawal by Subject|0|||
164360622|NCT02472795|593694762|FG003|Overall Study|Withdrawal by Subject|0|||
164360623|NCT02472795|593694763|FG004|Overall Study|Withdrawal by Subject|1|||
164360624|NCT04318080|593697109|FG000|Overall Study|Study closed by sponsor|10|||
164360625|NCT04318080|593697110|FG001|Overall Study|Study closed by sponsor|22|||
164360626|NCT04318080|593697109|FG000|Overall Study|Death|3|||
164360627|NCT04318080|593697110|FG001|Overall Study|Death|9|||
164360628|NCT04318080|593697109|FG000|Overall Study|Withdrawal by Subject|1|||
164360629|NCT04318080|593697110|FG001|Overall Study|Withdrawal by Subject|0|||
164360630|NCT04318080|593697109|FG000|Overall Study|Protocol Deviation|1|||
164360631|NCT04318080|593697110|FG001|Overall Study|Protocol Deviation|0|||
164360632|NCT06308822|593697111|FG000|Overall Study|Mutation Status Not Confirmed|17|||
164360633|NCT06308822|593697111|FG000|Overall Study|Adverse Event|1|||
164360634|NCT06308822|593697111|FG000|Overall Study|Death|5|||
164360635|NCT06308822|593697111|FG000|Overall Study|Disease progression|8|||
164360636|NCT06308822|593697111|FG000|Overall Study|Withdrawal by Subject|1|||
164360637|NCT06308822|593697111|FG000|Overall Study|Physician Decision|3|||
164360638|NCT02926924|593697112|FG000|Overall Study|withdrawal - reason unknown|0|||
164360639|NCT02926924|593697113|FG001|Overall Study|withdrawal - reason unknown|1|||
164360640|NCT01536379|593697114|FG000|Overall Study|Adverse Event|1|||
164360641|NCT01536379|593697115|FG001|Overall Study|Adverse Event|2|||
164360642|NCT01536379|593697114|FG000|Overall Study|Withdrawal by Subject|1|||
164360643|NCT01536379|593697115|FG001|Overall Study|Withdrawal by Subject|1|||
164360644|NCT04734652|593697128|FG000|Overall Study|Withdrawal by Subject|2|||
164360645|NCT04734652|593697129|FG001|Overall Study|Withdrawal by Subject|0|||
164360646|NCT04734652|593697128|FG000|Overall Study|Death|0|||
164360647|NCT04734652|593697129|FG001|Overall Study|Death|1|||
164360648|NCT04146545|593697132|FG000|Overall Study|deemed ineligible after randomization|1|||
164360649|NCT04146545|593697133|FG001|Overall Study|deemed ineligible after randomization|0|||
164360650|NCT04729127|593697134|FG000|Overall Study|Suspended/Terminated EI Services|4|||
164360651|NCT04729127|593697135|FG001|Overall Study|Suspended/Terminated EI Services|0|||
164360652|NCT04729127|593697136|FG002|Overall Study|Suspended/Terminated EI Services|4|||
164360653|NCT04729127|593697137|FG003|Overall Study|Suspended/Terminated EI Services|6|||
164360654|NCT04729127|593697138|FG004|Overall Study|Suspended/Terminated EI Services|0|||
164360655|NCT04729127|593697139|FG005|Overall Study|Suspended/Terminated EI Services|6|||
164360656|NCT04729127|593697140|FG006|Overall Study|Suspended/Terminated EI Services|2|||
164360657|NCT04729127|593697141|FG007|Overall Study|Suspended/Terminated EI Services|0|||
164360658|NCT04729127|593697142|FG008|Overall Study|Suspended/Terminated EI Services|2|||
164360659|NCT04729127|593697134|FG000|Overall Study|Withdrawal by Subject|1|||
164360660|NCT04729127|593697135|FG001|Overall Study|Withdrawal by Subject|0|||
164360661|NCT04729127|593697136|FG002|Overall Study|Withdrawal by Subject|1|||
164360662|NCT04729127|593697137|FG003|Overall Study|Withdrawal by Subject|0|||
164360663|NCT04729127|593697138|FG004|Overall Study|Withdrawal by Subject|0|||
164360664|NCT04729127|593697139|FG005|Overall Study|Withdrawal by Subject|0|||
164360665|NCT04729127|593697140|FG006|Overall Study|Withdrawal by Subject|0|||
164360666|NCT04729127|593697141|FG007|Overall Study|Withdrawal by Subject|0|||
164360667|NCT04729127|593697142|FG008|Overall Study|Withdrawal by Subject|0|||
164360668|NCT04729127|593697134|FG000|Overall Study|Switched Agency/Setting|1|||
164360669|NCT04729127|593697135|FG001|Overall Study|Switched Agency/Setting|0|||
164360670|NCT04729127|593697136|FG002|Overall Study|Switched Agency/Setting|1|||
164360671|NCT04729127|593697137|FG003|Overall Study|Switched Agency/Setting|1|||
164360672|NCT04729127|593697138|FG004|Overall Study|Switched Agency/Setting|0|||
164360673|NCT04729127|593697139|FG005|Overall Study|Switched Agency/Setting|1|||
164360674|NCT04729127|593697140|FG006|Overall Study|Switched Agency/Setting|1|||
164360675|NCT04729127|593697141|FG007|Overall Study|Switched Agency/Setting|0|||
164360676|NCT04729127|593697142|FG008|Overall Study|Switched Agency/Setting|1|||
164360677|NCT01139450|593697145|FG000|Overall Study|Withdrawal by Subject|7|||
164360678|NCT01139450|593697146|FG001|Overall Study|Withdrawal by Subject|10|||
164360679|NCT01139450|593697147|FG002|Overall Study|Withdrawal by Subject|13|||
164360680|NCT01139450|593697145|FG000|Overall Study|Lack of Efficacy|3|||
164360681|NCT01139450|593697146|FG001|Overall Study|Lack of Efficacy|1|||
164360682|NCT01139450|593697147|FG002|Overall Study|Lack of Efficacy|8|||
164360683|NCT01139450|593697145|FG000|Overall Study|Protocol Violation|6|||
164360684|NCT01139450|593697146|FG001|Overall Study|Protocol Violation|5|||
164360685|NCT01139450|593697147|FG002|Overall Study|Protocol Violation|2|||
164360686|NCT01139450|593697145|FG000|Overall Study|Lost to Follow-up|9|||
164360687|NCT01139450|593697146|FG001|Overall Study|Lost to Follow-up|7|||
164360688|NCT01139450|593697147|FG002|Overall Study|Lost to Follow-up|11|||
164360689|NCT01139450|593697145|FG000|Overall Study|Administrative|0|||
164360690|NCT01139450|593697146|FG001|Overall Study|Administrative|0|||
164360691|NCT01139450|593697147|FG002|Overall Study|Administrative|1|||
164360692|NCT01139450|593697145|FG000|Overall Study|Adverse Event|2|||
164360693|NCT01139450|593697146|FG001|Overall Study|Adverse Event|2|||
164010235|NCT01089725|592401457|FG004|Overall Study|Lack of Efficacy|4|||
164360694|NCT01139450|593697147|FG002|Overall Study|Adverse Event|3|||
164360695|NCT01277523|593697148|FG000|Overall Study|Adverse Event|1|||
164360696|NCT01277523|593697149|FG001|Overall Study|Adverse Event|0|||
164360697|NCT01277523|593697150|FG002|Overall Study|Adverse Event|0|||
164360698|NCT01277523|593697148|FG000|Overall Study|Protocol Violation|2|||
164360699|NCT01277523|593697149|FG001|Overall Study|Protocol Violation|0|||
164360700|NCT01277523|593697150|FG002|Overall Study|Protocol Violation|0|||
164360701|NCT01277523|593697148|FG000|Overall Study|Other Reason not Defined|0|||
164360702|NCT01277523|593697149|FG001|Overall Study|Other Reason not Defined|1|||
164010236|NCT01089725|592401453|FG000|Overall Study|Lost to Follow-up|2|||
164010237|NCT01089725|592401454|FG001|Overall Study|Lost to Follow-up|2|||
164010238|NCT01089725|592401455|FG002|Overall Study|Lost to Follow-up|0|||
164010239|NCT01089725|592401456|FG003|Overall Study|Lost to Follow-up|3|||
164010240|NCT01089725|592401457|FG004|Overall Study|Lost to Follow-up|0|||
164010241|NCT01089725|592401453|FG000|Overall Study|Protocol Violation|0|||
164010242|NCT01089725|592401454|FG001|Overall Study|Protocol Violation|0|||
164010243|NCT01089725|592401455|FG002|Overall Study|Protocol Violation|1|||
164010244|NCT01089725|592401456|FG003|Overall Study|Protocol Violation|1|||
164360703|NCT01277523|593697150|FG002|Overall Study|Other Reason not Defined|0|||
164360704|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
164360705|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360706|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360707|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360708|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360709|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360710|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360711|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360712|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
164360713|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360714|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
164360715|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360716|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360717|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360718|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360719|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360720|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360721|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
164360722|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
164360723|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
164360724|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
164360725|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
164360726|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
164360727|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
164360728|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
164360729|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
164360730|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
164360731|NCT03662542|593697155|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
164360732|NCT03662542|593697156|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360733|NCT03662542|593697157|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360734|NCT03662542|593697158|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360735|NCT03662542|593697159|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360736|NCT03662542|593697160|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360737|NCT03662542|593697161|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360738|NCT03662542|593697162|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360739|NCT03662542|593697163|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
164360740|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360741|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360742|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164010245|NCT01089725|592401457|FG004|Overall Study|Protocol Violation|0|||
164010246|NCT01089725|592401453|FG000|Overall Study|Withdrawal by Subject|5|||
164010247|NCT01089725|592401454|FG001|Overall Study|Withdrawal by Subject|5|||
164010248|NCT01089725|592401455|FG002|Overall Study|Withdrawal by Subject|4|||
164010249|NCT01089725|592401456|FG003|Overall Study|Withdrawal by Subject|5|||
164010250|NCT01089725|592401457|FG004|Overall Study|Withdrawal by Subject|4|||
164360743|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360744|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360745|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
164010251|NCT01089725|592401453|FG000|Overall Study|Study Terminated by Sponsor|51|||
164010252|NCT01089725|592401454|FG001|Overall Study|Study Terminated by Sponsor|56|||
164360746|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360747|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360748|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
164360749|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360750|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360751|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360752|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
164360753|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
164360754|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360755|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360756|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360757|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
164360758|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360759|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360760|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360761|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
164360762|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
164360763|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
164360764|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360765|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360766|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
164360767|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360768|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360769|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360770|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360771|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
164360772|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
164360773|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360774|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360775|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
164360776|NCT03662542|593697155|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360777|NCT03662542|593697156|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360778|NCT03662542|593697157|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360779|NCT03662542|593697158|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360780|NCT03662542|593697159|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360781|NCT03662542|593697160|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
164360782|NCT03662542|593697161|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360783|NCT03662542|593697162|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360784|NCT03662542|593697163|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
164360785|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360786|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360787|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360788|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360789|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360790|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360791|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360792|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
164360793|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
164360794|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
163901576|NCT00776009|592011378|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
163901577|NCT00776009|592011373|FG000|Period 2: Second Intervention|Protocol Violation|1|||
163901578|NCT00776009|592011374|FG001|Period 2: Second Intervention|Protocol Violation|0|||
163901579|NCT00776009|592011375|FG002|Period 2: Second Intervention|Protocol Violation|1|||
163901580|NCT00776009|592011376|FG003|Period 2: Second Intervention|Protocol Violation|0|||
163901581|NCT00776009|592011377|FG004|Period 2: Second Intervention|Protocol Violation|0|||
163901582|NCT00776009|592011378|FG005|Period 2: Second Intervention|Protocol Violation|0|||
163901583|NCT00776009|592011373|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
163901584|NCT00776009|592011374|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
163901585|NCT00776009|592011375|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
163901586|NCT00776009|592011376|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
164360795|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360796|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360797|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164010253|NCT01089725|592401455|FG002|Overall Study|Study Terminated by Sponsor|53|||
164010254|NCT01089725|592401456|FG003|Overall Study|Study Terminated by Sponsor|68|||
164360798|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360799|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360800|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
164360801|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
164360802|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
164360803|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360804|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360805|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360806|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360807|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360808|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360809|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
164360810|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
164360811|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
164360812|NCT03662542|593697155|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360813|NCT03662542|593697156|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360814|NCT03662542|593697157|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360815|NCT03662542|593697158|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360816|NCT03662542|593697159|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360817|NCT03662542|593697160|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
164360818|NCT03662542|593697161|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
164360819|NCT03662542|593697162|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
164360820|NCT03662542|593697163|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
164360821|NCT01217060|593697164|FG000|Overall Study|Withdrawal by Subject|1|||
164360822|NCT04762680|593697173|FG000|Phase 2|Adverse Event|0|||
164360823|NCT04762680|593697174|FG001|Phase 2|Adverse Event|1|||
164360824|NCT04762680|593697175|FG002|Phase 2|Adverse Event|0|||
164360825|NCT04762680|593697176|FG003|Phase 2|Adverse Event|0|||
164360826|NCT04762680|593697177|FG004|Phase 2|Adverse Event|0|||
164360827|NCT04762680|593697178|FG005|Phase 2|Adverse Event|0|||
164360828|NCT04762680|593697179|FG006|Phase 2|Adverse Event|0|||
164360829|NCT04762680|593697180|FG007|Phase 2|Adverse Event|0|||
164360830|NCT04762680|593697181|FG008|Phase 2|Adverse Event|0|||
164360831|NCT04762680|593697182|FG009|Phase 2|Adverse Event|0|||
164360832|NCT04762680|593697183|FG010|Phase 2|Adverse Event|0|||
164360833|NCT04762680|593697184|FG011|Phase 2|Adverse Event|0|||
164360834|NCT04762680|593697185|FG012|Phase 2|Adverse Event|0|||
164360835|NCT04762680|593697186|FG013|Phase 2|Adverse Event|0|||
164360836|NCT04762680|593697187|FG014|Phase 2|Adverse Event|0|||
164360837|NCT04762680|593697188|FG015|Phase 2|Adverse Event|0|||
164360838|NCT04762680|593697189|FG016|Phase 2|Adverse Event|0|||
164360839|NCT04762680|593697190|FG017|Phase 2|Adverse Event|0|||
164360840|NCT04762680|593697191|FG018|Phase 2|Adverse Event|0|||
164360841|NCT04762680|593697192|FG019|Phase 2|Adverse Event|0|||
164360842|NCT04762680|593697193|FG020|Phase 2|Adverse Event|0|||
164360843|NCT04762680|593697194|FG021|Phase 2|Adverse Event|0|||
164360844|NCT04762680|593697173|FG000|Phase 2|Protocol Violation|5|||
164360845|NCT04762680|593697174|FG001|Phase 2|Protocol Violation|5|||
164360846|NCT04762680|593697175|FG002|Phase 2|Protocol Violation|1|||
164360847|NCT04762680|593697176|FG003|Phase 2|Protocol Violation|0|||
164360848|NCT04762680|593697177|FG004|Phase 2|Protocol Violation|0|||
164360849|NCT04762680|593697178|FG005|Phase 2|Protocol Violation|0|||
164360850|NCT04762680|593697179|FG006|Phase 2|Protocol Violation|0|||
164360851|NCT04762680|593697180|FG007|Phase 2|Protocol Violation|0|||
164360852|NCT04762680|593697181|FG008|Phase 2|Protocol Violation|0|||
164360853|NCT04762680|593697182|FG009|Phase 2|Protocol Violation|0|||
164360854|NCT04762680|593697183|FG010|Phase 2|Protocol Violation|0|||
164360855|NCT04762680|593697184|FG011|Phase 2|Protocol Violation|0|||
164360856|NCT04762680|593697185|FG012|Phase 2|Protocol Violation|0|||
164360857|NCT04762680|593697186|FG013|Phase 2|Protocol Violation|0|||
164360858|NCT04762680|593697187|FG014|Phase 2|Protocol Violation|0|||
164360859|NCT04762680|593697188|FG015|Phase 2|Protocol Violation|0|||
164360860|NCT04762680|593697189|FG016|Phase 2|Protocol Violation|0|||
164360861|NCT04762680|593697190|FG017|Phase 2|Protocol Violation|0|||
164360862|NCT04762680|593697191|FG018|Phase 2|Protocol Violation|0|||
164010255|NCT01089725|592401457|FG004|Overall Study|Study Terminated by Sponsor|68|||
164010256|NCT01089725|592401453|FG000|Overall Study|Randomized, but not treated|0|||
164010257|NCT01089725|592401454|FG001|Overall Study|Randomized, but not treated|1|||
164010258|NCT01089725|592401455|FG002|Overall Study|Randomized, but not treated|2|||
164010259|NCT01089725|592401456|FG003|Overall Study|Randomized, but not treated|1|||
164010260|NCT01089725|592401457|FG004|Overall Study|Randomized, but not treated|2|||
164010261|NCT01089725|592401453|FG000|Overall Study|Other|3|||
164010262|NCT01089725|592401454|FG001|Overall Study|Other|0|||
164010263|NCT01089725|592401455|FG002|Overall Study|Other|0|||
164360863|NCT04762680|593697192|FG019|Phase 2|Protocol Violation|0|||
164360864|NCT04762680|593697193|FG020|Phase 2|Protocol Violation|0|||
164360865|NCT04762680|593697194|FG021|Phase 2|Protocol Violation|0|||
164360866|NCT04762680|593697173|FG000|Phase 2|Withdrawal by Subject|23|||
164360867|NCT04762680|593697174|FG001|Phase 2|Withdrawal by Subject|21|||
164360868|NCT04762680|593697175|FG002|Phase 2|Withdrawal by Subject|28|||
164360869|NCT04762680|593697176|FG003|Phase 2|Withdrawal by Subject|0|||
164360870|NCT04762680|593697177|FG004|Phase 2|Withdrawal by Subject|0|||
164360871|NCT04762680|593697178|FG005|Phase 2|Withdrawal by Subject|0|||
164360872|NCT04762680|593697179|FG006|Phase 2|Withdrawal by Subject|0|||
164360873|NCT04762680|593697180|FG007|Phase 2|Withdrawal by Subject|0|||
164360874|NCT04762680|593697181|FG008|Phase 2|Withdrawal by Subject|0|||
164360875|NCT04762680|593697182|FG009|Phase 2|Withdrawal by Subject|0|||
164360876|NCT04762680|593697183|FG010|Phase 2|Withdrawal by Subject|0|||
164360877|NCT04762680|593697184|FG011|Phase 2|Withdrawal by Subject|0|||
164360878|NCT04762680|593697185|FG012|Phase 2|Withdrawal by Subject|0|||
164360879|NCT04762680|593697186|FG013|Phase 2|Withdrawal by Subject|0|||
164360880|NCT04762680|593697187|FG014|Phase 2|Withdrawal by Subject|0|||
164360881|NCT04762680|593697188|FG015|Phase 2|Withdrawal by Subject|0|||
164360882|NCT04762680|593697189|FG016|Phase 2|Withdrawal by Subject|0|||
164360883|NCT04762680|593697190|FG017|Phase 2|Withdrawal by Subject|0|||
164360884|NCT04762680|593697191|FG018|Phase 2|Withdrawal by Subject|0|||
164360885|NCT04762680|593697192|FG019|Phase 2|Withdrawal by Subject|0|||
164360886|NCT04762680|593697193|FG020|Phase 2|Withdrawal by Subject|0|||
164360887|NCT04762680|593697194|FG021|Phase 2|Withdrawal by Subject|0|||
164360888|NCT04762680|593697173|FG000|Phase 2|Lost to Follow-up|14|||
164360889|NCT04762680|593697174|FG001|Phase 2|Lost to Follow-up|8|||
164360890|NCT04762680|593697175|FG002|Phase 2|Lost to Follow-up|9|||
164360891|NCT04762680|593697176|FG003|Phase 2|Lost to Follow-up|0|||
164360892|NCT04762680|593697177|FG004|Phase 2|Lost to Follow-up|0|||
164360893|NCT04762680|593697178|FG005|Phase 2|Lost to Follow-up|0|||
164360894|NCT04762680|593697179|FG006|Phase 2|Lost to Follow-up|0|||
164360895|NCT04762680|593697180|FG007|Phase 2|Lost to Follow-up|0|||
164360896|NCT04762680|593697181|FG008|Phase 2|Lost to Follow-up|0|||
164360897|NCT04762680|593697182|FG009|Phase 2|Lost to Follow-up|0|||
164360898|NCT04762680|593697183|FG010|Phase 2|Lost to Follow-up|0|||
164360899|NCT04762680|593697184|FG011|Phase 2|Lost to Follow-up|0|||
164360900|NCT04762680|593697185|FG012|Phase 2|Lost to Follow-up|0|||
164360901|NCT04762680|593697186|FG013|Phase 2|Lost to Follow-up|0|||
164360902|NCT04762680|593697187|FG014|Phase 2|Lost to Follow-up|0|||
164360903|NCT04762680|593697188|FG015|Phase 2|Lost to Follow-up|0|||
164360904|NCT04762680|593697189|FG016|Phase 2|Lost to Follow-up|0|||
164360905|NCT04762680|593697190|FG017|Phase 2|Lost to Follow-up|0|||
164360906|NCT04762680|593697191|FG018|Phase 2|Lost to Follow-up|0|||
164360907|NCT04762680|593697192|FG019|Phase 2|Lost to Follow-up|0|||
164360908|NCT04762680|593697193|FG020|Phase 2|Lost to Follow-up|0|||
164360909|NCT04762680|593697194|FG021|Phase 2|Lost to Follow-up|0|||
164360910|NCT04762680|593697173|FG000|Phase 3|Adverse Event|0|||
164010264|NCT01089725|592401456|FG003|Overall Study|Other|1|||
164010265|NCT01089725|592401457|FG004|Overall Study|Other|0|||
164010266|NCT03191396|592403120|FG000|Overall Study|Lost to Follow-up|0|||
164010267|NCT03191396|592403121|FG001|Overall Study|Lost to Follow-up|3|||
164010268|NCT03191396|592403120|FG000|Overall Study|Withdrawal by Subject|3|||
164010269|NCT03191396|592403121|FG001|Overall Study|Withdrawal by Subject|2|||
164010270|NCT01240811|592403122|FG000|Overall Study|Physician Decision|0|||
164010271|NCT01240811|592403123|FG001|Overall Study|Physician Decision|1|||
164010272|NCT01240811|592403124|FG002|Overall Study|Physician Decision|0|||
164010273|NCT01240811|592403122|FG000|Overall Study|Withdrawal by Subject|0|||
164010274|NCT01240811|592403123|FG001|Overall Study|Withdrawal by Subject|0|||
164010275|NCT01240811|592403124|FG002|Overall Study|Withdrawal by Subject|1|||
164010276|NCT01853228|592403143|FG000|Phase 1|Lack of Efficacy|8|||
164010277|NCT01853228|592403144|FG001|Phase 1|Lack of Efficacy|0|||
164010278|NCT01853228|592403143|FG000|Phase 1|Other|1|||
164010279|NCT01853228|592403144|FG001|Phase 1|Other|0|||
164010280|NCT01853228|592403143|FG000|Phase 2|Physician Decision|0|||
164010281|NCT01853228|592403144|FG001|Phase 2|Physician Decision|1|||
164010282|NCT01853228|592403143|FG000|Phase 2|Proceed To Transplant|0|||
164010283|NCT01853228|592403144|FG001|Phase 2|Proceed To Transplant|3|||
164360911|NCT04762680|593697174|FG001|Phase 3|Adverse Event|0|||
164360912|NCT04762680|593697175|FG002|Phase 3|Adverse Event|0|||
164360913|NCT04762680|593697176|FG003|Phase 3|Adverse Event|1|||
164360914|NCT04762680|593697177|FG004|Phase 3|Adverse Event|0|||
164360915|NCT04762680|593697178|FG005|Phase 3|Adverse Event|0|||
164360916|NCT04762680|593697179|FG006|Phase 3|Adverse Event|0|||
164360917|NCT04762680|593697180|FG007|Phase 3|Adverse Event|0|||
164360918|NCT04762680|593697181|FG008|Phase 3|Adverse Event|0|||
164360919|NCT04762680|593697182|FG009|Phase 3|Adverse Event|0|||
164360920|NCT04762680|593697183|FG010|Phase 3|Adverse Event|0|||
164360921|NCT04762680|593697184|FG011|Phase 3|Adverse Event|0|||
164360922|NCT04762680|593697185|FG012|Phase 3|Adverse Event|0|||
164360923|NCT04762680|593697186|FG013|Phase 3|Adverse Event|0|||
164360924|NCT04762680|593697187|FG014|Phase 3|Adverse Event|0|||
164360925|NCT04762680|593697188|FG015|Phase 3|Adverse Event|0|||
164360926|NCT04762680|593697189|FG016|Phase 3|Adverse Event|0|||
164360927|NCT04762680|593697190|FG017|Phase 3|Adverse Event|3|||
164360928|NCT04762680|593697191|FG018|Phase 3|Adverse Event|0|||
164360929|NCT04762680|593697192|FG019|Phase 3|Adverse Event|0|||
164360930|NCT04762680|593697193|FG020|Phase 3|Adverse Event|0|||
164360931|NCT04762680|593697194|FG021|Phase 3|Adverse Event|0|||
164360932|NCT04762680|593697173|FG000|Phase 3|Protocol Violation|0|||
164360933|NCT04762680|593697174|FG001|Phase 3|Protocol Violation|0|||
164360934|NCT04762680|593697175|FG002|Phase 3|Protocol Violation|0|||
164360935|NCT04762680|593697176|FG003|Phase 3|Protocol Violation|4|||
164010284|NCT01853228|592403143|FG000|Phase 2|Lack of Efficacy|0|||
164010285|NCT01853228|592403144|FG001|Phase 2|Lack of Efficacy|4|||
164010286|NCT02114203|592403150|FG000|Overall Study|Adverse Event|0|||
164010287|NCT02114203|592403151|FG001|Overall Study|Adverse Event|1|||
164010288|NCT02114203|592403152|FG002|Overall Study|Adverse Event|0|||
164010289|NCT02114203|592403150|FG000|Overall Study|Withdrawal by Subject|0|||
164010290|NCT02114203|592403151|FG001|Overall Study|Withdrawal by Subject|1|||
164360936|NCT04762680|593697177|FG004|Phase 3|Protocol Violation|1|||
164360937|NCT04762680|593697178|FG005|Phase 3|Protocol Violation|5|||
164010291|NCT02114203|592403152|FG002|Overall Study|Withdrawal by Subject|0|||
164010292|NCT01518699|592403153|FG000|Period 2|Protocol Violation|1|||
164010293|NCT01518699|592403154|FG001|Period 2|Protocol Violation|1|||
164010294|NCT01518699|592403155|FG002|Period 2|Protocol Violation|0|||
164010295|NCT01518699|592403156|FG003|Period 2|Protocol Violation|0|||
164010296|NCT01518699|592403157|FG004|Period 2|Protocol Violation|0|||
164010297|NCT01518699|592403158|FG005|Period 2|Protocol Violation|0|||
164010298|NCT01518699|592403153|FG000|Period 2|Lost to Follow-up|0|||
164010299|NCT01518699|592403154|FG001|Period 2|Lost to Follow-up|1|||
164010300|NCT01518699|592403155|FG002|Period 2|Lost to Follow-up|0|||
164010301|NCT01518699|592403156|FG003|Period 2|Lost to Follow-up|0|||
164010302|NCT01518699|592403157|FG004|Period 2|Lost to Follow-up|0|||
164010303|NCT01518699|592403158|FG005|Period 2|Lost to Follow-up|0|||
164010304|NCT01518699|592403153|FG000|Period 2|Adverse Event|1|||
164010305|NCT01518699|592403154|FG001|Period 2|Adverse Event|0|||
164010306|NCT01518699|592403155|FG002|Period 2|Adverse Event|0|||
164010307|NCT01518699|592403156|FG003|Period 2|Adverse Event|0|||
164010308|NCT01518699|592403157|FG004|Period 2|Adverse Event|0|||
164010309|NCT01518699|592403158|FG005|Period 2|Adverse Event|0|||
164010310|NCT01300286|592403160|FG000|Overall Study|did not get dosed|1|||
164010311|NCT03635190|592403161|FG000|Overall Study|Lost to Follow-up|4|||
164010312|NCT03635190|592403161|FG000|Overall Study|Death|3|||
164010313|NCT03635190|592403161|FG000|Overall Study|Withdrawal by Subject|1|||
164010314|NCT03635190|592403161|FG000|Overall Study|Patient moved and did not return for follow up|1|||
164010315|NCT03692910|592403162|FG000|Overall Study|Lost to Follow-up|4|||
164010316|NCT03692910|592403163|FG001|Overall Study|Lost to Follow-up|0|||
164010317|NCT03692910|592403164|FG002|Overall Study|Lost to Follow-up|0|||
164010318|NCT03692910|592403162|FG000|Overall Study|Withdrawal by Subject|2|||
164010319|NCT03692910|592403163|FG001|Overall Study|Withdrawal by Subject|0|||
164010320|NCT03692910|592403164|FG002|Overall Study|Withdrawal by Subject|0|||
164010321|NCT00486226|592403169|FG000|Overall Study|Death|3|||
164010322|NCT00486226|592403169|FG000|Overall Study|Adverse Event|1|||
164010323|NCT00486226|592403169|FG000|Overall Study|Withdrawal by Subject|1|||
164010324|NCT00486226|592403169|FG000|Overall Study|Lost to Follow-up|8|||
164010325|NCT01259492|592403170|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
164010326|NCT01259492|592403171|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
164010327|NCT01259492|592403172|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
164010328|NCT01259492|592403173|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
164010329|NCT01259492|592403170|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
164010330|NCT01259492|592403171|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
164010331|NCT01259492|592403172|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
164010332|NCT01259492|592403173|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
164010333|NCT01259492|592403170|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
164360938|NCT04762680|593697179|FG006|Phase 3|Protocol Violation|1|||
164360939|NCT04762680|593697180|FG007|Phase 3|Protocol Violation|0|||
164010334|NCT01259492|592403171|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
164010335|NCT01259492|592403172|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
164010336|NCT01259492|592403173|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
164360940|NCT04762680|593697181|FG008|Phase 3|Protocol Violation|0|||
164360941|NCT04762680|593697182|FG009|Phase 3|Protocol Violation|0|||
164010337|NCT01259492|592403170|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
164360942|NCT04762680|593697183|FG010|Phase 3|Protocol Violation|0|||
164360943|NCT04762680|593697184|FG011|Phase 3|Protocol Violation|2|||
164091786|NCT00984295|592700022|FG002|Overall Study|Withdrawal by Subject|12|||
164091787|NCT00984295|592700020|FG000|Overall Study|CAE - discontinued test vaccine|0|||
164091788|NCT00984295|592700021|FG001|Overall Study|CAE - discontinued test vaccine|1|||
164091789|NCT00984295|592700022|FG002|Overall Study|CAE - discontinued test vaccine|3|||
164091790|NCT00984295|592700020|FG000|Overall Study|Missed one or more blood samplings|3|||
164091791|NCT00984295|592700021|FG001|Overall Study|Missed one or more blood samplings|7|||
164091792|NCT00984295|592700022|FG002|Overall Study|Missed one or more blood samplings|2|||
164091793|NCT00984295|592700020|FG000|Overall Study|Incomplete safety follow-up|11|||
164091794|NCT00984295|592700021|FG001|Overall Study|Incomplete safety follow-up|2|||
164091795|NCT00984295|592700022|FG002|Overall Study|Incomplete safety follow-up|3|||
164091796|NCT05030753|592700030|FG000|9-week|Lost to Follow-up|10|||
164091797|NCT05030753|592700031|FG001|9-week|Lost to Follow-up|7|||
164091798|NCT05030753|592700030|FG000|9-week|Withdrawal by Subject|1|||
164091799|NCT05030753|592700031|FG001|9-week|Withdrawal by Subject|0|||
164091800|NCT05030753|592700030|FG000|9-week|Excluded from analysis due to missing covariates|2|||
164091801|NCT05030753|592700031|FG001|9-week|Excluded from analysis due to missing covariates|1|||
164091802|NCT05030753|592700030|FG000|6-month post intervention|Lost to Follow-up|5|||
164091803|NCT05030753|592700031|FG001|6-month post intervention|Lost to Follow-up|4|||
164091804|NCT05030753|592700030|FG000|6-month post intervention|Withdrawal by Subject|4|||
164091805|NCT05030753|592700031|FG001|6-month post intervention|Withdrawal by Subject|0|||
164091806|NCT05030753|592700030|FG000|18-month post intervention|Lost to Follow-up|3|||
164091807|NCT05030753|592700031|FG001|18-month post intervention|Lost to Follow-up|1|||
164091808|NCT00329602|592700036|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
164091809|NCT00329602|592700037|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
164091810|NCT00329602|592700038|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
164091811|NCT00329602|592700036|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
164091812|NCT00329602|592700037|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
164091813|NCT00329602|592700038|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
164091814|NCT00329602|592700036|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
164091815|NCT00329602|592700037|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
164091816|NCT00329602|592700038|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
164091817|NCT00329602|592700036|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
164091818|NCT00329602|592700037|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
164091819|NCT00329602|592700038|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
164091820|NCT00329602|592700036|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
164091821|NCT00329602|592700037|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
164091822|NCT00329602|592700038|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
164091823|NCT00329602|592700036|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
164091824|NCT00329602|592700037|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
164091825|NCT00329602|592700038|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
164091826|NCT02579096|592700039|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
164091827|NCT02579096|592700040|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
164091828|NCT02579096|592700039|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
164091829|NCT02579096|592700040|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
164091830|NCT02579096|592700039|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
164091831|NCT02579096|592700040|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
164091832|NCT02579096|592700039|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
164091833|NCT02579096|592700040|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
164091834|NCT02579096|592700039|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
164091835|NCT02579096|592700040|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
164091836|NCT02579096|592700039|FG000|Phase 2, Weeks 25 - 48|Death|2|||
164091837|NCT02579096|592700040|FG001|Phase 2, Weeks 25 - 48|Death|4|||
164091838|NCT02579096|592700039|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
164091839|NCT02579096|592700040|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
164091840|NCT02579096|592700039|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
164091841|NCT02579096|592700040|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
164091842|NCT02579096|592700039|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
164091843|NCT02579096|592700040|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
164091844|NCT02579096|592700039|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
164091845|NCT02579096|592700040|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
164091846|NCT02579096|592700039|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
164091847|NCT02579096|592700040|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
164091848|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Death|3|||
164091849|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Death|2|||
164091850|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
164091851|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
164091852|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
164091853|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
164091854|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
164091855|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
164360944|NCT04762680|593697185|FG012|Phase 3|Protocol Violation|3|||
164360945|NCT04762680|593697186|FG013|Phase 3|Protocol Violation|0|||
164360946|NCT04762680|593697187|FG014|Phase 3|Protocol Violation|0|||
164360947|NCT04762680|593697188|FG015|Phase 3|Protocol Violation|1|||
164360948|NCT04762680|593697189|FG016|Phase 3|Protocol Violation|0|||
164360949|NCT04762680|593697190|FG017|Phase 3|Protocol Violation|10|||
164010338|NCT01259492|592403171|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
164010339|NCT01259492|592403172|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
164010340|NCT01259492|592403173|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
164010341|NCT01259492|592403170|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
164010342|NCT01259492|592403171|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
164010343|NCT01259492|592403172|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
164010344|NCT01259492|592403173|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
164010345|NCT01259492|592403170|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
164010346|NCT01259492|592403171|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
164010347|NCT01259492|592403172|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
164010348|NCT01259492|592403173|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
164010349|NCT01259492|592403170|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
164010350|NCT01259492|592403171|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
164010351|NCT01259492|592403172|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
164010352|NCT01259492|592403173|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
164010353|NCT01259492|592403170|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
164010354|NCT01259492|592403171|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
164010355|NCT01259492|592403172|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
164010356|NCT01259492|592403173|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
164010357|NCT01259492|592403170|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
164010358|NCT01259492|592403171|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
164010359|NCT01259492|592403172|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
164010360|NCT01259492|592403173|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
164010361|NCT01259492|592403170|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
164010362|NCT01259492|592403171|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
164010363|NCT01259492|592403172|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
164010364|NCT01259492|592403173|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
164010365|NCT01259492|592403170|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
164010366|NCT01259492|592403171|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
164010367|NCT01259492|592403172|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
164360950|NCT04762680|593697191|FG018|Phase 3|Protocol Violation|0|||
164010368|NCT01259492|592403173|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
164010369|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
164010370|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
164010371|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
164360951|NCT04762680|593697192|FG019|Phase 3|Protocol Violation|0|||
164360952|NCT04762680|593697193|FG020|Phase 3|Protocol Violation|0|||
164010372|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
164010373|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
164010374|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
164010375|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
164360953|NCT04762680|593697194|FG021|Phase 3|Protocol Violation|0|||
164360954|NCT04762680|593697173|FG000|Phase 3|Withdrawal by Subject|0|||
164360955|NCT04762680|593697174|FG001|Phase 3|Withdrawal by Subject|0|||
164360956|NCT04762680|593697175|FG002|Phase 3|Withdrawal by Subject|0|||
164360957|NCT04762680|593697176|FG003|Phase 3|Withdrawal by Subject|13|||
164360958|NCT04762680|593697177|FG004|Phase 3|Withdrawal by Subject|17|||
164360959|NCT04762680|593697178|FG005|Phase 3|Withdrawal by Subject|12|||
164360960|NCT04762680|593697179|FG006|Phase 3|Withdrawal by Subject|8|||
164360961|NCT04762680|593697180|FG007|Phase 3|Withdrawal by Subject|3|||
164360962|NCT04762680|593697181|FG008|Phase 3|Withdrawal by Subject|2|||
164360963|NCT04762680|593697182|FG009|Phase 3|Withdrawal by Subject|4|||
164360964|NCT04762680|593697183|FG010|Phase 3|Withdrawal by Subject|3|||
164360965|NCT04762680|593697184|FG011|Phase 3|Withdrawal by Subject|1|||
164360966|NCT04762680|593697185|FG012|Phase 3|Withdrawal by Subject|3|||
164360967|NCT04762680|593697186|FG013|Phase 3|Withdrawal by Subject|2|||
164360968|NCT04762680|593697187|FG014|Phase 3|Withdrawal by Subject|1|||
164360969|NCT04762680|593697188|FG015|Phase 3|Withdrawal by Subject|4|||
164360970|NCT04762680|593697189|FG016|Phase 3|Withdrawal by Subject|6|||
164360971|NCT04762680|593697190|FG017|Phase 3|Withdrawal by Subject|32|||
164360972|NCT04762680|593697191|FG018|Phase 3|Withdrawal by Subject|0|||
164360973|NCT04762680|593697192|FG019|Phase 3|Withdrawal by Subject|0|||
164360974|NCT04762680|593697193|FG020|Phase 3|Withdrawal by Subject|0|||
164360975|NCT04762680|593697194|FG021|Phase 3|Withdrawal by Subject|0|||
164360976|NCT04762680|593697173|FG000|Phase 3|Lost to Follow-up|0|||
164360977|NCT04762680|593697174|FG001|Phase 3|Lost to Follow-up|0|||
164360978|NCT04762680|593697175|FG002|Phase 3|Lost to Follow-up|0|||
164360979|NCT04762680|593697176|FG003|Phase 3|Lost to Follow-up|9|||
164360980|NCT04762680|593697177|FG004|Phase 3|Lost to Follow-up|22|||
164360981|NCT04762680|593697178|FG005|Phase 3|Lost to Follow-up|24|||
164360982|NCT04762680|593697179|FG006|Phase 3|Lost to Follow-up|2|||
164360983|NCT04762680|593697180|FG007|Phase 3|Lost to Follow-up|4|||
164360984|NCT04762680|593697181|FG008|Phase 3|Lost to Follow-up|6|||
164360985|NCT04762680|593697182|FG009|Phase 3|Lost to Follow-up|4|||
164360986|NCT04762680|593697183|FG010|Phase 3|Lost to Follow-up|3|||
164360987|NCT04762680|593697184|FG011|Phase 3|Lost to Follow-up|0|||
164360988|NCT04762680|593697185|FG012|Phase 3|Lost to Follow-up|5|||
164360989|NCT04762680|593697186|FG013|Phase 3|Lost to Follow-up|4|||
164360990|NCT04762680|593697187|FG014|Phase 3|Lost to Follow-up|6|||
164360991|NCT04762680|593697188|FG015|Phase 3|Lost to Follow-up|1|||
164360992|NCT04762680|593697189|FG016|Phase 3|Lost to Follow-up|1|||
164360993|NCT04762680|593697190|FG017|Phase 3|Lost to Follow-up|66|||
164360994|NCT04762680|593697191|FG018|Phase 3|Lost to Follow-up|0|||
164360995|NCT04762680|593697192|FG019|Phase 3|Lost to Follow-up|0|||
164360996|NCT04762680|593697193|FG020|Phase 3|Lost to Follow-up|0|||
164360997|NCT04762680|593697194|FG021|Phase 3|Lost to Follow-up|0|||
164360998|NCT04762680|593697173|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164360999|NCT04762680|593697174|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361000|NCT04762680|593697175|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361001|NCT04762680|593697176|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361002|NCT04762680|593697177|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361003|NCT04762680|593697178|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361004|NCT04762680|593697179|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361005|NCT04762680|593697180|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361006|NCT04762680|593697181|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361007|NCT04762680|593697182|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361008|NCT04762680|593697183|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361009|NCT04762680|593697184|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361010|NCT04762680|593697185|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361011|NCT04762680|593697186|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361012|NCT04762680|593697187|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361013|NCT04762680|593697188|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361014|NCT04762680|593697189|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361015|NCT04762680|593697190|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361016|NCT04762680|593697191|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361017|NCT04762680|593697192|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361018|NCT04762680|593697193|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
164361019|NCT04762680|593697194|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
164361020|NCT04762680|593697173|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361021|NCT04762680|593697174|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361022|NCT04762680|593697175|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361023|NCT04762680|593697176|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361024|NCT04762680|593697177|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361025|NCT04762680|593697178|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361026|NCT04762680|593697179|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361027|NCT04762680|593697180|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361028|NCT04762680|593697181|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361029|NCT04762680|593697182|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361030|NCT04762680|593697183|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361031|NCT04762680|593697184|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361032|NCT04762680|593697185|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361033|NCT04762680|593697186|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361034|NCT04762680|593697187|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
164010376|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
164361035|NCT04762680|593697188|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361036|NCT04762680|593697189|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361037|NCT04762680|593697190|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361038|NCT04762680|593697191|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361039|NCT04762680|593697192|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
164361040|NCT04762680|593697193|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361041|NCT04762680|593697194|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
164361042|NCT03388138|593697195|FG000|Overall Study|Protocol Violation|1|||
164361043|NCT03388138|593697196|FG001|Overall Study|Protocol Violation|0|||
164361044|NCT01528072|593697197|FG000|Overall Study|Withdrawal by Subject|5|||
164361045|NCT01528072|593697197|FG000|Overall Study|Physician Decision|1|||
164361046|NCT01528072|593697197|FG000|Overall Study|Determined not eligible by AEAC|1|||
164361047|NCT01528072|593697197|FG000|Overall Study|Missed Visit|2|||
164361048|NCT01528072|593697197|FG000|Overall Study|Lost to Follow-up|5|||
164361049|NCT01528072|593697197|FG000|Overall Study|Explanted|2|||
164361050|NCT01528072|593697197|FG000|Overall Study|Site Closure|4|||
164361051|NCT01528072|593697197|FG000|Overall Study|Death|2|||
164361052|NCT01528072|593697197|FG000|Overall Study|Early Termination of Study|52|||
164361053|NCT02436759|593697204|FG000|Overall Study|Adverse Event|3|||
164361054|NCT02436759|593697205|FG001|Overall Study|Adverse Event|0|||
164361055|NCT02436759|593697204|FG000|Overall Study|Protocol Violation|1|||
164010377|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
164010378|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
164010379|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
164010380|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
164010381|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
164010382|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
164010383|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
164010384|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
164010385|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
164010386|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
164010387|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
164010388|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
164010389|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
164010390|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
164010391|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
164010392|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
164010393|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
164010394|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
164010395|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
164010396|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
164091856|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
164091857|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
164091858|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
164361056|NCT02436759|593697205|FG001|Overall Study|Protocol Violation|0|||
164361057|NCT02436759|593697204|FG000|Overall Study|Withdrawal by Subject|0|||
164361058|NCT02436759|593697205|FG001|Overall Study|Withdrawal by Subject|1|||
164361059|NCT04014075|593697206|FG000|Overall Study|Progressive Disease|53|||
164361060|NCT04014075|593697206|FG000|Overall Study|Adverse Event|15|||
164361061|NCT04014075|593697206|FG000|Overall Study|Clinical Progression|4|||
164361062|NCT04014075|593697206|FG000|Overall Study|Death|2|||
164361063|NCT04014075|593697206|FG000|Overall Study|Withdrawal by Subject|2|||
164361064|NCT04014075|593697206|FG000|Overall Study|Miscellaneous|2|||
164361065|NCT04014075|593697206|FG000|Overall Study|Physician Decision|1|||
164361066|NCT02584504|593697209|FG000|Double-blind Treatment|Participant withdrew consent|0|||
164361067|NCT02584504|593697210|FG001|Double-blind Treatment|Participant withdrew consent|0|||
164361068|NCT02584504|593697211|FG002|Double-blind Treatment|Participant withdrew consent|1|||
164010397|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
164010398|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
164010399|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
164010400|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
164010401|NCT01259492|592403170|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
164010402|NCT01259492|592403171|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
164361069|NCT02584504|593697209|FG000|Double-blind Treatment|Adverse Event|0|||
164361070|NCT02584504|593697210|FG001|Double-blind Treatment|Adverse Event|1|||
164361071|NCT02584504|593697211|FG002|Double-blind Treatment|Adverse Event|0|||
164361072|NCT02584504|593697209|FG000|Double-blind Treatment|Family Matter|0|||
164361073|NCT02584504|593697210|FG001|Double-blind Treatment|Family Matter|1|||
164361074|NCT02584504|593697211|FG002|Double-blind Treatment|Family Matter|0|||
164361075|NCT02584504|593697209|FG000|Open-label Treatment|Participant withdrew consent|0|||
164361076|NCT02584504|593697210|FG001|Open-label Treatment|Participant withdrew consent|0|||
164361077|NCT02584504|593697211|FG002|Open-label Treatment|Participant withdrew consent|4|||
164361078|NCT02584504|593697209|FG000|Open-label Treatment|Adverse Event|2|||
164361079|NCT02584504|593697210|FG001|Open-label Treatment|Adverse Event|2|||
164361080|NCT02584504|593697211|FG002|Open-label Treatment|Adverse Event|3|||
164361081|NCT02584504|593697209|FG000|Open-label Treatment|Physician Decision|0|||
164361082|NCT02584504|593697210|FG001|Open-label Treatment|Physician Decision|1|||
164361083|NCT02584504|593697211|FG002|Open-label Treatment|Physician Decision|0|||
164361084|NCT02584504|593697209|FG000|Open-label Treatment|Entered but not treated|0|||
164361085|NCT02584504|593697210|FG001|Open-label Treatment|Entered but not treated|1|||
164361086|NCT02584504|593697211|FG002|Open-label Treatment|Entered but not treated|1|||
164361087|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Death|3|||
164361088|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Death|2|||
164361089|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Death|4|||
164361090|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Death|3|||
164361091|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Death|0|||
164361092|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Death|0|||
164361093|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361094|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
164361095|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
164361096|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361097|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361098|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
164361099|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
164361100|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361101|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361102|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361103|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361104|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
164361105|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
164361106|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
164361107|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
164361108|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
164361109|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
164361110|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
164361111|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361112|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361113|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
164361114|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
164361115|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361116|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
164361117|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
164361118|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
164361119|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
164361120|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
164361121|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
164361122|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
164361123|NCT02432846|593697212|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361124|NCT02432846|593697213|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361125|NCT02432846|593697214|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
164361126|NCT02432846|593697215|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164010403|NCT01259492|592403172|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
164010404|NCT01259492|592403173|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
164010405|NCT03042611|592403178|FG000|Core Phase|Withdrawal by Subject|13|||
164361127|NCT02432846|593697216|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361128|NCT02432846|593697217|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
164361129|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
164361130|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
164361131|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
164361132|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
164361133|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
164010406|NCT03042611|592403179|FG001|Core Phase|Withdrawal by Subject|4|||
164010407|NCT03042611|592403180|FG002|Core Phase|Withdrawal by Subject|0|||
164361134|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
164361135|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361136|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361137|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361138|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
164361139|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
164361140|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
164361141|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361142|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361143|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361144|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361145|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
164361146|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
164361147|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361148|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361149|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361150|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
164361151|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
164361152|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
164361153|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361154|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361155|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361156|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
164361157|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
164361158|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
164361159|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361160|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361161|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361162|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
164361163|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
164361164|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
164361165|NCT02432846|593697212|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361166|NCT02432846|593697213|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361167|NCT02432846|593697214|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361168|NCT02432846|593697215|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361169|NCT02432846|593697216|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
164361170|NCT02432846|593697217|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
164361171|NCT01912287|593697218|FG000|Overall Study|Ineligible|1|||
164361172|NCT01912287|593697219|FG001|Overall Study|Ineligible|0|||
164361173|NCT01912287|593697220|FG002|Overall Study|Ineligible|1|||
164361174|NCT01912287|593697218|FG000|Overall Study|No-show|0|||
164361175|NCT01912287|593697219|FG001|Overall Study|No-show|0|||
164361176|NCT01912287|593697220|FG002|Overall Study|No-show|1|||
164361177|NCT01912287|593697218|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
164361178|NCT01912287|593697219|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
164010408|NCT03042611|592403181|FG003|Core Phase|Withdrawal by Subject|0|||
164010409|NCT03042611|592403178|FG000|Core Phase|Death|232|||
164010410|NCT03042611|592403179|FG001|Core Phase|Death|110|||
164361179|NCT01912287|593697220|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
164361180|NCT01912287|593697218|FG000|Overall Study|Felt treatment no longer needed|0|||
164361181|NCT01912287|593697219|FG001|Overall Study|Felt treatment no longer needed|1|||
164361182|NCT01912287|593697220|FG002|Overall Study|Felt treatment no longer needed|0|||
164361183|NCT01912287|593697218|FG000|Overall Study|Life circumstances|4|||
164361184|NCT01912287|593697219|FG001|Overall Study|Life circumstances|2|||
164361185|NCT01912287|593697220|FG002|Overall Study|Life circumstances|0|||
164361186|NCT01912287|593697218|FG000|Overall Study|Lost Interest|1|||
164010411|NCT03042611|592403180|FG002|Core Phase|Death|0|||
164010412|NCT03042611|592403181|FG003|Core Phase|Death|0|||
164010413|NCT03042611|592403178|FG000|Core Phase|Lost to Follow-up|4|||
164361187|NCT01912287|593697219|FG001|Overall Study|Lost Interest|0|||
164361188|NCT01912287|593697220|FG002|Overall Study|Lost Interest|0|||
164361189|NCT01912287|593697218|FG000|Overall Study|Uknown reason - subject drop out|5|||
164361190|NCT01912287|593697219|FG001|Overall Study|Uknown reason - subject drop out|7|||
164361191|NCT01912287|593697220|FG002|Overall Study|Uknown reason - subject drop out|3|||
164361192|NCT01912287|593697218|FG000|Overall Study|Missed Assesment|1|||
164361193|NCT01912287|593697219|FG001|Overall Study|Missed Assesment|1|||
164361194|NCT01912287|593697220|FG002|Overall Study|Missed Assesment|1|||
164361195|NCT01912287|593697218|FG000|Overall Study|Scheduling/change in availability|17|||
164361196|NCT01912287|593697219|FG001|Overall Study|Scheduling/change in availability|10|||
164361197|NCT01912287|593697220|FG002|Overall Study|Scheduling/change in availability|8|||
164361198|NCT00413192|593697221|FG000|Overall Study|Disease progression|26|||
164361199|NCT00413192|593697222|FG001|Overall Study|Disease progression|31|||
164361200|NCT00413192|593697223|FG002|Overall Study|Disease progression|16|||
164361201|NCT00413192|593697224|FG003|Overall Study|Disease progression|25|||
164361202|NCT00413192|593697221|FG000|Overall Study|Toxicity|3|||
164361203|NCT00413192|593697222|FG001|Overall Study|Toxicity|2|||
164361204|NCT00413192|593697223|FG002|Overall Study|Toxicity|2|||
164361205|NCT00413192|593697224|FG003|Overall Study|Toxicity|2|||
164361206|NCT00413192|593697221|FG000|Overall Study|Withdrawal by Subject|3|||
164361207|NCT00413192|593697222|FG001|Overall Study|Withdrawal by Subject|5|||
164010414|NCT03042611|592403179|FG001|Core Phase|Lost to Follow-up|7|||
164010415|NCT03042611|592403180|FG002|Core Phase|Lost to Follow-up|0|||
164010416|NCT03042611|592403181|FG003|Core Phase|Lost to Follow-up|0|||
164010417|NCT03042611|592403178|FG000|Core Phase|Physician Decision|7|||
164010418|NCT03042611|592403179|FG001|Core Phase|Physician Decision|2|||
164010419|NCT03042611|592403180|FG002|Core Phase|Physician Decision|0|||
164010420|NCT03042611|592403181|FG003|Core Phase|Physician Decision|0|||
164010421|NCT03042611|592403178|FG000|Core Phase|Study Closed|0|||
164010422|NCT03042611|592403179|FG001|Core Phase|Study Closed|1|||
164010423|NCT03042611|592403180|FG002|Core Phase|Study Closed|0|||
164010424|NCT03042611|592403181|FG003|Core Phase|Study Closed|0|||
164010425|NCT03042611|592403178|FG000|Extension Phase|Death|0|||
164010426|NCT03042611|592403179|FG001|Extension Phase|Death|0|||
164010427|NCT03042611|592403180|FG002|Extension Phase|Death|34|||
164010428|NCT03042611|592403181|FG003|Extension Phase|Death|16|||
164010429|NCT03042611|592403178|FG000|Extension Phase|Lost to Follow-up|0|||
164010430|NCT03042611|592403179|FG001|Extension Phase|Lost to Follow-up|0|||
164010431|NCT03042611|592403180|FG002|Extension Phase|Lost to Follow-up|1|||
164010432|NCT03042611|592403181|FG003|Extension Phase|Lost to Follow-up|1|||
164010433|NCT03042611|592403178|FG000|Extension Phase|Study Closed|0|||
164010434|NCT03042611|592403179|FG001|Extension Phase|Study Closed|0|||
164010435|NCT03042611|592403180|FG002|Extension Phase|Study Closed|17|||
164010436|NCT03042611|592403181|FG003|Extension Phase|Study Closed|11|||
164010437|NCT00474630|592403182|FG000|Overall Study|Adverse Event|98|||
164010438|NCT00474630|592403183|FG001|Overall Study|Adverse Event|26|||
164010439|NCT00474630|592403182|FG000|Overall Study|Lost to Follow-up|22|||
164010440|NCT00474630|592403183|FG001|Overall Study|Lost to Follow-up|15|||
164010441|NCT00474630|592403182|FG000|Overall Study|Withdrawal by Subject|21|||
164010442|NCT00474630|592403183|FG001|Overall Study|Withdrawal by Subject|15|||
164010443|NCT00474630|592403182|FG000|Overall Study|Protocol Violation|3|||
164010444|NCT00474630|592403183|FG001|Overall Study|Protocol Violation|4|||
164010445|NCT00474630|592403182|FG000|Overall Study|Lack of Efficacy|5|||
164010446|NCT00474630|592403183|FG001|Overall Study|Lack of Efficacy|6|||
164010447|NCT00474630|592403182|FG000|Overall Study|Drug noncompliance, other|11|||
164010448|NCT00474630|592403183|FG001|Overall Study|Drug noncompliance, other|4|||
164010449|NCT02397655|592403186|FG000|Overall Study|data not completed|1301|||
164010450|NCT00545818|592403200|FG000|Overall Study|Protocol Violation|1|||
164010451|NCT00545818|592403201|FG001|Overall Study|Protocol Violation|0|||
164010452|NCT00545818|592403200|FG000|Overall Study|Adverse Event|1|||
164361208|NCT00413192|593697223|FG002|Overall Study|Withdrawal by Subject|0|||
164361209|NCT00413192|593697224|FG003|Overall Study|Withdrawal by Subject|1|||
164361210|NCT00413192|593697221|FG000|Overall Study|Intercurrent illness|0|||
164361211|NCT00413192|593697222|FG001|Overall Study|Intercurrent illness|0|||
164361212|NCT00413192|593697223|FG002|Overall Study|Intercurrent illness|0|||
164010453|NCT00545818|592403201|FG001|Overall Study|Adverse Event|1|||
164010454|NCT00545818|592403200|FG000|Overall Study|Lost to Follow-up|1|||
164010455|NCT00545818|592403201|FG001|Overall Study|Lost to Follow-up|6|||
164010456|NCT02623361|592403202|FG000|Overall Study|Protocol Violation|0|||
164010457|NCT02623361|592403203|FG001|Overall Study|Protocol Violation|1|||
164361213|NCT00413192|593697224|FG003|Overall Study|Intercurrent illness|1|||
164361214|NCT00413192|593697221|FG000|Overall Study|Intercurrent death|0|||
164361215|NCT00413192|593697222|FG001|Overall Study|Intercurrent death|1|||
164010458|NCT02623361|592403202|FG000|Overall Study|Withdrawal by Subject|0|||
164010459|NCT02623361|592403203|FG001|Overall Study|Withdrawal by Subject|1|||
164010460|NCT00611455|592403204|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
164010461|NCT00611455|592403205|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
164010462|NCT00611455|592403206|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164361216|NCT00413192|593697223|FG002|Overall Study|Intercurrent death|0|||
164361217|NCT00413192|593697224|FG003|Overall Study|Intercurrent death|0|||
164361218|NCT00413192|593697221|FG000|Overall Study|Other|5|||
164361219|NCT00413192|593697222|FG001|Overall Study|Other|1|||
164361220|NCT00413192|593697223|FG002|Overall Study|Other|1|||
164361221|NCT00413192|593697224|FG003|Overall Study|Other|2|||
164361222|NCT00413192|593697221|FG000|Overall Study|Not treated|0|||
164361223|NCT00413192|593697222|FG001|Overall Study|Not treated|0|||
164361224|NCT00413192|593697223|FG002|Overall Study|Not treated|0|||
164361225|NCT00413192|593697224|FG003|Overall Study|Not treated|1|||
164361226|NCT01998633|593697225|FG000|Overall Study|Death|1|||
164361227|NCT02631850|593697226|FG000|Treatment Period|Lost to Follow-up|0|||
164361228|NCT02631850|593697227|FG001|Treatment Period|Lost to Follow-up|1|||
164361229|NCT02631850|593697228|FG002|Treatment Period|Lost to Follow-up|0|||
164361230|NCT02631850|593697229|FG003|Treatment Period|Lost to Follow-up|0|||
164361231|NCT02631850|593697226|FG000|Treatment Period|Protocol Violation|1|||
164361232|NCT02631850|593697227|FG001|Treatment Period|Protocol Violation|0|||
164361233|NCT02631850|593697228|FG002|Treatment Period|Protocol Violation|0|||
164361234|NCT02631850|593697229|FG003|Treatment Period|Protocol Violation|0|||
164361235|NCT02631850|593697226|FG000|Treatment Period|Withdrawal by Subject|0|||
164361236|NCT02631850|593697227|FG001|Treatment Period|Withdrawal by Subject|5|||
164361237|NCT02631850|593697228|FG002|Treatment Period|Withdrawal by Subject|2|||
164361238|NCT02631850|593697229|FG003|Treatment Period|Withdrawal by Subject|2|||
164361239|NCT02631850|593697226|FG000|Treatment Period|Adverse Event|1|||
164361240|NCT02631850|593697227|FG001|Treatment Period|Adverse Event|0|||
164361241|NCT02631850|593697228|FG002|Treatment Period|Adverse Event|2|||
164361242|NCT02631850|593697229|FG003|Treatment Period|Adverse Event|3|||
164361243|NCT02631850|593697226|FG000|Treatment Period|Family medical issue|1|||
164361244|NCT02631850|593697227|FG001|Treatment Period|Family medical issue|0|||
164361245|NCT02631850|593697228|FG002|Treatment Period|Family medical issue|0|||
164361246|NCT02631850|593697229|FG003|Treatment Period|Family medical issue|0|||
164361247|NCT02631850|593697226|FG000|6 Month Follow up|Lost to Follow-up|5|||
164361248|NCT02631850|593697227|FG001|6 Month Follow up|Lost to Follow-up|8|||
164361249|NCT02631850|593697228|FG002|6 Month Follow up|Lost to Follow-up|3|||
164361250|NCT02631850|593697229|FG003|6 Month Follow up|Lost to Follow-up|5|||
164361251|NCT02631850|593697226|FG000|6 Month Follow up|Withdrawal by Subject|1|||
164361252|NCT02631850|593697227|FG001|6 Month Follow up|Withdrawal by Subject|0|||
164361253|NCT02631850|593697228|FG002|6 Month Follow up|Withdrawal by Subject|0|||
164361254|NCT02631850|593697229|FG003|6 Month Follow up|Withdrawal by Subject|2|||
164010463|NCT00611455|592403204|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
164010464|NCT00611455|592403205|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164010465|NCT00611455|592403206|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
164010466|NCT00611455|592403204|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
164010467|NCT00611455|592403205|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
164010468|NCT00611455|592403206|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164010469|NCT00611455|592403204|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164010470|NCT00611455|592403205|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164010471|NCT00611455|592403206|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164010472|NCT00611455|592403204|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
164010473|NCT00611455|592403205|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
164010474|NCT00611455|592403206|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
164010475|NCT00611455|592403204|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
164010476|NCT00611455|592403205|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
164010477|NCT00611455|592403206|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
164010478|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
164010479|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
164010480|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
164010481|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
164010482|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
164010483|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
164010484|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
164010485|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
164361255|NCT02631850|593697226|FG000|6 Month Follow up|Adverse Event|1|||
164361256|NCT02631850|593697227|FG001|6 Month Follow up|Adverse Event|4|||
164361257|NCT02631850|593697228|FG002|6 Month Follow up|Adverse Event|1|||
164361258|NCT02631850|593697229|FG003|6 Month Follow up|Adverse Event|3|||
164361259|NCT02631850|593697226|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
164361260|NCT02631850|593697227|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
164361261|NCT02631850|593697228|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
164361262|NCT02631850|593697229|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
164361263|NCT00553150|593697250|FG000|Overall Study|Withdrawal by Subject|0|||
164010486|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
164010487|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
164361264|NCT00553150|593697251|FG001|Overall Study|Withdrawal by Subject|0|||
164361265|NCT00553150|593697252|FG002|Overall Study|Withdrawal by Subject|0|||
164361266|NCT00553150|593697253|FG003|Overall Study|Withdrawal by Subject|2|||
164361267|NCT00553150|593697250|FG000|Overall Study|Protocol Violation|0|||
164361268|NCT00553150|593697251|FG001|Overall Study|Protocol Violation|0|||
164361269|NCT00553150|593697252|FG002|Overall Study|Protocol Violation|0|||
164361270|NCT00553150|593697253|FG003|Overall Study|Protocol Violation|1|||
164361271|NCT00553150|593697250|FG000|Overall Study|Ineligible|0|||
164361272|NCT00553150|593697251|FG001|Overall Study|Ineligible|0|||
164361273|NCT00553150|593697252|FG002|Overall Study|Ineligible|0|||
164361274|NCT00553150|593697253|FG003|Overall Study|Ineligible|1|||
164361275|NCT00975481|593697255|FG000|Second Intervention Period|Adverse Event|2|||
164361276|NCT00975481|593697256|FG001|Second Intervention Period|Adverse Event|1|||
164361277|NCT00975481|593697257|FG002|Second Intervention Period|Adverse Event|0|||
164361278|NCT00975481|593697258|FG003|Second Intervention Period|Adverse Event|0|||
164361279|NCT00975481|593697259|FG004|Second Intervention Period|Adverse Event|0|||
164361280|NCT00975481|593697260|FG005|Second Intervention Period|Adverse Event|0|||
164361281|NCT00975481|593697255|FG000|Second Intervention Period|Withdrawal by Subject|0|||
164361282|NCT00975481|593697256|FG001|Second Intervention Period|Withdrawal by Subject|0|||
164361283|NCT00975481|593697257|FG002|Second Intervention Period|Withdrawal by Subject|1|||
164361284|NCT00975481|593697258|FG003|Second Intervention Period|Withdrawal by Subject|0|||
164361285|NCT00975481|593697259|FG004|Second Intervention Period|Withdrawal by Subject|0|||
163901587|NCT00776009|592011377|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
164091859|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
164361286|NCT00975481|593697260|FG005|Second Intervention Period|Withdrawal by Subject|0|||
164361287|NCT00975481|593697255|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
164361288|NCT00975481|593697256|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
164361289|NCT00975481|593697257|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
164361290|NCT00975481|593697258|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
164361291|NCT00975481|593697259|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
164361292|NCT00975481|593697260|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
164091860|NCT02579096|592700039|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
164091861|NCT02579096|592700040|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
164091862|NCT02097121|592700045|FG000|Overall Study|Other, not specified|4|||
164091863|NCT02097121|592700046|FG001|Overall Study|Other, not specified|2|||
164091864|NCT02097121|592700047|FG002|Overall Study|Other, not specified|3|||
164361293|NCT00975481|593697255|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
164361294|NCT00975481|593697256|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
164361295|NCT00975481|593697257|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
164361296|NCT00975481|593697258|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
164361297|NCT00975481|593697259|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
164361298|NCT00975481|593697260|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
164361299|NCT03559257|593697263|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
164361300|NCT03559257|593697264|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
164361301|NCT03559257|593697263|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164361302|NCT03559257|593697264|FG001|Double Blind Treatment Period|Protocol Violation|4|||
164361303|NCT03559257|593697263|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
164361304|NCT03559257|593697264|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
164361305|NCT03559257|593697263|FG000|Double Blind Treatment Period|Adverse Event|0|||
163901588|NCT00776009|592011378|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
163901589|NCT01536093|592011384|FG000|Overall Study|Death|1|||
163901590|NCT01536093|592011385|FG001|Overall Study|Death|2|||
163901591|NCT01536093|592011384|FG000|Overall Study|absence of maternal colostrum|2|||
163901592|NCT01536093|592011385|FG001|Overall Study|absence of maternal colostrum|0|||
163901593|NCT01536093|592011384|FG000|Overall Study|Withdrawal by Subject|0|||
163901594|NCT01536093|592011385|FG001|Overall Study|Withdrawal by Subject|1|||
163901595|NCT03631407|592011391|FG000|Overall Study|Withdrawal by Subject|3|||
163901596|NCT03631407|592011392|FG001|Overall Study|Withdrawal by Subject|2|||
163901597|NCT03631407|592011391|FG000|Overall Study|Sponsor Decision|0|||
163901598|NCT03631407|592011392|FG001|Overall Study|Sponsor Decision|2|||
163901599|NCT03631407|592011391|FG000|Overall Study|Death|16|||
163901600|NCT03631407|592011392|FG001|Overall Study|Death|16|||
163901601|NCT03631407|592011391|FG000|Overall Study|Randomized by mistake without study treatment|1|||
163901602|NCT03631407|592011392|FG001|Overall Study|Randomized by mistake without study treatment|0|||
163901603|NCT00811941|592011394|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
163901604|NCT00811941|592011395|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
163901605|NCT00811941|592011394|FG000|All Treated Patients|Adverse Event|2|||
163901606|NCT00811941|592011395|FG001|All Treated Patients|Adverse Event|43|||
163901607|NCT00811941|592011394|FG000|All Treated Patients|Lack of Efficacy|2|||
163901608|NCT00811941|592011395|FG001|All Treated Patients|Lack of Efficacy|3|||
163901609|NCT00811941|592011394|FG000|All Treated Patients|Non-compliance|1|||
163901610|NCT00811941|592011395|FG001|All Treated Patients|Non-compliance|8|||
163901611|NCT00811941|592011394|FG000|All Treated Patients|Protocol Violation|5|||
164361306|NCT03559257|593697264|FG001|Double Blind Treatment Period|Adverse Event|1|||
164361307|NCT03559257|593697263|FG000|Double Blind Treatment Period|Screen Failure|0|||
164361308|NCT03559257|593697264|FG001|Double Blind Treatment Period|Screen Failure|1|||
164361309|NCT03559257|593697263|FG000|Open-label Treatment Period|Adverse Event|1|||
164361310|NCT03559257|593697264|FG001|Open-label Treatment Period|Adverse Event|4|||
164361311|NCT03559257|593697263|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
164361312|NCT03559257|593697264|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
164361313|NCT03559257|593697263|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
164361314|NCT03559257|593697264|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164361315|NCT03559257|593697263|FG000|Open-label Treatment Period|Protocol Violation|2|||
164361316|NCT03559257|593697264|FG001|Open-label Treatment Period|Protocol Violation|0|||
164361317|NCT03559257|593697263|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
164361318|NCT03559257|593697264|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164361319|NCT03559257|593697263|FG000|Open-label Treatment Period|Physician Decision|0|||
164361320|NCT03559257|593697264|FG001|Open-label Treatment Period|Physician Decision|1|||
164361321|NCT03630120|593697266|FG000|Overall Study|Disease progression|0|||
164361322|NCT03630120|593697267|FG001|Overall Study|Disease progression|1|||
164361323|NCT03630120|593697268|FG002|Overall Study|Disease progression|1|||
164361324|NCT03630120|593697269|FG003|Overall Study|Disease progression|1|||
164361325|NCT03251079|593697270|FG000|Overall Study|Withdrawal by Subject|1|||
164361326|NCT01519960|593697271|FG000|Overall Study|Withdrawal from the study|26|||
164361327|NCT01519960|593697272|FG001|Overall Study|Withdrawal from the study|22|||
164361328|NCT01519960|593697273|FG002|Overall Study|Withdrawal from the study|5|||
164361329|NCT01387347|593697274|FG000|Overall Study|Lost to Follow-up|2|||
164010488|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
164010489|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
164010490|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
164010491|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
164010492|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
164010493|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
164010494|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
164010495|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
164010496|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
164010497|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
164010498|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
164010499|NCT00611455|592403204|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
164010500|NCT00611455|592403205|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
164010501|NCT00611455|592403206|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
164010502|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
164010503|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
164010504|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
164010505|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
164010506|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
164010507|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
164010508|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
164010509|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
164010510|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
164010511|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
164010512|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
164010513|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
164010514|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
164010515|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
164010516|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
164010517|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
164010518|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
164010519|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
164010520|NCT00611455|592403204|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
164010521|NCT00611455|592403205|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
164010522|NCT00611455|592403206|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
164010523|NCT03671369|592403207|FG000|Overall Study|Other|1|||
164010524|NCT03671369|592403207|FG000|Overall Study|Withdrawal by Subject|289|||
164010525|NCT03671369|592403207|FG000|Overall Study|Not willing to be vaccinated|1|||
164361330|NCT01387347|593697275|FG001|Overall Study|Lost to Follow-up|1|||
164361331|NCT00492115|593697281|FG000|Overall Study|Withdrawal by Subject|3|||
164361332|NCT00492115|593697282|FG001|Overall Study|Withdrawal by Subject|4|||
164361333|NCT02515045|593697290|FG000|Overall Study|Adverse Event|0|||
164361334|NCT02515045|593697291|FG001|Overall Study|Adverse Event|3|||
164361335|NCT02515045|593697292|FG002|Overall Study|Adverse Event|3|||
164361336|NCT02515045|593697290|FG000|Overall Study|Lost to Follow-up|0|||
164361337|NCT02515045|593697291|FG001|Overall Study|Lost to Follow-up|1|||
164361338|NCT02515045|593697292|FG002|Overall Study|Lost to Follow-up|1|||
164361339|NCT03255382|593697293|FG000|Overall Study|Adverse Event|3|||
164361340|NCT03255382|593697294|FG001|Overall Study|Adverse Event|0|||
164361341|NCT03255382|593697293|FG000|Overall Study|Lost to Follow-up|2|||
164361342|NCT03255382|593697294|FG001|Overall Study|Lost to Follow-up|0|||
164361343|NCT03255382|593697293|FG000|Overall Study|Withdrawal by Subject|2|||
164361344|NCT03255382|593697294|FG001|Overall Study|Withdrawal by Subject|0|||
164361345|NCT03255382|593697293|FG000|Overall Study|Other|6|||
164361346|NCT03255382|593697294|FG001|Overall Study|Other|0|||
164361347|NCT00624052|593697297|FG000|Overall Study|Adverse Event|7|||
164361348|NCT00624052|593697298|FG001|Overall Study|Adverse Event|6|||
164361349|NCT00624052|593697299|FG002|Overall Study|Adverse Event|0|||
164361350|NCT00624052|593697300|FG003|Overall Study|Adverse Event|3|||
164361351|NCT00624052|593697297|FG000|Overall Study|Lack of Efficacy|1|||
164361352|NCT00624052|593697298|FG001|Overall Study|Lack of Efficacy|1|||
164361353|NCT00624052|593697299|FG002|Overall Study|Lack of Efficacy|0|||
164361354|NCT00624052|593697300|FG003|Overall Study|Lack of Efficacy|0|||
164361355|NCT00624052|593697297|FG000|Overall Study|Lost to Follow-up|2|||
164361356|NCT00624052|593697298|FG001|Overall Study|Lost to Follow-up|3|||
164361357|NCT00624052|593697299|FG002|Overall Study|Lost to Follow-up|1|||
164361358|NCT00624052|593697300|FG003|Overall Study|Lost to Follow-up|0|||
164361359|NCT00624052|593697297|FG000|Overall Study|Non compliant with the protocol|2|||
164361360|NCT00624052|593697298|FG001|Overall Study|Non compliant with the protocol|1|||
164361361|NCT00624052|593697299|FG002|Overall Study|Non compliant with the protocol|1|||
164361362|NCT00624052|593697300|FG003|Overall Study|Non compliant with the protocol|1|||
164361363|NCT00624052|593697297|FG000|Overall Study|Consent withdrawn|3|||
164361364|NCT00624052|593697298|FG001|Overall Study|Consent withdrawn|1|||
164361365|NCT00624052|593697299|FG002|Overall Study|Consent withdrawn|1|||
164361366|NCT00624052|593697300|FG003|Overall Study|Consent withdrawn|0|||
164361367|NCT00624052|593697297|FG000|Overall Study|Changed job/ran out if meds|0|||
164361368|NCT00624052|593697298|FG001|Overall Study|Changed job/ran out if meds|2|||
164010526|NCT02732912|592403208|FG000|Overall Study|Discharged before night|2|||
164010527|NCT02732912|592403209|FG001|Overall Study|Discharged before night|6|||
164010528|NCT02732912|592403208|FG000|Overall Study|Incomplete completion of questionnaire|2|||
164010529|NCT02732912|592403209|FG001|Overall Study|Incomplete completion of questionnaire|3|||
164010530|NCT02732912|592403208|FG000|Overall Study|No outcome; discharged or refused|6|||
164010531|NCT02732912|592403209|FG001|Overall Study|No outcome; discharged or refused|9|||
164010532|NCT01507545|592403215|FG000|Overall Study|Withdrawal by Subject|6|||
164010533|NCT01507545|592403216|FG001|Overall Study|Withdrawal by Subject|2|||
164010534|NCT01507545|592403215|FG000|Overall Study|Lost to Follow-up|1|||
164010535|NCT01507545|592403216|FG001|Overall Study|Lost to Follow-up|0|||
164010536|NCT01507545|592403215|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
164010537|NCT01507545|592403216|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
164010538|NCT01507545|592403215|FG000|Overall Study|Progressive disease|60|||
164010539|NCT01507545|592403216|FG001|Overall Study|Progressive disease|27|||
164010540|NCT01507545|592403215|FG000|Overall Study|Other|6|||
164010541|NCT01507545|592403216|FG001|Overall Study|Other|4|||
164010542|NCT01873742|592403217|FG000|Overall Study|Lost to Follow-up|68|||
164010543|NCT01873742|592403218|FG001|Overall Study|Lost to Follow-up|76|||
164010544|NCT00790296|592403220|FG000|Overall Study|Did not meet study eligibility criteria|1|||
164010545|NCT00790296|592403221|FG001|Overall Study|Did not meet study eligibility criteria|1|||
164010546|NCT00790296|592403220|FG000|Overall Study|Adverse Event|0|||
164010547|NCT00790296|592403221|FG001|Overall Study|Adverse Event|1|||
164010548|NCT01971476|592403222|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
164010549|NCT01971476|592403223|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
164010550|NCT01971476|592403224|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
164010551|NCT01971476|592403222|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
164010552|NCT01971476|592403223|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
164010553|NCT01971476|592403224|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
164010554|NCT01971476|592403222|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
164010555|NCT01971476|592403223|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
164010556|NCT01971476|592403224|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
164010557|NCT01457339|592403232|FG000|Period 3 (100 mg)|Adverse Event|0|||
164010558|NCT01457339|592403233|FG001|Period 3 (100 mg)|Adverse Event|1|||
164010559|NCT01457339|592403232|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
164361369|NCT00624052|593697299|FG002|Overall Study|Changed job/ran out if meds|0|||
164361370|NCT00624052|593697300|FG003|Overall Study|Changed job/ran out if meds|0|||
164361371|NCT02291055|593697303|FG000|Overall Study|Death|2|||
164361372|NCT02291055|593697304|FG001|Overall Study|Death|2|||
164361373|NCT02291055|593697305|FG002|Overall Study|Death|5|||
164361374|NCT02291055|593697306|FG003|Overall Study|Death|8|||
164010560|NCT01457339|592403233|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
164010561|NCT01457339|592403232|FG000|Period 6 (250 mg)|Family Emergency|1|||
164010562|NCT01457339|592403233|FG001|Period 6 (250 mg)|Family Emergency|0|||
164361375|NCT02291055|593697307|FG004|Overall Study|Death|12|||
164361376|NCT02291055|593697303|FG000|Overall Study|Lost to Follow-up|0|||
164361377|NCT02291055|593697304|FG001|Overall Study|Lost to Follow-up|0|||
164361378|NCT02291055|593697305|FG002|Overall Study|Lost to Follow-up|0|||
164361379|NCT02291055|593697306|FG003|Overall Study|Lost to Follow-up|1|||
164361380|NCT02291055|593697307|FG004|Overall Study|Lost to Follow-up|2|||
164361381|NCT02291055|593697303|FG000|Overall Study|Withdrawal by Subject|3|||
164361382|NCT02291055|593697304|FG001|Overall Study|Withdrawal by Subject|1|||
164361383|NCT02291055|593697305|FG002|Overall Study|Withdrawal by Subject|1|||
164361384|NCT02291055|593697306|FG003|Overall Study|Withdrawal by Subject|5|||
164361385|NCT02291055|593697307|FG004|Overall Study|Withdrawal by Subject|10|||
164361386|NCT02291055|593697303|FG000|Overall Study|Progressive Disease|0|||
164361387|NCT02291055|593697304|FG001|Overall Study|Progressive Disease|0|||
164361388|NCT02291055|593697305|FG002|Overall Study|Progressive Disease|1|||
164361389|NCT02291055|593697306|FG003|Overall Study|Progressive Disease|4|||
164361390|NCT02291055|593697307|FG004|Overall Study|Progressive Disease|2|||
164361391|NCT02291055|593697303|FG000|Overall Study|Study Terminated by Sponsor|0|||
164361392|NCT02291055|593697304|FG001|Overall Study|Study Terminated by Sponsor|0|||
164361393|NCT02291055|593697305|FG002|Overall Study|Study Terminated by Sponsor|0|||
164361394|NCT02291055|593697306|FG003|Overall Study|Study Terminated by Sponsor|5|||
164010563|NCT01457339|592403232|FG000|Period 6 (250 mg)|Personal appointment|0|||
164010564|NCT01457339|592403233|FG001|Period 6 (250 mg)|Personal appointment|1|||
164010565|NCT00995371|592403234|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
164010566|NCT00995371|592403235|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
164010567|NCT00306891|592403236|FG000|Part A|Withdrawal by Subject|1|||
164361395|NCT02291055|593697307|FG004|Overall Study|Study Terminated by Sponsor|1|||
164361396|NCT02291055|593697303|FG000|Overall Study|Other|0|||
164361397|NCT02291055|593697304|FG001|Overall Study|Other|2|||
164361398|NCT02291055|593697305|FG002|Overall Study|Other|1|||
164361399|NCT02291055|593697306|FG003|Overall Study|Other|4|||
164361400|NCT02291055|593697307|FG004|Overall Study|Other|0|||
164361401|NCT01523886|593697308|FG000|Overall Study|surgery cancelled|0|||
164361402|NCT01523886|593697309|FG001|Overall Study|surgery cancelled|1|||
164361403|NCT00679263|593697313|FG000|Visit 2/Dose 1|Adverse Event|1|||
164361404|NCT00679263|593697314|FG001|Visit 2/Dose 1|Adverse Event|0|||
164361405|NCT00679263|593697315|FG002|Visit 2/Dose 1|Adverse Event|0|||
164361406|NCT00679263|593697313|FG000|Visit 2/Dose 1|subject not compliance|1|||
164361407|NCT00679263|593697314|FG001|Visit 2/Dose 1|subject not compliance|1|||
164010568|NCT00306891|592403237|FG001|Part A|Withdrawal by Subject|1|||
164361408|NCT00679263|593697315|FG002|Visit 2/Dose 1|subject not compliance|0|||
164361409|NCT01499563|593697323|FG000|Overall Study|Withdrawal by Subject|10|||
164361410|NCT01499563|593697324|FG001|Overall Study|Withdrawal by Subject|11|||
164361411|NCT01499563|593697325|FG002|Overall Study|Withdrawal by Subject|7|||
164010569|NCT00306891|592403238|FG002|Part A|Withdrawal by Subject|0|||
164010570|NCT00306891|592403239|FG003|Part A|Withdrawal by Subject|0|||
164010571|NCT00306891|592403236|FG000|Part A|Condition under investigation worsened|2|||
164010572|NCT00306891|592403237|FG001|Part A|Condition under investigation worsened|2|||
164010573|NCT00306891|592403238|FG002|Part A|Condition under investigation worsened|0|||
164010574|NCT00306891|592403239|FG003|Part A|Condition under investigation worsened|0|||
164010575|NCT00306891|592403236|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
164010576|NCT00306891|592403237|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
164010577|NCT00306891|592403238|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
164010578|NCT00306891|592403239|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
164010579|NCT00306891|592403236|FG000|Part A|Partial bowel obstruction|1|||
164010580|NCT00306891|592403237|FG001|Part A|Partial bowel obstruction|0|||
164010581|NCT00306891|592403238|FG002|Part A|Partial bowel obstruction|0|||
164010582|NCT00306891|592403239|FG003|Part A|Partial bowel obstruction|0|||
164010583|NCT00306891|592403236|FG000|Part A|Reaccumul. of ascites following drainage|0|||
164010584|NCT00306891|592403237|FG001|Part A|Reaccumul. of ascites following drainage|1|||
164010585|NCT00306891|592403238|FG002|Part A|Reaccumul. of ascites following drainage|0|||
164010586|NCT00306891|592403239|FG003|Part A|Reaccumul. of ascites following drainage|0|||
164010587|NCT00306891|592403236|FG000|Part A|Suspicion of second malignancy|0|||
164010588|NCT00306891|592403237|FG001|Part A|Suspicion of second malignancy|1|||
164010589|NCT00306891|592403238|FG002|Part A|Suspicion of second malignancy|0|||
164010590|NCT00306891|592403239|FG003|Part A|Suspicion of second malignancy|0|||
164010591|NCT00306891|592403236|FG000|Part A|QTC interval outwith elig. criteria|1|||
164010592|NCT00306891|592403237|FG001|Part A|QTC interval outwith elig. criteria|0|||
164010593|NCT00306891|592403238|FG002|Part A|QTC interval outwith elig. criteria|0|||
164361412|NCT01499563|593697326|FG003|Overall Study|Withdrawal by Subject|8|||
164361413|NCT01499563|593697323|FG000|Overall Study|Physician Decision|2|||
164361414|NCT01499563|593697324|FG001|Overall Study|Physician Decision|1|||
164361415|NCT01499563|593697325|FG002|Overall Study|Physician Decision|3|||
164361416|NCT01499563|593697326|FG003|Overall Study|Physician Decision|0|||
164361417|NCT01499563|593697323|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
164361418|NCT01499563|593697324|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
164361419|NCT01499563|593697325|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
164361420|NCT01499563|593697326|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
164361421|NCT01499563|593697323|FG000|Overall Study|Adverse Event|2|||
164361422|NCT01499563|593697324|FG001|Overall Study|Adverse Event|0|||
164361423|NCT01499563|593697325|FG002|Overall Study|Adverse Event|1|||
164361424|NCT01499563|593697326|FG003|Overall Study|Adverse Event|3|||
164361425|NCT01499563|593697323|FG000|Overall Study|Lack of Efficacy|0|||
164361426|NCT01499563|593697324|FG001|Overall Study|Lack of Efficacy|1|||
164361427|NCT01499563|593697325|FG002|Overall Study|Lack of Efficacy|6|||
164361428|NCT01499563|593697326|FG003|Overall Study|Lack of Efficacy|3|||
164361429|NCT01499563|593697323|FG000|Overall Study|Other|8|||
164361430|NCT01499563|593697324|FG001|Overall Study|Other|6|||
164361431|NCT01499563|593697325|FG002|Overall Study|Other|6|||
164361432|NCT01499563|593697326|FG003|Overall Study|Other|4|||
164361433|NCT03658538|593697327|FG000|Overall Study|Death|2|||
164361434|NCT03658538|593697328|FG001|Overall Study|Death|1|||
164361435|NCT03658538|593697327|FG000|Overall Study|Cancer diagnosis|1|||
164361436|NCT03658538|593697328|FG001|Overall Study|Cancer diagnosis|0|||
164361437|NCT03658538|593697327|FG000|Overall Study|Change residence|1|||
164361438|NCT03658538|593697328|FG001|Overall Study|Change residence|2|||
164361439|NCT03658538|593697327|FG000|Overall Study|Lost to Follow-up|3|||
164361440|NCT03658538|593697328|FG001|Overall Study|Lost to Follow-up|3|||
164361441|NCT03658538|593697327|FG000|Overall Study|Unblinded|2|||
164361442|NCT03658538|593697328|FG001|Overall Study|Unblinded|3|||
164361443|NCT03658538|593697327|FG000|Overall Study|Physician Decision|0|||
164361444|NCT03658538|593697328|FG001|Overall Study|Physician Decision|1|||
164361445|NCT03658538|593697327|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
164361446|NCT03658538|593697328|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
164361447|NCT03658538|593697327|FG000|Overall Study|Evicted from home|1|||
164361448|NCT03658538|593697328|FG001|Overall Study|Evicted from home|0|||
164361449|NCT00597012|593697331|FG000|Overall Study|Death|1|||
164361450|NCT00597012|593697332|FG001|Overall Study|Death|1|||
164361451|NCT00597012|593697331|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
164361452|NCT00597012|593697332|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
164361453|NCT00597012|593697331|FG000|Overall Study|Withdrawal by Subject|7|||
164361454|NCT00597012|593697332|FG001|Overall Study|Withdrawal by Subject|4|||
164361455|NCT00597012|593697331|FG000|Overall Study|Ineligible|2|||
164361456|NCT00597012|593697332|FG001|Overall Study|Ineligible|0|||
164361457|NCT00597012|593697331|FG000|Overall Study|Lost to Follow-up|0|||
164361458|NCT00597012|593697332|FG001|Overall Study|Lost to Follow-up|2|||
164010594|NCT00306891|592403239|FG003|Part A|QTC interval outwith elig. criteria|0|||
164010595|NCT00306891|592403236|FG000|Part B|Death|0|||
164010596|NCT00306891|592403237|FG001|Part B|Death|0|||
164010597|NCT00306891|592403238|FG002|Part B|Death|1|||
164010598|NCT00306891|592403239|FG003|Part B|Death|2|||
164010599|NCT00306891|592403236|FG000|Part B|Adverse Event|0|||
164010600|NCT00306891|592403237|FG001|Part B|Adverse Event|0|||
164010601|NCT00306891|592403238|FG002|Part B|Adverse Event|5|||
164010602|NCT00306891|592403239|FG003|Part B|Adverse Event|5|||
164010603|NCT00306891|592403236|FG000|Part B|Withdrawal by Subject|0|||
164010604|NCT00306891|592403237|FG001|Part B|Withdrawal by Subject|0|||
164010605|NCT00306891|592403238|FG002|Part B|Withdrawal by Subject|3|||
164010606|NCT00306891|592403239|FG003|Part B|Withdrawal by Subject|1|||
164010607|NCT00306891|592403236|FG000|Part B|Condition under investigation worsened|0|||
164010608|NCT00306891|592403237|FG001|Part B|Condition under investigation worsened|0|||
164010609|NCT00306891|592403238|FG002|Part B|Condition under investigation worsened|2|||
164010610|NCT00306891|592403239|FG003|Part B|Condition under investigation worsened|8|||
164010611|NCT00306891|592403236|FG000|Part B|Development of study specific disc crit.|0|||
164010612|NCT00306891|592403237|FG001|Part B|Development of study specific disc crit.|0|||
164010613|NCT00306891|592403238|FG002|Part B|Development of study specific disc crit.|0|||
164010614|NCT00306891|592403239|FG003|Part B|Development of study specific disc crit.|1|||
164010615|NCT00673673|592403240|FG000|Overall Study|Progressive disease|27|||
164361459|NCT01290666|593699374|FG000|Overall Study|Lost to Follow-up|11|||
164361460|NCT01290666|593699374|FG000|Overall Study|Withdrawal by Subject|23|||
164361461|NCT01290666|593699374|FG000|Overall Study|Early Termination of Study|4|||
164361462|NCT05089682|593699375|FG000|Overall Study|Withdrawal by Subject|2|||
164361463|NCT03992781|593699376|FG000|Overall Study|Lost to Follow-up|5|||
164361464|NCT03992781|593699376|FG000|Overall Study|Adverse Event|1|||
164361465|NCT03992781|593699376|FG000|Overall Study|Lack of Efficacy|5|||
164361466|NCT01996826|593699377|FG000|Overall Study|Lost to Follow-up|6|||
164361467|NCT01996826|593699378|FG001|Overall Study|Lost to Follow-up|2|||
164361468|NCT01996826|593699377|FG000|Overall Study|Physician Decision|1|||
164361469|NCT01996826|593699378|FG001|Overall Study|Physician Decision|1|||
164361470|NCT00695396|593699379|FG000|Overall Study|Study Closed Prematurely|5|||
164361471|NCT00695396|593699380|FG001|Overall Study|Study Closed Prematurely|6|||
164361472|NCT00695396|593699381|FG002|Overall Study|Study Closed Prematurely|8|||
164361473|NCT00695396|593699379|FG000|Overall Study|Withdrawal by Subject|2|||
164361474|NCT00695396|593699380|FG001|Overall Study|Withdrawal by Subject|2|||
164361475|NCT00695396|593699381|FG002|Overall Study|Withdrawal by Subject|0|||
164361476|NCT00518323|593699383|FG000|Overall Study|Lack of Efficacy|14|||
164361477|NCT00518323|593699384|FG001|Overall Study|Lack of Efficacy|2|||
164361478|NCT00518323|593699385|FG002|Overall Study|Lack of Efficacy|4|||
164361479|NCT00518323|593699386|FG003|Overall Study|Lack of Efficacy|20|||
164361480|NCT00518323|593699383|FG000|Overall Study|Withdrawal by Subject|1|||
164361481|NCT00518323|593699384|FG001|Overall Study|Withdrawal by Subject|2|||
164361482|NCT00518323|593699385|FG002|Overall Study|Withdrawal by Subject|4|||
164361483|NCT00518323|593699386|FG003|Overall Study|Withdrawal by Subject|2|||
164361484|NCT00518323|593699383|FG000|Overall Study|Lost to Follow-up|0|||
164361485|NCT00518323|593699384|FG001|Overall Study|Lost to Follow-up|2|||
164361486|NCT00518323|593699385|FG002|Overall Study|Lost to Follow-up|1|||
164361487|NCT00518323|593699386|FG003|Overall Study|Lost to Follow-up|3|||
164361488|NCT00518323|593699383|FG000|Overall Study|Adverse Event|1|||
164361489|NCT00518323|593699384|FG001|Overall Study|Adverse Event|1|||
164361490|NCT00518323|593699385|FG002|Overall Study|Adverse Event|1|||
164361491|NCT00518323|593699386|FG003|Overall Study|Adverse Event|0|||
164361492|NCT00518323|593699383|FG000|Overall Study|Prohibited medication and others|3|||
164361493|NCT00518323|593699384|FG001|Overall Study|Prohibited medication and others|1|||
164361494|NCT00518323|593699385|FG002|Overall Study|Prohibited medication and others|1|||
164361495|NCT00518323|593699386|FG003|Overall Study|Prohibited medication and others|0|||
164361496|NCT03164928|593699387|FG000|Overall Study|Lost to Follow-up|1|||
164361497|NCT03164928|593699388|FG001|Overall Study|Lost to Follow-up|0|||
164361498|NCT00326950|593699393|FG000|Overall Study|Progressive Disease|1|||
164361499|NCT01514760|593699394|FG000|Overall Study|Lost to Follow-up|2|||
164361500|NCT01275833|593699395|FG000|Overall Study|Study terminated|1|||
164361501|NCT01275833|593699396|FG001|Overall Study|Study terminated|1|||
164361502|NCT02118012|593699398|FG000|Overall Study|Adverse Event|0|||
164361503|NCT02118012|593699399|FG001|Overall Study|Adverse Event|1|||
164361504|NCT02118012|593699398|FG000|Overall Study|Physician Decision|0|||
164361505|NCT02118012|593699399|FG001|Overall Study|Physician Decision|1|||
164010616|NCT00673673|592403240|FG000|Overall Study|Adverse Event|4|||
164010617|NCT00673673|592403240|FG000|Overall Study|Withdrawal by Subject|3|||
164361506|NCT00536107|593699400|FG000|Overall Study|Death|5|||
164361507|NCT00536107|593699401|FG001|Overall Study|Death|1|||
164361508|NCT00536107|593699400|FG000|Overall Study|Incorrect enrolment|1|||
164361509|NCT00536107|593699401|FG001|Overall Study|Incorrect enrolment|0|||
164361510|NCT00536107|593699400|FG000|Overall Study|Withdrawal by Subject|0|||
164361511|NCT00536107|593699401|FG001|Overall Study|Withdrawal by Subject|1|||
164361512|NCT00536107|593699400|FG000|Overall Study|Study Termination|2|||
164361513|NCT00536107|593699401|FG001|Overall Study|Study Termination|4|||
164361514|NCT03329690|593699402|FG000|Overall Study|Progressive disease per RECIST|85|||
164361515|NCT03329690|593699403|FG001|Overall Study|Progressive disease per RECIST|44|||
164361516|NCT03329690|593699404|FG002|Overall Study|Progressive disease per RECIST|6|||
164361517|NCT03329690|593699405|FG003|Overall Study|Progressive disease per RECIST|16|||
164361518|NCT03329690|593699406|FG004|Overall Study|Progressive disease per RECIST|20|||
164010618|NCT00673673|592403240|FG000|Overall Study|Investigators' discretion|2|||
164361519|NCT03329690|593699402|FG000|Overall Study|Clinical progression|7|||
164361520|NCT03329690|593699403|FG001|Overall Study|Clinical progression|4|||
164361521|NCT03329690|593699404|FG002|Overall Study|Clinical progression|1|||
164361522|NCT03329690|593699405|FG003|Overall Study|Clinical progression|1|||
164361523|NCT03329690|593699406|FG004|Overall Study|Clinical progression|1|||
164361524|NCT03329690|593699402|FG000|Overall Study|Adverse Event|22|||
164361525|NCT03329690|593699403|FG001|Overall Study|Adverse Event|4|||
164361526|NCT03329690|593699404|FG002|Overall Study|Adverse Event|0|||
164361527|NCT03329690|593699405|FG003|Overall Study|Adverse Event|1|||
164361528|NCT03329690|593699406|FG004|Overall Study|Adverse Event|2|||
164361529|NCT03329690|593699402|FG000|Overall Study|Death|2|||
164361530|NCT03329690|593699403|FG001|Overall Study|Death|0|||
164361531|NCT03329690|593699404|FG002|Overall Study|Death|0|||
164361532|NCT03329690|593699405|FG003|Overall Study|Death|1|||
164361533|NCT03329690|593699406|FG004|Overall Study|Death|0|||
164361534|NCT03329690|593699402|FG000|Overall Study|Withdrawal by Subject|2|||
164361535|NCT03329690|593699403|FG001|Overall Study|Withdrawal by Subject|3|||
164361536|NCT03329690|593699404|FG002|Overall Study|Withdrawal by Subject|0|||
164361537|NCT03329690|593699405|FG003|Overall Study|Withdrawal by Subject|1|||
164361538|NCT03329690|593699406|FG004|Overall Study|Withdrawal by Subject|0|||
164361539|NCT03329690|593699402|FG000|Overall Study|Physician Decision|1|||
164361540|NCT03329690|593699403|FG001|Overall Study|Physician Decision|0|||
164361541|NCT03329690|593699404|FG002|Overall Study|Physician Decision|0|||
164361542|NCT03329690|593699405|FG003|Overall Study|Physician Decision|0|||
164361543|NCT03329690|593699406|FG004|Overall Study|Physician Decision|1|||
164361544|NCT03329690|593699402|FG000|Overall Study|Miscellaneous|6|||
164361545|NCT03329690|593699403|FG001|Overall Study|Miscellaneous|0|||
164361546|NCT03329690|593699404|FG002|Overall Study|Miscellaneous|0|||
164361547|NCT03329690|593699405|FG003|Overall Study|Miscellaneous|0|||
164361548|NCT03329690|593699406|FG004|Overall Study|Miscellaneous|0|||
164361549|NCT03329690|593699402|FG000|Overall Study|Did not receive treatment|1|||
164361550|NCT03329690|593699403|FG001|Overall Study|Did not receive treatment|0|||
164361551|NCT03329690|593699404|FG002|Overall Study|Did not receive treatment|0|||
164361552|NCT03329690|593699405|FG003|Overall Study|Did not receive treatment|1|||
164361553|NCT03329690|593699406|FG004|Overall Study|Did not receive treatment|0|||
164361554|NCT00619801|593699412|FG000|Overall Study|Lack of Efficacy|0|||
164361555|NCT00619801|593699413|FG001|Overall Study|Lack of Efficacy|1|||
164361556|NCT00619801|593699412|FG000|Overall Study|Withdrawal by Subject|1|||
164361557|NCT00619801|593699413|FG001|Overall Study|Withdrawal by Subject|1|||
164361558|NCT00619801|593699412|FG000|Overall Study|Loss of efficacy|0|||
164361559|NCT00619801|593699413|FG001|Overall Study|Loss of efficacy|1|||
164361560|NCT00450333|593699418|FG000|Overall Study|Study terminated|47|||
164361561|NCT00450333|593699419|FG001|Overall Study|Study terminated|54|||
164361562|NCT00450333|593699420|FG002|Overall Study|Study terminated|16|||
164361563|NCT00450333|593699421|FG003|Overall Study|Study terminated|21|||
164361564|NCT00450333|593699418|FG000|Overall Study|Adverse Event|1|||
164361565|NCT00450333|593699419|FG001|Overall Study|Adverse Event|7|||
164361566|NCT00450333|593699420|FG002|Overall Study|Adverse Event|2|||
164361567|NCT00450333|593699421|FG003|Overall Study|Adverse Event|2|||
164361568|NCT00450333|593699418|FG000|Overall Study|Protocol Violation|1|||
164361569|NCT00450333|593699419|FG001|Overall Study|Protocol Violation|0|||
164361570|NCT00450333|593699420|FG002|Overall Study|Protocol Violation|1|||
164361571|NCT00450333|593699421|FG003|Overall Study|Protocol Violation|0|||
164361572|NCT00450333|593699418|FG000|Overall Study|Withdrawal by Subject|1|||
164361573|NCT00450333|593699419|FG001|Overall Study|Withdrawal by Subject|0|||
164361574|NCT00450333|593699420|FG002|Overall Study|Withdrawal by Subject|3|||
164361575|NCT00450333|593699421|FG003|Overall Study|Withdrawal by Subject|0|||
164361576|NCT00450333|593699418|FG000|Overall Study|Kidney transplant|1|||
164361577|NCT00450333|593699419|FG001|Overall Study|Kidney transplant|0|||
164361578|NCT00450333|593699420|FG002|Overall Study|Kidney transplant|1|||
164361579|NCT00450333|593699421|FG003|Overall Study|Kidney transplant|3|||
164361580|NCT00450333|593699418|FG000|Overall Study|Death|3|||
164361581|NCT00450333|593699419|FG001|Overall Study|Death|2|||
164361582|NCT00450333|593699420|FG002|Overall Study|Death|2|||
164361583|NCT00450333|593699421|FG003|Overall Study|Death|2|||
164361584|NCT03855280|593699429|FG000|Treatment Phase|Adverse Event|1|||
164361585|NCT03855280|593699429|FG000|Treatment Phase|Withdrawal by Subject|1|||
164361586|NCT03855280|593699429|FG000|Continuation Phase|Protocol Violation|1|||
164361587|NCT03855280|593699429|FG000|Continuation Phase|Adverse Event|1|||
164361588|NCT03855280|593699429|FG000|Continuation Phase|Sponsor Concluded Study|1|||
164361589|NCT02738450|593699432|FG000|Overall Study|Withdrawal by Subject|0|||
164361590|NCT02738450|593699433|FG001|Overall Study|Withdrawal by Subject|2|||
164361591|NCT02738450|593699434|FG002|Overall Study|Withdrawal by Subject|0|||
164361592|NCT03204305|593699435|FG000|Overall Study|Lost to Follow-up|6|||
164361593|NCT03204305|593699436|FG001|Overall Study|Lost to Follow-up|4|||
164361594|NCT03204305|593699437|FG002|Overall Study|Lost to Follow-up|0|||
164361595|NCT03204305|593699438|FG003|Overall Study|Lost to Follow-up|0|||
164010619|NCT04538950|592403249|FG000|Overall Study|Pulmonary Issues|2|||
164361596|NCT03204305|593699435|FG000|Overall Study|Physician Decision|1|||
164361597|NCT03204305|593699436|FG001|Overall Study|Physician Decision|0|||
164361598|NCT03204305|593699437|FG002|Overall Study|Physician Decision|0|||
164361599|NCT03204305|593699438|FG003|Overall Study|Physician Decision|0|||
164361600|NCT03204305|593699435|FG000|Overall Study|failure to place arterial line|2|||
164361601|NCT03204305|593699436|FG001|Overall Study|failure to place arterial line|1|||
164361602|NCT03204305|593699437|FG002|Overall Study|failure to place arterial line|0|||
164361603|NCT03204305|593699438|FG003|Overall Study|failure to place arterial line|0|||
164361604|NCT03204305|593699435|FG000|Overall Study|Withdrawal by Subject|2|||
164361605|NCT03204305|593699436|FG001|Overall Study|Withdrawal by Subject|0|||
164361606|NCT03204305|593699437|FG002|Overall Study|Withdrawal by Subject|0|||
164361607|NCT03204305|593699438|FG003|Overall Study|Withdrawal by Subject|0|||
164361608|NCT01165554|593699445|FG000|Overall Study|Withdrawal by Subject|23|||
164361609|NCT02951156|593699446|FG000|Overall Study|Death|3|||
164361610|NCT02951156|593699447|FG001|Overall Study|Death|8|||
164361611|NCT02951156|593699448|FG002|Overall Study|Death|5|||
164361612|NCT02951156|593699446|FG000|Overall Study|Progressive disease|1|||
164361613|NCT02951156|593699447|FG001|Overall Study|Progressive disease|0|||
164361614|NCT02951156|593699448|FG002|Overall Study|Progressive disease|1|||
164361615|NCT02951156|593699446|FG000|Overall Study|Withdrawal by Subject|0|||
164361616|NCT02951156|593699447|FG001|Overall Study|Withdrawal by Subject|0|||
164361617|NCT02951156|593699448|FG002|Overall Study|Withdrawal by Subject|1|||
164361618|NCT02951156|593699446|FG000|Overall Study|Study terminated by sponsor|0|||
164361619|NCT02951156|593699447|FG001|Overall Study|Study terminated by sponsor|0|||
164361620|NCT02951156|593699448|FG002|Overall Study|Study terminated by sponsor|1|||
164361621|NCT02951156|593699446|FG000|Overall Study|Other|5|||
164361622|NCT02951156|593699447|FG001|Overall Study|Other|1|||
164361623|NCT02951156|593699448|FG002|Overall Study|Other|2|||
164361624|NCT01603459|593699451|FG000|Overall Study|Adverse Event|5|||
164361625|NCT01603459|593699451|FG000|Overall Study|Withdrawal by Subject|5|||
164361626|NCT01603459|593699451|FG000|Overall Study|Lost to Follow-up|3|||
164361627|NCT01603459|593699451|FG000|Overall Study|Predefined discontinuation criteria|3|||
164361628|NCT01603459|593699451|FG000|Overall Study|Non-compliance|1|||
164361629|NCT01603459|593699451|FG000|Overall Study|Administrative reason|1|||
164361630|NCT01092182|593699452|FG000|Overall Study|Death|0|||
164361631|NCT01092182|593699453|FG001|Overall Study|Death|5|||
164361632|NCT01092182|593699454|FG002|Overall Study|Death|3|||
164361633|NCT01092182|593699452|FG000|Overall Study|participant safety|1|||
164361634|NCT01092182|593699453|FG001|Overall Study|participant safety|2|||
164361635|NCT01092182|593699454|FG002|Overall Study|participant safety|0|||
164361636|NCT01092182|593699452|FG000|Overall Study|Physician Decision|0|||
164361637|NCT01092182|593699453|FG001|Overall Study|Physician Decision|6|||
164361638|NCT01092182|593699454|FG002|Overall Study|Physician Decision|0|||
164361639|NCT01092182|593699452|FG000|Overall Study|Did not meet criteria|0|||
164361640|NCT01092182|593699453|FG001|Overall Study|Did not meet criteria|0|||
164361641|NCT01092182|593699454|FG002|Overall Study|Did not meet criteria|25|||
164361642|NCT01092182|593699452|FG000|Overall Study|Non-compliance|0|||
164361643|NCT01092182|593699453|FG001|Overall Study|Non-compliance|3|||
164361644|NCT01092182|593699454|FG002|Overall Study|Non-compliance|0|||
164361645|NCT01092182|593699452|FG000|Overall Study|Participant refused follow-up|0|||
164361646|NCT01092182|593699453|FG001|Overall Study|Participant refused follow-up|2|||
164361647|NCT01092182|593699454|FG002|Overall Study|Participant refused follow-up|0|||
164361648|NCT01641692|593699455|FG000|Treatment Period 1|Adverse Event|1|||
164361649|NCT01641692|593699456|FG001|Treatment Period 1|Adverse Event|0|||
164361650|NCT01641692|593699457|FG002|Treatment Period 1|Adverse Event|0|||
164361651|NCT01641692|593699458|FG003|Treatment Period 1|Adverse Event|0|||
164361652|NCT01641692|593699459|FG004|Treatment Period 1|Adverse Event|0|||
164361653|NCT01641692|593699460|FG005|Treatment Period 1|Adverse Event|0|||
164361654|NCT01641692|593699461|FG006|Treatment Period 1|Adverse Event|0|||
164361655|NCT01641692|593699462|FG007|Treatment Period 1|Adverse Event|0|||
164361656|NCT01641692|593699455|FG000|Treatment Period 1|Lack of Efficacy|0|||
164361657|NCT01641692|593699456|FG001|Treatment Period 1|Lack of Efficacy|0|||
164361658|NCT01641692|593699457|FG002|Treatment Period 1|Lack of Efficacy|0|||
164361659|NCT01641692|593699458|FG003|Treatment Period 1|Lack of Efficacy|0|||
164361660|NCT01641692|593699459|FG004|Treatment Period 1|Lack of Efficacy|0|||
164361661|NCT01641692|593699460|FG005|Treatment Period 1|Lack of Efficacy|0|||
164361662|NCT01641692|593699461|FG006|Treatment Period 1|Lack of Efficacy|0|||
164361663|NCT01641692|593699462|FG007|Treatment Period 1|Lack of Efficacy|1|||
164361664|NCT01641692|593699455|FG000|Treatment Period 1|Protocol Violation|1|||
164361665|NCT01641692|593699456|FG001|Treatment Period 1|Protocol Violation|0|||
164361666|NCT01641692|593699457|FG002|Treatment Period 1|Protocol Violation|0|||
164361667|NCT01641692|593699458|FG003|Treatment Period 1|Protocol Violation|0|||
164361668|NCT01641692|593699459|FG004|Treatment Period 1|Protocol Violation|2|||
164361669|NCT01641692|593699460|FG005|Treatment Period 1|Protocol Violation|0|||
164361670|NCT01641692|593699461|FG006|Treatment Period 1|Protocol Violation|0|||
164361671|NCT01641692|593699462|FG007|Treatment Period 1|Protocol Violation|0|||
164361672|NCT01641692|593699455|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361673|NCT01641692|593699456|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361674|NCT01641692|593699457|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361675|NCT01641692|593699458|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361676|NCT01641692|593699459|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
164361677|NCT01641692|593699460|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361678|NCT01641692|593699461|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
164361679|NCT01641692|593699462|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
164361680|NCT01641692|593699455|FG000|Treatment Period 1|Lost to Follow-up|0|||
164361681|NCT01641692|593699456|FG001|Treatment Period 1|Lost to Follow-up|0|||
164361682|NCT01641692|593699457|FG002|Treatment Period 1|Lost to Follow-up|1|||
164361683|NCT01641692|593699458|FG003|Treatment Period 1|Lost to Follow-up|0|||
164361684|NCT01641692|593699459|FG004|Treatment Period 1|Lost to Follow-up|0|||
164361685|NCT01641692|593699460|FG005|Treatment Period 1|Lost to Follow-up|0|||
164361686|NCT01641692|593699461|FG006|Treatment Period 1|Lost to Follow-up|0|||
164361687|NCT01641692|593699462|FG007|Treatment Period 1|Lost to Follow-up|0|||
164361688|NCT01641692|593699455|FG000|Treatment Period 1|Physician Decision|0|||
164361689|NCT01641692|593699456|FG001|Treatment Period 1|Physician Decision|0|||
164361690|NCT01641692|593699457|FG002|Treatment Period 1|Physician Decision|0|||
164361691|NCT01641692|593699458|FG003|Treatment Period 1|Physician Decision|0|||
164361692|NCT01641692|593699459|FG004|Treatment Period 1|Physician Decision|1|||
164361693|NCT01641692|593699460|FG005|Treatment Period 1|Physician Decision|0|||
164361694|NCT01641692|593699461|FG006|Treatment Period 1|Physician Decision|0|||
164361695|NCT01641692|593699462|FG007|Treatment Period 1|Physician Decision|0|||
164361696|NCT01641692|593699455|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164361697|NCT01641692|593699456|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164361698|NCT01641692|593699457|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164361699|NCT01641692|593699458|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164361700|NCT01641692|593699459|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164361701|NCT01641692|593699460|FG005|Treatment Period 1|Withdrawal by Subject|2|||
164361702|NCT01641692|593699461|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164361703|NCT01641692|593699462|FG007|Treatment Period 1|Withdrawal by Subject|1|||
164361704|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
164361705|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361706|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361707|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361708|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361709|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361710|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361711|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
164361712|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361713|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361714|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361715|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361716|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361717|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361718|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
164361719|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164361720|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361721|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361722|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
164361723|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361724|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
164361725|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361726|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361727|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361728|NCT01641692|593699455|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361729|NCT01641692|593699456|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361730|NCT01641692|593699457|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164361731|NCT01641692|593699458|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361732|NCT01641692|593699459|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361733|NCT01641692|593699460|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164361734|NCT01641692|593699461|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164361735|NCT01641692|593699462|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164361736|NCT01641692|593699455|FG000|Treatment Period 2|Lack of Efficacy|1|||
164361737|NCT01641692|593699456|FG001|Treatment Period 2|Lack of Efficacy|0|||
164361738|NCT01641692|593699457|FG002|Treatment Period 2|Lack of Efficacy|0|||
164361739|NCT01641692|593699458|FG003|Treatment Period 2|Lack of Efficacy|0|||
164361740|NCT01641692|593699459|FG004|Treatment Period 2|Lack of Efficacy|0|||
164361741|NCT01641692|593699460|FG005|Treatment Period 2|Lack of Efficacy|0|||
164361742|NCT01641692|593699461|FG006|Treatment Period 2|Lack of Efficacy|0|||
164361743|NCT01641692|593699462|FG007|Treatment Period 2|Lack of Efficacy|0|||
164361744|NCT01641692|593699455|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
164361745|NCT01641692|593699456|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361746|NCT01641692|593699457|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361747|NCT01641692|593699458|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361748|NCT01641692|593699459|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361749|NCT01641692|593699460|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361750|NCT01641692|593699461|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164010620|NCT04538950|592403249|FG000|Overall Study|illness|2|||
164361751|NCT01641692|593699462|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164361752|NCT01641692|593699455|FG000|Treatment Period 2|Lost to Follow-up|0|||
164361753|NCT01641692|593699456|FG001|Treatment Period 2|Lost to Follow-up|0|||
164361754|NCT01641692|593699457|FG002|Treatment Period 2|Lost to Follow-up|0|||
164361755|NCT01641692|593699458|FG003|Treatment Period 2|Lost to Follow-up|0|||
164361756|NCT01641692|593699459|FG004|Treatment Period 2|Lost to Follow-up|0|||
164361757|NCT01641692|593699460|FG005|Treatment Period 2|Lost to Follow-up|1|||
164361758|NCT01641692|593699461|FG006|Treatment Period 2|Lost to Follow-up|0|||
164361759|NCT01641692|593699462|FG007|Treatment Period 2|Lost to Follow-up|0|||
164361760|NCT01641692|593699455|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164361761|NCT01641692|593699456|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164361762|NCT01641692|593699457|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164361763|NCT01641692|593699458|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164361764|NCT01641692|593699459|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164361765|NCT01641692|593699460|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164361766|NCT01641692|593699461|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164361767|NCT01641692|593699462|FG007|Treatment Period 2|Withdrawal by Subject|1|||
164361768|NCT01641692|593699455|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361769|NCT01641692|593699456|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361770|NCT01641692|593699457|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361771|NCT01641692|593699458|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361772|NCT01641692|593699459|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
164361773|NCT01641692|593699460|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361774|NCT01641692|593699461|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
164361775|NCT01641692|593699462|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
164361776|NCT01641692|593699455|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361777|NCT01641692|593699456|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361778|NCT01641692|593699457|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164361779|NCT01641692|593699458|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361780|NCT01641692|593699459|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361781|NCT01641692|593699460|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164361782|NCT01641692|593699461|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164361783|NCT01641692|593699462|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164361784|NCT01641692|593699455|FG000|Treatment Period 3|Adverse Event|0|||
164361785|NCT01641692|593699456|FG001|Treatment Period 3|Adverse Event|0|||
164361786|NCT01641692|593699457|FG002|Treatment Period 3|Adverse Event|0|||
164361787|NCT01641692|593699458|FG003|Treatment Period 3|Adverse Event|0|||
164361788|NCT01641692|593699459|FG004|Treatment Period 3|Adverse Event|0|||
164361789|NCT01641692|593699460|FG005|Treatment Period 3|Adverse Event|0|||
164361790|NCT01641692|593699461|FG006|Treatment Period 3|Adverse Event|1|||
164361791|NCT01641692|593699462|FG007|Treatment Period 3|Adverse Event|0|||
164361792|NCT01641692|593699455|FG000|Treatment Period 3|Protocol Violation|0|||
164361793|NCT01641692|593699456|FG001|Treatment Period 3|Protocol Violation|0|||
164361794|NCT01641692|593699457|FG002|Treatment Period 3|Protocol Violation|1|||
164361795|NCT01641692|593699458|FG003|Treatment Period 3|Protocol Violation|0|||
164361796|NCT01641692|593699459|FG004|Treatment Period 3|Protocol Violation|0|||
164010621|NCT04579393|592403252|FG000|Overall Study|Withdrawal by Subject|2|||
164010622|NCT04579393|592403253|FG001|Overall Study|Withdrawal by Subject|2|||
164361797|NCT01641692|593699460|FG005|Treatment Period 3|Protocol Violation|0|||
164361798|NCT01641692|593699461|FG006|Treatment Period 3|Protocol Violation|0|||
164361799|NCT01641692|593699462|FG007|Treatment Period 3|Protocol Violation|0|||
164361800|NCT01641692|593699455|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361801|NCT01641692|593699456|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361802|NCT01641692|593699457|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361803|NCT01641692|593699458|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361804|NCT01641692|593699459|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361805|NCT01641692|593699460|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361806|NCT01641692|593699461|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
164361807|NCT01641692|593699462|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164361808|NCT01641692|593699455|FG000|Treatment Period 3|Lost to Follow-up|0|||
164361809|NCT01641692|593699456|FG001|Treatment Period 3|Lost to Follow-up|1|||
164361810|NCT01641692|593699457|FG002|Treatment Period 3|Lost to Follow-up|0|||
164010623|NCT04579393|592403252|FG000|Overall Study|Death|1|||
164010624|NCT04579393|592403253|FG001|Overall Study|Death|3|||
164010625|NCT01282814|592403256|FG000|First Intervention|Emesis During Dosing Interval|0|||
164010626|NCT01282814|592403257|FG001|First Intervention|Emesis During Dosing Interval|3|||
164361811|NCT01641692|593699458|FG003|Treatment Period 3|Lost to Follow-up|0|||
164010627|NCT01282814|592403256|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
164010628|NCT01282814|592403257|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164010629|NCT02519231|592403260|FG000|Overall Study|Lost to Follow-up|2|||
164361812|NCT01641692|593699459|FG004|Treatment Period 3|Lost to Follow-up|0|||
164361813|NCT01641692|593699460|FG005|Treatment Period 3|Lost to Follow-up|0|||
164361814|NCT01641692|593699461|FG006|Treatment Period 3|Lost to Follow-up|0|||
164361815|NCT01641692|593699462|FG007|Treatment Period 3|Lost to Follow-up|0|||
164361816|NCT01641692|593699455|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361817|NCT01641692|593699456|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361818|NCT01641692|593699457|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361819|NCT01641692|593699458|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361820|NCT01641692|593699459|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361821|NCT01641692|593699460|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
164361822|NCT01641692|593699461|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361823|NCT01641692|593699462|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
164361824|NCT01641692|593699455|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361825|NCT01641692|593699456|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
164361826|NCT01641692|593699457|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361827|NCT01641692|593699458|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361828|NCT01641692|593699459|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
164361829|NCT01641692|593699460|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361830|NCT01641692|593699461|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
164361831|NCT01641692|593699462|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
164361832|NCT01166178|593699463|FG000|Overall Study|Withdrawal by Subject|1|||
164361833|NCT01166178|593699464|FG001|Overall Study|Withdrawal by Subject|0|||
164361834|NCT01166178|593699463|FG000|Overall Study|Study was terminated|20|||
164361835|NCT01166178|593699464|FG001|Overall Study|Study was terminated|8|||
164361836|NCT04948450|593699465|FG000|Overall Study|Return home|1|||
164361837|NCT04948450|593699466|FG001|Overall Study|Return home|3|||
164361838|NCT01173718|593699477|FG000|Overall Study|Death|17|||
164361839|NCT01173718|593699477|FG000|Overall Study|Abandonment of study graft|27|||
164361840|NCT02005250|593699479|FG000|Overall Study|Lost to Follow-up|15|||
164361841|NCT02005250|593699480|FG001|Overall Study|Lost to Follow-up|5|||
164361842|NCT02738151|593699481|FG000|Overall Study|Randomized but not treated|4|||
164361843|NCT02738151|593699482|FG001|Overall Study|Randomized but not treated|1|||
164361844|NCT02738151|593699481|FG000|Overall Study|Adverse Event|4|||
164361845|NCT02738151|593699482|FG001|Overall Study|Adverse Event|5|||
164361846|NCT02738151|593699481|FG000|Overall Study|Hypoglycemia|0|||
164361847|NCT02738151|593699482|FG001|Overall Study|Hypoglycemia|1|||
164361848|NCT02738151|593699481|FG000|Overall Study|Poor Compliance to Protocol|4|||
164361849|NCT02738151|593699482|FG001|Overall Study|Poor Compliance to Protocol|3|||
164361850|NCT02738151|593699481|FG000|Overall Study|Other than specified above|11|||
164361851|NCT02738151|593699482|FG001|Overall Study|Other than specified above|21|||
164361852|NCT03333044|593699486|FG000|Overall Study|Pregnancy|1|||
164361853|NCT03333044|593699487|FG001|Overall Study|Pregnancy|0|||
164361854|NCT03333044|593699488|FG002|Overall Study|Pregnancy|0|||
164361855|NCT03333044|593699486|FG000|Overall Study|Lost to Follow-up|0|||
164361856|NCT03333044|593699487|FG001|Overall Study|Lost to Follow-up|14|||
164361857|NCT03333044|593699488|FG002|Overall Study|Lost to Follow-up|6|||
164361858|NCT04007094|593699496|FG000|Overall Study|Lost to Follow-up|1|||
164361859|NCT04007094|593699497|FG001|Overall Study|Lost to Follow-up|1|||
164361860|NCT02921776|593699502|FG000|Overall Study|patient deterioration, fatigue|2|||
164361861|NCT02921776|593699503|FG001|Overall Study|patient deterioration, fatigue|6|||
164361862|NCT02921776|593699504|FG002|Overall Study|patient deterioration, fatigue|0|||
164361863|NCT02921776|593699505|FG003|Overall Study|patient deterioration, fatigue|0|||
164361864|NCT02921776|593699506|FG004|Overall Study|patient deterioration, fatigue|0|||
164361865|NCT02921776|593699507|FG005|Overall Study|patient deterioration, fatigue|0|||
164361866|NCT02921776|593699508|FG006|Overall Study|patient deterioration, fatigue|0|||
164010630|NCT02519231|592403261|FG001|Overall Study|Lost to Follow-up|5|||
164010631|NCT02519231|592403260|FG000|Overall Study|Withdrawal by Subject|0|||
164010632|NCT02519231|592403261|FG001|Overall Study|Withdrawal by Subject|1|||
164010633|NCT02704429|592403262|FG000|Part A: 24 Weeks|Adverse Event|3|||
164010634|NCT02704429|592403263|FG001|Part A: 24 Weeks|Adverse Event|0|||
164010635|NCT02704429|592403262|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
164010636|NCT02704429|592403263|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
164010637|NCT00104104|592403264|FG000|Overall Study|Adverse Event|8|||
164010638|NCT00104104|592403265|FG001|Overall Study|Adverse Event|8|||
164010639|NCT00104104|592403264|FG000|Overall Study|Abnormal laboratory value(s)|20|||
164010640|NCT00104104|592403265|FG001|Overall Study|Abnormal laboratory value(s)|14|||
164010641|NCT00104104|592403264|FG000|Overall Study|Lack of Efficacy|0|||
164010642|NCT00104104|592403265|FG001|Overall Study|Lack of Efficacy|3|||
164010643|NCT00104104|592403264|FG000|Overall Study|Condition no longer requires study drug|7|||
164010644|NCT00104104|592403265|FG001|Overall Study|Condition no longer requires study drug|4|||
164010645|NCT00104104|592403264|FG000|Overall Study|Protocol Violation|5|||
164010646|NCT00104104|592403265|FG001|Overall Study|Protocol Violation|2|||
164361867|NCT02921776|593699509|FG007|Overall Study|patient deterioration, fatigue|0|||
164361868|NCT02921776|593699502|FG000|Overall Study|Withdrawal by Subject|0|||
164361869|NCT02921776|593699503|FG001|Overall Study|Withdrawal by Subject|2|||
164361870|NCT02921776|593699504|FG002|Overall Study|Withdrawal by Subject|0|||
164361871|NCT02921776|593699505|FG003|Overall Study|Withdrawal by Subject|1|||
164361872|NCT02921776|593699506|FG004|Overall Study|Withdrawal by Subject|1|||
164361873|NCT02921776|593699507|FG005|Overall Study|Withdrawal by Subject|0|||
164361874|NCT02921776|593699508|FG006|Overall Study|Withdrawal by Subject|8|||
164361875|NCT02921776|593699509|FG007|Overall Study|Withdrawal by Subject|1|||
164361876|NCT02921776|593699502|FG000|Overall Study|Death|0|||
164361877|NCT02921776|593699503|FG001|Overall Study|Death|0|||
164361878|NCT02921776|593699504|FG002|Overall Study|Death|0|||
164361879|NCT02921776|593699505|FG003|Overall Study|Death|2|||
164361880|NCT02921776|593699506|FG004|Overall Study|Death|0|||
164361881|NCT02921776|593699507|FG005|Overall Study|Death|0|||
164361882|NCT02921776|593699508|FG006|Overall Study|Death|0|||
164361883|NCT02921776|593699509|FG007|Overall Study|Death|0|||
164361884|NCT02921776|593699502|FG000|Overall Study|extubation or early discharge|0|||
164361885|NCT02921776|593699503|FG001|Overall Study|extubation or early discharge|0|||
164361886|NCT02921776|593699504|FG002|Overall Study|extubation or early discharge|0|||
164361887|NCT02921776|593699505|FG003|Overall Study|extubation or early discharge|5|||
164361888|NCT02921776|593699506|FG004|Overall Study|extubation or early discharge|5|||
164361889|NCT02921776|593699507|FG005|Overall Study|extubation or early discharge|0|||
164361890|NCT02921776|593699508|FG006|Overall Study|extubation or early discharge|0|||
164361891|NCT02921776|593699509|FG007|Overall Study|extubation or early discharge|0|||
164361892|NCT02921776|593699502|FG000|Overall Study|Lost to Follow-up|0|||
164361893|NCT02921776|593699503|FG001|Overall Study|Lost to Follow-up|0|||
164361894|NCT02921776|593699504|FG002|Overall Study|Lost to Follow-up|0|||
164361895|NCT02921776|593699505|FG003|Overall Study|Lost to Follow-up|0|||
164361896|NCT02921776|593699506|FG004|Overall Study|Lost to Follow-up|0|||
164361897|NCT02921776|593699507|FG005|Overall Study|Lost to Follow-up|2|||
164361898|NCT02921776|593699508|FG006|Overall Study|Lost to Follow-up|3|||
164361899|NCT02921776|593699509|FG007|Overall Study|Lost to Follow-up|6|||
164361900|NCT04350788|593699519|FG000|Overall Study|Lost to Follow-up|6|||
164361901|NCT04350788|593699520|FG001|Overall Study|Lost to Follow-up|2|||
164361902|NCT04350788|593699519|FG000|Overall Study|Withdrawal by Subject|2|||
164361903|NCT04350788|593699520|FG001|Overall Study|Withdrawal by Subject|4|||
164361904|NCT04350788|593699519|FG000|Overall Study|Protocol Violation|4|||
164361905|NCT04350788|593699520|FG001|Overall Study|Protocol Violation|0|||
164361906|NCT04537234|593699521|FG000|Overall Study|Withdrawal by Subject|2|||
164361907|NCT04537234|593699522|FG001|Overall Study|Withdrawal by Subject|0|||
164361908|NCT00378209|593699523|FG000|Overall Study|Progressive disease|11|||
164361909|NCT00378209|593699523|FG000|Overall Study|Adverse Event|3|||
164361910|NCT00378209|593699523|FG000|Overall Study|Initiation of non-protocol therapy|3|||
164361911|NCT00378209|593699523|FG000|Overall Study|Physician Decision|3|||
164361912|NCT00378209|593699523|FG000|Overall Study|Death|1|||
164361913|NCT00378209|593699523|FG000|Overall Study|Treatment delay|1|||
164361914|NCT02070744|593699524|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361915|NCT02070744|593699525|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361916|NCT02070744|593699526|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361917|NCT02070744|593699527|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
164361918|NCT02070744|593699528|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
164361919|NCT02070744|593699524|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361920|NCT02070744|593699525|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361921|NCT02070744|593699526|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361922|NCT02070744|593699527|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
164361923|NCT02070744|593699528|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
164361924|NCT02070744|593699524|FG000|OLE Phase (48 Weeks)|Other|0|||
164361925|NCT02070744|593699525|FG001|OLE Phase (48 Weeks)|Other|0|||
164361926|NCT02070744|593699526|FG002|OLE Phase (48 Weeks)|Other|0|||
164361927|NCT02070744|593699527|FG003|OLE Phase (48 Weeks)|Other|0|||
164361928|NCT02070744|593699528|FG004|OLE Phase (48 Weeks)|Other|1|||
164361929|NCT01239368|593701574|FG000|Overall Study|Principal investigator discretion|1|||
164361930|NCT01239368|593701575|FG001|Overall Study|Principal investigator discretion|0|||
164361931|NCT01239368|593701576|FG002|Overall Study|Principal investigator discretion|0|||
163901612|NCT00811941|592011395|FG001|All Treated Patients|Protocol Violation|17|||
163901613|NCT00811941|592011394|FG000|All Treated Patients|Withdrawal by Subject|35|||
163901614|NCT00811941|592011395|FG001|All Treated Patients|Withdrawal by Subject|94|||
163901615|NCT00811941|592011394|FG000|All Treated Patients|Lost to Follow-up|3|||
163901616|NCT00811941|592011395|FG001|All Treated Patients|Lost to Follow-up|12|||
163901617|NCT00811941|592011394|FG000|All Treated Patients|Other Reason|4|||
163901618|NCT00811941|592011395|FG001|All Treated Patients|Other Reason|14|||
163901619|NCT03802994|592011398|FG000|Overall Study|Lost to Follow-up|0|||
163901620|NCT03802994|592011399|FG001|Overall Study|Lost to Follow-up|2|||
163901621|NCT03802994|592011400|FG002|Overall Study|Lost to Follow-up|3|||
163901622|NCT03802994|592011401|FG003|Overall Study|Lost to Follow-up|2|||
164361932|NCT01239368|593701577|FG003|Overall Study|Principal investigator discretion|0|||
164361933|NCT01239368|593701578|FG004|Overall Study|Principal investigator discretion|1|||
164361934|NCT01239368|593701579|FG005|Overall Study|Principal investigator discretion|2|||
164361935|NCT01239368|593701580|FG006|Overall Study|Principal investigator discretion|0|||
164361936|NCT01239368|593701581|FG007|Overall Study|Principal investigator discretion|0|||
164361937|NCT01239368|593701582|FG008|Overall Study|Principal investigator discretion|0|||
164010647|NCT00104104|592403264|FG000|Overall Study|Withdrawal by Subject|11|||
164010648|NCT00104104|592403265|FG001|Overall Study|Withdrawal by Subject|15|||
164010649|NCT00104104|592403264|FG000|Overall Study|Lost to Follow-up|3|||
164361938|NCT01239368|593701583|FG009|Overall Study|Principal investigator discretion|1|||
164361939|NCT01239368|593701574|FG000|Overall Study|Disease progression on study|1|||
164361940|NCT01239368|593701575|FG001|Overall Study|Disease progression on study|1|||
164361941|NCT01239368|593701576|FG002|Overall Study|Disease progression on study|1|||
164361942|NCT01239368|593701577|FG003|Overall Study|Disease progression on study|1|||
164361943|NCT01239368|593701578|FG004|Overall Study|Disease progression on study|4|||
164361944|NCT01239368|593701579|FG005|Overall Study|Disease progression on study|2|||
164361945|NCT01239368|593701580|FG006|Overall Study|Disease progression on study|5|||
164361946|NCT01239368|593701581|FG007|Overall Study|Disease progression on study|0|||
164361947|NCT01239368|593701582|FG008|Overall Study|Disease progression on study|0|||
164361948|NCT01239368|593701583|FG009|Overall Study|Disease progression on study|2|||
164361949|NCT01239368|593701574|FG000|Overall Study|Refused further treatment|0|||
164361950|NCT01239368|593701575|FG001|Overall Study|Refused further treatment|0|||
164361951|NCT01239368|593701576|FG002|Overall Study|Refused further treatment|0|||
164361952|NCT01239368|593701577|FG003|Overall Study|Refused further treatment|0|||
164361953|NCT01239368|593701578|FG004|Overall Study|Refused further treatment|0|||
164361954|NCT01239368|593701579|FG005|Overall Study|Refused further treatment|0|||
164361955|NCT01239368|593701580|FG006|Overall Study|Refused further treatment|0|||
164361956|NCT01239368|593701581|FG007|Overall Study|Refused further treatment|0|||
164361957|NCT01239368|593701582|FG008|Overall Study|Refused further treatment|0|||
164361958|NCT01239368|593701583|FG009|Overall Study|Refused further treatment|1|||
164361959|NCT01239368|593701574|FG000|Overall Study|Death|0|||
164361960|NCT01239368|593701575|FG001|Overall Study|Death|0|||
164361961|NCT01239368|593701576|FG002|Overall Study|Death|0|||
164361962|NCT01239368|593701577|FG003|Overall Study|Death|0|||
164361963|NCT01239368|593701578|FG004|Overall Study|Death|0|||
164361964|NCT01239368|593701579|FG005|Overall Study|Death|0|||
164361965|NCT01239368|593701580|FG006|Overall Study|Death|1|||
164361966|NCT01239368|593701581|FG007|Overall Study|Death|0|||
164361967|NCT01239368|593701582|FG008|Overall Study|Death|0|||
164361968|NCT01239368|593701583|FG009|Overall Study|Death|0|||
164361969|NCT03181399|593701585|FG000|6 Months on Treatment|Protocol non-compliance|7|||
164361970|NCT03181399|593701585|FG000|6 Months on Treatment|Adverse Event|4|||
164361971|NCT03181399|593701585|FG000|6 Months on Treatment|Tried alternative treatment|2|||
164361972|NCT03181399|593701585|FG000|6 Months on Treatment|Lost to Follow-up|2|||
164361973|NCT03181399|593701585|FG000|6 Months on Treatment|Personal reasons|1|||
164361974|NCT03181399|593701585|FG000|3 Months Off-treatment|Parent unable to travel|1|||
164361975|NCT00939809|593701587|FG000|Overall Study|Adverse Event|2|||
164361976|NCT00939809|593701587|FG000|Overall Study|Death|1|||
164361977|NCT01921179|593701588|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
164361978|NCT01921179|593701589|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
164361979|NCT01921179|593701588|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
164361980|NCT01921179|593701589|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
164361981|NCT00858442|593701591|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
164361982|NCT00858442|593701592|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
164361983|NCT02016625|593701593|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
164361984|NCT02016625|593701594|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
164361985|NCT02016625|593701593|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
164361986|NCT02016625|593701594|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
164361987|NCT02016625|593701593|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
164361988|NCT02016625|593701594|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
164361989|NCT02603809|593701597|FG000|Overall Study|Withdrawal by Subject|4|||
164361990|NCT02603809|593701598|FG001|Overall Study|Withdrawal by Subject|1|||
164361991|NCT02603809|593701599|FG002|Overall Study|Withdrawal by Subject|2|||
164361992|NCT02603809|593701600|FG003|Overall Study|Withdrawal by Subject|3|||
164010650|NCT00104104|592403265|FG001|Overall Study|Lost to Follow-up|7|||
164010651|NCT00104104|592403264|FG000|Overall Study|Administrative problems|12|||
164361993|NCT02603809|593701601|FG004|Overall Study|Withdrawal by Subject|3|||
164361994|NCT02603809|593701602|FG005|Overall Study|Withdrawal by Subject|4|||
164361995|NCT02603809|593701597|FG000|Overall Study|Lost to Follow-up|2|||
164361996|NCT02603809|593701598|FG001|Overall Study|Lost to Follow-up|3|||
164010652|NCT00104104|592403265|FG001|Overall Study|Administrative problems|13|||
164010653|NCT00104104|592403264|FG000|Overall Study|Death|9|||
164010654|NCT00104104|592403265|FG001|Overall Study|Death|6|||
164361997|NCT02603809|593701599|FG002|Overall Study|Lost to Follow-up|1|||
164361998|NCT02603809|593701600|FG003|Overall Study|Lost to Follow-up|4|||
164361999|NCT02603809|593701601|FG004|Overall Study|Lost to Follow-up|2|||
164362000|NCT02603809|593701602|FG005|Overall Study|Lost to Follow-up|2|||
164362001|NCT02603809|593701597|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
164362002|NCT02603809|593701598|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
164362003|NCT02603809|593701599|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
164362004|NCT02603809|593701600|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
164362005|NCT02603809|593701601|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
164362006|NCT02603809|593701602|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
164362007|NCT02603809|593701597|FG000|Overall Study|Physician Decision|0|||
164362008|NCT02603809|593701598|FG001|Overall Study|Physician Decision|0|||
164362009|NCT02603809|593701599|FG002|Overall Study|Physician Decision|0|||
164362010|NCT02603809|593701600|FG003|Overall Study|Physician Decision|1|||
164362011|NCT02603809|593701601|FG004|Overall Study|Physician Decision|2|||
164362012|NCT02603809|593701602|FG005|Overall Study|Physician Decision|1|||
164362013|NCT02603809|593701597|FG000|Overall Study|Adverse Event|3|||
164362014|NCT02603809|593701598|FG001|Overall Study|Adverse Event|0|||
164362015|NCT02603809|593701599|FG002|Overall Study|Adverse Event|2|||
164362016|NCT02603809|593701600|FG003|Overall Study|Adverse Event|2|||
164362017|NCT02603809|593701601|FG004|Overall Study|Adverse Event|1|||
164362018|NCT02603809|593701602|FG005|Overall Study|Adverse Event|1|||
164362019|NCT02603809|593701597|FG000|Overall Study|Lack of Efficacy|0|||
164362020|NCT02603809|593701598|FG001|Overall Study|Lack of Efficacy|1|||
164362021|NCT02603809|593701599|FG002|Overall Study|Lack of Efficacy|0|||
164362022|NCT02603809|593701600|FG003|Overall Study|Lack of Efficacy|0|||
164362023|NCT02603809|593701601|FG004|Overall Study|Lack of Efficacy|0|||
164362024|NCT02603809|593701602|FG005|Overall Study|Lack of Efficacy|1|||
164362025|NCT00380978|593701604|FG000|Overall Study|Refused allocated intervention|0|||
164362026|NCT00380978|593701605|FG001|Overall Study|Refused allocated intervention|6|||
164362027|NCT00380978|593701604|FG000|Overall Study|Wrong study envelope|0|||
164362028|NCT00380978|593701605|FG001|Overall Study|Wrong study envelope|2|||
164362029|NCT00380978|593701604|FG000|Overall Study|Allocation prior to analgesia request|1|||
164362030|NCT00380978|593701605|FG001|Overall Study|Allocation prior to analgesia request|2|||
164362031|NCT00380978|593701604|FG000|Overall Study|Parous patient|1|||
163901623|NCT03802994|592011402|FG004|Overall Study|Lost to Follow-up|2|||
163901624|NCT00942266|592011408|FG000|Overall Study|Withdrawal by Subject|1|||
163901625|NCT00942266|592011409|FG001|Overall Study|Withdrawal by Subject|0|||
164362032|NCT00380978|593701605|FG001|Overall Study|Parous patient|0|||
164362033|NCT01254227|593701606|FG000|Overall Study|Withdrawal by Subject|6|||
164362034|NCT01254227|593701606|FG000|Overall Study|Lost to Follow-up|6|||
164362035|NCT01254227|593701606|FG000|Overall Study|Adverse Event|5|||
164362036|NCT01254227|593701606|FG000|Overall Study|Abnormal test procedure result|5|||
163901626|NCT00942266|592011408|FG000|Overall Study|Adverse Event|2|||
163901627|NCT00942266|592011409|FG001|Overall Study|Adverse Event|1|||
163901628|NCT00942266|592011408|FG000|Overall Study|Disease Progression|38|||
163901629|NCT00942266|592011409|FG001|Overall Study|Disease Progression|11|||
163901630|NCT00942266|592011408|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
163901631|NCT00942266|592011409|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
163901632|NCT00942266|592011408|FG000|Overall Study|Intercurrent illness|0|||
163901633|NCT00942266|592011409|FG001|Overall Study|Intercurrent illness|1|||
163901634|NCT00942266|592011408|FG000|Overall Study|Physician Decision|2|||
163901635|NCT00942266|592011409|FG001|Overall Study|Physician Decision|0|||
163901636|NCT00942266|592011408|FG000|Overall Study|medical deterioration (pneumonia)|0|||
163901637|NCT00942266|592011409|FG001|Overall Study|medical deterioration (pneumonia)|1|||
163901638|NCT04795167|592011420|FG000|Overall Study|Death|1|||
163901639|NCT04795167|592011421|FG001|Overall Study|Death|18|||
163901640|NCT04795167|592011422|FG002|Overall Study|Death|1|||
163901641|NCT04795167|592011420|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
163901642|NCT04795167|592011421|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
163901643|NCT04795167|592011422|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
163901644|NCT02029235|592011424|FG000|Overall Study|Non-compliance with study meds or diary|4|||
163901645|NCT02029235|592011425|FG001|Overall Study|Non-compliance with study meds or diary|1|||
163901646|NCT01400958|592011426|FG000|Overall Study|Physician Decision|0|||
163901647|NCT01400958|592011427|FG001|Overall Study|Physician Decision|1|||
163901648|NCT01400958|592011426|FG000|Overall Study|Withdrawal by Subject|0|||
163901649|NCT01400958|592011427|FG001|Overall Study|Withdrawal by Subject|1|||
163901650|NCT01400958|592011426|FG000|Overall Study|Adverse Event|1|||
163901651|NCT01400958|592011427|FG001|Overall Study|Adverse Event|0|||
163901652|NCT04436289|592011428|FG000|Overall Study|Death prior to hospital discharge|8|||
163901653|NCT04436289|592011429|FG001|Overall Study|Death prior to hospital discharge|5|||
163901654|NCT04436289|592011430|FG002|Overall Study|Death prior to hospital discharge|0|||
163901655|NCT04436289|592011431|FG003|Overall Study|Death prior to hospital discharge|1|||
163901656|NCT04436289|592011428|FG000|Overall Study|Withdrawal by Subject|0|||
163901657|NCT04436289|592011429|FG001|Overall Study|Withdrawal by Subject|1|||
163901658|NCT04436289|592011430|FG002|Overall Study|Withdrawal by Subject|4|||
163901659|NCT04436289|592011431|FG003|Overall Study|Withdrawal by Subject|0|||
163901660|NCT04436289|592011428|FG000|Overall Study|Extended hospital stay|0|||
163901661|NCT04436289|592011429|FG001|Overall Study|Extended hospital stay|1|||
164362037|NCT01254227|593701606|FG000|Overall Study|Administrative problems|2|||
164362038|NCT01254227|593701606|FG000|Overall Study|Death|1|||
164362039|NCT01254227|593701606|FG000|Overall Study|Protocol deviation|1|||
164362040|NCT02750592|593701607|FG000|Overall Study|Adverse Event|3|||
164362041|NCT02750592|593701607|FG000|Overall Study|Lack of Efficacy|2|||
164362042|NCT02981342|593701608|FG000|Overall Study|Adverse Event|0|||
164362043|NCT02981342|593701609|FG001|Overall Study|Adverse Event|0|||
164362044|NCT02981342|593701610|FG002|Overall Study|Adverse Event|0|||
164362045|NCT02981342|593701611|FG003|Overall Study|Adverse Event|1|||
164362046|NCT02981342|593701608|FG000|Overall Study|Death|0|||
164362047|NCT02981342|593701609|FG001|Overall Study|Death|9|||
164362048|NCT02981342|593701610|FG002|Overall Study|Death|9|||
164362049|NCT02981342|593701611|FG003|Overall Study|Death|4|||
164362050|NCT02981342|593701608|FG000|Overall Study|Withdrawal by Subject|0|||
164362051|NCT02981342|593701609|FG001|Overall Study|Withdrawal by Subject|0|||
164362052|NCT02981342|593701610|FG002|Overall Study|Withdrawal by Subject|3|||
164362053|NCT02981342|593701611|FG003|Overall Study|Withdrawal by Subject|1|||
164362054|NCT02981342|593701608|FG000|Overall Study|Study closed by sponsor|0|||
164362055|NCT02981342|593701609|FG001|Overall Study|Study closed by sponsor|0|||
164362056|NCT02981342|593701610|FG002|Overall Study|Study closed by sponsor|1|||
164362057|NCT02981342|593701611|FG003|Overall Study|Study closed by sponsor|1|||
164362058|NCT02981342|593701608|FG000|Overall Study|Randomized, Never Treated|0|||
164362059|NCT02981342|593701609|FG001|Overall Study|Randomized, Never Treated|1|||
164362060|NCT02981342|593701610|FG002|Overall Study|Randomized, Never Treated|0|||
164362061|NCT02981342|593701611|FG003|Overall Study|Randomized, Never Treated|7|||
164362062|NCT02981342|593701608|FG000|Overall Study|Lost to Follow-up|0|||
164362063|NCT02981342|593701609|FG001|Overall Study|Lost to Follow-up|1|||
164362064|NCT02981342|593701610|FG002|Overall Study|Lost to Follow-up|0|||
164362065|NCT02981342|593701611|FG003|Overall Study|Lost to Follow-up|0|||
164362066|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
164362067|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
164362068|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
164362069|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
164362070|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
164362071|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
164362072|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
164362073|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
164362074|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
164362075|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
164362076|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
164362077|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
164362078|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
164362079|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
164362080|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
164362081|NCT03970733|593701612|FG000|Main Study Phase (18 Months)|Other|1|||
164362082|NCT03970733|593701613|FG001|Main Study Phase (18 Months)|Other|1|||
164362083|NCT03970733|593701614|FG002|Main Study Phase (18 Months)|Other|0|||
164362084|NCT03970733|593701615|FG003|Main Study Phase (18 Months)|Other|0|||
164362085|NCT03970733|593701616|FG004|Main Study Phase (18 Months)|Other|0|||
164362086|NCT03970733|593701612|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362087|NCT03970733|593701613|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362088|NCT03970733|593701614|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362089|NCT03970733|593701615|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
164362090|NCT03970733|593701616|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
164362091|NCT02784821|593701620|FG000|Overall Study|Death|0|||
164010655|NCT00447421|592403267|FG000|Overall Study|Lack of Efficacy|1|||
164010656|NCT00447421|592403267|FG000|Overall Study|Adverse Event|3|||
164010657|NCT00447421|592403267|FG000|Overall Study|Sponsor Decision|2|||
164010658|NCT01707147|592403268|FG000|Overall Study|Administered Trajenta prior to contract|5|||
164010659|NCT01707147|592403268|FG000|Overall Study|Patients who have not taken Trajenta|1|||
164010660|NCT01707147|592403268|FG000|Overall Study|Follow-up failure|17|||
164010661|NCT01707147|592403268|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
164010662|NCT02725177|592403269|FG000|Overall Study|Physician Decision|4|||
164362092|NCT02784821|593701621|FG001|Overall Study|Death|5|||
164362093|NCT02784821|593701622|FG002|Overall Study|Death|4|||
164362094|NCT02784821|593701623|FG003|Overall Study|Death|5|||
164362095|NCT02794103|593701624|FG000|Overall Study|Loss to follow up due to high sedation|3|||
164362096|NCT00112502|593701625|FG000|Overall Study|Withdrawal by Subject|0|||
164362097|NCT00112502|593701626|FG001|Overall Study|Withdrawal by Subject|1|||
164362098|NCT00112502|593701627|FG002|Overall Study|Withdrawal by Subject|1|||
164362099|NCT00112502|593701628|FG003|Overall Study|Withdrawal by Subject|4|||
164362100|NCT00112502|593701629|FG004|Overall Study|Withdrawal by Subject|2|||
164362101|NCT00112502|593701630|FG005|Overall Study|Withdrawal by Subject|5|||
164362102|NCT00112502|593701631|FG006|Overall Study|Withdrawal by Subject|3|||
164362103|NCT00112502|593701632|FG007|Overall Study|Withdrawal by Subject|7|||
164362104|NCT00265343|593701635|FG000|Overall Study|Adverse Event|10|||
164362105|NCT00265343|593701636|FG001|Overall Study|Adverse Event|7|||
164362106|NCT00265343|593701635|FG000|Overall Study|Withdrawal by Subject|3|||
164362107|NCT00265343|593701636|FG001|Overall Study|Withdrawal by Subject|9|||
164362108|NCT00265343|593701635|FG000|Overall Study|Other|8|||
164362109|NCT00265343|593701636|FG001|Overall Study|Other|3|||
164362110|NCT02608268|593701637|FG000|Overall Study|Adverse Event|0|||
164362111|NCT02608268|593701638|FG001|Overall Study|Adverse Event|0|||
164362112|NCT02608268|593701639|FG002|Overall Study|Adverse Event|1|||
164362113|NCT02608268|593701640|FG003|Overall Study|Adverse Event|0|||
164362114|NCT02608268|593701641|FG004|Overall Study|Adverse Event|0|||
164362115|NCT02608268|593701642|FG005|Overall Study|Adverse Event|0|||
164362116|NCT02608268|593701643|FG006|Overall Study|Adverse Event|0|||
164362117|NCT02608268|593701644|FG007|Overall Study|Adverse Event|0|||
164362118|NCT02608268|593701645|FG008|Overall Study|Adverse Event|0|||
164362119|NCT02608268|593701646|FG009|Overall Study|Adverse Event|0|||
164362120|NCT02608268|593701647|FG010|Overall Study|Adverse Event|0|||
164362121|NCT02608268|593701648|FG011|Overall Study|Adverse Event|0|||
164362122|NCT02608268|593701649|FG012|Overall Study|Adverse Event|2|||
164362123|NCT02608268|593701650|FG013|Overall Study|Adverse Event|0|||
164362124|NCT02608268|593701651|FG014|Overall Study|Adverse Event|0|||
164362125|NCT02608268|593701652|FG015|Overall Study|Adverse Event|0|||
164362126|NCT02608268|593701653|FG016|Overall Study|Adverse Event|0|||
164362127|NCT02608268|593701654|FG017|Overall Study|Adverse Event|0|||
164362128|NCT02608268|593701655|FG018|Overall Study|Adverse Event|0|||
164362129|NCT02608268|593701656|FG019|Overall Study|Adverse Event|0|||
164362130|NCT02608268|593701657|FG020|Overall Study|Adverse Event|1|||
164362131|NCT02608268|593701658|FG021|Overall Study|Adverse Event|1|||
164362132|NCT02608268|593701659|FG022|Overall Study|Adverse Event|0|||
164362133|NCT02608268|593701660|FG023|Overall Study|Adverse Event|0|||
164362134|NCT02608268|593701661|FG024|Overall Study|Adverse Event|1|||
164362135|NCT02608268|593701662|FG025|Overall Study|Adverse Event|0|||
164362136|NCT02608268|593701663|FG026|Overall Study|Adverse Event|0|||
164010663|NCT02725177|592403269|FG000|Overall Study|Adverse Event|1|||
164010664|NCT01326962|592403273|FG000|Overall Study|Adverse Event|1|||
164010665|NCT01326962|592403273|FG000|Overall Study|Withdrawal by Subject|1|||
164010666|NCT01326962|592403273|FG000|Overall Study|Lost to Follow-up|3|||
164010667|NCT01326962|592403273|FG000|Overall Study|Other|2|||
164010668|NCT02053246|592403274|FG000|Overall Study|Withdrawal by Subject|3|||
164010669|NCT02053246|592403274|FG000|Overall Study|Physician Decision|1|||
164010670|NCT02707757|592403275|FG000|Overall Study|Protocol Violation|3|||
164010671|NCT02707757|592403276|FG001|Overall Study|Protocol Violation|2|||
164010672|NCT02707757|592403275|FG000|Overall Study|Withdrawal by Subject|2|||
164010673|NCT02707757|592403276|FG001|Overall Study|Withdrawal by Subject|0|||
164010674|NCT02707757|592403275|FG000|Overall Study|Death|0|||
164010675|NCT02707757|592403276|FG001|Overall Study|Death|1|||
164010676|NCT02707757|592403275|FG000|Overall Study|Adverse Event|6|||
164010677|NCT02707757|592403276|FG001|Overall Study|Adverse Event|4|||
164010678|NCT02707757|592403275|FG000|Overall Study|Renal transplant/elective operation|1|||
164010679|NCT02707757|592403276|FG001|Overall Study|Renal transplant/elective operation|5|||
164010680|NCT01318902|592403277|FG000|Overall Study|Symptomatic Deterioration|0|||
164010681|NCT01318902|592403278|FG001|Overall Study|Symptomatic Deterioration|1|||
164010682|NCT01318902|592403279|FG002|Overall Study|Symptomatic Deterioration|1|||
164010683|NCT01318902|592403280|FG003|Overall Study|Symptomatic Deterioration|2|||
164010684|NCT01318902|592403277|FG000|Overall Study|Withdrawal by Patient|0|||
164010685|NCT01318902|592403278|FG001|Overall Study|Withdrawal by Patient|1|||
164010686|NCT01318902|592403279|FG002|Overall Study|Withdrawal by Patient|0|||
164010687|NCT01318902|592403280|FG003|Overall Study|Withdrawal by Patient|3|||
164010688|NCT01318902|592403277|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
164010689|NCT01318902|592403278|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164010690|NCT01318902|592403279|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164010691|NCT01318902|592403280|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
164010692|NCT01318902|592403277|FG000|Overall Study|Adverse Event|0|||
164010693|NCT01318902|592403278|FG001|Overall Study|Adverse Event|1|||
164010694|NCT01318902|592403279|FG002|Overall Study|Adverse Event|0|||
164010695|NCT01318902|592403280|FG003|Overall Study|Adverse Event|0|||
164010696|NCT01318902|592403277|FG000|Overall Study|Terminated by Sponsor|0|||
164010697|NCT01318902|592403278|FG001|Overall Study|Terminated by Sponsor|0|||
164010698|NCT01318902|592403279|FG002|Overall Study|Terminated by Sponsor|1|||
164362137|NCT02608268|593701664|FG027|Overall Study|Adverse Event|0|||
164362138|NCT02608268|593701665|FG028|Overall Study|Adverse Event|1|||
164362139|NCT02608268|593701666|FG029|Overall Study|Adverse Event|0|||
164362140|NCT02608268|593701637|FG000|Overall Study|Death|1|||
164362141|NCT02608268|593701638|FG001|Overall Study|Death|0|||
164362142|NCT02608268|593701639|FG002|Overall Study|Death|0|||
164362143|NCT02608268|593701640|FG003|Overall Study|Death|0|||
164362144|NCT02608268|593701641|FG004|Overall Study|Death|0|||
164362145|NCT02608268|593701642|FG005|Overall Study|Death|0|||
164362146|NCT02608268|593701643|FG006|Overall Study|Death|0|||
164362147|NCT02608268|593701644|FG007|Overall Study|Death|0|||
164362148|NCT02608268|593701645|FG008|Overall Study|Death|1|||
164362149|NCT02608268|593701646|FG009|Overall Study|Death|1|||
164362150|NCT02608268|593701647|FG010|Overall Study|Death|0|||
164362151|NCT02608268|593701648|FG011|Overall Study|Death|0|||
164362152|NCT02608268|593701649|FG012|Overall Study|Death|0|||
164362153|NCT02608268|593701650|FG013|Overall Study|Death|0|||
164362154|NCT02608268|593701651|FG014|Overall Study|Death|0|||
164362155|NCT02608268|593701652|FG015|Overall Study|Death|1|||
164362156|NCT02608268|593701653|FG016|Overall Study|Death|0|||
164362157|NCT02608268|593701654|FG017|Overall Study|Death|1|||
164362158|NCT02608268|593701655|FG018|Overall Study|Death|0|||
164362159|NCT02608268|593701656|FG019|Overall Study|Death|1|||
164362160|NCT02608268|593701657|FG020|Overall Study|Death|1|||
164362161|NCT02608268|593701658|FG021|Overall Study|Death|0|||
164362162|NCT02608268|593701659|FG022|Overall Study|Death|0|||
164362163|NCT02608268|593701660|FG023|Overall Study|Death|0|||
164362164|NCT02608268|593701661|FG024|Overall Study|Death|1|||
164362165|NCT02608268|593701662|FG025|Overall Study|Death|2|||
164362166|NCT02608268|593701663|FG026|Overall Study|Death|0|||
164362167|NCT02608268|593701664|FG027|Overall Study|Death|1|||
164362168|NCT02608268|593701665|FG028|Overall Study|Death|4|||
164362169|NCT02608268|593701666|FG029|Overall Study|Death|0|||
164362170|NCT02608268|593701637|FG000|Overall Study|Physician Decision|0|||
164362171|NCT02608268|593701638|FG001|Overall Study|Physician Decision|0|||
164362172|NCT02608268|593701639|FG002|Overall Study|Physician Decision|0|||
164362173|NCT02608268|593701640|FG003|Overall Study|Physician Decision|0|||
164362174|NCT02608268|593701641|FG004|Overall Study|Physician Decision|0|||
164362175|NCT02608268|593701642|FG005|Overall Study|Physician Decision|0|||
164362176|NCT02608268|593701643|FG006|Overall Study|Physician Decision|0|||
164362177|NCT02608268|593701644|FG007|Overall Study|Physician Decision|0|||
164362178|NCT02608268|593701645|FG008|Overall Study|Physician Decision|0|||
164362179|NCT02608268|593701646|FG009|Overall Study|Physician Decision|0|||
164362180|NCT02608268|593701647|FG010|Overall Study|Physician Decision|1|||
164362181|NCT02608268|593701648|FG011|Overall Study|Physician Decision|0|||
164362182|NCT02608268|593701649|FG012|Overall Study|Physician Decision|0|||
164362183|NCT02608268|593701650|FG013|Overall Study|Physician Decision|1|||
164362184|NCT02608268|593701651|FG014|Overall Study|Physician Decision|0|||
164362185|NCT02608268|593701652|FG015|Overall Study|Physician Decision|0|||
164362186|NCT02608268|593701653|FG016|Overall Study|Physician Decision|0|||
164362187|NCT02608268|593701654|FG017|Overall Study|Physician Decision|0|||
164362188|NCT02608268|593701655|FG018|Overall Study|Physician Decision|0|||
164010699|NCT01318902|592403280|FG003|Overall Study|Terminated by Sponsor|0|||
164010700|NCT01894516|592404948|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
164010701|NCT01894516|592404949|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
164010702|NCT01894516|592404950|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
164010703|NCT01894516|592404951|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
164010704|NCT01894516|592404948|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
164010705|NCT01894516|592404949|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164010706|NCT01894516|592404950|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164010707|NCT01894516|592404951|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
164010708|NCT01894516|592404948|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
164010709|NCT01894516|592404949|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
164010710|NCT01894516|592404950|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
164010711|NCT01894516|592404951|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
164010712|NCT01894516|592404948|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
164010713|NCT01894516|592404949|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
164010714|NCT01894516|592404950|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
164010715|NCT01894516|592404951|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
164010716|NCT01894516|592404948|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
164010717|NCT01894516|592404949|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
164010718|NCT01894516|592404950|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
164010719|NCT01894516|592404951|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
164091865|NCT02097121|592700045|FG000|Overall Study|Lack of Efficacy|2|||
164362189|NCT02608268|593701656|FG019|Overall Study|Physician Decision|0|||
164362190|NCT02608268|593701657|FG020|Overall Study|Physician Decision|0|||
164362191|NCT02608268|593701658|FG021|Overall Study|Physician Decision|0|||
164362192|NCT02608268|593701659|FG022|Overall Study|Physician Decision|1|||
164362193|NCT02608268|593701660|FG023|Overall Study|Physician Decision|1|||
164362194|NCT02608268|593701661|FG024|Overall Study|Physician Decision|1|||
164362195|NCT02608268|593701662|FG025|Overall Study|Physician Decision|0|||
164362196|NCT02608268|593701663|FG026|Overall Study|Physician Decision|0|||
164362197|NCT02608268|593701664|FG027|Overall Study|Physician Decision|2|||
164362198|NCT02608268|593701665|FG028|Overall Study|Physician Decision|1|||
164362199|NCT02608268|593701666|FG029|Overall Study|Physician Decision|1|||
164362200|NCT02608268|593701637|FG000|Overall Study|Progressive disease|12|||
164362201|NCT02608268|593701638|FG001|Overall Study|Progressive disease|8|||
164362202|NCT02608268|593701639|FG002|Overall Study|Progressive disease|13|||
164362203|NCT02608268|593701640|FG003|Overall Study|Progressive disease|5|||
164362204|NCT02608268|593701641|FG004|Overall Study|Progressive disease|2|||
164362205|NCT02608268|593701642|FG005|Overall Study|Progressive disease|4|||
164362206|NCT02608268|593701643|FG006|Overall Study|Progressive disease|6|||
164362207|NCT02608268|593701644|FG007|Overall Study|Progressive disease|2|||
164362208|NCT02608268|593701645|FG008|Overall Study|Progressive disease|5|||
164362209|NCT02608268|593701646|FG009|Overall Study|Progressive disease|6|||
164362210|NCT02608268|593701647|FG010|Overall Study|Progressive disease|5|||
164362211|NCT02608268|593701648|FG011|Overall Study|Progressive disease|5|||
164362212|NCT02608268|593701649|FG012|Overall Study|Progressive disease|4|||
164362213|NCT02608268|593701650|FG013|Overall Study|Progressive disease|11|||
164362214|NCT02608268|593701651|FG014|Overall Study|Progressive disease|6|||
164362215|NCT02608268|593701652|FG015|Overall Study|Progressive disease|3|||
164362216|NCT02608268|593701653|FG016|Overall Study|Progressive disease|5|||
164362217|NCT02608268|593701654|FG017|Overall Study|Progressive disease|5|||
164362218|NCT02608268|593701655|FG018|Overall Study|Progressive disease|5|||
164362219|NCT02608268|593701656|FG019|Overall Study|Progressive disease|2|||
164362220|NCT02608268|593701657|FG020|Overall Study|Progressive disease|10|||
164362221|NCT02608268|593701658|FG021|Overall Study|Progressive disease|4|||
164362222|NCT02608268|593701659|FG022|Overall Study|Progressive disease|5|||
164362223|NCT02608268|593701660|FG023|Overall Study|Progressive disease|5|||
164362224|NCT02608268|593701661|FG024|Overall Study|Progressive disease|3|||
164362225|NCT02608268|593701662|FG025|Overall Study|Progressive disease|11|||
164362226|NCT02608268|593701663|FG026|Overall Study|Progressive disease|16|||
164362227|NCT02608268|593701664|FG027|Overall Study|Progressive disease|11|||
164362228|NCT02608268|593701665|FG028|Overall Study|Progressive disease|10|||
164362229|NCT02608268|593701666|FG029|Overall Study|Progressive disease|15|||
164362230|NCT02608268|593701637|FG000|Overall Study|Subject/guardian decision|1|||
164362231|NCT02608268|593701638|FG001|Overall Study|Subject/guardian decision|1|||
164362232|NCT02608268|593701639|FG002|Overall Study|Subject/guardian decision|2|||
164362233|NCT02608268|593701640|FG003|Overall Study|Subject/guardian decision|0|||
164362234|NCT02608268|593701641|FG004|Overall Study|Subject/guardian decision|0|||
164362235|NCT02608268|593701642|FG005|Overall Study|Subject/guardian decision|0|||
164362236|NCT02608268|593701643|FG006|Overall Study|Subject/guardian decision|0|||
164362237|NCT02608268|593701644|FG007|Overall Study|Subject/guardian decision|0|||
164362238|NCT02608268|593701645|FG008|Overall Study|Subject/guardian decision|2|||
164362239|NCT02608268|593701646|FG009|Overall Study|Subject/guardian decision|2|||
164362240|NCT02608268|593701647|FG010|Overall Study|Subject/guardian decision|0|||
164362241|NCT02608268|593701648|FG011|Overall Study|Subject/guardian decision|1|||
164362242|NCT02608268|593701649|FG012|Overall Study|Subject/guardian decision|0|||
164362243|NCT02608268|593701650|FG013|Overall Study|Subject/guardian decision|1|||
164362244|NCT02608268|593701651|FG014|Overall Study|Subject/guardian decision|0|||
164362245|NCT02608268|593701652|FG015|Overall Study|Subject/guardian decision|1|||
164362246|NCT02608268|593701653|FG016|Overall Study|Subject/guardian decision|0|||
164362247|NCT02608268|593701654|FG017|Overall Study|Subject/guardian decision|0|||
164362248|NCT02608268|593701655|FG018|Overall Study|Subject/guardian decision|1|||
164362249|NCT02608268|593701656|FG019|Overall Study|Subject/guardian decision|0|||
164362250|NCT02608268|593701657|FG020|Overall Study|Subject/guardian decision|0|||
164362251|NCT02608268|593701658|FG021|Overall Study|Subject/guardian decision|0|||
164362252|NCT02608268|593701659|FG022|Overall Study|Subject/guardian decision|1|||
164362253|NCT02608268|593701660|FG023|Overall Study|Subject/guardian decision|0|||
164362254|NCT02608268|593701661|FG024|Overall Study|Subject/guardian decision|0|||
164362255|NCT02608268|593701662|FG025|Overall Study|Subject/guardian decision|1|||
164362256|NCT02608268|593701663|FG026|Overall Study|Subject/guardian decision|1|||
164010720|NCT01894516|592404948|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
164010721|NCT01894516|592404949|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
164010722|NCT01894516|592404950|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
164010723|NCT01894516|592404951|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
164010724|NCT01894516|592404948|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
164010725|NCT01894516|592404949|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
164010726|NCT01894516|592404950|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
164010727|NCT01894516|592404951|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
164010728|NCT01894516|592404948|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164362257|NCT02608268|593701664|FG027|Overall Study|Subject/guardian decision|1|||
164362258|NCT02608268|593701665|FG028|Overall Study|Subject/guardian decision|1|||
164362259|NCT02608268|593701666|FG029|Overall Study|Subject/guardian decision|0|||
164362260|NCT01859494|593701676|FG000|Overall Study|Adverse Event|1|||
164362261|NCT00297037|593701681|FG000|Overall Study|Withdrawal by Subject|2|||
164362262|NCT00297037|593701682|FG001|Overall Study|Withdrawal by Subject|0|||
164362263|NCT03814746|593701685|FG000|Overall Study|Participant decision|9|||
164362264|NCT03814746|593701686|FG001|Overall Study|Participant decision|6|||
164362265|NCT03814746|593701687|FG002|Overall Study|Participant decision|15|||
164362266|NCT03814746|593701685|FG000|Overall Study|Physician Decision|2|||
164362267|NCT03814746|593701686|FG001|Overall Study|Physician Decision|2|||
164362268|NCT03814746|593701687|FG002|Overall Study|Physician Decision|4|||
164362269|NCT03814746|593701685|FG000|Overall Study|Death|2|||
164362270|NCT03814746|593701686|FG001|Overall Study|Death|2|||
164362271|NCT03814746|593701687|FG002|Overall Study|Death|2|||
164362272|NCT03814746|593701685|FG000|Overall Study|Adverse Event|2|||
164362273|NCT03814746|593701686|FG001|Overall Study|Adverse Event|2|||
164362274|NCT03814746|593701687|FG002|Overall Study|Adverse Event|1|||
164362275|NCT03814746|593701685|FG000|Overall Study|Lost to Follow-up|2|||
164362276|NCT03814746|593701686|FG001|Overall Study|Lost to Follow-up|1|||
164362277|NCT03814746|593701687|FG002|Overall Study|Lost to Follow-up|2|||
164362278|NCT03814746|593701685|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164362279|NCT03814746|593701686|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164362280|NCT03814746|593701687|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
164362281|NCT03814746|593701685|FG000|Overall Study|Pregnancy|0|||
164362282|NCT03814746|593701686|FG001|Overall Study|Pregnancy|1|||
164362283|NCT03814746|593701687|FG002|Overall Study|Pregnancy|1|||
164362284|NCT03814746|593701685|FG000|Overall Study|Protocol Violation|1|||
164362285|NCT03814746|593701686|FG001|Overall Study|Protocol Violation|0|||
164362286|NCT03814746|593701687|FG002|Overall Study|Protocol Violation|0|||
164362287|NCT00371254|593701693|FG000|Overall Study|Disease progression|13|||
164362288|NCT00371254|593701694|FG001|Overall Study|Disease progression|13|||
164362289|NCT00371254|593701693|FG000|Overall Study|Study drug toxicity|3|||
164362290|NCT00371254|593701694|FG001|Overall Study|Study drug toxicity|5|||
164362291|NCT00371254|593701693|FG000|Overall Study|Subject request|5|||
164362292|NCT00371254|593701694|FG001|Overall Study|Subject request|0|||
164362293|NCT00371254|593701693|FG000|Overall Study|Investigator Decision|2|||
164362294|NCT00371254|593701694|FG001|Overall Study|Investigator Decision|0|||
164362295|NCT00371254|593701693|FG000|Overall Study|Adverse event unrelated to study drug|0|||
164362296|NCT00371254|593701694|FG001|Overall Study|Adverse event unrelated to study drug|1|||
164362297|NCT00371254|593701693|FG000|Overall Study|Lost to Follow-up|0|||
164362298|NCT00371254|593701694|FG001|Overall Study|Lost to Follow-up|1|||
164362299|NCT00371254|593701693|FG000|Overall Study|Withdrawal by Subject|0|||
164362300|NCT00371254|593701694|FG001|Overall Study|Withdrawal by Subject|1|||
164362301|NCT01817725|593701695|FG000|Overall Study|Withdrawal by Subject|1|||
164362302|NCT00909779|593701696|FG000|Overall Study|Adverse Event|53|||
164362303|NCT00909779|593701697|FG001|Overall Study|Adverse Event|55|||
164362304|NCT00909779|593701696|FG000|Overall Study|Lack of Efficacy|7|||
164362305|NCT00909779|593701697|FG001|Overall Study|Lack of Efficacy|4|||
164362306|NCT00909779|593701696|FG000|Overall Study|Lost to Follow-up|19|||
164362307|NCT00909779|593701697|FG001|Overall Study|Lost to Follow-up|15|||
164362308|NCT00909779|593701696|FG000|Overall Study|Physician Decision|8|||
164362309|NCT00909779|593701697|FG001|Overall Study|Physician Decision|2|||
164362310|NCT00909779|593701696|FG000|Overall Study|Protocol Violation|2|||
164362311|NCT00909779|593701697|FG001|Overall Study|Protocol Violation|5|||
164362312|NCT00909779|593701696|FG000|Overall Study|Withdrawal by Subject|116|||
164362313|NCT00909779|593701697|FG001|Overall Study|Withdrawal by Subject|80|||
164362314|NCT00909779|593701696|FG000|Overall Study|Site Ceasing Operation|2|||
164362315|NCT00909779|593701697|FG001|Overall Study|Site Ceasing Operation|2|||
164362316|NCT00909779|593701696|FG000|Overall Study|Medical Monitor Decision|1|||
164362317|NCT00909779|593701697|FG001|Overall Study|Medical Monitor Decision|0|||
164362318|NCT00909779|593701696|FG000|Overall Study|Noncompliance|1|||
164362319|NCT00909779|593701697|FG001|Overall Study|Noncompliance|1|||
164362320|NCT00909779|593701696|FG000|Overall Study|Randomized in error|1|||
164362321|NCT00909779|593701697|FG001|Overall Study|Randomized in error|1|||
164362322|NCT02809677|593701698|FG000|Overall Study|Withdrawal by Subject|8|||
164362323|NCT05172544|593701701|FG000|Overall Study|Withdrawal by Subject|1|||
164362324|NCT05172544|593701702|FG001|Overall Study|Withdrawal by Subject|0|||
164362325|NCT05172544|593701703|FG002|Overall Study|Withdrawal by Subject|0|||
164362326|NCT05172544|593701701|FG000|Overall Study|Physician Decision|0|||
164362327|NCT05172544|593701702|FG001|Overall Study|Physician Decision|0|||
164362328|NCT05172544|593701703|FG002|Overall Study|Physician Decision|1|||
164362329|NCT04829318|593701704|FG000|Overall Study|Adverse Event|6|||
164362330|NCT04829318|593701704|FG000|Overall Study|Death|1|||
164362331|NCT04829318|593701704|FG000|Overall Study|Lost to Follow-up|1|||
164091866|NCT02097121|592700046|FG001|Overall Study|Lack of Efficacy|1|||
164362332|NCT04829318|593701704|FG000|Overall Study|Physician Decision|1|||
164362333|NCT04829318|593701704|FG000|Overall Study|Withdrawal by Subject|19|||
164362334|NCT04829318|593701704|FG000|Overall Study|Site terminated by sponsor|1|||
164362335|NCT04829318|593701704|FG000|Overall Study|Sponsor decision|5|||
164362336|NCT04829318|593701704|FG000|Overall Study|Other|1|||
164362337|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
164362338|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
164362339|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
164362340|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
164362341|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
164362342|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
164362343|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
164362344|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
164362345|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
164362346|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
164362347|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
164362348|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
164362349|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
164362350|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
164362351|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
164362352|NCT00561080|593701710|FG000|Vaccination Period (up to Month 4)|Other|0|||
164362353|NCT00561080|593701711|FG001|Vaccination Period (up to Month 4)|Other|2|||
164362354|NCT00561080|593701712|FG002|Vaccination Period (up to Month 4)|Other|1|||
164362355|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
164362356|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
164362357|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
164362358|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
164362359|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
164362360|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
164362361|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
164362362|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
164362363|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
164010729|NCT01894516|592404949|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164362364|NCT00561080|593701710|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
164362365|NCT00561080|593701711|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
164362366|NCT00561080|593701712|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
164362367|NCT02295995|593701713|FG000|Overall Study|Lost to Follow-up|5|||
164362368|NCT02295995|593701714|FG001|Overall Study|Lost to Follow-up|1|||
164362369|NCT03158051|593701717|FG000|Overall Study|Lost to Follow-up|41|||
164362370|NCT03158051|593701718|FG001|Overall Study|Lost to Follow-up|47|||
164362371|NCT03158051|593701717|FG000|Overall Study|Physician Decision|6|||
164362372|NCT03158051|593701718|FG001|Overall Study|Physician Decision|7|||
164362373|NCT03158051|593701717|FG000|Overall Study|Withdrawal by Subject|24|||
164362374|NCT03158051|593701718|FG001|Overall Study|Withdrawal by Subject|15|||
164362375|NCT03158051|593701717|FG000|Overall Study|Death|0|||
164362376|NCT03158051|593701718|FG001|Overall Study|Death|1|||
164362377|NCT02588833|593701719|FG000|Part 1|Withdrawal by Subject|1|||
164362378|NCT02588833|593701720|FG001|Part 1|Withdrawal by Subject|0|||
164362379|NCT02588833|593701719|FG000|Part 2A|Physician Decision|0|||
164362380|NCT02588833|593701720|FG001|Part 2A|Physician Decision|1|||
164362381|NCT02588833|593701719|FG000|Part 2A|Withdrawal by Subject|0|||
164362382|NCT02588833|593701720|FG001|Part 2A|Withdrawal by Subject|1|||
164362383|NCT02588833|593701719|FG000|Part 2B|Adverse Event|0|||
164362384|NCT02588833|593701720|FG001|Part 2B|Adverse Event|1|||
164362385|NCT02588833|593701719|FG000|Part 2C|Adverse Event|0|||
164362386|NCT02588833|593701720|FG001|Part 2C|Adverse Event|1|||
164010730|NCT01894516|592404950|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
164010731|NCT01894516|592404951|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
164010732|NCT00375934|592404959|FG000|Overall Study|Adverse Event|1|||
164010733|NCT00375934|592404960|FG001|Overall Study|Adverse Event|1|||
164010734|NCT00375934|592404959|FG000|Overall Study|Withdrawal by Subject|2|||
164010735|NCT00375934|592404960|FG001|Overall Study|Withdrawal by Subject|2|||
164010736|NCT00375934|592404959|FG000|Overall Study|Lack of Efficacy|0|||
164010737|NCT00375934|592404960|FG001|Overall Study|Lack of Efficacy|2|||
164010738|NCT00375934|592404959|FG000|Overall Study|Physician Decision|0|||
164010739|NCT00375934|592404960|FG001|Overall Study|Physician Decision|1|||
164010740|NCT00893113|592404962|FG000|Overall Study|Lost to Follow-up|4|||
164010741|NCT00893113|592404963|FG001|Overall Study|Lost to Follow-up|8|||
164010742|NCT00893113|592404962|FG000|Overall Study|Early Termination|1|||
164010743|NCT00893113|592404963|FG001|Overall Study|Early Termination|1|||
164010744|NCT00893113|592404962|FG000|Overall Study|Withdrew Consent|8|||
164010745|NCT00893113|592404963|FG001|Overall Study|Withdrew Consent|7|||
164010746|NCT00500149|592404969|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
164010747|NCT00500149|592404970|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
164010748|NCT00500149|592404969|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
164010749|NCT00500149|592404970|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
164010750|NCT00500149|592404969|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
164010751|NCT00500149|592404970|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
164010752|NCT00500149|592404969|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
164010753|NCT00500149|592404970|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
164010754|NCT00500149|592404969|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
164010755|NCT00500149|592404970|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
164091867|NCT02097121|592700047|FG002|Overall Study|Lack of Efficacy|3|||
164362387|NCT02588833|593701719|FG000|Part 2C|Withdrawal by Subject|0|||
164362388|NCT02588833|593701720|FG001|Part 2C|Withdrawal by Subject|1|||
164362389|NCT02588833|593701719|FG000|Part 3 (Safety Follow-up)|Other|0|||
164362390|NCT02588833|593701720|FG001|Part 3 (Safety Follow-up)|Other|2|||
164362391|NCT03649711|593701723|FG000|Overall Study|Adverse Event|0|||
164362392|NCT03649711|593701724|FG001|Overall Study|Adverse Event|1|||
164362393|NCT03649711|593701725|FG002|Overall Study|Adverse Event|0|||
164362394|NCT03649711|593701723|FG000|Overall Study|Kidney Transplant|1|||
164362395|NCT03649711|593701724|FG001|Overall Study|Kidney Transplant|0|||
164362396|NCT03649711|593701725|FG002|Overall Study|Kidney Transplant|0|||
164362397|NCT01581307|593701726|FG000|Overall Study|Withdrawal by Subject|1|||
164010756|NCT00500149|592404969|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
164010757|NCT00500149|592404970|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
164010758|NCT00500149|592404969|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
164010759|NCT00500149|592404970|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
164362398|NCT07114198|593701731|FG000|Overall Study|Protocol Violation|1|||
164362399|NCT07114198|593701732|FG001|Overall Study|Protocol Violation|1|||
164362400|NCT04709575|593703911|FG000|Overall Study|Withdrawal by Subject|6|||
164010760|NCT01157169|592404971|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
164010761|NCT01157169|592404972|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
164010762|NCT01157169|592404971|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
164010763|NCT01157169|592404972|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
164010764|NCT00663858|592404973|FG000|Overall Study|Adverse Event|9|||
164010765|NCT00663858|592404974|FG001|Overall Study|Adverse Event|1|||
164010766|NCT00663858|592404975|FG002|Overall Study|Adverse Event|6|||
164010767|NCT00663858|592404973|FG000|Overall Study|Lack of Efficacy|5|||
164010768|NCT00663858|592404974|FG001|Overall Study|Lack of Efficacy|1|||
164010769|NCT00663858|592404975|FG002|Overall Study|Lack of Efficacy|3|||
164010770|NCT00663858|592404973|FG000|Overall Study|Withdrawal by Subject|7|||
164010771|NCT00663858|592404974|FG001|Overall Study|Withdrawal by Subject|3|||
164010772|NCT00663858|592404975|FG002|Overall Study|Withdrawal by Subject|3|||
164010773|NCT00663858|592404973|FG000|Overall Study|Protocol Violation|5|||
164010774|NCT00663858|592404974|FG001|Overall Study|Protocol Violation|3|||
164010775|NCT00663858|592404975|FG002|Overall Study|Protocol Violation|4|||
164010776|NCT00663858|592404973|FG000|Overall Study|Other|8|||
164010777|NCT00663858|592404974|FG001|Overall Study|Other|2|||
164010778|NCT00663858|592404975|FG002|Overall Study|Other|4|||
164010779|NCT02940886|592404976|FG000|Overall Study|Adverse Event|7|||
164010780|NCT02940886|592404977|FG001|Overall Study|Adverse Event|3|||
164010781|NCT02940886|592404976|FG000|Overall Study|Protocol Violation|0|||
164010782|NCT02940886|592404977|FG001|Overall Study|Protocol Violation|2|||
164010783|NCT02940886|592404976|FG000|Overall Study|Withdrawal by Subject|28|||
164010784|NCT02940886|592404977|FG001|Overall Study|Withdrawal by Subject|20|||
164010785|NCT02940886|592404976|FG000|Overall Study|Death|1|||
164010786|NCT02940886|592404977|FG001|Overall Study|Death|0|||
164010787|NCT02940886|592404976|FG000|Overall Study|Lack of Efficacy|1|||
164010788|NCT02940886|592404977|FG001|Overall Study|Lack of Efficacy|0|||
164010789|NCT02940886|592404976|FG000|Overall Study|Lost to Follow-up|49|||
164010790|NCT02940886|592404977|FG001|Overall Study|Lost to Follow-up|21|||
164010791|NCT02940886|592404976|FG000|Overall Study|Physician Decision|9|||
164010792|NCT02940886|592404977|FG001|Overall Study|Physician Decision|4|||
164010793|NCT02940886|592404976|FG000|Overall Study|Sponsor decision|0|||
164010794|NCT02940886|592404977|FG001|Overall Study|Sponsor decision|1|||
164010795|NCT02940886|592404976|FG000|Overall Study|No treatment|7|||
164010796|NCT02940886|592404977|FG001|Overall Study|No treatment|2|||
164010797|NCT02940886|592404976|FG000|Overall Study|Enrolment error|0|||
164010798|NCT02940886|592404977|FG001|Overall Study|Enrolment error|1|||
164010799|NCT00950690|592404980|FG000|Overall Study|Death|4|||
164010800|NCT00950690|592404980|FG000|Overall Study|Adverse Event|15|||
164010801|NCT00950690|592404980|FG000|Overall Study|Lack of Efficacy|22|||
164010802|NCT00950690|592404980|FG000|Overall Study|Lost to Follow-up|40|||
164010803|NCT00950690|592404980|FG000|Overall Study|Other|163|||
164010804|NCT01713036|592404981|FG000|Overall Study|Death|1|||
164010805|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
164010806|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
164010807|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
164010808|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
164010809|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
164010810|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
164010811|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
164010812|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
164010813|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
164010814|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
164010815|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
164010816|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
164112589|NCT02483416|592774035|FG000|Overall Study|Treatment stop|3|||
164362401|NCT04709575|593703912|FG001|Overall Study|Withdrawal by Subject|2|||
164362402|NCT04709575|593703911|FG000|Overall Study|Lost to Follow-up|2|||
164362403|NCT04709575|593703912|FG001|Overall Study|Lost to Follow-up|2|||
164362404|NCT04709575|593703911|FG000|Overall Study|Adverse Event|1|||
164362405|NCT04709575|593703912|FG001|Overall Study|Adverse Event|0|||
164362406|NCT04709575|593703911|FG000|Overall Study|Protocol Violation|1|||
164362407|NCT04709575|593703912|FG001|Overall Study|Protocol Violation|1|||
164362408|NCT02967692|593703913|FG000|Overall Study|Progressive disease|3|||
164362409|NCT02967692|593703914|FG001|Overall Study|Progressive disease|15|||
164362410|NCT02967692|593703915|FG002|Overall Study|Progressive disease|114|||
164362411|NCT02967692|593703916|FG003|Overall Study|Progressive disease|151|||
164362412|NCT02967692|593703913|FG000|Overall Study|Subject/guardian decision|1|||
164362413|NCT02967692|593703914|FG001|Overall Study|Subject/guardian decision|1|||
164362414|NCT02967692|593703915|FG002|Overall Study|Subject/guardian decision|14|||
164362415|NCT02967692|593703916|FG003|Overall Study|Subject/guardian decision|22|||
164362416|NCT02967692|593703913|FG000|Overall Study|Death|0|||
164362417|NCT02967692|593703914|FG001|Overall Study|Death|1|||
164362418|NCT02967692|593703915|FG002|Overall Study|Death|13|||
164362419|NCT02967692|593703916|FG003|Overall Study|Death|13|||
164362420|NCT02967692|593703913|FG000|Overall Study|Protocol deviation|1|||
164362421|NCT02967692|593703914|FG001|Overall Study|Protocol deviation|0|||
164091868|NCT02097121|592700045|FG000|Overall Study|Withdrawal by Subject|0|||
164091869|NCT02097121|592700046|FG001|Overall Study|Withdrawal by Subject|1|||
164091870|NCT02097121|592700047|FG002|Overall Study|Withdrawal by Subject|2|||
164091871|NCT02097121|592700045|FG000|Overall Study|Adverse Event|0|||
164091872|NCT02097121|592700046|FG001|Overall Study|Adverse Event|1|||
164091873|NCT02097121|592700047|FG002|Overall Study|Adverse Event|0|||
164091874|NCT02097121|592700045|FG000|Overall Study|Lost to Follow-up|1|||
164091875|NCT02097121|592700046|FG001|Overall Study|Lost to Follow-up|1|||
164091876|NCT02097121|592700047|FG002|Overall Study|Lost to Follow-up|2|||
164091877|NCT00510510|592700048|FG000|Overall Study|Adverse Event|4|||
164362422|NCT02967692|593703915|FG002|Overall Study|Protocol deviation|1|||
164362423|NCT02967692|593703916|FG003|Overall Study|Protocol deviation|1|||
164362424|NCT02967692|593703913|FG000|Overall Study|Lost to Follow-up|0|||
164362425|NCT02967692|593703914|FG001|Overall Study|Lost to Follow-up|0|||
164362426|NCT02967692|593703915|FG002|Overall Study|Lost to Follow-up|1|||
164362427|NCT02967692|593703916|FG003|Overall Study|Lost to Follow-up|0|||
164362428|NCT02967692|593703913|FG000|Overall Study|Physician Decision|0|||
164362429|NCT02967692|593703914|FG001|Overall Study|Physician Decision|0|||
164362430|NCT02967692|593703915|FG002|Overall Study|Physician Decision|22|||
164362431|NCT02967692|593703916|FG003|Overall Study|Physician Decision|13|||
164362432|NCT02967692|593703913|FG000|Overall Study|Adverse Event|2|||
164010817|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
164010818|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
164010819|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
164010820|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
164010821|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
164010822|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
164010823|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
164010824|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
164010825|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
164010826|NCT00092547|592404982|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
164010827|NCT00092547|592404983|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
164010828|NCT00092547|592404984|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
164010829|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
164010830|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
164010831|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
164010832|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
164010833|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
164010834|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
164010835|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
164091878|NCT00510510|592700049|FG001|Overall Study|Adverse Event|3|||
164091879|NCT00510510|592700050|FG002|Overall Study|Adverse Event|6|||
164091880|NCT00510510|592700048|FG000|Overall Study|Lack of Efficacy|0|||
164091881|NCT00510510|592700049|FG001|Overall Study|Lack of Efficacy|1|||
164091882|NCT00510510|592700050|FG002|Overall Study|Lack of Efficacy|1|||
164362433|NCT02967692|593703914|FG001|Overall Study|Adverse Event|9|||
164362434|NCT02967692|593703915|FG002|Overall Study|Adverse Event|60|||
164362435|NCT02967692|593703916|FG003|Overall Study|Adverse Event|28|||
164362436|NCT02967692|593703913|FG000|Overall Study|Study terminated by sponsor|2|||
164362437|NCT02967692|593703914|FG001|Overall Study|Study terminated by sponsor|1|||
164362438|NCT02967692|593703915|FG002|Overall Study|Study terminated by sponsor|42|||
164091883|NCT00510510|592700048|FG000|Overall Study|Subjects no longer requires study drug|0|||
164091884|NCT00510510|592700049|FG001|Overall Study|Subjects no longer requires study drug|0|||
164091885|NCT00510510|592700050|FG002|Overall Study|Subjects no longer requires study drug|2|||
164091886|NCT00510510|592700048|FG000|Overall Study|Withdrawal by Subject|1|||
164091887|NCT00510510|592700049|FG001|Overall Study|Withdrawal by Subject|2|||
164091888|NCT00510510|592700050|FG002|Overall Study|Withdrawal by Subject|3|||
164091889|NCT00510510|592700048|FG000|Overall Study|Lost to Follow-up|0|||
164091890|NCT00510510|592700049|FG001|Overall Study|Lost to Follow-up|0|||
164091891|NCT00510510|592700050|FG002|Overall Study|Lost to Follow-up|1|||
164091892|NCT00510510|592700048|FG000|Overall Study|Protocol Violation|0|||
164091893|NCT00510510|592700049|FG001|Overall Study|Protocol Violation|3|||
164091894|NCT00510510|592700050|FG002|Overall Study|Protocol Violation|4|||
164091895|NCT03595657|592700051|FG000|Overall Study|Adverse Event|14|||
164091896|NCT03595657|592700051|FG000|Overall Study|Death|1|||
164091897|NCT03595657|592700051|FG000|Overall Study|Lack of Efficacy|40|||
164091898|NCT03595657|592700051|FG000|Overall Study|Withdrawal by Subject|10|||
164091899|NCT03595657|592700051|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
164091900|NCT03595657|592700051|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
164091901|NCT01066052|592700052|FG000|Overall Study|Enrolled But Not Treated|3|||
164091902|NCT01066052|592700053|FG001|Overall Study|Enrolled But Not Treated|0|||
164091903|NCT03184441|592700054|FG000|Overall Study|Withdrawal by Subject|1|||
164091904|NCT01200394|592700055|FG000|Overall Study|Adverse Event|0|||
164091905|NCT01200394|592700056|FG001|Overall Study|Adverse Event|14|||
164091906|NCT01200394|592700055|FG000|Overall Study|Death|1|||
164091907|NCT01200394|592700056|FG001|Overall Study|Death|0|||
164091908|NCT01200394|592700055|FG000|Overall Study|Lost to Follow-up|0|||
164091909|NCT01200394|592700056|FG001|Overall Study|Lost to Follow-up|1|||
164091910|NCT01200394|592700055|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164091911|NCT01200394|592700056|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
164091912|NCT01200394|592700055|FG000|Overall Study|Protocol Violation|0|||
164091913|NCT01200394|592700056|FG001|Overall Study|Protocol Violation|3|||
164091914|NCT01200394|592700055|FG000|Overall Study|Withdrawal by Subject|0|||
164091915|NCT01200394|592700056|FG001|Overall Study|Withdrawal by Subject|5|||
164091916|NCT01200394|592700055|FG000|Overall Study|Other|0|||
164091917|NCT01200394|592700056|FG001|Overall Study|Other|1|||
164091918|NCT02729896|592700059|FG000|Overall Study|Death|0|||
164091919|NCT02729896|592700060|FG001|Overall Study|Death|2|||
164091920|NCT02729896|592700061|FG002|Overall Study|Death|13|||
164091921|NCT02729896|592700059|FG000|Overall Study|Lost to Follow-up|0|||
164091922|NCT02729896|592700060|FG001|Overall Study|Lost to Follow-up|2|||
164091923|NCT02729896|592700061|FG002|Overall Study|Lost to Follow-up|3|||
164091924|NCT02729896|592700059|FG000|Overall Study|Other|0|||
164091925|NCT02729896|592700060|FG001|Overall Study|Other|2|||
164091926|NCT02729896|592700061|FG002|Overall Study|Other|0|||
164091927|NCT02729896|592700059|FG000|Overall Study|Physician Decision|1|||
164091928|NCT02729896|592700060|FG001|Overall Study|Physician Decision|2|||
164091929|NCT02729896|592700061|FG002|Overall Study|Physician Decision|3|||
164091930|NCT02729896|592700059|FG000|Overall Study|Progressive Disease|0|||
164091931|NCT02729896|592700060|FG001|Overall Study|Progressive Disease|1|||
164091932|NCT02729896|592700061|FG002|Overall Study|Progressive Disease|0|||
164091933|NCT02729896|592700059|FG000|Overall Study|Withdrawal by Subject|1|||
164091934|NCT02729896|592700060|FG001|Overall Study|Withdrawal by Subject|0|||
164091935|NCT02729896|592700061|FG002|Overall Study|Withdrawal by Subject|3|||
164091936|NCT02199509|592700062|FG000|Overall Study|Suicidal Ideation|0|||
164091937|NCT02199509|592700063|FG001|Overall Study|Suicidal Ideation|1|||
164091938|NCT02199509|592700062|FG000|Overall Study|Misunderstood titration schedule|1|||
164091939|NCT02199509|592700063|FG001|Overall Study|Misunderstood titration schedule|0|||
164091940|NCT04094870|592700064|FG000|Overall Study|Lost to Follow-up|1|||
164091941|NCT04094870|592700065|FG001|Overall Study|Lost to Follow-up|1|||
164091942|NCT02708277|592700067|FG000|Overall Study|Lost to Follow-up|7|||
164091943|NCT02708277|592700068|FG001|Overall Study|Lost to Follow-up|4|||
164091944|NCT02742181|592700069|FG000|Overall Study|Physician Decision|1|||
164091945|NCT02742181|592700070|FG001|Overall Study|Physician Decision|0|||
164091946|NCT02739984|592700071|FG000|Overall Study|Sponsor Decision|1|||
164091947|NCT02739984|592700072|FG001|Overall Study|Sponsor Decision|0|||
164091948|NCT02739984|592700071|FG000|Overall Study|Withdrawal by Subject|1|||
164091949|NCT02739984|592700072|FG001|Overall Study|Withdrawal by Subject|1|||
164091950|NCT02739984|592700071|FG000|Overall Study|Death|0|||
164091951|NCT02739984|592700072|FG001|Overall Study|Death|1|||
164091952|NCT02739984|592700071|FG000|Overall Study|Lost to Follow-up|3|||
164091953|NCT02739984|592700072|FG001|Overall Study|Lost to Follow-up|0|||
164091954|NCT01048333|592700077|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164091955|NCT01048333|592700078|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
164091956|NCT01048333|592700079|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164362439|NCT02967692|593703916|FG003|Overall Study|Study terminated by sponsor|37|||
164362440|NCT04447417|593703920|FG000|Overall Study|Withdrawal by Subject|1|||
164362441|NCT04447417|593703921|FG001|Overall Study|Withdrawal by Subject|0|||
164362442|NCT04447417|593703920|FG000|Overall Study|Failure to meet inclusion criteria|1|||
164362443|NCT04447417|593703921|FG001|Overall Study|Failure to meet inclusion criteria|0|||
164362444|NCT04447417|593703920|FG000|Overall Study|Lost to Follow-up|1|||
164362445|NCT04447417|593703921|FG001|Overall Study|Lost to Follow-up|0|||
164362446|NCT00702403|593703922|FG000|From Consent to Engraftment|Progressive leukemia|6|||
164362447|NCT00702403|593703922|FG000|From Consent to Engraftment|Critically ill|2|||
164362448|NCT00702403|593703922|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
164362449|NCT00702403|593703922|FG000|From Consent to Engraftment|Myocardial infarction|1|||
164362450|NCT00702403|593703922|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
164362451|NCT00702403|593703922|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
164362452|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
164362453|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
164362454|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Non-compliance|2|||
164362455|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
164362456|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
164362457|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Suicide|1|||
164362458|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
164362459|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
164362460|NCT00702403|593703922|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
164362461|NCT00066066|593703926|FG000|Overall Study|Lost to Follow-up|6|||
164362462|NCT00066066|593703927|FG001|Overall Study|Lost to Follow-up|4|||
164362463|NCT00066066|593703928|FG002|Overall Study|Lost to Follow-up|7|||
164362464|NCT00066066|593703929|FG003|Overall Study|Lost to Follow-up|4|||
164362465|NCT00066066|593703930|FG004|Overall Study|Lost to Follow-up|3|||
164362466|NCT00066066|593703931|FG005|Overall Study|Lost to Follow-up|5|||
164010836|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
164010837|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
164010838|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
164010839|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
164010840|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
164010841|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
164010842|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
164010843|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
164010844|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
164010845|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
164010846|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
164010847|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
164010848|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
164010849|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
164010850|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
164010851|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
164010852|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
164010853|NCT00092547|592404982|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
164010854|NCT00092547|592404983|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
164010855|NCT00092547|592404984|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
164010856|NCT00092547|592404982|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
164091957|NCT01048333|592700080|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164091958|NCT01048333|592700081|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164362467|NCT02155738|593703932|FG000|Overall Study|Missing critical information|1|||
164362468|NCT02155738|593703933|FG001|Overall Study|Missing critical information|0|||
164362469|NCT02155738|593703934|FG002|Overall Study|Missing critical information|0|||
164362470|NCT02155738|593703935|FG003|Overall Study|Missing critical information|1|||
164362471|NCT01466348|593703938|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
164112590|NCT02483416|592774036|FG001|Overall Study|Treatment stop|0|||
164010857|NCT00092547|592404983|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
164010858|NCT00092547|592404984|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
164010859|NCT00092547|592404982|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
164010860|NCT00092547|592404983|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
164010861|NCT00092547|592404984|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
164010862|NCT00092547|592404982|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
164010863|NCT00092547|592404983|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
164010864|NCT00092547|592404984|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
164362472|NCT01466348|593703939|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
164362473|NCT02189473|593703942|FG000|Overall Study|Death|22|||
164362474|NCT02189473|593703943|FG001|Overall Study|Death|23|||
164362475|NCT02189473|593703942|FG000|Overall Study|Lost to Follow-up|1|||
164362476|NCT02189473|593703943|FG001|Overall Study|Lost to Follow-up|2|||
164010865|NCT00092547|592404982|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
164010866|NCT00092547|592404983|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
164010867|NCT00092547|592404984|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
164010868|NCT01166659|592404985|FG000|Overall Study|Subject Decision|8|||
164010869|NCT01166659|592404985|FG000|Overall Study|Investigator Decision|2|||
164010870|NCT01166659|592404985|FG000|Overall Study|Death|1|||
164010871|NCT01166659|592404985|FG000|Overall Study|Lost to Follow-up|1|||
164010872|NCT01166659|592404985|FG000|Overall Study|Study Closed at Site|1|||
164010873|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
164010874|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
164010875|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
164010876|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
164010877|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
164010878|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
164010879|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
164010880|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
164010881|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
164010882|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
164010883|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
164010884|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
164010885|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
164010886|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
164010887|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
164010888|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
164010889|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
164010890|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
164010891|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
164010892|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
164010893|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
164010894|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
164010895|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
164010896|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
164010897|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
164010898|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
164010899|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
164010900|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
164010901|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
164010902|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
164010903|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
164362477|NCT02385266|593703949|FG000|Overall Study|Withdrawal by Subject|1|||
164362478|NCT02385266|593703950|FG001|Overall Study|Withdrawal by Subject|3|||
164362479|NCT00914810|593703951|FG000|Overall Study|Withdrawal by Subject|1|||
164362480|NCT00914810|593703952|FG001|Overall Study|Withdrawal by Subject|0|||
164362481|NCT00914810|593703951|FG000|Overall Study|Relocated out of state|1|||
164362482|NCT00914810|593703952|FG001|Overall Study|Relocated out of state|0|||
164362483|NCT00914810|593703951|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
164362484|NCT00914810|593703952|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
164362485|NCT02082210|593703953|FG000|Overall Study|Death|0|||
164362486|NCT02082210|593703954|FG001|Overall Study|Death|0|||
164362487|NCT02082210|593703955|FG002|Overall Study|Death|1|||
164362488|NCT02082210|593703956|FG003|Overall Study|Death|1|||
164362489|NCT02082210|593703957|FG004|Overall Study|Death|1|||
164010904|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
164010905|NCT00958568|592404996|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
164362490|NCT02082210|593703958|FG005|Overall Study|Death|0|||
164362491|NCT02082210|593703953|FG000|Overall Study|Withdrawal by Subject|0|||
164362492|NCT02082210|593703954|FG001|Overall Study|Withdrawal by Subject|0|||
164362493|NCT02082210|593703955|FG002|Overall Study|Withdrawal by Subject|0|||
164362494|NCT02082210|593703956|FG003|Overall Study|Withdrawal by Subject|1|||
164362495|NCT02082210|593703957|FG004|Overall Study|Withdrawal by Subject|2|||
164362496|NCT02082210|593703958|FG005|Overall Study|Withdrawal by Subject|2|||
164362497|NCT02082210|593703953|FG000|Overall Study|Clinical Progression|0|||
164362498|NCT02082210|593703954|FG001|Overall Study|Clinical Progression|0|||
164362499|NCT02082210|593703955|FG002|Overall Study|Clinical Progression|0|||
164362500|NCT02082210|593703956|FG003|Overall Study|Clinical Progression|1|||
164362501|NCT02082210|593703957|FG004|Overall Study|Clinical Progression|0|||
164362502|NCT02082210|593703958|FG005|Overall Study|Clinical Progression|0|||
164362503|NCT02082210|593703953|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362504|NCT02082210|593703954|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362505|NCT02082210|593703955|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
164362506|NCT02082210|593703956|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
164362507|NCT02082210|593703957|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362508|NCT02082210|593703958|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
164362509|NCT02082210|593703953|FG000|Overall Study|Physician Decision|0|||
164362510|NCT02082210|593703954|FG001|Overall Study|Physician Decision|0|||
164362511|NCT02082210|593703955|FG002|Overall Study|Physician Decision|1|||
164362512|NCT02082210|593703956|FG003|Overall Study|Physician Decision|1|||
164362513|NCT02082210|593703957|FG004|Overall Study|Physician Decision|0|||
164362514|NCT02082210|593703958|FG005|Overall Study|Physician Decision|0|||
164362515|NCT02529137|593703964|FG000|Overall Study|Discontinuation for different reasons|8|||
164362516|NCT02731729|593703965|FG000|Overall Study|Death|2|||
164362517|NCT02731729|593703966|FG001|Overall Study|Death|2|||
164362518|NCT02731729|593703965|FG000|Overall Study|Study terminated by Sponsor|6|||
164362519|NCT02731729|593703966|FG001|Overall Study|Study terminated by Sponsor|6|||
164362520|NCT02731729|593703965|FG000|Overall Study|Withdrawal by Subject|1|||
164362521|NCT02731729|593703966|FG001|Overall Study|Withdrawal by Subject|0|||
164362522|NCT01344447|593703967|FG000|Overall Study|Adverse Event|1|||
164362523|NCT01344447|593703967|FG000|Overall Study|Protocol Violation|1|||
164362524|NCT01344447|593703967|FG000|Overall Study|Withdrawal by Subject|1|||
164362525|NCT01344447|593703967|FG000|Overall Study|The contrast was not seen|1|||
164362526|NCT01344447|593703967|FG000|Overall Study|Physician Decision|1|||
164362527|NCT01344447|593703967|FG000|Overall Study|MRA unsuccessful|1|||
164362528|NCT01344447|593703967|FG000|Overall Study|Bolus tracking failed|1|||
164362529|NCT01344447|593703967|FG000|Overall Study|Error of power injector|1|||
164362530|NCT01660711|593703968|FG000|Overall Study|Adverse Event|7|||
164362531|NCT01660711|593703968|FG000|Overall Study|Withdrawal by Subject|1|||
164362532|NCT00952341|593703970|FG000|Cycle 1|Adverse Event|4|||
164362533|NCT00952341|593703971|FG001|Cycle 1|Adverse Event|1|||
164362534|NCT00952341|593703970|FG000|Cycle 1|Withdrawal by Subject|3|||
164362535|NCT00952341|593703971|FG001|Cycle 1|Withdrawal by Subject|8|||
164362536|NCT00952341|593703970|FG000|Cycle 1|Protocol Violation|2|||
164362537|NCT00952341|593703971|FG001|Cycle 1|Protocol Violation|1|||
164362538|NCT00952341|593703970|FG000|Cycle 1|Lost to Follow-up|11|||
164362539|NCT00952341|593703971|FG001|Cycle 1|Lost to Follow-up|2|||
164362540|NCT00952341|593703970|FG000|Cycle 1|Physician Decision|0|||
164362541|NCT00952341|593703971|FG001|Cycle 1|Physician Decision|1|||
164362542|NCT00952341|593703970|FG000|Cycle 2|Withdrawal by Subject|1|||
164362543|NCT00952341|593703971|FG001|Cycle 2|Withdrawal by Subject|1|||
164362544|NCT00952341|593703970|FG000|Cycle 2|Protocol Violation|1|||
164362545|NCT00952341|593703971|FG001|Cycle 2|Protocol Violation|0|||
164362546|NCT00952341|593703970|FG000|Cycle 2|Lost to Follow-up|6|||
164362547|NCT00952341|593703971|FG001|Cycle 2|Lost to Follow-up|9|||
164362548|NCT00952341|593703970|FG000|Cycle 2|Physician Decision|1|||
164362549|NCT00952341|593703971|FG001|Cycle 2|Physician Decision|1|||
164362550|NCT00952341|593703970|FG000|Cycle 2|Progressive Disease|0|||
164362551|NCT00952341|593703971|FG001|Cycle 2|Progressive Disease|1|||
164362552|NCT02066467|593703976|FG000|Overall Study|Did not undergo implant procedure|24|||
164362553|NCT02066467|593703976|FG000|Overall Study|Attempted to implant withoput success|43|||
164362554|NCT02066467|593703976|FG000|Overall Study|Consent ineligible|1|||
164362555|NCT02066467|593703976|FG000|Overall Study|Death|54|||
164362556|NCT02066467|593703976|FG000|Overall Study|Lost to Follow-up|51|||
164362557|NCT02066467|593703976|FG000|Overall Study|Adverse Event|20|||
164362558|NCT02066467|593703976|FG000|Overall Study|Withdrawal by Subject|16|||
164362559|NCT02066467|593703976|FG000|Overall Study|Physician Decision|2|||
164362560|NCT02066467|593703976|FG000|Overall Study|Not defined|4|||
164362561|NCT00581776|593703980|FG000|Overall Study|Disease progression or no response|3|||
164362562|NCT02357901|593703981|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
164362563|NCT02357901|593703982|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
164362564|NCT02357901|593703983|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
164362565|NCT02357901|593703984|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
164362566|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
164362567|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
164362568|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
164362569|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
164010906|NCT00958568|592404997|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
164010907|NCT00958568|592404998|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
164010908|NCT00958568|592404999|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
164010909|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
164010910|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
164362570|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
164362571|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
164362572|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
164362573|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
164362574|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
164362575|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
164362576|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
164362577|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
164362578|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
164362579|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
164362580|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
164362581|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
164362582|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
164362583|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
164362584|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
164362585|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
164362586|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
164362587|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
164362588|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
164010911|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
164010912|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
164010913|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
164010914|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
164010915|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
164010916|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
164362589|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
164362590|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
164362591|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
164362592|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
164362593|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
164010917|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
164010918|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
164010919|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
164010920|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
164010921|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
164010922|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
164010923|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
164010924|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
164010925|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
164010926|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
164010927|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
164010928|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
164010929|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
164010930|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
164010931|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
164010932|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
164010933|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
164010934|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
164010935|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
164010936|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
164010937|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
164010938|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
164010939|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
164010940|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
164091959|NCT01048333|592700082|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
164091960|NCT04947579|592700084|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164010941|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
164362594|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
164362595|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
164362596|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
164362597|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
164362598|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
164362599|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
164362600|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
164362601|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
164362602|NCT02357901|593703981|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
164362603|NCT02357901|593703982|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
164362604|NCT02357901|593703983|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
164362605|NCT02357901|593703984|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
164362606|NCT02759120|593703991|FG000|Overall Study|Death|34|||
164362607|NCT02759120|593703992|FG001|Overall Study|Death|36|||
164362608|NCT02759120|593703991|FG000|Overall Study|Lost to Follow-up|4|||
164362609|NCT02759120|593703992|FG001|Overall Study|Lost to Follow-up|7|||
164362610|NCT02759120|593703991|FG000|Overall Study|Physician Decision|3|||
164362611|NCT02759120|593703992|FG001|Overall Study|Physician Decision|0|||
164362612|NCT02759120|593703991|FG000|Overall Study|Withdrawal by Subject|28|||
164362613|NCT02759120|593703992|FG001|Overall Study|Withdrawal by Subject|15|||
164362614|NCT02759120|593703991|FG000|Overall Study|Moved out of area|3|||
164362615|NCT02759120|593703992|FG001|Overall Study|Moved out of area|4|||
164362616|NCT02759120|593703991|FG000|Overall Study|Lung transplant|3|||
164362617|NCT02759120|593703992|FG001|Overall Study|Lung transplant|5|||
164362618|NCT02759120|593703991|FG000|Overall Study|Other reason not completed|10|||
164362619|NCT02759120|593703992|FG001|Overall Study|Other reason not completed|12|||
164362620|NCT04461015|593703996|FG000|Overall Study|IV access lost during the study|0|||
164362621|NCT04461015|593703997|FG001|Overall Study|IV access lost during the study|1|||
164362622|NCT04461015|593703996|FG000|Overall Study|Withdrawal by Subject|0|||
164362623|NCT04461015|593703997|FG001|Overall Study|Withdrawal by Subject|1|||
164362624|NCT00483379|593704001|FG000|Treatment Period|Adverse Event|1|||
164362625|NCT00483379|593704002|FG001|Treatment Period|Adverse Event|0|||
164362626|NCT00483379|593704001|FG000|Treatment Period|Withdrawal by Subject|1|||
164362627|NCT00483379|593704002|FG001|Treatment Period|Withdrawal by Subject|0|||
164362628|NCT02418468|593704004|FG000|Overall Study|Adverse Event|1|||
164362629|NCT02418468|593704005|FG001|Overall Study|Adverse Event|0|||
164362630|NCT02418468|593704004|FG000|Overall Study|Withdrawal of informed consent|1|||
164362631|NCT02418468|593704005|FG001|Overall Study|Withdrawal of informed consent|1|||
164362632|NCT02914769|593704006|FG000|Overall Study|Protocol Violation|3|||
164362633|NCT02914769|593704007|FG001|Overall Study|Protocol Violation|2|||
164362634|NCT02914769|593704006|FG000|Overall Study|Withdrawal by Subject|0|||
164362635|NCT02914769|593704007|FG001|Overall Study|Withdrawal by Subject|1|||
164362636|NCT02337907|593704008|FG000|Overall Study|Other than listed|1|||
164362637|NCT02337907|593704009|FG001|Overall Study|Other than listed|0|||
164362638|NCT02337907|593704010|FG002|Overall Study|Other than listed|0|||
164362639|NCT02337907|593704011|FG003|Overall Study|Other than listed|1|||
164362640|NCT02337907|593704012|FG004|Overall Study|Other than listed|1|||
164362641|NCT02337907|593704013|FG005|Overall Study|Other than listed|0|||
164362642|NCT02337907|593704008|FG000|Overall Study|Withdrawal by Subject|2|||
164362643|NCT02337907|593704009|FG001|Overall Study|Withdrawal by Subject|3|||
164362644|NCT02337907|593704010|FG002|Overall Study|Withdrawal by Subject|0|||
164362645|NCT02337907|593704011|FG003|Overall Study|Withdrawal by Subject|2|||
164362646|NCT02337907|593704012|FG004|Overall Study|Withdrawal by Subject|5|||
164362647|NCT02337907|593704013|FG005|Overall Study|Withdrawal by Subject|0|||
164362648|NCT02337907|593704008|FG000|Overall Study|Lost to Follow-up|0|||
164362649|NCT02337907|593704009|FG001|Overall Study|Lost to Follow-up|0|||
164362650|NCT02337907|593704010|FG002|Overall Study|Lost to Follow-up|0|||
164362651|NCT02337907|593704011|FG003|Overall Study|Lost to Follow-up|0|||
164362652|NCT02337907|593704012|FG004|Overall Study|Lost to Follow-up|0|||
164362653|NCT02337907|593704013|FG005|Overall Study|Lost to Follow-up|1|||
164362654|NCT02337907|593704008|FG000|Overall Study|Adverse Event|1|||
164362655|NCT02337907|593704009|FG001|Overall Study|Adverse Event|1|||
164362656|NCT02337907|593704010|FG002|Overall Study|Adverse Event|1|||
164362657|NCT02337907|593704011|FG003|Overall Study|Adverse Event|1|||
164362658|NCT02337907|593704012|FG004|Overall Study|Adverse Event|4|||
164362659|NCT02337907|593704013|FG005|Overall Study|Adverse Event|0|||
164010942|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
164362660|NCT01592344|593704014|FG000|Overall Study|Adverse Event|1|||
164362661|NCT01592344|593704015|FG001|Overall Study|Adverse Event|1|||
164362662|NCT01592344|593704014|FG000|Overall Study|Lack of Efficacy|1|||
164362663|NCT01592344|593704015|FG001|Overall Study|Lack of Efficacy|0|||
164362664|NCT01592344|593704014|FG000|Overall Study|not available at primary outcome visit|2|||
164362665|NCT01592344|593704015|FG001|Overall Study|not available at primary outcome visit|4|||
164362666|NCT00099437|593704016|FG000|Overall Study|Lost to Follow-up|30|||
164362667|NCT00099437|593704017|FG001|Overall Study|Lost to Follow-up|33|||
164362668|NCT00099437|593704016|FG000|Overall Study|Death|293|||
164362669|NCT00099437|593704017|FG001|Overall Study|Death|261|||
164362670|NCT00099437|593704016|FG000|Overall Study|Withdrawal by Subject|6|||
164362671|NCT00099437|593704017|FG001|Overall Study|Withdrawal by Subject|10|||
164362672|NCT00099437|593704016|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
164362673|NCT00099437|593704017|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
164362674|NCT02738333|593704018|FG000|Overall Study|Death|1|||
164362675|NCT02738333|593704019|FG001|Overall Study|Death|0|||
164362676|NCT02738333|593704020|FG002|Overall Study|Death|0|||
164362677|NCT02738333|593704018|FG000|Overall Study|Lost to Follow-up|1|||
164362678|NCT02738333|593704019|FG001|Overall Study|Lost to Follow-up|0|||
164362679|NCT02738333|593704020|FG002|Overall Study|Lost to Follow-up|0|||
164362680|NCT00949325|593704021|FG000|Overall Study|Adverse Event|0|||
164362681|NCT00949325|593704022|FG001|Overall Study|Adverse Event|2|||
164362682|NCT00949325|593704023|FG002|Overall Study|Adverse Event|0|||
164362683|NCT03311659|593704032|FG000|Overall Study|Protocol Violation|1|||
164362684|NCT01176266|593704033|FG000|Overall Study|Death|6|||
164362685|NCT01176266|593704033|FG000|Overall Study|Withdrawal by Subject|3|||
164362686|NCT01179477|593704034|FG000|Overall Study|Death|542|||
164362687|NCT01179477|593704034|FG000|Overall Study|Unsuccessful implant|80|||
164362688|NCT01179477|593704034|FG000|Overall Study|Non-death withdrawal|438|||
164362689|NCT01179477|593704034|FG000|Overall Study|Did not complete final visit|27|||
164010943|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
164010944|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
164010945|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
164010946|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
164010947|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
164010948|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
164010949|NCT00958568|592404996|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
164010950|NCT00958568|592404997|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
164010951|NCT00958568|592404998|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
164010952|NCT00958568|592404999|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
164010953|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
164010954|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
164010955|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
164010956|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
164010957|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
164010958|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
164010959|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
164010960|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
164010961|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
164010962|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
164010963|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
164010964|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
164010965|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
164010966|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
164010967|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
164010968|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
164010969|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
164010970|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
164010971|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
164010972|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
164010973|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
164010974|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
164010975|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
164010976|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
164010977|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
164010978|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
164362690|NCT04327388|593704036|FG000|Overall Study|Adverse Event|17|||
164362691|NCT04327388|593704037|FG001|Overall Study|Adverse Event|18|||
164362692|NCT04327388|593704038|FG002|Overall Study|Adverse Event|9|||
164010979|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
164010980|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
164362693|NCT04327388|593704036|FG000|Overall Study|Other|1|||
164362694|NCT04327388|593704037|FG001|Overall Study|Other|2|||
164362695|NCT04327388|593704038|FG002|Overall Study|Other|0|||
164362696|NCT04327388|593704036|FG000|Overall Study|Randomized and not treated|2|||
164362697|NCT04327388|593704037|FG001|Overall Study|Randomized and not treated|0|||
164362698|NCT04327388|593704038|FG002|Overall Study|Randomized and not treated|2|||
164362699|NCT00728130|593704039|FG000|Overall Study|Withdrawal by Subject|1|||
164362700|NCT00728130|593704039|FG000|Overall Study|Paperwork not completed in time|1|||
164362701|NCT00728130|593704039|FG000|Overall Study|Physician Decision|1|||
164362702|NCT04053023|593704042|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
164362703|NCT04053023|593704043|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
164362704|NCT03447990|593704044|FG000|Overall Study|Withdrawal by Subject|0|||
164362705|NCT03447990|593704045|FG001|Overall Study|Withdrawal by Subject|0|||
164362706|NCT03447990|593704046|FG002|Overall Study|Withdrawal by Subject|0|||
164362707|NCT03447990|593704047|FG003|Overall Study|Withdrawal by Subject|0|||
164362708|NCT03447990|593704048|FG004|Overall Study|Withdrawal by Subject|0|||
164362709|NCT03447990|593704049|FG005|Overall Study|Withdrawal by Subject|0|||
164362710|NCT03447990|593704050|FG006|Overall Study|Withdrawal by Subject|1|||
164362711|NCT03755414|593704051|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
164362712|NCT03755414|593704052|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
164362713|NCT03755414|593704053|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
164362714|NCT03755414|593704051|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
164362715|NCT03755414|593704052|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
164362716|NCT03755414|593704053|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
164362717|NCT03755414|593704051|FG000|Overall Study|Non-compliance|0|||
164362718|NCT03755414|593704052|FG001|Overall Study|Non-compliance|1|||
164010981|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
164362719|NCT03755414|593704053|FG002|Overall Study|Non-compliance|0|||
164362720|NCT02153112|593704054|FG000|Overall Study|Adverse Event|0|||
164362721|NCT02153112|593704055|FG001|Overall Study|Adverse Event|0|||
164362722|NCT02153112|593704056|FG002|Overall Study|Adverse Event|1|||
164362723|NCT02153112|593704057|FG003|Overall Study|Adverse Event|0|||
164362724|NCT02153112|593704058|FG004|Overall Study|Adverse Event|0|||
164362725|NCT02153112|593704059|FG005|Overall Study|Adverse Event|0|||
164362726|NCT02153112|593704060|FG006|Overall Study|Adverse Event|0|||
164362727|NCT02153112|593704061|FG007|Overall Study|Adverse Event|0|||
164362728|NCT02153112|593704062|FG008|Overall Study|Adverse Event|0|||
164362729|NCT02153112|593704063|FG009|Overall Study|Adverse Event|0|||
164362730|NCT02153112|593704054|FG000|Overall Study|Lost to Follow-up|1|||
164362731|NCT02153112|593704055|FG001|Overall Study|Lost to Follow-up|1|||
164362732|NCT02153112|593704056|FG002|Overall Study|Lost to Follow-up|0|||
164362733|NCT02153112|593704057|FG003|Overall Study|Lost to Follow-up|0|||
164362734|NCT02153112|593704058|FG004|Overall Study|Lost to Follow-up|2|||
164010982|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
164010983|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
164010984|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
164010985|NCT00958568|592404996|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
164010986|NCT00958568|592404997|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
164010987|NCT00958568|592404998|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
164010988|NCT00958568|592404999|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
164010989|NCT00915005|592405000|FG000|Overall Study|Withdrawal by Subject|4|||
164010990|NCT00915005|592405001|FG001|Overall Study|Withdrawal by Subject|4|||
164010991|NCT00915005|592405000|FG000|Overall Study|Patient preferred protons therapy|6|||
164010992|NCT00915005|592405001|FG001|Overall Study|Patient preferred protons therapy|0|||
164010993|NCT00915005|592405000|FG000|Overall Study|Insurance denial|3|||
164010994|NCT00915005|592405001|FG001|Overall Study|Insurance denial|15|||
164010995|NCT00589472|592405006|FG000|Overall Study|Adverse Event|1|||
164010996|NCT00117338|592405007|FG000|Overall Study|Adverse Event|0|||
164010997|NCT00117338|592405008|FG001|Overall Study|Adverse Event|1|||
164010998|NCT00117338|592405007|FG000|Overall Study|Protocol Violation|3|||
164010999|NCT00117338|592405008|FG001|Overall Study|Protocol Violation|2|||
164011000|NCT00117338|592405007|FG000|Overall Study|Withdrawal by Subject|1|||
164011001|NCT00117338|592405008|FG001|Overall Study|Withdrawal by Subject|0|||
164362735|NCT02153112|593704059|FG005|Overall Study|Lost to Follow-up|1|||
164362736|NCT02153112|593704060|FG006|Overall Study|Lost to Follow-up|1|||
164011002|NCT00117338|592405007|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
164011003|NCT00117338|592405008|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
164011004|NCT00117338|592405007|FG000|Overall Study|Lack of Efficacy|0|||
164091961|NCT04947579|592700085|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164011005|NCT00117338|592405008|FG001|Overall Study|Lack of Efficacy|1|||
164362737|NCT02153112|593704061|FG007|Overall Study|Lost to Follow-up|0|||
164362738|NCT02153112|593704062|FG008|Overall Study|Lost to Follow-up|1|||
164091962|NCT04947579|592700086|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164091963|NCT04947579|592700087|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
164091964|NCT04947579|592700088|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164091965|NCT04947579|592700089|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
164091966|NCT04947579|592700084|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164091967|NCT04947579|592700085|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164091968|NCT04947579|592700086|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
164091969|NCT04947579|592700087|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164091970|NCT04947579|592700088|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164091971|NCT04947579|592700089|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
164091972|NCT04947579|592700084|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
164091973|NCT04947579|592700085|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
164091974|NCT04947579|592700086|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
164091975|NCT04947579|592700087|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
164091976|NCT04947579|592700088|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
164091977|NCT04947579|592700089|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
164091978|NCT04947579|592700084|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
164091979|NCT04947579|592700085|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
164091980|NCT04947579|592700086|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
164091981|NCT04947579|592700087|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
164091982|NCT04947579|592700088|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
164091983|NCT04947579|592700089|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
164091984|NCT04947579|592700084|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
164091985|NCT04947579|592700085|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164091986|NCT04947579|592700086|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164091987|NCT04947579|592700087|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164091988|NCT04947579|592700088|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164091989|NCT04947579|592700089|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
164091990|NCT04947579|592700084|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164091991|NCT04947579|592700085|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164091992|NCT04947579|592700086|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
164091993|NCT04947579|592700087|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164091994|NCT04947579|592700088|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164091995|NCT04947579|592700089|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
164091996|NCT04947579|592700084|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164091997|NCT04947579|592700085|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
164091998|NCT04947579|592700086|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164091999|NCT04947579|592700087|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164092000|NCT04947579|592700088|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
164092001|NCT04947579|592700089|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
164092002|NCT04947579|592700084|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164092003|NCT04947579|592700085|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164092004|NCT04947579|592700086|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
164092005|NCT04947579|592700087|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164092006|NCT04947579|592700088|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164092007|NCT04947579|592700089|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
164092008|NCT04947579|592700084|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
164092009|NCT04947579|592700085|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
164092010|NCT04947579|592700086|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
164092011|NCT04947579|592700087|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
164011006|NCT01380093|592405009|FG000|Naloxone Challenge Phase|Screen failures|21|||
164011007|NCT01380093|592405010|FG001|Naloxone Challenge Phase|Screen failures|0|||
164011008|NCT01380093|592405011|FG002|Naloxone Challenge Phase|Screen failures|0|||
164011009|NCT01380093|592405012|FG003|Naloxone Challenge Phase|Screen failures|0|||
164011010|NCT01380093|592405013|FG004|Naloxone Challenge Phase|Screen failures|0|||
164011011|NCT01380093|592405014|FG005|Naloxone Challenge Phase|Screen failures|0|||
164011012|NCT01380093|592405015|FG006|Naloxone Challenge Phase|Screen failures|0|||
164011013|NCT01380093|592405016|FG007|Naloxone Challenge Phase|Screen failures|0|||
164011014|NCT01380093|592405017|FG008|Naloxone Challenge Phase|Screen failures|0|||
164011015|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164011016|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
164011017|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164011018|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164011019|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164092012|NCT04947579|592700088|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
164112591|NCT03387462|592774038|FG000|Overall Study|Lost to Follow-up|1|||
164092013|NCT04947579|592700089|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
164092014|NCT04947579|592700084|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
164092015|NCT04947579|592700085|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
164092016|NCT04947579|592700086|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
164092017|NCT04947579|592700087|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
164092018|NCT04947579|592700088|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
164092019|NCT04947579|592700089|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
164092020|NCT04947579|592700084|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
164092021|NCT04947579|592700085|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
164092022|NCT04947579|592700086|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
164092023|NCT04947579|592700087|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
164092024|NCT04947579|592700088|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
164092025|NCT04947579|592700089|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
164092026|NCT00634179|592700090|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
164092027|NCT00767325|592700091|FG000|Overall Study|Lack of Efficacy|2|||
164092028|NCT00767325|592700091|FG000|Overall Study|Adverse Event|7|||
164092029|NCT00767325|592700091|FG000|Overall Study|Lost to Follow-up|3|||
164092030|NCT00767325|592700091|FG000|Overall Study|No longer met study criteria|2|||
164092031|NCT00767325|592700091|FG000|Overall Study|Missed visit due to family reasons|1|||
164092032|NCT03538756|592700092|FG000|Long-Term Follow-up|Adverse Event|0|||
164092033|NCT03538756|592700093|FG001|Long-Term Follow-up|Adverse Event|0|||
164092034|NCT03538756|592700094|FG002|Long-Term Follow-up|Adverse Event|6|||
164092035|NCT03538756|592700092|FG000|Long-Term Follow-up|Death|0|||
164092036|NCT03538756|592700093|FG001|Long-Term Follow-up|Death|0|||
164092037|NCT03538756|592700094|FG002|Long-Term Follow-up|Death|1|||
164092038|NCT03538756|592700092|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
164092039|NCT03538756|592700093|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
164092040|NCT03538756|592700094|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
164092041|NCT03538756|592700092|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
164092042|NCT03538756|592700093|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
164092043|NCT03538756|592700094|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
164092044|NCT03538756|592700092|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
164092045|NCT03538756|592700093|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
164092046|NCT03538756|592700094|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
164092047|NCT00996736|592700095|FG000|Overall Study|Death|1|||
164092048|NCT00996736|592700096|FG001|Overall Study|Death|1|||
164092049|NCT00996736|592700095|FG000|Overall Study|Lost to Follow-up|15|||
164092050|NCT00996736|592700096|FG001|Overall Study|Lost to Follow-up|14|||
164092051|NCT00996736|592700095|FG000|Overall Study|Visit not within 3-month window|5|||
164092052|NCT00996736|592700096|FG001|Overall Study|Visit not within 3-month window|3|||
164092053|NCT02346201|592700097|FG000|Overall Study|Adverse Event|3|||
164092054|NCT02346201|592700098|FG001|Overall Study|Adverse Event|2|||
164092055|NCT02346201|592700097|FG000|Overall Study|Lost to Follow-up|1|||
164092056|NCT02346201|592700098|FG001|Overall Study|Lost to Follow-up|0|||
164092057|NCT02346201|592700097|FG000|Overall Study|Withdrawal by Subject|6|||
164092058|NCT02346201|592700098|FG001|Overall Study|Withdrawal by Subject|3|||
164092059|NCT02346201|592700097|FG000|Overall Study|Unavailable for future follow-up|0|||
164092060|NCT02346201|592700098|FG001|Overall Study|Unavailable for future follow-up|1|||
164092061|NCT02346201|592700097|FG000|Overall Study|Physician Decision|0|||
164092062|NCT02346201|592700098|FG001|Overall Study|Physician Decision|1|||
164092063|NCT02346201|592700097|FG000|Overall Study|Missed final visit|0|||
164092064|NCT02346201|592700098|FG001|Overall Study|Missed final visit|2|||
164092065|NCT00409578|592700101|FG000|Overall Study|Adverse Event|27|||
164092066|NCT00409578|592700102|FG001|Overall Study|Adverse Event|37|||
164092067|NCT00409578|592700103|FG002|Overall Study|Adverse Event|25|||
164092068|NCT00409578|592700104|FG003|Overall Study|Adverse Event|33|||
164092069|NCT00409578|592700101|FG000|Overall Study|Abnormal laboratory value(s)|2|||
164092070|NCT00409578|592700102|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164092071|NCT00409578|592700103|FG002|Overall Study|Abnormal laboratory value(s)|2|||
164092072|NCT00409578|592700104|FG003|Overall Study|Abnormal laboratory value(s)|4|||
164092073|NCT00409578|592700101|FG000|Overall Study|Lack of Efficacy|0|||
164092074|NCT00409578|592700102|FG001|Overall Study|Lack of Efficacy|0|||
164092075|NCT00409578|592700103|FG002|Overall Study|Lack of Efficacy|0|||
164092076|NCT00409578|592700104|FG003|Overall Study|Lack of Efficacy|2|||
164092077|NCT00409578|592700101|FG000|Overall Study|Subject no longer requires study drug|0|||
164092078|NCT00409578|592700102|FG001|Overall Study|Subject no longer requires study drug|0|||
164092079|NCT00409578|592700103|FG002|Overall Study|Subject no longer requires study drug|0|||
164092080|NCT00409578|592700104|FG003|Overall Study|Subject no longer requires study drug|1|||
164092081|NCT00409578|592700101|FG000|Overall Study|Withdrawal by Subject|8|||
164092082|NCT00409578|592700102|FG001|Overall Study|Withdrawal by Subject|15|||
164092083|NCT00409578|592700103|FG002|Overall Study|Withdrawal by Subject|16|||
164092084|NCT00409578|592700104|FG003|Overall Study|Withdrawal by Subject|17|||
164092085|NCT00409578|592700101|FG000|Overall Study|Lost to Follow-up|2|||
164011020|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164362739|NCT02153112|593704063|FG009|Overall Study|Lost to Follow-up|1|||
164362740|NCT02153112|593704054|FG000|Overall Study|Withdrawal by Subject|3|||
164362741|NCT02153112|593704055|FG001|Overall Study|Withdrawal by Subject|1|||
164362742|NCT02153112|593704056|FG002|Overall Study|Withdrawal by Subject|2|||
164362743|NCT02153112|593704057|FG003|Overall Study|Withdrawal by Subject|2|||
164362744|NCT02153112|593704058|FG004|Overall Study|Withdrawal by Subject|1|||
164362745|NCT02153112|593704059|FG005|Overall Study|Withdrawal by Subject|1|||
164362746|NCT02153112|593704060|FG006|Overall Study|Withdrawal by Subject|7|||
164362747|NCT02153112|593704061|FG007|Overall Study|Withdrawal by Subject|2|||
164362748|NCT02153112|593704062|FG008|Overall Study|Withdrawal by Subject|13|||
164362749|NCT02153112|593704063|FG009|Overall Study|Withdrawal by Subject|12|||
164011021|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164011022|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164011023|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
164011024|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011025|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
164011026|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
164011027|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011028|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011029|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011030|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011031|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011032|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
164011033|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011034|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
164011035|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011036|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011037|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011038|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011039|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011040|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011041|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
164011042|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011043|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
164011044|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
164011045|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011046|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011047|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011048|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011049|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011050|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
164011051|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011052|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
164011053|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
164362750|NCT02153112|593704054|FG000|Overall Study|Reason not Specified|0|||
164362751|NCT02153112|593704055|FG001|Overall Study|Reason not Specified|0|||
164362752|NCT02153112|593704056|FG002|Overall Study|Reason not Specified|0|||
164362753|NCT02153112|593704057|FG003|Overall Study|Reason not Specified|0|||
164362754|NCT02153112|593704058|FG004|Overall Study|Reason not Specified|0|||
164362755|NCT02153112|593704059|FG005|Overall Study|Reason not Specified|0|||
164362756|NCT02153112|593704060|FG006|Overall Study|Reason not Specified|0|||
164362757|NCT02153112|593704061|FG007|Overall Study|Reason not Specified|0|||
164362758|NCT02153112|593704062|FG008|Overall Study|Reason not Specified|1|||
164362759|NCT02153112|593704063|FG009|Overall Study|Reason not Specified|1|||
164011054|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011055|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011056|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011057|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011058|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011059|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
164011060|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011061|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011062|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
164011063|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
164362760|NCT00423150|593704064|FG000|Overall Study|Adverse Event|11|||
164362761|NCT00423150|593704064|FG000|Overall Study|Progression of disease being studied|69|||
164362762|NCT00423150|593704064|FG000|Overall Study|Withdrawal by Subject|1|||
164011064|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011065|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011066|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011067|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011068|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
164011069|NCT01380093|592405009|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011070|NCT01380093|592405010|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011071|NCT01380093|592405011|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
164011072|NCT01380093|592405012|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011073|NCT01380093|592405013|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011074|NCT01380093|592405014|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011075|NCT01380093|592405015|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011076|NCT01380093|592405016|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164011077|NCT01380093|592405017|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
164092086|NCT00409578|592700102|FG001|Overall Study|Lost to Follow-up|0|||
164011078|NCT01380093|592405009|FG000|Treatment Phase: Second Intervention|Other|0|||
164011079|NCT01380093|592405010|FG001|Treatment Phase: Second Intervention|Other|0|||
164092087|NCT00409578|592700103|FG002|Overall Study|Lost to Follow-up|2|||
164092088|NCT00409578|592700104|FG003|Overall Study|Lost to Follow-up|2|||
164092089|NCT00409578|592700101|FG000|Overall Study|Administrative problems|8|||
164092090|NCT00409578|592700102|FG001|Overall Study|Administrative problems|9|||
164092091|NCT00409578|592700103|FG002|Overall Study|Administrative problems|2|||
164092092|NCT00409578|592700104|FG003|Overall Study|Administrative problems|4|||
164092093|NCT00409578|592700101|FG000|Overall Study|Death|2|||
164092094|NCT00409578|592700102|FG001|Overall Study|Death|4|||
164092095|NCT00409578|592700103|FG002|Overall Study|Death|4|||
164092096|NCT00409578|592700104|FG003|Overall Study|Death|2|||
164092097|NCT00409578|592700101|FG000|Overall Study|Protocol Violation|3|||
164092098|NCT00409578|592700102|FG001|Overall Study|Protocol Violation|2|||
164092099|NCT00409578|592700103|FG002|Overall Study|Protocol Violation|3|||
164092100|NCT00409578|592700104|FG003|Overall Study|Protocol Violation|1|||
164092101|NCT00409578|592700101|FG000|Overall Study|Missing|0|||
164092102|NCT00409578|592700102|FG001|Overall Study|Missing|1|||
164092103|NCT00409578|592700103|FG002|Overall Study|Missing|0|||
164092104|NCT00409578|592700104|FG003|Overall Study|Missing|1|||
164092105|NCT05200858|592700105|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
164092106|NCT05200858|592700106|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
164092107|NCT05200858|592700107|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
164092108|NCT05200858|592700108|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
164092109|NCT02109133|592700109|FG000|Overall Study|Lost to Follow-up|1|||
164092110|NCT02109133|592700110|FG001|Overall Study|Lost to Follow-up|0|||
164092111|NCT02448771|592700111|FG000|Overall Study|Disease Progression|30|||
164092112|NCT02448771|592700111|FG000|Overall Study|Unacceptable Toxicity|1|||
164092113|NCT02448771|592700111|FG000|Overall Study|Physician Decision|3|||
164092114|NCT02448771|592700111|FG000|Overall Study|Started new therapy|2|||
164092115|NCT00770315|592700113|FG000|Overall Study|Adverse Event|11|||
164092116|NCT00770315|592700114|FG001|Overall Study|Adverse Event|17|||
164092117|NCT00770315|592700115|FG002|Overall Study|Adverse Event|16|||
164092118|NCT00770315|592700116|FG003|Overall Study|Adverse Event|6|||
164092119|NCT00770315|592700113|FG000|Overall Study|Lost to Follow-up|9|||
164092120|NCT00770315|592700114|FG001|Overall Study|Lost to Follow-up|5|||
164092121|NCT00770315|592700115|FG002|Overall Study|Lost to Follow-up|10|||
164092122|NCT00770315|592700116|FG003|Overall Study|Lost to Follow-up|3|||
164092123|NCT00770315|592700113|FG000|Overall Study|Withdrawal by Subject|13|||
164092124|NCT00770315|592700114|FG001|Overall Study|Withdrawal by Subject|17|||
164092125|NCT00770315|592700115|FG002|Overall Study|Withdrawal by Subject|24|||
164092126|NCT00770315|592700116|FG003|Overall Study|Withdrawal by Subject|20|||
164092127|NCT00770315|592700113|FG000|Overall Study|Noncompliance with Protocol|7|||
164092128|NCT00770315|592700114|FG001|Overall Study|Noncompliance with Protocol|4|||
164092129|NCT00770315|592700115|FG002|Overall Study|Noncompliance with Protocol|7|||
164092130|NCT00770315|592700116|FG003|Overall Study|Noncompliance with Protocol|9|||
164092131|NCT05771428|592701974|FG000|Overall Study|Adverse Event|0|||
164092132|NCT05771428|592701975|FG001|Overall Study|Adverse Event|1|||
164092133|NCT05771428|592701976|FG002|Overall Study|Adverse Event|1|||
164092134|NCT05771428|592701977|FG003|Overall Study|Adverse Event|1|||
164092135|NCT05771428|592701974|FG000|Overall Study|Withdrawal by Subject|3|||
164092136|NCT05771428|592701975|FG001|Overall Study|Withdrawal by Subject|2|||
164092137|NCT05771428|592701976|FG002|Overall Study|Withdrawal by Subject|1|||
164092138|NCT05771428|592701977|FG003|Overall Study|Withdrawal by Subject|4|||
164362763|NCT00423150|593704064|FG000|Overall Study|Non-compliance with protocol|1|||
164362764|NCT00423150|593704064|FG000|Overall Study|Administrative|4|||
164011080|NCT01380093|592405011|FG002|Treatment Phase: Second Intervention|Other|0|||
164092139|NCT05771428|592701974|FG000|Overall Study|Other|0|||
164092140|NCT05771428|592701975|FG001|Overall Study|Other|1|||
164092141|NCT05771428|592701976|FG002|Overall Study|Other|2|||
164092142|NCT05771428|592701977|FG003|Overall Study|Other|1|||
164092143|NCT05771428|592701974|FG000|Overall Study|Randomized but Not Treated|0|||
164092144|NCT05771428|592701975|FG001|Overall Study|Randomized but Not Treated|0|||
164092145|NCT05771428|592701976|FG002|Overall Study|Randomized but Not Treated|1|||
164092146|NCT05771428|592701977|FG003|Overall Study|Randomized but Not Treated|0|||
164092147|NCT04025229|592701978|FG000|Overall Study|Adverse Event|1|||
164092148|NCT04025229|592701979|FG001|Overall Study|Adverse Event|0|||
164092149|NCT04025229|592701978|FG000|Overall Study|Withdrawal by Subject|0|||
164092150|NCT04025229|592701979|FG001|Overall Study|Withdrawal by Subject|2|||
164092151|NCT04025229|592701978|FG000|Overall Study|Death|0|||
164092152|NCT04025229|592701979|FG001|Overall Study|Death|1|||
164092153|NCT04025229|592701978|FG000|Overall Study|Physician Decision|0|||
164092154|NCT04025229|592701979|FG001|Overall Study|Physician Decision|1|||
164092155|NCT03815942|592701980|FG000|Overall Study|Withdrawal by Subject|0|||
164092156|NCT03815942|592701981|FG001|Overall Study|Withdrawal by Subject|17|||
164092157|NCT01374919|592701982|FG000|Overall Study|Withdrawal by Subject|2|||
164092158|NCT00366899|592701983|FG000|Infant Series|Withdrawal by Subject|4|||
164092159|NCT00366899|592701984|FG001|Infant Series|Withdrawal by Subject|7|||
164092160|NCT00366899|592701983|FG000|Infant Series|Protocol Violation|2|||
164092161|NCT00366899|592701984|FG001|Infant Series|Protocol Violation|1|||
164092162|NCT00366899|592701983|FG000|Infant Series|Failed to return|1|||
164092163|NCT00366899|592701984|FG001|Infant Series|Failed to return|1|||
164092164|NCT00366899|592701983|FG000|Infant Series|Lost to Follow-up|0|||
164092165|NCT00366899|592701984|FG001|Infant Series|Lost to Follow-up|2|||
164092166|NCT00366899|592701983|FG000|Infant Series|Adverse Event|0|||
164092167|NCT00366899|592701984|FG001|Infant Series|Adverse Event|1|||
164092168|NCT00366899|592701983|FG000|Infant Series|Physician Decision|1|||
164092169|NCT00366899|592701984|FG001|Infant Series|Physician Decision|0|||
164092170|NCT00366899|592701983|FG000|Infant Series|Randomized but not consented|1|||
164092171|NCT00366899|592701984|FG001|Infant Series|Randomized but not consented|0|||
164092172|NCT00366899|592701983|FG000|After Infant Series|Lost to Follow-up|4|||
164092173|NCT00366899|592701984|FG001|After Infant Series|Lost to Follow-up|3|||
164362765|NCT05104567|593704066|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164011081|NCT01380093|592405012|FG003|Treatment Phase: Second Intervention|Other|1|||
164011082|NCT01380093|592405013|FG004|Treatment Phase: Second Intervention|Other|0|||
164011083|NCT01380093|592405014|FG005|Treatment Phase: Second Intervention|Other|0|||
164011084|NCT01380093|592405015|FG006|Treatment Phase: Second Intervention|Other|0|||
164011085|NCT01380093|592405016|FG007|Treatment Phase: Second Intervention|Other|0|||
164011086|NCT01380093|592405017|FG008|Treatment Phase: Second Intervention|Other|0|||
164011087|NCT01380093|592405009|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
164011088|NCT01380093|592405010|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
164011089|NCT01380093|592405011|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
164011090|NCT01380093|592405012|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
164011091|NCT01380093|592405013|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
164011092|NCT01380093|592405014|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
164011093|NCT01380093|592405015|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
164011094|NCT01380093|592405016|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
164011095|NCT01380093|592405017|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
164011096|NCT01380093|592405009|FG000|Treatment Phase: Third Intervention|Other|0|||
164011097|NCT01380093|592405010|FG001|Treatment Phase: Third Intervention|Other|0|||
164011098|NCT01380093|592405011|FG002|Treatment Phase: Third Intervention|Other|0|||
164011099|NCT01380093|592405012|FG003|Treatment Phase: Third Intervention|Other|0|||
164011100|NCT01380093|592405013|FG004|Treatment Phase: Third Intervention|Other|0|||
164011101|NCT01380093|592405014|FG005|Treatment Phase: Third Intervention|Other|0|||
164011102|NCT01380093|592405015|FG006|Treatment Phase: Third Intervention|Other|0|||
164011103|NCT01380093|592405016|FG007|Treatment Phase: Third Intervention|Other|0|||
164011104|NCT01380093|592405017|FG008|Treatment Phase: Third Intervention|Other|1|||
164011105|NCT03952650|592405018|FG000|Overall Study|TRAVEL|0|||
164011106|NCT03952650|592405019|FG001|Overall Study|TRAVEL|4|||
164092174|NCT00366899|592701983|FG000|After Infant Series|Withdrawal by Subject|1|||
164092175|NCT00366899|592701984|FG001|After Infant Series|Withdrawal by Subject|4|||
164092176|NCT00366899|592701983|FG000|After Infant Series|Adverse Event|1|||
164092177|NCT00366899|592701984|FG001|After Infant Series|Adverse Event|2|||
164092178|NCT00366899|592701983|FG000|After Infant Series|Protocol Violation|1|||
164092179|NCT00366899|592701984|FG001|After Infant Series|Protocol Violation|0|||
164092180|NCT00366899|592701983|FG000|Toddler Dose|Withdrawal by Subject|1|||
164092181|NCT00366899|592701984|FG001|Toddler Dose|Withdrawal by Subject|1|||
164092182|NCT00366899|592701983|FG000|Toddler Dose|Protocol Violation|1|||
164092183|NCT00366899|592701984|FG001|Toddler Dose|Protocol Violation|0|||
164092184|NCT03311646|592701991|FG000|Overall Study|Physician Decision|1|||
164092185|NCT03311646|592701991|FG000|Overall Study|Withdrawal by Subject|5|||
164011107|NCT03952650|592405020|FG002|Overall Study|TRAVEL|0|||
164011108|NCT03952650|592405021|FG003|Overall Study|TRAVEL|4|||
164011109|NCT03952650|592405022|FG004|Overall Study|TRAVEL|0|||
164011110|NCT03952650|592405023|FG005|Overall Study|TRAVEL|3|||
164092186|NCT03311646|592701991|FG000|Overall Study|Lost to Follow-up|5|||
164092187|NCT03311646|592701991|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
164011111|NCT03952650|592405024|FG006|Overall Study|TRAVEL|2|||
164011112|NCT03952650|592405018|FG000|Overall Study|Withdrawal by Subject|0|||
164011113|NCT03952650|592405019|FG001|Overall Study|Withdrawal by Subject|2|||
164011114|NCT03952650|592405020|FG002|Overall Study|Withdrawal by Subject|0|||
164011115|NCT03952650|592405021|FG003|Overall Study|Withdrawal by Subject|3|||
164011116|NCT03952650|592405022|FG004|Overall Study|Withdrawal by Subject|0|||
164011117|NCT03952650|592405023|FG005|Overall Study|Withdrawal by Subject|1|||
164011118|NCT03952650|592405024|FG006|Overall Study|Withdrawal by Subject|1|||
164011119|NCT03952650|592405018|FG000|Overall Study|Lost to Follow-up|0|||
164011120|NCT03952650|592405019|FG001|Overall Study|Lost to Follow-up|1|||
164011121|NCT03952650|592405020|FG002|Overall Study|Lost to Follow-up|0|||
164011122|NCT03952650|592405021|FG003|Overall Study|Lost to Follow-up|0|||
164011123|NCT03952650|592405022|FG004|Overall Study|Lost to Follow-up|0|||
164011124|NCT03952650|592405023|FG005|Overall Study|Lost to Follow-up|1|||
164011125|NCT03952650|592405024|FG006|Overall Study|Lost to Follow-up|1|||
164011126|NCT03952650|592405018|FG000|Overall Study|Received wrong vaccine and travelled|0|||
164011127|NCT03952650|592405019|FG001|Overall Study|Received wrong vaccine and travelled|0|||
164011128|NCT03952650|592405020|FG002|Overall Study|Received wrong vaccine and travelled|0|||
164011129|NCT03952650|592405021|FG003|Overall Study|Received wrong vaccine and travelled|0|||
164011130|NCT03952650|592405022|FG004|Overall Study|Received wrong vaccine and travelled|0|||
164011131|NCT03952650|592405023|FG005|Overall Study|Received wrong vaccine and travelled|1|||
164011132|NCT03952650|592405024|FG006|Overall Study|Received wrong vaccine and travelled|0|||
164011133|NCT03952650|592405018|FG000|Overall Study|Unable to make study visit|0|||
164011134|NCT03952650|592405019|FG001|Overall Study|Unable to make study visit|0|||
164011135|NCT03952650|592405020|FG002|Overall Study|Unable to make study visit|0|||
164011136|NCT03952650|592405021|FG003|Overall Study|Unable to make study visit|0|||
164011137|NCT03952650|592405022|FG004|Overall Study|Unable to make study visit|0|||
164011138|NCT03952650|592405023|FG005|Overall Study|Unable to make study visit|1|||
164011139|NCT03952650|592405024|FG006|Overall Study|Unable to make study visit|0|||
164011140|NCT00771030|592405027|FG000|Overall Study|Adverse Event|0|||
164011141|NCT00771030|592405028|FG001|Overall Study|Adverse Event|1|||
164011142|NCT00771030|592405029|FG002|Overall Study|Adverse Event|0|||
164011143|NCT00771030|592405030|FG003|Overall Study|Adverse Event|0|||
164011144|NCT00771030|592405031|FG004|Overall Study|Adverse Event|0|||
164011145|NCT00771030|592405032|FG005|Overall Study|Adverse Event|0|||
164011146|NCT00771030|592405033|FG006|Overall Study|Adverse Event|0|||
164011147|NCT01022853|592405040|FG000|Overall Study|Progressive disease|2|||
164011148|NCT01022853|592405041|FG001|Overall Study|Progressive disease|3|||
164011149|NCT01022853|592405042|FG002|Overall Study|Progressive disease|11|||
164011150|NCT01022853|592405043|FG003|Overall Study|Progressive disease|7|||
164011151|NCT01022853|592405044|FG004|Overall Study|Progressive disease|1|||
164011152|NCT01022853|592405040|FG000|Overall Study|Dose-limiting toxicity|0|||
164011153|NCT01022853|592405041|FG001|Overall Study|Dose-limiting toxicity|0|||
164011154|NCT01022853|592405042|FG002|Overall Study|Dose-limiting toxicity|0|||
164011155|NCT01022853|592405043|FG003|Overall Study|Dose-limiting toxicity|0|||
164011156|NCT01022853|592405044|FG004|Overall Study|Dose-limiting toxicity|1|||
164011157|NCT01022853|592405040|FG000|Overall Study|Withdrawal by Subject|0|||
164011158|NCT01022853|592405041|FG001|Overall Study|Withdrawal by Subject|1|||
164011159|NCT01022853|592405042|FG002|Overall Study|Withdrawal by Subject|1|||
164011160|NCT01022853|592405043|FG003|Overall Study|Withdrawal by Subject|1|||
164011161|NCT01022853|592405044|FG004|Overall Study|Withdrawal by Subject|0|||
164011162|NCT01022853|592405040|FG000|Overall Study|Other not stated above|1|||
164011163|NCT01022853|592405041|FG001|Overall Study|Other not stated above|0|||
164011164|NCT01022853|592405042|FG002|Overall Study|Other not stated above|1|||
164011165|NCT01022853|592405043|FG003|Overall Study|Other not stated above|0|||
164011166|NCT01022853|592405044|FG004|Overall Study|Other not stated above|0|||
164011167|NCT01651052|592405045|FG000|Overall Study|Death|21|||
164011168|NCT01651052|592405045|FG000|Overall Study|Explant|1|||
164011169|NCT01651052|592405045|FG000|Overall Study|Withdrawal by Subject|1|||
164011170|NCT01651052|592405045|FG000|Overall Study|Lost to Follow-up|3|||
164011171|NCT03503773|592405046|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
164011172|NCT03503773|592405047|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
164011173|NCT03503773|592405046|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
164011174|NCT03503773|592405047|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
164011175|NCT03503773|592405046|FG000|Overall Study|Not completing the primary ABPM|3|||
164011176|NCT03503773|592405047|FG001|Overall Study|Not completing the primary ABPM|1|||
164011177|NCT03503773|592405046|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164011178|NCT03503773|592405047|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164011179|NCT02498821|592405051|FG000|Overall Study|Screen failure|3|||
164011180|NCT02498821|592405052|FG001|Overall Study|Screen failure|5|||
164011181|NCT04156646|592405059|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
164011182|NCT04156646|592405060|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
164011183|NCT01208181|592405061|FG000|Part 1|Withdrawal by Subject|11|||
164011184|NCT01208181|592405062|FG001|Part 1|Withdrawal by Subject|10|||
164362766|NCT05104567|593704067|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
164362767|NCT05104567|593704068|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362768|NCT05104567|593704069|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362769|NCT05104567|593704070|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362770|NCT05104567|593704071|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362771|NCT05104567|593704072|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
164362772|NCT05104567|593704066|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
164362773|NCT05104567|593704067|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
164362774|NCT05104567|593704068|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
164362775|NCT05104567|593704069|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
164362776|NCT05104567|593704070|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
164362777|NCT05104567|593704071|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
164362778|NCT05104567|593704072|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
164362779|NCT05104567|593704066|FG000|Overall Study|Progressive disease|3|||
164362780|NCT05104567|593704067|FG001|Overall Study|Progressive disease|13|||
164362781|NCT05104567|593704068|FG002|Overall Study|Progressive disease|13|||
164362782|NCT05104567|593704069|FG003|Overall Study|Progressive disease|17|||
164362783|NCT05104567|593704070|FG004|Overall Study|Progressive disease|17|||
164362784|NCT05104567|593704071|FG005|Overall Study|Progressive disease|28|||
164362785|NCT05104567|593704072|FG006|Overall Study|Progressive disease|24|||
164362786|NCT05104567|593704066|FG000|Overall Study|Withdrawal by Subject|1|||
164362787|NCT05104567|593704067|FG001|Overall Study|Withdrawal by Subject|1|||
164362788|NCT05104567|593704068|FG002|Overall Study|Withdrawal by Subject|2|||
164362789|NCT05104567|593704069|FG003|Overall Study|Withdrawal by Subject|0|||
164362790|NCT05104567|593704070|FG004|Overall Study|Withdrawal by Subject|0|||
164362791|NCT05104567|593704071|FG005|Overall Study|Withdrawal by Subject|0|||
164362792|NCT05104567|593704072|FG006|Overall Study|Withdrawal by Subject|0|||
164362793|NCT05104567|593704066|FG000|Overall Study|Other|1|||
164362794|NCT05104567|593704067|FG001|Overall Study|Other|1|||
164362795|NCT05104567|593704068|FG002|Overall Study|Other|1|||
164362796|NCT05104567|593704069|FG003|Overall Study|Other|0|||
164362797|NCT05104567|593704070|FG004|Overall Study|Other|0|||
164362798|NCT05104567|593704071|FG005|Overall Study|Other|0|||
164362799|NCT05104567|593704072|FG006|Overall Study|Other|0|||
164362800|NCT01464346|593704073|FG000|Overall Study|Withdrawal by Subject|0|||
164362801|NCT01464346|593704074|FG001|Overall Study|Withdrawal by Subject|0|||
164362802|NCT01464346|593704075|FG002|Overall Study|Withdrawal by Subject|1|||
164362803|NCT03999892|593704076|FG000|Overall Study|Lost to Follow-up|1|||
164362804|NCT01848756|593704077|FG000|Overall Study|Adverse Event|1|||
164362805|NCT01848756|593704077|FG000|Overall Study|Withdrawal by Subject|1|||
164362806|NCT01848756|593704077|FG000|Overall Study|Enrolled in Error|1|||
164362807|NCT01286012|593704078|FG000|Overall Study|Adverse Event|3|||
164362808|NCT01286012|593704079|FG001|Overall Study|Adverse Event|3|||
164362809|NCT01286012|593704078|FG000|Overall Study|Death|2|||
164362810|NCT01286012|593704079|FG001|Overall Study|Death|3|||
164362811|NCT01286012|593704078|FG000|Overall Study|Protocol Violation|1|||
164362812|NCT01286012|593704079|FG001|Overall Study|Protocol Violation|1|||
164362813|NCT01286012|593704078|FG000|Overall Study|Withdrawal by Subject|4|||
164362814|NCT01286012|593704079|FG001|Overall Study|Withdrawal by Subject|4|||
164362815|NCT01286012|593704078|FG000|Overall Study|Physician Decision|2|||
164362816|NCT01286012|593704079|FG001|Overall Study|Physician Decision|0|||
164362817|NCT01286012|593704078|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
164362818|NCT01286012|593704079|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
164362819|NCT04056195|593704082|FG000|Overall Study|Adverse Event|1|||
164362820|NCT04056195|593704083|FG001|Overall Study|Adverse Event|0|||
164362821|NCT04056195|593704084|FG002|Overall Study|Adverse Event|0|||
164362822|NCT04056195|593704082|FG000|Overall Study|Withdrawal by Subject|0|||
164362823|NCT04056195|593704083|FG001|Overall Study|Withdrawal by Subject|1|||
164362824|NCT04056195|593704084|FG002|Overall Study|Withdrawal by Subject|1|||
164362825|NCT04056195|593704082|FG000|Overall Study|Physician Decision|1|||
164362826|NCT04056195|593704083|FG001|Overall Study|Physician Decision|1|||
164362827|NCT04056195|593704084|FG002|Overall Study|Physician Decision|1|||
164362828|NCT01498458|593704085|FG000|Overall Study|Adverse Event|4|||
164362829|NCT01498458|593704085|FG000|Overall Study|Physician Decision|3|||
164362830|NCT02226003|593704086|FG000|Overall Study|Lost to Follow-up|2|||
164362831|NCT02226003|593704087|FG001|Overall Study|Lost to Follow-up|1|||
164362832|NCT02226003|593704088|FG002|Overall Study|Lost to Follow-up|3|||
164362833|NCT02226003|593704086|FG000|Overall Study|Withdrawal by Subject|0|||
164362834|NCT02226003|593704087|FG001|Overall Study|Withdrawal by Subject|0|||
164362835|NCT02226003|593704088|FG002|Overall Study|Withdrawal by Subject|3|||
164362836|NCT03279692|593704094|FG000|Overall Study|Withdrawal by Subject|1|||
164362837|NCT02446990|593704095|FG000|Overall Study|Death|485|||
164362838|NCT02446990|593704096|FG001|Overall Study|Death|458|||
164362839|NCT02446990|593704095|FG000|Overall Study|Lost to Follow-up|3|||
164362840|NCT02446990|593704096|FG001|Overall Study|Lost to Follow-up|1|||
164362841|NCT02446990|593704095|FG000|Overall Study|Physician Decision|1|||
164362842|NCT02446990|593704096|FG001|Overall Study|Physician Decision|0|||
164362843|NCT02446990|593704095|FG000|Overall Study|Withdrawal by Subject|231|||
164362844|NCT02446990|593704096|FG001|Overall Study|Withdrawal by Subject|199|||
164362845|NCT01064401|593704097|FG000|Overall Study|Adverse Event|47|||
164362846|NCT01064401|593704098|FG001|Overall Study|Adverse Event|56|||
164362847|NCT01064401|593704097|FG000|Overall Study|Lack of Efficacy|46|||
164362848|NCT01064401|593704098|FG001|Overall Study|Lack of Efficacy|23|||
164362849|NCT01064401|593704097|FG000|Overall Study|Lost to Follow-up|12|||
164362850|NCT01064401|593704098|FG001|Overall Study|Lost to Follow-up|9|||
164362851|NCT01064401|593704097|FG000|Overall Study|Consent Withdrawn|98|||
164362852|NCT01064401|593704098|FG001|Overall Study|Consent Withdrawn|80|||
164362853|NCT01064401|593704097|FG000|Overall Study|Investigator Decision|4|||
164362854|NCT01064401|593704098|FG001|Overall Study|Investigator Decision|6|||
164362855|NCT01064401|593704097|FG000|Overall Study|Death|4|||
164362856|NCT01064401|593704098|FG001|Overall Study|Death|0|||
164362857|NCT01064401|593704097|FG000|Overall Study|Pregnancy|4|||
164362858|NCT01064401|593704098|FG001|Overall Study|Pregnancy|7|||
164362859|NCT01064401|593704097|FG000|Overall Study|Noncompliance|7|||
164362860|NCT01064401|593704098|FG001|Overall Study|Noncompliance|8|||
164362861|NCT01064401|593704097|FG000|Overall Study|Site Closure|4|||
164362862|NCT01064401|593704098|FG001|Overall Study|Site Closure|5|||
164362863|NCT01064401|593704097|FG000|Overall Study|Other|2|||
164362864|NCT01064401|593704098|FG001|Overall Study|Other|1|||
164011185|NCT01208181|592405063|FG002|Part 1|Withdrawal by Subject|0|||
164011186|NCT01208181|592405064|FG003|Part 1|Withdrawal by Subject|0|||
164011187|NCT01208181|592405065|FG004|Part 1|Withdrawal by Subject|0|||
164011188|NCT01208181|592405061|FG000|Part 1|Technical problem|5|||
164011189|NCT01208181|592405062|FG001|Part 1|Technical problem|0|||
164011190|NCT01208181|592405063|FG002|Part 1|Technical problem|0|||
164011191|NCT01208181|592405064|FG003|Part 1|Technical problem|0|||
164011192|NCT01208181|592405065|FG004|Part 1|Technical problem|0|||
164011193|NCT01208181|592405061|FG000|Part 1|Protocol Violation|10|||
164011194|NCT01208181|592405062|FG001|Part 1|Protocol Violation|5|||
164011195|NCT01208181|592405063|FG002|Part 1|Protocol Violation|0|||
164011196|NCT01208181|592405064|FG003|Part 1|Protocol Violation|0|||
164011197|NCT01208181|592405065|FG004|Part 1|Protocol Violation|0|||
164011198|NCT01208181|592405061|FG000|Part 1|Physician Decision|4|||
164011199|NCT01208181|592405062|FG001|Part 1|Physician Decision|0|||
164362865|NCT04439253|593705884|FG000|Overall Study|Adverse Event|1|||
164362866|NCT04439253|593705884|FG000|Overall Study|Disease progression|2|||
164362867|NCT04439253|593705884|FG000|Overall Study|Complicating disease|1|||
164011200|NCT01208181|592405063|FG002|Part 1|Physician Decision|0|||
164011201|NCT01208181|592405064|FG003|Part 1|Physician Decision|0|||
164011202|NCT01208181|592405065|FG004|Part 1|Physician Decision|0|||
164011203|NCT01208181|592405061|FG000|Part 1|Non-compliance with study drug|1|||
164011204|NCT01208181|592405062|FG001|Part 1|Non-compliance with study drug|1|||
164362868|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
164362869|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
164362870|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
164362871|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
164362872|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
164362873|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
164362874|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
164362875|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
164362876|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
164362877|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
164362878|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
164362879|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
164011205|NCT01208181|592405063|FG002|Part 1|Non-compliance with study drug|0|||
164011206|NCT01208181|592405064|FG003|Part 1|Non-compliance with study drug|0|||
164011207|NCT01208181|592405065|FG004|Part 1|Non-compliance with study drug|0|||
164011208|NCT01208181|592405061|FG000|Part 1|Lost to Follow-up|5|||
164362880|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
164362881|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
164362882|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
164362883|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
164362884|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
164362885|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
164011209|NCT01208181|592405062|FG001|Part 1|Lost to Follow-up|3|||
164011210|NCT01208181|592405063|FG002|Part 1|Lost to Follow-up|0|||
164011211|NCT01208181|592405064|FG003|Part 1|Lost to Follow-up|0|||
164011212|NCT01208181|592405065|FG004|Part 1|Lost to Follow-up|1|||
164011213|NCT01208181|592405061|FG000|Part 1|Lack of Efficacy|37|||
164011214|NCT01208181|592405062|FG001|Part 1|Lack of Efficacy|12|||
164362886|NCT00887354|593705887|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
164362887|NCT00887354|593705888|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
164362888|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
164362889|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
164362890|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
164362891|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
164362892|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
164362893|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
164362894|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
164362895|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
164362896|NCT00887354|593705887|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
164362897|NCT00887354|593705888|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
164362898|NCT00192504|593705891|FG000|Overall Study|Lost to Follow-up|1|||
164362899|NCT00192504|593705892|FG001|Overall Study|Lost to Follow-up|0|||
164362900|NCT00192504|593705893|FG002|Overall Study|Lost to Follow-up|0|||
164362901|NCT00192504|593705894|FG003|Overall Study|Lost to Follow-up|0|||
164362902|NCT00192504|593705891|FG000|Overall Study|Dosing window missed|0|||
164362903|NCT00192504|593705892|FG001|Overall Study|Dosing window missed|0|||
164362904|NCT00192504|593705893|FG002|Overall Study|Dosing window missed|1|||
164362905|NCT00192504|593705894|FG003|Overall Study|Dosing window missed|0|||
164362906|NCT00542919|593705897|FG000|Overall Study|Adverse Event|1|||
164362907|NCT00542919|593705898|FG001|Overall Study|Adverse Event|5|||
164362908|NCT00542919|593705899|FG002|Overall Study|Adverse Event|1|||
164362909|NCT00542919|593705897|FG000|Overall Study|Withdrawal by Subject|1|||
164011215|NCT01208181|592405063|FG002|Part 1|Lack of Efficacy|0|||
164011216|NCT01208181|592405064|FG003|Part 1|Lack of Efficacy|0|||
164011217|NCT01208181|592405065|FG004|Part 1|Lack of Efficacy|17|||
164011218|NCT01208181|592405061|FG000|Part 1|Adverse Event|26|||
164011219|NCT01208181|592405062|FG001|Part 1|Adverse Event|24|||
164362910|NCT00542919|593705898|FG001|Overall Study|Withdrawal by Subject|0|||
164362911|NCT00542919|593705899|FG002|Overall Study|Withdrawal by Subject|3|||
164362912|NCT00542919|593705897|FG000|Overall Study|Physician Decision|2|||
164362913|NCT00542919|593705898|FG001|Overall Study|Physician Decision|2|||
164362914|NCT00542919|593705899|FG002|Overall Study|Physician Decision|1|||
164362915|NCT00542919|593705897|FG000|Overall Study|Sponsor Decision|1|||
164362916|NCT00542919|593705898|FG001|Overall Study|Sponsor Decision|0|||
164362917|NCT00542919|593705899|FG002|Overall Study|Sponsor Decision|0|||
164362918|NCT00542919|593705897|FG000|Overall Study|Lost to Follow-up|2|||
164362919|NCT00542919|593705898|FG001|Overall Study|Lost to Follow-up|0|||
164011220|NCT01208181|592405063|FG002|Part 1|Adverse Event|0|||
164362920|NCT00542919|593705899|FG002|Overall Study|Lost to Follow-up|1|||
164362921|NCT05123222|593705906|FG000|Overall Study|Lost to Follow-up|2|||
164362922|NCT05123222|593705907|FG001|Overall Study|Lost to Follow-up|0|||
164362923|NCT05123222|593705908|FG002|Overall Study|Lost to Follow-up|0|||
164362924|NCT05123222|593705909|FG003|Overall Study|Lost to Follow-up|0|||
164011221|NCT01208181|592405064|FG003|Part 1|Adverse Event|0|||
164362925|NCT05123222|593705906|FG000|Overall Study|Protocol Violation|0|||
164011222|NCT01208181|592405065|FG004|Part 1|Adverse Event|4|||
164011223|NCT01208181|592405061|FG000|Part 2|Adverse Event|0|||
164362926|NCT05123222|593705907|FG001|Overall Study|Protocol Violation|0|||
164011224|NCT01208181|592405062|FG001|Part 2|Adverse Event|0|||
164011225|NCT01208181|592405063|FG002|Part 2|Adverse Event|6|||
164011226|NCT01208181|592405064|FG003|Part 2|Adverse Event|7|||
164011227|NCT01208181|592405065|FG004|Part 2|Adverse Event|0|||
164011228|NCT01208181|592405061|FG000|Part 2|Withdrawal by Subject|0|||
164011229|NCT01208181|592405062|FG001|Part 2|Withdrawal by Subject|0|||
164011230|NCT01208181|592405063|FG002|Part 2|Withdrawal by Subject|1|||
164011231|NCT01208181|592405064|FG003|Part 2|Withdrawal by Subject|1|||
164011232|NCT01208181|592405065|FG004|Part 2|Withdrawal by Subject|0|||
164011233|NCT01208181|592405061|FG000|Part 2|Protocol Violation|0|||
164362927|NCT05123222|593705908|FG002|Overall Study|Protocol Violation|1|||
164362928|NCT05123222|593705909|FG003|Overall Study|Protocol Violation|0|||
164362929|NCT02535741|593705910|FG000|Overall Study|Adverse Event|3|||
164011234|NCT01208181|592405062|FG001|Part 2|Protocol Violation|0|||
164011235|NCT01208181|592405063|FG002|Part 2|Protocol Violation|1|||
164011236|NCT01208181|592405064|FG003|Part 2|Protocol Violation|0|||
164011237|NCT01208181|592405065|FG004|Part 2|Protocol Violation|0|||
164011238|NCT01208181|592405061|FG000|Part 2|Physician Decision|0|||
164011239|NCT01208181|592405062|FG001|Part 2|Physician Decision|0|||
164011240|NCT01208181|592405063|FG002|Part 2|Physician Decision|1|||
164011241|NCT01208181|592405064|FG003|Part 2|Physician Decision|2|||
164011242|NCT01208181|592405065|FG004|Part 2|Physician Decision|0|||
164011243|NCT01208181|592405061|FG000|Part 2|Non-compliance with study drug|0|||
164011244|NCT01208181|592405062|FG001|Part 2|Non-compliance with study drug|0|||
164011245|NCT01208181|592405063|FG002|Part 2|Non-compliance with study drug|1|||
164011246|NCT01208181|592405064|FG003|Part 2|Non-compliance with study drug|1|||
164011247|NCT01208181|592405065|FG004|Part 2|Non-compliance with study drug|0|||
164011248|NCT01208181|592405061|FG000|Part 2|Lost to Follow-up|0|||
164011249|NCT01208181|592405062|FG001|Part 2|Lost to Follow-up|0|||
164011250|NCT01208181|592405063|FG002|Part 2|Lost to Follow-up|1|||
164011251|NCT01208181|592405064|FG003|Part 2|Lost to Follow-up|2|||
164362930|NCT02535741|593705910|FG000|Overall Study|Withdrawal by Subject|9|||
164092188|NCT00531206|592701994|FG000|Overall Study|Adverse Event related|5|||
164092189|NCT00531206|592701994|FG000|Overall Study|Lack of Efficacy|2|||
164092190|NCT00531206|592701994|FG000|Overall Study|Lost to Follow-up|5|||
164092191|NCT00531206|592701994|FG000|Overall Study|including non-related adverse events|8|||
164092192|NCT01439165|592702005|FG000|Overall Study|Protocol Violation|3|||
164092193|NCT01439165|592702006|FG001|Overall Study|Protocol Violation|0|||
164092194|NCT01439165|592702005|FG000|Overall Study|Lost to Follow-up|11|||
164092195|NCT01439165|592702006|FG001|Overall Study|Lost to Follow-up|1|||
164092196|NCT01439165|592702005|FG000|Overall Study|Withdrawal by Subject|7|||
164092197|NCT01439165|592702006|FG001|Overall Study|Withdrawal by Subject|1|||
164092198|NCT03331042|592702007|FG000|Overall Study|Protocol Violation|1|||
164092199|NCT03331042|592702008|FG001|Overall Study|Protocol Violation|0|||
164362931|NCT02535741|593705910|FG000|Overall Study|Lost to Follow-up|10|||
164362932|NCT02535741|593705910|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
164362933|NCT02535741|593705910|FG000|Overall Study|Missing data|6|||
164362934|NCT03020823|593705913|FG000|Overall Study|Physician Decision|4|||
164362935|NCT03020823|593705913|FG000|Overall Study|Lack of Efficacy|4|||
164362936|NCT03020823|593705913|FG000|Overall Study|Adverse Event|2|||
164092200|NCT03331042|592702009|FG002|Overall Study|Protocol Violation|0|||
164092201|NCT03331042|592702010|FG003|Overall Study|Protocol Violation|0|||
164092202|NCT03331042|592702007|FG000|Overall Study|Physician Decision|0|||
164092203|NCT03331042|592702008|FG001|Overall Study|Physician Decision|0|||
164092204|NCT03331042|592702009|FG002|Overall Study|Physician Decision|1|||
164092205|NCT03331042|592702010|FG003|Overall Study|Physician Decision|0|||
164092206|NCT03331042|592702007|FG000|Overall Study|Lost to Follow-up|0|||
164092207|NCT03331042|592702008|FG001|Overall Study|Lost to Follow-up|0|||
164092208|NCT03331042|592702009|FG002|Overall Study|Lost to Follow-up|0|||
164092209|NCT03331042|592702010|FG003|Overall Study|Lost to Follow-up|1|||
164362937|NCT03739112|593705914|FG000|Overall Study|Adverse Event|2|||
164362938|NCT03739112|593705915|FG001|Overall Study|Adverse Event|2|||
164362939|NCT03739112|593705914|FG000|Overall Study|Withdrawal by Subject|38|||
164362940|NCT03739112|593705915|FG001|Overall Study|Withdrawal by Subject|19|||
164362941|NCT03739112|593705914|FG000|Overall Study|Lost to Follow-up|31|||
164362942|NCT03739112|593705915|FG001|Overall Study|Lost to Follow-up|33|||
164362943|NCT03739112|593705914|FG000|Overall Study|Protocol Deviation|12|||
164362944|NCT03739112|593705915|FG001|Overall Study|Protocol Deviation|9|||
164362945|NCT03739112|593705914|FG000|Overall Study|Physician Decision|1|||
164362946|NCT03739112|593705915|FG001|Overall Study|Physician Decision|0|||
164362947|NCT03739112|593705914|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
164362948|NCT03739112|593705915|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
164362949|NCT03739112|593705914|FG000|Overall Study|Site went on hold|65|||
164362950|NCT03739112|593705915|FG001|Overall Study|Site went on hold|67|||
164362951|NCT03739112|593705914|FG000|Overall Study|Other than specified|8|||
164362952|NCT03739112|593705915|FG001|Overall Study|Other than specified|5|||
164362953|NCT03739112|593705914|FG000|Overall Study|Randomized but not vaccinated|31|||
164362954|NCT03739112|593705915|FG001|Overall Study|Randomized but not vaccinated|25|||
164362955|NCT00588822|593705917|FG000|Overall Study|progression of disease|8|||
164362956|NCT01727141|593705921|FG000|Overall Study|Physician Decision|0|||
164362957|NCT01727141|593705922|FG001|Overall Study|Physician Decision|1|||
164362958|NCT01727141|593705923|FG002|Overall Study|Physician Decision|0|||
164362959|NCT01727141|593705924|FG003|Overall Study|Physician Decision|2|||
164362960|NCT01727141|593705921|FG000|Overall Study|Lost to Follow-up|0|||
164362961|NCT01727141|593705922|FG001|Overall Study|Lost to Follow-up|2|||
164362962|NCT01727141|593705923|FG002|Overall Study|Lost to Follow-up|0|||
164362963|NCT01727141|593705924|FG003|Overall Study|Lost to Follow-up|0|||
164362964|NCT01727141|593705921|FG000|Overall Study|Death|0|||
164092210|NCT00755196|592702012|FG000|Overall Study|Lost to Follow-up|1|||
164092211|NCT00755196|592702012|FG000|Overall Study|Lack of Efficiency|1|||
164092212|NCT02388763|592702013|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
164092213|NCT02388763|592702014|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
164092214|NCT02388763|592702013|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
164092215|NCT02388763|592702014|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
164092216|NCT01604850|592702015|FG000|Overall Study|Enrolled but never treated|0|||
164092217|NCT01604850|592702016|FG001|Overall Study|Enrolled but never treated|1|||
164362965|NCT01727141|593705922|FG001|Overall Study|Death|1|||
164092218|NCT01604850|592702015|FG000|Overall Study|Efficacy Failure|50|||
164092219|NCT01604850|592702016|FG001|Overall Study|Efficacy Failure|29|||
164092220|NCT01604850|592702015|FG000|Overall Study|Lost to Follow-up|1|||
164362966|NCT01727141|593705923|FG002|Overall Study|Death|1|||
164362967|NCT01727141|593705924|FG003|Overall Study|Death|1|||
164362968|NCT01727141|593705921|FG000|Overall Study|Protocol deviation|1|||
164362969|NCT01727141|593705922|FG001|Overall Study|Protocol deviation|1|||
164092221|NCT01604850|592702016|FG001|Overall Study|Lost to Follow-up|0|||
164362970|NCT01727141|593705923|FG002|Overall Study|Protocol deviation|0|||
164362971|NCT01727141|593705924|FG003|Overall Study|Protocol deviation|1|||
164362972|NCT01727141|593705921|FG000|Overall Study|Withdrawal by Subject|4|||
164362973|NCT01727141|593705922|FG001|Overall Study|Withdrawal by Subject|4|||
164362974|NCT01727141|593705923|FG002|Overall Study|Withdrawal by Subject|2|||
164362975|NCT01727141|593705924|FG003|Overall Study|Withdrawal by Subject|11|||
164362976|NCT01957462|593705925|FG000|Test Period 1|Withdrawal by Subject|1|||
164362977|NCT01957462|593705926|FG001|Test Period 1|Withdrawal by Subject|0|||
164362978|NCT01957462|593705925|FG000|Test Period 1|Adverse Event|1|||
164362979|NCT01957462|593705926|FG001|Test Period 1|Adverse Event|0|||
164362980|NCT03102918|593705929|FG000|Overall Study|Protocol Violation|1|||
164362981|NCT03102918|593705930|FG001|Overall Study|Protocol Violation|0|||
164362982|NCT04765358|593705931|FG000|Overall Study|Withdrawal by Subject|1|||
164362983|NCT01652664|593705932|FG000|Overall Study|Treatment Failure|5|||
164362984|NCT01652664|593705933|FG001|Overall Study|Treatment Failure|1|||
164362985|NCT01652664|593705932|FG000|Overall Study|Inadequate IOP control|1|||
164362986|NCT01652664|593705933|FG001|Overall Study|Inadequate IOP control|0|||
164362987|NCT00491387|593705935|FG000|Overall Study|study terminated|20|||
164362988|NCT02063854|593705942|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
164362989|NCT02063854|593705943|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
164362990|NCT02063854|593705944|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
164362991|NCT02063854|593705945|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
164362992|NCT02063854|593705946|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
164362993|NCT02063854|593705947|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
164362994|NCT02063854|593705948|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
164362995|NCT02063854|593705942|FG000|Overall Study|Major Protocol Deviation|0|||
164362996|NCT02063854|593705943|FG001|Overall Study|Major Protocol Deviation|0|||
164362997|NCT02063854|593705944|FG002|Overall Study|Major Protocol Deviation|3|||
164362998|NCT02063854|593705945|FG003|Overall Study|Major Protocol Deviation|0|||
164362999|NCT02063854|593705946|FG004|Overall Study|Major Protocol Deviation|0|||
164363000|NCT02063854|593705947|FG005|Overall Study|Major Protocol Deviation|0|||
164363001|NCT02063854|593705948|FG006|Overall Study|Major Protocol Deviation|0|||
164363002|NCT02063854|593705942|FG000|Overall Study|Voluntary Withdrawal|2|||
164363003|NCT02063854|593705943|FG001|Overall Study|Voluntary Withdrawal|0|||
164363004|NCT02063854|593705944|FG002|Overall Study|Voluntary Withdrawal|8|||
164363005|NCT02063854|593705945|FG003|Overall Study|Voluntary Withdrawal|1|||
164363006|NCT02063854|593705946|FG004|Overall Study|Voluntary Withdrawal|3|||
164363007|NCT02063854|593705947|FG005|Overall Study|Voluntary Withdrawal|6|||
164363008|NCT02063854|593705948|FG006|Overall Study|Voluntary Withdrawal|1|||
164363009|NCT02063854|593705942|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
164363010|NCT02063854|593705943|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
164363011|NCT02063854|593705944|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
164363012|NCT02063854|593705945|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
164363013|NCT02063854|593705946|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
164363014|NCT02063854|593705947|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
164363015|NCT02063854|593705948|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
164363016|NCT02063854|593705942|FG000|Overall Study|Reason Not Specified|1|||
164363017|NCT02063854|593705943|FG001|Overall Study|Reason Not Specified|0|||
164363018|NCT02063854|593705944|FG002|Overall Study|Reason Not Specified|0|||
164363019|NCT02063854|593705945|FG003|Overall Study|Reason Not Specified|0|||
164363020|NCT02063854|593705946|FG004|Overall Study|Reason Not Specified|0|||
164363021|NCT02063854|593705947|FG005|Overall Study|Reason Not Specified|0|||
164363022|NCT02063854|593705948|FG006|Overall Study|Reason Not Specified|0|||
164363023|NCT02063854|593705942|FG000|Overall Study|Did Not Receive Study Drug|0|||
164363024|NCT02063854|593705943|FG001|Overall Study|Did Not Receive Study Drug|0|||
164363025|NCT02063854|593705944|FG002|Overall Study|Did Not Receive Study Drug|0|||
164363026|NCT02063854|593705945|FG003|Overall Study|Did Not Receive Study Drug|0|||
164363027|NCT02063854|593705946|FG004|Overall Study|Did Not Receive Study Drug|0|||
164363028|NCT02063854|593705947|FG005|Overall Study|Did Not Receive Study Drug|1|||
164363029|NCT02063854|593705948|FG006|Overall Study|Did Not Receive Study Drug|0|||
164363030|NCT02419742|593705949|FG000|Overall Study|Adverse Event|2|||
164363031|NCT02419742|593705950|FG001|Overall Study|Adverse Event|0|||
164363032|NCT02419742|593705949|FG000|Overall Study|Disease Progression|0|||
164363033|NCT02419742|593705950|FG001|Overall Study|Disease Progression|1|||
164363034|NCT02419742|593705949|FG000|Overall Study|Withdrew Consent|2|||
164363035|NCT02419742|593705950|FG001|Overall Study|Withdrew Consent|1|||
164363036|NCT02419742|593705949|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
164011252|NCT01208181|592405065|FG004|Part 2|Lost to Follow-up|0|||
164363037|NCT02419742|593705950|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
164363038|NCT01413360|593705955|FG000|Overall Study|Lost to Follow-up|2|||
164363039|NCT01413360|593705955|FG000|Overall Study|Adverse Event|1|||
164011253|NCT01208181|592405061|FG000|Part 2|Lack of Efficacy|0|||
164363040|NCT02246673|593705957|FG000|Overall Study|Sponsor Decision|1|||
164363041|NCT02246673|593705958|FG001|Overall Study|Sponsor Decision|0|||
164363042|NCT02246673|593705959|FG002|Overall Study|Sponsor Decision|0|||
164363043|NCT02246673|593705960|FG003|Overall Study|Sponsor Decision|0|||
164363044|NCT02246673|593705961|FG004|Overall Study|Sponsor Decision|0|||
164011254|NCT01208181|592405062|FG001|Part 2|Lack of Efficacy|0|||
163901662|NCT04436289|592011430|FG002|Overall Study|Extended hospital stay|0|||
163901663|NCT04436289|592011431|FG003|Overall Study|Extended hospital stay|0|||
163901664|NCT04436289|592011428|FG000|Overall Study|Lost to Follow-up|0|||
163901665|NCT04436289|592011429|FG001|Overall Study|Lost to Follow-up|4|||
163901666|NCT04436289|592011430|FG002|Overall Study|Lost to Follow-up|1|||
163901667|NCT04436289|592011431|FG003|Overall Study|Lost to Follow-up|3|||
163901668|NCT03357952|592011436|FG000|Overall Study|Withdrawal by Subject|0|||
163901669|NCT03357952|592011437|FG001|Overall Study|Withdrawal by Subject|1|||
163901670|NCT03357952|592011436|FG000|Overall Study|Sponsor Decision|9|||
163901671|NCT03357952|592011437|FG001|Overall Study|Sponsor Decision|0|||
163901672|NCT01675492|592011440|FG000|Overall Study|study completed early - product approval|42|||
163901673|NCT04517435|592011457|FG000|Overall Study|Withdrawal by Subject|0|||
163901674|NCT04517435|592011458|FG001|Overall Study|Withdrawal by Subject|0|||
164363045|NCT02246673|593705957|FG000|Overall Study|Withdrawal by Subject|0|||
164011255|NCT01208181|592405063|FG002|Part 2|Lack of Efficacy|5|||
164011256|NCT01208181|592405064|FG003|Part 2|Lack of Efficacy|7|||
164011257|NCT01208181|592405065|FG004|Part 2|Lack of Efficacy|0|||
164011258|NCT00942708|592405066|FG000|Overall Study|Withdrawal by Subject|1|||
164363046|NCT02246673|593705958|FG001|Overall Study|Withdrawal by Subject|0|||
164363047|NCT02246673|593705959|FG002|Overall Study|Withdrawal by Subject|0|||
164363048|NCT02246673|593705960|FG003|Overall Study|Withdrawal by Subject|0|||
164363049|NCT02246673|593705961|FG004|Overall Study|Withdrawal by Subject|1|||
164363050|NCT02246673|593705957|FG000|Overall Study|Lost to Follow-up|0|||
164363051|NCT02246673|593705958|FG001|Overall Study|Lost to Follow-up|0|||
164363052|NCT02246673|593705959|FG002|Overall Study|Lost to Follow-up|0|||
164363053|NCT02246673|593705960|FG003|Overall Study|Lost to Follow-up|1|||
164363054|NCT02246673|593705961|FG004|Overall Study|Lost to Follow-up|0|||
164363055|NCT02246673|593705957|FG000|Overall Study|Protocol Violation|0|||
164363056|NCT02246673|593705958|FG001|Overall Study|Protocol Violation|0|||
164363057|NCT02246673|593705959|FG002|Overall Study|Protocol Violation|0|||
164363058|NCT02246673|593705960|FG003|Overall Study|Protocol Violation|1|||
164363059|NCT02246673|593705961|FG004|Overall Study|Protocol Violation|0|||
164363060|NCT05413369|593705962|FG000|Overall Study|Adverse Event|1|||
164363061|NCT05413369|593705963|FG001|Overall Study|Adverse Event|1|||
164363062|NCT05413369|593705962|FG000|Overall Study|Withdrawal by Subject|13|||
164363063|NCT05413369|593705963|FG001|Overall Study|Withdrawal by Subject|4|||
164363064|NCT05413369|593705962|FG000|Overall Study|Non-compliance with study schedule|2|||
164363065|NCT05413369|593705963|FG001|Overall Study|Non-compliance with study schedule|1|||
164363066|NCT05413369|593705962|FG000|Overall Study|Other|1|||
164363067|NCT05413369|593705963|FG001|Overall Study|Other|1|||
164363068|NCT01679002|593705968|FG000|Overall Study|Adverse Event|1|||
164363069|NCT01679002|593705969|FG001|Overall Study|Adverse Event|1|||
164363070|NCT01679002|593705970|FG002|Overall Study|Adverse Event|0|||
164363071|NCT00730912|593705973|FG000|Overall Study|Discontinued|0|||
164363072|NCT00730912|593705974|FG001|Overall Study|Discontinued|0|||
164363073|NCT00730912|593705975|FG002|Overall Study|Discontinued|1|||
164363074|NCT02205333|593705979|FG000|Overall Study|Death|5|||
164363075|NCT02205333|593705980|FG001|Overall Study|Death|6|||
164363076|NCT02205333|593705981|FG002|Overall Study|Death|2|||
164363077|NCT02205333|593705982|FG003|Overall Study|Death|6|||
164363078|NCT02205333|593705983|FG004|Overall Study|Death|5|||
164363079|NCT02205333|593705984|FG005|Overall Study|Death|3|||
164363080|NCT02205333|593705985|FG006|Overall Study|Death|3|||
164363081|NCT02205333|593705986|FG007|Overall Study|Death|2|||
164363082|NCT02205333|593705987|FG008|Overall Study|Death|0|||
164363083|NCT02205333|593705979|FG000|Overall Study|Withdrawal by Subject|1|||
164363084|NCT02205333|593705980|FG001|Overall Study|Withdrawal by Subject|0|||
164363085|NCT02205333|593705981|FG002|Overall Study|Withdrawal by Subject|0|||
164363086|NCT02205333|593705982|FG003|Overall Study|Withdrawal by Subject|1|||
163901675|NCT04517435|592011459|FG002|Overall Study|Withdrawal by Subject|1|||
164011259|NCT01645930|592405072|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
164011260|NCT01645930|592405072|FG000|Overall Study|Progressive Disease|12|||
164011261|NCT01645930|592405072|FG000|Overall Study|Adverse Event|4|||
164112592|NCT01460628|592774039|FG000|Overall Study|Adverse Event|3|||
164363087|NCT02205333|593705983|FG004|Overall Study|Withdrawal by Subject|0|||
164363088|NCT02205333|593705984|FG005|Overall Study|Withdrawal by Subject|0|||
164363089|NCT02205333|593705985|FG006|Overall Study|Withdrawal by Subject|2|||
164363090|NCT02205333|593705986|FG007|Overall Study|Withdrawal by Subject|0|||
164363091|NCT02205333|593705987|FG008|Overall Study|Withdrawal by Subject|0|||
164363092|NCT00455429|593705988|FG000|Overall Study|Study Terminated by Sponsor|0|||
164363093|NCT00455429|593705989|FG001|Overall Study|Study Terminated by Sponsor|0|||
164363094|NCT00455429|593705990|FG002|Overall Study|Study Terminated by Sponsor|0|||
164363095|NCT00455429|593705991|FG003|Overall Study|Study Terminated by Sponsor|3|||
164363096|NCT00455429|593705988|FG000|Overall Study|Lost to Follow-up|1|||
164363097|NCT00455429|593705989|FG001|Overall Study|Lost to Follow-up|0|||
163901676|NCT04517435|592011457|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
163901677|NCT04517435|592011458|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
163901678|NCT04517435|592011459|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
164011262|NCT01645930|592405072|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
164011263|NCT01645930|592405072|FG000|Overall Study|Withdrawal by Participant|2|||
164011264|NCT01645930|592405072|FG000|Overall Study|Reason not Defined|1|||
164363098|NCT00455429|593705990|FG002|Overall Study|Lost to Follow-up|0|||
164363099|NCT00455429|593705991|FG003|Overall Study|Lost to Follow-up|3|||
164363100|NCT00455429|593705988|FG000|Overall Study|Withdrawal by Subject|0|||
164363101|NCT00455429|593705989|FG001|Overall Study|Withdrawal by Subject|1|||
164363102|NCT00455429|593705990|FG002|Overall Study|Withdrawal by Subject|1|||
164363103|NCT00455429|593705991|FG003|Overall Study|Withdrawal by Subject|0|||
164363104|NCT00455429|593705988|FG000|Overall Study|Lack of Efficacy|0|||
164363105|NCT00455429|593705989|FG001|Overall Study|Lack of Efficacy|1|||
164363106|NCT00455429|593705990|FG002|Overall Study|Lack of Efficacy|0|||
164363107|NCT00455429|593705991|FG003|Overall Study|Lack of Efficacy|1|||
164363108|NCT00455429|593705988|FG000|Overall Study|Adverse Event|0|||
164363109|NCT00455429|593705989|FG001|Overall Study|Adverse Event|1|||
164363110|NCT00455429|593705990|FG002|Overall Study|Adverse Event|0|||
164363111|NCT00455429|593705991|FG003|Overall Study|Adverse Event|3|||
164363112|NCT00455429|593705988|FG000|Overall Study|Randomly assigned but not treated|0|||
164363113|NCT00455429|593705989|FG001|Overall Study|Randomly assigned but not treated|0|||
164363114|NCT00455429|593705990|FG002|Overall Study|Randomly assigned but not treated|0|||
164363115|NCT00455429|593705991|FG003|Overall Study|Randomly assigned but not treated|2|||
164363116|NCT00455429|593705988|FG000|Overall Study|Personal Reason|1|||
164363117|NCT00455429|593705989|FG001|Overall Study|Personal Reason|0|||
164363118|NCT00455429|593705990|FG002|Overall Study|Personal Reason|0|||
164363119|NCT00455429|593705991|FG003|Overall Study|Personal Reason|0|||
164363120|NCT00455429|593705988|FG000|Overall Study|Non-compliance|0|||
164363121|NCT00455429|593705989|FG001|Overall Study|Non-compliance|0|||
164363122|NCT00455429|593705990|FG002|Overall Study|Non-compliance|0|||
164363123|NCT00455429|593705991|FG003|Overall Study|Non-compliance|1|||
164363124|NCT00455429|593705988|FG000|Overall Study|Other|0|||
164363125|NCT00455429|593705989|FG001|Overall Study|Other|2|||
164363126|NCT00455429|593705990|FG002|Overall Study|Other|0|||
164363127|NCT00455429|593705991|FG003|Overall Study|Other|1|||
164363128|NCT04351087|593705992|FG000|Overall Study|Lost to Follow-up|7|||
164363129|NCT04351087|593705993|FG001|Overall Study|Lost to Follow-up|3|||
164363130|NCT04351087|593705992|FG000|Overall Study|Withdrawal by Subject|3|||
164363131|NCT04351087|593705993|FG001|Overall Study|Withdrawal by Subject|4|||
164363132|NCT04351087|593705992|FG000|Overall Study|Lack of Efficacy|3|||
164363133|NCT04351087|593705993|FG001|Overall Study|Lack of Efficacy|2|||
164363134|NCT03519347|593705994|FG000|Interventional Crossover Period 1|Death|0|||
164363135|NCT03519347|593705995|FG001|Interventional Crossover Period 1|Death|0|||
164363136|NCT03519347|593705996|FG002|Interventional Crossover Period 1|Death|0|||
164363137|NCT03519347|593705997|FG003|Interventional Crossover Period 1|Death|1|||
164363138|NCT01412021|593705998|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
164363139|NCT01412021|593705998|FG000|Overall Study|Treatment Prior to Approval|3|||
164363140|NCT01412021|593705998|FG000|Overall Study|Transferred to Other Hospital|9|||
164363141|NCT01675128|593706003|FG000|Overall Study|Disease progression on study|1|||
164363142|NCT01675128|593706004|FG001|Overall Study|Disease progression on study|1|||
164363143|NCT01675128|593706005|FG002|Overall Study|Disease progression on study|1|||
164363144|NCT01675128|593706003|FG000|Overall Study|Refused further treatment|1|||
164363145|NCT01675128|593706004|FG001|Overall Study|Refused further treatment|0|||
164363146|NCT01675128|593706005|FG002|Overall Study|Refused further treatment|0|||
164363147|NCT01675128|593706003|FG000|Overall Study|Pulmonary complication; off study|0|||
164363148|NCT01675128|593706004|FG001|Overall Study|Pulmonary complication; off study|1|||
164363149|NCT01675128|593706005|FG002|Overall Study|Pulmonary complication; off study|0|||
164363150|NCT03526458|593706010|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
164363151|NCT03526458|593706011|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
164363152|NCT03526458|593706010|FG000|Overall Study|Stone passed, surgery cancelled|2|||
164363153|NCT03526458|593706011|FG001|Overall Study|Stone passed, surgery cancelled|1|||
164363154|NCT03526458|593706010|FG000|Overall Study|Withdrawal by Subject|1|||
164363155|NCT03526458|593706011|FG001|Overall Study|Withdrawal by Subject|0|||
164011265|NCT02263365|592405073|FG000|Overall Study|Physician Decision|22|||
164011266|NCT02263365|592405074|FG001|Overall Study|Physician Decision|18|||
164011267|NCT00393458|592405077|FG000|Overall Study|Adverse Event|35|||
164363156|NCT03526458|593706010|FG000|Overall Study|Physician Decision|2|||
164363157|NCT03526458|593706011|FG001|Overall Study|Physician Decision|1|||
164363158|NCT03526458|593706010|FG000|Overall Study|Lack of equipment|1|||
164363159|NCT03526458|593706011|FG001|Overall Study|Lack of equipment|1|||
164363160|NCT00484939|593706012|FG000|Overall Study|Death|9|||
164363161|NCT00484939|593706013|FG001|Overall Study|Death|13|||
164363162|NCT00484939|593706012|FG000|Overall Study|Adverse Event|22|||
164363163|NCT00484939|593706013|FG001|Overall Study|Adverse Event|12|||
164363164|NCT00484939|593706012|FG000|Overall Study|Patient Withdrew Consent|19|||
164363165|NCT00484939|593706013|FG001|Overall Study|Patient Withdrew Consent|10|||
164363166|NCT00484939|593706012|FG000|Overall Study|Protocol Violation|3|||
164363167|NCT00484939|593706013|FG001|Overall Study|Protocol Violation|3|||
164363168|NCT00484939|593706012|FG000|Overall Study|Lost to Follow-up|0|||
164363169|NCT00484939|593706013|FG001|Overall Study|Lost to Follow-up|3|||
164363170|NCT00484939|593706012|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
164363171|NCT00484939|593706013|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
164363172|NCT00484939|593706012|FG000|Overall Study|Disease progression|67|||
164363173|NCT00484939|593706013|FG001|Overall Study|Disease progression|88|||
164363174|NCT00484939|593706012|FG000|Overall Study|Screen Failure|2|||
164363175|NCT00484939|593706013|FG001|Overall Study|Screen Failure|2|||
164363176|NCT00484939|593706012|FG000|Overall Study|Reason Not Specified|11|||
164363177|NCT00484939|593706013|FG001|Overall Study|Reason Not Specified|6|||
164363178|NCT00735878|593706014|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
164363179|NCT00735878|593706015|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
164363180|NCT00735878|593706016|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
164363181|NCT04404855|593706017|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
164363182|NCT04404855|593706018|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
164363183|NCT01522365|593706021|FG000|Overall Study|Withdrawal by Subject|1|||
164363184|NCT01522365|593706022|FG001|Overall Study|Withdrawal by Subject|1|||
164363185|NCT01522365|593706021|FG000|Overall Study|Lost to Follow-up|1|||
163901679|NCT03656718|592011460|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
164363186|NCT01522365|593706022|FG001|Overall Study|Lost to Follow-up|1|||
164363187|NCT00651755|593706023|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
164363188|NCT00651755|593706024|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
164363189|NCT00651755|593706023|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
164363190|NCT00651755|593706024|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
164363191|NCT02466555|593706027|FG000|Overall Study|Lost to Follow-up|2|||
164363192|NCT01120756|593706028|FG000|Overall Study|Withdrawal by Subject|1|||
164363193|NCT01120756|593706029|FG001|Overall Study|Withdrawal by Subject|1|||
164363194|NCT03760146|593706032|FG000|Overall Study|Adverse Event|11|||
164363195|NCT03760146|593706033|FG001|Overall Study|Adverse Event|8|||
164363196|NCT03760146|593706034|FG002|Overall Study|Adverse Event|0|||
164363197|NCT03760146|593706035|FG003|Overall Study|Adverse Event|0|||
164363198|NCT03760146|593706036|FG004|Overall Study|Adverse Event|0|||
164363199|NCT03760146|593706037|FG005|Overall Study|Adverse Event|0|||
164363200|NCT03760146|593706032|FG000|Overall Study|Death|1|||
164363201|NCT03760146|593706033|FG001|Overall Study|Death|0|||
164363202|NCT03760146|593706034|FG002|Overall Study|Death|0|||
164363203|NCT03760146|593706035|FG003|Overall Study|Death|0|||
164363204|NCT03760146|593706036|FG004|Overall Study|Death|0|||
164363205|NCT03760146|593706037|FG005|Overall Study|Death|0|||
164363206|NCT03760146|593706032|FG000|Overall Study|Lost to Follow-up|41|||
164363207|NCT03760146|593706033|FG001|Overall Study|Lost to Follow-up|28|||
164363208|NCT03760146|593706034|FG002|Overall Study|Lost to Follow-up|9|||
164363209|NCT03760146|593706035|FG003|Overall Study|Lost to Follow-up|2|||
163901680|NCT03656718|592011461|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
164363210|NCT03760146|593706036|FG004|Overall Study|Lost to Follow-up|14|||
164363211|NCT03760146|593706037|FG005|Overall Study|Lost to Follow-up|8|||
164363212|NCT03760146|593706032|FG000|Overall Study|No longer met eligibility criteria|3|||
164363213|NCT03760146|593706033|FG001|Overall Study|No longer met eligibility criteria|9|||
164363214|NCT03760146|593706034|FG002|Overall Study|No longer met eligibility criteria|0|||
164363215|NCT03760146|593706035|FG003|Overall Study|No longer met eligibility criteria|0|||
164363216|NCT03760146|593706036|FG004|Overall Study|No longer met eligibility criteria|1|||
164363217|NCT03760146|593706037|FG005|Overall Study|No longer met eligibility criteria|0|||
164363218|NCT03760146|593706032|FG000|Overall Study|Protocol Violation|21|||
163901681|NCT03656718|592011462|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
163901682|NCT03656718|592011463|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
163901683|NCT03656718|592011464|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
164011268|NCT00393458|592405078|FG001|Overall Study|Adverse Event|24|||
164011269|NCT00393458|592405079|FG002|Overall Study|Adverse Event|40|||
164011270|NCT00393458|592405080|FG003|Overall Study|Adverse Event|35|||
164011271|NCT00393458|592405077|FG000|Overall Study|Subject withdrew consent|27|||
164011272|NCT00393458|592405078|FG001|Overall Study|Subject withdrew consent|40|||
164011273|NCT00393458|592405079|FG002|Overall Study|Subject withdrew consent|33|||
164363219|NCT03760146|593706033|FG001|Overall Study|Protocol Violation|13|||
164363220|NCT03760146|593706034|FG002|Overall Study|Protocol Violation|1|||
164363221|NCT03760146|593706035|FG003|Overall Study|Protocol Violation|0|||
164363222|NCT03760146|593706036|FG004|Overall Study|Protocol Violation|1|||
163901684|NCT03656718|592011465|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
163901685|NCT03656718|592011466|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
164011274|NCT00393458|592405080|FG003|Overall Study|Subject withdrew consent|50|||
164363223|NCT03760146|593706037|FG005|Overall Study|Protocol Violation|0|||
164363224|NCT03760146|593706032|FG000|Overall Study|Withdrawal by Subject|19|||
164363225|NCT03760146|593706033|FG001|Overall Study|Withdrawal by Subject|20|||
164363226|NCT03760146|593706034|FG002|Overall Study|Withdrawal by Subject|1|||
164363227|NCT03760146|593706035|FG003|Overall Study|Withdrawal by Subject|0|||
164363228|NCT03760146|593706036|FG004|Overall Study|Withdrawal by Subject|1|||
164363229|NCT03760146|593706037|FG005|Overall Study|Withdrawal by Subject|0|||
164363230|NCT00529542|593706038|FG000|Overall Study|Withdrawal by Subject|1|||
164363231|NCT00529542|593706039|FG001|Overall Study|Withdrawal by Subject|0|||
164363232|NCT00529542|593706038|FG000|Overall Study|Lost to Follow-up|0|||
164363233|NCT00529542|593706039|FG001|Overall Study|Lost to Follow-up|1|||
164363234|NCT00445965|593706042|FG000|Overall Study|Adverse Event|2|||
164363235|NCT00445965|593706042|FG000|Overall Study|Physician Decision|1|||
164363236|NCT00445965|593706042|FG000|Overall Study|Enrolled but not treated|1|||
164363237|NCT00445965|593706042|FG000|Overall Study|Removed due to progressive disease|29|||
164363238|NCT02865915|593706047|FG000|Overall Study|Pregnancy|1|||
164363239|NCT02865915|593706048|FG001|Overall Study|Pregnancy|0|||
164363240|NCT02865915|593706047|FG000|Overall Study|Withdrawal by Subject|1|||
164363241|NCT02865915|593706048|FG001|Overall Study|Withdrawal by Subject|1|||
164363242|NCT02865915|593706047|FG000|Overall Study|Adverse Event|0|||
164363243|NCT02865915|593706048|FG001|Overall Study|Adverse Event|4|||
164363244|NCT02865915|593706047|FG000|Overall Study|Lost to Follow-up|0|||
164363245|NCT02865915|593706048|FG001|Overall Study|Lost to Follow-up|1|||
164363246|NCT02865915|593706047|FG000|Overall Study|Protocol Violation|0|||
164363247|NCT02865915|593706048|FG001|Overall Study|Protocol Violation|1|||
164363248|NCT02865915|593706047|FG000|Overall Study|Study terminated by sponsor|23|||
164363249|NCT02865915|593706048|FG001|Overall Study|Study terminated by sponsor|18|||
164363250|NCT02865915|593706047|FG000|Overall Study|Dosing group discontinued|0|||
164363251|NCT02865915|593706048|FG001|Overall Study|Dosing group discontinued|5|||
164363252|NCT05760300|593706053|FG000|Overall Study|Adverse Event|0|||
164363253|NCT05760300|593706054|FG001|Overall Study|Adverse Event|0|||
164363254|NCT05760300|593706055|FG002|Overall Study|Adverse Event|1|||
164363255|NCT05760300|593706056|FG003|Overall Study|Adverse Event|0|||
164363256|NCT05760300|593706053|FG000|Overall Study|Participant Decision|1|||
164363257|NCT05760300|593706054|FG001|Overall Study|Participant Decision|0|||
164363258|NCT05760300|593706055|FG002|Overall Study|Participant Decision|0|||
164363259|NCT05760300|593706056|FG003|Overall Study|Participant Decision|0|||
164363260|NCT00699972|593707945|FG000|Overall Study|Adverse Event|7|||
164363261|NCT00699972|593707946|FG001|Overall Study|Adverse Event|9|||
164363262|NCT00699972|593707947|FG002|Overall Study|Adverse Event|24|||
164363263|NCT00699972|593707945|FG000|Overall Study|Lost to Follow-up|0|||
164363264|NCT00699972|593707946|FG001|Overall Study|Lost to Follow-up|2|||
164363265|NCT00699972|593707947|FG002|Overall Study|Lost to Follow-up|0|||
164363266|NCT00699972|593707945|FG000|Overall Study|Withdrawal by Subject|3|||
164011275|NCT00393458|592405077|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
164011276|NCT00393458|592405078|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
164011277|NCT00393458|592405079|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
164363267|NCT00699972|593707946|FG001|Overall Study|Withdrawal by Subject|7|||
164363268|NCT00699972|593707947|FG002|Overall Study|Withdrawal by Subject|4|||
164363269|NCT00699972|593707945|FG000|Overall Study|Lack of Efficacy|2|||
164363270|NCT00699972|593707946|FG001|Overall Study|Lack of Efficacy|0|||
164363271|NCT00699972|593707947|FG002|Overall Study|Lack of Efficacy|2|||
164363272|NCT00699972|593707945|FG000|Overall Study|Administrative/Other|3|||
164363273|NCT00699972|593707946|FG001|Overall Study|Administrative/Other|1|||
164363274|NCT00699972|593707947|FG002|Overall Study|Administrative/Other|4|||
164363275|NCT00699972|593707945|FG000|Overall Study|Randomized, Not Treated|1|||
164363276|NCT00699972|593707946|FG001|Overall Study|Randomized, Not Treated|0|||
164363277|NCT00699972|593707947|FG002|Overall Study|Randomized, Not Treated|1|||
164363278|NCT01545817|593707948|FG000|Pazopanib|Disease progression|51|||
164363279|NCT01545817|593707949|FG001|Pazopanib|Disease progression|0|||
164363280|NCT01545817|593707948|FG000|Pazopanib|Adverse Event|19|||
164363281|NCT01545817|593707949|FG001|Pazopanib|Adverse Event|0|||
163901686|NCT03656718|592011460|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
163901687|NCT03656718|592011461|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
163901688|NCT03656718|592011462|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
163901689|NCT03656718|592011463|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
163901690|NCT03656718|592011464|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
163901691|NCT03656718|592011465|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
164011278|NCT00393458|592405080|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
163901692|NCT03656718|592011466|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
163901693|NCT03656718|592011460|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
163901694|NCT03656718|592011461|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
163901695|NCT03656718|592011462|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
163901696|NCT03656718|592011463|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
164011279|NCT00393458|592405077|FG000|Overall Study|Protocol deviation|11|||
164363282|NCT01545817|593707948|FG000|Pazopanib|Other reason|4|||
164363283|NCT01545817|593707949|FG001|Pazopanib|Other reason|0|||
164363284|NCT01545817|593707948|FG000|Everolimus|Other reason|0|||
164363285|NCT01545817|593707949|FG001|Everolimus|Other reason|7|||
164363286|NCT01545817|593707948|FG000|Everolimus|Disease progression|0|||
164363287|NCT01545817|593707949|FG001|Everolimus|Disease progression|25|||
164363288|NCT01545817|593707948|FG000|Everolimus|Adverse Event|0|||
164363289|NCT01545817|593707949|FG001|Everolimus|Adverse Event|6|||
164363290|NCT03989440|593707954|FG000|Overall Study|COVID-19 travel restrictions|0|||
164363291|NCT03989440|593707955|FG001|Overall Study|COVID-19 travel restrictions|0|||
164363292|NCT03989440|593707956|FG002|Overall Study|COVID-19 travel restrictions|1|||
164363293|NCT03989440|593707957|FG003|Overall Study|COVID-19 travel restrictions|0|||
164363294|NCT03989440|593707958|FG004|Overall Study|COVID-19 travel restrictions|0|||
164363295|NCT03989440|593707959|FG005|Overall Study|COVID-19 travel restrictions|0|||
164363296|NCT03989440|593707954|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
164363297|NCT03989440|593707955|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
164363298|NCT03989440|593707956|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
164363299|NCT03989440|593707957|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
164363300|NCT03989440|593707958|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
164363301|NCT03989440|593707959|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
164363302|NCT01955161|593707960|FG000|Overall Study|Withdrawal before treatment|2|||
164363303|NCT01955161|593707961|FG001|Overall Study|Withdrawal before treatment|0|||
164363304|NCT01955161|593707962|FG002|Overall Study|Withdrawal before treatment|1|||
164363305|NCT01955161|593707960|FG000|Overall Study|Adverse Event|10|||
164363306|NCT01955161|593707961|FG001|Overall Study|Adverse Event|14|||
164363307|NCT01955161|593707962|FG002|Overall Study|Adverse Event|15|||
164363308|NCT01955161|593707960|FG000|Overall Study|Death|1|||
164363309|NCT01955161|593707961|FG001|Overall Study|Death|1|||
164363310|NCT01955161|593707962|FG002|Overall Study|Death|3|||
164363311|NCT01955161|593707960|FG000|Overall Study|Withdrawal by Subject|9|||
164363312|NCT01955161|593707961|FG001|Overall Study|Withdrawal by Subject|8|||
164363313|NCT01955161|593707962|FG002|Overall Study|Withdrawal by Subject|12|||
164363314|NCT01955161|593707960|FG000|Overall Study|Protocol Violation|2|||
164363315|NCT01955161|593707961|FG001|Overall Study|Protocol Violation|0|||
164363316|NCT01955161|593707962|FG002|Overall Study|Protocol Violation|0|||
164363317|NCT01955161|593707960|FG000|Overall Study|Other reason: physician decision|0|||
164363318|NCT01955161|593707961|FG001|Overall Study|Other reason: physician decision|1|||
164363319|NCT01955161|593707962|FG002|Overall Study|Other reason: physician decision|1|||
164363320|NCT01955161|593707960|FG000|Overall Study|Other reason: disallowed medication|1|||
164363321|NCT01955161|593707961|FG001|Overall Study|Other reason: disallowed medication|0|||
164363322|NCT01955161|593707962|FG002|Overall Study|Other reason: disallowed medication|1|||
164363323|NCT01955161|593707960|FG000|Overall Study|Other reason: caregiver unavailable|1|||
164363324|NCT01955161|593707961|FG001|Overall Study|Other reason: caregiver unavailable|0|||
164363325|NCT01955161|593707962|FG002|Overall Study|Other reason: caregiver unavailable|0|||
164363326|NCT01955161|593707960|FG000|Overall Study|Other reason: moved to nursing home|0|||
164363327|NCT01955161|593707961|FG001|Overall Study|Other reason: moved to nursing home|1|||
164363328|NCT01955161|593707962|FG002|Overall Study|Other reason: moved to nursing home|0|||
164363329|NCT01955161|593707960|FG000|Overall Study|Other reason: insufficient compliance|0|||
164011280|NCT00393458|592405078|FG001|Overall Study|Protocol deviation|11|||
164011281|NCT00393458|592405079|FG002|Overall Study|Protocol deviation|11|||
164011282|NCT00393458|592405080|FG003|Overall Study|Protocol deviation|10|||
164011283|NCT00393458|592405077|FG000|Overall Study|Administrative problems|7|||
164011284|NCT00393458|592405078|FG001|Overall Study|Administrative problems|8|||
164011285|NCT00393458|592405079|FG002|Overall Study|Administrative problems|5|||
164011286|NCT00393458|592405080|FG003|Overall Study|Administrative problems|2|||
164011287|NCT00393458|592405077|FG000|Overall Study|Lost to Follow-up|5|||
164011288|NCT00393458|592405078|FG001|Overall Study|Lost to Follow-up|6|||
164011289|NCT00393458|592405079|FG002|Overall Study|Lost to Follow-up|5|||
164011290|NCT00393458|592405080|FG003|Overall Study|Lost to Follow-up|3|||
164011291|NCT00393458|592405077|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164011292|NCT00393458|592405078|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164011293|NCT00393458|592405079|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164011294|NCT00393458|592405080|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164011295|NCT00393458|592405077|FG000|Overall Study|Death|1|||
164011296|NCT00393458|592405078|FG001|Overall Study|Death|1|||
164011297|NCT00393458|592405079|FG002|Overall Study|Death|5|||
164011298|NCT00393458|592405080|FG003|Overall Study|Death|5|||
164011299|NCT00393458|592405077|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164011300|NCT00393458|592405078|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164011301|NCT00393458|592405079|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164011302|NCT00393458|592405080|FG003|Overall Study|Abnormal test procedure result(s)|2|||
164011303|NCT00393458|592405077|FG000|Overall Study|Subject no longer requires study drug|0|||
164011304|NCT00393458|592405078|FG001|Overall Study|Subject no longer requires study drug|1|||
164011305|NCT00393458|592405079|FG002|Overall Study|Subject no longer requires study drug|0|||
164011306|NCT00393458|592405080|FG003|Overall Study|Subject no longer requires study drug|0|||
164363330|NCT01955161|593707961|FG001|Overall Study|Other reason: insufficient compliance|0|||
164363331|NCT01955161|593707962|FG002|Overall Study|Other reason: insufficient compliance|1|||
164363332|NCT01955161|593707960|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
164363333|NCT01955161|593707961|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
164363334|NCT01955161|593707962|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
164011307|NCT01056523|592405087|FG000|Overall Study|Death|1|||
164011308|NCT01056523|592405088|FG001|Overall Study|Death|0|||
164011309|NCT01056523|592405089|FG002|Overall Study|Death|2|||
164011310|NCT01056523|592405090|FG003|Overall Study|Death|3|||
164011311|NCT01056523|592405091|FG004|Overall Study|Death|0|||
164011312|NCT01056523|592405092|FG005|Overall Study|Death|0|||
164011313|NCT01056523|592405093|FG006|Overall Study|Death|1|||
164011314|NCT02209597|592405098|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
164011315|NCT02209597|592405098|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
164011316|NCT02209597|592405098|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
164011317|NCT02209597|592405098|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
164011318|NCT01988012|592406757|FG000|Overall Study|Adverse Event|5|||
164011319|NCT01988012|592406757|FG000|Overall Study|Insufficient Therapeutic Response|3|||
164011320|NCT01988012|592406757|FG000|Overall Study|Patient Withdrawal of Consent|4|||
164363335|NCT01955161|593707960|FG000|Overall Study|Other reason: patient's will|0|||
164363336|NCT01955161|593707961|FG001|Overall Study|Other reason: patient's will|0|||
164363337|NCT01955161|593707962|FG002|Overall Study|Other reason: patient's will|1|||
164363338|NCT04608500|593707963|FG000|Overall Study|Adverse Event|2|||
164363339|NCT04608500|593707964|FG001|Overall Study|Adverse Event|0|||
164363340|NCT04608500|593707963|FG000|Overall Study|Lost to Follow-up|15|||
164363341|NCT04608500|593707964|FG001|Overall Study|Lost to Follow-up|9|||
164363342|NCT04608500|593707963|FG000|Overall Study|Participant request|11|||
164363343|NCT04608500|593707964|FG001|Overall Study|Participant request|7|||
164363344|NCT04608500|593707963|FG000|Overall Study|Protocol Violation|1|||
164363345|NCT04608500|593707964|FG001|Overall Study|Protocol Violation|0|||
164363346|NCT04608500|593707963|FG000|Overall Study|Other|6|||
164363347|NCT04608500|593707964|FG001|Overall Study|Other|2|||
164363348|NCT00706641|593707969|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
164363349|NCT00706641|593707969|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
164363350|NCT00706641|593707969|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
164363351|NCT04782856|593707970|FG000|Overall Study|Withdrawal by Subject|0|||
164363352|NCT04782856|593707971|FG001|Overall Study|Withdrawal by Subject|1|||
164363353|NCT01030523|593707972|FG000|Initial Study (5 Years)|Death|1|||
164363354|NCT01030523|593707973|FG001|Initial Study (5 Years)|Death|0|||
164363355|NCT01030523|593707972|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
164363356|NCT01030523|593707973|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
164363357|NCT01030523|593707972|FG000|Initial Study (5 Years)|Implant failure|1|||
164011321|NCT01988012|592406757|FG000|Overall Study|Lost to Follow-up|1|||
164011322|NCT01988012|592406757|FG000|Overall Study|Physician Decision|1|||
164011323|NCT01988012|592406757|FG000|Overall Study|Protocol Violation|1|||
164011324|NCT01058369|592406758|FG000|Overall Study|Adverse Event|1|||
164011325|NCT01058369|592406758|FG000|Overall Study|Early termination study|1|||
164011326|NCT01666444|592406761|FG000|Overall Study|Did not initiate treatment|2|||
164011327|NCT01666444|592406762|FG001|Overall Study|Did not initiate treatment|1|||
164011328|NCT01650779|592406764|FG000|Overall Study|Withdrawal by Subject|1|||
164011329|NCT03567291|592406766|FG000|Period I|Adverse Event|14|||
164011330|NCT03567291|592406767|FG001|Period I|Adverse Event|0|||
164011331|NCT03567291|592406768|FG002|Period I|Adverse Event|0|||
164011332|NCT03567291|592406769|FG003|Period I|Adverse Event|0|||
164011333|NCT03567291|592406766|FG000|Period I|Protocol Violation|1|||
164011334|NCT03567291|592406767|FG001|Period I|Protocol Violation|0|||
164011335|NCT03567291|592406768|FG002|Period I|Protocol Violation|0|||
164011336|NCT03567291|592406769|FG003|Period I|Protocol Violation|0|||
164011337|NCT03567291|592406766|FG000|Period I|Withdrawal by Subject|23|||
164011338|NCT03567291|592406767|FG001|Period I|Withdrawal by Subject|0|||
164011339|NCT03567291|592406768|FG002|Period I|Withdrawal by Subject|0|||
164011340|NCT03567291|592406769|FG003|Period I|Withdrawal by Subject|0|||
164011341|NCT03567291|592406766|FG000|Period I|Lost to Follow-up|2|||
164011342|NCT03567291|592406767|FG001|Period I|Lost to Follow-up|0|||
164011343|NCT03567291|592406768|FG002|Period I|Lost to Follow-up|0|||
164011344|NCT03567291|592406769|FG003|Period I|Lost to Follow-up|0|||
164011345|NCT03567291|592406766|FG000|Period I|Terminated by sponsor|44|||
164011346|NCT03567291|592406767|FG001|Period I|Terminated by sponsor|0|||
164011347|NCT03567291|592406768|FG002|Period I|Terminated by sponsor|0|||
164011348|NCT03567291|592406769|FG003|Period I|Terminated by sponsor|0|||
164011349|NCT03567291|592406766|FG000|Period I|Missing or unknown|7|||
164011350|NCT03567291|592406767|FG001|Period I|Missing or unknown|0|||
164011351|NCT03567291|592406768|FG002|Period I|Missing or unknown|0|||
164011352|NCT03567291|592406769|FG003|Period I|Missing or unknown|0|||
164011353|NCT03567291|592406766|FG000|Period II|Adverse Event|0|||
164011354|NCT03567291|592406767|FG001|Period II|Adverse Event|1|||
164011355|NCT03567291|592406768|FG002|Period II|Adverse Event|0|||
164011356|NCT03567291|592406769|FG003|Period II|Adverse Event|0|||
164011357|NCT03567291|592406766|FG000|Period II|Missing or unknown|0|||
164011358|NCT03567291|592406767|FG001|Period II|Missing or unknown|2|||
164011359|NCT03567291|592406768|FG002|Period II|Missing or unknown|1|||
164011360|NCT03567291|592406769|FG003|Period II|Missing or unknown|0|||
164011361|NCT03567291|592406766|FG000|Period III|Adverse Event|0|||
164011362|NCT03567291|592406767|FG001|Period III|Adverse Event|0|||
164011363|NCT03567291|592406768|FG002|Period III|Adverse Event|0|||
164011364|NCT03567291|592406769|FG003|Period III|Adverse Event|4|||
164363358|NCT01030523|593707973|FG001|Initial Study (5 Years)|Implant failure|0|||
164363359|NCT01030523|593707972|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
164363360|NCT01030523|593707973|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
164363361|NCT01030523|593707972|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
164363362|NCT01030523|593707973|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
164363363|NCT01030523|593707972|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
164363364|NCT01030523|593707973|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
164363365|NCT04475588|593707976|FG000|Overall Study|Adverse Event|2|||
164363366|NCT04475588|593707977|FG001|Overall Study|Adverse Event|0|||
164363367|NCT01327300|593707978|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
164363368|NCT01327300|593707979|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
164363369|NCT01063764|593707980|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
164363370|NCT01063764|593707980|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
164011365|NCT03567291|592406766|FG000|Period III|Withdrawal by Subject|0|||
164011366|NCT03567291|592406767|FG001|Period III|Withdrawal by Subject|0|||
164011367|NCT03567291|592406768|FG002|Period III|Withdrawal by Subject|0|||
164011368|NCT03567291|592406769|FG003|Period III|Withdrawal by Subject|4|||
164011369|NCT03567291|592406766|FG000|Period III|Lost to Follow-up|0|||
164011370|NCT03567291|592406767|FG001|Period III|Lost to Follow-up|0|||
164011371|NCT03567291|592406768|FG002|Period III|Lost to Follow-up|0|||
164011372|NCT03567291|592406769|FG003|Period III|Lost to Follow-up|1|||
164011373|NCT03567291|592406766|FG000|Period III|Terminated by sponsor|0|||
164011374|NCT03567291|592406767|FG001|Period III|Terminated by sponsor|0|||
164011375|NCT03567291|592406768|FG002|Period III|Terminated by sponsor|0|||
164011376|NCT03567291|592406769|FG003|Period III|Terminated by sponsor|68|||
164011377|NCT03567291|592406766|FG000|Period III|Missing or unknown|0|||
164011378|NCT03567291|592406767|FG001|Period III|Missing or unknown|0|||
164011379|NCT03567291|592406768|FG002|Period III|Missing or unknown|0|||
164011380|NCT03567291|592406769|FG003|Period III|Missing or unknown|8|||
164011381|NCT01103349|592406772|FG000|Overall Study|Adverse Event|8|||
164011382|NCT01103349|592406773|FG001|Overall Study|Adverse Event|5|||
164011383|NCT01103349|592406774|FG002|Overall Study|Adverse Event|3|||
164011384|NCT01103349|592406772|FG000|Overall Study|Consent withdrawn|1|||
164011385|NCT01103349|592406773|FG001|Overall Study|Consent withdrawn|0|||
164011386|NCT01103349|592406774|FG002|Overall Study|Consent withdrawn|0|||
164011387|NCT01103349|592406772|FG000|Overall Study|Incorrectly included in the trial|1|||
164011388|NCT01103349|592406773|FG001|Overall Study|Incorrectly included in the trial|0|||
164011389|NCT01103349|592406774|FG002|Overall Study|Incorrectly included in the trial|0|||
164011390|NCT01103349|592406772|FG000|Overall Study|Withdrawal by Subject|1|||
164011391|NCT01103349|592406773|FG001|Overall Study|Withdrawal by Subject|1|||
164011392|NCT01103349|592406774|FG002|Overall Study|Withdrawal by Subject|0|||
164011393|NCT01103349|592406772|FG000|Overall Study|did not want to take trial medication|0|||
164011394|NCT01103349|592406773|FG001|Overall Study|did not want to take trial medication|1|||
164011395|NCT01103349|592406774|FG002|Overall Study|did not want to take trial medication|0|||
164011396|NCT01103349|592406772|FG000|Overall Study|forgot to take medication|0|||
164011397|NCT01103349|592406773|FG001|Overall Study|forgot to take medication|0|||
164011398|NCT01103349|592406774|FG002|Overall Study|forgot to take medication|1|||
164011399|NCT01736683|592406778|FG000|Overall Study|Disease Relapse|0|||
164011400|NCT01736683|592406779|FG001|Overall Study|Disease Relapse|0|||
164011401|NCT01736683|592406780|FG002|Overall Study|Disease Relapse|2|||
164011402|NCT01736683|592406781|FG003|Overall Study|Disease Relapse|1|||
164011403|NCT01736683|592406782|FG004|Overall Study|Disease Relapse|0|||
164011404|NCT01736683|592406778|FG000|Overall Study|Adverse Event|0|||
164011405|NCT01736683|592406779|FG001|Overall Study|Adverse Event|2|||
164011406|NCT01736683|592406780|FG002|Overall Study|Adverse Event|2|||
164011407|NCT01736683|592406781|FG003|Overall Study|Adverse Event|3|||
164011408|NCT01736683|592406782|FG004|Overall Study|Adverse Event|2|||
164011409|NCT01736683|592406778|FG000|Overall Study|Withdrawal by Subject|0|||
164011410|NCT01736683|592406779|FG001|Overall Study|Withdrawal by Subject|0|||
164011411|NCT01736683|592406780|FG002|Overall Study|Withdrawal by Subject|3|||
164011412|NCT01736683|592406781|FG003|Overall Study|Withdrawal by Subject|1|||
164011413|NCT01736683|592406782|FG004|Overall Study|Withdrawal by Subject|1|||
164011414|NCT01736683|592406778|FG000|Overall Study|Lack of Therapeutic Effect|7|||
164011415|NCT01736683|592406779|FG001|Overall Study|Lack of Therapeutic Effect|4|||
164011416|NCT01736683|592406780|FG002|Overall Study|Lack of Therapeutic Effect|13|||
164011417|NCT01736683|592406781|FG003|Overall Study|Lack of Therapeutic Effect|20|||
164011418|NCT01736683|592406782|FG004|Overall Study|Lack of Therapeutic Effect|1|||
164011419|NCT01736683|592406778|FG000|Overall Study|Progressive Disease|0|||
164011420|NCT01736683|592406779|FG001|Overall Study|Progressive Disease|0|||
164011421|NCT01736683|592406780|FG002|Overall Study|Progressive Disease|0|||
164011422|NCT01736683|592406781|FG003|Overall Study|Progressive Disease|1|||
164011423|NCT01736683|592406782|FG004|Overall Study|Progressive Disease|0|||
164011424|NCT01736683|592406778|FG000|Overall Study|Other|0|||
164011425|NCT01736683|592406779|FG001|Overall Study|Other|0|||
164011426|NCT01736683|592406780|FG002|Overall Study|Other|1|||
164011427|NCT01736683|592406781|FG003|Overall Study|Other|9|||
164363371|NCT01063764|593707980|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
164092222|NCT01604850|592702015|FG000|Overall Study|Subject withdrew consent|1|||
164092223|NCT01604850|592702016|FG001|Overall Study|Subject withdrew consent|0|||
164092224|NCT01703832|592702017|FG000|Overall Study|Withdrawal by Subject|1|||
164092225|NCT01703832|592702018|FG001|Overall Study|Withdrawal by Subject|0|||
164092226|NCT00243932|592702019|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
164092227|NCT00243932|592702020|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
164092228|NCT00243932|592702021|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
164092229|NCT01458405|592702025|FG000|Phase 1 (up to 12 Months)|Other|0|||
164092230|NCT01458405|592702026|FG001|Phase 1 (up to 12 Months)|Other|1|||
164092231|NCT01458405|592702027|FG002|Phase 1 (up to 12 Months)|Other|0|||
164092232|NCT01458405|592702028|FG003|Phase 1 (up to 12 Months)|Other|0|||
164092233|NCT01458405|592702025|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
164092234|NCT01458405|592702026|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
164092235|NCT01458405|592702027|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
164092236|NCT01458405|592702028|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
164092237|NCT01458405|592702025|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
164092238|NCT01458405|592702026|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
164092239|NCT01458405|592702027|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
163901697|NCT03656718|592011464|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
163901698|NCT03656718|592011465|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
164092240|NCT01458405|592702028|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
164092241|NCT01458405|592702025|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
164363372|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
164363373|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
164363374|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
164363375|NCT01063764|593707980|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
164363376|NCT00697515|593707981|FG000|Dose Optimization Period|Adverse Event|4|||
164363377|NCT00697515|593707982|FG001|Dose Optimization Period|Adverse Event|0|||
164363378|NCT00697515|593707981|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
164363379|NCT00697515|593707982|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
164363380|NCT00697515|593707981|FG000|Dose Optimization Period|Lost to Follow-up|2|||
164363381|NCT00697515|593707982|FG001|Dose Optimization Period|Lost to Follow-up|0|||
164363382|NCT00697515|593707981|FG000|Dose Optimization Period|sponsor request|2|||
164363383|NCT00697515|593707982|FG001|Dose Optimization Period|sponsor request|0|||
164363384|NCT00697515|593707981|FG000|Dose Optimization Period|called to active duty|1|||
164363385|NCT00697515|593707982|FG001|Dose Optimization Period|called to active duty|0|||
164363386|NCT00697515|593707981|FG000|Dose Optimization Period|elevated QTc|1|||
164363387|NCT00697515|593707982|FG001|Dose Optimization Period|elevated QTc|0|||
164363388|NCT00697515|593707981|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
164363389|NCT00697515|593707982|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
164363390|NCT00697515|593707981|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
164363391|NCT00697515|593707982|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
164363392|NCT00697515|593707981|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
164363393|NCT00697515|593707982|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
164363394|NCT00697515|593707981|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
164363395|NCT00697515|593707982|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
164363396|NCT02603432|593707983|FG000|Overall Study|Adverse Event|1|||
164363397|NCT02603432|593707984|FG001|Overall Study|Adverse Event|0|||
164363398|NCT02603432|593707983|FG000|Overall Study|Death|221|||
164363399|NCT02603432|593707984|FG001|Overall Study|Death|242|||
164363400|NCT02603432|593707983|FG000|Overall Study|Lost to Follow-up|3|||
164363401|NCT02603432|593707984|FG001|Overall Study|Lost to Follow-up|9|||
164363402|NCT02603432|593707983|FG000|Overall Study|Progressive Disease|7|||
164363403|NCT02603432|593707984|FG001|Overall Study|Progressive Disease|5|||
164363404|NCT02603432|593707983|FG000|Overall Study|Withdrawal by Subject|12|||
164363405|NCT02603432|593707984|FG001|Overall Study|Withdrawal by Subject|18|||
164363406|NCT02603432|593707983|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
164363407|NCT02603432|593707984|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164363408|NCT02603432|593707983|FG000|Overall Study|Study terminated by sponsor|74|||
164363409|NCT02603432|593707984|FG001|Overall Study|Study terminated by sponsor|75|||
164363410|NCT02603432|593707983|FG000|Overall Study|Other|13|||
164363411|NCT02603432|593707984|FG001|Overall Study|Other|0|||
164363412|NCT01231581|593707985|FG000|Overall Study|Lost to Follow-up|2|||
164363413|NCT01231581|593707986|FG001|Overall Study|Lost to Follow-up|2|||
164363414|NCT01231581|593707985|FG000|Overall Study|Withdrawal by Subject|6|||
164363415|NCT01231581|593707986|FG001|Overall Study|Withdrawal by Subject|9|||
164363416|NCT01231581|593707985|FG000|Overall Study|Study Closed/Terminated|6|||
164363417|NCT01231581|593707986|FG001|Overall Study|Study Closed/Terminated|5|||
164363418|NCT01231581|593707985|FG000|Overall Study|Death|65|||
164363419|NCT01231581|593707986|FG001|Overall Study|Death|64|||
164363420|NCT01231581|593707985|FG000|Overall Study|Ongoing|1|||
164363421|NCT01231581|593707986|FG001|Overall Study|Ongoing|0|||
164363422|NCT05954052|593707987|FG000|Overall Study|Adverse Event|1|||
164363423|NCT01649375|593707988|FG000|Up to Week 16|Adverse Event|2|||
164363424|NCT01649375|593707989|FG001|Up to Week 16|Adverse Event|5|||
164363425|NCT01649375|593707990|FG002|Up to Week 16|Adverse Event|4|||
164363426|NCT01649375|593707991|FG003|Up to Week 16|Adverse Event|0|||
164363427|NCT01649375|593707992|FG004|Up to Week 16|Adverse Event|0|||
164363428|NCT01649375|593707988|FG000|Up to Week 16|Lack of Efficacy|0|||
164363429|NCT01649375|593707989|FG001|Up to Week 16|Lack of Efficacy|0|||
164363430|NCT01649375|593707990|FG002|Up to Week 16|Lack of Efficacy|1|||
164011428|NCT01736683|592406782|FG004|Overall Study|Other|1|||
164363431|NCT01649375|593707991|FG003|Up to Week 16|Lack of Efficacy|0|||
164363432|NCT01649375|593707992|FG004|Up to Week 16|Lack of Efficacy|0|||
164363433|NCT01649375|593707988|FG000|Up to Week 16|Physician Decision|0|||
164363434|NCT01649375|593707989|FG001|Up to Week 16|Physician Decision|0|||
164011429|NCT01936649|592406792|FG000|Overall Study|Withdrawal by Subject|4|||
164011430|NCT01936649|592406792|FG000|Overall Study|Physician Decision|2|||
164011431|NCT01936649|592406792|FG000|Overall Study|Protocol Violation|2|||
164011432|NCT01936649|592406792|FG000|Overall Study|Other than specified above|5|||
164011433|NCT03554005|592406795|FG000|Overall Study|Not in participant's best interest|0|||
164363435|NCT01649375|593707990|FG002|Up to Week 16|Physician Decision|1|||
164363436|NCT01649375|593707991|FG003|Up to Week 16|Physician Decision|0|||
164363437|NCT01649375|593707992|FG004|Up to Week 16|Physician Decision|0|||
164363438|NCT01649375|593707988|FG000|Up to Week 16|Withdrawal by Subject|2|||
164011434|NCT03554005|592406796|FG001|Overall Study|Not in participant's best interest|0|||
164011435|NCT03554005|592406797|FG002|Overall Study|Not in participant's best interest|0|||
164363439|NCT01649375|593707989|FG001|Up to Week 16|Withdrawal by Subject|1|||
164363440|NCT01649375|593707990|FG002|Up to Week 16|Withdrawal by Subject|2|||
164363441|NCT01649375|593707991|FG003|Up to Week 16|Withdrawal by Subject|0|||
164363442|NCT01649375|593707992|FG004|Up to Week 16|Withdrawal by Subject|0|||
164363443|NCT01649375|593707988|FG000|Up to Week 16|Death|1|||
164363444|NCT01649375|593707989|FG001|Up to Week 16|Death|0|||
164363445|NCT01649375|593707990|FG002|Up to Week 16|Death|0|||
164363446|NCT01649375|593707991|FG003|Up to Week 16|Death|0|||
164363447|NCT01649375|593707992|FG004|Up to Week 16|Death|0|||
164363448|NCT01649375|593707988|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
164363449|NCT01649375|593707989|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
164363450|NCT01649375|593707990|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
164363451|NCT01649375|593707991|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
164363452|NCT01649375|593707992|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
164363453|NCT01649375|593707988|FG000|Week 16 up to Week 260|Non-compliance|0|||
164363454|NCT01649375|593707989|FG001|Week 16 up to Week 260|Non-compliance|1|||
164363455|NCT01649375|593707990|FG002|Week 16 up to Week 260|Non-compliance|0|||
164363456|NCT01649375|593707991|FG003|Week 16 up to Week 260|Non-compliance|1|||
164363457|NCT01649375|593707992|FG004|Week 16 up to Week 260|Non-compliance|0|||
164363458|NCT01649375|593707988|FG000|Week 16 up to Week 260|Physician Decision|0|||
164363459|NCT01649375|593707989|FG001|Week 16 up to Week 260|Physician Decision|2|||
164363460|NCT01649375|593707990|FG002|Week 16 up to Week 260|Physician Decision|0|||
164363461|NCT01649375|593707991|FG003|Week 16 up to Week 260|Physician Decision|0|||
164363462|NCT01649375|593707992|FG004|Week 16 up to Week 260|Physician Decision|0|||
164363463|NCT01649375|593707988|FG000|Week 16 up to Week 260|Technical issues|0|||
164363464|NCT01649375|593707989|FG001|Week 16 up to Week 260|Technical issues|1|||
164363465|NCT01649375|593707990|FG002|Week 16 up to Week 260|Technical issues|0|||
164363466|NCT01649375|593707991|FG003|Week 16 up to Week 260|Technical issues|1|||
164363467|NCT01649375|593707992|FG004|Week 16 up to Week 260|Technical issues|0|||
164363468|NCT01649375|593707988|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
164363469|NCT01649375|593707989|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
164363470|NCT01649375|593707990|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
164363471|NCT01649375|593707991|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
164363472|NCT01649375|593707992|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
164363473|NCT01649375|593707988|FG000|Week 16 up to Week 260|Death|1|||
164363474|NCT01649375|593707989|FG001|Week 16 up to Week 260|Death|1|||
164363475|NCT01649375|593707990|FG002|Week 16 up to Week 260|Death|0|||
164363476|NCT01649375|593707991|FG003|Week 16 up to Week 260|Death|0|||
164363477|NCT01649375|593707992|FG004|Week 16 up to Week 260|Death|0|||
164363478|NCT01649375|593707988|FG000|Week 16 up to Week 260|Adverse Event|5|||
164363479|NCT01649375|593707989|FG001|Week 16 up to Week 260|Adverse Event|2|||
164363480|NCT01649375|593707990|FG002|Week 16 up to Week 260|Adverse Event|0|||
163901699|NCT03656718|592011466|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
163901700|NCT03656718|592011460|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163901701|NCT03656718|592011461|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163901702|NCT03656718|592011462|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163901703|NCT03656718|592011463|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
163901704|NCT03656718|592011464|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
164363481|NCT01649375|593707991|FG003|Week 16 up to Week 260|Adverse Event|3|||
164363482|NCT01649375|593707992|FG004|Week 16 up to Week 260|Adverse Event|2|||
164363483|NCT01921829|593707995|FG000|Overall Study|Withdrawal by Subject|0|||
164363484|NCT01921829|593707996|FG001|Overall Study|Withdrawal by Subject|1|||
164363485|NCT01316276|593708001|FG000|Overall Study|Death|1|||
164363486|NCT01316276|593708001|FG000|Overall Study|Adverse Event|19|||
164363487|NCT01316276|593708001|FG000|Overall Study|Withdrawal of consent|24|||
164363488|NCT01316276|593708001|FG000|Overall Study|Lost to Follow-up|1|||
164363489|NCT01316276|593708001|FG000|Overall Study|Other|22|||
164363490|NCT00605475|593708002|FG000|Overall Study|Abnormal Laboratory Values|0|||
164363491|NCT00605475|593708003|FG001|Overall Study|Abnormal Laboratory Values|0|||
164363492|NCT00605475|593708004|FG002|Overall Study|Abnormal Laboratory Values|0|||
164363493|NCT00605475|593708005|FG003|Overall Study|Abnormal Laboratory Values|0|||
164363494|NCT00605475|593708006|FG004|Overall Study|Abnormal Laboratory Values|0|||
164363495|NCT00605475|593708007|FG005|Overall Study|Abnormal Laboratory Values|0|||
164363496|NCT00605475|593708008|FG006|Overall Study|Abnormal Laboratory Values|0|||
164363497|NCT00605475|593708009|FG007|Overall Study|Abnormal Laboratory Values|0|||
164363498|NCT00605475|593708010|FG008|Overall Study|Abnormal Laboratory Values|1|||
164363499|NCT00605475|593708011|FG009|Overall Study|Abnormal Laboratory Values|0|||
164363500|NCT00605475|593708002|FG000|Overall Study|Administrative problems|0|||
164363501|NCT00605475|593708003|FG001|Overall Study|Administrative problems|0|||
164363502|NCT00605475|593708004|FG002|Overall Study|Administrative problems|0|||
164363503|NCT00605475|593708005|FG003|Overall Study|Administrative problems|0|||
164363504|NCT00605475|593708006|FG004|Overall Study|Administrative problems|0|||
164363505|NCT00605475|593708007|FG005|Overall Study|Administrative problems|0|||
164363506|NCT00605475|593708008|FG006|Overall Study|Administrative problems|1|||
164363507|NCT00605475|593708009|FG007|Overall Study|Administrative problems|0|||
164363508|NCT00605475|593708010|FG008|Overall Study|Administrative problems|0|||
164363509|NCT00605475|593708011|FG009|Overall Study|Administrative problems|0|||
164363510|NCT00605475|593708002|FG000|Overall Study|Lost to Follow-up|0|||
164363511|NCT00605475|593708003|FG001|Overall Study|Lost to Follow-up|0|||
164363512|NCT00605475|593708004|FG002|Overall Study|Lost to Follow-up|0|||
164363513|NCT00605475|593708005|FG003|Overall Study|Lost to Follow-up|0|||
164363514|NCT00605475|593708006|FG004|Overall Study|Lost to Follow-up|0|||
164363515|NCT00605475|593708007|FG005|Overall Study|Lost to Follow-up|0|||
164363516|NCT00605475|593708008|FG006|Overall Study|Lost to Follow-up|0|||
164363517|NCT00605475|593708009|FG007|Overall Study|Lost to Follow-up|0|||
164363518|NCT00605475|593708010|FG008|Overall Study|Lost to Follow-up|1|||
164363519|NCT00605475|593708011|FG009|Overall Study|Lost to Follow-up|1|||
164363520|NCT00605475|593708002|FG000|Overall Study|Protocol Violation|0|||
164363521|NCT00605475|593708003|FG001|Overall Study|Protocol Violation|0|||
164363522|NCT00605475|593708004|FG002|Overall Study|Protocol Violation|0|||
164363523|NCT00605475|593708005|FG003|Overall Study|Protocol Violation|0|||
164363524|NCT00605475|593708006|FG004|Overall Study|Protocol Violation|1|||
164363525|NCT00605475|593708007|FG005|Overall Study|Protocol Violation|0|||
164363526|NCT00605475|593708008|FG006|Overall Study|Protocol Violation|0|||
164363527|NCT00605475|593708009|FG007|Overall Study|Protocol Violation|0|||
164363528|NCT00605475|593708010|FG008|Overall Study|Protocol Violation|0|||
164363529|NCT00605475|593708011|FG009|Overall Study|Protocol Violation|0|||
164363530|NCT00605475|593708002|FG000|Overall Study|Withdrawal by Subject|0|||
164363531|NCT00605475|593708003|FG001|Overall Study|Withdrawal by Subject|0|||
164363532|NCT00605475|593708004|FG002|Overall Study|Withdrawal by Subject|0|||
164363533|NCT00605475|593708005|FG003|Overall Study|Withdrawal by Subject|0|||
164363534|NCT00605475|593708006|FG004|Overall Study|Withdrawal by Subject|0|||
164363535|NCT00605475|593708007|FG005|Overall Study|Withdrawal by Subject|2|||
164363536|NCT00605475|593708008|FG006|Overall Study|Withdrawal by Subject|0|||
164363537|NCT00605475|593708009|FG007|Overall Study|Withdrawal by Subject|0|||
164363538|NCT00605475|593708010|FG008|Overall Study|Withdrawal by Subject|0|||
164363539|NCT00605475|593708011|FG009|Overall Study|Withdrawal by Subject|1|||
164363540|NCT03538158|593708017|FG000|Overall Study|Lost to Follow-up|13|||
164363541|NCT03538158|593708018|FG001|Overall Study|Lost to Follow-up|7|||
164363542|NCT03538158|593708017|FG000|Overall Study|Withdrawal by Subject|2|||
164363543|NCT03538158|593708018|FG001|Overall Study|Withdrawal by Subject|1|||
164363544|NCT04519645|593708025|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
164363545|NCT04519645|593708026|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
164363546|NCT04519645|593708027|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
164363547|NCT04519645|593708025|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
164363548|NCT04519645|593708026|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
164363549|NCT04519645|593708027|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
164363550|NCT04519645|593708025|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
164363551|NCT04519645|593708026|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
164363552|NCT04519645|593708027|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
164363553|NCT04519645|593708025|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
164363554|NCT04519645|593708026|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
164363555|NCT04519645|593708027|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
163901705|NCT03656718|592011465|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
164363556|NCT05517382|593708036|FG000|Overall Study|Lost to Follow-up|0|||
164363557|NCT05517382|593708037|FG001|Overall Study|Lost to Follow-up|1|||
164363558|NCT03886220|593708040|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
163901706|NCT03656718|592011466|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
163901707|NCT03656718|592011460|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
164363559|NCT03886220|593708041|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
164363560|NCT03886220|593708040|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
164363561|NCT03886220|593708041|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164363562|NCT03886220|593708040|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164363563|NCT03886220|593708041|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
164363564|NCT00271947|593708045|FG000|Overall Study|Lost to Follow-up|1|||
164363565|NCT00698581|593708048|FG000|Overall Study|Lack of Efficacy|23|||
164363566|NCT00698581|593708049|FG001|Overall Study|Lack of Efficacy|11|||
164363567|NCT00698581|593708048|FG000|Overall Study|Withdrawal by Subject|6|||
164363568|NCT00698581|593708049|FG001|Overall Study|Withdrawal by Subject|0|||
164363569|NCT00698581|593708048|FG000|Overall Study|Other reason|9|||
164363570|NCT00698581|593708049|FG001|Overall Study|Other reason|1|||
164363571|NCT00698581|593708048|FG000|Overall Study|SAE, non-fatal|1|||
164363572|NCT00698581|593708049|FG001|Overall Study|SAE, non-fatal|0|||
164363573|NCT00698581|593708048|FG000|Overall Study|AE, non-serious non-fatal|4|||
164363574|NCT00698581|593708049|FG001|Overall Study|AE, non-serious non-fatal|0|||
164363575|NCT00698581|593708048|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164363576|NCT00698581|593708049|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164363577|NCT00698581|593708048|FG000|Overall Study|AE of unknown type|1|||
164363578|NCT00698581|593708049|FG001|Overall Study|AE of unknown type|0|||
164363579|NCT00449644|593708050|FG000|Overall Study|Adverse Event|0|||
164363580|NCT00449644|593708051|FG001|Overall Study|Adverse Event|0|||
164363581|NCT00449644|593708052|FG002|Overall Study|Adverse Event|3|||
164363582|NCT00449644|593708053|FG003|Overall Study|Adverse Event|5|||
164363583|NCT00449644|593708050|FG000|Overall Study|Death|1|||
164363584|NCT00449644|593708051|FG001|Overall Study|Death|0|||
164363585|NCT00449644|593708052|FG002|Overall Study|Death|6|||
164363586|NCT00449644|593708053|FG003|Overall Study|Death|1|||
164363587|NCT00449644|593708050|FG000|Overall Study|Lost to Follow-up|1|||
164363588|NCT00449644|593708051|FG001|Overall Study|Lost to Follow-up|1|||
164363589|NCT00449644|593708052|FG002|Overall Study|Lost to Follow-up|5|||
164363590|NCT00449644|593708053|FG003|Overall Study|Lost to Follow-up|3|||
164363591|NCT00449644|593708050|FG000|Overall Study|Pregnancy|0|||
164363592|NCT00449644|593708051|FG001|Overall Study|Pregnancy|0|||
164363593|NCT00449644|593708052|FG002|Overall Study|Pregnancy|3|||
164363594|NCT00449644|593708053|FG003|Overall Study|Pregnancy|2|||
164363595|NCT00449644|593708050|FG000|Overall Study|Protocol Violation|4|||
164363596|NCT00449644|593708051|FG001|Overall Study|Protocol Violation|4|||
164363597|NCT00449644|593708052|FG002|Overall Study|Protocol Violation|3|||
164363598|NCT00449644|593708053|FG003|Overall Study|Protocol Violation|7|||
164363599|NCT00449644|593708050|FG000|Overall Study|Withdrawal by Subject|3|||
164363600|NCT00449644|593708051|FG001|Overall Study|Withdrawal by Subject|4|||
164363601|NCT00449644|593708052|FG002|Overall Study|Withdrawal by Subject|6|||
164363602|NCT00449644|593708053|FG003|Overall Study|Withdrawal by Subject|7|||
164363603|NCT00449644|593708050|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
164363604|NCT00449644|593708051|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
164363605|NCT00449644|593708052|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
164363606|NCT00449644|593708053|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
164363607|NCT00449644|593708050|FG000|Overall Study|Other|1|||
164363608|NCT00449644|593708051|FG001|Overall Study|Other|4|||
164363609|NCT00449644|593708052|FG002|Overall Study|Other|1|||
164363610|NCT00449644|593708053|FG003|Overall Study|Other|0|||
164363611|NCT00449644|593708050|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
164363612|NCT00449644|593708051|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
164363613|NCT00449644|593708052|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
164363614|NCT00449644|593708053|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
164363615|NCT05778786|593708058|FG000|Period 1|COVID-19 Related|3|||
164363616|NCT05778786|593708059|FG001|Period 1|COVID-19 Related|3|||
164363617|NCT05778786|593708058|FG000|Period 1|Withdrew Consent during Study|1|||
164363618|NCT05778786|593708059|FG001|Period 1|Withdrew Consent during Study|0|||
164363619|NCT05778786|593708058|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
164363620|NCT05778786|593708059|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
164363621|NCT05778786|593708058|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
164363622|NCT05778786|593708059|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
164363623|NCT02075658|593708060|FG000|Overall Study|Physician Decision|2|||
164363624|NCT02075658|593708061|FG001|Overall Study|Physician Decision|2|||
164363625|NCT02406651|593708063|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
164363626|NCT00718328|593708068|FG000|Overall Study|Lost to Follow-up|1|||
164363627|NCT00718328|593708069|FG001|Overall Study|Lost to Follow-up|0|||
164363628|NCT00663052|593708070|FG000|Overall Study|Adverse Event|6|||
164363629|NCT00663052|593708071|FG001|Overall Study|Adverse Event|3|||
164363630|NCT00663052|593708070|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
164363631|NCT00663052|593708071|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164363632|NCT00663052|593708070|FG000|Overall Study|Protocol Violation|1|||
164363633|NCT00663052|593708071|FG001|Overall Study|Protocol Violation|0|||
164363634|NCT00663052|593708070|FG000|Overall Study|Withdrawal by Subject|2|||
164363635|NCT00663052|593708071|FG001|Overall Study|Withdrawal by Subject|5|||
164363636|NCT00663052|593708070|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
164363637|NCT00663052|593708071|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
164363638|NCT00663052|593708070|FG000|Overall Study|Other|0|||
164363639|NCT00663052|593708071|FG001|Overall Study|Other|1|||
164363640|NCT02946047|593708073|FG000|Overall Study|Adverse Event|1|||
164363641|NCT02946047|593708074|FG001|Overall Study|Adverse Event|0|||
164363642|NCT02946047|593708075|FG002|Overall Study|Adverse Event|0|||
164363643|NCT02946047|593708076|FG003|Overall Study|Adverse Event|0|||
164363644|NCT03615105|593708077|FG000|Overall Study|Protocol Violation|1|||
164363645|NCT03615105|593708078|FG001|Overall Study|Protocol Violation|0|||
164363646|NCT03615105|593708079|FG002|Overall Study|Protocol Violation|0|||
164363647|NCT03615105|593708077|FG000|Overall Study|Death|0|||
164363648|NCT03615105|593708078|FG001|Overall Study|Death|2|||
164363649|NCT03615105|593708079|FG002|Overall Study|Death|0|||
164363650|NCT05041322|593708080|FG000|Baseline|Withdrawal by Subject|1|||
164363651|NCT05041322|593708081|FG001|Baseline|Withdrawal by Subject|0|||
164363652|NCT05041322|593708080|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
164363653|NCT05041322|593708081|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
164363654|NCT05041322|593708080|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
164363655|NCT05041322|593708081|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
164363656|NCT01252940|593708082|FG000|Main Study Phase|Randomized but not treated|4|||
164363657|NCT01252940|593708083|FG001|Main Study Phase|Randomized but not treated|2|||
164363658|NCT01252940|593708082|FG000|Main Study Phase|Adverse Event|3|||
164363659|NCT01252940|593708083|FG001|Main Study Phase|Adverse Event|1|||
164363660|NCT01252940|593708082|FG000|Main Study Phase|Lack of Efficacy|1|||
164363661|NCT01252940|593708083|FG001|Main Study Phase|Lack of Efficacy|0|||
164363662|NCT01252940|593708082|FG000|Main Study Phase|Lost to Follow-up|6|||
164363663|NCT01252940|593708083|FG001|Main Study Phase|Lost to Follow-up|1|||
164363664|NCT01252940|593708082|FG000|Main Study Phase|Physician Decision|1|||
164363665|NCT01252940|593708083|FG001|Main Study Phase|Physician Decision|0|||
164363666|NCT01252940|593708082|FG000|Main Study Phase|Protocol Violation|4|||
164363667|NCT01252940|593708083|FG001|Main Study Phase|Protocol Violation|2|||
164363668|NCT01252940|593708082|FG000|Main Study Phase|Withdrawal by Subject|6|||
164363669|NCT01252940|593708083|FG001|Main Study Phase|Withdrawal by Subject|5|||
164363670|NCT01252940|593708082|FG000|Main Study Phase|Subject Non-compliance|1|||
164363671|NCT01252940|593708083|FG001|Main Study Phase|Subject Non-compliance|1|||
164363672|NCT01252940|593708082|FG000|Extension Phase|Adverse Event|2|||
164363673|NCT01252940|593708083|FG001|Extension Phase|Adverse Event|1|||
164363674|NCT01252940|593708082|FG000|Extension Phase|Lack of Efficacy|1|||
164363675|NCT01252940|593708083|FG001|Extension Phase|Lack of Efficacy|0|||
164363676|NCT01252940|593708082|FG000|Extension Phase|Lost to Follow-up|5|||
164363677|NCT01252940|593708083|FG001|Extension Phase|Lost to Follow-up|0|||
164363678|NCT01252940|593708082|FG000|Extension Phase|Physician Decision|0|||
164363679|NCT01252940|593708083|FG001|Extension Phase|Physician Decision|1|||
164363680|NCT01252940|593708082|FG000|Extension Phase|Subject Non-compliance|1|||
164363681|NCT01252940|593708083|FG001|Extension Phase|Subject Non-compliance|0|||
164363682|NCT01252940|593708082|FG000|Extension Phase|Withdrawal by Subject|1|||
164363683|NCT01252940|593708083|FG001|Extension Phase|Withdrawal by Subject|1|||
164363684|NCT01502423|593708084|FG000|Overall Study|Withdrawal by Subject|0|||
164363685|NCT01502423|593708085|FG001|Overall Study|Withdrawal by Subject|1|||
164363686|NCT04199117|593708086|FG000|Overall Study|Withdrawal by Subject|3|||
164363687|NCT04199117|593708087|FG001|Overall Study|Withdrawal by Subject|0|||
164363688|NCT04199117|593708088|FG002|Overall Study|Withdrawal by Subject|0|||
164363689|NCT04199117|593708089|FG003|Overall Study|Withdrawal by Subject|1|||
164363690|NCT04199117|593708090|FG004|Overall Study|Withdrawal by Subject|1|||
164363691|NCT04199117|593708091|FG005|Overall Study|Withdrawal by Subject|0|||
164363692|NCT04199117|593708092|FG006|Overall Study|Withdrawal by Subject|0|||
164363693|NCT04199117|593708093|FG007|Overall Study|Withdrawal by Subject|2|||
164363694|NCT04199117|593708094|FG008|Overall Study|Withdrawal by Subject|0|||
164363695|NCT04199117|593708095|FG009|Overall Study|Withdrawal by Subject|0|||
164363696|NCT04199117|593708096|FG010|Overall Study|Withdrawal by Subject|1|||
164363697|NCT04199117|593708097|FG011|Overall Study|Withdrawal by Subject|1|||
164011436|NCT03554005|592406798|FG003|Overall Study|Not in participant's best interest|0|||
164011437|NCT03554005|592406799|FG004|Overall Study|Not in participant's best interest|0|||
164011438|NCT03554005|592406800|FG005|Overall Study|Not in participant's best interest|1|||
164011439|NCT03554005|592406795|FG000|Overall Study|Disease Progression|1|||
164363698|NCT04199117|593708098|FG012|Overall Study|Withdrawal by Subject|2|||
164363699|NCT04199117|593708099|FG013|Overall Study|Withdrawal by Subject|1|||
164363700|NCT04199117|593708100|FG014|Overall Study|Withdrawal by Subject|1|||
164363701|NCT04199117|593708101|FG015|Overall Study|Withdrawal by Subject|1|||
164363702|NCT04199117|593708086|FG000|Overall Study|Death|1|||
164363703|NCT04199117|593708087|FG001|Overall Study|Death|1|||
164363704|NCT04199117|593708088|FG002|Overall Study|Death|0|||
164363705|NCT04199117|593708089|FG003|Overall Study|Death|0|||
164011440|NCT03554005|592406796|FG001|Overall Study|Disease Progression|1|||
164363706|NCT04199117|593708090|FG004|Overall Study|Death|0|||
164363707|NCT04199117|593708091|FG005|Overall Study|Death|0|||
164363708|NCT04199117|593708092|FG006|Overall Study|Death|0|||
164363709|NCT04199117|593708093|FG007|Overall Study|Death|0|||
164363710|NCT04199117|593708094|FG008|Overall Study|Death|0|||
164363711|NCT04199117|593708095|FG009|Overall Study|Death|0|||
164363712|NCT04199117|593708096|FG010|Overall Study|Death|0|||
164363713|NCT04199117|593708097|FG011|Overall Study|Death|1|||
164363714|NCT04199117|593708098|FG012|Overall Study|Death|0|||
164363715|NCT04199117|593708099|FG013|Overall Study|Death|1|||
164363716|NCT04199117|593708100|FG014|Overall Study|Death|0|||
164363717|NCT04199117|593708101|FG015|Overall Study|Death|0|||
164363718|NCT04199117|593708086|FG000|Overall Study|Withdrawal by PI|0|||
164363719|NCT04199117|593708087|FG001|Overall Study|Withdrawal by PI|0|||
164363720|NCT04199117|593708088|FG002|Overall Study|Withdrawal by PI|0|||
164363721|NCT04199117|593708089|FG003|Overall Study|Withdrawal by PI|0|||
164363722|NCT04199117|593708090|FG004|Overall Study|Withdrawal by PI|0|||
164363723|NCT04199117|593708091|FG005|Overall Study|Withdrawal by PI|0|||
164363724|NCT04199117|593708092|FG006|Overall Study|Withdrawal by PI|0|||
164363725|NCT04199117|593708093|FG007|Overall Study|Withdrawal by PI|0|||
164363726|NCT04199117|593708094|FG008|Overall Study|Withdrawal by PI|0|||
164363727|NCT04199117|593708095|FG009|Overall Study|Withdrawal by PI|0|||
164363728|NCT04199117|593708096|FG010|Overall Study|Withdrawal by PI|0|||
164363729|NCT04199117|593708097|FG011|Overall Study|Withdrawal by PI|0|||
164363730|NCT04199117|593708098|FG012|Overall Study|Withdrawal by PI|1|||
164363731|NCT04199117|593708099|FG013|Overall Study|Withdrawal by PI|0|||
164363732|NCT04199117|593708100|FG014|Overall Study|Withdrawal by PI|0|||
164363733|NCT04199117|593708101|FG015|Overall Study|Withdrawal by PI|0|||
164363734|NCT04383743|593708102|FG000|Overall Study|Withdrawal by Subject|1|||
164363735|NCT04383743|593708102|FG000|Overall Study|Adverse Event|1|||
164363736|NCT04814433|593708105|FG000|Overall Study|Survey not returned|4|||
164363737|NCT04814433|593708106|FG001|Overall Study|Survey not returned|8|||
164363738|NCT04814433|593708107|FG002|Overall Study|Survey not returned|4|||
164363739|NCT04814433|593708108|FG003|Overall Study|Survey not returned|5|||
164363740|NCT03482791|593708113|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
164363741|NCT03482791|593708114|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
164363742|NCT01721330|593708116|FG000|Overall Study|Withdrawal by Subject|0|||
164363743|NCT01721330|593708117|FG001|Overall Study|Withdrawal by Subject|1|||
164363744|NCT00296374|593708118|FG000|Overall Study|Adverse Event|14|||
164363745|NCT00296374|593708119|FG001|Overall Study|Adverse Event|10|||
164363746|NCT00296374|593708120|FG002|Overall Study|Adverse Event|7|||
164363747|NCT00296374|593708118|FG000|Overall Study|Withdrawal by Subject|3|||
164363748|NCT00296374|593708119|FG001|Overall Study|Withdrawal by Subject|5|||
164363749|NCT00296374|593708120|FG002|Overall Study|Withdrawal by Subject|11|||
164363750|NCT00296374|593708118|FG000|Overall Study|Incorrect enrollment|3|||
164363751|NCT00296374|593708119|FG001|Overall Study|Incorrect enrollment|3|||
164363752|NCT00296374|593708120|FG002|Overall Study|Incorrect enrollment|4|||
164363753|NCT00296374|593708118|FG000|Overall Study|Protocol Violation|1|||
164363754|NCT00296374|593708119|FG001|Overall Study|Protocol Violation|2|||
164363755|NCT00296374|593708120|FG002|Overall Study|Protocol Violation|3|||
164363756|NCT00296374|593708118|FG000|Overall Study|Lost to Follow-up|3|||
164363757|NCT00296374|593708119|FG001|Overall Study|Lost to Follow-up|1|||
164363758|NCT00296374|593708120|FG002|Overall Study|Lost to Follow-up|1|||
164363759|NCT00296374|593708118|FG000|Overall Study|Relocated to another state|1|||
164363760|NCT00296374|593708119|FG001|Overall Study|Relocated to another state|0|||
164363761|NCT00296374|593708120|FG002|Overall Study|Relocated to another state|0|||
164363762|NCT00296374|593708118|FG000|Overall Study|Stopped drug before end of study visit|0|||
164363763|NCT00296374|593708119|FG001|Overall Study|Stopped drug before end of study visit|1|||
164363764|NCT00296374|593708120|FG002|Overall Study|Stopped drug before end of study visit|0|||
164363765|NCT00296374|593708118|FG000|Overall Study|Nephrologist introduced ACE|0|||
164363766|NCT00296374|593708119|FG001|Overall Study|Nephrologist introduced ACE|1|||
164363767|NCT00296374|593708120|FG002|Overall Study|Nephrologist introduced ACE|0|||
164363768|NCT00296374|593708118|FG000|Overall Study|Pregnancy|0|||
164092242|NCT01458405|592702026|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
164092243|NCT01458405|592702027|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
164363769|NCT00296374|593708119|FG001|Overall Study|Pregnancy|0|||
164363770|NCT00296374|593708120|FG002|Overall Study|Pregnancy|2|||
164363771|NCT00296374|593708118|FG000|Overall Study|Other|0|||
164363772|NCT00296374|593708119|FG001|Overall Study|Other|0|||
164363773|NCT00296374|593708120|FG002|Overall Study|Other|1|||
164363774|NCT01816893|593708121|FG000|Washout Period|Withdrawal by Subject|2|||
164363775|NCT01816893|593708122|FG001|Washout Period|Withdrawal by Subject|0|||
164363776|NCT02747420|593709460|FG000|Overall Study|Lost to Follow-up|4|||
164363777|NCT02747420|593709461|FG001|Overall Study|Lost to Follow-up|2|||
164363778|NCT02747420|593709460|FG000|Overall Study|Withdrawal by Subject|3|||
164363779|NCT02747420|593709461|FG001|Overall Study|Withdrawal by Subject|2|||
164363780|NCT00798369|593709462|FG000|Overall Study|Subject withdrew consent|0|||
164363781|NCT00798369|593709463|FG001|Overall Study|Subject withdrew consent|0|||
164363782|NCT00798369|593709464|FG002|Overall Study|Subject withdrew consent|1|||
164363783|NCT00798369|593709465|FG003|Overall Study|Subject withdrew consent|1|||
164363784|NCT00798369|593709466|FG004|Overall Study|Subject withdrew consent|0|||
164363785|NCT00798369|593709467|FG005|Overall Study|Subject withdrew consent|2|||
163901708|NCT03656718|592011461|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163901709|NCT03656718|592011462|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163901710|NCT03656718|592011463|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
163901711|NCT03656718|592011464|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164363786|NCT00798369|593709462|FG000|Overall Study|Lost to Follow-up|1|||
164363787|NCT00798369|593709463|FG001|Overall Study|Lost to Follow-up|1|||
164363788|NCT00798369|593709464|FG002|Overall Study|Lost to Follow-up|1|||
164363789|NCT00798369|593709465|FG003|Overall Study|Lost to Follow-up|0|||
164363790|NCT00798369|593709466|FG004|Overall Study|Lost to Follow-up|1|||
164363791|NCT00798369|593709467|FG005|Overall Study|Lost to Follow-up|0|||
164363792|NCT00798369|593709462|FG000|Overall Study|Adminstrative problems|0|||
164363793|NCT00798369|593709463|FG001|Overall Study|Adminstrative problems|0|||
164363794|NCT00798369|593709464|FG002|Overall Study|Adminstrative problems|0|||
164363795|NCT00798369|593709465|FG003|Overall Study|Adminstrative problems|0|||
164363796|NCT00798369|593709466|FG004|Overall Study|Adminstrative problems|0|||
164363797|NCT00798369|593709467|FG005|Overall Study|Adminstrative problems|1|||
164363798|NCT04307446|593709468|FG000|Overall Study|Lost to Follow-up|2|||
164363799|NCT04307446|593709469|FG001|Overall Study|Lost to Follow-up|0|||
164363800|NCT05620576|593709470|FG000|Overall Study|Adverse Event|1|||
164363801|NCT05620576|593709471|FG001|Overall Study|Adverse Event|1|||
164363802|NCT05620576|593709470|FG000|Overall Study|Lost to Follow-up|3|||
164363803|NCT05620576|593709471|FG001|Overall Study|Lost to Follow-up|1|||
164363804|NCT05620576|593709470|FG000|Overall Study|Physician Decision|0|||
164363805|NCT05620576|593709471|FG001|Overall Study|Physician Decision|1|||
164363806|NCT05620576|593709470|FG000|Overall Study|Protocol Deviation|1|||
164363807|NCT05620576|593709471|FG001|Overall Study|Protocol Deviation|1|||
164363808|NCT05620576|593709470|FG000|Overall Study|Withdrawal by Subject|2|||
164363809|NCT05620576|593709471|FG001|Overall Study|Withdrawal by Subject|3|||
164363810|NCT02622828|593709472|FG000|Overall Study|participant withdrew|3|||
164363811|NCT00666757|593709476|FG000|Overall Study|Lost to Follow-up|39|||
164363812|NCT00666757|593709477|FG001|Overall Study|Lost to Follow-up|35|||
164363813|NCT00666757|593709476|FG000|Overall Study|Protocol Violation|23|||
164363814|NCT00666757|593709477|FG001|Overall Study|Protocol Violation|24|||
164363815|NCT00666757|593709476|FG000|Overall Study|Adverse Event|22|||
164363816|NCT00666757|593709477|FG001|Overall Study|Adverse Event|12|||
164363817|NCT00666757|593709476|FG000|Overall Study|Withdrawal by Subject|13|||
164363818|NCT00666757|593709477|FG001|Overall Study|Withdrawal by Subject|17|||
164363819|NCT00666757|593709476|FG000|Overall Study|Lack of Efficacy|3|||
164363820|NCT00666757|593709477|FG001|Overall Study|Lack of Efficacy|6|||
164363821|NCT00666757|593709476|FG000|Overall Study|Physician Decision|0|||
164363822|NCT00666757|593709477|FG001|Overall Study|Physician Decision|2|||
164363823|NCT00666757|593709476|FG000|Overall Study|Sponsor decision|0|||
164363824|NCT00666757|593709477|FG001|Overall Study|Sponsor decision|1|||
164363825|NCT02510794|593709480|FG000|Overall Study|Adverse Event|0|||
164363826|NCT02510794|593709481|FG001|Overall Study|Adverse Event|1|||
164363827|NCT02510794|593709482|FG002|Overall Study|Adverse Event|0|||
164363828|NCT02510794|593709483|FG003|Overall Study|Adverse Event|0|||
164363829|NCT02510794|593709480|FG000|Overall Study|Death|1|||
164363830|NCT02510794|593709481|FG001|Overall Study|Death|2|||
164363831|NCT02510794|593709482|FG002|Overall Study|Death|1|||
164363832|NCT02510794|593709483|FG003|Overall Study|Death|1|||
164363833|NCT02510794|593709480|FG000|Overall Study|Lack of Efficacy|3|||
164363834|NCT02510794|593709481|FG001|Overall Study|Lack of Efficacy|1|||
164363835|NCT02510794|593709482|FG002|Overall Study|Lack of Efficacy|1|||
164363836|NCT02510794|593709483|FG003|Overall Study|Lack of Efficacy|0|||
164363837|NCT02510794|593709480|FG000|Overall Study|Participant moved out of the area|0|||
164363838|NCT02510794|593709481|FG001|Overall Study|Participant moved out of the area|0|||
163901712|NCT03656718|592011465|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
164363839|NCT02510794|593709482|FG002|Overall Study|Participant moved out of the area|0|||
164363840|NCT02510794|593709483|FG003|Overall Study|Participant moved out of the area|1|||
164363841|NCT02510794|593709480|FG000|Overall Study|Physician Decision|3|||
164363842|NCT02510794|593709481|FG001|Overall Study|Physician Decision|0|||
164363843|NCT02510794|593709482|FG002|Overall Study|Physician Decision|0|||
164363844|NCT02510794|593709483|FG003|Overall Study|Physician Decision|0|||
164363845|NCT02510794|593709480|FG000|Overall Study|Protocol Violation|0|||
164363846|NCT02510794|593709481|FG001|Overall Study|Protocol Violation|0|||
164363847|NCT02510794|593709482|FG002|Overall Study|Protocol Violation|1|||
164363848|NCT02510794|593709483|FG003|Overall Study|Protocol Violation|0|||
164363849|NCT02510794|593709480|FG000|Overall Study|Withdrawal by Subject|1|||
164363850|NCT02510794|593709481|FG001|Overall Study|Withdrawal by Subject|2|||
164363851|NCT02510794|593709482|FG002|Overall Study|Withdrawal by Subject|4|||
164011441|NCT03554005|592406797|FG002|Overall Study|Disease Progression|1|||
164363852|NCT02510794|593709483|FG003|Overall Study|Withdrawal by Subject|3|||
164363853|NCT01856790|593709484|FG000|Closed Loop Control|Withdrawal by Subject|2|||
164363854|NCT01856790|593709484|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
164363855|NCT04091646|593709485|FG000|Overall Study|Adverse Event|2|||
164363856|NCT04091646|593709486|FG001|Overall Study|Adverse Event|1|||
164363857|NCT04091646|593709485|FG000|Overall Study|Lost to Follow-up|6|||
164363858|NCT04091646|593709486|FG001|Overall Study|Lost to Follow-up|2|||
164363859|NCT04091646|593709485|FG000|Overall Study|Protocol Violation|0|||
164363860|NCT04091646|593709486|FG001|Overall Study|Protocol Violation|1|||
164363861|NCT04091646|593709485|FG000|Overall Study|Withdrawal by Subject|4|||
164363862|NCT04091646|593709486|FG001|Overall Study|Withdrawal by Subject|1|||
164363863|NCT04091646|593709485|FG000|Overall Study|Participant Incarcerated|1|||
164363864|NCT04091646|593709486|FG001|Overall Study|Participant Incarcerated|0|||
164363865|NCT03168464|593709489|FG000|Overall Study|Death|9|||
164363866|NCT03168464|593709489|FG000|Overall Study|Progression of disease|6|||
164363867|NCT00634088|593709490|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
164363868|NCT00634088|593709491|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
164363869|NCT00634088|593709492|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
164363870|NCT00634088|593709493|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
164363871|NCT00634088|593709490|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
164363872|NCT00634088|593709491|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
164363873|NCT00634088|593709492|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
164363874|NCT00634088|593709493|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
164363875|NCT00634088|593709490|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
164363876|NCT00634088|593709491|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
164363877|NCT00634088|593709492|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
164363878|NCT00634088|593709493|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
164363879|NCT00634088|593709490|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
164363880|NCT00634088|593709491|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
164363881|NCT00634088|593709492|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
164363882|NCT00634088|593709493|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
164363883|NCT00634088|593709490|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
164363884|NCT00634088|593709491|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
164363885|NCT00634088|593709492|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
164363886|NCT00634088|593709493|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
164363887|NCT00634088|593709490|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
164363888|NCT00634088|593709491|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
164363889|NCT00634088|593709492|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
164363890|NCT00634088|593709493|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
164363891|NCT02438722|593709494|FG000|Overall Study|Adverse Event|12|||
164363892|NCT02438722|593709495|FG001|Overall Study|Adverse Event|9|||
164363893|NCT02438722|593709494|FG000|Overall Study|Refusal unrelated to AE|2|||
164363894|NCT02438722|593709495|FG001|Overall Study|Refusal unrelated to AE|5|||
164363895|NCT02438722|593709494|FG000|Overall Study|Disease progression/relapse|46|||
164363896|NCT02438722|593709495|FG001|Overall Study|Disease progression/relapse|51|||
164363897|NCT02438722|593709494|FG000|Overall Study|Death|0|||
164363898|NCT02438722|593709495|FG001|Overall Study|Death|3|||
164363899|NCT02438722|593709494|FG000|Overall Study|Physician Decision|2|||
164363900|NCT02438722|593709495|FG001|Overall Study|Physician Decision|2|||
164363901|NCT02438722|593709494|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
164363902|NCT02438722|593709495|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
164363903|NCT02438722|593709494|FG000|Overall Study|Withdrawal by Subject|0|||
164363904|NCT02438722|593709495|FG001|Overall Study|Withdrawal by Subject|1|||
164363905|NCT02438722|593709494|FG000|Overall Study|On protocol treatment|15|||
164363906|NCT02438722|593709495|FG001|Overall Study|On protocol treatment|14|||
164363907|NCT02438722|593709494|FG000|Overall Study|Did not receive protocol treatment|5|||
164363908|NCT02438722|593709495|FG001|Overall Study|Did not receive protocol treatment|0|||
164363909|NCT04356963|593709499|FG000|First Session|Withdrawal by Subject|1|||
164363910|NCT04356963|593709499|FG000|Second Session|Withdrawal by Subject|3|||
163901713|NCT03656718|592011466|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
163901714|NCT03656718|592011460|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163901715|NCT03656718|592011461|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163901716|NCT03656718|592011462|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163901717|NCT03656718|592011463|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
163901718|NCT03656718|592011464|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
164011442|NCT03554005|592406798|FG003|Overall Study|Disease Progression|1|||
164363911|NCT04356963|593709499|FG000|Second Session|Lost to Follow-up|1|||
164363912|NCT04356963|593709499|FG000|Third Session|Lost to Follow-up|6|||
164011443|NCT03554005|592406799|FG004|Overall Study|Disease Progression|5|||
164363913|NCT04356963|593709499|FG000|Third Session|Withdrawal by Subject|1|||
164363914|NCT01577758|593709501|FG000|Dose Escalation Phase|Adverse Event|0|||
164363915|NCT01577758|593709502|FG001|Dose Escalation Phase|Adverse Event|0|||
164363916|NCT01577758|593709503|FG002|Dose Escalation Phase|Adverse Event|0|||
164011444|NCT03554005|592406800|FG005|Overall Study|Disease Progression|6|||
164011445|NCT03554005|592406795|FG000|Overall Study|Adverse Event|0|||
164011446|NCT03554005|592406796|FG001|Overall Study|Adverse Event|0|||
164363917|NCT01577758|593709504|FG003|Dose Escalation Phase|Adverse Event|0|||
164363918|NCT01577758|593709505|FG004|Dose Escalation Phase|Adverse Event|0|||
164363919|NCT01577758|593709506|FG005|Dose Escalation Phase|Adverse Event|2|||
164363920|NCT01577758|593709507|FG006|Dose Escalation Phase|Adverse Event|1|||
164363921|NCT01577758|593709508|FG007|Dose Escalation Phase|Adverse Event|0|||
164363922|NCT01577758|593709501|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363923|NCT01577758|593709502|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363924|NCT01577758|593709503|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
164363925|NCT01577758|593709504|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363926|NCT01577758|593709505|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
164363927|NCT01577758|593709506|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
164363928|NCT01577758|593709507|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363929|NCT01577758|593709508|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
164363930|NCT01577758|593709501|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164363931|NCT01577758|593709502|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164363932|NCT01577758|593709503|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164363933|NCT01577758|593709504|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164363934|NCT01577758|593709505|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
164363935|NCT01577758|593709506|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
164363936|NCT01577758|593709507|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
164363937|NCT01577758|593709508|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
164363938|NCT01577758|593709501|FG000|Dose Escalation Phase|Progression Disease|2|||
164363939|NCT01577758|593709502|FG001|Dose Escalation Phase|Progression Disease|2|||
164363940|NCT01577758|593709503|FG002|Dose Escalation Phase|Progression Disease|1|||
164363941|NCT01577758|593709504|FG003|Dose Escalation Phase|Progression Disease|2|||
164363942|NCT01577758|593709505|FG004|Dose Escalation Phase|Progression Disease|5|||
164363943|NCT01577758|593709506|FG005|Dose Escalation Phase|Progression Disease|0|||
164363944|NCT01577758|593709507|FG006|Dose Escalation Phase|Progression Disease|0|||
164363945|NCT01577758|593709508|FG007|Dose Escalation Phase|Progression Disease|0|||
164363946|NCT01577758|593709501|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363947|NCT01577758|593709502|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363948|NCT01577758|593709503|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363949|NCT01577758|593709504|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363950|NCT01577758|593709505|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363951|NCT01577758|593709506|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363952|NCT01577758|593709507|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
164363953|NCT01577758|593709508|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
164363954|NCT01577758|593709501|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363955|NCT01577758|593709502|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363956|NCT01577758|593709503|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363957|NCT01577758|593709504|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363958|NCT01577758|593709505|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363959|NCT01577758|593709506|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363960|NCT01577758|593709507|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
164363961|NCT01577758|593709508|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
164363962|NCT01577758|593709501|FG000|mCRC Expansion Phase|Progression Disease|0|||
164363963|NCT01577758|593709502|FG001|mCRC Expansion Phase|Progression Disease|0|||
164363964|NCT01577758|593709503|FG002|mCRC Expansion Phase|Progression Disease|0|||
164363965|NCT01577758|593709504|FG003|mCRC Expansion Phase|Progression Disease|0|||
164363966|NCT01577758|593709505|FG004|mCRC Expansion Phase|Progression Disease|0|||
164363967|NCT01577758|593709506|FG005|mCRC Expansion Phase|Progression Disease|0|||
164363968|NCT01577758|593709507|FG006|mCRC Expansion Phase|Progression Disease|0|||
164363969|NCT01577758|593709508|FG007|mCRC Expansion Phase|Progression Disease|19|||
164363970|NCT02410954|593709510|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
164363971|NCT02410954|593709511|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
164363972|NCT02410954|593709510|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
164011447|NCT03554005|592406797|FG002|Overall Study|Adverse Event|0|||
164363973|NCT02410954|593709511|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
164363974|NCT00791518|593709513|FG000|Overall Study|Protocol Violation|93|||
164363975|NCT02488681|593709514|FG000|Overall Study|Implant unsuccessful|7|||
164363976|NCT00720057|593709515|FG000|Overall Study|Lost to Follow-up|0|||
164363977|NCT00720057|593709516|FG001|Overall Study|Lost to Follow-up|2|||
164363978|NCT00720057|593709515|FG000|Overall Study|Protocol Violation|1|||
164363979|NCT00720057|593709516|FG001|Overall Study|Protocol Violation|0|||
164363980|NCT00720057|593709515|FG000|Overall Study|Withdrawal by Subject|0|||
164363981|NCT00720057|593709516|FG001|Overall Study|Withdrawal by Subject|1|||
164363982|NCT04969224|593709521|FG000|Overall Study|Adverse Event|1|||
164363983|NCT04969224|593709521|FG000|Overall Study|Enrolled but never dosed|1|||
164363984|NCT04191382|593709525|FG000|Overall Study|Withdrawal by Subject|1|||
164363985|NCT04191382|593709526|FG001|Overall Study|Withdrawal by Subject|0|||
164363986|NCT04191382|593709527|FG002|Overall Study|Withdrawal by Subject|0|||
164363987|NCT03054870|593709533|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
164363988|NCT03054870|593709533|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
164363989|NCT02009046|593709534|FG000|Overall Study|Lost to Follow-up|256|||
164363990|NCT02009046|593709535|FG001|Overall Study|Lost to Follow-up|206|||
164363991|NCT00271609|593709543|FG000|Overall Study|Adverse Event|11|||
164363992|NCT00271609|593709544|FG001|Overall Study|Adverse Event|3|||
164363993|NCT00271609|593709543|FG000|Overall Study|Withdrawal by Subject|2|||
164363994|NCT00271609|593709544|FG001|Overall Study|Withdrawal by Subject|0|||
164363995|NCT03341533|593709545|FG000|Overall Study|Withdrawal by Subject|1|||
164363996|NCT03341533|593709546|FG001|Overall Study|Withdrawal by Subject|1|||
164363997|NCT03341533|593709545|FG000|Overall Study|Not eligible after randomization|2|||
164363998|NCT03341533|593709546|FG001|Overall Study|Not eligible after randomization|1|||
164363999|NCT00643682|593709547|FG000|Overall Study|did not keep appointment|522|||
164364000|NCT00643682|593709548|FG001|Overall Study|did not keep appointment|509|||
164364001|NCT00003641|593709555|FG000|Overall Study|Withdrawal by Subject|0|||
164364002|NCT00003641|593709556|FG001|Overall Study|Withdrawal by Subject|100|||
164364003|NCT00003641|593709555|FG000|Overall Study|Adverse Event|0|||
164364004|NCT00003641|593709556|FG001|Overall Study|Adverse Event|38|||
164364005|NCT00003641|593709555|FG000|Overall Study|Disease progression|0|||
164364006|NCT00003641|593709556|FG001|Overall Study|Disease progression|2|||
164364007|NCT00003641|593709555|FG000|Overall Study|Unknown/missing|0|||
164364008|NCT00003641|593709556|FG001|Overall Study|Unknown/missing|22|||
164364009|NCT00003641|593709555|FG000|Overall Study|Should not receive interferon therapy|2|||
164364010|NCT00003641|593709556|FG001|Overall Study|Should not receive interferon therapy|0|||
164364011|NCT00003641|593709555|FG000|Overall Study|Never started interferon|567|||
164364012|NCT00003641|593709556|FG001|Overall Study|Never started interferon|12|||
164364013|NCT01782664|593709557|FG000|Overall Study|Adverse Event|2|||
164364014|NCT01782664|593709558|FG001|Overall Study|Adverse Event|2|||
164364015|NCT01782664|593709559|FG002|Overall Study|Adverse Event|2|||
164364016|NCT01782664|593709560|FG003|Overall Study|Adverse Event|2|||
164364017|NCT01782664|593709561|FG004|Overall Study|Adverse Event|0|||
164364018|NCT01782664|593709562|FG005|Overall Study|Adverse Event|0|||
164364019|NCT01782664|593709557|FG000|Overall Study|Lack of Efficacy|2|||
164364020|NCT01782664|593709558|FG001|Overall Study|Lack of Efficacy|0|||
164364021|NCT01782664|593709559|FG002|Overall Study|Lack of Efficacy|2|||
164364022|NCT01782664|593709560|FG003|Overall Study|Lack of Efficacy|2|||
164364023|NCT01782664|593709561|FG004|Overall Study|Lack of Efficacy|0|||
164364024|NCT01782664|593709562|FG005|Overall Study|Lack of Efficacy|0|||
164364025|NCT01782664|593709557|FG000|Overall Study|Protocol Violation|0|||
164364026|NCT01782664|593709558|FG001|Overall Study|Protocol Violation|1|||
164364027|NCT01782664|593709559|FG002|Overall Study|Protocol Violation|0|||
164364028|NCT01782664|593709560|FG003|Overall Study|Protocol Violation|1|||
164364029|NCT01782664|593709561|FG004|Overall Study|Protocol Violation|0|||
164364030|NCT01782664|593709562|FG005|Overall Study|Protocol Violation|0|||
164364031|NCT01782664|593709557|FG000|Overall Study|Withdrawal by Subject|2|||
164364032|NCT01782664|593709558|FG001|Overall Study|Withdrawal by Subject|2|||
164364033|NCT01782664|593709559|FG002|Overall Study|Withdrawal by Subject|0|||
164011448|NCT03554005|592406798|FG003|Overall Study|Adverse Event|0|||
164011449|NCT03554005|592406799|FG004|Overall Study|Adverse Event|0|||
164011450|NCT03554005|592406800|FG005|Overall Study|Adverse Event|3|||
164011451|NCT03554005|592406795|FG000|Overall Study|Physician Decision|0|||
164011452|NCT03554005|592406796|FG001|Overall Study|Physician Decision|0|||
164011453|NCT03554005|592406797|FG002|Overall Study|Physician Decision|0|||
164011454|NCT03554005|592406798|FG003|Overall Study|Physician Decision|0|||
164011455|NCT03554005|592406799|FG004|Overall Study|Physician Decision|1|||
164011456|NCT03554005|592406800|FG005|Overall Study|Physician Decision|0|||
164011457|NCT03554005|592406795|FG000|Overall Study|Other|0|||
164011458|NCT03554005|592406796|FG001|Overall Study|Other|0|||
164364034|NCT01782664|593709560|FG003|Overall Study|Withdrawal by Subject|0|||
164364035|NCT01782664|593709561|FG004|Overall Study|Withdrawal by Subject|0|||
164364036|NCT01782664|593709562|FG005|Overall Study|Withdrawal by Subject|0|||
164364037|NCT04170348|593709563|FG000|Overall Study|Lost to Follow-up|2|||
164364038|NCT04170348|593709564|FG001|Overall Study|Lost to Follow-up|2|||
164364039|NCT04170348|593709563|FG000|Overall Study|Withdrawal by Subject|1|||
164364040|NCT04170348|593709564|FG001|Overall Study|Withdrawal by Subject|5|||
164364041|NCT04170348|593709563|FG000|Overall Study|Non-adherence|1|||
164364042|NCT04170348|593709564|FG001|Overall Study|Non-adherence|1|||
164364043|NCT04170348|593709563|FG000|Overall Study|Adverse Event|1|||
164364044|NCT04170348|593709564|FG001|Overall Study|Adverse Event|0|||
164364045|NCT01082965|593709566|FG000|Overall Study|Protocol Violation|0|||
164364046|NCT01082965|593709567|FG001|Overall Study|Protocol Violation|1|||
164011459|NCT03554005|592406797|FG002|Overall Study|Other|0|||
164364047|NCT01082965|593709566|FG000|Overall Study|Other|1|||
164011460|NCT03554005|592406798|FG003|Overall Study|Other|0|||
164011461|NCT03554005|592406799|FG004|Overall Study|Other|0|||
164011462|NCT03554005|592406800|FG005|Overall Study|Other|1|||
164011463|NCT00631488|592406801|FG000|Overall Study|Adverse Event|1|||
164011464|NCT00631488|592406802|FG001|Overall Study|Adverse Event|0|||
164011465|NCT00631488|592406803|FG002|Overall Study|Adverse Event|0|||
164011466|NCT00631488|592406801|FG000|Overall Study|Lost to Follow-up|2|||
164011467|NCT00631488|592406802|FG001|Overall Study|Lost to Follow-up|2|||
164011468|NCT00631488|592406803|FG002|Overall Study|Lost to Follow-up|0|||
164011469|NCT00631488|592406801|FG000|Overall Study|Physician Decision|1|||
164011470|NCT00631488|592406802|FG001|Overall Study|Physician Decision|0|||
164011471|NCT00631488|592406803|FG002|Overall Study|Physician Decision|1|||
164011472|NCT00631488|592406801|FG000|Overall Study|Protocol Violation|0|||
164364048|NCT01082965|593709567|FG001|Overall Study|Other|1|||
164364049|NCT03642717|593709568|FG000|Overall Study|Lost to Follow-up|2|||
164364050|NCT03642717|593709568|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
164364051|NCT03642717|593709568|FG000|Overall Study|Taken study drug prior to contract date|3|||
164364052|NCT02587065|593709569|FG000|Overall Study|Adverse Event|14|||
164364053|NCT02587065|593709569|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
164364054|NCT02587065|593709569|FG000|Overall Study|Non-adherence to the Protocol|3|||
164364055|NCT02587065|593709569|FG000|Overall Study|Discontinuation of Study Medication|2|||
164364056|NCT02587065|593709569|FG000|Overall Study|Reason not Specified|3|||
164364057|NCT01559012|593709570|FG000|Overall Study|Withdrawal by Subject|0|||
164364058|NCT01559012|593709571|FG001|Overall Study|Withdrawal by Subject|1|||
164364059|NCT00946712|593709572|FG000|Overall Study|Adverse Event|118|||
164364060|NCT00946712|593709573|FG001|Overall Study|Adverse Event|124|||
164364061|NCT00946712|593709572|FG000|Overall Study|Disease progression|308|||
164364062|NCT00946712|593709573|FG001|Overall Study|Disease progression|404|||
164364063|NCT00946712|593709572|FG000|Overall Study|Death|21|||
164364064|NCT00946712|593709573|FG001|Overall Study|Death|22|||
164364065|NCT00946712|593709572|FG000|Overall Study|No treatment given|25|||
164364066|NCT00946712|593709573|FG001|Overall Study|No treatment given|29|||
164364067|NCT00946712|593709572|FG000|Overall Study|Other reasons|61|||
164364068|NCT00946712|593709573|FG001|Overall Study|Other reasons|73|||
164364069|NCT00946712|593709572|FG000|Overall Study|On Treatment|0|||
164364070|NCT00946712|593709573|FG001|Overall Study|On Treatment|4|||
164364071|NCT00946712|593709572|FG000|Overall Study|Ineligible|14|||
164364072|NCT00946712|593709573|FG001|Overall Study|Ineligible|6|||
164364073|NCT00302458|593709576|FG000|Overall Study|Lost to Follow-up|1|||
164364074|NCT00302458|593709576|FG000|Overall Study|Ineligible after screening|1|||
164364075|NCT00302458|593709576|FG000|Overall Study|Withdrawal by Subject|1|||
164364076|NCT00853723|593709577|FG000|Overall Study|Adverse Event|3|||
164364077|NCT00853723|593709578|FG001|Overall Study|Adverse Event|4|||
163901719|NCT03656718|592011465|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
163901720|NCT03656718|592011466|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
163901721|NCT03656718|592011460|FG000|Treatment Period Part C|Disease progression|0|||
164364078|NCT00853723|593709579|FG002|Overall Study|Adverse Event|1|||
164364079|NCT00853723|593709577|FG000|Overall Study|Withdrawal by Subject|2|||
164364080|NCT00853723|593709578|FG001|Overall Study|Withdrawal by Subject|1|||
164364081|NCT00853723|593709579|FG002|Overall Study|Withdrawal by Subject|0|||
164364082|NCT00853723|593709577|FG000|Overall Study|Protocol Violation|1|||
164364083|NCT00853723|593709578|FG001|Overall Study|Protocol Violation|2|||
164364084|NCT00853723|593709579|FG002|Overall Study|Protocol Violation|1|||
164364085|NCT04248933|593709580|FG000|Overall Study|Lost to Follow-up|9|||
164364086|NCT04248933|593709580|FG000|Overall Study|Withdrawal by Subject|2|||
164364087|NCT02642432|593709583|FG000|Overall Study|Adverse Event|2|||
164364088|NCT02642432|593709583|FG000|Overall Study|Withdrew Consent|1|||
164364089|NCT02642432|593709583|FG000|Overall Study|Lost to Follow-up|2|||
163901722|NCT03656718|592011461|FG001|Treatment Period Part C|Disease progression|0|||
163901723|NCT03656718|592011462|FG002|Treatment Period Part C|Disease progression|0|||
164364090|NCT02642432|593709583|FG000|Overall Study|Other|3|||
163901724|NCT03656718|592011463|FG003|Treatment Period Part C|Disease progression|0|||
163901725|NCT03656718|592011464|FG004|Treatment Period Part C|Disease progression|12|||
163901726|NCT03656718|592011465|FG005|Treatment Period Part C|Disease progression|0|||
164364091|NCT02447081|593709584|FG000|Overall Study|Death|161|||
164364092|NCT02447081|593709584|FG000|Overall Study|Lost to Follow-up|36|||
164364093|NCT02447081|593709584|FG000|Overall Study|Visit not completed|17|||
164364094|NCT02447081|593709584|FG000|Overall Study|unsuccessful implant procedure|10|||
163901727|NCT03656718|592011466|FG006|Treatment Period Part C|Disease progression|0|||
164364095|NCT02867709|593709587|FG000|Treatment Period|Adverse Event|1|||
164364096|NCT02867709|593709588|FG001|Treatment Period|Adverse Event|1|||
164364097|NCT02867709|593709589|FG002|Treatment Period|Adverse Event|2|||
164364098|NCT02867709|593709587|FG000|Treatment Period|Withdrawal of Consent|7|||
163901728|NCT03656718|592011460|FG000|Treatment Period Part C|Death|0|||
163901729|NCT03656718|592011461|FG001|Treatment Period Part C|Death|0|||
164011473|NCT00631488|592406802|FG001|Overall Study|Protocol Violation|0|||
164011474|NCT00631488|592406803|FG002|Overall Study|Protocol Violation|1|||
164364099|NCT02867709|593709588|FG001|Treatment Period|Withdrawal of Consent|9|||
164364100|NCT02867709|593709589|FG002|Treatment Period|Withdrawal of Consent|8|||
164364101|NCT02867709|593709587|FG000|Treatment Period|Lost to Follow-up|17|||
164364102|NCT02867709|593709588|FG001|Treatment Period|Lost to Follow-up|20|||
164364103|NCT02867709|593709589|FG002|Treatment Period|Lost to Follow-up|20|||
164364104|NCT02867709|593709587|FG000|Treatment Period|Lack of Qualifying Event|42|||
164364105|NCT02867709|593709588|FG001|Treatment Period|Lack of Qualifying Event|55|||
164364106|NCT02867709|593709589|FG002|Treatment Period|Lack of Qualifying Event|42|||
164364107|NCT02867709|593709587|FG000|Treatment Period|Protocol Violation|3|||
164364108|NCT02867709|593709588|FG001|Treatment Period|Protocol Violation|2|||
164364109|NCT02867709|593709589|FG002|Treatment Period|Protocol Violation|3|||
164364110|NCT02867709|593709587|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
164364111|NCT02867709|593709588|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
164364112|NCT02867709|593709589|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
164364113|NCT02867709|593709587|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
164364114|NCT02867709|593709588|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
164364115|NCT02867709|593709589|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
164364116|NCT02867709|593709587|FG000|Safety Follow-up Period|Pregnancy|0|||
164364117|NCT02867709|593709588|FG001|Safety Follow-up Period|Pregnancy|1|||
164364118|NCT02867709|593709589|FG002|Safety Follow-up Period|Pregnancy|0|||
164364119|NCT02867709|593709587|FG000|Safety Follow-up Period|Protocol Violation|0|||
164364120|NCT02867709|593709588|FG001|Safety Follow-up Period|Protocol Violation|1|||
164364121|NCT02867709|593709589|FG002|Safety Follow-up Period|Protocol Violation|1|||
164364122|NCT03188094|593709592|FG000|Overall Study|Screen failure|1|||
164364123|NCT03188094|593709593|FG001|Overall Study|Screen failure|0|||
164364124|NCT03188094|593709594|FG002|Overall Study|Screen failure|0|||
164364125|NCT03188094|593709592|FG000|Overall Study|Pregnancy|3|||
164364126|NCT03188094|593709593|FG001|Overall Study|Pregnancy|0|||
164364127|NCT03188094|593709594|FG002|Overall Study|Pregnancy|0|||
164364128|NCT03188094|593709592|FG000|Overall Study|Ineligible|1|||
164364129|NCT03188094|593709593|FG001|Overall Study|Ineligible|0|||
164364130|NCT03188094|593709594|FG002|Overall Study|Ineligible|0|||
164364131|NCT03188094|593709592|FG000|Overall Study|Lost to Follow-up|0|||
164364132|NCT03188094|593709593|FG001|Overall Study|Lost to Follow-up|0|||
164364133|NCT03188094|593709594|FG002|Overall Study|Lost to Follow-up|17|||
164364134|NCT01894581|593709595|FG000|Overall Study|Withdrawal by Subject|2|||
164364135|NCT01894581|593709596|FG001|Overall Study|Withdrawal by Subject|3|||
164364136|NCT01894581|593709595|FG000|Overall Study|Screen Failure|3|||
164364137|NCT01894581|593709596|FG001|Overall Study|Screen Failure|4|||
164364138|NCT03313804|593709597|FG000|Treatment|Death|5|||
164364139|NCT03313804|593709597|FG000|Treatment|still on treatment|2|||
164364140|NCT03313804|593709597|FG000|Follow Up|still on follow up|3|||
164364141|NCT03795298|593709598|FG000|Overall Study|Death|34|||
164364142|NCT03795298|593709599|FG001|Overall Study|Death|29|||
164364143|NCT03795298|593709598|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
164364144|NCT03795298|593709599|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
164364145|NCT03795298|593709598|FG000|Overall Study|Lost to Follow-up|28|||
164364146|NCT03795298|593709599|FG001|Overall Study|Lost to Follow-up|17|||
164364147|NCT03795298|593709598|FG000|Overall Study|Physician Decision|5|||
164364148|NCT03795298|593709599|FG001|Overall Study|Physician Decision|4|||
164364149|NCT03795298|593709598|FG000|Overall Study|Withdrawal by Subject|43|||
164364150|NCT03795298|593709599|FG001|Overall Study|Withdrawal by Subject|28|||
164364151|NCT03795298|593709598|FG000|Overall Study|Reason not reported|7|||
164364152|NCT03795298|593709599|FG001|Overall Study|Reason not reported|9|||
164364153|NCT03971695|593711480|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364154|NCT03971695|593711481|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364155|NCT03971695|593711482|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364156|NCT03971695|593711483|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
164364157|NCT03971695|593711484|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
164364158|NCT03971695|593711485|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364159|NCT03971695|593711486|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364160|NCT03971695|593711487|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364161|NCT03971695|593711488|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
164364162|NCT03971695|593711489|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
164364163|NCT03971695|593711490|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
164364164|NCT03971695|593711491|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
164364165|NCT03971695|593711492|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
164364166|NCT00156533|593711493|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
164364167|NCT00156533|593711494|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
164364168|NCT00156533|593711495|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
164364169|NCT00156533|593711496|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
164364170|NCT00156533|593711493|FG000|Overall Study|Withdrawal by Subject|1|||
164364171|NCT00156533|593711494|FG001|Overall Study|Withdrawal by Subject|0|||
164364172|NCT00156533|593711495|FG002|Overall Study|Withdrawal by Subject|0|||
164364173|NCT00156533|593711496|FG003|Overall Study|Withdrawal by Subject|1|||
164092244|NCT01458405|592702028|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
164092245|NCT03499964|592702029|FG000|Overall Study|Lack of Efficacy|6|||
164364174|NCT00156533|593711493|FG000|Overall Study|Failed Screening|1|||
164364175|NCT00156533|593711494|FG001|Overall Study|Failed Screening|0|||
164364176|NCT00156533|593711495|FG002|Overall Study|Failed Screening|1|||
164364177|NCT00156533|593711496|FG003|Overall Study|Failed Screening|1|||
164364178|NCT01881230|593711497|FG000|Overall Study|Death|2|||
164364179|NCT01881230|593711498|FG001|Overall Study|Death|0|||
164364180|NCT01881230|593711499|FG002|Overall Study|Death|1|||
164364181|NCT01881230|593711497|FG000|Overall Study|Adverse Event|9|||
164364182|NCT01881230|593711498|FG001|Overall Study|Adverse Event|13|||
164364183|NCT01881230|593711499|FG002|Overall Study|Adverse Event|12|||
164364184|NCT01881230|593711497|FG000|Overall Study|Progressive Disease|31|||
164364185|NCT01881230|593711498|FG001|Overall Study|Progressive Disease|35|||
164364186|NCT01881230|593711499|FG002|Overall Study|Progressive Disease|36|||
164364187|NCT01881230|593711497|FG000|Overall Study|Symptomatic Deterioration|3|||
164364188|NCT01881230|593711498|FG001|Overall Study|Symptomatic Deterioration|3|||
164364189|NCT01881230|593711499|FG002|Overall Study|Symptomatic Deterioration|1|||
164364190|NCT01881230|593711497|FG000|Overall Study|Withdrawal by Subject|6|||
164364191|NCT01881230|593711498|FG001|Overall Study|Withdrawal by Subject|4|||
164364192|NCT01881230|593711499|FG002|Overall Study|Withdrawal by Subject|6|||
164364193|NCT01881230|593711497|FG000|Overall Study|Physician Decision|4|||
164364194|NCT01881230|593711498|FG001|Overall Study|Physician Decision|3|||
164364195|NCT01881230|593711499|FG002|Overall Study|Physician Decision|6|||
164364196|NCT01881230|593711497|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164364197|NCT01881230|593711498|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164364198|NCT01881230|593711499|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164364199|NCT01881230|593711497|FG000|Overall Study|Given Commercially Available Drug|0|||
164364200|NCT01881230|593711498|FG001|Overall Study|Given Commercially Available Drug|0|||
164364201|NCT01881230|593711499|FG002|Overall Study|Given Commercially Available Drug|2|||
164364202|NCT01881230|593711497|FG000|Overall Study|Protocol Violation|1|||
164364203|NCT01881230|593711498|FG001|Overall Study|Protocol Violation|1|||
164364204|NCT01881230|593711499|FG002|Overall Study|Protocol Violation|0|||
164364205|NCT01881230|593711497|FG000|Overall Study|Miscellaneous|3|||
164364206|NCT01881230|593711498|FG001|Overall Study|Miscellaneous|3|||
164364207|NCT01881230|593711499|FG002|Overall Study|Miscellaneous|0|||
164364208|NCT01881230|593711497|FG000|Overall Study|Untreated: Other|0|||
164364209|NCT01881230|593711498|FG001|Overall Study|Untreated: Other|0|||
164364210|NCT01881230|593711499|FG002|Overall Study|Untreated: Other|1|||
164364211|NCT01881230|593711497|FG000|Overall Study|Untreated: Death|0|||
164364212|NCT01881230|593711498|FG001|Overall Study|Untreated: Death|0|||
164364213|NCT01881230|593711499|FG002|Overall Study|Untreated: Death|1|||
164364214|NCT01881230|593711497|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
164364215|NCT01881230|593711498|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
164364216|NCT01881230|593711499|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
164364217|NCT05129488|593711500|FG000|Overall Study|Protocol Violation|3|||
164364218|NCT02515942|593711501|FG000|Overall Study|Adverse Event|5|||
164364219|NCT02515942|593711502|FG001|Overall Study|Adverse Event|0|||
164364220|NCT02515942|593711503|FG002|Overall Study|Adverse Event|0|||
164364221|NCT02515942|593711501|FG000|Overall Study|Death|0|||
164364222|NCT02515942|593711502|FG001|Overall Study|Death|0|||
164364223|NCT02515942|593711503|FG002|Overall Study|Death|1|||
164364224|NCT02515942|593711501|FG000|Overall Study|Lack of Efficacy|0|||
164364225|NCT02515942|593711502|FG001|Overall Study|Lack of Efficacy|0|||
164364226|NCT02515942|593711503|FG002|Overall Study|Lack of Efficacy|1|||
164364227|NCT02515942|593711501|FG000|Overall Study|Lost to Follow-up|2|||
164364228|NCT02515942|593711502|FG001|Overall Study|Lost to Follow-up|0|||
164364229|NCT02515942|593711503|FG002|Overall Study|Lost to Follow-up|0|||
164364230|NCT02515942|593711501|FG000|Overall Study|Withdrawal by Subject|0|||
164364231|NCT02515942|593711502|FG001|Overall Study|Withdrawal by Subject|3|||
164364232|NCT02515942|593711503|FG002|Overall Study|Withdrawal by Subject|2|||
164092246|NCT03499964|592702030|FG001|Overall Study|Lack of Efficacy|26|||
164364233|NCT03616912|593711504|FG000|Overall Study|Adverse Event|17|||
164092247|NCT03499964|592702029|FG000|Overall Study|Adverse Event|1|||
164092248|NCT03499964|592702030|FG001|Overall Study|Adverse Event|0|||
164092249|NCT03499964|592702029|FG000|Overall Study|Death|1|||
164364234|NCT03616912|593711505|FG001|Overall Study|Adverse Event|21|||
164364235|NCT03616912|593711506|FG002|Overall Study|Adverse Event|9|||
164364236|NCT03616912|593711507|FG003|Overall Study|Adverse Event|0|||
164364237|NCT03616912|593711508|FG004|Overall Study|Adverse Event|0|||
164364238|NCT03616912|593711509|FG005|Overall Study|Adverse Event|0|||
164364239|NCT03616912|593711504|FG000|Overall Study|Death|1|||
164364240|NCT03616912|593711505|FG001|Overall Study|Death|1|||
164364241|NCT03616912|593711506|FG002|Overall Study|Death|0|||
164364242|NCT03616912|593711507|FG003|Overall Study|Death|0|||
164364243|NCT03616912|593711508|FG004|Overall Study|Death|0|||
164092250|NCT03499964|592702030|FG001|Overall Study|Death|0|||
164364244|NCT03616912|593711509|FG005|Overall Study|Death|0|||
164364245|NCT03616912|593711504|FG000|Overall Study|Lack of Efficacy|13|||
164364246|NCT03616912|593711505|FG001|Overall Study|Lack of Efficacy|6|||
164364247|NCT03616912|593711506|FG002|Overall Study|Lack of Efficacy|8|||
164364248|NCT03616912|593711507|FG003|Overall Study|Lack of Efficacy|4|||
164364249|NCT03616912|593711508|FG004|Overall Study|Lack of Efficacy|5|||
164364250|NCT03616912|593711509|FG005|Overall Study|Lack of Efficacy|1|||
164364251|NCT03616912|593711504|FG000|Overall Study|Lost to Follow-up|1|||
164364252|NCT03616912|593711505|FG001|Overall Study|Lost to Follow-up|2|||
164364253|NCT03616912|593711506|FG002|Overall Study|Lost to Follow-up|3|||
164364254|NCT03616912|593711507|FG003|Overall Study|Lost to Follow-up|0|||
164364255|NCT03616912|593711508|FG004|Overall Study|Lost to Follow-up|0|||
164364256|NCT03616912|593711509|FG005|Overall Study|Lost to Follow-up|0|||
164364257|NCT03616912|593711504|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
164364258|NCT03616912|593711505|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
164364259|NCT03616912|593711506|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
164364260|NCT03616912|593711507|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
164364261|NCT03616912|593711508|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
164364262|NCT03616912|593711509|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
164364263|NCT03616912|593711504|FG000|Overall Study|Withdrawal by Subject|12|||
164364264|NCT03616912|593711505|FG001|Overall Study|Withdrawal by Subject|12|||
164364265|NCT03616912|593711506|FG002|Overall Study|Withdrawal by Subject|15|||
164364266|NCT03616912|593711507|FG003|Overall Study|Withdrawal by Subject|2|||
164364267|NCT03616912|593711508|FG004|Overall Study|Withdrawal by Subject|0|||
164364268|NCT03616912|593711509|FG005|Overall Study|Withdrawal by Subject|2|||
164364269|NCT03616912|593711504|FG000|Overall Study|Study Terminated by Sponsor|0|||
164364270|NCT03616912|593711505|FG001|Overall Study|Study Terminated by Sponsor|0|||
164364271|NCT03616912|593711506|FG002|Overall Study|Study Terminated by Sponsor|0|||
164364272|NCT03616912|593711507|FG003|Overall Study|Study Terminated by Sponsor|10|||
164364273|NCT03616912|593711508|FG004|Overall Study|Study Terminated by Sponsor|9|||
164364274|NCT03616912|593711509|FG005|Overall Study|Study Terminated by Sponsor|11|||
164364275|NCT03616912|593711504|FG000|Overall Study|Protocol Deviation|1|||
164364276|NCT03616912|593711505|FG001|Overall Study|Protocol Deviation|1|||
164364277|NCT03616912|593711506|FG002|Overall Study|Protocol Deviation|0|||
164364278|NCT03616912|593711507|FG003|Overall Study|Protocol Deviation|0|||
164364279|NCT03616912|593711508|FG004|Overall Study|Protocol Deviation|0|||
164364280|NCT03616912|593711509|FG005|Overall Study|Protocol Deviation|0|||
164364281|NCT03616912|593711504|FG000|Overall Study|Pregnancy|1|||
164364282|NCT03616912|593711505|FG001|Overall Study|Pregnancy|0|||
164364283|NCT03616912|593711506|FG002|Overall Study|Pregnancy|4|||
164364284|NCT03616912|593711507|FG003|Overall Study|Pregnancy|0|||
164364285|NCT03616912|593711508|FG004|Overall Study|Pregnancy|0|||
164364286|NCT03616912|593711509|FG005|Overall Study|Pregnancy|0|||
164364287|NCT03616912|593711504|FG000|Overall Study|Protocol Violation|1|||
164364288|NCT03616912|593711505|FG001|Overall Study|Protocol Violation|0|||
164364289|NCT03616912|593711506|FG002|Overall Study|Protocol Violation|2|||
164364290|NCT03616912|593711507|FG003|Overall Study|Protocol Violation|0|||
164364291|NCT03616912|593711508|FG004|Overall Study|Protocol Violation|0|||
164364292|NCT03616912|593711509|FG005|Overall Study|Protocol Violation|0|||
164364293|NCT03616912|593711504|FG000|Overall Study|Physician Decision|2|||
164364294|NCT03616912|593711505|FG001|Overall Study|Physician Decision|0|||
164364295|NCT03616912|593711506|FG002|Overall Study|Physician Decision|0|||
164364296|NCT03616912|593711507|FG003|Overall Study|Physician Decision|0|||
164364297|NCT03616912|593711508|FG004|Overall Study|Physician Decision|1|||
164364298|NCT03616912|593711509|FG005|Overall Study|Physician Decision|0|||
164364299|NCT03616912|593711504|FG000|Overall Study|Randomized But Never Treated|0|||
164364300|NCT03616912|593711505|FG001|Overall Study|Randomized But Never Treated|2|||
164364301|NCT03616912|593711506|FG002|Overall Study|Randomized But Never Treated|0|||
164364302|NCT03616912|593711507|FG003|Overall Study|Randomized But Never Treated|0|||
164364303|NCT03616912|593711508|FG004|Overall Study|Randomized But Never Treated|0|||
164364304|NCT03616912|593711509|FG005|Overall Study|Randomized But Never Treated|0|||
164364305|NCT01723163|593711510|FG000|Treatment Phase|Withdrawal by Subject|14|||
164364306|NCT01723163|593711511|FG001|Treatment Phase|Withdrawal by Subject|6|||
164364307|NCT01723163|593711510|FG000|Treatment Phase|Withdrawal by PI|5|||
164364308|NCT01723163|593711511|FG001|Treatment Phase|Withdrawal by PI|1|||
164364309|NCT01723163|593711510|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
164364310|NCT01723163|593711511|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
164112679|NCT02372006|592774098|FG000|Overall Study|Adverse Event|0|||
164364311|NCT01723163|593711510|FG000|3-Month Follow-up|Unable to Contact|12|||
164364312|NCT01723163|593711511|FG001|3-Month Follow-up|Unable to Contact|19|||
164364313|NCT01723163|593711510|FG000|6-Month Follow-up|Death|1|||
164364314|NCT01723163|593711511|FG001|6-Month Follow-up|Death|0|||
164364315|NCT01723163|593711510|FG000|6-Month Follow-up|Unable to Contact|17|||
164364316|NCT01723163|593711511|FG001|6-Month Follow-up|Unable to Contact|15|||
163901730|NCT03656718|592011462|FG002|Treatment Period Part C|Death|0|||
164364317|NCT01723163|593711510|FG000|12-Month Follow-up|Death|1|||
164364318|NCT01723163|593711511|FG001|12-Month Follow-up|Death|0|||
163901731|NCT03656718|592011463|FG003|Treatment Period Part C|Death|0|||
163901732|NCT03656718|592011464|FG004|Treatment Period Part C|Death|1|||
164364319|NCT01723163|593711510|FG000|12-Month Follow-up|Unable to Contact|23|||
164364320|NCT01723163|593711511|FG001|12-Month Follow-up|Unable to Contact|28|||
164364321|NCT01124604|593711512|FG000|Overall Study|Adverse Event|10|||
164364322|NCT01124604|593711513|FG001|Overall Study|Adverse Event|1|||
164364323|NCT01124604|593711512|FG000|Overall Study|Lack of Efficacy|1|||
164364324|NCT01124604|593711513|FG001|Overall Study|Lack of Efficacy|0|||
164364325|NCT01124604|593711512|FG000|Overall Study|Withdrawal by Subject|4|||
164364326|NCT01124604|593711513|FG001|Overall Study|Withdrawal by Subject|0|||
164364327|NCT01124604|593711512|FG000|Overall Study|Disease Progression|0|||
164364328|NCT01124604|593711513|FG001|Overall Study|Disease Progression|1|||
164364329|NCT01859507|593711514|FG000|Overall Study|left the country|4|||
164364330|NCT01762943|593711515|FG000|Overall Study|Physician Decision|1|||
164364331|NCT01762943|593711516|FG001|Overall Study|Physician Decision|1|||
164364332|NCT01762943|593711515|FG000|Overall Study|Protocol Violation|1|||
164364333|NCT01762943|593711516|FG001|Overall Study|Protocol Violation|0|||
164364334|NCT01762943|593711515|FG000|Overall Study|Withdrawal by Subject|2|||
164364335|NCT01762943|593711516|FG001|Overall Study|Withdrawal by Subject|1|||
164364336|NCT00539838|593711517|FG000|Overall Study|Fail to return|2|||
164364337|NCT00539838|593711518|FG001|Overall Study|Fail to return|0|||
164364338|NCT00539838|593711519|FG002|Overall Study|Fail to return|0|||
164364339|NCT00539838|593711517|FG000|Overall Study|Withdrawal by Subject|0|||
164364340|NCT00539838|593711518|FG001|Overall Study|Withdrawal by Subject|4|||
164364341|NCT00539838|593711519|FG002|Overall Study|Withdrawal by Subject|0|||
164364342|NCT00539838|593711517|FG000|Overall Study|Death|0|||
164364343|NCT00539838|593711518|FG001|Overall Study|Death|2|||
164364344|NCT00539838|593711519|FG002|Overall Study|Death|0|||
164364345|NCT00539838|593711517|FG000|Overall Study|Did not cooperate|1|||
164364346|NCT00539838|593711518|FG001|Overall Study|Did not cooperate|0|||
164364347|NCT00539838|593711519|FG002|Overall Study|Did not cooperate|1|||
164364348|NCT00539838|593711517|FG000|Overall Study|Administrative|4|||
164364349|NCT00539838|593711518|FG001|Overall Study|Administrative|0|||
164364350|NCT00539838|593711519|FG002|Overall Study|Administrative|8|||
164364351|NCT03090100|593711523|FG000|Overall Study|Adverse Event|9|||
164364352|NCT03090100|593711524|FG001|Overall Study|Adverse Event|11|||
164364353|NCT03090100|593711523|FG000|Overall Study|Pregnancy|1|||
164364354|NCT03090100|593711524|FG001|Overall Study|Pregnancy|1|||
164364355|NCT03090100|593711523|FG000|Overall Study|Lack of Efficacy|2|||
164364356|NCT03090100|593711524|FG001|Overall Study|Lack of Efficacy|7|||
164364357|NCT03090100|593711523|FG000|Overall Study|Lost to Follow-up|2|||
164364358|NCT03090100|593711524|FG001|Overall Study|Lost to Follow-up|2|||
164364359|NCT03090100|593711523|FG000|Overall Study|Withdrawal by Subject|7|||
164364360|NCT03090100|593711524|FG001|Overall Study|Withdrawal by Subject|19|||
164364361|NCT03090100|593711523|FG000|Overall Study|Protocol Violation|2|||
164364362|NCT03090100|593711524|FG001|Overall Study|Protocol Violation|6|||
164364363|NCT03090100|593711523|FG000|Overall Study|Non-compliance|2|||
164364364|NCT03090100|593711524|FG001|Overall Study|Non-compliance|0|||
164364365|NCT03090100|593711523|FG000|Overall Study|Other|2|||
164364366|NCT03090100|593711524|FG001|Overall Study|Other|2|||
164364367|NCT03446040|593711525|FG000|Overall Study|Disease progression|3|||
164364368|NCT03446040|593711526|FG001|Overall Study|Disease progression|3|||
164364369|NCT03446040|593711527|FG002|Overall Study|Disease progression|3|||
164364370|NCT03446040|593711528|FG003|Overall Study|Disease progression|4|||
164364371|NCT03446040|593711529|FG004|Overall Study|Disease progression|4|||
164364372|NCT03446040|593711530|FG005|Overall Study|Disease progression|6|||
164364373|NCT03446040|593711531|FG006|Overall Study|Disease progression|3|||
164364374|NCT03446040|593711532|FG007|Overall Study|Disease progression|4|||
164364375|NCT03446040|593711533|FG008|Overall Study|Disease progression|2|||
164364376|NCT03446040|593711534|FG009|Overall Study|Disease progression|4|||
164364377|NCT03446040|593711535|FG010|Overall Study|Disease progression|9|||
164364378|NCT03446040|593711536|FG011|Overall Study|Disease progression|3|||
164364379|NCT03446040|593711537|FG012|Overall Study|Disease progression|7|||
164364380|NCT03446040|593711538|FG013|Overall Study|Disease progression|7|||
164364381|NCT03446040|593711525|FG000|Overall Study|Study drug toxicity|0|||
164364382|NCT03446040|593711526|FG001|Overall Study|Study drug toxicity|0|||
164364383|NCT03446040|593711527|FG002|Overall Study|Study drug toxicity|0|||
164364384|NCT03446040|593711528|FG003|Overall Study|Study drug toxicity|0|||
164364385|NCT03446040|593711529|FG004|Overall Study|Study drug toxicity|0|||
163901733|NCT03656718|592011465|FG005|Treatment Period Part C|Death|0|||
164364386|NCT03446040|593711530|FG005|Overall Study|Study drug toxicity|0|||
164364387|NCT03446040|593711531|FG006|Overall Study|Study drug toxicity|0|||
164364388|NCT03446040|593711532|FG007|Overall Study|Study drug toxicity|0|||
164364389|NCT03446040|593711533|FG008|Overall Study|Study drug toxicity|1|||
164364390|NCT03446040|593711534|FG009|Overall Study|Study drug toxicity|0|||
164364391|NCT03446040|593711535|FG010|Overall Study|Study drug toxicity|0|||
164364392|NCT03446040|593711536|FG011|Overall Study|Study drug toxicity|0|||
164364393|NCT03446040|593711537|FG012|Overall Study|Study drug toxicity|0|||
164364394|NCT03446040|593711538|FG013|Overall Study|Study drug toxicity|0|||
164364395|NCT03446040|593711525|FG000|Overall Study|Adverse Event|0|||
164011475|NCT02855411|592406809|FG000|Overall Study|Study terminated by sponsor|21|||
164364396|NCT03446040|593711526|FG001|Overall Study|Adverse Event|0|||
164364397|NCT03446040|593711527|FG002|Overall Study|Adverse Event|0|||
164364398|NCT03446040|593711528|FG003|Overall Study|Adverse Event|0|||
164364399|NCT03446040|593711529|FG004|Overall Study|Adverse Event|0|||
164364400|NCT03446040|593711530|FG005|Overall Study|Adverse Event|2|||
164364401|NCT03446040|593711531|FG006|Overall Study|Adverse Event|0|||
164364402|NCT03446040|593711532|FG007|Overall Study|Adverse Event|0|||
164364403|NCT03446040|593711533|FG008|Overall Study|Adverse Event|1|||
164011476|NCT02855411|592406809|FG000|Overall Study|Does not meet entrance criteria|14|||
164011477|NCT01342640|592406812|FG000|Overall Study|Adverse Event|3|||
164011478|NCT01342640|592406812|FG000|Overall Study|Protocol Violation|16|||
164011479|NCT01342640|592406812|FG000|Overall Study|Lost to Follow-up|21|||
164011480|NCT01342640|592406812|FG000|Overall Study|Other|1|||
164011481|NCT00670111|592406815|FG000|Enrollment to One Month|Testing Failure|0|||
164011482|NCT00670111|592406816|FG001|Enrollment to One Month|Testing Failure|0|||
164011483|NCT00670111|592406817|FG002|Enrollment to One Month|Testing Failure|13|||
164011484|NCT00670111|592406815|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
164011485|NCT00670111|592406816|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
164011486|NCT00670111|592406817|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
164011487|NCT00670111|592406815|FG000|Enrollment to One Month|Physician Decision|1|||
164011488|NCT00670111|592406816|FG001|Enrollment to One Month|Physician Decision|0|||
164011489|NCT00670111|592406817|FG002|Enrollment to One Month|Physician Decision|0|||
164011490|NCT03988751|592406818|FG000|Overall Study|Withdrawal by Subject|1|||
164011491|NCT03988751|592406819|FG001|Overall Study|Withdrawal by Subject|0|||
164011492|NCT03988751|592406818|FG000|Overall Study|Protocol Violation|0|||
164011493|NCT03988751|592406819|FG001|Overall Study|Protocol Violation|1|||
164011494|NCT00844883|592406820|FG000|Overall Study|Bridged to liver transplant|3|||
164011495|NCT00844883|592406820|FG000|Overall Study|Bridged to resection|1|||
164011496|NCT02441803|592406822|FG000|Overall Study|Physician Decision|0|||
164011497|NCT02441803|592406823|FG001|Overall Study|Physician Decision|2|||
164011498|NCT02441803|592406824|FG002|Overall Study|Physician Decision|2|||
164011499|NCT02873221|592406828|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
164011500|NCT02873221|592406829|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
164011501|NCT02873221|592406830|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
164011502|NCT02873221|592406828|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
164011503|NCT02873221|592406829|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
164011504|NCT02873221|592406830|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
164011505|NCT02873221|592406828|FG000|Treatment Period|Protocol Violation|2|||
164011506|NCT02873221|592406829|FG001|Treatment Period|Protocol Violation|5|||
164011507|NCT02873221|592406830|FG002|Treatment Period|Protocol Violation|8|||
164011508|NCT02873221|592406828|FG000|Treatment Period|Pregnancy|4|||
164011509|NCT02873221|592406829|FG001|Treatment Period|Pregnancy|6|||
164011510|NCT02873221|592406830|FG002|Treatment Period|Pregnancy|3|||
164011511|NCT02873221|592406828|FG000|Treatment Period|Lack of Qualifying Event|0|||
164011512|NCT02873221|592406829|FG001|Treatment Period|Lack of Qualifying Event|3|||
164011513|NCT02873221|592406830|FG002|Treatment Period|Lack of Qualifying Event|1|||
164011514|NCT02873221|592406828|FG000|Treatment Period|Withdrawal of Consent|52|||
164011515|NCT02873221|592406829|FG001|Treatment Period|Withdrawal of Consent|51|||
164011516|NCT02873221|592406830|FG002|Treatment Period|Withdrawal of Consent|41|||
164011517|NCT02873221|592406828|FG000|Treatment Period|Lack of Efficacy|0|||
164011518|NCT02873221|592406829|FG001|Treatment Period|Lack of Efficacy|17|||
164011519|NCT02873221|592406830|FG002|Treatment Period|Lack of Efficacy|12|||
164011520|NCT02873221|592406828|FG000|Treatment Period|Adverse Event|4|||
164011521|NCT02873221|592406829|FG001|Treatment Period|Adverse Event|9|||
164011522|NCT02873221|592406830|FG002|Treatment Period|Adverse Event|11|||
164011523|NCT02873221|592406828|FG000|Treatment Period|Lost to Follow-up|26|||
164011524|NCT02873221|592406829|FG001|Treatment Period|Lost to Follow-up|30|||
164011525|NCT02873221|592406830|FG002|Treatment Period|Lost to Follow-up|26|||
164011526|NCT02873221|592406828|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164011527|NCT02873221|592406829|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
164011528|NCT02873221|592406830|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
164011529|NCT02873221|592406828|FG000|Safety Follow-up Period|Protocol Violation|0|||
164011530|NCT02873221|592406829|FG001|Safety Follow-up Period|Protocol Violation|0|||
164011531|NCT02873221|592406830|FG002|Safety Follow-up Period|Protocol Violation|1|||
164011532|NCT02873221|592406828|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
164011533|NCT02873221|592406829|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
164011534|NCT02873221|592406830|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
164011535|NCT02873221|592406828|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
164011536|NCT02873221|592406829|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
164011537|NCT02873221|592406830|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
164011538|NCT02240628|592406833|FG000|Overall Study|Physician Decision|6|||
164011539|NCT02240628|592406834|FG001|Overall Study|Physician Decision|5|||
164364404|NCT03446040|593711534|FG009|Overall Study|Adverse Event|0|||
164364405|NCT03446040|593711535|FG010|Overall Study|Adverse Event|0|||
164011540|NCT00850499|592406835|FG000|Overall Study|Adverse Event|3|||
164011541|NCT00850499|592406836|FG001|Overall Study|Adverse Event|1|||
164011542|NCT00850499|592406835|FG000|Overall Study|Lack of Efficacy|0|||
164011543|NCT00850499|592406836|FG001|Overall Study|Lack of Efficacy|1|||
164011544|NCT00552305|592406837|FG000|Overall Study|Adverse Event|43|||
164011545|NCT00552305|592406837|FG000|Overall Study|Lack of Efficacy|120|||
164011546|NCT00552305|592406837|FG000|Overall Study|Lost to Follow-up|4|||
164011547|NCT00552305|592406837|FG000|Overall Study|Protocol Violation|3|||
164011548|NCT00552305|592406837|FG000|Overall Study|Withdrawal by Subject|44|||
164011549|NCT00552305|592406837|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
164011550|NCT00552305|592406837|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
164011551|NCT00552305|592406837|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
164011552|NCT00552305|592406837|FG000|Overall Study|Unsatisfactory compliance|11|||
164011553|NCT00552305|592406837|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
164011554|NCT00552305|592406837|FG000|Overall Study|AE/Other: prohibited drug required|1|||
164011555|NCT00552305|592406837|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
164011556|NCT00552305|592406837|FG000|Overall Study|Other: Site closed|4|||
164011557|NCT00552305|592406837|FG000|Overall Study|Other: Personal problems|1|||
164011558|NCT00552305|592406837|FG000|Overall Study|Other: Unable to attend visits|1|||
164011559|NCT00552305|592406837|FG000|Overall Study|Other: Subject underwent surgery|4|||
164011560|NCT00552305|592406837|FG000|Overall Study|Other: Subject became pregnant|1|||
164011561|NCT00552305|592406837|FG000|Overall Study|Other: Health problems, not drug related|1|||
164011562|NCT00552305|592406837|FG000|Overall Study|Other: Subject moved from area|2|||
164011563|NCT00552305|592406837|FG000|Overall Study|Other: Subject incarcerated|1|||
164011564|NCT00552305|592406837|FG000|Overall Study|Other: Subject went to rehab|1|||
164011565|NCT01749735|592406840|FG000|Overall Study|Withdrawal by Subject|1|||
164011566|NCT01749735|592406841|FG001|Overall Study|Withdrawal by Subject|0|||
164011567|NCT01703819|592406842|FG000|Overall Study|Adverse Event|0|||
164011568|NCT01703819|592406843|FG001|Overall Study|Adverse Event|1|||
164011569|NCT01703819|592406842|FG000|Overall Study|Withdrawal by Subject|0|||
164011570|NCT01703819|592406843|FG001|Overall Study|Withdrawal by Subject|1|||
164011571|NCT01302041|592406844|FG000|Overall Study|Death|5|||
164011572|NCT01302041|592406844|FG000|Overall Study|Withdrawal by Subject|4|||
164011573|NCT01302041|592406844|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
164011574|NCT01302041|592406844|FG000|Overall Study|Other-Miscellaneous Reason|2|||
164011575|NCT02234583|592406849|FG000|Overall Study|Adverse Event|172|||
164011576|NCT02234583|592406850|FG001|Overall Study|Adverse Event|156|||
164011577|NCT02234583|592406849|FG000|Overall Study|Withdrawal by Subject|109|||
164011578|NCT02234583|592406850|FG001|Overall Study|Withdrawal by Subject|157|||
164011579|NCT02234583|592406849|FG000|Overall Study|Lost to Follow-up|0|||
164011580|NCT02234583|592406850|FG001|Overall Study|Lost to Follow-up|1|||
164011581|NCT02234583|592406849|FG000|Overall Study|Lack of Efficacy|58|||
164011582|NCT02234583|592406850|FG001|Overall Study|Lack of Efficacy|103|||
164011583|NCT02234583|592406849|FG000|Overall Study|Protocol Violation|35|||
164011584|NCT02234583|592406850|FG001|Overall Study|Protocol Violation|42|||
164011585|NCT02234583|592406849|FG000|Overall Study|Other|39|||
164011586|NCT02234583|592406850|FG001|Overall Study|Other|97|||
164011587|NCT01849250|592406851|FG000|Overall Study|Withdrawal by Subject|1|||
164011588|NCT01849250|592406852|FG001|Overall Study|Withdrawal by Subject|0|||
164011589|NCT01849250|592406851|FG000|Overall Study|Not Evaluable|5|||
164011590|NCT01849250|592406852|FG001|Overall Study|Not Evaluable|3|||
164011591|NCT01849250|592406851|FG000|Overall Study|Screen Failure|1|||
164011592|NCT01849250|592406852|FG001|Overall Study|Screen Failure|0|||
164011593|NCT04504032|592406853|FG000|Overall Study|Adverse Event|1|||
164011594|NCT04504032|592406854|FG001|Overall Study|Adverse Event|2|||
164011595|NCT04504032|592406853|FG000|Overall Study|Lost to Follow-up|6|||
164011596|NCT04504032|592406854|FG001|Overall Study|Lost to Follow-up|9|||
164011597|NCT04504032|592406853|FG000|Overall Study|Protocol Violation|2|||
164011598|NCT04504032|592406854|FG001|Overall Study|Protocol Violation|0|||
164011599|NCT04504032|592406853|FG000|Overall Study|Study terminated by sponsor|1|||
164011600|NCT04504032|592406854|FG001|Overall Study|Study terminated by sponsor|2|||
164011601|NCT04504032|592406853|FG000|Overall Study|Withdrawal by Subject|9|||
164011602|NCT04504032|592406854|FG001|Overall Study|Withdrawal by Subject|11|||
164011603|NCT04504032|592406853|FG000|Overall Study|Disease progression prior to dosing|15|||
164011604|NCT04504032|592406854|FG001|Overall Study|Disease progression prior to dosing|3|||
164011605|NCT04504032|592406853|FG000|Overall Study|Drug supply issues|1|||
164011606|NCT04504032|592406854|FG001|Overall Study|Drug supply issues|1|||
164011607|NCT04504032|592406853|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
164011608|NCT04504032|592406854|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
164011609|NCT01839188|592406855|FG000|Overall Study|Withdrawal by Subject|1|||
164011610|NCT01671488|592406856|FG000|Overall Study|Withdrawal by Subject|1|||
164011611|NCT02285010|592406857|FG000|Overall Study|not abdominal hysterectomy|2|||
164011612|NCT02285010|592406858|FG001|Overall Study|not abdominal hysterectomy|0|||
164011613|NCT02285010|592406857|FG000|Overall Study|Not spinal anesthesia|3|||
164011614|NCT02285010|592406858|FG001|Overall Study|Not spinal anesthesia|1|||
163901734|NCT03656718|592011466|FG006|Treatment Period Part C|Death|0|||
163901735|NCT03656718|592011460|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163901736|NCT03656718|592011461|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163901737|NCT03656718|592011462|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163901738|NCT03656718|592011463|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163901739|NCT03656718|592011464|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
163901740|NCT03656718|592011465|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163901741|NCT03656718|592011466|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
163901742|NCT03656718|592011460|FG000|Treatment Period Part C|Other reasons|0|||
163901743|NCT03656718|592011461|FG001|Treatment Period Part C|Other reasons|0|||
163901744|NCT03656718|592011462|FG002|Treatment Period Part C|Other reasons|0|||
163901745|NCT03656718|592011463|FG003|Treatment Period Part C|Other reasons|0|||
163901746|NCT03656718|592011464|FG004|Treatment Period Part C|Other reasons|1|||
163901747|NCT03656718|592011465|FG005|Treatment Period Part C|Other reasons|0|||
163901748|NCT03656718|592011466|FG006|Treatment Period Part C|Other reasons|0|||
163901749|NCT03656718|592011460|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
163901750|NCT03656718|592011461|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
163901751|NCT03656718|592011462|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
163901752|NCT03656718|592011463|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
163901753|NCT03656718|592011464|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
163901754|NCT03656718|592011465|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
163901755|NCT03656718|592011466|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
163901756|NCT06191679|592011467|FG000|Baseline|Lost to Follow-up|1|||
163901757|NCT06191679|592011468|FG001|Baseline|Lost to Follow-up|0|||
163901758|NCT06191679|592011469|FG002|Baseline|Lost to Follow-up|1|||
163901759|NCT06191679|592011470|FG003|Baseline|Lost to Follow-up|0|||
163901760|NCT06191679|592011467|FG000|Allocation to Group|Withdrawal by Subject|0|||
163901761|NCT06191679|592011468|FG001|Allocation to Group|Withdrawal by Subject|1|||
163901762|NCT06191679|592011469|FG002|Allocation to Group|Withdrawal by Subject|2|||
163901763|NCT06191679|592011470|FG003|Allocation to Group|Withdrawal by Subject|0|||
163901764|NCT06191679|592011467|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
163901765|NCT06191679|592011468|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
163901766|NCT06191679|592011469|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
163901767|NCT06191679|592011470|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
163901768|NCT06191679|592011467|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
163901769|NCT06191679|592011468|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
163901770|NCT06191679|592011469|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
163901771|NCT06191679|592011470|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
163901772|NCT06191679|592011467|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
163901773|NCT06191679|592011468|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
163901774|NCT06191679|592011469|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
163901775|NCT06191679|592011470|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
163901776|NCT03211247|592011471|FG000|Overall Study|Adverse Event|8|||
163901777|NCT03211247|592011472|FG001|Overall Study|Adverse Event|0|||
163901778|NCT03211247|592011473|FG002|Overall Study|Adverse Event|1|||
163901779|NCT03211247|592011474|FG003|Overall Study|Adverse Event|0|||
163901780|NCT03211247|592011475|FG004|Overall Study|Adverse Event|0|||
163901781|NCT03211247|592011471|FG000|Overall Study|Lost to Follow-up|2|||
163901782|NCT03211247|592011472|FG001|Overall Study|Lost to Follow-up|1|||
163901783|NCT03211247|592011473|FG002|Overall Study|Lost to Follow-up|0|||
163901784|NCT03211247|592011474|FG003|Overall Study|Lost to Follow-up|0|||
163901785|NCT03211247|592011475|FG004|Overall Study|Lost to Follow-up|0|||
163901786|NCT03211247|592011471|FG000|Overall Study|Physician Decision|1|||
163901787|NCT03211247|592011472|FG001|Overall Study|Physician Decision|2|||
163901788|NCT03211247|592011473|FG002|Overall Study|Physician Decision|0|||
163901789|NCT03211247|592011474|FG003|Overall Study|Physician Decision|0|||
163901790|NCT03211247|592011475|FG004|Overall Study|Physician Decision|0|||
163901791|NCT03211247|592011471|FG000|Overall Study|Non-compliance with study drug|2|||
163901792|NCT03211247|592011472|FG001|Overall Study|Non-compliance with study drug|0|||
163901793|NCT03211247|592011473|FG002|Overall Study|Non-compliance with study drug|0|||
163901794|NCT03211247|592011474|FG003|Overall Study|Non-compliance with study drug|0|||
163901795|NCT03211247|592011475|FG004|Overall Study|Non-compliance with study drug|0|||
163901796|NCT03211247|592011471|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
163901797|NCT03211247|592011472|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
163901798|NCT03211247|592011473|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
163901799|NCT03211247|592011474|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
163901800|NCT03211247|592011475|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
163901801|NCT03211247|592011471|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
164011615|NCT01478347|592406859|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
164092251|NCT03499964|592702029|FG000|Overall Study|Withdrawal by Subject|2|||
164092252|NCT03499964|592702030|FG001|Overall Study|Withdrawal by Subject|1|||
164092253|NCT03499964|592702029|FG000|Overall Study|Lost to Follow-up|1|||
164092254|NCT03499964|592702030|FG001|Overall Study|Lost to Follow-up|0|||
164092255|NCT02497781|592702031|FG000|Overall Study|Withdrawal by Subject|2|||
164092256|NCT02497781|592702032|FG001|Overall Study|Withdrawal by Subject|0|||
164092257|NCT02497781|592702031|FG000|Overall Study|Lack of Efficacy|0|||
164092258|NCT02497781|592702032|FG001|Overall Study|Lack of Efficacy|1|||
164092259|NCT02497781|592702031|FG000|Overall Study|Randomised but not treated|1|||
164092260|NCT02497781|592702032|FG001|Overall Study|Randomised but not treated|1|||
164092261|NCT02497781|592702031|FG000|Overall Study|Lost to Follow-up|1|||
164092262|NCT02497781|592702032|FG001|Overall Study|Lost to Follow-up|1|||
164092263|NCT01193608|592702033|FG000|Overall Study|Other|0|||
164092264|NCT01193608|592702034|FG001|Overall Study|Other|1|||
164092265|NCT01193608|592702035|FG002|Overall Study|Other|0|||
164092266|NCT01193608|592702036|FG003|Overall Study|Other|0|||
164092267|NCT01193608|592702037|FG004|Overall Study|Other|0|||
164092268|NCT01193608|592702038|FG005|Overall Study|Other|0|||
164092269|NCT01193608|592702033|FG000|Overall Study|Withdrawal by Subject|0|||
164092270|NCT01193608|592702034|FG001|Overall Study|Withdrawal by Subject|1|||
164092271|NCT01193608|592702035|FG002|Overall Study|Withdrawal by Subject|2|||
164092272|NCT01193608|592702036|FG003|Overall Study|Withdrawal by Subject|3|||
164092273|NCT01193608|592702037|FG004|Overall Study|Withdrawal by Subject|3|||
164092274|NCT01193608|592702038|FG005|Overall Study|Withdrawal by Subject|0|||
164092275|NCT01193608|592702033|FG000|Overall Study|Lost to Follow-up|0|||
164092276|NCT01193608|592702034|FG001|Overall Study|Lost to Follow-up|0|||
164092277|NCT01193608|592702035|FG002|Overall Study|Lost to Follow-up|0|||
164092278|NCT01193608|592702036|FG003|Overall Study|Lost to Follow-up|0|||
164092279|NCT01193608|592702037|FG004|Overall Study|Lost to Follow-up|1|||
164092280|NCT01193608|592702038|FG005|Overall Study|Lost to Follow-up|2|||
164092281|NCT01193608|592702033|FG000|Overall Study|Adverse Event|0|||
164092282|NCT01193608|592702034|FG001|Overall Study|Adverse Event|0|||
164092283|NCT01193608|592702035|FG002|Overall Study|Adverse Event|0|||
164092284|NCT01193608|592702036|FG003|Overall Study|Adverse Event|0|||
164092285|NCT01193608|592702037|FG004|Overall Study|Adverse Event|1|||
164092286|NCT01193608|592702038|FG005|Overall Study|Adverse Event|0|||
164092287|NCT01047345|592702039|FG000|Base Study|Adverse Event|3|||
164092288|NCT01047345|592702040|FG001|Base Study|Adverse Event|0|||
164092289|NCT01047345|592702041|FG002|Base Study|Adverse Event|0|||
164092290|NCT01047345|592702039|FG000|Base Study|Lost to Follow-up|4|||
164092291|NCT01047345|592702040|FG001|Base Study|Lost to Follow-up|1|||
164092292|NCT01047345|592702041|FG002|Base Study|Lost to Follow-up|0|||
164092293|NCT01047345|592702039|FG000|Base Study|Protocol Violation|3|||
164092294|NCT01047345|592702040|FG001|Base Study|Protocol Violation|1|||
164092295|NCT01047345|592702041|FG002|Base Study|Protocol Violation|0|||
164092296|NCT01047345|592702039|FG000|Base Study|Withdrawal by Subject|12|||
164092297|NCT01047345|592702040|FG001|Base Study|Withdrawal by Subject|4|||
164092298|NCT01047345|592702041|FG002|Base Study|Withdrawal by Subject|0|||
164092299|NCT01047345|592702039|FG000|Extension|Withdrawal by Subject|0|||
164092300|NCT01047345|592702040|FG001|Extension|Withdrawal by Subject|0|||
164092301|NCT01047345|592702041|FG002|Extension|Withdrawal by Subject|1|||
164092302|NCT01047345|592702039|FG000|Extension|Lost to Follow-up|0|||
164092303|NCT01047345|592702040|FG001|Extension|Lost to Follow-up|0|||
164092304|NCT01047345|592702041|FG002|Extension|Lost to Follow-up|5|||
164092305|NCT00712010|592702042|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
164092306|NCT00995553|592702043|FG000|Overall Study|Withdrawal by Subject|2|||
164092307|NCT00995553|592702044|FG001|Overall Study|Withdrawal by Subject|6|||
164092308|NCT00950807|592702045|FG000|Treatment Period 1|Lack of Efficacy|1|||
164092309|NCT00950807|592702046|FG001|Treatment Period 1|Lack of Efficacy|0|||
164092310|NCT00950807|592702047|FG002|Treatment Period 1|Lack of Efficacy|0|||
164092311|NCT00950807|592702048|FG003|Treatment Period 1|Lack of Efficacy|0|||
164092312|NCT00950807|592702049|FG004|Treatment Period 1|Lack of Efficacy|0|||
164092313|NCT00950807|592702050|FG005|Treatment Period 1|Lack of Efficacy|1|||
164092314|NCT00950807|592702051|FG006|Treatment Period 1|Lack of Efficacy|0|||
164092315|NCT00950807|592702052|FG007|Treatment Period 1|Lack of Efficacy|0|||
164092316|NCT00950807|592702053|FG008|Treatment Period 1|Lack of Efficacy|0|||
164092317|NCT00950807|592702054|FG009|Treatment Period 1|Lack of Efficacy|0|||
164092318|NCT00950807|592702045|FG000|Treatment Period 1|Protocol Violation|1|||
164092319|NCT00950807|592702046|FG001|Treatment Period 1|Protocol Violation|0|||
164092320|NCT00950807|592702047|FG002|Treatment Period 1|Protocol Violation|0|||
164092321|NCT00950807|592702048|FG003|Treatment Period 1|Protocol Violation|0|||
164092322|NCT00950807|592702049|FG004|Treatment Period 1|Protocol Violation|0|||
164092323|NCT00950807|592702050|FG005|Treatment Period 1|Protocol Violation|0|||
164092324|NCT00950807|592702051|FG006|Treatment Period 1|Protocol Violation|0|||
164092325|NCT00950807|592702052|FG007|Treatment Period 1|Protocol Violation|0|||
164092326|NCT00950807|592702053|FG008|Treatment Period 1|Protocol Violation|0|||
164092327|NCT00950807|592702054|FG009|Treatment Period 1|Protocol Violation|0|||
164092328|NCT00950807|592702045|FG000|Treatment Period 1|Lost to Follow-up|0|||
164011616|NCT01478347|592406859|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
164011617|NCT01478347|592406859|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
164011618|NCT03245814|592406860|FG000|Overall Study|Lost to Follow-up|5|||
164011619|NCT03245814|592406861|FG001|Overall Study|Lost to Follow-up|8|||
164011620|NCT03245814|592406860|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
164011621|NCT03245814|592406861|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
164011622|NCT01164501|592406862|FG000|Overall Study|Not treated|2|||
164011623|NCT01164501|592406863|FG001|Overall Study|Not treated|0|||
164011624|NCT01164501|592406864|FG002|Overall Study|Not treated|1|||
164011625|NCT01164501|592406862|FG000|Overall Study|Adverse Event|18|||
164011626|NCT01164501|592406863|FG001|Overall Study|Adverse Event|4|||
164011627|NCT01164501|592406864|FG002|Overall Study|Adverse Event|21|||
164011628|NCT01164501|592406862|FG000|Overall Study|Lack of Efficacy|0|||
164011629|NCT01164501|592406863|FG001|Overall Study|Lack of Efficacy|0|||
164011630|NCT01164501|592406864|FG002|Overall Study|Lack of Efficacy|1|||
164011631|NCT01164501|592406862|FG000|Overall Study|Non compliant with protocol|1|||
164011632|NCT01164501|592406863|FG001|Overall Study|Non compliant with protocol|1|||
164011633|NCT01164501|592406864|FG002|Overall Study|Non compliant with protocol|4|||
164011634|NCT01164501|592406862|FG000|Overall Study|Lost to Follow-up|3|||
164011635|NCT01164501|592406863|FG001|Overall Study|Lost to Follow-up|0|||
164011636|NCT01164501|592406864|FG002|Overall Study|Lost to Follow-up|3|||
164011637|NCT01164501|592406862|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
164011638|NCT01164501|592406863|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
164011639|NCT01164501|592406864|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
164011640|NCT01164501|592406862|FG000|Overall Study|Other reason not defined above|9|||
164011641|NCT01164501|592406863|FG001|Overall Study|Other reason not defined above|1|||
164011642|NCT01164501|592406864|FG002|Overall Study|Other reason not defined above|4|||
164011643|NCT01096667|592406868|FG000|Overall Study|Lost to Follow-up|1|||
164011644|NCT01096667|592406869|FG001|Overall Study|Lost to Follow-up|1|||
164011645|NCT01096667|592406870|FG002|Overall Study|Lost to Follow-up|1|||
164011646|NCT01096667|592406871|FG003|Overall Study|Lost to Follow-up|0|||
164011647|NCT01096667|592406872|FG004|Overall Study|Lost to Follow-up|0|||
164011648|NCT01096667|592406868|FG000|Overall Study|Withdrawal by Subject|1|||
164011649|NCT01096667|592406869|FG001|Overall Study|Withdrawal by Subject|0|||
164011650|NCT01096667|592406870|FG002|Overall Study|Withdrawal by Subject|0|||
164011651|NCT01096667|592406871|FG003|Overall Study|Withdrawal by Subject|1|||
164011652|NCT01096667|592406872|FG004|Overall Study|Withdrawal by Subject|0|||
164011653|NCT01096667|592406868|FG000|Overall Study|Reason not available|0|||
164011654|NCT01096667|592406869|FG001|Overall Study|Reason not available|1|||
164011655|NCT01096667|592406870|FG002|Overall Study|Reason not available|1|||
164011656|NCT01096667|592406871|FG003|Overall Study|Reason not available|1|||
164011657|NCT01096667|592406872|FG004|Overall Study|Reason not available|0|||
164011658|NCT01096667|592406868|FG000|Overall Study|Protocol Violation|0|||
164011659|NCT01096667|592406869|FG001|Overall Study|Protocol Violation|0|||
164011660|NCT01096667|592406870|FG002|Overall Study|Protocol Violation|0|||
164011661|NCT01096667|592406871|FG003|Overall Study|Protocol Violation|1|||
164011662|NCT01096667|592406872|FG004|Overall Study|Protocol Violation|0|||
164011663|NCT01096667|592406868|FG000|Overall Study|Not treated|1|||
164011664|NCT01096667|592406869|FG001|Overall Study|Not treated|0|||
164011665|NCT01096667|592406870|FG002|Overall Study|Not treated|0|||
164011666|NCT01096667|592406871|FG003|Overall Study|Not treated|0|||
164011667|NCT01096667|592406872|FG004|Overall Study|Not treated|0|||
164011668|NCT00206518|592406873|FG000|Overall Study|Lack of Efficacy|6|||
164011669|NCT00206518|592406874|FG001|Overall Study|Lack of Efficacy|4|||
164011670|NCT00206518|592406873|FG000|Overall Study|Adverse Event|2|||
164011671|NCT00206518|592406874|FG001|Overall Study|Adverse Event|1|||
164011672|NCT00206518|592406873|FG000|Overall Study|Physician Decision|1|||
164011673|NCT00206518|592406874|FG001|Overall Study|Physician Decision|0|||
164011674|NCT00206518|592406873|FG000|Overall Study|Protocol Violation|1|||
164011675|NCT00206518|592406874|FG001|Overall Study|Protocol Violation|1|||
164011676|NCT02335450|592406875|FG000|Overall Study|Pregnancy|1|||
164011677|NCT01845077|592406876|FG000|Washout Period|Lost to Follow-up|0|||
164011678|NCT01845077|592406877|FG001|Washout Period|Lost to Follow-up|1|||
164011679|NCT01845077|592406878|FG002|Washout Period|Lost to Follow-up|0|||
164011680|NCT01845077|592406879|FG003|Washout Period|Lost to Follow-up|1|||
164011681|NCT01845077|592406880|FG004|Washout Period|Lost to Follow-up|0|||
164011682|NCT01845077|592406881|FG005|Washout Period|Lost to Follow-up|1|||
164011683|NCT01845077|592406876|FG000|Washout Period|Adverse Event|1|||
164011684|NCT01845077|592406877|FG001|Washout Period|Adverse Event|0|||
164011685|NCT01845077|592406878|FG002|Washout Period|Adverse Event|0|||
164011686|NCT01845077|592406879|FG003|Washout Period|Adverse Event|0|||
164011687|NCT01845077|592406880|FG004|Washout Period|Adverse Event|0|||
164011688|NCT01845077|592406881|FG005|Washout Period|Adverse Event|0|||
164011689|NCT01845077|592406876|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
164011690|NCT01845077|592406877|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
164011691|NCT01845077|592406878|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
164011692|NCT01845077|592406879|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
164112680|NCT02372006|592774099|FG001|Overall Study|Adverse Event|0|||
164092329|NCT00950807|592702046|FG001|Treatment Period 1|Lost to Follow-up|0|||
164092330|NCT00950807|592702047|FG002|Treatment Period 1|Lost to Follow-up|1|||
164092331|NCT00950807|592702048|FG003|Treatment Period 1|Lost to Follow-up|0|||
164092332|NCT00950807|592702049|FG004|Treatment Period 1|Lost to Follow-up|0|||
164092333|NCT00950807|592702050|FG005|Treatment Period 1|Lost to Follow-up|0|||
164092334|NCT00950807|592702051|FG006|Treatment Period 1|Lost to Follow-up|0|||
164092335|NCT00950807|592702052|FG007|Treatment Period 1|Lost to Follow-up|0|||
164092336|NCT00950807|592702053|FG008|Treatment Period 1|Lost to Follow-up|0|||
164092337|NCT00950807|592702054|FG009|Treatment Period 1|Lost to Follow-up|0|||
164092338|NCT00950807|592702045|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164092339|NCT00950807|592702046|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164092340|NCT00950807|592702047|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164092341|NCT00950807|592702048|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164092342|NCT00950807|592702049|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164092343|NCT00950807|592702050|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164092344|NCT00950807|592702051|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164092345|NCT00950807|592702052|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164092346|NCT00950807|592702053|FG008|Treatment Period 1|Withdrawal by Subject|1|||
164092347|NCT00950807|592702054|FG009|Treatment Period 1|Withdrawal by Subject|0|||
164092348|NCT00950807|592702045|FG000|Treatment Period 1|Adverse Event|0|||
164092349|NCT00950807|592702046|FG001|Treatment Period 1|Adverse Event|0|||
164092350|NCT00950807|592702047|FG002|Treatment Period 1|Adverse Event|0|||
164092351|NCT00950807|592702048|FG003|Treatment Period 1|Adverse Event|0|||
164092352|NCT00950807|592702049|FG004|Treatment Period 1|Adverse Event|0|||
164092353|NCT00950807|592702050|FG005|Treatment Period 1|Adverse Event|1|||
164092354|NCT00950807|592702051|FG006|Treatment Period 1|Adverse Event|0|||
164092355|NCT00950807|592702052|FG007|Treatment Period 1|Adverse Event|0|||
164092356|NCT00950807|592702053|FG008|Treatment Period 1|Adverse Event|0|||
164092357|NCT00950807|592702054|FG009|Treatment Period 1|Adverse Event|0|||
164092358|NCT00950807|592702045|FG000|Washout Period 1|Lack of Efficacy|0|||
164092359|NCT00950807|592702046|FG001|Washout Period 1|Lack of Efficacy|0|||
164092360|NCT00950807|592702047|FG002|Washout Period 1|Lack of Efficacy|0|||
164092361|NCT00950807|592702048|FG003|Washout Period 1|Lack of Efficacy|0|||
164092362|NCT00950807|592702049|FG004|Washout Period 1|Lack of Efficacy|0|||
164092363|NCT00950807|592702050|FG005|Washout Period 1|Lack of Efficacy|0|||
164092364|NCT00950807|592702051|FG006|Washout Period 1|Lack of Efficacy|1|||
164092365|NCT00950807|592702052|FG007|Washout Period 1|Lack of Efficacy|0|||
164092366|NCT00950807|592702053|FG008|Washout Period 1|Lack of Efficacy|0|||
164092367|NCT00950807|592702054|FG009|Washout Period 1|Lack of Efficacy|0|||
164092368|NCT00950807|592702045|FG000|Washout Period 1|Withdrawal by Subject|0|||
164092369|NCT00950807|592702046|FG001|Washout Period 1|Withdrawal by Subject|0|||
164092370|NCT00950807|592702047|FG002|Washout Period 1|Withdrawal by Subject|0|||
164092371|NCT00950807|592702048|FG003|Washout Period 1|Withdrawal by Subject|0|||
164092372|NCT00950807|592702049|FG004|Washout Period 1|Withdrawal by Subject|0|||
164092373|NCT00950807|592702050|FG005|Washout Period 1|Withdrawal by Subject|0|||
164092374|NCT00950807|592702051|FG006|Washout Period 1|Withdrawal by Subject|0|||
164092375|NCT00950807|592702052|FG007|Washout Period 1|Withdrawal by Subject|0|||
164092376|NCT00950807|592702053|FG008|Washout Period 1|Withdrawal by Subject|1|||
164092377|NCT00950807|592702054|FG009|Washout Period 1|Withdrawal by Subject|0|||
164092378|NCT00950807|592702045|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
164092379|NCT00950807|592702046|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092380|NCT00950807|592702047|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092381|NCT00950807|592702048|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092382|NCT00950807|592702049|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092383|NCT00950807|592702050|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092384|NCT00950807|592702051|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
164092385|NCT00950807|592702052|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
164092386|NCT00950807|592702053|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092387|NCT00950807|592702054|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
164092388|NCT00950807|592702045|FG000|Washout Period 1|Adverse Event|2|||
164092389|NCT00950807|592702046|FG001|Washout Period 1|Adverse Event|0|||
164092390|NCT00950807|592702047|FG002|Washout Period 1|Adverse Event|0|||
164092391|NCT00950807|592702048|FG003|Washout Period 1|Adverse Event|1|||
164092392|NCT00950807|592702049|FG004|Washout Period 1|Adverse Event|1|||
164092393|NCT00950807|592702050|FG005|Washout Period 1|Adverse Event|0|||
164092394|NCT00950807|592702051|FG006|Washout Period 1|Adverse Event|0|||
164092395|NCT00950807|592702052|FG007|Washout Period 1|Adverse Event|0|||
164092396|NCT00950807|592702053|FG008|Washout Period 1|Adverse Event|0|||
164092397|NCT00950807|592702054|FG009|Washout Period 1|Adverse Event|0|||
163901802|NCT03211247|592011472|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
163901803|NCT03211247|592011473|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
163901804|NCT03211247|592011474|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
163901805|NCT03211247|592011475|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
163901806|NCT03211247|592011471|FG000|Overall Study|Protocol Violation|0|||
163901807|NCT03211247|592011472|FG001|Overall Study|Protocol Violation|1|||
164011693|NCT01845077|592406880|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
164011694|NCT01845077|592406881|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
164011695|NCT01845077|592406876|FG000|Washout Period|Protocol Violation|0|||
164011696|NCT01845077|592406877|FG001|Washout Period|Protocol Violation|0|||
164011697|NCT01845077|592406878|FG002|Washout Period|Protocol Violation|0|||
164011698|NCT01845077|592406879|FG003|Washout Period|Protocol Violation|1|||
164011699|NCT01845077|592406880|FG004|Washout Period|Protocol Violation|1|||
164011700|NCT01845077|592406881|FG005|Washout Period|Protocol Violation|0|||
164011701|NCT02613572|592406882|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
164011702|NCT02613572|592406883|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
164011703|NCT02613572|592406884|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
164011704|NCT02613572|592406882|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
164011705|NCT02613572|592406883|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
164011706|NCT02613572|592406884|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
164011707|NCT00312377|592406889|FG000|Overall Study|Death|403|||
164011708|NCT00312377|592406890|FG001|Overall Study|Death|418|||
164011709|NCT00312377|592406889|FG000|Overall Study|Withdrawal by Subject|23|||
164011710|NCT00312377|592406890|FG001|Overall Study|Withdrawal by Subject|30|||
164011711|NCT00312377|592406889|FG000|Overall Study|Lost to Follow-up|9|||
164011712|NCT00312377|592406890|FG001|Overall Study|Lost to Follow-up|12|||
164011713|NCT00312377|592406889|FG000|Overall Study|Non-compliance|0|||
164011714|NCT00312377|592406890|FG001|Overall Study|Non-compliance|2|||
164011715|NCT00312377|592406889|FG000|Overall Study|Randomised but never received treatment|6|||
164011716|NCT00312377|592406890|FG001|Overall Study|Randomised but never received treatment|6|||
164011717|NCT00312377|592406889|FG000|Overall Study|Discontinue treatment survival follow up|202|||
164011718|NCT00312377|592406890|FG001|Overall Study|Discontinue treatment survival follow up|200|||
164011719|NCT00312377|592406889|FG000|Overall Study|Site ended participation in study|1|||
164011720|NCT00312377|592406890|FG001|Overall Study|Site ended participation in study|0|||
164011721|NCT00231478|592406891|FG000|Overall Study|Protocol Violation|3|||
164011722|NCT00231478|592406892|FG001|Overall Study|Protocol Violation|2|||
164011723|NCT00231478|592406891|FG000|Overall Study|Refused Treatment|1|||
164011724|NCT00231478|592406892|FG001|Overall Study|Refused Treatment|1|||
164011725|NCT00231478|592406891|FG000|Overall Study|Withdrawal by Subject|1|||
164011726|NCT00231478|592406892|FG001|Overall Study|Withdrawal by Subject|0|||
164011727|NCT00231478|592406891|FG000|Overall Study|Adverse Event|0|||
164011728|NCT00231478|592406892|FG001|Overall Study|Adverse Event|1|||
164011729|NCT00231478|592406891|FG000|Overall Study|Administrative|3|||
164011730|NCT00231478|592406892|FG001|Overall Study|Administrative|2|||
164011731|NCT05258058|592406895|FG000|Overall Study|Withdrawal by Subject|2|||
164011732|NCT01001494|592406896|FG000|Overall Study|Adverse Event|8|||
164011733|NCT01001494|592406897|FG001|Overall Study|Adverse Event|4|||
164011734|NCT01001494|592406898|FG002|Overall Study|Adverse Event|6|||
164011735|NCT01001494|592406896|FG000|Overall Study|Protocol Violation|0|||
164011736|NCT01001494|592406897|FG001|Overall Study|Protocol Violation|1|||
164011737|NCT01001494|592406898|FG002|Overall Study|Protocol Violation|1|||
164011738|NCT01001494|592406896|FG000|Overall Study|Lost to Follow-up|2|||
164011739|NCT01001494|592406897|FG001|Overall Study|Lost to Follow-up|0|||
164011740|NCT01001494|592406898|FG002|Overall Study|Lost to Follow-up|1|||
164011741|NCT01001494|592406896|FG000|Overall Study|Withdrawal by Subject|9|||
164011742|NCT01001494|592406897|FG001|Overall Study|Withdrawal by Subject|7|||
164011743|NCT01001494|592406898|FG002|Overall Study|Withdrawal by Subject|17|||
164011744|NCT01001494|592406896|FG000|Overall Study|COPD exacerbation|3|||
164011745|NCT01001494|592406897|FG001|Overall Study|COPD exacerbation|4|||
164011746|NCT01001494|592406898|FG002|Overall Study|COPD exacerbation|5|||
164011747|NCT01001494|592406896|FG000|Overall Study|Lack of Efficacy|2|||
164011748|NCT01001494|592406897|FG001|Overall Study|Lack of Efficacy|0|||
164011749|NCT01001494|592406898|FG002|Overall Study|Lack of Efficacy|8|||
164011750|NCT01001494|592406896|FG000|Overall Study|Other|0|||
164011751|NCT01001494|592406897|FG001|Overall Study|Other|1|||
164011752|NCT01001494|592406898|FG002|Overall Study|Other|3|||
164011753|NCT02179398|592406899|FG000|Overall Study|Lack of obligatory data|3|||
164011754|NCT02179398|592406900|FG001|Overall Study|Lack of obligatory data|3|||
164011755|NCT02179398|592406899|FG000|Overall Study|Lost to Follow-up|0|||
164011756|NCT02179398|592406900|FG001|Overall Study|Lost to Follow-up|1|||
164011757|NCT01524289|592406901|FG000|Overall Study|Lost to Follow-up|0|||
164011758|NCT01524289|592406902|FG001|Overall Study|Lost to Follow-up|1|||
164011759|NCT01524289|592406901|FG000|Overall Study|Physician Decision|1|||
164011760|NCT01524289|592406902|FG001|Overall Study|Physician Decision|0|||
164011761|NCT01524289|592406901|FG000|Overall Study|Protocol Violation|5|||
164011762|NCT01524289|592406902|FG001|Overall Study|Protocol Violation|1|||
164011763|NCT01524289|592406901|FG000|Overall Study|Withdrawal by Subject|11|||
164011764|NCT01524289|592406902|FG001|Overall Study|Withdrawal by Subject|7|||
164011765|NCT01524289|592406901|FG000|Overall Study|Adverse Event|12|||
164011766|NCT01524289|592406902|FG001|Overall Study|Adverse Event|5|||
164011767|NCT01524289|592406901|FG000|Overall Study|Did not take study medication|1|||
164011768|NCT01524289|592406902|FG001|Overall Study|Did not take study medication|0|||
164011769|NCT00408681|592406909|FG000|Overall Study|Lack of Efficacy|2|||
164011770|NCT00408681|592406909|FG000|Overall Study|Adverse Event|7|||
164011771|NCT01787591|592406911|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
164011772|NCT01787591|592406912|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
164011773|NCT01787591|592406913|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
164011774|NCT01787591|592406914|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
164011775|NCT00815308|592406915|FG000|Overall Study|Adverse Event|4|||
164011776|NCT00815308|592406915|FG000|Overall Study|Withdrawal by Subject|0|||
164011777|NCT00815308|592406915|FG000|Overall Study|Protocol Violation|6|||
164011778|NCT03429556|592406916|FG000|Overall Study|Lost to Follow-up|0|||
164011779|NCT03429556|592406917|FG001|Overall Study|Lost to Follow-up|1|||
164011780|NCT03429556|592406918|FG002|Overall Study|Lost to Follow-up|0|||
164011781|NCT03429556|592406919|FG003|Overall Study|Lost to Follow-up|0|||
164011782|NCT00377299|592406920|FG000|Overall Study|Lost to Follow-up|14|||
164011783|NCT00377299|592406921|FG001|Overall Study|Lost to Follow-up|19|||
164011784|NCT00377299|592406920|FG000|Overall Study|Adverse Event|0|||
164011785|NCT00377299|592406921|FG001|Overall Study|Adverse Event|1|||
164011786|NCT00377299|592406920|FG000|Overall Study|Withdrawal by Subject|5|||
164011787|NCT00377299|592406921|FG001|Overall Study|Withdrawal by Subject|4|||
164011788|NCT04799782|592406922|FG000|Washout|Physician Decision|2|||
164011789|NCT04799782|592406923|FG001|Washout|Physician Decision|0|||
164011790|NCT04799782|592406922|FG000|Washout|Withdrawal by Subject|0|||
164011791|NCT04799782|592406923|FG001|Washout|Withdrawal by Subject|2|||
164011792|NCT04799782|592406922|FG000|Washout|Lost to Follow-up|0|||
164011793|NCT04799782|592406923|FG001|Washout|Lost to Follow-up|1|||
164011794|NCT02050048|592406927|FG000|Overall Study|Lost to Follow-up|0|||
164011795|NCT02050048|592406928|FG001|Overall Study|Lost to Follow-up|1|||
164011796|NCT02050048|592406927|FG000|Overall Study|Death|1|||
164011797|NCT02050048|592406928|FG001|Overall Study|Death|0|||
164011798|NCT02050048|592406927|FG000|Overall Study|Ineligible after ERCP|4|||
164011799|NCT02050048|592406928|FG001|Overall Study|Ineligible after ERCP|1|||
164011800|NCT01589094|592406933|FG000|Overall Study|Did not receive treatment|2|||
164011801|NCT00907738|592406934|FG000|Overall Study|Adverse Event|2|||
164011802|NCT00907738|592406935|FG001|Overall Study|Adverse Event|0|||
164011803|NCT00907738|592406936|FG002|Overall Study|Adverse Event|1|||
164011804|NCT00907738|592406937|FG003|Overall Study|Adverse Event|0|||
164011805|NCT00907738|592406938|FG004|Overall Study|Adverse Event|0|||
164011806|NCT00907738|592406934|FG000|Overall Study|not specified or withdrew consent|3|||
164011807|NCT00907738|592406935|FG001|Overall Study|not specified or withdrew consent|0|||
164011808|NCT00907738|592406936|FG002|Overall Study|not specified or withdrew consent|0|||
164011809|NCT00907738|592406937|FG003|Overall Study|not specified or withdrew consent|0|||
164011810|NCT00907738|592406938|FG004|Overall Study|not specified or withdrew consent|0|||
164011811|NCT00907738|592406934|FG000|Overall Study|Disease progression|8|||
164011812|NCT00907738|592406935|FG001|Overall Study|Disease progression|1|||
164011813|NCT00907738|592406936|FG002|Overall Study|Disease progression|6|||
164011814|NCT00907738|592406937|FG003|Overall Study|Disease progression|4|||
164011815|NCT00907738|592406938|FG004|Overall Study|Disease progression|2|||
164011816|NCT05363293|592406939|FG000|Overall Study|Withdrawal by Subject|1|||
164011817|NCT05363293|592406940|FG001|Overall Study|Withdrawal by Subject|0|||
164011818|NCT05363293|592406941|FG002|Overall Study|Withdrawal by Subject|0|||
164011819|NCT05363293|592406942|FG003|Overall Study|Withdrawal by Subject|0|||
164011820|NCT05363293|592406943|FG004|Overall Study|Withdrawal by Subject|0|||
164011821|NCT05363293|592406944|FG005|Overall Study|Withdrawal by Subject|0|||
164011822|NCT05363293|592406945|FG006|Overall Study|Withdrawal by Subject|0|||
164011823|NCT05363293|592406946|FG007|Overall Study|Withdrawal by Subject|0|||
164011824|NCT05363293|592406947|FG008|Overall Study|Withdrawal by Subject|0|||
164011825|NCT05363293|592406948|FG009|Overall Study|Withdrawal by Subject|0|||
164011826|NCT04773041|592406949|FG000|Overall Study|Unable to data match|1|||
164011827|NCT04773041|592406950|FG001|Overall Study|Unable to data match|0|||
164011828|NCT04773041|592406951|FG002|Overall Study|Unable to data match|0|||
164011829|NCT05270694|592408624|FG000|Overall Study|Death|1|||
164011830|NCT05270694|592408624|FG000|Overall Study|Medical issues impacted ability to participate|2|||
164011831|NCT05270694|592408624|FG000|Overall Study|Lost to Follow-up|3|||
164011832|NCT05270694|592408624|FG000|Overall Study|Withdrawal by Subject|3|||
164011833|NCT04267562|592408627|FG000|Assessed for Eligibility|Screen Failure|64|||
164011834|NCT04267562|592408627|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
164011835|NCT04267562|592408627|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
164011836|NCT04267562|592408627|FG000|Assessed for Eligibility|Site closure|6|||
164011837|NCT04267562|592408627|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
164011838|NCT04267562|592408627|FG000|Assessed for Eligibility|Physician Decision|1|||
164011839|NCT04267562|592408627|FG000|Month 24|Elective hysterectomy|1|||
164011840|NCT04267562|592408627|FG000|Month 24|Lost to Follow-up|1|||
164011841|NCT04267562|592408627|FG000|Month 36|Elective hysterectomy|2|||
164011842|NCT04267562|592408627|FG000|Month 36|Lost to Follow-up|3|||
164011843|NCT03270085|592408633|FG000|Overall Study|Withdrawal by Subject|1|||
164011844|NCT03270085|592408634|FG001|Overall Study|Withdrawal by Subject|0|||
164011845|NCT00592358|592408636|FG000|Overall Study|Withdrawal by Subject|2|||
164011846|NCT00592358|592408636|FG000|Overall Study|Adverse Event|1|||
164011847|NCT00592358|592408636|FG000|Overall Study|Lack of Efficacy|2|||
164011848|NCT00592358|592408636|FG000|Overall Study|Inability to swallow pills|1|||
164011849|NCT00084682|592408637|FG000|Overall Study|Withdrawal by Subject|1|||
164011850|NCT00634543|592408640|FG000|Overall Study|Other|1|||
164011851|NCT00634543|592408641|FG001|Overall Study|Other|2|||
164011852|NCT00634543|592408640|FG000|Overall Study|Protocol Violation|3|||
164011853|NCT00634543|592408641|FG001|Overall Study|Protocol Violation|3|||
164011854|NCT00634543|592408640|FG000|Overall Study|Adverse Event|11|||
164011855|NCT00634543|592408641|FG001|Overall Study|Adverse Event|11|||
164011856|NCT00634543|592408640|FG000|Overall Study|Withdrawal by Subject|4|||
164011857|NCT00634543|592408641|FG001|Overall Study|Withdrawal by Subject|4|||
164011858|NCT00634543|592408640|FG000|Overall Study|Lost to Follow-up|0|||
164011859|NCT00634543|592408641|FG001|Overall Study|Lost to Follow-up|1|||
164011860|NCT01013883|592408642|FG000|Overall Study|Lost to Follow-up|2|||
164011861|NCT01013883|592408643|FG001|Overall Study|Lost to Follow-up|2|||
164011862|NCT01371838|592408644|FG000|Overall Study|Withdrawal by Subject|27|||
164011863|NCT01371838|592408645|FG001|Overall Study|Withdrawal by Subject|33|||
164011864|NCT01371838|592408644|FG000|Overall Study|Lost to Follow-up|10|||
164011865|NCT01371838|592408645|FG001|Overall Study|Lost to Follow-up|20|||
164011866|NCT01371838|592408644|FG000|Overall Study|Death|3|||
164011867|NCT01371838|592408645|FG001|Overall Study|Death|4|||
164011868|NCT01371838|592408644|FG000|Overall Study|Protocol Violation|3|||
164011869|NCT01371838|592408645|FG001|Overall Study|Protocol Violation|0|||
164011870|NCT01371838|592408644|FG000|Overall Study|Investigator Decision|3|||
164011871|NCT01371838|592408645|FG001|Overall Study|Investigator Decision|8|||
164011872|NCT01371838|592408644|FG000|Overall Study|Last follow-up visit not conducted|2|||
164011873|NCT01371838|592408645|FG001|Overall Study|Last follow-up visit not conducted|0|||
164011874|NCT01371838|592408644|FG000|Overall Study|Lack of therapeutic response|0|||
164011875|NCT01371838|592408645|FG001|Overall Study|Lack of therapeutic response|1|||
164011876|NCT01371838|592408644|FG000|Overall Study|Surgery|1|||
164011877|NCT01371838|592408645|FG001|Overall Study|Surgery|0|||
164011878|NCT02241512|592408648|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
164011879|NCT02241512|592408649|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
164011880|NCT00641043|592408652|FG000|Overall Study|Adverse Event|6|||
164011881|NCT00641043|592408653|FG001|Overall Study|Adverse Event|4|||
164011882|NCT00641043|592408652|FG000|Overall Study|Protocol Violation|2|||
164011883|NCT00641043|592408653|FG001|Overall Study|Protocol Violation|3|||
164011884|NCT00641043|592408652|FG000|Overall Study|Lost to Follow-up|3|||
164011885|NCT00641043|592408653|FG001|Overall Study|Lost to Follow-up|2|||
164011886|NCT00641043|592408652|FG000|Overall Study|Withdrawal by Subject|4|||
164011887|NCT00641043|592408653|FG001|Overall Study|Withdrawal by Subject|4|||
164011888|NCT00641043|592408652|FG000|Overall Study|Other incl. lack of efficacy|4|||
164011889|NCT00641043|592408653|FG001|Overall Study|Other incl. lack of efficacy|2|||
164011890|NCT04275310|592408654|FG000|Overall Study|Non-randomized due to running out of funding|4|||
164011891|NCT04275310|592408655|FG001|Overall Study|Non-randomized due to running out of funding|0|||
164011892|NCT00972244|592408656|FG000|Overall Study|Incorrect Enrolment|1|||
164011893|NCT00972244|592408657|FG001|Overall Study|Incorrect Enrolment|0|||
164011894|NCT00972244|592408658|FG002|Overall Study|Incorrect Enrolment|0|||
164011895|NCT00972244|592408659|FG003|Overall Study|Incorrect Enrolment|0|||
164011896|NCT00972244|592408660|FG004|Overall Study|Incorrect Enrolment|0|||
164011897|NCT00972244|592408656|FG000|Overall Study|Adverse Event|0|||
164011898|NCT00972244|592408657|FG001|Overall Study|Adverse Event|1|||
164011899|NCT00972244|592408658|FG002|Overall Study|Adverse Event|1|||
164011900|NCT00972244|592408659|FG003|Overall Study|Adverse Event|0|||
164011901|NCT00972244|592408660|FG004|Overall Study|Adverse Event|0|||
164011902|NCT00972244|592408656|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
164011903|NCT00972244|592408657|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
164011904|NCT00972244|592408658|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
164011905|NCT00972244|592408659|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
164011906|NCT00972244|592408660|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
164011907|NCT00972244|592408656|FG000|Overall Study|Withdrawal by Subject|1|||
164011908|NCT00972244|592408657|FG001|Overall Study|Withdrawal by Subject|2|||
164011909|NCT00972244|592408658|FG002|Overall Study|Withdrawal by Subject|1|||
164011910|NCT00972244|592408659|FG003|Overall Study|Withdrawal by Subject|0|||
164011911|NCT00972244|592408660|FG004|Overall Study|Withdrawal by Subject|1|||
164011912|NCT00972244|592408656|FG000|Overall Study|Safety|0|||
164011913|NCT00972244|592408657|FG001|Overall Study|Safety|0|||
164011914|NCT00972244|592408658|FG002|Overall Study|Safety|0|||
164011915|NCT00972244|592408659|FG003|Overall Study|Safety|0|||
164011916|NCT00972244|592408660|FG004|Overall Study|Safety|1|||
164011917|NCT00972244|592408656|FG000|Overall Study|Death|1|||
164011918|NCT00972244|592408657|FG001|Overall Study|Death|0|||
164011919|NCT00972244|592408658|FG002|Overall Study|Death|0|||
164011920|NCT00972244|592408659|FG003|Overall Study|Death|0|||
164011921|NCT00972244|592408660|FG004|Overall Study|Death|0|||
164011922|NCT00972244|592408656|FG000|Overall Study|Various|0|||
164011923|NCT00972244|592408657|FG001|Overall Study|Various|0|||
164011924|NCT00972244|592408658|FG002|Overall Study|Various|0|||
164011925|NCT00972244|592408659|FG003|Overall Study|Various|0|||
164011926|NCT00972244|592408660|FG004|Overall Study|Various|2|||
164011927|NCT00283712|592408665|FG000|Overall Study|Death|0|||
164011928|NCT00283712|592408666|FG001|Overall Study|Death|1|||
164011929|NCT00090285|592408668|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
164011930|NCT00090285|592408669|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
164011931|NCT00090285|592408670|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164011932|NCT00090285|592408671|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164011933|NCT00090285|592408672|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164011934|NCT00090285|592408673|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
164011935|NCT00090285|592408668|FG000|Base Study Vaccination Period|Adverse Event|2|||
164011936|NCT00090285|592408669|FG001|Base Study Vaccination Period|Adverse Event|4|||
164011937|NCT00090285|592408670|FG002|Base Study Vaccination Period|Adverse Event|0|||
164011938|NCT00090285|592408671|FG003|Base Study Vaccination Period|Adverse Event|0|||
164011939|NCT00090285|592408672|FG004|Base Study Vaccination Period|Adverse Event|0|||
164011940|NCT00090285|592408673|FG005|Base Study Vaccination Period|Adverse Event|0|||
164011941|NCT00090285|592408668|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
164011942|NCT00090285|592408669|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
164011943|NCT00090285|592408670|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
164011944|NCT00090285|592408671|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
164011945|NCT00090285|592408672|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
164011946|NCT00090285|592408673|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
164011947|NCT00090285|592408668|FG000|Base Study Vaccination Period|Protocol Violation|2|||
164011948|NCT00090285|592408669|FG001|Base Study Vaccination Period|Protocol Violation|3|||
164011949|NCT00090285|592408670|FG002|Base Study Vaccination Period|Protocol Violation|0|||
164011950|NCT00090285|592408671|FG003|Base Study Vaccination Period|Protocol Violation|0|||
164011951|NCT00090285|592408672|FG004|Base Study Vaccination Period|Protocol Violation|0|||
164011952|NCT00090285|592408673|FG005|Base Study Vaccination Period|Protocol Violation|0|||
164011953|NCT00090285|592408668|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
164011954|NCT00090285|592408669|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
164011955|NCT00090285|592408670|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
164011956|NCT00090285|592408671|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
164011957|NCT00090285|592408672|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164011958|NCT00090285|592408673|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
164011959|NCT00090285|592408668|FG000|Base Study Vaccination Period|Uncooperative|2|||
164011960|NCT00090285|592408669|FG001|Base Study Vaccination Period|Uncooperative|2|||
164011961|NCT00090285|592408670|FG002|Base Study Vaccination Period|Uncooperative|0|||
164011962|NCT00090285|592408671|FG003|Base Study Vaccination Period|Uncooperative|0|||
164011963|NCT00090285|592408672|FG004|Base Study Vaccination Period|Uncooperative|0|||
164011964|NCT00090285|592408673|FG005|Base Study Vaccination Period|Uncooperative|0|||
164011965|NCT00090285|592408668|FG000|Base Study Vaccination Period|Moved|20|||
164011966|NCT00090285|592408669|FG001|Base Study Vaccination Period|Moved|21|||
164011967|NCT00090285|592408670|FG002|Base Study Vaccination Period|Moved|0|||
164011968|NCT00090285|592408671|FG003|Base Study Vaccination Period|Moved|0|||
164011969|NCT00090285|592408672|FG004|Base Study Vaccination Period|Moved|0|||
164011970|NCT00090285|592408673|FG005|Base Study Vaccination Period|Moved|0|||
164011971|NCT00090285|592408668|FG000|Base Study Vaccination Period|Site Terminated|1|||
164011972|NCT00090285|592408669|FG001|Base Study Vaccination Period|Site Terminated|0|||
164011973|NCT00090285|592408670|FG002|Base Study Vaccination Period|Site Terminated|0|||
164011974|NCT00090285|592408671|FG003|Base Study Vaccination Period|Site Terminated|0|||
164011975|NCT00090285|592408672|FG004|Base Study Vaccination Period|Site Terminated|0|||
164011976|NCT00090285|592408673|FG005|Base Study Vaccination Period|Site Terminated|0|||
164011977|NCT00090285|592408668|FG000|Base Study Vaccination Period|Other|2|||
164011978|NCT00090285|592408669|FG001|Base Study Vaccination Period|Other|2|||
164011979|NCT00090285|592408670|FG002|Base Study Vaccination Period|Other|0|||
164011980|NCT00090285|592408671|FG003|Base Study Vaccination Period|Other|0|||
164011981|NCT00090285|592408672|FG004|Base Study Vaccination Period|Other|0|||
164011982|NCT00090285|592408673|FG005|Base Study Vaccination Period|Other|0|||
164011983|NCT00090285|592408668|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
164011984|NCT00090285|592408669|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
164011985|NCT00090285|592408670|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
164011986|NCT00090285|592408671|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
164011987|NCT00090285|592408672|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
164011988|NCT00090285|592408673|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
164011989|NCT00090285|592408668|FG000|Base Study Vaccination Period|HIV positive|1|||
164011990|NCT00090285|592408669|FG001|Base Study Vaccination Period|HIV positive|1|||
164011991|NCT00090285|592408670|FG002|Base Study Vaccination Period|HIV positive|0|||
164092398|NCT00950807|592702045|FG000|Treatment Period 2|Lack of Efficacy|1|||
164011992|NCT00090285|592408671|FG003|Base Study Vaccination Period|HIV positive|0|||
164092399|NCT00950807|592702046|FG001|Treatment Period 2|Lack of Efficacy|0|||
164092400|NCT00950807|592702047|FG002|Treatment Period 2|Lack of Efficacy|0|||
164092401|NCT00950807|592702048|FG003|Treatment Period 2|Lack of Efficacy|0|||
164092402|NCT00950807|592702049|FG004|Treatment Period 2|Lack of Efficacy|0|||
164092403|NCT00950807|592702050|FG005|Treatment Period 2|Lack of Efficacy|0|||
164092404|NCT00950807|592702051|FG006|Treatment Period 2|Lack of Efficacy|0|||
164092405|NCT00950807|592702052|FG007|Treatment Period 2|Lack of Efficacy|0|||
164092406|NCT00950807|592702053|FG008|Treatment Period 2|Lack of Efficacy|0|||
164092407|NCT00950807|592702054|FG009|Treatment Period 2|Lack of Efficacy|0|||
164092408|NCT00950807|592702045|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164092409|NCT00950807|592702046|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164092410|NCT00950807|592702047|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164092411|NCT00950807|592702048|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164092412|NCT00950807|592702049|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164092413|NCT00950807|592702050|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164092414|NCT00950807|592702051|FG006|Treatment Period 2|Withdrawal by Subject|1|||
164092415|NCT00950807|592702052|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164092416|NCT00950807|592702053|FG008|Treatment Period 2|Withdrawal by Subject|0|||
164092417|NCT00950807|592702054|FG009|Treatment Period 2|Withdrawal by Subject|0|||
164092418|NCT00950807|592702045|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
164092419|NCT00950807|592702046|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092420|NCT00950807|592702047|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092421|NCT00950807|592702048|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092422|NCT00950807|592702049|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092423|NCT00950807|592702050|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092424|NCT00950807|592702051|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092425|NCT00950807|592702052|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092426|NCT00950807|592702053|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092427|NCT00950807|592702054|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
164092428|NCT00950807|592702045|FG000|Treatment Period 2|Adverse Event|0|||
164092429|NCT00950807|592702046|FG001|Treatment Period 2|Adverse Event|1|||
164092430|NCT00950807|592702047|FG002|Treatment Period 2|Adverse Event|0|||
164092431|NCT00950807|592702048|FG003|Treatment Period 2|Adverse Event|1|||
164092432|NCT00950807|592702049|FG004|Treatment Period 2|Adverse Event|0|||
164092433|NCT00950807|592702050|FG005|Treatment Period 2|Adverse Event|1|||
164092434|NCT00950807|592702051|FG006|Treatment Period 2|Adverse Event|0|||
164092435|NCT00950807|592702052|FG007|Treatment Period 2|Adverse Event|1|||
164092436|NCT00950807|592702053|FG008|Treatment Period 2|Adverse Event|0|||
164092437|NCT00950807|592702054|FG009|Treatment Period 2|Adverse Event|0|||
164092438|NCT00950807|592702045|FG000|Washout Period 2|Lack of Efficacy|1|||
164092439|NCT00950807|592702046|FG001|Washout Period 2|Lack of Efficacy|0|||
164092440|NCT00950807|592702047|FG002|Washout Period 2|Lack of Efficacy|0|||
164092441|NCT00950807|592702048|FG003|Washout Period 2|Lack of Efficacy|0|||
164092442|NCT00950807|592702049|FG004|Washout Period 2|Lack of Efficacy|0|||
164092443|NCT00950807|592702050|FG005|Washout Period 2|Lack of Efficacy|0|||
164092444|NCT00950807|592702051|FG006|Washout Period 2|Lack of Efficacy|0|||
164092445|NCT00950807|592702052|FG007|Washout Period 2|Lack of Efficacy|0|||
164092446|NCT00950807|592702053|FG008|Washout Period 2|Lack of Efficacy|0|||
164092447|NCT00950807|592702054|FG009|Washout Period 2|Lack of Efficacy|0|||
164092448|NCT00950807|592702045|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164092449|NCT00950807|592702046|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164092450|NCT00950807|592702047|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164092451|NCT00950807|592702048|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164092452|NCT00950807|592702049|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164092453|NCT00950807|592702050|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164092454|NCT00950807|592702051|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164092455|NCT00950807|592702052|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
164092456|NCT00950807|592702053|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164092457|NCT00950807|592702054|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
164092458|NCT00950807|592702045|FG000|Washout Period 2|Adverse Event|3|||
164092459|NCT00950807|592702046|FG001|Washout Period 2|Adverse Event|0|||
164092460|NCT00950807|592702047|FG002|Washout Period 2|Adverse Event|0|||
164092461|NCT00950807|592702048|FG003|Washout Period 2|Adverse Event|1|||
164092462|NCT00950807|592702049|FG004|Washout Period 2|Adverse Event|0|||
164092463|NCT00950807|592702050|FG005|Washout Period 2|Adverse Event|0|||
164092464|NCT00950807|592702051|FG006|Washout Period 2|Adverse Event|0|||
164092465|NCT00950807|592702052|FG007|Washout Period 2|Adverse Event|0|||
164092466|NCT00950807|592702053|FG008|Washout Period 2|Adverse Event|0|||
164092467|NCT00950807|592702054|FG009|Washout Period 2|Adverse Event|0|||
164092468|NCT00950807|592702045|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164092469|NCT00950807|592702046|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164092470|NCT00950807|592702047|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164092471|NCT00950807|592702048|FG003|Treatment Period 3|Withdrawal by Subject|0|||
164092472|NCT00950807|592702049|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163901808|NCT03211247|592011473|FG002|Overall Study|Protocol Violation|0|||
163901809|NCT03211247|592011474|FG003|Overall Study|Protocol Violation|0|||
163901810|NCT03211247|592011475|FG004|Overall Study|Protocol Violation|0|||
163901811|NCT02415127|592011476|FG000|Overall Study|Adverse Event|1|||
163901812|NCT02415127|592011477|FG001|Overall Study|Adverse Event|0|||
163901813|NCT05827068|592011478|FG000|Overall Study|Lost to Follow-up|1|||
163901814|NCT05827068|592011479|FG001|Overall Study|Lost to Follow-up|4|||
163901815|NCT05827068|592011480|FG002|Overall Study|Lost to Follow-up|1|||
163901816|NCT05827068|592011481|FG003|Overall Study|Lost to Follow-up|1|||
163901817|NCT05827068|592011482|FG004|Overall Study|Lost to Follow-up|2|||
163901818|NCT05827068|592011483|FG005|Overall Study|Lost to Follow-up|4|||
163901819|NCT05827068|592011484|FG006|Overall Study|Lost to Follow-up|1|||
163901820|NCT05827068|592011478|FG000|Overall Study|Withdrawal by Subject|4|||
163901821|NCT05827068|592011479|FG001|Overall Study|Withdrawal by Subject|0|||
163901822|NCT05827068|592011480|FG002|Overall Study|Withdrawal by Subject|1|||
163901823|NCT05827068|592011481|FG003|Overall Study|Withdrawal by Subject|2|||
163901824|NCT05827068|592011482|FG004|Overall Study|Withdrawal by Subject|3|||
163901825|NCT05827068|592011483|FG005|Overall Study|Withdrawal by Subject|0|||
163901826|NCT05827068|592011484|FG006|Overall Study|Withdrawal by Subject|1|||
164011993|NCT00090285|592408672|FG004|Base Study Vaccination Period|HIV positive|0|||
164011994|NCT00090285|592408673|FG005|Base Study Vaccination Period|HIV positive|0|||
164011995|NCT00090285|592408668|FG000|Base Study Follow-up Period|Adverse Event|3|||
164011996|NCT00090285|592408669|FG001|Base Study Follow-up Period|Adverse Event|10|||
164011997|NCT00090285|592408670|FG002|Base Study Follow-up Period|Adverse Event|0|||
164011998|NCT00090285|592408671|FG003|Base Study Follow-up Period|Adverse Event|0|||
164011999|NCT00090285|592408672|FG004|Base Study Follow-up Period|Adverse Event|0|||
164012000|NCT00090285|592408673|FG005|Base Study Follow-up Period|Adverse Event|0|||
164012001|NCT00090285|592408668|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
164012002|NCT00090285|592408669|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
164012003|NCT00090285|592408670|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
164012004|NCT00090285|592408671|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
164012005|NCT00090285|592408672|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
164012006|NCT00090285|592408673|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
164012007|NCT00090285|592408668|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
164012008|NCT00090285|592408669|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
164012009|NCT00090285|592408670|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
164012010|NCT00090285|592408671|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
164012011|NCT00090285|592408672|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
164012012|NCT00090285|592408673|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
164012013|NCT00090285|592408668|FG000|Base Study Follow-up Period|Moved|41|||
164012014|NCT00090285|592408669|FG001|Base Study Follow-up Period|Moved|36|||
164012015|NCT00090285|592408670|FG002|Base Study Follow-up Period|Moved|0|||
164012016|NCT00090285|592408671|FG003|Base Study Follow-up Period|Moved|0|||
164012017|NCT00090285|592408672|FG004|Base Study Follow-up Period|Moved|0|||
164012018|NCT00090285|592408673|FG005|Base Study Follow-up Period|Moved|0|||
164012019|NCT00090285|592408668|FG000|Base Study Follow-up Period|Other|2|||
164012020|NCT00090285|592408669|FG001|Base Study Follow-up Period|Other|0|||
164012021|NCT00090285|592408670|FG002|Base Study Follow-up Period|Other|0|||
164012022|NCT00090285|592408671|FG003|Base Study Follow-up Period|Other|0|||
164012023|NCT00090285|592408672|FG004|Base Study Follow-up Period|Other|0|||
164012024|NCT00090285|592408673|FG005|Base Study Follow-up Period|Other|0|||
164012025|NCT00090285|592408668|FG000|Base Study Follow-up Period|Protocol Violation|1|||
164012026|NCT00090285|592408669|FG001|Base Study Follow-up Period|Protocol Violation|0|||
164012027|NCT00090285|592408670|FG002|Base Study Follow-up Period|Protocol Violation|0|||
164012028|NCT00090285|592408671|FG003|Base Study Follow-up Period|Protocol Violation|0|||
164012029|NCT00090285|592408672|FG004|Base Study Follow-up Period|Protocol Violation|0|||
164012030|NCT00090285|592408673|FG005|Base Study Follow-up Period|Protocol Violation|0|||
164012031|NCT00090285|592408668|FG000|Base Study Follow-up Period|Uncooperative|3|||
164012032|NCT00090285|592408669|FG001|Base Study Follow-up Period|Uncooperative|4|||
164012033|NCT00090285|592408670|FG002|Base Study Follow-up Period|Uncooperative|0|||
164012034|NCT00090285|592408671|FG003|Base Study Follow-up Period|Uncooperative|0|||
164012035|NCT00090285|592408672|FG004|Base Study Follow-up Period|Uncooperative|0|||
164012036|NCT00090285|592408673|FG005|Base Study Follow-up Period|Uncooperative|0|||
164012037|NCT00090285|592408668|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
164012038|NCT00090285|592408669|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
164012039|NCT00090285|592408670|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
164012040|NCT00090285|592408671|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
164012041|NCT00090285|592408672|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
163901827|NCT05827068|592011478|FG000|Overall Study|Physician Decision|0|||
163901828|NCT05827068|592011479|FG001|Overall Study|Physician Decision|0|||
163901829|NCT05827068|592011480|FG002|Overall Study|Physician Decision|0|||
163901830|NCT05827068|592011481|FG003|Overall Study|Physician Decision|0|||
163901831|NCT05827068|592011482|FG004|Overall Study|Physician Decision|1|||
164012042|NCT00090285|592408673|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
164012043|NCT00090285|592408668|FG000|Extension 1|Adverse Event|0|||
163901832|NCT05827068|592011483|FG005|Overall Study|Physician Decision|0|||
163901833|NCT05827068|592011484|FG006|Overall Study|Physician Decision|1|||
164092473|NCT00950807|592702050|FG005|Treatment Period 3|Withdrawal by Subject|0|||
164092474|NCT00950807|592702051|FG006|Treatment Period 3|Withdrawal by Subject|0|||
164092475|NCT00950807|592702052|FG007|Treatment Period 3|Withdrawal by Subject|0|||
164092476|NCT00950807|592702053|FG008|Treatment Period 3|Withdrawal by Subject|0|||
164092477|NCT00950807|592702054|FG009|Treatment Period 3|Withdrawal by Subject|1|||
164092478|NCT00950807|592702045|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
164092479|NCT00950807|592702046|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092480|NCT00950807|592702047|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092481|NCT00950807|592702048|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092482|NCT00950807|592702049|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092483|NCT00950807|592702050|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092484|NCT00950807|592702051|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092485|NCT00950807|592702052|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
164092486|NCT00950807|592702053|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092487|NCT00950807|592702054|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
164092488|NCT00950807|592702045|FG000|Treatment Period 3|Adverse Event|0|||
164092489|NCT00950807|592702046|FG001|Treatment Period 3|Adverse Event|0|||
164092490|NCT00950807|592702047|FG002|Treatment Period 3|Adverse Event|0|||
164092491|NCT00950807|592702048|FG003|Treatment Period 3|Adverse Event|0|||
164092492|NCT00950807|592702049|FG004|Treatment Period 3|Adverse Event|0|||
164092493|NCT00950807|592702050|FG005|Treatment Period 3|Adverse Event|0|||
164092494|NCT00950807|592702051|FG006|Treatment Period 3|Adverse Event|1|||
164092495|NCT00950807|592702052|FG007|Treatment Period 3|Adverse Event|0|||
164092496|NCT00950807|592702053|FG008|Treatment Period 3|Adverse Event|0|||
164092497|NCT00950807|592702054|FG009|Treatment Period 3|Adverse Event|0|||
164092498|NCT01492400|592702058|FG000|Overall Study|Miscellaneous Reasons|2|||
164092499|NCT01492400|592702059|FG001|Overall Study|Miscellaneous Reasons|3|||
164092500|NCT01492400|592702058|FG000|Overall Study|Personal Reasons|0|||
164092501|NCT01492400|592702059|FG001|Overall Study|Personal Reasons|5|||
164092502|NCT01492400|592702058|FG000|Overall Study|Lost to Follow-up|3|||
164092503|NCT01492400|592702059|FG001|Overall Study|Lost to Follow-up|1|||
164092504|NCT01492400|592702058|FG000|Overall Study|Pregnancy|0|||
164092505|NCT01492400|592702059|FG001|Overall Study|Pregnancy|1|||
164092506|NCT01492400|592702058|FG000|Overall Study|Lack of Efficacy|1|||
164092507|NCT01492400|592702059|FG001|Overall Study|Lack of Efficacy|1|||
164092508|NCT01492400|592702058|FG000|Overall Study|Adverse Event|10|||
164092509|NCT01492400|592702059|FG001|Overall Study|Adverse Event|5|||
164092510|NCT00659607|592702060|FG000|Overall Study|No blood pressure recorded|147|||
164092511|NCT00659607|592702060|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
164092512|NCT00659607|592702060|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
164092513|NCT00659607|592702060|FG000|Overall Study|No recorded efficacy data|15|||
164092514|NCT00659607|592702060|FG000|Overall Study|Inconsistent BP measuring date|2|||
164092515|NCT02153736|592702064|FG000|Overall Study|Lost to Follow-up|1|||
164092516|NCT02153736|592702065|FG001|Overall Study|Lost to Follow-up|0|||
164092517|NCT02153736|592702064|FG000|Overall Study|Medical status change made ineligible|1|||
164092518|NCT02153736|592702065|FG001|Overall Study|Medical status change made ineligible|0|||
164092519|NCT02153736|592702064|FG000|Overall Study|Death|0|||
164092520|NCT02153736|592702065|FG001|Overall Study|Death|1|||
164092521|NCT02153736|592702064|FG000|Overall Study|Withdrawal by Subject|0|||
163901834|NCT05827068|592011478|FG000|Overall Study|Other Than Specified|0|||
163901835|NCT05827068|592011479|FG001|Overall Study|Other Than Specified|1|||
163901836|NCT05827068|592011480|FG002|Overall Study|Other Than Specified|0|||
163901837|NCT05827068|592011481|FG003|Overall Study|Other Than Specified|0|||
164364406|NCT03446040|593711536|FG011|Overall Study|Adverse Event|0|||
163901838|NCT05827068|592011482|FG004|Overall Study|Other Than Specified|0|||
163901839|NCT05827068|592011483|FG005|Overall Study|Other Than Specified|0|||
163901840|NCT05827068|592011484|FG006|Overall Study|Other Than Specified|0|||
163901841|NCT05464732|592011487|FG000|Overall Study|Lost to Follow-up|0|||
163901842|NCT05464732|592011488|FG001|Overall Study|Lost to Follow-up|1|||
163901843|NCT05464732|592011487|FG000|Overall Study|Adverse Event|1|||
163901844|NCT05464732|592011488|FG001|Overall Study|Adverse Event|0|||
164092522|NCT02153736|592702065|FG001|Overall Study|Withdrawal by Subject|1|||
164092523|NCT02568384|592702066|FG000|Overall Study|Mobile devices incompatible with App|2|||
164092524|NCT01734772|592702067|FG000|Overall Study|Adverse Event|1|||
164092525|NCT01734772|592702068|FG001|Overall Study|Adverse Event|2|||
164092526|NCT01734772|592702067|FG000|Overall Study|Withdrawal by Subject|0|||
163901845|NCT04153890|592011489|FG000|Overall Study|Lost to Follow-up|9|||
163901846|NCT04153890|592011490|FG001|Overall Study|Lost to Follow-up|0|||
164092527|NCT01734772|592702068|FG001|Overall Study|Withdrawal by Subject|1|||
164092528|NCT00720122|592702071|FG000|Overall Study|Lost to Follow-up|1|||
164092529|NCT00720122|592702071|FG000|Overall Study|Physician Decision|1|||
164092530|NCT00720122|592702071|FG000|Overall Study|Withdrawal by Subject|7|||
164092531|NCT00661999|592702072|FG000|Overall Study|Adverse Event|11|||
164092532|NCT00661999|592702073|FG001|Overall Study|Adverse Event|5|||
164092533|NCT00661999|592702074|FG002|Overall Study|Adverse Event|8|||
164092534|NCT00661999|592702072|FG000|Overall Study|Death|8|||
164092535|NCT00661999|592702073|FG001|Overall Study|Death|6|||
164092536|NCT00661999|592702074|FG002|Overall Study|Death|3|||
164092537|NCT00661999|592702072|FG000|Overall Study|Other Reasons|5|||
164092538|NCT00661999|592702073|FG001|Overall Study|Other Reasons|12|||
164092539|NCT00661999|592702074|FG002|Overall Study|Other Reasons|23|||
164092540|NCT00661999|592702072|FG000|Overall Study|Withdrawal by Subject|30|||
164092541|NCT00661999|592702073|FG001|Overall Study|Withdrawal by Subject|23|||
164092542|NCT00661999|592702074|FG002|Overall Study|Withdrawal by Subject|14|||
164092543|NCT00661999|592702072|FG000|Overall Study|Alternative Treatment|1|||
164092544|NCT00661999|592702073|FG001|Overall Study|Alternative Treatment|0|||
164092545|NCT00661999|592702074|FG002|Overall Study|Alternative Treatment|0|||
164092546|NCT00661999|592702072|FG000|Overall Study|Other Medical Problems|4|||
164092547|NCT00661999|592702073|FG001|Overall Study|Other Medical Problems|4|||
164092548|NCT00661999|592702074|FG002|Overall Study|Other Medical Problems|9|||
164092549|NCT03066999|592702075|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
164092550|NCT03066999|592702076|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
164092551|NCT01139164|592702079|FG000|Overall Study|Withdrawn prior to study start|0|||
164092552|NCT01139164|592702080|FG001|Overall Study|Withdrawn prior to study start|2|||
164092553|NCT01139164|592702081|FG002|Overall Study|Withdrawn prior to study start|0|||
164092554|NCT01790568|592702082|FG000|Overall Study|Progression prior to transplant|0|||
164092555|NCT01790568|592702083|FG001|Overall Study|Progression prior to transplant|1|||
164092556|NCT01361126|592702084|FG000|Overall Study|Sponsor decision|0|||
164092557|NCT01361126|592702085|FG001|Overall Study|Sponsor decision|2|||
164092558|NCT00264810|592702086|FG000|Baseline|Withdrawal by Subject|10|||
164092559|NCT00264810|592702087|FG001|Baseline|Withdrawal by Subject|10|||
164092560|NCT00264810|592702086|FG000|Baseline|Physician Decision|7|||
164092561|NCT00264810|592702087|FG001|Baseline|Physician Decision|8|||
164092562|NCT00264810|592702086|FG000|Baseline|Subject Compliance Failure|3|||
164092563|NCT00264810|592702087|FG001|Baseline|Subject Compliance Failure|3|||
164092564|NCT00264810|592702086|FG000|Baseline|Insufficient Seizure Frequency|2|||
164092565|NCT00264810|592702087|FG001|Baseline|Insufficient Seizure Frequency|2|||
164092566|NCT00264810|592702086|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
164092567|NCT00264810|592702087|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
164092568|NCT00264810|592702086|FG000|Baseline|Other|0|||
164092569|NCT00264810|592702087|FG001|Baseline|Other|1|||
164092570|NCT00264810|592702086|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
164092571|NCT00264810|592702087|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
164092572|NCT00264810|592702086|FG000|Stimulation Optimization Period|Death|0|||
164092573|NCT00264810|592702087|FG001|Stimulation Optimization Period|Death|1|||
164092574|NCT00264810|592702086|FG000|Blinded Evaluation Period|Explant due to infection|1|||
164092575|NCT00264810|592702087|FG001|Blinded Evaluation Period|Explant due to infection|1|||
164092576|NCT00264810|592702086|FG000|Open Label Evaluation Period|Explant due to infection|1|||
164092577|NCT00264810|592702087|FG001|Open Label Evaluation Period|Explant due to infection|1|||
164092578|NCT00264810|592702086|FG000|Open Label Evaluation Period|Death|3|||
164092579|NCT00264810|592702087|FG001|Open Label Evaluation Period|Death|2|||
164092580|NCT00264810|592702086|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
164092581|NCT00264810|592702087|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
164092582|NCT02994056|592702088|FG000|Overall Study|Death|8|||
164092583|NCT02994056|592702088|FG000|Overall Study|Withdrew Consent|1|||
164092584|NCT01835145|592702092|FG000|Overall Study|Ineligible prior to treatment|1|||
164092585|NCT01835145|592702093|FG001|Overall Study|Ineligible prior to treatment|0|||
164092586|NCT01658943|592702097|FG000|Overall Study|Adverse Event|6|||
164092587|NCT01658943|592702098|FG001|Overall Study|Adverse Event|13|||
164092588|NCT01658943|592702097|FG000|Overall Study|Withdrawal by Subject|9|||
164092589|NCT01658943|592702098|FG001|Overall Study|Withdrawal by Subject|2|||
164092590|NCT01658943|592702097|FG000|Overall Study|Progression/Relapse|39|||
164092591|NCT01658943|592702098|FG001|Overall Study|Progression/Relapse|40|||
164092592|NCT01658943|592702097|FG000|Overall Study|Death|4|||
164092593|NCT01658943|592702098|FG001|Overall Study|Death|2|||
164092594|NCT01658943|592702097|FG000|Overall Study|not protocol specified|4|||
164092595|NCT01658943|592702098|FG001|Overall Study|not protocol specified|1|||
164092596|NCT01658943|592702097|FG000|Overall Study|Not eligible|7|||
164092597|NCT01658943|592702098|FG001|Overall Study|Not eligible|9|||
164092598|NCT01658943|592702097|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
164092599|NCT01658943|592702098|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
164092600|NCT01592370|592702099|FG000|Overall Study|Disease Progression|62|||
164092601|NCT01592370|592702100|FG001|Overall Study|Disease Progression|16|||
164092602|NCT01592370|592702101|FG002|Overall Study|Disease Progression|52|||
164092603|NCT01592370|592702102|FG003|Overall Study|Disease Progression|3|||
164092604|NCT01592370|592702103|FG004|Overall Study|Disease Progression|3|||
164092605|NCT01592370|592702104|FG005|Overall Study|Disease Progression|31|||
164092606|NCT01592370|592702105|FG006|Overall Study|Disease Progression|14|||
164092607|NCT01592370|592702099|FG000|Overall Study|Study Drug Toxicity|14|||
164092608|NCT01592370|592702100|FG001|Overall Study|Study Drug Toxicity|3|||
164092609|NCT01592370|592702101|FG002|Overall Study|Study Drug Toxicity|0|||
164092610|NCT01592370|592702102|FG003|Overall Study|Study Drug Toxicity|0|||
164092611|NCT01592370|592702103|FG004|Overall Study|Study Drug Toxicity|0|||
164092612|NCT01592370|592702104|FG005|Overall Study|Study Drug Toxicity|0|||
164092613|NCT01592370|592702105|FG006|Overall Study|Study Drug Toxicity|1|||
164092614|NCT01592370|592702099|FG000|Overall Study|AE unrelated to study drug|4|||
164092615|NCT01592370|592702100|FG001|Overall Study|AE unrelated to study drug|3|||
164092616|NCT01592370|592702101|FG002|Overall Study|AE unrelated to study drug|0|||
164092617|NCT01592370|592702102|FG003|Overall Study|AE unrelated to study drug|0|||
164092618|NCT01592370|592702103|FG004|Overall Study|AE unrelated to study drug|0|||
164092619|NCT01592370|592702104|FG005|Overall Study|AE unrelated to study drug|0|||
164092620|NCT01592370|592702105|FG006|Overall Study|AE unrelated to study drug|1|||
164092621|NCT01592370|592702099|FG000|Overall Study|Request to discontinue study treatment|5|||
164092622|NCT01592370|592702100|FG001|Overall Study|Request to discontinue study treatment|0|||
164092623|NCT01592370|592702101|FG002|Overall Study|Request to discontinue study treatment|2|||
164092624|NCT01592370|592702102|FG003|Overall Study|Request to discontinue study treatment|0|||
164092625|NCT01592370|592702103|FG004|Overall Study|Request to discontinue study treatment|1|||
164092626|NCT01592370|592702104|FG005|Overall Study|Request to discontinue study treatment|2|||
164092627|NCT01592370|592702105|FG006|Overall Study|Request to discontinue study treatment|0|||
164092628|NCT01592370|592702099|FG000|Overall Study|Withdrew consent|1|||
164092629|NCT01592370|592702100|FG001|Overall Study|Withdrew consent|2|||
164092630|NCT01592370|592702101|FG002|Overall Study|Withdrew consent|1|||
164092631|NCT01592370|592702102|FG003|Overall Study|Withdrew consent|1|||
164092632|NCT01592370|592702103|FG004|Overall Study|Withdrew consent|0|||
164092633|NCT01592370|592702104|FG005|Overall Study|Withdrew consent|0|||
164092634|NCT01592370|592702105|FG006|Overall Study|Withdrew consent|0|||
164092635|NCT01592370|592702099|FG000|Overall Study|Maximum clinical benefit|11|||
164092636|NCT01592370|592702100|FG001|Overall Study|Maximum clinical benefit|1|||
164092637|NCT01592370|592702101|FG002|Overall Study|Maximum clinical benefit|7|||
164092638|NCT01592370|592702102|FG003|Overall Study|Maximum clinical benefit|1|||
164092639|NCT01592370|592702103|FG004|Overall Study|Maximum clinical benefit|0|||
164092640|NCT01592370|592702104|FG005|Overall Study|Maximum clinical benefit|0|||
164092641|NCT01592370|592702105|FG006|Overall Study|Maximum clinical benefit|0|||
164092642|NCT01592370|592702099|FG000|Overall Study|No longer meets study criteria|1|||
164092643|NCT01592370|592702100|FG001|Overall Study|No longer meets study criteria|0|||
164092644|NCT01592370|592702101|FG002|Overall Study|No longer meets study criteria|0|||
164092645|NCT01592370|592702102|FG003|Overall Study|No longer meets study criteria|0|||
164092646|NCT01592370|592702103|FG004|Overall Study|No longer meets study criteria|0|||
164092647|NCT01592370|592702104|FG005|Overall Study|No longer meets study criteria|0|||
164092648|NCT01592370|592702105|FG006|Overall Study|No longer meets study criteria|0|||
164092649|NCT01592370|592702099|FG000|Overall Study|Other Reasons|6|||
164364407|NCT03446040|593711537|FG012|Overall Study|Adverse Event|0|||
164364408|NCT03446040|593711538|FG013|Overall Study|Adverse Event|0|||
164364409|NCT03446040|593711525|FG000|Overall Study|Death|0|||
164364410|NCT03446040|593711526|FG001|Overall Study|Death|0|||
164364411|NCT03446040|593711527|FG002|Overall Study|Death|0|||
164364412|NCT03446040|593711528|FG003|Overall Study|Death|0|||
164364413|NCT03446040|593711529|FG004|Overall Study|Death|0|||
164364414|NCT03446040|593711530|FG005|Overall Study|Death|0|||
164364415|NCT03446040|593711531|FG006|Overall Study|Death|0|||
164364416|NCT03446040|593711532|FG007|Overall Study|Death|0|||
164364417|NCT03446040|593711533|FG008|Overall Study|Death|0|||
164364418|NCT03446040|593711534|FG009|Overall Study|Death|0|||
164364419|NCT03446040|593711535|FG010|Overall Study|Death|1|||
164364420|NCT03446040|593711536|FG011|Overall Study|Death|0|||
164364421|NCT03446040|593711537|FG012|Overall Study|Death|0|||
164364422|NCT03446040|593711538|FG013|Overall Study|Death|2|||
164364423|NCT03446040|593711525|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
164364424|NCT03446040|593711526|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
164092650|NCT01592370|592702100|FG001|Overall Study|Other Reasons|0|||
164092651|NCT01592370|592702101|FG002|Overall Study|Other Reasons|10|||
164092652|NCT01592370|592702102|FG003|Overall Study|Other Reasons|0|||
164092653|NCT01592370|592702103|FG004|Overall Study|Other Reasons|0|||
164092654|NCT01592370|592702104|FG005|Overall Study|Other Reasons|1|||
164092655|NCT01592370|592702105|FG006|Overall Study|Other Reasons|0|||
164092656|NCT01592370|592702099|FG000|Overall Study|Not Treated|0|||
164092657|NCT01592370|592702100|FG001|Overall Study|Not Treated|0|||
164092658|NCT01592370|592702101|FG002|Overall Study|Not Treated|0|||
164364425|NCT03446040|593711527|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
164364426|NCT03446040|593711528|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
164364427|NCT03446040|593711529|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
164364428|NCT03446040|593711530|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
164364429|NCT03446040|593711531|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
164364430|NCT03446040|593711532|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
164364431|NCT03446040|593711533|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
164364432|NCT03446040|593711534|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
164364433|NCT03446040|593711535|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
164364434|NCT03446040|593711536|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
164364435|NCT03446040|593711537|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
164364436|NCT03446040|593711538|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
164364437|NCT03446040|593711525|FG000|Overall Study|Participant withdrew consent|0|||
164364438|NCT03446040|593711526|FG001|Overall Study|Participant withdrew consent|0|||
164364439|NCT03446040|593711527|FG002|Overall Study|Participant withdrew consent|0|||
164364440|NCT03446040|593711528|FG003|Overall Study|Participant withdrew consent|0|||
164364441|NCT03446040|593711529|FG004|Overall Study|Participant withdrew consent|0|||
164364442|NCT03446040|593711530|FG005|Overall Study|Participant withdrew consent|1|||
164364443|NCT03446040|593711531|FG006|Overall Study|Participant withdrew consent|0|||
164364444|NCT03446040|593711532|FG007|Overall Study|Participant withdrew consent|1|||
164364445|NCT03446040|593711533|FG008|Overall Study|Participant withdrew consent|0|||
164364446|NCT03446040|593711534|FG009|Overall Study|Participant withdrew consent|0|||
164364447|NCT03446040|593711535|FG010|Overall Study|Participant withdrew consent|0|||
164364448|NCT03446040|593711536|FG011|Overall Study|Participant withdrew consent|0|||
164364449|NCT03446040|593711537|FG012|Overall Study|Participant withdrew consent|0|||
164364450|NCT03446040|593711538|FG013|Overall Study|Participant withdrew consent|0|||
164364451|NCT03446040|593711525|FG000|Overall Study|Not reported|0|||
164364452|NCT03446040|593711526|FG001|Overall Study|Not reported|0|||
164364453|NCT03446040|593711527|FG002|Overall Study|Not reported|1|||
164364454|NCT03446040|593711528|FG003|Overall Study|Not reported|0|||
164364455|NCT03446040|593711529|FG004|Overall Study|Not reported|0|||
164364456|NCT03446040|593711530|FG005|Overall Study|Not reported|0|||
164364457|NCT03446040|593711531|FG006|Overall Study|Not reported|0|||
164364458|NCT03446040|593711532|FG007|Overall Study|Not reported|0|||
164364459|NCT03446040|593711533|FG008|Overall Study|Not reported|0|||
164364460|NCT03446040|593711534|FG009|Overall Study|Not reported|0|||
164364461|NCT03446040|593711535|FG010|Overall Study|Not reported|0|||
164364462|NCT03446040|593711536|FG011|Overall Study|Not reported|0|||
164364463|NCT03446040|593711537|FG012|Overall Study|Not reported|0|||
164364464|NCT03446040|593711538|FG013|Overall Study|Not reported|0|||
164364465|NCT00456521|593711539|FG000|Overall Study|Adverse Event|150|||
164364466|NCT00456521|593711540|FG001|Overall Study|Adverse Event|25|||
164364467|NCT00456521|593711539|FG000|Overall Study|Withdrawal by Subject|43|||
164364468|NCT00456521|593711540|FG001|Overall Study|Withdrawal by Subject|24|||
164364469|NCT00456521|593711539|FG000|Overall Study|Lost to Follow-up|22|||
164364470|NCT00456521|593711540|FG001|Overall Study|Lost to Follow-up|17|||
164364471|NCT00456521|593711539|FG000|Overall Study|Lack of Efficacy|3|||
164364472|NCT00456521|593711540|FG001|Overall Study|Lack of Efficacy|6|||
164364473|NCT00456521|593711539|FG000|Overall Study|Protocol Violation|4|||
164364474|NCT00456521|593711540|FG001|Overall Study|Protocol Violation|0|||
164364475|NCT00456521|593711539|FG000|Overall Study|Pregnancy|1|||
164364476|NCT00456521|593711540|FG001|Overall Study|Pregnancy|1|||
164364477|NCT00456521|593711539|FG000|Overall Study|Drug non-compliance, moved, other|26|||
164364478|NCT00456521|593711540|FG001|Overall Study|Drug non-compliance, moved, other|11|||
164364479|NCT02596854|593711541|FG000|Overall Study|Withdrawn|8|||
164364480|NCT00464568|593711544|FG000|Overall Study|Adverse Event|2|||
164364481|NCT00405587|593711545|FG000|Overall Study|Death|0|||
164364482|NCT00405587|593711546|FG001|Overall Study|Death|0|||
164364483|NCT00405587|593711547|FG002|Overall Study|Death|0|||
164364484|NCT00405587|593711548|FG003|Overall Study|Death|1|||
164364485|NCT00405587|593711545|FG000|Overall Study|Disease Progression|22|||
164364486|NCT00405587|593711546|FG001|Overall Study|Disease Progression|23|||
164364487|NCT00405587|593711547|FG002|Overall Study|Disease Progression|21|||
164364488|NCT00405587|593711548|FG003|Overall Study|Disease Progression|17|||
164364489|NCT00405587|593711545|FG000|Overall Study|Physician Decision|3|||
164364490|NCT00405587|593711546|FG001|Overall Study|Physician Decision|2|||
164364491|NCT00405587|593711547|FG002|Overall Study|Physician Decision|0|||
164364492|NCT00405587|593711548|FG003|Overall Study|Physician Decision|0|||
164012044|NCT00090285|592408669|FG001|Extension 1|Adverse Event|0|||
164012045|NCT00090285|592408670|FG002|Extension 1|Adverse Event|2|||
164012046|NCT00090285|592408671|FG003|Extension 1|Adverse Event|0|||
164012047|NCT00090285|592408672|FG004|Extension 1|Adverse Event|0|||
164364493|NCT00405587|593711545|FG000|Overall Study|Adverse Event|1|||
164364494|NCT00405587|593711546|FG001|Overall Study|Adverse Event|0|||
164364495|NCT00405587|593711547|FG002|Overall Study|Adverse Event|0|||
164364496|NCT00405587|593711548|FG003|Overall Study|Adverse Event|0|||
164364497|NCT00405587|593711545|FG000|Overall Study|Lost to Follow-up|0|||
164364498|NCT00405587|593711546|FG001|Overall Study|Lost to Follow-up|1|||
164012048|NCT00090285|592408673|FG005|Extension 1|Adverse Event|0|||
164012049|NCT00090285|592408668|FG000|Extension 1|Lost to Follow-up|0|||
164012050|NCT00090285|592408669|FG001|Extension 1|Lost to Follow-up|0|||
164012051|NCT00090285|592408670|FG002|Extension 1|Lost to Follow-up|35|||
164364499|NCT00405587|593711547|FG002|Overall Study|Lost to Follow-up|1|||
164364500|NCT00405587|593711548|FG003|Overall Study|Lost to Follow-up|0|||
164364501|NCT00405587|593711545|FG000|Overall Study|Radiation induced necrosis|0|||
164364502|NCT00405587|593711546|FG001|Overall Study|Radiation induced necrosis|1|||
164364503|NCT00405587|593711547|FG002|Overall Study|Radiation induced necrosis|0|||
164364504|NCT00405587|593711548|FG003|Overall Study|Radiation induced necrosis|0|||
164364505|NCT00405587|593711545|FG000|Overall Study|Withdrawal by Subject|0|||
164364506|NCT00405587|593711546|FG001|Overall Study|Withdrawal by Subject|0|||
164364507|NCT00405587|593711547|FG002|Overall Study|Withdrawal by Subject|0|||
164364508|NCT00405587|593711548|FG003|Overall Study|Withdrawal by Subject|2|||
164364509|NCT00405587|593711545|FG000|Overall Study|Participant not dosed|0|||
164364510|NCT00405587|593711546|FG001|Overall Study|Participant not dosed|1|||
164364511|NCT00405587|593711547|FG002|Overall Study|Participant not dosed|0|||
164364512|NCT00405587|593711548|FG003|Overall Study|Participant not dosed|0|||
164364513|NCT00507442|593711551|FG000|Overall Study|Adverse Event|8|||
164364514|NCT00507442|593711552|FG001|Overall Study|Adverse Event|11|||
164364515|NCT00507442|593711553|FG002|Overall Study|Adverse Event|4|||
164364516|NCT00507442|593711554|FG003|Overall Study|Adverse Event|1|||
164364517|NCT00507442|593711551|FG000|Overall Study|Protocol Violation|0|||
164364518|NCT00507442|593711552|FG001|Overall Study|Protocol Violation|1|||
164364519|NCT00507442|593711553|FG002|Overall Study|Protocol Violation|0|||
164364520|NCT00507442|593711554|FG003|Overall Study|Protocol Violation|0|||
164364521|NCT00507442|593711551|FG000|Overall Study|Lost to Follow-up|0|||
164364522|NCT00507442|593711552|FG001|Overall Study|Lost to Follow-up|0|||
164364523|NCT00507442|593711553|FG002|Overall Study|Lost to Follow-up|1|||
164364524|NCT00507442|593711554|FG003|Overall Study|Lost to Follow-up|0|||
164364525|NCT00507442|593711551|FG000|Overall Study|Physician Decision|0|||
164364526|NCT00507442|593711552|FG001|Overall Study|Physician Decision|2|||
164364527|NCT00507442|593711553|FG002|Overall Study|Physician Decision|4|||
164364528|NCT00507442|593711554|FG003|Overall Study|Physician Decision|1|||
164364529|NCT00507442|593711551|FG000|Overall Study|Progressive Disease|2|||
164364530|NCT00507442|593711552|FG001|Overall Study|Progressive Disease|4|||
164364531|NCT00507442|593711553|FG002|Overall Study|Progressive Disease|2|||
164364532|NCT00507442|593711554|FG003|Overall Study|Progressive Disease|0|||
164364533|NCT00507442|593711551|FG000|Overall Study|Withdrawal by Subject|4|||
164364534|NCT00507442|593711552|FG001|Overall Study|Withdrawal by Subject|4|||
164364535|NCT00507442|593711553|FG002|Overall Study|Withdrawal by Subject|2|||
164364536|NCT00507442|593711554|FG003|Overall Study|Withdrawal by Subject|1|||
164364537|NCT00507442|593711551|FG000|Overall Study|Other|2|||
164364538|NCT00507442|593711552|FG001|Overall Study|Other|5|||
164364539|NCT00507442|593711553|FG002|Overall Study|Other|2|||
164364540|NCT00507442|593711554|FG003|Overall Study|Other|2|||
164364541|NCT00930579|593711555|FG000|Overall Study|Withdrawal by Subject|1|||
164364542|NCT00930579|593711555|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
164012052|NCT00090285|592408671|FG003|Extension 1|Lost to Follow-up|0|||
164012053|NCT00090285|592408672|FG004|Extension 1|Lost to Follow-up|0|||
164012054|NCT00090285|592408673|FG005|Extension 1|Lost to Follow-up|0|||
164012055|NCT00090285|592408668|FG000|Extension 1|Withdrawal by Subject|0|||
164012056|NCT00090285|592408669|FG001|Extension 1|Withdrawal by Subject|0|||
164012057|NCT00090285|592408670|FG002|Extension 1|Withdrawal by Subject|13|||
164092659|NCT01592370|592702102|FG003|Overall Study|Not Treated|0|||
164092660|NCT01592370|592702103|FG004|Overall Study|Not Treated|2|||
164092661|NCT01592370|592702104|FG005|Overall Study|Not Treated|2|||
164092662|NCT01592370|592702105|FG006|Overall Study|Not Treated|0|||
164092663|NCT01346410|592702107|FG000|Overall Study|Death|1|||
164092664|NCT00979628|592702108|FG000|Overall Study|received regimen < 24 hours|7|||
164092665|NCT00979628|592702109|FG001|Overall Study|received regimen < 24 hours|6|||
164092666|NCT00979628|592702110|FG002|Overall Study|received regimen < 24 hours|5|||
164092667|NCT00979628|592702108|FG000|Overall Study|received steroids|1|||
164092668|NCT00979628|592702109|FG001|Overall Study|received steroids|1|||
164092669|NCT00979628|592702110|FG002|Overall Study|received steroids|0|||
164364543|NCT02255981|593711557|FG000|Overall Study|Lost to Follow-up|3|||
164364544|NCT02255981|593711557|FG000|Overall Study|Withdrawal by Subject|1|||
164364545|NCT02672423|593711558|FG000|Period 1|Adverse Event|0|||
164364546|NCT02672423|593711559|FG001|Period 1|Adverse Event|0|||
164364547|NCT02672423|593711560|FG002|Period 1|Adverse Event|0|||
164364548|NCT02672423|593711561|FG003|Period 1|Adverse Event|0|||
164364549|NCT02672423|593711562|FG004|Period 1|Adverse Event|1|||
164364550|NCT02672423|593711563|FG005|Period 1|Adverse Event|0|||
164364551|NCT02672423|593711564|FG006|Period 1|Adverse Event|0|||
164364552|NCT02672423|593711565|FG007|Period 1|Adverse Event|0|||
164092670|NCT00979628|592702108|FG000|Overall Study|transferred to ICU|1|||
164092671|NCT00979628|592702109|FG001|Overall Study|transferred to ICU|2|||
164364553|NCT02672423|593711566|FG008|Period 1|Adverse Event|0|||
164364554|NCT02672423|593711567|FG009|Period 1|Adverse Event|0|||
164364555|NCT02672423|593711558|FG000|Period 2|Withdrawal by Subject|0|||
164364556|NCT02672423|593711559|FG001|Period 2|Withdrawal by Subject|0|||
164364557|NCT02672423|593711560|FG002|Period 2|Withdrawal by Subject|1|||
164364558|NCT02672423|593711561|FG003|Period 2|Withdrawal by Subject|0|||
164364559|NCT02672423|593711562|FG004|Period 2|Withdrawal by Subject|0|||
164364560|NCT02672423|593711563|FG005|Period 2|Withdrawal by Subject|0|||
164364561|NCT02672423|593711564|FG006|Period 2|Withdrawal by Subject|0|||
164364562|NCT02672423|593711565|FG007|Period 2|Withdrawal by Subject|0|||
164364563|NCT02672423|593711566|FG008|Period 2|Withdrawal by Subject|0|||
164364564|NCT02672423|593711567|FG009|Period 2|Withdrawal by Subject|0|||
164364565|NCT02672423|593711558|FG000|Period 3|Withdrawal by Subject|0|||
164364566|NCT02672423|593711559|FG001|Period 3|Withdrawal by Subject|0|||
164364567|NCT02672423|593711560|FG002|Period 3|Withdrawal by Subject|0|||
164364568|NCT02672423|593711561|FG003|Period 3|Withdrawal by Subject|0|||
164364569|NCT02672423|593711562|FG004|Period 3|Withdrawal by Subject|0|||
164364570|NCT02672423|593711563|FG005|Period 3|Withdrawal by Subject|0|||
164364571|NCT02672423|593711564|FG006|Period 3|Withdrawal by Subject|0|||
164364572|NCT02672423|593711565|FG007|Period 3|Withdrawal by Subject|1|||
164364573|NCT02672423|593711566|FG008|Period 3|Withdrawal by Subject|0|||
164364574|NCT02672423|593711567|FG009|Period 3|Withdrawal by Subject|0|||
164364575|NCT02672423|593711558|FG000|Period 3|Physician Decision|0|||
164364576|NCT02672423|593711559|FG001|Period 3|Physician Decision|0|||
164364577|NCT02672423|593711560|FG002|Period 3|Physician Decision|0|||
164364578|NCT02672423|593711561|FG003|Period 3|Physician Decision|0|||
164364579|NCT02672423|593711562|FG004|Period 3|Physician Decision|0|||
164364580|NCT02672423|593711563|FG005|Period 3|Physician Decision|1|||
164364581|NCT02672423|593711564|FG006|Period 3|Physician Decision|0|||
164364582|NCT02672423|593711565|FG007|Period 3|Physician Decision|0|||
164364583|NCT02672423|593711566|FG008|Period 3|Physician Decision|0|||
164364584|NCT02672423|593711567|FG009|Period 3|Physician Decision|0|||
164364585|NCT01454570|593711576|FG000|Overall Study|Withdrawal by Subject|2|||
164364586|NCT01454570|593711576|FG000|Overall Study|Screen Failure|7|||
164364587|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
164364588|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
164364589|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
164364590|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
164364591|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
164364592|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
164364593|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
164364594|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
164364595|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
164364596|NCT00885755|593711577|FG000|Part I: Trastuzumab+Taxane|Death|0|||
164364597|NCT00885755|593711578|FG001|Part I: Trastuzumab+Taxane|Death|0|||
164364598|NCT00885755|593711579|FG002|Part I: Trastuzumab+Taxane|Death|1|||
164364599|NCT00885755|593711577|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
164364600|NCT00885755|593711578|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
164364601|NCT00885755|593711579|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
164364602|NCT00325754|593711580|FG000|Overall Study|Adverse Event|4|||
164364603|NCT00325754|593711581|FG001|Overall Study|Adverse Event|1|||
164364604|NCT02625090|593711588|FG000|Overall Study|Participant wants to be pregnant|2|||
164364605|NCT02625090|593711588|FG000|Overall Study|For the Promoter|1|||
164364606|NCT02625090|593711588|FG000|Overall Study|Sponsor's Decision|9|||
164364607|NCT02625090|593711588|FG000|Overall Study|Somnolence|1|||
164364608|NCT02625090|593711588|FG000|Overall Study|Study terminated by Sponsor|7|||
164364609|NCT02625090|593711588|FG000|Overall Study|Negative Benefit/Risk|1|||
164364610|NCT02625090|593711588|FG000|Overall Study|Protocol Deviation|2|||
164364611|NCT02625090|593711588|FG000|Overall Study|Lack of Efficacy|16|||
164364612|NCT02625090|593711588|FG000|Overall Study|Adverse Event|3|||
164364613|NCT04649164|593711589|FG000|Overall Study|Withdrawal by Subject|1|||
164364614|NCT04649164|593711590|FG001|Overall Study|Withdrawal by Subject|1|||
164364615|NCT04649164|593711591|FG002|Overall Study|Withdrawal by Subject|2|||
164364616|NCT04649164|593711589|FG000|Overall Study|Participant's care recipient expired|0|||
164364617|NCT04649164|593711590|FG001|Overall Study|Participant's care recipient expired|0|||
164364618|NCT04649164|593711591|FG002|Overall Study|Participant's care recipient expired|2|||
164364619|NCT02250443|593711592|FG000|Overall Study|Administrative problems|7|||
164364620|NCT02250443|593711592|FG000|Overall Study|Adverse Event|3|||
164364621|NCT01549964|593711593|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
164364622|NCT01549964|593711594|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
164364623|NCT01549964|593711595|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
164364624|NCT01549964|593711596|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
164012058|NCT00090285|592408671|FG003|Extension 1|Withdrawal by Subject|1|||
164012059|NCT00090285|592408672|FG004|Extension 1|Withdrawal by Subject|0|||
164012060|NCT00090285|592408673|FG005|Extension 1|Withdrawal by Subject|0|||
164012061|NCT00090285|592408668|FG000|Extension 1|Other|0|||
164012062|NCT00090285|592408669|FG001|Extension 1|Other|0|||
164012063|NCT00090285|592408670|FG002|Extension 1|Other|4|||
164012064|NCT00090285|592408671|FG003|Extension 1|Other|0|||
164012065|NCT00090285|592408672|FG004|Extension 1|Other|0|||
164012066|NCT00090285|592408673|FG005|Extension 1|Other|0|||
164012067|NCT00090285|592408668|FG000|Extension 1|Moved|0|||
164012068|NCT00090285|592408669|FG001|Extension 1|Moved|0|||
164012069|NCT00090285|592408670|FG002|Extension 1|Moved|3|||
164012070|NCT00090285|592408671|FG003|Extension 1|Moved|0|||
164364625|NCT01549964|593711593|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
164364626|NCT01549964|593711594|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
164364627|NCT01549964|593711595|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
164364628|NCT01549964|593711596|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
164364629|NCT01549964|593711593|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
164364630|NCT01549964|593711594|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
164364631|NCT01549964|593711595|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
164364632|NCT01549964|593711596|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
164364633|NCT01549964|593711593|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
164364634|NCT01549964|593711594|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
164364635|NCT01549964|593711595|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
164364636|NCT01549964|593711596|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
164364637|NCT01549964|593711593|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
164364638|NCT01549964|593711594|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
164364639|NCT01549964|593711595|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
164364640|NCT01549964|593711596|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
164364641|NCT01549964|593711593|FG000|24-Week Treatment Period|Other|1|||
164364642|NCT01549964|593711594|FG001|24-Week Treatment Period|Other|0|||
164364643|NCT01549964|593711595|FG002|24-Week Treatment Period|Other|1|||
164364644|NCT01549964|593711596|FG003|24-Week Treatment Period|Other|0|||
164364645|NCT01549964|593711593|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
164364646|NCT01549964|593711594|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
164364647|NCT01549964|593711595|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
164364648|NCT01549964|593711596|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
164364649|NCT01549964|593711593|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
164364650|NCT01549964|593711594|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
164364651|NCT01549964|593711595|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
164364652|NCT01549964|593711596|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
164364653|NCT01549964|593711593|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
164364654|NCT01549964|593711594|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
164364655|NCT01549964|593711595|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
164364656|NCT01549964|593711596|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
164364657|NCT01549964|593711593|FG000|80-Week Extension Period|Pregnancy|0|||
164364658|NCT01549964|593711594|FG001|80-Week Extension Period|Pregnancy|0|||
164364659|NCT01549964|593711595|FG002|80-Week Extension Period|Pregnancy|1|||
164364660|NCT01549964|593711596|FG003|80-Week Extension Period|Pregnancy|0|||
164012071|NCT00090285|592408672|FG004|Extension 1|Moved|0|||
164012072|NCT00090285|592408673|FG005|Extension 1|Moved|0|||
164364661|NCT01549964|593711593|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
164364662|NCT01549964|593711594|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
164364663|NCT01549964|593711595|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
164012073|NCT00090285|592408668|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
164012074|NCT00090285|592408669|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
164012075|NCT00090285|592408670|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
164012076|NCT00090285|592408671|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
164012077|NCT00090285|592408672|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
164012078|NCT00090285|592408673|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
164012079|NCT00090285|592408668|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164364664|NCT01549964|593711596|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
164364665|NCT01549964|593711593|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
164364666|NCT01549964|593711594|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
164364667|NCT01549964|593711595|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
164364668|NCT01549964|593711596|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
164364669|NCT01549964|593711593|FG000|80-Week Extension Period|Lost to Follow-up|1|||
164364670|NCT01549964|593711594|FG001|80-Week Extension Period|Lost to Follow-up|0|||
164364671|NCT01549964|593711595|FG002|80-Week Extension Period|Lost to Follow-up|2|||
164364672|NCT01549964|593711596|FG003|80-Week Extension Period|Lost to Follow-up|1|||
164364673|NCT01549964|593711593|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
164364674|NCT01549964|593711594|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
164364675|NCT01549964|593711595|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
164364676|NCT01549964|593711596|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
164364677|NCT02290821|593711601|FG000|Overall Study|Withdrawal by Subject|1|||
164364678|NCT02290821|593711602|FG001|Overall Study|Withdrawal by Subject|1|||
164364679|NCT02290821|593711601|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
164364680|NCT02290821|593711602|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
164364681|NCT02290821|593711601|FG000|Overall Study|Lost to Follow-up|3|||
164364682|NCT02290821|593711602|FG001|Overall Study|Lost to Follow-up|2|||
164364683|NCT03343483|593711608|FG000|Overall Study|Death|0|||
164364684|NCT03343483|593711609|FG001|Overall Study|Death|3|||
164364685|NCT03343483|593711608|FG000|Overall Study|Lost to Follow-up|9|||
164364686|NCT03343483|593711609|FG001|Overall Study|Lost to Follow-up|13|||
164364687|NCT03343483|593711608|FG000|Overall Study|Withdrawal by Subject|8|||
164364688|NCT03343483|593711609|FG001|Overall Study|Withdrawal by Subject|17|||
164364689|NCT01488097|593711612|FG000|Overall Study|Lost to Follow-up|1|||
164364690|NCT02726074|593711615|FG000|Overall Study|Withdrawal by Subject|4|||
164364691|NCT02726074|593711615|FG000|Overall Study|Adverse Event|14|||
164364692|NCT02726074|593711615|FG000|Overall Study|Protocol Violation|3|||
164364693|NCT02726074|593711615|FG000|Overall Study|Lost to Follow-up|2|||
164364694|NCT02726074|593711615|FG000|Overall Study|Others|3|||
164364695|NCT00579826|593711616|FG000|Overall Study|Withdrawal by Subject|5|||
164364696|NCT00579826|593711617|FG001|Overall Study|Withdrawal by Subject|3|||
164364697|NCT00454987|593711620|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
164364698|NCT00454987|593711621|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
164364699|NCT00454987|593711622|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
164364700|NCT00454987|593711620|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
164364701|NCT00454987|593711621|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
164364702|NCT00454987|593711622|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
164364703|NCT00454987|593711620|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
164364704|NCT00454987|593711621|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
164364705|NCT00454987|593711622|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
164364706|NCT00973479|593711626|FG000|Overall Study|Lost to Follow-up|0|||
164364707|NCT00973479|593711627|FG001|Overall Study|Lost to Follow-up|3|||
164364708|NCT00973479|593711626|FG000|Overall Study|Death|2|||
164364709|NCT00973479|593711627|FG001|Overall Study|Death|2|||
164364710|NCT00973479|593711626|FG000|Overall Study|Withdrawal by Subject|15|||
164364711|NCT00973479|593711627|FG001|Overall Study|Withdrawal by Subject|16|||
164364712|NCT00973479|593711626|FG000|Overall Study|Lack of Efficacy|5|||
164364713|NCT00973479|593711627|FG001|Overall Study|Lack of Efficacy|7|||
164364714|NCT00973479|593711626|FG000|Overall Study|Adverse Event|12|||
164364715|NCT00973479|593711627|FG001|Overall Study|Adverse Event|32|||
164364716|NCT00973479|593711626|FG000|Overall Study|Protocol Violation|2|||
164364717|NCT00973479|593711627|FG001|Overall Study|Protocol Violation|2|||
164364718|NCT00973479|593711626|FG000|Overall Study|Other|1|||
164364719|NCT00973479|593711627|FG001|Overall Study|Other|7|||
164364720|NCT05075850|593711628|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
164364721|NCT04256785|593711629|FG000|Overall Study|Adverse Event|8|||
164364722|NCT04256785|593711630|FG001|Overall Study|Adverse Event|6|||
164364723|NCT04256785|593711629|FG000|Overall Study|Lack of Efficacy|3|||
164364724|NCT04256785|593711630|FG001|Overall Study|Lack of Efficacy|4|||
164364725|NCT04256785|593711629|FG000|Overall Study|Lost to Follow-up|7|||
164364726|NCT04256785|593711630|FG001|Overall Study|Lost to Follow-up|7|||
164364727|NCT04256785|593711629|FG000|Overall Study|Protocol Violation|1|||
164364728|NCT04256785|593711630|FG001|Overall Study|Protocol Violation|0|||
164364729|NCT04256785|593711629|FG000|Overall Study|Withdrawal by Subject|4|||
164364730|NCT04256785|593711630|FG001|Overall Study|Withdrawal by Subject|1|||
164364731|NCT04256785|593711629|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
164364732|NCT04256785|593711630|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
164364733|NCT01265849|593711631|FG000|Overall Study|Randomized//Treatment not initiated|1|||
164364734|NCT01265849|593711632|FG001|Overall Study|Randomized//Treatment not initiated|4|||
164364735|NCT01265849|593711633|FG002|Overall Study|Randomized//Treatment not initiated|0|||
164364736|NCT01265849|593711631|FG000|Overall Study|Physician Decision|1|||
164364737|NCT01265849|593711632|FG001|Overall Study|Physician Decision|2|||
164364738|NCT01265849|593711633|FG002|Overall Study|Physician Decision|0|||
164012080|NCT00090285|592408669|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164012081|NCT00090285|592408670|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164012082|NCT00090285|592408671|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164012083|NCT00090285|592408672|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
164012084|NCT00090285|592408673|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
164012085|NCT00090285|592408668|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164012086|NCT00090285|592408669|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164012087|NCT00090285|592408670|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164012088|NCT00090285|592408671|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164012089|NCT00090285|592408672|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
164012090|NCT00090285|592408673|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
164012091|NCT00090285|592408668|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
164012092|NCT00090285|592408669|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
164012093|NCT00090285|592408670|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
164012094|NCT00090285|592408671|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
164012095|NCT00090285|592408672|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
164364739|NCT01265849|593711631|FG000|Overall Study|Lost to Follow-up|18|||
164364740|NCT01265849|593711632|FG001|Overall Study|Lost to Follow-up|15|||
164364741|NCT01265849|593711633|FG002|Overall Study|Lost to Follow-up|5|||
164364742|NCT01265849|593711631|FG000|Overall Study|Not otherwise specified|1|||
164364743|NCT01265849|593711632|FG001|Overall Study|Not otherwise specified|6|||
164364744|NCT01265849|593711633|FG002|Overall Study|Not otherwise specified|1|||
164364745|NCT01265849|593711631|FG000|Overall Study|Withdrawal by Subject|25|||
164364746|NCT01265849|593711632|FG001|Overall Study|Withdrawal by Subject|34|||
164364747|NCT01265849|593711633|FG002|Overall Study|Withdrawal by Subject|13|||
164364748|NCT00362115|593711634|FG000|Overall Study|Adverse Event|0|||
164364749|NCT00362115|593711635|FG001|Overall Study|Adverse Event|1|||
164364750|NCT00362115|593711636|FG002|Overall Study|Adverse Event|1|||
164364751|NCT00362115|593711637|FG003|Overall Study|Adverse Event|1|||
164364752|NCT00362115|593711638|FG004|Overall Study|Adverse Event|2|||
164364753|NCT00362115|593711639|FG005|Overall Study|Adverse Event|2|||
164364754|NCT00362115|593711640|FG006|Overall Study|Adverse Event|1|||
164364755|NCT00362115|593711634|FG000|Overall Study|Protocol Violation|0|||
164364756|NCT00362115|593711635|FG001|Overall Study|Protocol Violation|0|||
164364757|NCT00362115|593711636|FG002|Overall Study|Protocol Violation|0|||
164364758|NCT00362115|593711637|FG003|Overall Study|Protocol Violation|0|||
164364759|NCT00362115|593711638|FG004|Overall Study|Protocol Violation|0|||
164364760|NCT00362115|593711639|FG005|Overall Study|Protocol Violation|1|||
164364761|NCT00362115|593711640|FG006|Overall Study|Protocol Violation|0|||
164364762|NCT00362115|593711634|FG000|Overall Study|Lost to Follow-up|0|||
164364763|NCT00362115|593711635|FG001|Overall Study|Lost to Follow-up|1|||
164364764|NCT00362115|593711636|FG002|Overall Study|Lost to Follow-up|0|||
164364765|NCT00362115|593711637|FG003|Overall Study|Lost to Follow-up|0|||
164364766|NCT00362115|593711638|FG004|Overall Study|Lost to Follow-up|2|||
164364767|NCT00362115|593711639|FG005|Overall Study|Lost to Follow-up|0|||
164364768|NCT00362115|593711640|FG006|Overall Study|Lost to Follow-up|1|||
164364769|NCT00362115|593711634|FG000|Overall Study|Withdrawal by Subject|1|||
164364770|NCT00362115|593711635|FG001|Overall Study|Withdrawal by Subject|3|||
164364771|NCT00362115|593711636|FG002|Overall Study|Withdrawal by Subject|1|||
164364772|NCT00362115|593711637|FG003|Overall Study|Withdrawal by Subject|0|||
164364773|NCT00362115|593711638|FG004|Overall Study|Withdrawal by Subject|1|||
164364774|NCT00362115|593711639|FG005|Overall Study|Withdrawal by Subject|3|||
164364775|NCT00362115|593711640|FG006|Overall Study|Withdrawal by Subject|4|||
164364776|NCT00362115|593711634|FG000|Overall Study|Lack of Efficacy|1|||
164364777|NCT00362115|593711635|FG001|Overall Study|Lack of Efficacy|0|||
164364778|NCT00362115|593711636|FG002|Overall Study|Lack of Efficacy|5|||
164364779|NCT00362115|593711637|FG003|Overall Study|Lack of Efficacy|2|||
164364780|NCT00362115|593711638|FG004|Overall Study|Lack of Efficacy|2|||
164364781|NCT00362115|593711639|FG005|Overall Study|Lack of Efficacy|0|||
164364782|NCT00362115|593711640|FG006|Overall Study|Lack of Efficacy|3|||
164364783|NCT00362115|593711634|FG000|Overall Study|Physician Decision|0|||
164012096|NCT00090285|592408673|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
164012097|NCT02747043|592408674|FG000|Overall Study|Other|1|||
164012098|NCT02747043|592408675|FG001|Overall Study|Other|1|||
164012099|NCT02747043|592408674|FG000|Overall Study|Adverse Event|3|||
164012100|NCT02747043|592408675|FG001|Overall Study|Adverse Event|1|||
164012101|NCT02747043|592408674|FG000|Overall Study|Withdrawal by Subject|1|||
164012102|NCT02747043|592408675|FG001|Overall Study|Withdrawal by Subject|1|||
164012103|NCT02747043|592408674|FG000|Overall Study|Physician Decision|1|||
164364784|NCT00362115|593711635|FG001|Overall Study|Physician Decision|0|||
164364785|NCT00362115|593711636|FG002|Overall Study|Physician Decision|0|||
164364786|NCT00362115|593711637|FG003|Overall Study|Physician Decision|0|||
164364787|NCT00362115|593711638|FG004|Overall Study|Physician Decision|0|||
164364788|NCT00362115|593711639|FG005|Overall Study|Physician Decision|0|||
164364789|NCT00362115|593711640|FG006|Overall Study|Physician Decision|3|||
164364790|NCT00362115|593711634|FG000|Overall Study|Other|0|||
164364791|NCT00362115|593711635|FG001|Overall Study|Other|1|||
164364792|NCT00362115|593711636|FG002|Overall Study|Other|0|||
164364793|NCT00362115|593711637|FG003|Overall Study|Other|1|||
164364794|NCT00362115|593711638|FG004|Overall Study|Other|0|||
164364795|NCT00362115|593711639|FG005|Overall Study|Other|1|||
164364796|NCT00362115|593711640|FG006|Overall Study|Other|0|||
164364797|NCT01170091|593711641|FG000|Overall Study|Missing efficacy evaluation|3|||
164364798|NCT01170091|593711641|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
164364799|NCT03194321|593711642|FG000|Overall Study|Withdrawal by Subject|1|||
164364800|NCT03194321|593711642|FG000|Overall Study|Lost to Follow-up|1|||
164364801|NCT03194321|593711642|FG000|Overall Study|Travel for Follow-up|1|||
164364802|NCT02188589|593711643|FG000|Overall Study|Withdrawal by Subject|5|||
164364803|NCT00741039|593711646|FG000|Overall Study|Patient non-compliance|2|||
164364804|NCT00741039|593711647|FG001|Overall Study|Patient non-compliance|0|||
164364805|NCT00878709|593711648|FG000|Overall Study|Withdrawal by Subject|197|||
164364806|NCT00878709|593711649|FG001|Overall Study|Withdrawal by Subject|120|||
164364807|NCT00878709|593711648|FG000|Overall Study|Lost to Follow-up|35|||
164364808|NCT00878709|593711649|FG001|Overall Study|Lost to Follow-up|33|||
164364809|NCT00878709|593711648|FG000|Overall Study|Other Reasons|93|||
164364810|NCT00878709|593711649|FG001|Overall Study|Other Reasons|84|||
164364811|NCT00768300|593711650|FG000|Overall Study|Randomized but not treated|1|||
164364812|NCT00768300|593711651|FG001|Overall Study|Randomized but not treated|1|||
164364813|NCT00768300|593711650|FG000|Overall Study|Adverse Event|10|||
164364814|NCT00768300|593711651|FG001|Overall Study|Adverse Event|2|||
164364815|NCT00768300|593711650|FG000|Overall Study|Protocol Violation|6|||
164364816|NCT00768300|593711651|FG001|Overall Study|Protocol Violation|1|||
164364817|NCT00768300|593711650|FG000|Overall Study|Withdrawal by Subject|13|||
164364818|NCT00768300|593711651|FG001|Overall Study|Withdrawal by Subject|7|||
164364819|NCT00768300|593711650|FG000|Overall Study|Physician Decision|2|||
164364820|NCT00768300|593711651|FG001|Overall Study|Physician Decision|3|||
164364821|NCT00768300|593711650|FG000|Overall Study|Study discontinued by Sponsor|271|||
164364822|NCT00768300|593711651|FG001|Overall Study|Study discontinued by Sponsor|140|||
164364823|NCT00768300|593711650|FG000|Overall Study|Death|21|||
164364824|NCT00768300|593711651|FG001|Overall Study|Death|5|||
164364825|NCT00768300|593711650|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
164364826|NCT00768300|593711651|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
164364827|NCT00768300|593711650|FG000|Overall Study|Screen failure following randomization|1|||
164364828|NCT00768300|593711651|FG001|Overall Study|Screen failure following randomization|0|||
164364829|NCT00768300|593711650|FG000|Overall Study|Received lung transplant|1|||
164364830|NCT00768300|593711651|FG001|Overall Study|Received lung transplant|1|||
164364831|NCT00768300|593711650|FG000|Overall Study|Lost to Follow-up|0|||
164364832|NCT00768300|593711651|FG001|Overall Study|Lost to Follow-up|1|||
164364833|NCT00768300|593711650|FG000|Overall Study|Began prohibited concomitant medication|0|||
164364834|NCT00768300|593711651|FG001|Overall Study|Began prohibited concomitant medication|1|||
164364835|NCT00768300|593711650|FG000|Overall Study|Treated but never dosed with Study drug|1|||
164364836|NCT00768300|593711651|FG001|Overall Study|Treated but never dosed with Study drug|0|||
164364837|NCT00768300|593711650|FG000|Overall Study|Missing data|1|||
164012104|NCT02747043|592408675|FG001|Overall Study|Physician Decision|1|||
164012105|NCT02747043|592408674|FG000|Overall Study|Protocol Violation|0|||
164012106|NCT02747043|592408675|FG001|Overall Study|Protocol Violation|1|||
164012107|NCT02747043|592408674|FG000|Overall Study|Disease progression|4|||
164012108|NCT02747043|592408675|FG001|Overall Study|Disease progression|0|||
164012109|NCT02046564|592408676|FG000|Overall Study|Adverse Event|6|||
164012110|NCT02046564|592408677|FG001|Overall Study|Adverse Event|3|||
164012111|NCT02046564|592408676|FG000|Overall Study|Physician Decision|0|||
164012112|NCT02046564|592408677|FG001|Overall Study|Physician Decision|1|||
164012113|NCT02046564|592408676|FG000|Overall Study|Protocol Violation|3|||
164012114|NCT02046564|592408677|FG001|Overall Study|Protocol Violation|1|||
164012115|NCT02046564|592408676|FG000|Overall Study|Withdrawal by Subject|4|||
164012116|NCT02046564|592408677|FG001|Overall Study|Withdrawal by Subject|10|||
164012117|NCT02046564|592408676|FG000|Overall Study|Subject met withdrawal criteria|2|||
164012118|NCT02046564|592408677|FG001|Overall Study|Subject met withdrawal criteria|5|||
164012119|NCT00907478|592408678|FG000|Overall Study|Ineligibility determined|0|||
164012120|NCT00907478|592408679|FG001|Overall Study|Ineligibility determined|0|||
164012121|NCT00907478|592408680|FG002|Overall Study|Ineligibility determined|1|||
164364838|NCT00768300|593711651|FG001|Overall Study|Missing data|0|||
164364839|NCT02068222|593711652|FG000|Overall Study|Lost to Follow-up|1|||
164364840|NCT03011307|593711655|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
164364841|NCT03011307|593711656|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
164364842|NCT03011307|593711655|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
164364843|NCT03011307|593711656|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
164364844|NCT03011307|593711655|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
164012122|NCT00907478|592408678|FG000|Overall Study|Noncompliance|0|||
164364845|NCT03011307|593711656|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
164364846|NCT05198843|593711658|FG000|Overall Study|Lack of Efficacy|1|||
164364847|NCT00567892|593711662|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364848|NCT00567892|593711663|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364849|NCT00567892|593711664|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
164364850|NCT00567892|593711665|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
164364851|NCT00567892|593711662|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364852|NCT00567892|593711663|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364853|NCT00567892|593711664|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
164364854|NCT00567892|593711665|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
164364855|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
164364856|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
164364857|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
164364858|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
164364859|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
164364860|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
164364861|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
164364862|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
164364863|NCT01541969|593713124|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
164364864|NCT01541969|593713125|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
164364865|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
164364866|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
164364867|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
164364868|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
164364869|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
164364870|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
164364871|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
164364872|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
164364873|NCT01541969|593713124|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
164092672|NCT00979628|592702110|FG002|Overall Study|transferred to ICU|1|||
164364874|NCT01541969|593713125|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
164364875|NCT01365507|593713126|FG000|Overall Study|Withdrawal Criteria|8|||
164364876|NCT01365507|593713127|FG001|Overall Study|Withdrawal Criteria|5|||
164364877|NCT01365507|593713126|FG000|Overall Study|Unclassified|1|||
164364878|NCT01365507|593713127|FG001|Overall Study|Unclassified|4|||
164364879|NCT01614990|593713128|FG000|Overall Study|Protocol Violation|1|||
164364880|NCT01614990|593713129|FG001|Overall Study|Protocol Violation|1|||
164364881|NCT02255500|593713136|FG000|Overall Study|Withdrawal by Subject|1|||
164364882|NCT02255500|593713137|FG001|Overall Study|Withdrawal by Subject|0|||
164364883|NCT04254978|593713141|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
164364884|NCT04254978|593713141|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
164364885|NCT04254978|593713141|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
164364886|NCT04254978|593713141|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
164364887|NCT04254978|593713141|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
164364888|NCT04254978|593713141|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
164364889|NCT02449239|593713142|FG000|Induction Phase|Lack of Efficacy|64|||
164364890|NCT02449239|593713142|FG000|Induction Phase|Adverse Event|1|||
164364891|NCT02449239|593713142|FG000|Induction Phase|Lost to Follow-up|1|||
164364892|NCT02449239|593713142|FG000|Induction Phase|Protocol Violation|1|||
164364893|NCT02449239|593713142|FG000|Induction Phase|Physician Decision|1|||
164364894|NCT02449239|593713142|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
164364895|NCT02449239|593713142|FG000|Induction Phase|Withdrawal by Subject|1|||
164364896|NCT02449239|593713142|FG000|Maintenance Month 3|Lack of Efficacy|14|||
164364897|NCT02449239|593713142|FG000|Maintenance Month 6|Lack of Efficacy|10|||
164364898|NCT02449239|593713142|FG000|Maintenance Month 6|Adverse Event|2|||
164364899|NCT02449239|593713142|FG000|Maintenance Month 6|Physician Decision|1|||
164092673|NCT05905783|592702111|FG000|Overall Study|Lost to Follow-up|12|||
164092674|NCT05905783|592702112|FG001|Overall Study|Lost to Follow-up|18|||
164092675|NCT05905783|592702111|FG000|Overall Study|Withdrawal by Subject|29|||
164364900|NCT02449239|593713142|FG000|Maintenance Month 9|Lack of Efficacy|2|||
164092676|NCT05905783|592702112|FG001|Overall Study|Withdrawal by Subject|37|||
164092677|NCT05905783|592702111|FG000|Overall Study|Decision by sponsor|69|||
164364901|NCT02449239|593713142|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
164364902|NCT02449239|593713142|FG000|Maintenance Month 12|Lack of Efficacy|5|||
164364903|NCT02449239|593713142|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
164364904|NCT02449239|593713142|FG000|Maintenance Month 12|Subject moved from area|1|||
164364905|NCT02449239|593713142|FG000|Maintenance Month 15|Lack of Efficacy|1|||
164364906|NCT02449239|593713142|FG000|Maintenance Month 21|Lack of Efficacy|1|||
164092678|NCT05905783|592702112|FG001|Overall Study|Decision by sponsor|65|||
164092679|NCT00911859|592702113|FG000|Treatment Period|Adverse Event|3|||
164364907|NCT02449239|593713142|FG000|Maintenance Month 21|Sponsor decision|1|||
164364908|NCT03257631|593713143|FG000|Overall Study|Death|1|||
164364909|NCT03257631|593713144|FG001|Overall Study|Death|0|||
164364910|NCT03257631|593713145|FG002|Overall Study|Death|1|||
164364911|NCT03257631|593713146|FG003|Overall Study|Death|1|||
164364912|NCT03257631|593713143|FG000|Overall Study|Progressive Disease|10|||
164092680|NCT00911859|592702114|FG001|Treatment Period|Adverse Event|3|||
164092681|NCT00911859|592702115|FG002|Treatment Period|Adverse Event|7|||
164092682|NCT00911859|592702113|FG000|Treatment Period|Death|1|||
164092683|NCT00911859|592702114|FG001|Treatment Period|Death|3|||
164092684|NCT00911859|592702115|FG002|Treatment Period|Death|5|||
164092685|NCT00911859|592702113|FG000|Treatment Period|Lack of Efficacy|1|||
164092686|NCT00911859|592702114|FG001|Treatment Period|Lack of Efficacy|7|||
164092687|NCT00911859|592702115|FG002|Treatment Period|Lack of Efficacy|5|||
164092688|NCT00911859|592702113|FG000|Treatment Period|Physician Decision|3|||
164092689|NCT00911859|592702114|FG001|Treatment Period|Physician Decision|3|||
164092690|NCT00911859|592702115|FG002|Treatment Period|Physician Decision|3|||
164364913|NCT03257631|593713144|FG001|Overall Study|Progressive Disease|9|||
164364914|NCT03257631|593713145|FG002|Overall Study|Progressive Disease|17|||
164364915|NCT03257631|593713146|FG003|Overall Study|Progressive Disease|8|||
164364916|NCT03257631|593713143|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164364917|NCT03257631|593713144|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164364918|NCT03257631|593713145|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164364919|NCT03257631|593713146|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
164364920|NCT03257631|593713143|FG000|Overall Study|Adverse Event|0|||
164364921|NCT03257631|593713144|FG001|Overall Study|Adverse Event|0|||
164364922|NCT03257631|593713145|FG002|Overall Study|Adverse Event|2|||
164364923|NCT03257631|593713146|FG003|Overall Study|Adverse Event|0|||
164364924|NCT03509675|593713150|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
164364925|NCT03509675|593713151|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
164364926|NCT03509675|593713150|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
164364927|NCT03509675|593713151|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
164364928|NCT03509675|593713150|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
164364929|NCT03509675|593713151|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
164364930|NCT03509675|593713150|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
164364931|NCT03509675|593713151|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
164364932|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
164364933|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
164364934|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
164364935|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
164364936|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
164364937|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
164364938|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
164364939|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
164364940|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
164364941|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
164364942|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
164092691|NCT00911859|592702113|FG000|Treatment Period|Withdrawal by Subject|0|||
164092692|NCT00911859|592702114|FG001|Treatment Period|Withdrawal by Subject|4|||
164364943|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
164364944|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
164364945|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
164364946|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
164364947|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
164364948|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
164364949|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
163901847|NCT04153890|592011491|FG002|Overall Study|Lost to Follow-up|9|||
163901848|NCT04153890|592011492|FG003|Overall Study|Lost to Follow-up|0|||
163901849|NCT04153890|592011489|FG000|Overall Study|Death|0|||
163901850|NCT04153890|592011490|FG001|Overall Study|Death|2|||
163901851|NCT04153890|592011491|FG002|Overall Study|Death|0|||
163901852|NCT04153890|592011492|FG003|Overall Study|Death|0|||
163901853|NCT04153890|592011489|FG000|Overall Study|Withdrawal by Subject|0|||
163901854|NCT04153890|592011490|FG001|Overall Study|Withdrawal by Subject|0|||
163901855|NCT04153890|592011491|FG002|Overall Study|Withdrawal by Subject|0|||
163901856|NCT04153890|592011492|FG003|Overall Study|Withdrawal by Subject|2|||
163901857|NCT03610581|592011493|FG000|Overall Study|Study terminated by sponsor|2|||
163901858|NCT03610581|592011494|FG001|Overall Study|Study terminated by sponsor|0|||
163901859|NCT03610581|592011493|FG000|Overall Study|Other|0|||
163901860|NCT03610581|592011494|FG001|Overall Study|Other|1|||
163901861|NCT03610581|592011493|FG000|Overall Study|Withdrawal by Subject|1|||
163901862|NCT03610581|592011494|FG001|Overall Study|Withdrawal by Subject|0|||
163901863|NCT05630833|592011499|FG000|Overall Study|Adverse Event|3|||
164092693|NCT00911859|592702115|FG002|Treatment Period|Withdrawal by Subject|5|||
164092694|NCT00911859|592702113|FG000|Treatment Period|Did not receive study treatment|0|||
163901864|NCT05630833|592011500|FG001|Overall Study|Adverse Event|0|||
164364950|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
164364951|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
164364952|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
164364953|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
164364954|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
164364955|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
164364956|NCT00277212|593713152|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
164364957|NCT00277212|593713153|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
164364958|NCT00277212|593713154|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
164364959|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
164364960|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
164364961|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
164364962|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
164364963|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
164364964|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
164364965|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
164364966|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
164364967|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
164364968|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
164364969|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
164364970|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
164364971|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
164364972|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
164364973|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
164364974|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
164364975|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
164364976|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
164364977|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
164364978|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
164364979|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
164364980|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
164364981|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
164364982|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
164364983|NCT00277212|593713152|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
164364984|NCT00277212|593713153|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
164364985|NCT00277212|593713154|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
164364986|NCT00902564|593713155|FG000|Overall Study|Withdrawal by Subject|2|||
164364987|NCT03239470|593713158|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
164364988|NCT03239470|593713159|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
164364989|NCT01023581|593713160|FG000|Overall Study|Adverse Event|4|||
164364990|NCT01023581|593713161|FG001|Overall Study|Adverse Event|4|||
164364991|NCT01023581|593713162|FG002|Overall Study|Adverse Event|7|||
164364992|NCT01023581|593713163|FG003|Overall Study|Adverse Event|3|||
164364993|NCT01023581|593713164|FG004|Overall Study|Adverse Event|2|||
164364994|NCT01023581|593713165|FG005|Overall Study|Adverse Event|5|||
164364995|NCT01023581|593713166|FG006|Overall Study|Adverse Event|11|||
164364996|NCT01023581|593713160|FG000|Overall Study|Major protocol deviation|2|||
164364997|NCT01023581|593713161|FG001|Overall Study|Major protocol deviation|0|||
164364998|NCT01023581|593713162|FG002|Overall Study|Major protocol deviation|3|||
164364999|NCT01023581|593713163|FG003|Overall Study|Major protocol deviation|0|||
164365000|NCT01023581|593713164|FG004|Overall Study|Major protocol deviation|0|||
164365001|NCT01023581|593713165|FG005|Overall Study|Major protocol deviation|0|||
164365002|NCT01023581|593713166|FG006|Overall Study|Major protocol deviation|0|||
164365003|NCT01023581|593713160|FG000|Overall Study|Lost to Follow-up|4|||
164365004|NCT01023581|593713161|FG001|Overall Study|Lost to Follow-up|8|||
164365005|NCT01023581|593713162|FG002|Overall Study|Lost to Follow-up|7|||
164365006|NCT01023581|593713163|FG003|Overall Study|Lost to Follow-up|2|||
163901865|NCT05630833|592011499|FG000|Overall Study|Lack of Efficacy|0|||
163901866|NCT05630833|592011500|FG001|Overall Study|Lack of Efficacy|1|||
163901867|NCT05630833|592011499|FG000|Overall Study|Lost to Follow-up|1|||
163901868|NCT05630833|592011500|FG001|Overall Study|Lost to Follow-up|0|||
163901869|NCT05630833|592011499|FG000|Overall Study|Withdrawal by Subject|3|||
163901870|NCT05630833|592011500|FG001|Overall Study|Withdrawal by Subject|1|||
163901871|NCT04306367|592011501|FG000|Overall Study|Progression of Disease|9|||
163901872|NCT04306367|592011501|FG000|Overall Study|Adverse Event|3|||
163901873|NCT04306367|592011501|FG000|Overall Study|Withdrawal by Subject|1|||
163901874|NCT02751528|592011508|FG000|Overall Study|Withdrawal by Subject|1|||
163901875|NCT02751528|592011508|FG000|Overall Study|Adverse Event|1|||
163901876|NCT05485805|592011509|FG000|Overall Study|Withdrawal by Subject|1|||
163901877|NCT05485805|592011510|FG001|Overall Study|Withdrawal by Subject|2|||
163901878|NCT05485805|592011511|FG002|Overall Study|Withdrawal by Subject|2|||
164012123|NCT00907478|592408679|FG001|Overall Study|Noncompliance|0|||
164012124|NCT00907478|592408680|FG002|Overall Study|Noncompliance|1|||
164012125|NCT00907478|592408678|FG000|Overall Study|Adverse Event|3|||
164365007|NCT01023581|593713164|FG004|Overall Study|Lost to Follow-up|5|||
164365008|NCT01023581|593713165|FG005|Overall Study|Lost to Follow-up|2|||
164365009|NCT01023581|593713166|FG006|Overall Study|Lost to Follow-up|2|||
164365010|NCT01023581|593713160|FG000|Overall Study|Withdrawal by Subject|13|||
164365011|NCT01023581|593713161|FG001|Overall Study|Withdrawal by Subject|8|||
164365012|NCT01023581|593713162|FG002|Overall Study|Withdrawal by Subject|16|||
164365013|NCT01023581|593713163|FG003|Overall Study|Withdrawal by Subject|10|||
164365014|NCT01023581|593713164|FG004|Overall Study|Withdrawal by Subject|6|||
164365015|NCT01023581|593713165|FG005|Overall Study|Withdrawal by Subject|8|||
164365016|NCT01023581|593713166|FG006|Overall Study|Withdrawal by Subject|5|||
164365017|NCT01023581|593713160|FG000|Overall Study|Pregnancy|0|||
164365018|NCT01023581|593713161|FG001|Overall Study|Pregnancy|0|||
164365019|NCT01023581|593713162|FG002|Overall Study|Pregnancy|0|||
164365020|NCT01023581|593713163|FG003|Overall Study|Pregnancy|2|||
164365021|NCT01023581|593713164|FG004|Overall Study|Pregnancy|0|||
164365022|NCT01023581|593713165|FG005|Overall Study|Pregnancy|1|||
164365023|NCT01023581|593713166|FG006|Overall Study|Pregnancy|0|||
164365024|NCT01023581|593713160|FG000|Overall Study|Lack of Efficacy|9|||
164365025|NCT01023581|593713161|FG001|Overall Study|Lack of Efficacy|3|||
164365026|NCT01023581|593713162|FG002|Overall Study|Lack of Efficacy|6|||
164365027|NCT01023581|593713163|FG003|Overall Study|Lack of Efficacy|2|||
164365028|NCT01023581|593713164|FG004|Overall Study|Lack of Efficacy|1|||
164365029|NCT01023581|593713165|FG005|Overall Study|Lack of Efficacy|2|||
164365030|NCT01023581|593713166|FG006|Overall Study|Lack of Efficacy|1|||
164365031|NCT01023581|593713160|FG000|Overall Study|Physician Decision|2|||
164365032|NCT01023581|593713161|FG001|Overall Study|Physician Decision|0|||
164365033|NCT01023581|593713162|FG002|Overall Study|Physician Decision|2|||
164365034|NCT01023581|593713163|FG003|Overall Study|Physician Decision|1|||
164365035|NCT01023581|593713164|FG004|Overall Study|Physician Decision|1|||
164365036|NCT01023581|593713165|FG005|Overall Study|Physician Decision|1|||
164365037|NCT01023581|593713166|FG006|Overall Study|Physician Decision|1|||
164365038|NCT01023581|593713160|FG000|Overall Study|Other|1|||
164365039|NCT01023581|593713161|FG001|Overall Study|Other|0|||
164365040|NCT01023581|593713162|FG002|Overall Study|Other|1|||
164365041|NCT01023581|593713163|FG003|Overall Study|Other|0|||
164365042|NCT01023581|593713164|FG004|Overall Study|Other|1|||
164365043|NCT01023581|593713165|FG005|Overall Study|Other|0|||
164365044|NCT01023581|593713166|FG006|Overall Study|Other|0|||
164365045|NCT02474199|593713167|FG000|Overall Study|Lost to Follow-up|1|||
164365046|NCT02474199|593713168|FG001|Overall Study|Lost to Follow-up|0|||
163901879|NCT05485805|592011512|FG003|Overall Study|Withdrawal by Subject|0|||
163901880|NCT05485805|592011513|FG004|Overall Study|Withdrawal by Subject|2|||
163901881|NCT05485805|592011509|FG000|Overall Study|Adverse Event|0|||
164365047|NCT02474199|593713169|FG002|Overall Study|Lost to Follow-up|0|||
164365048|NCT02474199|593713170|FG003|Overall Study|Lost to Follow-up|0|||
164365049|NCT02474199|593713167|FG000|Overall Study|Withdrawal by Subject|1|||
164365050|NCT02474199|593713168|FG001|Overall Study|Withdrawal by Subject|2|||
164365051|NCT02474199|593713169|FG002|Overall Study|Withdrawal by Subject|0|||
164365052|NCT02474199|593713170|FG003|Overall Study|Withdrawal by Subject|1|||
164365053|NCT02474199|593713167|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
164365054|NCT02474199|593713168|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
164365055|NCT02474199|593713169|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
164365056|NCT02474199|593713170|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
164365057|NCT02474199|593713167|FG000|Overall Study|Did not meet eligibility criteria|0|||
164365058|NCT02474199|593713168|FG001|Overall Study|Did not meet eligibility criteria|0|||
164365059|NCT02474199|593713169|FG002|Overall Study|Did not meet eligibility criteria|2|||
164365060|NCT02474199|593713170|FG003|Overall Study|Did not meet eligibility criteria|2|||
164365061|NCT03314584|593713177|FG000|Overall Study|Withdrawal by Subject|3|||
164365062|NCT03314584|593713178|FG001|Overall Study|Withdrawal by Subject|3|||
164365063|NCT03314584|593713177|FG000|Overall Study|Lost to Follow-up|4|||
164365064|NCT03314584|593713178|FG001|Overall Study|Lost to Follow-up|0|||
164365065|NCT06134817|593713179|FG000|Overall Study|Physician Departure - termination of study|1|||
164365066|NCT03406858|593713186|FG000|Overall Study|Failure to receive treatment drug.|1|||
164365067|NCT03406858|593713186|FG000|Overall Study|ineligible|1|||
164365068|NCT06027866|593713187|FG000|Overall Study|Withdrawal by Subject|2|||
164365069|NCT01046682|593713194|FG000|Overall Study|Adverse Event|2|||
163901882|NCT05485805|592011510|FG001|Overall Study|Adverse Event|1|||
163901883|NCT05485805|592011511|FG002|Overall Study|Adverse Event|0|||
164012126|NCT00907478|592408679|FG001|Overall Study|Adverse Event|1|||
164365070|NCT01046682|593713195|FG001|Overall Study|Adverse Event|0|||
164365071|NCT05071183|593713198|FG000|Overall Study|Death|1|||
164365072|NCT05071183|593713199|FG001|Overall Study|Death|2|||
164365073|NCT05071183|593713200|FG002|Overall Study|Death|0|||
164365074|NCT05071183|593713198|FG000|Overall Study|Other Reasons|1|||
164365075|NCT05071183|593713199|FG001|Overall Study|Other Reasons|3|||
164365076|NCT05071183|593713200|FG002|Overall Study|Other Reasons|2|||
164365077|NCT02046148|593713201|FG000|Overall Study|Lost to Follow-up|1|||
164365078|NCT02046148|593713202|FG001|Overall Study|Lost to Follow-up|1|||
164365079|NCT02046148|593713201|FG000|Overall Study|Withdrawal by Subject|0|||
164365080|NCT02046148|593713202|FG001|Overall Study|Withdrawal by Subject|2|||
164365081|NCT03506373|593713204|FG000|Overall Study|Adverse Event|6|||
164365082|NCT03506373|593713204|FG000|Overall Study|Withdrawal by Subject|2|||
164365083|NCT03506373|593713204|FG000|Overall Study|Disease progression|5|||
164365084|NCT03506373|593713204|FG000|Overall Study|Other|3|||
164365085|NCT00107198|593713209|FG000|Overall Study|Lack of Efficacy|28|||
164365086|NCT00107198|593713209|FG000|Overall Study|Lost to Follow-up|12|||
164365087|NCT00107198|593713209|FG000|Overall Study|Protocol Violation|1|||
164365088|NCT00107198|593713209|FG000|Overall Study|Withdrawal by Subject|6|||
164365089|NCT00107198|593713209|FG000|Overall Study|Ineligible|5|||
164365090|NCT02939560|593713216|FG000|Overall Study|Withdrawal by Subject|2|||
164365091|NCT02939560|593713216|FG000|Overall Study|Protocol Violation|1|||
164365092|NCT03340025|593713217|FG000|Overall Study|Lost to Follow-up|2|||
164365093|NCT03340025|593713218|FG001|Overall Study|Lost to Follow-up|2|||
164365094|NCT02420691|593713219|FG000|Overall Study|Adverse Event|3|||
164365095|NCT02420691|593713219|FG000|Overall Study|Withdrawal by Subject|3|||
164365096|NCT01852812|593713220|FG000|Overall Study|Adverse Event|0|||
164365097|NCT01852812|593713221|FG001|Overall Study|Adverse Event|0|||
164365098|NCT01852812|593713222|FG002|Overall Study|Adverse Event|1|||
164365099|NCT01852812|593713220|FG000|Overall Study|Non-compliance With Study Drug|0|||
164365100|NCT01852812|593713221|FG001|Overall Study|Non-compliance With Study Drug|1|||
164365101|NCT01852812|593713222|FG002|Overall Study|Non-compliance With Study Drug|0|||
164365102|NCT01293240|593713226|FG000|Overall Study|Noncompliance|2|||
164365103|NCT01520363|593713227|FG000|Overall Study|Withdrawal by Subject|2|||
164365104|NCT01520363|593713228|FG001|Overall Study|Withdrawal by Subject|0|||
164365105|NCT03165110|593713232|FG000|Overall Study|Anroid phone software incompatibility|1|||
164365106|NCT01498952|593713233|FG000|Overall Study|Death|2|||
164365107|NCT01498952|593713234|FG001|Overall Study|Death|2|||
164365108|NCT01498952|593713235|FG002|Overall Study|Death|0|||
164365109|NCT01498952|593713236|FG003|Overall Study|Death|0|||
164365110|NCT01498952|593713237|FG004|Overall Study|Death|0|||
164365111|NCT05533632|593713238|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
164365112|NCT05533632|593713238|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
164365113|NCT05533632|593713238|FG000|Overall Study|Lost to Follow-up|1|||
164365114|NCT05533632|593713238|FG000|Overall Study|Withdrawal by Subject|4|||
164365115|NCT05533632|593713238|FG000|Overall Study|Adverse Event|4|||
164365116|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|5|||
164365117|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365118|NCT00304356|593713239|FG000|Nitazoxanide|number is 0|1|||
164365119|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365120|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365121|NCT00304356|593713239|FG000|Nitazoxanide|Physician Decision|1|||
164365122|NCT01154218|593713240|FG000|Third Intervention Period|Adverse Event|0|||
164365123|NCT01154218|593713241|FG001|Third Intervention Period|Adverse Event|1|||
164365124|NCT01154218|593713242|FG002|Third Intervention Period|Adverse Event|0|||
164365125|NCT01154218|593713243|FG003|Third Intervention Period|Adverse Event|0|||
164365126|NCT01154218|593713240|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164365127|NCT01154218|593713241|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164365128|NCT01154218|593713242|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164365129|NCT01154218|593713243|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
164365130|NCT01154218|593713240|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
164365131|NCT01154218|593713241|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
164365132|NCT01154218|593713242|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
164365133|NCT01154218|593713243|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
164365134|NCT01374087|593713247|FG000|Overall Study|Adverse Event|1|||
164092695|NCT00911859|592702114|FG001|Treatment Period|Did not receive study treatment|1|||
164365135|NCT01374087|593713248|FG001|Overall Study|Adverse Event|0|||
164365136|NCT01374087|593713247|FG000|Overall Study|Disease progression|2|||
164365137|NCT01374087|593713248|FG001|Overall Study|Disease progression|2|||
164365138|NCT01374087|593713247|FG000|Overall Study|Study discontinued|13|||
164365139|NCT01374087|593713248|FG001|Overall Study|Study discontinued|13|||
164365140|NCT04690751|593713249|FG000|Overall Study|Protocol Violation|0|||
164365141|NCT04690751|593713250|FG001|Overall Study|Protocol Violation|1|||
164365142|NCT04690751|593713251|FG002|Overall Study|Protocol Violation|0|||
164365143|NCT04690751|593713252|FG003|Overall Study|Protocol Violation|1|||
164365144|NCT04690751|593713253|FG004|Overall Study|Protocol Violation|2|||
164365145|NCT04690751|593713254|FG005|Overall Study|Protocol Violation|0|||
164365146|NCT04690751|593713249|FG000|Overall Study|Adverse Event|0|||
164365147|NCT04690751|593713250|FG001|Overall Study|Adverse Event|0|||
164365148|NCT04690751|593713251|FG002|Overall Study|Adverse Event|1|||
164365149|NCT04690751|593713252|FG003|Overall Study|Adverse Event|0|||
164365150|NCT04690751|593713253|FG004|Overall Study|Adverse Event|0|||
164365151|NCT04690751|593713254|FG005|Overall Study|Adverse Event|0|||
164365152|NCT04690751|593713249|FG000|Overall Study|Positive urine drug screen test|0|||
164365153|NCT04690751|593713250|FG001|Overall Study|Positive urine drug screen test|0|||
164365154|NCT04690751|593713251|FG002|Overall Study|Positive urine drug screen test|0|||
164365155|NCT04690751|593713252|FG003|Overall Study|Positive urine drug screen test|0|||
164365156|NCT04690751|593713253|FG004|Overall Study|Positive urine drug screen test|1|||
164365157|NCT04690751|593713254|FG005|Overall Study|Positive urine drug screen test|0|||
164365158|NCT01344161|593713255|FG000|Overall Study|Lost to Follow-up|4|||
164365159|NCT01344161|593713256|FG001|Overall Study|Lost to Follow-up|1|||
164365160|NCT01344161|593713255|FG000|Overall Study|Pregnancy|0|||
164365161|NCT01344161|593713256|FG001|Overall Study|Pregnancy|1|||
164365162|NCT01344161|593713255|FG000|Overall Study|Protocol Violation|1|||
164365163|NCT01344161|593713256|FG001|Overall Study|Protocol Violation|1|||
164365164|NCT04364620|593713257|FG000|Overall Study|Disease Progression|20|||
164365165|NCT04364620|593713257|FG000|Overall Study|Adverse Event|5|||
164365166|NCT04364620|593713257|FG000|Overall Study|Physician Decision|4|||
164365167|NCT04364620|593713257|FG000|Overall Study|Death|3|||
164365168|NCT04364620|593713257|FG000|Overall Study|Other|2|||
164365169|NCT04364620|593713257|FG000|Overall Study|Withdrawal by Subject|1|||
164365170|NCT03336216|593714995|FG000|Randomization|Not reported|2|||
164365171|NCT03336216|593714996|FG001|Randomization|Not reported|0|||
164365172|NCT03336216|593714997|FG002|Randomization|Not reported|1|||
164365173|NCT03336216|593714998|FG003|Randomization|Not reported|0|||
164365174|NCT03336216|593714995|FG000|Randomization|Other reasons|1|||
164365175|NCT03336216|593714996|FG001|Randomization|Other reasons|1|||
164365176|NCT03336216|593714997|FG002|Randomization|Other reasons|1|||
164365177|NCT03336216|593714998|FG003|Randomization|Other reasons|0|||
164365178|NCT03336216|593714995|FG000|Randomization|Participant no longer meets study criteria|0|||
164365179|NCT03336216|593714996|FG001|Randomization|Participant no longer meets study criteria|2|||
164365180|NCT03336216|593714997|FG002|Randomization|Participant no longer meets study criteria|4|||
164365181|NCT03336216|593714998|FG003|Randomization|Participant no longer meets study criteria|1|||
164365182|NCT03336216|593714995|FG000|Randomization|Lost to Follow-up|1|||
164365183|NCT03336216|593714996|FG001|Randomization|Lost to Follow-up|0|||
164365184|NCT03336216|593714997|FG002|Randomization|Lost to Follow-up|0|||
164365185|NCT03336216|593714998|FG003|Randomization|Lost to Follow-up|0|||
164365186|NCT03336216|593714995|FG000|Randomization|Participant withdrew consent|9|||
164365187|NCT03336216|593714996|FG001|Randomization|Participant withdrew consent|1|||
164365188|NCT03336216|593714997|FG002|Randomization|Participant withdrew consent|0|||
164365189|NCT03336216|593714998|FG003|Randomization|Participant withdrew consent|0|||
164365190|NCT03336216|593714995|FG000|Randomization|Adverse Event|1|||
164365191|NCT03336216|593714996|FG001|Randomization|Adverse Event|1|||
164365192|NCT03336216|593714997|FG002|Randomization|Adverse Event|0|||
164365193|NCT03336216|593714998|FG003|Randomization|Adverse Event|0|||
164365194|NCT03336216|593714995|FG000|Treatment|Adverse Event|2|||
164365195|NCT03336216|593714996|FG001|Treatment|Adverse Event|3|||
164365196|NCT03336216|593714997|FG002|Treatment|Adverse Event|4|||
164365197|NCT03336216|593714998|FG003|Treatment|Adverse Event|4|||
164365198|NCT03336216|593714995|FG000|Treatment|Participant request to discontinue treatment|2|||
164365199|NCT03336216|593714996|FG001|Treatment|Participant request to discontinue treatment|1|||
164365200|NCT03336216|593714997|FG002|Treatment|Participant request to discontinue treatment|2|||
164365201|NCT03336216|593714998|FG003|Treatment|Participant request to discontinue treatment|2|||
164365202|NCT03336216|593714995|FG000|Treatment|Participant withdrew consent|7|||
163901884|NCT05485805|592011512|FG003|Overall Study|Adverse Event|0|||
163901885|NCT05485805|592011513|FG004|Overall Study|Adverse Event|0|||
164365203|NCT03336216|593714996|FG001|Treatment|Participant withdrew consent|2|||
164365204|NCT03336216|593714997|FG002|Treatment|Participant withdrew consent|3|||
164365205|NCT03336216|593714998|FG003|Treatment|Participant withdrew consent|2|||
164365206|NCT03336216|593714995|FG000|Treatment|Death|2|||
164365207|NCT03336216|593714996|FG001|Treatment|Death|3|||
164365208|NCT03336216|593714997|FG002|Treatment|Death|3|||
163901886|NCT05485805|592011509|FG000|Overall Study|Lost to Follow-up|1|||
164365209|NCT03336216|593714998|FG003|Treatment|Death|4|||
164365210|NCT03336216|593714995|FG000|Treatment|Participant no longer meets study criteria|0|||
164365211|NCT03336216|593714996|FG001|Treatment|Participant no longer meets study criteria|1|||
164365212|NCT03336216|593714997|FG002|Treatment|Participant no longer meets study criteria|0|||
163901887|NCT05485805|592011510|FG001|Overall Study|Lost to Follow-up|1|||
164365213|NCT03336216|593714998|FG003|Treatment|Participant no longer meets study criteria|0|||
164365214|NCT03336216|593714995|FG000|Treatment|Other reasons|2|||
164365215|NCT03336216|593714996|FG001|Treatment|Other reasons|0|||
164365216|NCT03336216|593714997|FG002|Treatment|Other reasons|0|||
163901888|NCT05485805|592011511|FG002|Overall Study|Lost to Follow-up|3|||
164365217|NCT03336216|593714998|FG003|Treatment|Other reasons|3|||
164365218|NCT03336216|593714995|FG000|Treatment|Disease progression|23|||
164365219|NCT03336216|593714996|FG001|Treatment|Disease progression|34|||
164365220|NCT03336216|593714997|FG002|Treatment|Disease progression|33|||
164365221|NCT03336216|593714998|FG003|Treatment|Disease progression|26|||
164365222|NCT03336216|593714995|FG000|Treatment|Study drug toxicity|0|||
164365223|NCT03336216|593714996|FG001|Treatment|Study drug toxicity|3|||
164365224|NCT03336216|593714997|FG002|Treatment|Study drug toxicity|2|||
164365225|NCT03336216|593714998|FG003|Treatment|Study drug toxicity|0|||
164365226|NCT03336216|593714995|FG000|Treatment|Adverse Event unrelated to study drug|1|||
164365227|NCT03336216|593714996|FG001|Treatment|Adverse Event unrelated to study drug|1|||
164365228|NCT03336216|593714997|FG002|Treatment|Adverse Event unrelated to study drug|1|||
164012127|NCT00907478|592408680|FG002|Overall Study|Adverse Event|2|||
164012128|NCT00907478|592408678|FG000|Overall Study|Withdrawal by Subject|8|||
164012129|NCT00907478|592408679|FG001|Overall Study|Withdrawal by Subject|9|||
164012130|NCT00907478|592408680|FG002|Overall Study|Withdrawal by Subject|6|||
164012131|NCT00907478|592408678|FG000|Overall Study|Requirement for alternative therapy|1|||
164012132|NCT00907478|592408679|FG001|Overall Study|Requirement for alternative therapy|2|||
164012133|NCT00907478|592408680|FG002|Overall Study|Requirement for alternative therapy|3|||
164012134|NCT00907478|592408678|FG000|Overall Study|Physician Decision|2|||
164012135|NCT00907478|592408679|FG001|Overall Study|Physician Decision|0|||
164012136|NCT00907478|592408680|FG002|Overall Study|Physician Decision|3|||
164012137|NCT00907478|592408678|FG000|Overall Study|Death|4|||
164012138|NCT00907478|592408679|FG001|Overall Study|Death|2|||
164012139|NCT00907478|592408680|FG002|Overall Study|Death|1|||
164012140|NCT00907478|592408678|FG000|Overall Study|Protocol-specified criteria|5|||
164092696|NCT00911859|592702115|FG002|Treatment Period|Did not receive study treatment|0|||
164092697|NCT00911859|592702113|FG000|Maintainance Period|Lack of Efficacy|0|||
164365229|NCT03336216|593714998|FG003|Treatment|Adverse Event unrelated to study drug|0|||
164365230|NCT03336216|593714995|FG000|Treatment|Disease Recurrence|1|||
164365231|NCT03336216|593714996|FG001|Treatment|Disease Recurrence|0|||
164365232|NCT03336216|593714997|FG002|Treatment|Disease Recurrence|0|||
164365233|NCT03336216|593714998|FG003|Treatment|Disease Recurrence|0|||
164365234|NCT00922766|593715001|FG000|Overall Study|Death|3|||
164365235|NCT00922766|593715001|FG000|Overall Study|Withdrawal by Subject|2|||
164365236|NCT00922766|593715001|FG000|Overall Study|Other|1|||
164365237|NCT00922766|593715001|FG000|Overall Study|Adverse Event|1|||
164365238|NCT02658890|593715010|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365239|NCT02658890|593715011|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365240|NCT02658890|593715012|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365241|NCT02658890|593715013|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365242|NCT02658890|593715014|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365243|NCT02658890|593715015|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365244|NCT02658890|593715016|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365245|NCT02658890|593715017|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365246|NCT02658890|593715018|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365247|NCT02658890|593715019|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365248|NCT02658890|593715020|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365249|NCT02658890|593715021|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365250|NCT02658890|593715022|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365251|NCT02658890|593715023|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365252|NCT02658890|593715024|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365253|NCT02658890|593715025|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365254|NCT02658890|593715026|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365255|NCT02658890|593715027|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365256|NCT02658890|593715028|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365257|NCT02658890|593715029|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365258|NCT02658890|593715030|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365259|NCT02658890|593715031|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365260|NCT02658890|593715032|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365261|NCT02658890|593715033|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365262|NCT02658890|593715034|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365263|NCT02658890|593715035|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365264|NCT02658890|593715036|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365265|NCT02658890|593715010|FG000|Treatment Phase|Adverse Event|0|||
164365266|NCT02658890|593715011|FG001|Treatment Phase|Adverse Event|1|||
164365267|NCT02658890|593715012|FG002|Treatment Phase|Adverse Event|2|||
164365268|NCT02658890|593715013|FG003|Treatment Phase|Adverse Event|2|||
164012141|NCT00907478|592408679|FG001|Overall Study|Protocol-specified criteria|2|||
164012142|NCT00907478|592408680|FG002|Overall Study|Protocol-specified criteria|3|||
164012143|NCT00907478|592408678|FG000|Overall Study|Pregnancy|0|||
164365269|NCT02658890|593715014|FG004|Treatment Phase|Adverse Event|1|||
164365270|NCT02658890|593715015|FG005|Treatment Phase|Adverse Event|0|||
164365271|NCT02658890|593715016|FG006|Treatment Phase|Adverse Event|0|||
164365272|NCT02658890|593715017|FG007|Treatment Phase|Adverse Event|2|||
164365273|NCT02658890|593715018|FG008|Treatment Phase|Adverse Event|1|||
164365274|NCT02658890|593715019|FG009|Treatment Phase|Adverse Event|2|||
164365275|NCT02658890|593715020|FG010|Treatment Phase|Adverse Event|3|||
164365276|NCT02658890|593715021|FG011|Treatment Phase|Adverse Event|0|||
164365277|NCT02658890|593715022|FG012|Treatment Phase|Adverse Event|1|||
164365278|NCT02658890|593715023|FG013|Treatment Phase|Adverse Event|4|||
164365279|NCT02658890|593715024|FG014|Treatment Phase|Adverse Event|0|||
164365280|NCT02658890|593715025|FG015|Treatment Phase|Adverse Event|0|||
164365281|NCT02658890|593715026|FG016|Treatment Phase|Adverse Event|0|||
164365282|NCT02658890|593715027|FG017|Treatment Phase|Adverse Event|0|||
164365283|NCT02658890|593715028|FG018|Treatment Phase|Adverse Event|5|||
164365284|NCT02658890|593715029|FG019|Treatment Phase|Adverse Event|1|||
164365285|NCT02658890|593715030|FG020|Treatment Phase|Adverse Event|3|||
164365286|NCT02658890|593715031|FG021|Treatment Phase|Adverse Event|0|||
164365287|NCT02658890|593715032|FG022|Treatment Phase|Adverse Event|5|||
164365288|NCT02658890|593715033|FG023|Treatment Phase|Adverse Event|0|||
164365289|NCT02658890|593715034|FG024|Treatment Phase|Adverse Event|0|||
164365290|NCT02658890|593715035|FG025|Treatment Phase|Adverse Event|2|||
164365291|NCT02658890|593715036|FG026|Treatment Phase|Adverse Event|1|||
164365292|NCT02658890|593715010|FG000|Treatment Phase|Death|0|||
164365293|NCT02658890|593715011|FG001|Treatment Phase|Death|0|||
164365294|NCT02658890|593715012|FG002|Treatment Phase|Death|0|||
164365295|NCT02658890|593715013|FG003|Treatment Phase|Death|0|||
164365296|NCT02658890|593715014|FG004|Treatment Phase|Death|0|||
164365297|NCT02658890|593715015|FG005|Treatment Phase|Death|0|||
164365298|NCT02658890|593715016|FG006|Treatment Phase|Death|0|||
164365299|NCT02658890|593715017|FG007|Treatment Phase|Death|0|||
164365300|NCT02658890|593715018|FG008|Treatment Phase|Death|0|||
164365301|NCT02658890|593715019|FG009|Treatment Phase|Death|0|||
164365302|NCT02658890|593715020|FG010|Treatment Phase|Death|0|||
164365303|NCT02658890|593715021|FG011|Treatment Phase|Death|0|||
164365304|NCT02658890|593715022|FG012|Treatment Phase|Death|0|||
164365305|NCT02658890|593715023|FG013|Treatment Phase|Death|0|||
164365306|NCT02658890|593715024|FG014|Treatment Phase|Death|0|||
164365307|NCT02658890|593715025|FG015|Treatment Phase|Death|0|||
164365308|NCT02658890|593715026|FG016|Treatment Phase|Death|0|||
164365309|NCT02658890|593715027|FG017|Treatment Phase|Death|0|||
164365310|NCT02658890|593715028|FG018|Treatment Phase|Death|1|||
164365311|NCT02658890|593715029|FG019|Treatment Phase|Death|0|||
164365312|NCT02658890|593715030|FG020|Treatment Phase|Death|0|||
164365313|NCT02658890|593715031|FG021|Treatment Phase|Death|0|||
164365314|NCT02658890|593715032|FG022|Treatment Phase|Death|0|||
164365315|NCT02658890|593715033|FG023|Treatment Phase|Death|0|||
164365316|NCT02658890|593715034|FG024|Treatment Phase|Death|0|||
164365317|NCT02658890|593715035|FG025|Treatment Phase|Death|0|||
164365318|NCT02658890|593715036|FG026|Treatment Phase|Death|0|||
164365319|NCT02658890|593715010|FG000|Treatment Phase|Lost to Follow-up|0|||
164365320|NCT02658890|593715011|FG001|Treatment Phase|Lost to Follow-up|0|||
164365321|NCT02658890|593715012|FG002|Treatment Phase|Lost to Follow-up|0|||
164365322|NCT02658890|593715013|FG003|Treatment Phase|Lost to Follow-up|0|||
164365323|NCT02658890|593715014|FG004|Treatment Phase|Lost to Follow-up|0|||
164365324|NCT02658890|593715015|FG005|Treatment Phase|Lost to Follow-up|0|||
164365325|NCT02658890|593715016|FG006|Treatment Phase|Lost to Follow-up|1|||
164365326|NCT02658890|593715017|FG007|Treatment Phase|Lost to Follow-up|0|||
164365327|NCT02658890|593715018|FG008|Treatment Phase|Lost to Follow-up|0|||
164365328|NCT02658890|593715019|FG009|Treatment Phase|Lost to Follow-up|0|||
164365329|NCT02658890|593715020|FG010|Treatment Phase|Lost to Follow-up|0|||
164365330|NCT02658890|593715021|FG011|Treatment Phase|Lost to Follow-up|0|||
164365331|NCT02658890|593715022|FG012|Treatment Phase|Lost to Follow-up|0|||
164365332|NCT02658890|593715023|FG013|Treatment Phase|Lost to Follow-up|0|||
164365333|NCT02658890|593715024|FG014|Treatment Phase|Lost to Follow-up|0|||
163901889|NCT05485805|592011512|FG003|Overall Study|Lost to Follow-up|1|||
163901890|NCT05485805|592011513|FG004|Overall Study|Lost to Follow-up|0|||
163901891|NCT04218357|592011514|FG000|1st Allocation|Withdrawal by Subject|1|||
163901892|NCT04218357|592011515|FG001|1st Allocation|Withdrawal by Subject|0|||
163901893|NCT05349838|592011516|FG000|Overall Study|Virological Failure|1|||
163901894|NCT05349838|592011517|FG001|Overall Study|Virological Failure|2|||
163901895|NCT05349838|592011516|FG000|Overall Study|Withdrawal by Subject|2|||
163901896|NCT05349838|592011517|FG001|Overall Study|Withdrawal by Subject|3|||
163901897|NCT05349838|592011516|FG000|Overall Study|Adverse Event|3|||
163901898|NCT05349838|592011517|FG001|Overall Study|Adverse Event|1|||
163901899|NCT05349838|592011516|FG000|Overall Study|Lost to Follow-up|1|||
164365334|NCT02658890|593715025|FG015|Treatment Phase|Lost to Follow-up|0|||
164365335|NCT02658890|593715026|FG016|Treatment Phase|Lost to Follow-up|0|||
164365336|NCT02658890|593715027|FG017|Treatment Phase|Lost to Follow-up|0|||
164365337|NCT02658890|593715028|FG018|Treatment Phase|Lost to Follow-up|0|||
164365338|NCT02658890|593715029|FG019|Treatment Phase|Lost to Follow-up|0|||
164365339|NCT02658890|593715030|FG020|Treatment Phase|Lost to Follow-up|0|||
164365340|NCT02658890|593715031|FG021|Treatment Phase|Lost to Follow-up|0|||
163901900|NCT05349838|592011517|FG001|Overall Study|Lost to Follow-up|2|||
163901901|NCT05349838|592011516|FG000|Overall Study|Other reasons|5|||
163901902|NCT05349838|592011517|FG001|Overall Study|Other reasons|1|||
163901903|NCT05037513|592011522|FG000|Intervention Period|Lost to Follow-up|1|||
163901904|NCT05037513|592011523|FG001|Intervention Period|Lost to Follow-up|2|||
163901905|NCT05037513|592011522|FG000|Follow Up Period|Lost to Follow-up|16|||
163901906|NCT05037513|592011523|FG001|Follow Up Period|Lost to Follow-up|21|||
163901907|NCT05037513|592011522|FG000|Follow Up Period|Death|0|||
163901908|NCT05037513|592011523|FG001|Follow Up Period|Death|1|||
163901909|NCT05037513|592011522|FG000|Follow Up Period|Incarcerated|4|||
163901910|NCT05037513|592011523|FG001|Follow Up Period|Incarcerated|2|||
163901911|NCT03664804|592011525|FG000|Overall Study|Withdrawal by Subject|7|||
163901912|NCT05529992|592011526|FG000|Overall Study|Withdrawal by Subject|1|||
163901913|NCT06140290|592011527|FG000|Period 1|Adverse Event|1|||
163901914|NCT06140290|592011528|FG001|Period 1|Adverse Event|0|||
163901915|NCT06140290|592011527|FG000|Period 2|Assigned but not treated|0|||
163901916|NCT06140290|592011528|FG001|Period 2|Assigned but not treated|1|||
163901917|NCT06140290|592011527|FG000|Period 2|Withdrawal by Subject|0|||
163901918|NCT06140290|592011528|FG001|Period 2|Withdrawal by Subject|1|||
163901919|NCT02036970|592013025|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163901920|NCT02036970|592013026|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163901921|NCT02036970|592013027|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
163901922|NCT02036970|592013028|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
163901923|NCT02036970|592013029|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
163901924|NCT02036970|592013030|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
163901925|NCT02036970|592013031|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
164365341|NCT02658890|593715032|FG022|Treatment Phase|Lost to Follow-up|0|||
164365342|NCT02658890|593715033|FG023|Treatment Phase|Lost to Follow-up|0|||
164365343|NCT02658890|593715034|FG024|Treatment Phase|Lost to Follow-up|0|||
164365344|NCT02658890|593715035|FG025|Treatment Phase|Lost to Follow-up|0|||
164365345|NCT02658890|593715036|FG026|Treatment Phase|Lost to Follow-up|0|||
164365346|NCT02658890|593715010|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
164365347|NCT02658890|593715011|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
164365348|NCT02658890|593715012|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
164365349|NCT02658890|593715013|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
164365350|NCT02658890|593715014|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
164365351|NCT02658890|593715015|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
164365352|NCT02658890|593715016|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
164365353|NCT02658890|593715017|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
164365354|NCT02658890|593715018|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
164365355|NCT02658890|593715019|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
164365356|NCT02658890|593715020|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
164365357|NCT02658890|593715021|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
164365358|NCT02658890|593715022|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
164365359|NCT02658890|593715023|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
164365360|NCT02658890|593715024|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
164365361|NCT02658890|593715025|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
164365362|NCT02658890|593715026|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
164365363|NCT02658890|593715027|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
164365364|NCT02658890|593715028|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
164365365|NCT02658890|593715029|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
163901926|NCT02036970|592013032|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
163901927|NCT02036970|592013033|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
163901928|NCT02036970|592013034|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
163901929|NCT02036970|592013025|FG000|Part 1: Day 1 Through Week 16|Death|0|||
163901930|NCT02036970|592013026|FG001|Part 1: Day 1 Through Week 16|Death|0|||
163901931|NCT02036970|592013027|FG002|Part 1: Day 1 Through Week 16|Death|0|||
163901932|NCT02036970|592013028|FG003|Part 1: Day 1 Through Week 16|Death|0|||
163901933|NCT02036970|592013029|FG004|Part 1: Day 1 Through Week 16|Death|0|||
163901934|NCT02036970|592013030|FG005|Part 1: Day 1 Through Week 16|Death|0|||
163901935|NCT02036970|592013031|FG006|Part 1: Day 1 Through Week 16|Death|0|||
163901936|NCT02036970|592013032|FG007|Part 1: Day 1 Through Week 16|Death|0|||
163901937|NCT02036970|592013033|FG008|Part 1: Day 1 Through Week 16|Death|1|||
163901938|NCT02036970|592013034|FG009|Part 1: Day 1 Through Week 16|Death|0|||
163901939|NCT02036970|592013025|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
163901940|NCT02036970|592013026|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164365366|NCT02658890|593715030|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
164365367|NCT02658890|593715031|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
164365368|NCT02658890|593715032|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
164365369|NCT02658890|593715033|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
164365370|NCT02658890|593715034|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
164365371|NCT02658890|593715035|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
164365372|NCT02658890|593715036|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
163901941|NCT02036970|592013027|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
163901942|NCT02036970|592013028|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163901943|NCT02036970|592013029|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
164365373|NCT02658890|593715010|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
164365374|NCT02658890|593715011|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
164365375|NCT02658890|593715012|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
164365376|NCT02658890|593715013|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
164365377|NCT02658890|593715014|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
164365378|NCT02658890|593715015|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
164365379|NCT02658890|593715016|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
164365380|NCT02658890|593715017|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
164365381|NCT02658890|593715018|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
164365382|NCT02658890|593715019|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
164365383|NCT02658890|593715020|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
164365384|NCT02658890|593715021|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
164365385|NCT02658890|593715022|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
164365386|NCT02658890|593715023|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
164365387|NCT02658890|593715024|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
164365388|NCT02658890|593715025|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
164365389|NCT02658890|593715026|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
164365390|NCT02658890|593715027|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
164365391|NCT02658890|593715028|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
164365392|NCT02658890|593715029|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
164365393|NCT02658890|593715030|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
164365394|NCT02658890|593715031|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
164365395|NCT02658890|593715032|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
164365396|NCT02658890|593715033|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
164365397|NCT02658890|593715034|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
164365398|NCT02658890|593715035|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
164365399|NCT02658890|593715036|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
164365400|NCT02658890|593715010|FG000|Treatment Phase|Other Reasons|0|||
164365401|NCT02658890|593715011|FG001|Treatment Phase|Other Reasons|0|||
164365402|NCT02658890|593715012|FG002|Treatment Phase|Other Reasons|0|||
164365403|NCT02658890|593715013|FG003|Treatment Phase|Other Reasons|0|||
164365404|NCT02658890|593715014|FG004|Treatment Phase|Other Reasons|0|||
164365405|NCT02658890|593715015|FG005|Treatment Phase|Other Reasons|0|||
164365406|NCT02658890|593715016|FG006|Treatment Phase|Other Reasons|1|||
164365407|NCT02658890|593715017|FG007|Treatment Phase|Other Reasons|0|||
164365408|NCT02658890|593715018|FG008|Treatment Phase|Other Reasons|1|||
164365409|NCT02658890|593715019|FG009|Treatment Phase|Other Reasons|0|||
164365410|NCT02658890|593715020|FG010|Treatment Phase|Other Reasons|0|||
164365411|NCT02658890|593715021|FG011|Treatment Phase|Other Reasons|0|||
164365412|NCT02658890|593715022|FG012|Treatment Phase|Other Reasons|0|||
164365413|NCT02658890|593715023|FG013|Treatment Phase|Other Reasons|2|||
164365414|NCT02658890|593715024|FG014|Treatment Phase|Other Reasons|0|||
164365415|NCT02658890|593715025|FG015|Treatment Phase|Other Reasons|0|||
164365416|NCT02658890|593715026|FG016|Treatment Phase|Other Reasons|0|||
164365417|NCT02658890|593715027|FG017|Treatment Phase|Other Reasons|0|||
164365418|NCT02658890|593715028|FG018|Treatment Phase|Other Reasons|1|||
164365419|NCT02658890|593715029|FG019|Treatment Phase|Other Reasons|0|||
164365420|NCT02658890|593715030|FG020|Treatment Phase|Other Reasons|0|||
164365421|NCT02658890|593715031|FG021|Treatment Phase|Other Reasons|0|||
164365422|NCT02658890|593715032|FG022|Treatment Phase|Other Reasons|0|||
164365423|NCT02658890|593715033|FG023|Treatment Phase|Other Reasons|0|||
164365424|NCT02658890|593715034|FG024|Treatment Phase|Other Reasons|1|||
164365425|NCT02658890|593715035|FG025|Treatment Phase|Other Reasons|0|||
164365426|NCT02658890|593715036|FG026|Treatment Phase|Other Reasons|1|||
164365427|NCT02658890|593715010|FG000|Treatment Phase|Progressive Disease|6|||
164365428|NCT02658890|593715011|FG001|Treatment Phase|Progressive Disease|7|||
164365429|NCT02658890|593715012|FG002|Treatment Phase|Progressive Disease|6|||
164365430|NCT02658890|593715013|FG003|Treatment Phase|Progressive Disease|12|||
164365431|NCT02658890|593715014|FG004|Treatment Phase|Progressive Disease|6|||
164365432|NCT02658890|593715015|FG005|Treatment Phase|Progressive Disease|18|||
164365433|NCT02658890|593715016|FG006|Treatment Phase|Progressive Disease|12|||
164365434|NCT02658890|593715017|FG007|Treatment Phase|Progressive Disease|19|||
164365435|NCT02658890|593715018|FG008|Treatment Phase|Progressive Disease|26|||
163901944|NCT02036970|592013030|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163901945|NCT02036970|592013031|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163901946|NCT02036970|592013032|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163901947|NCT02036970|592013033|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
163901948|NCT02036970|592013034|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
163901949|NCT02036970|592013025|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163901950|NCT02036970|592013026|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164365436|NCT02658890|593715019|FG009|Treatment Phase|Progressive Disease|8|||
163901951|NCT02036970|592013027|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164365437|NCT02658890|593715020|FG010|Treatment Phase|Progressive Disease|7|||
163901952|NCT02036970|592013028|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164365438|NCT02658890|593715021|FG011|Treatment Phase|Progressive Disease|9|||
164365439|NCT02658890|593715022|FG012|Treatment Phase|Progressive Disease|8|||
164012144|NCT00907478|592408679|FG001|Overall Study|Pregnancy|1|||
164012145|NCT00907478|592408680|FG002|Overall Study|Pregnancy|1|||
164012146|NCT00907478|592408678|FG000|Overall Study|Lost to Follow-up|1|||
164012147|NCT00907478|592408679|FG001|Overall Study|Lost to Follow-up|0|||
164012148|NCT00907478|592408680|FG002|Overall Study|Lost to Follow-up|0|||
164012149|NCT00907478|592408678|FG000|Overall Study|Other|3|||
164012150|NCT00907478|592408679|FG001|Overall Study|Other|0|||
164365440|NCT02658890|593715023|FG013|Treatment Phase|Progressive Disease|29|||
164365441|NCT02658890|593715024|FG014|Treatment Phase|Progressive Disease|6|||
164365442|NCT02658890|593715025|FG015|Treatment Phase|Progressive Disease|2|||
164365443|NCT02658890|593715026|FG016|Treatment Phase|Progressive Disease|32|||
164365444|NCT02658890|593715027|FG017|Treatment Phase|Progressive Disease|14|||
164365445|NCT02658890|593715028|FG018|Treatment Phase|Progressive Disease|40|||
164365446|NCT02658890|593715029|FG019|Treatment Phase|Progressive Disease|32|||
164365447|NCT02658890|593715030|FG020|Treatment Phase|Progressive Disease|19|||
164365448|NCT02658890|593715031|FG021|Treatment Phase|Progressive Disease|30|||
164365449|NCT02658890|593715032|FG022|Treatment Phase|Progressive Disease|15|||
164365450|NCT02658890|593715033|FG023|Treatment Phase|Progressive Disease|0|||
164365451|NCT02658890|593715034|FG024|Treatment Phase|Progressive Disease|0|||
164365452|NCT02658890|593715035|FG025|Treatment Phase|Progressive Disease|14|||
164365453|NCT02658890|593715036|FG026|Treatment Phase|Progressive Disease|11|||
164365454|NCT02658890|593715010|FG000|Treatment Phase|Study Drug Toxicity|0|||
164365455|NCT02658890|593715011|FG001|Treatment Phase|Study Drug Toxicity|0|||
164365456|NCT02658890|593715012|FG002|Treatment Phase|Study Drug Toxicity|2|||
164365457|NCT02658890|593715013|FG003|Treatment Phase|Study Drug Toxicity|0|||
164365458|NCT02658890|593715014|FG004|Treatment Phase|Study Drug Toxicity|0|||
164365459|NCT02658890|593715015|FG005|Treatment Phase|Study Drug Toxicity|0|||
164365460|NCT02658890|593715016|FG006|Treatment Phase|Study Drug Toxicity|0|||
164365461|NCT02658890|593715017|FG007|Treatment Phase|Study Drug Toxicity|0|||
164365462|NCT02658890|593715018|FG008|Treatment Phase|Study Drug Toxicity|3|||
164365463|NCT02658890|593715019|FG009|Treatment Phase|Study Drug Toxicity|0|||
164365464|NCT02658890|593715020|FG010|Treatment Phase|Study Drug Toxicity|1|||
164365465|NCT02658890|593715021|FG011|Treatment Phase|Study Drug Toxicity|1|||
164365466|NCT02658890|593715022|FG012|Treatment Phase|Study Drug Toxicity|2|||
164365467|NCT02658890|593715023|FG013|Treatment Phase|Study Drug Toxicity|9|||
164012151|NCT00907478|592408680|FG002|Overall Study|Other|1|||
164365468|NCT02658890|593715024|FG014|Treatment Phase|Study Drug Toxicity|0|||
164365469|NCT02658890|593715025|FG015|Treatment Phase|Study Drug Toxicity|1|||
164365470|NCT02658890|593715026|FG016|Treatment Phase|Study Drug Toxicity|1|||
164365471|NCT02658890|593715027|FG017|Treatment Phase|Study Drug Toxicity|0|||
164365472|NCT02658890|593715028|FG018|Treatment Phase|Study Drug Toxicity|8|||
164365473|NCT02658890|593715029|FG019|Treatment Phase|Study Drug Toxicity|3|||
164365474|NCT02658890|593715030|FG020|Treatment Phase|Study Drug Toxicity|2|||
164365475|NCT02658890|593715031|FG021|Treatment Phase|Study Drug Toxicity|0|||
164365476|NCT02658890|593715032|FG022|Treatment Phase|Study Drug Toxicity|8|||
164365477|NCT02658890|593715033|FG023|Treatment Phase|Study Drug Toxicity|0|||
164365478|NCT02658890|593715034|FG024|Treatment Phase|Study Drug Toxicity|0|||
164365479|NCT02658890|593715035|FG025|Treatment Phase|Study Drug Toxicity|2|||
164365480|NCT02658890|593715036|FG026|Treatment Phase|Study Drug Toxicity|0|||
164365481|NCT02658890|593715010|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365482|NCT02658890|593715011|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365483|NCT02658890|593715012|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365484|NCT02658890|593715013|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365485|NCT02658890|593715014|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365486|NCT02658890|593715015|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365487|NCT02658890|593715016|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365488|NCT02658890|593715017|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164012152|NCT03648476|592408683|FG000|Overall Study|Withdrawal by Subject|2|||
164012153|NCT03648476|592408684|FG001|Overall Study|Withdrawal by Subject|1|||
164365489|NCT02658890|593715018|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365490|NCT02658890|593715019|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365491|NCT02658890|593715020|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365492|NCT02658890|593715021|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365493|NCT02658890|593715022|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365494|NCT02658890|593715023|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365495|NCT02658890|593715024|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365496|NCT02658890|593715025|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365497|NCT02658890|593715026|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365498|NCT02658890|593715027|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365499|NCT02658890|593715028|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365500|NCT02658890|593715029|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365501|NCT02658890|593715030|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365502|NCT02658890|593715031|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365503|NCT02658890|593715032|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
164365504|NCT02658890|593715033|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365505|NCT02658890|593715034|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365506|NCT02658890|593715035|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365507|NCT02658890|593715036|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
164365508|NCT02658890|593715010|FG000|Treatment Phase|Withdrawal by Subject|0|||
164365509|NCT02658890|593715011|FG001|Treatment Phase|Withdrawal by Subject|1|||
164365510|NCT02658890|593715012|FG002|Treatment Phase|Withdrawal by Subject|0|||
164365511|NCT02658890|593715013|FG003|Treatment Phase|Withdrawal by Subject|0|||
164365512|NCT02658890|593715014|FG004|Treatment Phase|Withdrawal by Subject|0|||
164365513|NCT02658890|593715015|FG005|Treatment Phase|Withdrawal by Subject|0|||
164365514|NCT02658890|593715016|FG006|Treatment Phase|Withdrawal by Subject|1|||
164365515|NCT02658890|593715017|FG007|Treatment Phase|Withdrawal by Subject|0|||
164365516|NCT02658890|593715018|FG008|Treatment Phase|Withdrawal by Subject|0|||
164365517|NCT02658890|593715019|FG009|Treatment Phase|Withdrawal by Subject|1|||
164365518|NCT02658890|593715020|FG010|Treatment Phase|Withdrawal by Subject|0|||
164365519|NCT02658890|593715021|FG011|Treatment Phase|Withdrawal by Subject|0|||
164365520|NCT02658890|593715022|FG012|Treatment Phase|Withdrawal by Subject|1|||
164365521|NCT02658890|593715023|FG013|Treatment Phase|Withdrawal by Subject|3|||
164365522|NCT02658890|593715024|FG014|Treatment Phase|Withdrawal by Subject|0|||
164365523|NCT02658890|593715025|FG015|Treatment Phase|Withdrawal by Subject|0|||
164365524|NCT02658890|593715026|FG016|Treatment Phase|Withdrawal by Subject|1|||
164365525|NCT02658890|593715027|FG017|Treatment Phase|Withdrawal by Subject|0|||
164365526|NCT02658890|593715028|FG018|Treatment Phase|Withdrawal by Subject|4|||
164365527|NCT02658890|593715029|FG019|Treatment Phase|Withdrawal by Subject|3|||
164365528|NCT02658890|593715030|FG020|Treatment Phase|Withdrawal by Subject|0|||
164365529|NCT02658890|593715031|FG021|Treatment Phase|Withdrawal by Subject|4|||
164365530|NCT02658890|593715032|FG022|Treatment Phase|Withdrawal by Subject|1|||
164365531|NCT02658890|593715033|FG023|Treatment Phase|Withdrawal by Subject|1|||
164365532|NCT02658890|593715034|FG024|Treatment Phase|Withdrawal by Subject|0|||
164365533|NCT02658890|593715035|FG025|Treatment Phase|Withdrawal by Subject|0|||
164365534|NCT02658890|593715036|FG026|Treatment Phase|Withdrawal by Subject|0|||
164365535|NCT02404311|593715037|FG000|Part A: Month 0-18|Death|2|||
164365536|NCT02404311|593715038|FG001|Part A: Month 0-18|Death|0|||
164365537|NCT02404311|593715039|FG002|Part A: Month 0-18|Death|0|||
164365538|NCT02404311|593715040|FG003|Part A: Month 0-18|Death|0|||
164365539|NCT02404311|593715041|FG004|Part A: Month 0-18|Death|0|||
164365540|NCT02404311|593715037|FG000|Part A: Month 0-18|Physician Decision|1|||
164365541|NCT02404311|593715038|FG001|Part A: Month 0-18|Physician Decision|0|||
164365542|NCT02404311|593715039|FG002|Part A: Month 0-18|Physician Decision|0|||
164365543|NCT02404311|593715040|FG003|Part A: Month 0-18|Physician Decision|0|||
164365544|NCT02404311|593715041|FG004|Part A: Month 0-18|Physician Decision|0|||
164365545|NCT02404311|593715037|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
164365546|NCT02404311|593715038|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
164365547|NCT02404311|593715039|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
164365548|NCT02404311|593715040|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
164365549|NCT02404311|593715041|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
164365550|NCT02404311|593715037|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
164365551|NCT02404311|593715038|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
164365552|NCT02404311|593715039|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
164365553|NCT02404311|593715040|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
164365554|NCT02404311|593715041|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
163901953|NCT02036970|592013029|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
163901954|NCT02036970|592013030|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164365555|NCT02404311|593715037|FG000|Part A: Month 0-18|HIV Infection|6|||
164365556|NCT02404311|593715038|FG001|Part A: Month 0-18|HIV Infection|2|||
164365557|NCT02404311|593715039|FG002|Part A: Month 0-18|HIV Infection|0|||
164365558|NCT02404311|593715040|FG003|Part A: Month 0-18|HIV Infection|0|||
164365559|NCT02404311|593715041|FG004|Part A: Month 0-18|HIV Infection|0|||
164365560|NCT02404311|593715037|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
164365561|NCT02404311|593715038|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
164365562|NCT02404311|593715039|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
164365563|NCT02404311|593715040|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
164365564|NCT02404311|593715041|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
164365565|NCT00159588|593715042|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
164365566|NCT00159588|593715043|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
164365567|NCT00159588|593715044|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
164365568|NCT02864251|593715050|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
164365569|NCT02864251|593715051|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
164365570|NCT02864251|593715052|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
164365571|NCT02864251|593715050|FG000|Pre-Treatment|Withdrawal by Participant|0|||
164365572|NCT02864251|593715051|FG001|Pre-Treatment|Withdrawal by Participant|0|||
164365573|NCT02864251|593715052|FG002|Pre-Treatment|Withdrawal by Participant|4|||
164365574|NCT02864251|593715050|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
164365575|NCT02864251|593715051|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
164365576|NCT02864251|593715052|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
164365577|NCT02864251|593715050|FG000|Pre-Treatment|Other Reasons|0|||
164365578|NCT02864251|593715051|FG001|Pre-Treatment|Other Reasons|1|||
164365579|NCT02864251|593715052|FG002|Pre-Treatment|Other Reasons|1|||
164365580|NCT02864251|593715050|FG000|Treatment|Disease Progression|109|||
164365581|NCT02864251|593715051|FG001|Treatment|Disease Progression|52|||
164365582|NCT02864251|593715052|FG002|Treatment|Disease Progression|101|||
164365583|NCT02864251|593715050|FG000|Treatment|Study Drug Toxicity|9|||
164365584|NCT02864251|593715051|FG001|Treatment|Study Drug Toxicity|4|||
164365585|NCT02864251|593715052|FG002|Treatment|Study Drug Toxicity|10|||
164365586|NCT02864251|593715050|FG000|Treatment|Death|0|||
164365587|NCT02864251|593715051|FG001|Treatment|Death|2|||
164365588|NCT02864251|593715052|FG002|Treatment|Death|3|||
164365589|NCT02864251|593715050|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
164365590|NCT02864251|593715051|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
164365591|NCT02864251|593715052|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
164365592|NCT02864251|593715050|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
164365593|NCT02864251|593715051|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
164365594|NCT02864251|593715052|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
164365595|NCT02864251|593715050|FG000|Treatment|Withdrawal by Participant|8|||
164365596|NCT02864251|593715051|FG001|Treatment|Withdrawal by Participant|5|||
164365597|NCT02864251|593715052|FG002|Treatment|Withdrawal by Participant|13|||
164365598|NCT02864251|593715050|FG000|Treatment|Maximum Clinical Benefit|1|||
164365599|NCT02864251|593715051|FG001|Treatment|Maximum Clinical Benefit|0|||
164365600|NCT02864251|593715052|FG002|Treatment|Maximum Clinical Benefit|1|||
164365601|NCT02864251|593715050|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
164365602|NCT02864251|593715051|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
164365603|NCT02864251|593715052|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
164365604|NCT02864251|593715050|FG000|Treatment|Other Reasons|1|||
164365605|NCT02864251|593715051|FG001|Treatment|Other Reasons|1|||
164365606|NCT02864251|593715052|FG002|Treatment|Other Reasons|4|||
164365607|NCT02864251|593715050|FG000|Treatment|Administrative Reason by Sponsor|1|||
164365608|NCT02864251|593715051|FG001|Treatment|Administrative Reason by Sponsor|0|||
164365609|NCT02864251|593715052|FG002|Treatment|Administrative Reason by Sponsor|0|||
164365610|NCT02532647|593715055|FG000|Overall Study|Did not receive trial medication|1|||
164365611|NCT02532647|593715056|FG001|Overall Study|Did not receive trial medication|0|||
164365612|NCT02532647|593715057|FG002|Overall Study|Did not receive trial medication|1|||
164365613|NCT03897179|593715064|FG000|Overall Study|Withdrawal by Subject|1|||
164365614|NCT01480076|593715065|FG000|Overall Study|Run-in Failure|52|||
164365615|NCT01480076|593715065|FG000|Overall Study|Adverse Event|39|||
164365616|NCT01480076|593715065|FG000|Overall Study|Death|2|||
164365617|NCT01480076|593715065|FG000|Overall Study|Disease Progression|5|||
164365618|NCT01480076|593715065|FG000|Overall Study|Non-compliance With Study Protocol|15|||
164365619|NCT01480076|593715065|FG000|Overall Study|Withdrawal by Subject|105|||
164365620|NCT01480076|593715065|FG000|Overall Study|Lost to Follow-up|7|||
164365621|NCT01480076|593715065|FG000|Overall Study|Investigator Decision|13|||
164365622|NCT01480076|593715065|FG000|Overall Study|Other|52|||
164365623|NCT02503332|593715066|FG000|Overall Study|Adverse Event|17|||
164365624|NCT02503332|593715067|FG001|Overall Study|Adverse Event|5|||
164365625|NCT02503332|593715068|FG002|Overall Study|Adverse Event|3|||
164365626|NCT02503332|593715069|FG003|Overall Study|Adverse Event|1|||
164365627|NCT02503332|593715066|FG000|Overall Study|Investigator's Decision|5|||
164365628|NCT02503332|593715067|FG001|Overall Study|Investigator's Decision|1|||
164365629|NCT02503332|593715068|FG002|Overall Study|Investigator's Decision|0|||
164365630|NCT02503332|593715069|FG003|Overall Study|Investigator's Decision|0|||
164365631|NCT02503332|593715066|FG000|Overall Study|Sponsor's Decision|1|||
164365632|NCT02503332|593715067|FG001|Overall Study|Sponsor's Decision|0|||
164365633|NCT02503332|593715068|FG002|Overall Study|Sponsor's Decision|0|||
164365634|NCT02503332|593715069|FG003|Overall Study|Sponsor's Decision|1|||
164365635|NCT02503332|593715066|FG000|Overall Study|Subject Request|6|||
164365636|NCT02503332|593715067|FG001|Overall Study|Subject Request|5|||
163901955|NCT02036970|592013031|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
164365637|NCT02503332|593715068|FG002|Overall Study|Subject Request|2|||
164365638|NCT02503332|593715069|FG003|Overall Study|Subject Request|1|||
164365639|NCT02503332|593715066|FG000|Overall Study|Death|0|||
164365640|NCT02503332|593715067|FG001|Overall Study|Death|2|||
164365641|NCT02503332|593715068|FG002|Overall Study|Death|2|||
164365642|NCT02503332|593715069|FG003|Overall Study|Death|0|||
164365643|NCT02503332|593715066|FG000|Overall Study|Other|5|||
164365644|NCT02503332|593715067|FG001|Overall Study|Other|6|||
164365645|NCT02503332|593715068|FG002|Overall Study|Other|1|||
164365646|NCT02503332|593715069|FG003|Overall Study|Other|1|||
164365647|NCT05694546|593715071|FG000|Overall Study|Lost to Follow-up|11|||
164365648|NCT02120950|593715072|FG000|Overall Study|Adverse Event|5|||
164365649|NCT02120950|593715073|FG001|Overall Study|Adverse Event|4|||
164365650|NCT02120950|593715074|FG002|Overall Study|Adverse Event|3|||
164365651|NCT02120950|593715072|FG000|Overall Study|Death|3|||
164365652|NCT02120950|593715073|FG001|Overall Study|Death|0|||
164365653|NCT02120950|593715074|FG002|Overall Study|Death|1|||
164365654|NCT02120950|593715072|FG000|Overall Study|Withdrawal by Subject|6|||
164365655|NCT02120950|593715073|FG001|Overall Study|Withdrawal by Subject|3|||
164365656|NCT02120950|593715074|FG002|Overall Study|Withdrawal by Subject|2|||
164365657|NCT02120950|593715072|FG000|Overall Study|Protocol Violation|1|||
164365658|NCT02120950|593715073|FG001|Overall Study|Protocol Violation|1|||
164365659|NCT02120950|593715074|FG002|Overall Study|Protocol Violation|7|||
164365660|NCT02120950|593715072|FG000|Overall Study|Other reasons|5|||
164365661|NCT02120950|593715073|FG001|Overall Study|Other reasons|4|||
164365662|NCT02120950|593715074|FG002|Overall Study|Other reasons|1|||
164365663|NCT02120950|593715072|FG000|Overall Study|Lost to Follow-up|0|||
164365664|NCT02120950|593715073|FG001|Overall Study|Lost to Follow-up|2|||
164365665|NCT02120950|593715074|FG002|Overall Study|Lost to Follow-up|1|||
164365666|NCT02424383|593715075|FG000|Overall Study|Withdrawal by Subject|32|||
164365667|NCT02424383|593715075|FG000|Overall Study|Death|170|||
164365668|NCT02424383|593715075|FG000|Overall Study|Sponsor's decision|3|||
164365669|NCT02424383|593715075|FG000|Overall Study|Investigator's decision|44|||
164365670|NCT02424383|593715075|FG000|Overall Study|Lost to Follow-up|81|||
164365671|NCT02424383|593715075|FG000|Overall Study|Other|7|||
164365672|NCT02424383|593715075|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
164365673|NCT03412084|593715079|FG000|Overall Study|Withdrawal by Subject|2|||
164365674|NCT03412084|593715080|FG001|Overall Study|Withdrawal by Subject|0|||
164365675|NCT03412084|593715079|FG000|Overall Study|Participant moved|1|||
164365676|NCT03412084|593715080|FG001|Overall Study|Participant moved|0|||
164365677|NCT03412084|593715079|FG000|Overall Study|Lost to Follow-up|1|||
164365678|NCT03412084|593715080|FG001|Overall Study|Lost to Follow-up|1|||
164365679|NCT01928862|593715084|FG000|Overall Study|Lost to Follow-up|1|||
164365680|NCT01928862|593715085|FG001|Overall Study|Lost to Follow-up|0|||
164365681|NCT01928862|593715086|FG002|Overall Study|Lost to Follow-up|0|||
164365682|NCT01928862|593715087|FG003|Overall Study|Lost to Follow-up|0|||
164365683|NCT01928862|593715088|FG004|Overall Study|Lost to Follow-up|1|||
164365684|NCT01752855|593715092|FG000|Overall Study|Adverse Event|1|||
164365685|NCT01752855|593715093|FG001|Overall Study|Adverse Event|0|||
164365686|NCT01752855|593715092|FG000|Overall Study|Withdrew Consent|0|||
164365687|NCT01752855|593715093|FG001|Overall Study|Withdrew Consent|2|||
164365688|NCT01752855|593715092|FG000|Overall Study|Lack of Efficacy|0|||
164365689|NCT01752855|593715093|FG001|Overall Study|Lack of Efficacy|2|||
164365690|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
164365691|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
163901956|NCT02036970|592013032|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
163901957|NCT02036970|592013033|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
163901958|NCT02036970|592013034|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
163901959|NCT02036970|592013025|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164365692|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
164365693|NCT01478321|593715095|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
164365694|NCT01478321|593715095|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
163901960|NCT02036970|592013026|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163901961|NCT02036970|592013027|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163901962|NCT02036970|592013028|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
163901963|NCT02036970|592013029|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163901964|NCT02036970|592013030|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163901965|NCT02036970|592013031|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164365695|NCT01478321|593715095|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
164365696|NCT01478321|593715095|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
164365697|NCT01478321|593715095|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
164365698|NCT00314574|593715096|FG000|Overall Study|Death|3|||
164365699|NCT00314574|593715097|FG001|Overall Study|Death|0|||
164365700|NCT00314574|593715096|FG000|Overall Study|Adverse Event|11|||
164365701|NCT00314574|593715097|FG001|Overall Study|Adverse Event|16|||
164365702|NCT00314574|593715096|FG000|Overall Study|Lost to Follow-up|19|||
164012154|NCT00907881|592408685|FG000|Overall Study|Lost to Follow-up|59|||
164012155|NCT00907881|592408685|FG000|Overall Study|Noncompliance|5|||
164012156|NCT00907881|592408685|FG000|Overall Study|Withdrawal by Subject|5|||
164012157|NCT00907881|592408685|FG000|Overall Study|Protocol Violation|1|||
164012158|NCT00907881|592408685|FG000|Overall Study|Missing discontinuation information|15|||
164012159|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
164012160|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
164012161|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
164012162|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164012163|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164012164|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164012165|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164012166|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
164012167|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
164092698|NCT00911859|592702114|FG001|Maintainance Period|Lack of Efficacy|0|||
164092699|NCT00911859|592702115|FG002|Maintainance Period|Lack of Efficacy|9|||
164092700|NCT00911859|592702113|FG000|Maintainance Period|Physician Decision|0|||
164092701|NCT00911859|592702114|FG001|Maintainance Period|Physician Decision|0|||
164092702|NCT00911859|592702115|FG002|Maintainance Period|Physician Decision|9|||
164365703|NCT00314574|593715097|FG001|Overall Study|Lost to Follow-up|25|||
164365704|NCT00314574|593715096|FG000|Overall Study|Withdrawal by Subject|33|||
164365705|NCT00314574|593715097|FG001|Overall Study|Withdrawal by Subject|22|||
164365706|NCT00314574|593715096|FG000|Overall Study|Physician Decision|22|||
164365707|NCT00314574|593715097|FG001|Overall Study|Physician Decision|15|||
164365708|NCT00314574|593715096|FG000|Overall Study|Pregnancy|6|||
164365709|NCT00314574|593715097|FG001|Overall Study|Pregnancy|4|||
164365710|NCT00314574|593715096|FG000|Overall Study|Data unknown at database lock|0|||
164365711|NCT00314574|593715097|FG001|Overall Study|Data unknown at database lock|1|||
164365712|NCT02053753|593715098|FG000|Overall Study|Withdrawal by Subject|2|||
164365713|NCT02053753|593715099|FG001|Overall Study|Withdrawal by Subject|4|||
164365714|NCT02053753|593715098|FG000|Overall Study|Decision by Sponsor|1|||
164365715|NCT02053753|593715099|FG001|Overall Study|Decision by Sponsor|1|||
164365716|NCT02053753|593715098|FG000|Overall Study|Lost to Follow-up|4|||
164365717|NCT02053753|593715099|FG001|Overall Study|Lost to Follow-up|3|||
164365718|NCT02439320|593715100|FG000|Overall Study|Adverse Event|0|||
164365719|NCT02439320|593715101|FG001|Overall Study|Adverse Event|2|||
164365720|NCT02439320|593715102|FG002|Overall Study|Adverse Event|0|||
164365721|NCT02439320|593715100|FG000|Overall Study|Lost to Follow-up|37|||
164365722|NCT02439320|593715101|FG001|Overall Study|Lost to Follow-up|34|||
164365723|NCT02439320|593715102|FG002|Overall Study|Lost to Follow-up|42|||
164365724|NCT02439320|593715100|FG000|Overall Study|Death|0|||
164365725|NCT02439320|593715101|FG001|Overall Study|Death|1|||
164365726|NCT02439320|593715102|FG002|Overall Study|Death|0|||
164365727|NCT02439320|593715100|FG000|Overall Study|Noncompliance with Protocol|10|||
164365728|NCT02439320|593715101|FG001|Overall Study|Noncompliance with Protocol|11|||
164365729|NCT02439320|593715102|FG002|Overall Study|Noncompliance with Protocol|7|||
164365730|NCT02439320|593715100|FG000|Overall Study|Pregnancy|0|||
164365731|NCT02439320|593715101|FG001|Overall Study|Pregnancy|1|||
164365732|NCT02439320|593715102|FG002|Overall Study|Pregnancy|1|||
164365733|NCT02439320|593715100|FG000|Overall Study|Withdrawal by Subject|12|||
164365734|NCT02439320|593715101|FG001|Overall Study|Withdrawal by Subject|16|||
164365735|NCT02439320|593715102|FG002|Overall Study|Withdrawal by Subject|14|||
164365736|NCT02439320|593715100|FG000|Overall Study|Physician Decision|2|||
164365737|NCT02439320|593715101|FG001|Overall Study|Physician Decision|1|||
164365738|NCT02439320|593715102|FG002|Overall Study|Physician Decision|0|||
164365739|NCT02439320|593715100|FG000|Overall Study|Sponsor Request|0|||
164365740|NCT02439320|593715101|FG001|Overall Study|Sponsor Request|2|||
164365741|NCT02439320|593715102|FG002|Overall Study|Sponsor Request|1|||
164365742|NCT02439320|593715100|FG000|Overall Study|Randomization Failure|35|||
164365743|NCT02439320|593715101|FG001|Overall Study|Randomization Failure|46|||
164365744|NCT02439320|593715102|FG002|Overall Study|Randomization Failure|34|||
164365745|NCT01505608|593715103|FG000|Phase I|Lack of Efficacy|0|||
164365746|NCT01505608|593715104|FG001|Phase I|Lack of Efficacy|4|||
164365747|NCT01505608|593715103|FG000|Phase I|Adverse Event|0|||
164365748|NCT01505608|593715104|FG001|Phase I|Adverse Event|1|||
164012168|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
164365749|NCT01505608|593715103|FG000|Phase I|Withdrawal by Subject|0|||
164365750|NCT01505608|593715104|FG001|Phase I|Withdrawal by Subject|1|||
164365751|NCT01505608|593715103|FG000|Phase II|Lack of Efficacy|2|||
164365752|NCT01505608|593715104|FG001|Phase II|Lack of Efficacy|1|||
164365753|NCT01505608|593715103|FG000|Phase II|Protocol Violation|0|||
164012169|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
164092703|NCT00911859|592702113|FG000|Maintainance Period|Withdrawal by Subject|0|||
164092704|NCT00911859|592702114|FG001|Maintainance Period|Withdrawal by Subject|0|||
164092705|NCT00911859|592702115|FG002|Maintainance Period|Withdrawal by Subject|3|||
164365754|NCT01505608|593715104|FG001|Phase II|Protocol Violation|1|||
164365755|NCT01251380|593715114|FG000|Overall Study|Other (Not otherwise specified)|12|||
164365756|NCT01251380|593715114|FG000|Overall Study|Withdrawal by Subject|6|||
164365757|NCT01251380|593715114|FG000|Overall Study|Lack of Efficacy|1|||
164365758|NCT01251380|593715114|FG000|Overall Study|Adverse Event|1|||
164365759|NCT01251380|593715114|FG000|Overall Study|Lost to Follow-up|2|||
164365760|NCT00751348|593715115|FG000|Overall Study|Withdrawal by Subject|5|||
164365761|NCT00751348|593715116|FG001|Overall Study|Withdrawal by Subject|2|||
164012170|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164012171|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164012172|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164012173|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164012174|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
164012175|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
164012176|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
164012177|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
164012178|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164012179|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164012180|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164012181|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164012182|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
164012183|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
164365762|NCT00751348|593715115|FG000|Overall Study|Migration from study area|1|||
164365763|NCT00751348|593715116|FG001|Overall Study|Migration from study area|0|||
164365764|NCT02404350|593715121|FG000|Overall Study|Adverse Event|2|||
164365765|NCT02404350|593715122|FG001|Overall Study|Adverse Event|2|||
164365766|NCT02404350|593715123|FG002|Overall Study|Adverse Event|3|||
164365767|NCT02404350|593715124|FG003|Overall Study|Adverse Event|9|||
164365768|NCT02404350|593715121|FG000|Overall Study|Lack of Efficacy|3|||
164365769|NCT02404350|593715122|FG001|Overall Study|Lack of Efficacy|1|||
164365770|NCT02404350|593715123|FG002|Overall Study|Lack of Efficacy|0|||
164365771|NCT02404350|593715124|FG003|Overall Study|Lack of Efficacy|3|||
164365772|NCT02404350|593715121|FG000|Overall Study|Lost to Follow-up|2|||
164365773|NCT02404350|593715122|FG001|Overall Study|Lost to Follow-up|0|||
164365774|NCT02404350|593715123|FG002|Overall Study|Lost to Follow-up|0|||
164365775|NCT02404350|593715124|FG003|Overall Study|Lost to Follow-up|1|||
164365776|NCT02404350|593715121|FG000|Overall Study|Physician Decision|1|||
164365777|NCT02404350|593715122|FG001|Overall Study|Physician Decision|0|||
164365778|NCT02404350|593715123|FG002|Overall Study|Physician Decision|0|||
164365779|NCT02404350|593715124|FG003|Overall Study|Physician Decision|2|||
164365780|NCT02404350|593715121|FG000|Overall Study|Pregnancy|0|||
164365781|NCT02404350|593715122|FG001|Overall Study|Pregnancy|0|||
164365782|NCT02404350|593715123|FG002|Overall Study|Pregnancy|0|||
164365783|NCT02404350|593715124|FG003|Overall Study|Pregnancy|1|||
164365784|NCT02404350|593715121|FG000|Overall Study|Withdrawal by Subject|7|||
164365785|NCT02404350|593715122|FG001|Overall Study|Withdrawal by Subject|3|||
164365786|NCT02404350|593715123|FG002|Overall Study|Withdrawal by Subject|3|||
164365787|NCT02404350|593715124|FG003|Overall Study|Withdrawal by Subject|19|||
164365788|NCT02404350|593715121|FG000|Overall Study|Due to Non-compliance with treatment|0|||
164365789|NCT02404350|593715122|FG001|Overall Study|Due to Non-compliance with treatment|0|||
164365790|NCT02404350|593715123|FG002|Overall Study|Due to Non-compliance with treatment|0|||
164365791|NCT02404350|593715124|FG003|Overall Study|Due to Non-compliance with treatment|1|||
164365792|NCT02404350|593715121|FG000|Overall Study|Due to Technical problems|0|||
164365793|NCT02404350|593715122|FG001|Overall Study|Due to Technical problems|0|||
164365794|NCT02404350|593715123|FG002|Overall Study|Due to Technical problems|0|||
164365795|NCT02404350|593715124|FG003|Overall Study|Due to Technical problems|1|||
164365796|NCT05389657|593715125|FG000|Overall Study|Lost to Follow-up|7|||
164365797|NCT05389657|593715126|FG001|Overall Study|Lost to Follow-up|8|||
164365798|NCT00743652|593715127|FG000|Overall Study|Parent/Legal Guardian Request|3|||
164365799|NCT00743652|593715128|FG001|Overall Study|Parent/Legal Guardian Request|2|||
164365800|NCT00743652|593715129|FG002|Overall Study|Parent/Legal Guardian Request|2|||
164365801|NCT00743652|593715130|FG003|Overall Study|Parent/Legal Guardian Request|2|||
164365802|NCT00743652|593715131|FG004|Overall Study|Parent/Legal Guardian Request|0|||
164365803|NCT00743652|593715127|FG000|Overall Study|Adverse Event|3|||
164365804|NCT00743652|593715128|FG001|Overall Study|Adverse Event|0|||
164365805|NCT00743652|593715129|FG002|Overall Study|Adverse Event|0|||
164012184|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
164012185|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164012186|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164365806|NCT00743652|593715130|FG003|Overall Study|Adverse Event|0|||
164365807|NCT00743652|593715131|FG004|Overall Study|Adverse Event|0|||
164365808|NCT00743652|593715127|FG000|Overall Study|Death|2|||
164365809|NCT00743652|593715128|FG001|Overall Study|Death|0|||
164365810|NCT00743652|593715129|FG002|Overall Study|Death|0|||
164365811|NCT00743652|593715130|FG003|Overall Study|Death|0|||
164365812|NCT00743652|593715131|FG004|Overall Study|Death|0|||
164365813|NCT00743652|593715127|FG000|Overall Study|Investigator Request|0|||
164365814|NCT00743652|593715128|FG001|Overall Study|Investigator Request|0|||
164365815|NCT00743652|593715129|FG002|Overall Study|Investigator Request|0|||
164365816|NCT00743652|593715130|FG003|Overall Study|Investigator Request|2|||
164365817|NCT00743652|593715131|FG004|Overall Study|Investigator Request|0|||
164365818|NCT00743652|593715127|FG000|Overall Study|Other|1|||
164365819|NCT00743652|593715128|FG001|Overall Study|Other|1|||
164365820|NCT00743652|593715129|FG002|Overall Study|Other|0|||
164365821|NCT00743652|593715130|FG003|Overall Study|Other|0|||
164365822|NCT00743652|593715131|FG004|Overall Study|Other|0|||
164365823|NCT00743652|593715127|FG000|Overall Study|Lost to Follow-up|1|||
164365824|NCT00743652|593715128|FG001|Overall Study|Lost to Follow-up|0|||
164365825|NCT00743652|593715129|FG002|Overall Study|Lost to Follow-up|0|||
164365826|NCT00743652|593715130|FG003|Overall Study|Lost to Follow-up|0|||
164365827|NCT00743652|593715131|FG004|Overall Study|Lost to Follow-up|0|||
164365828|NCT05237206|593715133|FG000|Overall Study|screen failure-did not receive treatment|8|||
164365829|NCT05237206|593715133|FG000|Overall Study|did not receive treatment|3|||
164365830|NCT01085097|593715136|FG000|Overall Study|Adverse Event|0|||
164365831|NCT01085097|593715137|FG001|Overall Study|Adverse Event|0|||
164365832|NCT01085097|593715138|FG002|Overall Study|Adverse Event|2|||
164365833|NCT01085097|593715136|FG000|Overall Study|Treatment failure|2|||
164365834|NCT01085097|593715137|FG001|Overall Study|Treatment failure|0|||
164365835|NCT01085097|593715138|FG002|Overall Study|Treatment failure|0|||
164365836|NCT06049043|593715139|FG000|Overall Study|Lost to Follow-up|11|||
164365837|NCT06049043|593715140|FG001|Overall Study|Lost to Follow-up|9|||
164365838|NCT03089606|593715143|FG000|Overall Study|Progression after Cycle 1|1|||
164365839|NCT00335972|593715144|FG000|Overall Study|not given treatments|0|||
164365840|NCT00335972|593715145|FG001|Overall Study|not given treatments|3|||
164365841|NCT03965962|593715147|FG000|Overall Study|Adverse Event|1|||
164365842|NCT03965962|593715148|FG001|Overall Study|Adverse Event|0|||
164365843|NCT03965962|593715149|FG002|Overall Study|Adverse Event|0|||
164365844|NCT03965962|593715150|FG003|Overall Study|Adverse Event|0|||
164365845|NCT03965962|593715147|FG000|Overall Study|Protocol Violation|21|||
164365846|NCT03965962|593715148|FG001|Overall Study|Protocol Violation|4|||
164365847|NCT03965962|593715149|FG002|Overall Study|Protocol Violation|10|||
164365848|NCT03965962|593715150|FG003|Overall Study|Protocol Violation|5|||
164365849|NCT03965962|593715147|FG000|Overall Study|Lost to Follow-up|0|||
164365850|NCT03965962|593715148|FG001|Overall Study|Lost to Follow-up|1|||
164365851|NCT03965962|593715149|FG002|Overall Study|Lost to Follow-up|0|||
164365852|NCT03965962|593715150|FG003|Overall Study|Lost to Follow-up|0|||
164365853|NCT03965962|593715147|FG000|Overall Study|Withdrawal by Subject|3|||
164365854|NCT03965962|593715148|FG001|Overall Study|Withdrawal by Subject|0|||
164365855|NCT03965962|593715149|FG002|Overall Study|Withdrawal by Subject|0|||
164365856|NCT03965962|593715150|FG003|Overall Study|Withdrawal by Subject|1|||
164365857|NCT02154581|593715158|FG000|Overall Study|Lost to Follow-up|7|||
164365858|NCT02154581|593715159|FG001|Overall Study|Lost to Follow-up|8|||
164012187|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164365859|NCT00403273|593716966|FG000|Overall Study|Lost to Follow-up|3|||
164365860|NCT00403273|593716967|FG001|Overall Study|Lost to Follow-up|2|||
164365861|NCT00403273|593716966|FG000|Overall Study|Physician Decision|0|||
164365862|NCT00403273|593716967|FG001|Overall Study|Physician Decision|1|||
164365863|NCT00403273|593716966|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
164012188|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164012189|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164012190|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
164012191|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
164012192|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
164012193|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
164012194|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164012195|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164012196|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164012197|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164012198|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
164012199|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
164012200|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
164012201|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164365864|NCT00403273|593716967|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
164365865|NCT00589108|593716972|FG000|Overall Study|Lost to Follow-up|1|||
164365866|NCT00589108|593716973|FG001|Overall Study|Lost to Follow-up|1|||
164365867|NCT00589108|593716974|FG002|Overall Study|Lost to Follow-up|1|||
164365868|NCT00589108|593716972|FG000|Overall Study|Death|3|||
164365869|NCT00589108|593716973|FG001|Overall Study|Death|3|||
164365870|NCT00589108|593716974|FG002|Overall Study|Death|4|||
164365871|NCT03256552|593716975|FG000|Overall Study|Protocol Violation|1|||
164365872|NCT03256552|593716975|FG000|Overall Study|Physician Decision|1|||
164365873|NCT03256552|593716975|FG000|Overall Study|Adverse Event|1|||
164365874|NCT03256552|593716975|FG000|Overall Study|Withdrawal by Subject|2|||
164365875|NCT01012622|593716976|FG000|Overall Study|Withdrawal by Subject|6|||
164365876|NCT01012622|593716976|FG000|Overall Study|Lost to Follow-up|5|||
164365877|NCT01012622|593716976|FG000|Overall Study|Adverse Event|7|||
164365878|NCT01012622|593716976|FG000|Overall Study|non-compliance with the drug|9|||
164012202|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164012203|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164012204|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164365879|NCT01012622|593716976|FG000|Overall Study|Other|1|||
164365880|NCT01012622|593716976|FG000|Overall Study|screening failure|1|||
164365881|NCT01012622|593716976|FG000|Overall Study|withdrawal of consent by a parent|2|||
164365882|NCT01176292|593716977|FG000|Overall Study|Lost to Follow-up|2|||
164365883|NCT01176292|593716978|FG001|Overall Study|Lost to Follow-up|4|||
164365884|NCT01176292|593716977|FG000|Overall Study|Adverse Event|1|||
164365885|NCT01176292|593716978|FG001|Overall Study|Adverse Event|1|||
164365886|NCT01176292|593716977|FG000|Overall Study|Physician Decision|0|||
164365887|NCT01176292|593716978|FG001|Overall Study|Physician Decision|2|||
164365888|NCT01176292|593716977|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
164365889|NCT01176292|593716978|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
164365890|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
164365891|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
164365892|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
164365893|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
164365894|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
164365895|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
164365896|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
164365897|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
164365898|NCT00380393|593716979|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
164365899|NCT00380393|593716980|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
164365900|NCT00380393|593716979|FG000|Month 14|Withdrawal by Subject|9|||
164365901|NCT00380393|593716980|FG001|Month 14|Withdrawal by Subject|7|||
164365902|NCT00380393|593716979|FG000|Month 14|Death|1|||
164365903|NCT00380393|593716980|FG001|Month 14|Death|0|||
164365904|NCT00380393|593716979|FG000|Month 14|Lost to Follow-up|0|||
164365905|NCT00380393|593716980|FG001|Month 14|Lost to Follow-up|1|||
164365906|NCT00380393|593716979|FG000|Month 14|Migrated/moved from study area|39|||
164365907|NCT00380393|593716980|FG001|Month 14|Migrated/moved from study area|42|||
164365908|NCT00380393|593716979|FG000|Month 14|Protocol Violation|2|||
164365909|NCT00380393|593716980|FG001|Month 14|Protocol Violation|0|||
164365910|NCT00380393|593716979|FG000|Month 14|Others|6|||
164365911|NCT00380393|593716980|FG001|Month 14|Others|6|||
164365912|NCT00076011|593716993|FG000|Overall Study|Death|1|||
164365913|NCT00076011|593716993|FG000|Overall Study|Adverse Event|10|||
164365914|NCT00076011|593716993|FG000|Overall Study|Lack of Efficacy|25|||
164365915|NCT00076011|593716993|FG000|Overall Study|Withdrawal by Subject|1|||
164365916|NCT00076011|593716993|FG000|Overall Study|Study terminated by sponsor|3|||
164365917|NCT00076011|593716993|FG000|Overall Study|Other|11|||
164365918|NCT00076011|593716993|FG000|Overall Study|Ongoing|1|||
164365919|NCT00278954|593716997|FG000|Overall Study|Adverse Event|3|||
164365920|NCT00278954|593716997|FG000|Overall Study|Lost to Follow-up|1|||
164365921|NCT00278954|593716997|FG000|Overall Study|Withdrawal by Subject|1|||
164365922|NCT04343521|593717001|FG000|Overall Study|Adverse Event|0|||
164365923|NCT04343521|593717002|FG001|Overall Study|Adverse Event|2|||
164365924|NCT04343521|593717001|FG000|Overall Study|Death|1|||
164365925|NCT04343521|593717002|FG001|Overall Study|Death|2|||
164365926|NCT04343521|593717001|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
164365927|NCT04343521|593717002|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
164365928|NCT04343521|593717001|FG000|Overall Study|Withdrawal by Subject|70|||
164365929|NCT04343521|593717002|FG001|Overall Study|Withdrawal by Subject|95|||
164365930|NCT04343521|593717001|FG000|Overall Study|Withdrawal by study team|6|||
164365931|NCT04343521|593717002|FG001|Overall Study|Withdrawal by study team|12|||
164365932|NCT02211131|593717003|FG000|Overall Study|Death|26|||
164365933|NCT02211131|593717004|FG001|Overall Study|Death|16|||
164012205|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164012206|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
164012207|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
164012208|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
164365934|NCT02211131|593717003|FG000|Overall Study|Lost to Follow-up|4|||
164365935|NCT02211131|593717004|FG001|Overall Study|Lost to Follow-up|3|||
164012209|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164012210|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164365936|NCT02211131|593717003|FG000|Overall Study|Decision by Sponsor|1|||
164365937|NCT02211131|593717004|FG001|Overall Study|Decision by Sponsor|1|||
164365938|NCT02211131|593717003|FG000|Overall Study|Withdrawal by Subject|3|||
164365939|NCT02211131|593717004|FG001|Overall Study|Withdrawal by Subject|8|||
164365940|NCT05664490|593717005|FG000|Overall Study|Withdrawal by Subject|0|||
164365941|NCT05664490|593717006|FG001|Overall Study|Withdrawal by Subject|1|||
164365942|NCT05664490|593717005|FG000|Overall Study|Lost to Follow-up|14|||
164365943|NCT05664490|593717006|FG001|Overall Study|Lost to Follow-up|22|||
164365944|NCT03144180|593717007|FG000|Overall Study|STAT Delivery|1|||
164365945|NCT03144180|593717008|FG001|Overall Study|STAT Delivery|1|||
164012211|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164012212|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164012213|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164012214|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
164012215|NCT01097616|592408686|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012216|NCT01097616|592408687|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012217|NCT01097616|592408688|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
164012218|NCT01097616|592408689|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012219|NCT01097616|592408690|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012220|NCT01097616|592408691|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012221|NCT01097616|592408692|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012222|NCT01097616|592408693|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
164012223|NCT01097616|592408686|FG000|Optional DB EXT Phase|Adverse Event|0|||
164012224|NCT01097616|592408687|FG001|Optional DB EXT Phase|Adverse Event|7|||
164012225|NCT01097616|592408688|FG002|Optional DB EXT Phase|Adverse Event|2|||
164012226|NCT01097616|592408689|FG003|Optional DB EXT Phase|Adverse Event|0|||
164012227|NCT01097616|592408690|FG004|Optional DB EXT Phase|Adverse Event|0|||
164012228|NCT01097616|592408691|FG005|Optional DB EXT Phase|Adverse Event|0|||
164012229|NCT01097616|592408692|FG006|Optional DB EXT Phase|Adverse Event|0|||
164012230|NCT01097616|592408693|FG007|Optional DB EXT Phase|Adverse Event|0|||
164012231|NCT01097616|592408686|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
164012232|NCT01097616|592408687|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
164012233|NCT01097616|592408688|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
164012234|NCT01097616|592408689|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
164012235|NCT01097616|592408690|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
164012236|NCT01097616|592408691|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
164365946|NCT03144180|593717007|FG000|Overall Study|Provider forgot to fill out forms|1|||
164365947|NCT03144180|593717008|FG001|Overall Study|Provider forgot to fill out forms|3|||
164365948|NCT03144180|593717007|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
164365949|NCT03144180|593717008|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
164365950|NCT03144180|593717007|FG000|Overall Study|Scrub tech removed tube cap|0|||
164365951|NCT03144180|593717008|FG001|Overall Study|Scrub tech removed tube cap|1|||
164365952|NCT03261947|593717009|FG000|Overall Study|Death|10|||
164365953|NCT03261947|593717010|FG001|Overall Study|Death|13|||
164365954|NCT03261947|593717011|FG002|Overall Study|Death|17|||
164365955|NCT03261947|593717012|FG003|Overall Study|Death|12|||
164365956|NCT03261947|593717013|FG004|Overall Study|Death|8|||
164365957|NCT03261947|593717009|FG000|Overall Study|Lost to Follow-up|0|||
164365958|NCT03261947|593717010|FG001|Overall Study|Lost to Follow-up|0|||
164365959|NCT03261947|593717011|FG002|Overall Study|Lost to Follow-up|2|||
164365960|NCT03261947|593717012|FG003|Overall Study|Lost to Follow-up|1|||
164365961|NCT03261947|593717013|FG004|Overall Study|Lost to Follow-up|0|||
164365962|NCT03261947|593717009|FG000|Overall Study|Withdrawal by Subject|0|||
164365963|NCT03261947|593717010|FG001|Overall Study|Withdrawal by Subject|0|||
164365964|NCT03261947|593717011|FG002|Overall Study|Withdrawal by Subject|3|||
164365965|NCT03261947|593717012|FG003|Overall Study|Withdrawal by Subject|0|||
164365966|NCT03261947|593717013|FG004|Overall Study|Withdrawal by Subject|1|||
164365967|NCT03261947|593717009|FG000|Overall Study|Site Terminated by Sponsor|0|||
164365968|NCT03261947|593717010|FG001|Overall Study|Site Terminated by Sponsor|0|||
164365969|NCT03261947|593717011|FG002|Overall Study|Site Terminated by Sponsor|4|||
164365970|NCT03261947|593717012|FG003|Overall Study|Site Terminated by Sponsor|7|||
164365971|NCT03261947|593717013|FG004|Overall Study|Site Terminated by Sponsor|5|||
164365972|NCT03261947|593717009|FG000|Overall Study|Reason not Specified|2|||
164365973|NCT03261947|593717010|FG001|Overall Study|Reason not Specified|0|||
164365974|NCT03261947|593717011|FG002|Overall Study|Reason not Specified|4|||
164365975|NCT03261947|593717012|FG003|Overall Study|Reason not Specified|1|||
164365976|NCT03261947|593717013|FG004|Overall Study|Reason not Specified|3|||
164365977|NCT03969992|593717014|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
164365978|NCT03969992|593717015|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
164365979|NCT03969992|593717016|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
164012237|NCT01097616|592408692|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
164012238|NCT01097616|592408693|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
164365980|NCT03969992|593717014|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
164365981|NCT03969992|593717015|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
164365982|NCT03969992|593717016|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
164365983|NCT03969992|593717014|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
164365984|NCT03969992|593717015|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
164012239|NCT01097616|592408686|FG000|Optional DB EXT Phase|Protocol Violation|0|||
164012240|NCT01097616|592408687|FG001|Optional DB EXT Phase|Protocol Violation|2|||
164012241|NCT01097616|592408688|FG002|Optional DB EXT Phase|Protocol Violation|3|||
164012242|NCT01097616|592408689|FG003|Optional DB EXT Phase|Protocol Violation|0|||
164365985|NCT03969992|593717016|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
164365986|NCT03969992|593717014|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
164365987|NCT03969992|593717015|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
164365988|NCT03969992|593717016|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
164365989|NCT03969992|593717014|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
164365990|NCT03969992|593717015|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
164365991|NCT03969992|593717016|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
164365992|NCT00228917|593717017|FG000|Overall Study|Migrated/moved from study area|0|||
164365993|NCT00228917|593717018|FG001|Overall Study|Migrated/moved from study area|0|||
164365994|NCT00228917|593717019|FG002|Overall Study|Migrated/moved from study area|0|||
164365995|NCT00228917|593717020|FG003|Overall Study|Migrated/moved from study area|0|||
164365996|NCT00228917|593717021|FG004|Overall Study|Migrated/moved from study area|0|||
164365997|NCT00228917|593717022|FG005|Overall Study|Migrated/moved from study area|2|||
164365998|NCT00228917|593717023|FG006|Overall Study|Migrated/moved from study area|0|||
164365999|NCT00228917|593717024|FG007|Overall Study|Migrated/moved from study area|0|||
164366000|NCT02063737|593717027|FG000|Overall Study|Lost to Follow-up|11|||
164366001|NCT02063737|593717028|FG001|Overall Study|Lost to Follow-up|4|||
164366002|NCT04372602|593717029|FG000|Overall Study|Withdrawal by Subject|1|||
164366003|NCT04372602|593717030|FG001|Overall Study|Withdrawal by Subject|1|||
164366004|NCT04372602|593717029|FG000|Overall Study|Adverse Event|0|||
164366005|NCT04372602|593717030|FG001|Overall Study|Adverse Event|1|||
164366006|NCT04372602|593717029|FG000|Overall Study|Transitioned to comfort care|0|||
164366007|NCT04372602|593717030|FG001|Overall Study|Transitioned to comfort care|1|||
164366008|NCT04120974|593717031|FG000|Overall Study|Death|1|||
164366009|NCT04120974|593717031|FG000|Overall Study|Physician Decision|1|||
164366010|NCT04120974|593717031|FG000|Overall Study|Lost to Follow-up|6|||
164366011|NCT00129129|593717032|FG000|Primary Phase|Adverse Event|2|||
164012243|NCT01097616|592408690|FG004|Optional DB EXT Phase|Protocol Violation|0|||
164012244|NCT01097616|592408691|FG005|Optional DB EXT Phase|Protocol Violation|0|||
164012245|NCT01097616|592408692|FG006|Optional DB EXT Phase|Protocol Violation|0|||
164012246|NCT01097616|592408693|FG007|Optional DB EXT Phase|Protocol Violation|0|||
164012247|NCT01097616|592408686|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
164012248|NCT01097616|592408687|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
164012249|NCT01097616|592408688|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
164012250|NCT01097616|592408689|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
164012251|NCT01097616|592408690|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
164012252|NCT01097616|592408691|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
164012253|NCT01097616|592408692|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
164012254|NCT01097616|592408693|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
164012255|NCT01097616|592408686|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
164012256|NCT01097616|592408687|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
164012257|NCT01097616|592408688|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
164012258|NCT01097616|592408689|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
164012259|NCT01097616|592408690|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
164012260|NCT01097616|592408691|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
164012261|NCT01097616|592408692|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
164012262|NCT01097616|592408693|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
164012263|NCT01097616|592408686|FG000|Optional DB EXT Phase|Physician Decision|1|||
164012264|NCT01097616|592408687|FG001|Optional DB EXT Phase|Physician Decision|0|||
164012265|NCT01097616|592408688|FG002|Optional DB EXT Phase|Physician Decision|0|||
164012266|NCT01097616|592408689|FG003|Optional DB EXT Phase|Physician Decision|0|||
164366012|NCT00129129|593717033|FG001|Primary Phase|Adverse Event|1|||
164366013|NCT00129129|593717034|FG002|Primary Phase|Adverse Event|0|||
164366014|NCT00129129|593717035|FG003|Primary Phase|Adverse Event|0|||
164366015|NCT00129129|593717036|FG004|Primary Phase|Adverse Event|0|||
164366016|NCT00129129|593717032|FG000|Primary Phase|Withdrawal by Subject|12|||
164366017|NCT00129129|593717033|FG001|Primary Phase|Withdrawal by Subject|10|||
164366018|NCT00129129|593717034|FG002|Primary Phase|Withdrawal by Subject|0|||
164366019|NCT00129129|593717035|FG003|Primary Phase|Withdrawal by Subject|0|||
164366020|NCT00129129|593717036|FG004|Primary Phase|Withdrawal by Subject|0|||
164366021|NCT00129129|593717032|FG000|Primary Phase|Migration from study area|1|||
164366022|NCT00129129|593717033|FG001|Primary Phase|Migration from study area|3|||
164012267|NCT01097616|592408690|FG004|Optional DB EXT Phase|Physician Decision|0|||
164012268|NCT01097616|592408691|FG005|Optional DB EXT Phase|Physician Decision|0|||
164012269|NCT01097616|592408692|FG006|Optional DB EXT Phase|Physician Decision|0|||
164012270|NCT01097616|592408693|FG007|Optional DB EXT Phase|Physician Decision|0|||
164366023|NCT00129129|593717034|FG002|Primary Phase|Migration from study area|0|||
164366024|NCT00129129|593717035|FG003|Primary Phase|Migration from study area|0|||
164366025|NCT00129129|593717036|FG004|Primary Phase|Migration from study area|0|||
164366026|NCT00129129|593717032|FG000|Primary Phase|Lost to Follow-up|8|||
164366027|NCT00129129|593717033|FG001|Primary Phase|Lost to Follow-up|6|||
164366028|NCT00129129|593717034|FG002|Primary Phase|Lost to Follow-up|0|||
164012271|NCT01097616|592408686|FG000|DB RO Phase|Adverse Event|0|||
164012272|NCT01097616|592408687|FG001|DB RO Phase|Adverse Event|0|||
164366029|NCT00129129|593717035|FG003|Primary Phase|Lost to Follow-up|0|||
164366030|NCT00129129|593717036|FG004|Primary Phase|Lost to Follow-up|0|||
164366031|NCT00129129|593717032|FG000|Primary Phase|Other|2|||
164366032|NCT00129129|593717033|FG001|Primary Phase|Other|5|||
164366033|NCT00129129|593717034|FG002|Primary Phase|Other|0|||
164366034|NCT00129129|593717035|FG003|Primary Phase|Other|0|||
164366035|NCT00129129|593717036|FG004|Primary Phase|Other|0|||
164366036|NCT00129129|593717032|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
164366037|NCT00129129|593717033|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
164366038|NCT00129129|593717034|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
164366039|NCT00129129|593717035|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
164366040|NCT00129129|593717036|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
164366041|NCT00129129|593717032|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
164366042|NCT00129129|593717033|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
164366043|NCT00129129|593717034|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
164366044|NCT00129129|593717035|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
164366045|NCT00129129|593717036|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
164366046|NCT00129129|593717032|FG000|Fourth Dose Phase|Migration from study area|0|||
164366047|NCT00129129|593717033|FG001|Fourth Dose Phase|Migration from study area|0|||
164366048|NCT00129129|593717034|FG002|Fourth Dose Phase|Migration from study area|0|||
164366049|NCT00129129|593717035|FG003|Fourth Dose Phase|Migration from study area|0|||
164366050|NCT00129129|593717036|FG004|Fourth Dose Phase|Migration from study area|2|||
164366051|NCT00129129|593717032|FG000|Fourth Dose Phase|Other|0|||
164366052|NCT00129129|593717033|FG001|Fourth Dose Phase|Other|0|||
164366053|NCT00129129|593717034|FG002|Fourth Dose Phase|Other|0|||
164366054|NCT00129129|593717035|FG003|Fourth Dose Phase|Other|1|||
164366055|NCT00129129|593717036|FG004|Fourth Dose Phase|Other|1|||
164366056|NCT00129129|593717032|FG000|Fourth Dose Phase|Protocol Violation|0|||
164366057|NCT00129129|593717033|FG001|Fourth Dose Phase|Protocol Violation|0|||
164366058|NCT00129129|593717034|FG002|Fourth Dose Phase|Protocol Violation|0|||
164366059|NCT00129129|593717035|FG003|Fourth Dose Phase|Protocol Violation|1|||
164366060|NCT00129129|593717036|FG004|Fourth Dose Phase|Protocol Violation|0|||
164366061|NCT03190889|593717037|FG000|Overall Study|Lost to Follow-up|7|||
164366062|NCT03190889|593717038|FG001|Overall Study|Lost to Follow-up|7|||
164366063|NCT03190889|593717039|FG002|Overall Study|Lost to Follow-up|3|||
164366064|NCT03190889|593717037|FG000|Overall Study|Withdrawal by Subject|1|||
164366065|NCT03190889|593717038|FG001|Overall Study|Withdrawal by Subject|1|||
164366066|NCT03190889|593717039|FG002|Overall Study|Withdrawal by Subject|2|||
164366067|NCT03190889|593717037|FG000|Overall Study|Did not complete protocol|4|||
164366068|NCT03190889|593717038|FG001|Overall Study|Did not complete protocol|9|||
164366069|NCT03190889|593717039|FG002|Overall Study|Did not complete protocol|0|||
164366070|NCT03190889|593717037|FG000|Overall Study|COVID-19|1|||
164366071|NCT03190889|593717038|FG001|Overall Study|COVID-19|0|||
164366072|NCT03190889|593717039|FG002|Overall Study|COVID-19|2|||
164366073|NCT02140567|593717041|FG000|Overall Study|Problems with recording equipment|6|||
164366074|NCT02882854|593717044|FG000|Overall Study|Lost to Follow-up|1|||
164366075|NCT02882854|593717045|FG001|Overall Study|Lost to Follow-up|2|||
164366076|NCT02882854|593717044|FG000|Overall Study|Physician Decision|0|||
164366077|NCT02882854|593717045|FG001|Overall Study|Physician Decision|1|||
164366078|NCT02039674|593717046|FG000|Overall Study|Adverse Event|0|||
164366079|NCT02039674|593717047|FG001|Overall Study|Adverse Event|0|||
164366080|NCT02039674|593717048|FG002|Overall Study|Adverse Event|0|||
164366081|NCT02039674|593717049|FG003|Overall Study|Adverse Event|1|||
164366082|NCT02039674|593717050|FG004|Overall Study|Adverse Event|0|||
164366083|NCT02039674|593717051|FG005|Overall Study|Adverse Event|0|||
164366084|NCT02039674|593717052|FG006|Overall Study|Adverse Event|0|||
164366085|NCT02039674|593717053|FG007|Overall Study|Adverse Event|0|||
164366086|NCT02039674|593717054|FG008|Overall Study|Adverse Event|2|||
164366087|NCT02039674|593717055|FG009|Overall Study|Adverse Event|1|||
164366088|NCT02039674|593717056|FG010|Overall Study|Adverse Event|0|||
164366089|NCT02039674|593717057|FG011|Overall Study|Adverse Event|2|||
164366090|NCT02039674|593717058|FG012|Overall Study|Adverse Event|3|||
164366091|NCT02039674|593717059|FG013|Overall Study|Adverse Event|1|||
164366092|NCT02039674|593717046|FG000|Overall Study|Death|2|||
164366093|NCT02039674|593717047|FG001|Overall Study|Death|0|||
164366094|NCT02039674|593717048|FG002|Overall Study|Death|2|||
164366095|NCT02039674|593717049|FG003|Overall Study|Death|3|||
164366096|NCT02039674|593717050|FG004|Overall Study|Death|0|||
164366097|NCT02039674|593717051|FG005|Overall Study|Death|0|||
164366098|NCT02039674|593717052|FG006|Overall Study|Death|1|||
164366099|NCT02039674|593717053|FG007|Overall Study|Death|0|||
164366100|NCT02039674|593717054|FG008|Overall Study|Death|2|||
164366101|NCT02039674|593717055|FG009|Overall Study|Death|0|||
164366102|NCT02039674|593717056|FG010|Overall Study|Death|1|||
164366103|NCT02039674|593717057|FG011|Overall Study|Death|3|||
164366104|NCT02039674|593717058|FG012|Overall Study|Death|2|||
164366105|NCT02039674|593717059|FG013|Overall Study|Death|8|||
164366106|NCT02039674|593717046|FG000|Overall Study|Excluded Medication|1|||
164366107|NCT02039674|593717047|FG001|Overall Study|Excluded Medication|1|||
164366108|NCT02039674|593717048|FG002|Overall Study|Excluded Medication|0|||
164366109|NCT02039674|593717049|FG003|Overall Study|Excluded Medication|1|||
164366110|NCT02039674|593717050|FG004|Overall Study|Excluded Medication|0|||
164366111|NCT02039674|593717051|FG005|Overall Study|Excluded Medication|1|||
164366112|NCT02039674|593717052|FG006|Overall Study|Excluded Medication|0|||
164366113|NCT02039674|593717053|FG007|Overall Study|Excluded Medication|0|||
164366114|NCT02039674|593717054|FG008|Overall Study|Excluded Medication|2|||
164366115|NCT02039674|593717055|FG009|Overall Study|Excluded Medication|3|||
164366116|NCT02039674|593717056|FG010|Overall Study|Excluded Medication|5|||
164366117|NCT02039674|593717057|FG011|Overall Study|Excluded Medication|6|||
164366118|NCT02039674|593717058|FG012|Overall Study|Excluded Medication|8|||
164366119|NCT02039674|593717059|FG013|Overall Study|Excluded Medication|3|||
164366120|NCT02039674|593717046|FG000|Overall Study|Lost to Follow-up|0|||
164366121|NCT02039674|593717047|FG001|Overall Study|Lost to Follow-up|0|||
164366122|NCT02039674|593717048|FG002|Overall Study|Lost to Follow-up|0|||
164366123|NCT02039674|593717049|FG003|Overall Study|Lost to Follow-up|0|||
164366124|NCT02039674|593717050|FG004|Overall Study|Lost to Follow-up|1|||
164366125|NCT02039674|593717051|FG005|Overall Study|Lost to Follow-up|1|||
164366126|NCT02039674|593717052|FG006|Overall Study|Lost to Follow-up|0|||
164366127|NCT02039674|593717053|FG007|Overall Study|Lost to Follow-up|0|||
164366128|NCT02039674|593717054|FG008|Overall Study|Lost to Follow-up|0|||
164366129|NCT02039674|593717055|FG009|Overall Study|Lost to Follow-up|0|||
164366130|NCT02039674|593717056|FG010|Overall Study|Lost to Follow-up|0|||
164366131|NCT02039674|593717057|FG011|Overall Study|Lost to Follow-up|2|||
164366132|NCT02039674|593717058|FG012|Overall Study|Lost to Follow-up|2|||
164366133|NCT02039674|593717059|FG013|Overall Study|Lost to Follow-up|1|||
164366134|NCT02039674|593717046|FG000|Overall Study|Physician Decision|0|||
164366135|NCT02039674|593717047|FG001|Overall Study|Physician Decision|0|||
164366136|NCT02039674|593717048|FG002|Overall Study|Physician Decision|0|||
164366137|NCT02039674|593717049|FG003|Overall Study|Physician Decision|0|||
164366138|NCT02039674|593717050|FG004|Overall Study|Physician Decision|0|||
164366139|NCT02039674|593717051|FG005|Overall Study|Physician Decision|0|||
164366140|NCT02039674|593717052|FG006|Overall Study|Physician Decision|0|||
164366141|NCT02039674|593717053|FG007|Overall Study|Physician Decision|0|||
164366142|NCT02039674|593717054|FG008|Overall Study|Physician Decision|0|||
164366143|NCT02039674|593717055|FG009|Overall Study|Physician Decision|0|||
164366144|NCT02039674|593717056|FG010|Overall Study|Physician Decision|0|||
164366145|NCT02039674|593717057|FG011|Overall Study|Physician Decision|1|||
164366146|NCT02039674|593717058|FG012|Overall Study|Physician Decision|1|||
164366147|NCT02039674|593717059|FG013|Overall Study|Physician Decision|0|||
164366148|NCT02039674|593717046|FG000|Overall Study|Progressive Disease|8|||
164366149|NCT02039674|593717047|FG001|Overall Study|Progressive Disease|8|||
164366150|NCT02039674|593717048|FG002|Overall Study|Progressive Disease|6|||
164366151|NCT02039674|593717049|FG003|Overall Study|Progressive Disease|7|||
164366152|NCT02039674|593717050|FG004|Overall Study|Progressive Disease|9|||
164366153|NCT02039674|593717051|FG005|Overall Study|Progressive Disease|10|||
164366154|NCT02039674|593717052|FG006|Overall Study|Progressive Disease|1|||
164366155|NCT02039674|593717053|FG007|Overall Study|Progressive Disease|3|||
164366156|NCT02039674|593717054|FG008|Overall Study|Progressive Disease|6|||
164366157|NCT02039674|593717055|FG009|Overall Study|Progressive Disease|4|||
164366158|NCT02039674|593717056|FG010|Overall Study|Progressive Disease|0|||
164366159|NCT02039674|593717057|FG011|Overall Study|Progressive Disease|34|||
164366160|NCT02039674|593717058|FG012|Overall Study|Progressive Disease|34|||
164366161|NCT02039674|593717059|FG013|Overall Study|Progressive Disease|18|||
163901966|NCT02036970|592013032|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
163901967|NCT02036970|592013033|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164366162|NCT02039674|593717046|FG000|Overall Study|Withdrawal by Subject|1|||
164366163|NCT02039674|593717047|FG001|Overall Study|Withdrawal by Subject|2|||
164366164|NCT02039674|593717048|FG002|Overall Study|Withdrawal by Subject|3|||
164366165|NCT02039674|593717049|FG003|Overall Study|Withdrawal by Subject|0|||
164366166|NCT02039674|593717050|FG004|Overall Study|Withdrawal by Subject|1|||
164366167|NCT02039674|593717051|FG005|Overall Study|Withdrawal by Subject|0|||
164366168|NCT02039674|593717052|FG006|Overall Study|Withdrawal by Subject|0|||
164366169|NCT02039674|593717053|FG007|Overall Study|Withdrawal by Subject|0|||
164366170|NCT02039674|593717054|FG008|Overall Study|Withdrawal by Subject|0|||
164366171|NCT02039674|593717055|FG009|Overall Study|Withdrawal by Subject|1|||
164366172|NCT02039674|593717056|FG010|Overall Study|Withdrawal by Subject|1|||
163901968|NCT02036970|592013034|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
164366173|NCT02039674|593717057|FG011|Overall Study|Withdrawal by Subject|4|||
163901969|NCT02036970|592013025|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
163901970|NCT02036970|592013026|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
163901971|NCT02036970|592013027|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
164366174|NCT02039674|593717058|FG012|Overall Study|Withdrawal by Subject|6|||
164366175|NCT02039674|593717059|FG013|Overall Study|Withdrawal by Subject|2|||
164366176|NCT02039674|593717046|FG000|Overall Study|Clinical Progression|0|||
164366177|NCT02039674|593717047|FG001|Overall Study|Clinical Progression|0|||
164366178|NCT02039674|593717048|FG002|Overall Study|Clinical Progression|0|||
164366179|NCT02039674|593717049|FG003|Overall Study|Clinical Progression|0|||
164366180|NCT02039674|593717050|FG004|Overall Study|Clinical Progression|0|||
164366181|NCT02039674|593717051|FG005|Overall Study|Clinical Progression|0|||
164366182|NCT02039674|593717052|FG006|Overall Study|Clinical Progression|1|||
164366183|NCT02039674|593717053|FG007|Overall Study|Clinical Progression|0|||
164366184|NCT02039674|593717054|FG008|Overall Study|Clinical Progression|0|||
164366185|NCT02039674|593717055|FG009|Overall Study|Clinical Progression|0|||
164366186|NCT02039674|593717056|FG010|Overall Study|Clinical Progression|0|||
164366187|NCT02039674|593717057|FG011|Overall Study|Clinical Progression|0|||
164366188|NCT02039674|593717058|FG012|Overall Study|Clinical Progression|1|||
164366189|NCT02039674|593717059|FG013|Overall Study|Clinical Progression|0|||
164012273|NCT01097616|592408688|FG002|DB RO Phase|Adverse Event|0|||
164012274|NCT01097616|592408689|FG003|DB RO Phase|Adverse Event|0|||
164012275|NCT01097616|592408690|FG004|DB RO Phase|Adverse Event|0|||
164012276|NCT01097616|592408691|FG005|DB RO Phase|Adverse Event|0|||
164012277|NCT01097616|592408692|FG006|DB RO Phase|Adverse Event|1|||
164012278|NCT01097616|592408693|FG007|DB RO Phase|Adverse Event|0|||
164012279|NCT01097616|592408686|FG000|DB RO Phase|Withdrawal by Subject|0|||
164012280|NCT01097616|592408687|FG001|DB RO Phase|Withdrawal by Subject|0|||
164012281|NCT01097616|592408688|FG002|DB RO Phase|Withdrawal by Subject|0|||
164012282|NCT01097616|592408689|FG003|DB RO Phase|Withdrawal by Subject|0|||
164012283|NCT01097616|592408690|FG004|DB RO Phase|Withdrawal by Subject|0|||
164012284|NCT01097616|592408691|FG005|DB RO Phase|Withdrawal by Subject|1|||
164012285|NCT01097616|592408692|FG006|DB RO Phase|Withdrawal by Subject|0|||
164012286|NCT01097616|592408693|FG007|DB RO Phase|Withdrawal by Subject|0|||
164012287|NCT01097616|592408686|FG000|DB RO Phase|Lost to Follow-up|0|||
164012288|NCT01097616|592408687|FG001|DB RO Phase|Lost to Follow-up|0|||
164012289|NCT01097616|592408688|FG002|DB RO Phase|Lost to Follow-up|0|||
164366190|NCT02039674|593717046|FG000|Overall Study|Sponsor Decision|1|||
164366191|NCT02039674|593717047|FG001|Overall Study|Sponsor Decision|1|||
164366192|NCT02039674|593717048|FG002|Overall Study|Sponsor Decision|1|||
164366193|NCT02039674|593717049|FG003|Overall Study|Sponsor Decision|1|||
164366194|NCT02039674|593717050|FG004|Overall Study|Sponsor Decision|1|||
164366195|NCT02039674|593717051|FG005|Overall Study|Sponsor Decision|0|||
164366196|NCT02039674|593717052|FG006|Overall Study|Sponsor Decision|0|||
164366197|NCT02039674|593717053|FG007|Overall Study|Sponsor Decision|0|||
164366198|NCT02039674|593717054|FG008|Overall Study|Sponsor Decision|0|||
164366199|NCT02039674|593717055|FG009|Overall Study|Sponsor Decision|3|||
164366200|NCT02039674|593717056|FG010|Overall Study|Sponsor Decision|0|||
164366201|NCT02039674|593717057|FG011|Overall Study|Sponsor Decision|8|||
164366202|NCT02039674|593717058|FG012|Overall Study|Sponsor Decision|5|||
164366203|NCT02039674|593717059|FG013|Overall Study|Sponsor Decision|0|||
164366204|NCT02039674|593717046|FG000|Overall Study|Other|0|||
164012290|NCT01097616|592408689|FG003|DB RO Phase|Lost to Follow-up|1|||
164012291|NCT01097616|592408690|FG004|DB RO Phase|Lost to Follow-up|1|||
164366205|NCT02039674|593717047|FG001|Overall Study|Other|0|||
164366206|NCT02039674|593717048|FG002|Overall Study|Other|0|||
164366207|NCT02039674|593717049|FG003|Overall Study|Other|0|||
164366208|NCT02039674|593717050|FG004|Overall Study|Other|0|||
164366209|NCT02039674|593717051|FG005|Overall Study|Other|0|||
164366210|NCT02039674|593717052|FG006|Overall Study|Other|0|||
164366211|NCT02039674|593717053|FG007|Overall Study|Other|0|||
164366212|NCT02039674|593717054|FG008|Overall Study|Other|0|||
164366213|NCT02039674|593717055|FG009|Overall Study|Other|0|||
164366214|NCT02039674|593717056|FG010|Overall Study|Other|0|||
164366215|NCT02039674|593717057|FG011|Overall Study|Other|0|||
164012292|NCT01097616|592408691|FG005|DB RO Phase|Lost to Follow-up|0|||
164012293|NCT01097616|592408692|FG006|DB RO Phase|Lost to Follow-up|0|||
164012294|NCT01097616|592408693|FG007|DB RO Phase|Lost to Follow-up|1|||
164366216|NCT02039674|593717058|FG012|Overall Study|Other|1|||
164366217|NCT02039674|593717059|FG013|Overall Study|Other|0|||
164366218|NCT01358357|593717060|FG000|Open Label Phase|Adverse Event|0|||
164366219|NCT01358357|593717061|FG001|Open Label Phase|Adverse Event|0|||
164366220|NCT01358357|593717062|FG002|Open Label Phase|Adverse Event|59|||
164366221|NCT01358357|593717060|FG000|Open Label Phase|Lack of Efficacy|0|||
164366222|NCT01358357|593717061|FG001|Open Label Phase|Lack of Efficacy|0|||
164366223|NCT01358357|593717062|FG002|Open Label Phase|Lack of Efficacy|107|||
164366224|NCT01358357|593717060|FG000|Open Label Phase|Lost to Follow-up|0|||
164366225|NCT01358357|593717061|FG001|Open Label Phase|Lost to Follow-up|0|||
164366226|NCT01358357|593717062|FG002|Open Label Phase|Lost to Follow-up|76|||
164366227|NCT01358357|593717060|FG000|Open Label Phase|Protocol Violation|0|||
164366228|NCT01358357|593717061|FG001|Open Label Phase|Protocol Violation|0|||
164366229|NCT01358357|593717062|FG002|Open Label Phase|Protocol Violation|45|||
164366230|NCT01358357|593717060|FG000|Open Label Phase|Withdrawal by Subject|0|||
164366231|NCT01358357|593717061|FG001|Open Label Phase|Withdrawal by Subject|0|||
164366232|NCT01358357|593717062|FG002|Open Label Phase|Withdrawal by Subject|112|||
164366233|NCT01358357|593717060|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
164366234|NCT01358357|593717061|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
164366235|NCT01358357|593717062|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
164366236|NCT01358357|593717060|FG000|Open Label Phase|Terminated at study completion|0|||
164366237|NCT01358357|593717061|FG001|Open Label Phase|Terminated at study completion|0|||
164366238|NCT01358357|593717062|FG002|Open Label Phase|Terminated at study completion|5|||
164366239|NCT01358357|593717060|FG000|Open Label Phase|Mood episode|0|||
164366240|NCT01358357|593717061|FG001|Open Label Phase|Mood episode|0|||
164366241|NCT01358357|593717062|FG002|Open Label Phase|Mood episode|42|||
164366242|NCT01358357|593717060|FG000|Double-Blind Phase|Adverse Event|8|||
164366243|NCT01358357|593717061|FG001|Double-Blind Phase|Adverse Event|5|||
164366244|NCT01358357|593717062|FG002|Double-Blind Phase|Adverse Event|0|||
164366245|NCT01358357|593717060|FG000|Double-Blind Phase|Lost to Follow-up|5|||
164366246|NCT01358357|593717061|FG001|Double-Blind Phase|Lost to Follow-up|7|||
164366247|NCT01358357|593717062|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164366248|NCT01358357|593717060|FG000|Double-Blind Phase|Protocol Violation|1|||
164366249|NCT01358357|593717061|FG001|Double-Blind Phase|Protocol Violation|11|||
164366250|NCT01358357|593717062|FG002|Double-Blind Phase|Protocol Violation|0|||
164366251|NCT01358357|593717060|FG000|Double-Blind Phase|Protocol Violation|16|||
164366252|NCT01358357|593717061|FG001|Double-Blind Phase|Protocol Violation|12|||
164366253|NCT01358357|593717062|FG002|Double-Blind Phase|Protocol Violation|0|||
164366254|NCT01358357|593717060|FG000|Double-Blind Phase|Terminated at study completion|2|||
164366255|NCT01358357|593717061|FG001|Double-Blind Phase|Terminated at study completion|0|||
164366256|NCT01358357|593717062|FG002|Double-Blind Phase|Terminated at study completion|0|||
164366257|NCT01358357|593717060|FG000|Double-Blind Phase|Recurrence of mood event|48|||
164366258|NCT01358357|593717061|FG001|Double-Blind Phase|Recurrence of mood event|64|||
164366259|NCT01358357|593717062|FG002|Double-Blind Phase|Recurrence of mood event|0|||
164366260|NCT01358357|593717060|FG000|Double-Blind Phase|Administrative|0|||
164366261|NCT01358357|593717061|FG001|Double-Blind Phase|Administrative|1|||
164366262|NCT01358357|593717062|FG002|Double-Blind Phase|Administrative|0|||
164366263|NCT03774433|593717067|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
164366264|NCT00108160|593717068|FG000|Overall Study|Lost to Follow-up|25|||
164366265|NCT00108160|593717069|FG001|Overall Study|Lost to Follow-up|12|||
164366266|NCT00108160|593717068|FG000|Overall Study|Death|1|||
164366267|NCT00108160|593717069|FG001|Overall Study|Death|2|||
164366268|NCT00108160|593717068|FG000|Overall Study|Withdrawal by Subject|4|||
164366269|NCT00108160|593717069|FG001|Overall Study|Withdrawal by Subject|2|||
164366270|NCT00108160|593717068|FG000|Overall Study|Protocol Violation|9|||
164366271|NCT00108160|593717069|FG001|Overall Study|Protocol Violation|5|||
164366272|NCT02081079|593717070|FG000|Overall Study|Lack of Efficacy|3|||
164366273|NCT02081079|593717071|FG001|Overall Study|Lack of Efficacy|2|||
164366274|NCT02081079|593717070|FG000|Overall Study|Lost to Follow-up|1|||
164366275|NCT02081079|593717071|FG001|Overall Study|Lost to Follow-up|0|||
164366276|NCT00768144|593717072|FG000|Overall Study|Adverse Event|13|||
164366277|NCT00768144|593717072|FG000|Overall Study|Progressive Disease|21|||
164366278|NCT00768144|593717072|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
164366279|NCT00768144|593717072|FG000|Overall Study|Pt Withdrew Consent|1|||
164366280|NCT01712854|593717073|FG000|Overall Study|Physician Decision|1|||
164366281|NCT01150123|593717074|FG000|Overall Study|Withdrawal by Subject|1|||
164366282|NCT01150123|593717075|FG001|Overall Study|Withdrawal by Subject|1|||
164366283|NCT01150123|593717076|FG002|Overall Study|Withdrawal by Subject|2|||
164366284|NCT01150123|593717077|FG003|Overall Study|Withdrawal by Subject|1|||
164366285|NCT01150123|593717078|FG004|Overall Study|Withdrawal by Subject|1|||
164366286|NCT01150123|593717079|FG005|Overall Study|Withdrawal by Subject|1|||
164366287|NCT01150123|593717080|FG006|Overall Study|Withdrawal by Subject|0|||
164366288|NCT01150123|593717081|FG007|Overall Study|Withdrawal by Subject|3|||
164366289|NCT01150123|593717082|FG008|Overall Study|Withdrawal by Subject|2|||
164366290|NCT01150123|593717083|FG009|Overall Study|Withdrawal by Subject|0|||
164366291|NCT01150123|593717084|FG010|Overall Study|Withdrawal by Subject|1|||
164366292|NCT01150123|593717085|FG011|Overall Study|Withdrawal by Subject|0|||
164366293|NCT01150123|593717086|FG012|Overall Study|Withdrawal by Subject|1|||
164366294|NCT01150123|593717087|FG013|Overall Study|Withdrawal by Subject|0|||
164366295|NCT01150123|593717088|FG014|Overall Study|Withdrawal by Subject|0|||
164366296|NCT01150123|593717089|FG015|Overall Study|Withdrawal by Subject|1|||
164366297|NCT01150123|593717090|FG016|Overall Study|Withdrawal by Subject|0|||
164366298|NCT01150123|593717091|FG017|Overall Study|Withdrawal by Subject|1|||
164366299|NCT01150123|593717074|FG000|Overall Study|Lost to Follow-up|2|||
164366300|NCT01150123|593717075|FG001|Overall Study|Lost to Follow-up|1|||
164366301|NCT01150123|593717076|FG002|Overall Study|Lost to Follow-up|2|||
164366302|NCT01150123|593717077|FG003|Overall Study|Lost to Follow-up|2|||
164366303|NCT01150123|593717078|FG004|Overall Study|Lost to Follow-up|2|||
164366304|NCT01150123|593717079|FG005|Overall Study|Lost to Follow-up|5|||
164366305|NCT01150123|593717080|FG006|Overall Study|Lost to Follow-up|0|||
164366306|NCT01150123|593717081|FG007|Overall Study|Lost to Follow-up|0|||
164366307|NCT01150123|593717082|FG008|Overall Study|Lost to Follow-up|3|||
164366308|NCT01150123|593717083|FG009|Overall Study|Lost to Follow-up|1|||
164366309|NCT01150123|593717084|FG010|Overall Study|Lost to Follow-up|1|||
164366310|NCT01150123|593717085|FG011|Overall Study|Lost to Follow-up|1|||
164366311|NCT01150123|593717086|FG012|Overall Study|Lost to Follow-up|2|||
164366312|NCT01150123|593717087|FG013|Overall Study|Lost to Follow-up|0|||
164366313|NCT01150123|593717088|FG014|Overall Study|Lost to Follow-up|0|||
164366314|NCT01150123|593717089|FG015|Overall Study|Lost to Follow-up|0|||
164366315|NCT01150123|593717090|FG016|Overall Study|Lost to Follow-up|0|||
164366316|NCT01150123|593717091|FG017|Overall Study|Lost to Follow-up|0|||
164366317|NCT02171260|593717092|FG000|Overall Study|Death|0|||
164366318|NCT02171260|593717093|FG001|Overall Study|Death|0|||
164366319|NCT02171260|593717094|FG002|Overall Study|Death|0|||
164366320|NCT02171260|593717095|FG003|Overall Study|Death|1|||
164366321|NCT02171260|593717092|FG000|Overall Study|Physician Decision|1|||
164366322|NCT02171260|593717093|FG001|Overall Study|Physician Decision|0|||
164366323|NCT02171260|593717094|FG002|Overall Study|Physician Decision|1|||
164366324|NCT02171260|593717095|FG003|Overall Study|Physician Decision|0|||
164366325|NCT02171260|593717092|FG000|Overall Study|Withdrawal by Subject|1|||
164366326|NCT02171260|593717093|FG001|Overall Study|Withdrawal by Subject|0|||
164366327|NCT02171260|593717094|FG002|Overall Study|Withdrawal by Subject|0|||
164366328|NCT02171260|593717095|FG003|Overall Study|Withdrawal by Subject|0|||
164366329|NCT02171260|593717092|FG000|Overall Study|Evidence of progressive disease|4|||
164366330|NCT02171260|593717093|FG001|Overall Study|Evidence of progressive disease|6|||
164366331|NCT02171260|593717094|FG002|Overall Study|Evidence of progressive disease|4|||
164366332|NCT02171260|593717095|FG003|Overall Study|Evidence of progressive disease|4|||
164366333|NCT00322842|593717100|FG000|Overall Study|Withdrawal by Subject|0|||
164366334|NCT00322842|593717101|FG001|Overall Study|Withdrawal by Subject|1|||
164366335|NCT00322842|593717100|FG000|Overall Study|Lost to Follow-up|0|||
164366336|NCT00322842|593717101|FG001|Overall Study|Lost to Follow-up|1|||
164366337|NCT00322842|593717100|FG000|Overall Study|Refused transplant|1|||
164366338|NCT00322842|593717101|FG001|Overall Study|Refused transplant|0|||
164366339|NCT00322842|593717100|FG000|Overall Study|Death|1|||
164366340|NCT00322842|593717101|FG001|Overall Study|Death|0|||
164366341|NCT00323492|593717102|FG000|Study Phase 1|Adverse Event|2|||
164366342|NCT00323492|593717103|FG001|Study Phase 1|Adverse Event|0|||
164366343|NCT00323492|593717104|FG002|Study Phase 1|Adverse Event|0|||
164366344|NCT00323492|593717102|FG000|Study Phase 2|Adverse Event|1|||
164366345|NCT00323492|593717103|FG001|Study Phase 2|Adverse Event|0|||
164366346|NCT00323492|593717104|FG002|Study Phase 2|Adverse Event|0|||
164366347|NCT00323492|593717102|FG000|Study Phase 2|Physician Decision|1|||
164366348|NCT00323492|593717103|FG001|Study Phase 2|Physician Decision|0|||
164366349|NCT00323492|593717104|FG002|Study Phase 2|Physician Decision|0|||
164092706|NCT00911859|592702113|FG000|Follow-up Period|Death|5|||
164366350|NCT00323492|593717102|FG000|Study Phase 2|Lost to Follow-up|1|||
164366351|NCT00323492|593717103|FG001|Study Phase 2|Lost to Follow-up|0|||
164366352|NCT00323492|593717104|FG002|Study Phase 2|Lost to Follow-up|0|||
164366353|NCT00323492|593717102|FG000|Study Phase 2|Withdrawal by Subject|0|||
164366354|NCT00323492|593717103|FG001|Study Phase 2|Withdrawal by Subject|1|||
164366355|NCT00323492|593717104|FG002|Study Phase 2|Withdrawal by Subject|0|||
164366356|NCT00323492|593717102|FG000|Study Phase 2|Noncompliance with study schedule|0|||
164366357|NCT00323492|593717103|FG001|Study Phase 2|Noncompliance with study schedule|0|||
164366358|NCT00323492|593717104|FG002|Study Phase 2|Noncompliance with study schedule|1|||
164366359|NCT00323492|593717102|FG000|Study Phase 2|Protocol Violation|1|||
164366360|NCT00323492|593717103|FG001|Study Phase 2|Protocol Violation|0|||
164092707|NCT00911859|592702114|FG001|Follow-up Period|Death|8|||
164092708|NCT00911859|592702115|FG002|Follow-up Period|Death|10|||
164366361|NCT00323492|593717104|FG002|Study Phase 2|Protocol Violation|0|||
164366362|NCT03082599|593717105|FG000|Overall Study|Lost to Follow-up|1|||
164366363|NCT03082599|593717106|FG001|Overall Study|Lost to Follow-up|0|||
164366364|NCT02486042|593717107|FG000|Overall Study|Physician Decision|1|||
164366365|NCT02486042|593717108|FG001|Overall Study|Physician Decision|7|||
164366366|NCT02486042|593717107|FG000|Overall Study|Hospital transfer|2|||
164366367|NCT02486042|593717108|FG001|Overall Study|Hospital transfer|2|||
164366368|NCT02486042|593717107|FG000|Overall Study|Withdrawal by Subject|0|||
164366369|NCT02486042|593717108|FG001|Overall Study|Withdrawal by Subject|2|||
164366370|NCT01466387|593717109|FG000|Overall Study|Adverse Event|0|||
164366371|NCT01466387|593717110|FG001|Overall Study|Adverse Event|0|||
164366372|NCT01466387|593717111|FG002|Overall Study|Adverse Event|1|||
164366373|NCT01466387|593717112|FG003|Overall Study|Adverse Event|1|||
164366374|NCT01466387|593717113|FG004|Overall Study|Adverse Event|0|||
164366375|NCT01466387|593717114|FG005|Overall Study|Adverse Event|0|||
164366376|NCT01466387|593717109|FG000|Overall Study|Lost to Follow-up|0|||
164366377|NCT01466387|593717110|FG001|Overall Study|Lost to Follow-up|0|||
164366378|NCT01466387|593717111|FG002|Overall Study|Lost to Follow-up|0|||
164366379|NCT01466387|593717112|FG003|Overall Study|Lost to Follow-up|0|||
164366380|NCT01466387|593717113|FG004|Overall Study|Lost to Follow-up|0|||
164366381|NCT01466387|593717114|FG005|Overall Study|Lost to Follow-up|1|||
164366382|NCT01466387|593717109|FG000|Overall Study|Protocol Violation|1|||
164366383|NCT01466387|593717110|FG001|Overall Study|Protocol Violation|0|||
164366384|NCT01466387|593717111|FG002|Overall Study|Protocol Violation|0|||
164366385|NCT01466387|593717112|FG003|Overall Study|Protocol Violation|1|||
164366386|NCT01466387|593717113|FG004|Overall Study|Protocol Violation|0|||
164366387|NCT01466387|593717114|FG005|Overall Study|Protocol Violation|0|||
164366388|NCT00832585|593717125|FG000|Overall Study|Withdrawal by Subject|1|||
164366389|NCT00832585|593717125|FG000|Overall Study|Lost to Follow-up|1|||
164366390|NCT00673179|593717127|FG000|Overall Study|Toxicity/Complications|3|||
164366391|NCT00673179|593717128|FG001|Overall Study|Toxicity/Complications|0|||
164366392|NCT00352846|593717129|FG000|Overall Study|Disease progression|0|||
164366393|NCT00352846|593717130|FG001|Overall Study|Disease progression|2|||
164366394|NCT00352846|593717129|FG000|Overall Study|Withdrawal by Subject|3|||
164366395|NCT00352846|593717130|FG001|Overall Study|Withdrawal by Subject|8|||
164366396|NCT00352846|593717129|FG000|Overall Study|Ineligible|3|||
164366397|NCT00352846|593717130|FG001|Overall Study|Ineligible|2|||
164366398|NCT00352846|593717129|FG000|Overall Study|Non-compliance|2|||
164366399|NCT00352846|593717130|FG001|Overall Study|Non-compliance|0|||
164366400|NCT00352846|593717129|FG000|Overall Study|Death|0|||
164366401|NCT00352846|593717130|FG001|Overall Study|Death|1|||
164366402|NCT00281684|593717131|FG000|Overall Study|Lost to Follow-up|0|||
164366403|NCT00281684|593717132|FG001|Overall Study|Lost to Follow-up|0|||
164366404|NCT00281684|593717133|FG002|Overall Study|Lost to Follow-up|1|||
164366405|NCT00281684|593717134|FG003|Overall Study|Lost to Follow-up|0|||
164366406|NCT00281684|593717131|FG000|Overall Study|Withdrawal by Subject|1|||
164366407|NCT00281684|593717132|FG001|Overall Study|Withdrawal by Subject|0|||
164366408|NCT00281684|593717133|FG002|Overall Study|Withdrawal by Subject|0|||
164366409|NCT00281684|593717134|FG003|Overall Study|Withdrawal by Subject|0|||
164366410|NCT01531387|593717138|FG000|Overall Study|Early termination of study|11|||
164366411|NCT01531387|593717139|FG001|Overall Study|Early termination of study|11|||
164366412|NCT00578942|593717142|FG000|Overall Study|Lost to Follow-up|1|||
164366413|NCT01124643|593717143|FG000|Overall Study|Death|1|||
164366414|NCT04220411|593717144|FG000|Overall Study|Adverse Event|0|||
164366415|NCT04220411|593717145|FG001|Overall Study|Adverse Event|0|||
164366416|NCT04220411|593717146|FG002|Overall Study|Adverse Event|0|||
164366417|NCT04220411|593717147|FG003|Overall Study|Adverse Event|1|||
164366418|NCT00502697|593718492|FG000|Overall Study|Withdrawal by Subject|3|||
164366419|NCT00502697|593718493|FG001|Overall Study|Withdrawal by Subject|1|||
164366420|NCT00502697|593718492|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
164366421|NCT00502697|593718493|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
164366422|NCT00502697|593718492|FG000|Overall Study|found not to meet eligibility criteria|3|||
164366423|NCT00502697|593718493|FG001|Overall Study|found not to meet eligibility criteria|4|||
164366424|NCT00502697|593718492|FG000|Overall Study|did not meet assignment criteria|4|||
164366425|NCT00502697|593718493|FG001|Overall Study|did not meet assignment criteria|2|||
164366426|NCT02268409|593718505|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
164366427|NCT02268409|593718505|FG000|Overall Study|Death|1|||
164366428|NCT02268409|593718505|FG000|Overall Study|Lost to Follow-up|1|||
164366429|NCT02268409|593718505|FG000|Overall Study|Protocol Violation|3|||
164366430|NCT02268409|593718505|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
163901972|NCT02036970|592013028|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
163901973|NCT02036970|592013029|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
163901974|NCT02036970|592013030|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
164366431|NCT02268409|593718505|FG000|Overall Study|Withdrawal by Subject|5|||
164366432|NCT03026257|593718506|FG000|Overall Study|Adverse Event|3|||
164366433|NCT03026257|593718507|FG001|Overall Study|Adverse Event|0|||
164366434|NCT03026257|593718508|FG002|Overall Study|Adverse Event|0|||
164366435|NCT03026257|593718509|FG003|Overall Study|Adverse Event|0|||
164366436|NCT03026257|593718510|FG004|Overall Study|Adverse Event|0|||
164366437|NCT03026257|593718511|FG005|Overall Study|Adverse Event|0|||
164366438|NCT03026257|593718506|FG000|Overall Study|Lost to Follow-up|1|||
164366439|NCT03026257|593718507|FG001|Overall Study|Lost to Follow-up|0|||
164366440|NCT03026257|593718508|FG002|Overall Study|Lost to Follow-up|0|||
164366441|NCT03026257|593718509|FG003|Overall Study|Lost to Follow-up|0|||
164366442|NCT03026257|593718510|FG004|Overall Study|Lost to Follow-up|0|||
164366443|NCT03026257|593718511|FG005|Overall Study|Lost to Follow-up|0|||
164366444|NCT03026257|593718506|FG000|Overall Study|Protocol Violation|1|||
164366445|NCT03026257|593718507|FG001|Overall Study|Protocol Violation|0|||
164366446|NCT03026257|593718508|FG002|Overall Study|Protocol Violation|0|||
164366447|NCT03026257|593718509|FG003|Overall Study|Protocol Violation|1|||
164366448|NCT03026257|593718510|FG004|Overall Study|Protocol Violation|1|||
164366449|NCT03026257|593718511|FG005|Overall Study|Protocol Violation|0|||
164366450|NCT03026257|593718506|FG000|Overall Study|Withdrawal by Subject|1|||
164366451|NCT03026257|593718507|FG001|Overall Study|Withdrawal by Subject|1|||
164366452|NCT03026257|593718508|FG002|Overall Study|Withdrawal by Subject|0|||
164366453|NCT03026257|593718509|FG003|Overall Study|Withdrawal by Subject|0|||
164366454|NCT03026257|593718510|FG004|Overall Study|Withdrawal by Subject|0|||
164366455|NCT03026257|593718511|FG005|Overall Study|Withdrawal by Subject|0|||
164366456|NCT02181556|593718513|FG000|Overall Study|Withdrawal by Subject|1|||
164366457|NCT00427635|593718514|FG000|Treatment Phase|Withdrawal by Subject|1|||
164366458|NCT00427635|593718515|FG001|Treatment Phase|Withdrawal by Subject|0|||
164366459|NCT00427635|593718514|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
164366460|NCT00427635|593718515|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
164366461|NCT00838201|593718518|FG000|Overall Study|Investigator decision, or other reasons|2|||
164366462|NCT00838201|593718519|FG001|Overall Study|Investigator decision, or other reasons|3|||
164366463|NCT00838201|593718518|FG000|Overall Study|Noncompliance|0|||
164366464|NCT00838201|593718519|FG001|Overall Study|Noncompliance|1|||
164366465|NCT00838201|593718518|FG000|Overall Study|Administrative decision|1|||
164366466|NCT00838201|593718519|FG001|Overall Study|Administrative decision|2|||
164366467|NCT00838201|593718518|FG000|Overall Study|Disease progression|3|||
164366468|NCT00838201|593718519|FG001|Overall Study|Disease progression|3|||
164366469|NCT00838201|593718518|FG000|Overall Study|Consent withdrawn|16|||
164366470|NCT00838201|593718519|FG001|Overall Study|Consent withdrawn|19|||
164366471|NCT00838201|593718518|FG000|Overall Study|Lost to Follow-up|4|||
164366472|NCT00838201|593718519|FG001|Overall Study|Lost to Follow-up|3|||
164366473|NCT00838201|593718518|FG000|Overall Study|Adverse Event|5|||
164366474|NCT00838201|593718519|FG001|Overall Study|Adverse Event|9|||
164366475|NCT00838201|593718518|FG000|Overall Study|Death|11|||
164366476|NCT00838201|593718519|FG001|Overall Study|Death|13|||
164366477|NCT00489853|593718520|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
164366478|NCT00489853|593718521|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
164366479|NCT00489853|593718522|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
164366480|NCT00489853|593718520|FG000|Wash-out Period 1|Adverse Event|0|||
164366481|NCT00489853|593718521|FG001|Wash-out Period 1|Adverse Event|1|||
164366482|NCT00489853|593718522|FG002|Wash-out Period 1|Adverse Event|1|||
164366483|NCT00489853|593718520|FG000|Wash-out Period 1|Protocol Violation|0|||
164366484|NCT00489853|593718521|FG001|Wash-out Period 1|Protocol Violation|1|||
164366485|NCT00489853|593718522|FG002|Wash-out Period 1|Protocol Violation|1|||
164366486|NCT00489853|593718520|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
164366487|NCT00489853|593718521|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
164366488|NCT00489853|593718522|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
164366489|NCT00489853|593718520|FG000|Wash-out Period 2|Adverse Event|1|||
164366490|NCT00489853|593718521|FG001|Wash-out Period 2|Adverse Event|1|||
164366491|NCT00489853|593718522|FG002|Wash-out Period 2|Adverse Event|0|||
164366492|NCT00489853|593718520|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
164366493|NCT00489853|593718521|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
164366494|NCT00489853|593718522|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
164366495|NCT00489853|593718520|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
164366496|NCT00489853|593718521|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
164366497|NCT00489853|593718522|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
164366498|NCT00704535|593718523|FG000|Overall Study|Adverse Event|2|||
164366499|NCT00704535|593718523|FG000|Overall Study|Death|2|||
164366500|NCT00704535|593718523|FG000|Overall Study|Lost to Follow-up|8|||
164366501|NCT00704535|593718523|FG000|Overall Study|Protocol Violation|10|||
164366502|NCT00704535|593718523|FG000|Overall Study|Completed status not on Case Report Form|124|||
164366503|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
164366504|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
164366505|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
164366506|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
164366507|NCT01589445|593718526|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
164012295|NCT01097616|592408686|FG000|DB RO Phase|Not Treated in RO|0|||
164366508|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
164366509|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
164366510|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
164366511|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
164366512|NCT01589445|593718526|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
164366513|NCT00481195|593718538|FG000|Overall Study|Adverse Event|16|||
164366514|NCT00481195|593718539|FG001|Overall Study|Adverse Event|11|||
164366515|NCT00481195|593718538|FG000|Overall Study|Lack of Efficacy|1|||
164366516|NCT00481195|593718539|FG001|Overall Study|Lack of Efficacy|3|||
164366517|NCT00481195|593718538|FG000|Overall Study|Lost to Follow-up|4|||
164366518|NCT00481195|593718539|FG001|Overall Study|Lost to Follow-up|6|||
164366519|NCT00481195|593718538|FG000|Overall Study|Physician Decision|3|||
164366520|NCT00481195|593718539|FG001|Overall Study|Physician Decision|1|||
164366521|NCT00481195|593718538|FG000|Overall Study|Protocol Violation|10|||
164366522|NCT00481195|593718539|FG001|Overall Study|Protocol Violation|7|||
164366523|NCT00481195|593718538|FG000|Overall Study|Withdrawal by Subject|3|||
164366524|NCT00481195|593718539|FG001|Overall Study|Withdrawal by Subject|9|||
164366525|NCT00481195|593718538|FG000|Overall Study|Miscellaneous|2|||
164366526|NCT00481195|593718539|FG001|Overall Study|Miscellaneous|2|||
164366527|NCT02932904|593718540|FG000|Overall Study|Reason not Specified|1|||
164366528|NCT02932904|593718541|FG001|Overall Study|Reason not Specified|0|||
164366529|NCT02932904|593718542|FG002|Overall Study|Reason not Specified|2|||
164366530|NCT02932904|593718543|FG003|Overall Study|Reason not Specified|2|||
164366531|NCT02932904|593718540|FG000|Overall Study|Noncompliance with Study Drug|2|||
164366532|NCT02932904|593718541|FG001|Overall Study|Noncompliance with Study Drug|3|||
164366533|NCT02932904|593718542|FG002|Overall Study|Noncompliance with Study Drug|3|||
164366534|NCT02932904|593718543|FG003|Overall Study|Noncompliance with Study Drug|4|||
164366535|NCT02932904|593718540|FG000|Overall Study|Pregnancy|0|||
164366536|NCT02932904|593718541|FG001|Overall Study|Pregnancy|1|||
164366537|NCT02932904|593718542|FG002|Overall Study|Pregnancy|1|||
164366538|NCT02932904|593718543|FG003|Overall Study|Pregnancy|0|||
164366539|NCT02932904|593718540|FG000|Overall Study|Study Termination|0|||
164366540|NCT02932904|593718541|FG001|Overall Study|Study Termination|1|||
164366541|NCT02932904|593718542|FG002|Overall Study|Study Termination|0|||
164366542|NCT02932904|593718543|FG003|Overall Study|Study Termination|0|||
164366543|NCT02932904|593718540|FG000|Overall Study|Voluntary Withdrawal|2|||
164366544|NCT02932904|593718541|FG001|Overall Study|Voluntary Withdrawal|1|||
164366545|NCT02932904|593718542|FG002|Overall Study|Voluntary Withdrawal|4|||
164366546|NCT02932904|593718543|FG003|Overall Study|Voluntary Withdrawal|2|||
164366547|NCT02932904|593718540|FG000|Overall Study|Lost to Follow-up|5|||
164366548|NCT02932904|593718541|FG001|Overall Study|Lost to Follow-up|3|||
164366549|NCT02932904|593718542|FG002|Overall Study|Lost to Follow-up|6|||
164366550|NCT02932904|593718543|FG003|Overall Study|Lost to Follow-up|0|||
164366551|NCT02932904|593718540|FG000|Overall Study|Significant Protocol Deviation|2|||
164366552|NCT02932904|593718541|FG001|Overall Study|Significant Protocol Deviation|3|||
164366553|NCT02932904|593718542|FG002|Overall Study|Significant Protocol Deviation|6|||
164366554|NCT02932904|593718543|FG003|Overall Study|Significant Protocol Deviation|1|||
164366555|NCT02932904|593718540|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164366556|NCT02932904|593718541|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
164366557|NCT02932904|593718542|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
164366558|NCT02932904|593718543|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
164366559|NCT02932904|593718540|FG000|Overall Study|Randomized But Not Treated|1|||
164366560|NCT02932904|593718541|FG001|Overall Study|Randomized But Not Treated|1|||
164366561|NCT02932904|593718542|FG002|Overall Study|Randomized But Not Treated|0|||
164366562|NCT02932904|593718543|FG003|Overall Study|Randomized But Not Treated|2|||
164012296|NCT01097616|592408687|FG001|DB RO Phase|Not Treated in RO|0|||
164366563|NCT01476696|593718548|FG000|Overall Study|Sponsor decision|2|||
164012297|NCT01097616|592408688|FG002|DB RO Phase|Not Treated in RO|0|||
164366564|NCT01476696|593718549|FG001|Overall Study|Sponsor decision|1|||
164012298|NCT01097616|592408689|FG003|DB RO Phase|Not Treated in RO|0|||
164012299|NCT01097616|592408690|FG004|DB RO Phase|Not Treated in RO|0|||
164012300|NCT01097616|592408691|FG005|DB RO Phase|Not Treated in RO|1|||
164012301|NCT01097616|592408692|FG006|DB RO Phase|Not Treated in RO|0|||
164012302|NCT01097616|592408693|FG007|DB RO Phase|Not Treated in RO|0|||
164012303|NCT01325493|592408694|FG000|Overall Study|Protocol Violation|0|||
164366565|NCT01476696|593718550|FG002|Overall Study|Sponsor decision|0|||
164366566|NCT01476696|593718548|FG000|Overall Study|Withdrawal by Subject|1|||
164366567|NCT01476696|593718549|FG001|Overall Study|Withdrawal by Subject|0|||
164366568|NCT01476696|593718550|FG002|Overall Study|Withdrawal by Subject|0|||
164366569|NCT01498640|593718554|FG000|Overall Study|Lost to Follow-up|1|||
164366570|NCT01498640|593718554|FG000|Overall Study|Death|1|||
164366571|NCT01498640|593718554|FG000|Overall Study|Other|3|||
164366572|NCT02590939|593718555|FG000|Overall Study|Withdrawal by Subject|3|||
164366573|NCT02590939|593718556|FG001|Overall Study|Withdrawal by Subject|1|||
164366574|NCT02590939|593718555|FG000|Overall Study|Failed the nociceptive test|2|||
164366575|NCT02590939|593718556|FG001|Overall Study|Failed the nociceptive test|1|||
164366576|NCT02225743|593718557|FG000|Overall Study|Withdrawal by Subject|18|||
164366577|NCT01319877|593718562|FG000|Overall Study|Lost to Follow-up|100|||
164366578|NCT01319877|593718563|FG001|Overall Study|Lost to Follow-up|37|||
164366579|NCT01319877|593718562|FG000|Overall Study|Physician Decision|2|||
164366580|NCT01319877|593718563|FG001|Overall Study|Physician Decision|0|||
164366581|NCT01319877|593718562|FG000|Overall Study|Disease Progression|2|||
164366582|NCT01319877|593718563|FG001|Overall Study|Disease Progression|2|||
164366583|NCT01319877|593718562|FG000|Overall Study|Withdrawal by Subject|0|||
164366584|NCT01319877|593718563|FG001|Overall Study|Withdrawal by Subject|1|||
164366585|NCT01319877|593718562|FG000|Overall Study|Reason Not Specified|4|||
164366586|NCT01319877|593718563|FG001|Overall Study|Reason Not Specified|5|||
164366587|NCT02347189|593718567|FG000|Overall Study|No implant attempted of study device|9|||
164366588|NCT02347189|593718567|FG000|Overall Study|No primary outcome data available|2|||
164366589|NCT02677987|593718568|FG000|Overall Study|Withdrawal by Subject|3|||
164366590|NCT02677987|593718569|FG001|Overall Study|Withdrawal by Subject|0|||
164366591|NCT02677987|593718568|FG000|Overall Study|Lost to Follow-up|1|||
164366592|NCT02677987|593718569|FG001|Overall Study|Lost to Follow-up|0|||
164366593|NCT03320564|593718570|FG000|Overall Study|Protocol Violation|1|||
164366594|NCT01527682|593718571|FG000|Overall Study|Protocol Violation|8|||
164366595|NCT01359254|593718572|FG000|Overall Study|Death|1|||
164366596|NCT01359254|593718573|FG001|Overall Study|Death|0|||
164366597|NCT04668950|593718574|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
164366598|NCT04668950|593718575|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
164366599|NCT04668950|593718574|FG000|Overall Study|Could not confirm started study medication|15|||
164366600|NCT04668950|593718575|FG001|Overall Study|Could not confirm started study medication|15|||
164366601|NCT04668950|593718574|FG000|Overall Study|Could not confirm baseline status|6|||
164366602|NCT04668950|593718575|FG001|Overall Study|Could not confirm baseline status|2|||
164366603|NCT04668950|593718574|FG000|Overall Study|Drop out and did not start medication|15|||
164366604|NCT04668950|593718575|FG001|Overall Study|Drop out and did not start medication|17|||
164366605|NCT04668950|593718574|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
164366606|NCT04668950|593718575|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
164366607|NCT04668950|593718574|FG000|Overall Study|Other|2|||
164366608|NCT04668950|593718575|FG001|Overall Study|Other|4|||
164366609|NCT03979638|593718576|FG000|Period 1|Physician Decision|1|||
164366610|NCT03979638|593718577|FG001|Period 1|Physician Decision|1|||
164366611|NCT03979638|593718576|FG000|Period 1|Withdrawal by Subject|4|||
164366612|NCT03979638|593718577|FG001|Period 1|Withdrawal by Subject|3|||
164366613|NCT03979638|593718576|FG000|Period 1|Study terminated by Sponsor|1|||
164366614|NCT03979638|593718577|FG001|Period 1|Study terminated by Sponsor|3|||
164366615|NCT03979638|593718576|FG000|Period 1|Protocol Violation|1|||
164366616|NCT03979638|593718577|FG001|Period 1|Protocol Violation|0|||
164366617|NCT03979638|593718576|FG000|Period 2|Study terminated by Sponsor|1|||
164366618|NCT03979638|593718577|FG001|Period 2|Study terminated by Sponsor|1|||
164366619|NCT00600938|593718578|FG000|Core Study|Abnormal test procedure result(s)|3|||
164366620|NCT00600938|593718579|FG001|Core Study|Abnormal test procedure result(s)|2|||
164366621|NCT00600938|593718580|FG002|Core Study|Abnormal test procedure result(s)|0|||
164366622|NCT00600938|593718581|FG003|Core Study|Abnormal test procedure result(s)|0|||
164366623|NCT00600938|593718578|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
164366624|NCT00600938|593718579|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
164366625|NCT00600938|593718580|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
164366626|NCT00600938|593718581|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
164366627|NCT00600938|593718578|FG000|Core Study|Patient withdrew consent|7|||
164366628|NCT00600938|593718579|FG001|Core Study|Patient withdrew consent|12|||
164366629|NCT00600938|593718580|FG002|Core Study|Patient withdrew consent|0|||
164366630|NCT00600938|593718581|FG003|Core Study|Patient withdrew consent|0|||
164366631|NCT00600938|593718578|FG000|Core Study|Lost to Follow-up|3|||
164366632|NCT00600938|593718579|FG001|Core Study|Lost to Follow-up|2|||
164366633|NCT00600938|593718580|FG002|Core Study|Lost to Follow-up|0|||
164366634|NCT00600938|593718581|FG003|Core Study|Lost to Follow-up|0|||
164366635|NCT00600938|593718578|FG000|Core Study|Death|1|||
164366636|NCT00600938|593718579|FG001|Core Study|Death|1|||
164366637|NCT00600938|593718580|FG002|Core Study|Death|0|||
164366638|NCT00600938|593718581|FG003|Core Study|Death|0|||
164366639|NCT00600938|593718578|FG000|Core Study|Protocol Violation|1|||
164366640|NCT00600938|593718579|FG001|Core Study|Protocol Violation|2|||
164012304|NCT01325493|592408695|FG001|Overall Study|Protocol Violation|1|||
164012305|NCT01325493|592408694|FG000|Overall Study|loss of neuromonitoring signals|0|||
164012306|NCT01325493|592408695|FG001|Overall Study|loss of neuromonitoring signals|2|||
164366641|NCT00600938|593718580|FG002|Core Study|Protocol Violation|0|||
164366642|NCT00600938|593718581|FG003|Core Study|Protocol Violation|0|||
164366643|NCT00600938|593718578|FG000|Extension Study|Adverse Event|1|||
164366644|NCT00600938|593718579|FG001|Extension Study|Adverse Event|0|||
164366645|NCT00600938|593718580|FG002|Extension Study|Adverse Event|2|||
164366646|NCT00600938|593718581|FG003|Extension Study|Adverse Event|0|||
164366647|NCT00600938|593718578|FG000|Extension Study|Abnormal test procedure results|0|||
164366648|NCT00600938|593718579|FG001|Extension Study|Abnormal test procedure results|1|||
164366649|NCT00600938|593718580|FG002|Extension Study|Abnormal test procedure results|1|||
164366650|NCT00600938|593718581|FG003|Extension Study|Abnormal test procedure results|1|||
164366651|NCT00600938|593718578|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
164366652|NCT00600938|593718579|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
164366653|NCT00600938|593718580|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
164366654|NCT00600938|593718581|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
164366655|NCT00600938|593718578|FG000|Extension Study|Withdrawal by Subject|2|||
164366656|NCT00600938|593718579|FG001|Extension Study|Withdrawal by Subject|2|||
164366657|NCT00600938|593718580|FG002|Extension Study|Withdrawal by Subject|3|||
164366658|NCT00600938|593718581|FG003|Extension Study|Withdrawal by Subject|0|||
164366659|NCT00600938|593718578|FG000|Extension Study|Lost to Follow-up|1|||
164366660|NCT00600938|593718579|FG001|Extension Study|Lost to Follow-up|1|||
164366661|NCT00600938|593718580|FG002|Extension Study|Lost to Follow-up|2|||
164366662|NCT00600938|593718581|FG003|Extension Study|Lost to Follow-up|0|||
164366663|NCT00600938|593718578|FG000|Extension Study|Death|1|||
164366664|NCT00600938|593718579|FG001|Extension Study|Death|0|||
164366665|NCT00600938|593718580|FG002|Extension Study|Death|0|||
164366666|NCT00600938|593718581|FG003|Extension Study|Death|0|||
164366667|NCT02680639|593718582|FG000|Screening Period|Screen Failure|7|||
164366668|NCT02680639|593718583|FG001|Screening Period|Screen Failure|0|||
164366669|NCT02680639|593718584|FG002|Screening Period|Screen Failure|0|||
164366670|NCT02678676|593718585|FG000|Overall Study|Death|619|||
164366671|NCT02678676|593718586|FG001|Overall Study|Death|649|||
164366672|NCT02678676|593718585|FG000|Overall Study|Withdrawal by Subject|13|||
164366673|NCT02678676|593718586|FG001|Overall Study|Withdrawal by Subject|5|||
164366674|NCT02678676|593718585|FG000|Overall Study|Lost to Follow-up|171|||
164366675|NCT02678676|593718586|FG001|Overall Study|Lost to Follow-up|151|||
164366676|NCT02678676|593718585|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
164366677|NCT02678676|593718586|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
164366678|NCT03200899|593718587|FG000|Overall Study|Lost to Follow-up|10|||
164366679|NCT03200899|593718588|FG001|Overall Study|Lost to Follow-up|23|||
164366680|NCT01342510|593718603|FG000|Overall Study|Protocol Violation|12|||
164366681|NCT01342510|593718604|FG001|Overall Study|Protocol Violation|6|||
164366682|NCT01342510|593718605|FG002|Overall Study|Protocol Violation|13|||
164366683|NCT01342510|593718606|FG003|Overall Study|Protocol Violation|11|||
164366684|NCT01400516|593718608|FG000|Primary Trial|Withdrawal by Subject|0|||
164366685|NCT01400516|593718609|FG001|Primary Trial|Withdrawal by Subject|2|||
164366686|NCT00549562|593718612|FG000|Overall Study|Adverse Event|1|||
164366687|NCT00549562|593718612|FG000|Overall Study|Lack of Efficacy|1|||
164366688|NCT00323115|593718616|FG000|Vaccine Administration|Adverse Event|1|||
164366689|NCT00323115|593718616|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
164366690|NCT02496533|593718617|FG000|Overall Study|Lack of data on outcome|3|||
164366691|NCT02496533|593718618|FG001|Overall Study|Lack of data on outcome|0|||
164366692|NCT02496533|593718617|FG000|Overall Study|Patient did not complete all measures|0|||
164366693|NCT02496533|593718618|FG001|Overall Study|Patient did not complete all measures|4|||
164366694|NCT02496533|593718617|FG000|Overall Study|Late for radiologic testing|0|||
164366695|NCT02496533|593718618|FG001|Overall Study|Late for radiologic testing|2|||
164366696|NCT05756790|593718619|FG000|Overall Study|Withdrawal by Subject|1|||
164366697|NCT05756790|593718620|FG001|Overall Study|Withdrawal by Subject|1|||
164366698|NCT05756790|593718621|FG002|Overall Study|Withdrawal by Subject|1|||
164366699|NCT05756790|593718622|FG003|Overall Study|Withdrawal by Subject|1|||
164366700|NCT05756790|593718623|FG004|Overall Study|Withdrawal by Subject|0|||
164366701|NCT05756790|593718624|FG005|Overall Study|Withdrawal by Subject|0|||
164366702|NCT05756790|593718619|FG000|Overall Study|Protocol Violation|0|||
164366703|NCT05756790|593718620|FG001|Overall Study|Protocol Violation|0|||
164366704|NCT05756790|593718621|FG002|Overall Study|Protocol Violation|1|||
164366705|NCT05756790|593718622|FG003|Overall Study|Protocol Violation|1|||
164366706|NCT05756790|593718623|FG004|Overall Study|Protocol Violation|0|||
164366707|NCT05756790|593718624|FG005|Overall Study|Protocol Violation|0|||
164366708|NCT05756790|593718619|FG000|Overall Study|Ineligible|0|||
164366709|NCT05756790|593718620|FG001|Overall Study|Ineligible|0|||
164366710|NCT05756790|593718621|FG002|Overall Study|Ineligible|0|||
164366711|NCT05756790|593718622|FG003|Overall Study|Ineligible|0|||
164366712|NCT05756790|593718623|FG004|Overall Study|Ineligible|2|||
164366713|NCT05756790|593718624|FG005|Overall Study|Ineligible|2|||
164366714|NCT03265249|593720172|FG000|Overall Study|Withdrawal by Subject|0|||
164366715|NCT03265249|593720173|FG001|Overall Study|Withdrawal by Subject|1|||
164366716|NCT03873987|593720177|FG000|Overall Study|Adverse Event|1|||
164366717|NCT03873987|593720178|FG001|Overall Study|Adverse Event|0|||
164366718|NCT03873987|593720177|FG000|Overall Study|staff was unable to start a new IV line|1|||
164366719|NCT03873987|593720178|FG001|Overall Study|staff was unable to start a new IV line|0|||
164366720|NCT03873987|593720177|FG000|Overall Study|Lost to Follow-up|0|||
164366721|NCT03873987|593720178|FG001|Overall Study|Lost to Follow-up|1|||
164366722|NCT01465022|593720179|FG000|Overall Study|Lost to Follow-up|15|||
164366723|NCT01465022|593720180|FG001|Overall Study|Lost to Follow-up|14|||
164366724|NCT01465022|593720181|FG002|Overall Study|Lost to Follow-up|0|||
164366725|NCT01465022|593720179|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
164366726|NCT01465022|593720180|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
164366727|NCT01465022|593720181|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
164366728|NCT01465022|593720179|FG000|Overall Study|Not Randomized|0|||
164366729|NCT01465022|593720180|FG001|Overall Study|Not Randomized|0|||
164366730|NCT01465022|593720181|FG002|Overall Study|Not Randomized|70|||
164366731|NCT00004888|593720182|FG000|Overall Study|Adverse Event|5|||
164366732|NCT00004888|593720183|FG001|Overall Study|Adverse Event|10|||
164366733|NCT00004888|593720182|FG000|Overall Study|Withdrawal by Subject|0|||
164366734|NCT00004888|593720183|FG001|Overall Study|Withdrawal by Subject|3|||
164366735|NCT00004888|593720182|FG000|Overall Study|Physician Decision|1|||
164366736|NCT00004888|593720183|FG001|Overall Study|Physician Decision|1|||
164366737|NCT00004888|593720182|FG000|Overall Study|Progressive Disease|4|||
164366738|NCT00004888|593720183|FG001|Overall Study|Progressive Disease|9|||
164366739|NCT00004888|593720182|FG000|Overall Study|Death without progressive disease|0|||
164366740|NCT00004888|593720183|FG001|Overall Study|Death without progressive disease|1|||
164366741|NCT00004888|593720182|FG000|Overall Study|Toxic death|1|||
164366742|NCT00004888|593720183|FG001|Overall Study|Toxic death|0|||
164366743|NCT00136084|593720184|FG000|Overall Study|Death|12|||
164366744|NCT00136084|593720185|FG001|Overall Study|Death|5|||
164366745|NCT00136084|593720184|FG000|Overall Study|Unacceptable toxicity|8|||
164366746|NCT00136084|593720185|FG001|Overall Study|Unacceptable toxicity|11|||
164366747|NCT00136084|593720184|FG000|Overall Study|Relapse|20|||
164366748|NCT00136084|593720185|FG001|Overall Study|Relapse|23|||
164366749|NCT00136084|593720184|FG000|Overall Study|Lost to Follow-up|2|||
164366750|NCT00136084|593720185|FG001|Overall Study|Lost to Follow-up|0|||
164366751|NCT00136084|593720184|FG000|Overall Study|No Response|1|||
164366752|NCT00136084|593720185|FG001|Overall Study|No Response|2|||
164366753|NCT00136084|593720184|FG000|Overall Study|Withdrawal by Subject|5|||
164366754|NCT00136084|593720185|FG001|Overall Study|Withdrawal by Subject|1|||
164366755|NCT02579265|593720186|FG000|Overall Study|Weaned off earlier than 28 days|44|||
164366756|NCT02579265|593720187|FG001|Overall Study|Weaned off earlier than 28 days|43|||
164366757|NCT02579265|593720186|FG000|Overall Study|Adverse Event|2|||
164366758|NCT02579265|593720187|FG001|Overall Study|Adverse Event|0|||
164366759|NCT02579265|593720186|FG000|Overall Study|Any other reason not specified|0|||
164366760|NCT02579265|593720187|FG001|Overall Study|Any other reason not specified|2|||
164366761|NCT02579265|593720186|FG000|Overall Study|Withdrawal by Subject|2|||
164366762|NCT02579265|593720187|FG001|Overall Study|Withdrawal by Subject|0|||
164366763|NCT02579265|593720186|FG000|Overall Study|Physician Decision|1|||
164366764|NCT02579265|593720187|FG001|Overall Study|Physician Decision|0|||
164366765|NCT02579265|593720186|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
164366766|NCT02579265|593720187|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
164366767|NCT02174848|593720188|FG000|Overall Study|Adverse Event|2|||
164366768|NCT02174848|593720189|FG001|Overall Study|Adverse Event|1|||
164366769|NCT02174848|593720188|FG000|Overall Study|Withdrawal by Subject|3|||
164366770|NCT02174848|593720189|FG001|Overall Study|Withdrawal by Subject|3|||
164366771|NCT02174848|593720188|FG000|Overall Study|Lost to Follow-up|0|||
164366772|NCT02174848|593720189|FG001|Overall Study|Lost to Follow-up|1|||
164366773|NCT02174848|593720188|FG000|Overall Study|Worsening of disease|1|||
164366774|NCT02174848|593720189|FG001|Overall Study|Worsening of disease|1|||
164366775|NCT02174848|593720188|FG000|Overall Study|Unable to comply with study requirements|1|||
164366776|NCT02174848|593720189|FG001|Overall Study|Unable to comply with study requirements|0|||
164366777|NCT02520011|593720191|FG000|Overall Study|Adverse Event|0|||
164366778|NCT02520011|593720192|FG001|Overall Study|Adverse Event|1|||
164366779|NCT02520011|593720193|FG002|Overall Study|Adverse Event|2|||
164366780|NCT02520011|593720191|FG000|Overall Study|Death|0|||
164366781|NCT02520011|593720192|FG001|Overall Study|Death|8|||
164366782|NCT02520011|593720193|FG002|Overall Study|Death|1|||
164366783|NCT02520011|593720191|FG000|Overall Study|Lack of Efficacy|4|||
164366784|NCT02520011|593720192|FG001|Overall Study|Lack of Efficacy|26|||
164366785|NCT02520011|593720193|FG002|Overall Study|Lack of Efficacy|4|||
164366786|NCT02520011|593720191|FG000|Overall Study|Physician Decision|0|||
164366787|NCT02520011|593720192|FG001|Overall Study|Physician Decision|2|||
164366788|NCT02520011|593720193|FG002|Overall Study|Physician Decision|0|||
164366789|NCT02520011|593720191|FG000|Overall Study|Withdrawal by Subject|1|||
164366790|NCT02520011|593720192|FG001|Overall Study|Withdrawal by Subject|3|||
164366791|NCT02520011|593720193|FG002|Overall Study|Withdrawal by Subject|0|||
164366792|NCT02520011|593720191|FG000|Overall Study|Protocol Deviation|0|||
164366793|NCT02520011|593720192|FG001|Overall Study|Protocol Deviation|1|||
164012307|NCT01325493|592408694|FG000|Overall Study|Allergy|1|||
164012308|NCT01325493|592408695|FG001|Overall Study|Allergy|0|||
164012309|NCT02927171|592408696|FG000|Overall Study|Lost to Follow-up|0|||
164366794|NCT02520011|593720193|FG002|Overall Study|Protocol Deviation|0|||
164366795|NCT02520011|593720191|FG000|Overall Study|Patient went to hospice|0|||
164366796|NCT02520011|593720192|FG001|Overall Study|Patient went to hospice|1|||
164366797|NCT02520011|593720193|FG002|Overall Study|Patient went to hospice|0|||
164366798|NCT02520011|593720191|FG000|Overall Study|Progressive disease following response|0|||
164366799|NCT02520011|593720192|FG001|Overall Study|Progressive disease following response|4|||
164366800|NCT02520011|593720193|FG002|Overall Study|Progressive disease following response|2|||
164366801|NCT00644969|593720194|FG000|Treatment Phase|Randomized, not treated|1|||
164012310|NCT02927171|592408697|FG001|Overall Study|Lost to Follow-up|1|||
164366802|NCT00644969|593720195|FG001|Treatment Phase|Randomized, not treated|0|||
164366803|NCT00644969|593720194|FG000|Treatment Phase|Adverse Event|3|||
164366804|NCT00644969|593720195|FG001|Treatment Phase|Adverse Event|0|||
164366805|NCT00644969|593720194|FG000|Treatment Phase|Withdrawal by Subject|4|||
164366806|NCT00644969|593720195|FG001|Treatment Phase|Withdrawal by Subject|0|||
164366807|NCT00644969|593720194|FG000|Treatment Phase|Lost to Follow-up|2|||
164366808|NCT00644969|593720195|FG001|Treatment Phase|Lost to Follow-up|2|||
164366809|NCT00644969|593720194|FG000|Treatment Phase|Other|4|||
164366810|NCT00644969|593720195|FG001|Treatment Phase|Other|1|||
164366811|NCT00644969|593720194|FG000|Post Treatment Phase|Death|1|||
164366812|NCT00644969|593720195|FG001|Post Treatment Phase|Death|0|||
164366813|NCT00644969|593720194|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
164366814|NCT00644969|593720195|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
164366815|NCT00644969|593720194|FG000|Post Treatment Phase|Lost to Follow-up|4|||
164366816|NCT00644969|593720195|FG001|Post Treatment Phase|Lost to Follow-up|1|||
164366817|NCT00644969|593720194|FG000|Post Treatment Phase|Other|1|||
164366818|NCT00644969|593720195|FG001|Post Treatment Phase|Other|0|||
164366819|NCT00997503|593720201|FG000|Overall Study|Death|53|||
164366820|NCT00997503|593720201|FG000|Overall Study|Withdrawal by Subject|76|||
164366821|NCT00997503|593720201|FG000|Overall Study|Lost to Follow-up|33|||
164366822|NCT00997503|593720201|FG000|Overall Study|Adverse Event|3|||
164366823|NCT00997503|593720201|FG000|Overall Study|Physician Decision|10|||
164366824|NCT00997503|593720201|FG000|Overall Study|Missed 12-month follow-up|85|||
164366825|NCT00997503|593720201|FG000|Overall Study|Other reason|13|||
164366826|NCT01933048|593720202|FG000|Overall Study|Lost to Follow-up|15|||
164366827|NCT01933048|593720203|FG001|Overall Study|Lost to Follow-up|18|||
164366828|NCT01933048|593720202|FG000|Overall Study|personal reasons|1|||
164366829|NCT01933048|593720203|FG001|Overall Study|personal reasons|1|||
164366830|NCT01933048|593720202|FG000|Overall Study|Protocol Violation|7|||
164366831|NCT01933048|593720203|FG001|Overall Study|Protocol Violation|8|||
164366832|NCT01933048|593720202|FG000|Overall Study|Physician Decision|1|||
164366833|NCT01933048|593720203|FG001|Overall Study|Physician Decision|0|||
164366834|NCT01933048|593720202|FG000|Overall Study|unknown reasons|1|||
164366835|NCT01933048|593720203|FG001|Overall Study|unknown reasons|1|||
164366836|NCT02780804|593720207|FG000|Overall Study|Death|1|||
164366837|NCT02780804|593720208|FG001|Overall Study|Death|0|||
164366838|NCT02780804|593720209|FG002|Overall Study|Death|0|||
164366839|NCT02780804|593720207|FG000|Overall Study|Lack of Efficacy|5|||
164366840|NCT02780804|593720208|FG001|Overall Study|Lack of Efficacy|8|||
164366841|NCT02780804|593720209|FG002|Overall Study|Lack of Efficacy|4|||
164366842|NCT02780804|593720207|FG000|Overall Study|Physician Decision|0|||
164366843|NCT02780804|593720208|FG001|Overall Study|Physician Decision|0|||
164366844|NCT02780804|593720209|FG002|Overall Study|Physician Decision|2|||
164366845|NCT02780804|593720207|FG000|Overall Study|Withdrawal by Subject|0|||
164366846|NCT02780804|593720208|FG001|Overall Study|Withdrawal by Subject|1|||
164366847|NCT02780804|593720209|FG002|Overall Study|Withdrawal by Subject|0|||
164366848|NCT02476968|593720210|FG000|Overall Study|Other|0|||
164366849|NCT02476968|593720211|FG001|Overall Study|Other|2|||
164366850|NCT02476968|593720212|FG002|Overall Study|Other|0|||
164366851|NCT02476968|593720210|FG000|Overall Study|Lost to Follow-up|10|||
164366852|NCT02476968|593720211|FG001|Overall Study|Lost to Follow-up|0|||
164366853|NCT02476968|593720212|FG002|Overall Study|Lost to Follow-up|1|||
164366854|NCT02476968|593720210|FG000|Overall Study|Death|48|||
164366855|NCT02476968|593720211|FG001|Overall Study|Death|8|||
164366856|NCT02476968|593720212|FG002|Overall Study|Death|1|||
164366857|NCT02476968|593720210|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164366858|NCT02476968|593720211|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164366859|NCT02476968|593720212|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164366860|NCT02476968|593720210|FG000|Overall Study|Patient decision|37|||
164366861|NCT02476968|593720211|FG001|Overall Study|Patient decision|8|||
164366862|NCT02476968|593720212|FG002|Overall Study|Patient decision|0|||
164366863|NCT04171414|593720222|FG000|Overall Study|Death|1|||
164366864|NCT04171414|593720222|FG000|Overall Study|Withdrawal by Subject|1|||
164366865|NCT01714310|593720223|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
164366866|NCT01714310|593720224|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
164366867|NCT01714310|593720225|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
164366868|NCT01714310|593720223|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
164366869|NCT01714310|593720224|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
164366870|NCT01714310|593720225|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
164366871|NCT01714310|593720223|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
164366872|NCT01714310|593720224|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
164366873|NCT01714310|593720225|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
164366874|NCT01714310|593720223|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
164366875|NCT01714310|593720224|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
164366876|NCT01714310|593720225|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
164366877|NCT02487394|593720226|FG000|Phase 1|Withdrawal by Subject|0|||
164366878|NCT02487394|593720227|FG001|Phase 1|Withdrawal by Subject|1|||
164366879|NCT01641367|593720228|FG000|Cohorts|Death|18|||
164366880|NCT01641367|593720229|FG001|Cohorts|Death|1|||
164366881|NCT01641367|593720230|FG002|Cohorts|Death|2|||
164366882|NCT01641367|593720231|FG003|Cohorts|Death|0|||
164366883|NCT01641367|593720232|FG004|Cohorts|Death|1|||
164366884|NCT01641367|593720233|FG005|Cohorts|Death|1|||
164366885|NCT01641367|593720234|FG006|Cohorts|Death|0|||
164366886|NCT01641367|593720235|FG007|Cohorts|Death|0|||
164366887|NCT01641367|593720228|FG000|Cohorts|Lost to Follow-up|16|||
164366888|NCT01641367|593720229|FG001|Cohorts|Lost to Follow-up|0|||
164366889|NCT01641367|593720230|FG002|Cohorts|Lost to Follow-up|2|||
164366890|NCT01641367|593720231|FG003|Cohorts|Lost to Follow-up|0|||
164366891|NCT01641367|593720232|FG004|Cohorts|Lost to Follow-up|2|||
164366892|NCT01641367|593720233|FG005|Cohorts|Lost to Follow-up|0|||
164366893|NCT01641367|593720234|FG006|Cohorts|Lost to Follow-up|0|||
164366894|NCT01641367|593720235|FG007|Cohorts|Lost to Follow-up|0|||
164366895|NCT01641367|593720228|FG000|Randomized Adherence Intervention|Death|0|||
164366896|NCT01641367|593720229|FG001|Randomized Adherence Intervention|Death|0|||
164366897|NCT01641367|593720230|FG002|Randomized Adherence Intervention|Death|0|||
164366898|NCT01641367|593720231|FG003|Randomized Adherence Intervention|Death|0|||
164366899|NCT01641367|593720232|FG004|Randomized Adherence Intervention|Death|0|||
164366900|NCT01641367|593720233|FG005|Randomized Adherence Intervention|Death|0|||
164366901|NCT01641367|593720234|FG006|Randomized Adherence Intervention|Death|11|||
164366902|NCT01641367|593720235|FG007|Randomized Adherence Intervention|Death|12|||
164366903|NCT01641367|593720228|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366904|NCT01641367|593720229|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366905|NCT01641367|593720230|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366906|NCT01641367|593720231|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366907|NCT01641367|593720232|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366908|NCT01641367|593720233|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
164366909|NCT01641367|593720234|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
164366910|NCT01641367|593720235|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
164366911|NCT00218296|593720238|FG000|Overall Study|Lost to Follow-up|9|||
164366912|NCT00218296|593720239|FG001|Overall Study|Lost to Follow-up|7|||
164366913|NCT00218296|593720238|FG000|Overall Study|Withdrawal by Subject|36|||
164366914|NCT00218296|593720239|FG001|Overall Study|Withdrawal by Subject|47|||
164366915|NCT00218296|593720238|FG000|Overall Study|Randomized but did not enter treatment|66|||
164366916|NCT00218296|593720239|FG001|Overall Study|Randomized but did not enter treatment|67|||
164366917|NCT04064294|593720250|FG000|Overall Study|Adverse Event|1|||
164366918|NCT04064294|593720251|FG001|Overall Study|Adverse Event|0|||
164366919|NCT04064294|593720252|FG002|Overall Study|Adverse Event|0|||
164366920|NCT01289847|593720254|FG000|Overall Study|Patient could not comply with visits|1|||
164366921|NCT00006478|593720265|FG000|Overall Study|Vaccine could not be produced|1|||
164366922|NCT00006478|593720265|FG000|Overall Study|Physician Decision|6|||
164366923|NCT03161483|593720268|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
164366924|NCT03161483|593720269|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
164366925|NCT03161483|593720270|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
164366926|NCT03161483|593720271|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
164366927|NCT03161483|593720268|FG000|Treatment Period|Death|1|||
164366928|NCT03161483|593720269|FG001|Treatment Period|Death|0|||
164366929|NCT03161483|593720270|FG002|Treatment Period|Death|0|||
164366930|NCT03161483|593720271|FG003|Treatment Period|Death|0|||
164366931|NCT03161483|593720268|FG000|Treatment Period|Adverse Event|5|||
164366932|NCT03161483|593720269|FG001|Treatment Period|Adverse Event|2|||
164366933|NCT03161483|593720270|FG002|Treatment Period|Adverse Event|1|||
164366934|NCT03161483|593720271|FG003|Treatment Period|Adverse Event|11|||
164366935|NCT03161483|593720268|FG000|Treatment Period|Pregnancy|1|||
164366936|NCT03161483|593720269|FG001|Treatment Period|Pregnancy|0|||
164366937|NCT03161483|593720270|FG002|Treatment Period|Pregnancy|0|||
164366938|NCT03161483|593720271|FG003|Treatment Period|Pregnancy|0|||
164366939|NCT03161483|593720268|FG000|Treatment Period|Lack of Efficacy|0|||
164366940|NCT03161483|593720269|FG001|Treatment Period|Lack of Efficacy|0|||
164366941|NCT03161483|593720270|FG002|Treatment Period|Lack of Efficacy|0|||
164366942|NCT03161483|593720271|FG003|Treatment Period|Lack of Efficacy|1|||
164092709|NCT00911859|592702113|FG000|Follow-up Period|Lost to Follow-up|1|||
164366943|NCT03161483|593720268|FG000|Treatment Period|Withdrawal by Subject|2|||
164366944|NCT03161483|593720269|FG001|Treatment Period|Withdrawal by Subject|5|||
164092710|NCT00911859|592702114|FG001|Follow-up Period|Lost to Follow-up|1|||
164366945|NCT03161483|593720270|FG002|Treatment Period|Withdrawal by Subject|2|||
164366946|NCT03161483|593720271|FG003|Treatment Period|Withdrawal by Subject|6|||
164366947|NCT03161483|593720268|FG000|Treatment Period|Lost to Follow-up|0|||
164366948|NCT03161483|593720269|FG001|Treatment Period|Lost to Follow-up|0|||
164366949|NCT03161483|593720270|FG002|Treatment Period|Lost to Follow-up|0|||
164366950|NCT03161483|593720271|FG003|Treatment Period|Lost to Follow-up|1|||
164366951|NCT03161483|593720268|FG000|Treatment Period|Protocol Violation|0|||
164366952|NCT03161483|593720269|FG001|Treatment Period|Protocol Violation|0|||
164366953|NCT03161483|593720270|FG002|Treatment Period|Protocol Violation|0|||
164366954|NCT03161483|593720271|FG003|Treatment Period|Protocol Violation|1|||
164366955|NCT03161483|593720268|FG000|Treatment Period|Other reasons|1|||
164366956|NCT03161483|593720269|FG001|Treatment Period|Other reasons|1|||
164366957|NCT03161483|593720270|FG002|Treatment Period|Other reasons|0|||
164366958|NCT03161483|593720271|FG003|Treatment Period|Other reasons|0|||
164366959|NCT00600756|593720276|FG000|Analysis After 6 Months|Adverse Event|43|||
164366960|NCT00600756|593720277|FG001|Analysis After 6 Months|Adverse Event|33|||
164366961|NCT00600756|593720276|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
164366962|NCT00600756|593720277|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
164366963|NCT00600756|593720276|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
164366964|NCT00600756|593720277|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
164366965|NCT00600756|593720276|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
164366966|NCT00600756|593720277|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
164366967|NCT00600756|593720276|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
164366968|NCT00600756|593720277|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
164366969|NCT00600756|593720276|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
164366970|NCT00600756|593720277|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
164366971|NCT00600756|593720276|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
164366972|NCT00600756|593720277|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
164366973|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
164366974|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
164366975|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
164366976|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
164366977|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
164366978|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
164366979|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
164366980|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
164366981|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
164366982|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
164366983|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
164366984|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
164366985|NCT00600756|593720276|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
164366986|NCT00600756|593720277|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
164366987|NCT04753164|593720278|FG000|Overall Study|Adverse Event|0|||
164366988|NCT04753164|593720279|FG001|Overall Study|Adverse Event|2|||
164366989|NCT04753164|593720278|FG000|Overall Study|Withdrawal by Subject|9|||
164366990|NCT04753164|593720279|FG001|Overall Study|Withdrawal by Subject|7|||
164366991|NCT04753164|593720278|FG000|Overall Study|Lost to Follow-up|6|||
164366992|NCT04753164|593720279|FG001|Overall Study|Lost to Follow-up|6|||
164366993|NCT04753164|593720278|FG000|Overall Study|Other|12|||
164366994|NCT04753164|593720279|FG001|Overall Study|Other|5|||
164366995|NCT00694369|593720280|FG000|Overall Study|Adverse Event|0|||
164366996|NCT00694369|593720281|FG001|Overall Study|Adverse Event|1|||
164366997|NCT00694369|593720282|FG002|Overall Study|Adverse Event|0|||
164366998|NCT00694369|593720283|FG003|Overall Study|Adverse Event|1|||
164366999|NCT00694369|593720284|FG004|Overall Study|Adverse Event|3|||
164367000|NCT00694369|593720280|FG000|Overall Study|Lost to Follow-up|0|||
164367001|NCT00694369|593720281|FG001|Overall Study|Lost to Follow-up|0|||
164367002|NCT00694369|593720282|FG002|Overall Study|Lost to Follow-up|1|||
164367003|NCT00694369|593720283|FG003|Overall Study|Lost to Follow-up|1|||
164367004|NCT00694369|593720284|FG004|Overall Study|Lost to Follow-up|0|||
164367005|NCT00694369|593720280|FG000|Overall Study|Physician Decision|0|||
164367006|NCT00694369|593720281|FG001|Overall Study|Physician Decision|0|||
164367007|NCT00694369|593720282|FG002|Overall Study|Physician Decision|0|||
164367008|NCT00694369|593720283|FG003|Overall Study|Physician Decision|0|||
164367009|NCT00694369|593720284|FG004|Overall Study|Physician Decision|1|||
164367010|NCT00694369|593720280|FG000|Overall Study|Protocol Violation|0|||
164367011|NCT00694369|593720281|FG001|Overall Study|Protocol Violation|1|||
164367012|NCT00694369|593720282|FG002|Overall Study|Protocol Violation|0|||
164367013|NCT00694369|593720283|FG003|Overall Study|Protocol Violation|0|||
164367014|NCT00694369|593720284|FG004|Overall Study|Protocol Violation|0|||
164367015|NCT00694369|593720280|FG000|Overall Study|Withdrawal by Subject|1|||
164367016|NCT00694369|593720281|FG001|Overall Study|Withdrawal by Subject|1|||
164367017|NCT00694369|593720282|FG002|Overall Study|Withdrawal by Subject|1|||
164367018|NCT00694369|593720283|FG003|Overall Study|Withdrawal by Subject|1|||
164367019|NCT00694369|593720284|FG004|Overall Study|Withdrawal by Subject|2|||
164092711|NCT00911859|592702115|FG002|Follow-up Period|Lost to Follow-up|0|||
164367020|NCT00439556|593720285|FG000|Overall Study|Patient was taken off study for non-comp|0|||
164092712|NCT00911859|592702113|FG000|Follow-up Period|Withdrawal by Subject|0|||
164367021|NCT00439556|593720286|FG001|Overall Study|Patient was taken off study for non-comp|1|||
164367022|NCT00439556|593720287|FG002|Overall Study|Patient was taken off study for non-comp|0|||
164367023|NCT02871739|593720288|FG000|Overall Study|Lost to Follow-up|3|||
164092713|NCT00911859|592702114|FG001|Follow-up Period|Withdrawal by Subject|4|||
164092714|NCT00911859|592702115|FG002|Follow-up Period|Withdrawal by Subject|4|||
164367024|NCT02871739|593720289|FG001|Overall Study|Lost to Follow-up|2|||
164367025|NCT02871739|593720290|FG002|Overall Study|Lost to Follow-up|0|||
164367026|NCT02871739|593720291|FG003|Overall Study|Lost to Follow-up|2|||
164367027|NCT01324388|593720294|FG000|Part 1 of Study|Adverse Event|2|||
164367028|NCT01324388|593720295|FG001|Part 1 of Study|Adverse Event|0|||
164367029|NCT01324388|593720296|FG002|Part 1 of Study|Adverse Event|0|||
164367030|NCT01324388|593720297|FG003|Part 1 of Study|Adverse Event|0|||
164367031|NCT01324388|593720294|FG000|Part 1 of Study|Protocol Violation|1|||
164367032|NCT01324388|593720295|FG001|Part 1 of Study|Protocol Violation|2|||
164367033|NCT01324388|593720296|FG002|Part 1 of Study|Protocol Violation|0|||
164367034|NCT01324388|593720297|FG003|Part 1 of Study|Protocol Violation|0|||
164367035|NCT01324388|593720294|FG000|Part 1 of Study|Physician Decision|1|||
164367036|NCT01324388|593720295|FG001|Part 1 of Study|Physician Decision|0|||
164367037|NCT01324388|593720296|FG002|Part 1 of Study|Physician Decision|0|||
164367038|NCT01324388|593720297|FG003|Part 1 of Study|Physician Decision|0|||
164367039|NCT01324388|593720294|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
164367040|NCT01324388|593720295|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
164367041|NCT01324388|593720296|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
164367042|NCT01324388|593720297|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
164367043|NCT01324388|593720294|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
164367044|NCT01324388|593720295|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
164367045|NCT01324388|593720296|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
164367046|NCT01324388|593720297|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
164367047|NCT01405963|593720298|FG000|Overall Study|Moved Away|2|||
164367048|NCT01405963|593720299|FG001|Overall Study|Moved Away|0|||
164367049|NCT01405963|593720298|FG000|Overall Study|Adverse Event|0|||
164367050|NCT01405963|593720299|FG001|Overall Study|Adverse Event|1|||
164367051|NCT01405963|593720298|FG000|Overall Study|Lost to Follow-up|0|||
164367052|NCT01405963|593720299|FG001|Overall Study|Lost to Follow-up|1|||
164367053|NCT00850395|593720306|FG000|Overall Study|Death|1|||
164367054|NCT00850395|593720306|FG000|Overall Study|Adverse Event|1|||
164367055|NCT00850395|593720306|FG000|Overall Study|Insufficient clinical response|3|||
164367056|NCT00850395|593720306|FG000|Overall Study|Other|5|||
164367057|NCT01737047|593720307|FG000|Overall Study|Death|10|||
164367058|NCT01737047|593720308|FG001|Overall Study|Death|0|||
164367059|NCT01737047|593720309|FG002|Overall Study|Death|1|||
164367060|NCT01737047|593720307|FG000|Overall Study|Withdrawal by Subject|17|||
164367061|NCT01737047|593720308|FG001|Overall Study|Withdrawal by Subject|11|||
164367062|NCT01737047|593720309|FG002|Overall Study|Withdrawal by Subject|4|||
164367063|NCT02802592|593720310|FG000|Overall Study|Study terminated due to loss of funding|4|||
164367064|NCT04007523|593720311|FG000|Overall Study|Withdrawal by Subject|0|||
164367065|NCT04007523|593720312|FG001|Overall Study|Withdrawal by Subject|1|||
164367066|NCT04007523|593720313|FG002|Overall Study|Withdrawal by Subject|1|||
164367067|NCT04007523|593720314|FG003|Overall Study|Withdrawal by Subject|0|||
164367068|NCT04007523|593720311|FG000|Overall Study|ICU Transfer|0|||
164367069|NCT04007523|593720312|FG001|Overall Study|ICU Transfer|1|||
164367070|NCT04007523|593720313|FG002|Overall Study|ICU Transfer|0|||
164367071|NCT04007523|593720314|FG003|Overall Study|ICU Transfer|0|||
164367072|NCT04007523|593720311|FG000|Overall Study|COVID hospital closure|0|||
164367073|NCT04007523|593720312|FG001|Overall Study|COVID hospital closure|0|||
164367074|NCT04007523|593720313|FG002|Overall Study|COVID hospital closure|1|||
164367075|NCT04007523|593720314|FG003|Overall Study|COVID hospital closure|2|||
164367076|NCT04007523|593720311|FG000|Overall Study|Surgery cancelled|0|||
164367077|NCT04007523|593720312|FG001|Overall Study|Surgery cancelled|0|||
164367078|NCT04007523|593720313|FG002|Overall Study|Surgery cancelled|1|||
164367079|NCT04007523|593720314|FG003|Overall Study|Surgery cancelled|1|||
164367080|NCT01826487|593720315|FG000|Overall Study|Adverse Event|1|||
164367081|NCT01826487|593720316|FG001|Overall Study|Adverse Event|1|||
164367082|NCT01826487|593720315|FG000|Overall Study|Lost to Follow-up|1|||
164367083|NCT01826487|593720316|FG001|Overall Study|Lost to Follow-up|0|||
164367084|NCT01826487|593720315|FG000|Overall Study|Withdrawal by Subject|1|||
164367085|NCT01826487|593720316|FG001|Overall Study|Withdrawal by Subject|3|||
164367086|NCT01826487|593720315|FG000|Overall Study|Protocol Violation|1|||
164012311|NCT04530825|592408700|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
164367087|NCT01826487|593720316|FG001|Overall Study|Protocol Violation|1|||
164367088|NCT01408030|593720317|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
164367089|NCT01408030|593720318|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
164367090|NCT01408030|593720319|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
164367091|NCT01408030|593720320|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
164367092|NCT01408030|593720317|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
164367093|NCT01408030|593720318|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
164367094|NCT01408030|593720319|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
164367095|NCT01408030|593720320|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
164367096|NCT01408030|593720317|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
164367097|NCT01408030|593720318|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
164367098|NCT01408030|593720319|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
164367099|NCT01408030|593720320|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
164367100|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
164367101|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
164367102|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
164367103|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
164367104|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
164367105|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
164367106|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
164367107|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
164367108|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
164367109|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
164367110|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
164367111|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
164367112|NCT01408030|593720317|FG000|Observation Phase (Off Drug)|Other|1|||
164367113|NCT01408030|593720318|FG001|Observation Phase (Off Drug)|Other|1|||
164367114|NCT01408030|593720319|FG002|Observation Phase (Off Drug)|Other|1|||
164367115|NCT01408030|593720320|FG003|Observation Phase (Off Drug)|Other|1|||
164367116|NCT03608774|593720322|FG000|Overall Study|Lost to Follow-up|5|||
164367117|NCT03608774|593720323|FG001|Overall Study|Lost to Follow-up|5|||
164367118|NCT03608774|593720322|FG000|Overall Study|Withdrawal by Subject|1|||
164367119|NCT03608774|593720323|FG001|Overall Study|Withdrawal by Subject|0|||
164367120|NCT03608774|593720322|FG000|Overall Study|Protocol Violation|1|||
164367121|NCT03608774|593720323|FG001|Overall Study|Protocol Violation|0|||
164367122|NCT03608774|593720322|FG000|Overall Study|Not eligible at enrollment|0|||
164367123|NCT03608774|593720323|FG001|Overall Study|Not eligible at enrollment|1|||
164367124|NCT03608774|593720322|FG000|Overall Study|Health related event|0|||
164367125|NCT03608774|593720323|FG001|Overall Study|Health related event|1|||
164367126|NCT01586819|593720324|FG000|Overall Study|Withdrawal by Subject|1|||
164367127|NCT01586819|593720325|FG001|Overall Study|Withdrawal by Subject|0|||
164367128|NCT04837131|593720326|FG000|Overall Study|Death|1|||
164367129|NCT04837131|593720326|FG000|Overall Study|Withdrawal by Subject|1|||
164367130|NCT04837131|593720326|FG000|Overall Study|Adverse Event|1|||
164367131|NCT04837131|593720326|FG000|Overall Study|Protocol Violation|1|||
164367132|NCT04439318|593720327|FG000|Overall Study|Ineligible|1|||
164367133|NCT04439318|593720327|FG000|Overall Study|Never Started Treatment|3|||
164367134|NCT04439318|593720327|FG000|Overall Study|Adverse Event|10|||
164367135|NCT04439318|593720327|FG000|Overall Study|Death|2|||
164367136|NCT04439318|593720327|FG000|Overall Study|Disease Progression|25|||
164367137|NCT04439318|593720327|FG000|Overall Study|Other Complicating Disease|2|||
164367138|NCT04439318|593720327|FG000|Overall Study|Withdrawal by Subject|4|||
164367139|NCT04439318|593720327|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
164367140|NCT04439318|593720327|FG000|Overall Study|Non-Compliance|1|||
164367141|NCT04439318|593720327|FG000|Overall Study|Still on Treatment|1|||
164367142|NCT00409617|593721817|FG000|Overall Study|Adverse Event|57|||
164367143|NCT00409617|593721817|FG000|Overall Study|Lack of Efficacy|54|||
164367144|NCT00409617|593721817|FG000|Overall Study|Lost to Follow-up|2|||
164367145|NCT00409617|593721817|FG000|Overall Study|Protocol Violation|24|||
164367146|NCT00409617|593721817|FG000|Overall Study|Withdrawal by Subject|8|||
164367147|NCT00409617|593721817|FG000|Overall Study|Administrative reasons|1|||
164367148|NCT00409617|593721817|FG000|Overall Study|Not described|14|||
164367149|NCT00149747|593721828|FG000|Overall Study|Death|1|||
164367150|NCT00149747|593721829|FG001|Overall Study|Death|0|||
164367151|NCT00149747|593721828|FG000|Overall Study|Withdrawal by Subject|3|||
164367152|NCT00149747|593721829|FG001|Overall Study|Withdrawal by Subject|3|||
164367153|NCT02689258|593721830|FG000|Overall Study|Subject Non-Compliance|0|||
164367154|NCT02689258|593721831|FG001|Overall Study|Subject Non-Compliance|1|||
164367155|NCT02689258|593721832|FG002|Overall Study|Subject Non-Compliance|0|||
164367156|NCT02689258|593721833|FG003|Overall Study|Subject Non-Compliance|0|||
164367157|NCT02689258|593721834|FG004|Overall Study|Subject Non-Compliance|0|||
164367158|NCT02689258|593721835|FG005|Overall Study|Subject Non-Compliance|0|||
164367159|NCT02689258|593721836|FG006|Overall Study|Subject Non-Compliance|0|||
164367160|NCT02689258|593721837|FG007|Overall Study|Subject Non-Compliance|0|||
164367161|NCT02689258|593721838|FG008|Overall Study|Subject Non-Compliance|0|||
164367162|NCT02689258|593721839|FG009|Overall Study|Subject Non-Compliance|0|||
164367163|NCT02689258|593721840|FG010|Overall Study|Subject Non-Compliance|0|||
164367164|NCT02689258|593721841|FG011|Overall Study|Subject Non-Compliance|0|||
164367165|NCT02689258|593721830|FG000|Overall Study|Subject Refusal to Continue|0|||
164367166|NCT02689258|593721831|FG001|Overall Study|Subject Refusal to Continue|1|||
164367167|NCT02689258|593721832|FG002|Overall Study|Subject Refusal to Continue|0|||
164367168|NCT02689258|593721833|FG003|Overall Study|Subject Refusal to Continue|0|||
164367169|NCT02689258|593721834|FG004|Overall Study|Subject Refusal to Continue|0|||
164367170|NCT02689258|593721835|FG005|Overall Study|Subject Refusal to Continue|0|||
164367171|NCT02689258|593721836|FG006|Overall Study|Subject Refusal to Continue|0|||
164367172|NCT02689258|593721837|FG007|Overall Study|Subject Refusal to Continue|0|||
164367173|NCT02689258|593721838|FG008|Overall Study|Subject Refusal to Continue|1|||
164367174|NCT02689258|593721839|FG009|Overall Study|Subject Refusal to Continue|0|||
164367175|NCT02689258|593721840|FG010|Overall Study|Subject Refusal to Continue|0|||
164367176|NCT02689258|593721841|FG011|Overall Study|Subject Refusal to Continue|1|||
164367177|NCT02689258|593721830|FG000|Overall Study|Other|0|||
164367178|NCT02689258|593721831|FG001|Overall Study|Other|2|||
164367179|NCT02689258|593721832|FG002|Overall Study|Other|0|||
164367180|NCT02689258|593721833|FG003|Overall Study|Other|0|||
164367181|NCT02689258|593721834|FG004|Overall Study|Other|1|||
164367182|NCT02689258|593721835|FG005|Overall Study|Other|0|||
164367183|NCT02689258|593721836|FG006|Overall Study|Other|0|||
164367184|NCT02689258|593721837|FG007|Overall Study|Other|0|||
164367185|NCT02689258|593721838|FG008|Overall Study|Other|1|||
164367186|NCT02689258|593721839|FG009|Overall Study|Other|0|||
164367187|NCT02689258|593721840|FG010|Overall Study|Other|0|||
164367188|NCT02689258|593721841|FG011|Overall Study|Other|0|||
164367189|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
164367190|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
164367191|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
164367192|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
164367193|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
164367194|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
164367195|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
164367196|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164367197|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164367198|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
164367199|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
164367200|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
164367201|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
164367202|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
164367203|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
164367204|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
164367205|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367206|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367207|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367208|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
164367209|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
164367210|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
164367211|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
164367212|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
164367213|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
164367214|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367215|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
164367216|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367217|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367218|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
164367219|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367220|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367221|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367222|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
164367223|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
164367224|NCT03373383|593721842|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
164367225|NCT03373383|593721843|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
164367226|NCT03373383|593721844|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
164367227|NCT03373383|593721845|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
164367228|NCT03373383|593721846|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
164367229|NCT03373383|593721842|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
164367230|NCT03373383|593721843|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367231|NCT03373383|593721844|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367232|NCT03373383|593721845|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367233|NCT03373383|593721846|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
164367234|NCT02159521|593721848|FG000|Overall Study|Enrolled but not treated|3|||
164367235|NCT02159521|593721848|FG000|Overall Study|Withdrawal by Subject|7|||
164367236|NCT02159521|593721848|FG000|Overall Study|Lost to Follow-up|6|||
164367237|NCT02159521|593721848|FG000|Overall Study|Death|1|||
164367238|NCT02159521|593721848|FG000|Overall Study|Other than specified|1|||
164367239|NCT00907374|593721851|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
164367240|NCT00907374|593721852|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
164367241|NCT03818516|593721853|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
164367242|NCT00594464|593721854|FG000|Overall Study|Withdrawal by Subject|1|||
164367243|NCT00594464|593721854|FG000|Overall Study|Delay in operation|2|||
164367244|NCT00785486|593721855|FG000|Midazolam Alone|Withdrawal by Subject|1|||
164367245|NCT02907359|593721862|FG000|Overall Study|Death|234|||
164367246|NCT02907359|593721863|FG001|Overall Study|Death|117|||
164367247|NCT02907359|593721862|FG000|Overall Study|Withdrawal by Subject|6|||
164367248|NCT02907359|593721863|FG001|Overall Study|Withdrawal by Subject|11|||
164367249|NCT02907359|593721862|FG000|Overall Study|Lost to Follow-up|1|||
164367250|NCT02907359|593721863|FG001|Overall Study|Lost to Follow-up|0|||
164367251|NCT00746941|593721866|FG000|Overall Study|Death|2|||
164367252|NCT00746941|593721867|FG001|Overall Study|Death|0|||
164367253|NCT00746941|593721868|FG002|Overall Study|Death|0|||
164367254|NCT00746941|593721869|FG003|Overall Study|Death|6|||
164367255|NCT00746941|593721866|FG000|Overall Study|Physician Decision|0|||
164367256|NCT00746941|593721867|FG001|Overall Study|Physician Decision|0|||
164367257|NCT00746941|593721868|FG002|Overall Study|Physician Decision|2|||
164367258|NCT00746941|593721869|FG003|Overall Study|Physician Decision|0|||
164367259|NCT00746941|593721866|FG000|Overall Study|Withdrawal by Subject|3|||
164367260|NCT00746941|593721867|FG001|Overall Study|Withdrawal by Subject|0|||
164367261|NCT00746941|593721868|FG002|Overall Study|Withdrawal by Subject|0|||
164367262|NCT00746941|593721869|FG003|Overall Study|Withdrawal by Subject|2|||
164367263|NCT00746941|593721866|FG000|Overall Study|Other, reason not provided|2|||
164367264|NCT00746941|593721867|FG001|Overall Study|Other, reason not provided|4|||
164367265|NCT00746941|593721868|FG002|Overall Study|Other, reason not provided|0|||
164367266|NCT00746941|593721869|FG003|Overall Study|Other, reason not provided|4|||
164367267|NCT00746941|593721866|FG000|Overall Study|Adverse Event|0|||
164367268|NCT00746941|593721867|FG001|Overall Study|Adverse Event|0|||
164367269|NCT00746941|593721868|FG002|Overall Study|Adverse Event|0|||
164367270|NCT00746941|593721869|FG003|Overall Study|Adverse Event|1|||
164367271|NCT01524692|593721877|FG000|Overall Study|Withdrawal by Subject|3|||
164367272|NCT01709695|593721879|FG000|Overall Study|Withdrawal by Subject|1|||
164367273|NCT01709695|593721880|FG001|Overall Study|Withdrawal by Subject|1|||
164367274|NCT03065244|593721884|FG000|Overall Study|Lost to Follow-up|1|||
164367275|NCT03065244|593721885|FG001|Overall Study|Lost to Follow-up|1|||
164367276|NCT03065244|593721884|FG000|Overall Study|Diagnosed with a different disease|1|||
164367277|NCT03065244|593721885|FG001|Overall Study|Diagnosed with a different disease|1|||
164367278|NCT03065244|593721884|FG000|Overall Study|Protocol Violation|0|||
164367279|NCT03065244|593721885|FG001|Overall Study|Protocol Violation|1|||
164367280|NCT03065244|593721884|FG000|Overall Study|Withdrawal by Subject|1|||
164367281|NCT03065244|593721885|FG001|Overall Study|Withdrawal by Subject|1|||
164367282|NCT03717480|593721886|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
164367283|NCT01894152|593721887|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
164367284|NCT02741700|593721888|FG000|Overall Study|Lost to Follow-up|17|||
164367285|NCT02741700|593721889|FG001|Overall Study|Lost to Follow-up|8|||
164367286|NCT02741700|593721888|FG000|Overall Study|Withdrawal by Subject|2|||
164367287|NCT02741700|593721889|FG001|Overall Study|Withdrawal by Subject|5|||
164367288|NCT02741700|593721888|FG000|Overall Study|Physician Decision|3|||
164367289|NCT02741700|593721889|FG001|Overall Study|Physician Decision|0|||
164367290|NCT02741700|593721888|FG000|Overall Study|Moved out of State|0|||
164367291|NCT02741700|593721889|FG001|Overall Study|Moved out of State|1|||
164367292|NCT02741700|593721888|FG000|Overall Study|Death|4|||
164367293|NCT02741700|593721889|FG001|Overall Study|Death|5|||
164367294|NCT01774786|593721891|FG000|Overall Study|Death|300|||
164367295|NCT01774786|593721892|FG001|Overall Study|Death|319|||
164367296|NCT01774786|593721891|FG000|Overall Study|Lost to Follow-up|6|||
164367297|NCT01774786|593721892|FG001|Overall Study|Lost to Follow-up|7|||
164367298|NCT01774786|593721891|FG000|Overall Study|Withdrawal by Subject|18|||
164367299|NCT01774786|593721892|FG001|Overall Study|Withdrawal by Subject|14|||
164367300|NCT01774786|593721891|FG000|Overall Study|Physician Decision|2|||
164367301|NCT01774786|593721892|FG001|Overall Study|Physician Decision|0|||
164367302|NCT01774786|593721891|FG000|Overall Study|Non-compliance|0|||
164367303|NCT01774786|593721892|FG001|Overall Study|Non-compliance|1|||
164367304|NCT01774786|593721891|FG000|Overall Study|Reason Not Specified|2|||
164367305|NCT01774786|593721892|FG001|Overall Study|Reason Not Specified|5|||
164367306|NCT00075582|593721893|FG000|Overall Study|Adverse Event|3|||
164367307|NCT00075582|593721894|FG001|Overall Study|Adverse Event|1|||
164367308|NCT00075582|593721893|FG000|Overall Study|Lack of Efficacy|4|||
164367309|NCT00075582|593721894|FG001|Overall Study|Lack of Efficacy|8|||
164367310|NCT00075582|593721893|FG000|Overall Study|Physician Decision|5|||
164367311|NCT00075582|593721894|FG001|Overall Study|Physician Decision|8|||
164367312|NCT00075582|593721893|FG000|Overall Study|Withdrawal by Subject|2|||
164367313|NCT00075582|593721894|FG001|Overall Study|Withdrawal by Subject|2|||
164367314|NCT00075582|593721893|FG000|Overall Study|Ineligible for study|36|||
164367315|NCT00075582|593721894|FG001|Overall Study|Ineligible for study|16|||
164367316|NCT04544293|593721895|FG000|Double-blind|Adverse Event|2|||
164367317|NCT04544293|593721896|FG001|Double-blind|Adverse Event|1|||
164367318|NCT04544293|593721895|FG000|Double-blind|Pregnancy|0|||
164367319|NCT04544293|593721896|FG001|Double-blind|Pregnancy|1|||
164367320|NCT04544293|593721895|FG000|Double-blind|Lost to Follow-up|0|||
164367321|NCT04544293|593721896|FG001|Double-blind|Lost to Follow-up|1|||
164367322|NCT04544293|593721895|FG000|Open-Label Extension|Study ongoing|79|||
164367323|NCT04544293|593721896|FG001|Open-Label Extension|Study ongoing|81|||
164367324|NCT02965703|593721901|FG000|Overall Study|Withdrawal by Subject|6|||
164367325|NCT02965703|593721902|FG001|Overall Study|Withdrawal by Subject|3|||
164367326|NCT02965703|593721903|FG002|Overall Study|Withdrawal by Subject|1|||
164367327|NCT02965703|593721901|FG000|Overall Study|Protocol Violation|1|||
164367328|NCT02965703|593721902|FG001|Overall Study|Protocol Violation|0|||
164367329|NCT02965703|593721903|FG002|Overall Study|Protocol Violation|0|||
164367330|NCT02965703|593721901|FG000|Overall Study|Adverse Event|1|||
164367331|NCT02965703|593721902|FG001|Overall Study|Adverse Event|1|||
164367332|NCT02965703|593721903|FG002|Overall Study|Adverse Event|0|||
164367333|NCT02965703|593721901|FG000|Overall Study|Lost to Follow-up|2|||
164367334|NCT02965703|593721902|FG001|Overall Study|Lost to Follow-up|1|||
164367335|NCT02965703|593721903|FG002|Overall Study|Lost to Follow-up|1|||
164367336|NCT00744627|593721904|FG000|Overall Study|Adverse Event|6|||
164367337|NCT00744627|593721905|FG001|Overall Study|Adverse Event|9|||
164367338|NCT00744627|593721904|FG000|Overall Study|Lack of Efficacy|7|||
164367339|NCT00744627|593721905|FG001|Overall Study|Lack of Efficacy|3|||
164367340|NCT00744627|593721904|FG000|Overall Study|Noncompliance|0|||
164367341|NCT00744627|593721905|FG001|Overall Study|Noncompliance|1|||
164367342|NCT00744627|593721904|FG000|Overall Study|Protocol Deviations|0|||
164367343|NCT00744627|593721905|FG001|Overall Study|Protocol Deviations|2|||
164367344|NCT00744627|593721904|FG000|Overall Study|Voluntary Withdrawal|9|||
164367345|NCT00744627|593721905|FG001|Overall Study|Voluntary Withdrawal|6|||
164367346|NCT00744627|593721904|FG000|Overall Study|Lost to Follow-up|2|||
164367347|NCT00744627|593721905|FG001|Overall Study|Lost to Follow-up|1|||
164367348|NCT00744627|593721904|FG000|Overall Study|Other|1|||
164367349|NCT00744627|593721905|FG001|Overall Study|Other|0|||
164367350|NCT02268786|593721906|FG000|Overall Study|No Euploid Embryos available|42|||
164367351|NCT02268786|593721907|FG001|Overall Study|No Euploid Embryos available|0|||
164367352|NCT02268786|593721906|FG000|Overall Study|Withdrawal by Subject|7|||
164367353|NCT02268786|593721907|FG001|Overall Study|Withdrawal by Subject|14|||
164367354|NCT02268786|593721906|FG000|Overall Study|Thaw Failure|6|||
164367355|NCT02268786|593721907|FG001|Overall Study|Thaw Failure|4|||
164367356|NCT02268786|593721906|FG000|Overall Study|Protocol Violation|1|||
164367357|NCT02268786|593721907|FG001|Overall Study|Protocol Violation|0|||
164367358|NCT01062555|593721918|FG000|Phase 1|Death|10|||
164367359|NCT01062555|593721919|FG001|Phase 1|Death|17|||
164367360|NCT01062555|593721920|FG002|Phase 1|Death|0|||
164367361|NCT01062555|593721921|FG003|Phase 1|Death|0|||
164367362|NCT01062555|593721918|FG000|Phase 1|Graft Failure|12|||
164367363|NCT01062555|593721919|FG001|Phase 1|Graft Failure|8|||
164367364|NCT01062555|593721920|FG002|Phase 1|Graft Failure|0|||
164367365|NCT01062555|593721921|FG003|Phase 1|Graft Failure|0|||
164367366|NCT01062555|593721918|FG000|Phase 1|Withdrawal by Subject|1|||
164367367|NCT01062555|593721919|FG001|Phase 1|Withdrawal by Subject|1|||
164367368|NCT01062555|593721920|FG002|Phase 1|Withdrawal by Subject|0|||
164367369|NCT01062555|593721921|FG003|Phase 1|Withdrawal by Subject|0|||
164367370|NCT01062555|593721918|FG000|Phase 2|Death|0|||
164367371|NCT01062555|593721919|FG001|Phase 2|Death|0|||
164367372|NCT01062555|593721920|FG002|Phase 2|Death|8|||
164367373|NCT01062555|593721921|FG003|Phase 2|Death|3|||
164367374|NCT01062555|593721918|FG000|Phase 2|Graft failure|0|||
164367375|NCT01062555|593721919|FG001|Phase 2|Graft failure|0|||
164367376|NCT01062555|593721920|FG002|Phase 2|Graft failure|7|||
164367377|NCT01062555|593721921|FG003|Phase 2|Graft failure|4|||
164367378|NCT01062555|593721918|FG000|Phase 2|Withdrawal by Subject|0|||
164367379|NCT01062555|593721919|FG001|Phase 2|Withdrawal by Subject|0|||
164367380|NCT01062555|593721920|FG002|Phase 2|Withdrawal by Subject|0|||
164367381|NCT01062555|593721921|FG003|Phase 2|Withdrawal by Subject|7|||
164367382|NCT01062555|593721918|FG000|Phase 2|Protocol Violation|0|||
164367383|NCT01062555|593721919|FG001|Phase 2|Protocol Violation|0|||
164367384|NCT01062555|593721920|FG002|Phase 2|Protocol Violation|0|||
163901975|NCT02036970|592013031|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
164367385|NCT01062555|593721921|FG003|Phase 2|Protocol Violation|3|||
164367386|NCT01062555|593721918|FG000|Phase 2|Physician Decision|0|||
164367387|NCT01062555|593721919|FG001|Phase 2|Physician Decision|0|||
164367388|NCT01062555|593721920|FG002|Phase 2|Physician Decision|0|||
164367389|NCT01062555|593721921|FG003|Phase 2|Physician Decision|17|||
164367390|NCT03560531|593721922|FG000|Overall Study|Death|4|||
164367391|NCT03560531|593721923|FG001|Overall Study|Death|1|||
164367392|NCT03560531|593721924|FG002|Overall Study|Death|1|||
164367393|NCT03560531|593721925|FG003|Overall Study|Death|2|||
164367394|NCT03560531|593721926|FG004|Overall Study|Death|6|||
164367395|NCT03560531|593721927|FG005|Overall Study|Death|1|||
164367396|NCT03560531|593721928|FG006|Overall Study|Death|4|||
164367397|NCT03560531|593721929|FG007|Overall Study|Death|8|||
164367398|NCT03560531|593721930|FG008|Overall Study|Death|1|||
164112681|NCT02372006|592774100|FG002|Overall Study|Adverse Event|3|||
164367399|NCT03560531|593721931|FG009|Overall Study|Death|3|||
164367400|NCT03560531|593721932|FG010|Overall Study|Death|2|||
164367401|NCT03560531|593721933|FG011|Overall Study|Death|0|||
164367402|NCT03560531|593721934|FG012|Overall Study|Death|4|||
164367403|NCT03560531|593721935|FG013|Overall Study|Death|1|||
164367404|NCT03560531|593721922|FG000|Overall Study|Lost to Follow-up|1|||
164367405|NCT03560531|593721923|FG001|Overall Study|Lost to Follow-up|1|||
164367406|NCT03560531|593721924|FG002|Overall Study|Lost to Follow-up|0|||
164367407|NCT03560531|593721925|FG003|Overall Study|Lost to Follow-up|0|||
164367408|NCT03560531|593721926|FG004|Overall Study|Lost to Follow-up|0|||
164367409|NCT03560531|593721927|FG005|Overall Study|Lost to Follow-up|0|||
164367410|NCT03560531|593721928|FG006|Overall Study|Lost to Follow-up|1|||
164367411|NCT03560531|593721929|FG007|Overall Study|Lost to Follow-up|0|||
164367412|NCT03560531|593721930|FG008|Overall Study|Lost to Follow-up|0|||
164367413|NCT03560531|593721931|FG009|Overall Study|Lost to Follow-up|0|||
164367414|NCT03560531|593721932|FG010|Overall Study|Lost to Follow-up|0|||
164367415|NCT03560531|593721933|FG011|Overall Study|Lost to Follow-up|0|||
164367416|NCT03560531|593721934|FG012|Overall Study|Lost to Follow-up|0|||
164367417|NCT03560531|593721935|FG013|Overall Study|Lost to Follow-up|0|||
164367418|NCT03560531|593721922|FG000|Overall Study|Withdrawal by Subject|1|||
164367419|NCT03560531|593721923|FG001|Overall Study|Withdrawal by Subject|0|||
164367420|NCT03560531|593721924|FG002|Overall Study|Withdrawal by Subject|0|||
164367421|NCT03560531|593721925|FG003|Overall Study|Withdrawal by Subject|0|||
164367422|NCT03560531|593721926|FG004|Overall Study|Withdrawal by Subject|0|||
164367423|NCT03560531|593721927|FG005|Overall Study|Withdrawal by Subject|0|||
164367424|NCT03560531|593721928|FG006|Overall Study|Withdrawal by Subject|0|||
164367425|NCT03560531|593721929|FG007|Overall Study|Withdrawal by Subject|3|||
164367426|NCT03560531|593721930|FG008|Overall Study|Withdrawal by Subject|2|||
164367427|NCT03560531|593721931|FG009|Overall Study|Withdrawal by Subject|0|||
164367428|NCT03560531|593721932|FG010|Overall Study|Withdrawal by Subject|0|||
164367429|NCT03560531|593721933|FG011|Overall Study|Withdrawal by Subject|0|||
164367430|NCT03560531|593721934|FG012|Overall Study|Withdrawal by Subject|2|||
164367431|NCT03560531|593721935|FG013|Overall Study|Withdrawal by Subject|0|||
164367432|NCT03560531|593721922|FG000|Overall Study|Study end per-protocol|1|||
164367433|NCT03560531|593721923|FG001|Overall Study|Study end per-protocol|1|||
164367434|NCT03560531|593721924|FG002|Overall Study|Study end per-protocol|2|||
164367435|NCT03560531|593721925|FG003|Overall Study|Study end per-protocol|0|||
164367436|NCT03560531|593721926|FG004|Overall Study|Study end per-protocol|1|||
164367437|NCT03560531|593721927|FG005|Overall Study|Study end per-protocol|0|||
164367438|NCT03560531|593721928|FG006|Overall Study|Study end per-protocol|0|||
164367439|NCT03560531|593721929|FG007|Overall Study|Study end per-protocol|0|||
164367440|NCT03560531|593721930|FG008|Overall Study|Study end per-protocol|0|||
164367441|NCT03560531|593721931|FG009|Overall Study|Study end per-protocol|0|||
164367442|NCT03560531|593721932|FG010|Overall Study|Study end per-protocol|0|||
164367443|NCT03560531|593721933|FG011|Overall Study|Study end per-protocol|0|||
164367444|NCT03560531|593721934|FG012|Overall Study|Study end per-protocol|0|||
164367445|NCT03560531|593721935|FG013|Overall Study|Study end per-protocol|0|||
164367446|NCT03560531|593721922|FG000|Overall Study|Early study termination by sponsor|9|||
164367447|NCT03560531|593721923|FG001|Overall Study|Early study termination by sponsor|0|||
164367448|NCT03560531|593721924|FG002|Overall Study|Early study termination by sponsor|0|||
164367449|NCT03560531|593721925|FG003|Overall Study|Early study termination by sponsor|4|||
164367450|NCT03560531|593721926|FG004|Overall Study|Early study termination by sponsor|8|||
164367451|NCT03560531|593721927|FG005|Overall Study|Early study termination by sponsor|2|||
164367452|NCT03560531|593721928|FG006|Overall Study|Early study termination by sponsor|5|||
164367453|NCT03560531|593721929|FG007|Overall Study|Early study termination by sponsor|64|||
164367454|NCT03560531|593721930|FG008|Overall Study|Early study termination by sponsor|7|||
164367455|NCT03560531|593721931|FG009|Overall Study|Early study termination by sponsor|2|||
164367456|NCT03560531|593721932|FG010|Overall Study|Early study termination by sponsor|16|||
164367457|NCT03560531|593721933|FG011|Overall Study|Early study termination by sponsor|2|||
164367458|NCT03560531|593721934|FG012|Overall Study|Early study termination by sponsor|6|||
164367459|NCT03560531|593721935|FG013|Overall Study|Early study termination by sponsor|2|||
164367460|NCT02968979|593721936|FG000|Overall Study|Protocol Violation|7|||
164367461|NCT02968979|593721936|FG000|Overall Study|Withdrawal by Subject|1|||
164367462|NCT01471379|593721937|FG000|Overall Study|Adverse Event|1|||
164367463|NCT01471379|593721938|FG001|Overall Study|Adverse Event|0|||
164367464|NCT01471379|593721939|FG002|Overall Study|Adverse Event|0|||
164367465|NCT01471379|593721937|FG000|Overall Study|Study terminated|0|||
164367466|NCT01471379|593721938|FG001|Overall Study|Study terminated|1|||
164012312|NCT04530825|592408701|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
164012313|NCT04530825|592408702|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
164012314|NCT04530825|592408703|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
164367467|NCT01471379|593721939|FG002|Overall Study|Study terminated|0|||
164367468|NCT00788827|593721940|FG000|Overall Study|Lack of Efficacy|2|||
164367469|NCT02818777|593721952|FG000|Overall Study|Adverse Event|3|||
164367470|NCT02028988|593721953|FG000|Overall Study|Withdrawal by Subject|2|||
164367471|NCT00747435|593721956|FG000|Overall Study|Lost to Follow-up|2|||
164367472|NCT00747435|593721956|FG000|Overall Study|Withdrawal by Subject|3|||
164367473|NCT00747435|593721956|FG000|Overall Study|Still undergoing follow up|1|||
164367474|NCT01324349|593721957|FG000|Overall Study|Death|1|||
164367475|NCT01324349|593721958|FG001|Overall Study|Death|1|||
164367476|NCT01324349|593721957|FG000|Overall Study|Withdrawal by Subject|0|||
164367477|NCT01324349|593721958|FG001|Overall Study|Withdrawal by Subject|1|||
164367478|NCT00851799|593721959|FG000|Overall Study|Death|1|||
164367479|NCT00851799|593721960|FG001|Overall Study|Death|0|||
164367480|NCT00851799|593721961|FG002|Overall Study|Death|1|||
164367481|NCT00851799|593721959|FG000|Overall Study|Lost to Follow-up|5|||
164367482|NCT00851799|593721960|FG001|Overall Study|Lost to Follow-up|3|||
164367483|NCT00851799|593721961|FG002|Overall Study|Lost to Follow-up|10|||
164367484|NCT00851799|593721959|FG000|Overall Study|Not able to get to clinic|8|||
164367485|NCT00851799|593721960|FG001|Overall Study|Not able to get to clinic|5|||
164367486|NCT00851799|593721961|FG002|Overall Study|Not able to get to clinic|9|||
164367487|NCT00851799|593721959|FG000|Overall Study|Not willing to adhere to requirements|1|||
164367488|NCT00851799|593721960|FG001|Overall Study|Not willing to adhere to requirements|2|||
164367489|NCT00851799|593721961|FG002|Overall Study|Not willing to adhere to requirements|2|||
164367490|NCT00851799|593721959|FG000|Overall Study|Withdrew consent prior study completion|1|||
164367491|NCT00851799|593721960|FG001|Overall Study|Withdrew consent prior study completion|2|||
164367492|NCT00851799|593721961|FG002|Overall Study|Withdrew consent prior study completion|1|||
164367493|NCT00851799|593721959|FG000|Overall Study|Severe Debilitation|0|||
164367494|NCT00851799|593721960|FG001|Overall Study|Severe Debilitation|1|||
164367495|NCT00851799|593721961|FG002|Overall Study|Severe Debilitation|0|||
164367496|NCT00851799|593721959|FG000|Overall Study|Completed protocol due to pregnancy|0|||
164367497|NCT00851799|593721960|FG001|Overall Study|Completed protocol due to pregnancy|0|||
164367498|NCT00851799|593721961|FG002|Overall Study|Completed protocol due to pregnancy|1|||
164367499|NCT02276612|593721964|FG000|Overall Study|Death|1|||
164367500|NCT02276612|593721965|FG001|Overall Study|Death|0|||
164367501|NCT02276612|593721964|FG000|Overall Study|Pregnancy|1|||
164367502|NCT02276612|593721965|FG001|Overall Study|Pregnancy|0|||
164367503|NCT02276612|593721964|FG000|Overall Study|Withdrew Consent|1|||
164367504|NCT02276612|593721965|FG001|Overall Study|Withdrew Consent|0|||
164367505|NCT02276612|593721964|FG000|Overall Study|Lost to Follow-up|1|||
164367506|NCT02276612|593721965|FG001|Overall Study|Lost to Follow-up|0|||
164367507|NCT04365556|593721966|FG000|Overall Study|No longer eligible due to treatment plan|1|||
164367508|NCT04365556|593721967|FG001|Overall Study|No longer eligible due to treatment plan|0|||
164367509|NCT04365556|593721966|FG000|Overall Study|Lost to Follow-up|3|||
164367510|NCT04365556|593721967|FG001|Overall Study|Lost to Follow-up|2|||
164367511|NCT00302003|593723826|FG000|Overall Study|Lack of Efficacy|62|||
164367512|NCT00302003|593723826|FG000|Overall Study|Lost to Follow-up|1|||
164367513|NCT00302003|593723826|FG000|Overall Study|Physician Decision|2|||
164367514|NCT00302003|593723826|FG000|Overall Study|Withdrawal by Subject|5|||
164367515|NCT00302003|593723826|FG000|Overall Study|Ineligible|9|||
164367516|NCT00302003|593723826|FG000|Overall Study|Protocol Violation|1|||
164367517|NCT02042924|593723827|FG000|Overall Study|Early Death|1|||
164367518|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
164367519|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
164367520|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
164367521|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
164367522|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
164367523|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
164367524|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
164367525|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
164367526|NCT04033003|593723828|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
164367527|NCT04033003|593723829|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
164367528|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
164367529|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
164367530|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
164367531|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
164367532|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
164367533|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
164367534|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
164367535|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
164367536|NCT04033003|593723828|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
164367537|NCT04033003|593723829|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
164367538|NCT04033003|593723828|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
164367539|NCT04033003|593723829|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
164367540|NCT04033003|593723828|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
164367541|NCT04033003|593723829|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
164367542|NCT04033003|593723828|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
164367543|NCT04033003|593723829|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
164367544|NCT02919670|593723830|FG000|Overall Study|Only 17 participants met compliance|43|||
164367545|NCT02919670|593723831|FG001|Overall Study|Only 17 participants met compliance|39|||
164367546|NCT02256891|593723832|FG000|Overall Study|Death|0|||
164367547|NCT02256891|593723833|FG001|Overall Study|Death|2|||
164367548|NCT02256891|593723832|FG000|Overall Study|Lost to Follow-up|0|||
164367549|NCT02256891|593723833|FG001|Overall Study|Lost to Follow-up|3|||
164367550|NCT02256891|593723832|FG000|Overall Study|Physician Decision|7|||
164367551|NCT02256891|593723833|FG001|Overall Study|Physician Decision|3|||
164367552|NCT02256891|593723832|FG000|Overall Study|Screen Fail|5|||
164367553|NCT02256891|593723833|FG001|Overall Study|Screen Fail|4|||
164367554|NCT02256891|593723832|FG000|Overall Study|Equipment Malfunction|0|||
164367555|NCT02256891|593723833|FG001|Overall Study|Equipment Malfunction|1|||
164367556|NCT04920123|593723836|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164367557|NCT04920123|593723837|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164367558|NCT04920123|593723838|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164367559|NCT00826267|593723839|FG000|Overall Study|Other Adverse Event|1|||
164367560|NCT00826267|593723840|FG001|Overall Study|Other Adverse Event|0|||
164367561|NCT00826267|593723841|FG002|Overall Study|Other Adverse Event|0|||
164367562|NCT02586493|593723854|FG000|Overall Study|Adverse Event|4|||
164367563|NCT02586493|593723854|FG000|Overall Study|Protocol Violation|6|||
164367564|NCT02586493|593723854|FG000|Overall Study|Lost to Follow-up|1|||
164367565|NCT02586493|593723854|FG000|Overall Study|Withdrawal by Subject|1|||
164367566|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
164367567|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
164367568|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
164367569|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
164367570|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
164367571|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
164367572|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
164367573|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
164367574|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
164367575|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
164367576|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
164367577|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
164367578|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
164367579|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
164367580|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
164367581|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Death|5|||
164367582|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Death|0|||
164367583|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Death|2|||
164367584|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Death|0|||
164367585|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Death|4|||
164367586|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
164367587|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
164367588|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
164367589|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
164367590|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
164367591|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
164367592|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
164367593|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
164367594|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
164367595|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
164367596|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
164367597|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
164367598|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
164367599|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
164367600|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
164367601|NCT01604343|593723862|FG000|Prior to W52 Administration(Through W52)|Other|15|||
164367602|NCT01604343|593723863|FG001|Prior to W52 Administration(Through W52)|Other|0|||
164367603|NCT01604343|593723864|FG002|Prior to W52 Administration(Through W52)|Other|10|||
164367604|NCT01604343|593723865|FG003|Prior to W52 Administration(Through W52)|Other|0|||
164367605|NCT01604343|593723866|FG004|Prior to W52 Administration(Through W52)|Other|6|||
164367606|NCT01604343|593723862|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
164367607|NCT01604343|593723863|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
164367608|NCT01604343|593723864|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
164367609|NCT01604343|593723865|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
164367610|NCT01604343|593723866|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
164367611|NCT01604343|593723862|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
164367612|NCT01604343|593723863|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
164367613|NCT01604343|593723864|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
164367614|NCT01604343|593723865|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
164367615|NCT01604343|593723866|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
164367616|NCT01604343|593723862|FG000|Week 52 to Week 104|Adverse Event|0|||
164367617|NCT01604343|593723863|FG001|Week 52 to Week 104|Adverse Event|12|||
164367618|NCT01604343|593723864|FG002|Week 52 to Week 104|Adverse Event|26|||
164367619|NCT01604343|593723865|FG003|Week 52 to Week 104|Adverse Event|21|||
164367620|NCT01604343|593723866|FG004|Week 52 to Week 104|Adverse Event|27|||
164367621|NCT01604343|593723862|FG000|Week 52 to Week 104|Death|0|||
164367622|NCT01604343|593723863|FG001|Week 52 to Week 104|Death|4|||
164367623|NCT01604343|593723864|FG002|Week 52 to Week 104|Death|2|||
164367624|NCT01604343|593723865|FG003|Week 52 to Week 104|Death|5|||
164367625|NCT01604343|593723866|FG004|Week 52 to Week 104|Death|0|||
164367626|NCT01604343|593723862|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
164367627|NCT01604343|593723863|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
164367628|NCT01604343|593723864|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
164367629|NCT01604343|593723865|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
164367630|NCT01604343|593723866|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
164367631|NCT01604343|593723862|FG000|Week 52 to Week 104|Physician Decision|0|||
164367632|NCT01604343|593723863|FG001|Week 52 to Week 104|Physician Decision|1|||
164367633|NCT01604343|593723864|FG002|Week 52 to Week 104|Physician Decision|0|||
164367634|NCT01604343|593723865|FG003|Week 52 to Week 104|Physician Decision|0|||
164367635|NCT01604343|593723866|FG004|Week 52 to Week 104|Physician Decision|2|||
164367636|NCT01604343|593723862|FG000|Week 52 to Week 104|Pregnancy|0|||
164367637|NCT01604343|593723863|FG001|Week 52 to Week 104|Pregnancy|0|||
164367638|NCT01604343|593723864|FG002|Week 52 to Week 104|Pregnancy|1|||
164367639|NCT01604343|593723865|FG003|Week 52 to Week 104|Pregnancy|2|||
164367640|NCT01604343|593723866|FG004|Week 52 to Week 104|Pregnancy|1|||
164367641|NCT01604343|593723862|FG000|Week 52 to Week 104|Other|0|||
164367642|NCT01604343|593723863|FG001|Week 52 to Week 104|Other|11|||
164367643|NCT01604343|593723864|FG002|Week 52 to Week 104|Other|11|||
164367644|NCT01604343|593723865|FG003|Week 52 to Week 104|Other|6|||
164367645|NCT01604343|593723866|FG004|Week 52 to Week 104|Other|3|||
164367646|NCT01604343|593723862|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
164367647|NCT01604343|593723863|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
164367648|NCT01604343|593723864|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
164367649|NCT01604343|593723865|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
164367650|NCT01604343|593723866|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
164367651|NCT01604343|593723862|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
164367652|NCT01604343|593723863|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
164367653|NCT01604343|593723864|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
164367654|NCT01604343|593723865|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
164367655|NCT01604343|593723866|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
164367656|NCT01604343|593723862|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
164367657|NCT01604343|593723863|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
164367658|NCT01604343|593723864|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
164367659|NCT01604343|593723865|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
164367660|NCT01604343|593723866|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
164367661|NCT00436748|593723867|FG000|Overall Study|Ineligibility Determined|1|||
164367662|NCT00436748|593723868|FG001|Overall Study|Ineligibility Determined|1|||
164367663|NCT00436748|593723867|FG000|Overall Study|Adverse Event|0|||
164367664|NCT00436748|593723868|FG001|Overall Study|Adverse Event|2|||
164367665|NCT00436748|593723867|FG000|Overall Study|Consent Withdrawn|1|||
164367666|NCT00436748|593723868|FG001|Overall Study|Consent Withdrawn|4|||
164367667|NCT00436748|593723867|FG000|Overall Study|Administrative Decision|1|||
164367668|NCT00436748|593723868|FG001|Overall Study|Administrative Decision|0|||
164367669|NCT00436748|593723867|FG000|Overall Study|Lost to Follow-up|0|||
164367670|NCT00436748|593723868|FG001|Overall Study|Lost to Follow-up|1|||
164367671|NCT00436748|593723867|FG000|Overall Study|Protocol-specified Criteria|5|||
164367672|NCT00436748|593723868|FG001|Overall Study|Protocol-specified Criteria|4|||
164367673|NCT00436748|593723867|FG000|Overall Study|Other|3|||
164367674|NCT00436748|593723868|FG001|Overall Study|Other|0|||
164367675|NCT00850200|593723869|FG000|Overall Study|Physician Decision|2|||
164367676|NCT00850200|593723869|FG000|Overall Study|Did not recieve treatment|2|||
164367677|NCT00850200|593723869|FG000|Overall Study|Withdrawal by Subject|1|||
164367678|NCT02711800|593723870|FG000|Overall Study|Lost to Follow-up|1|||
164367679|NCT02711800|593723870|FG000|Overall Study|Withdrawal by Subject|1|||
164367680|NCT05442554|593723873|FG000|Overall Study|Adverse Event|1|||
164367681|NCT01990495|593723885|FG000|Overall Study|Physician Decision|5|||
164367682|NCT01990495|593723886|FG001|Overall Study|Physician Decision|4|||
164367683|NCT00097721|593723887|FG000|Overall Study|Adverse Event|8|||
164367684|NCT00097721|593723888|FG001|Overall Study|Adverse Event|1|||
164367685|NCT00097721|593723887|FG000|Overall Study|Withdrawal by Subject|6|||
164367686|NCT00097721|593723888|FG001|Overall Study|Withdrawal by Subject|1|||
164367687|NCT00097721|593723887|FG000|Overall Study|Progressive Disease|55|||
164367688|NCT00097721|593723888|FG001|Overall Study|Progressive Disease|27|||
164367689|NCT00097721|593723887|FG000|Overall Study|Physician Decision|1|||
164367690|NCT00097721|593723888|FG001|Overall Study|Physician Decision|3|||
164367691|NCT00097721|593723887|FG000|Overall Study|Reason not given|1|||
164367692|NCT00097721|593723888|FG001|Overall Study|Reason not given|1|||
164367693|NCT00449956|593723889|FG000|Overall Study|Adverse Event|7|||
164367694|NCT00449956|593723890|FG001|Overall Study|Adverse Event|1|||
164367695|NCT00449956|593723891|FG002|Overall Study|Adverse Event|6|||
164367696|NCT00449956|593723889|FG000|Overall Study|Lack of Efficacy|0|||
164367697|NCT00449956|593723890|FG001|Overall Study|Lack of Efficacy|0|||
164367698|NCT00449956|593723891|FG002|Overall Study|Lack of Efficacy|1|||
164367699|NCT00449956|593723889|FG000|Overall Study|Protocol Violation|1|||
164367700|NCT00449956|593723890|FG001|Overall Study|Protocol Violation|1|||
164367701|NCT00449956|593723891|FG002|Overall Study|Protocol Violation|1|||
164367702|NCT00449956|593723889|FG000|Overall Study|Withdrawal by Subject|0|||
164367703|NCT00449956|593723890|FG001|Overall Study|Withdrawal by Subject|1|||
164367704|NCT00449956|593723891|FG002|Overall Study|Withdrawal by Subject|0|||
164367705|NCT00449956|593723889|FG000|Overall Study|Physician Decision|2|||
164367706|NCT00449956|593723890|FG001|Overall Study|Physician Decision|1|||
164367707|NCT00449956|593723891|FG002|Overall Study|Physician Decision|1|||
164367708|NCT02972632|593723901|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164367709|NCT02972632|593723901|FG000|Overall Study|Lost to Follow-up|4|||
164367710|NCT02972632|593723901|FG000|Overall Study|Voluntary Withdrawal|10|||
164367711|NCT02126969|593723902|FG000|Overall Study|Withdrawal by Subject|1|||
164367712|NCT02126969|593723903|FG001|Overall Study|Withdrawal by Subject|2|||
164367713|NCT00354172|593723904|FG000|Overall Study|Did not receive transplant|1|||
164367714|NCT01828034|593723905|FG000|Overall Study|Withdrawal by Subject|0|||
164367715|NCT01828034|593723906|FG001|Overall Study|Withdrawal by Subject|0|||
164367716|NCT01828034|593723907|FG002|Overall Study|Withdrawal by Subject|0|||
164367717|NCT01828034|593723908|FG003|Overall Study|Withdrawal by Subject|1|||
164367718|NCT02023151|593723909|FG000|Overall Study|Lost to Follow-up|4|||
163901976|NCT02036970|592013032|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
163901977|NCT02036970|592013033|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
163901978|NCT02036970|592013034|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
163901979|NCT02036970|592013025|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901980|NCT02036970|592013026|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901981|NCT02036970|592013027|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901982|NCT02036970|592013028|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901983|NCT02036970|592013029|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901984|NCT02036970|592013030|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901985|NCT02036970|592013031|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901986|NCT02036970|592013032|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
163901987|NCT02036970|592013033|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901988|NCT02036970|592013034|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
163901989|NCT02036970|592013025|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901990|NCT02036970|592013026|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
163901991|NCT02036970|592013027|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
163901992|NCT02036970|592013028|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901993|NCT02036970|592013029|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901994|NCT02036970|592013030|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901995|NCT02036970|592013031|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901996|NCT02036970|592013032|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901997|NCT02036970|592013033|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
163901998|NCT02036970|592013034|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
163901999|NCT02036970|592013025|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
163902000|NCT02036970|592013026|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
163902001|NCT02036970|592013027|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
163902002|NCT02036970|592013028|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
164367719|NCT03450707|593723910|FG000|Overall Study|Outside enrollment window|4|||
164367720|NCT03450707|593723911|FG001|Overall Study|Outside enrollment window|1|||
164367721|NCT03450707|593723910|FG000|Overall Study|Death|1|||
164367722|NCT03450707|593723911|FG001|Overall Study|Death|0|||
164367723|NCT03450707|593723910|FG000|Overall Study|Indication for thiamine|1|||
164367724|NCT03450707|593723911|FG001|Overall Study|Indication for thiamine|1|||
164367725|NCT03450707|593723910|FG000|Overall Study|Evidence of traumatic brain injury|1|||
164367726|NCT03450707|593723911|FG001|Overall Study|Evidence of traumatic brain injury|0|||
164367727|NCT03450707|593723910|FG000|Overall Study|Following commands|0|||
164367728|NCT03450707|593723911|FG001|Overall Study|Following commands|3|||
163902003|NCT02036970|592013029|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
163902004|NCT02036970|592013030|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
163902005|NCT02036970|592013031|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
163902006|NCT02036970|592013032|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
163902007|NCT02036970|592013033|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
164012315|NCT04530825|592408700|FG000|Overall Study|Did not complete follow-up|3|||
164012316|NCT04530825|592408701|FG001|Overall Study|Did not complete follow-up|0|||
164012317|NCT04530825|592408702|FG002|Overall Study|Did not complete follow-up|0|||
164367729|NCT03450707|593723910|FG000|Overall Study|Lactate < 3.5|0|||
163902008|NCT02036970|592013034|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
163902009|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
163902010|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
164367730|NCT03450707|593723911|FG001|Overall Study|Lactate < 3.5|2|||
164367731|NCT03450707|593723910|FG000|Overall Study|Rearrest with ECMO|0|||
164144026|NCT00086281|592888580|FG009|Phase 1|Serious Adverse Event|0|||
164367732|NCT03450707|593723911|FG001|Overall Study|Rearrest with ECMO|1|||
164367733|NCT03450707|593723910|FG000|Overall Study|Indication for thiamine + head CT results|0|||
164367734|NCT03450707|593723911|FG001|Overall Study|Indication for thiamine + head CT results|1|||
164367735|NCT03450707|593723910|FG000|Overall Study|Family/patient goals of care|0|||
164367736|NCT03450707|593723911|FG001|Overall Study|Family/patient goals of care|1|||
164367737|NCT02871375|593723912|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
164367738|NCT02871375|593723913|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
164367739|NCT01988571|593723916|FG000|Overall Study|Death|3|||
164367740|NCT01988571|593723917|FG001|Overall Study|Death|1|||
164367741|NCT01988571|593723916|FG000|Overall Study|Physician Decision|2|||
164367742|NCT01988571|593723917|FG001|Overall Study|Physician Decision|1|||
164367743|NCT01988571|593723916|FG000|Overall Study|Lost to Follow-up|3|||
164367744|NCT01988571|593723917|FG001|Overall Study|Lost to Follow-up|0|||
164367745|NCT01988571|593723916|FG000|Overall Study|Withdrawal by Subject|31|||
164367746|NCT01988571|593723917|FG001|Overall Study|Withdrawal by Subject|33|||
164367747|NCT00004412|593723918|FG000|Randomized Period|Moved to Crossover Period|3|||
164367748|NCT00004412|593723919|FG001|Randomized Period|Moved to Crossover Period|0|||
164367749|NCT00004412|593723920|FG002|Randomized Period|Moved to Crossover Period|0|||
164367750|NCT00337103|593723921|FG000|Overall Study|Progressive Disease|414|||
164367751|NCT00337103|593723922|FG001|Overall Study|Progressive Disease|410|||
164367752|NCT00337103|593723921|FG000|Overall Study|Adverse Event|45|||
164367753|NCT00337103|593723922|FG001|Overall Study|Adverse Event|59|||
164367754|NCT00337103|593723921|FG000|Overall Study|Subject Choice|34|||
164367755|NCT00337103|593723922|FG001|Overall Study|Subject Choice|27|||
164367756|NCT00337103|593723921|FG000|Overall Study|Clinical Progression|27|||
164367757|NCT00337103|593723922|FG001|Overall Study|Clinical Progression|24|||
164367758|NCT00337103|593723921|FG000|Overall Study|Physician Decision|15|||
164367759|NCT00337103|593723922|FG001|Overall Study|Physician Decision|14|||
164367760|NCT00337103|593723921|FG000|Overall Study|Withdrawal by Subject|8|||
164367761|NCT00337103|593723922|FG001|Overall Study|Withdrawal by Subject|5|||
164367762|NCT00337103|593723921|FG000|Overall Study|Other|5|||
164367763|NCT00337103|593723922|FG001|Overall Study|Other|6|||
164367764|NCT00337103|593723921|FG000|Overall Study|Entry Criteria Not Met|4|||
164367765|NCT00337103|593723922|FG001|Overall Study|Entry Criteria Not Met|1|||
164367766|NCT00337103|593723921|FG000|Overall Study|Lost to Follow-up|1|||
164367767|NCT00337103|593723922|FG001|Overall Study|Lost to Follow-up|2|||
164367768|NCT00337103|593723921|FG000|Overall Study|Death|1|||
164367769|NCT00337103|593723922|FG001|Overall Study|Death|0|||
164367770|NCT03387813|593723923|FG000|Overall Study|Death|40|||
164367771|NCT03387813|593723924|FG001|Overall Study|Death|37|||
164367772|NCT03387813|593723925|FG002|Overall Study|Death|190|||
164367773|NCT03387813|593723923|FG000|Overall Study|Withdrawal by Subject|9|||
164367774|NCT03387813|593723924|FG001|Overall Study|Withdrawal by Subject|19|||
164367775|NCT03387813|593723925|FG002|Overall Study|Withdrawal by Subject|32|||
164367776|NCT03387813|593723923|FG000|Overall Study|Lost to Follow-up|3|||
164367777|NCT03387813|593723924|FG001|Overall Study|Lost to Follow-up|9|||
164367778|NCT03387813|593723925|FG002|Overall Study|Lost to Follow-up|15|||
164367779|NCT03387813|593723923|FG000|Overall Study|Non-Compliance|6|||
164367780|NCT03387813|593723924|FG001|Overall Study|Non-Compliance|6|||
164367781|NCT03387813|593723925|FG002|Overall Study|Non-Compliance|31|||
164367782|NCT03387813|593723923|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
164367783|NCT03387813|593723924|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
164367784|NCT03387813|593723925|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
164367785|NCT03131440|593723928|FG000|Overall Study|Withdrawal by Subject|1|||
164367786|NCT03131440|593723929|FG001|Overall Study|Withdrawal by Subject|3|||
164367787|NCT03131440|593723930|FG002|Overall Study|Withdrawal by Subject|0|||
164367788|NCT03131440|593723931|FG003|Overall Study|Withdrawal by Subject|0|||
164367789|NCT03131440|593723932|FG004|Overall Study|Withdrawal by Subject|1|||
164367790|NCT03131440|593723933|FG005|Overall Study|Withdrawal by Subject|0|||
164367791|NCT03131440|593723934|FG006|Overall Study|Withdrawal by Subject|0|||
164367792|NCT03131440|593723935|FG007|Overall Study|Withdrawal by Subject|1|||
164367793|NCT03131440|593723936|FG008|Overall Study|Withdrawal by Subject|1|||
164367794|NCT03131440|593723937|FG009|Overall Study|Withdrawal by Subject|1|||
164367795|NCT03131440|593723938|FG010|Overall Study|Withdrawal by Subject|0|||
164367796|NCT03131440|593723939|FG011|Overall Study|Withdrawal by Subject|1|||
164367797|NCT03131440|593723940|FG012|Overall Study|Withdrawal by Subject|1|||
164367798|NCT03131440|593723941|FG013|Overall Study|Withdrawal by Subject|0|||
164367799|NCT03131440|593723942|FG014|Overall Study|Withdrawal by Subject|1|||
164367800|NCT03131440|593723943|FG015|Overall Study|Withdrawal by Subject|0|||
164367801|NCT03131440|593723944|FG016|Overall Study|Withdrawal by Subject|0|||
164367802|NCT03131440|593723945|FG017|Overall Study|Withdrawal by Subject|0|||
164367803|NCT03131440|593723946|FG018|Overall Study|Withdrawal by Subject|1|||
164367804|NCT03131440|593723947|FG019|Overall Study|Withdrawal by Subject|0|||
164367805|NCT03131440|593723948|FG020|Overall Study|Withdrawal by Subject|1|||
164367806|NCT03131440|593723949|FG021|Overall Study|Withdrawal by Subject|1|||
164367807|NCT03131440|593723950|FG022|Overall Study|Withdrawal by Subject|1|||
164367808|NCT03131440|593723951|FG023|Overall Study|Withdrawal by Subject|0|||
164367809|NCT03131440|593723952|FG024|Overall Study|Withdrawal by Subject|0|||
164367810|NCT03131440|593723953|FG025|Overall Study|Withdrawal by Subject|0|||
164367811|NCT03131440|593723954|FG026|Overall Study|Withdrawal by Subject|0|||
164367812|NCT03131440|593723955|FG027|Overall Study|Withdrawal by Subject|0|||
164367813|NCT03131440|593723956|FG028|Overall Study|Withdrawal by Subject|0|||
164367814|NCT03131440|593723957|FG029|Overall Study|Withdrawal by Subject|0|||
164367815|NCT03131440|593723958|FG030|Overall Study|Withdrawal by Subject|1|||
164367816|NCT03131440|593723959|FG031|Overall Study|Withdrawal by Subject|0|||
164367817|NCT03131440|593723928|FG000|Overall Study|Lost to Follow-up|0|||
164367818|NCT03131440|593723929|FG001|Overall Study|Lost to Follow-up|0|||
164367819|NCT03131440|593723930|FG002|Overall Study|Lost to Follow-up|0|||
164012318|NCT04530825|592408703|FG003|Overall Study|Did not complete follow-up|0|||
164012319|NCT04101422|592408705|FG000|Overall Study|Ineligible|1|||
164012320|NCT04101422|592408706|FG001|Overall Study|Ineligible|0|||
164012321|NCT04101422|592408707|FG002|Overall Study|Ineligible|9|||
164012322|NCT04101422|592408708|FG003|Overall Study|Ineligible|0|||
164367820|NCT03131440|593723931|FG003|Overall Study|Lost to Follow-up|0|||
164367821|NCT03131440|593723932|FG004|Overall Study|Lost to Follow-up|0|||
164367822|NCT03131440|593723933|FG005|Overall Study|Lost to Follow-up|1|||
164367823|NCT03131440|593723934|FG006|Overall Study|Lost to Follow-up|0|||
164367824|NCT03131440|593723935|FG007|Overall Study|Lost to Follow-up|0|||
164367825|NCT03131440|593723936|FG008|Overall Study|Lost to Follow-up|0|||
164367826|NCT03131440|593723937|FG009|Overall Study|Lost to Follow-up|0|||
164367827|NCT03131440|593723938|FG010|Overall Study|Lost to Follow-up|0|||
164367828|NCT03131440|593723939|FG011|Overall Study|Lost to Follow-up|0|||
164367829|NCT03131440|593723940|FG012|Overall Study|Lost to Follow-up|0|||
164367830|NCT03131440|593723941|FG013|Overall Study|Lost to Follow-up|0|||
164367831|NCT03131440|593723942|FG014|Overall Study|Lost to Follow-up|0|||
164367832|NCT03131440|593723943|FG015|Overall Study|Lost to Follow-up|0|||
164367833|NCT03131440|593723944|FG016|Overall Study|Lost to Follow-up|0|||
164367834|NCT03131440|593723945|FG017|Overall Study|Lost to Follow-up|0|||
164367835|NCT03131440|593723946|FG018|Overall Study|Lost to Follow-up|0|||
164367836|NCT03131440|593723947|FG019|Overall Study|Lost to Follow-up|2|||
164367837|NCT03131440|593723948|FG020|Overall Study|Lost to Follow-up|1|||
164367838|NCT03131440|593723949|FG021|Overall Study|Lost to Follow-up|0|||
164367839|NCT03131440|593723950|FG022|Overall Study|Lost to Follow-up|1|||
164367840|NCT03131440|593723951|FG023|Overall Study|Lost to Follow-up|0|||
164367841|NCT03131440|593723952|FG024|Overall Study|Lost to Follow-up|1|||
164367842|NCT03131440|593723953|FG025|Overall Study|Lost to Follow-up|0|||
164367843|NCT03131440|593723954|FG026|Overall Study|Lost to Follow-up|0|||
164367844|NCT03131440|593723955|FG027|Overall Study|Lost to Follow-up|2|||
164367845|NCT03131440|593723956|FG028|Overall Study|Lost to Follow-up|0|||
164367846|NCT03131440|593723957|FG029|Overall Study|Lost to Follow-up|2|||
164367847|NCT03131440|593723958|FG030|Overall Study|Lost to Follow-up|0|||
164367848|NCT03131440|593723959|FG031|Overall Study|Lost to Follow-up|0|||
164367849|NCT03131440|593723928|FG000|Overall Study|Death|0|||
164367850|NCT03131440|593723929|FG001|Overall Study|Death|0|||
164367851|NCT03131440|593723930|FG002|Overall Study|Death|0|||
164367852|NCT03131440|593723931|FG003|Overall Study|Death|0|||
164367853|NCT03131440|593723932|FG004|Overall Study|Death|0|||
164367854|NCT03131440|593723933|FG005|Overall Study|Death|0|||
164367855|NCT03131440|593723934|FG006|Overall Study|Death|0|||
164367856|NCT03131440|593723935|FG007|Overall Study|Death|0|||
164367857|NCT03131440|593723936|FG008|Overall Study|Death|0|||
164367858|NCT03131440|593723937|FG009|Overall Study|Death|0|||
164367859|NCT03131440|593723938|FG010|Overall Study|Death|0|||
164367860|NCT03131440|593723939|FG011|Overall Study|Death|0|||
164367861|NCT03131440|593723940|FG012|Overall Study|Death|0|||
164367862|NCT03131440|593723941|FG013|Overall Study|Death|0|||
164367863|NCT03131440|593723942|FG014|Overall Study|Death|0|||
164012323|NCT04101422|592408705|FG000|Overall Study|Withdrawal by Subject|0|||
164012324|NCT04101422|592408706|FG001|Overall Study|Withdrawal by Subject|0|||
164367864|NCT03131440|593723943|FG015|Overall Study|Death|0|||
164012325|NCT04101422|592408707|FG002|Overall Study|Withdrawal by Subject|1|||
164367865|NCT03131440|593723944|FG016|Overall Study|Death|0|||
164367866|NCT03131440|593723945|FG017|Overall Study|Death|0|||
164012326|NCT04101422|592408708|FG003|Overall Study|Withdrawal by Subject|0|||
164367867|NCT03131440|593723946|FG018|Overall Study|Death|0|||
164012327|NCT04101422|592408705|FG000|Overall Study|Not attending to the stimuli|0|||
164367868|NCT03131440|593723947|FG019|Overall Study|Death|0|||
164367869|NCT03131440|593723948|FG020|Overall Study|Death|0|||
164367870|NCT03131440|593723949|FG021|Overall Study|Death|0|||
164367871|NCT03131440|593723950|FG022|Overall Study|Death|0|||
164367872|NCT03131440|593723951|FG023|Overall Study|Death|0|||
164367873|NCT03131440|593723952|FG024|Overall Study|Death|0|||
164367874|NCT03131440|593723953|FG025|Overall Study|Death|1|||
164367875|NCT03131440|593723954|FG026|Overall Study|Death|0|||
164367876|NCT03131440|593723955|FG027|Overall Study|Death|0|||
164367877|NCT03131440|593723956|FG028|Overall Study|Death|0|||
164367878|NCT03131440|593723957|FG029|Overall Study|Death|0|||
164367879|NCT03131440|593723958|FG030|Overall Study|Death|0|||
164367880|NCT03131440|593723959|FG031|Overall Study|Death|0|||
164367881|NCT03742141|593723962|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
164367882|NCT01354496|593723968|FG000|Period 1|Adverse Event|0|||
164367883|NCT01354496|593723969|FG001|Period 1|Adverse Event|0|||
164367884|NCT01354496|593723970|FG002|Period 1|Adverse Event|1|||
164367885|NCT01354496|593723971|FG003|Period 1|Adverse Event|0|||
164367886|NCT01354496|593723972|FG004|Period 1|Adverse Event|0|||
164367887|NCT01354496|593723973|FG005|Period 1|Adverse Event|0|||
164367888|NCT01354496|593723968|FG000|Period 1|Physician Decision|0|||
164367889|NCT01354496|593723969|FG001|Period 1|Physician Decision|0|||
164367890|NCT01354496|593723970|FG002|Period 1|Physician Decision|1|||
164367891|NCT01354496|593723971|FG003|Period 1|Physician Decision|0|||
164367892|NCT01354496|593723972|FG004|Period 1|Physician Decision|0|||
164367893|NCT01354496|593723973|FG005|Period 1|Physician Decision|0|||
164367894|NCT01354496|593723968|FG000|Period 2|Adverse Event|0|||
164367895|NCT01354496|593723969|FG001|Period 2|Adverse Event|0|||
164367896|NCT01354496|593723970|FG002|Period 2|Adverse Event|0|||
164367897|NCT01354496|593723971|FG003|Period 2|Adverse Event|1|||
164367898|NCT01354496|593723972|FG004|Period 2|Adverse Event|0|||
164367899|NCT01354496|593723973|FG005|Period 2|Adverse Event|0|||
164367900|NCT01354496|593723968|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164367901|NCT01354496|593723969|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
164367902|NCT01354496|593723970|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164367903|NCT01354496|593723971|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
164367904|NCT01354496|593723972|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164012328|NCT04101422|592408706|FG001|Overall Study|Not attending to the stimuli|0|||
164012329|NCT04101422|592408707|FG002|Overall Study|Not attending to the stimuli|4|||
164012330|NCT04101422|592408708|FG003|Overall Study|Not attending to the stimuli|0|||
164367905|NCT01354496|593723973|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
164367906|NCT00500292|593723975|FG000|Overall Study|Adverse Event|3|||
164367907|NCT00500292|593723976|FG001|Overall Study|Adverse Event|6|||
164367908|NCT00500292|593723977|FG002|Overall Study|Adverse Event|4|||
164367909|NCT00500292|593723975|FG000|Overall Study|Condition under investigation worsened|21|||
164367910|NCT00500292|593723976|FG001|Overall Study|Condition under investigation worsened|23|||
164367911|NCT00500292|593723977|FG002|Overall Study|Condition under investigation worsened|19|||
164367912|NCT00500292|593723975|FG000|Overall Study|Withdrawal by Subject|0|||
164367913|NCT00500292|593723976|FG001|Overall Study|Withdrawal by Subject|1|||
164367914|NCT00500292|593723977|FG002|Overall Study|Withdrawal by Subject|0|||
164367915|NCT00500292|593723975|FG000|Overall Study|Other|1|||
164367916|NCT00500292|593723976|FG001|Overall Study|Other|1|||
164367917|NCT00500292|593723977|FG002|Overall Study|Other|4|||
164367918|NCT05045144|593723978|FG000|Overall Study|Lost to Follow-up|3|||
164367919|NCT05045144|593723979|FG001|Overall Study|Lost to Follow-up|2|||
164367920|NCT05045144|593723980|FG002|Overall Study|Lost to Follow-up|3|||
164367921|NCT05045144|593723981|FG003|Overall Study|Lost to Follow-up|5|||
164367922|NCT05045144|593723982|FG004|Overall Study|Lost to Follow-up|13|||
164367923|NCT05045144|593723978|FG000|Overall Study|Withdrawal by Subject|0|||
164367924|NCT05045144|593723979|FG001|Overall Study|Withdrawal by Subject|1|||
164367925|NCT05045144|593723980|FG002|Overall Study|Withdrawal by Subject|0|||
164367926|NCT05045144|593723981|FG003|Overall Study|Withdrawal by Subject|0|||
164367927|NCT05045144|593723982|FG004|Overall Study|Withdrawal by Subject|0|||
164367928|NCT05045144|593723978|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367929|NCT05045144|593723979|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367930|NCT05045144|593723980|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164367931|NCT05045144|593723981|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367932|NCT05045144|593723982|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164367933|NCT02385084|593723983|FG000|Period 2|Protocol Violation|0|||
164367934|NCT02385084|593723984|FG001|Period 2|Protocol Violation|0|||
164367935|NCT02385084|593723985|FG002|Period 2|Protocol Violation|1|||
164367936|NCT02385084|593723986|FG003|Period 2|Protocol Violation|0|||
164012331|NCT04101422|592408705|FG000|Overall Study|Did not download app|0|||
164012332|NCT04101422|592408706|FG001|Overall Study|Did not download app|0|||
164012333|NCT04101422|592408707|FG002|Overall Study|Did not download app|0|||
164367937|NCT02385084|593723987|FG004|Period 2|Protocol Violation|0|||
164367938|NCT02385084|593723988|FG005|Period 2|Protocol Violation|0|||
164367939|NCT04809220|593723989|FG000|Overall Study|Adverse Event|4|||
164367940|NCT04809220|593723990|FG001|Overall Study|Adverse Event|0|||
164367941|NCT04809220|593723989|FG000|Overall Study|Death|1|||
164367942|NCT04809220|593723990|FG001|Overall Study|Death|0|||
164367943|NCT04809220|593723989|FG000|Overall Study|Lost to Follow-up|3|||
164367944|NCT04809220|593723990|FG001|Overall Study|Lost to Follow-up|0|||
164367945|NCT04809220|593723989|FG000|Overall Study|Physician Decision|0|||
164367946|NCT04809220|593723990|FG001|Overall Study|Physician Decision|1|||
164367947|NCT04809220|593723989|FG000|Overall Study|Withdrawal by Subject|9|||
164367948|NCT04809220|593723990|FG001|Overall Study|Withdrawal by Subject|5|||
164367949|NCT04809220|593723989|FG000|Overall Study|Due to long-term overseas business trips|1|||
164367950|NCT04809220|593723990|FG001|Overall Study|Due to long-term overseas business trips|0|||
164367951|NCT00729183|593723991|FG000|Overall Study|Adverse Event|11|||
164367952|NCT00729183|593723992|FG001|Overall Study|Adverse Event|5|||
164367953|NCT00729183|593723991|FG000|Overall Study|Lack of Efficacy|0|||
164367954|NCT00729183|593723992|FG001|Overall Study|Lack of Efficacy|1|||
164367955|NCT00729183|593723991|FG000|Overall Study|Lost to Follow-up|3|||
164367956|NCT00729183|593723992|FG001|Overall Study|Lost to Follow-up|1|||
164367957|NCT00729183|593723991|FG000|Overall Study|Physician Decision|1|||
164367958|NCT00729183|593723992|FG001|Overall Study|Physician Decision|1|||
164367959|NCT00729183|593723991|FG000|Overall Study|Protocol Violation|1|||
164367960|NCT00729183|593723992|FG001|Overall Study|Protocol Violation|0|||
164367961|NCT00729183|593723991|FG000|Overall Study|Withdrawal by Subject|9|||
164367962|NCT00729183|593723992|FG001|Overall Study|Withdrawal by Subject|7|||
164367963|NCT01070316|593724000|FG000|Extension Phase|Lack of Efficacy|3|||
164367964|NCT01070316|593724000|FG000|Extension Phase|Withdrawal by Subject|1|||
164367965|NCT00748215|593724003|FG000|Overall Study|Withdrawal by Subject|7|||
164367966|NCT00748215|593724004|FG001|Overall Study|Withdrawal by Subject|7|||
164367967|NCT00748215|593724003|FG000|Overall Study|Treatment change|2|||
164367968|NCT00748215|593724004|FG001|Overall Study|Treatment change|1|||
164367969|NCT00748215|593724003|FG000|Overall Study|Change in patient condition|0|||
164367970|NCT00748215|593724004|FG001|Overall Study|Change in patient condition|3|||
164367971|NCT00748215|593724003|FG000|Overall Study|Non-compliant|0|||
164367972|NCT00748215|593724004|FG001|Overall Study|Non-compliant|2|||
164367973|NCT00748215|593724003|FG000|Overall Study|Adverse Event|0|||
164367974|NCT00748215|593724004|FG001|Overall Study|Adverse Event|5|||
164367975|NCT01113879|593724007|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
164367976|NCT01113879|593724008|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
164367977|NCT04151290|593724009|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
164367978|NCT00082433|593724013|FG000|Overall Study|Adverse Event|12|||
164367979|NCT00082433|593724014|FG001|Overall Study|Adverse Event|17|||
164367980|NCT00082433|593724013|FG000|Overall Study|Death|8|||
164367981|NCT00082433|593724014|FG001|Overall Study|Death|18|||
164367982|NCT00082433|593724013|FG000|Overall Study|Disease Progression/Relapse|270|||
164367983|NCT00082433|593724014|FG001|Overall Study|Disease Progression/Relapse|388|||
164367984|NCT00082433|593724013|FG000|Overall Study|Physician Decision|50|||
164367985|NCT00082433|593724014|FG001|Overall Study|Physician Decision|61|||
164367986|NCT00082433|593724013|FG000|Overall Study|Lost to Follow-up|1|||
164367987|NCT00082433|593724014|FG001|Overall Study|Lost to Follow-up|2|||
164367988|NCT00082433|593724013|FG000|Overall Study|Study Drug Toxicity|179|||
164367989|NCT00082433|593724014|FG001|Overall Study|Study Drug Toxicity|66|||
164367990|NCT00082433|593724013|FG000|Overall Study|Withdrawal by Subject|55|||
164367991|NCT00082433|593724014|FG001|Overall Study|Withdrawal by Subject|30|||
164367992|NCT00082433|593724013|FG000|Overall Study|Still On Treatment|2|||
164367993|NCT00082433|593724014|FG001|Overall Study|Still On Treatment|1|||
164367994|NCT00082433|593724013|FG000|Overall Study|Not Treated|12|||
164367995|NCT00082433|593724014|FG001|Overall Study|Not Treated|11|||
164367996|NCT00082433|593724013|FG000|Overall Study|Ineligible|2|||
164367997|NCT00082433|593724014|FG001|Overall Study|Ineligible|1|||
164367998|NCT00082433|593724013|FG000|Overall Study|Noncompliance|2|||
164367999|NCT00082433|593724014|FG001|Overall Study|Noncompliance|1|||
164368000|NCT00082433|593724013|FG000|Overall Study|New primary cancer|1|||
164368001|NCT00082433|593724014|FG001|Overall Study|New primary cancer|0|||
164368002|NCT00082433|593724013|FG000|Overall Study|Impending surgery|0|||
164368003|NCT00082433|593724014|FG001|Overall Study|Impending surgery|1|||
164368004|NCT01796197|593724015|FG000|Overall Study|Lost to Follow-up|1|||
164368005|NCT01796197|593724015|FG000|Overall Study|Lack of Efficacy|1|||
164368006|NCT04097821|593724016|FG000|Overall Study|Subject Decision|0|||
164368007|NCT04097821|593724017|FG001|Overall Study|Subject Decision|0|||
164368008|NCT04097821|593724018|FG002|Overall Study|Subject Decision|0|||
164368009|NCT04097821|593724019|FG003|Overall Study|Subject Decision|1|||
164368010|NCT04097821|593724020|FG004|Overall Study|Subject Decision|2|||
164368011|NCT04097821|593724021|FG005|Overall Study|Subject Decision|2|||
164368012|NCT04097821|593724022|FG006|Overall Study|Subject Decision|0|||
164368013|NCT04097821|593724023|FG007|Overall Study|Subject Decision|1|||
164368014|NCT04097821|593724016|FG000|Overall Study|Death|0|||
164368015|NCT04097821|593724017|FG001|Overall Study|Death|0|||
164368016|NCT04097821|593724018|FG002|Overall Study|Death|3|||
164368017|NCT04097821|593724019|FG003|Overall Study|Death|1|||
164368018|NCT04097821|593724020|FG004|Overall Study|Death|0|||
164368019|NCT04097821|593724021|FG005|Overall Study|Death|0|||
164368020|NCT04097821|593724022|FG006|Overall Study|Death|0|||
164368021|NCT04097821|593724023|FG007|Overall Study|Death|0|||
164368022|NCT04097821|593724016|FG000|Overall Study|Physician Decision|1|||
164368023|NCT04097821|593724017|FG001|Overall Study|Physician Decision|2|||
164368024|NCT04097821|593724018|FG002|Overall Study|Physician Decision|0|||
164368025|NCT04097821|593724019|FG003|Overall Study|Physician Decision|0|||
164368026|NCT04097821|593724020|FG004|Overall Study|Physician Decision|0|||
164368027|NCT04097821|593724021|FG005|Overall Study|Physician Decision|0|||
164368028|NCT04097821|593724022|FG006|Overall Study|Physician Decision|0|||
164144027|NCT00086281|592888581|FG010|Phase 1|Serious Adverse Event|0|||
164368029|NCT04097821|593724023|FG007|Overall Study|Physician Decision|0|||
164368030|NCT04097821|593724016|FG000|Overall Study|Adverse Event|0|||
164368031|NCT04097821|593724017|FG001|Overall Study|Adverse Event|0|||
164368032|NCT04097821|593724018|FG002|Overall Study|Adverse Event|1|||
164368033|NCT04097821|593724019|FG003|Overall Study|Adverse Event|1|||
164368034|NCT04097821|593724020|FG004|Overall Study|Adverse Event|0|||
164368035|NCT04097821|593724021|FG005|Overall Study|Adverse Event|0|||
164368036|NCT04097821|593724022|FG006|Overall Study|Adverse Event|0|||
164368037|NCT04097821|593724023|FG007|Overall Study|Adverse Event|0|||
164368038|NCT04097821|593724016|FG000|Overall Study|New Therapy For Study Indication|0|||
164368039|NCT04097821|593724017|FG001|Overall Study|New Therapy For Study Indication|0|||
164368040|NCT04097821|593724018|FG002|Overall Study|New Therapy For Study Indication|0|||
164368041|NCT04097821|593724019|FG003|Overall Study|New Therapy For Study Indication|0|||
164368042|NCT04097821|593724020|FG004|Overall Study|New Therapy For Study Indication|0|||
164368043|NCT04097821|593724021|FG005|Overall Study|New Therapy For Study Indication|0|||
164368044|NCT04097821|593724022|FG006|Overall Study|New Therapy For Study Indication|1|||
164368045|NCT04097821|593724023|FG007|Overall Study|New Therapy For Study Indication|0|||
164368046|NCT00244712|593724024|FG000|Overall Study|Adverse Event|20|||
164368047|NCT00244712|593724025|FG001|Overall Study|Adverse Event|21|||
164368048|NCT00244712|593724024|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
164368049|NCT00244712|593724025|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
164368050|NCT00244712|593724024|FG000|Overall Study|Lack of Compliance|10|||
164368051|NCT00244712|593724025|FG001|Overall Study|Lack of Compliance|11|||
164368052|NCT00244712|593724024|FG000|Overall Study|Lost to Follow-up|45|||
164368053|NCT00244712|593724025|FG001|Overall Study|Lost to Follow-up|52|||
164368054|NCT00244712|593724024|FG000|Overall Study|Withdrawal by Subject|13|||
164368055|NCT00244712|593724025|FG001|Overall Study|Withdrawal by Subject|23|||
164368056|NCT00244712|593724024|FG000|Overall Study|Protocol Violation, disease progression|13|||
164368057|NCT00244712|593724025|FG001|Overall Study|Protocol Violation, disease progression|11|||
164368058|NCT03299842|593725182|FG000|Overall Study|Caregiver withdrew consent|2|||
164368059|NCT03299842|593725182|FG000|Overall Study|Child would not keep the watch on|3|||
164368060|NCT04380857|593725183|FG000|Overall Study|Lost to Follow-up|3|||
164368061|NCT04380857|593725184|FG001|Overall Study|Lost to Follow-up|3|||
164368062|NCT02558790|593725185|FG000|Overall Study|Lost to Follow-up|2|||
164368063|NCT02558790|593725185|FG000|Overall Study|Physician Decision|1|||
164368064|NCT02558790|593725185|FG000|Overall Study|Withdrawal by Subject|1|||
164368065|NCT02558790|593725185|FG000|Overall Study|Screen Fail|3|||
164368066|NCT05083442|593725186|FG000|Overall Study|Lost to Follow-up|1|||
164368067|NCT05083442|593725187|FG001|Overall Study|Lost to Follow-up|0|||
164368068|NCT05083442|593725186|FG000|Overall Study|Lack of Efficacy|0|||
164368069|NCT05083442|593725187|FG001|Overall Study|Lack of Efficacy|1|||
164368070|NCT05083442|593725186|FG000|Overall Study|Withdrawal by Subject|1|||
164368071|NCT05083442|593725187|FG001|Overall Study|Withdrawal by Subject|3|||
164368072|NCT05083442|593725186|FG000|Overall Study|scheduling difficulties|1|||
164368073|NCT05083442|593725187|FG001|Overall Study|scheduling difficulties|2|||
164368074|NCT04865354|593725190|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
164368075|NCT04865354|593725191|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
164368076|NCT04865354|593725190|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
164368077|NCT04865354|593725191|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
164368078|NCT04865354|593725190|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
164368079|NCT04865354|593725191|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
164368080|NCT02945410|593725197|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368081|NCT02945410|593725198|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
164368082|NCT02945410|593725199|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368083|NCT02945410|593725200|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368084|NCT02945410|593725201|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368085|NCT02945410|593725202|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
164368086|NCT02945410|593725197|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
164368087|NCT02945410|593725198|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
164368088|NCT02945410|593725199|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
164368089|NCT02945410|593725200|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
164368090|NCT02945410|593725201|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
164368091|NCT02945410|593725202|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
164012334|NCT04101422|592408708|FG003|Overall Study|Did not download app|17|||
164368092|NCT02945410|593725197|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368093|NCT02945410|593725198|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368094|NCT02945410|593725199|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
164368095|NCT02945410|593725200|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368096|NCT02945410|593725201|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
164368097|NCT02945410|593725202|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
164368098|NCT00110812|593725203|FG000|Main Study|Death|0|||
164368099|NCT00110812|593725204|FG001|Main Study|Death|0|||
164368100|NCT00110812|593725205|FG002|Main Study|Death|2|||
164368101|NCT00110812|593725203|FG000|Main Study|Withdrawal by Subject|0|||
164368102|NCT00110812|593725204|FG001|Main Study|Withdrawal by Subject|0|||
164368103|NCT00110812|593725205|FG002|Main Study|Withdrawal by Subject|1|||
164368104|NCT00110812|593725203|FG000|Main Study|Lost to Follow-up|8|||
164368105|NCT00110812|593725204|FG001|Main Study|Lost to Follow-up|11|||
164368106|NCT00110812|593725205|FG002|Main Study|Lost to Follow-up|10|||
164368107|NCT00110812|593725203|FG000|Extended Follow-up|Death|1|||
164368108|NCT00110812|593725204|FG001|Extended Follow-up|Death|0|||
164368109|NCT00110812|593725205|FG002|Extended Follow-up|Death|3|||
164368110|NCT00110812|593725203|FG000|Extended Follow-up|Withdrawal by Subject|0|||
164368111|NCT00110812|593725204|FG001|Extended Follow-up|Withdrawal by Subject|1|||
164368112|NCT00110812|593725205|FG002|Extended Follow-up|Withdrawal by Subject|0|||
164368113|NCT00110812|593725203|FG000|Extended Follow-up|Lost to Follow-up|1|||
164368114|NCT00110812|593725204|FG001|Extended Follow-up|Lost to Follow-up|3|||
164368115|NCT00110812|593725205|FG002|Extended Follow-up|Lost to Follow-up|1|||
164368116|NCT04200248|593725206|FG000|Overall Study|Personal reasons|0|||
164368117|NCT04200248|593725207|FG001|Overall Study|Personal reasons|0|||
164368118|NCT04200248|593725208|FG002|Overall Study|Personal reasons|1|||
164368119|NCT04200248|593725206|FG000|Overall Study|Discontinued prior to treatment|3|||
164368120|NCT04200248|593725207|FG001|Overall Study|Discontinued prior to treatment|3|||
164368121|NCT04200248|593725208|FG002|Overall Study|Discontinued prior to treatment|2|||
164368122|NCT01454726|593725209|FG000|Overall Study|Withdrawal by Subject|0|||
164368123|NCT01454726|593725210|FG001|Overall Study|Withdrawal by Subject|1|||
164368124|NCT01886833|593725211|FG000|Overall Study|IgA not available from both periods|204|||
164368125|NCT04476030|593725212|FG000|Overall Study|Withdrawal by Subject|20|||
164368126|NCT04476030|593725213|FG001|Overall Study|Withdrawal by Subject|16|||
164368127|NCT04476030|593725212|FG000|Overall Study|Adverse Event|10|||
164368128|NCT04476030|593725213|FG001|Overall Study|Adverse Event|11|||
164368129|NCT04476030|593725212|FG000|Overall Study|Lost to Follow-up|7|||
164368130|NCT04476030|593725213|FG001|Overall Study|Lost to Follow-up|4|||
164368131|NCT04476030|593725212|FG000|Overall Study|Physician Decision|1|||
164368132|NCT04476030|593725213|FG001|Overall Study|Physician Decision|1|||
164368133|NCT04476030|593725212|FG000|Overall Study|Protocol Deviation|2|||
164368134|NCT04476030|593725213|FG001|Overall Study|Protocol Deviation|0|||
164368135|NCT04476030|593725212|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
164368136|NCT04476030|593725213|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
164368137|NCT04476030|593725212|FG000|Overall Study|Randomized but not Dosed|2|||
164368138|NCT04476030|593725213|FG001|Overall Study|Randomized but not Dosed|8|||
164368139|NCT02342704|593725214|FG000|Overall Study|Physician Decision|0|||
164368140|NCT02342704|593725215|FG001|Overall Study|Physician Decision|3|||
164368141|NCT02342704|593725214|FG000|Overall Study|Sponsor Termination|49|||
164368142|NCT02342704|593725215|FG001|Overall Study|Sponsor Termination|43|||
164368143|NCT02342704|593725214|FG000|Overall Study|Other|0|||
164368144|NCT02342704|593725215|FG001|Overall Study|Other|1|||
164368145|NCT02342704|593725214|FG000|Overall Study|Withdrawal by Subject|1|||
164368146|NCT02342704|593725215|FG001|Overall Study|Withdrawal by Subject|0|||
164368147|NCT02342704|593725214|FG000|Overall Study|Lost to Follow-up|2|||
164368148|NCT02342704|593725215|FG001|Overall Study|Lost to Follow-up|1|||
164368149|NCT02342704|593725214|FG000|Overall Study|Adverse Event|1|||
164368150|NCT02342704|593725215|FG001|Overall Study|Adverse Event|3|||
164368151|NCT01675882|593725216|FG000|Overall Study|Adverse Event|0|||
164368152|NCT01675882|593725217|FG001|Overall Study|Adverse Event|2|||
164368153|NCT01675882|593725218|FG002|Overall Study|Adverse Event|1|||
164368154|NCT01675882|593725219|FG003|Overall Study|Adverse Event|0|||
164368155|NCT01675882|593725216|FG000|Overall Study|Participant unwilling to continue|2|||
164368156|NCT01675882|593725217|FG001|Overall Study|Participant unwilling to continue|4|||
164368157|NCT01675882|593725218|FG002|Overall Study|Participant unwilling to continue|2|||
164368158|NCT01675882|593725219|FG003|Overall Study|Participant unwilling to continue|1|||
164368159|NCT01675882|593725216|FG000|Overall Study|Lost to Follow-up|0|||
164368160|NCT01675882|593725217|FG001|Overall Study|Lost to Follow-up|1|||
164368161|NCT01675882|593725218|FG002|Overall Study|Lost to Follow-up|0|||
164368162|NCT01675882|593725219|FG003|Overall Study|Lost to Follow-up|0|||
164368163|NCT01675882|593725216|FG000|Overall Study|Non-compliance|0|||
164368164|NCT01675882|593725217|FG001|Overall Study|Non-compliance|0|||
164368165|NCT01675882|593725218|FG002|Overall Study|Non-compliance|0|||
164368166|NCT01675882|593725219|FG003|Overall Study|Non-compliance|1|||
164368167|NCT01446965|593725222|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
164368168|NCT01446965|593725223|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
164144028|NCT00086281|592888582|FG011|Phase 1|Serious Adverse Event|0|||
164368169|NCT01446965|593725222|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
164368170|NCT01446965|593725223|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
164368171|NCT02016482|593725233|FG000|Period A|Adverse Event|3|||
164368172|NCT02016482|593725234|FG001|Period A|Adverse Event|5|||
164368173|NCT02016482|593725233|FG000|Period A|Withdrawal by Subject|3|||
164368174|NCT02016482|593725234|FG001|Period A|Withdrawal by Subject|4|||
164368175|NCT02016482|593725233|FG000|Period A|Lost to Follow-up|3|||
164368176|NCT02016482|593725234|FG001|Period A|Lost to Follow-up|3|||
164368177|NCT02016482|593725233|FG000|Period A|Lack of Efficacy|2|||
164368178|NCT02016482|593725234|FG001|Period A|Lack of Efficacy|1|||
164368179|NCT02016482|593725233|FG000|Period A|Other|3|||
164368180|NCT02016482|593725234|FG001|Period A|Other|0|||
164368181|NCT02016482|593725233|FG000|Period A|Protocol Violation|0|||
164368182|NCT02016482|593725234|FG001|Period A|Protocol Violation|1|||
164368183|NCT02016482|593725233|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
164368184|NCT02016482|593725234|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
164368185|NCT02016482|593725233|FG000|Period B|Withdrawal by Subject|1|||
164368186|NCT02016482|593725234|FG001|Period B|Withdrawal by Subject|1|||
164368187|NCT02016482|593725233|FG000|Period B|Lost to Follow-up|2|||
164368188|NCT02016482|593725234|FG001|Period B|Lost to Follow-up|0|||
164368189|NCT02016482|593725233|FG000|Period B|Lack of Efficacy|6|||
164368190|NCT02016482|593725234|FG001|Period B|Lack of Efficacy|4|||
164368191|NCT02016482|593725233|FG000|Period B|Other|4|||
164368192|NCT02016482|593725234|FG001|Period B|Other|0|||
164368193|NCT02016482|593725233|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
164368194|NCT02016482|593725234|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
164368195|NCT00606892|593725235|FG000|First Intervention|Protocol Violation|1|||
164368196|NCT00606892|593725236|FG001|First Intervention|Protocol Violation|4|||
164368197|NCT00855309|593725238|FG000|Overall Study|patient never recieved drug|1|||
164368198|NCT00855309|593725239|FG001|Overall Study|patient never recieved drug|0|||
164368199|NCT00829296|593725240|FG000|Overall Study|Adverse Event|5|||
164368200|NCT00829296|593725241|FG001|Overall Study|Adverse Event|4|||
164368201|NCT04960228|593725247|FG000|Overall Study|Withdrawal by Subject|216|||
164368202|NCT04960228|593725248|FG001|Overall Study|Withdrawal by Subject|35|||
164368203|NCT04960228|593725247|FG000|Overall Study|Failed attention check|69|||
164368204|NCT04960228|593725248|FG001|Overall Study|Failed attention check|148|||
164368205|NCT04960228|593725247|FG000|Overall Study|Flagged for response quality by Dynata|3|||
164368206|NCT04960228|593725248|FG001|Overall Study|Flagged for response quality by Dynata|3|||
164368207|NCT02547129|593725249|FG000|Overall Study|Difficulty with ongoing infection|1|||
164368208|NCT02547129|593725250|FG001|Overall Study|Difficulty with ongoing infection|0|||
164368209|NCT00794196|593725251|FG000|Overall Study|Lost to Follow-up|5|||
164368210|NCT00794196|593725252|FG001|Overall Study|Lost to Follow-up|23|||
164368211|NCT01640366|593725253|FG000|Overall Study|Withdrawal by Subject|1|||
164368212|NCT01640366|593725253|FG000|Overall Study|Protocol Violation|16|||
164368213|NCT01640366|593725253|FG000|Overall Study|Lost to Follow-up|5|||
164368214|NCT04964128|593725254|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
164368215|NCT04964128|593725254|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
164368216|NCT00994240|593725256|FG000|Overall Study|Lost to Follow-up|3|||
164368217|NCT00994240|593725257|FG001|Overall Study|Lost to Follow-up|2|||
164368218|NCT00994240|593725256|FG000|Overall Study|Withdrawal by Subject|1|||
164368219|NCT00994240|593725257|FG001|Overall Study|Withdrawal by Subject|0|||
164368220|NCT00994240|593725256|FG000|Overall Study|study termination|2|||
164368221|NCT00994240|593725257|FG001|Overall Study|study termination|3|||
164368222|NCT01200797|593725260|FG000|Overall Study|symptomatic deterioration|2|||
164368223|NCT01200797|593725260|FG000|Overall Study|Adverse Event|4|||
164368224|NCT01200797|593725260|FG000|Overall Study|Disease Progression|13|||
164368225|NCT03745144|593725263|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
164368226|NCT03745144|593725264|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
164368227|NCT03745144|593725265|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
164368228|NCT03745144|593725263|FG000|Period 1|Other|0|||
164368229|NCT03745144|593725264|FG001|Period 1|Other|0|||
164368230|NCT03745144|593725265|FG002|Period 1|Other|1|||
164368231|NCT00642668|593725270|FG000|Overall Study|Lost to Follow-up|1|||
164368232|NCT00642668|593725270|FG000|Overall Study|Adverse Event|2|||
164368233|NCT00642668|593725270|FG000|Overall Study|Death|2|||
164368234|NCT00642668|593725270|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164368235|NCT00642668|593725270|FG000|Overall Study|Failure to Return|1|||
164368236|NCT00642668|593725270|FG000|Overall Study|Dialysis Initiation|5|||
164368237|NCT00642668|593725270|FG000|Overall Study|Blood Transfusion|2|||
164368238|NCT00896337|593725271|FG000|Overall Study|Death|7|||
164368239|NCT00896337|593725271|FG000|Overall Study|Withdrawal by Subject|7|||
164368240|NCT00896337|593725271|FG000|Overall Study|Lost to Follow-up|11|||
164368241|NCT01177540|593725272|FG000|Overall Study|Adverse Event|1|||
164368242|NCT01177540|593725273|FG001|Overall Study|Adverse Event|0|||
164368243|NCT02013167|593725275|FG000|Overall Study|Withdrawal by Subject|15|||
164368244|NCT02013167|593725276|FG001|Overall Study|Withdrawal by Subject|14|||
164092715|NCT00911859|592702113|FG000|Follow-up Period|Study terminated by sponsor|5|||
164368245|NCT02013167|593725275|FG000|Overall Study|Sponsor Decision|1|||
164368246|NCT02013167|593725276|FG001|Overall Study|Sponsor Decision|3|||
164368247|NCT02013167|593725275|FG000|Overall Study|Lost to Follow-up|0|||
164368248|NCT02013167|593725276|FG001|Overall Study|Lost to Follow-up|1|||
164368249|NCT02013167|593725275|FG000|Overall Study|Death|85|||
164368250|NCT02013167|593725276|FG001|Overall Study|Death|160|||
164368251|NCT01077804|593725288|FG000|Overall Study|Unreachable|102|||
164368252|NCT01077804|593725288|FG000|Overall Study|Refused to continue|79|||
164368253|NCT01077804|593725288|FG000|Overall Study|Other|18|||
164368254|NCT02776917|593725289|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
164368255|NCT00560950|593725296|FG000|Overall Study|Lost to Follow-up|1|||
164368256|NCT00560950|593725297|FG001|Overall Study|Lost to Follow-up|0|||
164368257|NCT00574405|593727158|FG000|Overall Study|Withdrawal by Subject|3|||
164368258|NCT00574405|593727159|FG001|Overall Study|Withdrawal by Subject|2|||
164368259|NCT01336738|593727160|FG000|Overall Study|Adverse Event|0|||
164368260|NCT01336738|593727161|FG001|Overall Study|Adverse Event|3|||
164368261|NCT01336738|593727162|FG002|Overall Study|Adverse Event|2|||
164368262|NCT01336738|593727163|FG003|Overall Study|Adverse Event|1|||
164368263|NCT01336738|593727164|FG004|Overall Study|Adverse Event|3|||
164368264|NCT01336738|593727160|FG000|Overall Study|Lost to Follow-up|2|||
164368265|NCT01336738|593727161|FG001|Overall Study|Lost to Follow-up|1|||
164368266|NCT01336738|593727162|FG002|Overall Study|Lost to Follow-up|2|||
164368267|NCT01336738|593727163|FG003|Overall Study|Lost to Follow-up|2|||
164368268|NCT01336738|593727164|FG004|Overall Study|Lost to Follow-up|2|||
164368269|NCT01336738|593727160|FG000|Overall Study|Did not meet entrance criteria|0|||
164368270|NCT01336738|593727161|FG001|Overall Study|Did not meet entrance criteria|1|||
164368271|NCT01336738|593727162|FG002|Overall Study|Did not meet entrance criteria|0|||
164368272|NCT01336738|593727163|FG003|Overall Study|Did not meet entrance criteria|0|||
164368273|NCT01336738|593727164|FG004|Overall Study|Did not meet entrance criteria|0|||
164368274|NCT01336738|593727160|FG000|Overall Study|Protocol Violation|0|||
164368275|NCT01336738|593727161|FG001|Overall Study|Protocol Violation|1|||
164368276|NCT01336738|593727162|FG002|Overall Study|Protocol Violation|0|||
164368277|NCT01336738|593727163|FG003|Overall Study|Protocol Violation|0|||
164368278|NCT01336738|593727164|FG004|Overall Study|Protocol Violation|0|||
164368279|NCT01336738|593727160|FG000|Overall Study|Withdrawal by Subject|2|||
164368280|NCT01336738|593727161|FG001|Overall Study|Withdrawal by Subject|0|||
164368281|NCT01336738|593727162|FG002|Overall Study|Withdrawal by Subject|2|||
164368282|NCT01336738|593727163|FG003|Overall Study|Withdrawal by Subject|1|||
164368283|NCT01336738|593727164|FG004|Overall Study|Withdrawal by Subject|1|||
164368284|NCT01336738|593727160|FG000|Overall Study|Other|3|||
164368285|NCT01336738|593727161|FG001|Overall Study|Other|3|||
164368286|NCT01336738|593727162|FG002|Overall Study|Other|2|||
164368287|NCT01336738|593727163|FG003|Overall Study|Other|3|||
164368288|NCT01336738|593727164|FG004|Overall Study|Other|4|||
164368289|NCT01083433|593727165|FG000|Overall Study|Lost to Follow-up|2|||
164368290|NCT01083433|593727166|FG001|Overall Study|Lost to Follow-up|1|||
164368291|NCT01083433|593727167|FG002|Overall Study|Lost to Follow-up|1|||
164368292|NCT01083433|593727165|FG000|Overall Study|Withdrawal by Subject|0|||
164368293|NCT01083433|593727166|FG001|Overall Study|Withdrawal by Subject|5|||
164368294|NCT01083433|593727167|FG002|Overall Study|Withdrawal by Subject|3|||
164368295|NCT01083433|593727165|FG000|Overall Study|Pregnancy|0|||
164368296|NCT01083433|593727166|FG001|Overall Study|Pregnancy|0|||
164368297|NCT01083433|593727167|FG002|Overall Study|Pregnancy|1|||
164368298|NCT02970968|593727169|FG000|Overall Study|Withdrawal by Subject|3|||
164368299|NCT02970968|593727170|FG001|Overall Study|Withdrawal by Subject|3|||
164368300|NCT02970968|593727169|FG000|Overall Study|Adverse Event|1|||
164368301|NCT02970968|593727170|FG001|Overall Study|Adverse Event|2|||
164368302|NCT02970968|593727169|FG000|Overall Study|Lost to Follow-up|1|||
164368303|NCT02970968|593727170|FG001|Overall Study|Lost to Follow-up|1|||
164368304|NCT02970968|593727169|FG000|Overall Study|Non-Compliance|0|||
164368305|NCT02970968|593727170|FG001|Overall Study|Non-Compliance|1|||
164368306|NCT03003520|593727171|FG000|Overall Study|Adverse Event|9|||
164368307|NCT03003520|593727172|FG001|Overall Study|Adverse Event|0|||
164368308|NCT03003520|593727171|FG000|Overall Study|Death|1|||
164368309|NCT03003520|593727172|FG001|Overall Study|Death|0|||
164368310|NCT03003520|593727171|FG000|Overall Study|Other reasons|4|||
164368311|NCT03003520|593727172|FG001|Overall Study|Other reasons|0|||
164368312|NCT03003520|593727171|FG000|Overall Study|Withdrawal by Subject|6|||
164368313|NCT03003520|593727172|FG001|Overall Study|Withdrawal by Subject|0|||
164368314|NCT03003520|593727171|FG000|Overall Study|Progressive disease|9|||
164368315|NCT03003520|593727172|FG001|Overall Study|Progressive disease|1|||
164368316|NCT01332149|593727173|FG000|Overall Study|Adverse Event|11|||
164368317|NCT01332149|593727174|FG001|Overall Study|Adverse Event|9|||
164368318|NCT01332149|593727173|FG000|Overall Study|Other unspecified|5|||
163902011|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
163902012|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
163902013|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
163902014|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
163902015|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
164368319|NCT01332149|593727174|FG001|Overall Study|Other unspecified|7|||
164368320|NCT01332149|593727173|FG000|Overall Study|Protocol Violation|1|||
164368321|NCT01332149|593727174|FG001|Overall Study|Protocol Violation|3|||
164368322|NCT01332149|593727173|FG000|Overall Study|Withdrawal by Subject|4|||
164368323|NCT01332149|593727174|FG001|Overall Study|Withdrawal by Subject|5|||
164368324|NCT01332149|593727173|FG000|Overall Study|Lost to Follow-up|1|||
164368325|NCT01332149|593727174|FG001|Overall Study|Lost to Follow-up|1|||
164368326|NCT01332149|593727173|FG000|Overall Study|Insufficient clinical response|4|||
164368327|NCT01332149|593727174|FG001|Overall Study|Insufficient clinical response|7|||
164368328|NCT01332149|593727173|FG000|Overall Study|Did not meet entrance criteria|3|||
164368329|NCT01332149|593727174|FG001|Overall Study|Did not meet entrance criteria|4|||
164368330|NCT01332149|593727173|FG000|Overall Study|Randomized but not treated|1|||
164368331|NCT01332149|593727174|FG001|Overall Study|Randomized but not treated|2|||
164368332|NCT04982029|593727175|FG000|Overall Study|Lost to Follow-up|2|||
164368333|NCT04982029|593727176|FG001|Overall Study|Lost to Follow-up|3|||
164368334|NCT03264404|593727177|FG000|Overall Study|Death|2|||
164368335|NCT03264404|593727177|FG000|Overall Study|Physician Decision|1|||
164368336|NCT03264404|593727177|FG000|Overall Study|Disease Progression|28|||
164368337|NCT03264404|593727177|FG000|Overall Study|Adverse Event|1|||
164368338|NCT03264404|593727177|FG000|Overall Study|Off study prior to treatment|2|||
164368339|NCT02565381|593727178|FG000|Overall Study|Lost to Follow-up|1|||
164368340|NCT02565381|593727179|FG001|Overall Study|Lost to Follow-up|0|||
164368341|NCT02565381|593727180|FG002|Overall Study|Lost to Follow-up|1|||
164368342|NCT04615949|593727183|FG000|Overall Study|Withdrawal by Subject|2|||
164368343|NCT04615949|593727184|FG001|Overall Study|Withdrawal by Subject|4|||
164368344|NCT04615949|593727183|FG000|Overall Study|Lost to Follow-up|2|||
164368345|NCT04615949|593727184|FG001|Overall Study|Lost to Follow-up|2|||
164368346|NCT04615949|593727183|FG000|Overall Study|Death|0|||
164368347|NCT04615949|593727184|FG001|Overall Study|Death|2|||
164368348|NCT03036566|593727185|FG000|Overall Study|Lost to Follow-up|3|||
164368349|NCT05458856|593727186|FG000|Overall Study|Withdrawal by Subject|5|||
164368350|NCT05458856|593727186|FG000|Overall Study|Death|4|||
164368351|NCT05458856|593727186|FG000|Overall Study|Protocol Deviation|3|||
164368352|NCT05458856|593727186|FG000|Overall Study|Physician Decision|1|||
164368353|NCT01852292|593727190|FG000|Overall Study|Untreated - did not receive study drug|3|||
164368354|NCT01852292|593727191|FG001|Overall Study|Untreated - did not receive study drug|1|||
164368355|NCT01852292|593727190|FG000|Overall Study|Death|9|||
164368356|NCT01852292|593727191|FG001|Overall Study|Death|8|||
164368357|NCT01852292|593727190|FG000|Overall Study|Patient/guardian decision|8|||
164368358|NCT01852292|593727191|FG001|Overall Study|Patient/guardian decision|4|||
164368359|NCT01852292|593727190|FG000|Overall Study|Adverse Event|8|||
164368360|NCT01852292|593727191|FG001|Overall Study|Adverse Event|11|||
164368361|NCT01852292|593727190|FG000|Overall Study|Physician Decision|6|||
164368362|NCT01852292|593727191|FG001|Overall Study|Physician Decision|2|||
164368363|NCT01852292|593727190|FG000|Overall Study|Protocol Violation|2|||
164368364|NCT01852292|593727191|FG001|Overall Study|Protocol Violation|0|||
164368365|NCT01852292|593727190|FG000|Overall Study|Non-compliance with study treatment|1|||
164368366|NCT01852292|593727191|FG001|Overall Study|Non-compliance with study treatment|0|||
164368367|NCT01852292|593727190|FG000|Overall Study|Study terminated by Sponsor|0|||
164368368|NCT01852292|593727191|FG001|Overall Study|Study terminated by Sponsor|1|||
164368369|NCT01852292|593727190|FG000|Overall Study|Progressive disease|42|||
164368370|NCT01852292|593727191|FG001|Overall Study|Progressive disease|52|||
164368371|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Adverse Event|2|||
164368372|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Adverse Event|3|||
164368373|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Adverse Event|4|||
164368374|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Adverse Event|4|||
164368375|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
164368376|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
163902016|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
164092716|NCT00911859|592702114|FG001|Follow-up Period|Study terminated by sponsor|33|||
164092717|NCT00911859|592702115|FG002|Follow-up Period|Study terminated by sponsor|27|||
164092718|NCT03008460|592702120|FG000|Overall Study|Protocol deviation|0|||
164092719|NCT03008460|592702121|FG001|Overall Study|Protocol deviation|2|||
164092720|NCT03008460|592702120|FG000|Overall Study|Study drug not dispensed|0|||
164092721|NCT03008460|592702121|FG001|Overall Study|Study drug not dispensed|1|||
164092722|NCT03008460|592702120|FG000|Overall Study|Adverse Event|0|||
164092723|NCT03008460|592702121|FG001|Overall Study|Adverse Event|1|||
164092724|NCT03008460|592702120|FG000|Overall Study|Withdrawal by Subject|5|||
164092725|NCT03008460|592702121|FG001|Overall Study|Withdrawal by Subject|6|||
164092726|NCT03008460|592702120|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
164092727|NCT03008460|592702121|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
164092728|NCT03008460|592702120|FG000|Overall Study|End of study visit outside permitted time window|0|||
164092729|NCT03008460|592702121|FG001|Overall Study|End of study visit outside permitted time window|1|||
164368377|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
163902017|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
163902018|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
164092730|NCT03008460|592702120|FG000|Overall Study|Lost to Follow-up|1|||
164092731|NCT03008460|592702121|FG001|Overall Study|Lost to Follow-up|3|||
164368378|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
164368379|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
164368380|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
164368381|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
164368382|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
164368383|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
164368384|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
164092732|NCT04272801|592702127|FG000|Overall Study|Withdrawal by Subject|4|||
164092733|NCT04272801|592702127|FG000|Overall Study|Lost to Follow-up|4|||
164092734|NCT04272801|592702127|FG000|Overall Study|Ineligible|1|||
164092735|NCT00752856|592702128|FG000|Overall Study|randomized but did not do viral kinetics|0|||
164368385|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
164368386|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
164368387|NCT00071812|593727194|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
164368388|NCT00071812|593727195|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
164368389|NCT00071812|593727196|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
164368390|NCT00071812|593727197|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
164368391|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
164368392|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
164368393|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
164368394|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
164368395|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164368396|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164368397|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164368398|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
164368399|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164368400|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164368401|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164368402|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
164368403|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164368404|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164368405|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164368406|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
164368407|NCT00071812|593727194|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164368408|NCT00071812|593727195|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164368409|NCT00071812|593727196|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
164368410|NCT00071812|593727197|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
164368411|NCT01940120|593727200|FG000|Overall Study|Death|40|||
164368412|NCT01940120|593727200|FG000|Overall Study|Withdrawal by Subject|8|||
164368413|NCT03711162|593727202|FG000|Overall Study|Adverse Event|5|||
164368414|NCT03711162|593727203|FG001|Overall Study|Adverse Event|2|||
164368415|NCT03711162|593727204|FG002|Overall Study|Adverse Event|4|||
164368416|NCT03711162|593727202|FG000|Overall Study|Death|11|||
164368417|NCT03711162|593727203|FG001|Overall Study|Death|7|||
164368418|NCT03711162|593727204|FG002|Overall Study|Death|8|||
164368419|NCT03711162|593727202|FG000|Overall Study|Lost to Follow-up|1|||
164368420|NCT03711162|593727203|FG001|Overall Study|Lost to Follow-up|0|||
164368421|NCT03711162|593727204|FG002|Overall Study|Lost to Follow-up|1|||
164368422|NCT03711162|593727202|FG000|Overall Study|Study Terminated by Sponsor|139|||
164368423|NCT03711162|593727203|FG001|Overall Study|Study Terminated by Sponsor|152|||
164368424|NCT03711162|593727204|FG002|Overall Study|Study Terminated by Sponsor|146|||
164368425|NCT03711162|593727202|FG000|Overall Study|Withdrawal by Subject|17|||
164368426|NCT03711162|593727203|FG001|Overall Study|Withdrawal by Subject|10|||
164368427|NCT03711162|593727204|FG002|Overall Study|Withdrawal by Subject|10|||
164368428|NCT03711162|593727202|FG000|Overall Study|Miscellaneous|1|||
164368429|NCT03711162|593727203|FG001|Overall Study|Miscellaneous|2|||
164368430|NCT03711162|593727204|FG002|Overall Study|Miscellaneous|2|||
164368431|NCT03711162|593727202|FG000|Overall Study|Not Treated|1|||
164368432|NCT03711162|593727203|FG001|Overall Study|Not Treated|0|||
164368433|NCT03711162|593727204|FG002|Overall Study|Not Treated|1|||
164368434|NCT03711162|593727202|FG000|Overall Study|Physician Decision|0|||
164368435|NCT03711162|593727203|FG001|Overall Study|Physician Decision|2|||
164368436|NCT03711162|593727204|FG002|Overall Study|Physician Decision|0|||
164368437|NCT03711162|593727202|FG000|Overall Study|Lack of Efficacy|0|||
164368438|NCT03711162|593727203|FG001|Overall Study|Lack of Efficacy|0|||
164368439|NCT03711162|593727204|FG002|Overall Study|Lack of Efficacy|2|||
164368440|NCT03711162|593727202|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
164368441|NCT03711162|593727203|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
164368442|NCT03711162|593727204|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
163902019|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
163902020|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
163902021|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
163902022|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
164368443|NCT01275066|593727207|FG000|Overall Study|Withdrawal by Subject|0|||
164368444|NCT01275066|593727208|FG001|Overall Study|Withdrawal by Subject|0|||
164368445|NCT01275066|593727209|FG002|Overall Study|Withdrawal by Subject|1|||
164368446|NCT01275066|593727207|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
164368447|NCT01275066|593727208|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
164368448|NCT01275066|593727209|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
163902023|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
164368449|NCT03240133|593727210|FG000|Overall Study|Withdrawal by Subject|0|||
164368450|NCT03240133|593727211|FG001|Overall Study|Withdrawal by Subject|1|||
164368451|NCT03240133|593727212|FG002|Overall Study|Withdrawal by Subject|0|||
164368452|NCT03240133|593727210|FG000|Overall Study|Adverse Event|1|||
164368453|NCT03240133|593727211|FG001|Overall Study|Adverse Event|1|||
164368454|NCT03240133|593727212|FG002|Overall Study|Adverse Event|0|||
164368455|NCT03240133|593727210|FG000|Overall Study|Rash|1|||
164368456|NCT03240133|593727211|FG001|Overall Study|Rash|0|||
164368457|NCT03240133|593727212|FG002|Overall Study|Rash|0|||
164368458|NCT03240133|593727210|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
164368459|NCT03240133|593727211|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
164368460|NCT03240133|593727212|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
164368461|NCT03240133|593727210|FG000|Overall Study|Intercurrent illness.|0|||
164368462|NCT03240133|593727211|FG001|Overall Study|Intercurrent illness.|1|||
164368463|NCT03240133|593727212|FG002|Overall Study|Intercurrent illness.|0|||
164368464|NCT03240133|593727210|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
164368465|NCT03240133|593727211|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
164368466|NCT03240133|593727212|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
164368467|NCT00749463|593727213|FG000|Overall Study|Adverse Event|0|||
164368468|NCT00749463|593727214|FG001|Overall Study|Adverse Event|4|||
164368469|NCT00749463|593727215|FG002|Overall Study|Adverse Event|1|||
164368470|NCT00749463|593727213|FG000|Overall Study|Withdrawal by Subject|1|||
164368471|NCT00749463|593727214|FG001|Overall Study|Withdrawal by Subject|0|||
164368472|NCT00749463|593727215|FG002|Overall Study|Withdrawal by Subject|0|||
164368473|NCT00116831|593727216|FG000|Overall Study|Adverse Event|14|||
164368474|NCT00116831|593727217|FG001|Overall Study|Adverse Event|16|||
164368475|NCT00116831|593727216|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
164368476|NCT00116831|593727217|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
164368477|NCT00116831|593727216|FG000|Overall Study|Lost to Follow-up|8|||
164368478|NCT00116831|593727217|FG001|Overall Study|Lost to Follow-up|6|||
164368479|NCT00116831|593727216|FG000|Overall Study|Protocol Violation|3|||
164368480|NCT00116831|593727217|FG001|Overall Study|Protocol Violation|6|||
164368481|NCT00116831|593727216|FG000|Overall Study|Hypoglycaemic events|1|||
164368482|NCT00116831|593727217|FG001|Overall Study|Hypoglycaemic events|0|||
164368483|NCT00116831|593727216|FG000|Overall Study|Low haemoglobin on screening|1|||
164368484|NCT00116831|593727217|FG001|Overall Study|Low haemoglobin on screening|0|||
164368485|NCT00116831|593727216|FG000|Overall Study|Withdrawn investigational product|1|||
164368486|NCT00116831|593727217|FG001|Overall Study|Withdrawn investigational product|0|||
164368487|NCT00116831|593727216|FG000|Overall Study|Withdrawal by Subject|32|||
164368488|NCT00116831|593727217|FG001|Overall Study|Withdrawal by Subject|32|||
164368489|NCT00116831|593727216|FG000|Overall Study|Insufficient therapeutic effect|0|||
164368490|NCT00116831|593727217|FG001|Overall Study|Insufficient therapeutic effect|1|||
164368491|NCT00116831|593727216|FG000|Overall Study|Missing data for participant|1|||
164368492|NCT00116831|593727217|FG001|Overall Study|Missing data for participant|0|||
164368493|NCT04904185|593727218|FG000|Overall Study|Expansion failure|1|||
164368494|NCT04904185|593727219|FG001|Overall Study|Expansion failure|0|||
164368495|NCT04904185|593727218|FG000|Overall Study|Late response on prior treatment|1|||
164368496|NCT04904185|593727219|FG001|Overall Study|Late response on prior treatment|0|||
164368497|NCT01344369|593727222|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
164368498|NCT01344369|593727223|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
164368499|NCT01344369|593727222|FG000|Washout of 28 Days|Physician Decision|0|||
164368500|NCT01344369|593727223|FG001|Washout of 28 Days|Physician Decision|1|||
164368501|NCT01344369|593727222|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
164368502|NCT01344369|593727223|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
164368503|NCT00333229|593727228|FG000|Overall Study|Lack of Efficacy|0|||
164368504|NCT00333229|593727229|FG001|Overall Study|Lack of Efficacy|1|||
164368505|NCT00735371|593727238|FG000|Overall Study|Adverse Event|3|||
164368506|NCT00735371|593727239|FG001|Overall Study|Adverse Event|3|||
164368507|NCT00735371|593727240|FG002|Overall Study|Adverse Event|4|||
164368508|NCT00735371|593727241|FG003|Overall Study|Adverse Event|1|||
164368509|NCT00735371|593727238|FG000|Overall Study|Protocol Violation|2|||
164368510|NCT00735371|593727239|FG001|Overall Study|Protocol Violation|2|||
164368511|NCT00735371|593727240|FG002|Overall Study|Protocol Violation|0|||
164368512|NCT00735371|593727241|FG003|Overall Study|Protocol Violation|3|||
164368513|NCT00735371|593727238|FG000|Overall Study|Withdrawal by Subject|0|||
164368514|NCT00735371|593727239|FG001|Overall Study|Withdrawal by Subject|2|||
164368515|NCT00735371|593727240|FG002|Overall Study|Withdrawal by Subject|2|||
164368516|NCT00735371|593727241|FG003|Overall Study|Withdrawal by Subject|0|||
164368517|NCT00735371|593727238|FG000|Overall Study|Lost to Follow-up|1|||
163902024|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163902025|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
164368518|NCT00735371|593727239|FG001|Overall Study|Lost to Follow-up|1|||
164368519|NCT00735371|593727240|FG002|Overall Study|Lost to Follow-up|3|||
164368520|NCT00735371|593727241|FG003|Overall Study|Lost to Follow-up|1|||
164368521|NCT00735371|593727238|FG000|Overall Study|Lack of Efficacy|4|||
164368522|NCT00735371|593727239|FG001|Overall Study|Lack of Efficacy|2|||
164368523|NCT00735371|593727240|FG002|Overall Study|Lack of Efficacy|0|||
164368524|NCT00735371|593727241|FG003|Overall Study|Lack of Efficacy|4|||
163902026|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
164368525|NCT00735371|593727238|FG000|Overall Study|Sponsor Decision|3|||
164368526|NCT00735371|593727239|FG001|Overall Study|Sponsor Decision|1|||
164368527|NCT00735371|593727240|FG002|Overall Study|Sponsor Decision|0|||
164368528|NCT00735371|593727241|FG003|Overall Study|Sponsor Decision|1|||
164368529|NCT00735371|593727238|FG000|Overall Study|Protocol Violation|0|||
164368530|NCT00735371|593727239|FG001|Overall Study|Protocol Violation|1|||
164368531|NCT00735371|593727240|FG002|Overall Study|Protocol Violation|2|||
164368532|NCT00735371|593727241|FG003|Overall Study|Protocol Violation|0|||
164368533|NCT00735371|593727238|FG000|Overall Study|Prior Vyvanse Exposure|1|||
164368534|NCT00735371|593727239|FG001|Overall Study|Prior Vyvanse Exposure|1|||
164368535|NCT00735371|593727240|FG002|Overall Study|Prior Vyvanse Exposure|0|||
164368536|NCT00735371|593727241|FG003|Overall Study|Prior Vyvanse Exposure|0|||
164368537|NCT00735371|593727238|FG000|Overall Study|Exclusion criteria|1|||
164368538|NCT00735371|593727239|FG001|Overall Study|Exclusion criteria|0|||
164368539|NCT00735371|593727240|FG002|Overall Study|Exclusion criteria|0|||
164368540|NCT00735371|593727241|FG003|Overall Study|Exclusion criteria|0|||
164368541|NCT01533246|593727242|FG000|Overall Study|Adverse Event|1|||
164368542|NCT01533246|593727242|FG000|Overall Study|Withdrawal by Subject|1|||
164368543|NCT04225923|593727265|FG000|Overall Study|Protocol Violation|1|||
164368544|NCT04225923|593727266|FG001|Overall Study|Protocol Violation|0|||
164368545|NCT04225923|593727267|FG002|Overall Study|Protocol Violation|1|||
164368546|NCT04225923|593727265|FG000|Overall Study|Withdrawal by Subject|4|||
164368547|NCT04225923|593727266|FG001|Overall Study|Withdrawal by Subject|1|||
164368548|NCT04225923|593727267|FG002|Overall Study|Withdrawal by Subject|3|||
164368549|NCT04225923|593727265|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
164368550|NCT04225923|593727266|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
164368551|NCT04225923|593727267|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
164368552|NCT01585766|593727273|FG000|Overall Study|Withdrawal by Subject|0|||
164368553|NCT01585766|593727274|FG001|Overall Study|Withdrawal by Subject|1|||
164368554|NCT01585766|593727275|FG002|Overall Study|Withdrawal by Subject|1|||
164368555|NCT01585766|593727276|FG003|Overall Study|Withdrawal by Subject|0|||
164368556|NCT01585766|593727277|FG004|Overall Study|Withdrawal by Subject|0|||
164368557|NCT01585766|593727278|FG005|Overall Study|Withdrawal by Subject|0|||
164368558|NCT01585766|593727273|FG000|Overall Study|Death|0|||
164368559|NCT01585766|593727274|FG001|Overall Study|Death|1|||
164368560|NCT01585766|593727275|FG002|Overall Study|Death|0|||
164368561|NCT01585766|593727276|FG003|Overall Study|Death|0|||
164368562|NCT01585766|593727277|FG004|Overall Study|Death|0|||
164368563|NCT01585766|593727278|FG005|Overall Study|Death|0|||
164368564|NCT01585766|593727273|FG000|Overall Study|Physician Decision|0|||
164368565|NCT01585766|593727274|FG001|Overall Study|Physician Decision|0|||
164368566|NCT01585766|593727275|FG002|Overall Study|Physician Decision|1|||
164368567|NCT01585766|593727276|FG003|Overall Study|Physician Decision|0|||
164368568|NCT01585766|593727277|FG004|Overall Study|Physician Decision|0|||
164368569|NCT01585766|593727278|FG005|Overall Study|Physician Decision|0|||
164368570|NCT01364428|593727279|FG000|Overall Study|Adverse Event|1|||
164368571|NCT01364428|593727280|FG001|Overall Study|Adverse Event|2|||
164368572|NCT01364428|593727279|FG000|Overall Study|Protocol Violation|2|||
164368573|NCT01364428|593727280|FG001|Overall Study|Protocol Violation|0|||
164368574|NCT01364428|593727279|FG000|Overall Study|Withdrawal Criteria|14|||
164368575|NCT01364428|593727280|FG001|Overall Study|Withdrawal Criteria|10|||
164368576|NCT01364428|593727279|FG000|Overall Study|Other|3|||
164368577|NCT01364428|593727280|FG001|Overall Study|Other|3|||
164368578|NCT01987427|593727281|FG000|Overall Study|Adverse Event|4|||
164368579|NCT01987427|593727282|FG001|Overall Study|Adverse Event|2|||
164368580|NCT01987427|593727283|FG002|Overall Study|Adverse Event|8|||
164368581|NCT01987427|593727281|FG000|Overall Study|Lost to Follow-up|6|||
164368582|NCT01987427|593727282|FG001|Overall Study|Lost to Follow-up|6|||
164012335|NCT04101422|592408705|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
164012336|NCT04101422|592408706|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
164012337|NCT04101422|592408707|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
164012338|NCT04101422|592408708|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
164368583|NCT01987427|593727283|FG002|Overall Study|Lost to Follow-up|9|||
164368584|NCT01987427|593727281|FG000|Overall Study|Withdrawal by Subject|2|||
164368585|NCT01987427|593727282|FG001|Overall Study|Withdrawal by Subject|1|||
164368586|NCT01987427|593727283|FG002|Overall Study|Withdrawal by Subject|3|||
164368587|NCT01987427|593727281|FG000|Overall Study|Lack of Efficacy|1|||
164368588|NCT01987427|593727282|FG001|Overall Study|Lack of Efficacy|0|||
164368589|NCT01987427|593727283|FG002|Overall Study|Lack of Efficacy|0|||
164368590|NCT01987427|593727281|FG000|Overall Study|Other|1|||
164368591|NCT01987427|593727282|FG001|Overall Study|Other|1|||
164368592|NCT01987427|593727283|FG002|Overall Study|Other|0|||
164368593|NCT02129803|593727291|FG000|Overall Study|Protocol Violation|4|||
164368594|NCT02129803|593727292|FG001|Overall Study|Protocol Violation|0|||
164368595|NCT02129803|593727291|FG000|Overall Study|Physician Decision|0|||
164368596|NCT02129803|593727292|FG001|Overall Study|Physician Decision|1|||
164368597|NCT02129803|593727291|FG000|Overall Study|Difficulty sleeping|1|||
164368598|NCT02129803|593727292|FG001|Overall Study|Difficulty sleeping|0|||
164368599|NCT02129803|593727291|FG000|Overall Study|Morning headache|0|||
164368600|NCT02129803|593727292|FG001|Overall Study|Morning headache|1|||
164368601|NCT02129803|593727291|FG000|Overall Study|Withdrawal by Subject|1|||
164368602|NCT02129803|593727292|FG001|Overall Study|Withdrawal by Subject|1|||
164368603|NCT02319031|593727293|FG000|Treatment Period|Death|1|||
164368604|NCT02319031|593727294|FG001|Treatment Period|Death|0|||
164368605|NCT01465464|593727305|FG000|Overall Study|Adverse Event|96|||
164368606|NCT01465464|593727306|FG001|Overall Study|Adverse Event|49|||
164368607|NCT01465464|593727305|FG000|Overall Study|Lack of Efficacy|139|||
164368608|NCT01465464|593727306|FG001|Overall Study|Lack of Efficacy|190|||
164368609|NCT01465464|593727305|FG000|Overall Study|Physician Decision|13|||
164368610|NCT01465464|593727306|FG001|Overall Study|Physician Decision|5|||
164368611|NCT01465464|593727305|FG000|Overall Study|Protocol Violation|1|||
164368612|NCT01465464|593727306|FG001|Overall Study|Protocol Violation|1|||
164368613|NCT01465464|593727305|FG000|Overall Study|Withdrawal by Subject|46|||
164368614|NCT01465464|593727306|FG001|Overall Study|Withdrawal by Subject|30|||
164368615|NCT01465464|593727305|FG000|Overall Study|Other|9|||
164368616|NCT01465464|593727306|FG001|Overall Study|Other|3|||
164368617|NCT01465464|593727305|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
164368618|NCT01465464|593727306|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
164368619|NCT01183975|593727309|FG000|Overall Study|Lost to Follow-up|73|||
164368620|NCT04371380|593727310|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
164368621|NCT04371380|593727311|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
164368622|NCT04371380|593727312|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
164368623|NCT02376166|593727315|FG000|Overall Study|Adverse Event|1|||
164368624|NCT02376166|593727315|FG000|Overall Study|Discontinued metformin early|2|||
164368625|NCT02739269|593727321|FG000|Overall Study|Protocol Violation|5|||
164368626|NCT02739269|593727322|FG001|Overall Study|Protocol Violation|0|||
164368627|NCT02739269|593727321|FG000|Overall Study|Cycle cancellation|2|||
164368628|NCT02739269|593727322|FG001|Overall Study|Cycle cancellation|2|||
164368629|NCT02739269|593727321|FG000|Overall Study|Withdrawal by Subject|0|||
164368630|NCT02739269|593727322|FG001|Overall Study|Withdrawal by Subject|2|||
164368631|NCT02244580|593727323|FG000|Overall Study|No cancer tissues available|241|||
164368632|NCT01228747|593727324|FG000|Overall Study|Adverse Event|8|||
164368633|NCT01228747|593727325|FG001|Overall Study|Adverse Event|4|||
164368634|NCT01228747|593727324|FG000|Overall Study|Lack of Efficacy|40|||
164368635|NCT01228747|593727325|FG001|Overall Study|Lack of Efficacy|27|||
164368636|NCT01228747|593727324|FG000|Overall Study|Protocol Violation|6|||
164368637|NCT01228747|593727325|FG001|Overall Study|Protocol Violation|5|||
164368638|NCT01228747|593727324|FG000|Overall Study|Lost to Follow-up|4|||
164368639|NCT01228747|593727325|FG001|Overall Study|Lost to Follow-up|3|||
164368640|NCT01228747|593727324|FG000|Overall Study|Withdrawal by Subject|5|||
164368641|NCT01228747|593727325|FG001|Overall Study|Withdrawal by Subject|1|||
164368642|NCT01228747|593727324|FG000|Overall Study|Other Reason|2|||
164368643|NCT01228747|593727325|FG001|Overall Study|Other Reason|5|||
164368644|NCT02136576|593727327|FG000|Overall Study|Lost to Follow-up|2|||
164368645|NCT02136576|593727328|FG001|Overall Study|Lost to Follow-up|0|||
164368646|NCT02136576|593727329|FG002|Overall Study|Lost to Follow-up|0|||
164368647|NCT01708174|593727330|FG000|Treatment Period|Withdrawal by Subject|1|||
164368648|NCT01708174|593727331|FG001|Treatment Period|Withdrawal by Subject|0|||
164368649|NCT01708174|593727332|FG002|Treatment Period|Withdrawal by Subject|0|||
164368650|NCT01708174|593727330|FG000|Treatment Period|Progressive disease|0|||
164368651|NCT01708174|593727331|FG001|Treatment Period|Progressive disease|1|||
164368652|NCT01708174|593727332|FG002|Treatment Period|Progressive disease|0|||
164368653|NCT01708174|593727330|FG000|Treatment Period|Death|0|||
164012339|NCT00718861|592408709|FG000|Overall Study|Withdrawal by Subject|15|||
164012340|NCT00718861|592408710|FG001|Overall Study|Withdrawal by Subject|10|||
164012341|NCT00718861|592408709|FG000|Overall Study|Adverse Event|2|||
164368654|NCT01708174|593727331|FG001|Treatment Period|Death|0|||
164368655|NCT01708174|593727332|FG002|Treatment Period|Death|1|||
164368656|NCT01708174|593727330|FG000|Treatment Period|Adverse Event|0|||
164368657|NCT01708174|593727331|FG001|Treatment Period|Adverse Event|1|||
164368658|NCT01708174|593727332|FG002|Treatment Period|Adverse Event|0|||
164368659|NCT00923559|593727333|FG000|Overall Study|Lost to Follow-up|2|||
164368660|NCT00923559|593727334|FG001|Overall Study|Lost to Follow-up|3|||
164368661|NCT02268812|593727335|FG000|Overall Study|Adverse Event|8|||
164368662|NCT02268812|593727336|FG001|Overall Study|Adverse Event|26|||
164368663|NCT02268812|593727337|FG002|Overall Study|Adverse Event|7|||
164368664|NCT02268812|593727338|FG003|Overall Study|Adverse Event|10|||
164368665|NCT02268812|593727335|FG000|Overall Study|Protocol deviation|0|||
164368666|NCT02268812|593727336|FG001|Overall Study|Protocol deviation|0|||
164368667|NCT02268812|593727337|FG002|Overall Study|Protocol deviation|1|||
164368668|NCT02268812|593727338|FG003|Overall Study|Protocol deviation|0|||
164368669|NCT02268812|593727335|FG000|Overall Study|Withdrawal by Subject|0|||
164368670|NCT02268812|593727336|FG001|Overall Study|Withdrawal by Subject|1|||
164368671|NCT02268812|593727337|FG002|Overall Study|Withdrawal by Subject|0|||
164368672|NCT02268812|593727338|FG003|Overall Study|Withdrawal by Subject|0|||
164368673|NCT02268812|593727335|FG000|Overall Study|Physician Decision|3|||
164368674|NCT02268812|593727336|FG001|Overall Study|Physician Decision|1|||
164368675|NCT02268812|593727337|FG002|Overall Study|Physician Decision|0|||
164368676|NCT02268812|593727338|FG003|Overall Study|Physician Decision|1|||
164368677|NCT02268812|593727335|FG000|Overall Study|Other|5|||
164368678|NCT02268812|593727336|FG001|Overall Study|Other|4|||
164368679|NCT02268812|593727337|FG002|Overall Study|Other|1|||
164368680|NCT02268812|593727338|FG003|Overall Study|Other|3|||
164368681|NCT01951157|593727341|FG000|Overall Study|Progressive Disease|12|||
164368682|NCT01951157|593727342|FG001|Overall Study|Progressive Disease|13|||
164368683|NCT01951157|593727343|FG002|Overall Study|Progressive Disease|10|||
164368684|NCT01951157|593727341|FG000|Overall Study|Treatment-unrelated AE|1|||
164368685|NCT01951157|593727342|FG001|Overall Study|Treatment-unrelated AE|0|||
164368686|NCT01951157|593727343|FG002|Overall Study|Treatment-unrelated AE|3|||
164368687|NCT01951157|593727341|FG000|Overall Study|Study Termination|0|||
164368688|NCT01951157|593727342|FG001|Overall Study|Study Termination|0|||
164368689|NCT01951157|593727343|FG002|Overall Study|Study Termination|1|||
164368690|NCT01951157|593727341|FG000|Overall Study|Physician Decision|5|||
164368691|NCT01951157|593727342|FG001|Overall Study|Physician Decision|3|||
164368692|NCT01951157|593727343|FG002|Overall Study|Physician Decision|2|||
164368693|NCT01951157|593727341|FG000|Overall Study|Non-treatmentrelated death|2|||
164368694|NCT01951157|593727342|FG001|Overall Study|Non-treatmentrelated death|2|||
164368695|NCT01951157|593727343|FG002|Overall Study|Non-treatmentrelated death|2|||
164368696|NCT01951157|593727341|FG000|Overall Study|No treated|0|||
164368697|NCT01951157|593727342|FG001|Overall Study|No treated|1|||
164368698|NCT01951157|593727343|FG002|Overall Study|No treated|0|||
164368699|NCT01951157|593727341|FG000|Overall Study|Treatment-related AE|2|||
164368700|NCT01951157|593727342|FG001|Overall Study|Treatment-related AE|0|||
164368701|NCT01951157|593727343|FG002|Overall Study|Treatment-related AE|4|||
164368702|NCT01951157|593727341|FG000|Overall Study|Consent withdrawn by subject|0|||
164368703|NCT01951157|593727342|FG001|Overall Study|Consent withdrawn by subject|1|||
164368704|NCT01951157|593727343|FG002|Overall Study|Consent withdrawn by subject|3|||
164368705|NCT01951157|593727341|FG000|Overall Study|Treatment-related death|0|||
164368706|NCT01951157|593727342|FG001|Overall Study|Treatment-related death|2|||
164368707|NCT01951157|593727343|FG002|Overall Study|Treatment-related death|0|||
164368708|NCT02620046|593727354|FG000|Overall Study|Adverse Event|22|||
164368709|NCT02620046|593727355|FG001|Overall Study|Adverse Event|42|||
164368710|NCT02620046|593727354|FG000|Overall Study|Lost to Follow-up|4|||
164368711|NCT02620046|593727355|FG001|Overall Study|Lost to Follow-up|10|||
164368712|NCT02620046|593727354|FG000|Overall Study|Withdrawal by Subject|36|||
164368713|NCT02620046|593727355|FG001|Overall Study|Withdrawal by Subject|66|||
164368714|NCT02620046|593727354|FG000|Overall Study|Site Termination|3|||
164368715|NCT02620046|593727355|FG001|Overall Study|Site Termination|3|||
164368716|NCT02620046|593727354|FG000|Overall Study|Pregnancy|3|||
164368717|NCT02620046|593727355|FG001|Overall Study|Pregnancy|7|||
163902027|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163902028|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
163902029|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
163902030|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
163902031|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
163902032|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
163902033|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
163902034|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Other|1|||
163902035|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Other|0|||
163902036|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Other|0|||
163902037|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Other|0|||
163902038|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Other|0|||
163902039|NCT02386098|592013037|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
163902040|NCT02386098|592013038|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
163902041|NCT02386098|592013039|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
163902042|NCT02386098|592013040|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
164368718|NCT02620046|593727354|FG000|Overall Study|Lack of Efficacy|81|||
164368719|NCT02620046|593727355|FG001|Overall Study|Lack of Efficacy|146|||
163902043|NCT02386098|592013041|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
164012342|NCT00718861|592408710|FG001|Overall Study|Adverse Event|1|||
164368720|NCT02620046|593727354|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
164368721|NCT02620046|593727355|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
164368722|NCT02620046|593727354|FG000|Overall Study|Reason Not Specified|13|||
164368723|NCT02620046|593727355|FG001|Overall Study|Reason Not Specified|21|||
164368724|NCT02620046|593727354|FG000|Overall Study|Significant Protocol Deviation|0|||
164368725|NCT02620046|593727355|FG001|Overall Study|Significant Protocol Deviation|1|||
164368726|NCT01914666|593729317|FG000|Treatment Period|Lack of Efficacy|0|||
164368727|NCT01914666|593729318|FG001|Treatment Period|Lack of Efficacy|0|||
164368728|NCT01914666|593729319|FG002|Treatment Period|Lack of Efficacy|2|||
164368729|NCT01914666|593729317|FG000|Treatment Period|Adverse Event|10|||
164368730|NCT01914666|593729318|FG001|Treatment Period|Adverse Event|4|||
164368731|NCT01914666|593729319|FG002|Treatment Period|Adverse Event|2|||
164368732|NCT01914666|593729317|FG000|Treatment Period|Withdrawal by Subject|3|||
164368733|NCT01914666|593729318|FG001|Treatment Period|Withdrawal by Subject|2|||
164368734|NCT01914666|593729319|FG002|Treatment Period|Withdrawal by Subject|2|||
164368735|NCT01914666|593729317|FG000|Treatment Period|Physician Decision|0|||
164368736|NCT01914666|593729318|FG001|Treatment Period|Physician Decision|0|||
164368737|NCT01914666|593729319|FG002|Treatment Period|Physician Decision|2|||
164368738|NCT02388737|593729321|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
164368739|NCT02388737|593729322|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
164368740|NCT02388737|593729323|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
164368741|NCT02388737|593729321|FG000|Overall Study|Major Protocol Deviation|18|||
164368742|NCT02388737|593729322|FG001|Overall Study|Major Protocol Deviation|25|||
164368743|NCT02388737|593729323|FG002|Overall Study|Major Protocol Deviation|22|||
164368744|NCT02388737|593729321|FG000|Overall Study|Lost to Follow-up|5|||
164368745|NCT02388737|593729322|FG001|Overall Study|Lost to Follow-up|1|||
164368746|NCT02388737|593729323|FG002|Overall Study|Lost to Follow-up|4|||
164368747|NCT02388737|593729321|FG000|Overall Study|Voluntary Withdrawal|10|||
164368748|NCT02388737|593729322|FG001|Overall Study|Voluntary Withdrawal|18|||
164368749|NCT02388737|593729323|FG002|Overall Study|Voluntary Withdrawal|17|||
164368750|NCT02388737|593729321|FG000|Overall Study|Lack of Efficacy|3|||
164368751|NCT02388737|593729322|FG001|Overall Study|Lack of Efficacy|0|||
164368752|NCT02388737|593729323|FG002|Overall Study|Lack of Efficacy|3|||
164368753|NCT02388737|593729321|FG000|Overall Study|Reason Not Specified|5|||
164368754|NCT02388737|593729322|FG001|Overall Study|Reason Not Specified|5|||
164368755|NCT02388737|593729323|FG002|Overall Study|Reason Not Specified|4|||
164368756|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
164368757|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
164368758|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
164368759|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
164368760|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
164368761|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
164368762|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
164368763|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
164368764|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
164368765|NCT03252522|593729324|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
164368766|NCT03252522|593729325|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
164368767|NCT03252522|593729326|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
164368768|NCT03252522|593729324|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
164368769|NCT03252522|593729325|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
164368770|NCT03252522|593729326|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
164368771|NCT03252522|593729324|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
164368772|NCT03252522|593729325|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
164368773|NCT03252522|593729326|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
164368774|NCT03252522|593729324|FG000|Phase 2: Open Label|Adverse Event|0|||
164368775|NCT03252522|593729325|FG001|Phase 2: Open Label|Adverse Event|0|||
164368776|NCT03252522|593729326|FG002|Phase 2: Open Label|Adverse Event|2|||
164368777|NCT03252522|593729324|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
164368778|NCT03252522|593729325|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
164368779|NCT03252522|593729326|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
164368780|NCT04152447|593729328|FG000|Overall Study|Lost to Follow-up|1|||
164368781|NCT04152447|593729329|FG001|Overall Study|Lost to Follow-up|0|||
164368782|NCT04152447|593729328|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
163902044|NCT02702843|592013042|FG000|Overall Study|Insufficient data to analyze|15|||
164368783|NCT04152447|593729329|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
163902045|NCT02702843|592013043|FG001|Overall Study|Insufficient data to analyze|23|||
164368784|NCT04152447|593729328|FG000|Overall Study|Withdrawal by Subject|0|||
164368785|NCT04152447|593729329|FG001|Overall Study|Withdrawal by Subject|1|||
164368786|NCT04152447|593729328|FG000|Overall Study|Found ineligible after enrolling|1|||
163902046|NCT05029284|592013046|FG000|Overall Study|Lost to Follow-up|1|||
163902047|NCT03002194|592013048|FG000|Overall Study|Lost to Follow-up|6|||
163902048|NCT03002194|592013048|FG000|Overall Study|Adverse Event|1|||
163902049|NCT03002194|592013048|FG000|Overall Study|Lack of Efficacy|1|||
163902050|NCT03002194|592013048|FG000|Overall Study|Withdrawal by Subject|2|||
163902051|NCT02232737|592013049|FG000|Overall Study|Lost to Follow-up|18|||
163902052|NCT02232737|592013050|FG001|Overall Study|Lost to Follow-up|28|||
163902053|NCT02232737|592013051|FG002|Overall Study|Lost to Follow-up|33|||
164368787|NCT04152447|593729329|FG001|Overall Study|Found ineligible after enrolling|1|||
164368788|NCT04152447|593729328|FG000|Overall Study|Did not receive VR headset in time.|0|||
164368789|NCT04152447|593729329|FG001|Overall Study|Did not receive VR headset in time.|2|||
164368790|NCT03240575|593729330|FG000|Overall Study|Adverse Event|0|||
164368791|NCT03240575|593729331|FG001|Overall Study|Adverse Event|2|||
164368792|NCT03240575|593729332|FG002|Overall Study|Adverse Event|0|||
164368793|NCT03240575|593729333|FG003|Overall Study|Adverse Event|1|||
164368794|NCT03240575|593729330|FG000|Overall Study|Withdrawal by Subject|2|||
164368795|NCT03240575|593729331|FG001|Overall Study|Withdrawal by Subject|11|||
164368796|NCT03240575|593729332|FG002|Overall Study|Withdrawal by Subject|0|||
164368797|NCT03240575|593729333|FG003|Overall Study|Withdrawal by Subject|1|||
164368798|NCT03240575|593729330|FG000|Overall Study|Other|0|||
164368799|NCT03240575|593729331|FG001|Overall Study|Other|1|||
164368800|NCT03240575|593729332|FG002|Overall Study|Other|0|||
164368801|NCT03240575|593729333|FG003|Overall Study|Other|0|||
164368802|NCT04482179|593729334|FG000|Overall Study|Death|1|||
164368803|NCT04482179|593729335|FG001|Overall Study|Death|0|||
164368804|NCT04482179|593729334|FG000|Overall Study|Withdrawal by Subject|1|||
164368805|NCT04482179|593729335|FG001|Overall Study|Withdrawal by Subject|0|||
164368806|NCT04127786|593729338|FG000|Primary Series|Adverse Event|1|||
164368807|NCT04127786|593729339|FG001|Primary Series|Adverse Event|0|||
164368808|NCT04127786|593729340|FG002|Primary Series|Adverse Event|0|||
164368809|NCT04127786|593729341|FG003|Primary Series|Adverse Event|1|||
164368810|NCT04127786|593729342|FG004|Primary Series|Adverse Event|0|||
164368811|NCT04127786|593729343|FG005|Primary Series|Adverse Event|1|||
164368812|NCT04127786|593729338|FG000|Primary Series|Protocol Violation|5|||
164368813|NCT04127786|593729339|FG001|Primary Series|Protocol Violation|3|||
164368814|NCT04127786|593729340|FG002|Primary Series|Protocol Violation|4|||
164368815|NCT04127786|593729341|FG003|Primary Series|Protocol Violation|3|||
164368816|NCT04127786|593729342|FG004|Primary Series|Protocol Violation|2|||
164368817|NCT04127786|593729343|FG005|Primary Series|Protocol Violation|0|||
164368818|NCT04127786|593729338|FG000|Primary Series|Withdrawal by Subject|0|||
164368819|NCT04127786|593729339|FG001|Primary Series|Withdrawal by Subject|0|||
164368820|NCT04127786|593729340|FG002|Primary Series|Withdrawal by Subject|0|||
164368821|NCT04127786|593729341|FG003|Primary Series|Withdrawal by Subject|1|||
164368822|NCT04127786|593729342|FG004|Primary Series|Withdrawal by Subject|0|||
164368823|NCT04127786|593729343|FG005|Primary Series|Withdrawal by Subject|0|||
164368824|NCT04127786|593729338|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
164368825|NCT04127786|593729339|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
164368826|NCT04127786|593729340|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
164368827|NCT04127786|593729341|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
164368828|NCT04127786|593729342|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
164368829|NCT04127786|593729343|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
164368830|NCT04127786|593729338|FG000|Booster Phase|Withdrawal by Subject|2|||
164368831|NCT04127786|593729339|FG001|Booster Phase|Withdrawal by Subject|0|||
164368832|NCT04127786|593729340|FG002|Booster Phase|Withdrawal by Subject|0|||
164368833|NCT04127786|593729341|FG003|Booster Phase|Withdrawal by Subject|0|||
164368834|NCT04127786|593729342|FG004|Booster Phase|Withdrawal by Subject|0|||
164368835|NCT04127786|593729343|FG005|Booster Phase|Withdrawal by Subject|0|||
164368836|NCT03034954|593729344|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
164368837|NCT03034954|593729345|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
164368838|NCT03568942|593729350|FG000|Overall Study|Family emergency|1|||
164368839|NCT03568942|593729350|FG000|Overall Study|Lost to Follow-up|1|||
164368840|NCT04145895|593729356|FG000|Overall Study|Physician Decision|2|||
164368841|NCT04145895|593729357|FG001|Overall Study|Physician Decision|0|||
164368842|NCT04145895|593729356|FG000|Overall Study|Withdrawal by Subject|0|||
163902054|NCT02232737|592013049|FG000|Overall Study|Personal reasons|7|||
163902055|NCT02232737|592013050|FG001|Overall Study|Personal reasons|8|||
164368843|NCT04145895|593729357|FG001|Overall Study|Withdrawal by Subject|2|||
164368844|NCT00913744|593729358|FG000|Overall Study|Adverse Event|2|||
164368845|NCT00913744|593729359|FG001|Overall Study|Adverse Event|0|||
164368846|NCT00913744|593729358|FG000|Overall Study|Withdrawal by Subject|2|||
164368847|NCT00913744|593729359|FG001|Overall Study|Withdrawal by Subject|1|||
164368848|NCT00913744|593729358|FG000|Overall Study|Death|1|||
164368849|NCT00913744|593729359|FG001|Overall Study|Death|0|||
164368850|NCT00805935|593729360|FG000|Overall Study|Stimulation Failure|1|||
164368851|NCT00805935|593729361|FG001|Overall Study|Stimulation Failure|5|||
164368852|NCT00805935|593729362|FG002|Overall Study|Stimulation Failure|2|||
164368853|NCT00805935|593729363|FG003|Overall Study|Stimulation Failure|2|||
163902056|NCT02232737|592013051|FG002|Overall Study|Personal reasons|14|||
163902057|NCT02232737|592013049|FG000|Overall Study|Adverse Event|6|||
163902058|NCT02232737|592013050|FG001|Overall Study|Adverse Event|3|||
163902059|NCT02232737|592013051|FG002|Overall Study|Adverse Event|8|||
163902060|NCT02232737|592013049|FG000|Overall Study|Incarcerated|2|||
163902061|NCT02232737|592013050|FG001|Overall Study|Incarcerated|1|||
163902062|NCT02232737|592013051|FG002|Overall Study|Incarcerated|2|||
163902063|NCT02232737|592013049|FG000|Overall Study|Withdrawal by Subject|0|||
163902064|NCT02232737|592013050|FG001|Overall Study|Withdrawal by Subject|1|||
164368854|NCT00805935|593729360|FG000|Overall Study|Cycle cancelled|0|||
164368855|NCT00805935|593729361|FG001|Overall Study|Cycle cancelled|0|||
164368856|NCT00805935|593729362|FG002|Overall Study|Cycle cancelled|2|||
164368857|NCT00805935|593729363|FG003|Overall Study|Cycle cancelled|0|||
164368858|NCT00805935|593729360|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
164368859|NCT00805935|593729361|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
164368860|NCT00805935|593729362|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
164368861|NCT00805935|593729363|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
164368862|NCT00805935|593729360|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
164368863|NCT00805935|593729361|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
164368864|NCT00805935|593729362|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
164368865|NCT00805935|593729363|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
164368866|NCT00805935|593729360|FG000|Overall Study|Lost to Follow-up|1|||
164368867|NCT00805935|593729361|FG001|Overall Study|Lost to Follow-up|0|||
164368868|NCT00805935|593729362|FG002|Overall Study|Lost to Follow-up|0|||
164368869|NCT00805935|593729363|FG003|Overall Study|Lost to Follow-up|0|||
164368870|NCT00805935|593729360|FG000|Overall Study|No positive serum pregnancy|8|||
164368871|NCT00805935|593729361|FG001|Overall Study|No positive serum pregnancy|7|||
164368872|NCT00805935|593729362|FG002|Overall Study|No positive serum pregnancy|6|||
164368873|NCT00805935|593729363|FG003|Overall Study|No positive serum pregnancy|5|||
164368874|NCT00805935|593729360|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164368875|NCT00805935|593729361|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164368876|NCT00805935|593729362|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
164368877|NCT00805935|593729363|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
164368878|NCT00805935|593729360|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
164368879|NCT00805935|593729361|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
164368880|NCT00805935|593729362|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
164368881|NCT00805935|593729363|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
164368882|NCT00805935|593729360|FG000|Overall Study|Biochemical pregnancy|0|||
164368883|NCT00805935|593729361|FG001|Overall Study|Biochemical pregnancy|1|||
164368884|NCT00805935|593729362|FG002|Overall Study|Biochemical pregnancy|0|||
164368885|NCT00805935|593729363|FG003|Overall Study|Biochemical pregnancy|0|||
164368886|NCT00805935|593729360|FG000|Overall Study|Chemical pregnancy|0|||
164368887|NCT00805935|593729361|FG001|Overall Study|Chemical pregnancy|5|||
164368888|NCT00805935|593729362|FG002|Overall Study|Chemical pregnancy|3|||
164368889|NCT00805935|593729363|FG003|Overall Study|Chemical pregnancy|2|||
164368890|NCT00805935|593729360|FG000|Overall Study|Ectopic pregnancy|0|||
164368891|NCT00805935|593729361|FG001|Overall Study|Ectopic pregnancy|0|||
164368892|NCT00805935|593729362|FG002|Overall Study|Ectopic pregnancy|1|||
164368893|NCT00805935|593729363|FG003|Overall Study|Ectopic pregnancy|0|||
164368894|NCT00805935|593729360|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
164368895|NCT00805935|593729361|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
164368896|NCT00805935|593729362|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
164368897|NCT00805935|593729363|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
164368898|NCT00283439|593729364|FG000|Overall Study|Adverse Event|0|||
164368899|NCT00283439|593729365|FG001|Overall Study|Adverse Event|0|||
164368900|NCT00283439|593729366|FG002|Overall Study|Adverse Event|0|||
164368901|NCT00283439|593729367|FG003|Overall Study|Adverse Event|1|||
164368902|NCT00283439|593729364|FG000|Overall Study|Death|0|||
163902065|NCT02232737|592013051|FG002|Overall Study|Withdrawal by Subject|2|||
164368903|NCT00283439|593729365|FG001|Overall Study|Death|0|||
164368904|NCT00283439|593729366|FG002|Overall Study|Death|1|||
164368905|NCT00283439|593729367|FG003|Overall Study|Death|0|||
164368906|NCT00283439|593729364|FG000|Overall Study|Disease progression|0|||
164368907|NCT00283439|593729365|FG001|Overall Study|Disease progression|1|||
164368908|NCT00283439|593729366|FG002|Overall Study|Disease progression|0|||
164368909|NCT00283439|593729367|FG003|Overall Study|Disease progression|0|||
164368910|NCT00283439|593729364|FG000|Overall Study|Requirement for alternative therapy|1|||
164368911|NCT00283439|593729365|FG001|Overall Study|Requirement for alternative therapy|2|||
164368912|NCT00283439|593729366|FG002|Overall Study|Requirement for alternative therapy|5|||
164368913|NCT00283439|593729367|FG003|Overall Study|Requirement for alternative therapy|2|||
164368914|NCT00283439|593729364|FG000|Overall Study|Stem cell transplant|6|||
164368915|NCT00283439|593729365|FG001|Overall Study|Stem cell transplant|6|||
164368916|NCT00283439|593729366|FG002|Overall Study|Stem cell transplant|4|||
164368917|NCT00283439|593729367|FG003|Overall Study|Stem cell transplant|3|||
164368918|NCT00283439|593729364|FG000|Overall Study|Treatment discontinued|0|||
164368919|NCT00283439|593729365|FG001|Overall Study|Treatment discontinued|2|||
164368920|NCT00283439|593729366|FG002|Overall Study|Treatment discontinued|1|||
164368921|NCT00283439|593729367|FG003|Overall Study|Treatment discontinued|3|||
164368922|NCT00283439|593729364|FG000|Overall Study|Other|1|||
164368923|NCT00283439|593729365|FG001|Overall Study|Other|0|||
164368924|NCT00283439|593729366|FG002|Overall Study|Other|0|||
164368925|NCT00283439|593729367|FG003|Overall Study|Other|0|||
164368926|NCT01539226|593729368|FG000|Overall Study|Withdrawal by Subject|24|||
164368927|NCT01539226|593729369|FG001|Overall Study|Withdrawal by Subject|54|||
164368928|NCT01539226|593729368|FG000|Overall Study|Lost to Follow-up|20|||
164368929|NCT01539226|593729369|FG001|Overall Study|Lost to Follow-up|54|||
164368930|NCT01539226|593729368|FG000|Overall Study|Death|1|||
164368931|NCT01539226|593729369|FG001|Overall Study|Death|2|||
164368932|NCT01539226|593729368|FG000|Overall Study|Adverse Event|2|||
164368933|NCT01539226|593729369|FG001|Overall Study|Adverse Event|0|||
164368934|NCT01539226|593729368|FG000|Overall Study|Pregnancy|13|||
164368935|NCT01539226|593729369|FG001|Overall Study|Pregnancy|29|||
164368936|NCT01539226|593729368|FG000|Overall Study|inappropriate enrollment|0|||
164368937|NCT01539226|593729369|FG001|Overall Study|inappropriate enrollment|1|||
164368938|NCT01539226|593729368|FG000|Overall Study|Multiple Reasons|3|||
164368939|NCT01539226|593729369|FG001|Overall Study|Multiple Reasons|1|||
164368940|NCT01539226|593729368|FG000|Overall Study|not HIV seroconversion-related|93|||
164368941|NCT01539226|593729369|FG001|Overall Study|not HIV seroconversion-related|176|||
164368942|NCT01539226|593729368|FG000|Overall Study|HIV seroconversion-related|55|||
164368943|NCT01539226|593729369|FG001|Overall Study|HIV seroconversion-related|80|||
164368944|NCT01539226|593729368|FG000|Overall Study|Non-compliance|6|||
164368945|NCT01539226|593729369|FG001|Overall Study|Non-compliance|8|||
164368946|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
164368947|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
164368948|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
164368949|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
164368950|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
164368951|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
164368952|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
164368953|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
164368954|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
164368955|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
164368956|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
164368957|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
164368958|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
164368959|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
164368960|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
164368961|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
164368962|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
164368963|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
164368964|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
164012343|NCT00718861|592408709|FG000|Overall Study|Lost to Follow-up|2|||
164368965|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
164368966|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
164368967|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
164368968|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
164368969|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
164368970|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
164368971|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
164368972|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
164368973|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
164368974|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
164368975|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
164368976|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
164012344|NCT00718861|592408710|FG001|Overall Study|Lost to Follow-up|1|||
164368977|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
164368978|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
164012345|NCT00718861|592408709|FG000|Overall Study|Administrative Problems|1|||
164012346|NCT00718861|592408710|FG001|Overall Study|Administrative Problems|1|||
164368979|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
164368980|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
164368981|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
164368982|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
164368983|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
164368984|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
164368985|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
164368986|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
164368987|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
164368988|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
164368989|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
164368990|NCT01218516|593729370|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
164368991|NCT01218516|593729371|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
164368992|NCT01218516|593729372|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
164368993|NCT01218516|593729373|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
164368994|NCT01632891|593729374|FG000|Overall Study|Lost to Follow-up|0|||
164368995|NCT01632891|593729375|FG001|Overall Study|Lost to Follow-up|1|||
164368996|NCT01632891|593729374|FG000|Overall Study|Withdrawal by Subject|1|||
164368997|NCT01632891|593729375|FG001|Overall Study|Withdrawal by Subject|0|||
164368998|NCT00240071|593729376|FG000|Overall Study|Withdrawal by Subject|3|||
164368999|NCT04206293|593729389|FG000|Overall Study|Consent withdrawal|1|||
164369000|NCT03325166|593729394|FG000|Overall Study|Adverse Event|1|||
164369001|NCT00782210|593729398|FG000|Overall Study|Adverse Event|21|||
164369002|NCT00782210|593729399|FG001|Overall Study|Adverse Event|17|||
164369003|NCT00782210|593729400|FG002|Overall Study|Adverse Event|16|||
164369004|NCT00782210|593729398|FG000|Overall Study|Lost to Follow-up|2|||
164369005|NCT00782210|593729399|FG001|Overall Study|Lost to Follow-up|1|||
164369006|NCT00782210|593729400|FG002|Overall Study|Lost to Follow-up|2|||
164369007|NCT00782210|593729398|FG000|Overall Study|Withdrawal by Subject|11|||
164369008|NCT00782210|593729399|FG001|Overall Study|Withdrawal by Subject|8|||
164369009|NCT00782210|593729400|FG002|Overall Study|Withdrawal by Subject|11|||
164369010|NCT00782210|593729398|FG000|Overall Study|Non compliance with protocol|0|||
164369011|NCT00782210|593729399|FG001|Overall Study|Non compliance with protocol|3|||
164369012|NCT00782210|593729400|FG002|Overall Study|Non compliance with protocol|2|||
164369013|NCT00782210|593729398|FG000|Overall Study|Lack of Efficacy|13|||
164369014|NCT00782210|593729399|FG001|Overall Study|Lack of Efficacy|4|||
164369015|NCT00782210|593729400|FG002|Overall Study|Lack of Efficacy|1|||
164369016|NCT00782210|593729398|FG000|Overall Study|Other reason not described above|3|||
164369017|NCT00782210|593729399|FG001|Overall Study|Other reason not described above|2|||
164369018|NCT00782210|593729400|FG002|Overall Study|Other reason not described above|3|||
164369019|NCT01610791|593729405|FG000|Overall Study|Lost to Follow-up|7|||
164369020|NCT01610791|593729405|FG000|Overall Study|Adverse Event|6|||
164369021|NCT01610791|593729405|FG000|Overall Study|Physician Decision|1|||
164369022|NCT01610791|593729405|FG000|Overall Study|Adverse event and Investigator decision|1|||
164369023|NCT01610791|593729405|FG000|Overall Study|Death|1|||
164369024|NCT01610791|593729405|FG000|Overall Study|Not determined|5|||
164369025|NCT05923229|593729408|FG000|Overall Study|Withdrawal by Subject|3|||
164369026|NCT05923229|593729409|FG001|Overall Study|Withdrawal by Subject|0|||
164369027|NCT05923229|593729408|FG000|Overall Study|Health related|2|||
164369028|NCT05923229|593729409|FG001|Overall Study|Health related|1|||
164369029|NCT04304001|593729410|FG000|Overall Study|Lost to Follow-up|13|||
164369030|NCT04304001|593729411|FG001|Overall Study|Lost to Follow-up|9|||
164369031|NCT04164901|593729412|FG000|Overall Study|Withdrawal by Subject|4|||
164369032|NCT04164901|593729413|FG001|Overall Study|Withdrawal by Subject|4|||
164369033|NCT02465528|593729414|FG000|Overall Study|Progressive disease|0|||
164369034|NCT02465528|593729415|FG001|Overall Study|Progressive disease|2|||
164369035|NCT02465528|593729416|FG002|Overall Study|Progressive disease|9|||
164369036|NCT02465528|593729417|FG003|Overall Study|Progressive disease|4|||
164369037|NCT02465528|593729414|FG000|Overall Study|Study terminated by sponsor|1|||
164369038|NCT02465528|593729415|FG001|Overall Study|Study terminated by sponsor|2|||
164369039|NCT02465528|593729416|FG002|Overall Study|Study terminated by sponsor|0|||
164369040|NCT02465528|593729417|FG003|Overall Study|Study terminated by sponsor|0|||
164369041|NCT02465528|593729414|FG000|Overall Study|Withdrawal by Subject|0|||
164369042|NCT02465528|593729415|FG001|Overall Study|Withdrawal by Subject|0|||
164369043|NCT02465528|593729416|FG002|Overall Study|Withdrawal by Subject|2|||
164369044|NCT02465528|593729417|FG003|Overall Study|Withdrawal by Subject|0|||
164369045|NCT02465528|593729414|FG000|Overall Study|Adverse Event|0|||
164369046|NCT02465528|593729415|FG001|Overall Study|Adverse Event|0|||
164369047|NCT02465528|593729416|FG002|Overall Study|Adverse Event|0|||
164369048|NCT02465528|593729417|FG003|Overall Study|Adverse Event|1|||
164369049|NCT02465528|593729414|FG000|Overall Study|Physician Decision|0|||
164369050|NCT02465528|593729415|FG001|Overall Study|Physician Decision|0|||
164369051|NCT02465528|593729416|FG002|Overall Study|Physician Decision|1|||
164369052|NCT02465528|593729417|FG003|Overall Study|Physician Decision|0|||
164369053|NCT05358821|593729418|FG000|Overall Study|Withdrawal by Subject|0|||
164369054|NCT05358821|593729419|FG001|Overall Study|Withdrawal by Subject|1|||
164369055|NCT05358821|593729420|FG002|Overall Study|Withdrawal by Subject|0|||
164369056|NCT05358821|593729418|FG000|Overall Study|Withdrawal of Consent|0|||
164369057|NCT05358821|593729419|FG001|Overall Study|Withdrawal of Consent|0|||
164369058|NCT05358821|593729420|FG002|Overall Study|Withdrawal of Consent|1|||
164369059|NCT04627064|593729423|FG000|Overall Study|Progressive disease|8|||
164369060|NCT04627064|593729424|FG001|Overall Study|Progressive disease|0|||
164369061|NCT04627064|593729423|FG000|Overall Study|Withdrawal by Subject|2|||
164369062|NCT04627064|593729424|FG001|Overall Study|Withdrawal by Subject|0|||
164369063|NCT04627064|593729423|FG000|Overall Study|Physician Decision|1|||
164369064|NCT04627064|593729424|FG001|Overall Study|Physician Decision|0|||
164369065|NCT02086110|593729428|FG000|Overall Study|Withdrawal by Subject|1|||
164369066|NCT02086110|593729429|FG001|Overall Study|Withdrawal by Subject|1|||
164369067|NCT01869192|593729430|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
164369068|NCT01869192|593729431|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
164369069|NCT01869192|593729430|FG000|Postoperative Chemotherapy|Physician Decision|0|||
164369070|NCT01869192|593729431|FG001|Postoperative Chemotherapy|Physician Decision|2|||
164369071|NCT02286193|593729434|FG000|Overall Study|Referred: CRS unable to make contact|62|||
164369072|NCT02286193|593729434|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
164369073|NCT02286193|593729434|FG000|Overall Study|Referred: Declined service|38|||
164369074|NCT00423891|593729435|FG000|Enrolled|Withdrawal by Subject|0|||
164369075|NCT00423891|593729436|FG001|Enrolled|Withdrawal by Subject|0|||
164369076|NCT00423891|593729437|FG002|Enrolled|Withdrawal by Subject|1|||
164369077|NCT00423891|593729435|FG000|Enrolled|Lost to Follow-up|0|||
164369078|NCT00423891|593729436|FG001|Enrolled|Lost to Follow-up|0|||
164369079|NCT00423891|593729437|FG002|Enrolled|Lost to Follow-up|1|||
164369080|NCT00423891|593729435|FG000|Enrolled|No longer met criteria|11|||
164369081|NCT00423891|593729436|FG001|Enrolled|No longer met criteria|2|||
164369082|NCT00423891|593729437|FG002|Enrolled|No longer met criteria|1|||
164369083|NCT00423891|593729435|FG000|Treatment|Withdrawal by Subject|1|||
164369084|NCT00423891|593729436|FG001|Treatment|Withdrawal by Subject|0|||
164369085|NCT00423891|593729437|FG002|Treatment|Withdrawal by Subject|0|||
164369086|NCT00423891|593729435|FG000|Treatment|Lost to Follow-up|1|||
164369087|NCT00423891|593729436|FG001|Treatment|Lost to Follow-up|0|||
164369088|NCT00423891|593729437|FG002|Treatment|Lost to Follow-up|0|||
164369089|NCT00423891|593729435|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
164369090|NCT00423891|593729436|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
164369091|NCT00423891|593729437|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
164369092|NCT00423891|593729435|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
164369093|NCT00423891|593729436|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
164369094|NCT00423891|593729437|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
164369095|NCT01907828|593729442|FG000|Overall Study|Exclusion criteria not met|0|||
164369096|NCT01907828|593729443|FG001|Overall Study|Exclusion criteria not met|1|||
164369097|NCT01907828|593729442|FG000|Overall Study|Withdrawal by Subject|3|||
164369098|NCT01907828|593729443|FG001|Overall Study|Withdrawal by Subject|4|||
164369099|NCT01907828|593729442|FG000|Overall Study|Lost to Follow-up|3|||
164369100|NCT01907828|593729443|FG001|Overall Study|Lost to Follow-up|0|||
164369101|NCT01907828|593729442|FG000|Overall Study|Participant refused 24-month follow-up|1|||
164369102|NCT01907828|593729443|FG001|Overall Study|Participant refused 24-month follow-up|0|||
164369103|NCT01907828|593729442|FG000|Overall Study|Participant met exclusion criteria|0|||
164369104|NCT01907828|593729443|FG001|Overall Study|Participant met exclusion criteria|1|||
164369105|NCT01073865|593729444|FG000|Overall Study|Reasons other than below|19|||
164369106|NCT01073865|593729445|FG001|Overall Study|Reasons other than below|31|||
164369107|NCT01073865|593729444|FG000|Overall Study|Lost to Follow-up|1|||
164369108|NCT01073865|593729445|FG001|Overall Study|Lost to Follow-up|1|||
164369109|NCT01073865|593729444|FG000|Overall Study|Death|3|||
164369110|NCT01073865|593729445|FG001|Overall Study|Death|2|||
164369111|NCT01073865|593729444|FG000|Overall Study|Withdrawal by Subject|5|||
164369112|NCT01073865|593729445|FG001|Overall Study|Withdrawal by Subject|5|||
164369113|NCT03925324|593729446|FG000|Overall Study|Death|1|||
164369114|NCT03925324|593729447|FG001|Overall Study|Death|1|||
164369115|NCT00696137|593729451|FG000|Overall Study|Withdrawal by Subject|2|||
164369116|NCT02197806|593729459|FG000|Overall Study|Adverse Event|0|||
163902066|NCT02232737|592013049|FG000|Overall Study|Death|0|||
164369117|NCT02197806|593729460|FG001|Overall Study|Adverse Event|1|||
164369118|NCT02197806|593729461|FG002|Overall Study|Adverse Event|0|||
164369119|NCT02197806|593729462|FG003|Overall Study|Adverse Event|1|||
164369120|NCT00680901|593729463|FG000|Overall Study|Ongoing: On Study Treatment|1|||
164369121|NCT00680901|593729464|FG001|Overall Study|Ongoing: On Study Treatment|0|||
164369122|NCT00680901|593729463|FG000|Overall Study|Ongoing: In Follow Up|1|||
164369123|NCT00680901|593729464|FG001|Overall Study|Ongoing: In Follow Up|0|||
164369124|NCT00680901|593729463|FG000|Overall Study|Adverse Event|1|||
164369125|NCT00680901|593729464|FG001|Overall Study|Adverse Event|1|||
164369126|NCT00680901|593729463|FG000|Overall Study|Lost to Follow-up|3|||
164369127|NCT00680901|593729464|FG001|Overall Study|Lost to Follow-up|5|||
164369128|NCT00680901|593729463|FG000|Overall Study|Subject decided to withdraw from the study|4|||
164369129|NCT00680901|593729464|FG001|Overall Study|Subject decided to withdraw from the study|15|||
164369130|NCT00680901|593729463|FG000|Overall Study|Sponsor decision|1|||
164369131|NCT00680901|593729464|FG001|Overall Study|Sponsor decision|0|||
164369132|NCT00680901|593729463|FG000|Overall Study|Physician Decision|0|||
164369133|NCT00680901|593729464|FG001|Overall Study|Physician Decision|2|||
164369134|NCT00680901|593729463|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
164369135|NCT00680901|593729464|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
164369136|NCT00680901|593729463|FG000|Overall Study|Other protocol defined stopping criteria|17|||
164369137|NCT00680901|593729464|FG001|Overall Study|Other protocol defined stopping criteria|17|||
164369138|NCT04251221|593729467|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
164369139|NCT04251221|593729468|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
164369140|NCT02120794|593729471|FG000|Overall Study|Withdrawal by Subject|43|||
164369141|NCT02120794|593729471|FG000|Overall Study|Adverse Event|10|||
164369142|NCT02120794|593729471|FG000|Overall Study|Physician Decision|4|||
164369143|NCT02120794|593729471|FG000|Overall Study|Due to insurance coverage|1|||
164369144|NCT01148511|593729472|FG000|Exposed to Study Drug|Protocol Violation|2|||
164369145|NCT01148511|593729473|FG001|Exposed to Study Drug|Protocol Violation|0|||
164369146|NCT01148511|593729474|FG002|Exposed to Study Drug|Protocol Violation|0|||
164369147|NCT01148511|593729472|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
164369148|NCT01148511|593729473|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
164369149|NCT01148511|593729474|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
164369150|NCT01148511|593729472|FG000|Randomized|Adverse Event|0|||
164369151|NCT01148511|593729473|FG001|Randomized|Adverse Event|1|||
164369152|NCT01148511|593729474|FG002|Randomized|Adverse Event|0|||
164369153|NCT01148511|593729472|FG000|Randomized|Protocol Violation|0|||
164369154|NCT01148511|593729473|FG001|Randomized|Protocol Violation|2|||
164369155|NCT01148511|593729474|FG002|Randomized|Protocol Violation|1|||
164369156|NCT01148511|593729472|FG000|Randomized|Lost to Follow-up|0|||
164369157|NCT01148511|593729473|FG001|Randomized|Lost to Follow-up|1|||
164369158|NCT01148511|593729474|FG002|Randomized|Lost to Follow-up|1|||
164369159|NCT01148511|593729472|FG000|Randomized|Consent withdrawal|0|||
164369160|NCT01148511|593729473|FG001|Randomized|Consent withdrawal|5|||
164369161|NCT01148511|593729474|FG002|Randomized|Consent withdrawal|3|||
164369162|NCT01148511|593729472|FG000|Randomized|Other|0|||
164369163|NCT01148511|593729473|FG001|Randomized|Other|1|||
164369164|NCT01148511|593729474|FG002|Randomized|Other|1|||
164369165|NCT00969553|593729483|FG000|Overall Study|Progressive disease (PD)|2|||
164369166|NCT00969553|593729484|FG001|Overall Study|Progressive disease (PD)|2|||
164369167|NCT00969553|593729485|FG002|Overall Study|Progressive disease (PD)|6|||
164369168|NCT00969553|593729486|FG003|Overall Study|Progressive disease (PD)|9|||
164369169|NCT00969553|593729487|FG004|Overall Study|Progressive disease (PD)|2|||
164369170|NCT00969553|593729488|FG005|Overall Study|Progressive disease (PD)|4|||
164369171|NCT00969553|593729489|FG006|Overall Study|Progressive disease (PD)|2|||
164369172|NCT00969553|593729490|FG007|Overall Study|Progressive disease (PD)|12|||
164369173|NCT00969553|593729491|FG008|Overall Study|Progressive disease (PD)|3|||
164369174|NCT00969553|593729483|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369175|NCT00969553|593729484|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369176|NCT00969553|593729485|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369177|NCT00969553|593729486|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369178|NCT00969553|593729487|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
164369179|NCT00969553|593729488|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369180|NCT00969553|593729489|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369181|NCT00969553|593729490|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369182|NCT00969553|593729491|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
164369183|NCT00969553|593729483|FG000|Overall Study|Other Adverse Event|0|||
164369184|NCT00969553|593729484|FG001|Overall Study|Other Adverse Event|0|||
164369185|NCT00969553|593729485|FG002|Overall Study|Other Adverse Event|0|||
164012347|NCT00718861|592408709|FG000|Overall Study|Death|1|||
164012348|NCT00718861|592408710|FG001|Overall Study|Death|5|||
164012349|NCT04230486|592408717|FG000|Overall Study|Screen Failure|1|||
164012350|NCT04983901|592408718|FG000|Overall Study|Death|1|||
164012351|NCT04983901|592408719|FG001|Overall Study|Death|4|||
164369186|NCT00969553|593729486|FG003|Overall Study|Other Adverse Event|1|||
164369187|NCT00969553|593729487|FG004|Overall Study|Other Adverse Event|0|||
164369188|NCT00969553|593729488|FG005|Overall Study|Other Adverse Event|0|||
164369189|NCT00969553|593729489|FG006|Overall Study|Other Adverse Event|1|||
164369190|NCT00969553|593729490|FG007|Overall Study|Other Adverse Event|0|||
164369191|NCT00969553|593729491|FG008|Overall Study|Other Adverse Event|0|||
164369192|NCT00969553|593729483|FG000|Overall Study|Refused cont. medication|1|||
164369193|NCT00969553|593729484|FG001|Overall Study|Refused cont. medication|1|||
164369194|NCT00969553|593729485|FG002|Overall Study|Refused cont. medication|0|||
164369195|NCT00969553|593729486|FG003|Overall Study|Refused cont. medication|2|||
164369196|NCT00969553|593729487|FG004|Overall Study|Refused cont. medication|0|||
164369197|NCT00969553|593729488|FG005|Overall Study|Refused cont. medication|0|||
164369198|NCT00969553|593729489|FG006|Overall Study|Refused cont. medication|0|||
164369199|NCT00969553|593729490|FG007|Overall Study|Refused cont. medication|1|||
164369200|NCT00969553|593729491|FG008|Overall Study|Refused cont. medication|0|||
164369201|NCT00969553|593729483|FG000|Overall Study|Not specified above|0|||
164369202|NCT00969553|593729484|FG001|Overall Study|Not specified above|0|||
164369203|NCT00969553|593729485|FG002|Overall Study|Not specified above|0|||
164369204|NCT00969553|593729486|FG003|Overall Study|Not specified above|4|||
164369205|NCT00969553|593729487|FG004|Overall Study|Not specified above|0|||
164369206|NCT00969553|593729488|FG005|Overall Study|Not specified above|0|||
164369207|NCT00969553|593729489|FG006|Overall Study|Not specified above|1|||
164369208|NCT00969553|593729490|FG007|Overall Study|Not specified above|1|||
164369209|NCT00969553|593729491|FG008|Overall Study|Not specified above|0|||
164369210|NCT04243538|593729492|FG000|Overall Study|Withdrawal by Subject|0|||
164369211|NCT04243538|593729493|FG001|Overall Study|Withdrawal by Subject|2|||
164369212|NCT04243538|593729492|FG000|Overall Study|Lost to Follow-up|0|||
164369213|NCT04243538|593729493|FG001|Overall Study|Lost to Follow-up|3|||
164369214|NCT04536727|593729494|FG000|Overall Study|Lost to Follow-up|1|||
164369215|NCT04536727|593729495|FG001|Overall Study|Lost to Follow-up|1|||
164369216|NCT04536727|593729494|FG000|Overall Study|Death|0|||
164369217|NCT04536727|593729495|FG001|Overall Study|Death|1|||
164369218|NCT00500370|593729496|FG000|Overall Study|Adverse Event|9|||
164012352|NCT04983901|592408718|FG000|Overall Study|Lost to Follow-up|3|||
164012353|NCT04983901|592408719|FG001|Overall Study|Lost to Follow-up|0|||
164012354|NCT04983901|592408718|FG000|Overall Study|Protocol Violation|1|||
164012355|NCT04983901|592408719|FG001|Overall Study|Protocol Violation|0|||
164369219|NCT00500370|593729497|FG001|Overall Study|Adverse Event|3|||
164369220|NCT00500370|593729496|FG000|Overall Study|Lost to Follow-up|10|||
164369221|NCT00500370|593729497|FG001|Overall Study|Lost to Follow-up|10|||
164369222|NCT00500370|593729496|FG000|Overall Study|Protocol Violation|2|||
164369223|NCT00500370|593729497|FG001|Overall Study|Protocol Violation|4|||
164369224|NCT00500370|593729496|FG000|Overall Study|Sponsor Decision|2|||
164369225|NCT00500370|593729497|FG001|Overall Study|Sponsor Decision|0|||
164369226|NCT00500370|593729496|FG000|Overall Study|Subject Decision|10|||
164369227|NCT00500370|593729497|FG001|Overall Study|Subject Decision|17|||
164369228|NCT05308901|593731210|FG000|Overall Study|Death|6|||
164369229|NCT02586012|593731211|FG000|Overall Study|Withdrawal by Subject|1|||
164369230|NCT02586012|593731212|FG001|Overall Study|Withdrawal by Subject|1|||
164369231|NCT02586012|593731213|FG002|Overall Study|Withdrawal by Subject|0|||
164369232|NCT02586012|593731214|FG003|Overall Study|Withdrawal by Subject|1|||
164369233|NCT02586012|593731215|FG004|Overall Study|Withdrawal by Subject|0|||
164369234|NCT02586012|593731216|FG005|Overall Study|Withdrawal by Subject|2|||
164369235|NCT02586012|593731211|FG000|Overall Study|Protocol Violation|0|||
164369236|NCT02586012|593731212|FG001|Overall Study|Protocol Violation|0|||
164369237|NCT02586012|593731213|FG002|Overall Study|Protocol Violation|0|||
164369238|NCT02586012|593731214|FG003|Overall Study|Protocol Violation|0|||
164369239|NCT02586012|593731215|FG004|Overall Study|Protocol Violation|0|||
164369240|NCT02586012|593731216|FG005|Overall Study|Protocol Violation|1|||
164369241|NCT02586012|593731211|FG000|Overall Study|study terminated|0|||
164369242|NCT02586012|593731212|FG001|Overall Study|study terminated|2|||
164369243|NCT02586012|593731213|FG002|Overall Study|study terminated|1|||
164369244|NCT02586012|593731214|FG003|Overall Study|study terminated|1|||
164369245|NCT02586012|593731215|FG004|Overall Study|study terminated|1|||
164369246|NCT02586012|593731216|FG005|Overall Study|study terminated|0|||
164369247|NCT01816139|593731218|FG000|Overall Study|Adverse Event|6|||
164369248|NCT01816139|593731219|FG001|Overall Study|Adverse Event|8|||
164369249|NCT01816139|593731218|FG000|Overall Study|Lack of Efficacy|1|||
164369250|NCT01816139|593731219|FG001|Overall Study|Lack of Efficacy|2|||
164369251|NCT01816139|593731218|FG000|Overall Study|Lost to Follow-up|5|||
164369252|NCT01816139|593731219|FG001|Overall Study|Lost to Follow-up|3|||
164012356|NCT04983901|592408718|FG000|Overall Study|Withdrawal by Subject|1|||
164012357|NCT04983901|592408719|FG001|Overall Study|Withdrawal by Subject|2|||
164369253|NCT01816139|593731218|FG000|Overall Study|Withdrew Consent|6|||
164369254|NCT01816139|593731219|FG001|Overall Study|Withdrew Consent|4|||
164369255|NCT01816139|593731218|FG000|Overall Study|Protocol Violation|6|||
164369256|NCT01816139|593731219|FG001|Overall Study|Protocol Violation|3|||
164369257|NCT01816139|593731218|FG000|Overall Study|Reason not Specified|4|||
164369258|NCT01816139|593731219|FG001|Overall Study|Reason not Specified|2|||
164369259|NCT01572038|593731220|FG000|Overall Study|Death|648|||
164369260|NCT01572038|593731220|FG000|Overall Study|Withdrawal by Subject|204|||
164369261|NCT01572038|593731220|FG000|Overall Study|Lost to Follow-up|81|||
164369262|NCT01572038|593731220|FG000|Overall Study|Physician Decision|20|||
164369263|NCT01572038|593731220|FG000|Overall Study|Patient Decision|14|||
164369264|NCT01572038|593731220|FG000|Overall Study|Progressive Disease|8|||
164369265|NCT01572038|593731220|FG000|Overall Study|Site Closed Before Completing Form|6|||
164369266|NCT01572038|593731220|FG000|Overall Study|Enrolled into Another Trial|3|||
164369267|NCT01572038|593731220|FG000|Overall Study|Participated in Another Trial|3|||
164369268|NCT01572038|593731220|FG000|Overall Study|Termination by Sponsor|2|||
164369269|NCT01572038|593731220|FG000|Overall Study|Patient Deterioration|1|||
164369270|NCT01572038|593731220|FG000|Overall Study|Sponsor Decision|1|||
164369271|NCT02554656|593731221|FG000|Overall Study|Protocol Violation|3|||
164369272|NCT01888497|593731222|FG000|Washout Period 1|Withdrawal by Subject|0|||
164369273|NCT01888497|593731223|FG001|Washout Period 1|Withdrawal by Subject|0|||
164369274|NCT01888497|593731224|FG002|Washout Period 1|Withdrawal by Subject|1|||
164369275|NCT01888497|593731225|FG003|Washout Period 1|Withdrawal by Subject|1|||
164369276|NCT01888497|593731222|FG000|Washout Period 2|Adverse Event|0|||
164369277|NCT01888497|593731223|FG001|Washout Period 2|Adverse Event|0|||
164369278|NCT01888497|593731224|FG002|Washout Period 2|Adverse Event|0|||
164369279|NCT01888497|593731225|FG003|Washout Period 2|Adverse Event|1|||
164369280|NCT01888497|593731222|FG000|Washout Period 2|Withdrawal by Subject|0|||
164369281|NCT01888497|593731223|FG001|Washout Period 2|Withdrawal by Subject|0|||
164369282|NCT01888497|593731224|FG002|Washout Period 2|Withdrawal by Subject|0|||
164369283|NCT01888497|593731225|FG003|Washout Period 2|Withdrawal by Subject|1|||
164369284|NCT01140477|593731228|FG000|Overall Study|Lost to Follow-up|4|||
164369285|NCT01140477|593731229|FG001|Overall Study|Lost to Follow-up|0|||
164369286|NCT01140477|593731228|FG000|Overall Study|Withdrawal by Subject|1|||
164369287|NCT01140477|593731229|FG001|Overall Study|Withdrawal by Subject|4|||
164369288|NCT01140477|593731228|FG000|Overall Study|Surgical complication preventing implant|2|||
164369289|NCT01140477|593731229|FG001|Overall Study|Surgical complication preventing implant|0|||
164369290|NCT01140477|593731228|FG000|Overall Study|Death|1|||
164369291|NCT01140477|593731229|FG001|Overall Study|Death|1|||
164369292|NCT01140477|593731228|FG000|Overall Study|Subject explanted|0|||
164369293|NCT01140477|593731229|FG001|Overall Study|Subject explanted|1|||
164369294|NCT04013191|593731230|FG000|Overall Study|Adverse Event|1|||
164369295|NCT04013191|593731231|FG001|Overall Study|Adverse Event|0|||
164369296|NCT01904604|593731234|FG000|Overall Study|Withdrew before receiving dosing|0|||
164369297|NCT01904604|593731235|FG001|Overall Study|Withdrew before receiving dosing|1|||
164369298|NCT01904604|593731236|FG002|Overall Study|Withdrew before receiving dosing|0|||
164369299|NCT01904604|593731234|FG000|Overall Study|Non-compliance|1|||
164369300|NCT01904604|593731235|FG001|Overall Study|Non-compliance|0|||
164369301|NCT01904604|593731236|FG002|Overall Study|Non-compliance|0|||
164369302|NCT01904604|593731234|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
164369303|NCT01904604|593731235|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
164369304|NCT01904604|593731236|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
164369305|NCT01904604|593731234|FG000|Overall Study|Patch site reactions|1|||
164369306|NCT01904604|593731235|FG001|Overall Study|Patch site reactions|1|||
164369307|NCT01904604|593731236|FG002|Overall Study|Patch site reactions|0|||
164369308|NCT01904604|593731234|FG000|Overall Study|Increased syncope|0|||
164369309|NCT01904604|593731235|FG001|Overall Study|Increased syncope|1|||
164369310|NCT01904604|593731236|FG002|Overall Study|Increased syncope|0|||
164369311|NCT01904604|593731234|FG000|Overall Study|Unrelated illness|0|||
164369312|NCT01904604|593731235|FG001|Overall Study|Unrelated illness|1|||
164369313|NCT01904604|593731236|FG002|Overall Study|Unrelated illness|0|||
164369314|NCT01904604|593731234|FG000|Overall Study|Passed Week 52 OFC|1|||
164369315|NCT01904604|593731235|FG001|Overall Study|Passed Week 52 OFC|0|||
164369316|NCT01904604|593731236|FG002|Overall Study|Passed Week 52 OFC|0|||
164369317|NCT01904604|593731234|FG000|Overall Study|Withdrawal by Subject|1|||
164369318|NCT01904604|593731235|FG001|Overall Study|Withdrawal by Subject|2|||
164369319|NCT01904604|593731236|FG002|Overall Study|Withdrawal by Subject|0|||
164369320|NCT01904604|593731234|FG000|Overall Study|Participant Relocated|1|||
164369321|NCT01904604|593731235|FG001|Overall Study|Participant Relocated|1|||
164369322|NCT01904604|593731236|FG002|Overall Study|Participant Relocated|1|||
164369323|NCT01904604|593731234|FG000|Overall Study|Lost to Follow-up|0|||
164369324|NCT01904604|593731235|FG001|Overall Study|Lost to Follow-up|0|||
164369325|NCT01904604|593731236|FG002|Overall Study|Lost to Follow-up|1|||
164369326|NCT04144166|593731240|FG000|Overall Study|Discharged before study start|1|||
164369327|NCT04144166|593731240|FG000|Overall Study|Pregnancy|1|||
164369328|NCT04144166|593731240|FG000|Overall Study|Nail polish could not be removed from finger|1|||
164369329|NCT01236755|593731242|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
164369330|NCT01236755|593731242|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
164369331|NCT01236755|593731242|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
164369332|NCT01236755|593731242|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
164369333|NCT01481116|593731243|FG000|Overall Study|Adverse Event|26|||
163902067|NCT02232737|592013050|FG001|Overall Study|Death|1|||
164369334|NCT01481116|593731244|FG001|Overall Study|Adverse Event|26|||
164369335|NCT01481116|593731245|FG002|Overall Study|Adverse Event|42|||
164369336|NCT01481116|593731243|FG000|Overall Study|Major Protocol Deviation|3|||
164369337|NCT01481116|593731244|FG001|Overall Study|Major Protocol Deviation|7|||
164369338|NCT01481116|593731245|FG002|Overall Study|Major Protocol Deviation|1|||
164369339|NCT01481116|593731243|FG000|Overall Study|Lost to Follow-up|8|||
164369340|NCT01481116|593731244|FG001|Overall Study|Lost to Follow-up|12|||
164369341|NCT01481116|593731245|FG002|Overall Study|Lost to Follow-up|11|||
164369342|NCT01481116|593731243|FG000|Overall Study|Withdrawal by Subject|37|||
164369343|NCT01481116|593731244|FG001|Overall Study|Withdrawal by Subject|33|||
164369344|NCT01481116|593731245|FG002|Overall Study|Withdrawal by Subject|37|||
164369345|NCT01481116|593731243|FG000|Overall Study|Study Termination|730|||
164369346|NCT01481116|593731244|FG001|Overall Study|Study Termination|729|||
164369347|NCT01481116|593731245|FG002|Overall Study|Study Termination|713|||
164369348|NCT01481116|593731243|FG000|Overall Study|Pregnancy|0|||
164369349|NCT01481116|593731244|FG001|Overall Study|Pregnancy|0|||
164369350|NCT01481116|593731245|FG002|Overall Study|Pregnancy|1|||
164012358|NCT01174784|592408720|FG000|Overall Study|Screen fails|4|||
164012359|NCT02416908|592408721|FG000|Dose Escalation Phase|Adverse Event|0|||
164012360|NCT02416908|592408722|FG001|Dose Escalation Phase|Adverse Event|0|||
164012361|NCT02416908|592408723|FG002|Dose Escalation Phase|Adverse Event|3|||
164012362|NCT02416908|592408724|FG003|Dose Escalation Phase|Adverse Event|0|||
164012363|NCT02416908|592408721|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164369351|NCT01481116|593731243|FG000|Overall Study|Lack of Efficacy|3|||
164369352|NCT01481116|593731244|FG001|Overall Study|Lack of Efficacy|3|||
164369353|NCT01481116|593731245|FG002|Overall Study|Lack of Efficacy|1|||
164092736|NCT00752856|592702129|FG001|Overall Study|randomized but did not do viral kinetics|1|||
164092737|NCT02688608|592702130|FG000|Overall Study|Lost to Follow-up|1|||
164092738|NCT02456909|592702131|FG000|Overall Study|Did not receive allocated intervention|24|||
164369354|NCT01481116|593731243|FG000|Overall Study|Contraindications|1|||
164369355|NCT01481116|593731244|FG001|Overall Study|Contraindications|1|||
164369356|NCT01481116|593731245|FG002|Overall Study|Contraindications|0|||
164369357|NCT01481116|593731243|FG000|Overall Study|Other|1|||
164369358|NCT01481116|593731244|FG001|Overall Study|Other|1|||
164369359|NCT01481116|593731245|FG002|Overall Study|Other|0|||
164369360|NCT01481116|593731243|FG000|Overall Study|Participant Started Taking Glipizide|1|||
164369361|NCT01481116|593731244|FG001|Overall Study|Participant Started Taking Glipizide|0|||
164369362|NCT01481116|593731245|FG002|Overall Study|Participant Started Taking Glipizide|0|||
164369363|NCT01481116|593731243|FG000|Overall Study|Participant Moved Out of Area|2|||
164369364|NCT01481116|593731244|FG001|Overall Study|Participant Moved Out of Area|0|||
164369365|NCT01481116|593731245|FG002|Overall Study|Participant Moved Out of Area|1|||
164369366|NCT01481116|593731243|FG000|Overall Study|Participant Moved Out of Country|1|||
164369367|NCT01481116|593731244|FG001|Overall Study|Participant Moved Out of Country|0|||
164369368|NCT01481116|593731245|FG002|Overall Study|Participant Moved Out of Country|1|||
164369369|NCT01481116|593731243|FG000|Overall Study|Investigator Decision|3|||
164369370|NCT01481116|593731244|FG001|Overall Study|Investigator Decision|2|||
164369371|NCT01481116|593731245|FG002|Overall Study|Investigator Decision|1|||
164369372|NCT01481116|593731243|FG000|Overall Study|Sponsor Decision|0|||
164369373|NCT01481116|593731244|FG001|Overall Study|Sponsor Decision|1|||
164369374|NCT01481116|593731245|FG002|Overall Study|Sponsor Decision|3|||
164369375|NCT01481116|593731243|FG000|Overall Study|Non-Compliant With Study Drug|0|||
164369376|NCT01481116|593731244|FG001|Overall Study|Non-Compliant With Study Drug|1|||
164369377|NCT01481116|593731245|FG002|Overall Study|Non-Compliant With Study Drug|1|||
164369378|NCT01481116|593731243|FG000|Overall Study|Investigator's Discretion|2|||
164369379|NCT01481116|593731244|FG001|Overall Study|Investigator's Discretion|0|||
164369380|NCT01481116|593731245|FG002|Overall Study|Investigator's Discretion|0|||
164369381|NCT01481116|593731243|FG000|Overall Study|Death|2|||
164369382|NCT01481116|593731244|FG001|Overall Study|Death|1|||
164369383|NCT01481116|593731245|FG002|Overall Study|Death|0|||
164369384|NCT01481116|593731243|FG000|Overall Study|Hypoglycemic Event|4|||
164369385|NCT01481116|593731244|FG001|Overall Study|Hypoglycemic Event|0|||
164369386|NCT01481116|593731245|FG002|Overall Study|Hypoglycemic Event|0|||
164369387|NCT03848845|593731246|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
164369388|NCT03848845|593731247|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
164369389|NCT03848845|593731248|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
164369390|NCT03848845|593731249|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
164369391|NCT03848845|593731246|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
164369392|NCT03848845|593731247|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
164369393|NCT03848845|593731248|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
164369394|NCT03848845|593731249|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
164369395|NCT03848845|593731246|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
164369396|NCT03848845|593731247|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
164369397|NCT03848845|593731248|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
164369398|NCT03848845|593731249|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
164369399|NCT03848845|593731246|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
164369400|NCT03848845|593731247|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
164369401|NCT03848845|593731248|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
164369402|NCT03848845|593731249|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
164369403|NCT02433834|593731251|FG000|Overall Study|Protocol-specified criteria|7|||
164369404|NCT02433834|593731251|FG000|Overall Study|Protocol Violation|3|||
164369405|NCT02433834|593731251|FG000|Overall Study|Lost to Follow-up|6|||
164369406|NCT02433834|593731251|FG000|Overall Study|Withdrawal by Subject|14|||
164369407|NCT02433834|593731251|FG000|Overall Study|Adverse Event|6|||
164369408|NCT02433834|593731251|FG000|Overall Study|Physician Decision|1|||
164369409|NCT02821962|593731252|FG000|Overall Study|Lost to Follow-up|2|||
164369410|NCT02821962|593731253|FG001|Overall Study|Lost to Follow-up|0|||
164369411|NCT04098458|593731258|FG000|Overall Study|Death|1|||
164369412|NCT04098458|593731258|FG000|Overall Study|did not meet study inclusion criteria|3|||
164092739|NCT02456909|592702132|FG001|Overall Study|Did not receive allocated intervention|26|||
164369413|NCT02272413|593731263|FG000|Randomized Through Treatment Start|Not treated|3|||
164369414|NCT02272413|593731264|FG001|Randomized Through Treatment Start|Not treated|5|||
163902068|NCT02232737|592013051|FG002|Overall Study|Death|1|||
164144029|NCT00086281|592888583|FG012|Phase 1|Serious Adverse Event|0|||
164369415|NCT02272413|593731263|FG000|Pre-switch Period|Adverse Event|38|||
164369416|NCT02272413|593731264|FG001|Pre-switch Period|Adverse Event|37|||
164369417|NCT02272413|593731263|FG000|Pre-switch Period|Death|26|||
164369418|NCT02272413|593731264|FG001|Pre-switch Period|Death|26|||
164369419|NCT02272413|593731263|FG000|Pre-switch Period|Withdrawal by Subject|27|||
164369420|NCT02272413|593731264|FG001|Pre-switch Period|Withdrawal by Subject|15|||
164369421|NCT02272413|593731263|FG000|Pre-switch Period|Physician Decision|6|||
164369422|NCT02272413|593731264|FG001|Pre-switch Period|Physician Decision|18|||
164369423|NCT02272413|593731263|FG000|Pre-switch Period|Progressive disease|185|||
164369424|NCT02272413|593731264|FG001|Pre-switch Period|Progressive disease|173|||
164369425|NCT02272413|593731263|FG000|Pre-switch Period|Lost to Follow-up|0|||
164369426|NCT02272413|593731264|FG001|Pre-switch Period|Lost to Follow-up|2|||
164369427|NCT02272413|593731263|FG000|Pre-switch Period|Protocol Violation|1|||
164369428|NCT02272413|593731264|FG001|Pre-switch Period|Protocol Violation|0|||
164369429|NCT02272413|593731263|FG000|Pre-switch Period|Other than listed|10|||
164369430|NCT02272413|593731264|FG001|Pre-switch Period|Other than listed|11|||
164369431|NCT02272413|593731263|FG000|Post-switch Period|Adverse Event|4|||
164369432|NCT02272413|593731264|FG001|Post-switch Period|Adverse Event|4|||
164369433|NCT02272413|593731263|FG000|Post-switch Period|Death|3|||
164369434|NCT02272413|593731264|FG001|Post-switch Period|Death|2|||
164369435|NCT02272413|593731263|FG000|Post-switch Period|Withdrawal by Subject|1|||
164369436|NCT02272413|593731264|FG001|Post-switch Period|Withdrawal by Subject|2|||
164369437|NCT02272413|593731263|FG000|Post-switch Period|Physician Decision|1|||
164369438|NCT02272413|593731264|FG001|Post-switch Period|Physician Decision|1|||
164369439|NCT02272413|593731263|FG000|Post-switch Period|Progressive disease|21|||
164369440|NCT02272413|593731264|FG001|Post-switch Period|Progressive disease|21|||
164369441|NCT02272413|593731263|FG000|Post-switch Period|Study terminated by sponsor|8|||
164369442|NCT02272413|593731264|FG001|Post-switch Period|Study terminated by sponsor|11|||
164369443|NCT02272413|593731263|FG000|Post-switch Period|Other than listed|4|||
164012364|NCT02416908|592408722|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164369444|NCT02272413|593731264|FG001|Post-switch Period|Other than listed|5|||
164369445|NCT04327999|593731265|FG000|Overall Study|Protocol Violation|1|||
164369446|NCT02872116|593731266|FG000|Pre-Treatment|Disease Progression|0|||
164369447|NCT02872116|593731267|FG001|Pre-Treatment|Disease Progression|1|||
164369448|NCT02872116|593731268|FG002|Pre-Treatment|Disease Progression|0|||
164369449|NCT02872116|593731266|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
164369450|NCT02872116|593731267|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
164369451|NCT02872116|593731268|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
164369452|NCT02872116|593731266|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
164369453|NCT02872116|593731267|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
164369454|NCT02872116|593731268|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
164369455|NCT02872116|593731266|FG000|Pre-Treatment|Participant withdrew consent|2|||
164369456|NCT02872116|593731267|FG001|Pre-Treatment|Participant withdrew consent|20|||
164369457|NCT02872116|593731268|FG002|Pre-Treatment|Participant withdrew consent|3|||
164369458|NCT02872116|593731266|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
164369459|NCT02872116|593731267|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
164369460|NCT02872116|593731268|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
164369461|NCT02872116|593731266|FG000|Pre-Treatment|Other reasons|1|||
164369462|NCT02872116|593731267|FG001|Pre-Treatment|Other reasons|2|||
164369463|NCT02872116|593731268|FG002|Pre-Treatment|Other reasons|2|||
164369464|NCT02872116|593731266|FG000|Treatment|Death|121|||
164369465|NCT02872116|593731267|FG001|Treatment|Death|94|||
164369466|NCT02872116|593731268|FG002|Treatment|Death|68|||
164369467|NCT02872116|593731266|FG000|Treatment|Lost to Follow-up|5|||
164369468|NCT02872116|593731267|FG001|Treatment|Lost to Follow-up|7|||
164369469|NCT02872116|593731268|FG002|Treatment|Lost to Follow-up|3|||
164369470|NCT02872116|593731266|FG000|Treatment|Participant withdrew consent|20|||
164369471|NCT02872116|593731267|FG001|Treatment|Participant withdrew consent|40|||
164369472|NCT02872116|593731268|FG002|Treatment|Participant withdrew consent|8|||
164369473|NCT02872116|593731266|FG000|Treatment|Other reasons|13|||
164369474|NCT02872116|593731267|FG001|Treatment|Other reasons|12|||
164012365|NCT02416908|592408723|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
164012366|NCT02416908|592408724|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164012367|NCT01214434|592408727|FG000|Overall Study|Withdrawal by Subject|1|||
164012368|NCT01214434|592408728|FG001|Overall Study|Withdrawal by Subject|0|||
164369475|NCT02872116|593731268|FG002|Treatment|Other reasons|5|||
164369476|NCT03792672|593731273|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
164369477|NCT03792672|593731274|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369478|NCT03792672|593731275|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369479|NCT03792672|593731276|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
164369480|NCT03792672|593731277|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369481|NCT03792672|593731278|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
164369482|NCT03792672|593731273|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
164369483|NCT03792672|593731274|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
164369484|NCT03792672|593731275|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
164369485|NCT03792672|593731276|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
164369486|NCT03792672|593731277|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
164369487|NCT03792672|593731278|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
164092740|NCT02456909|592702131|FG000|Overall Study|Did not complete the primary outcome|0|||
164369488|NCT03792672|593731273|FG000|Treatment Period 4 (2 Days)|Other|1|||
164369489|NCT03792672|593731274|FG001|Treatment Period 4 (2 Days)|Other|0|||
164369490|NCT03792672|593731275|FG002|Treatment Period 4 (2 Days)|Other|0|||
164369491|NCT03792672|593731276|FG003|Treatment Period 4 (2 Days)|Other|0|||
164369492|NCT03792672|593731277|FG004|Treatment Period 4 (2 Days)|Other|0|||
164369493|NCT03792672|593731278|FG005|Treatment Period 4 (2 Days)|Other|0|||
164369494|NCT00453999|593731279|FG000|Overall Study|Adverse Event|1|||
164369495|NCT00453999|593731280|FG001|Overall Study|Adverse Event|2|||
164369496|NCT00453999|593731281|FG002|Overall Study|Adverse Event|1|||
163902069|NCT02232737|592013049|FG000|Overall Study|Physician Decision|1|||
163902070|NCT02232737|592013050|FG001|Overall Study|Physician Decision|3|||
163902071|NCT02232737|592013051|FG002|Overall Study|Physician Decision|1|||
163902072|NCT02232737|592013049|FG000|Overall Study|Protocol Violation|1|||
163902073|NCT02232737|592013050|FG001|Overall Study|Protocol Violation|0|||
163902074|NCT02232737|592013051|FG002|Overall Study|Protocol Violation|1|||
163902075|NCT02232737|592013049|FG000|Overall Study|Reason unknown|1|||
163902076|NCT02232737|592013050|FG001|Overall Study|Reason unknown|0|||
163902077|NCT02232737|592013051|FG002|Overall Study|Reason unknown|0|||
163902078|NCT02200705|592013054|FG000|Overall Study|Excluded|12|||
163902079|NCT02200705|592013054|FG000|Overall Study|Death|21|||
163902080|NCT02200705|592013054|FG000|Overall Study|Withdrawal by Subject|22|||
163902081|NCT02200705|592013054|FG000|Overall Study|Lost to Follow-up|13|||
163902082|NCT02200705|592013054|FG000|Overall Study|Physician Decision|5|||
163902083|NCT02200705|592013054|FG000|Overall Study|Adverse Event|2|||
163902084|NCT03116464|592013059|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
163902085|NCT00065182|592013068|FG000|Overall Study|Adverse Event|24|||
163902086|NCT00065182|592013069|FG001|Overall Study|Adverse Event|17|||
163902087|NCT00065182|592013068|FG000|Overall Study|Lost to Follow-up|0|||
163902088|NCT00065182|592013069|FG001|Overall Study|Lost to Follow-up|4|||
163902089|NCT00065182|592013068|FG000|Overall Study|Protocol Violation|3|||
163902090|NCT00065182|592013069|FG001|Overall Study|Protocol Violation|4|||
163902091|NCT00065182|592013068|FG000|Overall Study|Serious adverse events (SAE)|1|||
163902092|NCT00065182|592013069|FG001|Overall Study|Serious adverse events (SAE)|0|||
163902093|NCT00065182|592013068|FG000|Overall Study|Sponsor Decision|11|||
163902094|NCT00065182|592013069|FG001|Overall Study|Sponsor Decision|7|||
163902095|NCT00065182|592013068|FG000|Overall Study|Withdrawal by Subject|8|||
163902096|NCT00065182|592013069|FG001|Overall Study|Withdrawal by Subject|3|||
163902097|NCT00065182|592013068|FG000|Overall Study|No clinical benefit|1|||
163902098|NCT00065182|592013069|FG001|Overall Study|No clinical benefit|0|||
163902099|NCT00065182|592013068|FG000|Overall Study|Death|0|||
163902100|NCT00065182|592013069|FG001|Overall Study|Death|1|||
163902101|NCT00065182|592013068|FG000|Overall Study|Decline in Status|0|||
163902102|NCT00065182|592013069|FG001|Overall Study|Decline in Status|1|||
163902103|NCT02633215|592013070|FG000|Overall Study|Lost to Follow-up|2|||
163902104|NCT02633215|592013071|FG001|Overall Study|Lost to Follow-up|3|||
163902105|NCT02568215|592013072|FG000|Overall Study|Death|1|||
163902106|NCT02568215|592013073|FG001|Overall Study|Death|2|||
163902107|NCT02568215|592013074|FG002|Overall Study|Death|0|||
163902108|NCT02568215|592013072|FG000|Overall Study|Physician Decision|2|||
163902109|NCT02568215|592013073|FG001|Overall Study|Physician Decision|2|||
163902110|NCT02568215|592013074|FG002|Overall Study|Physician Decision|2|||
163902111|NCT02568215|592013072|FG000|Overall Study|Lost to Follow-up|29|||
163902112|NCT02568215|592013073|FG001|Overall Study|Lost to Follow-up|32|||
163902113|NCT02568215|592013074|FG002|Overall Study|Lost to Follow-up|41|||
163902114|NCT02568215|592013072|FG000|Overall Study|Withdrawal by Subject|21|||
163902115|NCT02568215|592013073|FG001|Overall Study|Withdrawal by Subject|19|||
163902116|NCT02568215|592013074|FG002|Overall Study|Withdrawal by Subject|22|||
163902117|NCT02568215|592013072|FG000|Overall Study|Protocol Violation|1|||
163902118|NCT02568215|592013073|FG001|Overall Study|Protocol Violation|1|||
163902119|NCT02568215|592013074|FG002|Overall Study|Protocol Violation|0|||
164369497|NCT00453999|593731279|FG000|Overall Study|Lost to Follow-up|0|||
164012369|NCT01214434|592408727|FG000|Overall Study|Lost to Follow-up|2|||
164012370|NCT01214434|592408728|FG001|Overall Study|Lost to Follow-up|2|||
164012371|NCT01214434|592408727|FG000|Overall Study|Site error|1|||
164012372|NCT01214434|592408728|FG001|Overall Study|Site error|0|||
164012373|NCT03792750|592408730|FG000|Overall Study|Death|3|||
164012374|NCT01879618|592408738|FG000|Overall Study|Does not meet entrance criteria|1|||
164012375|NCT01879618|592408738|FG000|Overall Study|Withdrawal by Subject|1|||
164012376|NCT01879618|592408738|FG000|Overall Study|Surgery;changed schedule; not available|8|||
164012377|NCT01879618|592408738|FG000|Overall Study|Protocol Violation|6|||
164369498|NCT00453999|593731280|FG001|Overall Study|Lost to Follow-up|1|||
164369499|NCT00453999|593731281|FG002|Overall Study|Lost to Follow-up|1|||
164369500|NCT00453999|593731279|FG000|Overall Study|Withdrawal by Subject|2|||
164369501|NCT00453999|593731280|FG001|Overall Study|Withdrawal by Subject|1|||
164369502|NCT00453999|593731281|FG002|Overall Study|Withdrawal by Subject|1|||
164369503|NCT00453999|593731279|FG000|Overall Study|Subject Request|2|||
164369504|NCT00453999|593731280|FG001|Overall Study|Subject Request|1|||
164369505|NCT00453999|593731281|FG002|Overall Study|Subject Request|0|||
164369506|NCT04238728|593731284|FG000|Overall Study|Withdrawal by Subject|1|||
164369507|NCT04238728|593731284|FG000|Overall Study|Lost to Follow-up|2|||
164369508|NCT04414553|593731286|FG000|Overall Study|Lost to Follow-up|20|||
164369509|NCT00974571|593731288|FG000|Overall Study|Adverse Event|31|||
164369510|NCT00974571|593731289|FG001|Overall Study|Adverse Event|4|||
164369511|NCT00974571|593731290|FG002|Overall Study|Adverse Event|27|||
164369512|NCT00974571|593731288|FG000|Overall Study|Lack of Efficacy|3|||
164369513|NCT00974571|593731289|FG001|Overall Study|Lack of Efficacy|2|||
164369514|NCT00974571|593731290|FG002|Overall Study|Lack of Efficacy|9|||
164369515|NCT00974571|593731288|FG000|Overall Study|Lost to Follow-up|2|||
164369516|NCT00974571|593731289|FG001|Overall Study|Lost to Follow-up|1|||
164369517|NCT00974571|593731290|FG002|Overall Study|Lost to Follow-up|2|||
164369518|NCT00974571|593731288|FG000|Overall Study|Protocol Violation|13|||
164369519|NCT00974571|593731289|FG001|Overall Study|Protocol Violation|4|||
164369520|NCT00974571|593731290|FG002|Overall Study|Protocol Violation|18|||
164369521|NCT00974571|593731288|FG000|Overall Study|Withdrawal by Subject|14|||
164369522|NCT00974571|593731289|FG001|Overall Study|Withdrawal by Subject|5|||
164369523|NCT00974571|593731290|FG002|Overall Study|Withdrawal by Subject|16|||
164369524|NCT00974571|593731288|FG000|Overall Study|Patient Moved|1|||
164369525|NCT00974571|593731289|FG001|Overall Study|Patient Moved|0|||
164369526|NCT00974571|593731290|FG002|Overall Study|Patient Moved|1|||
164012378|NCT01879618|592408738|FG000|Overall Study|Adverse Event|5|||
164012379|NCT00394914|592408739|FG000|Treatment Period|Adverse Event|0|||
164012380|NCT00394914|592408740|FG001|Treatment Period|Adverse Event|3|||
164012381|NCT00394914|592408741|FG002|Treatment Period|Adverse Event|1|||
164012382|NCT00394914|592408739|FG000|Treatment Period|Lost to Follow-up|0|||
164012383|NCT00394914|592408740|FG001|Treatment Period|Lost to Follow-up|1|||
164012384|NCT00394914|592408741|FG002|Treatment Period|Lost to Follow-up|0|||
164092741|NCT02456909|592702132|FG001|Overall Study|Did not complete the primary outcome|1|||
164012385|NCT00394914|592408739|FG000|Treatment Period|Withdrawal by Subject|0|||
164012386|NCT00394914|592408740|FG001|Treatment Period|Withdrawal by Subject|2|||
164369527|NCT00974571|593731288|FG000|Overall Study|Other|4|||
164369528|NCT00974571|593731289|FG001|Overall Study|Other|0|||
164369529|NCT00974571|593731290|FG002|Overall Study|Other|10|||
164369530|NCT03778931|593731302|FG000|Overall Study|Withdrawal by Subject|12|||
164369531|NCT03778931|593731303|FG001|Overall Study|Withdrawal by Subject|25|||
164369532|NCT03778931|593731302|FG000|Overall Study|Physician Decision|1|||
164012387|NCT00394914|592408741|FG002|Treatment Period|Withdrawal by Subject|2|||
164369533|NCT03778931|593731303|FG001|Overall Study|Physician Decision|3|||
164369534|NCT03778931|593731302|FG000|Overall Study|Participant Noncompliance|1|||
164369535|NCT03778931|593731303|FG001|Overall Study|Participant Noncompliance|1|||
164369536|NCT03778931|593731302|FG000|Overall Study|Lost to Follow-up|4|||
164369537|NCT03778931|593731303|FG001|Overall Study|Lost to Follow-up|1|||
164369538|NCT03778931|593731302|FG000|Overall Study|Death|69|||
164369539|NCT03778931|593731303|FG001|Overall Study|Death|79|||
164369540|NCT04180020|593731306|FG000|Overall Study|missed visit|18|||
164369541|NCT04180020|593731307|FG001|Overall Study|missed visit|16|||
164369542|NCT04180020|593731306|FG000|Overall Study|Death|2|||
164369543|NCT04180020|593731307|FG001|Overall Study|Death|3|||
164369544|NCT04180020|593731306|FG000|Overall Study|Withdrawal by Subject|1|||
164369545|NCT04180020|593731307|FG001|Overall Study|Withdrawal by Subject|5|||
164369546|NCT04180020|593731306|FG000|Overall Study|incarcerated|1|||
164369547|NCT04180020|593731307|FG001|Overall Study|incarcerated|1|||
164369548|NCT04180020|593731306|FG000|Overall Study|Physician Decision|0|||
164369549|NCT04180020|593731307|FG001|Overall Study|Physician Decision|2|||
164369550|NCT03216850|593731312|FG000|Overall Study|Pre-analytical error|6|||
164369551|NCT03554291|593731315|FG000|Overall Study|Death|2|||
164369552|NCT03554291|593731316|FG001|Overall Study|Death|1|||
164369553|NCT03554291|593731315|FG000|Overall Study|Lost to Follow-up|1|||
164369554|NCT03554291|593731316|FG001|Overall Study|Lost to Follow-up|0|||
164369555|NCT03554291|593731315|FG000|Overall Study|Withdrawal by Subject|1|||
164369556|NCT03554291|593731316|FG001|Overall Study|Withdrawal by Subject|0|||
164369557|NCT03554291|593731315|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
164369558|NCT03554291|593731316|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
164369559|NCT00537381|593731317|FG000|Overall Study|Adverse Event|13|||
164369560|NCT00537381|593731318|FG001|Overall Study|Adverse Event|9|||
164369561|NCT00537381|593731317|FG000|Overall Study|Death|3|||
164369562|NCT00537381|593731318|FG001|Overall Study|Death|3|||
164369563|NCT00537381|593731317|FG000|Overall Study|Withdrawal by Subject|5|||
164369564|NCT00537381|593731318|FG001|Overall Study|Withdrawal by Subject|14|||
164369565|NCT00537381|593731317|FG000|Overall Study|Physician Decision|7|||
164369566|NCT00537381|593731318|FG001|Overall Study|Physician Decision|6|||
164369567|NCT00537381|593731317|FG000|Overall Study|Disease Progression|9|||
164369568|NCT00537381|593731318|FG001|Overall Study|Disease Progression|18|||
164369569|NCT00537381|593731317|FG000|Overall Study|Sponsor decision|14|||
164369570|NCT00537381|593731318|FG001|Overall Study|Sponsor decision|9|||
164369571|NCT00537381|593731317|FG000|Overall Study|Other|5|||
164369572|NCT00537381|593731318|FG001|Overall Study|Other|3|||
164369573|NCT02357940|593731325|FG000|Overall Study|Adverse Event|0|||
164369574|NCT02357940|593731326|FG001|Overall Study|Adverse Event|1|||
164369575|NCT02357940|593731325|FG000|Overall Study|Investigator's judgement|0|||
164369576|NCT02357940|593731326|FG001|Overall Study|Investigator's judgement|1|||
164012388|NCT00394914|592408739|FG000|Treatment Period|Noncompliance with protocol|0|||
164012389|NCT00394914|592408740|FG001|Treatment Period|Noncompliance with protocol|3|||
164012390|NCT00394914|592408741|FG002|Treatment Period|Noncompliance with protocol|2|||
164012391|NCT00394914|592408739|FG000|Treatment Period|Did not meet protocol eligibility|0|||
164012392|NCT00394914|592408740|FG001|Treatment Period|Did not meet protocol eligibility|1|||
164012393|NCT00394914|592408741|FG002|Treatment Period|Did not meet protocol eligibility|1|||
164012394|NCT00465738|592408747|FG000|Overall Study|Lost to Follow-up|2|||
164012395|NCT00465738|592408748|FG001|Overall Study|Lost to Follow-up|0|||
164012396|NCT00465738|592408747|FG000|Overall Study|Adverse Event|0|||
164369577|NCT04258605|593731329|FG000|Overall Study|Death|1|||
164012397|NCT00465738|592408748|FG001|Overall Study|Adverse Event|1|||
164012398|NCT00465738|592408747|FG000|Overall Study|Withdrawal by Subject|2|||
164012399|NCT00465738|592408748|FG001|Overall Study|Withdrawal by Subject|0|||
164369578|NCT04258605|593731330|FG001|Overall Study|Death|0|||
164369579|NCT04258605|593731329|FG000|Overall Study|Early study termination|21|||
164369580|NCT04258605|593731330|FG001|Overall Study|Early study termination|2|||
164369581|NCT02910167|593731331|FG000|Overall Study|Adverse Event|1|||
164369582|NCT02910167|593731331|FG000|Overall Study|Lost to Follow-up|18|||
164369583|NCT00842348|593731339|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
164369584|NCT00842348|593731340|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
164369585|NCT00842348|593731339|FG000|Study 729|Disease progression/death|19|||
164369586|NCT00842348|593731340|FG001|Study 729|Disease progression/death|30|||
164369587|NCT00842348|593731339|FG000|Study 729|Adverse Event|1|||
164369588|NCT00842348|593731340|FG001|Study 729|Adverse Event|1|||
164369589|NCT00842348|593731339|FG000|Study 729|Protocol Violation|1|||
164369590|NCT00842348|593731340|FG001|Study 729|Protocol Violation|1|||
164369591|NCT00842348|593731339|FG000|Study 729|Withdrawal by Subject|2|||
164369592|NCT00842348|593731340|FG001|Study 729|Withdrawal by Subject|4|||
164369593|NCT00842348|593731339|FG000|Study 729|Due to Sponsor stopping the study|1|||
164369594|NCT00842348|593731340|FG001|Study 729|Due to Sponsor stopping the study|1|||
164369595|NCT00842348|593731339|FG000|Study 729|Due to non-availability of IP|0|||
164369596|NCT00842348|593731340|FG001|Study 729|Due to non-availability of IP|1|||
164369597|NCT00842348|593731339|FG000|Study 729|Sponsor's decision|1|||
164369598|NCT00842348|593731340|FG001|Study 729|Sponsor's decision|0|||
164369599|NCT00842348|593731339|FG000|Study 729|Surgical resection|1|||
164369600|NCT00842348|593731340|FG001|Study 729|Surgical resection|0|||
164369601|NCT00603746|593731341|FG000|Overall Study|Adverse Event|2|||
164369602|NCT00603746|593731342|FG001|Overall Study|Adverse Event|3|||
164369603|NCT00603746|593731343|FG002|Overall Study|Adverse Event|0|||
164369604|NCT00603746|593731344|FG003|Overall Study|Adverse Event|1|||
164369605|NCT00603746|593731345|FG004|Overall Study|Adverse Event|0|||
164369606|NCT00603746|593731346|FG005|Overall Study|Adverse Event|4|||
164369607|NCT00603746|593731341|FG000|Overall Study|Lack of Efficacy|34|||
164369608|NCT00603746|593731342|FG001|Overall Study|Lack of Efficacy|11|||
164369609|NCT00603746|593731343|FG002|Overall Study|Lack of Efficacy|6|||
164369610|NCT00603746|593731344|FG003|Overall Study|Lack of Efficacy|11|||
164369611|NCT00603746|593731345|FG004|Overall Study|Lack of Efficacy|12|||
164369612|NCT00603746|593731346|FG005|Overall Study|Lack of Efficacy|8|||
164369613|NCT00603746|593731341|FG000|Overall Study|Protocol Violation|0|||
164369614|NCT00603746|593731342|FG001|Overall Study|Protocol Violation|3|||
164369615|NCT00603746|593731343|FG002|Overall Study|Protocol Violation|1|||
164369616|NCT00603746|593731344|FG003|Overall Study|Protocol Violation|0|||
164369617|NCT00603746|593731345|FG004|Overall Study|Protocol Violation|1|||
164369618|NCT00603746|593731346|FG005|Overall Study|Protocol Violation|0|||
164369619|NCT00603746|593731341|FG000|Overall Study|Lost to Follow-up|0|||
164369620|NCT00603746|593731342|FG001|Overall Study|Lost to Follow-up|1|||
164369621|NCT00603746|593731343|FG002|Overall Study|Lost to Follow-up|1|||
164369622|NCT00603746|593731344|FG003|Overall Study|Lost to Follow-up|0|||
164369623|NCT00603746|593731345|FG004|Overall Study|Lost to Follow-up|0|||
164369624|NCT00603746|593731346|FG005|Overall Study|Lost to Follow-up|0|||
164369625|NCT00603746|593731341|FG000|Overall Study|Physician Decision|1|||
164369626|NCT00603746|593731342|FG001|Overall Study|Physician Decision|0|||
164369627|NCT00603746|593731343|FG002|Overall Study|Physician Decision|0|||
164369628|NCT00603746|593731344|FG003|Overall Study|Physician Decision|0|||
164369629|NCT00603746|593731345|FG004|Overall Study|Physician Decision|1|||
164369630|NCT00603746|593731346|FG005|Overall Study|Physician Decision|0|||
164369631|NCT00603746|593731341|FG000|Overall Study|Withdrawal by Subject|1|||
164369632|NCT00603746|593731342|FG001|Overall Study|Withdrawal by Subject|0|||
164369633|NCT00603746|593731343|FG002|Overall Study|Withdrawal by Subject|0|||
164369634|NCT00603746|593731344|FG003|Overall Study|Withdrawal by Subject|1|||
164369635|NCT00603746|593731345|FG004|Overall Study|Withdrawal by Subject|3|||
164369636|NCT00603746|593731346|FG005|Overall Study|Withdrawal by Subject|1|||
164369637|NCT00026793|593731351|FG000|Overall Study|Death on study due to underlying disease|4|||
164369638|NCT00026793|593731351|FG000|Overall Study|Physician Decision|2|||
164369639|NCT00026793|593731351|FG000|Overall Study|Off study|2|||
164369640|NCT01449526|593731352|FG000|Overall Study|Lost to Follow-up|1|||
164369641|NCT01449526|593731353|FG001|Overall Study|Lost to Follow-up|2|||
164369642|NCT01449526|593731352|FG000|Overall Study|Withdrawal by Subject|1|||
164369643|NCT01449526|593731353|FG001|Overall Study|Withdrawal by Subject|1|||
164369644|NCT01449526|593731352|FG000|Overall Study|Symptoms/complaints|0|||
164369645|NCT01449526|593731353|FG001|Overall Study|Symptoms/complaints|1|||
164369646|NCT01449526|593731352|FG000|Overall Study|Lack of Motivation|0|||
164369647|NCT01449526|593731353|FG001|Overall Study|Lack of Motivation|1|||
164369648|NCT01449526|593731352|FG000|Overall Study|Cannot maintain visits|0|||
164369649|NCT01449526|593731353|FG001|Overall Study|Cannot maintain visits|1|||
164369650|NCT01132495|593731354|FG000|Overall Study|Various reasons|40|||
164369651|NCT01132495|593731355|FG001|Overall Study|Various reasons|38|||
164369652|NCT01132495|593731356|FG002|Overall Study|Various reasons|20|||
164369653|NCT01132495|593731357|FG003|Overall Study|Various reasons|12|||
164369654|NCT03913091|593731358|FG000|Overall Study|Lost to Follow-up|18|||
164369655|NCT03913091|593731359|FG001|Overall Study|Lost to Follow-up|11|||
164369656|NCT03913091|593731358|FG000|Overall Study|Required additional meds/surgery|1|||
164012400|NCT00465738|592408747|FG000|Overall Study|Other|2|||
164369657|NCT03913091|593731359|FG001|Overall Study|Required additional meds/surgery|2|||
164012401|NCT00465738|592408748|FG001|Overall Study|Other|5|||
164369658|NCT03913091|593731358|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
164369659|NCT03913091|593731359|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
164369660|NCT00655564|593731360|FG000|Overall Study|Adverse Event|1|||
164369661|NCT00655564|593731360|FG000|Overall Study|Lost to Follow-up|1|||
164369662|NCT00655564|593731360|FG000|Overall Study|Desired Alternate Therapy|1|||
164369663|NCT01581593|593733333|FG000|Overall Study|Withdrawal by Subject|1|||
164369664|NCT00653224|593733334|FG000|Overall Study|Adverse Event|2|||
164369665|NCT00653224|593733335|FG001|Overall Study|Adverse Event|1|||
164369666|NCT00653224|593733334|FG000|Overall Study|Lack of Efficacy|1|||
164369667|NCT00653224|593733335|FG001|Overall Study|Lack of Efficacy|2|||
164369668|NCT00653224|593733334|FG000|Overall Study|Loss of efficacy|1|||
164369669|NCT00653224|593733335|FG001|Overall Study|Loss of efficacy|0|||
164369670|NCT00653224|593733334|FG000|Overall Study|Lost to Follow-up|1|||
164369671|NCT00653224|593733335|FG001|Overall Study|Lost to Follow-up|0|||
164369672|NCT00653224|593733334|FG000|Overall Study|Other|2|||
164369673|NCT00653224|593733335|FG001|Overall Study|Other|4|||
164369674|NCT03756558|593733336|FG000|Overall Study|Death|1|||
164369675|NCT03756558|593733336|FG000|Overall Study|Lost to Follow-up|2|||
164369676|NCT03756558|593733336|FG000|Overall Study|Withdrawal by Subject|2|||
164369677|NCT02896400|593733337|FG000|1 Month Follow-up|Lost to Follow-up|7|||
164369678|NCT02896400|593733338|FG001|1 Month Follow-up|Lost to Follow-up|7|||
164369679|NCT02896400|593733339|FG002|1 Month Follow-up|Lost to Follow-up|5|||
164369680|NCT02896400|593733340|FG003|1 Month Follow-up|Lost to Follow-up|8|||
164369681|NCT02896400|593733341|FG004|1 Month Follow-up|Lost to Follow-up|9|||
164369682|NCT02896400|593733342|FG005|1 Month Follow-up|Lost to Follow-up|6|||
164369683|NCT02896400|593733343|FG006|1 Month Follow-up|Lost to Follow-up|5|||
164369684|NCT02896400|593733344|FG007|1 Month Follow-up|Lost to Follow-up|6|||
164369685|NCT02896400|593733345|FG008|1 Month Follow-up|Lost to Follow-up|4|||
164369686|NCT02896400|593733346|FG009|1 Month Follow-up|Lost to Follow-up|7|||
164369687|NCT02896400|593733347|FG010|1 Month Follow-up|Lost to Follow-up|5|||
164369688|NCT02896400|593733348|FG011|1 Month Follow-up|Lost to Follow-up|5|||
164369689|NCT02896400|593733349|FG012|1 Month Follow-up|Lost to Follow-up|3|||
164369690|NCT02896400|593733350|FG013|1 Month Follow-up|Lost to Follow-up|4|||
164369691|NCT02896400|593733351|FG014|1 Month Follow-up|Lost to Follow-up|1|||
164369692|NCT02896400|593733352|FG015|1 Month Follow-up|Lost to Follow-up|2|||
164369693|NCT02896400|593733337|FG000|1 Month Follow-up|Death|0|||
164369694|NCT02896400|593733338|FG001|1 Month Follow-up|Death|0|||
164369695|NCT02896400|593733339|FG002|1 Month Follow-up|Death|0|||
164369696|NCT02896400|593733340|FG003|1 Month Follow-up|Death|0|||
164369697|NCT02896400|593733341|FG004|1 Month Follow-up|Death|0|||
164369698|NCT02896400|593733342|FG005|1 Month Follow-up|Death|0|||
164369699|NCT02896400|593733343|FG006|1 Month Follow-up|Death|0|||
164369700|NCT02896400|593733344|FG007|1 Month Follow-up|Death|0|||
164369701|NCT02896400|593733345|FG008|1 Month Follow-up|Death|0|||
164369702|NCT02896400|593733346|FG009|1 Month Follow-up|Death|0|||
164369703|NCT02896400|593733347|FG010|1 Month Follow-up|Death|0|||
164369704|NCT02896400|593733348|FG011|1 Month Follow-up|Death|0|||
164369705|NCT02896400|593733349|FG012|1 Month Follow-up|Death|0|||
164369706|NCT02896400|593733350|FG013|1 Month Follow-up|Death|0|||
164369707|NCT02896400|593733351|FG014|1 Month Follow-up|Death|0|||
164369708|NCT02896400|593733352|FG015|1 Month Follow-up|Death|1|||
164369709|NCT02896400|593733337|FG000|3 Month Follow-up|Lost to Follow-up|6|||
164369710|NCT02896400|593733338|FG001|3 Month Follow-up|Lost to Follow-up|3|||
164369711|NCT02896400|593733339|FG002|3 Month Follow-up|Lost to Follow-up|6|||
164369712|NCT02896400|593733340|FG003|3 Month Follow-up|Lost to Follow-up|11|||
164369713|NCT02896400|593733341|FG004|3 Month Follow-up|Lost to Follow-up|12|||
164369714|NCT02896400|593733342|FG005|3 Month Follow-up|Lost to Follow-up|6|||
164369715|NCT02896400|593733343|FG006|3 Month Follow-up|Lost to Follow-up|4|||
164369716|NCT02896400|593733344|FG007|3 Month Follow-up|Lost to Follow-up|3|||
164369717|NCT02896400|593733345|FG008|3 Month Follow-up|Lost to Follow-up|6|||
164369718|NCT02896400|593733346|FG009|3 Month Follow-up|Lost to Follow-up|5|||
164369719|NCT02896400|593733347|FG010|3 Month Follow-up|Lost to Follow-up|6|||
164369720|NCT02896400|593733348|FG011|3 Month Follow-up|Lost to Follow-up|6|||
164369721|NCT02896400|593733349|FG012|3 Month Follow-up|Lost to Follow-up|3|||
164369722|NCT02896400|593733350|FG013|3 Month Follow-up|Lost to Follow-up|5|||
164369723|NCT02896400|593733351|FG014|3 Month Follow-up|Lost to Follow-up|3|||
164369724|NCT02896400|593733352|FG015|3 Month Follow-up|Lost to Follow-up|2|||
164369725|NCT02896400|593733337|FG000|3 Month Follow-up|Death|0|||
164369726|NCT02896400|593733338|FG001|3 Month Follow-up|Death|0|||
164369727|NCT02896400|593733339|FG002|3 Month Follow-up|Death|0|||
164369728|NCT02896400|593733340|FG003|3 Month Follow-up|Death|0|||
164369729|NCT02896400|593733341|FG004|3 Month Follow-up|Death|0|||
164369730|NCT02896400|593733342|FG005|3 Month Follow-up|Death|0|||
164369731|NCT02896400|593733343|FG006|3 Month Follow-up|Death|0|||
164092742|NCT02130466|592702133|FG000|Overall Study|Death|4|||
164369732|NCT02896400|593733344|FG007|3 Month Follow-up|Death|0|||
164369733|NCT02896400|593733345|FG008|3 Month Follow-up|Death|0|||
164369734|NCT02896400|593733346|FG009|3 Month Follow-up|Death|0|||
164369735|NCT02896400|593733347|FG010|3 Month Follow-up|Death|0|||
164369736|NCT02896400|593733348|FG011|3 Month Follow-up|Death|0|||
164369737|NCT02896400|593733349|FG012|3 Month Follow-up|Death|0|||
164369738|NCT02896400|593733350|FG013|3 Month Follow-up|Death|1|||
164369739|NCT02896400|593733351|FG014|3 Month Follow-up|Death|1|||
164369740|NCT02896400|593733352|FG015|3 Month Follow-up|Death|0|||
164369741|NCT02896400|593733337|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369742|NCT02896400|593733338|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369743|NCT02896400|593733339|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369744|NCT02896400|593733340|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369745|NCT02896400|593733341|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369746|NCT02896400|593733342|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369747|NCT02896400|593733343|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
164369748|NCT02896400|593733344|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
164369749|NCT02896400|593733345|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369750|NCT02896400|593733346|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369751|NCT02896400|593733347|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369752|NCT02896400|593733348|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369753|NCT02896400|593733349|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369754|NCT02896400|593733350|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
164369755|NCT02896400|593733351|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
164369756|NCT02896400|593733352|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
164369757|NCT02896400|593733337|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
164369758|NCT02896400|593733338|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369759|NCT02896400|593733339|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
164369760|NCT02896400|593733340|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
164369761|NCT02896400|593733341|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
164369762|NCT02896400|593733342|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369763|NCT02896400|593733343|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369764|NCT02896400|593733344|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
164369765|NCT02896400|593733345|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
164369766|NCT02896400|593733346|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
164369767|NCT02896400|593733347|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
164369768|NCT02896400|593733348|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
164369769|NCT02896400|593733349|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
164369770|NCT02896400|593733350|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
164369771|NCT02896400|593733351|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
164369772|NCT02896400|593733352|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
164369773|NCT02984020|593733353|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
164369774|NCT02984020|593733353|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
164369775|NCT02984020|593733353|FG000|Overall Study|Other significant protocol violation|2|||
164369776|NCT00588445|593733354|FG000|Overall Study|Protocol Violation|1|||
164369777|NCT00588445|593733354|FG000|Overall Study|Withdrawal by Subject|3|||
164369778|NCT00588445|593733354|FG000|Overall Study|Disease Progression|1|||
164369779|NCT00588445|593733354|FG000|Overall Study|Not Treated|10|||
164369780|NCT00358527|593733355|FG000|Overall Study|Adverse Event|4|||
164369781|NCT00358527|593733356|FG001|Overall Study|Adverse Event|0|||
164369782|NCT00358527|593733355|FG000|Overall Study|Withdrawal by Subject|1|||
164369783|NCT00358527|593733356|FG001|Overall Study|Withdrawal by Subject|1|||
164369784|NCT00358527|593733355|FG000|Overall Study|Non-compliance with protocol|6|||
164369785|NCT00358527|593733356|FG001|Overall Study|Non-compliance with protocol|1|||
164369786|NCT00358527|593733355|FG000|Overall Study|Administrative|2|||
164369787|NCT00358527|593733356|FG001|Overall Study|Administrative|1|||
164369788|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
164369789|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
164369790|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
164369791|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
164012402|NCT02489630|592408751|FG000|Overall Study|Oversedation|1|||
164012403|NCT02489630|592408752|FG001|Overall Study|Oversedation|1|||
164012404|NCT02489630|592408751|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
164369792|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
164369793|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
164369794|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
164369795|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
164369796|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
164369797|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
164369798|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
164369799|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
164369800|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
164369801|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
164369802|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
164369803|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
164369804|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
164369805|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
164369806|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
164369807|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
164369808|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
164369809|NCT00934544|593733359|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
164369810|NCT00934544|593733360|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
164369811|NCT00934544|593733361|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
164369812|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
164369813|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
164369814|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
164369815|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
164369816|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
164369817|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
164369818|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
164369819|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
164369820|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
164369821|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
164369822|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
164369823|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
164369824|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
164369825|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
164369826|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
164369827|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
164369828|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
164369829|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
164369830|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
164369831|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
164369832|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
164369833|NCT00934544|593733359|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
164369834|NCT00934544|593733360|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
164369835|NCT00934544|593733361|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
164369836|NCT02643251|593733362|FG000|Overall Study|Adverse Event|3|||
164369837|NCT02643251|593733363|FG001|Overall Study|Adverse Event|1|||
164369838|NCT02643251|593733362|FG000|Overall Study|Withdrawal by Subject|2|||
164012405|NCT02489630|592408752|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
164012406|NCT00734929|592408755|FG000|Overall Study|Lost to Follow-up|1|||
164012407|NCT00734929|592408756|FG001|Overall Study|Lost to Follow-up|2|||
164012408|NCT00734929|592408755|FG000|Overall Study|No intervention/ screen fail|5|||
164369839|NCT02643251|593733363|FG001|Overall Study|Withdrawal by Subject|0|||
164369840|NCT02643251|593733362|FG000|Overall Study|Lost to Follow-up|4|||
164369841|NCT02643251|593733363|FG001|Overall Study|Lost to Follow-up|1|||
164369842|NCT02643251|593733362|FG000|Overall Study|Protocol Violation|1|||
164369843|NCT02643251|593733363|FG001|Overall Study|Protocol Violation|0|||
164369844|NCT02643251|593733362|FG000|Overall Study|PI Decision to terminate patient|1|||
164369845|NCT02643251|593733363|FG001|Overall Study|PI Decision to terminate patient|0|||
164369846|NCT00348556|593733364|FG000|Overall Study|Adverse Event|1|||
164369847|NCT00192075|593733365|FG000|Overall Study|Disease Progression|23|||
164369848|NCT00192075|593733366|FG001|Overall Study|Disease Progression|6|||
164369849|NCT00192075|593733365|FG000|Overall Study|Adverse Event|1|||
164369850|NCT00192075|593733366|FG001|Overall Study|Adverse Event|3|||
164369851|NCT00192075|593733365|FG000|Overall Study|Death|0|||
164369852|NCT00192075|593733366|FG001|Overall Study|Death|1|||
164369853|NCT00192075|593733365|FG000|Overall Study|Lack of Efficacy|0|||
164369854|NCT00192075|593733366|FG001|Overall Study|Lack of Efficacy|0|||
164369855|NCT00192075|593733365|FG000|Overall Study|Physician Decision|3|||
164369856|NCT00192075|593733366|FG001|Overall Study|Physician Decision|0|||
164369857|NCT00192075|593733365|FG000|Overall Study|Withdrawal by Subject|5|||
164369858|NCT00192075|593733366|FG001|Overall Study|Withdrawal by Subject|5|||
164369859|NCT00192075|593733365|FG000|Overall Study|Patient Non-Compliance|0|||
164369860|NCT00192075|593733366|FG001|Overall Study|Patient Non-Compliance|1|||
164369861|NCT00192075|593733365|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
164369862|NCT00192075|593733366|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
164369863|NCT00192075|593733365|FG000|Overall Study|Other|5|||
164369864|NCT00192075|593733366|FG001|Overall Study|Other|2|||
164369865|NCT00779675|593733367|FG000|Treatment Period|Adverse Event|87|||
164369866|NCT00779675|593733367|FG000|Treatment Period|Treatment Failure|80|||
164369867|NCT00779675|593733367|FG000|Treatment Period|Transferred to Another Study|38|||
164369868|NCT00779675|593733367|FG000|Treatment Period|Lost to Follow-up|23|||
164369869|NCT00779675|593733367|FG000|Treatment Period|Withdrawal by Subject|46|||
164369870|NCT00779675|593733367|FG000|Treatment Period|Protocol Violation|54|||
164369871|NCT00779675|593733367|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
164369872|NCT00779675|593733367|FG000|Treatment Period|Administrative|3|||
164369873|NCT00779675|593733367|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
164369874|NCT00779675|593733367|FG000|Extended Treatment Period|Protocol Violation|13|||
164369875|NCT00779675|593733367|FG000|Extended Treatment Period|Adverse Event|6|||
164369876|NCT00779675|593733367|FG000|Extended Treatment Period|Treatment Failure|11|||
164369877|NCT00779675|593733367|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
164369878|NCT00779675|593733367|FG000|Extended Treatment Period|Lost to Follow-up|6|||
164369879|NCT01944059|593733368|FG000|Overall Study|Lost to Follow-up|1|||
164369880|NCT01944059|593733368|FG000|Overall Study|Physician Decision|3|||
164369881|NCT01944059|593733368|FG000|Overall Study|Withdrawal by Subject|1|||
164369882|NCT01944059|593733368|FG000|Overall Study|Adverse Event|2|||
164369883|NCT00430092|593733375|FG000|Overall Study|Adverse Event|0|||
164369884|NCT00430092|593733376|FG001|Overall Study|Adverse Event|0|||
164369885|NCT00430092|593733377|FG002|Overall Study|Adverse Event|1|||
164369886|NCT00430092|593733375|FG000|Overall Study|Lack of Efficacy|5|||
164369887|NCT00430092|593733376|FG001|Overall Study|Lack of Efficacy|2|||
164369888|NCT00430092|593733377|FG002|Overall Study|Lack of Efficacy|54|||
164369889|NCT00430092|593733375|FG000|Overall Study|Lost to Follow-up|1|||
164369890|NCT00430092|593733376|FG001|Overall Study|Lost to Follow-up|0|||
164369891|NCT00430092|593733377|FG002|Overall Study|Lost to Follow-up|0|||
164369892|NCT00430092|593733375|FG000|Overall Study|Protocol Violation|0|||
164369893|NCT00430092|593733376|FG001|Overall Study|Protocol Violation|1|||
164369894|NCT00430092|593733377|FG002|Overall Study|Protocol Violation|1|||
164369895|NCT00430092|593733375|FG000|Overall Study|Withdrawal by Subject|0|||
164369896|NCT00430092|593733376|FG001|Overall Study|Withdrawal by Subject|1|||
164369897|NCT00430092|593733377|FG002|Overall Study|Withdrawal by Subject|1|||
164369898|NCT01956110|593733378|FG000|Overall Study|Protocol Violation|25|||
164369899|NCT01956110|593733379|FG001|Overall Study|Protocol Violation|11|||
164369900|NCT01956110|593733378|FG000|Overall Study|Adverse Event|9|||
164369901|NCT01956110|593733379|FG001|Overall Study|Adverse Event|10|||
164369902|NCT01956110|593733378|FG000|Overall Study|Personal reasons|1|||
164369903|NCT01956110|593733379|FG001|Overall Study|Personal reasons|1|||
164369904|NCT02118428|593733384|FG000|Overall Study|Physician Decision|0|||
164369905|NCT02118428|593733385|FG001|Overall Study|Physician Decision|1|||
164369906|NCT02118428|593733386|FG002|Overall Study|Physician Decision|0|||
164369907|NCT02118428|593733384|FG000|Overall Study|Withdrawal by Subject|2|||
164369908|NCT02118428|593733385|FG001|Overall Study|Withdrawal by Subject|2|||
164369909|NCT02118428|593733386|FG002|Overall Study|Withdrawal by Subject|0|||
164369910|NCT02118428|593733384|FG000|Overall Study|Death|7|||
164369911|NCT02118428|593733385|FG001|Overall Study|Death|5|||
164369912|NCT02118428|593733386|FG002|Overall Study|Death|0|||
164369913|NCT02118428|593733384|FG000|Overall Study|Lost to Follow-up|3|||
164369914|NCT02118428|593733385|FG001|Overall Study|Lost to Follow-up|1|||
164369915|NCT02118428|593733386|FG002|Overall Study|Lost to Follow-up|0|||
164369916|NCT02118428|593733384|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
164369917|NCT02118428|593733385|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
164369918|NCT02118428|593733386|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
164369919|NCT01633944|593733389|FG000|Open-label Titration Phase|Adverse Event|109|||
164369920|NCT01633944|593733390|FG001|Open-label Titration Phase|Adverse Event|0|||
164369921|NCT01633944|593733391|FG002|Open-label Titration Phase|Adverse Event|0|||
164369922|NCT01633944|593733389|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
164369923|NCT01633944|593733390|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
164369924|NCT01633944|593733391|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
164369925|NCT01633944|593733389|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
164369926|NCT01633944|593733390|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
164369927|NCT01633944|593733391|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
164369928|NCT01633944|593733389|FG000|Open-label Titration Phase|Protocol Violation|24|||
164369929|NCT01633944|593733390|FG001|Open-label Titration Phase|Protocol Violation|0|||
164369930|NCT01633944|593733391|FG002|Open-label Titration Phase|Protocol Violation|0|||
164369931|NCT01633944|593733389|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
164369932|NCT01633944|593733390|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
164369933|NCT01633944|593733391|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
164369934|NCT01633944|593733389|FG000|Open-label Titration Phase|Other|68|||
164369935|NCT01633944|593733390|FG001|Open-label Titration Phase|Other|0|||
164369936|NCT01633944|593733391|FG002|Open-label Titration Phase|Other|0|||
164369937|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164369938|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Adverse Event|13|||
164369939|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Adverse Event|7|||
164369940|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
164369941|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
164369942|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
164369943|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164369944|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
164369945|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
164369946|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
164369947|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
164369948|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
164369949|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164369950|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
164369951|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
164369952|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
164369953|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
164369954|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
164369955|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
164369956|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
164369957|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
164369958|NCT01633944|593733389|FG000|Double-blind Treatment Phase|Other|0|||
164369959|NCT01633944|593733390|FG001|Double-blind Treatment Phase|Other|7|||
164369960|NCT01633944|593733391|FG002|Double-blind Treatment Phase|Other|0|||
164369961|NCT00463060|593733392|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
164369962|NCT00463060|593733392|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
164369963|NCT01400841|593733393|FG000|Initial Study Phase (6 Months)|Death|1|||
164369964|NCT01400841|593733393|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
164369965|NCT00701129|593733394|FG000|Overall Study|Death|2|||
164369966|NCT00910715|593733395|FG000|Overall Study|Lost to Follow-up|22|||
164369967|NCT00910715|593733396|FG001|Overall Study|Lost to Follow-up|26|||
164369968|NCT00910715|593733397|FG002|Overall Study|Lost to Follow-up|0|||
164369969|NCT00706966|593733398|FG000|Overall Study|Adverse Event|1|||
164369970|NCT02884089|593733399|FG000|Period 1|Dosing error|2|||
164369971|NCT02884089|593733400|FG001|Period 1|Dosing error|2|||
164369972|NCT02884089|593733401|FG002|Period 1|Dosing error|0|||
164369973|NCT02884089|593733402|FG003|Period 1|Dosing error|0|||
164369974|NCT02884089|593733399|FG000|Washout Period 1|Lost to Follow-up|0|||
164369975|NCT02884089|593733400|FG001|Washout Period 1|Lost to Follow-up|1|||
164369976|NCT02884089|593733401|FG002|Washout Period 1|Lost to Follow-up|0|||
164369977|NCT02884089|593733402|FG003|Washout Period 1|Lost to Follow-up|1|||
164092743|NCT02130466|592702134|FG001|Overall Study|Death|1|||
164369978|NCT02884089|593733399|FG000|Washout Period 1|Withdrawal by Subject|0|||
164369979|NCT02884089|593733400|FG001|Washout Period 1|Withdrawal by Subject|1|||
164369980|NCT02884089|593733401|FG002|Washout Period 1|Withdrawal by Subject|0|||
164092744|NCT02130466|592702135|FG002|Overall Study|Death|1|||
164092745|NCT02130466|592702136|FG003|Overall Study|Death|3|||
164369981|NCT02884089|593733402|FG003|Washout Period 1|Withdrawal by Subject|0|||
164369982|NCT02884089|593733399|FG000|Period 2|Adverse Event|1|||
164369983|NCT02884089|593733400|FG001|Period 2|Adverse Event|0|||
164369984|NCT02884089|593733401|FG002|Period 2|Adverse Event|0|||
164369985|NCT02884089|593733402|FG003|Period 2|Adverse Event|0|||
164092746|NCT02130466|592702137|FG004|Overall Study|Death|2|||
164369986|NCT02884089|593733399|FG000|Period 3|Withdrawal by Subject|0|||
164369987|NCT02884089|593733400|FG001|Period 3|Withdrawal by Subject|0|||
164369988|NCT02884089|593733401|FG002|Period 3|Withdrawal by Subject|1|||
164369989|NCT02884089|593733402|FG003|Period 3|Withdrawal by Subject|0|||
164369990|NCT02884089|593733399|FG000|Washout Period 3|Withdrawal by Subject|0|||
164369991|NCT02884089|593733400|FG001|Washout Period 3|Withdrawal by Subject|0|||
164369992|NCT02884089|593733401|FG002|Washout Period 3|Withdrawal by Subject|1|||
164369993|NCT02884089|593733402|FG003|Washout Period 3|Withdrawal by Subject|0|||
164369994|NCT02884089|593733399|FG000|Washout Period 3|Lost to Follow-up|0|||
164369995|NCT02884089|593733400|FG001|Washout Period 3|Lost to Follow-up|0|||
164369996|NCT02884089|593733401|FG002|Washout Period 3|Lost to Follow-up|0|||
164369997|NCT02884089|593733402|FG003|Washout Period 3|Lost to Follow-up|1|||
164369998|NCT02884089|593733399|FG000|Period 4|Withdrawal by Subject|0|||
164369999|NCT02884089|593733400|FG001|Period 4|Withdrawal by Subject|1|||
164370000|NCT02884089|593733401|FG002|Period 4|Withdrawal by Subject|0|||
164370001|NCT02884089|593733402|FG003|Period 4|Withdrawal by Subject|0|||
164370002|NCT02884089|593733399|FG000|Period 4|Lost to Follow-up|1|||
164370003|NCT02884089|593733400|FG001|Period 4|Lost to Follow-up|0|||
164370004|NCT02884089|593733401|FG002|Period 4|Lost to Follow-up|0|||
164370005|NCT02884089|593733402|FG003|Period 4|Lost to Follow-up|0|||
164370006|NCT02884089|593733399|FG000|Follow-up Visit|Withdrawal by Subject|1|||
164370007|NCT02884089|593733400|FG001|Follow-up Visit|Withdrawal by Subject|0|||
164370008|NCT02884089|593733401|FG002|Follow-up Visit|Withdrawal by Subject|0|||
164370009|NCT02884089|593733402|FG003|Follow-up Visit|Withdrawal by Subject|1|||
164370010|NCT01631474|593733403|FG000|Overall Study|Lost to Follow-up|8|||
164370011|NCT01631474|593733404|FG001|Overall Study|Lost to Follow-up|5|||
164370012|NCT01631474|593733405|FG002|Overall Study|Lost to Follow-up|7|||
164370013|NCT01631474|593733406|FG003|Overall Study|Lost to Follow-up|5|||
164370014|NCT01631474|593733407|FG004|Overall Study|Lost to Follow-up|5|||
164370015|NCT01631474|593733403|FG000|Overall Study|Withdrawal by Subject|4|||
164370016|NCT01631474|593733404|FG001|Overall Study|Withdrawal by Subject|4|||
164370017|NCT01631474|593733405|FG002|Overall Study|Withdrawal by Subject|2|||
164370018|NCT01631474|593733406|FG003|Overall Study|Withdrawal by Subject|6|||
164370019|NCT01631474|593733407|FG004|Overall Study|Withdrawal by Subject|5|||
164370020|NCT01631474|593733403|FG000|Overall Study|Lack of Efficacy|2|||
164370021|NCT01631474|593733404|FG001|Overall Study|Lack of Efficacy|2|||
164370022|NCT01631474|593733405|FG002|Overall Study|Lack of Efficacy|0|||
164370023|NCT01631474|593733406|FG003|Overall Study|Lack of Efficacy|0|||
164370024|NCT01631474|593733407|FG004|Overall Study|Lack of Efficacy|2|||
164370025|NCT01631474|593733403|FG000|Overall Study|Noncompliance with Study Drug|0|||
164370026|NCT01631474|593733404|FG001|Overall Study|Noncompliance with Study Drug|0|||
164370027|NCT01631474|593733405|FG002|Overall Study|Noncompliance with Study Drug|0|||
164370028|NCT01631474|593733406|FG003|Overall Study|Noncompliance with Study Drug|0|||
164370029|NCT01631474|593733407|FG004|Overall Study|Noncompliance with Study Drug|1|||
164370030|NCT01631474|593733403|FG000|Overall Study|Adverse Event|0|||
164370031|NCT01631474|593733404|FG001|Overall Study|Adverse Event|1|||
164370032|NCT01631474|593733405|FG002|Overall Study|Adverse Event|0|||
164370033|NCT01631474|593733406|FG003|Overall Study|Adverse Event|0|||
164370034|NCT01631474|593733407|FG004|Overall Study|Adverse Event|0|||
164370035|NCT01467076|593733408|FG000|Overall Study|Lost to Follow-up|1|||
164370036|NCT01467076|593733409|FG001|Overall Study|Lost to Follow-up|0|||
164370037|NCT01467076|593733410|FG002|Overall Study|Lost to Follow-up|0|||
164370038|NCT03354429|593733411|FG000|Overall Study|Withdrawal by Subject|8|||
164370039|NCT03354429|593733412|FG001|Overall Study|Withdrawal by Subject|7|||
164370040|NCT03354429|593733411|FG000|Overall Study|Lost to Follow-up|1|||
164370041|NCT03354429|593733412|FG001|Overall Study|Lost to Follow-up|0|||
164370042|NCT00654381|593733418|FG000|1st Stage|Adverse Event|3|||
164370043|NCT00654381|593733419|FG001|1st Stage|Adverse Event|3|||
164370044|NCT00654381|593733420|FG002|1st Stage|Adverse Event|3|||
164370045|NCT00654381|593733421|FG003|1st Stage|Adverse Event|3|||
164092747|NCT02130466|592702138|FG005|Overall Study|Death|30|||
164092748|NCT02130466|592702139|FG006|Overall Study|Death|45|||
164370046|NCT00654381|593733422|FG004|1st Stage|Adverse Event|2|||
164370047|NCT00654381|593733423|FG005|1st Stage|Adverse Event|1|||
164370048|NCT00654381|593733418|FG000|1st Stage|Withdrawal by Subject|0|||
164370049|NCT00654381|593733419|FG001|1st Stage|Withdrawal by Subject|0|||
164370050|NCT00654381|593733420|FG002|1st Stage|Withdrawal by Subject|0|||
164370051|NCT00654381|593733421|FG003|1st Stage|Withdrawal by Subject|1|||
164370052|NCT00654381|593733422|FG004|1st Stage|Withdrawal by Subject|0|||
164370053|NCT00654381|593733423|FG005|1st Stage|Withdrawal by Subject|1|||
164370054|NCT00654381|593733418|FG000|1st Stage|Investigator's decision|0|||
164370055|NCT00654381|593733419|FG001|1st Stage|Investigator's decision|0|||
164370056|NCT00654381|593733420|FG002|1st Stage|Investigator's decision|0|||
164370057|NCT00654381|593733421|FG003|1st Stage|Investigator's decision|1|||
164370058|NCT00654381|593733422|FG004|1st Stage|Investigator's decision|0|||
164370059|NCT00654381|593733423|FG005|1st Stage|Investigator's decision|0|||
164370060|NCT00654381|593733418|FG000|2nd Stage|Adverse Event|2|||
164370061|NCT00654381|593733419|FG001|2nd Stage|Adverse Event|0|||
164370062|NCT00654381|593733420|FG002|2nd Stage|Adverse Event|2|||
164370063|NCT00654381|593733421|FG003|2nd Stage|Adverse Event|3|||
164370064|NCT00654381|593733422|FG004|2nd Stage|Adverse Event|7|||
164370065|NCT00654381|593733423|FG005|2nd Stage|Adverse Event|2|||
164370066|NCT00654381|593733418|FG000|2nd Stage|Withdrawal by Subject|0|||
164370067|NCT00654381|593733419|FG001|2nd Stage|Withdrawal by Subject|0|||
164370068|NCT00654381|593733420|FG002|2nd Stage|Withdrawal by Subject|0|||
164370069|NCT00654381|593733421|FG003|2nd Stage|Withdrawal by Subject|0|||
164370070|NCT00654381|593733422|FG004|2nd Stage|Withdrawal by Subject|1|||
164370071|NCT00654381|593733423|FG005|2nd Stage|Withdrawal by Subject|1|||
164370072|NCT00654381|593733418|FG000|2nd Stage|Investigator's decision|0|||
164370073|NCT00654381|593733419|FG001|2nd Stage|Investigator's decision|0|||
164370074|NCT00654381|593733420|FG002|2nd Stage|Investigator's decision|1|||
164370075|NCT00654381|593733421|FG003|2nd Stage|Investigator's decision|1|||
164370076|NCT00654381|593733422|FG004|2nd Stage|Investigator's decision|0|||
164370077|NCT00654381|593733423|FG005|2nd Stage|Investigator's decision|0|||
164370078|NCT00654381|593733418|FG000|Extension Stage|Adverse Event|1|||
164370079|NCT00654381|593733419|FG001|Extension Stage|Adverse Event|2|||
164370080|NCT00654381|593733420|FG002|Extension Stage|Adverse Event|9|||
164370081|NCT00654381|593733421|FG003|Extension Stage|Adverse Event|7|||
164370082|NCT00654381|593733422|FG004|Extension Stage|Adverse Event|1|||
164370083|NCT00654381|593733423|FG005|Extension Stage|Adverse Event|1|||
164370084|NCT00654381|593733418|FG000|Extension Stage|Protocol Violation|0|||
164370085|NCT00654381|593733419|FG001|Extension Stage|Protocol Violation|0|||
164370086|NCT00654381|593733420|FG002|Extension Stage|Protocol Violation|0|||
164370087|NCT00654381|593733421|FG003|Extension Stage|Protocol Violation|1|||
164370088|NCT00654381|593733422|FG004|Extension Stage|Protocol Violation|0|||
164370089|NCT00654381|593733423|FG005|Extension Stage|Protocol Violation|0|||
164370090|NCT00654381|593733418|FG000|Extension Stage|Lack of Efficacy|0|||
164370091|NCT00654381|593733419|FG001|Extension Stage|Lack of Efficacy|0|||
164370092|NCT00654381|593733420|FG002|Extension Stage|Lack of Efficacy|1|||
164370093|NCT00654381|593733421|FG003|Extension Stage|Lack of Efficacy|0|||
164370094|NCT00654381|593733422|FG004|Extension Stage|Lack of Efficacy|0|||
164370095|NCT00654381|593733423|FG005|Extension Stage|Lack of Efficacy|0|||
164370096|NCT00654381|593733418|FG000|Extension Stage|Withdrawal by Subject|0|||
164370097|NCT00654381|593733419|FG001|Extension Stage|Withdrawal by Subject|0|||
164370098|NCT00654381|593733420|FG002|Extension Stage|Withdrawal by Subject|1|||
164012409|NCT00734929|592408756|FG001|Overall Study|No intervention/ screen fail|3|||
164012410|NCT02961764|592408757|FG000|Overall Study|Protocol Violation|0|||
164012411|NCT02961764|592408758|FG001|Overall Study|Protocol Violation|1|||
164012412|NCT02961764|592408757|FG000|Overall Study|Death|2|||
164012413|NCT02961764|592408758|FG001|Overall Study|Death|0|||
164012414|NCT02961764|592408757|FG000|Overall Study|Lost to Follow-up|35|||
164370099|NCT00654381|593733421|FG003|Extension Stage|Withdrawal by Subject|1|||
164370100|NCT00654381|593733422|FG004|Extension Stage|Withdrawal by Subject|1|||
164370101|NCT00654381|593733423|FG005|Extension Stage|Withdrawal by Subject|1|||
164370102|NCT00654381|593733418|FG000|Extension Stage|Closure of the trial site|0|||
164370103|NCT00654381|593733419|FG001|Extension Stage|Closure of the trial site|0|||
164370104|NCT00654381|593733420|FG002|Extension Stage|Closure of the trial site|0|||
164370105|NCT00654381|593733421|FG003|Extension Stage|Closure of the trial site|0|||
164370106|NCT00654381|593733422|FG004|Extension Stage|Closure of the trial site|1|||
164370107|NCT00654381|593733423|FG005|Extension Stage|Closure of the trial site|1|||
164370108|NCT05040152|593733429|FG000|Overall Study|Withdrawal by Subject|5|||
164012415|NCT02961764|592408758|FG001|Overall Study|Lost to Follow-up|24|||
164012416|NCT02961764|592408757|FG000|Overall Study|Withdrawal by Subject|2|||
164012417|NCT02961764|592408758|FG001|Overall Study|Withdrawal by Subject|0|||
164370109|NCT05040152|593733430|FG001|Overall Study|Withdrawal by Subject|0|||
164370110|NCT05040152|593733429|FG000|Overall Study|Lost to Follow-up|0|||
164370111|NCT05040152|593733430|FG001|Overall Study|Lost to Follow-up|2|||
164370112|NCT00006489|593733432|FG000|Overall Study|Adverse Event|3|||
164370113|NCT00006489|593733433|FG001|Overall Study|Adverse Event|2|||
164370114|NCT00006489|593733434|FG002|Overall Study|Adverse Event|4|||
164370115|NCT00006489|593733435|FG003|Overall Study|Adverse Event|3|||
164370116|NCT00006489|593733432|FG000|Overall Study|Withdrawal by Subject|10|||
164370117|NCT00006489|593733433|FG001|Overall Study|Withdrawal by Subject|9|||
164370118|NCT00006489|593733434|FG002|Overall Study|Withdrawal by Subject|9|||
164370119|NCT00006489|593733435|FG003|Overall Study|Withdrawal by Subject|6|||
164370120|NCT00006489|593733432|FG000|Overall Study|Scheduling Conflict|0|||
164370121|NCT00006489|593733433|FG001|Overall Study|Scheduling Conflict|3|||
164370122|NCT00006489|593733434|FG002|Overall Study|Scheduling Conflict|2|||
164370123|NCT00006489|593733435|FG003|Overall Study|Scheduling Conflict|1|||
164370124|NCT00006489|593733432|FG000|Overall Study|Death|0|||
164370125|NCT00006489|593733433|FG001|Overall Study|Death|0|||
164370126|NCT00006489|593733434|FG002|Overall Study|Death|0|||
164370127|NCT00006489|593733435|FG003|Overall Study|Death|1|||
164370128|NCT00578175|593733436|FG000|Overall Study|Adverse Event|0|||
164370129|NCT00578175|593733437|FG001|Overall Study|Adverse Event|1|||
164370130|NCT00578175|593733438|FG002|Overall Study|Adverse Event|1|||
164370131|NCT00578175|593733436|FG000|Overall Study|Other reasons|70|||
164370132|NCT00578175|593733437|FG001|Overall Study|Other reasons|42|||
164370133|NCT00578175|593733438|FG002|Overall Study|Other reasons|23|||
164370134|NCT03029624|593733444|FG000|Overall Study|Adverse Event|1|||
164370135|NCT03029624|593733444|FG000|Overall Study|Withdrawal by Subject|1|||
164370136|NCT03029624|593733444|FG000|Overall Study|Lack of Efficacy|1|||
164370137|NCT03029624|593733444|FG000|Overall Study|MRI need|2|||
164370138|NCT01371656|593733445|FG000|Overall Study|Death|7|||
164370139|NCT01371656|593733446|FG001|Overall Study|Death|4|||
164370140|NCT01371656|593733445|FG000|Overall Study|Physician Decision|46|||
164370141|NCT01371656|593733446|FG001|Overall Study|Physician Decision|7|||
164370142|NCT01371656|593733445|FG000|Overall Study|Withdrawal by Subject|7|||
164370143|NCT01371656|593733446|FG001|Overall Study|Withdrawal by Subject|0|||
164370144|NCT01371656|593733445|FG000|Overall Study|Ineligible|4|||
164370145|NCT01371656|593733446|FG001|Overall Study|Ineligible|3|||
164370146|NCT04334460|593733453|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
164370147|NCT04334460|593733454|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
164370148|NCT04334460|593733453|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
164370149|NCT04334460|593733454|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
164370150|NCT00775437|593733455|FG000|Overall Study|Loss of efficacy|2|||
164370151|NCT00775437|593733455|FG000|Overall Study|Withdrawal by Subject|3|||
164370152|NCT00775437|593733455|FG000|Overall Study|Lost to Follow-up|1|||
164370153|NCT02442778|593733462|FG000|Overall Study|Adverse Event|2|||
164012418|NCT02369510|592408759|FG000|Overall Study|Spilled Medication|1|||
164012419|NCT02369510|592408760|FG001|Overall Study|Spilled Medication|2|||
164012420|NCT02369510|592408761|FG002|Overall Study|Spilled Medication|1|||
164012421|NCT02369510|592408759|FG000|Overall Study|Epidural Activation|1|||
164012422|NCT02369510|592408760|FG001|Overall Study|Epidural Activation|1|||
164012423|NCT02369510|592408761|FG002|Overall Study|Epidural Activation|5|||
164012424|NCT03067311|592408763|FG000|Overall Study|Lost to Follow-up|1|||
164012425|NCT03067311|592408764|FG001|Overall Study|Lost to Follow-up|1|||
164012426|NCT03067311|592408763|FG000|Overall Study|Moved away|1|||
164012427|NCT03067311|592408764|FG001|Overall Study|Moved away|1|||
164012428|NCT02160977|592408765|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
164012429|NCT02160977|592408766|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
164012430|NCT02160977|592408765|FG000|Three Months After Surgery|Lost to Follow-up|0|||
164012431|NCT02160977|592408766|FG001|Three Months After Surgery|Lost to Follow-up|2|||
164012432|NCT02160977|592408765|FG000|Six Months After Surgery|Lost to Follow-up|2|||
164370154|NCT02442778|593733463|FG001|Overall Study|Adverse Event|6|||
164370155|NCT02442778|593733464|FG002|Overall Study|Adverse Event|6|||
164370156|NCT02442778|593733462|FG000|Overall Study|Death|0|||
164370157|NCT02442778|593733463|FG001|Overall Study|Death|2|||
164370158|NCT02442778|593733464|FG002|Overall Study|Death|0|||
164370159|NCT02442778|593733462|FG000|Overall Study|Lack of Efficacy|1|||
164370160|NCT02442778|593733463|FG001|Overall Study|Lack of Efficacy|0|||
164370161|NCT02442778|593733464|FG002|Overall Study|Lack of Efficacy|0|||
164012433|NCT02160977|592408766|FG001|Six Months After Surgery|Lost to Follow-up|1|||
164012434|NCT00128206|592410524|FG000|Overall Study|Lost to Follow-up|137|||
164012435|NCT00128206|592410525|FG001|Overall Study|Lost to Follow-up|118|||
164012436|NCT00128206|592410524|FG000|Overall Study|Adverse Event|0|||
164012437|NCT00128206|592410525|FG001|Overall Study|Adverse Event|2|||
164012438|NCT03032068|592410528|FG000|Overall Study|Adverse Event|1|||
164012439|NCT01597622|592410529|FG000|Overall Study|Adverse Event|7|||
164012440|NCT01597622|592410529|FG000|Overall Study|Lack of Efficacy|3|||
164012441|NCT01597622|592410529|FG000|Overall Study|Protocol Violation|1|||
164370162|NCT02442778|593733462|FG000|Overall Study|Lost to Follow-up|1|||
164370163|NCT02442778|593733463|FG001|Overall Study|Lost to Follow-up|1|||
164370164|NCT02442778|593733464|FG002|Overall Study|Lost to Follow-up|1|||
164370165|NCT02442778|593733462|FG000|Overall Study|Non-compliance with study drug|2|||
164370166|NCT02442778|593733463|FG001|Overall Study|Non-compliance with study drug|0|||
164370167|NCT02442778|593733464|FG002|Overall Study|Non-compliance with study drug|1|||
164370168|NCT02442778|593733462|FG000|Overall Study|Physician Decision|1|||
164370169|NCT02442778|593733463|FG001|Overall Study|Physician Decision|1|||
164370170|NCT02442778|593733464|FG002|Overall Study|Physician Decision|1|||
164370171|NCT02442778|593733462|FG000|Overall Study|Protocol Deviation|3|||
164370172|NCT02442778|593733463|FG001|Overall Study|Protocol Deviation|0|||
164370173|NCT02442778|593733464|FG002|Overall Study|Protocol Deviation|1|||
164370174|NCT02442778|593733462|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
164370175|NCT02442778|593733463|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
164370176|NCT02442778|593733464|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
164370177|NCT02442778|593733462|FG000|Overall Study|Withdrawal by Subject|4|||
164370178|NCT02442778|593733463|FG001|Overall Study|Withdrawal by Subject|4|||
164370179|NCT02442778|593733464|FG002|Overall Study|Withdrawal by Subject|3|||
164370180|NCT02442778|593733462|FG000|Overall Study|Reason not specified|1|||
164370181|NCT02442778|593733463|FG001|Overall Study|Reason not specified|4|||
164370182|NCT02442778|593733464|FG002|Overall Study|Reason not specified|0|||
164370183|NCT02641379|593733467|FG000|Overall Study|Exclusion criterion during screening|1|||
164370184|NCT02641379|593733468|FG001|Overall Study|Exclusion criterion during screening|0|||
164370185|NCT02641379|593733469|FG002|Overall Study|Exclusion criterion during screening|0|||
164370186|NCT02641379|593733470|FG003|Overall Study|Exclusion criterion during screening|1|||
164370187|NCT02641379|593733471|FG004|Overall Study|Exclusion criterion during screening|2|||
164370188|NCT02641379|593733472|FG005|Overall Study|Exclusion criterion during screening|0|||
164370189|NCT02641379|593733473|FG006|Overall Study|Exclusion criterion during screening|0|||
164370190|NCT02641379|593733474|FG007|Overall Study|Exclusion criterion during screening|0|||
164370191|NCT02641379|593733475|FG008|Overall Study|Exclusion criterion during screening|0|||
164370192|NCT02641379|593733476|FG009|Overall Study|Exclusion criterion during screening|0|||
164370193|NCT02641379|593733477|FG010|Overall Study|Exclusion criterion during screening|0|||
164370194|NCT02641379|593733467|FG000|Overall Study|Withdrawal of informed consent|0|||
164370195|NCT02641379|593733468|FG001|Overall Study|Withdrawal of informed consent|1|||
164370196|NCT02641379|593733469|FG002|Overall Study|Withdrawal of informed consent|0|||
164370197|NCT02641379|593733470|FG003|Overall Study|Withdrawal of informed consent|0|||
164370198|NCT02641379|593733471|FG004|Overall Study|Withdrawal of informed consent|0|||
164012442|NCT01597622|592410529|FG000|Overall Study|Lost to Follow-up|1|||
164012443|NCT01597622|592410529|FG000|Overall Study|Investigator Discretion|5|||
164012444|NCT01597622|592410529|FG000|Overall Study|Withdrawal by Subject|20|||
164012445|NCT01597622|592410529|FG000|Overall Study|Death|1|||
164012446|NCT00408421|592410530|FG000|Treatment Initial Randomization|Adverse Event|5|||
164012447|NCT00408421|592410531|FG001|Treatment Initial Randomization|Adverse Event|9|||
164012448|NCT00408421|592410532|FG002|Treatment Initial Randomization|Adverse Event|0|||
164012449|NCT00408421|592410530|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
164012450|NCT00408421|592410531|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
164012451|NCT00408421|592410532|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
164012452|NCT00408421|592410530|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
164012453|NCT00408421|592410531|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
164012454|NCT00408421|592410532|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
164012455|NCT00408421|592410530|FG000|Treatment Initial Randomization|Physician Decision|1|||
164012456|NCT00408421|592410531|FG001|Treatment Initial Randomization|Physician Decision|0|||
164012457|NCT00408421|592410532|FG002|Treatment Initial Randomization|Physician Decision|0|||
164012458|NCT00408421|592410530|FG000|Treatment Initial Randomization|Protocol Violation|0|||
164012459|NCT00408421|592410531|FG001|Treatment Initial Randomization|Protocol Violation|1|||
164012460|NCT00408421|592410532|FG002|Treatment Initial Randomization|Protocol Violation|0|||
164012461|NCT00408421|592410530|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
164012462|NCT00408421|592410531|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
164012463|NCT00408421|592410532|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
164012464|NCT00408421|592410530|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
164012465|NCT00408421|592410531|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
164012466|NCT00408421|592410532|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
164012467|NCT00408421|592410530|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
164012468|NCT00408421|592410531|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
164012469|NCT00408421|592410532|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
164012470|NCT00408421|592410530|FG000|Treatment Re-Randomization|Adverse Event|2|||
164370199|NCT02641379|593733472|FG005|Overall Study|Withdrawal of informed consent|0|||
164370200|NCT02641379|593733473|FG006|Overall Study|Withdrawal of informed consent|0|||
164370201|NCT02641379|593733474|FG007|Overall Study|Withdrawal of informed consent|1|||
164370202|NCT02641379|593733475|FG008|Overall Study|Withdrawal of informed consent|0|||
164370203|NCT02641379|593733476|FG009|Overall Study|Withdrawal of informed consent|0|||
164370204|NCT02641379|593733477|FG010|Overall Study|Withdrawal of informed consent|0|||
164370205|NCT02641379|593733467|FG000|Overall Study|Adverse Event|7|||
164370206|NCT02641379|593733468|FG001|Overall Study|Adverse Event|8|||
164370207|NCT02641379|593733469|FG002|Overall Study|Adverse Event|2|||
164370208|NCT02641379|593733470|FG003|Overall Study|Adverse Event|2|||
164370209|NCT02641379|593733471|FG004|Overall Study|Adverse Event|5|||
164370210|NCT02641379|593733472|FG005|Overall Study|Adverse Event|1|||
164370211|NCT02641379|593733473|FG006|Overall Study|Adverse Event|5|||
164370212|NCT02641379|593733474|FG007|Overall Study|Adverse Event|0|||
164370213|NCT02641379|593733475|FG008|Overall Study|Adverse Event|1|||
164370214|NCT02641379|593733476|FG009|Overall Study|Adverse Event|1|||
164370215|NCT02641379|593733477|FG010|Overall Study|Adverse Event|5|||
164370216|NCT02641379|593733467|FG000|Overall Study|Lack of Efficacy|0|||
164370217|NCT02641379|593733468|FG001|Overall Study|Lack of Efficacy|0|||
164370218|NCT02641379|593733469|FG002|Overall Study|Lack of Efficacy|2|||
164370219|NCT02641379|593733470|FG003|Overall Study|Lack of Efficacy|0|||
164370220|NCT02641379|593733471|FG004|Overall Study|Lack of Efficacy|0|||
164370221|NCT02641379|593733472|FG005|Overall Study|Lack of Efficacy|2|||
164370222|NCT02641379|593733473|FG006|Overall Study|Lack of Efficacy|0|||
164370223|NCT02641379|593733474|FG007|Overall Study|Lack of Efficacy|5|||
164370224|NCT02641379|593733475|FG008|Overall Study|Lack of Efficacy|0|||
164370225|NCT02641379|593733476|FG009|Overall Study|Lack of Efficacy|0|||
164370226|NCT02641379|593733477|FG010|Overall Study|Lack of Efficacy|0|||
164370227|NCT02641379|593733467|FG000|Overall Study|Participant unable to attend study visit|4|||
164370228|NCT02641379|593733468|FG001|Overall Study|Participant unable to attend study visit|10|||
164370229|NCT02641379|593733469|FG002|Overall Study|Participant unable to attend study visit|1|||
164370230|NCT02641379|593733470|FG003|Overall Study|Participant unable to attend study visit|2|||
164370231|NCT02641379|593733471|FG004|Overall Study|Participant unable to attend study visit|5|||
164370232|NCT02641379|593733472|FG005|Overall Study|Participant unable to attend study visit|1|||
164370233|NCT02641379|593733473|FG006|Overall Study|Participant unable to attend study visit|1|||
164370234|NCT02641379|593733474|FG007|Overall Study|Participant unable to attend study visit|1|||
164370235|NCT02641379|593733475|FG008|Overall Study|Participant unable to attend study visit|0|||
164370236|NCT02641379|593733476|FG009|Overall Study|Participant unable to attend study visit|2|||
164370237|NCT02641379|593733477|FG010|Overall Study|Participant unable to attend study visit|0|||
164370238|NCT02641379|593733467|FG000|Overall Study|Participant's compliance|0|||
164370239|NCT02641379|593733468|FG001|Overall Study|Participant's compliance|1|||
164370240|NCT02641379|593733469|FG002|Overall Study|Participant's compliance|0|||
164370241|NCT02641379|593733470|FG003|Overall Study|Participant's compliance|1|||
164370242|NCT02641379|593733471|FG004|Overall Study|Participant's compliance|0|||
164370243|NCT02641379|593733472|FG005|Overall Study|Participant's compliance|2|||
164370244|NCT02641379|593733473|FG006|Overall Study|Participant's compliance|0|||
164370245|NCT02641379|593733474|FG007|Overall Study|Participant's compliance|0|||
164370246|NCT02641379|593733475|FG008|Overall Study|Participant's compliance|1|||
164370247|NCT02641379|593733476|FG009|Overall Study|Participant's compliance|1|||
164370248|NCT02641379|593733477|FG010|Overall Study|Participant's compliance|1|||
164370249|NCT02641379|593733467|FG000|Overall Study|Participant cannot be reached|4|||
164370250|NCT02641379|593733468|FG001|Overall Study|Participant cannot be reached|4|||
164370251|NCT02641379|593733469|FG002|Overall Study|Participant cannot be reached|0|||
164370252|NCT02641379|593733470|FG003|Overall Study|Participant cannot be reached|8|||
163902120|NCT02568215|592013072|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
163902121|NCT02568215|592013073|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
163902122|NCT02568215|592013074|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
163902123|NCT02568215|592013072|FG000|Overall Study|Other|0|||
163902124|NCT02568215|592013073|FG001|Overall Study|Other|1|||
163902125|NCT02568215|592013074|FG002|Overall Study|Other|4|||
163902126|NCT01641900|592013075|FG000|Overall Study|Withdrawal by Subject|2|||
164012471|NCT00408421|592410531|FG001|Treatment Re-Randomization|Adverse Event|2|||
164012472|NCT00408421|592410532|FG002|Treatment Re-Randomization|Adverse Event|4|||
164012473|NCT00408421|592410530|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
164370253|NCT02641379|593733471|FG004|Overall Study|Participant cannot be reached|2|||
164370254|NCT02641379|593733472|FG005|Overall Study|Participant cannot be reached|1|||
163902127|NCT01641900|592013076|FG001|Overall Study|Withdrawal by Subject|2|||
163902128|NCT00263757|592013077|FG000|Overall Study|Withdrawal by Subject|5|||
163902129|NCT00263757|592013078|FG001|Overall Study|Withdrawal by Subject|4|||
163902130|NCT00263757|592013077|FG000|Overall Study|Screen failure|0|||
164370255|NCT02641379|593733473|FG006|Overall Study|Participant cannot be reached|0|||
164370256|NCT02641379|593733474|FG007|Overall Study|Participant cannot be reached|1|||
164370257|NCT02641379|593733475|FG008|Overall Study|Participant cannot be reached|0|||
164370258|NCT02641379|593733476|FG009|Overall Study|Participant cannot be reached|2|||
164370259|NCT02641379|593733477|FG010|Overall Study|Participant cannot be reached|1|||
164370260|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 24|15|||
164370261|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 24|21|||
164012474|NCT00408421|592410531|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
164370262|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 24|62|||
164370263|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 24|0|||
164370264|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 24|0|||
164370265|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 24|6|||
164370266|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 24|3|||
164370267|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 24|8|||
164370268|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 24|0|||
164370269|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 24|1|||
164370270|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 24|0|||
164370271|NCT02641379|593733467|FG000|Overall Study|PCR positive at follow up 2|1|||
164370272|NCT02641379|593733468|FG001|Overall Study|PCR positive at follow up 2|0|||
164370273|NCT02641379|593733469|FG002|Overall Study|PCR positive at follow up 2|0|||
164370274|NCT02641379|593733470|FG003|Overall Study|PCR positive at follow up 2|0|||
164370275|NCT02641379|593733471|FG004|Overall Study|PCR positive at follow up 2|0|||
164370276|NCT02641379|593733472|FG005|Overall Study|PCR positive at follow up 2|0|||
164370277|NCT02641379|593733473|FG006|Overall Study|PCR positive at follow up 2|0|||
164370278|NCT02641379|593733474|FG007|Overall Study|PCR positive at follow up 2|0|||
164370279|NCT02641379|593733475|FG008|Overall Study|PCR positive at follow up 2|0|||
164370280|NCT02641379|593733476|FG009|Overall Study|PCR positive at follow up 2|0|||
164370281|NCT02641379|593733477|FG010|Overall Study|PCR positive at follow up 2|0|||
164370282|NCT02641379|593733467|FG000|Overall Study|Participant showed relapse|1|||
164370283|NCT02641379|593733468|FG001|Overall Study|Participant showed relapse|0|||
164370284|NCT02641379|593733469|FG002|Overall Study|Participant showed relapse|0|||
164370285|NCT02641379|593733470|FG003|Overall Study|Participant showed relapse|0|||
164370286|NCT02641379|593733471|FG004|Overall Study|Participant showed relapse|0|||
164370287|NCT02641379|593733472|FG005|Overall Study|Participant showed relapse|0|||
164370288|NCT02641379|593733473|FG006|Overall Study|Participant showed relapse|1|||
164370289|NCT02641379|593733474|FG007|Overall Study|Participant showed relapse|0|||
164370290|NCT02641379|593733475|FG008|Overall Study|Participant showed relapse|0|||
164370291|NCT02641379|593733476|FG009|Overall Study|Participant showed relapse|0|||
164370292|NCT02641379|593733477|FG010|Overall Study|Participant showed relapse|0|||
164370293|NCT02641379|593733467|FG000|Overall Study|Participant stopped study/treatment|1|||
163902131|NCT00263757|592013078|FG001|Overall Study|Screen failure|1|||
164370294|NCT02641379|593733468|FG001|Overall Study|Participant stopped study/treatment|3|||
164370295|NCT02641379|593733469|FG002|Overall Study|Participant stopped study/treatment|1|||
164370296|NCT02641379|593733470|FG003|Overall Study|Participant stopped study/treatment|0|||
164370297|NCT02641379|593733471|FG004|Overall Study|Participant stopped study/treatment|0|||
164370298|NCT02641379|593733472|FG005|Overall Study|Participant stopped study/treatment|1|||
164370299|NCT02641379|593733473|FG006|Overall Study|Participant stopped study/treatment|2|||
164370300|NCT02641379|593733474|FG007|Overall Study|Participant stopped study/treatment|0|||
164370301|NCT02641379|593733475|FG008|Overall Study|Participant stopped study/treatment|1|||
164370302|NCT02641379|593733476|FG009|Overall Study|Participant stopped study/treatment|0|||
164370303|NCT02641379|593733477|FG010|Overall Study|Participant stopped study/treatment|0|||
164370304|NCT02641379|593733467|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
164370305|NCT02641379|593733468|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
164370306|NCT02641379|593733469|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
164370307|NCT02641379|593733470|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
164370308|NCT02641379|593733471|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
164370309|NCT02641379|593733472|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
164370310|NCT02641379|593733473|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
164370311|NCT02641379|593733474|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
164370312|NCT02641379|593733475|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
164370313|NCT02641379|593733476|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
164370314|NCT02641379|593733477|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
164370315|NCT02641379|593733467|FG000|Overall Study|Financial problems|0|||
163902132|NCT00263757|592013077|FG000|Overall Study|Adverse Event|3|||
163902133|NCT00263757|592013078|FG001|Overall Study|Adverse Event|3|||
163902134|NCT00713596|592013079|FG000|Overall Study|Study was terminated|2|||
163902135|NCT00713596|592013080|FG001|Overall Study|Study was terminated|3|||
163902136|NCT00713596|592013081|FG002|Overall Study|Study was terminated|2|||
163902137|NCT03712371|592013082|FG000|Overall Study|Lack of Efficacy|0|||
163902138|NCT03712371|592013083|FG001|Overall Study|Lack of Efficacy|0|||
163902139|NCT03712371|592013084|FG002|Overall Study|Lack of Efficacy|0|||
163902140|NCT03712371|592013085|FG003|Overall Study|Lack of Efficacy|1|||
163902141|NCT01211184|592013090|FG000|Overall Study|Withdrawal by Subject|0|||
163902142|NCT01211184|592013091|FG001|Overall Study|Withdrawal by Subject|2|||
164370316|NCT02641379|593733468|FG001|Overall Study|Financial problems|1|||
164370317|NCT02641379|593733469|FG002|Overall Study|Financial problems|0|||
164370318|NCT02641379|593733470|FG003|Overall Study|Financial problems|0|||
164370319|NCT02641379|593733471|FG004|Overall Study|Financial problems|0|||
164370320|NCT02641379|593733472|FG005|Overall Study|Financial problems|0|||
164370321|NCT02641379|593733473|FG006|Overall Study|Financial problems|0|||
164370322|NCT02641379|593733474|FG007|Overall Study|Financial problems|0|||
164370323|NCT02641379|593733475|FG008|Overall Study|Financial problems|0|||
164370324|NCT02641379|593733476|FG009|Overall Study|Financial problems|0|||
164370325|NCT02641379|593733477|FG010|Overall Study|Financial problems|0|||
164370326|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 68|0|||
164370327|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 68|1|||
164370328|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 68|0|||
164370329|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 68|0|||
164370330|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 68|0|||
164370331|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 68|0|||
164370332|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 68|0|||
164370333|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 68|0|||
164370334|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 68|0|||
164370335|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 68|0|||
164370336|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 68|0|||
164370337|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 48|0|||
164370338|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 48|1|||
164370339|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 48|0|||
164370340|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 48|0|||
164370341|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 48|0|||
164370342|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 48|0|||
164370343|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 48|0|||
164370344|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 48|0|||
164370345|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 48|0|||
164370346|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 48|0|||
164370347|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 48|0|||
164370348|NCT02641379|593733467|FG000|Overall Study|PCR not performed at Week 12|0|||
164370349|NCT02641379|593733468|FG001|Overall Study|PCR not performed at Week 12|0|||
164370350|NCT02641379|593733469|FG002|Overall Study|PCR not performed at Week 12|1|||
164370351|NCT02641379|593733470|FG003|Overall Study|PCR not performed at Week 12|0|||
164370352|NCT02641379|593733471|FG004|Overall Study|PCR not performed at Week 12|0|||
164370353|NCT02641379|593733472|FG005|Overall Study|PCR not performed at Week 12|0|||
164370354|NCT02641379|593733473|FG006|Overall Study|PCR not performed at Week 12|0|||
164370355|NCT02641379|593733474|FG007|Overall Study|PCR not performed at Week 12|0|||
164370356|NCT02641379|593733475|FG008|Overall Study|PCR not performed at Week 12|0|||
164370357|NCT02641379|593733476|FG009|Overall Study|PCR not performed at Week 12|0|||
164370358|NCT02641379|593733477|FG010|Overall Study|PCR not performed at Week 12|0|||
164370359|NCT02641379|593733467|FG000|Overall Study|No PCR at baseline|0|||
164370360|NCT02641379|593733468|FG001|Overall Study|No PCR at baseline|0|||
164370361|NCT02641379|593733469|FG002|Overall Study|No PCR at baseline|1|||
164370362|NCT02641379|593733470|FG003|Overall Study|No PCR at baseline|0|||
164370363|NCT02641379|593733471|FG004|Overall Study|No PCR at baseline|0|||
164370364|NCT02641379|593733472|FG005|Overall Study|No PCR at baseline|0|||
164370365|NCT02641379|593733473|FG006|Overall Study|No PCR at baseline|0|||
164012475|NCT00408421|592410532|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
164012476|NCT00408421|592410530|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
164012477|NCT00408421|592410531|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
164012478|NCT00408421|592410532|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
164012479|NCT00408421|592410530|FG000|Treatment Re-Randomization|Physician Decision|1|||
164012480|NCT00408421|592410531|FG001|Treatment Re-Randomization|Physician Decision|3|||
164012481|NCT00408421|592410532|FG002|Treatment Re-Randomization|Physician Decision|0|||
164012482|NCT00408421|592410530|FG000|Treatment Re-Randomization|Protocol Violation|1|||
164012483|NCT00408421|592410531|FG001|Treatment Re-Randomization|Protocol Violation|1|||
164012484|NCT00408421|592410532|FG002|Treatment Re-Randomization|Protocol Violation|0|||
164012485|NCT00408421|592410530|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
164012486|NCT00408421|592410531|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
164012487|NCT00408421|592410532|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
164012488|NCT00710034|592410535|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
164012489|NCT00710034|592410536|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
164012490|NCT00710034|592410535|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
164012491|NCT00710034|592410536|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
164370366|NCT02641379|593733474|FG007|Overall Study|No PCR at baseline|0|||
164370367|NCT02641379|593733475|FG008|Overall Study|No PCR at baseline|0|||
164370368|NCT02641379|593733476|FG009|Overall Study|No PCR at baseline|0|||
164370369|NCT02641379|593733477|FG010|Overall Study|No PCR at baseline|0|||
164370370|NCT02641379|593733467|FG000|Overall Study|PCR positive at Week 28|0|||
164370371|NCT02641379|593733468|FG001|Overall Study|PCR positive at Week 28|0|||
164370372|NCT02641379|593733469|FG002|Overall Study|PCR positive at Week 28|1|||
164370373|NCT02641379|593733470|FG003|Overall Study|PCR positive at Week 28|0|||
164370374|NCT02641379|593733471|FG004|Overall Study|PCR positive at Week 28|0|||
164370375|NCT02641379|593733472|FG005|Overall Study|PCR positive at Week 28|0|||
164370376|NCT02641379|593733473|FG006|Overall Study|PCR positive at Week 28|0|||
164012492|NCT00710034|592410535|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
164012493|NCT00710034|592410536|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
164012494|NCT00710034|592410535|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
164012495|NCT00710034|592410536|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
164370377|NCT02641379|593733474|FG007|Overall Study|PCR positive at Week 28|0|||
164370378|NCT02641379|593733475|FG008|Overall Study|PCR positive at Week 28|0|||
164370379|NCT02641379|593733476|FG009|Overall Study|PCR positive at Week 28|0|||
164370380|NCT02641379|593733477|FG010|Overall Study|PCR positive at Week 28|0|||
164370381|NCT02641379|593733467|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
164370382|NCT02641379|593733468|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
164370383|NCT02641379|593733469|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
164370384|NCT02641379|593733470|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
164370385|NCT02641379|593733471|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
164370386|NCT02641379|593733472|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
164370387|NCT02641379|593733473|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
164370388|NCT02641379|593733474|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
164370389|NCT02641379|593733475|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
164370390|NCT02641379|593733476|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
164370391|NCT02641379|593733477|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
164370392|NCT02641379|593733467|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
164370393|NCT02641379|593733468|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
164370394|NCT02641379|593733469|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
164370395|NCT02641379|593733470|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
164370396|NCT02641379|593733471|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
164370397|NCT02641379|593733472|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
164370398|NCT02641379|593733473|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
164370399|NCT02641379|593733474|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
164370400|NCT02641379|593733475|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
164370401|NCT02641379|593733476|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
164370402|NCT02641379|593733477|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
164370403|NCT02641379|593733467|FG000|Overall Study|Baseline viral load unavailable|0|||
164370404|NCT02641379|593733468|FG001|Overall Study|Baseline viral load unavailable|0|||
164370405|NCT02641379|593733469|FG002|Overall Study|Baseline viral load unavailable|0|||
164370406|NCT02641379|593733470|FG003|Overall Study|Baseline viral load unavailable|1|||
164012496|NCT00710034|592410535|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
164012497|NCT00710034|592410536|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
164370407|NCT02641379|593733471|FG004|Overall Study|Baseline viral load unavailable|0|||
164370408|NCT02641379|593733472|FG005|Overall Study|Baseline viral load unavailable|0|||
164370409|NCT02641379|593733473|FG006|Overall Study|Baseline viral load unavailable|0|||
164370410|NCT02641379|593733474|FG007|Overall Study|Baseline viral load unavailable|0|||
164012498|NCT00710034|592410535|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
164370411|NCT02641379|593733475|FG008|Overall Study|Baseline viral load unavailable|0|||
164370412|NCT02641379|593733476|FG009|Overall Study|Baseline viral load unavailable|0|||
164370413|NCT02641379|593733477|FG010|Overall Study|Baseline viral load unavailable|0|||
164370414|NCT02641379|593733467|FG000|Overall Study|Blood could not be drawn|0|||
164370415|NCT02641379|593733468|FG001|Overall Study|Blood could not be drawn|0|||
164370416|NCT02641379|593733469|FG002|Overall Study|Blood could not be drawn|0|||
164370417|NCT02641379|593733470|FG003|Overall Study|Blood could not be drawn|0|||
164370418|NCT02641379|593733471|FG004|Overall Study|Blood could not be drawn|1|||
164370419|NCT02641379|593733472|FG005|Overall Study|Blood could not be drawn|0|||
164370420|NCT02641379|593733473|FG006|Overall Study|Blood could not be drawn|0|||
164370421|NCT02641379|593733474|FG007|Overall Study|Blood could not be drawn|0|||
164370422|NCT02641379|593733475|FG008|Overall Study|Blood could not be drawn|0|||
164370423|NCT02641379|593733476|FG009|Overall Study|Blood could not be drawn|0|||
164370424|NCT02641379|593733477|FG010|Overall Study|Blood could not be drawn|0|||
164370425|NCT02641379|593733467|FG000|Overall Study|Protocol Violation|0|||
164370426|NCT02641379|593733468|FG001|Overall Study|Protocol Violation|0|||
164370427|NCT02641379|593733469|FG002|Overall Study|Protocol Violation|0|||
164370428|NCT02641379|593733470|FG003|Overall Study|Protocol Violation|0|||
164370429|NCT02641379|593733471|FG004|Overall Study|Protocol Violation|2|||
164370430|NCT02641379|593733472|FG005|Overall Study|Protocol Violation|0|||
164370431|NCT02641379|593733473|FG006|Overall Study|Protocol Violation|0|||
164370432|NCT02641379|593733474|FG007|Overall Study|Protocol Violation|0|||
164370433|NCT02641379|593733475|FG008|Overall Study|Protocol Violation|1|||
164370434|NCT02641379|593733476|FG009|Overall Study|Protocol Violation|0|||
164370435|NCT02641379|593733477|FG010|Overall Study|Protocol Violation|0|||
164370436|NCT02641379|593733467|FG000|Overall Study|Participation in sili rescue study|0|||
164370437|NCT02641379|593733468|FG001|Overall Study|Participation in sili rescue study|0|||
164370438|NCT02641379|593733469|FG002|Overall Study|Participation in sili rescue study|0|||
164370439|NCT02641379|593733470|FG003|Overall Study|Participation in sili rescue study|0|||
164370440|NCT02641379|593733471|FG004|Overall Study|Participation in sili rescue study|0|||
164370441|NCT02641379|593733472|FG005|Overall Study|Participation in sili rescue study|1|||
164370442|NCT02641379|593733473|FG006|Overall Study|Participation in sili rescue study|0|||
164370443|NCT02641379|593733474|FG007|Overall Study|Participation in sili rescue study|0|||
164370444|NCT02641379|593733475|FG008|Overall Study|Participation in sili rescue study|0|||
164370445|NCT02641379|593733476|FG009|Overall Study|Participation in sili rescue study|0|||
164370446|NCT02641379|593733477|FG010|Overall Study|Participation in sili rescue study|0|||
164370447|NCT02641379|593733467|FG000|Overall Study|Lost to Follow-up|0|||
164370448|NCT02641379|593733468|FG001|Overall Study|Lost to Follow-up|0|||
164370449|NCT02641379|593733469|FG002|Overall Study|Lost to Follow-up|0|||
164370450|NCT02641379|593733470|FG003|Overall Study|Lost to Follow-up|0|||
164370451|NCT02641379|593733471|FG004|Overall Study|Lost to Follow-up|0|||
164370452|NCT02641379|593733472|FG005|Overall Study|Lost to Follow-up|0|||
164370453|NCT02641379|593733473|FG006|Overall Study|Lost to Follow-up|0|||
164370454|NCT02641379|593733474|FG007|Overall Study|Lost to Follow-up|0|||
164370455|NCT02641379|593733475|FG008|Overall Study|Lost to Follow-up|1|||
164370456|NCT02641379|593733476|FG009|Overall Study|Lost to Follow-up|0|||
164370457|NCT02641379|593733477|FG010|Overall Study|Lost to Follow-up|0|||
164370458|NCT02641379|593733467|FG000|Overall Study|Source data not found|0|||
164370459|NCT02641379|593733468|FG001|Overall Study|Source data not found|0|||
164370460|NCT02641379|593733469|FG002|Overall Study|Source data not found|0|||
164370461|NCT02641379|593733470|FG003|Overall Study|Source data not found|0|||
164370462|NCT02641379|593733471|FG004|Overall Study|Source data not found|0|||
164370463|NCT02641379|593733472|FG005|Overall Study|Source data not found|1|||
164370464|NCT02641379|593733473|FG006|Overall Study|Source data not found|0|||
164370465|NCT02641379|593733474|FG007|Overall Study|Source data not found|0|||
164370466|NCT02641379|593733475|FG008|Overall Study|Source data not found|0|||
164370467|NCT02641379|593733476|FG009|Overall Study|Source data not found|0|||
164370468|NCT02641379|593733477|FG010|Overall Study|Source data not found|0|||
164370469|NCT02641379|593733467|FG000|Overall Study|Participant showed weight reduction|0|||
164370470|NCT02641379|593733468|FG001|Overall Study|Participant showed weight reduction|0|||
164370471|NCT02641379|593733469|FG002|Overall Study|Participant showed weight reduction|0|||
164370472|NCT02641379|593733470|FG003|Overall Study|Participant showed weight reduction|0|||
164370473|NCT02641379|593733471|FG004|Overall Study|Participant showed weight reduction|0|||
164370474|NCT02641379|593733472|FG005|Overall Study|Participant showed weight reduction|0|||
164370475|NCT02641379|593733473|FG006|Overall Study|Participant showed weight reduction|0|||
164012499|NCT00710034|592410536|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
164012500|NCT00710034|592410535|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
164370476|NCT02641379|593733474|FG007|Overall Study|Participant showed weight reduction|1|||
164370477|NCT02641379|593733475|FG008|Overall Study|Participant showed weight reduction|0|||
164370478|NCT02641379|593733476|FG009|Overall Study|Participant showed weight reduction|0|||
164370479|NCT02641379|593733477|FG010|Overall Study|Participant showed weight reduction|0|||
164370480|NCT02641379|593733467|FG000|Overall Study|Non-response Week 12|0|||
164370481|NCT02641379|593733468|FG001|Overall Study|Non-response Week 12|0|||
164370482|NCT02641379|593733469|FG002|Overall Study|Non-response Week 12|0|||
164370483|NCT02641379|593733470|FG003|Overall Study|Non-response Week 12|0|||
164370484|NCT02641379|593733471|FG004|Overall Study|Non-response Week 12|0|||
164370485|NCT02641379|593733472|FG005|Overall Study|Non-response Week 12|0|||
164370486|NCT02641379|593733473|FG006|Overall Study|Non-response Week 12|0|||
164370487|NCT02641379|593733474|FG007|Overall Study|Non-response Week 12|1|||
164370488|NCT02641379|593733475|FG008|Overall Study|Non-response Week 12|0|||
164370489|NCT02641379|593733476|FG009|Overall Study|Non-response Week 12|0|||
164370490|NCT02641379|593733477|FG010|Overall Study|Non-response Week 12|0|||
164370491|NCT02641379|593733467|FG000|Overall Study|No 2 Log drop at Week 12|0|||
164370492|NCT02641379|593733468|FG001|Overall Study|No 2 Log drop at Week 12|0|||
164370493|NCT02641379|593733469|FG002|Overall Study|No 2 Log drop at Week 12|0|||
164370494|NCT02641379|593733470|FG003|Overall Study|No 2 Log drop at Week 12|0|||
164370495|NCT02641379|593733471|FG004|Overall Study|No 2 Log drop at Week 12|0|||
164370496|NCT02641379|593733472|FG005|Overall Study|No 2 Log drop at Week 12|0|||
164370497|NCT02641379|593733473|FG006|Overall Study|No 2 Log drop at Week 12|0|||
164370498|NCT02641379|593733474|FG007|Overall Study|No 2 Log drop at Week 12|0|||
164370499|NCT02641379|593733475|FG008|Overall Study|No 2 Log drop at Week 12|0|||
164370500|NCT02641379|593733476|FG009|Overall Study|No 2 Log drop at Week 12|0|||
164370501|NCT02641379|593733477|FG010|Overall Study|No 2 Log drop at Week 12|1|||
164370502|NCT02641379|593733467|FG000|Overall Study|Negative PCR result|0|||
164370503|NCT02641379|593733468|FG001|Overall Study|Negative PCR result|0|||
164370504|NCT02641379|593733469|FG002|Overall Study|Negative PCR result|0|||
164370505|NCT02641379|593733470|FG003|Overall Study|Negative PCR result|0|||
164370506|NCT02641379|593733471|FG004|Overall Study|Negative PCR result|0|||
164370507|NCT02641379|593733472|FG005|Overall Study|Negative PCR result|0|||
164370508|NCT02641379|593733473|FG006|Overall Study|Negative PCR result|0|||
164370509|NCT02641379|593733474|FG007|Overall Study|Negative PCR result|0|||
164370510|NCT02641379|593733475|FG008|Overall Study|Negative PCR result|0|||
164370511|NCT02641379|593733476|FG009|Overall Study|Negative PCR result|1|||
164370512|NCT02641379|593733477|FG010|Overall Study|Negative PCR result|0|||
164370513|NCT02641379|593733467|FG000|Overall Study|Participant's PCR high|0|||
164370514|NCT02641379|593733468|FG001|Overall Study|Participant's PCR high|0|||
164370515|NCT02641379|593733469|FG002|Overall Study|Participant's PCR high|0|||
164370516|NCT02641379|593733470|FG003|Overall Study|Participant's PCR high|0|||
164012501|NCT00710034|592410536|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
164012502|NCT00710034|592410535|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
164012503|NCT00710034|592410536|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
164012504|NCT00710034|592410535|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
164012505|NCT00710034|592410536|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
164370517|NCT02641379|593733471|FG004|Overall Study|Participant's PCR high|0|||
164370518|NCT02641379|593733472|FG005|Overall Study|Participant's PCR high|0|||
164370519|NCT02641379|593733473|FG006|Overall Study|Participant's PCR high|0|||
164370520|NCT02641379|593733474|FG007|Overall Study|Participant's PCR high|1|||
164370521|NCT02641379|593733475|FG008|Overall Study|Participant's PCR high|0|||
164370522|NCT02641379|593733476|FG009|Overall Study|Participant's PCR high|0|||
164370523|NCT02641379|593733477|FG010|Overall Study|Participant's PCR high|0|||
164370524|NCT02641379|593733467|FG000|Overall Study|Participant treated after Week 24|0|||
164370525|NCT02641379|593733468|FG001|Overall Study|Participant treated after Week 24|0|||
164370526|NCT02641379|593733469|FG002|Overall Study|Participant treated after Week 24|0|||
164370527|NCT02641379|593733470|FG003|Overall Study|Participant treated after Week 24|0|||
164370528|NCT02641379|593733471|FG004|Overall Study|Participant treated after Week 24|0|||
164370529|NCT02641379|593733472|FG005|Overall Study|Participant treated after Week 24|0|||
164370530|NCT02641379|593733473|FG006|Overall Study|Participant treated after Week 24|0|||
164370531|NCT02641379|593733474|FG007|Overall Study|Participant treated after Week 24|0|||
164370532|NCT02641379|593733475|FG008|Overall Study|Participant treated after Week 24|1|||
164370533|NCT02641379|593733476|FG009|Overall Study|Participant treated after Week 24|0|||
164370534|NCT02641379|593733477|FG010|Overall Study|Participant treated after Week 24|0|||
164370535|NCT02641379|593733467|FG000|Overall Study|Missing PCR result at Week 8|0|||
164370536|NCT02641379|593733468|FG001|Overall Study|Missing PCR result at Week 8|0|||
164370537|NCT02641379|593733469|FG002|Overall Study|Missing PCR result at Week 8|0|||
164370538|NCT02641379|593733470|FG003|Overall Study|Missing PCR result at Week 8|0|||
164370539|NCT02641379|593733471|FG004|Overall Study|Missing PCR result at Week 8|0|||
164370540|NCT02641379|593733472|FG005|Overall Study|Missing PCR result at Week 8|0|||
164370541|NCT02641379|593733473|FG006|Overall Study|Missing PCR result at Week 8|0|||
164370542|NCT02641379|593733474|FG007|Overall Study|Missing PCR result at Week 8|0|||
164012506|NCT00710034|592410535|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
164370543|NCT02641379|593733475|FG008|Overall Study|Missing PCR result at Week 8|0|||
164370544|NCT02641379|593733476|FG009|Overall Study|Missing PCR result at Week 8|1|||
164370545|NCT02641379|593733477|FG010|Overall Study|Missing PCR result at Week 8|0|||
164370546|NCT02641379|593733467|FG000|Overall Study|PCR positive|0|||
164370547|NCT02641379|593733468|FG001|Overall Study|PCR positive|0|||
164370548|NCT02641379|593733469|FG002|Overall Study|PCR positive|0|||
164370549|NCT02641379|593733470|FG003|Overall Study|PCR positive|0|||
164370550|NCT02641379|593733471|FG004|Overall Study|PCR positive|0|||
164370551|NCT02641379|593733472|FG005|Overall Study|PCR positive|0|||
164370552|NCT02641379|593733473|FG006|Overall Study|PCR positive|1|||
164370553|NCT02641379|593733474|FG007|Overall Study|PCR positive|0|||
164370554|NCT02641379|593733475|FG008|Overall Study|PCR positive|0|||
164370555|NCT02641379|593733476|FG009|Overall Study|PCR positive|0|||
164370556|NCT02641379|593733477|FG010|Overall Study|PCR positive|0|||
164370557|NCT01165138|593733478|FG000|Overall Study|Adverse Event|0|||
164370558|NCT01165138|593733479|FG001|Overall Study|Adverse Event|1|||
164370559|NCT01165138|593733480|FG002|Overall Study|Adverse Event|0|||
164370560|NCT01165138|593733481|FG003|Overall Study|Adverse Event|2|||
164370561|NCT01165138|593733478|FG000|Overall Study|Lack of Efficacy|0|||
164370562|NCT01165138|593733479|FG001|Overall Study|Lack of Efficacy|32|||
164370563|NCT01165138|593733480|FG002|Overall Study|Lack of Efficacy|6|||
164370564|NCT01165138|593733481|FG003|Overall Study|Lack of Efficacy|7|||
164370565|NCT01165138|593733478|FG000|Overall Study|Protocol Violation|0|||
164370566|NCT01165138|593733479|FG001|Overall Study|Protocol Violation|7|||
164370567|NCT01165138|593733480|FG002|Overall Study|Protocol Violation|0|||
164370568|NCT01165138|593733481|FG003|Overall Study|Protocol Violation|2|||
164370569|NCT01165138|593733478|FG000|Overall Study|Lost to Follow-up|0|||
164370570|NCT01165138|593733479|FG001|Overall Study|Lost to Follow-up|0|||
164370571|NCT01165138|593733480|FG002|Overall Study|Lost to Follow-up|1|||
164370572|NCT01165138|593733481|FG003|Overall Study|Lost to Follow-up|2|||
164370573|NCT01165138|593733478|FG000|Overall Study|Physician Decision|0|||
164370574|NCT01165138|593733479|FG001|Overall Study|Physician Decision|6|||
164370575|NCT01165138|593733480|FG002|Overall Study|Physician Decision|7|||
164370576|NCT01165138|593733481|FG003|Overall Study|Physician Decision|6|||
164370577|NCT01165138|593733478|FG000|Overall Study|Withdrawal by Subject|0|||
164370578|NCT01165138|593733479|FG001|Overall Study|Withdrawal by Subject|6|||
164370579|NCT01165138|593733480|FG002|Overall Study|Withdrawal by Subject|6|||
164370580|NCT01165138|593733481|FG003|Overall Study|Withdrawal by Subject|3|||
164370581|NCT01644175|593733484|FG000|Overall Study|Randomized But Not Treated|0|||
164370582|NCT01644175|593733485|FG001|Overall Study|Randomized But Not Treated|2|||
164370583|NCT01644175|593733484|FG000|Overall Study|Adverse Event|8|||
164370584|NCT01644175|593733485|FG001|Overall Study|Adverse Event|13|||
164370585|NCT01644175|593733484|FG000|Overall Study|Death|1|||
164370586|NCT01644175|593733485|FG001|Overall Study|Death|2|||
164370587|NCT01644175|593733484|FG000|Overall Study|Poor compliance to protocol|9|||
164370588|NCT01644175|593733485|FG001|Overall Study|Poor compliance to protocol|10|||
164370589|NCT01644175|593733484|FG000|Overall Study|Physician Decision|1|||
164370590|NCT01644175|593733485|FG001|Overall Study|Physician Decision|2|||
164370591|NCT01644175|593733484|FG000|Overall Study|Participant Moved|1|||
164370592|NCT01644175|593733485|FG001|Overall Study|Participant Moved|2|||
164370593|NCT01644175|593733484|FG000|Overall Study|Consent withdrawn by participant|3|||
164370594|NCT01644175|593733485|FG001|Overall Study|Consent withdrawn by participant|4|||
164370595|NCT01644175|593733484|FG000|Overall Study|Related to Autoinjector Administration|2|||
164370596|NCT01644175|593733485|FG001|Overall Study|Related to Autoinjector Administration|1|||
164370597|NCT01644175|593733484|FG000|Overall Study|Last visit outside protocol visit window|4|||
164370598|NCT01644175|593733485|FG001|Overall Study|Last visit outside protocol visit window|11|||
164370599|NCT01644175|593733484|FG000|Overall Study|Selection criteria finally not met|0|||
164370600|NCT01644175|593733485|FG001|Overall Study|Selection criteria finally not met|1|||
164370601|NCT01644175|593733484|FG000|Overall Study|Site closure|2|||
164370602|NCT01644175|593733485|FG001|Overall Study|Site closure|2|||
164370603|NCT01644175|593733484|FG000|Overall Study|Lost to Follow-up|1|||
164370604|NCT01644175|593733485|FG001|Overall Study|Lost to Follow-up|0|||
164370605|NCT01644175|593733484|FG000|Overall Study|Other than specified above|0|||
164370606|NCT01644175|593733485|FG001|Overall Study|Other than specified above|3|||
164370607|NCT01398956|593733489|FG000|Overall Study|Withdrawal by Subject|4|||
164370608|NCT01398956|593733489|FG000|Overall Study|AE, non-serious non-fatal|4|||
164092749|NCT02130466|592702140|FG007|Overall Study|Death|2|||
164370609|NCT01398956|593733489|FG000|Overall Study|Withdrawal Criteria No.3|1|||
164370610|NCT01398956|593733489|FG000|Overall Study|Subject moved a long distance|1|||
164370611|NCT00856908|593733490|FG000|Overall Study|Lost to Follow-up|1|||
164370612|NCT00856908|593733491|FG001|Overall Study|Lost to Follow-up|0|||
164370613|NCT01063595|593733495|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
164370614|NCT01063595|593733496|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
164370615|NCT01063595|593733495|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
164370616|NCT01063595|593733496|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
164370617|NCT01063595|593733495|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
164370618|NCT01063595|593733496|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
164370619|NCT01063595|593733495|FG000|First Intervention|Adverse Event|1|||
164370620|NCT01063595|593733496|FG001|First Intervention|Adverse Event|4|||
163902143|NCT01211184|592013092|FG002|Overall Study|Withdrawal by Subject|1|||
163902144|NCT01421667|592013093|FG000|Overall Study|Withdrawal by Subject|0|||
163902145|NCT01421667|592013094|FG001|Overall Study|Withdrawal by Subject|1|||
163902146|NCT01421667|592013095|FG002|Overall Study|Withdrawal by Subject|2|||
163902147|NCT01421667|592013096|FG003|Overall Study|Withdrawal by Subject|1|||
163902148|NCT01421667|592013093|FG000|Overall Study|Lost to Follow-up|0|||
164370621|NCT01063595|593733495|FG000|First Intervention|Withdrawal by Subject|1|||
164370622|NCT01063595|593733496|FG001|First Intervention|Withdrawal by Subject|0|||
164370623|NCT01063595|593733495|FG000|First Intervention|Reason not Specified|0|||
164370624|NCT01063595|593733496|FG001|First Intervention|Reason not Specified|1|||
164370625|NCT00451035|593733497|FG000|Overall Study|Disease progression|11|||
164370626|NCT00451035|593733497|FG000|Overall Study|Death|3|||
164370627|NCT00451035|593733497|FG000|Overall Study|New anti-neoplastic therapy|3|||
164370628|NCT01623596|593733498|FG000|Overall Study|Abnormal laboratory values|2|||
164370629|NCT01623596|593733499|FG001|Overall Study|Abnormal laboratory values|0|||
164370630|NCT01623596|593733498|FG000|Overall Study|Administrative problems|9|||
164370631|NCT01623596|593733499|FG001|Overall Study|Administrative problems|13|||
164370632|NCT01623596|593733498|FG000|Overall Study|Adverse Event|20|||
164370633|NCT01623596|593733499|FG001|Overall Study|Adverse Event|29|||
164370634|NCT01623596|593733498|FG000|Overall Study|Death|0|||
164370635|NCT01623596|593733499|FG001|Overall Study|Death|2|||
164370636|NCT01623596|593733498|FG000|Overall Study|Lost to Follow-up|12|||
164370637|NCT01623596|593733499|FG001|Overall Study|Lost to Follow-up|16|||
164370638|NCT01623596|593733498|FG000|Overall Study|Withdrawal by Subject|13|||
164370639|NCT01623596|593733499|FG001|Overall Study|Withdrawal by Subject|31|||
164370640|NCT01623596|593733498|FG000|Overall Study|Patient no longer requires study drug|1|||
164370641|NCT01623596|593733499|FG001|Overall Study|Patient no longer requires study drug|0|||
164370642|NCT01623596|593733498|FG000|Overall Study|Protocol Violation|0|||
164370643|NCT01623596|593733499|FG001|Overall Study|Protocol Violation|6|||
164370644|NCT01623596|593733498|FG000|Overall Study|Lack of Efficacy|5|||
164370645|NCT01623596|593733499|FG001|Overall Study|Lack of Efficacy|3|||
164370646|NCT04059146|593733500|FG000|Overall Study|Withdrawal by Subject|0|||
164370647|NCT04059146|593733501|FG001|Overall Study|Withdrawal by Subject|1|||
164370648|NCT01712256|593733507|FG000|Overall Study|Lost to Follow-up|1|||
164370649|NCT00962104|593733510|FG000|Overall Study|Adverse Event|10|||
164370650|NCT00962104|593733511|FG001|Overall Study|Adverse Event|3|||
164370651|NCT00962104|593733510|FG000|Overall Study|Entry Criteria Not Met|1|||
164370652|NCT00962104|593733511|FG001|Overall Study|Entry Criteria Not Met|2|||
164370653|NCT00962104|593733510|FG000|Overall Study|Lack of Efficacy|0|||
164370654|NCT00962104|593733511|FG001|Overall Study|Lack of Efficacy|1|||
164370655|NCT00962104|593733510|FG000|Overall Study|Lost to Follow-up|10|||
164370656|NCT00962104|593733511|FG001|Overall Study|Lost to Follow-up|4|||
164370657|NCT00962104|593733510|FG000|Overall Study|Physician Decision|1|||
164370658|NCT00962104|593733511|FG001|Overall Study|Physician Decision|0|||
164370659|NCT00962104|593733510|FG000|Overall Study|Protocol Violation|6|||
164370660|NCT00962104|593733511|FG001|Overall Study|Protocol Violation|8|||
164370661|NCT00962104|593733510|FG000|Overall Study|Sponsor Decision|0|||
164370662|NCT00962104|593733511|FG001|Overall Study|Sponsor Decision|1|||
164370663|NCT00962104|593733510|FG000|Overall Study|Withdrawal by Subject|10|||
164370664|NCT00962104|593733511|FG001|Overall Study|Withdrawal by Subject|6|||
164370665|NCT00962104|593733510|FG000|Overall Study|Other|2|||
164370666|NCT00962104|593733511|FG001|Overall Study|Other|0|||
164370667|NCT03274986|593733512|FG000|Overall Study|Withdrawal by Subject|0|||
164370668|NCT03274986|593733513|FG001|Overall Study|Withdrawal by Subject|1|||
164370669|NCT03274986|593733512|FG000|Overall Study|Lost to Follow-up|0|||
164370670|NCT03274986|593733513|FG001|Overall Study|Lost to Follow-up|1|||
164370671|NCT01524627|593733515|FG000|Overall Study|Physician Decision|0|||
164370672|NCT01524627|593733516|FG001|Overall Study|Physician Decision|1|||
164370673|NCT01524627|593733515|FG000|Overall Study|Lost to Follow-up|1|||
164370674|NCT01524627|593733516|FG001|Overall Study|Lost to Follow-up|1|||
164370675|NCT05627518|593733519|FG000|Treatment Period 1|Adverse Event|0|||
164370676|NCT05627518|593733520|FG001|Treatment Period 1|Adverse Event|0|||
164370677|NCT05627518|593733521|FG002|Treatment Period 1|Adverse Event|1|||
164370678|NCT05627518|593733522|FG003|Treatment Period 1|Adverse Event|0|||
164370679|NCT05627518|593733523|FG004|Treatment Period 1|Adverse Event|0|||
164370680|NCT05627518|593733524|FG005|Treatment Period 1|Adverse Event|0|||
164370681|NCT05627518|593733525|FG006|Treatment Period 1|Adverse Event|0|||
164370682|NCT05627518|593733526|FG007|Treatment Period 1|Adverse Event|1|||
164370683|NCT05627518|593733519|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164370684|NCT05627518|593733520|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164370685|NCT05627518|593733521|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164370686|NCT05627518|593733522|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164370687|NCT05627518|593733523|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164370688|NCT05627518|593733524|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164370689|NCT05627518|593733525|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164370690|NCT05627518|593733526|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164370691|NCT05627518|593733519|FG000|Treatment Period 1|Protocol Violation|0|||
164370692|NCT05627518|593733520|FG001|Treatment Period 1|Protocol Violation|0|||
163902149|NCT01421667|592013094|FG001|Overall Study|Lost to Follow-up|1|||
164370693|NCT05627518|593733521|FG002|Treatment Period 1|Protocol Violation|0|||
164370694|NCT05627518|593733522|FG003|Treatment Period 1|Protocol Violation|0|||
164370695|NCT05627518|593733523|FG004|Treatment Period 1|Protocol Violation|0|||
164370696|NCT05627518|593733524|FG005|Treatment Period 1|Protocol Violation|0|||
164370697|NCT05627518|593733525|FG006|Treatment Period 1|Protocol Violation|6|||
164370698|NCT05627518|593733526|FG007|Treatment Period 1|Protocol Violation|6|||
164370699|NCT05627518|593733519|FG000|Treatment Period 2|Adverse Event|1|||
164370700|NCT05627518|593733520|FG001|Treatment Period 2|Adverse Event|0|||
164370701|NCT05627518|593733521|FG002|Treatment Period 2|Adverse Event|0|||
164370702|NCT05627518|593733522|FG003|Treatment Period 2|Adverse Event|0|||
164370703|NCT05627518|593733523|FG004|Treatment Period 2|Adverse Event|0|||
164370704|NCT05627518|593733524|FG005|Treatment Period 2|Adverse Event|0|||
164370705|NCT05627518|593733525|FG006|Treatment Period 2|Adverse Event|0|||
164370706|NCT05627518|593733526|FG007|Treatment Period 2|Adverse Event|0|||
164370707|NCT05627518|593733519|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164370708|NCT05627518|593733520|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164370709|NCT05627518|593733521|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164370710|NCT05627518|593733522|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164370711|NCT05627518|593733523|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164370712|NCT05627518|593733524|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164370713|NCT05627518|593733525|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164370714|NCT05627518|593733526|FG007|Treatment Period 2|Withdrawal by Subject|0|||
164370715|NCT01101841|593735826|FG000|Overall Study|Adverse Event|15|||
164370716|NCT01101841|593735827|FG001|Overall Study|Adverse Event|15|||
164370717|NCT01101841|593735826|FG000|Overall Study|Lost to Follow-up|9|||
164370718|NCT01101841|593735827|FG001|Overall Study|Lost to Follow-up|3|||
164370719|NCT01101841|593735826|FG000|Overall Study|Withdrawal by Subject|21|||
164370720|NCT01101841|593735827|FG001|Overall Study|Withdrawal by Subject|40|||
164370721|NCT01101841|593735826|FG000|Overall Study|Protocol Violation|1|||
164370722|NCT01101841|593735827|FG001|Overall Study|Protocol Violation|1|||
164370723|NCT01101841|593735826|FG000|Overall Study|Physician Decision|0|||
164370724|NCT01101841|593735827|FG001|Overall Study|Physician Decision|2|||
164370725|NCT01101841|593735826|FG000|Overall Study|Lack of Efficacy|0|||
164370726|NCT01101841|593735827|FG001|Overall Study|Lack of Efficacy|2|||
164370727|NCT01101841|593735826|FG000|Overall Study|Other|0|||
164370728|NCT01101841|593735827|FG001|Overall Study|Other|1|||
164370729|NCT01101841|593735826|FG000|Overall Study|Suicidality Tracking Scale|3|||
164370730|NCT01101841|593735827|FG001|Overall Study|Suicidality Tracking Scale|1|||
164370731|NCT01101841|593735826|FG000|Overall Study|Eligibility Criteria|1|||
164370732|NCT01101841|593735827|FG001|Overall Study|Eligibility Criteria|2|||
164370733|NCT00145509|593735830|FG000|Overall Study|Adverse Event|10|||
164370734|NCT00145509|593735831|FG001|Overall Study|Adverse Event|3|||
164370735|NCT00145509|593735830|FG000|Overall Study|Lack of Efficacy|3|||
164370736|NCT00145509|593735831|FG001|Overall Study|Lack of Efficacy|1|||
164370737|NCT00145509|593735830|FG000|Overall Study|Lost to Follow-up|5|||
164370738|NCT00145509|593735831|FG001|Overall Study|Lost to Follow-up|9|||
164370739|NCT00145509|593735830|FG000|Overall Study|Withdrew Consent|2|||
164370740|NCT00145509|593735831|FG001|Overall Study|Withdrew Consent|7|||
164370741|NCT00145509|593735830|FG000|Overall Study|Reason not provided|2|||
164370742|NCT00145509|593735831|FG001|Overall Study|Reason not provided|1|||
164370743|NCT00697346|593735836|FG000|Overall Study|Adverse Event|4|||
164370744|NCT00697346|593735837|FG001|Overall Study|Adverse Event|5|||
164370745|NCT00697346|593735838|FG002|Overall Study|Adverse Event|0|||
164370746|NCT00697346|593735836|FG000|Overall Study|Progressive Disease|19|||
164370747|NCT00697346|593735837|FG001|Overall Study|Progressive Disease|18|||
164370748|NCT00697346|593735838|FG002|Overall Study|Progressive Disease|0|||
164370749|NCT00697346|593735836|FG000|Overall Study|Symptomatic Deterioration|0|||
164370750|NCT00697346|593735837|FG001|Overall Study|Symptomatic Deterioration|1|||
164370751|NCT00697346|593735838|FG002|Overall Study|Symptomatic Deterioration|0|||
164370752|NCT00697346|593735836|FG000|Overall Study|Withdrawal by Subject|2|||
164370753|NCT00697346|593735837|FG001|Overall Study|Withdrawal by Subject|2|||
164370754|NCT00697346|593735838|FG002|Overall Study|Withdrawal by Subject|0|||
164370755|NCT00697346|593735836|FG000|Overall Study|Reason not Specified|3|||
164370756|NCT00697346|593735837|FG001|Overall Study|Reason not Specified|0|||
164370757|NCT00697346|593735838|FG002|Overall Study|Reason not Specified|1|||
164370758|NCT03569371|593735839|FG000|Overall Study|Lack of Efficacy|1|||
164012507|NCT00710034|592410536|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
164012508|NCT00710034|592410535|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
164012509|NCT00710034|592410536|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
164012510|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
164370759|NCT03569371|593735839|FG000|Overall Study|Lost to Follow-up|1|||
164012511|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
164092750|NCT02130466|592702141|FG008|Overall Study|Death|3|||
164370760|NCT03569371|593735839|FG000|Overall Study|Adverse Event|1|||
164370761|NCT03643562|593735840|FG000|Overall Study|Adverse Event|1|||
164370762|NCT03643562|593735841|FG001|Overall Study|Adverse Event|0|||
164370763|NCT03643562|593735840|FG000|Overall Study|Lack of Efficacy|0|||
164370764|NCT03643562|593735841|FG001|Overall Study|Lack of Efficacy|1|||
164370765|NCT03643562|593735840|FG000|Overall Study|Physician Decision|0|||
164370766|NCT03643562|593735841|FG001|Overall Study|Physician Decision|1|||
164370767|NCT03643562|593735840|FG000|Overall Study|Study Terminated by Sponsor|2|||
164370768|NCT03643562|593735841|FG001|Overall Study|Study Terminated by Sponsor|10|||
164370769|NCT03643562|593735840|FG000|Overall Study|Withdrawal by Subject|2|||
163902150|NCT01421667|592013095|FG002|Overall Study|Lost to Follow-up|0|||
163902151|NCT01421667|592013096|FG003|Overall Study|Lost to Follow-up|0|||
163902152|NCT00503906|592013097|FG000|Overall Study|Withdrawal by Subject|1|||
163902153|NCT05580003|592013098|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902154|NCT05580003|592013099|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902155|NCT05580003|592013100|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902156|NCT05580003|592013101|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902157|NCT05580003|592013102|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902158|NCT05580003|592013103|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902159|NCT05580003|592013104|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
163902160|NCT05580003|592013105|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902161|NCT05580003|592013106|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902162|NCT05580003|592013107|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902163|NCT05580003|592013108|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902164|NCT05580003|592013109|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902165|NCT05580003|592013110|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902166|NCT05580003|592013111|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902167|NCT05580003|592013112|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902168|NCT05580003|592013113|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902169|NCT05580003|592013114|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164012512|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
164012513|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
164012514|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Death|8|||
163902170|NCT05580003|592013115|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902171|NCT05580003|592013116|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902172|NCT05580003|592013117|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902173|NCT05580003|592013118|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902174|NCT05580003|592013119|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902175|NCT05580003|592013120|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902176|NCT05580003|592013121|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902177|NCT05580003|592013122|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
164012515|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Death|3|||
164370770|NCT03643562|593735841|FG001|Overall Study|Withdrawal by Subject|2|||
164370771|NCT03643562|593735840|FG000|Overall Study|Other than specified|3|||
164370772|NCT03643562|593735841|FG001|Overall Study|Other than specified|2|||
164370773|NCT01982253|593735844|FG000|Overall Study|Withdrawal by Subject|1|||
164370774|NCT01982253|593735845|FG001|Overall Study|Withdrawal by Subject|0|||
164370775|NCT01982253|593735846|FG002|Overall Study|Withdrawal by Subject|0|||
164370776|NCT01982253|593735844|FG000|Overall Study|Study terminated by sponsor|1|||
164370777|NCT01982253|593735845|FG001|Overall Study|Study terminated by sponsor|4|||
164370778|NCT01982253|593735846|FG002|Overall Study|Study terminated by sponsor|4|||
164370779|NCT02223767|593735850|FG000|Overall Study|Withdrawal by Subject|4|||
164370780|NCT02223767|593735851|FG001|Overall Study|Withdrawal by Subject|4|||
164370781|NCT02789176|593735852|FG000|Overall Study|Death|0|||
164370782|NCT02789176|593735853|FG001|Overall Study|Death|0|||
164370783|NCT02789176|593735854|FG002|Overall Study|Death|3|||
164370784|NCT02789176|593735855|FG003|Overall Study|Death|0|||
164370785|NCT02789176|593735852|FG000|Overall Study|Withdrawal by Subject|0|||
164370786|NCT02789176|593735853|FG001|Overall Study|Withdrawal by Subject|0|||
164370787|NCT02789176|593735854|FG002|Overall Study|Withdrawal by Subject|1|||
164370788|NCT02789176|593735855|FG003|Overall Study|Withdrawal by Subject|0|||
164370789|NCT02789176|593735852|FG000|Overall Study|Lost to Follow-up|8|||
164370790|NCT02789176|593735853|FG001|Overall Study|Lost to Follow-up|2|||
164370791|NCT02789176|593735854|FG002|Overall Study|Lost to Follow-up|6|||
164370792|NCT02789176|593735855|FG003|Overall Study|Lost to Follow-up|1|||
164012516|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
164370793|NCT00770120|593735861|FG000|Overall Study|Progression|31|||
163902178|NCT05580003|592013123|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902179|NCT05580003|592013124|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902180|NCT05580003|592013125|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
163902181|NCT05580003|592013098|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164092751|NCT02130466|592702142|FG009|Overall Study|Death|4|||
164370794|NCT00770120|593735861|FG000|Overall Study|Adverse Event|11|||
164370795|NCT00770120|593735861|FG000|Overall Study|Not Protocol Specified|11|||
164370796|NCT00770120|593735861|FG000|Overall Study|Death|3|||
164370797|NCT00770120|593735861|FG000|Overall Study|Withdrawal by Subject|2|||
164370798|NCT00770120|593735861|FG000|Overall Study|Ineligible|1|||
164370799|NCT00770120|593735861|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
164370800|NCT00770120|593735861|FG000|Overall Study|Reason under Review|1|||
164370801|NCT02412631|593735862|FG000|Overall Study|Adverse Event|1|||
164370802|NCT02412631|593735863|FG001|Overall Study|Adverse Event|2|||
164370803|NCT02412631|593735862|FG000|Overall Study|Lost to Follow-up|5|||
164370804|NCT02412631|593735863|FG001|Overall Study|Lost to Follow-up|9|||
164370805|NCT02412631|593735862|FG000|Overall Study|Withdrawal by Subject|9|||
164370806|NCT02412631|593735863|FG001|Overall Study|Withdrawal by Subject|3|||
164370807|NCT02412631|593735862|FG000|Overall Study|Early stop by FDA|5|||
164370808|NCT02412631|593735863|FG001|Overall Study|Early stop by FDA|2|||
164370809|NCT02412631|593735862|FG000|Overall Study|Unspecified reason|6|||
164370810|NCT02412631|593735863|FG001|Overall Study|Unspecified reason|8|||
164370811|NCT03100825|593735868|FG000|Overall Study|Participant/Guardian Decision|7|||
164370812|NCT03100825|593735868|FG000|Overall Study|Physician Decision|1|||
164370813|NCT00994448|593735869|FG000|Overall Study|Adverse Event|1|||
164370814|NCT00994448|593735870|FG001|Overall Study|Adverse Event|0|||
164370815|NCT00994448|593735869|FG000|Overall Study|Lost to Follow-up|5|||
164370816|NCT00994448|593735870|FG001|Overall Study|Lost to Follow-up|1|||
164370817|NCT00994448|593735869|FG000|Overall Study|Withdrawal by Subject|1|||
164370818|NCT00994448|593735870|FG001|Overall Study|Withdrawal by Subject|1|||
164370819|NCT00994448|593735869|FG000|Overall Study|Physician Decision|1|||
164370820|NCT00994448|593735870|FG001|Overall Study|Physician Decision|0|||
164370821|NCT05288556|593735872|FG000|Overall Study|Protocol Violation|1|||
164370822|NCT05288556|593735872|FG000|Overall Study|Withdrawal by Subject|1|||
164370823|NCT02704364|593735873|FG000|Overall Study|Adverse Event|1|||
164370824|NCT02704364|593735874|FG001|Overall Study|Adverse Event|1|||
164370825|NCT02704364|593735875|FG002|Overall Study|Adverse Event|0|||
164370826|NCT02704364|593735873|FG000|Overall Study|Noncompliance with study drug|1|||
164370827|NCT02704364|593735874|FG001|Overall Study|Noncompliance with study drug|1|||
164370828|NCT02704364|593735875|FG002|Overall Study|Noncompliance with study drug|0|||
164370829|NCT02704364|593735873|FG000|Overall Study|Other|0|||
164370830|NCT02704364|593735874|FG001|Overall Study|Other|1|||
164370831|NCT02704364|593735875|FG002|Overall Study|Other|1|||
164370832|NCT01232296|593735876|FG000|Overall Study|Adverse Event|24|||
164370833|NCT01232296|593735877|FG001|Overall Study|Adverse Event|12|||
164370834|NCT01232296|593735876|FG000|Overall Study|Physician Decision|1|||
164370835|NCT01232296|593735877|FG001|Overall Study|Physician Decision|1|||
164370836|NCT01232296|593735876|FG000|Overall Study|Progressive disease|43|||
164370837|NCT01232296|593735877|FG001|Overall Study|Progressive disease|61|||
164370838|NCT01232296|593735876|FG000|Overall Study|Study terminated by sponsor|0|||
164370839|NCT01232296|593735877|FG001|Overall Study|Study terminated by sponsor|1|||
164370840|NCT01232296|593735876|FG000|Overall Study|Technical problems|3|||
164370841|NCT01232296|593735877|FG001|Overall Study|Technical problems|0|||
164370842|NCT01232296|593735876|FG000|Overall Study|Subject/guardian decision|10|||
164370843|NCT01232296|593735877|FG001|Overall Study|Subject/guardian decision|2|||
164370844|NCT01232296|593735876|FG000|Overall Study|Death|1|||
164370845|NCT01232296|593735877|FG001|Overall Study|Death|6|||
164370846|NCT01461096|593735879|FG000|Overall Study|Death|3|||
164370847|NCT01461096|593735880|FG001|Overall Study|Death|6|||
164370848|NCT01461096|593735879|FG000|Overall Study|Severe debilitation, unable to continue|1|||
164370849|NCT01461096|593735880|FG001|Overall Study|Severe debilitation, unable to continue|1|||
164370850|NCT01461096|593735879|FG000|Overall Study|Subj not able to get to clinic|15|||
164370851|NCT01461096|593735880|FG001|Overall Study|Subj not able to get to clinic|13|||
164370852|NCT01461096|593735879|FG000|Overall Study|Site is closing|27|||
164370853|NCT01461096|593735880|FG001|Overall Study|Site is closing|30|||
164370854|NCT01461096|593735879|FG000|Overall Study|Withdrawal by Subject|5|||
164370855|NCT01461096|593735880|FG001|Overall Study|Withdrawal by Subject|3|||
164370856|NCT01461096|593735879|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
164370857|NCT01461096|593735880|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
164370858|NCT01461096|593735879|FG000|Overall Study|Lost to Follow-up|8|||
164370859|NCT01461096|593735880|FG001|Overall Study|Lost to Follow-up|4|||
163902182|NCT05580003|592013099|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902183|NCT05580003|592013100|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902184|NCT05580003|592013101|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164370860|NCT04889625|593735882|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
164370861|NCT04889625|593735883|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
164370862|NCT04889625|593735882|FG000|Period 1|Subject out of window|0|||
164370863|NCT04889625|593735883|FG001|Period 1|Subject out of window|1|||
164370864|NCT04889625|593735882|FG000|Period 1|Wrong add power dispensed|0|||
164370865|NCT04889625|593735883|FG001|Period 1|Wrong add power dispensed|1|||
164370866|NCT04889625|593735882|FG000|Period 1|Discontinued due to fitting guide error|1|||
163902185|NCT05580003|592013102|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902186|NCT05580003|592013103|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
164370867|NCT04889625|593735883|FG001|Period 1|Discontinued due to fitting guide error|1|||
164370868|NCT04889625|593735882|FG000|Period 2|Test article no longer available|1|||
164370869|NCT04889625|593735883|FG001|Period 2|Test article no longer available|0|||
164370870|NCT04889625|593735882|FG000|Period 2|Incorrect lens dispensed|1|||
164370871|NCT04889625|593735883|FG001|Period 2|Incorrect lens dispensed|0|||
164370872|NCT04889625|593735882|FG000|Period 2|Wrong add power dispensed|0|||
164370873|NCT04889625|593735883|FG001|Period 2|Wrong add power dispensed|1|||
164370874|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
164370875|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
164370876|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
164370877|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
164370878|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
164370879|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
164370880|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
164092752|NCT02130466|592702143|FG010|Overall Study|Death|5|||
164092753|NCT02130466|592702144|FG011|Overall Study|Death|3|||
164092754|NCT02130466|592702145|FG012|Overall Study|Death|11|||
164370881|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
164370882|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
164370883|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
164370884|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
164370885|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
164370886|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
164370887|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
164370888|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
164370889|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
164370890|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
164370891|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
164370892|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Death|0|||
164370893|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Death|0|||
164370894|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Death|1|||
164370895|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Death|0|||
164370896|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Death|0|||
164370897|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Death|0|||
164370898|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Death|0|||
164370899|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Death|0|||
164370900|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Death|0|||
164370901|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
164370902|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
164370903|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
164370904|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370905|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370906|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370907|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370908|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370909|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
164370910|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
164370911|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
164370912|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
164370913|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370914|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370915|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370916|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370917|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370918|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
164370919|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
164370920|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
164370921|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
164370922|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
164370923|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
164370924|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
164012517|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
164012518|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
164012519|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
164012520|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
164012521|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
164012522|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
164012523|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
164012524|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
164012525|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
164012526|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
164012527|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
164092755|NCT02130466|592702146|FG013|Overall Study|Death|7|||
164370925|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
164370926|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
164370927|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
164370928|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
164370929|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
164370930|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
164370931|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
164370932|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
164370933|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
164370934|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
164370935|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
164370936|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
164370937|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
164370938|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
164370939|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
164370940|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370941|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370942|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370943|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370944|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370945|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
164370946|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370947|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
164370948|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370949|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370950|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370951|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370952|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370953|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370954|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
164370955|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
164370956|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
164370957|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
164370958|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
164370959|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
164370960|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
164370961|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
164370962|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
164370963|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
164370964|NCT00404352|593735884|FG000|Double Blind (up to 24 Month)|Other|0|||
164370965|NCT00404352|593735885|FG001|Double Blind (up to 24 Month)|Other|1|||
164370966|NCT00404352|593735886|FG002|Double Blind (up to 24 Month)|Other|0|||
164370967|NCT00404352|593735887|FG003|Double Blind (up to 24 Month)|Other|0|||
164370968|NCT00404352|593735888|FG004|Double Blind (up to 24 Month)|Other|0|||
164370969|NCT00404352|593735889|FG005|Double Blind (up to 24 Month)|Other|0|||
164370970|NCT00404352|593735890|FG006|Double Blind (up to 24 Month)|Other|0|||
164370971|NCT00404352|593735891|FG007|Double Blind (up to 24 Month)|Other|0|||
164370972|NCT00404352|593735892|FG008|Double Blind (up to 24 Month)|Other|0|||
164370973|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
164370974|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
164370975|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
164370976|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
164370977|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
164370978|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
164370979|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
164370980|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
164370981|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
164370982|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
164370983|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
164370984|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
164012528|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
164012529|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
164370985|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
164370986|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
164012530|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
164370987|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
164370988|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
164370989|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
164370990|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
164370991|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370992|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370993|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370994|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370995|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
164370996|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370997|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370998|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164370999|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
164371000|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371001|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371002|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371003|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371004|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371005|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
164371006|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371007|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371008|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
164371009|NCT00404352|593735884|FG000|Open Label (up to 24 Month)|Disease progression|0|||
164371010|NCT00404352|593735885|FG001|Open Label (up to 24 Month)|Disease progression|0|||
164371011|NCT00404352|593735886|FG002|Open Label (up to 24 Month)|Disease progression|0|||
164371012|NCT00404352|593735887|FG003|Open Label (up to 24 Month)|Disease progression|1|||
164371013|NCT00404352|593735888|FG004|Open Label (up to 24 Month)|Disease progression|0|||
164371014|NCT00404352|593735889|FG005|Open Label (up to 24 Month)|Disease progression|0|||
164371015|NCT00404352|593735890|FG006|Open Label (up to 24 Month)|Disease progression|0|||
164371016|NCT00404352|593735891|FG007|Open Label (up to 24 Month)|Disease progression|0|||
164371017|NCT00404352|593735892|FG008|Open Label (up to 24 Month)|Disease progression|0|||
164371018|NCT00404352|593735884|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371019|NCT00404352|593735885|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371020|NCT00404352|593735886|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371021|NCT00404352|593735887|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371022|NCT00404352|593735888|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371023|NCT00404352|593735889|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371024|NCT00404352|593735890|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
164371025|NCT00404352|593735891|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
164371026|NCT00404352|593735892|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
164371027|NCT00404352|593735884|FG000|Open Label Extension (up to 36 Months)|Other|0|||
164371028|NCT00404352|593735885|FG001|Open Label Extension (up to 36 Months)|Other|0|||
164371029|NCT00404352|593735886|FG002|Open Label Extension (up to 36 Months)|Other|0|||
164371030|NCT00404352|593735887|FG003|Open Label Extension (up to 36 Months)|Other|0|||
164371031|NCT00404352|593735888|FG004|Open Label Extension (up to 36 Months)|Other|0|||
164371032|NCT00404352|593735889|FG005|Open Label Extension (up to 36 Months)|Other|0|||
164371033|NCT00404352|593735890|FG006|Open Label Extension (up to 36 Months)|Other|0|||
164371034|NCT00404352|593735891|FG007|Open Label Extension (up to 36 Months)|Other|0|||
164371035|NCT00404352|593735892|FG008|Open Label Extension (up to 36 Months)|Other|2|||
164371036|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
164371037|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371038|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371039|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371040|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371041|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371042|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
164371043|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
164371044|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163902187|NCT05580003|592013104|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902188|NCT05580003|592013105|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902189|NCT05580003|592013106|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164092756|NCT02130466|592702133|FG000|Overall Study|Lost to Follow-up|1|||
164092757|NCT02130466|592702134|FG001|Overall Study|Lost to Follow-up|0|||
164371045|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371046|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371047|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371048|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371049|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
164371050|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
164371051|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163902190|NCT05580003|592013107|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164092758|NCT02130466|592702135|FG002|Overall Study|Lost to Follow-up|0|||
164371052|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371053|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371054|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164092759|NCT02130466|592702136|FG003|Overall Study|Lost to Follow-up|0|||
164371055|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371056|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
164371057|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
164371058|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371059|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371060|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371061|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371062|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371063|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
164371064|NCT01479621|593735895|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
164371065|NCT01479621|593735896|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371066|NCT01479621|593735897|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371067|NCT01479621|593735898|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371068|NCT01479621|593735899|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371069|NCT01479621|593735900|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371070|NCT01479621|593735901|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
164371071|NCT01479621|593735895|FG000|Treatment Period|Adverse Event|0|||
164371072|NCT01479621|593735896|FG001|Treatment Period|Adverse Event|0|||
164371073|NCT01479621|593735897|FG002|Treatment Period|Adverse Event|0|||
164371074|NCT01479621|593735898|FG003|Treatment Period|Adverse Event|0|||
164371075|NCT01479621|593735899|FG004|Treatment Period|Adverse Event|1|||
164371076|NCT01479621|593735900|FG005|Treatment Period|Adverse Event|2|||
164371077|NCT01479621|593735901|FG006|Treatment Period|Adverse Event|2|||
164371078|NCT01479621|593735895|FG000|Treatment Period|Withdrawal by Subject|0|||
164371079|NCT01479621|593735896|FG001|Treatment Period|Withdrawal by Subject|4|||
164371080|NCT01479621|593735897|FG002|Treatment Period|Withdrawal by Subject|2|||
164371081|NCT01479621|593735898|FG003|Treatment Period|Withdrawal by Subject|2|||
164371082|NCT01479621|593735899|FG004|Treatment Period|Withdrawal by Subject|5|||
164371083|NCT01479621|593735900|FG005|Treatment Period|Withdrawal by Subject|5|||
164371084|NCT01479621|593735901|FG006|Treatment Period|Withdrawal by Subject|1|||
164371085|NCT01479621|593735895|FG000|Treatment Period|Physician Decision|0|||
164371086|NCT01479621|593735896|FG001|Treatment Period|Physician Decision|0|||
164371087|NCT01479621|593735897|FG002|Treatment Period|Physician Decision|0|||
164371088|NCT01479621|593735898|FG003|Treatment Period|Physician Decision|0|||
164371089|NCT01479621|593735899|FG004|Treatment Period|Physician Decision|1|||
164371090|NCT01479621|593735900|FG005|Treatment Period|Physician Decision|1|||
164371091|NCT01479621|593735901|FG006|Treatment Period|Physician Decision|0|||
164371092|NCT01479621|593735895|FG000|Treatment Period|Non-compliance to study drug|0|||
164371093|NCT01479621|593735896|FG001|Treatment Period|Non-compliance to study drug|1|||
164371094|NCT01479621|593735897|FG002|Treatment Period|Non-compliance to study drug|0|||
164371095|NCT01479621|593735898|FG003|Treatment Period|Non-compliance to study drug|0|||
164371096|NCT01479621|593735899|FG004|Treatment Period|Non-compliance to study drug|0|||
164371097|NCT01479621|593735900|FG005|Treatment Period|Non-compliance to study drug|0|||
164371098|NCT01479621|593735901|FG006|Treatment Period|Non-compliance to study drug|1|||
164371099|NCT01479621|593735895|FG000|Treatment Period|Protocol Violation|0|||
164371100|NCT01479621|593735896|FG001|Treatment Period|Protocol Violation|9|||
164371101|NCT01479621|593735897|FG002|Treatment Period|Protocol Violation|6|||
164371102|NCT01479621|593735898|FG003|Treatment Period|Protocol Violation|5|||
164371103|NCT01479621|593735899|FG004|Treatment Period|Protocol Violation|2|||
164371104|NCT01479621|593735900|FG005|Treatment Period|Protocol Violation|10|||
164092760|NCT02130466|592702137|FG004|Overall Study|Lost to Follow-up|0|||
164092761|NCT02130466|592702138|FG005|Overall Study|Lost to Follow-up|1|||
164371105|NCT01479621|593735901|FG006|Treatment Period|Protocol Violation|6|||
164371106|NCT01479621|593735895|FG000|Treatment Period|Pregnancy|0|||
164371107|NCT01479621|593735896|FG001|Treatment Period|Pregnancy|0|||
164371108|NCT01479621|593735897|FG002|Treatment Period|Pregnancy|2|||
164371109|NCT01479621|593735898|FG003|Treatment Period|Pregnancy|0|||
164371110|NCT01479621|593735899|FG004|Treatment Period|Pregnancy|0|||
164092762|NCT02130466|592702139|FG006|Overall Study|Lost to Follow-up|0|||
164371111|NCT01479621|593735900|FG005|Treatment Period|Pregnancy|0|||
164371112|NCT01479621|593735901|FG006|Treatment Period|Pregnancy|0|||
164371113|NCT01479621|593735895|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
164371114|NCT01479621|593735896|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
164371115|NCT01479621|593735897|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
164092763|NCT02130466|592702140|FG007|Overall Study|Lost to Follow-up|0|||
164371116|NCT01479621|593735898|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
164371117|NCT01479621|593735899|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
164371118|NCT01479621|593735900|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
164371119|NCT01479621|593735901|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
164371120|NCT01479621|593735895|FG000|Treatment Period|Lost to Follow-up|0|||
164371121|NCT01479621|593735896|FG001|Treatment Period|Lost to Follow-up|0|||
164371122|NCT01479621|593735897|FG002|Treatment Period|Lost to Follow-up|1|||
164371123|NCT01479621|593735898|FG003|Treatment Period|Lost to Follow-up|0|||
164371124|NCT01479621|593735899|FG004|Treatment Period|Lost to Follow-up|2|||
164371125|NCT01479621|593735900|FG005|Treatment Period|Lost to Follow-up|2|||
164371126|NCT01479621|593735901|FG006|Treatment Period|Lost to Follow-up|1|||
164371127|NCT01479621|593735895|FG000|Treatment Period|Met stopping criteria|0|||
164371128|NCT01479621|593735896|FG001|Treatment Period|Met stopping criteria|8|||
164371129|NCT01479621|593735897|FG002|Treatment Period|Met stopping criteria|7|||
164371130|NCT01479621|593735898|FG003|Treatment Period|Met stopping criteria|4|||
164371131|NCT01479621|593735899|FG004|Treatment Period|Met stopping criteria|9|||
164371132|NCT01479621|593735900|FG005|Treatment Period|Met stopping criteria|20|||
164371133|NCT01479621|593735901|FG006|Treatment Period|Met stopping criteria|6|||
164371134|NCT02308735|593735904|FG000|Overall Study|Physician Decision|2|||
164371135|NCT02308735|593735905|FG001|Overall Study|Physician Decision|0|||
164371136|NCT02308735|593735906|FG002|Overall Study|Physician Decision|0|||
164371137|NCT02308735|593735907|FG003|Overall Study|Physician Decision|2|||
164371138|NCT01417481|593735913|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
164371139|NCT01417481|593735914|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164371140|NCT00582933|593735917|FG000|Overall Study|Physician Decision|3|||
164371141|NCT02457598|593735918|FG000|Overall Study|Progressive Disease|2|||
164371142|NCT02457598|593735919|FG001|Overall Study|Progressive Disease|2|||
164371143|NCT02457598|593735920|FG002|Overall Study|Progressive Disease|1|||
164371144|NCT02457598|593735921|FG003|Overall Study|Progressive Disease|11|||
164371145|NCT02457598|593735922|FG004|Overall Study|Progressive Disease|7|||
164371146|NCT02457598|593735923|FG005|Overall Study|Progressive Disease|3|||
164371147|NCT02457598|593735924|FG006|Overall Study|Progressive Disease|2|||
164371148|NCT02457598|593735925|FG007|Overall Study|Progressive Disease|1|||
164371149|NCT02457598|593735926|FG008|Overall Study|Progressive Disease|1|||
164371150|NCT02457598|593735927|FG009|Overall Study|Progressive Disease|2|||
164371151|NCT02457598|593735928|FG010|Overall Study|Progressive Disease|45|||
164371152|NCT02457598|593735929|FG011|Overall Study|Progressive Disease|6|||
164371153|NCT02457598|593735930|FG012|Overall Study|Progressive Disease|2|||
164371154|NCT02457598|593735931|FG013|Overall Study|Progressive Disease|2|||
164371155|NCT02457598|593735932|FG014|Overall Study|Progressive Disease|10|||
164371156|NCT02457598|593735933|FG015|Overall Study|Progressive Disease|1|||
164371157|NCT02457598|593735934|FG016|Overall Study|Progressive Disease|1|||
164371158|NCT02457598|593735918|FG000|Overall Study|Investigator's Discretion|0|||
164371159|NCT02457598|593735919|FG001|Overall Study|Investigator's Discretion|2|||
164371160|NCT02457598|593735920|FG002|Overall Study|Investigator's Discretion|2|||
164371161|NCT02457598|593735921|FG003|Overall Study|Investigator's Discretion|2|||
164371162|NCT02457598|593735922|FG004|Overall Study|Investigator's Discretion|0|||
164371163|NCT02457598|593735923|FG005|Overall Study|Investigator's Discretion|0|||
164371164|NCT02457598|593735924|FG006|Overall Study|Investigator's Discretion|0|||
164371165|NCT02457598|593735925|FG007|Overall Study|Investigator's Discretion|1|||
164371166|NCT02457598|593735926|FG008|Overall Study|Investigator's Discretion|2|||
164371167|NCT02457598|593735927|FG009|Overall Study|Investigator's Discretion|0|||
164371168|NCT02457598|593735928|FG010|Overall Study|Investigator's Discretion|10|||
164371169|NCT02457598|593735929|FG011|Overall Study|Investigator's Discretion|2|||
164371170|NCT02457598|593735930|FG012|Overall Study|Investigator's Discretion|2|||
164371171|NCT02457598|593735931|FG013|Overall Study|Investigator's Discretion|1|||
164371172|NCT02457598|593735932|FG014|Overall Study|Investigator's Discretion|5|||
164371173|NCT02457598|593735933|FG015|Overall Study|Investigator's Discretion|0|||
164371174|NCT02457598|593735934|FG016|Overall Study|Investigator's Discretion|0|||
164371175|NCT02457598|593735918|FG000|Overall Study|Study Terminated by Sponsor|0|||
164371176|NCT02457598|593735919|FG001|Overall Study|Study Terminated by Sponsor|1|||
164371177|NCT02457598|593735920|FG002|Overall Study|Study Terminated by Sponsor|0|||
164371178|NCT02457598|593735921|FG003|Overall Study|Study Terminated by Sponsor|4|||
164371179|NCT02457598|593735922|FG004|Overall Study|Study Terminated by Sponsor|1|||
164371180|NCT02457598|593735923|FG005|Overall Study|Study Terminated by Sponsor|0|||
164092764|NCT02130466|592702141|FG008|Overall Study|Lost to Follow-up|0|||
164371181|NCT02457598|593735924|FG006|Overall Study|Study Terminated by Sponsor|1|||
164371182|NCT02457598|593735925|FG007|Overall Study|Study Terminated by Sponsor|0|||
164371183|NCT02457598|593735926|FG008|Overall Study|Study Terminated by Sponsor|0|||
164371184|NCT02457598|593735927|FG009|Overall Study|Study Terminated by Sponsor|0|||
164371185|NCT02457598|593735928|FG010|Overall Study|Study Terminated by Sponsor|4|||
164371186|NCT02457598|593735929|FG011|Overall Study|Study Terminated by Sponsor|0|||
164371187|NCT02457598|593735930|FG012|Overall Study|Study Terminated by Sponsor|1|||
164092765|NCT02130466|592702142|FG009|Overall Study|Lost to Follow-up|0|||
164371188|NCT02457598|593735931|FG013|Overall Study|Study Terminated by Sponsor|0|||
164371189|NCT02457598|593735932|FG014|Overall Study|Study Terminated by Sponsor|8|||
164371190|NCT02457598|593735933|FG015|Overall Study|Study Terminated by Sponsor|1|||
164371191|NCT02457598|593735934|FG016|Overall Study|Study Terminated by Sponsor|0|||
164371192|NCT02457598|593735918|FG000|Overall Study|Adverse Event|0|||
164371193|NCT02457598|593735919|FG001|Overall Study|Adverse Event|1|||
164371194|NCT02457598|593735920|FG002|Overall Study|Adverse Event|1|||
164371195|NCT02457598|593735921|FG003|Overall Study|Adverse Event|4|||
164371196|NCT02457598|593735922|FG004|Overall Study|Adverse Event|1|||
164371197|NCT02457598|593735923|FG005|Overall Study|Adverse Event|0|||
164371198|NCT02457598|593735924|FG006|Overall Study|Adverse Event|0|||
164371199|NCT02457598|593735925|FG007|Overall Study|Adverse Event|1|||
164371200|NCT02457598|593735926|FG008|Overall Study|Adverse Event|0|||
164371201|NCT02457598|593735927|FG009|Overall Study|Adverse Event|1|||
164371202|NCT02457598|593735928|FG010|Overall Study|Adverse Event|6|||
164371203|NCT02457598|593735929|FG011|Overall Study|Adverse Event|0|||
164371204|NCT02457598|593735930|FG012|Overall Study|Adverse Event|0|||
164371205|NCT02457598|593735931|FG013|Overall Study|Adverse Event|1|||
164371206|NCT02457598|593735932|FG014|Overall Study|Adverse Event|2|||
164371207|NCT02457598|593735933|FG015|Overall Study|Adverse Event|0|||
164371208|NCT02457598|593735934|FG016|Overall Study|Adverse Event|0|||
164371209|NCT02457598|593735918|FG000|Overall Study|Death|0|||
164371210|NCT02457598|593735919|FG001|Overall Study|Death|0|||
164371211|NCT02457598|593735920|FG002|Overall Study|Death|0|||
164371212|NCT02457598|593735921|FG003|Overall Study|Death|3|||
164371213|NCT02457598|593735922|FG004|Overall Study|Death|0|||
164371214|NCT02457598|593735923|FG005|Overall Study|Death|1|||
164371215|NCT02457598|593735924|FG006|Overall Study|Death|0|||
164371216|NCT02457598|593735925|FG007|Overall Study|Death|0|||
164371217|NCT02457598|593735926|FG008|Overall Study|Death|0|||
164371218|NCT02457598|593735927|FG009|Overall Study|Death|0|||
164371219|NCT02457598|593735928|FG010|Overall Study|Death|3|||
164371220|NCT02457598|593735929|FG011|Overall Study|Death|0|||
164371221|NCT02457598|593735930|FG012|Overall Study|Death|0|||
164371222|NCT02457598|593735931|FG013|Overall Study|Death|1|||
164371223|NCT02457598|593735932|FG014|Overall Study|Death|2|||
164371224|NCT02457598|593735933|FG015|Overall Study|Death|0|||
164371225|NCT02457598|593735934|FG016|Overall Study|Death|1|||
164371226|NCT02457598|593735918|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371227|NCT02457598|593735919|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
164371228|NCT02457598|593735920|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371229|NCT02457598|593735921|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371230|NCT02457598|593735922|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371231|NCT02457598|593735923|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371232|NCT02457598|593735924|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371233|NCT02457598|593735925|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371234|NCT02457598|593735926|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371235|NCT02457598|593735927|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371236|NCT02457598|593735928|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
164371237|NCT02457598|593735929|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371238|NCT02457598|593735930|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371239|NCT02457598|593735931|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
164371240|NCT02457598|593735932|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371241|NCT02457598|593735933|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371242|NCT02457598|593735934|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
164371243|NCT02457598|593735918|FG000|Overall Study|Withdrew Consent|0|||
164371244|NCT02457598|593735919|FG001|Overall Study|Withdrew Consent|0|||
164371245|NCT02457598|593735920|FG002|Overall Study|Withdrew Consent|0|||
164371246|NCT02457598|593735921|FG003|Overall Study|Withdrew Consent|0|||
164371247|NCT02457598|593735922|FG004|Overall Study|Withdrew Consent|0|||
164371248|NCT02457598|593735923|FG005|Overall Study|Withdrew Consent|0|||
164012531|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
164012532|NCT00494871|592410537|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
164012533|NCT00494871|592410538|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
164012534|NCT00494871|592410537|FG000|Follow-up (FU) Period|Adverse Event|1|||
164371249|NCT02457598|593735924|FG006|Overall Study|Withdrew Consent|0|||
164371250|NCT02457598|593735925|FG007|Overall Study|Withdrew Consent|2|||
164371251|NCT02457598|593735926|FG008|Overall Study|Withdrew Consent|0|||
164371252|NCT02457598|593735927|FG009|Overall Study|Withdrew Consent|0|||
164371253|NCT02457598|593735928|FG010|Overall Study|Withdrew Consent|3|||
164371254|NCT02457598|593735929|FG011|Overall Study|Withdrew Consent|0|||
164371255|NCT02457598|593735930|FG012|Overall Study|Withdrew Consent|0|||
164371256|NCT02457598|593735931|FG013|Overall Study|Withdrew Consent|1|||
164371257|NCT02457598|593735932|FG014|Overall Study|Withdrew Consent|0|||
164371258|NCT02457598|593735933|FG015|Overall Study|Withdrew Consent|0|||
164371259|NCT02457598|593735934|FG016|Overall Study|Withdrew Consent|0|||
164371260|NCT02457598|593735918|FG000|Overall Study|Unacceptable Toxicity|0|||
164371261|NCT02457598|593735919|FG001|Overall Study|Unacceptable Toxicity|0|||
164371262|NCT02457598|593735920|FG002|Overall Study|Unacceptable Toxicity|0|||
164371263|NCT02457598|593735921|FG003|Overall Study|Unacceptable Toxicity|0|||
164371264|NCT02457598|593735922|FG004|Overall Study|Unacceptable Toxicity|0|||
164371265|NCT02457598|593735923|FG005|Overall Study|Unacceptable Toxicity|0|||
164371266|NCT02457598|593735924|FG006|Overall Study|Unacceptable Toxicity|0|||
164371267|NCT02457598|593735925|FG007|Overall Study|Unacceptable Toxicity|0|||
164371268|NCT02457598|593735926|FG008|Overall Study|Unacceptable Toxicity|0|||
164371269|NCT02457598|593735927|FG009|Overall Study|Unacceptable Toxicity|0|||
164371270|NCT02457598|593735928|FG010|Overall Study|Unacceptable Toxicity|1|||
164371271|NCT02457598|593735929|FG011|Overall Study|Unacceptable Toxicity|0|||
164371272|NCT02457598|593735930|FG012|Overall Study|Unacceptable Toxicity|1|||
164371273|NCT02457598|593735931|FG013|Overall Study|Unacceptable Toxicity|1|||
164371274|NCT02457598|593735932|FG014|Overall Study|Unacceptable Toxicity|1|||
164371275|NCT02457598|593735933|FG015|Overall Study|Unacceptable Toxicity|0|||
164371276|NCT02457598|593735934|FG016|Overall Study|Unacceptable Toxicity|0|||
164371277|NCT02457598|593735918|FG000|Overall Study|Intercurrent Illness|0|||
164371278|NCT02457598|593735919|FG001|Overall Study|Intercurrent Illness|0|||
164371279|NCT02457598|593735920|FG002|Overall Study|Intercurrent Illness|0|||
164371280|NCT02457598|593735921|FG003|Overall Study|Intercurrent Illness|0|||
164371281|NCT02457598|593735922|FG004|Overall Study|Intercurrent Illness|0|||
164371282|NCT02457598|593735923|FG005|Overall Study|Intercurrent Illness|0|||
164371283|NCT02457598|593735924|FG006|Overall Study|Intercurrent Illness|0|||
164371284|NCT02457598|593735925|FG007|Overall Study|Intercurrent Illness|0|||
164371285|NCT02457598|593735926|FG008|Overall Study|Intercurrent Illness|0|||
164371286|NCT02457598|593735927|FG009|Overall Study|Intercurrent Illness|0|||
164371287|NCT02457598|593735928|FG010|Overall Study|Intercurrent Illness|1|||
164371288|NCT02457598|593735929|FG011|Overall Study|Intercurrent Illness|0|||
164371289|NCT02457598|593735930|FG012|Overall Study|Intercurrent Illness|0|||
164371290|NCT02457598|593735931|FG013|Overall Study|Intercurrent Illness|0|||
164371291|NCT02457598|593735932|FG014|Overall Study|Intercurrent Illness|0|||
164371292|NCT02457598|593735933|FG015|Overall Study|Intercurrent Illness|0|||
164371293|NCT02457598|593735934|FG016|Overall Study|Intercurrent Illness|0|||
164371294|NCT02457598|593735918|FG000|Overall Study|Protocol Violation|0|||
164371295|NCT02457598|593735919|FG001|Overall Study|Protocol Violation|0|||
164371296|NCT02457598|593735920|FG002|Overall Study|Protocol Violation|0|||
164371297|NCT02457598|593735921|FG003|Overall Study|Protocol Violation|0|||
164371298|NCT02457598|593735922|FG004|Overall Study|Protocol Violation|0|||
164371299|NCT02457598|593735923|FG005|Overall Study|Protocol Violation|0|||
164371300|NCT02457598|593735924|FG006|Overall Study|Protocol Violation|0|||
164371301|NCT02457598|593735925|FG007|Overall Study|Protocol Violation|0|||
164371302|NCT02457598|593735926|FG008|Overall Study|Protocol Violation|0|||
164371303|NCT02457598|593735927|FG009|Overall Study|Protocol Violation|0|||
164371304|NCT02457598|593735928|FG010|Overall Study|Protocol Violation|1|||
164371305|NCT02457598|593735929|FG011|Overall Study|Protocol Violation|0|||
164371306|NCT02457598|593735930|FG012|Overall Study|Protocol Violation|0|||
164371307|NCT02457598|593735931|FG013|Overall Study|Protocol Violation|0|||
164371308|NCT02457598|593735932|FG014|Overall Study|Protocol Violation|0|||
164371309|NCT02457598|593735933|FG015|Overall Study|Protocol Violation|0|||
164371310|NCT02457598|593735934|FG016|Overall Study|Protocol Violation|0|||
164371311|NCT03316885|593735941|FG000|Overall Study|Adverse Event|1|||
164371312|NCT03316885|593735941|FG000|Overall Study|Death|10|||
164371313|NCT03316885|593735941|FG000|Overall Study|Lost to Follow-up|4|||
164371314|NCT03316885|593735941|FG000|Overall Study|Withdrawal by Subject|9|||
164371315|NCT03316885|593735941|FG000|Overall Study|COVID related|8|||
164371316|NCT01736696|593735949|FG000|Overall Study|Withdrawal by Subject|0|||
164371317|NCT01736696|593735950|FG001|Overall Study|Withdrawal by Subject|0|||
164371318|NCT01736696|593735951|FG002|Overall Study|Withdrawal by Subject|1|||
164371319|NCT01736696|593735952|FG003|Overall Study|Withdrawal by Subject|0|||
164371320|NCT01736696|593735953|FG004|Overall Study|Withdrawal by Subject|0|||
164371321|NCT01736696|593735954|FG005|Overall Study|Withdrawal by Subject|0|||
164371322|NCT01736696|593735955|FG006|Overall Study|Withdrawal by Subject|0|||
164371323|NCT01116232|593735956|FG000|Overall Study|Progressive diease|4|||
164371324|NCT00405548|593735957|FG000|Overall Study|Cognitive Memory problems on study day|1|||
163902191|NCT05580003|592013108|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902192|NCT05580003|592013109|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902193|NCT05580003|592013110|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902194|NCT05580003|592013111|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902195|NCT05580003|592013112|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164371325|NCT00405548|593735958|FG001|Overall Study|Cognitive Memory problems on study day|0|||
164371326|NCT00405548|593735957|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
164371327|NCT00405548|593735958|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
164371328|NCT00405548|593735957|FG000|Overall Study|Unable to self-administer shots|1|||
164371329|NCT00405548|593735958|FG001|Overall Study|Unable to self-administer shots|0|||
164371330|NCT00405548|593735957|FG000|Overall Study|Venous access failed during study day|1|||
164371331|NCT00405548|593735958|FG001|Overall Study|Venous access failed during study day|0|||
164371332|NCT00405548|593735957|FG000|Overall Study|Withdrawal by Subject|1|||
164371333|NCT00405548|593735958|FG001|Overall Study|Withdrawal by Subject|0|||
164371334|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Death|3|||
164371335|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Death|2|||
164371336|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Death|0|||
164371337|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Death|0|||
164371338|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Death|0|||
164371339|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Death|0|||
164371340|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Death|0|||
164371341|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Death|0|||
164371342|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
164371343|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371344|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371345|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371346|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371347|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371348|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371349|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
164371350|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371351|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
164371352|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371353|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371354|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371355|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371356|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371357|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
164371358|NCT02036502|593735959|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
164371359|NCT02036502|593735960|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
164371360|NCT02036502|593735961|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
164371361|NCT02036502|593735962|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
164371362|NCT02036502|593735963|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
164371363|NCT02036502|593735964|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
164371364|NCT02036502|593735965|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
164371365|NCT02036502|593735966|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
164371366|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371367|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371368|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
164371369|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
164371370|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
164371371|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371372|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371373|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
164371374|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371375|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371376|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
164371377|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371378|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371379|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371380|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371381|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
164371382|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Death|0|||
164371383|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Death|0|||
164371384|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Death|1|||
164371385|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Death|0|||
164371386|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Death|0|||
164371387|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Death|0|||
164371388|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Death|0|||
164371389|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Death|0|||
164371390|NCT02036502|593735959|FG000|Part 2:Dose Confirmation|Not treated|0|||
164371391|NCT02036502|593735960|FG001|Part 2:Dose Confirmation|Not treated|0|||
164371392|NCT02036502|593735961|FG002|Part 2:Dose Confirmation|Not treated|0|||
164371393|NCT02036502|593735962|FG003|Part 2:Dose Confirmation|Not treated|1|||
164371394|NCT02036502|593735963|FG004|Part 2:Dose Confirmation|Not treated|0|||
164371395|NCT02036502|593735964|FG005|Part 2:Dose Confirmation|Not treated|0|||
164371396|NCT02036502|593735965|FG006|Part 2:Dose Confirmation|Not treated|0|||
164371397|NCT02036502|593735966|FG007|Part 2:Dose Confirmation|Not treated|0|||
164371398|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Adverse Event|0|||
164371399|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Adverse Event|0|||
164371400|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Adverse Event|0|||
164371401|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Adverse Event|0|||
164371402|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Adverse Event|0|||
164371403|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Adverse Event|4|||
164371404|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Adverse Event|0|||
164371405|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Adverse Event|2|||
164371406|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Death|0|||
164371407|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Death|0|||
164371408|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Death|0|||
164371409|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Death|0|||
164371410|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Death|0|||
164371411|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Death|24|||
164371412|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Death|0|||
164371413|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Death|3|||
164371414|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371415|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371416|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371417|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371418|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371419|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371420|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
164371421|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
164371422|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Physician Decision|0|||
164371423|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Physician Decision|0|||
164371424|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Physician Decision|0|||
164371425|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Physician Decision|0|||
164371426|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Physician Decision|0|||
164371427|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Physician Decision|1|||
164371428|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Physician Decision|0|||
164371429|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Physician Decision|0|||
164371430|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
164012535|NCT00494871|592410538|FG001|Follow-up (FU) Period|Adverse Event|1|||
164012536|NCT00494871|592410537|FG000|Follow-up (FU) Period|Death|13|||
164012537|NCT00494871|592410538|FG001|Follow-up (FU) Period|Death|12|||
164012538|NCT00494871|592410537|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
164012539|NCT00494871|592410538|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
164012540|NCT00494871|592410537|FG000|Follow-up (FU) Period|Physician Decision|0|||
164012541|NCT00494871|592410538|FG001|Follow-up (FU) Period|Physician Decision|1|||
164012542|NCT00494871|592410537|FG000|Follow-up (FU) Period|Protocol Violation|1|||
164012543|NCT00494871|592410538|FG001|Follow-up (FU) Period|Protocol Violation|0|||
164012544|NCT00494871|592410537|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
164371431|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
164371432|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
164371433|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
164371434|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
164371435|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
164371436|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
164371437|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
164371438|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371439|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371440|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371441|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371442|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371443|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
164371444|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
164371445|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
164371446|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371447|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371448|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371449|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371450|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
164371451|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
164371452|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
164371453|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
164371454|NCT02036502|593735959|FG000|Part 3:Dose Expansion|Not Treated|0|||
164371455|NCT02036502|593735960|FG001|Part 3:Dose Expansion|Not Treated|0|||
164371456|NCT02036502|593735961|FG002|Part 3:Dose Expansion|Not Treated|0|||
164371457|NCT02036502|593735962|FG003|Part 3:Dose Expansion|Not Treated|0|||
164371458|NCT02036502|593735963|FG004|Part 3:Dose Expansion|Not Treated|0|||
164371459|NCT02036502|593735964|FG005|Part 3:Dose Expansion|Not Treated|2|||
164371460|NCT02036502|593735965|FG006|Part 3:Dose Expansion|Not Treated|0|||
164371461|NCT02036502|593735966|FG007|Part 3:Dose Expansion|Not Treated|0|||
164371462|NCT00811577|593735972|FG000|Overall Study|Lost to Follow-up|7|||
164371463|NCT00811577|593735973|FG001|Overall Study|Lost to Follow-up|1|||
164371464|NCT00811577|593735972|FG000|Overall Study|Withdrawal by Subject|3|||
164371465|NCT00811577|593735973|FG001|Overall Study|Withdrawal by Subject|0|||
164371466|NCT04011410|593735974|FG000|Overall Study|Withdrawal by Subject|1|||
164371467|NCT01068509|593735975|FG000|Overall Study|Death|0|||
164371468|NCT01068509|593735976|FG001|Overall Study|Death|0|||
164371469|NCT01068509|593735977|FG002|Overall Study|Death|1|||
164371470|NCT01068509|593735975|FG000|Overall Study|Disease Progression|5|||
164371471|NCT01068509|593735976|FG001|Overall Study|Disease Progression|20|||
164371472|NCT01068509|593735977|FG002|Overall Study|Disease Progression|18|||
164371473|NCT01068509|593735975|FG000|Overall Study|Lost to Follow-up|1|||
164371474|NCT01068509|593735976|FG001|Overall Study|Lost to Follow-up|0|||
164371475|NCT01068509|593735977|FG002|Overall Study|Lost to Follow-up|0|||
164371476|NCT01068509|593735975|FG000|Overall Study|Withdrew Consent|0|||
164371477|NCT01068509|593735976|FG001|Overall Study|Withdrew Consent|1|||
164371478|NCT01068509|593735977|FG002|Overall Study|Withdrew Consent|2|||
164371479|NCT01068509|593735975|FG000|Overall Study|Reason Not Specified|0|||
164371480|NCT01068509|593735976|FG001|Overall Study|Reason Not Specified|1|||
164371481|NCT01068509|593735977|FG002|Overall Study|Reason Not Specified|0|||
164371482|NCT01455012|593735978|FG000|Overall Study|Adverse Event|0|||
164371483|NCT01455012|593735979|FG001|Overall Study|Adverse Event|2|||
164371484|NCT01455012|593735978|FG000|Overall Study|Lack of Efficacy|6|||
164371485|NCT01455012|593735979|FG001|Overall Study|Lack of Efficacy|1|||
164371486|NCT01455012|593735978|FG000|Overall Study|Withdrawal by Subject|3|||
164371487|NCT01455012|593735979|FG001|Overall Study|Withdrawal by Subject|1|||
164371488|NCT01455012|593735978|FG000|Overall Study|Unknown reason|2|||
164371489|NCT01455012|593735979|FG001|Overall Study|Unknown reason|0|||
164371490|NCT01418937|593735982|FG000|Overall Study|Lost to Follow-up|5|||
164371491|NCT01418937|593735982|FG000|Overall Study|Protocol Violation|1|||
164371492|NCT01418937|593735982|FG000|Overall Study|Pregnancy|1|||
164371493|NCT01418937|593735982|FG000|Overall Study|Withdrawal by Subject|1|||
164371494|NCT03323658|593736005|FG000|Overall Study|Adverse Event|0|||
164371495|NCT03323658|593736006|FG001|Overall Study|Adverse Event|1|||
164371496|NCT03323658|593736007|FG002|Overall Study|Adverse Event|0|||
164371497|NCT00615056|593736008|FG000|Overall Study|Death|31|||
164371498|NCT00615056|593736009|FG001|Overall Study|Death|31|||
164371499|NCT00615056|593736010|FG002|Overall Study|Death|21|||
164371500|NCT00615056|593736011|FG003|Overall Study|Death|23|||
164371501|NCT00615056|593736008|FG000|Overall Study|Lost to Follow-up|1|||
164371502|NCT00615056|593736009|FG001|Overall Study|Lost to Follow-up|2|||
164371503|NCT00615056|593736010|FG002|Overall Study|Lost to Follow-up|4|||
164371504|NCT00615056|593736011|FG003|Overall Study|Lost to Follow-up|5|||
164371505|NCT00615056|593736008|FG000|Overall Study|Other|13|||
164371506|NCT00615056|593736009|FG001|Overall Study|Other|15|||
164371507|NCT00615056|593736010|FG002|Overall Study|Other|10|||
164371508|NCT00615056|593736011|FG003|Overall Study|Other|7|||
164371509|NCT00615056|593736008|FG000|Overall Study|Objective progression or relapse|0|||
164012545|NCT00494871|592410538|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
164371510|NCT00615056|593736009|FG001|Overall Study|Objective progression or relapse|2|||
164371511|NCT00615056|593736010|FG002|Overall Study|Objective progression or relapse|0|||
164371512|NCT00615056|593736011|FG003|Overall Study|Objective progression or relapse|0|||
164371513|NCT00615056|593736008|FG000|Overall Study|Withdrawal by Subject|0|||
164371514|NCT00615056|593736009|FG001|Overall Study|Withdrawal by Subject|1|||
164371515|NCT00615056|593736010|FG002|Overall Study|Withdrawal by Subject|1|||
164371516|NCT00615056|593736011|FG003|Overall Study|Withdrawal by Subject|0|||
164371517|NCT00615056|593736008|FG000|Overall Study|Discontinued by Sponsor|1|||
164371518|NCT00615056|593736009|FG001|Overall Study|Discontinued by Sponsor|0|||
164371519|NCT00615056|593736010|FG002|Overall Study|Discontinued by Sponsor|0|||
164371520|NCT00615056|593736011|FG003|Overall Study|Discontinued by Sponsor|0|||
164371521|NCT00615056|593736008|FG000|Overall Study|Randomized but not treated|3|||
164371522|NCT00615056|593736009|FG001|Overall Study|Randomized but not treated|0|||
164371523|NCT00615056|593736010|FG002|Overall Study|Randomized but not treated|0|||
164371524|NCT00615056|593736011|FG003|Overall Study|Randomized but not treated|0|||
164371525|NCT00717769|593736012|FG000|Overall Study|Adverse Event|9|||
164371526|NCT00717769|593736013|FG001|Overall Study|Adverse Event|6|||
164371527|NCT00717769|593736014|FG002|Overall Study|Adverse Event|1|||
164371528|NCT00717769|593736012|FG000|Overall Study|Lack of compliance|0|||
164371529|NCT00717769|593736013|FG001|Overall Study|Lack of compliance|2|||
164371530|NCT00717769|593736014|FG002|Overall Study|Lack of compliance|0|||
164371531|NCT00717769|593736012|FG000|Overall Study|Lost to Follow-up|3|||
164371532|NCT00717769|593736013|FG001|Overall Study|Lost to Follow-up|4|||
164371533|NCT00717769|593736014|FG002|Overall Study|Lost to Follow-up|0|||
164371534|NCT00717769|593736012|FG000|Overall Study|Lack of Efficacy|1|||
164371535|NCT00717769|593736013|FG001|Overall Study|Lack of Efficacy|2|||
164371536|NCT00717769|593736014|FG002|Overall Study|Lack of Efficacy|0|||
164371537|NCT00717769|593736012|FG000|Overall Study|Protocol Violation|0|||
164371538|NCT00717769|593736013|FG001|Overall Study|Protocol Violation|2|||
164371539|NCT00717769|593736014|FG002|Overall Study|Protocol Violation|0|||
164371540|NCT00717769|593736012|FG000|Overall Study|Sponsor decision|1|||
164371541|NCT00717769|593736013|FG001|Overall Study|Sponsor decision|0|||
164371542|NCT00717769|593736014|FG002|Overall Study|Sponsor decision|10|||
164371543|NCT00717769|593736012|FG000|Overall Study|Withdrew consent|2|||
164371544|NCT00717769|593736013|FG001|Overall Study|Withdrew consent|2|||
164371545|NCT00717769|593736014|FG002|Overall Study|Withdrew consent|0|||
164371546|NCT01380184|593736017|FG000|Part 1 (19 Days)|Adverse Event|1|||
164371547|NCT01380184|593736017|FG000|Part 2|Adverse Event|5|||
164371548|NCT01380184|593736017|FG000|Part 2|Disease Progression|8|||
164371549|NCT01380184|593736017|FG000|Part 2|Lost to Follow-up|1|||
164371550|NCT00692770|593736021|FG000|Overall Study|Protocol Violation|2|||
164371551|NCT00692770|593736022|FG001|Overall Study|Protocol Violation|7|||
164371552|NCT00692770|593736021|FG000|Overall Study|Withdrawal by Subject|97|||
164371553|NCT00692770|593736022|FG001|Overall Study|Withdrawal by Subject|36|||
164371554|NCT00692770|593736021|FG000|Overall Study|Adverse Event|136|||
164371555|NCT00692770|593736022|FG001|Overall Study|Adverse Event|41|||
164371556|NCT00692770|593736021|FG000|Overall Study|Death|10|||
164371557|NCT00692770|593736022|FG001|Overall Study|Death|5|||
164371558|NCT00692770|593736021|FG000|Overall Study|Lost to Follow-up|7|||
164371559|NCT00692770|593736022|FG001|Overall Study|Lost to Follow-up|3|||
164371560|NCT00692770|593736021|FG000|Overall Study|Non-compliant with study medication|11|||
164371561|NCT00692770|593736022|FG001|Overall Study|Non-compliant with study medication|5|||
164371562|NCT00692770|593736021|FG000|Overall Study|Progression by clinical judgment|2|||
164371563|NCT00692770|593736022|FG001|Overall Study|Progression by clinical judgment|3|||
164371564|NCT00692770|593736021|FG000|Overall Study|Physician decision not protocol driven|10|||
164371565|NCT00692770|593736022|FG001|Overall Study|Physician decision not protocol driven|14|||
164371566|NCT00692770|593736021|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
164371567|NCT00692770|593736022|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
164012546|NCT00494871|592410537|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
164012547|NCT00494871|592410538|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
164012548|NCT03825042|592410539|FG000|Overall Study|Adverse Event|1|||
164012549|NCT03825042|592410540|FG001|Overall Study|Adverse Event|0|||
164012550|NCT03825042|592410539|FG000|Overall Study|Withdrawal by Subject|1|||
164371568|NCT00692770|593736021|FG000|Overall Study|Protocol driven decision point|3|||
164371569|NCT00692770|593736022|FG001|Overall Study|Protocol driven decision point|7|||
164371570|NCT00692770|593736021|FG000|Overall Study|Completed all planned assessments|79|||
164371571|NCT00692770|593736022|FG001|Overall Study|Completed all planned assessments|101|||
164371572|NCT00692770|593736021|FG000|Overall Study|Radiological and clinical progression|8|||
164371573|NCT00692770|593736022|FG001|Overall Study|Radiological and clinical progression|8|||
164012551|NCT03825042|592410540|FG001|Overall Study|Withdrawal by Subject|0|||
164012552|NCT00521339|592410542|FG000|Treatment Phase|Adverse Event|2|||
164371574|NCT00692770|593736021|FG000|Overall Study|Clinical endpoint reached|16|||
164371575|NCT00692770|593736022|FG001|Overall Study|Clinical endpoint reached|43|||
164371576|NCT00692770|593736021|FG000|Overall Study|Study terminated by sponsor|2|||
164371577|NCT00692770|593736022|FG001|Overall Study|Study terminated by sponsor|2|||
164371578|NCT00692770|593736021|FG000|Overall Study|Randomized but not treated|3|||
164371579|NCT00692770|593736022|FG001|Overall Study|Randomized but not treated|4|||
164371580|NCT04248816|593736023|FG000|Overall Study|Ineligible post-randomization|7|||
164371581|NCT04248816|593736024|FG001|Overall Study|Ineligible post-randomization|21|||
164012553|NCT00521339|592410543|FG001|Treatment Phase|Adverse Event|0|||
164371582|NCT04248816|593736025|FG002|Overall Study|Ineligible post-randomization|25|||
164371583|NCT04327986|593736026|FG000|Overall Study|Physician Decision|2|||
164371584|NCT04327986|593736027|FG001|Overall Study|Physician Decision|0|||
164371585|NCT04327986|593736028|FG002|Overall Study|Physician Decision|0|||
164371586|NCT04327986|593736026|FG000|Overall Study|Death|1|||
164012554|NCT00521339|592410544|FG002|Treatment Phase|Adverse Event|0|||
164371587|NCT04327986|593736027|FG001|Overall Study|Death|0|||
164371588|NCT04327986|593736028|FG002|Overall Study|Death|0|||
164371589|NCT03350503|593736032|FG000|Overall Study|Adverse Event|5|||
164371590|NCT03350503|593736032|FG000|Overall Study|Withdrawal by Subject|5|||
164371591|NCT03350503|593736032|FG000|Overall Study|Continuation impossible due to move|4|||
164371592|NCT03350503|593736032|FG000|Overall Study|Physician Decision|3|||
164371593|NCT03829046|593736035|FG000|Overall Study|Withdrawal by Subject|1|||
164371594|NCT03829046|593736036|FG001|Overall Study|Withdrawal by Subject|0|||
164371595|NCT00262067|593736037|FG000|Overall Study|Death|190|||
164371596|NCT00262067|593736038|FG001|Overall Study|Death|89|||
164371597|NCT00262067|593736039|FG002|Overall Study|Death|186|||
164371598|NCT00262067|593736040|FG003|Overall Study|Death|99|||
164371599|NCT00262067|593736037|FG000|Overall Study|Lost to Follow-up|5|||
164371600|NCT00262067|593736038|FG001|Overall Study|Lost to Follow-up|4|||
164371601|NCT00262067|593736039|FG002|Overall Study|Lost to Follow-up|7|||
164371602|NCT00262067|593736040|FG003|Overall Study|Lost to Follow-up|5|||
164371603|NCT00262067|593736037|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
164371604|NCT00262067|593736038|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
164371605|NCT00262067|593736039|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
164371606|NCT00262067|593736040|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
164371607|NCT00262067|593736037|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
164371608|NCT00262067|593736038|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
164371609|NCT00262067|593736039|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
164371610|NCT00262067|593736040|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
164371611|NCT04804813|593736041|FG000|Overall Study|Protocol Violation|2|||
164371612|NCT04804813|593736042|FG001|Overall Study|Protocol Violation|0|||
164371613|NCT04804813|593736041|FG000|Overall Study|Withdrawal by Subject|1|||
164371614|NCT04804813|593736042|FG001|Overall Study|Withdrawal by Subject|0|||
164371615|NCT01012817|593737861|FG000|Overall Study|Withdrawal by Subject|0|||
164371616|NCT01012817|593737862|FG001|Overall Study|Withdrawal by Subject|0|||
164371617|NCT01012817|593737863|FG002|Overall Study|Withdrawal by Subject|0|||
164371618|NCT01012817|593737864|FG003|Overall Study|Withdrawal by Subject|1|||
164371619|NCT01012817|593737865|FG004|Overall Study|Withdrawal by Subject|0|||
164371620|NCT01012817|593737866|FG005|Overall Study|Withdrawal by Subject|0|||
164371621|NCT01012817|593737867|FG006|Overall Study|Withdrawal by Subject|0|||
164371622|NCT01012817|593737868|FG007|Overall Study|Withdrawal by Subject|1|||
164371623|NCT01012817|593737869|FG008|Overall Study|Withdrawal by Subject|0|||
164371624|NCT01012817|593737870|FG009|Overall Study|Withdrawal by Subject|0|||
164371625|NCT01012817|593737871|FG010|Overall Study|Withdrawal by Subject|1|||
164371626|NCT01012817|593737872|FG011|Overall Study|Withdrawal by Subject|1|||
164371627|NCT01012817|593737873|FG012|Overall Study|Withdrawal by Subject|0|||
164371628|NCT01012817|593737874|FG013|Overall Study|Withdrawal by Subject|1|||
164371629|NCT01012817|593737861|FG000|Overall Study|Adverse Event|0|||
164371630|NCT01012817|593737862|FG001|Overall Study|Adverse Event|0|||
164371631|NCT01012817|593737863|FG002|Overall Study|Adverse Event|0|||
164371632|NCT01012817|593737864|FG003|Overall Study|Adverse Event|0|||
164371633|NCT01012817|593737865|FG004|Overall Study|Adverse Event|0|||
164371634|NCT01012817|593737866|FG005|Overall Study|Adverse Event|1|||
164371635|NCT01012817|593737867|FG006|Overall Study|Adverse Event|0|||
164371636|NCT01012817|593737868|FG007|Overall Study|Adverse Event|0|||
164371637|NCT01012817|593737869|FG008|Overall Study|Adverse Event|0|||
164371638|NCT01012817|593737870|FG009|Overall Study|Adverse Event|0|||
164371639|NCT01012817|593737871|FG010|Overall Study|Adverse Event|1|||
164371640|NCT01012817|593737872|FG011|Overall Study|Adverse Event|0|||
164371641|NCT01012817|593737873|FG012|Overall Study|Adverse Event|0|||
164371642|NCT01012817|593737874|FG013|Overall Study|Adverse Event|1|||
164371643|NCT00634647|593737875|FG000|Overall Study|death on study|3|||
164371644|NCT00634647|593737875|FG000|Overall Study|refused further treatment|3|||
164371645|NCT00634647|593737875|FG000|Overall Study|declined to participate before treatment|1|||
164371646|NCT01700179|593737876|FG000|Overall Study|Physician Decision|2|||
164371647|NCT01896895|593737877|FG000|Double-blind MP|Physician Decision|0|||
164371648|NCT01896895|593737878|FG001|Double-blind MP|Physician Decision|0|||
164371649|NCT01896895|593737879|FG002|Double-blind MP|Physician Decision|1|||
164371650|NCT01896895|593737880|FG003|Double-blind MP|Physician Decision|0|||
164371651|NCT01896895|593737877|FG000|Double-blind MP|Withdrawal by Subject|0|||
164371652|NCT01896895|593737878|FG001|Double-blind MP|Withdrawal by Subject|2|||
164371653|NCT01896895|593737879|FG002|Double-blind MP|Withdrawal by Subject|1|||
164371654|NCT01896895|593737880|FG003|Double-blind MP|Withdrawal by Subject|0|||
164371655|NCT01896895|593737877|FG000|Double-blind MP|Lost to Follow-up|1|||
164371656|NCT01896895|593737878|FG001|Double-blind MP|Lost to Follow-up|0|||
164371657|NCT01896895|593737879|FG002|Double-blind MP|Lost to Follow-up|1|||
164371658|NCT01896895|593737880|FG003|Double-blind MP|Lost to Follow-up|0|||
164371659|NCT03277846|593737881|FG000|Overall Study|Inpatient stay too brief|12|||
164371660|NCT03277846|593737882|FG001|Overall Study|Inpatient stay too brief|11|||
164371661|NCT01207778|593737883|FG000|Overall Study|Lost to Follow-up|0|||
164371662|NCT01207778|593737884|FG001|Overall Study|Lost to Follow-up|3|||
164371663|NCT01207778|593737885|FG002|Overall Study|Lost to Follow-up|3|||
164371664|NCT05168475|593737888|FG000|Period 1|Protocol Violation|1|||
164371665|NCT05168475|593737888|FG000|Period 1|IMP shortage|2|||
164371666|NCT05168475|593737888|FG000|Period 1|Not randomised|2|||
164371667|NCT05168475|593737888|FG000|Period 2|IMP shortage|1|||
164371668|NCT01589822|593737889|FG000|Overall Study|Withdrawal by Subject|1|||
164371669|NCT01589822|593737890|FG001|Overall Study|Withdrawal by Subject|2|||
164371670|NCT01589822|593737891|FG002|Overall Study|Withdrawal by Subject|0|||
164371671|NCT01589822|593737889|FG000|Overall Study|Death|1|||
164371672|NCT01589822|593737890|FG001|Overall Study|Death|0|||
164371673|NCT01589822|593737891|FG002|Overall Study|Death|0|||
164371674|NCT01589822|593737889|FG000|Overall Study|Missed 90 day visit|2|||
164371675|NCT01589822|593737890|FG001|Overall Study|Missed 90 day visit|1|||
164371676|NCT01589822|593737891|FG002|Overall Study|Missed 90 day visit|1|||
164371677|NCT00646204|593737892|FG000|Overall Study|Adverse Event|3|||
164371678|NCT00646204|593737893|FG001|Overall Study|Adverse Event|0|||
164371679|NCT00646204|593737892|FG000|Overall Study|Withdrawal by Subject|1|||
164371680|NCT00646204|593737893|FG001|Overall Study|Withdrawal by Subject|0|||
164371681|NCT00773175|593737903|FG000|Overall Study|Adverse Event|2|||
164371682|NCT00773175|593737904|FG001|Overall Study|Adverse Event|0|||
164371683|NCT00773175|593737903|FG000|Overall Study|Consent Withdrawn|0|||
164371684|NCT00773175|593737904|FG001|Overall Study|Consent Withdrawn|2|||
164371685|NCT00503841|593737905|FG000|Overall Study|All screen failures|44|||
164371686|NCT01302964|593737906|FG000|Overall Study|Adverse Event|1|||
164371687|NCT01302964|593737907|FG001|Overall Study|Adverse Event|0|||
164371688|NCT05723770|593737908|FG000|Overall Study|Lost to Follow-up|4|||
164371689|NCT05723770|593737908|FG000|Overall Study|Withdrawal by Subject|2|||
164371690|NCT01945489|593737909|FG000|Cycle 1|Adverse Event|2|||
164371691|NCT01945489|593737910|FG001|Cycle 1|Adverse Event|0|||
164371692|NCT01945489|593737909|FG000|Cycle 1|Lost to Follow-up|4|||
164371693|NCT01945489|593737910|FG001|Cycle 1|Lost to Follow-up|0|||
164371694|NCT01945489|593737909|FG000|Cycle 1|Personal Reasons|4|||
164371695|NCT01945489|593737910|FG001|Cycle 1|Personal Reasons|2|||
164371696|NCT01945489|593737909|FG000|Cycle 1|Protocol Violation|0|||
164371697|NCT01945489|593737910|FG001|Cycle 1|Protocol Violation|1|||
164371698|NCT01945489|593737909|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
164371699|NCT01945489|593737910|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
164371700|NCT01945489|593737909|FG000|Cycle 2|Adverse Event|1|||
164371701|NCT01945489|593737910|FG001|Cycle 2|Adverse Event|0|||
164371702|NCT01945489|593737909|FG000|Cycle 2|Lost to Follow-up|0|||
164371703|NCT01945489|593737910|FG001|Cycle 2|Lost to Follow-up|1|||
164371704|NCT00394212|593737913|FG000|Overall Study|Lost to Follow-up|3|||
164371705|NCT00394212|593737914|FG001|Overall Study|Lost to Follow-up|0|||
164371706|NCT00394212|593737913|FG000|Overall Study|Withdrawal by Subject|4|||
164371707|NCT00394212|593737914|FG001|Overall Study|Withdrawal by Subject|1|||
164371708|NCT00596011|593737916|FG000|Overall Study|Withdrawal by Subject|2|||
164371709|NCT00596011|593737917|FG001|Overall Study|Withdrawal by Subject|3|||
164371710|NCT00596011|593737916|FG000|Overall Study|Adverse Event|11|||
164371711|NCT00596011|593737917|FG001|Overall Study|Adverse Event|7|||
164371712|NCT02347527|593737918|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
164371713|NCT02347527|593737919|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
164371714|NCT02347527|593737920|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
164371715|NCT02347527|593737921|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
163902196|NCT05580003|592013113|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902197|NCT05580003|592013114|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164371716|NCT02347527|593737918|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
164371717|NCT02347527|593737919|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
164371718|NCT02347527|593737920|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
164371719|NCT02347527|593737921|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
164371720|NCT02347527|593737918|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
163902198|NCT05580003|592013115|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164371721|NCT02347527|593737919|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
164371722|NCT02347527|593737920|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
164371723|NCT02347527|593737921|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
163902199|NCT05580003|592013116|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164371724|NCT02347527|593737918|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
164371725|NCT02347527|593737919|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
164371726|NCT02347527|593737920|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
163902200|NCT05580003|592013117|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
164371727|NCT02347527|593737921|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
164371728|NCT02347527|593737918|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
164371729|NCT02347527|593737919|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
164371730|NCT02347527|593737920|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
164371731|NCT02347527|593737921|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
164371732|NCT01466270|593737926|FG000|Overall Study|Withdrawal by Subject|4|||
164371733|NCT01466270|593737927|FG001|Overall Study|Withdrawal by Subject|1|||
164371734|NCT01466270|593737926|FG000|Overall Study|Physician Decision|1|||
164371735|NCT01466270|593737927|FG001|Overall Study|Physician Decision|0|||
164371736|NCT01466270|593737926|FG000|Overall Study|Lost to Follow-up|1|||
164371737|NCT01466270|593737927|FG001|Overall Study|Lost to Follow-up|3|||
164371738|NCT01466270|593737926|FG000|Overall Study|Progression|1|||
164371739|NCT01466270|593737927|FG001|Overall Study|Progression|0|||
164371740|NCT01466270|593737926|FG000|Overall Study|Toxicity|4|||
164371741|NCT01466270|593737927|FG001|Overall Study|Toxicity|1|||
164371742|NCT01466270|593737926|FG000|Overall Study|Multiple|1|||
164371743|NCT01466270|593737927|FG001|Overall Study|Multiple|1|||
164371744|NCT00749775|593737934|FG000|Overall Study|Protocol Violation|24|||
164371745|NCT00749775|593737934|FG000|Overall Study|Lost to Follow-up|36|||
164371746|NCT00749775|593737934|FG000|Overall Study|No visit after first day of treatment|44|||
164371747|NCT00749775|593737934|FG000|Overall Study|No drug administration|3|||
164371748|NCT03364049|593737945|FG000|Overall Study|Death|6|||
164371749|NCT03364049|593737946|FG001|Overall Study|Death|4|||
164371750|NCT03364049|593737947|FG002|Overall Study|Death|5|||
164371751|NCT03364049|593737948|FG003|Overall Study|Death|14|||
164371752|NCT03364049|593737945|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
164371753|NCT03364049|593737946|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
164371754|NCT03364049|593737947|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
164371755|NCT03364049|593737948|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
164371756|NCT03364049|593737945|FG000|Overall Study|Withdrawal by Subject|0|||
164371757|NCT03364049|593737946|FG001|Overall Study|Withdrawal by Subject|1|||
164371758|NCT03364049|593737947|FG002|Overall Study|Withdrawal by Subject|1|||
164371759|NCT03364049|593737948|FG003|Overall Study|Withdrawal by Subject|1|||
164371760|NCT01340976|593737951|FG000|Overall Study|Physician Decision|2|||
164371761|NCT01340976|593737952|FG001|Overall Study|Physician Decision|0|||
164371762|NCT01340976|593737953|FG002|Overall Study|Physician Decision|1|||
164371763|NCT01340976|593737954|FG003|Overall Study|Physician Decision|1|||
164371764|NCT01340976|593737955|FG004|Overall Study|Physician Decision|1|||
164371765|NCT01340976|593737956|FG005|Overall Study|Physician Decision|0|||
164371766|NCT01340976|593737951|FG000|Overall Study|Death|0|||
164371767|NCT01340976|593737952|FG001|Overall Study|Death|1|||
164371768|NCT01340976|593737953|FG002|Overall Study|Death|0|||
164371769|NCT01340976|593737954|FG003|Overall Study|Death|0|||
164371770|NCT01340976|593737955|FG004|Overall Study|Death|0|||
164371771|NCT01340976|593737956|FG005|Overall Study|Death|0|||
164371772|NCT01340976|593737951|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
164371773|NCT01340976|593737952|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371774|NCT01340976|593737953|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371775|NCT01340976|593737954|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371776|NCT01340976|593737955|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371777|NCT01340976|593737956|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
164371778|NCT01340976|593737951|FG000|Overall Study|Withdrawal by Subject|0|||
164371779|NCT01340976|593737952|FG001|Overall Study|Withdrawal by Subject|0|||
164371780|NCT01340976|593737953|FG002|Overall Study|Withdrawal by Subject|0|||
164371781|NCT01340976|593737954|FG003|Overall Study|Withdrawal by Subject|1|||
164371782|NCT01340976|593737955|FG004|Overall Study|Withdrawal by Subject|1|||
164371783|NCT01340976|593737956|FG005|Overall Study|Withdrawal by Subject|0|||
164371784|NCT01340976|593737951|FG000|Overall Study|Other anemia treatment|1|||
164371785|NCT01340976|593737952|FG001|Overall Study|Other anemia treatment|0|||
164371786|NCT01340976|593737953|FG002|Overall Study|Other anemia treatment|2|||
164371787|NCT01340976|593737954|FG003|Overall Study|Other anemia treatment|1|||
164371788|NCT01340976|593737955|FG004|Overall Study|Other anemia treatment|0|||
164371789|NCT01340976|593737956|FG005|Overall Study|Other anemia treatment|1|||
164371790|NCT01340976|593737951|FG000|Overall Study|Adverse Event|0|||
164371791|NCT01340976|593737952|FG001|Overall Study|Adverse Event|1|||
164371792|NCT01340976|593737953|FG002|Overall Study|Adverse Event|0|||
164371793|NCT01340976|593737954|FG003|Overall Study|Adverse Event|0|||
164371794|NCT01340976|593737955|FG004|Overall Study|Adverse Event|0|||
164371795|NCT01340976|593737956|FG005|Overall Study|Adverse Event|0|||
164371796|NCT02953821|593737957|FG000|Overall Study|Adverse Event|0|||
164371797|NCT02953821|593737958|FG001|Overall Study|Adverse Event|4|||
164371798|NCT02953821|593737957|FG000|Overall Study|Death|1|||
164371799|NCT02953821|593737958|FG001|Overall Study|Death|0|||
164371800|NCT02953821|593737957|FG000|Overall Study|Progressive Disease|5|||
164371801|NCT02953821|593737958|FG001|Overall Study|Progressive Disease|1|||
164371802|NCT02953821|593737957|FG000|Overall Study|Lost to Follow-up|2|||
164371803|NCT02953821|593737958|FG001|Overall Study|Lost to Follow-up|0|||
164371804|NCT02953821|593737957|FG000|Overall Study|Physician Decision|1|||
164371805|NCT02953821|593737958|FG001|Overall Study|Physician Decision|1|||
164371806|NCT02953821|593737957|FG000|Overall Study|Withdrawal by Subject|3|||
164371807|NCT02953821|593737958|FG001|Overall Study|Withdrawal by Subject|3|||
164371808|NCT02953821|593737957|FG000|Overall Study|Change of address|0|||
164371809|NCT02953821|593737958|FG001|Overall Study|Change of address|1|||
164371810|NCT02953821|593737957|FG000|Overall Study|Lack of Efficacy|1|||
164371811|NCT02953821|593737958|FG001|Overall Study|Lack of Efficacy|0|||
164371812|NCT02953821|593737957|FG000|Overall Study|Out of state for indeterminate time|0|||
164371813|NCT02953821|593737958|FG001|Overall Study|Out of state for indeterminate time|1|||
164371814|NCT02953821|593737957|FG000|Overall Study|No improvement|0|||
164371815|NCT02953821|593737958|FG001|Overall Study|No improvement|1|||
164371816|NCT02953821|593737957|FG000|Overall Study|Refused follow-up visit|2|||
164371817|NCT02953821|593737958|FG001|Overall Study|Refused follow-up visit|1|||
164371818|NCT03064126|593737959|FG000|Overall Study|Death|40|||
164371819|NCT03064126|593737960|FG001|Overall Study|Death|16|||
164371820|NCT03064126|593737961|FG002|Overall Study|Death|4|||
164371821|NCT03064126|593737962|FG003|Overall Study|Death|2|||
164371822|NCT03064126|593737959|FG000|Overall Study|Withdrawal by Subject|17|||
164371823|NCT03064126|593737960|FG001|Overall Study|Withdrawal by Subject|9|||
164371824|NCT03064126|593737961|FG002|Overall Study|Withdrawal by Subject|0|||
164371825|NCT03064126|593737962|FG003|Overall Study|Withdrawal by Subject|2|||
164371826|NCT03064126|593737959|FG000|Overall Study|Lost to Follow-up|7|||
164371827|NCT03064126|593737960|FG001|Overall Study|Lost to Follow-up|3|||
164371828|NCT03064126|593737961|FG002|Overall Study|Lost to Follow-up|0|||
164371829|NCT03064126|593737962|FG003|Overall Study|Lost to Follow-up|0|||
164371830|NCT03064126|593737959|FG000|Overall Study|Adverse Event|2|||
164371831|NCT03064126|593737960|FG001|Overall Study|Adverse Event|0|||
164371832|NCT03064126|593737961|FG002|Overall Study|Adverse Event|0|||
164371833|NCT03064126|593737962|FG003|Overall Study|Adverse Event|0|||
164371834|NCT03064126|593737959|FG000|Overall Study|Physician Decision|3|||
164371835|NCT03064126|593737960|FG001|Overall Study|Physician Decision|0|||
164371836|NCT03064126|593737961|FG002|Overall Study|Physician Decision|0|||
164371837|NCT03064126|593737962|FG003|Overall Study|Physician Decision|0|||
164371838|NCT03064126|593737959|FG000|Overall Study|Other reason for early termination|3|||
164371839|NCT03064126|593737960|FG001|Overall Study|Other reason for early termination|2|||
164371840|NCT03064126|593737961|FG002|Overall Study|Other reason for early termination|0|||
164371841|NCT03064126|593737962|FG003|Overall Study|Other reason for early termination|0|||
164371842|NCT03064126|593737959|FG000|Overall Study|Missed Visit|3|||
164371843|NCT03064126|593737960|FG001|Overall Study|Missed Visit|1|||
164371844|NCT03064126|593737961|FG002|Overall Study|Missed Visit|0|||
164371845|NCT03064126|593737962|FG003|Overall Study|Missed Visit|0|||
164371846|NCT03907683|593737968|FG000|Overall Study|Pregnancy|1|||
164371847|NCT03907683|593737968|FG000|Overall Study|Withdrawal by Subject|1|||
164371848|NCT03400332|593737969|FG000|Pre-Treatment|Other reasons|0|||
164371849|NCT03400332|593737970|FG001|Pre-Treatment|Other reasons|0|||
164371850|NCT03400332|593737971|FG002|Pre-Treatment|Other reasons|0|||
164371851|NCT03400332|593737972|FG003|Pre-Treatment|Other reasons|0|||
164371852|NCT03400332|593737973|FG004|Pre-Treatment|Other reasons|0|||
164371853|NCT03400332|593737974|FG005|Pre-Treatment|Other reasons|0|||
164371854|NCT03400332|593737975|FG006|Pre-Treatment|Other reasons|0|||
164371855|NCT03400332|593737976|FG007|Pre-Treatment|Other reasons|0|||
164371856|NCT03400332|593737977|FG008|Pre-Treatment|Other reasons|1|||
164371857|NCT03400332|593737969|FG000|Pre-Treatment|No longer met study criteria|0|||
164371858|NCT03400332|593737970|FG001|Pre-Treatment|No longer met study criteria|0|||
164371859|NCT03400332|593737971|FG002|Pre-Treatment|No longer met study criteria|0|||
164371860|NCT03400332|593737972|FG003|Pre-Treatment|No longer met study criteria|0|||
164371861|NCT03400332|593737973|FG004|Pre-Treatment|No longer met study criteria|0|||
164371862|NCT03400332|593737974|FG005|Pre-Treatment|No longer met study criteria|0|||
164371863|NCT03400332|593737975|FG006|Pre-Treatment|No longer met study criteria|0|||
164371864|NCT03400332|593737976|FG007|Pre-Treatment|No longer met study criteria|0|||
164371865|NCT03400332|593737977|FG008|Pre-Treatment|No longer met study criteria|1|||
164371866|NCT03400332|593737969|FG000|Pre-Treatment|Withdrawal by Subject|0|||
164371867|NCT03400332|593737970|FG001|Pre-Treatment|Withdrawal by Subject|0|||
164371868|NCT03400332|593737971|FG002|Pre-Treatment|Withdrawal by Subject|0|||
164371869|NCT03400332|593737972|FG003|Pre-Treatment|Withdrawal by Subject|0|||
164371870|NCT03400332|593737973|FG004|Pre-Treatment|Withdrawal by Subject|0|||
164371871|NCT03400332|593737974|FG005|Pre-Treatment|Withdrawal by Subject|0|||
164371872|NCT03400332|593737975|FG006|Pre-Treatment|Withdrawal by Subject|0|||
164371873|NCT03400332|593737976|FG007|Pre-Treatment|Withdrawal by Subject|0|||
164371874|NCT03400332|593737977|FG008|Pre-Treatment|Withdrawal by Subject|1|||
164371875|NCT03400332|593737969|FG000|Treatment|Participant withdrew consent|2|||
164371876|NCT03400332|593737970|FG001|Treatment|Participant withdrew consent|2|||
164371877|NCT03400332|593737971|FG002|Treatment|Participant withdrew consent|0|||
164371878|NCT03400332|593737972|FG003|Treatment|Participant withdrew consent|0|||
164371879|NCT03400332|593737973|FG004|Treatment|Participant withdrew consent|3|||
164371880|NCT03400332|593737974|FG005|Treatment|Participant withdrew consent|3|||
164371881|NCT03400332|593737975|FG006|Treatment|Participant withdrew consent|1|||
164371882|NCT03400332|593737976|FG007|Treatment|Participant withdrew consent|1|||
164371883|NCT03400332|593737977|FG008|Treatment|Participant withdrew consent|1|||
164371884|NCT03400332|593737969|FG000|Treatment|Other reasons|0|||
164371885|NCT03400332|593737970|FG001|Treatment|Other reasons|1|||
164371886|NCT03400332|593737971|FG002|Treatment|Other reasons|1|||
164371887|NCT03400332|593737972|FG003|Treatment|Other reasons|0|||
164371888|NCT03400332|593737973|FG004|Treatment|Other reasons|3|||
164371889|NCT03400332|593737974|FG005|Treatment|Other reasons|1|||
164371890|NCT03400332|593737975|FG006|Treatment|Other reasons|2|||
164371891|NCT03400332|593737976|FG007|Treatment|Other reasons|0|||
164371892|NCT03400332|593737977|FG008|Treatment|Other reasons|1|||
164371893|NCT03400332|593737969|FG000|Treatment|Lost to Follow-up|0|||
164371894|NCT03400332|593737970|FG001|Treatment|Lost to Follow-up|1|||
164371895|NCT03400332|593737971|FG002|Treatment|Lost to Follow-up|0|||
164371896|NCT03400332|593737972|FG003|Treatment|Lost to Follow-up|0|||
164371897|NCT03400332|593737973|FG004|Treatment|Lost to Follow-up|0|||
164371898|NCT03400332|593737974|FG005|Treatment|Lost to Follow-up|0|||
164371899|NCT03400332|593737975|FG006|Treatment|Lost to Follow-up|0|||
164371900|NCT03400332|593737976|FG007|Treatment|Lost to Follow-up|0|||
164371901|NCT03400332|593737977|FG008|Treatment|Lost to Follow-up|0|||
164371902|NCT03400332|593737969|FG000|Treatment|Death|3|||
164371903|NCT03400332|593737970|FG001|Treatment|Death|1|||
164371904|NCT03400332|593737971|FG002|Treatment|Death|2|||
164371905|NCT03400332|593737972|FG003|Treatment|Death|3|||
164371906|NCT03400332|593737973|FG004|Treatment|Death|6|||
164371907|NCT03400332|593737974|FG005|Treatment|Death|2|||
164371908|NCT03400332|593737975|FG006|Treatment|Death|1|||
164371909|NCT03400332|593737976|FG007|Treatment|Death|3|||
164371910|NCT03400332|593737977|FG008|Treatment|Death|6|||
164371911|NCT00048542|593737978|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164371912|NCT00048542|593737979|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
164371913|NCT00048542|593737980|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164371914|NCT00048542|593737981|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164012555|NCT00521339|592410542|FG000|Treatment Phase|Intolerability to study drug|2|||
164012556|NCT00521339|592410543|FG001|Treatment Phase|Intolerability to study drug|0|||
164012557|NCT00521339|592410544|FG002|Treatment Phase|Intolerability to study drug|0|||
164012558|NCT00521339|592410542|FG000|Treatment Phase|Lack of Efficacy|3|||
164371915|NCT00048542|593737982|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164371916|NCT00048542|593737983|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
164371917|NCT00048542|593737984|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
164371918|NCT00048542|593737985|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
164371919|NCT00048542|593737978|FG000|Double-Blind Phase|Protocol Violation|0|||
164371920|NCT00048542|593737979|FG001|Double-Blind Phase|Protocol Violation|0|||
164371921|NCT00048542|593737980|FG002|Double-Blind Phase|Protocol Violation|1|||
164371922|NCT00048542|593737981|FG003|Double-Blind Phase|Protocol Violation|0|||
164371923|NCT00048542|593737982|FG004|Double-Blind Phase|Protocol Violation|0|||
164371924|NCT00048542|593737983|FG005|Double-Blind Phase|Protocol Violation|0|||
164012559|NCT00521339|592410543|FG001|Treatment Phase|Lack of Efficacy|0|||
164371925|NCT00048542|593737984|FG006|Double-Blind Phase|Protocol Violation|0|||
164371926|NCT00048542|593737985|FG007|Double-Blind Phase|Protocol Violation|0|||
164371927|NCT00048542|593737978|FG000|Double-Blind Phase|Sponsor request or decision|2|||
164371928|NCT00048542|593737979|FG001|Double-Blind Phase|Sponsor request or decision|0|||
164371929|NCT00048542|593737980|FG002|Double-Blind Phase|Sponsor request or decision|0|||
164371930|NCT00048542|593737981|FG003|Double-Blind Phase|Sponsor request or decision|0|||
164371931|NCT00048542|593737982|FG004|Double-Blind Phase|Sponsor request or decision|0|||
164371932|NCT00048542|593737983|FG005|Double-Blind Phase|Sponsor request or decision|0|||
164371933|NCT00048542|593737984|FG006|Double-Blind Phase|Sponsor request or decision|0|||
164012560|NCT00521339|592410544|FG002|Treatment Phase|Lack of Efficacy|0|||
164012561|NCT00521339|592410542|FG000|Treatment Phase|Withdrawal by Subject|3|||
164012562|NCT00521339|592410543|FG001|Treatment Phase|Withdrawal by Subject|0|||
164371934|NCT00048542|593737985|FG007|Double-Blind Phase|Sponsor request or decision|0|||
164371935|NCT00048542|593737978|FG000|Double-Blind Phase|Randomized in error|1|||
164371936|NCT00048542|593737979|FG001|Double-Blind Phase|Randomized in error|0|||
164371937|NCT00048542|593737980|FG002|Double-Blind Phase|Randomized in error|0|||
164371938|NCT00048542|593737981|FG003|Double-Blind Phase|Randomized in error|0|||
164371939|NCT00048542|593737982|FG004|Double-Blind Phase|Randomized in error|0|||
164371940|NCT00048542|593737983|FG005|Double-Blind Phase|Randomized in error|0|||
164371941|NCT00048542|593737984|FG006|Double-Blind Phase|Randomized in error|0|||
164371942|NCT00048542|593737985|FG007|Double-Blind Phase|Randomized in error|0|||
164371943|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371944|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371945|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371946|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371947|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
164371948|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
164371949|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371950|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
164371951|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371952|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371953|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371954|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371955|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371956|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
164371957|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371958|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
164371959|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371960|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371961|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371962|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371963|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
164371964|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
164371965|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371966|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
164371967|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
164371968|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
164371969|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
164371970|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
164371971|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
164371972|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
164371973|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
164371974|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
164371975|NCT00048542|593737978|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371976|NCT00048542|593737979|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371977|NCT00048542|593737980|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371978|NCT00048542|593737981|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371979|NCT00048542|593737982|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
164371980|NCT00048542|593737983|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
164371981|NCT00048542|593737984|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371982|NCT00048542|593737985|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
164371983|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371984|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371985|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371986|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371987|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371988|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
164371989|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
164371990|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
164371991|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371992|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371993|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371994|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371995|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371996|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
164371997|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
164371998|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
164371999|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372000|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372001|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372002|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372003|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372004|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
164372005|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
164372006|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
164372007|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372008|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372009|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372010|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372011|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372012|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
164372013|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
164372014|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
164372015|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372016|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372017|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372018|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372019|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372020|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
164372021|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
164372022|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
164372023|NCT00048542|593737978|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372024|NCT00048542|593737979|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372025|NCT00048542|593737980|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372026|NCT00048542|593737981|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372027|NCT00048542|593737982|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372028|NCT00048542|593737983|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
164372029|NCT00048542|593737984|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
164372030|NCT00048542|593737985|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
164372031|NCT04033159|593737990|FG000|Washout Period|Physician Decision|0|||
164372032|NCT04033159|593737991|FG001|Washout Period|Physician Decision|1|||
164372033|NCT04033159|593737992|FG002|Washout Period|Physician Decision|0|||
164372034|NCT04033159|593737990|FG000|Washout Period|Study terminated by Sponsor|0|||
164372035|NCT04033159|593737991|FG001|Washout Period|Study terminated by Sponsor|7|||
164372036|NCT04033159|593737992|FG002|Washout Period|Study terminated by Sponsor|0|||
164372037|NCT04033159|593737990|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
164372038|NCT04033159|593737991|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
164372039|NCT04033159|593737992|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
164372040|NCT02027844|593737993|FG000|Overall Study|Withdrawal by Subject|3|||
164372041|NCT02027844|593737994|FG001|Overall Study|Withdrawal by Subject|2|||
164372042|NCT02027844|593737995|FG002|Overall Study|Withdrawal by Subject|1|||
164372043|NCT02027844|593737993|FG000|Overall Study|Lost to Follow-up|0|||
164372044|NCT02027844|593737994|FG001|Overall Study|Lost to Follow-up|2|||
164372045|NCT02027844|593737995|FG002|Overall Study|Lost to Follow-up|1|||
164372046|NCT02027844|593737993|FG000|Overall Study|Protocol Violation|0|||
164372047|NCT02027844|593737994|FG001|Overall Study|Protocol Violation|2|||
164372048|NCT02027844|593737995|FG002|Overall Study|Protocol Violation|0|||
164372049|NCT02027844|593737993|FG000|Overall Study|Incomlete data|2|||
164372050|NCT02027844|593737994|FG001|Overall Study|Incomlete data|0|||
164372051|NCT02027844|593737995|FG002|Overall Study|Incomlete data|0|||
164372052|NCT01452412|593738006|FG000|Overall Study|Withdrawal by Subject|15|||
164372053|NCT01452412|593738007|FG001|Overall Study|Withdrawal by Subject|11|||
164372054|NCT01452412|593738006|FG000|Overall Study|Adverse Event|4|||
164372055|NCT01452412|593738007|FG001|Overall Study|Adverse Event|3|||
164372056|NCT01452412|593738006|FG000|Overall Study|Lost to Follow-up|5|||
164372057|NCT01452412|593738007|FG001|Overall Study|Lost to Follow-up|3|||
164372058|NCT01452412|593738006|FG000|Overall Study|Death|1|||
164372059|NCT01452412|593738007|FG001|Overall Study|Death|0|||
164372060|NCT01452412|593738006|FG000|Overall Study|Initiated dialysis|1|||
164372061|NCT01452412|593738007|FG001|Overall Study|Initiated dialysis|0|||
164372062|NCT01452412|593738006|FG000|Overall Study|Other|2|||
164012563|NCT00521339|592410544|FG002|Treatment Phase|Withdrawal by Subject|0|||
164012564|NCT00521339|592410542|FG000|Treatment Phase|Lost to Follow-up|1|||
164372063|NCT01452412|593738007|FG001|Overall Study|Other|0|||
164372064|NCT02346136|593738008|FG000|Overall Study|Withdrawal by Subject|7|||
164372065|NCT02346136|593738009|FG001|Overall Study|Withdrawal by Subject|5|||
164372066|NCT02346136|593738008|FG000|Overall Study|Death|1|||
164372067|NCT02346136|593738009|FG001|Overall Study|Death|0|||
164372068|NCT02346136|593738008|FG000|Overall Study|Study termination|14|||
164372069|NCT02346136|593738009|FG001|Overall Study|Study termination|18|||
164012565|NCT00521339|592410543|FG001|Treatment Phase|Lost to Follow-up|0|||
164012566|NCT00521339|592410544|FG002|Treatment Phase|Lost to Follow-up|0|||
164372070|NCT03047135|593738010|FG000|Overall Study|Still being treated|3|||
164012567|NCT00521339|592410542|FG000|Treatment Phase|Protocol Violation|1|||
164012568|NCT00521339|592410543|FG001|Treatment Phase|Protocol Violation|0|||
164012569|NCT00521339|592410544|FG002|Treatment Phase|Protocol Violation|0|||
164372071|NCT00323414|593738011|FG000|Overall Study|Withdrawal by Subject|0|||
164372072|NCT00323414|593738012|FG001|Overall Study|Withdrawal by Subject|1|||
164372073|NCT04382911|593738013|FG000|Overall Study|unable to be imaged prior to surgery|2|||
164372074|NCT05619692|593738020|FG000|Overall Study|Adverse Event|2|||
164372075|NCT05619692|593738021|FG001|Overall Study|Adverse Event|2|||
164372076|NCT05619692|593738020|FG000|Overall Study|Withdrawal by Participant|3|||
164372077|NCT05619692|593738021|FG001|Overall Study|Withdrawal by Participant|4|||
164372078|NCT05619692|593738020|FG000|Overall Study|Lost to Follow-up|2|||
164372079|NCT05619692|593738021|FG001|Overall Study|Lost to Follow-up|1|||
164372080|NCT05619692|593738020|FG000|Overall Study|Randomized but not treated|1|||
164372081|NCT05619692|593738021|FG001|Overall Study|Randomized but not treated|3|||
164372082|NCT02703636|593738023|FG000|Overall Study|Adverse Event|14|||
164012570|NCT00521339|592410542|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
164012571|NCT00521339|592410543|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
164372083|NCT02703636|593738023|FG000|Overall Study|Study stopped by sponsor|1|||
164372084|NCT02703636|593738023|FG000|Overall Study|Withdrawal by Subject|1|||
164372085|NCT01224639|593738027|FG000|Overall Study|Withdrawal by Subject|0|||
164372086|NCT01224639|593738028|FG001|Overall Study|Withdrawal by Subject|0|||
164372087|NCT01224639|593738029|FG002|Overall Study|Withdrawal by Subject|0|||
164372088|NCT01224639|593738030|FG003|Overall Study|Withdrawal by Subject|0|||
164372089|NCT01224639|593738031|FG004|Overall Study|Withdrawal by Subject|2|||
164372090|NCT01224639|593738032|FG005|Overall Study|Withdrawal by Subject|0|||
164372091|NCT01224639|593738033|FG006|Overall Study|Withdrawal by Subject|1|||
164372092|NCT01224639|593738034|FG007|Overall Study|Withdrawal by Subject|1|||
164372093|NCT01224639|593738027|FG000|Overall Study|Adverse Event|0|||
164372094|NCT01224639|593738028|FG001|Overall Study|Adverse Event|0|||
164372095|NCT01224639|593738029|FG002|Overall Study|Adverse Event|0|||
164372096|NCT01224639|593738030|FG003|Overall Study|Adverse Event|0|||
164372097|NCT01224639|593738031|FG004|Overall Study|Adverse Event|0|||
164372098|NCT01224639|593738032|FG005|Overall Study|Adverse Event|0|||
164372099|NCT01224639|593738033|FG006|Overall Study|Adverse Event|0|||
164372100|NCT01224639|593738034|FG007|Overall Study|Adverse Event|1|||
164372101|NCT04656132|593738035|FG000|Overall Study|Lost to Follow-up|4|||
164372102|NCT04656132|593738035|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
164372103|NCT04365699|593738036|FG000|Overall Study|Death|2|||
164372104|NCT04365699|593738037|FG001|Overall Study|Death|5|||
164372105|NCT04365699|593738038|FG002|Overall Study|Death|15|||
164372106|NCT02196324|593738041|FG000|Overall Study|Withdrawal by Subject|8|||
164372107|NCT02196324|593738042|FG001|Overall Study|Withdrawal by Subject|4|||
164372108|NCT02196324|593738041|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
164372109|NCT02196324|593738042|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
164372110|NCT02196324|593738041|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
164372111|NCT02196324|593738042|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
164372112|NCT02196324|593738041|FG000|Overall Study|Other|1|||
164372113|NCT02196324|593738042|FG001|Overall Study|Other|0|||
164372114|NCT00834912|593738043|FG000|Treatment Period 1|Adverse Event|0|||
164372115|NCT00834912|593738044|FG001|Treatment Period 1|Adverse Event|1|||
164372116|NCT00834912|593738045|FG002|Treatment Period 1|Adverse Event|0|||
164372117|NCT00834912|593738046|FG003|Treatment Period 1|Adverse Event|1|||
164372118|NCT00834912|593738047|FG004|Treatment Period 1|Adverse Event|0|||
164372119|NCT00834912|593738048|FG005|Treatment Period 1|Adverse Event|0|||
164372120|NCT00834912|593738043|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164372121|NCT00834912|593738044|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164372122|NCT00834912|593738045|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164372123|NCT00834912|593738046|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164372124|NCT00834912|593738047|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164012572|NCT00521339|592410544|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
164012573|NCT00521339|592410542|FG000|Treatment Extension Phase|Death|0|||
164012574|NCT00521339|592410543|FG001|Treatment Extension Phase|Death|0|||
164012575|NCT00521339|592410544|FG002|Treatment Extension Phase|Death|1|||
164372125|NCT00834912|593738048|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164372126|NCT01399593|593738052|FG000|Overall Study|Physician Decision|1|||
164372127|NCT01399593|593738053|FG001|Overall Study|Physician Decision|0|||
164372128|NCT01399593|593738052|FG000|Overall Study|Adverse Event|1|||
164372129|NCT01399593|593738053|FG001|Overall Study|Adverse Event|0|||
164372130|NCT01399593|593738052|FG000|Overall Study|Death|1|||
164372131|NCT01399593|593738053|FG001|Overall Study|Death|1|||
164372132|NCT01399593|593738052|FG000|Overall Study|Transplantectomy|0|||
164372133|NCT01399593|593738053|FG001|Overall Study|Transplantectomy|1|||
164372134|NCT00344773|593738055|FG000|Overall Study|Adverse Event|2|||
164372135|NCT00344773|593738055|FG000|Overall Study|Objective Disease Progression|16|||
164012576|NCT03314519|592410545|FG000|Overall Study|Protocol Violation|3|||
164372136|NCT00344773|593738055|FG000|Overall Study|Withdrawal by Subject|1|||
164372137|NCT00344773|593738055|FG000|Overall Study|Not Eligible for the study|2|||
164372138|NCT02849548|593738063|FG000|Overall Study|Lost to Follow-up|1|||
164012577|NCT03314519|592410546|FG001|Overall Study|Protocol Violation|2|||
164372139|NCT02849548|593738064|FG001|Overall Study|Lost to Follow-up|2|||
164372140|NCT02849548|593738063|FG000|Overall Study|Protocol Violation|1|||
164372141|NCT02849548|593738064|FG001|Overall Study|Protocol Violation|0|||
164372142|NCT00714259|593738065|FG000|Overall Study|Death|2|||
164372143|NCT02357147|593738066|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
164372144|NCT02357147|593738067|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
164372145|NCT02357147|593738066|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
164372146|NCT02357147|593738067|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
164372147|NCT02357147|593738066|FG000|Combination Treatment Phase|Investigator Discretion|1|||
164372148|NCT02357147|593738067|FG001|Combination Treatment Phase|Investigator Discretion|1|||
164372149|NCT02357147|593738066|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
164372150|NCT02357147|593738067|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
164372151|NCT02357147|593738066|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
164372152|NCT02357147|593738067|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
164372153|NCT02357147|593738066|FG000|Combination Treatment Phase|Adverse Event|12|||
164372154|NCT02357147|593738067|FG001|Combination Treatment Phase|Adverse Event|4|||
164372155|NCT02357147|593738066|FG000|Combination Treatment Phase|Death|1|||
164372156|NCT02357147|593738067|FG001|Combination Treatment Phase|Death|1|||
164372157|NCT02357147|593738066|FG000|Combination Treatment Phase|Sponsor Decision|0|||
163902201|NCT05580003|592013118|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902202|NCT05580003|592013119|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902203|NCT05580003|592013120|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902204|NCT05580003|592013121|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902205|NCT05580003|592013122|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902206|NCT05580003|592013123|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902207|NCT05580003|592013124|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902208|NCT05580003|592013125|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
163902209|NCT05580003|592013098|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902210|NCT05580003|592013099|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902211|NCT05580003|592013100|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902212|NCT05580003|592013101|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
163902213|NCT05580003|592013102|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902214|NCT05580003|592013103|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902215|NCT05580003|592013104|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902216|NCT05580003|592013105|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902217|NCT05580003|592013106|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902218|NCT05580003|592013107|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902219|NCT05580003|592013108|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902220|NCT05580003|592013109|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902221|NCT05580003|592013110|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902222|NCT05580003|592013111|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902223|NCT05580003|592013112|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902224|NCT05580003|592013113|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902225|NCT05580003|592013114|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902226|NCT05580003|592013115|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902227|NCT05580003|592013116|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902228|NCT05580003|592013117|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902229|NCT05580003|592013118|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902230|NCT05580003|592013119|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902231|NCT05580003|592013120|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902232|NCT05580003|592013121|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902233|NCT05580003|592013122|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902234|NCT05580003|592013123|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902235|NCT05580003|592013124|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902236|NCT05580003|592013125|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
163902237|NCT05580003|592013098|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902238|NCT05580003|592013099|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
163902239|NCT05580003|592013100|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902240|NCT05580003|592013101|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902241|NCT05580003|592013102|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902242|NCT05580003|592013103|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902243|NCT05580003|592013104|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902244|NCT05580003|592013105|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164092766|NCT02130466|592702143|FG010|Overall Study|Lost to Follow-up|0|||
164372158|NCT02357147|593738067|FG001|Combination Treatment Phase|Sponsor Decision|12|||
163902245|NCT05580003|592013106|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902246|NCT05580003|592013107|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164372159|NCT02357147|593738066|FG000|Combination Treatment Phase|Other|1|||
164372160|NCT02357147|593738067|FG001|Combination Treatment Phase|Other|0|||
164372161|NCT02357147|593738066|FG000|Combination Treatment Phase|Not treated|0|||
164372162|NCT02357147|593738067|FG001|Combination Treatment Phase|Not treated|2|||
164092767|NCT02130466|592702144|FG011|Overall Study|Lost to Follow-up|0|||
164372163|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
164372164|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
164372165|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164372166|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
164372167|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
164372168|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
164372169|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Adverse Event|0|||
164372170|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Adverse Event|3|||
164372171|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
164372172|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
164372173|NCT02357147|593738066|FG000|Maintenance Treatment Phase|Not Treated|1|||
164372174|NCT02357147|593738067|FG001|Maintenance Treatment Phase|Not Treated|0|||
164372175|NCT02177266|593739830|FG000|Overall Study|Adverse Event|0|||
164372176|NCT02177266|593739831|FG001|Overall Study|Adverse Event|1|||
164372177|NCT02177266|593739830|FG000|Overall Study|Withdrawal by Subject|1|||
164372178|NCT02177266|593739831|FG001|Overall Study|Withdrawal by Subject|0|||
164372179|NCT03019627|593739832|FG000|Overall Study|Adverse Event|8|||
164372180|NCT03019627|593739833|FG001|Overall Study|Adverse Event|0|||
164372181|NCT03019627|593739832|FG000|Overall Study|Unrelated to adverse event|1|||
164372182|NCT03019627|593739833|FG001|Overall Study|Unrelated to adverse event|3|||
164372183|NCT03019627|593739832|FG000|Overall Study|Lost to Follow-up|2|||
164372184|NCT03019627|593739833|FG001|Overall Study|Lost to Follow-up|1|||
164372185|NCT03019627|593739832|FG000|Overall Study|not compliance|2|||
164372186|NCT03019627|593739833|FG001|Overall Study|not compliance|2|||
164372187|NCT03019627|593739832|FG000|Overall Study|Other|2|||
164372188|NCT03019627|593739833|FG001|Overall Study|Other|2|||
164372189|NCT05107128|593739834|FG000|Overall Study|Adverse Event|2|||
164372190|NCT05107128|593739835|FG001|Overall Study|Adverse Event|0|||
164372191|NCT05107128|593739834|FG000|Overall Study|Withdrawal by Subject|3|||
164372192|NCT05107128|593739835|FG001|Overall Study|Withdrawal by Subject|3|||
164372193|NCT05107128|593739834|FG000|Overall Study|Withdrawal of Consent|0|||
164372194|NCT05107128|593739835|FG001|Overall Study|Withdrawal of Consent|1|||
164372195|NCT05107128|593739834|FG000|Overall Study|Reason Not Specified|2|||
164372196|NCT05107128|593739835|FG001|Overall Study|Reason Not Specified|0|||
164372197|NCT03761628|593739836|FG000|Overall Study|Withdrawal by Subject|3|||
164372198|NCT03761628|593739836|FG000|Overall Study|Physician Decision|1|||
164372199|NCT03761628|593739836|FG000|Overall Study|Pregnancy|1|||
164372200|NCT03761628|593739836|FG000|Overall Study|Lost to Follow-up|1|||
164372201|NCT01470469|593739839|FG000|Overall Study|Withdrawal by Subject|4|||
164372202|NCT01470469|593739840|FG001|Overall Study|Withdrawal by Subject|6|||
164372203|NCT01470469|593739839|FG000|Overall Study|Lack of Efficacy|1|||
164372204|NCT01470469|593739840|FG001|Overall Study|Lack of Efficacy|7|||
164372205|NCT01470469|593739839|FG000|Overall Study|Adverse Event|0|||
164372206|NCT01470469|593739840|FG001|Overall Study|Adverse Event|7|||
164372207|NCT01470469|593739839|FG000|Overall Study|Lost to Follow-up|2|||
164372208|NCT01470469|593739840|FG001|Overall Study|Lost to Follow-up|2|||
164372209|NCT01470469|593739839|FG000|Overall Study|Protocol Violation|1|||
164372210|NCT01470469|593739840|FG001|Overall Study|Protocol Violation|1|||
164372211|NCT01470469|593739839|FG000|Overall Study|Other|2|||
164372212|NCT01470469|593739840|FG001|Overall Study|Other|1|||
164372213|NCT05459129|593739841|FG000|Overall Study|Death|1|||
164372214|NCT05459129|593739842|FG001|Overall Study|Death|0|||
164372215|NCT05459129|593739841|FG000|Overall Study|Study Terminated By Sponsor|5|||
164372216|NCT05459129|593739842|FG001|Overall Study|Study Terminated By Sponsor|6|||
164372217|NCT04649151|593739850|FG000|Overall Study|Pregnancy|0|||
164372218|NCT04649151|593739851|FG001|Overall Study|Pregnancy|0|||
164372219|NCT04649151|593739852|FG002|Overall Study|Pregnancy|0|||
164372220|NCT04649151|593739853|FG003|Overall Study|Pregnancy|0|||
164372221|NCT04649151|593739854|FG004|Overall Study|Pregnancy|3|||
164372222|NCT04649151|593739850|FG000|Overall Study|Physician Decision|10|||
164092768|NCT02130466|592702145|FG012|Overall Study|Lost to Follow-up|1|||
164092769|NCT02130466|592702146|FG013|Overall Study|Lost to Follow-up|0|||
164092770|NCT02130466|592702133|FG000|Overall Study|Physician Decision|0|||
164092771|NCT02130466|592702134|FG001|Overall Study|Physician Decision|0|||
164372223|NCT04649151|593739851|FG001|Overall Study|Physician Decision|0|||
164372224|NCT04649151|593739852|FG002|Overall Study|Physician Decision|0|||
164372225|NCT04649151|593739853|FG003|Overall Study|Physician Decision|1|||
164372226|NCT04649151|593739854|FG004|Overall Study|Physician Decision|1|||
164372227|NCT04649151|593739850|FG000|Overall Study|Protocol Deviation|25|||
164372228|NCT04649151|593739851|FG001|Overall Study|Protocol Deviation|3|||
164372229|NCT04649151|593739852|FG002|Overall Study|Protocol Deviation|0|||
164372230|NCT04649151|593739853|FG003|Overall Study|Protocol Deviation|0|||
164372231|NCT04649151|593739854|FG004|Overall Study|Protocol Deviation|0|||
164372232|NCT04649151|593739850|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
164092772|NCT02130466|592702135|FG002|Overall Study|Physician Decision|0|||
164092773|NCT02130466|592702136|FG003|Overall Study|Physician Decision|0|||
164372233|NCT04649151|593739851|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
164372234|NCT04649151|593739852|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
164372235|NCT04649151|593739853|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
164372236|NCT04649151|593739854|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
164372237|NCT04649151|593739850|FG000|Overall Study|Withdrawal by Subject|370|||
164372238|NCT04649151|593739851|FG001|Overall Study|Withdrawal by Subject|113|||
164372239|NCT04649151|593739852|FG002|Overall Study|Withdrawal by Subject|2|||
164372240|NCT04649151|593739853|FG003|Overall Study|Withdrawal by Subject|7|||
164372241|NCT04649151|593739854|FG004|Overall Study|Withdrawal by Subject|15|||
164372242|NCT04649151|593739850|FG000|Overall Study|Adverse Event|1|||
164372243|NCT04649151|593739851|FG001|Overall Study|Adverse Event|0|||
164372244|NCT04649151|593739852|FG002|Overall Study|Adverse Event|0|||
164372245|NCT04649151|593739853|FG003|Overall Study|Adverse Event|0|||
164372246|NCT04649151|593739854|FG004|Overall Study|Adverse Event|0|||
164372247|NCT04649151|593739850|FG000|Overall Study|Lost to Follow-up|256|||
164372248|NCT04649151|593739851|FG001|Overall Study|Lost to Follow-up|29|||
164372249|NCT04649151|593739852|FG002|Overall Study|Lost to Follow-up|10|||
164372250|NCT04649151|593739853|FG003|Overall Study|Lost to Follow-up|3|||
164372251|NCT04649151|593739854|FG004|Overall Study|Lost to Follow-up|6|||
164372252|NCT04649151|593739850|FG000|Overall Study|Other than specified|59|||
164372253|NCT04649151|593739851|FG001|Overall Study|Other than specified|294|||
164372254|NCT04649151|593739852|FG002|Overall Study|Other than specified|0|||
164372255|NCT04649151|593739853|FG003|Overall Study|Other than specified|0|||
164372256|NCT04649151|593739854|FG004|Overall Study|Other than specified|4|||
164372257|NCT04649151|593739850|FG000|Overall Study|Death|0|||
164372258|NCT04649151|593739851|FG001|Overall Study|Death|0|||
164372259|NCT04649151|593739852|FG002|Overall Study|Death|0|||
164372260|NCT04649151|593739853|FG003|Overall Study|Death|0|||
164372261|NCT04649151|593739854|FG004|Overall Study|Death|1|||
164372262|NCT03752619|593739855|FG000|Overall Study|Lost to Follow-up|2|||
164372263|NCT03752619|593739856|FG001|Overall Study|Lost to Follow-up|1|||
164372264|NCT03752619|593739855|FG000|Overall Study|Withdrawal by Subject|1|||
164372265|NCT03752619|593739856|FG001|Overall Study|Withdrawal by Subject|1|||
164372266|NCT03752619|593739855|FG000|Overall Study|Adverse Event|0|||
164372267|NCT03752619|593739856|FG001|Overall Study|Adverse Event|1|||
164372268|NCT04476017|593739857|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
164372269|NCT04476017|593739858|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
164372270|NCT03362502|593739859|FG000|Overall Study|Death|0|||
164372271|NCT03362502|593739860|FG001|Overall Study|Death|0|||
164372272|NCT03362502|593739861|FG002|Overall Study|Death|1|||
164372273|NCT03795610|593739864|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
164372274|NCT03795610|593739864|FG000|Overall Study|Withdrawal by Subject|1|||
164372275|NCT03795610|593739864|FG000|Overall Study|Screen Failure (Unknown)|1|||
164372276|NCT02775344|593739865|FG000|Overall Study|No ovarian cyst identified|3|||
164372277|NCT02775344|593739866|FG001|Overall Study|No ovarian cyst identified|2|||
164372278|NCT03909165|593739877|FG000|Overall Study|Physician Decision|0|||
164372279|NCT03909165|593739878|FG001|Overall Study|Physician Decision|1|||
164372280|NCT03909165|593739879|FG002|Overall Study|Physician Decision|0|||
164372281|NCT03909165|593739880|FG003|Overall Study|Physician Decision|0|||
164372282|NCT03909165|593739881|FG004|Overall Study|Physician Decision|0|||
164372283|NCT03909165|593739877|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
163902247|NCT05580003|592013108|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902248|NCT05580003|592013109|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164372284|NCT03909165|593739878|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164372285|NCT03909165|593739879|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164372286|NCT03909165|593739880|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164372287|NCT03909165|593739881|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164372288|NCT03909165|593739877|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164372289|NCT03909165|593739878|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
164372290|NCT03909165|593739879|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
164372291|NCT03909165|593739880|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
164372292|NCT03909165|593739881|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
164372293|NCT03909165|593739877|FG000|Overall Study|Previous Drug Exposure|0|||
164372294|NCT03909165|593739878|FG001|Overall Study|Previous Drug Exposure|0|||
163902249|NCT05580003|592013110|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902250|NCT05580003|592013111|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902251|NCT05580003|592013112|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902252|NCT05580003|592013113|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902253|NCT05580003|592013114|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902254|NCT05580003|592013115|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902255|NCT05580003|592013116|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902256|NCT05580003|592013117|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902257|NCT05580003|592013118|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164092774|NCT02130466|592702137|FG004|Overall Study|Physician Decision|0|||
164372295|NCT03909165|593739879|FG002|Overall Study|Previous Drug Exposure|1|||
164372296|NCT03909165|593739880|FG003|Overall Study|Previous Drug Exposure|0|||
164372297|NCT03909165|593739881|FG004|Overall Study|Previous Drug Exposure|0|||
164372298|NCT03909165|593739877|FG000|Overall Study|Early Discharge|1|||
164372299|NCT03909165|593739878|FG001|Overall Study|Early Discharge|0|||
164372300|NCT03909165|593739879|FG002|Overall Study|Early Discharge|0|||
164372301|NCT03909165|593739880|FG003|Overall Study|Early Discharge|0|||
164372302|NCT03909165|593739881|FG004|Overall Study|Early Discharge|0|||
164372303|NCT06034496|593739882|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
164372304|NCT06034496|593739883|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
164372305|NCT06034496|593739882|FG000|Overall Study|Withdrawal by Subject|5|||
164372306|NCT06034496|593739883|FG001|Overall Study|Withdrawal by Subject|4|||
164372307|NCT02018458|593739884|FG000|Overall Study|Death|4|||
164372308|NCT03277261|593739891|FG000|Overall Study|Adverse Event|17|||
164372309|NCT03277261|593739892|FG001|Overall Study|Adverse Event|1|||
164372310|NCT03277261|593739891|FG000|Overall Study|Participant Withdrawal of Consent|6|||
164372311|NCT03277261|593739892|FG001|Overall Study|Participant Withdrawal of Consent|15|||
164372312|NCT03277261|593739891|FG000|Overall Study|Investigator / Sponsor Decision|4|||
164372313|NCT03277261|593739892|FG001|Overall Study|Investigator / Sponsor Decision|2|||
164372314|NCT03277261|593739891|FG000|Overall Study|Pregnancy|2|||
164372315|NCT03277261|593739892|FG001|Overall Study|Pregnancy|0|||
164372316|NCT03277261|593739891|FG000|Overall Study|Lost to Follow-up|2|||
164372317|NCT03277261|593739892|FG001|Overall Study|Lost to Follow-up|2|||
164372318|NCT03277261|593739891|FG000|Overall Study|Lack of Efficacy|2|||
164372319|NCT03277261|593739892|FG001|Overall Study|Lack of Efficacy|2|||
164372320|NCT03277261|593739891|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
164372321|NCT03277261|593739892|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
164372322|NCT03762083|593739893|FG000|Overall Study|Withdrawal by Subject|2|||
164372323|NCT03762083|593739893|FG000|Overall Study|Physician Decision|1|||
164372324|NCT01203072|593739894|FG000|Overall Study|Adverse Event|5|||
164372325|NCT01203072|593739895|FG001|Overall Study|Adverse Event|3|||
164372326|NCT01203072|593739896|FG002|Overall Study|Adverse Event|2|||
164372327|NCT01203072|593739897|FG003|Overall Study|Adverse Event|4|||
164372328|NCT01203072|593739898|FG004|Overall Study|Adverse Event|2|||
164372329|NCT01203072|593739894|FG000|Overall Study|Lack of Efficacy|1|||
164372330|NCT01203072|593739895|FG001|Overall Study|Lack of Efficacy|0|||
164372331|NCT01203072|593739896|FG002|Overall Study|Lack of Efficacy|0|||
164372332|NCT01203072|593739897|FG003|Overall Study|Lack of Efficacy|0|||
164372333|NCT01203072|593739898|FG004|Overall Study|Lack of Efficacy|0|||
164372334|NCT01203072|593739894|FG000|Overall Study|Lost to Follow-up|0|||
164372335|NCT01203072|593739895|FG001|Overall Study|Lost to Follow-up|1|||
164372336|NCT01203072|593739896|FG002|Overall Study|Lost to Follow-up|0|||
164372337|NCT01203072|593739897|FG003|Overall Study|Lost to Follow-up|0|||
164372338|NCT01203072|593739898|FG004|Overall Study|Lost to Follow-up|0|||
164372339|NCT01203072|593739894|FG000|Overall Study|Protocol Violation|2|||
164372340|NCT01203072|593739895|FG001|Overall Study|Protocol Violation|0|||
164372341|NCT01203072|593739896|FG002|Overall Study|Protocol Violation|0|||
164372342|NCT01203072|593739897|FG003|Overall Study|Protocol Violation|0|||
164372343|NCT01203072|593739898|FG004|Overall Study|Protocol Violation|1|||
164372344|NCT01203072|593739894|FG000|Overall Study|Withdrawal by Subject|2|||
164372345|NCT01203072|593739895|FG001|Overall Study|Withdrawal by Subject|2|||
164372346|NCT01203072|593739896|FG002|Overall Study|Withdrawal by Subject|1|||
163902258|NCT05580003|592013119|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902259|NCT05580003|592013120|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
164372347|NCT01203072|593739897|FG003|Overall Study|Withdrawal by Subject|2|||
164372348|NCT01203072|593739898|FG004|Overall Study|Withdrawal by Subject|3|||
164372349|NCT00235872|593739899|FG000|Overall Study|Adverse Event|34|||
164372350|NCT00235872|593739899|FG000|Overall Study|Death|1|||
164372351|NCT00235872|593739899|FG000|Overall Study|Lost to Follow-up|1|||
164372352|NCT00235872|593739899|FG000|Overall Study|Withdrawal by Subject|50|||
164372353|NCT00235872|593739899|FG000|Overall Study|Administrative reason|61|||
164372354|NCT00116558|593739900|FG000|Overall Study|Death|11|||
164372355|NCT00116558|593739901|FG001|Overall Study|Death|5|||
164372356|NCT00116558|593739902|FG002|Overall Study|Death|3|||
163902260|NCT05580003|592013121|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902261|NCT05580003|592013122|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902262|NCT05580003|592013123|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902263|NCT05580003|592013124|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902264|NCT05580003|592013125|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
163902265|NCT05580003|592013098|FG000|Part 2 (up to 10 Days)|Other|0|||
163902266|NCT05580003|592013099|FG001|Part 2 (up to 10 Days)|Other|0|||
163902267|NCT05580003|592013100|FG002|Part 2 (up to 10 Days)|Other|0|||
164372357|NCT00116558|593739900|FG000|Overall Study|Withdrawal by Subject|17|||
164372358|NCT00116558|593739901|FG001|Overall Study|Withdrawal by Subject|3|||
164372359|NCT00116558|593739902|FG002|Overall Study|Withdrawal by Subject|12|||
164372360|NCT00116558|593739900|FG000|Overall Study|disease progression|3|||
164372361|NCT00116558|593739901|FG001|Overall Study|disease progression|7|||
164372362|NCT00116558|593739902|FG002|Overall Study|disease progression|18|||
164372363|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
164372364|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
164372365|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Graft loss|1|||
164372366|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Graft loss|2|||
164372367|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Death|5|||
164372368|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Death|3|||
164372369|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
164372370|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
164372371|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
164372372|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
164372373|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
164372374|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
164372375|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
164372376|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
164372377|NCT00378014|593739903|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
164372378|NCT00378014|593739904|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
164372379|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
164372380|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
164372381|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Death|1|||
164372382|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Death|2|||
164372383|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
164372384|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
164372385|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
164372386|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
164372387|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
164372388|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
164372389|NCT00378014|593739903|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
164372390|NCT00378014|593739904|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
164372391|NCT00414661|593739905|FG000|Overall Study|Death|2|||
164372392|NCT00414661|593739906|FG001|Overall Study|Death|5|||
164372393|NCT00414661|593739907|FG002|Overall Study|Death|0|||
164372394|NCT00414661|593739908|FG003|Overall Study|Death|0|||
164372395|NCT00414661|593739905|FG000|Overall Study|Lost to Follow-up|1|||
164372396|NCT00414661|593739906|FG001|Overall Study|Lost to Follow-up|4|||
164372397|NCT00414661|593739907|FG002|Overall Study|Lost to Follow-up|0|||
164372398|NCT00414661|593739908|FG003|Overall Study|Lost to Follow-up|1|||
164372399|NCT00414661|593739905|FG000|Overall Study|Withdrawal by Subject|5|||
164372400|NCT00414661|593739906|FG001|Overall Study|Withdrawal by Subject|2|||
164372401|NCT00414661|593739907|FG002|Overall Study|Withdrawal by Subject|2|||
164372402|NCT00414661|593739908|FG003|Overall Study|Withdrawal by Subject|2|||
164372403|NCT00414661|593739905|FG000|Overall Study|Other|6|||
164372404|NCT00414661|593739906|FG001|Overall Study|Other|3|||
164372405|NCT00414661|593739907|FG002|Overall Study|Other|0|||
164372406|NCT00414661|593739908|FG003|Overall Study|Other|0|||
164372407|NCT02852265|593739912|FG000|3-month Follow-up|Lost to Follow-up|1|||
164372408|NCT02852265|593739913|FG001|3-month Follow-up|Lost to Follow-up|1|||
164372409|NCT01143090|593739914|FG000|Overall Study|Lack of Efficacy|2|||
164372410|NCT01143090|593739914|FG000|Overall Study|Adverse Event|17|||
164372411|NCT01143090|593739914|FG000|Overall Study|Lost to Follow-up|9|||
164372412|NCT01143090|593739914|FG000|Overall Study|Protocol Violation|2|||
164372413|NCT01143090|593739914|FG000|Overall Study|Withdrawal by Subject|18|||
164372414|NCT01143090|593739914|FG000|Overall Study|Non-compliance with study drug|1|||
164372415|NCT01143090|593739914|FG000|Overall Study|Failure to meet eligibility criteria|1|||
164372416|NCT01143090|593739914|FG000|Overall Study|Administrative|1|||
164372417|NCT01800916|593739917|FG000|Test Period 1 (1 Week)|Convex product user|0|||
164372418|NCT01800916|593739918|FG001|Test Period 1 (1 Week)|Convex product user|0|||
164372419|NCT01800916|593739919|FG002|Test Period 1 (1 Week)|Convex product user|0|||
164372420|NCT01800916|593739920|FG003|Test Period 1 (1 Week)|Convex product user|1|||
164372421|NCT01800916|593739921|FG004|Test Period 1 (1 Week)|Convex product user|0|||
164372422|NCT01800916|593739922|FG005|Test Period 1 (1 Week)|Convex product user|0|||
164372423|NCT01800916|593739923|FG006|Test Period 1 (1 Week)|Convex product user|0|||
164012578|NCT04003155|592410549|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
164012579|NCT04003155|592410550|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
164372424|NCT01800916|593739924|FG007|Test Period 1 (1 Week)|Convex product user|0|||
164372425|NCT01800916|593739925|FG008|Test Period 1 (1 Week)|Convex product user|0|||
164372426|NCT01800916|593739917|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
164372427|NCT01800916|593739918|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
164372428|NCT01800916|593739919|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
164372429|NCT01800916|593739920|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
164372430|NCT01800916|593739921|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
164372431|NCT01800916|593739922|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
164372432|NCT01800916|593739923|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
164372433|NCT01800916|593739924|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
164372434|NCT01800916|593739925|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
164372435|NCT00727714|593739933|FG000|Overall Study|Lost to Follow-up|2|||
164372436|NCT00325234|593739936|FG000|Overall Study|Adverse Event|10|||
164372437|NCT00325234|593739937|FG001|Overall Study|Adverse Event|7|||
164372438|NCT00325234|593739936|FG000|Overall Study|Death due to Study Disease|1|||
164372439|NCT00325234|593739937|FG001|Overall Study|Death due to Study Disease|0|||
164372440|NCT00325234|593739936|FG000|Overall Study|Entry Criteria Not Met|1|||
164372441|NCT00325234|593739937|FG001|Overall Study|Entry Criteria Not Met|2|||
164372442|NCT00325234|593739936|FG000|Overall Study|Subject Decision|6|||
164372443|NCT00325234|593739937|FG001|Overall Study|Subject Decision|8|||
164372444|NCT00325234|593739936|FG000|Overall Study|Physician Decision|17|||
164372445|NCT00325234|593739937|FG001|Overall Study|Physician Decision|12|||
164372446|NCT00325234|593739936|FG000|Overall Study|Progressive Disease|34|||
164372447|NCT00325234|593739937|FG001|Overall Study|Progressive Disease|37|||
164372448|NCT01234467|593739938|FG000|Overall Study|Adverse Event|3|||
164372449|NCT01234467|593739938|FG000|Overall Study|Death|2|||
164372450|NCT01234467|593739938|FG000|Overall Study|Withdrawal by Subject|2|||
164372451|NCT01234467|593739938|FG000|Overall Study|Disease Progression|2|||
164372452|NCT01234467|593739938|FG000|Overall Study|Clinical deterioration|1|||
164372453|NCT01234467|593739938|FG000|Overall Study|Physician Decision|1|||
164372454|NCT01234467|593739938|FG000|Overall Study|Other complicating disease (stroke)|1|||
164372455|NCT00559962|593739941|FG000|Overall Study|Adverse Event|1|||
164372456|NCT00559962|593739942|FG001|Overall Study|Adverse Event|7|||
164372457|NCT00559962|593739943|FG002|Overall Study|Adverse Event|8|||
164372458|NCT00559962|593739944|FG003|Overall Study|Adverse Event|5|||
164372459|NCT00559962|593739945|FG004|Overall Study|Adverse Event|11|||
164372460|NCT00559962|593739946|FG005|Overall Study|Adverse Event|4|||
164372461|NCT00559962|593739947|FG006|Overall Study|Adverse Event|4|||
164372462|NCT00559962|593739948|FG007|Overall Study|Adverse Event|2|||
164372463|NCT00559962|593739941|FG000|Overall Study|Lost to Follow-up|0|||
163902268|NCT05580003|592013101|FG003|Part 2 (up to 10 Days)|Other|0|||
163902269|NCT05580003|592013102|FG004|Part 2 (up to 10 Days)|Other|0|||
163902270|NCT05580003|592013103|FG005|Part 2 (up to 10 Days)|Other|0|||
163902271|NCT05580003|592013104|FG006|Part 2 (up to 10 Days)|Other|0|||
163902272|NCT05580003|592013105|FG007|Part 2 (up to 10 Days)|Other|0|||
163902273|NCT05580003|592013106|FG008|Part 2 (up to 10 Days)|Other|0|||
163902274|NCT05580003|592013107|FG009|Part 2 (up to 10 Days)|Other|1|||
164372464|NCT00559962|593739942|FG001|Overall Study|Lost to Follow-up|1|||
164372465|NCT00559962|593739943|FG002|Overall Study|Lost to Follow-up|0|||
164372466|NCT00559962|593739944|FG003|Overall Study|Lost to Follow-up|0|||
164372467|NCT00559962|593739945|FG004|Overall Study|Lost to Follow-up|0|||
164372468|NCT00559962|593739946|FG005|Overall Study|Lost to Follow-up|0|||
164372469|NCT00559962|593739947|FG006|Overall Study|Lost to Follow-up|0|||
164372470|NCT00559962|593739948|FG007|Overall Study|Lost to Follow-up|0|||
164372471|NCT00559962|593739941|FG000|Overall Study|Withdrawal by Subject|1|||
164372472|NCT00559962|593739942|FG001|Overall Study|Withdrawal by Subject|1|||
164372473|NCT00559962|593739943|FG002|Overall Study|Withdrawal by Subject|2|||
164372474|NCT00559962|593739944|FG003|Overall Study|Withdrawal by Subject|0|||
164372475|NCT00559962|593739945|FG004|Overall Study|Withdrawal by Subject|3|||
164372476|NCT00559962|593739946|FG005|Overall Study|Withdrawal by Subject|1|||
164372477|NCT00559962|593739947|FG006|Overall Study|Withdrawal by Subject|0|||
164372478|NCT00559962|593739948|FG007|Overall Study|Withdrawal by Subject|2|||
164372479|NCT00559962|593739941|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
164372480|NCT00559962|593739942|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
164372481|NCT00559962|593739943|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
164372482|NCT00559962|593739944|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
164372483|NCT00559962|593739945|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
164372484|NCT00559962|593739946|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
164372485|NCT00559962|593739947|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
164372486|NCT00559962|593739948|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
164372487|NCT01639040|593739958|FG000|Overall Study|Adverse Event|1|||
164372488|NCT01639040|593739959|FG001|Overall Study|Adverse Event|0|||
164372489|NCT04370691|593739960|FG000|Overall Study|Pending visit|48|||
164372490|NCT04370691|593739960|FG000|Overall Study|Have Not Reached Lower Window|15|||
164372491|NCT04370691|593739960|FG000|Overall Study|Termination|14|||
164372492|NCT04370691|593739960|FG000|Overall Study|Missed or Overdue|10|||
164372493|NCT00486265|593739961|FG000|Overall Study|Adverse Event|1|||
164372494|NCT00486265|593739961|FG000|Overall Study|Lack of Efficacy|8|||
164372495|NCT03013543|593739962|FG000|Overall Study|Withdrawal by Subject|0|||
164372496|NCT03013543|593739963|FG001|Overall Study|Withdrawal by Subject|2|||
164372497|NCT03013543|593739964|FG002|Overall Study|Withdrawal by Subject|0|||
164372498|NCT03013543|593739965|FG003|Overall Study|Withdrawal by Subject|5|||
164372499|NCT03013543|593739966|FG004|Overall Study|Withdrawal by Subject|6|||
164372500|NCT03013543|593739967|FG005|Overall Study|Withdrawal by Subject|2|||
164372501|NCT03013543|593739968|FG006|Overall Study|Withdrawal by Subject|3|||
164372502|NCT03013543|593739969|FG007|Overall Study|Withdrawal by Subject|1|||
164372503|NCT03013543|593739970|FG008|Overall Study|Withdrawal by Subject|0|||
164372504|NCT03013543|593739971|FG009|Overall Study|Withdrawal by Subject|4|||
164372505|NCT03013543|593739962|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164372506|NCT03013543|593739963|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164372507|NCT03013543|593739964|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
164372508|NCT03013543|593739965|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
164372509|NCT03013543|593739966|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
164372510|NCT03013543|593739967|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
164372511|NCT03013543|593739968|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
164372512|NCT03013543|593739969|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
164372513|NCT03013543|593739970|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
164372514|NCT03013543|593739971|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
164372515|NCT03013543|593739962|FG000|Overall Study|Other|0|||
164372516|NCT03013543|593739963|FG001|Overall Study|Other|0|||
164372517|NCT03013543|593739964|FG002|Overall Study|Other|2|||
164372518|NCT03013543|593739965|FG003|Overall Study|Other|0|||
164372519|NCT03013543|593739966|FG004|Overall Study|Other|2|||
164372520|NCT03013543|593739967|FG005|Overall Study|Other|0|||
164372521|NCT03013543|593739968|FG006|Overall Study|Other|0|||
164372522|NCT03013543|593739969|FG007|Overall Study|Other|0|||
164372523|NCT03013543|593739970|FG008|Overall Study|Other|1|||
164372524|NCT03013543|593739971|FG009|Overall Study|Other|0|||
164372525|NCT03013543|593739962|FG000|Overall Study|Adverse Event|0|||
164372526|NCT03013543|593739963|FG001|Overall Study|Adverse Event|0|||
164372527|NCT03013543|593739964|FG002|Overall Study|Adverse Event|0|||
164372528|NCT03013543|593739965|FG003|Overall Study|Adverse Event|3|||
164372529|NCT03013543|593739966|FG004|Overall Study|Adverse Event|2|||
164372530|NCT03013543|593739967|FG005|Overall Study|Adverse Event|1|||
164372531|NCT03013543|593739968|FG006|Overall Study|Adverse Event|3|||
164372532|NCT03013543|593739969|FG007|Overall Study|Adverse Event|8|||
164372533|NCT03013543|593739970|FG008|Overall Study|Adverse Event|0|||
164372534|NCT03013543|593739971|FG009|Overall Study|Adverse Event|2|||
164372535|NCT03013543|593739962|FG000|Overall Study|Death|0|||
164372536|NCT03013543|593739963|FG001|Overall Study|Death|0|||
164372537|NCT03013543|593739964|FG002|Overall Study|Death|0|||
164372538|NCT03013543|593739965|FG003|Overall Study|Death|1|||
164372539|NCT03013543|593739966|FG004|Overall Study|Death|0|||
164372540|NCT03013543|593739967|FG005|Overall Study|Death|0|||
164372541|NCT03013543|593739968|FG006|Overall Study|Death|0|||
164372542|NCT03013543|593739969|FG007|Overall Study|Death|0|||
164372543|NCT03013543|593739970|FG008|Overall Study|Death|0|||
164372544|NCT03013543|593739971|FG009|Overall Study|Death|0|||
164372545|NCT03013543|593739962|FG000|Overall Study|Lack of Efficacy|0|||
164372546|NCT03013543|593739963|FG001|Overall Study|Lack of Efficacy|0|||
164372547|NCT03013543|593739964|FG002|Overall Study|Lack of Efficacy|0|||
164372548|NCT03013543|593739965|FG003|Overall Study|Lack of Efficacy|1|||
164372549|NCT03013543|593739966|FG004|Overall Study|Lack of Efficacy|0|||
164372550|NCT03013543|593739967|FG005|Overall Study|Lack of Efficacy|0|||
164372551|NCT03013543|593739968|FG006|Overall Study|Lack of Efficacy|0|||
164372552|NCT03013543|593739969|FG007|Overall Study|Lack of Efficacy|0|||
164372553|NCT03013543|593739970|FG008|Overall Study|Lack of Efficacy|0|||
164372554|NCT03013543|593739971|FG009|Overall Study|Lack of Efficacy|0|||
164372555|NCT03013543|593739962|FG000|Overall Study|Lost to Follow-up|0|||
164372556|NCT03013543|593739963|FG001|Overall Study|Lost to Follow-up|0|||
164372557|NCT03013543|593739964|FG002|Overall Study|Lost to Follow-up|0|||
164372558|NCT03013543|593739965|FG003|Overall Study|Lost to Follow-up|1|||
164372559|NCT03013543|593739966|FG004|Overall Study|Lost to Follow-up|0|||
164372560|NCT03013543|593739967|FG005|Overall Study|Lost to Follow-up|0|||
164372561|NCT03013543|593739968|FG006|Overall Study|Lost to Follow-up|1|||
164372562|NCT03013543|593739969|FG007|Overall Study|Lost to Follow-up|0|||
164372563|NCT03013543|593739970|FG008|Overall Study|Lost to Follow-up|0|||
164372564|NCT03013543|593739971|FG009|Overall Study|Lost to Follow-up|2|||
164372565|NCT03013543|593739962|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164372566|NCT03013543|593739963|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164372567|NCT03013543|593739964|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164372568|NCT03013543|593739965|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164372569|NCT03013543|593739966|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164372570|NCT03013543|593739967|FG005|Overall Study|Non-Compliance With Study Drug|0|||
164372571|NCT03013543|593739968|FG006|Overall Study|Non-Compliance With Study Drug|0|||
164372572|NCT03013543|593739969|FG007|Overall Study|Non-Compliance With Study Drug|0|||
164372573|NCT03013543|593739970|FG008|Overall Study|Non-Compliance With Study Drug|1|||
164372574|NCT03013543|593739971|FG009|Overall Study|Non-Compliance With Study Drug|0|||
164372575|NCT03013543|593739962|FG000|Overall Study|Physician Decision|0|||
164372576|NCT03013543|593739963|FG001|Overall Study|Physician Decision|0|||
164372577|NCT03013543|593739964|FG002|Overall Study|Physician Decision|0|||
164372578|NCT03013543|593739965|FG003|Overall Study|Physician Decision|0|||
164372579|NCT03013543|593739966|FG004|Overall Study|Physician Decision|1|||
164372580|NCT03013543|593739967|FG005|Overall Study|Physician Decision|0|||
164372581|NCT03013543|593739968|FG006|Overall Study|Physician Decision|0|||
164372582|NCT03013543|593739969|FG007|Overall Study|Physician Decision|0|||
164372583|NCT03013543|593739970|FG008|Overall Study|Physician Decision|0|||
164372584|NCT03013543|593739971|FG009|Overall Study|Physician Decision|0|||
164372585|NCT03013543|593739962|FG000|Overall Study|Protocol Violation|0|||
164372586|NCT03013543|593739963|FG001|Overall Study|Protocol Violation|0|||
164372587|NCT03013543|593739964|FG002|Overall Study|Protocol Violation|0|||
164372588|NCT03013543|593739965|FG003|Overall Study|Protocol Violation|0|||
164372589|NCT03013543|593739966|FG004|Overall Study|Protocol Violation|0|||
164372590|NCT03013543|593739967|FG005|Overall Study|Protocol Violation|0|||
164372591|NCT03013543|593739968|FG006|Overall Study|Protocol Violation|0|||
164372592|NCT03013543|593739969|FG007|Overall Study|Protocol Violation|0|||
164372593|NCT03013543|593739970|FG008|Overall Study|Protocol Violation|0|||
164372594|NCT03013543|593739971|FG009|Overall Study|Protocol Violation|1|||
164372595|NCT02552316|593739973|FG000|Overall Study|Withdrawal by Subject|1|||
164372596|NCT02552316|593739973|FG000|Overall Study|Withdrawal due to non-compliance|1|||
164372597|NCT04116710|593739977|FG000|Overall Study|Death|4|||
164372598|NCT04116710|593739978|FG001|Overall Study|Death|6|||
164372599|NCT04116710|593739979|FG002|Overall Study|Death|3|||
164372600|NCT04116710|593739980|FG003|Overall Study|Death|1|||
164372601|NCT04116710|593739977|FG000|Overall Study|Withdrawal by Subject|0|||
164372602|NCT04116710|593739978|FG001|Overall Study|Withdrawal by Subject|0|||
164372603|NCT04116710|593739979|FG002|Overall Study|Withdrawal by Subject|0|||
164372604|NCT04116710|593739980|FG003|Overall Study|Withdrawal by Subject|1|||
164372605|NCT01256593|593739981|FG000|Overall Study|Protocol Violation|26|||
164372606|NCT01256593|593739981|FG000|Overall Study|No Drug Administration Information|2|||
164372607|NCT01256593|593739981|FG000|Overall Study|No Visit After Treatment|186|||
164372608|NCT01110915|593739984|FG000|Overall Study|Death|2|||
164372609|NCT01110915|593739985|FG001|Overall Study|Death|1|||
164372610|NCT01110915|593739984|FG000|Overall Study|Lost to Follow-up|1|||
164372611|NCT01110915|593739985|FG001|Overall Study|Lost to Follow-up|0|||
164372612|NCT01110915|593739984|FG000|Overall Study|Withdrawal by Subject|7|||
164372613|NCT01110915|593739985|FG001|Overall Study|Withdrawal by Subject|1|||
164372614|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
164372615|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
164372616|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
164372617|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
164372618|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
164372619|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
164372620|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
164372621|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
164372622|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
164372623|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
164372624|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
164372625|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
164372626|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
164372627|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
164372628|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
164372629|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
164372630|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
164372631|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
164372632|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
164372633|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
164372634|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
164372635|NCT02161718|593739988|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
164372636|NCT02161718|593739989|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
164372637|NCT02161718|593739990|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
164372638|NCT02161718|593739988|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
164372639|NCT02161718|593739989|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
164372640|NCT02161718|593739990|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
164372641|NCT02161718|593739988|FG000|Post- Randomization Period|Lost to Follow-up|0|||
164372642|NCT02161718|593739989|FG001|Post- Randomization Period|Lost to Follow-up|9|||
164372643|NCT02161718|593739990|FG002|Post- Randomization Period|Lost to Follow-up|15|||
164372644|NCT02161718|593739988|FG000|Post- Randomization Period|Adverse Event|0|||
164372645|NCT02161718|593739989|FG001|Post- Randomization Period|Adverse Event|9|||
164372646|NCT02161718|593739990|FG002|Post- Randomization Period|Adverse Event|10|||
164372647|NCT02161718|593739988|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
164372648|NCT02161718|593739989|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
164372649|NCT02161718|593739990|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
164372650|NCT02161718|593739988|FG000|Post- Randomization Period|Physician Decision|0|||
164372651|NCT02161718|593739989|FG001|Post- Randomization Period|Physician Decision|2|||
164372652|NCT02161718|593739990|FG002|Post- Randomization Period|Physician Decision|4|||
164372653|NCT02161718|593739988|FG000|Post- Randomization Period|Protocol Violation|0|||
164372654|NCT02161718|593739989|FG001|Post- Randomization Period|Protocol Violation|2|||
164372655|NCT02161718|593739990|FG002|Post- Randomization Period|Protocol Violation|3|||
164372656|NCT02161718|593739988|FG000|Post- Randomization Period|Lack of Efficacy|0|||
164372657|NCT02161718|593739989|FG001|Post- Randomization Period|Lack of Efficacy|0|||
164372658|NCT02161718|593739990|FG002|Post- Randomization Period|Lack of Efficacy|1|||
164372659|NCT02161718|593739988|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
164372660|NCT02161718|593739989|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
164372661|NCT02161718|593739990|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
164372662|NCT02161718|593739988|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
164372663|NCT02161718|593739989|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
164372664|NCT02161718|593739990|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
164372665|NCT02161718|593739988|FG000|Post- Randomization Period|Relocation|0|||
164372666|NCT02161718|593739989|FG001|Post- Randomization Period|Relocation|3|||
164372667|NCT02161718|593739990|FG002|Post- Randomization Period|Relocation|0|||
164372668|NCT02948842|593739993|FG000|Overall Study|Withdrawal by Subject|4|||
164372669|NCT01537783|593739994|FG000|Overall Study|Lost to Follow-up|11|||
164372670|NCT01537783|593739995|FG001|Overall Study|Lost to Follow-up|2|||
164372671|NCT02350309|593739997|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372672|NCT02350309|593739998|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372673|NCT02350309|593739999|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
164372674|NCT02350309|593740000|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372675|NCT02350309|593740001|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372676|NCT02350309|593740002|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
164372677|NCT02350309|593739997|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372678|NCT02350309|593739998|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372679|NCT02350309|593739999|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372680|NCT02350309|593740000|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372681|NCT02350309|593740001|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
164372682|NCT02350309|593740002|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
164372683|NCT00207142|593740003|FG000|Induction Phase|Adverse Event|9|||
164372684|NCT00207142|593740004|FG001|Induction Phase|Adverse Event|0|||
164372685|NCT00207142|593740005|FG002|Induction Phase|Adverse Event|0|||
164372686|NCT00207142|593740006|FG003|Induction Phase|Adverse Event|0|||
164372687|NCT00207142|593740003|FG000|Induction Phase|Death|1|||
164372688|NCT00207142|593740004|FG001|Induction Phase|Death|0|||
164372689|NCT00207142|593740005|FG002|Induction Phase|Death|0|||
164372690|NCT00207142|593740006|FG003|Induction Phase|Death|0|||
164372691|NCT00207142|593740003|FG000|Induction Phase|Lack of Efficacy|1|||
164372692|NCT00207142|593740004|FG001|Induction Phase|Lack of Efficacy|0|||
164372693|NCT00207142|593740005|FG002|Induction Phase|Lack of Efficacy|0|||
164372694|NCT00207142|593740006|FG003|Induction Phase|Lack of Efficacy|0|||
164372695|NCT00207142|593740003|FG000|Induction Phase|Lost to Follow-up|5|||
164372696|NCT00207142|593740004|FG001|Induction Phase|Lost to Follow-up|0|||
164372697|NCT00207142|593740005|FG002|Induction Phase|Lost to Follow-up|0|||
164372698|NCT00207142|593740006|FG003|Induction Phase|Lost to Follow-up|0|||
164372699|NCT00207142|593740003|FG000|Induction Phase|Physician Decision|2|||
164372700|NCT00207142|593740004|FG001|Induction Phase|Physician Decision|0|||
164372701|NCT00207142|593740005|FG002|Induction Phase|Physician Decision|0|||
164372702|NCT00207142|593740006|FG003|Induction Phase|Physician Decision|0|||
164372703|NCT00207142|593740003|FG000|Induction Phase|Poor/noncompliance|2|||
164372704|NCT00207142|593740004|FG001|Induction Phase|Poor/noncompliance|0|||
164372705|NCT00207142|593740005|FG002|Induction Phase|Poor/noncompliance|0|||
164372706|NCT00207142|593740006|FG003|Induction Phase|Poor/noncompliance|0|||
164372707|NCT00207142|593740003|FG000|Induction Phase|Pregnancy|1|||
164372708|NCT00207142|593740004|FG001|Induction Phase|Pregnancy|0|||
164372709|NCT00207142|593740005|FG002|Induction Phase|Pregnancy|0|||
164372710|NCT00207142|593740006|FG003|Induction Phase|Pregnancy|0|||
164372711|NCT00207142|593740003|FG000|Induction Phase|Subject no longer meets study criteria|3|||
164372712|NCT00207142|593740004|FG001|Induction Phase|Subject no longer meets study criteria|0|||
164372713|NCT00207142|593740005|FG002|Induction Phase|Subject no longer meets study criteria|0|||
164372714|NCT00207142|593740006|FG003|Induction Phase|Subject no longer meets study criteria|0|||
164372715|NCT00207142|593740003|FG000|Induction Phase|Withdrawal by Subject|4|||
164372716|NCT00207142|593740004|FG001|Induction Phase|Withdrawal by Subject|0|||
164372717|NCT00207142|593740005|FG002|Induction Phase|Withdrawal by Subject|0|||
164372718|NCT00207142|593740006|FG003|Induction Phase|Withdrawal by Subject|0|||
164372719|NCT00207142|593740003|FG000|Induction Phase|Incarceration|1|||
164372720|NCT00207142|593740004|FG001|Induction Phase|Incarceration|0|||
164372721|NCT00207142|593740005|FG002|Induction Phase|Incarceration|0|||
164372722|NCT00207142|593740006|FG003|Induction Phase|Incarceration|0|||
164372723|NCT00207142|593740003|FG000|Induction Phase|Missing lab data|1|||
164372724|NCT00207142|593740004|FG001|Induction Phase|Missing lab data|0|||
164372725|NCT00207142|593740005|FG002|Induction Phase|Missing lab data|0|||
164372726|NCT00207142|593740006|FG003|Induction Phase|Missing lab data|0|||
164372727|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
164372728|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
164372729|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
164372730|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
164372731|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
164372732|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
164372733|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
164372734|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
164372735|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
164372736|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
164372737|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
164372738|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
164372739|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
164372740|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
164372741|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
164372742|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
164372743|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
164372744|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
164372745|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
164372746|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
164372747|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
164372748|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
164372749|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
164372750|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
164372751|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
164372752|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
164372753|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
164372754|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
164372755|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Death|0|||
164372756|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Death|0|||
164372757|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Death|0|||
164372758|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Death|1|||
164372759|NCT00207142|593740003|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
164372760|NCT00207142|593740004|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
164372761|NCT00207142|593740005|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
164372762|NCT00207142|593740006|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
164372763|NCT01554618|593740007|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
164372764|NCT01554618|593740008|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
164372765|NCT01554618|593740007|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
164372766|NCT01554618|593740008|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
164372767|NCT01554618|593740007|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
164372768|NCT01554618|593740008|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
164372769|NCT01554618|593740007|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
164372770|NCT01554618|593740008|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
164372771|NCT01554618|593740007|FG000|Open-Label Extension Period|Physician Decision|0|||
164372772|NCT01554618|593740008|FG001|Open-Label Extension Period|Physician Decision|1|||
164372773|NCT01554618|593740007|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
164372774|NCT01554618|593740008|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
164372775|NCT01857063|593740009|FG000|Period 1 (7 Days)|Adverse Event|0|||
164372776|NCT01857063|593740010|FG001|Period 1 (7 Days)|Adverse Event|1|||
164372777|NCT01857063|593740009|FG000|Period 1 (7 Days)|Physician Decision|1|||
164372778|NCT01857063|593740010|FG001|Period 1 (7 Days)|Physician Decision|0|||
164372779|NCT01857063|593740009|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
164372780|NCT01857063|593740010|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
164372781|NCT01857063|593740009|FG000|Period 2 (7 Days)|Adverse Event|2|||
164372782|NCT01857063|593740010|FG001|Period 2 (7 Days)|Adverse Event|1|||
164372783|NCT01857063|593740009|FG000|Period 2 (7 Days)|Physician Decision|1|||
164372784|NCT01857063|593740010|FG001|Period 2 (7 Days)|Physician Decision|1|||
164372785|NCT01857063|593740009|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
164372786|NCT01857063|593740010|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
164372787|NCT00058825|593740011|FG000|Overall Study|Relapse|9|||
164372788|NCT00058825|593740011|FG000|Overall Study|Progressive Disease|5|||
164372789|NCT00058825|593740011|FG000|Overall Study|Graft Failure|5|||
164372790|NCT00058825|593740011|FG000|Overall Study|Death|3|||
164372791|NCT01205165|593740013|FG000|Overall Study|Lost to Follow-up|2|||
164372792|NCT00329407|593740020|FG000|Overall Study|Withdrawal by Subject|1|||
164372793|NCT00978068|593740021|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
164372794|NCT00978068|593740022|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
164372795|NCT00978068|593740021|FG000|Overall Study|Death|1|||
164372796|NCT00978068|593740022|FG001|Overall Study|Death|2|||
164372797|NCT00978068|593740021|FG000|Overall Study|Lost to Follow-up|1|||
164372798|NCT00978068|593740022|FG001|Overall Study|Lost to Follow-up|2|||
164372799|NCT00978068|593740021|FG000|Overall Study|Physician Decision|0|||
164372800|NCT00978068|593740022|FG001|Overall Study|Physician Decision|1|||
164012580|NCT04003155|592410551|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
164012581|NCT04003155|592410552|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
164372801|NCT00978068|593740021|FG000|Overall Study|Unable to Comply with Study|0|||
164372802|NCT00978068|593740022|FG001|Overall Study|Unable to Comply with Study|2|||
164372803|NCT02275481|593740023|FG000|Overall Study|Death|2|||
164372804|NCT02275481|593740024|FG001|Overall Study|Death|1|||
164372805|NCT02275481|593740023|FG000|Overall Study|Lost to Follow-up|2|||
164372806|NCT02275481|593740024|FG001|Overall Study|Lost to Follow-up|0|||
164012582|NCT04003155|592410553|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
164372807|NCT02275481|593740023|FG000|Overall Study|Withdrawal by Subject|3|||
164092775|NCT02130466|592702138|FG005|Overall Study|Physician Decision|1|||
164372808|NCT02275481|593740024|FG001|Overall Study|Withdrawal by Subject|0|||
164372809|NCT02275481|593740023|FG000|Overall Study|all other reasons combined|2|||
164372810|NCT02275481|593740024|FG001|Overall Study|all other reasons combined|1|||
164372811|NCT02275481|593740023|FG000|Overall Study|Physician Decision|0|||
164372812|NCT02275481|593740024|FG001|Overall Study|Physician Decision|1|||
164372813|NCT01215227|593740025|FG000|Overall Study|Adverse Event|11|||
164372814|NCT01215227|593740026|FG001|Overall Study|Adverse Event|11|||
164372815|NCT01215227|593740027|FG002|Overall Study|Adverse Event|4|||
164372816|NCT01215227|593740028|FG003|Overall Study|Adverse Event|8|||
164372817|NCT01215227|593740029|FG004|Overall Study|Adverse Event|7|||
164372818|NCT01215227|593740030|FG005|Overall Study|Adverse Event|6|||
164372819|NCT01215227|593740025|FG000|Overall Study|Treatment Failure|8|||
164372820|NCT01215227|593740026|FG001|Overall Study|Treatment Failure|4|||
164372821|NCT01215227|593740027|FG002|Overall Study|Treatment Failure|1|||
164372822|NCT01215227|593740028|FG003|Overall Study|Treatment Failure|5|||
164372823|NCT01215227|593740029|FG004|Overall Study|Treatment Failure|1|||
164372824|NCT01215227|593740030|FG005|Overall Study|Treatment Failure|1|||
164372825|NCT01215227|593740025|FG000|Overall Study|Lost to Follow-up|1|||
164372826|NCT01215227|593740026|FG001|Overall Study|Lost to Follow-up|4|||
164372827|NCT01215227|593740027|FG002|Overall Study|Lost to Follow-up|1|||
164372828|NCT01215227|593740028|FG003|Overall Study|Lost to Follow-up|1|||
164372829|NCT01215227|593740029|FG004|Overall Study|Lost to Follow-up|1|||
164372830|NCT01215227|593740030|FG005|Overall Study|Lost to Follow-up|2|||
164372831|NCT01215227|593740025|FG000|Overall Study|Subject Withdrew Consent|16|||
164372832|NCT01215227|593740026|FG001|Overall Study|Subject Withdrew Consent|20|||
164372833|NCT01215227|593740027|FG002|Overall Study|Subject Withdrew Consent|7|||
164372834|NCT01215227|593740028|FG003|Overall Study|Subject Withdrew Consent|10|||
164372835|NCT01215227|593740029|FG004|Overall Study|Subject Withdrew Consent|11|||
164372836|NCT01215227|593740030|FG005|Overall Study|Subject Withdrew Consent|8|||
164372837|NCT01215227|593740025|FG000|Overall Study|Non-Compliance With Protocol|2|||
164372838|NCT01215227|593740026|FG001|Overall Study|Non-Compliance With Protocol|6|||
164372839|NCT01215227|593740027|FG002|Overall Study|Non-Compliance With Protocol|1|||
164372840|NCT01215227|593740028|FG003|Overall Study|Non-Compliance With Protocol|0|||
164372841|NCT01215227|593740029|FG004|Overall Study|Non-Compliance With Protocol|0|||
164372842|NCT01215227|593740030|FG005|Overall Study|Non-Compliance With Protocol|0|||
164372843|NCT01215227|593740025|FG000|Overall Study|Administrative|83|||
164372844|NCT01215227|593740026|FG001|Overall Study|Administrative|73|||
164372845|NCT01215227|593740027|FG002|Overall Study|Administrative|42|||
164372846|NCT01215227|593740028|FG003|Overall Study|Administrative|24|||
164372847|NCT01215227|593740029|FG004|Overall Study|Administrative|28|||
164372848|NCT01215227|593740030|FG005|Overall Study|Administrative|40|||
164372849|NCT01215227|593740025|FG000|Overall Study|Missing Status|0|||
164372850|NCT01215227|593740026|FG001|Overall Study|Missing Status|1|||
164372851|NCT01215227|593740027|FG002|Overall Study|Missing Status|0|||
164372852|NCT01215227|593740028|FG003|Overall Study|Missing Status|0|||
164372853|NCT01215227|593740029|FG004|Overall Study|Missing Status|0|||
164372854|NCT01215227|593740030|FG005|Overall Study|Missing Status|0|||
164372855|NCT01215227|593740025|FG000|Overall Study|Randomized but not treated|0|||
164372856|NCT01215227|593740026|FG001|Overall Study|Randomized but not treated|0|||
163902275|NCT05580003|592013108|FG010|Part 2 (up to 10 Days)|Other|0|||
164372857|NCT01215227|593740027|FG002|Overall Study|Randomized but not treated|1|||
164372858|NCT01215227|593740028|FG003|Overall Study|Randomized but not treated|1|||
163902276|NCT05580003|592013109|FG011|Part 2 (up to 10 Days)|Other|0|||
163902277|NCT05580003|592013110|FG012|Part 2 (up to 10 Days)|Other|0|||
164372859|NCT01215227|593740029|FG004|Overall Study|Randomized but not treated|0|||
164372860|NCT01215227|593740030|FG005|Overall Study|Randomized but not treated|1|||
164372861|NCT01393405|593740031|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
164372862|NCT01393405|593740032|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
164372863|NCT01393405|593740033|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
164372864|NCT01393405|593740031|FG000|Induction Period (week1-16)|Adverse Event|16|||
164372865|NCT01393405|593740032|FG001|Induction Period (week1-16)|Adverse Event|0|||
164372866|NCT01393405|593740033|FG002|Induction Period (week1-16)|Adverse Event|0|||
164372867|NCT01393405|593740031|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
164372868|NCT01393405|593740032|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
164372869|NCT01393405|593740033|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
164372870|NCT01393405|593740031|FG000|Maintenance Period Week|Lack of Efficacy|0|||
164372871|NCT01393405|593740032|FG001|Maintenance Period Week|Lack of Efficacy|22|||
164372872|NCT01393405|593740033|FG002|Maintenance Period Week|Lack of Efficacy|22|||
163902278|NCT05580003|592013111|FG013|Part 2 (up to 10 Days)|Other|0|||
164372873|NCT01393405|593740031|FG000|Maintenance Period Week|Adverse Event|0|||
164372874|NCT01393405|593740032|FG001|Maintenance Period Week|Adverse Event|5|||
164372875|NCT01393405|593740033|FG002|Maintenance Period Week|Adverse Event|2|||
164372876|NCT01393405|593740031|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
164372877|NCT01393405|593740032|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
163902279|NCT05580003|592013112|FG014|Part 2 (up to 10 Days)|Other|0|||
163902280|NCT05580003|592013113|FG015|Part 2 (up to 10 Days)|Other|0|||
163902281|NCT05580003|592013114|FG016|Part 2 (up to 10 Days)|Other|0|||
164372878|NCT01393405|593740033|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
164372879|NCT01393405|593740031|FG000|Maintenance Period Week|Lost to Follow-up|0|||
164372880|NCT01393405|593740032|FG001|Maintenance Period Week|Lost to Follow-up|1|||
164372881|NCT01393405|593740033|FG002|Maintenance Period Week|Lost to Follow-up|0|||
164372882|NCT01434290|593740034|FG000|Overall Study|Protocol Violation|6|||
164372883|NCT01434290|593740035|FG001|Overall Study|Protocol Violation|3|||
163902282|NCT05580003|592013115|FG017|Part 2 (up to 10 Days)|Other|0|||
163902283|NCT05580003|592013116|FG018|Part 2 (up to 10 Days)|Other|0|||
163902284|NCT05580003|592013117|FG019|Part 2 (up to 10 Days)|Other|0|||
163902285|NCT05580003|592013118|FG020|Part 2 (up to 10 Days)|Other|0|||
164372884|NCT01434290|593740034|FG000|Overall Study|No protocol treatment|2|||
164372885|NCT01434290|593740035|FG001|Overall Study|No protocol treatment|4|||
164372886|NCT02281552|593740036|FG000|Overall Study|Medication error|1|||
164372887|NCT02281552|593740037|FG001|Overall Study|Medication error|0|||
164372888|NCT02281552|593740036|FG000|Overall Study|Insufficient clinical response|0|||
164372889|NCT02281552|593740037|FG001|Overall Study|Insufficient clinical response|1|||
164372890|NCT02281552|593740036|FG000|Overall Study|Adverse Event|3|||
164372891|NCT02281552|593740037|FG001|Overall Study|Adverse Event|9|||
164372892|NCT01359592|593742062|FG000|Initial Registration|Adverse Event|1|||
163902286|NCT05580003|592013119|FG021|Part 2 (up to 10 Days)|Other|0|||
163902287|NCT05580003|592013120|FG022|Part 2 (up to 10 Days)|Other|0|||
163902288|NCT05580003|592013121|FG023|Part 2 (up to 10 Days)|Other|0|||
163902289|NCT05580003|592013122|FG024|Part 2 (up to 10 Days)|Other|0|||
163902290|NCT05580003|592013123|FG025|Part 2 (up to 10 Days)|Other|0|||
163902291|NCT05580003|592013124|FG026|Part 2 (up to 10 Days)|Other|0|||
163902292|NCT05580003|592013125|FG027|Part 2 (up to 10 Days)|Other|0|||
163902293|NCT05580003|592013098|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902294|NCT05580003|592013099|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902295|NCT05580003|592013100|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902296|NCT05580003|592013101|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902297|NCT05580003|592013102|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902298|NCT05580003|592013103|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902299|NCT05580003|592013104|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902300|NCT05580003|592013105|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902301|NCT05580003|592013106|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902302|NCT05580003|592013107|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902303|NCT05580003|592013108|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902304|NCT05580003|592013109|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902305|NCT05580003|592013110|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902306|NCT05580003|592013111|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902307|NCT05580003|592013112|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902308|NCT05580003|592013113|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902309|NCT05580003|592013114|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902310|NCT05580003|592013115|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902311|NCT05580003|592013116|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902312|NCT05580003|592013117|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
164372893|NCT01359592|593742063|FG001|Initial Registration|Adverse Event|0|||
164372894|NCT01359592|593742064|FG002|Initial Registration|Adverse Event|0|||
164372895|NCT01359592|593742065|FG003|Initial Registration|Adverse Event|0|||
164372896|NCT01359592|593742062|FG000|Initial Registration|Death|1|||
164372897|NCT01359592|593742063|FG001|Initial Registration|Death|0|||
164372898|NCT01359592|593742064|FG002|Initial Registration|Death|0|||
164372899|NCT01359592|593742065|FG003|Initial Registration|Death|0|||
164372900|NCT01359592|593742062|FG000|Initial Registration|Other reason not protocol specified|1|||
164372901|NCT01359592|593742063|FG001|Initial Registration|Other reason not protocol specified|0|||
164372902|NCT01359592|593742064|FG002|Initial Registration|Other reason not protocol specified|0|||
163902313|NCT05580003|592013118|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
164372903|NCT01359592|593742065|FG003|Initial Registration|Other reason not protocol specified|0|||
163902314|NCT05580003|592013119|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902315|NCT05580003|592013120|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902316|NCT05580003|592013121|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902317|NCT05580003|592013122|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902318|NCT05580003|592013123|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902319|NCT05580003|592013124|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902320|NCT05580003|592013125|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
163902321|NCT05580003|592013098|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902322|NCT05580003|592013099|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902323|NCT05580003|592013100|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902324|NCT05580003|592013101|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902325|NCT05580003|592013102|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164372904|NCT01359592|593742062|FG000|Initial Registration|Ineligible|26|||
164372905|NCT01359592|593742063|FG001|Initial Registration|Ineligible|0|||
163902326|NCT05580003|592013103|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902327|NCT05580003|592013104|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902328|NCT05580003|592013105|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164372906|NCT01359592|593742064|FG002|Initial Registration|Ineligible|0|||
164372907|NCT01359592|593742065|FG003|Initial Registration|Ineligible|0|||
164372908|NCT01359592|593742062|FG000|PET-Directed Therapy|Adverse Event|0|||
164372909|NCT01359592|593742063|FG001|PET-Directed Therapy|Adverse Event|0|||
164372910|NCT01359592|593742064|FG002|PET-Directed Therapy|Adverse Event|1|||
164372911|NCT01359592|593742065|FG003|PET-Directed Therapy|Adverse Event|0|||
164372912|NCT01359592|593742062|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
164372913|NCT01359592|593742063|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
164372914|NCT01359592|593742064|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
164372915|NCT01359592|593742065|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
164372916|NCT01359592|593742062|FG000|PET-Directed Therapy|Ineligible|0|||
164372917|NCT01359592|593742063|FG001|PET-Directed Therapy|Ineligible|0|||
164372918|NCT01359592|593742064|FG002|PET-Directed Therapy|Ineligible|24|||
164372919|NCT01359592|593742065|FG003|PET-Directed Therapy|Ineligible|0|||
164372920|NCT02365636|593742066|FG000|Overall Study|Adverse Event|3|||
164372921|NCT02365636|593742067|FG001|Overall Study|Adverse Event|3|||
164372922|NCT02365636|593742068|FG002|Overall Study|Adverse Event|2|||
164372923|NCT02365636|593742066|FG000|Overall Study|Protocol Violation|1|||
164372924|NCT02365636|593742067|FG001|Overall Study|Protocol Violation|4|||
164372925|NCT02365636|593742068|FG002|Overall Study|Protocol Violation|0|||
164372926|NCT02365636|593742066|FG000|Overall Study|Lost to Follow-up|0|||
164372927|NCT02365636|593742067|FG001|Overall Study|Lost to Follow-up|0|||
164372928|NCT02365636|593742068|FG002|Overall Study|Lost to Follow-up|1|||
164372929|NCT02365636|593742066|FG000|Overall Study|Other|2|||
164372930|NCT02365636|593742067|FG001|Overall Study|Other|0|||
164372931|NCT02365636|593742068|FG002|Overall Study|Other|0|||
164372932|NCT01454934|593742069|FG000|Overall Study|Clinical progression|28|||
164372933|NCT01454934|593742070|FG001|Overall Study|Clinical progression|25|||
164372934|NCT01454934|593742069|FG000|Overall Study|Other|6|||
164372935|NCT01454934|593742070|FG001|Overall Study|Other|17|||
164372936|NCT01454934|593742069|FG000|Overall Study|Adverse Event|28|||
164372937|NCT01454934|593742070|FG001|Overall Study|Adverse Event|24|||
164372938|NCT01454934|593742069|FG000|Overall Study|Withdrawn consent|2|||
164372939|NCT01454934|593742070|FG001|Overall Study|Withdrawn consent|5|||
164372940|NCT01454934|593742069|FG000|Overall Study|Withdrawal by Subject|11|||
164372941|NCT01454934|593742070|FG001|Overall Study|Withdrawal by Subject|15|||
164372942|NCT01454934|593742069|FG000|Overall Study|Disease progression|194|||
164372943|NCT01454934|593742070|FG001|Overall Study|Disease progression|181|||
164372944|NCT01454934|593742069|FG000|Overall Study|Lost to Follow-up|0|||
164372945|NCT01454934|593742070|FG001|Overall Study|Lost to Follow-up|1|||
164372946|NCT01454934|593742069|FG000|Overall Study|Not treated|1|||
164372947|NCT01454934|593742070|FG001|Overall Study|Not treated|2|||
164372948|NCT03912233|593742071|FG000|Overall Study|Adverse Event|1|||
164372949|NCT03912233|593742072|FG001|Overall Study|Adverse Event|0|||
164372950|NCT03912233|593742073|FG002|Overall Study|Adverse Event|0|||
164372951|NCT03912233|593742074|FG003|Overall Study|Adverse Event|0|||
164372952|NCT03912233|593742075|FG004|Overall Study|Adverse Event|0|||
164372953|NCT03912233|593742076|FG005|Overall Study|Adverse Event|0|||
164372954|NCT03912233|593742071|FG000|Overall Study|Physician Decision|1|||
164372955|NCT03912233|593742072|FG001|Overall Study|Physician Decision|0|||
164372956|NCT03912233|593742073|FG002|Overall Study|Physician Decision|0|||
164372957|NCT03912233|593742074|FG003|Overall Study|Physician Decision|0|||
164372958|NCT03912233|593742075|FG004|Overall Study|Physician Decision|0|||
164372959|NCT03912233|593742076|FG005|Overall Study|Physician Decision|0|||
164372960|NCT03912233|593742071|FG000|Overall Study|Other|0|||
164372961|NCT03912233|593742072|FG001|Overall Study|Other|0|||
164372962|NCT03912233|593742073|FG002|Overall Study|Other|0|||
164372963|NCT03912233|593742074|FG003|Overall Study|Other|0|||
164372964|NCT03912233|593742075|FG004|Overall Study|Other|7|||
164372965|NCT03912233|593742076|FG005|Overall Study|Other|12|||
164372966|NCT02583256|593742077|FG000|Overall Study|Withdrawal by Subject|0|||
164372967|NCT02583256|593742078|FG001|Overall Study|Withdrawal by Subject|1|||
164372968|NCT02583256|593742079|FG002|Overall Study|Withdrawal by Subject|1|||
164372969|NCT02583256|593742080|FG003|Overall Study|Withdrawal by Subject|0|||
164372970|NCT02583256|593742077|FG000|Overall Study|Lost to Follow-up|1|||
164372971|NCT02583256|593742078|FG001|Overall Study|Lost to Follow-up|1|||
164372972|NCT02583256|593742079|FG002|Overall Study|Lost to Follow-up|0|||
164372973|NCT02583256|593742080|FG003|Overall Study|Lost to Follow-up|1|||
164372974|NCT02583256|593742077|FG000|Overall Study|Administrative/Other|2|||
164372975|NCT02583256|593742078|FG001|Overall Study|Administrative/Other|0|||
164372976|NCT02583256|593742079|FG002|Overall Study|Administrative/Other|1|||
164372977|NCT02583256|593742080|FG003|Overall Study|Administrative/Other|2|||
164372978|NCT01023659|593742087|FG000|Overall Study|Lost to Follow-up|73|||
164372979|NCT01023659|593742088|FG001|Overall Study|Lost to Follow-up|228|||
164372980|NCT01023659|593742089|FG002|Overall Study|Lost to Follow-up|99|||
164372981|NCT04537806|593742090|FG000|Overall Study|Randomized but not treated|1|||
164372982|NCT04537806|593742091|FG001|Overall Study|Randomized but not treated|0|||
164372983|NCT04537806|593742090|FG000|Overall Study|Adverse Event|1|||
164372984|NCT04537806|593742091|FG001|Overall Study|Adverse Event|1|||
164372985|NCT01802775|593742094|FG000|Overall Study|Death|0|||
164372986|NCT01802775|593742095|FG001|Overall Study|Death|3|||
164372987|NCT01802775|593742094|FG000|Overall Study|Reason not provided|0|||
164372988|NCT01802775|593742095|FG001|Overall Study|Reason not provided|1|||
164372989|NCT01802775|593742094|FG000|Overall Study|Physician Decision|1|||
164372990|NCT01802775|593742095|FG001|Overall Study|Physician Decision|0|||
164372991|NCT01802775|593742094|FG000|Overall Study|Adverse Event|1|||
164372992|NCT01802775|593742095|FG001|Overall Study|Adverse Event|1|||
164372993|NCT01802775|593742094|FG000|Overall Study|Withdrawal by Subject|3|||
164372994|NCT01802775|593742095|FG001|Overall Study|Withdrawal by Subject|5|||
164372995|NCT01802775|593742094|FG000|Overall Study|Lost to Follow-up|1|||
164372996|NCT01802775|593742095|FG001|Overall Study|Lost to Follow-up|2|||
164372997|NCT00519649|593742096|FG000|Overall Study|Withdrawal by Subject|1|||
164372998|NCT01465802|593742097|FG000|Overall Study|Study terminated by sponsor|1|||
164372999|NCT01465802|593742098|FG001|Overall Study|Study terminated by sponsor|0|||
164373000|NCT01465802|593742099|FG002|Overall Study|Study terminated by sponsor|0|||
164373001|NCT01465802|593742100|FG003|Overall Study|Study terminated by sponsor|1|||
164373002|NCT01465802|593742101|FG004|Overall Study|Study terminated by sponsor|7|||
164373003|NCT01465802|593742097|FG000|Overall Study|Withdrawal by Subject|7|||
164373004|NCT01465802|593742098|FG001|Overall Study|Withdrawal by Subject|7|||
164373005|NCT01465802|593742099|FG002|Overall Study|Withdrawal by Subject|0|||
164373006|NCT01465802|593742100|FG003|Overall Study|Withdrawal by Subject|8|||
164373007|NCT01465802|593742101|FG004|Overall Study|Withdrawal by Subject|1|||
164373008|NCT01465802|593742097|FG000|Overall Study|Lost to Follow-up|1|||
164373009|NCT01465802|593742098|FG001|Overall Study|Lost to Follow-up|1|||
164373010|NCT01465802|593742099|FG002|Overall Study|Lost to Follow-up|0|||
164373011|NCT01465802|593742100|FG003|Overall Study|Lost to Follow-up|0|||
164373012|NCT01465802|593742101|FG004|Overall Study|Lost to Follow-up|0|||
164373013|NCT01465802|593742097|FG000|Overall Study|Reason not specified|9|||
164373014|NCT01465802|593742098|FG001|Overall Study|Reason not specified|4|||
164373015|NCT01465802|593742099|FG002|Overall Study|Reason not specified|0|||
164373016|NCT01465802|593742100|FG003|Overall Study|Reason not specified|10|||
164373017|NCT01465802|593742101|FG004|Overall Study|Reason not specified|2|||
164373018|NCT01465802|593742097|FG000|Overall Study|Death|15|||
164373019|NCT01465802|593742098|FG001|Overall Study|Death|12|||
164373020|NCT01465802|593742099|FG002|Overall Study|Death|0|||
164373021|NCT01465802|593742100|FG003|Overall Study|Death|10|||
164373022|NCT01465802|593742101|FG004|Overall Study|Death|2|||
164373023|NCT01067352|593742102|FG000|Overall Study|Withdrawal by Subject|1|||
164373024|NCT01067352|593742103|FG001|Overall Study|Withdrawal by Subject|2|||
164373025|NCT01067352|593742104|FG002|Overall Study|Withdrawal by Subject|1|||
164373026|NCT01067352|593742102|FG000|Overall Study|Physician Decision|0|||
164373027|NCT01067352|593742103|FG001|Overall Study|Physician Decision|1|||
164373028|NCT01067352|593742104|FG002|Overall Study|Physician Decision|0|||
164373029|NCT02103478|593742105|FG000|Overall Study|Adverse Event|0|||
164373030|NCT02103478|593742106|FG001|Overall Study|Adverse Event|0|||
164373031|NCT02103478|593742107|FG002|Overall Study|Adverse Event|1|||
164373032|NCT02103478|593742108|FG003|Overall Study|Adverse Event|1|||
164373033|NCT02103478|593742109|FG004|Overall Study|Adverse Event|2|||
164373034|NCT02103478|593742110|FG005|Overall Study|Adverse Event|1|||
164373035|NCT02103478|593742111|FG006|Overall Study|Adverse Event|0|||
164373036|NCT02103478|593742112|FG007|Overall Study|Adverse Event|0|||
164373037|NCT02103478|593742113|FG008|Overall Study|Adverse Event|0|||
164373038|NCT02103478|593742105|FG000|Overall Study|Death|2|||
164373039|NCT02103478|593742106|FG001|Overall Study|Death|2|||
164373040|NCT02103478|593742107|FG002|Overall Study|Death|1|||
164373041|NCT02103478|593742108|FG003|Overall Study|Death|1|||
164092776|NCT02130466|592702139|FG006|Overall Study|Physician Decision|1|||
164373042|NCT02103478|593742109|FG004|Overall Study|Death|5|||
164373043|NCT02103478|593742110|FG005|Overall Study|Death|15|||
164373044|NCT02103478|593742111|FG006|Overall Study|Death|14|||
164373045|NCT02103478|593742112|FG007|Overall Study|Death|10|||
164373046|NCT02103478|593742113|FG008|Overall Study|Death|11|||
164373047|NCT02103478|593742105|FG000|Overall Study|Progressive Disease|2|||
164373048|NCT02103478|593742106|FG001|Overall Study|Progressive Disease|1|||
164373049|NCT02103478|593742107|FG002|Overall Study|Progressive Disease|2|||
164373050|NCT02103478|593742108|FG003|Overall Study|Progressive Disease|0|||
164373051|NCT02103478|593742109|FG004|Overall Study|Progressive Disease|9|||
164373052|NCT02103478|593742110|FG005|Overall Study|Progressive Disease|1|||
164373053|NCT02103478|593742111|FG006|Overall Study|Progressive Disease|2|||
164373054|NCT02103478|593742112|FG007|Overall Study|Progressive Disease|0|||
164373055|NCT02103478|593742113|FG008|Overall Study|Progressive Disease|1|||
164373056|NCT02103478|593742105|FG000|Overall Study|Withdrawal by Subject|2|||
164373057|NCT02103478|593742106|FG001|Overall Study|Withdrawal by Subject|0|||
164373058|NCT02103478|593742107|FG002|Overall Study|Withdrawal by Subject|0|||
164373059|NCT02103478|593742108|FG003|Overall Study|Withdrawal by Subject|4|||
164373060|NCT02103478|593742109|FG004|Overall Study|Withdrawal by Subject|0|||
164373061|NCT02103478|593742110|FG005|Overall Study|Withdrawal by Subject|0|||
164373062|NCT02103478|593742111|FG006|Overall Study|Withdrawal by Subject|1|||
164373063|NCT02103478|593742112|FG007|Overall Study|Withdrawal by Subject|1|||
164373064|NCT02103478|593742113|FG008|Overall Study|Withdrawal by Subject|0|||
164373065|NCT02103478|593742105|FG000|Overall Study|Lost to Follow-up|0|||
164373066|NCT02103478|593742106|FG001|Overall Study|Lost to Follow-up|0|||
164373067|NCT02103478|593742107|FG002|Overall Study|Lost to Follow-up|0|||
164373068|NCT02103478|593742108|FG003|Overall Study|Lost to Follow-up|0|||
164373069|NCT02103478|593742109|FG004|Overall Study|Lost to Follow-up|0|||
164373070|NCT02103478|593742110|FG005|Overall Study|Lost to Follow-up|0|||
164373071|NCT02103478|593742111|FG006|Overall Study|Lost to Follow-up|0|||
164373072|NCT02103478|593742112|FG007|Overall Study|Lost to Follow-up|1|||
164373073|NCT02103478|593742113|FG008|Overall Study|Lost to Follow-up|0|||
164373074|NCT02103478|593742105|FG000|Overall Study|Other|1|||
164373075|NCT02103478|593742106|FG001|Overall Study|Other|3|||
164373076|NCT02103478|593742107|FG002|Overall Study|Other|2|||
164373077|NCT02103478|593742108|FG003|Overall Study|Other|0|||
164373078|NCT02103478|593742109|FG004|Overall Study|Other|3|||
164373079|NCT02103478|593742110|FG005|Overall Study|Other|8|||
164373080|NCT02103478|593742111|FG006|Overall Study|Other|8|||
164373081|NCT02103478|593742112|FG007|Overall Study|Other|4|||
164373082|NCT02103478|593742113|FG008|Overall Study|Other|2|||
164373083|NCT03219333|593742114|FG000|Overall Study|Withdrawal by Subject|9|||
164373084|NCT03219333|593742115|FG001|Overall Study|Withdrawal by Subject|4|||
164373085|NCT03219333|593742114|FG000|Overall Study|Lost to Follow-up|1|||
164373086|NCT03219333|593742115|FG001|Overall Study|Lost to Follow-up|1|||
164373087|NCT03219333|593742114|FG000|Overall Study|Death|104|||
164373088|NCT03219333|593742115|FG001|Overall Study|Death|72|||
164373089|NCT03219333|593742114|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
164373090|NCT03219333|593742115|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
164373091|NCT03219333|593742114|FG000|Overall Study|Other|2|||
164373092|NCT03219333|593742115|FG001|Overall Study|Other|2|||
164373093|NCT00723606|593742116|FG000|Overall Study|Adverse Event|2|||
164373094|NCT00723606|593742117|FG001|Overall Study|Adverse Event|5|||
164373095|NCT00723606|593742116|FG000|Overall Study|Other|2|||
164373096|NCT00723606|593742117|FG001|Overall Study|Other|0|||
164373097|NCT00723606|593742116|FG000|Overall Study|Withdrawal by Subject|0|||
164373098|NCT00723606|593742117|FG001|Overall Study|Withdrawal by Subject|2|||
164373099|NCT02566759|593742118|FG000|All Parts|Withdrawal by Subject|0|||
164373100|NCT02566759|593742119|FG001|All Parts|Withdrawal by Subject|1|||
164373101|NCT02566759|593742120|FG002|All Parts|Withdrawal by Subject|0|||
164373102|NCT02566759|593742121|FG003|All Parts|Withdrawal by Subject|0|||
164373103|NCT02566759|593742122|FG004|All Parts|Withdrawal by Subject|0|||
164373104|NCT02566759|593742123|FG005|All Parts|Withdrawal by Subject|0|||
164373105|NCT02566759|593742124|FG006|All Parts|Withdrawal by Subject|0|||
164373106|NCT02566759|593742125|FG007|All Parts|Withdrawal by Subject|0|||
164373107|NCT02566759|593742126|FG008|All Parts|Withdrawal by Subject|0|||
164373108|NCT02566759|593742127|FG009|All Parts|Withdrawal by Subject|0|||
164373109|NCT02566759|593742128|FG010|All Parts|Withdrawal by Subject|0|||
164373110|NCT02566759|593742129|FG011|All Parts|Withdrawal by Subject|0|||
164373111|NCT02566759|593742130|FG012|All Parts|Withdrawal by Subject|0|||
164373112|NCT02566759|593742131|FG013|All Parts|Withdrawal by Subject|0|||
164373113|NCT02566759|593742132|FG014|All Parts|Withdrawal by Subject|0|||
164373114|NCT02566759|593742133|FG015|All Parts|Withdrawal by Subject|0|||
164373115|NCT02566759|593742134|FG016|All Parts|Withdrawal by Subject|0|||
164373116|NCT02566759|593742118|FG000|All Parts|Adverse Event|0|||
164373117|NCT02566759|593742119|FG001|All Parts|Adverse Event|0|||
164373118|NCT02566759|593742120|FG002|All Parts|Adverse Event|0|||
164373119|NCT02566759|593742121|FG003|All Parts|Adverse Event|0|||
164373120|NCT02566759|593742122|FG004|All Parts|Adverse Event|0|||
164373121|NCT02566759|593742123|FG005|All Parts|Adverse Event|0|||
164373122|NCT02566759|593742124|FG006|All Parts|Adverse Event|0|||
164373123|NCT02566759|593742125|FG007|All Parts|Adverse Event|0|||
164373124|NCT02566759|593742126|FG008|All Parts|Adverse Event|0|||
164373125|NCT02566759|593742127|FG009|All Parts|Adverse Event|0|||
164373126|NCT02566759|593742128|FG010|All Parts|Adverse Event|0|||
164373127|NCT02566759|593742129|FG011|All Parts|Adverse Event|0|||
164373128|NCT02566759|593742130|FG012|All Parts|Adverse Event|1|||
164373129|NCT02566759|593742131|FG013|All Parts|Adverse Event|3|||
164373130|NCT02566759|593742132|FG014|All Parts|Adverse Event|0|||
164373131|NCT02566759|593742133|FG015|All Parts|Adverse Event|0|||
164373132|NCT02566759|593742134|FG016|All Parts|Adverse Event|0|||
164373133|NCT02566759|593742118|FG000|All Parts|Other|0|||
164373134|NCT02566759|593742119|FG001|All Parts|Other|0|||
164373135|NCT02566759|593742120|FG002|All Parts|Other|0|||
164373136|NCT02566759|593742121|FG003|All Parts|Other|0|||
164373137|NCT02566759|593742122|FG004|All Parts|Other|0|||
164373138|NCT02566759|593742123|FG005|All Parts|Other|0|||
164373139|NCT02566759|593742124|FG006|All Parts|Other|0|||
164373140|NCT02566759|593742125|FG007|All Parts|Other|0|||
164373141|NCT02566759|593742126|FG008|All Parts|Other|0|||
164373142|NCT02566759|593742127|FG009|All Parts|Other|0|||
164373143|NCT02566759|593742128|FG010|All Parts|Other|0|||
164373144|NCT02566759|593742129|FG011|All Parts|Other|0|||
164373145|NCT02566759|593742130|FG012|All Parts|Other|0|||
164373146|NCT02566759|593742131|FG013|All Parts|Other|2|||
164373147|NCT02566759|593742132|FG014|All Parts|Other|0|||
164373148|NCT02566759|593742133|FG015|All Parts|Other|0|||
164373149|NCT02566759|593742134|FG016|All Parts|Other|0|||
164373150|NCT02566759|593742118|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373151|NCT02566759|593742119|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373152|NCT02566759|593742120|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373153|NCT02566759|593742121|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373154|NCT02566759|593742122|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373155|NCT02566759|593742123|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373156|NCT02566759|593742124|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373157|NCT02566759|593742125|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373158|NCT02566759|593742126|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373159|NCT02566759|593742127|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373160|NCT02566759|593742128|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373161|NCT02566759|593742129|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373162|NCT02566759|593742130|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373163|NCT02566759|593742131|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373164|NCT02566759|593742132|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373165|NCT02566759|593742133|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
164373166|NCT02566759|593742134|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
164373167|NCT01096784|593742135|FG000|Overall Study|Withdrawal by Subject|2|||
164373168|NCT01096784|593742136|FG001|Overall Study|Withdrawal by Subject|1|||
164373169|NCT01096784|593742135|FG000|Overall Study|Adverse Event|11|||
164373170|NCT01096784|593742136|FG001|Overall Study|Adverse Event|9|||
164373171|NCT01096784|593742135|FG000|Overall Study|Protocol Deviation|2|||
164373172|NCT01096784|593742136|FG001|Overall Study|Protocol Deviation|2|||
164373173|NCT01096784|593742135|FG000|Overall Study|Administrative Decision|0|||
164373174|NCT01096784|593742136|FG001|Overall Study|Administrative Decision|1|||
164373175|NCT01096784|593742135|FG000|Overall Study|Other Unspecified|0|||
164373176|NCT01096784|593742136|FG001|Overall Study|Other Unspecified|1|||
164373177|NCT00976898|593742137|FG000|Overall Study|Protocol Violation|1|||
164373178|NCT00976898|593742137|FG000|Overall Study|Adverse Event|1|||
164373179|NCT00976898|593742137|FG000|Overall Study|Physician Decision|1|||
164373180|NCT00976898|593742137|FG000|Overall Study|Liver Transplant|1|||
164373181|NCT00976898|593742137|FG000|Overall Study|Progressive Disease|1|||
164373182|NCT05132127|593742142|FG000|Overall Study|Adverse Event|1|||
164373183|NCT05220397|593742143|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164373184|NCT05220397|593742144|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164373185|NCT05220397|593742145|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
164373186|NCT05220397|593742146|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164373187|NCT05220397|593742147|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
164012583|NCT04003155|592410549|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
164012584|NCT04003155|592410550|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
164012585|NCT04003155|592410551|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
164012586|NCT04003155|592410552|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
164012587|NCT04003155|592410553|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
164012588|NCT04003155|592410549|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
164373188|NCT02659020|593742148|FG000|Overall Study|Adverse Event|0|||
164373189|NCT02659020|593742149|FG001|Overall Study|Adverse Event|0|||
164373190|NCT02659020|593742150|FG002|Overall Study|Adverse Event|0|||
164373191|NCT02659020|593742151|FG003|Overall Study|Adverse Event|2|||
164373192|NCT02659020|593742152|FG004|Overall Study|Adverse Event|0|||
164373193|NCT02659020|593742153|FG005|Overall Study|Adverse Event|0|||
164373194|NCT02659020|593742154|FG006|Overall Study|Adverse Event|2|||
164373195|NCT02659020|593742148|FG000|Overall Study|Lost to Follow-up|1|||
164373196|NCT02659020|593742149|FG001|Overall Study|Lost to Follow-up|2|||
164373197|NCT02659020|593742150|FG002|Overall Study|Lost to Follow-up|1|||
164373198|NCT02659020|593742151|FG003|Overall Study|Lost to Follow-up|6|||
164012589|NCT04003155|592410550|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
164012590|NCT04003155|592410551|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
164373199|NCT02659020|593742152|FG004|Overall Study|Lost to Follow-up|1|||
164373200|NCT02659020|593742153|FG005|Overall Study|Lost to Follow-up|5|||
164373201|NCT02659020|593742154|FG006|Overall Study|Lost to Follow-up|0|||
164373202|NCT02659020|593742148|FG000|Overall Study|Physician Decision|0|||
164373203|NCT02659020|593742149|FG001|Overall Study|Physician Decision|0|||
164373204|NCT02659020|593742150|FG002|Overall Study|Physician Decision|0|||
164373205|NCT02659020|593742151|FG003|Overall Study|Physician Decision|1|||
164373206|NCT02659020|593742152|FG004|Overall Study|Physician Decision|1|||
164373207|NCT02659020|593742153|FG005|Overall Study|Physician Decision|0|||
164373208|NCT02659020|593742154|FG006|Overall Study|Physician Decision|1|||
164373209|NCT02659020|593742148|FG000|Overall Study|Withdrawal by Subject|2|||
164373210|NCT02659020|593742149|FG001|Overall Study|Withdrawal by Subject|1|||
164373211|NCT02659020|593742150|FG002|Overall Study|Withdrawal by Subject|0|||
164373212|NCT02659020|593742151|FG003|Overall Study|Withdrawal by Subject|3|||
164373213|NCT02659020|593742152|FG004|Overall Study|Withdrawal by Subject|3|||
164373214|NCT02659020|593742153|FG005|Overall Study|Withdrawal by Subject|6|||
164373215|NCT02659020|593742154|FG006|Overall Study|Withdrawal by Subject|3|||
164373216|NCT02659020|593742148|FG000|Overall Study|Progressive Disease|0|||
164373217|NCT02659020|593742149|FG001|Overall Study|Progressive Disease|0|||
164373218|NCT02659020|593742150|FG002|Overall Study|Progressive Disease|0|||
164373219|NCT02659020|593742151|FG003|Overall Study|Progressive Disease|4|||
164373220|NCT02659020|593742152|FG004|Overall Study|Progressive Disease|1|||
164373221|NCT02659020|593742153|FG005|Overall Study|Progressive Disease|0|||
164373222|NCT02659020|593742154|FG006|Overall Study|Progressive Disease|2|||
164373223|NCT01120210|593742155|FG000|MAIN INFUSION|Adverse Event|1|||
164373224|NCT01120210|593742156|FG001|MAIN INFUSION|Adverse Event|0|||
164373225|NCT01120210|593742155|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
164373226|NCT01120210|593742156|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
164373227|NCT02043015|593742163|FG000|Overall Study|Lost to Follow-up|4|||
164373228|NCT02043015|593742163|FG000|Overall Study|Withdrawal by Subject|4|||
164373229|NCT02043015|593742163|FG000|Overall Study|Removed once target enrollment reached|15|||
164373230|NCT02043015|593742163|FG000|Overall Study|Participant moved away from study city|4|||
164373231|NCT02043015|593742163|FG000|Overall Study|Incarceration|1|||
164373232|NCT04049760|593742165|FG000|Overall Study|Withdrawal by Subject|1|||
164373233|NCT00393939|593742171|FG000|Overall Study|Protocol Violation|1|||
164373234|NCT00393939|593742172|FG001|Overall Study|Protocol Violation|1|||
164373235|NCT00393939|593742171|FG000|Overall Study|Lost to Follow-up|2|||
164373236|NCT00393939|593742172|FG001|Overall Study|Lost to Follow-up|4|||
164373237|NCT00393939|593742171|FG000|Overall Study|Death|10|||
164373238|NCT00393939|593742172|FG001|Overall Study|Death|4|||
164373239|NCT00393939|593742171|FG000|Overall Study|Sponsor|5|||
164373240|NCT00393939|593742172|FG001|Overall Study|Sponsor|13|||
164373241|NCT00393939|593742171|FG000|Overall Study|Objective progression or relapse|239|||
164373242|NCT00393939|593742172|FG001|Overall Study|Objective progression or relapse|223|||
164373243|NCT00393939|593742171|FG000|Overall Study|Withdrawal by Subject|2|||
164373244|NCT00393939|593742172|FG001|Overall Study|Withdrawal by Subject|7|||
164373245|NCT00393939|593742171|FG000|Overall Study|Other|37|||
164373246|NCT00393939|593742172|FG001|Overall Study|Other|45|||
164373247|NCT01494610|593742173|FG000|Period 1|Withdrawal by Subject|1|||
164373248|NCT01494610|593742174|FG001|Period 1|Withdrawal by Subject|1|||
164373249|NCT01494610|593742173|FG000|Period 3|Adverse Event|1|||
164373250|NCT01494610|593742174|FG001|Period 3|Adverse Event|0|||
164373251|NCT01494610|593742173|FG000|Period 3|Withdrawal by Subject|1|||
164373252|NCT01494610|593742174|FG001|Period 3|Withdrawal by Subject|0|||
164373253|NCT01494610|593742173|FG000|Period 4|Protocol Violation|1|||
164373254|NCT01494610|593742174|FG001|Period 4|Protocol Violation|0|||
164373255|NCT02385799|593742175|FG000|Overall Study|Lost to Follow-up|1|||
164373256|NCT02385799|593742176|FG001|Overall Study|Lost to Follow-up|2|||
164373257|NCT02385799|593742175|FG000|Overall Study|Adverse Event|4|||
164373258|NCT02385799|593742176|FG001|Overall Study|Adverse Event|2|||
164373259|NCT02385799|593742175|FG000|Overall Study|Withdrawal by Subject|0|||
164373260|NCT02385799|593742176|FG001|Overall Study|Withdrawal by Subject|4|||
164373261|NCT03995953|593742177|FG000|Overall Study|Death|3|||
163902329|NCT05580003|592013106|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164373262|NCT03995953|593742178|FG001|Overall Study|Death|0|||
164373263|NCT03995953|593742179|FG002|Overall Study|Death|3|||
164373264|NCT03995953|593742180|FG003|Overall Study|Death|0|||
164373265|NCT03995953|593742181|FG004|Overall Study|Death|3|||
164373266|NCT03995953|593742182|FG005|Overall Study|Death|0|||
164373267|NCT03995953|593742183|FG006|Overall Study|Death|0|||
163902330|NCT05580003|592013107|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902331|NCT05580003|592013108|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902332|NCT05580003|592013109|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164373268|NCT03995953|593742184|FG007|Overall Study|Death|0|||
164373269|NCT03995953|593742185|FG008|Overall Study|Death|1|||
164373270|NCT03995953|593742186|FG009|Overall Study|Death|0|||
164373271|NCT03995953|593742187|FG010|Overall Study|Death|0|||
164373272|NCT03995953|593742188|FG011|Overall Study|Death|0|||
164373273|NCT03995953|593742177|FG000|Overall Study|Lost to Follow-up|6|||
164373274|NCT03995953|593742178|FG001|Overall Study|Lost to Follow-up|54|||
164373275|NCT03995953|593742179|FG002|Overall Study|Lost to Follow-up|3|||
164373276|NCT03995953|593742180|FG003|Overall Study|Lost to Follow-up|32|||
164373277|NCT03995953|593742181|FG004|Overall Study|Lost to Follow-up|5|||
164373278|NCT03995953|593742182|FG005|Overall Study|Lost to Follow-up|44|||
164373279|NCT03995953|593742183|FG006|Overall Study|Lost to Follow-up|0|||
164373280|NCT03995953|593742184|FG007|Overall Study|Lost to Follow-up|31|||
164373281|NCT03995953|593742185|FG008|Overall Study|Lost to Follow-up|8|||
164373282|NCT03995953|593742186|FG009|Overall Study|Lost to Follow-up|36|||
164373283|NCT03995953|593742187|FG010|Overall Study|Lost to Follow-up|5|||
164373284|NCT03995953|593742188|FG011|Overall Study|Lost to Follow-up|41|||
164373285|NCT03995953|593742177|FG000|Overall Study|Withdrawal by Subject|4|||
164373286|NCT03995953|593742178|FG001|Overall Study|Withdrawal by Subject|0|||
164373287|NCT03995953|593742179|FG002|Overall Study|Withdrawal by Subject|1|||
164373288|NCT03995953|593742180|FG003|Overall Study|Withdrawal by Subject|0|||
164373289|NCT03995953|593742181|FG004|Overall Study|Withdrawal by Subject|1|||
164373290|NCT03995953|593742182|FG005|Overall Study|Withdrawal by Subject|0|||
164373291|NCT03995953|593742183|FG006|Overall Study|Withdrawal by Subject|1|||
164373292|NCT03995953|593742184|FG007|Overall Study|Withdrawal by Subject|0|||
164373293|NCT03995953|593742185|FG008|Overall Study|Withdrawal by Subject|3|||
164373294|NCT03995953|593742186|FG009|Overall Study|Withdrawal by Subject|0|||
164373295|NCT03995953|593742187|FG010|Overall Study|Withdrawal by Subject|3|||
164373296|NCT03995953|593742188|FG011|Overall Study|Withdrawal by Subject|0|||
164373297|NCT03995953|593742177|FG000|Overall Study|Health Issues|0|||
164373298|NCT03995953|593742178|FG001|Overall Study|Health Issues|0|||
164373299|NCT03995953|593742179|FG002|Overall Study|Health Issues|0|||
164373300|NCT03995953|593742180|FG003|Overall Study|Health Issues|0|||
164373301|NCT03995953|593742181|FG004|Overall Study|Health Issues|1|||
164373302|NCT03995953|593742182|FG005|Overall Study|Health Issues|0|||
164373303|NCT03995953|593742183|FG006|Overall Study|Health Issues|0|||
164373304|NCT03995953|593742184|FG007|Overall Study|Health Issues|0|||
164373305|NCT03995953|593742185|FG008|Overall Study|Health Issues|4|||
164373306|NCT03995953|593742186|FG009|Overall Study|Health Issues|0|||
164373307|NCT03995953|593742187|FG010|Overall Study|Health Issues|0|||
164373308|NCT03995953|593742188|FG011|Overall Study|Health Issues|0|||
164373309|NCT03995953|593742177|FG000|Overall Study|Relocated|11|||
164373310|NCT03995953|593742178|FG001|Overall Study|Relocated|0|||
164373311|NCT03995953|593742179|FG002|Overall Study|Relocated|16|||
164373312|NCT03995953|593742180|FG003|Overall Study|Relocated|0|||
164373313|NCT03995953|593742181|FG004|Overall Study|Relocated|14|||
164373314|NCT03995953|593742182|FG005|Overall Study|Relocated|0|||
164373315|NCT03995953|593742183|FG006|Overall Study|Relocated|16|||
164373316|NCT03995953|593742184|FG007|Overall Study|Relocated|0|||
164373317|NCT03995953|593742185|FG008|Overall Study|Relocated|14|||
164373318|NCT03995953|593742186|FG009|Overall Study|Relocated|0|||
164373319|NCT03995953|593742187|FG010|Overall Study|Relocated|15|||
164373320|NCT03995953|593742188|FG011|Overall Study|Relocated|0|||
164373321|NCT02388997|593742189|FG000|Overall Study|Adverse Event|1|||
164373322|NCT02388997|593742190|FG001|Overall Study|Adverse Event|2|||
164373323|NCT02388997|593742189|FG000|Overall Study|Withdrawal by Subject|2|||
164373324|NCT02388997|593742190|FG001|Overall Study|Withdrawal by Subject|1|||
164373325|NCT02388997|593742189|FG000|Overall Study|Lung function exclusion criteria|0|||
164373326|NCT02388997|593742190|FG001|Overall Study|Lung function exclusion criteria|2|||
164373327|NCT02388997|593742189|FG000|Overall Study|Tested positive for virus during run-in|0|||
164373328|NCT02388997|593742190|FG001|Overall Study|Tested positive for virus during run-in|1|||
164373329|NCT02130765|593742191|FG000|Overall Study|Did not receive treatment|4|||
164373330|NCT02130765|593742192|FG001|Overall Study|Did not receive treatment|0|||
164373331|NCT02130765|593742193|FG002|Overall Study|Did not receive treatment|0|||
164373332|NCT02130765|593742194|FG003|Overall Study|Did not receive treatment|0|||
164373333|NCT00006184|593742197|FG000|Overall Study|Death|1|||
164373334|NCT00006184|593742198|FG001|Overall Study|Death|0|||
164373335|NCT04958109|593742199|FG000|Overall Study|Withdrawal by Subject|0|||
164373336|NCT04958109|593742200|FG001|Overall Study|Withdrawal by Subject|1|||
164373337|NCT04958109|593742199|FG000|Overall Study|Lost to Follow-up|0|||
164373338|NCT04958109|593742200|FG001|Overall Study|Lost to Follow-up|1|||
164373339|NCT01256710|593742201|FG000|Overall Study|Death|449|||
164373340|NCT01256710|593742201|FG000|Overall Study|System Explant|67|||
164373341|NCT01256710|593742201|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
164373342|NCT01256710|593742201|FG000|Overall Study|Lost to Follow-up|67|||
164373343|NCT01256710|593742201|FG000|Overall Study|Withdrawal by Subject|29|||
164373344|NCT01256710|593742201|FG000|Overall Study|Physician Decision|9|||
164373345|NCT01256710|593742201|FG000|Overall Study|Subject Noncompliance|2|||
164373346|NCT01256710|593742201|FG000|Overall Study|Study Terminated by Sponsor|273|||
164373347|NCT00715793|593742202|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
164373348|NCT00715793|593742203|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
164373349|NCT00715793|593742202|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
164373350|NCT00715793|593742203|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
164373351|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373352|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
164373353|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
164373354|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
164373355|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373356|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373357|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373358|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373359|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373360|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373361|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373362|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373363|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373364|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373365|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373366|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373367|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373368|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373369|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373370|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373371|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373372|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373373|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373374|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
164373375|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373376|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
164373377|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373378|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373379|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373380|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373381|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373382|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373383|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373384|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373385|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373386|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373387|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373388|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373389|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373390|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373391|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164012591|NCT04003155|592410552|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
164012592|NCT04003155|592410553|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
164373392|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373393|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373394|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373395|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373396|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373397|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373398|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
164373399|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373400|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
164373401|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373402|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373403|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373404|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164012593|NCT04003155|592410549|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
164373405|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373406|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373407|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373408|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373409|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373410|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373411|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373412|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373413|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373414|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373415|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373416|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373417|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373418|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373419|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373420|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373421|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373422|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
164373423|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
164373424|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
164373425|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
164373426|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
164373427|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373428|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373429|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373430|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373431|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373432|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373433|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373434|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373435|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373436|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373437|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373438|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373439|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373440|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373441|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373442|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373443|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373444|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373445|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373446|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
164373447|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
164373448|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
164373449|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
164373450|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
164373451|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373452|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373453|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373454|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373455|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373456|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373457|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373458|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373459|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373460|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373461|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373462|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373463|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373464|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373465|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373466|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373467|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373468|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373469|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373470|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
164373471|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373472|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
164373473|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373474|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
164373475|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373476|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373477|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373478|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373479|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373480|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373481|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373482|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373483|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373484|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373485|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373486|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373487|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373488|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373489|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373490|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373491|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373492|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373493|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373494|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
164373495|NCT02346240|593742204|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373496|NCT02346240|593742205|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373497|NCT02346240|593742206|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
164373498|NCT02346240|593742207|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373499|NCT02346240|593742208|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373500|NCT02346240|593742209|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373501|NCT02346240|593742210|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373502|NCT02346240|593742211|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373503|NCT02346240|593742212|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373504|NCT02346240|593742213|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373505|NCT02346240|593742214|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373506|NCT02346240|593742215|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373507|NCT02346240|593742216|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373508|NCT02346240|593742217|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373509|NCT02346240|593742218|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373510|NCT02346240|593742219|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373511|NCT02346240|593742220|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373512|NCT02346240|593742221|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373513|NCT02346240|593742222|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373514|NCT02346240|593742223|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373515|NCT02346240|593742224|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373516|NCT02346240|593742225|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373517|NCT02346240|593742226|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373518|NCT02346240|593742227|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
164373519|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373520|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373521|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373522|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373523|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373524|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373525|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373526|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164373527|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164373528|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373529|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373530|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373531|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373532|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164373533|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
164373534|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164373535|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
164373536|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373537|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373538|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373539|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373540|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373541|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373542|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164373543|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373544|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373545|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373546|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373547|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373548|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373549|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373550|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373551|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373552|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373553|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373554|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373555|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373556|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
164373557|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373558|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
164373559|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373560|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373561|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373562|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373563|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373564|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373565|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373566|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
164373567|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373568|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373569|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373570|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373571|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373572|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373573|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373574|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373575|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373576|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373577|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373578|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373579|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373580|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373581|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
164373582|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373583|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373584|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373585|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373586|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164092777|NCT02130466|592702140|FG007|Overall Study|Physician Decision|0|||
164373587|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373588|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373589|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373590|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164373591|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373592|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373593|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373594|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373595|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373596|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373597|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373598|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373599|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373600|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373601|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373602|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
164373603|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373604|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
164373605|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
164373606|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
164373607|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164373608|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373609|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373610|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373611|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373612|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373613|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373614|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164373615|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373616|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373617|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373618|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373619|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373620|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373621|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373622|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373623|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373624|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373625|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373626|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373627|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373628|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
164373629|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
164373630|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
164373631|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
164373632|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373633|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373634|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373635|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373636|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373637|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373638|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
164373639|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373640|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373641|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373642|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373643|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373644|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373645|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
164373646|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373647|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373648|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373649|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373650|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164012594|NCT04003155|592410550|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
164012595|NCT04003155|592410551|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
164012596|NCT04003155|592410552|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
164012597|NCT04003155|592410553|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
164373651|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373652|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373653|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373654|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373655|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373656|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373657|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373658|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373659|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373660|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373661|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373662|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
164373663|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373664|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373665|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373666|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373667|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373668|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373669|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373670|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373671|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373672|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373673|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373674|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373675|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373676|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373677|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
164373678|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373679|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373680|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373681|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373682|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373683|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373684|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373685|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373686|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
164373687|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373688|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373689|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373690|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373691|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373692|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373693|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373694|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373695|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373696|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
164373697|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373698|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373699|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373700|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373701|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373702|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373703|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373704|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373705|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373706|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373707|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373708|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373709|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373710|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
164373711|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373712|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373713|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373714|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373715|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373716|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373717|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373718|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373719|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373720|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373721|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
164373722|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373723|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373724|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373725|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373726|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373727|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373728|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373729|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373730|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373731|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373732|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373733|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373734|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
164373735|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373736|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373737|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373738|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373739|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373740|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373741|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373742|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373743|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373744|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373745|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373746|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373747|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373748|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373749|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
164373750|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373751|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373752|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373753|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373754|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373755|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373756|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373757|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373758|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
164373759|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373760|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373761|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373762|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373763|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373764|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373765|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373766|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373767|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373768|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373769|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373770|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373771|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373772|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373773|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
164373774|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373775|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373776|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373777|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373778|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373779|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373780|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373781|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373782|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
164373783|NCT02346240|593742204|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373784|NCT02346240|593742205|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373785|NCT02346240|593742206|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373786|NCT02346240|593742207|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373787|NCT02346240|593742208|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373788|NCT02346240|593742209|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373789|NCT02346240|593742210|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373790|NCT02346240|593742211|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373791|NCT02346240|593742212|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373792|NCT02346240|593742213|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373793|NCT02346240|593742214|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373794|NCT02346240|593742215|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373795|NCT02346240|593742216|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373796|NCT02346240|593742217|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373797|NCT02346240|593742218|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
164373798|NCT02346240|593742219|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373799|NCT02346240|593742220|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373800|NCT02346240|593742221|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373801|NCT02346240|593742222|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373802|NCT02346240|593742223|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373803|NCT02346240|593742224|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373804|NCT02346240|593742225|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373805|NCT02346240|593742226|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373806|NCT02346240|593742227|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
164373807|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373808|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373809|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373810|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373811|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164092778|NCT02130466|592702141|FG008|Overall Study|Physician Decision|0|||
164373812|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373813|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373814|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373815|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373816|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373817|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373818|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373819|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373820|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373821|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373822|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373823|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
164373824|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
164373825|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
164373826|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
164373827|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
164373828|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
164373829|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
164373830|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
164373831|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373832|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373833|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373834|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373835|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373836|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373837|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373838|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373839|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373840|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373841|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373842|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373843|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373844|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373845|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373846|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373847|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373848|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373849|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
164373850|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
164373851|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373852|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
164373853|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373854|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
164373855|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373856|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373857|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373858|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373859|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373860|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373861|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373862|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373863|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373864|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164012598|NCT04003155|592410549|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
164012599|NCT04003155|592410550|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
164012600|NCT04003155|592410551|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
164012601|NCT04003155|592410552|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
164012602|NCT04003155|592410553|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
164373865|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373866|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373867|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373868|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373869|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373870|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373871|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373872|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373873|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164373874|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373875|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373876|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164373877|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373878|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164373879|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373880|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373881|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373882|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373883|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373884|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373885|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373886|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373887|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373888|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373889|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373890|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373891|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373892|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373893|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373894|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373895|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373896|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373897|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373898|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373899|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373900|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
164373901|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373902|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
164373903|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373904|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373905|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373906|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373907|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373908|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373909|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373910|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373911|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373912|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373913|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373914|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373915|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373916|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373917|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373918|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373919|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373920|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
164373921|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
164373922|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
164373923|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164373924|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164373925|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164373926|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
164373927|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373928|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373929|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373930|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373931|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373932|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373933|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373934|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164092779|NCT02130466|592702142|FG009|Overall Study|Physician Decision|0|||
164373935|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373936|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373937|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373938|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373939|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373940|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373941|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373942|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373943|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
163902333|NCT05580003|592013110|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164012603|NCT04003155|592410549|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
164012604|NCT04003155|592410550|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
164012605|NCT04003155|592410551|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
164012606|NCT04003155|592410552|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
164012607|NCT04003155|592410553|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
164092780|NCT02130466|592702143|FG010|Overall Study|Physician Decision|0|||
164373944|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373945|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
164373946|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164373947|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164373948|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
164373949|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164373950|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164373951|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373952|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373953|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373954|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373955|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373956|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373957|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373958|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373959|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373960|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373961|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373962|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373963|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373964|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373965|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373966|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373967|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373968|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373969|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
164373970|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
164373971|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
163902334|NCT05580003|592013111|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902335|NCT05580003|592013112|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902336|NCT05580003|592013113|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902337|NCT05580003|592013114|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902338|NCT05580003|592013115|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902339|NCT05580003|592013116|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902340|NCT05580003|592013117|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902341|NCT05580003|592013118|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
163902342|NCT05580003|592013119|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164373972|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
164373973|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
164373974|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
164373975|NCT02346240|593742204|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373976|NCT02346240|593742205|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373977|NCT02346240|593742206|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373978|NCT02346240|593742207|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373979|NCT02346240|593742208|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373980|NCT02346240|593742209|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373981|NCT02346240|593742210|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373982|NCT02346240|593742211|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373983|NCT02346240|593742212|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373984|NCT02346240|593742213|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373985|NCT02346240|593742214|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373986|NCT02346240|593742215|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373987|NCT02346240|593742216|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373988|NCT02346240|593742217|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373989|NCT02346240|593742218|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373990|NCT02346240|593742219|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373991|NCT02346240|593742220|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373992|NCT02346240|593742221|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373993|NCT02346240|593742222|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
164373994|NCT02346240|593742223|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373995|NCT02346240|593742224|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373996|NCT02346240|593742225|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373997|NCT02346240|593742226|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373998|NCT02346240|593742227|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
164373999|NCT02681302|593742228|FG000|Overall Study|Withdrawal by Subject|1|||
164374000|NCT02681302|593742229|FG001|Overall Study|Withdrawal by Subject|1|||
164374001|NCT02681302|593742230|FG002|Overall Study|Withdrawal by Subject|0|||
164374002|NCT02681302|593742231|FG003|Overall Study|Withdrawal by Subject|0|||
164374003|NCT02681302|593742232|FG004|Overall Study|Withdrawal by Subject|1|||
164374004|NCT02681302|593742233|FG005|Overall Study|Withdrawal by Subject|0|||
164374005|NCT02681302|593742228|FG000|Overall Study|Screen Failure|2|||
164374006|NCT02681302|593742229|FG001|Overall Study|Screen Failure|4|||
164374007|NCT02681302|593742230|FG002|Overall Study|Screen Failure|2|||
164374008|NCT02681302|593742231|FG003|Overall Study|Screen Failure|0|||
164374009|NCT02681302|593742232|FG004|Overall Study|Screen Failure|1|||
164374010|NCT02681302|593742233|FG005|Overall Study|Screen Failure|1|||
164374011|NCT02681302|593742228|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374012|NCT02681302|593742229|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374013|NCT02681302|593742230|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374014|NCT02681302|593742231|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374015|NCT02681302|593742232|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
164374016|NCT02681302|593742233|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
164374017|NCT02942017|593742234|FG000|Overall Study|Adverse Event|0|||
164374018|NCT02942017|593742235|FG001|Overall Study|Adverse Event|1|||
164374019|NCT02942017|593742234|FG000|Overall Study|Withdrawal by Subject|0|||
164374020|NCT02942017|593742235|FG001|Overall Study|Withdrawal by Subject|1|||
164374021|NCT02942017|593742234|FG000|Overall Study|Lost to Follow-up|1|||
164374022|NCT02942017|593742235|FG001|Overall Study|Lost to Follow-up|1|||
164374023|NCT02942017|593742234|FG000|Overall Study|Randomized but not dosed|1|||
164374024|NCT02942017|593742235|FG001|Overall Study|Randomized but not dosed|3|||
164374025|NCT00477672|593742236|FG000|Overall Study|Adverse Event|3|||
164374026|NCT00477672|593742237|FG001|Overall Study|Adverse Event|5|||
164374027|NCT00477672|593742238|FG002|Overall Study|Adverse Event|6|||
164374028|NCT00477672|593742236|FG000|Overall Study|Death|0|||
164374029|NCT00477672|593742237|FG001|Overall Study|Death|1|||
164374030|NCT00477672|593742238|FG002|Overall Study|Death|0|||
164374031|NCT00477672|593742236|FG000|Overall Study|Disease progression|0|||
164374032|NCT00477672|593742237|FG001|Overall Study|Disease progression|1|||
164374033|NCT00477672|593742238|FG002|Overall Study|Disease progression|0|||
164374034|NCT00477672|593742236|FG000|Overall Study|Physician Decision|1|||
164374035|NCT00477672|593742237|FG001|Overall Study|Physician Decision|0|||
164374036|NCT00477672|593742238|FG002|Overall Study|Physician Decision|0|||
164374037|NCT00477672|593742236|FG000|Overall Study|Protocol noncompliance|0|||
164374038|NCT00477672|593742237|FG001|Overall Study|Protocol noncompliance|2|||
164374039|NCT00477672|593742238|FG002|Overall Study|Protocol noncompliance|0|||
164374040|NCT00477672|593742236|FG000|Overall Study|Consent withdrawn|2|||
164374041|NCT00477672|593742237|FG001|Overall Study|Consent withdrawn|5|||
164374042|NCT00477672|593742238|FG002|Overall Study|Consent withdrawn|10|||
164374043|NCT00477672|593742236|FG000|Overall Study|Discretion of Sponsor|1|||
164374044|NCT00477672|593742237|FG001|Overall Study|Discretion of Sponsor|2|||
164374045|NCT00477672|593742238|FG002|Overall Study|Discretion of Sponsor|0|||
164374046|NCT00838565|593742239|FG000|Overall Study|Withdrawal by Subject|0|||
164374047|NCT00838565|593742240|FG001|Overall Study|Withdrawal by Subject|0|||
164374048|NCT00838565|593742241|FG002|Overall Study|Withdrawal by Subject|1|||
164374049|NCT00838565|593742242|FG003|Overall Study|Withdrawal by Subject|0|||
164374050|NCT00838565|593742243|FG004|Overall Study|Withdrawal by Subject|0|||
164374051|NCT00838565|593742244|FG005|Overall Study|Withdrawal by Subject|2|||
164374052|NCT00838565|593742239|FG000|Overall Study|Other|0|||
164374053|NCT00838565|593742240|FG001|Overall Study|Other|2|||
164374054|NCT00838565|593742241|FG002|Overall Study|Other|0|||
164374055|NCT00838565|593742242|FG003|Overall Study|Other|0|||
164374056|NCT00838565|593742243|FG004|Overall Study|Other|0|||
164374057|NCT00838565|593742244|FG005|Overall Study|Other|0|||
164374058|NCT00838565|593742239|FG000|Overall Study|Randomized but not Treated|0|||
164374059|NCT00838565|593742240|FG001|Overall Study|Randomized but not Treated|1|||
164374060|NCT00838565|593742241|FG002|Overall Study|Randomized but not Treated|0|||
164374061|NCT00838565|593742242|FG003|Overall Study|Randomized but not Treated|0|||
164374062|NCT00838565|593742243|FG004|Overall Study|Randomized but not Treated|0|||
164374063|NCT00838565|593742244|FG005|Overall Study|Randomized but not Treated|0|||
164374064|NCT00458484|593742245|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
164374065|NCT00458484|593742246|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
164374066|NCT00458484|593742247|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
164374067|NCT00458484|593742248|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
164374068|NCT00458484|593742249|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
164374069|NCT00458484|593742250|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
164374070|NCT00458484|593742251|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
164374071|NCT01838642|593742252|FG000|Overall Study|Died on study|1|||
164374072|NCT02253810|593742253|FG000|Overall Study|Withdrawal by Subject|2|||
164374073|NCT02253810|593742254|FG001|Overall Study|Withdrawal by Subject|1|||
164374074|NCT02253810|593742253|FG000|Overall Study|Unknown concomitant procedure|3|||
164374075|NCT02253810|593742254|FG001|Overall Study|Unknown concomitant procedure|2|||
164374076|NCT00291668|593742256|FG000|Overall Study|Lack of Efficacy|1|||
163902343|NCT05580003|592013120|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902344|NCT05580003|592013121|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164374077|NCT00291668|593742257|FG001|Overall Study|Lack of Efficacy|0|||
164374078|NCT00291668|593742258|FG002|Overall Study|Lack of Efficacy|0|||
164374079|NCT00291668|593742256|FG000|Overall Study|SAE, non-fatal|1|||
164374080|NCT00291668|593742257|FG001|Overall Study|SAE, non-fatal|1|||
164374081|NCT00291668|593742258|FG002|Overall Study|SAE, non-fatal|1|||
164374082|NCT00291668|593742256|FG000|Overall Study|AE, non-serious non-fatal|1|||
164374083|NCT00291668|593742257|FG001|Overall Study|AE, non-serious non-fatal|0|||
164374084|NCT00291668|593742258|FG002|Overall Study|AE, non-serious non-fatal|0|||
163902345|NCT05580003|592013122|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
164374085|NCT00291668|593742256|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164374086|NCT00291668|593742257|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164374087|NCT00291668|593742258|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164374088|NCT01557400|593742259|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
164374089|NCT01557400|593742259|FG000|Overall Study|Adverse Event|3|||
164374090|NCT01557400|593742259|FG000|Overall Study|Lost to Follow-up|5|||
164374091|NCT01557400|593742259|FG000|Overall Study|Withdrawal by Subject|9|||
164374092|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
164374093|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
164374094|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
164374095|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164374096|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
163902346|NCT05580003|592013123|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902347|NCT05580003|592013124|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902348|NCT05580003|592013125|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
163902349|NCT05580003|592013098|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164374097|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164374098|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374099|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374100|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
164374101|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374102|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374103|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
164374104|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
164374105|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
164374106|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
164374107|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164374108|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164374109|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164374110|NCT04019041|593742262|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374111|NCT04019041|593742263|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374112|NCT04019041|593742264|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
164374113|NCT04019041|593742265|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374114|NCT04019041|593742266|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374115|NCT04019041|593742267|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
164374116|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164374117|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164374118|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164374119|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
164374120|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
164374121|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
164374122|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374123|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374124|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374125|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
164374126|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374127|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
164374128|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374129|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374130|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374131|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374132|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
164374133|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
164374134|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164374135|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164374136|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164374137|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
164374138|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
164374139|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
164374140|NCT04019041|593742262|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374141|NCT04019041|593742263|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374142|NCT04019041|593742264|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374143|NCT04019041|593742265|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164374144|NCT04019041|593742266|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
164374145|NCT04019041|593742267|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
164374146|NCT03925727|593742268|FG000|Overall Study|Adverse Event|4|||
164374147|NCT03925727|593742269|FG001|Overall Study|Adverse Event|0|||
164374148|NCT03925727|593742270|FG002|Overall Study|Adverse Event|3|||
164374149|NCT03925727|593742268|FG000|Overall Study|Protocol Violation|1|||
164374150|NCT03925727|593742269|FG001|Overall Study|Protocol Violation|2|||
164374151|NCT03925727|593742270|FG002|Overall Study|Protocol Violation|2|||
164374152|NCT03925727|593742268|FG000|Overall Study|Withdrawal by Subject|3|||
164374153|NCT03925727|593742269|FG001|Overall Study|Withdrawal by Subject|2|||
164374154|NCT03925727|593742270|FG002|Overall Study|Withdrawal by Subject|4|||
164374155|NCT03925727|593742268|FG000|Overall Study|Administrative Reasons|3|||
164012608|NCT04003155|592410549|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
164012609|NCT04003155|592410550|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
164012610|NCT04003155|592410551|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
164012611|NCT04003155|592410552|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
164012612|NCT04003155|592410553|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
164374156|NCT03925727|593742269|FG001|Overall Study|Administrative Reasons|1|||
164374157|NCT03925727|593742270|FG002|Overall Study|Administrative Reasons|2|||
164374158|NCT03925727|593742268|FG000|Overall Study|Randomized in error or Disqualified|8|||
164374159|NCT03925727|593742269|FG001|Overall Study|Randomized in error or Disqualified|1|||
164374160|NCT03925727|593742270|FG002|Overall Study|Randomized in error or Disqualified|7|||
164374161|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
164374162|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
164374163|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
164374164|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
164374165|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
164374166|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
164374167|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
164374168|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
164374169|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
164374170|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
164374171|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
164374172|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
164374173|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
164374174|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
164374175|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
164374176|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
164374177|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
164374178|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
164374179|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
164374180|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
164374181|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Other|3|||
164374182|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Other|0|||
164374183|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Other|2|||
164374184|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Other|2|||
164374185|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Other|7|||
164374186|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374187|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374188|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374189|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
164374190|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374191|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374192|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374193|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374194|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374195|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
164374196|NCT00213148|593742271|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
164374197|NCT00213148|593742272|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
164374198|NCT00213148|593742273|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
164374199|NCT00213148|593742274|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
164374200|NCT00213148|593742275|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
164374201|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
164374202|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
164374203|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
164374204|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
164374205|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
164374206|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
164374207|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
164374208|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
164374209|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
164374210|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
164374211|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Other|2|||
164374212|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Other|1|||
164374213|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Other|2|||
164374214|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Other|8|||
164374215|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Other|7|||
164374216|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374217|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
164374218|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374219|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374220|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
164374221|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
164374222|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374223|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374224|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374225|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
164374226|NCT00213148|593742271|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
164374227|NCT00213148|593742272|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
164374228|NCT00213148|593742273|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
164374229|NCT00213148|593742274|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
164374230|NCT00213148|593742275|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
164374231|NCT00213148|593742271|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
164374232|NCT00213148|593742272|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
164374233|NCT00213148|593742273|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
164374234|NCT00213148|593742274|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
164374235|NCT00213148|593742275|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
164374236|NCT00213148|593742271|FG000|Cycle 3 (1 Month)|Other|0|||
164374237|NCT00213148|593742272|FG001|Cycle 3 (1 Month)|Other|0|||
164374238|NCT00213148|593742273|FG002|Cycle 3 (1 Month)|Other|1|||
164374239|NCT00213148|593742274|FG003|Cycle 3 (1 Month)|Other|1|||
164374240|NCT00213148|593742275|FG004|Cycle 3 (1 Month)|Other|0|||
164374241|NCT02321462|593742278|FG000|Overall Study|Withdrawal by Subject|5|||
164374242|NCT02321462|593742279|FG001|Overall Study|Withdrawal by Subject|2|||
164374243|NCT02321462|593742278|FG000|Overall Study|Subject withdrawn before any treatment|1|||
164374244|NCT02321462|593742279|FG001|Overall Study|Subject withdrawn before any treatment|1|||
164012613|NCT04003155|592410549|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
164012614|NCT04003155|592410550|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
164012615|NCT04003155|592410551|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
164374245|NCT03044197|593742283|FG000|Overall Study|Withdrawal by Subject|3|||
164374246|NCT03044197|593742284|FG001|Overall Study|Withdrawal by Subject|1|||
164374247|NCT01574352|593742286|FG000|Overall Study|Withdrawal by Subject|6|||
164374248|NCT01574352|593742287|FG001|Overall Study|Withdrawal by Subject|13|||
164374249|NCT01574352|593742286|FG000|Overall Study|Injury in non-camp related sport|1|||
164374250|NCT01574352|593742287|FG001|Overall Study|Injury in non-camp related sport|0|||
164374251|NCT00245765|593742288|FG000|Overall Study|Adverse Event|1|||
164374252|NCT00245765|593742289|FG001|Overall Study|Adverse Event|1|||
164374253|NCT00245765|593742290|FG002|Overall Study|Adverse Event|0|||
164374254|NCT00245765|593742288|FG000|Overall Study|Lack of Efficacy|14|||
164374255|NCT00245765|593742289|FG001|Overall Study|Lack of Efficacy|7|||
164374256|NCT00245765|593742290|FG002|Overall Study|Lack of Efficacy|0|||
164374257|NCT00245765|593742288|FG000|Overall Study|Lost to Follow-up|1|||
164374258|NCT00245765|593742289|FG001|Overall Study|Lost to Follow-up|2|||
164374259|NCT00245765|593742290|FG002|Overall Study|Lost to Follow-up|0|||
164374260|NCT00245765|593742288|FG000|Overall Study|Withdrawal by Subject|1|||
164374261|NCT00245765|593742289|FG001|Overall Study|Withdrawal by Subject|0|||
164374262|NCT00245765|593742290|FG002|Overall Study|Withdrawal by Subject|3|||
164374263|NCT00245765|593742288|FG000|Overall Study|Other reason|2|||
164374264|NCT00245765|593742289|FG001|Overall Study|Other reason|0|||
164374265|NCT00245765|593742290|FG002|Overall Study|Other reason|1|||
164374266|NCT00245765|593742288|FG000|Overall Study|Other|13|||
164374267|NCT00245765|593742289|FG001|Overall Study|Other|4|||
164374268|NCT00245765|593742290|FG002|Overall Study|Other|4|||
164374269|NCT00660348|593742291|FG000|Overall Study|Withdrawal by Subject|1|||
164374270|NCT00660348|593742292|FG001|Overall Study|Withdrawal by Subject|0|||
164374271|NCT02741115|593742293|FG000|Overall Study|Adverse Event|1|||
164374272|NCT02741115|593742294|FG001|Overall Study|Adverse Event|0|||
164374273|NCT02741115|593742293|FG000|Overall Study|Lost to Follow-up|7|||
164374274|NCT02741115|593742294|FG001|Overall Study|Lost to Follow-up|4|||
164374275|NCT02741115|593742293|FG000|Overall Study|Withdrawal by Subject|4|||
164374276|NCT02741115|593742294|FG001|Overall Study|Withdrawal by Subject|2|||
164374277|NCT06425458|593742295|FG000|Overall Study|Removed by study team|2|||
164374278|NCT06425458|593742295|FG000|Overall Study|Lost to Follow-up|5|||
164374279|NCT03945981|593742298|FG000|Overall Study|Lost to Follow-up|12|||
164374280|NCT03945981|593742298|FG000|Overall Study|Physician Decision|4|||
164092781|NCT02130466|592702144|FG011|Overall Study|Physician Decision|0|||
164374281|NCT03945981|593742298|FG000|Overall Study|Withdrawal by Subject|6|||
164374282|NCT03945981|593742298|FG000|Overall Study|Protocol Violation|1|||
164374283|NCT00256698|593742301|FG000|Overall Study|Withdrawal by Subject|7|||
164374284|NCT00256698|593742302|FG001|Overall Study|Withdrawal by Subject|7|||
164374285|NCT00256698|593742301|FG000|Overall Study|Adverse Event|13|||
164374286|NCT00256698|593742302|FG001|Overall Study|Adverse Event|6|||
164374287|NCT00256698|593742301|FG000|Overall Study|Protocol Violation|6|||
164374288|NCT00256698|593742302|FG001|Overall Study|Protocol Violation|5|||
164374289|NCT00256698|593742301|FG000|Overall Study|Lost to Follow-up|1|||
164374290|NCT00256698|593742302|FG001|Overall Study|Lost to Follow-up|3|||
164374291|NCT00256698|593742301|FG000|Overall Study|disease progression|97|||
164374292|NCT00256698|593742302|FG001|Overall Study|disease progression|105|||
164374293|NCT00256698|593742301|FG000|Overall Study|still ongoing at data cut-off|41|||
164374294|NCT00256698|593742302|FG001|Overall Study|still ongoing at data cut-off|46|||
164374295|NCT00256698|593742301|FG000|Overall Study|withdrawn due to osteoporosis|1|||
164374296|NCT00256698|593742302|FG001|Overall Study|withdrawn due to osteoporosis|0|||
164374297|NCT00256698|593742301|FG000|Overall Study|Prematurely Discontinued|1|||
164374298|NCT00256698|593742302|FG001|Overall Study|Prematurely Discontinued|0|||
164374299|NCT03548584|593743528|FG000|Overall Study|Lost to Follow-up|0|||
164374300|NCT03548584|593743529|FG001|Overall Study|Lost to Follow-up|0|||
164374301|NCT03548584|593743530|FG002|Overall Study|Lost to Follow-up|1|||
164374302|NCT03548584|593743528|FG000|Overall Study|Adverse Event|1|||
164374303|NCT03548584|593743529|FG001|Overall Study|Adverse Event|11|||
164374304|NCT03548584|593743530|FG002|Overall Study|Adverse Event|5|||
164374305|NCT03548584|593743528|FG000|Overall Study|Site Terminated by Sponsor|1|||
164374306|NCT03548584|593743529|FG001|Overall Study|Site Terminated by Sponsor|3|||
164374307|NCT03548584|593743530|FG002|Overall Study|Site Terminated by Sponsor|2|||
164374308|NCT03548584|593743528|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
164374309|NCT03548584|593743529|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
164374310|NCT03548584|593743530|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
164374311|NCT03548584|593743528|FG000|Overall Study|Lack of Efficacy|0|||
164374312|NCT03548584|593743529|FG001|Overall Study|Lack of Efficacy|1|||
164374313|NCT03548584|593743530|FG002|Overall Study|Lack of Efficacy|0|||
164374314|NCT03548584|593743528|FG000|Overall Study|Non-compliance with Study Drug|0|||
164374315|NCT03548584|593743529|FG001|Overall Study|Non-compliance with Study Drug|1|||
164374316|NCT03548584|593743530|FG002|Overall Study|Non-compliance with Study Drug|0|||
164374317|NCT03548584|593743528|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
164374318|NCT03548584|593743529|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
164374319|NCT03548584|593743530|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
164374320|NCT04346615|593743531|FG000|Overall Study|Lost to Follow-up|0|||
164374321|NCT04346615|593743532|FG001|Overall Study|Lost to Follow-up|2|||
164374322|NCT04346615|593743531|FG000|Overall Study|Withdrawal by Subject|1|||
164374323|NCT04346615|593743532|FG001|Overall Study|Withdrawal by Subject|0|||
164374324|NCT04346615|593743531|FG000|Overall Study|Death|5|||
164374325|NCT04346615|593743532|FG001|Overall Study|Death|1|||
164374326|NCT04346615|593743531|FG000|Overall Study|Other|0|||
164374327|NCT04346615|593743532|FG001|Overall Study|Other|2|||
164374328|NCT04346615|593743531|FG000|Overall Study|Randomized not treated|1|||
164374329|NCT04346615|593743532|FG001|Overall Study|Randomized not treated|0|||
164374330|NCT02096835|593743537|FG000|Overall Study|Withdrawal by Subject|1|||
164374331|NCT02096835|593743538|FG001|Overall Study|Withdrawal by Subject|0|||
164374332|NCT02096835|593743539|FG002|Overall Study|Withdrawal by Subject|0|||
164374333|NCT02096835|593743537|FG000|Overall Study|converted to open procedures|1|||
164374334|NCT02096835|593743538|FG001|Overall Study|converted to open procedures|0|||
164374335|NCT02096835|593743539|FG002|Overall Study|converted to open procedures|0|||
164374336|NCT02096835|593743537|FG000|Overall Study|Lost to Follow-up|1|||
164374337|NCT02096835|593743538|FG001|Overall Study|Lost to Follow-up|0|||
164374338|NCT02096835|593743539|FG002|Overall Study|Lost to Follow-up|1|||
164374339|NCT01677195|593743540|FG000|Overall Study|Lost to Follow-up|14|||
164374340|NCT01677195|593743541|FG001|Overall Study|Lost to Follow-up|22|||
164374341|NCT01677195|593743542|FG002|Overall Study|Lost to Follow-up|22|||
164374342|NCT01677195|593743540|FG000|Overall Study|Withdrawal by Subject|1|||
164374343|NCT01677195|593743541|FG001|Overall Study|Withdrawal by Subject|0|||
164374344|NCT01677195|593743542|FG002|Overall Study|Withdrawal by Subject|1|||
164374345|NCT01677195|593743540|FG000|Overall Study|Adverse Event|6|||
164374346|NCT01677195|593743541|FG001|Overall Study|Adverse Event|4|||
164374347|NCT01677195|593743542|FG002|Overall Study|Adverse Event|1|||
164374348|NCT01677195|593743540|FG000|Overall Study|Physician Decision|1|||
164374349|NCT01677195|593743541|FG001|Overall Study|Physician Decision|2|||
164374350|NCT01677195|593743542|FG002|Overall Study|Physician Decision|2|||
164374351|NCT01677195|593743540|FG000|Overall Study|Pregnancy|0|||
164374352|NCT01677195|593743541|FG001|Overall Study|Pregnancy|1|||
164374353|NCT01677195|593743542|FG002|Overall Study|Pregnancy|0|||
164374354|NCT01677195|593743540|FG000|Overall Study|Protocol Violation|7|||
164374355|NCT01677195|593743541|FG001|Overall Study|Protocol Violation|3|||
164374356|NCT01677195|593743542|FG002|Overall Study|Protocol Violation|4|||
164374357|NCT04368429|593743543|FG000|Overall Study|Adverse Event|1|||
164374358|NCT04368429|593743544|FG001|Overall Study|Adverse Event|0|||
164374359|NCT03633396|593743547|FG000|Overall Study|Withdrawal by Subject|4|||
164374360|NCT03633396|593743548|FG001|Overall Study|Withdrawal by Subject|4|||
164374361|NCT03633396|593743547|FG000|Overall Study|Adverse Event|1|||
164374362|NCT03633396|593743548|FG001|Overall Study|Adverse Event|1|||
164374363|NCT03633396|593743547|FG000|Overall Study|Lack of Efficacy|1|||
164374364|NCT03633396|593743548|FG001|Overall Study|Lack of Efficacy|0|||
164374365|NCT03633396|593743547|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
164374366|NCT03633396|593743548|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
164374367|NCT00023673|593743549|FG000|Overall Study|Ineligible / no protocol treatment|0|||
164374368|NCT00023673|593743550|FG001|Overall Study|Ineligible / no protocol treatment|0|||
164374369|NCT00023673|593743551|FG002|Overall Study|Ineligible / no protocol treatment|0|||
164374370|NCT00023673|593743552|FG003|Overall Study|Ineligible / no protocol treatment|1|||
164374371|NCT00023673|593743549|FG000|Overall Study|Patient withdrew consent|0|||
164374372|NCT00023673|593743550|FG001|Overall Study|Patient withdrew consent|0|||
164374373|NCT00023673|593743551|FG002|Overall Study|Patient withdrew consent|0|||
164374374|NCT00023673|593743552|FG003|Overall Study|Patient withdrew consent|1|||
164374375|NCT00110266|593743553|FG000|Overall Study|Adverse Event|27|||
164374376|NCT00110266|593743553|FG000|Overall Study|Abnormal laboratory value|15|||
164374377|NCT00110266|593743553|FG000|Overall Study|Withdrawal by Subject|16|||
164374378|NCT00110266|593743553|FG000|Overall Study|Death|17|||
164374379|NCT00110266|593743553|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164374380|NCT00110266|593743553|FG000|Overall Study|Participant condition no longer requires study drug|1|||
164374381|NCT00667342|593743558|FG000|Overall Study|Protocol Violation|1|||
164374382|NCT00667342|593743559|FG001|Overall Study|Protocol Violation|0|||
164374383|NCT00667342|593743560|FG002|Overall Study|Protocol Violation|0|||
164374384|NCT00667342|593743558|FG000|Overall Study|Withdrawal by Subject|1|||
164374385|NCT00667342|593743559|FG001|Overall Study|Withdrawal by Subject|0|||
164374386|NCT00667342|593743560|FG002|Overall Study|Withdrawal by Subject|0|||
164374387|NCT00667342|593743558|FG000|Overall Study|Physician Decision|3|||
164374388|NCT00667342|593743559|FG001|Overall Study|Physician Decision|0|||
164374389|NCT00667342|593743560|FG002|Overall Study|Physician Decision|0|||
164374390|NCT00667342|593743558|FG000|Overall Study|Relapse or tumor progression|9|||
164374391|NCT00667342|593743559|FG001|Overall Study|Relapse or tumor progression|0|||
164374392|NCT00667342|593743560|FG002|Overall Study|Relapse or tumor progression|7|||
164374393|NCT00667342|593743558|FG000|Overall Study|Adverse Event|0|||
164374394|NCT00667342|593743559|FG001|Overall Study|Adverse Event|0|||
164374395|NCT00667342|593743560|FG002|Overall Study|Adverse Event|1|||
164374396|NCT00667342|593743558|FG000|Overall Study|Ineligible|0|||
164374397|NCT00667342|593743559|FG001|Overall Study|Ineligible|0|||
164374398|NCT00667342|593743560|FG002|Overall Study|Ineligible|1|||
164374399|NCT01433263|593743561|FG000|Overall Study|Adverse Event|3|||
164374400|NCT01433263|593743562|FG001|Overall Study|Adverse Event|1|||
164374401|NCT01433263|593743561|FG000|Overall Study|Death|5|||
164374402|NCT01433263|593743562|FG001|Overall Study|Death|3|||
164374403|NCT01433263|593743561|FG000|Overall Study|Lost to Follow-up|0|||
164374404|NCT01433263|593743562|FG001|Overall Study|Lost to Follow-up|1|||
164374405|NCT01433263|593743561|FG000|Overall Study|Protocol Deviation|1|||
164374406|NCT01433263|593743562|FG001|Overall Study|Protocol Deviation|0|||
164374407|NCT01433263|593743561|FG000|Overall Study|Withdrawal by Subject|10|||
164374408|NCT01433263|593743562|FG001|Overall Study|Withdrawal by Subject|7|||
164374409|NCT00293384|593743563|FG000|Overall Study|Non-compliance|2|||
164374410|NCT00293384|593743563|FG000|Overall Study|Missed dosage/study drug|1|||
164012616|NCT04003155|592410552|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
164374411|NCT00293384|593743563|FG000|Overall Study|Ineligible|2|||
164374412|NCT04709237|593743565|FG000|Overall Study|Lost to Follow-up|1|||
164374413|NCT04709237|593743566|FG001|Overall Study|Lost to Follow-up|0|||
164374414|NCT04709237|593743567|FG002|Overall Study|Lost to Follow-up|0|||
164374415|NCT02610192|593743568|FG000|Overall Study|Received other treatment|8|||
164374416|NCT02610192|593743568|FG000|Overall Study|Physician Decision|1|||
164374417|NCT00326612|593743576|FG000|Overall Study|They did not have a seizure requiring tx|129|||
164374418|NCT00326612|593743577|FG001|Overall Study|They did not have a seizure requiring tx|137|||
164374419|NCT00419562|593743578|FG000|Overall Study|Lost to Follow-up|12|||
164374420|NCT00419562|593743579|FG001|Overall Study|Lost to Follow-up|13|||
164374421|NCT00419562|593743578|FG000|Overall Study|Withdrawal by Subject|20|||
164374422|NCT00419562|593743579|FG001|Overall Study|Withdrawal by Subject|18|||
164374423|NCT00419562|593743578|FG000|Overall Study|Participant Institutionalized|1|||
164374424|NCT00419562|593743579|FG001|Overall Study|Participant Institutionalized|0|||
164374425|NCT00640510|593743580|FG000|Overall Study|Lack of Efficacy|0|||
164374426|NCT00640510|593743581|FG001|Overall Study|Lack of Efficacy|1|||
164374427|NCT00640510|593743580|FG000|Overall Study|Protocol Violation|1|||
164374428|NCT00640510|593743581|FG001|Overall Study|Protocol Violation|0|||
164374429|NCT00640510|593743580|FG000|Overall Study|Physician Decision|0|||
164374430|NCT00640510|593743581|FG001|Overall Study|Physician Decision|1|||
164374431|NCT00355238|593743582|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164374432|NCT00355238|593743583|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164374433|NCT00355238|593743584|FG002|Overall Study|Adverse event unrelated to study drug|0|||
164374434|NCT00355238|593743585|FG003|Overall Study|Adverse event unrelated to study drug|1|||
164374435|NCT00355238|593743582|FG000|Overall Study|Death|1|||
164374436|NCT00355238|593743583|FG001|Overall Study|Death|0|||
164374437|NCT00355238|593743584|FG002|Overall Study|Death|0|||
164374438|NCT00355238|593743585|FG003|Overall Study|Death|0|||
164374439|NCT00355238|593743582|FG000|Overall Study|Disease progression|37|||
164374440|NCT00355238|593743583|FG001|Overall Study|Disease progression|36|||
164374441|NCT00355238|593743584|FG002|Overall Study|Disease progression|16|||
164374442|NCT00355238|593743585|FG003|Overall Study|Disease progression|11|||
164374443|NCT00355238|593743582|FG000|Overall Study|Study drug toxicity|11|||
164374444|NCT00355238|593743583|FG001|Overall Study|Study drug toxicity|7|||
164374445|NCT00355238|593743584|FG002|Overall Study|Study drug toxicity|5|||
164374446|NCT00355238|593743585|FG003|Overall Study|Study drug toxicity|2|||
164374447|NCT00355238|593743582|FG000|Overall Study|Participant withdrew consent|3|||
164374448|NCT00355238|593743583|FG001|Overall Study|Participant withdrew consent|1|||
164374449|NCT00355238|593743584|FG002|Overall Study|Participant withdrew consent|0|||
164374450|NCT00355238|593743585|FG003|Overall Study|Participant withdrew consent|0|||
164374451|NCT00355238|593743582|FG000|Overall Study|Participant request to discontinue study treatment|1|||
164374452|NCT00355238|593743583|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164374453|NCT00355238|593743584|FG002|Overall Study|Participant request to discontinue study treatment|1|||
164374454|NCT00355238|593743585|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164374455|NCT00480636|593743586|FG000|Overall Study|Death|12|||
164374456|NCT00480636|593743586|FG000|Overall Study|Lost to Follow-up|4|||
164374457|NCT00480636|593743586|FG000|Overall Study|Other|2|||
164374458|NCT00480636|593743586|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
164374459|NCT02506816|593743587|FG000|Overall Study|Adverse Event|3|||
164374460|NCT00546715|593743590|FG000|Overall Study|Withdrawal by Subject|0|||
164374461|NCT00546715|593743591|FG001|Overall Study|Withdrawal by Subject|1|||
164374462|NCT00546715|593743592|FG002|Overall Study|Withdrawal by Subject|0|||
164374463|NCT00546715|593743593|FG003|Overall Study|Withdrawal by Subject|0|||
164374464|NCT02477020|593743596|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
164374465|NCT02477020|593743597|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
164374466|NCT02477020|593743596|FG000|Overall Study|Voluntary Withdrawal|7|||
164374467|NCT02477020|593743597|FG001|Overall Study|Voluntary Withdrawal|16|||
164374468|NCT02477020|593743596|FG000|Overall Study|Reason not Specified|3|||
164374469|NCT02477020|593743597|FG001|Overall Study|Reason not Specified|1|||
164374470|NCT02477020|593743596|FG000|Overall Study|Lack of Efficacy|14|||
164374471|NCT02477020|593743597|FG001|Overall Study|Lack of Efficacy|5|||
164374472|NCT03852316|593743598|FG000|Overall Study|Protocol Violation|1|||
164374473|NCT03852316|593743598|FG000|Overall Study|Withdrawal by Subject|2|||
164374474|NCT03852316|593743598|FG000|Overall Study|Enrolled but Device not Utilized|1|||
164374475|NCT01049919|593743599|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
164374476|NCT01049919|593743600|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
164374477|NCT01049919|593743599|FG000|Overall Study|Withdrawal by Subject|5|||
164374478|NCT01049919|593743600|FG001|Overall Study|Withdrawal by Subject|0|||
164374479|NCT01049919|593743599|FG000|Overall Study|Lost to Follow-up|6|||
164374480|NCT01049919|593743600|FG001|Overall Study|Lost to Follow-up|1|||
164374481|NCT01049919|593743599|FG000|Overall Study|Physician Decision|2|||
164374482|NCT01049919|593743600|FG001|Overall Study|Physician Decision|0|||
164374483|NCT01049919|593743599|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
164374484|NCT01049919|593743600|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
164374485|NCT01049919|593743599|FG000|Overall Study|Early study termination by sponsor.|2|||
164374486|NCT01049919|593743600|FG001|Overall Study|Early study termination by sponsor.|0|||
164374487|NCT04354831|593743601|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
164374488|NCT04354831|593743602|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
164374489|NCT01018264|593743603|FG000|Overall Study|Withdrawal by Subject|1|||
164012617|NCT04003155|592410553|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
164012618|NCT04003155|592410549|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
164012619|NCT04003155|592410550|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
164012620|NCT04003155|592410551|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
164012621|NCT04003155|592410552|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
164012622|NCT04003155|592410553|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
164374490|NCT01018264|593743604|FG001|Overall Study|Withdrawal by Subject|0|||
164374491|NCT01018264|593743603|FG000|Overall Study|Lost to Follow-up|0|||
164374492|NCT01018264|593743604|FG001|Overall Study|Lost to Follow-up|1|||
164374493|NCT02504372|593743605|FG000|Overall Study|Death|136|||
164374494|NCT02504372|593743606|FG001|Overall Study|Death|154|||
164374495|NCT02504372|593743605|FG000|Overall Study|Lost to Follow-up|0|||
164374496|NCT02504372|593743606|FG001|Overall Study|Lost to Follow-up|2|||
164374497|NCT02504372|593743605|FG000|Overall Study|Withdrawal of consent|25|||
164374498|NCT02504372|593743606|FG001|Overall Study|Withdrawal of consent|16|||
164374499|NCT02504372|593743605|FG000|Overall Study|Participants ongoing|429|||
164374500|NCT02504372|593743606|FG001|Overall Study|Participants ongoing|415|||
164374501|NCT03491150|593743608|FG000|Overall Study|Adverse Event|1|||
164374502|NCT03491150|593743609|FG001|Overall Study|Adverse Event|0|||
164374503|NCT03491150|593743608|FG000|Overall Study|Study Terminated by Sponsor|74|||
164374504|NCT03491150|593743609|FG001|Overall Study|Study Terminated by Sponsor|70|||
164374505|NCT03491150|593743608|FG000|Overall Study|Other|0|||
164374506|NCT03491150|593743609|FG001|Overall Study|Other|1|||
164374507|NCT03491150|593743608|FG000|Overall Study|Withdrawal by Subject|1|||
164374508|NCT03491150|593743609|FG001|Overall Study|Withdrawal by Subject|2|||
164374509|NCT05179421|593743612|FG000|First Infusion Day|Adverse Event|1|||
164374510|NCT05179421|593743613|FG001|First Infusion Day|Adverse Event|0|||
164374511|NCT00813124|593743615|FG000|Overall Study|Death|2|||
164374512|NCT00813124|593743615|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
164374513|NCT00813124|593743615|FG000|Overall Study|Withdrawal by Subject|1|||
164374514|NCT03746522|593743616|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
164374515|NCT03746522|593743617|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
164374516|NCT03746522|593743618|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
164374517|NCT03746522|593743616|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
164374518|NCT03746522|593743617|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
164374519|NCT03746522|593743618|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
164374520|NCT03746522|593743616|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
164374521|NCT03746522|593743617|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
164374522|NCT03746522|593743618|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
164374523|NCT03746522|593743616|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
164374524|NCT03746522|593743617|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
164374525|NCT03746522|593743618|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
164374526|NCT03746522|593743616|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
164374527|NCT03746522|593743617|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
164374528|NCT03746522|593743618|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
164374529|NCT03323099|593743619|FG000|Overall Study|Withdrawal by Subject|6|||
164374530|NCT03323099|593743620|FG001|Overall Study|Withdrawal by Subject|12|||
164374531|NCT03323099|593743619|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
164374532|NCT03323099|593743620|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
164374533|NCT00767676|593743621|FG000|Overall Study|Investigator error|54|||
164374534|NCT02052739|593743623|FG000|Overall Study|Withdrew due to Adverse Event|3|||
164374535|NCT02052739|593743624|FG001|Overall Study|Withdrew due to Adverse Event|0|||
164374536|NCT02052739|593743623|FG000|Overall Study|Participant Died|2|||
164374537|NCT02052739|593743624|FG001|Overall Study|Participant Died|1|||
164374538|NCT04907032|593743625|FG000|Overall Study|Withdrawal by Subject|7|||
164374539|NCT04907032|593743626|FG001|Overall Study|Withdrawal by Subject|1|||
164374540|NCT03962543|593743643|FG000|Treatment Phase|Death|0|||
164374541|NCT03962543|593743644|FG001|Treatment Phase|Death|1|||
164374542|NCT03962543|593743643|FG000|Treatment Phase|Withdrawal by Subject|3|||
164374543|NCT03962543|593743644|FG001|Treatment Phase|Withdrawal by Subject|0|||
164374544|NCT03962543|593743643|FG000|Treatment Phase|Adverse Event|3|||
164374545|NCT03962543|593743644|FG001|Treatment Phase|Adverse Event|12|||
164374546|NCT03962543|593743643|FG000|Treatment Phase|Lost to Follow-up|1|||
164374547|NCT03962543|593743644|FG001|Treatment Phase|Lost to Follow-up|2|||
164374548|NCT03962543|593743643|FG000|Treatment Phase|Radiographic PD|9|||
164374549|NCT03962543|593743644|FG001|Treatment Phase|Radiographic PD|3|||
164374550|NCT03962543|593743643|FG000|Treatment Phase|Participant Decision|3|||
164374551|NCT03962543|593743644|FG001|Treatment Phase|Participant Decision|8|||
164374552|NCT03962543|593743643|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
164374553|NCT03962543|593743644|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
164374554|NCT03962543|593743643|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
164374555|NCT03962543|593743644|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
164374556|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
164374557|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
164374558|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
164374559|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
164012623|NCT01912872|592410557|FG000|Overall Study|Lost to Follow-up|2|||
164374560|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
164374561|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
164374562|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
164374563|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
164374564|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
164374565|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
164374566|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
164374567|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
164374568|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
164374569|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
164374570|NCT03962543|593743643|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
164374571|NCT03962543|593743644|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
164374572|NCT02777125|593743645|FG000|Overall Study|Consent form violation|14|||
164374573|NCT02777125|593743646|FG001|Overall Study|Consent form violation|12|||
164374574|NCT02777125|593743645|FG000|Overall Study|Assent form violation|21|||
164374575|NCT02777125|593743646|FG001|Overall Study|Assent form violation|23|||
164374576|NCT02777125|593743645|FG000|Overall Study|Protocol Violation|8|||
164374577|NCT02777125|593743646|FG001|Overall Study|Protocol Violation|12|||
164374578|NCT02917031|593743647|FG000|Overall Study|Reason not specified|7|||
164374579|NCT02917031|593743648|FG001|Overall Study|Reason not specified|5|||
164374580|NCT02917031|593743649|FG002|Overall Study|Reason not specified|6|||
164374581|NCT02917031|593743647|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
164374582|NCT02917031|593743648|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
164374583|NCT02917031|593743649|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
164374584|NCT02917031|593743647|FG000|Overall Study|Withdrawal by Subject|3|||
164374585|NCT02917031|593743648|FG001|Overall Study|Withdrawal by Subject|3|||
164374586|NCT02917031|593743649|FG002|Overall Study|Withdrawal by Subject|0|||
164374587|NCT02917031|593743647|FG000|Overall Study|Physician Decision|1|||
164374588|NCT02917031|593743648|FG001|Overall Study|Physician Decision|0|||
164374589|NCT02917031|593743649|FG002|Overall Study|Physician Decision|0|||
164374590|NCT02917031|593743647|FG000|Overall Study|Adverse Event|4|||
164374591|NCT02917031|593743648|FG001|Overall Study|Adverse Event|1|||
164374592|NCT02917031|593743649|FG002|Overall Study|Adverse Event|5|||
164374593|NCT02917031|593743647|FG000|Overall Study|Death|2|||
164374594|NCT02917031|593743648|FG001|Overall Study|Death|3|||
164374595|NCT02917031|593743649|FG002|Overall Study|Death|4|||
164374596|NCT02742103|593745347|FG000|Overall Study|Protocol Violation|1|||
164374597|NCT02742103|593745348|FG001|Overall Study|Protocol Violation|0|||
164374598|NCT02742103|593745347|FG000|Overall Study|Death|2|||
164374599|NCT02742103|593745348|FG001|Overall Study|Death|2|||
164374600|NCT02742103|593745347|FG000|Overall Study|Adverse Event|1|||
164374601|NCT02742103|593745348|FG001|Overall Study|Adverse Event|0|||
164374602|NCT02742103|593745347|FG000|Overall Study|Moved to another town|0|||
164374603|NCT02742103|593745348|FG001|Overall Study|Moved to another town|1|||
164374604|NCT02742103|593745347|FG000|Overall Study|Withdrawal by Subject|5|||
164374605|NCT02742103|593745348|FG001|Overall Study|Withdrawal by Subject|2|||
164374606|NCT00533949|593745351|FG000|Overall Study|Protocol Violation|12|||
164374607|NCT00533949|593745352|FG001|Overall Study|Protocol Violation|12|||
164374608|NCT00533949|593745353|FG002|Overall Study|Protocol Violation|9|||
164374609|NCT00533949|593745354|FG003|Overall Study|Protocol Violation|9|||
164374610|NCT00533949|593745351|FG000|Overall Study|Withdrawal by Subject|3|||
164374611|NCT00533949|593745352|FG001|Overall Study|Withdrawal by Subject|2|||
164374612|NCT00533949|593745353|FG002|Overall Study|Withdrawal by Subject|1|||
164374613|NCT00533949|593745354|FG003|Overall Study|Withdrawal by Subject|1|||
164374614|NCT00727194|593745355|FG000|Screening Period|Low QMG scores|0|||
164374615|NCT00727194|593745356|FG001|Screening Period|Low QMG scores|0|||
164374616|NCT00727194|593745357|FG002|Screening Period|Low QMG scores|6|||
164374617|NCT00727194|593745355|FG000|Screening Period|Lacked AChR antibodies|0|||
164374618|NCT00727194|593745356|FG001|Screening Period|Lacked AChR antibodies|0|||
164374619|NCT00727194|593745357|FG002|Screening Period|Lacked AChR antibodies|5|||
164374620|NCT00727194|593745355|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
164374621|NCT00727194|593745356|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
164374622|NCT00727194|593745357|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
164374623|NCT00727194|593745355|FG000|Screening Period|Severe infections|0|||
164374624|NCT00727194|593745356|FG001|Screening Period|Severe infections|0|||
164374625|NCT00727194|593745357|FG002|Screening Period|Severe infections|2|||
164374626|NCT00727194|593745355|FG000|Screening Period|History of thymoma|0|||
164374627|NCT00727194|593745356|FG001|Screening Period|History of thymoma|0|||
164374628|NCT00727194|593745357|FG002|Screening Period|History of thymoma|1|||
164374629|NCT00727194|593745355|FG000|Treatment Period 2|Lack of Efficacy|0|||
164374630|NCT00727194|593745356|FG001|Treatment Period 2|Lack of Efficacy|1|||
164374631|NCT00727194|593745357|FG002|Treatment Period 2|Lack of Efficacy|0|||
164374632|NCT02349711|593745361|FG000|Overall Study|Withdrawal by Subject|2|||
164374633|NCT02349711|593745362|FG001|Overall Study|Withdrawal by Subject|1|||
164374634|NCT02349711|593745361|FG000|Overall Study|Lost to Follow-up|1|||
164374635|NCT02349711|593745362|FG001|Overall Study|Lost to Follow-up|1|||
164374636|NCT04269161|593745367|FG000|Overall Study|Change of modality and no longer eligible|3|||
164374637|NCT04269161|593745368|FG001|Overall Study|Change of modality and no longer eligible|3|||
164374638|NCT04269161|593745367|FG000|Overall Study|Required procedure outside of NICU|1|||
164374639|NCT04269161|593745368|FG001|Overall Study|Required procedure outside of NICU|0|||
164374640|NCT04269161|593745367|FG000|Overall Study|Equipment issue|1|||
164374641|NCT04269161|593745368|FG001|Overall Study|Equipment issue|1|||
164374642|NCT02472756|593745369|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
164374643|NCT02472756|593745369|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
164374644|NCT02472756|593745369|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
164374645|NCT02472756|593745369|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
164374646|NCT02472756|593745369|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
164374647|NCT01440322|593745373|FG000|Overall Study|Discomfort|2|||
164374648|NCT01440322|593745374|FG001|Overall Study|Discomfort|0|||
164374649|NCT01440322|593745373|FG000|Overall Study|Biomicroscopy|1|||
164374650|NCT01440322|593745374|FG001|Overall Study|Biomicroscopy|0|||
164374651|NCT01440322|593745373|FG000|Overall Study|Symptoms and Problems|1|||
164374652|NCT01440322|593745374|FG001|Overall Study|Symptoms and Problems|0|||
164374653|NCT01440322|593745373|FG000|Overall Study|Unacceptable Subjective Vision|1|||
164374654|NCT01440322|593745374|FG001|Overall Study|Unacceptable Subjective Vision|0|||
164374655|NCT01440322|593745373|FG000|Overall Study|Other Product Related|1|||
164374656|NCT01440322|593745374|FG001|Overall Study|Other Product Related|0|||
164374657|NCT01440322|593745373|FG000|Overall Study|Unrelated Medical Problem|0|||
164374658|NCT01440322|593745374|FG001|Overall Study|Unrelated Medical Problem|1|||
164374659|NCT01440322|593745373|FG000|Overall Study|Other Non-Product Related|1|||
164374660|NCT01440322|593745374|FG001|Overall Study|Other Non-Product Related|0|||
164374661|NCT04300296|593745376|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
164374662|NCT04300296|593745377|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374663|NCT04300296|593745378|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374664|NCT04300296|593745379|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374665|NCT04300296|593745380|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374666|NCT04300296|593745381|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
164374667|NCT04300296|593745376|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374668|NCT04300296|593745377|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374669|NCT04300296|593745378|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374670|NCT04300296|593745379|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374671|NCT04300296|593745380|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
164374672|NCT04300296|593745381|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
164374673|NCT04300296|593745376|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
164374674|NCT04300296|593745377|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
164374675|NCT04300296|593745378|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
164374676|NCT04300296|593745379|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
164374677|NCT04300296|593745380|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
164374678|NCT04300296|593745381|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
164374679|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
164374680|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
164374681|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
164374682|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
164374683|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
164374684|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
164374685|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
164374686|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
164374687|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
164374688|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
164374689|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
164012624|NCT01912872|592410558|FG001|Overall Study|Lost to Follow-up|3|||
164374690|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
164374691|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374692|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
164374693|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374694|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374695|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374696|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
164374697|NCT04300296|593745376|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
164374698|NCT04300296|593745377|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
164374699|NCT04300296|593745378|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
164374700|NCT04300296|593745379|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
164374701|NCT04300296|593745380|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
164374702|NCT04300296|593745381|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
164374703|NCT05044234|593745384|FG000|Overall Study|Lost to Follow-up|2|||
164374704|NCT05044234|593745385|FG001|Overall Study|Lost to Follow-up|1|||
164374705|NCT05044234|593745386|FG002|Overall Study|Lost to Follow-up|1|||
164374706|NCT05044234|593745387|FG003|Overall Study|Lost to Follow-up|2|||
164374707|NCT05044234|593745384|FG000|Overall Study|Withdrawal by Subject|6|||
164374708|NCT05044234|593745385|FG001|Overall Study|Withdrawal by Subject|4|||
164374709|NCT05044234|593745386|FG002|Overall Study|Withdrawal by Subject|5|||
164374710|NCT05044234|593745387|FG003|Overall Study|Withdrawal by Subject|8|||
164374711|NCT05044234|593745384|FG000|Overall Study|Study terminated by Sponsor|21|||
164374712|NCT05044234|593745385|FG001|Overall Study|Study terminated by Sponsor|21|||
164374713|NCT05044234|593745386|FG002|Overall Study|Study terminated by Sponsor|20|||
164374714|NCT05044234|593745387|FG003|Overall Study|Study terminated by Sponsor|14|||
164374715|NCT05044234|593745384|FG000|Overall Study|Other, not specified|0|||
164374716|NCT05044234|593745385|FG001|Overall Study|Other, not specified|0|||
164374717|NCT05044234|593745386|FG002|Overall Study|Other, not specified|1|||
164374718|NCT05044234|593745387|FG003|Overall Study|Other, not specified|2|||
164374719|NCT05044234|593745384|FG000|Overall Study|Delayed data entry|0|||
164374720|NCT05044234|593745385|FG001|Overall Study|Delayed data entry|0|||
164374721|NCT05044234|593745386|FG002|Overall Study|Delayed data entry|0|||
164374722|NCT05044234|593745387|FG003|Overall Study|Delayed data entry|1|||
164374723|NCT00279708|593745395|FG000|Overall Study|Withdrawal by Subject|2|||
164374724|NCT00279708|593745396|FG001|Overall Study|Withdrawal by Subject|3|||
164374725|NCT00279708|593745395|FG000|Overall Study|Adverse Event|1|||
164374726|NCT00279708|593745396|FG001|Overall Study|Adverse Event|1|||
164374727|NCT02624284|593745397|FG000|Overall Study|Withdrawal by Subject|3|||
164374728|NCT02624284|593745398|FG001|Overall Study|Withdrawal by Subject|6|||
164374729|NCT02624284|593745399|FG002|Overall Study|Withdrawal by Subject|3|||
164374730|NCT02624284|593745397|FG000|Overall Study|Protocol Violation|9|||
164374731|NCT02624284|593745398|FG001|Overall Study|Protocol Violation|10|||
164374732|NCT02624284|593745399|FG002|Overall Study|Protocol Violation|7|||
164374733|NCT02624284|593745397|FG000|Overall Study|Revealed exclusionary condition|2|||
164374734|NCT02624284|593745398|FG001|Overall Study|Revealed exclusionary condition|2|||
164374735|NCT02624284|593745399|FG002|Overall Study|Revealed exclusionary condition|0|||
164374736|NCT02624284|593745397|FG000|Overall Study|Adverse Event|0|||
164374737|NCT02624284|593745398|FG001|Overall Study|Adverse Event|0|||
164374738|NCT02624284|593745399|FG002|Overall Study|Adverse Event|1|||
164374739|NCT02940691|593745400|FG000|Overall Study|Lost to Follow-up|5|||
164374740|NCT02940691|593745400|FG000|Overall Study|Incarceration|1|||
164374741|NCT00812929|593745403|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
164374742|NCT00812929|593745404|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
164374743|NCT00812929|593745405|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
164374744|NCT00812929|593745406|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
164374745|NCT00812929|593745407|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
164374746|NCT00812929|593745408|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
164374747|NCT00812929|593745409|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
164374748|NCT00812929|593745410|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
164374749|NCT00812929|593745411|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
164374750|NCT00812929|593745412|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
164374751|NCT00812929|593745403|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
164374752|NCT00812929|593745404|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
164374753|NCT00812929|593745405|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
164374754|NCT00812929|593745406|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
164374755|NCT00812929|593745407|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
164374756|NCT00812929|593745408|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
164374757|NCT00812929|593745409|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
164374758|NCT00812929|593745410|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
164374759|NCT00812929|593745411|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
164374760|NCT00812929|593745412|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
164374761|NCT00812929|593745403|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
164374762|NCT00812929|593745404|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
164374763|NCT00812929|593745405|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
164374764|NCT00812929|593745406|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
164374765|NCT00812929|593745407|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
163902350|NCT05580003|592013099|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902351|NCT05580003|592013100|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902352|NCT05580003|592013101|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902353|NCT05580003|592013102|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902354|NCT05580003|592013103|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164012625|NCT01912872|592410559|FG002|Overall Study|Lost to Follow-up|5|||
164374766|NCT00812929|593745408|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
164374767|NCT00812929|593745409|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
164374768|NCT00812929|593745410|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
164374769|NCT00812929|593745411|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
164374770|NCT00812929|593745412|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
164374771|NCT02975934|593745414|FG000|Treatment Phase|Never initiated study drug|0|||
164374772|NCT02975934|593745415|FG001|Treatment Phase|Never initiated study drug|5|||
164374773|NCT02975934|593745416|FG002|Treatment Phase|Never initiated study drug|0|||
164374774|NCT02075840|593745417|FG000|Overall Study|Withdrawal by Subject|13|||
164374775|NCT02075840|593745418|FG001|Overall Study|Withdrawal by Subject|22|||
164374776|NCT02075840|593745417|FG000|Overall Study|Reason not specified|1|||
164374777|NCT02075840|593745418|FG001|Overall Study|Reason not specified|0|||
164374778|NCT02075840|593745417|FG000|Overall Study|Adverse Event|0|||
164374779|NCT02075840|593745418|FG001|Overall Study|Adverse Event|2|||
164374780|NCT02075840|593745417|FG000|Overall Study|Death|35|||
164374781|NCT02075840|593745418|FG001|Overall Study|Death|40|||
164374782|NCT02075840|593745417|FG000|Overall Study|Lost to Follow-up|3|||
164374783|NCT02075840|593745418|FG001|Overall Study|Lost to Follow-up|2|||
164374784|NCT02075840|593745417|FG000|Overall Study|Physician Decision|1|||
164374785|NCT02075840|593745418|FG001|Overall Study|Physician Decision|3|||
164374786|NCT02075840|593745417|FG000|Overall Study|Ongoing at CCOD|99|||
164374787|NCT02075840|593745418|FG001|Overall Study|Ongoing at CCOD|82|||
164374788|NCT02644967|593745444|FG000|Overall Study|Death|26|||
164374789|NCT02644967|593745444|FG000|Overall Study|Physician Decision|1|||
164374790|NCT02644967|593745444|FG000|Overall Study|Withdrawal by Subject|2|||
164374791|NCT02644967|593745444|FG000|Overall Study|Protocol Violation|1|||
164374792|NCT02644967|593745444|FG000|Overall Study|Progressive Disease|1|||
164374793|NCT02644967|593745444|FG000|Overall Study|Study Terminated by Sponsor|4|||
164374794|NCT02287896|593745445|FG000|Second Injection Visit|Withdrawal by Subject|0|||
164374795|NCT02287896|593745446|FG001|Second Injection Visit|Withdrawal by Subject|1|||
164374796|NCT01147653|593745451|FG000|Year 2|Withdrawal by Subject|2|||
164374797|NCT01147653|593745452|FG001|Year 2|Withdrawal by Subject|3|||
164374798|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
164374799|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
164374800|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
164374801|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
164374802|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
164374803|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
164374804|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
164374805|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
164374806|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
164374807|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
164374808|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
164374809|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
164374810|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
164374811|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
164374812|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
164374813|NCT00280566|593745453|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
164374814|NCT00280566|593745454|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
164374815|NCT00280566|593745455|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
164374816|NCT00280566|593745453|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
164374817|NCT00280566|593745454|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
164374818|NCT00280566|593745455|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
164374819|NCT00280566|593745453|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
164374820|NCT00280566|593745454|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
164374821|NCT00280566|593745455|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
164374822|NCT00280566|593745453|FG000|Period 2 Double Blind|Adverse Event|0|||
164374823|NCT00280566|593745454|FG001|Period 2 Double Blind|Adverse Event|11|||
164374824|NCT00280566|593745455|FG002|Period 2 Double Blind|Adverse Event|15|||
164374825|NCT00280566|593745453|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
164374826|NCT00280566|593745454|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
164374827|NCT00280566|593745455|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
164374828|NCT00280566|593745453|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
164374829|NCT00280566|593745454|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
164374830|NCT00280566|593745455|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
164374831|NCT00280566|593745453|FG000|Period 2 Double Blind|miscellaneous|0|||
164374832|NCT00280566|593745454|FG001|Period 2 Double Blind|miscellaneous|10|||
164374833|NCT00280566|593745455|FG002|Period 2 Double Blind|miscellaneous|5|||
164374834|NCT01077960|593745458|FG000|Overall Study|Adverse Event|6|||
164374835|NCT01077960|593745458|FG000|Overall Study|Protocol Violation|3|||
164374836|NCT01077960|593745458|FG000|Overall Study|Lost to Follow-up|5|||
164374837|NCT01077960|593745458|FG000|Overall Study|Subject decision|1|||
164374838|NCT01077960|593745458|FG000|Overall Study|Reason unspecified|1|||
164374839|NCT03837899|593745462|FG000|Overall Study|Death|6|||
164374840|NCT03837899|593745463|FG001|Overall Study|Death|8|||
164374841|NCT03837899|593745464|FG002|Overall Study|Death|3|||
164374842|NCT03837899|593745465|FG003|Overall Study|Death|7|||
164374843|NCT03837899|593745466|FG004|Overall Study|Death|8|||
164374844|NCT03837899|593745467|FG005|Overall Study|Death|7|||
164374845|NCT03837899|593745462|FG000|Overall Study|Moved to post-trial access program|0|||
164374846|NCT03837899|593745463|FG001|Overall Study|Moved to post-trial access program|1|||
164374847|NCT03837899|593745464|FG002|Overall Study|Moved to post-trial access program|0|||
164374848|NCT03837899|593745465|FG003|Overall Study|Moved to post-trial access program|0|||
164374849|NCT03837899|593745466|FG004|Overall Study|Moved to post-trial access program|0|||
164374850|NCT03837899|593745467|FG005|Overall Study|Moved to post-trial access program|0|||
164374851|NCT03837899|593745462|FG000|Overall Study|Other|0|||
164374852|NCT03837899|593745463|FG001|Overall Study|Other|0|||
164374853|NCT03837899|593745464|FG002|Overall Study|Other|0|||
164374854|NCT03837899|593745465|FG003|Overall Study|Other|0|||
164374855|NCT03837899|593745466|FG004|Overall Study|Other|0|||
164374856|NCT03837899|593745467|FG005|Overall Study|Other|2|||
164374857|NCT03837899|593745462|FG000|Overall Study|Lost to Follow-up|0|||
164374858|NCT03837899|593745463|FG001|Overall Study|Lost to Follow-up|1|||
164374859|NCT03837899|593745464|FG002|Overall Study|Lost to Follow-up|0|||
164374860|NCT03837899|593745465|FG003|Overall Study|Lost to Follow-up|0|||
164374861|NCT03837899|593745466|FG004|Overall Study|Lost to Follow-up|0|||
164374862|NCT03837899|593745467|FG005|Overall Study|Lost to Follow-up|0|||
164374863|NCT03837899|593745462|FG000|Overall Study|Withdrawal by Subject|0|||
164374864|NCT03837899|593745463|FG001|Overall Study|Withdrawal by Subject|0|||
164374865|NCT03837899|593745464|FG002|Overall Study|Withdrawal by Subject|0|||
164374866|NCT03837899|593745465|FG003|Overall Study|Withdrawal by Subject|1|||
164374867|NCT03837899|593745466|FG004|Overall Study|Withdrawal by Subject|0|||
164374868|NCT03837899|593745467|FG005|Overall Study|Withdrawal by Subject|0|||
164374869|NCT03837899|593745462|FG000|Overall Study|Study specific discontinuation criteria|0|||
164374870|NCT03837899|593745463|FG001|Overall Study|Study specific discontinuation criteria|1|||
164374871|NCT03837899|593745464|FG002|Overall Study|Study specific discontinuation criteria|0|||
164374872|NCT03837899|593745465|FG003|Overall Study|Study specific discontinuation criteria|0|||
164374873|NCT03837899|593745466|FG004|Overall Study|Study specific discontinuation criteria|3|||
164374874|NCT03837899|593745467|FG005|Overall Study|Study specific discontinuation criteria|1|||
164374875|NCT01403974|593745468|FG000|Overall Study|Progressive disease according to RECIST|3|||
164374876|NCT01403974|593745469|FG001|Overall Study|Progressive disease according to RECIST|3|||
164374877|NCT01403974|593745470|FG002|Overall Study|Progressive disease according to RECIST|2|||
164374878|NCT01403974|593745471|FG003|Overall Study|Progressive disease according to RECIST|3|||
164374879|NCT01403974|593745472|FG004|Overall Study|Progressive disease according to RECIST|3|||
164374880|NCT01403974|593745473|FG005|Overall Study|Progressive disease according to RECIST|2|||
164374881|NCT01403974|593745474|FG006|Overall Study|Progressive disease according to RECIST|3|||
164374882|NCT01403974|593745475|FG007|Overall Study|Progressive disease according to RECIST|2|||
164374883|NCT01403974|593745476|FG008|Overall Study|Progressive disease according to RECIST|6|||
164374884|NCT01403974|593745477|FG009|Overall Study|Progressive disease according to RECIST|2|||
164374885|NCT01403974|593745478|FG010|Overall Study|Progressive disease according to RECIST|3|||
164374886|NCT01403974|593745479|FG011|Overall Study|Progressive disease according to RECIST|2|||
164374887|NCT01403974|593745480|FG012|Overall Study|Progressive disease according to RECIST|2|||
164374888|NCT01403974|593745481|FG013|Overall Study|Progressive disease according to RECIST|3|||
164374889|NCT01403974|593745482|FG014|Overall Study|Progressive disease according to RECIST|1|||
164374890|NCT01403974|593745483|FG015|Overall Study|Progressive disease according to RECIST|8|||
164374891|NCT01403974|593745468|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
164374892|NCT01403974|593745469|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
164374893|NCT01403974|593745470|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
164374894|NCT01403974|593745471|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
164374895|NCT01403974|593745472|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
164374896|NCT01403974|593745473|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
164374897|NCT01403974|593745474|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
164374898|NCT01403974|593745475|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
164374899|NCT01403974|593745476|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
164374900|NCT01403974|593745477|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
164374901|NCT01403974|593745478|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
164374902|NCT01403974|593745479|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
164374903|NCT01403974|593745480|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
164374904|NCT01403974|593745481|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
164374905|NCT01403974|593745482|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
164374906|NCT01403974|593745483|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
164374907|NCT01403974|593745468|FG000|Overall Study|Refused to continue study medication|0|||
164012626|NCT01912872|592410560|FG003|Overall Study|Lost to Follow-up|5|||
164374908|NCT01403974|593745469|FG001|Overall Study|Refused to continue study medication|0|||
164374909|NCT01403974|593745470|FG002|Overall Study|Refused to continue study medication|0|||
164374910|NCT01403974|593745471|FG003|Overall Study|Refused to continue study medication|0|||
164374911|NCT01403974|593745472|FG004|Overall Study|Refused to continue study medication|0|||
164374912|NCT01403974|593745473|FG005|Overall Study|Refused to continue study medication|1|||
164374913|NCT01403974|593745474|FG006|Overall Study|Refused to continue study medication|0|||
164374914|NCT01403974|593745475|FG007|Overall Study|Refused to continue study medication|0|||
164374915|NCT01403974|593745476|FG008|Overall Study|Refused to continue study medication|1|||
164374916|NCT01403974|593745477|FG009|Overall Study|Refused to continue study medication|0|||
164374917|NCT01403974|593745478|FG010|Overall Study|Refused to continue study medication|1|||
164374918|NCT01403974|593745479|FG011|Overall Study|Refused to continue study medication|0|||
164374919|NCT01403974|593745480|FG012|Overall Study|Refused to continue study medication|0|||
164374920|NCT01403974|593745481|FG013|Overall Study|Refused to continue study medication|0|||
164374921|NCT01403974|593745482|FG014|Overall Study|Refused to continue study medication|0|||
164374922|NCT01403974|593745483|FG015|Overall Study|Refused to continue study medication|4|||
164374923|NCT01403974|593745468|FG000|Overall Study|Adverse Event|0|||
164374924|NCT01403974|593745469|FG001|Overall Study|Adverse Event|0|||
164374925|NCT01403974|593745470|FG002|Overall Study|Adverse Event|1|||
164374926|NCT01403974|593745471|FG003|Overall Study|Adverse Event|0|||
164374927|NCT01403974|593745472|FG004|Overall Study|Adverse Event|0|||
164374928|NCT01403974|593745473|FG005|Overall Study|Adverse Event|0|||
164374929|NCT01403974|593745474|FG006|Overall Study|Adverse Event|0|||
164374930|NCT01403974|593745475|FG007|Overall Study|Adverse Event|1|||
164374931|NCT01403974|593745476|FG008|Overall Study|Adverse Event|0|||
164374932|NCT01403974|593745477|FG009|Overall Study|Adverse Event|0|||
164374933|NCT01403974|593745478|FG010|Overall Study|Adverse Event|0|||
164374934|NCT01403974|593745479|FG011|Overall Study|Adverse Event|0|||
164374935|NCT01403974|593745480|FG012|Overall Study|Adverse Event|1|||
164374936|NCT01403974|593745481|FG013|Overall Study|Adverse Event|0|||
164374937|NCT01403974|593745482|FG014|Overall Study|Adverse Event|0|||
164374938|NCT01403974|593745483|FG015|Overall Study|Adverse Event|0|||
164374939|NCT01403974|593745468|FG000|Overall Study|Other than specified|0|||
164374940|NCT01403974|593745469|FG001|Overall Study|Other than specified|0|||
164374941|NCT01403974|593745470|FG002|Overall Study|Other than specified|0|||
164374942|NCT01403974|593745471|FG003|Overall Study|Other than specified|0|||
164374943|NCT01403974|593745472|FG004|Overall Study|Other than specified|0|||
164374944|NCT01403974|593745473|FG005|Overall Study|Other than specified|0|||
164374945|NCT01403974|593745474|FG006|Overall Study|Other than specified|0|||
164374946|NCT01403974|593745475|FG007|Overall Study|Other than specified|0|||
164374947|NCT01403974|593745476|FG008|Overall Study|Other than specified|0|||
164374948|NCT01403974|593745477|FG009|Overall Study|Other than specified|1|||
164374949|NCT01403974|593745478|FG010|Overall Study|Other than specified|0|||
164374950|NCT01403974|593745479|FG011|Overall Study|Other than specified|1|||
164374951|NCT01403974|593745480|FG012|Overall Study|Other than specified|0|||
164374952|NCT01403974|593745481|FG013|Overall Study|Other than specified|0|||
164374953|NCT01403974|593745482|FG014|Overall Study|Other than specified|0|||
164374954|NCT01403974|593745483|FG015|Overall Study|Other than specified|0|||
164374955|NCT01526889|593745484|FG000|Treatment Period|Adverse Event|2|||
164374956|NCT01526889|593745485|FG001|Treatment Period|Adverse Event|0|||
164374957|NCT01526889|593745484|FG000|Treatment Extension Period|Administrative problems|1|||
164374958|NCT01526889|593745485|FG001|Treatment Extension Period|Administrative problems|0|||
164374959|NCT03571516|593745488|FG000|Overall Study|Severe diarrhea|1|||
164374960|NCT03571516|593745489|FG001|Overall Study|Severe diarrhea|0|||
164374961|NCT03571516|593745488|FG000|Overall Study|Withdrawal by Subject|0|||
164374962|NCT03571516|593745489|FG001|Overall Study|Withdrawal by Subject|1|||
164374963|NCT00613509|593745493|FG000|Cycle 1|Adverse Event|2|||
164374964|NCT00613509|593745494|FG001|Cycle 1|Adverse Event|1|||
164374965|NCT00613509|593745493|FG000|Cycle 1|Disease Progression|2|||
164374966|NCT00613509|593745494|FG001|Cycle 1|Disease Progression|6|||
164374967|NCT00613509|593745493|FG000|Cycle 1|Unacceptable Toxicity|1|||
164374968|NCT00613509|593745494|FG001|Cycle 1|Unacceptable Toxicity|0|||
164374969|NCT00613509|593745493|FG000|Cycle 1|Other administrative reason|0|||
164374970|NCT00613509|593745494|FG001|Cycle 1|Other administrative reason|1|||
164374971|NCT03465878|593745495|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
164374972|NCT03465878|593745496|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
164374973|NCT03465878|593745497|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
164374974|NCT03465878|593745498|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
164374975|NCT03465878|593745495|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
164374976|NCT03465878|593745496|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
164374977|NCT03465878|593745497|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
164374978|NCT03465878|593745498|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
164374979|NCT03465878|593745495|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
164374980|NCT03465878|593745496|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
164374981|NCT03465878|593745497|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
164374982|NCT03465878|593745498|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
164374983|NCT02540954|593745499|FG000|Overall Study|Physician Decision|3|||
164374984|NCT02540954|593745500|FG001|Overall Study|Physician Decision|1|||
164374985|NCT02540954|593745499|FG000|Overall Study|Withdrawal by Subject|6|||
164374986|NCT02540954|593745500|FG001|Overall Study|Withdrawal by Subject|5|||
164374987|NCT02540954|593745499|FG000|Overall Study|Lost to Follow-up|1|||
164374988|NCT02540954|593745500|FG001|Overall Study|Lost to Follow-up|1|||
164012627|NCT01912872|592410557|FG000|Overall Study|Other unspecified|3|||
164374989|NCT02540954|593745499|FG000|Overall Study|Adverse Event|4|||
164374990|NCT02540954|593745500|FG001|Overall Study|Adverse Event|2|||
164374991|NCT02540954|593745499|FG000|Overall Study|Death|0|||
164374992|NCT02540954|593745500|FG001|Overall Study|Death|3|||
164374993|NCT02540954|593745499|FG000|Overall Study|Treatment failure|1|||
164374994|NCT02540954|593745500|FG001|Overall Study|Treatment failure|0|||
164374995|NCT02540954|593745499|FG000|Overall Study|Other reason|4|||
164374996|NCT02540954|593745500|FG001|Overall Study|Other reason|2|||
164374997|NCT02448875|593745504|FG000|Overall Study|Adverse Event|2|||
164374998|NCT02448875|593745505|FG001|Overall Study|Adverse Event|1|||
164374999|NCT02448875|593745506|FG002|Overall Study|Adverse Event|0|||
164375000|NCT02448875|593745504|FG000|Overall Study|Lost to Follow-up|1|||
164375001|NCT02448875|593745505|FG001|Overall Study|Lost to Follow-up|0|||
164375002|NCT02448875|593745506|FG002|Overall Study|Lost to Follow-up|0|||
164375003|NCT02448875|593745504|FG000|Overall Study|Investigator Decision|3|||
164375004|NCT02448875|593745505|FG001|Overall Study|Investigator Decision|0|||
164375005|NCT02448875|593745506|FG002|Overall Study|Investigator Decision|1|||
164375006|NCT02448875|593745504|FG000|Overall Study|Withdrawal by Subject|1|||
164375007|NCT02448875|593745505|FG001|Overall Study|Withdrawal by Subject|0|||
164375008|NCT02448875|593745506|FG002|Overall Study|Withdrawal by Subject|0|||
164375009|NCT01806896|593745507|FG000|Overall Study|Adverse Event|2|||
164375010|NCT01806896|593745508|FG001|Overall Study|Adverse Event|0|||
164375011|NCT01806896|593745507|FG000|Overall Study|Other|1|||
164375012|NCT01806896|593745508|FG001|Overall Study|Other|0|||
164375013|NCT02434770|593745509|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
164375014|NCT02434770|593745510|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
164375015|NCT02434770|593745511|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
164375016|NCT02434770|593745509|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
164375017|NCT02434770|593745510|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
164375018|NCT02434770|593745511|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
164375019|NCT02434770|593745509|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
164375020|NCT02434770|593745510|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
164375021|NCT02434770|593745511|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
164375022|NCT02434770|593745509|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
164375023|NCT02434770|593745510|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
164375024|NCT02434770|593745511|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
164375025|NCT02434770|593745509|FG000|Week 1 to Week 18|Death|1|||
164375026|NCT02434770|593745510|FG001|Week 1 to Week 18|Death|0|||
164375027|NCT02434770|593745511|FG002|Week 1 to Week 18|Death|0|||
164012628|NCT01912872|592410558|FG001|Overall Study|Other unspecified|1|||
164012629|NCT01912872|592410559|FG002|Overall Study|Other unspecified|3|||
164012630|NCT01912872|592410560|FG003|Overall Study|Other unspecified|0|||
164012631|NCT01912872|592410557|FG000|Overall Study|Informed consent withdrawn|0|||
164012632|NCT01912872|592410558|FG001|Overall Study|Informed consent withdrawn|0|||
164375028|NCT02434770|593745509|FG000|Week 18 to Week|Lost to Follow-up|2|||
164375029|NCT02434770|593745510|FG001|Week 18 to Week|Lost to Follow-up|2|||
164375030|NCT02434770|593745511|FG002|Week 18 to Week|Lost to Follow-up|1|||
164375031|NCT02434770|593745509|FG000|Week 18 to Week|Withdrawal by Subject|0|||
164375032|NCT02434770|593745510|FG001|Week 18 to Week|Withdrawal by Subject|0|||
164375033|NCT02434770|593745511|FG002|Week 18 to Week|Withdrawal by Subject|2|||
164375034|NCT02434770|593745509|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
164012633|NCT01912872|592410559|FG002|Overall Study|Informed consent withdrawn|1|||
164012634|NCT01912872|592410560|FG003|Overall Study|Informed consent withdrawn|1|||
164012635|NCT01912872|592410557|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
164012636|NCT01912872|592410558|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
164012637|NCT01912872|592410559|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
164375035|NCT02434770|593745510|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
164375036|NCT02434770|593745511|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
164375037|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
164375038|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
164375039|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
164375040|NCT01282424|593745517|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
164375041|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
164375042|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
164375043|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
164375044|NCT01282424|593745517|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
164375045|NCT03316872|593745519|FG000|Overall Study|Death|1|||
164375046|NCT04074317|593745520|FG000|Third Period|Withdrawal by Subject|0|||
164375047|NCT04074317|593745521|FG001|Third Period|Withdrawal by Subject|0|||
164375048|NCT04074317|593745522|FG002|Third Period|Withdrawal by Subject|0|||
164375049|NCT04074317|593745523|FG003|Third Period|Withdrawal by Subject|1|||
164375050|NCT04074317|593745524|FG004|Third Period|Withdrawal by Subject|0|||
164375051|NCT04074317|593745525|FG005|Third Period|Withdrawal by Subject|0|||
164375052|NCT01038778|593745527|FG000|Overall Study|Withdrawal by Subject|0|||
164375053|NCT01038778|593745528|FG001|Overall Study|Withdrawal by Subject|2|||
164375054|NCT01038778|593745529|FG002|Overall Study|Withdrawal by Subject|3|||
164375055|NCT02283788|593745530|FG000|Overall Study|Adverse Event|1|||
164375056|NCT02283788|593745531|FG001|Overall Study|Adverse Event|3|||
164375057|NCT02283788|593745532|FG002|Overall Study|Adverse Event|5|||
164375058|NCT02283788|593745533|FG003|Overall Study|Adverse Event|1|||
164375059|NCT02283788|593745530|FG000|Overall Study|Withdrawal by Subject|0|||
164375060|NCT02283788|593745531|FG001|Overall Study|Withdrawal by Subject|1|||
164375061|NCT02283788|593745532|FG002|Overall Study|Withdrawal by Subject|0|||
164375062|NCT02283788|593745533|FG003|Overall Study|Withdrawal by Subject|1|||
164375063|NCT01610700|593747092|FG000|Overall Study|Adverse Event|3|||
164375064|NCT01610700|593747093|FG001|Overall Study|Adverse Event|1|||
164375065|NCT01610700|593747092|FG000|Overall Study|Withdrawal by Subject|0|||
164375066|NCT01610700|593747093|FG001|Overall Study|Withdrawal by Subject|1|||
164375067|NCT01610700|593747092|FG000|Overall Study|subject took one dose of street cannabis|0|||
164375068|NCT01610700|593747093|FG001|Overall Study|subject took one dose of street cannabis|1|||
164375069|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Adverse Event|9|||
164375070|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Adverse Event|2|||
164375071|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
164375072|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
164375073|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
164375074|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
164375075|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Physician Decision|1|||
164375076|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Physician Decision|1|||
164375077|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Pregnancy|2|||
164375078|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Pregnancy|0|||
164375079|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
164375080|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
164375081|NCT02896127|593747097|FG000|COMPLETED WEEK 52|Technical problems|1|||
164375082|NCT02896127|593747098|FG001|COMPLETED WEEK 52|Technical problems|0|||
164375083|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
164375084|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
164375085|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
164375086|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
164375087|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
164375088|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
164375089|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
164375090|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
164375091|NCT02896127|593747097|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
164375092|NCT02896127|593747098|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
164375093|NCT01782313|593747099|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
164375094|NCT01782313|593747099|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
164375095|NCT01782313|593747099|FG000|Treated Cycle 3|Progressive Disease|21|||
164375096|NCT01782313|593747099|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
164375097|NCT01782313|593747099|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
164375098|NCT01782313|593747099|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
164375099|NCT01782313|593747099|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
164375100|NCT01782313|593747099|FG000|Survival Follow up|Lost to Follow-up|1|||
164375101|NCT00958776|593747100|FG000|Overall Study|Adverse Event|0|||
164375102|NCT00958776|593747101|FG001|Overall Study|Adverse Event|1|||
164375103|NCT00958776|593747100|FG000|Overall Study|Physician Decision|1|||
164375104|NCT00958776|593747101|FG001|Overall Study|Physician Decision|0|||
164375105|NCT00958776|593747100|FG000|Overall Study|Lost to Follow-up|2|||
164375106|NCT00958776|593747101|FG001|Overall Study|Lost to Follow-up|6|||
164375107|NCT00958776|593747100|FG000|Overall Study|Withdrawal by Subject|7|||
164375108|NCT00958776|593747101|FG001|Overall Study|Withdrawal by Subject|16|||
164375109|NCT00958776|593747100|FG000|Overall Study|Protocol Violation|1|||
164375110|NCT00958776|593747101|FG001|Overall Study|Protocol Violation|1|||
164375111|NCT00958776|593747100|FG000|Overall Study|Death|2|||
164375112|NCT00958776|593747101|FG001|Overall Study|Death|1|||
164375113|NCT00958776|593747100|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
164375114|NCT00958776|593747101|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
164375115|NCT00958776|593747100|FG000|Overall Study|Missing|1|||
164375116|NCT00958776|593747101|FG001|Overall Study|Missing|1|||
164375117|NCT00326911|593747102|FG000|Overall Study|Hospitalization prior to treatment|0|||
164375118|NCT00326911|593747103|FG001|Overall Study|Hospitalization prior to treatment|1|||
164375119|NCT00326911|593747102|FG000|Overall Study|Physician decision prior to treatment|1|||
164375120|NCT00326911|593747103|FG001|Overall Study|Physician decision prior to treatment|0|||
164375121|NCT00326911|593747102|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
164375122|NCT00326911|593747103|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
164375123|NCT00418691|593747112|FG000|Overall Study|Lost to Follow-up|1|||
164375124|NCT00418691|593747113|FG001|Overall Study|Lost to Follow-up|2|||
164375125|NCT00418691|593747114|FG002|Overall Study|Lost to Follow-up|3|||
164375126|NCT00418691|593747112|FG000|Overall Study|Started new medication voiding entry|0|||
164375127|NCT00418691|593747113|FG001|Overall Study|Started new medication voiding entry|0|||
164375128|NCT00418691|593747114|FG002|Overall Study|Started new medication voiding entry|1|||
164375129|NCT00418691|593747112|FG000|Overall Study|Progressive Disease|1|||
164375130|NCT00418691|593747113|FG001|Overall Study|Progressive Disease|0|||
164375131|NCT00418691|593747114|FG002|Overall Study|Progressive Disease|1|||
164375132|NCT00501540|593747115|FG000|Overall Study|Death|5|||
164375133|NCT02331446|593747116|FG000|Overall Study|Lost to Follow-up|2|||
164375134|NCT02331446|593747117|FG001|Overall Study|Lost to Follow-up|1|||
164375135|NCT02331446|593747118|FG002|Overall Study|Lost to Follow-up|0|||
164092782|NCT02130466|592702145|FG012|Overall Study|Physician Decision|0|||
164092783|NCT02130466|592702146|FG013|Overall Study|Physician Decision|0|||
164092784|NCT02130466|592702133|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164092785|NCT02130466|592702134|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
164375136|NCT02331446|593747119|FG003|Overall Study|Lost to Follow-up|1|||
164375137|NCT02331446|593747116|FG000|Overall Study|Personal Problem|2|||
164375138|NCT02331446|593747117|FG001|Overall Study|Personal Problem|0|||
164375139|NCT02331446|593747118|FG002|Overall Study|Personal Problem|0|||
164375140|NCT02331446|593747119|FG003|Overall Study|Personal Problem|0|||
164375141|NCT02331446|593747116|FG000|Overall Study|Disease|0|||
164375142|NCT02331446|593747117|FG001|Overall Study|Disease|2|||
164375143|NCT02331446|593747118|FG002|Overall Study|Disease|2|||
164375144|NCT02331446|593747119|FG003|Overall Study|Disease|1|||
164375145|NCT02331446|593747116|FG000|Overall Study|Physician Decision|0|||
164375146|NCT02331446|593747117|FG001|Overall Study|Physician Decision|1|||
164375147|NCT02331446|593747118|FG002|Overall Study|Physician Decision|0|||
164375148|NCT02331446|593747119|FG003|Overall Study|Physician Decision|1|||
164375149|NCT02331446|593747116|FG000|Overall Study|Lost before baseline analysis|0|||
164375150|NCT02331446|593747117|FG001|Overall Study|Lost before baseline analysis|1|||
163902355|NCT05580003|592013104|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902356|NCT05580003|592013105|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902357|NCT05580003|592013106|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902358|NCT05580003|592013107|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902359|NCT05580003|592013108|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902360|NCT05580003|592013109|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902361|NCT05580003|592013110|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902362|NCT05580003|592013111|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164375151|NCT02331446|593747118|FG002|Overall Study|Lost before baseline analysis|1|||
163902363|NCT05580003|592013112|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164092786|NCT02130466|592702135|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164092787|NCT02130466|592702136|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
164092788|NCT02130466|592702137|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164375152|NCT02331446|593747119|FG003|Overall Study|Lost before baseline analysis|0|||
164375153|NCT02984995|593747120|FG000|Overall Study|Required stem cell transplant|13|||
164092789|NCT02130466|592702138|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
164092790|NCT02130466|592702139|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
164092791|NCT02130466|592702140|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164092792|NCT02130466|592702141|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164092793|NCT02130466|592702142|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164375154|NCT02984995|593747121|FG001|Overall Study|Required stem cell transplant|2|||
164375155|NCT02984995|593747120|FG000|Overall Study|Progressive disease|11|||
164375156|NCT02984995|593747121|FG001|Overall Study|Progressive disease|1|||
164375157|NCT02984995|593747120|FG000|Overall Study|Adverse Event|1|||
164375158|NCT02984995|593747121|FG001|Overall Study|Adverse Event|0|||
163902364|NCT05580003|592013113|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164375159|NCT04182100|593747122|FG000|Overall Study|Adverse Event|1|||
164375160|NCT04182100|593747122|FG000|Overall Study|Withdrawal by Subject|1|||
164375161|NCT00433654|593747124|FG000|Overall Study|Death|4|||
163902365|NCT05580003|592013114|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902366|NCT05580003|592013115|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902367|NCT05580003|592013116|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902368|NCT05580003|592013117|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902369|NCT05580003|592013118|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902370|NCT05580003|592013119|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
163902371|NCT05580003|592013120|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902372|NCT05580003|592013121|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902373|NCT05580003|592013122|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902374|NCT05580003|592013123|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
163902375|NCT05580003|592013124|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164375162|NCT00433654|593747125|FG001|Overall Study|Death|0|||
164375163|NCT00433654|593747124|FG000|Overall Study|Missed visit|6|||
164375164|NCT00433654|593747125|FG001|Overall Study|Missed visit|3|||
164375165|NCT00433654|593747124|FG000|Overall Study|Subject not yet due for visit|4|||
164375166|NCT00433654|593747125|FG001|Overall Study|Subject not yet due for visit|0|||
164375167|NCT00433654|593747124|FG000|Overall Study|Withdrawal by Subject|1|||
164375168|NCT00433654|593747125|FG001|Overall Study|Withdrawal by Subject|2|||
164375169|NCT00499603|593747128|FG000|Overall Study|Adverse Event|0|||
164375170|NCT00499603|593747129|FG001|Overall Study|Adverse Event|1|||
164375171|NCT00937547|593747130|FG000|Overall Study|misdiagnosis|1|||
164375172|NCT00937547|593747131|FG001|Overall Study|misdiagnosis|6|||
164375173|NCT00937547|593747132|FG002|Overall Study|misdiagnosis|7|||
164375174|NCT04439240|593747133|FG000|Overall Study|Ineligible|2|||
164375175|NCT04439240|593747133|FG000|Overall Study|Never started treatment|2|||
164375176|NCT04439240|593747133|FG000|Overall Study|Adverse Event|12|||
164375177|NCT04439240|593747133|FG000|Overall Study|Death|2|||
164375178|NCT04439240|593747133|FG000|Overall Study|Disease progression|25|||
164375179|NCT04439240|593747133|FG000|Overall Study|Other diseases|2|||
164375180|NCT04439240|593747133|FG000|Overall Study|Withdrawal by Subject|3|||
164375181|NCT04439240|593747133|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
164375182|NCT04439240|593747133|FG000|Overall Study|Symptomatic decline|1|||
164375183|NCT04439240|593747133|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
164375184|NCT04439240|593747133|FG000|Overall Study|Clinical progression|1|||
164375185|NCT00079274|593747135|FG000|Overall Study|Withdrawal by Subject|111|||
164375186|NCT00079274|593747136|FG001|Overall Study|Withdrawal by Subject|10|||
164375187|NCT00079274|593747137|FG002|Overall Study|Withdrawal by Subject|12|||
164375188|NCT00079274|593747138|FG003|Overall Study|Withdrawal by Subject|163|||
164375189|NCT00079274|593747139|FG004|Overall Study|Withdrawal by Subject|7|||
164375190|NCT00079274|593747140|FG005|Overall Study|Withdrawal by Subject|8|||
164375191|NCT00079274|593747141|FG006|Overall Study|Withdrawal by Subject|0|||
164375192|NCT00079274|593747135|FG000|Overall Study|Adverse Event|130|||
164375193|NCT00079274|593747136|FG001|Overall Study|Adverse Event|8|||
164375194|NCT00079274|593747137|FG002|Overall Study|Adverse Event|8|||
164375195|NCT00079274|593747138|FG003|Overall Study|Adverse Event|184|||
164375196|NCT00079274|593747139|FG004|Overall Study|Adverse Event|7|||
164375197|NCT00079274|593747140|FG005|Overall Study|Adverse Event|8|||
164375198|NCT00079274|593747141|FG006|Overall Study|Adverse Event|0|||
164375199|NCT00079274|593747135|FG000|Overall Study|Recurrence|21|||
164375200|NCT00079274|593747136|FG001|Overall Study|Recurrence|0|||
164375201|NCT00079274|593747137|FG002|Overall Study|Recurrence|1|||
164375202|NCT00079274|593747138|FG003|Overall Study|Recurrence|15|||
164375203|NCT00079274|593747139|FG004|Overall Study|Recurrence|0|||
164375204|NCT00079274|593747140|FG005|Overall Study|Recurrence|2|||
164375205|NCT00079274|593747141|FG006|Overall Study|Recurrence|0|||
164375206|NCT00079274|593747135|FG000|Overall Study|Alternate Treatment|6|||
164375207|NCT00079274|593747136|FG001|Overall Study|Alternate Treatment|1|||
164375208|NCT00079274|593747137|FG002|Overall Study|Alternate Treatment|0|||
164375209|NCT00079274|593747138|FG003|Overall Study|Alternate Treatment|3|||
164375210|NCT00079274|593747139|FG004|Overall Study|Alternate Treatment|0|||
164375211|NCT00079274|593747140|FG005|Overall Study|Alternate Treatment|0|||
164375212|NCT00079274|593747141|FG006|Overall Study|Alternate Treatment|0|||
164375213|NCT00079274|593747135|FG000|Overall Study|Other Medical Problems|6|||
164375214|NCT00079274|593747136|FG001|Overall Study|Other Medical Problems|1|||
164375215|NCT00079274|593747137|FG002|Overall Study|Other Medical Problems|0|||
163902376|NCT05580003|592013125|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
164375216|NCT00079274|593747138|FG003|Overall Study|Other Medical Problems|7|||
164375217|NCT00079274|593747139|FG004|Overall Study|Other Medical Problems|0|||
164375218|NCT00079274|593747140|FG005|Overall Study|Other Medical Problems|0|||
164375219|NCT00079274|593747141|FG006|Overall Study|Other Medical Problems|0|||
164375220|NCT00079274|593747135|FG000|Overall Study|Death|4|||
164375221|NCT00079274|593747136|FG001|Overall Study|Death|0|||
164375222|NCT00079274|593747137|FG002|Overall Study|Death|1|||
164375223|NCT00079274|593747138|FG003|Overall Study|Death|15|||
164375224|NCT00079274|593747139|FG004|Overall Study|Death|0|||
164375225|NCT00079274|593747140|FG005|Overall Study|Death|0|||
164375226|NCT00079274|593747141|FG006|Overall Study|Death|0|||
164375227|NCT00079274|593747135|FG000|Overall Study|Cytogenetic resistance|0|||
164375228|NCT00079274|593747136|FG001|Overall Study|Cytogenetic resistance|0|||
164375229|NCT00079274|593747137|FG002|Overall Study|Cytogenetic resistance|0|||
164375230|NCT00079274|593747138|FG003|Overall Study|Cytogenetic resistance|2|||
164375231|NCT00079274|593747139|FG004|Overall Study|Cytogenetic resistance|0|||
164375232|NCT00079274|593747140|FG005|Overall Study|Cytogenetic resistance|0|||
164375233|NCT00079274|593747141|FG006|Overall Study|Cytogenetic resistance|0|||
164375234|NCT00079274|593747135|FG000|Overall Study|Other|43|||
164375235|NCT00079274|593747136|FG001|Overall Study|Other|7|||
164375236|NCT00079274|593747137|FG002|Overall Study|Other|5|||
164375237|NCT00079274|593747138|FG003|Overall Study|Other|55|||
164375238|NCT00079274|593747139|FG004|Overall Study|Other|1|||
164375239|NCT00079274|593747140|FG005|Overall Study|Other|2|||
164375240|NCT00079274|593747141|FG006|Overall Study|Other|0|||
164375241|NCT01302392|593747142|FG000|Overall Study|Lost to Follow-up|1|||
164375242|NCT01302392|593747143|FG001|Overall Study|Lost to Follow-up|0|||
164375243|NCT01302392|593747142|FG000|Overall Study|Withdrawal by Subject|6|||
164375244|NCT01302392|593747143|FG001|Overall Study|Withdrawal by Subject|1|||
164375245|NCT00670228|593747144|FG000|Overall Study|Adverse Event|1|||
164375246|NCT00670228|593747145|FG001|Overall Study|Adverse Event|0|||
164375247|NCT00670228|593747144|FG000|Overall Study|Death or MACE|0|||
164375248|NCT00670228|593747145|FG001|Overall Study|Death or MACE|1|||
164375249|NCT00670228|593747144|FG000|Overall Study|Not treated|2|||
164375250|NCT00670228|593747145|FG001|Overall Study|Not treated|2|||
164375251|NCT00670228|593747144|FG000|Overall Study|Not meeting the selection criteria|2|||
164375252|NCT00670228|593747145|FG001|Overall Study|Not meeting the selection criteria|0|||
164375253|NCT03604692|593747146|FG000|Overall Study|Investigator's Decision|0|||
164375254|NCT03604692|593747147|FG001|Overall Study|Investigator's Decision|0|||
164375255|NCT03604692|593747148|FG002|Overall Study|Investigator's Decision|0|||
164375256|NCT03604692|593747149|FG003|Overall Study|Investigator's Decision|1|||
164375257|NCT03604692|593747150|FG004|Overall Study|Investigator's Decision|0|||
164375258|NCT03604692|593747151|FG005|Overall Study|Investigator's Decision|7|||
164375259|NCT03604692|593747146|FG000|Overall Study|Withdrawal by Subject|0|||
164375260|NCT03604692|593747147|FG001|Overall Study|Withdrawal by Subject|0|||
164375261|NCT03604692|593747148|FG002|Overall Study|Withdrawal by Subject|0|||
164375262|NCT03604692|593747149|FG003|Overall Study|Withdrawal by Subject|0|||
164375263|NCT03604692|593747150|FG004|Overall Study|Withdrawal by Subject|0|||
164375264|NCT03604692|593747151|FG005|Overall Study|Withdrawal by Subject|2|||
164375265|NCT03604692|593747146|FG000|Overall Study|Progressive Disease|1|||
164375266|NCT03604692|593747147|FG001|Overall Study|Progressive Disease|0|||
164375267|NCT03604692|593747148|FG002|Overall Study|Progressive Disease|1|||
164375268|NCT03604692|593747149|FG003|Overall Study|Progressive Disease|0|||
164375269|NCT03604692|593747150|FG004|Overall Study|Progressive Disease|3|||
164375270|NCT03604692|593747151|FG005|Overall Study|Progressive Disease|4|||
164375271|NCT03604692|593747146|FG000|Overall Study|Difficulty Coming into Site|0|||
164375272|NCT03604692|593747147|FG001|Overall Study|Difficulty Coming into Site|0|||
164375273|NCT03604692|593747148|FG002|Overall Study|Difficulty Coming into Site|0|||
164375274|NCT03604692|593747149|FG003|Overall Study|Difficulty Coming into Site|0|||
164375275|NCT03604692|593747150|FG004|Overall Study|Difficulty Coming into Site|0|||
164375276|NCT03604692|593747151|FG005|Overall Study|Difficulty Coming into Site|1|||
164375277|NCT03604692|593747146|FG000|Overall Study|Death|0|||
164375278|NCT03604692|593747147|FG001|Overall Study|Death|0|||
163902377|NCT05580003|592013098|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902378|NCT05580003|592013099|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902379|NCT05580003|592013100|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164375279|NCT03604692|593747148|FG002|Overall Study|Death|1|||
164375280|NCT03604692|593747149|FG003|Overall Study|Death|0|||
164375281|NCT03604692|593747150|FG004|Overall Study|Death|0|||
164375282|NCT03604692|593747151|FG005|Overall Study|Death|0|||
164375283|NCT03604692|593747146|FG000|Overall Study|Drug Intolerance|0|||
164375284|NCT03604692|593747147|FG001|Overall Study|Drug Intolerance|0|||
163902380|NCT05580003|592013101|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164375285|NCT03604692|593747148|FG002|Overall Study|Drug Intolerance|0|||
164375286|NCT03604692|593747149|FG003|Overall Study|Drug Intolerance|1|||
164375287|NCT03604692|593747150|FG004|Overall Study|Drug Intolerance|0|||
164375288|NCT03604692|593747151|FG005|Overall Study|Drug Intolerance|0|||
164375289|NCT03604692|593747146|FG000|Overall Study|Noncompliance with follow-up visit|0|||
164375290|NCT03604692|593747147|FG001|Overall Study|Noncompliance with follow-up visit|0|||
164375291|NCT03604692|593747148|FG002|Overall Study|Noncompliance with follow-up visit|0|||
164375292|NCT03604692|593747149|FG003|Overall Study|Noncompliance with follow-up visit|1|||
164375293|NCT03604692|593747150|FG004|Overall Study|Noncompliance with follow-up visit|0|||
164375294|NCT03604692|593747151|FG005|Overall Study|Noncompliance with follow-up visit|0|||
164375295|NCT03604692|593747146|FG000|Overall Study|Not Treated|0|||
164375296|NCT03604692|593747147|FG001|Overall Study|Not Treated|0|||
164375297|NCT03604692|593747148|FG002|Overall Study|Not Treated|0|||
164375298|NCT03604692|593747149|FG003|Overall Study|Not Treated|0|||
164375299|NCT03604692|593747150|FG004|Overall Study|Not Treated|1|||
164375300|NCT03604692|593747151|FG005|Overall Study|Not Treated|0|||
164375301|NCT00637195|593747152|FG000|Overall Study|Lost to Follow-up|1|||
164375302|NCT00637195|593747153|FG001|Overall Study|Lost to Follow-up|0|||
164375303|NCT00637195|593747152|FG000|Overall Study|Other|2|||
164375304|NCT00637195|593747153|FG001|Overall Study|Other|0|||
164375305|NCT00637195|593747152|FG000|Overall Study|Withdrawal by Subject|0|||
164375306|NCT00637195|593747153|FG001|Overall Study|Withdrawal by Subject|1|||
164375307|NCT00547703|593747156|FG000|Overall Study|Lost to Follow-up|1|||
164375308|NCT00547703|593747157|FG001|Overall Study|Lost to Follow-up|0|||
164375309|NCT01193556|593747163|FG000|Overall Study|Study termination|26|||
164375310|NCT01193556|593747164|FG001|Overall Study|Study termination|25|||
164375311|NCT01696032|593747165|FG000|Overall Study|Withdrawal by Subject|0|||
164375312|NCT01696032|593747166|FG001|Overall Study|Withdrawal by Subject|0|||
164375313|NCT01696032|593747167|FG002|Overall Study|Withdrawal by Subject|1|||
164375314|NCT01696032|593747168|FG003|Overall Study|Withdrawal by Subject|2|||
164375315|NCT01696032|593747165|FG000|Overall Study|Death|14|||
164375316|NCT01696032|593747166|FG001|Overall Study|Death|4|||
164375317|NCT01696032|593747167|FG002|Overall Study|Death|43|||
164375318|NCT01696032|593747168|FG003|Overall Study|Death|18|||
164375319|NCT01696032|593747165|FG000|Overall Study|Lost to Follow-up|0|||
164375320|NCT01696032|593747166|FG001|Overall Study|Lost to Follow-up|1|||
164375321|NCT01696032|593747167|FG002|Overall Study|Lost to Follow-up|0|||
164375322|NCT01696032|593747168|FG003|Overall Study|Lost to Follow-up|0|||
164375323|NCT01696032|593747165|FG000|Overall Study|Database lock|0|||
164375324|NCT01696032|593747166|FG001|Overall Study|Database lock|1|||
164375325|NCT01696032|593747167|FG002|Overall Study|Database lock|7|||
164375326|NCT01696032|593747168|FG003|Overall Study|Database lock|2|||
164375327|NCT00376168|593747171|FG000|Overall Study|Adverse Event|1|||
164375328|NCT00376168|593747172|FG001|Overall Study|Adverse Event|1|||
164375329|NCT00376168|593747171|FG000|Overall Study|Pregnancy|1|||
164375330|NCT00376168|593747172|FG001|Overall Study|Pregnancy|0|||
164375331|NCT01020019|593747173|FG000|Overall Study|Lost to Follow-up|21|||
164375332|NCT01020019|593747174|FG001|Overall Study|Lost to Follow-up|18|||
164375333|NCT01020019|593747173|FG000|Overall Study|Adverse Event|1|||
164375334|NCT01020019|593747174|FG001|Overall Study|Adverse Event|5|||
164375335|NCT01020019|593747173|FG000|Overall Study|not interested in treatment|4|||
164375336|NCT01020019|593747174|FG001|Overall Study|not interested in treatment|4|||
164375337|NCT01020019|593747173|FG000|Overall Study|moving|0|||
164375338|NCT01020019|593747174|FG001|Overall Study|moving|2|||
164375339|NCT05091528|593747175|FG000|Overall Study|Study Termination by Sponsor|0|||
164375340|NCT05091528|593747176|FG001|Overall Study|Study Termination by Sponsor|1|||
164375341|NCT05091528|593747177|FG002|Overall Study|Study Termination by Sponsor|0|||
164375342|NCT05091528|593747178|FG003|Overall Study|Study Termination by Sponsor|1|||
164375343|NCT02214121|593747181|FG000|Part A|Patient decision|2|||
164375344|NCT02214121|593747182|FG001|Part A|Patient decision|0|||
164375345|NCT02214121|593747183|FG002|Part A|Patient decision|0|||
164375346|NCT02214121|593747181|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
164375347|NCT02214121|593747182|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
164012638|NCT01912872|592410560|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
164375348|NCT02214121|593747183|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
164375349|NCT02214121|593747181|FG000|Part A|Other|1|||
164375350|NCT02214121|593747182|FG001|Part A|Other|0|||
164375351|NCT02214121|593747183|FG002|Part A|Other|0|||
164375352|NCT02214121|593747181|FG000|Part B|Patient decision|0|||
164375353|NCT02214121|593747182|FG001|Part B|Patient decision|1|||
164375354|NCT02214121|593747183|FG002|Part B|Patient decision|0|||
164375355|NCT02214121|593747181|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
164375356|NCT02214121|593747182|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
164375357|NCT02214121|593747183|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
164375358|NCT02214121|593747181|FG000|Part B|Lost to Follow-up|0|||
164375359|NCT02214121|593747182|FG001|Part B|Lost to Follow-up|0|||
164375360|NCT02214121|593747183|FG002|Part B|Lost to Follow-up|1|||
164375361|NCT02375672|593747184|FG000|Overall Study|remain on follow up|20|||
164375362|NCT02203591|593747185|FG000|Overall Study|Did not meet treatment day baseline|147|||
164375363|NCT02203591|593747186|FG001|Overall Study|Did not meet treatment day baseline|141|||
164375364|NCT02203591|593747187|FG002|Overall Study|Did not meet treatment day baseline|150|||
164375365|NCT02203591|593747188|FG003|Overall Study|Did not meet treatment day baseline|45|||
164375366|NCT02203591|593747189|FG004|Overall Study|Did not meet treatment day baseline|33|||
164375367|NCT02203591|593747190|FG005|Overall Study|Did not meet treatment day baseline|35|||
164375368|NCT02203591|593747191|FG006|Overall Study|Did not meet treatment day baseline|29|||
164375369|NCT02203591|593747192|FG007|Overall Study|Did not meet treatment day baseline|12|||
164375370|NCT02203591|593747185|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
164375371|NCT02203591|593747186|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
164375372|NCT02203591|593747187|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
164375373|NCT02203591|593747188|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
164375374|NCT02203591|593747189|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
164375375|NCT02203591|593747190|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
164375376|NCT02203591|593747191|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
164375377|NCT02203591|593747192|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
164375378|NCT04115358|593747193|FG000|Overall Study|exfoliation|0|||
164375379|NCT04115358|593747194|FG001|Overall Study|exfoliation|0|||
164375380|NCT04115358|593747195|FG002|Overall Study|exfoliation|1|||
164375381|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375382|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375383|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
164375384|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375385|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375386|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
164375387|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
164375388|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
164375389|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
164375390|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
164375391|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
164375392|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
164375393|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
164375394|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
164375395|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
164375396|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375397|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375398|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375399|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375400|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375401|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
164375402|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164375403|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375404|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164375405|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375406|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375407|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
164375408|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164375409|NCT01573624|593747198|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
164375410|NCT01573624|593747199|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
164375411|NCT01573624|593747200|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375412|NCT01573624|593747201|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375413|NCT01573624|593747202|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
164375414|NCT01573624|593747203|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375415|NCT01573624|593747204|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
164375416|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375417|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375418|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375419|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375420|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375421|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
164375422|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
164375423|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375424|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
164375425|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375426|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
164375427|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375428|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
164375429|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
164375430|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
164375431|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375432|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
164375433|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
164375434|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375435|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375436|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
164375437|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375438|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375439|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375440|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375441|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375442|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
164375443|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
164375444|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375445|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375446|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375447|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
164375448|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375449|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
164375450|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
164375451|NCT01573624|593747198|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375452|NCT01573624|593747199|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375453|NCT01573624|593747200|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375454|NCT01573624|593747201|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375455|NCT01573624|593747202|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375456|NCT01573624|593747203|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375457|NCT01573624|593747204|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375458|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
164375459|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
164375460|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
164375461|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
164375462|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
164375463|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
164375464|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
164375465|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375466|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
164375467|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375468|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375469|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375470|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
164375471|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
164375472|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
164375473|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375474|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375475|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375476|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375477|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375478|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
164375479|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
163902381|NCT05580003|592013102|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902382|NCT05580003|592013103|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902383|NCT05580003|592013104|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164375480|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164375481|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
163902384|NCT05580003|592013105|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902385|NCT05580003|592013106|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902386|NCT05580003|592013107|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902387|NCT05580003|592013108|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902388|NCT05580003|592013109|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902389|NCT05580003|592013110|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902390|NCT05580003|592013111|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902391|NCT05580003|592013112|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902392|NCT05580003|592013113|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902393|NCT05580003|592013114|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902394|NCT05580003|592013115|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902395|NCT05580003|592013116|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902396|NCT05580003|592013117|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902397|NCT05580003|592013118|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902398|NCT05580003|592013119|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902399|NCT05580003|592013120|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902400|NCT05580003|592013121|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164375482|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164375483|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164375484|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164375485|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164375486|NCT01573624|593747198|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
164375487|NCT01573624|593747199|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375488|NCT01573624|593747200|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375489|NCT01573624|593747201|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375490|NCT01573624|593747202|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375491|NCT01573624|593747203|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375492|NCT01573624|593747204|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
164375493|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
164375494|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375495|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375496|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375497|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
164375498|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
163902401|NCT05580003|592013122|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164375499|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
164375500|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
164375501|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375502|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375503|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375504|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375505|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
164375506|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
164375507|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375508|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
164375509|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375510|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375511|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375512|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375513|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
164375514|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375515|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
164375516|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375517|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375518|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375519|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375520|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
164375521|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375522|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375523|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375524|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375525|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
164375526|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164375527|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
164012639|NCT01912872|592410557|FG000|Overall Study|Protocol Violation|0|||
163902402|NCT05580003|592013123|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
164012640|NCT01912872|592410558|FG001|Overall Study|Protocol Violation|0|||
163902403|NCT05580003|592013124|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
163902404|NCT05580003|592013125|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
163902405|NCT05580003|592013098|FG000|Part 6 Period 2 (Day 1)|Other|0|||
163902406|NCT05580003|592013099|FG001|Part 6 Period 2 (Day 1)|Other|0|||
163902407|NCT05580003|592013100|FG002|Part 6 Period 2 (Day 1)|Other|0|||
163902408|NCT05580003|592013101|FG003|Part 6 Period 2 (Day 1)|Other|0|||
163902409|NCT05580003|592013102|FG004|Part 6 Period 2 (Day 1)|Other|0|||
163902410|NCT05580003|592013103|FG005|Part 6 Period 2 (Day 1)|Other|0|||
163902411|NCT05580003|592013104|FG006|Part 6 Period 2 (Day 1)|Other|0|||
163902412|NCT05580003|592013105|FG007|Part 6 Period 2 (Day 1)|Other|0|||
163902413|NCT05580003|592013106|FG008|Part 6 Period 2 (Day 1)|Other|0|||
163902414|NCT05580003|592013107|FG009|Part 6 Period 2 (Day 1)|Other|0|||
163902415|NCT05580003|592013108|FG010|Part 6 Period 2 (Day 1)|Other|0|||
163902416|NCT05580003|592013109|FG011|Part 6 Period 2 (Day 1)|Other|0|||
163902417|NCT05580003|592013110|FG012|Part 6 Period 2 (Day 1)|Other|0|||
163902418|NCT05580003|592013111|FG013|Part 6 Period 2 (Day 1)|Other|0|||
163902419|NCT05580003|592013112|FG014|Part 6 Period 2 (Day 1)|Other|0|||
163902420|NCT05580003|592013113|FG015|Part 6 Period 2 (Day 1)|Other|0|||
163902421|NCT05580003|592013114|FG016|Part 6 Period 2 (Day 1)|Other|0|||
163902422|NCT05580003|592013115|FG017|Part 6 Period 2 (Day 1)|Other|0|||
163902423|NCT05580003|592013116|FG018|Part 6 Period 2 (Day 1)|Other|0|||
163902424|NCT05580003|592013117|FG019|Part 6 Period 2 (Day 1)|Other|0|||
163902425|NCT05580003|592013118|FG020|Part 6 Period 2 (Day 1)|Other|0|||
163902426|NCT05580003|592013119|FG021|Part 6 Period 2 (Day 1)|Other|0|||
163902427|NCT05580003|592013120|FG022|Part 6 Period 2 (Day 1)|Other|0|||
163902428|NCT05580003|592013121|FG023|Part 6 Period 2 (Day 1)|Other|0|||
163902429|NCT05580003|592013122|FG024|Part 6 Period 2 (Day 1)|Other|1|||
163902430|NCT05580003|592013123|FG025|Part 6 Period 2 (Day 1)|Other|0|||
163902431|NCT05580003|592013124|FG026|Part 6 Period 2 (Day 1)|Other|0|||
163902432|NCT05580003|592013125|FG027|Part 6 Period 2 (Day 1)|Other|0|||
163902433|NCT03516812|592013126|FG000|Overall Study|Adverse Event|4|||
163902434|NCT03516812|592013126|FG000|Overall Study|Lack of Efficacy|2|||
163902435|NCT03840902|592013127|FG000|Overall Study|Randomized but not treated|1|||
163902436|NCT03840902|592013128|FG001|Overall Study|Randomized but not treated|1|||
163902437|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163902438|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
163902439|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163902440|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
163902441|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163902442|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
163902443|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163902444|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163902445|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163902446|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163902447|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
163902448|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
163902449|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163902450|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163902451|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163902452|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163902453|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
163902454|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
163902455|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
163902456|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163902457|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163902458|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
163902459|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163902460|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
163902461|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163902462|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163902463|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
164012641|NCT01912872|592410559|FG002|Overall Study|Protocol Violation|1|||
164012642|NCT01912872|592410560|FG003|Overall Study|Protocol Violation|0|||
164012643|NCT01912872|592410557|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163902464|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163902465|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
163902466|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
163902467|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
163902468|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
163902469|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
163902470|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
163902471|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
163902472|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
163902473|NCT02392234|592013129|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163902474|NCT02392234|592013130|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
164012644|NCT01912872|592410558|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164375528|NCT01573624|593747198|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375529|NCT01573624|593747199|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375530|NCT01573624|593747200|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375531|NCT01573624|593747201|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375532|NCT01573624|593747202|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375533|NCT01573624|593747203|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
164375534|NCT01573624|593747204|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
164375535|NCT01573624|593747198|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
164375536|NCT01573624|593747199|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164375537|NCT01573624|593747200|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164375538|NCT01573624|593747201|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164375539|NCT01573624|593747202|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
164375540|NCT01573624|593747203|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
164375541|NCT01573624|593747204|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
164375542|NCT01573624|593747198|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375543|NCT01573624|593747199|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
164375544|NCT01573624|593747200|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375545|NCT01573624|593747201|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375546|NCT01573624|593747202|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375547|NCT01573624|593747203|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
164375548|NCT01573624|593747204|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
164375549|NCT01573624|593747198|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
164375550|NCT01573624|593747199|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375551|NCT01573624|593747200|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375552|NCT01573624|593747201|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375553|NCT01573624|593747202|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375554|NCT01573624|593747203|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375555|NCT01573624|593747204|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
164375556|NCT01573624|593747198|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375557|NCT01573624|593747199|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375558|NCT01573624|593747200|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375559|NCT01573624|593747201|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375560|NCT01573624|593747202|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
164375561|NCT01573624|593747203|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
164375562|NCT01573624|593747204|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
164375563|NCT01573624|593747198|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
164375564|NCT01573624|593747199|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375565|NCT01573624|593747200|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375566|NCT01573624|593747201|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375567|NCT01573624|593747202|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375568|NCT01573624|593747203|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375569|NCT01573624|593747204|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
164375570|NCT04399161|593747205|FG000|Overall Study|Withdrawal by Subject|1|||
164375571|NCT04399161|593747206|FG001|Overall Study|Withdrawal by Subject|0|||
164375572|NCT04399161|593747207|FG002|Overall Study|Withdrawal by Subject|2|||
164375573|NCT04399161|593747205|FG000|Overall Study|Protocol Violation|1|||
163902475|NCT02392234|592013131|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
163902476|NCT02392234|592013132|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163902477|NCT02392234|592013133|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
163902478|NCT02392234|592013134|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
163902479|NCT02392234|592013129|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
164092794|NCT02130466|592702143|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
164144030|NCT00086281|592888584|FG013|Phase 1|Serious Adverse Event|0|||
164375574|NCT04399161|593747206|FG001|Overall Study|Protocol Violation|2|||
164375575|NCT04399161|593747207|FG002|Overall Study|Protocol Violation|0|||
164375576|NCT03417141|593747208|FG000|Overall Study|Withdrawal by Subject|1|||
164375577|NCT03417141|593747208|FG000|Overall Study|Protocol Violation|3|||
164375578|NCT01420081|593747209|FG000|Overall Study|Death|1|||
164375579|NCT01420081|593747210|FG001|Overall Study|Death|0|||
164375580|NCT01420081|593747211|FG002|Overall Study|Death|8|||
164375581|NCT01420081|593747212|FG003|Overall Study|Death|0|||
164375582|NCT01420081|593747213|FG004|Overall Study|Death|7|||
164375583|NCT01420081|593747214|FG005|Overall Study|Death|12|||
164375584|NCT01420081|593747215|FG006|Overall Study|Death|0|||
164375585|NCT01420081|593747216|FG007|Overall Study|Death|1|||
164375586|NCT01420081|593747217|FG008|Overall Study|Death|1|||
164375587|NCT01420081|593747209|FG000|Overall Study|Lost to Follow-up|0|||
164375588|NCT01420081|593747210|FG001|Overall Study|Lost to Follow-up|0|||
164375589|NCT01420081|593747211|FG002|Overall Study|Lost to Follow-up|0|||
164375590|NCT01420081|593747212|FG003|Overall Study|Lost to Follow-up|0|||
164375591|NCT01420081|593747213|FG004|Overall Study|Lost to Follow-up|1|||
164375592|NCT01420081|593747214|FG005|Overall Study|Lost to Follow-up|1|||
164375593|NCT01420081|593747215|FG006|Overall Study|Lost to Follow-up|0|||
164375594|NCT01420081|593747216|FG007|Overall Study|Lost to Follow-up|0|||
164375595|NCT01420081|593747217|FG008|Overall Study|Lost to Follow-up|0|||
164375596|NCT01420081|593747209|FG000|Overall Study|Study Terminated by Sponsor|2|||
164375597|NCT01420081|593747210|FG001|Overall Study|Study Terminated by Sponsor|1|||
164375598|NCT01420081|593747211|FG002|Overall Study|Study Terminated by Sponsor|1|||
164375599|NCT01420081|593747212|FG003|Overall Study|Study Terminated by Sponsor|3|||
164375600|NCT01420081|593747213|FG004|Overall Study|Study Terminated by Sponsor|11|||
164375601|NCT01420081|593747214|FG005|Overall Study|Study Terminated by Sponsor|7|||
164375602|NCT01420081|593747215|FG006|Overall Study|Study Terminated by Sponsor|3|||
164375603|NCT01420081|593747216|FG007|Overall Study|Study Terminated by Sponsor|2|||
164375604|NCT01420081|593747217|FG008|Overall Study|Study Terminated by Sponsor|2|||
164375605|NCT01420081|593747209|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
164375606|NCT01420081|593747210|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
164375607|NCT01420081|593747211|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
164375608|NCT01420081|593747212|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
164375609|NCT01420081|593747213|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
164375610|NCT01420081|593747214|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
164375611|NCT01420081|593747215|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
164375612|NCT01420081|593747216|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
164375613|NCT01420081|593747217|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
164375614|NCT01420081|593747209|FG000|Overall Study|Other Reasons|0|||
164375615|NCT01420081|593747210|FG001|Overall Study|Other Reasons|0|||
164375616|NCT01420081|593747211|FG002|Overall Study|Other Reasons|1|||
164375617|NCT01420081|593747212|FG003|Overall Study|Other Reasons|0|||
164375618|NCT01420081|593747213|FG004|Overall Study|Other Reasons|0|||
164375619|NCT01420081|593747214|FG005|Overall Study|Other Reasons|0|||
164092795|NCT02130466|592702144|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164092796|NCT02130466|592702145|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
164092797|NCT02130466|592702146|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
164092798|NCT02130466|592702133|FG000|Overall Study|Withdrawal by Subject|1|||
164092799|NCT02130466|592702134|FG001|Overall Study|Withdrawal by Subject|0|||
164092800|NCT02130466|592702135|FG002|Overall Study|Withdrawal by Subject|0|||
164092801|NCT02130466|592702136|FG003|Overall Study|Withdrawal by Subject|0|||
164092802|NCT02130466|592702137|FG004|Overall Study|Withdrawal by Subject|0|||
164092803|NCT02130466|592702138|FG005|Overall Study|Withdrawal by Subject|1|||
164092804|NCT02130466|592702139|FG006|Overall Study|Withdrawal by Subject|0|||
164092805|NCT02130466|592702140|FG007|Overall Study|Withdrawal by Subject|0|||
164092806|NCT02130466|592702141|FG008|Overall Study|Withdrawal by Subject|1|||
164092807|NCT02130466|592702142|FG009|Overall Study|Withdrawal by Subject|0|||
164092808|NCT02130466|592702143|FG010|Overall Study|Withdrawal by Subject|0|||
164092809|NCT02130466|592702144|FG011|Overall Study|Withdrawal by Subject|0|||
164092810|NCT02130466|592702145|FG012|Overall Study|Withdrawal by Subject|0|||
164092811|NCT02130466|592702146|FG013|Overall Study|Withdrawal by Subject|0|||
164092812|NCT04529109|592702148|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
164092813|NCT04529109|592702149|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
164092814|NCT01508936|592702151|FG000|Overall Study|Adverse Event|11|||
164375620|NCT01420081|593747215|FG006|Overall Study|Other Reasons|0|||
164375621|NCT01420081|593747216|FG007|Overall Study|Other Reasons|0|||
164375622|NCT01420081|593747217|FG008|Overall Study|Other Reasons|0|||
164375623|NCT01723228|593747219|FG000|Overall Study|Adverse Event|2|||
164375624|NCT01723228|593747220|FG001|Overall Study|Adverse Event|6|||
164375625|NCT01723228|593747219|FG000|Overall Study|Withdrawal by Subject|2|||
164375626|NCT01723228|593747220|FG001|Overall Study|Withdrawal by Subject|1|||
164375627|NCT01723228|593747219|FG000|Overall Study|Protocol Violation|0|||
164375628|NCT01723228|593747220|FG001|Overall Study|Protocol Violation|2|||
164375629|NCT01723228|593747219|FG000|Overall Study|Lost to Follow-up|2|||
164375630|NCT01723228|593747220|FG001|Overall Study|Lost to Follow-up|1|||
164375631|NCT01723228|593747219|FG000|Overall Study|Other|2|||
164375632|NCT01723228|593747220|FG001|Overall Study|Other|1|||
164375633|NCT01864291|593747221|FG000|Overall Study|need for revision surgery|2|||
164375634|NCT01282216|593747222|FG000|Overall Study|Graft failure|0|||
164375635|NCT01282216|593747223|FG001|Overall Study|Graft failure|0|||
164375636|NCT01282216|593747224|FG002|Overall Study|Graft failure|3|||
164375637|NCT01282216|593747225|FG003|Overall Study|Graft failure|2|||
164375638|NCT01282216|593747222|FG000|Overall Study|Physician Decision|0|||
164375639|NCT01282216|593747223|FG001|Overall Study|Physician Decision|0|||
164375640|NCT01282216|593747224|FG002|Overall Study|Physician Decision|11|||
164375641|NCT01282216|593747225|FG003|Overall Study|Physician Decision|0|||
164375642|NCT01282216|593747222|FG000|Overall Study|Relapse|0|||
164375643|NCT01282216|593747223|FG001|Overall Study|Relapse|0|||
164375644|NCT01282216|593747224|FG002|Overall Study|Relapse|17|||
164375645|NCT01282216|593747225|FG003|Overall Study|Relapse|6|||
164375646|NCT01282216|593747222|FG000|Overall Study|Death|0|||
164375647|NCT01282216|593747223|FG001|Overall Study|Death|0|||
164375648|NCT01282216|593747224|FG002|Overall Study|Death|2|||
164375649|NCT01282216|593747225|FG003|Overall Study|Death|0|||
164375650|NCT03080961|593747227|FG000|Overall Study|Withdrawal by Subject|3|||
164375651|NCT03508219|593747234|FG000|Overall Study|Death|2|||
164375652|NCT03508219|593747234|FG000|Overall Study|Withdrawal by Subject|1|||
164375653|NCT03508219|593747234|FG000|Overall Study|Lost to Follow-up|4|||
164375654|NCT03508219|593747234|FG000|Overall Study|Missed visit|2|||
164375655|NCT04466891|593747235|FG000|Overall Study|Death|60|||
164375656|NCT04466891|593747236|FG001|Overall Study|Death|6|||
164375657|NCT04466891|593747235|FG000|Overall Study|Withdrawal by Subject|8|||
164375658|NCT04466891|593747236|FG001|Overall Study|Withdrawal by Subject|1|||
164375659|NCT04466891|593747235|FG000|Overall Study|Study terminated by sponsor|5|||
164375660|NCT04466891|593747236|FG001|Overall Study|Study terminated by sponsor|0|||
164375661|NCT04466891|593747235|FG000|Overall Study|Lost to Follow-up|2|||
164375662|NCT04466891|593747236|FG001|Overall Study|Lost to Follow-up|0|||
164375663|NCT04466891|593747235|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
164375664|NCT04466891|593747236|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
164375665|NCT00445328|593747237|FG000|Overall Study|Death|0|||
164092815|NCT01508936|592702152|FG001|Overall Study|Adverse Event|32|||
164092816|NCT01508936|592702151|FG000|Overall Study|Lack of Efficacy|0|||
164375666|NCT00445328|593747238|FG001|Overall Study|Death|1|||
164375667|NCT00445328|593747237|FG000|Overall Study|Adverse Event|0|||
164375668|NCT00445328|593747238|FG001|Overall Study|Adverse Event|3|||
164375669|NCT00445328|593747237|FG000|Overall Study|Other|0|||
164375670|NCT00445328|593747238|FG001|Overall Study|Other|2|||
164375671|NCT00445328|593747237|FG000|Overall Study|Withdrawal by Subject|2|||
164375672|NCT00445328|593747238|FG001|Overall Study|Withdrawal by Subject|0|||
164375673|NCT00445328|593747237|FG000|Overall Study|Protocol Violation|1|||
164375674|NCT00445328|593747238|FG001|Overall Study|Protocol Violation|0|||
164375675|NCT00590954|593747241|FG000|Overall Study|Inevaluable|2|||
164375676|NCT02239536|593747242|FG000|Overall Study|Non-neoplastic polyp|23|||
164375677|NCT02239536|593747243|FG001|Overall Study|Non-neoplastic polyp|17|||
164375678|NCT02143414|593748679|FG000|Induction|Adverse Event|1|||
164375679|NCT02143414|593748680|FG001|Induction|Adverse Event|2|||
164375680|NCT02143414|593748679|FG000|Induction|Death|1|||
164375681|NCT02143414|593748680|FG001|Induction|Death|2|||
164375682|NCT02143414|593748679|FG000|Induction|Patient refusal|1|||
164375683|NCT02143414|593748680|FG001|Induction|Patient refusal|1|||
164375684|NCT02143414|593748679|FG000|Induction|Refractory|1|||
164375685|NCT02143414|593748680|FG001|Induction|Refractory|0|||
164375686|NCT02143414|593748679|FG000|Induction|Began alternative treatment|1|||
164375687|NCT02143414|593748680|FG001|Induction|Began alternative treatment|0|||
164375688|NCT02143414|593748679|FG000|Induction|Ineligible for postremission|5|||
164375689|NCT02143414|593748680|FG001|Induction|Ineligible for postremission|1|||
164375690|NCT02143414|593748679|FG000|Post-remission|Adverse Event|0|||
164375691|NCT02143414|593748680|FG001|Post-remission|Adverse Event|2|||
164375692|NCT02143414|593748679|FG000|Post-remission|Disease progression/relapse|5|||
164375693|NCT02143414|593748680|FG001|Post-remission|Disease progression/relapse|0|||
164375694|NCT02143414|593748679|FG000|Maintenance|Adverse Event|4|||
164375695|NCT02143414|593748680|FG001|Maintenance|Adverse Event|6|||
164375696|NCT02143414|593748679|FG000|Maintenance|Disease progression/relapse|3|||
164375697|NCT02143414|593748680|FG001|Maintenance|Disease progression/relapse|2|||
164375698|NCT02143414|593748679|FG000|Maintenance|Patient refusal|2|||
164375699|NCT02143414|593748680|FG001|Maintenance|Patient refusal|1|||
164375700|NCT02143414|593748679|FG000|Maintenance|Physician Decision|1|||
164375701|NCT02143414|593748680|FG001|Maintenance|Physician Decision|0|||
164375702|NCT02143414|593748679|FG000|Maintenance|Death|0|||
164375703|NCT02143414|593748680|FG001|Maintenance|Death|1|||
164375704|NCT02143414|593748679|FG000|Maintenance|On protocol treatment|0|||
164375705|NCT02143414|593748680|FG001|Maintenance|On protocol treatment|6|||
164375706|NCT00978731|593748684|FG000|Overall Study|Death|4|||
164375707|NCT00978731|593748685|FG001|Overall Study|Death|1|||
164375708|NCT00978731|593748686|FG002|Overall Study|Death|1|||
164375709|NCT00978731|593748687|FG003|Overall Study|Death|0|||
164375710|NCT00978731|593748684|FG000|Overall Study|Lost to Follow-up|0|||
164375711|NCT00978731|593748685|FG001|Overall Study|Lost to Follow-up|0|||
164375712|NCT00978731|593748686|FG002|Overall Study|Lost to Follow-up|0|||
164375713|NCT00978731|593748687|FG003|Overall Study|Lost to Follow-up|1|||
164375714|NCT00978731|593748684|FG000|Overall Study|Adverse Event|5|||
164375715|NCT00978731|593748685|FG001|Overall Study|Adverse Event|2|||
164375716|NCT00978731|593748686|FG002|Overall Study|Adverse Event|0|||
164375717|NCT00978731|593748687|FG003|Overall Study|Adverse Event|0|||
164375718|NCT00978731|593748684|FG000|Overall Study|Participant's request|1|||
164375719|NCT00978731|593748685|FG001|Overall Study|Participant's request|0|||
164012645|NCT01912872|592410559|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164012646|NCT01912872|592410560|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
164012647|NCT01912872|592410557|FG000|Overall Study|Withdrawal of study medication|0|||
164012648|NCT01912872|592410558|FG001|Overall Study|Withdrawal of study medication|0|||
164012649|NCT01912872|592410559|FG002|Overall Study|Withdrawal of study medication|0|||
164012650|NCT01912872|592410560|FG003|Overall Study|Withdrawal of study medication|2|||
164012651|NCT01912872|592410557|FG000|Overall Study|Missing|0|||
164012652|NCT01912872|592410558|FG001|Overall Study|Missing|0|||
164012653|NCT01912872|592410559|FG002|Overall Study|Missing|0|||
164012654|NCT01912872|592410560|FG003|Overall Study|Missing|1|||
164012655|NCT01277289|592410562|FG000|Overall Study|fragile vein|1|||
164012656|NCT01277289|592410563|FG001|Overall Study|fragile vein|0|||
164375720|NCT00978731|593748686|FG002|Overall Study|Participant's request|0|||
164375721|NCT00978731|593748687|FG003|Overall Study|Participant's request|0|||
164375722|NCT00978731|593748684|FG000|Overall Study|Administrative reason|3|||
164375723|NCT00978731|593748685|FG001|Overall Study|Administrative reason|3|||
164375724|NCT00978731|593748686|FG002|Overall Study|Administrative reason|1|||
164375725|NCT00978731|593748687|FG003|Overall Study|Administrative reason|0|||
164375726|NCT00978731|593748684|FG000|Overall Study|Deterioration without progression|0|||
164375727|NCT00978731|593748685|FG001|Overall Study|Deterioration without progression|1|||
164375728|NCT00978731|593748686|FG002|Overall Study|Deterioration without progression|0|||
164375729|NCT00978731|593748687|FG003|Overall Study|Deterioration without progression|0|||
164375730|NCT00978731|593748684|FG000|Overall Study|Disease progression/relapse|5|||
164375731|NCT00978731|593748685|FG001|Overall Study|Disease progression/relapse|4|||
164375732|NCT00978731|593748686|FG002|Overall Study|Disease progression/relapse|2|||
164375733|NCT00978731|593748687|FG003|Overall Study|Disease progression/relapse|2|||
164375734|NCT00978731|593748684|FG000|Overall Study|Study closure|3|||
164375735|NCT00978731|593748685|FG001|Overall Study|Study closure|4|||
164375736|NCT00978731|593748686|FG002|Overall Study|Study closure|1|||
164375737|NCT00978731|593748687|FG003|Overall Study|Study closure|1|||
164375738|NCT00978731|593748684|FG000|Overall Study|No response|1|||
164375739|NCT00978731|593748685|FG001|Overall Study|No response|0|||
164375740|NCT00978731|593748686|FG002|Overall Study|No response|0|||
164375741|NCT00978731|593748687|FG003|Overall Study|No response|0|||
164012657|NCT01277289|592410562|FG000|Overall Study|Physician Decision|1|||
164375742|NCT02649972|593748692|FG000|Overall Study|Not treated|1|||
164375743|NCT03107988|593748693|FG000|Overall Study|Adverse Event|0|||
164375744|NCT03107988|593748694|FG001|Overall Study|Adverse Event|0|||
164375745|NCT03107988|593748695|FG002|Overall Study|Adverse Event|0|||
164012658|NCT01277289|592410563|FG001|Overall Study|Physician Decision|0|||
164012659|NCT01277289|592410562|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
164012660|NCT01277289|592410563|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
164012661|NCT01277289|592410562|FG000|Overall Study|Protocol Violation|1|||
164012662|NCT01277289|592410563|FG001|Overall Study|Protocol Violation|1|||
164375746|NCT03107988|593748696|FG003|Overall Study|Adverse Event|1|||
164375747|NCT03107988|593748697|FG004|Overall Study|Adverse Event|0|||
164375748|NCT03107988|593748698|FG005|Overall Study|Adverse Event|1|||
164375749|NCT03107988|593748699|FG006|Overall Study|Adverse Event|0|||
164012663|NCT01277289|592410562|FG000|Overall Study|Adverse Event|2|||
164375750|NCT03107988|593748700|FG007|Overall Study|Adverse Event|1|||
164375751|NCT03107988|593748701|FG008|Overall Study|Adverse Event|0|||
164375752|NCT03107988|593748702|FG009|Overall Study|Adverse Event|0|||
164375753|NCT03107988|593748703|FG010|Overall Study|Adverse Event|0|||
164375754|NCT03107988|593748704|FG011|Overall Study|Adverse Event|0|||
164375755|NCT03107988|593748705|FG012|Overall Study|Adverse Event|0|||
164375756|NCT03107988|593748693|FG000|Overall Study|Disease Progression or Relapse|1|||
164375757|NCT03107988|593748694|FG001|Overall Study|Disease Progression or Relapse|2|||
164375758|NCT03107988|593748695|FG002|Overall Study|Disease Progression or Relapse|2|||
164375759|NCT03107988|593748696|FG003|Overall Study|Disease Progression or Relapse|5|||
164375760|NCT03107988|593748697|FG004|Overall Study|Disease Progression or Relapse|1|||
164375761|NCT03107988|593748698|FG005|Overall Study|Disease Progression or Relapse|1|||
164375762|NCT03107988|593748699|FG006|Overall Study|Disease Progression or Relapse|0|||
164375763|NCT03107988|593748700|FG007|Overall Study|Disease Progression or Relapse|0|||
164375764|NCT03107988|593748701|FG008|Overall Study|Disease Progression or Relapse|0|||
164375765|NCT03107988|593748702|FG009|Overall Study|Disease Progression or Relapse|1|||
164375766|NCT03107988|593748703|FG010|Overall Study|Disease Progression or Relapse|4|||
164375767|NCT03107988|593748704|FG011|Overall Study|Disease Progression or Relapse|0|||
164375768|NCT03107988|593748705|FG012|Overall Study|Disease Progression or Relapse|0|||
164375769|NCT03107988|593748693|FG000|Overall Study|Ineligible|0|||
164375770|NCT03107988|593748694|FG001|Overall Study|Ineligible|0|||
164375771|NCT03107988|593748695|FG002|Overall Study|Ineligible|0|||
164375772|NCT03107988|593748696|FG003|Overall Study|Ineligible|0|||
164375773|NCT03107988|593748697|FG004|Overall Study|Ineligible|0|||
164375774|NCT03107988|593748698|FG005|Overall Study|Ineligible|0|||
164375775|NCT03107988|593748699|FG006|Overall Study|Ineligible|0|||
164375776|NCT03107988|593748700|FG007|Overall Study|Ineligible|0|||
164375777|NCT03107988|593748701|FG008|Overall Study|Ineligible|1|||
164375778|NCT03107988|593748702|FG009|Overall Study|Ineligible|0|||
164375779|NCT03107988|593748703|FG010|Overall Study|Ineligible|0|||
164375780|NCT03107988|593748704|FG011|Overall Study|Ineligible|0|||
164375781|NCT03107988|593748705|FG012|Overall Study|Ineligible|0|||
164375782|NCT01344057|593748706|FG000|Overall Study|Premature Withdrawal|1|||
164375783|NCT00529386|593748707|FG000|Overall Study|Lost to Follow-up|1|||
164375784|NCT04027686|593748708|FG000|Overall Study|Lost to Follow-up|2|||
164375785|NCT04027686|593748709|FG001|Overall Study|Lost to Follow-up|0|||
164375786|NCT04027686|593748708|FG000|Overall Study|Withdrawal by Subject|0|||
164375787|NCT04027686|593748709|FG001|Overall Study|Withdrawal by Subject|1|||
163902480|NCT02392234|592013130|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163902481|NCT02392234|592013131|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163902482|NCT02392234|592013132|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163902483|NCT02392234|592013133|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163902484|NCT02392234|592013134|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
163902485|NCT02816398|592013139|FG000|Overall Study|Death|5|||
163902486|NCT02816398|592013139|FG000|Overall Study|Lack of Efficacy|8|||
163902487|NCT02816398|592013139|FG000|Overall Study|Lost to Follow-up|1|||
163902488|NCT01387516|592013140|FG000|Overall Study|Lost to Follow-up|4|||
163902489|NCT01387516|592013141|FG001|Overall Study|Lost to Follow-up|4|||
163902490|NCT01387516|592013142|FG002|Overall Study|Lost to Follow-up|2|||
163902491|NCT01387516|592013143|FG003|Overall Study|Lost to Follow-up|3|||
163902492|NCT01387516|592013140|FG000|Overall Study|Withdrawal by Subject|1|||
163902493|NCT01387516|592013141|FG001|Overall Study|Withdrawal by Subject|1|||
163902494|NCT01387516|592013142|FG002|Overall Study|Withdrawal by Subject|2|||
163902495|NCT01387516|592013143|FG003|Overall Study|Withdrawal by Subject|0|||
163902496|NCT01387516|592013140|FG000|Overall Study|Death|0|||
163902497|NCT01387516|592013141|FG001|Overall Study|Death|0|||
163902498|NCT01387516|592013142|FG002|Overall Study|Death|0|||
163902499|NCT01387516|592013143|FG003|Overall Study|Death|1|||
163902500|NCT03582475|592013144|FG000|Treatment Period|Withdrawal by Subject|0|||
163902501|NCT03582475|592013145|FG001|Treatment Period|Withdrawal by Subject|1|||
163902502|NCT03582475|592013144|FG000|Follow-up Period|Withdrawal by Subject|0|||
163902503|NCT03582475|592013145|FG001|Follow-up Period|Withdrawal by Subject|1|||
163902504|NCT03509909|592013151|FG000|Overall Study|Withdrawal by Subject|16|||
163902505|NCT03509909|592013152|FG001|Overall Study|Withdrawal by Subject|9|||
163902506|NCT03509909|592013151|FG000|Overall Study|Lost to Follow-up|3|||
163902507|NCT03509909|592013152|FG001|Overall Study|Lost to Follow-up|4|||
163902508|NCT03509909|592013151|FG000|Overall Study|Adverse Event|2|||
163902509|NCT03509909|592013152|FG001|Overall Study|Adverse Event|0|||
163902510|NCT03683576|592013154|FG000|Overall Study|Withdrawal by Subject|2|||
163902511|NCT03683576|592013155|FG001|Overall Study|Withdrawal by Subject|0|||
163902512|NCT03683576|592013156|FG002|Overall Study|Withdrawal by Subject|8|||
163902513|NCT03683576|592013157|FG003|Overall Study|Withdrawal by Subject|3|||
163902514|NCT03683576|592013154|FG000|Overall Study|Adverse Event|3|||
163902515|NCT03683576|592013155|FG001|Overall Study|Adverse Event|0|||
163902516|NCT03683576|592013156|FG002|Overall Study|Adverse Event|0|||
163902517|NCT03683576|592013157|FG003|Overall Study|Adverse Event|4|||
163902518|NCT03683576|592013154|FG000|Overall Study|Lack of Efficacy|1|||
163902519|NCT03683576|592013155|FG001|Overall Study|Lack of Efficacy|0|||
163902520|NCT03683576|592013156|FG002|Overall Study|Lack of Efficacy|1|||
163902521|NCT03683576|592013157|FG003|Overall Study|Lack of Efficacy|1|||
163902522|NCT03683576|592013154|FG000|Overall Study|Lost to Follow-up|0|||
163902523|NCT03683576|592013155|FG001|Overall Study|Lost to Follow-up|1|||
163902524|NCT03683576|592013156|FG002|Overall Study|Lost to Follow-up|2|||
163902525|NCT03683576|592013157|FG003|Overall Study|Lost to Follow-up|0|||
163902526|NCT03683576|592013154|FG000|Overall Study|Other, Not Specified|0|||
163902527|NCT03683576|592013155|FG001|Overall Study|Other, Not Specified|2|||
163902528|NCT03683576|592013156|FG002|Overall Study|Other, Not Specified|0|||
163902529|NCT03683576|592013157|FG003|Overall Study|Other, Not Specified|0|||
163902530|NCT03683576|592013154|FG000|Overall Study|Protocol Violation|0|||
163902531|NCT03683576|592013155|FG001|Overall Study|Protocol Violation|1|||
163902532|NCT03683576|592013156|FG002|Overall Study|Protocol Violation|1|||
163902533|NCT03683576|592013157|FG003|Overall Study|Protocol Violation|0|||
163902534|NCT01588951|592013158|FG000|Overall Study|Ineligible in retrospect|0|||
163902535|NCT01588951|592013159|FG001|Overall Study|Ineligible in retrospect|0|||
163902536|NCT01588951|592013160|FG002|Overall Study|Ineligible in retrospect|1|||
163902537|NCT02454959|592013161|FG000|Overall Study|Protocol-Specified Criteria|3|||
163902538|NCT02454959|592013161|FG000|Overall Study|Physician Decision|1|||
164012664|NCT01277289|592410563|FG001|Overall Study|Adverse Event|1|||
164375788|NCT02939404|593748710|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
164375789|NCT02939404|593748711|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
163902539|NCT02454959|592013161|FG000|Overall Study|Withdrawal by Subject|3|||
163902540|NCT02454959|592013161|FG000|Overall Study|Adverse Event|2|||
163902541|NCT02350634|592013162|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
163902542|NCT02307682|592013179|FG000|Overall Study|Adverse Event|9|||
163902543|NCT02307682|592013180|FG001|Overall Study|Adverse Event|8|||
164012665|NCT01277289|592410562|FG000|Overall Study|consent withdrawn|1|||
164012666|NCT01277289|592410563|FG001|Overall Study|consent withdrawn|1|||
163902544|NCT02307682|592013181|FG002|Overall Study|Adverse Event|12|||
163902545|NCT02307682|592013179|FG000|Overall Study|Lack of Efficacy|1|||
163902546|NCT02307682|592013180|FG001|Overall Study|Lack of Efficacy|0|||
163902547|NCT02307682|592013181|FG002|Overall Study|Lack of Efficacy|1|||
163902548|NCT02307682|592013179|FG000|Overall Study|Physician Decision|2|||
163902549|NCT02307682|592013180|FG001|Overall Study|Physician Decision|2|||
163902550|NCT02307682|592013181|FG002|Overall Study|Physician Decision|8|||
163902551|NCT02307682|592013179|FG000|Overall Study|Progressive Disease|1|||
164012667|NCT01277289|592410562|FG000|Overall Study|premature closure of the study|4|||
164375790|NCT02939404|593748710|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
164375791|NCT02939404|593748711|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
164375792|NCT01428193|593748712|FG000|Overall Study|Physician Decision|1|||
164375793|NCT01428193|593748712|FG000|Overall Study|Elevated screening liver enzymes|1|||
164375794|NCT00357370|593748717|FG000|Cohort 2|Lack of Efficacy|0|||
164375795|NCT00357370|593748718|FG001|Cohort 2|Lack of Efficacy|2|||
164375796|NCT00357370|593748719|FG002|Cohort 2|Lack of Efficacy|1|||
164375797|NCT00357370|593748717|FG000|Cohort 2|Adverse Event|1|||
164375798|NCT00357370|593748718|FG001|Cohort 2|Adverse Event|1|||
164375799|NCT00357370|593748719|FG002|Cohort 2|Adverse Event|1|||
164375800|NCT00357370|593748717|FG000|Cohort 2|Lost to Follow-up|0|||
164375801|NCT00357370|593748718|FG001|Cohort 2|Lost to Follow-up|1|||
164375802|NCT00357370|593748719|FG002|Cohort 2|Lost to Follow-up|0|||
164375803|NCT00357370|593748717|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
164375804|NCT00357370|593748718|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
164375805|NCT00357370|593748719|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
164375806|NCT00357370|593748717|FG000|Cohort 2|Withdrawal by Subject|0|||
164375807|NCT00357370|593748718|FG001|Cohort 2|Withdrawal by Subject|2|||
164375808|NCT00357370|593748719|FG002|Cohort 2|Withdrawal by Subject|0|||
164375809|NCT02075437|593748721|FG000|Overall Study|Withdrawal by Subject|5|||
164375810|NCT02075437|593748721|FG000|Overall Study|Lost to Follow-up|1|||
164375811|NCT01632800|593748722|FG000|Overall Study|Subject did not fit in apparatus|1|||
164375812|NCT01502644|593748725|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
164375813|NCT01502644|593748726|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
164375814|NCT01502644|593748727|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
164375815|NCT01502644|593748728|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
164375816|NCT01502644|593748725|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
164375817|NCT01502644|593748726|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
164375818|NCT01502644|593748727|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
164375819|NCT01502644|593748728|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
164375820|NCT01502644|593748725|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
164375821|NCT01502644|593748726|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
164375822|NCT01502644|593748727|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
164375823|NCT01502644|593748728|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
164375824|NCT01502644|593748725|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
164375825|NCT01502644|593748726|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
164375826|NCT01502644|593748727|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
164375827|NCT01502644|593748728|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
164375828|NCT01502644|593748725|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
164375829|NCT01502644|593748726|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
164375830|NCT01502644|593748727|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
164375831|NCT01502644|593748728|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
164375832|NCT03306264|593748731|FG000|Overall Study|Death|33|||
164375833|NCT03306264|593748732|FG001|Overall Study|Death|25|||
164375834|NCT03306264|593748733|FG002|Overall Study|Death|34|||
164375835|NCT03306264|593748734|FG003|Overall Study|Death|34|||
164375836|NCT03306264|593748731|FG000|Overall Study|Complete Consent Withdrawal|4|||
164375837|NCT03306264|593748732|FG001|Overall Study|Complete Consent Withdrawal|4|||
164375838|NCT03306264|593748733|FG002|Overall Study|Complete Consent Withdrawal|1|||
164375839|NCT03306264|593748734|FG003|Overall Study|Complete Consent Withdrawal|8|||
164375840|NCT03306264|593748731|FG000|Overall Study|Lost to Follow-up|1|||
164012668|NCT01277289|592410563|FG001|Overall Study|premature closure of the study|2|||
164092817|NCT01508936|592702152|FG001|Overall Study|Lack of Efficacy|1|||
164375841|NCT03306264|593748732|FG001|Overall Study|Lost to Follow-up|0|||
164375842|NCT03306264|593748733|FG002|Overall Study|Lost to Follow-up|1|||
164375843|NCT03306264|593748734|FG003|Overall Study|Lost to Follow-up|0|||
164375844|NCT03306264|593748731|FG000|Overall Study|Rollover to ASTX727-06|10|||
164375845|NCT03306264|593748732|FG001|Overall Study|Rollover to ASTX727-06|18|||
164375846|NCT03306264|593748733|FG002|Overall Study|Rollover to ASTX727-06|4|||
164375847|NCT03306264|593748734|FG003|Overall Study|Rollover to ASTX727-06|2|||
164375848|NCT03306264|593748731|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
164375849|NCT03306264|593748732|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
164375850|NCT03306264|593748733|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
164375851|NCT03306264|593748734|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
164375852|NCT02722928|593748740|FG000|Overall Study|Standard CT was not as required per prot|5|||
164375853|NCT02722928|593748741|FG001|Overall Study|Standard CT was not as required per prot|13|||
164375854|NCT02722928|593748740|FG000|Overall Study|Required Intraoperative MRI|5|||
164375855|NCT02722928|593748741|FG001|Overall Study|Required Intraoperative MRI|7|||
164375856|NCT00094653|593748744|FG000|Overall Study|Death|306|||
164375857|NCT00094653|593748745|FG001|Overall Study|Death|100|||
164375858|NCT00094653|593748746|FG002|Overall Study|Death|119|||
164375859|NCT00094653|593748744|FG000|Overall Study|Subject Withdrew Consent|10|||
164375860|NCT00094653|593748745|FG001|Overall Study|Subject Withdrew Consent|2|||
164375861|NCT00094653|593748746|FG002|Overall Study|Subject Withdrew Consent|3|||
164375862|NCT00094653|593748744|FG000|Overall Study|Other|2|||
164375863|NCT00094653|593748745|FG001|Overall Study|Other|2|||
164375864|NCT00094653|593748746|FG002|Overall Study|Other|2|||
164375865|NCT00094653|593748744|FG000|Overall Study|Lost to Follow-up|3|||
164375866|NCT00094653|593748745|FG001|Overall Study|Lost to Follow-up|2|||
164375867|NCT00094653|593748746|FG002|Overall Study|Lost to Follow-up|1|||
164375868|NCT00094653|593748744|FG000|Overall Study|Protocol Violation|0|||
164375869|NCT00094653|593748745|FG001|Overall Study|Protocol Violation|0|||
164375870|NCT00094653|593748746|FG002|Overall Study|Protocol Violation|1|||
164375871|NCT03921411|593748747|FG000|Overall Study|Withdrawal by Subject|1|||
164375872|NCT03921411|593748747|FG000|Overall Study|Protocol Deviation|2|||
164375873|NCT03921411|593748747|FG000|Overall Study|Enrolled, but never treated|2|||
164375874|NCT03120013|593748751|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
164375875|NCT03120013|593748752|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164375876|NCT05059600|593748753|FG000|Overall Study|Enrolled but not Treated|10|||
164375877|NCT02152995|593748754|FG000|Overall Study|Withdrawal by Subject|1|||
164375878|NCT02152995|593748755|FG001|Overall Study|Withdrawal by Subject|0|||
164375879|NCT02098109|593748756|FG000|Overall Study|Protocol Violation|3|||
164375880|NCT02098109|593748757|FG001|Overall Study|Protocol Violation|0|||
164375881|NCT01541826|593748758|FG000|Overall Study|Lost to Follow-up|2|||
164375882|NCT01541826|593748759|FG001|Overall Study|Lost to Follow-up|3|||
164375883|NCT01541826|593748760|FG002|Overall Study|Lost to Follow-up|0|||
164375884|NCT01541826|593748758|FG000|Overall Study|Withdrawal by Subject|2|||
164375885|NCT01541826|593748759|FG001|Overall Study|Withdrawal by Subject|0|||
164375886|NCT01541826|593748760|FG002|Overall Study|Withdrawal by Subject|0|||
164375887|NCT01565291|593748761|FG000|Overall Study|Withdrawal by Subject|1|||
164375888|NCT01565291|593748762|FG001|Overall Study|Withdrawal by Subject|0|||
164375889|NCT04552587|593748770|FG000|Overall Study|Lost to Follow-up|4|||
164375890|NCT01822132|593748771|FG000|Overall Study|Lost to Follow-up|4|||
164375891|NCT01822132|593748772|FG001|Overall Study|Lost to Follow-up|2|||
164375892|NCT00854581|593748774|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
164375893|NCT00854581|593748774|FG000|Induction (Up to Day 21)|Death|1|||
164375894|NCT00854581|593748774|FG000|Induction (Up to Day 21)|Physician Decision|1|||
163902552|NCT02307682|592013180|FG001|Overall Study|Progressive Disease|0|||
164375895|NCT00854581|593748774|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
164375896|NCT00313612|593748775|FG000|Overall Study|Patient never received treatment|0|||
164375897|NCT00313612|593748776|FG001|Overall Study|Patient never received treatment|1|||
164375898|NCT02705820|593748777|FG000|Overall Study|Death|2|||
164375899|NCT02705820|593748777|FG000|Overall Study|Disease Progression|34|||
164375900|NCT02705820|593748777|FG000|Overall Study|Clinical Deterioration|3|||
164375901|NCT02702401|593748781|FG000|Overall Study|Death|242|||
164375902|NCT02702401|593748782|FG001|Overall Study|Death|125|||
164375903|NCT02702401|593748781|FG000|Overall Study|Withdrawal by Subject|15|||
164375904|NCT02702401|593748782|FG001|Overall Study|Withdrawal by Subject|5|||
164375905|NCT02702401|593748781|FG000|Overall Study|Sponsor Decision|19|||
164375906|NCT02702401|593748782|FG001|Overall Study|Sponsor Decision|3|||
164375907|NCT02702401|593748781|FG000|Overall Study|Physician Decision|1|||
164375908|NCT02702401|593748782|FG001|Overall Study|Physician Decision|2|||
164375909|NCT02702401|593748781|FG000|Overall Study|Lost to Follow-up|1|||
163902553|NCT02307682|592013181|FG002|Overall Study|Progressive Disease|0|||
163902554|NCT02307682|592013179|FG000|Overall Study|Withdrawal by Subject|26|||
164144031|NCT00086281|592888585|FG014|Phase 1|Serious Adverse Event|1|||
164375910|NCT02702401|593748782|FG001|Overall Study|Lost to Follow-up|0|||
164375911|NCT00677807|593748783|FG000|Overall Study|Adverse Event|4|||
164375912|NCT00677807|593748784|FG001|Overall Study|Adverse Event|1|||
164375913|NCT00677807|593748785|FG002|Overall Study|Adverse Event|6|||
164375914|NCT00677807|593748783|FG000|Overall Study|Lack of Efficacy|0|||
164375915|NCT00677807|593748784|FG001|Overall Study|Lack of Efficacy|0|||
164375916|NCT00677807|593748785|FG002|Overall Study|Lack of Efficacy|2|||
164375917|NCT00677807|593748783|FG000|Overall Study|Participant no longer needs study drug|0|||
164375918|NCT00677807|593748784|FG001|Overall Study|Participant no longer needs study drug|0|||
164375919|NCT00677807|593748785|FG002|Overall Study|Participant no longer needs study drug|1|||
164375920|NCT00677807|593748783|FG000|Overall Study|Withdrawal by Subject|10|||
164375921|NCT00677807|593748784|FG001|Overall Study|Withdrawal by Subject|3|||
164375922|NCT00677807|593748785|FG002|Overall Study|Withdrawal by Subject|6|||
164375923|NCT00677807|593748783|FG000|Overall Study|Lost to Follow-up|2|||
164375924|NCT00677807|593748784|FG001|Overall Study|Lost to Follow-up|2|||
164375925|NCT00677807|593748785|FG002|Overall Study|Lost to Follow-up|2|||
164375926|NCT00677807|593748783|FG000|Overall Study|Administrative problems|1|||
164375927|NCT00677807|593748784|FG001|Overall Study|Administrative problems|1|||
164375928|NCT00677807|593748785|FG002|Overall Study|Administrative problems|2|||
164375929|NCT00677807|593748783|FG000|Overall Study|Death|0|||
164375930|NCT00677807|593748784|FG001|Overall Study|Death|1|||
164375931|NCT00677807|593748785|FG002|Overall Study|Death|1|||
164375932|NCT00677807|593748783|FG000|Overall Study|Protocol Deviation|1|||
164375933|NCT00677807|593748784|FG001|Overall Study|Protocol Deviation|3|||
164375934|NCT00677807|593748785|FG002|Overall Study|Protocol Deviation|0|||
164375935|NCT01393743|593748791|FG000|Core Study|Adverse Event|5|||
164375936|NCT01393743|593748792|FG001|Core Study|Adverse Event|9|||
164375937|NCT01393743|593748793|FG002|Core Study|Adverse Event|0|||
164375938|NCT01393743|593748791|FG000|Core Study|Lost to Follow-up|1|||
164375939|NCT01393743|593748792|FG001|Core Study|Lost to Follow-up|1|||
164375940|NCT01393743|593748793|FG002|Core Study|Lost to Follow-up|0|||
164375941|NCT01393743|593748791|FG000|Core Study|Participant's Choice|2|||
164375942|NCT01393743|593748792|FG001|Core Study|Participant's Choice|3|||
164375943|NCT01393743|593748793|FG002|Core Study|Participant's Choice|0|||
164375944|NCT01393743|593748791|FG000|Core Study|Inadequate therapeutic effect|2|||
164375945|NCT01393743|593748792|FG001|Core Study|Inadequate therapeutic effect|0|||
164375946|NCT01393743|593748793|FG002|Core Study|Inadequate therapeutic effect|0|||
164375947|NCT01393743|593748791|FG000|Extension Phase|Adverse Event|0|||
164375948|NCT01393743|593748792|FG001|Extension Phase|Adverse Event|0|||
164375949|NCT01393743|593748793|FG002|Extension Phase|Adverse Event|12|||
164375950|NCT01393743|593748791|FG000|Extension Phase|Lost to Follow-up|0|||
164375951|NCT01393743|593748792|FG001|Extension Phase|Lost to Follow-up|0|||
164375952|NCT01393743|593748793|FG002|Extension Phase|Lost to Follow-up|2|||
164375953|NCT01393743|593748791|FG000|Extension Phase|Participant choice|0|||
164375954|NCT01393743|593748792|FG001|Extension Phase|Participant choice|0|||
164375955|NCT01393743|593748793|FG002|Extension Phase|Participant choice|16|||
164375956|NCT01393743|593748791|FG000|Extension Phase|Inadequate therapeutic effect|0|||
164375957|NCT01393743|593748792|FG001|Extension Phase|Inadequate therapeutic effect|0|||
164375958|NCT01393743|593748793|FG002|Extension Phase|Inadequate therapeutic effect|7|||
164375959|NCT01393743|593748791|FG000|Extension Phase|Withdrawal by Subject|0|||
164375960|NCT01393743|593748792|FG001|Extension Phase|Withdrawal by Subject|0|||
164375961|NCT01393743|593748793|FG002|Extension Phase|Withdrawal by Subject|8|||
164375962|NCT01393743|593748791|FG000|Extension Phase|Pregnancy|0|||
164375963|NCT01393743|593748792|FG001|Extension Phase|Pregnancy|0|||
164375964|NCT01393743|593748793|FG002|Extension Phase|Pregnancy|1|||
164375965|NCT01393743|593748791|FG000|Extension Phase|Other|0|||
164375966|NCT01393743|593748792|FG001|Extension Phase|Other|0|||
164375967|NCT01393743|593748793|FG002|Extension Phase|Other|14|||
164375968|NCT00989833|593748798|FG000|Overall Study|Lost to Follow-up|0|||
164375969|NCT00989833|593748799|FG001|Overall Study|Lost to Follow-up|1|||
164375970|NCT00989833|593748800|FG002|Overall Study|Lost to Follow-up|0|||
164375971|NCT00989833|593748798|FG000|Overall Study|Protocol Violation|1|||
164375972|NCT00989833|593748799|FG001|Overall Study|Protocol Violation|2|||
164375973|NCT00989833|593748800|FG002|Overall Study|Protocol Violation|1|||
164375974|NCT00989833|593748798|FG000|Overall Study|Withdrawal by Subject|0|||
164375975|NCT00989833|593748799|FG001|Overall Study|Withdrawal by Subject|0|||
164375976|NCT00989833|593748800|FG002|Overall Study|Withdrawal by Subject|1|||
164375977|NCT00989833|593748798|FG000|Overall Study|Incorrectly randomized|1|||
164375978|NCT00989833|593748799|FG001|Overall Study|Incorrectly randomized|0|||
164375979|NCT00989833|593748800|FG002|Overall Study|Incorrectly randomized|0|||
164375980|NCT00678561|593748802|FG000|Overall Study|Adverse Event|0|||
164375981|NCT00678561|593748803|FG001|Overall Study|Adverse Event|1|||
164375982|NCT00678561|593748804|FG002|Overall Study|Adverse Event|1|||
164375983|NCT00678561|593748805|FG003|Overall Study|Adverse Event|0|||
164375984|NCT00678561|593748806|FG004|Overall Study|Adverse Event|1|||
164375985|NCT00678561|593748807|FG005|Overall Study|Adverse Event|0|||
164375986|NCT00678561|593748808|FG006|Overall Study|Adverse Event|0|||
164375987|NCT00678561|593748809|FG007|Overall Study|Adverse Event|0|||
164375988|NCT00678561|593748802|FG000|Overall Study|Protocol Violation|0|||
164375989|NCT00678561|593748803|FG001|Overall Study|Protocol Violation|0|||
164375990|NCT00678561|593748804|FG002|Overall Study|Protocol Violation|0|||
164375991|NCT00678561|593748805|FG003|Overall Study|Protocol Violation|0|||
164375992|NCT00678561|593748806|FG004|Overall Study|Protocol Violation|1|||
164375993|NCT00678561|593748807|FG005|Overall Study|Protocol Violation|1|||
164375994|NCT00678561|593748808|FG006|Overall Study|Protocol Violation|0|||
164375995|NCT00678561|593748809|FG007|Overall Study|Protocol Violation|0|||
164375996|NCT00678561|593748802|FG000|Overall Study|Withdrawal by Subject|0|||
164375997|NCT00678561|593748803|FG001|Overall Study|Withdrawal by Subject|0|||
164375998|NCT00678561|593748804|FG002|Overall Study|Withdrawal by Subject|0|||
164375999|NCT00678561|593748805|FG003|Overall Study|Withdrawal by Subject|0|||
164376000|NCT00678561|593748806|FG004|Overall Study|Withdrawal by Subject|0|||
164376001|NCT00678561|593748807|FG005|Overall Study|Withdrawal by Subject|0|||
164376002|NCT00678561|593748808|FG006|Overall Study|Withdrawal by Subject|0|||
164376003|NCT00678561|593748809|FG007|Overall Study|Withdrawal by Subject|1|||
164376004|NCT05645432|593748810|FG000|Overall Study|Withdrawal by Subject|1|||
164376005|NCT03195478|593748811|FG000|Overall Study|Disease Progression|5|||
164376006|NCT03195478|593748812|FG001|Overall Study|Disease Progression|4|||
164376007|NCT03195478|593748813|FG002|Overall Study|Disease Progression|6|||
164376008|NCT03195478|593748814|FG003|Overall Study|Disease Progression|1|||
164376009|NCT03195478|593748811|FG000|Overall Study|Study Drug Toxicity|2|||
164376010|NCT03195478|593748812|FG001|Overall Study|Study Drug Toxicity|0|||
164376011|NCT03195478|593748813|FG002|Overall Study|Study Drug Toxicity|0|||
164376012|NCT03195478|593748814|FG003|Overall Study|Study Drug Toxicity|1|||
164376013|NCT03195478|593748811|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
164376014|NCT03195478|593748812|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
164376015|NCT03195478|593748813|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
164376016|NCT03195478|593748814|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
164376017|NCT03195478|593748811|FG000|Overall Study|Participant Withdrew Consent|1|||
164376018|NCT03195478|593748812|FG001|Overall Study|Participant Withdrew Consent|0|||
164376019|NCT03195478|593748813|FG002|Overall Study|Participant Withdrew Consent|0|||
164376020|NCT03195478|593748814|FG003|Overall Study|Participant Withdrew Consent|0|||
164376021|NCT03195478|593748811|FG000|Overall Study|Maximum Clinical benefit|0|||
164376022|NCT03195478|593748812|FG001|Overall Study|Maximum Clinical benefit|0|||
164376023|NCT03195478|593748813|FG002|Overall Study|Maximum Clinical benefit|1|||
164376024|NCT03195478|593748814|FG003|Overall Study|Maximum Clinical benefit|0|||
164376025|NCT03195478|593748811|FG000|Overall Study|Other Reasons|0|||
164376026|NCT03195478|593748812|FG001|Overall Study|Other Reasons|0|||
164376027|NCT03195478|593748813|FG002|Overall Study|Other Reasons|1|||
164376028|NCT03195478|593748814|FG003|Overall Study|Other Reasons|0|||
164376029|NCT04101526|593749773|FG000|Overall Study|Did not complete all sleep diary entries|0|||
164376030|NCT04101526|593749774|FG001|Overall Study|Did not complete all sleep diary entries|1|||
164376031|NCT02944578|593749775|FG000|Overall Study|Physician Decision|1|||
164376032|NCT02944578|593749776|FG001|Overall Study|Physician Decision|0|||
164376033|NCT00548808|593749779|FG000|Overall Study|Lost to Follow-up|9|||
164376034|NCT00548808|593749780|FG001|Overall Study|Lost to Follow-up|3|||
164376035|NCT00548808|593749779|FG000|Overall Study|Protocol Violation|8|||
164376036|NCT00548808|593749780|FG001|Overall Study|Protocol Violation|8|||
164376037|NCT00548808|593749779|FG000|Overall Study|Withdrawal by Subject|8|||
164376038|NCT00548808|593749780|FG001|Overall Study|Withdrawal by Subject|4|||
164376039|NCT00548808|593749779|FG000|Overall Study|Physician Decision|6|||
164376040|NCT00548808|593749780|FG001|Overall Study|Physician Decision|3|||
164376041|NCT00548808|593749779|FG000|Overall Study|Adverse Event|4|||
164376042|NCT00548808|593749780|FG001|Overall Study|Adverse Event|5|||
164376043|NCT00548808|593749779|FG000|Overall Study|Death|2|||
164376044|NCT00548808|593749780|FG001|Overall Study|Death|0|||
164376045|NCT00548808|593749779|FG000|Overall Study|Entry Criteria Not Met|2|||
164376046|NCT00548808|593749780|FG001|Overall Study|Entry Criteria Not Met|2|||
164376047|NCT00548808|593749779|FG000|Overall Study|Lack of Efficacy|2|||
164376048|NCT00548808|593749780|FG001|Overall Study|Lack of Efficacy|0|||
164376049|NCT00548808|593749779|FG000|Overall Study|Sponsor Decision|1|||
164376050|NCT00548808|593749780|FG001|Overall Study|Sponsor Decision|1|||
164376051|NCT00424372|593749782|FG000|Overall Study|Death|1|||
164376052|NCT00424372|593749782|FG000|Overall Study|Adverse Event|18|||
164376053|NCT00424372|593749782|FG000|Overall Study|Lack of Efficacy|6|||
164376054|NCT00424372|593749782|FG000|Overall Study|Withdrawal by Subject|4|||
164376055|NCT00424372|593749782|FG000|Overall Study|Protocol Violation|1|||
164376056|NCT00424372|593749782|FG000|Overall Study|Health deterioration|1|||
164376057|NCT04879745|593749784|FG000|Overall Study|Lost to Follow-up|4|||
164376058|NCT04879745|593749785|FG001|Overall Study|Lost to Follow-up|1|||
164376059|NCT00120042|593749786|FG000|Overall Study|all completed protocl|0|||
164376060|NCT00120042|593749787|FG001|Overall Study|all completed protocl|0|||
164376061|NCT00120042|593749788|FG002|Overall Study|all completed protocl|0|||
164376062|NCT04532112|593749791|FG000|Overall Study|Adverse Event|3|||
164376063|NCT04532112|593749792|FG001|Overall Study|Adverse Event|0|||
164376064|NCT03592641|593749793|FG000|Overall Study|Withdrawal by Subject|1|||
164376065|NCT00844545|593749795|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
164376066|NCT00844545|593749795|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
164376067|NCT00844545|593749795|FG000|Extension Treatment Period|Adverse Event|2|||
164376068|NCT00844545|593749795|FG000|Post Treatment Period|Withdrawal by Subject|1|||
164376069|NCT01126541|593749796|FG000|Overall Study|Adverse Event|0|||
164376070|NCT01126541|593749797|FG001|Overall Study|Adverse Event|2|||
164376071|NCT01126541|593749798|FG002|Overall Study|Adverse Event|4|||
164376072|NCT01126541|593749796|FG000|Overall Study|Death|0|||
164376073|NCT01126541|593749797|FG001|Overall Study|Death|1|||
164376074|NCT01126541|593749798|FG002|Overall Study|Death|0|||
164376075|NCT01126541|593749796|FG000|Overall Study|Lack of Efficacy|6|||
164376076|NCT01126541|593749797|FG001|Overall Study|Lack of Efficacy|1|||
164376077|NCT01126541|593749798|FG002|Overall Study|Lack of Efficacy|11|||
164376078|NCT01126541|593749796|FG000|Overall Study|Lost to Follow-up|1|||
164376079|NCT01126541|593749797|FG001|Overall Study|Lost to Follow-up|2|||
164376080|NCT01126541|593749798|FG002|Overall Study|Lost to Follow-up|2|||
164376081|NCT01126541|593749796|FG000|Overall Study|Withdrawal by Subject|2|||
164376082|NCT01126541|593749797|FG001|Overall Study|Withdrawal by Subject|5|||
164376083|NCT01126541|593749798|FG002|Overall Study|Withdrawal by Subject|6|||
164376084|NCT01126541|593749796|FG000|Overall Study|Protocol Violation|0|||
164376085|NCT01126541|593749797|FG001|Overall Study|Protocol Violation|0|||
164376086|NCT01126541|593749798|FG002|Overall Study|Protocol Violation|1|||
164376087|NCT01126541|593749796|FG000|Overall Study|Administrative reason or other|1|||
164376088|NCT01126541|593749797|FG001|Overall Study|Administrative reason or other|1|||
164376089|NCT01126541|593749798|FG002|Overall Study|Administrative reason or other|2|||
164376090|NCT04456699|593749803|FG000|Overall Study|Death|48|||
164376091|NCT04456699|593749804|FG001|Overall Study|Death|50|||
164376092|NCT04456699|593749805|FG002|Overall Study|Death|52|||
164376093|NCT04456699|593749803|FG000|Overall Study|Physician Decision|0|||
164376094|NCT04456699|593749804|FG001|Overall Study|Physician Decision|0|||
164376095|NCT04456699|593749805|FG002|Overall Study|Physician Decision|2|||
164376096|NCT04456699|593749803|FG000|Overall Study|Sponsor Decision|55|||
164376097|NCT04456699|593749804|FG001|Overall Study|Sponsor Decision|61|||
164376098|NCT04456699|593749805|FG002|Overall Study|Sponsor Decision|50|||
164376099|NCT04456699|593749803|FG000|Overall Study|Withdrawal by Subject|8|||
164376100|NCT04456699|593749804|FG001|Overall Study|Withdrawal by Subject|4|||
164376101|NCT04456699|593749805|FG002|Overall Study|Withdrawal by Subject|5|||
164376102|NCT02114879|593749806|FG000|Overall Study|Withdrawal by Subject|9|||
164376103|NCT02114879|593749807|FG001|Overall Study|Withdrawal by Subject|5|||
164376104|NCT02114879|593749806|FG000|Overall Study|Death|6|||
164376105|NCT02114879|593749807|FG001|Overall Study|Death|11|||
164376106|NCT02114879|593749806|FG000|Overall Study|Lost to Follow-up|4|||
164376107|NCT02114879|593749807|FG001|Overall Study|Lost to Follow-up|6|||
164376108|NCT02114879|593749806|FG000|Overall Study|Physician Decision|0|||
164376109|NCT02114879|593749807|FG001|Overall Study|Physician Decision|2|||
164376110|NCT00480779|593749809|FG000|Overall Study|Other|2|||
164376111|NCT00480779|593749810|FG001|Overall Study|Other|0|||
164376112|NCT00480779|593749809|FG000|Overall Study|Job and Health-related|0|||
164376113|NCT00480779|593749810|FG001|Overall Study|Job and Health-related|3|||
164376114|NCT01365273|593749811|FG000|Overall Study|Lost to Follow-up|1|||
164376115|NCT01365273|593749812|FG001|Overall Study|Lost to Follow-up|0|||
164376116|NCT01365273|593749811|FG000|Overall Study|Protocol Violation|0|||
164376117|NCT01365273|593749812|FG001|Overall Study|Protocol Violation|1|||
164376118|NCT01365273|593749811|FG000|Overall Study|Physician Decision|1|||
164376119|NCT01365273|593749812|FG001|Overall Study|Physician Decision|0|||
164376120|NCT04847674|593749816|FG000|Overall Study|Withdrawal by Subject|0|||
164376121|NCT04847674|593749817|FG001|Overall Study|Withdrawal by Subject|1|||
164376122|NCT04847674|593749818|FG002|Overall Study|Withdrawal by Subject|0|||
164376123|NCT04847674|593749816|FG000|Overall Study|Lost to Follow-up|0|||
164376124|NCT04847674|593749817|FG001|Overall Study|Lost to Follow-up|0|||
164376125|NCT04847674|593749818|FG002|Overall Study|Lost to Follow-up|2|||
164376126|NCT04847674|593749816|FG000|Overall Study|Other than specified|21|||
164376127|NCT04847674|593749817|FG001|Overall Study|Other than specified|20|||
164376128|NCT04847674|593749818|FG002|Overall Study|Other than specified|20|||
164376129|NCT01524770|593749823|FG000|First Intervention|Withdrawal by Subject|1|||
164376130|NCT01524770|593749824|FG001|First Intervention|Withdrawal by Subject|0|||
164376131|NCT01524770|593749823|FG000|First Intervention|Adverse Event|1|||
164376132|NCT01524770|593749824|FG001|First Intervention|Adverse Event|1|||
164376133|NCT01524770|593749823|FG000|First Intervention|Protocol Violation|1|||
164376134|NCT01524770|593749824|FG001|First Intervention|Protocol Violation|0|||
164376135|NCT00689481|593749825|FG000|Overall Study|Adverse Event|7|||
163902555|NCT02307682|592013180|FG001|Overall Study|Withdrawal by Subject|34|||
163902556|NCT02307682|592013181|FG002|Overall Study|Withdrawal by Subject|23|||
163902557|NCT02307682|592013179|FG000|Overall Study|Death|9|||
164376136|NCT00689481|593749826|FG001|Overall Study|Adverse Event|1|||
164376137|NCT00689481|593749825|FG000|Overall Study|Lost to Follow-up|4|||
164376138|NCT00689481|593749826|FG001|Overall Study|Lost to Follow-up|3|||
164376139|NCT00689481|593749825|FG000|Overall Study|Lack of Efficacy|4|||
164376140|NCT00689481|593749826|FG001|Overall Study|Lack of Efficacy|3|||
164376141|NCT00689481|593749825|FG000|Overall Study|Non-compliance with study treatment|1|||
164376142|NCT00689481|593749826|FG001|Overall Study|Non-compliance with study treatment|1|||
164376143|NCT00689481|593749825|FG000|Overall Study|Withdrawal by Subject|8|||
164376144|NCT00689481|593749826|FG001|Overall Study|Withdrawal by Subject|4|||
164376145|NCT00689481|593749825|FG000|Overall Study|Excluded medication started during study|0|||
164376146|NCT00689481|593749826|FG001|Overall Study|Excluded medication started during study|1|||
164376147|NCT00689481|593749825|FG000|Overall Study|Subject early term, left on vacation|0|||
164376148|NCT00689481|593749826|FG001|Overall Study|Subject early term, left on vacation|1|||
164376149|NCT03337724|593749827|FG000|Overall Study|Reason not Specified|12|||
164376150|NCT03337724|593749828|FG001|Overall Study|Reason not Specified|21|||
164376151|NCT03337724|593749829|FG002|Overall Study|Reason not Specified|9|||
164376152|NCT03337724|593749830|FG003|Overall Study|Reason not Specified|9|||
164376153|NCT03337724|593749831|FG004|Overall Study|Reason not Specified|29|||
164376154|NCT03337724|593749827|FG000|Overall Study|Withdrawal by Subject|13|||
164376155|NCT03337724|593749828|FG001|Overall Study|Withdrawal by Subject|15|||
164376156|NCT03337724|593749829|FG002|Overall Study|Withdrawal by Subject|4|||
164376157|NCT03337724|593749830|FG003|Overall Study|Withdrawal by Subject|15|||
164376158|NCT03337724|593749831|FG004|Overall Study|Withdrawal by Subject|6|||
164376159|NCT03337724|593749827|FG000|Overall Study|Protocol Deviation|0|||
164376160|NCT03337724|593749828|FG001|Overall Study|Protocol Deviation|1|||
164376161|NCT03337724|593749829|FG002|Overall Study|Protocol Deviation|1|||
164376162|NCT03337724|593749830|FG003|Overall Study|Protocol Deviation|1|||
164376163|NCT03337724|593749831|FG004|Overall Study|Protocol Deviation|0|||
164376164|NCT03337724|593749827|FG000|Overall Study|Adverse Event|1|||
164376165|NCT03337724|593749828|FG001|Overall Study|Adverse Event|1|||
164376166|NCT03337724|593749829|FG002|Overall Study|Adverse Event|0|||
164376167|NCT03337724|593749830|FG003|Overall Study|Adverse Event|1|||
164376168|NCT03337724|593749831|FG004|Overall Study|Adverse Event|0|||
164376169|NCT03337724|593749827|FG000|Overall Study|Death|40|||
164376170|NCT03337724|593749828|FG001|Overall Study|Death|89|||
164376171|NCT03337724|593749829|FG002|Overall Study|Death|43|||
164376172|NCT03337724|593749830|FG003|Overall Study|Death|76|||
164376173|NCT03337724|593749831|FG004|Overall Study|Death|50|||
164376174|NCT03337724|593749827|FG000|Overall Study|Lost to Follow-up|5|||
164376175|NCT03337724|593749828|FG001|Overall Study|Lost to Follow-up|5|||
164376176|NCT03337724|593749829|FG002|Overall Study|Lost to Follow-up|4|||
164376177|NCT03337724|593749830|FG003|Overall Study|Lost to Follow-up|7|||
164376178|NCT03337724|593749831|FG004|Overall Study|Lost to Follow-up|4|||
164376179|NCT03337724|593749827|FG000|Overall Study|Physician Decision|16|||
164376180|NCT03337724|593749828|FG001|Overall Study|Physician Decision|34|||
164376181|NCT03337724|593749829|FG002|Overall Study|Physician Decision|14|||
164376182|NCT03337724|593749830|FG003|Overall Study|Physician Decision|34|||
164376183|NCT03337724|593749831|FG004|Overall Study|Physician Decision|13|||
164376184|NCT03337724|593749827|FG000|Overall Study|Progressive Disease|0|||
164376185|NCT03337724|593749828|FG001|Overall Study|Progressive Disease|2|||
164376186|NCT03337724|593749829|FG002|Overall Study|Progressive Disease|1|||
164376187|NCT03337724|593749830|FG003|Overall Study|Progressive Disease|2|||
164376188|NCT03337724|593749831|FG004|Overall Study|Progressive Disease|0|||
164376189|NCT03337724|593749827|FG000|Overall Study|Symptomatic Deterioration|0|||
164376190|NCT03337724|593749828|FG001|Overall Study|Symptomatic Deterioration|0|||
164376191|NCT03337724|593749829|FG002|Overall Study|Symptomatic Deterioration|0|||
164376192|NCT03337724|593749830|FG003|Overall Study|Symptomatic Deterioration|1|||
164376193|NCT03337724|593749831|FG004|Overall Study|Symptomatic Deterioration|0|||
164376194|NCT00528528|593749832|FG000|Overall Study|Lost to Follow-up|0|||
164376195|NCT00528528|593749833|FG001|Overall Study|Lost to Follow-up|0|||
164376196|NCT00528528|593749834|FG002|Overall Study|Lost to Follow-up|1|||
164376197|NCT00528528|593749835|FG003|Overall Study|Lost to Follow-up|1|||
164376198|NCT00528528|593749832|FG000|Overall Study|Ineligible to continue the trial|0|||
164376199|NCT00528528|593749833|FG001|Overall Study|Ineligible to continue the trial|0|||
164376200|NCT00528528|593749834|FG002|Overall Study|Ineligible to continue the trial|0|||
164376201|NCT00528528|593749835|FG003|Overall Study|Ineligible to continue the trial|1|||
164376202|NCT00528528|593749832|FG000|Overall Study|Other|0|||
164376203|NCT00528528|593749833|FG001|Overall Study|Other|1|||
164376204|NCT00528528|593749834|FG002|Overall Study|Other|0|||
164376205|NCT00528528|593749835|FG003|Overall Study|Other|0|||
164376206|NCT00528528|593749832|FG000|Overall Study|Withdrawal by Subject|3|||
164376207|NCT00528528|593749833|FG001|Overall Study|Withdrawal by Subject|2|||
164376208|NCT00528528|593749834|FG002|Overall Study|Withdrawal by Subject|1|||
164376209|NCT00528528|593749835|FG003|Overall Study|Withdrawal by Subject|1|||
164376210|NCT00528528|593749832|FG000|Overall Study|Ongoing participant|0|||
164376211|NCT00528528|593749833|FG001|Overall Study|Ongoing participant|0|||
164376212|NCT00528528|593749834|FG002|Overall Study|Ongoing participant|1|||
164376213|NCT00528528|593749835|FG003|Overall Study|Ongoing participant|0|||
164376214|NCT00773097|593749836|FG000|Overall Study|Withdrawal by Subject|1|||
164376215|NCT00773097|593749836|FG000|Overall Study|Physician Decision|6|||
164376216|NCT04602624|593749840|FG000|Overall Study|Protocol Deviation|1|||
164376217|NCT04602624|593749840|FG000|Overall Study|Withdrawal by Participant|1|||
164376218|NCT04084769|593749841|FG000|Overall Study|Protocol Violation|1|||
164376219|NCT04084769|593749842|FG001|Overall Study|Protocol Violation|3|||
164376220|NCT04084769|593749843|FG002|Overall Study|Protocol Violation|0|||
164376221|NCT04084769|593749844|FG003|Overall Study|Protocol Violation|1|||
164376222|NCT04084769|593749841|FG000|Overall Study|Withdrawal by Subject|0|||
164376223|NCT04084769|593749842|FG001|Overall Study|Withdrawal by Subject|1|||
164376224|NCT04084769|593749843|FG002|Overall Study|Withdrawal by Subject|0|||
164376225|NCT04084769|593749844|FG003|Overall Study|Withdrawal by Subject|0|||
164376226|NCT04084769|593749841|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164376227|NCT04084769|593749842|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164376228|NCT04084769|593749843|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164376229|NCT04084769|593749844|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164376230|NCT04084769|593749841|FG000|Overall Study|Lost to Follow-up|2|||
164376231|NCT04084769|593749842|FG001|Overall Study|Lost to Follow-up|0|||
164376232|NCT04084769|593749843|FG002|Overall Study|Lost to Follow-up|0|||
164376233|NCT04084769|593749844|FG003|Overall Study|Lost to Follow-up|0|||
164376234|NCT00316199|593749845|FG000|Overall Study|Adverse Event|2|||
164376235|NCT00316199|593749845|FG000|Overall Study|Death|8|||
164376236|NCT00316199|593749845|FG000|Overall Study|Lost to Follow-up|2|||
164376237|NCT04477304|593749846|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
164376238|NCT04477304|593749847|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
164376239|NCT02782949|593749849|FG000|Overall Study|Protocol Violation|1|||
164376240|NCT02782949|593749850|FG001|Overall Study|Protocol Violation|0|||
164376241|NCT02782949|593749849|FG000|Overall Study|Withdrawal by Subject|0|||
164376242|NCT02782949|593749850|FG001|Overall Study|Withdrawal by Subject|1|||
164376243|NCT03238911|593749853|FG000|Overall Study|Withdrawal by Subject|1|||
164376244|NCT03238911|593749854|FG001|Overall Study|Withdrawal by Subject|2|||
164376245|NCT03238911|593749853|FG000|Overall Study|Lost to Follow-up|2|||
164376246|NCT03238911|593749854|FG001|Overall Study|Lost to Follow-up|1|||
164376247|NCT06023394|593749858|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
164376248|NCT06023394|593749859|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
164376249|NCT06023394|593749858|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
164376250|NCT06023394|593749859|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
164376251|NCT06023394|593749858|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
164376252|NCT06023394|593749859|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
164376253|NCT06023394|593749858|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
164376254|NCT06023394|593749859|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
164376255|NCT02556710|593751740|FG000|Overall Study|Surgical treatment|3|||
164376256|NCT02556710|593751741|FG001|Overall Study|Surgical treatment|0|||
164376257|NCT02556710|593751740|FG000|Overall Study|Required proscribed pain medication|2|||
164376258|NCT02556710|593751741|FG001|Overall Study|Required proscribed pain medication|1|||
164376259|NCT02556710|593751740|FG000|Overall Study|Lack of Efficacy|1|||
164376260|NCT02556710|593751741|FG001|Overall Study|Lack of Efficacy|0|||
164376261|NCT02556710|593751740|FG000|Overall Study|Worsening osteoarthritis|1|||
164376262|NCT02556710|593751741|FG001|Overall Study|Worsening osteoarthritis|0|||
164376263|NCT02556710|593751740|FG000|Overall Study|Moved out of state|1|||
164376264|NCT02556710|593751741|FG001|Overall Study|Moved out of state|0|||
164376265|NCT02556710|593751740|FG000|Overall Study|Missing reason|3|||
164376266|NCT02556710|593751741|FG001|Overall Study|Missing reason|1|||
164376267|NCT02556710|593751740|FG000|Overall Study|Pain as lack of efficacy|0|||
164376268|NCT02556710|593751741|FG001|Overall Study|Pain as lack of efficacy|4|||
164376269|NCT03370341|593751746|FG000|Overall Study|Lost to Follow-up|0|||
164376270|NCT03370341|593751747|FG001|Overall Study|Lost to Follow-up|1|||
164376271|NCT01707004|593751750|FG000|Overall Study|Physician Decision|3|||
164376272|NCT02573324|593751754|FG000|Overall Study|Withdrawal by Subject|26|||
164376273|NCT02573324|593751755|FG001|Overall Study|Withdrawal by Subject|23|||
164376274|NCT02573324|593751756|FG002|Overall Study|Withdrawal by Subject|3|||
164376275|NCT02573324|593751754|FG000|Overall Study|Lost to Follow-up|4|||
164376276|NCT02573324|593751755|FG001|Overall Study|Lost to Follow-up|5|||
164376277|NCT02573324|593751756|FG002|Overall Study|Lost to Follow-up|0|||
164376278|NCT02573324|593751754|FG000|Overall Study|Study Terminated by Sponsor|107|||
164376279|NCT02573324|593751755|FG001|Overall Study|Study Terminated by Sponsor|89|||
164376280|NCT02573324|593751756|FG002|Overall Study|Study Terminated by Sponsor|2|||
164376281|NCT02573324|593751754|FG000|Overall Study|Death|182|||
164376282|NCT02573324|593751755|FG001|Overall Study|Death|200|||
164376283|NCT02573324|593751756|FG002|Overall Study|Death|1|||
164376284|NCT02573324|593751754|FG000|Overall Study|Other, Not Specified|20|||
164376285|NCT02573324|593751755|FG001|Overall Study|Other, Not Specified|27|||
164376286|NCT02573324|593751756|FG002|Overall Study|Other, Not Specified|0|||
163902558|NCT02307682|592013180|FG001|Overall Study|Death|7|||
163902559|NCT02307682|592013181|FG002|Overall Study|Death|12|||
164376287|NCT02573324|593751754|FG000|Overall Study|Unknown Reason|2|||
164376288|NCT02573324|593751755|FG001|Overall Study|Unknown Reason|0|||
164376289|NCT02573324|593751756|FG002|Overall Study|Unknown Reason|0|||
164376290|NCT01607905|593751757|FG000|Overall Study|Withdrawal by participant|7|||
164376291|NCT01607905|593751758|FG001|Overall Study|Withdrawal by participant|2|||
164376292|NCT01607905|593751759|FG002|Overall Study|Withdrawal by participant|4|||
163902560|NCT02307682|592013179|FG000|Overall Study|Lost to Follow-up|1|||
164376293|NCT01607905|593751760|FG003|Overall Study|Withdrawal by participant|6|||
164376294|NCT01607905|593751761|FG004|Overall Study|Withdrawal by participant|0|||
164376295|NCT01607905|593751762|FG005|Overall Study|Withdrawal by participant|4|||
164376296|NCT01607905|593751763|FG006|Overall Study|Withdrawal by participant|12|||
164376297|NCT01607905|593751757|FG000|Overall Study|Incidence or severity of AEs|5|||
164376298|NCT01607905|593751758|FG001|Overall Study|Incidence or severity of AEs|1|||
164376299|NCT01607905|593751759|FG002|Overall Study|Incidence or severity of AEs|1|||
164376300|NCT01607905|593751760|FG003|Overall Study|Incidence or severity of AEs|3|||
164376301|NCT01607905|593751761|FG004|Overall Study|Incidence or severity of AEs|0|||
163902561|NCT02307682|592013180|FG001|Overall Study|Lost to Follow-up|5|||
164376302|NCT01607905|593751762|FG005|Overall Study|Incidence or severity of AEs|2|||
164376303|NCT01607905|593751763|FG006|Overall Study|Incidence or severity of AEs|8|||
164376304|NCT01607905|593751757|FG000|Overall Study|Disease progression|44|||
164376305|NCT01607905|593751758|FG001|Overall Study|Disease progression|16|||
164376306|NCT01607905|593751759|FG002|Overall Study|Disease progression|15|||
164376307|NCT01607905|593751760|FG003|Overall Study|Disease progression|11|||
164376308|NCT01607905|593751761|FG004|Overall Study|Disease progression|6|||
164376309|NCT01607905|593751762|FG005|Overall Study|Disease progression|7|||
164376310|NCT01607905|593751763|FG006|Overall Study|Disease progression|21|||
164376311|NCT01607905|593751757|FG000|Overall Study|Non-compliance with study procedures|0|||
164376312|NCT01607905|593751758|FG001|Overall Study|Non-compliance with study procedures|0|||
164376313|NCT01607905|593751759|FG002|Overall Study|Non-compliance with study procedures|0|||
164376314|NCT01607905|593751760|FG003|Overall Study|Non-compliance with study procedures|0|||
164376315|NCT01607905|593751761|FG004|Overall Study|Non-compliance with study procedures|0|||
164376316|NCT01607905|593751762|FG005|Overall Study|Non-compliance with study procedures|0|||
164376317|NCT01607905|593751763|FG006|Overall Study|Non-compliance with study procedures|1|||
164376318|NCT01607905|593751757|FG000|Overall Study|Death|1|||
164376319|NCT01607905|593751758|FG001|Overall Study|Death|1|||
164376320|NCT01607905|593751759|FG002|Overall Study|Death|1|||
164376321|NCT01607905|593751760|FG003|Overall Study|Death|1|||
164376322|NCT01607905|593751761|FG004|Overall Study|Death|0|||
164376323|NCT01607905|593751762|FG005|Overall Study|Death|0|||
164376324|NCT01607905|593751763|FG006|Overall Study|Death|3|||
164376325|NCT01607905|593751757|FG000|Overall Study|Other treatments become available|1|||
164376326|NCT01607905|593751758|FG001|Overall Study|Other treatments become available|0|||
164376327|NCT01607905|593751759|FG002|Overall Study|Other treatments become available|0|||
164376328|NCT01607905|593751760|FG003|Overall Study|Other treatments become available|0|||
164376329|NCT01607905|593751761|FG004|Overall Study|Other treatments become available|0|||
164376330|NCT01607905|593751762|FG005|Overall Study|Other treatments become available|0|||
164376331|NCT01607905|593751763|FG006|Overall Study|Other treatments become available|1|||
164376332|NCT01607905|593751757|FG000|Overall Study|Investigator discretion|0|||
164376333|NCT01607905|593751758|FG001|Overall Study|Investigator discretion|0|||
164376334|NCT01607905|593751759|FG002|Overall Study|Investigator discretion|0|||
164376335|NCT01607905|593751760|FG003|Overall Study|Investigator discretion|0|||
164376336|NCT01607905|593751761|FG004|Overall Study|Investigator discretion|0|||
164376337|NCT01607905|593751762|FG005|Overall Study|Investigator discretion|1|||
164376338|NCT01607905|593751763|FG006|Overall Study|Investigator discretion|0|||
164376339|NCT01607905|593751757|FG000|Overall Study|Other|1|||
164376340|NCT01607905|593751758|FG001|Overall Study|Other|0|||
164376341|NCT01607905|593751759|FG002|Overall Study|Other|0|||
164376342|NCT01607905|593751760|FG003|Overall Study|Other|0|||
164376343|NCT01607905|593751761|FG004|Overall Study|Other|0|||
164376344|NCT01607905|593751762|FG005|Overall Study|Other|0|||
164376345|NCT01607905|593751763|FG006|Overall Study|Other|1|||
164376346|NCT01607905|593751757|FG000|Overall Study|Randomized but not treated|1|||
164376347|NCT01607905|593751758|FG001|Overall Study|Randomized but not treated|0|||
164376348|NCT01607905|593751759|FG002|Overall Study|Randomized but not treated|0|||
164376349|NCT01607905|593751760|FG003|Overall Study|Randomized but not treated|0|||
164376350|NCT01607905|593751761|FG004|Overall Study|Randomized but not treated|1|||
164376351|NCT01607905|593751762|FG005|Overall Study|Randomized but not treated|1|||
164376352|NCT01607905|593751763|FG006|Overall Study|Randomized but not treated|0|||
164376353|NCT00941733|593751764|FG000|Overall Study|Death|24|||
164376354|NCT00941733|593751765|FG001|Overall Study|Death|10|||
164376355|NCT00941733|593751764|FG000|Overall Study|Withdrawal by Subject|14|||
164376356|NCT00941733|593751765|FG001|Overall Study|Withdrawal by Subject|6|||
164376357|NCT00941733|593751764|FG000|Overall Study|Adverse Event|20|||
164376358|NCT00941733|593751765|FG001|Overall Study|Adverse Event|4|||
164376359|NCT00941733|593751764|FG000|Overall Study|Lost to Follow-up|1|||
164376360|NCT00941733|593751765|FG001|Overall Study|Lost to Follow-up|2|||
164012669|NCT04760314|592410566|FG000|Induction Period|Withdrawal by Subject|0|||
164376361|NCT00941733|593751764|FG000|Overall Study|Protocol Violation|15|||
164376362|NCT00941733|593751765|FG001|Overall Study|Protocol Violation|6|||
164376363|NCT00194012|593751766|FG000|Randomized Phase|Lack of Efficacy|8|||
164376364|NCT00194012|593751767|FG001|Randomized Phase|Lack of Efficacy|18|||
164376365|NCT00194012|593751766|FG000|Randomized Phase|Study nonadherence|2|||
164376366|NCT00194012|593751767|FG001|Randomized Phase|Study nonadherence|1|||
164376367|NCT00194012|593751766|FG000|Randomized Phase|Withdrawal by Subject|3|||
164376368|NCT00194012|593751767|FG001|Randomized Phase|Withdrawal by Subject|3|||
164376369|NCT00194012|593751766|FG000|Randomized Phase|Adverse Event|2|||
164376370|NCT00194012|593751767|FG001|Randomized Phase|Adverse Event|1|||
164376371|NCT00194012|593751766|FG000|Randomized Phase|Participant reported having a rash|1|||
164376372|NCT00194012|593751767|FG001|Randomized Phase|Participant reported having a rash|0|||
164376373|NCT00194012|593751766|FG000|Randomized Phase|Emesis and enuresis|0|||
164376374|NCT00194012|593751767|FG001|Randomized Phase|Emesis and enuresis|1|||
164376375|NCT00194012|593751766|FG000|Randomized Phase|Oral/nasal twitching|0|||
164376376|NCT00194012|593751767|FG001|Randomized Phase|Oral/nasal twitching|1|||
164376377|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Weight Gain|1|||
164376378|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Weight Gain|0|||
164012670|NCT04760314|592410567|FG001|Induction Period|Withdrawal by Subject|1|||
164376379|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
164376380|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
164376381|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
164376382|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
164376383|NCT00194012|593751766|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
164376384|NCT00194012|593751767|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
164376385|NCT01105533|593751768|FG000|Overall Study|Death|0|||
164376386|NCT01105533|593751769|FG001|Overall Study|Death|0|||
164376387|NCT01105533|593751770|FG002|Overall Study|Death|0|||
164376388|NCT01105533|593751771|FG003|Overall Study|Death|0|||
164376389|NCT01105533|593751772|FG004|Overall Study|Death|1|||
164376390|NCT01105533|593751773|FG005|Overall Study|Death|0|||
164376391|NCT01105533|593751774|FG006|Overall Study|Death|0|||
164376392|NCT01105533|593751775|FG007|Overall Study|Death|0|||
164376393|NCT01105533|593751776|FG008|Overall Study|Death|0|||
164376394|NCT01105533|593751768|FG000|Overall Study|Lack of Efficacy|1|||
164376395|NCT01105533|593751769|FG001|Overall Study|Lack of Efficacy|1|||
164376396|NCT01105533|593751770|FG002|Overall Study|Lack of Efficacy|3|||
164376397|NCT01105533|593751771|FG003|Overall Study|Lack of Efficacy|3|||
164376398|NCT01105533|593751772|FG004|Overall Study|Lack of Efficacy|4|||
164376399|NCT01105533|593751773|FG005|Overall Study|Lack of Efficacy|5|||
164376400|NCT01105533|593751774|FG006|Overall Study|Lack of Efficacy|3|||
164376401|NCT01105533|593751775|FG007|Overall Study|Lack of Efficacy|2|||
164376402|NCT01105533|593751776|FG008|Overall Study|Lack of Efficacy|9|||
164376403|NCT01105533|593751768|FG000|Overall Study|Adverse Event|0|||
164376404|NCT01105533|593751769|FG001|Overall Study|Adverse Event|0|||
164376405|NCT01105533|593751770|FG002|Overall Study|Adverse Event|0|||
164376406|NCT01105533|593751771|FG003|Overall Study|Adverse Event|0|||
164376407|NCT01105533|593751772|FG004|Overall Study|Adverse Event|1|||
164376408|NCT01105533|593751773|FG005|Overall Study|Adverse Event|2|||
164376409|NCT01105533|593751774|FG006|Overall Study|Adverse Event|2|||
164376410|NCT01105533|593751775|FG007|Overall Study|Adverse Event|0|||
164376411|NCT01105533|593751776|FG008|Overall Study|Adverse Event|1|||
164376412|NCT01105533|593751768|FG000|Overall Study|Other|0|||
164376413|NCT01105533|593751769|FG001|Overall Study|Other|0|||
164376414|NCT01105533|593751770|FG002|Overall Study|Other|0|||
164376415|NCT01105533|593751771|FG003|Overall Study|Other|0|||
164376416|NCT01105533|593751772|FG004|Overall Study|Other|1|||
164376417|NCT01105533|593751773|FG005|Overall Study|Other|0|||
164376418|NCT01105533|593751774|FG006|Overall Study|Other|3|||
164376419|NCT01105533|593751775|FG007|Overall Study|Other|1|||
164376420|NCT01105533|593751776|FG008|Overall Study|Other|2|||
164376421|NCT01105533|593751768|FG000|Overall Study|Physician Decision|0|||
164376422|NCT01105533|593751769|FG001|Overall Study|Physician Decision|0|||
164376423|NCT01105533|593751770|FG002|Overall Study|Physician Decision|0|||
164376424|NCT01105533|593751771|FG003|Overall Study|Physician Decision|0|||
164376425|NCT01105533|593751772|FG004|Overall Study|Physician Decision|0|||
164376426|NCT01105533|593751773|FG005|Overall Study|Physician Decision|0|||
164376427|NCT01105533|593751774|FG006|Overall Study|Physician Decision|0|||
164376428|NCT01105533|593751775|FG007|Overall Study|Physician Decision|1|||
164376429|NCT01105533|593751776|FG008|Overall Study|Physician Decision|0|||
164376430|NCT03892889|593751777|FG000|Overall Study|Adverse Event|17|||
164376431|NCT03892889|593751777|FG000|Overall Study|Lack of Efficacy|1|||
164376432|NCT03892889|593751777|FG000|Overall Study|Lost to Follow-up|46|||
164376433|NCT03892889|593751777|FG000|Overall Study|Non-compliance with study drug|22|||
164376434|NCT03892889|593751777|FG000|Overall Study|Pregnancy|1|||
164376435|NCT03892889|593751777|FG000|Overall Study|Protocol Deviation|3|||
164376436|NCT03892889|593751777|FG000|Overall Study|Withdrawal by Subject|50|||
164376437|NCT03892889|593751777|FG000|Overall Study|Withdrawal by Caregiver|1|||
164376438|NCT03892889|593751777|FG000|Overall Study|Study Terminated by Sponsor|50|||
164376439|NCT03892889|593751777|FG000|Overall Study|Physician Decision|8|||
164376440|NCT03892889|593751777|FG000|Overall Study|Reason not Specified|5|||
164376441|NCT00630877|593751780|FG000|Overall Study|Adverse Event|11|||
164376442|NCT00630877|593751781|FG001|Overall Study|Adverse Event|8|||
164012671|NCT04760314|592410568|FG002|Induction Period|Withdrawal by Subject|1|||
164012672|NCT04760314|592410569|FG003|Induction Period|Withdrawal by Subject|0|||
164012673|NCT04760314|592410570|FG004|Induction Period|Withdrawal by Subject|0|||
164012674|NCT04760314|592410571|FG005|Induction Period|Withdrawal by Subject|0|||
164012675|NCT04760314|592410572|FG006|Induction Period|Withdrawal by Subject|0|||
164376443|NCT00630877|593751782|FG002|Overall Study|Adverse Event|7|||
164376444|NCT00630877|593751780|FG000|Overall Study|Withdrawal by Subject|3|||
164376445|NCT00630877|593751781|FG001|Overall Study|Withdrawal by Subject|4|||
164376446|NCT00630877|593751782|FG002|Overall Study|Withdrawal by Subject|0|||
164376447|NCT00630877|593751780|FG000|Overall Study|Lost to Follow-up|2|||
164376448|NCT00630877|593751781|FG001|Overall Study|Lost to Follow-up|0|||
164376449|NCT00630877|593751782|FG002|Overall Study|Lost to Follow-up|0|||
164376450|NCT00630877|593751780|FG000|Overall Study|Noncompliance|2|||
164376451|NCT00630877|593751781|FG001|Overall Study|Noncompliance|3|||
164376452|NCT00630877|593751782|FG002|Overall Study|Noncompliance|1|||
164376453|NCT00630877|593751780|FG000|Overall Study|Protocol violation|1|||
164376454|NCT00630877|593751781|FG001|Overall Study|Protocol violation|0|||
164376455|NCT00630877|593751782|FG002|Overall Study|Protocol violation|1|||
164376456|NCT00630877|593751780|FG000|Overall Study|Personal reasons|0|||
163902562|NCT02307682|592013181|FG002|Overall Study|Lost to Follow-up|6|||
163902563|NCT02307682|592013179|FG000|Overall Study|Protocol Deviation|0|||
164376457|NCT00630877|593751781|FG001|Overall Study|Personal reasons|0|||
164376458|NCT00630877|593751782|FG002|Overall Study|Personal reasons|1|||
164376459|NCT01639001|593751789|FG000|Overall Study|Refused further follow-up|9|||
164376460|NCT01639001|593751790|FG001|Overall Study|Refused further follow-up|12|||
164376461|NCT01639001|593751789|FG000|Overall Study|Lost to Follow-up|3|||
164376462|NCT01639001|593751790|FG001|Overall Study|Lost to Follow-up|0|||
164376463|NCT01639001|593751789|FG000|Overall Study|Death|62|||
164376464|NCT01639001|593751790|FG001|Overall Study|Death|61|||
164376465|NCT01639001|593751789|FG000|Overall Study|Randomized but not treated|0|||
164376466|NCT01639001|593751790|FG001|Overall Study|Randomized but not treated|2|||
164376467|NCT01639001|593751789|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
164376468|NCT01639001|593751790|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
164376469|NCT02097134|593751791|FG000|Overall Study|Physician Decision|4|||
164376470|NCT02097134|593751791|FG000|Overall Study|Non-Protocol Therapy|1|||
164376471|NCT02097134|593751791|FG000|Overall Study|Progressive Disease|3|||
164376472|NCT02097134|593751791|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
164376473|NCT00679341|593751793|FG000|Overall Study|Disease progression|42|||
164376474|NCT00679341|593751794|FG001|Overall Study|Disease progression|36|||
164376475|NCT00679341|593751793|FG000|Overall Study|Adverse Event|5|||
164376476|NCT00679341|593751794|FG001|Overall Study|Adverse Event|6|||
164376477|NCT00679341|593751793|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
164376478|NCT00679341|593751794|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
164376479|NCT00679341|593751793|FG000|Overall Study|Death|1|||
164376480|NCT00679341|593751794|FG001|Overall Study|Death|1|||
164376481|NCT00679341|593751793|FG000|Overall Study|Other|1|||
164376482|NCT00679341|593751794|FG001|Overall Study|Other|0|||
164376483|NCT00679341|593751793|FG000|Overall Study|Physician Decision|1|||
164376484|NCT00679341|593751794|FG001|Overall Study|Physician Decision|0|||
164376485|NCT00679341|593751793|FG000|Overall Study|Not treated|0|||
164376486|NCT00679341|593751794|FG001|Overall Study|Not treated|2|||
164376487|NCT00679341|593751793|FG000|Overall Study|Physician/patient decision to withdraw|0|||
164376488|NCT00679341|593751794|FG001|Overall Study|Physician/patient decision to withdraw|6|||
164376489|NCT00298896|593751798|FG000|Overall Study|Death|3|||
164376490|NCT00298896|593751798|FG000|Overall Study|Physician Decision|2|||
164376491|NCT00298896|593751798|FG000|Overall Study|Intercurrent Illness|1|||
164376492|NCT00298896|593751798|FG000|Overall Study|Disease Progression|41|||
164376493|NCT00298896|593751798|FG000|Overall Study|Withdrawal by Subject|2|||
164376494|NCT00298896|593751798|FG000|Overall Study|Assigned to treatment in error|1|||
164376495|NCT02880371|593751799|FG000|Phase 1b|Lost to Follow-up|1|||
164376496|NCT02880371|593751800|FG001|Phase 1b|Lost to Follow-up|0|||
164376497|NCT02880371|593751801|FG002|Phase 1b|Lost to Follow-up|0|||
164376498|NCT02880371|593751802|FG003|Phase 1b|Lost to Follow-up|0|||
164376499|NCT02880371|593751803|FG004|Phase 1b|Lost to Follow-up|0|||
164376500|NCT02880371|593751804|FG005|Phase 1b|Lost to Follow-up|0|||
164376501|NCT02880371|593751805|FG006|Phase 1b|Lost to Follow-up|0|||
164376502|NCT02880371|593751806|FG007|Phase 1b|Lost to Follow-up|0|||
164376503|NCT02880371|593751799|FG000|Phase 1b|Participants terminated by Sponsor|1|||
164376504|NCT02880371|593751800|FG001|Phase 1b|Participants terminated by Sponsor|0|||
164376505|NCT02880371|593751801|FG002|Phase 1b|Participants terminated by Sponsor|0|||
164376506|NCT02880371|593751802|FG003|Phase 1b|Participants terminated by Sponsor|0|||
163902564|NCT02307682|592013180|FG001|Overall Study|Protocol Deviation|0|||
163902565|NCT02307682|592013181|FG002|Overall Study|Protocol Deviation|2|||
163902566|NCT02307682|592013179|FG000|Overall Study|Other|1|||
163902567|NCT02307682|592013180|FG001|Overall Study|Other|1|||
163902568|NCT02307682|592013181|FG002|Overall Study|Other|0|||
163902569|NCT03997474|592013183|FG000|Overall Study|Death|6|||
163902570|NCT03997474|592013184|FG001|Overall Study|Death|2|||
164376507|NCT02880371|593751803|FG004|Phase 1b|Participants terminated by Sponsor|0|||
164376508|NCT02880371|593751804|FG005|Phase 1b|Participants terminated by Sponsor|0|||
164376509|NCT02880371|593751805|FG006|Phase 1b|Participants terminated by Sponsor|0|||
164376510|NCT02880371|593751806|FG007|Phase 1b|Participants terminated by Sponsor|0|||
163902571|NCT03997474|592013185|FG002|Overall Study|Death|1|||
163902572|NCT03997474|592013183|FG000|Overall Study|Physician Decision|2|||
163902573|NCT03997474|592013184|FG001|Overall Study|Physician Decision|0|||
163902574|NCT03997474|592013185|FG002|Overall Study|Physician Decision|0|||
164376511|NCT02880371|593751799|FG000|Phase 1b|Withdrawal by Subject|0|||
164376512|NCT02880371|593751800|FG001|Phase 1b|Withdrawal by Subject|0|||
164376513|NCT02880371|593751801|FG002|Phase 1b|Withdrawal by Subject|1|||
164376514|NCT02880371|593751802|FG003|Phase 1b|Withdrawal by Subject|0|||
164012676|NCT04760314|592410573|FG007|Induction Period|Withdrawal by Subject|0|||
164012677|NCT04760314|592410574|FG008|Induction Period|Withdrawal by Subject|0|||
164012678|NCT04760314|592410575|FG009|Induction Period|Withdrawal by Subject|0|||
164376515|NCT02880371|593751803|FG004|Phase 1b|Withdrawal by Subject|0|||
164376516|NCT02880371|593751804|FG005|Phase 1b|Withdrawal by Subject|0|||
164376517|NCT02880371|593751805|FG006|Phase 1b|Withdrawal by Subject|0|||
164376518|NCT02880371|593751806|FG007|Phase 1b|Withdrawal by Subject|0|||
164376519|NCT02880371|593751799|FG000|Phase 1b|Death|4|||
164376520|NCT02880371|593751800|FG001|Phase 1b|Death|6|||
164376521|NCT02880371|593751801|FG002|Phase 1b|Death|5|||
164376522|NCT02880371|593751802|FG003|Phase 1b|Death|1|||
164376523|NCT02880371|593751803|FG004|Phase 1b|Death|0|||
164376524|NCT02880371|593751804|FG005|Phase 1b|Death|0|||
164376525|NCT02880371|593751805|FG006|Phase 1b|Death|0|||
164376526|NCT02880371|593751806|FG007|Phase 1b|Death|0|||
164376527|NCT02880371|593751799|FG000|Phase 1b|Enrolled but not Treated|0|||
164376528|NCT02880371|593751800|FG001|Phase 1b|Enrolled but not Treated|1|||
164376529|NCT02880371|593751801|FG002|Phase 1b|Enrolled but not Treated|0|||
164376530|NCT02880371|593751802|FG003|Phase 1b|Enrolled but not Treated|0|||
164376531|NCT02880371|593751803|FG004|Phase 1b|Enrolled but not Treated|0|||
164376532|NCT02880371|593751804|FG005|Phase 1b|Enrolled but not Treated|0|||
164376533|NCT02880371|593751805|FG006|Phase 1b|Enrolled but not Treated|0|||
164376534|NCT02880371|593751806|FG007|Phase 1b|Enrolled but not Treated|0|||
164376535|NCT02880371|593751799|FG000|Phase 2|Enrolled but not Treated|0|||
164376536|NCT02880371|593751800|FG001|Phase 2|Enrolled but not Treated|0|||
164376537|NCT02880371|593751801|FG002|Phase 2|Enrolled but not Treated|0|||
164376538|NCT02880371|593751802|FG003|Phase 2|Enrolled but not Treated|0|||
164376539|NCT02880371|593751803|FG004|Phase 2|Enrolled but not Treated|0|||
164376540|NCT02880371|593751804|FG005|Phase 2|Enrolled but not Treated|1|||
164376541|NCT02880371|593751805|FG006|Phase 2|Enrolled but not Treated|1|||
164376542|NCT02880371|593751806|FG007|Phase 2|Enrolled but not Treated|0|||
164376543|NCT02880371|593751799|FG000|Phase 2|Other|0|||
164376544|NCT02880371|593751800|FG001|Phase 2|Other|0|||
164376545|NCT02880371|593751801|FG002|Phase 2|Other|0|||
164376546|NCT02880371|593751802|FG003|Phase 2|Other|0|||
164376547|NCT02880371|593751803|FG004|Phase 2|Other|0|||
164376548|NCT02880371|593751804|FG005|Phase 2|Other|1|||
164376549|NCT02880371|593751805|FG006|Phase 2|Other|2|||
164376550|NCT02880371|593751806|FG007|Phase 2|Other|1|||
164376551|NCT02880371|593751799|FG000|Phase 2|Participants terminated by Sponsor|0|||
164376552|NCT02880371|593751800|FG001|Phase 2|Participants terminated by Sponsor|0|||
164376553|NCT02880371|593751801|FG002|Phase 2|Participants terminated by Sponsor|0|||
164376554|NCT02880371|593751802|FG003|Phase 2|Participants terminated by Sponsor|0|||
164376555|NCT02880371|593751803|FG004|Phase 2|Participants terminated by Sponsor|1|||
164376556|NCT02880371|593751804|FG005|Phase 2|Participants terminated by Sponsor|6|||
164376557|NCT02880371|593751805|FG006|Phase 2|Participants terminated by Sponsor|1|||
164376558|NCT02880371|593751806|FG007|Phase 2|Participants terminated by Sponsor|5|||
164376559|NCT02880371|593751799|FG000|Phase 2|Death|0|||
164376560|NCT02880371|593751800|FG001|Phase 2|Death|0|||
164376561|NCT02880371|593751801|FG002|Phase 2|Death|0|||
164376562|NCT02880371|593751802|FG003|Phase 2|Death|0|||
164376563|NCT02880371|593751803|FG004|Phase 2|Death|1|||
164376564|NCT02880371|593751804|FG005|Phase 2|Death|10|||
164376565|NCT02880371|593751805|FG006|Phase 2|Death|20|||
164376566|NCT02880371|593751806|FG007|Phase 2|Death|5|||
164376567|NCT02880371|593751799|FG000|Phase 2|Lost to Follow-up|0|||
164376568|NCT02880371|593751800|FG001|Phase 2|Lost to Follow-up|0|||
164376569|NCT02880371|593751801|FG002|Phase 2|Lost to Follow-up|0|||
164376570|NCT02880371|593751802|FG003|Phase 2|Lost to Follow-up|0|||
164376571|NCT02880371|593751803|FG004|Phase 2|Lost to Follow-up|0|||
164376572|NCT02880371|593751804|FG005|Phase 2|Lost to Follow-up|0|||
164376573|NCT02880371|593751805|FG006|Phase 2|Lost to Follow-up|3|||
164376574|NCT02880371|593751806|FG007|Phase 2|Lost to Follow-up|0|||
164376575|NCT02880371|593751799|FG000|Phase 2|Withdrawal by Subject|0|||
164376576|NCT02880371|593751800|FG001|Phase 2|Withdrawal by Subject|0|||
164376577|NCT02880371|593751801|FG002|Phase 2|Withdrawal by Subject|0|||
164376578|NCT02880371|593751802|FG003|Phase 2|Withdrawal by Subject|0|||
164376579|NCT02880371|593751803|FG004|Phase 2|Withdrawal by Subject|0|||
164376580|NCT02880371|593751804|FG005|Phase 2|Withdrawal by Subject|1|||
164376581|NCT02880371|593751805|FG006|Phase 2|Withdrawal by Subject|1|||
164376582|NCT02880371|593751806|FG007|Phase 2|Withdrawal by Subject|0|||
164376583|NCT02880371|593751799|FG000|Phase 2|End of Study page not completed by error|0|||
164376584|NCT02880371|593751800|FG001|Phase 2|End of Study page not completed by error|0|||
164144032|NCT00086281|592888571|FG000|Phase 2|Adverse Event|0|||
164376585|NCT02880371|593751801|FG002|Phase 2|End of Study page not completed by error|0|||
164376586|NCT02880371|593751802|FG003|Phase 2|End of Study page not completed by error|0|||
164376587|NCT02880371|593751803|FG004|Phase 2|End of Study page not completed by error|0|||
164376588|NCT02880371|593751804|FG005|Phase 2|End of Study page not completed by error|1|||
164376589|NCT02880371|593751805|FG006|Phase 2|End of Study page not completed by error|0|||
164376590|NCT02880371|593751806|FG007|Phase 2|End of Study page not completed by error|0|||
164376591|NCT03285646|593751811|FG000|Overall Study|Adverse Event|1|||
164376592|NCT03285646|593751812|FG001|Overall Study|Adverse Event|0|||
164376593|NCT03285646|593751811|FG000|Overall Study|Withdrawal by Subject|10|||
164376594|NCT03285646|593751812|FG001|Overall Study|Withdrawal by Subject|2|||
164376595|NCT03285646|593751811|FG000|Overall Study|Lost to Follow-up|2|||
164376596|NCT03285646|593751812|FG001|Overall Study|Lost to Follow-up|1|||
164376597|NCT03285646|593751811|FG000|Overall Study|Investigator/Sponsor Decision|0|||
164376598|NCT03285646|593751812|FG001|Overall Study|Investigator/Sponsor Decision|1|||
164376599|NCT02660359|593751813|FG000|Overall Study|Protocol Deviation|0|||
164376600|NCT02660359|593751814|FG001|Overall Study|Protocol Deviation|0|||
164376601|NCT02660359|593751815|FG002|Overall Study|Protocol Deviation|1|||
164376602|NCT02660359|593751813|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
164376603|NCT02660359|593751814|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
164376604|NCT02660359|593751815|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
164376605|NCT02660359|593751813|FG000|Overall Study|Lack of Efficacy|1|||
164376606|NCT02660359|593751814|FG001|Overall Study|Lack of Efficacy|1|||
164376607|NCT02660359|593751815|FG002|Overall Study|Lack of Efficacy|1|||
164376608|NCT02660359|593751813|FG000|Overall Study|Adverse Event|0|||
164376609|NCT02660359|593751814|FG001|Overall Study|Adverse Event|1|||
164376610|NCT02660359|593751815|FG002|Overall Study|Adverse Event|0|||
164376611|NCT02660359|593751813|FG000|Overall Study|Other|2|||
164376612|NCT02660359|593751814|FG001|Overall Study|Other|1|||
164376613|NCT02660359|593751815|FG002|Overall Study|Other|3|||
164376614|NCT02660359|593751813|FG000|Overall Study|Withdrawal by Subject|7|||
164376615|NCT02660359|593751814|FG001|Overall Study|Withdrawal by Subject|5|||
164376616|NCT02660359|593751815|FG002|Overall Study|Withdrawal by Subject|8|||
164376617|NCT02660359|593751813|FG000|Overall Study|Lost to Follow-up|3|||
164376618|NCT02660359|593751814|FG001|Overall Study|Lost to Follow-up|3|||
164376619|NCT02660359|593751815|FG002|Overall Study|Lost to Follow-up|0|||
164376620|NCT02664038|593751816|FG000|13 Week|Lost to Follow-up|7|||
164376621|NCT02664038|593751817|FG001|13 Week|Lost to Follow-up|14|||
164376622|NCT02664038|593751816|FG000|13 Week|Withdrawal by Subject|1|||
164376623|NCT02664038|593751817|FG001|13 Week|Withdrawal by Subject|0|||
164376624|NCT02664038|593751816|FG000|26 Week|Lost to Follow-up|5|||
164376625|NCT02664038|593751817|FG001|26 Week|Lost to Follow-up|4|||
164376626|NCT06640829|593751826|FG000|Overall Study|Withdrawal by Subject|1|||
164376627|NCT06640829|593751826|FG000|Overall Study|Lost to Follow-up|1|||
164376628|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Adverse Event|41|||
164376629|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Adverse Event|24|||
164376630|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
164376631|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
164376632|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
164376633|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
164376634|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Physician Decision|0|||
164376635|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Physician Decision|6|||
164376636|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
164376637|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
164376638|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
164376639|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
164376640|NCT00673452|593751831|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
164376641|NCT00673452|593751832|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
164376642|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
164376643|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
164376644|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
164376645|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
164376646|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
164376647|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
164376648|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
164376649|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
164376650|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
164376651|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
164376652|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
164376653|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
164376654|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
164376655|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
164376656|NCT00673452|593751831|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
164376657|NCT00673452|593751832|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
164376658|NCT04936685|593751833|FG000|Overall Study|Protocol Violation|1|||
164376659|NCT04936685|593751834|FG001|Overall Study|Protocol Violation|0|||
164376660|NCT03049813|593751835|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
164376661|NCT03049813|593751836|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
164376662|NCT03049813|593751837|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
164376663|NCT03049813|593751838|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
164376664|NCT03049813|593751835|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
164376665|NCT03049813|593751836|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
164376666|NCT03049813|593751837|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
164376667|NCT03049813|593751838|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
164376668|NCT03049813|593751835|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
164376669|NCT03049813|593751836|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
164092818|NCT01508936|592702151|FG000|Overall Study|Withdrawal by Subject|4|||
164376670|NCT03049813|593751837|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
164376671|NCT03049813|593751838|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
164376672|NCT03049813|593751835|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
164376673|NCT03049813|593751836|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
164376674|NCT03049813|593751837|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
164376675|NCT03049813|593751838|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
164376676|NCT00179413|593751839|FG000|Overall Study|Adverse Event|38|||
164376677|NCT00179413|593751840|FG001|Overall Study|Adverse Event|20|||
164376678|NCT00179413|593751839|FG000|Overall Study|Withdrawal by Subject|87|||
164376679|NCT00179413|593751840|FG001|Overall Study|Withdrawal by Subject|95|||
164376680|NCT01813019|593751841|FG000|Overall Study|Adverse Event|0|||
164376681|NCT01813019|593751842|FG001|Overall Study|Adverse Event|3|||
164376682|NCT01813019|593751841|FG000|Overall Study|Withdrawal by Subject|3|||
164376683|NCT01813019|593751842|FG001|Overall Study|Withdrawal by Subject|2|||
164376684|NCT01813019|593751841|FG000|Overall Study|administrative problems|2|||
164376685|NCT01813019|593751842|FG001|Overall Study|administrative problems|0|||
164376686|NCT01813019|593751841|FG000|Overall Study|Protocol Deviation|2|||
164376687|NCT01813019|593751842|FG001|Overall Study|Protocol Deviation|1|||
164376688|NCT00439140|593751845|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
164376689|NCT00439140|593751846|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
164376690|NCT00439140|593751847|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
164376691|NCT00439140|593751845|FG000|Treatment Cycle 1|Personal reasons|0|||
164376692|NCT00439140|593751846|FG001|Treatment Cycle 1|Personal reasons|2|||
164376693|NCT00439140|593751847|FG002|Treatment Cycle 1|Personal reasons|0|||
164376694|NCT00439140|593751845|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
164376695|NCT00439140|593751846|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
164376696|NCT00439140|593751847|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
164376697|NCT00439140|593751845|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
164376698|NCT00439140|593751846|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
164376699|NCT00439140|593751847|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
164376700|NCT00439140|593751845|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
164376701|NCT00439140|593751846|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
164376702|NCT00439140|593751847|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
164376703|NCT01458171|593751851|FG000|Overall Study|Adverse Event|1|||
164376704|NCT00578565|593751856|FG000|Overall Study|Adverse Event|3|||
164376705|NCT03025828|593751857|FG000|Overall Study|Lost to Follow-up|1|||
164376706|NCT01192152|593751858|FG000|Period 1|left prematurely (while on treatment B)|0|||
164376707|NCT01192152|593751859|FG001|Period 1|left prematurely (while on treatment B)|1|||
164376708|NCT01192152|593751858|FG000|Period 3|family emergency|1|||
164376709|NCT01192152|593751859|FG001|Period 3|family emergency|0|||
164376710|NCT02143843|593751860|FG000|Overall Study|Adverse Event|8|||
164376711|NCT02143843|593751860|FG000|Overall Study|Lack of Efficacy|2|||
164376712|NCT02143843|593751860|FG000|Overall Study|Withdrawal by Subject|2|||
164376713|NCT02519712|593751863|FG000|Overall Study|Disease Relapse|1|||
164376714|NCT02519712|593751863|FG000|Overall Study|Disease Progression|1|||
164376715|NCT02519712|593751863|FG000|Overall Study|Accruals are donors|2|||
164376716|NCT01339390|593751874|FG000|Overall Study|Death|32|||
164376717|NCT01339390|593751875|FG001|Overall Study|Death|29|||
164376718|NCT01339390|593751874|FG000|Overall Study|Lost to Follow-up|125|||
164376719|NCT01339390|593751875|FG001|Overall Study|Lost to Follow-up|127|||
164376720|NCT00378703|593751876|FG000|Overall Study|Disease progression|59|||
164376721|NCT00378703|593751877|FG001|Overall Study|Disease progression|43|||
164376722|NCT00378703|593751878|FG002|Overall Study|Disease progression|48|||
164376723|NCT00378703|593751879|FG003|Overall Study|Disease progression|49|||
164092819|NCT01508936|592702152|FG001|Overall Study|Withdrawal by Subject|18|||
164092820|NCT01508936|592702151|FG000|Overall Study|Protocol Violation|2|||
164092821|NCT01508936|592702152|FG001|Overall Study|Protocol Violation|3|||
164092822|NCT01508936|592702151|FG000|Overall Study|Lost to Follow-up|2|||
164092823|NCT01508936|592702152|FG001|Overall Study|Lost to Follow-up|9|||
164376724|NCT00378703|593751876|FG000|Overall Study|Adverse Event|11|||
164376725|NCT00378703|593751877|FG001|Overall Study|Adverse Event|17|||
164376726|NCT00378703|593751878|FG002|Overall Study|Adverse Event|20|||
164376727|NCT00378703|593751879|FG003|Overall Study|Adverse Event|18|||
164376728|NCT00378703|593751876|FG000|Overall Study|Death|2|||
164376729|NCT00378703|593751877|FG001|Overall Study|Death|2|||
164376730|NCT00378703|593751878|FG002|Overall Study|Death|4|||
164376731|NCT00378703|593751879|FG003|Overall Study|Death|3|||
164376732|NCT00378703|593751876|FG000|Overall Study|Withdrawal by Subject|4|||
164376733|NCT00378703|593751877|FG001|Overall Study|Withdrawal by Subject|8|||
164376734|NCT00378703|593751878|FG002|Overall Study|Withdrawal by Subject|5|||
164376735|NCT00378703|593751879|FG003|Overall Study|Withdrawal by Subject|7|||
164376736|NCT00378703|593751876|FG000|Overall Study|Physician Decision|1|||
164376737|NCT00378703|593751877|FG001|Overall Study|Physician Decision|4|||
164092824|NCT01508936|592702151|FG000|Overall Study|Other|0|||
164376738|NCT00378703|593751878|FG002|Overall Study|Physician Decision|1|||
164376739|NCT00378703|593751879|FG003|Overall Study|Physician Decision|0|||
164376740|NCT00378703|593751876|FG000|Overall Study|Alternative therapy|4|||
164376741|NCT00378703|593751877|FG001|Overall Study|Alternative therapy|2|||
164376742|NCT00378703|593751878|FG002|Overall Study|Alternative therapy|0|||
164376743|NCT00378703|593751879|FG003|Overall Study|Alternative therapy|0|||
163902575|NCT03997474|592013183|FG000|Overall Study|study terminated by sponsor|1|||
163902576|NCT03997474|592013184|FG001|Overall Study|study terminated by sponsor|0|||
163902577|NCT03997474|592013185|FG002|Overall Study|study terminated by sponsor|1|||
163902578|NCT03277989|592013187|FG000|Overall Study|Lost to Follow-up|6|||
163902579|NCT03277989|592013187|FG000|Overall Study|Adverse Event|6|||
163902580|NCT03277989|592013187|FG000|Overall Study|Withdrawal by Subject|3|||
163902581|NCT03277989|592013187|FG000|Overall Study|Didn't Receive Study Device|7|||
163902582|NCT03277989|592013187|FG000|Overall Study|Site Closure|26|||
163902583|NCT03277989|592013187|FG000|Overall Study|Sponsor Closure|107|||
164012679|NCT04760314|592410576|FG010|Induction Period|Withdrawal by Subject|0|||
164012680|NCT04760314|592410566|FG000|Induction Period|Adverse Event|0|||
164012681|NCT04760314|592410567|FG001|Induction Period|Adverse Event|0|||
164012682|NCT04760314|592410568|FG002|Induction Period|Adverse Event|2|||
164012683|NCT04760314|592410569|FG003|Induction Period|Adverse Event|0|||
164012684|NCT04760314|592410570|FG004|Induction Period|Adverse Event|0|||
164012685|NCT04760314|592410571|FG005|Induction Period|Adverse Event|0|||
164012686|NCT04760314|592410572|FG006|Induction Period|Adverse Event|0|||
164012687|NCT04760314|592410573|FG007|Induction Period|Adverse Event|0|||
164012688|NCT04760314|592410574|FG008|Induction Period|Adverse Event|0|||
164012689|NCT04760314|592410575|FG009|Induction Period|Adverse Event|0|||
164012690|NCT04760314|592410576|FG010|Induction Period|Adverse Event|0|||
164012691|NCT04760314|592410566|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012692|NCT04760314|592410567|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012693|NCT04760314|592410568|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012694|NCT04760314|592410569|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
164012695|NCT04760314|592410570|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
164012696|NCT04760314|592410571|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
164012697|NCT04760314|592410572|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
164012698|NCT04760314|592410573|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012699|NCT04760314|592410574|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012700|NCT04760314|592410575|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012701|NCT04760314|592410576|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
164012702|NCT04760314|592410566|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012703|NCT04760314|592410567|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012704|NCT04760314|592410568|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012705|NCT04760314|592410569|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
164012706|NCT04760314|592410570|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012707|NCT04760314|592410571|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
164012708|NCT04760314|592410572|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
164012709|NCT04760314|592410573|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012710|NCT04760314|592410574|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012711|NCT04760314|592410575|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012712|NCT04760314|592410576|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
164012713|NCT04760314|592410566|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012714|NCT04760314|592410567|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012715|NCT04760314|592410568|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012716|NCT04760314|592410569|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012717|NCT04760314|592410570|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
164012718|NCT04760314|592410571|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012719|NCT04760314|592410572|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012720|NCT04760314|592410573|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012721|NCT04760314|592410574|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012722|NCT04760314|592410575|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012723|NCT04760314|592410576|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
164012724|NCT04760314|592410566|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
164012725|NCT04760314|592410567|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
164012726|NCT04760314|592410568|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
164012727|NCT04760314|592410569|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
164012728|NCT04760314|592410570|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
164012729|NCT04760314|592410571|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
164012730|NCT04760314|592410572|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
164012731|NCT04760314|592410573|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
164012732|NCT04760314|592410574|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
164012733|NCT04760314|592410575|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
164012734|NCT04760314|592410576|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
164376744|NCT00378703|593751876|FG000|Overall Study|Other complicated disease|0|||
164376745|NCT00378703|593751877|FG001|Overall Study|Other complicated disease|2|||
164376746|NCT00378703|593751878|FG002|Overall Study|Other complicated disease|2|||
163902584|NCT00371345|592014696|FG000|Overall Study|Disease Progression|21|||
163902585|NCT00371345|592014697|FG001|Overall Study|Disease Progression|35|||
163902586|NCT00371345|592014696|FG000|Overall Study|Study Drug Toxicity|1|||
163902587|NCT00371345|592014697|FG001|Overall Study|Study Drug Toxicity|7|||
163902588|NCT00371345|592014696|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
163902589|NCT00371345|592014697|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
163902590|NCT00371345|592014696|FG000|Overall Study|Participant Request|1|||
163902591|NCT00371345|592014697|FG001|Overall Study|Participant Request|1|||
163902592|NCT00371345|592014696|FG000|Overall Study|Participant Withdrew Consent|0|||
163902593|NCT00371345|592014697|FG001|Overall Study|Participant Withdrew Consent|1|||
163902594|NCT00705406|592014698|FG000|Overall Study|Lost to Follow-up|3|||
163902595|NCT00705406|592014699|FG001|Overall Study|Lost to Follow-up|3|||
163902596|NCT00705406|592014698|FG000|Overall Study|Did not receive study drug|1|||
163902597|NCT00705406|592014699|FG001|Overall Study|Did not receive study drug|2|||
163902598|NCT00442104|592014700|FG000|Overall Study|Adverse Event|5|||
163902599|NCT00442104|592014700|FG000|Overall Study|Death|2|||
163902600|NCT00442104|592014700|FG000|Overall Study|Lost to Follow-up|3|||
163902601|NCT00442104|592014700|FG000|Overall Study|Withdrawal by Subject|5|||
163902602|NCT00442104|592014700|FG000|Overall Study|Insufficient Clinical Response|10|||
163902603|NCT00442104|592014700|FG000|Overall Study|Other|21|||
163902604|NCT00442104|592014700|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
163902605|NCT04545619|592014701|FG000|Overall Study|due to equipment challenges|1|||
163902606|NCT00975585|592014702|FG000|Overall Study|Adverse Event|0|||
163902607|NCT00975585|592014703|FG001|Overall Study|Adverse Event|4|||
163902608|NCT00975585|592014702|FG000|Overall Study|Lost to Follow-up|3|||
163902609|NCT00975585|592014703|FG001|Overall Study|Lost to Follow-up|5|||
164376747|NCT00378703|593751879|FG003|Overall Study|Other complicated disease|0|||
164376748|NCT00378703|593751876|FG000|Overall Study|Symptomatic deterioration|0|||
164376749|NCT00378703|593751877|FG001|Overall Study|Symptomatic deterioration|1|||
164376750|NCT00378703|593751878|FG002|Overall Study|Symptomatic deterioration|0|||
164376751|NCT00378703|593751879|FG003|Overall Study|Symptomatic deterioration|2|||
164376752|NCT00378703|593751876|FG000|Overall Study|Surgery|1|||
164376753|NCT00378703|593751877|FG001|Overall Study|Surgery|0|||
164376754|NCT00378703|593751878|FG002|Overall Study|Surgery|0|||
164376755|NCT00378703|593751879|FG003|Overall Study|Surgery|1|||
164376756|NCT00378703|593751876|FG000|Overall Study|Joint decision of physician and patient|1|||
164376757|NCT00378703|593751877|FG001|Overall Study|Joint decision of physician and patient|0|||
164376758|NCT00378703|593751878|FG002|Overall Study|Joint decision of physician and patient|0|||
164376759|NCT00378703|593751879|FG003|Overall Study|Joint decision of physician and patient|0|||
164376760|NCT00378703|593751876|FG000|Overall Study|Adverse events and progressive disease|0|||
164376761|NCT00378703|593751877|FG001|Overall Study|Adverse events and progressive disease|0|||
164376762|NCT00378703|593751878|FG002|Overall Study|Adverse events and progressive disease|0|||
164376763|NCT00378703|593751879|FG003|Overall Study|Adverse events and progressive disease|1|||
164376764|NCT00378703|593751876|FG000|Overall Study|Relocation|0|||
164376765|NCT00378703|593751877|FG001|Overall Study|Relocation|0|||
164376766|NCT00378703|593751878|FG002|Overall Study|Relocation|1|||
164376767|NCT00378703|593751879|FG003|Overall Study|Relocation|0|||
164376768|NCT00378703|593751876|FG000|Overall Study|Ineligible|4|||
164376769|NCT00378703|593751877|FG001|Overall Study|Ineligible|7|||
164376770|NCT00378703|593751878|FG002|Overall Study|Ineligible|7|||
164376771|NCT00378703|593751879|FG003|Overall Study|Ineligible|7|||
164376772|NCT00378703|593751876|FG000|Overall Study|Never started treatment|1|||
164376773|NCT00378703|593751877|FG001|Overall Study|Never started treatment|4|||
164376774|NCT00378703|593751878|FG002|Overall Study|Never started treatment|0|||
164376775|NCT00378703|593751879|FG003|Overall Study|Never started treatment|0|||
164376776|NCT00378703|593751876|FG000|Overall Study|Other|1|||
163902610|NCT00975585|592014702|FG000|Overall Study|Withdrawal by Subject|2|||
163902611|NCT00975585|592014703|FG001|Overall Study|Withdrawal by Subject|1|||
163902612|NCT00975585|592014702|FG000|Overall Study|Lens issue|2|||
163902613|NCT00975585|592014703|FG001|Overall Study|Lens issue|2|||
163902614|NCT00683800|592014705|FG000|Overall Study|Adverse Event|195|||
163902615|NCT00683800|592014706|FG001|Overall Study|Adverse Event|102|||
164376777|NCT00378703|593751877|FG001|Overall Study|Other|1|||
164376778|NCT00378703|593751878|FG002|Overall Study|Other|2|||
164376779|NCT00378703|593751879|FG003|Overall Study|Other|3|||
164376780|NCT03181542|593751882|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
163902616|NCT00683800|592014705|FG000|Overall Study|Death|0|||
163902617|NCT00683800|592014706|FG001|Overall Study|Death|1|||
163902618|NCT00683800|592014705|FG000|Overall Study|Lost to Follow-up|57|||
164376781|NCT03181542|593751883|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
164376782|NCT01462357|593751885|FG000|Overall Study|Death|0|||
163902619|NCT00683800|592014706|FG001|Overall Study|Lost to Follow-up|44|||
164376783|NCT01462357|593751886|FG001|Overall Study|Death|0|||
164376784|NCT01462357|593751887|FG002|Overall Study|Death|1|||
164376785|NCT01462357|593751885|FG000|Overall Study|Withdrawal by Subject|3|||
164376786|NCT01462357|593751886|FG001|Overall Study|Withdrawal by Subject|11|||
164376787|NCT01462357|593751887|FG002|Overall Study|Withdrawal by Subject|3|||
164376788|NCT01462357|593751885|FG000|Overall Study|Migrated/moved from study area|2|||
164376789|NCT01462357|593751886|FG001|Overall Study|Migrated/moved from study area|3|||
164376790|NCT01462357|593751887|FG002|Overall Study|Migrated/moved from study area|1|||
164376791|NCT01462357|593751885|FG000|Overall Study|Lost to Follow-up|3|||
164376792|NCT01462357|593751886|FG001|Overall Study|Lost to Follow-up|5|||
164376793|NCT01462357|593751887|FG002|Overall Study|Lost to Follow-up|7|||
164376794|NCT02908529|593751888|FG000|Overall Study|Lost to Follow-up|0|||
164376795|NCT02908529|593751889|FG001|Overall Study|Lost to Follow-up|2|||
164376796|NCT04497987|593751890|FG000|Overall Study|Adverse Event|1|||
164376797|NCT04497987|593751891|FG001|Overall Study|Adverse Event|0|||
164376798|NCT04497987|593751890|FG000|Overall Study|Death|21|||
164376799|NCT04497987|593751891|FG001|Overall Study|Death|13|||
164376800|NCT04497987|593751890|FG000|Overall Study|Lost to Follow-up|19|||
164376801|NCT04497987|593751891|FG001|Overall Study|Lost to Follow-up|17|||
164376802|NCT04497987|593751890|FG000|Overall Study|Other - as reported by the investigator|22|||
164376803|NCT04497987|593751891|FG001|Overall Study|Other - as reported by the investigator|16|||
164376804|NCT04497987|593751890|FG000|Overall Study|Physician Decision|1|||
164376805|NCT04497987|593751891|FG001|Overall Study|Physician Decision|0|||
164376806|NCT04497987|593751890|FG000|Overall Study|Withdrawal by Subject|35|||
164376807|NCT04497987|593751891|FG001|Overall Study|Withdrawal by Subject|21|||
164376808|NCT04579679|593751899|FG000|Overall Study|New Antitumor Therapy|6|||
164376809|NCT04579679|593751900|FG001|Overall Study|New Antitumor Therapy|4|||
164376810|NCT04579679|593751901|FG002|Overall Study|New Antitumor Therapy|7|||
164376811|NCT04579679|593751902|FG003|Overall Study|New Antitumor Therapy|0|||
164376812|NCT04579679|593751899|FG000|Overall Study|Withdrawal of Consent|1|||
164376813|NCT04579679|593751900|FG001|Overall Study|Withdrawal of Consent|1|||
164376814|NCT04579679|593751901|FG002|Overall Study|Withdrawal of Consent|2|||
164376815|NCT04579679|593751902|FG003|Overall Study|Withdrawal of Consent|4|||
164376816|NCT04579679|593751899|FG000|Overall Study|Death|2|||
164376817|NCT04579679|593751900|FG001|Overall Study|Death|2|||
164376818|NCT04579679|593751901|FG002|Overall Study|Death|2|||
164376819|NCT04579679|593751902|FG003|Overall Study|Death|0|||
164376820|NCT04579679|593751899|FG000|Overall Study|Adverse Event|0|||
164376821|NCT04579679|593751900|FG001|Overall Study|Adverse Event|4|||
164376822|NCT04579679|593751901|FG002|Overall Study|Adverse Event|0|||
164376823|NCT04579679|593751902|FG003|Overall Study|Adverse Event|0|||
164376824|NCT04579679|593751899|FG000|Overall Study|Disease Progression|9|||
164376825|NCT04579679|593751900|FG001|Overall Study|Disease Progression|13|||
164376826|NCT04579679|593751901|FG002|Overall Study|Disease Progression|7|||
164376827|NCT04579679|593751902|FG003|Overall Study|Disease Progression|0|||
164376828|NCT04579679|593751899|FG000|Overall Study|Physician Decision|0|||
164376829|NCT04579679|593751900|FG001|Overall Study|Physician Decision|0|||
164376830|NCT04579679|593751901|FG002|Overall Study|Physician Decision|1|||
164376831|NCT04579679|593751902|FG003|Overall Study|Physician Decision|0|||
164376832|NCT04579679|593751899|FG000|Overall Study|Study Terminated by Sponsor|2|||
164376833|NCT04579679|593751900|FG001|Overall Study|Study Terminated by Sponsor|7|||
164376834|NCT04579679|593751901|FG002|Overall Study|Study Terminated by Sponsor|1|||
164376835|NCT04579679|593751902|FG003|Overall Study|Study Terminated by Sponsor|0|||
164376836|NCT00646958|593754157|FG000|Overall Study|Lack of Efficacy|1|||
164376837|NCT00646958|593754158|FG001|Overall Study|Lack of Efficacy|0|||
164376838|NCT00646958|593754159|FG002|Overall Study|Lack of Efficacy|0|||
164376839|NCT00646958|593754157|FG000|Overall Study|Adverse Event|4|||
164376840|NCT00646958|593754158|FG001|Overall Study|Adverse Event|0|||
164092825|NCT01508936|592702152|FG001|Overall Study|Other|5|||
164376841|NCT00646958|593754159|FG002|Overall Study|Adverse Event|0|||
164376842|NCT00646958|593754157|FG000|Overall Study|Lost to Follow-up|1|||
164376843|NCT00646958|593754158|FG001|Overall Study|Lost to Follow-up|5|||
164376844|NCT00646958|593754159|FG002|Overall Study|Lost to Follow-up|7|||
164376845|NCT00646958|593754157|FG000|Overall Study|Protocol Violation|1|||
164376846|NCT00646958|593754158|FG001|Overall Study|Protocol Violation|1|||
164376847|NCT00646958|593754159|FG002|Overall Study|Protocol Violation|0|||
164376848|NCT00646958|593754157|FG000|Overall Study|Abnormal screening lab tests|1|||
164376849|NCT00646958|593754158|FG001|Overall Study|Abnormal screening lab tests|1|||
164376850|NCT00646958|593754159|FG002|Overall Study|Abnormal screening lab tests|0|||
164376851|NCT00646958|593754157|FG000|Overall Study|Withdrawal by Subject|1|||
164092826|NCT01508936|592702151|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
164376852|NCT00646958|593754158|FG001|Overall Study|Withdrawal by Subject|2|||
164376853|NCT00646958|593754159|FG002|Overall Study|Withdrawal by Subject|0|||
164376854|NCT00646958|593754157|FG000|Overall Study|Did not receive study drug|2|||
164376855|NCT00646958|593754158|FG001|Overall Study|Did not receive study drug|0|||
164092827|NCT01508936|592702152|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
164376856|NCT00646958|593754159|FG002|Overall Study|Did not receive study drug|2|||
164376857|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
164012735|NCT04760314|592410566|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012736|NCT04760314|592410567|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012737|NCT04760314|592410568|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012738|NCT04760314|592410569|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012739|NCT04760314|592410570|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012740|NCT04760314|592410571|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012741|NCT04760314|592410572|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012742|NCT04760314|592410573|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164012743|NCT04760314|592410574|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164012744|NCT04760314|592410575|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164012745|NCT04760314|592410576|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
164012746|NCT04760314|592410566|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012747|NCT04760314|592410567|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012748|NCT04760314|592410568|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012749|NCT04760314|592410569|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012750|NCT04760314|592410570|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012751|NCT04760314|592410571|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012752|NCT04760314|592410572|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012753|NCT04760314|592410573|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
164012754|NCT04760314|592410574|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
164012755|NCT04760314|592410575|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
164012756|NCT04760314|592410576|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164012757|NCT04760314|592410566|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012758|NCT04760314|592410567|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012759|NCT04760314|592410568|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012760|NCT04760314|592410569|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012761|NCT04760314|592410570|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012762|NCT04760314|592410571|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164376858|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376859|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376860|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376861|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376862|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164376863|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
164376864|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376865|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376866|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376867|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376868|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164376869|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
164376870|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376871|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376872|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376873|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376874|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164376875|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
164376876|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376877|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376878|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164012763|NCT04760314|592410572|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012764|NCT04760314|592410573|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
164012765|NCT04760314|592410574|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012766|NCT04760314|592410575|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164012767|NCT04760314|592410576|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164092828|NCT00679367|592702153|FG000|Overall Study|Adverse Event|7|||
164376879|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376880|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164376881|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
164376882|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376883|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376884|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376885|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376886|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164376887|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
164376888|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376889|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376890|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376891|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376892|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
164376893|NCT02139644|593754160|FG000|Run-In Period (Pre-assignment)|Other|6|||
164376894|NCT02139644|593754161|FG001|Run-In Period (Pre-assignment)|Other|0|||
164376895|NCT02139644|593754162|FG002|Run-In Period (Pre-assignment)|Other|0|||
164376896|NCT02139644|593754163|FG003|Run-In Period (Pre-assignment)|Other|0|||
164376897|NCT02139644|593754164|FG004|Run-In Period (Pre-assignment)|Other|0|||
164376898|NCT02139644|593754165|FG005|Run-In Period (Pre-assignment)|Other|0|||
164376899|NCT02139644|593754160|FG000|Treatment Period|Adverse Event|0|||
164376900|NCT02139644|593754161|FG001|Treatment Period|Adverse Event|0|||
164376901|NCT02139644|593754162|FG002|Treatment Period|Adverse Event|3|||
164376902|NCT02139644|593754163|FG003|Treatment Period|Adverse Event|2|||
164376903|NCT02139644|593754164|FG004|Treatment Period|Adverse Event|1|||
164376904|NCT02139644|593754165|FG005|Treatment Period|Adverse Event|6|||
164376905|NCT02139644|593754160|FG000|Treatment Period|Withdrawal by Subject|0|||
164376906|NCT02139644|593754161|FG001|Treatment Period|Withdrawal by Subject|0|||
164376907|NCT02139644|593754162|FG002|Treatment Period|Withdrawal by Subject|2|||
164376908|NCT02139644|593754163|FG003|Treatment Period|Withdrawal by Subject|2|||
164376909|NCT02139644|593754164|FG004|Treatment Period|Withdrawal by Subject|3|||
164376910|NCT02139644|593754165|FG005|Treatment Period|Withdrawal by Subject|2|||
164376911|NCT02139644|593754160|FG000|Treatment Period|Non-compliance|0|||
164376912|NCT02139644|593754161|FG001|Treatment Period|Non-compliance|0|||
164376913|NCT02139644|593754162|FG002|Treatment Period|Non-compliance|0|||
164376914|NCT02139644|593754163|FG003|Treatment Period|Non-compliance|1|||
164376915|NCT02139644|593754164|FG004|Treatment Period|Non-compliance|0|||
164376916|NCT02139644|593754165|FG005|Treatment Period|Non-compliance|0|||
164376917|NCT02139644|593754160|FG000|Treatment Period|Protocol Violation|0|||
164376918|NCT02139644|593754161|FG001|Treatment Period|Protocol Violation|0|||
164376919|NCT02139644|593754162|FG002|Treatment Period|Protocol Violation|0|||
164376920|NCT02139644|593754163|FG003|Treatment Period|Protocol Violation|1|||
164376921|NCT02139644|593754164|FG004|Treatment Period|Protocol Violation|1|||
164376922|NCT02139644|593754165|FG005|Treatment Period|Protocol Violation|1|||
164376923|NCT02139644|593754160|FG000|Treatment Period|Disease progression|0|||
164376924|NCT02139644|593754161|FG001|Treatment Period|Disease progression|0|||
164376925|NCT02139644|593754162|FG002|Treatment Period|Disease progression|0|||
164376926|NCT02139644|593754163|FG003|Treatment Period|Disease progression|1|||
164376927|NCT02139644|593754164|FG004|Treatment Period|Disease progression|1|||
164376928|NCT02139644|593754165|FG005|Treatment Period|Disease progression|2|||
164376929|NCT02139644|593754160|FG000|Treatment Period|Lost to Follow-up|0|||
164376930|NCT02139644|593754161|FG001|Treatment Period|Lost to Follow-up|0|||
164376931|NCT02139644|593754162|FG002|Treatment Period|Lost to Follow-up|1|||
164376932|NCT02139644|593754163|FG003|Treatment Period|Lost to Follow-up|1|||
164376933|NCT02139644|593754164|FG004|Treatment Period|Lost to Follow-up|1|||
164376934|NCT02139644|593754165|FG005|Treatment Period|Lost to Follow-up|1|||
164376935|NCT02139644|593754160|FG000|Treatment Period|Lack of Efficacy|0|||
164376936|NCT02139644|593754161|FG001|Treatment Period|Lack of Efficacy|0|||
164376937|NCT02139644|593754162|FG002|Treatment Period|Lack of Efficacy|1|||
164376938|NCT02139644|593754163|FG003|Treatment Period|Lack of Efficacy|0|||
164376939|NCT02139644|593754164|FG004|Treatment Period|Lack of Efficacy|1|||
164376940|NCT02139644|593754165|FG005|Treatment Period|Lack of Efficacy|4|||
164376941|NCT02139644|593754160|FG000|Treatment Period|Other|0|||
164376942|NCT02139644|593754161|FG001|Treatment Period|Other|3|||
164376943|NCT02139644|593754162|FG002|Treatment Period|Other|1|||
164376944|NCT02139644|593754163|FG003|Treatment Period|Other|1|||
164012768|NCT04760314|592410566|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012769|NCT04760314|592410567|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012770|NCT04760314|592410568|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012771|NCT04760314|592410569|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012772|NCT04760314|592410570|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
164376945|NCT02139644|593754164|FG004|Treatment Period|Other|0|||
164376946|NCT02139644|593754165|FG005|Treatment Period|Other|1|||
164376947|NCT02453594|593754168|FG000|Overall Study|Protocol Violation|0|||
164012773|NCT04760314|592410571|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
164376948|NCT02453594|593754169|FG001|Overall Study|Protocol Violation|0|||
164376949|NCT02453594|593754170|FG002|Overall Study|Protocol Violation|1|||
164376950|NCT02453594|593754168|FG000|Overall Study|Cohort Was Closed|17|||
164376951|NCT02453594|593754169|FG001|Overall Study|Cohort Was Closed|21|||
164376952|NCT02453594|593754170|FG002|Overall Study|Cohort Was Closed|14|||
164376953|NCT02453594|593754168|FG000|Overall Study|Death|20|||
164376954|NCT02453594|593754169|FG001|Overall Study|Death|24|||
164376955|NCT02453594|593754170|FG002|Overall Study|Death|16|||
164376956|NCT02453594|593754168|FG000|Overall Study|Lost to Follow-up|6|||
164376957|NCT02453594|593754169|FG001|Overall Study|Lost to Follow-up|14|||
164376958|NCT02453594|593754170|FG002|Overall Study|Lost to Follow-up|2|||
164376959|NCT02453594|593754168|FG000|Overall Study|Physician Decision|2|||
164376960|NCT02453594|593754169|FG001|Overall Study|Physician Decision|4|||
164376961|NCT02453594|593754170|FG002|Overall Study|Physician Decision|0|||
164376962|NCT02453594|593754168|FG000|Overall Study|Site Terminated by Sponsor|1|||
164376963|NCT02453594|593754169|FG001|Overall Study|Site Terminated by Sponsor|0|||
164376964|NCT02453594|593754170|FG002|Overall Study|Site Terminated by Sponsor|1|||
164376965|NCT02453594|593754168|FG000|Overall Study|Transitioned to Extension Study|16|||
164376966|NCT02453594|593754169|FG001|Overall Study|Transitioned to Extension Study|9|||
164376967|NCT02453594|593754170|FG002|Overall Study|Transitioned to Extension Study|16|||
164012774|NCT04760314|592410572|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012775|NCT04760314|592410573|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012776|NCT04760314|592410574|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
164376968|NCT02453594|593754168|FG000|Overall Study|Withdrawal by Subject|7|||
164376969|NCT02453594|593754169|FG001|Overall Study|Withdrawal by Subject|9|||
164376970|NCT02453594|593754170|FG002|Overall Study|Withdrawal by Subject|11|||
164376971|NCT01694706|593754179|FG000|Overall Study|Adverse Event|0|||
164376972|NCT01694706|593754180|FG001|Overall Study|Adverse Event|1|||
164376973|NCT01694706|593754181|FG002|Overall Study|Adverse Event|0|||
164376974|NCT01694706|593754179|FG000|Overall Study|other reason not defined above|1|||
164376975|NCT01694706|593754180|FG001|Overall Study|other reason not defined above|0|||
164376976|NCT01694706|593754181|FG002|Overall Study|other reason not defined above|0|||
164376977|NCT00451282|593754182|FG000|Overall Study|Lost to Follow-up|6|||
164376978|NCT00451282|593754183|FG001|Overall Study|Lost to Follow-up|5|||
164376979|NCT01797536|593754184|FG000|Overall Study|Adverse Event|0|||
164376980|NCT01797536|593754185|FG001|Overall Study|Adverse Event|1|||
164376981|NCT01797536|593754186|FG002|Overall Study|Adverse Event|0|||
164376982|NCT01797536|593754187|FG003|Overall Study|Adverse Event|0|||
164376983|NCT00098839|593754188|FG000|Overall Study|Adverse Event|5|||
164376984|NCT00098839|593754189|FG001|Overall Study|Adverse Event|2|||
164376985|NCT00098839|593754188|FG000|Overall Study|Death|1|||
164376986|NCT00098839|593754189|FG001|Overall Study|Death|2|||
164376987|NCT00098839|593754188|FG000|Overall Study|Physician Decision|4|||
164376988|NCT00098839|593754189|FG001|Overall Study|Physician Decision|14|||
164376989|NCT00098839|593754188|FG000|Overall Study|Withdrawal by Subject|1|||
164376990|NCT00098839|593754189|FG001|Overall Study|Withdrawal by Subject|0|||
164376991|NCT00098839|593754188|FG000|Overall Study|Refusal of further protocol therapy|3|||
164376992|NCT00098839|593754189|FG001|Overall Study|Refusal of further protocol therapy|1|||
164376993|NCT00098839|593754188|FG000|Overall Study|Relapse|6|||
164376994|NCT00098839|593754189|FG001|Overall Study|Relapse|3|||
164376995|NCT00098839|593754188|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
164376996|NCT00098839|593754189|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
164376997|NCT00098839|593754188|FG000|Overall Study|Ineligible|2|||
164376998|NCT00098839|593754189|FG001|Overall Study|Ineligible|0|||
164376999|NCT00456092|593754190|FG000|Extension Phase|Grade 2 or Greater AE|2|||
164377000|NCT00456092|593754191|FG001|Extension Phase|Grade 2 or Greater AE|2|||
164377001|NCT00456092|593754192|FG002|Extension Phase|Grade 2 or Greater AE|0|||
164377002|NCT00456092|593754193|FG003|Extension Phase|Grade 2 or Greater AE|0|||
164377003|NCT00456092|593754194|FG004|Extension Phase|Grade 2 or Greater AE|2|||
164377004|NCT00456092|593754190|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
164377005|NCT00456092|593754191|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
164377006|NCT00456092|593754192|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
164377007|NCT00456092|593754193|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
164377008|NCT00456092|593754194|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
164377009|NCT00456092|593754190|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
164012777|NCT04760314|592410575|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
164012778|NCT04760314|592410576|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
164012779|NCT01372878|592410584|FG000|Overall Study|Withdrawal by Subject|63|||
164012780|NCT01372878|592410584|FG000|Overall Study|Protocol Violation|17|||
164012781|NCT01372878|592410584|FG000|Overall Study|incomplete study procedure|104|||
164377010|NCT00456092|593754191|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
164377011|NCT00456092|593754192|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
164377012|NCT00456092|593754193|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
164377013|NCT00456092|593754194|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
164377014|NCT00456092|593754190|FG000|Extension Phase|Withdrew Consent|2|||
164377015|NCT00456092|593754191|FG001|Extension Phase|Withdrew Consent|0|||
164012782|NCT02616029|592410587|FG000|Overall Study|Adverse Event|1|||
164012783|NCT02616029|592410588|FG001|Overall Study|Adverse Event|0|||
164012784|NCT02616029|592410587|FG000|Overall Study|Death|0|||
164012785|NCT02616029|592410588|FG001|Overall Study|Death|1|||
164377016|NCT00456092|593754192|FG002|Extension Phase|Withdrew Consent|0|||
164377017|NCT00456092|593754193|FG003|Extension Phase|Withdrew Consent|0|||
164377018|NCT00456092|593754194|FG004|Extension Phase|Withdrew Consent|0|||
164377019|NCT00456092|593754190|FG000|Extension Phase|Lost to Follow-up|1|||
164377020|NCT00456092|593754191|FG001|Extension Phase|Lost to Follow-up|1|||
164377021|NCT00456092|593754192|FG002|Extension Phase|Lost to Follow-up|0|||
164377022|NCT00456092|593754193|FG003|Extension Phase|Lost to Follow-up|0|||
164377023|NCT00456092|593754194|FG004|Extension Phase|Lost to Follow-up|1|||
164377024|NCT00456092|593754190|FG000|Extension Phase|Other|2|||
164377025|NCT00456092|593754191|FG001|Extension Phase|Other|0|||
164377026|NCT00456092|593754192|FG002|Extension Phase|Other|0|||
164377027|NCT00456092|593754193|FG003|Extension Phase|Other|1|||
164377028|NCT00456092|593754194|FG004|Extension Phase|Other|1|||
164377029|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
164377030|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
164377031|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
164377032|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
164377033|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
164377034|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
164377035|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
164377036|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
164377037|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
164377038|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
164377039|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
164377040|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377041|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377042|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377043|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
164377044|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
164377045|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
164377046|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
164377047|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
164377048|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
164377049|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
164377050|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
164377051|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
164377052|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
164377053|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
164377054|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
164377055|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
164377056|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
164377057|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
164377058|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
164377059|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
164377060|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
164377061|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
164377062|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
164377063|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
164377064|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164377065|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164377066|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
164377067|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164377068|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
164377069|NCT00456092|593754190|FG000|Treatment Phase (12 Weeks)|Other|1|||
164377070|NCT00456092|593754191|FG001|Treatment Phase (12 Weeks)|Other|0|||
164377071|NCT00456092|593754192|FG002|Treatment Phase (12 Weeks)|Other|1|||
164377072|NCT00456092|593754193|FG003|Treatment Phase (12 Weeks)|Other|0|||
164377073|NCT00456092|593754194|FG004|Treatment Phase (12 Weeks)|Other|0|||
164377074|NCT01358981|593754198|FG000|Period 1|Withdrawal by Subject|0|||
164377075|NCT01358981|593754199|FG001|Period 1|Withdrawal by Subject|0|||
164377076|NCT01358981|593754200|FG002|Period 1|Withdrawal by Subject|0|||
164377077|NCT01358981|593754201|FG003|Period 1|Withdrawal by Subject|1|||
164377078|NCT01358981|593754202|FG004|Period 1|Withdrawal by Subject|0|||
164377079|NCT01358981|593754203|FG005|Period 1|Withdrawal by Subject|0|||
164377080|NCT01358981|593754204|FG006|Period 1|Withdrawal by Subject|0|||
164377081|NCT01332305|593754205|FG000|Overall Study|Adverse Event|1|||
164377082|NCT01332305|593754206|FG001|Overall Study|Adverse Event|4|||
164377083|NCT01332305|593754207|FG002|Overall Study|Adverse Event|6|||
164377084|NCT01332305|593754208|FG003|Overall Study|Adverse Event|3|||
164377085|NCT01332305|593754209|FG004|Overall Study|Adverse Event|5|||
164377086|NCT01332305|593754205|FG000|Overall Study|Withdrawal by Subject|6|||
164377087|NCT01332305|593754206|FG001|Overall Study|Withdrawal by Subject|5|||
164377088|NCT01332305|593754207|FG002|Overall Study|Withdrawal by Subject|4|||
164377089|NCT01332305|593754208|FG003|Overall Study|Withdrawal by Subject|1|||
164377090|NCT01332305|593754209|FG004|Overall Study|Withdrawal by Subject|0|||
164377091|NCT01332305|593754205|FG000|Overall Study|Lost to Follow-up|0|||
164377092|NCT01332305|593754206|FG001|Overall Study|Lost to Follow-up|2|||
164377093|NCT01332305|593754207|FG002|Overall Study|Lost to Follow-up|3|||
164377094|NCT01332305|593754208|FG003|Overall Study|Lost to Follow-up|2|||
164377095|NCT01332305|593754209|FG004|Overall Study|Lost to Follow-up|3|||
164377096|NCT01332305|593754205|FG000|Overall Study|Protocol Violation|1|||
164377097|NCT01332305|593754206|FG001|Overall Study|Protocol Violation|2|||
164377098|NCT01332305|593754207|FG002|Overall Study|Protocol Violation|1|||
164377099|NCT01332305|593754208|FG003|Overall Study|Protocol Violation|0|||
164377100|NCT01332305|593754209|FG004|Overall Study|Protocol Violation|3|||
164377101|NCT01332305|593754205|FG000|Overall Study|Withdrawal by Sponsor|1|||
164377102|NCT01332305|593754206|FG001|Overall Study|Withdrawal by Sponsor|0|||
164377103|NCT01332305|593754207|FG002|Overall Study|Withdrawal by Sponsor|0|||
164377104|NCT01332305|593754208|FG003|Overall Study|Withdrawal by Sponsor|1|||
164377105|NCT01332305|593754209|FG004|Overall Study|Withdrawal by Sponsor|1|||
164377106|NCT01332305|593754205|FG000|Overall Study|Treatment Failure|1|||
164377107|NCT01332305|593754206|FG001|Overall Study|Treatment Failure|1|||
164377108|NCT01332305|593754207|FG002|Overall Study|Treatment Failure|0|||
164377109|NCT01332305|593754208|FG003|Overall Study|Treatment Failure|0|||
164377110|NCT01332305|593754209|FG004|Overall Study|Treatment Failure|0|||
164377111|NCT01332305|593754205|FG000|Overall Study|Physician Decision|0|||
164377112|NCT01332305|593754206|FG001|Overall Study|Physician Decision|0|||
164377113|NCT01332305|593754207|FG002|Overall Study|Physician Decision|0|||
164377114|NCT01332305|593754208|FG003|Overall Study|Physician Decision|1|||
164377115|NCT01332305|593754209|FG004|Overall Study|Physician Decision|0|||
164377116|NCT01600040|593754210|FG000|Overall Study|Withdrawal by Subject|1|||
164377117|NCT01401530|593754216|FG000|Overall Study|Disease Progression|1|||
164377118|NCT01401530|593754217|FG001|Overall Study|Disease Progression|2|||
164377119|NCT01401530|593754218|FG002|Overall Study|Disease Progression|1|||
164377120|NCT01401530|593754216|FG000|Overall Study|Adverse Event|1|||
164377121|NCT01401530|593754217|FG001|Overall Study|Adverse Event|1|||
164377122|NCT01401530|593754218|FG002|Overall Study|Adverse Event|1|||
164377123|NCT01401530|593754216|FG000|Overall Study|Participant Choice|1|||
164377124|NCT01401530|593754217|FG001|Overall Study|Participant Choice|2|||
164377125|NCT01401530|593754218|FG002|Overall Study|Participant Choice|1|||
164377126|NCT01401530|593754216|FG000|Overall Study|Physician Decision|0|||
164377127|NCT01401530|593754217|FG001|Overall Study|Physician Decision|1|||
164377128|NCT01401530|593754218|FG002|Overall Study|Physician Decision|0|||
164377129|NCT03670810|593754219|FG000|Main Study|Adverse Event|37|||
164377130|NCT03670810|593754220|FG001|Main Study|Adverse Event|38|||
164377131|NCT03670810|593754221|FG002|Main Study|Adverse Event|3|||
164377132|NCT03670810|593754222|FG003|Main Study|Adverse Event|4|||
164377133|NCT03670810|593754223|FG004|Main Study|Adverse Event|4|||
164377134|NCT03670810|593754224|FG005|Main Study|Adverse Event|5|||
164377135|NCT03670810|593754225|FG006|Main Study|Adverse Event|0|||
164377136|NCT03670810|593754226|FG007|Main Study|Adverse Event|0|||
164377137|NCT03670810|593754227|FG008|Main Study|Adverse Event|0|||
164377138|NCT03670810|593754219|FG000|Main Study|Lack of Efficacy|8|||
164377139|NCT03670810|593754220|FG001|Main Study|Lack of Efficacy|9|||
164377140|NCT03670810|593754221|FG002|Main Study|Lack of Efficacy|3|||
164377141|NCT03670810|593754222|FG003|Main Study|Lack of Efficacy|4|||
164377142|NCT03670810|593754223|FG004|Main Study|Lack of Efficacy|0|||
164377143|NCT03670810|593754224|FG005|Main Study|Lack of Efficacy|0|||
164377144|NCT03670810|593754225|FG006|Main Study|Lack of Efficacy|0|||
164377145|NCT03670810|593754226|FG007|Main Study|Lack of Efficacy|0|||
164377146|NCT03670810|593754227|FG008|Main Study|Lack of Efficacy|0|||
164377147|NCT03670810|593754219|FG000|Main Study|Lost to Follow-up|9|||
164377148|NCT03670810|593754220|FG001|Main Study|Lost to Follow-up|7|||
164377149|NCT03670810|593754221|FG002|Main Study|Lost to Follow-up|4|||
164377150|NCT03670810|593754222|FG003|Main Study|Lost to Follow-up|6|||
164377151|NCT03670810|593754223|FG004|Main Study|Lost to Follow-up|1|||
164377152|NCT03670810|593754224|FG005|Main Study|Lost to Follow-up|0|||
164377153|NCT03670810|593754225|FG006|Main Study|Lost to Follow-up|0|||
164377154|NCT03670810|593754226|FG007|Main Study|Lost to Follow-up|0|||
164377155|NCT03670810|593754227|FG008|Main Study|Lost to Follow-up|0|||
164377156|NCT03670810|593754219|FG000|Main Study|Non-compliance with Study Drug|0|||
164377157|NCT03670810|593754220|FG001|Main Study|Non-compliance with Study Drug|2|||
164377158|NCT03670810|593754221|FG002|Main Study|Non-compliance with Study Drug|3|||
164377159|NCT03670810|593754222|FG003|Main Study|Non-compliance with Study Drug|0|||
164377160|NCT03670810|593754223|FG004|Main Study|Non-compliance with Study Drug|0|||
164377161|NCT03670810|593754224|FG005|Main Study|Non-compliance with Study Drug|0|||
164377162|NCT03670810|593754225|FG006|Main Study|Non-compliance with Study Drug|0|||
164377163|NCT03670810|593754226|FG007|Main Study|Non-compliance with Study Drug|1|||
164377164|NCT03670810|593754227|FG008|Main Study|Non-compliance with Study Drug|0|||
164377165|NCT03670810|593754219|FG000|Main Study|Physician Decision|3|||
164377166|NCT03670810|593754220|FG001|Main Study|Physician Decision|0|||
164377167|NCT03670810|593754221|FG002|Main Study|Physician Decision|1|||
164377168|NCT03670810|593754222|FG003|Main Study|Physician Decision|0|||
164377169|NCT03670810|593754223|FG004|Main Study|Physician Decision|0|||
164377170|NCT03670810|593754224|FG005|Main Study|Physician Decision|0|||
164377171|NCT03670810|593754225|FG006|Main Study|Physician Decision|1|||
164377172|NCT03670810|593754226|FG007|Main Study|Physician Decision|1|||
164377173|NCT03670810|593754227|FG008|Main Study|Physician Decision|0|||
164377174|NCT03670810|593754219|FG000|Main Study|Pregnancy|1|||
164377175|NCT03670810|593754220|FG001|Main Study|Pregnancy|2|||
164377176|NCT03670810|593754221|FG002|Main Study|Pregnancy|0|||
164377177|NCT03670810|593754222|FG003|Main Study|Pregnancy|0|||
164377178|NCT03670810|593754223|FG004|Main Study|Pregnancy|0|||
164377179|NCT03670810|593754224|FG005|Main Study|Pregnancy|0|||
164377180|NCT03670810|593754225|FG006|Main Study|Pregnancy|0|||
164377181|NCT03670810|593754226|FG007|Main Study|Pregnancy|0|||
164377182|NCT03670810|593754227|FG008|Main Study|Pregnancy|0|||
164377183|NCT03670810|593754219|FG000|Main Study|Protocol Deviation|2|||
164377184|NCT03670810|593754220|FG001|Main Study|Protocol Deviation|12|||
164377185|NCT03670810|593754221|FG002|Main Study|Protocol Deviation|8|||
164377186|NCT03670810|593754222|FG003|Main Study|Protocol Deviation|4|||
164377187|NCT03670810|593754223|FG004|Main Study|Protocol Deviation|0|||
164377188|NCT03670810|593754224|FG005|Main Study|Protocol Deviation|0|||
164377189|NCT03670810|593754225|FG006|Main Study|Protocol Deviation|0|||
164377190|NCT03670810|593754226|FG007|Main Study|Protocol Deviation|0|||
164377191|NCT03670810|593754227|FG008|Main Study|Protocol Deviation|0|||
164377192|NCT03670810|593754219|FG000|Main Study|Withdrawal by Subject|21|||
164377193|NCT03670810|593754220|FG001|Main Study|Withdrawal by Subject|21|||
164377194|NCT03670810|593754221|FG002|Main Study|Withdrawal by Subject|8|||
164377195|NCT03670810|593754222|FG003|Main Study|Withdrawal by Subject|9|||
164377196|NCT03670810|593754223|FG004|Main Study|Withdrawal by Subject|5|||
164377197|NCT03670810|593754224|FG005|Main Study|Withdrawal by Subject|2|||
164377198|NCT03670810|593754225|FG006|Main Study|Withdrawal by Subject|1|||
164377199|NCT03670810|593754226|FG007|Main Study|Withdrawal by Subject|1|||
164377200|NCT03670810|593754227|FG008|Main Study|Withdrawal by Subject|0|||
164377201|NCT03670810|593754219|FG000|Main Study|Participant did not want to take the three other treatments|1|||
164377202|NCT03670810|593754220|FG001|Main Study|Participant did not want to take the three other treatments|0|||
164377203|NCT03670810|593754221|FG002|Main Study|Participant did not want to take the three other treatments|0|||
164377204|NCT03670810|593754222|FG003|Main Study|Participant did not want to take the three other treatments|0|||
164377205|NCT03670810|593754223|FG004|Main Study|Participant did not want to take the three other treatments|0|||
164377206|NCT03670810|593754224|FG005|Main Study|Participant did not want to take the three other treatments|0|||
164377207|NCT03670810|593754225|FG006|Main Study|Participant did not want to take the three other treatments|0|||
164377208|NCT03670810|593754226|FG007|Main Study|Participant did not want to take the three other treatments|0|||
164377209|NCT03670810|593754227|FG008|Main Study|Participant did not want to take the three other treatments|0|||
164377210|NCT03670810|593754219|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377211|NCT03670810|593754220|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
164377212|NCT03670810|593754221|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377213|NCT03670810|593754222|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377214|NCT03670810|593754223|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377215|NCT03670810|593754224|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377216|NCT03670810|593754225|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
163902620|NCT00683800|592014705|FG000|Overall Study|Other|5|||
164377217|NCT03670810|593754226|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164377218|NCT03670810|593754227|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
164012786|NCT02616029|592410587|FG000|Overall Study|Protocol Violation|1|||
164377219|NCT03670810|593754219|FG000|Main Study|Travel and Coronavirus issues|0|||
164377220|NCT03670810|593754220|FG001|Main Study|Travel and Coronavirus issues|0|||
164377221|NCT03670810|593754221|FG002|Main Study|Travel and Coronavirus issues|0|||
164377222|NCT03670810|593754222|FG003|Main Study|Travel and Coronavirus issues|1|||
164377223|NCT03670810|593754223|FG004|Main Study|Travel and Coronavirus issues|0|||
164377224|NCT03670810|593754224|FG005|Main Study|Travel and Coronavirus issues|0|||
164377225|NCT03670810|593754225|FG006|Main Study|Travel and Coronavirus issues|0|||
164377226|NCT03670810|593754226|FG007|Main Study|Travel and Coronavirus issues|0|||
164377227|NCT03670810|593754227|FG008|Main Study|Travel and Coronavirus issues|0|||
164377228|NCT03670810|593754219|FG000|Open Label Extension|Protocol Deviation|0|||
164377229|NCT03670810|593754220|FG001|Open Label Extension|Protocol Deviation|0|||
164377230|NCT03670810|593754221|FG002|Open Label Extension|Protocol Deviation|0|||
164377231|NCT03670810|593754222|FG003|Open Label Extension|Protocol Deviation|0|||
164377232|NCT03670810|593754223|FG004|Open Label Extension|Protocol Deviation|0|||
164377233|NCT03670810|593754224|FG005|Open Label Extension|Protocol Deviation|0|||
164377234|NCT03670810|593754225|FG006|Open Label Extension|Protocol Deviation|0|||
164377235|NCT03670810|593754226|FG007|Open Label Extension|Protocol Deviation|0|||
164377236|NCT03670810|593754227|FG008|Open Label Extension|Protocol Deviation|5|||
164377237|NCT03670810|593754219|FG000|Open Label Extension|Death|0|||
164377238|NCT03670810|593754220|FG001|Open Label Extension|Death|0|||
164377239|NCT03670810|593754221|FG002|Open Label Extension|Death|0|||
164377240|NCT03670810|593754222|FG003|Open Label Extension|Death|0|||
164377241|NCT03670810|593754223|FG004|Open Label Extension|Death|0|||
164377242|NCT03670810|593754224|FG005|Open Label Extension|Death|0|||
164377243|NCT03670810|593754225|FG006|Open Label Extension|Death|0|||
164377244|NCT03670810|593754226|FG007|Open Label Extension|Death|0|||
164012787|NCT02616029|592410588|FG001|Overall Study|Protocol Violation|0|||
164012788|NCT02616029|592410587|FG000|Overall Study|Withdrew Consent|1|||
164012789|NCT02616029|592410588|FG001|Overall Study|Withdrew Consent|0|||
164012790|NCT02616029|592410587|FG000|Overall Study|Enrolled and Never Treated|1|||
164012791|NCT02616029|592410588|FG001|Overall Study|Enrolled and Never Treated|1|||
164377245|NCT03670810|593754227|FG008|Open Label Extension|Death|1|||
164377246|NCT03670810|593754219|FG000|Open Label Extension|COVID-19|0|||
164377247|NCT03670810|593754220|FG001|Open Label Extension|COVID-19|0|||
164377248|NCT03670810|593754221|FG002|Open Label Extension|COVID-19|0|||
164377249|NCT03670810|593754222|FG003|Open Label Extension|COVID-19|0|||
164377250|NCT03670810|593754223|FG004|Open Label Extension|COVID-19|0|||
164377251|NCT03670810|593754224|FG005|Open Label Extension|COVID-19|0|||
164377252|NCT03670810|593754225|FG006|Open Label Extension|COVID-19|0|||
164377253|NCT03670810|593754226|FG007|Open Label Extension|COVID-19|0|||
164377254|NCT03670810|593754227|FG008|Open Label Extension|COVID-19|1|||
164377255|NCT03670810|593754219|FG000|Open Label Extension|Lack of Efficacy|0|||
164377256|NCT03670810|593754220|FG001|Open Label Extension|Lack of Efficacy|0|||
164377257|NCT03670810|593754221|FG002|Open Label Extension|Lack of Efficacy|0|||
164377258|NCT03670810|593754222|FG003|Open Label Extension|Lack of Efficacy|0|||
164377259|NCT03670810|593754223|FG004|Open Label Extension|Lack of Efficacy|0|||
164377260|NCT03670810|593754224|FG005|Open Label Extension|Lack of Efficacy|0|||
164377261|NCT03670810|593754225|FG006|Open Label Extension|Lack of Efficacy|0|||
164377262|NCT03670810|593754226|FG007|Open Label Extension|Lack of Efficacy|0|||
164377263|NCT03670810|593754227|FG008|Open Label Extension|Lack of Efficacy|39|||
164377264|NCT03670810|593754219|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
164377265|NCT03670810|593754220|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
164377266|NCT03670810|593754221|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
164377267|NCT03670810|593754222|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
164377268|NCT03670810|593754223|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
164377269|NCT03670810|593754224|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
164377270|NCT03670810|593754225|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
164377271|NCT03670810|593754226|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
164377272|NCT03670810|593754227|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
164377273|NCT03670810|593754219|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377274|NCT03670810|593754220|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377275|NCT03670810|593754221|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377276|NCT03670810|593754222|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377277|NCT03670810|593754223|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377278|NCT03670810|593754224|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377279|NCT03670810|593754225|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377280|NCT03670810|593754226|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
164377281|NCT03670810|593754227|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
164377282|NCT03670810|593754219|FG000|Open Label Extension|Withdrawal by Subject|0|||
164012792|NCT00479466|592410589|FG000|Overall Study|Adverse Event|5|||
164377283|NCT03670810|593754220|FG001|Open Label Extension|Withdrawal by Subject|0|||
164377284|NCT03670810|593754221|FG002|Open Label Extension|Withdrawal by Subject|0|||
164377285|NCT03670810|593754222|FG003|Open Label Extension|Withdrawal by Subject|0|||
164377286|NCT03670810|593754223|FG004|Open Label Extension|Withdrawal by Subject|0|||
164377287|NCT03670810|593754224|FG005|Open Label Extension|Withdrawal by Subject|0|||
164377288|NCT03670810|593754225|FG006|Open Label Extension|Withdrawal by Subject|0|||
164377289|NCT03670810|593754226|FG007|Open Label Extension|Withdrawal by Subject|0|||
164377290|NCT03670810|593754227|FG008|Open Label Extension|Withdrawal by Subject|46|||
164377291|NCT03670810|593754219|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377292|NCT03670810|593754220|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377293|NCT03670810|593754221|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377294|NCT03670810|593754222|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377295|NCT03670810|593754223|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377296|NCT03670810|593754224|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377297|NCT03670810|593754225|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377298|NCT03670810|593754226|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
164377299|NCT03670810|593754227|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
164377300|NCT03670810|593754219|FG000|Open Label Extension|Physician Decision|0|||
164377301|NCT03670810|593754220|FG001|Open Label Extension|Physician Decision|0|||
164377302|NCT03670810|593754221|FG002|Open Label Extension|Physician Decision|0|||
164377303|NCT03670810|593754222|FG003|Open Label Extension|Physician Decision|0|||
164377304|NCT03670810|593754223|FG004|Open Label Extension|Physician Decision|0|||
164377305|NCT03670810|593754224|FG005|Open Label Extension|Physician Decision|0|||
164377306|NCT03670810|593754225|FG006|Open Label Extension|Physician Decision|0|||
164377307|NCT03670810|593754226|FG007|Open Label Extension|Physician Decision|0|||
164377308|NCT03670810|593754227|FG008|Open Label Extension|Physician Decision|2|||
164377309|NCT03670810|593754219|FG000|Open Label Extension|Non-compliance with study drug|0|||
164377310|NCT03670810|593754220|FG001|Open Label Extension|Non-compliance with study drug|0|||
164377311|NCT03670810|593754221|FG002|Open Label Extension|Non-compliance with study drug|0|||
164377312|NCT03670810|593754222|FG003|Open Label Extension|Non-compliance with study drug|0|||
164377313|NCT03670810|593754223|FG004|Open Label Extension|Non-compliance with study drug|0|||
164377314|NCT03670810|593754224|FG005|Open Label Extension|Non-compliance with study drug|0|||
164377315|NCT03670810|593754225|FG006|Open Label Extension|Non-compliance with study drug|0|||
164377316|NCT03670810|593754226|FG007|Open Label Extension|Non-compliance with study drug|0|||
164377317|NCT03670810|593754227|FG008|Open Label Extension|Non-compliance with study drug|5|||
164377318|NCT03670810|593754219|FG000|Open Label Extension|Pregnancy|0|||
164377319|NCT03670810|593754220|FG001|Open Label Extension|Pregnancy|0|||
164377320|NCT03670810|593754221|FG002|Open Label Extension|Pregnancy|0|||
164377321|NCT03670810|593754222|FG003|Open Label Extension|Pregnancy|0|||
164377322|NCT03670810|593754223|FG004|Open Label Extension|Pregnancy|0|||
164377323|NCT03670810|593754224|FG005|Open Label Extension|Pregnancy|0|||
164377324|NCT03670810|593754225|FG006|Open Label Extension|Pregnancy|0|||
164377325|NCT03670810|593754226|FG007|Open Label Extension|Pregnancy|0|||
164377326|NCT03670810|593754227|FG008|Open Label Extension|Pregnancy|3|||
164377327|NCT03670810|593754219|FG000|Open Label Extension|Adverse Event|0|||
164377328|NCT03670810|593754220|FG001|Open Label Extension|Adverse Event|0|||
164377329|NCT03670810|593754221|FG002|Open Label Extension|Adverse Event|0|||
164377330|NCT03670810|593754222|FG003|Open Label Extension|Adverse Event|0|||
164377331|NCT03670810|593754223|FG004|Open Label Extension|Adverse Event|0|||
164377332|NCT03670810|593754224|FG005|Open Label Extension|Adverse Event|0|||
164377333|NCT03670810|593754225|FG006|Open Label Extension|Adverse Event|0|||
164377334|NCT03670810|593754226|FG007|Open Label Extension|Adverse Event|0|||
164377335|NCT03670810|593754227|FG008|Open Label Extension|Adverse Event|24|||
164377336|NCT03670810|593754219|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
164377337|NCT03670810|593754220|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
164377338|NCT03670810|593754221|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
164377339|NCT03670810|593754222|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
164377340|NCT03670810|593754223|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
164377341|NCT03670810|593754224|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
164012793|NCT00479466|592410590|FG001|Overall Study|Adverse Event|1|||
164377342|NCT03670810|593754225|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
164377343|NCT03670810|593754226|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
164377344|NCT03670810|593754227|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
164377345|NCT03670810|593754219|FG000|Open Label Extension|Lost to Follow-up|0|||
164377346|NCT03670810|593754220|FG001|Open Label Extension|Lost to Follow-up|0|||
164377347|NCT03670810|593754221|FG002|Open Label Extension|Lost to Follow-up|0|||
164012794|NCT00479466|592410591|FG002|Overall Study|Adverse Event|0|||
164012795|NCT00479466|592410592|FG003|Overall Study|Adverse Event|1|||
164012796|NCT00479466|592410593|FG004|Overall Study|Adverse Event|2|||
163902621|NCT00683800|592014706|FG001|Overall Study|Other|2|||
163902622|NCT00683800|592014705|FG000|Overall Study|Protocol Violation|13|||
163902623|NCT00683800|592014706|FG001|Overall Study|Protocol Violation|16|||
163902624|NCT00683800|592014705|FG000|Overall Study|Withdrawal by Subject|66|||
163902625|NCT00683800|592014706|FG001|Overall Study|Withdrawal by Subject|64|||
163902626|NCT00683800|592014705|FG000|Overall Study|Lack of Efficacy|61|||
163902627|NCT00683800|592014706|FG001|Overall Study|Lack of Efficacy|104|||
163902628|NCT00683800|592014705|FG000|Overall Study|Randomized, not treated|35|||
163902629|NCT00683800|592014706|FG001|Overall Study|Randomized, not treated|33|||
164377348|NCT03670810|593754222|FG003|Open Label Extension|Lost to Follow-up|0|||
164377349|NCT03670810|593754223|FG004|Open Label Extension|Lost to Follow-up|0|||
164377350|NCT03670810|593754224|FG005|Open Label Extension|Lost to Follow-up|0|||
164377351|NCT03670810|593754225|FG006|Open Label Extension|Lost to Follow-up|0|||
164377352|NCT03670810|593754226|FG007|Open Label Extension|Lost to Follow-up|0|||
164377353|NCT03670810|593754227|FG008|Open Label Extension|Lost to Follow-up|23|||
164377354|NCT00678691|593754228|FG000|Overall Study|Adverse Event|6|||
164377355|NCT00678691|593754229|FG001|Overall Study|Adverse Event|4|||
164377356|NCT00779766|593754230|FG000|Month 24|Serious Adverse Event|2|||
164377357|NCT00779766|593754231|FG001|Month 24|Serious Adverse Event|3|||
164377358|NCT00779766|593754230|FG000|Month 24|Adverse Event|3|||
164377359|NCT00779766|593754231|FG001|Month 24|Adverse Event|3|||
164377360|NCT00779766|593754230|FG000|Month 24|Protocol Violation|3|||
164377361|NCT00779766|593754231|FG001|Month 24|Protocol Violation|1|||
164377362|NCT00779766|593754230|FG000|Month 24|Withdrawal by Subject|159|||
164377363|NCT00779766|593754231|FG001|Month 24|Withdrawal by Subject|127|||
164377364|NCT00779766|593754230|FG000|Month 24|Migrated/moved from study area|138|||
164377365|NCT00779766|593754231|FG001|Month 24|Migrated/moved from study area|162|||
164377366|NCT00779766|593754230|FG000|Month 24|Lost to Follow-up|9|||
164377367|NCT00779766|593754231|FG001|Month 24|Lost to Follow-up|9|||
164377368|NCT00779766|593754230|FG000|Month 24|Other|18|||
164377369|NCT00779766|593754231|FG001|Month 24|Other|27|||
164377370|NCT00779766|593754230|FG000|Month 48|Withdrawal by Subject|68|||
164377371|NCT00779766|593754231|FG001|Month 48|Withdrawal by Subject|63|||
164377372|NCT00779766|593754230|FG000|Month 48|Migrated/moved from study area|76|||
164377373|NCT00779766|593754231|FG001|Month 48|Migrated/moved from study area|75|||
164377374|NCT00779766|593754230|FG000|Month 48|Lost to Follow-up|29|||
164377375|NCT00779766|593754231|FG001|Month 48|Lost to Follow-up|30|||
164377376|NCT00779766|593754230|FG000|Month 48|Other|1|||
164377377|NCT00779766|593754231|FG001|Month 48|Other|0|||
164377378|NCT00779766|593754230|FG000|Month 72|Withdrawal by Subject|55|||
164377379|NCT00779766|593754231|FG001|Month 72|Withdrawal by Subject|71|||
164377380|NCT00779766|593754230|FG000|Month 72|Migrated/moved from study area|124|||
164377381|NCT00779766|593754231|FG001|Month 72|Migrated/moved from study area|109|||
164377382|NCT00779766|593754230|FG000|Month 72|Lost to Follow-up|6|||
164377383|NCT00779766|593754231|FG001|Month 72|Lost to Follow-up|8|||
164377384|NCT00779766|593754230|FG000|Month 72|Other|0|||
164377385|NCT00779766|593754231|FG001|Month 72|Other|1|||
164377386|NCT01412424|593754232|FG000|Core Treatment Period|Treatment Failure|24|||
164377387|NCT01412424|593754232|FG000|Core Treatment Period|Adverse Event|21|||
164377388|NCT01412424|593754232|FG000|Core Treatment Period|Patient Request|5|||
164377389|NCT01412424|593754232|FG000|Core Treatment Period|Lost to Follow-up|2|||
163902630|NCT00205179|592014709|FG000|Overall Study|Death|0|||
163902631|NCT00205179|592014710|FG001|Overall Study|Death|2|||
163902632|NCT00205179|592014709|FG000|Overall Study|Physician Decision|1|||
164377390|NCT01412424|593754232|FG000|Core Treatment Period|Sponsor Request|1|||
164377391|NCT01412424|593754232|FG000|Extension Treatment Period|Adverse Event|2|||
164377392|NCT01412424|593754232|FG000|Extension Treatment Period|Treatment Failure|2|||
164377393|NCT01412424|593754232|FG000|Extension Treatment Period|Patient Request|2|||
164377394|NCT01252290|593754235|FG000|Overall Study|Withdrawal by Subject|1|||
164377395|NCT02247349|593754236|FG000|Overall Study|Disease Progression|7|||
164377396|NCT02247349|593754237|FG001|Overall Study|Disease Progression|4|||
164377397|NCT02247349|593754238|FG002|Overall Study|Disease Progression|26|||
164377398|NCT02247349|593754239|FG003|Overall Study|Disease Progression|31|||
164377399|NCT02247349|593754240|FG004|Overall Study|Disease Progression|16|||
164377400|NCT02247349|593754241|FG005|Overall Study|Disease Progression|6|||
164377401|NCT02247349|593754236|FG000|Overall Study|Study drug toxicity|0|||
164377402|NCT02247349|593754237|FG001|Overall Study|Study drug toxicity|1|||
163902633|NCT00205179|592014710|FG001|Overall Study|Physician Decision|1|||
163902634|NCT00205179|592014709|FG000|Overall Study|Adverse Event|1|||
163902635|NCT00205179|592014710|FG001|Overall Study|Adverse Event|1|||
163902636|NCT01619059|592014717|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
164377403|NCT02247349|593754238|FG002|Overall Study|Study drug toxicity|1|||
164377404|NCT02247349|593754239|FG003|Overall Study|Study drug toxicity|1|||
164377405|NCT02247349|593754240|FG004|Overall Study|Study drug toxicity|2|||
163902637|NCT01619059|592014718|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
164012797|NCT00479466|592410594|FG005|Overall Study|Adverse Event|0|||
164012798|NCT00479466|592410589|FG000|Overall Study|Hyperglycemia|0|||
164377406|NCT02247349|593754241|FG005|Overall Study|Study drug toxicity|2|||
164377407|NCT02247349|593754236|FG000|Overall Study|Death|0|||
164377408|NCT02247349|593754237|FG001|Overall Study|Death|0|||
164377409|NCT02247349|593754238|FG002|Overall Study|Death|0|||
164377410|NCT02247349|593754239|FG003|Overall Study|Death|1|||
164377411|NCT02247349|593754240|FG004|Overall Study|Death|0|||
164377412|NCT02247349|593754241|FG005|Overall Study|Death|0|||
164377413|NCT02247349|593754236|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
164377414|NCT02247349|593754237|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
164377415|NCT02247349|593754238|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
164377416|NCT02247349|593754239|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
164377417|NCT02247349|593754240|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
164377418|NCT02247349|593754241|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
164377419|NCT02247349|593754236|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164377420|NCT02247349|593754237|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164377421|NCT02247349|593754238|FG002|Overall Study|Participant request to discontinue study treatment|1|||
164377422|NCT02247349|593754239|FG003|Overall Study|Participant request to discontinue study treatment|2|||
164377423|NCT02247349|593754240|FG004|Overall Study|Participant request to discontinue study treatment|1|||
164377424|NCT02247349|593754241|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164377425|NCT02247349|593754236|FG000|Overall Study|Withdrawal by Subject|0|||
164377426|NCT02247349|593754237|FG001|Overall Study|Withdrawal by Subject|1|||
164377427|NCT02247349|593754238|FG002|Overall Study|Withdrawal by Subject|0|||
164377428|NCT02247349|593754239|FG003|Overall Study|Withdrawal by Subject|0|||
164377429|NCT02247349|593754240|FG004|Overall Study|Withdrawal by Subject|0|||
164377430|NCT02247349|593754241|FG005|Overall Study|Withdrawal by Subject|0|||
164377431|NCT02247349|593754236|FG000|Overall Study|Administrative reason by sponsor|0|||
164377432|NCT02247349|593754237|FG001|Overall Study|Administrative reason by sponsor|0|||
164377433|NCT02247349|593754238|FG002|Overall Study|Administrative reason by sponsor|0|||
164377434|NCT02247349|593754239|FG003|Overall Study|Administrative reason by sponsor|0|||
164377435|NCT02247349|593754240|FG004|Overall Study|Administrative reason by sponsor|1|||
164377436|NCT02247349|593754241|FG005|Overall Study|Administrative reason by sponsor|0|||
164377437|NCT02247349|593754236|FG000|Overall Study|Other reasons|0|||
164377438|NCT02247349|593754237|FG001|Overall Study|Other reasons|0|||
164377439|NCT02247349|593754238|FG002|Overall Study|Other reasons|1|||
164377440|NCT02247349|593754239|FG003|Overall Study|Other reasons|0|||
164377441|NCT02247349|593754240|FG004|Overall Study|Other reasons|0|||
164377442|NCT02247349|593754241|FG005|Overall Study|Other reasons|0|||
164377443|NCT00617240|593754243|FG000|Overall Study|Lack of Efficacy|1|||
164377444|NCT00617240|593754244|FG001|Overall Study|Lack of Efficacy|0|||
164377445|NCT01611259|593754245|FG000|Overall Study|Physician Decision|1|||
164377446|NCT01611259|593754245|FG000|Overall Study|Lack of Efficacy|2|||
164377447|NCT01611259|593754245|FG000|Overall Study|Adverse Event|4|||
164377448|NCT01611259|593754245|FG000|Overall Study|Withdrawal by Subject|7|||
164377449|NCT00382733|593754247|FG000|Overall Study|Withdrawal by Subject|0|||
164377450|NCT00382733|593754248|FG001|Overall Study|Withdrawal by Subject|1|||
164377451|NCT00382733|593754249|FG002|Overall Study|Withdrawal by Subject|0|||
164377452|NCT00382733|593754250|FG003|Overall Study|Withdrawal by Subject|0|||
164377453|NCT00382733|593754251|FG004|Overall Study|Withdrawal by Subject|0|||
164377454|NCT03075644|593754254|FG000|Overall Study|Withdrawal by Subject|1|||
164377455|NCT03075644|593754255|FG001|Overall Study|Withdrawal by Subject|1|||
164377456|NCT04292730|593754270|FG000|Overall Study|Lost to Follow-up|8|||
164377457|NCT04292730|593754271|FG001|Overall Study|Lost to Follow-up|12|||
164377458|NCT04292730|593754272|FG002|Overall Study|Lost to Follow-up|12|||
164377459|NCT04292730|593754273|FG003|Overall Study|Lost to Follow-up|48|||
164377460|NCT04292730|593754270|FG000|Overall Study|Death|2|||
164377461|NCT04292730|593754271|FG001|Overall Study|Death|2|||
163902638|NCT01619059|592014717|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
163902639|NCT01619059|592014718|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
163902640|NCT01619059|592014717|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
163902641|NCT01619059|592014718|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
164377462|NCT04292730|593754272|FG002|Overall Study|Death|4|||
164377463|NCT04292730|593754273|FG003|Overall Study|Death|12|||
164377464|NCT04292730|593754270|FG000|Overall Study|Withdrew Consent|2|||
164377465|NCT04292730|593754271|FG001|Overall Study|Withdrew Consent|2|||
164377466|NCT04292730|593754272|FG002|Overall Study|Withdrew Consent|5|||
164377467|NCT04292730|593754273|FG003|Overall Study|Withdrew Consent|6|||
164377468|NCT04292730|593754270|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164377469|NCT04292730|593754271|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164377470|NCT04292730|593754272|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164377471|NCT04292730|593754273|FG003|Overall Study|Non-Compliance with Study Drug|0|||
164377472|NCT04292730|593754270|FG000|Overall Study|Protocol Violation|0|||
164377473|NCT04292730|593754271|FG001|Overall Study|Protocol Violation|0|||
164377474|NCT04292730|593754272|FG002|Overall Study|Protocol Violation|1|||
164377475|NCT04292730|593754273|FG003|Overall Study|Protocol Violation|0|||
164377476|NCT04292730|593754270|FG000|Overall Study|Randomized but not Treated|8|||
164012799|NCT00479466|592410590|FG001|Overall Study|Hyperglycemia|0|||
164377477|NCT04292730|593754271|FG001|Overall Study|Randomized but not Treated|4|||
164377478|NCT04292730|593754272|FG002|Overall Study|Randomized but not Treated|0|||
164377479|NCT04292730|593754273|FG003|Overall Study|Randomized but not Treated|14|||
164377480|NCT01527292|593754274|FG000|Overall Study|Physician Decision|0|||
164377481|NCT01527292|593754275|FG001|Overall Study|Physician Decision|3|||
164377482|NCT00314366|593754278|FG000|Overall Study|not treated due to patient medical condi|1|||
164377483|NCT00314366|593754279|FG001|Overall Study|not treated due to patient medical condi|0|||
164377484|NCT01482767|593754280|FG000|Overall Study|Death|1|||
164377485|NCT01482767|593754281|FG001|Overall Study|Death|1|||
164377486|NCT01482767|593754280|FG000|Overall Study|Withdrawal by Subject|7|||
164377487|NCT01482767|593754281|FG001|Overall Study|Withdrawal by Subject|5|||
164377488|NCT01482767|593754280|FG000|Overall Study|Lost to Follow-up|12|||
164377489|NCT01482767|593754281|FG001|Overall Study|Lost to Follow-up|6|||
163902642|NCT01619059|592014717|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
163902643|NCT01619059|592014718|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
163902644|NCT01619059|592014717|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
163902645|NCT01619059|592014718|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
163902646|NCT01619059|592014717|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
163902647|NCT01619059|592014718|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
163902648|NCT01619059|592014717|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
164377490|NCT01482767|593754280|FG000|Overall Study|Adverse Event|0|||
164377491|NCT01482767|593754281|FG001|Overall Study|Adverse Event|3|||
164377492|NCT01482767|593754280|FG000|Overall Study|Site closure|22|||
164377493|NCT01482767|593754281|FG001|Overall Study|Site closure|14|||
164377494|NCT01482767|593754280|FG000|Overall Study|Non-adherence to study requirements|4|||
164377495|NCT01482767|593754281|FG001|Overall Study|Non-adherence to study requirements|7|||
164377496|NCT01482767|593754280|FG000|Overall Study|Alternate HCV treatment|7|||
164377497|NCT01482767|593754281|FG001|Overall Study|Alternate HCV treatment|8|||
164377498|NCT01482767|593754280|FG000|Overall Study|Ineligible|0|||
164377499|NCT01482767|593754281|FG001|Overall Study|Ineligible|5|||
163902649|NCT01619059|592014718|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
163902650|NCT01619059|592014717|FG000|Long-Term (LT) Treatment Period|Death|1|||
163902651|NCT01619059|592014718|FG001|Long-Term (LT) Treatment Period|Death|0|||
163902652|NCT01619059|592014717|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
163902653|NCT01619059|592014718|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
163902654|NCT01619059|592014717|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
163902655|NCT01619059|592014718|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
163902656|NCT04949542|592014721|FG000|Overall Study|Lost to Follow-up|4|||
163902657|NCT04949542|592014722|FG001|Overall Study|Lost to Follow-up|1|||
163902658|NCT03021993|592014724|FG000|Overall Study|Withdrawal by Subject|4|||
163902659|NCT03021993|592014724|FG000|Overall Study|Physician Decision|1|||
163902660|NCT03021993|592014724|FG000|Overall Study|enrolled but were not treated|1|||
163902661|NCT03021993|592014724|FG000|Overall Study|Death|3|||
163902662|NCT02101775|592014726|FG000|Overall Study|Adverse Event|4|||
163902663|NCT02101775|592014727|FG001|Overall Study|Adverse Event|0|||
163902664|NCT02101775|592014728|FG002|Overall Study|Adverse Event|0|||
163902665|NCT02101775|592014726|FG000|Overall Study|Admission to Hospital|0|||
163902666|NCT02101775|592014727|FG001|Overall Study|Admission to Hospital|1|||
163902667|NCT02101775|592014728|FG002|Overall Study|Admission to Hospital|0|||
163902668|NCT03170648|592014736|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
163902669|NCT03170648|592014736|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
163902670|NCT02499328|592014742|FG000|Overall Study|Withdrawal by Subject|1|||
163902671|NCT02499328|592014743|FG001|Overall Study|Withdrawal by Subject|1|||
163902672|NCT02499328|592014744|FG002|Overall Study|Withdrawal by Subject|5|||
163902673|NCT02499328|592014745|FG003|Overall Study|Withdrawal by Subject|3|||
163902674|NCT02499328|592014746|FG004|Overall Study|Withdrawal by Subject|5|||
163902675|NCT02499328|592014747|FG005|Overall Study|Withdrawal by Subject|0|||
163902676|NCT02499328|592014748|FG006|Overall Study|Withdrawal by Subject|0|||
163902677|NCT02499328|592014749|FG007|Overall Study|Withdrawal by Subject|0|||
163902678|NCT02499328|592014750|FG008|Overall Study|Withdrawal by Subject|2|||
164377500|NCT01482767|593754280|FG000|Overall Study|Nurse error|1|||
164377501|NCT01482767|593754281|FG001|Overall Study|Nurse error|0|||
164377502|NCT03400033|593754291|FG000|Overall Study|Withdrawal by Subject|1|||
164377503|NCT03400033|593754292|FG001|Overall Study|Withdrawal by Subject|2|||
164377504|NCT01247090|593754295|FG000|Overall Study|Physician Decision|1|||
164012800|NCT00479466|592410591|FG002|Overall Study|Hyperglycemia|0|||
164012801|NCT00479466|592410592|FG003|Overall Study|Hyperglycemia|0|||
164012802|NCT00479466|592410593|FG004|Overall Study|Hyperglycemia|0|||
164377505|NCT01247090|593754296|FG001|Overall Study|Physician Decision|0|||
164377506|NCT01247090|593754297|FG002|Overall Study|Physician Decision|0|||
164012803|NCT00479466|592410594|FG005|Overall Study|Hyperglycemia|1|||
164377507|NCT01247090|593754295|FG000|Overall Study|Withdrawal by Subject|0|||
164377508|NCT01247090|593754296|FG001|Overall Study|Withdrawal by Subject|1|||
163902679|NCT02499328|592014751|FG009|Overall Study|Withdrawal by Subject|2|||
163902680|NCT02499328|592014752|FG010|Overall Study|Withdrawal by Subject|0|||
164012804|NCT00479466|592410589|FG000|Overall Study|Lack of Efficacy|2|||
164012805|NCT00479466|592410590|FG001|Overall Study|Lack of Efficacy|0|||
164377509|NCT01247090|593754297|FG002|Overall Study|Withdrawal by Subject|0|||
164377510|NCT00006916|593754299|FG000|Overall Study|Device not inserted|4|||
164377511|NCT00006916|593754299|FG000|Overall Study|Complication of device insertion|1|||
164377512|NCT02457325|593754304|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
164377513|NCT02457325|593754305|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
164377514|NCT01541930|593754310|FG000|Overall Study|Withdrawal by Subject|1|||
164377515|NCT03385239|593754311|FG000|Overall Study|Voluntary Withdrawal|2|||
164377516|NCT03385239|593754312|FG001|Overall Study|Voluntary Withdrawal|3|||
164377517|NCT03385239|593754313|FG002|Overall Study|Voluntary Withdrawal|2|||
164377518|NCT03385239|593754314|FG003|Overall Study|Voluntary Withdrawal|3|||
164377519|NCT03385239|593754315|FG004|Overall Study|Voluntary Withdrawal|0|||
164377520|NCT03385239|593754311|FG000|Overall Study|Adverse Event|0|||
164377521|NCT03385239|593754312|FG001|Overall Study|Adverse Event|0|||
164377522|NCT03385239|593754313|FG002|Overall Study|Adverse Event|1|||
164377523|NCT03385239|593754314|FG003|Overall Study|Adverse Event|0|||
164377524|NCT03385239|593754315|FG004|Overall Study|Adverse Event|0|||
164377525|NCT03385239|593754311|FG000|Overall Study|Other|0|||
164377526|NCT03385239|593754312|FG001|Overall Study|Other|0|||
164377527|NCT03385239|593754313|FG002|Overall Study|Other|0|||
164377528|NCT03385239|593754314|FG003|Overall Study|Other|1|||
164377529|NCT03385239|593754315|FG004|Overall Study|Other|0|||
164377530|NCT01574703|593754316|FG000|Overall Study|Adverse Event|0|||
164377531|NCT01574703|593754317|FG001|Overall Study|Adverse Event|2|||
164377532|NCT01574703|593754318|FG002|Overall Study|Adverse Event|1|||
164377533|NCT01574703|593754319|FG003|Overall Study|Adverse Event|1|||
164377534|NCT01574703|593754316|FG000|Overall Study|Protocol Violation|0|||
164377535|NCT01574703|593754317|FG001|Overall Study|Protocol Violation|0|||
164377536|NCT01574703|593754318|FG002|Overall Study|Protocol Violation|0|||
164377537|NCT01574703|593754319|FG003|Overall Study|Protocol Violation|1|||
164377538|NCT01574703|593754316|FG000|Overall Study|Unspecified Reason|27|||
164377539|NCT01574703|593754317|FG001|Overall Study|Unspecified Reason|15|||
164377540|NCT01574703|593754318|FG002|Overall Study|Unspecified Reason|20|||
164377541|NCT01574703|593754319|FG003|Overall Study|Unspecified Reason|16|||
164377542|NCT01574703|593754316|FG000|Overall Study|Withdrawal by Subject|53|||
164377543|NCT01574703|593754317|FG001|Overall Study|Withdrawal by Subject|52|||
164377544|NCT01574703|593754318|FG002|Overall Study|Withdrawal by Subject|36|||
164377545|NCT01574703|593754319|FG003|Overall Study|Withdrawal by Subject|61|||
164377546|NCT01574703|593754316|FG000|Overall Study|Met Withdrawal Criteria|0|||
164377547|NCT01574703|593754317|FG001|Overall Study|Met Withdrawal Criteria|1|||
164377548|NCT01574703|593754318|FG002|Overall Study|Met Withdrawal Criteria|1|||
164377549|NCT01574703|593754319|FG003|Overall Study|Met Withdrawal Criteria|0|||
164377550|NCT01574703|593754316|FG000|Overall Study|Lost to Follow-up|43|||
164377551|NCT01574703|593754317|FG001|Overall Study|Lost to Follow-up|41|||
164377552|NCT01574703|593754318|FG002|Overall Study|Lost to Follow-up|46|||
164377553|NCT01574703|593754319|FG003|Overall Study|Lost to Follow-up|35|||
164377554|NCT01574703|593754316|FG000|Overall Study|Death|2|||
164377555|NCT01574703|593754317|FG001|Overall Study|Death|1|||
164377556|NCT01574703|593754318|FG002|Overall Study|Death|1|||
164377557|NCT01574703|593754319|FG003|Overall Study|Death|0|||
164377558|NCT02751983|593754324|FG000|Treatment|Stopped ACT, but Remained in study|2|||
164377559|NCT02751983|593754325|FG001|Treatment|Stopped ACT, but Remained in study|0|||
164377560|NCT02751983|593754324|FG000|Treatment|Discharged prior to beginning ACT|2|||
164377561|NCT02751983|593754325|FG001|Treatment|Discharged prior to beginning ACT|0|||
164377562|NCT02751983|593754324|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
164377563|NCT02751983|593754325|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
164377564|NCT02751983|593754324|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
164377565|NCT02751983|593754325|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
164377566|NCT02751983|593754324|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
164377567|NCT02751983|593754325|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
164377568|NCT02167256|593754326|FG000|Overall Study|Adverse Event|13|||
164377569|NCT02167256|593754327|FG001|Overall Study|Adverse Event|6|||
164377570|NCT02167256|593754326|FG000|Overall Study|Withdrawal by Subject|4|||
164377571|NCT02167256|593754327|FG001|Overall Study|Withdrawal by Subject|4|||
164377572|NCT02167256|593754326|FG000|Overall Study|non-compliance|3|||
164377573|NCT02167256|593754327|FG001|Overall Study|non-compliance|0|||
164377574|NCT02167256|593754326|FG000|Overall Study|Study partner unable to participate|1|||
164377575|NCT02167256|593754327|FG001|Overall Study|Study partner unable to participate|0|||
164377576|NCT03467425|593754328|FG000|Overall Study|Adverse Event|9|||
164377577|NCT03467425|593754329|FG001|Overall Study|Adverse Event|9|||
164377578|NCT03467425|593754328|FG000|Overall Study|Lack of Efficacy|3|||
164377579|NCT03467425|593754329|FG001|Overall Study|Lack of Efficacy|1|||
164377580|NCT03467425|593754328|FG000|Overall Study|Protocol Violation|0|||
164377581|NCT03467425|593754329|FG001|Overall Study|Protocol Violation|1|||
164377582|NCT03467425|593754328|FG000|Overall Study|Lost to Follow-up|18|||
164377583|NCT03467425|593754329|FG001|Overall Study|Lost to Follow-up|25|||
164377584|NCT03467425|593754328|FG000|Overall Study|Physician Decision|2|||
164377585|NCT03467425|593754329|FG001|Overall Study|Physician Decision|1|||
164377586|NCT03467425|593754328|FG000|Overall Study|Withdrawal by Subject|15|||
163902681|NCT02499328|592014753|FG011|Overall Study|Withdrawal by Subject|3|||
163902682|NCT02499328|592014754|FG012|Overall Study|Withdrawal by Subject|7|||
163902683|NCT02499328|592014755|FG013|Overall Study|Withdrawal by Subject|3|||
163902684|NCT02499328|592014756|FG014|Overall Study|Withdrawal by Subject|1|||
163902685|NCT02499328|592014757|FG015|Overall Study|Withdrawal by Subject|0|||
163902686|NCT02499328|592014758|FG016|Overall Study|Withdrawal by Subject|0|||
163902687|NCT02499328|592014759|FG017|Overall Study|Withdrawal by Subject|3|||
163902688|NCT02499328|592014760|FG018|Overall Study|Withdrawal by Subject|0|||
163902689|NCT02499328|592014742|FG000|Overall Study|Lost to Follow-up|0|||
163902690|NCT02499328|592014743|FG001|Overall Study|Lost to Follow-up|1|||
163902691|NCT02499328|592014744|FG002|Overall Study|Lost to Follow-up|1|||
163902692|NCT02499328|592014745|FG003|Overall Study|Lost to Follow-up|2|||
163902693|NCT02499328|592014746|FG004|Overall Study|Lost to Follow-up|0|||
163902694|NCT02499328|592014747|FG005|Overall Study|Lost to Follow-up|0|||
163902695|NCT02499328|592014748|FG006|Overall Study|Lost to Follow-up|0|||
163902696|NCT02499328|592014749|FG007|Overall Study|Lost to Follow-up|2|||
163902697|NCT02499328|592014750|FG008|Overall Study|Lost to Follow-up|3|||
163902698|NCT02499328|592014751|FG009|Overall Study|Lost to Follow-up|0|||
163902699|NCT02499328|592014752|FG010|Overall Study|Lost to Follow-up|0|||
163902700|NCT02499328|592014753|FG011|Overall Study|Lost to Follow-up|0|||
163902701|NCT02499328|592014754|FG012|Overall Study|Lost to Follow-up|0|||
163902702|NCT02499328|592014755|FG013|Overall Study|Lost to Follow-up|0|||
163902703|NCT02499328|592014756|FG014|Overall Study|Lost to Follow-up|0|||
163902704|NCT02499328|592014757|FG015|Overall Study|Lost to Follow-up|0|||
163902705|NCT02499328|592014758|FG016|Overall Study|Lost to Follow-up|0|||
163902706|NCT02499328|592014759|FG017|Overall Study|Lost to Follow-up|0|||
163902707|NCT02499328|592014760|FG018|Overall Study|Lost to Follow-up|1|||
163902708|NCT02499328|592014742|FG000|Overall Study|Death|0|||
163902709|NCT02499328|592014743|FG001|Overall Study|Death|3|||
163902710|NCT02499328|592014744|FG002|Overall Study|Death|3|||
163902711|NCT02499328|592014745|FG003|Overall Study|Death|2|||
163902712|NCT02499328|592014746|FG004|Overall Study|Death|4|||
164012806|NCT00479466|592410591|FG002|Overall Study|Lack of Efficacy|1|||
164012807|NCT00479466|592410592|FG003|Overall Study|Lack of Efficacy|0|||
164012808|NCT00479466|592410593|FG004|Overall Study|Lack of Efficacy|0|||
164012809|NCT00479466|592410594|FG005|Overall Study|Lack of Efficacy|0|||
164012810|NCT00479466|592410589|FG000|Overall Study|Lost to Follow-up|0|||
164012811|NCT00479466|592410590|FG001|Overall Study|Lost to Follow-up|1|||
164012812|NCT00479466|592410591|FG002|Overall Study|Lost to Follow-up|1|||
164012813|NCT00479466|592410592|FG003|Overall Study|Lost to Follow-up|0|||
164012814|NCT00479466|592410593|FG004|Overall Study|Lost to Follow-up|2|||
164012815|NCT00479466|592410594|FG005|Overall Study|Lost to Follow-up|2|||
164012816|NCT00479466|592410589|FG000|Overall Study|Physician Decision|2|||
164377587|NCT03467425|593754329|FG001|Overall Study|Withdrawal by Subject|17|||
164377588|NCT00025883|593754330|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
164377589|NCT00025883|593754330|FG000|Overall Study|no baseline data|1|||
164377590|NCT00025883|593754330|FG000|Overall Study|Death|1|||
164377591|NCT00025883|593754330|FG000|Overall Study|Adverse Event|1|||
164377592|NCT00025883|593754330|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
164377593|NCT02920983|593754331|FG000|Dispense 1|Unacceptable Lens Fit|0|||
164377594|NCT02920983|593754332|FG001|Dispense 1|Unacceptable Lens Fit|0|||
164377595|NCT02920983|593754333|FG002|Dispense 1|Unacceptable Lens Fit|0|||
164377596|NCT02920983|593754334|FG003|Dispense 1|Unacceptable Lens Fit|0|||
164377597|NCT02920983|593754335|FG004|Dispense 1|Unacceptable Lens Fit|1|||
164377598|NCT02920983|593754336|FG005|Dispense 1|Unacceptable Lens Fit|0|||
164377599|NCT02920983|593754331|FG000|Dispense 2|Unscceptable lens fit|1|||
164377600|NCT02920983|593754332|FG001|Dispense 2|Unscceptable lens fit|0|||
164377601|NCT02920983|593754333|FG002|Dispense 2|Unscceptable lens fit|0|||
164377602|NCT02920983|593754334|FG003|Dispense 2|Unscceptable lens fit|0|||
164377603|NCT02920983|593754335|FG004|Dispense 2|Unscceptable lens fit|1|||
164012817|NCT00479466|592410590|FG001|Overall Study|Physician Decision|1|||
164377604|NCT02920983|593754336|FG005|Dispense 2|Unscceptable lens fit|0|||
164377605|NCT02920983|593754331|FG000|Dispense 3|Unacceptable Lens Fit|1|||
163902713|NCT02499328|592014747|FG005|Overall Study|Death|7|||
163902714|NCT02499328|592014748|FG006|Overall Study|Death|3|||
163902715|NCT02499328|592014749|FG007|Overall Study|Death|0|||
163902716|NCT02499328|592014750|FG008|Overall Study|Death|2|||
163902717|NCT02499328|592014751|FG009|Overall Study|Death|6|||
163902718|NCT02499328|592014752|FG010|Overall Study|Death|6|||
163902719|NCT02499328|592014753|FG011|Overall Study|Death|20|||
163902720|NCT02499328|592014754|FG012|Overall Study|Death|9|||
163902721|NCT02499328|592014755|FG013|Overall Study|Death|7|||
164012818|NCT00479466|592410591|FG002|Overall Study|Physician Decision|1|||
164377606|NCT02920983|593754332|FG001|Dispense 3|Unacceptable Lens Fit|1|||
164377607|NCT02920983|593754333|FG002|Dispense 3|Unacceptable Lens Fit|0|||
164377608|NCT02920983|593754334|FG003|Dispense 3|Unacceptable Lens Fit|0|||
163902722|NCT02499328|592014756|FG014|Overall Study|Death|3|||
163902723|NCT02499328|592014757|FG015|Overall Study|Death|1|||
163902724|NCT02499328|592014758|FG016|Overall Study|Death|1|||
164012819|NCT00479466|592410592|FG003|Overall Study|Physician Decision|0|||
164377609|NCT02920983|593754335|FG004|Dispense 3|Unacceptable Lens Fit|1|||
164092829|NCT00679367|592702153|FG000|Overall Study|inability to swallow oral drugs|1|||
164377610|NCT02920983|593754336|FG005|Dispense 3|Unacceptable Lens Fit|0|||
164377611|NCT01451424|593754337|FG000|Overall Study|Withdrawal by Subject|1|||
164377612|NCT01451424|593754338|FG001|Overall Study|Withdrawal by Subject|1|||
164377613|NCT01451424|593754339|FG002|Overall Study|Withdrawal by Subject|0|||
164377614|NCT01451424|593754340|FG003|Overall Study|Withdrawal by Subject|2|||
164377615|NCT01451424|593754337|FG000|Overall Study|Lost to Follow-up|0|||
164377616|NCT01451424|593754338|FG001|Overall Study|Lost to Follow-up|1|||
164377617|NCT01451424|593754339|FG002|Overall Study|Lost to Follow-up|0|||
164377618|NCT01451424|593754340|FG003|Overall Study|Lost to Follow-up|1|||
164377619|NCT01451424|593754337|FG000|Overall Study|Physician Decision|0|||
164377620|NCT01451424|593754338|FG001|Overall Study|Physician Decision|0|||
164377621|NCT01451424|593754339|FG002|Overall Study|Physician Decision|1|||
164377622|NCT01451424|593754340|FG003|Overall Study|Physician Decision|1|||
164377623|NCT01451424|593754337|FG000|Overall Study|Adverse Event|0|||
164377624|NCT01451424|593754338|FG001|Overall Study|Adverse Event|0|||
164377625|NCT01451424|593754339|FG002|Overall Study|Adverse Event|0|||
164377626|NCT01451424|593754340|FG003|Overall Study|Adverse Event|1|||
164377627|NCT01387607|593754346|FG000|Overall Study|Adverse Event|23|||
164377628|NCT01387607|593754347|FG001|Overall Study|Adverse Event|11|||
164377629|NCT01387607|593754346|FG000|Overall Study|Lack of Efficacy|8|||
164377630|NCT01387607|593754347|FG001|Overall Study|Lack of Efficacy|6|||
164377631|NCT01387607|593754346|FG000|Overall Study|Lost to Follow-up|2|||
164377632|NCT01387607|593754347|FG001|Overall Study|Lost to Follow-up|1|||
164377633|NCT01387607|593754346|FG000|Overall Study|No longer meets eligibility criteria|0|||
164377634|NCT01387607|593754347|FG001|Overall Study|No longer meets eligibility criteria|1|||
164377635|NCT01387607|593754346|FG000|Overall Study|Protocol Violation|1|||
164377636|NCT01387607|593754347|FG001|Overall Study|Protocol Violation|5|||
164377637|NCT01387607|593754346|FG000|Overall Study|Withdrawal by Subject|13|||
164377638|NCT01387607|593754347|FG001|Overall Study|Withdrawal by Subject|14|||
164377639|NCT01387607|593754346|FG000|Overall Study|Other|1|||
164377640|NCT01387607|593754347|FG001|Overall Study|Other|1|||
164377641|NCT01387607|593754346|FG000|Overall Study|Randomized, not treated|3|||
164377642|NCT01387607|593754347|FG001|Overall Study|Randomized, not treated|6|||
164377643|NCT02553421|593754349|FG000|Overall Study|Lost to Follow-up|21|||
164377644|NCT02553421|593754350|FG001|Overall Study|Lost to Follow-up|1|||
164377645|NCT02553421|593754349|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
164377646|NCT02553421|593754350|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
164377647|NCT02553421|593754349|FG000|Overall Study|Improper Device Placement|3|||
164377648|NCT02553421|593754350|FG001|Overall Study|Improper Device Placement|0|||
164377649|NCT03665038|593754353|FG000|Overall Study|Lost to Follow-up|0|||
164377650|NCT03665038|593754354|FG001|Overall Study|Lost to Follow-up|0|||
164377651|NCT03665038|593754355|FG002|Overall Study|Lost to Follow-up|1|||
164377652|NCT03013491|593754356|FG000|Main Study|Death|2|||
164377653|NCT03013491|593754357|FG001|Main Study|Death|2|||
164377654|NCT03013491|593754358|FG002|Main Study|Death|5|||
164377655|NCT03013491|593754359|FG003|Main Study|Death|3|||
164377656|NCT03013491|593754360|FG004|Main Study|Death|9|||
164377657|NCT03013491|593754361|FG005|Main Study|Death|12|||
164377658|NCT03013491|593754362|FG006|Main Study|Death|3|||
164377659|NCT03013491|593754363|FG007|Main Study|Death|5|||
164377660|NCT03013491|593754364|FG008|Main Study|Death|1|||
164092830|NCT00679367|592702153|FG000|Overall Study|Lack of Efficacy|3|||
164377661|NCT03013491|593754365|FG009|Main Study|Death|2|||
164092831|NCT00679367|592702153|FG000|Overall Study|Withdrawal by Subject|1|||
164092832|NCT01611090|592702154|FG000|Randomized Period|Lost to Follow-up|8|||
164092833|NCT01611090|592702155|FG001|Randomized Period|Lost to Follow-up|3|||
164377662|NCT03013491|593754366|FG010|Main Study|Death|4|||
164377663|NCT03013491|593754367|FG011|Main Study|Death|1|||
164377664|NCT03013491|593754368|FG012|Main Study|Death|1|||
164377665|NCT03013491|593754369|FG013|Main Study|Death|4|||
164377666|NCT03013491|593754370|FG014|Main Study|Death|0|||
164377667|NCT03013491|593754371|FG015|Main Study|Death|3|||
164377668|NCT03013491|593754372|FG016|Main Study|Death|5|||
164377669|NCT03013491|593754373|FG017|Main Study|Death|1|||
164377670|NCT03013491|593754374|FG018|Main Study|Death|47|||
164377671|NCT03013491|593754356|FG000|Main Study|Lost to Follow-up|0|||
164377672|NCT03013491|593754357|FG001|Main Study|Lost to Follow-up|0|||
164377673|NCT03013491|593754358|FG002|Main Study|Lost to Follow-up|1|||
164377674|NCT03013491|593754359|FG003|Main Study|Lost to Follow-up|0|||
164377675|NCT03013491|593754360|FG004|Main Study|Lost to Follow-up|1|||
164092834|NCT01611090|592702156|FG002|Randomized Period|Lost to Follow-up|0|||
164092835|NCT01611090|592702154|FG000|Randomized Period|Withdrawal by Subject|22|||
164377676|NCT03013491|593754361|FG005|Main Study|Lost to Follow-up|0|||
164092836|NCT01611090|592702155|FG001|Randomized Period|Withdrawal by Subject|26|||
164377677|NCT03013491|593754362|FG006|Main Study|Lost to Follow-up|0|||
164377678|NCT03013491|593754363|FG007|Main Study|Lost to Follow-up|0|||
164377679|NCT03013491|593754364|FG008|Main Study|Lost to Follow-up|0|||
164377680|NCT03013491|593754365|FG009|Main Study|Lost to Follow-up|0|||
164377681|NCT03013491|593754366|FG010|Main Study|Lost to Follow-up|0|||
164377682|NCT03013491|593754367|FG011|Main Study|Lost to Follow-up|0|||
164377683|NCT03013491|593754368|FG012|Main Study|Lost to Follow-up|0|||
164377684|NCT03013491|593754369|FG013|Main Study|Lost to Follow-up|0|||
164377685|NCT03013491|593754370|FG014|Main Study|Lost to Follow-up|0|||
164377686|NCT03013491|593754371|FG015|Main Study|Lost to Follow-up|0|||
164377687|NCT03013491|593754372|FG016|Main Study|Lost to Follow-up|0|||
163902725|NCT02499328|592014759|FG017|Overall Study|Death|16|||
163902726|NCT02499328|592014760|FG018|Overall Study|Death|5|||
163902727|NCT02499328|592014742|FG000|Overall Study|"Other"|2|||
164377688|NCT03013491|593754373|FG017|Main Study|Lost to Follow-up|0|||
164377689|NCT03013491|593754374|FG018|Main Study|Lost to Follow-up|3|||
164377690|NCT03013491|593754356|FG000|Main Study|Termination of the study by Sponsor|0|||
164377691|NCT03013491|593754357|FG001|Main Study|Termination of the study by Sponsor|0|||
164377692|NCT03013491|593754358|FG002|Main Study|Termination of the study by Sponsor|2|||
164377693|NCT03013491|593754359|FG003|Main Study|Termination of the study by Sponsor|0|||
164377694|NCT03013491|593754360|FG004|Main Study|Termination of the study by Sponsor|1|||
164377695|NCT03013491|593754361|FG005|Main Study|Termination of the study by Sponsor|2|||
164377696|NCT03013491|593754362|FG006|Main Study|Termination of the study by Sponsor|0|||
164377697|NCT03013491|593754363|FG007|Main Study|Termination of the study by Sponsor|0|||
164377698|NCT03013491|593754364|FG008|Main Study|Termination of the study by Sponsor|1|||
164377699|NCT03013491|593754365|FG009|Main Study|Termination of the study by Sponsor|1|||
164377700|NCT03013491|593754366|FG010|Main Study|Termination of the study by Sponsor|1|||
164377701|NCT03013491|593754367|FG011|Main Study|Termination of the study by Sponsor|2|||
164377702|NCT03013491|593754368|FG012|Main Study|Termination of the study by Sponsor|0|||
164377703|NCT03013491|593754369|FG013|Main Study|Termination of the study by Sponsor|0|||
164377704|NCT03013491|593754370|FG014|Main Study|Termination of the study by Sponsor|0|||
164377705|NCT03013491|593754371|FG015|Main Study|Termination of the study by Sponsor|0|||
164377706|NCT03013491|593754372|FG016|Main Study|Termination of the study by Sponsor|0|||
164377707|NCT03013491|593754373|FG017|Main Study|Termination of the study by Sponsor|1|||
164377708|NCT03013491|593754374|FG018|Main Study|Termination of the study by Sponsor|13|||
164377709|NCT03013491|593754356|FG000|Main Study|Withdrawal by Subject|0|||
164377710|NCT03013491|593754357|FG001|Main Study|Withdrawal by Subject|0|||
164377711|NCT03013491|593754358|FG002|Main Study|Withdrawal by Subject|0|||
164377712|NCT03013491|593754359|FG003|Main Study|Withdrawal by Subject|4|||
164377713|NCT03013491|593754360|FG004|Main Study|Withdrawal by Subject|2|||
164377714|NCT03013491|593754361|FG005|Main Study|Withdrawal by Subject|1|||
164377715|NCT03013491|593754362|FG006|Main Study|Withdrawal by Subject|0|||
164377716|NCT03013491|593754363|FG007|Main Study|Withdrawal by Subject|0|||
164377717|NCT03013491|593754364|FG008|Main Study|Withdrawal by Subject|0|||
164377718|NCT03013491|593754365|FG009|Main Study|Withdrawal by Subject|0|||
164377719|NCT03013491|593754366|FG010|Main Study|Withdrawal by Subject|1|||
164377720|NCT03013491|593754367|FG011|Main Study|Withdrawal by Subject|2|||
164377721|NCT03013491|593754368|FG012|Main Study|Withdrawal by Subject|0|||
164377722|NCT03013491|593754369|FG013|Main Study|Withdrawal by Subject|2|||
164377723|NCT03013491|593754370|FG014|Main Study|Withdrawal by Subject|0|||
164377724|NCT03013491|593754371|FG015|Main Study|Withdrawal by Subject|0|||
164377725|NCT03013491|593754372|FG016|Main Study|Withdrawal by Subject|0|||
164377726|NCT03013491|593754373|FG017|Main Study|Withdrawal by Subject|0|||
164377727|NCT03013491|593754374|FG018|Main Study|Withdrawal by Subject|18|||
164377728|NCT03013491|593754356|FG000|Main Study|Disease progression|0|||
164377729|NCT03013491|593754357|FG001|Main Study|Disease progression|0|||
164377730|NCT03013491|593754358|FG002|Main Study|Disease progression|0|||
164377731|NCT03013491|593754359|FG003|Main Study|Disease progression|1|||
164377732|NCT03013491|593754360|FG004|Main Study|Disease progression|0|||
164377733|NCT03013491|593754361|FG005|Main Study|Disease progression|0|||
164377734|NCT03013491|593754362|FG006|Main Study|Disease progression|0|||
164377735|NCT03013491|593754363|FG007|Main Study|Disease progression|0|||
164377736|NCT03013491|593754364|FG008|Main Study|Disease progression|1|||
164377737|NCT03013491|593754365|FG009|Main Study|Disease progression|0|||
164377738|NCT03013491|593754366|FG010|Main Study|Disease progression|1|||
164377739|NCT03013491|593754367|FG011|Main Study|Disease progression|0|||
164377740|NCT03013491|593754368|FG012|Main Study|Disease progression|0|||
164377741|NCT03013491|593754369|FG013|Main Study|Disease progression|0|||
164377742|NCT03013491|593754370|FG014|Main Study|Disease progression|0|||
164377743|NCT03013491|593754371|FG015|Main Study|Disease progression|0|||
164377744|NCT03013491|593754372|FG016|Main Study|Disease progression|0|||
164377745|NCT03013491|593754373|FG017|Main Study|Disease progression|0|||
164377746|NCT03013491|593754374|FG018|Main Study|Disease progression|4|||
164377747|NCT03013491|593754356|FG000|Main Study|Symptomatic deterioration|0|||
164377748|NCT03013491|593754357|FG001|Main Study|Symptomatic deterioration|0|||
164377749|NCT03013491|593754358|FG002|Main Study|Symptomatic deterioration|0|||
163902728|NCT02499328|592014743|FG001|Overall Study|"Other"|2|||
163902729|NCT02499328|592014744|FG002|Overall Study|"Other"|1|||
164377750|NCT03013491|593754359|FG003|Main Study|Symptomatic deterioration|0|||
164377751|NCT03013491|593754360|FG004|Main Study|Symptomatic deterioration|0|||
164377752|NCT03013491|593754361|FG005|Main Study|Symptomatic deterioration|1|||
164377753|NCT03013491|593754362|FG006|Main Study|Symptomatic deterioration|0|||
164377754|NCT03013491|593754363|FG007|Main Study|Symptomatic deterioration|0|||
164377755|NCT03013491|593754364|FG008|Main Study|Symptomatic deterioration|0|||
163902730|NCT02499328|592014745|FG003|Overall Study|"Other"|3|||
164012820|NCT00479466|592410593|FG004|Overall Study|Physician Decision|0|||
164012821|NCT00479466|592410594|FG005|Overall Study|Physician Decision|0|||
164012822|NCT00479466|592410589|FG000|Overall Study|Pregnancy|0|||
164012823|NCT00479466|592410590|FG001|Overall Study|Pregnancy|0|||
164012824|NCT00479466|592410591|FG002|Overall Study|Pregnancy|0|||
164012825|NCT00479466|592410592|FG003|Overall Study|Pregnancy|0|||
164377756|NCT03013491|593754365|FG009|Main Study|Symptomatic deterioration|0|||
164377757|NCT03013491|593754366|FG010|Main Study|Symptomatic deterioration|0|||
164377758|NCT03013491|593754367|FG011|Main Study|Symptomatic deterioration|0|||
164377759|NCT03013491|593754368|FG012|Main Study|Symptomatic deterioration|0|||
164377760|NCT03013491|593754369|FG013|Main Study|Symptomatic deterioration|0|||
164377761|NCT03013491|593754370|FG014|Main Study|Symptomatic deterioration|0|||
164377762|NCT03013491|593754371|FG015|Main Study|Symptomatic deterioration|0|||
164377763|NCT03013491|593754372|FG016|Main Study|Symptomatic deterioration|0|||
164377764|NCT03013491|593754373|FG017|Main Study|Symptomatic deterioration|0|||
164377765|NCT03013491|593754374|FG018|Main Study|Symptomatic deterioration|0|||
164377766|NCT03013491|593754356|FG000|Main Study|Protocol version 8.0 approval|0|||
164377767|NCT03013491|593754357|FG001|Main Study|Protocol version 8.0 approval|0|||
164377768|NCT03013491|593754358|FG002|Main Study|Protocol version 8.0 approval|0|||
164377769|NCT03013491|593754359|FG003|Main Study|Protocol version 8.0 approval|0|||
164377770|NCT03013491|593754360|FG004|Main Study|Protocol version 8.0 approval|0|||
164377771|NCT03013491|593754361|FG005|Main Study|Protocol version 8.0 approval|0|||
164377772|NCT03013491|593754362|FG006|Main Study|Protocol version 8.0 approval|0|||
164377773|NCT03013491|593754363|FG007|Main Study|Protocol version 8.0 approval|0|||
164377774|NCT03013491|593754364|FG008|Main Study|Protocol version 8.0 approval|0|||
164377775|NCT03013491|593754365|FG009|Main Study|Protocol version 8.0 approval|0|||
164377776|NCT03013491|593754366|FG010|Main Study|Protocol version 8.0 approval|1|||
164377777|NCT03013491|593754367|FG011|Main Study|Protocol version 8.0 approval|0|||
164377778|NCT03013491|593754368|FG012|Main Study|Protocol version 8.0 approval|0|||
164377779|NCT03013491|593754369|FG013|Main Study|Protocol version 8.0 approval|0|||
164377780|NCT03013491|593754370|FG014|Main Study|Protocol version 8.0 approval|0|||
164377781|NCT03013491|593754371|FG015|Main Study|Protocol version 8.0 approval|0|||
164377782|NCT03013491|593754372|FG016|Main Study|Protocol version 8.0 approval|0|||
164377783|NCT03013491|593754373|FG017|Main Study|Protocol version 8.0 approval|0|||
164377784|NCT03013491|593754374|FG018|Main Study|Protocol version 8.0 approval|0|||
164377785|NCT03013491|593754356|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
164377786|NCT03013491|593754357|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
164377787|NCT03013491|593754358|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
164377788|NCT03013491|593754359|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
164377789|NCT03013491|593754360|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
164377790|NCT03013491|593754361|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
164377791|NCT03013491|593754362|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
164012826|NCT00479466|592410593|FG004|Overall Study|Pregnancy|1|||
164377792|NCT03013491|593754363|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
164377793|NCT03013491|593754364|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
164377794|NCT03013491|593754365|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
164377795|NCT03013491|593754366|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
164012827|NCT00479466|592410594|FG005|Overall Study|Pregnancy|0|||
164012828|NCT00479466|592410589|FG000|Overall Study|Protocol Violation|1|||
164012829|NCT00479466|592410590|FG001|Overall Study|Protocol Violation|0|||
164012830|NCT00479466|592410591|FG002|Overall Study|Protocol Violation|0|||
164377796|NCT03013491|593754367|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
164377797|NCT03013491|593754368|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
164377798|NCT03013491|593754369|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
164377799|NCT03013491|593754370|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
164377800|NCT03013491|593754371|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
164377801|NCT03013491|593754372|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
164377802|NCT03013491|593754373|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
164377803|NCT03013491|593754374|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
164377804|NCT03013491|593754356|FG000|Main Study|Start of new anticancer therapy|0|||
164377805|NCT03013491|593754357|FG001|Main Study|Start of new anticancer therapy|0|||
164377806|NCT03013491|593754358|FG002|Main Study|Start of new anticancer therapy|0|||
164377807|NCT03013491|593754359|FG003|Main Study|Start of new anticancer therapy|0|||
164377808|NCT03013491|593754360|FG004|Main Study|Start of new anticancer therapy|0|||
164377809|NCT03013491|593754361|FG005|Main Study|Start of new anticancer therapy|0|||
164377810|NCT03013491|593754362|FG006|Main Study|Start of new anticancer therapy|0|||
164377811|NCT03013491|593754363|FG007|Main Study|Start of new anticancer therapy|0|||
164377812|NCT03013491|593754364|FG008|Main Study|Start of new anticancer therapy|0|||
164377813|NCT03013491|593754365|FG009|Main Study|Start of new anticancer therapy|0|||
164377814|NCT03013491|593754366|FG010|Main Study|Start of new anticancer therapy|0|||
164377815|NCT03013491|593754367|FG011|Main Study|Start of new anticancer therapy|0|||
164377816|NCT03013491|593754368|FG012|Main Study|Start of new anticancer therapy|0|||
164377817|NCT03013491|593754369|FG013|Main Study|Start of new anticancer therapy|0|||
163902731|NCT02499328|592014746|FG004|Overall Study|"Other"|6|||
163902732|NCT02499328|592014747|FG005|Overall Study|"Other"|2|||
164377818|NCT03013491|593754370|FG014|Main Study|Start of new anticancer therapy|0|||
164377819|NCT03013491|593754371|FG015|Main Study|Start of new anticancer therapy|0|||
164377820|NCT03013491|593754372|FG016|Main Study|Start of new anticancer therapy|0|||
164377821|NCT03013491|593754373|FG017|Main Study|Start of new anticancer therapy|0|||
164377822|NCT03013491|593754374|FG018|Main Study|Start of new anticancer therapy|2|||
164377823|NCT03013491|593754356|FG000|Long-term Extension|Disease progression|0|||
164377824|NCT03013491|593754357|FG001|Long-term Extension|Disease progression|0|||
164377825|NCT03013491|593754358|FG002|Long-term Extension|Disease progression|0|||
164377826|NCT03013491|593754359|FG003|Long-term Extension|Disease progression|1|||
164377827|NCT03013491|593754360|FG004|Long-term Extension|Disease progression|0|||
164377828|NCT03013491|593754361|FG005|Long-term Extension|Disease progression|0|||
164377829|NCT03013491|593754362|FG006|Long-term Extension|Disease progression|0|||
164377830|NCT03013491|593754363|FG007|Long-term Extension|Disease progression|0|||
164377831|NCT03013491|593754364|FG008|Long-term Extension|Disease progression|0|||
164377832|NCT03013491|593754365|FG009|Long-term Extension|Disease progression|0|||
164377833|NCT03013491|593754366|FG010|Long-term Extension|Disease progression|0|||
164377834|NCT03013491|593754367|FG011|Long-term Extension|Disease progression|0|||
164377835|NCT03013491|593754368|FG012|Long-term Extension|Disease progression|0|||
164377836|NCT03013491|593754369|FG013|Long-term Extension|Disease progression|0|||
164377837|NCT03013491|593754370|FG014|Long-term Extension|Disease progression|0|||
164377838|NCT03013491|593754371|FG015|Long-term Extension|Disease progression|0|||
164377839|NCT03013491|593754372|FG016|Long-term Extension|Disease progression|0|||
164377840|NCT03013491|593754373|FG017|Long-term Extension|Disease progression|0|||
164377841|NCT03013491|593754374|FG018|Long-term Extension|Disease progression|1|||
164377842|NCT03013491|593754356|FG000|Long-term Extension|Withdrawal by Subject|0|||
164377843|NCT03013491|593754357|FG001|Long-term Extension|Withdrawal by Subject|0|||
164377844|NCT03013491|593754358|FG002|Long-term Extension|Withdrawal by Subject|0|||
164377845|NCT03013491|593754359|FG003|Long-term Extension|Withdrawal by Subject|0|||
164377846|NCT03013491|593754360|FG004|Long-term Extension|Withdrawal by Subject|0|||
164377847|NCT03013491|593754361|FG005|Long-term Extension|Withdrawal by Subject|0|||
164377848|NCT03013491|593754362|FG006|Long-term Extension|Withdrawal by Subject|0|||
164377849|NCT03013491|593754363|FG007|Long-term Extension|Withdrawal by Subject|1|||
164377850|NCT03013491|593754364|FG008|Long-term Extension|Withdrawal by Subject|0|||
163902733|NCT02499328|592014748|FG006|Overall Study|"Other"|3|||
163902734|NCT02499328|592014749|FG007|Overall Study|"Other"|4|||
163902735|NCT02499328|592014750|FG008|Overall Study|"Other"|6|||
163902736|NCT02499328|592014751|FG009|Overall Study|"Other"|16|||
163902737|NCT02499328|592014752|FG010|Overall Study|"Other"|13|||
164377851|NCT03013491|593754365|FG009|Long-term Extension|Withdrawal by Subject|0|||
164377852|NCT03013491|593754366|FG010|Long-term Extension|Withdrawal by Subject|0|||
164377853|NCT03013491|593754367|FG011|Long-term Extension|Withdrawal by Subject|0|||
164377854|NCT03013491|593754368|FG012|Long-term Extension|Withdrawal by Subject|0|||
164377855|NCT03013491|593754369|FG013|Long-term Extension|Withdrawal by Subject|0|||
164377856|NCT03013491|593754370|FG014|Long-term Extension|Withdrawal by Subject|0|||
164377857|NCT03013491|593754371|FG015|Long-term Extension|Withdrawal by Subject|0|||
164377858|NCT03013491|593754372|FG016|Long-term Extension|Withdrawal by Subject|0|||
164377859|NCT03013491|593754373|FG017|Long-term Extension|Withdrawal by Subject|0|||
163902738|NCT02499328|592014753|FG011|Overall Study|"Other"|31|||
163902739|NCT02499328|592014754|FG012|Overall Study|"Other"|8|||
164377860|NCT03013491|593754374|FG018|Long-term Extension|Withdrawal by Subject|0|||
164377861|NCT03013491|593754356|FG000|Long-term Extension|Adverse Event|0|||
164377862|NCT03013491|593754357|FG001|Long-term Extension|Adverse Event|0|||
164377863|NCT03013491|593754358|FG002|Long-term Extension|Adverse Event|0|||
164377864|NCT03013491|593754359|FG003|Long-term Extension|Adverse Event|0|||
164377865|NCT03013491|593754360|FG004|Long-term Extension|Adverse Event|0|||
164377866|NCT03013491|593754361|FG005|Long-term Extension|Adverse Event|0|||
164377867|NCT03013491|593754362|FG006|Long-term Extension|Adverse Event|0|||
164377868|NCT03013491|593754363|FG007|Long-term Extension|Adverse Event|0|||
164377869|NCT03013491|593754364|FG008|Long-term Extension|Adverse Event|0|||
164377870|NCT03013491|593754365|FG009|Long-term Extension|Adverse Event|0|||
164377871|NCT03013491|593754366|FG010|Long-term Extension|Adverse Event|0|||
164377872|NCT03013491|593754367|FG011|Long-term Extension|Adverse Event|0|||
164377873|NCT03013491|593754368|FG012|Long-term Extension|Adverse Event|0|||
164377874|NCT03013491|593754369|FG013|Long-term Extension|Adverse Event|0|||
164377875|NCT03013491|593754370|FG014|Long-term Extension|Adverse Event|0|||
164377876|NCT03013491|593754371|FG015|Long-term Extension|Adverse Event|0|||
164377877|NCT03013491|593754372|FG016|Long-term Extension|Adverse Event|0|||
164377878|NCT03013491|593754373|FG017|Long-term Extension|Adverse Event|0|||
164377879|NCT03013491|593754374|FG018|Long-term Extension|Adverse Event|1|||
164377880|NCT03013491|593754356|FG000|Long-term Extension|Death|0|||
164377881|NCT03013491|593754357|FG001|Long-term Extension|Death|0|||
164377882|NCT03013491|593754358|FG002|Long-term Extension|Death|0|||
164377883|NCT03013491|593754359|FG003|Long-term Extension|Death|0|||
164377884|NCT03013491|593754360|FG004|Long-term Extension|Death|0|||
164377885|NCT03013491|593754361|FG005|Long-term Extension|Death|0|||
164377886|NCT03013491|593754362|FG006|Long-term Extension|Death|0|||
164377887|NCT03013491|593754363|FG007|Long-term Extension|Death|0|||
164377888|NCT03013491|593754364|FG008|Long-term Extension|Death|0|||
164377889|NCT03013491|593754365|FG009|Long-term Extension|Death|0|||
164377890|NCT03013491|593754366|FG010|Long-term Extension|Death|0|||
164377891|NCT03013491|593754367|FG011|Long-term Extension|Death|0|||
164377892|NCT03013491|593754368|FG012|Long-term Extension|Death|0|||
164377893|NCT03013491|593754369|FG013|Long-term Extension|Death|0|||
164377894|NCT03013491|593754370|FG014|Long-term Extension|Death|0|||
164377895|NCT03013491|593754371|FG015|Long-term Extension|Death|0|||
164377896|NCT03013491|593754372|FG016|Long-term Extension|Death|0|||
164012831|NCT00479466|592410592|FG003|Overall Study|Protocol Violation|0|||
164012832|NCT00479466|592410593|FG004|Overall Study|Protocol Violation|0|||
164012833|NCT00479466|592410594|FG005|Overall Study|Protocol Violation|0|||
164012834|NCT00479466|592410589|FG000|Overall Study|Withdrawal by Subject|3|||
164012835|NCT00479466|592410590|FG001|Overall Study|Withdrawal by Subject|5|||
164012836|NCT00479466|592410591|FG002|Overall Study|Withdrawal by Subject|0|||
164377897|NCT03013491|593754373|FG017|Long-term Extension|Death|0|||
164377898|NCT03013491|593754374|FG018|Long-term Extension|Death|1|||
164377899|NCT03890367|593754378|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164377900|NCT03890367|593754379|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164377901|NCT03890367|593754380|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164377902|NCT03890367|593754378|FG000|Overall Study|Protocol deviation|2|||
164377903|NCT03890367|593754379|FG001|Overall Study|Protocol deviation|2|||
164377904|NCT03890367|593754380|FG002|Overall Study|Protocol deviation|1|||
164377905|NCT03890367|593754378|FG000|Overall Study|Lost to Follow-up|1|||
164377906|NCT03890367|593754379|FG001|Overall Study|Lost to Follow-up|1|||
164377907|NCT03890367|593754380|FG002|Overall Study|Lost to Follow-up|0|||
164377908|NCT04524403|593756237|FG000|Overall Study|Withdrawal by Subject|10|||
164377909|NCT04524403|593756238|FG001|Overall Study|Withdrawal by Subject|3|||
164377910|NCT04524403|593756239|FG002|Overall Study|Withdrawal by Subject|8|||
164012837|NCT00479466|592410592|FG003|Overall Study|Withdrawal by Subject|2|||
164012838|NCT00479466|592410593|FG004|Overall Study|Withdrawal by Subject|3|||
164012839|NCT00479466|592410594|FG005|Overall Study|Withdrawal by Subject|1|||
164092837|NCT01611090|592702156|FG002|Randomized Period|Withdrawal by Subject|0|||
164092838|NCT01611090|592702154|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
164092839|NCT01611090|592702155|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
164092840|NCT01611090|592702156|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
164377911|NCT04524403|593756237|FG000|Overall Study|Lost to Follow-up|3|||
164377912|NCT04524403|593756238|FG001|Overall Study|Lost to Follow-up|4|||
164377913|NCT04524403|593756239|FG002|Overall Study|Lost to Follow-up|3|||
164377914|NCT04524403|593756237|FG000|Overall Study|Adverse Event|3|||
164012840|NCT00532883|592410606|FG000|Overall Study|Adverse Event|1|||
164012841|NCT00532883|592410607|FG001|Overall Study|Adverse Event|0|||
164092841|NCT01611090|592702154|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
164377915|NCT04524403|593756238|FG001|Overall Study|Adverse Event|1|||
164377916|NCT04524403|593756239|FG002|Overall Study|Adverse Event|4|||
164377917|NCT04524403|593756237|FG000|Overall Study|Non-compliant with study drug|1|||
164377918|NCT04524403|593756238|FG001|Overall Study|Non-compliant with study drug|2|||
164377919|NCT04524403|593756239|FG002|Overall Study|Non-compliant with study drug|3|||
164377920|NCT04524403|593756237|FG000|Overall Study|Moved|0|||
164377921|NCT04524403|593756238|FG001|Overall Study|Moved|1|||
164377922|NCT04524403|593756239|FG002|Overall Study|Moved|0|||
164377923|NCT00991302|593756240|FG000|Overall Study|Death|0|||
164377924|NCT00991302|593756241|FG001|Overall Study|Death|1|||
164377925|NCT00991302|593756240|FG000|Overall Study|Lost to Follow-up|14|||
164377926|NCT00991302|593756241|FG001|Overall Study|Lost to Follow-up|12|||
164377927|NCT01709318|593756242|FG000|Overall Study|Adverse Event|3|||
164377928|NCT01709318|593756243|FG001|Overall Study|Adverse Event|4|||
164377929|NCT01709318|593756244|FG002|Overall Study|Adverse Event|2|||
164377930|NCT01709318|593756245|FG003|Overall Study|Adverse Event|2|||
164377931|NCT01709318|593756246|FG004|Overall Study|Adverse Event|0|||
164377932|NCT01709318|593756247|FG005|Overall Study|Adverse Event|1|||
164377933|NCT01709318|593756248|FG006|Overall Study|Adverse Event|2|||
164377934|NCT01709318|593756242|FG000|Overall Study|Lost to Follow-up|2|||
164377935|NCT01709318|593756243|FG001|Overall Study|Lost to Follow-up|0|||
164377936|NCT01709318|593756244|FG002|Overall Study|Lost to Follow-up|0|||
164377937|NCT01709318|593756245|FG003|Overall Study|Lost to Follow-up|0|||
164377938|NCT01709318|593756246|FG004|Overall Study|Lost to Follow-up|1|||
164377939|NCT01709318|593756247|FG005|Overall Study|Lost to Follow-up|1|||
164377940|NCT01709318|593756248|FG006|Overall Study|Lost to Follow-up|1|||
164377941|NCT01709318|593756242|FG000|Overall Study|Non-compliance with Study Drug|0|||
164377942|NCT01709318|593756243|FG001|Overall Study|Non-compliance with Study Drug|2|||
164377943|NCT01709318|593756244|FG002|Overall Study|Non-compliance with Study Drug|1|||
164377944|NCT01709318|593756245|FG003|Overall Study|Non-compliance with Study Drug|1|||
164377945|NCT01709318|593756246|FG004|Overall Study|Non-compliance with Study Drug|0|||
164377946|NCT01709318|593756247|FG005|Overall Study|Non-compliance with Study Drug|0|||
164377947|NCT01709318|593756248|FG006|Overall Study|Non-compliance with Study Drug|2|||
164377948|NCT01709318|593756242|FG000|Overall Study|Physician Decision|0|||
164377949|NCT01709318|593756243|FG001|Overall Study|Physician Decision|0|||
164377950|NCT01709318|593756244|FG002|Overall Study|Physician Decision|0|||
164377951|NCT01709318|593756245|FG003|Overall Study|Physician Decision|0|||
164377952|NCT01709318|593756246|FG004|Overall Study|Physician Decision|0|||
164377953|NCT01709318|593756247|FG005|Overall Study|Physician Decision|0|||
164377954|NCT01709318|593756248|FG006|Overall Study|Physician Decision|1|||
164377955|NCT01709318|593756242|FG000|Overall Study|Pregnancy|0|||
164377956|NCT01709318|593756243|FG001|Overall Study|Pregnancy|0|||
164377957|NCT01709318|593756244|FG002|Overall Study|Pregnancy|0|||
164377958|NCT01709318|593756245|FG003|Overall Study|Pregnancy|0|||
164377959|NCT01709318|593756246|FG004|Overall Study|Pregnancy|1|||
164377960|NCT01709318|593756247|FG005|Overall Study|Pregnancy|0|||
164377961|NCT01709318|593756248|FG006|Overall Study|Pregnancy|0|||
164377962|NCT01709318|593756242|FG000|Overall Study|Protocol Violation|0|||
164377963|NCT01709318|593756243|FG001|Overall Study|Protocol Violation|0|||
164377964|NCT01709318|593756244|FG002|Overall Study|Protocol Violation|0|||
164377965|NCT01709318|593756245|FG003|Overall Study|Protocol Violation|0|||
164377966|NCT01709318|593756246|FG004|Overall Study|Protocol Violation|2|||
164377967|NCT01709318|593756247|FG005|Overall Study|Protocol Violation|0|||
164377968|NCT01709318|593756248|FG006|Overall Study|Protocol Violation|1|||
164377969|NCT01709318|593756242|FG000|Overall Study|Technical Problems|1|||
164377970|NCT01709318|593756243|FG001|Overall Study|Technical Problems|0|||
164377971|NCT01709318|593756244|FG002|Overall Study|Technical Problems|0|||
164377972|NCT01709318|593756245|FG003|Overall Study|Technical Problems|0|||
164377973|NCT01709318|593756246|FG004|Overall Study|Technical Problems|0|||
164377974|NCT01709318|593756247|FG005|Overall Study|Technical Problems|0|||
164377975|NCT01709318|593756248|FG006|Overall Study|Technical Problems|0|||
164377976|NCT01709318|593756242|FG000|Overall Study|Withdrawal by Subject|3|||
164377977|NCT01709318|593756243|FG001|Overall Study|Withdrawal by Subject|0|||
163902740|NCT02499328|592014755|FG013|Overall Study|"Other"|7|||
163902741|NCT02499328|592014756|FG014|Overall Study|"Other"|6|||
163902742|NCT02499328|592014757|FG015|Overall Study|"Other"|0|||
163902743|NCT02499328|592014758|FG016|Overall Study|"Other"|0|||
163902744|NCT02499328|592014759|FG017|Overall Study|"Other"|34|||
163902745|NCT02499328|592014760|FG018|Overall Study|"Other"|43|||
163902746|NCT02499328|592014742|FG000|Overall Study|Disease Progression|0|||
163902747|NCT02499328|592014743|FG001|Overall Study|Disease Progression|0|||
163902748|NCT02499328|592014744|FG002|Overall Study|Disease Progression|0|||
163902749|NCT02499328|592014745|FG003|Overall Study|Disease Progression|0|||
163902750|NCT02499328|592014746|FG004|Overall Study|Disease Progression|0|||
163902751|NCT02499328|592014747|FG005|Overall Study|Disease Progression|0|||
163902752|NCT02499328|592014748|FG006|Overall Study|Disease Progression|1|||
163902753|NCT02499328|592014749|FG007|Overall Study|Disease Progression|0|||
163902754|NCT02499328|592014750|FG008|Overall Study|Disease Progression|1|||
163902755|NCT02499328|592014751|FG009|Overall Study|Disease Progression|0|||
163902756|NCT02499328|592014752|FG010|Overall Study|Disease Progression|1|||
163902757|NCT02499328|592014753|FG011|Overall Study|Disease Progression|0|||
163902758|NCT02499328|592014754|FG012|Overall Study|Disease Progression|0|||
163902759|NCT02499328|592014755|FG013|Overall Study|Disease Progression|0|||
164377978|NCT01709318|593756244|FG002|Overall Study|Withdrawal by Subject|3|||
163902760|NCT02499328|592014756|FG014|Overall Study|Disease Progression|0|||
164377979|NCT01709318|593756245|FG003|Overall Study|Withdrawal by Subject|3|||
164377980|NCT01709318|593756246|FG004|Overall Study|Withdrawal by Subject|0|||
164377981|NCT01709318|593756247|FG005|Overall Study|Withdrawal by Subject|2|||
164377982|NCT01709318|593756248|FG006|Overall Study|Withdrawal by Subject|4|||
164377983|NCT01709318|593756242|FG000|Overall Study|Other Protocol Specified Criteria|0|||
164377984|NCT01709318|593756243|FG001|Overall Study|Other Protocol Specified Criteria|1|||
164377985|NCT01709318|593756244|FG002|Overall Study|Other Protocol Specified Criteria|0|||
164377986|NCT01709318|593756245|FG003|Overall Study|Other Protocol Specified Criteria|0|||
164377987|NCT01709318|593756246|FG004|Overall Study|Other Protocol Specified Criteria|0|||
164377988|NCT01709318|593756247|FG005|Overall Study|Other Protocol Specified Criteria|0|||
164377989|NCT01709318|593756248|FG006|Overall Study|Other Protocol Specified Criteria|0|||
164377990|NCT00827372|593756253|FG000|Overall Study|Adverse Event|5|||
164377991|NCT00827372|593756253|FG000|Overall Study|Lack of Efficacy|3|||
164377992|NCT03085927|593756254|FG000|Overall Study|Withdrawal by Subject|1|||
164377993|NCT03085927|593756255|FG001|Overall Study|Withdrawal by Subject|4|||
164377994|NCT03085927|593756254|FG000|Overall Study|Lost to Follow-up|3|||
164377995|NCT03085927|593756255|FG001|Overall Study|Lost to Follow-up|1|||
164377996|NCT03085927|593756254|FG000|Overall Study|Death|1|||
164377997|NCT03085927|593756255|FG001|Overall Study|Death|0|||
164377998|NCT03085927|593756254|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
164377999|NCT03085927|593756255|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
164378000|NCT03085927|593756254|FG000|Overall Study|Dyad Became Ineligible|0|||
164378001|NCT03085927|593756255|FG001|Overall Study|Dyad Became Ineligible|1|||
164378002|NCT02564471|593756256|FG000|Overall Study|Adverse Event|1|||
164378003|NCT02564471|593756257|FG001|Overall Study|Adverse Event|0|||
164378004|NCT02564471|593756258|FG002|Overall Study|Adverse Event|0|||
164378005|NCT02564471|593756259|FG003|Overall Study|Adverse Event|0|||
164378006|NCT02564471|593756256|FG000|Overall Study|Withdrawal by Subject|2|||
164378007|NCT02564471|593756257|FG001|Overall Study|Withdrawal by Subject|1|||
164378008|NCT02564471|593756258|FG002|Overall Study|Withdrawal by Subject|3|||
164378009|NCT02564471|593756259|FG003|Overall Study|Withdrawal by Subject|0|||
164378010|NCT02564471|593756256|FG000|Overall Study|Lost to Follow-up|0|||
164378011|NCT02564471|593756257|FG001|Overall Study|Lost to Follow-up|2|||
164378012|NCT02564471|593756258|FG002|Overall Study|Lost to Follow-up|0|||
164378013|NCT02564471|593756259|FG003|Overall Study|Lost to Follow-up|0|||
164378014|NCT01312909|593756260|FG000|Overall Study|Randomized but not treated|1|||
164378015|NCT01312909|593756261|FG001|Overall Study|Randomized but not treated|3|||
164378016|NCT01312909|593756262|FG002|Overall Study|Randomized but not treated|1|||
164378017|NCT01312909|593756260|FG000|Overall Study|Adverse Event|1|||
164378018|NCT01312909|593756261|FG001|Overall Study|Adverse Event|0|||
164378019|NCT01312909|593756262|FG002|Overall Study|Adverse Event|3|||
164378020|NCT01312909|593756260|FG000|Overall Study|Protocol Violation|2|||
164378021|NCT01312909|593756261|FG001|Overall Study|Protocol Violation|0|||
164378022|NCT01312909|593756262|FG002|Overall Study|Protocol Violation|2|||
164378023|NCT01312909|593756260|FG000|Overall Study|Other|9|||
164378024|NCT01312909|593756261|FG001|Overall Study|Other|6|||
164378025|NCT01312909|593756262|FG002|Overall Study|Other|11|||
164378026|NCT01312909|593756260|FG000|Overall Study|Withdrawal by Subject|8|||
164378027|NCT01312909|593756261|FG001|Overall Study|Withdrawal by Subject|10|||
164378028|NCT01312909|593756262|FG002|Overall Study|Withdrawal by Subject|7|||
164378029|NCT01312909|593756260|FG000|Overall Study|Lost to Follow-up|21|||
164378030|NCT01312909|593756261|FG001|Overall Study|Lost to Follow-up|17|||
164378031|NCT01312909|593756262|FG002|Overall Study|Lost to Follow-up|20|||
164378032|NCT01312909|593756260|FG000|Overall Study|Insufficient clinical response|0|||
164378033|NCT01312909|593756261|FG001|Overall Study|Insufficient clinical response|0|||
164378034|NCT01312909|593756262|FG002|Overall Study|Insufficient clinical response|1|||
164378035|NCT01312909|593756260|FG000|Overall Study|Entrance criteria not met|0|||
164378036|NCT01312909|593756261|FG001|Overall Study|Entrance criteria not met|0|||
164378037|NCT01312909|593756262|FG002|Overall Study|Entrance criteria not met|2|||
164378038|NCT02200042|593756263|FG000|Overall Study|Withdrawal by Subject|0|||
164378039|NCT02200042|593756264|FG001|Overall Study|Withdrawal by Subject|1|||
164378040|NCT01777997|593756267|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
164378041|NCT01777997|593756267|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
164378042|NCT01777997|593756267|FG000|Weeks 48 to 72/96 on ART|Death|1|||
164378043|NCT01777997|593756267|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
164378044|NCT00306592|593756268|FG000|Overall Study|Adverse Event|8|||
164378045|NCT00306592|593756269|FG001|Overall Study|Adverse Event|15|||
164378046|NCT00306592|593756268|FG000|Overall Study|Lost to Follow-up|1|||
164378047|NCT00306592|593756269|FG001|Overall Study|Lost to Follow-up|0|||
164378048|NCT00306592|593756268|FG000|Overall Study|Noncompliance|0|||
164378049|NCT00306592|593756269|FG001|Overall Study|Noncompliance|2|||
164378050|NCT00306592|593756268|FG000|Overall Study|Persistent Antibodies|6|||
164378051|NCT00306592|593756269|FG001|Overall Study|Persistent Antibodies|3|||
164378052|NCT00306592|593756268|FG000|Overall Study|Voluntary|10|||
164378053|NCT00306592|593756269|FG001|Overall Study|Voluntary|6|||
164378054|NCT00306592|593756268|FG000|Overall Study|Other|5|||
164378055|NCT00306592|593756269|FG001|Overall Study|Other|10|||
164378056|NCT00306592|593756268|FG000|Overall Study|Other|1|||
164378057|NCT00306592|593756269|FG001|Overall Study|Other|2|||
164378058|NCT00306592|593756268|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
164378059|NCT00306592|593756269|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
164378060|NCT01923181|593756270|FG000|Overall Study|Protocol Violation|2|||
164378061|NCT01923181|593756271|FG001|Overall Study|Protocol Violation|2|||
164378062|NCT01923181|593756272|FG002|Overall Study|Protocol Violation|0|||
164378063|NCT01923181|593756273|FG003|Overall Study|Protocol Violation|2|||
164378064|NCT01923181|593756274|FG004|Overall Study|Protocol Violation|2|||
164378065|NCT01923181|593756275|FG005|Overall Study|Protocol Violation|1|||
164378066|NCT01923181|593756276|FG006|Overall Study|Protocol Violation|1|||
164378067|NCT01923181|593756277|FG007|Overall Study|Protocol Violation|2|||
164378068|NCT01923181|593756278|FG008|Overall Study|Protocol Violation|1|||
164378069|NCT01923181|593756270|FG000|Overall Study|Withdrawal by Subject|0|||
164378070|NCT01923181|593756271|FG001|Overall Study|Withdrawal by Subject|1|||
164378071|NCT01923181|593756272|FG002|Overall Study|Withdrawal by Subject|0|||
164378072|NCT01923181|593756273|FG003|Overall Study|Withdrawal by Subject|1|||
164378073|NCT01923181|593756274|FG004|Overall Study|Withdrawal by Subject|4|||
164378074|NCT01923181|593756275|FG005|Overall Study|Withdrawal by Subject|2|||
164378075|NCT01923181|593756276|FG006|Overall Study|Withdrawal by Subject|4|||
164378076|NCT01923181|593756277|FG007|Overall Study|Withdrawal by Subject|3|||
164378077|NCT01923181|593756278|FG008|Overall Study|Withdrawal by Subject|1|||
164378078|NCT01923181|593756270|FG000|Overall Study|Other|1|||
164378079|NCT01923181|593756271|FG001|Overall Study|Other|0|||
164378080|NCT01923181|593756272|FG002|Overall Study|Other|0|||
164378081|NCT01923181|593756273|FG003|Overall Study|Other|1|||
164378082|NCT01923181|593756274|FG004|Overall Study|Other|0|||
164378083|NCT01923181|593756275|FG005|Overall Study|Other|0|||
164378084|NCT01923181|593756276|FG006|Overall Study|Other|0|||
164378085|NCT01923181|593756277|FG007|Overall Study|Other|0|||
164378086|NCT01923181|593756278|FG008|Overall Study|Other|0|||
164378087|NCT01923181|593756270|FG000|Overall Study|Lost to Follow-up|0|||
164378088|NCT01923181|593756271|FG001|Overall Study|Lost to Follow-up|3|||
164378089|NCT01923181|593756272|FG002|Overall Study|Lost to Follow-up|2|||
164378090|NCT01923181|593756273|FG003|Overall Study|Lost to Follow-up|1|||
164378091|NCT01923181|593756274|FG004|Overall Study|Lost to Follow-up|2|||
164378092|NCT01923181|593756275|FG005|Overall Study|Lost to Follow-up|1|||
164378093|NCT01923181|593756276|FG006|Overall Study|Lost to Follow-up|3|||
164378094|NCT01923181|593756277|FG007|Overall Study|Lost to Follow-up|3|||
164378095|NCT01923181|593756278|FG008|Overall Study|Lost to Follow-up|1|||
164378096|NCT02932891|593756281|FG000|Overall Study|Lost to Follow-up|2|||
164378097|NCT02932891|593756281|FG000|Overall Study|HPA Suppress|2|||
164378098|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378099|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
164378100|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378101|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378102|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378103|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
164378104|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
164378105|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
164378106|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
164378107|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164378108|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164378109|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164378110|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
164378111|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378112|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378113|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378114|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378115|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
164378116|NCT04622254|593756282|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378117|NCT04622254|593756283|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
164378118|NCT04622254|593756284|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
164378119|NCT04622254|593756285|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378120|NCT04622254|593756286|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378121|NCT04622254|593756287|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164378122|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378123|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378124|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378125|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
164378126|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378127|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164378128|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378129|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378130|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378131|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
164378132|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164378133|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
164378134|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378135|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378136|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378137|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
164378138|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378139|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164378140|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378141|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378142|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378143|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
164378144|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378145|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164378146|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164378147|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164378148|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164378149|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
164378150|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
164378151|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
164378152|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164378153|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164378154|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164378155|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
164378156|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
164378157|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
164378158|NCT04622254|593756282|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
164378159|NCT04622254|593756283|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
164378160|NCT04622254|593756284|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
164378161|NCT04622254|593756285|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
164378162|NCT04622254|593756286|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
164378163|NCT04622254|593756287|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
164378164|NCT02652624|593756288|FG000|Randomized Phase|Pregnancy|3|||
164378165|NCT02652624|593756289|FG001|Randomized Phase|Pregnancy|1|||
164378166|NCT02652624|593756288|FG000|Randomized Phase|Investigator's Discretion|0|||
164378167|NCT02652624|593756289|FG001|Randomized Phase|Investigator's Discretion|2|||
164378168|NCT02652624|593756288|FG000|Randomized Phase|Death|0|||
164378169|NCT02652624|593756289|FG001|Randomized Phase|Death|1|||
164378170|NCT02652624|593756288|FG000|Randomized Phase|Lost to Follow-up|0|||
164378171|NCT02652624|593756289|FG001|Randomized Phase|Lost to Follow-up|1|||
164378172|NCT02652624|593756288|FG000|Extension Phase|Lost to Follow-up|3|||
164378173|NCT02652624|593756289|FG001|Extension Phase|Lost to Follow-up|1|||
164378174|NCT02652624|593756288|FG000|Extension Phase|Pregnancy|1|||
164378175|NCT02652624|593756289|FG001|Extension Phase|Pregnancy|1|||
164378176|NCT02652624|593756288|FG000|Extension Phase|Adverse Event|0|||
164378177|NCT02652624|593756289|FG001|Extension Phase|Adverse Event|1|||
164378178|NCT02652624|593756288|FG000|Extension Phase|Withdrew Consent|0|||
164378179|NCT02652624|593756289|FG001|Extension Phase|Withdrew Consent|1|||
164378180|NCT00654628|593756290|FG000|6-week Active Treatment Period|Adverse Event|9|||
164378181|NCT00654628|593756290|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
164378182|NCT00654628|593756290|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
164378183|NCT00654628|593756290|FG000|6-week Active Treatment Period|Out of window period|1|||
164378184|NCT00654628|593756290|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
164378185|NCT00654628|593756290|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
164378186|NCT00912405|593756293|FG000|Overall Study|Lost to Follow-up|5|||
164378187|NCT00953329|593756294|FG000|Overall Study|Lack of Efficacy|1|||
164378188|NCT01434823|593756297|FG000|Overall Study|Incomplete data in medical record|4|||
164378189|NCT01434823|593756298|FG001|Overall Study|Incomplete data in medical record|7|||
164378190|NCT03228680|593756304|FG000|Overall Study|Adverse Event|13|||
164378191|NCT03228680|593756305|FG001|Overall Study|Adverse Event|18|||
164378192|NCT03228680|593756304|FG000|Overall Study|Randomization failure|0|||
164378193|NCT03228680|593756305|FG001|Overall Study|Randomization failure|1|||
164378194|NCT03228680|593756304|FG000|Overall Study|Withdrawal by Subject|1|||
164378195|NCT03228680|593756305|FG001|Overall Study|Withdrawal by Subject|0|||
164378196|NCT03228680|593756304|FG000|Overall Study|Other|9|||
164378197|NCT03228680|593756305|FG001|Overall Study|Other|16|||
164378198|NCT02167035|593756306|FG000|Overall Study|Adverse Event|2|||
164378199|NCT02167035|593756307|FG001|Overall Study|Adverse Event|2|||
164378200|NCT02167035|593756306|FG000|Overall Study|Lost to Follow-up|3|||
164378201|NCT02167035|593756307|FG001|Overall Study|Lost to Follow-up|3|||
164378202|NCT02167035|593756306|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
164378203|NCT02167035|593756307|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
164378204|NCT00796861|593756314|FG000|Overall Study|Withdrawal by Subject|2|||
164012842|NCT00532883|592410608|FG002|Overall Study|Adverse Event|0|||
164012843|NCT00532883|592410609|FG003|Overall Study|Adverse Event|1|||
164378205|NCT00796861|593756314|FG000|Overall Study|Death|2|||
164378206|NCT02252081|593756315|FG000|Overall Study|Withdrawal by Subject|2|||
164378207|NCT02252081|593756316|FG001|Overall Study|Withdrawal by Subject|1|||
164012844|NCT00532883|592410606|FG000|Overall Study|Lost to Follow-up|1|||
164012845|NCT00532883|592410607|FG001|Overall Study|Lost to Follow-up|1|||
164012846|NCT00532883|592410608|FG002|Overall Study|Lost to Follow-up|1|||
164012847|NCT00532883|592410609|FG003|Overall Study|Lost to Follow-up|0|||
164012848|NCT00532883|592410606|FG000|Overall Study|Withdrawal by Subject|0|||
164012849|NCT00532883|592410607|FG001|Overall Study|Withdrawal by Subject|1|||
164012850|NCT00532883|592410608|FG002|Overall Study|Withdrawal by Subject|1|||
164012851|NCT00532883|592410609|FG003|Overall Study|Withdrawal by Subject|0|||
164012852|NCT00532883|592410606|FG000|Overall Study|Subject was Nonadherent|0|||
164012853|NCT00532883|592410607|FG001|Overall Study|Subject was Nonadherent|1|||
164012854|NCT00532883|592410608|FG002|Overall Study|Subject was Nonadherent|1|||
164012855|NCT00532883|592410609|FG003|Overall Study|Subject was Nonadherent|0|||
164012856|NCT00532883|592410606|FG000|Overall Study|Early Study Termination|4|||
164012857|NCT00532883|592410607|FG001|Overall Study|Early Study Termination|4|||
164012858|NCT00532883|592410608|FG002|Overall Study|Early Study Termination|1|||
164012859|NCT00532883|592410609|FG003|Overall Study|Early Study Termination|4|||
164012860|NCT02075255|592410610|FG000|Overall Study|Study specific withdrawal criteria|0|||
164012861|NCT02075255|592410611|FG001|Overall Study|Study specific withdrawal criteria|1|||
164012862|NCT02075255|592410612|FG002|Overall Study|Study specific withdrawal criteria|1|||
164012863|NCT02075255|592410610|FG000|Overall Study|Withdrawal by Subject|4|||
164012864|NCT02075255|592410611|FG001|Overall Study|Withdrawal by Subject|1|||
164012865|NCT02075255|592410612|FG002|Overall Study|Withdrawal by Subject|0|||
164012866|NCT02075255|592410610|FG000|Overall Study|Lost to Follow-up|0|||
164012867|NCT02075255|592410611|FG001|Overall Study|Lost to Follow-up|0|||
164012868|NCT02075255|592410612|FG002|Overall Study|Lost to Follow-up|1|||
164012869|NCT02075255|592410610|FG000|Overall Study|Adverse Event|0|||
164012870|NCT02075255|592410611|FG001|Overall Study|Adverse Event|0|||
164012871|NCT02075255|592410612|FG002|Overall Study|Adverse Event|1|||
164012872|NCT02075255|592410610|FG000|Overall Study|Death|0|||
164012873|NCT02075255|592410611|FG001|Overall Study|Death|2|||
164378208|NCT02252081|593756315|FG000|Overall Study|Adverse Event|4|||
164378209|NCT02252081|593756316|FG001|Overall Study|Adverse Event|1|||
164378210|NCT02252081|593756315|FG000|Overall Study|non compliance & others|0|||
164378211|NCT02252081|593756316|FG001|Overall Study|non compliance & others|2|||
164378212|NCT00403455|593756320|FG000|Overall Study|Withdrawal by Subject|1|||
164378213|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
164378214|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
164378215|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
164378216|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
164378217|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
163902761|NCT02499328|592014757|FG015|Overall Study|Disease Progression|0|||
163902762|NCT02499328|592014758|FG016|Overall Study|Disease Progression|0|||
163902763|NCT02499328|592014759|FG017|Overall Study|Disease Progression|2|||
163902764|NCT02499328|592014760|FG018|Overall Study|Disease Progression|0|||
163902765|NCT02499328|592014742|FG000|Overall Study|Adverse Event|1|||
164378218|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
164378219|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
164378220|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
164378221|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
164378222|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
164378223|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
164378224|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
164378225|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
164378226|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
164378227|NCT03732638|593756327|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
163902766|NCT02499328|592014743|FG001|Overall Study|Adverse Event|0|||
164012874|NCT02075255|592410612|FG002|Overall Study|Death|0|||
164012875|NCT01469013|592410613|FG000|Part A (Treatment Period)|Adverse Event|1|||
164012876|NCT01469013|592410614|FG001|Part A (Treatment Period)|Adverse Event|0|||
164012877|NCT01469013|592410615|FG002|Part A (Treatment Period)|Adverse Event|0|||
163902767|NCT02499328|592014744|FG002|Overall Study|Adverse Event|0|||
164012878|NCT01469013|592410616|FG003|Part A (Treatment Period)|Adverse Event|0|||
164012879|NCT01469013|592410617|FG004|Part A (Treatment Period)|Adverse Event|1|||
164012880|NCT01469013|592410618|FG005|Part A (Treatment Period)|Adverse Event|0|||
164012881|NCT01469013|592410619|FG006|Part A (Treatment Period)|Adverse Event|0|||
164378228|NCT03732638|593756328|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
164378229|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
163902768|NCT02499328|592014745|FG003|Overall Study|Adverse Event|1|||
164012882|NCT01469013|592410620|FG007|Part A (Treatment Period)|Adverse Event|0|||
164012883|NCT01469013|592410621|FG008|Part A (Treatment Period)|Adverse Event|0|||
164012884|NCT01469013|592410622|FG009|Part A (Treatment Period)|Adverse Event|0|||
164012885|NCT01469013|592410623|FG010|Part A (Treatment Period)|Adverse Event|0|||
164012886|NCT01469013|592410624|FG011|Part A (Treatment Period)|Adverse Event|0|||
164012887|NCT01469013|592410625|FG012|Part A (Treatment Period)|Adverse Event|0|||
164012888|NCT01469013|592410613|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012889|NCT01469013|592410614|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012890|NCT01469013|592410615|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
164012891|NCT01469013|592410616|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012892|NCT01469013|592410617|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012893|NCT01469013|592410618|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012894|NCT01469013|592410619|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012895|NCT01469013|592410620|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012896|NCT01469013|592410621|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012897|NCT01469013|592410622|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
164378230|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
164378231|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
164378232|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
164378233|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
164378234|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
164378235|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
164378236|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
164378237|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
164378238|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
164378239|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
164378240|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
164378241|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
164378242|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
164378243|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
164378244|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
164378245|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
164378246|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
164378247|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
164378248|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
164378249|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
164378250|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
164378251|NCT03732638|593756327|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
164378252|NCT03732638|593756328|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
164378253|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
164378254|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
164378255|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
164378256|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
164378257|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
164378258|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
164378259|NCT03732638|593756327|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
164378260|NCT03732638|593756328|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
164378261|NCT02992899|593756329|FG000|Overall Study|Withdrawal by Subject|1|||
164378262|NCT02992899|593756330|FG001|Overall Study|Withdrawal by Subject|0|||
164378263|NCT02992899|593756329|FG000|Overall Study|Lost to Follow-up|1|||
164012898|NCT01469013|592410623|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012899|NCT01469013|592410624|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012900|NCT01469013|592410625|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
164012901|NCT01469013|592410613|FG000|Part B (Extension Period)|Adverse Event|0|||
164378264|NCT02992899|593756330|FG001|Overall Study|Lost to Follow-up|3|||
164378265|NCT02738775|593756331|FG000|Overall Study|Withdrawal by Subject|0|||
164378266|NCT02738775|593756332|FG001|Overall Study|Withdrawal by Subject|1|||
164378267|NCT02738775|593756333|FG002|Overall Study|Withdrawal by Subject|0|||
164378268|NCT02738775|593756334|FG003|Overall Study|Withdrawal by Subject|0|||
164378269|NCT02738775|593756335|FG004|Overall Study|Withdrawal by Subject|0|||
164378270|NCT02738775|593756336|FG005|Overall Study|Withdrawal by Subject|0|||
164378271|NCT02738775|593756331|FG000|Overall Study|Adverse Event|0|||
164378272|NCT02738775|593756332|FG001|Overall Study|Adverse Event|0|||
164378273|NCT02738775|593756333|FG002|Overall Study|Adverse Event|0|||
164378274|NCT02738775|593756334|FG003|Overall Study|Adverse Event|1|||
164378275|NCT02738775|593756335|FG004|Overall Study|Adverse Event|0|||
164378276|NCT02738775|593756336|FG005|Overall Study|Adverse Event|0|||
164378277|NCT02738775|593756331|FG000|Overall Study|Pregnancy|0|||
164378278|NCT02738775|593756332|FG001|Overall Study|Pregnancy|1|||
164378279|NCT02738775|593756333|FG002|Overall Study|Pregnancy|0|||
164378280|NCT02738775|593756334|FG003|Overall Study|Pregnancy|0|||
164378281|NCT02738775|593756335|FG004|Overall Study|Pregnancy|0|||
164378282|NCT02738775|593756336|FG005|Overall Study|Pregnancy|0|||
164012902|NCT01469013|592410614|FG001|Part B (Extension Period)|Adverse Event|0|||
164012903|NCT01469013|592410615|FG002|Part B (Extension Period)|Adverse Event|0|||
164012904|NCT01469013|592410616|FG003|Part B (Extension Period)|Adverse Event|0|||
164378283|NCT02738775|593756331|FG000|Overall Study|Missing|0|||
164378284|NCT02738775|593756332|FG001|Overall Study|Missing|0|||
164378285|NCT02738775|593756333|FG002|Overall Study|Missing|0|||
164378286|NCT02738775|593756334|FG003|Overall Study|Missing|0|||
164378287|NCT02738775|593756335|FG004|Overall Study|Missing|0|||
164378288|NCT02738775|593756336|FG005|Overall Study|Missing|1|||
164378289|NCT02370888|593756337|FG000|Overall Study|disease progression|2|||
164378290|NCT02370888|593756337|FG000|Overall Study|did not meet chimerism criteria|6|||
164378291|NCT04574362|593756338|FG000|Overall Study|Other|0|||
164378292|NCT04574362|593756339|FG001|Overall Study|Other|5|||
164378293|NCT04574362|593756338|FG000|Overall Study|COVID-19|0|||
164378294|NCT04574362|593756339|FG001|Overall Study|COVID-19|1|||
164378295|NCT04574362|593756338|FG000|Overall Study|Adverse Event|1|||
164378296|NCT04574362|593756339|FG001|Overall Study|Adverse Event|1|||
164378297|NCT04574362|593756338|FG000|Overall Study|Withdrawal by Subject|2|||
164378298|NCT04574362|593756339|FG001|Overall Study|Withdrawal by Subject|4|||
164378299|NCT04574362|593756338|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
164378300|NCT04574362|593756339|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
164378301|NCT04574362|593756338|FG000|Overall Study|Participant refused to come to the hospital|1|||
164378302|NCT04574362|593756339|FG001|Overall Study|Participant refused to come to the hospital|0|||
164378303|NCT04574362|593756338|FG000|Overall Study|Participant refused the visit|1|||
164378304|NCT04574362|593756339|FG001|Overall Study|Participant refused the visit|0|||
164378305|NCT04574362|593756338|FG000|Overall Study|Participant quit early because of business trip|1|||
164378306|NCT04574362|593756339|FG001|Overall Study|Participant quit early because of business trip|0|||
164378307|NCT01785524|593756340|FG000|Overall Study|Withdrawal by Subject|2|||
164378308|NCT01785524|593756341|FG001|Overall Study|Withdrawal by Subject|2|||
164378309|NCT01060384|593756342|FG000|Overall Study|Withdrawal by Subject|0|||
164378310|NCT01060384|593756343|FG001|Overall Study|Withdrawal by Subject|1|||
164378311|NCT01060384|593756344|FG002|Overall Study|Withdrawal by Subject|0|||
164378312|NCT01060384|593756345|FG003|Overall Study|Withdrawal by Subject|0|||
164378313|NCT01060384|593756346|FG004|Overall Study|Withdrawal by Subject|0|||
164378314|NCT01060384|593756342|FG000|Overall Study|Death|0|||
164378315|NCT01060384|593756343|FG001|Overall Study|Death|0|||
164378316|NCT01060384|593756344|FG002|Overall Study|Death|0|||
164378317|NCT01060384|593756345|FG003|Overall Study|Death|0|||
164378318|NCT01060384|593756346|FG004|Overall Study|Death|1|||
164378319|NCT01060384|593756342|FG000|Overall Study|Intercurrent illness|0|||
164378320|NCT01060384|593756343|FG001|Overall Study|Intercurrent illness|0|||
164378321|NCT01060384|593756344|FG002|Overall Study|Intercurrent illness|0|||
164378322|NCT01060384|593756345|FG003|Overall Study|Intercurrent illness|0|||
164378323|NCT01060384|593756346|FG004|Overall Study|Intercurrent illness|1|||
164378324|NCT00642304|593756347|FG000|Overall Study|Adverse Event|1|||
164378325|NCT00642304|593756347|FG000|Overall Study|Death|1|||
164378326|NCT00642304|593756347|FG000|Overall Study|Blood transfusion|2|||
164378327|NCT00642304|593756347|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
164378328|NCT00642304|593756347|FG000|Overall Study|Transplantation|1|||
164378329|NCT03192150|593756354|FG000|Overall Study|Adverse Event|14|||
164378330|NCT03192150|593756355|FG001|Overall Study|Adverse Event|12|||
164378331|NCT03192150|593756354|FG000|Overall Study|Lack of Efficacy|23|||
164378332|NCT03192150|593756355|FG001|Overall Study|Lack of Efficacy|30|||
164378333|NCT03192150|593756354|FG000|Overall Study|Lost to Follow-up|1|||
164378334|NCT03192150|593756355|FG001|Overall Study|Lost to Follow-up|1|||
164378335|NCT03192150|593756354|FG000|Overall Study|Withdrawal by Subject|4|||
164378336|NCT03192150|593756355|FG001|Overall Study|Withdrawal by Subject|2|||
164378337|NCT03192150|593756354|FG000|Overall Study|Protocol Violation|5|||
164378338|NCT03192150|593756355|FG001|Overall Study|Protocol Violation|2|||
164378339|NCT03192150|593756354|FG000|Overall Study|Surgery Canceled|6|||
164378340|NCT03192150|593756355|FG001|Overall Study|Surgery Canceled|2|||
163902769|NCT02499328|592014746|FG004|Overall Study|Adverse Event|0|||
163902770|NCT02499328|592014747|FG005|Overall Study|Adverse Event|0|||
163902771|NCT02499328|592014748|FG006|Overall Study|Adverse Event|0|||
163902772|NCT02499328|592014749|FG007|Overall Study|Adverse Event|0|||
163902773|NCT02499328|592014750|FG008|Overall Study|Adverse Event|0|||
163902774|NCT02499328|592014751|FG009|Overall Study|Adverse Event|0|||
163902775|NCT02499328|592014752|FG010|Overall Study|Adverse Event|0|||
163902776|NCT02499328|592014753|FG011|Overall Study|Adverse Event|0|||
163902777|NCT02499328|592014754|FG012|Overall Study|Adverse Event|1|||
163902778|NCT02499328|592014755|FG013|Overall Study|Adverse Event|0|||
163902779|NCT02499328|592014756|FG014|Overall Study|Adverse Event|0|||
163902780|NCT02499328|592014757|FG015|Overall Study|Adverse Event|0|||
163902781|NCT02499328|592014758|FG016|Overall Study|Adverse Event|0|||
163902782|NCT02499328|592014759|FG017|Overall Study|Adverse Event|0|||
164378341|NCT03192150|593756354|FG000|Overall Study|Other-Various Administrative Reasons|2|||
164378342|NCT03192150|593756355|FG001|Overall Study|Other-Various Administrative Reasons|5|||
164378343|NCT00482391|593756356|FG000|Overall Study|Withdrawal by Subject|1|||
164378344|NCT00482391|593756356|FG000|Overall Study|Adverse Event|1|||
164378345|NCT00482391|593756356|FG000|Overall Study|Death|1|||
164378346|NCT02606136|593756362|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
163902783|NCT02499328|592014760|FG018|Overall Study|Adverse Event|0|||
163902784|NCT03611075|592014761|FG000|Overall Study|Physician Decision|0|||
163902785|NCT03611075|592014762|FG001|Overall Study|Physician Decision|1|||
163902786|NCT03611075|592014763|FG002|Overall Study|Physician Decision|1|||
163902787|NCT03611075|592014764|FG003|Overall Study|Physician Decision|0|||
163902788|NCT03611075|592014765|FG004|Overall Study|Physician Decision|0|||
163902789|NCT03611075|592014766|FG005|Overall Study|Physician Decision|0|||
163902790|NCT03611075|592014767|FG006|Overall Study|Physician Decision|0|||
164378347|NCT02606136|593756362|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
164378348|NCT02606136|593756362|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
164378349|NCT02606136|593756362|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
164378350|NCT04694131|593756365|FG000|Overall Study|Withdrawal by Subject|7|||
164378351|NCT04694131|593756365|FG000|Overall Study|Screen Failure|1|||
164378352|NCT04694131|593756365|FG000|Overall Study|High stimulation threshold|3|||
164378353|NCT02399085|593756366|FG000|Overall Study|Adverse Event|16|||
164378354|NCT02399085|593756366|FG000|Overall Study|Death|2|||
164378355|NCT02399085|593756366|FG000|Overall Study|Withdrawal by Subject|8|||
164378356|NCT02399085|593756366|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
164378357|NCT02399085|593756366|FG000|Overall Study|Physician Decision|5|||
164378358|NCT02410811|593756370|FG000|Overall Study|Withdrawal by Subject|0|||
164378359|NCT02410811|593756371|FG001|Overall Study|Withdrawal by Subject|0|||
164378360|NCT02410811|593756372|FG002|Overall Study|Withdrawal by Subject|1|||
164378361|NCT02410811|593756373|FG003|Overall Study|Withdrawal by Subject|0|||
164378362|NCT00353366|593756374|FG000|Overall Study|Adverse Event|8|||
164378363|NCT00353366|593756374|FG000|Overall Study|Protocol Violation|12|||
164378364|NCT00353366|593756374|FG000|Overall Study|Withdrawal by Subject|12|||
164378365|NCT00353366|593756374|FG000|Overall Study|Lost to Follow-up|92|||
164378366|NCT00353366|593756374|FG000|Overall Study|Other|19|||
164378367|NCT00259857|593756375|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
164378368|NCT00259857|593756376|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
164378369|NCT00259857|593756375|FG000|24 Months Treatment|Lost to Follow-up|0|||
164378370|NCT00259857|593756376|FG001|24 Months Treatment|Lost to Follow-up|3|||
164378371|NCT05267054|593756377|FG000|Overall Study|Death|13|||
164378372|NCT05267054|593756378|FG001|Overall Study|Death|14|||
164378373|NCT05267054|593756377|FG000|Overall Study|Study Ended by Sponsor|9|||
164378374|NCT05267054|593756378|FG001|Overall Study|Study Ended by Sponsor|13|||
164378375|NCT05267054|593756377|FG000|Overall Study|Lost to Follow-up|1|||
164378376|NCT05267054|593756378|FG001|Overall Study|Lost to Follow-up|1|||
164378377|NCT05267054|593756377|FG000|Overall Study|Withdrawal by Subject|1|||
164378378|NCT05267054|593756378|FG001|Overall Study|Withdrawal by Subject|1|||
164378379|NCT01552226|593756381|FG000|Overall Study|Withdrawal by Subject|4|||
164378380|NCT01552226|593756382|FG001|Overall Study|Withdrawal by Subject|4|||
164378381|NCT01469065|593756386|FG000|Overall Study|Lack of Efficacy|0|||
164378382|NCT01469065|593756387|FG001|Overall Study|Lack of Efficacy|0|||
164378383|NCT01469065|593756388|FG002|Overall Study|Lack of Efficacy|0|||
164378384|NCT01469065|593756389|FG003|Overall Study|Lack of Efficacy|0|||
164378385|NCT01469065|593756390|FG004|Overall Study|Lack of Efficacy|1|||
164378386|NCT01469065|593756386|FG000|Overall Study|Other|0|||
164378387|NCT01469065|593756387|FG001|Overall Study|Other|1|||
164378388|NCT01469065|593756388|FG002|Overall Study|Other|0|||
164378389|NCT01469065|593756389|FG003|Overall Study|Other|0|||
164378390|NCT01469065|593756390|FG004|Overall Study|Other|0|||
164378391|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
164378392|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
164378393|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
164378394|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
164378395|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
164378396|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
164378397|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
164378398|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
164378399|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
163902791|NCT03611075|592014768|FG007|Overall Study|Physician Decision|0|||
163902792|NCT03611075|592014769|FG008|Overall Study|Physician Decision|0|||
163902793|NCT03611075|592014761|FG000|Overall Study|Lost to Follow-up|1|||
163902794|NCT03611075|592014762|FG001|Overall Study|Lost to Follow-up|0|||
164012905|NCT01469013|592410617|FG004|Part B (Extension Period)|Adverse Event|0|||
164012906|NCT01469013|592410618|FG005|Part B (Extension Period)|Adverse Event|2|||
163902795|NCT03611075|592014763|FG002|Overall Study|Lost to Follow-up|0|||
164378400|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
164378401|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
164378402|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
164378403|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
164378404|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
163902796|NCT03611075|592014764|FG003|Overall Study|Lost to Follow-up|2|||
163902797|NCT03611075|592014765|FG004|Overall Study|Lost to Follow-up|0|||
164378405|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
164378406|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
164378407|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
164378408|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
164378409|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
164378410|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
164378411|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
164378412|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
164378413|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
164378414|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
164378415|NCT04542070|593756391|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
164378416|NCT04542070|593756392|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
164378417|NCT04542070|593756393|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
164378418|NCT04542070|593756394|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
164378419|NCT04542070|593756391|FG000|Maintenance + Extension Period|Adverse Event|10|||
164378420|NCT04542070|593756392|FG001|Maintenance + Extension Period|Adverse Event|2|||
164378421|NCT04542070|593756393|FG002|Maintenance + Extension Period|Adverse Event|0|||
164378422|NCT04542070|593756394|FG003|Maintenance + Extension Period|Adverse Event|0|||
164378423|NCT04542070|593756391|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
164378424|NCT04542070|593756392|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
164378425|NCT04542070|593756393|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
164378426|NCT04542070|593756394|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
164378427|NCT04542070|593756391|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
164378428|NCT04542070|593756392|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
164378429|NCT04542070|593756393|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
164378430|NCT04542070|593756394|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
164378431|NCT04542070|593756391|FG000|Maintenance + Extension Period|Physician Decision|1|||
164378432|NCT04542070|593756392|FG001|Maintenance + Extension Period|Physician Decision|1|||
164378433|NCT04542070|593756393|FG002|Maintenance + Extension Period|Physician Decision|0|||
164378434|NCT04542070|593756394|FG003|Maintenance + Extension Period|Physician Decision|0|||
164378435|NCT04542070|593756391|FG000|Maintenance + Extension Period|Protocol Violation|2|||
164378436|NCT04542070|593756392|FG001|Maintenance + Extension Period|Protocol Violation|5|||
164378437|NCT04542070|593756393|FG002|Maintenance + Extension Period|Protocol Violation|0|||
164378438|NCT04542070|593756394|FG003|Maintenance + Extension Period|Protocol Violation|0|||
164378439|NCT04542070|593756391|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
164378440|NCT04542070|593756392|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
164378441|NCT04542070|593756393|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
164378442|NCT04542070|593756394|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
164378443|NCT04542070|593756391|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
164378444|NCT04542070|593756392|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
164378445|NCT04542070|593756393|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
164378446|NCT04542070|593756394|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
164378447|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
164378448|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
164378449|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
164378450|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
164378451|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
164378452|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
164378453|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
164378454|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
164378455|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
164378456|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
164378457|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
164378458|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
164378459|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
164378460|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
164378461|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
164378462|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
164378463|NCT04542070|593756391|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
164378464|NCT04542070|593756392|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
164378465|NCT04542070|593756393|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
164378466|NCT04542070|593756394|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
164378467|NCT03511560|593756397|FG000|Overall Study|Death|0|||
164378468|NCT03511560|593756398|FG001|Overall Study|Death|1|||
164378469|NCT03511560|593756397|FG000|Overall Study|Adverse Event|0|||
164378470|NCT03511560|593756398|FG001|Overall Study|Adverse Event|2|||
164012907|NCT01469013|592410619|FG006|Part B (Extension Period)|Adverse Event|5|||
164378471|NCT03511560|593756397|FG000|Overall Study|Transplant cancelled|0|||
164378472|NCT03511560|593756398|FG001|Overall Study|Transplant cancelled|1|||
164378473|NCT03511560|593756397|FG000|Overall Study|Patient switched to another drug|1|||
164378474|NCT03511560|593756398|FG001|Overall Study|Patient switched to another drug|0|||
164378475|NCT02383758|593758499|FG000|Overall Study|Withdrawal by Subject|0|||
164378476|NCT02383758|593758500|FG001|Overall Study|Withdrawal by Subject|2|||
164378477|NCT00600821|593758502|FG000|Overall Study|Death|45|||
164378478|NCT00600821|593758503|FG001|Overall Study|Death|46|||
164378479|NCT00600821|593758502|FG000|Overall Study|Lost to Follow-up|2|||
164378480|NCT00600821|593758503|FG001|Overall Study|Lost to Follow-up|2|||
164012908|NCT01469013|592410620|FG007|Part B (Extension Period)|Adverse Event|5|||
164012909|NCT01469013|592410621|FG008|Part B (Extension Period)|Adverse Event|3|||
164012910|NCT01469013|592410622|FG009|Part B (Extension Period)|Adverse Event|3|||
164012911|NCT01469013|592410623|FG010|Part B (Extension Period)|Adverse Event|1|||
164378481|NCT00600821|593758502|FG000|Overall Study|Withdrawal by Subject|1|||
164012912|NCT01469013|592410624|FG011|Part B (Extension Period)|Adverse Event|6|||
164012913|NCT01469013|592410625|FG012|Part B (Extension Period)|Adverse Event|3|||
164012914|NCT01469013|592410613|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
164012915|NCT01469013|592410614|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
164012916|NCT01469013|592410615|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
164012917|NCT01469013|592410616|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
164012918|NCT01469013|592410617|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
164012919|NCT01469013|592410618|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
164012920|NCT01469013|592410619|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
164012921|NCT01469013|592410620|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
164012922|NCT01469013|592410621|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
164012923|NCT01469013|592410622|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
164012924|NCT01469013|592410623|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
164012925|NCT01469013|592410624|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
164012926|NCT01469013|592410625|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
164012927|NCT05232097|592410626|FG000|Overall Study|Physician Decision|1|||
164012928|NCT02902809|592410629|FG000|Overall Study|Discontinuation of asthma program|28|||
164012929|NCT00532259|592410630|FG000|Overall Study|Withdrawal by Subject|2|||
164012930|NCT00532259|592410630|FG000|Overall Study|Adverse Event|1|||
164012931|NCT00532259|592410630|FG000|Overall Study|Death|1|||
164012932|NCT00532259|592410630|FG000|Overall Study|Lack of Efficacy|21|||
164012933|NCT00532259|592410630|FG000|Overall Study|Lost to Follow-up|3|||
164012934|NCT00532259|592410630|FG000|Overall Study|Physician Decision|3|||
164012935|NCT00532259|592410630|FG000|Overall Study|Protocol Violation|1|||
164012936|NCT00871858|592410631|FG000|Overall Study|Protocol Violation|3|||
164012937|NCT00871858|592410632|FG001|Overall Study|Protocol Violation|4|||
164012938|NCT00871858|592410631|FG000|Overall Study|Adverse Event|1|||
164012939|NCT00871858|592410632|FG001|Overall Study|Adverse Event|1|||
164012940|NCT00871858|592410631|FG000|Overall Study|Withdrawal by Subject|1|||
164012941|NCT00871858|592410632|FG001|Overall Study|Withdrawal by Subject|1|||
164012942|NCT00871858|592410631|FG000|Overall Study|Lost to Follow-up|0|||
164012943|NCT00871858|592410632|FG001|Overall Study|Lost to Follow-up|1|||
164012944|NCT02795767|592410637|FG000|Overall Study|Received Commercial Emicizumab|1|||
164378482|NCT00600821|593758503|FG001|Overall Study|Withdrawal by Subject|1|||
164378483|NCT00600821|593758502|FG000|Overall Study|Terminated by sponsor|8|||
164378484|NCT00600821|593758503|FG001|Overall Study|Terminated by sponsor|6|||
164378485|NCT00600821|593758502|FG000|Overall Study|Objective progression or relapse|0|||
164378486|NCT00600821|593758503|FG001|Overall Study|Objective progression or relapse|1|||
164378487|NCT00600821|593758502|FG000|Overall Study|Randomized but not treated|0|||
164378488|NCT00600821|593758503|FG001|Overall Study|Randomized but not treated|1|||
164378489|NCT00600821|593758502|FG000|Overall Study|Other|2|||
164378490|NCT00600821|593758503|FG001|Overall Study|Other|3|||
164378491|NCT02602288|593758506|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
164378492|NCT02602288|593758507|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
164378493|NCT02602288|593758506|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
164378494|NCT02602288|593758507|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
164378495|NCT02602288|593758506|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
164012945|NCT02795767|592410638|FG001|Overall Study|Received Commercial Emicizumab|0|||
164012946|NCT02795767|592410639|FG002|Overall Study|Received Commercial Emicizumab|0|||
164012947|NCT04983940|592410640|FG000|Overall Study|Lost to Follow-up|14|||
164378496|NCT02602288|593758507|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
164378497|NCT02602288|593758506|FG000|12 Month Follow-up|Lost to Follow-up|0|||
164378498|NCT02602288|593758507|FG001|12 Month Follow-up|Lost to Follow-up|4|||
164378499|NCT02602288|593758506|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
164012948|NCT04983940|592410640|FG000|Overall Study|Lack of Efficacy|2|||
164012949|NCT01748760|592410641|FG000|Overall Study|Withdrawal by Subject|1|||
164012950|NCT01748760|592410642|FG001|Overall Study|Withdrawal by Subject|1|||
164012951|NCT01748760|592410641|FG000|Overall Study|Lost to Follow-up|5|||
164012952|NCT01748760|592410642|FG001|Overall Study|Lost to Follow-up|1|||
164378500|NCT02602288|593758507|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
164378501|NCT01310413|593758508|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
164378502|NCT01310413|593758509|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
164378503|NCT01310413|593758510|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
164378504|NCT01310413|593758511|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
164378505|NCT01310413|593758512|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
164378506|NCT01310413|593758513|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
164378507|NCT01310413|593758514|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
164378508|NCT01310413|593758508|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
164378509|NCT01310413|593758509|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
164378510|NCT01310413|593758510|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
164378511|NCT01310413|593758511|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
164378512|NCT01310413|593758512|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
164378513|NCT01310413|593758513|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
164378514|NCT01310413|593758514|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
164378515|NCT01310413|593758508|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
164378516|NCT01310413|593758509|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
164378517|NCT01310413|593758510|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
164378518|NCT01310413|593758511|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
164378519|NCT01310413|593758512|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
164378520|NCT01310413|593758513|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
164378521|NCT01310413|593758514|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
164378522|NCT01310413|593758508|FG000|Day 0 to Day 385|Other|1|||
164378523|NCT01310413|593758509|FG001|Day 0 to Day 385|Other|0|||
164378524|NCT01310413|593758510|FG002|Day 0 to Day 385|Other|3|||
164378525|NCT01310413|593758511|FG003|Day 0 to Day 385|Other|0|||
164378526|NCT01310413|593758512|FG004|Day 0 to Day 385|Other|0|||
164378527|NCT01310413|593758513|FG005|Day 0 to Day 385|Other|0|||
164378528|NCT01310413|593758514|FG006|Day 0 to Day 385|Other|0|||
164378529|NCT01310413|593758508|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378530|NCT01310413|593758509|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378531|NCT01310413|593758510|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378532|NCT01310413|593758511|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378533|NCT01310413|593758512|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378534|NCT01310413|593758513|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
164378535|NCT01310413|593758514|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
164378536|NCT01310413|593758508|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
164378537|NCT01310413|593758509|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
164378538|NCT01310413|593758510|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
164378539|NCT01310413|593758511|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
164378540|NCT01310413|593758512|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
164378541|NCT01310413|593758513|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
164378542|NCT01310413|593758514|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
164378543|NCT01076400|593758516|FG000|Overall Study|Adverse Event|2|||
164378544|NCT01076400|593758517|FG001|Overall Study|Adverse Event|0|||
164378545|NCT01076400|593758518|FG002|Overall Study|Adverse Event|0|||
164378546|NCT01076400|593758516|FG000|Overall Study|Progressive Disease|5|||
164378547|NCT01076400|593758517|FG001|Overall Study|Progressive Disease|0|||
164378548|NCT01076400|593758518|FG002|Overall Study|Progressive Disease|0|||
164378549|NCT02066298|593758523|FG000|Overall Study|Lost to Follow-up|3|||
164378550|NCT02066298|593758524|FG001|Overall Study|Lost to Follow-up|2|||
164378551|NCT02066298|593758525|FG002|Overall Study|Lost to Follow-up|3|||
164378552|NCT02066298|593758526|FG003|Overall Study|Lost to Follow-up|2|||
164378553|NCT02066298|593758527|FG004|Overall Study|Lost to Follow-up|3|||
164378554|NCT02066298|593758528|FG005|Overall Study|Lost to Follow-up|4|||
164378555|NCT02066298|593758523|FG000|Overall Study|Withdrawal by Subject|6|||
164378556|NCT02066298|593758524|FG001|Overall Study|Withdrawal by Subject|6|||
164378557|NCT02066298|593758525|FG002|Overall Study|Withdrawal by Subject|6|||
164378558|NCT02066298|593758526|FG003|Overall Study|Withdrawal by Subject|4|||
164378559|NCT02066298|593758527|FG004|Overall Study|Withdrawal by Subject|5|||
164378560|NCT02066298|593758528|FG005|Overall Study|Withdrawal by Subject|8|||
164378561|NCT02066298|593758523|FG000|Overall Study|Physician Decision|0|||
164378562|NCT02066298|593758524|FG001|Overall Study|Physician Decision|0|||
164378563|NCT02066298|593758525|FG002|Overall Study|Physician Decision|1|||
164378564|NCT02066298|593758526|FG003|Overall Study|Physician Decision|0|||
164378565|NCT02066298|593758527|FG004|Overall Study|Physician Decision|1|||
164378566|NCT02066298|593758528|FG005|Overall Study|Physician Decision|0|||
164378567|NCT01643473|593758529|FG000|Overall Study|Lost to Follow-up|1|||
164378568|NCT01643473|593758530|FG001|Overall Study|Lost to Follow-up|0|||
164378569|NCT01519518|593758532|FG000|Overall Study|Consent not available|7|||
164378570|NCT01519518|593758533|FG001|Overall Study|Consent not available|10|||
164378571|NCT02033889|593758534|FG000|Overall Study|Adverse Event|3|||
164378572|NCT02033889|593758535|FG001|Overall Study|Adverse Event|1|||
164378573|NCT02033889|593758536|FG002|Overall Study|Adverse Event|3|||
164378574|NCT02033889|593758534|FG000|Overall Study|Death|3|||
164378575|NCT02033889|593758535|FG001|Overall Study|Death|1|||
164378576|NCT02033889|593758536|FG002|Overall Study|Death|2|||
164378577|NCT02033889|593758534|FG000|Overall Study|Excluded Medication|1|||
164378578|NCT02033889|593758535|FG001|Overall Study|Excluded Medication|1|||
164378579|NCT02033889|593758536|FG002|Overall Study|Excluded Medication|0|||
164378580|NCT02033889|593758534|FG000|Overall Study|Lost to Follow-up|8|||
164378581|NCT02033889|593758535|FG001|Overall Study|Lost to Follow-up|5|||
164378582|NCT02033889|593758536|FG002|Overall Study|Lost to Follow-up|6|||
164378583|NCT02033889|593758534|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164378584|NCT02033889|593758535|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164378585|NCT02033889|593758536|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164378586|NCT02033889|593758534|FG000|Overall Study|Physician Decision|0|||
164378587|NCT02033889|593758535|FG001|Overall Study|Physician Decision|1|||
164378588|NCT02033889|593758536|FG002|Overall Study|Physician Decision|1|||
164378589|NCT02033889|593758534|FG000|Overall Study|Participant moved|0|||
164378590|NCT02033889|593758535|FG001|Overall Study|Participant moved|1|||
164378591|NCT02033889|593758536|FG002|Overall Study|Participant moved|0|||
164378592|NCT02033889|593758534|FG000|Overall Study|Withdrawal by Subject|18|||
164378593|NCT02033889|593758535|FG001|Overall Study|Withdrawal by Subject|10|||
164378594|NCT02033889|593758536|FG002|Overall Study|Withdrawal by Subject|13|||
164378595|NCT01265953|593758542|FG000|Overall Study|Non compliance|5|||
164378596|NCT01265953|593758543|FG001|Overall Study|Non compliance|3|||
164378597|NCT00182689|593758544|FG000|Overall Study|Adverse Event|8|||
164378598|NCT00182689|593758545|FG001|Overall Study|Adverse Event|11|||
164378599|NCT00182689|593758544|FG000|Overall Study|Withdrawal by Subject|2|||
164378600|NCT00182689|593758545|FG001|Overall Study|Withdrawal by Subject|2|||
164378601|NCT00182689|593758544|FG000|Overall Study|Progression|27|||
164378602|NCT00182689|593758545|FG001|Overall Study|Progression|29|||
164378603|NCT00182689|593758544|FG000|Overall Study|Death|1|||
164378604|NCT00182689|593758545|FG001|Overall Study|Death|0|||
164378605|NCT00182689|593758544|FG000|Overall Study|not protocol specified|0|||
164378606|NCT00182689|593758545|FG001|Overall Study|not protocol specified|3|||
164378607|NCT00182689|593758544|FG000|Overall Study|Ineligible|1|||
164378608|NCT00182689|593758545|FG001|Overall Study|Ineligible|4|||
164378609|NCT00182689|593758544|FG000|Overall Study|Never received treatment|1|||
164378610|NCT00182689|593758545|FG001|Overall Study|Never received treatment|0|||
164378611|NCT01640301|593758546|FG000|Overall Study|Death|0|||
164378612|NCT01640301|593758547|FG001|Overall Study|Death|8|||
164378613|NCT00659646|593758548|FG000|Overall Study|Protocol Violation|12|||
164378614|NCT00659646|593758549|FG001|Overall Study|Protocol Violation|8|||
164378615|NCT00659646|593758548|FG000|Overall Study|Adverse Event|1|||
164378616|NCT00659646|593758549|FG001|Overall Study|Adverse Event|0|||
164378617|NCT00659646|593758548|FG000|Overall Study|Lost to Follow-up|1|||
164378618|NCT00659646|593758549|FG001|Overall Study|Lost to Follow-up|0|||
164378619|NCT00659646|593758548|FG000|Overall Study|protocol noncompliance after randomized|1|||
164378620|NCT00659646|593758549|FG001|Overall Study|protocol noncompliance after randomized|0|||
164378621|NCT02391948|593758555|FG000|6-month Assessment|Death|0|||
164378622|NCT02391948|593758556|FG001|6-month Assessment|Death|0|||
164378623|NCT02391948|593758557|FG002|6-month Assessment|Death|0|||
164378624|NCT02391948|593758558|FG003|6-month Assessment|Death|0|||
164378625|NCT02391948|593758559|FG004|6-month Assessment|Death|1|||
164378626|NCT02391948|593758555|FG000|6-month Assessment|Withdrawal by Subject|0|||
164378627|NCT02391948|593758556|FG001|6-month Assessment|Withdrawal by Subject|0|||
164378628|NCT02391948|593758557|FG002|6-month Assessment|Withdrawal by Subject|1|||
164378629|NCT02391948|593758558|FG003|6-month Assessment|Withdrawal by Subject|2|||
164378630|NCT02391948|593758559|FG004|6-month Assessment|Withdrawal by Subject|0|||
164378631|NCT02391948|593758555|FG000|6-month Assessment|Lost to Follow-up|4|||
164378632|NCT02391948|593758556|FG001|6-month Assessment|Lost to Follow-up|5|||
164378633|NCT02391948|593758557|FG002|6-month Assessment|Lost to Follow-up|2|||
164378634|NCT02391948|593758558|FG003|6-month Assessment|Lost to Follow-up|3|||
164378635|NCT02391948|593758559|FG004|6-month Assessment|Lost to Follow-up|1|||
164378636|NCT02391948|593758555|FG000|6-month Assessment|Medical issue/illness|1|||
164378637|NCT02391948|593758556|FG001|6-month Assessment|Medical issue/illness|1|||
164378638|NCT02391948|593758557|FG002|6-month Assessment|Medical issue/illness|0|||
164378639|NCT02391948|593758558|FG003|6-month Assessment|Medical issue/illness|0|||
164378640|NCT02391948|593758559|FG004|6-month Assessment|Medical issue/illness|0|||
164378641|NCT02391948|593758555|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
164378642|NCT02391948|593758556|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
164378643|NCT02391948|593758557|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
164378644|NCT02391948|593758558|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
164378645|NCT02391948|593758559|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
164378646|NCT02391948|593758555|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
164378647|NCT02391948|593758556|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
164378648|NCT02391948|593758557|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
163902798|NCT03611075|592014766|FG005|Overall Study|Lost to Follow-up|0|||
163902799|NCT03611075|592014767|FG006|Overall Study|Lost to Follow-up|0|||
163902800|NCT03611075|592014768|FG007|Overall Study|Lost to Follow-up|0|||
163902801|NCT03611075|592014769|FG008|Overall Study|Lost to Follow-up|0|||
164378649|NCT02391948|593758558|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
164378650|NCT02391948|593758559|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
164378651|NCT02391948|593758555|FG000|12-month Assessment|Death|0|||
164378652|NCT02391948|593758556|FG001|12-month Assessment|Death|0|||
164378653|NCT02391948|593758557|FG002|12-month Assessment|Death|0|||
164378654|NCT02391948|593758558|FG003|12-month Assessment|Death|1|||
164378655|NCT02391948|593758559|FG004|12-month Assessment|Death|0|||
164378656|NCT02391948|593758555|FG000|12-month Assessment|Withdrawal by Subject|1|||
164378657|NCT02391948|593758556|FG001|12-month Assessment|Withdrawal by Subject|0|||
164378658|NCT02391948|593758557|FG002|12-month Assessment|Withdrawal by Subject|0|||
164378659|NCT02391948|593758558|FG003|12-month Assessment|Withdrawal by Subject|1|||
164378660|NCT02391948|593758559|FG004|12-month Assessment|Withdrawal by Subject|0|||
164378661|NCT02391948|593758555|FG000|12-month Assessment|Lost to Follow-up|5|||
164378662|NCT02391948|593758556|FG001|12-month Assessment|Lost to Follow-up|4|||
164378663|NCT02391948|593758557|FG002|12-month Assessment|Lost to Follow-up|4|||
164378664|NCT02391948|593758558|FG003|12-month Assessment|Lost to Follow-up|4|||
164378665|NCT02391948|593758559|FG004|12-month Assessment|Lost to Follow-up|5|||
164378666|NCT02391948|593758555|FG000|12-month Assessment|Medical issue/illness|0|||
164378667|NCT02391948|593758556|FG001|12-month Assessment|Medical issue/illness|1|||
164378668|NCT02391948|593758557|FG002|12-month Assessment|Medical issue/illness|0|||
164378669|NCT02391948|593758558|FG003|12-month Assessment|Medical issue/illness|1|||
164378670|NCT02391948|593758559|FG004|12-month Assessment|Medical issue/illness|0|||
164378671|NCT02391948|593758555|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
164378672|NCT02391948|593758556|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
164378673|NCT02391948|593758557|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
164378674|NCT02391948|593758558|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
164378675|NCT02391948|593758559|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
164378676|NCT02391948|593758555|FG000|18-month Assessment|Death|0|||
164378677|NCT02391948|593758556|FG001|18-month Assessment|Death|0|||
164378678|NCT02391948|593758557|FG002|18-month Assessment|Death|0|||
164378679|NCT02391948|593758558|FG003|18-month Assessment|Death|1|||
164378680|NCT02391948|593758559|FG004|18-month Assessment|Death|1|||
164378681|NCT02391948|593758555|FG000|18-month Assessment|Withdrawal by Subject|1|||
164378682|NCT02391948|593758556|FG001|18-month Assessment|Withdrawal by Subject|0|||
164378683|NCT02391948|593758557|FG002|18-month Assessment|Withdrawal by Subject|0|||
164378684|NCT02391948|593758558|FG003|18-month Assessment|Withdrawal by Subject|1|||
164378685|NCT02391948|593758559|FG004|18-month Assessment|Withdrawal by Subject|0|||
164378686|NCT02391948|593758555|FG000|18-month Assessment|Lost to Follow-up|2|||
164378687|NCT02391948|593758556|FG001|18-month Assessment|Lost to Follow-up|6|||
164378688|NCT02391948|593758557|FG002|18-month Assessment|Lost to Follow-up|2|||
164378689|NCT02391948|593758558|FG003|18-month Assessment|Lost to Follow-up|2|||
164378690|NCT02391948|593758559|FG004|18-month Assessment|Lost to Follow-up|3|||
164378691|NCT02391948|593758555|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
164378692|NCT02391948|593758556|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
164378693|NCT02391948|593758557|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
164378694|NCT02391948|593758558|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
164378695|NCT02391948|593758559|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
164378696|NCT02391948|593758555|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
164378697|NCT02391948|593758556|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
164378698|NCT02391948|593758557|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
164378699|NCT02391948|593758558|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
164378700|NCT02391948|593758559|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
164378701|NCT02391948|593758555|FG000|24-month Assessment|Death|0|||
164378702|NCT02391948|593758556|FG001|24-month Assessment|Death|0|||
164378703|NCT02391948|593758557|FG002|24-month Assessment|Death|0|||
164378704|NCT02391948|593758558|FG003|24-month Assessment|Death|0|||
164378705|NCT02391948|593758559|FG004|24-month Assessment|Death|1|||
164378706|NCT02391948|593758555|FG000|24-month Assessment|Withdrawal by Subject|1|||
164378707|NCT02391948|593758556|FG001|24-month Assessment|Withdrawal by Subject|1|||
164378708|NCT02391948|593758557|FG002|24-month Assessment|Withdrawal by Subject|0|||
164378709|NCT02391948|593758558|FG003|24-month Assessment|Withdrawal by Subject|0|||
164378710|NCT02391948|593758559|FG004|24-month Assessment|Withdrawal by Subject|1|||
164378711|NCT02391948|593758555|FG000|24-month Assessment|Lost to Follow-up|5|||
164378712|NCT02391948|593758556|FG001|24-month Assessment|Lost to Follow-up|4|||
164378713|NCT02391948|593758557|FG002|24-month Assessment|Lost to Follow-up|0|||
164378714|NCT02391948|593758558|FG003|24-month Assessment|Lost to Follow-up|0|||
164378715|NCT02391948|593758559|FG004|24-month Assessment|Lost to Follow-up|0|||
164378716|NCT02391948|593758555|FG000|24-month Assessment|Medical issue/illness|0|||
163902802|NCT03611075|592014761|FG000|Overall Study|Withdrawal by Subject|0|||
164378717|NCT02391948|593758556|FG001|24-month Assessment|Medical issue/illness|0|||
164378718|NCT02391948|593758557|FG002|24-month Assessment|Medical issue/illness|1|||
163902803|NCT03611075|592014762|FG001|Overall Study|Withdrawal by Subject|1|||
163902804|NCT03611075|592014763|FG002|Overall Study|Withdrawal by Subject|1|||
163902805|NCT03611075|592014764|FG003|Overall Study|Withdrawal by Subject|1|||
163902806|NCT03611075|592014765|FG004|Overall Study|Withdrawal by Subject|0|||
164378719|NCT02391948|593758558|FG003|24-month Assessment|Medical issue/illness|0|||
164378720|NCT02391948|593758559|FG004|24-month Assessment|Medical issue/illness|0|||
164378721|NCT02391948|593758555|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
164378722|NCT02391948|593758556|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
164378723|NCT02391948|593758557|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
164378724|NCT02391948|593758558|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
164378725|NCT02391948|593758559|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
164378726|NCT02348489|593758560|FG000|Overall Study|Death|336|||
164378727|NCT02348489|593758561|FG001|Overall Study|Death|335|||
164378728|NCT02348489|593758560|FG000|Overall Study|Withdrawal by Subject|14|||
164378729|NCT02348489|593758561|FG001|Overall Study|Withdrawal by Subject|27|||
164378730|NCT02348489|593758560|FG000|Overall Study|Lost to Follow-up|3|||
164378731|NCT02348489|593758561|FG001|Overall Study|Lost to Follow-up|5|||
164378732|NCT00201006|593758562|FG000|Overall Study|Withdrawal by Subject|7|||
164378733|NCT00201006|593758563|FG001|Overall Study|Withdrawal by Subject|2|||
164378734|NCT00201006|593758564|FG002|Overall Study|Withdrawal by Subject|3|||
164378735|NCT00201006|593758562|FG000|Overall Study|Adverse Event|1|||
164378736|NCT00201006|593758563|FG001|Overall Study|Adverse Event|0|||
164378737|NCT00201006|593758564|FG002|Overall Study|Adverse Event|1|||
164378738|NCT01969838|593758567|FG000|Double-blind Phase|Adverse Event|10|||
164378739|NCT01969838|593758568|FG001|Double-blind Phase|Adverse Event|4|||
164378740|NCT01969838|593758569|FG002|Double-blind Phase|Adverse Event|0|||
164378741|NCT01969838|593758570|FG003|Double-blind Phase|Adverse Event|0|||
164378742|NCT01969838|593758567|FG000|Double-blind Phase|Death|5|||
164378743|NCT01969838|593758568|FG001|Double-blind Phase|Death|2|||
164378744|NCT01969838|593758569|FG002|Double-blind Phase|Death|0|||
163902807|NCT03611075|592014766|FG005|Overall Study|Withdrawal by Subject|0|||
163902808|NCT03611075|592014767|FG006|Overall Study|Withdrawal by Subject|1|||
163902809|NCT03611075|592014768|FG007|Overall Study|Withdrawal by Subject|0|||
163902810|NCT03611075|592014769|FG008|Overall Study|Withdrawal by Subject|0|||
163902811|NCT03611075|592014761|FG000|Overall Study|Reason unknown|0|||
163902812|NCT03611075|592014762|FG001|Overall Study|Reason unknown|0|||
163902813|NCT03611075|592014763|FG002|Overall Study|Reason unknown|0|||
163902814|NCT03611075|592014764|FG003|Overall Study|Reason unknown|1|||
163902815|NCT03611075|592014765|FG004|Overall Study|Reason unknown|0|||
163902816|NCT03611075|592014766|FG005|Overall Study|Reason unknown|0|||
163902817|NCT03611075|592014767|FG006|Overall Study|Reason unknown|1|||
163902818|NCT03611075|592014768|FG007|Overall Study|Reason unknown|0|||
163902819|NCT03611075|592014769|FG008|Overall Study|Reason unknown|0|||
163902820|NCT02972359|592014770|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
163902821|NCT02972359|592014770|FG000|Overall Study|Lack of Efficacy|1|||
163902822|NCT02972359|592014770|FG000|Overall Study|Adverse Event|4|||
163902823|NCT02972359|592014770|FG000|Overall Study|Death|1|||
163902824|NCT02972359|592014770|FG000|Overall Study|Withdrawal by Subject|30|||
163902825|NCT02972359|592014770|FG000|Overall Study|Protocol Violation|1|||
163902826|NCT02972359|592014770|FG000|Overall Study|Lost to Follow-up|26|||
163902827|NCT02972359|592014770|FG000|Overall Study|Other reasons|5|||
164012953|NCT01004146|592410649|FG000|Overall Study|Withdrawal by Subject|4|||
164012954|NCT01004146|592410650|FG001|Overall Study|Withdrawal by Subject|5|||
164378745|NCT01969838|593758570|FG003|Double-blind Phase|Death|0|||
164378746|NCT01969838|593758567|FG000|Double-blind Phase|Physician Decision|5|||
164378747|NCT01969838|593758568|FG001|Double-blind Phase|Physician Decision|1|||
164378748|NCT01969838|593758569|FG002|Double-blind Phase|Physician Decision|0|||
164378749|NCT01969838|593758570|FG003|Double-blind Phase|Physician Decision|0|||
164378750|NCT01969838|593758567|FG000|Double-blind Phase|Subject Decision|4|||
164378751|NCT01969838|593758568|FG001|Double-blind Phase|Subject Decision|2|||
163902828|NCT02972359|592014770|FG000|Overall Study|Missing|1|||
163902829|NCT03488719|592014771|FG000|Overall Study|Adverse Event|0|||
163902830|NCT03488719|592014772|FG001|Overall Study|Adverse Event|4|||
163902831|NCT03488719|592014773|FG002|Overall Study|Adverse Event|2|||
163902832|NCT03488719|592014771|FG000|Overall Study|Other|0|||
163902833|NCT03488719|592014772|FG001|Overall Study|Other|0|||
164012955|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Adverse Event|37|||
164012956|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Adverse Event|0|||
163902834|NCT03488719|592014773|FG002|Overall Study|Other|5|||
163902835|NCT03414684|592014778|FG000|First-course Treatment|Complete response|0|||
163902836|NCT03414684|592014779|FG001|First-course Treatment|Complete response|1|||
164012957|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Adverse Event|0|||
164378752|NCT01969838|593758569|FG002|Double-blind Phase|Subject Decision|0|||
164378753|NCT01969838|593758570|FG003|Double-blind Phase|Subject Decision|0|||
164378754|NCT01969838|593758567|FG000|Double-blind Phase|Disease Progression|2|||
164378755|NCT01969838|593758568|FG001|Double-blind Phase|Disease Progression|0|||
164378756|NCT01969838|593758569|FG002|Double-blind Phase|Disease Progression|0|||
164378757|NCT01969838|593758570|FG003|Double-blind Phase|Disease Progression|0|||
163902837|NCT03414684|592014778|FG000|First-course Treatment|Intercurrent illness|1|||
163902838|NCT03414684|592014779|FG001|First-course Treatment|Intercurrent illness|0|||
163902839|NCT03414684|592014778|FG000|First-course Treatment|Progressive Disease|31|||
164012958|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Adverse Event|0|||
164012959|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Death|2|||
164012960|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Death|0|||
164012961|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Death|0|||
164012962|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Death|0|||
164012963|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
164012964|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
164012965|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
164012966|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
164012967|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
164012968|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
164012969|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
164012970|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
164378758|NCT01969838|593758567|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
164378759|NCT01969838|593758568|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
164378760|NCT01969838|593758569|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
164378761|NCT01969838|593758570|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
164378762|NCT01969838|593758567|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
164378763|NCT01969838|593758568|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
164378764|NCT01969838|593758569|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
164378765|NCT01969838|593758570|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
164378766|NCT01969838|593758567|FG000|Open-label Phase|Adverse Event|0|||
164378767|NCT01969838|593758568|FG001|Open-label Phase|Adverse Event|0|||
164378768|NCT01969838|593758569|FG002|Open-label Phase|Adverse Event|37|||
164378769|NCT01969838|593758570|FG003|Open-label Phase|Adverse Event|49|||
164378770|NCT01969838|593758567|FG000|Open-label Phase|Disease Progression|0|||
164378771|NCT01969838|593758568|FG001|Open-label Phase|Disease Progression|0|||
164378772|NCT01969838|593758569|FG002|Open-label Phase|Disease Progression|26|||
164378773|NCT01969838|593758570|FG003|Open-label Phase|Disease Progression|27|||
164378774|NCT01969838|593758567|FG000|Open-label Phase|Lack of Efficacy|0|||
164378775|NCT01969838|593758568|FG001|Open-label Phase|Lack of Efficacy|0|||
164378776|NCT01969838|593758569|FG002|Open-label Phase|Lack of Efficacy|17|||
164378777|NCT01969838|593758570|FG003|Open-label Phase|Lack of Efficacy|19|||
164378778|NCT01969838|593758567|FG000|Open-label Phase|Subject Decision|0|||
164378779|NCT01969838|593758568|FG001|Open-label Phase|Subject Decision|0|||
164378780|NCT01969838|593758569|FG002|Open-label Phase|Subject Decision|14|||
164378781|NCT01969838|593758570|FG003|Open-label Phase|Subject Decision|15|||
164378782|NCT01969838|593758567|FG000|Open-label Phase|Death|0|||
164378783|NCT01969838|593758568|FG001|Open-label Phase|Death|0|||
164378784|NCT01969838|593758569|FG002|Open-label Phase|Death|13|||
164378785|NCT01969838|593758570|FG003|Open-label Phase|Death|11|||
164378786|NCT01969838|593758567|FG000|Open-label Phase|Physician Decision|0|||
164378787|NCT01969838|593758568|FG001|Open-label Phase|Physician Decision|0|||
164378788|NCT01969838|593758569|FG002|Open-label Phase|Physician Decision|9|||
164378789|NCT01969838|593758570|FG003|Open-label Phase|Physician Decision|14|||
164378790|NCT01969838|593758567|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
164378791|NCT01969838|593758568|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
164378792|NCT01969838|593758569|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
164012971|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
164012972|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
164012973|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
164012974|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
164012975|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
164012976|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
164012977|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
164012978|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
164012979|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Physician Decision|4|||
164012980|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Physician Decision|0|||
164378793|NCT01969838|593758570|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
164378794|NCT00408993|593758571|FG000|Overall Study|Adverse Event|15|||
164378795|NCT00408993|593758572|FG001|Overall Study|Adverse Event|4|||
164378796|NCT00408993|593758571|FG000|Overall Study|Protocol Violation|1|||
164378797|NCT00408993|593758572|FG001|Overall Study|Protocol Violation|6|||
164378798|NCT00408993|593758571|FG000|Overall Study|Lack of Efficacy|1|||
164378799|NCT00408993|593758572|FG001|Overall Study|Lack of Efficacy|4|||
164378800|NCT00408993|593758571|FG000|Overall Study|Withdrawal by Subject|2|||
164378801|NCT00408993|593758572|FG001|Overall Study|Withdrawal by Subject|3|||
164012981|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Physician Decision|0|||
164012982|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Physician Decision|0|||
164012983|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Pregnancy|1|||
164378802|NCT04193202|593758573|FG000|Overall Study|Adverse Event|2|||
164378803|NCT04193202|593758574|FG001|Overall Study|Adverse Event|1|||
164378804|NCT04193202|593758573|FG000|Overall Study|Death|0|||
164378805|NCT04193202|593758574|FG001|Overall Study|Death|1|||
164378806|NCT04193202|593758573|FG000|Overall Study|Physician Decision|1|||
164378807|NCT04193202|593758574|FG001|Overall Study|Physician Decision|1|||
164378808|NCT04193202|593758573|FG000|Overall Study|Protocol Violation|2|||
164378809|NCT04193202|593758574|FG001|Overall Study|Protocol Violation|2|||
163902840|NCT03414684|592014779|FG001|First-course Treatment|Progressive Disease|32|||
163902841|NCT03414684|592014778|FG000|First-course Treatment|Adverse Event|1|||
163902842|NCT03414684|592014779|FG001|First-course Treatment|Adverse Event|2|||
163902843|NCT03414684|592014778|FG000|First-course Treatment|Physician Decision|0|||
163902844|NCT03414684|592014779|FG001|First-course Treatment|Physician Decision|1|||
163902845|NCT03414684|592014778|FG000|First-course Treatment|Withdrawal by Subject|0|||
163902846|NCT03414684|592014779|FG001|First-course Treatment|Withdrawal by Subject|1|||
163902847|NCT03414684|592014778|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
163902848|NCT03414684|592014779|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
164378810|NCT04193202|593758573|FG000|Overall Study|Withdrawal by Subject|11|||
164378811|NCT04193202|593758574|FG001|Overall Study|Withdrawal by Subject|5|||
164378812|NCT02488629|593758575|FG000|Overall Study|Lack of Efficacy|3|||
164378813|NCT02488629|593758576|FG001|Overall Study|Lack of Efficacy|1|||
164378814|NCT02488629|593758577|FG002|Overall Study|Lack of Efficacy|0|||
164378815|NCT02488629|593758578|FG003|Overall Study|Lack of Efficacy|0|||
164378816|NCT02488629|593758575|FG000|Overall Study|Withdrawal by Subject|0|||
164378817|NCT02488629|593758576|FG001|Overall Study|Withdrawal by Subject|1|||
164378818|NCT02488629|593758577|FG002|Overall Study|Withdrawal by Subject|0|||
164378819|NCT02488629|593758578|FG003|Overall Study|Withdrawal by Subject|0|||
164378820|NCT00577122|593758579|FG000|Overall Study|Adverse Event|0|||
164378821|NCT00577122|593758580|FG001|Overall Study|Adverse Event|2|||
164378822|NCT00577122|593758579|FG000|Overall Study|Progression, relapse during active trt|6|||
163902849|NCT03414684|592014778|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
163902850|NCT03414684|592014779|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
164378823|NCT00577122|593758580|FG001|Overall Study|Progression, relapse during active trt|8|||
164378824|NCT00577122|593758579|FG000|Overall Study|Prog, refract disease during active trt|8|||
164378825|NCT00577122|593758580|FG001|Overall Study|Prog, refract disease during active trt|5|||
164378826|NCT00577122|593758579|FG000|Overall Study|Alternative Therapy|0|||
164378827|NCT00577122|593758580|FG001|Overall Study|Alternative Therapy|1|||
164378828|NCT02148003|593758581|FG000|Overall Study|Failed inclusion criteria|1|||
164378829|NCT02148003|593758582|FG001|Overall Study|Failed inclusion criteria|0|||
164378830|NCT02148003|593758581|FG000|Overall Study|Met exclusion criteria|0|||
164378831|NCT02148003|593758582|FG001|Overall Study|Met exclusion criteria|1|||
164378832|NCT02148003|593758581|FG000|Overall Study|Withdrawal by Subject|0|||
164378833|NCT02148003|593758582|FG001|Overall Study|Withdrawal by Subject|1|||
164378834|NCT00436280|593758588|FG000|Period 1: Induction|Adverse Event|8|||
164378835|NCT00436280|593758588|FG000|Period 1: Induction|Progressive Disease|12|||
164378836|NCT00436280|593758588|FG000|Period 1: Induction|Stable Disease|6|||
164378837|NCT00436280|593758588|FG000|Period 1: Induction|Withdrawal by Subject|1|||
164378838|NCT00436280|593758588|FG000|Period 1: Induction|Death|1|||
164378839|NCT00436280|593758588|FG000|Period 2: Consolidation|Adverse Event|1|||
164378840|NCT00436280|593758588|FG000|Period 2: Consolidation|Progressive Disease|10|||
164378841|NCT00436280|593758588|FG000|Period 2: Consolidation|Stable Disease|1|||
164378842|NCT00436280|593758588|FG000|Period 2: Consolidation|Physician Decision|2|||
164378843|NCT00436280|593758588|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
164378844|NCT00436280|593758588|FG000|Period 2: Consolidation|Death|1|||
164378845|NCT00436280|593758588|FG000|Period 3: Maintenance|Adverse Event|6|||
164378846|NCT00436280|593758588|FG000|Period 3: Maintenance|Progressive Disease|12|||
164378847|NCT02039427|593758589|FG000|Overall Study|Duration of surgery > 3h|1|||
164378848|NCT02039427|593758590|FG001|Overall Study|Duration of surgery > 3h|1|||
164378849|NCT02039427|593758591|FG002|Overall Study|Duration of surgery > 3h|0|||
164378850|NCT02039427|593758592|FG003|Overall Study|Duration of surgery > 3h|0|||
164378851|NCT02039427|593758589|FG000|Overall Study|Withdrawal on concent|0|||
164378852|NCT02039427|593758590|FG001|Overall Study|Withdrawal on concent|0|||
164378853|NCT02039427|593758591|FG002|Overall Study|Withdrawal on concent|0|||
164378854|NCT02039427|593758592|FG003|Overall Study|Withdrawal on concent|1|||
164378855|NCT02039427|593758589|FG000|Overall Study|Cancellation of surgery|0|||
164378856|NCT02039427|593758590|FG001|Overall Study|Cancellation of surgery|0|||
164378857|NCT02039427|593758591|FG002|Overall Study|Cancellation of surgery|1|||
164378858|NCT02039427|593758592|FG003|Overall Study|Cancellation of surgery|0|||
164378859|NCT02039427|593758589|FG000|Overall Study|Loss of follow - up|1|||
164378860|NCT02039427|593758590|FG001|Overall Study|Loss of follow - up|0|||
164378861|NCT02039427|593758591|FG002|Overall Study|Loss of follow - up|2|||
164378862|NCT02039427|593758592|FG003|Overall Study|Loss of follow - up|4|||
164378863|NCT02039427|593758589|FG000|Overall Study|Steroid Use|1|||
164378864|NCT02039427|593758590|FG001|Overall Study|Steroid Use|0|||
164378865|NCT02039427|593758591|FG002|Overall Study|Steroid Use|0|||
164378866|NCT02039427|593758592|FG003|Overall Study|Steroid Use|0|||
164378867|NCT03160703|593758596|FG000|Overall Study|Withdrawal by Subject|0|||
164378868|NCT03160703|593758597|FG001|Overall Study|Withdrawal by Subject|0|||
164092842|NCT01611090|592702155|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
164092843|NCT01611090|592702156|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
164092844|NCT00922779|592702157|FG000|Overall Study|Adverse Event|67|||
164092845|NCT00922779|592702157|FG000|Overall Study|Pregnancy|7|||
164092846|NCT00922779|592702157|FG000|Overall Study|Withdrawal by Subject|308|||
164092847|NCT00922779|592702157|FG000|Overall Study|Lost to Follow-up|44|||
164092848|NCT00922779|592702157|FG000|Overall Study|Other|27|||
164092849|NCT00922779|592702157|FG000|Overall Study|Missing|1874|||
164092850|NCT03968224|592702158|FG000|Overall Study|Lost to Follow-up|11|||
164092851|NCT03968224|592702159|FG001|Overall Study|Lost to Follow-up|18|||
164092852|NCT03601637|592703394|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
164092853|NCT03601637|592703395|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
164092854|NCT03601637|592703394|FG000|Overall Study|Adverse Event|1|||
164092855|NCT03601637|592703395|FG001|Overall Study|Adverse Event|1|||
164092856|NCT03601637|592703394|FG000|Overall Study|Other|0|||
164378869|NCT03160703|593758598|FG002|Overall Study|Withdrawal by Subject|0|||
164378870|NCT03160703|593758599|FG003|Overall Study|Withdrawal by Subject|1|||
164378871|NCT00087568|593758600|FG000|Overall Study|Adverse Event|4|||
164378872|NCT00087568|593758601|FG001|Overall Study|Adverse Event|0|||
164378873|NCT00087568|593758600|FG000|Overall Study|Withdrawal by Subject|1|||
164378874|NCT00087568|593758601|FG001|Overall Study|Withdrawal by Subject|1|||
164092857|NCT03601637|592703395|FG001|Overall Study|Other|1|||
164092858|NCT02322047|592703397|FG000|Overall Study|Physician Decision|1|||
164378875|NCT00087568|593758600|FG000|Overall Study|Lost to Follow-up|1|||
164092859|NCT02322047|592703398|FG001|Overall Study|Physician Decision|0|||
164092860|NCT02322047|592703399|FG002|Overall Study|Physician Decision|0|||
164092861|NCT02322047|592703400|FG003|Overall Study|Physician Decision|0|||
164378876|NCT00087568|593758601|FG001|Overall Study|Lost to Follow-up|0|||
164378877|NCT00087568|593758600|FG000|Overall Study|Lack of Efficacy|24|||
164378878|NCT00087568|593758601|FG001|Overall Study|Lack of Efficacy|1|||
164378879|NCT03728582|593758606|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
164378880|NCT03728582|593758607|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
164378881|NCT03728582|593758606|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
164378882|NCT03728582|593758607|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
164378883|NCT00047463|593758608|FG000|Overall Study|Withdrawal by Subject|0|||
164378884|NCT00047463|593758609|FG001|Overall Study|Withdrawal by Subject|3|||
164378885|NCT01274637|593758616|FG000|Overall Study|Withdrawal by Subject|0|||
164378886|NCT01274637|593758617|FG001|Overall Study|Withdrawal by Subject|1|||
164378887|NCT01274637|593758616|FG000|Overall Study|Lost to Follow-up|0|||
164378888|NCT01274637|593758617|FG001|Overall Study|Lost to Follow-up|1|||
164378889|NCT01824303|593758629|FG000|Randomized Study|Withdrawal by Subject|1|||
164378890|NCT01824303|593758630|FG001|Randomized Study|Withdrawal by Subject|1|||
164378891|NCT01824303|593758629|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
164378892|NCT01824303|593758630|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
164378893|NCT03296696|593758635|FG000|Overall Study|Started Other Antitumor Therapy|1|||
164378894|NCT03296696|593758636|FG001|Overall Study|Started Other Antitumor Therapy|2|||
164378895|NCT03296696|593758637|FG002|Overall Study|Started Other Antitumor Therapy|1|||
164378896|NCT03296696|593758638|FG003|Overall Study|Started Other Antitumor Therapy|2|||
164378897|NCT03296696|593758639|FG004|Overall Study|Started Other Antitumor Therapy|1|||
164378898|NCT03296696|593758640|FG005|Overall Study|Started Other Antitumor Therapy|1|||
164378899|NCT03296696|593758641|FG006|Overall Study|Started Other Antitumor Therapy|2|||
164378900|NCT03296696|593758642|FG007|Overall Study|Started Other Antitumor Therapy|3|||
164378901|NCT03296696|593758643|FG008|Overall Study|Started Other Antitumor Therapy|1|||
164378902|NCT03296696|593758644|FG009|Overall Study|Started Other Antitumor Therapy|0|||
164378903|NCT03296696|593758635|FG000|Overall Study|Death|0|||
164378904|NCT03296696|593758636|FG001|Overall Study|Death|1|||
164378905|NCT03296696|593758637|FG002|Overall Study|Death|1|||
164378906|NCT03296696|593758638|FG003|Overall Study|Death|2|||
164378907|NCT03296696|593758639|FG004|Overall Study|Death|2|||
164378908|NCT03296696|593758640|FG005|Overall Study|Death|3|||
164378909|NCT03296696|593758641|FG006|Overall Study|Death|1|||
164378910|NCT03296696|593758642|FG007|Overall Study|Death|2|||
164378911|NCT03296696|593758643|FG008|Overall Study|Death|0|||
164378912|NCT03296696|593758644|FG009|Overall Study|Death|0|||
164378913|NCT03296696|593758635|FG000|Overall Study|Withdrawal by Subject|0|||
164378914|NCT03296696|593758636|FG001|Overall Study|Withdrawal by Subject|0|||
164378915|NCT03296696|593758637|FG002|Overall Study|Withdrawal by Subject|1|||
164378916|NCT03296696|593758638|FG003|Overall Study|Withdrawal by Subject|0|||
164378917|NCT03296696|593758639|FG004|Overall Study|Withdrawal by Subject|1|||
164378918|NCT03296696|593758640|FG005|Overall Study|Withdrawal by Subject|0|||
164378919|NCT03296696|593758641|FG006|Overall Study|Withdrawal by Subject|0|||
164378920|NCT03296696|593758642|FG007|Overall Study|Withdrawal by Subject|0|||
164378921|NCT03296696|593758643|FG008|Overall Study|Withdrawal by Subject|0|||
164378922|NCT03296696|593758644|FG009|Overall Study|Withdrawal by Subject|1|||
164378923|NCT01350128|593758645|FG000|Overall Study|Withdrawal by Subject|3|||
164378924|NCT01350128|593758645|FG000|Overall Study|Protocol discontinuation criteria|8|||
164378925|NCT01350128|593758645|FG000|Overall Study|Physician Decision|1|||
164378926|NCT01350128|593758645|FG000|Overall Study|Lost to Follow-up|2|||
164378927|NCT01859715|593758649|FG000|Overall Study|No 2nd VAS|16|||
164378928|NCT01859715|593758650|FG001|Overall Study|No 2nd VAS|8|||
164378929|NCT01859715|593758651|FG002|Overall Study|No 2nd VAS|23|||
164378930|NCT00086580|593758655|FG000|Treatment Period|Disease progression|9|||
164378931|NCT00086580|593758656|FG001|Treatment Period|Disease progression|8|||
164378932|NCT00086580|593758655|FG000|Treatment Period|Unable to comply with protocol|3|||
164378933|NCT00086580|593758656|FG001|Treatment Period|Unable to comply with protocol|1|||
164378934|NCT00086580|593758655|FG000|Treatment Period|Withdrawal by Subject|7|||
164378935|NCT00086580|593758656|FG001|Treatment Period|Withdrawal by Subject|8|||
164378936|NCT00086580|593758655|FG000|Treatment Period|Physician Decision|13|||
164378937|NCT00086580|593758656|FG001|Treatment Period|Physician Decision|7|||
164378938|NCT00086580|593758655|FG000|Treatment Period|AE - not treatment related|7|||
164378939|NCT00086580|593758656|FG001|Treatment Period|AE - not treatment related|7|||
164378940|NCT00086580|593758655|FG000|Treatment Period|Toxicity - treatment related|15|||
164378941|NCT00086580|593758656|FG001|Treatment Period|Toxicity - treatment related|15|||
164378942|NCT00086580|593758655|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
164378943|NCT00086580|593758656|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
164378944|NCT00086580|593758655|FG000|Treatment Period|Death|5|||
164378945|NCT00086580|593758656|FG001|Treatment Period|Death|7|||
164378946|NCT00086580|593758655|FG000|Treatment Period|Other|5|||
164378947|NCT00086580|593758656|FG001|Treatment Period|Other|3|||
164378948|NCT00086580|593758655|FG000|Follow-up Period|Disease progression|72|||
164378949|NCT00086580|593758656|FG001|Follow-up Period|Disease progression|99|||
164378950|NCT00086580|593758655|FG000|Follow-up Period|Unable to comply with protocol|5|||
164378951|NCT00086580|593758656|FG001|Follow-up Period|Unable to comply with protocol|0|||
164378952|NCT00086580|593758655|FG000|Follow-up Period|Withdrawal by Subject|6|||
164378953|NCT00086580|593758656|FG001|Follow-up Period|Withdrawal by Subject|6|||
164378954|NCT00086580|593758655|FG000|Follow-up Period|Physician Decision|0|||
164378955|NCT00086580|593758656|FG001|Follow-up Period|Physician Decision|1|||
164378956|NCT00086580|593758655|FG000|Follow-up Period|AE - not related|1|||
164378957|NCT00086580|593758656|FG001|Follow-up Period|AE - not related|0|||
164378958|NCT00086580|593758655|FG000|Follow-up Period|Death|13|||
164378959|NCT00086580|593758656|FG001|Follow-up Period|Death|7|||
164378960|NCT00086580|593758655|FG000|Follow-up Period|Other|7|||
164378961|NCT00086580|593758656|FG001|Follow-up Period|Other|6|||
164378962|NCT00086580|593758655|FG000|Observation Period|Unable to comply with protocol|1|||
164378963|NCT00086580|593758656|FG001|Observation Period|Unable to comply with protocol|1|||
164378964|NCT00086580|593758655|FG000|Observation Period|Withdrawal by Subject|4|||
164378965|NCT00086580|593758656|FG001|Observation Period|Withdrawal by Subject|2|||
164378966|NCT00086580|593758655|FG000|Observation Period|Death|33|||
164378967|NCT00086580|593758656|FG001|Observation Period|Death|55|||
164378968|NCT00086580|593758655|FG000|Observation Period|Other|8|||
164378969|NCT00086580|593758656|FG001|Observation Period|Other|7|||
164378970|NCT00806546|593758663|FG000|Overall Study|Enrolled, not treated|35|||
164378971|NCT00806546|593758663|FG000|Overall Study|Lost to Follow-up|32|||
164092862|NCT02322047|592703397|FG000|Overall Study|Withdrawal by Subject|1|||
164378972|NCT00806546|593758663|FG000|Overall Study|Adverse Event|74|||
164378973|NCT00806546|593758663|FG000|Overall Study|Withdrawal by Subject|75|||
164378974|NCT00806546|593758663|FG000|Overall Study|Protocol Violation|49|||
164378975|NCT00806546|593758663|FG000|Overall Study|Various|42|||
164378976|NCT00558103|593758664|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
164378977|NCT00558103|593758665|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
164378978|NCT00558103|593758666|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
164378979|NCT00558103|593758667|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
164378980|NCT00558103|593758668|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
164378981|NCT00558103|593758669|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
164378982|NCT00558103|593758664|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
164378983|NCT00558103|593758665|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
164378984|NCT00558103|593758666|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
164378985|NCT00558103|593758667|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
164378986|NCT00558103|593758668|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
164378987|NCT00558103|593758669|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
164378988|NCT00558103|593758664|FG000|Randomized Treatment Phase|Disease Progression|1|||
164378989|NCT00558103|593758665|FG001|Randomized Treatment Phase|Disease Progression|0|||
164378990|NCT00558103|593758666|FG002|Randomized Treatment Phase|Disease Progression|1|||
164378991|NCT00558103|593758667|FG003|Randomized Treatment Phase|Disease Progression|0|||
164378992|NCT00558103|593758668|FG004|Randomized Treatment Phase|Disease Progression|0|||
164378993|NCT00558103|593758669|FG005|Randomized Treatment Phase|Disease Progression|0|||
164378994|NCT00558103|593758664|FG000|Randomized Treatment Phase|Adverse Event|0|||
164378995|NCT00558103|593758665|FG001|Randomized Treatment Phase|Adverse Event|0|||
164378996|NCT00558103|593758666|FG002|Randomized Treatment Phase|Adverse Event|0|||
164378997|NCT00558103|593758667|FG003|Randomized Treatment Phase|Adverse Event|1|||
164378998|NCT00558103|593758668|FG004|Randomized Treatment Phase|Adverse Event|1|||
164378999|NCT00558103|593758669|FG005|Randomized Treatment Phase|Adverse Event|0|||
164379000|NCT00558103|593758664|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
164379001|NCT00558103|593758665|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
164379002|NCT00558103|593758666|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
164379003|NCT00558103|593758667|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
164379004|NCT00558103|593758668|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
164379005|NCT00558103|593758669|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
164379006|NCT00558103|593758664|FG000|Monotherapy Extension Phase|Disease Progression|0|||
164379007|NCT00558103|593758665|FG001|Monotherapy Extension Phase|Disease Progression|0|||
164379008|NCT00558103|593758666|FG002|Monotherapy Extension Phase|Disease Progression|0|||
164379009|NCT00558103|593758667|FG003|Monotherapy Extension Phase|Disease Progression|0|||
164379010|NCT00558103|593758668|FG004|Monotherapy Extension Phase|Disease Progression|0|||
164379011|NCT00558103|593758669|FG005|Monotherapy Extension Phase|Disease Progression|8|||
164379012|NCT00308711|593758672|FG000|Overall Study|Withdrawal by Subject|1|||
164379013|NCT00308711|593758673|FG001|Overall Study|Withdrawal by Subject|0|||
164379014|NCT00308711|593758674|FG002|Overall Study|Withdrawal by Subject|1|||
164379015|NCT00308711|593758672|FG000|Overall Study|Protocol Violation|0|||
164379016|NCT00308711|593758673|FG001|Overall Study|Protocol Violation|1|||
164379017|NCT00308711|593758674|FG002|Overall Study|Protocol Violation|1|||
164379018|NCT00308711|593758672|FG000|Overall Study|Lost to Follow-up|0|||
164379019|NCT00308711|593758673|FG001|Overall Study|Lost to Follow-up|1|||
164379020|NCT00308711|593758674|FG002|Overall Study|Lost to Follow-up|0|||
164379021|NCT00308711|593758672|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
164379022|NCT00308711|593758673|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
164379023|NCT00308711|593758674|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
164379024|NCT00308711|593758672|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
164379025|NCT00308711|593758673|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
164379026|NCT00308711|593758674|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
164379027|NCT03139916|593758677|FG000|Overall Study|Withdrawal by Subject|2|||
164379028|NCT03139916|593758677|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
164379029|NCT01957475|593758678|FG000|Test Period 1|Withdrawal by Subject|1|||
164379030|NCT01957475|593758679|FG001|Test Period 1|Withdrawal by Subject|0|||
164379031|NCT01957475|593758678|FG000|Test Period 1|Other|1|||
164379032|NCT01957475|593758679|FG001|Test Period 1|Other|0|||
164379033|NCT01957475|593758678|FG000|Test Period 1|Lack of Efficacy|0|||
164379034|NCT01957475|593758679|FG001|Test Period 1|Lack of Efficacy|1|||
164379035|NCT01957475|593758678|FG000|Test Period 2|Adverse Event|1|||
164379036|NCT01957475|593758679|FG001|Test Period 2|Adverse Event|0|||
164379037|NCT02469610|593758680|FG000|Overall Study|Death|1|||
164379038|NCT02469610|593758681|FG001|Overall Study|Death|0|||
164379039|NCT02469610|593758680|FG000|Overall Study|Lost to Follow-up|1|||
164379040|NCT02469610|593758681|FG001|Overall Study|Lost to Follow-up|0|||
164379041|NCT02469610|593758680|FG000|Overall Study|exclusion criteria|2|||
164379042|NCT02469610|593758681|FG001|Overall Study|exclusion criteria|1|||
164379043|NCT00414388|593758684|FG000|Overall Study|Adverse Event|1|||
164379044|NCT02318693|593758685|FG000|Overall Study|Protocol Violation|0|||
164379045|NCT02318693|593758686|FG001|Overall Study|Protocol Violation|1|||
164379046|NCT03591575|593758687|FG000|Overall Study|Adverse Event|2|||
164379047|NCT03591575|593758688|FG001|Overall Study|Adverse Event|0|||
164379048|NCT03591575|593758687|FG000|Overall Study|Withdrawal by Subject|4|||
164379049|NCT03591575|593758688|FG001|Overall Study|Withdrawal by Subject|1|||
164379050|NCT00813358|593758691|FG000|Overall Study|Death|32|||
164379051|NCT00813358|593758691|FG000|Overall Study|Lost to Follow-up|12|||
164379052|NCT00813358|593758691|FG000|Overall Study|other endpoints|5|||
164012984|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Pregnancy|0|||
164012985|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Pregnancy|0|||
164012986|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Pregnancy|0|||
164012987|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
164012988|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
164012989|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
164012990|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
164012991|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
164012992|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
164012993|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
164012994|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
164012995|NCT01855789|592410659|FG000|1) Baseline up to Week 24|Other|4|||
164012996|NCT01855789|592410660|FG001|1) Baseline up to Week 24|Other|0|||
164012997|NCT01855789|592410661|FG002|1) Baseline up to Week 24|Other|0|||
164012998|NCT01855789|592410662|FG003|1) Baseline up to Week 24|Other|0|||
164012999|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
164013000|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
164013001|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
164013002|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
164013003|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
164013004|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
164013005|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
164013006|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
164013007|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
164013008|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
164013009|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
164379053|NCT00813358|593758691|FG000|Overall Study|Withdrawal by Subject|20|||
164379054|NCT00218543|593758692|FG000|Overall Study|Lost to Follow-up|8|||
164379055|NCT00218543|593758692|FG000|Overall Study|relocated|1|||
164379056|NCT00218543|593758692|FG000|Overall Study|Withdrawal by Subject|1|||
164379057|NCT00218543|593758692|FG000|Overall Study|Physician Decision|3|||
164013010|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
164013011|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
164013012|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
164013013|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
164013014|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
164013015|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
164013016|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
164013017|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
164013018|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
164013019|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
164013020|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
164013021|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
164013022|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
164013023|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
164013024|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
164013025|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
164013026|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
164379058|NCT00218543|593758692|FG000|Overall Study|Adverse Event|2|||
164013027|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
164013028|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
164092863|NCT02322047|592703398|FG001|Overall Study|Withdrawal by Subject|0|||
164092864|NCT02322047|592703399|FG002|Overall Study|Withdrawal by Subject|0|||
164092865|NCT02322047|592703400|FG003|Overall Study|Withdrawal by Subject|1|||
164092866|NCT02322047|592703397|FG000|Overall Study|Adverse Event|0|||
164379059|NCT03265119|593758693|FG000|Overall Study|Adverse Event|2|||
164379060|NCT03265119|593758694|FG001|Overall Study|Adverse Event|1|||
164379061|NCT03265119|593758693|FG000|Overall Study|Lack of Efficacy|3|||
164379062|NCT03265119|593758694|FG001|Overall Study|Lack of Efficacy|0|||
164379063|NCT03265119|593758693|FG000|Overall Study|Protocol Violation|1|||
164379064|NCT03265119|593758694|FG001|Overall Study|Protocol Violation|2|||
164379065|NCT03265119|593758693|FG000|Overall Study|Withdrawal by Subject|2|||
164379066|NCT03265119|593758694|FG001|Overall Study|Withdrawal by Subject|4|||
164379067|NCT03265119|593758693|FG000|Overall Study|Lost to Follow-up|1|||
164379068|NCT03265119|593758694|FG001|Overall Study|Lost to Follow-up|0|||
164013029|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
164013030|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
164092867|NCT02322047|592703398|FG001|Overall Study|Adverse Event|1|||
164092868|NCT02322047|592703399|FG002|Overall Study|Adverse Event|0|||
164092869|NCT02322047|592703400|FG003|Overall Study|Adverse Event|0|||
164379069|NCT03265119|593758693|FG000|Overall Study|Lack of Compliance|1|||
164379070|NCT03265119|593758694|FG001|Overall Study|Lack of Compliance|0|||
164379071|NCT04740034|593758695|FG000|Overall Study|Death|0|||
164379072|NCT04740034|593758696|FG001|Overall Study|Death|1|||
164379073|NCT04740034|593758697|FG002|Overall Study|Death|2|||
164379074|NCT04740034|593758698|FG003|Overall Study|Death|3|||
164379075|NCT04740034|593758699|FG004|Overall Study|Death|4|||
164379076|NCT04740034|593758700|FG005|Overall Study|Death|4|||
164379077|NCT04740034|593758701|FG006|Overall Study|Death|2|||
164379078|NCT04740034|593758702|FG007|Overall Study|Death|2|||
164379079|NCT04740034|593758703|FG008|Overall Study|Death|2|||
164379080|NCT04740034|593758704|FG009|Overall Study|Death|4|||
164379081|NCT04740034|593758705|FG010|Overall Study|Death|0|||
164379082|NCT04740034|593758695|FG000|Overall Study|Lost to Follow-up|0|||
164379083|NCT04740034|593758696|FG001|Overall Study|Lost to Follow-up|0|||
164379084|NCT04740034|593758697|FG002|Overall Study|Lost to Follow-up|0|||
164379085|NCT04740034|593758698|FG003|Overall Study|Lost to Follow-up|1|||
164379086|NCT04740034|593758699|FG004|Overall Study|Lost to Follow-up|2|||
164379087|NCT04740034|593758700|FG005|Overall Study|Lost to Follow-up|2|||
164379088|NCT04740034|593758701|FG006|Overall Study|Lost to Follow-up|0|||
164379089|NCT04740034|593758702|FG007|Overall Study|Lost to Follow-up|0|||
164379090|NCT04740034|593758703|FG008|Overall Study|Lost to Follow-up|0|||
164379091|NCT04740034|593758704|FG009|Overall Study|Lost to Follow-up|1|||
164379092|NCT04740034|593758705|FG010|Overall Study|Lost to Follow-up|0|||
164379093|NCT04740034|593758695|FG000|Overall Study|Withdrawal by Subject|1|||
164379094|NCT04740034|593758696|FG001|Overall Study|Withdrawal by Subject|0|||
164379095|NCT04740034|593758697|FG002|Overall Study|Withdrawal by Subject|0|||
164379096|NCT04740034|593758698|FG003|Overall Study|Withdrawal by Subject|0|||
164379097|NCT04740034|593758699|FG004|Overall Study|Withdrawal by Subject|0|||
164379098|NCT04740034|593758700|FG005|Overall Study|Withdrawal by Subject|0|||
164379099|NCT04740034|593758701|FG006|Overall Study|Withdrawal by Subject|0|||
164379100|NCT04740034|593758702|FG007|Overall Study|Withdrawal by Subject|1|||
164379101|NCT04740034|593758703|FG008|Overall Study|Withdrawal by Subject|0|||
164379102|NCT04740034|593758704|FG009|Overall Study|Withdrawal by Subject|1|||
164379103|NCT04740034|593758705|FG010|Overall Study|Withdrawal by Subject|0|||
164379104|NCT04740034|593758695|FG000|Overall Study|Decision by sponsor|0|||
164379105|NCT04740034|593758696|FG001|Overall Study|Decision by sponsor|0|||
164379106|NCT04740034|593758697|FG002|Overall Study|Decision by sponsor|1|||
164379107|NCT04740034|593758698|FG003|Overall Study|Decision by sponsor|0|||
164379108|NCT04740034|593758699|FG004|Overall Study|Decision by sponsor|0|||
164379109|NCT04740034|593758700|FG005|Overall Study|Decision by sponsor|0|||
164379110|NCT04740034|593758701|FG006|Overall Study|Decision by sponsor|1|||
164379111|NCT04740034|593758702|FG007|Overall Study|Decision by sponsor|2|||
164379112|NCT04740034|593758703|FG008|Overall Study|Decision by sponsor|1|||
164379113|NCT04740034|593758704|FG009|Overall Study|Decision by sponsor|1|||
164379114|NCT04740034|593758705|FG010|Overall Study|Decision by sponsor|2|||
164379115|NCT02086591|593760351|FG000|Overall Study|Adverse Event|1|||
164379116|NCT02086591|593760351|FG000|Overall Study|Withdrawal by Subject|1|||
164379117|NCT02086591|593760351|FG000|Overall Study|protocol terminated|3|||
164379118|NCT00274716|593760356|FG000|Phase A|Other non-reported reason|4|||
164379119|NCT00274716|593760357|FG001|Phase A|Other non-reported reason|2|||
164379120|NCT00274716|593760358|FG002|Phase A|Other non-reported reason|1|||
164379121|NCT00274716|593760359|FG003|Phase A|Other non-reported reason|2|||
164379122|NCT00274716|593760360|FG004|Phase A|Other non-reported reason|0|||
164379123|NCT00274716|593760361|FG005|Phase A|Other non-reported reason|1|||
164379124|NCT00274716|593760356|FG000|Phase A|Participant moved|0|||
164379125|NCT00274716|593760357|FG001|Phase A|Participant moved|0|||
164379126|NCT00274716|593760358|FG002|Phase A|Participant moved|1|||
164379127|NCT00274716|593760359|FG003|Phase A|Participant moved|0|||
164379128|NCT00274716|593760360|FG004|Phase A|Participant moved|0|||
164379129|NCT00274716|593760361|FG005|Phase A|Participant moved|1|||
164013031|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
164013032|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
164013033|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
164013034|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
164379130|NCT00274716|593760356|FG000|Phase A|Site Terminated|0|||
164379131|NCT00274716|593760357|FG001|Phase A|Site Terminated|0|||
164379132|NCT00274716|593760358|FG002|Phase A|Site Terminated|0|||
164379133|NCT00274716|593760359|FG003|Phase A|Site Terminated|1|||
164379134|NCT00274716|593760360|FG004|Phase A|Site Terminated|0|||
164379135|NCT00274716|593760361|FG005|Phase A|Site Terminated|0|||
164379136|NCT00274716|593760356|FG000|Phase A|Protocol Violation|1|||
164379137|NCT00274716|593760357|FG001|Phase A|Protocol Violation|0|||
164379138|NCT00274716|593760358|FG002|Phase A|Protocol Violation|0|||
164379139|NCT00274716|593760359|FG003|Phase A|Protocol Violation|1|||
164379140|NCT00274716|593760360|FG004|Phase A|Protocol Violation|0|||
164379141|NCT00274716|593760361|FG005|Phase A|Protocol Violation|0|||
164379142|NCT00274716|593760356|FG000|Phase A|Met criteria for discontinuation|1|||
164379143|NCT00274716|593760357|FG001|Phase A|Met criteria for discontinuation|1|||
164379144|NCT00274716|593760358|FG002|Phase A|Met criteria for discontinuation|0|||
164379145|NCT00274716|593760359|FG003|Phase A|Met criteria for discontinuation|0|||
164379146|NCT00274716|593760360|FG004|Phase A|Met criteria for discontinuation|0|||
164379147|NCT00274716|593760361|FG005|Phase A|Met criteria for discontinuation|0|||
164379148|NCT00274716|593760356|FG000|Phase A|Withdrawal by Subject|2|||
164013035|NCT01855789|592410659|FG000|2) Week 24 up to End of Study|Other|0|||
164013036|NCT01855789|592410660|FG001|2) Week 24 up to End of Study|Other|0|||
164013037|NCT01855789|592410661|FG002|2) Week 24 up to End of Study|Other|0|||
164379149|NCT00274716|593760357|FG001|Phase A|Withdrawal by Subject|2|||
164379150|NCT00274716|593760358|FG002|Phase A|Withdrawal by Subject|1|||
164379151|NCT00274716|593760359|FG003|Phase A|Withdrawal by Subject|3|||
164379152|NCT00274716|593760360|FG004|Phase A|Withdrawal by Subject|0|||
164379153|NCT00274716|593760361|FG005|Phase A|Withdrawal by Subject|1|||
164379154|NCT00274716|593760356|FG000|Phase A|Adverse Event|2|||
164379155|NCT00274716|593760357|FG001|Phase A|Adverse Event|3|||
164379156|NCT00274716|593760358|FG002|Phase A|Adverse Event|3|||
164379157|NCT00274716|593760359|FG003|Phase A|Adverse Event|0|||
164379158|NCT00274716|593760360|FG004|Phase A|Adverse Event|2|||
164379159|NCT00274716|593760361|FG005|Phase A|Adverse Event|0|||
164379160|NCT00274716|593760356|FG000|Phase A|Completed but did not enter Phase B|1|||
164379161|NCT00274716|593760357|FG001|Phase A|Completed but did not enter Phase B|2|||
164379162|NCT00274716|593760358|FG002|Phase A|Completed but did not enter Phase B|2|||
164379163|NCT00274716|593760359|FG003|Phase A|Completed but did not enter Phase B|2|||
164379164|NCT00274716|593760360|FG004|Phase A|Completed but did not enter Phase B|1|||
164379165|NCT00274716|593760361|FG005|Phase A|Completed but did not enter Phase B|1|||
164379166|NCT00274716|593760356|FG000|Phase B|Adverse Event|0|||
164379167|NCT00274716|593760357|FG001|Phase B|Adverse Event|0|||
164379168|NCT00274716|593760358|FG002|Phase B|Adverse Event|2|||
164379169|NCT00274716|593760359|FG003|Phase B|Adverse Event|0|||
164379170|NCT00274716|593760360|FG004|Phase B|Adverse Event|0|||
164379171|NCT00274716|593760361|FG005|Phase B|Adverse Event|1|||
164379172|NCT00274716|593760356|FG000|Phase B|Protocol Violation|0|||
164379173|NCT00274716|593760357|FG001|Phase B|Protocol Violation|2|||
164379174|NCT00274716|593760358|FG002|Phase B|Protocol Violation|0|||
164379175|NCT00274716|593760359|FG003|Phase B|Protocol Violation|0|||
164379176|NCT00274716|593760360|FG004|Phase B|Protocol Violation|0|||
164379177|NCT00274716|593760361|FG005|Phase B|Protocol Violation|0|||
164379178|NCT00274716|593760356|FG000|Phase B|Withdrawal by Subject|0|||
164379179|NCT00274716|593760357|FG001|Phase B|Withdrawal by Subject|1|||
164379180|NCT00274716|593760358|FG002|Phase B|Withdrawal by Subject|0|||
164379181|NCT00274716|593760359|FG003|Phase B|Withdrawal by Subject|0|||
164379182|NCT00274716|593760360|FG004|Phase B|Withdrawal by Subject|0|||
164379183|NCT00274716|593760361|FG005|Phase B|Withdrawal by Subject|0|||
164379184|NCT00274716|593760356|FG000|Phase B|Participant moved|1|||
164379185|NCT00274716|593760357|FG001|Phase B|Participant moved|0|||
164379186|NCT00274716|593760358|FG002|Phase B|Participant moved|0|||
164379187|NCT00274716|593760359|FG003|Phase B|Participant moved|0|||
164379188|NCT00274716|593760360|FG004|Phase B|Participant moved|0|||
164379189|NCT00274716|593760361|FG005|Phase B|Participant moved|0|||
164379190|NCT00274716|593760356|FG000|Phase B|Other non-reported reason|0|||
164379191|NCT00274716|593760357|FG001|Phase B|Other non-reported reason|0|||
164379192|NCT00274716|593760358|FG002|Phase B|Other non-reported reason|1|||
164379193|NCT00274716|593760359|FG003|Phase B|Other non-reported reason|1|||
164379194|NCT00274716|593760360|FG004|Phase B|Other non-reported reason|0|||
164379195|NCT00274716|593760361|FG005|Phase B|Other non-reported reason|0|||
164379196|NCT00274716|593760356|FG000|Phase B|Lost to Follow-up|0|||
164379197|NCT00274716|593760357|FG001|Phase B|Lost to Follow-up|1|||
164379198|NCT00274716|593760358|FG002|Phase B|Lost to Follow-up|0|||
164379199|NCT00274716|593760359|FG003|Phase B|Lost to Follow-up|0|||
164379200|NCT00274716|593760360|FG004|Phase B|Lost to Follow-up|0|||
164379201|NCT00274716|593760361|FG005|Phase B|Lost to Follow-up|0|||
164013038|NCT01855789|592410662|FG003|2) Week 24 up to End of Study|Other|1|||
164013039|NCT01863758|592410663|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
164013040|NCT01863758|592410663|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
164013041|NCT02975349|592410667|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164013042|NCT02975349|592410668|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164013043|NCT02975349|592410669|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164379202|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
164379203|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
164379204|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
164379205|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
164379206|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
164379207|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
164379208|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
164379209|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
164379210|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
164379211|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164379212|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
164379213|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
164379214|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
164379215|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
164379216|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
164379217|NCT01257204|593760362|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
164379218|NCT01257204|593760363|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
164379219|NCT01257204|593760364|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
164379220|NCT01257204|593760362|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
164379221|NCT01257204|593760363|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
164379222|NCT01257204|593760364|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
164379223|NCT01257204|593760362|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
164379224|NCT01257204|593760363|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
164379225|NCT01257204|593760364|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
164379226|NCT01257204|593760362|FG000|Follow-up Period (up to Week 48)|Other|0|||
164379227|NCT01257204|593760363|FG001|Follow-up Period (up to Week 48)|Other|0|||
164379228|NCT01257204|593760364|FG002|Follow-up Period (up to Week 48)|Other|5|||
164379229|NCT02489981|593760366|FG000|Overall Study|Adverse Event|21|||
164379230|NCT02489981|593760366|FG000|Overall Study|Insufficient effectiveness|16|||
164379231|NCT02489981|593760366|FG000|Overall Study|Improved|31|||
164379232|NCT02489981|593760366|FG000|Overall Study|Lost to Follow-up|31|||
164379233|NCT02489981|593760366|FG000|Overall Study|Other than listed|28|||
164379234|NCT01565993|593760367|FG000|Overall Study|Physician Decision|0|||
164379235|NCT01565993|593760368|FG001|Overall Study|Physician Decision|3|||
164379236|NCT04086472|593760371|FG000|Overall Study|Lost to Follow-up|1|||
164379237|NCT04086472|593760372|FG001|Overall Study|Lost to Follow-up|0|||
164379238|NCT04086472|593760373|FG002|Overall Study|Lost to Follow-up|0|||
164379239|NCT04086472|593760374|FG003|Overall Study|Lost to Follow-up|0|||
164379240|NCT04086472|593760375|FG004|Overall Study|Lost to Follow-up|1|||
164379241|NCT04086472|593760371|FG000|Overall Study|Physician Decision|0|||
164379242|NCT04086472|593760372|FG001|Overall Study|Physician Decision|1|||
164379243|NCT04086472|593760373|FG002|Overall Study|Physician Decision|1|||
164379244|NCT04086472|593760374|FG003|Overall Study|Physician Decision|0|||
164379245|NCT04086472|593760375|FG004|Overall Study|Physician Decision|0|||
164379246|NCT04086472|593760371|FG000|Overall Study|Withdrawal by Subject|1|||
164379247|NCT04086472|593760372|FG001|Overall Study|Withdrawal by Subject|1|||
163902851|NCT03414684|592014778|FG000|First-course Treatment|Still on treatment|3|||
163902852|NCT03414684|592014779|FG001|First-course Treatment|Still on treatment|0|||
164379248|NCT04086472|593760373|FG002|Overall Study|Withdrawal by Subject|1|||
164379249|NCT04086472|593760374|FG003|Overall Study|Withdrawal by Subject|0|||
164379250|NCT04086472|593760375|FG004|Overall Study|Withdrawal by Subject|0|||
164379251|NCT04086472|593760371|FG000|Overall Study|Various reasons|2|||
164379252|NCT04086472|593760372|FG001|Overall Study|Various reasons|0|||
164379253|NCT04086472|593760373|FG002|Overall Study|Various reasons|0|||
164379254|NCT04086472|593760374|FG003|Overall Study|Various reasons|3|||
164379255|NCT04086472|593760375|FG004|Overall Study|Various reasons|1|||
164379256|NCT03348904|593760376|FG000|Overall Study|Administrative reason by the sponsor|0|||
164379257|NCT03348904|593760377|FG001|Overall Study|Administrative reason by the sponsor|1|||
164379258|NCT03348904|593760378|FG002|Overall Study|Administrative reason by the sponsor|0|||
164379259|NCT01513291|593760383|FG000|Treatment Period|Adverse Event|8|||
164379260|NCT01513291|593760384|FG001|Treatment Period|Adverse Event|4|||
164379261|NCT01513291|593760385|FG002|Treatment Period|Adverse Event|0|||
164379262|NCT01513291|593760386|FG003|Treatment Period|Adverse Event|0|||
164379263|NCT01513291|593760387|FG004|Treatment Period|Adverse Event|0|||
164379264|NCT01513291|593760383|FG000|Treatment Period|Lack of Efficacy|3|||
164379265|NCT01513291|593760384|FG001|Treatment Period|Lack of Efficacy|0|||
164379266|NCT01513291|593760385|FG002|Treatment Period|Lack of Efficacy|0|||
164379267|NCT01513291|593760386|FG003|Treatment Period|Lack of Efficacy|0|||
164379268|NCT01513291|593760387|FG004|Treatment Period|Lack of Efficacy|0|||
164379269|NCT01513291|593760383|FG000|Treatment Period|Lost to Follow-up|2|||
164379270|NCT01513291|593760384|FG001|Treatment Period|Lost to Follow-up|3|||
164379271|NCT01513291|593760385|FG002|Treatment Period|Lost to Follow-up|0|||
164379272|NCT01513291|593760386|FG003|Treatment Period|Lost to Follow-up|0|||
164379273|NCT01513291|593760387|FG004|Treatment Period|Lost to Follow-up|0|||
164379274|NCT01513291|593760383|FG000|Treatment Period|Physician Decision|1|||
164379275|NCT01513291|593760384|FG001|Treatment Period|Physician Decision|0|||
164379276|NCT01513291|593760385|FG002|Treatment Period|Physician Decision|0|||
164379277|NCT01513291|593760386|FG003|Treatment Period|Physician Decision|0|||
164379278|NCT01513291|593760387|FG004|Treatment Period|Physician Decision|0|||
164379279|NCT01513291|593760383|FG000|Treatment Period|Protocol Violation|1|||
164379280|NCT01513291|593760384|FG001|Treatment Period|Protocol Violation|2|||
164379281|NCT01513291|593760385|FG002|Treatment Period|Protocol Violation|0|||
163902853|NCT03414684|592014778|FG000|First-course Treatment|Never started protocol therapy|2|||
164379282|NCT01513291|593760386|FG003|Treatment Period|Protocol Violation|0|||
164379283|NCT01513291|593760387|FG004|Treatment Period|Protocol Violation|0|||
164379284|NCT01513291|593760383|FG000|Treatment Period|Withdrawal by Subject|8|||
163902854|NCT03414684|592014779|FG001|First-course Treatment|Never started protocol therapy|1|||
164379285|NCT01513291|593760384|FG001|Treatment Period|Withdrawal by Subject|5|||
164379286|NCT01513291|593760385|FG002|Treatment Period|Withdrawal by Subject|0|||
164379287|NCT01513291|593760386|FG003|Treatment Period|Withdrawal by Subject|0|||
164379288|NCT01513291|593760387|FG004|Treatment Period|Withdrawal by Subject|0|||
164379289|NCT01513291|593760383|FG000|Treatment Period|Randomized not treated|0|||
164379290|NCT01513291|593760384|FG001|Treatment Period|Randomized not treated|2|||
164379291|NCT01513291|593760385|FG002|Treatment Period|Randomized not treated|0|||
164379292|NCT01513291|593760386|FG003|Treatment Period|Randomized not treated|0|||
164379293|NCT01513291|593760387|FG004|Treatment Period|Randomized not treated|0|||
164379294|NCT01513291|593760383|FG000|Run-out Period|Lost to Follow-up|0|||
164379295|NCT01513291|593760384|FG001|Run-out Period|Lost to Follow-up|0|||
164379296|NCT01513291|593760385|FG002|Run-out Period|Lost to Follow-up|0|||
164379297|NCT01513291|593760386|FG003|Run-out Period|Lost to Follow-up|1|||
164379298|NCT01513291|593760387|FG004|Run-out Period|Lost to Follow-up|0|||
164379299|NCT01513291|593760383|FG000|Run-out Period|Withdrawal by Subject|0|||
164379300|NCT01513291|593760384|FG001|Run-out Period|Withdrawal by Subject|0|||
164379301|NCT01513291|593760385|FG002|Run-out Period|Withdrawal by Subject|0|||
164379302|NCT01513291|593760386|FG003|Run-out Period|Withdrawal by Subject|1|||
164379303|NCT01513291|593760387|FG004|Run-out Period|Withdrawal by Subject|0|||
164379304|NCT01034397|593760388|FG000|Overall Study|Lack of compliance|0|||
164379305|NCT01034397|593760389|FG001|Overall Study|Lack of compliance|1|||
164379306|NCT01034397|593760388|FG000|Overall Study|Lack of Efficacy|3|||
164379307|NCT01034397|593760389|FG001|Overall Study|Lack of Efficacy|0|||
164379308|NCT01034397|593760388|FG000|Overall Study|Adverse Event|4|||
164379309|NCT01034397|593760389|FG001|Overall Study|Adverse Event|0|||
164379310|NCT01034397|593760388|FG000|Overall Study|Other|0|||
164379311|NCT01034397|593760389|FG001|Overall Study|Other|1|||
164379312|NCT01931839|593760390|FG000|Overall Study|Death|0|||
164379313|NCT01931839|593760391|FG001|Overall Study|Death|1|||
164379314|NCT01931839|593760392|FG002|Overall Study|Death|2|||
164379315|NCT01931839|593760393|FG003|Overall Study|Death|0|||
164379316|NCT01931839|593760394|FG004|Overall Study|Death|0|||
164379317|NCT01931839|593760395|FG005|Overall Study|Death|0|||
164379318|NCT01931839|593760396|FG006|Overall Study|Death|0|||
164379319|NCT01931839|593760390|FG000|Overall Study|Physician Decision|1|||
164379320|NCT01931839|593760391|FG001|Overall Study|Physician Decision|0|||
164379321|NCT01931839|593760392|FG002|Overall Study|Physician Decision|1|||
164379322|NCT01931839|593760393|FG003|Overall Study|Physician Decision|0|||
164379323|NCT01931839|593760394|FG004|Overall Study|Physician Decision|0|||
164379324|NCT01931839|593760395|FG005|Overall Study|Physician Decision|0|||
163902855|NCT03414684|592014778|FG000|Crossover Treatment|Progressive disease|0|||
164379325|NCT01931839|593760396|FG006|Overall Study|Physician Decision|1|||
164379326|NCT01931839|593760390|FG000|Overall Study|Withdrawal of consent|0|||
164379327|NCT01931839|593760391|FG001|Overall Study|Withdrawal of consent|0|||
164379328|NCT01931839|593760392|FG002|Overall Study|Withdrawal of consent|0|||
164379329|NCT01931839|593760393|FG003|Overall Study|Withdrawal of consent|0|||
164379330|NCT01931839|593760394|FG004|Overall Study|Withdrawal of consent|1|||
164379331|NCT01931839|593760395|FG005|Overall Study|Withdrawal of consent|0|||
164379332|NCT01931839|593760396|FG006|Overall Study|Withdrawal of consent|0|||
164379333|NCT01931839|593760390|FG000|Overall Study|Adverse Event|9|||
164379334|NCT01931839|593760391|FG001|Overall Study|Adverse Event|4|||
164379335|NCT01931839|593760392|FG002|Overall Study|Adverse Event|1|||
164379336|NCT01931839|593760393|FG003|Overall Study|Adverse Event|3|||
164379337|NCT01931839|593760394|FG004|Overall Study|Adverse Event|0|||
164379338|NCT01931839|593760395|FG005|Overall Study|Adverse Event|0|||
164379339|NCT01931839|593760396|FG006|Overall Study|Adverse Event|1|||
164379340|NCT01931839|593760390|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
164379341|NCT01931839|593760391|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
164379342|NCT01931839|593760392|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
164379343|NCT01931839|593760393|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
164379344|NCT01931839|593760394|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
164379345|NCT01931839|593760395|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
164379346|NCT01931839|593760396|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
164379347|NCT01931839|593760390|FG000|Overall Study|Other non-compliance|15|||
163902856|NCT03414684|592014779|FG001|Crossover Treatment|Progressive disease|12|||
164092870|NCT02322047|592703397|FG000|Overall Study|Lost to Follow-up|0|||
164379348|NCT01931839|593760391|FG001|Overall Study|Other non-compliance|9|||
164379349|NCT01931839|593760392|FG002|Overall Study|Other non-compliance|12|||
164379350|NCT01931839|593760393|FG003|Overall Study|Other non-compliance|3|||
164379351|NCT01931839|593760394|FG004|Overall Study|Other non-compliance|0|||
163902857|NCT03414684|592014778|FG000|Crossover Treatment|Adverse Event|0|||
164379352|NCT01931839|593760395|FG005|Overall Study|Other non-compliance|3|||
164379353|NCT01931839|593760396|FG006|Overall Study|Other non-compliance|0|||
164379354|NCT01931839|593760390|FG000|Overall Study|Lost to Follow-up|1|||
164379355|NCT01931839|593760391|FG001|Overall Study|Lost to Follow-up|2|||
164379356|NCT01931839|593760392|FG002|Overall Study|Lost to Follow-up|4|||
164379357|NCT01931839|593760393|FG003|Overall Study|Lost to Follow-up|5|||
164379358|NCT01931839|593760394|FG004|Overall Study|Lost to Follow-up|0|||
164379359|NCT01931839|593760395|FG005|Overall Study|Lost to Follow-up|0|||
164379360|NCT01931839|593760396|FG006|Overall Study|Lost to Follow-up|0|||
164379361|NCT01931839|593760390|FG000|Overall Study|Other|4|||
164379362|NCT01931839|593760391|FG001|Overall Study|Other|2|||
164379363|NCT01931839|593760392|FG002|Overall Study|Other|6|||
164379364|NCT01931839|593760393|FG003|Overall Study|Other|0|||
164379365|NCT01931839|593760394|FG004|Overall Study|Other|0|||
164379366|NCT01931839|593760395|FG005|Overall Study|Other|0|||
164379367|NCT01931839|593760396|FG006|Overall Study|Other|0|||
164379368|NCT01430585|593760397|FG000|Overall Study|Death|1|||
164379369|NCT01430585|593760397|FG000|Overall Study|Objective Progression or Relapse|3|||
164379370|NCT01430585|593760397|FG000|Overall Study|Study Terminated by Sponsor|3|||
164379371|NCT01430585|593760397|FG000|Overall Study|Other|7|||
164379372|NCT01448850|593760398|FG000|Overall Study|Death|3|||
164379373|NCT01448850|593760399|FG001|Overall Study|Death|6|||
164379374|NCT01448850|593760398|FG000|Overall Study|Withdrawal by Subject|13|||
164379375|NCT01448850|593760399|FG001|Overall Study|Withdrawal by Subject|21|||
164379376|NCT01448850|593760398|FG000|Overall Study|Lost to Follow-up|3|||
164379377|NCT01448850|593760399|FG001|Overall Study|Lost to Follow-up|1|||
164379378|NCT01448850|593760398|FG000|Overall Study|Other|15|||
164379379|NCT01448850|593760399|FG001|Overall Study|Other|12|||
164379380|NCT03235024|593760402|FG000|Overall Study|Adverse Event|2|||
164379381|NCT03235024|593760403|FG001|Overall Study|Adverse Event|2|||
164379382|NCT03235024|593760402|FG000|Overall Study|Death|1|||
164379383|NCT03235024|593760403|FG001|Overall Study|Death|0|||
164379384|NCT03235024|593760402|FG000|Overall Study|Lost to Follow-up|2|||
164379385|NCT03235024|593760403|FG001|Overall Study|Lost to Follow-up|5|||
164379386|NCT03235024|593760402|FG000|Overall Study|Protocol Violation|1|||
164379387|NCT03235024|593760403|FG001|Overall Study|Protocol Violation|0|||
164379388|NCT03235024|593760402|FG000|Overall Study|Withdrawal by Subject|0|||
164379389|NCT03235024|593760403|FG001|Overall Study|Withdrawal by Subject|3|||
164379390|NCT02357576|593760404|FG000|Treatment Period|Withdrawal by Subject|0|||
164379391|NCT02357576|593760405|FG001|Treatment Period|Withdrawal by Subject|1|||
164379392|NCT02357576|593760404|FG000|Treatment Period|Physician Decision|0|||
164379393|NCT02357576|593760405|FG001|Treatment Period|Physician Decision|1|||
164379394|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
164379395|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
164379396|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
164379397|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
164379398|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
164379399|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
164379400|NCT02357576|593760404|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
164379401|NCT02357576|593760405|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
164379402|NCT00261716|593760406|FG000|Overall Study|Withdrawal by Subject|6|||
164379403|NCT00261716|593760407|FG001|Overall Study|Withdrawal by Subject|8|||
164379404|NCT00261716|593760406|FG000|Overall Study|Lost to Follow-up|0|||
164379405|NCT00261716|593760407|FG001|Overall Study|Lost to Follow-up|2|||
164379406|NCT00699699|593760410|FG000|Overall Study|Adverse Event|36|||
164379407|NCT00699699|593760410|FG000|Overall Study|Individual different reasons|21|||
164379408|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
164379409|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
164379410|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
164379411|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
164379412|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
164379413|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
164379414|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
164379415|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
164379416|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
164379417|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
164379418|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
164379419|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
164379420|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
164379421|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
164379422|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
164379423|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
164379424|NCT02047110|593760411|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
164379425|NCT02047110|593760412|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
164379426|NCT02047110|593760413|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
164379427|NCT02047110|593760414|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
164379428|NCT02047110|593760411|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
164379429|NCT02047110|593760412|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
164379430|NCT02047110|593760413|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
164379431|NCT02047110|593760414|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
164379432|NCT02047110|593760411|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
164379433|NCT02047110|593760412|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
164379434|NCT02047110|593760413|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
164379435|NCT02047110|593760414|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
164379436|NCT02047110|593760411|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
164379437|NCT02047110|593760412|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
164379438|NCT02047110|593760413|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
164379439|NCT02047110|593760414|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
164379440|NCT02047110|593760411|FG000|Escape Treatment Period|Adverse Event|1|||
164379441|NCT02047110|593760412|FG001|Escape Treatment Period|Adverse Event|2|||
164379442|NCT02047110|593760413|FG002|Escape Treatment Period|Adverse Event|2|||
164379443|NCT02047110|593760414|FG003|Escape Treatment Period|Adverse Event|0|||
164379444|NCT02047110|593760411|FG000|Escape Treatment Period|Other than specified|1|||
164379445|NCT02047110|593760412|FG001|Escape Treatment Period|Other than specified|2|||
164379446|NCT02047110|593760413|FG002|Escape Treatment Period|Other than specified|0|||
164379447|NCT02047110|593760414|FG003|Escape Treatment Period|Other than specified|1|||
164379448|NCT02047110|593760411|FG000|OLE Treatment Period|Other than specified|0|||
164379449|NCT02047110|593760412|FG001|OLE Treatment Period|Other than specified|0|||
164379450|NCT02047110|593760413|FG002|OLE Treatment Period|Other than specified|1|||
164379451|NCT02047110|593760414|FG003|OLE Treatment Period|Other than specified|0|||
164379452|NCT00705575|593760415|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164379453|NCT00705575|593760416|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164379454|NCT00705575|593760415|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164379455|NCT00705575|593760416|FG001|Overall Study|Abnormal test procedure result(s)|12|||
164379456|NCT00705575|593760415|FG000|Overall Study|Adverse Event|11|||
164379457|NCT00705575|593760416|FG001|Overall Study|Adverse Event|15|||
164379458|NCT00705575|593760415|FG000|Overall Study|Lost to Follow-up|3|||
164379459|NCT00705575|593760416|FG001|Overall Study|Lost to Follow-up|4|||
164379460|NCT00705575|593760415|FG000|Overall Study|Protocol Violation|2|||
164379461|NCT00705575|593760416|FG001|Overall Study|Protocol Violation|2|||
164379462|NCT00705575|593760415|FG000|Overall Study|Withdrawal by Subject|5|||
164379463|NCT00705575|593760416|FG001|Overall Study|Withdrawal by Subject|10|||
164379464|NCT01000051|593760418|FG000|Overall Study|Withdrawal by Subject|1|||
164379465|NCT01000051|593760419|FG001|Overall Study|Withdrawal by Subject|1|||
164379466|NCT01000051|593760418|FG000|Overall Study|Disease Progression|1|||
164379467|NCT01000051|593760419|FG001|Overall Study|Disease Progression|0|||
164379468|NCT01000051|593760418|FG000|Overall Study|Serious noncompliance|1|||
164379469|NCT01000051|593760419|FG001|Overall Study|Serious noncompliance|0|||
164379470|NCT02170727|593760420|FG000|Overall Study|Lost to Follow-up|1|||
164379471|NCT02170727|593760421|FG001|Overall Study|Lost to Follow-up|0|||
164379472|NCT02170727|593760420|FG000|Overall Study|Withdrawal by Subject|2|||
164379473|NCT02170727|593760421|FG001|Overall Study|Withdrawal by Subject|0|||
164379474|NCT01959581|593760424|FG000|Overall Study|Lost to Follow-up|5|||
164379475|NCT03304379|593760435|FG000|Overall Study|Protocol Violation|8|||
164379476|NCT03304379|593760436|FG001|Overall Study|Protocol Violation|10|||
164379477|NCT03304379|593760437|FG002|Overall Study|Protocol Violation|5|||
164379478|NCT03304379|593760438|FG003|Overall Study|Protocol Violation|0|||
164379479|NCT03304379|593760439|FG004|Overall Study|Protocol Violation|2|||
164379480|NCT03304379|593760435|FG000|Overall Study|Adverse Event|4|||
164379481|NCT03304379|593760436|FG001|Overall Study|Adverse Event|20|||
164379482|NCT03304379|593760437|FG002|Overall Study|Adverse Event|17|||
164379483|NCT03304379|593760438|FG003|Overall Study|Adverse Event|1|||
164379484|NCT03304379|593760439|FG004|Overall Study|Adverse Event|0|||
164379485|NCT03304379|593760435|FG000|Overall Study|Lack of Efficacy|17|||
164379486|NCT03304379|593760436|FG001|Overall Study|Lack of Efficacy|16|||
164379487|NCT03304379|593760437|FG002|Overall Study|Lack of Efficacy|20|||
164379488|NCT03304379|593760438|FG003|Overall Study|Lack of Efficacy|0|||
164379489|NCT03304379|593760439|FG004|Overall Study|Lack of Efficacy|0|||
164379490|NCT03304379|593760435|FG000|Overall Study|Physician Decision|6|||
164379491|NCT03304379|593760436|FG001|Overall Study|Physician Decision|10|||
164379492|NCT03304379|593760437|FG002|Overall Study|Physician Decision|6|||
164379493|NCT03304379|593760438|FG003|Overall Study|Physician Decision|9|||
164379494|NCT03304379|593760439|FG004|Overall Study|Physician Decision|10|||
164379495|NCT03304379|593760435|FG000|Overall Study|Withdrawal by Subject|26|||
164379496|NCT03304379|593760436|FG001|Overall Study|Withdrawal by Subject|58|||
164379497|NCT03304379|593760437|FG002|Overall Study|Withdrawal by Subject|66|||
164379498|NCT03304379|593760438|FG003|Overall Study|Withdrawal by Subject|3|||
164379499|NCT03304379|593760439|FG004|Overall Study|Withdrawal by Subject|5|||
164379500|NCT03304379|593760435|FG000|Overall Study|Lost to Follow-up|8|||
164379501|NCT03304379|593760436|FG001|Overall Study|Lost to Follow-up|24|||
164379502|NCT03304379|593760437|FG002|Overall Study|Lost to Follow-up|35|||
163902858|NCT03414684|592014779|FG001|Crossover Treatment|Adverse Event|3|||
163902859|NCT03414684|592014778|FG000|Crossover Treatment|Physician Decision|0|||
163902860|NCT03414684|592014779|FG001|Crossover Treatment|Physician Decision|1|||
163902861|NCT03414684|592014778|FG000|Crossover Treatment|Still on treatment|0|||
163902862|NCT03414684|592014779|FG001|Crossover Treatment|Still on treatment|2|||
163902863|NCT04038580|592014780|FG000|Washout 1|Death|0|||
164379503|NCT03304379|593760438|FG003|Overall Study|Lost to Follow-up|4|||
164379504|NCT03304379|593760439|FG004|Overall Study|Lost to Follow-up|0|||
164379505|NCT03304379|593760435|FG000|Overall Study|Death|1|||
164379506|NCT03304379|593760436|FG001|Overall Study|Death|2|||
164379507|NCT03304379|593760437|FG002|Overall Study|Death|0|||
164379508|NCT03304379|593760438|FG003|Overall Study|Death|0|||
164379509|NCT03304379|593760439|FG004|Overall Study|Death|0|||
164379510|NCT03304379|593760435|FG000|Overall Study|Other|0|||
164379511|NCT03304379|593760436|FG001|Overall Study|Other|1|||
164379512|NCT03304379|593760437|FG002|Overall Study|Other|0|||
164379513|NCT03304379|593760438|FG003|Overall Study|Other|0|||
164379514|NCT03304379|593760439|FG004|Overall Study|Other|0|||
164379515|NCT02802345|593760447|FG000|Overall Study|Not Treated|0|||
164379516|NCT02802345|593760448|FG001|Overall Study|Not Treated|1|||
164379517|NCT02802345|593760447|FG000|Overall Study|Adverse Event|28|||
164379518|NCT02802345|593760448|FG001|Overall Study|Adverse Event|20|||
164379519|NCT02802345|593760447|FG000|Overall Study|Withdrawal by Subject|3|||
164379520|NCT02802345|593760448|FG001|Overall Study|Withdrawal by Subject|3|||
164379521|NCT02802345|593760447|FG000|Overall Study|Protocol Violation|0|||
164379522|NCT02802345|593760448|FG001|Overall Study|Protocol Violation|1|||
164379523|NCT02802345|593760447|FG000|Overall Study|Other than listed|1|||
164379524|NCT02802345|593760448|FG001|Overall Study|Other than listed|5|||
164379525|NCT03969212|593760451|FG000|Overall Study|Adverse Event|1|||
164379526|NCT03969212|593760452|FG001|Overall Study|Adverse Event|0|||
164379527|NCT03969212|593760453|FG002|Overall Study|Adverse Event|0|||
164379528|NCT03969212|593760454|FG003|Overall Study|Adverse Event|0|||
164379529|NCT03969212|593760451|FG000|Overall Study|Lost to Follow-up|2|||
164379530|NCT03969212|593760452|FG001|Overall Study|Lost to Follow-up|2|||
164379531|NCT03969212|593760453|FG002|Overall Study|Lost to Follow-up|2|||
164379532|NCT03969212|593760454|FG003|Overall Study|Lost to Follow-up|2|||
164379533|NCT03969212|593760451|FG000|Overall Study|Protocol Violation|0|||
164379534|NCT03969212|593760452|FG001|Overall Study|Protocol Violation|0|||
164379535|NCT03969212|593760453|FG002|Overall Study|Protocol Violation|0|||
164379536|NCT03969212|593760454|FG003|Overall Study|Protocol Violation|1|||
164379537|NCT03969212|593760451|FG000|Overall Study|Withdrawal by Subject|7|||
164379538|NCT03969212|593760452|FG001|Overall Study|Withdrawal by Subject|13|||
164379539|NCT03969212|593760453|FG002|Overall Study|Withdrawal by Subject|5|||
164379540|NCT03969212|593760454|FG003|Overall Study|Withdrawal by Subject|11|||
164379541|NCT03969212|593760451|FG000|Overall Study|Physician Decision|0|||
164379542|NCT03969212|593760452|FG001|Overall Study|Physician Decision|0|||
164379543|NCT03969212|593760453|FG002|Overall Study|Physician Decision|1|||
164379544|NCT03969212|593760454|FG003|Overall Study|Physician Decision|0|||
164379545|NCT03969212|593760451|FG000|Overall Study|Reason not Specified|22|||
164379546|NCT03969212|593760452|FG001|Overall Study|Reason not Specified|23|||
164379547|NCT03969212|593760453|FG002|Overall Study|Reason not Specified|28|||
164379548|NCT03969212|593760454|FG003|Overall Study|Reason not Specified|26|||
164379549|NCT02075320|593760456|FG000|Overall Study|Withdrawal by Subject|2|||
164379550|NCT03773757|593760457|FG000|Overall Study|Withdrawal by Subject|2|||
164379551|NCT03773757|593760458|FG001|Overall Study|Withdrawal by Subject|4|||
164379552|NCT00057746|593760459|FG000|Overall Study|Withdrawal by Subject|0|||
164379553|NCT00057746|593760460|FG001|Overall Study|Withdrawal by Subject|0|||
164379554|NCT00057746|593760461|FG002|Overall Study|Withdrawal by Subject|1|||
164379555|NCT01109316|593760462|FG000|Study Period 1|Adverse Event|0|||
164379556|NCT01109316|593760463|FG001|Study Period 1|Adverse Event|0|||
164379557|NCT01109316|593760464|FG002|Study Period 1|Adverse Event|1|||
164379558|NCT01109316|593760465|FG003|Study Period 1|Adverse Event|0|||
164379559|NCT01109316|593760466|FG004|Study Period 1|Adverse Event|0|||
163902864|NCT04038580|592014781|FG001|Washout 1|Death|0|||
164379560|NCT01109316|593760467|FG005|Study Period 1|Adverse Event|0|||
164379561|NCT01109316|593760462|FG000|Study Period 1|Lost to Follow-up|0|||
164379562|NCT01109316|593760463|FG001|Study Period 1|Lost to Follow-up|0|||
164379563|NCT01109316|593760464|FG002|Study Period 1|Lost to Follow-up|1|||
163902865|NCT04038580|592014782|FG002|Washout 1|Death|0|||
163902866|NCT04038580|592014783|FG003|Washout 1|Death|1|||
164379564|NCT01109316|593760465|FG003|Study Period 1|Lost to Follow-up|1|||
164379565|NCT01109316|593760466|FG004|Study Period 1|Lost to Follow-up|0|||
164379566|NCT01109316|593760467|FG005|Study Period 1|Lost to Follow-up|0|||
164379567|NCT01109316|593760462|FG000|Study Period 1|Withdrawal by Subject|0|||
164379568|NCT01109316|593760463|FG001|Study Period 1|Withdrawal by Subject|0|||
164379569|NCT01109316|593760464|FG002|Study Period 1|Withdrawal by Subject|1|||
164379570|NCT01109316|593760465|FG003|Study Period 1|Withdrawal by Subject|0|||
164379571|NCT01109316|593760466|FG004|Study Period 1|Withdrawal by Subject|2|||
164379572|NCT01109316|593760467|FG005|Study Period 1|Withdrawal by Subject|0|||
164379573|NCT01109316|593760462|FG000|Study Period 1|Sponsor Decision|0|||
164379574|NCT01109316|593760463|FG001|Study Period 1|Sponsor Decision|0|||
164379575|NCT01109316|593760464|FG002|Study Period 1|Sponsor Decision|0|||
164379576|NCT01109316|593760465|FG003|Study Period 1|Sponsor Decision|0|||
164379577|NCT01109316|593760466|FG004|Study Period 1|Sponsor Decision|0|||
164379578|NCT01109316|593760467|FG005|Study Period 1|Sponsor Decision|2|||
164379579|NCT01109316|593760462|FG000|Study Period 2|Entry Criteria Not Met|0|||
164379580|NCT01109316|593760463|FG001|Study Period 2|Entry Criteria Not Met|1|||
164379581|NCT01109316|593760464|FG002|Study Period 2|Entry Criteria Not Met|0|||
164379582|NCT01109316|593760465|FG003|Study Period 2|Entry Criteria Not Met|0|||
164379583|NCT01109316|593760466|FG004|Study Period 2|Entry Criteria Not Met|0|||
164379584|NCT01109316|593760467|FG005|Study Period 2|Entry Criteria Not Met|0|||
164379585|NCT01109316|593760462|FG000|Study Period 2|Physician Decision|0|||
164379586|NCT01109316|593760463|FG001|Study Period 2|Physician Decision|0|||
164379587|NCT01109316|593760464|FG002|Study Period 2|Physician Decision|0|||
164379588|NCT01109316|593760465|FG003|Study Period 2|Physician Decision|1|||
164379589|NCT01109316|593760466|FG004|Study Period 2|Physician Decision|0|||
164379590|NCT01109316|593760467|FG005|Study Period 2|Physician Decision|0|||
164379591|NCT01109316|593760462|FG000|Study Period 2|Protocol Violation|1|||
164379592|NCT01109316|593760463|FG001|Study Period 2|Protocol Violation|0|||
164379593|NCT01109316|593760464|FG002|Study Period 2|Protocol Violation|0|||
164379594|NCT01109316|593760465|FG003|Study Period 2|Protocol Violation|0|||
164379595|NCT01109316|593760466|FG004|Study Period 2|Protocol Violation|0|||
164379596|NCT01109316|593760467|FG005|Study Period 2|Protocol Violation|0|||
164379597|NCT01109316|593760462|FG000|Study Period 2|Withdrawal by Subject|0|||
164379598|NCT01109316|593760463|FG001|Study Period 2|Withdrawal by Subject|0|||
164379599|NCT01109316|593760464|FG002|Study Period 2|Withdrawal by Subject|1|||
163902867|NCT04038580|592014784|FG004|Washout 1|Death|0|||
163902868|NCT04038580|592014785|FG005|Washout 1|Death|0|||
163902869|NCT04038580|592014780|FG000|Washout 1|Withdrawal by Subject|0|||
163902870|NCT04038580|592014781|FG001|Washout 1|Withdrawal by Subject|0|||
163902871|NCT04038580|592014782|FG002|Washout 1|Withdrawal by Subject|0|||
163902872|NCT04038580|592014783|FG003|Washout 1|Withdrawal by Subject|0|||
163902873|NCT04038580|592014784|FG004|Washout 1|Withdrawal by Subject|1|||
163902874|NCT04038580|592014785|FG005|Washout 1|Withdrawal by Subject|0|||
163902875|NCT04038580|592014780|FG000|Wash-out 2|Withdrawal by Subject|1|||
163902876|NCT04038580|592014781|FG001|Wash-out 2|Withdrawal by Subject|0|||
163902877|NCT04038580|592014782|FG002|Wash-out 2|Withdrawal by Subject|0|||
164013044|NCT02975349|592410670|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164013045|NCT02975349|592410671|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164013046|NCT02975349|592410672|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164013047|NCT02975349|592410673|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164013048|NCT02975349|592410667|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164013049|NCT02975349|592410668|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164013050|NCT02975349|592410669|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164013051|NCT02975349|592410670|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164013052|NCT02975349|592410671|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164013053|NCT02975349|592410672|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163902878|NCT04038580|592014783|FG003|Wash-out 2|Withdrawal by Subject|2|||
163902879|NCT04038580|592014784|FG004|Wash-out 2|Withdrawal by Subject|0|||
163902880|NCT04038580|592014785|FG005|Wash-out 2|Withdrawal by Subject|1|||
164013054|NCT02975349|592410673|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164013055|NCT02975349|592410667|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
164013056|NCT02975349|592410668|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
164013057|NCT02975349|592410669|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
164013058|NCT02975349|592410670|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
164013059|NCT02975349|592410671|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
164013060|NCT02975349|592410672|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
164013061|NCT02975349|592410673|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
164013062|NCT02975349|592410667|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
164013063|NCT02975349|592410668|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
164013064|NCT02975349|592410669|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
164013065|NCT02975349|592410670|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
164013066|NCT02975349|592410671|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
164013067|NCT02975349|592410672|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
164013068|NCT02975349|592410673|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
164379600|NCT01109316|593760465|FG003|Study Period 2|Withdrawal by Subject|0|||
164013069|NCT02975349|592410667|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
164013070|NCT02975349|592410668|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
164013071|NCT02975349|592410669|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
164013072|NCT02975349|592410670|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
164013073|NCT02975349|592410671|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
164013074|NCT02975349|592410672|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
164013075|NCT02975349|592410673|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
164013076|NCT02975349|592410667|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164013077|NCT02975349|592410668|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164013078|NCT02975349|592410669|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164013079|NCT02975349|592410670|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
164013080|NCT02975349|592410671|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164013081|NCT02975349|592410672|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164013082|NCT02975349|592410673|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
164013083|NCT02975349|592410667|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164013084|NCT02975349|592410668|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
164013085|NCT02975349|592410669|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164013086|NCT02975349|592410670|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164013087|NCT02975349|592410671|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164013088|NCT02975349|592410672|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164013089|NCT02975349|592410673|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
164379601|NCT01109316|593760466|FG004|Study Period 2|Withdrawal by Subject|0|||
164379602|NCT01109316|593760467|FG005|Study Period 2|Withdrawal by Subject|1|||
164379603|NCT01109316|593760462|FG000|Study Period 3|Lost to Follow-up|0|||
164379604|NCT01109316|593760463|FG001|Study Period 3|Lost to Follow-up|0|||
164379605|NCT01109316|593760464|FG002|Study Period 3|Lost to Follow-up|0|||
164379606|NCT01109316|593760465|FG003|Study Period 3|Lost to Follow-up|0|||
164379607|NCT01109316|593760466|FG004|Study Period 3|Lost to Follow-up|1|||
164379608|NCT01109316|593760467|FG005|Study Period 3|Lost to Follow-up|0|||
164013090|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
164013091|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
164013092|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
164013093|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
164013094|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
164013095|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
164013096|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
164013097|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164013098|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164013099|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164013100|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164013101|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
164013102|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164013103|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
164013104|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164013105|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164379609|NCT01109316|593760462|FG000|Study Period 3|Withdrawal by Subject|1|||
164379610|NCT01109316|593760463|FG001|Study Period 3|Withdrawal by Subject|0|||
164379611|NCT01109316|593760464|FG002|Study Period 3|Withdrawal by Subject|0|||
164379612|NCT01109316|593760465|FG003|Study Period 3|Withdrawal by Subject|0|||
164379613|NCT01109316|593760466|FG004|Study Period 3|Withdrawal by Subject|1|||
164379614|NCT01109316|593760467|FG005|Study Period 3|Withdrawal by Subject|0|||
164379615|NCT02985736|593760474|FG000|Overall Study|Lost to Follow-up|3|||
164379616|NCT00550836|593760475|FG000|Overall Study|Withdrawal by Subject|3|||
164379617|NCT00550836|593760476|FG001|Overall Study|Withdrawal by Subject|9|||
164379618|NCT01826825|593760477|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
164379619|NCT01826825|593760478|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
164379620|NCT01858194|593760479|FG000|Overall Study|Total Artificial Heart Implant|0|||
164379621|NCT01858194|593760480|FG001|Overall Study|Total Artificial Heart Implant|1|||
164379622|NCT01858194|593760479|FG000|Overall Study|Lost to Follow-up|0|||
164379623|NCT01858194|593760480|FG001|Overall Study|Lost to Follow-up|1|||
164379624|NCT02563028|593760482|FG000|Overall Study|Lack of equipment|1|||
164379625|NCT02563028|593760482|FG000|Overall Study|Unable to elicit VEP post induction|1|||
164379626|NCT01856543|593760483|FG000|Overall Study|Treatment discontinued|6|||
164379627|NCT01856543|593760484|FG001|Overall Study|Treatment discontinued|3|||
164379628|NCT01856543|593760483|FG000|Overall Study|Withdrawn before start|7|||
164379629|NCT01856543|593760484|FG001|Overall Study|Withdrawn before start|3|||
164379630|NCT04545515|593760485|FG000|Overall Study|Adverse Event|1|||
164379631|NCT04545515|593760485|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
164379632|NCT04545515|593760485|FG000|Overall Study|Commercial drug is available for participant|7|||
164379633|NCT01552772|593760486|FG000|Overall Study|Lost to Follow-up|2|||
164379634|NCT01552772|593760486|FG000|Overall Study|Adverse Event|1|||
164379635|NCT01552772|593760486|FG000|Overall Study|Protocol Deviation|1|||
164379636|NCT01848990|593760488|FG000|Overall Study|Adverse Event|6|||
164379637|NCT01848990|593760489|FG001|Overall Study|Adverse Event|2|||
164379638|NCT01848990|593760490|FG002|Overall Study|Adverse Event|0|||
164379639|NCT01848990|593760488|FG000|Overall Study|Lost to Follow-up|6|||
164379640|NCT01848990|593760489|FG001|Overall Study|Lost to Follow-up|2|||
164379641|NCT01848990|593760490|FG002|Overall Study|Lost to Follow-up|2|||
164379642|NCT01848990|593760488|FG000|Overall Study|Protocol Violation|1|||
164379643|NCT01848990|593760489|FG001|Overall Study|Protocol Violation|1|||
164379644|NCT01848990|593760490|FG002|Overall Study|Protocol Violation|0|||
164379645|NCT01848990|593760488|FG000|Overall Study|Withdrawal by Subject|29|||
164013106|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164013107|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164013108|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
164013109|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
164013110|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
164013111|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
164013112|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
164013113|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
164013114|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
164013115|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
164013116|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
164013117|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
164013118|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
164013119|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
164013120|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
164013121|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
164013122|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
164013123|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
164013124|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
164013125|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164013126|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164013127|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
164013128|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164013129|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164013130|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
164013131|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
164013132|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
164379646|NCT01848990|593760489|FG001|Overall Study|Withdrawal by Subject|10|||
164379647|NCT01848990|593760490|FG002|Overall Study|Withdrawal by Subject|11|||
164379648|NCT01848990|593760488|FG000|Overall Study|Physician Decision|1|||
164379649|NCT01848990|593760489|FG001|Overall Study|Physician Decision|1|||
164379650|NCT01848990|593760490|FG002|Overall Study|Physician Decision|0|||
164013133|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
164013134|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
164379651|NCT01848990|593760488|FG000|Overall Study|Non Compliance|1|||
164379652|NCT01848990|593760489|FG001|Overall Study|Non Compliance|0|||
164379653|NCT01848990|593760490|FG002|Overall Study|Non Compliance|0|||
164379654|NCT01848990|593760488|FG000|Overall Study|Death|1|||
164379655|NCT01848990|593760489|FG001|Overall Study|Death|0|||
164013135|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
164013136|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
164013137|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
164013138|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
164013139|NCT02975349|592410667|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
164013140|NCT02975349|592410668|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
164013141|NCT02975349|592410669|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
164013142|NCT02975349|592410670|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
164013143|NCT02975349|592410671|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
164013144|NCT02975349|592410672|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
164013145|NCT02975349|592410673|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
164013146|NCT01663740|592410674|FG000|Overall Study|Lost to Follow-up|1|||
164013147|NCT01663740|592410675|FG001|Overall Study|Lost to Follow-up|4|||
164013148|NCT01663740|592410674|FG000|Overall Study|Other|9|||
164013149|NCT01663740|592410675|FG001|Overall Study|Other|2|||
164013150|NCT01663740|592410674|FG000|Overall Study|Inclusion/Exclusion not met|1|||
164013151|NCT01663740|592410675|FG001|Overall Study|Inclusion/Exclusion not met|0|||
164013152|NCT01663740|592410674|FG000|Overall Study|Death|0|||
164013153|NCT01663740|592410675|FG001|Overall Study|Death|1|||
164013154|NCT01663740|592410674|FG000|Overall Study|Withdrawal by Subject|2|||
164013155|NCT01663740|592410675|FG001|Overall Study|Withdrawal by Subject|1|||
164013156|NCT01663740|592410674|FG000|Overall Study|No end of study status|3|||
164013157|NCT01663740|592410675|FG001|Overall Study|No end of study status|0|||
164013158|NCT02658656|592410676|FG000|Screening|Failed eligibility criteria|0|||
164013159|NCT02658656|592410677|FG001|Screening|Failed eligibility criteria|0|||
164013160|NCT02658656|592410678|FG002|Screening|Failed eligibility criteria|263|||
164013161|NCT02658656|592410676|FG000|Randomization|Withdrawal by Subject|8|||
164013162|NCT02658656|592410677|FG001|Randomization|Withdrawal by Subject|7|||
164013163|NCT02658656|592410678|FG002|Randomization|Withdrawal by Subject|0|||
164013164|NCT02658656|592410676|FG000|Randomization|Lost to Follow-up|1|||
164013165|NCT02658656|592410677|FG001|Randomization|Lost to Follow-up|3|||
164013166|NCT02658656|592410678|FG002|Randomization|Lost to Follow-up|0|||
164013167|NCT02658656|592410676|FG000|Randomization|Adverse Event|4|||
164013168|NCT02658656|592410677|FG001|Randomization|Adverse Event|0|||
164013169|NCT02658656|592410678|FG002|Randomization|Adverse Event|0|||
164013170|NCT02658656|592410676|FG000|Randomization|Administrative Termination|3|||
164379656|NCT01848990|593760490|FG002|Overall Study|Death|1|||
164379657|NCT01848990|593760488|FG000|Overall Study|Other|1|||
164379658|NCT01848990|593760489|FG001|Overall Study|Other|4|||
164379659|NCT01848990|593760490|FG002|Overall Study|Other|2|||
164379660|NCT00700011|593760491|FG000|Overall Study|Death|0|||
164379661|NCT00700011|593760492|FG001|Overall Study|Death|1|||
164379662|NCT00004031|593760493|FG000|Overall Study|Adverse Event|5|||
164379663|NCT00004031|593760494|FG001|Overall Study|Adverse Event|0|||
164379664|NCT00004031|593760493|FG000|Overall Study|Refusal unrelated to adverse events|2|||
164379665|NCT00004031|593760494|FG001|Overall Study|Refusal unrelated to adverse events|11|||
164379666|NCT00004031|593760493|FG000|Overall Study|Progression/relapse|9|||
164379667|NCT00004031|593760494|FG001|Overall Study|Progression/relapse|4|||
164379668|NCT00004031|593760493|FG000|Overall Study|Death|3|||
164379669|NCT00004031|593760494|FG001|Overall Study|Death|1|||
164379670|NCT00004031|593760493|FG000|Overall Study|Other- not protocol specified|3|||
164379671|NCT00004031|593760494|FG001|Overall Study|Other- not protocol specified|3|||
164379672|NCT00004031|593760493|FG000|Overall Study|Reason under review|3|||
164379673|NCT00004031|593760494|FG001|Overall Study|Reason under review|2|||
164379674|NCT00512096|593760498|FG000|Overall Study|Adverse Event|2|||
164379675|NCT00512096|593760498|FG000|Overall Study|Withdrawal by Subject|2|||
164379676|NCT00512096|593760498|FG000|Overall Study|Lack of Efficacy|3|||
164379677|NCT00298038|593760505|FG000|Overall Study|Lost to Follow-up|0|||
164379678|NCT00298038|593760506|FG001|Overall Study|Lost to Follow-up|1|||
164379679|NCT00298038|593760505|FG000|Overall Study|Liver Transplant|0|||
164379680|NCT00298038|593760506|FG001|Overall Study|Liver Transplant|1|||
164013171|NCT02658656|592410677|FG001|Randomization|Administrative Termination|1|||
164013172|NCT02658656|592410678|FG002|Randomization|Administrative Termination|0|||
164013173|NCT02658656|592410676|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
164013174|NCT02658656|592410677|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
164013175|NCT02658656|592410678|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
164379681|NCT00298038|593760505|FG000|Overall Study|Protocol Violation|1|||
164379682|NCT00298038|593760506|FG001|Overall Study|Protocol Violation|3|||
164379683|NCT00298038|593760505|FG000|Overall Study|Death|6|||
164092871|NCT02322047|592703398|FG001|Overall Study|Lost to Follow-up|0|||
164379684|NCT00298038|593760506|FG001|Overall Study|Death|3|||
164379685|NCT00298038|593760505|FG000|Overall Study|Withdrawal by Subject|6|||
164379686|NCT00298038|593760506|FG001|Overall Study|Withdrawal by Subject|9|||
164379687|NCT00298038|593760505|FG000|Overall Study|Adverse Event|8|||
164379688|NCT00298038|593760506|FG001|Overall Study|Adverse Event|7|||
164013176|NCT02658656|592410676|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
164013177|NCT02658656|592410677|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
164013178|NCT02658656|592410678|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
164013179|NCT02658656|592410676|FG000|Randomization|Not eligible for Randomization|1|||
164013180|NCT02658656|592410677|FG001|Randomization|Not eligible for Randomization|0|||
164013181|NCT02658656|592410678|FG002|Randomization|Not eligible for Randomization|0|||
164013182|NCT02658656|592410676|FG000|Randomization|Protocol Violation|1|||
164013183|NCT02658656|592410677|FG001|Randomization|Protocol Violation|0|||
164013184|NCT02658656|592410678|FG002|Randomization|Protocol Violation|0|||
164013185|NCT02112448|592410679|FG000|Overall Study|lab values precluding use of ketorolac|2|||
164013186|NCT02112448|592410680|FG001|Overall Study|lab values precluding use of ketorolac|2|||
164013187|NCT02112448|592410679|FG000|Overall Study|Protocol Violation|1|||
164013188|NCT02112448|592410680|FG001|Overall Study|Protocol Violation|2|||
164013189|NCT02112448|592410679|FG000|Overall Study|Physician Decision|4|||
164013190|NCT02112448|592410680|FG001|Overall Study|Physician Decision|6|||
164013191|NCT02112448|592410679|FG000|Overall Study|required heparin so could not use ketoro|1|||
164013192|NCT02112448|592410680|FG001|Overall Study|required heparin so could not use ketoro|0|||
164013193|NCT03625986|592412389|FG000|Randomization Period|Lost to Follow-up|7|||
164013194|NCT03625986|592412390|FG001|Randomization Period|Lost to Follow-up|12|||
164013195|NCT03625986|592412389|FG000|Randomization Period|Withdrawal by Subject|10|||
164013196|NCT03625986|592412390|FG001|Randomization Period|Withdrawal by Subject|6|||
164013197|NCT04359823|592412391|FG000|Overall Study|Lost to Follow-up|0|||
164013198|NCT04359823|592412392|FG001|Overall Study|Lost to Follow-up|1|||
164013199|NCT04359823|592412391|FG000|Overall Study|Withdrawal by Subject|0|||
164013200|NCT04359823|592412392|FG001|Overall Study|Withdrawal by Subject|1|||
164013201|NCT01850563|592412393|FG000|Overall Study|Not eligible|3|||
164013202|NCT01850563|592412394|FG001|Overall Study|Not eligible|0|||
164013203|NCT03132805|592412405|FG000|Overall Study|Lost to Follow-up|142|||
164013204|NCT03132805|592412406|FG001|Overall Study|Lost to Follow-up|141|||
164013205|NCT03132805|592412407|FG002|Overall Study|Lost to Follow-up|113|||
164013206|NCT03009539|592412408|FG000|Overall Study|Lost to Follow-up|132|||
164013207|NCT03009539|592412409|FG001|Overall Study|Lost to Follow-up|113|||
164013208|NCT03009539|592412410|FG002|Overall Study|Lost to Follow-up|132|||
164013209|NCT03009539|592412411|FG003|Overall Study|Lost to Follow-up|113|||
164379689|NCT00298038|593760505|FG000|Overall Study|Breakthrough overt HE episode|28|||
164379690|NCT00298038|593760506|FG001|Overall Study|Breakthrough overt HE episode|69|||
164379691|NCT00298038|593760505|FG000|Overall Study|Noncompliance|1|||
164379692|NCT00298038|593760506|FG001|Overall Study|Noncompliance|0|||
164379693|NCT00298038|593760505|FG000|Overall Study|Cocaine Abuse|1|||
164379694|NCT00298038|593760506|FG001|Overall Study|Cocaine Abuse|0|||
164379695|NCT00298038|593760505|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
164379696|NCT00298038|593760506|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
164379697|NCT02696096|593760507|FG000|Overall Study|ruled out at screening|1|||
164379698|NCT02696096|593760507|FG000|Overall Study|did not attend second fMRI|1|||
164379699|NCT01940705|593760508|FG000|Overall Study|Lost to Follow-up|1|||
164379700|NCT01940705|593760509|FG001|Overall Study|Lost to Follow-up|3|||
164379701|NCT01940705|593760510|FG002|Overall Study|Lost to Follow-up|2|||
164379702|NCT01940705|593760511|FG003|Overall Study|Lost to Follow-up|2|||
164379703|NCT01940705|593760508|FG000|Overall Study|Withdrawal by Subject|2|||
164379704|NCT01940705|593760509|FG001|Overall Study|Withdrawal by Subject|2|||
164379705|NCT01940705|593760510|FG002|Overall Study|Withdrawal by Subject|3|||
164379706|NCT01940705|593760511|FG003|Overall Study|Withdrawal by Subject|2|||
164379707|NCT01940705|593760508|FG000|Overall Study|Intervention not given|0|||
164379708|NCT01940705|593760509|FG001|Overall Study|Intervention not given|3|||
164379709|NCT01940705|593760510|FG002|Overall Study|Intervention not given|3|||
164379710|NCT01940705|593760511|FG003|Overall Study|Intervention not given|0|||
164379711|NCT01940705|593760508|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
164379712|NCT01940705|593760509|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
164379713|NCT01940705|593760510|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
164379714|NCT01940705|593760511|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
164379715|NCT02447991|593760512|FG000|Overall Study|Withdrawn by subject - no data|0|||
164379716|NCT02447991|593760513|FG001|Overall Study|Withdrawn by subject - no data|2|||
164379717|NCT02447991|593760512|FG000|Overall Study|Withdrawn by Subject - with data|4|||
164379718|NCT02447991|593760513|FG001|Overall Study|Withdrawn by Subject - with data|4|||
164379719|NCT02447991|593760512|FG000|Overall Study|Lost to Follow-up - no data|3|||
164379720|NCT02447991|593760513|FG001|Overall Study|Lost to Follow-up - no data|6|||
164379721|NCT02447991|593760512|FG000|Overall Study|Lost to follow-up - with data|0|||
164379722|NCT02447991|593760513|FG001|Overall Study|Lost to follow-up - with data|3|||
164379723|NCT02447991|593760512|FG000|Overall Study|End of study - no treatment results|3|||
164379724|NCT02447991|593760513|FG001|Overall Study|End of study - no treatment results|6|||
164013210|NCT04543955|592412412|FG000|Overall Study|Company cancelled study|1|||
164013211|NCT04543955|592412413|FG001|Overall Study|Company cancelled study|0|||
164013212|NCT03918642|592412414|FG000|Overall Study|Lost to Follow-up|12|||
164013213|NCT03918642|592412415|FG001|Overall Study|Lost to Follow-up|10|||
164013214|NCT03515538|592412431|FG000|Overall Study|Lack of Efficacy|2|||
164013215|NCT03515538|592412432|FG001|Overall Study|Lack of Efficacy|0|||
164013216|NCT03515538|592412433|FG002|Overall Study|Lack of Efficacy|2|||
164013217|NCT03515538|592412434|FG003|Overall Study|Lack of Efficacy|0|||
164013218|NCT03515538|592412431|FG000|Overall Study|Death|0|||
164013219|NCT03515538|592412432|FG001|Overall Study|Death|0|||
164013220|NCT03515538|592412433|FG002|Overall Study|Death|1|||
164013221|NCT03515538|592412434|FG003|Overall Study|Death|0|||
164013222|NCT03515538|592412431|FG000|Overall Study|Protocol Violation|0|||
164013223|NCT03515538|592412432|FG001|Overall Study|Protocol Violation|0|||
164013224|NCT03515538|592412433|FG002|Overall Study|Protocol Violation|0|||
164013225|NCT03515538|592412434|FG003|Overall Study|Protocol Violation|1|||
164013226|NCT03515538|592412431|FG000|Overall Study|Screen failure (baseline dropout)|0|||
164013227|NCT03515538|592412432|FG001|Overall Study|Screen failure (baseline dropout)|1|||
164013228|NCT03515538|592412433|FG002|Overall Study|Screen failure (baseline dropout)|0|||
164013229|NCT03515538|592412434|FG003|Overall Study|Screen failure (baseline dropout)|0|||
164013230|NCT03515538|592412431|FG000|Overall Study|Withdrawal by Subject|2|||
164013231|NCT03515538|592412432|FG001|Overall Study|Withdrawal by Subject|2|||
164013232|NCT03515538|592412433|FG002|Overall Study|Withdrawal by Subject|1|||
164013233|NCT03515538|592412434|FG003|Overall Study|Withdrawal by Subject|3|||
164013234|NCT03515538|592412431|FG000|Overall Study|Physician Decision|1|||
164013235|NCT03515538|592412432|FG001|Overall Study|Physician Decision|0|||
164013236|NCT03515538|592412433|FG002|Overall Study|Physician Decision|0|||
164013237|NCT03515538|592412434|FG003|Overall Study|Physician Decision|1|||
164013238|NCT02345161|592412437|FG000|Overall Study|Withdrawal by Subject|25|||
164013239|NCT02345161|592412438|FG001|Overall Study|Withdrawal by Subject|33|||
164013240|NCT02345161|592412437|FG000|Overall Study|Adverse Event|16|||
164013241|NCT02345161|592412438|FG001|Overall Study|Adverse Event|19|||
164013242|NCT02345161|592412437|FG000|Overall Study|Physician Decision|4|||
164013243|NCT02345161|592412438|FG001|Overall Study|Physician Decision|4|||
164013244|NCT02345161|592412437|FG000|Overall Study|Lost to Follow-up|0|||
164013245|NCT02345161|592412438|FG001|Overall Study|Lost to Follow-up|1|||
164013246|NCT03088605|592412439|FG000|Overall Study|Withdrawal by Subject|1|||
164013247|NCT03088605|592412440|FG001|Overall Study|Withdrawal by Subject|0|||
164013248|NCT02225223|592412442|FG000|Overall Study|Death|10|||
164379725|NCT02447991|593760512|FG000|Overall Study|End of study - partial treatment results|0|||
164379726|NCT02447991|593760513|FG001|Overall Study|End of study - partial treatment results|9|||
164013249|NCT02225223|592412443|FG001|Overall Study|Death|1|||
164013250|NCT02225223|592412442|FG000|Overall Study|Lost to Follow-up|5|||
164013251|NCT02225223|592412443|FG001|Overall Study|Lost to Follow-up|0|||
164013252|NCT02225223|592412442|FG000|Overall Study|Other|1|||
164013253|NCT02225223|592412443|FG001|Overall Study|Other|2|||
164379727|NCT00829621|593760514|FG000|Overall Study|Death|1|||
164379728|NCT00829621|593760515|FG001|Overall Study|Death|0|||
164379729|NCT00829621|593760514|FG000|Overall Study|Lost to Follow-up|3|||
164379730|NCT00829621|593760515|FG001|Overall Study|Lost to Follow-up|4|||
164379731|NCT03551210|593760516|FG000|Overall Study|Adverse Event|5|||
164379732|NCT03551210|593760517|FG001|Overall Study|Adverse Event|6|||
164379733|NCT03551210|593760516|FG000|Overall Study|Withdrawal by Subject|1|||
164379734|NCT03551210|593760517|FG001|Overall Study|Withdrawal by Subject|7|||
164379735|NCT03551210|593760516|FG000|Overall Study|Needed in other antibiotic treatment|2|||
164379736|NCT03551210|593760517|FG001|Overall Study|Needed in other antibiotic treatment|5|||
164379737|NCT03551210|593760516|FG000|Overall Study|Lost to Follow-up|1|||
164379738|NCT03551210|593760517|FG001|Overall Study|Lost to Follow-up|1|||
164379739|NCT03551210|593760516|FG000|Overall Study|Absence of visit 4 and 5|1|||
164379740|NCT03551210|593760517|FG001|Overall Study|Absence of visit 4 and 5|0|||
164013254|NCT02225223|592412442|FG000|Overall Study|Physician Decision|1|||
164013255|NCT02225223|592412443|FG001|Overall Study|Physician Decision|0|||
164013256|NCT02225223|592412442|FG000|Overall Study|Withdrawal by Subject|2|||
164379741|NCT03551210|593760516|FG000|Overall Study|No drug for dispensing|0|||
164013257|NCT02225223|592412443|FG001|Overall Study|Withdrawal by Subject|2|||
164013258|NCT03666143|592412444|FG000|Overall Study|Death|158|||
164013259|NCT03666143|592412444|FG000|Overall Study|Sponsor Decision|31|||
164013260|NCT03666143|592412444|FG000|Overall Study|Withdrawal by Subject|11|||
164013261|NCT03666143|592412444|FG000|Overall Study|Lost to Follow-up|5|||
164379742|NCT03551210|593760517|FG001|Overall Study|No drug for dispensing|1|||
164379743|NCT04260191|593761829|FG000|Overall Study|Decision by Sponsor|0|||
164379744|NCT04260191|593761830|FG001|Overall Study|Decision by Sponsor|1|||
164379745|NCT04260191|593761831|FG002|Overall Study|Decision by Sponsor|0|||
164379746|NCT04260191|593761829|FG000|Overall Study|Withdrawal by Subject|1|||
164379747|NCT04260191|593761830|FG001|Overall Study|Withdrawal by Subject|0|||
164379748|NCT04260191|593761831|FG002|Overall Study|Withdrawal by Subject|3|||
164379749|NCT04260191|593761829|FG000|Overall Study|Death|4|||
164379750|NCT04260191|593761830|FG001|Overall Study|Death|3|||
164379751|NCT04260191|593761831|FG002|Overall Study|Death|2|||
164379752|NCT02343458|593761832|FG000|Overall Study|Adverse Event|15|||
164379753|NCT02343458|593761833|FG001|Overall Study|Adverse Event|14|||
164379754|NCT02343458|593761834|FG002|Overall Study|Adverse Event|15|||
164379755|NCT02343458|593761835|FG003|Overall Study|Adverse Event|3|||
164013262|NCT03666143|592412444|FG000|Overall Study|Physician Decision|1|||
164013263|NCT03666143|592412444|FG000|Overall Study|Rolled into extension study|9|||
164013264|NCT03666143|592412444|FG000|Overall Study|Progressive Disease|1|||
164013265|NCT02639182|592412450|FG000|Overall Study|Disease Progression|50|||
164013266|NCT02639182|592412451|FG001|Overall Study|Disease Progression|49|||
164013267|NCT02639182|592412450|FG000|Overall Study|Adverse Event|7|||
164013268|NCT02639182|592412451|FG001|Overall Study|Adverse Event|5|||
164013269|NCT02639182|592412450|FG000|Overall Study|Physician Decision|3|||
164013270|NCT02639182|592412451|FG001|Overall Study|Physician Decision|3|||
164013271|NCT02639182|592412450|FG000|Overall Study|Withdrew Consent|5|||
164013272|NCT02639182|592412451|FG001|Overall Study|Withdrew Consent|4|||
164013273|NCT02639182|592412450|FG000|Overall Study|Lost to Follow-up|0|||
164013274|NCT02639182|592412451|FG001|Overall Study|Lost to Follow-up|1|||
164013275|NCT02639182|592412450|FG000|Overall Study|Study Closure|1|||
164013276|NCT02639182|592412451|FG001|Overall Study|Study Closure|2|||
164013277|NCT02639182|592412450|FG000|Overall Study|Sponsor Ended Study|0|||
164013278|NCT02639182|592412451|FG001|Overall Study|Sponsor Ended Study|1|||
164013279|NCT02639182|592412450|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
164013280|NCT02639182|592412451|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
164013281|NCT02546856|592412452|FG000|4 Months Evaluation|Death|2|||
164013282|NCT02546856|592412453|FG001|4 Months Evaluation|Death|3|||
164013283|NCT02546856|592412452|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
164013284|NCT02546856|592412453|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
164013285|NCT02546856|592412452|FG000|4 Months Evaluation|Lost to Follow-up|3|||
164013286|NCT02546856|592412453|FG001|4 Months Evaluation|Lost to Follow-up|3|||
164013287|NCT02546856|592412452|FG000|4 Months Evaluation|Physician Decision|3|||
164013288|NCT02546856|592412453|FG001|4 Months Evaluation|Physician Decision|0|||
164013289|NCT02546856|592412452|FG000|4 Months Evaluation|Working or living abroad|5|||
164013290|NCT02546856|592412453|FG001|4 Months Evaluation|Working or living abroad|1|||
164013291|NCT02546856|592412452|FG000|4 Months Evaluation|reasons not due to titration|4|||
164013292|NCT02546856|592412453|FG001|4 Months Evaluation|reasons not due to titration|1|||
164013293|NCT02546856|592412452|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
164379756|NCT02343458|593761832|FG000|Overall Study|Lack of Efficacy|3|||
164379757|NCT02343458|593761833|FG001|Overall Study|Lack of Efficacy|8|||
164379758|NCT02343458|593761834|FG002|Overall Study|Lack of Efficacy|4|||
164379759|NCT02343458|593761835|FG003|Overall Study|Lack of Efficacy|8|||
164379760|NCT02343458|593761832|FG000|Overall Study|Withdrawal by Subject|18|||
164379761|NCT02343458|593761833|FG001|Overall Study|Withdrawal by Subject|17|||
164379762|NCT02343458|593761834|FG002|Overall Study|Withdrawal by Subject|23|||
164379763|NCT02343458|593761835|FG003|Overall Study|Withdrawal by Subject|14|||
164379764|NCT02343458|593761832|FG000|Overall Study|Physician Decision|1|||
164379765|NCT02343458|593761833|FG001|Overall Study|Physician Decision|4|||
164379766|NCT02343458|593761834|FG002|Overall Study|Physician Decision|2|||
164379767|NCT02343458|593761835|FG003|Overall Study|Physician Decision|2|||
164379768|NCT02343458|593761832|FG000|Overall Study|Lost to Follow-up|5|||
164379769|NCT02343458|593761833|FG001|Overall Study|Lost to Follow-up|5|||
164379770|NCT02343458|593761834|FG002|Overall Study|Lost to Follow-up|3|||
164379771|NCT02343458|593761835|FG003|Overall Study|Lost to Follow-up|1|||
164379772|NCT02343458|593761832|FG000|Overall Study|Protocol Violation|2|||
164379773|NCT02343458|593761833|FG001|Overall Study|Protocol Violation|5|||
164379774|NCT02343458|593761834|FG002|Overall Study|Protocol Violation|2|||
164013294|NCT02546856|592412453|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
164013295|NCT02546856|592412452|FG000|6 Months Evaluation|Death|1|||
164013296|NCT02546856|592412453|FG001|6 Months Evaluation|Death|1|||
164379775|NCT02343458|593761835|FG003|Overall Study|Protocol Violation|2|||
164379776|NCT02343458|593761832|FG000|Overall Study|Protocol Specified Criteria|17|||
164379777|NCT02343458|593761833|FG001|Overall Study|Protocol Specified Criteria|13|||
164379778|NCT02343458|593761834|FG002|Overall Study|Protocol Specified Criteria|14|||
164379779|NCT02343458|593761835|FG003|Overall Study|Protocol Specified Criteria|8|||
164379780|NCT01913041|593761836|FG000|Overall Study|Protocol Violation|35|||
164379781|NCT01913041|593761836|FG000|Overall Study|Withdrawal by Subject|3|||
164379782|NCT01913041|593761836|FG000|Overall Study|Physician Decision|1|||
164379783|NCT01513317|593761837|FG000|Overall Study|Withdrawal by Subject|15|||
164379784|NCT01513317|593761838|FG001|Overall Study|Withdrawal by Subject|4|||
164379785|NCT01513317|593761837|FG000|Overall Study|Death|1|||
164379786|NCT01513317|593761838|FG001|Overall Study|Death|1|||
164379787|NCT01513317|593761837|FG000|Overall Study|Study terminated by sponsor|18|||
164379788|NCT01513317|593761838|FG001|Overall Study|Study terminated by sponsor|18|||
164379789|NCT01513317|593761837|FG000|Overall Study|Other|0|||
164379790|NCT01513317|593761838|FG001|Overall Study|Other|1|||
164379791|NCT02564198|593761839|FG000|Overall Study|Withdrawal by Subject|2|||
164379792|NCT02564198|593761840|FG001|Overall Study|Withdrawal by Subject|4|||
164013297|NCT02546856|592412452|FG000|6 Months Evaluation|Lost to Follow-up|1|||
164013298|NCT02546856|592412453|FG001|6 Months Evaluation|Lost to Follow-up|1|||
164013299|NCT02546856|592412452|FG000|6 Months Evaluation|Working or living abroad|6|||
164013300|NCT02546856|592412453|FG001|6 Months Evaluation|Working or living abroad|4|||
164013301|NCT02546856|592412452|FG000|6 Months Evaluation|reasons not due to titration|0|||
164013302|NCT02546856|592412453|FG001|6 Months Evaluation|reasons not due to titration|1|||
164013303|NCT00130208|592412456|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
164013304|NCT00130208|592412457|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
164013305|NCT00130208|592412456|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
164013306|NCT00130208|592412457|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
164013307|NCT00130208|592412456|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
164013308|NCT00130208|592412457|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
164013309|NCT00130208|592412456|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
164013310|NCT00130208|592412457|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
164013311|NCT00130208|592412456|FG000|Maintenance Period (26 Weeks)|Other|1|||
164013312|NCT00130208|592412457|FG001|Maintenance Period (26 Weeks)|Other|1|||
164013313|NCT00130208|592412456|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
164013314|NCT00130208|592412457|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
164013315|NCT00130208|592412456|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
164013316|NCT00130208|592412457|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
164013317|NCT00130208|592412456|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
164013318|NCT00130208|592412457|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
164013319|NCT00130208|592412456|FG000|Washout Period (8 Weeks)|Other|1|||
164013320|NCT00130208|592412457|FG001|Washout Period (8 Weeks)|Other|1|||
164013321|NCT04655586|592412458|FG000|Overall Study|Physician Decision|1|||
164013322|NCT04655586|592412459|FG001|Overall Study|Physician Decision|3|||
164013323|NCT04655586|592412460|FG002|Overall Study|Physician Decision|4|||
164013324|NCT04655586|592412458|FG000|Overall Study|Withdrawal by Subject|1|||
164013325|NCT04655586|592412459|FG001|Overall Study|Withdrawal by Subject|3|||
164379793|NCT02564198|593761841|FG002|Overall Study|Withdrawal by Subject|0|||
164379794|NCT02564198|593761839|FG000|Overall Study|Adverse Event|0|||
164379795|NCT02564198|593761840|FG001|Overall Study|Adverse Event|1|||
164379796|NCT02564198|593761841|FG002|Overall Study|Adverse Event|0|||
164379797|NCT02866682|593761844|FG000|Overall Study|Death|0|||
164379798|NCT02866682|593761845|FG001|Overall Study|Death|1|||
164379799|NCT02866682|593761844|FG000|Overall Study|Lost to Follow-up|0|||
164379800|NCT02866682|593761845|FG001|Overall Study|Lost to Follow-up|4|||
164379801|NCT02866682|593761844|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
164013326|NCT04655586|592412460|FG002|Overall Study|Withdrawal by Subject|1|||
164013327|NCT03268746|592412461|FG000|Overall Study|Withdrawal by Subject|1|||
164013328|NCT00986258|592412462|FG000|Observation Period|Not eligible to be dosed|11|||
164092872|NCT02322047|592703399|FG002|Overall Study|Lost to Follow-up|1|||
164379802|NCT02866682|593761845|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
164379803|NCT02866682|593761844|FG000|Overall Study|Other|0|||
164379804|NCT02866682|593761845|FG001|Overall Study|Other|1|||
164379805|NCT01750268|593761846|FG000|Overall Study|Lost to Follow-up|0|||
164379806|NCT01750268|593761847|FG001|Overall Study|Lost to Follow-up|2|||
164379807|NCT01750268|593761846|FG000|Overall Study|Physician Decision|0|||
164379808|NCT01750268|593761847|FG001|Overall Study|Physician Decision|3|||
164379809|NCT01750268|593761846|FG000|Overall Study|Withdrawal by Subject|2|||
164379810|NCT01750268|593761847|FG001|Overall Study|Withdrawal by Subject|0|||
164379811|NCT01529645|593761850|FG000|Overall Study|Lost to Follow-up|0|||
164379812|NCT01529645|593761851|FG001|Overall Study|Lost to Follow-up|1|||
164379813|NCT01529645|593761852|FG002|Overall Study|Lost to Follow-up|1|||
164379814|NCT01529645|593761853|FG003|Overall Study|Lost to Follow-up|1|||
164379815|NCT01529645|593761854|FG004|Overall Study|Lost to Follow-up|1|||
164379816|NCT01529645|593761855|FG005|Overall Study|Lost to Follow-up|0|||
164379817|NCT01529645|593761856|FG006|Overall Study|Lost to Follow-up|2|||
164379818|NCT01529645|593761857|FG007|Overall Study|Lost to Follow-up|0|||
164379819|NCT01529645|593761858|FG008|Overall Study|Lost to Follow-up|1|||
164379820|NCT01529645|593761859|FG009|Overall Study|Lost to Follow-up|0|||
164379821|NCT01529645|593761850|FG000|Overall Study|SAE - Premature contractions|0|||
164379822|NCT01529645|593761851|FG001|Overall Study|SAE - Premature contractions|0|||
164379823|NCT01529645|593761852|FG002|Overall Study|SAE - Premature contractions|1|||
164379824|NCT01529645|593761853|FG003|Overall Study|SAE - Premature contractions|0|||
164379825|NCT01529645|593761854|FG004|Overall Study|SAE - Premature contractions|0|||
164379826|NCT01529645|593761855|FG005|Overall Study|SAE - Premature contractions|0|||
164379827|NCT01529645|593761856|FG006|Overall Study|SAE - Premature contractions|0|||
164379828|NCT01529645|593761857|FG007|Overall Study|SAE - Premature contractions|0|||
164379829|NCT01529645|593761858|FG008|Overall Study|SAE - Premature contractions|0|||
164379830|NCT01529645|593761859|FG009|Overall Study|SAE - Premature contractions|0|||
164379831|NCT01529645|593761850|FG000|Overall Study|Withdrawal by Subject|2|||
164379832|NCT01529645|593761851|FG001|Overall Study|Withdrawal by Subject|0|||
164379833|NCT01529645|593761852|FG002|Overall Study|Withdrawal by Subject|0|||
164379834|NCT01529645|593761853|FG003|Overall Study|Withdrawal by Subject|1|||
164379835|NCT01529645|593761854|FG004|Overall Study|Withdrawal by Subject|1|||
164379836|NCT01529645|593761855|FG005|Overall Study|Withdrawal by Subject|1|||
164379837|NCT01529645|593761856|FG006|Overall Study|Withdrawal by Subject|0|||
164379838|NCT01529645|593761857|FG007|Overall Study|Withdrawal by Subject|0|||
164379839|NCT01529645|593761858|FG008|Overall Study|Withdrawal by Subject|0|||
164379840|NCT01529645|593761859|FG009|Overall Study|Withdrawal by Subject|0|||
164379841|NCT03455855|593761860|FG000|Overall Study|Lost to Follow-up|4|||
164379842|NCT03455855|593761861|FG001|Overall Study|Lost to Follow-up|2|||
164379843|NCT00924950|593761862|FG000|Overall Study|Lost to Follow-up|2|||
164379844|NCT01602315|593761863|FG000|Overall Study|Protocol Violation|0|||
164379845|NCT01602315|593761864|FG001|Overall Study|Protocol Violation|0|||
164379846|NCT01602315|593761865|FG002|Overall Study|Protocol Violation|0|||
164379847|NCT01602315|593761866|FG003|Overall Study|Protocol Violation|0|||
164379848|NCT01602315|593761867|FG004|Overall Study|Protocol Violation|0|||
164379849|NCT01602315|593761868|FG005|Overall Study|Protocol Violation|1|||
164379850|NCT01602315|593761869|FG006|Overall Study|Protocol Violation|0|||
164379851|NCT01602315|593761863|FG000|Overall Study|Physician Decision|2|||
164379852|NCT01602315|593761864|FG001|Overall Study|Physician Decision|0|||
164379853|NCT01602315|593761865|FG002|Overall Study|Physician Decision|0|||
164379854|NCT01602315|593761866|FG003|Overall Study|Physician Decision|0|||
164379855|NCT01602315|593761867|FG004|Overall Study|Physician Decision|2|||
164379856|NCT01602315|593761868|FG005|Overall Study|Physician Decision|1|||
164379857|NCT01602315|593761869|FG006|Overall Study|Physician Decision|1|||
164379858|NCT01602315|593761863|FG000|Overall Study|Disease progression|6|||
164379859|NCT01602315|593761864|FG001|Overall Study|Disease progression|3|||
164379860|NCT01602315|593761865|FG002|Overall Study|Disease progression|10|||
164379861|NCT01602315|593761866|FG003|Overall Study|Disease progression|1|||
164379862|NCT01602315|593761867|FG004|Overall Study|Disease progression|41|||
164379863|NCT01602315|593761868|FG005|Overall Study|Disease progression|12|||
164379864|NCT01602315|593761869|FG006|Overall Study|Disease progression|15|||
164379865|NCT01602315|593761863|FG000|Overall Study|Death|1|||
164379866|NCT01602315|593761864|FG001|Overall Study|Death|1|||
164379867|NCT01602315|593761865|FG002|Overall Study|Death|1|||
164379868|NCT01602315|593761866|FG003|Overall Study|Death|1|||
164379869|NCT01602315|593761867|FG004|Overall Study|Death|7|||
164379870|NCT01602315|593761868|FG005|Overall Study|Death|2|||
164379871|NCT01602315|593761869|FG006|Overall Study|Death|2|||
164379872|NCT01602315|593761863|FG000|Overall Study|Withdrawal by Subject|2|||
164379873|NCT01602315|593761864|FG001|Overall Study|Withdrawal by Subject|0|||
164379874|NCT01602315|593761865|FG002|Overall Study|Withdrawal by Subject|2|||
164379875|NCT01602315|593761866|FG003|Overall Study|Withdrawal by Subject|0|||
164379876|NCT01602315|593761867|FG004|Overall Study|Withdrawal by Subject|6|||
164379877|NCT01602315|593761868|FG005|Overall Study|Withdrawal by Subject|0|||
164379878|NCT01602315|593761869|FG006|Overall Study|Withdrawal by Subject|1|||
164379879|NCT01602315|593761863|FG000|Overall Study|Adverse Event|5|||
164379880|NCT01602315|593761864|FG001|Overall Study|Adverse Event|1|||
164379881|NCT01602315|593761865|FG002|Overall Study|Adverse Event|5|||
163902881|NCT04038580|592014780|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
163902882|NCT04038580|592014781|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
164013329|NCT00986258|592412462|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
164013330|NCT00986258|592412462|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
164013331|NCT00986258|592412462|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
164013332|NCT00986258|592412462|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
164013333|NCT00986258|592412462|FG000|Titration and Optimal Dose Period|Other|1|||
164013334|NCT00986258|592412462|FG000|Maintenance Period|Adverse Event|5|||
164013335|NCT00986258|592412462|FG000|Maintenance Period|Lack of Efficacy|2|||
164013336|NCT00986258|592412462|FG000|Maintenance Period|Withdrawal by Subject|2|||
164013337|NCT01035606|592412465|FG000|Overall Study|change in health, job demands,family|3|||
164013338|NCT01035606|592412466|FG001|Overall Study|change in health, job demands,family|3|||
164013339|NCT01035606|592412467|FG002|Overall Study|change in health, job demands,family|4|||
164013340|NCT01070303|592412468|FG000|Overall Study|Adverse Event|39|||
164013341|NCT01070303|592412468|FG000|Overall Study|Withdrawal by Subject|20|||
164013342|NCT01070303|592412468|FG000|Overall Study|Lost to Follow-up|9|||
164013343|NCT01070303|592412468|FG000|Overall Study|Protocol Violation|0|||
164013344|NCT01070303|592412468|FG000|Overall Study|Lack of Efficacy|2|||
164013345|NCT01070303|592412468|FG000|Overall Study|Administrative Reason|1|||
164013346|NCT01070303|592412468|FG000|Overall Study|Other|18|||
164013347|NCT02145156|592412469|FG000|Overall Study|No match to vaccination records|60|||
164013348|NCT02145156|592412470|FG001|Overall Study|No match to vaccination records|52|||
164013349|NCT02145156|592412471|FG002|Overall Study|No match to vaccination records|41|||
164013350|NCT02064439|592412473|FG000|Overall Study|Adverse Event|51|||
164013351|NCT02064439|592412474|FG001|Overall Study|Adverse Event|47|||
164013352|NCT02064439|592412475|FG002|Overall Study|Adverse Event|46|||
164013353|NCT02064439|592412473|FG000|Overall Study|Death|0|||
164013354|NCT02064439|592412474|FG001|Overall Study|Death|2|||
164013355|NCT02064439|592412475|FG002|Overall Study|Death|3|||
164013356|NCT02064439|592412473|FG000|Overall Study|Withdrawal by Subject|29|||
163902883|NCT04038580|592014782|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
163902884|NCT04038580|592014783|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
163902885|NCT04038580|592014784|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
163902886|NCT04038580|592014785|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
163902887|NCT04038580|592014780|FG000|Wash-out 3|Withdrawal by Subject|1|||
163902888|NCT04038580|592014781|FG001|Wash-out 3|Withdrawal by Subject|0|||
164013357|NCT02064439|592412474|FG001|Overall Study|Withdrawal by Subject|18|||
164013358|NCT02064439|592412475|FG002|Overall Study|Withdrawal by Subject|26|||
164013359|NCT02064439|592412473|FG000|Overall Study|Protocol Violation|3|||
163902889|NCT04038580|592014782|FG002|Wash-out 3|Withdrawal by Subject|2|||
163902890|NCT04038580|592014783|FG003|Wash-out 3|Withdrawal by Subject|0|||
163902891|NCT04038580|592014784|FG004|Wash-out 3|Withdrawal by Subject|0|||
163902892|NCT04038580|592014785|FG005|Wash-out 3|Withdrawal by Subject|0|||
164013360|NCT02064439|592412474|FG001|Overall Study|Protocol Violation|5|||
164379882|NCT01602315|593761866|FG003|Overall Study|Adverse Event|4|||
164379883|NCT01602315|593761867|FG004|Overall Study|Adverse Event|15|||
164379884|NCT01602315|593761868|FG005|Overall Study|Adverse Event|3|||
164379885|NCT01602315|593761869|FG006|Overall Study|Adverse Event|9|||
164379886|NCT01602315|593761863|FG000|Overall Study|Subject/guardian decision|0|||
164379887|NCT01602315|593761864|FG001|Overall Study|Subject/guardian decision|0|||
164379888|NCT01602315|593761865|FG002|Overall Study|Subject/guardian decision|0|||
164379889|NCT01602315|593761866|FG003|Overall Study|Subject/guardian decision|0|||
163902893|NCT03477175|592014786|FG000|Overall Study|Unable to travel due to COVID-19|0|||
163902894|NCT03477175|592014787|FG001|Overall Study|Unable to travel due to COVID-19|1|||
163902895|NCT03477175|592014786|FG000|Overall Study|Physician Decision|1|||
163902896|NCT03477175|592014787|FG001|Overall Study|Physician Decision|0|||
163902897|NCT03477175|592014786|FG000|Overall Study|Transitioned to commercial drug|6|||
164379890|NCT01602315|593761867|FG004|Overall Study|Subject/guardian decision|0|||
164379891|NCT01602315|593761868|FG005|Overall Study|Subject/guardian decision|0|||
164379892|NCT01602315|593761869|FG006|Overall Study|Subject/guardian decision|1|||
164379893|NCT01602315|593761863|FG000|Overall Study|Cross-over patients to combo treatment|0|||
164379894|NCT01602315|593761864|FG001|Overall Study|Cross-over patients to combo treatment|0|||
164379895|NCT01602315|593761865|FG002|Overall Study|Cross-over patients to combo treatment|0|||
164379896|NCT01602315|593761866|FG003|Overall Study|Cross-over patients to combo treatment|0|||
164379897|NCT01602315|593761867|FG004|Overall Study|Cross-over patients to combo treatment|0|||
164379898|NCT01602315|593761868|FG005|Overall Study|Cross-over patients to combo treatment|16|||
164379899|NCT01602315|593761869|FG006|Overall Study|Cross-over patients to combo treatment|0|||
164379900|NCT02212730|593761872|FG000|Overall Study|Tumor not of the required cell histology|1|||
164379901|NCT02212730|593761873|FG001|Overall Study|Tumor not of the required cell histology|0|||
164379902|NCT02212730|593761872|FG000|Overall Study|Withdrawal by Subject|1|||
164379903|NCT02212730|593761873|FG001|Overall Study|Withdrawal by Subject|0|||
164379904|NCT02212730|593761872|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
164379905|NCT02212730|593761873|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
164379906|NCT00961259|593761874|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
164379907|NCT00961259|593761875|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
164379908|NCT00961259|593761876|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
164379909|NCT02691455|593761879|FG000|Overall Study|Withdrawal by Subject|1|||
164013361|NCT02064439|592412475|FG002|Overall Study|Protocol Violation|3|||
164013362|NCT02064439|592412473|FG000|Overall Study|Lost to Follow-up|1|||
164013363|NCT02064439|592412474|FG001|Overall Study|Lost to Follow-up|3|||
164013364|NCT02064439|592412475|FG002|Overall Study|Lost to Follow-up|4|||
164013365|NCT02064439|592412473|FG000|Overall Study|Non-compliance with study medication|21|||
164013366|NCT02064439|592412474|FG001|Overall Study|Non-compliance with study medication|19|||
164013367|NCT02064439|592412475|FG002|Overall Study|Non-compliance with study medication|23|||
164013368|NCT02064439|592412473|FG000|Overall Study|Physician Decision|0|||
164013369|NCT02064439|592412474|FG001|Overall Study|Physician Decision|1|||
164013370|NCT02064439|592412475|FG002|Overall Study|Physician Decision|1|||
164013371|NCT02064439|592412473|FG000|Overall Study|Logistical difficulties|6|||
164013372|NCT02064439|592412474|FG001|Overall Study|Logistical difficulties|5|||
164013373|NCT02064439|592412475|FG002|Overall Study|Logistical difficulties|2|||
164013374|NCT02064439|592412473|FG000|Overall Study|Efficacy outcome reached|18|||
164013375|NCT02064439|592412474|FG001|Overall Study|Efficacy outcome reached|16|||
164013376|NCT02064439|592412475|FG002|Overall Study|Efficacy outcome reached|57|||
164013377|NCT02064439|592412473|FG000|Overall Study|Safety outcome reached|12|||
164013378|NCT02064439|592412474|FG001|Overall Study|Safety outcome reached|20|||
164013379|NCT02064439|592412475|FG002|Overall Study|Safety outcome reached|10|||
164013380|NCT02064439|592412473|FG000|Overall Study|Other|2|||
164013381|NCT02064439|592412474|FG001|Overall Study|Other|2|||
164013382|NCT02064439|592412475|FG002|Overall Study|Other|7|||
164013383|NCT02433288|592412476|FG000|Overall Study|Severe non-compliance to protocol|13|||
164013384|NCT02433288|592412477|FG001|Overall Study|Severe non-compliance to protocol|7|||
164013385|NCT02433288|592412476|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
164013386|NCT02433288|592412477|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
164013387|NCT02433288|592412476|FG000|Overall Study|Withdrawal by Subject|101|||
164013388|NCT02433288|592412477|FG001|Overall Study|Withdrawal by Subject|99|||
164013389|NCT02433288|592412476|FG000|Overall Study|Lost to Follow-up|2|||
164013390|NCT02433288|592412477|FG001|Overall Study|Lost to Follow-up|14|||
164013391|NCT02433288|592412476|FG000|Overall Study|Death|0|||
164013392|NCT02433288|592412477|FG001|Overall Study|Death|3|||
164013393|NCT00858702|592412480|FG000|Overall Study|Lack of Efficacy|1|||
164013394|NCT00858702|592412481|FG001|Overall Study|Lack of Efficacy|0|||
164013395|NCT00858702|592412480|FG000|Overall Study|Protocol Violation|1|||
164013396|NCT00858702|592412481|FG001|Overall Study|Protocol Violation|1|||
164013397|NCT00858702|592412480|FG000|Overall Study|Other|2|||
164013398|NCT00858702|592412481|FG001|Overall Study|Other|1|||
164013399|NCT00858702|592412480|FG000|Overall Study|Withdrawal by Subject|1|||
164013400|NCT00858702|592412481|FG001|Overall Study|Withdrawal by Subject|0|||
164013401|NCT01740440|592412484|FG000|Overall Study|Lost to Follow-up|3|||
164379910|NCT02691455|593761880|FG001|Overall Study|Withdrawal by Subject|2|||
164379911|NCT02691455|593761879|FG000|Overall Study|Lost to Follow-up|15|||
164013402|NCT01063751|592412485|FG000|Overall Study|Censored from analyses|42|||
164013403|NCT01063751|592412485|FG000|Overall Study|Withdrawal by Subject|34|||
164013404|NCT01063751|592412485|FG000|Overall Study|Lost to Follow-up|30|||
164092873|NCT02322047|592703400|FG003|Overall Study|Lost to Follow-up|1|||
164013405|NCT01063751|592412485|FG000|Overall Study|Death|13|||
164013406|NCT01063751|592412485|FG000|Overall Study|Sponsored Terminated Study|60|||
164013407|NCT01063751|592412485|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
164013408|NCT01063751|592412485|FG000|Overall Study|Investigator site closed|10|||
164013409|NCT01063751|592412485|FG000|Overall Study|Revision|6|||
164092874|NCT00920140|592703403|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
164092875|NCT00920140|592703404|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
164092876|NCT00920140|592703405|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
164092877|NCT00920140|592703406|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
164092878|NCT00920140|592703407|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
164092879|NCT00920140|592703403|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
164092880|NCT00920140|592703404|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
164092881|NCT00920140|592703405|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
164013410|NCT01063751|592412485|FG000|Overall Study|Physician Decision|4|||
164013411|NCT02805907|592412486|FG000|Overall Study|Lost to Follow-up|3|||
164013412|NCT02805907|592412487|FG001|Overall Study|Lost to Follow-up|3|||
164013413|NCT03408873|592412492|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
164013414|NCT03408873|592412492|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
164013415|NCT03408873|592412492|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
164013416|NCT03408873|592412492|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
164013417|NCT03408873|592412492|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
164013418|NCT03408873|592412492|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
164013419|NCT01264965|592412498|FG000|Overall Study|Withdrawal by Subject|10|||
164013420|NCT00425438|592412501|FG000|Overall Study|Termination by Sponsor|25|||
164013421|NCT00425438|592412502|FG001|Overall Study|Termination by Sponsor|27|||
164013422|NCT01327339|592412503|FG000|Overall Study|Protocol Violation|8|||
164013423|NCT01172288|592412504|FG000|Overall Study|Adverse Event|1|||
164013424|NCT01172288|592412505|FG001|Overall Study|Adverse Event|0|||
164013425|NCT01172288|592412504|FG000|Overall Study|Protocol Violation|0|||
164013426|NCT01172288|592412505|FG001|Overall Study|Protocol Violation|1|||
164013427|NCT03303339|592412508|FG000|Overall Study|Death|2|||
164013428|NCT03303339|592412509|FG001|Overall Study|Death|2|||
164013429|NCT03303339|592412510|FG002|Overall Study|Death|2|||
164013430|NCT03303339|592412511|FG003|Overall Study|Death|1|||
164013431|NCT03303339|592412512|FG004|Overall Study|Death|4|||
164013432|NCT03303339|592412513|FG005|Overall Study|Death|2|||
164013433|NCT03303339|592412514|FG006|Overall Study|Death|2|||
164013434|NCT03303339|592412515|FG007|Overall Study|Death|2|||
164013435|NCT03303339|592412516|FG008|Overall Study|Death|3|||
164013436|NCT03303339|592412517|FG009|Overall Study|Death|3|||
164013437|NCT03303339|592412518|FG010|Overall Study|Death|4|||
164013438|NCT03303339|592412519|FG011|Overall Study|Death|24|||
164013439|NCT03303339|592412508|FG000|Overall Study|Study Terminated by Sponsor|0|||
164013440|NCT03303339|592412509|FG001|Overall Study|Study Terminated by Sponsor|0|||
164013441|NCT03303339|592412510|FG002|Overall Study|Study Terminated by Sponsor|0|||
164013442|NCT03303339|592412511|FG003|Overall Study|Study Terminated by Sponsor|0|||
164013443|NCT03303339|592412512|FG004|Overall Study|Study Terminated by Sponsor|0|||
164013444|NCT03303339|592412513|FG005|Overall Study|Study Terminated by Sponsor|0|||
164013445|NCT03303339|592412514|FG006|Overall Study|Study Terminated by Sponsor|0|||
164013446|NCT03303339|592412515|FG007|Overall Study|Study Terminated by Sponsor|0|||
164013447|NCT03303339|592412516|FG008|Overall Study|Study Terminated by Sponsor|1|||
164013448|NCT03303339|592412517|FG009|Overall Study|Study Terminated by Sponsor|0|||
164013449|NCT03303339|592412518|FG010|Overall Study|Study Terminated by Sponsor|1|||
164013450|NCT03303339|592412519|FG011|Overall Study|Study Terminated by Sponsor|1|||
164013451|NCT03303339|592412508|FG000|Overall Study|Withdrawal by Subject|1|||
164013452|NCT03303339|592412509|FG001|Overall Study|Withdrawal by Subject|0|||
164013453|NCT03303339|592412510|FG002|Overall Study|Withdrawal by Subject|0|||
164379912|NCT02691455|593761880|FG001|Overall Study|Lost to Follow-up|15|||
164379913|NCT03394391|593761881|FG000|Overall Study|Lost to Follow-up|1|||
164379914|NCT03394391|593761882|FG001|Overall Study|Lost to Follow-up|2|||
164092882|NCT00920140|592703406|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
164092883|NCT00920140|592703407|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
164092884|NCT00920140|592703403|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164379915|NCT00723801|593761887|FG000|Overall Study|Lost to Follow-up|1|||
164379916|NCT00723801|593761888|FG001|Overall Study|Lost to Follow-up|2|||
164379917|NCT00723801|593761887|FG000|Overall Study|Protocol Violation|2|||
164379918|NCT00723801|593761888|FG001|Overall Study|Protocol Violation|1|||
164379919|NCT01532687|593761899|FG000|Overall Study|Death|2|||
164379920|NCT01532687|593761900|FG001|Overall Study|Death|0|||
164379921|NCT01532687|593761899|FG000|Overall Study|Adverse Event|6|||
164379922|NCT01532687|593761900|FG001|Overall Study|Adverse Event|1|||
164379923|NCT01532687|593761899|FG000|Overall Study|Withdrawal by Subject|1|||
164379924|NCT01532687|593761900|FG001|Overall Study|Withdrawal by Subject|0|||
164379925|NCT01532687|593761899|FG000|Overall Study|Physician Decision|2|||
164379926|NCT01532687|593761900|FG001|Overall Study|Physician Decision|1|||
164379927|NCT01532687|593761899|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
164379928|NCT01532687|593761900|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
164379929|NCT04116229|593761901|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
164379930|NCT04116229|593761902|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
164379931|NCT04116229|593761901|FG000|Overall Study|Scheduling not possible.|0|||
164379932|NCT04116229|593761902|FG001|Overall Study|Scheduling not possible.|1|||
164379933|NCT02809976|593761903|FG000|Overall Study|Lost to Follow-up|1|||
164013454|NCT03303339|592412511|FG003|Overall Study|Withdrawal by Subject|0|||
164379934|NCT02809976|593761903|FG000|Overall Study|Withdrawal by Subject|1|||
164379935|NCT01163682|593761905|FG000|Overall Study|Lost to Follow-up|6|||
164379936|NCT01163682|593761906|FG001|Overall Study|Lost to Follow-up|9|||
164379937|NCT00211081|593761910|FG000|Overall Study|Withdrawal by Subject|2|||
164379938|NCT01263873|593761911|FG000|Overall Study|One provider unable to complete numbers|1|||
164379939|NCT01263873|593761912|FG001|Overall Study|One provider unable to complete numbers|1|||
164379940|NCT00113516|593761913|FG000|Part 1|Adverse Event|6|||
164379941|NCT00113516|593761914|FG001|Part 1|Adverse Event|0|||
164379942|NCT00113516|593761913|FG000|Part 1|Death|3|||
164379943|NCT00113516|593761914|FG001|Part 1|Death|0|||
164379944|NCT00113516|593761913|FG000|Part 1|Other|3|||
164379945|NCT00113516|593761914|FG001|Part 1|Other|0|||
164379946|NCT00113516|593761913|FG000|Part 1|Withdrawal by Subject|2|||
164379947|NCT00113516|593761914|FG001|Part 1|Withdrawal by Subject|0|||
164379948|NCT00113516|593761913|FG000|Part 1|Lack of Efficacy|2|||
164379949|NCT00113516|593761914|FG001|Part 1|Lack of Efficacy|0|||
164379950|NCT00113516|593761913|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
164379951|NCT00113516|593761914|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
164379952|NCT00113516|593761913|FG000|Part 1|Laboratory Abnormality|1|||
164379953|NCT00113516|593761914|FG001|Part 1|Laboratory Abnormality|0|||
164379954|NCT00113516|593761913|FG000|Part 1|Ongoing|1|||
164379955|NCT00113516|593761914|FG001|Part 1|Ongoing|0|||
164379956|NCT00113516|593761913|FG000|Part 1|Missing|65|||
164379957|NCT00113516|593761914|FG001|Part 1|Missing|0|||
164379958|NCT00113516|593761913|FG000|Part 2|Adverse Event|0|||
164379959|NCT00113516|593761914|FG001|Part 2|Adverse Event|16|||
164379960|NCT00113516|593761913|FG000|Part 2|Death|0|||
164379961|NCT00113516|593761914|FG001|Part 2|Death|5|||
164379962|NCT00113516|593761913|FG000|Part 2|Lack of Efficacy|0|||
164379963|NCT00113516|593761914|FG001|Part 2|Lack of Efficacy|37|||
164379964|NCT00113516|593761913|FG000|Part 2|Withdrawal by Subject|0|||
164379965|NCT00113516|593761914|FG001|Part 2|Withdrawal by Subject|3|||
164379966|NCT00113516|593761913|FG000|Part 2|Other|0|||
164379967|NCT00113516|593761914|FG001|Part 2|Other|3|||
164379968|NCT00113516|593761913|FG000|Part 2|Laboratory Abnormality|0|||
164379969|NCT00113516|593761914|FG001|Part 2|Laboratory Abnormality|1|||
164379970|NCT00113516|593761913|FG000|Part 2|Ongoing|0|||
164379971|NCT00113516|593761914|FG001|Part 2|Ongoing|1|||
164379972|NCT03217136|593761923|FG000|Overall Study|Lost to Follow-up|2|||
164379973|NCT03217136|593761924|FG001|Overall Study|Lost to Follow-up|1|||
164379974|NCT03217136|593761923|FG000|Overall Study|Site Randomized Participant in Error|0|||
164379975|NCT03217136|593761924|FG001|Overall Study|Site Randomized Participant in Error|1|||
164379976|NCT03217136|593761923|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
164379977|NCT03217136|593761924|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
164379978|NCT03217136|593761923|FG000|Overall Study|Dispensing Error|1|||
164379979|NCT03217136|593761924|FG001|Overall Study|Dispensing Error|0|||
164379980|NCT03217136|593761923|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164379981|NCT03217136|593761924|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164379982|NCT03755765|593761925|FG000|Overall Study|Withdrawal by Subject|2|||
164379983|NCT03755765|593761926|FG001|Overall Study|Withdrawal by Subject|4|||
164379984|NCT03755765|593761927|FG002|Overall Study|Withdrawal by Subject|4|||
164379985|NCT02104557|593761928|FG000|Overall Study|Adverse Event|24|||
164379986|NCT02104557|593761928|FG000|Overall Study|Lost to Follow-up|34|||
164379987|NCT02104557|593761928|FG000|Overall Study|Violated the usage and dosage|14|||
164379988|NCT02104557|593761928|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
164379989|NCT02104557|593761928|FG000|Overall Study|Administered Sayana prior to the contract|1|||
164379990|NCT02104557|593761928|FG000|Overall Study|Other|17|||
164379991|NCT02104557|593761928|FG000|Overall Study|Change to other contraception methods|5|||
164379992|NCT02104557|593761928|FG000|Overall Study|Discontinuation due to no pain|1|||
164379993|NCT02104557|593761928|FG000|Overall Study|Withdrawal consent|2|||
164379994|NCT02104557|593761928|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
164379995|NCT02104557|593761928|FG000|Overall Study|Discontinuation of contraception|9|||
164379996|NCT01158222|593761932|FG000|Overall Study|Not eligible for intermediate phase|17|||
164379997|NCT00111228|593761935|FG000|Overall Study|Withdrawal by Subject|5|||
164379998|NCT00111228|593761936|FG001|Overall Study|Withdrawal by Subject|1|||
164379999|NCT00111228|593761937|FG002|Overall Study|Withdrawal by Subject|0|||
164380000|NCT02579616|593761938|FG000|Overall Study|Participants did not receive treatment|3|||
164380001|NCT01490060|593761939|FG000|Cycle 1|Change of Treatment|0|||
164380002|NCT01490060|593761940|FG001|Cycle 1|Change of Treatment|1|||
164380003|NCT01490060|593761941|FG002|Cycle 1|Change of Treatment|1|||
164380004|NCT01490060|593761942|FG003|Cycle 1|Change of Treatment|1|||
164380005|NCT01490060|593761939|FG000|Cycle 1|Insurance Denied|0|||
164380006|NCT01490060|593761940|FG001|Cycle 1|Insurance Denied|0|||
164380007|NCT01490060|593761941|FG002|Cycle 1|Insurance Denied|2|||
164380008|NCT01490060|593761942|FG003|Cycle 1|Insurance Denied|0|||
164380009|NCT01490060|593761939|FG000|Cycle 1|Withdrawal by Subject|0|||
164380010|NCT01490060|593761940|FG001|Cycle 1|Withdrawal by Subject|0|||
164380011|NCT01490060|593761941|FG002|Cycle 1|Withdrawal by Subject|0|||
164380012|NCT01490060|593761942|FG003|Cycle 1|Withdrawal by Subject|1|||
164380013|NCT01490060|593761939|FG000|Cycle 1|Treatment at Another Facility|0|||
164380014|NCT01490060|593761940|FG001|Cycle 1|Treatment at Another Facility|0|||
164380015|NCT01490060|593761941|FG002|Cycle 1|Treatment at Another Facility|0|||
164380016|NCT01490060|593761942|FG003|Cycle 1|Treatment at Another Facility|1|||
164380017|NCT01490060|593761939|FG000|Cycle 2|Change of Treatment|1|||
164380018|NCT01490060|593761940|FG001|Cycle 2|Change of Treatment|1|||
164380019|NCT01490060|593761941|FG002|Cycle 2|Change of Treatment|0|||
164380020|NCT01490060|593761942|FG003|Cycle 2|Change of Treatment|0|||
164380021|NCT01490060|593761939|FG000|Cycle 2|Non-Compliance|0|||
164380022|NCT01490060|593761940|FG001|Cycle 2|Non-Compliance|0|||
164380023|NCT01490060|593761941|FG002|Cycle 2|Non-Compliance|1|||
164380024|NCT01490060|593761942|FG003|Cycle 2|Non-Compliance|0|||
164380025|NCT01490060|593761939|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
164380026|NCT01490060|593761940|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
164380027|NCT01490060|593761941|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
164380028|NCT01490060|593761942|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
164380029|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
164380030|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
164380031|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
164380032|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
164380033|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
164380034|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
164380035|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
164380036|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
164380037|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
164380038|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
164380039|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
164380040|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
164380041|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
164380042|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
164380043|NCT02464969|593761943|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
164380044|NCT02464969|593761944|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
164092885|NCT00920140|592703404|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
164092886|NCT00920140|592703405|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164380045|NCT02464969|593761943|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
164380046|NCT02464969|593761944|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
164380047|NCT02464969|593761943|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
164380048|NCT02464969|593761944|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
164380049|NCT02464969|593761943|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
164380050|NCT02464969|593761944|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
164380051|NCT02863354|593761945|FG000|Year 1|Lost to Follow-up|1|||
164380052|NCT02863354|593761946|FG001|Year 1|Lost to Follow-up|1|||
164380053|NCT02863354|593761945|FG000|Year 1|Withdrawal by Subject|3|||
164380054|NCT02863354|593761946|FG001|Year 1|Withdrawal by Subject|0|||
164380055|NCT02863354|593761945|FG000|Year 1|Death|0|||
164380056|NCT02863354|593761946|FG001|Year 1|Death|1|||
164380057|NCT02863354|593761945|FG000|Year 2|Lost to Follow-up|2|||
164380058|NCT02863354|593761946|FG001|Year 2|Lost to Follow-up|2|||
164380059|NCT00724451|593761952|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
164380060|NCT00724451|593761952|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
164380061|NCT00724451|593761952|FG000|Overall Study|Not Eligible for Treatment|431|||
164380062|NCT00724451|593761952|FG000|Overall Study|Participant Refused Treatment|89|||
164380063|NCT00724451|593761952|FG000|Overall Study|Never Started Treatment|89|||
164380064|NCT00724451|593761952|FG000|Overall Study|Unknown; No Data Sources Available|9|||
164380065|NCT00724451|593761952|FG000|Overall Study|Physician Decision|116|||
164380066|NCT00724451|593761952|FG000|Overall Study|Withdrawal by Subject|45|||
164380067|NCT00724451|593761952|FG000|Overall Study|Investigator + Participant Decision|13|||
163902898|NCT03477175|592014787|FG001|Overall Study|Transitioned to commercial drug|6|||
164092887|NCT00920140|592703406|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164092888|NCT00920140|592703407|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
164092889|NCT00920140|592703403|FG000|Phase 2|Adverse Event|0|||
164380068|NCT00720876|593761953|FG000|Overall Study|found to be ineligible after starting tx|2|||
164380069|NCT03495908|593761955|FG000|Overall Study|Withdrawal by Subject|3|||
164380070|NCT03495908|593761956|FG001|Overall Study|Withdrawal by Subject|1|||
164380071|NCT03495908|593761955|FG000|Overall Study|Lost to Follow-up|1|||
164380072|NCT03495908|593761956|FG001|Overall Study|Lost to Follow-up|4|||
164092890|NCT00920140|592703404|FG001|Phase 2|Adverse Event|0|||
164380073|NCT03495908|593761955|FG000|Overall Study|Adverse Event|0|||
164380074|NCT03495908|593761956|FG001|Overall Study|Adverse Event|2|||
164380075|NCT03495908|593761955|FG000|Overall Study|Death|1|||
164380076|NCT03495908|593761956|FG001|Overall Study|Death|0|||
164380077|NCT03495908|593761955|FG000|Overall Study|Physician Decision|5|||
164380078|NCT03495908|593761956|FG001|Overall Study|Physician Decision|4|||
164380079|NCT03495908|593761955|FG000|Overall Study|No documented reason|0|||
164380080|NCT03495908|593761956|FG001|Overall Study|No documented reason|2|||
164380081|NCT01559311|593761959|FG000|Overall Study|Protocol Violation|0|||
164380082|NCT01559311|593761960|FG001|Overall Study|Protocol Violation|0|||
164380083|NCT01559311|593761961|FG002|Overall Study|Protocol Violation|2|||
164380084|NCT01559311|593761959|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
164380085|NCT01559311|593761960|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
164380086|NCT01559311|593761961|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
164380087|NCT01559311|593761959|FG000|Overall Study|Withdrawal by Subject|2|||
164380088|NCT01559311|593761960|FG001|Overall Study|Withdrawal by Subject|1|||
164380089|NCT01559311|593761961|FG002|Overall Study|Withdrawal by Subject|0|||
164380090|NCT01559311|593761959|FG000|Overall Study|Death|0|||
164380091|NCT01559311|593761960|FG001|Overall Study|Death|2|||
164380092|NCT01559311|593761961|FG002|Overall Study|Death|3|||
164380093|NCT01559311|593761959|FG000|Overall Study|Lost to Follow-up|0|||
164380094|NCT01559311|593761960|FG001|Overall Study|Lost to Follow-up|3|||
164380095|NCT01559311|593761961|FG002|Overall Study|Lost to Follow-up|2|||
164380096|NCT01559311|593761959|FG000|Overall Study|Adverse Event|0|||
163902899|NCT03477175|592014786|FG000|Overall Study|Lost to Follow-up|1|||
163902900|NCT03477175|592014787|FG001|Overall Study|Lost to Follow-up|1|||
164380097|NCT01559311|593761960|FG001|Overall Study|Adverse Event|0|||
164380098|NCT01559311|593761961|FG002|Overall Study|Adverse Event|1|||
164380099|NCT03027466|593761962|FG000|Overall Study|Opting out of the app|1869|||
164380100|NCT03027466|593761963|FG001|Overall Study|Opting out of the app|1819|||
164380101|NCT03027466|593761964|FG002|Overall Study|Opting out of the app|1743|||
164380102|NCT03027466|593761965|FG003|Overall Study|Opting out of the app|1821|||
164380103|NCT03286140|593761966|FG000|Overall Study|Withdrawal by Subject|10|||
164380104|NCT03286140|593761967|FG001|Overall Study|Withdrawal by Subject|5|||
164380105|NCT03286140|593761966|FG000|Overall Study|Lost to Follow-up|5|||
164380106|NCT03286140|593761967|FG001|Overall Study|Lost to Follow-up|10|||
164380107|NCT03286140|593761966|FG000|Overall Study|Failure to comply|0|||
164380108|NCT03286140|593761967|FG001|Overall Study|Failure to comply|1|||
164380109|NCT02158039|593761968|FG000|Overall Study|Withdrawal by Subject|1|||
164380110|NCT02158039|593761968|FG000|Overall Study|Screen Failure|9|||
164380111|NCT00515827|593761969|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
164380112|NCT00515827|593761970|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
164380113|NCT00515827|593761969|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
164380114|NCT00515827|593761970|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
164380115|NCT02052466|593761971|FG000|Overall Study|Withdrawal by Subject|1|||
164380116|NCT02052466|593761971|FG000|Overall Study|Acromial fracture|1|||
164380117|NCT02293005|593763392|FG000|Overall Study|Adverse Event|2|||
164380118|NCT02293005|593763392|FG000|Overall Study|Death|4|||
164380119|NCT02293005|593763392|FG000|Overall Study|Lost to Follow-up|1|||
164380120|NCT02293005|593763392|FG000|Overall Study|Withdrawal by Subject|2|||
164380121|NCT02293005|593763392|FG000|Overall Study|Progression|17|||
164380122|NCT02766608|593763393|FG000|Overall Study|Adverse Event|27|||
164380123|NCT02766608|593763394|FG001|Overall Study|Adverse Event|22|||
164380124|NCT02766608|593763395|FG002|Overall Study|Adverse Event|17|||
164380125|NCT02766608|593763396|FG003|Overall Study|Adverse Event|13|||
164380126|NCT02766608|593763397|FG004|Overall Study|Adverse Event|12|||
164380127|NCT02766608|593763393|FG000|Overall Study|Withdrawal by Subject|21|||
164380128|NCT02766608|593763394|FG001|Overall Study|Withdrawal by Subject|20|||
164380129|NCT02766608|593763395|FG002|Overall Study|Withdrawal by Subject|24|||
164380130|NCT02766608|593763396|FG003|Overall Study|Withdrawal by Subject|13|||
164380131|NCT02766608|593763397|FG004|Overall Study|Withdrawal by Subject|10|||
164380132|NCT02766608|593763393|FG000|Overall Study|Lack of Efficacy|16|||
164380133|NCT02766608|593763394|FG001|Overall Study|Lack of Efficacy|15|||
164380134|NCT02766608|593763395|FG002|Overall Study|Lack of Efficacy|32|||
164380135|NCT02766608|593763396|FG003|Overall Study|Lack of Efficacy|8|||
163902901|NCT03477175|592014786|FG000|Overall Study|Withdrawal by Subject|3|||
163902902|NCT03477175|592014787|FG001|Overall Study|Withdrawal by Subject|1|||
164380136|NCT02766608|593763397|FG004|Overall Study|Lack of Efficacy|2|||
164380137|NCT02766608|593763393|FG000|Overall Study|Lost to Follow-up|6|||
164380138|NCT02766608|593763394|FG001|Overall Study|Lost to Follow-up|3|||
164380139|NCT02766608|593763395|FG002|Overall Study|Lost to Follow-up|5|||
164380140|NCT02766608|593763396|FG003|Overall Study|Lost to Follow-up|2|||
164380141|NCT02766608|593763397|FG004|Overall Study|Lost to Follow-up|2|||
164380142|NCT02766608|593763393|FG000|Overall Study|Physician Decision|3|||
164380143|NCT02766608|593763394|FG001|Overall Study|Physician Decision|2|||
164380144|NCT02766608|593763395|FG002|Overall Study|Physician Decision|3|||
164380145|NCT02766608|593763396|FG003|Overall Study|Physician Decision|1|||
164380146|NCT02766608|593763397|FG004|Overall Study|Physician Decision|2|||
164380147|NCT02766608|593763393|FG000|Overall Study|Protocol disc criteria|3|||
164380148|NCT02766608|593763394|FG001|Overall Study|Protocol disc criteria|3|||
164380149|NCT02766608|593763395|FG002|Overall Study|Protocol disc criteria|4|||
164380150|NCT02766608|593763396|FG003|Overall Study|Protocol disc criteria|0|||
164380151|NCT02766608|593763397|FG004|Overall Study|Protocol disc criteria|0|||
164380152|NCT02766608|593763393|FG000|Overall Study|Protocol Violation|0|||
164380153|NCT02766608|593763394|FG001|Overall Study|Protocol Violation|4|||
164380154|NCT02766608|593763395|FG002|Overall Study|Protocol Violation|4|||
164380155|NCT02766608|593763396|FG003|Overall Study|Protocol Violation|0|||
164380156|NCT02766608|593763397|FG004|Overall Study|Protocol Violation|1|||
164380157|NCT02766608|593763393|FG000|Overall Study|Administrative Reasons|3|||
164380158|NCT02766608|593763394|FG001|Overall Study|Administrative Reasons|1|||
164380159|NCT02766608|593763395|FG002|Overall Study|Administrative Reasons|1|||
164380160|NCT02766608|593763396|FG003|Overall Study|Administrative Reasons|0|||
164380161|NCT02766608|593763397|FG004|Overall Study|Administrative Reasons|0|||
164380162|NCT02648698|593763405|FG000|Overall Study|Protocol Violation|1|||
164380163|NCT02648698|593763406|FG001|Overall Study|Protocol Violation|5|||
164380164|NCT03143829|593763409|FG000|Overall Study|Withdrawal by Subject|2|||
164380165|NCT03143829|593763410|FG001|Overall Study|Withdrawal by Subject|5|||
164380166|NCT03143829|593763409|FG000|Overall Study|Lost to Follow-up|0|||
164380167|NCT03143829|593763410|FG001|Overall Study|Lost to Follow-up|2|||
164380168|NCT03143829|593763409|FG000|Overall Study|Death|1|||
164380169|NCT03143829|593763410|FG001|Overall Study|Death|1|||
164380170|NCT03143829|593763409|FG000|Overall Study|changed treatment, no longer eligible|2|||
164380171|NCT03143829|593763410|FG001|Overall Study|changed treatment, no longer eligible|2|||
164380172|NCT00672477|593763411|FG000|Overall Study|Adverse Event|10|||
164380173|NCT00672477|593763412|FG001|Overall Study|Adverse Event|7|||
164380174|NCT00672477|593763411|FG000|Overall Study|Death|7|||
164380175|NCT00672477|593763412|FG001|Overall Study|Death|11|||
164380176|NCT00672477|593763411|FG000|Overall Study|Physician Decision|2|||
164380177|NCT00672477|593763412|FG001|Overall Study|Physician Decision|0|||
164380178|NCT00672477|593763411|FG000|Overall Study|Protocol Violation|1|||
164380179|NCT00672477|593763412|FG001|Overall Study|Protocol Violation|1|||
164380180|NCT00672477|593763411|FG000|Overall Study|Withdrawal by Subject|5|||
164380181|NCT00672477|593763412|FG001|Overall Study|Withdrawal by Subject|3|||
164380182|NCT00672477|593763411|FG000|Overall Study|Lack of Efficacy|1|||
164380183|NCT00672477|593763412|FG001|Overall Study|Lack of Efficacy|1|||
164380184|NCT00672477|593763411|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
164380185|NCT00672477|593763412|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
164380186|NCT00938431|593763416|FG000|Overall Study|Adverse Event|5|||
164380187|NCT00938431|593763417|FG001|Overall Study|Adverse Event|8|||
164380188|NCT00938431|593763418|FG002|Overall Study|Adverse Event|6|||
164380189|NCT00938431|593763416|FG000|Overall Study|Lack of Efficacy|0|||
164380190|NCT00938431|593763417|FG001|Overall Study|Lack of Efficacy|1|||
164380191|NCT00938431|593763418|FG002|Overall Study|Lack of Efficacy|0|||
164380192|NCT00938431|593763416|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
164380193|NCT00938431|593763417|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
164380194|NCT00938431|593763418|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
164380195|NCT00938431|593763416|FG000|Overall Study|Dosing compliance issue|0|||
164380196|NCT00938431|593763417|FG001|Overall Study|Dosing compliance issue|0|||
164380197|NCT00938431|593763418|FG002|Overall Study|Dosing compliance issue|1|||
164380198|NCT00938431|593763416|FG000|Overall Study|Reached maximum dose early|0|||
164380199|NCT00938431|593763417|FG001|Overall Study|Reached maximum dose early|0|||
164380200|NCT00938431|593763418|FG002|Overall Study|Reached maximum dose early|1|||
164380201|NCT03738865|593763421|FG000|Overall Study|Withdrawal by Subject|3|||
164380202|NCT03738865|593763422|FG001|Overall Study|Withdrawal by Subject|3|||
164380203|NCT03738865|593763421|FG000|Overall Study|Adverse Event|2|||
164380204|NCT03738865|593763422|FG001|Overall Study|Adverse Event|0|||
164380205|NCT03738865|593763421|FG000|Overall Study|Physician Decision|0|||
164380206|NCT03738865|593763422|FG001|Overall Study|Physician Decision|1|||
164380207|NCT02057757|593763423|FG000|Overall Study|Withdrawal by Subject|3|||
164380208|NCT02057757|593763424|FG001|Overall Study|Withdrawal by Subject|5|||
164380209|NCT02057757|593763423|FG000|Overall Study|Death|2|||
164380210|NCT02057757|593763424|FG001|Overall Study|Death|0|||
164380211|NCT02057757|593763423|FG000|Overall Study|Lost to Follow-up|8|||
164380212|NCT02057757|593763424|FG001|Overall Study|Lost to Follow-up|3|||
164380213|NCT02057757|593763423|FG000|Overall Study|Non-compliance|1|||
164380214|NCT02057757|593763424|FG001|Overall Study|Non-compliance|0|||
164380215|NCT00440271|593763425|FG000|Overall Study|Protocol Violation|1|||
164380216|NCT00440271|593763426|FG001|Overall Study|Protocol Violation|1|||
164380217|NCT00440271|593763425|FG000|Overall Study|Adverse Event|0|||
164380218|NCT00440271|593763426|FG001|Overall Study|Adverse Event|1|||
164380219|NCT00440271|593763425|FG000|Overall Study|Lost to Follow-up|1|||
164380220|NCT00440271|593763426|FG001|Overall Study|Lost to Follow-up|0|||
164380221|NCT00440271|593763425|FG000|Overall Study|Withdrawal by Subject|0|||
164380222|NCT00440271|593763426|FG001|Overall Study|Withdrawal by Subject|2|||
164380223|NCT00440271|593763425|FG000|Overall Study|Lack of Efficacy|0|||
164380224|NCT00440271|593763426|FG001|Overall Study|Lack of Efficacy|1|||
164380225|NCT00440271|593763425|FG000|Overall Study|Due to closure of trial|8|||
164380226|NCT00440271|593763426|FG001|Overall Study|Due to closure of trial|10|||
164380227|NCT00440271|593763425|FG000|Overall Study|Other|2|||
164380228|NCT00440271|593763426|FG001|Overall Study|Other|0|||
164380229|NCT00048724|593763430|FG000|Overall Study|Adverse Event|53|||
164380230|NCT00048724|593763431|FG001|Overall Study|Adverse Event|12|||
164380231|NCT00048724|593763430|FG000|Overall Study|Withdrawal by Subject|34|||
164380232|NCT00048724|593763431|FG001|Overall Study|Withdrawal by Subject|54|||
164380233|NCT00048724|593763430|FG000|Overall Study|Lost to Follow-up|5|||
164380234|NCT00048724|593763431|FG001|Overall Study|Lost to Follow-up|5|||
164380235|NCT00048724|593763430|FG000|Overall Study|Protocol-defined Clinical Event|17|||
164380236|NCT00048724|593763431|FG001|Overall Study|Protocol-defined Clinical Event|32|||
164380237|NCT00048724|593763430|FG000|Overall Study|Noncompliance With Protocol|4|||
164380238|NCT00048724|593763431|FG001|Overall Study|Noncompliance With Protocol|12|||
164380239|NCT00048724|593763430|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
164380240|NCT00048724|593763431|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
164013455|NCT03303339|592412512|FG004|Overall Study|Withdrawal by Subject|0|||
164013456|NCT03303339|592412513|FG005|Overall Study|Withdrawal by Subject|1|||
164013457|NCT03303339|592412514|FG006|Overall Study|Withdrawal by Subject|1|||
164013458|NCT03303339|592412515|FG007|Overall Study|Withdrawal by Subject|0|||
164013459|NCT03303339|592412516|FG008|Overall Study|Withdrawal by Subject|0|||
164013460|NCT03303339|592412517|FG009|Overall Study|Withdrawal by Subject|0|||
164013461|NCT03303339|592412518|FG010|Overall Study|Withdrawal by Subject|0|||
164013462|NCT03303339|592412519|FG011|Overall Study|Withdrawal by Subject|2|||
164013463|NCT03303339|592412508|FG000|Overall Study|Physician Decision|0|||
164013464|NCT03303339|592412509|FG001|Overall Study|Physician Decision|0|||
164013465|NCT03303339|592412510|FG002|Overall Study|Physician Decision|0|||
164013466|NCT03303339|592412511|FG003|Overall Study|Physician Decision|0|||
164013467|NCT03303339|592412512|FG004|Overall Study|Physician Decision|1|||
164013468|NCT03303339|592412513|FG005|Overall Study|Physician Decision|0|||
164013469|NCT03303339|592412514|FG006|Overall Study|Physician Decision|0|||
164013470|NCT03303339|592412515|FG007|Overall Study|Physician Decision|0|||
164013471|NCT03303339|592412516|FG008|Overall Study|Physician Decision|0|||
164013472|NCT03303339|592412517|FG009|Overall Study|Physician Decision|0|||
164013473|NCT03303339|592412518|FG010|Overall Study|Physician Decision|0|||
164013474|NCT03303339|592412519|FG011|Overall Study|Physician Decision|0|||
164013475|NCT03303339|592412508|FG000|Overall Study|Safety/Non-compliance|0|||
164013476|NCT03303339|592412509|FG001|Overall Study|Safety/Non-compliance|0|||
164013477|NCT03303339|592412510|FG002|Overall Study|Safety/Non-compliance|0|||
164013478|NCT03303339|592412511|FG003|Overall Study|Safety/Non-compliance|0|||
164013479|NCT03303339|592412512|FG004|Overall Study|Safety/Non-compliance|0|||
164013480|NCT03303339|592412513|FG005|Overall Study|Safety/Non-compliance|0|||
164013481|NCT03303339|592412514|FG006|Overall Study|Safety/Non-compliance|0|||
164013482|NCT03303339|592412515|FG007|Overall Study|Safety/Non-compliance|0|||
164013483|NCT03303339|592412516|FG008|Overall Study|Safety/Non-compliance|0|||
164013484|NCT03303339|592412517|FG009|Overall Study|Safety/Non-compliance|0|||
164013485|NCT03303339|592412518|FG010|Overall Study|Safety/Non-compliance|0|||
164013486|NCT03303339|592412519|FG011|Overall Study|Safety/Non-compliance|1|||
164013487|NCT00510692|592412521|FG000|Overall Study|Adverse Event|1|||
164013488|NCT00510692|592412522|FG001|Overall Study|Adverse Event|3|||
164013489|NCT00510692|592412521|FG000|Overall Study|Withdrawal by Subject|1|||
164013490|NCT00510692|592412522|FG001|Overall Study|Withdrawal by Subject|0|||
164013491|NCT02116972|592412523|FG000|Overall Study|Adverse Event|4|||
164013492|NCT02116972|592412524|FG001|Overall Study|Adverse Event|4|||
164013493|NCT02116972|592412525|FG002|Overall Study|Adverse Event|1|||
164013494|NCT02116972|592412523|FG000|Overall Study|Withdrawal by Subject|1|||
164013495|NCT02116972|592412524|FG001|Overall Study|Withdrawal by Subject|1|||
164013496|NCT02116972|592412525|FG002|Overall Study|Withdrawal by Subject|5|||
164013497|NCT02116972|592412523|FG000|Overall Study|Protocol Violation|1|||
164013498|NCT02116972|592412524|FG001|Overall Study|Protocol Violation|0|||
164013499|NCT02116972|592412525|FG002|Overall Study|Protocol Violation|1|||
164013500|NCT02116972|592412523|FG000|Overall Study|Lost to Follow-up|4|||
164013501|NCT02116972|592412524|FG001|Overall Study|Lost to Follow-up|3|||
164013502|NCT02116972|592412525|FG002|Overall Study|Lost to Follow-up|1|||
164013503|NCT02116972|592412523|FG000|Overall Study|Lack of Efficacy|6|||
164013504|NCT02116972|592412524|FG001|Overall Study|Lack of Efficacy|6|||
164013505|NCT02116972|592412525|FG002|Overall Study|Lack of Efficacy|5|||
164380241|NCT00048724|593763430|FG000|Overall Study|Administrative|1|||
164380242|NCT00048724|593763431|FG001|Overall Study|Administrative|1|||
164380243|NCT03586869|593763432|FG000|Overall Study|Progressive Disease|3|||
164013506|NCT02116972|592412523|FG000|Overall Study|scheduling conflicts and relocation|3|||
164013507|NCT02116972|592412524|FG001|Overall Study|scheduling conflicts and relocation|3|||
164013508|NCT02116972|592412525|FG002|Overall Study|scheduling conflicts and relocation|6|||
164013509|NCT00784784|592412526|FG000|Overall Study|Withdrawal by Subject|2|||
164013510|NCT00784784|592412527|FG001|Overall Study|Withdrawal by Subject|2|||
164013511|NCT00872898|592412528|FG000|Part Two - Double Blind|Adverse Event|4|||
164380244|NCT00226941|593763433|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
164013512|NCT00872898|592412529|FG001|Part Two - Double Blind|Adverse Event|3|||
164013513|NCT00872898|592412528|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
164013514|NCT00872898|592412529|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
164013515|NCT00872898|592412528|FG000|Part Two - Double Blind|Protocol Violation|1|||
164013516|NCT00872898|592412529|FG001|Part Two - Double Blind|Protocol Violation|0|||
164013517|NCT00872898|592412528|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
164013518|NCT00872898|592412529|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
164013519|NCT00872898|592412528|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
164013520|NCT00872898|592412529|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
164013521|NCT00872898|592412528|FG000|Part Two - Double Blind|Other reasons|2|||
164013522|NCT00872898|592412529|FG001|Part Two - Double Blind|Other reasons|0|||
164013523|NCT03176966|592412532|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
164013524|NCT03176966|592412533|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
164013525|NCT03176966|592412532|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
164013526|NCT03176966|592412533|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
164013527|NCT03176966|592412532|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
164013528|NCT03176966|592412533|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
164013529|NCT03176966|592412532|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
164013530|NCT03176966|592412533|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
164013531|NCT03176966|592412532|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
164013532|NCT03176966|592412533|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
164013533|NCT03176966|592412532|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
164013534|NCT03176966|592412533|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
164013535|NCT03176966|592412532|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
164013536|NCT03176966|592412533|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
164013537|NCT01903434|592412538|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
164013538|NCT01903434|592412539|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
164013539|NCT01903434|592412538|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
164013540|NCT01903434|592412539|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
164013541|NCT00404768|592412540|FG000|Part A and B|Withdrawn due to labor progression|1|||
164013542|NCT00404768|592412541|FG001|Part A and B|Withdrawn due to labor progression|0|||
164013543|NCT00404768|592412542|FG002|Part A and B|Withdrawn due to labor progression|0|||
164013544|NCT00404768|592412543|FG003|Part A and B|Withdrawn due to labor progression|0|||
164013545|NCT00404768|592412540|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
164013546|NCT00404768|592412541|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
164013547|NCT00404768|592412542|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
164013548|NCT00404768|592412543|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
164013549|NCT00404768|592412540|FG000|Part C|Adverse Event|0|||
164013550|NCT00404768|592412541|FG001|Part C|Adverse Event|0|||
164013551|NCT00404768|592412542|FG002|Part C|Adverse Event|0|||
164013552|NCT00404768|592412543|FG003|Part C|Adverse Event|3|||
164380245|NCT00226941|593763434|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
164380246|NCT00226941|593763435|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
164380247|NCT00226941|593763436|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
164380248|NCT00226941|593763433|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
164380249|NCT00226941|593763434|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
164380250|NCT00226941|593763435|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
164380251|NCT00226941|593763436|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
164380252|NCT00009737|593763437|FG000|Overall Study|Adverse Event|112|||
164380253|NCT00009737|593763438|FG001|Overall Study|Adverse Event|75|||
164380254|NCT00009737|593763437|FG000|Overall Study|Death|4|||
164380255|NCT00009737|593763438|FG001|Overall Study|Death|6|||
164380256|NCT00009737|593763437|FG000|Overall Study|Lack of Efficacy|17|||
164380257|NCT00009737|593763438|FG001|Overall Study|Lack of Efficacy|15|||
164380258|NCT00009737|593763437|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
164380259|NCT00009737|593763438|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
164380260|NCT00009737|593763437|FG000|Overall Study|Other Protocol Violation|1|||
164380261|NCT00009737|593763438|FG001|Overall Study|Other Protocol Violation|0|||
164380262|NCT00009737|593763437|FG000|Overall Study|Refused Treatment|15|||
164380263|NCT00009737|593763438|FG001|Overall Study|Refused Treatment|16|||
164380264|NCT00009737|593763437|FG000|Overall Study|Lost to Follow-up|1|||
164380265|NCT00009737|593763438|FG001|Overall Study|Lost to Follow-up|1|||
164380266|NCT00009737|593763437|FG000|Overall Study|Administrative/Other Reasons|7|||
164380267|NCT00009737|593763438|FG001|Overall Study|Administrative/Other Reasons|1|||
164380268|NCT02732847|593763439|FG000|Overall Study|some filled early|42|||
164380269|NCT02732847|593763440|FG001|Overall Study|some filled early|42|||
164380270|NCT00003498|593763441|FG000|Overall Study|Not evaluable.|4|||
164380271|NCT01260922|593763444|FG000|First Intervention|Withdrawal by Subject|0|||
164380272|NCT01260922|593763445|FG001|First Intervention|Withdrawal by Subject|1|||
164013553|NCT00404768|592412540|FG000|Part C|Lost to Follow-up|0|||
164013554|NCT00404768|592412541|FG001|Part C|Lost to Follow-up|0|||
164380273|NCT01260922|593763444|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
164013555|NCT00404768|592412542|FG002|Part C|Lost to Follow-up|3|||
164380274|NCT01260922|593763445|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
164380275|NCT01260922|593763444|FG000|Second Intervention|Emesis|0|||
164380276|NCT01260922|593763445|FG001|Second Intervention|Emesis|2|||
164380277|NCT03732248|593763448|FG000|Overall Study|Withdrawal by Subject|1|||
164380278|NCT03732248|593763449|FG001|Overall Study|Withdrawal by Subject|0|||
164380279|NCT00414050|593763450|FG000|Overall Study|Adverse Event|1|||
164380280|NCT00414050|593763451|FG001|Overall Study|Adverse Event|1|||
164380281|NCT00414050|593763452|FG002|Overall Study|Adverse Event|1|||
164380282|NCT00414050|593763453|FG003|Overall Study|Adverse Event|1|||
164380283|NCT00414050|593763450|FG000|Overall Study|Lost to Follow-up|2|||
164380284|NCT00414050|593763451|FG001|Overall Study|Lost to Follow-up|2|||
164380285|NCT00414050|593763452|FG002|Overall Study|Lost to Follow-up|1|||
164380286|NCT00414050|593763453|FG003|Overall Study|Lost to Follow-up|1|||
164380287|NCT00414050|593763450|FG000|Overall Study|Withdrawal by Subject|5|||
164380288|NCT00414050|593763451|FG001|Overall Study|Withdrawal by Subject|3|||
164380289|NCT00414050|593763452|FG002|Overall Study|Withdrawal by Subject|2|||
164380290|NCT00414050|593763453|FG003|Overall Study|Withdrawal by Subject|4|||
164380291|NCT00414050|593763450|FG000|Overall Study|Subject discontinued for other reason|1|||
164380292|NCT00414050|593763451|FG001|Overall Study|Subject discontinued for other reason|2|||
164380293|NCT00414050|593763452|FG002|Overall Study|Subject discontinued for other reason|2|||
164380294|NCT00414050|593763453|FG003|Overall Study|Subject discontinued for other reason|1|||
164380295|NCT00414050|593763450|FG000|Overall Study|Subject Moved|0|||
164380296|NCT00414050|593763451|FG001|Overall Study|Subject Moved|0|||
164380297|NCT00414050|593763452|FG002|Overall Study|Subject Moved|0|||
164380298|NCT00414050|593763453|FG003|Overall Study|Subject Moved|1|||
164380299|NCT02604589|593763460|FG000|Overall Study|catheter dislodgement|0|||
164380300|NCT02604589|593763461|FG001|Overall Study|catheter dislodgement|0|||
164380301|NCT02604589|593763462|FG002|Overall Study|catheter dislodgement|1|||
164380302|NCT05013905|593763472|FG000|Overall Study|Adverse Event|1|||
164380303|NCT05013905|593763472|FG000|Overall Study|Lack of Efficacy|1|||
164380304|NCT02550652|593763483|FG000|Overall Study|Death|1|||
164380305|NCT02550652|593763484|FG001|Overall Study|Death|4|||
164380306|NCT02550652|593763483|FG000|Overall Study|Lack of Efficacy|1|||
164380307|NCT02550652|593763484|FG001|Overall Study|Lack of Efficacy|0|||
164380308|NCT02550652|593763483|FG000|Overall Study|Withdrawal by Subject|4|||
164380309|NCT02550652|593763484|FG001|Overall Study|Withdrawal by Subject|7|||
164380310|NCT02550652|593763483|FG000|Overall Study|Post Trial Access|1|||
164380311|NCT02550652|593763484|FG001|Overall Study|Post Trial Access|0|||
164380312|NCT02550652|593763483|FG000|Overall Study|Lost to Follow-up|1|||
164380313|NCT02550652|593763484|FG001|Overall Study|Lost to Follow-up|3|||
164380314|NCT02550652|593763483|FG000|Overall Study|Physician Decision|0|||
164380315|NCT02550652|593763484|FG001|Overall Study|Physician Decision|2|||
164380316|NCT02550652|593763483|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
164380317|NCT02550652|593763484|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
164380318|NCT02486406|593763485|FG000|Overall Study|Withdrew consent|1|||
163902903|NCT03477175|592014786|FG000|Overall Study|Adverse Event|1|||
163902904|NCT03477175|592014787|FG001|Overall Study|Adverse Event|5|||
163902905|NCT03477175|592014786|FG000|Overall Study|Disease Progression|7|||
163902906|NCT03477175|592014787|FG001|Overall Study|Disease Progression|7|||
163902907|NCT02078648|592014788|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
163902908|NCT02078648|592014789|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
163902909|NCT02078648|592014788|FG000|Overall Study|Adverse Event|0|||
163902910|NCT02078648|592014789|FG001|Overall Study|Adverse Event|1|||
163902911|NCT02078648|592014788|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
163902912|NCT02078648|592014789|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
163902913|NCT02078648|592014788|FG000|Overall Study|Withdrawal by Subject|3|||
163902914|NCT02078648|592014789|FG001|Overall Study|Withdrawal by Subject|1|||
163902915|NCT02078648|592014788|FG000|Overall Study|Investigator Decision|5|||
164380319|NCT02486406|593763486|FG001|Overall Study|Withdrew consent|0|||
163902916|NCT02078648|592014789|FG001|Overall Study|Investigator Decision|7|||
163902917|NCT02078648|592014788|FG000|Overall Study|Death|1|||
163902918|NCT02078648|592014789|FG001|Overall Study|Death|1|||
163902919|NCT02078648|592014788|FG000|Overall Study|Undefined|0|||
164380320|NCT02486406|593763487|FG002|Overall Study|Withdrew consent|0|||
164380321|NCT02486406|593763488|FG003|Overall Study|Withdrew consent|1|||
164380322|NCT02486406|593763485|FG000|Overall Study|Lost to Follow-up|1|||
164380323|NCT02486406|593763486|FG001|Overall Study|Lost to Follow-up|3|||
164380324|NCT02486406|593763487|FG002|Overall Study|Lost to Follow-up|1|||
164380325|NCT02486406|593763488|FG003|Overall Study|Lost to Follow-up|3|||
164380326|NCT02486406|593763485|FG000|Overall Study|Other, not specified|0|||
164380327|NCT02486406|593763486|FG001|Overall Study|Other, not specified|0|||
164380328|NCT02486406|593763487|FG002|Overall Study|Other, not specified|1|||
164380329|NCT02486406|593763488|FG003|Overall Study|Other, not specified|0|||
164380330|NCT03509948|593763506|FG000|Overall Study|Protocol Violation|0|||
164380331|NCT03509948|593763507|FG001|Overall Study|Protocol Violation|1|||
164380332|NCT03254134|593763509|FG000|Overall Study|Not eligible patients|599|||
164380333|NCT03254134|593763510|FG001|Overall Study|Not eligible patients|3630|||
164380334|NCT00205712|593763511|FG000|Overall Study|Lost to Follow-up|0|||
164380335|NCT00205712|593763512|FG001|Overall Study|Lost to Follow-up|1|||
163902920|NCT02078648|592014789|FG001|Overall Study|Undefined|1|||
163902921|NCT04088227|592014790|FG000|Overall Study|Withdrawal by Subject|1|||
163902922|NCT04088227|592014791|FG001|Overall Study|Withdrawal by Subject|0|||
163902923|NCT04088227|592014790|FG000|Overall Study|Surgery postponed >5weeks|1|||
163902924|NCT04088227|592014791|FG001|Overall Study|Surgery postponed >5weeks|0|||
163902925|NCT04021862|592014792|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163902926|NCT04021862|592014793|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
163902927|NCT04021862|592014794|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163902928|NCT04021862|592014795|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163902929|NCT04021862|592014796|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163902930|NCT04021862|592014797|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
163902931|NCT04021862|592014792|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
163902932|NCT04021862|592014793|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163902933|NCT04021862|592014794|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163902934|NCT04021862|592014795|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163902935|NCT04021862|592014796|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163902936|NCT04021862|592014797|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
163902937|NCT04021862|592014792|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163902938|NCT04021862|592014793|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163902939|NCT04021862|592014794|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
163902940|NCT04021862|592014795|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163902941|NCT04021862|592014796|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163902942|NCT04021862|592014797|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
163902943|NCT04021862|592014792|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
163902944|NCT04021862|592014793|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
163902945|NCT04021862|592014794|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
163902946|NCT04021862|592014795|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
163902947|NCT04021862|592014796|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
163902948|NCT04021862|592014797|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
163902949|NCT04021862|592014792|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163902950|NCT04021862|592014793|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163902951|NCT04021862|592014794|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163902952|NCT04021862|592014795|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
163902953|NCT04021862|592014796|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163902954|NCT04021862|592014797|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
163902955|NCT01855750|592014798|FG000|Overall Study|Death|78|||
163902956|NCT01855750|592014799|FG001|Overall Study|Death|78|||
163902957|NCT01855750|592014798|FG000|Overall Study|Lost to Follow-up|9|||
163902958|NCT01855750|592014799|FG001|Overall Study|Lost to Follow-up|23|||
163902959|NCT01855750|592014798|FG000|Overall Study|Withdrawal by Subject|35|||
163902960|NCT01855750|592014799|FG001|Overall Study|Withdrawal by Subject|28|||
163902961|NCT01855750|592014798|FG000|Overall Study|Sponsor ends the study|297|||
163902962|NCT01855750|592014799|FG001|Overall Study|Sponsor ends the study|290|||
163902963|NCT05379270|592014800|FG000|Overall Study|Withdrawal by Subject|1|||
163902964|NCT05379270|592014801|FG001|Overall Study|Withdrawal by Subject|1|||
163902965|NCT05025384|592014802|FG000|Overall Study|Physician Decision|5|||
163902966|NCT05025384|592014803|FG001|Overall Study|Physician Decision|6|||
163902967|NCT03160885|592014804|FG000|Initial Treatment Period|Not dosed|2|||
163902968|NCT03160885|592014805|FG001|Initial Treatment Period|Not dosed|0|||
163902969|NCT03160885|592014806|FG002|Initial Treatment Period|Not dosed|0|||
164013556|NCT00404768|592412543|FG003|Part C|Lost to Follow-up|1|||
164013557|NCT00404768|592412540|FG000|Part C|Withdrawal by Subject|0|||
164013558|NCT00404768|592412541|FG001|Part C|Withdrawal by Subject|0|||
164013559|NCT00404768|592412542|FG002|Part C|Withdrawal by Subject|2|||
164013560|NCT00404768|592412543|FG003|Part C|Withdrawal by Subject|1|||
164013561|NCT00404768|592412540|FG000|Part C|Early withdrawal from study medication|0|||
163902970|NCT03160885|592014807|FG003|Initial Treatment Period|Not dosed|0|||
163902971|NCT03160885|592014808|FG004|Initial Treatment Period|Not dosed|0|||
163902972|NCT03160885|592014809|FG005|Initial Treatment Period|Not dosed|0|||
163902973|NCT03160885|592014810|FG006|Initial Treatment Period|Not dosed|0|||
164013562|NCT00404768|592412541|FG001|Part C|Early withdrawal from study medication|0|||
164380336|NCT01009099|593763513|FG000|Overall Study|Lost to Follow-up|1|||
164380337|NCT01009099|593763514|FG001|Overall Study|Lost to Follow-up|0|||
164380338|NCT01009099|593763513|FG000|Overall Study|Physician Decision|3|||
164013563|NCT00404768|592412542|FG002|Part C|Early withdrawal from study medication|1|||
164013564|NCT00404768|592412543|FG003|Part C|Early withdrawal from study medication|0|||
164013565|NCT00404768|592412540|FG000|Part C|Participant did not respond to therapy|0|||
164013566|NCT00404768|592412541|FG001|Part C|Participant did not respond to therapy|0|||
164013567|NCT00404768|592412542|FG002|Part C|Participant did not respond to therapy|1|||
164013568|NCT00404768|592412543|FG003|Part C|Participant did not respond to therapy|1|||
164013569|NCT00404768|592412540|FG000|Part C|Physician withdrew the study medication|0|||
164013570|NCT00404768|592412541|FG001|Part C|Physician withdrew the study medication|0|||
164013571|NCT00404768|592412542|FG002|Part C|Physician withdrew the study medication|1|||
164013572|NCT00404768|592412543|FG003|Part C|Physician withdrew the study medication|0|||
164013573|NCT00404768|592412540|FG000|Part C|Participant delivered baby|0|||
164013574|NCT00404768|592412541|FG001|Part C|Participant delivered baby|0|||
164013575|NCT00404768|592412542|FG002|Part C|Participant delivered baby|0|||
164013576|NCT00404768|592412543|FG003|Part C|Participant delivered baby|1|||
164013577|NCT00404768|592412540|FG000|Part C|Unsatisfactory uterine response to IP|0|||
164013578|NCT00404768|592412541|FG001|Part C|Unsatisfactory uterine response to IP|0|||
164013579|NCT00404768|592412542|FG002|Part C|Unsatisfactory uterine response to IP|0|||
164013580|NCT00404768|592412543|FG003|Part C|Unsatisfactory uterine response to IP|1|||
164013581|NCT00404768|592412540|FG000|Part C|Active labor|0|||
164013582|NCT00404768|592412541|FG001|Part C|Active labor|0|||
164013583|NCT00404768|592412542|FG002|Part C|Active labor|0|||
164013584|NCT00404768|592412543|FG003|Part C|Active labor|1|||
164013585|NCT00404768|592412540|FG000|Part C|Lack of Efficacy|0|||
164013586|NCT00404768|592412541|FG001|Part C|Lack of Efficacy|0|||
164013587|NCT00404768|592412542|FG002|Part C|Lack of Efficacy|0|||
164013588|NCT00404768|592412543|FG003|Part C|Lack of Efficacy|2|||
164013589|NCT00404768|592412540|FG000|Part C|Treatment failure|0|||
164013590|NCT00404768|592412541|FG001|Part C|Treatment failure|0|||
164013591|NCT00404768|592412542|FG002|Part C|Treatment failure|0|||
164013592|NCT00404768|592412543|FG003|Part C|Treatment failure|1|||
164013593|NCT00404768|592412540|FG000|Part C|Investigator discretion|0|||
164013594|NCT00404768|592412541|FG001|Part C|Investigator discretion|0|||
164013595|NCT00404768|592412542|FG002|Part C|Investigator discretion|0|||
164013596|NCT00404768|592412543|FG003|Part C|Investigator discretion|1|||
164013597|NCT00404768|592412540|FG000|Part C|Researcher suspended study medication|0|||
164013598|NCT00404768|592412541|FG001|Part C|Researcher suspended study medication|0|||
164013599|NCT00404768|592412542|FG002|Part C|Researcher suspended study medication|0|||
164013600|NCT00404768|592412543|FG003|Part C|Researcher suspended study medication|1|||
164013601|NCT01118143|592412544|FG000|Overall Study|Withdrawal by Subject|2|||
164013602|NCT01118143|592412545|FG001|Overall Study|Withdrawal by Subject|5|||
164013603|NCT03151148|592414452|FG000|Overall Study|Lost to Follow-up|1|||
164013604|NCT03151148|592414453|FG001|Overall Study|Lost to Follow-up|0|||
164013605|NCT03151148|592414452|FG000|Overall Study|Withdrawal by Subject|1|||
164013606|NCT03151148|592414453|FG001|Overall Study|Withdrawal by Subject|0|||
164013607|NCT01228071|592414454|FG000|Overall Study|Protocol Violation|1|||
164013608|NCT01228071|592414454|FG000|Overall Study|Withdrawal by Subject|1|||
164013609|NCT04439838|592414455|FG000|Overall Study|Withdrawal by Subject|0|||
164013610|NCT04439838|592414456|FG001|Overall Study|Withdrawal by Subject|0|||
164013611|NCT04439838|592414457|FG002|Overall Study|Withdrawal by Subject|0|||
164013612|NCT04439838|592414458|FG003|Overall Study|Withdrawal by Subject|0|||
164013613|NCT04439838|592414459|FG004|Overall Study|Withdrawal by Subject|0|||
164013614|NCT04439838|592414460|FG005|Overall Study|Withdrawal by Subject|0|||
164013615|NCT04439838|592414461|FG006|Overall Study|Withdrawal by Subject|0|||
164013616|NCT04439838|592414462|FG007|Overall Study|Withdrawal by Subject|0|||
164013617|NCT04439838|592414463|FG008|Overall Study|Withdrawal by Subject|1|||
164013618|NCT00960440|592414466|FG000|Overall Study|Death|0|||
164013619|NCT00960440|592414467|FG001|Overall Study|Death|0|||
164013620|NCT00960440|592414468|FG002|Overall Study|Death|0|||
164380339|NCT01009099|593763514|FG001|Overall Study|Physician Decision|2|||
164380340|NCT01009099|593763513|FG000|Overall Study|Withdrawal by Subject|1|||
164380341|NCT01009099|593763514|FG001|Overall Study|Withdrawal by Subject|1|||
164380342|NCT01009099|593763513|FG000|Overall Study|Death|0|||
164380343|NCT01009099|593763514|FG001|Overall Study|Death|1|||
164013621|NCT00960440|592414469|FG003|Overall Study|Death|1|||
164013622|NCT00960440|592414466|FG000|Overall Study|Adverse Event|12|||
164013623|NCT00960440|592414467|FG001|Overall Study|Adverse Event|12|||
164013624|NCT00960440|592414468|FG002|Overall Study|Adverse Event|4|||
164013625|NCT00960440|592414469|FG003|Overall Study|Adverse Event|4|||
164013626|NCT00960440|592414466|FG000|Overall Study|Lack of Efficacy|2|||
164013627|NCT00960440|592414467|FG001|Overall Study|Lack of Efficacy|5|||
164380344|NCT02188485|593763525|FG000|Overall Study|Withdrawal by Subject|2|||
164380345|NCT02188485|593763526|FG001|Overall Study|Withdrawal by Subject|1|||
164013628|NCT00960440|592414468|FG002|Overall Study|Lack of Efficacy|3|||
164013629|NCT00960440|592414469|FG003|Overall Study|Lack of Efficacy|8|||
164013630|NCT00960440|592414466|FG000|Overall Study|Protocol Violation|2|||
164380346|NCT02188485|593763525|FG000|Overall Study|PI withdrew, lack of capacity|0|||
164013631|NCT00960440|592414467|FG001|Overall Study|Protocol Violation|8|||
164380347|NCT02188485|593763526|FG001|Overall Study|PI withdrew, lack of capacity|2|||
164380348|NCT00799617|593763527|FG000|Main Testosterone Trial|Randomized in error|1|||
163902974|NCT03160885|592014804|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
163902975|NCT03160885|592014805|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
163902976|NCT03160885|592014806|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163902977|NCT03160885|592014807|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163902978|NCT03160885|592014808|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163902979|NCT03160885|592014809|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163902980|NCT03160885|592014810|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
163902981|NCT03160885|592014804|FG000|Open-label Treatment|Not dosed|0|||
163902982|NCT03160885|592014805|FG001|Open-label Treatment|Not dosed|0|||
164380349|NCT00799617|593763528|FG001|Main Testosterone Trial|Randomized in error|1|||
164380350|NCT00799617|593763527|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
164380351|NCT00799617|593763528|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
164380352|NCT00799617|593763527|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
164380353|NCT00799617|593763528|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
164380354|NCT00799617|593763527|FG000|Sexual Funtion Trial|No Baseline Data|4|||
164380355|NCT00799617|593763528|FG001|Sexual Funtion Trial|No Baseline Data|7|||
164380356|NCT00799617|593763527|FG000|Physical Function Trial|Lost to Follow-up|6|||
164380357|NCT00799617|593763528|FG001|Physical Function Trial|Lost to Follow-up|11|||
164380358|NCT00799617|593763527|FG000|Vitality Trial|Lost to Follow-up|7|||
164380359|NCT00799617|593763528|FG001|Vitality Trial|Lost to Follow-up|22|||
164380360|NCT00799617|593763527|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
163902983|NCT03160885|592014806|FG002|Open-label Treatment|Not dosed|0|||
163902984|NCT03160885|592014807|FG003|Open-label Treatment|Not dosed|0|||
163902985|NCT03160885|592014808|FG004|Open-label Treatment|Not dosed|0|||
163902986|NCT03160885|592014809|FG005|Open-label Treatment|Not dosed|0|||
163902987|NCT03160885|592014810|FG006|Open-label Treatment|Not dosed|2|||
163902988|NCT03160885|592014804|FG000|Open-label Treatment|Discontinued IMP|0|||
163902989|NCT03160885|592014805|FG001|Open-label Treatment|Discontinued IMP|0|||
163902990|NCT03160885|592014806|FG002|Open-label Treatment|Discontinued IMP|0|||
163902991|NCT03160885|592014807|FG003|Open-label Treatment|Discontinued IMP|0|||
163902992|NCT03160885|592014808|FG004|Open-label Treatment|Discontinued IMP|0|||
163902993|NCT03160885|592014809|FG005|Open-label Treatment|Discontinued IMP|0|||
163902994|NCT03160885|592014810|FG006|Open-label Treatment|Discontinued IMP|131|||
163902995|NCT03160885|592014804|FG000|Open-label Treatment|Completed Week 50|0|||
163902996|NCT03160885|592014805|FG001|Open-label Treatment|Completed Week 50|0|||
163902997|NCT03160885|592014806|FG002|Open-label Treatment|Completed Week 50|0|||
163902998|NCT03160885|592014807|FG003|Open-label Treatment|Completed Week 50|0|||
163902999|NCT03160885|592014808|FG004|Open-label Treatment|Completed Week 50|0|||
163903000|NCT03160885|592014809|FG005|Open-label Treatment|Completed Week 50|0|||
163903001|NCT03160885|592014810|FG006|Open-label Treatment|Completed Week 50|4|||
163903002|NCT03160885|592014804|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163903003|NCT03160885|592014805|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163903004|NCT03160885|592014806|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163903005|NCT03160885|592014807|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
163903006|NCT03160885|592014808|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163903007|NCT03160885|592014809|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163903008|NCT03160885|592014810|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
163903009|NCT03160885|592014804|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
163903010|NCT03160885|592014805|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
164380361|NCT00799617|593763528|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
164380362|NCT00799617|593763527|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
164380363|NCT00799617|593763528|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
164380364|NCT00799617|593763527|FG000|Bone Trial|Month 12 scan not available|6|||
164380365|NCT00799617|593763528|FG001|Bone Trial|Month 12 scan not available|16|||
164380366|NCT00799617|593763527|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
164380367|NCT00799617|593763528|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
164380368|NCT00799617|593763527|FG000|Anemia Trial|Withdrawal by Subject|3|||
164380369|NCT00799617|593763528|FG001|Anemia Trial|Withdrawal by Subject|3|||
164380370|NCT01712984|593763529|FG000|Overall Study|Adverse Event|0|||
164380371|NCT01712984|593763530|FG001|Overall Study|Adverse Event|0|||
164380372|NCT01712984|593763531|FG002|Overall Study|Adverse Event|1|||
163903011|NCT03160885|592014806|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
163903012|NCT03160885|592014807|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
163903013|NCT03160885|592014808|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
164380373|NCT01712984|593763529|FG000|Overall Study|Protocol Violation|2|||
164380374|NCT01712984|593763530|FG001|Overall Study|Protocol Violation|0|||
164380375|NCT01712984|593763531|FG002|Overall Study|Protocol Violation|1|||
164380376|NCT01712984|593763529|FG000|Overall Study|Lost to Follow-up|8|||
164380377|NCT01712984|593763530|FG001|Overall Study|Lost to Follow-up|10|||
164013632|NCT00960440|592414468|FG002|Overall Study|Protocol Violation|3|||
164013633|NCT00960440|592414469|FG003|Overall Study|Protocol Violation|4|||
164013634|NCT00960440|592414466|FG000|Overall Study|Withdrawal by Subject|9|||
164013635|NCT00960440|592414467|FG001|Overall Study|Withdrawal by Subject|5|||
164013636|NCT00960440|592414468|FG002|Overall Study|Withdrawal by Subject|2|||
164013637|NCT00960440|592414469|FG003|Overall Study|Withdrawal by Subject|1|||
164013638|NCT00960440|592414466|FG000|Overall Study|Other|1|||
164013639|NCT00960440|592414467|FG001|Overall Study|Other|1|||
164013640|NCT00960440|592414468|FG002|Overall Study|Other|1|||
164013641|NCT00960440|592414469|FG003|Overall Study|Other|0|||
164013642|NCT03332667|592414472|FG000|Overall Study|Adverse Event|0|||
164013643|NCT03332667|592414473|FG001|Overall Study|Adverse Event|0|||
164013644|NCT03332667|592414474|FG002|Overall Study|Adverse Event|2|||
164013645|NCT03332667|592414475|FG003|Overall Study|Adverse Event|1|||
164013646|NCT03332667|592414472|FG000|Overall Study|Withdrawal by Subject|2|||
164013647|NCT03332667|592414473|FG001|Overall Study|Withdrawal by Subject|1|||
164013648|NCT03332667|592414474|FG002|Overall Study|Withdrawal by Subject|5|||
164013649|NCT03332667|592414475|FG003|Overall Study|Withdrawal by Subject|1|||
164380378|NCT01712984|593763531|FG002|Overall Study|Lost to Follow-up|1|||
164380379|NCT01712984|593763529|FG000|Overall Study|Withdrawal by Subject|6|||
164380380|NCT01712984|593763530|FG001|Overall Study|Withdrawal by Subject|6|||
164380381|NCT01712984|593763531|FG002|Overall Study|Withdrawal by Subject|7|||
164380382|NCT00096044|593763534|FG000|Overall Study|Withdrawal by Subject|9|||
164380383|NCT00096044|593763534|FG000|Overall Study|Adverse Event|21|||
164380384|NCT00096044|593763534|FG000|Overall Study|Disease Progression|4|||
164380385|NCT03149237|593763535|FG000|Overall Study|Withdrawal by Subject|4|||
164380386|NCT03149237|593763536|FG001|Overall Study|Withdrawal by Subject|5|||
164380387|NCT02442830|593763537|FG000|Overall Study|Technical Failure|0|||
164380388|NCT02442830|593763538|FG001|Overall Study|Technical Failure|1|||
164380389|NCT00595582|593763540|FG000|Overall Study|Pilot study that PI terminated|2|||
164380390|NCT00595582|593763540|FG000|Overall Study|Lost to Follow-up|1|||
164380391|NCT00595582|593763540|FG000|Overall Study|Adverse Event|2|||
164380392|NCT00595582|593763540|FG000|Overall Study|Physician Decision|5|||
164380393|NCT03851016|593763541|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164380394|NCT03851016|593763542|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
164380395|NCT03878134|593763543|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
164380396|NCT00586469|593763544|FG000|Overall Study|Adverse Event|0|||
164380397|NCT00586469|593763545|FG001|Overall Study|Adverse Event|1|||
164380398|NCT04055116|593763548|FG000|First Intervention|Physician Decision|2|||
164380399|NCT04055116|593763549|FG001|First Intervention|Physician Decision|7|||
164380400|NCT01976845|593763555|FG000|Overall Study|Physician Decision|8|||
164380401|NCT01976845|593763556|FG001|Overall Study|Physician Decision|8|||
164380402|NCT01976845|593763557|FG002|Overall Study|Physician Decision|3|||
164380403|NCT01660412|593763558|FG000|Overall Study|Protocol Violation|0|||
164380404|NCT01660412|593763559|FG001|Overall Study|Protocol Violation|3|||
164380405|NCT01818336|593765059|FG000|Overall Study|Declined retest visit|0|||
164380406|NCT01818336|593765060|FG001|Overall Study|Declined retest visit|11|||
164380407|NCT01818336|593765059|FG000|Overall Study|Lost to Follow-up|0|||
164380408|NCT01818336|593765060|FG001|Overall Study|Lost to Follow-up|1|||
164380409|NCT03042312|593765063|FG000|Overall Study|Administrative Reason|1|||
164380410|NCT03042312|593765064|FG001|Overall Study|Administrative Reason|1|||
164380411|NCT03042312|593765063|FG000|Overall Study|Adverse Event|0|||
164380412|NCT03042312|593765064|FG001|Overall Study|Adverse Event|1|||
164380413|NCT03042312|593765063|FG000|Overall Study|Lost to Follow-up|1|||
164380414|NCT03042312|593765064|FG001|Overall Study|Lost to Follow-up|3|||
164380415|NCT03042312|593765063|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
164380416|NCT03042312|593765064|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
164380417|NCT03042312|593765063|FG000|Overall Study|Withdrawal by Subject|4|||
164380418|NCT03042312|593765064|FG001|Overall Study|Withdrawal by Subject|5|||
164013650|NCT03332667|592414472|FG000|Overall Study|Disease Progression or Relapse|2|||
164013651|NCT03332667|592414473|FG001|Overall Study|Disease Progression or Relapse|1|||
164092891|NCT00920140|592703405|FG002|Phase 2|Adverse Event|14|||
164380419|NCT04258839|593765065|FG000|Overall Study|Adverse Event|2|||
164380420|NCT04258839|593765066|FG001|Overall Study|Adverse Event|4|||
164380421|NCT04258839|593765065|FG000|Overall Study|Lack of Efficacy|0|||
164380422|NCT04258839|593765066|FG001|Overall Study|Lack of Efficacy|2|||
164380423|NCT04258839|593765065|FG000|Overall Study|Lost to Follow-up|2|||
164380424|NCT04258839|593765066|FG001|Overall Study|Lost to Follow-up|0|||
164380425|NCT04258839|593765065|FG000|Overall Study|Withdrawal by Subject|1|||
164380426|NCT04258839|593765066|FG001|Overall Study|Withdrawal by Subject|2|||
164380427|NCT04258839|593765065|FG000|Overall Study|Withdrawal by Caregiver|5|||
164380428|NCT04258839|593765066|FG001|Overall Study|Withdrawal by Caregiver|6|||
164380429|NCT04258839|593765065|FG000|Overall Study|Reason not Specified|0|||
164380430|NCT04258839|593765066|FG001|Overall Study|Reason not Specified|1|||
164380431|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Adverse Event|4|||
164380432|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Adverse Event|1|||
164380433|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Adverse Event|1|||
164380434|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
164380435|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
164380436|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
164380437|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Pregnancy|3|||
164380438|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Pregnancy|0|||
164380439|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Pregnancy|0|||
164380440|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
164380441|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
164380442|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
164380443|NCT03328897|593765067|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
164013652|NCT03332667|592414474|FG002|Overall Study|Disease Progression or Relapse|3|||
164013653|NCT03332667|592414475|FG003|Overall Study|Disease Progression or Relapse|0|||
164013654|NCT03332667|592414472|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
164013655|NCT03332667|592414473|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
164013656|NCT03332667|592414474|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
164013657|NCT03332667|592414475|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
164013658|NCT03332667|592414472|FG000|Overall Study|No Treatment Received|0|||
164013659|NCT03332667|592414473|FG001|Overall Study|No Treatment Received|0|||
164013660|NCT03332667|592414474|FG002|Overall Study|No Treatment Received|1|||
164013661|NCT03332667|592414475|FG003|Overall Study|No Treatment Received|0|||
164013662|NCT00546351|592414476|FG000|Overall Study|Adverse Event|76|||
164013663|NCT00546351|592414476|FG000|Overall Study|Lack of Efficacy|15|||
164013664|NCT00546351|592414476|FG000|Overall Study|Withdrawal by Subject|109|||
164013665|NCT00546351|592414476|FG000|Overall Study|Lost to Follow-up|9|||
164013666|NCT00546351|592414476|FG000|Overall Study|Protocol Deviation|1|||
164013667|NCT00546351|592414476|FG000|Overall Study|Unsatisfactory compliance|9|||
164013668|NCT00546351|592414476|FG000|Overall Study|Other reasons for premature termination|17|||
164013669|NCT04734873|592414477|FG000|Overall Study|Lost to Follow-up|1|||
164013670|NCT04734873|592414478|FG001|Overall Study|Lost to Follow-up|3|||
164013671|NCT04734873|592414479|FG002|Overall Study|Lost to Follow-up|2|||
164013672|NCT04734873|592414477|FG000|Overall Study|Randomized but not dosed|1|||
164013673|NCT04734873|592414478|FG001|Overall Study|Randomized but not dosed|0|||
164013674|NCT04734873|592414479|FG002|Overall Study|Randomized but not dosed|1|||
164013675|NCT00609609|592414480|FG000|Overall Study|Withdrawal by Subject|2|||
164013676|NCT00609609|592414481|FG001|Overall Study|Withdrawal by Subject|0|||
164013677|NCT00609609|592414480|FG000|Overall Study|Progression|4|||
164013678|NCT00609609|592414481|FG001|Overall Study|Progression|2|||
164013679|NCT03065530|592414482|FG000|Overall Study|Lack of Efficacy|1|||
164013680|NCT03065530|592414483|FG001|Overall Study|Lack of Efficacy|1|||
164013681|NCT03065530|592414484|FG002|Overall Study|Lack of Efficacy|0|||
164013682|NCT03065530|592414485|FG003|Overall Study|Lack of Efficacy|1|||
164013683|NCT03065530|592414482|FG000|Overall Study|Protocol Violation|1|||
164380444|NCT03328897|593765068|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
164380445|NCT03328897|593765069|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
164380446|NCT03328897|593765067|FG000|Follow-up Epoch|Adverse Event|4|||
164380447|NCT03328897|593765068|FG001|Follow-up Epoch|Adverse Event|0|||
164380448|NCT03328897|593765069|FG002|Follow-up Epoch|Adverse Event|1|||
164380449|NCT03328897|593765067|FG000|Follow-up Epoch|Lack of Efficacy|1|||
164380450|NCT03328897|593765068|FG001|Follow-up Epoch|Lack of Efficacy|1|||
164380451|NCT03328897|593765069|FG002|Follow-up Epoch|Lack of Efficacy|1|||
164380452|NCT03328897|593765067|FG000|Follow-up Epoch|Lost to Follow-up|0|||
164380453|NCT03328897|593765068|FG001|Follow-up Epoch|Lost to Follow-up|1|||
164380454|NCT03328897|593765069|FG002|Follow-up Epoch|Lost to Follow-up|0|||
164380455|NCT03328897|593765067|FG000|Follow-up Epoch|Pregnancy|1|||
164380456|NCT03328897|593765068|FG001|Follow-up Epoch|Pregnancy|0|||
164380457|NCT03328897|593765069|FG002|Follow-up Epoch|Pregnancy|0|||
164380458|NCT03328897|593765067|FG000|Follow-up Epoch|Patient/guardian decision|2|||
164380459|NCT03328897|593765068|FG001|Follow-up Epoch|Patient/guardian decision|1|||
164380460|NCT03328897|593765069|FG002|Follow-up Epoch|Patient/guardian decision|0|||
164380461|NCT00608829|593765070|FG000|Overall Study|Death|6|||
164380462|NCT00608829|593765070|FG000|Overall Study|Withdrawal by Subject|4|||
164380463|NCT00608829|593765070|FG000|Overall Study|Subject refuses to follow up or return.|5|||
164380464|NCT02080091|593765082|FG000|Overall Study|Study Terminated|22|||
164380465|NCT02080091|593765082|FG000|Overall Study|Death|1|||
164380466|NCT02080091|593765082|FG000|Overall Study|Withdrawal by Subject|1|||
164380467|NCT02080091|593765082|FG000|Overall Study|Other|1|||
164380468|NCT03019536|593765084|FG000|Overall Study|Withdrawal by Subject|1|||
164380469|NCT03019536|593765085|FG001|Overall Study|Withdrawal by Subject|1|||
164380470|NCT03019536|593765086|FG002|Overall Study|Withdrawal by Subject|0|||
164380471|NCT03019536|593765084|FG000|Overall Study|Adverse Event|0|||
164380472|NCT03019536|593765085|FG001|Overall Study|Adverse Event|0|||
164380473|NCT03019536|593765086|FG002|Overall Study|Adverse Event|2|||
164380474|NCT03422003|593765087|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
164380475|NCT03422003|593765088|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
164380476|NCT03422003|593765087|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
164380477|NCT03422003|593765088|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
164380478|NCT00317772|593765089|FG000|Overall Study|Adverse Event|0|||
164380479|NCT00317772|593765090|FG001|Overall Study|Adverse Event|0|||
164380480|NCT00317772|593765091|FG002|Overall Study|Adverse Event|0|||
164380481|NCT00317772|593765092|FG003|Overall Study|Adverse Event|2|||
164380482|NCT00317772|593765089|FG000|Overall Study|Disease Progression|2|||
164380483|NCT00317772|593765090|FG001|Overall Study|Disease Progression|2|||
164380484|NCT00317772|593765091|FG002|Overall Study|Disease Progression|1|||
164380485|NCT00317772|593765092|FG003|Overall Study|Disease Progression|7|||
164380486|NCT00966940|593765093|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
164380487|NCT00966940|593765094|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
164380488|NCT00966940|593765093|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
164380489|NCT00966940|593765094|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
164380490|NCT01040871|593765097|FG000|Overall Study|Adverse Event|6|||
164380491|NCT01040871|593765098|FG001|Overall Study|Adverse Event|2|||
164380492|NCT01040871|593765097|FG000|Overall Study|Withdrawal by Subject|2|||
164380493|NCT01040871|593765098|FG001|Overall Study|Withdrawal by Subject|0|||
164380494|NCT01040871|593765097|FG000|Overall Study|Death|1|||
164380495|NCT01040871|593765098|FG001|Overall Study|Death|3|||
164380496|NCT01040871|593765097|FG000|Overall Study|Lack of Efficacy|1|||
164380497|NCT01040871|593765098|FG001|Overall Study|Lack of Efficacy|1|||
164380498|NCT01040871|593765097|FG000|Overall Study|drug supply issue|1|||
164380499|NCT01040871|593765098|FG001|Overall Study|drug supply issue|0|||
164380500|NCT01040871|593765097|FG000|Overall Study|Randomized and Not Treated|2|||
164380501|NCT01040871|593765098|FG001|Overall Study|Randomized and Not Treated|1|||
164380502|NCT02886572|593765099|FG000|Overall Study|Death|8|||
164380503|NCT03087591|593765101|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
164380504|NCT03087591|593765101|FG000|Overall Study|Withdrawal by Subject|1|||
164380505|NCT02621606|593765102|FG000|Overall Study|Withdrawal by Subject|0|||
164380506|NCT02621606|593765103|FG001|Overall Study|Withdrawal by Subject|1|||
164380507|NCT02621606|593765104|FG002|Overall Study|Withdrawal by Subject|0|||
164380508|NCT01175824|593765105|FG000|Overall Study|Adverse Event|2|||
163903014|NCT03160885|592014809|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
163903015|NCT03160885|592014810|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
163903016|NCT03160885|592014804|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163903017|NCT03160885|592014805|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163903018|NCT03160885|592014806|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
163903019|NCT03160885|592014807|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
164013684|NCT03065530|592414483|FG001|Overall Study|Protocol Violation|0|||
164380509|NCT01175824|593765106|FG001|Overall Study|Adverse Event|1|||
164380510|NCT01175824|593765105|FG000|Overall Study|Lack of Efficacy|2|||
164380511|NCT01175824|593765106|FG001|Overall Study|Lack of Efficacy|0|||
164380512|NCT01175824|593765105|FG000|Overall Study|Lost to Follow-up|0|||
164380513|NCT01175824|593765106|FG001|Overall Study|Lost to Follow-up|1|||
164380514|NCT01175824|593765105|FG000|Overall Study|Physician Decision|0|||
164013685|NCT03065530|592414484|FG002|Overall Study|Protocol Violation|1|||
164013686|NCT03065530|592414485|FG003|Overall Study|Protocol Violation|1|||
164013687|NCT02385123|592414488|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
164013688|NCT04498910|592414489|FG000|Overall Study|Lost to Follow-up|0|||
164013689|NCT04498910|592414490|FG001|Overall Study|Lost to Follow-up|1|||
164013690|NCT04498910|592414489|FG000|Overall Study|Withdrawal by Subject|2|||
164013691|NCT04498910|592414490|FG001|Overall Study|Withdrawal by Subject|1|||
164013692|NCT04498910|592414489|FG000|Overall Study|Adverse Event|1|||
164013693|NCT04498910|592414490|FG001|Overall Study|Adverse Event|0|||
164013694|NCT01809262|592414491|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013695|NCT01809262|592414492|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013696|NCT01809262|592414493|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013697|NCT01809262|592414494|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013698|NCT01809262|592414495|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
164013699|NCT01809262|592414496|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013700|NCT01809262|592414497|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013701|NCT01809262|592414498|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013702|NCT01809262|592414499|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013703|NCT01809262|592414500|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
164013704|NCT01809262|592414491|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164013705|NCT01809262|592414492|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
164013706|NCT01809262|592414493|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164013707|NCT01809262|592414494|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164013708|NCT01809262|592414495|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164013709|NCT01809262|592414496|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164013710|NCT01809262|592414497|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164013711|NCT01809262|592414498|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164380515|NCT01175824|593765106|FG001|Overall Study|Physician Decision|4|||
164380516|NCT01175824|593765105|FG000|Overall Study|Protocol Violation|2|||
164380517|NCT01175824|593765106|FG001|Overall Study|Protocol Violation|5|||
164380518|NCT01175824|593765105|FG000|Overall Study|Withdrawal by Subject|3|||
164380519|NCT01175824|593765106|FG001|Overall Study|Withdrawal by Subject|7|||
164380520|NCT01175824|593765105|FG000|Overall Study|Sponsor Decision|1|||
164380521|NCT01175824|593765106|FG001|Overall Study|Sponsor Decision|0|||
164380522|NCT01175824|593765105|FG000|Overall Study|Entry Criteria Not Met|6|||
164380523|NCT01175824|593765106|FG001|Overall Study|Entry Criteria Not Met|4|||
164380524|NCT01774903|593765107|FG000|Overall Study|Adverse Event|7|||
164380525|NCT01774903|593765107|FG000|Overall Study|Withdrawal by Subject|2|||
164380526|NCT01774903|593765107|FG000|Overall Study|Lack of Efficacy|1|||
164380527|NCT01774903|593765107|FG000|Overall Study|Ineligible to continue the trial|1|||
164380528|NCT00982319|593765108|FG000|Overall Study|Surgery date change|1|||
164380529|NCT00982319|593765109|FG001|Overall Study|Surgery date change|0|||
164380530|NCT00982319|593765108|FG000|Overall Study|Preop values out of acceptable range|1|||
164380531|NCT00982319|593765109|FG001|Overall Study|Preop values out of acceptable range|1|||
164380532|NCT00982319|593765108|FG000|Overall Study|Pregnancy|0|||
164380533|NCT00982319|593765109|FG001|Overall Study|Pregnancy|1|||
164380534|NCT00767000|593765110|FG000|54-week Study|Adverse Event|4|||
164380535|NCT00767000|593765111|FG001|54-week Study|Adverse Event|6|||
164380536|NCT00767000|593765112|FG002|54-week Study|Adverse Event|6|||
164380537|NCT00767000|593765113|FG003|54-week Study|Adverse Event|8|||
164380538|NCT00767000|593765114|FG004|54-week Study|Adverse Event|4|||
164380539|NCT00767000|593765110|FG000|54-week Study|Creaninine/creatinine clearance|2|||
164380540|NCT00767000|593765111|FG001|54-week Study|Creaninine/creatinine clearance|1|||
164380541|NCT00767000|593765112|FG002|54-week Study|Creaninine/creatinine clearance|2|||
164380542|NCT00767000|593765113|FG003|54-week Study|Creaninine/creatinine clearance|2|||
164380543|NCT00767000|593765114|FG004|54-week Study|Creaninine/creatinine clearance|4|||
164380544|NCT00767000|593765110|FG000|54-week Study|Hyperglycemia|0|||
164380545|NCT00767000|593765111|FG001|54-week Study|Hyperglycemia|0|||
164380546|NCT00767000|593765112|FG002|54-week Study|Hyperglycemia|1|||
164380547|NCT00767000|593765113|FG003|54-week Study|Hyperglycemia|0|||
164380548|NCT00767000|593765114|FG004|54-week Study|Hyperglycemia|1|||
164380549|NCT00767000|593765110|FG000|54-week Study|Hypoglycemia|0|||
164380550|NCT00767000|593765111|FG001|54-week Study|Hypoglycemia|1|||
164380551|NCT00767000|593765112|FG002|54-week Study|Hypoglycemia|0|||
164380552|NCT00767000|593765113|FG003|54-week Study|Hypoglycemia|0|||
164380553|NCT00767000|593765114|FG004|54-week Study|Hypoglycemia|0|||
164013712|NCT01809262|592414499|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164380554|NCT00767000|593765110|FG000|54-week Study|Interruption of study medication|0|||
164380555|NCT00767000|593765111|FG001|54-week Study|Interruption of study medication|0|||
164380556|NCT00767000|593765112|FG002|54-week Study|Interruption of study medication|1|||
164013713|NCT01809262|592414500|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
164380557|NCT00767000|593765113|FG003|54-week Study|Interruption of study medication|0|||
164380558|NCT00767000|593765114|FG004|54-week Study|Interruption of study medication|0|||
164380559|NCT00767000|593765110|FG000|54-week Study|Lack of Efficacy|2|||
164380560|NCT00767000|593765111|FG001|54-week Study|Lack of Efficacy|0|||
164380561|NCT00767000|593765112|FG002|54-week Study|Lack of Efficacy|1|||
164380562|NCT00767000|593765113|FG003|54-week Study|Lack of Efficacy|0|||
164380563|NCT00767000|593765114|FG004|54-week Study|Lack of Efficacy|5|||
164380564|NCT00767000|593765110|FG000|54-week Study|Lost to Follow-up|4|||
164380565|NCT00767000|593765111|FG001|54-week Study|Lost to Follow-up|0|||
164380566|NCT00767000|593765112|FG002|54-week Study|Lost to Follow-up|1|||
164380567|NCT00767000|593765113|FG003|54-week Study|Lost to Follow-up|4|||
164380568|NCT00767000|593765114|FG004|54-week Study|Lost to Follow-up|2|||
164380569|NCT00767000|593765110|FG000|54-week Study|Physician Decision|4|||
164380570|NCT00767000|593765111|FG001|54-week Study|Physician Decision|0|||
164380571|NCT00767000|593765112|FG002|54-week Study|Physician Decision|1|||
164380572|NCT00767000|593765113|FG003|54-week Study|Physician Decision|1|||
164380573|NCT00767000|593765114|FG004|54-week Study|Physician Decision|1|||
164380574|NCT00767000|593765110|FG000|54-week Study|Progressive disease|0|||
164380575|NCT00767000|593765111|FG001|54-week Study|Progressive disease|0|||
164380576|NCT00767000|593765112|FG002|54-week Study|Progressive disease|1|||
164380577|NCT00767000|593765113|FG003|54-week Study|Progressive disease|0|||
164380578|NCT00767000|593765114|FG004|54-week Study|Progressive disease|0|||
164380579|NCT00767000|593765110|FG000|54-week Study|Protocol Violation|0|||
164380580|NCT00767000|593765111|FG001|54-week Study|Protocol Violation|0|||
164380581|NCT00767000|593765112|FG002|54-week Study|Protocol Violation|1|||
164380582|NCT00767000|593765113|FG003|54-week Study|Protocol Violation|2|||
164380583|NCT00767000|593765114|FG004|54-week Study|Protocol Violation|0|||
164380584|NCT00767000|593765110|FG000|54-week Study|Withdrawal by Subject|2|||
164380585|NCT00767000|593765111|FG001|54-week Study|Withdrawal by Subject|3|||
164380586|NCT00767000|593765112|FG002|54-week Study|Withdrawal by Subject|5|||
164380587|NCT00767000|593765113|FG003|54-week Study|Withdrawal by Subject|11|||
164380588|NCT00767000|593765114|FG004|54-week Study|Withdrawal by Subject|13|||
164380589|NCT00767000|593765110|FG000|54-week Study|Study terminated by sponsor|90|||
164380590|NCT00767000|593765111|FG001|54-week Study|Study terminated by sponsor|102|||
164380591|NCT00767000|593765112|FG002|54-week Study|Study terminated by sponsor|89|||
164380592|NCT00767000|593765113|FG003|54-week Study|Study terminated by sponsor|196|||
164380593|NCT00767000|593765114|FG004|54-week Study|Study terminated by sponsor|194|||
164380594|NCT00767000|593765110|FG000|54-week Study|Reason not reported|0|||
164380595|NCT00767000|593765111|FG001|54-week Study|Reason not reported|0|||
164380596|NCT00767000|593765112|FG002|54-week Study|Reason not reported|0|||
164380597|NCT00767000|593765113|FG003|54-week Study|Reason not reported|1|||
164380598|NCT00767000|593765114|FG004|54-week Study|Reason not reported|0|||
164380599|NCT00767000|593765110|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
164380600|NCT00767000|593765111|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
164380601|NCT00767000|593765112|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
164380602|NCT00767000|593765113|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
164380603|NCT00767000|593765114|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
164380604|NCT01252251|593765121|FG000|Overall Study|Withdrawal by Subject|1|||
164380605|NCT01324024|593765122|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
164380606|NCT01324024|593765123|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164380607|NCT00097591|593765125|FG000|Overall Study|Withdrawal of consent|342|||
164380608|NCT00097591|593765126|FG001|Overall Study|Withdrawal of consent|323|||
164380609|NCT00097591|593765125|FG000|Overall Study|Less than 6 months on study drug|9|||
164380610|NCT00097591|593765126|FG001|Overall Study|Less than 6 months on study drug|7|||
164380611|NCT00097591|593765125|FG000|Overall Study|Unable to attend termination visit|53|||
164380612|NCT00097591|593765126|FG001|Overall Study|Unable to attend termination visit|51|||
164380613|NCT00097591|593765125|FG000|Overall Study|Lost to follow up|6|||
164380614|NCT00097591|593765126|FG001|Overall Study|Lost to follow up|10|||
164380615|NCT00097591|593765125|FG000|Overall Study|Other|0|||
164380616|NCT00097591|593765126|FG001|Overall Study|Other|3|||
164380617|NCT01743092|593765131|FG000|Overall Study|Lost to Follow-up|14|||
164380618|NCT01743092|593765132|FG001|Overall Study|Lost to Follow-up|15|||
164380619|NCT03603964|593765133|FG000|Overall Study|Death|9|||
164380620|NCT03603964|593765133|FG000|Overall Study|Withdrawal by participant|7|||
164380621|NCT03603964|593765133|FG000|Overall Study|Study terminated by Sponsor|19|||
164380622|NCT00563797|593765134|FG000|Overall Study|Lost to Follow-up|7|||
164380623|NCT00563797|593765135|FG001|Overall Study|Lost to Follow-up|2|||
164380624|NCT00530023|593765138|FG000|Overall Study|Withdrawal by Subject|0|||
164380625|NCT00530023|593765139|FG001|Overall Study|Withdrawal by Subject|1|||
164380626|NCT01877421|593765147|FG000|Phase 2|Lost to Follow-up|0|||
164380627|NCT01877421|593765148|FG001|Phase 2|Lost to Follow-up|0|||
164380628|NCT01877421|593765149|FG002|Phase 2|Lost to Follow-up|0|||
164380629|NCT01877421|593765150|FG003|Phase 2|Lost to Follow-up|0|||
164380630|NCT01877421|593765151|FG004|Phase 2|Lost to Follow-up|0|||
164380631|NCT01877421|593765152|FG005|Phase 2|Lost to Follow-up|0|||
164380632|NCT01877421|593765153|FG006|Phase 2|Lost to Follow-up|1|||
164380633|NCT01877421|593765154|FG007|Phase 2|Lost to Follow-up|0|||
164380634|NCT01877421|593765155|FG008|Phase 2|Lost to Follow-up|0|||
164380635|NCT01877421|593765156|FG009|Phase 2|Lost to Follow-up|0|||
164380636|NCT01877421|593765157|FG010|Phase 2|Lost to Follow-up|0|||
164380637|NCT01877421|593765158|FG011|Phase 2|Lost to Follow-up|0|||
164380638|NCT01877421|593765159|FG012|Phase 2|Lost to Follow-up|0|||
164380639|NCT01877421|593765160|FG013|Phase 2|Lost to Follow-up|0|||
164380640|NCT01877421|593765161|FG014|Phase 2|Lost to Follow-up|0|||
164380641|NCT01877421|593765162|FG015|Phase 2|Lost to Follow-up|0|||
164380642|NCT01877421|593765163|FG016|Phase 2|Lost to Follow-up|0|||
164380643|NCT01877421|593765164|FG017|Phase 2|Lost to Follow-up|0|||
164380644|NCT01877421|593765147|FG000|Phase 2|Withdrawal by Subject|0|||
164380645|NCT01877421|593765148|FG001|Phase 2|Withdrawal by Subject|0|||
164380646|NCT01877421|593765149|FG002|Phase 2|Withdrawal by Subject|0|||
164380647|NCT01877421|593765150|FG003|Phase 2|Withdrawal by Subject|0|||
164380648|NCT01877421|593765151|FG004|Phase 2|Withdrawal by Subject|0|||
164380649|NCT01877421|593765152|FG005|Phase 2|Withdrawal by Subject|0|||
164380650|NCT01877421|593765153|FG006|Phase 2|Withdrawal by Subject|0|||
164380651|NCT01877421|593765154|FG007|Phase 2|Withdrawal by Subject|0|||
164380652|NCT01877421|593765155|FG008|Phase 2|Withdrawal by Subject|1|||
164380653|NCT01877421|593765156|FG009|Phase 2|Withdrawal by Subject|0|||
164380654|NCT01877421|593765157|FG010|Phase 2|Withdrawal by Subject|1|||
164380655|NCT01877421|593765158|FG011|Phase 2|Withdrawal by Subject|0|||
164380656|NCT01877421|593765159|FG012|Phase 2|Withdrawal by Subject|1|||
164380657|NCT01877421|593765160|FG013|Phase 2|Withdrawal by Subject|0|||
164380658|NCT01877421|593765161|FG014|Phase 2|Withdrawal by Subject|0|||
164380659|NCT01877421|593765162|FG015|Phase 2|Withdrawal by Subject|1|||
164380660|NCT01877421|593765163|FG016|Phase 2|Withdrawal by Subject|0|||
164380661|NCT01877421|593765164|FG017|Phase 2|Withdrawal by Subject|0|||
164380662|NCT01877421|593765147|FG000|Phase 2|Protocol Violation|0|||
164380663|NCT01877421|593765148|FG001|Phase 2|Protocol Violation|0|||
164380664|NCT01877421|593765149|FG002|Phase 2|Protocol Violation|0|||
164380665|NCT01877421|593765150|FG003|Phase 2|Protocol Violation|0|||
164380666|NCT01877421|593765151|FG004|Phase 2|Protocol Violation|0|||
164380667|NCT01877421|593765152|FG005|Phase 2|Protocol Violation|0|||
164380668|NCT01877421|593765153|FG006|Phase 2|Protocol Violation|0|||
164380669|NCT01877421|593765154|FG007|Phase 2|Protocol Violation|0|||
164380670|NCT01877421|593765155|FG008|Phase 2|Protocol Violation|0|||
164380671|NCT01877421|593765156|FG009|Phase 2|Protocol Violation|0|||
164380672|NCT01877421|593765157|FG010|Phase 2|Protocol Violation|1|||
164380673|NCT01877421|593765158|FG011|Phase 2|Protocol Violation|0|||
164380674|NCT01877421|593765159|FG012|Phase 2|Protocol Violation|0|||
164380675|NCT01877421|593765160|FG013|Phase 2|Protocol Violation|0|||
164380676|NCT01877421|593765161|FG014|Phase 2|Protocol Violation|0|||
164380677|NCT01877421|593765162|FG015|Phase 2|Protocol Violation|0|||
164380678|NCT01877421|593765163|FG016|Phase 2|Protocol Violation|0|||
164380679|NCT01877421|593765164|FG017|Phase 2|Protocol Violation|0|||
164380680|NCT01416805|593765170|FG000|Overall Study|Lost to Follow-up|4|||
163903020|NCT03160885|592014808|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
163903021|NCT03160885|592014809|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
163903022|NCT03160885|592014810|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
163903023|NCT03160885|592014804|FG000|Maintenance Treatment Period|Completed Week 50|0|||
163903024|NCT03160885|592014805|FG001|Maintenance Treatment Period|Completed Week 50|0|||
163903025|NCT03160885|592014806|FG002|Maintenance Treatment Period|Completed Week 50|1|||
163903026|NCT03160885|592014807|FG003|Maintenance Treatment Period|Completed Week 50|0|||
163903027|NCT03160885|592014808|FG004|Maintenance Treatment Period|Completed Week 50|0|||
163903028|NCT03160885|592014809|FG005|Maintenance Treatment Period|Completed Week 50|0|||
164380681|NCT01416805|593765171|FG001|Overall Study|Lost to Follow-up|4|||
164380682|NCT04632940|593765175|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
164380683|NCT04632940|593765176|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
164380684|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
164380685|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
164380686|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
164380687|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
164380688|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
164380689|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
164380690|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
164380691|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
164380692|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
164380693|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
164380694|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Other than specified|0|||
164380695|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Other than specified|1|||
164380696|NCT04632940|593765175|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
164380697|NCT04632940|593765176|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
164380698|NCT01649856|593765180|FG000|Overall Study|Withdrawal by Subject|14|||
164380699|NCT01649856|593765181|FG001|Overall Study|Withdrawal by Subject|14|||
163903029|NCT03160885|592014810|FG006|Maintenance Treatment Period|Completed Week 50|0|||
164380700|NCT01649856|593765180|FG000|Overall Study|Protocol Violation|4|||
163903030|NCT03425682|592014811|FG000|Overall Study|Lost to Follow-up|2|||
164380701|NCT01649856|593765181|FG001|Overall Study|Protocol Violation|4|||
164380702|NCT01649856|593765180|FG000|Overall Study|Treatment Failure|1|||
164380703|NCT01649856|593765181|FG001|Overall Study|Treatment Failure|1|||
164380704|NCT01649856|593765180|FG000|Overall Study|Death|69|||
164380705|NCT01649856|593765181|FG001|Overall Study|Death|34|||
164380706|NCT01649856|593765180|FG000|Overall Study|Stable or Progressed Disease|5|||
164380707|NCT01649856|593765181|FG001|Overall Study|Stable or Progressed Disease|3|||
164380708|NCT01649856|593765180|FG000|Overall Study|Lost to Follow-up|20|||
164380709|NCT01649856|593765181|FG001|Overall Study|Lost to Follow-up|16|||
164380710|NCT01649856|593765180|FG000|Overall Study|Lack of Compliance|6|||
164380711|NCT01649856|593765181|FG001|Overall Study|Lack of Compliance|1|||
164380712|NCT01649856|593765180|FG000|Overall Study|Other|20|||
164380713|NCT01649856|593765181|FG001|Overall Study|Other|5|||
164380714|NCT00179647|593765182|FG000|Overall Study|Adverse Event|294|||
164380715|NCT00179647|593765182|FG000|Overall Study|Lack of Efficacy|478|||
164380716|NCT00179647|593765182|FG000|Overall Study|Withdrawal by Subject|83|||
164380717|NCT00179647|593765182|FG000|Overall Study|Lost to Follow-up|4|||
164380718|NCT00179647|593765182|FG000|Overall Study|Death|94|||
164380719|NCT00179647|593765182|FG000|Overall Study|Other|960|||
164380720|NCT00622635|593765183|FG000|Treatment Period 1|Adverse Event|0|||
164380721|NCT00622635|593765184|FG001|Treatment Period 1|Adverse Event|0|||
164380722|NCT00622635|593765185|FG002|Treatment Period 1|Adverse Event|1|||
164380723|NCT00622635|593765186|FG003|Treatment Period 1|Adverse Event|0|||
164380724|NCT00622635|593765187|FG004|Treatment Period 1|Adverse Event|0|||
164380725|NCT00622635|593765188|FG005|Treatment Period 1|Adverse Event|0|||
164380726|NCT00622635|593765183|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164380727|NCT00622635|593765184|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164380728|NCT00622635|593765185|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164380729|NCT00622635|593765186|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164380730|NCT00622635|593765187|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164380731|NCT00622635|593765188|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164380732|NCT00622635|593765183|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380733|NCT00622635|593765184|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380734|NCT00622635|593765185|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380735|NCT00622635|593765186|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380736|NCT00622635|593765187|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
164380737|NCT00622635|593765188|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
164380738|NCT00622635|593765183|FG000|Treatment Period 2|Adverse Event|1|||
164380739|NCT00622635|593765184|FG001|Treatment Period 2|Adverse Event|0|||
164380740|NCT00622635|593765185|FG002|Treatment Period 2|Adverse Event|0|||
164380741|NCT00622635|593765186|FG003|Treatment Period 2|Adverse Event|0|||
164380742|NCT00622635|593765187|FG004|Treatment Period 2|Adverse Event|0|||
164380743|NCT00622635|593765188|FG005|Treatment Period 2|Adverse Event|0|||
164380744|NCT00622635|593765183|FG000|Treatment Period 3|Adverse Event|0|||
164380745|NCT00622635|593765184|FG001|Treatment Period 3|Adverse Event|0|||
164380746|NCT00622635|593765185|FG002|Treatment Period 3|Adverse Event|0|||
164380747|NCT00622635|593765186|FG003|Treatment Period 3|Adverse Event|2|||
164380748|NCT00622635|593765187|FG004|Treatment Period 3|Adverse Event|0|||
164380749|NCT00622635|593765188|FG005|Treatment Period 3|Adverse Event|0|||
164380750|NCT00622635|593765183|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164380751|NCT00622635|593765184|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164380752|NCT00622635|593765185|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164380753|NCT00622635|593765186|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164380754|NCT00622635|593765187|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163903031|NCT03425682|592014812|FG001|Overall Study|Lost to Follow-up|4|||
164380755|NCT00622635|593765188|FG005|Treatment Period 3|Withdrawal by Subject|0|||
164380756|NCT00281840|593765189|FG000|Overall Study|Adverse Event|12|||
163903032|NCT03425682|592014811|FG000|Overall Study|Withdrawal by Subject|0|||
164380757|NCT00281840|593765189|FG000|Overall Study|Physician Decision|6|||
164380758|NCT00281840|593765189|FG000|Overall Study|Withdrawal by Subject|3|||
164380759|NCT00281840|593765189|FG000|Overall Study|Disease Progression|2|||
164380760|NCT00281840|593765189|FG000|Overall Study|exceed maximum delay in treatment|1|||
164380761|NCT00281840|593765189|FG000|Overall Study|Complicating Disease|1|||
164380762|NCT00835406|593765190|FG000|Period: First Intervention|Adverse Event|0|||
164380763|NCT00835406|593765191|FG001|Period: First Intervention|Adverse Event|1|||
164380764|NCT00835406|593765190|FG000|Period: First Intervention|Withdrawal by Subject|2|||
164380765|NCT00835406|593765191|FG001|Period: First Intervention|Withdrawal by Subject|0|||
164380766|NCT00835406|593765190|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
164380767|NCT00835406|593765191|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
164380768|NCT01849588|593765195|FG000|Overall Study|Lack of Efficacy|3|||
164380769|NCT01706250|593765196|FG000|Overall Study|Lost to Follow-up|2|||
164380770|NCT01079234|593765202|FG000|Main: Week 0 to 26|Adverse Event|5|||
164380771|NCT01079234|593765203|FG001|Main: Week 0 to 26|Adverse Event|4|||
164380772|NCT01079234|593765204|FG002|Main: Week 0 to 26|Adverse Event|1|||
164380773|NCT01079234|593765205|FG003|Main: Week 0 to 26|Adverse Event|0|||
164380774|NCT01079234|593765202|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
164380775|NCT01079234|593765203|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
164380776|NCT01079234|593765204|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
164380777|NCT01079234|593765205|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
164380778|NCT01079234|593765202|FG000|Main: Week 0 to 26|Protocol Violation|6|||
164380779|NCT01079234|593765203|FG001|Main: Week 0 to 26|Protocol Violation|2|||
164380780|NCT01079234|593765204|FG002|Main: Week 0 to 26|Protocol Violation|4|||
164380781|NCT01079234|593765205|FG003|Main: Week 0 to 26|Protocol Violation|0|||
164380782|NCT01079234|593765202|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
164380783|NCT01079234|593765203|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
164380784|NCT01079234|593765204|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
164380785|NCT01079234|593765205|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
164380786|NCT01079234|593765202|FG000|Main: Week 0 to 26|Unclassified|7|||
164380787|NCT01079234|593765203|FG001|Main: Week 0 to 26|Unclassified|13|||
164380788|NCT01079234|593765204|FG002|Main: Week 0 to 26|Unclassified|4|||
164380789|NCT01079234|593765205|FG003|Main: Week 0 to 26|Unclassified|0|||
164380790|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Adverse Event|0|||
164380791|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Adverse Event|0|||
164380792|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Adverse Event|1|||
164380793|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Adverse Event|0|||
164380794|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
164380795|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
164380796|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
164380797|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
164380798|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
164380799|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
164380800|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
164380801|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
164380802|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
164380803|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
164380804|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
164380805|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
164380806|NCT01079234|593765202|FG000|Extension: Week 27 to 52|Unclassified|0|||
164380807|NCT01079234|593765203|FG001|Extension: Week 27 to 52|Unclassified|0|||
164380808|NCT01079234|593765204|FG002|Extension: Week 27 to 52|Unclassified|4|||
164380809|NCT01079234|593765205|FG003|Extension: Week 27 to 52|Unclassified|7|||
164380810|NCT01071512|593765214|FG000|Overall Study|Adverse Event|1|||
164380811|NCT01071512|593765214|FG000|Overall Study|Development of antibodies to drug|2|||
164380812|NCT01071512|593765214|FG000|Overall Study|positive anti-JC virus antibody test|2|||
164380813|NCT00183872|593765215|FG000|Overall Study|Death|3|||
164380814|NCT00183872|593765215|FG000|Overall Study|Adverse Event|9|||
164380815|NCT00183872|593765215|FG000|Overall Study|Withdrawal by Subject|2|||
164380816|NCT00183872|593765215|FG000|Overall Study|Drug delayed more than 28 days|2|||
164380817|NCT04587193|593765216|FG000|Overall Study|Screen failure after consent|3|||
164380818|NCT04587193|593765217|FG001|Overall Study|Screen failure after consent|0|||
164380819|NCT04587193|593765216|FG000|Overall Study|Device broke during study|3|||
164380820|NCT04587193|593765217|FG001|Overall Study|Device broke during study|2|||
164380821|NCT00508742|593765218|FG000|Period 1: Infant Series|Adverse Event|5|||
164380822|NCT00508742|593765219|FG001|Period 1: Infant Series|Adverse Event|4|||
164380823|NCT00508742|593765218|FG000|Period 1: Infant Series|Protocol Violation|1|||
164380824|NCT00508742|593765219|FG001|Period 1: Infant Series|Protocol Violation|0|||
164380825|NCT00508742|593765218|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
164380826|NCT00508742|593765219|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
164380827|NCT00508742|593765218|FG000|Period 1: Infant Series|Physician Decision|1|||
164380828|NCT00508742|593765219|FG001|Period 1: Infant Series|Physician Decision|0|||
164380829|NCT00508742|593765218|FG000|Period 1: Infant Series|Other|4|||
164380830|NCT00508742|593765219|FG001|Period 1: Infant Series|Other|1|||
163903033|NCT03425682|592014812|FG001|Overall Study|Withdrawal by Subject|3|||
164380831|NCT00508742|593765218|FG000|Period 2: After Infant Series|Adverse Event|2|||
164380832|NCT00508742|593765219|FG001|Period 2: After Infant Series|Adverse Event|6|||
164380833|NCT00508742|593765218|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
164380834|NCT00508742|593765219|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
164380835|NCT00508742|593765218|FG000|Period 2: After Infant Series|Protocol Violation|1|||
164380836|NCT00508742|593765219|FG001|Period 2: After Infant Series|Protocol Violation|0|||
164380837|NCT00508742|593765218|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
164380838|NCT00508742|593765219|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
164380839|NCT00508742|593765218|FG000|Period 2: After Infant Series|Failed to Return|1|||
164380840|NCT00508742|593765219|FG001|Period 2: After Infant Series|Failed to Return|0|||
164380841|NCT00508742|593765218|FG000|Period 2: After Infant Series|Other|2|||
164380842|NCT00508742|593765219|FG001|Period 2: After Infant Series|Other|1|||
164380843|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Adverse Event|1|||
164380844|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Adverse Event|0|||
164380845|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
164380846|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
164380847|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
164380848|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
164380849|NCT00508742|593765218|FG000|Period 3: Toddler Dose|Other|5|||
164380850|NCT00508742|593765219|FG001|Period 3: Toddler Dose|Other|4|||
164380851|NCT02501096|593765220|FG000|Overall Study|Lost to Follow-up|0|||
164380852|NCT02501096|593765221|FG001|Overall Study|Lost to Follow-up|0|||
164380853|NCT02501096|593765222|FG002|Overall Study|Lost to Follow-up|0|||
164380854|NCT02501096|593765223|FG003|Overall Study|Lost to Follow-up|0|||
164380855|NCT02501096|593765224|FG004|Overall Study|Lost to Follow-up|1|||
164380856|NCT02501096|593765225|FG005|Overall Study|Lost to Follow-up|1|||
164380857|NCT02501096|593765226|FG006|Overall Study|Lost to Follow-up|3|||
164380858|NCT02501096|593765227|FG007|Overall Study|Lost to Follow-up|0|||
164380859|NCT02501096|593765228|FG008|Overall Study|Lost to Follow-up|0|||
164380860|NCT02501096|593765220|FG000|Overall Study|Withdrawal by Subject|1|||
164380861|NCT02501096|593765221|FG001|Overall Study|Withdrawal by Subject|0|||
164380862|NCT02501096|593765222|FG002|Overall Study|Withdrawal by Subject|7|||
164380863|NCT02501096|593765223|FG003|Overall Study|Withdrawal by Subject|13|||
164380864|NCT02501096|593765224|FG004|Overall Study|Withdrawal by Subject|2|||
164380865|NCT02501096|593765225|FG005|Overall Study|Withdrawal by Subject|2|||
164380866|NCT02501096|593765226|FG006|Overall Study|Withdrawal by Subject|2|||
164380867|NCT02501096|593765227|FG007|Overall Study|Withdrawal by Subject|3|||
164380868|NCT02501096|593765228|FG008|Overall Study|Withdrawal by Subject|0|||
164380869|NCT02501096|593765220|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
164380870|NCT02501096|593765221|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
164380871|NCT02501096|593765222|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
164380872|NCT02501096|593765223|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
164380873|NCT02501096|593765224|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
164380874|NCT02501096|593765225|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
164380875|NCT02501096|593765226|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
164380876|NCT02501096|593765227|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
164380877|NCT02501096|593765228|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
164380878|NCT02501096|593765220|FG000|Overall Study|Death|1|||
164380879|NCT02501096|593765221|FG001|Overall Study|Death|1|||
164380880|NCT02501096|593765222|FG002|Overall Study|Death|88|||
164380881|NCT02501096|593765223|FG003|Overall Study|Death|74|||
164380882|NCT02501096|593765224|FG004|Overall Study|Death|15|||
164380883|NCT02501096|593765225|FG005|Overall Study|Death|16|||
164380884|NCT02501096|593765226|FG006|Overall Study|Death|15|||
164380885|NCT02501096|593765227|FG007|Overall Study|Death|16|||
164380886|NCT02501096|593765228|FG008|Overall Study|Death|1|||
164380887|NCT00437034|593765229|FG000|Overall Study|Adverse Event|1|||
164380888|NCT00437034|593765229|FG000|Overall Study|Disease progression during treatment|5|||
164380889|NCT00853658|593765231|FG000|Overall Study|Death|713|||
164380890|NCT00853658|593765232|FG001|Overall Study|Death|768|||
164380891|NCT00853658|593765233|FG002|Overall Study|Death|753|||
164380892|NCT00853658|593765231|FG000|Overall Study|Lost to Follow-up|11|||
164380893|NCT00853658|593765232|FG001|Overall Study|Lost to Follow-up|6|||
164380894|NCT00853658|593765233|FG002|Overall Study|Lost to Follow-up|11|||
164380895|NCT00853658|593765231|FG000|Overall Study|H.A. Request|26|||
164380896|NCT00853658|593765232|FG001|Overall Study|H.A. Request|23|||
164380897|NCT00853658|593765233|FG002|Overall Study|H.A. Request|19|||
164380898|NCT00853658|593765231|FG000|Overall Study|IRB request|0|||
164380899|NCT00853658|593765232|FG001|Overall Study|IRB request|0|||
164380900|NCT00853658|593765233|FG002|Overall Study|IRB request|2|||
164380901|NCT00853658|593765231|FG000|Overall Study|Vital Status known (alive) at study end|2|||
164380902|NCT00853658|593765232|FG001|Overall Study|Vital Status known (alive) at study end|3|||
164380903|NCT00853658|593765233|FG002|Overall Study|Vital Status known (alive) at study end|3|||
164380904|NCT00853658|593765231|FG000|Overall Study|Vital Status unknown at study end|1|||
164380905|NCT00853658|593765232|FG001|Overall Study|Vital Status unknown at study end|1|||
164380906|NCT00853658|593765233|FG002|Overall Study|Vital Status unknown at study end|0|||
164380907|NCT00853658|593765231|FG000|Overall Study|Vital Status at study end N/A|8|||
164380908|NCT00853658|593765232|FG001|Overall Study|Vital Status at study end N/A|10|||
164380909|NCT00853658|593765233|FG002|Overall Study|Vital Status at study end N/A|10|||
164380910|NCT00853658|593765231|FG000|Overall Study|Patient's request|21|||
164380911|NCT00853658|593765232|FG001|Overall Study|Patient's request|17|||
164380912|NCT00853658|593765233|FG002|Overall Study|Patient's request|11|||
164380913|NCT00853658|593765231|FG000|Overall Study|Missing study completion information|5|||
164013714|NCT02345434|592414503|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
164380914|NCT00853658|593765232|FG001|Overall Study|Missing study completion information|4|||
164380915|NCT00853658|593765233|FG002|Overall Study|Missing study completion information|6|||
164092892|NCT00920140|592703406|FG003|Phase 2|Adverse Event|2|||
164380916|NCT02797262|593765234|FG000|Overall Study|Withdrawal by Subject|5|||
164380917|NCT02797262|593765235|FG001|Overall Study|Withdrawal by Subject|1|||
164380918|NCT02797262|593765234|FG000|Overall Study|Lost to Follow-up|10|||
164380919|NCT02797262|593765235|FG001|Overall Study|Lost to Follow-up|7|||
164380920|NCT02797262|593765234|FG000|Overall Study|Death|1|||
164380921|NCT02797262|593765235|FG001|Overall Study|Death|2|||
164380922|NCT02797262|593765234|FG000|Overall Study|Adverse Event|1|||
164380923|NCT02797262|593765235|FG001|Overall Study|Adverse Event|0|||
164380924|NCT02797262|593765234|FG000|Overall Study|COVID-19|2|||
164380925|NCT02797262|593765235|FG001|Overall Study|COVID-19|1|||
164380926|NCT02797262|593765234|FG000|Overall Study|Out-of-country|1|||
164380927|NCT02797262|593765235|FG001|Overall Study|Out-of-country|0|||
164380928|NCT01337089|593766922|FG000|Overall Study|Adverse Event|237|||
164380929|NCT01337089|593766922|FG000|Overall Study|Withdrawal by Subject|129|||
164380930|NCT01337089|593766922|FG000|Overall Study|Withdrawal by Investigator|33|||
164380931|NCT01337089|593766922|FG000|Overall Study|Met Withdrawal Criteria|3|||
164380932|NCT01337089|593766922|FG000|Overall Study|Lost to Follow-up|2|||
164380933|NCT01404312|593766923|FG000|Overall Study|Death|21|||
164380934|NCT01404312|593766924|FG001|Overall Study|Death|27|||
164380935|NCT01404312|593766923|FG000|Overall Study|Withdrawal by Subject|15|||
164380936|NCT01404312|593766924|FG001|Overall Study|Withdrawal by Subject|18|||
164380937|NCT01404312|593766923|FG000|Overall Study|Participant Unable to get to clinic|93|||
164380938|NCT01404312|593766924|FG001|Overall Study|Participant Unable to get to clinic|103|||
164380939|NCT01404312|593766923|FG000|Overall Study|Lost to Follow-up|115|||
164380940|NCT01404312|593766924|FG001|Overall Study|Lost to Follow-up|111|||
164380941|NCT01404312|593766923|FG000|Overall Study|Site closed|22|||
164380942|NCT01404312|593766924|FG001|Overall Study|Site closed|21|||
164380943|NCT01404312|593766923|FG000|Overall Study|Participant not willing to adhere to req|31|||
164380944|NCT01404312|593766924|FG001|Overall Study|Participant not willing to adhere to req|29|||
164380945|NCT01404312|593766923|FG000|Overall Study|Severe debilitation, unable to continue|1|||
164380946|NCT01404312|593766924|FG001|Overall Study|Severe debilitation, unable to continue|2|||
164380947|NCT02627677|593766925|FG000|Overall Study|Adverse event (not progressive disease)|1|||
164380948|NCT02627677|593766926|FG001|Overall Study|Adverse event (not progressive disease)|4|||
164380949|NCT02627677|593766927|FG002|Overall Study|Adverse event (not progressive disease)|1|||
164380950|NCT02627677|593766925|FG000|Overall Study|Progressive disease|1|||
164380951|NCT02627677|593766926|FG001|Overall Study|Progressive disease|3|||
164380952|NCT02627677|593766927|FG002|Overall Study|Progressive disease|0|||
164380953|NCT02627677|593766925|FG000|Overall Study|Lack of Efficacy|1|||
164380954|NCT02627677|593766926|FG001|Overall Study|Lack of Efficacy|2|||
164380955|NCT02627677|593766927|FG002|Overall Study|Lack of Efficacy|0|||
164380956|NCT02627677|593766925|FG000|Overall Study|Lost to Follow-up|0|||
164380957|NCT02627677|593766926|FG001|Overall Study|Lost to Follow-up|0|||
164380958|NCT02627677|593766927|FG002|Overall Study|Lost to Follow-up|1|||
164380959|NCT02627677|593766925|FG000|Overall Study|Pregnancy|0|||
164380960|NCT02627677|593766926|FG001|Overall Study|Pregnancy|1|||
164380961|NCT02627677|593766927|FG002|Overall Study|Pregnancy|0|||
164380962|NCT02627677|593766925|FG000|Overall Study|Study Terminated by Sponsor|5|||
164380963|NCT02627677|593766926|FG001|Overall Study|Study Terminated by Sponsor|10|||
164380964|NCT02627677|593766927|FG002|Overall Study|Study Terminated by Sponsor|6|||
164380965|NCT02627677|593766925|FG000|Overall Study|Physician Decision|0|||
164380966|NCT02627677|593766926|FG001|Overall Study|Physician Decision|0|||
164380967|NCT02627677|593766927|FG002|Overall Study|Physician Decision|2|||
164380968|NCT02627677|593766925|FG000|Overall Study|Withdrawal by Subject|2|||
164380969|NCT02627677|593766926|FG001|Overall Study|Withdrawal by Subject|1|||
164380970|NCT02627677|593766927|FG002|Overall Study|Withdrawal by Subject|1|||
164380971|NCT02627677|593766925|FG000|Overall Study|Reason not Specified|0|||
164380972|NCT02627677|593766926|FG001|Overall Study|Reason not Specified|0|||
164380973|NCT02627677|593766927|FG002|Overall Study|Reason not Specified|1|||
164380974|NCT02627677|593766925|FG000|Overall Study|Randomized but not Treated|1|||
164380975|NCT02627677|593766926|FG001|Overall Study|Randomized but not Treated|0|||
164380976|NCT02627677|593766927|FG002|Overall Study|Randomized but not Treated|0|||
164380977|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
164380978|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
164380979|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
164380980|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
164380981|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Death|235|||
164380982|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Death|167|||
164380983|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Death|1|||
164380984|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Death|0|||
164380985|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
164380986|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
164380987|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
164380988|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
164380989|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
164380990|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
164380991|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
164092893|NCT00920140|592703407|FG004|Phase 2|Adverse Event|3|||
164092894|NCT00920140|592703403|FG000|Phase 2|Lack of Efficacy|0|||
164092895|NCT00920140|592703404|FG001|Phase 2|Lack of Efficacy|0|||
164092896|NCT00920140|592703405|FG002|Phase 2|Lack of Efficacy|29|||
164092897|NCT00920140|592703406|FG003|Phase 2|Lack of Efficacy|14|||
164092898|NCT00920140|592703407|FG004|Phase 2|Lack of Efficacy|5|||
164092899|NCT00920140|592703403|FG000|Phase 2|Lost to Follow-up|0|||
164092900|NCT00920140|592703404|FG001|Phase 2|Lost to Follow-up|0|||
164092901|NCT00920140|592703405|FG002|Phase 2|Lost to Follow-up|0|||
164092902|NCT00920140|592703406|FG003|Phase 2|Lost to Follow-up|1|||
164092903|NCT00920140|592703407|FG004|Phase 2|Lost to Follow-up|0|||
164092904|NCT00920140|592703403|FG000|Phase 2|Physician Decision|0|||
164092905|NCT00920140|592703404|FG001|Phase 2|Physician Decision|0|||
164092906|NCT00920140|592703405|FG002|Phase 2|Physician Decision|3|||
164092907|NCT00920140|592703406|FG003|Phase 2|Physician Decision|3|||
164092908|NCT00920140|592703407|FG004|Phase 2|Physician Decision|2|||
164092909|NCT00920140|592703403|FG000|Phase 2|Withdrawal by Subject|0|||
164092910|NCT00920140|592703404|FG001|Phase 2|Withdrawal by Subject|0|||
164092911|NCT00920140|592703405|FG002|Phase 2|Withdrawal by Subject|4|||
164092912|NCT00920140|592703406|FG003|Phase 2|Withdrawal by Subject|2|||
164092913|NCT00920140|592703407|FG004|Phase 2|Withdrawal by Subject|1|||
164380992|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
164380993|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Other|1|||
164380994|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Other|2|||
164380995|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Other|0|||
164380996|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Other|0|||
164380997|NCT00673049|593766932|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
164380998|NCT00673049|593766933|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
164380999|NCT00673049|593766934|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
164381000|NCT00673049|593766935|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
164381001|NCT00673049|593766932|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
164381002|NCT00673049|593766933|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
164381003|NCT00673049|593766934|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
164381004|NCT00673049|593766935|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
164381005|NCT00673049|593766932|FG000|After Progression on Erlotinib|Death|0|||
164381006|NCT00673049|593766933|FG001|After Progression on Erlotinib|Death|0|||
164381007|NCT00673049|593766934|FG002|After Progression on Erlotinib|Death|0|||
164381008|NCT00673049|593766935|FG003|After Progression on Erlotinib|Death|71|||
164381009|NCT00673049|593766932|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
164381010|NCT00673049|593766933|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
164381011|NCT00673049|593766934|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
164381012|NCT00673049|593766935|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
164381013|NCT00673049|593766932|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
164381014|NCT00673049|593766933|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
164381015|NCT00673049|593766934|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
164381016|NCT00673049|593766935|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
164381017|NCT00673049|593766932|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
164381018|NCT00673049|593766933|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
164381019|NCT00673049|593766934|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
164381020|NCT00673049|593766935|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
164381021|NCT00975975|593766939|FG000|Overall Study|Death|6|||
164381022|NCT01863446|593766940|FG000|Overall Study|Withdrawal by Subject|1|||
164381023|NCT01863446|593766941|FG001|Overall Study|Withdrawal by Subject|0|||
164092914|NCT01400425|592703408|FG000|Overall Study|Withdrawal by Subject|10|||
164092915|NCT00720096|592703410|FG000|Overall Study|Withdrawal by Subject|0|||
164092916|NCT00720096|592703411|FG001|Overall Study|Withdrawal by Subject|2|||
164092917|NCT04557124|592703412|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
164092918|NCT04557124|592703413|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
164092919|NCT04557124|592703412|FG000|Mid-point (1 Month)|Missed testing|5|||
164092920|NCT04557124|592703413|FG001|Mid-point (1 Month)|Missed testing|4|||
164381024|NCT01863446|593766942|FG002|Overall Study|Withdrawal by Subject|1|||
164092921|NCT04557124|592703412|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
164092922|NCT04557124|592703413|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
164092923|NCT04557124|592703412|FG000|Post-testing (2 Months)|Missed testing|1|||
164092924|NCT04557124|592703413|FG001|Post-testing (2 Months)|Missed testing|5|||
164381025|NCT01863446|593766943|FG003|Overall Study|Withdrawal by Subject|2|||
164381026|NCT01863446|593766940|FG000|Overall Study|Physician Decision|0|||
164381027|NCT01863446|593766941|FG001|Overall Study|Physician Decision|0|||
164381028|NCT01863446|593766942|FG002|Overall Study|Physician Decision|1|||
164381029|NCT01863446|593766943|FG003|Overall Study|Physician Decision|0|||
164381030|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
164381031|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
164381032|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
164381033|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
164381034|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
164381035|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
164381036|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Death|1|||
164381037|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Death|0|||
164381038|NCT02554773|593766944|FG000|Original Dose Regimen (SAS 1)|Other|4|||
164381039|NCT02554773|593766945|FG001|Original Dose Regimen (SAS 1)|Other|0|||
164381040|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
164381041|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
164381042|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
164381043|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
164381044|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
164381045|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
164381046|NCT02554773|593766944|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
164381047|NCT02554773|593766945|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
164381048|NCT02956629|593766949|FG000|Overall Study|Adverse Event|0|||
164381049|NCT02956629|593766950|FG001|Overall Study|Adverse Event|0|||
164381050|NCT02956629|593766951|FG002|Overall Study|Adverse Event|1|||
164381051|NCT02956629|593766952|FG003|Overall Study|Adverse Event|0|||
164381052|NCT02956629|593766953|FG004|Overall Study|Adverse Event|0|||
164381053|NCT02956629|593766954|FG005|Overall Study|Adverse Event|0|||
164381054|NCT02956629|593766949|FG000|Overall Study|Lost to Follow-up|2|||
164381055|NCT02956629|593766950|FG001|Overall Study|Lost to Follow-up|5|||
164381056|NCT02956629|593766951|FG002|Overall Study|Lost to Follow-up|3|||
164381057|NCT02956629|593766952|FG003|Overall Study|Lost to Follow-up|1|||
164381058|NCT02956629|593766953|FG004|Overall Study|Lost to Follow-up|0|||
164381059|NCT02956629|593766954|FG005|Overall Study|Lost to Follow-up|1|||
164381060|NCT02956629|593766949|FG000|Overall Study|Withdrawal by Subject|3|||
164381061|NCT02956629|593766950|FG001|Overall Study|Withdrawal by Subject|1|||
164381062|NCT02956629|593766951|FG002|Overall Study|Withdrawal by Subject|0|||
164381063|NCT02956629|593766952|FG003|Overall Study|Withdrawal by Subject|0|||
164381064|NCT02956629|593766953|FG004|Overall Study|Withdrawal by Subject|0|||
164381065|NCT02956629|593766954|FG005|Overall Study|Withdrawal by Subject|0|||
164381066|NCT03224468|593766958|FG000|Overall Study|Did not obtain MM card|53|||
164381067|NCT03224468|593766959|FG001|Overall Study|Did not obtain MM card|0|||
164381068|NCT03224468|593766958|FG000|Overall Study|Lost to Follow-up|4|||
164381069|NCT03224468|593766959|FG001|Overall Study|Lost to Follow-up|11|||
164381070|NCT03224468|593766958|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
164381071|NCT03224468|593766959|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
164381072|NCT04713748|593766960|FG000|Overall Study|Not enough kits allocated|35|||
164381073|NCT01557946|593766961|FG000|Overall Study|Adverse Event|3|||
164381074|NCT01557946|593766962|FG001|Overall Study|Adverse Event|0|||
164381075|NCT00406029|593766963|FG000|Overall Study|Adverse Event|12|||
164381076|NCT00406029|593766964|FG001|Overall Study|Adverse Event|2|||
164381077|NCT00406029|593766965|FG002|Overall Study|Adverse Event|5|||
164381078|NCT00406029|593766966|FG003|Overall Study|Adverse Event|10|||
164381079|NCT00406029|593766967|FG004|Overall Study|Adverse Event|7|||
164381080|NCT00406029|593766963|FG000|Overall Study|Withdrawal by Subject|3|||
164381081|NCT00406029|593766964|FG001|Overall Study|Withdrawal by Subject|4|||
164381082|NCT00406029|593766965|FG002|Overall Study|Withdrawal by Subject|2|||
164381083|NCT00406029|593766966|FG003|Overall Study|Withdrawal by Subject|2|||
164381084|NCT00406029|593766967|FG004|Overall Study|Withdrawal by Subject|0|||
164381085|NCT00406029|593766963|FG000|Overall Study|Protocol Violation|1|||
164381086|NCT00406029|593766964|FG001|Overall Study|Protocol Violation|2|||
164381087|NCT00406029|593766965|FG002|Overall Study|Protocol Violation|0|||
164381088|NCT00406029|593766966|FG003|Overall Study|Protocol Violation|2|||
164381089|NCT00406029|593766967|FG004|Overall Study|Protocol Violation|0|||
164381090|NCT00406029|593766963|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381091|NCT00406029|593766964|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381092|NCT00406029|593766965|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
164381093|NCT00406029|593766966|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381094|NCT00406029|593766967|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
164381095|NCT00406029|593766963|FG000|Overall Study|Randomized in Error|0|||
164381096|NCT00406029|593766964|FG001|Overall Study|Randomized in Error|0|||
164381097|NCT00406029|593766965|FG002|Overall Study|Randomized in Error|2|||
164381098|NCT00406029|593766966|FG003|Overall Study|Randomized in Error|3|||
164381099|NCT00406029|593766967|FG004|Overall Study|Randomized in Error|1|||
164381100|NCT00812812|593766968|FG000|Overall Study|Adverse Event|2|||
164381101|NCT00812812|593766969|FG001|Overall Study|Adverse Event|1|||
164381102|NCT00812812|593766968|FG000|Overall Study|Lack of Efficacy|1|||
164381103|NCT00812812|593766969|FG001|Overall Study|Lack of Efficacy|0|||
164381104|NCT00812812|593766968|FG000|Overall Study|Lost to Follow-up|0|||
164381105|NCT00812812|593766969|FG001|Overall Study|Lost to Follow-up|1|||
164381106|NCT00812812|593766968|FG000|Overall Study|Withdrawal by Subject|0|||
164381107|NCT00812812|593766969|FG001|Overall Study|Withdrawal by Subject|2|||
164381108|NCT02114892|593766970|FG000|Overall Study|Lost to Follow-up|1|||
164381109|NCT02114892|593766971|FG001|Overall Study|Lost to Follow-up|2|||
164381110|NCT02178475|593766976|FG000|Overall Study|Withdrawal by Subject|7|||
164381111|NCT02178475|593766976|FG000|Overall Study|Lost to Follow-up|10|||
164381112|NCT02178475|593766976|FG000|Overall Study|Death|13|||
164381113|NCT02178475|593766976|FG000|Overall Study|Protocol-specified Criteria|99|||
164381114|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381115|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381116|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381117|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381118|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
164381119|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
164381120|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
164381121|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381122|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381123|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381124|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
164381125|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
164381126|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381127|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
164381128|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
164381129|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381130|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381131|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
164381132|NCT00718042|593766977|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381133|NCT00718042|593766978|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
164381134|NCT00718042|593766979|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381135|NCT00718042|593766980|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381136|NCT00718042|593766981|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381137|NCT00718042|593766982|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
164381138|NCT00718042|593766977|FG000|Donor Follow-up|Lost to Follow-up|13|||
164381139|NCT00718042|593766978|FG001|Donor Follow-up|Lost to Follow-up|0|||
164381140|NCT00718042|593766979|FG002|Donor Follow-up|Lost to Follow-up|0|||
164381141|NCT00718042|593766980|FG003|Donor Follow-up|Lost to Follow-up|0|||
164381142|NCT00718042|593766981|FG004|Donor Follow-up|Lost to Follow-up|19|||
164381143|NCT00718042|593766982|FG005|Donor Follow-up|Lost to Follow-up|0|||
164381144|NCT04327934|593766983|FG000|Overall Study|Did not qualify|7|||
164381145|NCT04327934|593766984|FG001|Overall Study|Did not qualify|4|||
164381146|NCT04327934|593766983|FG000|Overall Study|Physician Decision|0|||
164381147|NCT04327934|593766984|FG001|Overall Study|Physician Decision|1|||
164381148|NCT02443298|593766985|FG000|Overall Study|Adverse Event|3|||
164381149|NCT02443298|593766986|FG001|Overall Study|Adverse Event|3|||
164381150|NCT02443298|593766985|FG000|Overall Study|Withdrawal by Subject|1|||
164381151|NCT02443298|593766986|FG001|Overall Study|Withdrawal by Subject|2|||
164381152|NCT03095417|593766987|FG000|Overall Study|missed|1|||
164381153|NCT03095417|593766988|FG001|Overall Study|missed|2|||
164381154|NCT03095417|593766989|FG002|Overall Study|missed|0|||
164381155|NCT03095417|593766990|FG003|Overall Study|missed|1|||
164381156|NCT03095417|593766987|FG000|Overall Study|Lost to Follow-up|2|||
164381157|NCT03095417|593766988|FG001|Overall Study|Lost to Follow-up|2|||
164381158|NCT03095417|593766989|FG002|Overall Study|Lost to Follow-up|1|||
164381159|NCT03095417|593766990|FG003|Overall Study|Lost to Follow-up|0|||
164381160|NCT03095417|593766987|FG000|Overall Study|refusal|0|||
164381161|NCT03095417|593766988|FG001|Overall Study|refusal|1|||
164381162|NCT03095417|593766989|FG002|Overall Study|refusal|0|||
164381163|NCT03095417|593766990|FG003|Overall Study|refusal|1|||
164381164|NCT03095417|593766987|FG000|Overall Study|Withdrawal by Subject|8|||
164381165|NCT03095417|593766988|FG001|Overall Study|Withdrawal by Subject|2|||
164381166|NCT03095417|593766989|FG002|Overall Study|Withdrawal by Subject|5|||
164381167|NCT03095417|593766990|FG003|Overall Study|Withdrawal by Subject|4|||
164381168|NCT03095417|593766987|FG000|Overall Study|Physician Decision|1|||
164381169|NCT03095417|593766988|FG001|Overall Study|Physician Decision|2|||
164381170|NCT03095417|593766989|FG002|Overall Study|Physician Decision|2|||
164300020|NCT05138653|593472971|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
164300021|NCT05138653|593472972|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300022|NCT05138653|593472973|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
164300023|NCT05138653|593472974|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300024|NCT05138653|593472975|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
164300025|NCT05138653|593472976|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
164300026|NCT05138653|593472961|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300027|NCT05138653|593472962|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300028|NCT05138653|593472963|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300029|NCT05138653|593472964|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300030|NCT05138653|593472965|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300031|NCT05138653|593472966|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300032|NCT05138653|593472967|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300033|NCT05138653|593472968|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300034|NCT05138653|593472969|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300035|NCT05138653|593472970|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300036|NCT05138653|593472971|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300037|NCT05138653|593472972|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300038|NCT05138653|593472973|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300039|NCT05138653|593472974|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300040|NCT05138653|593472975|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
164300041|NCT05138653|593472976|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
164300042|NCT05138653|593472961|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300043|NCT05138653|593472962|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300044|NCT05138653|593472963|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300045|NCT05138653|593472964|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300046|NCT05138653|593472965|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300047|NCT05138653|593472966|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300048|NCT05138653|593472967|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300049|NCT05138653|593472968|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300050|NCT05138653|593472969|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300051|NCT05138653|593472970|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300052|NCT05138653|593472971|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300053|NCT05138653|593472972|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300054|NCT05138653|593472973|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300055|NCT05138653|593472974|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
164300056|NCT05138653|593472975|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300057|NCT05138653|593472976|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
164300058|NCT03204188|593472984|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
164300059|NCT03204188|593472984|FG000|Immunotherapy Phase (1 Year)|Death|1|||
164300060|NCT03204188|593472984|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
164300061|NCT03204188|593472984|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
164300062|NCT00091949|593475092|FG000|Overall Study|Withdrawal by Subject|117|||
164300063|NCT00091949|593475093|FG001|Overall Study|Withdrawal by Subject|110|||
164300064|NCT00091949|593475092|FG000|Overall Study|Lost to Follow-up|58|||
164300065|NCT00091949|593475093|FG001|Overall Study|Lost to Follow-up|41|||
164300066|NCT01256788|593475097|FG000|Overall Study|Lost to Follow-up|5|||
164300067|NCT01256788|593475098|FG001|Overall Study|Lost to Follow-up|8|||
164300068|NCT01256788|593475099|FG002|Overall Study|Lost to Follow-up|3|||
164300069|NCT01148979|593475108|FG000|Overall Study|Lost to Follow-up|0|||
164300070|NCT01148979|593475109|FG001|Overall Study|Lost to Follow-up|1|||
164300071|NCT00777153|593475110|FG000|Overall Study|Lost to Follow-up|1|||
164300072|NCT00777153|593475111|FG001|Overall Study|Lost to Follow-up|1|||
164300073|NCT00777153|593475112|FG002|Overall Study|Lost to Follow-up|0|||
164300074|NCT00777153|593475110|FG000|Overall Study|Death|85|||
164300075|NCT00777153|593475111|FG001|Overall Study|Death|73|||
164300076|NCT00777153|593475112|FG002|Overall Study|Death|33|||
164300077|NCT00777153|593475110|FG000|Overall Study|Withdrawal by Subject|3|||
164300078|NCT00777153|593475111|FG001|Overall Study|Withdrawal by Subject|4|||
164300079|NCT00777153|593475112|FG002|Overall Study|Withdrawal by Subject|3|||
164300080|NCT00777153|593475110|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
164300081|NCT00777153|593475111|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
164300082|NCT00777153|593475112|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
164300083|NCT01597596|593475113|FG000|Overall Study|Study terminated by sponsor|1|||
164300084|NCT01597596|593475114|FG001|Overall Study|Study terminated by sponsor|0|||
164013715|NCT02345434|592414504|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
164013716|NCT00859898|592414506|FG000|Overall Study|Lack of Efficacy|0|||
164013717|NCT00859898|592414507|FG001|Overall Study|Lack of Efficacy|1|||
164013718|NCT00859898|592414508|FG002|Overall Study|Lack of Efficacy|1|||
164013719|NCT00859898|592414506|FG000|Overall Study|Adverse Event|4|||
164013720|NCT00859898|592414507|FG001|Overall Study|Adverse Event|9|||
164013721|NCT00859898|592414508|FG002|Overall Study|Adverse Event|8|||
164300085|NCT01597596|593475113|FG000|Overall Study|Physician Decision|0|||
164300086|NCT01597596|593475114|FG001|Overall Study|Physician Decision|1|||
164300087|NCT02266888|593475126|FG000|Overall Study|Death|2|||
164300088|NCT02266888|593475127|FG001|Overall Study|Death|2|||
164013722|NCT00859898|592414506|FG000|Overall Study|Withdrawal by Subject|11|||
164013723|NCT00859898|592414507|FG001|Overall Study|Withdrawal by Subject|8|||
164013724|NCT00859898|592414508|FG002|Overall Study|Withdrawal by Subject|11|||
164013725|NCT00859898|592414506|FG000|Overall Study|Death|0|||
164013726|NCT00859898|592414507|FG001|Overall Study|Death|0|||
164013727|NCT00859898|592414508|FG002|Overall Study|Death|1|||
164013728|NCT00859898|592414506|FG000|Overall Study|Lost to Follow-up|10|||
164013729|NCT00859898|592414507|FG001|Overall Study|Lost to Follow-up|11|||
164300089|NCT02266888|593475128|FG002|Overall Study|Death|4|||
164300090|NCT02266888|593475129|FG003|Overall Study|Death|2|||
164300091|NCT02266888|593475126|FG000|Overall Study|Physician Decision|0|||
164300092|NCT02266888|593475127|FG001|Overall Study|Physician Decision|1|||
164300093|NCT02266888|593475128|FG002|Overall Study|Physician Decision|2|||
164300094|NCT02266888|593475129|FG003|Overall Study|Physician Decision|2|||
164300095|NCT02266888|593475126|FG000|Overall Study|Study Terminated|5|||
164300096|NCT02266888|593475127|FG001|Overall Study|Study Terminated|1|||
164300097|NCT02266888|593475128|FG002|Overall Study|Study Terminated|0|||
164300098|NCT02266888|593475129|FG003|Overall Study|Study Terminated|0|||
164300099|NCT02266888|593475126|FG000|Overall Study|No Longer Eligible|0|||
164300100|NCT02266888|593475127|FG001|Overall Study|No Longer Eligible|0|||
164300101|NCT02266888|593475128|FG002|Overall Study|No Longer Eligible|0|||
164300102|NCT02266888|593475129|FG003|Overall Study|No Longer Eligible|2|||
164300103|NCT02266888|593475126|FG000|Overall Study|Randomization Closed|0|||
164300104|NCT02266888|593475127|FG001|Overall Study|Randomization Closed|0|||
164300105|NCT02266888|593475128|FG002|Overall Study|Randomization Closed|4|||
164300106|NCT02266888|593475129|FG003|Overall Study|Randomization Closed|0|||
164300107|NCT02266888|593475126|FG000|Overall Study|Personnel unavailable at transplant|0|||
164300108|NCT02266888|593475127|FG001|Overall Study|Personnel unavailable at transplant|0|||
164300109|NCT02266888|593475128|FG002|Overall Study|Personnel unavailable at transplant|0|||
164300110|NCT02266888|593475129|FG003|Overall Study|Personnel unavailable at transplant|1|||
164300111|NCT02266888|593475126|FG000|Overall Study|Transfer of care|0|||
164300112|NCT02266888|593475127|FG001|Overall Study|Transfer of care|0|||
164300113|NCT02266888|593475128|FG002|Overall Study|Transfer of care|1|||
164300114|NCT02266888|593475129|FG003|Overall Study|Transfer of care|0|||
164300115|NCT02224560|593475134|FG000|Overall Study|Protocol Deviation|1|||
164300116|NCT02224560|593475135|FG001|Overall Study|Protocol Deviation|0|||
164300117|NCT02224560|593475136|FG002|Overall Study|Protocol Deviation|0|||
164300118|NCT02224560|593475134|FG000|Overall Study|Withdrawal by Subject|2|||
164300119|NCT02224560|593475135|FG001|Overall Study|Withdrawal by Subject|0|||
164300120|NCT02224560|593475136|FG002|Overall Study|Withdrawal by Subject|1|||
164300121|NCT02224560|593475134|FG000|Overall Study|Met Withdrawal Criteria|1|||
164300122|NCT02224560|593475135|FG001|Overall Study|Met Withdrawal Criteria|0|||
164300123|NCT02224560|593475136|FG002|Overall Study|Met Withdrawal Criteria|0|||
164300124|NCT02224560|593475134|FG000|Overall Study|Adverse Event|4|||
164300125|NCT02224560|593475135|FG001|Overall Study|Adverse Event|1|||
164300126|NCT02224560|593475136|FG002|Overall Study|Adverse Event|1|||
164300127|NCT02224560|593475134|FG000|Overall Study|Withdrawn by Investigator|1|||
164300128|NCT02224560|593475135|FG001|Overall Study|Withdrawn by Investigator|1|||
164300129|NCT02224560|593475136|FG002|Overall Study|Withdrawn by Investigator|0|||
164300130|NCT00728689|593475137|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
164300131|NCT00728689|593475138|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
164300132|NCT01523366|593475139|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164300133|NCT01523366|593475140|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164300134|NCT01523366|593475139|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
164300135|NCT01523366|593475140|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
164300136|NCT02461758|593475141|FG000|Overall Study|Lost to Follow-up|0|||
164300137|NCT02461758|593475142|FG001|Overall Study|Lost to Follow-up|1|||
164300138|NCT02461758|593475143|FG002|Overall Study|Lost to Follow-up|1|||
164300139|NCT02461758|593475144|FG003|Overall Study|Lost to Follow-up|0|||
164300140|NCT04543279|593475146|FG000|Overall Study|Withdrawal by Subject|1|||
164300141|NCT04543279|593475147|FG001|Overall Study|Withdrawal by Subject|0|||
164300142|NCT04543279|593475146|FG000|Overall Study|Adverse Event|1|||
164300143|NCT04543279|593475147|FG001|Overall Study|Adverse Event|0|||
164381171|NCT03095417|593766990|FG003|Overall Study|Physician Decision|2|||
164381172|NCT03095417|593766987|FG000|Overall Study|Death|1|||
164381173|NCT03095417|593766988|FG001|Overall Study|Death|2|||
164381174|NCT03095417|593766989|FG002|Overall Study|Death|1|||
164381175|NCT03095417|593766990|FG003|Overall Study|Death|3|||
164381176|NCT02571452|593766991|FG000|Overall Study Treatment|Protocol Violation|0|||
164381177|NCT02571452|593766992|FG001|Overall Study Treatment|Protocol Violation|1|||
164381178|NCT02571452|593766991|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
164381179|NCT02571452|593766992|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
164381180|NCT02571452|593766991|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
164381181|NCT02571452|593766992|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
164381182|NCT03698773|593767006|FG000|Overall Study|Lost to Follow-up|2|||
164381183|NCT03698773|593767007|FG001|Overall Study|Lost to Follow-up|1|||
164381184|NCT01158924|593767008|FG000|Overall Study|Withdrawal by Subject|1|||
164381185|NCT01158924|593767009|FG001|Overall Study|Withdrawal by Subject|2|||
164381186|NCT01158924|593767008|FG000|Overall Study|Lost to Follow-up|0|||
164381187|NCT01158924|593767009|FG001|Overall Study|Lost to Follow-up|1|||
164381188|NCT01599650|593767010|FG000|Overall Study|Administrative issue|1|||
164381189|NCT01599650|593767011|FG001|Overall Study|Administrative issue|0|||
164381190|NCT01599650|593767012|FG002|Overall Study|Administrative issue|1|||
164381191|NCT01599650|593767010|FG000|Overall Study|Physician Decision|2|||
164381192|NCT01599650|593767011|FG001|Overall Study|Physician Decision|0|||
164381193|NCT01599650|593767012|FG002|Overall Study|Physician Decision|7|||
164381194|NCT01599650|593767010|FG000|Overall Study|Protocol Violation|0|||
164013730|NCT00859898|592414508|FG002|Overall Study|Lost to Follow-up|5|||
164013731|NCT00859898|592414506|FG000|Overall Study|poor/non-compliance|2|||
164013732|NCT00859898|592414507|FG001|Overall Study|poor/non-compliance|0|||
164013733|NCT00859898|592414508|FG002|Overall Study|poor/non-compliance|0|||
164013734|NCT00859898|592414506|FG000|Overall Study|No longer meets criteria|0|||
164013735|NCT00859898|592414507|FG001|Overall Study|No longer meets criteria|1|||
164013736|NCT00859898|592414508|FG002|Overall Study|No longer meets criteria|0|||
164013737|NCT00859898|592414506|FG000|Overall Study|non-specified|1|||
164013738|NCT00859898|592414507|FG001|Overall Study|non-specified|1|||
164013739|NCT00859898|592414508|FG002|Overall Study|non-specified|1|||
164013740|NCT03215264|592414510|FG000|Dose Level 2|Adverse Event|0|||
164013741|NCT03215264|592414511|FG001|Dose Level 2|Adverse Event|1|||
164013742|NCT03215264|592414512|FG002|Dose Level 2|Adverse Event|0|||
164013743|NCT03215264|592414510|FG000|Dose Level 3|Withdrawal by Subject|0|||
164013744|NCT03215264|592414511|FG001|Dose Level 3|Withdrawal by Subject|0|||
164013745|NCT03215264|592414512|FG002|Dose Level 3|Withdrawal by Subject|1|||
164381195|NCT01599650|593767011|FG001|Overall Study|Protocol Violation|3|||
164381196|NCT01599650|593767012|FG002|Overall Study|Protocol Violation|0|||
164381197|NCT01599650|593767010|FG000|Overall Study|Death|2|||
164381198|NCT01599650|593767011|FG001|Overall Study|Death|1|||
164381199|NCT01599650|593767012|FG002|Overall Study|Death|2|||
164381200|NCT01599650|593767010|FG000|Overall Study|Lost to Follow-up|3|||
164381201|NCT01599650|593767011|FG001|Overall Study|Lost to Follow-up|3|||
164381202|NCT01599650|593767012|FG002|Overall Study|Lost to Follow-up|3|||
164381203|NCT01599650|593767010|FG000|Overall Study|Withdrawal by Subject|11|||
164381204|NCT01599650|593767011|FG001|Overall Study|Withdrawal by Subject|11|||
164381205|NCT01599650|593767012|FG002|Overall Study|Withdrawal by Subject|10|||
164381206|NCT01599650|593767010|FG000|Overall Study|Adverse Event|3|||
164381207|NCT01599650|593767011|FG001|Overall Study|Adverse Event|8|||
164381208|NCT01599650|593767012|FG002|Overall Study|Adverse Event|4|||
164381209|NCT01731171|593767013|FG000|Overall Study|Withdrawal by Subject|4|||
164381210|NCT01731171|593767014|FG001|Overall Study|Withdrawal by Subject|1|||
164381211|NCT01731171|593767013|FG000|Overall Study|Lost to Follow-up|3|||
164381212|NCT01731171|593767014|FG001|Overall Study|Lost to Follow-up|2|||
164381213|NCT01731171|593767013|FG000|Overall Study|Moved out of Area|0|||
164381214|NCT01731171|593767014|FG001|Overall Study|Moved out of Area|2|||
164381215|NCT01731171|593767013|FG000|Overall Study|Terminated for Lack of Adherence|0|||
164381216|NCT01731171|593767014|FG001|Overall Study|Terminated for Lack of Adherence|1|||
164381217|NCT01731171|593767013|FG000|Overall Study|Terminated for Safety Reasons|0|||
164381218|NCT01731171|593767014|FG001|Overall Study|Terminated for Safety Reasons|1|||
164381219|NCT01410110|593767015|FG000|Overall Study|Withdrawal by Subject|4|||
164381220|NCT01410110|593767016|FG001|Overall Study|Withdrawal by Subject|2|||
164381221|NCT01700946|593767017|FG000|Overall Study|Lost to Follow-up|1|||
164381222|NCT01700946|593767018|FG001|Overall Study|Lost to Follow-up|0|||
164381223|NCT01700946|593767017|FG000|Overall Study|Physician Decision|7|||
164381224|NCT01700946|593767018|FG001|Overall Study|Physician Decision|12|||
164381225|NCT01700946|593767017|FG000|Overall Study|Withdrawal by Subject|0|||
164381226|NCT01700946|593767018|FG001|Overall Study|Withdrawal by Subject|2|||
164381227|NCT01700946|593767017|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
164381228|NCT01700946|593767018|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
164381229|NCT01700946|593767017|FG000|Overall Study|Relapse|2|||
164381230|NCT01700946|593767018|FG001|Overall Study|Relapse|1|||
164381231|NCT01700946|593767017|FG000|Overall Study|Unacceptable toxicity|1|||
164381232|NCT01700946|593767018|FG001|Overall Study|Unacceptable toxicity|0|||
164381233|NCT00684424|593767019|FG000|Overall Study|Adverse Event|1|||
164381234|NCT00684424|593767019|FG000|Overall Study|Lost to Follow-up|2|||
164381235|NCT00684424|593767019|FG000|Overall Study|Other|2|||
164381236|NCT02138214|593767020|FG000|Overall Study|Withdrawal by Subject|0|||
164381237|NCT02138214|593767021|FG001|Overall Study|Withdrawal by Subject|1|||
164381238|NCT02138214|593767022|FG002|Overall Study|Withdrawal by Subject|0|||
164381239|NCT02138214|593767020|FG000|Overall Study|Lost to Follow-up|0|||
164381240|NCT02138214|593767021|FG001|Overall Study|Lost to Follow-up|2|||
164381241|NCT02138214|593767022|FG002|Overall Study|Lost to Follow-up|4|||
164381242|NCT02138214|593767020|FG000|Overall Study|Screen Failure|0|||
164381243|NCT02138214|593767021|FG001|Overall Study|Screen Failure|1|||
164381244|NCT02138214|593767022|FG002|Overall Study|Screen Failure|0|||
164381245|NCT02185768|593767023|FG000|Overall Study|Patients were not treated|2|||
164381246|NCT03221257|593767024|FG000|Overall Study|Lost to Follow-up|0|||
164381247|NCT03221257|593767025|FG001|Overall Study|Lost to Follow-up|1|||
164381248|NCT03221257|593767024|FG000|Overall Study|Withdrawal by Subject|1|||
164381249|NCT03221257|593767025|FG001|Overall Study|Withdrawal by Subject|1|||
164381250|NCT01334866|593767026|FG000|Overall Study|Withdrawal by Subject|10|||
164381251|NCT01334866|593767026|FG000|Overall Study|Lost to Follow-up|3|||
164381252|NCT01334866|593767026|FG000|Overall Study|Physician Decision|3|||
164381253|NCT01334866|593767026|FG000|Overall Study|medically necessary prior to procedure|2|||
164381254|NCT01334866|593767026|FG000|Overall Study|medically necessary post-procedure|1|||
164381255|NCT01971346|593767030|FG000|Overall Study|Protocol Violation|3|||
164381256|NCT01971346|593767030|FG000|Overall Study|Lost to Follow-up|2|||
164381257|NCT01971346|593767030|FG000|Overall Study|Withdrawal by Subject|2|||
164381258|NCT01971346|593767030|FG000|Overall Study|Physician Decision|1|||
164381259|NCT04187196|593767031|FG000|Overall Study|Screen Failure|2|||
164381260|NCT04187196|593767032|FG001|Overall Study|Screen Failure|0|||
164381261|NCT01687166|593767033|FG000|Overall Study|Attempt subject|2|||
164381262|NCT01687166|593767034|FG001|Overall Study|Attempt subject|3|||
164381263|NCT01687166|593767035|FG002|Overall Study|Attempt subject|2|||
164381264|NCT01687166|593767036|FG003|Overall Study|Attempt subject|0|||
164381265|NCT01687166|593767033|FG000|Overall Study|Did not meet eligibility criteria|4|||
164381266|NCT01687166|593767034|FG001|Overall Study|Did not meet eligibility criteria|6|||
164381267|NCT01687166|593767035|FG002|Overall Study|Did not meet eligibility criteria|1|||
164381268|NCT01687166|593767036|FG003|Overall Study|Did not meet eligibility criteria|1|||
164381269|NCT01687166|593767033|FG000|Overall Study|Adverse Event|2|||
164381270|NCT01687166|593767034|FG001|Overall Study|Adverse Event|1|||
164381271|NCT01687166|593767035|FG002|Overall Study|Adverse Event|0|||
164381272|NCT01687166|593767036|FG003|Overall Study|Adverse Event|0|||
164381273|NCT01687166|593767033|FG000|Overall Study|Physician Decision|3|||
164381274|NCT01687166|593767034|FG001|Overall Study|Physician Decision|2|||
164381275|NCT01687166|593767035|FG002|Overall Study|Physician Decision|1|||
164381276|NCT01687166|593767036|FG003|Overall Study|Physician Decision|0|||
164381277|NCT01687166|593767033|FG000|Overall Study|Withdrawal by Subject|11|||
164381278|NCT01687166|593767034|FG001|Overall Study|Withdrawal by Subject|4|||
164381279|NCT01687166|593767035|FG002|Overall Study|Withdrawal by Subject|3|||
164381280|NCT01687166|593767036|FG003|Overall Study|Withdrawal by Subject|0|||
164381281|NCT01687166|593767033|FG000|Overall Study|Lost to Follow-up|2|||
164381282|NCT01687166|593767034|FG001|Overall Study|Lost to Follow-up|5|||
164381283|NCT01687166|593767035|FG002|Overall Study|Lost to Follow-up|1|||
164381284|NCT01687166|593767036|FG003|Overall Study|Lost to Follow-up|0|||
164381285|NCT01687166|593767033|FG000|Overall Study|Equipment/Device Availability|0|||
164381286|NCT01687166|593767034|FG001|Overall Study|Equipment/Device Availability|1|||
164381287|NCT01687166|593767035|FG002|Overall Study|Equipment/Device Availability|0|||
164381288|NCT01687166|593767036|FG003|Overall Study|Equipment/Device Availability|0|||
164381289|NCT01687166|593767033|FG000|Overall Study|Death|1|||
164381290|NCT01687166|593767034|FG001|Overall Study|Death|1|||
164381291|NCT01687166|593767035|FG002|Overall Study|Death|0|||
164381292|NCT01687166|593767036|FG003|Overall Study|Death|0|||
164381293|NCT01687166|593767033|FG000|Overall Study|Protocol Violation|1|||
164381294|NCT01687166|593767034|FG001|Overall Study|Protocol Violation|1|||
164381295|NCT01687166|593767035|FG002|Overall Study|Protocol Violation|1|||
164381296|NCT01687166|593767036|FG003|Overall Study|Protocol Violation|0|||
164381297|NCT01687166|593767033|FG000|Overall Study|Subject moved out of state|0|||
164381298|NCT01687166|593767034|FG001|Overall Study|Subject moved out of state|1|||
164381299|NCT01687166|593767035|FG002|Overall Study|Subject moved out of state|0|||
164381300|NCT01687166|593767036|FG003|Overall Study|Subject moved out of state|0|||
164381301|NCT01687166|593767033|FG000|Overall Study|Patient unable to be compliant|1|||
164381302|NCT01687166|593767034|FG001|Overall Study|Patient unable to be compliant|0|||
164381303|NCT01687166|593767035|FG002|Overall Study|Patient unable to be compliant|0|||
164381304|NCT01687166|593767036|FG003|Overall Study|Patient unable to be compliant|0|||
164381305|NCT01687166|593767033|FG000|Overall Study|Physician choice to use different device|1|||
164381306|NCT01687166|593767034|FG001|Overall Study|Physician choice to use different device|2|||
164381307|NCT01687166|593767035|FG002|Overall Study|Physician choice to use different device|4|||
164381308|NCT01687166|593767036|FG003|Overall Study|Physician choice to use different device|0|||
164381309|NCT01687166|593767033|FG000|Overall Study|Insurance|0|||
164381310|NCT01687166|593767034|FG001|Overall Study|Insurance|0|||
164381311|NCT01687166|593767035|FG002|Overall Study|Insurance|1|||
164381312|NCT01687166|593767036|FG003|Overall Study|Insurance|1|||
164381313|NCT02755831|593767037|FG000|Overall Study|Lost to Follow-up|3|||
164381314|NCT02755831|593767038|FG001|Overall Study|Lost to Follow-up|3|||
164381315|NCT01600586|593767039|FG000|Overall Study|Physician Decision|3|||
164381316|NCT01600586|593767040|FG001|Overall Study|Physician Decision|3|||
164381317|NCT01227512|593767042|FG000|Overall Study|Physician Decision|6|||
164381318|NCT01227512|593767043|FG001|Overall Study|Physician Decision|6|||
164381319|NCT01227512|593767042|FG000|Overall Study|Adverse Event|4|||
164381320|NCT01227512|593767043|FG001|Overall Study|Adverse Event|3|||
164381321|NCT01227512|593767042|FG000|Overall Study|Withdrawal by Subject|3|||
164381322|NCT01227512|593767043|FG001|Overall Study|Withdrawal by Subject|0|||
164381323|NCT01227512|593767042|FG000|Overall Study|Participant met withdrawal criteria|0|||
164381324|NCT01227512|593767043|FG001|Overall Study|Participant met withdrawal criteria|1|||
164381325|NCT01978184|593767045|FG000|Overall Study|Progressive disease|5|||
164381326|NCT01978184|593767046|FG001|Overall Study|Progressive disease|5|||
164381327|NCT01978184|593767045|FG000|Overall Study|Other than PDA|2|||
164381328|NCT01978184|593767046|FG001|Overall Study|Other than PDA|2|||
164381329|NCT01978184|593767045|FG000|Overall Study|Physician Decision|0|||
164381330|NCT01978184|593767046|FG001|Overall Study|Physician Decision|3|||
164381331|NCT01978184|593767045|FG000|Overall Study|Noncompliance|1|||
164381332|NCT01978184|593767046|FG001|Overall Study|Noncompliance|2|||
164381333|NCT01978184|593767045|FG000|Overall Study|Death|1|||
164381334|NCT01978184|593767046|FG001|Overall Study|Death|0|||
164381335|NCT01978184|593767045|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
164381336|NCT01978184|593767046|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
164381337|NCT02460198|593767049|FG000|Overall Study|Adverse Event|1|||
164381338|NCT02460198|593767050|FG001|Overall Study|Adverse Event|3|||
164381339|NCT02460198|593767049|FG000|Overall Study|Death|36|||
164381340|NCT02460198|593767050|FG001|Overall Study|Death|28|||
164381341|NCT02460198|593767049|FG000|Overall Study|Lost to Follow-up|1|||
164381342|NCT02460198|593767050|FG001|Overall Study|Lost to Follow-up|1|||
164381343|NCT02460198|593767049|FG000|Overall Study|Transferred to Extension Study|15|||
164381344|NCT02460198|593767050|FG001|Overall Study|Transferred to Extension Study|15|||
164381345|NCT02460198|593767049|FG000|Overall Study|Withdrawal by Subject|2|||
164381346|NCT02460198|593767050|FG001|Overall Study|Withdrawal by Subject|4|||
164381347|NCT02460198|593767049|FG000|Overall Study|Site Terminated By Sponsor|0|||
164381348|NCT02460198|593767050|FG001|Overall Study|Site Terminated By Sponsor|1|||
164381349|NCT02460198|593767049|FG000|Overall Study|Did Not Continue on Extension Study|6|||
164381350|NCT02460198|593767050|FG001|Overall Study|Did Not Continue on Extension Study|11|||
164381351|NCT01069289|593767053|FG000|Overall Study|Withdrawal by Subject|15|||
164381352|NCT01069289|593767054|FG001|Overall Study|Withdrawal by Subject|26|||
164381353|NCT01069289|593767053|FG000|Overall Study|Adverse Event|21|||
164381354|NCT01069289|593767054|FG001|Overall Study|Adverse Event|28|||
164013746|NCT00367640|592414513|FG000|Overall Study|Adverse Event|3|||
164013747|NCT00367640|592414514|FG001|Overall Study|Adverse Event|6|||
164013748|NCT00367640|592414515|FG002|Overall Study|Adverse Event|8|||
164013749|NCT00367640|592414516|FG003|Overall Study|Adverse Event|0|||
164013750|NCT00367640|592414513|FG000|Overall Study|Withdrawal by Subject|8|||
164013751|NCT00367640|592414514|FG001|Overall Study|Withdrawal by Subject|11|||
164013752|NCT00367640|592414515|FG002|Overall Study|Withdrawal by Subject|8|||
164013753|NCT00367640|592414516|FG003|Overall Study|Withdrawal by Subject|6|||
164013754|NCT00367640|592414513|FG000|Overall Study|Any other reason not above-mentioned|7|||
164013755|NCT00367640|592414514|FG001|Overall Study|Any other reason not above-mentioned|5|||
164013756|NCT00367640|592414515|FG002|Overall Study|Any other reason not above-mentioned|3|||
164013757|NCT00367640|592414516|FG003|Overall Study|Any other reason not above-mentioned|4|||
164381355|NCT01069289|593767053|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164381356|NCT01069289|593767054|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164381357|NCT01069289|593767053|FG000|Overall Study|Severe non-compliance to protocol|3|||
164381358|NCT01069289|593767054|FG001|Overall Study|Severe non-compliance to protocol|2|||
164381359|NCT01069289|593767053|FG000|Overall Study|Due to deteriorating health condition|1|||
164381360|NCT01069289|593767054|FG001|Overall Study|Due to deteriorating health condition|0|||
164381361|NCT00965848|593767055|FG000|Overall Study|Protocol Violation|3|||
164381362|NCT00965848|593767056|FG001|Overall Study|Protocol Violation|0|||
164381363|NCT00965848|593767057|FG002|Overall Study|Protocol Violation|1|||
164381364|NCT00965848|593767055|FG000|Overall Study|Death|11|||
164381365|NCT00965848|593767056|FG001|Overall Study|Death|1|||
164381366|NCT00965848|593767057|FG002|Overall Study|Death|5|||
164381367|NCT00965848|593767055|FG000|Overall Study|Lost to Follow-up|0|||
164381368|NCT00965848|593767056|FG001|Overall Study|Lost to Follow-up|0|||
164381369|NCT00965848|593767057|FG002|Overall Study|Lost to Follow-up|1|||
164381370|NCT00965848|593767055|FG000|Overall Study|Withdrawal by Subject|1|||
164381371|NCT00965848|593767056|FG001|Overall Study|Withdrawal by Subject|0|||
164013758|NCT02417233|592414517|FG000|Overall Study|Death|4|||
164381372|NCT00965848|593767057|FG002|Overall Study|Withdrawal by Subject|0|||
164381373|NCT00965848|593767055|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
164381374|NCT00965848|593767056|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
164381375|NCT00965848|593767057|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
164013759|NCT02417233|592414518|FG001|Overall Study|Death|10|||
164013760|NCT02417233|592414519|FG002|Overall Study|Death|14|||
164013761|NCT02417233|592414517|FG000|Overall Study|Lost to Follow-up|27|||
164013762|NCT02417233|592414518|FG001|Overall Study|Lost to Follow-up|39|||
164381376|NCT00965848|593767055|FG000|Overall Study|Not Clinically Evaluable|7|||
164381377|NCT00965848|593767056|FG001|Overall Study|Not Clinically Evaluable|1|||
164381378|NCT00965848|593767057|FG002|Overall Study|Not Clinically Evaluable|1|||
164013763|NCT02417233|592414519|FG002|Overall Study|Lost to Follow-up|34|||
164013764|NCT02417233|592414517|FG000|Overall Study|Protocol Violation|2|||
164013765|NCT02417233|592414518|FG001|Overall Study|Protocol Violation|0|||
164381379|NCT00965848|593767055|FG000|Overall Study|Other|5|||
164381380|NCT00965848|593767056|FG001|Overall Study|Other|0|||
164381381|NCT00965848|593767057|FG002|Overall Study|Other|1|||
164381382|NCT00691210|593767058|FG000|Overall Study|Progression of Disease|0|||
164381383|NCT00691210|593767059|FG001|Overall Study|Progression of Disease|0|||
164381384|NCT00691210|593767060|FG002|Overall Study|Progression of Disease|0|||
164381385|NCT00691210|593767061|FG003|Overall Study|Progression of Disease|2|||
164381386|NCT00691210|593767062|FG004|Overall Study|Progression of Disease|0|||
164381387|NCT00691210|593767063|FG005|Overall Study|Progression of Disease|0|||
164381388|NCT00691210|593767064|FG006|Overall Study|Progression of Disease|0|||
164381389|NCT00691210|593767065|FG007|Overall Study|Progression of Disease|0|||
164381390|NCT00691210|593767058|FG000|Overall Study|Lack of Efficacy|0|||
164381391|NCT00691210|593767059|FG001|Overall Study|Lack of Efficacy|0|||
164381392|NCT00691210|593767060|FG002|Overall Study|Lack of Efficacy|0|||
164381393|NCT00691210|593767061|FG003|Overall Study|Lack of Efficacy|1|||
164381394|NCT00691210|593767062|FG004|Overall Study|Lack of Efficacy|0|||
164381395|NCT00691210|593767063|FG005|Overall Study|Lack of Efficacy|1|||
164381396|NCT00691210|593767064|FG006|Overall Study|Lack of Efficacy|0|||
164381397|NCT00691210|593767065|FG007|Overall Study|Lack of Efficacy|0|||
164381398|NCT02707640|593767066|FG000|Overall Study|Adverse Event|4|||
164381399|NCT02707640|593767067|FG001|Overall Study|Adverse Event|2|||
164381400|NCT02707640|593767066|FG000|Overall Study|Death|1|||
164381401|NCT02707640|593767067|FG001|Overall Study|Death|2|||
164381402|NCT02707640|593767066|FG000|Overall Study|Physician Decision|2|||
164381403|NCT02707640|593767067|FG001|Overall Study|Physician Decision|0|||
164381404|NCT02707640|593767066|FG000|Overall Study|Withdrawal by Subject|0|||
164381405|NCT02707640|593767067|FG001|Overall Study|Withdrawal by Subject|1|||
164381406|NCT02707640|593767066|FG000|Overall Study|Participant's Personal Decision|1|||
164381407|NCT02707640|593767067|FG001|Overall Study|Participant's Personal Decision|2|||
164381408|NCT02707640|593767066|FG000|Overall Study|Sponsor Discretion|1|||
164381409|NCT02707640|593767067|FG001|Overall Study|Sponsor Discretion|0|||
164381410|NCT02517905|593767068|FG000|Overall Study|Lost to Follow-up|4|||
164381411|NCT02517905|593767069|FG001|Overall Study|Lost to Follow-up|0|||
164381412|NCT02517905|593767068|FG000|Overall Study|Withdrawal by Subject|4|||
164381413|NCT02517905|593767069|FG001|Overall Study|Withdrawal by Subject|0|||
164381414|NCT02517905|593767068|FG000|Overall Study|Screen failure|2|||
164381415|NCT02517905|593767069|FG001|Overall Study|Screen failure|2|||
164381416|NCT00023452|593767070|FG000|Overall Study|Ineligible for Study|163|||
164381417|NCT00023452|593767071|FG001|Overall Study|Ineligible for Study|159|||
164381418|NCT00023452|593767070|FG000|Overall Study|Out of Window|129|||
164381419|NCT00023452|593767071|FG001|Overall Study|Out of Window|69|||
164381420|NCT00023452|593767070|FG000|Overall Study|Death|2|||
164381421|NCT00023452|593767071|FG001|Overall Study|Death|0|||
164381422|NCT00023452|593767070|FG000|Overall Study|Withdrawal by Subject|66|||
164381423|NCT00023452|593767071|FG001|Overall Study|Withdrawal by Subject|54|||
164381424|NCT00023452|593767070|FG000|Overall Study|Adverse Event|139|||
164381425|NCT00023452|593767071|FG001|Overall Study|Adverse Event|196|||
164381426|NCT00023452|593767070|FG000|Overall Study|Lost to Follow-up|293|||
164381427|NCT00023452|593767071|FG001|Overall Study|Lost to Follow-up|60|||
164381428|NCT00023452|593767070|FG000|Overall Study|Physician Decision|49|||
164381429|NCT00023452|593767071|FG001|Overall Study|Physician Decision|21|||
164381430|NCT00023452|593767070|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
164381431|NCT00023452|593767071|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
164381432|NCT00023452|593767070|FG000|Overall Study|Pregnant|53|||
164381433|NCT00023452|593767071|FG001|Overall Study|Pregnant|20|||
164381434|NCT00023452|593767070|FG000|Overall Study|Other|204|||
164381435|NCT00023452|593767071|FG001|Overall Study|Other|69|||
164013766|NCT02417233|592414519|FG002|Overall Study|Protocol Violation|2|||
164013767|NCT02417233|592414517|FG000|Overall Study|Withdrawal by Subject|2|||
164381436|NCT05789875|593767072|FG000|Overall Study|Lost to Follow-up|6|||
164381437|NCT01994395|593767073|FG000|Overall Study|Withdrawal by Subject|1|||
164381438|NCT01994395|593767074|FG001|Overall Study|Withdrawal by Subject|2|||
164381439|NCT00459134|593767082|FG000|Overall Study|Physician Decision|1|||
164381440|NCT00459134|593767083|FG001|Overall Study|Physician Decision|1|||
164013768|NCT02417233|592414518|FG001|Overall Study|Withdrawal by Subject|1|||
164381441|NCT00459134|593767082|FG000|Overall Study|Withdrawal by Subject|8|||
164381442|NCT00459134|593767083|FG001|Overall Study|Withdrawal by Subject|7|||
164381443|NCT00459134|593767082|FG000|Overall Study|Lost to Follow-up|6|||
164381444|NCT00459134|593767083|FG001|Overall Study|Lost to Follow-up|7|||
164381445|NCT00459134|593767082|FG000|Overall Study|Surgery|1|||
164013769|NCT02417233|592414519|FG002|Overall Study|Withdrawal by Subject|8|||
164381446|NCT00459134|593767083|FG001|Overall Study|Surgery|2|||
164381447|NCT00459134|593767082|FG000|Overall Study|Toxicity|4|||
164381448|NCT00459134|593767083|FG001|Overall Study|Toxicity|5|||
164381449|NCT00459134|593767082|FG000|Overall Study|Progression|1|||
164381450|NCT00459134|593767083|FG001|Overall Study|Progression|0|||
164381451|NCT00459134|593767082|FG000|Overall Study|Multiple Reasons|2|||
164381452|NCT00459134|593767083|FG001|Overall Study|Multiple Reasons|3|||
164381453|NCT02770391|593767084|FG000|Overall Study|Lost to Follow-up|2|||
164381454|NCT02770391|593767084|FG000|Overall Study|Withdrawal by Subject|1|||
164381455|NCT02770391|593767084|FG000|Overall Study|Surgery delayed unevaluable|2|||
164381456|NCT02770391|593767084|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
164381457|NCT03333486|593767085|FG000|Overall Study|Withdrawal by Subject|1|||
164381458|NCT03333486|593767085|FG000|Overall Study|Lost to Follow-up|1|||
164381459|NCT01755416|593767091|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
164381460|NCT01755416|593767092|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
164381461|NCT02805257|593769427|FG000|Overall Study|Lost to Follow-up|7|||
164381462|NCT02805257|593769428|FG001|Overall Study|Lost to Follow-up|6|||
164381463|NCT02805257|593769427|FG000|Overall Study|Death|0|||
164381464|NCT02805257|593769428|FG001|Overall Study|Death|1|||
164381465|NCT00612066|593769429|FG000|Overall Study|Adverse Event|1|||
164381466|NCT01043874|593769433|FG000|Overall Study|Adverse Event|3|||
164381467|NCT01043874|593769433|FG000|Overall Study|Withdrawal by Subject|1|||
164381468|NCT01043874|593769433|FG000|Overall Study|Lack of Efficacy|1|||
164381469|NCT01043874|593769433|FG000|Overall Study|Administrative Problems|1|||
164381470|NCT01627249|593769434|FG000|Overall Study|Death|3|||
164381471|NCT01627249|593769435|FG001|Overall Study|Death|5|||
164381472|NCT01627249|593769436|FG002|Overall Study|Death|3|||
164381473|NCT01627249|593769434|FG000|Overall Study|Withdrawal by Subject|12|||
164381474|NCT01627249|593769435|FG001|Overall Study|Withdrawal by Subject|6|||
164381475|NCT01627249|593769436|FG002|Overall Study|Withdrawal by Subject|9|||
164381476|NCT01627249|593769434|FG000|Overall Study|Missed Visit|1|||
164381477|NCT01627249|593769435|FG001|Overall Study|Missed Visit|1|||
164381478|NCT01627249|593769436|FG002|Overall Study|Missed Visit|0|||
164381479|NCT03266588|593769437|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
164381480|NCT03266588|593769438|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
164381481|NCT03266588|593769439|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
164381482|NCT03266588|593769437|FG000|Observational Period|Withdrawal by Subject|44|||
164381483|NCT03266588|593769438|FG001|Observational Period|Withdrawal by Subject|22|||
164381484|NCT03266588|593769439|FG002|Observational Period|Withdrawal by Subject|13|||
164381485|NCT03266588|593769437|FG000|Observational Period|Non-compliance|18|||
164013770|NCT02417233|592414517|FG000|Overall Study|Relocation out of study area|1|||
164381486|NCT03266588|593769438|FG001|Observational Period|Non-compliance|12|||
164381487|NCT03266588|593769439|FG002|Observational Period|Non-compliance|10|||
164381488|NCT03266588|593769437|FG000|Observational Period|Lost to Follow-up|8|||
164381489|NCT03266588|593769438|FG001|Observational Period|Lost to Follow-up|12|||
164381490|NCT03266588|593769439|FG002|Observational Period|Lost to Follow-up|4|||
164381491|NCT03266588|593769437|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
164381492|NCT03266588|593769438|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
164381493|NCT03266588|593769439|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
164381494|NCT03266588|593769437|FG000|Observational Period|Protocol Deviation|1|||
164381495|NCT03266588|593769438|FG001|Observational Period|Protocol Deviation|0|||
164381496|NCT03266588|593769439|FG002|Observational Period|Protocol Deviation|0|||
164381497|NCT03266588|593769437|FG000|Observational Period|Other Reasons|3|||
164381498|NCT03266588|593769438|FG001|Observational Period|Other Reasons|0|||
164381499|NCT03266588|593769439|FG002|Observational Period|Other Reasons|1|||
164381500|NCT03266588|593769437|FG000|Long-term Treatment Period|Adverse Event|33|||
164381501|NCT03266588|593769438|FG001|Long-term Treatment Period|Adverse Event|17|||
164381502|NCT03266588|593769439|FG002|Long-term Treatment Period|Adverse Event|8|||
164381503|NCT03266588|593769437|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
164381504|NCT03266588|593769438|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
164381505|NCT03266588|593769439|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
164381506|NCT03266588|593769437|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
164381507|NCT03266588|593769438|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
164381508|NCT03266588|593769439|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
164381509|NCT03266588|593769437|FG000|Long-term Treatment Period|Non-Compliance|126|||
164381510|NCT03266588|593769438|FG001|Long-term Treatment Period|Non-Compliance|57|||
164381511|NCT03266588|593769439|FG002|Long-term Treatment Period|Non-Compliance|7|||
164381512|NCT03266588|593769437|FG000|Long-term Treatment Period|Pregnancy|11|||
164381513|NCT03266588|593769438|FG001|Long-term Treatment Period|Pregnancy|5|||
164381514|NCT03266588|593769439|FG002|Long-term Treatment Period|Pregnancy|0|||
164381515|NCT03266588|593769437|FG000|Long-term Treatment Period|Protocol Deviation|17|||
164381516|NCT03266588|593769438|FG001|Long-term Treatment Period|Protocol Deviation|10|||
164381517|NCT03266588|593769439|FG002|Long-term Treatment Period|Protocol Deviation|4|||
164381518|NCT03266588|593769437|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
164381519|NCT03266588|593769438|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
164381520|NCT03266588|593769439|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
164381521|NCT03266588|593769437|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
164381522|NCT03266588|593769438|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
164381523|NCT03266588|593769439|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
164381524|NCT03266588|593769437|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
164381525|NCT03266588|593769438|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
164381526|NCT03266588|593769439|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
164381527|NCT03266588|593769437|FG000|Long-term Treatment Period|Other Reasons|5|||
164381528|NCT03266588|593769438|FG001|Long-term Treatment Period|Other Reasons|0|||
164381529|NCT03266588|593769439|FG002|Long-term Treatment Period|Other Reasons|0|||
164381530|NCT03266588|593769437|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
164381531|NCT03266588|593769438|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
164381532|NCT03266588|593769439|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
164381533|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Adverse Event|5|||
164381534|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Adverse Event|8|||
164381535|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Adverse Event|4|||
164381536|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Adverse Event|8|||
164381537|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
164381538|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
164381539|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
164381540|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
164381541|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
164381542|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
164381543|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
164381544|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
164381545|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Physician Decision|1|||
164381546|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Physician Decision|0|||
164381547|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Physician Decision|0|||
164381548|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Physician Decision|0|||
164381549|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
164013771|NCT02417233|592414518|FG001|Overall Study|Relocation out of study area|0|||
164013772|NCT02417233|592414519|FG002|Overall Study|Relocation out of study area|1|||
164381550|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
164381551|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
164381552|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
164381553|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Pregnancy|0|||
164381554|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Pregnancy|1|||
164381555|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Pregnancy|0|||
164013773|NCT02417233|592414517|FG000|Overall Study|Mentally unstable|0|||
164013774|NCT02417233|592414518|FG001|Overall Study|Mentally unstable|1|||
164013775|NCT02417233|592414519|FG002|Overall Study|Mentally unstable|0|||
164013776|NCT03799718|592414527|FG000|Overall Study|Adverse Event|2|||
164013777|NCT01188798|592414528|FG000|Overall Study|Death|0|||
164013778|NCT01188798|592414529|FG001|Overall Study|Death|1|||
164013779|NCT01188798|592414528|FG000|Overall Study|Required additional transplant|1|||
164381556|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Pregnancy|0|||
164381557|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
164381558|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
164381559|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
164381560|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
164381561|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Death|0|||
164381562|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Death|1|||
164381563|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Death|0|||
164381564|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Death|0|||
164381565|NCT00071487|593769444|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
164381566|NCT00071487|593769445|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
164381567|NCT00071487|593769446|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
164381568|NCT00071487|593769447|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
164381569|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
164381570|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
164381571|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
164381572|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
164381573|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164381574|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164381575|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
164381576|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
164381577|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164381578|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164381579|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
164381580|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
164381581|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
164381582|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
164381583|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
164381584|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
164381585|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164381586|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164381587|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
164381588|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
164381589|NCT00071487|593769444|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164381590|NCT00071487|593769445|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164381591|NCT00071487|593769446|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
164381592|NCT00071487|593769447|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
164381593|NCT02696850|593769450|FG000|Overall Study|Withdrawal by Subject|3|||
164381594|NCT02696850|593769451|FG001|Overall Study|Withdrawal by Subject|3|||
164381595|NCT02696850|593769450|FG000|Overall Study|Lost to Follow-up|8|||
164381596|NCT02696850|593769451|FG001|Overall Study|Lost to Follow-up|5|||
164381597|NCT02044510|593769454|FG000|Overall Study|Adverse Event|1|||
164381598|NCT02044510|593769455|FG001|Overall Study|Adverse Event|2|||
164381599|NCT01933334|593769462|FG000|Overall Study|Adverse Event|5|||
164381600|NCT01933334|593769463|FG001|Overall Study|Adverse Event|1|||
164381601|NCT01933334|593769462|FG000|Overall Study|Withdrawal by Subject|0|||
164381602|NCT01933334|593769463|FG001|Overall Study|Withdrawal by Subject|1|||
164381603|NCT02039505|593769464|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
164381604|NCT02039505|593769465|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
164381605|NCT02039505|593769466|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
164013780|NCT01188798|592414529|FG001|Overall Study|Required additional transplant|1|||
164013781|NCT01188798|592414528|FG000|Overall Study|Protocol closure|1|||
164013782|NCT01188798|592414529|FG001|Overall Study|Protocol closure|1|||
164013783|NCT00700752|592414531|FG000|First Intervention|Withdrawal by Subject|0|||
164092925|NCT04557124|592703412|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
164092926|NCT04557124|592703413|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
164381606|NCT02039505|593769467|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164381607|NCT02039505|593769468|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164381608|NCT02039505|593769469|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164381609|NCT02039505|593769470|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
164013784|NCT00700752|592414532|FG001|First Intervention|Withdrawal by Subject|2|||
164092927|NCT04557124|592703412|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
164381610|NCT02039505|593769464|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
164381611|NCT02039505|593769465|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
164381612|NCT02039505|593769466|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
164381613|NCT02039505|593769467|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381614|NCT02039505|593769468|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381615|NCT02039505|593769469|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381616|NCT02039505|593769470|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
164381617|NCT02039505|593769464|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
164381618|NCT02039505|593769465|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381619|NCT02039505|593769466|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381620|NCT02039505|593769467|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381621|NCT02039505|593769468|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381622|NCT02039505|593769469|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381623|NCT02039505|593769470|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
164381624|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381625|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381626|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381627|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
164381628|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
164381629|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
164381630|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
164381631|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381632|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381633|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381634|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
164381635|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
164381636|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
164381637|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
164381638|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381639|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381640|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381641|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
164381642|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
164381643|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
164381644|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
164381645|NCT02039505|593769464|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381646|NCT02039505|593769465|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381647|NCT02039505|593769466|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381648|NCT02039505|593769467|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
164381649|NCT02039505|593769468|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381650|NCT02039505|593769469|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381651|NCT02039505|593769470|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
164381652|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381653|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381654|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381655|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381656|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381657|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
164381658|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
164381659|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381660|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381661|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381662|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381663|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381664|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
164381665|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
164381666|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381667|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381668|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381669|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381670|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381671|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
164381672|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
164381673|NCT02039505|593769464|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381674|NCT02039505|593769465|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381675|NCT02039505|593769466|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381676|NCT02039505|593769467|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381677|NCT02039505|593769468|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381678|NCT02039505|593769469|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
164381679|NCT02039505|593769470|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
164381680|NCT01722331|593769471|FG000|Part 1|Adverse Event|5|||
164381681|NCT01722331|593769472|FG001|Part 1|Adverse Event|0|||
164381682|NCT01722331|593769473|FG002|Part 1|Adverse Event|0|||
164381683|NCT01722331|593769474|FG003|Part 1|Adverse Event|0|||
164381684|NCT01722331|593769475|FG004|Part 1|Adverse Event|0|||
164381685|NCT01722331|593769476|FG005|Part 1|Adverse Event|0|||
164381686|NCT01722331|593769477|FG006|Part 1|Adverse Event|0|||
164381687|NCT01722331|593769471|FG000|Part 1|Lack of Efficacy|0|||
164381688|NCT01722331|593769472|FG001|Part 1|Lack of Efficacy|0|||
164381689|NCT01722331|593769473|FG002|Part 1|Lack of Efficacy|1|||
164381690|NCT01722331|593769474|FG003|Part 1|Lack of Efficacy|0|||
164381691|NCT01722331|593769475|FG004|Part 1|Lack of Efficacy|2|||
164381692|NCT01722331|593769476|FG005|Part 1|Lack of Efficacy|0|||
164381693|NCT01722331|593769477|FG006|Part 1|Lack of Efficacy|0|||
164381694|NCT01722331|593769471|FG000|Part 1|Lost to Follow-up|1|||
164381695|NCT01722331|593769472|FG001|Part 1|Lost to Follow-up|0|||
164381696|NCT01722331|593769473|FG002|Part 1|Lost to Follow-up|2|||
164381697|NCT01722331|593769474|FG003|Part 1|Lost to Follow-up|0|||
164381698|NCT01722331|593769475|FG004|Part 1|Lost to Follow-up|1|||
164381699|NCT01722331|593769476|FG005|Part 1|Lost to Follow-up|0|||
164381700|NCT01722331|593769477|FG006|Part 1|Lost to Follow-up|0|||
164381701|NCT01722331|593769471|FG000|Part 1|Physician Decision|0|||
164381702|NCT01722331|593769472|FG001|Part 1|Physician Decision|0|||
164381703|NCT01722331|593769473|FG002|Part 1|Physician Decision|3|||
164381704|NCT01722331|593769474|FG003|Part 1|Physician Decision|0|||
164381705|NCT01722331|593769475|FG004|Part 1|Physician Decision|1|||
164381706|NCT01722331|593769476|FG005|Part 1|Physician Decision|0|||
164381707|NCT01722331|593769477|FG006|Part 1|Physician Decision|0|||
164381708|NCT01722331|593769471|FG000|Part 1|Pregnancy|1|||
164381709|NCT01722331|593769472|FG001|Part 1|Pregnancy|0|||
164381710|NCT01722331|593769473|FG002|Part 1|Pregnancy|0|||
164381711|NCT01722331|593769474|FG003|Part 1|Pregnancy|0|||
164381712|NCT01722331|593769475|FG004|Part 1|Pregnancy|0|||
164381713|NCT01722331|593769476|FG005|Part 1|Pregnancy|0|||
164381714|NCT01722331|593769477|FG006|Part 1|Pregnancy|0|||
164381715|NCT01722331|593769471|FG000|Part 1|Progressive Disease|0|||
164381716|NCT01722331|593769472|FG001|Part 1|Progressive Disease|0|||
164381717|NCT01722331|593769473|FG002|Part 1|Progressive Disease|0|||
164381718|NCT01722331|593769474|FG003|Part 1|Progressive Disease|0|||
164381719|NCT01722331|593769475|FG004|Part 1|Progressive Disease|1|||
164381720|NCT01722331|593769476|FG005|Part 1|Progressive Disease|0|||
164381721|NCT01722331|593769477|FG006|Part 1|Progressive Disease|0|||
164381722|NCT01722331|593769471|FG000|Part 1|Protocol Violation|1|||
164381723|NCT01722331|593769472|FG001|Part 1|Protocol Violation|0|||
164013785|NCT03662334|592414533|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
164013786|NCT03662334|592414534|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
164381724|NCT01722331|593769473|FG002|Part 1|Protocol Violation|0|||
164381725|NCT01722331|593769474|FG003|Part 1|Protocol Violation|0|||
164381726|NCT01722331|593769475|FG004|Part 1|Protocol Violation|1|||
164381727|NCT01722331|593769476|FG005|Part 1|Protocol Violation|0|||
164381728|NCT01722331|593769477|FG006|Part 1|Protocol Violation|0|||
164381729|NCT01722331|593769471|FG000|Part 1|Withdrawal by Subject|2|||
164013787|NCT01097330|592414535|FG000|Overall Study|Study terminated early|7|||
164013788|NCT01097330|592414536|FG001|Overall Study|Study terminated early|5|||
164013789|NCT01024465|592414537|FG000|Overall Study|Adverse Event|2|||
164013790|NCT01024465|592414537|FG000|Overall Study|Physician Decision|1|||
164381730|NCT01722331|593769472|FG001|Part 1|Withdrawal by Subject|0|||
164381731|NCT01722331|593769473|FG002|Part 1|Withdrawal by Subject|3|||
164381732|NCT01722331|593769474|FG003|Part 1|Withdrawal by Subject|0|||
164381733|NCT01722331|593769475|FG004|Part 1|Withdrawal by Subject|3|||
164381734|NCT01722331|593769476|FG005|Part 1|Withdrawal by Subject|0|||
164013791|NCT03078608|592414539|FG000|Overall Study|Death|1|||
164381735|NCT01722331|593769477|FG006|Part 1|Withdrawal by Subject|0|||
164381736|NCT01722331|593769471|FG000|Part 2|Adverse Event|3|||
164381737|NCT01722331|593769472|FG001|Part 2|Adverse Event|0|||
164381738|NCT01722331|593769473|FG002|Part 2|Adverse Event|0|||
164381739|NCT01722331|593769474|FG003|Part 2|Adverse Event|0|||
164381740|NCT01722331|593769475|FG004|Part 2|Adverse Event|0|||
164381741|NCT01722331|593769476|FG005|Part 2|Adverse Event|1|||
164381742|NCT01722331|593769477|FG006|Part 2|Adverse Event|0|||
164381743|NCT01722331|593769471|FG000|Part 2|Lack of Efficacy|3|||
164381744|NCT01722331|593769472|FG001|Part 2|Lack of Efficacy|0|||
164381745|NCT01722331|593769473|FG002|Part 2|Lack of Efficacy|11|||
164381746|NCT01722331|593769474|FG003|Part 2|Lack of Efficacy|0|||
164381747|NCT01722331|593769475|FG004|Part 2|Lack of Efficacy|0|||
164381748|NCT01722331|593769476|FG005|Part 2|Lack of Efficacy|3|||
164381749|NCT01722331|593769477|FG006|Part 2|Lack of Efficacy|3|||
164381750|NCT01722331|593769471|FG000|Part 2|Lost to Follow-up|0|||
164381751|NCT01722331|593769472|FG001|Part 2|Lost to Follow-up|0|||
164381752|NCT01722331|593769473|FG002|Part 2|Lost to Follow-up|3|||
164381753|NCT01722331|593769474|FG003|Part 2|Lost to Follow-up|0|||
164381754|NCT01722331|593769475|FG004|Part 2|Lost to Follow-up|0|||
164381755|NCT01722331|593769476|FG005|Part 2|Lost to Follow-up|1|||
164381756|NCT01722331|593769477|FG006|Part 2|Lost to Follow-up|1|||
164381757|NCT01722331|593769471|FG000|Part 2|Non-Compliance with Study Drug|1|||
164381758|NCT01722331|593769472|FG001|Part 2|Non-Compliance with Study Drug|0|||
164381759|NCT01722331|593769473|FG002|Part 2|Non-Compliance with Study Drug|1|||
164381760|NCT01722331|593769474|FG003|Part 2|Non-Compliance with Study Drug|0|||
164381761|NCT01722331|593769475|FG004|Part 2|Non-Compliance with Study Drug|0|||
164381762|NCT01722331|593769476|FG005|Part 2|Non-Compliance with Study Drug|0|||
164381763|NCT01722331|593769477|FG006|Part 2|Non-Compliance with Study Drug|0|||
164381764|NCT01722331|593769471|FG000|Part 2|Physician Decision|0|||
164381765|NCT01722331|593769472|FG001|Part 2|Physician Decision|0|||
164381766|NCT01722331|593769473|FG002|Part 2|Physician Decision|2|||
164381767|NCT01722331|593769474|FG003|Part 2|Physician Decision|0|||
164381768|NCT01722331|593769475|FG004|Part 2|Physician Decision|0|||
164381769|NCT01722331|593769476|FG005|Part 2|Physician Decision|0|||
164381770|NCT01722331|593769477|FG006|Part 2|Physician Decision|0|||
164381771|NCT01722331|593769471|FG000|Part 2|Pregnancy|0|||
164381772|NCT01722331|593769472|FG001|Part 2|Pregnancy|0|||
164381773|NCT01722331|593769473|FG002|Part 2|Pregnancy|0|||
164381774|NCT01722331|593769474|FG003|Part 2|Pregnancy|0|||
164381775|NCT01722331|593769475|FG004|Part 2|Pregnancy|0|||
164381776|NCT01722331|593769476|FG005|Part 2|Pregnancy|1|||
164381777|NCT01722331|593769477|FG006|Part 2|Pregnancy|0|||
164381778|NCT01722331|593769471|FG000|Part 2|Progressive Disease|0|||
164381779|NCT01722331|593769472|FG001|Part 2|Progressive Disease|0|||
164381780|NCT01722331|593769473|FG002|Part 2|Progressive Disease|1|||
164381781|NCT01722331|593769474|FG003|Part 2|Progressive Disease|0|||
164381782|NCT01722331|593769475|FG004|Part 2|Progressive Disease|0|||
164381783|NCT01722331|593769476|FG005|Part 2|Progressive Disease|0|||
164381784|NCT01722331|593769477|FG006|Part 2|Progressive Disease|0|||
164381785|NCT01722331|593769471|FG000|Part 2|Protocol Violation|1|||
164381786|NCT01722331|593769472|FG001|Part 2|Protocol Violation|0|||
164381787|NCT01722331|593769473|FG002|Part 2|Protocol Violation|0|||
164381788|NCT01722331|593769474|FG003|Part 2|Protocol Violation|0|||
164381789|NCT01722331|593769475|FG004|Part 2|Protocol Violation|0|||
164381790|NCT01722331|593769476|FG005|Part 2|Protocol Violation|0|||
164381791|NCT01722331|593769477|FG006|Part 2|Protocol Violation|0|||
164381792|NCT01722331|593769471|FG000|Part 2|Withdrawal by Subject|5|||
164381793|NCT01722331|593769472|FG001|Part 2|Withdrawal by Subject|0|||
164381794|NCT01722331|593769473|FG002|Part 2|Withdrawal by Subject|3|||
164381795|NCT01722331|593769474|FG003|Part 2|Withdrawal by Subject|0|||
164381796|NCT01722331|593769475|FG004|Part 2|Withdrawal by Subject|0|||
164381797|NCT01722331|593769476|FG005|Part 2|Withdrawal by Subject|2|||
164381798|NCT01722331|593769477|FG006|Part 2|Withdrawal by Subject|2|||
164381799|NCT01722331|593769471|FG000|Part 2|Other Protocol Specified Criteria|6|||
164381800|NCT01722331|593769472|FG001|Part 2|Other Protocol Specified Criteria|0|||
164381801|NCT01722331|593769473|FG002|Part 2|Other Protocol Specified Criteria|10|||
164381802|NCT01722331|593769474|FG003|Part 2|Other Protocol Specified Criteria|0|||
164381803|NCT01722331|593769475|FG004|Part 2|Other Protocol Specified Criteria|0|||
164381804|NCT01722331|593769476|FG005|Part 2|Other Protocol Specified Criteria|2|||
164381805|NCT01722331|593769477|FG006|Part 2|Other Protocol Specified Criteria|1|||
164381806|NCT01722331|593769471|FG000|Part 3|Adverse Event|2|||
164381807|NCT01722331|593769472|FG001|Part 3|Adverse Event|2|||
164381808|NCT01722331|593769473|FG002|Part 3|Adverse Event|0|||
164381809|NCT01722331|593769474|FG003|Part 3|Adverse Event|1|||
164381810|NCT01722331|593769475|FG004|Part 3|Adverse Event|0|||
164381811|NCT01722331|593769476|FG005|Part 3|Adverse Event|0|||
164381812|NCT01722331|593769477|FG006|Part 3|Adverse Event|0|||
164381813|NCT01722331|593769471|FG000|Part 3|Death|1|||
164381814|NCT01722331|593769472|FG001|Part 3|Death|0|||
164381815|NCT01722331|593769473|FG002|Part 3|Death|0|||
164381816|NCT01722331|593769474|FG003|Part 3|Death|0|||
164381817|NCT01722331|593769475|FG004|Part 3|Death|0|||
164381818|NCT01722331|593769476|FG005|Part 3|Death|0|||
164381819|NCT01722331|593769477|FG006|Part 3|Death|0|||
164381820|NCT01722331|593769471|FG000|Part 3|Lack of Efficacy|1|||
164381821|NCT01722331|593769472|FG001|Part 3|Lack of Efficacy|0|||
164381822|NCT01722331|593769473|FG002|Part 3|Lack of Efficacy|0|||
164381823|NCT01722331|593769474|FG003|Part 3|Lack of Efficacy|0|||
164381824|NCT01722331|593769475|FG004|Part 3|Lack of Efficacy|0|||
164381825|NCT01722331|593769476|FG005|Part 3|Lack of Efficacy|0|||
164381826|NCT01722331|593769477|FG006|Part 3|Lack of Efficacy|0|||
164381827|NCT01722331|593769471|FG000|Part 3|Lost to Follow-up|3|||
164381828|NCT01722331|593769472|FG001|Part 3|Lost to Follow-up|4|||
164381829|NCT01722331|593769473|FG002|Part 3|Lost to Follow-up|0|||
164381830|NCT01722331|593769474|FG003|Part 3|Lost to Follow-up|0|||
164381831|NCT01722331|593769475|FG004|Part 3|Lost to Follow-up|0|||
164381832|NCT01722331|593769476|FG005|Part 3|Lost to Follow-up|1|||
164381833|NCT01722331|593769477|FG006|Part 3|Lost to Follow-up|0|||
164013792|NCT03078608|592414540|FG001|Overall Study|Death|2|||
164013793|NCT03078608|592414541|FG002|Overall Study|Death|0|||
164381834|NCT01722331|593769471|FG000|Part 3|Non-Compliance with Study Drug|0|||
164381835|NCT01722331|593769472|FG001|Part 3|Non-Compliance with Study Drug|1|||
164381836|NCT01722331|593769473|FG002|Part 3|Non-Compliance with Study Drug|0|||
164381837|NCT01722331|593769474|FG003|Part 3|Non-Compliance with Study Drug|0|||
164381838|NCT01722331|593769475|FG004|Part 3|Non-Compliance with Study Drug|0|||
164381839|NCT01722331|593769476|FG005|Part 3|Non-Compliance with Study Drug|0|||
164381840|NCT01722331|593769477|FG006|Part 3|Non-Compliance with Study Drug|0|||
164381841|NCT01722331|593769471|FG000|Part 3|Physician Decision|1|||
164381842|NCT01722331|593769472|FG001|Part 3|Physician Decision|1|||
164381843|NCT01722331|593769473|FG002|Part 3|Physician Decision|0|||
164381844|NCT01722331|593769474|FG003|Part 3|Physician Decision|0|||
164381845|NCT01722331|593769475|FG004|Part 3|Physician Decision|0|||
164381846|NCT01722331|593769476|FG005|Part 3|Physician Decision|0|||
164381847|NCT01722331|593769477|FG006|Part 3|Physician Decision|1|||
164381848|NCT01722331|593769471|FG000|Part 3|Protocol Violation|2|||
164381849|NCT01722331|593769472|FG001|Part 3|Protocol Violation|1|||
164381850|NCT01722331|593769473|FG002|Part 3|Protocol Violation|0|||
164381851|NCT01722331|593769474|FG003|Part 3|Protocol Violation|0|||
164381852|NCT01722331|593769475|FG004|Part 3|Protocol Violation|0|||
164381853|NCT01722331|593769476|FG005|Part 3|Protocol Violation|0|||
164381854|NCT01722331|593769477|FG006|Part 3|Protocol Violation|0|||
164381855|NCT01722331|593769471|FG000|Part 3|Withdrawal by Subject|4|||
164381856|NCT01722331|593769472|FG001|Part 3|Withdrawal by Subject|7|||
164381857|NCT01722331|593769473|FG002|Part 3|Withdrawal by Subject|0|||
164381858|NCT01722331|593769474|FG003|Part 3|Withdrawal by Subject|0|||
164381859|NCT01722331|593769475|FG004|Part 3|Withdrawal by Subject|0|||
164381860|NCT01722331|593769476|FG005|Part 3|Withdrawal by Subject|2|||
164381861|NCT01722331|593769477|FG006|Part 3|Withdrawal by Subject|1|||
164381862|NCT01722331|593769471|FG000|Part 3|Other Protocol Specified Criteria|1|||
164381863|NCT01722331|593769472|FG001|Part 3|Other Protocol Specified Criteria|1|||
164381864|NCT01722331|593769473|FG002|Part 3|Other Protocol Specified Criteria|0|||
164381865|NCT01722331|593769474|FG003|Part 3|Other Protocol Specified Criteria|0|||
164381866|NCT01722331|593769475|FG004|Part 3|Other Protocol Specified Criteria|0|||
164381867|NCT01722331|593769476|FG005|Part 3|Other Protocol Specified Criteria|0|||
164381868|NCT01722331|593769477|FG006|Part 3|Other Protocol Specified Criteria|0|||
164381869|NCT04265755|593769480|FG000|Overall Study|Withdrawal by Subject|39|||
164381870|NCT04265755|593769480|FG000|Overall Study|Decision by sponsor|2|||
164381871|NCT04265755|593769480|FG000|Overall Study|Lost to Follow-up|11|||
164381872|NCT04265755|593769480|FG000|Overall Study|Death|1|||
164381873|NCT04067141|593769483|FG000|First Intervention|Withdrawal by Subject|0|||
164381874|NCT04067141|593769484|FG001|First Intervention|Withdrawal by Subject|1|||
164381875|NCT04067141|593769483|FG000|Second Intervention|Adverse Event|0|||
164381876|NCT04067141|593769484|FG001|Second Intervention|Adverse Event|2|||
164381877|NCT02013765|593769487|FG000|Overall Study|Trial was terminated by sponsor|1|||
164381878|NCT02822794|593769489|FG000|Overall Study|Withdrew Consent|1|||
164381879|NCT02822794|593769490|FG001|Overall Study|Withdrew Consent|0|||
164381880|NCT04788147|593769491|FG000|Overall Study|Screen Failure|3|||
164381881|NCT04788147|593769492|FG001|Overall Study|Screen Failure|10|||
164381882|NCT04788147|593769491|FG000|Overall Study|Incomplete RMRS image session|2|||
164381883|NCT04788147|593769492|FG001|Overall Study|Incomplete RMRS image session|0|||
164381884|NCT02266381|593769493|FG000|Overall Study|Physician Decision|3|||
164381885|NCT02266381|593769494|FG001|Overall Study|Physician Decision|5|||
164381886|NCT02266381|593769495|FG002|Overall Study|Physician Decision|4|||
164381887|NCT05101252|593769496|FG000|Overall Study|Unsatisfactory Test Article|1|||
164381888|NCT05101252|593769497|FG001|Overall Study|Unsatisfactory Test Article|0|||
164381889|NCT05101252|593769496|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
164381890|NCT05101252|593769497|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
164381891|NCT05101252|593769496|FG000|Overall Study|Withdrew Consent during study|0|||
164381892|NCT05101252|593769497|FG001|Overall Study|Withdrew Consent during study|1|||
164381893|NCT05101252|593769496|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
164381894|NCT05101252|593769497|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
164381895|NCT02520531|593769504|FG000|Overall Study|Revision of study device components|2|||
164013794|NCT03078608|592414542|FG003|Overall Study|Death|0|||
164013795|NCT03078608|592414539|FG000|Overall Study|Withdrawal by Subject|8|||
164381896|NCT02520531|593769505|FG001|Overall Study|Revision of study device components|2|||
164381897|NCT02520531|593769504|FG000|Overall Study|Death|1|||
164381898|NCT02520531|593769505|FG001|Overall Study|Death|2|||
164381899|NCT02520531|593769504|FG000|Overall Study|Lost to Follow-up|1|||
164381900|NCT02520531|593769505|FG001|Overall Study|Lost to Follow-up|1|||
164381901|NCT02520531|593769504|FG000|Overall Study|Meet exclusion criterion|0|||
164381902|NCT02520531|593769505|FG001|Overall Study|Meet exclusion criterion|1|||
164381903|NCT02520531|593769504|FG000|Overall Study|Withdrawal by Subject|1|||
164381904|NCT02520531|593769505|FG001|Overall Study|Withdrawal by Subject|0|||
164381905|NCT02520531|593769504|FG000|Overall Study|Not study device|1|||
164381906|NCT02520531|593769505|FG001|Overall Study|Not study device|0|||
164381907|NCT00958880|593769515|FG000|Overall Study|Lost to Follow-up|2|||
164381908|NCT00958880|593769516|FG001|Overall Study|Lost to Follow-up|2|||
164381909|NCT02316717|593769519|FG000|Overall Study|Adverse Event|2|||
164381910|NCT02316717|593769520|FG001|Overall Study|Adverse Event|2|||
164381911|NCT02316717|593769521|FG002|Overall Study|Adverse Event|0|||
164381912|NCT02316717|593769519|FG000|Overall Study|Lost to Follow-up|1|||
164381913|NCT02316717|593769520|FG001|Overall Study|Lost to Follow-up|2|||
164381914|NCT02316717|593769521|FG002|Overall Study|Lost to Follow-up|1|||
164381915|NCT02316717|593769519|FG000|Overall Study|Non compliance|3|||
164381916|NCT02316717|593769520|FG001|Overall Study|Non compliance|1|||
164381917|NCT02316717|593769521|FG002|Overall Study|Non compliance|0|||
164381918|NCT02316717|593769519|FG000|Overall Study|Protocol Violation|2|||
164381919|NCT02316717|593769520|FG001|Overall Study|Protocol Violation|0|||
164381920|NCT02316717|593769521|FG002|Overall Study|Protocol Violation|0|||
164381921|NCT02316717|593769519|FG000|Overall Study|Withdrawal by Subject|2|||
164381922|NCT02316717|593769520|FG001|Overall Study|Withdrawal by Subject|1|||
164381923|NCT02316717|593769521|FG002|Overall Study|Withdrawal by Subject|1|||
164381924|NCT02316717|593769519|FG000|Overall Study|Death|0|||
164381925|NCT02316717|593769520|FG001|Overall Study|Death|0|||
164381926|NCT02316717|593769521|FG002|Overall Study|Death|1|||
164381927|NCT02316717|593769519|FG000|Overall Study|Physician Decision|0|||
164381928|NCT02316717|593769520|FG001|Overall Study|Physician Decision|1|||
164381929|NCT02316717|593769521|FG002|Overall Study|Physician Decision|0|||
164381930|NCT02316717|593769519|FG000|Overall Study|TBC|1|||
164381931|NCT02316717|593769520|FG001|Overall Study|TBC|0|||
164381932|NCT02316717|593769521|FG002|Overall Study|TBC|0|||
164381933|NCT00298831|593769522|FG000|Overall Study|Adverse Event|1|||
164381934|NCT00298831|593769522|FG000|Overall Study|Lost to Follow-up|3|||
164381935|NCT00298831|593769522|FG000|Overall Study|Withdrawal by Subject|1|||
164381936|NCT00298831|593769522|FG000|Overall Study|Participants did not receive treatment|27|||
164381937|NCT01516879|593769523|FG000|Overall Study|Withdrawal by Subject|9|||
164381938|NCT01516879|593769524|FG001|Overall Study|Withdrawal by Subject|11|||
164381939|NCT01516879|593769523|FG000|Overall Study|Death|0|||
164381940|NCT01516879|593769524|FG001|Overall Study|Death|2|||
164381941|NCT01516879|593769523|FG000|Overall Study|Lost to Follow-up|2|||
164381942|NCT01516879|593769524|FG001|Overall Study|Lost to Follow-up|11|||
164381943|NCT01516879|593769523|FG000|Overall Study|Other|5|||
164381944|NCT01516879|593769524|FG001|Overall Study|Other|10|||
164381945|NCT04568122|593769525|FG000|Overall Study|Lost to Follow-up|48|||
164381946|NCT04568122|593769526|FG001|Overall Study|Lost to Follow-up|44|||
164381947|NCT04568122|593769527|FG002|Overall Study|Lost to Follow-up|4|||
164381948|NCT04568122|593769528|FG003|Overall Study|Lost to Follow-up|0|||
164381949|NCT04568122|593769529|FG004|Overall Study|Lost to Follow-up|0|||
164381950|NCT02460224|593769535|FG000|Overall Study|Adverse Event|0|||
164381951|NCT02460224|593769536|FG001|Overall Study|Adverse Event|0|||
164381952|NCT02460224|593769537|FG002|Overall Study|Adverse Event|0|||
164381953|NCT02460224|593769538|FG003|Overall Study|Adverse Event|0|||
164381954|NCT02460224|593769539|FG004|Overall Study|Adverse Event|0|||
164381955|NCT02460224|593769540|FG005|Overall Study|Adverse Event|0|||
164381956|NCT02460224|593769541|FG006|Overall Study|Adverse Event|1|||
164381957|NCT02460224|593769542|FG007|Overall Study|Adverse Event|0|||
164381958|NCT02460224|593769543|FG008|Overall Study|Adverse Event|0|||
164381959|NCT02460224|593769544|FG009|Overall Study|Adverse Event|0|||
164381960|NCT02460224|593769545|FG010|Overall Study|Adverse Event|0|||
164381961|NCT02460224|593769546|FG011|Overall Study|Adverse Event|0|||
164381962|NCT02460224|593769547|FG012|Overall Study|Adverse Event|1|||
164381963|NCT02460224|593769548|FG013|Overall Study|Adverse Event|0|||
164381964|NCT02460224|593769549|FG014|Overall Study|Adverse Event|0|||
164381965|NCT02460224|593769550|FG015|Overall Study|Adverse Event|0|||
164381966|NCT02460224|593769551|FG016|Overall Study|Adverse Event|1|||
164381967|NCT02460224|593769552|FG017|Overall Study|Adverse Event|0|||
164381968|NCT02460224|593769553|FG018|Overall Study|Adverse Event|1|||
164381969|NCT02460224|593769554|FG019|Overall Study|Adverse Event|0|||
164381970|NCT02460224|593769555|FG020|Overall Study|Adverse Event|1|||
164381971|NCT02460224|593769556|FG021|Overall Study|Adverse Event|1|||
164381972|NCT02460224|593769557|FG022|Overall Study|Adverse Event|1|||
164381973|NCT02460224|593769558|FG023|Overall Study|Adverse Event|0|||
164381974|NCT02460224|593769559|FG024|Overall Study|Adverse Event|0|||
164381975|NCT02460224|593769560|FG025|Overall Study|Adverse Event|0|||
164381976|NCT02460224|593769561|FG026|Overall Study|Adverse Event|11|||
164381977|NCT02460224|593769562|FG027|Overall Study|Adverse Event|1|||
164381978|NCT02460224|593769563|FG028|Overall Study|Adverse Event|6|||
164381979|NCT02460224|593769535|FG000|Overall Study|Death|0|||
164381980|NCT02460224|593769536|FG001|Overall Study|Death|0|||
164381981|NCT02460224|593769537|FG002|Overall Study|Death|0|||
164381982|NCT02460224|593769538|FG003|Overall Study|Death|0|||
164013796|NCT03078608|592414540|FG001|Overall Study|Withdrawal by Subject|1|||
164381983|NCT02460224|593769539|FG004|Overall Study|Death|0|||
164381984|NCT02460224|593769540|FG005|Overall Study|Death|2|||
164381985|NCT02460224|593769541|FG006|Overall Study|Death|1|||
164381986|NCT02460224|593769542|FG007|Overall Study|Death|0|||
164381987|NCT02460224|593769543|FG008|Overall Study|Death|0|||
164381988|NCT02460224|593769544|FG009|Overall Study|Death|1|||
164013797|NCT03078608|592414541|FG002|Overall Study|Withdrawal by Subject|0|||
164013798|NCT03078608|592414542|FG003|Overall Study|Withdrawal by Subject|0|||
164013799|NCT03078608|592414539|FG000|Overall Study|Lost to Follow-up|5|||
164013800|NCT03078608|592414540|FG001|Overall Study|Lost to Follow-up|8|||
164013801|NCT03078608|592414541|FG002|Overall Study|Lost to Follow-up|4|||
164013802|NCT03078608|592414542|FG003|Overall Study|Lost to Follow-up|1|||
164381989|NCT02460224|593769545|FG010|Overall Study|Death|0|||
164381990|NCT02460224|593769546|FG011|Overall Study|Death|0|||
164381991|NCT02460224|593769547|FG012|Overall Study|Death|0|||
164381992|NCT02460224|593769548|FG013|Overall Study|Death|1|||
164381993|NCT02460224|593769549|FG014|Overall Study|Death|0|||
164381994|NCT02460224|593769550|FG015|Overall Study|Death|0|||
164381995|NCT02460224|593769551|FG016|Overall Study|Death|2|||
164381996|NCT02460224|593769552|FG017|Overall Study|Death|1|||
164381997|NCT02460224|593769553|FG018|Overall Study|Death|0|||
164381998|NCT02460224|593769554|FG019|Overall Study|Death|2|||
164381999|NCT02460224|593769555|FG020|Overall Study|Death|0|||
164382000|NCT02460224|593769556|FG021|Overall Study|Death|0|||
164382001|NCT02460224|593769557|FG022|Overall Study|Death|0|||
164382002|NCT02460224|593769558|FG023|Overall Study|Death|0|||
164382003|NCT02460224|593769559|FG024|Overall Study|Death|1|||
164382004|NCT02460224|593769560|FG025|Overall Study|Death|1|||
164382005|NCT02460224|593769561|FG026|Overall Study|Death|5|||
164382006|NCT02460224|593769562|FG027|Overall Study|Death|0|||
164382007|NCT02460224|593769563|FG028|Overall Study|Death|1|||
164382008|NCT02460224|593769535|FG000|Overall Study|Lost to Follow-up|0|||
164382009|NCT02460224|593769536|FG001|Overall Study|Lost to Follow-up|0|||
164382010|NCT02460224|593769537|FG002|Overall Study|Lost to Follow-up|0|||
164382011|NCT02460224|593769538|FG003|Overall Study|Lost to Follow-up|0|||
164382012|NCT02460224|593769539|FG004|Overall Study|Lost to Follow-up|0|||
164382013|NCT02460224|593769540|FG005|Overall Study|Lost to Follow-up|0|||
164382014|NCT02460224|593769541|FG006|Overall Study|Lost to Follow-up|0|||
164382015|NCT02460224|593769542|FG007|Overall Study|Lost to Follow-up|0|||
164382016|NCT02460224|593769543|FG008|Overall Study|Lost to Follow-up|0|||
164382017|NCT02460224|593769544|FG009|Overall Study|Lost to Follow-up|0|||
164382018|NCT02460224|593769545|FG010|Overall Study|Lost to Follow-up|0|||
164382019|NCT02460224|593769546|FG011|Overall Study|Lost to Follow-up|0|||
164382020|NCT02460224|593769547|FG012|Overall Study|Lost to Follow-up|0|||
164382021|NCT02460224|593769548|FG013|Overall Study|Lost to Follow-up|0|||
164382022|NCT02460224|593769549|FG014|Overall Study|Lost to Follow-up|0|||
164382023|NCT02460224|593769550|FG015|Overall Study|Lost to Follow-up|0|||
164382024|NCT02460224|593769551|FG016|Overall Study|Lost to Follow-up|0|||
164382025|NCT02460224|593769552|FG017|Overall Study|Lost to Follow-up|0|||
164382026|NCT02460224|593769553|FG018|Overall Study|Lost to Follow-up|0|||
164382027|NCT02460224|593769554|FG019|Overall Study|Lost to Follow-up|0|||
164382028|NCT02460224|593769555|FG020|Overall Study|Lost to Follow-up|0|||
164382029|NCT02460224|593769556|FG021|Overall Study|Lost to Follow-up|0|||
164382030|NCT02460224|593769557|FG022|Overall Study|Lost to Follow-up|1|||
164382031|NCT02460224|593769558|FG023|Overall Study|Lost to Follow-up|0|||
164382032|NCT02460224|593769559|FG024|Overall Study|Lost to Follow-up|0|||
164382033|NCT02460224|593769560|FG025|Overall Study|Lost to Follow-up|0|||
164382034|NCT02460224|593769561|FG026|Overall Study|Lost to Follow-up|0|||
164382035|NCT02460224|593769562|FG027|Overall Study|Lost to Follow-up|0|||
164382036|NCT02460224|593769563|FG028|Overall Study|Lost to Follow-up|0|||
164382037|NCT02460224|593769535|FG000|Overall Study|Physician Decision|0|||
164382038|NCT02460224|593769536|FG001|Overall Study|Physician Decision|1|||
164382039|NCT02460224|593769537|FG002|Overall Study|Physician Decision|0|||
164382040|NCT02460224|593769538|FG003|Overall Study|Physician Decision|0|||
164382041|NCT02460224|593769539|FG004|Overall Study|Physician Decision|1|||
164382042|NCT02460224|593769540|FG005|Overall Study|Physician Decision|0|||
164382043|NCT02460224|593769541|FG006|Overall Study|Physician Decision|0|||
164382044|NCT02460224|593769542|FG007|Overall Study|Physician Decision|1|||
164382045|NCT02460224|593769543|FG008|Overall Study|Physician Decision|0|||
164382046|NCT02460224|593769544|FG009|Overall Study|Physician Decision|0|||
164382047|NCT02460224|593769545|FG010|Overall Study|Physician Decision|0|||
163903034|NCT03425682|592014811|FG000|Overall Study|Subject did not meet I/E|4|||
163903035|NCT03425682|592014812|FG001|Overall Study|Subject did not meet I/E|10|||
164382048|NCT02460224|593769546|FG011|Overall Study|Physician Decision|1|||
164382049|NCT02460224|593769547|FG012|Overall Study|Physician Decision|0|||
164382050|NCT02460224|593769548|FG013|Overall Study|Physician Decision|1|||
164382051|NCT02460224|593769549|FG014|Overall Study|Physician Decision|0|||
164382052|NCT02460224|593769550|FG015|Overall Study|Physician Decision|0|||
164382053|NCT02460224|593769551|FG016|Overall Study|Physician Decision|2|||
164382054|NCT02460224|593769552|FG017|Overall Study|Physician Decision|1|||
164382055|NCT02460224|593769553|FG018|Overall Study|Physician Decision|1|||
164382056|NCT02460224|593769554|FG019|Overall Study|Physician Decision|2|||
164382057|NCT02460224|593769555|FG020|Overall Study|Physician Decision|1|||
164382058|NCT02460224|593769556|FG021|Overall Study|Physician Decision|1|||
164382059|NCT02460224|593769557|FG022|Overall Study|Physician Decision|0|||
164382060|NCT02460224|593769558|FG023|Overall Study|Physician Decision|0|||
164382061|NCT02460224|593769559|FG024|Overall Study|Physician Decision|1|||
164382062|NCT02460224|593769560|FG025|Overall Study|Physician Decision|0|||
164382063|NCT02460224|593769561|FG026|Overall Study|Physician Decision|14|||
164382064|NCT02460224|593769562|FG027|Overall Study|Physician Decision|1|||
164382065|NCT02460224|593769563|FG028|Overall Study|Physician Decision|6|||
164382066|NCT02460224|593769535|FG000|Overall Study|Progressive disease|15|||
164382067|NCT02460224|593769536|FG001|Overall Study|Progressive disease|11|||
164382068|NCT02460224|593769537|FG002|Overall Study|Progressive disease|5|||
164382069|NCT02460224|593769538|FG003|Overall Study|Progressive disease|6|||
164382070|NCT02460224|593769539|FG004|Overall Study|Progressive disease|3|||
164382071|NCT02460224|593769540|FG005|Overall Study|Progressive disease|26|||
164382072|NCT02460224|593769541|FG006|Overall Study|Progressive disease|28|||
164382073|NCT02460224|593769542|FG007|Overall Study|Progressive disease|4|||
164382074|NCT02460224|593769543|FG008|Overall Study|Progressive disease|5|||
164382075|NCT02460224|593769544|FG009|Overall Study|Progressive disease|9|||
164382076|NCT02460224|593769545|FG010|Overall Study|Progressive disease|5|||
164382077|NCT02460224|593769546|FG011|Overall Study|Progressive disease|4|||
164382078|NCT02460224|593769547|FG012|Overall Study|Progressive disease|5|||
164382079|NCT02460224|593769548|FG013|Overall Study|Progressive disease|4|||
164382080|NCT02460224|593769549|FG014|Overall Study|Progressive disease|5|||
164382081|NCT02460224|593769550|FG015|Overall Study|Progressive disease|5|||
164382082|NCT02460224|593769551|FG016|Overall Study|Progressive disease|15|||
164382083|NCT02460224|593769552|FG017|Overall Study|Progressive disease|3|||
164382084|NCT02460224|593769553|FG018|Overall Study|Progressive disease|8|||
164382085|NCT02460224|593769554|FG019|Overall Study|Progressive disease|3|||
164382086|NCT02460224|593769555|FG020|Overall Study|Progressive disease|4|||
164382087|NCT02460224|593769556|FG021|Overall Study|Progressive disease|9|||
164382088|NCT02460224|593769557|FG022|Overall Study|Progressive disease|4|||
164382089|NCT02460224|593769558|FG023|Overall Study|Progressive disease|11|||
163903036|NCT03835754|592014813|FG000|Overall Study|Death|4|||
164382090|NCT02460224|593769559|FG024|Overall Study|Progressive disease|4|||
164382091|NCT02460224|593769560|FG025|Overall Study|Progressive disease|5|||
164382092|NCT02460224|593769561|FG026|Overall Study|Progressive disease|85|||
164382093|NCT02460224|593769562|FG027|Overall Study|Progressive disease|17|||
164382094|NCT02460224|593769563|FG028|Overall Study|Progressive disease|77|||
164382095|NCT02460224|593769535|FG000|Overall Study|Subject/guardian decision|2|||
164382096|NCT02460224|593769536|FG001|Overall Study|Subject/guardian decision|0|||
164382097|NCT02460224|593769537|FG002|Overall Study|Subject/guardian decision|1|||
164382098|NCT02460224|593769538|FG003|Overall Study|Subject/guardian decision|0|||
164382099|NCT02460224|593769539|FG004|Overall Study|Subject/guardian decision|2|||
164382100|NCT02460224|593769540|FG005|Overall Study|Subject/guardian decision|2|||
164382101|NCT02460224|593769541|FG006|Overall Study|Subject/guardian decision|0|||
163903037|NCT05810285|592014814|FG000|Overall Study|Death|4|||
164382102|NCT02460224|593769542|FG007|Overall Study|Subject/guardian decision|0|||
164382103|NCT02460224|593769543|FG008|Overall Study|Subject/guardian decision|1|||
164382104|NCT02460224|593769544|FG009|Overall Study|Subject/guardian decision|1|||
164382105|NCT02460224|593769545|FG010|Overall Study|Subject/guardian decision|0|||
164382106|NCT02460224|593769546|FG011|Overall Study|Subject/guardian decision|1|||
164382107|NCT02460224|593769547|FG012|Overall Study|Subject/guardian decision|0|||
164382108|NCT02460224|593769548|FG013|Overall Study|Subject/guardian decision|0|||
164382109|NCT02460224|593769549|FG014|Overall Study|Subject/guardian decision|0|||
164382110|NCT02460224|593769550|FG015|Overall Study|Subject/guardian decision|1|||
164382111|NCT02460224|593769551|FG016|Overall Study|Subject/guardian decision|0|||
164382112|NCT02460224|593769552|FG017|Overall Study|Subject/guardian decision|1|||
164382113|NCT02460224|593769553|FG018|Overall Study|Subject/guardian decision|2|||
164382114|NCT02460224|593769554|FG019|Overall Study|Subject/guardian decision|0|||
164382115|NCT02460224|593769555|FG020|Overall Study|Subject/guardian decision|0|||
164382116|NCT02460224|593769556|FG021|Overall Study|Subject/guardian decision|1|||
164382117|NCT02460224|593769557|FG022|Overall Study|Subject/guardian decision|0|||
164382118|NCT02460224|593769558|FG023|Overall Study|Subject/guardian decision|0|||
164382119|NCT02460224|593769559|FG024|Overall Study|Subject/guardian decision|0|||
164382120|NCT02460224|593769560|FG025|Overall Study|Subject/guardian decision|0|||
164382121|NCT02460224|593769561|FG026|Overall Study|Subject/guardian decision|6|||
164382122|NCT02460224|593769562|FG027|Overall Study|Subject/guardian decision|2|||
164382123|NCT02460224|593769563|FG028|Overall Study|Subject/guardian decision|3|||
164382124|NCT01916304|593769564|FG000|Overall Study|Screening failure|17|||
164382125|NCT02774681|593769571|FG000|Treatment on Study|Progressive Disease|7|||
164382126|NCT02774681|593769571|FG000|Follow-Up for 3 Years|Death|11|||
164382127|NCT02774681|593769571|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
164382128|NCT03146650|593769576|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
164382129|NCT03146650|593769576|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
164382130|NCT03146650|593769576|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
164382131|NCT03146650|593769576|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
164382132|NCT03146650|593769576|FG000|2 Year Follow-up|Death|11|||
164382133|NCT03146650|593769576|FG000|2 Year Follow-up|Still in follow-up|7|||
164382134|NCT03146650|593769576|FG000|2 Year Follow-up|Lost to Follow-up|1|||
164382135|NCT00931307|593769577|FG000|Overall Study|Lack of Efficacy|12|||
164382136|NCT00931307|593769577|FG000|Overall Study|Biomicroscopy|1|||
164382137|NCT04666441|593769578|FG000|Overall Study|Lost to Follow-up|1|||
164382138|NCT04666441|593769579|FG001|Overall Study|Lost to Follow-up|4|||
164382139|NCT04666441|593769580|FG002|Overall Study|Lost to Follow-up|1|||
164382140|NCT04666441|593769581|FG003|Overall Study|Lost to Follow-up|3|||
164382141|NCT04666441|593769582|FG004|Overall Study|Lost to Follow-up|0|||
164382142|NCT04666441|593769583|FG005|Overall Study|Lost to Follow-up|2|||
164382143|NCT04666441|593769584|FG006|Overall Study|Lost to Follow-up|2|||
164382144|NCT04666441|593769585|FG007|Overall Study|Lost to Follow-up|2|||
164382145|NCT04666441|593769578|FG000|Overall Study|Subject Decision|1|||
164382146|NCT04666441|593769579|FG001|Overall Study|Subject Decision|1|||
164382147|NCT04666441|593769580|FG002|Overall Study|Subject Decision|3|||
164382148|NCT04666441|593769581|FG003|Overall Study|Subject Decision|1|||
164382149|NCT04666441|593769582|FG004|Overall Study|Subject Decision|0|||
164382150|NCT04666441|593769583|FG005|Overall Study|Subject Decision|1|||
164382151|NCT04666441|593769584|FG006|Overall Study|Subject Decision|3|||
164382152|NCT04666441|593769585|FG007|Overall Study|Subject Decision|2|||
164382153|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
164382154|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
164382155|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
164382156|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
164382157|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
164382158|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
164382159|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
164382160|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
164382161|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
164382162|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
164382163|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
164382164|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
164382165|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
164382166|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
164382167|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
164382168|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
164382169|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
164382170|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
164382171|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
164382172|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
164382173|NCT00813761|593769586|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
164382174|NCT00813761|593769587|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
164382175|NCT00813761|593769588|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
164382176|NCT00813761|593769589|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
164382177|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
164382178|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
164382179|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
164382180|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
164382181|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
164382182|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
164382183|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
164382184|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
164382185|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
164382186|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
164382187|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
164382188|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
164382189|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
164382190|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
164382191|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
164382192|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
164382193|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
164382194|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
164382195|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
164382196|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
164382197|NCT00813761|593769586|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
164382198|NCT00813761|593769587|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
164382199|NCT00813761|593769588|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
164382200|NCT00813761|593769589|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
164382201|NCT02047604|593769594|FG000|Overall Study|Withdrawal by Subject|0|||
164382202|NCT02047604|593769595|FG001|Overall Study|Withdrawal by Subject|0|||
164382203|NCT02047604|593769596|FG002|Overall Study|Withdrawal by Subject|0|||
164382204|NCT02047604|593769597|FG003|Overall Study|Withdrawal by Subject|0|||
164382205|NCT02047604|593769598|FG004|Overall Study|Withdrawal by Subject|1|||
164382206|NCT02047604|593769599|FG005|Overall Study|Withdrawal by Subject|1|||
164382207|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
164382208|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
164382209|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
164382210|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
164382211|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
164382212|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
164382213|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
164382214|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
164382215|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
164382216|NCT00983814|593769600|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
164382217|NCT00983814|593769601|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
164382218|NCT00983814|593769602|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
164382219|NCT00983814|593769600|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
164382220|NCT00983814|593769601|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
164382221|NCT00983814|593769602|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
164382222|NCT01181895|593769603|FG000|Overall Study|Adverse Event|3|||
164382223|NCT01181895|593769604|FG001|Overall Study|Adverse Event|1|||
164382224|NCT01181895|593769605|FG002|Overall Study|Adverse Event|1|||
164382225|NCT01181895|593769603|FG000|Overall Study|Lack of Efficacy|8|||
164382226|NCT01181895|593769604|FG001|Overall Study|Lack of Efficacy|9|||
164382227|NCT01181895|593769605|FG002|Overall Study|Lack of Efficacy|9|||
164382228|NCT01181895|593769603|FG000|Overall Study|Protocol Violation|2|||
164382229|NCT01181895|593769604|FG001|Overall Study|Protocol Violation|1|||
164382230|NCT01181895|593769605|FG002|Overall Study|Protocol Violation|0|||
164382231|NCT01181895|593769603|FG000|Overall Study|Lost to Follow-up|0|||
164382232|NCT01181895|593769604|FG001|Overall Study|Lost to Follow-up|1|||
164382233|NCT01181895|593769605|FG002|Overall Study|Lost to Follow-up|2|||
164382234|NCT01181895|593769603|FG000|Overall Study|Investigator Discretion|1|||
164382235|NCT01181895|593769604|FG001|Overall Study|Investigator Discretion|2|||
164382236|NCT01181895|593769605|FG002|Overall Study|Investigator Discretion|1|||
164382237|NCT01181895|593769603|FG000|Overall Study|Withdrawal by Subject|3|||
164382238|NCT01181895|593769604|FG001|Overall Study|Withdrawal by Subject|0|||
164382239|NCT01181895|593769605|FG002|Overall Study|Withdrawal by Subject|5|||
164382240|NCT00555438|593769606|FG000|10 Days Post-operative|Death|4|||
164382241|NCT00555438|593769606|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
164382242|NCT00766415|593769607|FG000|Overall Study|Withdrawal by Subject|0|||
164382243|NCT00766415|593769608|FG001|Overall Study|Withdrawal by Subject|1|||
164382244|NCT01114516|593769609|FG000|Overall Study|Lost to Follow-up|2|||
164382245|NCT01114516|593769610|FG001|Overall Study|Lost to Follow-up|1|||
164382246|NCT03136068|593771130|FG000|Overall Study|Lost to Follow-up|1|||
164382247|NCT03136068|593771131|FG001|Overall Study|Lost to Follow-up|1|||
164382248|NCT03136068|593771130|FG000|Overall Study|Protocol Violation|1|||
164382249|NCT03136068|593771131|FG001|Overall Study|Protocol Violation|0|||
164382250|NCT00432380|593771132|FG000|Overall Study|Migrated/moved from study area|3|||
164382251|NCT00432380|593771133|FG001|Overall Study|Migrated/moved from study area|4|||
164382252|NCT00432380|593771134|FG002|Overall Study|Migrated/moved from study area|1|||
164382253|NCT00432380|593771132|FG000|Overall Study|Adverse Event|1|||
164382254|NCT00432380|593771133|FG001|Overall Study|Adverse Event|0|||
164382255|NCT00432380|593771134|FG002|Overall Study|Adverse Event|0|||
164382256|NCT01071395|593771135|FG000|Overall Study|Withdrawal by Subject|2|||
164382257|NCT01071395|593771136|FG001|Overall Study|Withdrawal by Subject|1|||
164382258|NCT01071395|593771135|FG000|Overall Study|Adverse Event|3|||
164382259|NCT01071395|593771136|FG001|Overall Study|Adverse Event|1|||
164382260|NCT04419493|593771137|FG000|Wash-out After Period 1|Adverse Event|1|||
164382261|NCT04419493|593771138|FG001|Wash-out After Period 1|Adverse Event|2|||
164382262|NCT04419493|593771139|FG002|Wash-out After Period 1|Adverse Event|1|||
164382263|NCT04419493|593771140|FG003|Wash-out After Period 1|Adverse Event|0|||
164382264|NCT00524134|593771141|FG000|Overall Study|Withdrawal by Subject|1|||
164382265|NCT00524134|593771141|FG000|Overall Study|Physician Decision|1|||
164382266|NCT03794089|593771142|FG000|Overall Study|Lost to Follow-up|4|||
164382267|NCT03794089|593771143|FG001|Overall Study|Lost to Follow-up|1|||
164382268|NCT03794089|593771142|FG000|Overall Study|Withdrawal by Subject|2|||
164382269|NCT03794089|593771143|FG001|Overall Study|Withdrawal by Subject|0|||
164382270|NCT03985423|593771144|FG000|Overall Study|Adverse Event|1|||
164382271|NCT03985423|593771144|FG000|Overall Study|Death|2|||
164382272|NCT03985423|593771144|FG000|Overall Study|Physician Decision|1|||
164382273|NCT03985423|593771144|FG000|Overall Study|Withdrawal by Subject|2|||
164382274|NCT03985423|593771144|FG000|Overall Study|Lack of insurance and citizenship|1|||
164382275|NCT01045447|593771155|FG000|Overall Study|Adverse Event|0|||
164382276|NCT01045447|593771156|FG001|Overall Study|Adverse Event|1|||
164382277|NCT01045447|593771155|FG000|Overall Study|Lack of Efficacy|3|||
164382278|NCT01045447|593771156|FG001|Overall Study|Lack of Efficacy|1|||
164382279|NCT01045447|593771155|FG000|Overall Study|Protocol Violation|6|||
164382280|NCT01045447|593771156|FG001|Overall Study|Protocol Violation|3|||
164382281|NCT01045447|593771155|FG000|Overall Study|Withdrawal Criteria|10|||
164382282|NCT01045447|593771156|FG001|Overall Study|Withdrawal Criteria|10|||
164382283|NCT01045447|593771155|FG000|Overall Study|Unclassified|17|||
164382284|NCT01045447|593771156|FG001|Overall Study|Unclassified|13|||
164382285|NCT01782131|593771160|FG000|Overall Study|Death|93|||
164382286|NCT01782131|593771161|FG001|Overall Study|Death|96|||
164382287|NCT01782131|593771160|FG000|Overall Study|Lost to Follow-up|1|||
164382288|NCT01782131|593771161|FG001|Overall Study|Lost to Follow-up|3|||
164382289|NCT01782131|593771160|FG000|Overall Study|Withdrawal by Subject|10|||
164382290|NCT01782131|593771161|FG001|Overall Study|Withdrawal by Subject|10|||
164382291|NCT01782131|593771160|FG000|Overall Study|Randomized but not treated|5|||
164382292|NCT01782131|593771161|FG001|Overall Study|Randomized but not treated|5|||
164382293|NCT01782131|593771160|FG000|Overall Study|Reason not provided|0|||
164382294|NCT01782131|593771161|FG001|Overall Study|Reason not provided|1|||
164382295|NCT00796718|593771162|FG000|Overall Study|Adverse Event|2|||
164382296|NCT00796718|593771162|FG000|Overall Study|Exclusion Criteria|1|||
164382297|NCT00796718|593771162|FG000|Overall Study|Lost to Follow-up|5|||
164382298|NCT00796718|593771162|FG000|Overall Study|Withdrawal by Informed Consent|1|||
164382299|NCT01073618|593771163|FG000|Overall Study|Death|208|||
164382300|NCT01073618|593771163|FG000|Overall Study|Adverse Event|19|||
164382301|NCT01073618|593771163|FG000|Overall Study|Other|80|||
164382302|NCT00353704|593771175|FG000|Overall Study|Protocol Violation|3|||
164382303|NCT00353704|593771176|FG001|Overall Study|Protocol Violation|1|||
164382304|NCT02807948|593771177|FG000|Overall Study|Physician Decision|1|||
164382305|NCT02807948|593771178|FG001|Overall Study|Physician Decision|0|||
164382306|NCT03727750|593771179|FG000|Overall Study|Death|45|||
164382307|NCT03727750|593771179|FG000|Overall Study|Withdrawal by Subject|2|||
164382308|NCT03727750|593771179|FG000|Overall Study|Lost to Follow-up|1|||
164382309|NCT03727750|593771179|FG000|Overall Study|Other|1|||
164382310|NCT01154166|593771180|FG000|Overall Study|Adverse Event|14|||
164382311|NCT01154166|593771181|FG001|Overall Study|Adverse Event|9|||
164382312|NCT01154166|593771180|FG000|Overall Study|Lost to Follow-up|1|||
164382313|NCT01154166|593771181|FG001|Overall Study|Lost to Follow-up|1|||
164382314|NCT01154166|593771180|FG000|Overall Study|Protocol Violation|4|||
164382315|NCT01154166|593771181|FG001|Overall Study|Protocol Violation|1|||
164382316|NCT01154166|593771180|FG000|Overall Study|Withdrawal by Subject|10|||
164092928|NCT04557124|592703413|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
164382317|NCT01154166|593771181|FG001|Overall Study|Withdrawal by Subject|1|||
164382318|NCT01154166|593771180|FG000|Overall Study|Lack of Efficacy|3|||
164382319|NCT01154166|593771181|FG001|Overall Study|Lack of Efficacy|0|||
164382320|NCT01154166|593771180|FG000|Overall Study|Disease Progression|1|||
164382321|NCT01154166|593771181|FG001|Overall Study|Disease Progression|0|||
164382322|NCT01154166|593771180|FG000|Overall Study|Poor Compliance|1|||
164382323|NCT01154166|593771181|FG001|Overall Study|Poor Compliance|0|||
164382324|NCT03614793|593771182|FG000|Overall Study|Lost to Follow-up|1|||
164382325|NCT03614793|593771183|FG001|Overall Study|Lost to Follow-up|2|||
164382326|NCT03614793|593771182|FG000|Overall Study|Lack of Efficacy|0|||
164382327|NCT03614793|593771183|FG001|Overall Study|Lack of Efficacy|5|||
164382328|NCT03614793|593771182|FG000|Overall Study|Withdrawal by Subject|0|||
164382329|NCT03614793|593771183|FG001|Overall Study|Withdrawal by Subject|1|||
164382330|NCT03614793|593771182|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
164382331|NCT03614793|593771183|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
164382332|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
164382333|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
164382334|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
164382335|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Death|1|||
164382336|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
164382337|NCT02840877|593771184|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
164382338|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
164382339|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Treatment failure|1|||
164382340|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
164382341|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
164382342|NCT02840877|593771184|FG000|12 Weeks to 6 Months|Death|1|||
164382343|NCT02840877|593771184|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
164382344|NCT02840877|593771184|FG000|6 Months to 18 Months|Treatment failure|7|||
164382345|NCT02840877|593771184|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
164382346|NCT02840877|593771184|FG000|6 Months to 18 Months|Moved/transferred out|6|||
164382347|NCT02840877|593771184|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
164382348|NCT02840877|593771184|FG000|6 Months to 18 Months|Death|4|||
164382349|NCT02840877|593771184|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
164382350|NCT02840877|593771184|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
164382351|NCT02840877|593771184|FG000|6 Months to 18 Months|Still in study.|14|||
164382352|NCT04317586|593771185|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
164382353|NCT04317586|593771185|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
164382354|NCT01276327|593771188|FG000|Overall Study|Adverse Event|1|||
164382355|NCT01276327|593771189|FG001|Overall Study|Adverse Event|3|||
164382356|NCT01276327|593771188|FG000|Overall Study|Withdrawal by Subject|1|||
164382357|NCT01276327|593771189|FG001|Overall Study|Withdrawal by Subject|0|||
164382358|NCT00807092|593771190|FG000|Overall Study|Adverse Event|0|||
164382359|NCT00807092|593771191|FG001|Overall Study|Adverse Event|1|||
164382360|NCT00807092|593771190|FG000|Overall Study|Protocol Violation|0|||
164382361|NCT00807092|593771191|FG001|Overall Study|Protocol Violation|2|||
164382362|NCT00807092|593771190|FG000|Overall Study|Withdrawal by Subject|1|||
164382363|NCT00807092|593771191|FG001|Overall Study|Withdrawal by Subject|0|||
164382364|NCT00807092|593771190|FG000|Overall Study|CGMS data collection failed|0|||
164382365|NCT00807092|593771191|FG001|Overall Study|CGMS data collection failed|1|||
164382366|NCT01794949|593771192|FG000|Overall Study|Lost to Follow-up|1|||
164382367|NCT01794949|593771193|FG001|Overall Study|Lost to Follow-up|0|||
164382368|NCT03003676|593771194|FG000|Overall Study|Lack of Efficacy|5|||
164382369|NCT03003676|593771195|FG001|Overall Study|Lack of Efficacy|7|||
164382370|NCT03003676|593771194|FG000|Overall Study|Withdrawal by Subject|0|||
164382371|NCT03003676|593771195|FG001|Overall Study|Withdrawal by Subject|1|||
164382372|NCT03003676|593771194|FG000|Overall Study|Hepatitis B infection|1|||
164382373|NCT03003676|593771195|FG001|Overall Study|Hepatitis B infection|0|||
164382374|NCT02530619|593771210|FG000|Registered for Study|Withdrawal by Subject|2|||
164382375|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
164382376|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
164382377|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
164382378|NCT02530619|593771210|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
164382379|NCT02530619|593771210|FG000|Follow-up Period (6 Months)|Death|4|||
164382380|NCT02530619|593771210|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
164382381|NCT02530619|593771210|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
164013803|NCT00723840|592414543|FG000|Overall Study|Lost to Follow-up|2|||
164382382|NCT00359762|593771222|FG000|Period II|Adverse Event|17|||
164382383|NCT00359762|593771223|FG001|Period II|Adverse Event|0|||
164382384|NCT00359762|593771224|FG002|Period II|Adverse Event|0|||
164382385|NCT00359762|593771225|FG003|Period II|Adverse Event|0|||
164382386|NCT00359762|593771226|FG004|Period II|Adverse Event|49|||
164382387|NCT00359762|593771222|FG000|Period II|Protocol Violation|18|||
164382388|NCT00359762|593771223|FG001|Period II|Protocol Violation|0|||
164382389|NCT00359762|593771224|FG002|Period II|Protocol Violation|0|||
164382390|NCT00359762|593771225|FG003|Period II|Protocol Violation|0|||
164382391|NCT00359762|593771226|FG004|Period II|Protocol Violation|11|||
164382392|NCT00359762|593771222|FG000|Period II|Physician Decision|17|||
164382393|NCT00359762|593771223|FG001|Period II|Physician Decision|0|||
164382394|NCT00359762|593771224|FG002|Period II|Physician Decision|0|||
164382395|NCT00359762|593771225|FG003|Period II|Physician Decision|0|||
164382396|NCT00359762|593771226|FG004|Period II|Physician Decision|23|||
164382397|NCT00359762|593771222|FG000|Period II|Death|2|||
164382398|NCT00359762|593771223|FG001|Period II|Death|0|||
164382399|NCT00359762|593771224|FG002|Period II|Death|0|||
164382400|NCT00359762|593771225|FG003|Period II|Death|0|||
164013804|NCT00723840|592414543|FG000|Overall Study|Failure to return|18|||
164013805|NCT00723840|592414543|FG000|Overall Study|Withdrawal by Subject|55|||
164013806|NCT00723840|592414543|FG000|Overall Study|Serious Adverse Events|3|||
164013807|NCT00723840|592414543|FG000|Overall Study|Other Medical Event|2|||
164382401|NCT00359762|593771226|FG004|Period II|Death|4|||
164382402|NCT00359762|593771222|FG000|Period II|Lack of Efficacy|11|||
164382403|NCT00359762|593771223|FG001|Period II|Lack of Efficacy|0|||
164382404|NCT00359762|593771224|FG002|Period II|Lack of Efficacy|0|||
164382405|NCT00359762|593771225|FG003|Period II|Lack of Efficacy|0|||
164382406|NCT00359762|593771226|FG004|Period II|Lack of Efficacy|8|||
164382407|NCT00359762|593771222|FG000|Period II|Lost to follow up|5|||
164382408|NCT00359762|593771223|FG001|Period II|Lost to follow up|0|||
164382409|NCT00359762|593771224|FG002|Period II|Lost to follow up|0|||
164382410|NCT00359762|593771225|FG003|Period II|Lost to follow up|0|||
164382411|NCT00359762|593771226|FG004|Period II|Lost to follow up|5|||
164382412|NCT00359762|593771222|FG000|Period II|Entry Criteria Not Met|8|||
164382413|NCT00359762|593771223|FG001|Period II|Entry Criteria Not Met|0|||
164382414|NCT00359762|593771224|FG002|Period II|Entry Criteria Not Met|0|||
164382415|NCT00359762|593771225|FG003|Period II|Entry Criteria Not Met|0|||
164382416|NCT00359762|593771226|FG004|Period II|Entry Criteria Not Met|4|||
164382417|NCT00359762|593771222|FG000|Period II|Subject Decision|50|||
164382418|NCT00359762|593771223|FG001|Period II|Subject Decision|0|||
164382419|NCT00359762|593771224|FG002|Period II|Subject Decision|0|||
164382420|NCT00359762|593771225|FG003|Period II|Subject Decision|0|||
164382421|NCT00359762|593771226|FG004|Period II|Subject Decision|70|||
164382422|NCT00359762|593771222|FG000|Period III|Protocol Violation|0|||
164382423|NCT00359762|593771223|FG001|Period III|Protocol Violation|5|||
164382424|NCT00359762|593771224|FG002|Period III|Protocol Violation|3|||
164382425|NCT00359762|593771225|FG003|Period III|Protocol Violation|8|||
164382426|NCT00359762|593771226|FG004|Period III|Protocol Violation|0|||
164382427|NCT00359762|593771222|FG000|Period III|Adverse Event|0|||
164382428|NCT00359762|593771223|FG001|Period III|Adverse Event|3|||
164382429|NCT00359762|593771224|FG002|Period III|Adverse Event|4|||
164382430|NCT00359762|593771225|FG003|Period III|Adverse Event|10|||
164382431|NCT00359762|593771226|FG004|Period III|Adverse Event|0|||
164382432|NCT00359762|593771222|FG000|Period III|Physician Decision|0|||
164382433|NCT00359762|593771223|FG001|Period III|Physician Decision|5|||
164382434|NCT00359762|593771224|FG002|Period III|Physician Decision|9|||
164382435|NCT00359762|593771225|FG003|Period III|Physician Decision|15|||
164382436|NCT00359762|593771226|FG004|Period III|Physician Decision|0|||
164382437|NCT00359762|593771222|FG000|Period III|Lack of Efficacy|0|||
164382438|NCT00359762|593771223|FG001|Period III|Lack of Efficacy|7|||
164382439|NCT00359762|593771224|FG002|Period III|Lack of Efficacy|5|||
164013808|NCT00723840|592414543|FG000|Overall Study|Unspecified reason|2|||
164382440|NCT00359762|593771225|FG003|Period III|Lack of Efficacy|9|||
164382441|NCT00359762|593771226|FG004|Period III|Lack of Efficacy|0|||
164382442|NCT00359762|593771222|FG000|Period III|Lost to follow up|0|||
164382443|NCT00359762|593771223|FG001|Period III|Lost to follow up|1|||
164382444|NCT00359762|593771224|FG002|Period III|Lost to follow up|1|||
164382445|NCT00359762|593771225|FG003|Period III|Lost to follow up|2|||
164382446|NCT00359762|593771226|FG004|Period III|Lost to follow up|0|||
164382447|NCT00359762|593771222|FG000|Period III|Entry Criteria Not Met|0|||
164382448|NCT00359762|593771223|FG001|Period III|Entry Criteria Not Met|1|||
164382449|NCT00359762|593771224|FG002|Period III|Entry Criteria Not Met|0|||
164382450|NCT00359762|593771225|FG003|Period III|Entry Criteria Not Met|1|||
164382451|NCT00359762|593771226|FG004|Period III|Entry Criteria Not Met|0|||
164382452|NCT00359762|593771222|FG000|Period III|Subject Decision|0|||
164382453|NCT00359762|593771223|FG001|Period III|Subject Decision|7|||
164382454|NCT00359762|593771224|FG002|Period III|Subject Decision|8|||
164382455|NCT00359762|593771225|FG003|Period III|Subject Decision|20|||
164382456|NCT00359762|593771226|FG004|Period III|Subject Decision|0|||
164382457|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
164382458|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
164382459|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
164382460|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382461|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382462|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382463|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382464|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382465|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
164382466|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
164382467|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
164382468|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
164382469|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382470|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382471|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382472|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382473|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164382474|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
164092929|NCT00442936|592703414|FG000|Overall Study|Protocol Violation|1|||
164382475|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382476|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
164382477|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
164382478|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382479|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382480|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164013809|NCT02760407|592414555|FG000|Overall Study|Death|2|||
164013810|NCT02760407|592414556|FG001|Overall Study|Death|3|||
164013811|NCT02760407|592414557|FG002|Overall Study|Death|1|||
164013812|NCT02760407|592414558|FG003|Overall Study|Death|1|||
164013813|NCT02760407|592414555|FG000|Overall Study|Lost to Follow-up|1|||
164013814|NCT02760407|592414556|FG001|Overall Study|Lost to Follow-up|7|||
164013815|NCT02760407|592414557|FG002|Overall Study|Lost to Follow-up|4|||
164013816|NCT02760407|592414558|FG003|Overall Study|Lost to Follow-up|6|||
164013817|NCT02760407|592414555|FG000|Overall Study|Withdrawal by Subject|25|||
164013818|NCT02760407|592414556|FG001|Overall Study|Withdrawal by Subject|31|||
164013819|NCT02760407|592414557|FG002|Overall Study|Withdrawal by Subject|37|||
164013820|NCT02760407|592414558|FG003|Overall Study|Withdrawal by Subject|25|||
164013821|NCT02760407|592414555|FG000|Overall Study|Violation of Eligibility criteria|0|||
164013822|NCT02760407|592414556|FG001|Overall Study|Violation of Eligibility criteria|0|||
164013823|NCT02760407|592414557|FG002|Overall Study|Violation of Eligibility criteria|1|||
164013824|NCT02760407|592414558|FG003|Overall Study|Violation of Eligibility criteria|1|||
164013825|NCT02760407|592414555|FG000|Overall Study|Personal reasons|0|||
164013826|NCT02760407|592414556|FG001|Overall Study|Personal reasons|0|||
164013827|NCT02760407|592414557|FG002|Overall Study|Personal reasons|0|||
164013828|NCT02760407|592414558|FG003|Overall Study|Personal reasons|1|||
164013829|NCT02760407|592414555|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
164013830|NCT02760407|592414556|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
164013831|NCT02760407|592414557|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
164013832|NCT02760407|592414558|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
164013833|NCT02760407|592414555|FG000|Overall Study|Use of prohibited Medication|0|||
164013834|NCT02760407|592414556|FG001|Overall Study|Use of prohibited Medication|0|||
164013835|NCT02760407|592414557|FG002|Overall Study|Use of prohibited Medication|1|||
164013836|NCT02760407|592414558|FG003|Overall Study|Use of prohibited Medication|0|||
164013837|NCT02760407|592414555|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
164013838|NCT02760407|592414556|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
164013839|NCT02760407|592414557|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
164013840|NCT02760407|592414558|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
164013841|NCT02760407|592414555|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
164013842|NCT02760407|592414556|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
164013843|NCT02760407|592414557|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
164013844|NCT02760407|592414558|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
164013845|NCT02760407|592414555|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
164013846|NCT02760407|592414556|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
164013847|NCT02760407|592414557|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
164013848|NCT02760407|592414558|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
164013849|NCT02760407|592414555|FG000|Overall Study|Inadequately Enrolled|0|||
164382481|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382482|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382483|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
164382484|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
164382485|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
164382486|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
164382487|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382488|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382489|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382490|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382491|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382492|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
164382493|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382494|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
164382495|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
164013850|NCT02760407|592414556|FG001|Overall Study|Inadequately Enrolled|0|||
164382496|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382497|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382498|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382499|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382500|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
164013851|NCT02760407|592414557|FG002|Overall Study|Inadequately Enrolled|0|||
164013852|NCT02760407|592414558|FG003|Overall Study|Inadequately Enrolled|1|||
164013853|NCT02760407|592414555|FG000|Overall Study|Withdrawal By PI's Decision|0|||
164013854|NCT02760407|592414556|FG001|Overall Study|Withdrawal By PI's Decision|1|||
164382501|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
164382502|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
164013855|NCT02760407|592414557|FG002|Overall Study|Withdrawal By PI's Decision|0|||
164013856|NCT02760407|592414558|FG003|Overall Study|Withdrawal By PI's Decision|0|||
164013857|NCT02760407|592414555|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
164382503|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382504|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382505|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382506|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382507|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382508|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382509|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382510|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
164382511|NCT01172938|593771227|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382512|NCT01172938|593771228|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
164382513|NCT01172938|593771229|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
164382514|NCT01172938|593771230|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382515|NCT01172938|593771231|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382516|NCT01172938|593771232|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382517|NCT01172938|593771233|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382518|NCT01172938|593771234|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382519|NCT01172938|593771235|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
164382520|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164382521|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
164382522|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
164382523|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
164382524|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
164382525|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
164382526|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164013858|NCT02760407|592414556|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
164013859|NCT02760407|592414557|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
164013860|NCT02760407|592414558|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
164013861|NCT02760407|592414555|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
164013862|NCT02760407|592414556|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
164382527|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164382528|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
164382529|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382530|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
164382531|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
164382532|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
164382533|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
164382534|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
164382535|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382536|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382537|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
164382538|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382539|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382540|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
164382541|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382542|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382543|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382544|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164013863|NCT02760407|592414557|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
164013864|NCT02760407|592414558|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
164072999|NCT01408576|592632757|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164382545|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382546|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
164382547|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
164382548|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
164382549|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
164382550|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
164382551|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
164382552|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
164382553|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
164382554|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
164382555|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
164382556|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382557|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
164382558|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
164382559|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
164382560|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382561|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382562|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382563|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382564|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
164382565|NCT01172938|593771227|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382566|NCT01172938|593771228|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382567|NCT01172938|593771229|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382568|NCT01172938|593771230|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382569|NCT01172938|593771231|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382570|NCT01172938|593771232|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
164382571|NCT01172938|593771233|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
164382572|NCT01172938|593771234|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382573|NCT01172938|593771235|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
164382574|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382575|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
164382576|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
164382577|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382578|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382579|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382580|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
164382581|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
164382582|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
164382583|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382584|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
164382585|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
164382586|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382587|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382588|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382589|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382590|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
164382591|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
164382592|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382593|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382594|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
164382595|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382596|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382597|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382598|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382599|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382600|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
164382601|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382602|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
164382603|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
164382604|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382605|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
163903038|NCT05810285|592014815|FG001|Overall Study|Death|21|||
163903039|NCT05810285|592014814|FG000|Overall Study|Adverse Event|18|||
163903040|NCT05810285|592014815|FG001|Overall Study|Adverse Event|16|||
163903041|NCT00345046|592015874|FG000|Overall Study|Protocol Violation|1|||
163903042|NCT00345046|592015875|FG001|Overall Study|Protocol Violation|1|||
163903043|NCT00345046|592015876|FG002|Overall Study|Protocol Violation|2|||
163903044|NCT02157116|592015883|FG000|Overall Study|Withdrawal by Subject|4|||
163903045|NCT02157116|592015883|FG000|Overall Study|Physician Decision|3|||
163903046|NCT02157116|592015883|FG000|Overall Study|Failed Screening|2|||
164382606|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382607|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
164382608|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
164382609|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
164382610|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382611|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382612|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
164382613|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382614|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382615|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382616|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382617|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382618|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
164382619|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382620|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
164382621|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
164382622|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382623|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382624|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382625|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382626|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
164382627|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
164382628|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382629|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
164382630|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382631|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382632|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382633|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382634|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382635|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
164382636|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
164382637|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382638|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
164382639|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382640|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382641|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382642|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382643|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382644|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382645|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
164382646|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382647|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382648|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382649|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382650|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382651|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382652|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382653|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
164382654|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
164382655|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382656|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
164382657|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
164382658|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382659|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382660|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382661|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
164382662|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
164382663|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
164382664|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
163903047|NCT02463448|592015884|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
163903048|NCT02463448|592015884|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
164382665|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
164382666|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
164382667|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382668|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382669|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382670|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
164382671|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
164382672|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
164382673|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382674|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382675|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382676|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382677|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382678|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382679|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382680|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
164382681|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
164382682|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382683|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
164382684|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382685|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382686|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382687|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382688|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382689|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382690|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
164382691|NCT01172938|593771227|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382692|NCT01172938|593771228|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382693|NCT01172938|593771229|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
164382694|NCT01172938|593771230|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382695|NCT01172938|593771231|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382696|NCT01172938|593771232|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382697|NCT01172938|593771233|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382698|NCT01172938|593771234|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382699|NCT01172938|593771235|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
164382700|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382701|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
164382702|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
164382703|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382704|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382705|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382706|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382707|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
164382708|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
164382709|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382710|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
164382711|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
164382712|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382713|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382714|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382715|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
164382716|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
164382717|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
164382718|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382719|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
164382720|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
164013865|NCT02760407|592414555|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
164013866|NCT02760407|592414556|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
164013867|NCT02760407|592414557|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
164013868|NCT02760407|592414558|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
164013869|NCT02760407|592414555|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
164013870|NCT02760407|592414556|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
164013871|NCT02760407|592414557|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
164013872|NCT02760407|592414558|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
164073000|NCT01408576|592632758|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164382721|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382722|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382723|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382724|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
164382725|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
164382726|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
164382727|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382728|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382729|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
164382730|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382731|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382732|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382733|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382734|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
164382735|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
164382736|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382737|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382738|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382739|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382740|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382741|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382742|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382743|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
164382744|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
164382745|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382746|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382747|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
164382748|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382749|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382750|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
164382751|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
163903049|NCT02463448|592015884|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
163903050|NCT02463448|592015884|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
163903051|NCT01728324|592015885|FG000|Termination of DBV|Adverse Event|14|||
163903052|NCT01728324|592015886|FG001|Termination of DBV|Adverse Event|13|||
163903053|NCT01728324|592015887|FG002|Termination of DBV|Adverse Event|4|||
163903054|NCT01728324|592015885|FG000|Termination of DBV|Lack of Efficacy|14|||
163903055|NCT01728324|592015886|FG001|Termination of DBV|Lack of Efficacy|12|||
163903056|NCT01728324|592015887|FG002|Termination of DBV|Lack of Efficacy|8|||
163903057|NCT01728324|592015885|FG000|Termination of DBV|Withdrawal by Subject|9|||
163903058|NCT01728324|592015886|FG001|Termination of DBV|Withdrawal by Subject|6|||
163903059|NCT01728324|592015887|FG002|Termination of DBV|Withdrawal by Subject|2|||
163903060|NCT01728324|592015885|FG000|Termination of DBV|Other than stated|1|||
163903061|NCT01728324|592015886|FG001|Termination of DBV|Other than stated|3|||
163903062|NCT01728324|592015887|FG002|Termination of DBV|Other than stated|0|||
163903063|NCT01728324|592015885|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
163903064|NCT01728324|592015886|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
163903065|NCT01728324|592015887|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
163903066|NCT01728324|592015885|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
164092930|NCT00442936|592703415|FG001|Overall Study|Protocol Violation|0|||
164382752|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
164382753|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
164382754|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382755|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382756|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
164382757|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382758|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382759|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382760|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382761|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382762|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
164382763|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382764|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
164382765|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382766|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
163903067|NCT01728324|592015886|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
164092931|NCT00442936|592703416|FG002|Overall Study|Protocol Violation|1|||
164382767|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382768|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382769|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382770|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
164382771|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
164382772|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382773|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
164382774|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
164382775|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382776|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382777|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382778|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382779|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
164382780|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
164382781|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382782|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382783|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
164382784|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382785|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382786|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382787|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382788|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382789|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
164382790|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382791|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382792|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
164382793|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382794|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382795|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382796|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382797|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382798|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
164382799|NCT01172938|593771227|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382800|NCT01172938|593771228|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382801|NCT01172938|593771229|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382802|NCT01172938|593771230|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382803|NCT01172938|593771231|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382804|NCT01172938|593771232|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382805|NCT01172938|593771233|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382806|NCT01172938|593771234|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
164382807|NCT01172938|593771235|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
164382808|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
164382809|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
164382810|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
164382811|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
164382812|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
164382813|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
164382814|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
164382815|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
164382816|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
164382817|NCT00403546|593771239|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
164382818|NCT00403546|593771240|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
164382819|NCT00403546|593771241|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
164013873|NCT02760407|592414555|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
164013874|NCT02760407|592414556|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
164013875|NCT02760407|592414557|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
164013876|NCT02760407|592414558|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
164013877|NCT02760407|592414555|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
164013878|NCT02760407|592414556|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
164382820|NCT00403546|593771239|FG000|Screening Phase|Screening Failure|22|||
164382821|NCT00403546|593771240|FG001|Screening Phase|Screening Failure|0|||
164382822|NCT00403546|593771241|FG002|Screening Phase|Screening Failure|0|||
164382823|NCT00403546|593771239|FG000|Screening Phase|Adverse Event|1|||
164382824|NCT00403546|593771240|FG001|Screening Phase|Adverse Event|0|||
164382825|NCT00403546|593771241|FG002|Screening Phase|Adverse Event|0|||
164382826|NCT00403546|593771239|FG000|Screening Phase|Terminated Prior to Randomization|5|||
164382827|NCT00403546|593771240|FG001|Screening Phase|Terminated Prior to Randomization|0|||
164382828|NCT00403546|593771241|FG002|Screening Phase|Terminated Prior to Randomization|0|||
164382829|NCT00403546|593771239|FG000|Randomized Trial|Early Terminations|0|||
164382830|NCT00403546|593771240|FG001|Randomized Trial|Early Terminations|17|||
164382831|NCT00403546|593771241|FG002|Randomized Trial|Early Terminations|16|||
164382832|NCT00793910|593771242|FG000|Overall Study|discarded study pills|0|||
164382833|NCT00793910|593771243|FG001|Overall Study|discarded study pills|1|||
164382834|NCT00793910|593771242|FG000|Overall Study|did not pick up medications|1|||
164382835|NCT00793910|593771243|FG001|Overall Study|did not pick up medications|1|||
164382836|NCT00793910|593771242|FG000|Overall Study|ineligible based on entry criteria|2|||
164382837|NCT00793910|593771243|FG001|Overall Study|ineligible based on entry criteria|3|||
164382838|NCT00793910|593771242|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
164382839|NCT00793910|593771243|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
164382840|NCT00793910|593771242|FG000|Overall Study|Withdrawal by Subject|0|||
164382841|NCT00793910|593771243|FG001|Overall Study|Withdrawal by Subject|1|||
164382842|NCT03634579|593771244|FG000|Overall Study|study termination|9|||
164382843|NCT05061446|593771245|FG000|Overall Study|Adverse Event|2|||
164382844|NCT05061446|593771246|FG001|Overall Study|Adverse Event|0|||
164382845|NCT05061446|593771247|FG002|Overall Study|Adverse Event|0|||
164382846|NCT05061446|593771245|FG000|Overall Study|Participant no longer available due to personal reason|0|||
164382847|NCT05061446|593771246|FG001|Overall Study|Participant no longer available due to personal reason|1|||
164382848|NCT05061446|593771247|FG002|Overall Study|Participant no longer available due to personal reason|0|||
164382849|NCT04111497|593771248|FG000|Overall Study|relapse of primary disease|1|||
164382850|NCT04111497|593771248|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
164382851|NCT01993719|593771251|FG000|First Drug Administration|Not treated|1|||
164382852|NCT01993719|593771252|FG001|First Drug Administration|Not treated|0|||
164382853|NCT01993719|593771253|FG002|First Drug Administration|Not treated|0|||
164382854|NCT01993719|593771254|FG003|First Drug Administration|Not treated|0|||
164382855|NCT01993719|593771255|FG004|First Drug Administration|Not treated|0|||
164382856|NCT02799082|593771256|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
164382857|NCT02799082|593771257|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
164382858|NCT02799082|593771256|FG000|Overall Study|Protocol Violation|0|||
164382859|NCT02799082|593771257|FG001|Overall Study|Protocol Violation|1|||
164382860|NCT01723904|593771262|FG000|Overall Study|Noncompliant|3|||
164382861|NCT01723904|593771262|FG000|Overall Study|Adverse Event|5|||
164382862|NCT01723904|593771262|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
164382863|NCT02617589|593771265|FG000|Randomization|Request to Discontinue Study Treatment|1|||
164382864|NCT02617589|593771266|FG001|Randomization|Request to Discontinue Study Treatment|3|||
164382865|NCT02617589|593771265|FG000|Randomization|Participant Withdrew Consent|1|||
164382866|NCT02617589|593771266|FG001|Randomization|Participant Withdrew Consent|2|||
164382867|NCT02617589|593771265|FG000|Treatment|Other Reasons|3|||
164382868|NCT02617589|593771266|FG001|Treatment|Other Reasons|3|||
164382869|NCT02617589|593771265|FG000|Treatment|Poor/Non Compliance|1|||
164382870|NCT02617589|593771266|FG001|Treatment|Poor/Non Compliance|1|||
164382871|NCT02617589|593771265|FG000|Treatment|Maximum Clinical Benefit|0|||
164382872|NCT02617589|593771266|FG001|Treatment|Maximum Clinical Benefit|2|||
164382873|NCT02617589|593771265|FG000|Treatment|Participant Withdrew Consent|2|||
164382874|NCT02617589|593771266|FG001|Treatment|Participant Withdrew Consent|6|||
164382875|NCT02617589|593771265|FG000|Treatment|Participant Request to Discontinue|12|||
164382876|NCT02617589|593771266|FG001|Treatment|Participant Request to Discontinue|21|||
164382877|NCT02617589|593771265|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
164382878|NCT02617589|593771266|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
164382879|NCT02617589|593771265|FG000|Treatment|Death|1|||
164382880|NCT02617589|593771266|FG001|Treatment|Death|1|||
164382881|NCT02617589|593771265|FG000|Treatment|Study Drug Toxicity|27|||
164382882|NCT02617589|593771266|FG001|Treatment|Study Drug Toxicity|20|||
163903068|NCT01728324|592015887|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
163903069|NCT01728324|592015885|FG000|Termination of FDV|Adverse Event|14|||
164382883|NCT02617589|593771265|FG000|Treatment|Disease Progression|216|||
164382884|NCT02617589|593771266|FG001|Treatment|Disease Progression|136|||
164382885|NCT01752933|593771267|FG000|Treatment|Disease Progression|3|||
163903070|NCT01728324|592015886|FG001|Termination of FDV|Adverse Event|13|||
163903071|NCT01728324|592015887|FG002|Termination of FDV|Adverse Event|4|||
163903072|NCT01728324|592015885|FG000|Termination of FDV|Lack of Efficacy|14|||
164382886|NCT01752933|593771268|FG001|Treatment|Disease Progression|29|||
164382887|NCT01752933|593771267|FG000|Treatment|Withdrawal by Subject|0|||
164382888|NCT01752933|593771268|FG001|Treatment|Withdrawal by Subject|5|||
164382889|NCT01752933|593771267|FG000|Treatment|Adverse Event|1|||
164382890|NCT01752933|593771268|FG001|Treatment|Adverse Event|4|||
164382891|NCT01752933|593771267|FG000|Treatment|Physician Decision|0|||
164382892|NCT01752933|593771268|FG001|Treatment|Physician Decision|3|||
164382893|NCT01752933|593771267|FG000|Treatment|Death|0|||
164382894|NCT01752933|593771268|FG001|Treatment|Death|2|||
164382895|NCT01752933|593771267|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
164382896|NCT01752933|593771268|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
164382897|NCT01752933|593771267|FG000|Treatment|Patient noncompliant|0|||
164382898|NCT01752933|593771268|FG001|Treatment|Patient noncompliant|1|||
164382899|NCT01752933|593771267|FG000|Treatment|Patient unable to travel to appointments|0|||
164382900|NCT01752933|593771268|FG001|Treatment|Patient unable to travel to appointments|1|||
164382901|NCT01752933|593771267|FG000|Overall Study and Follow-up|Death|4|||
164382902|NCT01752933|593771268|FG001|Overall Study and Follow-up|Death|34|||
164382903|NCT01752933|593771267|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
164382904|NCT01752933|593771268|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
164382905|NCT01752933|593771267|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
164382906|NCT01752933|593771268|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
164382907|NCT01752933|593771267|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
164382908|NCT01752933|593771268|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
164382909|NCT01591681|593771269|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
164382910|NCT01591681|593771269|FG000|Overall Study|Failed to use system during run-in|1|||
164382911|NCT03062891|593771270|FG000|Overall Study|Withdrawal by Subject|2|||
164382912|NCT03062891|593771271|FG001|Overall Study|Withdrawal by Subject|0|||
164382913|NCT03062891|593771270|FG000|Overall Study|Lost to Follow-up|50|||
164382914|NCT03062891|593771271|FG001|Overall Study|Lost to Follow-up|38|||
164382915|NCT01431508|593771285|FG000|Overall Study|Lack of Efficacy|1|||
164382916|NCT01431508|593771285|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
164382917|NCT00132769|593771286|FG000|Overall Study|Withdrawal by Subject|1|||
164382918|NCT00132769|593771287|FG001|Overall Study|Withdrawal by Subject|3|||
164382919|NCT00132769|593771286|FG000|Overall Study|Lack of Efficacy|7|||
164382920|NCT00132769|593771287|FG001|Overall Study|Lack of Efficacy|6|||
164382921|NCT00132769|593771286|FG000|Overall Study|Adverse Event|2|||
164382922|NCT00132769|593771287|FG001|Overall Study|Adverse Event|1|||
164382923|NCT00132769|593771286|FG000|Overall Study|Protocol Violation|1|||
164382924|NCT00132769|593771287|FG001|Overall Study|Protocol Violation|1|||
164382925|NCT02758236|593771289|FG000|Overall Study|Investigator discretion|43|||
164382926|NCT00441337|593771292|FG000|Overall Study|Disease Progression|6|||
164382927|NCT00441337|593771293|FG001|Overall Study|Disease Progression|6|||
164382928|NCT00441337|593771294|FG002|Overall Study|Disease Progression|4|||
164382929|NCT00441337|593771295|FG003|Overall Study|Disease Progression|18|||
164382930|NCT00441337|593771292|FG000|Overall Study|Lost to Follow-up|0|||
164382931|NCT00441337|593771293|FG001|Overall Study|Lost to Follow-up|0|||
164382932|NCT00441337|593771294|FG002|Overall Study|Lost to Follow-up|0|||
164382933|NCT00441337|593771295|FG003|Overall Study|Lost to Follow-up|1|||
164382934|NCT00441337|593771292|FG000|Overall Study|Sponsor Decision|0|||
164382935|NCT00441337|593771293|FG001|Overall Study|Sponsor Decision|0|||
164382936|NCT00441337|593771294|FG002|Overall Study|Sponsor Decision|1|||
164382937|NCT00441337|593771295|FG003|Overall Study|Sponsor Decision|2|||
164382938|NCT00441337|593771292|FG000|Overall Study|Did not meet inclusion criteria|0|||
164382939|NCT00441337|593771293|FG001|Overall Study|Did not meet inclusion criteria|0|||
164382940|NCT00441337|593771294|FG002|Overall Study|Did not meet inclusion criteria|1|||
164382941|NCT00441337|593771295|FG003|Overall Study|Did not meet inclusion criteria|0|||
164382942|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
164382943|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
164382944|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
164382945|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Death|1|||
164382946|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Death|0|||
164382947|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Death|0|||
164382948|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
164382949|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
164013879|NCT02760407|592414557|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
164073001|NCT01408576|592632756|FG000|Overall Study|AE, unknown type|0|||
164382950|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
164382951|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
164382952|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
164382953|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
164382954|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
164382955|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
164382956|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
164382957|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
164382958|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
164382959|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
164382960|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
164382961|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
164382962|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
164382963|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
164382964|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
164382965|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
164382966|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
164382967|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
164382968|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
164382969|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
164382970|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
164382971|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
164382972|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
164382973|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
164382974|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
164382975|NCT03655236|593771296|FG000|Subject Disposition in Part 1 Period|Other|0|||
164382976|NCT03655236|593771297|FG001|Subject Disposition in Part 1 Period|Other|2|||
164382977|NCT03655236|593771298|FG002|Subject Disposition in Part 1 Period|Other|2|||
164382978|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
164382979|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
164382980|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
164382981|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
164382982|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
164382983|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
164382984|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
164382985|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
164382986|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
164382987|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
164382988|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
164013880|NCT02760407|592414558|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
164013881|NCT02760407|592414555|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
164013882|NCT02760407|592414556|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
164013883|NCT02760407|592414557|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
164382989|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
164382990|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
164382991|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
164382992|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
164382993|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
164382994|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
164382995|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
164382996|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
164382997|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
164382998|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
164382999|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
164383000|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
164383001|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
164383002|NCT03655236|593771296|FG000|Subject Disposition in Part 2 Period|Other|1|||
164383003|NCT03655236|593771297|FG001|Subject Disposition in Part 2 Period|Other|0|||
164383004|NCT03655236|593771298|FG002|Subject Disposition in Part 2 Period|Other|0|||
164383005|NCT06748040|593771299|FG000|Overall Study|Death|3|||
164383006|NCT06748040|593771300|FG001|Overall Study|Death|4|||
164383007|NCT06748040|593771299|FG000|Overall Study|Lost to Follow-up|134|||
164383008|NCT06748040|593771300|FG001|Overall Study|Lost to Follow-up|132|||
164383009|NCT06748040|593771299|FG000|Overall Study|Withdrawal by Subject|3|||
164383010|NCT06748040|593771300|FG001|Overall Study|Withdrawal by Subject|5|||
164383011|NCT01159938|593773435|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164383012|NCT01159938|593773436|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164383013|NCT01159938|593773437|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
164383014|NCT01159938|593773438|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164383015|NCT01159938|593773439|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
164013884|NCT02760407|592414558|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
164013885|NCT02760407|592414555|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
164013886|NCT02760407|592414556|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
164013887|NCT02760407|592414557|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
164073002|NCT01408576|592632757|FG001|Overall Study|AE, unknown type|1|||
164013888|NCT02760407|592414558|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
164013889|NCT02760407|592414555|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
164013890|NCT02760407|592414556|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
164013891|NCT02760407|592414557|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
164013892|NCT02760407|592414558|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
164013893|NCT02522377|592414559|FG000|Overall Study|Withdrawal by Subject|1|||
164013894|NCT02522377|592414560|FG001|Overall Study|Withdrawal by Subject|0|||
164013895|NCT02522377|592414559|FG000|Overall Study|Remission Achieved|3|||
164013896|NCT02522377|592414560|FG001|Overall Study|Remission Achieved|0|||
164383016|NCT02105116|593773441|FG000|Overall Study|not eligible for step 2 of trial|5|||
164383017|NCT02105116|593773441|FG000|Overall Study|Death|1|||
164383018|NCT02318329|593773443|FG000|Overall Study|Progressive Disease|2|||
164383019|NCT02318329|593773444|FG001|Overall Study|Progressive Disease|3|||
164383020|NCT02318329|593773445|FG002|Overall Study|Progressive Disease|2|||
164383021|NCT02318329|593773446|FG003|Overall Study|Progressive Disease|3|||
164383022|NCT02318329|593773447|FG004|Overall Study|Progressive Disease|3|||
164383023|NCT02318329|593773448|FG005|Overall Study|Progressive Disease|3|||
164383024|NCT02318329|593773449|FG006|Overall Study|Progressive Disease|1|||
164383025|NCT02318329|593773450|FG007|Overall Study|Progressive Disease|1|||
164383026|NCT02318329|593773451|FG008|Overall Study|Progressive Disease|5|||
164383027|NCT02318329|593773452|FG009|Overall Study|Progressive Disease|39|||
164383028|NCT02318329|593773443|FG000|Overall Study|Death|0|||
164383029|NCT02318329|593773444|FG001|Overall Study|Death|0|||
164383030|NCT02318329|593773445|FG002|Overall Study|Death|0|||
164383031|NCT02318329|593773446|FG003|Overall Study|Death|0|||
164383032|NCT02318329|593773447|FG004|Overall Study|Death|0|||
164383033|NCT02318329|593773448|FG005|Overall Study|Death|0|||
164383034|NCT02318329|593773449|FG006|Overall Study|Death|0|||
164383035|NCT02318329|593773450|FG007|Overall Study|Death|0|||
164383036|NCT02318329|593773451|FG008|Overall Study|Death|0|||
164383037|NCT02318329|593773452|FG009|Overall Study|Death|5|||
164383038|NCT02318329|593773443|FG000|Overall Study|Lost to Follow-up|0|||
164383039|NCT02318329|593773444|FG001|Overall Study|Lost to Follow-up|0|||
164383040|NCT02318329|593773445|FG002|Overall Study|Lost to Follow-up|0|||
164383041|NCT02318329|593773446|FG003|Overall Study|Lost to Follow-up|0|||
164383042|NCT02318329|593773447|FG004|Overall Study|Lost to Follow-up|0|||
164383043|NCT02318329|593773448|FG005|Overall Study|Lost to Follow-up|0|||
164383044|NCT02318329|593773449|FG006|Overall Study|Lost to Follow-up|0|||
164383045|NCT02318329|593773450|FG007|Overall Study|Lost to Follow-up|0|||
164383046|NCT02318329|593773451|FG008|Overall Study|Lost to Follow-up|0|||
164383047|NCT02318329|593773452|FG009|Overall Study|Lost to Follow-up|1|||
164383048|NCT02318329|593773443|FG000|Overall Study|Withdrawal by Subject|0|||
164383049|NCT02318329|593773444|FG001|Overall Study|Withdrawal by Subject|0|||
164383050|NCT02318329|593773445|FG002|Overall Study|Withdrawal by Subject|0|||
164383051|NCT02318329|593773446|FG003|Overall Study|Withdrawal by Subject|0|||
164383052|NCT02318329|593773447|FG004|Overall Study|Withdrawal by Subject|0|||
164383053|NCT02318329|593773448|FG005|Overall Study|Withdrawal by Subject|0|||
164383054|NCT02318329|593773449|FG006|Overall Study|Withdrawal by Subject|0|||
164383055|NCT02318329|593773450|FG007|Overall Study|Withdrawal by Subject|0|||
164383056|NCT02318329|593773451|FG008|Overall Study|Withdrawal by Subject|0|||
164383057|NCT02318329|593773452|FG009|Overall Study|Withdrawal by Subject|6|||
164383058|NCT02318329|593773443|FG000|Overall Study|Other|1|||
164383059|NCT02318329|593773444|FG001|Overall Study|Other|1|||
164383060|NCT02318329|593773445|FG002|Overall Study|Other|1|||
164383061|NCT02318329|593773446|FG003|Overall Study|Other|0|||
164383062|NCT02318329|593773447|FG004|Overall Study|Other|0|||
164383063|NCT02318329|593773448|FG005|Overall Study|Other|0|||
164383064|NCT02318329|593773449|FG006|Overall Study|Other|0|||
164383065|NCT02318329|593773450|FG007|Overall Study|Other|0|||
164383066|NCT02318329|593773451|FG008|Overall Study|Other|1|||
164383067|NCT02318329|593773452|FG009|Overall Study|Other|1|||
164383068|NCT04837482|593773453|FG000|Period 2|Withdrawal by Subject|0|||
164383069|NCT04837482|593773454|FG001|Period 2|Withdrawal by Subject|1|||
164383070|NCT00581945|593773455|FG000|Overall Study|Adverse Event|4|||
164383071|NCT00581945|593773456|FG001|Overall Study|Adverse Event|4|||
164013897|NCT00945191|592414561|FG000|Overall Study|Did not achieve a complete response|18|||
164013898|NCT00945191|592414561|FG000|Overall Study|Participant relocated to another state|1|||
164013899|NCT00945191|592414561|FG000|Overall Study|Disease progression|3|||
164383072|NCT00581945|593773455|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164383073|NCT00581945|593773456|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164383074|NCT00581945|593773455|FG000|Overall Study|Withdrawal by Subject|2|||
164383075|NCT00581945|593773456|FG001|Overall Study|Withdrawal by Subject|6|||
164383076|NCT00581945|593773455|FG000|Overall Study|Death|1|||
164383077|NCT00581945|593773456|FG001|Overall Study|Death|0|||
164383078|NCT02979535|593773457|FG000|Overall Study|Non compliance with the protocol|78|||
164383079|NCT02979535|593773458|FG001|Overall Study|Non compliance with the protocol|82|||
164383080|NCT02979535|593773457|FG000|Overall Study|Consent withdrawn by participant|11|||
164383081|NCT02979535|593773458|FG001|Overall Study|Consent withdrawn by participant|18|||
164383082|NCT02979535|593773457|FG000|Overall Study|Lost to Follow-up|6|||
164013900|NCT00945191|592414561|FG000|Overall Study|Serious adverse event or adverse event|1|||
164013901|NCT00945191|592414561|FG000|Overall Study|Investigator's discretion|1|||
164013902|NCT01921270|592414568|FG000|Overall Study|Withdrawal by Subject|1|||
164013903|NCT00863928|592414571|FG000|Overall Study|Protocol Violation|26|||
164013904|NCT00863928|592414572|FG001|Overall Study|Protocol Violation|0|||
164013905|NCT00863928|592414571|FG000|Overall Study|Withdrawal by Subject|3|||
164013906|NCT00863928|592414572|FG001|Overall Study|Withdrawal by Subject|0|||
164013907|NCT00863928|592414571|FG000|Overall Study|surgery cancellation|4|||
164013908|NCT00863928|592414572|FG001|Overall Study|surgery cancellation|0|||
164013909|NCT00863928|592414571|FG000|Overall Study|medication allergy|3|||
164013910|NCT00863928|592414572|FG001|Overall Study|medication allergy|0|||
164013911|NCT03290300|592414573|FG000|Overall Study|Lost to Follow-up|3|||
164013912|NCT00864227|592414574|FG000|Overall Study|Withdrawal by Subject|1|||
164013913|NCT00864227|592414574|FG000|Overall Study|Disease Relapse/Progression|3|||
164013914|NCT02124798|592414575|FG000|Overall Study|Adverse Event|3|||
164013915|NCT02124798|592414575|FG000|Overall Study|Lost to Follow-up|1|||
164013916|NCT01797432|592414576|FG000|Overall Study|Lost to Follow-up|1|||
164013917|NCT01797432|592414576|FG000|Overall Study|Adverse Event|1|||
164013918|NCT01797432|592414576|FG000|Overall Study|Withdrawal by Subject|1|||
164013919|NCT01797432|592414576|FG000|Overall Study|lived too far from study site|1|||
164013920|NCT02792777|592414577|FG000|Overall Study|Withdrawal by Subject|2|||
164013921|NCT02792777|592414578|FG001|Overall Study|Withdrawal by Subject|0|||
164013922|NCT02792777|592414577|FG000|Overall Study|Recording malfunction|2|||
164013923|NCT02792777|592414578|FG001|Overall Study|Recording malfunction|0|||
164013924|NCT02792777|592414577|FG000|Overall Study|Later determined to be ineligible|2|||
164013925|NCT02792777|592414578|FG001|Overall Study|Later determined to be ineligible|0|||
164013926|NCT02792777|592414577|FG000|Overall Study|Participant interviewed twice|1|||
164013927|NCT02792777|592414578|FG001|Overall Study|Participant interviewed twice|0|||
164013928|NCT02795156|592414579|FG000|Overall Study|Progressive Disease|22|||
164013929|NCT02795156|592414580|FG001|Overall Study|Progressive Disease|7|||
164013930|NCT02795156|592414581|FG002|Overall Study|Progressive Disease|34|||
164013931|NCT02795156|592414582|FG003|Overall Study|Progressive Disease|7|||
164013932|NCT02795156|592414579|FG000|Overall Study|Adverse Event|13|||
164013933|NCT02795156|592414580|FG001|Overall Study|Adverse Event|2|||
164013934|NCT02795156|592414581|FG002|Overall Study|Adverse Event|3|||
164013935|NCT02795156|592414582|FG003|Overall Study|Adverse Event|2|||
164013936|NCT02795156|592414579|FG000|Overall Study|Death|1|||
164013937|NCT02795156|592414580|FG001|Overall Study|Death|1|||
164013938|NCT02795156|592414581|FG002|Overall Study|Death|1|||
164013939|NCT02795156|592414582|FG003|Overall Study|Death|0|||
164013940|NCT02795156|592414579|FG000|Overall Study|Physician Decision|1|||
164013941|NCT02795156|592414580|FG001|Overall Study|Physician Decision|0|||
164013942|NCT02795156|592414581|FG002|Overall Study|Physician Decision|1|||
164013943|NCT02795156|592414582|FG003|Overall Study|Physician Decision|0|||
164013944|NCT02795156|592414579|FG000|Overall Study|Withdrawal by Subject|2|||
164013945|NCT02795156|592414580|FG001|Overall Study|Withdrawal by Subject|0|||
164013946|NCT02795156|592414581|FG002|Overall Study|Withdrawal by Subject|3|||
164013947|NCT02795156|592414582|FG003|Overall Study|Withdrawal by Subject|0|||
164013948|NCT01137435|592414586|FG000|Overall Study|Lost to Follow-up|24|||
164013949|NCT01137435|592414586|FG000|Overall Study|Off label usage|4|||
164013950|NCT00487279|592414587|FG000|Overall Study|Death|1|||
164013951|NCT00487279|592414588|FG001|Overall Study|Death|0|||
164013952|NCT00487279|592414587|FG000|Overall Study|Withdrawal by Subject|0|||
164013953|NCT00487279|592414588|FG001|Overall Study|Withdrawal by Subject|2|||
164013954|NCT00501852|592414589|FG000|Overall Study|Adverse Event|3|||
164013955|NCT00501852|592414589|FG000|Overall Study|Withdrawal by Subject|2|||
164013956|NCT01171521|592414590|FG000|Overall Study|Lost to Follow-up|5|||
164013957|NCT01171521|592414590|FG000|Overall Study|screen failure|1|||
164013958|NCT00399802|592414591|FG000|Overall Study|Adverse Event|0|||
164013959|NCT00399802|592414592|FG001|Overall Study|Adverse Event|2|||
164013960|NCT00399802|592414591|FG000|Overall Study|Participant discontinued by mistake|0|||
164013961|NCT00399802|592414592|FG001|Overall Study|Participant discontinued by mistake|1|||
164013962|NCT00492921|592414593|FG000|Overall Study|Death|1|||
164013963|NCT00492921|592414594|FG001|Overall Study|Death|0|||
164013964|NCT00492921|592414595|FG002|Overall Study|Death|1|||
164013965|NCT00652093|592414596|FG000|Overall Study|Withdrawal by Subject|0|||
164013966|NCT00652093|592414597|FG001|Overall Study|Withdrawal by Subject|0|||
164013967|NCT00652093|592414598|FG002|Overall Study|Withdrawal by Subject|1|||
164013968|NCT00652093|592414599|FG003|Overall Study|Withdrawal by Subject|0|||
164013969|NCT00652093|592414600|FG004|Overall Study|Withdrawal by Subject|1|||
164013970|NCT00652093|592414601|FG005|Overall Study|Withdrawal by Subject|0|||
164013971|NCT00652093|592414596|FG000|Overall Study|Physician Decision|0|||
164013972|NCT00652093|592414597|FG001|Overall Study|Physician Decision|0|||
164013973|NCT00652093|592414598|FG002|Overall Study|Physician Decision|0|||
164013974|NCT00652093|592414599|FG003|Overall Study|Physician Decision|0|||
164013975|NCT00652093|592414600|FG004|Overall Study|Physician Decision|1|||
164013976|NCT00652093|592414601|FG005|Overall Study|Physician Decision|0|||
164013977|NCT01520922|592414604|FG000|Treatment Phase|Physician Decision|2|||
163903073|NCT01728324|592015886|FG001|Termination of FDV|Lack of Efficacy|12|||
163903074|NCT01728324|592015887|FG002|Termination of FDV|Lack of Efficacy|8|||
163903075|NCT01728324|592015885|FG000|Termination of FDV|Withdrawal by Subject|9|||
163903076|NCT01728324|592015886|FG001|Termination of FDV|Withdrawal by Subject|6|||
163903077|NCT01728324|592015887|FG002|Termination of FDV|Withdrawal by Subject|2|||
163903078|NCT01728324|592015885|FG000|Termination of FDV|Other than stated|1|||
163903079|NCT01728324|592015886|FG001|Termination of FDV|Other than stated|3|||
163903080|NCT01728324|592015887|FG002|Termination of FDV|Other than stated|0|||
163903081|NCT01728324|592015885|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
163903082|NCT01728324|592015886|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
163903083|NCT01728324|592015887|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
163903084|NCT01728324|592015885|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
163903085|NCT01728324|592015886|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
163903086|NCT01728324|592015887|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
163903087|NCT01728324|592015885|FG000|Termination of RBV|Adverse Event|15|||
163903088|NCT01728324|592015886|FG001|Termination of RBV|Adverse Event|16|||
163903089|NCT01728324|592015887|FG002|Termination of RBV|Adverse Event|5|||
163903090|NCT01728324|592015885|FG000|Termination of RBV|Lack of Efficacy|14|||
163903091|NCT01728324|592015886|FG001|Termination of RBV|Lack of Efficacy|11|||
163903092|NCT01728324|592015887|FG002|Termination of RBV|Lack of Efficacy|7|||
163903093|NCT01728324|592015885|FG000|Termination of RBV|Withdrawal by Subject|9|||
164013978|NCT01520922|592414605|FG001|Treatment Phase|Physician Decision|1|||
164013979|NCT01520922|592414604|FG000|Treatment Phase|Progression|0|||
164013980|NCT01520922|592414605|FG001|Treatment Phase|Progression|2|||
164383083|NCT02979535|593773458|FG001|Overall Study|Lost to Follow-up|1|||
164383084|NCT04820673|593773459|FG000|Overall Study|Adverse Event|6|||
164383085|NCT04820673|593773459|FG000|Overall Study|Due to Lack of Effectiveness|1|||
164383086|NCT04820673|593773459|FG000|Overall Study|Pregnancy|1|||
164383087|NCT04820673|593773459|FG000|Overall Study|Voluntary Withdrawal|20|||
164383088|NCT04820673|593773459|FG000|Overall Study|Lost to Follow-up|10|||
164383089|NCT00587587|593773462|FG000|Overall Study|Lost to Follow-up|6|||
164383090|NCT00587587|593773463|FG001|Overall Study|Lost to Follow-up|1|||
164383091|NCT02032901|593773466|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
164383092|NCT02032901|593773467|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
164383093|NCT02032901|593773466|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
164383094|NCT02032901|593773467|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
164383095|NCT00466193|593773468|FG000|Overall Study|Adverse Event|0|||
164383096|NCT00466193|593773469|FG001|Overall Study|Adverse Event|1|||
164383097|NCT00466193|593773468|FG000|Overall Study|Lost to Follow-up|2|||
164383098|NCT00466193|593773469|FG001|Overall Study|Lost to Follow-up|4|||
164383099|NCT00466193|593773468|FG000|Overall Study|Physician Decision|1|||
164383100|NCT00466193|593773469|FG001|Overall Study|Physician Decision|0|||
164383101|NCT00466193|593773468|FG000|Overall Study|Protocol Violation|1|||
164383102|NCT00466193|593773469|FG001|Overall Study|Protocol Violation|1|||
164383103|NCT00466193|593773468|FG000|Overall Study|Withdrawal by Subject|7|||
164383104|NCT00466193|593773469|FG001|Overall Study|Withdrawal by Subject|2|||
164383105|NCT00466193|593773468|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
164383106|NCT00466193|593773469|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
164383107|NCT00086346|593773476|FG000|Randomization|Did not receive test article|4|||
164383108|NCT00086346|593773477|FG001|Randomization|Did not receive test article|4|||
164383109|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Adverse Event|94|||
164383110|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Adverse Event|11|||
164013981|NCT01520922|592414604|FG000|Treatment Phase|Adverse Event|3|||
164013982|NCT01520922|592414605|FG001|Treatment Phase|Adverse Event|5|||
163903094|NCT01728324|592015886|FG001|Termination of RBV|Withdrawal by Subject|5|||
164013983|NCT01520922|592414604|FG000|Follow up|Lost to Follow-up|0|||
164383111|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
164383112|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
164383113|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
163903095|NCT01728324|592015887|FG002|Termination of RBV|Withdrawal by Subject|2|||
163903096|NCT01728324|592015885|FG000|Termination of RBV|Other than stated|1|||
163903097|NCT01728324|592015886|FG001|Termination of RBV|Other than stated|3|||
164013984|NCT01520922|592414605|FG001|Follow up|Lost to Follow-up|1|||
164383114|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
164383115|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
164383116|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
164383117|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
164383118|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
164383119|NCT00086346|593773476|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
164383120|NCT00086346|593773477|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
164383121|NCT04495374|593773478|FG000|Overall Study|Protocol Violation|2|||
164383122|NCT04495374|593773479|FG001|Overall Study|Protocol Violation|1|||
164383123|NCT02473614|593773480|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
164383124|NCT02473614|593773481|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
164073003|NCT01408576|592632758|FG002|Overall Study|AE, unknown type|0|||
164383125|NCT02525133|593773482|FG000|Overall Study|Adverse Event|0|||
164383126|NCT02525133|593773483|FG001|Overall Study|Adverse Event|1|||
164383127|NCT02525133|593773482|FG000|Overall Study|Death|0|||
164383128|NCT02525133|593773483|FG001|Overall Study|Death|1|||
164383129|NCT02525133|593773482|FG000|Overall Study|did not meet randomization criteria|1|||
164383130|NCT02525133|593773483|FG001|Overall Study|did not meet randomization criteria|0|||
164383131|NCT02525133|593773482|FG000|Overall Study|Lost to Follow-up|5|||
164383132|NCT02525133|593773483|FG001|Overall Study|Lost to Follow-up|1|||
164383133|NCT02525133|593773482|FG000|Overall Study|randomized not enrolled|3|||
164383134|NCT02525133|593773483|FG001|Overall Study|randomized not enrolled|0|||
164383135|NCT02525133|593773482|FG000|Overall Study|Withdrawal by Subject|1|||
164383136|NCT02525133|593773483|FG001|Overall Study|Withdrawal by Subject|0|||
164383137|NCT01343082|593773484|FG000|The run-in Period|Not meeting criteria|3|||
164383138|NCT01343082|593773485|FG001|The run-in Period|Not meeting criteria|4|||
164383139|NCT01343082|593773486|FG002|The run-in Period|Not meeting criteria|5|||
164383140|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
164383141|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
164383142|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
164383143|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
164383144|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
164383145|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
164383146|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
164383147|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
164383148|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
164013985|NCT01520922|592414604|FG000|Survival Follow-up|Withdrawal by Subject|1|||
164013986|NCT01520922|592414605|FG001|Survival Follow-up|Withdrawal by Subject|0|||
164013987|NCT01422304|592414610|FG000|Overall Study|Adverse Event|0|||
164013988|NCT01422304|592414611|FG001|Overall Study|Adverse Event|1|||
164013989|NCT01422304|592414610|FG000|Overall Study|Lost to Follow-up|14|||
164013990|NCT01422304|592414611|FG001|Overall Study|Lost to Follow-up|20|||
164013991|NCT01422304|592414610|FG000|Overall Study|Never Entered Follow-up|2|||
164013992|NCT01422304|592414611|FG001|Overall Study|Never Entered Follow-up|1|||
164013993|NCT01422304|592414610|FG000|Overall Study|Protocol Violation|1|||
164013994|NCT01422304|592414611|FG001|Overall Study|Protocol Violation|0|||
164013995|NCT01422304|592414610|FG000|Overall Study|Withdrawal by Subject|4|||
164013996|NCT01422304|592414611|FG001|Overall Study|Withdrawal by Subject|2|||
164013997|NCT01422304|592414610|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164013998|NCT01422304|592414611|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
164013999|NCT01422304|592414610|FG000|Overall Study|Not Treated|3|||
164014000|NCT01422304|592414611|FG001|Overall Study|Not Treated|11|||
164014001|NCT03461289|592414615|FG000|Overall Study|Death|1|||
164014002|NCT00564629|592414616|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
164014003|NCT00564629|592414617|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
164014004|NCT03241173|592414618|FG000|Overall Study|Death|3|||
164014005|NCT03241173|592414619|FG001|Overall Study|Death|2|||
164014006|NCT03241173|592414620|FG002|Overall Study|Death|4|||
164014007|NCT03241173|592414621|FG003|Overall Study|Death|4|||
164014008|NCT03241173|592414622|FG004|Overall Study|Death|2|||
164014009|NCT03241173|592414623|FG005|Overall Study|Death|2|||
164383149|NCT01343082|593773484|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
164383150|NCT01343082|593773485|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
164383151|NCT01343082|593773486|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
164383152|NCT01075074|593773487|FG000|Overall Study|Surgeon changed to open incisional case|1|||
164383153|NCT01075074|593773488|FG001|Overall Study|Surgeon changed to open incisional case|2|||
164383154|NCT01075074|593773489|FG002|Overall Study|Surgeon changed to open incisional case|2|||
164383155|NCT01375049|593773491|FG000|Overall Study|Adverse Event|2|||
164383156|NCT01375049|593773491|FG000|Overall Study|Lost to Follow-up|1|||
164383157|NCT01375049|593773491|FG000|Overall Study|Withdrawal by Subject|2|||
164383158|NCT01375049|593773491|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
164383159|NCT02082522|593773492|FG000|Overall Study|Sponsor termination|5|||
164383160|NCT02082522|593773493|FG001|Overall Study|Sponsor termination|3|||
164383161|NCT02082522|593773492|FG000|Overall Study|Withdrawal by Subject|2|||
164383162|NCT02082522|593773493|FG001|Overall Study|Withdrawal by Subject|4|||
164014010|NCT03241173|592414624|FG006|Overall Study|Death|3|||
164014011|NCT03241173|592414625|FG007|Overall Study|Death|1|||
164383163|NCT02082522|593773492|FG000|Overall Study|Death|1|||
164014012|NCT03241173|592414626|FG008|Overall Study|Death|0|||
164014013|NCT03241173|592414627|FG009|Overall Study|Death|5|||
164383164|NCT02082522|593773493|FG001|Overall Study|Death|0|||
164383165|NCT02082522|593773492|FG000|Overall Study|Lost to Follow-up|1|||
164383166|NCT02082522|593773493|FG001|Overall Study|Lost to Follow-up|0|||
164383167|NCT02082522|593773492|FG000|Overall Study|Physician Decision|3|||
164383168|NCT02082522|593773493|FG001|Overall Study|Physician Decision|1|||
164383169|NCT02082522|593773492|FG000|Overall Study|Disease progression|2|||
164383170|NCT02082522|593773493|FG001|Overall Study|Disease progression|2|||
164014014|NCT03241173|592414628|FG010|Overall Study|Death|4|||
164383171|NCT02082522|593773492|FG000|Overall Study|Chemotherapy change|1|||
164383172|NCT02082522|593773493|FG001|Overall Study|Chemotherapy change|3|||
164383173|NCT00633984|593773494|FG000|Overall Study|Lost to Follow-up|0|||
164383174|NCT00633984|593773495|FG001|Overall Study|Lost to Follow-up|6|||
164383175|NCT00633984|593773494|FG000|Overall Study|Withdrawal by Subject|8|||
164383176|NCT00633984|593773495|FG001|Overall Study|Withdrawal by Subject|7|||
164383177|NCT00633984|593773494|FG000|Overall Study|Hospitalized|1|||
164383178|NCT00633984|593773495|FG001|Overall Study|Hospitalized|0|||
164383179|NCT02496884|593773496|FG000|Overall Study|Counted twice as enrolled|2|||
164383180|NCT02496884|593773497|FG001|Overall Study|Counted twice as enrolled|0|||
164383181|NCT02496884|593773498|FG002|Overall Study|Counted twice as enrolled|0|||
164383182|NCT02496884|593773499|FG003|Overall Study|Counted twice as enrolled|0|||
164383183|NCT02496884|593773496|FG000|Overall Study|Withdrawal by Subject|0|||
164383184|NCT02496884|593773497|FG001|Overall Study|Withdrawal by Subject|3|||
164383185|NCT02496884|593773498|FG002|Overall Study|Withdrawal by Subject|0|||
164383186|NCT02496884|593773499|FG003|Overall Study|Withdrawal by Subject|0|||
164383187|NCT01168999|593773500|FG000|Overall Study|Lost to Follow-up|2|||
164383188|NCT01168999|593773501|FG001|Overall Study|Lost to Follow-up|1|||
164383189|NCT01168999|593773502|FG002|Overall Study|Lost to Follow-up|0|||
164383190|NCT01168999|593773503|FG003|Overall Study|Lost to Follow-up|0|||
164383191|NCT03766646|593773504|FG000|Overall Study|Withdrawal by Subject|1|||
164383192|NCT03766646|593773505|FG001|Overall Study|Withdrawal by Subject|0|||
164383193|NCT03766646|593773504|FG000|Overall Study|Protocol Violation|0|||
164383194|NCT03766646|593773505|FG001|Overall Study|Protocol Violation|3|||
164383195|NCT01854554|593773509|FG000|Overall Study|Denial of Insurance Coverage|12|||
164383196|NCT01854554|593773510|FG001|Overall Study|Denial of Insurance Coverage|0|||
164383197|NCT01854554|593773509|FG000|Overall Study|Decided to get treatment locally|1|||
164383198|NCT01854554|593773510|FG001|Overall Study|Decided to get treatment locally|5|||
164383199|NCT01854554|593773509|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
164383200|NCT01854554|593773510|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
164383201|NCT01854554|593773509|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164383202|NCT01854554|593773510|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
164383203|NCT01854554|593773509|FG000|Overall Study|Progression|0|||
164383204|NCT01854554|593773510|FG001|Overall Study|Progression|1|||
164383205|NCT01854554|593773509|FG000|Overall Study|Lost to Follow-up|0|||
164383206|NCT01854554|593773510|FG001|Overall Study|Lost to Follow-up|1|||
164383207|NCT02819726|593773511|FG000|Part A (All Participants)|Lost to Follow-up|0|||
164383208|NCT02819726|593773512|FG001|Part A (All Participants)|Lost to Follow-up|1|||
164383209|NCT02819726|593773513|FG002|Part A (All Participants)|Lost to Follow-up|0|||
164383210|NCT02819726|593773514|FG003|Part A (All Participants)|Lost to Follow-up|0|||
164383211|NCT02819726|593773511|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
164383212|NCT02819726|593773512|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
164383213|NCT02819726|593773513|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
164383214|NCT02819726|593773514|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
164383215|NCT02819726|593773511|FG000|Part A (All Participants)|Protocol non-compliance|3|||
164383216|NCT02819726|593773512|FG001|Part A (All Participants)|Protocol non-compliance|4|||
164383217|NCT02819726|593773513|FG002|Part A (All Participants)|Protocol non-compliance|5|||
164383218|NCT02819726|593773514|FG003|Part A (All Participants)|Protocol non-compliance|0|||
164383219|NCT02819726|593773511|FG000|Part B (All Participants)|Lost to Follow-up|1|||
164383220|NCT02819726|593773512|FG001|Part B (All Participants)|Lost to Follow-up|1|||
164383221|NCT02819726|593773513|FG002|Part B (All Participants)|Lost to Follow-up|2|||
164383222|NCT02819726|593773514|FG003|Part B (All Participants)|Lost to Follow-up|2|||
164383223|NCT02819726|593773511|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
164383224|NCT02819726|593773512|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
164383225|NCT02819726|593773513|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
164383226|NCT02819726|593773514|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
164383227|NCT02819726|593773511|FG000|Part B (All Participants)|Protocol non-compliance|0|||
164383228|NCT02819726|593773512|FG001|Part B (All Participants)|Protocol non-compliance|0|||
164383229|NCT02819726|593773513|FG002|Part B (All Participants)|Protocol non-compliance|1|||
164383230|NCT02819726|593773514|FG003|Part B (All Participants)|Protocol non-compliance|0|||
164383231|NCT00803023|593773517|FG000|Overall Study|Adverse Event|5|||
164383232|NCT00803023|593773518|FG001|Overall Study|Adverse Event|4|||
164383233|NCT00803023|593773519|FG002|Overall Study|Adverse Event|8|||
164383234|NCT00803023|593773520|FG003|Overall Study|Adverse Event|6|||
164383235|NCT00803023|593773517|FG000|Overall Study|Withdrawal by Subject|0|||
164383236|NCT00803023|593773518|FG001|Overall Study|Withdrawal by Subject|2|||
164383237|NCT00803023|593773519|FG002|Overall Study|Withdrawal by Subject|0|||
164383238|NCT00803023|593773520|FG003|Overall Study|Withdrawal by Subject|0|||
164383239|NCT00803023|593773517|FG000|Overall Study|Lost to Follow-up|0|||
164383240|NCT00803023|593773518|FG001|Overall Study|Lost to Follow-up|1|||
164383241|NCT00803023|593773519|FG002|Overall Study|Lost to Follow-up|2|||
164383242|NCT00803023|593773520|FG003|Overall Study|Lost to Follow-up|1|||
164383243|NCT00803023|593773517|FG000|Overall Study|Lack of Efficacy|0|||
164383244|NCT00803023|593773518|FG001|Overall Study|Lack of Efficacy|1|||
164383245|NCT00803023|593773519|FG002|Overall Study|Lack of Efficacy|1|||
163903098|NCT01728324|592015887|FG002|Termination of RBV|Other than stated|1|||
163903099|NCT01728324|592015885|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
163903100|NCT01728324|592015886|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
163903101|NCT01728324|592015887|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
163903102|NCT01728324|592015885|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
163903103|NCT01728324|592015886|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
163903104|NCT01728324|592015887|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
164383246|NCT00803023|593773520|FG003|Overall Study|Lack of Efficacy|1|||
163903105|NCT01787032|592015890|FG000|Overall Study|Protocol Violation|0|||
163903106|NCT01787032|592015891|FG001|Overall Study|Protocol Violation|0|||
163903107|NCT01787032|592015892|FG002|Overall Study|Protocol Violation|0|||
163903108|NCT01787032|592015893|FG003|Overall Study|Protocol Violation|0|||
163903109|NCT01787032|592015894|FG004|Overall Study|Protocol Violation|1|||
164383247|NCT02647658|593773521|FG000|Overall Study|Consent refusal|15|||
164383248|NCT02647658|593773522|FG001|Overall Study|Consent refusal|24|||
164383249|NCT04382326|593773524|FG000|Overall Study|Adverse Event, not serious|1|||
164383250|NCT04382326|593773525|FG001|Overall Study|Adverse Event, not serious|2|||
164383251|NCT04382326|593773524|FG000|Overall Study|Other|1|||
164383252|NCT04382326|593773525|FG001|Overall Study|Other|0|||
164383253|NCT04382326|593773524|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
164383254|NCT04382326|593773525|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
164383255|NCT04382326|593773524|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
164383256|NCT04382326|593773525|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
164383257|NCT04382326|593773524|FG000|Overall Study|Protocol Violation|29|||
164383258|NCT04382326|593773525|FG001|Overall Study|Protocol Violation|23|||
164383259|NCT04382326|593773524|FG000|Overall Study|Physician Decision|0|||
164383260|NCT04382326|593773525|FG001|Overall Study|Physician Decision|1|||
164383261|NCT04382326|593773524|FG000|Overall Study|Lost to Follow-up|48|||
163903110|NCT01787032|592015895|FG005|Overall Study|Protocol Violation|1|||
163903111|NCT00388726|592015896|FG000|Overall Study|Adverse Event|50|||
163903112|NCT00388726|592015897|FG001|Overall Study|Adverse Event|24|||
163903113|NCT00388726|592015896|FG000|Overall Study|Progressive Disease|336|||
163903114|NCT00388726|592015897|FG001|Overall Study|Progressive Disease|153|||
163903115|NCT00388726|592015896|FG000|Overall Study|Clinical Progression|61|||
163903116|NCT00388726|592015897|FG001|Overall Study|Clinical Progression|36|||
163903117|NCT00388726|592015896|FG000|Overall Study|Withdrawal by Subject|10|||
163903118|NCT00388726|592015897|FG001|Overall Study|Withdrawal by Subject|7|||
163903119|NCT00388726|592015896|FG000|Overall Study|Administrative|6|||
163903120|NCT00388726|592015897|FG001|Overall Study|Administrative|9|||
163903121|NCT00388726|592015896|FG000|Overall Study|Physician Decision|18|||
163903122|NCT00388726|592015897|FG001|Overall Study|Physician Decision|13|||
163903123|NCT00388726|592015896|FG000|Overall Study|Death|3|||
163903124|NCT00388726|592015897|FG001|Overall Study|Death|2|||
163903125|NCT02406092|592015898|FG000|Overall Study|Screen failure|10|||
163903126|NCT02406092|592015899|FG001|Overall Study|Screen failure|7|||
164383262|NCT04382326|593773525|FG001|Overall Study|Lost to Follow-up|63|||
164383263|NCT04382326|593773524|FG000|Overall Study|Adverse Event, non-fatal|1|||
164383264|NCT04382326|593773525|FG001|Overall Study|Adverse Event, non-fatal|1|||
164383265|NCT01181921|593773526|FG000|Overall Study|Lost to Follow-up|1|||
164383266|NCT02461589|593773527|FG000|Overall Study|Withdrawal by Subject|5|||
164383267|NCT02461589|593773528|FG001|Overall Study|Withdrawal by Subject|1|||
164383268|NCT02461589|593773529|FG002|Overall Study|Withdrawal by Subject|3|||
164383269|NCT02461589|593773530|FG003|Overall Study|Withdrawal by Subject|2|||
164383270|NCT02461589|593773531|FG004|Overall Study|Withdrawal by Subject|1|||
164383271|NCT02461589|593773532|FG005|Overall Study|Withdrawal by Subject|2|||
164383272|NCT02461589|593773533|FG006|Overall Study|Withdrawal by Subject|1|||
164383273|NCT02461589|593773534|FG007|Overall Study|Withdrawal by Subject|3|||
164383274|NCT02461589|593773535|FG008|Overall Study|Withdrawal by Subject|3|||
163903127|NCT02406092|592015898|FG000|Overall Study|Death|22|||
163903128|NCT02406092|592015899|FG001|Overall Study|Death|5|||
164014015|NCT03241173|592414629|FG011|Overall Study|Death|3|||
164383275|NCT02461589|593773536|FG009|Overall Study|Withdrawal by Subject|1|||
164383276|NCT02461589|593773527|FG000|Overall Study|Lost to Follow-up|0|||
164383277|NCT02461589|593773528|FG001|Overall Study|Lost to Follow-up|0|||
164383278|NCT02461589|593773529|FG002|Overall Study|Lost to Follow-up|2|||
163903129|NCT02406092|592015898|FG000|Overall Study|Lost to Follow-up|4|||
163903130|NCT02406092|592015899|FG001|Overall Study|Lost to Follow-up|1|||
163903131|NCT02406092|592015898|FG000|Overall Study|Adverse Event|1|||
163903132|NCT02406092|592015899|FG001|Overall Study|Adverse Event|0|||
163903133|NCT02406092|592015898|FG000|Overall Study|Withdrawal by Subject|1|||
164383279|NCT02461589|593773530|FG003|Overall Study|Lost to Follow-up|3|||
164383280|NCT02461589|593773531|FG004|Overall Study|Lost to Follow-up|1|||
164383281|NCT02461589|593773532|FG005|Overall Study|Lost to Follow-up|1|||
164383282|NCT02461589|593773533|FG006|Overall Study|Lost to Follow-up|3|||
164383283|NCT02461589|593773534|FG007|Overall Study|Lost to Follow-up|1|||
164383284|NCT02461589|593773535|FG008|Overall Study|Lost to Follow-up|3|||
164383285|NCT02461589|593773536|FG009|Overall Study|Lost to Follow-up|1|||
164383286|NCT02461589|593773527|FG000|Overall Study|Death|0|||
164383287|NCT02461589|593773528|FG001|Overall Study|Death|0|||
164383288|NCT02461589|593773529|FG002|Overall Study|Death|0|||
164383289|NCT02461589|593773530|FG003|Overall Study|Death|0|||
164383290|NCT02461589|593773531|FG004|Overall Study|Death|0|||
164383291|NCT02461589|593773532|FG005|Overall Study|Death|0|||
164383292|NCT02461589|593773533|FG006|Overall Study|Death|0|||
164383293|NCT02461589|593773534|FG007|Overall Study|Death|1|||
164383294|NCT02461589|593773535|FG008|Overall Study|Death|0|||
164383295|NCT02461589|593773536|FG009|Overall Study|Death|0|||
164383296|NCT02461589|593773527|FG000|Overall Study|Unclassified|0|||
164383297|NCT02461589|593773528|FG001|Overall Study|Unclassified|0|||
164383298|NCT02461589|593773529|FG002|Overall Study|Unclassified|0|||
164383299|NCT02461589|593773530|FG003|Overall Study|Unclassified|0|||
164383300|NCT02461589|593773531|FG004|Overall Study|Unclassified|0|||
164383301|NCT02461589|593773532|FG005|Overall Study|Unclassified|0|||
164383302|NCT02461589|593773533|FG006|Overall Study|Unclassified|1|||
164383303|NCT02461589|593773534|FG007|Overall Study|Unclassified|0|||
164383304|NCT02461589|593773535|FG008|Overall Study|Unclassified|0|||
164383305|NCT02461589|593773536|FG009|Overall Study|Unclassified|2|||
164383306|NCT02461589|593773527|FG000|Overall Study|Missing follow-up information|1|||
164383307|NCT02461589|593773528|FG001|Overall Study|Missing follow-up information|1|||
164383308|NCT02461589|593773529|FG002|Overall Study|Missing follow-up information|0|||
164383309|NCT02461589|593773530|FG003|Overall Study|Missing follow-up information|0|||
164383310|NCT02461589|593773531|FG004|Overall Study|Missing follow-up information|0|||
164383311|NCT02461589|593773532|FG005|Overall Study|Missing follow-up information|0|||
164383312|NCT02461589|593773533|FG006|Overall Study|Missing follow-up information|1|||
164383313|NCT02461589|593773534|FG007|Overall Study|Missing follow-up information|0|||
164383314|NCT02461589|593773535|FG008|Overall Study|Missing follow-up information|0|||
164383315|NCT02461589|593773536|FG009|Overall Study|Missing follow-up information|0|||
164383316|NCT02461589|593773527|FG000|Overall Study|Withdrawal from trial before exposure|0|||
164383317|NCT02461589|593773528|FG001|Overall Study|Withdrawal from trial before exposure|0|||
164383318|NCT02461589|593773529|FG002|Overall Study|Withdrawal from trial before exposure|0|||
164383319|NCT02461589|593773530|FG003|Overall Study|Withdrawal from trial before exposure|0|||
164383320|NCT02461589|593773531|FG004|Overall Study|Withdrawal from trial before exposure|0|||
164383321|NCT02461589|593773532|FG005|Overall Study|Withdrawal from trial before exposure|0|||
164383322|NCT02461589|593773533|FG006|Overall Study|Withdrawal from trial before exposure|0|||
164383323|NCT02461589|593773534|FG007|Overall Study|Withdrawal from trial before exposure|0|||
164383324|NCT02461589|593773535|FG008|Overall Study|Withdrawal from trial before exposure|0|||
164383325|NCT02461589|593773536|FG009|Overall Study|Withdrawal from trial before exposure|1|||
164383326|NCT01038921|593773541|FG000|Overall Study|Withdrawal by Subject|1|||
164383327|NCT01038921|593773542|FG001|Overall Study|Withdrawal by Subject|0|||
164383328|NCT01038921|593773541|FG000|Overall Study|Physician Decision|1|||
164383329|NCT01038921|593773542|FG001|Overall Study|Physician Decision|0|||
164383330|NCT01978119|593773543|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
164383331|NCT01978119|593773544|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
164383332|NCT01978119|593773543|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
164383333|NCT01978119|593773544|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164383334|NCT01978119|593773543|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164383335|NCT01978119|593773544|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
164383336|NCT03295201|593773547|FG000|Overall Study|Lost to Follow-up|1|||
164383337|NCT03295201|593773548|FG001|Overall Study|Lost to Follow-up|1|||
164383338|NCT03295201|593773547|FG000|Overall Study|Hospital admission|0|||
164383339|NCT03295201|593773548|FG001|Overall Study|Hospital admission|1|||
164383340|NCT02519504|593773549|FG000|Overall Study|Protocol Violation|6|||
164383341|NCT02519504|593773550|FG001|Overall Study|Protocol Violation|5|||
164383342|NCT02519504|593773549|FG000|Overall Study|Ineligible for direct testing|12|||
164383343|NCT02519504|593773550|FG001|Overall Study|Ineligible for direct testing|12|||
164383344|NCT02519504|593773549|FG000|Overall Study|Did not participate in direct testing|95|||
164383345|NCT02519504|593773550|FG001|Overall Study|Did not participate in direct testing|86|||
164383346|NCT02548962|593773551|FG000|Overall Study|Withdrawal by Subject|1|||
164383347|NCT02548962|593773552|FG001|Overall Study|Withdrawal by Subject|0|||
164014016|NCT03241173|592414630|FG012|Overall Study|Death|0|||
164014017|NCT03241173|592414631|FG013|Overall Study|Death|0|||
164383348|NCT01958918|593773556|FG000|Overall Study|Death|1|||
164383349|NCT01958918|593773557|FG001|Overall Study|Death|3|||
164383350|NCT01958918|593773556|FG000|Overall Study|Lost to Follow-up|4|||
164383351|NCT01958918|593773557|FG001|Overall Study|Lost to Follow-up|7|||
164383352|NCT01958918|593773556|FG000|Overall Study|Withdrawal by Subject|13|||
164014018|NCT03241173|592414632|FG014|Overall Study|Death|0|||
164383353|NCT01958918|593773557|FG001|Overall Study|Withdrawal by Subject|8|||
164383354|NCT01958918|593773556|FG000|Overall Study|Lack of Efficacy|13|||
164383355|NCT01958918|593773557|FG001|Overall Study|Lack of Efficacy|10|||
164383356|NCT01958918|593773556|FG000|Overall Study|Adverse Event|12|||
164383357|NCT01958918|593773557|FG001|Overall Study|Adverse Event|12|||
164383358|NCT01958918|593773556|FG000|Overall Study|administrative problems|0|||
164383359|NCT01958918|593773557|FG001|Overall Study|administrative problems|2|||
164383360|NCT00659269|593773561|FG000|Overall Study|Physician Decision|1|||
164383361|NCT00659269|593773562|FG001|Overall Study|Physician Decision|1|||
164383362|NCT00908960|593773563|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
164383363|NCT00908960|593773564|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
164383364|NCT00908960|593773565|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
164383365|NCT02401672|593773566|FG000|Overall Study|Withdrawal by Subject|1|||
164383366|NCT02401672|593773567|FG001|Overall Study|Withdrawal by Subject|3|||
164383367|NCT03653429|593773570|FG000|Overall Study|Physician Decision|4|||
164383368|NCT03653429|593773571|FG001|Overall Study|Physician Decision|10|||
164383369|NCT05857527|593773579|FG000|Overall Study|Withdrawal by Subject|0|||
164383370|NCT05857527|593773580|FG001|Overall Study|Withdrawal by Subject|1|||
164383371|NCT01592708|593773581|FG000|Overall Study|Protocol Violation|3|||
164383372|NCT01592708|593773582|FG001|Overall Study|Protocol Violation|0|||
164383373|NCT02610140|593773591|FG000|Randomization and Treatment Period|Radiological progression|23|||
164383374|NCT02610140|593773592|FG001|Randomization and Treatment Period|Radiological progression|15|||
164383375|NCT02610140|593773591|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
164383376|NCT02610140|593773592|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
164383377|NCT02610140|593773591|FG000|Randomization and Treatment Period|Protocol Violation|1|||
164383378|NCT02610140|593773592|FG001|Randomization and Treatment Period|Protocol Violation|0|||
164383379|NCT02610140|593773591|FG000|Randomization and Treatment Period|Physician Decision|0|||
164383380|NCT02610140|593773592|FG001|Randomization and Treatment Period|Physician Decision|1|||
164383381|NCT02610140|593773591|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
164383382|NCT02610140|593773592|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
164383383|NCT02610140|593773591|FG000|Randomization and Treatment Period|Death|7|||
164383384|NCT02610140|593773592|FG001|Randomization and Treatment Period|Death|1|||
164383385|NCT02610140|593773591|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
164383386|NCT02610140|593773592|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
164383387|NCT02610140|593773591|FG000|Randomization and Treatment Period|Adverse Event|44|||
164383388|NCT02610140|593773592|FG001|Randomization and Treatment Period|Adverse Event|13|||
164383389|NCT02610140|593773591|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
164383390|NCT02610140|593773592|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
164383391|NCT02610140|593773591|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
164383392|NCT02610140|593773592|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
164383393|NCT02610140|593773591|FG000|Randomization and Treatment Period|Not treated|3|||
164383394|NCT02610140|593773592|FG001|Randomization and Treatment Period|Not treated|10|||
164383395|NCT02610140|593773591|FG000|Safety Follow-up|Other|0|||
164383396|NCT02610140|593773592|FG001|Safety Follow-up|Other|2|||
164383397|NCT02610140|593773591|FG000|Safety Follow-up|Lost to Follow-up|1|||
164383398|NCT02610140|593773592|FG001|Safety Follow-up|Lost to Follow-up|0|||
164383399|NCT02610140|593773591|FG000|Safety Follow-up|No follow-up|5|||
164383400|NCT02610140|593773592|FG001|Safety Follow-up|No follow-up|3|||
164383401|NCT02610140|593773591|FG000|Safety Follow-up|Death|12|||
164383402|NCT02610140|593773592|FG001|Safety Follow-up|Death|2|||
164383403|NCT02610140|593773591|FG000|Safety Follow-up|Deterioration of general conditions|15|||
164383404|NCT02610140|593773592|FG001|Safety Follow-up|Deterioration of general conditions|5|||
164383405|NCT02610140|593773591|FG000|Safety Follow-up|Withdrawal by Subject|12|||
164383406|NCT02610140|593773592|FG001|Safety Follow-up|Withdrawal by Subject|12|||
164383407|NCT02610140|593773591|FG000|Active Follow-up|Progressive disease - radiological|30|||
164383408|NCT02610140|593773592|FG001|Active Follow-up|Progressive disease - radiological|22|||
164383409|NCT02610140|593773591|FG000|Active Follow-up|Death|8|||
164383410|NCT02610140|593773592|FG001|Active Follow-up|Death|1|||
164383411|NCT02610140|593773591|FG000|Active Follow-up|Withdrawal by Subject|4|||
164383412|NCT02610140|593773592|FG001|Active Follow-up|Withdrawal by Subject|0|||
164014019|NCT03241173|592414618|FG000|Overall Study|Withdrawal by Subject|0|||
164014020|NCT03241173|592414619|FG001|Overall Study|Withdrawal by Subject|0|||
164383413|NCT02610140|593773591|FG000|Active Follow-up|Progressive disease - clinical|1|||
164383414|NCT02610140|593773592|FG001|Active Follow-up|Progressive disease - clinical|2|||
164383415|NCT02610140|593773591|FG000|Active Follow-up|Deterioration of general conditions|1|||
164383416|NCT02610140|593773592|FG001|Active Follow-up|Deterioration of general conditions|0|||
164383417|NCT02610140|593773591|FG000|Active Follow-up|Ongoing but not completed|4|||
164383418|NCT02610140|593773592|FG001|Active Follow-up|Ongoing but not completed|1|||
164383419|NCT02610140|593773591|FG000|Long-term Follow-up|Death|86|||
164014021|NCT03241173|592414620|FG002|Overall Study|Withdrawal by Subject|1|||
164383420|NCT02610140|593773592|FG001|Long-term Follow-up|Death|44|||
164383421|NCT02610140|593773591|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
164383422|NCT02610140|593773592|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
164383423|NCT02610140|593773591|FG000|Long-term Follow-up|Lost to Follow-up|1|||
164383424|NCT02610140|593773592|FG001|Long-term Follow-up|Lost to Follow-up|2|||
164383425|NCT02610140|593773591|FG000|Long-term Follow-up|Ongoing but not completed|30|||
164383426|NCT02610140|593773592|FG001|Long-term Follow-up|Ongoing but not completed|17|||
164383427|NCT00887341|593773593|FG000|Overall Study|Refused treatment|1|||
164383428|NCT00887341|593773594|FG001|Overall Study|Refused treatment|0|||
164383429|NCT00887341|593773593|FG000|Overall Study|Withdrawal by Subject|1|||
164383430|NCT00887341|593773594|FG001|Overall Study|Withdrawal by Subject|1|||
164383431|NCT00887341|593773593|FG000|Overall Study|Adverse Event|0|||
164383432|NCT00887341|593773594|FG001|Overall Study|Adverse Event|1|||
164383433|NCT00887341|593773593|FG000|Overall Study|Lost to Follow-up|0|||
164383434|NCT00887341|593773594|FG001|Overall Study|Lost to Follow-up|1|||
164383435|NCT01312961|593773597|FG000|Overall Study|Adverse Event|3|||
164383436|NCT01312961|593773598|FG001|Overall Study|Adverse Event|3|||
164383437|NCT01312961|593773597|FG000|Overall Study|Lack of Efficacy|11|||
164383438|NCT01312961|593773598|FG001|Overall Study|Lack of Efficacy|1|||
164383439|NCT01312961|593773597|FG000|Overall Study|Poor compliance to protocol|1|||
164383440|NCT01312961|593773598|FG001|Overall Study|Poor compliance to protocol|0|||
164383441|NCT01312961|593773597|FG000|Overall Study|Other than specified above|2|||
164383442|NCT01312961|593773598|FG001|Overall Study|Other than specified above|3|||
164383443|NCT05402995|593773600|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
164383444|NCT05402995|593773601|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
164383445|NCT05402995|593773602|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
164383446|NCT05402995|593773603|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
164383447|NCT01337297|593773606|FG000|Overall Study|They entered to single anodal tDCS|4|||
164383448|NCT01337297|593773607|FG001|Overall Study|They entered to single anodal tDCS|3|||
164383449|NCT01337297|593773606|FG000|Overall Study|Lost to Follow-up|1|||
164383450|NCT01337297|593773607|FG001|Overall Study|Lost to Follow-up|3|||
164383451|NCT01800903|593773608|FG000|Second Test Period|unable to catheterise|1|||
164383452|NCT01800903|593773609|FG001|Second Test Period|unable to catheterise|0|||
164383453|NCT01800903|593773610|FG002|Second Test Period|unable to catheterise|0|||
164383454|NCT01800903|593773611|FG003|Second Test Period|unable to catheterise|0|||
164383455|NCT01800903|593773612|FG004|Second Test Period|unable to catheterise|0|||
164383456|NCT01800903|593773613|FG005|Second Test Period|unable to catheterise|0|||
164383457|NCT01306617|593773615|FG000|Overall Study|Adverse Event|1|||
164383458|NCT01306617|593773616|FG001|Overall Study|Adverse Event|0|||
164383459|NCT01306617|593773617|FG002|Overall Study|Adverse Event|0|||
164383460|NCT01306617|593773615|FG000|Overall Study|Virologic Failure|0|||
164383461|NCT01306617|593773616|FG001|Overall Study|Virologic Failure|0|||
164383462|NCT01306617|593773617|FG002|Overall Study|Virologic Failure|5|||
164383463|NCT01306617|593773615|FG000|Overall Study|Non-compliance|0|||
164383464|NCT01306617|593773616|FG001|Overall Study|Non-compliance|1|||
164014022|NCT03241173|592414621|FG003|Overall Study|Withdrawal by Subject|0|||
164383465|NCT01306617|593773617|FG002|Overall Study|Non-compliance|0|||
164383466|NCT01208233|593773619|FG000|Overall Study|Adverse Event|0|||
164383467|NCT01208233|593773620|FG001|Overall Study|Adverse Event|1|||
164383468|NCT01208233|593773621|FG002|Overall Study|Adverse Event|2|||
164383469|NCT01208233|593773622|FG003|Overall Study|Adverse Event|0|||
164383470|NCT01208233|593773623|FG004|Overall Study|Adverse Event|3|||
164383471|NCT01208233|593773624|FG005|Overall Study|Adverse Event|5|||
164383472|NCT01208233|593773619|FG000|Overall Study|Death|0|||
164383473|NCT01208233|593773620|FG001|Overall Study|Death|0|||
164383474|NCT01208233|593773621|FG002|Overall Study|Death|0|||
164014023|NCT03241173|592414622|FG004|Overall Study|Withdrawal by Subject|0|||
164014024|NCT03241173|592414623|FG005|Overall Study|Withdrawal by Subject|1|||
164383475|NCT01208233|593773622|FG003|Overall Study|Death|0|||
164383476|NCT01208233|593773623|FG004|Overall Study|Death|3|||
164383477|NCT01208233|593773624|FG005|Overall Study|Death|5|||
164383478|NCT01208233|593773619|FG000|Overall Study|Did not meet entrance criteria|2|||
164383479|NCT01208233|593773620|FG001|Overall Study|Did not meet entrance criteria|1|||
164383480|NCT01208233|593773621|FG002|Overall Study|Did not meet entrance criteria|1|||
164383481|NCT01208233|593773622|FG003|Overall Study|Did not meet entrance criteria|0|||
164383482|NCT01208233|593773623|FG004|Overall Study|Did not meet entrance criteria|1|||
164383483|NCT01208233|593773624|FG005|Overall Study|Did not meet entrance criteria|0|||
164383484|NCT01208233|593773619|FG000|Overall Study|Medication error without adverse event|0|||
164383485|NCT01208233|593773620|FG001|Overall Study|Medication error without adverse event|0|||
164383486|NCT01208233|593773621|FG002|Overall Study|Medication error without adverse event|0|||
164383487|NCT01208233|593773622|FG003|Overall Study|Medication error without adverse event|0|||
164383488|NCT01208233|593773623|FG004|Overall Study|Medication error without adverse event|0|||
164014025|NCT03241173|592414624|FG006|Overall Study|Withdrawal by Subject|0|||
164383489|NCT01208233|593773624|FG005|Overall Study|Medication error without adverse event|1|||
164383490|NCT01208233|593773619|FG000|Overall Study|Study terminated by sponsor|0|||
164383491|NCT01208233|593773620|FG001|Overall Study|Study terminated by sponsor|0|||
164383492|NCT01208233|593773621|FG002|Overall Study|Study terminated by sponsor|0|||
164383493|NCT01208233|593773622|FG003|Overall Study|Study terminated by sponsor|0|||
164383494|NCT01208233|593773623|FG004|Overall Study|Study terminated by sponsor|10|||
164383495|NCT01208233|593773624|FG005|Overall Study|Study terminated by sponsor|7|||
164383496|NCT01208233|593773619|FG000|Overall Study|Protocol Violation|0|||
164383497|NCT01208233|593773620|FG001|Overall Study|Protocol Violation|0|||
164383498|NCT01208233|593773621|FG002|Overall Study|Protocol Violation|0|||
164383499|NCT01208233|593773622|FG003|Overall Study|Protocol Violation|0|||
164383500|NCT01208233|593773623|FG004|Overall Study|Protocol Violation|3|||
164383501|NCT01208233|593773624|FG005|Overall Study|Protocol Violation|0|||
164383502|NCT01208233|593773619|FG000|Overall Study|Other|2|||
164383503|NCT01208233|593773620|FG001|Overall Study|Other|1|||
164383504|NCT01208233|593773621|FG002|Overall Study|Other|0|||
164383505|NCT01208233|593773622|FG003|Overall Study|Other|0|||
164383506|NCT01208233|593773623|FG004|Overall Study|Other|0|||
164383507|NCT01208233|593773624|FG005|Overall Study|Other|1|||
164383508|NCT01208233|593773619|FG000|Overall Study|Withdrawal by Subject|1|||
164383509|NCT01208233|593773620|FG001|Overall Study|Withdrawal by Subject|0|||
164383510|NCT01208233|593773621|FG002|Overall Study|Withdrawal by Subject|1|||
164383511|NCT01208233|593773622|FG003|Overall Study|Withdrawal by Subject|1|||
164383512|NCT01208233|593773623|FG004|Overall Study|Withdrawal by Subject|4|||
164383513|NCT01208233|593773624|FG005|Overall Study|Withdrawal by Subject|2|||
164383514|NCT04028388|593773628|FG000|Overall Study|Evaluations missing|3|||
164383515|NCT04028388|593773629|FG001|Overall Study|Evaluations missing|6|||
164383516|NCT04028388|593773628|FG000|Overall Study|Not started|2|||
164383517|NCT04028388|593773629|FG001|Overall Study|Not started|0|||
164383518|NCT00129259|593773636|FG000|Overall Study|Lost to Follow-up|1|||
164383519|NCT00129259|593773637|FG001|Overall Study|Lost to Follow-up|1|||
164383520|NCT00129259|593773636|FG000|Overall Study|Withdrawal by Subject|2|||
164383521|NCT00129259|593773637|FG001|Overall Study|Withdrawal by Subject|1|||
164383522|NCT00129259|593773636|FG000|Overall Study|Only available minimal phone assessments|0|||
164383523|NCT00129259|593773637|FG001|Overall Study|Only available minimal phone assessments|1|||
164383524|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383525|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383526|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383527|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383528|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383529|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383530|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383531|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383532|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383533|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383534|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383535|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
164383536|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383537|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383538|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383539|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
164383540|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383541|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
164383542|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
164383543|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
164383544|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
164383545|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
164383546|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
164383547|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
164383548|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
164383549|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
164383550|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
164383551|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
164383552|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383553|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383554|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383555|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
164383556|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383557|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383558|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383559|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164014026|NCT03241173|592414625|FG007|Overall Study|Withdrawal by Subject|0|||
164383560|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383561|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
164383562|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
164383563|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383564|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383565|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
164383566|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
164383567|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
164383568|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383569|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383570|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383571|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
164383572|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383573|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383574|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383575|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383576|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383577|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
164383578|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383579|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383580|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383581|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383582|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383583|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
164383584|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383585|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383586|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383587|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
164383588|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383589|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383590|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383591|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383592|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383593|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
164383594|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383595|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383596|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383597|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383598|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383599|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383600|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383601|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383602|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383603|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
164383604|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383605|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383606|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383607|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383608|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383609|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383610|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383611|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383612|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
164383613|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383614|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383615|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383616|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383617|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383618|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164014027|NCT03241173|592414626|FG008|Overall Study|Withdrawal by Subject|0|||
164014028|NCT03241173|592414627|FG009|Overall Study|Withdrawal by Subject|0|||
164383619|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
164383620|NCT01609556|593773638|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
164383621|NCT01609556|593773639|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383622|NCT01609556|593773640|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383623|NCT01609556|593773641|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383624|NCT01609556|593773642|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383625|NCT01609556|593773643|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
164383626|NCT01609556|593773644|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383627|NCT01609556|593773645|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383628|NCT01609556|593773646|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383629|NCT01609556|593773647|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383630|NCT01609556|593773648|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
164383631|NCT01609556|593773649|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383632|NCT01609556|593773650|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383633|NCT01609556|593773651|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383634|NCT01609556|593773652|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383635|NCT01609556|593773653|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
164383636|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383637|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383638|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383639|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383640|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383641|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383642|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383643|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383644|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383645|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383646|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383647|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
164383648|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
164383649|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
164383650|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
164383651|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
164383652|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383653|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383654|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383655|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383656|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383657|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383658|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383659|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383660|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383661|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383662|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383663|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
164383664|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
164383665|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
164383666|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
164383667|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
164383668|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383669|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383670|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383671|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383672|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383673|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383674|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383675|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383676|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383677|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383678|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383679|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
164383680|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
164383681|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
164383682|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
164383683|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
164383684|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
163903134|NCT02406092|592015899|FG001|Overall Study|Withdrawal by Subject|0|||
163903135|NCT03041233|592015900|FG000|Overall Study|Death|5|||
163903136|NCT03041233|592015900|FG000|Overall Study|Physician Decision|1|||
163903137|NCT03041233|592015900|FG000|Overall Study|Lost to Follow-up|16|||
163903138|NCT03041233|592015900|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
163903139|NCT03041233|592015900|FG000|Overall Study|Sponsor Request|1|||
163903140|NCT03041233|592015900|FG000|Overall Study|Duplicate subject|1|||
163903141|NCT03041233|592015900|FG000|Overall Study|Re-ablation|1|||
163903142|NCT00853593|592015904|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
164383685|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383686|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383687|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383688|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383689|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383690|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383691|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383692|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383693|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383694|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383695|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383696|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
164383697|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383698|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383699|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
164383700|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383701|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383702|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383703|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383704|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383705|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383706|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383707|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383708|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383709|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
163903143|NCT00853593|592015904|FG000|Overall Study|Model 4396 lead not attempted|29|||
163903144|NCT00853593|592015904|FG000|Overall Study|Implant not attempted|4|||
163903145|NCT00641537|592015907|FG000|96-week Period|Adverse Event|0|||
163903146|NCT00641537|592015908|FG001|96-week Period|Adverse Event|1|||
163903147|NCT00641537|592015909|FG002|96-week Period|Adverse Event|3|||
163903148|NCT00641537|592015910|FG003|96-week Period|Adverse Event|0|||
163903149|NCT00641537|592015911|FG004|96-week Period|Adverse Event|2|||
163903150|NCT00641537|592015912|FG005|96-week Period|Adverse Event|0|||
163903151|NCT00641537|592015913|FG006|96-week Period|Adverse Event|0|||
163903152|NCT00641537|592015914|FG007|96-week Period|Adverse Event|0|||
163903153|NCT00641537|592015907|FG000|96-week Period|Lost to Follow-up|3|||
163903154|NCT00641537|592015908|FG001|96-week Period|Lost to Follow-up|1|||
163903155|NCT00641537|592015909|FG002|96-week Period|Lost to Follow-up|2|||
163903156|NCT00641537|592015910|FG003|96-week Period|Lost to Follow-up|2|||
163903157|NCT00641537|592015911|FG004|96-week Period|Lost to Follow-up|4|||
163903158|NCT00641537|592015912|FG005|96-week Period|Lost to Follow-up|0|||
163903159|NCT00641537|592015913|FG006|96-week Period|Lost to Follow-up|1|||
163903160|NCT00641537|592015914|FG007|96-week Period|Lost to Follow-up|0|||
163903161|NCT00641537|592015907|FG000|96-week Period|Protocol Violation|0|||
163903162|NCT00641537|592015908|FG001|96-week Period|Protocol Violation|1|||
164383710|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383711|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
164383712|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
164383713|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
164383714|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
164383715|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
164383716|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383717|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383718|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383719|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383720|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
163903163|NCT00641537|592015909|FG002|96-week Period|Protocol Violation|0|||
163903164|NCT00641537|592015910|FG003|96-week Period|Protocol Violation|1|||
163903165|NCT00641537|592015911|FG004|96-week Period|Protocol Violation|0|||
163903166|NCT00641537|592015912|FG005|96-week Period|Protocol Violation|1|||
163903167|NCT00641537|592015913|FG006|96-week Period|Protocol Violation|0|||
163903168|NCT00641537|592015914|FG007|96-week Period|Protocol Violation|0|||
164383721|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383722|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383723|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383724|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383725|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383726|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383727|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383728|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383729|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383730|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
164383731|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
164383732|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383733|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383734|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383735|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383736|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383737|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383738|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383739|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383740|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383741|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383742|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383743|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383744|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
164383745|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
164383746|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
164383747|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
164383748|NCT01609556|593773638|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383749|NCT01609556|593773639|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383750|NCT01609556|593773640|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383751|NCT01609556|593773641|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383752|NCT01609556|593773642|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383753|NCT01609556|593773643|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383754|NCT01609556|593773644|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383755|NCT01609556|593773645|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383756|NCT01609556|593773646|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383757|NCT01609556|593773647|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383758|NCT01609556|593773648|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383759|NCT01609556|593773649|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383760|NCT01609556|593773650|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
164383761|NCT01609556|593773651|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383762|NCT01609556|593773652|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383763|NCT01609556|593773653|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
164383764|NCT01632579|593773656|FG000|Washout Period|Adverse Event|1|||
164383765|NCT01632579|593773657|FG001|Washout Period|Adverse Event|0|||
164383766|NCT01632579|593773658|FG002|Washout Period|Adverse Event|0|||
164383767|NCT01632579|593773659|FG003|Washout Period|Adverse Event|0|||
164383768|NCT01632579|593773660|FG004|Washout Period|Adverse Event|0|||
164383769|NCT01632579|593773661|FG005|Washout Period|Adverse Event|0|||
164383770|NCT01632579|593773662|FG006|Washout Period|Adverse Event|0|||
164383771|NCT01632579|593773663|FG007|Washout Period|Adverse Event|0|||
164383772|NCT01632579|593773664|FG008|Washout Period|Adverse Event|0|||
164383773|NCT01632579|593773656|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
164383774|NCT01632579|593773657|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
164383775|NCT01632579|593773658|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
164383776|NCT01632579|593773659|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
164383777|NCT01632579|593773660|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
164383778|NCT01632579|593773661|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
164383779|NCT01632579|593773662|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
164383780|NCT01632579|593773663|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
164383781|NCT01632579|593773664|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
164383782|NCT00162136|593773665|FG000|Overall Study|Adverse Event|1|||
164383783|NCT00162136|593773665|FG000|Overall Study|Death|1|||
164383784|NCT00162136|593773665|FG000|Overall Study|Disease Progression/Relapse|23|||
164383785|NCT00162136|593773665|FG000|Overall Study|Investigator Request|5|||
164383786|NCT00162136|593773665|FG000|Overall Study|Study Drug Toxicity|4|||
164383787|NCT00162136|593773665|FG000|Overall Study|Withdrawal by Subject|1|||
164383788|NCT01539291|593775650|FG000|Study GS-US-312-0116|Adverse Event|9|||
164383789|NCT01539291|593775651|FG001|Study GS-US-312-0116|Adverse Event|0|||
164383790|NCT01539291|593775652|FG002|Study GS-US-312-0116|Adverse Event|0|||
164383791|NCT01539291|593775653|FG003|Study GS-US-312-0116|Adverse Event|0|||
164383792|NCT01539291|593775650|FG000|Study GS-US-312-0116|Physician Decision|1|||
164383793|NCT01539291|593775651|FG001|Study GS-US-312-0116|Physician Decision|0|||
164383794|NCT01539291|593775652|FG002|Study GS-US-312-0116|Physician Decision|0|||
164383795|NCT01539291|593775653|FG003|Study GS-US-312-0116|Physician Decision|0|||
164383796|NCT01539291|593775650|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
164383797|NCT01539291|593775651|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
164383798|NCT01539291|593775652|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
164383799|NCT01539291|593775653|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
164383800|NCT01539291|593775650|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
164383801|NCT01539291|593775651|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
164383802|NCT01539291|593775652|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
164383803|NCT01539291|593775653|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
164383804|NCT01539291|593775650|FG000|Study GS-US-312-0116|Other|1|||
164383805|NCT01539291|593775651|FG001|Study GS-US-312-0116|Other|0|||
164383806|NCT01539291|593775652|FG002|Study GS-US-312-0116|Other|0|||
164383807|NCT01539291|593775653|FG003|Study GS-US-312-0116|Other|0|||
164383808|NCT01539291|593775650|FG000|Study GS-US-312-0117|Adverse Event|22|||
164383809|NCT01539291|593775651|FG001|Study GS-US-312-0117|Adverse Event|1|||
164383810|NCT01539291|593775652|FG002|Study GS-US-312-0117|Adverse Event|9|||
164383811|NCT01539291|593775653|FG003|Study GS-US-312-0117|Adverse Event|12|||
164383812|NCT01539291|593775650|FG000|Study GS-US-312-0117|Physician Decision|9|||
164383813|NCT01539291|593775651|FG001|Study GS-US-312-0117|Physician Decision|0|||
164383814|NCT01539291|593775652|FG002|Study GS-US-312-0117|Physician Decision|6|||
164383815|NCT01539291|593775653|FG003|Study GS-US-312-0117|Physician Decision|4|||
164383816|NCT01539291|593775650|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
164383817|NCT01539291|593775651|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
164383818|NCT01539291|593775652|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
164383819|NCT01539291|593775653|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
164383820|NCT01539291|593775650|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
164383821|NCT01539291|593775651|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
164383822|NCT01539291|593775652|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
164383823|NCT01539291|593775653|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
164383824|NCT01539291|593775650|FG000|Study GS-US-312-0117|Other|2|||
164383825|NCT01539291|593775651|FG001|Study GS-US-312-0117|Other|1|||
164383826|NCT01539291|593775652|FG002|Study GS-US-312-0117|Other|1|||
164383827|NCT01539291|593775653|FG003|Study GS-US-312-0117|Other|1|||
164383828|NCT04450264|593775654|FG000|Overall Study|Incomplete survey|13|||
164383829|NCT04450264|593775655|FG001|Overall Study|Incomplete survey|19|||
164383830|NCT00074282|593775658|FG000|Step 1|Adverse Event|32|||
164383831|NCT00074282|593775659|FG001|Step 1|Adverse Event|0|||
164383832|NCT00074282|593775660|FG002|Step 1|Adverse Event|0|||
164383833|NCT00074282|593775658|FG000|Step 1|Death|6|||
164383834|NCT00074282|593775659|FG001|Step 1|Death|0|||
164383835|NCT00074282|593775660|FG002|Step 1|Death|0|||
164383836|NCT00074282|593775658|FG000|Step 1|Withdrawal by Subject|7|||
164383837|NCT00074282|593775659|FG001|Step 1|Withdrawal by Subject|0|||
164383838|NCT00074282|593775660|FG002|Step 1|Withdrawal by Subject|0|||
164383839|NCT00074282|593775658|FG000|Step 1|Disease progression|2|||
164383840|NCT00074282|593775659|FG001|Step 1|Disease progression|0|||
164383841|NCT00074282|593775660|FG002|Step 1|Disease progression|0|||
164383842|NCT00074282|593775658|FG000|Step 1|Alternative therapy|2|||
164383843|NCT00074282|593775659|FG001|Step 1|Alternative therapy|0|||
164383844|NCT00074282|593775660|FG002|Step 1|Alternative therapy|0|||
164383845|NCT00074282|593775658|FG000|Step 1|Other complicating disease|2|||
164383846|NCT00074282|593775659|FG001|Step 1|Other complicating disease|0|||
164383847|NCT00074282|593775660|FG002|Step 1|Other complicating disease|0|||
164383848|NCT00074282|593775658|FG000|Step 1|Physician Decision|1|||
164383849|NCT00074282|593775659|FG001|Step 1|Physician Decision|0|||
164383850|NCT00074282|593775660|FG002|Step 1|Physician Decision|0|||
164383851|NCT00074282|593775658|FG000|Step 1|Ineligible|4|||
164383852|NCT00074282|593775659|FG001|Step 1|Ineligible|0|||
164383853|NCT00074282|593775660|FG002|Step 1|Ineligible|0|||
164383854|NCT00074282|593775658|FG000|Step 1|Never started treatment|2|||
164383855|NCT00074282|593775659|FG001|Step 1|Never started treatment|0|||
164383856|NCT00074282|593775660|FG002|Step 1|Never started treatment|0|||
163903169|NCT00641537|592015907|FG000|96-week Period|Death|2|||
164383857|NCT00074282|593775658|FG000|Step 2|Adverse Event|0|||
164383858|NCT00074282|593775659|FG001|Step 2|Adverse Event|2|||
164383859|NCT00074282|593775660|FG002|Step 2|Adverse Event|12|||
164383860|NCT00074282|593775658|FG000|Step 2|Disease progression|0|||
164383861|NCT00074282|593775659|FG001|Step 2|Disease progression|0|||
164383862|NCT00074282|593775660|FG002|Step 2|Disease progression|5|||
164383863|NCT00074282|593775658|FG000|Step 2|Death|0|||
164383864|NCT00074282|593775659|FG001|Step 2|Death|0|||
164383865|NCT00074282|593775660|FG002|Step 2|Death|3|||
164383866|NCT00074282|593775658|FG000|Step 2|Withdrawal by Subject|0|||
164383867|NCT00074282|593775659|FG001|Step 2|Withdrawal by Subject|0|||
163903170|NCT00641537|592015908|FG001|96-week Period|Death|0|||
164383868|NCT00074282|593775660|FG002|Step 2|Withdrawal by Subject|2|||
164014029|NCT03241173|592414628|FG010|Overall Study|Withdrawal by Subject|0|||
164014030|NCT03241173|592414629|FG011|Overall Study|Withdrawal by Subject|0|||
164014031|NCT03241173|592414630|FG012|Overall Study|Withdrawal by Subject|0|||
164014032|NCT03241173|592414631|FG013|Overall Study|Withdrawal by Subject|0|||
164014033|NCT03241173|592414632|FG014|Overall Study|Withdrawal by Subject|0|||
164014034|NCT03241173|592414618|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164014035|NCT03241173|592414619|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164014036|NCT03241173|592414620|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164014037|NCT03241173|592414621|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164014038|NCT03241173|592414622|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164014039|NCT03241173|592414623|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164014040|NCT03241173|592414624|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
164014041|NCT03241173|592414625|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164014042|NCT03241173|592414626|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164014043|NCT03241173|592414627|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164014044|NCT03241173|592414628|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
164014045|NCT03241173|592414629|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
164383869|NCT00074282|593775658|FG000|Step 2|Physician Decision|0|||
164383870|NCT00074282|593775659|FG001|Step 2|Physician Decision|0|||
164383871|NCT00074282|593775660|FG002|Step 2|Physician Decision|1|||
164383872|NCT00074282|593775658|FG000|Step 2|Ineligible|0|||
164383873|NCT00074282|593775659|FG001|Step 2|Ineligible|0|||
164383874|NCT00074282|593775660|FG002|Step 2|Ineligible|1|||
164383875|NCT02055352|593775664|FG000|Overall Study|Adverse Event|0|||
164383876|NCT02055352|593775665|FG001|Overall Study|Adverse Event|1|||
164383877|NCT02055352|593775664|FG000|Overall Study|Non-eligible|0|||
164383878|NCT02055352|593775665|FG001|Overall Study|Non-eligible|1|||
164383879|NCT02055352|593775664|FG000|Overall Study|Poor compliance|1|||
164383880|NCT02055352|593775665|FG001|Overall Study|Poor compliance|1|||
164383881|NCT02055352|593775664|FG000|Overall Study|Death|1|||
164383882|NCT02055352|593775665|FG001|Overall Study|Death|2|||
164383883|NCT02055352|593775664|FG000|Overall Study|Patient decision|1|||
164383884|NCT02055352|593775665|FG001|Overall Study|Patient decision|1|||
164383885|NCT02055352|593775664|FG000|Overall Study|Use of prohibited treatment|0|||
164383886|NCT02055352|593775665|FG001|Overall Study|Use of prohibited treatment|3|||
164383887|NCT02055352|593775664|FG000|Overall Study|AE, study drug would be detrimental|1|||
164383888|NCT02055352|593775665|FG001|Overall Study|AE, study drug would be detrimental|3|||
164383889|NCT02055352|593775664|FG000|Overall Study|Withdrawal of informed consent|1|||
164383890|NCT02055352|593775665|FG001|Overall Study|Withdrawal of informed consent|0|||
164383891|NCT02055352|593775664|FG000|Overall Study|Reason unknown|1|||
164383892|NCT02055352|593775665|FG001|Overall Study|Reason unknown|5|||
164383893|NCT04745169|593775666|FG000|Overall Study|Kidney transplantation|1|||
164383894|NCT04745169|593775666|FG000|Overall Study|Participant health problems|3|||
164383895|NCT04745169|593775666|FG000|Overall Study|Physician Decision|2|||
164383896|NCT00129987|593775670|FG000|1st Educational Session|Withdrawal by Subject|141|||
164383897|NCT00129987|593775671|FG001|1st Educational Session|Withdrawal by Subject|109|||
164383898|NCT00129987|593775670|FG000|1 Year|Withdrawal by Subject|32|||
164383899|NCT00129987|593775671|FG001|1 Year|Withdrawal by Subject|21|||
164383900|NCT00116805|593775672|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
164383901|NCT00116805|593775673|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
164383902|NCT00116805|593775672|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
164383903|NCT00116805|593775673|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
164383904|NCT00116805|593775672|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
164383905|NCT00116805|593775673|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
164383906|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
164383907|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
164383908|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
164383909|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
164383910|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
164383911|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
164383912|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
164383913|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
164383914|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
164014046|NCT03241173|592414630|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164014047|NCT03241173|592414631|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164383915|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
164383916|NCT00116805|593775672|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
164383917|NCT00116805|593775673|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
164383918|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
164014048|NCT03241173|592414632|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
164014049|NCT03241173|592414618|FG000|Overall Study|Lost to Follow-up|0|||
164014050|NCT03241173|592414619|FG001|Overall Study|Lost to Follow-up|0|||
164383919|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
164383920|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
164383921|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
164383922|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
164383923|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
164383924|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
164383925|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
164383926|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
164383927|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
164383928|NCT00116805|593775672|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
164383929|NCT00116805|593775673|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
164383930|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
164383931|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
164383932|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
164383933|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
164383934|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
164383935|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
164383936|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
164383937|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
164383938|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
164383939|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
164383940|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
164383941|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
164383942|NCT00116805|593775672|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
164383943|NCT00116805|593775673|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
164383944|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
164383945|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
164383946|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
164383947|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
164383948|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
164383949|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
164383950|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
164383951|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
164383952|NCT00116805|593775672|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
164383953|NCT00116805|593775673|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
164383954|NCT00116805|593775672|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
164383955|NCT00116805|593775673|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
164383956|NCT00116805|593775672|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
164383957|NCT00116805|593775673|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
164383958|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
164383959|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
164383960|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
164383961|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
164014051|NCT03241173|592414620|FG002|Overall Study|Lost to Follow-up|0|||
164014052|NCT03241173|592414621|FG003|Overall Study|Lost to Follow-up|0|||
164383962|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
164383963|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
164014053|NCT03241173|592414622|FG004|Overall Study|Lost to Follow-up|1|||
164014054|NCT03241173|592414623|FG005|Overall Study|Lost to Follow-up|0|||
164383964|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
164383965|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
164383966|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
164383967|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
164383968|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
164383969|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
164383970|NCT00116805|593775672|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
164383971|NCT00116805|593775673|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
164383972|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
164383973|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
164383974|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
164383975|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
164383976|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
164383977|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
164383978|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
164383979|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
164383980|NCT00116805|593775672|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
164383981|NCT00116805|593775673|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
164383982|NCT00116805|593775672|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
164383983|NCT00116805|593775673|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
164383984|NCT00116805|593775672|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
164383985|NCT00116805|593775673|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
164383986|NCT00116805|593775672|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
164383987|NCT00116805|593775673|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
164383988|NCT00116805|593775672|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
164383989|NCT00116805|593775673|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
164383990|NCT01575561|593775674|FG000|Overall Study|Adverse Event|9|||
164383991|NCT01575561|593775674|FG000|Overall Study|Lack of Efficacy|8|||
164383992|NCT01575561|593775674|FG000|Overall Study|Lost to Follow-up|6|||
164383993|NCT01575561|593775674|FG000|Overall Study|Protocol Violation|4|||
164383994|NCT01575561|593775674|FG000|Overall Study|Withdrawal by Subject|11|||
164383995|NCT01575561|593775674|FG000|Overall Study|administration|1|||
164383996|NCT01033747|593775676|FG000|Overall Study|Adverse Event|9|||
164383997|NCT01033747|593775677|FG001|Overall Study|Adverse Event|4|||
164383998|NCT01033747|593775676|FG000|Overall Study|Abnormal Laboratory Value|1|||
164383999|NCT01033747|593775677|FG001|Overall Study|Abnormal Laboratory Value|0|||
164384000|NCT01033747|593775676|FG000|Overall Study|Abnormal test procedure|0|||
164384001|NCT01033747|593775677|FG001|Overall Study|Abnormal test procedure|1|||
164384002|NCT01033747|593775676|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
164384003|NCT01033747|593775677|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
164384004|NCT01033747|593775676|FG000|Overall Study|Protocol Violation|1|||
164384005|NCT01033747|593775677|FG001|Overall Study|Protocol Violation|0|||
164384006|NCT01033747|593775676|FG000|Overall Study|Withdrawal by Subject|9|||
164384007|NCT01033747|593775677|FG001|Overall Study|Withdrawal by Subject|6|||
164384008|NCT01033747|593775676|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
164384009|NCT01033747|593775677|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
164384010|NCT01033747|593775676|FG000|Overall Study|Stopped at end of Extension 1|2|||
164384011|NCT01033747|593775677|FG001|Overall Study|Stopped at end of Extension 1|0|||
164384012|NCT02613481|593775678|FG000|Overall Study|Lost to Follow-up|7|||
164384013|NCT02613481|593775678|FG000|Overall Study|Withdrawal by Subject|2|||
164384014|NCT00844194|593775679|FG000|Overall Study|Adverse Event|17|||
164384015|NCT00844194|593775680|FG001|Overall Study|Adverse Event|5|||
164384016|NCT00844194|593775679|FG000|Overall Study|Protocol Violation|1|||
164384017|NCT00844194|593775680|FG001|Overall Study|Protocol Violation|1|||
164384018|NCT00844194|593775679|FG000|Overall Study|Lost to Follow-up|1|||
164384019|NCT00844194|593775680|FG001|Overall Study|Lost to Follow-up|1|||
164384020|NCT00844194|593775679|FG000|Overall Study|Withdrawal by Subject|2|||
164384021|NCT00844194|593775680|FG001|Overall Study|Withdrawal by Subject|1|||
164384022|NCT00844194|593775679|FG000|Overall Study|Lack of Efficacy|3|||
164384023|NCT00844194|593775680|FG001|Overall Study|Lack of Efficacy|0|||
164384024|NCT00844194|593775679|FG000|Overall Study|Other reason (not specified)|1|||
164384025|NCT00844194|593775680|FG001|Overall Study|Other reason (not specified)|0|||
164384026|NCT01542528|593775685|FG000|Overall Study|Lost to Follow-up|2|||
164384027|NCT01542528|593775686|FG001|Overall Study|Lost to Follow-up|1|||
164384028|NCT01542528|593775685|FG000|Overall Study|Physician Decision|1|||
164384029|NCT01542528|593775686|FG001|Overall Study|Physician Decision|0|||
163903171|NCT00641537|592015909|FG002|96-week Period|Death|1|||
164384030|NCT01542528|593775685|FG000|Overall Study|Withdrawal by Subject|9|||
164384031|NCT01542528|593775686|FG001|Overall Study|Withdrawal by Subject|6|||
164384032|NCT05282004|593775687|FG000|Overall Study|Adverse Event|2|||
164384033|NCT04808609|593775688|FG000|Overall Study|Lost to Follow-up|0|||
163903172|NCT00641537|592015910|FG003|96-week Period|Death|0|||
163903173|NCT00641537|592015911|FG004|96-week Period|Death|0|||
164384034|NCT04808609|593775689|FG001|Overall Study|Lost to Follow-up|2|||
164014055|NCT03241173|592414624|FG006|Overall Study|Lost to Follow-up|0|||
164014056|NCT03241173|592414625|FG007|Overall Study|Lost to Follow-up|0|||
164014057|NCT03241173|592414626|FG008|Overall Study|Lost to Follow-up|0|||
164014058|NCT03241173|592414627|FG009|Overall Study|Lost to Follow-up|1|||
164014059|NCT03241173|592414628|FG010|Overall Study|Lost to Follow-up|0|||
164014060|NCT03241173|592414629|FG011|Overall Study|Lost to Follow-up|0|||
164014061|NCT03241173|592414630|FG012|Overall Study|Lost to Follow-up|0|||
164014062|NCT03241173|592414631|FG013|Overall Study|Lost to Follow-up|0|||
164014063|NCT03241173|592414632|FG014|Overall Study|Lost to Follow-up|0|||
164384035|NCT04808609|593775688|FG000|Overall Study|Administrative Withdrawal|0|||
164384036|NCT04808609|593775689|FG001|Overall Study|Administrative Withdrawal|1|||
164384037|NCT00562159|593775690|FG000|Overall Study|Adverse Event|11|||
164384038|NCT00562159|593775691|FG001|Overall Study|Adverse Event|8|||
164384039|NCT00562159|593775690|FG000|Overall Study|Lost to Follow-up|5|||
164384040|NCT00562159|593775691|FG001|Overall Study|Lost to Follow-up|4|||
164384041|NCT00562159|593775690|FG000|Overall Study|Withdrawal by Subject|9|||
164384042|NCT00562159|593775691|FG001|Overall Study|Withdrawal by Subject|8|||
164384043|NCT00562159|593775690|FG000|Overall Study|Protocol Violation|12|||
164384044|NCT00562159|593775691|FG001|Overall Study|Protocol Violation|12|||
164384045|NCT00562159|593775690|FG000|Overall Study|Did not meet protocol eligibility|1|||
164384046|NCT00562159|593775691|FG001|Overall Study|Did not meet protocol eligibility|1|||
164384047|NCT01992536|593775703|FG000|Overall Study|Administrative Reason|0|||
164384048|NCT01992536|593775704|FG001|Overall Study|Administrative Reason|0|||
164384049|NCT01992536|593775705|FG002|Overall Study|Administrative Reason|0|||
164384050|NCT01992536|593775706|FG003|Overall Study|Administrative Reason|0|||
164384051|NCT01992536|593775707|FG004|Overall Study|Administrative Reason|0|||
164384052|NCT01992536|593775708|FG005|Overall Study|Administrative Reason|0|||
164384053|NCT01992536|593775709|FG006|Overall Study|Administrative Reason|7|||
164384054|NCT01992536|593775710|FG007|Overall Study|Administrative Reason|0|||
164384055|NCT01992536|593775711|FG008|Overall Study|Administrative Reason|0|||
164384056|NCT01992536|593775712|FG009|Overall Study|Administrative Reason|0|||
164384057|NCT01992536|593775703|FG000|Overall Study|Lost to Follow-up|4|||
164384058|NCT01992536|593775704|FG001|Overall Study|Lost to Follow-up|2|||
164384059|NCT01992536|593775705|FG002|Overall Study|Lost to Follow-up|1|||
164384060|NCT01992536|593775706|FG003|Overall Study|Lost to Follow-up|0|||
164384061|NCT01992536|593775707|FG004|Overall Study|Lost to Follow-up|0|||
164384062|NCT01992536|593775708|FG005|Overall Study|Lost to Follow-up|1|||
164384063|NCT01992536|593775709|FG006|Overall Study|Lost to Follow-up|0|||
164384064|NCT01992536|593775710|FG007|Overall Study|Lost to Follow-up|0|||
164384065|NCT01992536|593775711|FG008|Overall Study|Lost to Follow-up|1|||
164384066|NCT01992536|593775712|FG009|Overall Study|Lost to Follow-up|1|||
164384067|NCT01992536|593775703|FG000|Overall Study|Withdrawal by Subject|0|||
164384068|NCT01992536|593775704|FG001|Overall Study|Withdrawal by Subject|1|||
164014064|NCT00515463|592414633|FG000|Overall Study|Physician Decision|4|||
164014065|NCT00515463|592414634|FG001|Overall Study|Physician Decision|2|||
164014066|NCT00515463|592414633|FG000|Overall Study|Adverse Event|1|||
164014067|NCT00515463|592414634|FG001|Overall Study|Adverse Event|2|||
164384069|NCT01992536|593775705|FG002|Overall Study|Withdrawal by Subject|0|||
164384070|NCT01992536|593775706|FG003|Overall Study|Withdrawal by Subject|2|||
164384071|NCT01992536|593775707|FG004|Overall Study|Withdrawal by Subject|0|||
164384072|NCT01992536|593775708|FG005|Overall Study|Withdrawal by Subject|0|||
164384073|NCT01992536|593775709|FG006|Overall Study|Withdrawal by Subject|0|||
164384074|NCT01992536|593775710|FG007|Overall Study|Withdrawal by Subject|0|||
164384075|NCT01992536|593775711|FG008|Overall Study|Withdrawal by Subject|0|||
164384076|NCT01992536|593775712|FG009|Overall Study|Withdrawal by Subject|0|||
164384077|NCT01762761|593775713|FG000|Overall Study|Adverse Event|15|||
164014068|NCT00515463|592414633|FG000|Overall Study|Withdrawal by Subject|3|||
164014069|NCT00515463|592414634|FG001|Overall Study|Withdrawal by Subject|4|||
164014070|NCT00515463|592414633|FG000|Overall Study|Lost to Follow-up|6|||
164014071|NCT00515463|592414634|FG001|Overall Study|Lost to Follow-up|5|||
164384078|NCT01762761|593775714|FG001|Overall Study|Adverse Event|17|||
164384079|NCT01762761|593775713|FG000|Overall Study|Lack of Efficacy|9|||
164384080|NCT01762761|593775714|FG001|Overall Study|Lack of Efficacy|25|||
164384081|NCT01762761|593775713|FG000|Overall Study|Protocol Violation|1|||
164384082|NCT01762761|593775714|FG001|Overall Study|Protocol Violation|1|||
164384083|NCT01762761|593775713|FG000|Overall Study|Study closed/terminated|0|||
164384084|NCT01762761|593775714|FG001|Overall Study|Study closed/terminated|2|||
164384085|NCT01762761|593775713|FG000|Overall Study|Lost to Follow-up|3|||
164384086|NCT01762761|593775714|FG001|Overall Study|Lost to Follow-up|6|||
164384087|NCT01762761|593775713|FG000|Overall Study|Physician Decision|4|||
164384088|NCT01762761|593775714|FG001|Overall Study|Physician Decision|6|||
164384089|NCT01762761|593775713|FG000|Overall Study|Withdrawal by Subject|7|||
164384090|NCT01762761|593775714|FG001|Overall Study|Withdrawal by Subject|8|||
164384091|NCT02352493|593775717|FG000|Overall Study|Pregnancy|0|||
164384092|NCT02352493|593775718|FG001|Overall Study|Pregnancy|0|||
164384093|NCT02352493|593775719|FG002|Overall Study|Pregnancy|0|||
164384094|NCT02352493|593775720|FG003|Overall Study|Pregnancy|0|||
164384095|NCT02352493|593775721|FG004|Overall Study|Pregnancy|0|||
164384096|NCT02352493|593775722|FG005|Overall Study|Pregnancy|0|||
164384097|NCT02352493|593775723|FG006|Overall Study|Pregnancy|1|||
164384098|NCT02352493|593775724|FG007|Overall Study|Pregnancy|0|||
164384099|NCT02352493|593775725|FG008|Overall Study|Pregnancy|1|||
164384100|NCT02352493|593775726|FG009|Overall Study|Pregnancy|0|||
164384101|NCT02352493|593775727|FG010|Overall Study|Pregnancy|0|||
164384102|NCT02352493|593775728|FG011|Overall Study|Pregnancy|0|||
164384103|NCT02352493|593775729|FG012|Overall Study|Pregnancy|0|||
164384104|NCT02352493|593775730|FG013|Overall Study|Pregnancy|0|||
164384105|NCT02352493|593775731|FG014|Overall Study|Pregnancy|0|||
164384106|NCT02352493|593775732|FG015|Overall Study|Pregnancy|0|||
164384107|NCT02352493|593775733|FG016|Overall Study|Pregnancy|0|||
164384108|NCT02352493|593775734|FG017|Overall Study|Pregnancy|0|||
164384109|NCT02352493|593775717|FG000|Overall Study|Withdrawal by Subject|0|||
164384110|NCT02352493|593775718|FG001|Overall Study|Withdrawal by Subject|0|||
164384111|NCT02352493|593775719|FG002|Overall Study|Withdrawal by Subject|0|||
164384112|NCT02352493|593775720|FG003|Overall Study|Withdrawal by Subject|0|||
164384113|NCT02352493|593775721|FG004|Overall Study|Withdrawal by Subject|0|||
164384114|NCT02352493|593775722|FG005|Overall Study|Withdrawal by Subject|0|||
164384115|NCT02352493|593775723|FG006|Overall Study|Withdrawal by Subject|0|||
164384116|NCT02352493|593775724|FG007|Overall Study|Withdrawal by Subject|0|||
164384117|NCT02352493|593775725|FG008|Overall Study|Withdrawal by Subject|1|||
164384118|NCT02352493|593775726|FG009|Overall Study|Withdrawal by Subject|0|||
164384119|NCT02352493|593775727|FG010|Overall Study|Withdrawal by Subject|0|||
164384120|NCT02352493|593775728|FG011|Overall Study|Withdrawal by Subject|0|||
164384121|NCT02352493|593775729|FG012|Overall Study|Withdrawal by Subject|0|||
164384122|NCT02352493|593775730|FG013|Overall Study|Withdrawal by Subject|0|||
164384123|NCT02352493|593775731|FG014|Overall Study|Withdrawal by Subject|1|||
164384124|NCT02352493|593775732|FG015|Overall Study|Withdrawal by Subject|0|||
164384125|NCT02352493|593775733|FG016|Overall Study|Withdrawal by Subject|0|||
164384126|NCT02352493|593775734|FG017|Overall Study|Withdrawal by Subject|0|||
164384127|NCT02352493|593775717|FG000|Overall Study|Lost to Follow-up|0|||
164384128|NCT02352493|593775718|FG001|Overall Study|Lost to Follow-up|0|||
164384129|NCT02352493|593775719|FG002|Overall Study|Lost to Follow-up|0|||
164384130|NCT02352493|593775720|FG003|Overall Study|Lost to Follow-up|0|||
164384131|NCT02352493|593775721|FG004|Overall Study|Lost to Follow-up|0|||
164384132|NCT02352493|593775722|FG005|Overall Study|Lost to Follow-up|0|||
164384133|NCT02352493|593775723|FG006|Overall Study|Lost to Follow-up|0|||
164384134|NCT02352493|593775724|FG007|Overall Study|Lost to Follow-up|0|||
164384135|NCT02352493|593775725|FG008|Overall Study|Lost to Follow-up|0|||
164384136|NCT02352493|593775726|FG009|Overall Study|Lost to Follow-up|1|||
164384137|NCT02352493|593775727|FG010|Overall Study|Lost to Follow-up|0|||
164384138|NCT02352493|593775728|FG011|Overall Study|Lost to Follow-up|0|||
164384139|NCT02352493|593775729|FG012|Overall Study|Lost to Follow-up|1|||
164384140|NCT02352493|593775730|FG013|Overall Study|Lost to Follow-up|2|||
164384141|NCT02352493|593775731|FG014|Overall Study|Lost to Follow-up|0|||
164384142|NCT02352493|593775732|FG015|Overall Study|Lost to Follow-up|0|||
164384143|NCT02352493|593775733|FG016|Overall Study|Lost to Follow-up|0|||
164384144|NCT02352493|593775734|FG017|Overall Study|Lost to Follow-up|0|||
164384145|NCT02162810|593775735|FG000|Overall Study|Protocol Violation|1|||
164384146|NCT02162810|593775736|FG001|Overall Study|Protocol Violation|0|||
164384147|NCT02162810|593775735|FG000|Overall Study|patients did not report compliance|4|||
164384148|NCT02162810|593775736|FG001|Overall Study|patients did not report compliance|1|||
164384149|NCT00389324|593775737|FG000|Run-In Phase|Adverse Event|1|||
164384150|NCT00389324|593775737|FG000|Run-In Phase|Lost to Follow-up|1|||
164384151|NCT00389324|593775737|FG000|Run-In Phase|Withdrawal by Subject|1|||
164384152|NCT00389324|593775737|FG000|Subcutaneous Phase|Adverse Event|2|||
164384153|NCT00389324|593775737|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
164384154|NCT00389324|593775737|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
164384155|NCT00389324|593775737|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
164384156|NCT02317575|593775738|FG000|Period 1|Difficulty with venous cannulation|0|||
164384157|NCT02317575|593775739|FG001|Period 1|Difficulty with venous cannulation|1|||
164384158|NCT02317575|593775740|FG002|Period 1|Difficulty with venous cannulation|0|||
164384159|NCT02317575|593775741|FG003|Period 1|Difficulty with venous cannulation|0|||
164384160|NCT02317575|593775742|FG004|Period 1|Difficulty with venous cannulation|0|||
164014072|NCT00515463|592414633|FG000|Overall Study|Other|0|||
164014073|NCT00515463|592414634|FG001|Overall Study|Other|1|||
164014074|NCT02269319|592414635|FG000|Overall Study|Lost to Follow-up|4|||
164014075|NCT02269319|592414636|FG001|Overall Study|Lost to Follow-up|3|||
164014076|NCT02269319|592414635|FG000|Overall Study|Adverse Event|0|||
164014077|NCT02269319|592414636|FG001|Overall Study|Adverse Event|1|||
164014078|NCT02269319|592414635|FG000|Overall Study|Instructions not followed|1|||
164014079|NCT02269319|592414636|FG001|Overall Study|Instructions not followed|0|||
164014080|NCT01158534|592416225|FG000|Overall Study|Withdrawal by Subject|1|||
164014081|NCT01158534|592416225|FG000|Overall Study|Death|1|||
164014082|NCT01158534|592416225|FG000|Overall Study|Other|1|||
164014083|NCT01115569|592416226|FG000|Conversion/Titration Phase|Adverse Event|59|||
164014084|NCT01115569|592416227|FG001|Conversion/Titration Phase|Adverse Event|0|||
164014085|NCT01115569|592416226|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
164014086|NCT01115569|592416227|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
164014087|NCT01115569|592416226|FG000|Conversion/Titration Phase|Physician Decision|5|||
164014088|NCT01115569|592416227|FG001|Conversion/Titration Phase|Physician Decision|0|||
164014089|NCT01115569|592416226|FG000|Conversion/Titration Phase|Protocol Violation|68|||
164014090|NCT01115569|592416227|FG001|Conversion/Titration Phase|Protocol Violation|0|||
164014091|NCT01115569|592416226|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
164014092|NCT01115569|592416227|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
164014093|NCT01115569|592416226|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
164014094|NCT01115569|592416227|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
164014095|NCT01115569|592416226|FG000|Maintenance Phase|Adverse Event|0|||
164014096|NCT01115569|592416227|FG001|Maintenance Phase|Adverse Event|43|||
164014097|NCT01115569|592416226|FG000|Maintenance Phase|Lost to Follow-up|0|||
164014098|NCT01115569|592416227|FG001|Maintenance Phase|Lost to Follow-up|8|||
164014099|NCT01115569|592416226|FG000|Maintenance Phase|Physician Decision|0|||
164014100|NCT01115569|592416227|FG001|Maintenance Phase|Physician Decision|3|||
164014101|NCT01115569|592416226|FG000|Maintenance Phase|Protocol Violation|0|||
164014102|NCT01115569|592416227|FG001|Maintenance Phase|Protocol Violation|9|||
164014103|NCT01115569|592416226|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164014104|NCT01115569|592416227|FG001|Maintenance Phase|Withdrawal by Subject|27|||
164014105|NCT01115569|592416226|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
164014106|NCT01115569|592416227|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
164014107|NCT01115569|592416226|FG000|Maintenance Phase|Administrative|0|||
164014108|NCT01115569|592416227|FG001|Maintenance Phase|Administrative|1|||
164014109|NCT01614769|592416228|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
164014110|NCT01614769|592416229|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
164014111|NCT01614769|592416230|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
164014112|NCT01614769|592416231|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
164014113|NCT01614769|592416232|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
164014114|NCT01614769|592416233|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
164014115|NCT01614769|592416228|FG000|Period 1|Protocol Violation|0|||
164014116|NCT01614769|592416229|FG001|Period 1|Protocol Violation|0|||
164014117|NCT01614769|592416230|FG002|Period 1|Protocol Violation|0|||
164014118|NCT01614769|592416231|FG003|Period 1|Protocol Violation|1|||
164014119|NCT01614769|592416232|FG004|Period 1|Protocol Violation|0|||
164014120|NCT01614769|592416233|FG005|Period 1|Protocol Violation|0|||
164014121|NCT01614769|592416228|FG000|Period 1|Withdrawal by Subject|1|||
164014122|NCT01614769|592416229|FG001|Period 1|Withdrawal by Subject|0|||
164014123|NCT01614769|592416230|FG002|Period 1|Withdrawal by Subject|0|||
164014124|NCT01614769|592416231|FG003|Period 1|Withdrawal by Subject|0|||
164014125|NCT01614769|592416232|FG004|Period 1|Withdrawal by Subject|0|||
164014126|NCT01614769|592416233|FG005|Period 1|Withdrawal by Subject|0|||
164014127|NCT01614769|592416228|FG000|Period 3|Withdrawal by Subject|0|||
164014128|NCT01614769|592416229|FG001|Period 3|Withdrawal by Subject|0|||
164014129|NCT01614769|592416230|FG002|Period 3|Withdrawal by Subject|1|||
164014130|NCT01614769|592416231|FG003|Period 3|Withdrawal by Subject|0|||
164014131|NCT01614769|592416232|FG004|Period 3|Withdrawal by Subject|0|||
164014132|NCT01614769|592416233|FG005|Period 3|Withdrawal by Subject|0|||
164014133|NCT02115815|592416234|FG000|Overall Study|Withdrawal by Subject|2|||
164014134|NCT02115815|592416235|FG001|Overall Study|Withdrawal by Subject|0|||
164014135|NCT02115815|592416236|FG002|Overall Study|Withdrawal by Subject|0|||
164014136|NCT02115815|592416237|FG003|Overall Study|Withdrawal by Subject|0|||
164014137|NCT02115815|592416238|FG004|Overall Study|Withdrawal by Subject|0|||
164014138|NCT02115815|592416239|FG005|Overall Study|Withdrawal by Subject|0|||
164014139|NCT02115815|592416240|FG006|Overall Study|Withdrawal by Subject|0|||
164014140|NCT02115815|592416234|FG000|Overall Study|Not enough drug to dose participant|0|||
164014141|NCT02115815|592416235|FG001|Overall Study|Not enough drug to dose participant|0|||
164014142|NCT02115815|592416236|FG002|Overall Study|Not enough drug to dose participant|0|||
164014143|NCT02115815|592416237|FG003|Overall Study|Not enough drug to dose participant|0|||
164014144|NCT02115815|592416238|FG004|Overall Study|Not enough drug to dose participant|0|||
164014145|NCT02115815|592416239|FG005|Overall Study|Not enough drug to dose participant|1|||
164014146|NCT02115815|592416240|FG006|Overall Study|Not enough drug to dose participant|0|||
164014147|NCT02115815|592416234|FG000|Overall Study|Missed appointment, randomized in error|0|||
164384161|NCT02317575|593775738|FG000|Period 1|Withdrawal by Subject|1|||
164384162|NCT02317575|593775739|FG001|Period 1|Withdrawal by Subject|0|||
164384163|NCT02317575|593775740|FG002|Period 1|Withdrawal by Subject|0|||
164384164|NCT02317575|593775741|FG003|Period 1|Withdrawal by Subject|0|||
164384165|NCT02317575|593775742|FG004|Period 1|Withdrawal by Subject|0|||
164384166|NCT01465334|593775743|FG000|Overall Study|Disease Progression|1|||
164384167|NCT01465334|593775744|FG001|Overall Study|Disease Progression|0|||
164384168|NCT01465334|593775743|FG000|Overall Study|Adverse Event|1|||
164384169|NCT01465334|593775744|FG001|Overall Study|Adverse Event|0|||
164384170|NCT01465334|593775743|FG000|Overall Study|Richter's transformation|0|||
164384171|NCT01465334|593775744|FG001|Overall Study|Richter's transformation|3|||
164384172|NCT01465334|593775743|FG000|Overall Study|Refractory Disease|0|||
164384173|NCT01465334|593775744|FG001|Overall Study|Refractory Disease|3|||
164384174|NCT00572572|593775745|FG000|Overall Study|Withdrawal by Subject|3|||
164384175|NCT00572572|593775746|FG001|Overall Study|Withdrawal by Subject|6|||
164384176|NCT01831089|593775747|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
164384177|NCT01831089|593775748|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
164384178|NCT01831089|593775749|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
164384179|NCT01831089|593775750|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
164384180|NCT01831089|593775751|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
164384181|NCT01831089|593775752|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
164384182|NCT01831089|593775747|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
164384183|NCT01831089|593775748|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
164384184|NCT01831089|593775749|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
164384185|NCT01831089|593775750|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
164384186|NCT01831089|593775751|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
164384187|NCT01831089|593775752|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
164384188|NCT01831089|593775747|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384189|NCT01831089|593775748|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
164384190|NCT01831089|593775749|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384191|NCT01831089|593775750|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384192|NCT01831089|593775751|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164014148|NCT02115815|592416235|FG001|Overall Study|Missed appointment, randomized in error|0|||
164014149|NCT02115815|592416236|FG002|Overall Study|Missed appointment, randomized in error|0|||
164014150|NCT02115815|592416237|FG003|Overall Study|Missed appointment, randomized in error|0|||
164014151|NCT02115815|592416238|FG004|Overall Study|Missed appointment, randomized in error|0|||
164014152|NCT02115815|592416239|FG005|Overall Study|Missed appointment, randomized in error|1|||
164014153|NCT02115815|592416240|FG006|Overall Study|Missed appointment, randomized in error|0|||
164014154|NCT02819310|592416241|FG000|Overall Study|Withdrawal by Subject|37|||
164014155|NCT02819310|592416241|FG000|Overall Study|Lost to Follow-up|16|||
164014156|NCT02819310|592416241|FG000|Overall Study|Adverse Event|13|||
164014157|NCT02819310|592416241|FG000|Overall Study|Lack of Efficacy|5|||
164014158|NCT02819310|592416241|FG000|Overall Study|Physician Decision|8|||
164014159|NCT02819310|592416241|FG000|Overall Study|Protocol Violation|30|||
164014160|NCT01254604|592416246|FG000|Overall Study|Lost to Follow-up|1|||
164014161|NCT01254604|592416247|FG001|Overall Study|Lost to Follow-up|1|||
164014162|NCT01254604|592416246|FG000|Overall Study|Protocol Violation|2|||
164014163|NCT01254604|592416247|FG001|Overall Study|Protocol Violation|2|||
164014164|NCT01254604|592416246|FG000|Overall Study|Withdrawal by Subject|2|||
164014165|NCT01254604|592416247|FG001|Overall Study|Withdrawal by Subject|4|||
164014166|NCT01254604|592416246|FG000|Overall Study|Adverse Event|3|||
164384193|NCT01831089|593775752|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
164384194|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
164384195|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
164384196|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
164384197|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
164384198|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
164384199|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
164384200|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164014167|NCT01254604|592416247|FG001|Overall Study|Adverse Event|2|||
164014168|NCT03074162|592416248|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164384201|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164014169|NCT03074162|592416249|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164014170|NCT03074162|592416250|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
164014171|NCT03074162|592416251|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164014172|NCT03074162|592416252|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164014173|NCT03074162|592416253|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
164014174|NCT03074162|592416248|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164014175|NCT03074162|592416249|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164014176|NCT03074162|592416250|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
164384202|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
164384203|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164384204|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164384205|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
164384206|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
164384207|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
164384208|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
164384209|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
164384210|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
164384211|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
164384212|NCT01831089|593775747|FG000|Cohort III: Dose Level 3|Global end of study|0|||
164384213|NCT01831089|593775748|FG001|Cohort III: Dose Level 3|Global end of study|0|||
164384214|NCT01831089|593775749|FG002|Cohort III: Dose Level 3|Global end of study|1|||
164384215|NCT01831089|593775750|FG003|Cohort III: Dose Level 3|Global end of study|0|||
164384216|NCT01831089|593775751|FG004|Cohort III: Dose Level 3|Global end of study|0|||
164384217|NCT01831089|593775752|FG005|Cohort III: Dose Level 3|Global end of study|0|||
164384218|NCT01831089|593775747|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
164384219|NCT01831089|593775748|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
164384220|NCT01831089|593775749|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
164384221|NCT01831089|593775750|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
164384222|NCT01831089|593775751|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
164384223|NCT01831089|593775752|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
164384224|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
164384225|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
164384226|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
164384227|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
164384228|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
164384229|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
164384230|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384231|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384232|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384233|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384234|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
164384235|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
164384236|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Death|0|||
164384237|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Death|0|||
164384238|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Death|0|||
164384239|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Death|0|||
164384240|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Death|1|||
164384241|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Death|0|||
164384242|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Global end of study|0|||
164384243|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Global end of study|0|||
164384244|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Global end of study|0|||
164384245|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Global end of study|0|||
164384246|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Global end of study|2|||
164384247|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Global end of study|0|||
164384248|NCT01831089|593775747|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384249|NCT01831089|593775748|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384250|NCT01831089|593775749|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164014177|NCT03074162|592416251|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164014178|NCT03074162|592416252|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
164014179|NCT03074162|592416253|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
164384251|NCT01831089|593775750|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384252|NCT01831089|593775751|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
164384253|NCT01831089|593775752|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
164384254|NCT01831089|593775747|FG000|Cohort B: Arm B|Progressive disease|0|||
164384255|NCT01831089|593775748|FG001|Cohort B: Arm B|Progressive disease|0|||
164384256|NCT01831089|593775749|FG002|Cohort B: Arm B|Progressive disease|0|||
164384257|NCT01831089|593775750|FG003|Cohort B: Arm B|Progressive disease|0|||
164384258|NCT01831089|593775751|FG004|Cohort B: Arm B|Progressive disease|0|||
164384259|NCT01831089|593775752|FG005|Cohort B: Arm B|Progressive disease|8|||
164384260|NCT01831089|593775747|FG000|Cohort B: Arm B|Physician Decision|0|||
164384261|NCT01831089|593775748|FG001|Cohort B: Arm B|Physician Decision|0|||
163903174|NCT00641537|592015912|FG005|96-week Period|Death|0|||
163903175|NCT00641537|592015913|FG006|96-week Period|Death|0|||
163903176|NCT00641537|592015914|FG007|96-week Period|Death|0|||
163903177|NCT00641537|592015907|FG000|96-week Period|Other|4|||
163903178|NCT00641537|592015908|FG001|96-week Period|Other|7|||
163903179|NCT00641537|592015909|FG002|96-week Period|Other|14|||
163903180|NCT00641537|592015910|FG003|96-week Period|Other|9|||
163903181|NCT00641537|592015911|FG004|96-week Period|Other|11|||
163903182|NCT00641537|592015912|FG005|96-week Period|Other|6|||
163903183|NCT00641537|592015913|FG006|96-week Period|Other|4|||
163903184|NCT00641537|592015914|FG007|96-week Period|Other|6|||
163903185|NCT00641537|592015907|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
163903186|NCT00641537|592015908|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
163903187|NCT00641537|592015909|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
163903188|NCT00641537|592015910|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
163903189|NCT00641537|592015911|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
163903190|NCT00641537|592015912|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
163903191|NCT00641537|592015913|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
163903192|NCT00641537|592015914|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
163903193|NCT00641537|592015907|FG000|24-Week Supplemental Follow-up Period|Other|0|||
163903194|NCT00641537|592015908|FG001|24-Week Supplemental Follow-up Period|Other|2|||
163903195|NCT00641537|592015909|FG002|24-Week Supplemental Follow-up Period|Other|2|||
163903196|NCT00641537|592015910|FG003|24-Week Supplemental Follow-up Period|Other|1|||
163903197|NCT00641537|592015911|FG004|24-Week Supplemental Follow-up Period|Other|3|||
163903198|NCT00641537|592015912|FG005|24-Week Supplemental Follow-up Period|Other|0|||
163903199|NCT00641537|592015913|FG006|24-Week Supplemental Follow-up Period|Other|1|||
163903200|NCT00641537|592015914|FG007|24-Week Supplemental Follow-up Period|Other|1|||
163903201|NCT03229408|592015915|FG000|Overall Study|Withdrawal by Subject|4|||
163903202|NCT03229408|592015916|FG001|Overall Study|Withdrawal by Subject|1|||
163903203|NCT03229408|592015915|FG000|Overall Study|Adverse Event|2|||
163903204|NCT03229408|592015916|FG001|Overall Study|Adverse Event|0|||
163903205|NCT03229408|592015915|FG000|Overall Study|Pregnancy|0|||
163903206|NCT03229408|592015916|FG001|Overall Study|Pregnancy|1|||
163903207|NCT03229408|592015915|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
163903208|NCT03229408|592015916|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
163903209|NCT03745313|592015919|FG000|At 30 Days Follow-up|Death|2|||
163903210|NCT03745313|592015919|FG000|At 6 Months Follow-up|Death|1|||
163903211|NCT03745313|592015919|FG000|At 6 Months Follow-up|Missed Visit|1|||
163903212|NCT03745313|592015919|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
163903213|NCT03745313|592015919|FG000|At 1 Year Follow-up|Death|2|||
163903214|NCT03745313|592015919|FG000|At 1 Year Follow-up|Missed Visit|2|||
163903215|NCT03745313|592015919|FG000|At 2 Year Follow-up|Missed Visit|1|||
163903216|NCT02052440|592015923|FG000|Overall Study|Withdrawal by Subject|0|||
163903217|NCT02052440|592015924|FG001|Overall Study|Withdrawal by Subject|1|||
163903218|NCT01367236|592015925|FG000|Overall Study|Withdrawal by Subject|3|||
163903219|NCT01367236|592015926|FG001|Overall Study|Withdrawal by Subject|1|||
163903220|NCT02235298|592015927|FG000|Overall Study|Lost to Follow-up|6|||
163903221|NCT02235298|592015928|FG001|Overall Study|Lost to Follow-up|5|||
163903222|NCT02235298|592015927|FG000|Overall Study|Adverse Event|2|||
163903223|NCT02235298|592015928|FG001|Overall Study|Adverse Event|2|||
163903224|NCT02235298|592015927|FG000|Overall Study|Withdrawal by Subject|0|||
163903225|NCT02235298|592015928|FG001|Overall Study|Withdrawal by Subject|1|||
163903226|NCT02628626|592015933|FG000|Overall Study|Withdrawal by Subject|2|||
163903227|NCT02628626|592015934|FG001|Overall Study|Withdrawal by Subject|2|||
163903228|NCT01593020|592015935|FG000|Overall Study|Adverse Event|1|||
163903229|NCT01593020|592015936|FG001|Overall Study|Adverse Event|1|||
163903230|NCT01593020|592015935|FG000|Overall Study|Death|0|||
163903231|NCT01593020|592015936|FG001|Overall Study|Death|1|||
163903232|NCT01593020|592015935|FG000|Overall Study|Ineligible|1|||
163903233|NCT01593020|592015936|FG001|Overall Study|Ineligible|0|||
164384262|NCT01831089|593775749|FG002|Cohort B: Arm B|Physician Decision|0|||
163903234|NCT04801420|592015942|FG000|Overall Study|Other|1|||
164384263|NCT01831089|593775750|FG003|Cohort B: Arm B|Physician Decision|0|||
164384264|NCT01831089|593775751|FG004|Cohort B: Arm B|Physician Decision|0|||
164384265|NCT01831089|593775752|FG005|Cohort B: Arm B|Physician Decision|2|||
163903235|NCT04801420|592015943|FG001|Overall Study|Other|2|||
163903236|NCT04801420|592015944|FG002|Overall Study|Other|1|||
163903237|NCT04801420|592015942|FG000|Overall Study|Lost to Follow-up|7|||
163903238|NCT04801420|592015943|FG001|Overall Study|Lost to Follow-up|9|||
163903239|NCT04801420|592015944|FG002|Overall Study|Lost to Follow-up|10|||
163903240|NCT04801420|592015942|FG000|Overall Study|Moved from study area|0|||
163903241|NCT04801420|592015943|FG001|Overall Study|Moved from study area|1|||
163903242|NCT04801420|592015944|FG002|Overall Study|Moved from study area|1|||
163903243|NCT04801420|592015942|FG000|Overall Study|Withdrawal by Subject|5|||
163903244|NCT04801420|592015943|FG001|Overall Study|Withdrawal by Subject|1|||
163903245|NCT04801420|592015944|FG002|Overall Study|Withdrawal by Subject|4|||
164384266|NCT01831089|593775747|FG000|Cohort B: Arm B|Never treated|0|||
164384267|NCT01831089|593775748|FG001|Cohort B: Arm B|Never treated|0|||
164384268|NCT01831089|593775749|FG002|Cohort B: Arm B|Never treated|0|||
164384269|NCT01831089|593775750|FG003|Cohort B: Arm B|Never treated|0|||
164384270|NCT01831089|593775751|FG004|Cohort B: Arm B|Never treated|0|||
164384271|NCT01831089|593775752|FG005|Cohort B: Arm B|Never treated|2|||
164384272|NCT01831089|593775747|FG000|Cohort B: Arm B|Adverse Event|0|||
164384273|NCT01831089|593775748|FG001|Cohort B: Arm B|Adverse Event|0|||
164384274|NCT01831089|593775749|FG002|Cohort B: Arm B|Adverse Event|0|||
164384275|NCT01831089|593775750|FG003|Cohort B: Arm B|Adverse Event|0|||
163903246|NCT04801420|592015942|FG000|Overall Study|Individual stopping criteria reached|0|||
164384276|NCT01831089|593775751|FG004|Cohort B: Arm B|Adverse Event|0|||
164384277|NCT01831089|593775752|FG005|Cohort B: Arm B|Adverse Event|1|||
163903247|NCT04801420|592015943|FG001|Overall Study|Individual stopping criteria reached|1|||
164384278|NCT01831089|593775747|FG000|Cohort B: Arm B|Global end of study|0|||
164384279|NCT01831089|593775748|FG001|Cohort B: Arm B|Global end of study|0|||
164384280|NCT01831089|593775749|FG002|Cohort B: Arm B|Global end of study|0|||
163903248|NCT04801420|592015944|FG002|Overall Study|Individual stopping criteria reached|0|||
163903249|NCT04801420|592015942|FG000|Overall Study|Ongoing in the study|195|||
164384281|NCT01831089|593775750|FG003|Cohort B: Arm B|Global end of study|0|||
164384282|NCT01831089|593775751|FG004|Cohort B: Arm B|Global end of study|0|||
164384283|NCT01831089|593775752|FG005|Cohort B: Arm B|Global end of study|1|||
164384284|NCT00889421|593775753|FG000|Overall Study|Lack of Efficacy|3|||
164014180|NCT03074162|592416248|FG000|Period 3|Withdrawal by Subject|1|||
164014181|NCT03074162|592416249|FG001|Period 3|Withdrawal by Subject|0|||
164384285|NCT03936244|593775757|FG000|Overall Study|Lost to Follow-up|5|||
164384286|NCT03936244|593775758|FG001|Overall Study|Lost to Follow-up|1|||
164384287|NCT03936244|593775757|FG000|Overall Study|Physician Decision|7|||
164384288|NCT03936244|593775758|FG001|Overall Study|Physician Decision|3|||
164384289|NCT02480621|593775772|FG000|Randomization|Withdrawal by Subject|1|||
164384290|NCT02480621|593775773|FG001|Randomization|Withdrawal by Subject|0|||
164384291|NCT02480621|593775772|FG000|Randomization|Surgeon did not give intervention|0|||
164384292|NCT02480621|593775773|FG001|Randomization|Surgeon did not give intervention|1|||
164384293|NCT02480621|593775772|FG000|Follow Up|Lost to Follow-up|4|||
164014182|NCT03074162|592416250|FG002|Period 3|Withdrawal by Subject|0|||
164014183|NCT03074162|592416251|FG003|Period 3|Withdrawal by Subject|0|||
164014184|NCT03074162|592416252|FG004|Period 3|Withdrawal by Subject|1|||
164014185|NCT03074162|592416253|FG005|Period 3|Withdrawal by Subject|0|||
164014186|NCT02778867|592416254|FG000|Phase 1|Withdrawal by Subject|2|||
164014187|NCT02778867|592416255|FG001|Phase 1|Withdrawal by Subject|3|||
164014188|NCT02778867|592416256|FG002|Phase 1|Withdrawal by Subject|0|||
164014189|NCT02778867|592416257|FG003|Phase 1|Withdrawal by Subject|0|||
164014190|NCT02778867|592416254|FG000|Phase 2|Withdrawal by Subject|0|||
164014191|NCT02778867|592416255|FG001|Phase 2|Withdrawal by Subject|0|||
164014192|NCT02778867|592416256|FG002|Phase 2|Withdrawal by Subject|1|||
164014193|NCT02778867|592416257|FG003|Phase 2|Withdrawal by Subject|0|||
164014194|NCT02778867|592416254|FG000|Phase 2|Physician Decision|0|||
164014195|NCT02778867|592416255|FG001|Phase 2|Physician Decision|0|||
164014196|NCT02778867|592416256|FG002|Phase 2|Physician Decision|0|||
164014197|NCT02778867|592416257|FG003|Phase 2|Physician Decision|1|||
164014198|NCT02778867|592416254|FG000|Phase 2|Adverse Event|0|||
164014199|NCT02778867|592416255|FG001|Phase 2|Adverse Event|0|||
164014200|NCT02778867|592416256|FG002|Phase 2|Adverse Event|0|||
164014201|NCT02778867|592416257|FG003|Phase 2|Adverse Event|1|||
164014202|NCT02948777|592416258|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
164014203|NCT02311478|592416259|FG000|Overall Study|Withdrawal by Subject|1|||
164014204|NCT02311478|592416259|FG000|Overall Study|Lost to Follow-up|5|||
164014205|NCT02311478|592416259|FG000|Overall Study|Failed IUD Insertion|1|||
164014206|NCT03242928|592416261|FG000|Overall Study|Adverse Event|2|||
164014207|NCT03242928|592416262|FG001|Overall Study|Adverse Event|1|||
164014208|NCT03242928|592416261|FG000|Overall Study|Lost to Follow-up|2|||
164014209|NCT03242928|592416262|FG001|Overall Study|Lost to Follow-up|0|||
164014210|NCT03242928|592416261|FG000|Overall Study|Physician Decision|0|||
164014211|NCT03242928|592416262|FG001|Overall Study|Physician Decision|1|||
164384294|NCT02480621|593775773|FG001|Follow Up|Lost to Follow-up|2|||
164384295|NCT01748994|593775774|FG000|Overall Study|Lost to Follow-up|8|||
164384296|NCT01748994|593775775|FG001|Overall Study|Lost to Follow-up|6|||
164384297|NCT03105362|593775776|FG000|Overall Study|Withdrawal by Subject|1|||
164384298|NCT03105362|593775776|FG000|Overall Study|Lost to Follow-up|1|||
164384299|NCT00861341|593775778|FG000|Overall Study|Withdrawal by Subject|2|||
164384300|NCT01440946|593775779|FG000|Overall Study|Lost to Follow-up|1|||
164384301|NCT01440946|593775780|FG001|Overall Study|Lost to Follow-up|1|||
164384302|NCT01440946|593775779|FG000|Overall Study|Physician Decision|1|||
164384303|NCT01440946|593775780|FG001|Overall Study|Physician Decision|0|||
164384304|NCT01975389|593775781|FG000|Overall Study|Adverse Event|10|||
164384305|NCT01975389|593775782|FG001|Overall Study|Adverse Event|6|||
164384306|NCT01975389|593775781|FG000|Overall Study|Death|61|||
164384307|NCT01975389|593775782|FG001|Overall Study|Death|54|||
164384308|NCT01975389|593775781|FG000|Overall Study|Lost to Follow-up|81|||
164384309|NCT01975389|593775782|FG001|Overall Study|Lost to Follow-up|86|||
164384310|NCT01975389|593775781|FG000|Overall Study|Withdrawal by Subject|90|||
164384311|NCT01975389|593775782|FG001|Overall Study|Withdrawal by Subject|76|||
164384312|NCT01975389|593775781|FG000|Overall Study|Other|6|||
164384313|NCT01975389|593775782|FG001|Overall Study|Other|9|||
164384314|NCT01975389|593775781|FG000|Overall Study|Randomized, not treated|4|||
164384315|NCT01975389|593775782|FG001|Overall Study|Randomized, not treated|5|||
164384316|NCT02296112|593775789|FG000|Overall Study|Disease progression|7|||
164384317|NCT02296112|593775789|FG000|Overall Study|Toxicity|1|||
164384318|NCT02296112|593775789|FG000|Overall Study|Began an alternate therapy|1|||
164384319|NCT02778204|593775790|FG000|Overall Study|Adverse Event|1|||
164014212|NCT03242928|592416261|FG000|Overall Study|Withdrawal by Subject|5|||
164014213|NCT03242928|592416262|FG001|Overall Study|Withdrawal by Subject|3|||
164014214|NCT03276936|592416263|FG000|Overall Study|Adverse Event|4|||
164014215|NCT03276936|592416264|FG001|Overall Study|Adverse Event|2|||
164384320|NCT02778204|593775791|FG001|Overall Study|Adverse Event|0|||
164384321|NCT02778204|593775792|FG002|Overall Study|Adverse Event|0|||
164384322|NCT02778204|593775793|FG003|Overall Study|Adverse Event|0|||
164384323|NCT02778204|593775790|FG000|Overall Study|Withdrawal by Subject|0|||
164384324|NCT02778204|593775791|FG001|Overall Study|Withdrawal by Subject|0|||
164384325|NCT02778204|593775792|FG002|Overall Study|Withdrawal by Subject|1|||
164384326|NCT02778204|593775793|FG003|Overall Study|Withdrawal by Subject|2|||
164384327|NCT02778204|593775790|FG000|Overall Study|Lost to Follow-up|1|||
164384328|NCT02778204|593775791|FG001|Overall Study|Lost to Follow-up|0|||
164384329|NCT02778204|593775792|FG002|Overall Study|Lost to Follow-up|2|||
164384330|NCT02778204|593775793|FG003|Overall Study|Lost to Follow-up|1|||
164384331|NCT02778204|593775790|FG000|Overall Study|Protocol Violation|0|||
164384332|NCT02778204|593775791|FG001|Overall Study|Protocol Violation|0|||
164384333|NCT02778204|593775792|FG002|Overall Study|Protocol Violation|1|||
164384334|NCT02778204|593775793|FG003|Overall Study|Protocol Violation|0|||
164384335|NCT02778204|593775790|FG000|Overall Study|Eligibility Violation|0|||
164384336|NCT02778204|593775791|FG001|Overall Study|Eligibility Violation|0|||
164384337|NCT02778204|593775792|FG002|Overall Study|Eligibility Violation|0|||
164384338|NCT02778204|593775793|FG003|Overall Study|Eligibility Violation|1|||
164384339|NCT01720069|593775794|FG000|Overall Study|Could not use e-diary correctly|0|||
164384340|NCT01720069|593775795|FG001|Overall Study|Could not use e-diary correctly|1|||
164384341|NCT01720069|593775796|FG002|Overall Study|Could not use e-diary correctly|1|||
164384342|NCT01720069|593775794|FG000|Overall Study|Randomised without baseline values|0|||
164384343|NCT01720069|593775795|FG001|Overall Study|Randomised without baseline values|0|||
164384344|NCT01720069|593775796|FG002|Overall Study|Randomised without baseline values|1|||
164384345|NCT01720069|593775794|FG000|Overall Study|Adverse Event|0|||
164384346|NCT01720069|593775795|FG001|Overall Study|Adverse Event|0|||
164384347|NCT01720069|593775796|FG002|Overall Study|Adverse Event|1|||
164384348|NCT01720069|593775794|FG000|Overall Study|Lack of Efficacy|0|||
164384349|NCT01720069|593775795|FG001|Overall Study|Lack of Efficacy|4|||
164384350|NCT01720069|593775796|FG002|Overall Study|Lack of Efficacy|0|||
164384351|NCT01720069|593775794|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
164384352|NCT01720069|593775795|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
164384353|NCT01720069|593775796|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
164384354|NCT01720069|593775794|FG000|Overall Study|Withdrawal by Subject|0|||
164384355|NCT01720069|593775795|FG001|Overall Study|Withdrawal by Subject|2|||
164384356|NCT01720069|593775796|FG002|Overall Study|Withdrawal by Subject|1|||
164384357|NCT01720069|593775794|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
164384358|NCT01720069|593775795|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
164384359|NCT01720069|593775796|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
164384360|NCT01720069|593775794|FG000|Overall Study|Non-compliance on using e-diary|0|||
164384361|NCT01720069|593775795|FG001|Overall Study|Non-compliance on using e-diary|0|||
164384362|NCT01720069|593775796|FG002|Overall Study|Non-compliance on using e-diary|1|||
164384363|NCT01720069|593775794|FG000|Overall Study|Lost to Follow-up|0|||
164384364|NCT01720069|593775795|FG001|Overall Study|Lost to Follow-up|0|||
164384365|NCT01720069|593775796|FG002|Overall Study|Lost to Follow-up|1|||
164384366|NCT00360334|593775797|FG000|Overall Study|Adverse Event|7|||
164384367|NCT00360334|593775798|FG001|Overall Study|Adverse Event|4|||
164384368|NCT00360334|593775797|FG000|Overall Study|Protocol Violation|1|||
164384369|NCT00360334|593775798|FG001|Overall Study|Protocol Violation|1|||
164384370|NCT00360334|593775797|FG000|Overall Study|Physician Decision|2|||
164384371|NCT00360334|593775798|FG001|Overall Study|Physician Decision|3|||
164384372|NCT00360334|593775797|FG000|Overall Study|Lack of Efficacy|0|||
164384373|NCT00360334|593775798|FG001|Overall Study|Lack of Efficacy|1|||
164384374|NCT00360334|593775797|FG000|Overall Study|Entry criterion not met|1|||
164384375|NCT00360334|593775798|FG001|Overall Study|Entry criterion not met|2|||
164384376|NCT00360334|593775797|FG000|Overall Study|Subject decision|8|||
164384377|NCT00360334|593775798|FG001|Overall Study|Subject decision|2|||
164384378|NCT01898793|593775799|FG000|Overall Study|Death|2|||
164384379|NCT01898793|593775800|FG001|Overall Study|Death|1|||
164384380|NCT01898793|593775801|FG002|Overall Study|Death|4|||
164384381|NCT01898793|593775802|FG003|Overall Study|Death|0|||
164384382|NCT01898793|593775803|FG004|Overall Study|Death|0|||
164384383|NCT01898793|593775804|FG005|Overall Study|Death|0|||
164384384|NCT01898793|593775805|FG006|Overall Study|Death|0|||
164384385|NCT02239510|593777356|FG000|Overall Study|Lost to Follow-up|2|||
164384386|NCT02239510|593777357|FG001|Overall Study|Lost to Follow-up|1|||
164384387|NCT00982020|593777358|FG000|Overall Study|Adverse Event|19|||
164384388|NCT00982020|593777359|FG001|Overall Study|Adverse Event|15|||
164384389|NCT00982020|593777358|FG000|Overall Study|Withdrawal by Subject|11|||
164384390|NCT00982020|593777359|FG001|Overall Study|Withdrawal by Subject|14|||
164384391|NCT00982020|593777358|FG000|Overall Study|Lost to Follow-up|5|||
164384392|NCT00982020|593777359|FG001|Overall Study|Lost to Follow-up|11|||
164384393|NCT00982020|593777358|FG000|Overall Study|Lack of Efficacy|10|||
164384394|NCT00982020|593777359|FG001|Overall Study|Lack of Efficacy|4|||
164384395|NCT00982020|593777358|FG000|Overall Study|Parent/Caregiver Decision|5|||
164384396|NCT00982020|593777359|FG001|Overall Study|Parent/Caregiver Decision|5|||
164384397|NCT00982020|593777358|FG000|Overall Study|Treatment Non-compliance|3|||
164384398|NCT00982020|593777359|FG001|Overall Study|Treatment Non-compliance|6|||
164384399|NCT00982020|593777358|FG000|Overall Study|Physician Decision|2|||
164384400|NCT00982020|593777359|FG001|Overall Study|Physician Decision|5|||
164384401|NCT00982020|593777358|FG000|Overall Study|Entry Criteria Not Met|2|||
164384402|NCT00982020|593777359|FG001|Overall Study|Entry Criteria Not Met|1|||
164384403|NCT00982020|593777358|FG000|Overall Study|Protocol Violation|0|||
164384404|NCT00982020|593777359|FG001|Overall Study|Protocol Violation|2|||
164384405|NCT00982020|593777358|FG000|Overall Study|Clinical Relapse|0|||
164384406|NCT00982020|593777359|FG001|Overall Study|Clinical Relapse|1|||
164384407|NCT03551938|593777360|FG000|3-Month Follow Up|Lost to Follow-up|39|||
164384408|NCT03551938|593777361|FG001|3-Month Follow Up|Lost to Follow-up|38|||
164384409|NCT03551938|593777360|FG000|6-Month Follow Up|Lost to Follow-up|46|||
164384410|NCT03551938|593777361|FG001|6-Month Follow Up|Lost to Follow-up|42|||
164384411|NCT03551938|593777360|FG000|9-Month Follow Up|Lost to Follow-up|44|||
164384412|NCT03551938|593777361|FG001|9-Month Follow Up|Lost to Follow-up|43|||
164384413|NCT01925183|593777362|FG000|Overall Study|Adverse Event|1|||
164384414|NCT01925183|593777363|FG001|Overall Study|Adverse Event|0|||
164384415|NCT01114646|593777364|FG000|Overall Study|Withdrawal by Subject|3|||
164384416|NCT01114646|593777365|FG001|Overall Study|Withdrawal by Subject|2|||
164384417|NCT01046110|593777366|FG000|Overall Study|Adverse Event|9|||
164384418|NCT01046110|593777367|FG001|Overall Study|Adverse Event|2|||
164384419|NCT01046110|593777366|FG000|Overall Study|Lack of Efficacy|0|||
164384420|NCT01046110|593777367|FG001|Overall Study|Lack of Efficacy|1|||
164384421|NCT01046110|593777366|FG000|Overall Study|Protocol Violation|7|||
164384422|NCT01046110|593777367|FG001|Overall Study|Protocol Violation|12|||
164384423|NCT01046110|593777366|FG000|Overall Study|Withdrawal Criteria|3|||
164384424|NCT01046110|593777367|FG001|Overall Study|Withdrawal Criteria|5|||
164384425|NCT01046110|593777366|FG000|Overall Study|Unclassified|36|||
164384426|NCT01046110|593777367|FG001|Overall Study|Unclassified|35|||
164384427|NCT02667912|593777377|FG000|Overall Study|Death|3|||
164384428|NCT02667912|593777378|FG001|Overall Study|Death|1|||
164384429|NCT02667912|593777377|FG000|Overall Study|Withdrawal by Subject|1|||
164384430|NCT02667912|593777378|FG001|Overall Study|Withdrawal by Subject|2|||
164384431|NCT02667912|593777377|FG000|Overall Study|Withdrawal by Subject|1|||
164384432|NCT02667912|593777378|FG001|Overall Study|Withdrawal by Subject|0|||
164384433|NCT04443218|593777379|FG000|Overall Study|Exited study for other reasons|9|||
164384434|NCT04443218|593777379|FG000|Overall Study|Withdrawal by Subject|1|||
164384435|NCT04443218|593777379|FG000|Overall Study|Lost to Follow-up|4|||
164384436|NCT04443218|593777379|FG000|Overall Study|Death|19|||
164384437|NCT01047683|593777380|FG000|Overall Study|Adverse Event|3|||
164384438|NCT01047683|593777381|FG001|Overall Study|Adverse Event|1|||
164384439|NCT01047683|593777382|FG002|Overall Study|Adverse Event|0|||
164384440|NCT01047683|593777380|FG000|Overall Study|Withdrew Consent|1|||
164384441|NCT01047683|593777381|FG001|Overall Study|Withdrew Consent|4|||
164384442|NCT01047683|593777382|FG002|Overall Study|Withdrew Consent|2|||
164384443|NCT01047683|593777380|FG000|Overall Study|Lost to Follow-up|0|||
164384444|NCT01047683|593777381|FG001|Overall Study|Lost to Follow-up|1|||
164384445|NCT01047683|593777382|FG002|Overall Study|Lost to Follow-up|0|||
164384446|NCT01047683|593777380|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
164384447|NCT01047683|593777381|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
164384448|NCT01047683|593777382|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
164384449|NCT03447769|593777383|FG000|Overall Study|Progressive disease|138|||
164384450|NCT03447769|593777384|FG001|Overall Study|Progressive disease|148|||
164384451|NCT03447769|593777383|FG000|Overall Study|Study terminated by Sponsor|60|||
164384452|NCT03447769|593777384|FG001|Overall Study|Study terminated by Sponsor|44|||
164384453|NCT03447769|593777383|FG000|Overall Study|Adverse Event|34|||
163903250|NCT04801420|592015943|FG001|Overall Study|Ongoing in the study|195|||
163903251|NCT04801420|592015944|FG002|Overall Study|Ongoing in the study|192|||
163903252|NCT05525572|592015945|FG000|Overall Study|Lost to Follow-up|2|||
163903253|NCT00489307|592015952|FG000|Overall Study|Death|1|||
163903254|NCT00489307|592015953|FG001|Overall Study|Death|1|||
163903255|NCT00489307|592015952|FG000|Overall Study|Lost to Follow-up|2|||
163903256|NCT00489307|592015953|FG001|Overall Study|Lost to Follow-up|2|||
163903257|NCT00489307|592015952|FG000|Overall Study|Physician Decision|1|||
163903258|NCT00489307|592015953|FG001|Overall Study|Physician Decision|0|||
164384454|NCT03447769|593777384|FG001|Overall Study|Adverse Event|31|||
164384455|NCT03447769|593777383|FG000|Overall Study|Patient decision|27|||
164384456|NCT03447769|593777384|FG001|Overall Study|Patient decision|27|||
164384457|NCT03447769|593777383|FG000|Overall Study|Protocol deviation|4|||
164384458|NCT03447769|593777384|FG001|Overall Study|Protocol deviation|6|||
164384459|NCT03447769|593777383|FG000|Overall Study|Death|2|||
164384460|NCT03447769|593777384|FG001|Overall Study|Death|7|||
164384461|NCT03447769|593777383|FG000|Overall Study|Technical problems|1|||
164384462|NCT03447769|593777384|FG001|Overall Study|Technical problems|0|||
164384463|NCT03447769|593777383|FG000|Overall Study|Lost to Follow-up|0|||
164384464|NCT03447769|593777384|FG001|Overall Study|Lost to Follow-up|1|||
164384465|NCT03447769|593777383|FG000|Overall Study|Physician Decision|13|||
164384466|NCT03447769|593777384|FG001|Overall Study|Physician Decision|5|||
164384467|NCT00781326|593777387|FG000|Phase I|Adverse Event|1|||
164384468|NCT00781326|593777387|FG000|Phase I|Withdrawal by Subject|1|||
164384469|NCT00781326|593777387|FG000|Phase I|Physician Decision|2|||
164384470|NCT00096941|593777388|FG000|Overall Study|disease progression|3|||
164384471|NCT03029208|593777394|FG000|Overall Study|Withdrawal by Subject|2|||
164384472|NCT03029208|593777395|FG001|Overall Study|Withdrawal by Subject|3|||
164384473|NCT03029208|593777394|FG000|Overall Study|Lost to Follow-up|0|||
164384474|NCT03029208|593777395|FG001|Overall Study|Lost to Follow-up|1|||
164384475|NCT03893448|593777396|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
164384476|NCT03893448|593777397|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
164384477|NCT03893448|593777396|FG000|Overall Study|Physician Decision|8|||
164384478|NCT03893448|593777397|FG001|Overall Study|Physician Decision|14|||
164384479|NCT03893448|593777396|FG000|Overall Study|Lost to Follow-up|34|||
164384480|NCT03893448|593777397|FG001|Overall Study|Lost to Follow-up|27|||
164384481|NCT03893448|593777396|FG000|Overall Study|Death|1|||
164384482|NCT03893448|593777397|FG001|Overall Study|Death|0|||
164384483|NCT01525082|593777400|FG000|Overall Study|Death|1|||
164384484|NCT03321981|593777401|FG000|Overall Study|Progressive Disease (PD)|15|||
164384485|NCT03321981|593777402|FG001|Overall Study|Progressive Disease (PD)|30|||
164384486|NCT03321981|593777403|FG002|Overall Study|Progressive Disease (PD)|47|||
164384487|NCT03321981|593777401|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
164384488|NCT03321981|593777402|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
164384489|NCT03321981|593777403|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
164384490|NCT03321981|593777401|FG000|Overall Study|Adverse Event|0|||
164384491|NCT03321981|593777402|FG001|Overall Study|Adverse Event|0|||
164384492|NCT03321981|593777403|FG002|Overall Study|Adverse Event|2|||
164384493|NCT03321981|593777401|FG000|Overall Study|symptomatic deterioration|0|||
164384494|NCT03321981|593777402|FG001|Overall Study|symptomatic deterioration|1|||
164384495|NCT03321981|593777403|FG002|Overall Study|symptomatic deterioration|1|||
164384496|NCT03321981|593777401|FG000|Overall Study|Lack of compliance|0|||
164384497|NCT03321981|593777402|FG001|Overall Study|Lack of compliance|1|||
164384498|NCT03321981|593777403|FG002|Overall Study|Lack of compliance|0|||
164384499|NCT03321981|593777401|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
164384500|NCT03321981|593777402|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
164384501|NCT03321981|593777403|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
164384502|NCT03321981|593777401|FG000|Overall Study|Death|0|||
164384503|NCT03321981|593777402|FG001|Overall Study|Death|1|||
164384504|NCT03321981|593777403|FG002|Overall Study|Death|0|||
164384505|NCT03321981|593777401|FG000|Overall Study|Subject withdrawal of investigational product|0|||
164384506|NCT03321981|593777402|FG001|Overall Study|Subject withdrawal of investigational product|1|||
164384507|NCT03321981|593777403|FG002|Overall Study|Subject withdrawal of investigational product|0|||
164384508|NCT03321981|593777401|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
164384509|NCT03321981|593777402|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
164384510|NCT03321981|593777403|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
164384511|NCT03321981|593777401|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
164384512|NCT03321981|593777402|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
164384513|NCT03321981|593777403|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
164384514|NCT00022516|593777413|FG000|Overall Study|Adverse Event|0|||
164384515|NCT00022516|593777414|FG001|Overall Study|Adverse Event|59|||
164384516|NCT00022516|593777413|FG000|Overall Study|Lack of Efficacy|0|||
164384517|NCT00022516|593777414|FG001|Overall Study|Lack of Efficacy|27|||
164384518|NCT00022516|593777413|FG000|Overall Study|Physician Decision|0|||
164384519|NCT00022516|593777414|FG001|Overall Study|Physician Decision|1|||
164384520|NCT00022516|593777413|FG000|Overall Study|Protocol Violation|1|||
164384521|NCT00022516|593777414|FG001|Overall Study|Protocol Violation|3|||
164384522|NCT00022516|593777413|FG000|Overall Study|Withdrawal by Subject|2|||
164384523|NCT00022516|593777414|FG001|Overall Study|Withdrawal by Subject|113|||
164384524|NCT00022516|593777413|FG000|Overall Study|Incomplete documentation|0|||
164384525|NCT00022516|593777414|FG001|Overall Study|Incomplete documentation|27|||
164384526|NCT01568047|593777417|FG000|Overall Study|Ineligibility|1|||
164384527|NCT01568047|593777418|FG001|Overall Study|Ineligibility|0|||
164384528|NCT01568047|593777419|FG002|Overall Study|Ineligibility|0|||
164384529|NCT01568047|593777420|FG003|Overall Study|Ineligibility|0|||
164014216|NCT03276936|592416263|FG000|Overall Study|Lost to Follow-up|16|||
164014217|NCT03276936|592416264|FG001|Overall Study|Lost to Follow-up|13|||
164014218|NCT03276936|592416263|FG000|Overall Study|Withdrawal by Subject|30|||
164014219|NCT03276936|592416264|FG001|Overall Study|Withdrawal by Subject|20|||
164014220|NCT03276936|592416263|FG000|Overall Study|Not mentioned|6|||
164014221|NCT03276936|592416264|FG001|Overall Study|Not mentioned|3|||
164014222|NCT00943319|592416265|FG000|Overall Study|Death|1|||
164014223|NCT02043301|592416266|FG000|Overall Study|Discontinued|0|||
164014224|NCT02043301|592416267|FG001|Overall Study|Discontinued|1|||
164014225|NCT02043301|592416268|FG002|Overall Study|Discontinued|0|||
164384530|NCT01568047|593777417|FG000|Overall Study|Withdrawal by Subject|0|||
164014226|NCT03703375|592416272|FG000|Randomization Period|Withdrawal by Subject|0|||
164014227|NCT03703375|592416273|FG001|Randomization Period|Withdrawal by Subject|0|||
164014228|NCT03703375|592416274|FG002|Randomization Period|Withdrawal by Subject|0|||
164014229|NCT03703375|592416275|FG003|Randomization Period|Withdrawal by Subject|1|||
164014230|NCT03703375|592416272|FG000|Randomization Period|Completed safety run-in treatment|7|||
164014231|NCT03703375|592416273|FG001|Randomization Period|Completed safety run-in treatment|0|||
164014232|NCT03703375|592416274|FG002|Randomization Period|Completed safety run-in treatment|0|||
164014233|NCT03703375|592416275|FG003|Randomization Period|Completed safety run-in treatment|0|||
164014234|NCT03703375|592416272|FG000|Treatment Period|Other Reasons|0|||
164014235|NCT03703375|592416273|FG001|Treatment Period|Other Reasons|1|||
164014236|NCT03703375|592416274|FG002|Treatment Period|Other Reasons|0|||
164014237|NCT03703375|592416275|FG003|Treatment Period|Other Reasons|3|||
164014238|NCT03703375|592416272|FG000|Treatment Period|Consent Withdrawal|0|||
164014239|NCT03703375|592416273|FG001|Treatment Period|Consent Withdrawal|0|||
164014240|NCT03703375|592416274|FG002|Treatment Period|Consent Withdrawal|0|||
164014241|NCT03703375|592416275|FG003|Treatment Period|Consent Withdrawal|1|||
164014242|NCT03703375|592416272|FG000|Treatment Period|Death|1|||
164014243|NCT03703375|592416273|FG001|Treatment Period|Death|0|||
164014244|NCT03703375|592416274|FG002|Treatment Period|Death|1|||
164014245|NCT03703375|592416275|FG003|Treatment Period|Death|2|||
164014246|NCT03703375|592416272|FG000|Treatment Period|Toxicity of Study Treatment|2|||
164014247|NCT03703375|592416273|FG001|Treatment Period|Toxicity of Study Treatment|0|||
164014248|NCT03703375|592416274|FG002|Treatment Period|Toxicity of Study Treatment|4|||
164014249|NCT03703375|592416275|FG003|Treatment Period|Toxicity of Study Treatment|1|||
164014250|NCT03703375|592416272|FG000|Treatment Period|Progression|32|||
164014251|NCT03703375|592416273|FG001|Treatment Period|Progression|1|||
164014252|NCT03703375|592416274|FG002|Treatment Period|Progression|7|||
164014253|NCT03703375|592416275|FG003|Treatment Period|Progression|11|||
164014254|NCT03703375|592416272|FG000|Treatment Period|Completed treatment|7|||
164014255|NCT03703375|592416273|FG001|Treatment Period|Completed treatment|2|||
164014256|NCT03703375|592416274|FG002|Treatment Period|Completed treatment|0|||
164014257|NCT03703375|592416275|FG003|Treatment Period|Completed treatment|0|||
164014258|NCT03504774|592416276|FG000|Overall Study|Adverse Event|2|||
164014259|NCT03504774|592416277|FG001|Overall Study|Adverse Event|0|||
164384531|NCT01568047|593777418|FG001|Overall Study|Withdrawal by Subject|1|||
164384532|NCT01568047|593777419|FG002|Overall Study|Withdrawal by Subject|0|||
164384533|NCT01568047|593777420|FG003|Overall Study|Withdrawal by Subject|0|||
164384534|NCT01568047|593777417|FG000|Overall Study|Adverse Event|0|||
164384535|NCT01568047|593777418|FG001|Overall Study|Adverse Event|0|||
164384536|NCT01568047|593777419|FG002|Overall Study|Adverse Event|1|||
164384537|NCT01568047|593777420|FG003|Overall Study|Adverse Event|1|||
164384538|NCT03783923|593777421|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
164384539|NCT03783923|593777422|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
164384540|NCT03783923|593777421|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
164384541|NCT03783923|593777422|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
164384542|NCT03783923|593777421|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
164014260|NCT03504774|592416276|FG000|Overall Study|Lost to Follow-up|0|||
164014261|NCT03504774|592416277|FG001|Overall Study|Lost to Follow-up|1|||
164014262|NCT03504774|592416276|FG000|Overall Study|Protocol Violation|11|||
164014263|NCT03504774|592416277|FG001|Overall Study|Protocol Violation|3|||
164014264|NCT03504774|592416276|FG000|Overall Study|failed wk 52 DBPCFC|1|||
164014265|NCT03504774|592416277|FG001|Overall Study|failed wk 52 DBPCFC|0|||
164384543|NCT03783923|593777422|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
164384544|NCT03783923|593777421|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
164384545|NCT03783923|593777422|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
164384546|NCT03783923|593777421|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
164384547|NCT03783923|593777422|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
164384548|NCT02328326|593777427|FG000|Overall Study|Withdrawal by Subject|10|||
164014266|NCT00625365|592416280|FG000|Overall Study|Withdrawal by Subject|1|||
164384549|NCT02328326|593777428|FG001|Overall Study|Withdrawal by Subject|3|||
164384550|NCT02328326|593777427|FG000|Overall Study|Death|2|||
164384551|NCT02328326|593777428|FG001|Overall Study|Death|1|||
164384552|NCT02328326|593777427|FG000|Overall Study|Lost to Follow-up|10|||
164384553|NCT02328326|593777428|FG001|Overall Study|Lost to Follow-up|4|||
164384554|NCT02543346|593777429|FG000|Second Priming Visit|Withdrawal by Subject|0|||
164384555|NCT02543346|593777430|FG001|Second Priming Visit|Withdrawal by Subject|2|||
164384556|NCT02543346|593777431|FG002|Second Priming Visit|Withdrawal by Subject|2|||
164384557|NCT02543346|593777432|FG003|Second Priming Visit|Withdrawal by Subject|2|||
164384558|NCT02543346|593777429|FG000|Second Priming Visit|Adverse Event|1|||
164384559|NCT02543346|593777430|FG001|Second Priming Visit|Adverse Event|0|||
164384560|NCT02543346|593777431|FG002|Second Priming Visit|Adverse Event|0|||
164384561|NCT02543346|593777432|FG003|Second Priming Visit|Adverse Event|0|||
164384562|NCT02209324|593777435|FG000|Overall Study|Adverse Event|2|||
164384563|NCT02209324|593777435|FG000|Overall Study|Lack of Efficacy|1|||
164384564|NCT02209324|593777435|FG000|Overall Study|Lost to Follow-up|1|||
164384565|NCT02209324|593777435|FG000|Overall Study|Physician Decision|3|||
164384566|NCT02209324|593777435|FG000|Overall Study|Protocol Violation|14|||
164384567|NCT02209324|593777435|FG000|Overall Study|Withdrawal by Subject|8|||
164384568|NCT02209324|593777435|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
164014267|NCT00625365|592416280|FG000|Overall Study|No IV access|5|||
164014268|NCT00625365|592416280|FG000|Overall Study|VSD|1|||
164014269|NCT01781429|592416281|FG000|Overall Study|Death|0|||
164014270|NCT01781429|592416282|FG001|Overall Study|Death|0|||
164014271|NCT01781429|592416283|FG002|Overall Study|Death|0|||
164384569|NCT02209324|593777435|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
164384570|NCT02209324|593777435|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
164384571|NCT01985126|593777436|FG000|Overall Study|Death|15|||
164384572|NCT01985126|593777437|FG001|Overall Study|Death|69|||
164384573|NCT01985126|593777436|FG000|Overall Study|Lost to Follow-up|0|||
164384574|NCT01985126|593777437|FG001|Overall Study|Lost to Follow-up|8|||
164384575|NCT01985126|593777436|FG000|Overall Study|Study Terminated By Sponsor|1|||
164384576|NCT01985126|593777437|FG001|Overall Study|Study Terminated By Sponsor|22|||
163903259|NCT00489307|592015952|FG000|Overall Study|Withdrawal by Subject|2|||
163903260|NCT00489307|592015953|FG001|Overall Study|Withdrawal by Subject|4|||
163903261|NCT00489307|592015952|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
163903262|NCT00489307|592015953|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
163903263|NCT00489307|592015952|FG000|Overall Study|Surgery after assignment|1|||
163903264|NCT00489307|592015953|FG001|Overall Study|Surgery after assignment|0|||
163903265|NCT00489307|592015952|FG000|Overall Study|Did not fill up the forms|2|||
163903266|NCT00489307|592015953|FG001|Overall Study|Did not fill up the forms|1|||
163903267|NCT00489307|592015952|FG000|Overall Study|Patient or family refusal|5|||
163903268|NCT00489307|592015953|FG001|Overall Study|Patient or family refusal|9|||
163903269|NCT03227861|592015956|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
163903270|NCT03227861|592015956|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
163903271|NCT03227861|592015956|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
163903272|NCT03227861|592015956|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
163903273|NCT03227861|592015956|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
163903274|NCT03227861|592015956|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
163903275|NCT03227861|592015956|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
163903276|NCT03227861|592015956|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
163903277|NCT03227861|592015956|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
163903278|NCT03227861|592015956|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
163903279|NCT05613907|592015957|FG000|Overall Study|Lost to Follow-up|5|||
163903280|NCT05613907|592015957|FG000|Overall Study|Death|3|||
163903281|NCT05613907|592015957|FG000|Overall Study|Withdrawal by Subject|2|||
163903282|NCT03789656|592015967|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
163903283|NCT03789656|592015968|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
163903284|NCT03789656|592015969|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
163903285|NCT03789656|592015970|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
163903286|NCT03789656|592015971|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
163903287|NCT03789656|592015967|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163903288|NCT03789656|592015968|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163903289|NCT03789656|592015969|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
163903290|NCT03789656|592015970|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
163903291|NCT03789656|592015971|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
164014272|NCT01781429|592416284|FG003|Overall Study|Death|0|||
164384577|NCT01985126|593777436|FG000|Overall Study|Withdrawal by Subject|2|||
164384578|NCT01985126|593777437|FG001|Overall Study|Withdrawal by Subject|7|||
164384579|NCT03433456|593777440|FG000|Overall Study|Death|1|||
164384580|NCT03433456|593777441|FG001|Overall Study|Death|1|||
164384581|NCT03433456|593777440|FG000|Overall Study|Lost to Follow-up|14|||
164384582|NCT03433456|593777441|FG001|Overall Study|Lost to Follow-up|11|||
164384583|NCT03433456|593777440|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
164384584|NCT03433456|593777441|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
163903292|NCT03789656|592015967|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
163903293|NCT03789656|592015968|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163903294|NCT03789656|592015969|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163903295|NCT03789656|592015970|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163903296|NCT03789656|592015971|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
163903297|NCT03789656|592015967|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
163903298|NCT03789656|592015968|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163903299|NCT03789656|592015969|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163903300|NCT03789656|592015970|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163903301|NCT03789656|592015971|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
163903302|NCT04484623|592015978|FG000|Overall Study|Lost to Follow-up|0|||
163903303|NCT04484623|592015979|FG001|Overall Study|Lost to Follow-up|1|||
163903304|NCT04484623|592015978|FG000|Overall Study|Protocol Deviation|1|||
163903305|NCT04484623|592015979|FG001|Overall Study|Protocol Deviation|0|||
163903306|NCT04484623|592015978|FG000|Overall Study|Physician Decision|1|||
163903307|NCT04484623|592015979|FG001|Overall Study|Physician Decision|0|||
163903308|NCT04484623|592015978|FG000|Overall Study|Withdrawal by Subject|11|||
163903309|NCT04484623|592015979|FG001|Overall Study|Withdrawal by Subject|8|||
164384585|NCT01198600|593777446|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
164384586|NCT01198600|593777447|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
164384587|NCT01198600|593777448|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
164384588|NCT01198600|593777449|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
164384589|NCT01198600|593777446|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
164384590|NCT01198600|593777447|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
164384591|NCT01198600|593777448|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
164384592|NCT01198600|593777449|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
164384593|NCT01198600|593777446|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
164384594|NCT01198600|593777447|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
164384595|NCT01198600|593777448|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
164384596|NCT01198600|593777449|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
163903310|NCT04484623|592015978|FG000|Overall Study|Ongoing|94|||
163903311|NCT04484623|592015979|FG001|Overall Study|Ongoing|84|||
164384597|NCT01198600|593777446|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
164384598|NCT01198600|593777447|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
164384599|NCT01198600|593777448|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
164384600|NCT01198600|593777449|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
163903312|NCT05886777|592015980|FG000|Overall Study|Lost to Follow-up|1|||
163903313|NCT05886777|592015981|FG001|Overall Study|Lost to Follow-up|0|||
163903314|NCT05886777|592015982|FG002|Overall Study|Lost to Follow-up|2|||
163903315|NCT05886777|592015983|FG003|Overall Study|Lost to Follow-up|1|||
163903316|NCT05886777|592015984|FG004|Overall Study|Lost to Follow-up|0|||
163903317|NCT05886777|592015985|FG005|Overall Study|Lost to Follow-up|2|||
163903318|NCT05886777|592015986|FG006|Overall Study|Lost to Follow-up|0|||
163903319|NCT05886777|592015980|FG000|Overall Study|Other|0|||
163903320|NCT05886777|592015981|FG001|Overall Study|Other|2|||
163903321|NCT05886777|592015982|FG002|Overall Study|Other|1|||
163903322|NCT05886777|592015983|FG003|Overall Study|Other|0|||
163903323|NCT05886777|592015984|FG004|Overall Study|Other|0|||
163903324|NCT05886777|592015985|FG005|Overall Study|Other|0|||
163903325|NCT05886777|592015986|FG006|Overall Study|Other|0|||
163903326|NCT05886777|592015980|FG000|Overall Study|Withdrawal by Subject|1|||
163903327|NCT05886777|592015981|FG001|Overall Study|Withdrawal by Subject|0|||
163903328|NCT05886777|592015982|FG002|Overall Study|Withdrawal by Subject|1|||
163903329|NCT05886777|592015983|FG003|Overall Study|Withdrawal by Subject|4|||
163903330|NCT05886777|592015984|FG004|Overall Study|Withdrawal by Subject|3|||
163903331|NCT05886777|592015985|FG005|Overall Study|Withdrawal by Subject|1|||
163903332|NCT05886777|592015986|FG006|Overall Study|Withdrawal by Subject|1|||
163903333|NCT05886777|592015980|FG000|Overall Study|Protocol Violation|0|||
163903334|NCT05886777|592015981|FG001|Overall Study|Protocol Violation|0|||
164014273|NCT01781429|592416285|FG004|Overall Study|Death|0|||
164014274|NCT01781429|592416286|FG005|Overall Study|Death|0|||
163903335|NCT05886777|592015982|FG002|Overall Study|Protocol Violation|1|||
163903336|NCT05886777|592015983|FG003|Overall Study|Protocol Violation|0|||
163903337|NCT05886777|592015984|FG004|Overall Study|Protocol Violation|0|||
163903338|NCT05886777|592015985|FG005|Overall Study|Protocol Violation|0|||
163903339|NCT05886777|592015986|FG006|Overall Study|Protocol Violation|0|||
163903340|NCT05886777|592015980|FG000|Overall Study|No longer met eligibility criteria|0|||
163903341|NCT05886777|592015981|FG001|Overall Study|No longer met eligibility criteria|1|||
163903342|NCT05886777|592015982|FG002|Overall Study|No longer met eligibility criteria|0|||
163903343|NCT05886777|592015983|FG003|Overall Study|No longer met eligibility criteria|0|||
164014275|NCT01781429|592416287|FG006|Overall Study|Death|0|||
164384601|NCT01198600|593777446|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
164384602|NCT01198600|593777447|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
164384603|NCT01198600|593777448|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
164384604|NCT01198600|593777449|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
164384605|NCT01198600|593777446|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
164384606|NCT01198600|593777447|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
164384607|NCT01198600|593777448|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
164384608|NCT01198600|593777449|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
164384609|NCT01198600|593777446|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
164384610|NCT01198600|593777447|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
164384611|NCT01198600|593777448|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
164384612|NCT01198600|593777449|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
164384613|NCT01785602|593777450|FG000|Overall Study|Withdrawal by Subject|2|||
164384614|NCT01785602|593777451|FG001|Overall Study|Withdrawal by Subject|0|||
164014276|NCT01781429|592416288|FG007|Overall Study|Death|0|||
164014277|NCT01781429|592416289|FG008|Overall Study|Death|0|||
164014278|NCT01781429|592416290|FG009|Overall Study|Death|1|||
164014279|NCT01781429|592416291|FG010|Overall Study|Death|0|||
164014280|NCT01781429|592416292|FG011|Overall Study|Death|0|||
164014281|NCT01781429|592416293|FG012|Overall Study|Death|1|||
164014282|NCT01781429|592416294|FG013|Overall Study|Death|0|||
164014283|NCT01781429|592416295|FG014|Overall Study|Death|1|||
164014284|NCT01781429|592416296|FG015|Overall Study|Death|0|||
164014285|NCT01781429|592416281|FG000|Overall Study|Withdrawal by Subject|0|||
164014286|NCT01781429|592416282|FG001|Overall Study|Withdrawal by Subject|0|||
164014287|NCT01781429|592416283|FG002|Overall Study|Withdrawal by Subject|0|||
164384615|NCT01785602|593777450|FG000|Overall Study|Lost to Follow-up|1|||
164384616|NCT01785602|593777451|FG001|Overall Study|Lost to Follow-up|1|||
164384617|NCT01785602|593777450|FG000|Overall Study|Adverse Event|3|||
164384618|NCT01785602|593777451|FG001|Overall Study|Adverse Event|5|||
164384619|NCT01785602|593777450|FG000|Overall Study|Administrative problems|7|||
164384620|NCT01785602|593777451|FG001|Overall Study|Administrative problems|3|||
164384621|NCT04496258|593777454|FG000|Overall Study|Withdrawal by Subject|2|||
164384622|NCT04496258|593777455|FG001|Overall Study|Withdrawal by Subject|1|||
164384623|NCT02141516|593777456|FG000|Overall Study|Adverse Event|0|||
164384624|NCT02141516|593777457|FG001|Overall Study|Adverse Event|1|||
164384625|NCT02141516|593777458|FG002|Overall Study|Adverse Event|0|||
164384626|NCT02141516|593777456|FG000|Overall Study|Lost to Follow-up|0|||
164384627|NCT02141516|593777457|FG001|Overall Study|Lost to Follow-up|1|||
164384628|NCT02141516|593777458|FG002|Overall Study|Lost to Follow-up|0|||
164384629|NCT02141516|593777456|FG000|Overall Study|Other|0|||
164384630|NCT02141516|593777457|FG001|Overall Study|Other|3|||
164384631|NCT02141516|593777458|FG002|Overall Study|Other|0|||
164384632|NCT02041429|593777460|FG000|Overall Study|Progressive Disease|2|||
164384633|NCT02041429|593777461|FG001|Overall Study|Progressive Disease|2|||
164384634|NCT02041429|593777462|FG002|Overall Study|Progressive Disease|3|||
164384635|NCT02041429|593777463|FG003|Overall Study|Progressive Disease|2|||
164384636|NCT02041429|593777460|FG000|Overall Study|Toxicity|0|||
164384637|NCT02041429|593777461|FG001|Overall Study|Toxicity|1|||
164384638|NCT02041429|593777462|FG002|Overall Study|Toxicity|4|||
164384639|NCT02041429|593777463|FG003|Overall Study|Toxicity|2|||
164384640|NCT02041429|593777460|FG000|Overall Study|Withdrawal by Subject|0|||
164384641|NCT02041429|593777461|FG001|Overall Study|Withdrawal by Subject|1|||
164384642|NCT02041429|593777462|FG002|Overall Study|Withdrawal by Subject|0|||
164384643|NCT02041429|593777463|FG003|Overall Study|Withdrawal by Subject|0|||
164384644|NCT02041429|593777460|FG000|Overall Study|On Maintenance Therapy|1|||
164384645|NCT02041429|593777461|FG001|Overall Study|On Maintenance Therapy|0|||
164384646|NCT02041429|593777462|FG002|Overall Study|On Maintenance Therapy|0|||
164384647|NCT02041429|593777463|FG003|Overall Study|On Maintenance Therapy|2|||
164384648|NCT03251924|593777464|FG000|Overall Study|Disease Progression|6|||
164384649|NCT03251924|593777465|FG001|Overall Study|Disease Progression|6|||
164384650|NCT03251924|593777466|FG002|Overall Study|Disease Progression|7|||
164014288|NCT01781429|592416284|FG003|Overall Study|Withdrawal by Subject|0|||
164014289|NCT01781429|592416285|FG004|Overall Study|Withdrawal by Subject|0|||
164384651|NCT03251924|593777467|FG003|Overall Study|Disease Progression|8|||
164384652|NCT03251924|593777468|FG004|Overall Study|Disease Progression|8|||
164384653|NCT03251924|593777469|FG005|Overall Study|Disease Progression|7|||
164384654|NCT03251924|593777470|FG006|Overall Study|Disease Progression|6|||
164014290|NCT01781429|592416286|FG005|Overall Study|Withdrawal by Subject|0|||
164014291|NCT01781429|592416287|FG006|Overall Study|Withdrawal by Subject|0|||
164384655|NCT03251924|593777471|FG007|Overall Study|Disease Progression|10|||
164384656|NCT03251924|593777472|FG008|Overall Study|Disease Progression|6|||
164014292|NCT01781429|592416288|FG007|Overall Study|Withdrawal by Subject|0|||
164014293|NCT01781429|592416289|FG008|Overall Study|Withdrawal by Subject|1|||
164384657|NCT03251924|593777464|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
164384658|NCT03251924|593777465|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
164384659|NCT03251924|593777466|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
164384660|NCT03251924|593777467|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
164384661|NCT03251924|593777468|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
164014294|NCT01781429|592416290|FG009|Overall Study|Withdrawal by Subject|3|||
164014295|NCT01781429|592416291|FG010|Overall Study|Withdrawal by Subject|1|||
164014296|NCT01781429|592416292|FG011|Overall Study|Withdrawal by Subject|1|||
164014297|NCT01781429|592416293|FG012|Overall Study|Withdrawal by Subject|5|||
164014298|NCT01781429|592416294|FG013|Overall Study|Withdrawal by Subject|2|||
164014299|NCT01781429|592416295|FG014|Overall Study|Withdrawal by Subject|3|||
164014300|NCT01781429|592416296|FG015|Overall Study|Withdrawal by Subject|0|||
164014301|NCT01781429|592416281|FG000|Overall Study|Disease Progression|1|||
164014302|NCT01781429|592416282|FG001|Overall Study|Disease Progression|0|||
164014303|NCT01781429|592416283|FG002|Overall Study|Disease Progression|1|||
164014304|NCT01781429|592416284|FG003|Overall Study|Disease Progression|1|||
164014305|NCT01781429|592416285|FG004|Overall Study|Disease Progression|1|||
164014306|NCT01781429|592416286|FG005|Overall Study|Disease Progression|4|||
164014307|NCT01781429|592416287|FG006|Overall Study|Disease Progression|7|||
164014308|NCT01781429|592416288|FG007|Overall Study|Disease Progression|4|||
164014309|NCT01781429|592416289|FG008|Overall Study|Disease Progression|6|||
164014310|NCT01781429|592416290|FG009|Overall Study|Disease Progression|15|||
164014311|NCT01781429|592416291|FG010|Overall Study|Disease Progression|15|||
164014312|NCT01781429|592416292|FG011|Overall Study|Disease Progression|15|||
164014313|NCT01781429|592416293|FG012|Overall Study|Disease Progression|15|||
164014314|NCT01781429|592416294|FG013|Overall Study|Disease Progression|4|||
164014315|NCT01781429|592416295|FG014|Overall Study|Disease Progression|11|||
164014316|NCT01781429|592416296|FG015|Overall Study|Disease Progression|0|||
164014317|NCT01781429|592416281|FG000|Overall Study|Unacceptable Toxicity|0|||
164014318|NCT01781429|592416282|FG001|Overall Study|Unacceptable Toxicity|0|||
164014319|NCT01781429|592416283|FG002|Overall Study|Unacceptable Toxicity|0|||
164014320|NCT01781429|592416284|FG003|Overall Study|Unacceptable Toxicity|0|||
164014321|NCT01781429|592416285|FG004|Overall Study|Unacceptable Toxicity|0|||
164014322|NCT01781429|592416286|FG005|Overall Study|Unacceptable Toxicity|0|||
164014323|NCT01781429|592416287|FG006|Overall Study|Unacceptable Toxicity|0|||
164014324|NCT01781429|592416288|FG007|Overall Study|Unacceptable Toxicity|0|||
164014325|NCT01781429|592416289|FG008|Overall Study|Unacceptable Toxicity|0|||
164014326|NCT01781429|592416290|FG009|Overall Study|Unacceptable Toxicity|0|||
164014327|NCT01781429|592416291|FG010|Overall Study|Unacceptable Toxicity|0|||
164014328|NCT01781429|592416292|FG011|Overall Study|Unacceptable Toxicity|2|||
164014329|NCT01781429|592416293|FG012|Overall Study|Unacceptable Toxicity|0|||
164014330|NCT01781429|592416294|FG013|Overall Study|Unacceptable Toxicity|0|||
164014331|NCT01781429|592416295|FG014|Overall Study|Unacceptable Toxicity|0|||
164014332|NCT01781429|592416296|FG015|Overall Study|Unacceptable Toxicity|0|||
164014333|NCT01781429|592416281|FG000|Overall Study|Patient Condition Changed|0|||
164014334|NCT01781429|592416282|FG001|Overall Study|Patient Condition Changed|0|||
164014335|NCT01781429|592416283|FG002|Overall Study|Patient Condition Changed|0|||
164014336|NCT01781429|592416284|FG003|Overall Study|Patient Condition Changed|0|||
164014337|NCT01781429|592416285|FG004|Overall Study|Patient Condition Changed|0|||
164014338|NCT01781429|592416286|FG005|Overall Study|Patient Condition Changed|0|||
164014339|NCT01781429|592416287|FG006|Overall Study|Patient Condition Changed|0|||
164014340|NCT01781429|592416288|FG007|Overall Study|Patient Condition Changed|0|||
164014341|NCT01781429|592416289|FG008|Overall Study|Patient Condition Changed|0|||
164014342|NCT01781429|592416290|FG009|Overall Study|Patient Condition Changed|4|||
164014343|NCT01781429|592416291|FG010|Overall Study|Patient Condition Changed|0|||
164014344|NCT01781429|592416292|FG011|Overall Study|Patient Condition Changed|1|||
164014345|NCT01781429|592416293|FG012|Overall Study|Patient Condition Changed|0|||
164014346|NCT01781429|592416294|FG013|Overall Study|Patient Condition Changed|1|||
164014347|NCT01781429|592416295|FG014|Overall Study|Patient Condition Changed|0|||
164014348|NCT01781429|592416296|FG015|Overall Study|Patient Condition Changed|0|||
164014349|NCT01781429|592416281|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
164384662|NCT03251924|593777469|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
164384663|NCT03251924|593777470|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
164384664|NCT03251924|593777471|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
164384665|NCT03251924|593777472|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
164014350|NCT01781429|592416282|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
164014351|NCT01781429|592416283|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
164014352|NCT01781429|592416284|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
164384666|NCT03251924|593777464|FG000|Overall Study|Death|0|||
164384667|NCT03251924|593777465|FG001|Overall Study|Death|1|||
164384668|NCT03251924|593777466|FG002|Overall Study|Death|0|||
164014353|NCT01781429|592416285|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
164014354|NCT01781429|592416286|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
164014355|NCT01781429|592416287|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
164014356|NCT01781429|592416288|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
164014357|NCT01781429|592416289|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
164014358|NCT01781429|592416290|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
164014359|NCT01781429|592416291|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
164384669|NCT03251924|593777467|FG003|Overall Study|Death|1|||
164014360|NCT01781429|592416292|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
164384670|NCT03251924|593777468|FG004|Overall Study|Death|1|||
164384671|NCT03251924|593777469|FG005|Overall Study|Death|1|||
164384672|NCT03251924|593777470|FG006|Overall Study|Death|0|||
164384673|NCT03251924|593777471|FG007|Overall Study|Death|0|||
164384674|NCT03251924|593777472|FG008|Overall Study|Death|0|||
164384675|NCT03251924|593777464|FG000|Overall Study|Study Drug Toxicity|0|||
164384676|NCT03251924|593777465|FG001|Overall Study|Study Drug Toxicity|0|||
164384677|NCT03251924|593777466|FG002|Overall Study|Study Drug Toxicity|0|||
164384678|NCT03251924|593777467|FG003|Overall Study|Study Drug Toxicity|1|||
164384679|NCT03251924|593777468|FG004|Overall Study|Study Drug Toxicity|0|||
164384680|NCT03251924|593777469|FG005|Overall Study|Study Drug Toxicity|0|||
164384681|NCT03251924|593777470|FG006|Overall Study|Study Drug Toxicity|0|||
164384682|NCT03251924|593777471|FG007|Overall Study|Study Drug Toxicity|0|||
164384683|NCT03251924|593777472|FG008|Overall Study|Study Drug Toxicity|1|||
164384684|NCT03251924|593777464|FG000|Overall Study|Other Reasons|0|||
164384685|NCT03251924|593777465|FG001|Overall Study|Other Reasons|0|||
164384686|NCT03251924|593777466|FG002|Overall Study|Other Reasons|0|||
164384687|NCT03251924|593777467|FG003|Overall Study|Other Reasons|0|||
164384688|NCT03251924|593777468|FG004|Overall Study|Other Reasons|0|||
164384689|NCT03251924|593777469|FG005|Overall Study|Other Reasons|0|||
164384690|NCT03251924|593777470|FG006|Overall Study|Other Reasons|0|||
164384691|NCT03251924|593777471|FG007|Overall Study|Other Reasons|0|||
164384692|NCT03251924|593777472|FG008|Overall Study|Other Reasons|1|||
164384693|NCT03251924|593777464|FG000|Overall Study|Participant request to discontinue study treatment|0|||
164384694|NCT03251924|593777465|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164384695|NCT03251924|593777466|FG002|Overall Study|Participant request to discontinue study treatment|0|||
164384696|NCT03251924|593777467|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164384697|NCT03251924|593777468|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164384698|NCT03251924|593777469|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164384699|NCT03251924|593777470|FG006|Overall Study|Participant request to discontinue study treatment|0|||
164384700|NCT03251924|593777471|FG007|Overall Study|Participant request to discontinue study treatment|1|||
164384701|NCT03251924|593777472|FG008|Overall Study|Participant request to discontinue study treatment|0|||
164384702|NCT01427712|593777473|FG000|Overall Study|Transfer to a different hospital|2|||
164384703|NCT01427712|593777473|FG000|Overall Study|Lost to Follow-up|1|||
164384704|NCT01427712|593777473|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
164384705|NCT01427712|593777473|FG000|Overall Study|Failure to visit|1|||
164384706|NCT03169153|593777474|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164384707|NCT03169153|593777475|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
164384708|NCT03169153|593777474|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
164384709|NCT03169153|593777475|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
164384710|NCT03169153|593777474|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
164384711|NCT03169153|593777475|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
164384712|NCT03169153|593777474|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
164384713|NCT03169153|593777475|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
164384714|NCT00784043|593777476|FG000|Overall Study|Withdrawal by Subject|8|||
164384715|NCT00784043|593777477|FG001|Overall Study|Withdrawal by Subject|5|||
164384716|NCT00784043|593777476|FG000|Overall Study|Protocol Terminated|23|||
164384717|NCT00784043|593777477|FG001|Overall Study|Protocol Terminated|1|||
164384718|NCT02127307|593777484|FG000|Overall Study|Protocol Violation|36|||
164384719|NCT02127307|593777484|FG000|Overall Study|Lost to Follow-up|2|||
164384720|NCT02127307|593777484|FG000|Overall Study|Death|101|||
164384721|NCT02127307|593777484|FG000|Overall Study|Other than specified above|169|||
164384722|NCT00766376|593777485|FG000|Overall Study|Withdrawal by Subject|27|||
164384723|NCT00235989|593777486|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384724|NCT00235989|593777487|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384725|NCT00235989|593777488|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384726|NCT00235989|593777489|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384727|NCT00235989|593777490|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
164384728|NCT00235989|593777491|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
164384729|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
164384730|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
164384731|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
164384732|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
164384733|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
164384734|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
163903344|NCT05886777|592015984|FG004|Overall Study|No longer met eligibility criteria|0|||
164384735|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
164384736|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164384737|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
164384738|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164073004|NCT01408576|592632756|FG000|Overall Study|Other|10|||
164384739|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164384740|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
164384741|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
164014361|NCT01781429|592416293|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
164014362|NCT01781429|592416294|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
164014363|NCT01781429|592416295|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
164014364|NCT01781429|592416296|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
164014365|NCT01781429|592416281|FG000|Overall Study|Enrolled, but not treated|0|||
164014366|NCT01781429|592416282|FG001|Overall Study|Enrolled, but not treated|0|||
164014367|NCT01781429|592416283|FG002|Overall Study|Enrolled, but not treated|0|||
164014368|NCT01781429|592416284|FG003|Overall Study|Enrolled, but not treated|0|||
164014369|NCT01781429|592416285|FG004|Overall Study|Enrolled, but not treated|0|||
164014370|NCT01781429|592416286|FG005|Overall Study|Enrolled, but not treated|0|||
164014371|NCT01781429|592416287|FG006|Overall Study|Enrolled, but not treated|0|||
164014372|NCT01781429|592416288|FG007|Overall Study|Enrolled, but not treated|0|||
164014373|NCT01781429|592416289|FG008|Overall Study|Enrolled, but not treated|0|||
164014374|NCT01781429|592416290|FG009|Overall Study|Enrolled, but not treated|0|||
164014375|NCT01781429|592416291|FG010|Overall Study|Enrolled, but not treated|1|||
164014376|NCT01781429|592416292|FG011|Overall Study|Enrolled, but not treated|0|||
164014377|NCT01781429|592416293|FG012|Overall Study|Enrolled, but not treated|0|||
164014378|NCT01781429|592416294|FG013|Overall Study|Enrolled, but not treated|0|||
164014379|NCT01781429|592416295|FG014|Overall Study|Enrolled, but not treated|0|||
164014380|NCT01781429|592416296|FG015|Overall Study|Enrolled, but not treated|0|||
164014381|NCT03238248|592416297|FG000|Overall Study|Death|5|||
164014382|NCT03238248|592416297|FG000|Overall Study|Withdrawal by Subject|7|||
164014383|NCT03238248|592416297|FG000|Overall Study|Participant proceeding to transplant|10|||
164014384|NCT03238248|592416297|FG000|Overall Study|Lack of Efficacy|4|||
164014385|NCT03238248|592416297|FG000|Overall Study|Physician Decision|3|||
164014386|NCT03238248|592416297|FG000|Overall Study|Transitioning to another study|1|||
164014387|NCT03238248|592416297|FG000|Overall Study|No longer benefiting|1|||
164014388|NCT03238248|592416297|FG000|Overall Study|Other complicating disease|1|||
164014389|NCT03238248|592416297|FG000|Overall Study|Adverse Event|5|||
164014390|NCT03238248|592416297|FG000|Overall Study|Disease progression|26|||
164014391|NCT03238248|592416297|FG000|Overall Study|N/A participant is still on treatment|1|||
164014392|NCT03238248|592416297|FG000|Overall Study|Decline in condition|1|||
164014393|NCT03238248|592416297|FG000|Overall Study|Alternative therapy|2|||
164014394|NCT06094296|592416308|FG000|Overall Study|Progressive Disease|1|||
164014395|NCT06094296|592416309|FG001|Overall Study|Progressive Disease|0|||
164014396|NCT06094296|592416310|FG002|Overall Study|Progressive Disease|0|||
164014397|NCT06094296|592416311|FG003|Overall Study|Progressive Disease|0|||
164384742|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
164384743|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
164384744|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
164384745|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
164384746|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
164384747|NCT00235989|593777486|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
164384748|NCT00235989|593777487|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
164384749|NCT00235989|593777488|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
164384750|NCT00235989|593777489|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
164384751|NCT00235989|593777490|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
164384752|NCT00235989|593777491|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
164384753|NCT00983580|593777497|FG000|Overall Study|Cancel Prior to treatment|1|||
164384754|NCT00983580|593777498|FG001|Overall Study|Cancel Prior to treatment|3|||
164384755|NCT00983580|593777497|FG000|Overall Study|Protocol Violation|1|||
164384756|NCT00983580|593777498|FG001|Overall Study|Protocol Violation|1|||
164384757|NCT00983580|593777497|FG000|Overall Study|Ineligible|3|||
164384758|NCT00983580|593777498|FG001|Overall Study|Ineligible|0|||
164384759|NCT04382612|593777499|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
164384760|NCT01328002|593777501|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
164384761|NCT01328002|593777502|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
164384762|NCT01328002|593777501|FG000|Open-Label Period|Adverse Event|8|||
164384763|NCT01328002|593777502|FG001|Open-Label Period|Adverse Event|0|||
164384764|NCT01328002|593777501|FG000|Open-Label Period|Lack of Efficacy|3|||
164014398|NCT04964063|592416312|FG000|Overall Study|Adverse Event|4|||
164014399|NCT04964063|592416312|FG000|Overall Study|Lost to Follow-up|47|||
164014400|NCT04964063|592416312|FG000|Overall Study|Withdrawal by Subject|5|||
164014401|NCT04964063|592416312|FG000|Overall Study|Baseline Tasks Expired|41|||
164014402|NCT04964063|592416312|FG000|Overall Study|Participant withdrawn in error|1|||
164014403|NCT03350750|592416314|FG000|Overall Study|Death|1|||
164014404|NCT03350750|592416315|FG001|Overall Study|Death|1|||
164014405|NCT00321984|592416317|FG000|Overall Study|Adverse Event|9|||
164014406|NCT00321984|592416318|FG001|Overall Study|Adverse Event|6|||
164384765|NCT01328002|593777502|FG001|Open-Label Period|Lack of Efficacy|0|||
164384766|NCT01328002|593777501|FG000|Open-Label Period|Protocol Violation|2|||
164384767|NCT01328002|593777502|FG001|Open-Label Period|Protocol Violation|0|||
164384768|NCT01328002|593777501|FG000|Open-Label Period|Withdrawal by Subject|9|||
164384769|NCT01328002|593777502|FG001|Open-Label Period|Withdrawal by Subject|0|||
164384770|NCT01328002|593777501|FG000|Open-Label Period|Lost to Follow-up|6|||
164384771|NCT01328002|593777502|FG001|Open-Label Period|Lost to Follow-up|0|||
164384772|NCT01328002|593777501|FG000|Open-Label Period|Other Reason|2|||
164384773|NCT01328002|593777502|FG001|Open-Label Period|Other Reason|0|||
164384774|NCT01328002|593777501|FG000|Double-Blind Period|Adverse Event|1|||
164384775|NCT01328002|593777502|FG001|Double-Blind Period|Adverse Event|0|||
164384776|NCT01328002|593777501|FG000|Double-Blind Period|Lack of Efficacy|1|||
164384777|NCT01328002|593777502|FG001|Double-Blind Period|Lack of Efficacy|0|||
164384778|NCT01578551|593777503|FG000|Overall Study|Adverse Event|1|||
164384779|NCT01578551|593777504|FG001|Overall Study|Adverse Event|0|||
164384780|NCT02752048|593777506|FG000|Overall Study|Withdrawal by Subject|0|||
164384781|NCT02752048|593777507|FG001|Overall Study|Withdrawal by Subject|0|||
164384782|NCT02752048|593777508|FG002|Overall Study|Withdrawal by Subject|3|||
164384783|NCT00061048|593777509|FG000|Overall Study|Adverse Event|2|||
164384784|NCT00061048|593777509|FG000|Overall Study|disease progression|20|||
164384785|NCT00898677|593777510|FG000|Overall Study|Adverse Event|0|||
164384786|NCT00898677|593777511|FG001|Overall Study|Adverse Event|0|||
164384787|NCT00898677|593777512|FG002|Overall Study|Adverse Event|1|||
164384788|NCT00898677|593777513|FG003|Overall Study|Adverse Event|0|||
164384789|NCT00898677|593777510|FG000|Overall Study|Lost to Follow-up|0|||
164384790|NCT00898677|593777511|FG001|Overall Study|Lost to Follow-up|0|||
164384791|NCT00898677|593777512|FG002|Overall Study|Lost to Follow-up|2|||
164384792|NCT00898677|593777513|FG003|Overall Study|Lost to Follow-up|0|||
164384793|NCT00898677|593777510|FG000|Overall Study|Protocol Violation|1|||
164384794|NCT00898677|593777511|FG001|Overall Study|Protocol Violation|1|||
164384795|NCT00898677|593777512|FG002|Overall Study|Protocol Violation|2|||
164384796|NCT00898677|593777513|FG003|Overall Study|Protocol Violation|0|||
164384797|NCT00898677|593777510|FG000|Overall Study|Withdrawal by Subject|0|||
164384798|NCT00898677|593777511|FG001|Overall Study|Withdrawal by Subject|0|||
164384799|NCT00898677|593777512|FG002|Overall Study|Withdrawal by Subject|0|||
164384800|NCT00898677|593777513|FG003|Overall Study|Withdrawal by Subject|1|||
164384801|NCT00898677|593777510|FG000|Overall Study|Not Treated: Adverse Event|0|||
164384802|NCT00898677|593777511|FG001|Overall Study|Not Treated: Adverse Event|2|||
164384803|NCT00898677|593777512|FG002|Overall Study|Not Treated: Adverse Event|1|||
164384804|NCT00898677|593777513|FG003|Overall Study|Not Treated: Adverse Event|0|||
164384805|NCT00898677|593777510|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
164384806|NCT00898677|593777511|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
164384807|NCT00898677|593777512|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
164384808|NCT00898677|593777513|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
164384809|NCT00898677|593777510|FG000|Overall Study|Not Treated: Pregnancy|0|||
164384810|NCT00898677|593777511|FG001|Overall Study|Not Treated: Pregnancy|0|||
164384811|NCT00898677|593777512|FG002|Overall Study|Not Treated: Pregnancy|1|||
163903345|NCT05886777|592015985|FG005|Overall Study|No longer met eligibility criteria|0|||
163903346|NCT05886777|592015986|FG006|Overall Study|No longer met eligibility criteria|0|||
163903347|NCT03773107|592015987|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
163903348|NCT03773107|592015988|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
163903349|NCT03773107|592015989|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
163903350|NCT03773107|592015990|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
163903351|NCT07204444|592015992|FG000|Overall Study|Medical/Hospitalization|6|||
163903352|NCT07204444|592015993|FG001|Overall Study|Medical/Hospitalization|9|||
163903353|NCT07204444|592015994|FG002|Overall Study|Medical/Hospitalization|6|||
163903354|NCT07204444|592015992|FG000|Overall Study|Treatment Provider Issue|1|||
163903355|NCT07204444|592015993|FG001|Overall Study|Treatment Provider Issue|3|||
163903356|NCT07204444|592015994|FG002|Overall Study|Treatment Provider Issue|0|||
163903357|NCT07204444|592015992|FG000|Overall Study|Withdrawal by Subject|11|||
163903358|NCT07204444|592015993|FG001|Overall Study|Withdrawal by Subject|5|||
163903359|NCT07204444|592015994|FG002|Overall Study|Withdrawal by Subject|5|||
163903360|NCT07204444|592015992|FG000|Overall Study|Death|3|||
163903361|NCT07204444|592015993|FG001|Overall Study|Death|6|||
163903362|NCT07204444|592015994|FG002|Overall Study|Death|1|||
163903363|NCT07204444|592015992|FG000|Overall Study|Unable To Reach|29|||
164384812|NCT00898677|593777513|FG003|Overall Study|Not Treated: Pregnancy|0|||
164384813|NCT00898677|593777510|FG000|Overall Study|Not Treated: Protocol Violation|2|||
164384814|NCT00898677|593777511|FG001|Overall Study|Not Treated: Protocol Violation|0|||
164384815|NCT00898677|593777512|FG002|Overall Study|Not Treated: Protocol Violation|2|||
164384816|NCT00898677|593777513|FG003|Overall Study|Not Treated: Protocol Violation|0|||
164384817|NCT00898677|593777510|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
164384818|NCT00898677|593777511|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
164384819|NCT00898677|593777512|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
164384820|NCT00898677|593777513|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
164384821|NCT00898677|593777510|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
164384822|NCT00898677|593777511|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
164384823|NCT00898677|593777512|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
164384824|NCT00898677|593777513|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
163903364|NCT07204444|592015993|FG001|Overall Study|Unable To Reach|26|||
164384825|NCT00898677|593777510|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
164384826|NCT00898677|593777511|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
164384827|NCT00898677|593777512|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
163903365|NCT07204444|592015994|FG002|Overall Study|Unable To Reach|17|||
163903366|NCT07204444|592015992|FG000|Overall Study|Protocol Deviation|3|||
163903367|NCT07204444|592015993|FG001|Overall Study|Protocol Deviation|2|||
163903368|NCT07204444|592015994|FG002|Overall Study|Protocol Deviation|0|||
163903369|NCT04172675|592017168|FG000|Overall Study|Withdrawal by Subject|7|||
163903370|NCT04172675|592017169|FG001|Overall Study|Withdrawal by Subject|5|||
163903371|NCT04172675|592017170|FG002|Overall Study|Withdrawal by Subject|1|||
163903372|NCT04172675|592017171|FG003|Overall Study|Withdrawal by Subject|4|||
163903373|NCT00378898|592017172|FG000|Overall Study|Withdrawal by Subject|10|||
163903374|NCT00378898|592017173|FG001|Overall Study|Withdrawal by Subject|5|||
163903375|NCT00378898|592017172|FG000|Overall Study|Protocol Violation|1|||
163903376|NCT00378898|592017173|FG001|Overall Study|Protocol Violation|1|||
163903377|NCT00551421|592017174|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
163903378|NCT02000752|592017177|FG000|Overall Study|Dystocic delivery|19|||
163903379|NCT02000752|592017178|FG001|Overall Study|Dystocic delivery|8|||
163903380|NCT02000752|592017177|FG000|Overall Study|Shift Changes|12|||
163903381|NCT02000752|592017178|FG001|Overall Study|Shift Changes|5|||
163903382|NCT00512252|592017180|FG000|Overall Study|Lost to Follow-up|0|||
163903383|NCT00512252|592017181|FG001|Overall Study|Lost to Follow-up|0|||
163903384|NCT00512252|592017182|FG002|Overall Study|Lost to Follow-up|1|||
163903385|NCT00512252|592017180|FG000|Overall Study|Protocol Violation|0|||
164014407|NCT00321984|592416319|FG002|Overall Study|Adverse Event|8|||
163903386|NCT00512252|592017181|FG001|Overall Study|Protocol Violation|0|||
163903387|NCT00512252|592017182|FG002|Overall Study|Protocol Violation|1|||
164384828|NCT00898677|593777513|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
164384829|NCT00898677|593777510|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
164384830|NCT00898677|593777511|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
164384831|NCT00898677|593777512|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
164384832|NCT00898677|593777513|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
164384833|NCT00898677|593777510|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
164384834|NCT00898677|593777511|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
164384835|NCT00898677|593777512|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
164384836|NCT00898677|593777513|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
164384837|NCT00898677|593777510|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
164384838|NCT00898677|593777511|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
164384839|NCT00898677|593777512|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
164384840|NCT00898677|593777513|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
164384841|NCT00898677|593777510|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
164384842|NCT00898677|593777511|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
164384843|NCT00898677|593777512|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
164384844|NCT00898677|593777513|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
164384845|NCT00852397|593777514|FG000|Overall Study|Adverse Event|4|||
164384846|NCT00852397|593777515|FG001|Overall Study|Adverse Event|6|||
164384847|NCT00852397|593777516|FG002|Overall Study|Adverse Event|4|||
164384848|NCT00852397|593777514|FG000|Overall Study|Death|0|||
164384849|NCT00852397|593777515|FG001|Overall Study|Death|0|||
164384850|NCT00852397|593777516|FG002|Overall Study|Death|1|||
164384851|NCT00852397|593777514|FG000|Overall Study|Withdrawal by Subject|4|||
164384852|NCT00852397|593777515|FG001|Overall Study|Withdrawal by Subject|1|||
164384853|NCT00852397|593777516|FG002|Overall Study|Withdrawal by Subject|2|||
164384854|NCT00852397|593777514|FG000|Overall Study|Study terminated by sponsor|2|||
164384855|NCT00852397|593777515|FG001|Overall Study|Study terminated by sponsor|1|||
164384856|NCT00852397|593777516|FG002|Overall Study|Study terminated by sponsor|6|||
164384857|NCT00852397|593777514|FG000|Overall Study|Difficulty in study site visit|1|||
164384858|NCT00852397|593777515|FG001|Overall Study|Difficulty in study site visit|0|||
164384859|NCT00852397|593777516|FG002|Overall Study|Difficulty in study site visit|0|||
164384860|NCT00852397|593777514|FG000|Overall Study|Protocol Violation|0|||
164384861|NCT00852397|593777515|FG001|Overall Study|Protocol Violation|0|||
164384862|NCT00852397|593777516|FG002|Overall Study|Protocol Violation|1|||
164384863|NCT00836875|593777519|FG000|Overall Study|Death|3|||
164384864|NCT00836875|593777520|FG001|Overall Study|Death|2|||
164384865|NCT00836875|593777519|FG000|Overall Study|Withdrawal by Subject|0|||
164384866|NCT00836875|593777520|FG001|Overall Study|Withdrawal by Subject|1|||
164384867|NCT03964454|593777530|FG000|Overall Study|Lost to Follow-up|13|||
164384868|NCT03964454|593777531|FG001|Overall Study|Lost to Follow-up|7|||
164384869|NCT03964454|593777530|FG000|Overall Study|Withdrawal by Subject|4|||
164384870|NCT03964454|593777531|FG001|Overall Study|Withdrawal by Subject|11|||
164384871|NCT00464542|593779124|FG000|Pre-treatment|Withdrawal by Subject|2|||
164384872|NCT00993447|593779125|FG000|Overall Study|Withdrawal by Subject|23|||
164384873|NCT00993447|593779126|FG001|Overall Study|Withdrawal by Subject|8|||
164384874|NCT00993447|593779125|FG000|Overall Study|Protocol Violation|12|||
164384875|NCT00993447|593779126|FG001|Overall Study|Protocol Violation|8|||
164384876|NCT00993447|593779125|FG000|Overall Study|Lost to Follow-up|1|||
164384877|NCT00993447|593779126|FG001|Overall Study|Lost to Follow-up|3|||
164384878|NCT00993447|593779125|FG000|Overall Study|Adverse Event|1|||
164384879|NCT00993447|593779126|FG001|Overall Study|Adverse Event|0|||
164384880|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
164384881|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
164384882|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
164384883|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
164384884|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Adverse Event|5|||
164384885|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Adverse Event|3|||
164384886|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Adverse Event|4|||
164384887|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Adverse Event|10|||
164384888|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
164384889|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
164384890|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
164384891|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
164384892|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
164384893|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
164384894|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
164384895|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
164384896|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Pregnancy|5|||
163903388|NCT00512252|592017180|FG000|Overall Study|Death|0|||
163903389|NCT00512252|592017181|FG001|Overall Study|Death|0|||
163903390|NCT00512252|592017182|FG002|Overall Study|Death|1|||
164014408|NCT00321984|592416317|FG000|Overall Study|Protocol Violation|0|||
164014409|NCT00321984|592416318|FG001|Overall Study|Protocol Violation|1|||
164384897|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Pregnancy|0|||
164384898|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Pregnancy|3|||
164384899|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Pregnancy|2|||
164384900|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Non-compliance|1|||
164384901|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Non-compliance|4|||
164384902|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Non-compliance|0|||
164384903|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Non-compliance|3|||
164384904|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Other|0|||
164384905|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Other|3|||
164384906|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Other|3|||
164384907|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Other|1|||
164384908|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
164384909|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
164384910|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
164384911|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
164384912|NCT01760954|593779127|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
164384913|NCT01760954|593779128|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
164384914|NCT01760954|593779129|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
164384915|NCT01760954|593779130|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
164384916|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
164384917|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
164384918|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
164384919|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
164384920|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
164384921|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
164384922|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
164384923|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
164384924|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
164384925|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
164384926|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
164384927|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
164384928|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
164384929|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
164384930|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
164384931|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
164384932|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
164384933|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
164384934|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
164384935|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
164384936|NCT01760954|593779127|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
164384937|NCT01760954|593779128|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
164384938|NCT01760954|593779129|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
164384939|NCT01760954|593779130|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
164384940|NCT02707055|593779131|FG000|Phase 1|Withdrawal by Subject|1|||
164384941|NCT02707055|593779132|FG001|Phase 1|Withdrawal by Subject|2|||
164384942|NCT02707055|593779131|FG000|Phase 1|Physician Decision|0|||
164384943|NCT02707055|593779132|FG001|Phase 1|Physician Decision|1|||
164384944|NCT02707055|593779131|FG000|Phase 2|Adverse Event|1|||
164384945|NCT02707055|593779132|FG001|Phase 2|Adverse Event|2|||
164384946|NCT01880424|593779133|FG000|Overall Study|Adverse Event|7|||
164014410|NCT00321984|592416319|FG002|Overall Study|Protocol Violation|1|||
164014411|NCT00321984|592416317|FG000|Overall Study|Lost to Follow-up|2|||
164014412|NCT00321984|592416318|FG001|Overall Study|Lost to Follow-up|4|||
164014413|NCT00321984|592416319|FG002|Overall Study|Lost to Follow-up|2|||
164014414|NCT00321984|592416317|FG000|Overall Study|Withdrawal by Subject|8|||
164014415|NCT00321984|592416318|FG001|Overall Study|Withdrawal by Subject|6|||
164014416|NCT00321984|592416319|FG002|Overall Study|Withdrawal by Subject|5|||
164014417|NCT00321984|592416317|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
164014418|NCT00321984|592416318|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
164384947|NCT01880424|593779134|FG001|Overall Study|Adverse Event|6|||
164014419|NCT00321984|592416319|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
164384948|NCT01880424|593779133|FG000|Overall Study|Lack of Efficacy|1|||
164384949|NCT01880424|593779134|FG001|Overall Study|Lack of Efficacy|4|||
164384950|NCT01880424|593779133|FG000|Overall Study|Lost to Follow-up|3|||
164384951|NCT01880424|593779134|FG001|Overall Study|Lost to Follow-up|2|||
164384952|NCT01880424|593779133|FG000|Overall Study|Protocol Violation|11|||
164384953|NCT01880424|593779134|FG001|Overall Study|Protocol Violation|13|||
164384954|NCT01880424|593779133|FG000|Overall Study|Withdrawal by Subject|10|||
164384955|NCT01880424|593779134|FG001|Overall Study|Withdrawal by Subject|30|||
164384956|NCT01880424|593779133|FG000|Overall Study|Other|1|||
164384957|NCT01880424|593779134|FG001|Overall Study|Other|0|||
164384958|NCT02280044|593779137|FG000|Overall Study|Planned alternate|0|||
164384959|NCT02280044|593779138|FG001|Overall Study|Planned alternate|2|||
164384960|NCT05706506|593779139|FG000|Overall Study|Adverse Event|1|||
164384961|NCT05706506|593779139|FG000|Overall Study|Withdrawal by Subject|4|||
164384962|NCT05706506|593779139|FG000|Overall Study|Lost to Follow-up|2|||
164384963|NCT05706506|593779139|FG000|Overall Study|Inadvertent Enrolment|12|||
164384964|NCT05706506|593779139|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
164384965|NCT05706506|593779139|FG000|Overall Study|Participant Moved Out of State|1|||
164384966|NCT01075321|593779140|FG000|Overall Study|Withdrawal by Subject|0|||
164384967|NCT01075321|593779141|FG001|Overall Study|Withdrawal by Subject|0|||
164384968|NCT01075321|593779142|FG002|Overall Study|Withdrawal by Subject|1|||
164384969|NCT01075321|593779143|FG003|Overall Study|Withdrawal by Subject|1|||
164384970|NCT01075321|593779140|FG000|Overall Study|Protocol Violation|0|||
164384971|NCT01075321|593779141|FG001|Overall Study|Protocol Violation|0|||
164384972|NCT01075321|593779142|FG002|Overall Study|Protocol Violation|1|||
164384973|NCT01075321|593779143|FG003|Overall Study|Protocol Violation|0|||
164384974|NCT01075321|593779140|FG000|Overall Study|Treatment Incomplete due to progression|1|||
164384975|NCT01075321|593779141|FG001|Overall Study|Treatment Incomplete due to progression|0|||
164384976|NCT01075321|593779142|FG002|Overall Study|Treatment Incomplete due to progression|0|||
164384977|NCT01075321|593779143|FG003|Overall Study|Treatment Incomplete due to progression|0|||
164384978|NCT01075321|593779140|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
164384979|NCT01075321|593779141|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
164384980|NCT01075321|593779142|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
164384981|NCT01075321|593779143|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
164384982|NCT02646423|593779144|FG000|Overall Study|Adverse Event|5|||
164384983|NCT02646423|593779145|FG001|Overall Study|Adverse Event|7|||
164384984|NCT02646423|593779144|FG000|Overall Study|Ineligible|2|||
164384985|NCT02646423|593779145|FG001|Overall Study|Ineligible|1|||
164384986|NCT02246998|593779149|FG000|Overall Study|Adverse Event|0|||
164384987|NCT02246998|593779150|FG001|Overall Study|Adverse Event|1|||
164384988|NCT02246998|593779151|FG002|Overall Study|Adverse Event|1|||
164384989|NCT02246998|593779152|FG003|Overall Study|Adverse Event|0|||
164384990|NCT02246998|593779149|FG000|Overall Study|Lost to Follow-up|1|||
164384991|NCT02246998|593779150|FG001|Overall Study|Lost to Follow-up|0|||
163903391|NCT02357966|592017183|FG000|Overall Study|Death|0|||
163903392|NCT02357966|592017184|FG001|Overall Study|Death|0|||
164384992|NCT02246998|593779151|FG002|Overall Study|Lost to Follow-up|0|||
164384993|NCT02246998|593779152|FG003|Overall Study|Lost to Follow-up|1|||
164384994|NCT02246998|593779149|FG000|Overall Study|Randomized but Never Dosed|1|||
164384995|NCT02246998|593779150|FG001|Overall Study|Randomized but Never Dosed|2|||
164384996|NCT02246998|593779151|FG002|Overall Study|Randomized but Never Dosed|2|||
164384997|NCT02246998|593779152|FG003|Overall Study|Randomized but Never Dosed|1|||
164384998|NCT01303627|593779156|FG000|Overall Study|the failure while performing URS|0|||
164384999|NCT01303627|593779157|FG001|Overall Study|the failure while performing URS|1|||
164385000|NCT03489304|593779159|FG000|Overall Study|Lost to Follow-up|4|||
164385001|NCT00321919|593779160|FG000|Overall Study|Adverse Event|17|||
164385002|NCT00321919|593779161|FG001|Overall Study|Adverse Event|10|||
164385003|NCT00321919|593779160|FG000|Overall Study|Death|21|||
164385004|NCT00321919|593779161|FG001|Overall Study|Death|17|||
164385005|NCT00321919|593779160|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164385006|NCT00321919|593779161|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164385007|NCT00321919|593779160|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164385008|NCT00321919|593779161|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164385009|NCT00321919|593779160|FG000|Overall Study|Refused Treatment|23|||
164385010|NCT00321919|593779161|FG001|Overall Study|Refused Treatment|14|||
164385011|NCT00321919|593779160|FG000|Overall Study|Other Protocol Violation|2|||
164385012|NCT00321919|593779161|FG001|Overall Study|Other Protocol Violation|3|||
164385013|NCT00321919|593779160|FG000|Overall Study|Failure to Return|3|||
164385014|NCT00321919|593779161|FG001|Overall Study|Failure to Return|1|||
164385015|NCT00321919|593779160|FG000|Overall Study|Other withdrawal reason|7|||
164385016|NCT00321919|593779161|FG001|Overall Study|Other withdrawal reason|6|||
164385017|NCT02624804|593779162|FG000|Overall Study|Screen Failure|5|||
164385018|NCT02590354|593779163|FG000|Phase 1|Active hepatitis B or C infection|1|||
164385019|NCT02590354|593779163|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
164385020|NCT02590354|593779163|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
164385021|NCT02590354|593779163|FG000|Phase 1|Subject does not want to participate|20|||
163903393|NCT02357966|592017185|FG002|Overall Study|Death|1|||
164385022|NCT02590354|593779163|FG000|Phase 1|Lost to Follow-up|1|||
164385023|NCT02590354|593779163|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
164385024|NCT00996996|593779164|FG000|Overall Study|Progressive Disease|10|||
164385025|NCT00996996|593779164|FG000|Overall Study|Non-compliance|8|||
164385026|NCT00996996|593779164|FG000|Overall Study|Lost to Follow-up|9|||
164385027|NCT00996996|593779164|FG000|Overall Study|Death|5|||
164385028|NCT00996996|593779164|FG000|Overall Study|Did Not Receive Study Medications|1|||
164385029|NCT01227889|593779165|FG000|Randomized Phase (RP)|Adverse Event|13|||
164385030|NCT01227889|593779166|FG001|Randomized Phase (RP)|Adverse Event|0|||
164385031|NCT01227889|593779165|FG000|Randomized Phase (RP)|Physician Decision|13|||
164385032|NCT01227889|593779166|FG001|Randomized Phase (RP)|Physician Decision|5|||
164385033|NCT01227889|593779165|FG000|Randomized Phase (RP)|Progressive Disease|135|||
164385034|NCT01227889|593779166|FG001|Randomized Phase (RP)|Progressive Disease|52|||
164385035|NCT01227889|593779165|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
164385036|NCT01227889|593779166|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
164385037|NCT01227889|593779165|FG000|Randomized Phase (RP)|Missing|1|||
164014420|NCT00321984|592416317|FG000|Overall Study|Lack of Efficacy|3|||
164014421|NCT00321984|592416318|FG001|Overall Study|Lack of Efficacy|1|||
164014422|NCT00321984|592416319|FG002|Overall Study|Lack of Efficacy|3|||
164014423|NCT00321984|592416317|FG000|Overall Study|Noncompliant|0|||
164014424|NCT00321984|592416318|FG001|Overall Study|Noncompliant|0|||
164014425|NCT00321984|592416319|FG002|Overall Study|Noncompliant|2|||
164014426|NCT00321984|592416317|FG000|Overall Study|Pregnancy|0|||
164014427|NCT00321984|592416318|FG001|Overall Study|Pregnancy|1|||
164014428|NCT00321984|592416319|FG002|Overall Study|Pregnancy|0|||
164014429|NCT00321984|592416317|FG000|Overall Study|Per Subject Request|1|||
164014430|NCT00321984|592416318|FG001|Overall Study|Per Subject Request|0|||
164014431|NCT00321984|592416319|FG002|Overall Study|Per Subject Request|0|||
164014432|NCT00321984|592416317|FG000|Overall Study|Per Investigator Request|1|||
164014433|NCT00321984|592416318|FG001|Overall Study|Per Investigator Request|0|||
164014434|NCT00321984|592416319|FG002|Overall Study|Per Investigator Request|0|||
164014435|NCT00321984|592416317|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
164014436|NCT00321984|592416318|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
164014437|NCT00321984|592416319|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
164014438|NCT03964415|592416325|FG000|Overall Study|Sponsor's decision|1563|||
164014439|NCT03964415|592416326|FG001|Overall Study|Sponsor's decision|1528|||
164014440|NCT03964415|592416325|FG000|Overall Study|Lost to Follow-up|139|||
164014441|NCT03964415|592416326|FG001|Overall Study|Lost to Follow-up|146|||
164014442|NCT03964415|592416325|FG000|Overall Study|Withdrawal by Subject|68|||
164014443|NCT03964415|592416326|FG001|Overall Study|Withdrawal by Subject|72|||
164014444|NCT03964415|592416325|FG000|Overall Study|Physician Decision|34|||
164014445|NCT03964415|592416326|FG001|Overall Study|Physician Decision|48|||
164014446|NCT03964415|592416325|FG000|Overall Study|Adverse Event|3|||
164014447|NCT03964415|592416326|FG001|Overall Study|Adverse Event|0|||
164014448|NCT03964415|592416325|FG000|Overall Study|Death|4|||
164014449|NCT03964415|592416326|FG001|Overall Study|Death|6|||
164014450|NCT03964415|592416325|FG000|Overall Study|Protocol Violation|1|||
164014451|NCT03964415|592416326|FG001|Overall Study|Protocol Violation|4|||
164014452|NCT03964415|592416325|FG000|Overall Study|Other|35|||
164014453|NCT03964415|592416326|FG001|Overall Study|Other|38|||
164014454|NCT03964415|592416325|FG000|Overall Study|Randomized but not treated|6|||
164014455|NCT03964415|592416326|FG001|Overall Study|Randomized but not treated|7|||
164014456|NCT01302769|592416331|FG000|Overall Study|Lost to Follow-up|1|||
164014457|NCT01302769|592416332|FG001|Overall Study|Lost to Follow-up|1|||
164014458|NCT01734993|592416336|FG000|Overall Study|Adverse Event|1|||
164014459|NCT01734993|592416336|FG000|Overall Study|Lack of Efficacy|1|||
164014460|NCT01426386|592416337|FG000|Overall Study|Adverse Event|0|||
164014461|NCT01426386|592416338|FG001|Overall Study|Adverse Event|1|||
164014462|NCT01426386|592416339|FG002|Overall Study|Adverse Event|0|||
164014463|NCT01426386|592416340|FG003|Overall Study|Adverse Event|0|||
164014464|NCT01426386|592416341|FG004|Overall Study|Adverse Event|0|||
164014465|NCT01426386|592416342|FG005|Overall Study|Adverse Event|0|||
164014466|NCT01426386|592416337|FG000|Overall Study|Did not attend scheduled visit|1|||
164014467|NCT01426386|592416338|FG001|Overall Study|Did not attend scheduled visit|4|||
164014468|NCT01426386|592416339|FG002|Overall Study|Did not attend scheduled visit|0|||
164014469|NCT01426386|592416340|FG003|Overall Study|Did not attend scheduled visit|0|||
164014470|NCT01426386|592416341|FG004|Overall Study|Did not attend scheduled visit|2|||
164014471|NCT01426386|592416342|FG005|Overall Study|Did not attend scheduled visit|1|||
164014472|NCT01426386|592416337|FG000|Overall Study|Poor response|2|||
164014473|NCT01426386|592416338|FG001|Overall Study|Poor response|1|||
164014474|NCT01426386|592416339|FG002|Overall Study|Poor response|2|||
164014475|NCT01426386|592416340|FG003|Overall Study|Poor response|0|||
164385038|NCT01227889|593779166|FG001|Randomized Phase (RP)|Missing|3|||
164385039|NCT01227889|593779165|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
164014476|NCT01426386|592416341|FG004|Overall Study|Poor response|1|||
164014477|NCT01426386|592416342|FG005|Overall Study|Poor response|0|||
164385040|NCT01227889|593779166|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
164014478|NCT01426386|592416337|FG000|Overall Study|Personal reasons|0|||
164014479|NCT01426386|592416338|FG001|Overall Study|Personal reasons|0|||
164014480|NCT01426386|592416339|FG002|Overall Study|Personal reasons|0|||
164014481|NCT01426386|592416340|FG003|Overall Study|Personal reasons|0|||
164014482|NCT01426386|592416341|FG004|Overall Study|Personal reasons|1|||
164014483|NCT01426386|592416342|FG005|Overall Study|Personal reasons|0|||
164014484|NCT00257192|592416344|FG000|Overall Study|Adverse Event|21|||
164014485|NCT00257192|592416345|FG001|Overall Study|Adverse Event|10|||
164014486|NCT00257192|592416344|FG000|Overall Study|Laboratory abnormality|1|||
164014487|NCT00257192|592416345|FG001|Overall Study|Laboratory abnormality|1|||
164014488|NCT00257192|592416344|FG000|Overall Study|Lost to Follow-up|3|||
164014489|NCT00257192|592416345|FG001|Overall Study|Lost to Follow-up|3|||
164014490|NCT00257192|592416344|FG000|Overall Study|Insufficient clinical response|18|||
164014491|NCT00257192|592416345|FG001|Overall Study|Insufficient clinical response|18|||
164014492|NCT00257192|592416344|FG000|Overall Study|Withdrawal by Subject|14|||
164014493|NCT00257192|592416345|FG001|Overall Study|Withdrawal by Subject|2|||
164014494|NCT00257192|592416344|FG000|Overall Study|Randomized but not treated|0|||
164014495|NCT00257192|592416345|FG001|Overall Study|Randomized but not treated|1|||
164014496|NCT00257192|592416344|FG000|Overall Study|Study terminated by sponsor|1|||
164014497|NCT00257192|592416345|FG001|Overall Study|Study terminated by sponsor|0|||
164014498|NCT00257192|592416344|FG000|Overall Study|Miscellaneous|0|||
164014499|NCT00257192|592416345|FG001|Overall Study|Miscellaneous|4|||
164014500|NCT02062151|592416346|FG000|Overall Study|screen failure|1|||
164014501|NCT01158950|592416347|FG000|1st Intervention (1 Day)|Physician Decision|1|||
164014502|NCT01158950|592416348|FG001|1st Intervention (1 Day)|Physician Decision|2|||
164014503|NCT02137772|592416349|FG000|Overall Study|Adverse Event|6|||
164014504|NCT02137772|592416350|FG001|Overall Study|Adverse Event|3|||
164014505|NCT02137772|592416349|FG000|Overall Study|Death|71|||
164014506|NCT02137772|592416350|FG001|Overall Study|Death|44|||
164014507|NCT02137772|592416349|FG000|Overall Study|Lost to Follow-up|8|||
164014508|NCT02137772|592416350|FG001|Overall Study|Lost to Follow-up|4|||
164014509|NCT02137772|592416349|FG000|Overall Study|Physician Decision|15|||
164014510|NCT02137772|592416350|FG001|Overall Study|Physician Decision|5|||
164014511|NCT02137772|592416349|FG000|Overall Study|Withdrawal by Subject|28|||
164014512|NCT02137772|592416350|FG001|Overall Study|Withdrawal by Subject|17|||
164014513|NCT02137772|592416349|FG000|Overall Study|Non-compliance with study drug|1|||
164014514|NCT02137772|592416350|FG001|Overall Study|Non-compliance with study drug|0|||
164014515|NCT02137772|592416349|FG000|Overall Study|Not treated|3|||
164014516|NCT02137772|592416350|FG001|Overall Study|Not treated|2|||
164014517|NCT01844700|592416351|FG000|Overall Study|Lack of Efficacy|1|||
164014518|NCT01844700|592416352|FG001|Overall Study|Lack of Efficacy|0|||
164014519|NCT01844700|592416351|FG000|Overall Study|refused medication switch|1|||
164014520|NCT01844700|592416352|FG001|Overall Study|refused medication switch|0|||
164014521|NCT01844700|592416351|FG000|Overall Study|Withdrawal by Subject|1|||
164014522|NCT01844700|592416352|FG001|Overall Study|Withdrawal by Subject|0|||
164014523|NCT01844700|592416351|FG000|Overall Study|stopped taking meds|0|||
164014524|NCT01844700|592416352|FG001|Overall Study|stopped taking meds|1|||
164014525|NCT00638846|592416353|FG000|Overall Study|Adverse Event|0|||
164014526|NCT00638846|592416354|FG001|Overall Study|Adverse Event|1|||
164014527|NCT00638846|592416353|FG000|Overall Study|Lost to Follow-up|3|||
164014528|NCT00638846|592416354|FG001|Overall Study|Lost to Follow-up|2|||
164014529|NCT00638846|592416353|FG000|Overall Study|lens issue|1|||
164014530|NCT00638846|592416354|FG001|Overall Study|lens issue|3|||
164014531|NCT02746679|592416362|FG000|Overall Study|Lost to Follow-up|4|||
164014532|NCT02746679|592416363|FG001|Overall Study|Lost to Follow-up|6|||
164385041|NCT01227889|593779165|FG000|Crossover Phase|Adverse Event|0|||
164385042|NCT01227889|593779166|FG001|Crossover Phase|Adverse Event|1|||
164385043|NCT01227889|593779165|FG000|Crossover Phase|Physician Decision|0|||
164385044|NCT01227889|593779166|FG001|Crossover Phase|Physician Decision|3|||
164385045|NCT01227889|593779165|FG000|Crossover Phase|Progressive Disease|0|||
164385046|NCT01227889|593779166|FG001|Crossover Phase|Progressive Disease|31|||
164385047|NCT01227889|593779165|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
164385048|NCT01227889|593779166|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
164385049|NCT01227889|593779165|FG000|Crossover Phase|Withdrawal by Subject|0|||
164385050|NCT01227889|593779166|FG001|Crossover Phase|Withdrawal by Subject|1|||
164385051|NCT01709227|593779172|FG000|Overall Study|Physician Decision|1|||
164385052|NCT01709227|593779173|FG001|Overall Study|Physician Decision|0|||
164014533|NCT01416610|592416366|FG000|Overall Study|Adverse Event|4|||
164014534|NCT01416610|592416366|FG000|Overall Study|Adverse Event -Patient decision|3|||
164385053|NCT01709227|593779172|FG000|Overall Study|Pleural Peritoneal communication|0|||
164014535|NCT01416610|592416366|FG000|Overall Study|Lack of Efficacy|4|||
164014536|NCT01416610|592416366|FG000|Overall Study|No reason given|5|||
164014537|NCT01416610|592416366|FG000|Overall Study|Withdrawal by Subject|13|||
164014538|NCT01416610|592416366|FG000|Overall Study|Lost to Follow-up|7|||
164014539|NCT01416610|592416366|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
164014540|NCT04172831|592416368|FG000|Overall Study|Adverse Event|21|||
164014541|NCT04172831|592416369|FG001|Overall Study|Adverse Event|9|||
164014542|NCT04172831|592416368|FG000|Overall Study|Lack of Efficacy|2|||
164014543|NCT04172831|592416369|FG001|Overall Study|Lack of Efficacy|8|||
164385054|NCT01709227|593779173|FG001|Overall Study|Pleural Peritoneal communication|9|||
164385055|NCT02159482|593779174|FG000|Overall Study|Withdrawal by Subject|2|||
164385056|NCT02159482|593779174|FG000|Overall Study|Physician Decision|3|||
164385057|NCT04479618|593779175|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
164385058|NCT04479618|593779176|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
164385059|NCT04479618|593779177|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
164385060|NCT04479618|593779175|FG000|Overall Study|Lack of Efficacy|1|||
164385061|NCT04479618|593779176|FG001|Overall Study|Lack of Efficacy|0|||
164385062|NCT04479618|593779177|FG002|Overall Study|Lack of Efficacy|0|||
164385063|NCT04479618|593779175|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
164385064|NCT04479618|593779176|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
164385065|NCT04479618|593779177|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
164385066|NCT04479618|593779175|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
164014544|NCT04172831|592416368|FG000|Overall Study|Physician Decision|0|||
164014545|NCT04172831|592416369|FG001|Overall Study|Physician Decision|1|||
164014546|NCT04172831|592416368|FG000|Overall Study|Withdrawal by Subject|12|||
164014547|NCT04172831|592416369|FG001|Overall Study|Withdrawal by Subject|11|||
164014548|NCT04172831|592416368|FG000|Overall Study|Lost to Follow-up|4|||
164385067|NCT04479618|593779176|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
164385068|NCT04479618|593779177|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
164385069|NCT04479618|593779175|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
164385070|NCT04479618|593779176|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
164385071|NCT04479618|593779177|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
164385072|NCT04479618|593779175|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
164385073|NCT04479618|593779176|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
164385074|NCT04479618|593779177|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
164385075|NCT01430130|593779178|FG000|Overall Study|Lost to Follow-up|1|||
164385076|NCT01430130|593779178|FG000|Overall Study|Infection on Control Side of Incision|1|||
164385077|NCT00797667|593779179|FG000|Overall Study|Lack of Efficacy|0|||
164385078|NCT00797667|593779180|FG001|Overall Study|Lack of Efficacy|1|||
164385079|NCT00797667|593779181|FG002|Overall Study|Lack of Efficacy|0|||
164385080|NCT00797667|593779179|FG000|Overall Study|Lost to Follow-up|8|||
164385081|NCT00797667|593779180|FG001|Overall Study|Lost to Follow-up|12|||
164385082|NCT00797667|593779181|FG002|Overall Study|Lost to Follow-up|2|||
164385083|NCT00797667|593779179|FG000|Overall Study|Physician Decision|3|||
164385084|NCT00797667|593779180|FG001|Overall Study|Physician Decision|1|||
164385085|NCT00797667|593779181|FG002|Overall Study|Physician Decision|0|||
164385086|NCT00797667|593779179|FG000|Overall Study|Pregnancy|2|||
164385087|NCT00797667|593779180|FG001|Overall Study|Pregnancy|0|||
164385088|NCT00797667|593779181|FG002|Overall Study|Pregnancy|0|||
164385089|NCT00797667|593779179|FG000|Overall Study|Protocol Violation|2|||
164385090|NCT00797667|593779180|FG001|Overall Study|Protocol Violation|7|||
164385091|NCT00797667|593779181|FG002|Overall Study|Protocol Violation|0|||
164385092|NCT00797667|593779179|FG000|Overall Study|Study Terminated by Sponsor|217|||
164385093|NCT00797667|593779180|FG001|Overall Study|Study Terminated by Sponsor|216|||
164385094|NCT00797667|593779181|FG002|Overall Study|Study Terminated by Sponsor|115|||
164385095|NCT00797667|593779179|FG000|Overall Study|Withdrawal by Subject|9|||
164385096|NCT00797667|593779180|FG001|Overall Study|Withdrawal by Subject|14|||
164385097|NCT00797667|593779181|FG002|Overall Study|Withdrawal by Subject|2|||
164385098|NCT00797667|593779179|FG000|Overall Study|Adverse Event|19|||
164385099|NCT00797667|593779180|FG001|Overall Study|Adverse Event|8|||
164385100|NCT00797667|593779181|FG002|Overall Study|Adverse Event|8|||
164385101|NCT01485861|593779182|FG000|Phase Ib|Death|1|||
164385102|NCT01485861|593779183|FG001|Phase Ib|Death|0|||
164385103|NCT01485861|593779184|FG002|Phase Ib|Death|0|||
164385104|NCT01485861|593779185|FG003|Phase Ib|Death|0|||
164385105|NCT01485861|593779186|FG004|Phase Ib|Death|0|||
164385106|NCT01485861|593779187|FG005|Phase Ib|Death|0|||
164385107|NCT01485861|593779182|FG000|Phase Ib|Physician Decision|1|||
164385108|NCT01485861|593779183|FG001|Phase Ib|Physician Decision|1|||
164014549|NCT04172831|592416369|FG001|Overall Study|Lost to Follow-up|9|||
164014550|NCT04172831|592416368|FG000|Overall Study|COVID-19 related crisis|3|||
164014551|NCT04172831|592416369|FG001|Overall Study|COVID-19 related crisis|3|||
164014552|NCT04172831|592416368|FG000|Overall Study|Subject non-compliance|1|||
164385109|NCT01485861|593779184|FG002|Phase Ib|Physician Decision|0|||
164385110|NCT01485861|593779185|FG003|Phase Ib|Physician Decision|0|||
164385111|NCT01485861|593779186|FG004|Phase Ib|Physician Decision|0|||
164014553|NCT04172831|592416369|FG001|Overall Study|Subject non-compliance|1|||
164014554|NCT04172831|592416368|FG000|Overall Study|Family emergency|1|||
164014555|NCT04172831|592416369|FG001|Overall Study|Family emergency|0|||
164014556|NCT01696877|592416372|FG000|Overall Study|Adverse Event|0|||
164014557|NCT01696877|592416373|FG001|Overall Study|Adverse Event|1|||
164014558|NCT00469014|592416374|FG000|Initial Phase Randomization|Disease Progression|0|||
164014559|NCT00469014|592416375|FG001|Initial Phase Randomization|Disease Progression|1|||
164014560|NCT00469014|592416376|FG002|Initial Phase Randomization|Disease Progression|1|||
164014561|NCT00469014|592416377|FG003|Initial Phase Randomization|Disease Progression|0|||
164014562|NCT00469014|592416374|FG000|Initial Phase Randomization|No Response|1|||
164014563|NCT00469014|592416375|FG001|Initial Phase Randomization|No Response|0|||
164014564|NCT00469014|592416376|FG002|Initial Phase Randomization|No Response|0|||
164014565|NCT00469014|592416377|FG003|Initial Phase Randomization|No Response|1|||
164014566|NCT00469014|592416374|FG000|Adaptive Randomization|Not Evaluable|1|||
164014567|NCT00469014|592416375|FG001|Adaptive Randomization|Not Evaluable|0|||
164014568|NCT00469014|592416376|FG002|Adaptive Randomization|Not Evaluable|0|||
164014569|NCT00469014|592416377|FG003|Adaptive Randomization|Not Evaluable|1|||
164014570|NCT00469014|592416374|FG000|Adaptive Randomization|No Response|0|||
164014571|NCT00469014|592416375|FG001|Adaptive Randomization|No Response|1|||
164014572|NCT00469014|592416376|FG002|Adaptive Randomization|No Response|0|||
164014573|NCT00469014|592416377|FG003|Adaptive Randomization|No Response|0|||
164014574|NCT00469014|592416374|FG000|Adaptive Randomization|Death|0|||
164014575|NCT00469014|592416375|FG001|Adaptive Randomization|Death|0|||
164014576|NCT00469014|592416376|FG002|Adaptive Randomization|Death|1|||
164014577|NCT00469014|592416377|FG003|Adaptive Randomization|Death|0|||
164014578|NCT02119104|592416380|FG000|Overall Study|Protocol Violation|16|||
164014579|NCT00916721|592416383|FG000|Overall Study|Lost to Follow-up|0|||
164014580|NCT00916721|592416384|FG001|Overall Study|Lost to Follow-up|1|||
164014581|NCT00916721|592416383|FG000|Overall Study|Adverse Event|6|||
164014582|NCT00916721|592416384|FG001|Overall Study|Adverse Event|3|||
164385112|NCT01485861|593779187|FG005|Phase Ib|Physician Decision|0|||
164385113|NCT01485861|593779182|FG000|Phase Ib|Adverse Event|0|||
164385114|NCT01485861|593779183|FG001|Phase Ib|Adverse Event|4|||
164385115|NCT01485861|593779184|FG002|Phase Ib|Adverse Event|0|||
163903394|NCT02357966|592017186|FG003|Overall Study|Death|0|||
163903395|NCT02357966|592017187|FG004|Overall Study|Death|2|||
163903396|NCT02357966|592017188|FG005|Overall Study|Death|0|||
163903397|NCT02357966|592017183|FG000|Overall Study|Physician Decision|1|||
163903398|NCT02357966|592017184|FG001|Overall Study|Physician Decision|0|||
163903399|NCT02357966|592017185|FG002|Overall Study|Physician Decision|0|||
163903400|NCT02357966|592017186|FG003|Overall Study|Physician Decision|0|||
163903401|NCT02357966|592017187|FG004|Overall Study|Physician Decision|1|||
163903402|NCT02357966|592017188|FG005|Overall Study|Physician Decision|0|||
164385116|NCT01485861|593779185|FG003|Phase Ib|Adverse Event|0|||
164385117|NCT01485861|593779186|FG004|Phase Ib|Adverse Event|0|||
164385118|NCT01485861|593779187|FG005|Phase Ib|Adverse Event|0|||
164385119|NCT01485861|593779182|FG000|Phase Ib|Progression of disease|5|||
164385120|NCT01485861|593779183|FG001|Phase Ib|Progression of disease|0|||
164385121|NCT01485861|593779184|FG002|Phase Ib|Progression of disease|0|||
164385122|NCT01485861|593779185|FG003|Phase Ib|Progression of disease|0|||
164385123|NCT01485861|593779186|FG004|Phase Ib|Progression of disease|0|||
164385124|NCT01485861|593779187|FG005|Phase Ib|Progression of disease|0|||
163903403|NCT01779700|592017189|FG000|Overall Study|Adverse Event|4|||
164014583|NCT00916721|592416383|FG000|Overall Study|Withdrawal by Subject|2|||
164014584|NCT00916721|592416384|FG001|Overall Study|Withdrawal by Subject|2|||
164014585|NCT00916721|592416383|FG000|Overall Study|Protocol Violation|2|||
164014586|NCT00916721|592416384|FG001|Overall Study|Protocol Violation|4|||
164014587|NCT01519427|592416385|FG000|Overall Study|disease progression|2|||
164014588|NCT00798967|592416395|FG000|Overall Study|Adverse Event|2|||
164014589|NCT00798967|592416396|FG001|Overall Study|Adverse Event|3|||
164014590|NCT00798967|592416395|FG000|Overall Study|Withdrawal by Subject|0|||
164014591|NCT00798967|592416396|FG001|Overall Study|Withdrawal by Subject|1|||
164014592|NCT00798967|592416395|FG000|Overall Study|Physician Decision|1|||
164385125|NCT01485861|593779182|FG000|Phase Ib|Other|3|||
164385126|NCT01485861|593779183|FG001|Phase Ib|Other|0|||
164385127|NCT01485861|593779184|FG002|Phase Ib|Other|0|||
164385128|NCT01485861|593779185|FG003|Phase Ib|Other|0|||
164385129|NCT01485861|593779186|FG004|Phase Ib|Other|0|||
164385130|NCT01485861|593779187|FG005|Phase Ib|Other|0|||
164014593|NCT00798967|592416396|FG001|Overall Study|Physician Decision|0|||
164014594|NCT00798967|592416395|FG000|Overall Study|Randomized in error by site|1|||
164014595|NCT00798967|592416396|FG001|Overall Study|Randomized in error by site|0|||
164014596|NCT00633139|592416399|FG000|Overall Study|Non compliance|0|||
164385131|NCT01485861|593779182|FG000|Phase Ib|Withdrawal by Subject|4|||
164385132|NCT01485861|593779183|FG001|Phase Ib|Withdrawal by Subject|1|||
164385133|NCT01485861|593779184|FG002|Phase Ib|Withdrawal by Subject|0|||
164385134|NCT01485861|593779185|FG003|Phase Ib|Withdrawal by Subject|0|||
164385135|NCT01485861|593779186|FG004|Phase Ib|Withdrawal by Subject|0|||
164385136|NCT01485861|593779187|FG005|Phase Ib|Withdrawal by Subject|0|||
163903404|NCT01779700|592017190|FG001|Overall Study|Adverse Event|3|||
163903405|NCT01779700|592017189|FG000|Overall Study|Withdrawal by Subject|0|||
163903406|NCT01779700|592017190|FG001|Overall Study|Withdrawal by Subject|2|||
163903407|NCT00019604|592017191|FG000|Overall Study|Death|1|||
164385137|NCT01485861|593779182|FG000|Phase II|Death|0|||
164385138|NCT01485861|593779183|FG001|Phase II|Death|0|||
164014597|NCT00633139|592416400|FG001|Overall Study|Non compliance|0|||
164385139|NCT01485861|593779184|FG002|Phase II|Death|67|||
164385140|NCT01485861|593779185|FG003|Phase II|Death|71|||
164385141|NCT01485861|593779186|FG004|Phase II|Death|68|||
164385142|NCT01485861|593779187|FG005|Phase II|Death|0|||
164385143|NCT01485861|593779182|FG000|Phase II|Progression of Disease|0|||
164385144|NCT01485861|593779183|FG001|Phase II|Progression of Disease|0|||
164385145|NCT01485861|593779184|FG002|Phase II|Progression of Disease|1|||
164385146|NCT01485861|593779185|FG003|Phase II|Progression of Disease|0|||
164385147|NCT01485861|593779186|FG004|Phase II|Progression of Disease|0|||
164385148|NCT01485861|593779187|FG005|Phase II|Progression of Disease|0|||
164385149|NCT01485861|593779182|FG000|Phase II|Other|0|||
164385150|NCT01485861|593779183|FG001|Phase II|Other|0|||
164385151|NCT01485861|593779184|FG002|Phase II|Other|0|||
164385152|NCT01485861|593779185|FG003|Phase II|Other|1|||
164385153|NCT01485861|593779186|FG004|Phase II|Other|0|||
164385154|NCT01485861|593779187|FG005|Phase II|Other|0|||
164385155|NCT01485861|593779182|FG000|Phase II|Withdrawal by Subject|0|||
164385156|NCT01485861|593779183|FG001|Phase II|Withdrawal by Subject|0|||
164385157|NCT01485861|593779184|FG002|Phase II|Withdrawal by Subject|6|||
164385158|NCT01485861|593779185|FG003|Phase II|Withdrawal by Subject|3|||
164385159|NCT01485861|593779186|FG004|Phase II|Withdrawal by Subject|4|||
164385160|NCT01485861|593779187|FG005|Phase II|Withdrawal by Subject|0|||
164385161|NCT01485861|593779182|FG000|Phase II|Lost to Follow-up|0|||
164385162|NCT01485861|593779183|FG001|Phase II|Lost to Follow-up|0|||
164385163|NCT01485861|593779184|FG002|Phase II|Lost to Follow-up|2|||
164385164|NCT01485861|593779185|FG003|Phase II|Lost to Follow-up|3|||
164385165|NCT01485861|593779186|FG004|Phase II|Lost to Follow-up|5|||
164385166|NCT01485861|593779187|FG005|Phase II|Lost to Follow-up|0|||
164385167|NCT01485861|593779182|FG000|Phase II|Study Ended|0|||
164385168|NCT01485861|593779183|FG001|Phase II|Study Ended|0|||
164385169|NCT01485861|593779184|FG002|Phase II|Study Ended|7|||
164385170|NCT01485861|593779185|FG003|Phase II|Study Ended|8|||
164385171|NCT01485861|593779186|FG004|Phase II|Study Ended|6|||
164385172|NCT01485861|593779187|FG005|Phase II|Study Ended|0|||
164385173|NCT01485861|593779182|FG000|Safety Phase|Death|0|||
164385174|NCT01485861|593779183|FG001|Safety Phase|Death|0|||
164385175|NCT01485861|593779184|FG002|Safety Phase|Death|0|||
164385176|NCT01485861|593779185|FG003|Safety Phase|Death|0|||
164385177|NCT01485861|593779186|FG004|Safety Phase|Death|0|||
164385178|NCT01485861|593779187|FG005|Safety Phase|Death|2|||
164385179|NCT01485861|593779182|FG000|Safety Phase|Adverse Event|0|||
164385180|NCT01485861|593779183|FG001|Safety Phase|Adverse Event|0|||
164385181|NCT01485861|593779184|FG002|Safety Phase|Adverse Event|0|||
164014598|NCT00633139|592416401|FG002|Overall Study|Non compliance|1|||
164014599|NCT00633139|592416399|FG000|Overall Study|Withdrawal by Subject|0|||
164385182|NCT01485861|593779185|FG003|Safety Phase|Adverse Event|0|||
164385183|NCT01485861|593779186|FG004|Safety Phase|Adverse Event|0|||
164385184|NCT01485861|593779187|FG005|Safety Phase|Adverse Event|1|||
164385185|NCT01485861|593779182|FG000|Safety Phase|Other|0|||
164385186|NCT01485861|593779183|FG001|Safety Phase|Other|0|||
164385187|NCT01485861|593779184|FG002|Safety Phase|Other|0|||
164385188|NCT01485861|593779185|FG003|Safety Phase|Other|0|||
164385189|NCT01485861|593779186|FG004|Safety Phase|Other|0|||
164385190|NCT01485861|593779187|FG005|Safety Phase|Other|5|||
164385191|NCT01485861|593779182|FG000|Safety Phase|Progression of Disease|0|||
164385192|NCT01485861|593779183|FG001|Safety Phase|Progression of Disease|0|||
164385193|NCT01485861|593779184|FG002|Safety Phase|Progression of Disease|0|||
164385194|NCT01485861|593779185|FG003|Safety Phase|Progression of Disease|0|||
164385195|NCT01485861|593779186|FG004|Safety Phase|Progression of Disease|0|||
164385196|NCT01485861|593779187|FG005|Safety Phase|Progression of Disease|9|||
164014600|NCT00633139|592416400|FG001|Overall Study|Withdrawal by Subject|1|||
164014601|NCT00633139|592416401|FG002|Overall Study|Withdrawal by Subject|0|||
164385197|NCT01485861|593779182|FG000|Safety Phase|Withdrawal by Subject|0|||
164014602|NCT01507246|592416403|FG000|Overall Study|Required different surgical procedures|2|||
164385198|NCT01485861|593779183|FG001|Safety Phase|Withdrawal by Subject|0|||
164385199|NCT01485861|593779184|FG002|Safety Phase|Withdrawal by Subject|0|||
164385200|NCT01485861|593779185|FG003|Safety Phase|Withdrawal by Subject|0|||
164385201|NCT01485861|593779186|FG004|Safety Phase|Withdrawal by Subject|0|||
164385202|NCT01485861|593779187|FG005|Safety Phase|Withdrawal by Subject|6|||
164385203|NCT01485861|593779182|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385204|NCT01485861|593779183|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385205|NCT01485861|593779184|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385206|NCT01485861|593779185|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385207|NCT01485861|593779186|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
164385208|NCT01485861|593779187|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
164385209|NCT01986829|593779192|FG000|Overall Study|Death|1|||
164385210|NCT03795922|593779193|FG000|Overall Study|Adverse Event|2|||
164385211|NCT03795922|593779194|FG001|Overall Study|Adverse Event|1|||
164385212|NCT03795922|593779193|FG000|Overall Study|Withdrawal by Subject|5|||
164385213|NCT03795922|593779194|FG001|Overall Study|Withdrawal by Subject|13|||
164385214|NCT03795922|593779193|FG000|Overall Study|Lost to Follow-up|2|||
164385215|NCT03795922|593779194|FG001|Overall Study|Lost to Follow-up|3|||
164385216|NCT03795922|593779193|FG000|Overall Study|Pregnancy|0|||
164385217|NCT03795922|593779194|FG001|Overall Study|Pregnancy|1|||
164385218|NCT03795922|593779193|FG000|Overall Study|Physician Decision|1|||
164385219|NCT03795922|593779194|FG001|Overall Study|Physician Decision|2|||
164385220|NCT03795922|593779193|FG000|Overall Study|Protocol Violation|0|||
164385221|NCT03795922|593779194|FG001|Overall Study|Protocol Violation|1|||
164385222|NCT03795922|593779193|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
164385223|NCT03795922|593779194|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
164385224|NCT00701051|593779197|FG000|Screening|Failed Screening|40|||
164385225|NCT00701051|593779198|FG001|Screening|Failed Screening|0|||
164385226|NCT00701051|593779199|FG002|Screening|Failed Screening|0|||
164385227|NCT00701051|593779197|FG000|Screening|Time conflicts|19|||
164385228|NCT00701051|593779198|FG001|Screening|Time conflicts|0|||
164385229|NCT00701051|593779199|FG002|Screening|Time conflicts|0|||
164385230|NCT00701051|593779197|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
164385231|NCT00701051|593779198|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
164385232|NCT00701051|593779199|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
164385233|NCT01243944|593779200|FG000|Overall Study|Adverse Event|15|||
164385234|NCT01243944|593779201|FG001|Overall Study|Adverse Event|13|||
164385235|NCT01243944|593779200|FG000|Overall Study|Lost to Follow-up|2|||
164385236|NCT01243944|593779201|FG001|Overall Study|Lost to Follow-up|1|||
164385237|NCT01243944|593779200|FG000|Overall Study|Physician Decision|2|||
164385238|NCT01243944|593779201|FG001|Overall Study|Physician Decision|7|||
164385239|NCT01243944|593779200|FG000|Overall Study|Disease progression|12|||
164385240|NCT01243944|593779201|FG001|Overall Study|Disease progression|11|||
164385241|NCT01243944|593779200|FG000|Overall Study|Protocol deviation|1|||
164385242|NCT01243944|593779201|FG001|Overall Study|Protocol deviation|1|||
164385243|NCT01243944|593779200|FG000|Overall Study|Participant decision|10|||
164385244|NCT01243944|593779201|FG001|Overall Study|Participant decision|15|||
164385245|NCT01243944|593779200|FG000|Overall Study|Death|2|||
164385246|NCT01243944|593779201|FG001|Overall Study|Death|3|||
164385247|NCT01243944|593779200|FG000|Overall Study|Non-compliance with study treatment|1|||
164385248|NCT01243944|593779201|FG001|Overall Study|Non-compliance with study treatment|0|||
164385249|NCT02673697|593779208|FG000|Overall Study|Adverse Event|2|||
164385250|NCT02673697|593779209|FG001|Overall Study|Adverse Event|0|||
164385251|NCT02673697|593779208|FG000|Overall Study|Death|32|||
164385252|NCT02673697|593779209|FG001|Overall Study|Death|24|||
164385253|NCT02673697|593779208|FG000|Overall Study|Lost to Follow-up|5|||
164385254|NCT02673697|593779209|FG001|Overall Study|Lost to Follow-up|2|||
164385255|NCT02673697|593779208|FG000|Overall Study|Physician Decision|2|||
164385256|NCT02673697|593779209|FG001|Overall Study|Physician Decision|1|||
164385257|NCT02673697|593779208|FG000|Overall Study|Withdrawal by Subject|10|||
164385258|NCT02673697|593779209|FG001|Overall Study|Withdrawal by Subject|7|||
164385259|NCT02673697|593779208|FG000|Overall Study|Change subj medical status|1|||
164385260|NCT02673697|593779209|FG001|Overall Study|Change subj medical status|2|||
164385261|NCT02673697|593779208|FG000|Overall Study|Explant|10|||
164385262|NCT02673697|593779209|FG001|Overall Study|Explant|5|||
164385263|NCT02673697|593779208|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
164385264|NCT02673697|593779209|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
164385265|NCT00437489|593779210|FG000|Overall Study|Study terminated by sponsor|23|||
164385266|NCT00437489|593779211|FG001|Overall Study|Study terminated by sponsor|21|||
164385267|NCT00437489|593779210|FG000|Overall Study|Lost to Follow-up|0|||
164385268|NCT00437489|593779211|FG001|Overall Study|Lost to Follow-up|1|||
164385269|NCT03321019|593779216|FG000|Overall Study|Withdrawal by Subject|0|||
164385270|NCT03321019|593779217|FG001|Overall Study|Withdrawal by Subject|6|||
164385271|NCT03321019|593779216|FG000|Overall Study|Lost to Follow-up|0|||
164385272|NCT03321019|593779217|FG001|Overall Study|Lost to Follow-up|22|||
164385273|NCT03880578|593779218|FG000|Overall Study|Withdrawal by Subject|0|||
164385274|NCT03880578|593779219|FG001|Overall Study|Withdrawal by Subject|3|||
164014603|NCT01507246|592416404|FG001|Overall Study|Required different surgical procedures|1|||
164014604|NCT04083222|592416405|FG000|Overall Study|Voluntary Withdrawal|0|||
164385275|NCT03880578|593779220|FG002|Overall Study|Withdrawal by Subject|1|||
164385276|NCT03880578|593779218|FG000|Overall Study|Death|0|||
164385277|NCT03880578|593779219|FG001|Overall Study|Death|1|||
164385278|NCT03880578|593779220|FG002|Overall Study|Death|0|||
164385279|NCT04934670|593779221|FG000|Overall Study|Death|4|||
164385280|NCT04934670|593779222|FG001|Overall Study|Death|0|||
164385281|NCT04934670|593779221|FG000|Overall Study|Lost to Follow-up|1|||
164385282|NCT04934670|593779222|FG001|Overall Study|Lost to Follow-up|4|||
164385283|NCT03056690|593779224|FG000|Overall Study|Adverse Event|3|||
164385284|NCT03056690|593779225|FG001|Overall Study|Adverse Event|2|||
164385285|NCT03056690|593779224|FG000|Overall Study|Lack of Efficacy|1|||
164385286|NCT03056690|593779225|FG001|Overall Study|Lack of Efficacy|2|||
164385287|NCT03056690|593779224|FG000|Overall Study|Lost to Follow-up|3|||
164385288|NCT03056690|593779225|FG001|Overall Study|Lost to Follow-up|2|||
164385289|NCT03056690|593779224|FG000|Overall Study|Protocol Violation|2|||
164385290|NCT03056690|593779225|FG001|Overall Study|Protocol Violation|2|||
164385291|NCT03056690|593779224|FG000|Overall Study|Withdrawal by Subject|3|||
164385292|NCT03056690|593779225|FG001|Overall Study|Withdrawal by Subject|6|||
164385293|NCT03056690|593779224|FG000|Overall Study|Non-compliance with Study Drug|1|||
164385294|NCT03056690|593779225|FG001|Overall Study|Non-compliance with Study Drug|0|||
164385295|NCT03056690|593779224|FG000|Overall Study|Miscellaneous|1|||
164385296|NCT03056690|593779225|FG001|Overall Study|Miscellaneous|2|||
164385297|NCT01944046|593779229|FG000|Randomized to DB|Adverse Event|5|||
164385298|NCT01944046|593779230|FG001|Randomized to DB|Adverse Event|2|||
164385299|NCT01944046|593779229|FG000|Randomized to DB|Clinical Worsening|3|||
164385300|NCT01944046|593779230|FG001|Randomized to DB|Clinical Worsening|2|||
164385301|NCT01944046|593779229|FG000|Randomized to DB|Lost to Follow-up|3|||
164385302|NCT01944046|593779230|FG001|Randomized to DB|Lost to Follow-up|3|||
164385303|NCT01944046|593779229|FG000|Randomized to DB|Withdrawal by Subject|2|||
164385304|NCT01944046|593779230|FG001|Randomized to DB|Withdrawal by Subject|4|||
164385305|NCT01944046|593779229|FG000|Randomized to DB|Physician Decision|1|||
164385306|NCT01944046|593779230|FG001|Randomized to DB|Physician Decision|2|||
164385307|NCT01944046|593779229|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
164385308|NCT01944046|593779230|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
164385309|NCT01944046|593779229|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
164385310|NCT01944046|593779230|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
164385311|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
164385312|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
164385313|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Adverse Event|6|||
164385314|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Adverse Event|1|||
164385315|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
164385316|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
164385317|NCT01944046|593779229|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
164385318|NCT01944046|593779230|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
164385319|NCT00153101|593779236|FG000|Overall Study|Lost to Follow-up|14|||
164385320|NCT00153101|593779237|FG001|Overall Study|Lost to Follow-up|14|||
164385321|NCT00153101|593779238|FG002|Overall Study|Lost to Follow-up|12|||
164385322|NCT00153101|593779239|FG003|Overall Study|Lost to Follow-up|5|||
164385323|NCT00153101|593779240|FG004|Overall Study|Lost to Follow-up|5|||
164385324|NCT00153101|593779236|FG000|Overall Study|Withdrawal by Subject|3|||
164385325|NCT00153101|593779237|FG001|Overall Study|Withdrawal by Subject|4|||
164014605|NCT04083222|592416406|FG001|Overall Study|Voluntary Withdrawal|1|||
164014606|NCT04083222|592416405|FG000|Overall Study|Reason not Specified|0|||
164014607|NCT04083222|592416406|FG001|Overall Study|Reason not Specified|1|||
164014608|NCT03575468|592416409|FG000|Overall Study|Withdrawal by Subject|3|||
164014609|NCT03575468|592416410|FG001|Overall Study|Withdrawal by Subject|0|||
164014610|NCT03575468|592416409|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
164014611|NCT03575468|592416410|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
164014612|NCT03575468|592416409|FG000|Overall Study|Lost to Follow-up|13|||
164014613|NCT03575468|592416410|FG001|Overall Study|Lost to Follow-up|17|||
164014614|NCT01522651|592416411|FG000|Overall Study|Adverse Event|3|||
163903408|NCT00019604|592017191|FG000|Overall Study|Progressive disease|23|||
163903409|NCT00019604|592017191|FG000|Overall Study|Refused treatment|1|||
164014615|NCT01522651|592416412|FG001|Overall Study|Adverse Event|4|||
164014616|NCT01522651|592416413|FG002|Overall Study|Adverse Event|4|||
164385326|NCT00153101|593779238|FG002|Overall Study|Withdrawal by Subject|3|||
163903410|NCT00019604|592017191|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
164014617|NCT01522651|592416414|FG003|Overall Study|Adverse Event|5|||
163903411|NCT00019604|592017191|FG000|Overall Study|Going to have liver transplant|1|||
163903412|NCT00019604|592017191|FG000|Overall Study|Move to a different study|1|||
163903413|NCT00019604|592017191|FG000|Overall Study|Non compliant on systemic CH|1|||
163903414|NCT00019604|592017191|FG000|Overall Study|Non compliant|1|||
163903415|NCT00019604|592017191|FG000|Overall Study|Resectable disease|1|||
163903416|NCT00019604|592017191|FG000|Overall Study|Started new chemo regimen|1|||
163903417|NCT00019604|592017191|FG000|Overall Study|Pt going to immunotherapy study|1|||
163903418|NCT00019604|592017191|FG000|Overall Study|Too much disease|1|||
163903419|NCT00019604|592017191|FG000|Overall Study|Unable to evaluate|1|||
164014618|NCT01522651|592416415|FG004|Overall Study|Adverse Event|4|||
164014619|NCT01522651|592416411|FG000|Overall Study|Cardioversion|1|||
164014620|NCT01522651|592416412|FG001|Overall Study|Cardioversion|0|||
164385327|NCT00153101|593779239|FG003|Overall Study|Withdrawal by Subject|3|||
164385328|NCT00153101|593779240|FG004|Overall Study|Withdrawal by Subject|5|||
164385329|NCT00439777|593779241|FG000|Treatment Period|Death|29|||
164385330|NCT00439777|593779242|FG001|Treatment Period|Death|21|||
164385331|NCT00439777|593779241|FG000|Treatment Period|Study terminated by sponsor|125|||
163903420|NCT00019604|592017191|FG000|Overall Study|Details for other not available|4|||
163903421|NCT04608409|592017195|FG000|Overall Study|Physician Decision|1|||
163903422|NCT04608409|592017196|FG001|Overall Study|Physician Decision|1|||
163903423|NCT04608409|592017197|FG002|Overall Study|Physician Decision|2|||
163903424|NCT03392194|592017199|FG000|Overall Study|Withdrawal by Subject|1|||
164385332|NCT00439777|593779242|FG001|Treatment Period|Study terminated by sponsor|132|||
164385333|NCT00439777|593779241|FG000|Treatment Period|Site closed by investigator|0|||
164385334|NCT00439777|593779242|FG001|Treatment Period|Site closed by investigator|1|||
164385335|NCT00439777|593779241|FG000|Treatment Period|Did not take study treatment|7|||
163903425|NCT03392194|592017200|FG001|Overall Study|Withdrawal by Subject|2|||
163903426|NCT03392194|592017199|FG000|Overall Study|Conflicts with personal schedule|1|||
163903427|NCT03392194|592017200|FG001|Overall Study|Conflicts with personal schedule|0|||
163903428|NCT00918333|592017201|FG000|Overall Study|Drug not taken per protocol|1|||
163903429|NCT00918333|592017202|FG001|Overall Study|Drug not taken per protocol|0|||
163903430|NCT00918333|592017201|FG000|Overall Study|Inadequate amount of drugs provided|1|||
163903431|NCT00918333|592017202|FG001|Overall Study|Inadequate amount of drugs provided|4|||
163903432|NCT00918333|592017201|FG000|Overall Study|Ineligible|1|||
163903433|NCT00918333|592017202|FG001|Overall Study|Ineligible|0|||
163903434|NCT00918333|592017201|FG000|Overall Study|Withdrawal by Subject|0|||
163903435|NCT00918333|592017202|FG001|Overall Study|Withdrawal by Subject|1|||
163903436|NCT04497415|592017205|FG000|Overall Study|Lost to Follow-up|43|||
163903437|NCT04497415|592017206|FG001|Overall Study|Lost to Follow-up|27|||
163903438|NCT00620854|592017207|FG000|Washout 1|Withdrawal by Subject|0|||
163903439|NCT00620854|592017208|FG001|Washout 1|Withdrawal by Subject|0|||
163903440|NCT00620854|592017209|FG002|Washout 1|Withdrawal by Subject|1|||
163903441|NCT00620854|592017210|FG003|Washout 1|Withdrawal by Subject|1|||
163903442|NCT00620854|592017211|FG004|Washout 1|Withdrawal by Subject|0|||
163903443|NCT00620854|592017212|FG005|Washout 1|Withdrawal by Subject|0|||
163903444|NCT00463229|592017226|FG000|Overall Study|Lost to Follow-up|5|||
163903445|NCT00463229|592017227|FG001|Overall Study|Lost to Follow-up|7|||
163903446|NCT00463229|592017226|FG000|Overall Study|Death|4|||
163903447|NCT00463229|592017227|FG001|Overall Study|Death|3|||
163903448|NCT01359150|592017234|FG000|Overall Study|Lack of Efficacy|1|||
163903449|NCT01359150|592017235|FG001|Overall Study|Lack of Efficacy|1|||
163903450|NCT01359150|592017234|FG000|Overall Study|Withdrawal by Subject|1|||
163903451|NCT01359150|592017235|FG001|Overall Study|Withdrawal by Subject|1|||
163903452|NCT01359150|592017234|FG000|Overall Study|Adverse Event|4|||
163903453|NCT01359150|592017235|FG001|Overall Study|Adverse Event|3|||
163903454|NCT01359150|592017234|FG000|Overall Study|Other|1|||
163903455|NCT01359150|592017235|FG001|Overall Study|Other|0|||
163903456|NCT01170208|592017236|FG000|Overall Study|Withdrawal by Subject|5|||
163903457|NCT01170208|592017237|FG001|Overall Study|Withdrawal by Subject|0|||
163903458|NCT01170208|592017238|FG002|Overall Study|Withdrawal by Subject|1|||
163903459|NCT01170208|592017236|FG000|Overall Study|Protocol Violation|1|||
163903460|NCT01170208|592017237|FG001|Overall Study|Protocol Violation|0|||
163903461|NCT01170208|592017238|FG002|Overall Study|Protocol Violation|1|||
164014621|NCT01522651|592416413|FG002|Overall Study|Cardioversion|0|||
164014622|NCT01522651|592416414|FG003|Overall Study|Cardioversion|0|||
164014623|NCT01522651|592416415|FG004|Overall Study|Cardioversion|0|||
164014624|NCT01522651|592416411|FG000|Overall Study|Device Malfunction|0|||
164014625|NCT01522651|592416412|FG001|Overall Study|Device Malfunction|1|||
164014626|NCT01522651|592416413|FG002|Overall Study|Device Malfunction|0|||
164014627|NCT01522651|592416414|FG003|Overall Study|Device Malfunction|0|||
164014628|NCT01522651|592416415|FG004|Overall Study|Device Malfunction|0|||
164014629|NCT01522651|592416411|FG000|Overall Study|Investigator's Discretion|0|||
164014630|NCT01522651|592416412|FG001|Overall Study|Investigator's Discretion|1|||
164014631|NCT01522651|592416413|FG002|Overall Study|Investigator's Discretion|0|||
164014632|NCT01522651|592416414|FG003|Overall Study|Investigator's Discretion|0|||
164014633|NCT01522651|592416415|FG004|Overall Study|Investigator's Discretion|0|||
164014634|NCT01522651|592416411|FG000|Overall Study|Protocol Violation|3|||
164014635|NCT01522651|592416412|FG001|Overall Study|Protocol Violation|0|||
164014636|NCT01522651|592416413|FG002|Overall Study|Protocol Violation|0|||
164014637|NCT01522651|592416414|FG003|Overall Study|Protocol Violation|0|||
164014638|NCT01522651|592416415|FG004|Overall Study|Protocol Violation|0|||
164014639|NCT01522651|592416411|FG000|Overall Study|Reason Not Specified|0|||
164385336|NCT00439777|593779242|FG001|Treatment Period|Did not take study treatment|8|||
163903462|NCT03113409|592017239|FG000|Overall Study|Withdrawal by Subject|5|||
163903463|NCT03113409|592017240|FG001|Overall Study|Withdrawal by Subject|0|||
163903464|NCT03113409|592017241|FG002|Overall Study|Withdrawal by Subject|0|||
164014640|NCT01522651|592416412|FG001|Overall Study|Reason Not Specified|0|||
164014641|NCT01522651|592416413|FG002|Overall Study|Reason Not Specified|0|||
163903465|NCT02040870|592017242|FG000|Overall Study|Completed treatment phase|6|||
163903466|NCT02040870|592017242|FG000|Overall Study|Adverse Event|7|||
163903467|NCT02040870|592017242|FG000|Overall Study|Progressive disease|58|||
163903468|NCT02040870|592017242|FG000|Overall Study|Physician Decision|6|||
163903469|NCT02040870|592017242|FG000|Overall Study|Subject/guardian decision|10|||
164014642|NCT01522651|592416414|FG003|Overall Study|Reason Not Specified|1|||
163903470|NCT02040870|592017242|FG000|Overall Study|Lost to Follow-up|3|||
163903471|NCT02040870|592017242|FG000|Overall Study|Death|13|||
163903472|NCT01706159|592017252|FG000|Overall Study|Withdrawal Criteria|2|||
163903473|NCT01706159|592017253|FG001|Overall Study|Withdrawal Criteria|1|||
163903474|NCT01706159|592017252|FG000|Overall Study|Unclassified|6|||
164014643|NCT01522651|592416415|FG004|Overall Study|Reason Not Specified|0|||
163903475|NCT01706159|592017253|FG001|Overall Study|Unclassified|1|||
163903476|NCT03371017|592017254|FG000|Overall Study|Physician Decision|0|||
163903477|NCT03371017|592017255|FG001|Overall Study|Physician Decision|1|||
163903478|NCT03371017|592017254|FG000|Overall Study|Reason not Specified|0|||
163903479|NCT03371017|592017255|FG001|Overall Study|Reason not Specified|1|||
163903480|NCT03371017|592017254|FG000|Overall Study|Lost to Follow-up|13|||
163903481|NCT03371017|592017255|FG001|Overall Study|Lost to Follow-up|16|||
163903482|NCT03371017|592017254|FG000|Overall Study|Death|228|||
163903483|NCT03371017|592017255|FG001|Overall Study|Death|215|||
163903484|NCT03371017|592017254|FG000|Overall Study|Withdrawal by Subject|20|||
163903485|NCT03371017|592017255|FG001|Overall Study|Withdrawal by Subject|25|||
163903486|NCT03371017|592017254|FG000|Overall Study|Study Ended by Sponsor|37|||
163903487|NCT03371017|592017255|FG001|Overall Study|Study Ended by Sponsor|38|||
163903488|NCT03371017|592017254|FG000|Overall Study|Protocol Deviation|0|||
163903489|NCT03371017|592017255|FG001|Overall Study|Protocol Deviation|1|||
163903490|NCT04057131|592017256|FG000|Overall Study|Protocol Violation|24|||
163903491|NCT02830204|592017257|FG000|Overall Study|Death|9|||
163903492|NCT02830204|592017257|FG000|Overall Study|Withdrawal by Subject|1|||
163903493|NCT02517268|592017260|FG000|Overall Study|Withdrawal by Subject|1|||
163903494|NCT02517268|592017261|FG001|Overall Study|Withdrawal by Subject|0|||
163903495|NCT04686266|592017264|FG000|Overall Study|Withdrawal by Subject|0|||
163903496|NCT04686266|592017265|FG001|Overall Study|Withdrawal by Subject|1|||
163903497|NCT02401815|592017270|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903498|NCT02401815|592017271|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903499|NCT02401815|592017272|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903500|NCT02401815|592017273|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
163903501|NCT02401815|592017274|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903502|NCT02401815|592017275|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903503|NCT02401815|592017276|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903504|NCT02401815|592017277|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903505|NCT02401815|592017278|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903506|NCT02401815|592017279|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
163903507|NCT02401815|592017270|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
163903508|NCT02401815|592017271|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163903509|NCT02401815|592017272|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163903510|NCT02401815|592017273|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
163903511|NCT02401815|592017274|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163903512|NCT02401815|592017275|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163903513|NCT02401815|592017276|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164014644|NCT01522651|592416411|FG000|Overall Study|Participant Non-Compliance|1|||
164014645|NCT01522651|592416412|FG001|Overall Study|Participant Non-Compliance|0|||
164014646|NCT01522651|592416413|FG002|Overall Study|Participant Non-Compliance|0|||
164014647|NCT01522651|592416414|FG003|Overall Study|Participant Non-Compliance|0|||
164014648|NCT01522651|592416415|FG004|Overall Study|Participant Non-Compliance|0|||
164014649|NCT01522651|592416411|FG000|Overall Study|Withdrew Consent|1|||
164014650|NCT01522651|592416412|FG001|Overall Study|Withdrew Consent|1|||
164014651|NCT01522651|592416413|FG002|Overall Study|Withdrew Consent|0|||
164014652|NCT01522651|592416414|FG003|Overall Study|Withdrew Consent|1|||
164014653|NCT01522651|592416415|FG004|Overall Study|Withdrew Consent|1|||
164014654|NCT01522651|592416411|FG000|Overall Study|Randomized but Never Treated|0|||
164014655|NCT01522651|592416412|FG001|Overall Study|Randomized but Never Treated|1|||
164014656|NCT01522651|592416413|FG002|Overall Study|Randomized but Never Treated|0|||
164014657|NCT01522651|592416414|FG003|Overall Study|Randomized but Never Treated|1|||
164014658|NCT01522651|592416415|FG004|Overall Study|Randomized but Never Treated|1|||
164014659|NCT01989546|592417884|FG000|Overall Study|Clinical Progression|1|||
164014660|NCT01989546|592417884|FG000|Overall Study|Disease progression on study|8|||
164014661|NCT01793051|592417891|FG000|Overall Study|Withdrawal by Subject|6|||
164014662|NCT01793051|592417892|FG001|Overall Study|Withdrawal by Subject|4|||
164014663|NCT01793051|592417891|FG000|Overall Study|Adverse Event|0|||
164014664|NCT01793051|592417892|FG001|Overall Study|Adverse Event|2|||
164014665|NCT01793051|592417891|FG000|Overall Study|Too ill to continue|1|||
164014666|NCT01793051|592417892|FG001|Overall Study|Too ill to continue|0|||
164385337|NCT00439777|593779241|FG000|Treatment Period|Adverse Event|111|||
164385338|NCT00439777|593779242|FG001|Treatment Period|Adverse Event|92|||
164385339|NCT00439777|593779241|FG000|Treatment Period|Protocol Violation|23|||
164385340|NCT00439777|593779242|FG001|Treatment Period|Protocol Violation|30|||
164385341|NCT00439777|593779241|FG000|Treatment Period|Withdrawal by Subject|66|||
164385342|NCT00439777|593779242|FG001|Treatment Period|Withdrawal by Subject|118|||
164385343|NCT00439777|593779241|FG000|Treatment Period|Lack of Efficacy|1|||
164385344|NCT00439777|593779242|FG001|Treatment Period|Lack of Efficacy|4|||
164385345|NCT00439777|593779241|FG000|Treatment Period|Lost to Follow-up|8|||
164385346|NCT00439777|593779242|FG001|Treatment Period|Lost to Follow-up|10|||
164385347|NCT00439777|593779241|FG000|Treatment Period|Protocol driven decision point|1|||
164385348|NCT00439777|593779242|FG001|Treatment Period|Protocol driven decision point|3|||
164385349|NCT00439777|593779241|FG000|Treatment Period|Physician Decision|7|||
164385350|NCT00439777|593779242|FG001|Treatment Period|Physician Decision|18|||
164385351|NCT00439777|593779241|FG000|Treatment Period|Clinical endpoint reached|26|||
164385352|NCT00439777|593779242|FG001|Treatment Period|Clinical endpoint reached|13|||
164385353|NCT00439777|593779241|FG000|Treatment Period|Technical problems|3|||
164385354|NCT00439777|593779242|FG001|Treatment Period|Technical problems|1|||
164385355|NCT00439777|593779241|FG000|Treatment Period|Participant convenience|12|||
164385356|NCT00439777|593779242|FG001|Treatment Period|Participant convenience|8|||
164385357|NCT00439777|593779241|FG000|Observational Period|Protocol Violation|0|||
164385358|NCT00439777|593779242|FG001|Observational Period|Protocol Violation|2|||
164385359|NCT00439777|593779241|FG000|Observational Period|Withdrawal by Subject|9|||
164385360|NCT00439777|593779242|FG001|Observational Period|Withdrawal by Subject|5|||
164385361|NCT00439777|593779241|FG000|Observational Period|Lost to Follow-up|1|||
164385362|NCT00439777|593779242|FG001|Observational Period|Lost to Follow-up|11|||
164385363|NCT00439777|593779241|FG000|Observational Period|Death|27|||
164385364|NCT00439777|593779242|FG001|Observational Period|Death|20|||
164385365|NCT00439777|593779241|FG000|Observational Period|Study terminated by sponsor|3|||
164385366|NCT00439777|593779242|FG001|Observational Period|Study terminated by sponsor|1|||
164385367|NCT00439777|593779241|FG000|Observational Period|Protocol driven decision point|0|||
164385368|NCT00439777|593779242|FG001|Observational Period|Protocol driven decision point|1|||
164385369|NCT00439777|593779241|FG000|Observational Period|Lack of Efficacy|1|||
164385370|NCT00439777|593779242|FG001|Observational Period|Lack of Efficacy|0|||
164385371|NCT00439777|593779241|FG000|Observational Period|Technical problems|0|||
164014667|NCT01793051|592417891|FG000|Overall Study|Switched chemo|1|||
164014668|NCT01793051|592417892|FG001|Overall Study|Switched chemo|1|||
164014669|NCT01793051|592417891|FG000|Overall Study|Lack of compliance|1|||
164385372|NCT00439777|593779242|FG001|Observational Period|Technical problems|1|||
164385373|NCT00661492|593779243|FG000|Overall Study|Adverse Event|16|||
164385374|NCT00661492|593779244|FG001|Overall Study|Adverse Event|13|||
164385375|NCT00661492|593779243|FG000|Overall Study|Disease Progression|44|||
164385376|NCT00661492|593779244|FG001|Overall Study|Disease Progression|14|||
164385377|NCT00661492|593779243|FG000|Overall Study|Patient Request|6|||
164385378|NCT00661492|593779244|FG001|Overall Study|Patient Request|1|||
164385379|NCT00661492|593779243|FG000|Overall Study|Investigator Request|1|||
164385380|NCT00661492|593779244|FG001|Overall Study|Investigator Request|0|||
164385381|NCT00661492|593779243|FG000|Overall Study|Lost to Follow-up|0|||
164014670|NCT01793051|592417892|FG001|Overall Study|Lack of compliance|0|||
164014671|NCT01793051|592417891|FG000|Overall Study|Requested to be removed from the study|1|||
164014672|NCT01793051|592417892|FG001|Overall Study|Requested to be removed from the study|1|||
164014673|NCT00059215|592417894|FG000|Overall Study|Adverse Event|5|||
164014674|NCT00059215|592417895|FG001|Overall Study|Adverse Event|5|||
164014675|NCT00059215|592417896|FG002|Overall Study|Adverse Event|9|||
164014676|NCT00059215|592417897|FG003|Overall Study|Adverse Event|9|||
164014677|NCT00059215|592417894|FG000|Overall Study|Death|0|||
164014678|NCT00059215|592417895|FG001|Overall Study|Death|0|||
164014679|NCT00059215|592417896|FG002|Overall Study|Death|3|||
164014680|NCT00059215|592417897|FG003|Overall Study|Death|0|||
164014681|NCT00059215|592417894|FG000|Overall Study|Lost to Follow-up|1|||
164014682|NCT00059215|592417895|FG001|Overall Study|Lost to Follow-up|2|||
164014683|NCT00059215|592417896|FG002|Overall Study|Lost to Follow-up|0|||
164014684|NCT00059215|592417897|FG003|Overall Study|Lost to Follow-up|0|||
164385382|NCT00661492|593779244|FG001|Overall Study|Lost to Follow-up|1|||
164385383|NCT00661492|593779243|FG000|Overall Study|Other|1|||
164385384|NCT00661492|593779244|FG001|Overall Study|Other|0|||
164385385|NCT00803634|593779245|FG000|Overall Study|Withdrew Consent|1|||
164385386|NCT00803634|593779246|FG001|Overall Study|Withdrew Consent|0|||
164385387|NCT00803634|593779245|FG000|Overall Study|Lost to Follow-up|2|||
164385388|NCT00803634|593779246|FG001|Overall Study|Lost to Follow-up|3|||
164385389|NCT00803634|593779245|FG000|Overall Study|Death|3|||
164385390|NCT00803634|593779246|FG001|Overall Study|Death|2|||
164385391|NCT03791398|593779249|FG000|Overall Study|Progression of Disease Under Study|2|||
164014685|NCT00059215|592417894|FG000|Overall Study|Withdrawal by Subject|4|||
164014686|NCT00059215|592417895|FG001|Overall Study|Withdrawal by Subject|4|||
164014687|NCT00059215|592417896|FG002|Overall Study|Withdrawal by Subject|1|||
164014688|NCT00059215|592417897|FG003|Overall Study|Withdrawal by Subject|3|||
164014689|NCT00059215|592417894|FG000|Overall Study|Protocol Violation|1|||
164014690|NCT00059215|592417895|FG001|Overall Study|Protocol Violation|0|||
164014691|NCT00059215|592417896|FG002|Overall Study|Protocol Violation|1|||
164014692|NCT00059215|592417897|FG003|Overall Study|Protocol Violation|0|||
164014693|NCT00059215|592417894|FG000|Overall Study|Protocol entry criteria not met|1|||
164014694|NCT00059215|592417895|FG001|Overall Study|Protocol entry criteria not met|1|||
164014695|NCT00059215|592417896|FG002|Overall Study|Protocol entry criteria not met|0|||
164014696|NCT00059215|592417897|FG003|Overall Study|Protocol entry criteria not met|2|||
164014697|NCT00059215|592417894|FG000|Overall Study|Physician Decision|1|||
164014698|NCT00059215|592417895|FG001|Overall Study|Physician Decision|2|||
164014699|NCT00059215|592417896|FG002|Overall Study|Physician Decision|1|||
164014700|NCT00059215|592417897|FG003|Overall Study|Physician Decision|1|||
164014701|NCT04494633|592417898|FG000|Overall Study|Lost to Follow-up|5|||
164014702|NCT04494633|592417899|FG001|Overall Study|Lost to Follow-up|3|||
164014703|NCT04494633|592417898|FG000|Overall Study|Protocol Violation|1|||
164014704|NCT04494633|592417899|FG001|Overall Study|Protocol Violation|1|||
164014705|NCT01958671|592417900|FG000|Overall Study|Adverse Event|1|||
164014706|NCT01958671|592417901|FG001|Overall Study|Adverse Event|1|||
164014707|NCT01958671|592417902|FG002|Overall Study|Adverse Event|5|||
164014708|NCT01958671|592417900|FG000|Overall Study|Death|1|||
164014709|NCT01958671|592417901|FG001|Overall Study|Death|0|||
164014710|NCT01958671|592417902|FG002|Overall Study|Death|0|||
164014711|NCT01958671|592417900|FG000|Overall Study|Excluded medication|0|||
164014712|NCT01958671|592417901|FG001|Overall Study|Excluded medication|0|||
164014713|NCT01958671|592417902|FG002|Overall Study|Excluded medication|1|||
164014714|NCT01958671|592417900|FG000|Overall Study|Hyperglycemia|0|||
164385392|NCT03791398|593779250|FG001|Overall Study|Progression of Disease Under Study|0|||
164385393|NCT03791398|593779251|FG002|Overall Study|Progression of Disease Under Study|0|||
164385394|NCT01072201|593779252|FG000|Overall Study|Lost to Follow-up|0|||
164385395|NCT01072201|593779253|FG001|Overall Study|Lost to Follow-up|1|||
164014715|NCT01958671|592417901|FG001|Overall Study|Hyperglycemia|0|||
164014716|NCT01958671|592417902|FG002|Overall Study|Hyperglycemia|2|||
164014717|NCT01958671|592417900|FG000|Overall Study|Lost to Follow-up|7|||
164014718|NCT01958671|592417901|FG001|Overall Study|Lost to Follow-up|11|||
164014719|NCT01958671|592417902|FG002|Overall Study|Lost to Follow-up|7|||
164385396|NCT00818441|593779257|FG000|Overall Study|Death|69|||
164385397|NCT00818441|593779258|FG001|Overall Study|Death|26|||
164385398|NCT00818441|593779257|FG000|Overall Study|Other|5|||
164385399|NCT00818441|593779258|FG001|Overall Study|Other|0|||
164014720|NCT01958671|592417900|FG000|Overall Study|Non-compliance with study drug|1|||
164073005|NCT01408576|592632757|FG001|Overall Study|Other|16|||
164385400|NCT00818441|593779257|FG000|Overall Study|Lost to Follow-up|2|||
164385401|NCT00818441|593779258|FG001|Overall Study|Lost to Follow-up|1|||
164385402|NCT00818441|593779257|FG000|Overall Study|Withdrawal by Subject|2|||
164385403|NCT00818441|593779258|FG001|Overall Study|Withdrawal by Subject|0|||
164385404|NCT00818441|593779257|FG000|Overall Study|Adverse Event|0|||
164385405|NCT00818441|593779258|FG001|Overall Study|Adverse Event|1|||
164385406|NCT00818441|593779257|FG000|Overall Study|Study terminated by sponsor|11|||
164385407|NCT00818441|593779258|FG001|Overall Study|Study terminated by sponsor|2|||
164385408|NCT00774995|593779264|FG000|Overall Study|Protocol Violation|0|||
164385409|NCT00774995|593779265|FG001|Overall Study|Protocol Violation|0|||
164385410|NCT00774995|593779266|FG002|Overall Study|Protocol Violation|1|||
164385411|NCT00774995|593779267|FG003|Overall Study|Protocol Violation|0|||
164385412|NCT05349617|593781176|FG000|Overall Study|Death|1|||
164385413|NCT05349617|593781177|FG001|Overall Study|Death|1|||
164385414|NCT05349617|593781176|FG000|Overall Study|Lost to Follow-up|3|||
164385415|NCT05349617|593781177|FG001|Overall Study|Lost to Follow-up|8|||
164385416|NCT05349617|593781176|FG000|Overall Study|Withdrawal by Subject|2|||
164385417|NCT05349617|593781177|FG001|Overall Study|Withdrawal by Subject|10|||
164385418|NCT04401579|593781182|FG000|Overall Study|Death|23|||
164385419|NCT04401579|593781183|FG001|Overall Study|Death|36|||
164385420|NCT04401579|593781182|FG000|Overall Study|Lost to Follow-up|40|||
164385421|NCT04401579|593781183|FG001|Overall Study|Lost to Follow-up|41|||
164385422|NCT04401579|593781182|FG000|Overall Study|Withdrawal by Subject|8|||
164385423|NCT04401579|593781183|FG001|Overall Study|Withdrawal by Subject|16|||
164385424|NCT04401579|593781182|FG000|Overall Study|Physician Decision|1|||
164385425|NCT04401579|593781183|FG001|Overall Study|Physician Decision|2|||
164385426|NCT04401579|593781182|FG000|Overall Study|Became ineligible after enrollment|1|||
164385427|NCT04401579|593781183|FG001|Overall Study|Became ineligible after enrollment|1|||
164385428|NCT04401579|593781182|FG000|Overall Study|Enrolled but treatment not administered|7|||
164385429|NCT04401579|593781183|FG001|Overall Study|Enrolled but treatment not administered|9|||
164385430|NCT04401579|593781182|FG000|Overall Study|Adverse Event|2|||
164385431|NCT04401579|593781183|FG001|Overall Study|Adverse Event|1|||
164385432|NCT04401579|593781182|FG000|Overall Study|Scheduling error|1|||
164385433|NCT04401579|593781183|FG001|Overall Study|Scheduling error|2|||
164385434|NCT04401579|593781182|FG000|Overall Study|Transferred to another hospital|1|||
164385435|NCT04401579|593781183|FG001|Overall Study|Transferred to another hospital|2|||
164385436|NCT00489970|593781184|FG000|Persistence Year 9|Lost to Follow-up|2|||
164385437|NCT00489970|593781185|FG001|Persistence Year 9|Lost to Follow-up|2|||
164385438|NCT00489970|593781186|FG002|Persistence Year 9|Lost to Follow-up|3|||
164385439|NCT00489970|593781184|FG000|Persistence Year 9|Other|1|||
164385440|NCT00489970|593781185|FG001|Persistence Year 9|Other|0|||
164385441|NCT00489970|593781186|FG002|Persistence Year 9|Other|2|||
164385442|NCT00896168|593781189|FG000|Overall Study|Adverse Event|4|||
164385443|NCT00896168|593781190|FG001|Overall Study|Adverse Event|7|||
164385444|NCT00896168|593781189|FG000|Overall Study|Treatment failure|8|||
164385445|NCT00896168|593781190|FG001|Overall Study|Treatment failure|10|||
164385446|NCT00896168|593781189|FG000|Overall Study|Lost to Follow-up|1|||
164385447|NCT00896168|593781190|FG001|Overall Study|Lost to Follow-up|1|||
164385448|NCT00896168|593781189|FG000|Overall Study|Other|1|||
164385449|NCT00896168|593781190|FG001|Overall Study|Other|1|||
164385450|NCT00902304|593781191|FG000|Overall Study|Adverse Event|4|||
164385451|NCT00902304|593781192|FG001|Overall Study|Adverse Event|10|||
164385452|NCT00902304|593781193|FG002|Overall Study|Adverse Event|25|||
164385453|NCT00902304|593781191|FG000|Overall Study|Investigator discretion|3|||
164385454|NCT00902304|593781192|FG001|Overall Study|Investigator discretion|5|||
164385455|NCT00902304|593781193|FG002|Overall Study|Investigator discretion|13|||
163903514|NCT02401815|592017277|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
164385456|NCT00902304|593781191|FG000|Overall Study|Lost to Follow-up|7|||
164385457|NCT00902304|593781192|FG001|Overall Study|Lost to Follow-up|7|||
164385458|NCT00902304|593781193|FG002|Overall Study|Lost to Follow-up|7|||
164385459|NCT00902304|593781191|FG000|Overall Study|Protocol Violation|9|||
163903515|NCT02401815|592017278|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163903516|NCT02401815|592017279|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
163903517|NCT02401815|592017270|FG000|Dose Escalation (up to 670 Days)|Death|1|||
164385460|NCT00902304|593781192|FG001|Overall Study|Protocol Violation|18|||
164385461|NCT00902304|593781193|FG002|Overall Study|Protocol Violation|20|||
164385462|NCT00902304|593781191|FG000|Overall Study|Withdrawal by Subject|32|||
164385463|NCT00902304|593781192|FG001|Overall Study|Withdrawal by Subject|22|||
164385464|NCT00902304|593781193|FG002|Overall Study|Withdrawal by Subject|43|||
164385465|NCT00902304|593781191|FG000|Overall Study|includes pregnancy|3|||
164385466|NCT00902304|593781192|FG001|Overall Study|includes pregnancy|9|||
163903518|NCT02401815|592017271|FG001|Dose Escalation (up to 670 Days)|Death|2|||
164385467|NCT00902304|593781193|FG002|Overall Study|includes pregnancy|2|||
164385468|NCT00003457|593781197|FG000|Overall Study|Not evaluable|9|||
164385469|NCT01054729|593781198|FG000|Overall Study|Randomized but Not Treated|0|||
164385470|NCT01054729|593781199|FG001|Overall Study|Randomized but Not Treated|1|||
164385471|NCT01054729|593781200|FG002|Overall Study|Randomized but Not Treated|0|||
164385472|NCT01054729|593781201|FG003|Overall Study|Randomized but Not Treated|0|||
164385473|NCT01054729|593781198|FG000|Overall Study|Adverse Event|1|||
164385474|NCT01054729|593781199|FG001|Overall Study|Adverse Event|1|||
164385475|NCT01054729|593781200|FG002|Overall Study|Adverse Event|2|||
164385476|NCT01054729|593781201|FG003|Overall Study|Adverse Event|1|||
164385477|NCT01054729|593781198|FG000|Overall Study|Withdrawal by Subject|1|||
164385478|NCT01054729|593781199|FG001|Overall Study|Withdrawal by Subject|0|||
164385479|NCT01054729|593781200|FG002|Overall Study|Withdrawal by Subject|1|||
164014721|NCT01958671|592417901|FG001|Overall Study|Non-compliance with study drug|1|||
164014722|NCT01958671|592417902|FG002|Overall Study|Non-compliance with study drug|1|||
164014723|NCT01958671|592417900|FG000|Overall Study|Pregnancy|0|||
164014724|NCT01958671|592417901|FG001|Overall Study|Pregnancy|0|||
164014725|NCT01958671|592417902|FG002|Overall Study|Pregnancy|1|||
164014726|NCT01958671|592417900|FG000|Overall Study|Protocol Violation|0|||
164014727|NCT01958671|592417901|FG001|Overall Study|Protocol Violation|1|||
164014728|NCT01958671|592417902|FG002|Overall Study|Protocol Violation|0|||
164014729|NCT01958671|592417900|FG000|Overall Study|Study site terminated by sponsor|1|||
164014730|NCT01958671|592417901|FG001|Overall Study|Study site terminated by sponsor|0|||
164014731|NCT01958671|592417902|FG002|Overall Study|Study site terminated by sponsor|1|||
164014732|NCT01958671|592417900|FG000|Overall Study|Participant moved|0|||
164014733|NCT01958671|592417901|FG001|Overall Study|Participant moved|0|||
164014734|NCT01958671|592417902|FG002|Overall Study|Participant moved|1|||
164014735|NCT01958671|592417900|FG000|Overall Study|Withdrawal by Subject|8|||
164014736|NCT01958671|592417901|FG001|Overall Study|Withdrawal by Subject|10|||
164014737|NCT01958671|592417902|FG002|Overall Study|Withdrawal by Subject|13|||
164014738|NCT01703286|592417906|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
164014739|NCT01703286|592417907|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
164014740|NCT01703286|592417908|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
164014741|NCT01703286|592417909|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
164014742|NCT01703286|592417910|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
164014743|NCT01703286|592417911|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
164014744|NCT01703286|592417906|FG000|Period 2 Including Washout|Adverse Event|0|||
164014745|NCT01703286|592417907|FG001|Period 2 Including Washout|Adverse Event|0|||
164014746|NCT01703286|592417908|FG002|Period 2 Including Washout|Adverse Event|0|||
164014747|NCT01703286|592417909|FG003|Period 2 Including Washout|Adverse Event|1|||
164014748|NCT01703286|592417910|FG004|Period 2 Including Washout|Adverse Event|0|||
164014749|NCT01703286|592417911|FG005|Period 2 Including Washout|Adverse Event|0|||
164014750|NCT00931892|592417912|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
164014751|NCT00931892|592417913|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
164014752|NCT02207530|592417914|FG000|Overall Study|Worsening condition under investigation|78|||
164014753|NCT02207530|592417914|FG000|Overall Study|Patient decision to stop study treatment|5|||
164014754|NCT02207530|592417914|FG000|Overall Study|Adverse Event|8|||
164014755|NCT03952468|592417917|FG000|Overall Study|Death|0|||
164014756|NCT03952468|592417918|FG001|Overall Study|Death|1|||
164014757|NCT03952468|592417917|FG000|Overall Study|Adverse Event|0|||
164014758|NCT03952468|592417918|FG001|Overall Study|Adverse Event|1|||
164014759|NCT03952468|592417917|FG000|Overall Study|Physician Decision|1|||
164014760|NCT03952468|592417918|FG001|Overall Study|Physician Decision|0|||
164014761|NCT03952468|592417917|FG000|Overall Study|Lost to Follow-up|3|||
164014762|NCT03952468|592417918|FG001|Overall Study|Lost to Follow-up|4|||
164014763|NCT03952468|592417917|FG000|Overall Study|Withdrawal by Subject|2|||
164385480|NCT01054729|593781201|FG003|Overall Study|Withdrawal by Subject|0|||
164385481|NCT01054729|593781198|FG000|Overall Study|Lost to Follow-up|0|||
164385482|NCT01054729|593781199|FG001|Overall Study|Lost to Follow-up|1|||
164385483|NCT01054729|593781200|FG002|Overall Study|Lost to Follow-up|0|||
164385484|NCT01054729|593781201|FG003|Overall Study|Lost to Follow-up|0|||
164385485|NCT01054729|593781198|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
164014764|NCT03952468|592417918|FG001|Overall Study|Withdrawal by Subject|1|||
164014765|NCT01849848|592417921|FG000|Overall Study|Physician Decision|1|||
164014766|NCT01849848|592417921|FG000|Overall Study|Progression of the primary disease|3|||
164014767|NCT03649321|592417922|FG000|Overall Study|Withdrawal by Subject|1|||
164014768|NCT03649321|592417923|FG001|Overall Study|Withdrawal by Subject|0|||
164014769|NCT03649321|592417922|FG000|Overall Study|Death|1|||
164014770|NCT03649321|592417923|FG001|Overall Study|Death|0|||
164014771|NCT01702363|592417924|FG000|Overall Study|Adverse Event|14|||
164014772|NCT01702363|592417924|FG000|Overall Study|Lack of Efficacy|4|||
164014773|NCT01702363|592417924|FG000|Overall Study|Withdrawal by Subject|2|||
164014774|NCT00406315|592417925|FG000|Overall Study|Death|1|||
164014775|NCT00406315|592417925|FG000|Overall Study|Adverse Event|39|||
164014776|NCT00406315|592417925|FG000|Overall Study|Laboratory Abnormality|4|||
164014777|NCT00406315|592417925|FG000|Overall Study|Lack of Efficacy|13|||
164014778|NCT00406315|592417925|FG000|Overall Study|Other|33|||
164014779|NCT00406315|592417925|FG000|Overall Study|Lost to Follow-up|21|||
164014780|NCT00406315|592417925|FG000|Overall Study|Withdrawal by Subject|30|||
164014781|NCT01312428|592417926|FG000|Overall Study|Study Termination|3|||
164014782|NCT01312428|592417927|FG001|Overall Study|Study Termination|4|||
164385486|NCT01054729|593781199|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
164385487|NCT01054729|593781200|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
164385488|NCT01054729|593781201|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
164385489|NCT01054729|593781198|FG000|Overall Study|Non-responder|1|||
164385490|NCT01054729|593781199|FG001|Overall Study|Non-responder|0|||
164385491|NCT01054729|593781200|FG002|Overall Study|Non-responder|1|||
164385492|NCT01054729|593781201|FG003|Overall Study|Non-responder|1|||
164385493|NCT01054729|593781198|FG000|Overall Study|PEG/RBV Non-responder|1|||
164385494|NCT01054729|593781199|FG001|Overall Study|PEG/RBV Non-responder|0|||
164385495|NCT01054729|593781200|FG002|Overall Study|PEG/RBV Non-responder|1|||
164385496|NCT01054729|593781201|FG003|Overall Study|PEG/RBV Non-responder|0|||
164385497|NCT01054729|593781198|FG000|Overall Study|Personal/Obligations|0|||
164385498|NCT01054729|593781199|FG001|Overall Study|Personal/Obligations|1|||
164385499|NCT01054729|593781200|FG002|Overall Study|Personal/Obligations|0|||
164385500|NCT01054729|593781201|FG003|Overall Study|Personal/Obligations|0|||
164385501|NCT01054729|593781198|FG000|Overall Study|Subject moved|0|||
164385502|NCT01054729|593781199|FG001|Overall Study|Subject moved|0|||
164385503|NCT01054729|593781200|FG002|Overall Study|Subject moved|1|||
164385504|NCT01054729|593781201|FG003|Overall Study|Subject moved|0|||
164385505|NCT01054729|593781198|FG000|Overall Study|Lack of Efficacy|0|||
164385506|NCT01054729|593781199|FG001|Overall Study|Lack of Efficacy|0|||
164385507|NCT01054729|593781200|FG002|Overall Study|Lack of Efficacy|0|||
164385508|NCT01054729|593781201|FG003|Overall Study|Lack of Efficacy|1|||
164014783|NCT02202031|592417930|FG000|Overall Study|Lost to Follow-up|1|||
164385509|NCT01148810|593781202|FG000|Overall Study|Adverse Event|0|||
164385510|NCT01148810|593781203|FG001|Overall Study|Adverse Event|2|||
164385511|NCT01148810|593781202|FG000|Overall Study|Lack of Efficacy|0|||
164385512|NCT01148810|593781203|FG001|Overall Study|Lack of Efficacy|1|||
164385513|NCT01148810|593781202|FG000|Overall Study|Withdrawal by Subject|0|||
164385514|NCT01148810|593781203|FG001|Overall Study|Withdrawal by Subject|2|||
164385515|NCT01148810|593781202|FG000|Overall Study|Protocol Violation|1|||
164385516|NCT01148810|593781203|FG001|Overall Study|Protocol Violation|0|||
164014784|NCT02202031|592417931|FG001|Overall Study|Lost to Follow-up|0|||
164385517|NCT02731131|593781209|FG000|Overall Study|Psychiatric Disorder|0|||
164385518|NCT02731131|593781210|FG001|Overall Study|Psychiatric Disorder|1|||
164385519|NCT02731131|593781209|FG000|Overall Study|Refused Therapy|0|||
164385520|NCT02731131|593781210|FG001|Overall Study|Refused Therapy|1|||
164385521|NCT04831736|593781217|FG000|Overall Study|Withdrawal by Subject|0|||
164385522|NCT04831736|593781218|FG001|Overall Study|Withdrawal by Subject|1|||
164385523|NCT00795600|593781219|FG000|Overall Study|Adverse Event|1|||
164014785|NCT02202031|592417930|FG000|Overall Study|Too Busy|1|||
164014786|NCT02202031|592417931|FG001|Overall Study|Too Busy|3|||
164014787|NCT02202031|592417930|FG000|Overall Study|Illness/Medical Reason|0|||
164014788|NCT02202031|592417931|FG001|Overall Study|Illness/Medical Reason|2|||
164014789|NCT02202031|592417930|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
164014790|NCT02202031|592417931|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
164014791|NCT02214186|592417937|FG000|Overall Study|Lost to Follow-up|1|||
164014792|NCT02214186|592417938|FG001|Overall Study|Lost to Follow-up|1|||
164014793|NCT02214186|592417937|FG000|Overall Study|Protocol Violation|1|||
164014794|NCT02214186|592417938|FG001|Overall Study|Protocol Violation|1|||
164014795|NCT01525849|592417941|FG000|Overall Study|Lost to Follow-up|3|||
164014796|NCT01525849|592417942|FG001|Overall Study|Lost to Follow-up|2|||
164014797|NCT01525849|592417941|FG000|Overall Study|Withdrawal by Subject|1|||
164014798|NCT01525849|592417942|FG001|Overall Study|Withdrawal by Subject|9|||
164014799|NCT01525849|592417941|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
164014800|NCT01525849|592417942|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
164014801|NCT01525849|592417941|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
164014802|NCT01525849|592417942|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
164014803|NCT00339183|592417945|FG000|Overall Study|Adverse Event|5|||
164014804|NCT00339183|592417946|FG001|Overall Study|Adverse Event|3|||
164385524|NCT00795600|593781220|FG001|Overall Study|Adverse Event|1|||
164385525|NCT00795600|593781219|FG000|Overall Study|Protocol Violation|1|||
164385526|NCT00795600|593781220|FG001|Overall Study|Protocol Violation|2|||
164385527|NCT00795600|593781219|FG000|Overall Study|Withdrawal by Subject|1|||
164385528|NCT00795600|593781220|FG001|Overall Study|Withdrawal by Subject|0|||
164385529|NCT00795600|593781219|FG000|Overall Study|Unclassified|1|||
164385530|NCT00795600|593781220|FG001|Overall Study|Unclassified|1|||
164385531|NCT01659021|593781221|FG000|Main Study|Adverse Event|2|||
164385532|NCT01659021|593781222|FG001|Main Study|Adverse Event|3|||
164385533|NCT01659021|593781221|FG000|Main Study|Lost to Follow-up|1|||
164385534|NCT01659021|593781222|FG001|Main Study|Lost to Follow-up|0|||
164385535|NCT01659021|593781221|FG000|Main Study|Unknown Reasons|2|||
164385536|NCT01659021|593781222|FG001|Main Study|Unknown Reasons|1|||
164014805|NCT00339183|592417945|FG000|Overall Study|Withdrawal by Subject|16|||
164014806|NCT00339183|592417946|FG001|Overall Study|Withdrawal by Subject|19|||
164014807|NCT00339183|592417945|FG000|Overall Study|Physician Decision|2|||
164014808|NCT00339183|592417946|FG001|Overall Study|Physician Decision|4|||
164014809|NCT00339183|592417945|FG000|Overall Study|Lost to Follow-up|17|||
164014810|NCT00339183|592417946|FG001|Overall Study|Lost to Follow-up|17|||
164014811|NCT00339183|592417945|FG000|Overall Study|Protocol-specified criteria|12|||
164014812|NCT00339183|592417946|FG001|Overall Study|Protocol-specified criteria|8|||
164014813|NCT00339183|592417945|FG000|Overall Study|Missing reason|3|||
164014814|NCT00339183|592417946|FG001|Overall Study|Missing reason|1|||
164014815|NCT00339183|592417945|FG000|Overall Study|Other|46|||
164014816|NCT00339183|592417946|FG001|Overall Study|Other|40|||
164014817|NCT00339183|592417945|FG000|Overall Study|Ongoing|20|||
164014818|NCT00339183|592417946|FG001|Overall Study|Ongoing|13|||
164014819|NCT00793819|592417947|FG000|Overall Study|Adverse Event|8|||
164014820|NCT00793819|592417948|FG001|Overall Study|Adverse Event|4|||
164014821|NCT00793819|592417947|FG000|Overall Study|Lack of Efficacy|1|||
164014822|NCT00793819|592417948|FG001|Overall Study|Lack of Efficacy|1|||
164014823|NCT00793819|592417947|FG000|Overall Study|Withdrawal by Subject|4|||
164014824|NCT00793819|592417948|FG001|Overall Study|Withdrawal by Subject|3|||
164014825|NCT00793819|592417947|FG000|Overall Study|Lost to Follow-up|1|||
164014826|NCT00793819|592417948|FG001|Overall Study|Lost to Follow-up|1|||
164014827|NCT00002663|592417949|FG000|Overall Study|Death|4|||
164014828|NCT00002663|592417950|FG001|Overall Study|Death|1|||
164014829|NCT00002663|592417951|FG002|Overall Study|Death|1|||
164014830|NCT00002663|592417952|FG003|Overall Study|Death|0|||
164014831|NCT00002663|592417953|FG004|Overall Study|Death|0|||
164014832|NCT00002663|592417954|FG005|Overall Study|Death|13|||
164014833|NCT00002663|592417955|FG006|Overall Study|Death|0|||
164014834|NCT00002663|592417956|FG007|Overall Study|Death|1|||
164385537|NCT01659021|593781221|FG000|Main Study|Physician Decision|34|||
164014835|NCT00002663|592417957|FG008|Overall Study|Death|1|||
164014836|NCT00002663|592417958|FG009|Overall Study|Death|1|||
164014837|NCT00002663|592417949|FG000|Overall Study|Lost to Follow-up|3|||
164014838|NCT00002663|592417950|FG001|Overall Study|Lost to Follow-up|0|||
164014839|NCT00002663|592417951|FG002|Overall Study|Lost to Follow-up|0|||
164014840|NCT00002663|592417952|FG003|Overall Study|Lost to Follow-up|1|||
164014841|NCT00002663|592417953|FG004|Overall Study|Lost to Follow-up|0|||
164014842|NCT00002663|592417954|FG005|Overall Study|Lost to Follow-up|1|||
164092932|NCT00442936|592703417|FG003|Overall Study|Protocol Violation|1|||
164092933|NCT02428699|592703418|FG000|Washout Period 1|Screen Failure|1|||
164385538|NCT01659021|593781222|FG001|Main Study|Physician Decision|16|||
164385539|NCT01659021|593781221|FG000|Main Study|Withdrawal by Subject|19|||
164385540|NCT01659021|593781222|FG001|Main Study|Withdrawal by Subject|16|||
164385541|NCT01659021|593781221|FG000|Main Study|Study Terminated by Sponsor|16|||
164385542|NCT01659021|593781222|FG001|Main Study|Study Terminated by Sponsor|1|||
164385543|NCT01659021|593781221|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
164385544|NCT01659021|593781222|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
164385545|NCT01659021|593781221|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
164385546|NCT01659021|593781222|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
164385547|NCT01233817|593781223|FG000|Overall Study|Lost to Follow-up|1|||
164385548|NCT01233817|593781223|FG000|Overall Study|Withdrawal by Subject|2|||
164385549|NCT01248884|593781224|FG000|Overall Study|Withdrawal by Subject|1|||
164385550|NCT01248884|593781225|FG001|Overall Study|Withdrawal by Subject|3|||
164385551|NCT01248884|593781226|FG002|Overall Study|Withdrawal by Subject|1|||
164385552|NCT01248884|593781224|FG000|Overall Study|Adverse Event|1|||
164385553|NCT01248884|593781225|FG001|Overall Study|Adverse Event|0|||
164385554|NCT01248884|593781226|FG002|Overall Study|Adverse Event|0|||
164385555|NCT00840970|593781229|FG000|Overall Study|Adverse Event|0|||
164385556|NCT00840970|593781230|FG001|Overall Study|Adverse Event|0|||
164385557|NCT00840970|593781231|FG002|Overall Study|Adverse Event|1|||
164385558|NCT00504829|593781232|FG000|Overall Study|Protocol Violation|6|||
164385559|NCT00504829|593781233|FG001|Overall Study|Protocol Violation|4|||
164385560|NCT00504829|593781234|FG002|Overall Study|Protocol Violation|10|||
164385561|NCT03465540|593781235|FG000|Overall Study|Withdrawal by Subject|0|||
164385562|NCT03465540|593781236|FG001|Overall Study|Withdrawal by Subject|0|||
164385563|NCT03465540|593781237|FG002|Overall Study|Withdrawal by Subject|1|||
164385564|NCT03465540|593781238|FG003|Overall Study|Withdrawal by Subject|1|||
164385565|NCT03465540|593781239|FG004|Overall Study|Withdrawal by Subject|1|||
164385566|NCT03465540|593781240|FG005|Overall Study|Withdrawal by Subject|0|||
164385567|NCT03465540|593781235|FG000|Overall Study|Lost to Follow-up|0|||
164385568|NCT03465540|593781236|FG001|Overall Study|Lost to Follow-up|1|||
164014843|NCT00002663|592417955|FG006|Overall Study|Lost to Follow-up|0|||
164014844|NCT00002663|592417956|FG007|Overall Study|Lost to Follow-up|0|||
164014845|NCT00002663|592417957|FG008|Overall Study|Lost to Follow-up|0|||
164014846|NCT00002663|592417958|FG009|Overall Study|Lost to Follow-up|0|||
164385569|NCT03465540|593781237|FG002|Overall Study|Lost to Follow-up|0|||
164385570|NCT03465540|593781238|FG003|Overall Study|Lost to Follow-up|0|||
164385571|NCT03465540|593781239|FG004|Overall Study|Lost to Follow-up|1|||
164014847|NCT00002663|592417949|FG000|Overall Study|Other|0|||
164014848|NCT00002663|592417950|FG001|Overall Study|Other|1|||
164385572|NCT03465540|593781240|FG005|Overall Study|Lost to Follow-up|0|||
164385573|NCT03465540|593781235|FG000|Overall Study|Death|1|||
164014849|NCT00002663|592417951|FG002|Overall Study|Other|0|||
164014850|NCT00002663|592417952|FG003|Overall Study|Other|0|||
164014851|NCT00002663|592417953|FG004|Overall Study|Other|0|||
164014852|NCT00002663|592417954|FG005|Overall Study|Other|1|||
164014853|NCT00002663|592417955|FG006|Overall Study|Other|1|||
164014854|NCT00002663|592417956|FG007|Overall Study|Other|0|||
164014855|NCT00002663|592417957|FG008|Overall Study|Other|0|||
164014856|NCT00002663|592417958|FG009|Overall Study|Other|0|||
164014857|NCT00002663|592417949|FG000|Overall Study|Physician Decision|0|||
164014858|NCT00002663|592417950|FG001|Overall Study|Physician Decision|0|||
164014859|NCT00002663|592417951|FG002|Overall Study|Physician Decision|0|||
164014860|NCT00002663|592417952|FG003|Overall Study|Physician Decision|0|||
164014861|NCT00002663|592417953|FG004|Overall Study|Physician Decision|1|||
164014862|NCT00002663|592417954|FG005|Overall Study|Physician Decision|0|||
164014863|NCT00002663|592417955|FG006|Overall Study|Physician Decision|0|||
164014864|NCT00002663|592417956|FG007|Overall Study|Physician Decision|0|||
164014865|NCT00002663|592417957|FG008|Overall Study|Physician Decision|1|||
164014866|NCT00002663|592417958|FG009|Overall Study|Physician Decision|1|||
164014867|NCT00002663|592417949|FG000|Overall Study|Adverse Event|0|||
164014868|NCT00002663|592417950|FG001|Overall Study|Adverse Event|0|||
164014869|NCT00002663|592417951|FG002|Overall Study|Adverse Event|0|||
164014870|NCT00002663|592417952|FG003|Overall Study|Adverse Event|1|||
164014871|NCT00002663|592417953|FG004|Overall Study|Adverse Event|0|||
164014872|NCT00002663|592417954|FG005|Overall Study|Adverse Event|0|||
164014873|NCT00002663|592417955|FG006|Overall Study|Adverse Event|0|||
164014874|NCT00002663|592417956|FG007|Overall Study|Adverse Event|1|||
164014875|NCT00002663|592417957|FG008|Overall Study|Adverse Event|0|||
164014876|NCT00002663|592417958|FG009|Overall Study|Adverse Event|0|||
164014877|NCT00446446|592417960|FG000|Overall Study|Death|10|||
164014878|NCT00446446|592417960|FG000|Overall Study|Withdrawal by Subject|6|||
164014879|NCT00446446|592417960|FG000|Overall Study|Other|4|||
164014880|NCT00446446|592417960|FG000|Overall Study|Disease Progession|2|||
164014881|NCT00446446|592417960|FG000|Overall Study|Adverse Event|1|||
164014882|NCT00446446|592417960|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
164014883|NCT02142894|592417961|FG000|Overall Study|Protocol Violation|8|||
164014884|NCT00611130|592417967|FG000|Overall Study|Lost to Follow-up|25|||
164014885|NCT00611130|592417968|FG001|Overall Study|Lost to Follow-up|29|||
164014886|NCT00611130|592417967|FG000|Overall Study|Protocol noncompliance|7|||
164014887|NCT00611130|592417968|FG001|Overall Study|Protocol noncompliance|6|||
164014888|NCT00611130|592417967|FG000|Overall Study|Withdrawal by Subject|6|||
164014889|NCT00611130|592417968|FG001|Overall Study|Withdrawal by Subject|5|||
164014890|NCT00611130|592417967|FG000|Overall Study|Other|5|||
164014891|NCT00611130|592417968|FG001|Overall Study|Other|4|||
164014892|NCT00611130|592417967|FG000|Overall Study|Incarceration|3|||
164014893|NCT00611130|592417968|FG001|Overall Study|Incarceration|2|||
164014894|NCT00611130|592417967|FG000|Overall Study|Administrative|1|||
164014895|NCT00611130|592417968|FG001|Overall Study|Administrative|1|||
164014896|NCT00611130|592417967|FG000|Overall Study|Adverse Event|1|||
164014897|NCT00611130|592417968|FG001|Overall Study|Adverse Event|0|||
164014898|NCT00611130|592417967|FG000|Overall Study|Death|1|||
164014899|NCT00611130|592417968|FG001|Overall Study|Death|0|||
164014900|NCT00525148|592417976|FG000|Overall Study|Other Adverse Event|3|||
164014901|NCT00525148|592417977|FG001|Overall Study|Other Adverse Event|5|||
164014902|NCT00525148|592417978|FG002|Overall Study|Other Adverse Event|1|||
164014903|NCT00525148|592417979|FG003|Overall Study|Other Adverse Event|8|||
164014904|NCT00525148|592417976|FG000|Overall Study|Progressive disease|18|||
164014905|NCT00525148|592417977|FG001|Overall Study|Progressive disease|30|||
164014906|NCT00525148|592417978|FG002|Overall Study|Progressive disease|6|||
164014907|NCT00525148|592417979|FG003|Overall Study|Progressive disease|49|||
164014908|NCT00525148|592417976|FG000|Overall Study|Refused continuation of study medication|0|||
164014909|NCT00525148|592417977|FG001|Overall Study|Refused continuation of study medication|2|||
164014910|NCT00525148|592417978|FG002|Overall Study|Refused continuation of study medication|0|||
164014911|NCT00525148|592417979|FG003|Overall Study|Refused continuation of study medication|1|||
164014912|NCT00525148|592417976|FG000|Overall Study|Other than stated|2|||
164014913|NCT00525148|592417977|FG001|Overall Study|Other than stated|1|||
164014914|NCT00525148|592417978|FG002|Overall Study|Other than stated|0|||
164014915|NCT00525148|592417979|FG003|Overall Study|Other than stated|3|||
164014916|NCT05100199|592417980|FG000|Overall Study|Lost to Follow-up|5|||
164014917|NCT05100199|592417981|FG001|Overall Study|Lost to Follow-up|8|||
164014918|NCT05100199|592417982|FG002|Overall Study|Lost to Follow-up|3|||
164014919|NCT05100199|592417983|FG003|Overall Study|Lost to Follow-up|6|||
164014920|NCT05100199|592417980|FG000|Overall Study|Withdrawal by Subject|3|||
164014921|NCT05100199|592417981|FG001|Overall Study|Withdrawal by Subject|3|||
164014922|NCT05100199|592417982|FG002|Overall Study|Withdrawal by Subject|9|||
164014923|NCT05100199|592417983|FG003|Overall Study|Withdrawal by Subject|7|||
164014924|NCT05100199|592417980|FG000|Overall Study|Other|0|||
164014925|NCT05100199|592417981|FG001|Overall Study|Other|0|||
164014926|NCT05100199|592417982|FG002|Overall Study|Other|1|||
164014927|NCT05100199|592417983|FG003|Overall Study|Other|1|||
164014928|NCT01455428|592417984|FG000|Overall Study|Protocol Violation|2|||
164385574|NCT03465540|593781236|FG001|Overall Study|Death|1|||
164385575|NCT03465540|593781237|FG002|Overall Study|Death|0|||
164385576|NCT03465540|593781238|FG003|Overall Study|Death|2|||
164385577|NCT03465540|593781239|FG004|Overall Study|Death|0|||
164385578|NCT03465540|593781240|FG005|Overall Study|Death|2|||
164385579|NCT03465540|593781235|FG000|Overall Study|Protocol specified criteria|0|||
164385580|NCT03465540|593781236|FG001|Overall Study|Protocol specified criteria|2|||
164385581|NCT03465540|593781237|FG002|Overall Study|Protocol specified criteria|2|||
164385582|NCT03465540|593781238|FG003|Overall Study|Protocol specified criteria|0|||
164385583|NCT03465540|593781239|FG004|Overall Study|Protocol specified criteria|2|||
164385584|NCT03465540|593781240|FG005|Overall Study|Protocol specified criteria|0|||
164385585|NCT01854827|593781241|FG000|Overall Study|Death|1|||
164385586|NCT00736996|593781242|FG000|Overall Study|Lost to Follow-up|1|||
164385587|NCT00736996|593781243|FG001|Overall Study|Lost to Follow-up|9|||
164385588|NCT00736996|593781244|FG002|Overall Study|Lost to Follow-up|2|||
164385589|NCT00462384|593781245|FG000|Overall Study|Adverse Event|2|||
164385590|NCT00462384|593781245|FG000|Overall Study|Death|2|||
164385591|NCT00462384|593781245|FG000|Overall Study|Withdrawal by Subject|1|||
164385592|NCT00462384|593781245|FG000|Overall Study|Other|4|||
164385593|NCT04000165|593781246|FG000|Overall Study|Physician Decision|1|||
164385594|NCT04000165|593781246|FG000|Overall Study|Withdrawal by Subject|1|||
164385595|NCT01751568|593781251|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
164385596|NCT01751568|593781252|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
164385597|NCT01751568|593781253|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
164385598|NCT02660944|593781262|FG000|Overall Study|Adverse Event|3|||
164385599|NCT02660944|593781263|FG001|Overall Study|Adverse Event|4|||
164385600|NCT02660944|593781262|FG000|Overall Study|Physician Decision|3|||
164385601|NCT02660944|593781263|FG001|Overall Study|Physician Decision|1|||
164385602|NCT02660944|593781262|FG000|Overall Study|Withdrawal by Subject|5|||
164385603|NCT02660944|593781263|FG001|Overall Study|Withdrawal by Subject|3|||
164385604|NCT02660944|593781262|FG000|Overall Study|Lost to Follow-up|4|||
164385605|NCT02660944|593781263|FG001|Overall Study|Lost to Follow-up|1|||
164385606|NCT02660944|593781262|FG000|Overall Study|Subject schedule|0|||
164385607|NCT02660944|593781263|FG001|Overall Study|Subject schedule|1|||
164385608|NCT02660944|593781262|FG000|Overall Study|Exclusion criteria met|2|||
164385609|NCT02660944|593781263|FG001|Overall Study|Exclusion criteria met|0|||
164385610|NCT02843568|593781264|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
164385611|NCT02843568|593781265|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
164385612|NCT02843568|593781264|FG000|Overall Study|Death|3|||
164385613|NCT02843568|593781265|FG001|Overall Study|Death|3|||
164385614|NCT02843568|593781264|FG000|Overall Study|Withdrawal by Subject|1|||
164385615|NCT02843568|593781265|FG001|Overall Study|Withdrawal by Subject|1|||
164385616|NCT02843568|593781264|FG000|Overall Study|Lost to Follow-up|2|||
164385617|NCT02843568|593781265|FG001|Overall Study|Lost to Follow-up|0|||
164385618|NCT03586999|593781266|FG000|Overall Study|Lack of Efficacy|2|||
164385619|NCT04096560|593781267|FG000|Overall Study|Reason not Specified|1|||
164385620|NCT04096560|593781268|FG001|Overall Study|Reason not Specified|0|||
164385621|NCT04096560|593781269|FG002|Overall Study|Reason not Specified|0|||
164385622|NCT04096560|593781270|FG003|Overall Study|Reason not Specified|0|||
164385623|NCT04096560|593781271|FG004|Overall Study|Reason not Specified|1|||
164385624|NCT04096560|593781272|FG005|Overall Study|Reason not Specified|1|||
164385625|NCT04096560|593781273|FG006|Overall Study|Reason not Specified|1|||
164385626|NCT04096560|593781274|FG007|Overall Study|Reason not Specified|0|||
164385627|NCT04096560|593781267|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385628|NCT04096560|593781268|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385629|NCT04096560|593781269|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385630|NCT04096560|593781270|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385631|NCT04096560|593781271|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385632|NCT04096560|593781272|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
164385633|NCT04096560|593781273|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
164385634|NCT04096560|593781274|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
164385635|NCT04096560|593781267|FG000|Overall Study|Study Terminated by Sponsor|0|||
164385636|NCT04096560|593781268|FG001|Overall Study|Study Terminated by Sponsor|0|||
164385637|NCT04096560|593781269|FG002|Overall Study|Study Terminated by Sponsor|0|||
164385638|NCT04096560|593781270|FG003|Overall Study|Study Terminated by Sponsor|5|||
164385639|NCT04096560|593781271|FG004|Overall Study|Study Terminated by Sponsor|6|||
164385640|NCT04096560|593781272|FG005|Overall Study|Study Terminated by Sponsor|4|||
164385641|NCT04096560|593781273|FG006|Overall Study|Study Terminated by Sponsor|6|||
164385642|NCT04096560|593781274|FG007|Overall Study|Study Terminated by Sponsor|1|||
164385643|NCT04096560|593781267|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385644|NCT04096560|593781268|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385645|NCT04096560|593781269|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385646|NCT04096560|593781270|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385647|NCT04096560|593781271|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385648|NCT04096560|593781272|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385649|NCT04096560|593781273|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
164385650|NCT04096560|593781274|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
164385651|NCT00534352|593781277|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
164385652|NCT00534352|593781277|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
164385653|NCT00534352|593781277|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
164385654|NCT00534352|593781277|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
164385655|NCT00534352|593781277|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
164385656|NCT00534352|593781277|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
164385657|NCT03264989|593781280|FG000|Overall Study|Lost to Follow-up|1|||
164385658|NCT03264989|593781281|FG001|Overall Study|Lost to Follow-up|0|||
164385659|NCT03264989|593781280|FG000|Overall Study|New Therapy for study Indication|1|||
164385660|NCT03264989|593781281|FG001|Overall Study|New Therapy for study Indication|0|||
164385661|NCT03264989|593781280|FG000|Overall Study|Protocol Violation|0|||
164385662|NCT03264989|593781281|FG001|Overall Study|Protocol Violation|1|||
164385663|NCT03264989|593781280|FG000|Overall Study|Patient decision|13|||
164014929|NCT01455428|592417985|FG001|Overall Study|Protocol Violation|1|||
164014930|NCT01455428|592417984|FG000|Overall Study|Adverse Event|6|||
164014931|NCT01455428|592417985|FG001|Overall Study|Adverse Event|2|||
164014932|NCT01455428|592417984|FG000|Overall Study|Lost to Follow-up|1|||
164014933|NCT01455428|592417985|FG001|Overall Study|Lost to Follow-up|1|||
164014934|NCT01455428|592417984|FG000|Overall Study|Withdrawal by Subject|2|||
164014935|NCT01455428|592417985|FG001|Overall Study|Withdrawal by Subject|5|||
164014936|NCT01455428|592417984|FG000|Overall Study|Did not meet entrance criteria|0|||
164014937|NCT01455428|592417985|FG001|Overall Study|Did not meet entrance criteria|2|||
164014938|NCT01455428|592417984|FG000|Overall Study|Insufficient clinical response|0|||
164014939|NCT01455428|592417985|FG001|Overall Study|Insufficient clinical response|2|||
164014940|NCT01455428|592417984|FG000|Overall Study|Did not receive treatment|1|||
164014941|NCT01455428|592417985|FG001|Overall Study|Did not receive treatment|1|||
164014942|NCT01455428|592417984|FG000|Overall Study|Other|2|||
164014943|NCT01455428|592417985|FG001|Overall Study|Other|4|||
164014944|NCT03694522|592417988|FG000|Overall Study|Withdrawal by Subject|8|||
164014945|NCT03694522|592417989|FG001|Overall Study|Withdrawal by Subject|10|||
164014946|NCT03694522|592417988|FG000|Overall Study|Physician Decision|53|||
164014947|NCT03694522|592417989|FG001|Overall Study|Physician Decision|54|||
164014948|NCT03694522|592417988|FG000|Overall Study|Other|1|||
164014949|NCT03694522|592417989|FG001|Overall Study|Other|1|||
164014950|NCT03694522|592417988|FG000|Overall Study|Lost to Follow-up|0|||
164014951|NCT03694522|592417989|FG001|Overall Study|Lost to Follow-up|1|||
164014952|NCT01905397|592417992|FG000|Overall Study|Death|0|||
164014953|NCT01905397|592417993|FG001|Overall Study|Death|1|||
164014954|NCT01905397|592417992|FG000|Overall Study|Withdrawal by Subject|2|||
164014955|NCT01905397|592417993|FG001|Overall Study|Withdrawal by Subject|0|||
164014956|NCT01905397|592417992|FG000|Overall Study|Surgery canceled/aborted|9|||
164014957|NCT01905397|592417993|FG001|Overall Study|Surgery canceled/aborted|5|||
164014958|NCT01905397|592417992|FG000|Overall Study|Incision < 7 cm|2|||
164014959|NCT01905397|592417993|FG001|Overall Study|Incision < 7 cm|0|||
164014960|NCT01905397|592417992|FG000|Overall Study|Wrong treatment|1|||
164014961|NCT01905397|592417993|FG001|Overall Study|Wrong treatment|1|||
164014962|NCT01905397|592417992|FG000|Overall Study|Device not applied|3|||
164014963|NCT01905397|592417993|FG001|Overall Study|Device not applied|0|||
164014964|NCT01905397|592417992|FG000|Overall Study|Dressing not applied in operating room|1|||
164014965|NCT01905397|592417993|FG001|Overall Study|Dressing not applied in operating room|0|||
164014966|NCT01905397|592417992|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
164014967|NCT01905397|592417993|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
164014968|NCT01927562|592417996|FG000|Overall Study|Lost to Follow-up|30|||
164014969|NCT01927562|592417996|FG000|Overall Study|Withdrawal by Subject|3|||
164014970|NCT01927562|592417996|FG000|Overall Study|Physician Decision|5|||
164014971|NCT00642616|592417997|FG000|Overall Study|Adverse Event|2|||
164014972|NCT00642616|592417998|FG001|Overall Study|Adverse Event|0|||
164014973|NCT00642616|592417999|FG002|Overall Study|Adverse Event|1|||
164014974|NCT00642616|592418000|FG003|Overall Study|Adverse Event|0|||
164014975|NCT00642616|592417997|FG000|Overall Study|Study Terminated by Sponsor|7|||
164014976|NCT00642616|592417998|FG001|Overall Study|Study Terminated by Sponsor|6|||
164014977|NCT00642616|592417999|FG002|Overall Study|Study Terminated by Sponsor|4|||
164014978|NCT00642616|592418000|FG003|Overall Study|Study Terminated by Sponsor|5|||
164385664|NCT03264989|593781281|FG001|Overall Study|Patient decision|0|||
164385665|NCT03264989|593781280|FG000|Overall Study|Physician Decision|6|||
164385666|NCT03264989|593781281|FG001|Overall Study|Physician Decision|4|||
164385667|NCT03264989|593781280|FG000|Overall Study|Adverse Event|2|||
164014979|NCT00642616|592417997|FG000|Overall Study|Withdrawal by Subject|0|||
164014980|NCT00642616|592417998|FG001|Overall Study|Withdrawal by Subject|1|||
164014981|NCT00642616|592417999|FG002|Overall Study|Withdrawal by Subject|1|||
164385668|NCT03264989|593781281|FG001|Overall Study|Adverse Event|1|||
164014982|NCT00642616|592418000|FG003|Overall Study|Withdrawal by Subject|1|||
164014983|NCT00642616|592417997|FG000|Overall Study|Protocol Violation|0|||
164014984|NCT00642616|592417998|FG001|Overall Study|Protocol Violation|0|||
164014985|NCT00642616|592417999|FG002|Overall Study|Protocol Violation|2|||
164014986|NCT00642616|592418000|FG003|Overall Study|Protocol Violation|0|||
164014987|NCT00642616|592417997|FG000|Overall Study|Physician Decision|0|||
164014988|NCT00642616|592417998|FG001|Overall Study|Physician Decision|0|||
164014989|NCT00642616|592417999|FG002|Overall Study|Physician Decision|1|||
164014990|NCT00642616|592418000|FG003|Overall Study|Physician Decision|1|||
164014991|NCT02955186|592418004|FG000|Overall Study|Withdrawal by Subject|6|||
164014992|NCT02955186|592418005|FG001|Overall Study|Withdrawal by Subject|2|||
164014993|NCT02955186|592418004|FG000|Overall Study|Protocol Violation|1|||
164014994|NCT02955186|592418005|FG001|Overall Study|Protocol Violation|0|||
164014995|NCT01276847|592418007|FG000|Overall Study|Withdrawal by Subject|1|||
164014996|NCT01276847|592418008|FG001|Overall Study|Withdrawal by Subject|0|||
164014997|NCT01276847|592418009|FG002|Overall Study|Withdrawal by Subject|0|||
164014998|NCT04770155|592418010|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164014999|NCT04770155|592418011|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015000|NCT04770155|592418012|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015001|NCT04770155|592418013|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015002|NCT04770155|592418014|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015003|NCT04770155|592418015|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015004|NCT04770155|592418016|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015005|NCT04770155|592418017|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
164015006|NCT02021812|592418018|FG000|Overall Study|Death|8|||
164015007|NCT02021812|592418018|FG000|Overall Study|Withdrawal by Subject|3|||
164015008|NCT02021812|592418018|FG000|Overall Study|Lost to Follow-up|2|||
164015009|NCT02021812|592418018|FG000|Overall Study|Refuse to return, COVD 19|2|||
164015010|NCT00081289|592418019|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
164015011|NCT00081289|592418020|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
164015012|NCT00081289|592418019|FG000|Overall Study|Ineligible / no protocol treatment|3|||
164015013|NCT00081289|592418020|FG001|Overall Study|Ineligible / no protocol treatment|4|||
164015014|NCT02239094|592418023|FG000|Overall Study|Withdrawal by Subject|1|||
164015015|NCT02239094|592418023|FG000|Overall Study|Remitted before started|1|||
164015016|NCT01469052|592418026|FG000|Overall Study|Adverse Event|2|||
164015017|NCT01469052|592418027|FG001|Overall Study|Adverse Event|3|||
164015018|NCT01469052|592418028|FG002|Overall Study|Adverse Event|0|||
164015019|NCT01469052|592418029|FG003|Overall Study|Adverse Event|2|||
164015020|NCT01469052|592418030|FG004|Overall Study|Adverse Event|0|||
164015021|NCT01469052|592418031|FG005|Overall Study|Adverse Event|1|||
164015022|NCT01469052|592418026|FG000|Overall Study|Progressive disease|3|||
164015023|NCT01469052|592418027|FG001|Overall Study|Progressive disease|0|||
164015024|NCT01469052|592418028|FG002|Overall Study|Progressive disease|5|||
164015025|NCT01469052|592418029|FG003|Overall Study|Progressive disease|3|||
164015026|NCT01469052|592418030|FG004|Overall Study|Progressive disease|7|||
164015027|NCT01469052|592418031|FG005|Overall Study|Progressive disease|2|||
164015028|NCT01469052|592418026|FG000|Overall Study|Lack of Efficacy|0|||
164092934|NCT02428699|592703419|FG001|Washout Period 1|Screen Failure|2|||
164092935|NCT03127137|592703420|FG000|Overall Study|Requested sedation after consent|1|||
164092936|NCT03127137|592703421|FG001|Overall Study|Requested sedation after consent|0|||
164092937|NCT03127137|592703420|FG000|Overall Study|Malfunction in electronic data collection|1|||
164092938|NCT03127137|592703421|FG001|Overall Study|Malfunction in electronic data collection|0|||
164092939|NCT03127137|592703420|FG000|Overall Study|Post procedure testing could not be obtained|0|||
164385669|NCT03264989|593781280|FG000|Overall Study|Death|1|||
164385670|NCT03264989|593781281|FG001|Overall Study|Death|1|||
164385671|NCT03264989|593781280|FG000|Overall Study|Pregnancy|2|||
164385672|NCT03264989|593781281|FG001|Overall Study|Pregnancy|0|||
164385673|NCT03264989|593781280|FG000|Overall Study|End of Study|19|||
164385674|NCT03264989|593781281|FG001|Overall Study|End of Study|5|||
164385675|NCT00833924|593781287|FG000|Overall Study|Death|21|||
164385676|NCT00833924|593781287|FG000|Overall Study|Conversion|2|||
164385677|NCT00833924|593781287|FG000|Overall Study|Lost to Follow-up|2|||
164385678|NCT00833924|593781287|FG000|Overall Study|Withdrawal by Subject|13|||
164385679|NCT00833924|593781287|FG000|Overall Study|In study follow-up|71|||
164385680|NCT02504866|593781288|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
164385681|NCT02504866|593781289|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
164385682|NCT02504866|593781290|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
164385683|NCT01229436|593781291|FG000|Overall Study|Withdrawal by Subject|2|||
164385684|NCT01229436|593781291|FG000|Overall Study|Lost to Follow-up|3|||
164385685|NCT01775137|593781294|FG000|Overall Study|Death|1|||
164385686|NCT01775137|593781294|FG000|Overall Study|Protocol deviation|2|||
164385687|NCT01775137|593781294|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164385688|NCT01775137|593781294|FG000|Overall Study|Adverse Event|1|||
163903519|NCT02401815|592017272|FG002|Dose Escalation (up to 670 Days)|Death|3|||
163903520|NCT02401815|592017273|FG003|Dose Escalation (up to 670 Days)|Death|5|||
163903521|NCT02401815|592017274|FG004|Dose Escalation (up to 670 Days)|Death|4|||
163903522|NCT02401815|592017275|FG005|Dose Escalation (up to 670 Days)|Death|0|||
163903523|NCT02401815|592017276|FG006|Dose Escalation (up to 670 Days)|Death|0|||
163903524|NCT02401815|592017277|FG007|Dose Escalation (up to 670 Days)|Death|0|||
163903525|NCT02401815|592017278|FG008|Dose Escalation (up to 670 Days)|Death|0|||
163903526|NCT02401815|592017279|FG009|Dose Escalation (up to 670 Days)|Death|0|||
163903527|NCT02401815|592017270|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163903528|NCT02401815|592017271|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
163903529|NCT02401815|592017272|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163903530|NCT02401815|592017273|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163903531|NCT02401815|592017274|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
163903532|NCT02401815|592017275|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163903533|NCT02401815|592017276|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164385689|NCT01775137|593781294|FG000|Overall Study|Withdrawal by participants|5|||
164385690|NCT04796610|593781295|FG000|Overall Study|Withdrawal by Subject|1|||
164385691|NCT04796610|593781296|FG001|Overall Study|Withdrawal by Subject|0|||
164385692|NCT04796610|593781297|FG002|Overall Study|Withdrawal by Subject|0|||
164385693|NCT04796610|593781298|FG003|Overall Study|Withdrawal by Subject|0|||
164385694|NCT04796610|593781295|FG000|Overall Study|Lost to Follow-up|2|||
164385695|NCT04796610|593781296|FG001|Overall Study|Lost to Follow-up|0|||
164385696|NCT04796610|593781297|FG002|Overall Study|Lost to Follow-up|1|||
164385697|NCT04796610|593781298|FG003|Overall Study|Lost to Follow-up|1|||
164385698|NCT01459796|593781299|FG000|Overall Study|Non compliance with protocol|2|||
164385699|NCT01459796|593781300|FG001|Overall Study|Non compliance with protocol|4|||
164385700|NCT01459796|593781299|FG000|Overall Study|Adverse Event|5|||
164385701|NCT01459796|593781300|FG001|Overall Study|Adverse Event|5|||
164385702|NCT01459796|593781299|FG000|Overall Study|Withdrawal by Subject|6|||
164385703|NCT01459796|593781300|FG001|Overall Study|Withdrawal by Subject|3|||
164385704|NCT01459796|593781299|FG000|Overall Study|Lost to Follow-up|5|||
164385705|NCT01459796|593781300|FG001|Overall Study|Lost to Follow-up|4|||
164385706|NCT01459796|593781299|FG000|Overall Study|Reason unspecified|1|||
164385707|NCT01459796|593781300|FG001|Overall Study|Reason unspecified|2|||
164385708|NCT01459796|593781299|FG000|Overall Study|Decision by the sponsor|75|||
164385709|NCT01459796|593781300|FG001|Overall Study|Decision by the sponsor|108|||
164385710|NCT00733824|593781301|FG000|Phase I|Withdrawal by Subject|1|||
164385711|NCT00733824|593781302|FG001|Phase I|Withdrawal by Subject|0|||
164385712|NCT00733824|593781303|FG002|Phase I|Withdrawal by Subject|0|||
164385713|NCT00733824|593781304|FG003|Phase I|Withdrawal by Subject|0|||
164385714|NCT00733824|593781305|FG004|Phase I|Withdrawal by Subject|0|||
164385715|NCT01343056|593781306|FG000|Overall Study|Lost to Follow-up|7|||
164385716|NCT01343056|593781307|FG001|Overall Study|Lost to Follow-up|5|||
164385717|NCT01343056|593781308|FG002|Overall Study|Lost to Follow-up|3|||
164385718|NCT01343056|593781309|FG003|Overall Study|Lost to Follow-up|9|||
164385719|NCT02059148|593781310|FG000|Treatment 1|Protocol Violation|0|||
164385720|NCT02059148|593781311|FG001|Treatment 1|Protocol Violation|0|||
164385721|NCT02059148|593781312|FG002|Treatment 1|Protocol Violation|0|||
164385722|NCT02059148|593781313|FG003|Treatment 1|Protocol Violation|0|||
164385723|NCT02059148|593781314|FG004|Treatment 1|Protocol Violation|0|||
164385724|NCT02059148|593781315|FG005|Treatment 1|Protocol Violation|1|||
164385725|NCT03231371|593781316|FG000|Overall Study|Withdrawal by Subject|1|||
164385726|NCT03231371|593781316|FG000|Overall Study|chose or were ineligible to have MRI|12|||
164385727|NCT03067441|593781321|FG000|Overall Study|Withdrawal by Subject|16|||
164385728|NCT03067441|593781322|FG001|Overall Study|Withdrawal by Subject|34|||
164385729|NCT03067441|593781321|FG000|Overall Study|Lost to Follow-up|7|||
164385730|NCT03067441|593781322|FG001|Overall Study|Lost to Follow-up|5|||
164385731|NCT03067441|593781321|FG000|Overall Study|Adverse Event|7|||
164385732|NCT03067441|593781322|FG001|Overall Study|Adverse Event|14|||
164385733|NCT03067441|593781321|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
164385734|NCT03067441|593781322|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
164385735|NCT03067441|593781321|FG000|Overall Study|Physician Decision|1|||
164385736|NCT03067441|593781322|FG001|Overall Study|Physician Decision|3|||
164385737|NCT03067441|593781321|FG000|Overall Study|Other|1|||
164385738|NCT03067441|593781322|FG001|Overall Study|Other|1|||
164385739|NCT00856583|593781323|FG000|Overall Study|Lack of Efficacy|389|||
164385740|NCT00856583|593781324|FG001|Overall Study|Lack of Efficacy|377|||
164385741|NCT00856583|593781323|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
164385742|NCT00856583|593781324|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
164385743|NCT00856583|593781323|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
164385744|NCT00856583|593781324|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
164385745|NCT00856583|593781323|FG000|Overall Study|Non-compliance|305|||
164385746|NCT00856583|593781324|FG001|Overall Study|Non-compliance|262|||
164385747|NCT00856583|593781323|FG000|Overall Study|Withdrawal by Subject|1092|||
164385748|NCT00856583|593781324|FG001|Overall Study|Withdrawal by Subject|919|||
164385749|NCT00856583|593781323|FG000|Overall Study|Physician Decision|59|||
164015029|NCT01469052|592418027|FG001|Overall Study|Lack of Efficacy|0|||
164015030|NCT01469052|592418028|FG002|Overall Study|Lack of Efficacy|0|||
164015031|NCT01469052|592418029|FG003|Overall Study|Lack of Efficacy|0|||
164015032|NCT01469052|592418030|FG004|Overall Study|Lack of Efficacy|0|||
164015033|NCT01469052|592418031|FG005|Overall Study|Lack of Efficacy|2|||
164015034|NCT01469052|592418026|FG000|Overall Study|Moved to rollover protocol|1|||
164015035|NCT01469052|592418027|FG001|Overall Study|Moved to rollover protocol|0|||
164015036|NCT01469052|592418028|FG002|Overall Study|Moved to rollover protocol|1|||
164015037|NCT01469052|592418029|FG003|Overall Study|Moved to rollover protocol|0|||
164015038|NCT01469052|592418030|FG004|Overall Study|Moved to rollover protocol|0|||
164015039|NCT01469052|592418031|FG005|Overall Study|Moved to rollover protocol|1|||
164015040|NCT01469052|592418026|FG000|Overall Study|Other|0|||
164015041|NCT01469052|592418027|FG001|Overall Study|Other|1|||
164015042|NCT01469052|592418028|FG002|Overall Study|Other|0|||
164015043|NCT01469052|592418029|FG003|Overall Study|Other|0|||
164015044|NCT01469052|592418030|FG004|Overall Study|Other|1|||
164015045|NCT01469052|592418031|FG005|Overall Study|Other|0|||
164015046|NCT02508701|592418032|FG000|Overall Study|Lost to Follow-up|9|||
164015047|NCT02508701|592418033|FG001|Overall Study|Lost to Follow-up|5|||
164015048|NCT02508701|592418034|FG002|Overall Study|Lost to Follow-up|5|||
164015049|NCT02508701|592418035|FG003|Overall Study|Lost to Follow-up|3|||
164015050|NCT03648996|592418036|FG000|Overall Study|Withdrawal by Subject|0|||
164015051|NCT03648996|592418037|FG001|Overall Study|Withdrawal by Subject|2|||
164015052|NCT03648996|592418038|FG002|Overall Study|Withdrawal by Subject|2|||
164015053|NCT03648996|592418036|FG000|Overall Study|Physician Decision|2|||
164015054|NCT03648996|592418037|FG001|Overall Study|Physician Decision|0|||
164015055|NCT03648996|592418038|FG002|Overall Study|Physician Decision|0|||
164015056|NCT03894904|592418040|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
164015057|NCT03894904|592418041|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
164015058|NCT03894904|592418040|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
164015059|NCT03894904|592418041|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
164015060|NCT00365976|592418044|FG000|Overall Study|Withdrawal by Subject|1|||
164015061|NCT00365976|592418045|FG001|Overall Study|Withdrawal by Subject|5|||
164015062|NCT03090737|592418046|FG000|Overall Study|Other reasons|1|||
164015063|NCT03090737|592418046|FG000|Overall Study|Completed treatment as per protocol|17|||
164015064|NCT03090737|592418046|FG000|Overall Study|Maximum clinical benefit|2|||
164015065|NCT03090737|592418046|FG000|Overall Study|Adverse event unrelated to study drug|7|||
164015066|NCT03090737|592418046|FG000|Overall Study|Study drug toxicity|4|||
164015067|NCT03090737|592418046|FG000|Overall Study|Disease progression|98|||
164015068|NCT03596177|592418047|FG000|Single Blind Period|Withdrawal by Subject|1|||
164015069|NCT03596177|592418048|FG001|Single Blind Period|Withdrawal by Subject|1|||
164015070|NCT03596177|592418047|FG000|Single Blind Period|Other|1|||
164015071|NCT03596177|592418048|FG001|Single Blind Period|Other|0|||
164015072|NCT03596177|592418047|FG000|Double Blind Period|Withdrawal by Subject|0|||
164015073|NCT03596177|592418048|FG001|Double Blind Period|Withdrawal by Subject|1|||
164015074|NCT03596177|592418047|FG000|Double Blind Period|Other|0|||
164015075|NCT03596177|592418048|FG001|Double Blind Period|Other|4|||
164015076|NCT03596177|592418047|FG000|Double Blind Period|Death during safety follow-up|0|||
164015077|NCT03596177|592418048|FG001|Double Blind Period|Death during safety follow-up|1|||
164015078|NCT03103750|592418051|FG000|Overall Study|Adverse Event|1|||
164015079|NCT03103750|592418052|FG001|Overall Study|Adverse Event|0|||
164015080|NCT03103750|592418051|FG000|Overall Study|Lost to Follow-up|1|||
164015081|NCT03103750|592418052|FG001|Overall Study|Lost to Follow-up|0|||
164015082|NCT03103750|592418051|FG000|Overall Study|PET Equipment Related|2|||
164015083|NCT03103750|592418052|FG001|Overall Study|PET Equipment Related|2|||
164015084|NCT03123939|592418053|FG000|Overall Study|Lack of Efficacy|6|||
164015085|NCT03123939|592418053|FG000|Overall Study|Death|5|||
164015086|NCT03123939|592418053|FG000|Overall Study|Physician Decision|2|||
164385750|NCT00856583|593781324|FG001|Overall Study|Physician Decision|82|||
164385751|NCT00856583|593781323|FG000|Overall Study|Pregnancy|14|||
164015087|NCT03123939|592418053|FG000|Overall Study|Subject/guardian decision|2|||
164015088|NCT03123939|592418053|FG000|Overall Study|Lost to Follow-up|1|||
164015089|NCT03123939|592418053|FG000|Overall Study|New therapy for study indication|1|||
164385752|NCT00856583|593781324|FG001|Overall Study|Pregnancy|5|||
164385753|NCT00856583|593781323|FG000|Overall Study|Other|92|||
164385754|NCT00856583|593781324|FG001|Overall Study|Other|104|||
164015090|NCT03123939|592418053|FG000|Overall Study|Protocol deviation|1|||
164385755|NCT00856583|593781323|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
164385756|NCT00856583|593781324|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
164385757|NCT02056301|593781328|FG000|Overall Study|Protocol Violation|1|||
164015091|NCT03123939|592418053|FG000|Overall Study|Progressive disease|18|||
164015092|NCT03123939|592418053|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
164015093|NCT03123939|592418053|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
164015094|NCT04400318|592420049|FG000|Overall Study|Adverse Event|1|||
164015095|NCT04400318|592420050|FG001|Overall Study|Adverse Event|0|||
164015096|NCT04400318|592420049|FG000|Overall Study|Withdrawal by Subject|1|||
164015097|NCT04400318|592420050|FG001|Overall Study|Withdrawal by Subject|1|||
164015098|NCT04400318|592420049|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
164015099|NCT04400318|592420050|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
164015100|NCT00953043|592420053|FG000|Overall Study|Withdrawal by Subject|4|||
164015101|NCT00953043|592420054|FG001|Overall Study|Withdrawal by Subject|0|||
164015102|NCT00953043|592420053|FG000|Overall Study|Physician Decision|0|||
164015103|NCT00953043|592420054|FG001|Overall Study|Physician Decision|2|||
164015104|NCT03509207|592420055|FG000|Overall Study|Death|2|||
164015105|NCT02078713|592420056|FG000|Overall Study|Lost to Follow-up|49|||
164015106|NCT02078713|592420057|FG001|Overall Study|Lost to Follow-up|55|||
164015107|NCT02078713|592420058|FG002|Overall Study|Lost to Follow-up|0|||
164015108|NCT02078713|592420059|FG003|Overall Study|Lost to Follow-up|0|||
164015109|NCT02078713|592420056|FG000|Overall Study|Pregnant at baseline|3|||
164015110|NCT02078713|592420057|FG001|Overall Study|Pregnant at baseline|5|||
164015111|NCT02078713|592420058|FG002|Overall Study|Pregnant at baseline|0|||
164015112|NCT02078713|592420059|FG003|Overall Study|Pregnant at baseline|0|||
164015113|NCT02078713|592420056|FG000|Overall Study|Enrolled twice|0|||
164015114|NCT02078713|592420057|FG001|Overall Study|Enrolled twice|1|||
164015115|NCT02078713|592420058|FG002|Overall Study|Enrolled twice|0|||
164015116|NCT02078713|592420059|FG003|Overall Study|Enrolled twice|0|||
164015117|NCT02421120|592420064|FG000|Overall Study|Adverse Event|1|||
164015118|NCT00372190|592420065|FG000|Overall Study|Lost to Follow-up|3|||
164015119|NCT00372190|592420066|FG001|Overall Study|Lost to Follow-up|1|||
164015120|NCT01675531|592420067|FG000|Overall Study|Adverse Event|9|||
164015121|NCT01675531|592420067|FG000|Overall Study|Withdrawal by Subject|7|||
164015122|NCT01675531|592420067|FG000|Overall Study|Lack of Efficacy|1|||
164015123|NCT01675531|592420067|FG000|Overall Study|Protocol Violation|8|||
164015124|NCT00623467|592420068|FG000|Overall Study|Lost to Follow-up|1|||
164015125|NCT00623467|592420068|FG000|Overall Study|Protocol Violation|4|||
164015126|NCT00623467|592420068|FG000|Overall Study|Withdrawal by Subject|2|||
164015127|NCT00273858|592420082|FG000|Overall Study|Not completed 24 month observation time|334|||
164015128|NCT00273858|592420082|FG000|Overall Study|Lost to Follow-up|101|||
164015129|NCT00273858|592420082|FG000|Overall Study|Withdrawal by Subject|21|||
164015130|NCT00273858|592420082|FG000|Overall Study|Adverse Event|81|||
164015131|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
164015132|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
164015133|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
164015134|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
164015135|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
164015136|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
164015137|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
164015138|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
164015139|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
164015140|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
164015141|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
164015142|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
164015143|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
164015144|NCT02232516|592420083|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
164015145|NCT02232516|592420083|FG000|Survival Follow-up|Death|15|||
164015146|NCT02232516|592420083|FG000|Survival Follow-up|Withdrawal by Subject|3|||
164015147|NCT02232516|592420083|FG000|Survival Follow-up|Lost to Follow-up|1|||
164015148|NCT02232516|592420083|FG000|Survival Follow-up|Still in follow-up|5|||
164015149|NCT01070550|592420084|FG000|Overall Study|Adverse Event|43|||
164015150|NCT01070550|592420085|FG001|Overall Study|Adverse Event|1|||
164015151|NCT01070550|592420086|FG002|Overall Study|Adverse Event|3|||
164015152|NCT01070550|592420087|FG003|Overall Study|Adverse Event|0|||
164092940|NCT03127137|592703421|FG001|Overall Study|Post procedure testing could not be obtained|1|||
164092941|NCT04424407|592703422|FG000|Overall Study|Withdrawal by Subject|2|||
164385758|NCT02056301|593781329|FG001|Overall Study|Protocol Violation|2|||
164385759|NCT02056301|593781328|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
164385760|NCT02056301|593781329|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
164385761|NCT02056301|593781328|FG000|Overall Study|Withdrawal by Subject|0|||
163903534|NCT02401815|592017277|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163903535|NCT02401815|592017278|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
163903536|NCT02401815|592017279|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
164385762|NCT02056301|593781329|FG001|Overall Study|Withdrawal by Subject|1|||
164385763|NCT02056301|593781328|FG000|Overall Study|Issues with epidural|0|||
164385764|NCT02056301|593781329|FG001|Overall Study|Issues with epidural|3|||
164385765|NCT00499889|593781335|FG000|Overall Study|Infection prior to treatment|1|||
164385766|NCT03299192|593781336|FG000|Overall Study|Fell before classes started|1|||
164385767|NCT03299192|593781337|FG001|Overall Study|Fell before classes started|0|||
164385768|NCT03299192|593781338|FG002|Overall Study|Fell before classes started|0|||
164385769|NCT03299192|593781336|FG000|Overall Study|Other|0|||
164385770|NCT03299192|593781337|FG001|Overall Study|Other|2|||
164385771|NCT03299192|593781338|FG002|Overall Study|Other|1|||
164385772|NCT01418209|593781344|FG000|Overall Study|Withdrawal by Subject|1|||
164385773|NCT01418209|593781345|FG001|Overall Study|Withdrawal by Subject|0|||
164385774|NCT01418209|593781346|FG002|Overall Study|Withdrawal by Subject|1|||
164385775|NCT01418209|593781344|FG000|Overall Study|Did not provide hot flash diary data|1|||
164385776|NCT01418209|593781345|FG001|Overall Study|Did not provide hot flash diary data|3|||
164385777|NCT01418209|593781346|FG002|Overall Study|Did not provide hot flash diary data|3|||
164385778|NCT03779841|593781347|FG000|Randomized Population|Did Not Receive Treatment|3|||
164385779|NCT03779841|593781348|FG001|Randomized Population|Did Not Receive Treatment|1|||
164385780|NCT03779841|593781349|FG002|Randomized Population|Did Not Receive Treatment|0|||
164385781|NCT03779841|593781347|FG000|Treated (Safety) Population|Adverse Event|1|||
164385782|NCT03779841|593781348|FG001|Treated (Safety) Population|Adverse Event|1|||
164385783|NCT03779841|593781349|FG002|Treated (Safety) Population|Adverse Event|0|||
164385784|NCT03779841|593781347|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
164385785|NCT03779841|593781348|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
164385786|NCT03779841|593781349|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
164385787|NCT03779841|593781347|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
164385788|NCT03779841|593781348|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
164385789|NCT03779841|593781349|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
164385790|NCT03779841|593781347|FG000|Treated (Safety) Population|Death|1|||
164385791|NCT03779841|593781348|FG001|Treated (Safety) Population|Death|0|||
164385792|NCT03779841|593781349|FG002|Treated (Safety) Population|Death|2|||
164385793|NCT02788175|593781350|FG000|Overall Study|Protocol Violation|3|||
164385794|NCT02788175|593781350|FG000|Overall Study|Withdrawal by Subject|4|||
164385795|NCT02788175|593781350|FG000|Overall Study|Ineligible prior to study agent|6|||
164385796|NCT00136955|593783851|FG000|Overall Study|Adverse Event|8|||
164385797|NCT00136955|593783851|FG000|Overall Study|Lost to Follow-up|1|||
164385798|NCT00136955|593783851|FG000|Overall Study|Withdrawal by Subject|2|||
164385799|NCT00136955|593783851|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
163903537|NCT02401815|592017270|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
163903538|NCT02401815|592017271|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903539|NCT02401815|592017272|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903540|NCT02401815|592017273|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903541|NCT02401815|592017274|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
163903542|NCT02401815|592017275|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903543|NCT02401815|592017276|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903544|NCT02401815|592017277|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903545|NCT02401815|592017278|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903546|NCT02401815|592017279|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
163903547|NCT02401815|592017270|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
164015153|NCT01070550|592420088|FG004|Overall Study|Adverse Event|0|||
164015154|NCT01070550|592420089|FG005|Overall Study|Adverse Event|0|||
164385800|NCT04827576|593783852|FG000|Overall Study|Death|5|||
164385801|NCT04827576|593783853|FG001|Overall Study|Death|17|||
164385802|NCT04827576|593783854|FG002|Overall Study|Death|17|||
164385803|NCT04827576|593783855|FG003|Overall Study|Death|32|||
163903548|NCT02401815|592017271|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903549|NCT02401815|592017272|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903550|NCT02401815|592017273|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903551|NCT02401815|592017274|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903552|NCT02401815|592017275|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
164015155|NCT01070550|592420084|FG000|Overall Study|Death|20|||
164015156|NCT01070550|592420085|FG001|Overall Study|Death|4|||
164385804|NCT04827576|593783852|FG000|Overall Study|Study Terminated by Sponsor|2|||
164385805|NCT04827576|593783853|FG001|Overall Study|Study Terminated by Sponsor|9|||
164385806|NCT04827576|593783854|FG002|Overall Study|Study Terminated by Sponsor|7|||
163903553|NCT02401815|592017276|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903554|NCT02401815|592017277|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903555|NCT02401815|592017278|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903556|NCT02401815|592017279|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
163903557|NCT02401815|592017270|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903558|NCT02401815|592017271|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903559|NCT02401815|592017272|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903560|NCT02401815|592017273|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903561|NCT02401815|592017274|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164385807|NCT04827576|593783855|FG003|Overall Study|Study Terminated by Sponsor|5|||
164385808|NCT04827576|593783852|FG000|Overall Study|Investigator's Discretion|1|||
164385809|NCT04827576|593783853|FG001|Overall Study|Investigator's Discretion|0|||
164385810|NCT04827576|593783854|FG002|Overall Study|Investigator's Discretion|2|||
164385811|NCT04827576|593783855|FG003|Overall Study|Investigator's Discretion|5|||
164385812|NCT04827576|593783852|FG000|Overall Study|Withdrew Consent|0|||
164385813|NCT04827576|593783853|FG001|Overall Study|Withdrew Consent|3|||
164385814|NCT04827576|593783854|FG002|Overall Study|Withdrew Consent|0|||
164385815|NCT04827576|593783855|FG003|Overall Study|Withdrew Consent|0|||
164385816|NCT04827576|593783852|FG000|Overall Study|Lost to Follow-up|1|||
164385817|NCT04827576|593783853|FG001|Overall Study|Lost to Follow-up|0|||
164385818|NCT04827576|593783854|FG002|Overall Study|Lost to Follow-up|0|||
164385819|NCT04827576|593783855|FG003|Overall Study|Lost to Follow-up|0|||
163903562|NCT02401815|592017275|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903563|NCT02401815|592017276|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
163903564|NCT02401815|592017277|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903565|NCT02401815|592017278|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903566|NCT02401815|592017279|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903567|NCT02401815|592017270|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164385820|NCT01773226|593783856|FG000|Overall Study|Withdrawal by Subject|1|||
164385821|NCT00724282|593783857|FG000|Overall Study|Withdrawal by Subject|3|||
164385822|NCT00724282|593783857|FG000|Overall Study|Physician Decision|1|||
164385823|NCT00970502|593783858|FG000|Overall Study|Withdrawal by Subject|1|||
164385824|NCT01438411|593783859|FG000|Overall Study|Adverse Event|8|||
164385825|NCT01438411|593783859|FG000|Overall Study|Lost to Follow-up|1|||
164385826|NCT01438411|593783859|FG000|Overall Study|Lack of Efficacy|1|||
164385827|NCT01438411|593783859|FG000|Overall Study|Withdrawal by Subject|3|||
164385828|NCT01863680|593783860|FG000|Overall Study|Adverse Event|17|||
164385829|NCT01863680|593783860|FG000|Overall Study|Risk of OHSS|17|||
164385830|NCT01863680|593783860|FG000|Overall Study|Spontaneous pregnancy|2|||
164385831|NCT01863680|593783860|FG000|Overall Study|Withdrawal by Subject|1|||
164385832|NCT01863680|593783860|FG000|Overall Study|Did not undergo IVF/ET|14|||
164385833|NCT01863680|593783860|FG000|Overall Study|Other|6|||
164385834|NCT00618514|593783861|FG000|Overall Study|Lost to Follow-up|11|||
164385835|NCT00618514|593783862|FG001|Overall Study|Lost to Follow-up|12|||
164385836|NCT00618514|593783863|FG002|Overall Study|Lost to Follow-up|4|||
164385837|NCT00566228|593783870|FG000|Overall Study|Withdrawal by Subject|1|||
164385838|NCT00566228|593783871|FG001|Overall Study|Withdrawal by Subject|0|||
164385839|NCT00566228|593783870|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
164385840|NCT00566228|593783871|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
164385841|NCT00566228|593783870|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
164385842|NCT00566228|593783871|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
164385843|NCT00566228|593783870|FG000|Overall Study|progressed before infusion could occur|0|||
164385844|NCT00566228|593783871|FG001|Overall Study|progressed before infusion could occur|1|||
164385845|NCT03320070|593783874|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
164385846|NCT03320070|593783875|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
164385847|NCT03320070|593783874|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
164385848|NCT03320070|593783875|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
164385849|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
163903568|NCT02401815|592017271|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164385850|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
164385851|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
164385852|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
163903569|NCT02401815|592017272|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163903570|NCT02401815|592017273|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163903571|NCT02401815|592017274|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
164385853|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
164385854|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
164385855|NCT03320070|593783874|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
164385856|NCT03320070|593783875|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
164385857|NCT03586648|593783876|FG000|Period 1|Withdrawal by Subject|0|||
164092942|NCT04424407|592703422|FG000|Overall Study|Lost to Follow-up|1|||
164385858|NCT03586648|593783877|FG001|Period 1|Withdrawal by Subject|1|||
164385859|NCT03586648|593783876|FG000|Period 1|Lost to Follow-up|1|||
164385860|NCT03586648|593783877|FG001|Period 1|Lost to Follow-up|1|||
164385861|NCT03586648|593783876|FG000|Period 1|Adverse Event|1|||
164385862|NCT03586648|593783877|FG001|Period 1|Adverse Event|0|||
164385863|NCT03586648|593783876|FG000|Period 1|Study related symptoms or complaints|2|||
164385864|NCT03586648|593783877|FG001|Period 1|Study related symptoms or complaints|1|||
164385865|NCT03586648|593783876|FG000|Period 1|Physician Decision|0|||
164385866|NCT03586648|593783877|FG001|Period 1|Physician Decision|1|||
164385867|NCT03586648|593783876|FG000|Period 2|Adverse Event|1|||
164385868|NCT03586648|593783877|FG001|Period 2|Adverse Event|0|||
164385869|NCT02041195|593783878|FG000|Overall Study|Adverse Event|1|||
164385870|NCT02041195|593783879|FG001|Overall Study|Adverse Event|2|||
164385871|NCT02041195|593783880|FG002|Overall Study|Adverse Event|0|||
164385872|NCT02041195|593783881|FG003|Overall Study|Adverse Event|0|||
164385873|NCT02041195|593783882|FG004|Overall Study|Adverse Event|0|||
164385874|NCT02041195|593783883|FG005|Overall Study|Adverse Event|0|||
164385875|NCT02041195|593783884|FG006|Overall Study|Adverse Event|3|||
164385876|NCT02041195|593783885|FG007|Overall Study|Adverse Event|0|||
164385877|NCT02041195|593783878|FG000|Overall Study|Withdrawal by Subject|1|||
164385878|NCT02041195|593783879|FG001|Overall Study|Withdrawal by Subject|0|||
164385879|NCT02041195|593783880|FG002|Overall Study|Withdrawal by Subject|0|||
164385880|NCT02041195|593783881|FG003|Overall Study|Withdrawal by Subject|0|||
164385881|NCT02041195|593783882|FG004|Overall Study|Withdrawal by Subject|0|||
164385882|NCT02041195|593783883|FG005|Overall Study|Withdrawal by Subject|0|||
164385883|NCT02041195|593783884|FG006|Overall Study|Withdrawal by Subject|4|||
164385884|NCT02041195|593783885|FG007|Overall Study|Withdrawal by Subject|3|||
164385885|NCT02041195|593783878|FG000|Overall Study|Unable to comply with study visits|0|||
164385886|NCT02041195|593783879|FG001|Overall Study|Unable to comply with study visits|1|||
164385887|NCT02041195|593783880|FG002|Overall Study|Unable to comply with study visits|0|||
164385888|NCT02041195|593783881|FG003|Overall Study|Unable to comply with study visits|0|||
164385889|NCT02041195|593783882|FG004|Overall Study|Unable to comply with study visits|1|||
164385890|NCT02041195|593783883|FG005|Overall Study|Unable to comply with study visits|0|||
164385891|NCT02041195|593783884|FG006|Overall Study|Unable to comply with study visits|0|||
164385892|NCT02041195|593783885|FG007|Overall Study|Unable to comply with study visits|0|||
164385893|NCT02367911|593783888|FG000|Overall Study|Withdrawal by Subject|3|||
164385894|NCT02367911|593783889|FG001|Overall Study|Withdrawal by Subject|2|||
164385895|NCT02367911|593783888|FG000|Overall Study|Lost to Follow-up|2|||
164385896|NCT02367911|593783889|FG001|Overall Study|Lost to Follow-up|2|||
164385897|NCT00263666|593783890|FG000|Overall Study|Adverse Event|6|||
164385898|NCT00263666|593783891|FG001|Overall Study|Adverse Event|8|||
164385899|NCT00263666|593783890|FG000|Overall Study|Lost to Follow-up|1|||
163903572|NCT02401815|592017275|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
163903573|NCT02401815|592017276|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
163903574|NCT02401815|592017277|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163903575|NCT02401815|592017278|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163903576|NCT02401815|592017279|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
163903577|NCT02401815|592017270|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903578|NCT02401815|592017271|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903579|NCT02401815|592017272|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903580|NCT02401815|592017273|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903581|NCT02401815|592017274|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903582|NCT02401815|592017275|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
163903583|NCT02401815|592017276|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903584|NCT02401815|592017277|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903585|NCT02401815|592017278|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903586|NCT02401815|592017279|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
163903587|NCT02401815|592017270|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903588|NCT02401815|592017271|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903589|NCT02401815|592017272|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903590|NCT02401815|592017273|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903591|NCT02401815|592017274|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903592|NCT02401815|592017275|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903593|NCT02401815|592017276|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
163903594|NCT02401815|592017277|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
163903595|NCT02401815|592017278|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
163903596|NCT02401815|592017279|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
163903597|NCT02401815|592017270|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903598|NCT02401815|592017271|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903599|NCT02401815|592017272|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164385900|NCT00263666|593783891|FG001|Overall Study|Lost to Follow-up|2|||
164385901|NCT00263666|593783890|FG000|Overall Study|Withdrawal by Subject|0|||
164385902|NCT00263666|593783891|FG001|Overall Study|Withdrawal by Subject|1|||
164385903|NCT02492100|593783892|FG000|Overall Study|Death|1|||
164385904|NCT03832010|593783893|FG000|Overall Study|Withdrawal by Subject|2|||
164385905|NCT03832010|593783894|FG001|Overall Study|Withdrawal by Subject|1|||
164385906|NCT03832010|593783895|FG002|Overall Study|Withdrawal by Subject|0|||
164385907|NCT03832010|593783893|FG000|Overall Study|Lost to Follow-up|2|||
164385908|NCT03832010|593783894|FG001|Overall Study|Lost to Follow-up|1|||
164385909|NCT03832010|593783895|FG002|Overall Study|Lost to Follow-up|1|||
164385910|NCT02348216|593783896|FG000|Overall Study|Death|5|||
164385911|NCT02348216|593783897|FG001|Overall Study|Death|53|||
164385912|NCT02348216|593783898|FG002|Overall Study|Death|11|||
164385913|NCT02348216|593783899|FG003|Overall Study|Death|20|||
164385914|NCT02348216|593783900|FG004|Overall Study|Death|16|||
164385915|NCT02348216|593783901|FG005|Overall Study|Death|32|||
164385916|NCT02348216|593783902|FG006|Overall Study|Death|17|||
164385917|NCT02348216|593783896|FG000|Overall Study|Full consent withdrawal|0|||
164385918|NCT02348216|593783897|FG001|Overall Study|Full consent withdrawal|0|||
164385919|NCT02348216|593783898|FG002|Overall Study|Full consent withdrawal|0|||
164385920|NCT02348216|593783899|FG003|Overall Study|Full consent withdrawal|1|||
164385921|NCT02348216|593783900|FG004|Overall Study|Full consent withdrawal|3|||
164385922|NCT02348216|593783901|FG005|Overall Study|Full consent withdrawal|0|||
164385923|NCT02348216|593783902|FG006|Overall Study|Full consent withdrawal|3|||
164385924|NCT02348216|593783896|FG000|Overall Study|Lost to Follow-up|0|||
164385925|NCT02348216|593783897|FG001|Overall Study|Lost to Follow-up|5|||
164385926|NCT02348216|593783898|FG002|Overall Study|Lost to Follow-up|2|||
164385927|NCT02348216|593783899|FG003|Overall Study|Lost to Follow-up|0|||
164385928|NCT02348216|593783900|FG004|Overall Study|Lost to Follow-up|1|||
164385929|NCT02348216|593783901|FG005|Overall Study|Lost to Follow-up|1|||
164385930|NCT02348216|593783902|FG006|Overall Study|Lost to Follow-up|1|||
164385931|NCT02348216|593783896|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
164385932|NCT02348216|593783897|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
164385933|NCT02348216|593783898|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
164385934|NCT02348216|593783899|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
164385935|NCT02348216|593783900|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
164385936|NCT02348216|593783901|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
164385937|NCT02348216|593783902|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
164385938|NCT02348216|593783896|FG000|Overall Study|Reason not specified|2|||
164385939|NCT02348216|593783897|FG001|Overall Study|Reason not specified|19|||
164385940|NCT02348216|593783898|FG002|Overall Study|Reason not specified|11|||
164385941|NCT02348216|593783899|FG003|Overall Study|Reason not specified|17|||
164385942|NCT02348216|593783900|FG004|Overall Study|Reason not specified|21|||
164385943|NCT02348216|593783901|FG005|Overall Study|Reason not specified|17|||
164385944|NCT02348216|593783902|FG006|Overall Study|Reason not specified|19|||
164385945|NCT01055639|593783903|FG000|Overall Study|Adverse Event|0|||
164385946|NCT01055639|593783904|FG001|Overall Study|Adverse Event|1|||
164385947|NCT01055639|593783903|FG000|Overall Study|Lack of Efficacy|0|||
164385948|NCT01055639|593783904|FG001|Overall Study|Lack of Efficacy|1|||
164385949|NCT01055639|593783903|FG000|Overall Study|Lost to Follow-up|8|||
164385950|NCT01055639|593783904|FG001|Overall Study|Lost to Follow-up|11|||
164385951|NCT01055639|593783903|FG000|Overall Study|Protocol Violation|5|||
164385952|NCT01055639|593783904|FG001|Overall Study|Protocol Violation|5|||
164385953|NCT01055639|593783903|FG000|Overall Study|Withdrawal by Subject|8|||
164385954|NCT01055639|593783904|FG001|Overall Study|Withdrawal by Subject|11|||
164385955|NCT01202773|593783906|FG000|Overall Study|Adverse Event|4|||
164385956|NCT01202773|593783907|FG001|Overall Study|Adverse Event|5|||
164385957|NCT01202773|593783908|FG002|Overall Study|Adverse Event|5|||
164385958|NCT01202773|593783906|FG000|Overall Study|Lack of Efficacy|5|||
164385959|NCT01202773|593783907|FG001|Overall Study|Lack of Efficacy|4|||
164385960|NCT01202773|593783908|FG002|Overall Study|Lack of Efficacy|9|||
164385961|NCT01202773|593783906|FG000|Overall Study|Entry Criteria Not Met|2|||
164385962|NCT01202773|593783907|FG001|Overall Study|Entry Criteria Not Met|0|||
164385963|NCT01202773|593783908|FG002|Overall Study|Entry Criteria Not Met|1|||
164015157|NCT01070550|592420086|FG002|Overall Study|Death|3|||
164385964|NCT01202773|593783906|FG000|Overall Study|Lost to Follow-up|1|||
164385965|NCT01202773|593783907|FG001|Overall Study|Lost to Follow-up|2|||
164385966|NCT01202773|593783908|FG002|Overall Study|Lost to Follow-up|2|||
164385967|NCT01202773|593783906|FG000|Overall Study|Withdrawal by Subject|13|||
164385968|NCT01202773|593783907|FG001|Overall Study|Withdrawal by Subject|6|||
164385969|NCT01202773|593783908|FG002|Overall Study|Withdrawal by Subject|5|||
164385970|NCT01202773|593783906|FG000|Overall Study|Physician Decision|2|||
164385971|NCT01202773|593783907|FG001|Overall Study|Physician Decision|0|||
164385972|NCT01202773|593783908|FG002|Overall Study|Physician Decision|0|||
164385973|NCT01202773|593783906|FG000|Overall Study|Protocol Violation|11|||
164385974|NCT01202773|593783907|FG001|Overall Study|Protocol Violation|6|||
164385975|NCT01202773|593783908|FG002|Overall Study|Protocol Violation|10|||
164385976|NCT01202773|593783906|FG000|Overall Study|Sponsor Decision|19|||
164385977|NCT01202773|593783907|FG001|Overall Study|Sponsor Decision|20|||
164385978|NCT01202773|593783908|FG002|Overall Study|Sponsor Decision|23|||
164385979|NCT03058679|593783914|FG000|Baseline to Week 6|Lost to Follow-up|3|||
164385980|NCT03058679|593783915|FG001|Baseline to Week 6|Lost to Follow-up|2|||
164385981|NCT03058679|593783914|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
164385982|NCT03058679|593783915|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
164385983|NCT03058679|593783914|FG000|Baseline to Week 6|Adverse Event|6|||
164385984|NCT03058679|593783915|FG001|Baseline to Week 6|Adverse Event|6|||
164385985|NCT03058679|593783914|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
164015158|NCT01070550|592420087|FG003|Overall Study|Death|0|||
164015159|NCT01070550|592420088|FG004|Overall Study|Death|0|||
164015160|NCT01070550|592420089|FG005|Overall Study|Death|0|||
164015161|NCT01070550|592420084|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
164015162|NCT01070550|592420085|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164015163|NCT01070550|592420086|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164015164|NCT01070550|592420087|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164015165|NCT01070550|592420088|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164015166|NCT01070550|592420089|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164015167|NCT01070550|592420084|FG000|Overall Study|Early termination|3|||
164015168|NCT01070550|592420085|FG001|Overall Study|Early termination|0|||
164015169|NCT01070550|592420086|FG002|Overall Study|Early termination|0|||
164015170|NCT01070550|592420087|FG003|Overall Study|Early termination|0|||
164015171|NCT01070550|592420088|FG004|Overall Study|Early termination|0|||
164015172|NCT01070550|592420089|FG005|Overall Study|Early termination|0|||
164015173|NCT01070550|592420084|FG000|Overall Study|Failed to return|450|||
164015174|NCT01070550|592420085|FG001|Overall Study|Failed to return|33|||
164015175|NCT01070550|592420086|FG002|Overall Study|Failed to return|144|||
164015176|NCT01070550|592420087|FG003|Overall Study|Failed to return|40|||
164015177|NCT01070550|592420088|FG004|Overall Study|Failed to return|1|||
164015178|NCT01070550|592420089|FG005|Overall Study|Failed to return|2|||
164015179|NCT01070550|592420084|FG000|Overall Study|Incomplete treatment|2|||
164015180|NCT01070550|592420085|FG001|Overall Study|Incomplete treatment|0|||
164015181|NCT01070550|592420086|FG002|Overall Study|Incomplete treatment|0|||
164015182|NCT01070550|592420087|FG003|Overall Study|Incomplete treatment|0|||
164015183|NCT01070550|592420088|FG004|Overall Study|Incomplete treatment|0|||
164015184|NCT01070550|592420089|FG005|Overall Study|Incomplete treatment|0|||
164015185|NCT01070550|592420084|FG000|Overall Study|Lab test not done|22|||
164015186|NCT01070550|592420085|FG001|Overall Study|Lab test not done|3|||
164015187|NCT01070550|592420086|FG002|Overall Study|Lab test not done|4|||
164015188|NCT01070550|592420087|FG003|Overall Study|Lab test not done|1|||
164015189|NCT01070550|592420088|FG004|Overall Study|Lab test not done|0|||
164015190|NCT01070550|592420089|FG005|Overall Study|Lab test not done|1|||
164015191|NCT01070550|592420084|FG000|Overall Study|Lack of Efficacy|65|||
164015192|NCT01070550|592420085|FG001|Overall Study|Lack of Efficacy|1|||
164015193|NCT01070550|592420086|FG002|Overall Study|Lack of Efficacy|5|||
164015194|NCT01070550|592420087|FG003|Overall Study|Lack of Efficacy|5|||
164015195|NCT01070550|592420088|FG004|Overall Study|Lack of Efficacy|0|||
164015196|NCT01070550|592420089|FG005|Overall Study|Lack of Efficacy|1|||
164015197|NCT01070550|592420084|FG000|Overall Study|Miscellaneous|12|||
164015198|NCT01070550|592420085|FG001|Overall Study|Miscellaneous|2|||
164015199|NCT01070550|592420086|FG002|Overall Study|Miscellaneous|3|||
164015200|NCT01070550|592420087|FG003|Overall Study|Miscellaneous|1|||
164015201|NCT01070550|592420088|FG004|Overall Study|Miscellaneous|0|||
164015202|NCT01070550|592420089|FG005|Overall Study|Miscellaneous|0|||
164015203|NCT01070550|592420084|FG000|Overall Study|New treatment started|3|||
164015204|NCT01070550|592420085|FG001|Overall Study|New treatment started|1|||
164015205|NCT01070550|592420086|FG002|Overall Study|New treatment started|0|||
164015206|NCT01070550|592420087|FG003|Overall Study|New treatment started|2|||
164385986|NCT03058679|593783915|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
164385987|NCT03058679|593783914|FG000|Baseline to Week 6|Difficulty following the diet|0|||
164385988|NCT03058679|593783915|FG001|Baseline to Week 6|Difficulty following the diet|2|||
164385989|NCT03058679|593783914|FG000|Baseline to Week 6|Physician Decision|1|||
164385990|NCT03058679|593783915|FG001|Baseline to Week 6|Physician Decision|0|||
164385991|NCT03058679|593783914|FG000|Week 6 to Week 12|Change in medication|5|||
164385992|NCT03058679|593783915|FG001|Week 6 to Week 12|Change in medication|7|||
164015207|NCT01070550|592420088|FG004|Overall Study|New treatment started|0|||
164015208|NCT01070550|592420089|FG005|Overall Study|New treatment started|0|||
164092943|NCT00264797|592703423|FG000|Overall Study|Withdrawal by Subject|11|||
164015209|NCT01070550|592420084|FG000|Overall Study|Non-responders|493|||
164015210|NCT01070550|592420085|FG001|Overall Study|Non-responders|4|||
164015211|NCT01070550|592420086|FG002|Overall Study|Non-responders|21|||
164385993|NCT03058679|593783914|FG000|Week 6 to Week 12|Adverse Event|4|||
164015212|NCT01070550|592420087|FG003|Overall Study|Non-responders|20|||
164015213|NCT01070550|592420088|FG004|Overall Study|Non-responders|0|||
164015214|NCT01070550|592420089|FG005|Overall Study|Non-responders|2|||
163903600|NCT02401815|592017273|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903601|NCT02401815|592017274|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
164385994|NCT03058679|593783915|FG001|Week 6 to Week 12|Adverse Event|3|||
164385995|NCT03058679|593783914|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
164385996|NCT03058679|593783915|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
164385997|NCT03058679|593783914|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
164385998|NCT03058679|593783915|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
164385999|NCT04137380|593783920|FG000|Overall Study|Physician Decision|0|||
164386000|NCT04137380|593783921|FG001|Overall Study|Physician Decision|0|||
164386001|NCT04137380|593783922|FG002|Overall Study|Physician Decision|0|||
164386002|NCT04137380|593783923|FG003|Overall Study|Physician Decision|1|||
164386003|NCT04137380|593783924|FG004|Overall Study|Physician Decision|0|||
164386004|NCT04137380|593783925|FG005|Overall Study|Physician Decision|0|||
164386005|NCT04137380|593783926|FG006|Overall Study|Physician Decision|0|||
164386006|NCT00575588|593783932|FG000|Overall Study|Adverse Event|11|||
164386007|NCT00575588|593783933|FG001|Overall Study|Adverse Event|13|||
164386008|NCT00575588|593783932|FG000|Overall Study|Withdrawal by Subject|27|||
164386009|NCT00575588|593783933|FG001|Overall Study|Withdrawal by Subject|31|||
164386010|NCT00575588|593783932|FG000|Overall Study|Lost to Follow-up|1|||
164386011|NCT00575588|593783933|FG001|Overall Study|Lost to Follow-up|3|||
164386012|NCT00575588|593783932|FG000|Overall Study|Death|4|||
164386013|NCT00575588|593783933|FG001|Overall Study|Death|2|||
164386014|NCT00575588|593783932|FG000|Overall Study|Incorrect enrollment|8|||
164386015|NCT00575588|593783933|FG001|Overall Study|Incorrect enrollment|4|||
164386016|NCT00575588|593783932|FG000|Overall Study|Study specific discontinuation criteria|203|||
164386017|NCT00575588|593783933|FG001|Overall Study|Study specific discontinuation criteria|218|||
164386018|NCT00575588|593783932|FG000|Overall Study|Severe non-compliance to protocol|5|||
164386019|NCT00575588|593783933|FG001|Overall Study|Severe non-compliance to protocol|7|||
164386020|NCT00575588|593783932|FG000|Overall Study|Safety reasons|2|||
164386021|NCT00575588|593783933|FG001|Overall Study|Safety reasons|1|||
164386022|NCT00575588|593783932|FG000|Overall Study|Elevated triglyceride|1|||
164386023|NCT00575588|593783933|FG001|Overall Study|Elevated triglyceride|0|||
164386024|NCT00575588|593783932|FG000|Overall Study|Patient moved|1|||
164386025|NCT00575588|593783933|FG001|Overall Study|Patient moved|3|||
164386026|NCT00575588|593783932|FG000|Overall Study|Impossible to determine HbA1c|0|||
164386027|NCT00575588|593783933|FG001|Overall Study|Impossible to determine HbA1c|1|||
164386028|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Adverse Event|3|||
164386029|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Adverse Event|2|||
164386030|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Adverse Event|0|||
164386031|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Adverse Event|0|||
164386032|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Adverse Event|0|||
164386033|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Adverse Event|0|||
164386034|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Adverse Event|0|||
164386035|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
164386036|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
164386037|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386038|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386039|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386040|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386041|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
164386042|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Physician Decision|1|||
164386043|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Physician Decision|0|||
164386044|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Physician Decision|0|||
164386045|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Physician Decision|0|||
164386046|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Physician Decision|0|||
164386047|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Physician Decision|0|||
164386048|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Physician Decision|0|||
164386049|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
164386050|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
164386051|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386052|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386053|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386054|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386055|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
164386056|NCT02265705|593783934|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386057|NCT02265705|593783935|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
164386058|NCT02265705|593783936|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386059|NCT02265705|593783937|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386060|NCT02265705|593783938|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386061|NCT02265705|593783939|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386062|NCT02265705|593783940|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
164386063|NCT02265705|593783934|FG000|Rescue Period|Withdrawal by Subject|0|||
164386064|NCT02265705|593783935|FG001|Rescue Period|Withdrawal by Subject|0|||
164386065|NCT02265705|593783936|FG002|Rescue Period|Withdrawal by Subject|1|||
164386066|NCT02265705|593783937|FG003|Rescue Period|Withdrawal by Subject|0|||
164386067|NCT02265705|593783938|FG004|Rescue Period|Withdrawal by Subject|0|||
164386068|NCT02265705|593783939|FG005|Rescue Period|Withdrawal by Subject|0|||
164386069|NCT02265705|593783940|FG006|Rescue Period|Withdrawal by Subject|0|||
164386070|NCT02265705|593783934|FG000|Rescue Period|Death|0|||
164386071|NCT02265705|593783935|FG001|Rescue Period|Death|0|||
164386072|NCT02265705|593783936|FG002|Rescue Period|Death|1|||
164386073|NCT02265705|593783937|FG003|Rescue Period|Death|0|||
164386074|NCT02265705|593783938|FG004|Rescue Period|Death|0|||
164386075|NCT02265705|593783939|FG005|Rescue Period|Death|0|||
164386076|NCT02265705|593783940|FG006|Rescue Period|Death|0|||
164386077|NCT02265705|593783934|FG000|Rescue Period|Lack of Efficacy|0|||
164386078|NCT02265705|593783935|FG001|Rescue Period|Lack of Efficacy|0|||
164386079|NCT02265705|593783936|FG002|Rescue Period|Lack of Efficacy|1|||
164386080|NCT02265705|593783937|FG003|Rescue Period|Lack of Efficacy|0|||
164386081|NCT02265705|593783938|FG004|Rescue Period|Lack of Efficacy|0|||
164386082|NCT02265705|593783939|FG005|Rescue Period|Lack of Efficacy|0|||
164386083|NCT02265705|593783940|FG006|Rescue Period|Lack of Efficacy|0|||
164386084|NCT02265705|593783934|FG000|Open Label Period|Adverse Event|0|||
164386085|NCT02265705|593783935|FG001|Open Label Period|Adverse Event|0|||
164386086|NCT02265705|593783936|FG002|Open Label Period|Adverse Event|0|||
164386087|NCT02265705|593783937|FG003|Open Label Period|Adverse Event|2|||
164386088|NCT02265705|593783938|FG004|Open Label Period|Adverse Event|2|||
164386089|NCT02265705|593783939|FG005|Open Label Period|Adverse Event|0|||
164386090|NCT02265705|593783940|FG006|Open Label Period|Adverse Event|0|||
164386091|NCT02265705|593783934|FG000|Open Label Period|Physician Decision|0|||
164386092|NCT02265705|593783935|FG001|Open Label Period|Physician Decision|0|||
164386093|NCT02265705|593783936|FG002|Open Label Period|Physician Decision|0|||
164386094|NCT02265705|593783937|FG003|Open Label Period|Physician Decision|0|||
164386095|NCT02265705|593783938|FG004|Open Label Period|Physician Decision|1|||
164386096|NCT02265705|593783939|FG005|Open Label Period|Physician Decision|0|||
164386097|NCT02265705|593783940|FG006|Open Label Period|Physician Decision|0|||
164386098|NCT02265705|593783934|FG000|Open Label Period|Withdrawal by Subject|0|||
164386099|NCT02265705|593783935|FG001|Open Label Period|Withdrawal by Subject|0|||
164386100|NCT02265705|593783936|FG002|Open Label Period|Withdrawal by Subject|0|||
164386101|NCT02265705|593783937|FG003|Open Label Period|Withdrawal by Subject|0|||
164386102|NCT02265705|593783938|FG004|Open Label Period|Withdrawal by Subject|2|||
164386103|NCT02265705|593783939|FG005|Open Label Period|Withdrawal by Subject|0|||
164386104|NCT02265705|593783940|FG006|Open Label Period|Withdrawal by Subject|0|||
164386105|NCT02265705|593783934|FG000|Follow-up Period|Sponsor Decision|0|||
164386106|NCT02265705|593783935|FG001|Follow-up Period|Sponsor Decision|0|||
164386107|NCT02265705|593783936|FG002|Follow-up Period|Sponsor Decision|0|||
164386108|NCT02265705|593783937|FG003|Follow-up Period|Sponsor Decision|0|||
164386109|NCT02265705|593783938|FG004|Follow-up Period|Sponsor Decision|0|||
164386110|NCT02265705|593783939|FG005|Follow-up Period|Sponsor Decision|1|||
164386111|NCT02265705|593783940|FG006|Follow-up Period|Sponsor Decision|6|||
164386112|NCT02265705|593783934|FG000|Follow-up Period|Adverse Event|0|||
164386113|NCT02265705|593783935|FG001|Follow-up Period|Adverse Event|0|||
164386114|NCT02265705|593783936|FG002|Follow-up Period|Adverse Event|0|||
164386115|NCT02265705|593783937|FG003|Follow-up Period|Adverse Event|0|||
164386116|NCT02265705|593783938|FG004|Follow-up Period|Adverse Event|0|||
164386117|NCT02265705|593783939|FG005|Follow-up Period|Adverse Event|0|||
164386118|NCT02265705|593783940|FG006|Follow-up Period|Adverse Event|3|||
164386119|NCT02265705|593783934|FG000|Follow-up Period|Physician Decision|0|||
164386120|NCT02265705|593783935|FG001|Follow-up Period|Physician Decision|0|||
164386121|NCT02265705|593783936|FG002|Follow-up Period|Physician Decision|0|||
164386122|NCT02265705|593783937|FG003|Follow-up Period|Physician Decision|0|||
164386123|NCT02265705|593783938|FG004|Follow-up Period|Physician Decision|0|||
164386124|NCT02265705|593783939|FG005|Follow-up Period|Physician Decision|0|||
164386125|NCT02265705|593783940|FG006|Follow-up Period|Physician Decision|1|||
164386126|NCT02265705|593783934|FG000|Follow-up Period|Withdrawal by Subject|0|||
164386127|NCT02265705|593783935|FG001|Follow-up Period|Withdrawal by Subject|0|||
164386128|NCT02265705|593783936|FG002|Follow-up Period|Withdrawal by Subject|0|||
164386129|NCT02265705|593783937|FG003|Follow-up Period|Withdrawal by Subject|0|||
164386130|NCT02265705|593783938|FG004|Follow-up Period|Withdrawal by Subject|0|||
164386131|NCT02265705|593783939|FG005|Follow-up Period|Withdrawal by Subject|0|||
164386132|NCT02265705|593783940|FG006|Follow-up Period|Withdrawal by Subject|1|||
164386133|NCT02828111|593783945|FG000|Overall Study|Withdrawal by Subject|0|||
164386134|NCT02828111|593783946|FG001|Overall Study|Withdrawal by Subject|0|||
164386135|NCT02828111|593783947|FG002|Overall Study|Withdrawal by Subject|2|||
164386136|NCT02828111|593783948|FG003|Overall Study|Withdrawal by Subject|0|||
164386137|NCT02828111|593783949|FG004|Overall Study|Withdrawal by Subject|0|||
164386138|NCT02828111|593783945|FG000|Overall Study|Lost to Follow-up|0|||
164386139|NCT02828111|593783946|FG001|Overall Study|Lost to Follow-up|0|||
164386140|NCT02828111|593783947|FG002|Overall Study|Lost to Follow-up|0|||
164386141|NCT02828111|593783948|FG003|Overall Study|Lost to Follow-up|1|||
164386142|NCT02828111|593783949|FG004|Overall Study|Lost to Follow-up|1|||
164386143|NCT00614939|593783950|FG000|Overall Study|Withdrawal by Subject|10|||
164386144|NCT00614939|593783951|FG001|Overall Study|Withdrawal by Subject|17|||
164386145|NCT00614939|593783950|FG000|Overall Study|Study specific discontinuation criteris|13|||
164386146|NCT00614939|593783951|FG001|Overall Study|Study specific discontinuation criteris|16|||
164386147|NCT00614939|593783950|FG000|Overall Study|Adverse Event|2|||
164386148|NCT00614939|593783951|FG001|Overall Study|Adverse Event|5|||
164386149|NCT00614939|593783950|FG000|Overall Study|Incorrect enrollment|1|||
164386150|NCT00614939|593783951|FG001|Overall Study|Incorrect enrollment|2|||
164386151|NCT00614939|593783950|FG000|Overall Study|Death|4|||
164386152|NCT00614939|593783951|FG001|Overall Study|Death|3|||
164386153|NCT00614939|593783950|FG000|Overall Study|Poor/non-compliance|4|||
164386154|NCT00614939|593783951|FG001|Overall Study|Poor/non-compliance|0|||
164386155|NCT00614939|593783950|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
164386156|NCT00614939|593783951|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
164386157|NCT02079805|593783955|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164386158|NCT02079805|593783956|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164386159|NCT02079805|593783955|FG000|Overall Study|Voluntary Withdrawal|0|||
164386160|NCT02079805|593783956|FG001|Overall Study|Voluntary Withdrawal|1|||
164386161|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
164386162|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
164386163|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
164386164|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
164386165|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
164386166|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164386167|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
164386168|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164386169|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
164386170|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
164015215|NCT01070550|592420084|FG000|Overall Study|Not categorized|33|||
164015216|NCT01070550|592420085|FG001|Overall Study|Not categorized|2|||
164015217|NCT01070550|592420086|FG002|Overall Study|Not categorized|6|||
164015218|NCT01070550|592420087|FG003|Overall Study|Not categorized|1|||
164015219|NCT01070550|592420088|FG004|Overall Study|Not categorized|0|||
164015220|NCT01070550|592420089|FG005|Overall Study|Not categorized|1|||
164092944|NCT00264797|592703424|FG001|Overall Study|Withdrawal by Subject|11|||
164092945|NCT00264797|592703423|FG000|Overall Study|Lost to Follow-up|9|||
164092946|NCT00264797|592703424|FG001|Overall Study|Lost to Follow-up|17|||
164015221|NCT01070550|592420084|FG000|Overall Study|Protocol Violation|15|||
164015222|NCT01070550|592420085|FG001|Overall Study|Protocol Violation|1|||
164015223|NCT01070550|592420086|FG002|Overall Study|Protocol Violation|1|||
164015224|NCT01070550|592420087|FG003|Overall Study|Protocol Violation|1|||
164015225|NCT01070550|592420088|FG004|Overall Study|Protocol Violation|0|||
164015226|NCT01070550|592420089|FG005|Overall Study|Protocol Violation|0|||
164015227|NCT01070550|592420084|FG000|Overall Study|Relapse|44|||
164015228|NCT01070550|592420085|FG001|Overall Study|Relapse|5|||
164015229|NCT01070550|592420086|FG002|Overall Study|Relapse|14|||
164015230|NCT01070550|592420087|FG003|Overall Study|Relapse|4|||
164015231|NCT01070550|592420088|FG004|Overall Study|Relapse|0|||
164015232|NCT01070550|592420089|FG005|Overall Study|Relapse|0|||
164015233|NCT01070550|592420084|FG000|Overall Study|Result not available|3|||
164015234|NCT01070550|592420085|FG001|Overall Study|Result not available|1|||
164092947|NCT00264797|592703423|FG000|Overall Study|Moved from area|3|||
164092948|NCT00264797|592703424|FG001|Overall Study|Moved from area|1|||
164092949|NCT00264797|592703423|FG000|Overall Study|Practical Problems|2|||
164386171|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
164386172|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
164015235|NCT01070550|592420086|FG002|Overall Study|Result not available|3|||
164386173|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
164386174|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164386175|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164386176|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
164386177|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
164015236|NCT01070550|592420087|FG003|Overall Study|Result not available|0|||
164092950|NCT00264797|592703424|FG001|Overall Study|Practical Problems|3|||
164386178|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
164386179|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
164386180|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
164386181|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
164386182|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
164386183|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
164386184|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
164386185|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
164386186|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
164386187|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
164386188|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
164386189|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
164386190|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
164386191|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
164386192|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
164386193|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
164386194|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164386195|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
164386196|NCT00383435|593783957|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
164386197|NCT00383435|593783958|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
164386198|NCT00383435|593783959|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
164386199|NCT00383435|593783960|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
164386200|NCT00383435|593783961|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
164386201|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
164386202|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
164386203|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
164386204|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
164386205|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
164386206|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164386207|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164386208|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164015237|NCT01070550|592420088|FG004|Overall Study|Result not available|0|||
164015238|NCT01070550|592420089|FG005|Overall Study|Result not available|0|||
164015239|NCT01070550|592420084|FG000|Overall Study|Screen failure|1|||
164015240|NCT01070550|592420085|FG001|Overall Study|Screen failure|0|||
164015241|NCT01070550|592420086|FG002|Overall Study|Screen failure|0|||
164015242|NCT01070550|592420087|FG003|Overall Study|Screen failure|0|||
164015243|NCT01070550|592420088|FG004|Overall Study|Screen failure|0|||
164015244|NCT01070550|592420089|FG005|Overall Study|Screen failure|0|||
164015245|NCT01070550|592420084|FG000|Overall Study|Sponsor decision|1|||
164015246|NCT01070550|592420085|FG001|Overall Study|Sponsor decision|0|||
164015247|NCT01070550|592420086|FG002|Overall Study|Sponsor decision|0|||
164015248|NCT01070550|592420087|FG003|Overall Study|Sponsor decision|0|||
164015249|NCT01070550|592420088|FG004|Overall Study|Sponsor decision|0|||
164015250|NCT01070550|592420089|FG005|Overall Study|Sponsor decision|0|||
164015251|NCT01070550|592420084|FG000|Overall Study|Treatment duration shortened|1|||
164015252|NCT01070550|592420085|FG001|Overall Study|Treatment duration shortened|0|||
164015253|NCT01070550|592420086|FG002|Overall Study|Treatment duration shortened|0|||
164015254|NCT01070550|592420087|FG003|Overall Study|Treatment duration shortened|0|||
164015255|NCT01070550|592420088|FG004|Overall Study|Treatment duration shortened|0|||
164015256|NCT01070550|592420089|FG005|Overall Study|Treatment duration shortened|0|||
164015257|NCT01070550|592420084|FG000|Overall Study|Treatment interrupted|7|||
164015258|NCT01070550|592420085|FG001|Overall Study|Treatment interrupted|0|||
164015259|NCT01070550|592420086|FG002|Overall Study|Treatment interrupted|1|||
164015260|NCT01070550|592420087|FG003|Overall Study|Treatment interrupted|1|||
164015261|NCT01070550|592420088|FG004|Overall Study|Treatment interrupted|0|||
164015262|NCT01070550|592420089|FG005|Overall Study|Treatment interrupted|0|||
164015263|NCT01070550|592420084|FG000|Overall Study|Treatment not started|14|||
164015264|NCT01070550|592420085|FG001|Overall Study|Treatment not started|2|||
164015265|NCT01070550|592420086|FG002|Overall Study|Treatment not started|4|||
164015266|NCT01070550|592420087|FG003|Overall Study|Treatment not started|0|||
164092951|NCT00264797|592703423|FG000|Overall Study|Incarceration|4|||
164386209|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164015267|NCT01070550|592420088|FG004|Overall Study|Treatment not started|0|||
164015268|NCT01070550|592420089|FG005|Overall Study|Treatment not started|0|||
164015269|NCT01070550|592420084|FG000|Overall Study|Treatment restarted|0|||
164092952|NCT00264797|592703424|FG001|Overall Study|Incarceration|5|||
164015270|NCT01070550|592420085|FG001|Overall Study|Treatment restarted|1|||
164015271|NCT01070550|592420086|FG002|Overall Study|Treatment restarted|0|||
164386210|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
164386211|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164386212|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
164386213|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164386214|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164386215|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
163903602|NCT02401815|592017275|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903603|NCT02401815|592017276|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903604|NCT02401815|592017277|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
163903605|NCT02401815|592017278|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
163903606|NCT02401815|592017279|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
163903607|NCT02401815|592017270|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903608|NCT02401815|592017271|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903609|NCT02401815|592017272|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903610|NCT02401815|592017273|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903611|NCT02401815|592017274|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903612|NCT02401815|592017275|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903613|NCT02401815|592017276|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903614|NCT02401815|592017277|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903615|NCT02401815|592017278|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
163903616|NCT02401815|592017279|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
163903617|NCT02401815|592017270|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903618|NCT02401815|592017271|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903619|NCT02401815|592017272|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903620|NCT02401815|592017273|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903621|NCT02401815|592017274|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903622|NCT02401815|592017275|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903623|NCT02401815|592017276|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903624|NCT02401815|592017277|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903625|NCT02401815|592017278|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
163903626|NCT02401815|592017279|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
163903627|NCT02401815|592017270|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903628|NCT02401815|592017271|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903629|NCT02401815|592017272|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903630|NCT02401815|592017273|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903631|NCT02401815|592017274|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903632|NCT02401815|592017275|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903633|NCT02401815|592017276|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
164144033|NCT00086281|592888572|FG001|Phase 2|Adverse Event|0|||
164386216|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
164386217|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
164386218|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
164386219|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
164386220|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
164386221|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164386222|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
164386223|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
164386224|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
164386225|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164386226|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
164386227|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164386228|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164386229|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164386230|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
164386231|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164386232|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164386233|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164386234|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164386235|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164386236|NCT00383435|593783957|FG000|26-Week Treatment Safety Extension|Administrative|1|||
164386237|NCT00383435|593783958|FG001|26-Week Treatment Safety Extension|Administrative|1|||
164386238|NCT00383435|593783959|FG002|26-Week Treatment Safety Extension|Administrative|0|||
164092953|NCT00264797|592703423|FG000|Overall Study|Pressure/advice from Outsiders|1|||
164092954|NCT00264797|592703424|FG001|Overall Study|Pressure/advice from Outsiders|1|||
164092955|NCT00264797|592703423|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
164386239|NCT00383435|593783960|FG003|26-Week Treatment Safety Extension|Administrative|1|||
164386240|NCT00383435|593783961|FG004|26-Week Treatment Safety Extension|Administrative|0|||
164386241|NCT01753193|593783962|FG000|Overall Study|Withdrawal by Subject|23|||
164386242|NCT01753193|593783962|FG000|Overall Study|Lost to Follow-up|6|||
164386243|NCT01753193|593783962|FG000|Overall Study|Death|1|||
164386244|NCT01753193|593783962|FG000|Overall Study|Other|16|||
164386245|NCT00583557|593783963|FG000|Overall Study|Withdrawal by Subject|18|||
164386246|NCT00583557|593783963|FG000|Overall Study|Adverse Event|9|||
164386247|NCT00583557|593783963|FG000|Overall Study|Lack of Efficacy|31|||
164386248|NCT00583557|593783963|FG000|Overall Study|Lack of Compliance|5|||
164386249|NCT00583557|593783963|FG000|Overall Study|Other|5|||
164386250|NCT00583557|593783963|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
164386251|NCT02682264|593783964|FG000|Overall Study|Withdrawal by Subject|56|||
164386252|NCT02682264|593783965|FG001|Overall Study|Withdrawal by Subject|45|||
164386253|NCT02682264|593783964|FG000|Overall Study|Lost to Follow-up|49|||
164386254|NCT02682264|593783965|FG001|Overall Study|Lost to Follow-up|41|||
164386255|NCT02682264|593783964|FG000|Overall Study|Lack of Efficacy|14|||
164386256|NCT02682264|593783965|FG001|Overall Study|Lack of Efficacy|16|||
164386257|NCT02682264|593783964|FG000|Overall Study|Withdrawal by Parent|6|||
164386258|NCT02682264|593783965|FG001|Overall Study|Withdrawal by Parent|7|||
164386259|NCT02682264|593783964|FG000|Overall Study|Adverse Event|9|||
164386260|NCT02682264|593783965|FG001|Overall Study|Adverse Event|0|||
164386261|NCT02682264|593783964|FG000|Overall Study|Noncompliance with study drug|1|||
164386262|NCT02682264|593783965|FG001|Overall Study|Noncompliance with study drug|4|||
164386263|NCT02682264|593783964|FG000|Overall Study|Pregnancy|1|||
164386264|NCT02682264|593783965|FG001|Overall Study|Pregnancy|2|||
164386265|NCT02682264|593783964|FG000|Overall Study|Recovery|1|||
164386266|NCT02682264|593783965|FG001|Overall Study|Recovery|2|||
164386267|NCT02682264|593783964|FG000|Overall Study|Progressive Disease|1|||
164386268|NCT02682264|593783965|FG001|Overall Study|Progressive Disease|0|||
164386269|NCT02682264|593783964|FG000|Overall Study|Technical Problems|0|||
164386270|NCT02682264|593783965|FG001|Overall Study|Technical Problems|1|||
164386271|NCT02682264|593783964|FG000|Overall Study|Moved abroad and unable to continue|0|||
164386272|NCT02682264|593783965|FG001|Overall Study|Moved abroad and unable to continue|3|||
164386273|NCT02682264|593783964|FG000|Overall Study|Stopped test article application|0|||
163903634|NCT02401815|592017277|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
163903635|NCT02401815|592017278|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
163903636|NCT02401815|592017279|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
163903637|NCT00748709|592017280|FG000|Overall Study|Progressive disease|15|||
163903638|NCT00748709|592017280|FG000|Overall Study|Drug reducing Toxity|2|||
163903639|NCT00748709|592017280|FG000|Overall Study|Other Adverse Event|1|||
163903640|NCT00748709|592017280|FG000|Overall Study|Withdrawal by Subject|1|||
163903641|NCT00748709|592017280|FG000|Overall Study|Other Reasons|1|||
163903642|NCT05470114|592017282|FG000|Overall Study|Withdrawal by Subject|1|||
163903643|NCT05470114|592017283|FG001|Overall Study|Withdrawal by Subject|0|||
163903644|NCT05470114|592017282|FG000|Overall Study|Lost to Follow-up|1|||
163903645|NCT05470114|592017283|FG001|Overall Study|Lost to Follow-up|0|||
163903646|NCT05325294|592017288|FG000|Overall Study|Adverse Event|3|||
163903647|NCT05325294|592017289|FG001|Overall Study|Adverse Event|3|||
163903648|NCT05325294|592017288|FG000|Overall Study|Physician Decision|0|||
163903649|NCT05325294|592017289|FG001|Overall Study|Physician Decision|1|||
163903650|NCT05325294|592017288|FG000|Overall Study|Withdrawal by Subject|0|||
163903651|NCT05325294|592017289|FG001|Overall Study|Withdrawal by Subject|3|||
163903652|NCT05325294|592017288|FG000|Overall Study|Lost to Follow-up|1|||
163903653|NCT05325294|592017289|FG001|Overall Study|Lost to Follow-up|0|||
163903654|NCT05325294|592017288|FG000|Overall Study|Sponsor Request|0|||
163903655|NCT05325294|592017289|FG001|Overall Study|Sponsor Request|2|||
163903656|NCT04649047|592017290|FG000|Overall Study|Withdrawal by Subject|3|||
163903657|NCT02488408|592017291|FG000|Part A|Adverse Event|2|||
163903658|NCT02488408|592017292|FG001|Part A|Adverse Event|0|||
163903659|NCT02488408|592017293|FG002|Part A|Adverse Event|0|||
163903660|NCT02488408|592017294|FG003|Part A|Adverse Event|0|||
163903661|NCT02488408|592017295|FG004|Part A|Adverse Event|0|||
163903662|NCT02488408|592017296|FG005|Part A|Adverse Event|0|||
163903663|NCT02488408|592017297|FG006|Part A|Adverse Event|0|||
163903664|NCT02488408|592017298|FG007|Part A|Adverse Event|0|||
164386274|NCT02682264|593783965|FG001|Overall Study|Stopped test article application|1|||
164386275|NCT01131312|593783966|FG000|Overall Study|Lost to Follow-up|425|||
164386276|NCT01131312|593783967|FG001|Overall Study|Lost to Follow-up|229|||
164386277|NCT01131312|593783968|FG002|Overall Study|Lost to Follow-up|351|||
164386278|NCT02347761|593783969|FG000|All Collected|Death|1|||
164386279|NCT02347761|593783970|FG001|All Collected|Death|0|||
164386280|NCT02347761|593783971|FG002|All Collected|Death|0|||
164386281|NCT02347761|593783969|FG000|All Collected|Lost to Follow-up|3|||
164386282|NCT02347761|593783970|FG001|All Collected|Lost to Follow-up|2|||
164386283|NCT02347761|593783971|FG002|All Collected|Lost to Follow-up|3|||
164386284|NCT02347761|593783969|FG000|All Collected|Withdrawal by Subject|11|||
164386285|NCT02347761|593783970|FG001|All Collected|Withdrawal by Subject|11|||
164386286|NCT02347761|593783971|FG002|All Collected|Withdrawal by Subject|22|||
164386287|NCT02347761|593783969|FG000|All Collected|invetigator disretion|2|||
164386288|NCT02347761|593783970|FG001|All Collected|invetigator disretion|0|||
164386289|NCT02347761|593783971|FG002|All Collected|invetigator disretion|0|||
164386290|NCT02347761|593783969|FG000|All Collected|instillation site pain|0|||
164386291|NCT02347761|593783970|FG001|All Collected|instillation site pain|0|||
164386292|NCT02347761|593783971|FG002|All Collected|instillation site pain|1|||
164386293|NCT02347761|593783969|FG000|All Collected|exacerbation of COPD|0|||
164386294|NCT02347761|593783970|FG001|All Collected|exacerbation of COPD|0|||
164386295|NCT02347761|593783971|FG002|All Collected|exacerbation of COPD|1|||
164386296|NCT02347761|593783969|FG000|All Collected|moved/travel|0|||
164386297|NCT02347761|593783970|FG001|All Collected|moved/travel|1|||
164386298|NCT02347761|593783971|FG002|All Collected|moved/travel|0|||
164386299|NCT02347761|593783969|FG000|On Study Treatment|Lack of Efficacy|2|||
164386300|NCT02347761|593783970|FG001|On Study Treatment|Lack of Efficacy|3|||
164386301|NCT02347761|593783971|FG002|On Study Treatment|Lack of Efficacy|4|||
164386302|NCT02347761|593783969|FG000|On Study Treatment|non-compliance with study medication|0|||
164386303|NCT02347761|593783970|FG001|On Study Treatment|non-compliance with study medication|0|||
164386304|NCT02347761|593783971|FG002|On Study Treatment|non-compliance with study medication|2|||
164386305|NCT02347761|593783969|FG000|On Study Treatment|Withdrawal by Subject|7|||
164386306|NCT02347761|593783970|FG001|On Study Treatment|Withdrawal by Subject|3|||
164386307|NCT02347761|593783971|FG002|On Study Treatment|Withdrawal by Subject|5|||
164386308|NCT02347761|593783969|FG000|On Study Treatment|move/travel|2|||
164386309|NCT02347761|593783970|FG001|On Study Treatment|move/travel|6|||
164386310|NCT02347761|593783971|FG002|On Study Treatment|move/travel|5|||
164386311|NCT02347761|593783969|FG000|On Study Treatment|dissastisfaction with device|2|||
163903665|NCT02488408|592017299|FG008|Part A|Adverse Event|0|||
163903666|NCT02488408|592017300|FG009|Part A|Adverse Event|0|||
163903667|NCT02488408|592017291|FG000|Part A|Death|1|||
163903668|NCT02488408|592017292|FG001|Part A|Death|5|||
163903669|NCT02488408|592017293|FG002|Part A|Death|0|||
163903670|NCT02488408|592017294|FG003|Part A|Death|0|||
163903671|NCT02488408|592017295|FG004|Part A|Death|3|||
163903672|NCT02488408|592017296|FG005|Part A|Death|0|||
163903673|NCT02488408|592017297|FG006|Part A|Death|0|||
163903674|NCT02488408|592017298|FG007|Part A|Death|0|||
163903675|NCT02488408|592017299|FG008|Part A|Death|0|||
163903676|NCT02488408|592017300|FG009|Part A|Death|0|||
163903677|NCT02488408|592017291|FG000|Part A|Disease Progression|2|||
163903678|NCT02488408|592017292|FG001|Part A|Disease Progression|8|||
163903679|NCT02488408|592017293|FG002|Part A|Disease Progression|2|||
163903680|NCT02488408|592017294|FG003|Part A|Disease Progression|3|||
163903681|NCT02488408|592017295|FG004|Part A|Disease Progression|4|||
163903682|NCT02488408|592017296|FG005|Part A|Disease Progression|0|||
163903683|NCT02488408|592017297|FG006|Part A|Disease Progression|0|||
163903684|NCT02488408|592017298|FG007|Part A|Disease Progression|0|||
163903685|NCT02488408|592017299|FG008|Part A|Disease Progression|0|||
163903686|NCT02488408|592017300|FG009|Part A|Disease Progression|0|||
163903687|NCT02488408|592017291|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
163903688|NCT02488408|592017292|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
163903689|NCT02488408|592017293|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
163903690|NCT02488408|592017294|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
163903691|NCT02488408|592017295|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
163903692|NCT02488408|592017296|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
163903693|NCT02488408|592017297|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
163903694|NCT02488408|592017298|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
163903695|NCT02488408|592017299|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
163903696|NCT02488408|592017300|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
163903697|NCT02488408|592017291|FG000|Part A|Investigator Decision|0|||
163903698|NCT02488408|592017292|FG001|Part A|Investigator Decision|1|||
163903699|NCT02488408|592017293|FG002|Part A|Investigator Decision|1|||
163903700|NCT02488408|592017294|FG003|Part A|Investigator Decision|0|||
163903701|NCT02488408|592017295|FG004|Part A|Investigator Decision|0|||
163903702|NCT02488408|592017296|FG005|Part A|Investigator Decision|0|||
163903703|NCT02488408|592017297|FG006|Part A|Investigator Decision|0|||
164015272|NCT01070550|592420087|FG003|Overall Study|Treatment restarted|0|||
164015273|NCT01070550|592420088|FG004|Overall Study|Treatment restarted|0|||
164015274|NCT01070550|592420089|FG005|Overall Study|Treatment restarted|0|||
164092956|NCT00264797|592703424|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
164092957|NCT00264797|592703423|FG000|Overall Study|Other|3|||
164092958|NCT00264797|592703424|FG001|Overall Study|Other|4|||
164092959|NCT03992196|592703425|FG000|Enrollment|lost to follow-up prior dosing|1|||
164092960|NCT03992196|592703426|FG001|Enrollment|lost to follow-up prior dosing|0|||
164092961|NCT03992196|592703427|FG002|Enrollment|lost to follow-up prior dosing|0|||
164092962|NCT03992196|592703425|FG000|Treatment|Protocol Violation|0|||
164092963|NCT03992196|592703426|FG001|Treatment|Protocol Violation|0|||
164092964|NCT03992196|592703427|FG002|Treatment|Protocol Violation|1|||
164092965|NCT03992196|592703425|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
164092966|NCT03992196|592703426|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
164092967|NCT03992196|592703427|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
164092968|NCT03992196|592703425|FG000|Treatment|Withdrawal due to non-compliance|0|||
164092969|NCT03992196|592703426|FG001|Treatment|Withdrawal due to non-compliance|0|||
164092970|NCT03992196|592703427|FG002|Treatment|Withdrawal due to non-compliance|1|||
164092971|NCT03992196|592703425|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
164092972|NCT03992196|592703426|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
164092973|NCT03992196|592703427|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
164092974|NCT03992196|592703425|FG000|Treatment|Withdrawal by parent/guardian|0|||
164092975|NCT03992196|592703426|FG001|Treatment|Withdrawal by parent/guardian|0|||
164092976|NCT03992196|592703427|FG002|Treatment|Withdrawal by parent/guardian|2|||
164015275|NCT01070550|592420084|FG000|Overall Study|Treatment stopped|3|||
164015276|NCT01070550|592420085|FG001|Overall Study|Treatment stopped|0|||
164015277|NCT01070550|592420086|FG002|Overall Study|Treatment stopped|0|||
164015278|NCT01070550|592420087|FG003|Overall Study|Treatment stopped|0|||
164015279|NCT01070550|592420088|FG004|Overall Study|Treatment stopped|0|||
164015280|NCT01070550|592420089|FG005|Overall Study|Treatment stopped|0|||
164015281|NCT01070550|592420084|FG000|Overall Study|Treatment unavailable|1|||
164015282|NCT01070550|592420085|FG001|Overall Study|Treatment unavailable|0|||
164015283|NCT01070550|592420086|FG002|Overall Study|Treatment unavailable|0|||
164015284|NCT01070550|592420087|FG003|Overall Study|Treatment unavailable|0|||
164015285|NCT01070550|592420088|FG004|Overall Study|Treatment unavailable|0|||
164015286|NCT01070550|592420089|FG005|Overall Study|Treatment unavailable|0|||
164015287|NCT01070550|592420084|FG000|Overall Study|Treatment was stopped early|7|||
164015288|NCT01070550|592420085|FG001|Overall Study|Treatment was stopped early|0|||
164015289|NCT01070550|592420086|FG002|Overall Study|Treatment was stopped early|0|||
164015290|NCT01070550|592420087|FG003|Overall Study|Treatment was stopped early|0|||
164015291|NCT01070550|592420088|FG004|Overall Study|Treatment was stopped early|0|||
164015292|NCT01070550|592420089|FG005|Overall Study|Treatment was stopped early|0|||
164015293|NCT01070550|592420084|FG000|Overall Study|Other|5|||
164015294|NCT01070550|592420085|FG001|Overall Study|Other|0|||
164015295|NCT01070550|592420086|FG002|Overall Study|Other|0|||
164015296|NCT01070550|592420087|FG003|Overall Study|Other|1|||
164015297|NCT01070550|592420088|FG004|Overall Study|Other|0|||
164015298|NCT01070550|592420089|FG005|Overall Study|Other|0|||
164015299|NCT01070550|592420084|FG000|Overall Study|Withdrawal by Subject|35|||
164015300|NCT01070550|592420085|FG001|Overall Study|Withdrawal by Subject|0|||
164015301|NCT01070550|592420086|FG002|Overall Study|Withdrawal by Subject|3|||
164015302|NCT01070550|592420087|FG003|Overall Study|Withdrawal by Subject|0|||
164015303|NCT01070550|592420088|FG004|Overall Study|Withdrawal by Subject|0|||
164015304|NCT01070550|592420089|FG005|Overall Study|Withdrawal by Subject|0|||
164015305|NCT01585961|592420091|FG000|Overall Study|Death|6|||
164015306|NCT01585961|592420091|FG000|Overall Study|Physician Decision|1|||
164015307|NCT01585961|592420091|FG000|Overall Study|Decision to use non-study catheter|1|||
164015308|NCT01585961|592420091|FG000|Overall Study|Withdrawal by Subject|1|||
164015309|NCT01585961|592420091|FG000|Overall Study|Lost to Follow-up|23|||
164092977|NCT01249664|592703430|FG000|Overall Study|Withdrawal by Subject|5|||
164092978|NCT01249664|592703431|FG001|Overall Study|Withdrawal by Subject|0|||
164092979|NCT01249664|592703430|FG000|Overall Study|Adverse Event|1|||
164092980|NCT01249664|592703431|FG001|Overall Study|Adverse Event|0|||
164092981|NCT00454636|592703432|FG000|Overall Study|Adverse Event|10|||
164015310|NCT01585961|592420091|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
164092982|NCT00454636|592703433|FG001|Overall Study|Adverse Event|6|||
164092983|NCT00454636|592703434|FG002|Overall Study|Adverse Event|9|||
164092984|NCT00454636|592703435|FG003|Overall Study|Adverse Event|15|||
164092985|NCT00454636|592703432|FG000|Overall Study|Disease Progression|11|||
164386312|NCT02347761|593783970|FG001|On Study Treatment|dissastisfaction with device|1|||
164015311|NCT01258348|592420092|FG000|Overall Study|Adverse Event|1|||
164015312|NCT01258348|592420093|FG001|Overall Study|Adverse Event|1|||
164015313|NCT01258348|592420094|FG002|Overall Study|Adverse Event|3|||
164015314|NCT01258348|592420095|FG003|Overall Study|Adverse Event|2|||
164015315|NCT01258348|592420096|FG004|Overall Study|Adverse Event|4|||
164015316|NCT01258348|592420092|FG000|Overall Study|Progressive Disease|0|||
164015317|NCT01258348|592420093|FG001|Overall Study|Progressive Disease|3|||
164015318|NCT01258348|592420094|FG002|Overall Study|Progressive Disease|0|||
164015319|NCT01258348|592420095|FG003|Overall Study|Progressive Disease|2|||
164015320|NCT01258348|592420096|FG004|Overall Study|Progressive Disease|2|||
164015321|NCT01258348|592420092|FG000|Overall Study|Physician Decision|0|||
164015322|NCT01258348|592420093|FG001|Overall Study|Physician Decision|0|||
164386313|NCT02347761|593783971|FG002|On Study Treatment|dissastisfaction with device|4|||
164386314|NCT02347761|593783969|FG000|On Study Treatment|Lost to Follow-up|2|||
164386315|NCT02347761|593783970|FG001|On Study Treatment|Lost to Follow-up|1|||
164386316|NCT02347761|593783971|FG002|On Study Treatment|Lost to Follow-up|1|||
164386317|NCT02347761|593783969|FG000|On Study Treatment|investigator discretion|2|||
164386318|NCT02347761|593783970|FG001|On Study Treatment|investigator discretion|0|||
164386319|NCT02347761|593783971|FG002|On Study Treatment|investigator discretion|0|||
164386320|NCT02347761|593783969|FG000|On Study Treatment|durg not working|0|||
164386321|NCT02347761|593783970|FG001|On Study Treatment|durg not working|1|||
164015323|NCT01258348|592420094|FG002|Overall Study|Physician Decision|0|||
164015324|NCT01258348|592420095|FG003|Overall Study|Physician Decision|2|||
164015325|NCT01258348|592420096|FG004|Overall Study|Physician Decision|0|||
164015326|NCT01258348|592420092|FG000|Overall Study|Withdrawal by Subject|0|||
164015327|NCT01258348|592420093|FG001|Overall Study|Withdrawal by Subject|1|||
164015328|NCT01258348|592420094|FG002|Overall Study|Withdrawal by Subject|0|||
164015329|NCT01258348|592420095|FG003|Overall Study|Withdrawal by Subject|0|||
164015330|NCT01258348|592420096|FG004|Overall Study|Withdrawal by Subject|0|||
164015331|NCT01505491|592420098|FG000|Overall Study|Other reason not listed|1|||
164015332|NCT01505491|592420099|FG001|Overall Study|Other reason not listed|0|||
164015333|NCT01505491|592420100|FG002|Overall Study|Other reason not listed|0|||
164015334|NCT01505491|592420098|FG000|Overall Study|Withdrawal by Subject|1|||
164015335|NCT01505491|592420099|FG001|Overall Study|Withdrawal by Subject|1|||
164015336|NCT01505491|592420100|FG002|Overall Study|Withdrawal by Subject|4|||
164015337|NCT01505491|592420098|FG000|Overall Study|Lost to Follow-up|0|||
164015338|NCT01505491|592420099|FG001|Overall Study|Lost to Follow-up|0|||
164015339|NCT01505491|592420100|FG002|Overall Study|Lost to Follow-up|1|||
164015340|NCT01120093|592420109|FG000|Treatment Period 1|Adverse Event|0|||
164015341|NCT01120093|592420110|FG001|Treatment Period 1|Adverse Event|0|||
164015342|NCT01120093|592420111|FG002|Treatment Period 1|Adverse Event|1|||
164015343|NCT01120093|592420112|FG003|Treatment Period 1|Adverse Event|0|||
164015344|NCT01120093|592420113|FG004|Treatment Period 1|Adverse Event|1|||
164015345|NCT01120093|592420109|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164015346|NCT01120093|592420110|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164015347|NCT01120093|592420111|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164015348|NCT01120093|592420112|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164015349|NCT01120093|592420113|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164015350|NCT01120093|592420109|FG000|Treatment Period 2|Adverse Event|0|||
164015351|NCT01120093|592420110|FG001|Treatment Period 2|Adverse Event|0|||
164015352|NCT01120093|592420111|FG002|Treatment Period 2|Adverse Event|0|||
164015353|NCT01120093|592420112|FG003|Treatment Period 2|Adverse Event|1|||
164015354|NCT01120093|592420113|FG004|Treatment Period 2|Adverse Event|0|||
164015355|NCT01120093|592420109|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164015356|NCT01120093|592420110|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164015357|NCT01120093|592420111|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164015358|NCT01120093|592420112|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164015359|NCT01120093|592420113|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164015360|NCT01120093|592420109|FG000|Treatment Period 3|Lack of Efficacy|0|||
164015361|NCT01120093|592420110|FG001|Treatment Period 3|Lack of Efficacy|0|||
164015362|NCT01120093|592420111|FG002|Treatment Period 3|Lack of Efficacy|0|||
164015363|NCT01120093|592420112|FG003|Treatment Period 3|Lack of Efficacy|1|||
164015364|NCT01120093|592420113|FG004|Treatment Period 3|Lack of Efficacy|0|||
164015365|NCT01120093|592420109|FG000|Treatment Period 3|Adverse Event|0|||
164015366|NCT01120093|592420110|FG001|Treatment Period 3|Adverse Event|0|||
164015367|NCT01120093|592420111|FG002|Treatment Period 3|Adverse Event|0|||
164015368|NCT01120093|592420112|FG003|Treatment Period 3|Adverse Event|0|||
164015369|NCT01120093|592420113|FG004|Treatment Period 3|Adverse Event|1|||
164015370|NCT01120093|592420109|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164015371|NCT01120093|592420110|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164015372|NCT01120093|592420111|FG002|Treatment Period 3|Withdrawal by Subject|1|||
164015373|NCT01120093|592420112|FG003|Treatment Period 3|Withdrawal by Subject|0|||
164015374|NCT01120093|592420113|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164015375|NCT01120093|592420109|FG000|Treatment Period 4|Adverse Event|1|||
164015376|NCT01120093|592420110|FG001|Treatment Period 4|Adverse Event|0|||
164015377|NCT01120093|592420111|FG002|Treatment Period 4|Adverse Event|0|||
164015378|NCT01120093|592420112|FG003|Treatment Period 4|Adverse Event|0|||
164015379|NCT01120093|592420113|FG004|Treatment Period 4|Adverse Event|0|||
164015380|NCT01120093|592420109|FG000|Treatment Period 5|Adverse Event|0|||
164015381|NCT01120093|592420110|FG001|Treatment Period 5|Adverse Event|1|||
164015382|NCT01120093|592420111|FG002|Treatment Period 5|Adverse Event|0|||
164015383|NCT01120093|592420112|FG003|Treatment Period 5|Adverse Event|1|||
164015384|NCT01120093|592420113|FG004|Treatment Period 5|Adverse Event|0|||
164386322|NCT02347761|593783971|FG002|On Study Treatment|durg not working|1|||
164015385|NCT01797783|592420118|FG000|Overall Study|Adverse Event|1|||
163903704|NCT02488408|592017298|FG007|Part A|Investigator Decision|0|||
164015386|NCT01797783|592420119|FG001|Overall Study|Adverse Event|1|||
164015387|NCT01797783|592420118|FG000|Overall Study|Withdrawal by Subject|1|||
164015388|NCT01797783|592420119|FG001|Overall Study|Withdrawal by Subject|0|||
164015389|NCT02184143|592420121|FG000|Overall Study|Withdrawal by Subject|4|||
164015390|NCT02184143|592420122|FG001|Overall Study|Withdrawal by Subject|4|||
164015391|NCT02184143|592420121|FG000|Overall Study|Lost to Follow-up|5|||
164015392|NCT02184143|592420122|FG001|Overall Study|Lost to Follow-up|3|||
164015393|NCT02184143|592420121|FG000|Overall Study|Death|1|||
164015394|NCT02184143|592420122|FG001|Overall Study|Death|0|||
164015395|NCT00431847|592420123|FG000|Overall Study|completion of less than two study visits|6|||
164015396|NCT00431847|592420124|FG001|Overall Study|completion of less than two study visits|3|||
164015397|NCT00431847|592420125|FG002|Overall Study|completion of less than two study visits|4|||
164015398|NCT00431847|592420126|FG003|Overall Study|completion of less than two study visits|14|||
164015399|NCT00431847|592420127|FG004|Overall Study|completion of less than two study visits|0|||
164015400|NCT00431847|592420123|FG000|Overall Study|Protocol Violation|0|||
164015401|NCT00431847|592420124|FG001|Overall Study|Protocol Violation|0|||
164015402|NCT00431847|592420125|FG002|Overall Study|Protocol Violation|0|||
164015403|NCT00431847|592420126|FG003|Overall Study|Protocol Violation|0|||
164015404|NCT00431847|592420127|FG004|Overall Study|Protocol Violation|1|||
164015405|NCT00751101|592420130|FG000|Overall Study|Withdrawal by Subject|1|||
164015406|NCT00751101|592420131|FG001|Overall Study|Withdrawal by Subject|0|||
164015407|NCT00751101|592420130|FG000|Overall Study|No HFS / Never Started Patch/|0|||
164015408|NCT00751101|592420131|FG001|Overall Study|No HFS / Never Started Patch/|4|||
164015409|NCT00751101|592420130|FG000|Overall Study|Never began capecitabine|1|||
164015410|NCT00751101|592420131|FG001|Overall Study|Never began capecitabine|0|||
164015411|NCT00751101|592420130|FG000|Overall Study|Physician Decision|0|||
164015412|NCT00751101|592420131|FG001|Overall Study|Physician Decision|1|||
164386323|NCT02347761|593783969|FG000|On Study Treatment|Adverse Event|10|||
164386324|NCT02347761|593783970|FG001|On Study Treatment|Adverse Event|8|||
164386325|NCT02347761|593783971|FG002|On Study Treatment|Adverse Event|20|||
164386326|NCT01255358|593783972|FG000|Overall Study|Adverse Event|2|||
164386327|NCT01255358|593783972|FG000|Overall Study|Protocol Violation|2|||
164386328|NCT04079933|593783975|FG000|Overall Study|Withdrawal by Subject|3|||
164386329|NCT04079933|593783976|FG001|Overall Study|Withdrawal by Subject|4|||
164386330|NCT04079933|593783975|FG000|Overall Study|Lost to Follow-up|0|||
164386331|NCT04079933|593783976|FG001|Overall Study|Lost to Follow-up|1|||
164386332|NCT03207750|593783977|FG000|Overall Study|Adverse Event|3|||
164386333|NCT03207750|593783978|FG001|Overall Study|Adverse Event|2|||
163903705|NCT02488408|592017299|FG008|Part A|Investigator Decision|0|||
163903706|NCT02488408|592017300|FG009|Part A|Investigator Decision|0|||
163903707|NCT02488408|592017291|FG000|Part A|Withdrawal by Subject|0|||
163903708|NCT02488408|592017292|FG001|Part A|Withdrawal by Subject|0|||
163903709|NCT02488408|592017293|FG002|Part A|Withdrawal by Subject|2|||
163903710|NCT02488408|592017294|FG003|Part A|Withdrawal by Subject|0|||
163903711|NCT02488408|592017295|FG004|Part A|Withdrawal by Subject|0|||
163903712|NCT02488408|592017296|FG005|Part A|Withdrawal by Subject|0|||
163903713|NCT02488408|592017297|FG006|Part A|Withdrawal by Subject|0|||
163903714|NCT02488408|592017298|FG007|Part A|Withdrawal by Subject|0|||
163903715|NCT02488408|592017299|FG008|Part A|Withdrawal by Subject|0|||
163903716|NCT02488408|592017300|FG009|Part A|Withdrawal by Subject|0|||
163903717|NCT02488408|592017291|FG000|Part A|Other|1|||
163903718|NCT02488408|592017292|FG001|Part A|Other|0|||
163903719|NCT02488408|592017293|FG002|Part A|Other|0|||
163903720|NCT02488408|592017294|FG003|Part A|Other|0|||
163903721|NCT02488408|592017295|FG004|Part A|Other|0|||
163903722|NCT02488408|592017296|FG005|Part A|Other|0|||
163903723|NCT02488408|592017297|FG006|Part A|Other|0|||
163903724|NCT02488408|592017298|FG007|Part A|Other|0|||
163903725|NCT02488408|592017299|FG008|Part A|Other|0|||
163903726|NCT02488408|592017300|FG009|Part A|Other|0|||
163903727|NCT02488408|592017291|FG000|Part B|Adverse Event|0|||
163903728|NCT02488408|592017292|FG001|Part B|Adverse Event|0|||
163903729|NCT02488408|592017293|FG002|Part B|Adverse Event|0|||
163903730|NCT02488408|592017294|FG003|Part B|Adverse Event|0|||
163903731|NCT02488408|592017295|FG004|Part B|Adverse Event|0|||
163903732|NCT02488408|592017296|FG005|Part B|Adverse Event|2|||
163903733|NCT02488408|592017297|FG006|Part B|Adverse Event|2|||
163903734|NCT02488408|592017298|FG007|Part B|Adverse Event|7|||
163903735|NCT02488408|592017299|FG008|Part B|Adverse Event|2|||
163903736|NCT02488408|592017300|FG009|Part B|Adverse Event|2|||
163903737|NCT02488408|592017291|FG000|Part B|Death|0|||
163903738|NCT02488408|592017292|FG001|Part B|Death|0|||
163903739|NCT02488408|592017293|FG002|Part B|Death|0|||
163903740|NCT02488408|592017294|FG003|Part B|Death|0|||
163903741|NCT02488408|592017295|FG004|Part B|Death|0|||
163903742|NCT02488408|592017296|FG005|Part B|Death|3|||
163903743|NCT02488408|592017297|FG006|Part B|Death|1|||
163903744|NCT02488408|592017298|FG007|Part B|Death|2|||
163903745|NCT02488408|592017299|FG008|Part B|Death|2|||
163903746|NCT02488408|592017300|FG009|Part B|Death|2|||
164386334|NCT03207750|593783977|FG000|Overall Study|Lost to Follow-up|21|||
163903747|NCT02488408|592017291|FG000|Part B|Death due to Disease Progression|0|||
163903748|NCT02488408|592017292|FG001|Part B|Death due to Disease Progression|0|||
164386335|NCT03207750|593783978|FG001|Overall Study|Lost to Follow-up|29|||
164386336|NCT03207750|593783977|FG000|Overall Study|Protocol Violation|0|||
164386337|NCT03207750|593783978|FG001|Overall Study|Protocol Violation|1|||
164386338|NCT03207750|593783977|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
164386339|NCT03207750|593783978|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
164386340|NCT03207750|593783977|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
164386341|NCT03207750|593783978|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
164386342|NCT03207750|593783977|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
164386343|NCT03207750|593783978|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
164386344|NCT03207750|593783977|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
164386345|NCT03207750|593783978|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
164386346|NCT03207750|593783977|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
164386347|NCT03207750|593783978|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
164386348|NCT02493361|593783979|FG000|Overall Study|Withdrawal by Subject|3|||
164386349|NCT02937545|593783983|FG000|Overall Study|Withdrawal by Subject|1|||
164386350|NCT02937545|593783984|FG001|Overall Study|Withdrawal by Subject|2|||
164386351|NCT02937545|593783985|FG002|Overall Study|Withdrawal by Subject|6|||
164386352|NCT02937545|593783986|FG003|Overall Study|Withdrawal by Subject|7|||
164386353|NCT02937545|593783983|FG000|Overall Study|Lost to Follow-up|1|||
163903749|NCT02488408|592017293|FG002|Part B|Death due to Disease Progression|0|||
164015413|NCT00789477|592420135|FG000|Overall Study|Withdrawal by Subject|2|||
164015414|NCT00789477|592420136|FG001|Overall Study|Withdrawal by Subject|1|||
164015415|NCT00789477|592420137|FG002|Overall Study|Withdrawal by Subject|3|||
164015416|NCT00789477|592420138|FG003|Overall Study|Withdrawal by Subject|2|||
164015417|NCT00789477|592420139|FG004|Overall Study|Withdrawal by Subject|3|||
164015418|NCT00789477|592420135|FG000|Overall Study|Protocol Violation|1|||
164015419|NCT00789477|592420136|FG001|Overall Study|Protocol Violation|0|||
164015420|NCT00789477|592420137|FG002|Overall Study|Protocol Violation|0|||
164386354|NCT02937545|593783984|FG001|Overall Study|Lost to Follow-up|0|||
164386355|NCT02937545|593783985|FG002|Overall Study|Lost to Follow-up|0|||
164386356|NCT02937545|593783986|FG003|Overall Study|Lost to Follow-up|0|||
164386357|NCT02504294|593783989|FG000|Overall Study|Adverse Event|15|||
163903750|NCT02488408|592017294|FG003|Part B|Death due to Disease Progression|0|||
163903751|NCT02488408|592017295|FG004|Part B|Death due to Disease Progression|0|||
163903752|NCT02488408|592017296|FG005|Part B|Death due to Disease Progression|2|||
163903753|NCT02488408|592017297|FG006|Part B|Death due to Disease Progression|2|||
163903754|NCT02488408|592017298|FG007|Part B|Death due to Disease Progression|1|||
163903755|NCT02488408|592017299|FG008|Part B|Death due to Disease Progression|1|||
163903756|NCT02488408|592017300|FG009|Part B|Death due to Disease Progression|1|||
163903757|NCT02488408|592017291|FG000|Part B|Disease Progression|0|||
163903758|NCT02488408|592017292|FG001|Part B|Disease Progression|0|||
163903759|NCT02488408|592017293|FG002|Part B|Disease Progression|0|||
163903760|NCT02488408|592017294|FG003|Part B|Disease Progression|0|||
163903761|NCT02488408|592017295|FG004|Part B|Disease Progression|0|||
163903762|NCT02488408|592017296|FG005|Part B|Disease Progression|6|||
163903763|NCT02488408|592017297|FG006|Part B|Disease Progression|9|||
163903764|NCT02488408|592017298|FG007|Part B|Disease Progression|7|||
163903765|NCT02488408|592017299|FG008|Part B|Disease Progression|9|||
163903766|NCT02488408|592017300|FG009|Part B|Disease Progression|11|||
163903767|NCT02488408|592017291|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
163903768|NCT02488408|592017292|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
163903769|NCT02488408|592017293|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
163903770|NCT02488408|592017294|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
163903771|NCT02488408|592017295|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
163903772|NCT02488408|592017296|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
163903773|NCT02488408|592017297|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
163903774|NCT02488408|592017298|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
163903775|NCT02488408|592017299|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
163903776|NCT02488408|592017300|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
163903777|NCT02488408|592017291|FG000|Part B|Investigator Decision|0|||
163903778|NCT02488408|592017292|FG001|Part B|Investigator Decision|0|||
163903779|NCT02488408|592017293|FG002|Part B|Investigator Decision|0|||
163903780|NCT02488408|592017294|FG003|Part B|Investigator Decision|0|||
163903781|NCT02488408|592017295|FG004|Part B|Investigator Decision|0|||
163903782|NCT02488408|592017296|FG005|Part B|Investigator Decision|0|||
163903783|NCT02488408|592017297|FG006|Part B|Investigator Decision|1|||
163903784|NCT02488408|592017298|FG007|Part B|Investigator Decision|0|||
163903785|NCT02488408|592017299|FG008|Part B|Investigator Decision|2|||
163903786|NCT02488408|592017300|FG009|Part B|Investigator Decision|1|||
163903787|NCT00719888|592017301|FG000|Overall Study|Death|24|||
163903788|NCT00719888|592017302|FG001|Overall Study|Death|9|||
163903789|NCT00719888|592017301|FG000|Overall Study|Relapse|8|||
163903790|NCT00719888|592017302|FG001|Overall Study|Relapse|3|||
163903791|NCT00719888|592017301|FG000|Overall Study|Physician Decision|1|||
164386358|NCT02504294|593783990|FG001|Overall Study|Adverse Event|12|||
164386359|NCT02504294|593783989|FG000|Overall Study|Withdrawal by Subject|7|||
164386360|NCT02504294|593783990|FG001|Overall Study|Withdrawal by Subject|1|||
164386361|NCT02504294|593783989|FG000|Overall Study|Protocol Violation|27|||
164386362|NCT02504294|593783990|FG001|Overall Study|Protocol Violation|26|||
164386363|NCT02504294|593783989|FG000|Overall Study|Physician Decision|1|||
164386364|NCT02504294|593783990|FG001|Overall Study|Physician Decision|2|||
164386365|NCT02504294|593783989|FG000|Overall Study|Lost to Follow-up|6|||
164386366|NCT02504294|593783990|FG001|Overall Study|Lost to Follow-up|7|||
164015421|NCT00789477|592420138|FG003|Overall Study|Protocol Violation|1|||
164015422|NCT00789477|592420139|FG004|Overall Study|Protocol Violation|0|||
164015423|NCT00789477|592420135|FG000|Overall Study|Adverse Event|3|||
164015424|NCT00789477|592420136|FG001|Overall Study|Adverse Event|3|||
164015425|NCT00789477|592420137|FG002|Overall Study|Adverse Event|1|||
164015426|NCT00789477|592420138|FG003|Overall Study|Adverse Event|0|||
164015427|NCT00789477|592420139|FG004|Overall Study|Adverse Event|0|||
164015428|NCT00789477|592420135|FG000|Overall Study|Death|1|||
164015429|NCT00789477|592420136|FG001|Overall Study|Death|1|||
164015430|NCT00789477|592420137|FG002|Overall Study|Death|2|||
164015431|NCT00789477|592420138|FG003|Overall Study|Death|2|||
164015432|NCT00789477|592420139|FG004|Overall Study|Death|0|||
164015433|NCT00789477|592420135|FG000|Overall Study|Lost to Follow-up|0|||
164015434|NCT00789477|592420136|FG001|Overall Study|Lost to Follow-up|1|||
164015435|NCT00789477|592420137|FG002|Overall Study|Lost to Follow-up|4|||
164015436|NCT00789477|592420138|FG003|Overall Study|Lost to Follow-up|2|||
164015437|NCT00789477|592420139|FG004|Overall Study|Lost to Follow-up|4|||
164015438|NCT00789477|592420135|FG000|Overall Study|Lack of Efficacy|2|||
164015439|NCT00789477|592420136|FG001|Overall Study|Lack of Efficacy|0|||
164015440|NCT00789477|592420137|FG002|Overall Study|Lack of Efficacy|0|||
164015441|NCT00789477|592420138|FG003|Overall Study|Lack of Efficacy|0|||
164015442|NCT00789477|592420139|FG004|Overall Study|Lack of Efficacy|0|||
164015443|NCT00789477|592420135|FG000|Overall Study|Other|2|||
164015444|NCT00789477|592420136|FG001|Overall Study|Other|0|||
164015445|NCT00789477|592420137|FG002|Overall Study|Other|1|||
164015446|NCT00789477|592420138|FG003|Overall Study|Other|3|||
164015447|NCT00789477|592420139|FG004|Overall Study|Other|0|||
164015448|NCT00455858|592420140|FG000|Overall Study|Lost to Follow-up|2|||
164015449|NCT00455858|592420140|FG000|Overall Study|Protocol Violation|1|||
164092986|NCT00454636|592703433|FG001|Overall Study|Disease Progression|12|||
164386367|NCT02252211|593783991|FG000|Overall Study|Adverse Event|0|||
164386368|NCT02252211|593783992|FG001|Overall Study|Adverse Event|1|||
164386369|NCT02252211|593783993|FG002|Overall Study|Adverse Event|0|||
164386370|NCT02252211|593783991|FG000|Overall Study|Progressive disease|3|||
164386371|NCT02252211|593783992|FG001|Overall Study|Progressive disease|2|||
164386372|NCT02252211|593783993|FG002|Overall Study|Progressive disease|0|||
164386373|NCT02252211|593783991|FG000|Overall Study|Withdrawal by Subject|1|||
164386374|NCT02252211|593783992|FG001|Overall Study|Withdrawal by Subject|0|||
164386375|NCT02252211|593783993|FG002|Overall Study|Withdrawal by Subject|0|||
164386376|NCT02252211|593783991|FG000|Overall Study|Serious Adverse Event During Screening|1|||
164386377|NCT02252211|593783992|FG001|Overall Study|Serious Adverse Event During Screening|0|||
164386378|NCT02252211|593783993|FG002|Overall Study|Serious Adverse Event During Screening|1|||
164386379|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
164386380|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
164386381|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
164386382|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
164386383|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
164386384|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
164386385|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
164386386|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
164386387|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Other|0|||
164386388|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Other|1|||
164386389|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Other|0|||
164386390|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Other|0|||
164386391|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
164386392|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
164386393|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
164386394|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
164015450|NCT00455858|592420140|FG000|Overall Study|Lack of Efficacy|1|||
164015451|NCT00455858|592420140|FG000|Overall Study|Well controlled FPG without insulin|1|||
164015452|NCT00455858|592420140|FG000|Overall Study|Withdrawal|1|||
164015453|NCT02092389|592420141|FG000|Overall Study|Adverse Event|1|||
164015454|NCT02092389|592420141|FG000|Overall Study|Other|5|||
164386395|NCT05799495|593784000|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
164386396|NCT05799495|593784001|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
164386397|NCT05799495|593784002|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
164015455|NCT01242020|592420142|FG000|Overall Study|Withdrawal by Subject|2|||
164015456|NCT01242020|592420143|FG001|Overall Study|Withdrawal by Subject|0|||
164015457|NCT01242020|592420142|FG000|Overall Study|Failed screening|1|||
164386398|NCT05799495|593784003|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
164386399|NCT05799495|593784000|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164386400|NCT05799495|593784001|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164386401|NCT05799495|593784002|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
164386402|NCT05799495|593784003|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
164386403|NCT03694548|593784007|FG000|Part A Survey|Protocol Violation|3|||
164386404|NCT03694548|593784008|FG001|Part A Survey|Protocol Violation|3|||
164386405|NCT03694548|593784009|FG002|Part A Survey|Protocol Violation|0|||
164386406|NCT03694548|593784007|FG000|Part B Yoga Program|Protocol Violation|0|||
164386407|NCT03694548|593784008|FG001|Part B Yoga Program|Protocol Violation|0|||
164386408|NCT03694548|593784009|FG002|Part B Yoga Program|Protocol Violation|3|||
164386409|NCT03694548|593784007|FG000|Part B Yoga Program|Did not attend intervention|0|||
164386410|NCT03694548|593784008|FG001|Part B Yoga Program|Did not attend intervention|0|||
164386411|NCT03694548|593784009|FG002|Part B Yoga Program|Did not attend intervention|8|||
164386412|NCT04177108|593784010|FG000|Overall Study|Withdrawal by Subject|4|||
164386413|NCT04177108|593784011|FG001|Overall Study|Withdrawal by Subject|8|||
164386414|NCT04177108|593784012|FG002|Overall Study|Withdrawal by Subject|9|||
164386415|NCT04177108|593784013|FG003|Overall Study|Withdrawal by Subject|11|||
164386416|NCT04177108|593784014|FG004|Overall Study|Withdrawal by Subject|13|||
164386417|NCT04177108|593784010|FG000|Overall Study|Physician Decision|23|||
164386418|NCT04177108|593784011|FG001|Overall Study|Physician Decision|15|||
164386419|NCT04177108|593784012|FG002|Overall Study|Physician Decision|18|||
164386420|NCT04177108|593784013|FG003|Overall Study|Physician Decision|29|||
164386421|NCT04177108|593784014|FG004|Overall Study|Physician Decision|23|||
164386422|NCT04177108|593784010|FG000|Overall Study|Reason Not Specified|0|||
164386423|NCT04177108|593784011|FG001|Overall Study|Reason Not Specified|1|||
164386424|NCT04177108|593784012|FG002|Overall Study|Reason Not Specified|0|||
164386425|NCT04177108|593784013|FG003|Overall Study|Reason Not Specified|0|||
164386426|NCT04177108|593784014|FG004|Overall Study|Reason Not Specified|2|||
164386427|NCT04177108|593784010|FG000|Overall Study|Lost to Follow-up|0|||
164386428|NCT04177108|593784011|FG001|Overall Study|Lost to Follow-up|0|||
164386429|NCT04177108|593784012|FG002|Overall Study|Lost to Follow-up|1|||
164386430|NCT04177108|593784013|FG003|Overall Study|Lost to Follow-up|1|||
164386431|NCT04177108|593784014|FG004|Overall Study|Lost to Follow-up|1|||
164386432|NCT04177108|593784010|FG000|Overall Study|Death|16|||
164386433|NCT04177108|593784011|FG001|Overall Study|Death|19|||
164386434|NCT04177108|593784012|FG002|Overall Study|Death|13|||
164386435|NCT04177108|593784013|FG003|Overall Study|Death|17|||
164386436|NCT04177108|593784014|FG004|Overall Study|Death|18|||
164015458|NCT01242020|592420143|FG001|Overall Study|Failed screening|0|||
164015459|NCT02680847|592420144|FG000|Overall Study|Other|2|||
164015460|NCT02680847|592420145|FG001|Overall Study|Other|0|||
164015461|NCT02680847|592420146|FG002|Overall Study|Other|0|||
164015462|NCT02680847|592420144|FG000|Overall Study|No longer met eligibility criteria|2|||
164015463|NCT02680847|592420145|FG001|Overall Study|No longer met eligibility criteria|2|||
164015464|NCT02680847|592420146|FG002|Overall Study|No longer met eligibility criteria|0|||
164015465|NCT02680847|592420144|FG000|Overall Study|Unwilling to participate in study|1|||
164015466|NCT02680847|592420145|FG001|Overall Study|Unwilling to participate in study|1|||
164015467|NCT02680847|592420146|FG002|Overall Study|Unwilling to participate in study|0|||
164015468|NCT02680847|592420144|FG000|Overall Study|Lack of Efficacy|0|||
164015469|NCT02680847|592420145|FG001|Overall Study|Lack of Efficacy|0|||
164015470|NCT02680847|592420146|FG002|Overall Study|Lack of Efficacy|2|||
164015471|NCT02680847|592420144|FG000|Overall Study|Adverse Event|0|||
164015472|NCT02680847|592420145|FG001|Overall Study|Adverse Event|0|||
164015473|NCT02680847|592420146|FG002|Overall Study|Adverse Event|1|||
164015474|NCT01618656|592420150|FG000|Overall Study|Withdrawal by Subject|7|||
164015475|NCT01618656|592420151|FG001|Overall Study|Withdrawal by Subject|3|||
164015476|NCT01618656|592420150|FG000|Overall Study|Physician Decision|1|||
164386437|NCT00099983|593784015|FG000|Overall Study|Lost to Follow-up|2|||
164386438|NCT00099983|593784016|FG001|Overall Study|Lost to Follow-up|3|||
164386439|NCT00099983|593784015|FG000|Overall Study|Missing Source Documents|14|||
164386440|NCT00099983|593784016|FG001|Overall Study|Missing Source Documents|15|||
164386441|NCT00099983|593784015|FG000|Overall Study|Withdrawal by Subject|3|||
164386442|NCT00099983|593784016|FG001|Overall Study|Withdrawal by Subject|2|||
164015477|NCT01618656|592420151|FG001|Overall Study|Physician Decision|1|||
164015478|NCT01899144|592420152|FG000|Treatment Period 2|Other|1|||
164015479|NCT01899144|592420152|FG000|Treatment Period 3|Other|2|||
164015480|NCT01899144|592420152|FG000|Treatment Period 5|Other|1|||
164386443|NCT00099983|593784015|FG000|Overall Study|Adverse Event|1|||
164386444|NCT00099983|593784016|FG001|Overall Study|Adverse Event|1|||
164386445|NCT00099983|593784015|FG000|Overall Study|Lack of Efficacy|0|||
164386446|NCT00099983|593784016|FG001|Overall Study|Lack of Efficacy|1|||
164386447|NCT00099983|593784015|FG000|Overall Study|Unable to return for appointments|1|||
164386448|NCT00099983|593784016|FG001|Overall Study|Unable to return for appointments|1|||
164015481|NCT00751881|592420153|FG000|Core Treatment Period|Not treated|1|||
164015482|NCT00751881|592420154|FG001|Core Treatment Period|Not treated|1|||
164386449|NCT00099983|593784015|FG000|Overall Study|Moved|1|||
164386450|NCT00099983|593784016|FG001|Overall Study|Moved|0|||
164386451|NCT00099983|593784015|FG000|Overall Study|Other psychiatric problem|1|||
164386452|NCT00099983|593784016|FG001|Overall Study|Other psychiatric problem|0|||
164386453|NCT00099983|593784015|FG000|Overall Study|Incarcerated|0|||
164386454|NCT00099983|593784016|FG001|Overall Study|Incarcerated|1|||
164386455|NCT00099983|593784015|FG000|Overall Study|Intolerant of burden of visits|0|||
164386456|NCT00099983|593784016|FG001|Overall Study|Intolerant of burden of visits|1|||
164386457|NCT00099983|593784015|FG000|Overall Study|Other issue|1|||
164386458|NCT00099983|593784016|FG001|Overall Study|Other issue|0|||
164386459|NCT00101101|593784017|FG000|Overall Study|never received vaccine|20|||
164386460|NCT01603875|593784018|FG000|Overall Study|Preexisting rabies antibody|3|||
164386461|NCT01603875|593784019|FG001|Overall Study|Preexisting rabies antibody|4|||
164386462|NCT01603875|593784020|FG002|Overall Study|Preexisting rabies antibody|3|||
164386463|NCT01603875|593784018|FG000|Overall Study|Lost to Follow-up|4|||
164386464|NCT01603875|593784019|FG001|Overall Study|Lost to Follow-up|3|||
164386465|NCT01603875|593784020|FG002|Overall Study|Lost to Follow-up|6|||
164386466|NCT01603875|593784018|FG000|Overall Study|Protocol Violation|0|||
163903792|NCT00719888|592017302|FG001|Overall Study|Physician Decision|0|||
164386467|NCT01603875|593784019|FG001|Overall Study|Protocol Violation|1|||
164386468|NCT01603875|593784020|FG002|Overall Study|Protocol Violation|0|||
164386469|NCT01652716|593784024|FG000|Overall Study|Loss of glucose control|1|||
164386470|NCT01652716|593784025|FG001|Overall Study|Loss of glucose control|0|||
164386471|NCT01652716|593784024|FG000|Overall Study|Administrative|0|||
164386472|NCT01652716|593784025|FG001|Overall Study|Administrative|2|||
164386473|NCT01652716|593784024|FG000|Overall Study|Investigator decision|1|||
164386474|NCT01652716|593784025|FG001|Overall Study|Investigator decision|4|||
164386475|NCT01652716|593784024|FG000|Overall Study|Lost to Follow-up|12|||
164386476|NCT01652716|593784025|FG001|Overall Study|Lost to Follow-up|11|||
164386477|NCT01652716|593784024|FG000|Overall Study|Protocol Violation|2|||
164386478|NCT01652716|593784025|FG001|Overall Study|Protocol Violation|1|||
164386479|NCT01652716|593784024|FG000|Overall Study|Adverse Event|7|||
164386480|NCT01652716|593784025|FG001|Overall Study|Adverse Event|10|||
164386481|NCT01652716|593784024|FG000|Overall Study|Withdrawal by Subject|33|||
164386482|NCT01652716|593784025|FG001|Overall Study|Withdrawal by Subject|18|||
164386483|NCT04122443|593784028|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
164386484|NCT04122443|593784029|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
164386485|NCT04122443|593784030|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
164386486|NCT04122443|593784028|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
164386487|NCT04122443|593784029|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
164386488|NCT04122443|593784030|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
164386489|NCT05204134|593784031|FG000|Overall Study|Withdrawal by Subject|3|||
164386490|NCT05204134|593784031|FG000|Overall Study|Physician Decision|1|||
164386491|NCT01312467|593784035|FG000|Overall Study|Adverse Event|4|||
164386492|NCT01312467|593784035|FG000|Overall Study|Lost to Follow-up|1|||
164386493|NCT01312467|593784035|FG000|Overall Study|Withdrawal by Subject|2|||
164386494|NCT01312467|593784035|FG000|Overall Study|Deported to country of origin|1|||
163903793|NCT00719888|592017301|FG000|Overall Study|Withdrawal by Subject|1|||
163903794|NCT00719888|592017302|FG001|Overall Study|Withdrawal by Subject|0|||
163903795|NCT00491894|592017303|FG000|Overall Study|Adverse Event|14|||
163903796|NCT00491894|592017303|FG000|Overall Study|Withdrawal by Subject|5|||
163903797|NCT00491894|592017303|FG000|Overall Study|Death|3|||
163903798|NCT00491894|592017303|FG000|Overall Study|Lost to Follow-up|3|||
163903799|NCT00491894|592017303|FG000|Overall Study|Lack of Efficacy|2|||
163903800|NCT00491894|592017303|FG000|Overall Study|Other-Failed to meet any criteria|2|||
163903801|NCT00491894|592017303|FG000|Overall Study|Physician Decision|2|||
163903802|NCT00491894|592017303|FG000|Overall Study|Protocol Violation|2|||
163903803|NCT00491894|592017303|FG000|Overall Study|Other-Intake of prohibited medication|1|||
163903804|NCT05422339|592018754|FG000|Overall Study|Withdrawal by Subject|17|||
163903805|NCT05422339|592018755|FG001|Overall Study|Withdrawal by Subject|15|||
163903806|NCT01278030|592018762|FG000|Overall Study|Withdrawal by Subject|8|||
163903807|NCT01278030|592018763|FG001|Overall Study|Withdrawal by Subject|4|||
163903808|NCT05815342|592018768|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
163903809|NCT05815342|592018768|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
163903810|NCT05815342|592018768|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
163903811|NCT05815342|592018768|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
163903812|NCT05815342|592018768|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
163903813|NCT01555138|592018769|FG000|Overall Study|Death|0|||
163903814|NCT01555138|592018770|FG001|Overall Study|Death|1|||
164386495|NCT01312467|593784035|FG000|Overall Study|Another medical condition|1|||
164386496|NCT01312467|593784035|FG000|Overall Study|Ineligible|4|||
164386497|NCT03283670|593784036|FG000|Placebo Gas|Withdrawal by Subject|2|||
164386498|NCT03283670|593784036|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
164386499|NCT03283670|593784036|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
164386500|NCT01059617|593784037|FG000|Overall Study|Other|7|||
164386501|NCT01059617|593784038|FG001|Overall Study|Other|1|||
164015483|NCT00751881|592420155|FG002|Core Treatment Period|Not treated|2|||
164015484|NCT00751881|592420153|FG000|Core Treatment Period|Adverse Event|26|||
164015485|NCT00751881|592420154|FG001|Core Treatment Period|Adverse Event|54|||
164015486|NCT00751881|592420155|FG002|Core Treatment Period|Adverse Event|58|||
164015487|NCT00751881|592420153|FG000|Core Treatment Period|Lack of Efficacy|37|||
164015488|NCT00751881|592420154|FG001|Core Treatment Period|Lack of Efficacy|30|||
164015489|NCT00751881|592420155|FG002|Core Treatment Period|Lack of Efficacy|20|||
164015490|NCT00751881|592420153|FG000|Core Treatment Period|Poor compliance to protocol|15|||
164386502|NCT01059617|593784039|FG002|Overall Study|Other|8|||
164386503|NCT01059617|593784040|FG003|Overall Study|Other|6|||
164386504|NCT01968434|593784043|FG000|Overall Study|Lost to Follow-up|3|||
164386505|NCT01968434|593784044|FG001|Overall Study|Lost to Follow-up|6|||
164386506|NCT02199691|593784045|FG000|Overall Study|Protocol Violation|3|||
164386507|NCT02199691|593784046|FG001|Overall Study|Protocol Violation|3|||
164386508|NCT02199691|593784047|FG002|Overall Study|Protocol Violation|6|||
164386509|NCT02199691|593784048|FG003|Overall Study|Protocol Violation|7|||
164386510|NCT02199691|593784045|FG000|Overall Study|Withdrawal by Subject|5|||
164386511|NCT02199691|593784046|FG001|Overall Study|Withdrawal by Subject|3|||
164386512|NCT02199691|593784047|FG002|Overall Study|Withdrawal by Subject|12|||
164386513|NCT02199691|593784048|FG003|Overall Study|Withdrawal by Subject|13|||
164386514|NCT02199691|593784045|FG000|Overall Study|Lost to Follow-up|2|||
164386515|NCT02199691|593784046|FG001|Overall Study|Lost to Follow-up|1|||
164386516|NCT02199691|593784047|FG002|Overall Study|Lost to Follow-up|9|||
164386517|NCT02199691|593784048|FG003|Overall Study|Lost to Follow-up|10|||
164386518|NCT00612313|593784051|FG000|Overall Study|Withdrawal by Subject|6|||
164386519|NCT00612313|593784052|FG001|Overall Study|Withdrawal by Subject|9|||
164386520|NCT00612313|593784051|FG000|Overall Study|Lost to Follow-up|11|||
164386521|NCT00612313|593784052|FG001|Overall Study|Lost to Follow-up|4|||
164386522|NCT00791765|593786195|FG000|Weeks 1 to 12|Adverse Event|0|||
164386523|NCT00791765|593786196|FG001|Weeks 1 to 12|Adverse Event|1|||
164386524|NCT00791765|593786195|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
164386525|NCT00791765|593786196|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
164386526|NCT00791765|593786195|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
164386527|NCT00791765|593786196|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
164386528|NCT00791765|593786195|FG000|Weeks 1 to 12|Physician Decision|1|||
164386529|NCT00791765|593786196|FG001|Weeks 1 to 12|Physician Decision|0|||
164386530|NCT00791765|593786195|FG000|Weeks 1 to 12|Disease progression|3|||
164386531|NCT00791765|593786196|FG001|Weeks 1 to 12|Disease progression|0|||
164386532|NCT00791765|593786195|FG000|Weeks 1 to 12|Ineligibility determined|0|||
164386533|NCT00791765|593786196|FG001|Weeks 1 to 12|Ineligibility determined|3|||
164386534|NCT00791765|593786195|FG000|Weeks 13 to 24|Protocol deviation|2|||
164386535|NCT00791765|593786196|FG001|Weeks 13 to 24|Protocol deviation|0|||
164386536|NCT00791765|593786195|FG000|Weeks 13 to 24|Adverse Event|0|||
164386537|NCT00791765|593786196|FG001|Weeks 13 to 24|Adverse Event|3|||
164386538|NCT00791765|593786195|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
164386539|NCT00791765|593786196|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
164386540|NCT00791765|593786195|FG000|Weeks 13 to 24|Disease progression|0|||
164386541|NCT00791765|593786196|FG001|Weeks 13 to 24|Disease progression|1|||
164386542|NCT00791765|593786195|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
164386543|NCT00791765|593786196|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
164386544|NCT00791765|593786195|FG000|Weeks 13 to 24|Other|0|||
164386545|NCT00791765|593786196|FG001|Weeks 13 to 24|Other|1|||
164386546|NCT04295564|593786197|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
164386547|NCT04295564|593786198|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
164386548|NCT04537923|593786199|FG000|Overall Study|Adverse Event|2|||
164386549|NCT04537923|593786200|FG001|Overall Study|Adverse Event|1|||
164386550|NCT04537923|593786201|FG002|Overall Study|Adverse Event|2|||
164386551|NCT04537923|593786202|FG003|Overall Study|Adverse Event|4|||
164386552|NCT04537923|593786199|FG000|Overall Study|Death|3|||
164386553|NCT04537923|593786200|FG001|Overall Study|Death|3|||
164386554|NCT04537923|593786201|FG002|Overall Study|Death|1|||
163903815|NCT01555138|592018769|FG000|Overall Study|Lost to Follow-up|1|||
163903816|NCT01555138|592018770|FG001|Overall Study|Lost to Follow-up|0|||
163903817|NCT01555138|592018769|FG000|Overall Study|Abnormal Lab reults|1|||
163903818|NCT01555138|592018770|FG001|Overall Study|Abnormal Lab reults|3|||
163903819|NCT01555138|592018769|FG000|Overall Study|Lack of Efficacy|2|||
163903820|NCT01555138|592018770|FG001|Overall Study|Lack of Efficacy|2|||
163903821|NCT01555138|592018769|FG000|Overall Study|Protocol Violation|5|||
163903822|NCT01555138|592018770|FG001|Overall Study|Protocol Violation|3|||
163903823|NCT01555138|592018769|FG000|Overall Study|Administrative problems|8|||
163903824|NCT01555138|592018770|FG001|Overall Study|Administrative problems|0|||
163903825|NCT01555138|592018769|FG000|Overall Study|Withdrawal by Subject|16|||
163903826|NCT01555138|592018770|FG001|Overall Study|Withdrawal by Subject|15|||
163903827|NCT01555138|592018769|FG000|Overall Study|Adverse Event|14|||
164015491|NCT00751881|592420154|FG001|Core Treatment Period|Poor compliance to protocol|3|||
164386555|NCT04537923|593786202|FG003|Overall Study|Death|11|||
164386556|NCT04537923|593786199|FG000|Overall Study|Lost to Follow-up|1|||
164386557|NCT04537923|593786200|FG001|Overall Study|Lost to Follow-up|2|||
164015492|NCT00751881|592420155|FG002|Core Treatment Period|Poor compliance to protocol|4|||
164015493|NCT00751881|592420153|FG000|Core Treatment Period|Lost to Follow-up|6|||
164015494|NCT00751881|592420154|FG001|Core Treatment Period|Lost to Follow-up|4|||
164015495|NCT00751881|592420155|FG002|Core Treatment Period|Lost to Follow-up|3|||
164015496|NCT00751881|592420153|FG000|Core Treatment Period|Other: protocol deviation|3|||
164015497|NCT00751881|592420154|FG001|Core Treatment Period|Other: protocol deviation|3|||
164015498|NCT00751881|592420155|FG002|Core Treatment Period|Other: protocol deviation|7|||
164015499|NCT00751881|592420153|FG000|Core Treatment Period|Other: wish to parent|5|||
164015500|NCT00751881|592420154|FG001|Core Treatment Period|Other: wish to parent|7|||
164015501|NCT00751881|592420155|FG002|Core Treatment Period|Other: wish to parent|4|||
164015502|NCT00751881|592420153|FG000|Core Treatment Period|Other: personal/family constraints|6|||
164015503|NCT00751881|592420154|FG001|Core Treatment Period|Other: personal/family constraints|7|||
164015504|NCT00751881|592420155|FG002|Core Treatment Period|Other: personal/family constraints|10|||
164015505|NCT00751881|592420153|FG000|Core Treatment Period|Other: MS treatment change|6|||
164015506|NCT00751881|592420154|FG001|Core Treatment Period|Other: MS treatment change|4|||
164015507|NCT00751881|592420155|FG002|Core Treatment Period|Other: MS treatment change|4|||
164015508|NCT00751881|592420153|FG000|Core Treatment Period|Other: tolerability complaints|2|||
164015509|NCT00751881|592420154|FG001|Core Treatment Period|Other: tolerability complaints|0|||
164015510|NCT00751881|592420155|FG002|Core Treatment Period|Other: tolerability complaints|0|||
164015511|NCT00751881|592420153|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
164015512|NCT00751881|592420154|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
164015513|NCT00751881|592420155|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
164015514|NCT00751881|592420153|FG000|Extension Study Period|Adverse Event|18|||
164015515|NCT00751881|592420154|FG001|Extension Study Period|Adverse Event|20|||
164015516|NCT00751881|592420155|FG002|Extension Study Period|Adverse Event|21|||
164015517|NCT00751881|592420153|FG000|Extension Study Period|Lack of Efficacy|14|||
164015518|NCT00751881|592420154|FG001|Extension Study Period|Lack of Efficacy|10|||
164015519|NCT00751881|592420155|FG002|Extension Study Period|Lack of Efficacy|20|||
164015520|NCT00751881|592420153|FG000|Extension Study Period|Lost to Follow-up|4|||
164015521|NCT00751881|592420154|FG001|Extension Study Period|Lost to Follow-up|9|||
164015522|NCT00751881|592420155|FG002|Extension Study Period|Lost to Follow-up|6|||
164015523|NCT00751881|592420153|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
164015524|NCT00751881|592420154|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
164386558|NCT04537923|593786201|FG002|Overall Study|Lost to Follow-up|1|||
164386559|NCT04537923|593786202|FG003|Overall Study|Lost to Follow-up|6|||
164386560|NCT04537923|593786199|FG000|Overall Study|Physician Decision|1|||
164386561|NCT04537923|593786200|FG001|Overall Study|Physician Decision|0|||
164386562|NCT04537923|593786201|FG002|Overall Study|Physician Decision|2|||
164386563|NCT04537923|593786202|FG003|Overall Study|Physician Decision|5|||
164386564|NCT04537923|593786199|FG000|Overall Study|Pregnancy|1|||
164386565|NCT04537923|593786200|FG001|Overall Study|Pregnancy|0|||
164386566|NCT04537923|593786201|FG002|Overall Study|Pregnancy|0|||
164386567|NCT04537923|593786202|FG003|Overall Study|Pregnancy|0|||
164386568|NCT04537923|593786199|FG000|Overall Study|Withdrawal by Subject|4|||
164386569|NCT04537923|593786200|FG001|Overall Study|Withdrawal by Subject|4|||
164386570|NCT04537923|593786201|FG002|Overall Study|Withdrawal by Subject|4|||
164386571|NCT04537923|593786202|FG003|Overall Study|Withdrawal by Subject|58|||
164386572|NCT04537923|593786199|FG000|Overall Study|Missed study visits|2|||
164386573|NCT04537923|593786200|FG001|Overall Study|Missed study visits|0|||
164386574|NCT04537923|593786201|FG002|Overall Study|Missed study visits|0|||
164386575|NCT04537923|593786202|FG003|Overall Study|Missed study visits|3|||
164386576|NCT04537923|593786199|FG000|Overall Study|Sponsor's decision|0|||
164386577|NCT04537923|593786200|FG001|Overall Study|Sponsor's decision|0|||
164386578|NCT04537923|593786201|FG002|Overall Study|Sponsor's decision|1|||
164386579|NCT04537923|593786202|FG003|Overall Study|Sponsor's decision|1|||
164386580|NCT04537923|593786199|FG000|Overall Study|Safety reasons|1|||
164386581|NCT04537923|593786200|FG001|Overall Study|Safety reasons|0|||
164386582|NCT04537923|593786201|FG002|Overall Study|Safety reasons|0|||
164386583|NCT04537923|593786202|FG003|Overall Study|Safety reasons|0|||
164386584|NCT01261611|593786203|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
164386585|NCT01261611|593786204|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
164386586|NCT01261611|593786205|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
164386587|NCT01261611|593786203|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
164386588|NCT01261611|593786204|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
164386589|NCT01261611|593786205|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
164386590|NCT01261611|593786203|FG000|Treatment Cycle 1|Adverse Event|0|||
164386591|NCT01261611|593786204|FG001|Treatment Cycle 1|Adverse Event|1|||
164386592|NCT01261611|593786205|FG002|Treatment Cycle 1|Adverse Event|0|||
164386593|NCT01261611|593786203|FG000|Treatment Cycle 1|Protocol Violation|0|||
164386594|NCT01261611|593786204|FG001|Treatment Cycle 1|Protocol Violation|0|||
164015525|NCT00751881|592420155|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
164015526|NCT00751881|592420153|FG000|Extension Study Period|Other than specified above|26|||
164386595|NCT01261611|593786205|FG002|Treatment Cycle 1|Protocol Violation|2|||
164386596|NCT01261611|593786203|FG000|Treatment Cycle 2|Completed study|4|||
164386597|NCT01261611|593786204|FG001|Treatment Cycle 2|Completed study|0|||
164015527|NCT00751881|592420154|FG001|Extension Study Period|Other than specified above|30|||
164015528|NCT00751881|592420155|FG002|Extension Study Period|Other than specified above|18|||
164015529|NCT00866294|592420156|FG000|Overall Study|Adverse Event|12|||
164015530|NCT00866294|592420157|FG001|Overall Study|Adverse Event|13|||
164015531|NCT00866294|592420158|FG002|Overall Study|Adverse Event|9|||
164015532|NCT00866294|592420156|FG000|Overall Study|Lack of Efficacy|7|||
164015533|NCT00866294|592420157|FG001|Overall Study|Lack of Efficacy|1|||
164015534|NCT00866294|592420158|FG002|Overall Study|Lack of Efficacy|0|||
164015535|NCT00866294|592420156|FG000|Overall Study|Protocol Violation|2|||
164015536|NCT00866294|592420157|FG001|Overall Study|Protocol Violation|0|||
164015537|NCT00866294|592420158|FG002|Overall Study|Protocol Violation|0|||
164015538|NCT00866294|592420156|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
164015539|NCT00866294|592420157|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164015540|NCT00866294|592420158|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164015541|NCT00866294|592420156|FG000|Overall Study|Lost to Follow-up|1|||
164015542|NCT00866294|592420157|FG001|Overall Study|Lost to Follow-up|3|||
164015543|NCT00866294|592420158|FG002|Overall Study|Lost to Follow-up|0|||
164015544|NCT00866294|592420156|FG000|Overall Study|Physician Decision|6|||
164015545|NCT00866294|592420157|FG001|Overall Study|Physician Decision|2|||
164015546|NCT00866294|592420158|FG002|Overall Study|Physician Decision|1|||
164015547|NCT01651260|592420160|FG000|Overall Study|unable to apply product|3|||
164015548|NCT00530712|592420165|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
164015549|NCT00530712|592420165|FG000|30 Day Follow-up Visit|Missed Visit|5|||
164015550|NCT00530712|592420165|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
164015551|NCT00530712|592420165|FG000|6 Month Follow-up Visit|Missed Visit|3|||
164015552|NCT00530712|592420165|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
164015553|NCT00530712|592420165|FG000|6 Month Follow-up Visit|Death|2|||
164015554|NCT00530712|592420165|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
164015555|NCT00530712|592420165|FG000|12 Month Follow-up Visit|Missed Visit|3|||
164015556|NCT00530712|592420165|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
164015557|NCT00530712|592420165|FG000|12 Month Follow-up Visit|Death|9|||
164015558|NCT02749370|592420166|FG000|Overall Study|Withdrawal by Subject|11|||
164015559|NCT02749370|592420166|FG000|Overall Study|Lost to Follow-up|3|||
164015560|NCT03242759|592420171|FG000|Overall Study|Adverse Event|5|||
164015561|NCT03242759|592420172|FG001|Overall Study|Adverse Event|1|||
164015562|NCT03242759|592420171|FG000|Overall Study|Withdrawal by Subject|4|||
164015563|NCT03242759|592420172|FG001|Overall Study|Withdrawal by Subject|3|||
164015564|NCT03242759|592420171|FG000|Overall Study|Lost to Follow-up|3|||
164015565|NCT03242759|592420172|FG001|Overall Study|Lost to Follow-up|1|||
164015566|NCT03242759|592420171|FG000|Overall Study|Administrative problems|1|||
164015567|NCT03242759|592420172|FG001|Overall Study|Administrative problems|1|||
164015568|NCT03242759|592420171|FG000|Overall Study|Death|22|||
164015569|NCT03242759|592420172|FG001|Overall Study|Death|0|||
164015570|NCT03242759|592420171|FG000|Overall Study|Change visit schedule|0|||
164015571|NCT03242759|592420172|FG001|Overall Study|Change visit schedule|1|||
164015572|NCT00504166|592420177|FG000|Overall Study|Adverse Event|1|||
164015573|NCT00504166|592420178|FG001|Overall Study|Adverse Event|4|||
164015574|NCT00504166|592420177|FG000|Overall Study|Withdrawal by Subject|3|||
164015575|NCT00504166|592420178|FG001|Overall Study|Withdrawal by Subject|6|||
164015576|NCT00504166|592420177|FG000|Overall Study|Physician Decision|1|||
164015577|NCT00504166|592420178|FG001|Overall Study|Physician Decision|1|||
164015578|NCT00504166|592420177|FG000|Overall Study|Lost to Follow-up|1|||
164015579|NCT00504166|592420178|FG001|Overall Study|Lost to Follow-up|3|||
164015580|NCT00839098|592420179|FG000|Overall Study|Withdrawal by Subject|2|||
164015581|NCT00839098|592420180|FG001|Overall Study|Withdrawal by Subject|1|||
164386598|NCT01261611|593786205|FG002|Treatment Cycle 2|Completed study|0|||
164386599|NCT01261611|593786203|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
164386600|NCT01261611|593786204|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
164386601|NCT01261611|593786205|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
164386602|NCT01261611|593786203|FG000|Treatment Cycle 2|Adverse Event|1|||
164015582|NCT00839098|592420181|FG002|Overall Study|Withdrawal by Subject|7|||
164015583|NCT01345786|592420182|FG000|Overall Study|Adverse Event|0|||
164015584|NCT01345786|592420183|FG001|Overall Study|Adverse Event|1|||
164015585|NCT01345786|592420184|FG002|Overall Study|Adverse Event|3|||
164015586|NCT01345786|592420185|FG003|Overall Study|Adverse Event|1|||
164386603|NCT01261611|593786204|FG001|Treatment Cycle 2|Adverse Event|0|||
164386604|NCT01261611|593786205|FG002|Treatment Cycle 2|Adverse Event|0|||
164386605|NCT01261611|593786203|FG000|Treatment Cycle 2|Protocol Violation|2|||
164386606|NCT01261611|593786204|FG001|Treatment Cycle 2|Protocol Violation|0|||
164386607|NCT01261611|593786205|FG002|Treatment Cycle 2|Protocol Violation|0|||
164015587|NCT01345786|592420182|FG000|Overall Study|Subject withdrew consent|2|||
164015588|NCT01345786|592420183|FG001|Overall Study|Subject withdrew consent|2|||
164015589|NCT01345786|592420184|FG002|Overall Study|Subject withdrew consent|1|||
164015590|NCT01345786|592420185|FG003|Overall Study|Subject withdrew consent|0|||
164015591|NCT01345786|592420182|FG000|Overall Study|Noncompliance with protocol|1|||
164015592|NCT01345786|592420183|FG001|Overall Study|Noncompliance with protocol|0|||
164015593|NCT01345786|592420184|FG002|Overall Study|Noncompliance with protocol|1|||
164386608|NCT01261611|593786203|FG000|Treatment Cycle 2|Not otherwise specified|2|||
164386609|NCT01261611|593786204|FG001|Treatment Cycle 2|Not otherwise specified|0|||
164386610|NCT01261611|593786205|FG002|Treatment Cycle 2|Not otherwise specified|0|||
164386611|NCT01261611|593786203|FG000|Treatment Cycle 3|Completed study|24|||
164386612|NCT01261611|593786204|FG001|Treatment Cycle 3|Completed study|0|||
164386613|NCT01261611|593786205|FG002|Treatment Cycle 3|Completed study|0|||
164386614|NCT01261611|593786203|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
164386615|NCT01261611|593786204|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
164386616|NCT01261611|593786205|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
164386617|NCT01261611|593786203|FG000|Treatment Cycle 3|Adverse Event|1|||
164386618|NCT01261611|593786204|FG001|Treatment Cycle 3|Adverse Event|0|||
164386619|NCT01261611|593786205|FG002|Treatment Cycle 3|Adverse Event|0|||
164386620|NCT01261611|593786203|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
164386621|NCT01261611|593786204|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
164386622|NCT01261611|593786205|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
164386623|NCT01261611|593786203|FG000|Treatment Cycle 4|Completed study|87|||
164386624|NCT01261611|593786204|FG001|Treatment Cycle 4|Completed study|0|||
164386625|NCT01261611|593786205|FG002|Treatment Cycle 4|Completed study|0|||
164386626|NCT01261611|593786203|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
164386627|NCT01261611|593786204|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
164386628|NCT01261611|593786205|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
164386629|NCT01261611|593786203|FG000|Treatment Cycle 4|Adverse Event|1|||
164386630|NCT01261611|593786204|FG001|Treatment Cycle 4|Adverse Event|0|||
164386631|NCT01261611|593786205|FG002|Treatment Cycle 4|Adverse Event|0|||
164386632|NCT01261611|593786203|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
164386633|NCT01261611|593786204|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
164386634|NCT01261611|593786205|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
164386635|NCT01261611|593786203|FG000|Treatment Cycle 4|Not otherwise specified|3|||
164386636|NCT01261611|593786204|FG001|Treatment Cycle 4|Not otherwise specified|0|||
164015594|NCT01345786|592420185|FG003|Overall Study|Noncompliance with protocol|0|||
164015595|NCT01345786|592420182|FG000|Overall Study|Administrative|3|||
164015596|NCT01345786|592420183|FG001|Overall Study|Administrative|5|||
164015597|NCT01345786|592420184|FG002|Overall Study|Administrative|0|||
164015598|NCT01345786|592420185|FG003|Overall Study|Administrative|0|||
164015599|NCT01345786|592420182|FG000|Overall Study|Lost to Follow-up|0|||
164015600|NCT01345786|592420183|FG001|Overall Study|Lost to Follow-up|0|||
164015601|NCT01345786|592420184|FG002|Overall Study|Lost to Follow-up|0|||
164015602|NCT01345786|592420185|FG003|Overall Study|Lost to Follow-up|2|||
164015603|NCT02190435|592420186|FG000|Overall Study|First 12 patients were lead-ins|12|||
164015604|NCT02190435|592420187|FG001|Overall Study|First 12 patients were lead-ins|0|||
164015605|NCT02190435|592420186|FG000|Overall Study|3 consented screen fails|3|||
164015606|NCT02190435|592420187|FG001|Overall Study|3 consented screen fails|0|||
164015607|NCT02399475|592420196|FG000|Overall Study|Physician Decision|1|||
164015608|NCT02399475|592420197|FG001|Overall Study|Physician Decision|0|||
164015609|NCT02260193|592420198|FG000|Overall Study|Lack of Efficacy|0|||
164015610|NCT02260193|592420199|FG001|Overall Study|Lack of Efficacy|1|||
164015611|NCT02260193|592420200|FG002|Overall Study|Lack of Efficacy|6|||
164015612|NCT02260193|592420198|FG000|Overall Study|Adverse Event|3|||
164015613|NCT02260193|592420199|FG001|Overall Study|Adverse Event|4|||
164386637|NCT01261611|593786205|FG002|Treatment Cycle 4|Not otherwise specified|0|||
164386638|NCT01261611|593786203|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
164015614|NCT02260193|592420200|FG002|Overall Study|Adverse Event|1|||
164015615|NCT02260193|592420198|FG000|Overall Study|Protocol Violation|0|||
164015616|NCT02260193|592420199|FG001|Overall Study|Protocol Violation|4|||
164015617|NCT02260193|592420200|FG002|Overall Study|Protocol Violation|0|||
164015618|NCT02260193|592420198|FG000|Overall Study|Withdrawal by Subject|3|||
164015619|NCT02260193|592420199|FG001|Overall Study|Withdrawal by Subject|0|||
164015620|NCT02260193|592420200|FG002|Overall Study|Withdrawal by Subject|2|||
164015621|NCT02260193|592420198|FG000|Overall Study|Kidney Transplantation|0|||
164015622|NCT02260193|592420199|FG001|Overall Study|Kidney Transplantation|0|||
164015623|NCT02260193|592420200|FG002|Overall Study|Kidney Transplantation|1|||
164015624|NCT01963117|592420201|FG000|Overall Study|Death|1|||
164015625|NCT01070784|592420202|FG000|Overall Study|Withdrawal by Subject|6|||
164015626|NCT01070784|592420203|FG001|Overall Study|Withdrawal by Subject|9|||
164386639|NCT01261611|593786204|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
164386640|NCT01261611|593786205|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
164386641|NCT01261611|593786203|FG000|Treatment Cycle 5|Adverse Event|1|||
164386642|NCT01261611|593786204|FG001|Treatment Cycle 5|Adverse Event|0|||
164386643|NCT01261611|593786205|FG002|Treatment Cycle 5|Adverse Event|0|||
164386644|NCT01261611|593786203|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
164386645|NCT01261611|593786204|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
164386646|NCT01261611|593786205|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
164386647|NCT02527798|593786206|FG000|Overall Study|Physician Decision|1|||
164386648|NCT02527798|593786207|FG001|Overall Study|Physician Decision|0|||
164386649|NCT02527798|593786208|FG002|Overall Study|Physician Decision|1|||
164386650|NCT02527798|593786209|FG003|Overall Study|Physician Decision|1|||
164386651|NCT02527798|593786210|FG004|Overall Study|Physician Decision|0|||
164386652|NCT02527798|593786211|FG005|Overall Study|Physician Decision|0|||
164386653|NCT02527798|593786206|FG000|Overall Study|Death|0|||
164386654|NCT02527798|593786207|FG001|Overall Study|Death|0|||
164386655|NCT02527798|593786208|FG002|Overall Study|Death|1|||
164386656|NCT02527798|593786209|FG003|Overall Study|Death|0|||
164386657|NCT02527798|593786210|FG004|Overall Study|Death|0|||
164386658|NCT02527798|593786211|FG005|Overall Study|Death|0|||
164386659|NCT02527798|593786206|FG000|Overall Study|Withdrawal by Subject|0|||
164386660|NCT02527798|593786207|FG001|Overall Study|Withdrawal by Subject|1|||
164386661|NCT02527798|593786208|FG002|Overall Study|Withdrawal by Subject|2|||
164386662|NCT02527798|593786209|FG003|Overall Study|Withdrawal by Subject|0|||
164386663|NCT02527798|593786210|FG004|Overall Study|Withdrawal by Subject|0|||
164386664|NCT02527798|593786211|FG005|Overall Study|Withdrawal by Subject|0|||
164386665|NCT02527798|593786206|FG000|Overall Study|Reason undisclosed|1|||
164386666|NCT02527798|593786207|FG001|Overall Study|Reason undisclosed|0|||
164386667|NCT02527798|593786208|FG002|Overall Study|Reason undisclosed|1|||
164386668|NCT02527798|593786209|FG003|Overall Study|Reason undisclosed|0|||
164386669|NCT02527798|593786210|FG004|Overall Study|Reason undisclosed|0|||
164386670|NCT02527798|593786211|FG005|Overall Study|Reason undisclosed|0|||
164386671|NCT02527798|593786206|FG000|Overall Study|Did not receive intervention|1|||
164386672|NCT02527798|593786207|FG001|Overall Study|Did not receive intervention|1|||
164386673|NCT02527798|593786208|FG002|Overall Study|Did not receive intervention|0|||
164386674|NCT02527798|593786209|FG003|Overall Study|Did not receive intervention|0|||
164386675|NCT02527798|593786210|FG004|Overall Study|Did not receive intervention|0|||
164386676|NCT02527798|593786211|FG005|Overall Study|Did not receive intervention|0|||
164386677|NCT03859323|593786213|FG000|Overall Study|Lost to Follow-up|0|||
164386678|NCT03859323|593786214|FG001|Overall Study|Lost to Follow-up|0|||
164386679|NCT03859323|593786215|FG002|Overall Study|Lost to Follow-up|0|||
164386680|NCT03859323|593786216|FG003|Overall Study|Lost to Follow-up|0|||
164386681|NCT03859323|593786217|FG004|Overall Study|Lost to Follow-up|0|||
164386682|NCT03859323|593786218|FG005|Overall Study|Lost to Follow-up|0|||
164386683|NCT03859323|593786219|FG006|Overall Study|Lost to Follow-up|1|||
164386684|NCT03859323|593786220|FG007|Overall Study|Lost to Follow-up|0|||
164386685|NCT03859323|593786221|FG008|Overall Study|Lost to Follow-up|0|||
164386686|NCT03859323|593786222|FG009|Overall Study|Lost to Follow-up|0|||
164386687|NCT03859323|593786223|FG010|Overall Study|Lost to Follow-up|0|||
164386688|NCT03859323|593786224|FG011|Overall Study|Lost to Follow-up|0|||
164386689|NCT03859323|593786225|FG012|Overall Study|Lost to Follow-up|0|||
164386690|NCT03859323|593786213|FG000|Overall Study|Withdrawal by Subject|0|||
164386691|NCT03859323|593786214|FG001|Overall Study|Withdrawal by Subject|0|||
164386692|NCT03859323|593786215|FG002|Overall Study|Withdrawal by Subject|1|||
164386693|NCT03859323|593786216|FG003|Overall Study|Withdrawal by Subject|0|||
164386694|NCT03859323|593786217|FG004|Overall Study|Withdrawal by Subject|0|||
164386695|NCT03859323|593786218|FG005|Overall Study|Withdrawal by Subject|1|||
164386696|NCT03859323|593786219|FG006|Overall Study|Withdrawal by Subject|0|||
164386697|NCT03859323|593786220|FG007|Overall Study|Withdrawal by Subject|0|||
164386698|NCT03859323|593786221|FG008|Overall Study|Withdrawal by Subject|0|||
164386699|NCT03859323|593786222|FG009|Overall Study|Withdrawal by Subject|1|||
164386700|NCT03859323|593786223|FG010|Overall Study|Withdrawal by Subject|1|||
164386701|NCT03859323|593786224|FG011|Overall Study|Withdrawal by Subject|2|||
164386702|NCT03859323|593786225|FG012|Overall Study|Withdrawal by Subject|1|||
164386703|NCT03859323|593786213|FG000|Overall Study|Pregnancy|0|||
164386704|NCT03859323|593786214|FG001|Overall Study|Pregnancy|0|||
164386705|NCT03859323|593786215|FG002|Overall Study|Pregnancy|0|||
164386706|NCT03859323|593786216|FG003|Overall Study|Pregnancy|0|||
164386707|NCT03859323|593786217|FG004|Overall Study|Pregnancy|0|||
164386708|NCT03859323|593786218|FG005|Overall Study|Pregnancy|0|||
164386709|NCT03859323|593786219|FG006|Overall Study|Pregnancy|0|||
164386710|NCT03859323|593786220|FG007|Overall Study|Pregnancy|0|||
164386711|NCT03859323|593786221|FG008|Overall Study|Pregnancy|0|||
164386712|NCT03859323|593786222|FG009|Overall Study|Pregnancy|1|||
164386713|NCT03859323|593786223|FG010|Overall Study|Pregnancy|0|||
164386714|NCT03859323|593786224|FG011|Overall Study|Pregnancy|0|||
164386715|NCT03859323|593786225|FG012|Overall Study|Pregnancy|0|||
164386716|NCT01682460|593786227|FG000|Overall Study|Withdrawal by Subject|2|||
164386717|NCT01682460|593786227|FG000|Overall Study|Did not meet inclusion criteria|2|||
164386718|NCT02053350|593786231|FG000|Overall Study|Withdrawal by Subject|1|||
164386719|NCT02053350|593786231|FG000|Overall Study|Adverse Event|4|||
164386720|NCT01275625|593786232|FG000|Overall Study|Death|1|||
164386721|NCT01275625|593786232|FG000|Overall Study|Lack of Efficacy|2|||
164386722|NCT01275625|593786232|FG000|Overall Study|Lost to Follow-up|1|||
164386723|NCT01275625|593786232|FG000|Overall Study|Withdrawal by Subject|3|||
164386724|NCT01275625|593786232|FG000|Overall Study|Protocol Violation|1|||
164386725|NCT01275625|593786232|FG000|Overall Study|Adverse Event|4|||
164386726|NCT01275625|593786232|FG000|Overall Study|Other|1|||
164386727|NCT01585103|593786234|FG000|Overall Study|Unable to swallow Cytosponge|6|||
164386728|NCT03521635|593786235|FG000|Overall Study|Adverse Event|1|||
164386729|NCT03521635|593786236|FG001|Overall Study|Adverse Event|1|||
164386730|NCT03521635|593786235|FG000|Overall Study|Refused to complete study visit|1|||
164386731|NCT03521635|593786236|FG001|Overall Study|Refused to complete study visit|0|||
164386732|NCT03521635|593786235|FG000|Overall Study|Refused to continue trial medication|2|||
164386733|NCT03521635|593786236|FG001|Overall Study|Refused to continue trial medication|2|||
164386734|NCT03521635|593786235|FG000|Overall Study|Lost to Follow-up|0|||
164386735|NCT03521635|593786236|FG001|Overall Study|Lost to Follow-up|1|||
164386736|NCT03521635|593786235|FG000|Overall Study|Meet exclusion criteria|0|||
164386737|NCT03521635|593786236|FG001|Overall Study|Meet exclusion criteria|1|||
164386738|NCT03521635|593786235|FG000|Overall Study|Patient not taken study medicine|0|||
164386739|NCT03521635|593786236|FG001|Overall Study|Patient not taken study medicine|1|||
164386740|NCT01349569|593786237|FG000|Overall Study|Lack of Efficacy|4|||
164386741|NCT03581305|593786238|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
164386742|NCT03581305|593786239|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
164386743|NCT03581305|593786238|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
164386744|NCT03581305|593786239|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
164386745|NCT03581305|593786238|FG000|Serotonergic Study|Withdrawal by Subject|5|||
164386746|NCT03581305|593786239|FG001|Serotonergic Study|Withdrawal by Subject|1|||
163903828|NCT01555138|592018770|FG001|Overall Study|Adverse Event|14|||
163903829|NCT03220724|592018772|FG000|Overall Study|Lost to Follow-up|2|||
163903830|NCT03220724|592018773|FG001|Overall Study|Lost to Follow-up|2|||
163903831|NCT03220724|592018774|FG002|Overall Study|Lost to Follow-up|0|||
163903832|NCT03220724|592018775|FG003|Overall Study|Lost to Follow-up|3|||
163903833|NCT03220724|592018776|FG004|Overall Study|Lost to Follow-up|1|||
163903834|NCT03220724|592018777|FG005|Overall Study|Lost to Follow-up|0|||
163903835|NCT03220724|592018778|FG006|Overall Study|Lost to Follow-up|2|||
163903836|NCT03220724|592018779|FG007|Overall Study|Lost to Follow-up|1|||
163903837|NCT03220724|592018780|FG008|Overall Study|Lost to Follow-up|0|||
163903838|NCT03220724|592018772|FG000|Overall Study|Withdrawal by Subject|1|||
163903839|NCT03220724|592018773|FG001|Overall Study|Withdrawal by Subject|0|||
163903840|NCT03220724|592018774|FG002|Overall Study|Withdrawal by Subject|1|||
163903841|NCT03220724|592018775|FG003|Overall Study|Withdrawal by Subject|0|||
163903842|NCT03220724|592018776|FG004|Overall Study|Withdrawal by Subject|0|||
163903843|NCT03220724|592018777|FG005|Overall Study|Withdrawal by Subject|0|||
163903844|NCT03220724|592018778|FG006|Overall Study|Withdrawal by Subject|0|||
163903845|NCT03220724|592018779|FG007|Overall Study|Withdrawal by Subject|0|||
163903846|NCT03220724|592018780|FG008|Overall Study|Withdrawal by Subject|0|||
163903847|NCT01613417|592018783|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
163903848|NCT01613417|592018784|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
163903849|NCT00047385|592018785|FG000|Overall Study|Death before any screening|2|||
163903850|NCT00047385|592018786|FG001|Overall Study|Death before any screening|5|||
163903851|NCT00047385|592018785|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
163903852|NCT00047385|592018786|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
163903853|NCT00047385|592018785|FG000|Overall Study|Eligible for screening but had no screen|260|||
163903854|NCT00047385|592018786|FG001|Overall Study|Eligible for screening but had no screen|492|||
163903855|NCT03865732|592018787|FG000|Overall Study|Adverse Event|0|||
163903856|NCT03865732|592018788|FG001|Overall Study|Adverse Event|1|||
163903857|NCT00454194|592018789|FG000|Overall Study|Adverse Event|7|||
164386747|NCT01747772|593786240|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
164386748|NCT02244944|593786241|FG000|Overall Study|Withdrawal by Subject|1|||
164386749|NCT02244944|593786241|FG000|Overall Study|Study Terminated|1|||
164386750|NCT01003899|593786244|FG000|Overall Study|Other Adverse Event|8|||
164386751|NCT01003899|593786244|FG000|Overall Study|Not entered|4|||
164386752|NCT01003899|593786244|FG000|Overall Study|Not treated|1|||
164386753|NCT01003899|593786244|FG000|Overall Study|Progressive disease|34|||
164386754|NCT04969783|593786245|FG000|Overall Study|Lost to Follow-up|2|||
164386755|NCT04969783|593786246|FG001|Overall Study|Lost to Follow-up|0|||
164386756|NCT04969783|593786245|FG000|Overall Study|Withdrawal by Subject|4|||
164386757|NCT04969783|593786246|FG001|Overall Study|Withdrawal by Subject|0|||
164386758|NCT04969783|593786245|FG000|Overall Study|Physician Decision|6|||
164386759|NCT04969783|593786246|FG001|Overall Study|Physician Decision|0|||
164386760|NCT02489500|593786247|FG000|Overall Study|Death|1|||
164386761|NCT02489500|593786248|FG001|Overall Study|Death|1|||
164386762|NCT00987467|593786253|FG000|Overall Study|Lost to Follow-up|2|||
164386763|NCT00512135|593786254|FG000|Overall Study|Not Treated|5|||
164386764|NCT00512135|593786254|FG000|Overall Study|Lack of Efficacy|2|||
164386765|NCT00512135|593786254|FG000|Overall Study|Adverse Event|6|||
164386766|NCT00512135|593786254|FG000|Overall Study|Withdrawal by Subject|22|||
164386767|NCT00512135|593786254|FG000|Overall Study|Lost to Follow-up|27|||
164386768|NCT00512135|593786254|FG000|Overall Study|Other|22|||
164386769|NCT00262834|593786255|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
164386770|NCT00262834|593786256|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
164386771|NCT03422250|593786257|FG000|Intervention|Adverse Event|0|||
164386772|NCT03422250|593786258|FG001|Intervention|Adverse Event|1|||
164386773|NCT03422250|593786259|FG002|Intervention|Adverse Event|0|||
164386774|NCT03422250|593786260|FG003|Intervention|Adverse Event|1|||
164386775|NCT03422250|593786257|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
164386776|NCT03422250|593786258|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
164386777|NCT03422250|593786259|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
164386778|NCT03422250|593786260|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
164386779|NCT03422250|593786257|FG000|Follow-up|Withdrawal by Subject|0|||
164386780|NCT03422250|593786258|FG001|Follow-up|Withdrawal by Subject|0|||
164386781|NCT03422250|593786259|FG002|Follow-up|Withdrawal by Subject|0|||
164386782|NCT03422250|593786260|FG003|Follow-up|Withdrawal by Subject|1|||
164386783|NCT03422250|593786257|FG000|Follow-up|Adverse Event|0|||
164386784|NCT03422250|593786258|FG001|Follow-up|Adverse Event|0|||
164386785|NCT03422250|593786259|FG002|Follow-up|Adverse Event|0|||
164386786|NCT03422250|593786260|FG003|Follow-up|Adverse Event|1|||
164386787|NCT00377819|593786263|FG000|Overall Study|Adverse Event|2|||
164386788|NCT00377819|593786264|FG001|Overall Study|Adverse Event|3|||
164386789|NCT00377819|593786263|FG000|Overall Study|Withdrawal by Subject|10|||
164386790|NCT00377819|593786264|FG001|Overall Study|Withdrawal by Subject|4|||
164386791|NCT00377819|593786263|FG000|Overall Study|Death|0|||
164386792|NCT00377819|593786264|FG001|Overall Study|Death|1|||
164386793|NCT00377819|593786263|FG000|Overall Study|Lost to Follow-up|0|||
164386794|NCT00377819|593786264|FG001|Overall Study|Lost to Follow-up|1|||
164386795|NCT00377819|593786263|FG000|Overall Study|Protocol Violation|1|||
164386796|NCT00377819|593786264|FG001|Overall Study|Protocol Violation|1|||
164386797|NCT02416791|593786265|FG000|6 Months|Lost to Follow-up|0|||
163903858|NCT00454194|592018790|FG001|Overall Study|Adverse Event|2|||
163903859|NCT00454194|592018789|FG000|Overall Study|Withdrawal by Subject|12|||
163903860|NCT00454194|592018790|FG001|Overall Study|Withdrawal by Subject|8|||
164092987|NCT00454636|592703434|FG002|Overall Study|Disease Progression|4|||
164386798|NCT02416791|593786266|FG001|6 Months|Lost to Follow-up|0|||
163903861|NCT00454194|592018789|FG000|Overall Study|Other Medical Problems|1|||
164386799|NCT02416791|593786267|FG002|6 Months|Lost to Follow-up|1|||
164386800|NCT01054820|593786268|FG000|Overall Study|Withdrawal by Subject|2|||
164386801|NCT00467870|593786269|FG000|Overall Study|Adverse Event|13|||
164386802|NCT00467870|593786270|FG001|Overall Study|Adverse Event|9|||
164386803|NCT00467870|593786271|FG002|Overall Study|Adverse Event|1|||
164386804|NCT00467870|593786272|FG003|Overall Study|Adverse Event|15|||
164386805|NCT00467870|593786273|FG004|Overall Study|Adverse Event|15|||
164386806|NCT00467870|593786274|FG005|Overall Study|Adverse Event|1|||
163903862|NCT00454194|592018790|FG001|Overall Study|Other Medical Problems|2|||
163903863|NCT00454194|592018789|FG000|Overall Study|Other Unspecified Reason|2|||
164386807|NCT00467870|593786269|FG000|Overall Study|Protocol Violation|2|||
164386808|NCT00467870|593786270|FG001|Overall Study|Protocol Violation|1|||
164092988|NCT00454636|592703435|FG003|Overall Study|Disease Progression|11|||
164386809|NCT00467870|593786271|FG002|Overall Study|Protocol Violation|1|||
164386810|NCT00467870|593786272|FG003|Overall Study|Protocol Violation|2|||
164386811|NCT00467870|593786273|FG004|Overall Study|Protocol Violation|0|||
164386812|NCT00467870|593786274|FG005|Overall Study|Protocol Violation|0|||
164386813|NCT00467870|593786269|FG000|Overall Study|Withdrawal by Subject|14|||
164386814|NCT00467870|593786270|FG001|Overall Study|Withdrawal by Subject|21|||
164386815|NCT00467870|593786271|FG002|Overall Study|Withdrawal by Subject|0|||
164386816|NCT00467870|593786272|FG003|Overall Study|Withdrawal by Subject|9|||
164386817|NCT00467870|593786273|FG004|Overall Study|Withdrawal by Subject|10|||
164386818|NCT00467870|593786274|FG005|Overall Study|Withdrawal by Subject|1|||
164386819|NCT00467870|593786269|FG000|Overall Study|Lost to Follow-up|5|||
164386820|NCT00467870|593786270|FG001|Overall Study|Lost to Follow-up|3|||
164386821|NCT00467870|593786271|FG002|Overall Study|Lost to Follow-up|1|||
164386822|NCT00467870|593786272|FG003|Overall Study|Lost to Follow-up|1|||
164386823|NCT00467870|593786273|FG004|Overall Study|Lost to Follow-up|3|||
164386824|NCT00467870|593786274|FG005|Overall Study|Lost to Follow-up|0|||
164386825|NCT00467870|593786269|FG000|Overall Study|Subject Non-compliance|3|||
164386826|NCT00467870|593786270|FG001|Overall Study|Subject Non-compliance|4|||
164386827|NCT00467870|593786271|FG002|Overall Study|Subject Non-compliance|0|||
164386828|NCT00467870|593786272|FG003|Overall Study|Subject Non-compliance|1|||
164386829|NCT00467870|593786273|FG004|Overall Study|Subject Non-compliance|5|||
164386830|NCT00467870|593786274|FG005|Overall Study|Subject Non-compliance|0|||
164386831|NCT00467870|593786269|FG000|Overall Study|Other/Unknown|8|||
164386832|NCT00467870|593786270|FG001|Overall Study|Other/Unknown|5|||
164386833|NCT00467870|593786271|FG002|Overall Study|Other/Unknown|1|||
164386834|NCT00467870|593786272|FG003|Overall Study|Other/Unknown|5|||
164386835|NCT00467870|593786273|FG004|Overall Study|Other/Unknown|4|||
164386836|NCT00467870|593786274|FG005|Overall Study|Other/Unknown|0|||
164386837|NCT02239679|593786275|FG000|Overall Study|Lost to Follow-up|1|||
164386838|NCT02239679|593786276|FG001|Overall Study|Lost to Follow-up|0|||
164386839|NCT02239679|593786277|FG002|Overall Study|Lost to Follow-up|0|||
164386840|NCT02239679|593786275|FG000|Overall Study|Withdrawal by Subject|2|||
164386841|NCT02239679|593786276|FG001|Overall Study|Withdrawal by Subject|3|||
164386842|NCT02239679|593786277|FG002|Overall Study|Withdrawal by Subject|1|||
164386843|NCT01917526|593786278|FG000|Overall Study|Protocol Violation|1|||
164386844|NCT01917526|593786279|FG001|Overall Study|Protocol Violation|1|||
164386845|NCT00760929|593786283|FG000|Overall Study|Adverse Event|2|||
164386846|NCT00760929|593786284|FG001|Overall Study|Adverse Event|0|||
164386847|NCT00760929|593786285|FG002|Overall Study|Adverse Event|6|||
164386848|NCT00760929|593786286|FG003|Overall Study|Adverse Event|10|||
164386849|NCT00760929|593786283|FG000|Overall Study|Lack of Efficacy|0|||
164386850|NCT00760929|593786284|FG001|Overall Study|Lack of Efficacy|2|||
164386851|NCT00760929|593786285|FG002|Overall Study|Lack of Efficacy|1|||
164386852|NCT00760929|593786286|FG003|Overall Study|Lack of Efficacy|0|||
164386853|NCT00760929|593786283|FG000|Overall Study|Withdrawal by Subject|1|||
164386854|NCT00760929|593786284|FG001|Overall Study|Withdrawal by Subject|0|||
164386855|NCT00760929|593786285|FG002|Overall Study|Withdrawal by Subject|9|||
164386856|NCT00760929|593786286|FG003|Overall Study|Withdrawal by Subject|1|||
164386857|NCT00760929|593786283|FG000|Overall Study|Lost to Follow-up|0|||
164386858|NCT00760929|593786284|FG001|Overall Study|Lost to Follow-up|0|||
164386859|NCT00760929|593786285|FG002|Overall Study|Lost to Follow-up|1|||
164386860|NCT00760929|593786286|FG003|Overall Study|Lost to Follow-up|0|||
164386861|NCT00760929|593786283|FG000|Overall Study|Progression of Disease|21|||
164386862|NCT00760929|593786284|FG001|Overall Study|Progression of Disease|26|||
164386863|NCT00760929|593786285|FG002|Overall Study|Progression of Disease|38|||
164386864|NCT00760929|593786286|FG003|Overall Study|Progression of Disease|42|||
164386865|NCT00760929|593786283|FG000|Overall Study|Other|2|||
164386866|NCT00760929|593786284|FG001|Overall Study|Other|0|||
164386867|NCT00760929|593786285|FG002|Overall Study|Other|2|||
164092989|NCT00454636|592703432|FG000|Overall Study|Protocol Violation|3|||
164386868|NCT00760929|593786286|FG003|Overall Study|Other|1|||
164386869|NCT00760929|593786283|FG000|Overall Study|Death|0|||
164386870|NCT00760929|593786284|FG001|Overall Study|Death|0|||
164386871|NCT00760929|593786285|FG002|Overall Study|Death|1|||
164386872|NCT00760929|593786286|FG003|Overall Study|Death|0|||
164386873|NCT00760929|593786283|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164386874|NCT00760929|593786284|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164386875|NCT00760929|593786285|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
164092990|NCT00454636|592703433|FG001|Overall Study|Protocol Violation|2|||
164386876|NCT00760929|593786286|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
164386877|NCT02099838|593786287|FG000|Overall Study|Death|1|||
164386878|NCT02099838|593786288|FG001|Overall Study|Death|0|||
164386879|NCT02099838|593786287|FG000|Overall Study|Lost to Follow-up|3|||
164386880|NCT02099838|593786288|FG001|Overall Study|Lost to Follow-up|1|||
164386881|NCT02099838|593786287|FG000|Overall Study|Withdrawal by Subject|0|||
164386882|NCT02099838|593786288|FG001|Overall Study|Withdrawal by Subject|1|||
164386883|NCT04121962|593786289|FG000|Overall Study|Lost to Follow-up|42|||
164386884|NCT04121962|593786290|FG001|Overall Study|Lost to Follow-up|39|||
164386885|NCT01175382|593786291|FG000|Overall Study|Lost to Follow-up|4|||
164386886|NCT01175382|593786292|FG001|Overall Study|Lost to Follow-up|3|||
164386887|NCT01175382|593786293|FG002|Overall Study|Lost to Follow-up|1|||
164386888|NCT01175382|593786291|FG000|Overall Study|Physician Decision|0|||
164386889|NCT01175382|593786292|FG001|Overall Study|Physician Decision|1|||
164386890|NCT01175382|593786293|FG002|Overall Study|Physician Decision|0|||
164386891|NCT01175382|593786291|FG000|Overall Study|Withdrawal by Subject|0|||
164386892|NCT01175382|593786292|FG001|Overall Study|Withdrawal by Subject|0|||
163903864|NCT00454194|592018790|FG001|Overall Study|Other Unspecified Reason|2|||
164386893|NCT01175382|593786293|FG002|Overall Study|Withdrawal by Subject|1|||
163903865|NCT02095145|592018793|FG000|Overall Study|Withdrawal by Subject|1|||
163903866|NCT02095145|592018794|FG001|Overall Study|Withdrawal by Subject|0|||
163903867|NCT02085941|592018797|FG000|Overall Study|Lack of Efficacy|1|||
163903868|NCT02085941|592018798|FG001|Overall Study|Lack of Efficacy|0|||
163903869|NCT02085941|592018797|FG000|Overall Study|Death|6|||
163903870|NCT02085941|592018798|FG001|Overall Study|Death|1|||
163903871|NCT02085941|592018797|FG000|Overall Study|Lost to Follow-up|1|||
163903872|NCT02085941|592018798|FG001|Overall Study|Lost to Follow-up|0|||
163903873|NCT02085941|592018797|FG000|Overall Study|Physician Decision|0|||
163903874|NCT02085941|592018798|FG001|Overall Study|Physician Decision|2|||
163903875|NCT00229658|592018807|FG000|Overall Study|Administrative|2|||
163903876|NCT00229658|592018808|FG001|Overall Study|Administrative|1|||
163903877|NCT00229658|592018807|FG000|Overall Study|Investigator decision|13|||
163903878|NCT00229658|592018808|FG001|Overall Study|Investigator decision|10|||
163903879|NCT00229658|592018807|FG000|Overall Study|Other|80|||
163903880|NCT00229658|592018808|FG001|Overall Study|Other|60|||
163903881|NCT00229658|592018807|FG000|Overall Study|Lost to Follow-up|82|||
164386894|NCT01175382|593786291|FG000|Overall Study|No longer having problem|1|||
164386895|NCT01175382|593786292|FG001|Overall Study|No longer having problem|0|||
164386896|NCT01175382|593786293|FG002|Overall Study|No longer having problem|1|||
164386897|NCT01175382|593786291|FG000|Overall Study|Unable/unwilling to attend visits|3|||
164386898|NCT01175382|593786292|FG001|Overall Study|Unable/unwilling to attend visits|1|||
164386899|NCT01175382|593786293|FG002|Overall Study|Unable/unwilling to attend visits|2|||
164386900|NCT01175382|593786291|FG000|Overall Study|Unwilling to follow protocol|0|||
164386901|NCT01175382|593786292|FG001|Overall Study|Unwilling to follow protocol|1|||
164386902|NCT01175382|593786293|FG002|Overall Study|Unwilling to follow protocol|0|||
164386903|NCT01175382|593786291|FG000|Overall Study|Unable to tolerate study meds|0|||
164386904|NCT01175382|593786292|FG001|Overall Study|Unable to tolerate study meds|1|||
164386905|NCT01175382|593786293|FG002|Overall Study|Unable to tolerate study meds|1|||
164386906|NCT00774787|593786294|FG000|Overall Study|Lost to Follow-up|1|||
164386907|NCT04535037|593786295|FG000|Overall Study|Protocol Violation|1|||
164386908|NCT04535037|593786296|FG001|Overall Study|Protocol Violation|0|||
164386909|NCT04535037|593786295|FG000|Overall Study|Withdrawal by Subject|8|||
164386910|NCT04535037|593786296|FG001|Overall Study|Withdrawal by Subject|9|||
164386911|NCT04535037|593786295|FG000|Overall Study|Migrated / moved from the study area|1|||
164386912|NCT04535037|593786296|FG001|Overall Study|Migrated / moved from the study area|4|||
164386913|NCT04535037|593786295|FG000|Overall Study|Other|2|||
164386914|NCT04535037|593786296|FG001|Overall Study|Other|5|||
164386915|NCT02031276|593786297|FG000|Period 1 Double-blind IV|Adverse Event|6|||
164386916|NCT02031276|593786298|FG001|Period 1 Double-blind IV|Adverse Event|5|||
164386917|NCT02031276|593786299|FG002|Period 1 Double-blind IV|Adverse Event|1|||
164386918|NCT02031276|593786297|FG000|Period 1 Double-blind IV|Other|0|||
164386919|NCT02031276|593786298|FG001|Period 1 Double-blind IV|Other|1|||
164386920|NCT02031276|593786299|FG002|Period 1 Double-blind IV|Other|0|||
164386921|NCT02031276|593786297|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
164386922|NCT02031276|593786298|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
164386923|NCT02031276|593786299|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
164386924|NCT02031276|593786297|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
164386925|NCT02031276|593786298|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
164386926|NCT02031276|593786299|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
164386927|NCT02031276|593786297|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
164386928|NCT02031276|593786298|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
164386929|NCT02031276|593786299|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
164386930|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
164386931|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
164386932|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
164386933|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
164386934|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
164386935|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
164386936|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
164386937|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
164386938|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
163903882|NCT00229658|592018808|FG001|Overall Study|Lost to Follow-up|55|||
163903883|NCT00229658|592018807|FG000|Overall Study|Serious Adverse Event|2|||
163903884|NCT00229658|592018808|FG001|Overall Study|Serious Adverse Event|2|||
164386939|NCT02031276|593786297|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
164386940|NCT02031276|593786298|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
164386941|NCT02031276|593786299|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
164386942|NCT00765245|593786301|FG000|Overall Study|disease progression|3|||
164386943|NCT00765245|593786302|FG001|Overall Study|disease progression|2|||
164386944|NCT00765245|593786301|FG000|Overall Study|Withdrawal by Subject|3|||
164386945|NCT00765245|593786302|FG001|Overall Study|Withdrawal by Subject|0|||
163903885|NCT00229658|592018807|FG000|Overall Study|Withdrawal of consent|46|||
163903886|NCT00229658|592018808|FG001|Overall Study|Withdrawal of consent|39|||
163903887|NCT00093496|592018809|FG000|Overall Study|Protocol Violation|1|||
163903888|NCT00093496|592018810|FG001|Overall Study|Protocol Violation|3|||
163903889|NCT01953224|592018811|FG000|Overall Study|Lost to Follow-up|1|||
164015627|NCT01070784|592420202|FG000|Overall Study|Adverse Event|14|||
164015628|NCT01070784|592420203|FG001|Overall Study|Adverse Event|9|||
164015629|NCT01780389|592420204|FG000|Overall Study|Adverse Event|1|||
164015630|NCT00935220|592420205|FG000|Overall Study|Adverse Event|1|||
164015631|NCT00935220|592420205|FG000|Overall Study|Other reason (not specified)|1|||
164015632|NCT01095250|592420206|FG000|Overall Study|administrative reasons|8|||
164015633|NCT01095250|592420207|FG001|Overall Study|administrative reasons|10|||
164015634|NCT01095250|592420208|FG002|Overall Study|administrative reasons|7|||
164015635|NCT01095250|592420209|FG003|Overall Study|administrative reasons|5|||
164015636|NCT01095250|592420206|FG000|Overall Study|Withdrawal by Subject|0|||
164015637|NCT01095250|592420207|FG001|Overall Study|Withdrawal by Subject|0|||
164015638|NCT01095250|592420208|FG002|Overall Study|Withdrawal by Subject|1|||
164015639|NCT01095250|592420209|FG003|Overall Study|Withdrawal by Subject|0|||
164015640|NCT01000064|592420210|FG000|Overall Study|Withdrawal by Subject|1|||
164015641|NCT01000064|592420211|FG001|Overall Study|Withdrawal by Subject|1|||
164015642|NCT02518620|592420212|FG000|Overall Study|Adverse Event|23|||
164015643|NCT02518620|592420213|FG001|Overall Study|Adverse Event|11|||
164015644|NCT02518620|592420212|FG000|Overall Study|Lack of Efficacy|2|||
164015645|NCT02518620|592420213|FG001|Overall Study|Lack of Efficacy|0|||
164015646|NCT02518620|592420212|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164015647|NCT02518620|592420213|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164015648|NCT02518620|592420212|FG000|Overall Study|Physician Decision|1|||
164015649|NCT02518620|592420213|FG001|Overall Study|Physician Decision|1|||
164015650|NCT02518620|592420212|FG000|Overall Study|Sponsor's Decision|0|||
164015651|NCT02518620|592420213|FG001|Overall Study|Sponsor's Decision|3|||
164015652|NCT02518620|592420212|FG000|Overall Study|Lost to Follow-up|1|||
164015653|NCT02518620|592420213|FG001|Overall Study|Lost to Follow-up|1|||
164015654|NCT02518620|592420212|FG000|Overall Study|Withdrawal by Subject|17|||
164015655|NCT02518620|592420213|FG001|Overall Study|Withdrawal by Subject|9|||
164015656|NCT02518620|592420212|FG000|Overall Study|Death|1|||
164015657|NCT02518620|592420213|FG001|Overall Study|Death|0|||
164015658|NCT02518620|592420212|FG000|Overall Study|Pregnancy Wish|3|||
164015659|NCT02518620|592420213|FG001|Overall Study|Pregnancy Wish|0|||
164015660|NCT02518620|592420212|FG000|Overall Study|Pregnancy|1|||
164015661|NCT02518620|592420213|FG001|Overall Study|Pregnancy|0|||
164015662|NCT02518620|592420212|FG000|Overall Study|Relocation|2|||
164015663|NCT02518620|592420213|FG001|Overall Study|Relocation|1|||
164015664|NCT01415440|592420217|FG000|Overall Study|Lost to Follow-up|0|||
164015665|NCT01415440|592420218|FG001|Overall Study|Lost to Follow-up|1|||
164015666|NCT01415440|592420219|FG002|Overall Study|Lost to Follow-up|2|||
164015667|NCT01415440|592420217|FG000|Overall Study|Physician Decision|3|||
164015668|NCT01415440|592420218|FG001|Overall Study|Physician Decision|0|||
164015669|NCT01415440|592420219|FG002|Overall Study|Physician Decision|0|||
164015670|NCT01415440|592420217|FG000|Overall Study|Withdrawal by Subject|1|||
164015671|NCT01415440|592420218|FG001|Overall Study|Withdrawal by Subject|0|||
164015672|NCT01415440|592420219|FG002|Overall Study|Withdrawal by Subject|0|||
164015673|NCT00227877|592420220|FG000|Pre-visit Assessment|Technical difficulties|7|||
164015674|NCT00227877|592420221|FG001|Pre-visit Assessment|Technical difficulties|3|||
164015675|NCT00227877|592420222|FG002|Pre-visit Assessment|Technical difficulties|0|||
164015676|NCT00227877|592420223|FG003|Pre-visit Assessment|Technical difficulties|0|||
164015677|NCT00227877|592420220|FG000|Post-visit Checklist|Lost to Follow-up|24|||
164015678|NCT00227877|592420221|FG001|Post-visit Checklist|Lost to Follow-up|13|||
164015679|NCT00227877|592420222|FG002|Post-visit Checklist|Lost to Follow-up|1|||
164015680|NCT00227877|592420223|FG003|Post-visit Checklist|Lost to Follow-up|0|||
164015681|NCT00227877|592420220|FG000|3-months Follow-up|Completed late|135|||
164015682|NCT00227877|592420221|FG001|3-months Follow-up|Completed late|128|||
164386946|NCT00765245|593786301|FG000|Overall Study|Adverse Event|5|||
164386947|NCT00765245|593786302|FG001|Overall Study|Adverse Event|0|||
164386948|NCT00765245|593786301|FG000|Overall Study|Physician Decision|1|||
164386949|NCT00765245|593786302|FG001|Overall Study|Physician Decision|0|||
164386950|NCT00765245|593786301|FG000|Overall Study|Death|1|||
164386951|NCT00765245|593786302|FG001|Overall Study|Death|0|||
164386952|NCT04408469|593786308|FG000|Overall Study|Lost to Follow-up|6|||
164386953|NCT04408469|593786309|FG001|Overall Study|Lost to Follow-up|9|||
164386954|NCT04408469|593786308|FG000|Overall Study|Withdrawal by Subject|6|||
164386955|NCT04408469|593786309|FG001|Overall Study|Withdrawal by Subject|1|||
164386956|NCT04408469|593786308|FG000|Overall Study|Dismissal due to ineligibility|0|||
164386957|NCT04408469|593786309|FG001|Overall Study|Dismissal due to ineligibility|1|||
164386958|NCT04321460|593786310|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
164386959|NCT04321460|593786311|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
164386960|NCT03669081|593786314|FG000|Overall Study|Data could not be validated|1|||
164386961|NCT03669081|593786315|FG001|Overall Study|Data could not be validated|1|||
164386962|NCT01308749|593786320|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
164386963|NCT01308749|593786321|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
164386964|NCT01308749|593786320|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
164015683|NCT00227877|592420222|FG002|3-months Follow-up|Completed late|34|||
164015684|NCT00227877|592420223|FG003|3-months Follow-up|Completed late|8|||
164386965|NCT01308749|593786321|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
164386966|NCT01308749|593786320|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
164386967|NCT01308749|593786321|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
164386968|NCT02546544|593786322|FG000|Overall Study|Disease Progression|14|||
164386969|NCT02546544|593786322|FG000|Overall Study|Adverse Event|1|||
164386970|NCT02546544|593786322|FG000|Overall Study|Withdrawal by Subject|1|||
164386971|NCT02223390|593786323|FG000|Overall Study|Lost to Follow-up|9|||
164386972|NCT02223390|593786324|FG001|Overall Study|Lost to Follow-up|4|||
164386973|NCT01197950|593786328|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
164386974|NCT01197950|593786329|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
164386975|NCT01197950|593786330|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
164386976|NCT02553330|593786331|FG000|Overall Study|Study Terminated by Sponsor|2|||
164386977|NCT02553330|593786332|FG001|Overall Study|Study Terminated by Sponsor|13|||
164386978|NCT02553330|593786333|FG002|Overall Study|Study Terminated by Sponsor|12|||
164386979|NCT02553330|593786331|FG000|Overall Study|Withdrawal by Subject|3|||
164386980|NCT02553330|593786332|FG001|Overall Study|Withdrawal by Subject|19|||
164386981|NCT02553330|593786333|FG002|Overall Study|Withdrawal by Subject|21|||
164386982|NCT02553330|593786331|FG000|Overall Study|Other|0|||
164386983|NCT02553330|593786332|FG001|Overall Study|Other|1|||
164386984|NCT02553330|593786333|FG002|Overall Study|Other|0|||
164386985|NCT02553330|593786331|FG000|Overall Study|Non compliance to study treatment|0|||
164386986|NCT02553330|593786332|FG001|Overall Study|Non compliance to study treatment|1|||
164386987|NCT02553330|593786333|FG002|Overall Study|Non compliance to study treatment|0|||
164386988|NCT02553330|593786331|FG000|Overall Study|Adverse Event|0|||
164386989|NCT02553330|593786332|FG001|Overall Study|Adverse Event|1|||
164386990|NCT02553330|593786333|FG002|Overall Study|Adverse Event|0|||
164386991|NCT02553330|593786331|FG000|Overall Study|Lost to Follow-up|0|||
164386992|NCT02553330|593786332|FG001|Overall Study|Lost to Follow-up|4|||
164386993|NCT02553330|593786333|FG002|Overall Study|Lost to Follow-up|4|||
164386994|NCT01666002|593786334|FG000|Overall Study|Lost to Follow-up|5|||
164386995|NCT01666002|593786335|FG001|Overall Study|Lost to Follow-up|0|||
164386996|NCT02511431|593786336|FG000|Treatment|Lost to Follow-up|0|||
164386997|NCT02511431|593786337|FG001|Treatment|Lost to Follow-up|0|||
164386998|NCT02511431|593786338|FG002|Treatment|Lost to Follow-up|1|||
164015685|NCT00227877|592420220|FG000|3-months Follow-up|Lost to Follow-up|178|||
164015686|NCT00227877|592420221|FG001|3-months Follow-up|Lost to Follow-up|139|||
164015687|NCT00227877|592420222|FG002|3-months Follow-up|Lost to Follow-up|18|||
164015688|NCT00227877|592420223|FG003|3-months Follow-up|Lost to Follow-up|13|||
164015689|NCT00227877|592420220|FG000|12-months Follow-up|Completed late|78|||
164015690|NCT00227877|592420221|FG001|12-months Follow-up|Completed late|74|||
164015691|NCT00227877|592420222|FG002|12-months Follow-up|Completed late|1|||
164015692|NCT00227877|592420223|FG003|12-months Follow-up|Completed late|0|||
164015693|NCT00227877|592420220|FG000|12-months Follow-up|Lost to Follow-up|232|||
164015694|NCT00227877|592420221|FG001|12-months Follow-up|Lost to Follow-up|189|||
164015695|NCT00227877|592420222|FG002|12-months Follow-up|Lost to Follow-up|30|||
164015696|NCT00227877|592420223|FG003|12-months Follow-up|Lost to Follow-up|26|||
164015697|NCT02522481|592420226|FG000|Overall Study|discontinued|1|||
164015698|NCT02522481|592420226|FG000|Overall Study|Not dosed|2|||
164015699|NCT04191967|592421714|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
164015700|NCT04191967|592421714|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
164015701|NCT02322892|592421722|FG000|Overall Study|Surgery cancelled|1|||
164015702|NCT02322892|592421723|FG001|Overall Study|Surgery cancelled|2|||
164015703|NCT02322892|592421722|FG000|Overall Study|Met exclusion criteria|0|||
164015704|NCT02322892|592421723|FG001|Overall Study|Met exclusion criteria|1|||
164015705|NCT02322892|592421722|FG000|Overall Study|Protocol Violation|1|||
164015706|NCT02322892|592421723|FG001|Overall Study|Protocol Violation|0|||
164015707|NCT00747617|592421724|FG000|Overall Study|Lost to Follow-up|3|||
164015708|NCT00747617|592421725|FG001|Overall Study|Lost to Follow-up|1|||
164092991|NCT00454636|592703434|FG002|Overall Study|Protocol Violation|3|||
164092992|NCT00454636|592703435|FG003|Overall Study|Protocol Violation|3|||
164092993|NCT00454636|592703432|FG000|Overall Study|Death|6|||
164386999|NCT02511431|593786339|FG003|Treatment|Lost to Follow-up|0|||
164387000|NCT02511431|593786340|FG004|Treatment|Lost to Follow-up|0|||
164387001|NCT02511431|593786341|FG005|Treatment|Lost to Follow-up|1|||
164387002|NCT00346034|593786353|FG000|Overall Study|Adverse Event|34|||
164387003|NCT00346034|593786353|FG000|Overall Study|Lack of Efficacy|8|||
164387004|NCT00346034|593786353|FG000|Overall Study|Withdrawal by Subject|13|||
164387005|NCT00346034|593786353|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
164387006|NCT00346034|593786353|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
164387007|NCT02641080|593786355|FG000|Overall Study|Physician Decision|2|||
164387008|NCT02641080|593786356|FG001|Overall Study|Physician Decision|0|||
164387009|NCT02641080|593786355|FG000|Overall Study|Withdrawal by Subject|0|||
164387010|NCT02641080|593786356|FG001|Overall Study|Withdrawal by Subject|1|||
164387011|NCT02641080|593786355|FG000|Overall Study|Rehab Center denied use of pumps|0|||
164387012|NCT02641080|593786356|FG001|Overall Study|Rehab Center denied use of pumps|3|||
164387013|NCT02641080|593786355|FG000|Overall Study|Lost to Follow-up|0|||
164387014|NCT02641080|593786356|FG001|Overall Study|Lost to Follow-up|3|||
164387015|NCT06281548|593786361|FG000|Overall Study|Lost to Follow-up|3|||
164387016|NCT03835533|593786362|FG000|Overall Study|Death|5|||
164387017|NCT03835533|593786363|FG001|Overall Study|Death|10|||
164387018|NCT03835533|593786364|FG002|Overall Study|Death|9|||
164387019|NCT03835533|593786362|FG000|Overall Study|Withdrawal by Subject|2|||
164387020|NCT03835533|593786363|FG001|Overall Study|Withdrawal by Subject|2|||
164387021|NCT03835533|593786364|FG002|Overall Study|Withdrawal by Subject|2|||
164387022|NCT03835533|593786362|FG000|Overall Study|Lost to Follow-up|1|||
164387023|NCT03835533|593786363|FG001|Overall Study|Lost to Follow-up|0|||
164387024|NCT03835533|593786364|FG002|Overall Study|Lost to Follow-up|0|||
164387025|NCT03864900|593786367|FG000|Overall Study|Withdrawal by Subject|1|||
164387026|NCT03864900|593786368|FG001|Overall Study|Withdrawal by Subject|1|||
164387027|NCT03864900|593786367|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
164387028|NCT03864900|593786368|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
164387029|NCT03238001|593786369|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
164387030|NCT03238001|593786369|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
164387031|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
164387032|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
164387033|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
164387034|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
163903890|NCT01953224|592018812|FG001|Overall Study|Lost to Follow-up|1|||
163903891|NCT01953224|592018811|FG000|Overall Study|Withdrawal by Subject|1|||
163903892|NCT01953224|592018812|FG001|Overall Study|Withdrawal by Subject|2|||
163903893|NCT00586313|592018813|FG000|Overall Study|Lack of Efficacy|2|||
163903894|NCT03205566|592018818|FG000|Phase 1|Protocol Violation|1|||
163903895|NCT03205566|592018819|FG001|Phase 1|Protocol Violation|1|||
163903896|NCT03184987|592018820|FG000|Overall Study|Withdrawal by Subject|0|||
163903897|NCT03184987|592018821|FG001|Overall Study|Withdrawal by Subject|1|||
163903898|NCT03184987|592018822|FG002|Overall Study|Withdrawal by Subject|2|||
163903899|NCT03184987|592018820|FG000|Overall Study|Physician Decision|0|||
163903900|NCT03184987|592018821|FG001|Overall Study|Physician Decision|0|||
163903901|NCT03184987|592018822|FG002|Overall Study|Physician Decision|1|||
163903902|NCT03184987|592018820|FG000|Overall Study|Adverse Event|1|||
163903903|NCT03184987|592018821|FG001|Overall Study|Adverse Event|0|||
163903904|NCT03184987|592018822|FG002|Overall Study|Adverse Event|1|||
163903905|NCT01767467|592018823|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
163903906|NCT01767467|592018824|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
163903907|NCT01767467|592018823|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
163903908|NCT01767467|592018824|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
163903909|NCT01767467|592018823|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
163903910|NCT01767467|592018824|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
163903911|NCT01767467|592018823|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
163903912|NCT01767467|592018824|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
163903913|NCT01767467|592018823|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
163903914|NCT01767467|592018824|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
163903915|NCT01767467|592018823|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
163903916|NCT01767467|592018824|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
163903917|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
163903918|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
163903919|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
163903920|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
163903921|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
163903922|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
163903923|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
163903924|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
163903925|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
163903926|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
163903927|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
163903928|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
163903929|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
163903930|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
163903931|NCT01767467|592018823|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
163903932|NCT01767467|592018824|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
163903933|NCT00853580|592018825|FG000|Overall Study|Lost to Follow-up|3|||
163903934|NCT00853580|592018826|FG001|Overall Study|Lost to Follow-up|5|||
164015709|NCT01746732|592421726|FG000|Lead-In Period|Withdrawal by Subject|1|||
164015710|NCT01746732|592421727|FG001|Lead-In Period|Withdrawal by Subject|0|||
164015711|NCT01746732|592421728|FG002|Lead-In Period|Withdrawal by Subject|0|||
164015712|NCT01746732|592421726|FG000|Period 1|Physician Decision|0|||
164015713|NCT01746732|592421727|FG001|Period 1|Physician Decision|1|||
164015714|NCT01746732|592421728|FG002|Period 1|Physician Decision|0|||
164387035|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
164387036|NCT03238001|593786369|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
164387037|NCT01866709|593786376|FG000|Overall Study|Adverse Event|1|||
164387038|NCT01866709|593786377|FG001|Overall Study|Adverse Event|0|||
164387039|NCT02207829|593786379|FG000|Overall Study|Adverse Event|10|||
164387040|NCT02207829|593786380|FG001|Overall Study|Adverse Event|9|||
164387041|NCT02207829|593786379|FG000|Overall Study|Lack of Efficacy|7|||
164387042|NCT02207829|593786380|FG001|Overall Study|Lack of Efficacy|5|||
164387043|NCT02207829|593786379|FG000|Overall Study|Lost to Follow-up|2|||
164387044|NCT02207829|593786380|FG001|Overall Study|Lost to Follow-up|2|||
164387045|NCT02207829|593786379|FG000|Overall Study|Protocol deviation|5|||
164387046|NCT02207829|593786380|FG001|Overall Study|Protocol deviation|4|||
164387047|NCT02207829|593786379|FG000|Overall Study|Withdrew consent|18|||
164387048|NCT02207829|593786380|FG001|Overall Study|Withdrew consent|14|||
164387049|NCT03285477|593786394|FG000|Treatment and Response Assessment Period|Death|1|||
164387050|NCT03285477|593786395|FG001|Treatment and Response Assessment Period|Death|0|||
164387051|NCT03285477|593786394|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
164387052|NCT03285477|593786395|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
164387053|NCT03285477|593786394|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
164387054|NCT03285477|593786395|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
164387055|NCT03285477|593786394|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
164387056|NCT03285477|593786395|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
164387057|NCT03285477|593786394|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
164387058|NCT03285477|593786395|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
164387059|NCT00560833|593786396|FG000|Overall Study|Adverse Event|16|||
164387060|NCT00560833|593786397|FG001|Overall Study|Adverse Event|10|||
164387061|NCT00560833|593786398|FG002|Overall Study|Adverse Event|25|||
164387062|NCT00560833|593786399|FG003|Overall Study|Adverse Event|23|||
164387063|NCT00560833|593786400|FG004|Overall Study|Adverse Event|35|||
164387064|NCT00560833|593786396|FG000|Overall Study|Lost to Follow-up|0|||
164387065|NCT00560833|593786397|FG001|Overall Study|Lost to Follow-up|0|||
164387066|NCT00560833|593786398|FG002|Overall Study|Lost to Follow-up|1|||
164387067|NCT00560833|593786399|FG003|Overall Study|Lost to Follow-up|0|||
164387068|NCT00560833|593786400|FG004|Overall Study|Lost to Follow-up|0|||
164387069|NCT00560833|593786396|FG000|Overall Study|Lack of Efficacy|22|||
164387070|NCT00560833|593786397|FG001|Overall Study|Lack of Efficacy|9|||
164387071|NCT00560833|593786398|FG002|Overall Study|Lack of Efficacy|6|||
164387072|NCT00560833|593786399|FG003|Overall Study|Lack of Efficacy|4|||
164387073|NCT00560833|593786400|FG004|Overall Study|Lack of Efficacy|4|||
164387074|NCT00560833|593786396|FG000|Overall Study|Participant uncooperative|5|||
164387075|NCT00560833|593786397|FG001|Overall Study|Participant uncooperative|5|||
164387076|NCT00560833|593786398|FG002|Overall Study|Participant uncooperative|4|||
164387077|NCT00560833|593786399|FG003|Overall Study|Participant uncooperative|4|||
164387078|NCT00560833|593786400|FG004|Overall Study|Participant uncooperative|2|||
164387079|NCT00560833|593786396|FG000|Overall Study|Other|1|||
164387080|NCT00560833|593786397|FG001|Overall Study|Other|1|||
164387081|NCT00560833|593786398|FG002|Overall Study|Other|3|||
164387082|NCT00560833|593786399|FG003|Overall Study|Other|0|||
164387083|NCT00560833|593786400|FG004|Overall Study|Other|0|||
164387084|NCT00560833|593786396|FG000|Overall Study|Never received drug|0|||
164387085|NCT00560833|593786397|FG001|Overall Study|Never received drug|1|||
164387086|NCT00560833|593786398|FG002|Overall Study|Never received drug|0|||
164387087|NCT00560833|593786399|FG003|Overall Study|Never received drug|0|||
164387088|NCT00560833|593786400|FG004|Overall Study|Never received drug|1|||
164387089|NCT01307501|593786403|FG000|Overall Study|Treatment Failure|1|||
164387090|NCT01307501|593786403|FG000|Overall Study|Death|20|||
164387091|NCT01307501|593786403|FG000|Overall Study|Lost to Follow-up|1|||
164015715|NCT01746732|592421726|FG000|Period 2|Withdrawal by Subject|0|||
164387092|NCT01307501|593786403|FG000|Overall Study|Starting Hospice|1|||
164387093|NCT01209624|593786407|FG000|Overall Study|Death|2|||
164387094|NCT01209624|593786407|FG000|Overall Study|Adverse Event|13|||
164387095|NCT01209624|593786407|FG000|Overall Study|Lack of Efficacy|17|||
164387096|NCT01209624|593786407|FG000|Overall Study|Lost to Follow-up|290|||
164387097|NCT01209624|593786407|FG000|Overall Study|Other|4|||
164387098|NCT03564496|593786408|FG000|Overall Study|Withdrawal by Subject|1|||
164387099|NCT03564496|593786409|FG001|Overall Study|Withdrawal by Subject|1|||
164387100|NCT03564496|593786410|FG002|Overall Study|Withdrawal by Subject|0|||
164387101|NCT03564496|593786408|FG000|Overall Study|Screen failure|0|||
164387102|NCT03564496|593786409|FG001|Overall Study|Screen failure|3|||
164387103|NCT03564496|593786410|FG002|Overall Study|Screen failure|0|||
164387104|NCT00428610|593786411|FG000|Overall Study|Death Due to Adverse Event|3|||
164387105|NCT00428610|593786412|FG001|Overall Study|Death Due to Adverse Event|0|||
164387106|NCT00428610|593786413|FG002|Overall Study|Death Due to Adverse Event|5|||
164387107|NCT00428610|593786411|FG000|Overall Study|Death Due to Progressive Disease|0|||
164387108|NCT00428610|593786412|FG001|Overall Study|Death Due to Progressive Disease|0|||
164387109|NCT00428610|593786413|FG002|Overall Study|Death Due to Progressive Disease|2|||
164387110|NCT00428610|593786411|FG000|Overall Study|Adverse Event|2|||
164387111|NCT00428610|593786412|FG001|Overall Study|Adverse Event|3|||
164387112|NCT00428610|593786413|FG002|Overall Study|Adverse Event|2|||
164387113|NCT00428610|593786411|FG000|Overall Study|Investigator Decision|2|||
164387114|NCT00428610|593786412|FG001|Overall Study|Investigator Decision|1|||
164387115|NCT00428610|593786413|FG002|Overall Study|Investigator Decision|1|||
164387116|NCT00428610|593786411|FG000|Overall Study|Progressive Disease|42|||
164387117|NCT00428610|593786412|FG001|Overall Study|Progressive Disease|14|||
164387118|NCT00428610|593786413|FG002|Overall Study|Progressive Disease|22|||
164387119|NCT00428610|593786411|FG000|Overall Study|Withdrawal by Subject|4|||
164387120|NCT00428610|593786412|FG001|Overall Study|Withdrawal by Subject|0|||
164387121|NCT00428610|593786413|FG002|Overall Study|Withdrawal by Subject|0|||
164387122|NCT01432366|593788414|FG000|Overall Study|Non-Responder|7|||
164387123|NCT01432366|593788414|FG000|Overall Study|Adverse Event|8|||
164387124|NCT01432366|593788414|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
164387125|NCT01432366|593788414|FG000|Overall Study|Pregnancy|1|||
164387126|NCT01432366|593788414|FG000|Overall Study|Lost to Follow-up|13|||
164387127|NCT01432366|593788414|FG000|Overall Study|Lack of Efficacy|1|||
164387128|NCT01432366|593788414|FG000|Overall Study|Site Closed|20|||
164387129|NCT01432366|593788414|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
164387130|NCT01432366|593788414|FG000|Overall Study|Other|14|||
164387131|NCT01808690|593788415|FG000|Overall Study|Withdrawal by Subject|1|||
164387132|NCT01808690|593788416|FG001|Overall Study|Withdrawal by Subject|2|||
164387133|NCT03811912|593788417|FG000|Overall Study|Withdrew Consent|4|||
164387134|NCT03811912|593788418|FG001|Overall Study|Withdrew Consent|2|||
164387135|NCT02891187|593788419|FG000|Overall Study|Lost to Follow-up|1|||
164387136|NCT02891187|593788420|FG001|Overall Study|Lost to Follow-up|2|||
164387137|NCT02395120|593788421|FG000|Overall Study|Missed follow-up dental exam|57|||
164387138|NCT02395120|593788422|FG001|Overall Study|Missed follow-up dental exam|62|||
164387139|NCT02395120|593788423|FG002|Overall Study|Missed follow-up dental exam|6|||
164387140|NCT02395120|593788424|FG003|Overall Study|Missed follow-up dental exam|6|||
164387141|NCT02395120|593788425|FG004|Overall Study|Missed follow-up dental exam|51|||
164387142|NCT00674986|593788426|FG000|Overall Study|Adverse Event|2|||
164387143|NCT00674986|593788427|FG001|Overall Study|Adverse Event|1|||
164387144|NCT00674986|593788426|FG000|Overall Study|Subject withdrew consent|12|||
164387145|NCT00674986|593788427|FG001|Overall Study|Subject withdrew consent|19|||
164387146|NCT00674986|593788426|FG000|Overall Study|Lost to Follow-up|25|||
164387147|NCT00674986|593788427|FG001|Overall Study|Lost to Follow-up|53|||
164387148|NCT00674986|593788426|FG000|Overall Study|Other reasons|4|||
164387149|NCT00674986|593788427|FG001|Overall Study|Other reasons|8|||
164387150|NCT00377234|593788428|FG000|Overall Study|Adverse Event|14|||
164387151|NCT00377234|593788429|FG001|Overall Study|Adverse Event|17|||
164387152|NCT00377234|593788428|FG000|Overall Study|Withdrawal by Subject|11|||
164387153|NCT00377234|593788429|FG001|Overall Study|Withdrawal by Subject|9|||
164387154|NCT00377234|593788428|FG000|Overall Study|Lost to Follow-up|4|||
164387155|NCT00377234|593788429|FG001|Overall Study|Lost to Follow-up|2|||
164387156|NCT00377234|593788428|FG000|Overall Study|Administrative|2|||
164387157|NCT00377234|593788429|FG001|Overall Study|Administrative|1|||
163903935|NCT00853580|592018825|FG000|Overall Study|Protocol Violation|2|||
163903936|NCT00853580|592018826|FG001|Overall Study|Protocol Violation|1|||
163903937|NCT00853580|592018825|FG000|Overall Study|Withdrawal by Subject|2|||
163903938|NCT00853580|592018826|FG001|Overall Study|Withdrawal by Subject|8|||
164387158|NCT00377234|593788428|FG000|Overall Study|Not assigned|3|||
164387159|NCT00377234|593788429|FG001|Overall Study|Not assigned|2|||
164387160|NCT04546581|593788437|FG000|Overall Study|Adverse Event|9|||
164387161|NCT04546581|593788438|FG001|Overall Study|Adverse Event|3|||
164387162|NCT04546581|593788437|FG000|Overall Study|Physician Decision|0|||
164387163|NCT04546581|593788438|FG001|Overall Study|Physician Decision|1|||
164387164|NCT04546581|593788437|FG000|Overall Study|Protocol Violation|1|||
164387165|NCT04546581|593788438|FG001|Overall Study|Protocol Violation|2|||
163903939|NCT00853580|592018825|FG000|Overall Study|Commenced contraindicated therapy|0|||
164387166|NCT04546581|593788437|FG000|Overall Study|Withdrawal by Subject|3|||
164387167|NCT04546581|593788438|FG001|Overall Study|Withdrawal by Subject|7|||
164387168|NCT02526693|593788439|FG000|Overall Study|Physician Decision|3|||
164387169|NCT02526693|593788440|FG001|Overall Study|Physician Decision|1|||
164387170|NCT01798927|593788441|FG000|Overall Study|Withdrawal by Subject|1|||
164387171|NCT00626522|593788442|FG000|Overall Study|Protocol Violation|0|||
164387172|NCT00626522|593788443|FG001|Overall Study|Protocol Violation|0|||
164387173|NCT00626522|593788444|FG002|Overall Study|Protocol Violation|0|||
164387174|NCT00626522|593788445|FG003|Overall Study|Protocol Violation|0|||
164387175|NCT00626522|593788446|FG004|Overall Study|Protocol Violation|1|||
164387176|NCT00626522|593788447|FG005|Overall Study|Protocol Violation|0|||
163903940|NCT00853580|592018826|FG001|Overall Study|Commenced contraindicated therapy|2|||
164387177|NCT00626522|593788442|FG000|Overall Study|Adverse Event|2|||
164387178|NCT00626522|593788443|FG001|Overall Study|Adverse Event|1|||
164387179|NCT00626522|593788444|FG002|Overall Study|Adverse Event|2|||
164387180|NCT00626522|593788445|FG003|Overall Study|Adverse Event|0|||
164387181|NCT00626522|593788446|FG004|Overall Study|Adverse Event|1|||
164387182|NCT00626522|593788447|FG005|Overall Study|Adverse Event|1|||
164387183|NCT00626522|593788442|FG000|Overall Study|Withdrawal by Subject|2|||
164387184|NCT00626522|593788443|FG001|Overall Study|Withdrawal by Subject|5|||
164387185|NCT00626522|593788444|FG002|Overall Study|Withdrawal by Subject|5|||
164387186|NCT00626522|593788445|FG003|Overall Study|Withdrawal by Subject|0|||
164387187|NCT00626522|593788446|FG004|Overall Study|Withdrawal by Subject|4|||
164387188|NCT00626522|593788447|FG005|Overall Study|Withdrawal by Subject|1|||
164387189|NCT00626522|593788442|FG000|Overall Study|COPD exacerbation|0|||
164387190|NCT00626522|593788443|FG001|Overall Study|COPD exacerbation|0|||
164387191|NCT00626522|593788444|FG002|Overall Study|COPD exacerbation|0|||
164387192|NCT00626522|593788445|FG003|Overall Study|COPD exacerbation|1|||
164387193|NCT00626522|593788446|FG004|Overall Study|COPD exacerbation|1|||
164387194|NCT00626522|593788447|FG005|Overall Study|COPD exacerbation|0|||
164387195|NCT00626522|593788442|FG000|Overall Study|Lost to Follow-up|0|||
164387196|NCT00626522|593788443|FG001|Overall Study|Lost to Follow-up|1|||
164387197|NCT00626522|593788444|FG002|Overall Study|Lost to Follow-up|0|||
164387198|NCT00626522|593788445|FG003|Overall Study|Lost to Follow-up|0|||
164387199|NCT00626522|593788446|FG004|Overall Study|Lost to Follow-up|0|||
164387200|NCT00626522|593788447|FG005|Overall Study|Lost to Follow-up|0|||
164387201|NCT00626522|593788442|FG000|Overall Study|Inconsistent reason reported|1|||
164387202|NCT00626522|593788443|FG001|Overall Study|Inconsistent reason reported|0|||
164387203|NCT00626522|593788444|FG002|Overall Study|Inconsistent reason reported|0|||
164387204|NCT00626522|593788445|FG003|Overall Study|Inconsistent reason reported|0|||
164387205|NCT00626522|593788446|FG004|Overall Study|Inconsistent reason reported|0|||
164387206|NCT00626522|593788447|FG005|Overall Study|Inconsistent reason reported|0|||
164387207|NCT00626522|593788442|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
164387208|NCT00626522|593788443|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
164387209|NCT00626522|593788444|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
164387210|NCT00626522|593788445|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
164387211|NCT00626522|593788446|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
164387212|NCT00626522|593788447|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
164387213|NCT01159691|593788448|FG000|Overall Study|Lost to Follow-up|2|||
164387214|NCT01159691|593788448|FG000|Overall Study|Unknown reasons|1|||
164387215|NCT01159691|593788448|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
164387216|NCT01159691|593788448|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
164387217|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
164387218|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
164387219|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
164387220|NCT01159691|593788448|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
164387221|NCT01928719|593788449|FG000|Overall Study|Lost to Follow-up|26|||
164387222|NCT01928719|593788450|FG001|Overall Study|Lost to Follow-up|11|||
164387223|NCT01928719|593788449|FG000|Overall Study|Withdrawal by Subject|22|||
164387224|NCT01928719|593788450|FG001|Overall Study|Withdrawal by Subject|7|||
164387225|NCT01928719|593788449|FG000|Overall Study|Protocol Violation|3|||
164387226|NCT01928719|593788450|FG001|Overall Study|Protocol Violation|1|||
164387227|NCT01928719|593788449|FG000|Overall Study|Adverse Event|1|||
164387228|NCT01928719|593788450|FG001|Overall Study|Adverse Event|0|||
164387229|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
164015716|NCT01746732|592421727|FG001|Period 2|Withdrawal by Subject|0|||
164015717|NCT01746732|592421728|FG002|Period 2|Withdrawal by Subject|2|||
164015718|NCT01746732|592421726|FG000|Period 2|Adverse Event|0|||
164015719|NCT01746732|592421727|FG001|Period 2|Adverse Event|0|||
164015720|NCT01746732|592421728|FG002|Period 2|Adverse Event|1|||
164387230|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
164387231|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
164387232|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
164387233|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
164015721|NCT01746732|592421726|FG000|Period 2|Lost to Follow-up|0|||
164015722|NCT01746732|592421727|FG001|Period 2|Lost to Follow-up|0|||
164387234|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
164387235|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
164387236|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
164387237|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
164387238|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
164387239|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
164387240|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
164387241|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
164387242|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
164015723|NCT01746732|592421728|FG002|Period 2|Lost to Follow-up|1|||
164387243|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
164387244|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
164387245|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
164387246|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
164387247|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
164387248|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
164387249|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
164387250|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
164387251|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
164387252|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
164387253|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387254|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387255|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387256|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387257|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387258|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387259|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387260|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387261|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387262|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387263|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387264|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387265|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387266|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387267|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387268|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
164387269|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387270|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387271|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
164387272|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
164387273|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
164387274|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387275|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387276|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387277|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387278|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387279|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387280|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387281|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387282|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387283|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387284|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387285|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387286|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387287|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164387288|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
164015724|NCT02817555|592421729|FG000|Overall Study|Death|1|||
164387289|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
164387290|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
164387291|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
164387292|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
164387293|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
164015725|NCT02817555|592421730|FG001|Overall Study|Death|3|||
164015726|NCT02817555|592421729|FG000|Overall Study|moved away|1|||
164015727|NCT02817555|592421730|FG001|Overall Study|moved away|0|||
164015728|NCT02817555|592421729|FG000|Overall Study|transplant|1|||
164387294|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
164387295|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
164015729|NCT02817555|592421730|FG001|Overall Study|transplant|1|||
164015730|NCT02817555|592421729|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
164387296|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
164387297|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
164387298|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
164387299|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
164015731|NCT02817555|592421730|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
164015732|NCT02125331|592421731|FG000|Overall Study|Protocol Violation|1|||
164387300|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
164387301|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
164387302|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
164387303|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
164387304|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
164387305|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
164387306|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
164387307|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
164387308|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
164387309|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
164387310|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387311|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387312|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387313|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387314|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387315|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387316|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387317|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387318|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387319|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387320|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387321|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387322|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387323|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387324|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387325|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387326|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387327|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387328|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
164387329|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
164387330|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
164387331|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387332|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
164387333|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
164387334|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387335|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387336|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387337|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387338|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387339|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387340|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387341|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387342|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387343|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387344|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387345|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387346|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387347|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387348|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
164387349|NCT01490632|593788451|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387350|NCT01490632|593788452|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387351|NCT01490632|593788453|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387352|NCT01490632|593788454|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387353|NCT01490632|593788455|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
164387354|NCT01490632|593788456|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387355|NCT01490632|593788457|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387356|NCT01490632|593788458|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387357|NCT01490632|593788459|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164015733|NCT02125331|592421732|FG001|Overall Study|Protocol Violation|0|||
164015734|NCT02125331|592421731|FG000|Overall Study|technical problem|2|||
164015735|NCT02125331|592421732|FG001|Overall Study|technical problem|0|||
164015736|NCT02125331|592421731|FG000|Overall Study|screen failure|2|||
164387358|NCT01490632|593788460|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387359|NCT01490632|593788461|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
163903941|NCT01700205|592018827|FG000|Overall Study|Withdrawal by Subject|13|||
164387360|NCT01490632|593788462|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387361|NCT01490632|593788463|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387362|NCT01490632|593788464|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387363|NCT01490632|593788465|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387364|NCT01490632|593788466|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387365|NCT01490632|593788467|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387366|NCT01490632|593788468|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387367|NCT01490632|593788469|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387368|NCT01490632|593788470|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
164387369|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387370|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387371|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387372|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387373|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387374|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
164387375|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
164387376|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387377|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387378|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
164387379|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
164387380|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
164387381|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387382|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387383|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387384|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387385|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387386|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387387|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387388|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
164387389|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387390|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387391|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387392|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387393|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387394|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387395|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
164387396|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387397|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
164387398|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
164387399|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
164387400|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387401|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387402|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387403|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387404|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387405|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387406|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387407|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387408|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
164387409|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387410|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387411|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387412|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387413|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387414|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387415|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
164387416|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387417|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387418|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
164387419|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387420|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387421|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387422|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
163903942|NCT01700205|592018828|FG001|Overall Study|Withdrawal by Subject|13|||
163903943|NCT01700205|592018827|FG000|Overall Study|Protocol Violation|2|||
164387423|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387424|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387425|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387426|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387427|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387428|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
164387429|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387430|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387431|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387432|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387433|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387434|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387435|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
164387436|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387437|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387438|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387439|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387440|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387441|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387442|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387443|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387444|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387445|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387446|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387447|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387448|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
164387449|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387450|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387451|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387452|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
163903944|NCT01700205|592018828|FG001|Overall Study|Protocol Violation|2|||
163903945|NCT03335488|592018831|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
163903946|NCT03335488|592018832|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
163903947|NCT03335488|592018831|FG000|Safety Extension Period|Adverse Event|1|||
163903948|NCT03335488|592018832|FG001|Safety Extension Period|Adverse Event|0|||
164015737|NCT02125331|592421732|FG001|Overall Study|screen failure|0|||
164015738|NCT00137436|592421733|FG000|Overall Study|Adverse Event|13|||
164015739|NCT00137436|592421733|FG000|Overall Study|Death|2|||
164015740|NCT00137436|592421733|FG000|Overall Study|Lack of Efficacy|17|||
164015741|NCT00137436|592421733|FG000|Overall Study|Withdrawal by Subject|6|||
164015742|NCT00137436|592421733|FG000|Overall Study|Other|5|||
164015743|NCT01432262|592421734|FG000|Overall Study|Withdrawal by Subject|2|||
164015744|NCT01432262|592421735|FG001|Overall Study|Withdrawal by Subject|1|||
164015745|NCT00165646|592421736|FG000|Overall Study|Adverse Event|1|||
164015746|NCT00165646|592421737|FG001|Overall Study|Adverse Event|1|||
164015747|NCT00165646|592421738|FG002|Overall Study|Adverse Event|1|||
164015748|NCT00165646|592421736|FG000|Overall Study|Lack of Efficacy|1|||
164015749|NCT00165646|592421737|FG001|Overall Study|Lack of Efficacy|2|||
164015750|NCT00165646|592421738|FG002|Overall Study|Lack of Efficacy|0|||
164015751|NCT00165646|592421736|FG000|Overall Study|Withdrawal by Subject|0|||
164015752|NCT00165646|592421737|FG001|Overall Study|Withdrawal by Subject|2|||
164015753|NCT00165646|592421738|FG002|Overall Study|Withdrawal by Subject|1|||
164015754|NCT00165646|592421736|FG000|Overall Study|Physician Decision|2|||
164015755|NCT00165646|592421737|FG001|Overall Study|Physician Decision|0|||
164092994|NCT00454636|592703433|FG001|Overall Study|Death|1|||
164092995|NCT00454636|592703434|FG002|Overall Study|Death|1|||
164387453|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387454|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
164387455|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387456|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387457|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387458|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387459|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387460|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387461|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387462|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387463|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387464|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387465|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387466|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387467|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387468|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
164387469|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387470|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387471|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387472|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387473|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387474|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387475|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
164387476|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387477|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
164387478|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387479|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
164387480|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
164387481|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387482|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387483|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387484|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387485|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387486|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387487|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387488|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
164387489|NCT01490632|593788451|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387490|NCT01490632|593788452|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387491|NCT01490632|593788453|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387492|NCT01490632|593788454|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387493|NCT01490632|593788455|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387494|NCT01490632|593788456|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
164387495|NCT01490632|593788457|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
164387496|NCT01490632|593788458|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
164387497|NCT01490632|593788459|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
164387498|NCT01490632|593788460|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
164092996|NCT00454636|592703435|FG003|Overall Study|Death|1|||
163903949|NCT03335488|592018831|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
163903950|NCT03335488|592018832|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
163903951|NCT04971733|592018833|FG000|Overall Study|Adverse Event|1|||
163903952|NCT04971733|592018834|FG001|Overall Study|Adverse Event|1|||
163903953|NCT04971733|592018833|FG000|Overall Study|Subject choice|2|||
163903954|NCT04971733|592018834|FG001|Overall Study|Subject choice|0|||
163903955|NCT04971733|592018833|FG000|Overall Study|Withdrawal by Subject|1|||
163903956|NCT04971733|592018834|FG001|Overall Study|Withdrawal by Subject|0|||
163903957|NCT04971733|592018833|FG000|Overall Study|Other|1|||
163903958|NCT04971733|592018834|FG001|Overall Study|Other|0|||
163903959|NCT01160354|592018835|FG000|Overall Study|Death|0|||
163903960|NCT01160354|592018836|FG001|Overall Study|Death|1|||
164387499|NCT01490632|593788461|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
164387500|NCT01490632|593788462|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
164387501|NCT01490632|593788463|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387502|NCT01490632|593788464|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387503|NCT01490632|593788465|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387504|NCT01490632|593788466|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
163903961|NCT01160354|592018837|FG002|Overall Study|Death|1|||
163903962|NCT00600353|592018841|FG000|Overall Study|history of malignancy within 5 years|1|||
163903963|NCT00600353|592018842|FG001|Overall Study|history of malignancy within 5 years|0|||
163903964|NCT00600353|592018841|FG000|Overall Study|History of prepartive regimen|0|||
163903965|NCT00600353|592018842|FG001|Overall Study|History of prepartive regimen|1|||
163903966|NCT04941482|592018843|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
163903967|NCT04941482|592018844|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
163903968|NCT04200664|592018845|FG000|Overall Study|Withdrawal by Subject|1|||
163903969|NCT04200664|592018846|FG001|Overall Study|Withdrawal by Subject|0|||
163903970|NCT04200664|592018847|FG002|Overall Study|Withdrawal by Subject|0|||
163903971|NCT03362190|592018850|FG000|Overall Study|Adverse Event|0|||
163903972|NCT03362190|592018851|FG001|Overall Study|Adverse Event|0|||
163903973|NCT03362190|592018852|FG002|Overall Study|Adverse Event|0|||
163903974|NCT03362190|592018853|FG003|Overall Study|Adverse Event|1|||
163903975|NCT03362190|592018850|FG000|Overall Study|Withdrawal by Subject|0|||
163903976|NCT03362190|592018851|FG001|Overall Study|Withdrawal by Subject|0|||
163903977|NCT03362190|592018852|FG002|Overall Study|Withdrawal by Subject|0|||
163903978|NCT03362190|592018853|FG003|Overall Study|Withdrawal by Subject|1|||
163903979|NCT00687219|592018854|FG000|Overall Study|Adverse Event|8|||
163903980|NCT00687219|592018854|FG000|Overall Study|Discontinuance criteria met|7|||
163903981|NCT00687219|592018854|FG000|Overall Study|HCV-RNA positive conversion|34|||
163903982|NCT00687219|592018854|FG000|Overall Study|Withdrawal by Subject|1|||
164015756|NCT00165646|592421738|FG002|Overall Study|Physician Decision|2|||
164015757|NCT00165646|592421736|FG000|Overall Study|Protocol Violation|1|||
164015758|NCT00165646|592421737|FG001|Overall Study|Protocol Violation|0|||
164015759|NCT00165646|592421738|FG002|Overall Study|Protocol Violation|0|||
164387505|NCT01490632|593788467|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387506|NCT01490632|593788468|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387507|NCT01490632|593788469|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387508|NCT01490632|593788470|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
164387509|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387510|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387511|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387512|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387513|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387514|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387515|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387516|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387517|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
163903983|NCT00687219|592018854|FG000|Overall Study|Lack of Efficacy|1|||
164015760|NCT04657016|592421739|FG000|Overall Study|Adverse Event|2|||
163903984|NCT03102034|592018861|FG000|Overall Study|Withdrawal by Subject|1|||
163903985|NCT03102034|592018862|FG001|Overall Study|Withdrawal by Subject|0|||
164015761|NCT04657016|592421740|FG001|Overall Study|Adverse Event|4|||
164015762|NCT04657016|592421739|FG000|Overall Study|Death|1|||
164015763|NCT04657016|592421740|FG001|Overall Study|Death|1|||
163903986|NCT00676091|592018864|FG000|Infant Series|Parent or legal guardian request|10|||
163903987|NCT00676091|592018865|FG001|Infant Series|Parent or legal guardian request|8|||
163903988|NCT00676091|592018864|FG000|Infant Series|Protocol Violation|6|||
163903989|NCT00676091|592018865|FG001|Infant Series|Protocol Violation|3|||
163903990|NCT00676091|592018864|FG000|Infant Series|Adverse Event|2|||
164015764|NCT04657016|592421739|FG000|Overall Study|Lost to Follow-up|24|||
164015765|NCT04657016|592421740|FG001|Overall Study|Lost to Follow-up|12|||
164015766|NCT04657016|592421739|FG000|Overall Study|Physician Decision|1|||
164015767|NCT04657016|592421740|FG001|Overall Study|Physician Decision|2|||
164015768|NCT04657016|592421739|FG000|Overall Study|Pregnancy|2|||
164015769|NCT04657016|592421740|FG001|Overall Study|Pregnancy|2|||
164015770|NCT04657016|592421739|FG000|Overall Study|Protocol Deviation|1|||
164015771|NCT04657016|592421740|FG001|Overall Study|Protocol Deviation|0|||
164015772|NCT04657016|592421739|FG000|Overall Study|Withdrawal by Subject|28|||
164015773|NCT04657016|592421740|FG001|Overall Study|Withdrawal by Subject|14|||
164015774|NCT04657016|592421739|FG000|Overall Study|Other - as reported by the investigator|6|||
164015775|NCT04657016|592421740|FG001|Overall Study|Other - as reported by the investigator|0|||
164015776|NCT00701727|592421741|FG000|First Treatment Period|Adverse Event|0|||
164015777|NCT00701727|592421742|FG001|First Treatment Period|Adverse Event|0|||
164015778|NCT00701727|592421741|FG000|First Treatment Period|Withdrawal by Subject|1|||
164015779|NCT00701727|592421742|FG001|First Treatment Period|Withdrawal by Subject|0|||
164015780|NCT00701727|592421741|FG000|First Treatment Period|sponsor decision|0|||
164015781|NCT00701727|592421742|FG001|First Treatment Period|sponsor decision|1|||
164015782|NCT00701727|592421741|FG000|First Treatment Period|Lost to Follow-up|0|||
164015783|NCT00701727|592421742|FG001|First Treatment Period|Lost to Follow-up|1|||
164015784|NCT00701727|592421741|FG000|Second Treatment Period|Withdrawal by Subject|2|||
164015785|NCT00701727|592421742|FG001|Second Treatment Period|Withdrawal by Subject|0|||
164015786|NCT02601001|592421749|FG000|Dosing Period 2|Adverse Event|0|||
164015787|NCT02601001|592421750|FG001|Dosing Period 2|Adverse Event|0|||
164015788|NCT02601001|592421751|FG002|Dosing Period 2|Adverse Event|0|||
164015789|NCT02601001|592421752|FG003|Dosing Period 2|Adverse Event|0|||
164015790|NCT02601001|592421753|FG004|Dosing Period 2|Adverse Event|0|||
164015791|NCT02601001|592421754|FG005|Dosing Period 2|Adverse Event|0|||
164015792|NCT02601001|592421755|FG006|Dosing Period 2|Adverse Event|1|||
164015793|NCT01356602|592421758|FG000|Overall Study|Protocol Deviation|0|||
164015794|NCT01356602|592421759|FG001|Overall Study|Protocol Deviation|1|||
164015795|NCT01356602|592421760|FG002|Overall Study|Protocol Deviation|1|||
164015796|NCT01356602|592421758|FG000|Overall Study|Administrative Problems|1|||
164015797|NCT01356602|592421759|FG001|Overall Study|Administrative Problems|4|||
164015798|NCT01356602|592421760|FG002|Overall Study|Administrative Problems|5|||
164015799|NCT01356602|592421758|FG000|Overall Study|Lost to Follow-up|4|||
164015800|NCT01356602|592421759|FG001|Overall Study|Lost to Follow-up|5|||
164015801|NCT01356602|592421760|FG002|Overall Study|Lost to Follow-up|6|||
164015802|NCT01356602|592421758|FG000|Overall Study|Withdrawal by Subject|4|||
164015803|NCT01356602|592421759|FG001|Overall Study|Withdrawal by Subject|3|||
164015804|NCT01356602|592421760|FG002|Overall Study|Withdrawal by Subject|7|||
164015805|NCT01356602|592421758|FG000|Overall Study|Lack of Efficacy|0|||
164015806|NCT01356602|592421759|FG001|Overall Study|Lack of Efficacy|1|||
164015807|NCT01356602|592421760|FG002|Overall Study|Lack of Efficacy|4|||
164015808|NCT01356602|592421758|FG000|Overall Study|Adverse Event|0|||
164015809|NCT01356602|592421759|FG001|Overall Study|Adverse Event|1|||
164015810|NCT01356602|592421760|FG002|Overall Study|Adverse Event|1|||
164015811|NCT01931462|592421761|FG000|Overall Study|Withdrawal by Subject|1|||
164015812|NCT01701583|592421762|FG000|Overall Study|Withdrawal by Subject|2|||
164015813|NCT01701583|592421763|FG001|Overall Study|Withdrawal by Subject|0|||
164015814|NCT05070429|592421764|FG000|Overall Study|Death|0|||
164015815|NCT05070429|592421765|FG001|Overall Study|Death|4|||
164015816|NCT05070429|592421764|FG000|Overall Study|Withdrawal by Subject|2|||
164015817|NCT05070429|592421765|FG001|Overall Study|Withdrawal by Subject|1|||
164015818|NCT05070429|592421764|FG000|Overall Study|Other|15|||
164015819|NCT05070429|592421765|FG001|Overall Study|Other|5|||
164015820|NCT00615290|592421766|FG000|Overall Study|Adverse Event|2|||
164015821|NCT00615290|592421766|FG000|Overall Study|Lost to Follow-up|3|||
164015822|NCT00615290|592421766|FG000|Overall Study|Withdrawal by Subject|1|||
164015823|NCT00615290|592421766|FG000|Overall Study|Other|2|||
164015824|NCT02849990|592421767|FG000|Overall Study|Adverse Event|1|||
164015825|NCT02849990|592421767|FG000|Overall Study|Withdrawal by Subject|1|||
164015826|NCT01252134|592421768|FG000|Period 1, 8 Hours|Personal Reasons|0|||
164015827|NCT01252134|592421769|FG001|Period 1, 8 Hours|Personal Reasons|1|||
164015828|NCT01252134|592421770|FG002|Period 1, 8 Hours|Personal Reasons|1|||
164015829|NCT01252134|592421771|FG003|Period 1, 8 Hours|Personal Reasons|0|||
164015830|NCT01252134|592421772|FG004|Period 1, 8 Hours|Personal Reasons|0|||
164015831|NCT01252134|592421773|FG005|Period 1, 8 Hours|Personal Reasons|0|||
164015832|NCT02678741|592421774|FG000|Overall Study|Death|4|||
164015833|NCT02678741|592421774|FG000|Overall Study|Withdrawal by Subject|1|||
164015834|NCT02678741|592421774|FG000|Overall Study|ineligible|3|||
164015835|NCT02678741|592421774|FG000|Overall Study|Not RECIST Measurable|2|||
164015836|NCT02678741|592421774|FG000|Overall Study|Lack of Efficacy|10|||
164015837|NCT01795898|592421775|FG000|Overall Study|Adverse Event|27|||
164015838|NCT01795898|592421775|FG000|Overall Study|Lost to Follow-up|20|||
164015839|NCT01795898|592421775|FG000|Overall Study|Withdrawal of consent|6|||
164015840|NCT01795898|592421775|FG000|Overall Study|Diagnosed with metastasis|1|||
164015841|NCT01795898|592421775|FG000|Overall Study|No pain|1|||
164015842|NCT01795898|592421775|FG000|Overall Study|Death|1|||
164015843|NCT01795898|592421775|FG000|Overall Study|Withdrew consent & had adverse events|3|||
164015844|NCT01795898|592421775|FG000|Overall Study|Physician Decision|1|||
164015845|NCT02531373|592421784|FG000|Overall Study|Lack of Efficacy|0|||
164015846|NCT02531373|592421785|FG001|Overall Study|Lack of Efficacy|0|||
164015847|NCT02531373|592421786|FG002|Overall Study|Lack of Efficacy|0|||
164015848|NCT02531373|592421787|FG003|Overall Study|Lack of Efficacy|0|||
164015849|NCT02531373|592421788|FG004|Overall Study|Lack of Efficacy|3|||
164015850|NCT02531373|592421789|FG005|Overall Study|Lack of Efficacy|2|||
164015851|NCT02531373|592421790|FG006|Overall Study|Lack of Efficacy|4|||
164015852|NCT02531373|592421791|FG007|Overall Study|Lack of Efficacy|8|||
164015853|NCT02531373|592421792|FG008|Overall Study|Lack of Efficacy|5|||
164015854|NCT02531373|592421784|FG000|Overall Study|Lost to Follow-up|0|||
164015855|NCT02531373|592421785|FG001|Overall Study|Lost to Follow-up|0|||
164015856|NCT02531373|592421786|FG002|Overall Study|Lost to Follow-up|0|||
164015857|NCT02531373|592421787|FG003|Overall Study|Lost to Follow-up|0|||
164015858|NCT02531373|592421788|FG004|Overall Study|Lost to Follow-up|0|||
164015859|NCT02531373|592421789|FG005|Overall Study|Lost to Follow-up|2|||
164015860|NCT02531373|592421790|FG006|Overall Study|Lost to Follow-up|2|||
164015861|NCT02531373|592421791|FG007|Overall Study|Lost to Follow-up|0|||
164015862|NCT02531373|592421792|FG008|Overall Study|Lost to Follow-up|0|||
164015863|NCT02531373|592421784|FG000|Overall Study|Physician Decision|0|||
164015864|NCT02531373|592421785|FG001|Overall Study|Physician Decision|0|||
164015865|NCT02531373|592421786|FG002|Overall Study|Physician Decision|0|||
164015866|NCT02531373|592421787|FG003|Overall Study|Physician Decision|0|||
164015867|NCT02531373|592421788|FG004|Overall Study|Physician Decision|2|||
164015868|NCT02531373|592421789|FG005|Overall Study|Physician Decision|1|||
164015869|NCT02531373|592421790|FG006|Overall Study|Physician Decision|0|||
164015870|NCT02531373|592421791|FG007|Overall Study|Physician Decision|0|||
164015871|NCT02531373|592421792|FG008|Overall Study|Physician Decision|0|||
164015872|NCT02531373|592421784|FG000|Overall Study|Protocol Violation|0|||
164015873|NCT02531373|592421785|FG001|Overall Study|Protocol Violation|0|||
164015874|NCT02531373|592421786|FG002|Overall Study|Protocol Violation|0|||
164015875|NCT02531373|592421787|FG003|Overall Study|Protocol Violation|0|||
164015876|NCT02531373|592421788|FG004|Overall Study|Protocol Violation|0|||
164015877|NCT02531373|592421789|FG005|Overall Study|Protocol Violation|1|||
164015878|NCT02531373|592421790|FG006|Overall Study|Protocol Violation|1|||
164387518|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387519|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387520|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387521|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387522|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387523|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
164387524|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
164387525|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387526|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387527|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387528|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
164387529|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387530|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387531|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387532|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387533|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387534|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387535|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387536|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387537|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387538|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387539|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387540|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387541|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387542|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
164015879|NCT02531373|592421791|FG007|Overall Study|Protocol Violation|0|||
164015880|NCT02531373|592421792|FG008|Overall Study|Protocol Violation|1|||
164015881|NCT02531373|592421784|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164387543|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387544|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387545|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387546|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387547|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387548|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
164387549|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387550|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387551|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387552|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387553|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387554|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387555|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387556|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387557|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387558|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387559|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387560|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387561|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387562|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387563|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
164387564|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
164387565|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387566|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387567|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387568|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
164387569|NCT01490632|593788451|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387570|NCT01490632|593788452|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387571|NCT01490632|593788453|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164015882|NCT02531373|592421785|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164015883|NCT02531373|592421786|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164015884|NCT02531373|592421787|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164015885|NCT02531373|592421788|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164015886|NCT02531373|592421789|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
164015887|NCT02531373|592421790|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
164015888|NCT02531373|592421791|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
164015889|NCT02531373|592421792|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
164015890|NCT02531373|592421784|FG000|Overall Study|Withdrawal by Subject|0|||
163903991|NCT00676091|592018865|FG001|Infant Series|Adverse Event|3|||
164092997|NCT00454636|592703432|FG000|Overall Study|Patient refusal|1|||
164092998|NCT00454636|592703433|FG001|Overall Study|Patient refusal|1|||
164092999|NCT00454636|592703434|FG002|Overall Study|Patient refusal|3|||
164093000|NCT00454636|592703435|FG003|Overall Study|Patient refusal|2|||
164387572|NCT01490632|593788454|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387573|NCT01490632|593788455|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387574|NCT01490632|593788456|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387575|NCT01490632|593788457|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387576|NCT01490632|593788458|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387577|NCT01490632|593788459|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387578|NCT01490632|593788460|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387579|NCT01490632|593788461|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387580|NCT01490632|593788462|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387581|NCT01490632|593788463|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
164387582|NCT01490632|593788464|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
164387583|NCT01490632|593788465|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
164387584|NCT01490632|593788466|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
164387585|NCT01490632|593788467|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387586|NCT01490632|593788468|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387587|NCT01490632|593788469|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387588|NCT01490632|593788470|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
164387589|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
164387590|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
164387591|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
164387592|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
164387593|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
164387594|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
164387595|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
164387596|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
164387597|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
164387598|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
164387599|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
164387600|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
164387601|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
164387602|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
164387603|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
163903992|NCT00676091|592018864|FG000|Infant Series|Failed to return|1|||
163903993|NCT00676091|592018865|FG001|Infant Series|Failed to return|3|||
163903994|NCT00676091|592018864|FG000|Infant Series|Lost to Follow-up|1|||
163903995|NCT00676091|592018865|FG001|Infant Series|Lost to Follow-up|0|||
163903996|NCT00676091|592018864|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
163903997|NCT00676091|592018865|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
163903998|NCT00676091|592018864|FG000|After Infant Series|Adverse Event|0|||
163903999|NCT00676091|592018865|FG001|After Infant Series|Adverse Event|1|||
163904000|NCT00676091|592018864|FG000|After Infant Series|Protocol Violation|0|||
163904001|NCT00676091|592018865|FG001|After Infant Series|Protocol Violation|1|||
163904002|NCT00676091|592018864|FG000|After Infant Series|Failed to return|1|||
163904003|NCT00676091|592018865|FG001|After Infant Series|Failed to return|1|||
163904004|NCT00676091|592018864|FG000|Toddler Dose|Failed to return|2|||
163904005|NCT00676091|592018865|FG001|Toddler Dose|Failed to return|0|||
163904006|NCT00676091|592018864|FG000|Toddler Dose|Parent or legal guardian request|1|||
163904007|NCT00676091|592018865|FG001|Toddler Dose|Parent or legal guardian request|0|||
163904008|NCT00989196|592018871|FG000|Treatment Period|Lost to Follow-up|1|||
163904009|NCT00989196|592018872|FG001|Treatment Period|Lost to Follow-up|0|||
163904010|NCT04300023|592018875|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
163904011|NCT04300023|592018876|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
163904012|NCT05251363|592018877|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
163904013|NCT05251363|592018877|FG000|Overall Study After Implant Period|Death|9|||
163904014|NCT05251363|592018877|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
163904015|NCT05251363|592018877|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
163904016|NCT05251363|592018877|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
164015891|NCT02531373|592421785|FG001|Overall Study|Withdrawal by Subject|0|||
164015892|NCT02531373|592421786|FG002|Overall Study|Withdrawal by Subject|0|||
164015893|NCT02531373|592421787|FG003|Overall Study|Withdrawal by Subject|0|||
164015894|NCT02531373|592421788|FG004|Overall Study|Withdrawal by Subject|3|||
164015895|NCT02531373|592421789|FG005|Overall Study|Withdrawal by Subject|0|||
164015896|NCT02531373|592421790|FG006|Overall Study|Withdrawal by Subject|0|||
164015897|NCT02531373|592421791|FG007|Overall Study|Withdrawal by Subject|0|||
164015898|NCT02531373|592421792|FG008|Overall Study|Withdrawal by Subject|0|||
164015899|NCT01623531|592421793|FG000|Overall Study|Death|1|||
164015900|NCT01623531|592421794|FG001|Overall Study|Death|0|||
164015901|NCT01623531|592421793|FG000|Overall Study|Protocol Violation|2|||
164015902|NCT01623531|592421794|FG001|Overall Study|Protocol Violation|1|||
164015903|NCT01623531|592421793|FG000|Overall Study|Missing data at primary outcome time poi|1|||
164015904|NCT01623531|592421794|FG001|Overall Study|Missing data at primary outcome time poi|1|||
164015905|NCT02834403|592421795|FG000|Overall Study|Physician Decision|2|||
164015906|NCT02834403|592421796|FG001|Overall Study|Physician Decision|1|||
164015907|NCT02834403|592421797|FG002|Overall Study|Physician Decision|2|||
164015908|NCT02834403|592421798|FG003|Overall Study|Physician Decision|1|||
164015909|NCT02834403|592421799|FG004|Overall Study|Physician Decision|1|||
164015910|NCT02834403|592421800|FG005|Overall Study|Physician Decision|2|||
164015911|NCT02834403|592421801|FG006|Overall Study|Physician Decision|12|||
164015912|NCT02834403|592421795|FG000|Overall Study|Adverse Event|0|||
164015913|NCT02834403|592421796|FG001|Overall Study|Adverse Event|0|||
164015914|NCT02834403|592421797|FG002|Overall Study|Adverse Event|0|||
164015915|NCT02834403|592421798|FG003|Overall Study|Adverse Event|0|||
164015916|NCT02834403|592421799|FG004|Overall Study|Adverse Event|1|||
164015917|NCT02834403|592421800|FG005|Overall Study|Adverse Event|1|||
164015918|NCT02834403|592421801|FG006|Overall Study|Adverse Event|3|||
164015919|NCT02834403|592421795|FG000|Overall Study|Withdrawal by Subject|0|||
164015920|NCT02834403|592421796|FG001|Overall Study|Withdrawal by Subject|1|||
164015921|NCT02834403|592421797|FG002|Overall Study|Withdrawal by Subject|0|||
164015922|NCT02834403|592421798|FG003|Overall Study|Withdrawal by Subject|0|||
164015923|NCT02834403|592421799|FG004|Overall Study|Withdrawal by Subject|1|||
164015924|NCT02834403|592421800|FG005|Overall Study|Withdrawal by Subject|0|||
164015925|NCT02834403|592421801|FG006|Overall Study|Withdrawal by Subject|0|||
164015926|NCT02834403|592421795|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
164015927|NCT02834403|592421796|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
164015928|NCT02834403|592421797|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
164015929|NCT02834403|592421798|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
164015930|NCT02834403|592421799|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
164015931|NCT02834403|592421800|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
164015932|NCT02834403|592421801|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
164015933|NCT04705597|592421802|FG000|Overall Study|Death|16|||
164015934|NCT04705597|592421803|FG001|Overall Study|Death|9|||
164015935|NCT04705597|592421802|FG000|Overall Study|Lost to Follow-up|1|||
164015936|NCT04705597|592421803|FG001|Overall Study|Lost to Follow-up|0|||
164015937|NCT04705597|592421802|FG000|Overall Study|Withdrawal by Subject|1|||
164015938|NCT04705597|592421803|FG001|Overall Study|Withdrawal by Subject|2|||
164015939|NCT00390780|592421804|FG000|Overall Study|Not completed|10|||
164015940|NCT00390780|592421805|FG001|Overall Study|Not completed|4|||
164015941|NCT00390780|592421804|FG000|Overall Study|Protocol Violation|6|||
164015942|NCT00390780|592421805|FG001|Overall Study|Protocol Violation|4|||
164015943|NCT00390780|592421804|FG000|Overall Study|Lost to Follow-up|3|||
164015944|NCT00390780|592421805|FG001|Overall Study|Lost to Follow-up|6|||
164015945|NCT00390780|592421804|FG000|Overall Study|Adverse Event|2|||
164015946|NCT00390780|592421805|FG001|Overall Study|Adverse Event|3|||
164015947|NCT00390780|592421804|FG000|Overall Study|Death|1|||
164015948|NCT00390780|592421805|FG001|Overall Study|Death|3|||
164015949|NCT00390780|592421804|FG000|Overall Study|Withdrawal by Subject|1|||
164015950|NCT00390780|592421805|FG001|Overall Study|Withdrawal by Subject|2|||
164015951|NCT00390780|592421804|FG000|Overall Study|Inclusion criteria not satisfied|0|||
164093001|NCT00454636|592703432|FG000|Overall Study|Lost to Follow-up|0|||
164093002|NCT00454636|592703433|FG001|Overall Study|Lost to Follow-up|1|||
164093003|NCT00454636|592703434|FG002|Overall Study|Lost to Follow-up|0|||
164015952|NCT00390780|592421805|FG001|Overall Study|Inclusion criteria not satisfied|2|||
164015953|NCT00390780|592421804|FG000|Overall Study|Lost to follow up and other reasons|0|||
164015954|NCT00390780|592421805|FG001|Overall Study|Lost to follow up and other reasons|1|||
164015955|NCT00390780|592421804|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
164015956|NCT00390780|592421805|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
164093004|NCT00454636|592703435|FG003|Overall Study|Lost to Follow-up|0|||
164387604|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
164387605|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
164387606|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
164387607|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
164015957|NCT00390780|592421804|FG000|Overall Study|SAE, death|0|||
164015958|NCT00390780|592421805|FG001|Overall Study|SAE, death|1|||
164387608|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
164387609|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Death|0|||
164387610|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Death|0|||
164387611|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Death|0|||
164387612|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Death|0|||
164387613|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Death|0|||
164387614|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Death|0|||
164387615|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Death|0|||
164387616|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Death|0|||
164387617|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Death|0|||
164387618|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Death|0|||
164387619|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Death|0|||
164387620|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Death|0|||
164387621|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Death|0|||
164387622|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Death|0|||
164387623|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Death|0|||
164015959|NCT00305006|592421806|FG000|Overall Study|Withdrawal by Subject|1|||
164387624|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Death|0|||
164387625|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Death|0|||
164387626|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Death|0|||
164387627|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Death|1|||
164387628|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Death|0|||
164387629|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387630|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387631|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387632|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387633|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387634|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387635|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387636|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387637|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387638|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387639|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387640|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387641|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387642|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387643|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387644|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387645|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
164387646|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
164387647|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
164387648|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
164387649|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387650|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387651|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387652|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387653|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387654|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387655|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387656|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387657|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387658|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387659|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387660|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387661|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387662|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387663|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387664|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387665|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387666|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387667|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
164387668|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
164387669|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
164387670|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
164387671|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
164387672|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
164387673|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
164015960|NCT00305006|592421807|FG001|Overall Study|Withdrawal by Subject|0|||
164387674|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
164387675|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
164387676|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
164387677|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
164387678|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
164387679|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
164387680|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
164015961|NCT00305006|592421806|FG000|Overall Study|Failure to complete pretest|0|||
164015962|NCT00305006|592421807|FG001|Overall Study|Failure to complete pretest|1|||
164015963|NCT02606045|592421808|FG000|Overall Study|Study closed before treament could begin|1|||
164015964|NCT02606045|592421809|FG001|Overall Study|Study closed before treament could begin|2|||
164015965|NCT01996319|592421810|FG000|Overall Study|Protocol Violation|1|||
164015966|NCT01996319|592421811|FG001|Overall Study|Protocol Violation|0|||
164015967|NCT01996319|592421810|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
164015968|NCT01996319|592421811|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
164015969|NCT01996319|592421810|FG000|Overall Study|Adverse Event|2|||
164015970|NCT01996319|592421811|FG001|Overall Study|Adverse Event|2|||
164015971|NCT01671085|592421813|FG000|Overall Study|Withdrawal by Subject|1|||
164015972|NCT01671085|592421814|FG001|Overall Study|Withdrawal by Subject|0|||
164387681|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
164387682|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
164387683|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
164387684|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
164387685|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
164387686|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
164387687|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
164387688|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
164387689|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
164387690|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
164387691|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
164387692|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
164387693|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
164387694|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
164387695|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
164387696|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
164387697|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
164387698|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
164387699|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
164387700|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
164387701|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
164387702|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
164387703|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
164387704|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
164387705|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
164387706|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
164387707|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
164387708|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
164387709|NCT01490632|593788451|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387710|NCT01490632|593788452|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387711|NCT01490632|593788453|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387712|NCT01490632|593788454|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387713|NCT01490632|593788455|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387714|NCT01490632|593788456|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387715|NCT01490632|593788457|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387716|NCT01490632|593788458|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387717|NCT01490632|593788459|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164015973|NCT00637273|592421815|FG000|Overall Study|Adverse Event|11|||
164015974|NCT00637273|592421816|FG001|Overall Study|Adverse Event|5|||
164387718|NCT01490632|593788460|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387719|NCT01490632|593788461|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387720|NCT01490632|593788462|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387721|NCT01490632|593788463|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387722|NCT01490632|593788464|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164015975|NCT00637273|592421817|FG002|Overall Study|Adverse Event|7|||
164015976|NCT00637273|592421815|FG000|Overall Study|Lost to Follow-up|8|||
163904017|NCT05251363|592018877|FG000|Overall Study After Implant Period|Physician Decision|1|||
163904018|NCT05251363|592018877|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
163904019|NCT03070392|592020583|FG000|Overall Study|Not Treated|7|||
163904020|NCT03070392|592020584|FG001|Overall Study|Not Treated|0|||
163904021|NCT03070392|592020585|FG002|Overall Study|Not Treated|3|||
163904022|NCT03070392|592020586|FG003|Overall Study|Not Treated|12|||
163904023|NCT03070392|592020583|FG000|Overall Study|Death|3|||
163904024|NCT03070392|592020584|FG001|Overall Study|Death|0|||
163904025|NCT03070392|592020585|FG002|Overall Study|Death|0|||
163904026|NCT03070392|592020586|FG003|Overall Study|Death|1|||
163904027|NCT03070392|592020583|FG000|Overall Study|Withdrawal by Subject|7|||
163904028|NCT03070392|592020584|FG001|Overall Study|Withdrawal by Subject|0|||
163904029|NCT03070392|592020585|FG002|Overall Study|Withdrawal by Subject|0|||
163904030|NCT03070392|592020586|FG003|Overall Study|Withdrawal by Subject|3|||
163904031|NCT03070392|592020583|FG000|Overall Study|Physician Decision|1|||
163904032|NCT03070392|592020584|FG001|Overall Study|Physician Decision|0|||
163904033|NCT03070392|592020585|FG002|Overall Study|Physician Decision|0|||
163904034|NCT03070392|592020586|FG003|Overall Study|Physician Decision|2|||
163904035|NCT03070392|592020583|FG000|Overall Study|Progressive Disease|154|||
163904036|NCT03070392|592020584|FG001|Overall Study|Progressive Disease|6|||
163904037|NCT03070392|592020585|FG002|Overall Study|Progressive Disease|2|||
163904038|NCT03070392|592020586|FG003|Overall Study|Progressive Disease|70|||
163904039|NCT03070392|592020583|FG000|Overall Study|Adverse Event|6|||
163904040|NCT03070392|592020584|FG001|Overall Study|Adverse Event|1|||
163904041|NCT03070392|592020585|FG002|Overall Study|Adverse Event|1|||
163904042|NCT03070392|592020586|FG003|Overall Study|Adverse Event|3|||
163904043|NCT03070392|592020583|FG000|Overall Study|Alternate anticancer treatment|1|||
163904044|NCT03070392|592020584|FG001|Overall Study|Alternate anticancer treatment|0|||
163904045|NCT03070392|592020585|FG002|Overall Study|Alternate anticancer treatment|0|||
163904046|NCT03070392|592020586|FG003|Overall Study|Alternate anticancer treatment|1|||
163904047|NCT03070392|592020583|FG000|Overall Study|Ongoing|73|||
163904048|NCT03070392|592020584|FG001|Overall Study|Ongoing|0|||
163904049|NCT03070392|592020585|FG002|Overall Study|Ongoing|0|||
163904050|NCT03070392|592020586|FG003|Overall Study|Ongoing|11|||
163904051|NCT02972034|592020587|FG000|Overall Study|Death|11|||
163904052|NCT02972034|592020588|FG001|Overall Study|Death|1|||
163904053|NCT02972034|592020589|FG002|Overall Study|Death|3|||
163904054|NCT02972034|592020590|FG003|Overall Study|Death|3|||
163904055|NCT02972034|592020591|FG004|Overall Study|Death|2|||
163904056|NCT02972034|592020592|FG005|Overall Study|Death|2|||
163904057|NCT02972034|592020593|FG006|Overall Study|Death|3|||
163904058|NCT02972034|592020594|FG007|Overall Study|Death|4|||
163904059|NCT02972034|592020595|FG008|Overall Study|Death|8|||
163904060|NCT02972034|592020596|FG009|Overall Study|Death|11|||
163904061|NCT02972034|592020597|FG010|Overall Study|Death|3|||
163904062|NCT02972034|592020598|FG011|Overall Study|Death|2|||
163904063|NCT02972034|592020599|FG012|Overall Study|Death|11|||
163904064|NCT02972034|592020600|FG013|Overall Study|Death|10|||
163904065|NCT02972034|592020601|FG014|Overall Study|Death|9|||
163904066|NCT02972034|592020587|FG000|Overall Study|Lost to Follow-up|0|||
163904067|NCT02972034|592020588|FG001|Overall Study|Lost to Follow-up|0|||
163904068|NCT02972034|592020589|FG002|Overall Study|Lost to Follow-up|0|||
163904069|NCT02972034|592020590|FG003|Overall Study|Lost to Follow-up|0|||
163904070|NCT02972034|592020591|FG004|Overall Study|Lost to Follow-up|1|||
163904071|NCT02972034|592020592|FG005|Overall Study|Lost to Follow-up|0|||
164015977|NCT00637273|592421816|FG001|Overall Study|Lost to Follow-up|9|||
164015978|NCT00637273|592421817|FG002|Overall Study|Lost to Follow-up|13|||
164015979|NCT00637273|592421815|FG000|Overall Study|Protocol Violation|2|||
164015980|NCT00637273|592421816|FG001|Overall Study|Protocol Violation|4|||
163904072|NCT02972034|592020593|FG006|Overall Study|Lost to Follow-up|0|||
163904073|NCT02972034|592020594|FG007|Overall Study|Lost to Follow-up|1|||
163904074|NCT02972034|592020595|FG008|Overall Study|Lost to Follow-up|0|||
163904075|NCT02972034|592020596|FG009|Overall Study|Lost to Follow-up|0|||
163904076|NCT02972034|592020597|FG010|Overall Study|Lost to Follow-up|0|||
163904077|NCT02972034|592020598|FG011|Overall Study|Lost to Follow-up|0|||
163904078|NCT02972034|592020599|FG012|Overall Study|Lost to Follow-up|0|||
163904079|NCT02972034|592020600|FG013|Overall Study|Lost to Follow-up|0|||
163904080|NCT02972034|592020601|FG014|Overall Study|Lost to Follow-up|1|||
163904081|NCT02972034|592020587|FG000|Overall Study|Physician Decision|0|||
163904082|NCT02972034|592020588|FG001|Overall Study|Physician Decision|0|||
163904083|NCT02972034|592020589|FG002|Overall Study|Physician Decision|0|||
164015981|NCT00637273|592421817|FG002|Overall Study|Protocol Violation|1|||
164015982|NCT00637273|592421815|FG000|Overall Study|Withdrawal of Consent|18|||
164015983|NCT00637273|592421816|FG001|Overall Study|Withdrawal of Consent|6|||
163904084|NCT02972034|592020590|FG003|Overall Study|Physician Decision|0|||
163904085|NCT02972034|592020591|FG004|Overall Study|Physician Decision|0|||
164015984|NCT00637273|592421817|FG002|Overall Study|Withdrawal of Consent|18|||
163904086|NCT02972034|592020592|FG005|Overall Study|Physician Decision|0|||
163904087|NCT02972034|592020593|FG006|Overall Study|Physician Decision|0|||
163904088|NCT02972034|592020594|FG007|Overall Study|Physician Decision|1|||
163904089|NCT02972034|592020595|FG008|Overall Study|Physician Decision|0|||
163904090|NCT02972034|592020596|FG009|Overall Study|Physician Decision|0|||
164387723|NCT01490632|593788465|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387724|NCT01490632|593788466|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387725|NCT01490632|593788467|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
164387726|NCT01490632|593788468|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
164387727|NCT01490632|593788469|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
164387728|NCT01490632|593788470|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
164387729|NCT02332720|593788471|FG000|Part A and Part B|Lost to Follow-up|1|||
164387730|NCT02332720|593788472|FG001|Part A and Part B|Lost to Follow-up|0|||
164387731|NCT02332720|593788473|FG002|Part A and Part B|Lost to Follow-up|0|||
164387732|NCT02332720|593788474|FG003|Part A and Part B|Lost to Follow-up|0|||
164387733|NCT02332720|593788475|FG004|Part A and Part B|Lost to Follow-up|0|||
164387734|NCT02332720|593788476|FG005|Part A and Part B|Lost to Follow-up|2|||
164387735|NCT02332720|593788477|FG006|Part A and Part B|Lost to Follow-up|1|||
164387736|NCT02332720|593788478|FG007|Part A and Part B|Lost to Follow-up|1|||
164387737|NCT02332720|593788479|FG008|Part A and Part B|Lost to Follow-up|0|||
164387738|NCT02332720|593788480|FG009|Part A and Part B|Lost to Follow-up|0|||
164387739|NCT02332720|593788481|FG010|Part A and Part B|Lost to Follow-up|0|||
164387740|NCT02332720|593788482|FG011|Part A and Part B|Lost to Follow-up|0|||
164387741|NCT02332720|593788483|FG012|Part A and Part B|Lost to Follow-up|0|||
164387742|NCT02332720|593788484|FG013|Part A and Part B|Lost to Follow-up|0|||
164387743|NCT02332720|593788485|FG014|Part A and Part B|Lost to Follow-up|0|||
164387744|NCT02332720|593788486|FG015|Part A and Part B|Lost to Follow-up|1|||
164387745|NCT02332720|593788487|FG016|Part A and Part B|Lost to Follow-up|0|||
164387746|NCT02332720|593788488|FG017|Part A and Part B|Lost to Follow-up|0|||
164387747|NCT02332720|593788489|FG018|Part A and Part B|Lost to Follow-up|0|||
164015985|NCT00637273|592421815|FG000|Overall Study|Investigator Decision|1|||
164015986|NCT00637273|592421816|FG001|Overall Study|Investigator Decision|3|||
164015987|NCT00637273|592421817|FG002|Overall Study|Investigator Decision|1|||
164015988|NCT00637273|592421815|FG000|Overall Study|Administrative|2|||
164015989|NCT00637273|592421816|FG001|Overall Study|Administrative|0|||
164015990|NCT00637273|592421817|FG002|Overall Study|Administrative|0|||
164015991|NCT00637273|592421815|FG000|Overall Study|Loss of Glucose Control|1|||
164015992|NCT00637273|592421816|FG001|Overall Study|Loss of Glucose Control|1|||
164015993|NCT00637273|592421817|FG002|Overall Study|Loss of Glucose Control|1|||
164015994|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
164015995|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
164387748|NCT02332720|593788490|FG019|Part A and Part B|Lost to Follow-up|0|||
164387749|NCT02332720|593788491|FG020|Part A and Part B|Lost to Follow-up|0|||
164387750|NCT02332720|593788492|FG021|Part A and Part B|Lost to Follow-up|0|||
164387751|NCT02332720|593788493|FG022|Part A and Part B|Lost to Follow-up|0|||
164387752|NCT02332720|593788471|FG000|Part A and Part B|Adverse Event|0|||
164387753|NCT02332720|593788472|FG001|Part A and Part B|Adverse Event|0|||
164387754|NCT02332720|593788473|FG002|Part A and Part B|Adverse Event|0|||
164387755|NCT02332720|593788474|FG003|Part A and Part B|Adverse Event|0|||
163904091|NCT02972034|592020597|FG010|Overall Study|Physician Decision|1|||
163904092|NCT02972034|592020598|FG011|Overall Study|Physician Decision|0|||
164387756|NCT02332720|593788475|FG004|Part A and Part B|Adverse Event|0|||
164387757|NCT02332720|593788476|FG005|Part A and Part B|Adverse Event|0|||
164387758|NCT02332720|593788477|FG006|Part A and Part B|Adverse Event|0|||
164387759|NCT02332720|593788478|FG007|Part A and Part B|Adverse Event|0|||
164387760|NCT02332720|593788479|FG008|Part A and Part B|Adverse Event|0|||
164387761|NCT02332720|593788480|FG009|Part A and Part B|Adverse Event|0|||
164387762|NCT02332720|593788481|FG010|Part A and Part B|Adverse Event|0|||
164387763|NCT02332720|593788482|FG011|Part A and Part B|Adverse Event|0|||
164387764|NCT02332720|593788483|FG012|Part A and Part B|Adverse Event|0|||
164387765|NCT02332720|593788484|FG013|Part A and Part B|Adverse Event|0|||
164387766|NCT02332720|593788485|FG014|Part A and Part B|Adverse Event|0|||
164387767|NCT02332720|593788486|FG015|Part A and Part B|Adverse Event|0|||
163904093|NCT02972034|592020599|FG012|Overall Study|Physician Decision|0|||
163904094|NCT02972034|592020600|FG013|Overall Study|Physician Decision|0|||
163904095|NCT02972034|592020601|FG014|Overall Study|Physician Decision|0|||
164387768|NCT02332720|593788487|FG016|Part A and Part B|Adverse Event|0|||
164387769|NCT02332720|593788488|FG017|Part A and Part B|Adverse Event|1|||
164387770|NCT02332720|593788489|FG018|Part A and Part B|Adverse Event|0|||
164387771|NCT02332720|593788490|FG019|Part A and Part B|Adverse Event|0|||
164387772|NCT02332720|593788491|FG020|Part A and Part B|Adverse Event|0|||
164387773|NCT02332720|593788492|FG021|Part A and Part B|Adverse Event|0|||
164387774|NCT02332720|593788493|FG022|Part A and Part B|Adverse Event|0|||
164387775|NCT02332720|593788471|FG000|Part A and Part B|Physician Decision|0|||
164387776|NCT02332720|593788472|FG001|Part A and Part B|Physician Decision|0|||
164387777|NCT02332720|593788473|FG002|Part A and Part B|Physician Decision|0|||
164387778|NCT02332720|593788474|FG003|Part A and Part B|Physician Decision|0|||
164387779|NCT02332720|593788475|FG004|Part A and Part B|Physician Decision|0|||
164387780|NCT02332720|593788476|FG005|Part A and Part B|Physician Decision|0|||
164387781|NCT02332720|593788477|FG006|Part A and Part B|Physician Decision|0|||
164387782|NCT02332720|593788478|FG007|Part A and Part B|Physician Decision|0|||
164387783|NCT02332720|593788479|FG008|Part A and Part B|Physician Decision|0|||
164387784|NCT02332720|593788480|FG009|Part A and Part B|Physician Decision|0|||
164387785|NCT02332720|593788481|FG010|Part A and Part B|Physician Decision|0|||
164387786|NCT02332720|593788482|FG011|Part A and Part B|Physician Decision|0|||
164387787|NCT02332720|593788483|FG012|Part A and Part B|Physician Decision|0|||
164387788|NCT02332720|593788484|FG013|Part A and Part B|Physician Decision|0|||
163904096|NCT02972034|592020587|FG000|Overall Study|Sponsor Decision|0|||
164387789|NCT02332720|593788485|FG014|Part A and Part B|Physician Decision|0|||
164387790|NCT02332720|593788486|FG015|Part A and Part B|Physician Decision|0|||
164387791|NCT02332720|593788487|FG016|Part A and Part B|Physician Decision|0|||
164387792|NCT02332720|593788488|FG017|Part A and Part B|Physician Decision|0|||
164387793|NCT02332720|593788489|FG018|Part A and Part B|Physician Decision|1|||
164387794|NCT02332720|593788490|FG019|Part A and Part B|Physician Decision|0|||
164387795|NCT02332720|593788491|FG020|Part A and Part B|Physician Decision|0|||
164387796|NCT02332720|593788492|FG021|Part A and Part B|Physician Decision|0|||
164387797|NCT02332720|593788493|FG022|Part A and Part B|Physician Decision|0|||
164387798|NCT02332720|593788471|FG000|Part A and Part B|Withdrawal by Subject|0|||
164387799|NCT02332720|593788472|FG001|Part A and Part B|Withdrawal by Subject|0|||
164387800|NCT02332720|593788473|FG002|Part A and Part B|Withdrawal by Subject|0|||
164387801|NCT02332720|593788474|FG003|Part A and Part B|Withdrawal by Subject|0|||
164387802|NCT02332720|593788475|FG004|Part A and Part B|Withdrawal by Subject|0|||
164387803|NCT02332720|593788476|FG005|Part A and Part B|Withdrawal by Subject|1|||
164387804|NCT02332720|593788477|FG006|Part A and Part B|Withdrawal by Subject|0|||
164387805|NCT02332720|593788478|FG007|Part A and Part B|Withdrawal by Subject|0|||
164387806|NCT02332720|593788479|FG008|Part A and Part B|Withdrawal by Subject|0|||
164387807|NCT02332720|593788480|FG009|Part A and Part B|Withdrawal by Subject|0|||
164387808|NCT02332720|593788481|FG010|Part A and Part B|Withdrawal by Subject|0|||
164387809|NCT02332720|593788482|FG011|Part A and Part B|Withdrawal by Subject|0|||
164387810|NCT02332720|593788483|FG012|Part A and Part B|Withdrawal by Subject|0|||
164387811|NCT02332720|593788484|FG013|Part A and Part B|Withdrawal by Subject|0|||
164387812|NCT02332720|593788485|FG014|Part A and Part B|Withdrawal by Subject|0|||
164387813|NCT02332720|593788486|FG015|Part A and Part B|Withdrawal by Subject|0|||
164387814|NCT02332720|593788487|FG016|Part A and Part B|Withdrawal by Subject|0|||
164387815|NCT02332720|593788488|FG017|Part A and Part B|Withdrawal by Subject|0|||
164387816|NCT02332720|593788489|FG018|Part A and Part B|Withdrawal by Subject|0|||
164387817|NCT02332720|593788490|FG019|Part A and Part B|Withdrawal by Subject|1|||
164387818|NCT02332720|593788491|FG020|Part A and Part B|Withdrawal by Subject|0|||
164387819|NCT02332720|593788492|FG021|Part A and Part B|Withdrawal by Subject|0|||
164387820|NCT02332720|593788493|FG022|Part A and Part B|Withdrawal by Subject|0|||
164387821|NCT05732454|593788494|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
164387822|NCT05732454|593788495|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
164387823|NCT05732454|593788494|FG000|Part 1: DB Period|Adverse Event|1|||
164387824|NCT05732454|593788495|FG001|Part 1: DB Period|Adverse Event|0|||
164387825|NCT05732454|593788494|FG000|Part 1: DB Period|Lost to Follow-up|1|||
164387826|NCT05732454|593788495|FG001|Part 1: DB Period|Lost to Follow-up|0|||
164387827|NCT05732454|593788494|FG000|Part 1: DB Period|Protocol Violation|0|||
164387828|NCT05732454|593788495|FG001|Part 1: DB Period|Protocol Violation|1|||
164387829|NCT05732454|593788494|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
164387830|NCT05732454|593788495|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
164387831|NCT05732454|593788494|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
164387832|NCT05732454|593788495|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
164387833|NCT05732454|593788494|FG000|Part 1: OLE Period|Adverse Event|0|||
164387834|NCT05732454|593788495|FG001|Part 1: OLE Period|Adverse Event|1|||
164387835|NCT05732454|593788494|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
164387836|NCT05732454|593788495|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
164387837|NCT03725982|593788498|FG000|First Intervention|Withdrawal by Subject|0|||
164387838|NCT03725982|593788499|FG001|First Intervention|Withdrawal by Subject|1|||
164387839|NCT03725982|593788498|FG000|First Intervention|Physician Decision|1|||
164387840|NCT03725982|593788499|FG001|First Intervention|Physician Decision|1|||
164387841|NCT05912400|593788500|FG000|Overall Study|Lost to Follow-up|1|||
164387842|NCT05912400|593788501|FG001|Overall Study|Lost to Follow-up|0|||
164387843|NCT05912400|593788500|FG000|Overall Study|Physician Decision|6|||
164387844|NCT05912400|593788501|FG001|Overall Study|Physician Decision|0|||
164387845|NCT05912400|593788500|FG000|Overall Study|Withdrawal by Subject|1|||
164387846|NCT05912400|593788501|FG001|Overall Study|Withdrawal by Subject|0|||
164387847|NCT00838110|593788505|FG000|Overall Study|Death|0|||
164387848|NCT00838110|593788506|FG001|Overall Study|Death|0|||
164387849|NCT00838110|593788507|FG002|Overall Study|Death|1|||
164387850|NCT00838110|593788508|FG003|Overall Study|Death|2|||
164387851|NCT00838110|593788505|FG000|Overall Study|Adverse Event|11|||
164387852|NCT00838110|593788506|FG001|Overall Study|Adverse Event|10|||
164387853|NCT00838110|593788507|FG002|Overall Study|Adverse Event|8|||
164387854|NCT00838110|593788508|FG003|Overall Study|Adverse Event|7|||
164387855|NCT00838110|593788505|FG000|Overall Study|Withdrawal by Subject|5|||
164387856|NCT00838110|593788506|FG001|Overall Study|Withdrawal by Subject|6|||
164387857|NCT00838110|593788507|FG002|Overall Study|Withdrawal by Subject|3|||
164387858|NCT00838110|593788508|FG003|Overall Study|Withdrawal by Subject|4|||
164387859|NCT00838110|593788505|FG000|Overall Study|Other|3|||
164387860|NCT00838110|593788506|FG001|Overall Study|Other|3|||
164387861|NCT00838110|593788507|FG002|Overall Study|Other|3|||
164387862|NCT00838110|593788508|FG003|Overall Study|Other|2|||
164387863|NCT00838110|593788505|FG000|Overall Study|Protocol Violation|0|||
164387864|NCT00838110|593788506|FG001|Overall Study|Protocol Violation|2|||
164387865|NCT00838110|593788507|FG002|Overall Study|Protocol Violation|1|||
164387866|NCT00838110|593788508|FG003|Overall Study|Protocol Violation|1|||
164387867|NCT00838110|593788505|FG000|Overall Study|Lost to Follow-up|3|||
164387868|NCT00838110|593788506|FG001|Overall Study|Lost to Follow-up|0|||
164387869|NCT00838110|593788507|FG002|Overall Study|Lost to Follow-up|0|||
164387870|NCT00838110|593788508|FG003|Overall Study|Lost to Follow-up|0|||
164387871|NCT00838110|593788505|FG000|Overall Study|Did not meet eligibility criteria|0|||
164387872|NCT00838110|593788506|FG001|Overall Study|Did not meet eligibility criteria|0|||
164387873|NCT00838110|593788507|FG002|Overall Study|Did not meet eligibility criteria|1|||
164387874|NCT00838110|593788508|FG003|Overall Study|Did not meet eligibility criteria|2|||
164387875|NCT00838110|593788505|FG000|Overall Study|Randomized but not treated|0|||
164387876|NCT00838110|593788506|FG001|Overall Study|Randomized but not treated|1|||
164387877|NCT00838110|593788507|FG002|Overall Study|Randomized but not treated|0|||
164387878|NCT00838110|593788508|FG003|Overall Study|Randomized but not treated|0|||
164387879|NCT00352365|593788509|FG000|Induction Therapy|Adverse Event|7|||
164387880|NCT00352365|593788509|FG000|Induction Therapy|Progression/Relapse|8|||
164387881|NCT00352365|593788509|FG000|Induction Therapy|Death|7|||
164387882|NCT00352365|593788509|FG000|Induction Therapy|Not protocol specified|1|||
164387883|NCT00352365|593788509|FG000|Induction Therapy|Not eligible|3|||
164387884|NCT00352365|593788509|FG000|Induction Therapy|Death before starting protocol therapy|1|||
164387885|NCT00352365|593788509|FG000|Maintenance Therapy|Progression/Relapse|3|||
164387886|NCT00352365|593788509|FG000|Maintenance Therapy|Death|2|||
164387887|NCT00352365|593788509|FG000|Maintenance Therapy|Not protocol specified|3|||
164387888|NCT00352365|593788509|FG000|Maintenance Therapy|Not eligible|4|||
164387889|NCT01262651|593788510|FG000|Overall Study|Adverse Event|40|||
164387890|NCT01262651|593788511|FG001|Overall Study|Adverse Event|35|||
164387891|NCT01262651|593788510|FG000|Overall Study|Withdrawal by Subject|15|||
164387892|NCT01262651|593788511|FG001|Overall Study|Withdrawal by Subject|11|||
164387893|NCT01262651|593788510|FG000|Overall Study|Withdrawal by Investigator|2|||
164387894|NCT01262651|593788511|FG001|Overall Study|Withdrawal by Investigator|2|||
164387895|NCT01262651|593788510|FG000|Overall Study|Met Withdrawal Criteria|1|||
164387896|NCT01262651|593788511|FG001|Overall Study|Met Withdrawal Criteria|0|||
164387897|NCT04743908|593788512|FG000|Overall Study|Death|1|||
164387898|NCT04743908|593788513|FG001|Overall Study|Death|0|||
164387899|NCT04743908|593788512|FG000|Overall Study|Lost to Follow-up|181|||
164387900|NCT04743908|593788513|FG001|Overall Study|Lost to Follow-up|180|||
164387901|NCT04743908|593788512|FG000|Overall Study|Withdrawal by Subject|1|||
164387902|NCT04743908|593788513|FG001|Overall Study|Withdrawal by Subject|2|||
164387903|NCT03822533|593788514|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
164387904|NCT03822533|593788515|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
164387905|NCT03822533|593788514|FG000|3 Month Follow-up|Lost to Follow-up|2|||
164387906|NCT03822533|593788515|FG001|3 Month Follow-up|Lost to Follow-up|2|||
164387907|NCT03822533|593788514|FG000|6 Month Follow-up|Lost to Follow-up|3|||
164387908|NCT03822533|593788515|FG001|6 Month Follow-up|Lost to Follow-up|0|||
164387909|NCT03822533|593788514|FG000|12 Month Follow-up|Lost to Follow-up|2|||
164387910|NCT03822533|593788515|FG001|12 Month Follow-up|Lost to Follow-up|3|||
164387911|NCT03822533|593788514|FG000|12 Month Follow-up|Pregnancy|0|||
164387912|NCT03822533|593788515|FG001|12 Month Follow-up|Pregnancy|1|||
164387913|NCT03822533|593788514|FG000|12 Month Follow-up|Surgery|2|||
164387914|NCT03822533|593788515|FG001|12 Month Follow-up|Surgery|0|||
164387915|NCT03822533|593788514|FG000|12 Month Follow-up|Wrong address|1|||
164387916|NCT03822533|593788515|FG001|12 Month Follow-up|Wrong address|0|||
164387917|NCT03822533|593788514|FG000|12 Month Follow-up|No symptoms|1|||
163904097|NCT02972034|592020588|FG001|Overall Study|Sponsor Decision|0|||
163904098|NCT02972034|592020589|FG002|Overall Study|Sponsor Decision|0|||
163904099|NCT02972034|592020590|FG003|Overall Study|Sponsor Decision|1|||
163904100|NCT02972034|592020591|FG004|Overall Study|Sponsor Decision|0|||
163904101|NCT02972034|592020592|FG005|Overall Study|Sponsor Decision|0|||
163904102|NCT02972034|592020593|FG006|Overall Study|Sponsor Decision|1|||
163904103|NCT02972034|592020594|FG007|Overall Study|Sponsor Decision|1|||
163904104|NCT02972034|592020595|FG008|Overall Study|Sponsor Decision|1|||
163904105|NCT02972034|592020596|FG009|Overall Study|Sponsor Decision|2|||
163904106|NCT02972034|592020597|FG010|Overall Study|Sponsor Decision|2|||
163904107|NCT02972034|592020598|FG011|Overall Study|Sponsor Decision|0|||
163904108|NCT02972034|592020599|FG012|Overall Study|Sponsor Decision|1|||
163904109|NCT02972034|592020600|FG013|Overall Study|Sponsor Decision|0|||
163904110|NCT02972034|592020601|FG014|Overall Study|Sponsor Decision|1|||
163904111|NCT02972034|592020587|FG000|Overall Study|Withdrawal by Subject|3|||
163904112|NCT02972034|592020588|FG001|Overall Study|Withdrawal by Subject|0|||
163904113|NCT02972034|592020589|FG002|Overall Study|Withdrawal by Subject|0|||
163904114|NCT02972034|592020590|FG003|Overall Study|Withdrawal by Subject|0|||
163904115|NCT02972034|592020591|FG004|Overall Study|Withdrawal by Subject|1|||
163904116|NCT02972034|592020592|FG005|Overall Study|Withdrawal by Subject|1|||
163904117|NCT02972034|592020593|FG006|Overall Study|Withdrawal by Subject|0|||
163904118|NCT02972034|592020594|FG007|Overall Study|Withdrawal by Subject|0|||
163904119|NCT02972034|592020595|FG008|Overall Study|Withdrawal by Subject|1|||
163904120|NCT02972034|592020596|FG009|Overall Study|Withdrawal by Subject|1|||
163904121|NCT02972034|592020597|FG010|Overall Study|Withdrawal by Subject|2|||
163904122|NCT02972034|592020598|FG011|Overall Study|Withdrawal by Subject|1|||
163904123|NCT02972034|592020599|FG012|Overall Study|Withdrawal by Subject|1|||
163904124|NCT02972034|592020600|FG013|Overall Study|Withdrawal by Subject|1|||
163904125|NCT02972034|592020601|FG014|Overall Study|Withdrawal by Subject|0|||
163904126|NCT02972034|592020587|FG000|Overall Study|Screen Failure|0|||
163904127|NCT02972034|592020588|FG001|Overall Study|Screen Failure|0|||
163904128|NCT02972034|592020589|FG002|Overall Study|Screen Failure|0|||
163904129|NCT02972034|592020590|FG003|Overall Study|Screen Failure|0|||
163904130|NCT02972034|592020591|FG004|Overall Study|Screen Failure|0|||
163904131|NCT02972034|592020592|FG005|Overall Study|Screen Failure|0|||
163904132|NCT02972034|592020593|FG006|Overall Study|Screen Failure|0|||
163904133|NCT02972034|592020594|FG007|Overall Study|Screen Failure|0|||
163904134|NCT02972034|592020595|FG008|Overall Study|Screen Failure|0|||
163904135|NCT02972034|592020596|FG009|Overall Study|Screen Failure|0|||
163904136|NCT02972034|592020597|FG010|Overall Study|Screen Failure|0|||
163904137|NCT02972034|592020598|FG011|Overall Study|Screen Failure|0|||
163904138|NCT02972034|592020599|FG012|Overall Study|Screen Failure|1|||
163904139|NCT02972034|592020600|FG013|Overall Study|Screen Failure|0|||
163904140|NCT02972034|592020601|FG014|Overall Study|Screen Failure|0|||
163904141|NCT03861052|592020602|FG000|Overall Study|Adverse Event|1|||
163904142|NCT03861052|592020603|FG001|Overall Study|Adverse Event|1|||
163904143|NCT03861052|592020604|FG002|Overall Study|Adverse Event|2|||
163904144|NCT03861052|592020605|FG003|Overall Study|Adverse Event|4|||
163904145|NCT03861052|592020602|FG000|Overall Study|Lost to Follow-up|0|||
163904146|NCT03861052|592020603|FG001|Overall Study|Lost to Follow-up|0|||
163904147|NCT03861052|592020604|FG002|Overall Study|Lost to Follow-up|0|||
163904148|NCT03861052|592020605|FG003|Overall Study|Lost to Follow-up|1|||
163904149|NCT03861052|592020602|FG000|Overall Study|Physician Decision|0|||
163904150|NCT03861052|592020603|FG001|Overall Study|Physician Decision|1|||
163904151|NCT03861052|592020604|FG002|Overall Study|Physician Decision|0|||
163904152|NCT03861052|592020605|FG003|Overall Study|Physician Decision|0|||
163904153|NCT03861052|592020602|FG000|Overall Study|Withdrawal by Subject|2|||
163904154|NCT03861052|592020603|FG001|Overall Study|Withdrawal by Subject|5|||
163904155|NCT03861052|592020604|FG002|Overall Study|Withdrawal by Subject|3|||
163904156|NCT03861052|592020605|FG003|Overall Study|Withdrawal by Subject|0|||
163904157|NCT03861052|592020602|FG000|Overall Study|Relocation to other city|1|||
163904158|NCT03861052|592020603|FG001|Overall Study|Relocation to other city|0|||
163904159|NCT03861052|592020604|FG002|Overall Study|Relocation to other city|0|||
163904160|NCT03861052|592020605|FG003|Overall Study|Relocation to other city|0|||
163904161|NCT03009344|592020606|FG000|Overall Study|Lack of Efficacy|5|||
163904162|NCT03009344|592020606|FG000|Overall Study|Withdrawal by Subject|1|||
163904163|NCT03009344|592020606|FG000|Overall Study|Adverse Event|1|||
163904164|NCT03678688|592020607|FG000|Overall Study|Reason not Specified|0|||
163904165|NCT03678688|592020608|FG001|Overall Study|Reason not Specified|0|||
163904166|NCT03678688|592020609|FG002|Overall Study|Reason not Specified|3|||
163904167|NCT03678688|592020610|FG003|Overall Study|Reason not Specified|0|||
163904168|NCT03678688|592020611|FG004|Overall Study|Reason not Specified|1|||
163904169|NCT03678688|592020612|FG005|Overall Study|Reason not Specified|0|||
163904170|NCT03678688|592020613|FG006|Overall Study|Reason not Specified|0|||
164015996|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164015997|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164015998|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164387918|NCT03822533|593788515|FG001|12 Month Follow-up|No symptoms|0|||
164387919|NCT03822533|593788514|FG000|12 Month Follow-up|Changed primary care center|0|||
164387920|NCT03822533|593788515|FG001|12 Month Follow-up|Changed primary care center|1|||
164387921|NCT01412944|593788518|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387922|NCT01412944|593788519|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387923|NCT01412944|593788520|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
164387924|NCT01412944|593788521|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387925|NCT01412944|593788522|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387926|NCT01412944|593788523|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
164387927|NCT01412944|593788518|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387928|NCT01412944|593788519|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387929|NCT01412944|593788520|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387930|NCT01412944|593788521|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387931|NCT01412944|593788522|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
164387932|NCT01412944|593788523|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
164387933|NCT01412944|593788518|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387934|NCT01412944|593788519|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387935|NCT01412944|593788520|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387936|NCT01412944|593788521|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387937|NCT01412944|593788522|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
164387938|NCT01412944|593788523|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
164387939|NCT01412944|593788518|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
164387940|NCT01412944|593788519|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387941|NCT01412944|593788520|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387942|NCT01412944|593788521|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387943|NCT01412944|593788522|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387944|NCT01412944|593788523|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
164387945|NCT01412944|593788518|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
164387946|NCT01412944|593788519|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
164387947|NCT01412944|593788520|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
164387948|NCT01412944|593788521|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
164387949|NCT01412944|593788522|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
164387950|NCT01412944|593788523|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
164387951|NCT01412944|593788518|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387952|NCT01412944|593788519|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
164387953|NCT01412944|593788520|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387954|NCT01412944|593788521|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387955|NCT01412944|593788522|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387956|NCT01412944|593788523|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
164387957|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387958|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387959|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387960|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387961|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387962|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387963|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Adverse Event|0|||
164387964|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Adverse Event|0|||
164387965|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Adverse Event|0|||
164387966|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Adverse Event|0|||
164387967|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Adverse Event|1|||
164387968|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Adverse Event|0|||
164387969|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
164387970|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
164387971|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
164387972|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
164387973|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
164387974|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
164387975|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387976|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387977|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387978|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387979|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
164387980|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
164387981|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387982|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387983|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387984|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387985|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
164387986|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
164387987|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
164387988|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
164387989|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387990|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387991|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387992|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
164387993|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
164387994|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
164387995|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
164387996|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
164387997|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
164387998|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
164387999|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388000|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
164388001|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388002|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388003|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388004|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
164388005|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388006|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
164388007|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388008|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388009|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388010|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
164388011|NCT01412944|593788518|FG000|Entire: IV + Maintenance|Adverse Event|0|||
164388012|NCT01412944|593788519|FG001|Entire: IV + Maintenance|Adverse Event|1|||
164388013|NCT01412944|593788520|FG002|Entire: IV + Maintenance|Adverse Event|0|||
164388014|NCT01412944|593788521|FG003|Entire: IV + Maintenance|Adverse Event|0|||
164388015|NCT01412944|593788522|FG004|Entire: IV + Maintenance|Adverse Event|0|||
164388016|NCT01412944|593788523|FG005|Entire: IV + Maintenance|Adverse Event|0|||
164388017|NCT01990950|593788524|FG000|Overall Study|Death|3|||
164388018|NCT01990950|593788524|FG000|Overall Study|Lost to Follow-up|2|||
164388019|NCT01990950|593788524|FG000|Overall Study|Withdrawal by Subject|6|||
164388020|NCT02863926|593788525|FG000|Overall Study|Physician Decision|1|||
164388021|NCT02863926|593788526|FG001|Overall Study|Physician Decision|0|||
164388022|NCT02863926|593788525|FG000|Overall Study|Lost to Follow-up|1|||
164388023|NCT02863926|593788526|FG001|Overall Study|Lost to Follow-up|1|||
164388024|NCT02019719|593788532|FG000|Overall Study|Adverse Event|1|||
164388025|NCT02019719|593788533|FG001|Overall Study|Adverse Event|0|||
164388026|NCT02019719|593788534|FG002|Overall Study|Adverse Event|0|||
164388027|NCT02019719|593788535|FG003|Overall Study|Adverse Event|1|||
164388028|NCT02019719|593788536|FG004|Overall Study|Adverse Event|1|||
164388029|NCT02019719|593788532|FG000|Overall Study|Protocol Violation|1|||
164388030|NCT02019719|593788533|FG001|Overall Study|Protocol Violation|1|||
164388031|NCT02019719|593788534|FG002|Overall Study|Protocol Violation|0|||
164388032|NCT02019719|593788535|FG003|Overall Study|Protocol Violation|0|||
164388033|NCT02019719|593788536|FG004|Overall Study|Protocol Violation|0|||
164388034|NCT02019719|593788532|FG000|Overall Study|Protocol defined stopping criteria|2|||
164388035|NCT02019719|593788533|FG001|Overall Study|Protocol defined stopping criteria|0|||
164388036|NCT02019719|593788534|FG002|Overall Study|Protocol defined stopping criteria|0|||
164388037|NCT02019719|593788535|FG003|Overall Study|Protocol defined stopping criteria|1|||
164388038|NCT02019719|593788536|FG004|Overall Study|Protocol defined stopping criteria|1|||
164388039|NCT02019719|593788532|FG000|Overall Study|Physician Decision|2|||
164388040|NCT02019719|593788533|FG001|Overall Study|Physician Decision|0|||
164388041|NCT02019719|593788534|FG002|Overall Study|Physician Decision|0|||
164388042|NCT02019719|593788535|FG003|Overall Study|Physician Decision|0|||
164388043|NCT02019719|593788536|FG004|Overall Study|Physician Decision|0|||
164388044|NCT02417246|593788537|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
164388045|NCT02417246|593788538|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
164388046|NCT02417246|593788537|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
164388047|NCT02417246|593788538|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
164388048|NCT02417246|593788537|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
164388049|NCT02417246|593788538|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
164388050|NCT02417246|593788537|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
164388051|NCT02417246|593788538|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
164388052|NCT01921348|593788543|FG000|Overall Study|Withdrawal by Subject|1|||
164388053|NCT01921348|593788544|FG001|Overall Study|Withdrawal by Subject|0|||
163904171|NCT03678688|592020614|FG007|Overall Study|Reason not Specified|0|||
163904172|NCT03678688|592020615|FG008|Overall Study|Reason not Specified|0|||
163904173|NCT03678688|592020607|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
164388054|NCT01921348|593788543|FG000|Overall Study|Lost to Follow-up|0|||
164388055|NCT01921348|593788544|FG001|Overall Study|Lost to Follow-up|2|||
164388056|NCT02896855|593788547|FG000|Overall Study|Death|50|||
164388057|NCT02896855|593788548|FG001|Overall Study|Death|40|||
164388058|NCT02896855|593788547|FG000|Overall Study|Lost to Follow-up|15|||
163904174|NCT03678688|592020608|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
163904175|NCT03678688|592020609|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
163904176|NCT03678688|592020610|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
163904177|NCT03678688|592020611|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
163904178|NCT03678688|592020612|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
163904179|NCT03678688|592020613|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
163904180|NCT03678688|592020614|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
163904181|NCT03678688|592020615|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
163904182|NCT03678688|592020607|FG000|Overall Study|Covid Related Adverse Event|0|||
163904183|NCT03678688|592020608|FG001|Overall Study|Covid Related Adverse Event|0|||
163904184|NCT03678688|592020609|FG002|Overall Study|Covid Related Adverse Event|0|||
163904185|NCT03678688|592020610|FG003|Overall Study|Covid Related Adverse Event|0|||
163904186|NCT03678688|592020611|FG004|Overall Study|Covid Related Adverse Event|0|||
163904187|NCT03678688|592020612|FG005|Overall Study|Covid Related Adverse Event|3|||
163904188|NCT03678688|592020613|FG006|Overall Study|Covid Related Adverse Event|1|||
163904189|NCT03678688|592020614|FG007|Overall Study|Covid Related Adverse Event|1|||
163904190|NCT03678688|592020615|FG008|Overall Study|Covid Related Adverse Event|0|||
163904191|NCT03678688|592020607|FG000|Overall Study|Physician Decision|0|||
163904192|NCT03678688|592020608|FG001|Overall Study|Physician Decision|0|||
163904193|NCT03678688|592020609|FG002|Overall Study|Physician Decision|0|||
163904194|NCT03678688|592020610|FG003|Overall Study|Physician Decision|0|||
163904195|NCT03678688|592020611|FG004|Overall Study|Physician Decision|0|||
163904196|NCT03678688|592020612|FG005|Overall Study|Physician Decision|1|||
163904197|NCT03678688|592020613|FG006|Overall Study|Physician Decision|0|||
163904198|NCT03678688|592020614|FG007|Overall Study|Physician Decision|0|||
163904199|NCT03678688|592020615|FG008|Overall Study|Physician Decision|0|||
163904200|NCT03678688|592020607|FG000|Overall Study|Withdrawal by Subject|0|||
163904201|NCT03678688|592020608|FG001|Overall Study|Withdrawal by Subject|0|||
163904202|NCT03678688|592020609|FG002|Overall Study|Withdrawal by Subject|0|||
163904203|NCT03678688|592020610|FG003|Overall Study|Withdrawal by Subject|0|||
163904204|NCT03678688|592020611|FG004|Overall Study|Withdrawal by Subject|0|||
163904205|NCT03678688|592020612|FG005|Overall Study|Withdrawal by Subject|0|||
163904206|NCT03678688|592020613|FG006|Overall Study|Withdrawal by Subject|2|||
163904207|NCT03678688|592020614|FG007|Overall Study|Withdrawal by Subject|1|||
163904208|NCT03678688|592020615|FG008|Overall Study|Withdrawal by Subject|0|||
163904209|NCT02534233|592020621|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
163904210|NCT03136159|592020623|FG000|Overall Study|chorioamnionitis|2|||
163904211|NCT03136159|592020624|FG001|Overall Study|chorioamnionitis|0|||
163904212|NCT03136159|592020623|FG000|Overall Study|vertical skin incision|1|||
163904213|NCT03136159|592020624|FG001|Overall Study|vertical skin incision|0|||
163904214|NCT03136159|592020623|FG000|Overall Study|additional dressing|1|||
163904215|NCT03136159|592020624|FG001|Overall Study|additional dressing|0|||
163904216|NCT03136159|592020623|FG000|Overall Study|never got dressing placed|1|||
163904217|NCT03136159|592020624|FG001|Overall Study|never got dressing placed|0|||
163904218|NCT03823703|592020625|FG000|Overall Study|Sponsor request|0|||
163904219|NCT03823703|592020626|FG001|Overall Study|Sponsor request|3|||
163904220|NCT03823703|592020627|FG002|Overall Study|Sponsor request|4|||
163904221|NCT03823703|592020625|FG000|Overall Study|Adverse Event|3|||
163904222|NCT03823703|592020626|FG001|Overall Study|Adverse Event|1|||
163904223|NCT03823703|592020627|FG002|Overall Study|Adverse Event|0|||
163904224|NCT03823703|592020625|FG000|Overall Study|Withdrawal by Subject|0|||
163904225|NCT03823703|592020626|FG001|Overall Study|Withdrawal by Subject|1|||
163904226|NCT03823703|592020627|FG002|Overall Study|Withdrawal by Subject|0|||
163904227|NCT00799409|592020628|FG000|Overall Study|Withdrawal by Subject|1|||
164388059|NCT02896855|593788548|FG001|Overall Study|Lost to Follow-up|9|||
163904228|NCT00799409|592020629|FG001|Overall Study|Withdrawal by Subject|0|||
163904229|NCT00799409|592020630|FG002|Overall Study|Withdrawal by Subject|0|||
163904230|NCT00799409|592020628|FG000|Overall Study|Lost to Follow-up|1|||
163904231|NCT00799409|592020629|FG001|Overall Study|Lost to Follow-up|0|||
163904232|NCT00799409|592020630|FG002|Overall Study|Lost to Follow-up|0|||
163904233|NCT00799409|592020628|FG000|Overall Study|Optimal Dose Not Achieved|2|||
163904234|NCT00799409|592020629|FG001|Overall Study|Optimal Dose Not Achieved|0|||
163904235|NCT00799409|592020630|FG002|Overall Study|Optimal Dose Not Achieved|0|||
164388060|NCT02896855|593788547|FG000|Overall Study|Withdrawal by Subject|7|||
163904236|NCT00799409|592020628|FG000|Overall Study|Failure to follow study protocol)|1|||
164388061|NCT02896855|593788548|FG001|Overall Study|Withdrawal by Subject|4|||
164388062|NCT01205685|593788549|FG000|Overall Study|Disease Progression|10|||
164388063|NCT01205685|593788549|FG000|Overall Study|Withdrawal by Subject|1|||
164388064|NCT02169674|593788550|FG000|Overall Study|Withdrawal by Subject|2|||
164388065|NCT02169674|593788551|FG001|Overall Study|Withdrawal by Subject|1|||
164388066|NCT02169674|593788550|FG000|Overall Study|Seroprotected|30|||
164388067|NCT02169674|593788551|FG001|Overall Study|Seroprotected|76|||
164388068|NCT02169674|593788550|FG000|Overall Study|Lost to Follow-up|0|||
164388069|NCT02169674|593788551|FG001|Overall Study|Lost to Follow-up|1|||
164388070|NCT03525834|593788554|FG000|Overall Study|Progressive disease|1|||
164388071|NCT00941603|593788557|FG000|Overall Study|Adverse Event|10|||
164388072|NCT00941603|593788558|FG001|Overall Study|Adverse Event|15|||
164388073|NCT00941603|593788559|FG002|Overall Study|Adverse Event|5|||
164388074|NCT00941603|593788560|FG003|Overall Study|Adverse Event|1|||
163904237|NCT00799409|592020629|FG001|Overall Study|Failure to follow study protocol)|0|||
163904238|NCT00799409|592020630|FG002|Overall Study|Failure to follow study protocol)|0|||
163904239|NCT00799409|592020628|FG000|Overall Study|Did not attend lab school day 1|1|||
163904240|NCT00799409|592020629|FG001|Overall Study|Did not attend lab school day 1|0|||
163904241|NCT00799409|592020630|FG002|Overall Study|Did not attend lab school day 1|0|||
163904242|NCT00799409|592020628|FG000|Overall Study|medication compliance|1|||
163904243|NCT00799409|592020629|FG001|Overall Study|medication compliance|0|||
163904244|NCT00799409|592020630|FG002|Overall Study|medication compliance|0|||
163904245|NCT04323800|592020631|FG000|Overall Study|Withdrawal by Subject|4|||
163904246|NCT04323800|592020632|FG001|Overall Study|Withdrawal by Subject|4|||
163904247|NCT04323800|592020631|FG000|Overall Study|Incomplete transfusion|1|||
163904248|NCT04323800|592020632|FG001|Overall Study|Incomplete transfusion|0|||
163904249|NCT04323800|592020631|FG000|Overall Study|Other|0|||
163904250|NCT04323800|592020632|FG001|Overall Study|Other|1|||
163904251|NCT04323800|592020631|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
163904252|NCT04323800|592020632|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
163904253|NCT00489554|592020633|FG000|Overall Study|Adverse Event|2|||
164073006|NCT01408576|592632758|FG002|Overall Study|Other|18|||
164073007|NCT00802529|592632759|FG000|Overall Study|Lost to Follow-up|0|||
164073008|NCT00802529|592632760|FG001|Overall Study|Lost to Follow-up|1|||
164073009|NCT00552617|592632763|FG000|Overall Study|Not Treated|0|||
164073010|NCT00552617|592632764|FG001|Overall Study|Not Treated|0|||
164073011|NCT00552617|592632765|FG002|Overall Study|Not Treated|1|||
164073012|NCT00552617|592632766|FG003|Overall Study|Not Treated|0|||
164073013|NCT00552617|592632767|FG004|Overall Study|Not Treated|0|||
164388075|NCT00941603|593788561|FG004|Overall Study|Adverse Event|4|||
164388076|NCT00941603|593788562|FG005|Overall Study|Adverse Event|0|||
164388077|NCT00941603|593788557|FG000|Overall Study|Lost to Follow-up|0|||
164388078|NCT00941603|593788558|FG001|Overall Study|Lost to Follow-up|0|||
164388079|NCT00941603|593788559|FG002|Overall Study|Lost to Follow-up|0|||
164388080|NCT00941603|593788560|FG003|Overall Study|Lost to Follow-up|1|||
164388081|NCT00941603|593788561|FG004|Overall Study|Lost to Follow-up|0|||
164388082|NCT00941603|593788562|FG005|Overall Study|Lost to Follow-up|2|||
164388083|NCT00941603|593788557|FG000|Overall Study|Withdrawal by Subject|0|||
164388084|NCT00941603|593788558|FG001|Overall Study|Withdrawal by Subject|0|||
164388085|NCT00941603|593788559|FG002|Overall Study|Withdrawal by Subject|0|||
164388086|NCT00941603|593788560|FG003|Overall Study|Withdrawal by Subject|2|||
164388087|NCT00941603|593788561|FG004|Overall Study|Withdrawal by Subject|0|||
164388088|NCT00941603|593788562|FG005|Overall Study|Withdrawal by Subject|1|||
164388089|NCT00941603|593788557|FG000|Overall Study|Protocol Violation|0|||
164388090|NCT00941603|593788558|FG001|Overall Study|Protocol Violation|1|||
164388091|NCT00941603|593788559|FG002|Overall Study|Protocol Violation|0|||
164388092|NCT00941603|593788560|FG003|Overall Study|Protocol Violation|0|||
164388093|NCT00941603|593788561|FG004|Overall Study|Protocol Violation|0|||
164388094|NCT00941603|593788562|FG005|Overall Study|Protocol Violation|0|||
164388095|NCT00941603|593788557|FG000|Overall Study|Did not meet protocol eligibility|1|||
164388096|NCT00941603|593788558|FG001|Overall Study|Did not meet protocol eligibility|0|||
164388097|NCT00941603|593788559|FG002|Overall Study|Did not meet protocol eligibility|0|||
164388098|NCT00941603|593788560|FG003|Overall Study|Did not meet protocol eligibility|0|||
164388099|NCT00941603|593788561|FG004|Overall Study|Did not meet protocol eligibility|0|||
164388100|NCT00941603|593788562|FG005|Overall Study|Did not meet protocol eligibility|0|||
164388101|NCT03879798|593788565|FG000|Overall Study|Adverse Event|0|||
164388102|NCT03879798|593788566|FG001|Overall Study|Adverse Event|0|||
164388103|NCT03879798|593788567|FG002|Overall Study|Adverse Event|0|||
164388104|NCT03879798|593788568|FG003|Overall Study|Adverse Event|0|||
164388105|NCT03879798|593788569|FG004|Overall Study|Adverse Event|0|||
164388106|NCT03879798|593788570|FG005|Overall Study|Adverse Event|1|||
164388107|NCT03879798|593788565|FG000|Overall Study|Lack of Efficacy|0|||
164388108|NCT03879798|593788566|FG001|Overall Study|Lack of Efficacy|0|||
164388109|NCT03879798|593788567|FG002|Overall Study|Lack of Efficacy|0|||
164388110|NCT03879798|593788568|FG003|Overall Study|Lack of Efficacy|0|||
164388111|NCT03879798|593788569|FG004|Overall Study|Lack of Efficacy|0|||
164388112|NCT03879798|593788570|FG005|Overall Study|Lack of Efficacy|1|||
164388113|NCT03879798|593788565|FG000|Overall Study|Withdrawal by Subject|0|||
164388114|NCT03879798|593788566|FG001|Overall Study|Withdrawal by Subject|0|||
164388115|NCT03879798|593788567|FG002|Overall Study|Withdrawal by Subject|0|||
164388116|NCT03879798|593788568|FG003|Overall Study|Withdrawal by Subject|0|||
164388117|NCT03879798|593788569|FG004|Overall Study|Withdrawal by Subject|0|||
164388118|NCT03879798|593788570|FG005|Overall Study|Withdrawal by Subject|1|||
164388119|NCT01343407|593788571|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
164388120|NCT01343407|593788572|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
164388121|NCT01343407|593788573|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
164388122|NCT01343407|593788574|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
164388123|NCT01343407|593788575|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
164388124|NCT01343407|593788576|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
164388125|NCT01343407|593788571|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388126|NCT01343407|593788572|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388127|NCT01343407|593788573|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
164388128|NCT01343407|593788574|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388129|NCT01343407|593788575|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388130|NCT01343407|593788576|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
164388131|NCT06027216|593788577|FG000|Overall Study|Did not qualify|8|||
164388132|NCT01732835|593788581|FG000|6-month Primary Endpoint|Did not receive device|19|||
164388133|NCT01732835|593788581|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
164388134|NCT01732835|593788581|FG000|6-month Primary Endpoint|Adverse Event|3|||
164388135|NCT01732835|593788581|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
164388136|NCT01732835|593788581|FG000|2-year Extended Follow-up|Adverse Event|3|||
164388137|NCT01732835|593788581|FG000|2-year Extended Follow-up|Death|1|||
164388138|NCT00874029|593788586|FG000|Overall Study|Withdrawal by Subject|10|||
164388139|NCT00874029|593788586|FG000|Overall Study|Pregnancy|4|||
164388140|NCT00874029|593788586|FG000|Overall Study|Physician Decision|1|||
164388141|NCT00874029|593788586|FG000|Overall Study|Adverse Event|1|||
164388142|NCT00874029|593788586|FG000|Overall Study|Lost to Follow-up|5|||
164388143|NCT01767116|593788587|FG000|Overall Study|Lost to Follow-up|2|||
164388144|NCT01767116|593788588|FG001|Overall Study|Lost to Follow-up|2|||
164388145|NCT00968669|593788589|FG000|Overall Study|Lost to Follow-up|5|||
164388146|NCT00968669|593788590|FG001|Overall Study|Lost to Follow-up|2|||
164388147|NCT00968669|593788591|FG002|Overall Study|Lost to Follow-up|1|||
164388148|NCT00968669|593788592|FG003|Overall Study|Lost to Follow-up|4|||
164388149|NCT00968669|593788589|FG000|Overall Study|Withdrawal by Subject|9|||
164388150|NCT00968669|593788590|FG001|Overall Study|Withdrawal by Subject|7|||
164388151|NCT00968669|593788591|FG002|Overall Study|Withdrawal by Subject|5|||
164388152|NCT00968669|593788592|FG003|Overall Study|Withdrawal by Subject|3|||
164388153|NCT00968669|593788589|FG000|Overall Study|Pregnancy|0|||
164388154|NCT00968669|593788590|FG001|Overall Study|Pregnancy|0|||
163904254|NCT00489554|592020633|FG000|Overall Study|Withdrawal by Subject|1|||
163904255|NCT00489554|592020633|FG000|Overall Study|Lost to Follow-up|1|||
163904256|NCT01732757|592020634|FG000|Overall Study|Lost to Follow-up|1|||
163904257|NCT01732757|592020635|FG001|Overall Study|Lost to Follow-up|0|||
163904258|NCT01732757|592020636|FG002|Overall Study|Lost to Follow-up|0|||
163904259|NCT00925548|592020637|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
163904260|NCT00925548|592020638|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
163904261|NCT00731692|592020640|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
163904262|NCT00731692|592020641|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
163904263|NCT00731692|592020642|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
163904264|NCT00731692|592020640|FG000|Core Study (36 Months)|Physician Decision|1|||
163904265|NCT00731692|592020641|FG001|Core Study (36 Months)|Physician Decision|0|||
163904266|NCT00731692|592020642|FG002|Core Study (36 Months)|Physician Decision|2|||
163904267|NCT00731692|592020640|FG000|Core Study (36 Months)|Death|2|||
163904268|NCT00731692|592020641|FG001|Core Study (36 Months)|Death|1|||
163904269|NCT00731692|592020642|FG002|Core Study (36 Months)|Death|2|||
163904270|NCT00731692|592020640|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
163904271|NCT00731692|592020641|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
163904272|NCT00731692|592020642|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
163904273|NCT00731692|592020640|FG000|Core Study (36 Months)|Administrative|2|||
163904274|NCT00731692|592020641|FG001|Core Study (36 Months)|Administrative|2|||
163904275|NCT00731692|592020642|FG002|Core Study (36 Months)|Administrative|6|||
163904276|NCT00731692|592020640|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
163904277|NCT00731692|592020641|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
163904278|NCT00731692|592020642|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
163904279|NCT00731692|592020640|FG000|Core Study (36 Months)|Protocol Violation|4|||
163904280|NCT00731692|592020641|FG001|Core Study (36 Months)|Protocol Violation|5|||
163904281|NCT00731692|592020642|FG002|Core Study (36 Months)|Protocol Violation|8|||
163904282|NCT00731692|592020640|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
163904283|NCT00731692|592020641|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
163904284|NCT00731692|592020642|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
163904285|NCT00731692|592020640|FG000|Core Study (36 Months)|Adverse Event|25|||
163904286|NCT00731692|592020641|FG001|Core Study (36 Months)|Adverse Event|28|||
163904287|NCT00731692|592020642|FG002|Core Study (36 Months)|Adverse Event|29|||
163904288|NCT00731692|592020640|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
163904289|NCT00731692|592020641|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
163904290|NCT00731692|592020642|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
163904291|NCT00731692|592020640|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
163904292|NCT00731692|592020641|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
163904293|NCT00731692|592020642|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
163904294|NCT00731692|592020640|FG000|Extension Phase|Abnormal test procedure|0|||
163904295|NCT00731692|592020641|FG001|Extension Phase|Abnormal test procedure|0|||
163904296|NCT00731692|592020642|FG002|Extension Phase|Abnormal test procedure|1|||
163904297|NCT00731692|592020640|FG000|Extension Phase|Abnormal lab values|0|||
163904298|NCT00731692|592020641|FG001|Extension Phase|Abnormal lab values|0|||
163904299|NCT00731692|592020642|FG002|Extension Phase|Abnormal lab values|1|||
164093005|NCT00806156|592703436|FG000|Overall Study|Death|35|||
164388155|NCT00968669|593788591|FG002|Overall Study|Pregnancy|2|||
164388156|NCT00968669|593788592|FG003|Overall Study|Pregnancy|0|||
164388157|NCT00968669|593788589|FG000|Overall Study|AE|1|||
164388158|NCT00968669|593788590|FG001|Overall Study|AE|0|||
164388159|NCT00968669|593788591|FG002|Overall Study|AE|0|||
164388160|NCT00968669|593788592|FG003|Overall Study|AE|0|||
164388161|NCT00968669|593788589|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
164388162|NCT00968669|593788590|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
164388163|NCT00968669|593788591|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
164388164|NCT00968669|593788592|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
164388165|NCT00968669|593788589|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
164388166|NCT00968669|593788590|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
164388167|NCT00968669|593788591|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
163904300|NCT00731692|592020640|FG000|Extension Phase|Lost to Follow-up|0|||
164093006|NCT00806156|592703437|FG001|Overall Study|Death|95|||
164388168|NCT00968669|593788592|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
164388169|NCT00968669|593788589|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
163904301|NCT00731692|592020641|FG001|Extension Phase|Lost to Follow-up|1|||
163904302|NCT00731692|592020642|FG002|Extension Phase|Lost to Follow-up|4|||
164093007|NCT00806156|592703436|FG000|Overall Study|Did not meet eligibility criteria|1|||
164144034|NCT00086281|592888573|FG002|Phase 2|Adverse Event|0|||
164388170|NCT00968669|593788590|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
164388171|NCT00968669|593788591|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
164388172|NCT00968669|593788592|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
164388173|NCT00968669|593788589|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
164388174|NCT00968669|593788590|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
164388175|NCT00968669|593788591|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
164388176|NCT00968669|593788592|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
164388177|NCT00968669|593788589|FG000|Overall Study|EARLY WITHDRAWAL|0|||
164388178|NCT00968669|593788590|FG001|Overall Study|EARLY WITHDRAWAL|1|||
164388179|NCT00968669|593788591|FG002|Overall Study|EARLY WITHDRAWAL|0|||
164388180|NCT00968669|593788592|FG003|Overall Study|EARLY WITHDRAWAL|0|||
164388181|NCT00968669|593788589|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
164388182|NCT00968669|593788590|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
164388183|NCT00968669|593788591|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
164388184|NCT00968669|593788592|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
164388185|NCT00968669|593788589|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
164388186|NCT00968669|593788590|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
164388187|NCT00968669|593788591|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
164388188|NCT00968669|593788592|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
164388189|NCT00968669|593788589|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
164388190|NCT00968669|593788590|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
164388191|NCT00968669|593788591|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
164388192|NCT00968669|593788592|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
164388193|NCT00968669|593788589|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
164388194|NCT00968669|593788590|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
164388195|NCT00968669|593788591|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
164388196|NCT00968669|593788592|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
164388197|NCT00968669|593788589|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
164388198|NCT00968669|593788590|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
163904303|NCT00731692|592020640|FG000|Extension Phase|Withdrawal by Subject|4|||
163904304|NCT00731692|592020641|FG001|Extension Phase|Withdrawal by Subject|5|||
163904305|NCT00731692|592020642|FG002|Extension Phase|Withdrawal by Subject|3|||
164388199|NCT00968669|593788591|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
164388200|NCT00968669|593788592|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
163904306|NCT00731692|592020640|FG000|Extension Phase|Adverse Event|1|||
164388201|NCT00968669|593788589|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
164388202|NCT00968669|593788590|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
164388203|NCT00968669|593788591|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
164388204|NCT00968669|593788592|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
164388205|NCT00968669|593788589|FG000|Overall Study|SPONSOR DECISION|0|||
163904307|NCT00731692|592020641|FG001|Extension Phase|Adverse Event|1|||
163904308|NCT00731692|592020642|FG002|Extension Phase|Adverse Event|15|||
163904309|NCT00458783|592020643|FG000|Overall Study|Protocol Violation|1228|||
163904310|NCT00458783|592020644|FG001|Overall Study|Protocol Violation|1220|||
163904311|NCT01737398|592020645|FG000|Overall Study|Adverse event or SAE|16|||
163904312|NCT01737398|592020646|FG001|Overall Study|Adverse event or SAE|1|||
163904313|NCT01737398|592020645|FG000|Overall Study|Stopping rule met|2|||
163904314|NCT01737398|592020646|FG001|Overall Study|Stopping rule met|1|||
163904315|NCT01737398|592020645|FG000|Overall Study|Voluntary withdrawal|2|||
163904316|NCT01737398|592020646|FG001|Overall Study|Voluntary withdrawal|3|||
163904317|NCT01737398|592020645|FG000|Overall Study|Ineligibility|1|||
163904318|NCT01737398|592020646|FG001|Overall Study|Ineligibility|0|||
163904319|NCT01737398|592020645|FG000|Overall Study|Liver transplant|1|||
163904320|NCT01737398|592020646|FG001|Overall Study|Liver transplant|0|||
163904321|NCT01737398|592020645|FG000|Overall Study|Disease progression|2|||
163904322|NCT01737398|592020646|FG001|Overall Study|Disease progression|3|||
163904323|NCT01737398|592020645|FG000|Overall Study|Sponsor's decision|2|||
163904324|NCT01737398|592020646|FG001|Overall Study|Sponsor's decision|0|||
163904325|NCT02372799|592020647|FG000|Treatment Period|Adverse Event|3|||
163904326|NCT02372799|592020648|FG001|Treatment Period|Adverse Event|10|||
163904327|NCT02372799|592020649|FG002|Treatment Period|Adverse Event|6|||
163904328|NCT02372799|592020647|FG000|Treatment Period|Insufficient therapeutic response|2|||
163904329|NCT02372799|592020648|FG001|Treatment Period|Insufficient therapeutic response|2|||
163904330|NCT02372799|592020649|FG002|Treatment Period|Insufficient therapeutic response|0|||
163904331|NCT02372799|592020647|FG000|Treatment Period|Withdrawal by Subject|10|||
163904332|NCT02372799|592020648|FG001|Treatment Period|Withdrawal by Subject|10|||
163904333|NCT02372799|592020649|FG002|Treatment Period|Withdrawal by Subject|2|||
163904334|NCT02372799|592020647|FG000|Treatment Period|Lost to Follow-up|11|||
163904335|NCT02372799|592020648|FG001|Treatment Period|Lost to Follow-up|5|||
163904336|NCT02372799|592020649|FG002|Treatment Period|Lost to Follow-up|3|||
163904337|NCT02372799|592020647|FG000|Treatment Period|Protocol Violation|3|||
163904338|NCT02372799|592020648|FG001|Treatment Period|Protocol Violation|0|||
163904339|NCT02372799|592020649|FG002|Treatment Period|Protocol Violation|0|||
163904340|NCT02372799|592020647|FG000|Treatment Period|Non-compliance with study drug|4|||
163904341|NCT02372799|592020648|FG001|Treatment Period|Non-compliance with study drug|4|||
163904342|NCT02372799|592020649|FG002|Treatment Period|Non-compliance with study drug|4|||
163904343|NCT02372799|592020647|FG000|Treatment Period|Miscellaneous Reasons|1|||
163904344|NCT02372799|592020648|FG001|Treatment Period|Miscellaneous Reasons|1|||
163904345|NCT02372799|592020649|FG002|Treatment Period|Miscellaneous Reasons|0|||
163904346|NCT02372799|592020647|FG000|Down-taper Period|Lost to Follow-up|1|||
163904347|NCT02372799|592020648|FG001|Down-taper Period|Lost to Follow-up|2|||
163904348|NCT02372799|592020649|FG002|Down-taper Period|Lost to Follow-up|2|||
163904349|NCT00089609|592020650|FG000|Overall Study|Withdrawal by Subject|3|||
163904350|NCT00089609|592020651|FG001|Overall Study|Withdrawal by Subject|1|||
163904351|NCT00747006|592020652|FG000|Overall Study|Adverse Event|1|||
163904352|NCT00747006|592020653|FG001|Overall Study|Adverse Event|0|||
163904353|NCT00747006|592020654|FG002|Overall Study|Adverse Event|0|||
163904354|NCT00747006|592020652|FG000|Overall Study|Lost to Follow-up|0|||
163904355|NCT00747006|592020653|FG001|Overall Study|Lost to Follow-up|1|||
163904356|NCT00747006|592020654|FG002|Overall Study|Lost to Follow-up|0|||
163904357|NCT00747006|592020652|FG000|Overall Study|Physician Decision|2|||
163904358|NCT00747006|592020653|FG001|Overall Study|Physician Decision|0|||
163904359|NCT00747006|592020654|FG002|Overall Study|Physician Decision|1|||
163904360|NCT00357994|592020655|FG000|Overall Study|Adverse Event|1|||
163904361|NCT00357994|592020656|FG001|Overall Study|Adverse Event|2|||
163904362|NCT00357994|592020655|FG000|Overall Study|Lack of Efficacy|0|||
163904363|NCT00357994|592020656|FG001|Overall Study|Lack of Efficacy|1|||
164015999|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164016000|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
163904364|NCT00357994|592020655|FG000|Overall Study|Protocol Violation|1|||
163904365|NCT00357994|592020656|FG001|Overall Study|Protocol Violation|0|||
164016001|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164016002|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
164016003|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164016004|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164016005|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
164016006|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164016007|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
164016008|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
164016009|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
163904366|NCT02132949|592020661|FG000|Overall Study|Death|7|||
163904367|NCT02132949|592020662|FG001|Overall Study|Death|13|||
163904368|NCT02132949|592020661|FG000|Overall Study|Lost to Follow-up|14|||
163904369|NCT02132949|592020662|FG001|Overall Study|Lost to Follow-up|4|||
163904370|NCT02132949|592020661|FG000|Overall Study|Withdrawal by Subject|6|||
163904371|NCT02132949|592020662|FG001|Overall Study|Withdrawal by Subject|5|||
163904372|NCT02132949|592020661|FG000|Overall Study|Noncompliance|5|||
163904373|NCT02132949|592020662|FG001|Overall Study|Noncompliance|1|||
163904374|NCT02132949|592020661|FG000|Overall Study|Physician Decision|3|||
163904375|NCT02132949|592020662|FG001|Overall Study|Physician Decision|1|||
163904376|NCT02132949|592020661|FG000|Overall Study|Disease Progression|3|||
163904377|NCT02132949|592020662|FG001|Overall Study|Disease Progression|0|||
163904378|NCT02132949|592020661|FG000|Overall Study|Adverse Event|2|||
163904379|NCT02132949|592020662|FG001|Overall Study|Adverse Event|1|||
163904380|NCT02132949|592020661|FG000|Overall Study|Withdrew Prior to Treatment|1|||
163904381|NCT02132949|592020662|FG001|Overall Study|Withdrew Prior to Treatment|2|||
163904382|NCT02132949|592020661|FG000|Overall Study|Reason Unspecified|0|||
163904383|NCT02132949|592020662|FG001|Overall Study|Reason Unspecified|1|||
163904384|NCT00745875|592020669|FG000|Overall Study|Continuing study treatment|4|||
163904385|NCT00745875|592020670|FG001|Overall Study|Continuing study treatment|4|||
163904386|NCT01833455|592020673|FG000|Overall Study|Withdrawal by Subject|1|||
163904387|NCT01833455|592020674|FG001|Overall Study|Withdrawal by Subject|0|||
163904388|NCT03689946|592020677|FG000|Overall Study|Withdrawal by Subject|3|||
163904389|NCT03689946|592020677|FG000|Overall Study|Lost to Follow-up|3|||
163904390|NCT03689946|592020677|FG000|Overall Study|Data corruption|2|||
163904391|NCT02203799|592020682|FG000|Overall Study|Withdrawal by Subject|3|||
163904392|NCT02384382|592020685|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
163904393|NCT02384382|592020685|FG000|Overall Study|Death|1|||
163904394|NCT02384382|592020685|FG000|Overall Study|Adverse Event|1|||
163904395|NCT02384382|592020685|FG000|Overall Study|Disease progression|16|||
163904396|NCT01953692|592020686|FG000|Overall Study|Adverse Event|5|||
163904397|NCT01953692|592020687|FG001|Overall Study|Adverse Event|2|||
163904398|NCT01953692|592020688|FG002|Overall Study|Adverse Event|4|||
163904399|NCT01953692|592020689|FG003|Overall Study|Adverse Event|2|||
163904400|NCT01953692|592020690|FG004|Overall Study|Adverse Event|1|||
163904401|NCT01953692|592020691|FG005|Overall Study|Adverse Event|2|||
163904402|NCT01953692|592020692|FG006|Overall Study|Adverse Event|0|||
163904403|NCT01953692|592020693|FG007|Overall Study|Adverse Event|0|||
163904404|NCT01953692|592020694|FG008|Overall Study|Adverse Event|0|||
163904405|NCT01953692|592020686|FG000|Overall Study|Clinical Progression|0|||
163904406|NCT01953692|592020687|FG001|Overall Study|Clinical Progression|15|||
163904407|NCT01953692|592020688|FG002|Overall Study|Clinical Progression|7|||
163904408|NCT01953692|592020689|FG003|Overall Study|Clinical Progression|5|||
163904409|NCT01953692|592020690|FG004|Overall Study|Clinical Progression|0|||
163904410|NCT01953692|592020691|FG005|Overall Study|Clinical Progression|7|||
163904411|NCT01953692|592020692|FG006|Overall Study|Clinical Progression|20|||
163904412|NCT01953692|592020693|FG007|Overall Study|Clinical Progression|3|||
163904413|NCT01953692|592020694|FG008|Overall Study|Clinical Progression|3|||
163904414|NCT01953692|592020686|FG000|Overall Study|Death|5|||
163904415|NCT01953692|592020687|FG001|Overall Study|Death|0|||
163904416|NCT01953692|592020688|FG002|Overall Study|Death|2|||
163904417|NCT01953692|592020689|FG003|Overall Study|Death|2|||
163904418|NCT01953692|592020690|FG004|Overall Study|Death|1|||
163904419|NCT01953692|592020691|FG005|Overall Study|Death|3|||
163904420|NCT01953692|592020692|FG006|Overall Study|Death|6|||
163904421|NCT01953692|592020693|FG007|Overall Study|Death|2|||
163904422|NCT01953692|592020694|FG008|Overall Study|Death|1|||
163904423|NCT01953692|592020686|FG000|Overall Study|Excluded Medication|1|||
163904424|NCT01953692|592020687|FG001|Overall Study|Excluded Medication|0|||
163904425|NCT01953692|592020688|FG002|Overall Study|Excluded Medication|0|||
163904426|NCT01953692|592020689|FG003|Overall Study|Excluded Medication|0|||
163904427|NCT01953692|592020690|FG004|Overall Study|Excluded Medication|0|||
163904428|NCT01953692|592020691|FG005|Overall Study|Excluded Medication|0|||
163904429|NCT01953692|592020692|FG006|Overall Study|Excluded Medication|0|||
163904430|NCT01953692|592020693|FG007|Overall Study|Excluded Medication|0|||
163904431|NCT01953692|592020694|FG008|Overall Study|Excluded Medication|0|||
163904432|NCT01953692|592020686|FG000|Overall Study|Lost to Follow-up|1|||
163904433|NCT01953692|592020687|FG001|Overall Study|Lost to Follow-up|0|||
163904434|NCT01953692|592020688|FG002|Overall Study|Lost to Follow-up|3|||
163904435|NCT01953692|592020689|FG003|Overall Study|Lost to Follow-up|1|||
163904436|NCT01953692|592020690|FG004|Overall Study|Lost to Follow-up|0|||
163904437|NCT01953692|592020691|FG005|Overall Study|Lost to Follow-up|1|||
163904438|NCT01953692|592020692|FG006|Overall Study|Lost to Follow-up|0|||
164016010|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
164388206|NCT00968669|593788590|FG001|Overall Study|SPONSOR DECISION|1|||
164388207|NCT00968669|593788591|FG002|Overall Study|SPONSOR DECISION|0|||
164388208|NCT00968669|593788592|FG003|Overall Study|SPONSOR DECISION|0|||
163904439|NCT01953692|592020693|FG007|Overall Study|Lost to Follow-up|0|||
163904440|NCT01953692|592020694|FG008|Overall Study|Lost to Follow-up|0|||
163904441|NCT01953692|592020686|FG000|Overall Study|Physician Decision|11|||
163904442|NCT01953692|592020687|FG001|Overall Study|Physician Decision|4|||
163904443|NCT01953692|592020688|FG002|Overall Study|Physician Decision|2|||
163904444|NCT01953692|592020689|FG003|Overall Study|Physician Decision|2|||
163904445|NCT01953692|592020690|FG004|Overall Study|Physician Decision|1|||
163904446|NCT01953692|592020691|FG005|Overall Study|Physician Decision|2|||
163904447|NCT01953692|592020692|FG006|Overall Study|Physician Decision|4|||
163904448|NCT01953692|592020693|FG007|Overall Study|Physician Decision|1|||
164388209|NCT00968669|593788589|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
164388210|NCT00968669|593788590|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
164388211|NCT00968669|593788591|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
164388212|NCT00968669|593788592|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
164388213|NCT00968669|593788589|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
164388214|NCT00968669|593788590|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
164388215|NCT00968669|593788591|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
164388216|NCT00968669|593788592|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
164388217|NCT00968669|593788589|FG000|Overall Study|SUBJECT INCARCERATED|0|||
164388218|NCT00968669|593788590|FG001|Overall Study|SUBJECT INCARCERATED|1|||
164388219|NCT00968669|593788591|FG002|Overall Study|SUBJECT INCARCERATED|0|||
164388220|NCT00968669|593788592|FG003|Overall Study|SUBJECT INCARCERATED|0|||
164388221|NCT00968669|593788589|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
164388222|NCT00968669|593788590|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
164388223|NCT00968669|593788591|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
164388224|NCT00968669|593788592|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
164388225|NCT00968669|593788589|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
164388226|NCT00968669|593788590|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
164093008|NCT00806156|592703437|FG001|Overall Study|Did not meet eligibility criteria|0|||
164093009|NCT00806156|592703436|FG000|Overall Study|Study terminated by Sponsor|2|||
164388227|NCT00968669|593788591|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
164388228|NCT00968669|593788592|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
164388229|NCT04798586|593788595|FG000|Overall Study|Death|2|||
164388230|NCT01669343|593788597|FG000|Part A: All Patients|Withdrawal by Subject|7|||
164388231|NCT01669343|593788597|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
164388232|NCT01669343|593788597|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
164388233|NCT01669343|593788597|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
164388234|NCT01669343|593788597|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
164388235|NCT00968617|593788598|FG000|Overall Study|Study terminated by sponsor|6|||
164388236|NCT04433767|593788599|FG000|Overall Study|Adverse Event|1|||
164388237|NCT02371369|593788604|FG000|Part 1|Physician Decision|0|||
164388238|NCT02371369|593788605|FG001|Part 1|Physician Decision|3|||
164388239|NCT02371369|593788604|FG000|Part 1|Adverse Event|8|||
164388240|NCT02371369|593788605|FG001|Part 1|Adverse Event|0|||
164093010|NCT00806156|592703437|FG001|Overall Study|Study terminated by Sponsor|40|||
164093011|NCT00806156|592703436|FG000|Overall Study|Consent withdrawn by subject|1|||
164093012|NCT00806156|592703437|FG001|Overall Study|Consent withdrawn by subject|3|||
164093013|NCT00806156|592703436|FG000|Overall Study|Lost to Follow-up|0|||
164093014|NCT00806156|592703437|FG001|Overall Study|Lost to Follow-up|1|||
164093015|NCT01025037|592703442|FG000|Overall Study|Adverse Event|3|||
164093016|NCT01025037|592703442|FG000|Overall Study|Lost to Follow-up|7|||
164093017|NCT01025037|592703442|FG000|Overall Study|Withdrawal by Subject|1|||
164093018|NCT02674334|592703443|FG000|Overall Study|Lost to Follow-up|5|||
164093019|NCT02674334|592703444|FG001|Overall Study|Lost to Follow-up|3|||
164093020|NCT02674334|592703443|FG000|Overall Study|participant difficulty breathing|1|||
164093021|NCT02674334|592703444|FG001|Overall Study|participant difficulty breathing|0|||
164093022|NCT02674334|592703443|FG000|Overall Study|NIRS not recording|1|||
164093023|NCT02674334|592703444|FG001|Overall Study|NIRS not recording|0|||
164093024|NCT00860405|592703455|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
164093025|NCT00860405|592703456|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
164093026|NCT00864097|592703457|FG000|Overall Study|Death|0|||
164093027|NCT00864097|592703458|FG001|Overall Study|Death|1|||
164093028|NCT00864097|592703459|FG002|Overall Study|Death|0|||
164093029|NCT00864097|592703460|FG003|Overall Study|Death|0|||
164093030|NCT00864097|592703457|FG000|Overall Study|Adverse Event|6|||
164093031|NCT00864097|592703458|FG001|Overall Study|Adverse Event|8|||
164093032|NCT00864097|592703459|FG002|Overall Study|Adverse Event|11|||
164388241|NCT02371369|593788604|FG000|Part 1|Withdrawal by Subject|1|||
164388242|NCT02371369|593788605|FG001|Part 1|Withdrawal by Subject|6|||
164388243|NCT02371369|593788604|FG000|Part 1|Disease progression|0|||
164388244|NCT02371369|593788605|FG001|Part 1|Disease progression|1|||
164388245|NCT02371369|593788604|FG000|Part 1|Protocol Violation|0|||
164388246|NCT02371369|593788605|FG001|Part 1|Protocol Violation|1|||
164388247|NCT02371369|593788604|FG000|Part 2|Adverse Event|6|||
164388248|NCT02371369|593788605|FG001|Part 2|Adverse Event|5|||
164388249|NCT02371369|593788604|FG000|Part 2|Withdrawal by Subject|16|||
164388250|NCT02371369|593788605|FG001|Part 2|Withdrawal by Subject|6|||
164388251|NCT02371369|593788604|FG000|Part 2|Investigator decision|1|||
164388252|NCT02371369|593788605|FG001|Part 2|Investigator decision|2|||
164388253|NCT02371369|593788604|FG000|Part 2|Death|0|||
164388254|NCT02371369|593788605|FG001|Part 2|Death|1|||
164388255|NCT02371369|593788604|FG000|Part 2|Disease progression|1|||
164388256|NCT02371369|593788605|FG001|Part 2|Disease progression|0|||
164388257|NCT02371369|593788604|FG000|Part 2|Subject Noncompliance|1|||
164388258|NCT02371369|593788605|FG001|Part 2|Subject Noncompliance|0|||
164388259|NCT02371369|593788604|FG000|Part 2|Lost to Follow-up|1|||
164388260|NCT02371369|593788605|FG001|Part 2|Lost to Follow-up|1|||
164388261|NCT02371369|593788604|FG000|Part 2|Subject transitioned to commercial supply|6|||
164388262|NCT02371369|593788605|FG001|Part 2|Subject transitioned to commercial supply|4|||
164388263|NCT02371369|593788604|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
164388264|NCT02371369|593788605|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
164388265|NCT02371369|593788604|FG000|Part 2|Surgical resection of tumor|1|||
164388266|NCT02371369|593788605|FG001|Part 2|Surgical resection of tumor|1|||
164388267|NCT02371369|593788604|FG000|Part 2|Other|0|||
164388268|NCT02371369|593788605|FG001|Part 2|Other|1|||
164388269|NCT01024387|593788606|FG000|Overall Study|Radiographic Progression|29|||
164388270|NCT01024387|593788606|FG000|Overall Study|Symptomatic Progression|10|||
164388271|NCT01024387|593788606|FG000|Overall Study|Physician Decision|5|||
164388272|NCT01024387|593788606|FG000|Overall Study|Withdrawal by Subject|5|||
164388273|NCT01024387|593788606|FG000|Overall Study|Death|2|||
164388274|NCT01024387|593788606|FG000|Overall Study|Prolonged Treatment Delay|1|||
164388275|NCT01024387|593788606|FG000|Overall Study|Adverse Event|3|||
164388276|NCT01024387|593788606|FG000|Overall Study|Other|5|||
164388277|NCT03855189|593788607|FG000|Overall Study|Adverse Event|5|||
164388278|NCT03855189|593788608|FG001|Overall Study|Adverse Event|2|||
164388279|NCT03855189|593788609|FG002|Overall Study|Adverse Event|4|||
164388280|NCT03855189|593788607|FG000|Overall Study|Treatment Failure|1|||
164388281|NCT03855189|593788608|FG001|Overall Study|Treatment Failure|1|||
164388282|NCT03855189|593788609|FG002|Overall Study|Treatment Failure|2|||
164388283|NCT03855189|593788607|FG000|Overall Study|Noncompliance with Protocol|0|||
164388284|NCT03855189|593788608|FG001|Overall Study|Noncompliance with Protocol|1|||
164388285|NCT03855189|593788609|FG002|Overall Study|Noncompliance with Protocol|0|||
164388286|NCT03855189|593788607|FG000|Overall Study|Did Not Return|4|||
164388287|NCT03855189|593788608|FG001|Overall Study|Did Not Return|3|||
164388288|NCT03855189|593788609|FG002|Overall Study|Did Not Return|0|||
164388289|NCT01143259|593788610|FG000|Overall Study|Withdrawal by Subject|3|||
164388290|NCT01143259|593788611|FG001|Overall Study|Withdrawal by Subject|2|||
164388291|NCT01143259|593788610|FG000|Overall Study|Protocol Violation|13|||
164388292|NCT01143259|593788611|FG001|Overall Study|Protocol Violation|9|||
164388293|NCT01143259|593788610|FG000|Overall Study|Screen Failure|7|||
164388294|NCT01143259|593788611|FG001|Overall Study|Screen Failure|9|||
164388295|NCT04307186|593788612|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
164388296|NCT04307186|593788612|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
164388297|NCT04307186|593788612|FG000|Washout 3-14 Days|Progressive disease|1|||
164388298|NCT04307186|593788612|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
164388299|NCT04307186|593788612|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
164388300|NCT01618838|593788613|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
164388301|NCT01434602|593788614|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388302|NCT01434602|593788615|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
164388303|NCT01434602|593788616|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388304|NCT01434602|593788617|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388305|NCT01434602|593788618|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
164388306|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164388307|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164388308|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164388309|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
164388310|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
164016011|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
164388311|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164016012|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
164016013|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
164388312|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164388313|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164388314|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
164388315|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
164388316|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388317|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388318|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388319|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
164388320|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
164388321|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388322|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388323|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388324|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
164388325|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
164388326|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388327|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388328|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388329|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
164388330|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
164388331|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388332|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388333|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388334|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
164388335|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
164388336|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
164388337|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
164388338|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
164388339|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
164388340|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
164388341|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388342|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388343|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388344|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
164388345|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
164388346|NCT01434602|593788614|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164388347|NCT01434602|593788615|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164388348|NCT01434602|593788616|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164016014|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
164016015|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Other|0|||
164016016|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Other|1|||
164016017|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Other|0|||
164388349|NCT01434602|593788617|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
164388350|NCT01434602|593788618|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
164388351|NCT01587651|593788623|FG000|Overall Study|Adverse Event|0|||
164388352|NCT01587651|593788624|FG001|Overall Study|Adverse Event|1|||
164388353|NCT01587651|593788625|FG002|Overall Study|Adverse Event|0|||
164388354|NCT01587651|593788623|FG000|Overall Study|Protocol Violation|0|||
164388355|NCT01587651|593788624|FG001|Overall Study|Protocol Violation|1|||
164388356|NCT01587651|593788625|FG002|Overall Study|Protocol Violation|1|||
164388357|NCT01587651|593788623|FG000|Overall Study|Withdrawal by Subject|0|||
164388358|NCT01587651|593788624|FG001|Overall Study|Withdrawal by Subject|1|||
164388359|NCT01587651|593788625|FG002|Overall Study|Withdrawal by Subject|0|||
164388360|NCT00759109|593788628|FG000|Overall Study|Adverse Event|17|||
164388361|NCT00759109|593788629|FG001|Overall Study|Adverse Event|12|||
164388362|NCT00759109|593788628|FG000|Overall Study|Inability to comply|1|||
164388363|NCT00759109|593788629|FG001|Overall Study|Inability to comply|1|||
164388364|NCT00759109|593788628|FG000|Overall Study|Withdrawal by Subject|9|||
164388365|NCT00759109|593788629|FG001|Overall Study|Withdrawal by Subject|5|||
164388366|NCT00759109|593788628|FG000|Overall Study|Death|4|||
164388367|NCT00759109|593788629|FG001|Overall Study|Death|3|||
164388368|NCT00759109|593788628|FG000|Overall Study|Lost to Follow-up|4|||
164388369|NCT00759109|593788629|FG001|Overall Study|Lost to Follow-up|6|||
164388370|NCT00759109|593788628|FG000|Overall Study|Started new therapy|2|||
164388371|NCT00759109|593788629|FG001|Overall Study|Started new therapy|6|||
164388372|NCT00759109|593788628|FG000|Overall Study|HCV RNA negative|1|||
164388373|NCT00759109|593788629|FG001|Overall Study|HCV RNA negative|0|||
164388374|NCT00759109|593788628|FG000|Overall Study|Participant moved to a different city|0|||
164388375|NCT00759109|593788629|FG001|Overall Study|Participant moved to a different city|1|||
164388376|NCT00759109|593788628|FG000|Overall Study|Participant had a liver transplant|0|||
164388377|NCT00759109|593788629|FG001|Overall Study|Participant had a liver transplant|1|||
164388378|NCT00759109|593788628|FG000|Overall Study|Lost during study|1|||
164388379|NCT00759109|593788629|FG001|Overall Study|Lost during study|0|||
164388380|NCT00924287|593790219|FG000|Overall Study|Death|1|||
164388381|NCT00156065|593790222|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
164388382|NCT00156065|593790223|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
164388383|NCT00156065|593790224|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
164388384|NCT00156065|593790222|FG000|Overall Study|Adverse Event|8|||
164388385|NCT00156065|593790223|FG001|Overall Study|Adverse Event|11|||
164388386|NCT00156065|593790224|FG002|Overall Study|Adverse Event|4|||
164388387|NCT00156065|593790222|FG000|Overall Study|Lack of Efficacy|2|||
164388388|NCT00156065|593790223|FG001|Overall Study|Lack of Efficacy|9|||
164388389|NCT00156065|593790224|FG002|Overall Study|Lack of Efficacy|3|||
164388390|NCT00156065|593790222|FG000|Overall Study|Withdrawal by Subject|13|||
164388391|NCT00156065|593790223|FG001|Overall Study|Withdrawal by Subject|26|||
164388392|NCT00156065|593790224|FG002|Overall Study|Withdrawal by Subject|16|||
164388393|NCT00156065|593790222|FG000|Overall Study|Lost to Follow-up|5|||
164388394|NCT00156065|593790223|FG001|Overall Study|Lost to Follow-up|7|||
164388395|NCT00156065|593790224|FG002|Overall Study|Lost to Follow-up|1|||
164388396|NCT00156065|593790222|FG000|Overall Study|Other|2|||
164388397|NCT00156065|593790223|FG001|Overall Study|Other|9|||
164388398|NCT00156065|593790224|FG002|Overall Study|Other|3|||
164388399|NCT04579757|593790235|FG000|Overall Study|Adverse Event|0|||
164388400|NCT04579757|593790236|FG001|Overall Study|Adverse Event|0|||
164388401|NCT04579757|593790237|FG002|Overall Study|Adverse Event|0|||
164388402|NCT04579757|593790238|FG003|Overall Study|Adverse Event|2|||
163904449|NCT01953692|592020694|FG008|Overall Study|Physician Decision|0|||
163904450|NCT01953692|592020686|FG000|Overall Study|Protocol Violation|0|||
163904451|NCT01953692|592020687|FG001|Overall Study|Protocol Violation|2|||
163904452|NCT01953692|592020688|FG002|Overall Study|Protocol Violation|1|||
163904453|NCT01953692|592020689|FG003|Overall Study|Protocol Violation|0|||
163904454|NCT01953692|592020690|FG004|Overall Study|Protocol Violation|0|||
163904455|NCT01953692|592020691|FG005|Overall Study|Protocol Violation|0|||
163904456|NCT01953692|592020692|FG006|Overall Study|Protocol Violation|0|||
163904457|NCT01953692|592020693|FG007|Overall Study|Protocol Violation|1|||
163904458|NCT01953692|592020694|FG008|Overall Study|Protocol Violation|0|||
163904459|NCT01953692|592020686|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904460|NCT01953692|592020687|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904461|NCT01953692|592020688|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
164388403|NCT04579757|593790239|FG004|Overall Study|Adverse Event|1|||
164388404|NCT04579757|593790240|FG005|Overall Study|Adverse Event|1|||
164388405|NCT04579757|593790241|FG006|Overall Study|Adverse Event|0|||
164388406|NCT04579757|593790242|FG007|Overall Study|Adverse Event|0|||
164388407|NCT04579757|593790243|FG008|Overall Study|Adverse Event|0|||
164388408|NCT04579757|593790235|FG000|Overall Study|Death|4|||
164388409|NCT04579757|593790236|FG001|Overall Study|Death|1|||
164388410|NCT04579757|593790237|FG002|Overall Study|Death|14|||
163904462|NCT01953692|592020689|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904463|NCT01953692|592020690|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904464|NCT01953692|592020691|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904465|NCT01953692|592020692|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904466|NCT01953692|592020693|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
163904467|NCT01953692|592020694|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
163904468|NCT01953692|592020686|FG000|Overall Study|Withdrawal by Subject|4|||
163904469|NCT01953692|592020687|FG001|Overall Study|Withdrawal by Subject|2|||
163904470|NCT01953692|592020688|FG002|Overall Study|Withdrawal by Subject|1|||
163904471|NCT01953692|592020689|FG003|Overall Study|Withdrawal by Subject|2|||
163904472|NCT01953692|592020690|FG004|Overall Study|Withdrawal by Subject|0|||
163904473|NCT01953692|592020691|FG005|Overall Study|Withdrawal by Subject|3|||
163904474|NCT01953692|592020692|FG006|Overall Study|Withdrawal by Subject|2|||
164016018|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Other|0|||
164016019|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Other|0|||
164388411|NCT04579757|593790238|FG003|Overall Study|Death|3|||
164388412|NCT04579757|593790239|FG004|Overall Study|Death|2|||
164388413|NCT04579757|593790240|FG005|Overall Study|Death|7|||
164388414|NCT04579757|593790241|FG006|Overall Study|Death|0|||
164388415|NCT04579757|593790242|FG007|Overall Study|Death|1|||
164388416|NCT04579757|593790243|FG008|Overall Study|Death|3|||
164388417|NCT04579757|593790235|FG000|Overall Study|Physician Decision|0|||
164388418|NCT04579757|593790236|FG001|Overall Study|Physician Decision|0|||
164388419|NCT04579757|593790237|FG002|Overall Study|Physician Decision|0|||
164388420|NCT04579757|593790238|FG003|Overall Study|Physician Decision|2|||
164388421|NCT04579757|593790239|FG004|Overall Study|Physician Decision|1|||
164388422|NCT04579757|593790240|FG005|Overall Study|Physician Decision|1|||
164388423|NCT04579757|593790241|FG006|Overall Study|Physician Decision|1|||
164388424|NCT04579757|593790242|FG007|Overall Study|Physician Decision|0|||
164388425|NCT04579757|593790243|FG008|Overall Study|Physician Decision|0|||
164388426|NCT04579757|593790235|FG000|Overall Study|Study Terminated By Sponsor|0|||
164388427|NCT04579757|593790236|FG001|Overall Study|Study Terminated By Sponsor|0|||
164388428|NCT04579757|593790237|FG002|Overall Study|Study Terminated By Sponsor|0|||
164388429|NCT04579757|593790238|FG003|Overall Study|Study Terminated By Sponsor|0|||
164388430|NCT04579757|593790239|FG004|Overall Study|Study Terminated By Sponsor|2|||
164388431|NCT04579757|593790240|FG005|Overall Study|Study Terminated By Sponsor|0|||
164388432|NCT04579757|593790241|FG006|Overall Study|Study Terminated By Sponsor|0|||
164388433|NCT04579757|593790242|FG007|Overall Study|Study Terminated By Sponsor|2|||
164388434|NCT04579757|593790243|FG008|Overall Study|Study Terminated By Sponsor|0|||
164388435|NCT04579757|593790235|FG000|Overall Study|Withdrawal by Subject|1|||
164388436|NCT04579757|593790236|FG001|Overall Study|Withdrawal by Subject|1|||
164388437|NCT04579757|593790237|FG002|Overall Study|Withdrawal by Subject|0|||
164388438|NCT04579757|593790238|FG003|Overall Study|Withdrawal by Subject|0|||
164388439|NCT04579757|593790239|FG004|Overall Study|Withdrawal by Subject|2|||
164388440|NCT04579757|593790240|FG005|Overall Study|Withdrawal by Subject|1|||
164388441|NCT04579757|593790241|FG006|Overall Study|Withdrawal by Subject|0|||
164388442|NCT04579757|593790242|FG007|Overall Study|Withdrawal by Subject|3|||
164388443|NCT04579757|593790243|FG008|Overall Study|Withdrawal by Subject|0|||
164388444|NCT04579757|593790235|FG000|Overall Study|Radiological or Clinical PD|1|||
164388445|NCT04579757|593790236|FG001|Overall Study|Radiological or Clinical PD|4|||
164388446|NCT04579757|593790237|FG002|Overall Study|Radiological or Clinical PD|1|||
164388447|NCT04579757|593790238|FG003|Overall Study|Radiological or Clinical PD|3|||
164388448|NCT04579757|593790239|FG004|Overall Study|Radiological or Clinical PD|9|||
164388449|NCT04579757|593790240|FG005|Overall Study|Radiological or Clinical PD|4|||
164388450|NCT04579757|593790241|FG006|Overall Study|Radiological or Clinical PD|2|||
164388451|NCT04579757|593790242|FG007|Overall Study|Radiological or Clinical PD|2|||
164388452|NCT04579757|593790243|FG008|Overall Study|Radiological or Clinical PD|0|||
164016020|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Other|0|||
164016021|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Other|0|||
164016022|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
164016023|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
164388453|NCT04579757|593790235|FG000|Overall Study|Start of New Therapy|0|||
164388454|NCT04579757|593790236|FG001|Overall Study|Start of New Therapy|0|||
164388455|NCT04579757|593790237|FG002|Overall Study|Start of New Therapy|0|||
164388456|NCT04579757|593790238|FG003|Overall Study|Start of New Therapy|0|||
164388457|NCT04579757|593790239|FG004|Overall Study|Start of New Therapy|2|||
163904475|NCT01953692|592020693|FG007|Overall Study|Withdrawal by Subject|1|||
163904476|NCT01953692|592020694|FG008|Overall Study|Withdrawal by Subject|1|||
164388458|NCT04579757|593790240|FG005|Overall Study|Start of New Therapy|1|||
164016024|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
164388459|NCT04579757|593790241|FG006|Overall Study|Start of New Therapy|0|||
164388460|NCT04579757|593790242|FG007|Overall Study|Start of New Therapy|0|||
164388461|NCT04579757|593790243|FG008|Overall Study|Start of New Therapy|0|||
164388462|NCT01153633|593790244|FG000|Overall Study|Protocol Violation|1|||
164388463|NCT01153633|593790245|FG001|Overall Study|Protocol Violation|1|||
164388464|NCT01153633|593790244|FG000|Overall Study|Therapeutic failure|3|||
163904477|NCT01822756|592020701|FG000|Overall Study|Adverse Event|0|||
164388465|NCT01153633|593790245|FG001|Overall Study|Therapeutic failure|3|||
164388466|NCT00384085|593790246|FG000|Overall Study|Adverse Event|5|||
164388467|NCT00384085|593790247|FG001|Overall Study|Adverse Event|5|||
164388468|NCT00384085|593790248|FG002|Overall Study|Adverse Event|4|||
164388469|NCT00384085|593790246|FG000|Overall Study|Lack of Efficacy|0|||
164388470|NCT00384085|593790247|FG001|Overall Study|Lack of Efficacy|3|||
164388471|NCT00384085|593790248|FG002|Overall Study|Lack of Efficacy|2|||
164388472|NCT00384085|593790246|FG000|Overall Study|No longer Requires Study Treatment|1|||
164388473|NCT00384085|593790247|FG001|Overall Study|No longer Requires Study Treatment|0|||
164388474|NCT00384085|593790248|FG002|Overall Study|No longer Requires Study Treatment|1|||
164388475|NCT00384085|593790246|FG000|Overall Study|Protocol Violation|2|||
164388476|NCT00384085|593790247|FG001|Overall Study|Protocol Violation|2|||
164388477|NCT00384085|593790248|FG002|Overall Study|Protocol Violation|2|||
164388478|NCT00384085|593790246|FG000|Overall Study|Lost to Follow-up|9|||
164388479|NCT00384085|593790247|FG001|Overall Study|Lost to Follow-up|9|||
164388480|NCT00384085|593790248|FG002|Overall Study|Lost to Follow-up|10|||
164388481|NCT00384085|593790246|FG000|Overall Study|Progressive Disease|0|||
164388482|NCT00384085|593790247|FG001|Overall Study|Progressive Disease|1|||
164388483|NCT00384085|593790248|FG002|Overall Study|Progressive Disease|0|||
164388484|NCT00384085|593790246|FG000|Overall Study|Withdrawal by Subject|14|||
164388485|NCT00384085|593790247|FG001|Overall Study|Withdrawal by Subject|19|||
164388486|NCT00384085|593790248|FG002|Overall Study|Withdrawal by Subject|29|||
164388487|NCT00384085|593790246|FG000|Overall Study|Patient non-compliant|4|||
164388488|NCT00384085|593790247|FG001|Overall Study|Patient non-compliant|4|||
164388489|NCT00384085|593790248|FG002|Overall Study|Patient non-compliant|5|||
164388490|NCT00384085|593790246|FG000|Overall Study|Physician Decision|1|||
164388491|NCT00384085|593790247|FG001|Overall Study|Physician Decision|0|||
164388492|NCT00384085|593790248|FG002|Overall Study|Physician Decision|0|||
164388493|NCT00384085|593790246|FG000|Overall Study|Loss of site personnel|1|||
164388494|NCT00384085|593790247|FG001|Overall Study|Loss of site personnel|0|||
164388495|NCT00384085|593790248|FG002|Overall Study|Loss of site personnel|1|||
164388496|NCT00384085|593790246|FG000|Overall Study|Sponsor decision|1|||
164388497|NCT00384085|593790247|FG001|Overall Study|Sponsor decision|2|||
164388498|NCT00384085|593790248|FG002|Overall Study|Sponsor decision|1|||
164388499|NCT00384085|593790246|FG000|Overall Study|Patient moved|1|||
164388500|NCT00384085|593790247|FG001|Overall Study|Patient moved|0|||
164388501|NCT00384085|593790248|FG002|Overall Study|Patient moved|1|||
164388502|NCT00384085|593790246|FG000|Overall Study|Patient required surgery|0|||
164388503|NCT00384085|593790247|FG001|Overall Study|Patient required surgery|1|||
164388504|NCT00384085|593790248|FG002|Overall Study|Patient required surgery|0|||
164388505|NCT01944631|593790249|FG000|Overall Study|Adverse Event|1|||
164388506|NCT01944631|593790250|FG001|Overall Study|Adverse Event|0|||
164388507|NCT01944631|593790249|FG000|Overall Study|Lost to Follow-up|3|||
164388508|NCT01944631|593790250|FG001|Overall Study|Lost to Follow-up|1|||
164388509|NCT01944631|593790249|FG000|Overall Study|Withdrawal by Subject|0|||
164388510|NCT01944631|593790250|FG001|Overall Study|Withdrawal by Subject|1|||
164388511|NCT01843192|593790251|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
164388512|NCT01843192|593790252|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
164388513|NCT01843192|593790253|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
164388514|NCT00328510|593790256|FG000|Overall Study|Gag disorder, could not use frame|4|||
164388515|NCT00328510|593790257|FG001|Overall Study|Gag disorder, could not use frame|0|||
164388516|NCT00328510|593790256|FG000|Overall Study|Dentition problems, could not use frame|1|||
164388517|NCT00328510|593790257|FG001|Overall Study|Dentition problems, could not use frame|0|||
164388518|NCT00328510|593790256|FG000|Overall Study|Withdrawal by Subject|4|||
164388519|NCT00328510|593790257|FG001|Overall Study|Withdrawal by Subject|2|||
164388520|NCT00328510|593790256|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
164388521|NCT00328510|593790257|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
164388522|NCT00328510|593790256|FG000|Overall Study|Treatment changed to a single fraction|1|||
164388523|NCT00328510|593790257|FG001|Overall Study|Treatment changed to a single fraction|1|||
164388524|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
164388525|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
164388526|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Death|1|||
164388527|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Death|0|||
164388528|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
163904478|NCT01822756|592020702|FG001|Overall Study|Adverse Event|0|||
164388529|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
164388530|NCT00455195|593790258|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
164388531|NCT00455195|593790259|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
163904479|NCT01822756|592020703|FG002|Overall Study|Adverse Event|0|||
164388532|NCT01286779|593790260|FG000|Overall Study|Withdrawal by Subject|9|||
164388533|NCT01286779|593790260|FG000|Overall Study|Protocol Violation|5|||
164388534|NCT01286779|593790260|FG000|Overall Study|Physician Decision|2|||
164388535|NCT01286779|593790260|FG000|Overall Study|Participant had scheduled surgery|1|||
164388536|NCT01286779|593790260|FG000|Overall Study|Participant moved to another country|1|||
164388537|NCT01286779|593790260|FG000|Overall Study|Discontinued by sponsor|1|||
164388538|NCT00304070|593790261|FG000|Overall Study|Death|0|||
164388539|NCT00304070|593790262|FG001|Overall Study|Death|0|||
164388540|NCT00304070|593790263|FG002|Overall Study|Death|3|||
164388541|NCT00304070|593790261|FG000|Overall Study|Lost to Follow-up|0|||
164388542|NCT00304070|593790262|FG001|Overall Study|Lost to Follow-up|0|||
164388543|NCT00304070|593790263|FG002|Overall Study|Lost to Follow-up|1|||
164388544|NCT00304070|593790261|FG000|Overall Study|Physician Decision|0|||
164388545|NCT00304070|593790262|FG001|Overall Study|Physician Decision|0|||
164388546|NCT00304070|593790263|FG002|Overall Study|Physician Decision|3|||
164388547|NCT00304070|593790261|FG000|Overall Study|Withdrawal by Subject|0|||
164388548|NCT00304070|593790262|FG001|Overall Study|Withdrawal by Subject|0|||
164388549|NCT00304070|593790263|FG002|Overall Study|Withdrawal by Subject|1|||
164388550|NCT00304070|593790261|FG000|Overall Study|Progressive Disease|3|||
164388551|NCT00304070|593790262|FG001|Overall Study|Progressive Disease|7|||
164388552|NCT00304070|593790263|FG002|Overall Study|Progressive Disease|4|||
164388553|NCT00779246|593790272|FG000|Overall Study|Missing sufficient data for analysis|33|||
164388554|NCT00779246|593790273|FG001|Overall Study|Missing sufficient data for analysis|53|||
164388555|NCT02844946|593790274|FG000|Overall Study|Lost to Follow-up|7|||
164388556|NCT02844946|593790275|FG001|Overall Study|Lost to Follow-up|0|||
164388557|NCT02806986|593790276|FG000|Treatment Stage 1|Adverse Event|1|||
164388558|NCT02806986|593790276|FG000|Treatment Stage 2|Adverse Event|3|||
164388559|NCT02806986|593790276|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
164388560|NCT03646513|593790278|FG000|Overall Study|Premature study termination|4|||
164388561|NCT02334748|593790279|FG000|Overall Study|Adverse Event|1|||
164388562|NCT02334748|593790279|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
164388563|NCT02334748|593790279|FG000|Overall Study|Patient no longer required study drug|2|||
164388564|NCT02334748|593790279|FG000|Overall Study|Lack of Efficacy|4|||
164388565|NCT01046643|593790280|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
164388566|NCT01046643|593790281|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
164388567|NCT01046643|593790282|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
164388568|NCT01046643|593790283|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
164388569|NCT00093145|593790284|FG000|Overall Study|Unacceptable Toxicity Only|2|||
164388570|NCT00093145|593790284|FG000|Overall Study|Physician Decision|5|||
164388571|NCT00093145|593790284|FG000|Overall Study|Withdrawal by Subject|9|||
164388572|NCT00093145|593790284|FG000|Overall Study|Other|1|||
164388573|NCT01310036|593790285|FG000|Overall Study|Administrative/other|10|||
164388574|NCT01310036|593790285|FG000|Overall Study|Withdrew Consent|11|||
164016025|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
164388575|NCT01310036|593790285|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
164388576|NCT01310036|593790285|FG000|Overall Study|Progression of Disease|164|||
164388577|NCT01310036|593790285|FG000|Overall Study|Death|1|||
164388578|NCT01310036|593790285|FG000|Overall Study|Adverse event or intercurrent illness|12|||
164388579|NCT01175668|593790286|FG000|Overall Study|Withdrawal by Subject|2|||
164388580|NCT01175668|593790287|FG001|Overall Study|Withdrawal by Subject|0|||
164388581|NCT00817089|593790288|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
164388582|NCT00817089|593790289|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
164388583|NCT00817089|593790290|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
164388584|NCT00817089|593790291|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
164388585|NCT00817089|593790288|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
164388586|NCT00817089|593790289|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
164388587|NCT00817089|593790290|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
164388588|NCT00817089|593790291|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
164388589|NCT02043782|593790292|FG000|Period 1|Adverse Event|0|||
164388590|NCT02043782|593790293|FG001|Period 1|Adverse Event|0|||
164388591|NCT02043782|593790294|FG002|Period 1|Adverse Event|1|||
164388592|NCT02043782|593790295|FG003|Period 1|Adverse Event|0|||
164388593|NCT02043782|593790296|FG004|Period 1|Adverse Event|0|||
164016026|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
164388594|NCT02043782|593790297|FG005|Period 1|Adverse Event|0|||
164388595|NCT00709722|593790298|FG000|Overall Study|Adverse Event|1|||
164388596|NCT04667117|593790299|FG000|Investigational Period|Lost to Follow-up|0|||
164388597|NCT04667117|593790300|FG001|Investigational Period|Lost to Follow-up|0|||
164388598|NCT04667117|593790301|FG002|Investigational Period|Lost to Follow-up|1|||
164388599|NCT04667117|593790299|FG000|Investigational Period|Protocol Deviation|0|||
164388600|NCT04667117|593790300|FG001|Investigational Period|Protocol Deviation|1|||
164388601|NCT04667117|593790301|FG002|Investigational Period|Protocol Deviation|0|||
164388602|NCT04667117|593790299|FG000|Extension Period|Lost to Follow-up|1|||
164388603|NCT04667117|593790300|FG001|Extension Period|Lost to Follow-up|0|||
164388604|NCT04667117|593790301|FG002|Extension Period|Lost to Follow-up|0|||
164016027|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
163904480|NCT01822756|592020704|FG003|Overall Study|Adverse Event|2|||
163904481|NCT01822756|592020705|FG004|Overall Study|Adverse Event|0|||
163904482|NCT01822756|592020701|FG000|Overall Study|Disease progression|11|||
163904483|NCT01822756|592020702|FG001|Overall Study|Disease progression|1|||
163904484|NCT01822756|592020703|FG002|Overall Study|Disease progression|7|||
163904485|NCT01822756|592020704|FG003|Overall Study|Disease progression|2|||
163904486|NCT01822756|592020705|FG004|Overall Study|Disease progression|6|||
163904487|NCT01822756|592020701|FG000|Overall Study|Death|2|||
163904488|NCT01822756|592020702|FG001|Overall Study|Death|2|||
163904489|NCT01822756|592020703|FG002|Overall Study|Death|1|||
163904490|NCT01822756|592020704|FG003|Overall Study|Death|0|||
163904491|NCT01822756|592020705|FG004|Overall Study|Death|0|||
163904492|NCT01822756|592020701|FG000|Overall Study|Lost to Follow-up|1|||
163904493|NCT01822756|592020702|FG001|Overall Study|Lost to Follow-up|0|||
163904494|NCT01822756|592020703|FG002|Overall Study|Lost to Follow-up|1|||
163904495|NCT01822756|592020704|FG003|Overall Study|Lost to Follow-up|0|||
163904496|NCT01822756|592020705|FG004|Overall Study|Lost to Follow-up|1|||
163904497|NCT01822756|592020701|FG000|Overall Study|Physician Decision|0|||
163904498|NCT01822756|592020702|FG001|Overall Study|Physician Decision|1|||
163904499|NCT01822756|592020703|FG002|Overall Study|Physician Decision|0|||
163904500|NCT01822756|592020704|FG003|Overall Study|Physician Decision|0|||
164388605|NCT03359096|593790302|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
163904501|NCT01822756|592020705|FG004|Overall Study|Physician Decision|0|||
163904502|NCT01822756|592020701|FG000|Overall Study|disease progression & patient preference|2|||
163904503|NCT01822756|592020702|FG001|Overall Study|disease progression & patient preference|0|||
163904504|NCT01822756|592020703|FG002|Overall Study|disease progression & patient preference|1|||
163904505|NCT01822756|592020704|FG003|Overall Study|disease progression & patient preference|0|||
163904506|NCT01822756|592020705|FG004|Overall Study|disease progression & patient preference|0|||
164388606|NCT03359096|593790303|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
164388607|NCT03359096|593790302|FG000|First Intervention (4 Weeks)|Death|1|||
164388608|NCT03359096|593790303|FG001|First Intervention (4 Weeks)|Death|0|||
164388609|NCT03359096|593790302|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
164388610|NCT03359096|593790303|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
164388611|NCT02007577|593790314|FG000|Overall Study|Adverse Event|1|||
164388612|NCT02007577|593790315|FG001|Overall Study|Adverse Event|0|||
164388613|NCT02007577|593790314|FG000|Overall Study|Withdrawal by Subject|0|||
164388614|NCT02007577|593790315|FG001|Overall Study|Withdrawal by Subject|1|||
164388615|NCT01953926|593790316|FG000|Overall Study|Withdrawal by Subject|23|||
164388616|NCT01953926|593790317|FG001|Overall Study|Withdrawal by Subject|3|||
164388617|NCT01953926|593790318|FG002|Overall Study|Withdrawal by Subject|3|||
164388618|NCT01953926|593790319|FG003|Overall Study|Withdrawal by Subject|5|||
164388619|NCT01953926|593790320|FG004|Overall Study|Withdrawal by Subject|6|||
164388620|NCT01953926|593790321|FG005|Overall Study|Withdrawal by Subject|0|||
164388621|NCT01953926|593790322|FG006|Overall Study|Withdrawal by Subject|1|||
164388622|NCT01953926|593790316|FG000|Overall Study|Physician Decision|1|||
164388623|NCT01953926|593790317|FG001|Overall Study|Physician Decision|0|||
164388624|NCT01953926|593790318|FG002|Overall Study|Physician Decision|0|||
164388625|NCT01953926|593790319|FG003|Overall Study|Physician Decision|0|||
164388626|NCT01953926|593790320|FG004|Overall Study|Physician Decision|2|||
164388627|NCT01953926|593790321|FG005|Overall Study|Physician Decision|0|||
164388628|NCT01953926|593790322|FG006|Overall Study|Physician Decision|0|||
164388629|NCT01953926|593790316|FG000|Overall Study|Lost to Follow-up|18|||
164388630|NCT01953926|593790317|FG001|Overall Study|Lost to Follow-up|3|||
164388631|NCT01953926|593790318|FG002|Overall Study|Lost to Follow-up|0|||
164388632|NCT01953926|593790319|FG003|Overall Study|Lost to Follow-up|5|||
164388633|NCT01953926|593790320|FG004|Overall Study|Lost to Follow-up|3|||
164388634|NCT01953926|593790321|FG005|Overall Study|Lost to Follow-up|0|||
164388635|NCT01953926|593790322|FG006|Overall Study|Lost to Follow-up|0|||
164388636|NCT01953926|593790316|FG000|Overall Study|Protocol Violation|1|||
164388637|NCT01953926|593790317|FG001|Overall Study|Protocol Violation|0|||
164388638|NCT01953926|593790318|FG002|Overall Study|Protocol Violation|0|||
164388639|NCT01953926|593790319|FG003|Overall Study|Protocol Violation|0|||
164388640|NCT01953926|593790320|FG004|Overall Study|Protocol Violation|0|||
164388641|NCT01953926|593790321|FG005|Overall Study|Protocol Violation|0|||
164388642|NCT01953926|593790322|FG006|Overall Study|Protocol Violation|0|||
164388643|NCT01953926|593790316|FG000|Overall Study|Other, Disease progression|2|||
164388644|NCT01953926|593790317|FG001|Overall Study|Other, Disease progression|1|||
163904507|NCT01065779|592020706|FG000|Overall Study|Duplicate Investigation|1|||
163904508|NCT01065779|592020706|FG000|Overall Study|Investigation Before Contract Date|37|||
163904509|NCT01065779|592020706|FG000|Overall Study|Non-enrollment Period Administration|10|||
163904510|NCT01065779|592020706|FG000|Overall Study|Not Administered With Study Drug|17|||
163904511|NCT01065779|592020706|FG000|Overall Study|Failed to Follow-up|10|||
163904512|NCT01065779|592020706|FG000|Overall Study|Inclusion Criteria Violation|7|||
164388645|NCT01953926|593790318|FG002|Overall Study|Other, Disease progression|0|||
164388646|NCT01953926|593790319|FG003|Overall Study|Other, Disease progression|0|||
164388647|NCT01953926|593790320|FG004|Overall Study|Other, Disease progression|1|||
164388648|NCT01953926|593790321|FG005|Overall Study|Other, Disease progression|0|||
164388649|NCT01953926|593790322|FG006|Overall Study|Other, Disease progression|0|||
164388650|NCT01953926|593790316|FG000|Overall Study|Discontinuation of study by sponsor|41|||
164388651|NCT01953926|593790317|FG001|Overall Study|Discontinuation of study by sponsor|7|||
164388652|NCT01953926|593790318|FG002|Overall Study|Discontinuation of study by sponsor|5|||
164388653|NCT01953926|593790319|FG003|Overall Study|Discontinuation of study by sponsor|12|||
164388654|NCT01953926|593790320|FG004|Overall Study|Discontinuation of study by sponsor|46|||
164388655|NCT01953926|593790321|FG005|Overall Study|Discontinuation of study by sponsor|5|||
164388656|NCT01953926|593790322|FG006|Overall Study|Discontinuation of study by sponsor|6|||
164388657|NCT01953926|593790316|FG000|Overall Study|Not Treated|1|||
164388658|NCT01953926|593790317|FG001|Overall Study|Not Treated|0|||
164388659|NCT01953926|593790318|FG002|Overall Study|Not Treated|1|||
164388660|NCT01953926|593790319|FG003|Overall Study|Not Treated|0|||
164388661|NCT01953926|593790320|FG004|Overall Study|Not Treated|0|||
164388662|NCT01953926|593790321|FG005|Overall Study|Not Treated|0|||
164388663|NCT01953926|593790322|FG006|Overall Study|Not Treated|0|||
164388664|NCT04102501|593790326|FG000|Overall Study|Withdrawal by Subject|7|||
164388665|NCT04102501|593790327|FG001|Overall Study|Withdrawal by Subject|9|||
164388666|NCT04102501|593790326|FG000|Overall Study|Adverse Event|1|||
163904513|NCT02157948|592020707|FG000|Overall Study|Withdrawal by Subject|4|||
163904514|NCT02157948|592020708|FG001|Overall Study|Withdrawal by Subject|5|||
164388667|NCT04102501|593790327|FG001|Overall Study|Adverse Event|3|||
164388668|NCT02338362|593790329|FG000|Overall Study|Withdrawal by Subject|1|||
164388669|NCT02338362|593790330|FG001|Overall Study|Withdrawal by Subject|1|||
164388670|NCT03325712|593790335|FG000|Overall Study|Protocol Violation|0|||
164388671|NCT03325712|593790336|FG001|Overall Study|Protocol Violation|0|||
164388672|NCT03325712|593790337|FG002|Overall Study|Protocol Violation|0|||
164388673|NCT03325712|593790338|FG003|Overall Study|Protocol Violation|0|||
164388674|NCT03325712|593790339|FG004|Overall Study|Protocol Violation|1|||
164388675|NCT03325712|593790340|FG005|Overall Study|Protocol Violation|0|||
164388676|NCT03325712|593790341|FG006|Overall Study|Protocol Violation|0|||
164388677|NCT03325712|593790342|FG007|Overall Study|Protocol Violation|0|||
164388678|NCT03325712|593790335|FG000|Overall Study|Adverse Event|0|||
164388679|NCT03325712|593790336|FG001|Overall Study|Adverse Event|0|||
164388680|NCT03325712|593790337|FG002|Overall Study|Adverse Event|0|||
164388681|NCT03325712|593790338|FG003|Overall Study|Adverse Event|0|||
164388682|NCT03325712|593790339|FG004|Overall Study|Adverse Event|1|||
164388683|NCT03325712|593790340|FG005|Overall Study|Adverse Event|0|||
164388684|NCT03325712|593790341|FG006|Overall Study|Adverse Event|0|||
164388685|NCT03325712|593790342|FG007|Overall Study|Adverse Event|0|||
164388686|NCT02265237|593790343|FG000|As Treated (Overall Study)|Adverse Event|1|||
164388687|NCT02265237|593790344|FG001|As Treated (Overall Study)|Adverse Event|1|||
164388688|NCT02265237|593790345|FG002|As Treated (Overall Study)|Adverse Event|0|||
164388689|NCT02265237|593790346|FG003|As Treated (Overall Study)|Adverse Event|0|||
164388690|NCT02265237|593790343|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
164388691|NCT02265237|593790344|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
164388692|NCT02265237|593790345|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
164388693|NCT02265237|593790346|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
164388694|NCT02265237|593790343|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
164388695|NCT02265237|593790344|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
164388696|NCT02265237|593790345|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
164388697|NCT02265237|593790346|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
164388698|NCT02265237|593790343|FG000|As Treated (Overall Study)|Other|2|||
164388699|NCT02265237|593790344|FG001|As Treated (Overall Study)|Other|0|||
164388700|NCT02265237|593790345|FG002|As Treated (Overall Study)|Other|3|||
164388701|NCT02265237|593790346|FG003|As Treated (Overall Study)|Other|1|||
164388702|NCT01178853|593790348|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
164388703|NCT01178853|593790349|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
164388704|NCT01178853|593790348|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
164388705|NCT01178853|593790349|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
164388706|NCT01178853|593790348|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
164388707|NCT01178853|593790349|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
164388708|NCT01178853|593790348|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
164388709|NCT01178853|593790349|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
164388710|NCT01178853|593790348|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
164388711|NCT01178853|593790349|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
164388712|NCT03550313|593790350|FG000|Overall Study|Adverse Event|0|||
164388713|NCT03550313|593790351|FG001|Overall Study|Adverse Event|1|||
164388714|NCT03550313|593790352|FG002|Overall Study|Adverse Event|0|||
164388715|NCT03550313|593790350|FG000|Overall Study|Lost to Follow-up|5|||
164388716|NCT03550313|593790351|FG001|Overall Study|Lost to Follow-up|7|||
164388717|NCT03550313|593790352|FG002|Overall Study|Lost to Follow-up|12|||
164388718|NCT03550313|593790350|FG000|Overall Study|Study terminated by sponsor|44|||
164388719|NCT03550313|593790351|FG001|Overall Study|Study terminated by sponsor|37|||
164388720|NCT03550313|593790352|FG002|Overall Study|Study terminated by sponsor|48|||
163904515|NCT02157948|592020707|FG000|Overall Study|Lost to Follow-up|3|||
163904516|NCT02157948|592020708|FG001|Overall Study|Lost to Follow-up|2|||
164388721|NCT03550313|593790350|FG000|Overall Study|No longer met eligibility criteria|3|||
164388722|NCT03550313|593790351|FG001|Overall Study|No longer met eligibility criteria|5|||
164388723|NCT03550313|593790352|FG002|Overall Study|No longer met eligibility criteria|6|||
164388724|NCT03550313|593790350|FG000|Overall Study|Withdrawal by parent/guardian|20|||
164388725|NCT03550313|593790351|FG001|Overall Study|Withdrawal by parent/guardian|18|||
164388726|NCT03550313|593790352|FG002|Overall Study|Withdrawal by parent/guardian|26|||
164388727|NCT03550313|593790350|FG000|Overall Study|Other|4|||
164388728|NCT03550313|593790351|FG001|Overall Study|Other|2|||
164388729|NCT03550313|593790352|FG002|Overall Study|Other|2|||
164388730|NCT03550313|593790350|FG000|Overall Study|Randomized but not vaccinated|3|||
164388731|NCT03550313|593790351|FG001|Overall Study|Randomized but not vaccinated|23|||
164388732|NCT03550313|593790352|FG002|Overall Study|Randomized but not vaccinated|2|||
164388733|NCT03550313|593790350|FG000|Overall Study|Sites terminated due to quality issues|18|||
164388734|NCT03550313|593790351|FG001|Overall Study|Sites terminated due to quality issues|17|||
164388735|NCT03550313|593790352|FG002|Overall Study|Sites terminated due to quality issues|18|||
164388736|NCT00839072|593790353|FG000|First Intervention Period|Withdrawal by Subject|1|||
164388737|NCT00839072|593790354|FG001|First Intervention Period|Withdrawal by Subject|0|||
164388738|NCT00839072|593790353|FG000|First Intervention Period|Adverse Event|1|||
164388739|NCT00839072|593790354|FG001|First Intervention Period|Adverse Event|1|||
164388740|NCT00839072|593790353|FG000|Second Intervention Period|Withdrawal by Subject|1|||
164388741|NCT00839072|593790354|FG001|Second Intervention Period|Withdrawal by Subject|0|||
164388742|NCT00380068|593790355|FG000|Overall Study|Adverse Event|40|||
164388743|NCT00380068|593790355|FG000|Overall Study|Withdrawal by Subject|10|||
164388744|NCT00380068|593790355|FG000|Overall Study|Not compliant|6|||
164388745|NCT00380068|593790355|FG000|Overall Study|Lost to Follow-up|1|||
164388746|NCT00380068|593790355|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
164388747|NCT00380068|593790355|FG000|Overall Study|Lung transplant|3|||
164388748|NCT00380068|593790355|FG000|Overall Study|Physician Decision|2|||
164388749|NCT00380068|593790355|FG000|Overall Study|Partipant moved away|1|||
164388750|NCT00380068|593790355|FG000|Overall Study|Lack of Efficacy|5|||
164388751|NCT01297062|593790356|FG000|Overall Study|Adverse Event|2|||
164388752|NCT01297062|593790357|FG001|Overall Study|Adverse Event|0|||
164388753|NCT01297062|593790358|FG002|Overall Study|Adverse Event|1|||
164388754|NCT01297062|593790359|FG003|Overall Study|Adverse Event|0|||
164388755|NCT01297062|593790360|FG004|Overall Study|Adverse Event|0|||
164388756|NCT01297062|593790361|FG005|Overall Study|Adverse Event|0|||
164388757|NCT01297062|593790362|FG006|Overall Study|Adverse Event|0|||
164388758|NCT01297062|593790356|FG000|Overall Study|Physician Decision|1|||
164388759|NCT01297062|593790357|FG001|Overall Study|Physician Decision|0|||
164388760|NCT01297062|593790358|FG002|Overall Study|Physician Decision|1|||
164388761|NCT01297062|593790359|FG003|Overall Study|Physician Decision|0|||
164388762|NCT01297062|593790360|FG004|Overall Study|Physician Decision|0|||
164388763|NCT01297062|593790361|FG005|Overall Study|Physician Decision|0|||
164388764|NCT01297062|593790362|FG006|Overall Study|Physician Decision|6|||
164388765|NCT01297062|593790356|FG000|Overall Study|Protocol Violation|0|||
164388766|NCT01297062|593790357|FG001|Overall Study|Protocol Violation|0|||
164388767|NCT01297062|593790358|FG002|Overall Study|Protocol Violation|0|||
164388768|NCT01297062|593790359|FG003|Overall Study|Protocol Violation|0|||
164388769|NCT01297062|593790360|FG004|Overall Study|Protocol Violation|1|||
164388770|NCT01297062|593790361|FG005|Overall Study|Protocol Violation|0|||
164388771|NCT01297062|593790362|FG006|Overall Study|Protocol Violation|0|||
164388772|NCT01297062|593790356|FG000|Overall Study|Subject Decision|1|||
164388773|NCT01297062|593790357|FG001|Overall Study|Subject Decision|1|||
164388774|NCT01297062|593790358|FG002|Overall Study|Subject Decision|0|||
164388775|NCT01297062|593790359|FG003|Overall Study|Subject Decision|1|||
164388776|NCT01297062|593790360|FG004|Overall Study|Subject Decision|1|||
164016028|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
164016029|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
164016030|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
164016031|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
164016032|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
164388777|NCT01297062|593790361|FG005|Overall Study|Subject Decision|1|||
164388778|NCT01297062|593790362|FG006|Overall Study|Subject Decision|2|||
164388779|NCT03191903|593790363|FG000|Overall Study|Withdrawal by Subject|6|||
164388780|NCT03191903|593790364|FG001|Overall Study|Withdrawal by Subject|5|||
164388781|NCT03191903|593790365|FG002|Overall Study|Withdrawal by Subject|4|||
164388782|NCT03191903|593790363|FG000|Overall Study|Adverse Event|1|||
164388783|NCT03191903|593790364|FG001|Overall Study|Adverse Event|0|||
164388784|NCT03191903|593790365|FG002|Overall Study|Adverse Event|0|||
164388785|NCT03149328|593790366|FG000|Overall Study|Withdrawal by Subject|30|||
164388786|NCT03149328|593790367|FG001|Overall Study|Withdrawal by Subject|26|||
164388787|NCT03149328|593790366|FG000|Overall Study|Changed Dialysis Modality|18|||
164388788|NCT03149328|593790367|FG001|Overall Study|Changed Dialysis Modality|1|||
164073014|NCT00552617|592632768|FG005|Overall Study|Not Treated|0|||
164388789|NCT03149328|593790366|FG000|Overall Study|Transplant|9|||
164388790|NCT03149328|593790367|FG001|Overall Study|Transplant|1|||
164388791|NCT03149328|593790366|FG000|Overall Study|Lost to Follow-up|25|||
164388792|NCT03149328|593790367|FG001|Overall Study|Lost to Follow-up|16|||
164388793|NCT03149328|593790366|FG000|Overall Study|Left Study Site|1|||
164388794|NCT03149328|593790367|FG001|Overall Study|Left Study Site|2|||
164388795|NCT03149328|593790366|FG000|Overall Study|Language Barrier|1|||
164388796|NCT03149328|593790367|FG001|Overall Study|Language Barrier|0|||
164388797|NCT00503685|593790371|FG000|Overall Study|Adverse Event|0|||
164388798|NCT00503685|593790372|FG001|Overall Study|Adverse Event|0|||
164388799|NCT00503685|593790373|FG002|Overall Study|Adverse Event|2|||
164388800|NCT00503685|593790371|FG000|Overall Study|Withdrawal by Subject|0|||
164388801|NCT00503685|593790372|FG001|Overall Study|Withdrawal by Subject|1|||
164388802|NCT00503685|593790373|FG002|Overall Study|Withdrawal by Subject|0|||
164388803|NCT00503685|593790371|FG000|Overall Study|Protocol Violation|0|||
164388804|NCT00503685|593790372|FG001|Overall Study|Protocol Violation|1|||
164388805|NCT00503685|593790373|FG002|Overall Study|Protocol Violation|0|||
164388806|NCT00503685|593790371|FG000|Overall Study|Eligibility Criteria Not Met|0|||
164388807|NCT00503685|593790372|FG001|Overall Study|Eligibility Criteria Not Met|1|||
164388808|NCT00503685|593790373|FG002|Overall Study|Eligibility Criteria Not Met|0|||
164388809|NCT00927927|593790376|FG000|Overall Study|Withdrawal by Subject|0|||
164388810|NCT00927927|593790377|FG001|Overall Study|Withdrawal by Subject|0|||
164388811|NCT00927927|593790378|FG002|Overall Study|Withdrawal by Subject|0|||
164388812|NCT00927927|593790379|FG003|Overall Study|Withdrawal by Subject|0|||
164388813|NCT00927927|593790380|FG004|Overall Study|Withdrawal by Subject|0|||
164388814|NCT00927927|593790381|FG005|Overall Study|Withdrawal by Subject|0|||
164388815|NCT00927927|593790382|FG006|Overall Study|Withdrawal by Subject|0|||
164388816|NCT00927927|593790383|FG007|Overall Study|Withdrawal by Subject|2|||
164388817|NCT00927927|593790384|FG008|Overall Study|Withdrawal by Subject|0|||
164388818|NCT00927927|593790385|FG009|Overall Study|Withdrawal by Subject|0|||
164388819|NCT00927927|593790386|FG010|Overall Study|Withdrawal by Subject|0|||
164388820|NCT00927927|593790387|FG011|Overall Study|Withdrawal by Subject|2|||
164388821|NCT00927927|593790388|FG012|Overall Study|Withdrawal by Subject|0|||
164388822|NCT00927927|593790389|FG013|Overall Study|Withdrawal by Subject|0|||
164388823|NCT00927927|593790390|FG014|Overall Study|Withdrawal by Subject|0|||
164388824|NCT01110239|593790395|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
164388825|NCT01110239|593790396|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
164388826|NCT01110239|593790397|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
164388827|NCT01110239|593790398|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
164388828|NCT01110239|593790395|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
164388829|NCT01110239|593790396|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
164388830|NCT01110239|593790397|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
164388831|NCT01110239|593790398|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
164388832|NCT00080223|593790401|FG000|Overall Study|Adverse Event|23|||
164388833|NCT00080223|593790401|FG000|Overall Study|Death|21|||
164388834|NCT00080223|593790401|FG000|Overall Study|Withdrawal by Subject|13|||
164388835|NCT00080223|593790401|FG000|Overall Study|Lung Transplantation|9|||
164388836|NCT00080223|593790401|FG000|Overall Study|Non-compliance With Study Treatment|7|||
164388837|NCT00080223|593790401|FG000|Overall Study|Participant unwilling to continue|2|||
164388838|NCT00080223|593790401|FG000|Overall Study|Physician Decision|1|||
164388839|NCT02261363|593792353|FG000|Overall Study|Lost to Follow-up|21|||
164388840|NCT01517802|593792354|FG000|Overall Study|Death|1|||
164388841|NCT02605954|593792355|FG000|Overall Study|Adverse Event|5|||
164388842|NCT02605954|593792356|FG001|Overall Study|Adverse Event|1|||
164388843|NCT02605954|593792355|FG000|Overall Study|Investigator's Discretion|1|||
164388844|NCT02605954|593792356|FG001|Overall Study|Investigator's Discretion|0|||
164388845|NCT02605954|593792355|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164388846|NCT02605954|593792356|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164388847|NCT02605954|593792355|FG000|Overall Study|Withdrew Consent|2|||
164388848|NCT02605954|593792356|FG001|Overall Study|Withdrew Consent|2|||
164388849|NCT02605954|593792355|FG000|Overall Study|Lost to Follow-up|3|||
164388850|NCT02605954|593792356|FG001|Overall Study|Lost to Follow-up|0|||
164388851|NCT02605954|593792355|FG000|Overall Study|Randomized but not treated|0|||
164388852|NCT02605954|593792356|FG001|Overall Study|Randomized but not treated|1|||
164388853|NCT02301143|593792357|FG000|Induction Period|Enrolled But Not Treated|1|||
164388854|NCT02301143|593792358|FG001|Induction Period|Enrolled But Not Treated|0|||
164388855|NCT02301143|593792357|FG000|Induction Period|Death|1|||
164388856|NCT02301143|593792358|FG001|Induction Period|Death|0|||
164388857|NCT02301143|593792357|FG000|Induction Period|Adverse Event|22|||
164388858|NCT02301143|593792358|FG001|Induction Period|Adverse Event|0|||
164388859|NCT02301143|593792357|FG000|Induction Period|Progressive Disease|8|||
164388860|NCT02301143|593792358|FG001|Induction Period|Progressive Disease|0|||
164388861|NCT02301143|593792357|FG000|Induction Period|Withdrawal by Subject|3|||
164388862|NCT02301143|593792358|FG001|Induction Period|Withdrawal by Subject|0|||
164388863|NCT02301143|593792357|FG000|Induction Period|Noncompliance with Study Drug|1|||
164388864|NCT02301143|593792358|FG001|Induction Period|Noncompliance with Study Drug|0|||
164388865|NCT02301143|593792357|FG000|Induction Period|Physician Decision|4|||
164388866|NCT02301143|593792358|FG001|Induction Period|Physician Decision|0|||
164388867|NCT02301143|593792357|FG000|Induction Period|Symptomatic Deterioration|2|||
164388868|NCT02301143|593792358|FG001|Induction Period|Symptomatic Deterioration|0|||
164388869|NCT02301143|593792357|FG000|Induction Period|Protocol Violation|2|||
164388870|NCT02301143|593792358|FG001|Induction Period|Protocol Violation|0|||
164388871|NCT02301143|593792357|FG000|Induction Period|Other|1|||
164388872|NCT02301143|593792358|FG001|Induction Period|Other|0|||
164388873|NCT02301143|593792357|FG000|Investigator's Choice|Adverse Event|0|||
164388874|NCT02301143|593792358|FG001|Investigator's Choice|Adverse Event|3|||
164388875|NCT02301143|593792357|FG000|Investigator's Choice|Progressive Disease|0|||
164388876|NCT02301143|593792358|FG001|Investigator's Choice|Progressive Disease|3|||
164388877|NCT02301143|593792357|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
164388878|NCT02301143|593792358|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
164388879|NCT02301143|593792357|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
164388880|NCT02301143|593792358|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
164388881|NCT02301143|593792357|FG000|Investigator's Choice|Other|0|||
164388882|NCT02301143|593792358|FG001|Investigator's Choice|Other|1|||
164388883|NCT02301143|593792357|FG000|Investigator's Choice|Unresectable Surgery|0|||
164388884|NCT02301143|593792358|FG001|Investigator's Choice|Unresectable Surgery|1|||
164388885|NCT03214367|593792361|FG000|Lead-in Period|Withdrawal by Subject|50|||
164388886|NCT03214367|593792362|FG001|Lead-in Period|Withdrawal by Subject|0|||
164388887|NCT03214367|593792363|FG002|Lead-in Period|Withdrawal by Subject|0|||
164388888|NCT03214367|593792364|FG003|Lead-in Period|Withdrawal by Subject|0|||
164388889|NCT03214367|593792365|FG004|Lead-in Period|Withdrawal by Subject|2|||
164388890|NCT03214367|593792366|FG005|Lead-in Period|Withdrawal by Subject|0|||
164388891|NCT03214367|593792367|FG006|Lead-in Period|Withdrawal by Subject|0|||
164388892|NCT03214367|593792368|FG007|Lead-in Period|Withdrawal by Subject|0|||
164388893|NCT03214367|593792361|FG000|Lead-in Period|Adverse Event|3|||
164388894|NCT03214367|593792362|FG001|Lead-in Period|Adverse Event|0|||
164388895|NCT03214367|593792363|FG002|Lead-in Period|Adverse Event|0|||
164388896|NCT03214367|593792364|FG003|Lead-in Period|Adverse Event|0|||
164388897|NCT03214367|593792365|FG004|Lead-in Period|Adverse Event|0|||
164388898|NCT03214367|593792366|FG005|Lead-in Period|Adverse Event|0|||
164388899|NCT03214367|593792367|FG006|Lead-in Period|Adverse Event|0|||
164388900|NCT03214367|593792368|FG007|Lead-in Period|Adverse Event|0|||
164388901|NCT03214367|593792361|FG000|Lead-in Period|Lost to Follow-up|12|||
164388902|NCT03214367|593792362|FG001|Lead-in Period|Lost to Follow-up|0|||
164388903|NCT03214367|593792363|FG002|Lead-in Period|Lost to Follow-up|0|||
164388904|NCT03214367|593792364|FG003|Lead-in Period|Lost to Follow-up|0|||
164388905|NCT03214367|593792365|FG004|Lead-in Period|Lost to Follow-up|0|||
164388906|NCT03214367|593792366|FG005|Lead-in Period|Lost to Follow-up|0|||
164388907|NCT03214367|593792367|FG006|Lead-in Period|Lost to Follow-up|0|||
164388908|NCT03214367|593792368|FG007|Lead-in Period|Lost to Follow-up|0|||
164388909|NCT03214367|593792361|FG000|Lead-in Period|Sponsor Decision|11|||
164388910|NCT03214367|593792362|FG001|Lead-in Period|Sponsor Decision|0|||
164388911|NCT03214367|593792363|FG002|Lead-in Period|Sponsor Decision|0|||
164388912|NCT03214367|593792364|FG003|Lead-in Period|Sponsor Decision|0|||
164388913|NCT03214367|593792365|FG004|Lead-in Period|Sponsor Decision|0|||
164388914|NCT03214367|593792366|FG005|Lead-in Period|Sponsor Decision|0|||
164388915|NCT03214367|593792367|FG006|Lead-in Period|Sponsor Decision|0|||
164388916|NCT03214367|593792368|FG007|Lead-in Period|Sponsor Decision|0|||
164388917|NCT03214367|593792361|FG000|Lead-in Period|Physician Decision|12|||
164388918|NCT03214367|593792362|FG001|Lead-in Period|Physician Decision|0|||
164388919|NCT03214367|593792363|FG002|Lead-in Period|Physician Decision|0|||
164388920|NCT03214367|593792364|FG003|Lead-in Period|Physician Decision|0|||
164388921|NCT03214367|593792365|FG004|Lead-in Period|Physician Decision|0|||
164388922|NCT03214367|593792366|FG005|Lead-in Period|Physician Decision|0|||
164388923|NCT03214367|593792367|FG006|Lead-in Period|Physician Decision|0|||
164388924|NCT03214367|593792368|FG007|Lead-in Period|Physician Decision|0|||
164388925|NCT03214367|593792361|FG000|Lead-in Period|Protocol Violation|5|||
164388926|NCT03214367|593792362|FG001|Lead-in Period|Protocol Violation|0|||
164388927|NCT03214367|593792363|FG002|Lead-in Period|Protocol Violation|0|||
164388928|NCT03214367|593792364|FG003|Lead-in Period|Protocol Violation|0|||
164388929|NCT03214367|593792365|FG004|Lead-in Period|Protocol Violation|0|||
164388930|NCT03214367|593792366|FG005|Lead-in Period|Protocol Violation|0|||
163904517|NCT02157948|592020707|FG000|Overall Study|Protocol Specified Criteria|2|||
164388931|NCT03214367|593792367|FG006|Lead-in Period|Protocol Violation|0|||
164388932|NCT03214367|593792368|FG007|Lead-in Period|Protocol Violation|0|||
164388933|NCT03214367|593792361|FG000|Lead-in Period|Treatment Interruption|1|||
164388934|NCT03214367|593792362|FG001|Lead-in Period|Treatment Interruption|0|||
164388935|NCT03214367|593792363|FG002|Lead-in Period|Treatment Interruption|0|||
164388936|NCT03214367|593792364|FG003|Lead-in Period|Treatment Interruption|0|||
164388937|NCT03214367|593792365|FG004|Lead-in Period|Treatment Interruption|0|||
164388938|NCT03214367|593792366|FG005|Lead-in Period|Treatment Interruption|0|||
164388939|NCT03214367|593792367|FG006|Lead-in Period|Treatment Interruption|0|||
164388940|NCT03214367|593792368|FG007|Lead-in Period|Treatment Interruption|0|||
164388941|NCT03214367|593792361|FG000|Treatment Period|Adverse Event|0|||
164388942|NCT03214367|593792362|FG001|Treatment Period|Adverse Event|1|||
164388943|NCT03214367|593792363|FG002|Treatment Period|Adverse Event|4|||
164388944|NCT03214367|593792364|FG003|Treatment Period|Adverse Event|2|||
163904518|NCT02157948|592020708|FG001|Overall Study|Protocol Specified Criteria|1|||
163904519|NCT02157948|592020707|FG000|Overall Study|Decision by Sponsor|0|||
163904520|NCT02157948|592020708|FG001|Overall Study|Decision by Sponsor|1|||
163904521|NCT01801007|592020709|FG000|Overall Study|Adverse Event|2|||
163904522|NCT01801007|592020709|FG000|Overall Study|Lost to Follow-up|4|||
163904523|NCT01801007|592020709|FG000|Overall Study|Withdrawal by Subject|5|||
163904524|NCT02743819|592020710|FG000|Overall Study|Lack of Efficacy|5|||
163904525|NCT02743819|592020710|FG000|Overall Study|Death|2|||
163904526|NCT02743819|592020710|FG000|Overall Study|Adverse Event|1|||
163904527|NCT01683409|592020711|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163904528|NCT01683409|592020712|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163904529|NCT01683409|592020713|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
163904530|NCT01683409|592020714|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163904531|NCT01683409|592020715|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
163904532|NCT01683409|592020711|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
163904533|NCT01683409|592020712|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
163904534|NCT01683409|592020713|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
163904535|NCT01683409|592020714|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
163904536|NCT01683409|592020715|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
164388945|NCT03214367|593792365|FG004|Treatment Period|Adverse Event|0|||
164388946|NCT03214367|593792366|FG005|Treatment Period|Adverse Event|0|||
164388947|NCT03214367|593792367|FG006|Treatment Period|Adverse Event|0|||
164388948|NCT03214367|593792368|FG007|Treatment Period|Adverse Event|0|||
164388949|NCT03214367|593792361|FG000|Treatment Period|Death|0|||
164388950|NCT03214367|593792362|FG001|Treatment Period|Death|1|||
164388951|NCT03214367|593792363|FG002|Treatment Period|Death|1|||
164388952|NCT03214367|593792364|FG003|Treatment Period|Death|1|||
164388953|NCT03214367|593792365|FG004|Treatment Period|Death|0|||
164388954|NCT03214367|593792366|FG005|Treatment Period|Death|0|||
164388955|NCT03214367|593792367|FG006|Treatment Period|Death|0|||
164388956|NCT03214367|593792368|FG007|Treatment Period|Death|0|||
164388957|NCT03214367|593792361|FG000|Treatment Period|Lost to Follow-up|0|||
164388958|NCT03214367|593792362|FG001|Treatment Period|Lost to Follow-up|5|||
164388959|NCT03214367|593792363|FG002|Treatment Period|Lost to Follow-up|3|||
164388960|NCT03214367|593792364|FG003|Treatment Period|Lost to Follow-up|2|||
164388961|NCT03214367|593792365|FG004|Treatment Period|Lost to Follow-up|0|||
164388962|NCT03214367|593792366|FG005|Treatment Period|Lost to Follow-up|2|||
164388963|NCT03214367|593792367|FG006|Treatment Period|Lost to Follow-up|1|||
164388964|NCT03214367|593792368|FG007|Treatment Period|Lost to Follow-up|0|||
164388965|NCT03214367|593792361|FG000|Treatment Period|Sponsor Decision|0|||
164388966|NCT03214367|593792362|FG001|Treatment Period|Sponsor Decision|3|||
164388967|NCT03214367|593792363|FG002|Treatment Period|Sponsor Decision|0|||
164388968|NCT03214367|593792364|FG003|Treatment Period|Sponsor Decision|0|||
164388969|NCT03214367|593792365|FG004|Treatment Period|Sponsor Decision|0|||
164388970|NCT03214367|593792366|FG005|Treatment Period|Sponsor Decision|0|||
164388971|NCT03214367|593792367|FG006|Treatment Period|Sponsor Decision|0|||
164388972|NCT03214367|593792368|FG007|Treatment Period|Sponsor Decision|0|||
164388973|NCT03214367|593792361|FG000|Treatment Period|Physician Decision|0|||
164388974|NCT03214367|593792362|FG001|Treatment Period|Physician Decision|1|||
164388975|NCT03214367|593792363|FG002|Treatment Period|Physician Decision|2|||
164388976|NCT03214367|593792364|FG003|Treatment Period|Physician Decision|0|||
164388977|NCT03214367|593792365|FG004|Treatment Period|Physician Decision|0|||
164388978|NCT03214367|593792366|FG005|Treatment Period|Physician Decision|0|||
164388979|NCT03214367|593792367|FG006|Treatment Period|Physician Decision|0|||
164388980|NCT03214367|593792368|FG007|Treatment Period|Physician Decision|0|||
164388981|NCT03214367|593792361|FG000|Treatment Period|Protocol Violation|0|||
164388982|NCT03214367|593792362|FG001|Treatment Period|Protocol Violation|3|||
164388983|NCT03214367|593792363|FG002|Treatment Period|Protocol Violation|0|||
164388984|NCT03214367|593792364|FG003|Treatment Period|Protocol Violation|0|||
164388985|NCT03214367|593792365|FG004|Treatment Period|Protocol Violation|0|||
164388986|NCT03214367|593792366|FG005|Treatment Period|Protocol Violation|0|||
164388987|NCT03214367|593792367|FG006|Treatment Period|Protocol Violation|0|||
164388988|NCT03214367|593792368|FG007|Treatment Period|Protocol Violation|0|||
164388989|NCT03214367|593792361|FG000|Treatment Period|Withdrawal by Subject|0|||
164388990|NCT03214367|593792362|FG001|Treatment Period|Withdrawal by Subject|20|||
163904537|NCT01683409|592020711|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163904538|NCT01683409|592020712|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
163904539|NCT01683409|592020713|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
164388991|NCT03214367|593792363|FG002|Treatment Period|Withdrawal by Subject|23|||
164388992|NCT03214367|593792364|FG003|Treatment Period|Withdrawal by Subject|14|||
164388993|NCT03214367|593792365|FG004|Treatment Period|Withdrawal by Subject|0|||
164388994|NCT03214367|593792366|FG005|Treatment Period|Withdrawal by Subject|1|||
164388995|NCT03214367|593792367|FG006|Treatment Period|Withdrawal by Subject|1|||
164388996|NCT03214367|593792368|FG007|Treatment Period|Withdrawal by Subject|1|||
164388997|NCT03268811|593792371|FG000|Overall Study|Adverse Event|0|||
164388998|NCT03268811|593792372|FG001|Overall Study|Adverse Event|1|||
164388999|NCT04726709|593792373|FG000|Overall Study|Withdrawal by Subject|2|||
164093033|NCT00864097|592703460|FG003|Overall Study|Adverse Event|9|||
164389000|NCT04726709|593792374|FG001|Overall Study|Withdrawal by Subject|2|||
164389001|NCT02117570|593792377|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
164389002|NCT02117570|593792378|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
164389003|NCT02117570|593792379|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
164389004|NCT02117570|593792377|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
164389005|NCT02117570|593792378|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
164389006|NCT02117570|593792379|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
164389007|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
164389008|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
164389009|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
164389010|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
164389011|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
164389012|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
164389013|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
164389014|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
164389015|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
164389016|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
164389017|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
164389018|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
164389019|NCT02117570|593792377|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
164389020|NCT02117570|593792378|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
164389021|NCT02117570|593792379|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
164389022|NCT02148250|593792380|FG000|Screening|Withdrawal by Subject|5|||
164389023|NCT02148250|593792381|FG001|Screening|Withdrawal by Subject|0|||
164389024|NCT04447404|593792393|FG000|Overall Study|Death|2|||
164389025|NCT04447404|593792394|FG001|Overall Study|Death|0|||
164389026|NCT00574080|593792395|FG000|Overall Study|Death|10|||
164389027|NCT00574080|593792396|FG001|Overall Study|Death|10|||
164389028|NCT01221597|593792397|FG000|Overall Study|Adverse Event|4|||
164389029|NCT01221597|593792398|FG001|Overall Study|Adverse Event|1|||
164389030|NCT01221597|593792397|FG000|Overall Study|Withdrawal by Subject|20|||
164389031|NCT01221597|593792398|FG001|Overall Study|Withdrawal by Subject|6|||
164389032|NCT01221597|593792397|FG000|Overall Study|Lost to Follow-up|6|||
164389033|NCT01221597|593792398|FG001|Overall Study|Lost to Follow-up|5|||
164389034|NCT01221597|593792397|FG000|Overall Study|Protocol Violation|1|||
164389035|NCT01221597|593792398|FG001|Overall Study|Protocol Violation|0|||
164389036|NCT01221597|593792397|FG000|Overall Study|Other|3|||
164389037|NCT01221597|593792398|FG001|Overall Study|Other|4|||
164389038|NCT01221597|593792397|FG000|Overall Study|Death|2|||
164389039|NCT01221597|593792398|FG001|Overall Study|Death|0|||
164389040|NCT00563784|593792400|FG000|Overall Study|Withdrawal by Subject|2|||
164389041|NCT00563784|593792400|FG000|Overall Study|Screen Failures|20|||
164389042|NCT04004611|593792401|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389043|NCT04004611|593792402|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389044|NCT04004611|593792403|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389045|NCT04004611|593792404|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389046|NCT04004611|593792405|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389047|NCT04004611|593792406|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389048|NCT04004611|593792407|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389049|NCT04004611|593792408|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
164389050|NCT04004611|593792409|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
164389051|NCT04004611|593792401|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389052|NCT04004611|593792402|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389053|NCT04004611|593792403|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389054|NCT04004611|593792404|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389055|NCT04004611|593792405|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389056|NCT04004611|593792406|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
164389057|NCT04004611|593792407|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
164389058|NCT04004611|593792408|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
164389059|NCT04004611|593792409|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
164389060|NCT04004611|593792401|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389061|NCT04004611|593792402|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389062|NCT04004611|593792403|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389063|NCT04004611|593792404|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389064|NCT04004611|593792405|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
164389065|NCT04004611|593792406|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389066|NCT04004611|593792407|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389067|NCT04004611|593792408|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389068|NCT04004611|593792409|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
164389069|NCT04004611|593792401|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
164389070|NCT04004611|593792402|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
164389071|NCT04004611|593792403|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
164389072|NCT04004611|593792404|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
164389073|NCT04004611|593792405|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
164389074|NCT04004611|593792406|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
164389075|NCT04004611|593792407|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
164389076|NCT04004611|593792408|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
164389077|NCT04004611|593792409|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
164389078|NCT04004611|593792401|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
164389079|NCT04004611|593792402|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389080|NCT04004611|593792403|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
164389081|NCT04004611|593792404|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389082|NCT04004611|593792405|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389083|NCT04004611|593792406|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389084|NCT04004611|593792407|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389085|NCT04004611|593792408|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389086|NCT04004611|593792409|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
164389087|NCT04004611|593792401|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389088|NCT04004611|593792402|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
164389089|NCT04004611|593792403|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389090|NCT04004611|593792404|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389091|NCT04004611|593792405|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389092|NCT04004611|593792406|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389093|NCT04004611|593792407|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389094|NCT04004611|593792408|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389095|NCT04004611|593792409|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
164389096|NCT00320216|593792410|FG000|Overall Study|Adverse Event|0|||
164389097|NCT00320216|593792411|FG001|Overall Study|Adverse Event|6|||
164389098|NCT00320216|593792412|FG002|Overall Study|Adverse Event|0|||
164389099|NCT00320216|593792413|FG003|Overall Study|Adverse Event|2|||
164389100|NCT00320216|593792414|FG004|Overall Study|Adverse Event|2|||
164389101|NCT00320216|593792410|FG000|Overall Study|Lack of Efficacy|6|||
164389102|NCT00320216|593792411|FG001|Overall Study|Lack of Efficacy|2|||
164389103|NCT00320216|593792412|FG002|Overall Study|Lack of Efficacy|1|||
164389104|NCT00320216|593792413|FG003|Overall Study|Lack of Efficacy|0|||
164389105|NCT00320216|593792414|FG004|Overall Study|Lack of Efficacy|1|||
164389106|NCT00320216|593792410|FG000|Overall Study|Lost to Follow-up|3|||
164389107|NCT00320216|593792411|FG001|Overall Study|Lost to Follow-up|0|||
164389108|NCT00320216|593792412|FG002|Overall Study|Lost to Follow-up|0|||
164389109|NCT00320216|593792413|FG003|Overall Study|Lost to Follow-up|0|||
164389110|NCT00320216|593792414|FG004|Overall Study|Lost to Follow-up|0|||
164389111|NCT00320216|593792410|FG000|Overall Study|Other|7|||
164389112|NCT00320216|593792411|FG001|Overall Study|Other|2|||
164389113|NCT00320216|593792412|FG002|Overall Study|Other|5|||
164389114|NCT00320216|593792413|FG003|Overall Study|Other|1|||
164389115|NCT00320216|593792414|FG004|Overall Study|Other|3|||
164389116|NCT00148343|593792415|FG000|Overall Study|Withdrawal by Subject|12|||
164389117|NCT00148343|593792416|FG001|Overall Study|Withdrawal by Subject|7|||
164389118|NCT00148343|593792415|FG000|Overall Study|Physician Decision|3|||
164016033|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
164389119|NCT00148343|593792416|FG001|Overall Study|Physician Decision|4|||
164389120|NCT02384759|593792430|FG000|Overall Study|Patients not treated|3|||
164389121|NCT02384759|593792431|FG001|Overall Study|Patients not treated|2|||
164389122|NCT01605617|593792432|FG000|First Intervention|Adverse Event|0|||
164389123|NCT01605617|593792433|FG001|First Intervention|Adverse Event|1|||
164389124|NCT01605617|593792432|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
164389125|NCT01605617|593792433|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
164389126|NCT00121238|593792434|FG000|Overall Study|disease progression before intervention|1|||
164389127|NCT00121238|593792434|FG000|Overall Study|Protocol Violation|2|||
164389128|NCT01380327|593792435|FG000|Overall Study|Lost to Follow-up|0|||
164389129|NCT01380327|593792436|FG001|Overall Study|Lost to Follow-up|1|||
164389130|NCT01380327|593792437|FG002|Overall Study|Lost to Follow-up|1|||
164389131|NCT01380327|593792435|FG000|Overall Study|Protocol Violation|3|||
164016034|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
164016035|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
164300144|NCT04543279|593475146|FG000|Overall Study|Physician Decision|1|||
164300145|NCT04543279|593475147|FG001|Overall Study|Physician Decision|0|||
164300146|NCT00929695|593475150|FG000|Overall Study|Death|2|||
164300147|NCT00929695|593475151|FG001|Overall Study|Death|1|||
164300148|NCT00929695|593475150|FG000|Overall Study|Withdrawal by Subject|0|||
164300149|NCT00929695|593475151|FG001|Overall Study|Withdrawal by Subject|2|||
164300150|NCT00929695|593475150|FG000|Overall Study|discharge home|4|||
164300151|NCT00929695|593475151|FG001|Overall Study|discharge home|3|||
164300152|NCT00929695|593475150|FG000|Overall Study|incorrect stratification|2|||
164016036|NCT00365716|592421818|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
164300153|NCT00929695|593475151|FG001|Overall Study|incorrect stratification|0|||
164300154|NCT04030143|593475152|FG000|Overall Study|Adverse Event|5|||
164300155|NCT04030143|593475153|FG001|Overall Study|Adverse Event|10|||
164300156|NCT04030143|593475152|FG000|Overall Study|Lost to Follow-up|3|||
164300157|NCT04030143|593475153|FG001|Overall Study|Lost to Follow-up|7|||
164300158|NCT04030143|593475152|FG000|Overall Study|Protocol Deviation|2|||
164300159|NCT04030143|593475153|FG001|Overall Study|Protocol Deviation|2|||
164300160|NCT04030143|593475152|FG000|Overall Study|Withdrawal by Subject|16|||
164300161|NCT04030143|593475153|FG001|Overall Study|Withdrawal by Subject|18|||
164300162|NCT04030143|593475152|FG000|Overall Study|Physician Decision|1|||
164300163|NCT04030143|593475153|FG001|Overall Study|Physician Decision|1|||
164300164|NCT04030143|593475152|FG000|Overall Study|Due to Covid-19|2|||
164300165|NCT04030143|593475153|FG001|Overall Study|Due to Covid-19|3|||
164300166|NCT04030143|593475152|FG000|Overall Study|Not Due to Covid-19|1|||
164300167|NCT04030143|593475153|FG001|Overall Study|Not Due to Covid-19|1|||
164300168|NCT03216226|593475154|FG000|Overall Study|Adverse Event|3|||
164300169|NCT03216226|593475155|FG001|Overall Study|Adverse Event|0|||
164300170|NCT03216226|593475154|FG000|Overall Study|Protocol Violation|1|||
164300171|NCT03216226|593475155|FG001|Overall Study|Protocol Violation|3|||
164300172|NCT03216226|593475154|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
164300173|NCT03216226|593475155|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
164300174|NCT03216226|593475154|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
164300175|NCT03216226|593475155|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
164300176|NCT03216226|593475154|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
164300177|NCT03216226|593475155|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
164300178|NCT01352715|593475157|FG000|Overall Study|Death|3|||
164300179|NCT01352715|593475158|FG001|Overall Study|Death|3|||
164300180|NCT01352715|593475157|FG000|Overall Study|Lost to Follow-up|5|||
164300181|NCT01352715|593475158|FG001|Overall Study|Lost to Follow-up|7|||
164300182|NCT01352715|593475157|FG000|Overall Study|Withdrawal by Subject|4|||
164300183|NCT01352715|593475158|FG001|Overall Study|Withdrawal by Subject|8|||
164300184|NCT01352715|593475157|FG000|Overall Study|site closure|16|||
164300185|NCT01352715|593475158|FG001|Overall Study|site closure|15|||
164300186|NCT01352715|593475157|FG000|Overall Study|no final visit in closeout period|15|||
164300187|NCT01352715|593475158|FG001|Overall Study|no final visit in closeout period|12|||
164300188|NCT01352715|593475157|FG000|Overall Study|major ineligibility|2|||
164300189|NCT01352715|593475158|FG001|Overall Study|major ineligibility|1|||
164300190|NCT05966142|593475159|FG000|Overall Study|Death|3|||
164300191|NCT05966142|593475160|FG001|Overall Study|Death|3|||
164300192|NCT05966142|593475159|FG000|Overall Study|Lost to Follow-up|55|||
164300193|NCT05966142|593475160|FG001|Overall Study|Lost to Follow-up|52|||
164300194|NCT05966142|593475159|FG000|Overall Study|Physician Decision|1|||
164300195|NCT05966142|593475160|FG001|Overall Study|Physician Decision|0|||
164300196|NCT05966142|593475159|FG000|Overall Study|Withdrawal by Subject|9|||
164300197|NCT05966142|593475160|FG001|Overall Study|Withdrawal by Subject|8|||
164300198|NCT05966142|593475159|FG000|Overall Study|Duplicate Enrollment|1|||
164300199|NCT05966142|593475160|FG001|Overall Study|Duplicate Enrollment|0|||
163904540|NCT01683409|592020714|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163904541|NCT01683409|592020715|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
163904542|NCT01683409|592020711|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
163904543|NCT01683409|592020712|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
163904544|NCT01683409|592020713|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
163904545|NCT01683409|592020714|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
163904546|NCT01683409|592020715|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
163904547|NCT01683409|592020711|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163904548|NCT01683409|592020712|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163904549|NCT01683409|592020713|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
163904550|NCT01683409|592020714|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163904551|NCT01683409|592020715|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
163904552|NCT01683409|592020711|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
163904553|NCT01683409|592020712|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
163904554|NCT01683409|592020713|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
163904555|NCT01683409|592020714|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
163904556|NCT01683409|592020715|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
163904557|NCT01683409|592020711|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
163904558|NCT01683409|592020712|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
163904559|NCT01683409|592020713|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
163904560|NCT01683409|592020714|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
163904561|NCT01683409|592020715|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
163904562|NCT01683409|592020711|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
163904563|NCT01683409|592020712|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163904564|NCT01683409|592020713|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163904565|NCT01683409|592020714|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163904566|NCT01683409|592020715|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
163904567|NCT01683409|592020711|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
163904568|NCT01683409|592020712|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
163904569|NCT01683409|592020713|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
163904570|NCT01683409|592020714|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
163904571|NCT01683409|592020715|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
163904572|NCT01683409|592020711|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163904573|NCT01683409|592020712|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163904574|NCT01683409|592020713|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163904575|NCT01683409|592020714|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
163904576|NCT01683409|592020715|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
163904577|NCT01683409|592020711|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163904578|NCT01683409|592020712|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163904579|NCT01683409|592020713|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
163904580|NCT01683409|592020714|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163904581|NCT01683409|592020715|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
163904582|NCT00553332|592020721|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
163904583|NCT00145470|592020729|FG000|Overall Study|Adverse Event|19|||
163904584|NCT00145470|592020730|FG001|Overall Study|Adverse Event|25|||
163904585|NCT00145470|592020729|FG000|Overall Study|Lack of Efficacy|27|||
163904586|NCT00145470|592020730|FG001|Overall Study|Lack of Efficacy|13|||
163904587|NCT00145470|592020729|FG000|Overall Study|Withdrawal by Subject|36|||
163904588|NCT00145470|592020730|FG001|Overall Study|Withdrawal by Subject|34|||
163904589|NCT00145470|592020729|FG000|Overall Study|Lost to Follow-up|21|||
163904590|NCT00145470|592020730|FG001|Overall Study|Lost to Follow-up|17|||
163904591|NCT00145470|592020729|FG000|Overall Study|Reason Not Reported|9|||
163904592|NCT00145470|592020730|FG001|Overall Study|Reason Not Reported|9|||
163904593|NCT02063659|592020731|FG000|Double-Blind Treatment Period|Adverse Event|1|||
163904594|NCT02063659|592020732|FG001|Double-Blind Treatment Period|Adverse Event|2|||
163904595|NCT02063659|592020733|FG002|Double-Blind Treatment Period|Adverse Event|0|||
163904596|NCT02063659|592020734|FG003|Double-Blind Treatment Period|Adverse Event|0|||
163904597|NCT02063659|592020731|FG000|Double-Blind Treatment Period|Physician Decision|1|||
163904598|NCT02063659|592020732|FG001|Double-Blind Treatment Period|Physician Decision|0|||
163904599|NCT02063659|592020733|FG002|Double-Blind Treatment Period|Physician Decision|0|||
163904600|NCT02063659|592020734|FG003|Double-Blind Treatment Period|Physician Decision|0|||
163904601|NCT02063659|592020731|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
163904602|NCT02063659|592020732|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
163904603|NCT02063659|592020733|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
163904604|NCT02063659|592020734|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
163904605|NCT02063659|592020731|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
163904606|NCT02063659|592020732|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
163904607|NCT02063659|592020733|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
163904608|NCT02063659|592020734|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
163904609|NCT02063659|592020731|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
164389132|NCT01380327|593792436|FG001|Overall Study|Protocol Violation|2|||
164389133|NCT01380327|593792437|FG002|Overall Study|Protocol Violation|3|||
164389134|NCT01380327|593792435|FG000|Overall Study|Withdrawal by Subject|0|||
164389135|NCT01380327|593792436|FG001|Overall Study|Withdrawal by Subject|0|||
164389136|NCT01380327|593792437|FG002|Overall Study|Withdrawal by Subject|1|||
164389137|NCT01380327|593792435|FG000|Overall Study|Housing situation precluded ability to k|0|||
164389138|NCT01380327|593792436|FG001|Overall Study|Housing situation precluded ability to k|0|||
164389139|NCT01380327|593792437|FG002|Overall Study|Housing situation precluded ability to k|1|||
164389140|NCT01380327|593792435|FG000|Overall Study|Questionable onset of epilepsy|0|||
164389141|NCT01380327|593792436|FG001|Overall Study|Questionable onset of epilepsy|0|||
164389142|NCT01380327|593792437|FG002|Overall Study|Questionable onset of epilepsy|1|||
164389143|NCT03043664|593792438|FG000|Overall Study|Lost to Follow-up|1|||
164389144|NCT01540851|593792439|FG000|Overall Study|Lost to Follow-up|14|||
164389145|NCT01540851|593792440|FG001|Overall Study|Lost to Follow-up|15|||
164389146|NCT01540851|593792439|FG000|Overall Study|Withdrawal by Subject|7|||
164389147|NCT01540851|593792440|FG001|Overall Study|Withdrawal by Subject|3|||
164389148|NCT00325468|593792441|FG000|Overall Study|Adverse Event|1|||
164389149|NCT00325468|593792442|FG001|Overall Study|Adverse Event|1|||
164389150|NCT00325468|593792443|FG002|Overall Study|Adverse Event|0|||
164389151|NCT00325468|593792444|FG003|Overall Study|Adverse Event|5|||
164389152|NCT00325468|593792445|FG004|Overall Study|Adverse Event|1|||
164389153|NCT00325468|593792441|FG000|Overall Study|Death|2|||
164389154|NCT00325468|593792442|FG001|Overall Study|Death|0|||
164389155|NCT00325468|593792443|FG002|Overall Study|Death|2|||
164389156|NCT00325468|593792444|FG003|Overall Study|Death|4|||
164389157|NCT00325468|593792445|FG004|Overall Study|Death|0|||
164389158|NCT00325468|593792441|FG000|Overall Study|Lost to Follow-up|0|||
164389159|NCT00325468|593792442|FG001|Overall Study|Lost to Follow-up|0|||
164389160|NCT00325468|593792443|FG002|Overall Study|Lost to Follow-up|1|||
164389161|NCT00325468|593792444|FG003|Overall Study|Lost to Follow-up|2|||
164093034|NCT00864097|592703457|FG000|Overall Study|Lack of Efficacy|9|||
164389162|NCT00325468|593792445|FG004|Overall Study|Lost to Follow-up|2|||
164389163|NCT00325468|593792441|FG000|Overall Study|Physician Decision|1|||
163904610|NCT02063659|592020732|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
163904611|NCT02063659|592020733|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
163904612|NCT02063659|592020734|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
163904613|NCT02063659|592020731|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
163904614|NCT02063659|592020732|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
163904615|NCT02063659|592020733|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
163904616|NCT02063659|592020734|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
163904617|NCT02063659|592020731|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
163904618|NCT02063659|592020732|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
163904619|NCT02063659|592020733|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
163904620|NCT02063659|592020734|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
163904621|NCT02063659|592020731|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
163904622|NCT02063659|592020732|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
163904623|NCT02063659|592020733|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
163904624|NCT02063659|592020734|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
163904625|NCT04762277|592020735|FG000|Overall Study|Withdrawal by Subject|0|||
163904626|NCT04762277|592020736|FG001|Overall Study|Withdrawal by Subject|2|||
163904627|NCT04762277|592020735|FG000|Overall Study|Protocol Violation|0|||
163904628|NCT04762277|592020736|FG001|Overall Study|Protocol Violation|1|||
163904629|NCT04762277|592020735|FG000|Overall Study|Adverse Event|1|||
163904630|NCT04762277|592020736|FG001|Overall Study|Adverse Event|0|||
163904631|NCT02556918|592022120|FG000|Overall Study|Protocol Violation|5|||
163904632|NCT02556918|592022121|FG001|Overall Study|Protocol Violation|6|||
163904633|NCT02556918|592022120|FG000|Overall Study|Withdrawal by Subject|4|||
163904634|NCT02556918|592022121|FG001|Overall Study|Withdrawal by Subject|4|||
163904635|NCT04511702|592022131|FG000|Overall Study|Lost to Follow-up|3|||
163904636|NCT04511702|592022132|FG001|Overall Study|Lost to Follow-up|0|||
163904637|NCT04511702|592022133|FG002|Overall Study|Lost to Follow-up|4|||
163904638|NCT04511702|592022131|FG000|Overall Study|Withdrawal by Subject|17|||
163904639|NCT04511702|592022132|FG001|Overall Study|Withdrawal by Subject|1|||
163904640|NCT04511702|592022133|FG002|Overall Study|Withdrawal by Subject|8|||
163904641|NCT05349721|592022134|FG000|Part A (24 Weeks)|Adverse Event|9|||
163904642|NCT05349721|592022135|FG001|Part A (24 Weeks)|Adverse Event|2|||
163904643|NCT05349721|592022134|FG000|Part A (24 Weeks)|Death|8|||
163904644|NCT05349721|592022135|FG001|Part A (24 Weeks)|Death|3|||
163904645|NCT05349721|592022134|FG000|Part A (24 Weeks)|Disease Progression|1|||
163904646|NCT05349721|592022135|FG001|Part A (24 Weeks)|Disease Progression|1|||
163904647|NCT05349721|592022134|FG000|Part A (24 Weeks)|Screen Failure|2|||
163904648|NCT05349721|592022135|FG001|Part A (24 Weeks)|Screen Failure|0|||
163904649|NCT05349721|592022134|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
163904650|NCT05349721|592022135|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
163904651|NCT05349721|592022134|FG000|Part A (24 Weeks)|Other Than Specified|5|||
163904652|NCT05349721|592022135|FG001|Part A (24 Weeks)|Other Than Specified|1|||
163904653|NCT05349721|592022134|FG000|Part B (28 Weeks)|Adverse Event|3|||
164016037|NCT00365716|592421819|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
164016038|NCT00365716|592421820|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
164016039|NCT00365716|592421821|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
164016040|NCT00365716|592421822|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
164016041|NCT00365716|592421823|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
164016042|NCT00365716|592421824|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
164016043|NCT00365716|592421818|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
164016044|NCT00365716|592421819|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164073015|NCT00552617|592632769|FG006|Overall Study|Not Treated|0|||
163904654|NCT05349721|592022135|FG001|Part B (28 Weeks)|Adverse Event|0|||
163904655|NCT05349721|592022134|FG000|Part B (28 Weeks)|Death|21|||
163904656|NCT05349721|592022135|FG001|Part B (28 Weeks)|Death|11|||
163904657|NCT05349721|592022134|FG000|Part B (28 Weeks)|Disease Progression|2|||
163904658|NCT05349721|592022135|FG001|Part B (28 Weeks)|Disease Progression|1|||
163904659|NCT05349721|592022134|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
163904660|NCT05349721|592022135|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
163904661|NCT05349721|592022134|FG000|Part B (28 Weeks)|Physician Decision|1|||
164073016|NCT00552617|592632770|FG007|Overall Study|Not Treated|0|||
164073017|NCT00552617|592632771|FG008|Overall Study|Not Treated|0|||
163904662|NCT05349721|592022135|FG001|Part B (28 Weeks)|Physician Decision|0|||
163904663|NCT05349721|592022134|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
163904664|NCT05349721|592022135|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
163904665|NCT05349721|592022134|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
163904666|NCT05349721|592022135|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
163904667|NCT05349721|592022134|FG000|Part B (28 Weeks)|Other Than Specified|4|||
163904668|NCT05349721|592022135|FG001|Part B (28 Weeks)|Other Than Specified|2|||
163904669|NCT05349721|592022134|FG000|Part C (108 Weeks)|Death|0|||
163904670|NCT05349721|592022135|FG001|Part C (108 Weeks)|Death|1|||
163904671|NCT05349721|592022134|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
163904672|NCT05349721|592022135|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
163904673|NCT05349721|592022134|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
163904674|NCT05349721|592022135|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
163904675|NCT05349721|592022134|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
163904676|NCT05349721|592022135|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
163904677|NCT00108355|592022137|FG000|Overall Study|Peritonitis at index paracentesis|1|||
163904678|NCT00108355|592022138|FG001|Overall Study|Peritonitis at index paracentesis|1|||
163904679|NCT00108355|592022137|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
163904680|NCT00108355|592022138|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
163904681|NCT01583166|592022139|FG000|Overall Study|Withdrawal by Subject|4|||
163904682|NCT01583166|592022140|FG001|Overall Study|Withdrawal by Subject|6|||
163904683|NCT04652869|592022143|FG000|Overall Study|Withdrawal by Subject|0|||
163904684|NCT04652869|592022144|FG001|Overall Study|Withdrawal by Subject|2|||
163904685|NCT04652869|592022145|FG002|Overall Study|Withdrawal by Subject|0|||
164016045|NCT00365716|592421820|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164016046|NCT00365716|592421821|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
164016047|NCT00365716|592421822|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
164016048|NCT00365716|592421823|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164016049|NCT00365716|592421824|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
164016050|NCT00365716|592421818|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
164016051|NCT00365716|592421819|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
164016052|NCT00365716|592421820|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
163904686|NCT01372085|592022146|FG000|Washout Period 2|Physician Decision|0|||
163904687|NCT01372085|592022147|FG001|Washout Period 2|Physician Decision|0|||
163904688|NCT01372085|592022148|FG002|Washout Period 2|Physician Decision|0|||
163904689|NCT01372085|592022149|FG003|Washout Period 2|Physician Decision|0|||
163904690|NCT01372085|592022150|FG004|Washout Period 2|Physician Decision|1|||
163904691|NCT01372085|592022151|FG005|Washout Period 2|Physician Decision|0|||
163904692|NCT01372085|592022152|FG006|Washout Period 2|Physician Decision|0|||
163904693|NCT01372085|592022153|FG007|Washout Period 2|Physician Decision|0|||
163904694|NCT01372085|592022154|FG008|Washout Period 2|Physician Decision|0|||
163904695|NCT01372085|592022155|FG009|Washout Period 2|Physician Decision|0|||
163904696|NCT01372085|592022146|FG000|Washout Period 3|Withdrawal by Subject|0|||
163904697|NCT01372085|592022147|FG001|Washout Period 3|Withdrawal by Subject|0|||
163904698|NCT01372085|592022148|FG002|Washout Period 3|Withdrawal by Subject|0|||
163904699|NCT01372085|592022149|FG003|Washout Period 3|Withdrawal by Subject|0|||
163904700|NCT01372085|592022150|FG004|Washout Period 3|Withdrawal by Subject|0|||
163904701|NCT01372085|592022151|FG005|Washout Period 3|Withdrawal by Subject|2|||
163904702|NCT01372085|592022152|FG006|Washout Period 3|Withdrawal by Subject|0|||
163904703|NCT01372085|592022153|FG007|Washout Period 3|Withdrawal by Subject|0|||
163904704|NCT01372085|592022154|FG008|Washout Period 3|Withdrawal by Subject|0|||
163904705|NCT01372085|592022155|FG009|Washout Period 3|Withdrawal by Subject|0|||
163904706|NCT00562094|592022156|FG000|Overall Study|Lost to Follow-up|62|||
163904707|NCT03960645|592022157|FG000|Overall Study|Protocol Violation|1|||
163904708|NCT03960645|592022158|FG001|Overall Study|Protocol Violation|0|||
163904709|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
163904710|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
163904711|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
163904712|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
164093035|NCT00864097|592703458|FG001|Overall Study|Lack of Efficacy|3|||
164093036|NCT00864097|592703459|FG002|Overall Study|Lack of Efficacy|7|||
164093037|NCT00864097|592703460|FG003|Overall Study|Lack of Efficacy|2|||
164093038|NCT00864097|592703457|FG000|Overall Study|Lost to Follow-up|0|||
164093039|NCT00864097|592703458|FG001|Overall Study|Lost to Follow-up|1|||
163904713|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
163904714|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
163904715|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
163904716|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
163904717|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163904718|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
163904719|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
163904720|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
163904721|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163904722|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
163904723|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
163904724|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
163904725|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
163904726|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
163904727|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
163904728|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
163904729|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
163904730|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
163904731|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
163904732|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
163904733|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
163904734|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
163904735|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
163904736|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
163904737|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
163904738|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
163904739|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
163904740|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
163904741|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
163904742|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
163904743|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
163904744|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163904745|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163904746|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163904747|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
163904748|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
163904749|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
163904750|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
163904751|NCT03732807|592022163|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163904752|NCT03732807|592022164|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163904753|NCT03732807|592022165|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163904754|NCT03732807|592022166|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163904755|NCT03732807|592022167|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163904756|NCT03732807|592022168|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
163904757|NCT03732807|592022169|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
163904758|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
163904759|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
163904760|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
163904761|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
163904762|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
163904763|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
163904764|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
163904765|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
163904766|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
164016053|NCT00365716|592421821|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
164016054|NCT00365716|592421822|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
164016055|NCT00365716|592421823|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
164016056|NCT00365716|592421824|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
164016057|NCT00365716|592421818|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
164016058|NCT00365716|592421819|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
164016059|NCT00365716|592421820|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
164016060|NCT00365716|592421821|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
164016061|NCT00365716|592421822|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
164016062|NCT00365716|592421823|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
164016063|NCT00365716|592421824|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
164016064|NCT00365716|592421818|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
164073018|NCT00552617|592632772|FG009|Overall Study|Not Treated|1|||
164389164|NCT00325468|593792442|FG001|Overall Study|Physician Decision|1|||
163904767|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
163904768|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
164389165|NCT00325468|593792443|FG002|Overall Study|Physician Decision|0|||
163904769|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
164389166|NCT00325468|593792444|FG003|Overall Study|Physician Decision|1|||
164389167|NCT00325468|593792445|FG004|Overall Study|Physician Decision|0|||
164389168|NCT00325468|593792441|FG000|Overall Study|Withdrawal by Subject|3|||
164389169|NCT00325468|593792442|FG001|Overall Study|Withdrawal by Subject|1|||
164389170|NCT00325468|593792443|FG002|Overall Study|Withdrawal by Subject|0|||
164389171|NCT00325468|593792444|FG003|Overall Study|Withdrawal by Subject|14|||
164389172|NCT00325468|593792445|FG004|Overall Study|Withdrawal by Subject|4|||
164389173|NCT00325468|593792441|FG000|Overall Study|site closure etc|4|||
164389174|NCT00325468|593792442|FG001|Overall Study|site closure etc|2|||
164389175|NCT00325468|593792443|FG002|Overall Study|site closure etc|1|||
164389176|NCT00325468|593792444|FG003|Overall Study|site closure etc|8|||
164389177|NCT00325468|593792445|FG004|Overall Study|site closure etc|1|||
164389178|NCT03732209|593792446|FG000|Overall Study|Lost to Follow-up|4|||
164389179|NCT03732209|593792447|FG001|Overall Study|Lost to Follow-up|4|||
164389180|NCT03732209|593792446|FG000|Overall Study|Withdrawal by Subject|8|||
164389181|NCT03732209|593792447|FG001|Overall Study|Withdrawal by Subject|9|||
164389182|NCT05046795|593792448|FG000|Overall Study|Adverse Event|13|||
164389183|NCT05046795|593792449|FG001|Overall Study|Adverse Event|15|||
164389184|NCT05046795|593792448|FG000|Overall Study|Withdrawal by Subject|4|||
164389185|NCT05046795|593792449|FG001|Overall Study|Withdrawal by Subject|7|||
164389186|NCT05046795|593792448|FG000|Overall Study|Physician Decision|1|||
164389187|NCT05046795|593792449|FG001|Overall Study|Physician Decision|2|||
164389188|NCT05046795|593792448|FG000|Overall Study|Protocol Violation|1|||
164389189|NCT05046795|593792449|FG001|Overall Study|Protocol Violation|2|||
164389190|NCT05046795|593792448|FG000|Overall Study|Death|1|||
164389191|NCT05046795|593792449|FG001|Overall Study|Death|0|||
164389192|NCT05046795|593792448|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
164389193|NCT05046795|593792449|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
164389194|NCT01127178|593792450|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
164389195|NCT01127178|593792451|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
164389196|NCT01127178|593792450|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
164389197|NCT01127178|593792451|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
164389198|NCT01127178|593792450|FG000|Dose Escalation: Treatment Phase|Other|2|||
164389199|NCT01127178|593792451|FG001|Dose Escalation: Treatment Phase|Other|0|||
164389200|NCT01127178|593792450|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
164389201|NCT01127178|593792451|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
164389202|NCT01127178|593792450|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
164389203|NCT01127178|593792451|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
164389204|NCT01127178|593792450|FG000|Dose Escalation: Extension Phase|Other|1|||
164389205|NCT01127178|593792451|FG001|Dose Escalation: Extension Phase|Other|0|||
164389206|NCT03950739|593792452|FG000|Treatment Phase|Adverse Event|2|||
164389207|NCT03950739|593792452|FG000|Optional Extension Phase|Death|1|||
164389208|NCT03950739|593792452|FG000|Optional Extension Phase|Progressive Disease|5|||
164389209|NCT03950739|593792452|FG000|Optional Extension Phase|Adverse Event|7|||
164389210|NCT03950739|593792452|FG000|Optional Extension Phase|Lost to Follow-up|2|||
164389211|NCT03950739|593792452|FG000|Optional Extension Phase|Site Closure|2|||
164389212|NCT03950739|593792452|FG000|Optional Extension Phase|Pregnancy|1|||
164389213|NCT03625570|593792453|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
164389214|NCT03625570|593792454|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
164389215|NCT03625570|593792453|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
164389216|NCT03625570|593792454|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
164389217|NCT03625570|593792453|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
164389218|NCT03625570|593792454|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
164389219|NCT04139317|593792455|FG000|Overall Study|Adverse Event|10|||
164389220|NCT04139317|593792456|FG001|Overall Study|Adverse Event|2|||
164389221|NCT04139317|593792455|FG000|Overall Study|Death|6|||
164389222|NCT04139317|593792456|FG001|Overall Study|Death|4|||
164389223|NCT04139317|593792455|FG000|Overall Study|Lost to Follow-up|1|||
164389224|NCT04139317|593792456|FG001|Overall Study|Lost to Follow-up|0|||
164389225|NCT04139317|593792455|FG000|Overall Study|Physician Decision|3|||
164389226|NCT04139317|593792456|FG001|Overall Study|Physician Decision|1|||
164389227|NCT04139317|593792455|FG000|Overall Study|Progressive Disease|19|||
164389228|NCT04139317|593792456|FG001|Overall Study|Progressive Disease|9|||
164389229|NCT04139317|593792455|FG000|Overall Study|Subject Decision|2|||
164389230|NCT04139317|593792456|FG001|Overall Study|Subject Decision|2|||
164389231|NCT00345579|593792459|FG000|Overall Study|Adverse Event|9|||
164389232|NCT00345579|593792460|FG001|Overall Study|Adverse Event|6|||
164389233|NCT00345579|593792459|FG000|Overall Study|Protocol Violation|14|||
164389234|NCT00345579|593792460|FG001|Overall Study|Protocol Violation|5|||
164389235|NCT00345579|593792459|FG000|Overall Study|Withdrawal by Subject|50|||
164389236|NCT00345579|593792460|FG001|Overall Study|Withdrawal by Subject|17|||
164389237|NCT00345579|593792459|FG000|Overall Study|Lost to Follow-up|82|||
164389238|NCT00345579|593792460|FG001|Overall Study|Lost to Follow-up|36|||
164389239|NCT00345579|593792459|FG000|Overall Study|Other|9|||
164389240|NCT00345579|593792460|FG001|Overall Study|Other|1|||
164389241|NCT00782340|593792461|FG000|Open Label Titration|Adverse Event|12|||
164389242|NCT00782340|593792462|FG001|Open Label Titration|Adverse Event|0|||
164389243|NCT00782340|593792463|FG002|Open Label Titration|Adverse Event|0|||
164389244|NCT00782340|593792461|FG000|Open Label Titration|Treatment failure|50|||
164389245|NCT00782340|593792462|FG001|Open Label Titration|Treatment failure|0|||
164389246|NCT00782340|593792463|FG002|Open Label Titration|Treatment failure|0|||
164389247|NCT00782340|593792461|FG000|Open Label Titration|Protocol Violation|5|||
164389248|NCT00782340|593792462|FG001|Open Label Titration|Protocol Violation|0|||
164389249|NCT00782340|593792463|FG002|Open Label Titration|Protocol Violation|0|||
164389250|NCT00782340|593792461|FG000|Open Label Titration|Withdrawal by Subject|5|||
164389251|NCT00782340|593792462|FG001|Open Label Titration|Withdrawal by Subject|0|||
164389252|NCT00782340|593792463|FG002|Open Label Titration|Withdrawal by Subject|0|||
164389253|NCT00782340|593792461|FG000|Open Label Titration|Enrollment capped|16|||
164389254|NCT00782340|593792462|FG001|Open Label Titration|Enrollment capped|0|||
164389255|NCT00782340|593792463|FG002|Open Label Titration|Enrollment capped|0|||
164389256|NCT00782340|593792461|FG000|Open Label Titration|Did not meet responder criteria|2|||
164389257|NCT00782340|593792462|FG001|Open Label Titration|Did not meet responder criteria|0|||
164016065|NCT00365716|592421819|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164016066|NCT00365716|592421820|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164016067|NCT00365716|592421821|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164016068|NCT00365716|592421822|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
164073019|NCT00552617|592632763|FG000|Overall Study|Lost to Follow-up|0|||
164389258|NCT00782340|593792463|FG002|Open Label Titration|Did not meet responder criteria|0|||
164389259|NCT00782340|593792461|FG000|Open Label Titration|Lost to Follow-up|5|||
164389260|NCT00782340|593792462|FG001|Open Label Titration|Lost to Follow-up|0|||
164389261|NCT00782340|593792463|FG002|Open Label Titration|Lost to Follow-up|0|||
164389262|NCT00782340|593792461|FG000|Open Label Titration|Randomized in error|6|||
164389263|NCT00782340|593792462|FG001|Open Label Titration|Randomized in error|0|||
164389264|NCT00782340|593792463|FG002|Open Label Titration|Randomized in error|0|||
164389265|NCT01949480|593792464|FG000|Overall Study|Physician Decision|5|||
164389266|NCT01949480|593792465|FG001|Overall Study|Physician Decision|8|||
164389267|NCT00144339|593792466|FG000|Overall Study|Adverse Event|746|||
164389268|NCT00144339|593792467|FG001|Overall Study|Adverse Event|627|||
164389269|NCT00144339|593792466|FG000|Overall Study|Protocol Violation|75|||
164389270|NCT00144339|593792467|FG001|Overall Study|Protocol Violation|48|||
164389271|NCT00144339|593792466|FG000|Overall Study|Withdrawal by Subject|403|||
164389272|NCT00144339|593792467|FG001|Overall Study|Withdrawal by Subject|300|||
164389273|NCT00144339|593792466|FG000|Overall Study|Lost to Follow-up|76|||
164389274|NCT00144339|593792467|FG001|Overall Study|Lost to Follow-up|64|||
164389275|NCT00144339|593792466|FG000|Overall Study|Other|58|||
164389276|NCT00144339|593792467|FG001|Overall Study|Other|60|||
164389277|NCT00305058|593792468|FG000|Overall Study|Participant too young|1|||
164389278|NCT00305058|593792469|FG001|Overall Study|Participant too young|0|||
164389279|NCT00305058|593792468|FG000|Overall Study|Missing data collection instrument|3|||
164389280|NCT00305058|593792469|FG001|Overall Study|Missing data collection instrument|2|||
164389281|NCT00305058|593792468|FG000|Overall Study|Missing outcome data|3|||
164389282|NCT00305058|593792469|FG001|Overall Study|Missing outcome data|2|||
164389283|NCT03538626|593792470|FG000|Overall Study|Withdrawal by Subject|0|||
164389284|NCT03538626|593792471|FG001|Overall Study|Withdrawal by Subject|1|||
164389285|NCT03538626|593792472|FG002|Overall Study|Withdrawal by Subject|0|||
164389286|NCT03538626|593792473|FG003|Overall Study|Withdrawal by Subject|0|||
164389287|NCT03538626|593792474|FG004|Overall Study|Withdrawal by Subject|0|||
164389288|NCT03538626|593792475|FG005|Overall Study|Withdrawal by Subject|0|||
164389289|NCT03538626|593792476|FG006|Overall Study|Withdrawal by Subject|0|||
164389290|NCT03538626|593792477|FG007|Overall Study|Withdrawal by Subject|0|||
164389291|NCT03538626|593792470|FG000|Overall Study|Lost to Follow-up|0|||
164389292|NCT03538626|593792471|FG001|Overall Study|Lost to Follow-up|0|||
164389293|NCT03538626|593792472|FG002|Overall Study|Lost to Follow-up|0|||
164389294|NCT03538626|593792473|FG003|Overall Study|Lost to Follow-up|0|||
164389295|NCT03538626|593792474|FG004|Overall Study|Lost to Follow-up|0|||
164389296|NCT03538626|593792475|FG005|Overall Study|Lost to Follow-up|0|||
164389297|NCT03538626|593792476|FG006|Overall Study|Lost to Follow-up|1|||
164389298|NCT03538626|593792477|FG007|Overall Study|Lost to Follow-up|0|||
164389299|NCT00288587|593792478|FG000|Overall Study|Death|4|||
164389300|NCT00288587|593792479|FG001|Overall Study|Death|4|||
164389301|NCT00288587|593792478|FG000|Overall Study|Transplant|0|||
164389302|NCT00288587|593792479|FG001|Overall Study|Transplant|3|||
164389303|NCT00288587|593792478|FG000|Overall Study|Adverse Event|0|||
164389304|NCT00288587|593792479|FG001|Overall Study|Adverse Event|1|||
164389305|NCT00288587|593792478|FG000|Overall Study|Physician Decision|0|||
164389306|NCT00288587|593792479|FG001|Overall Study|Physician Decision|2|||
164389307|NCT00288587|593792478|FG000|Overall Study|Severe Aortic Stenosis|1|||
164389308|NCT00288587|593792479|FG001|Overall Study|Severe Aortic Stenosis|0|||
164389309|NCT02232893|593792485|FG000|Overall Study|Withdrawal by Subject|4|||
164389310|NCT02232893|593792486|FG001|Overall Study|Withdrawal by Subject|1|||
164389311|NCT02232893|593792485|FG000|Overall Study|Adverse Event|0|||
164389312|NCT02232893|593792486|FG001|Overall Study|Adverse Event|1|||
164389313|NCT02232893|593792485|FG000|Overall Study|Sponsor request early termination|0|||
164389314|NCT02232893|593792486|FG001|Overall Study|Sponsor request early termination|1|||
164389315|NCT02232893|593792485|FG000|Overall Study|Developed exclusion criteria|0|||
164389316|NCT02232893|593792486|FG001|Overall Study|Developed exclusion criteria|1|||
164389317|NCT02232893|593792485|FG000|Overall Study|Other|0|||
164389318|NCT02232893|593792486|FG001|Overall Study|Other|3|||
164389319|NCT01764945|593792487|FG000|Overall Study|Adverse Event|0|||
164389320|NCT01764945|593792488|FG001|Overall Study|Adverse Event|1|||
164389321|NCT01764945|593792489|FG002|Overall Study|Adverse Event|0|||
164389322|NCT01764945|593792490|FG003|Overall Study|Adverse Event|0|||
164389323|NCT01764945|593792491|FG004|Overall Study|Adverse Event|0|||
164389324|NCT01764945|593792492|FG005|Overall Study|Adverse Event|0|||
164389325|NCT01764945|593792493|FG006|Overall Study|Adverse Event|1|||
164389326|NCT01764945|593792494|FG007|Overall Study|Adverse Event|0|||
164389327|NCT05077267|593792497|FG000|Treatment Period|Lost to Follow-up|0|||
164389328|NCT05077267|593792498|FG001|Treatment Period|Lost to Follow-up|1|||
164389329|NCT05077267|593792499|FG002|Treatment Period|Lost to Follow-up|0|||
164389330|NCT05077267|593792497|FG000|Treatment Period|Withdrawal by Subject|0|||
164389331|NCT05077267|593792498|FG001|Treatment Period|Withdrawal by Subject|1|||
164389332|NCT05077267|593792499|FG002|Treatment Period|Withdrawal by Subject|0|||
164389333|NCT05077267|593792497|FG000|Follow-up Period|Lost to Follow-up|0|||
164389334|NCT05077267|593792498|FG001|Follow-up Period|Lost to Follow-up|5|||
164389335|NCT05077267|593792499|FG002|Follow-up Period|Lost to Follow-up|7|||
164389336|NCT05077267|593792497|FG000|Follow-up Period|Withdrawal by Subject|0|||
164389337|NCT05077267|593792498|FG001|Follow-up Period|Withdrawal by Subject|2|||
164389338|NCT05077267|593792499|FG002|Follow-up Period|Withdrawal by Subject|5|||
164389339|NCT05077267|593792497|FG000|Follow-up Period|Study terminated by sponsor|0|||
163904770|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
163904771|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
163904772|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
163904773|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
163904774|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
163904775|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
163904776|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
163904777|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
163904778|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
163904779|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163904780|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
163904781|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163904782|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163904783|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163904784|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163904785|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
163904786|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163904787|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
163904788|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163904789|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
163904790|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
163904791|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163904792|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
163904793|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
163904794|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
163904795|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163904796|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163904797|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
163904798|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163904799|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
163904800|NCT03732807|592022163|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
163904801|NCT03732807|592022164|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
163904802|NCT03732807|592022165|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
163904803|NCT03732807|592022166|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
164389340|NCT05077267|593792498|FG001|Follow-up Period|Study terminated by sponsor|27|||
164389341|NCT05077267|593792499|FG002|Follow-up Period|Study terminated by sponsor|23|||
164389342|NCT05077267|593792497|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
163904804|NCT03732807|592022167|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
163904805|NCT03732807|592022168|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
163904806|NCT03732807|592022169|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
163904807|NCT03345979|592022170|FG000|Overall Study|Withdrawal by Subject|20|||
163904808|NCT03345979|592022171|FG001|Overall Study|Withdrawal by Subject|31|||
163904809|NCT03345979|592022170|FG000|Overall Study|Adverse Event|10|||
163904810|NCT03345979|592022171|FG001|Overall Study|Adverse Event|11|||
163904811|NCT03345979|592022170|FG000|Overall Study|Lost to Follow-up|8|||
163904812|NCT03345979|592022171|FG001|Overall Study|Lost to Follow-up|9|||
163904813|NCT03345979|592022170|FG000|Overall Study|Lack of Efficacy|4|||
163904814|NCT03345979|592022171|FG001|Overall Study|Lack of Efficacy|2|||
163904815|NCT03345979|592022170|FG000|Overall Study|Protocol Violation|1|||
163904816|NCT03345979|592022171|FG001|Overall Study|Protocol Violation|3|||
163904817|NCT03345979|592022170|FG000|Overall Study|Physician Decision|0|||
163904818|NCT03345979|592022171|FG001|Overall Study|Physician Decision|2|||
163904819|NCT00734578|592022173|FG000|Overall Study|Adverse Event|4|||
163904820|NCT00734578|592022174|FG001|Overall Study|Adverse Event|6|||
163904821|NCT00734578|592022175|FG002|Overall Study|Adverse Event|1|||
163904822|NCT00734578|592022173|FG000|Overall Study|Protocol Violation|8|||
163904823|NCT00734578|592022174|FG001|Overall Study|Protocol Violation|6|||
163904824|NCT00734578|592022175|FG002|Overall Study|Protocol Violation|3|||
164016069|NCT00365716|592421823|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164016070|NCT00365716|592421824|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
164389343|NCT05077267|593792498|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
164389344|NCT05077267|593792499|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
164389345|NCT05077267|593792497|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
163904825|NCT00734578|592022173|FG000|Overall Study|Withdrawal by Subject|7|||
163904826|NCT00734578|592022174|FG001|Overall Study|Withdrawal by Subject|8|||
164389346|NCT05077267|593792498|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
164016071|NCT00365716|592421818|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164389347|NCT05077267|593792499|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
164389348|NCT02911948|593792500|FG000|Overall Study|Protocol Violation|0|||
164389349|NCT02911948|593792501|FG001|Overall Study|Protocol Violation|1|||
164389350|NCT02911948|593792500|FG000|Overall Study|Withdrawal by Subject|0|||
164389351|NCT02911948|593792501|FG001|Overall Study|Withdrawal by Subject|2|||
164389352|NCT02911948|593792500|FG000|Overall Study|Lack of Efficacy|0|||
164389353|NCT02911948|593792501|FG001|Overall Study|Lack of Efficacy|1|||
164389354|NCT02911948|593792500|FG000|Overall Study|Unclassified|0|||
164389355|NCT02911948|593792501|FG001|Overall Study|Unclassified|3|||
164389356|NCT00586105|593792508|FG000|Overall Study|Adverse Event|4|||
164389357|NCT00586105|593792508|FG000|Overall Study|Death|2|||
164389358|NCT00586105|593792508|FG000|Overall Study|Protocol Violation|1|||
164389359|NCT00586105|593792508|FG000|Overall Study|Withdrawal by Subject|3|||
164389360|NCT00586105|593792508|FG000|Overall Study|Disease progression|19|||
164389361|NCT00586105|593792508|FG000|Overall Study|Switched to commercial drug|9|||
164389362|NCT00586105|593792508|FG000|Overall Study|Reason not reported|1|||
164389363|NCT01136291|593792512|FG000|Overall Study|Lost to Follow-up|1|||
164389364|NCT01136291|593792513|FG001|Overall Study|Lost to Follow-up|1|||
164389365|NCT03965052|593792514|FG000|Overall Study|Protocol Violation|1|||
164389366|NCT03965052|593792515|FG001|Overall Study|Protocol Violation|0|||
164389367|NCT02308033|593792525|FG000|Overall Study|Normal Gram stain at Baseline|13|||
164389368|NCT02308033|593792526|FG001|Overall Study|Normal Gram stain at Baseline|10|||
164389369|NCT02308033|593792525|FG000|Overall Study|Positive for STD at Baseline|7|||
164389370|NCT02308033|593792526|FG001|Overall Study|Positive for STD at Baseline|4|||
164389371|NCT02308033|593792525|FG000|Overall Study|Lost to Follow-up|6|||
164389372|NCT02308033|593792526|FG001|Overall Study|Lost to Follow-up|5|||
164389373|NCT03165045|593792527|FG000|Visit 1|No registration after visit 1|9|||
164389374|NCT03165045|593792527|FG000|Visit 1|No treatment documented|10|||
164389375|NCT03165045|593792527|FG000|Visit 1|No visit 1|10|||
164389376|NCT03165045|593792527|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
164389377|NCT03165045|593792527|FG000|Visit 2|No available total CCQ score at all|29|||
164389378|NCT03165045|593792527|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
164389379|NCT04964089|593792530|FG000|Overall Study|Adverse Event|8|||
164389380|NCT04964089|593792531|FG001|Overall Study|Adverse Event|6|||
164389381|NCT04964089|593792530|FG000|Overall Study|Non-compliance with study schedule|1|||
164389382|NCT04964089|593792531|FG001|Overall Study|Non-compliance with study schedule|0|||
164389383|NCT04964089|593792530|FG000|Overall Study|Withdrawal by Subject|6|||
164389384|NCT04964089|593792531|FG001|Overall Study|Withdrawal by Subject|5|||
164389385|NCT04964089|593792530|FG000|Overall Study|Lost to Follow-up|1|||
164389386|NCT04964089|593792531|FG001|Overall Study|Lost to Follow-up|1|||
164389387|NCT04964089|593792530|FG000|Overall Study|Progressive disease|4|||
164389388|NCT04964089|593792531|FG001|Overall Study|Progressive disease|0|||
164389389|NCT04964089|593792530|FG000|Overall Study|Physician Decision|1|||
164389390|NCT04964089|593792531|FG001|Overall Study|Physician Decision|0|||
164389391|NCT04964089|593792530|FG000|Overall Study|Participant did not want to continue study treatment|1|||
164389392|NCT04964089|593792531|FG001|Overall Study|Participant did not want to continue study treatment|0|||
164389393|NCT04964089|593792530|FG000|Overall Study|Participant moved to different state|1|||
164389394|NCT04964089|593792531|FG001|Overall Study|Participant moved to different state|0|||
164389395|NCT04964089|593792530|FG000|Overall Study|Participant decided to discontinue|0|||
164389396|NCT04964089|593792531|FG001|Overall Study|Participant decided to discontinue|1|||
164389397|NCT00499369|593792534|FG000|Overall Study|Adverse Event|2|||
164389398|NCT00499369|593792535|FG001|Overall Study|Adverse Event|2|||
164389399|NCT00499369|593792536|FG002|Overall Study|Adverse Event|3|||
164389400|NCT00499369|593792537|FG003|Overall Study|Adverse Event|1|||
163904827|NCT00734578|592022175|FG002|Overall Study|Withdrawal by Subject|11|||
163904828|NCT00734578|592022173|FG000|Overall Study|Lost to Follow-up|9|||
164389401|NCT00499369|593792538|FG004|Overall Study|Adverse Event|2|||
164389402|NCT00499369|593792534|FG000|Overall Study|Withdrawal by Subject|0|||
164389403|NCT00499369|593792535|FG001|Overall Study|Withdrawal by Subject|1|||
164389404|NCT00499369|593792536|FG002|Overall Study|Withdrawal by Subject|1|||
164389405|NCT00499369|593792537|FG003|Overall Study|Withdrawal by Subject|0|||
164389406|NCT00499369|593792538|FG004|Overall Study|Withdrawal by Subject|0|||
164389407|NCT00499369|593792534|FG000|Overall Study|Progression|10|||
164389408|NCT00499369|593792535|FG001|Overall Study|Progression|12|||
164389409|NCT00499369|593792536|FG002|Overall Study|Progression|9|||
164389410|NCT00499369|593792537|FG003|Overall Study|Progression|6|||
164389411|NCT00499369|593792538|FG004|Overall Study|Progression|10|||
164389412|NCT00499369|593792534|FG000|Overall Study|Death|0|||
164389413|NCT00499369|593792535|FG001|Overall Study|Death|1|||
164389414|NCT00499369|593792536|FG002|Overall Study|Death|0|||
164389415|NCT00499369|593792537|FG003|Overall Study|Death|0|||
164389416|NCT00499369|593792538|FG004|Overall Study|Death|0|||
164389417|NCT00499369|593792534|FG000|Overall Study|Not protocol specified|2|||
164389418|NCT00499369|593792535|FG001|Overall Study|Not protocol specified|0|||
164389419|NCT00499369|593792536|FG002|Overall Study|Not protocol specified|3|||
164389420|NCT00499369|593792537|FG003|Overall Study|Not protocol specified|1|||
163904829|NCT00734578|592022174|FG001|Overall Study|Lost to Follow-up|3|||
163904830|NCT00734578|592022175|FG002|Overall Study|Lost to Follow-up|5|||
163904831|NCT00734578|592022173|FG000|Overall Study|Lack of Efficacy|3|||
163904832|NCT00734578|592022174|FG001|Overall Study|Lack of Efficacy|2|||
163904833|NCT00734578|592022175|FG002|Overall Study|Lack of Efficacy|5|||
163904834|NCT00734578|592022173|FG000|Overall Study|Randomized in error|1|||
163904835|NCT00734578|592022174|FG001|Overall Study|Randomized in error|0|||
163904836|NCT00734578|592022175|FG002|Overall Study|Randomized in error|0|||
164389421|NCT00499369|593792538|FG004|Overall Study|Not protocol specified|0|||
164389422|NCT00499369|593792534|FG000|Overall Study|Ineligible|2|||
164389423|NCT00499369|593792535|FG001|Overall Study|Ineligible|2|||
164389424|NCT00499369|593792536|FG002|Overall Study|Ineligible|1|||
163904837|NCT00734578|592022173|FG000|Overall Study|Exclusion criteria|1|||
163904838|NCT00734578|592022174|FG001|Overall Study|Exclusion criteria|0|||
163904839|NCT00734578|592022175|FG002|Overall Study|Exclusion criteria|0|||
163904840|NCT00999596|592022176|FG000|Overall Study|Statistical population not required|101|||
163904841|NCT03389802|592022183|FG000|Overall Study|Lack of Efficacy|3|||
163904842|NCT03389802|592022184|FG001|Overall Study|Lack of Efficacy|3|||
163904843|NCT03389802|592022185|FG002|Overall Study|Lack of Efficacy|13|||
163904844|NCT03389802|592022186|FG003|Overall Study|Lack of Efficacy|6|||
163904845|NCT03389802|592022187|FG004|Overall Study|Lack of Efficacy|1|||
163904846|NCT03389802|592022183|FG000|Overall Study|Adverse Event|0|||
163904847|NCT03389802|592022184|FG001|Overall Study|Adverse Event|0|||
163904848|NCT03389802|592022185|FG002|Overall Study|Adverse Event|1|||
163904849|NCT03389802|592022186|FG003|Overall Study|Adverse Event|0|||
163904850|NCT03389802|592022187|FG004|Overall Study|Adverse Event|4|||
163904851|NCT03389802|592022183|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
163904852|NCT03389802|592022184|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
163904853|NCT03389802|592022185|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
163904854|NCT03389802|592022186|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
163904855|NCT03389802|592022187|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
163904856|NCT02426138|592022188|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163904857|NCT02426138|592022189|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
163904858|NCT04677738|592022190|FG000|Overall Study|Withdrawal by Subject|4|||
163904859|NCT04677738|592022191|FG001|Overall Study|Withdrawal by Subject|2|||
163904860|NCT00467272|592022197|FG000|Overall Study|Pneumonia|2|||
163904861|NCT00467272|592022197|FG000|Overall Study|Thrombophlebitis|1|||
163904862|NCT00914966|592022198|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
163904863|NCT00914966|592022198|FG000|Step 1: 1500 Units|Physician Decision|1|||
163904864|NCT00914966|592022198|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
163904865|NCT01701401|592022199|FG000|Overall Study|Randomized But Not Treated|3|||
163904866|NCT01701401|592022200|FG001|Overall Study|Randomized But Not Treated|1|||
163904867|NCT01701401|592022201|FG002|Overall Study|Randomized But Not Treated|0|||
163904868|NCT01701401|592022202|FG003|Overall Study|Randomized But Not Treated|1|||
163904869|NCT01701401|592022199|FG000|Overall Study|Lost to Follow-up|5|||
163904870|NCT01701401|592022200|FG001|Overall Study|Lost to Follow-up|5|||
163904871|NCT01701401|592022201|FG002|Overall Study|Lost to Follow-up|1|||
163904872|NCT01701401|592022202|FG003|Overall Study|Lost to Follow-up|3|||
163904873|NCT01701401|592022199|FG000|Overall Study|Withdrew Consent|0|||
163904874|NCT01701401|592022200|FG001|Overall Study|Withdrew Consent|3|||
163904875|NCT01701401|592022201|FG002|Overall Study|Withdrew Consent|1|||
163904876|NCT01701401|592022202|FG003|Overall Study|Withdrew Consent|2|||
163904877|NCT01701401|592022199|FG000|Overall Study|Lack of Efficacy|1|||
163904878|NCT01701401|592022200|FG001|Overall Study|Lack of Efficacy|0|||
163904879|NCT01701401|592022201|FG002|Overall Study|Lack of Efficacy|2|||
163904880|NCT01701401|592022202|FG003|Overall Study|Lack of Efficacy|0|||
163904881|NCT01701401|592022199|FG000|Overall Study|Adverse Event|1|||
164389425|NCT00499369|593792537|FG003|Overall Study|Ineligible|1|||
164389426|NCT00499369|593792538|FG004|Overall Study|Ineligible|0|||
164389427|NCT01898195|593792539|FG000|Smoking Abstinence|Did not have good measurements|35|||
164389428|NCT01898195|593792540|FG001|Smoking Abstinence|Did not have good measurements|38|||
164389429|NCT01898195|593792541|FG002|Smoking Abstinence|Did not have good measurements|36|||
164389430|NCT02536508|593794257|FG000|Overall Study|Withdrawal by Subject|18|||
164389431|NCT02536508|593794258|FG001|Overall Study|Withdrawal by Subject|13|||
164389432|NCT02536508|593794259|FG002|Overall Study|Withdrawal by Subject|7|||
164389433|NCT02536508|593794257|FG000|Overall Study|Adverse Event|14|||
164389434|NCT02536508|593794258|FG001|Overall Study|Adverse Event|13|||
163904882|NCT01701401|592022200|FG001|Overall Study|Adverse Event|0|||
163904883|NCT01701401|592022201|FG002|Overall Study|Adverse Event|0|||
163904884|NCT01701401|592022202|FG003|Overall Study|Adverse Event|0|||
163904885|NCT01701401|592022199|FG000|Overall Study|Protocol Violation|0|||
163904886|NCT01701401|592022200|FG001|Overall Study|Protocol Violation|0|||
163904887|NCT01701401|592022201|FG002|Overall Study|Protocol Violation|1|||
163904888|NCT01701401|592022202|FG003|Overall Study|Protocol Violation|0|||
163904889|NCT02409680|592022206|FG000|Overall Study|Lost to Follow-up|15|||
163904890|NCT02409680|592022207|FG001|Overall Study|Lost to Follow-up|30|||
163904891|NCT04827732|592022208|FG000|Overall Study|Did not start treatment|0|||
163904892|NCT04827732|592022209|FG001|Overall Study|Did not start treatment|1|||
163904893|NCT04827732|592022210|FG002|Overall Study|Did not start treatment|0|||
164389435|NCT02536508|593794259|FG002|Overall Study|Adverse Event|6|||
164389436|NCT02536508|593794257|FG000|Overall Study|Lost to Follow-up|12|||
164389437|NCT02536508|593794258|FG001|Overall Study|Lost to Follow-up|4|||
164389438|NCT02536508|593794259|FG002|Overall Study|Lost to Follow-up|0|||
164389439|NCT02536508|593794257|FG000|Overall Study|Lack of Efficacy|3|||
164389440|NCT02536508|593794258|FG001|Overall Study|Lack of Efficacy|5|||
164389441|NCT02536508|593794259|FG002|Overall Study|Lack of Efficacy|4|||
164389442|NCT02536508|593794257|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
164389443|NCT02536508|593794258|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
164389444|NCT02536508|593794259|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
164389445|NCT02536508|593794257|FG000|Overall Study|Physician Decision|0|||
164389446|NCT02536508|593794258|FG001|Overall Study|Physician Decision|4|||
164389447|NCT02536508|593794259|FG002|Overall Study|Physician Decision|2|||
164389448|NCT02536508|593794257|FG000|Overall Study|Major Protocol Deviation|2|||
164389449|NCT02536508|593794258|FG001|Overall Study|Major Protocol Deviation|2|||
164389450|NCT02536508|593794259|FG002|Overall Study|Major Protocol Deviation|2|||
164389451|NCT02536508|593794257|FG000|Overall Study|Administrative Reasons|0|||
164389452|NCT02536508|593794258|FG001|Overall Study|Administrative Reasons|1|||
164389453|NCT02536508|593794259|FG002|Overall Study|Administrative Reasons|0|||
164389454|NCT00434057|593794261|FG000|Overall Study|Withdrawal by Subject|1|||
164389455|NCT00823719|593794266|FG000|Overall Study|Adverse Event|1|||
164389456|NCT00823719|593794267|FG001|Overall Study|Adverse Event|2|||
164389457|NCT00823719|593794266|FG000|Overall Study|Physician Decision|1|||
164389458|NCT00823719|593794267|FG001|Overall Study|Physician Decision|4|||
164389459|NCT00823719|593794266|FG000|Overall Study|Withdrawal by Subject|0|||
164389460|NCT00823719|593794267|FG001|Overall Study|Withdrawal by Subject|1|||
164389461|NCT00823719|593794266|FG000|Overall Study|Disease Progression|4|||
164389462|NCT00823719|593794267|FG001|Overall Study|Disease Progression|4|||
164389463|NCT02103439|593794273|FG000|Overall Study|Adverse Event|0|||
164389464|NCT02103439|593794274|FG001|Overall Study|Adverse Event|2|||
164389465|NCT02103439|593794273|FG000|Overall Study|Withdrawal by Subject|3|||
164389466|NCT02103439|593794274|FG001|Overall Study|Withdrawal by Subject|1|||
164389467|NCT02370602|593794275|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164389468|NCT02370602|593794276|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164389469|NCT02370602|593794277|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164389470|NCT02370602|593794278|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
164389471|NCT02370602|593794279|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164389472|NCT02370602|593794280|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
164389473|NCT00599326|593794284|FG000|Overall Study|Lost to Follow-up|1|||
164389474|NCT00599326|593794284|FG000|Overall Study|Noncompliant|1|||
164389475|NCT00784810|593794285|FG000|Overall Study|Adverse Event|32|||
164389476|NCT00784810|593794286|FG001|Overall Study|Adverse Event|20|||
164389477|NCT00784810|593794285|FG000|Overall Study|Lack of Efficacy|14|||
164389478|NCT00784810|593794286|FG001|Overall Study|Lack of Efficacy|11|||
164389479|NCT00784810|593794285|FG000|Overall Study|Withdrawal by Subject|11|||
164389480|NCT00784810|593794286|FG001|Overall Study|Withdrawal by Subject|9|||
164389481|NCT00784810|593794285|FG000|Overall Study|Administrative|5|||
164389482|NCT00784810|593794286|FG001|Overall Study|Administrative|8|||
164389483|NCT00784810|593794285|FG000|Overall Study|Lost to Follow-up|1|||
164389484|NCT00784810|593794286|FG001|Overall Study|Lost to Follow-up|1|||
164389485|NCT03305016|593794289|FG000|Overall Study|Withdrawal by Subject|2|||
164389486|NCT02119416|593794290|FG000|Overall Study|Protocol Violation|1|||
164389487|NCT02119416|593794291|FG001|Overall Study|Protocol Violation|1|||
164389488|NCT02119416|593794292|FG002|Overall Study|Protocol Violation|1|||
164389489|NCT02119416|593794290|FG000|Overall Study|wrong pubertal stage|1|||
164389490|NCT02119416|593794291|FG001|Overall Study|wrong pubertal stage|0|||
164389491|NCT02119416|593794292|FG002|Overall Study|wrong pubertal stage|1|||
164389492|NCT03434119|593794293|FG000|Overall Study|Randomized but not treated|1|||
164389493|NCT03434119|593794294|FG001|Overall Study|Randomized but not treated|0|||
164389494|NCT03434119|593794293|FG000|Overall Study|Adverse Event|1|||
164389495|NCT03434119|593794294|FG001|Overall Study|Adverse Event|0|||
164389496|NCT03434119|593794293|FG000|Overall Study|Poor Compliance to Protocol|0|||
164389497|NCT03434119|593794294|FG001|Overall Study|Poor Compliance to Protocol|1|||
164389498|NCT03434119|593794293|FG000|Overall Study|Study Terminated by Sponsor|91|||
164389499|NCT03434119|593794294|FG001|Overall Study|Study Terminated by Sponsor|102|||
164389500|NCT03434119|593794293|FG000|Overall Study|Withdrawal by Subject|7|||
164389501|NCT03434119|593794294|FG001|Overall Study|Withdrawal by Subject|5|||
164389502|NCT03434119|593794293|FG000|Overall Study|Other than specified|7|||
164389503|NCT03434119|593794294|FG001|Overall Study|Other than specified|5|||
164389504|NCT04420689|593794295|FG000|Overall Study|COVID-19 related hospitalization|0|||
164389505|NCT04420689|593794296|FG001|Overall Study|COVID-19 related hospitalization|0|||
164389506|NCT04420689|593794297|FG002|Overall Study|COVID-19 related hospitalization|0|||
164389507|NCT04420689|593794298|FG003|Overall Study|COVID-19 related hospitalization|0|||
164389508|NCT04420689|593794299|FG004|Overall Study|COVID-19 related hospitalization|1|||
164389509|NCT04420689|593794300|FG005|Overall Study|COVID-19 related hospitalization|0|||
164389510|NCT04420689|593794301|FG006|Overall Study|COVID-19 related hospitalization|0|||
164389511|NCT04420689|593794295|FG000|Overall Study|Physician Decision|0|||
164389512|NCT04420689|593794296|FG001|Overall Study|Physician Decision|0|||
164389513|NCT04420689|593794297|FG002|Overall Study|Physician Decision|0|||
163904894|NCT04827732|592022211|FG003|Overall Study|Did not start treatment|1|||
163904895|NCT05366751|592022212|FG000|Overall Study|Adverse Event|25|||
163904896|NCT05366751|592022212|FG000|Overall Study|Physician Decision|3|||
163904897|NCT05366751|592022212|FG000|Overall Study|Lost to Follow-up|2|||
163904898|NCT05366751|592022212|FG000|Overall Study|Withdrawal by Subject|14|||
163904899|NCT05366751|592022212|FG000|Overall Study|Study Terminated by Sponsor|50|||
163904900|NCT05366751|592022212|FG000|Overall Study|Site Terminated by Sponsor|3|||
163904901|NCT01690624|592022217|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
163904902|NCT01690624|592022218|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
163904903|NCT01690624|592022219|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
163904904|NCT01690624|592022220|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
163904905|NCT01690624|592022217|FG000|Overall Study|Adverse event (other than DLT)|3|||
163904906|NCT01690624|592022218|FG001|Overall Study|Adverse event (other than DLT)|1|||
163904907|NCT01690624|592022219|FG002|Overall Study|Adverse event (other than DLT)|1|||
163904908|NCT01690624|592022220|FG003|Overall Study|Adverse event (other than DLT)|1|||
163904909|NCT01690624|592022217|FG000|Overall Study|Withdrawal by Subject|0|||
163904910|NCT01690624|592022218|FG001|Overall Study|Withdrawal by Subject|0|||
163904911|NCT01690624|592022219|FG002|Overall Study|Withdrawal by Subject|1|||
163904912|NCT01690624|592022220|FG003|Overall Study|Withdrawal by Subject|0|||
163904913|NCT01690624|592022217|FG000|Overall Study|Sponsor is ending trial|0|||
163904914|NCT01690624|592022218|FG001|Overall Study|Sponsor is ending trial|0|||
163904915|NCT01690624|592022219|FG002|Overall Study|Sponsor is ending trial|0|||
163904916|NCT01690624|592022220|FG003|Overall Study|Sponsor is ending trial|1|||
163904917|NCT01690624|592022217|FG000|Overall Study|Physician Decision|0|||
163904918|NCT01690624|592022218|FG001|Overall Study|Physician Decision|0|||
163904919|NCT01690624|592022219|FG002|Overall Study|Physician Decision|0|||
163904920|NCT01690624|592022220|FG003|Overall Study|Physician Decision|1|||
163904921|NCT01690624|592022217|FG000|Overall Study|Withdrawal by Subject|0|||
163904922|NCT01690624|592022218|FG001|Overall Study|Withdrawal by Subject|1|||
163904923|NCT01690624|592022219|FG002|Overall Study|Withdrawal by Subject|0|||
163904924|NCT01690624|592022220|FG003|Overall Study|Withdrawal by Subject|0|||
163904925|NCT01690624|592022217|FG000|Overall Study|Lack of Efficacy|1|||
163904926|NCT01690624|592022218|FG001|Overall Study|Lack of Efficacy|1|||
163904927|NCT01690624|592022219|FG002|Overall Study|Lack of Efficacy|3|||
163904928|NCT01690624|592022220|FG003|Overall Study|Lack of Efficacy|0|||
163904929|NCT05293717|592022225|FG000|Overall Study|Physician Decision|1|||
163904930|NCT04693637|592023711|FG000|Overall Study|Death|4|||
163904931|NCT04693637|592023711|FG000|Overall Study|Withdrawal by Subject|3|||
163904932|NCT04693637|592023711|FG000|Overall Study|Physician Decision|2|||
163904933|NCT04693637|592023711|FG000|Overall Study|Lost to Follow-up|1|||
163904934|NCT03052517|592023712|FG000|Overall Study|Study Terminated By Sponsor|928|||
163904935|NCT03052517|592023713|FG001|Overall Study|Study Terminated By Sponsor|938|||
163904936|NCT03052517|592023714|FG002|Overall Study|Study Terminated By Sponsor|296|||
163904937|NCT03052517|592023712|FG000|Overall Study|Subject/Guardian Decision|50|||
163904938|NCT03052517|592023713|FG001|Overall Study|Subject/Guardian Decision|45|||
163904939|NCT03052517|592023714|FG002|Overall Study|Subject/Guardian Decision|22|||
163904940|NCT03052517|592023712|FG000|Overall Study|Lack of Efficacy|23|||
163904941|NCT03052517|592023713|FG001|Overall Study|Lack of Efficacy|14|||
163904942|NCT03052517|592023714|FG002|Overall Study|Lack of Efficacy|7|||
163904943|NCT03052517|592023712|FG000|Overall Study|Adverse Event|6|||
163904944|NCT03052517|592023713|FG001|Overall Study|Adverse Event|5|||
163904945|NCT03052517|592023714|FG002|Overall Study|Adverse Event|0|||
163904946|NCT03052517|592023712|FG000|Overall Study|Physician Decision|4|||
164093040|NCT00864097|592703459|FG002|Overall Study|Lost to Follow-up|0|||
164389514|NCT04420689|593794298|FG003|Overall Study|Physician Decision|0|||
164389515|NCT04420689|593794299|FG004|Overall Study|Physician Decision|0|||
164389516|NCT04420689|593794300|FG005|Overall Study|Physician Decision|1|||
163904947|NCT03052517|592023713|FG001|Overall Study|Physician Decision|5|||
163904948|NCT03052517|592023714|FG002|Overall Study|Physician Decision|1|||
163904949|NCT03052517|592023712|FG000|Overall Study|Death|3|||
163904950|NCT03052517|592023713|FG001|Overall Study|Death|0|||
163904951|NCT03052517|592023714|FG002|Overall Study|Death|1|||
163904952|NCT03052517|592023712|FG000|Overall Study|Lost to Follow-up|2|||
163904953|NCT03052517|592023713|FG001|Overall Study|Lost to Follow-up|4|||
163904954|NCT03052517|592023714|FG002|Overall Study|Lost to Follow-up|0|||
163904955|NCT03052517|592023712|FG000|Overall Study|Pregnancy|1|||
163904956|NCT03052517|592023713|FG001|Overall Study|Pregnancy|0|||
163904957|NCT03052517|592023714|FG002|Overall Study|Pregnancy|1|||
163904958|NCT03052517|592023712|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
163904959|NCT03052517|592023713|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
163904960|NCT03052517|592023714|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
163904961|NCT03052517|592023712|FG000|Overall Study|Technical Problems|0|||
163904962|NCT03052517|592023713|FG001|Overall Study|Technical Problems|1|||
163904963|NCT03052517|592023714|FG002|Overall Study|Technical Problems|0|||
163904964|NCT04885998|592023717|FG000|Overall Study|Withdrawal by Subject|0|||
163904965|NCT04885998|592023718|FG001|Overall Study|Withdrawal by Subject|2|||
163904966|NCT04885998|592023719|FG002|Overall Study|Withdrawal by Subject|0|||
163904967|NCT04885998|592023720|FG003|Overall Study|Withdrawal by Subject|3|||
163904968|NCT04885998|592023717|FG000|Overall Study|Lost to Follow-up|1|||
163904969|NCT04885998|592023718|FG001|Overall Study|Lost to Follow-up|1|||
163904970|NCT04885998|592023719|FG002|Overall Study|Lost to Follow-up|0|||
163904971|NCT04885998|592023720|FG003|Overall Study|Lost to Follow-up|0|||
163904972|NCT04885998|592023717|FG000|Overall Study|Death|2|||
163904973|NCT04885998|592023718|FG001|Overall Study|Death|1|||
163904974|NCT04885998|592023719|FG002|Overall Study|Death|2|||
163904975|NCT04885998|592023720|FG003|Overall Study|Death|2|||
163904976|NCT04885998|592023717|FG000|Overall Study|Decision by sponsor|1|||
163904977|NCT04885998|592023718|FG001|Overall Study|Decision by sponsor|1|||
163904978|NCT04885998|592023719|FG002|Overall Study|Decision by sponsor|0|||
163904979|NCT04885998|592023720|FG003|Overall Study|Decision by sponsor|0|||
163904980|NCT05260437|592023722|FG000|Overall Study|Lost to Follow-up|5|||
163904981|NCT05260437|592023723|FG001|Overall Study|Lost to Follow-up|2|||
163904982|NCT05260437|592023724|FG002|Overall Study|Lost to Follow-up|1|||
163904983|NCT05260437|592023725|FG003|Overall Study|Lost to Follow-up|2|||
163904984|NCT05260437|592023726|FG004|Overall Study|Lost to Follow-up|2|||
163904985|NCT05260437|592023722|FG000|Overall Study|Withdrawal by Subject|3|||
163904986|NCT05260437|592023723|FG001|Overall Study|Withdrawal by Subject|0|||
163904987|NCT05260437|592023724|FG002|Overall Study|Withdrawal by Subject|4|||
164016072|NCT00365716|592421819|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
164016073|NCT00365716|592421820|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
164016074|NCT00365716|592421821|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164016075|NCT00365716|592421822|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164016076|NCT00365716|592421823|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164389517|NCT04420689|593794301|FG006|Overall Study|Physician Decision|0|||
164389518|NCT04360824|593794304|FG000|Overall Study|Withdrawal by Subject|2|||
164389519|NCT04360824|593794305|FG001|Overall Study|Withdrawal by Subject|1|||
164389520|NCT04360824|593794304|FG000|Overall Study|Did not receive assigned treatment|1|||
164389521|NCT04360824|593794305|FG001|Overall Study|Did not receive assigned treatment|3|||
164389522|NCT02278328|593794309|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
164389523|NCT02278328|593794310|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
164389524|NCT02278328|593794311|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
164389525|NCT02278328|593794309|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
164389526|NCT02278328|593794310|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
164389527|NCT02278328|593794311|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
164389528|NCT02278328|593794309|FG000|Neuropsych Screening|incomplete consent|0|||
164389529|NCT02278328|593794310|FG001|Neuropsych Screening|incomplete consent|0|||
164389530|NCT02278328|593794311|FG002|Neuropsych Screening|incomplete consent|2|||
164389531|NCT02365467|593794312|FG000|Overall Study|Death|3|||
164389532|NCT01306162|593794313|FG000|Period 1|Adverse Event|0|||
164389533|NCT01306162|593794314|FG001|Period 1|Adverse Event|0|||
164016077|NCT00365716|592421824|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
164016078|NCT00365716|592421818|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
164073020|NCT00552617|592632764|FG001|Overall Study|Lost to Follow-up|0|||
164389534|NCT01306162|593794315|FG002|Period 1|Adverse Event|0|||
164389535|NCT01306162|593794316|FG003|Period 1|Adverse Event|1|||
164389536|NCT01306162|593794313|FG000|Washout 1|Non-compliance to protocol|0|||
164389537|NCT01306162|593794314|FG001|Washout 1|Non-compliance to protocol|1|||
164389538|NCT01306162|593794315|FG002|Washout 1|Non-compliance to protocol|0|||
164389539|NCT01306162|593794316|FG003|Washout 1|Non-compliance to protocol|0|||
164389540|NCT01109992|593794317|FG000|Overall Study|Withdrawal by Subject|0|||
164389541|NCT01109992|593794318|FG001|Overall Study|Withdrawal by Subject|1|||
164389542|NCT01109992|593794317|FG000|Overall Study|Movement during rest scan.|0|||
164389543|NCT01109992|593794318|FG001|Overall Study|Movement during rest scan.|1|||
164389544|NCT00690755|593794319|FG000|Overall Study|Physician Decision|2|||
164389545|NCT00690755|593794320|FG001|Overall Study|Physician Decision|0|||
164389546|NCT00690755|593794321|FG002|Overall Study|Physician Decision|46|||
164389547|NCT00690755|593794322|FG003|Overall Study|Physician Decision|5|||
164389548|NCT00690755|593794323|FG004|Overall Study|Physician Decision|0|||
164389549|NCT00690755|593794324|FG005|Overall Study|Physician Decision|4|||
164389550|NCT00690755|593794325|FG006|Overall Study|Physician Decision|0|||
164389551|NCT04287920|593794329|FG000|Overall Study|Lost to Follow-up|1|||
164389552|NCT04287920|593794330|FG001|Overall Study|Lost to Follow-up|1|||
164389553|NCT04287920|593794329|FG000|Overall Study|Withdrawal by Subject|0|||
164389554|NCT04287920|593794330|FG001|Overall Study|Withdrawal by Subject|3|||
164389555|NCT02952924|593794335|FG000|Overall Study|Protocol Violation|0|||
164389556|NCT02952924|593794336|FG001|Overall Study|Protocol Violation|0|||
164389557|NCT02952924|593794337|FG002|Overall Study|Protocol Violation|0|||
164389558|NCT02952924|593794338|FG003|Overall Study|Protocol Violation|0|||
164389559|NCT02952924|593794339|FG004|Overall Study|Protocol Violation|0|||
164389560|NCT02952924|593794340|FG005|Overall Study|Protocol Violation|0|||
164389561|NCT02952924|593794341|FG006|Overall Study|Protocol Violation|0|||
164389562|NCT02952924|593794342|FG007|Overall Study|Protocol Violation|0|||
164389563|NCT02952924|593794343|FG008|Overall Study|Protocol Violation|0|||
164389564|NCT02952924|593794344|FG009|Overall Study|Protocol Violation|0|||
164389565|NCT02952924|593794345|FG010|Overall Study|Protocol Violation|0|||
164389566|NCT02952924|593794346|FG011|Overall Study|Protocol Violation|0|||
164389567|NCT02952924|593794347|FG012|Overall Study|Protocol Violation|0|||
164389568|NCT02952924|593794348|FG013|Overall Study|Protocol Violation|0|||
164389569|NCT02952924|593794349|FG014|Overall Study|Protocol Violation|0|||
164389570|NCT02952924|593794350|FG015|Overall Study|Protocol Violation|0|||
164389571|NCT02952924|593794351|FG016|Overall Study|Protocol Violation|0|||
164389572|NCT02952924|593794352|FG017|Overall Study|Protocol Violation|0|||
164389573|NCT02952924|593794353|FG018|Overall Study|Protocol Violation|0|||
164389574|NCT02952924|593794354|FG019|Overall Study|Protocol Violation|1|||
164389575|NCT02952924|593794355|FG020|Overall Study|Protocol Violation|0|||
164389576|NCT02952924|593794356|FG021|Overall Study|Protocol Violation|0|||
164389577|NCT02952924|593794335|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
164389578|NCT02952924|593794336|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
164389579|NCT02952924|593794337|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
164389580|NCT02952924|593794338|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
164389581|NCT02952924|593794339|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
164389582|NCT02952924|593794340|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
164389583|NCT02952924|593794341|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
164389584|NCT02952924|593794342|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
164389585|NCT02952924|593794343|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
164389586|NCT02952924|593794344|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
164389587|NCT02952924|593794345|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
164389588|NCT02952924|593794346|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
164389589|NCT02952924|593794347|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
164389590|NCT02952924|593794348|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
164389591|NCT02952924|593794349|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
164389592|NCT02952924|593794350|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
164389593|NCT02952924|593794351|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
164389594|NCT02952924|593794352|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
164389595|NCT02952924|593794353|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
164389596|NCT02952924|593794354|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
164389597|NCT02952924|593794355|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
164389598|NCT02952924|593794356|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
164389599|NCT02952924|593794335|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389600|NCT02952924|593794336|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389601|NCT02952924|593794337|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389602|NCT02952924|593794338|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389603|NCT02952924|593794339|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389604|NCT02952924|593794340|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389605|NCT02952924|593794341|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389606|NCT02952924|593794342|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389607|NCT02952924|593794343|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389608|NCT02952924|593794344|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389609|NCT02952924|593794345|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389610|NCT02952924|593794346|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389611|NCT02952924|593794347|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389612|NCT02952924|593794348|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389613|NCT02952924|593794349|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389614|NCT02952924|593794350|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389615|NCT02952924|593794351|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389616|NCT02952924|593794352|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389617|NCT02952924|593794353|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389618|NCT02952924|593794354|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389619|NCT02952924|593794355|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
164389620|NCT02952924|593794356|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
164389621|NCT02952924|593794335|FG000|Overall Study|Noncompliance with study drug|0|||
164389622|NCT02952924|593794336|FG001|Overall Study|Noncompliance with study drug|0|||
164389623|NCT02952924|593794337|FG002|Overall Study|Noncompliance with study drug|0|||
164389624|NCT02952924|593794338|FG003|Overall Study|Noncompliance with study drug|0|||
164389625|NCT02952924|593794339|FG004|Overall Study|Noncompliance with study drug|0|||
164389626|NCT02952924|593794340|FG005|Overall Study|Noncompliance with study drug|0|||
164389627|NCT02952924|593794341|FG006|Overall Study|Noncompliance with study drug|0|||
164389628|NCT02952924|593794342|FG007|Overall Study|Noncompliance with study drug|0|||
164389629|NCT02952924|593794343|FG008|Overall Study|Noncompliance with study drug|0|||
164389630|NCT02952924|593794344|FG009|Overall Study|Noncompliance with study drug|0|||
164389631|NCT02952924|593794345|FG010|Overall Study|Noncompliance with study drug|0|||
164389632|NCT02952924|593794346|FG011|Overall Study|Noncompliance with study drug|0|||
164389633|NCT02952924|593794347|FG012|Overall Study|Noncompliance with study drug|0|||
164389634|NCT02952924|593794348|FG013|Overall Study|Noncompliance with study drug|0|||
164389635|NCT02952924|593794349|FG014|Overall Study|Noncompliance with study drug|0|||
164389636|NCT02952924|593794350|FG015|Overall Study|Noncompliance with study drug|0|||
164389637|NCT02952924|593794351|FG016|Overall Study|Noncompliance with study drug|0|||
164389638|NCT02952924|593794352|FG017|Overall Study|Noncompliance with study drug|0|||
164389639|NCT02952924|593794353|FG018|Overall Study|Noncompliance with study drug|0|||
164389640|NCT02952924|593794354|FG019|Overall Study|Noncompliance with study drug|0|||
164389641|NCT02952924|593794355|FG020|Overall Study|Noncompliance with study drug|0|||
164389642|NCT02952924|593794356|FG021|Overall Study|Noncompliance with study drug|1|||
164389643|NCT01435577|593794357|FG000|Overall Study|Adverse Event|10|||
164389644|NCT01435577|593794358|FG001|Overall Study|Adverse Event|0|||
164389645|NCT01435577|593794357|FG000|Overall Study|Lack of Efficacy|7|||
164389646|NCT01435577|593794358|FG001|Overall Study|Lack of Efficacy|51|||
164389647|NCT01435577|593794357|FG000|Overall Study|Alternative treatment started|0|||
164389648|NCT01435577|593794358|FG001|Overall Study|Alternative treatment started|1|||
164389649|NCT01934218|593794360|FG000|Double-blind Phase|Adverse Event|8|||
164389650|NCT01934218|593794361|FG001|Double-blind Phase|Adverse Event|8|||
164389651|NCT01934218|593794360|FG000|Double-blind Phase|Lack of Efficacy|6|||
164389652|NCT01934218|593794361|FG001|Double-blind Phase|Lack of Efficacy|7|||
164389653|NCT01934218|593794360|FG000|Double-blind Phase|Lost to Follow-up|7|||
164389654|NCT01934218|593794361|FG001|Double-blind Phase|Lost to Follow-up|14|||
164389655|NCT01934218|593794360|FG000|Double-blind Phase|Physician Decision|1|||
164389656|NCT01934218|593794361|FG001|Double-blind Phase|Physician Decision|2|||
164389657|NCT01934218|593794360|FG000|Double-blind Phase|Protocol Violation|4|||
164389658|NCT01934218|593794361|FG001|Double-blind Phase|Protocol Violation|0|||
164389659|NCT01934218|593794360|FG000|Double-blind Phase|Withdrawal by Subject|16|||
164389660|NCT01934218|593794361|FG001|Double-blind Phase|Withdrawal by Subject|13|||
164389661|NCT01934218|593794360|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
164389662|NCT01934218|593794361|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
164389663|NCT01934218|593794360|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
164389664|NCT01934218|593794361|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
164389665|NCT01934218|593794360|FG000|Open-Label Phase|Adverse Event|2|||
164389666|NCT01934218|593794361|FG001|Open-Label Phase|Adverse Event|4|||
164389667|NCT01934218|593794360|FG000|Open-Label Phase|Lack of Efficacy|1|||
164389668|NCT01934218|593794361|FG001|Open-Label Phase|Lack of Efficacy|4|||
164389669|NCT01934218|593794360|FG000|Open-Label Phase|Lost to Follow-up|4|||
164389670|NCT01934218|593794361|FG001|Open-Label Phase|Lost to Follow-up|2|||
164389671|NCT01934218|593794360|FG000|Open-Label Phase|Physician Decision|1|||
164389672|NCT01934218|593794361|FG001|Open-Label Phase|Physician Decision|0|||
164389673|NCT01934218|593794360|FG000|Open-Label Phase|Protocol Violation|1|||
164389674|NCT01934218|593794361|FG001|Open-Label Phase|Protocol Violation|0|||
164389675|NCT01934218|593794360|FG000|Open-Label Phase|Withdrawal by Subject|13|||
164389676|NCT01934218|593794361|FG001|Open-Label Phase|Withdrawal by Subject|11|||
164389677|NCT01934218|593794360|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
164389678|NCT01934218|593794361|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
164389679|NCT01934218|593794360|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
164389680|NCT01934218|593794361|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
164389681|NCT03273946|593794365|FG000|Overall Study|Withdrawal by Subject|5|||
164389682|NCT03273946|593794365|FG000|Overall Study|Unwillingness of the guardian|1|||
164389683|NCT03273946|593794365|FG000|Overall Study|Participant refused to use the drug|2|||
164389684|NCT03273946|593794365|FG000|Overall Study|Participant relative refused to use drug|1|||
164389685|NCT01220557|593794366|FG000|Overall Study|Lost to Follow-up|5|||
164389686|NCT01220557|593794367|FG001|Overall Study|Lost to Follow-up|3|||
164389687|NCT01220557|593794366|FG000|Overall Study|attended less than 6 lessons|1|||
164389688|NCT01220557|593794367|FG001|Overall Study|attended less than 6 lessons|2|||
164389689|NCT04323436|593794370|FG000|Overall Study|Adverse Event|7|||
164389690|NCT04323436|593794371|FG001|Overall Study|Adverse Event|0|||
164389691|NCT04323436|593794372|FG002|Overall Study|Adverse Event|0|||
164389692|NCT04323436|593794370|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
164389693|NCT04323436|593794371|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
164389694|NCT04323436|593794372|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
164389695|NCT04323436|593794370|FG000|Overall Study|Death|1|||
164389696|NCT04323436|593794371|FG001|Overall Study|Death|0|||
164389697|NCT04323436|593794372|FG002|Overall Study|Death|0|||
164389698|NCT04323436|593794370|FG000|Overall Study|Physician Decision|2|||
164389699|NCT04323436|593794371|FG001|Overall Study|Physician Decision|0|||
164389700|NCT04323436|593794372|FG002|Overall Study|Physician Decision|0|||
164389701|NCT04323436|593794370|FG000|Overall Study|Progressive disease|10|||
164389702|NCT04323436|593794371|FG001|Overall Study|Progressive disease|0|||
164389703|NCT04323436|593794372|FG002|Overall Study|Progressive disease|0|||
164389704|NCT04323436|593794370|FG000|Overall Study|Subject decision|3|||
164389705|NCT04323436|593794371|FG001|Overall Study|Subject decision|0|||
164389706|NCT04323436|593794372|FG002|Overall Study|Subject decision|0|||
164389707|NCT01682837|593794375|FG000|Baseline|Withdrawal by Subject|5|||
164389708|NCT01664078|593794376|FG000|Overall Study|Death|9|||
164389709|NCT01664078|593794376|FG000|Overall Study|Withdrawal by Subject|4|||
164389710|NCT01664078|593794376|FG000|Overall Study|Lost to Follow-up|2|||
164389711|NCT01664078|593794376|FG000|Overall Study|missed 5 year visit|1|||
164389712|NCT01664078|593794376|FG000|Overall Study|Other|53|||
164389713|NCT04782323|593794377|FG000|Overall Study|Death|1|||
164389714|NCT04782323|593794378|FG001|Overall Study|Death|0|||
164389715|NCT04782323|593794379|FG002|Overall Study|Death|0|||
164389716|NCT04782323|593794380|FG003|Overall Study|Death|0|||
164389717|NCT04782323|593794381|FG004|Overall Study|Death|1|||
164389718|NCT04782323|593794382|FG005|Overall Study|Death|1|||
164389719|NCT04782323|593794383|FG006|Overall Study|Death|1|||
164389720|NCT04782323|593794384|FG007|Overall Study|Death|0|||
164389721|NCT04782323|593794377|FG000|Overall Study|Withdrawal by Subject|0|||
164389722|NCT04782323|593794378|FG001|Overall Study|Withdrawal by Subject|0|||
164389723|NCT04782323|593794379|FG002|Overall Study|Withdrawal by Subject|1|||
164389724|NCT04782323|593794380|FG003|Overall Study|Withdrawal by Subject|0|||
164389725|NCT04782323|593794381|FG004|Overall Study|Withdrawal by Subject|0|||
164389726|NCT04782323|593794382|FG005|Overall Study|Withdrawal by Subject|1|||
164389727|NCT04782323|593794383|FG006|Overall Study|Withdrawal by Subject|0|||
164389728|NCT04782323|593794384|FG007|Overall Study|Withdrawal by Subject|1|||
164389729|NCT04782323|593794377|FG000|Overall Study|Lost to Follow-up|0|||
164389730|NCT04782323|593794378|FG001|Overall Study|Lost to Follow-up|1|||
163904988|NCT05260437|592023725|FG003|Overall Study|Withdrawal by Subject|5|||
163904989|NCT05260437|592023726|FG004|Overall Study|Withdrawal by Subject|0|||
164389731|NCT04782323|593794379|FG002|Overall Study|Lost to Follow-up|1|||
164389732|NCT04782323|593794380|FG003|Overall Study|Lost to Follow-up|0|||
164389733|NCT04782323|593794381|FG004|Overall Study|Lost to Follow-up|0|||
164389734|NCT04782323|593794382|FG005|Overall Study|Lost to Follow-up|1|||
164389735|NCT04782323|593794383|FG006|Overall Study|Lost to Follow-up|1|||
164389736|NCT04782323|593794384|FG007|Overall Study|Lost to Follow-up|2|||
164389737|NCT04782323|593794377|FG000|Overall Study|randomization in error|1|||
164389738|NCT04782323|593794378|FG001|Overall Study|randomization in error|0|||
164389739|NCT04782323|593794379|FG002|Overall Study|randomization in error|0|||
164389740|NCT04782323|593794380|FG003|Overall Study|randomization in error|0|||
164389741|NCT04782323|593794381|FG004|Overall Study|randomization in error|0|||
164389742|NCT04782323|593794382|FG005|Overall Study|randomization in error|0|||
164389743|NCT04782323|593794383|FG006|Overall Study|randomization in error|0|||
164389744|NCT04782323|593794384|FG007|Overall Study|randomization in error|0|||
164389745|NCT04369469|593794387|FG000|Overall Study|Lost to Follow-up|2|||
164389746|NCT04369469|593794388|FG001|Overall Study|Lost to Follow-up|4|||
164389747|NCT04369469|593794387|FG000|Overall Study|Physician Decision|2|||
164389748|NCT04369469|593794388|FG001|Overall Study|Physician Decision|1|||
164389749|NCT04369469|593794387|FG000|Overall Study|Withdrawal by Subject|2|||
164389750|NCT04369469|593794388|FG001|Overall Study|Withdrawal by Subject|3|||
164389751|NCT04369469|593794387|FG000|Overall Study|Adverse Event|1|||
164389752|NCT04369469|593794388|FG001|Overall Study|Adverse Event|0|||
164389753|NCT04369469|593794387|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
164389754|NCT04369469|593794388|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
164389755|NCT04369469|593794387|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
164389756|NCT04369469|593794388|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
164389757|NCT04369469|593794387|FG000|Overall Study|Unable to Provide Consent|0|||
164389758|NCT04369469|593794388|FG001|Overall Study|Unable to Provide Consent|1|||
164389759|NCT03135522|593794389|FG000|Overall Study|Adverse Event|1|||
164389760|NCT03135522|593794390|FG001|Overall Study|Adverse Event|0|||
164389761|NCT03832192|593794393|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
164389762|NCT03832192|593794394|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
164389763|NCT01337245|593794395|FG000|Overall Study|Lost to Follow-up|1|||
164389764|NCT04095858|593794396|FG000|Overall Study|Death|1|||
164389765|NCT04095858|593794397|FG001|Overall Study|Death|0|||
164389766|NCT04095858|593794396|FG000|Overall Study|Study terminated by Sponsor|2|||
164389767|NCT04095858|593794397|FG001|Overall Study|Study terminated by Sponsor|4|||
164389768|NCT01344460|593794398|FG000|Overall Study|Withdrawal by Subject|1|||
164389769|NCT01344460|593794398|FG000|Overall Study|Lost to Follow-up|2|||
164389770|NCT02838017|593794400|FG000|Overall Study|Lost to Follow-up|14|||
164389771|NCT02838017|593794401|FG001|Overall Study|Lost to Follow-up|11|||
164389772|NCT01692197|593794402|FG000|Overall Study|Failed Screening|3|||
164389773|NCT02120924|593794403|FG000|Overall Study|Lack of Efficacy|1|||
164389774|NCT02120924|593794404|FG001|Overall Study|Lack of Efficacy|2|||
164389775|NCT02120924|593794405|FG002|Overall Study|Lack of Efficacy|3|||
164389776|NCT02120924|593794403|FG000|Overall Study|Adverse Event|0|||
164389777|NCT02120924|593794404|FG001|Overall Study|Adverse Event|1|||
164389778|NCT02120924|593794405|FG002|Overall Study|Adverse Event|3|||
164389779|NCT02120924|593794403|FG000|Overall Study|Withdrawal by Subject|16|||
164389780|NCT02120924|593794404|FG001|Overall Study|Withdrawal by Subject|20|||
164389781|NCT02120924|593794405|FG002|Overall Study|Withdrawal by Subject|8|||
164389782|NCT02120924|593794403|FG000|Overall Study|Lost to Follow-up|14|||
164389783|NCT02120924|593794404|FG001|Overall Study|Lost to Follow-up|14|||
164389784|NCT02120924|593794405|FG002|Overall Study|Lost to Follow-up|11|||
164389785|NCT02120924|593794403|FG000|Overall Study|Pregnancy|2|||
164389786|NCT02120924|593794404|FG001|Overall Study|Pregnancy|0|||
164389787|NCT02120924|593794405|FG002|Overall Study|Pregnancy|0|||
164389788|NCT02120924|593794403|FG000|Overall Study|Protocol Violation|3|||
164389789|NCT02120924|593794404|FG001|Overall Study|Protocol Violation|7|||
164389790|NCT02120924|593794405|FG002|Overall Study|Protocol Violation|2|||
164389791|NCT02120924|593794403|FG000|Overall Study|Physician Decision|0|||
164389792|NCT02120924|593794404|FG001|Overall Study|Physician Decision|1|||
164389793|NCT02120924|593794405|FG002|Overall Study|Physician Decision|1|||
164389794|NCT02120924|593794403|FG000|Overall Study|Death|1|||
164389795|NCT02120924|593794404|FG001|Overall Study|Death|0|||
164389796|NCT02120924|593794405|FG002|Overall Study|Death|0|||
164389797|NCT02120924|593794403|FG000|Overall Study|Compliance with IP|5|||
164389798|NCT02120924|593794404|FG001|Overall Study|Compliance with IP|1|||
164389799|NCT02120924|593794405|FG002|Overall Study|Compliance with IP|1|||
164389800|NCT03483623|593794406|FG000|Overall Study|43 complete sets achieved|1|||
164389801|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
164389802|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
164389803|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
164389804|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
164389805|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
164389806|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
164389807|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
164389808|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
164389809|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
164389810|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
164389811|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
164389812|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
164389813|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
164389814|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
164389815|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
164389816|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
164389817|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
164389818|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
164073021|NCT00552617|592632765|FG002|Overall Study|Lost to Follow-up|0|||
164389819|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
164389820|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
164389821|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
164389822|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
164389823|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
164389824|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
164389825|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
164389826|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
164389827|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
164389828|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
164389829|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
164389830|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
164389831|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
164389832|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
164389833|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
164389834|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
164389835|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
164389836|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
164389837|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
164389838|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
164389839|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
164389840|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
164389841|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
164389842|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
164389843|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
164389844|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
164389845|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
164389846|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
164389847|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
164389848|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
164389849|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
164389850|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
164389851|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
164389852|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
164389853|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
164389854|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
164389855|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
164389856|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
164389857|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
164389858|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
164389859|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
164389860|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
164389861|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
164389862|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
164389863|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
164016079|NCT00365716|592421819|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
164016080|NCT00365716|592421820|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
164389864|NCT01884350|593794407|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
164389865|NCT01884350|593794408|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
164389866|NCT01884350|593794409|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
164389867|NCT02730819|593794422|FG000|Overall Study|Lost to Follow-up|9|||
164389868|NCT01308580|593794423|FG000|Overall Study|Lost to Follow-up|12|||
164389869|NCT01308580|593794424|FG001|Overall Study|Lost to Follow-up|7|||
164389870|NCT03403634|593794425|FG000|Overall Study|Disease progression|3|||
164389871|NCT03403634|593794425|FG000|Overall Study|Did not meet eligibility criteria|4|||
164389872|NCT00932893|593794426|FG000|Overall Study|Death|115|||
164389873|NCT00932893|593794427|FG001|Overall Study|Death|24|||
164389874|NCT00932893|593794426|FG000|Overall Study|Lost to Follow-up|8|||
164389875|NCT00932893|593794427|FG001|Overall Study|Lost to Follow-up|0|||
164389876|NCT00932893|593794426|FG000|Overall Study|Withdrawal by Subject|5|||
164389877|NCT00932893|593794427|FG001|Overall Study|Withdrawal by Subject|2|||
164389878|NCT00932893|593794426|FG000|Overall Study|Other|5|||
164389879|NCT00932893|593794427|FG001|Overall Study|Other|144|||
164016081|NCT00365716|592421821|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
164073022|NCT00552617|592632766|FG003|Overall Study|Lost to Follow-up|1|||
164389880|NCT01850004|593794428|FG000|Overall Study|Poor/Non-compliance|1|||
164389881|NCT01850004|593794428|FG000|Overall Study|Participant Withdrew Consent|9|||
164389882|NCT01850004|593794428|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
164389883|NCT01850004|593794428|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164389884|NCT01850004|593794428|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
164389885|NCT01850004|593794428|FG000|Overall Study|Other Reasons|2|||
164389886|NCT01850004|593794428|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
164389887|NCT01850004|593794428|FG000|Overall Study|Maximum Clinical Benefit|4|||
163904990|NCT05260437|592023722|FG000|Overall Study|Vaccine Not Administered|0|||
164389888|NCT02508311|593796267|FG000|Overall Study|Withdrawal by Subject|1|||
164389889|NCT02508311|593796268|FG001|Overall Study|Withdrawal by Subject|0|||
164389890|NCT04862143|593796269|FG000|Overall Study|Adverse Event|1|||
164389891|NCT04862143|593796269|FG000|Overall Study|Study terminated by sponsor|1|||
164389892|NCT04955639|593796270|FG000|Overall Study|Withdrawal by Subject|2|||
164389893|NCT04955639|593796271|FG001|Overall Study|Withdrawal by Subject|2|||
164389894|NCT04955639|593796270|FG000|Overall Study|Week 26 survey not completed|2|||
164389895|NCT04955639|593796271|FG001|Overall Study|Week 26 survey not completed|2|||
164389896|NCT00413153|593796272|FG000|Overall Study|Withdrawal by Subject|1|||
164389897|NCT00413153|593796273|FG001|Overall Study|Withdrawal by Subject|1|||
164389898|NCT00413153|593796272|FG000|Overall Study|Adverse Event|1|||
164389899|NCT00413153|593796273|FG001|Overall Study|Adverse Event|0|||
164389900|NCT03966157|593796278|FG000|Overall Study|Physician Decision|1|||
164389901|NCT03966157|593796279|FG001|Overall Study|Physician Decision|0|||
164389902|NCT04969250|593796280|FG000|Overall Study|Protocol Violation|0|||
164389903|NCT04969250|593796281|FG001|Overall Study|Protocol Violation|2|||
164389904|NCT04969250|593796282|FG002|Overall Study|Protocol Violation|3|||
164389905|NCT04969250|593796283|FG003|Overall Study|Protocol Violation|8|||
164389906|NCT04969250|593796280|FG000|Overall Study|Withdrawal by Subject|0|||
164389907|NCT04969250|593796281|FG001|Overall Study|Withdrawal by Subject|1|||
164389908|NCT04969250|593796282|FG002|Overall Study|Withdrawal by Subject|0|||
164389909|NCT04969250|593796283|FG003|Overall Study|Withdrawal by Subject|0|||
164389910|NCT00377676|593796284|FG000|Overall Study|Adverse Event|498|||
164389911|NCT00377676|593796285|FG001|Overall Study|Adverse Event|107|||
164389912|NCT00377676|593796284|FG000|Overall Study|Protocol Violation|33|||
164389913|NCT00377676|593796285|FG001|Overall Study|Protocol Violation|27|||
164389914|NCT00377676|593796284|FG000|Overall Study|Death|5|||
164389915|NCT00377676|593796285|FG001|Overall Study|Death|2|||
163904991|NCT05260437|592023723|FG001|Overall Study|Vaccine Not Administered|1|||
163904992|NCT05260437|592023724|FG002|Overall Study|Vaccine Not Administered|0|||
163904993|NCT05260437|592023725|FG003|Overall Study|Vaccine Not Administered|0|||
163904994|NCT05260437|592023726|FG004|Overall Study|Vaccine Not Administered|0|||
163904995|NCT00910962|592023727|FG000|Overall Study|Adverse Event|5|||
163904996|NCT00910962|592023728|FG001|Overall Study|Adverse Event|20|||
163904997|NCT00910962|592023729|FG002|Overall Study|Adverse Event|17|||
163904998|NCT00910962|592023727|FG000|Overall Study|Protocol Violation|1|||
163904999|NCT00910962|592023728|FG001|Overall Study|Protocol Violation|3|||
163905000|NCT00910962|592023729|FG002|Overall Study|Protocol Violation|3|||
163905001|NCT00910962|592023727|FG000|Overall Study|Lost to Follow-up|0|||
163905002|NCT00910962|592023728|FG001|Overall Study|Lost to Follow-up|3|||
164016082|NCT00365716|592421822|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
164016083|NCT00365716|592421823|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
164016084|NCT00365716|592421824|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
164016085|NCT00365716|592421818|FG000|Extension 1|Lost to Follow-up|0|||
164016086|NCT00365716|592421819|FG001|Extension 1|Lost to Follow-up|0|||
164016087|NCT00365716|592421820|FG002|Extension 1|Lost to Follow-up|0|||
164016088|NCT00365716|592421821|FG003|Extension 1|Lost to Follow-up|0|||
164389916|NCT00377676|593796284|FG000|Overall Study|Withdrawal by Subject|187|||
164389917|NCT00377676|593796285|FG001|Overall Study|Withdrawal by Subject|72|||
164389918|NCT00377676|593796284|FG000|Overall Study|Lost to Follow-up|120|||
164389919|NCT00377676|593796285|FG001|Overall Study|Lost to Follow-up|56|||
164389920|NCT00377676|593796284|FG000|Overall Study|Other|118|||
164389921|NCT00377676|593796285|FG001|Overall Study|Other|58|||
163905003|NCT00910962|592023729|FG002|Overall Study|Lost to Follow-up|1|||
164389922|NCT03834779|593796291|FG000|Overall Study|Death|1|||
164389923|NCT03834779|593796292|FG001|Overall Study|Death|2|||
164389924|NCT03834779|593796291|FG000|Overall Study|Lost to Follow-up|6|||
164389925|NCT03834779|593796292|FG001|Overall Study|Lost to Follow-up|4|||
164389926|NCT03579459|593796293|FG000|Overall Study|Adverse Event|7|||
164389927|NCT03579459|593796294|FG001|Overall Study|Adverse Event|6|||
164389928|NCT03579459|593796295|FG002|Overall Study|Adverse Event|2|||
164389929|NCT03579459|593796296|FG003|Overall Study|Adverse Event|6|||
164389930|NCT03579459|593796293|FG000|Overall Study|Death|1|||
164389931|NCT03579459|593796294|FG001|Overall Study|Death|0|||
164389932|NCT03579459|593796295|FG002|Overall Study|Death|1|||
164389933|NCT03579459|593796296|FG003|Overall Study|Death|2|||
164389934|NCT03579459|593796293|FG000|Overall Study|Lost to Follow-up|6|||
164389935|NCT03579459|593796294|FG001|Overall Study|Lost to Follow-up|2|||
164389936|NCT03579459|593796295|FG002|Overall Study|Lost to Follow-up|4|||
164389937|NCT03579459|593796296|FG003|Overall Study|Lost to Follow-up|1|||
164389938|NCT03579459|593796293|FG000|Overall Study|Physician Decision|0|||
164389939|NCT03579459|593796294|FG001|Overall Study|Physician Decision|1|||
164389940|NCT03579459|593796295|FG002|Overall Study|Physician Decision|0|||
164389941|NCT03579459|593796296|FG003|Overall Study|Physician Decision|1|||
164389942|NCT03579459|593796293|FG000|Overall Study|Protocol Violation|1|||
164389943|NCT03579459|593796294|FG001|Overall Study|Protocol Violation|2|||
164389944|NCT03579459|593796295|FG002|Overall Study|Protocol Violation|3|||
164389945|NCT03579459|593796296|FG003|Overall Study|Protocol Violation|5|||
164389946|NCT03579459|593796293|FG000|Overall Study|Withdrawal by Subject|12|||
164389947|NCT03579459|593796294|FG001|Overall Study|Withdrawal by Subject|8|||
164389948|NCT03579459|593796295|FG002|Overall Study|Withdrawal by Subject|11|||
164389949|NCT03579459|593796296|FG003|Overall Study|Withdrawal by Subject|8|||
164389950|NCT03579459|593796293|FG000|Overall Study|Medication error without associated adverse event|2|||
164389951|NCT03579459|593796294|FG001|Overall Study|Medication error without associated adverse event|1|||
164389952|NCT03579459|593796295|FG002|Overall Study|Medication error without associated adverse event|1|||
163905004|NCT00910962|592023727|FG000|Overall Study|Physician Decision|0|||
163905005|NCT00910962|592023728|FG001|Overall Study|Physician Decision|6|||
163905006|NCT00910962|592023729|FG002|Overall Study|Physician Decision|6|||
163905007|NCT00910962|592023727|FG000|Overall Study|Withdrawal by Subject|25|||
163905008|NCT00910962|592023728|FG001|Overall Study|Withdrawal by Subject|32|||
163905009|NCT00910962|592023729|FG002|Overall Study|Withdrawal by Subject|32|||
163905010|NCT00910962|592023727|FG000|Overall Study|Reached defined stopping criteria|12|||
163905011|NCT00910962|592023728|FG001|Overall Study|Reached defined stopping criteria|14|||
163905012|NCT00910962|592023729|FG002|Overall Study|Reached defined stopping criteria|17|||
163905013|NCT00195819|592023730|FG000|Double-Blind|Withdrawal by Subject|1|||
164389953|NCT03579459|593796296|FG003|Overall Study|Medication error without associated adverse event|0|||
164389954|NCT03579459|593796293|FG000|Overall Study|Other|0|||
164389955|NCT03579459|593796294|FG001|Overall Study|Other|1|||
164389956|NCT03579459|593796295|FG002|Overall Study|Other|1|||
164389957|NCT03579459|593796296|FG003|Overall Study|Other|0|||
164389958|NCT03579459|593796293|FG000|Overall Study|Randomized not vaccinated|0|||
164389959|NCT03579459|593796294|FG001|Overall Study|Randomized not vaccinated|2|||
164389960|NCT03579459|593796295|FG002|Overall Study|Randomized not vaccinated|0|||
164389961|NCT03579459|593796296|FG003|Overall Study|Randomized not vaccinated|1|||
164389962|NCT02528214|593796297|FG000|Overall Study|Protocol Violation|0|||
164389963|NCT02528214|593796298|FG001|Overall Study|Protocol Violation|1|||
164389964|NCT02528214|593796297|FG000|Overall Study|Adverse Event|0|||
164389965|NCT02528214|593796298|FG001|Overall Study|Adverse Event|1|||
164389966|NCT02528214|593796297|FG000|Overall Study|Other than specified above|0|||
164389967|NCT02528214|593796298|FG001|Overall Study|Other than specified above|1|||
164389968|NCT00407537|593796299|FG000|Overall Study|Death|5|||
164389969|NCT00407537|593796300|FG001|Overall Study|Death|2|||
164389970|NCT00407537|593796299|FG000|Overall Study|Adverse Event|36|||
164389971|NCT00407537|593796300|FG001|Overall Study|Adverse Event|0|||
164389972|NCT00407537|593796299|FG000|Overall Study|Lost to Follow-up|12|||
164389973|NCT00407537|593796300|FG001|Overall Study|Lost to Follow-up|19|||
164389974|NCT00407537|593796299|FG000|Overall Study|Other|6|||
164389975|NCT00407537|593796300|FG001|Overall Study|Other|7|||
164389976|NCT00407537|593796299|FG000|Overall Study|Withdrawal by Subject|34|||
164389977|NCT00407537|593796300|FG001|Overall Study|Withdrawal by Subject|16|||
164389978|NCT03593655|593796302|FG000|First Product Use Period|Withdrawal by Subject|1|||
164389979|NCT03593655|593796303|FG001|First Product Use Period|Withdrawal by Subject|1|||
164389980|NCT03593655|593796302|FG000|First Product Use Period|Lost to Follow-up|1|||
164389981|NCT03593655|593796303|FG001|First Product Use Period|Lost to Follow-up|3|||
164389982|NCT03593655|593796302|FG000|Second Product Use Period|Withdrawal by Subject|1|||
164389983|NCT03593655|593796303|FG001|Second Product Use Period|Withdrawal by Subject|1|||
163905014|NCT00195819|592023731|FG001|Double-Blind|Withdrawal by Subject|0|||
164389984|NCT03593655|593796302|FG000|Second Product Use Period|Lost to Follow-up|1|||
164389985|NCT03593655|593796303|FG001|Second Product Use Period|Lost to Follow-up|0|||
164389986|NCT03593655|593796302|FG000|Third Product Use Period|Lost to Follow-up|1|||
164389987|NCT03593655|593796303|FG001|Third Product Use Period|Lost to Follow-up|2|||
164016089|NCT00365716|592421822|FG004|Extension 1|Lost to Follow-up|0|||
164389988|NCT03593655|593796302|FG000|Third Product Use Period|Physician Decision|0|||
164389989|NCT03593655|593796303|FG001|Third Product Use Period|Physician Decision|1|||
164389990|NCT03593655|593796302|FG000|Third Product Use Period|Withdrawal by Subject|0|||
164389991|NCT03593655|593796303|FG001|Third Product Use Period|Withdrawal by Subject|1|||
164389992|NCT03526250|593796304|FG000|Overall Study|Adverse Event|4|||
164389993|NCT03526250|593796304|FG000|Overall Study|Progressive Disease|16|||
164389994|NCT03526250|593796304|FG000|Overall Study|No Treatment|3|||
164389995|NCT04420221|593796305|FG000|Overall Study|Withdrawal by Subject|0|||
164389996|NCT04420221|593796306|FG001|Overall Study|Withdrawal by Subject|0|||
164389997|NCT04420221|593796307|FG002|Overall Study|Withdrawal by Subject|0|||
164389998|NCT04420221|593796308|FG003|Overall Study|Withdrawal by Subject|0|||
164389999|NCT04420221|593796309|FG004|Overall Study|Withdrawal by Subject|0|||
164390000|NCT04420221|593796310|FG005|Overall Study|Withdrawal by Subject|20|||
164390001|NCT04420221|593796311|FG006|Overall Study|Withdrawal by Subject|5|||
164390002|NCT04420221|593796305|FG000|Overall Study|Other|0|||
164390003|NCT04420221|593796306|FG001|Overall Study|Other|0|||
164390004|NCT04420221|593796307|FG002|Overall Study|Other|0|||
164390005|NCT04420221|593796308|FG003|Overall Study|Other|0|||
164390006|NCT04420221|593796309|FG004|Overall Study|Other|0|||
164390007|NCT04420221|593796310|FG005|Overall Study|Other|1|||
164390008|NCT04420221|593796311|FG006|Overall Study|Other|1|||
164390009|NCT04420221|593796305|FG000|Overall Study|Lost to Follow-up|0|||
164390010|NCT04420221|593796306|FG001|Overall Study|Lost to Follow-up|0|||
164390011|NCT04420221|593796307|FG002|Overall Study|Lost to Follow-up|0|||
164390012|NCT04420221|593796308|FG003|Overall Study|Lost to Follow-up|0|||
164390013|NCT04420221|593796309|FG004|Overall Study|Lost to Follow-up|0|||
164390014|NCT04420221|593796310|FG005|Overall Study|Lost to Follow-up|3|||
164390015|NCT04420221|593796311|FG006|Overall Study|Lost to Follow-up|2|||
164390016|NCT04420221|593796305|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
164390017|NCT04420221|593796306|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
164390018|NCT04420221|593796307|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
164390019|NCT04420221|593796308|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
164390020|NCT04420221|593796309|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
164390021|NCT04420221|593796310|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
164390022|NCT04420221|593796311|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
164390023|NCT05348681|593796312|FG000|Overall Study|Study terminated by Sponsor|8|||
164390024|NCT05348681|593796313|FG001|Overall Study|Study terminated by Sponsor|3|||
164390025|NCT05348681|593796312|FG000|Overall Study|Withdrawal by Subject|1|||
164390026|NCT05348681|593796313|FG001|Overall Study|Withdrawal by Subject|1|||
164390027|NCT05348681|593796312|FG000|Overall Study|Lost to Follow-up|1|||
164390028|NCT05348681|593796313|FG001|Overall Study|Lost to Follow-up|1|||
164390029|NCT05348681|593796312|FG000|Overall Study|Adverse Event|1|||
164390030|NCT05348681|593796313|FG001|Overall Study|Adverse Event|0|||
164390031|NCT05348681|593796312|FG000|Overall Study|Other|2|||
164390032|NCT05348681|593796313|FG001|Overall Study|Other|1|||
164390033|NCT01040130|593796314|FG000|Overall Study|Adverse Event|1|||
164390034|NCT01040130|593796315|FG001|Overall Study|Adverse Event|1|||
164390035|NCT01040130|593796316|FG002|Overall Study|Adverse Event|0|||
164390036|NCT01040130|593796317|FG003|Overall Study|Adverse Event|5|||
164390037|NCT01040130|593796318|FG004|Overall Study|Adverse Event|0|||
164390038|NCT01040130|593796319|FG005|Overall Study|Adverse Event|3|||
164390039|NCT01040130|593796314|FG000|Overall Study|Protocol Violation|0|||
164390040|NCT01040130|593796315|FG001|Overall Study|Protocol Violation|0|||
164390041|NCT01040130|593796316|FG002|Overall Study|Protocol Violation|2|||
164390042|NCT01040130|593796317|FG003|Overall Study|Protocol Violation|0|||
164390043|NCT01040130|593796318|FG004|Overall Study|Protocol Violation|0|||
164390044|NCT01040130|593796319|FG005|Overall Study|Protocol Violation|0|||
164390045|NCT01040130|593796314|FG000|Overall Study|Withdrawal by Subject|0|||
164390046|NCT01040130|593796315|FG001|Overall Study|Withdrawal by Subject|2|||
164390047|NCT01040130|593796316|FG002|Overall Study|Withdrawal by Subject|0|||
164390048|NCT01040130|593796317|FG003|Overall Study|Withdrawal by Subject|0|||
164390049|NCT01040130|593796318|FG004|Overall Study|Withdrawal by Subject|0|||
164390050|NCT01040130|593796319|FG005|Overall Study|Withdrawal by Subject|1|||
164390051|NCT01040130|593796314|FG000|Overall Study|Other reasons not listed above|2|||
164390052|NCT01040130|593796315|FG001|Overall Study|Other reasons not listed above|0|||
164390053|NCT01040130|593796316|FG002|Overall Study|Other reasons not listed above|0|||
164390054|NCT01040130|593796317|FG003|Overall Study|Other reasons not listed above|0|||
164390055|NCT01040130|593796318|FG004|Overall Study|Other reasons not listed above|0|||
164390056|NCT01040130|593796319|FG005|Overall Study|Other reasons not listed above|0|||
164390057|NCT00553267|593796323|FG000|Overall Study|Adverse Event|8|||
164390058|NCT00553267|593796324|FG001|Overall Study|Adverse Event|10|||
164390059|NCT00553267|593796325|FG002|Overall Study|Adverse Event|5|||
164390060|NCT00553267|593796323|FG000|Overall Study|Non compliant with protocol|3|||
164390061|NCT00553267|593796324|FG001|Overall Study|Non compliant with protocol|3|||
164390062|NCT00553267|593796325|FG002|Overall Study|Non compliant with protocol|2|||
164390063|NCT00553267|593796323|FG000|Overall Study|Lost to Follow-up|0|||
164390064|NCT00553267|593796324|FG001|Overall Study|Lost to Follow-up|0|||
164390065|NCT00553267|593796325|FG002|Overall Study|Lost to Follow-up|1|||
164390066|NCT00553267|593796323|FG000|Overall Study|Consent withdrawn|2|||
164390067|NCT00553267|593796324|FG001|Overall Study|Consent withdrawn|3|||
164390068|NCT00553267|593796325|FG002|Overall Study|Consent withdrawn|1|||
164390069|NCT00553267|593796323|FG000|Overall Study|Specified category|1|||
164390070|NCT00553267|593796324|FG001|Overall Study|Specified category|2|||
164390071|NCT00553267|593796325|FG002|Overall Study|Specified category|1|||
164390072|NCT04389840|593796326|FG000|Overall Study|Adverse Event|0|||
164390073|NCT04389840|593796327|FG001|Overall Study|Adverse Event|0|||
164390074|NCT04389840|593796328|FG002|Overall Study|Adverse Event|0|||
164390075|NCT04389840|593796329|FG003|Overall Study|Adverse Event|1|||
164390076|NCT04389840|593796330|FG004|Overall Study|Adverse Event|0|||
164390077|NCT04389840|593796331|FG005|Overall Study|Adverse Event|0|||
164390078|NCT04389840|593796326|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
164390079|NCT04389840|593796327|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
164390080|NCT04389840|593796328|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
164390081|NCT04389840|593796329|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
164390082|NCT04389840|593796330|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
164390083|NCT04389840|593796331|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
164390084|NCT04389840|593796326|FG000|Overall Study|Death|0|||
164390085|NCT04389840|593796327|FG001|Overall Study|Death|1|||
164390086|NCT04389840|593796328|FG002|Overall Study|Death|0|||
164390087|NCT04389840|593796329|FG003|Overall Study|Death|0|||
164390088|NCT04389840|593796330|FG004|Overall Study|Death|0|||
164390089|NCT04389840|593796331|FG005|Overall Study|Death|0|||
164390090|NCT01618864|593796332|FG000|Overall Study|Withdrawal by Subject|2|||
164390091|NCT01618864|593796332|FG000|Overall Study|Lost to Follow-up|2|||
164390092|NCT03585244|593796333|FG000|Overall Study|Withdrawal by Subject|15|||
164390093|NCT01090453|593796339|FG000|Overall Study|Withdrawal by Subject|1|||
164390094|NCT01090453|593796340|FG001|Overall Study|Withdrawal by Subject|2|||
164390095|NCT01090453|593796339|FG000|Overall Study|Lost to Follow-up|7|||
164390096|NCT01090453|593796340|FG001|Overall Study|Lost to Follow-up|7|||
164390097|NCT01090453|593796339|FG000|Overall Study|Non serious AEs|1|||
164390098|NCT01090453|593796340|FG001|Overall Study|Non serious AEs|0|||
164390099|NCT01090453|593796339|FG000|Overall Study|Protocol Violation|2|||
164390100|NCT01090453|593796340|FG001|Overall Study|Protocol Violation|0|||
163905015|NCT00195819|592023730|FG000|Double-Blind|Moved|1|||
163905016|NCT00195819|592023731|FG001|Double-Blind|Moved|0|||
164390101|NCT01090453|593796339|FG000|Overall Study|Other|2|||
164390102|NCT01090453|593796340|FG001|Overall Study|Other|4|||
164390103|NCT01090453|593796339|FG000|Overall Study|Eligibility Criteria|0|||
164390104|NCT01090453|593796340|FG001|Overall Study|Eligibility Criteria|1|||
164390105|NCT00142909|593796346|FG000|Randomization|Various Reasons|7|||
164390106|NCT00142909|593796347|FG001|Randomization|Various Reasons|10|||
164390107|NCT00142909|593796346|FG000|Medications Begin|Protocol Violation|2|||
164390108|NCT00142909|593796347|FG001|Medications Begin|Protocol Violation|0|||
164390109|NCT00142909|593796346|FG000|Medications Begin|Withdrawal by Subject|5|||
164390110|NCT00142909|593796347|FG001|Medications Begin|Withdrawal by Subject|3|||
164390111|NCT00142909|593796346|FG000|Medications Begin|Withdrawal by Subject|2|||
164390112|NCT00142909|593796347|FG001|Medications Begin|Withdrawal by Subject|0|||
164390113|NCT01660763|593796351|FG000|Overall Study|Lack of Efficacy|45|||
164390114|NCT01660763|593796352|FG001|Overall Study|Lack of Efficacy|50|||
164390115|NCT01660763|593796351|FG000|Overall Study|Adverse Event|22|||
164390116|NCT01660763|593796352|FG001|Overall Study|Adverse Event|7|||
164390117|NCT01660763|593796351|FG000|Overall Study|Protocol Violation|1|||
164390118|NCT01660763|593796352|FG001|Overall Study|Protocol Violation|0|||
164390119|NCT01660763|593796351|FG000|Overall Study|Withdrawal by Subject|4|||
164390120|NCT01660763|593796352|FG001|Overall Study|Withdrawal by Subject|0|||
164390121|NCT01660763|593796351|FG000|Overall Study|Patient ready for early discharge|28|||
164390122|NCT01660763|593796352|FG001|Overall Study|Patient ready for early discharge|4|||
164390123|NCT00345397|593796353|FG000|Overall Study|Death|1|||
164390124|NCT01870843|593796354|FG000|Overall Study|Adverse Event|10|||
164390125|NCT01870843|593796354|FG000|Overall Study|Lost to Follow-up|24|||
164390126|NCT01870843|593796354|FG000|Overall Study|Death|1|||
164390127|NCT01870843|593796354|FG000|Overall Study|Withdrawal by Subject|18|||
164390128|NCT01365494|593796359|FG000|Overall Study|Adverse Event|1|||
164390129|NCT01365494|593796360|FG001|Overall Study|Adverse Event|0|||
164390130|NCT01365494|593796359|FG000|Overall Study|Withdrawal by Subject|0|||
164390131|NCT01365494|593796360|FG001|Overall Study|Withdrawal by Subject|1|||
164390132|NCT01365494|593796359|FG000|Overall Study|Lost to Follow-up|1|||
164390133|NCT01365494|593796360|FG001|Overall Study|Lost to Follow-up|2|||
164390134|NCT03021187|593796361|FG000|Overall Study|Death|0|||
164390135|NCT03021187|593796362|FG001|Overall Study|Death|0|||
164390136|NCT03021187|593796363|FG002|Overall Study|Death|3|||
164390137|NCT03021187|593796364|FG003|Overall Study|Death|0|||
164390138|NCT03021187|593796361|FG000|Overall Study|Withdrawal by Subject|0|||
164390139|NCT03021187|593796362|FG001|Overall Study|Withdrawal by Subject|6|||
164390140|NCT03021187|593796363|FG002|Overall Study|Withdrawal by Subject|2|||
164390141|NCT03021187|593796364|FG003|Overall Study|Withdrawal by Subject|5|||
164390142|NCT03021187|593796361|FG000|Overall Study|Lost to Follow-up|10|||
164390143|NCT03021187|593796362|FG001|Overall Study|Lost to Follow-up|3|||
164390144|NCT03021187|593796363|FG002|Overall Study|Lost to Follow-up|1|||
164390145|NCT03021187|593796364|FG003|Overall Study|Lost to Follow-up|4|||
164390146|NCT03351049|593796365|FG000|Overall Study|Withdrawal|26|||
164390147|NCT03351049|593796366|FG001|Overall Study|Withdrawal|22|||
164390148|NCT00718718|593796367|FG000|Prior to Week 12|Adverse Event|0|||
164390149|NCT00718718|593796368|FG001|Prior to Week 12|Adverse Event|0|||
164390150|NCT00718718|593796369|FG002|Prior to Week 12|Adverse Event|0|||
164390151|NCT00718718|593796370|FG003|Prior to Week 12|Adverse Event|0|||
164390152|NCT00718718|593796371|FG004|Prior to Week 12|Adverse Event|0|||
164390153|NCT00718718|593796372|FG005|Prior to Week 12|Adverse Event|0|||
164390154|NCT00718718|593796373|FG006|Prior to Week 12|Adverse Event|0|||
164390155|NCT00718718|593796374|FG007|Prior to Week 12|Adverse Event|1|||
164390156|NCT00718718|593796375|FG008|Prior to Week 12|Adverse Event|1|||
164390157|NCT00718718|593796376|FG009|Prior to Week 12|Adverse Event|0|||
164390158|NCT00718718|593796367|FG000|Prior to Week 12|Withdrawal by Subject|0|||
164390159|NCT00718718|593796368|FG001|Prior to Week 12|Withdrawal by Subject|0|||
164390160|NCT00718718|593796369|FG002|Prior to Week 12|Withdrawal by Subject|0|||
164390161|NCT00718718|593796370|FG003|Prior to Week 12|Withdrawal by Subject|0|||
164390162|NCT00718718|593796371|FG004|Prior to Week 12|Withdrawal by Subject|3|||
164390163|NCT00718718|593796372|FG005|Prior to Week 12|Withdrawal by Subject|0|||
164390164|NCT00718718|593796373|FG006|Prior to Week 12|Withdrawal by Subject|1|||
164390165|NCT00718718|593796374|FG007|Prior to Week 12|Withdrawal by Subject|1|||
164390166|NCT00718718|593796375|FG008|Prior to Week 12|Withdrawal by Subject|1|||
164390167|NCT00718718|593796376|FG009|Prior to Week 12|Withdrawal by Subject|0|||
164390168|NCT00718718|593796367|FG000|Prior to Week 12|Other|1|||
164390169|NCT00718718|593796368|FG001|Prior to Week 12|Other|0|||
164390170|NCT00718718|593796369|FG002|Prior to Week 12|Other|1|||
164390171|NCT00718718|593796370|FG003|Prior to Week 12|Other|0|||
164390172|NCT00718718|593796371|FG004|Prior to Week 12|Other|0|||
164390173|NCT00718718|593796372|FG005|Prior to Week 12|Other|0|||
164390174|NCT00718718|593796373|FG006|Prior to Week 12|Other|0|||
164390175|NCT00718718|593796374|FG007|Prior to Week 12|Other|0|||
164390176|NCT00718718|593796375|FG008|Prior to Week 12|Other|0|||
164390177|NCT00718718|593796376|FG009|Prior to Week 12|Other|0|||
164390178|NCT00718718|593796367|FG000|Week 12 to End of Study|Adverse Event|0|||
164390179|NCT00718718|593796368|FG001|Week 12 to End of Study|Adverse Event|0|||
164390180|NCT00718718|593796369|FG002|Week 12 to End of Study|Adverse Event|0|||
164390181|NCT00718718|593796370|FG003|Week 12 to End of Study|Adverse Event|0|||
164390182|NCT00718718|593796371|FG004|Week 12 to End of Study|Adverse Event|0|||
164390183|NCT00718718|593796372|FG005|Week 12 to End of Study|Adverse Event|0|||
164390184|NCT00718718|593796373|FG006|Week 12 to End of Study|Adverse Event|0|||
164390185|NCT00718718|593796374|FG007|Week 12 to End of Study|Adverse Event|1|||
164390186|NCT00718718|593796375|FG008|Week 12 to End of Study|Adverse Event|0|||
164390187|NCT00718718|593796376|FG009|Week 12 to End of Study|Adverse Event|0|||
164390188|NCT00718718|593796367|FG000|Week 12 to End of Study|Death|0|||
164390189|NCT00718718|593796368|FG001|Week 12 to End of Study|Death|0|||
164390190|NCT00718718|593796369|FG002|Week 12 to End of Study|Death|0|||
164390191|NCT00718718|593796370|FG003|Week 12 to End of Study|Death|0|||
164390192|NCT00718718|593796371|FG004|Week 12 to End of Study|Death|0|||
164390193|NCT00718718|593796372|FG005|Week 12 to End of Study|Death|1|||
164390194|NCT00718718|593796373|FG006|Week 12 to End of Study|Death|0|||
164390195|NCT00718718|593796374|FG007|Week 12 to End of Study|Death|0|||
164390196|NCT00718718|593796375|FG008|Week 12 to End of Study|Death|0|||
164390197|NCT00718718|593796376|FG009|Week 12 to End of Study|Death|0|||
164390198|NCT00718718|593796367|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
164390199|NCT00718718|593796368|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
164390200|NCT00718718|593796369|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
164390201|NCT00718718|593796370|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
164390202|NCT00718718|593796371|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
164390203|NCT00718718|593796372|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
164390204|NCT00718718|593796373|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
164390205|NCT00718718|593796374|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
164390206|NCT00718718|593796375|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
164390207|NCT00718718|593796376|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
164390208|NCT00718718|593796367|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
164390209|NCT00718718|593796368|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
164390210|NCT00718718|593796369|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
164390211|NCT00718718|593796370|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
164390212|NCT00718718|593796371|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
164390213|NCT00718718|593796372|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
164390214|NCT00718718|593796373|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
164390215|NCT00718718|593796374|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
164390216|NCT00718718|593796375|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
164390217|NCT00718718|593796376|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
164390218|NCT00718718|593796367|FG000|Week 12 to End of Study|Other|0|||
164390219|NCT00718718|593796368|FG001|Week 12 to End of Study|Other|1|||
164390220|NCT00718718|593796369|FG002|Week 12 to End of Study|Other|0|||
164390221|NCT00718718|593796370|FG003|Week 12 to End of Study|Other|1|||
164390222|NCT00718718|593796371|FG004|Week 12 to End of Study|Other|0|||
164390223|NCT00718718|593796372|FG005|Week 12 to End of Study|Other|0|||
164390224|NCT00718718|593796373|FG006|Week 12 to End of Study|Other|1|||
164390225|NCT00718718|593796374|FG007|Week 12 to End of Study|Other|0|||
164390226|NCT00718718|593796375|FG008|Week 12 to End of Study|Other|0|||
164390227|NCT00718718|593796376|FG009|Week 12 to End of Study|Other|0|||
164390228|NCT03099382|593796377|FG000|Overall Study|Protocol Violation|2|||
164390229|NCT03099382|593796378|FG001|Overall Study|Protocol Violation|3|||
164390230|NCT01802411|593796381|FG000|Overall Study|Death|2|||
164390231|NCT01802411|593796382|FG001|Overall Study|Death|1|||
164390232|NCT01802411|593796381|FG000|Overall Study|Adverse Event|2|||
164390233|NCT01802411|593796382|FG001|Overall Study|Adverse Event|7|||
164390234|NCT01802411|593796381|FG000|Overall Study|Lack of Efficacy|8|||
164390235|NCT01802411|593796382|FG001|Overall Study|Lack of Efficacy|10|||
164390236|NCT01802411|593796381|FG000|Overall Study|Withdrawal by Subject|0|||
164390237|NCT01802411|593796382|FG001|Overall Study|Withdrawal by Subject|2|||
164390238|NCT01802411|593796381|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
164390239|NCT01802411|593796382|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
164390240|NCT01802411|593796381|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
164390241|NCT01802411|593796382|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
164390242|NCT01802411|593796381|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
164390243|NCT01802411|593796382|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
164390244|NCT03930745|593796388|FG000|Overall Study|Lost to Follow-up|10|||
164390245|NCT03930745|593796389|FG001|Overall Study|Lost to Follow-up|5|||
164390246|NCT03930745|593796388|FG000|Overall Study|Withdrawal by Subject|1|||
164390247|NCT03930745|593796389|FG001|Overall Study|Withdrawal by Subject|2|||
164390248|NCT03930745|593796388|FG000|Overall Study|Protocol Violation|2|||
164390249|NCT03930745|593796389|FG001|Overall Study|Protocol Violation|2|||
164390250|NCT03930745|593796388|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
164390251|NCT03930745|593796389|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
164390252|NCT03930745|593796388|FG000|Overall Study|Adverse Event|0|||
164390253|NCT03930745|593796389|FG001|Overall Study|Adverse Event|1|||
164390254|NCT03930745|593796388|FG000|Overall Study|Pregnancy|0|||
164390255|NCT03930745|593796389|FG001|Overall Study|Pregnancy|1|||
164390256|NCT02715765|593796392|FG000|Overall Study|Study Termination|3|||
164390257|NCT02715765|593796393|FG001|Overall Study|Study Termination|0|||
164390258|NCT02715765|593796394|FG002|Overall Study|Study Termination|0|||
164390259|NCT03588572|593796395|FG000|Visitation 1|Lack of Efficacy|1|||
164390260|NCT03588572|593796396|FG001|Visitation 1|Lack of Efficacy|1|||
164390261|NCT03588572|593796395|FG000|Visitation 2|Lost to Follow-up|1|||
164390262|NCT03588572|593796396|FG001|Visitation 2|Lost to Follow-up|1|||
164390263|NCT03588572|593796395|FG000|Visitation 2|Lack of Efficacy|0|||
164390264|NCT03588572|593796396|FG001|Visitation 2|Lack of Efficacy|1|||
164390265|NCT03588572|593796395|FG000|Visitation 2|Withdrawal by Subject|1|||
164390266|NCT03588572|593796396|FG001|Visitation 2|Withdrawal by Subject|0|||
164390267|NCT03588572|593796395|FG000|Visitation 3|Lost to Follow-up|1|||
164390268|NCT03588572|593796396|FG001|Visitation 3|Lost to Follow-up|1|||
164390269|NCT03588572|593796395|FG000|Visitation 3|Physician Decision|1|||
164390270|NCT03588572|593796396|FG001|Visitation 3|Physician Decision|1|||
164390271|NCT03588572|593796395|FG000|Visitation 3|Withdrawal by Subject|1|||
164016090|NCT00365716|592421823|FG005|Extension 1|Lost to Follow-up|1|||
164016091|NCT00365716|592421824|FG006|Extension 1|Lost to Follow-up|0|||
164016092|NCT00365716|592421818|FG000|Extension 1|Other|0|||
164390272|NCT03588572|593796396|FG001|Visitation 3|Withdrawal by Subject|0|||
164390273|NCT01165281|593796402|FG000|Overall Study|Adverse Event|12|||
164390274|NCT01165281|593796403|FG001|Overall Study|Adverse Event|14|||
164016093|NCT00365716|592421819|FG001|Extension 1|Other|0|||
164390275|NCT01165281|593796402|FG000|Overall Study|Death|3|||
164390276|NCT01165281|593796403|FG001|Overall Study|Death|4|||
164390277|NCT01165281|593796402|FG000|Overall Study|Lack of Efficacy|4|||
164390278|NCT01165281|593796403|FG001|Overall Study|Lack of Efficacy|1|||
164390279|NCT01165281|593796402|FG000|Overall Study|Lost to Follow-up|0|||
164390280|NCT01165281|593796403|FG001|Overall Study|Lost to Follow-up|1|||
164016094|NCT00365716|592421820|FG002|Extension 1|Other|0|||
164390281|NCT01165281|593796402|FG000|Overall Study|Physician Decision|8|||
164390282|NCT01165281|593796403|FG001|Overall Study|Physician Decision|1|||
164390283|NCT01165281|593796402|FG000|Overall Study|Protocol Violation|6|||
164390284|NCT01165281|593796403|FG001|Overall Study|Protocol Violation|5|||
164390285|NCT01165281|593796402|FG000|Overall Study|Withdrawal by Subject|8|||
164390286|NCT01165281|593796403|FG001|Overall Study|Withdrawal by Subject|7|||
164390287|NCT01165281|593796402|FG000|Overall Study|Noncompliance with Study Drug|1|||
164390288|NCT01165281|593796403|FG001|Overall Study|Noncompliance with Study Drug|4|||
164390289|NCT01165281|593796402|FG000|Overall Study|Progressive Disease|10|||
164390290|NCT01165281|593796403|FG001|Overall Study|Progressive Disease|14|||
164390291|NCT01165281|593796402|FG000|Overall Study|Other|6|||
164390292|NCT01165281|593796403|FG001|Overall Study|Other|0|||
164390293|NCT02863991|593796406|FG000|Overall Study|Death|0|||
164390294|NCT02863991|593796407|FG001|Overall Study|Death|3|||
164390295|NCT02863991|593796406|FG000|Overall Study|Lack of Efficacy|0|||
164390296|NCT02863991|593796407|FG001|Overall Study|Lack of Efficacy|1|||
164390297|NCT02863991|593796406|FG000|Overall Study|Study Terminated|2|||
164390298|NCT02863991|593796407|FG001|Overall Study|Study Terminated|8|||
164390299|NCT03277313|593796408|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
164390300|NCT03277313|593796409|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
164390301|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
164390302|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
164390303|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
164390304|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
164390305|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
164390306|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
164390307|NCT03277313|593796408|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
164390308|NCT03277313|593796409|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
164390309|NCT00364858|593796410|FG000|Overall Study|Adverse Event|1|||
164390310|NCT00364858|593796411|FG001|Overall Study|Adverse Event|5|||
164390311|NCT00364858|593796410|FG000|Overall Study|Withdrawal by Subject|1|||
164390312|NCT00364858|593796411|FG001|Overall Study|Withdrawal by Subject|1|||
164390313|NCT00364858|593796410|FG000|Overall Study|Pregnancy|1|||
164390314|NCT00364858|593796411|FG001|Overall Study|Pregnancy|1|||
164390315|NCT00364858|593796410|FG000|Overall Study|Clinical failure|2|||
164390316|NCT00364858|593796411|FG001|Overall Study|Clinical failure|13|||
164390317|NCT00364858|593796410|FG000|Overall Study|Discontinuation at baseline|1|||
164390318|NCT00364858|593796411|FG001|Overall Study|Discontinuation at baseline|0|||
164390319|NCT00364858|593796410|FG000|Overall Study|Non-compliant|1|||
164390320|NCT00364858|593796411|FG001|Overall Study|Non-compliant|0|||
164390321|NCT00364858|593796410|FG000|Overall Study|Return to Q2 regimen|0|||
164390322|NCT00364858|593796411|FG001|Overall Study|Return to Q2 regimen|1|||
164390323|NCT00364858|593796410|FG000|Overall Study|Clinical baseline issue|0|||
164390324|NCT00364858|593796411|FG001|Overall Study|Clinical baseline issue|1|||
164390325|NCT00363766|593796412|FG000|Overall Study|Progressive Disease|15|||
164390326|NCT00363766|593796413|FG001|Overall Study|Progressive Disease|9|||
164390327|NCT00363766|593796412|FG000|Overall Study|Adverse Event|10|||
164390328|NCT00363766|593796413|FG001|Overall Study|Adverse Event|2|||
164390329|NCT00363766|593796412|FG000|Overall Study|Disease Related Death|1|||
164390330|NCT00363766|593796413|FG001|Overall Study|Disease Related Death|3|||
164390331|NCT00363766|593796412|FG000|Overall Study|Not Disease Related Death|3|||
164390332|NCT00363766|593796413|FG001|Overall Study|Not Disease Related Death|4|||
164390333|NCT00363766|593796412|FG000|Overall Study|Withdrawal by Subject|2|||
164390334|NCT00363766|593796413|FG001|Overall Study|Withdrawal by Subject|0|||
164390335|NCT00363766|593796412|FG000|Overall Study|Physician Decision|1|||
164390336|NCT00363766|593796413|FG001|Overall Study|Physician Decision|2|||
164390337|NCT00558285|593796414|FG000|Overall Study|Adverse Event|1|||
163905017|NCT00195819|592023730|FG000|Open-label|Adverse Event|0|||
164390338|NCT00558285|593796415|FG001|Overall Study|Adverse Event|1|||
164390339|NCT00558285|593796416|FG002|Overall Study|Adverse Event|4|||
163905018|NCT00195819|592023731|FG001|Open-label|Adverse Event|9|||
164390340|NCT00558285|593796417|FG003|Overall Study|Adverse Event|1|||
164390341|NCT00558285|593796418|FG004|Overall Study|Adverse Event|2|||
163905019|NCT00195819|592023730|FG000|Open-label|Lack of Efficacy|0|||
164390342|NCT00558285|593796414|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164390343|NCT00558285|593796415|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164390344|NCT00558285|593796416|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164390345|NCT00558285|593796417|FG003|Overall Study|Abnormal test procedure result(s)|0|||
164390346|NCT00558285|593796418|FG004|Overall Study|Abnormal test procedure result(s)|0|||
164390347|NCT00558285|593796414|FG000|Overall Study|Subject withdrew consent|2|||
164390348|NCT00558285|593796415|FG001|Overall Study|Subject withdrew consent|0|||
164390349|NCT00558285|593796416|FG002|Overall Study|Subject withdrew consent|1|||
164390350|NCT00558285|593796417|FG003|Overall Study|Subject withdrew consent|1|||
164390351|NCT00558285|593796418|FG004|Overall Study|Subject withdrew consent|1|||
164390352|NCT00558285|593796414|FG000|Overall Study|Lost to Follow-up|1|||
164390353|NCT00558285|593796415|FG001|Overall Study|Lost to Follow-up|1|||
164390354|NCT00558285|593796416|FG002|Overall Study|Lost to Follow-up|0|||
164390355|NCT00558285|593796417|FG003|Overall Study|Lost to Follow-up|0|||
164390356|NCT00558285|593796418|FG004|Overall Study|Lost to Follow-up|0|||
164390357|NCT00558285|593796414|FG000|Overall Study|Administrative problems|0|||
164390358|NCT00558285|593796415|FG001|Overall Study|Administrative problems|0|||
164390359|NCT00558285|593796416|FG002|Overall Study|Administrative problems|0|||
164390360|NCT00558285|593796417|FG003|Overall Study|Administrative problems|1|||
164390361|NCT00558285|593796418|FG004|Overall Study|Administrative problems|1|||
164390362|NCT00558285|593796414|FG000|Overall Study|Protocol deviation|1|||
164390363|NCT00558285|593796415|FG001|Overall Study|Protocol deviation|1|||
164390364|NCT00558285|593796416|FG002|Overall Study|Protocol deviation|0|||
164390365|NCT00558285|593796417|FG003|Overall Study|Protocol deviation|1|||
164390366|NCT00558285|593796418|FG004|Overall Study|Protocol deviation|0|||
164390367|NCT02345512|593796419|FG000|Overall Study|Adverse Event|1|||
164390368|NCT02345512|593796419|FG000|Overall Study|Withdrawal by Subject|1|||
164390369|NCT01660906|593796420|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
164390370|NCT02121847|593796421|FG000|Overall Study|Administrative Reasons|1|||
164390371|NCT02121847|593796421|FG000|Overall Study|Adverse Event|2|||
164390372|NCT03478891|593796429|FG000|Overall Study|Enrolled, but product never administered|0|||
164390373|NCT03478891|593796430|FG001|Overall Study|Enrolled, but product never administered|0|||
164390374|NCT03478891|593796431|FG002|Overall Study|Enrolled, but product never administered|1|||
164390375|NCT03478891|593796429|FG000|Overall Study|Moved from area|0|||
164390376|NCT03478891|593796430|FG001|Overall Study|Moved from area|0|||
164390377|NCT03478891|593796431|FG002|Overall Study|Moved from area|1|||
164390378|NCT03478891|593796429|FG000|Overall Study|Lost to Follow-up|1|||
164390379|NCT03478891|593796430|FG001|Overall Study|Lost to Follow-up|0|||
164390380|NCT03478891|593796431|FG002|Overall Study|Lost to Follow-up|1|||
164390381|NCT03823651|593796437|FG000|Overall Study|Death|5|||
164390382|NCT03823651|593796438|FG001|Overall Study|Death|0|||
164390383|NCT03823651|593796437|FG000|Overall Study|Physician Decision|1|||
164390384|NCT03823651|593796438|FG001|Overall Study|Physician Decision|0|||
164390385|NCT03823651|593796437|FG000|Overall Study|Caregiver to patient who died|0|||
164390386|NCT03823651|593796438|FG001|Overall Study|Caregiver to patient who died|5|||
164390387|NCT03823651|593796437|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
164390388|NCT03823651|593796438|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
164390389|NCT03864614|593796442|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
164390390|NCT03864614|593796443|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
164390391|NCT03864614|593796444|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
164390392|NCT03864614|593796445|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
164390393|NCT03864614|593796442|FG000|Overall Study|Withdrawal by Subject|72|||
164390394|NCT03864614|593796443|FG001|Overall Study|Withdrawal by Subject|100|||
164390395|NCT03864614|593796444|FG002|Overall Study|Withdrawal by Subject|1|||
164390396|NCT03864614|593796445|FG003|Overall Study|Withdrawal by Subject|21|||
164390397|NCT03864614|593796442|FG000|Overall Study|Lost to Follow-up|45|||
164390398|NCT03864614|593796443|FG001|Overall Study|Lost to Follow-up|54|||
164390399|NCT03864614|593796444|FG002|Overall Study|Lost to Follow-up|0|||
164390400|NCT03864614|593796445|FG003|Overall Study|Lost to Follow-up|9|||
164390401|NCT03864614|593796442|FG000|Overall Study|Adverse Event|42|||
164390402|NCT03864614|593796443|FG001|Overall Study|Adverse Event|30|||
164390403|NCT03864614|593796444|FG002|Overall Study|Adverse Event|1|||
164390404|NCT03864614|593796445|FG003|Overall Study|Adverse Event|9|||
164390405|NCT03864614|593796442|FG000|Overall Study|Protocol Deviation|6|||
164390406|NCT03864614|593796443|FG001|Overall Study|Protocol Deviation|26|||
164390407|NCT03864614|593796444|FG002|Overall Study|Protocol Deviation|0|||
164390408|NCT03864614|593796445|FG003|Overall Study|Protocol Deviation|1|||
164390409|NCT03864614|593796442|FG000|Overall Study|Physician Decision|7|||
164390410|NCT03864614|593796443|FG001|Overall Study|Physician Decision|10|||
163905020|NCT00195819|592023731|FG001|Open-label|Lack of Efficacy|2|||
164390411|NCT03864614|593796444|FG002|Overall Study|Physician Decision|1|||
164390412|NCT03864614|593796445|FG003|Overall Study|Physician Decision|5|||
164390413|NCT03864614|593796442|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
164390414|NCT03864614|593796443|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
164390415|NCT03864614|593796444|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
164390416|NCT03864614|593796445|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
164390417|NCT03864614|593796442|FG000|Overall Study|Sponsor Decision|1|||
164390418|NCT03864614|593796443|FG001|Overall Study|Sponsor Decision|2|||
164390419|NCT03864614|593796444|FG002|Overall Study|Sponsor Decision|0|||
164390420|NCT03864614|593796445|FG003|Overall Study|Sponsor Decision|0|||
164390421|NCT03864614|593796442|FG000|Overall Study|Pregnancy|0|||
164390422|NCT03864614|593796443|FG001|Overall Study|Pregnancy|1|||
164390423|NCT03864614|593796444|FG002|Overall Study|Pregnancy|0|||
164390424|NCT03864614|593796445|FG003|Overall Study|Pregnancy|0|||
164390425|NCT03864614|593796442|FG000|Overall Study|Other|7|||
164390426|NCT03864614|593796443|FG001|Overall Study|Other|9|||
164390427|NCT03864614|593796444|FG002|Overall Study|Other|1|||
164390428|NCT03864614|593796445|FG003|Overall Study|Other|4|||
164390429|NCT03864614|593796442|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
164390430|NCT03864614|593796443|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
164390431|NCT03864614|593796444|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
164390432|NCT03864614|593796445|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
164390433|NCT01912612|593798875|FG000|Overall Study|Adverse Event|4|||
164390434|NCT01912612|593798876|FG001|Overall Study|Adverse Event|0|||
164390435|NCT01912612|593798877|FG002|Overall Study|Adverse Event|0|||
164390436|NCT01912612|593798875|FG000|Overall Study|Withdrew consent|1|||
164390437|NCT01912612|593798876|FG001|Overall Study|Withdrew consent|0|||
164390438|NCT01912612|593798877|FG002|Overall Study|Withdrew consent|0|||
164390439|NCT01912612|593798875|FG000|Overall Study|Study design change|0|||
164390440|NCT01912612|593798876|FG001|Overall Study|Study design change|0|||
163905021|NCT00195819|592023730|FG000|Open-label|Pregnancy|0|||
163905022|NCT00195819|592023731|FG001|Open-label|Pregnancy|1|||
163905023|NCT00195819|592023730|FG000|Open-label|Protocol Violation|0|||
163905024|NCT00195819|592023731|FG001|Open-label|Protocol Violation|2|||
164390441|NCT01912612|593798877|FG002|Overall Study|Study design change|3|||
164390442|NCT01588184|593798878|FG000|Overall Study|Death|1|||
164390443|NCT01588184|593798879|FG001|Overall Study|Death|0|||
164390444|NCT01588184|593798880|FG002|Overall Study|Death|0|||
164390445|NCT01588184|593798881|FG003|Overall Study|Death|1|||
164390446|NCT01588184|593798882|FG004|Overall Study|Death|1|||
164390447|NCT01588184|593798883|FG005|Overall Study|Death|1|||
164390448|NCT01588184|593798878|FG000|Overall Study|Withdrawal by Subject|2|||
164390449|NCT01588184|593798879|FG001|Overall Study|Withdrawal by Subject|4|||
164390450|NCT01588184|593798880|FG002|Overall Study|Withdrawal by Subject|0|||
164390451|NCT01588184|593798881|FG003|Overall Study|Withdrawal by Subject|1|||
164390452|NCT01588184|593798882|FG004|Overall Study|Withdrawal by Subject|0|||
164390453|NCT01588184|593798883|FG005|Overall Study|Withdrawal by Subject|0|||
164390454|NCT01588184|593798878|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
164390455|NCT01588184|593798879|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
164390456|NCT01588184|593798880|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
164390457|NCT01588184|593798881|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
164390458|NCT01588184|593798882|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
164390459|NCT01588184|593798883|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
164390460|NCT01588184|593798878|FG000|Overall Study|multiple reasons|0|||
164390461|NCT01588184|593798879|FG001|Overall Study|multiple reasons|3|||
164390462|NCT01588184|593798880|FG002|Overall Study|multiple reasons|0|||
164390463|NCT01588184|593798881|FG003|Overall Study|multiple reasons|1|||
164390464|NCT01588184|593798882|FG004|Overall Study|multiple reasons|0|||
164390465|NCT01588184|593798883|FG005|Overall Study|multiple reasons|0|||
163905025|NCT00195819|592023730|FG000|Open-label|Moved|0|||
163905026|NCT00195819|592023731|FG001|Open-label|Moved|1|||
164390466|NCT01983293|593798887|FG000|Overall Study|Withdrawal by Subject|29|||
164390467|NCT01983293|593798888|FG001|Overall Study|Withdrawal by Subject|15|||
164390468|NCT01983293|593798887|FG000|Overall Study|Missing 12-month visit|3|||
164390469|NCT01983293|593798888|FG001|Overall Study|Missing 12-month visit|3|||
164390470|NCT01983293|593798887|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
164390471|NCT01983293|593798888|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
164390472|NCT03147248|593798889|FG000|Overall Study|Adverse Event|0|||
164390473|NCT03147248|593798890|FG001|Overall Study|Adverse Event|2|||
163905027|NCT00195819|592023730|FG000|Open-label|Withdrawal by Subject|0|||
163905028|NCT00195819|592023731|FG001|Open-label|Withdrawal by Subject|5|||
164390474|NCT03147248|593798891|FG002|Overall Study|Adverse Event|2|||
164390475|NCT03147248|593798892|FG003|Overall Study|Adverse Event|2|||
164390476|NCT03147248|593798893|FG004|Overall Study|Adverse Event|6|||
164390477|NCT03147248|593798894|FG005|Overall Study|Adverse Event|11|||
164390478|NCT03147248|593798889|FG000|Overall Study|Disease progression|1|||
164390479|NCT03147248|593798890|FG001|Overall Study|Disease progression|0|||
164390480|NCT03147248|593798891|FG002|Overall Study|Disease progression|0|||
164390481|NCT03147248|593798892|FG003|Overall Study|Disease progression|0|||
164390482|NCT03147248|593798893|FG004|Overall Study|Disease progression|0|||
164390483|NCT03147248|593798894|FG005|Overall Study|Disease progression|2|||
164390484|NCT03147248|593798889|FG000|Overall Study|Withdrawal by Subject|0|||
164390485|NCT03147248|593798890|FG001|Overall Study|Withdrawal by Subject|0|||
164390486|NCT03147248|593798891|FG002|Overall Study|Withdrawal by Subject|0|||
164390487|NCT03147248|593798892|FG003|Overall Study|Withdrawal by Subject|0|||
164390488|NCT03147248|593798893|FG004|Overall Study|Withdrawal by Subject|12|||
164390489|NCT03147248|593798894|FG005|Overall Study|Withdrawal by Subject|9|||
164390490|NCT03147248|593798889|FG000|Overall Study|Protocol Violation|0|||
164390491|NCT03147248|593798890|FG001|Overall Study|Protocol Violation|0|||
164390492|NCT03147248|593798891|FG002|Overall Study|Protocol Violation|0|||
164390493|NCT03147248|593798892|FG003|Overall Study|Protocol Violation|0|||
164390494|NCT03147248|593798893|FG004|Overall Study|Protocol Violation|2|||
164390495|NCT03147248|593798894|FG005|Overall Study|Protocol Violation|0|||
164390496|NCT03147248|593798889|FG000|Overall Study|Lost to Follow-up|0|||
164390497|NCT03147248|593798890|FG001|Overall Study|Lost to Follow-up|0|||
164390498|NCT03147248|593798891|FG002|Overall Study|Lost to Follow-up|0|||
164390499|NCT03147248|593798892|FG003|Overall Study|Lost to Follow-up|0|||
164390500|NCT03147248|593798893|FG004|Overall Study|Lost to Follow-up|2|||
164390501|NCT03147248|593798894|FG005|Overall Study|Lost to Follow-up|0|||
164390502|NCT03147248|593798889|FG000|Overall Study|Pregnancy|0|||
164390503|NCT03147248|593798890|FG001|Overall Study|Pregnancy|0|||
164390504|NCT03147248|593798891|FG002|Overall Study|Pregnancy|0|||
164390505|NCT03147248|593798892|FG003|Overall Study|Pregnancy|0|||
164390506|NCT03147248|593798893|FG004|Overall Study|Pregnancy|1|||
164390507|NCT03147248|593798894|FG005|Overall Study|Pregnancy|0|||
164390508|NCT03147248|593798889|FG000|Overall Study|Death|0|||
164390509|NCT03147248|593798890|FG001|Overall Study|Death|0|||
164390510|NCT03147248|593798891|FG002|Overall Study|Death|0|||
164390511|NCT03147248|593798892|FG003|Overall Study|Death|0|||
164390512|NCT03147248|593798893|FG004|Overall Study|Death|0|||
164390513|NCT03147248|593798894|FG005|Overall Study|Death|4|||
164390514|NCT03147248|593798889|FG000|Overall Study|Physician Decision|0|||
164016095|NCT00365716|592421821|FG003|Extension 1|Other|0|||
164016096|NCT00365716|592421822|FG004|Extension 1|Other|0|||
164016097|NCT00365716|592421823|FG005|Extension 1|Other|9|||
164016098|NCT00365716|592421824|FG006|Extension 1|Other|0|||
164016099|NCT00365716|592421818|FG000|Extension 1|Moved|0|||
164016100|NCT00365716|592421819|FG001|Extension 1|Moved|0|||
164016101|NCT00365716|592421820|FG002|Extension 1|Moved|0|||
164016102|NCT00365716|592421821|FG003|Extension 1|Moved|0|||
164016103|NCT00365716|592421822|FG004|Extension 1|Moved|0|||
164390515|NCT03147248|593798890|FG001|Overall Study|Physician Decision|0|||
164016104|NCT00365716|592421823|FG005|Extension 1|Moved|4|||
164016105|NCT00365716|592421824|FG006|Extension 1|Moved|0|||
164390516|NCT03147248|593798891|FG002|Overall Study|Physician Decision|0|||
164390517|NCT03147248|593798892|FG003|Overall Study|Physician Decision|0|||
164390518|NCT03147248|593798893|FG004|Overall Study|Physician Decision|2|||
164390519|NCT03147248|593798894|FG005|Overall Study|Physician Decision|4|||
164390520|NCT03147248|593798889|FG000|Overall Study|Prolonged Dosing Interval|0|||
164390521|NCT03147248|593798890|FG001|Overall Study|Prolonged Dosing Interval|0|||
164390522|NCT03147248|593798891|FG002|Overall Study|Prolonged Dosing Interval|0|||
164390523|NCT03147248|593798892|FG003|Overall Study|Prolonged Dosing Interval|0|||
164390524|NCT03147248|593798893|FG004|Overall Study|Prolonged Dosing Interval|1|||
164390525|NCT03147248|593798894|FG005|Overall Study|Prolonged Dosing Interval|1|||
164390526|NCT03750552|593798895|FG000|Overall Study|Adverse Event|5|||
164016106|NCT00365716|592421818|FG000|Extension 1|Withdrawal by Subject|0|||
164016107|NCT00365716|592421819|FG001|Extension 1|Withdrawal by Subject|0|||
164016108|NCT00365716|592421820|FG002|Extension 1|Withdrawal by Subject|0|||
164016109|NCT00365716|592421821|FG003|Extension 1|Withdrawal by Subject|0|||
164390527|NCT03750552|593798896|FG001|Overall Study|Adverse Event|1|||
164390528|NCT03750552|593798895|FG000|Overall Study|Withdrawal by Subject|1|||
164016110|NCT00365716|592421822|FG004|Extension 1|Withdrawal by Subject|0|||
164016111|NCT00365716|592421823|FG005|Extension 1|Withdrawal by Subject|3|||
164016112|NCT00365716|592421824|FG006|Extension 1|Withdrawal by Subject|0|||
164016113|NCT00365716|592421818|FG000|Extension 1|Pregnancy|0|||
164016114|NCT00365716|592421819|FG001|Extension 1|Pregnancy|0|||
164016115|NCT00365716|592421820|FG002|Extension 1|Pregnancy|0|||
164016116|NCT00365716|592421821|FG003|Extension 1|Pregnancy|0|||
164016117|NCT00365716|592421822|FG004|Extension 1|Pregnancy|0|||
164016118|NCT00365716|592421823|FG005|Extension 1|Pregnancy|4|||
164390529|NCT03750552|593798896|FG001|Overall Study|Withdrawal by Subject|1|||
164390530|NCT03750552|593798895|FG000|Overall Study|Other|2|||
164390531|NCT03750552|593798896|FG001|Overall Study|Other|0|||
164390532|NCT02062632|593798897|FG000|Overall Study|No treatment data|1|||
164390533|NCT00773968|593798900|FG000|Overall Study|Adverse Event|2|||
164390534|NCT00773968|593798900|FG000|Overall Study|Death|1|||
164390535|NCT00773968|593798900|FG000|Overall Study|Failure to Return|2|||
164390536|NCT00773968|593798900|FG000|Overall Study|Lack of Efficacy|3|||
164390537|NCT00773968|593798900|FG000|Overall Study|Protocol Violation|1|||
164390538|NCT00773968|593798900|FG000|Overall Study|Withdrawal by Subject|11|||
164390539|NCT00773968|593798900|FG000|Overall Study|Screen Failure|17|||
164390540|NCT00773968|593798900|FG000|Overall Study|Other|8|||
164390541|NCT02008890|593798903|FG000|Period 1|Withdrawal by Subject|7|||
164390542|NCT02008890|593798904|FG001|Period 1|Withdrawal by Subject|7|||
164390543|NCT02008890|593798905|FG002|Period 1|Withdrawal by Subject|5|||
164390544|NCT02008890|593798906|FG003|Period 1|Withdrawal by Subject|0|||
164390545|NCT02008890|593798907|FG004|Period 1|Withdrawal by Subject|0|||
164390546|NCT02008890|593798903|FG000|Period 1|Pregnancy|1|||
164390547|NCT02008890|593798904|FG001|Period 1|Pregnancy|0|||
164390548|NCT02008890|593798905|FG002|Period 1|Pregnancy|0|||
164390549|NCT02008890|593798906|FG003|Period 1|Pregnancy|0|||
164390550|NCT02008890|593798907|FG004|Period 1|Pregnancy|0|||
164390551|NCT02008890|593798903|FG000|Period 1|Physician Decision|1|||
164390552|NCT02008890|593798904|FG001|Period 1|Physician Decision|0|||
164390553|NCT02008890|593798905|FG002|Period 1|Physician Decision|1|||
164390554|NCT02008890|593798906|FG003|Period 1|Physician Decision|0|||
164390555|NCT02008890|593798907|FG004|Period 1|Physician Decision|0|||
164390556|NCT02008890|593798903|FG000|Period 1|Adverse Event|6|||
164390557|NCT02008890|593798904|FG001|Period 1|Adverse Event|8|||
164390558|NCT02008890|593798905|FG002|Period 1|Adverse Event|6|||
164390559|NCT02008890|593798906|FG003|Period 1|Adverse Event|0|||
164390560|NCT02008890|593798907|FG004|Period 1|Adverse Event|0|||
164390561|NCT02008890|593798903|FG000|Period 2|Adverse Event|12|||
164390562|NCT02008890|593798904|FG001|Period 2|Adverse Event|7|||
164390563|NCT02008890|593798905|FG002|Period 2|Adverse Event|0|||
164390564|NCT02008890|593798906|FG003|Period 2|Adverse Event|5|||
164390565|NCT02008890|593798907|FG004|Period 2|Adverse Event|5|||
164390566|NCT02008890|593798903|FG000|Period 2|Withdrawal by Subject|11|||
164390567|NCT02008890|593798904|FG001|Period 2|Withdrawal by Subject|8|||
164390568|NCT02008890|593798905|FG002|Period 2|Withdrawal by Subject|0|||
164390569|NCT02008890|593798906|FG003|Period 2|Withdrawal by Subject|7|||
164390570|NCT02008890|593798907|FG004|Period 2|Withdrawal by Subject|2|||
164390571|NCT02008890|593798903|FG000|Period 2|Physician Decision|4|||
164390572|NCT02008890|593798904|FG001|Period 2|Physician Decision|0|||
164390573|NCT02008890|593798905|FG002|Period 2|Physician Decision|0|||
164390574|NCT02008890|593798906|FG003|Period 2|Physician Decision|2|||
164390575|NCT02008890|593798907|FG004|Period 2|Physician Decision|1|||
164390576|NCT02008890|593798903|FG000|Period 2|Lost to Follow-up|0|||
164390577|NCT02008890|593798904|FG001|Period 2|Lost to Follow-up|0|||
164390578|NCT02008890|593798905|FG002|Period 2|Lost to Follow-up|1|||
164390579|NCT02008890|593798906|FG003|Period 2|Lost to Follow-up|0|||
164390580|NCT02008890|593798907|FG004|Period 2|Lost to Follow-up|0|||
164390581|NCT02008890|593798903|FG000|Extension Period|Withdrawal by Subject|3|||
164390582|NCT02008890|593798904|FG001|Extension Period|Withdrawal by Subject|2|||
164390583|NCT02008890|593798905|FG002|Extension Period|Withdrawal by Subject|0|||
164390584|NCT02008890|593798906|FG003|Extension Period|Withdrawal by Subject|4|||
164016119|NCT00365716|592421824|FG006|Extension 1|Pregnancy|0|||
164016120|NCT00365716|592421818|FG000|Extension 1|Protocol Violation|0|||
164016121|NCT00365716|592421819|FG001|Extension 1|Protocol Violation|0|||
164390585|NCT02008890|593798907|FG004|Extension Period|Withdrawal by Subject|2|||
164390586|NCT02008890|593798903|FG000|Extension Period|Lost to Follow-up|1|||
164390587|NCT02008890|593798904|FG001|Extension Period|Lost to Follow-up|0|||
164390588|NCT02008890|593798905|FG002|Extension Period|Lost to Follow-up|0|||
164390589|NCT02008890|593798906|FG003|Extension Period|Lost to Follow-up|0|||
164016122|NCT00365716|592421820|FG002|Extension 1|Protocol Violation|0|||
164390590|NCT02008890|593798907|FG004|Extension Period|Lost to Follow-up|0|||
164390591|NCT02008890|593798903|FG000|Extension Period|Adverse Event|1|||
164390592|NCT02008890|593798904|FG001|Extension Period|Adverse Event|3|||
164390593|NCT02008890|593798905|FG002|Extension Period|Adverse Event|0|||
164390594|NCT02008890|593798906|FG003|Extension Period|Adverse Event|0|||
164390595|NCT02008890|593798907|FG004|Extension Period|Adverse Event|2|||
164390596|NCT02207816|593798908|FG000|Overall Study|Serious Adverse Event|0|||
164390597|NCT02207816|593798909|FG001|Overall Study|Serious Adverse Event|5|||
164390598|NCT02207816|593798910|FG002|Overall Study|Serious Adverse Event|2|||
164390599|NCT02207816|593798908|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164390600|NCT02207816|593798909|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
164390601|NCT02207816|593798910|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164390602|NCT02207816|593798908|FG000|Overall Study|Withdrawal by Subject|4|||
164390603|NCT02207816|593798909|FG001|Overall Study|Withdrawal by Subject|9|||
164390604|NCT02207816|593798910|FG002|Overall Study|Withdrawal by Subject|7|||
164390605|NCT02207816|593798908|FG000|Overall Study|Migrated/Moved From Study Area|41|||
164390606|NCT02207816|593798909|FG001|Overall Study|Migrated/Moved From Study Area|60|||
164390607|NCT02207816|593798910|FG002|Overall Study|Migrated/Moved From Study Area|51|||
164390608|NCT02207816|593798908|FG000|Overall Study|Lost to Follow-up|3|||
164390609|NCT02207816|593798909|FG001|Overall Study|Lost to Follow-up|9|||
164390610|NCT02207816|593798910|FG002|Overall Study|Lost to Follow-up|1|||
164390611|NCT02207816|593798908|FG000|Overall Study|Other|1|||
164390612|NCT02207816|593798909|FG001|Overall Study|Other|2|||
164390613|NCT02207816|593798910|FG002|Overall Study|Other|4|||
164390614|NCT02522494|593798911|FG000|Overall Study|Lost to Follow-up|6|||
164390615|NCT02522494|593798912|FG001|Overall Study|Lost to Follow-up|2|||
164390616|NCT02522494|593798911|FG000|Overall Study|Withdrawal by Subject|1|||
164390617|NCT02522494|593798912|FG001|Overall Study|Withdrawal by Subject|0|||
164390618|NCT02522494|593798911|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
164390619|NCT02522494|593798912|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
164390620|NCT02522494|593798911|FG000|Overall Study|Participant did not watch the video|1|||
164390621|NCT02522494|593798912|FG001|Overall Study|Participant did not watch the video|0|||
164390622|NCT02522494|593798911|FG000|Overall Study|Death|0|||
164390623|NCT02522494|593798912|FG001|Overall Study|Death|1|||
164390624|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
164390625|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
164390626|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
164390627|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390628|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390629|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390630|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390631|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390632|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390633|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390634|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390635|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390636|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390637|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
164390638|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
164390639|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
164390640|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
164390641|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390642|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390643|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390644|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390645|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390646|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390647|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390648|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390649|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390650|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390651|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
164390652|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
164390653|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
164390654|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
164390655|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390656|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390657|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
163905029|NCT00787176|592023732|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
163905030|NCT00787176|592023733|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
163905031|NCT00787176|592023734|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
164390658|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390659|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390660|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390661|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390662|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390663|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390664|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390665|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
164390666|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
164390667|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
164390668|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
164390669|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390670|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390671|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390672|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390673|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390674|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390675|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390676|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390677|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390678|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390679|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
164390680|NCT02349295|593798915|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390681|NCT02349295|593798916|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
164390682|NCT02349295|593798917|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
164390683|NCT02349295|593798918|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390684|NCT02349295|593798919|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390685|NCT02349295|593798920|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390686|NCT02349295|593798921|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390687|NCT02349295|593798922|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390688|NCT02349295|593798923|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390689|NCT02349295|593798924|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390690|NCT02349295|593798925|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390691|NCT02349295|593798926|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390692|NCT02349295|593798927|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390693|NCT02349295|593798928|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
164390694|NCT02349295|593798915|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
164390695|NCT02349295|593798916|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
164390696|NCT02349295|593798917|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
164390697|NCT02349295|593798918|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
164390698|NCT02349295|593798919|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
164390699|NCT02349295|593798920|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
164390700|NCT02349295|593798921|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
164390701|NCT02349295|593798922|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
164390702|NCT02349295|593798923|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
164390703|NCT02349295|593798924|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
164390704|NCT02349295|593798925|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
164390705|NCT02349295|593798926|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
164390706|NCT02349295|593798927|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
164390707|NCT02349295|593798928|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
164390708|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390709|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390710|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390711|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390712|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390713|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390714|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390715|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
164390716|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
164390717|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
164390718|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
164390719|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390720|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390721|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
164390722|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390723|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390724|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390725|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390726|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390727|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390728|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390729|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
164390730|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
164390731|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
164390732|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
164390733|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390734|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390735|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
164390736|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390737|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390738|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390739|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390740|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390741|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390742|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390743|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
164390744|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390745|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
164390746|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390747|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390748|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390749|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
164390750|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
164390751|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
164390752|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
164093041|NCT00864097|592703460|FG003|Overall Study|Lost to Follow-up|1|||
164093042|NCT00864097|592703457|FG000|Overall Study|Withdrawal by Subject|15|||
164093043|NCT00864097|592703458|FG001|Overall Study|Withdrawal by Subject|11|||
164093044|NCT00864097|592703459|FG002|Overall Study|Withdrawal by Subject|11|||
164093045|NCT00864097|592703460|FG003|Overall Study|Withdrawal by Subject|12|||
164093046|NCT00864097|592703457|FG000|Overall Study|Protocol Violation|2|||
164093047|NCT00864097|592703458|FG001|Overall Study|Protocol Violation|1|||
164093048|NCT00864097|592703459|FG002|Overall Study|Protocol Violation|0|||
164093049|NCT00864097|592703460|FG003|Overall Study|Protocol Violation|1|||
164093050|NCT00864097|592703457|FG000|Overall Study|Terminated by sponsor|105|||
164093051|NCT00864097|592703458|FG001|Overall Study|Terminated by sponsor|112|||
164093052|NCT00864097|592703459|FG002|Overall Study|Terminated by sponsor|102|||
164093053|NCT00864097|592703460|FG003|Overall Study|Terminated by sponsor|99|||
164093054|NCT00864097|592703457|FG000|Overall Study|Randomized but not treated|2|||
164093055|NCT00864097|592703458|FG001|Overall Study|Randomized but not treated|0|||
164093056|NCT00864097|592703459|FG002|Overall Study|Randomized but not treated|1|||
164093057|NCT00864097|592703460|FG003|Overall Study|Randomized but not treated|0|||
164093058|NCT00864097|592703457|FG000|Overall Study|Other|0|||
164093059|NCT00864097|592703458|FG001|Overall Study|Other|0|||
164093060|NCT00864097|592703459|FG002|Overall Study|Other|0|||
164093061|NCT00864097|592703460|FG003|Overall Study|Other|1|||
164093062|NCT00927810|592703462|FG000|Overall Study|Withdrawal by Subject|0|||
164093063|NCT00927810|592703463|FG001|Overall Study|Withdrawal by Subject|3|||
164093064|NCT00927810|592703464|FG002|Overall Study|Withdrawal by Subject|0|||
164093065|NCT00927810|592703465|FG003|Overall Study|Withdrawal by Subject|1|||
164093066|NCT00927810|592703462|FG000|Overall Study|Lost to Follow-up|0|||
164093067|NCT00927810|592703463|FG001|Overall Study|Lost to Follow-up|2|||
164093068|NCT00927810|592703464|FG002|Overall Study|Lost to Follow-up|1|||
164093069|NCT00927810|592703465|FG003|Overall Study|Lost to Follow-up|1|||
164093070|NCT00927810|592703462|FG000|Overall Study|Death|0|||
164093071|NCT00927810|592703463|FG001|Overall Study|Death|2|||
164093072|NCT00927810|592703464|FG002|Overall Study|Death|0|||
164093073|NCT00927810|592703465|FG003|Overall Study|Death|0|||
164093074|NCT00927810|592703462|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164093075|NCT00927810|592703463|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164093076|NCT00927810|592703464|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164093077|NCT00927810|592703465|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164093078|NCT00320112|592703467|FG000|Overall Study|Lost to Follow-up|3|||
164093079|NCT00320112|592703468|FG001|Overall Study|Lost to Follow-up|4|||
164093080|NCT00320112|592703467|FG000|Overall Study|Withdrawal by Subject|3|||
164093081|NCT00320112|592703468|FG001|Overall Study|Withdrawal by Subject|0|||
164093082|NCT00320112|592703467|FG000|Overall Study|Death|2|||
164093083|NCT00320112|592703468|FG001|Overall Study|Death|1|||
164093084|NCT02899338|592703469|FG000|Overall Study|Adverse Event|1|||
164093085|NCT02899338|592703470|FG001|Overall Study|Adverse Event|2|||
164093086|NCT02899338|592703469|FG000|Overall Study|Withdrawal by Subject|2|||
164093087|NCT02899338|592703470|FG001|Overall Study|Withdrawal by Subject|0|||
164093088|NCT06179108|592703471|FG000|Overall Study|Withdrawal by Subject|16|||
164093089|NCT06179108|592703472|FG001|Overall Study|Withdrawal by Subject|19|||
164390753|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
164390754|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
164390755|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
164390756|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
164390757|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
164390758|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
164390759|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
164390760|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
164390761|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
164390762|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
164390763|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
164390764|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390765|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390766|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390767|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390768|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390769|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390770|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390771|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
164390772|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
164390773|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
164390774|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
164390775|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390776|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390777|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
164390778|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390779|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390780|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390781|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390782|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
163905032|NCT00787176|592023735|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
163905033|NCT01124045|592023736|FG000|Overall Study|Lost to Follow-up|0|||
164390783|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390784|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390785|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
164390786|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
164390787|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390788|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390789|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390790|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390791|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
164390792|NCT02349295|593798915|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390793|NCT02349295|593798916|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390794|NCT02349295|593798917|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390795|NCT02349295|593798918|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390796|NCT02349295|593798919|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390797|NCT02349295|593798920|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390798|NCT02349295|593798921|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390799|NCT02349295|593798922|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
164390800|NCT02349295|593798923|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
164390801|NCT02349295|593798924|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390802|NCT02349295|593798925|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390803|NCT02349295|593798926|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390804|NCT02349295|593798927|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390805|NCT02349295|593798928|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
164390806|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390807|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390808|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390809|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390810|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390811|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390812|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390813|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390814|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390815|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390816|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
164390817|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
164390818|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
164390819|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
164390820|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390821|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390822|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390823|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390824|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390825|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390826|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390827|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390828|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390829|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390830|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390831|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
164390832|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
164390833|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
164390834|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390835|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390836|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390837|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390838|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390839|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390840|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390841|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390842|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390843|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390844|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390845|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
164390846|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
164390847|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
164390848|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390849|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390850|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390851|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390852|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390853|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390854|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390855|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390856|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390857|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390858|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390859|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
164390860|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390861|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
164390862|NCT02349295|593798915|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390863|NCT02349295|593798916|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390864|NCT02349295|593798917|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390865|NCT02349295|593798918|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390866|NCT02349295|593798919|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390867|NCT02349295|593798920|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390868|NCT02349295|593798921|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390869|NCT02349295|593798922|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390870|NCT02349295|593798923|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390871|NCT02349295|593798924|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390872|NCT02349295|593798925|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390873|NCT02349295|593798926|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
164390874|NCT02349295|593798927|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390875|NCT02349295|593798928|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
164390876|NCT03240588|593798929|FG000|Overall Study|Death|3|||
164390877|NCT03240588|593798930|FG001|Overall Study|Death|0|||
164390878|NCT03240588|593798931|FG002|Overall Study|Death|0|||
164390879|NCT03240588|593798929|FG000|Overall Study|Adverse Event|5|||
164390880|NCT03240588|593798930|FG001|Overall Study|Adverse Event|4|||
164390881|NCT03240588|593798931|FG002|Overall Study|Adverse Event|0|||
164390882|NCT03240588|593798929|FG000|Overall Study|Lost to Follow-up|9|||
164390883|NCT03240588|593798930|FG001|Overall Study|Lost to Follow-up|4|||
164390884|NCT03240588|593798931|FG002|Overall Study|Lost to Follow-up|0|||
164390885|NCT03240588|593798929|FG000|Overall Study|Physician Decision|3|||
164390886|NCT03240588|593798930|FG001|Overall Study|Physician Decision|2|||
164390887|NCT03240588|593798931|FG002|Overall Study|Physician Decision|0|||
164390888|NCT03240588|593798929|FG000|Overall Study|Did not meet eligibility criteria|0|||
164390889|NCT03240588|593798930|FG001|Overall Study|Did not meet eligibility criteria|6|||
164390890|NCT03240588|593798931|FG002|Overall Study|Did not meet eligibility criteria|0|||
164390891|NCT03240588|593798929|FG000|Overall Study|No longer meets protocol criteria|12|||
164390892|NCT03240588|593798930|FG001|Overall Study|No longer meets protocol criteria|7|||
164390893|NCT03240588|593798931|FG002|Overall Study|No longer meets protocol criteria|0|||
164390894|NCT03240588|593798929|FG000|Overall Study|Withdrawal by Subject|60|||
164390895|NCT03240588|593798930|FG001|Overall Study|Withdrawal by Subject|52|||
164390896|NCT03240588|593798931|FG002|Overall Study|Withdrawal by Subject|7|||
164390897|NCT03240588|593798929|FG000|Overall Study|Other, additional details not available.|0|||
164390898|NCT03240588|593798930|FG001|Overall Study|Other, additional details not available.|12|||
164390899|NCT03240588|593798931|FG002|Overall Study|Other, additional details not available.|1|||
164390900|NCT03240588|593798929|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
164390901|NCT03240588|593798930|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
164390902|NCT03240588|593798931|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
164390903|NCT03240588|593798929|FG000|Overall Study|Closure of study|55|||
164390904|NCT03240588|593798930|FG001|Overall Study|Closure of study|3|||
164390905|NCT03240588|593798931|FG002|Overall Study|Closure of study|0|||
164390906|NCT03240588|593798929|FG000|Overall Study|Subject non-compliance|23|||
164390907|NCT03240588|593798930|FG001|Overall Study|Subject non-compliance|2|||
164390908|NCT03240588|593798931|FG002|Overall Study|Subject non-compliance|1|||
164390909|NCT03240588|593798929|FG000|Overall Study|Device Deficiency|1|||
164390910|NCT03240588|593798930|FG001|Overall Study|Device Deficiency|0|||
164390911|NCT03240588|593798931|FG002|Overall Study|Device Deficiency|0|||
164390912|NCT03240588|593798929|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
164390913|NCT03240588|593798930|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
164390914|NCT03240588|593798931|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
164390915|NCT01259713|593798935|FG000|Overall Study|Adverse Event|54|||
164390916|NCT01259713|593798936|FG001|Overall Study|Adverse Event|23|||
164390917|NCT01259713|593798935|FG000|Overall Study|Death Not Related to IFI|8|||
164390918|NCT01259713|593798936|FG001|Overall Study|Death Not Related to IFI|1|||
164016123|NCT00365716|592421821|FG003|Extension 1|Protocol Violation|0|||
164390919|NCT01259713|593798935|FG000|Overall Study|Investigators Discretion|14|||
164390920|NCT01259713|593798936|FG001|Overall Study|Investigators Discretion|6|||
164390921|NCT01259713|593798935|FG000|Overall Study|Lack of Efficacy|2|||
164390922|NCT01259713|593798936|FG001|Overall Study|Lack of Efficacy|0|||
164016124|NCT00365716|592421822|FG004|Extension 1|Protocol Violation|0|||
164390923|NCT01259713|593798935|FG000|Overall Study|Protocol Violation|5|||
163905034|NCT01124045|592023737|FG001|Overall Study|Lost to Follow-up|1|||
164390924|NCT01259713|593798936|FG001|Overall Study|Protocol Violation|4|||
164390925|NCT01259713|593798935|FG000|Overall Study|Subject Withdrew Consent|12|||
164390926|NCT01259713|593798936|FG001|Overall Study|Subject Withdrew Consent|7|||
164390927|NCT02091726|593798937|FG000|Overall Study|Lost to Follow-up|6|||
164390928|NCT06111742|593798944|FG000|Overall Study|Did not receive intervention|1|||
164390929|NCT06111742|593798945|FG001|Overall Study|Did not receive intervention|0|||
164390930|NCT06111742|593798946|FG002|Overall Study|Did not receive intervention|0|||
164390931|NCT06111742|593798944|FG000|Overall Study|Withdrawal by Subject|2|||
164390932|NCT06111742|593798945|FG001|Overall Study|Withdrawal by Subject|0|||
164390933|NCT06111742|593798946|FG002|Overall Study|Withdrawal by Subject|0|||
164390934|NCT03461003|593798947|FG000|Overall Study|Lost to Follow-up|2|||
164390935|NCT03461003|593798948|FG001|Overall Study|Lost to Follow-up|2|||
164390936|NCT03461003|593798947|FG000|Overall Study|Withdrawal by Subject|3|||
164390937|NCT03461003|593798948|FG001|Overall Study|Withdrawal by Subject|1|||
164390938|NCT01914926|593798949|FG000|Overall Study|Adverse Event|1|||
164390939|NCT01914926|593798950|FG001|Overall Study|Adverse Event|0|||
164390940|NCT01914926|593798949|FG000|Overall Study|uncooperative, agitated and removed|0|||
164390941|NCT01914926|593798950|FG001|Overall Study|uncooperative, agitated and removed|1|||
164390942|NCT00620750|593798958|FG000|Overall Study|Lost to Follow-up|25|||
164390943|NCT04477187|593798959|FG000|Overall Study|Lost to Follow-up|2|||
164390944|NCT00856856|593798964|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
164390945|NCT00856856|593798964|FG000|4-year Clinical Follow-up|Missed visit|1|||
164390946|NCT03073603|593798966|FG000|Overall Study|Noncompliance|3|||
164390947|NCT03073603|593798967|FG001|Overall Study|Noncompliance|1|||
164390948|NCT03073603|593798966|FG000|Overall Study|Adverse Event|5|||
164390949|NCT03073603|593798967|FG001|Overall Study|Adverse Event|3|||
164390950|NCT03073603|593798966|FG000|Overall Study|Physician Decision|1|||
164390951|NCT03073603|593798967|FG001|Overall Study|Physician Decision|2|||
164390952|NCT03073603|593798966|FG000|Overall Study|Required treatment not allowed by protocol|1|||
164390953|NCT03073603|593798967|FG001|Overall Study|Required treatment not allowed by protocol|0|||
164390954|NCT03073603|593798966|FG000|Overall Study|Financial or insurance-related|8|||
164390955|NCT03073603|593798967|FG001|Overall Study|Financial or insurance-related|0|||
164390956|NCT03073603|593798966|FG000|Overall Study|Withdrawal by Subject|0|||
164390957|NCT03073603|593798967|FG001|Overall Study|Withdrawal by Subject|1|||
164390958|NCT03073603|593798966|FG000|Overall Study|Discontinued DMT|4|||
164390959|NCT03073603|593798967|FG001|Overall Study|Discontinued DMT|0|||
164390960|NCT03073603|593798966|FG000|Overall Study|Restarted DMT|0|||
164390961|NCT03073603|593798967|FG001|Overall Study|Restarted DMT|1|||
164390962|NCT02473952|593798968|FG000|Overall Study|Adverse Event|2|||
163905035|NCT01124045|592023736|FG000|Overall Study|Physician Decision|0|||
163905036|NCT01124045|592023737|FG001|Overall Study|Physician Decision|2|||
163905037|NCT03298087|592023741|FG000|Overall Study|Withdrawal by Subject|4|||
163905038|NCT01079806|592023742|FG000|Day 1 to Week 96|Adverse Event|0|||
163905039|NCT01079806|592023743|FG001|Day 1 to Week 96|Adverse Event|3|||
164390963|NCT02473952|593798969|FG001|Overall Study|Adverse Event|2|||
164390964|NCT02473952|593798968|FG000|Overall Study|Withdrawal by Subject|0|||
163905040|NCT01079806|592023742|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
164390965|NCT02473952|593798969|FG001|Overall Study|Withdrawal by Subject|6|||
164390966|NCT00922428|593798970|FG000|Overall Study|retrospective/extremely implausible data|2|||
164390967|NCT00922428|593798970|FG000|Overall Study|no medication use or questionable use|13|||
164390968|NCT04757649|593798971|FG000|Overall Study|Withdrawal by Subject|1|||
164390969|NCT04757649|593798971|FG000|Overall Study|Adverse Event|1|||
164390970|NCT02862106|593798972|FG000|Overall Study|Adverse Event|4|||
164390971|NCT02862106|593798973|FG001|Overall Study|Adverse Event|0|||
164390972|NCT02862106|593798972|FG000|Overall Study|Protocol Violation|16|||
164390973|NCT02862106|593798973|FG001|Overall Study|Protocol Violation|1|||
164390974|NCT02862106|593798972|FG000|Overall Study|Lost to Follow-up|15|||
163905041|NCT01079806|592023743|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
164390975|NCT02862106|593798973|FG001|Overall Study|Lost to Follow-up|5|||
164390976|NCT02862106|593798972|FG000|Overall Study|Withdrawal by Subject|2|||
164016125|NCT00365716|592421823|FG005|Extension 1|Protocol Violation|1|||
164016126|NCT00365716|592421824|FG006|Extension 1|Protocol Violation|0|||
164016127|NCT00365716|592421818|FG000|Extension 2|Lost to Follow-up|0|||
164016128|NCT00365716|592421819|FG001|Extension 2|Lost to Follow-up|0|||
164016129|NCT00365716|592421820|FG002|Extension 2|Lost to Follow-up|0|||
164390977|NCT02862106|593798973|FG001|Overall Study|Withdrawal by Subject|0|||
164390978|NCT02862106|593798972|FG000|Overall Study|Subjects moved to other city|1|||
164390979|NCT02862106|593798973|FG001|Overall Study|Subjects moved to other city|0|||
164390980|NCT00096135|593798980|FG000|Overall Study|Physician Decision|20|||
164390981|NCT00096135|593798981|FG001|Overall Study|Physician Decision|4|||
164390982|NCT00096135|593798980|FG000|Overall Study|Refusal of further protocol therapy|4|||
163905042|NCT01079806|592023742|FG000|Day 1 to Week 96|Pregnancy|0|||
163905043|NCT01079806|592023743|FG001|Day 1 to Week 96|Pregnancy|1|||
163905044|NCT01079806|592023742|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
164016130|NCT00365716|592421821|FG003|Extension 2|Lost to Follow-up|0|||
164390983|NCT00096135|593798981|FG001|Overall Study|Refusal of further protocol therapy|1|||
164390984|NCT00096135|593798980|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
164390985|NCT00096135|593798981|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
164390986|NCT00096135|593798980|FG000|Overall Study|Other, specify|15|||
164390987|NCT00096135|593798981|FG001|Overall Study|Other, specify|3|||
164390988|NCT00096135|593798980|FG000|Overall Study|Ineligible|2|||
164390989|NCT00096135|593798981|FG001|Overall Study|Ineligible|0|||
164390990|NCT00833989|593798990|FG000|Overall Study|Physician Decision|0|||
164390991|NCT00833989|593798991|FG001|Overall Study|Physician Decision|0|||
164390992|NCT00833989|593798992|FG002|Overall Study|Physician Decision|0|||
164390993|NCT00833989|593798993|FG003|Overall Study|Physician Decision|1|||
164390994|NCT00833989|593798990|FG000|Overall Study|Withdrawal by Subject|3|||
164390995|NCT00833989|593798991|FG001|Overall Study|Withdrawal by Subject|0|||
164390996|NCT00833989|593798992|FG002|Overall Study|Withdrawal by Subject|1|||
164390997|NCT00833989|593798993|FG003|Overall Study|Withdrawal by Subject|1|||
164390998|NCT02310750|593798996|FG000|HP Period 1|Lost to Follow-up|0|||
164390999|NCT02310750|593798997|FG001|HP Period 1|Lost to Follow-up|0|||
164391000|NCT02310750|593798998|FG002|HP Period 1|Lost to Follow-up|0|||
164391001|NCT02310750|593798999|FG003|HP Period 1|Lost to Follow-up|0|||
164391002|NCT02310750|593799000|FG004|HP Period 1|Lost to Follow-up|0|||
164391003|NCT02310750|593799001|FG005|HP Period 1|Lost to Follow-up|0|||
164391004|NCT02310750|593799002|FG006|HP Period 1|Lost to Follow-up|1|||
164391005|NCT02310750|593799003|FG007|HP Period 1|Lost to Follow-up|0|||
164391006|NCT02310750|593799004|FG008|HP Period 1|Lost to Follow-up|0|||
164391007|NCT02310750|593799005|FG009|HP Period 1|Lost to Follow-up|0|||
164391008|NCT02310750|593799006|FG010|HP Period 1|Lost to Follow-up|0|||
164391009|NCT02310750|593799007|FG011|HP Period 1|Lost to Follow-up|0|||
164391010|NCT02310750|593799008|FG012|HP Period 1|Lost to Follow-up|0|||
164391011|NCT02310750|593799009|FG013|HP Period 1|Lost to Follow-up|0|||
164391012|NCT02310750|593799010|FG014|HP Period 1|Lost to Follow-up|0|||
164391013|NCT02310750|593799011|FG015|HP Period 1|Lost to Follow-up|0|||
164391014|NCT02310750|593798996|FG000|HP Period 1|Withdrawal by Subject|1|||
164391015|NCT02310750|593798997|FG001|HP Period 1|Withdrawal by Subject|0|||
164391016|NCT02310750|593798998|FG002|HP Period 1|Withdrawal by Subject|0|||
164391017|NCT02310750|593798999|FG003|HP Period 1|Withdrawal by Subject|1|||
164391018|NCT02310750|593799000|FG004|HP Period 1|Withdrawal by Subject|0|||
164391019|NCT02310750|593799001|FG005|HP Period 1|Withdrawal by Subject|0|||
164391020|NCT02310750|593799002|FG006|HP Period 1|Withdrawal by Subject|0|||
164391021|NCT02310750|593799003|FG007|HP Period 1|Withdrawal by Subject|0|||
164391022|NCT02310750|593799004|FG008|HP Period 1|Withdrawal by Subject|0|||
164391023|NCT02310750|593799005|FG009|HP Period 1|Withdrawal by Subject|0|||
164391024|NCT02310750|593799006|FG010|HP Period 1|Withdrawal by Subject|0|||
164391025|NCT02310750|593799007|FG011|HP Period 1|Withdrawal by Subject|0|||
164391026|NCT02310750|593799008|FG012|HP Period 1|Withdrawal by Subject|0|||
164391027|NCT02310750|593799009|FG013|HP Period 1|Withdrawal by Subject|0|||
164391028|NCT02310750|593799010|FG014|HP Period 1|Withdrawal by Subject|0|||
164391029|NCT02310750|593799011|FG015|HP Period 1|Withdrawal by Subject|0|||
164391030|NCT02310750|593798996|FG000|HP Washout 1|Lost to Follow-up|0|||
164391031|NCT02310750|593798997|FG001|HP Washout 1|Lost to Follow-up|0|||
164391032|NCT02310750|593798998|FG002|HP Washout 1|Lost to Follow-up|1|||
164391033|NCT02310750|593798999|FG003|HP Washout 1|Lost to Follow-up|1|||
164391034|NCT02310750|593799000|FG004|HP Washout 1|Lost to Follow-up|2|||
164391035|NCT02310750|593799001|FG005|HP Washout 1|Lost to Follow-up|2|||
164391036|NCT02310750|593799002|FG006|HP Washout 1|Lost to Follow-up|3|||
164391037|NCT02310750|593799003|FG007|HP Washout 1|Lost to Follow-up|0|||
164391038|NCT02310750|593799004|FG008|HP Washout 1|Lost to Follow-up|0|||
164391039|NCT02310750|593799005|FG009|HP Washout 1|Lost to Follow-up|0|||
164391040|NCT02310750|593799006|FG010|HP Washout 1|Lost to Follow-up|0|||
164391041|NCT02310750|593799007|FG011|HP Washout 1|Lost to Follow-up|0|||
164391042|NCT02310750|593799008|FG012|HP Washout 1|Lost to Follow-up|0|||
164391043|NCT02310750|593799009|FG013|HP Washout 1|Lost to Follow-up|0|||
164391044|NCT02310750|593799010|FG014|HP Washout 1|Lost to Follow-up|0|||
164391045|NCT02310750|593799011|FG015|HP Washout 1|Lost to Follow-up|0|||
164391046|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391047|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391048|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391049|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
164391050|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391051|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
164391052|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391053|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391054|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
164391055|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
164391056|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391057|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391058|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391059|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391060|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391061|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
164391062|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391063|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391064|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391065|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391066|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391067|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391068|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391069|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391070|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391071|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
164391072|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391073|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391074|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391075|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391076|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391077|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
164391078|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391079|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391080|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391081|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391082|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391083|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391084|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391085|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
164391086|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
164391087|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
164391088|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391089|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391090|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391091|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391092|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391093|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
164391094|NCT02310750|593798996|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164093090|NCT06179108|592703473|FG002|Overall Study|Withdrawal by Subject|10|||
164093091|NCT06179108|592703474|FG003|Overall Study|Withdrawal by Subject|11|||
164093092|NCT06179108|592703471|FG000|Overall Study|Lost to Follow-up|12|||
164093093|NCT06179108|592703472|FG001|Overall Study|Lost to Follow-up|4|||
164093094|NCT06179108|592703473|FG002|Overall Study|Lost to Follow-up|1|||
164093095|NCT06179108|592703474|FG003|Overall Study|Lost to Follow-up|9|||
164093096|NCT06179108|592703471|FG000|Overall Study|Adverse Event|2|||
164093097|NCT06179108|592703472|FG001|Overall Study|Adverse Event|3|||
164093098|NCT06179108|592703473|FG002|Overall Study|Adverse Event|3|||
164093099|NCT06179108|592703474|FG003|Overall Study|Adverse Event|2|||
164093100|NCT06179108|592703471|FG000|Overall Study|Protocol Violation|0|||
164093101|NCT06179108|592703472|FG001|Overall Study|Protocol Violation|1|||
164093102|NCT06179108|592703473|FG002|Overall Study|Protocol Violation|0|||
164093103|NCT06179108|592703474|FG003|Overall Study|Protocol Violation|1|||
164093104|NCT06179108|592703471|FG000|Overall Study|Physician Decision|1|||
164093105|NCT06179108|592703472|FG001|Overall Study|Physician Decision|1|||
164093106|NCT06179108|592703473|FG002|Overall Study|Physician Decision|0|||
164093107|NCT06179108|592703474|FG003|Overall Study|Physician Decision|0|||
164093108|NCT06179108|592703471|FG000|Overall Study|Lack of Efficacy|0|||
164093109|NCT06179108|592703472|FG001|Overall Study|Lack of Efficacy|0|||
164093110|NCT06179108|592703473|FG002|Overall Study|Lack of Efficacy|0|||
164093111|NCT06179108|592703474|FG003|Overall Study|Lack of Efficacy|1|||
164093112|NCT06179108|592703471|FG000|Overall Study|Death|0|||
164093113|NCT06179108|592703472|FG001|Overall Study|Death|0|||
164093114|NCT06179108|592703473|FG002|Overall Study|Death|0|||
164093115|NCT06179108|592703474|FG003|Overall Study|Death|1|||
164093116|NCT00814463|592703476|FG000|Overall Study|Lost to Follow-up|1|||
164093117|NCT01370408|592703477|FG000|Overall Study|treatment failure|9|||
164093118|NCT02780687|592703480|FG000|Overall Study|Adverse Event|1|||
164093119|NCT02780687|592703481|FG001|Overall Study|Adverse Event|1|||
164093120|NCT02780687|592703480|FG000|Overall Study|Withdrawal by Subject|2|||
164093121|NCT02780687|592703481|FG001|Overall Study|Withdrawal by Subject|1|||
164093122|NCT02780687|592703480|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
164093123|NCT02780687|592703481|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
164093124|NCT02780687|592703480|FG000|Overall Study|progressive disease|29|||
164093125|NCT02780687|592703481|FG001|Overall Study|progressive disease|6|||
164093126|NCT05014412|592703484|FG000|Overall Study|Death|11|||
164093127|NCT05014412|592703485|FG001|Overall Study|Death|7|||
164093128|NCT05014412|592703486|FG002|Overall Study|Death|4|||
164391095|NCT02310750|593798997|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391096|NCT02310750|593798998|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391097|NCT02310750|593798999|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391098|NCT02310750|593799000|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391099|NCT02310750|593799001|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391100|NCT02310750|593799002|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391101|NCT02310750|593799003|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
164391102|NCT02310750|593799004|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
164391103|NCT02310750|593799005|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391104|NCT02310750|593799006|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391105|NCT02310750|593799007|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391106|NCT02310750|593799008|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391107|NCT02310750|593799009|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391108|NCT02310750|593799010|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391109|NCT02310750|593799011|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
164391110|NCT02310750|593798996|FG000|HP Washout 2|Lost to Follow-up|0|||
164391111|NCT02310750|593798997|FG001|HP Washout 2|Lost to Follow-up|0|||
164391112|NCT02310750|593798998|FG002|HP Washout 2|Lost to Follow-up|0|||
164391113|NCT02310750|593798999|FG003|HP Washout 2|Lost to Follow-up|0|||
164391114|NCT02310750|593799000|FG004|HP Washout 2|Lost to Follow-up|1|||
164391115|NCT02310750|593799001|FG005|HP Washout 2|Lost to Follow-up|0|||
164391116|NCT02310750|593799002|FG006|HP Washout 2|Lost to Follow-up|7|||
164391117|NCT02310750|593799003|FG007|HP Washout 2|Lost to Follow-up|0|||
164391118|NCT02310750|593799004|FG008|HP Washout 2|Lost to Follow-up|0|||
164391119|NCT02310750|593799005|FG009|HP Washout 2|Lost to Follow-up|0|||
164391120|NCT02310750|593799006|FG010|HP Washout 2|Lost to Follow-up|0|||
164391121|NCT02310750|593799007|FG011|HP Washout 2|Lost to Follow-up|0|||
164391122|NCT02310750|593799008|FG012|HP Washout 2|Lost to Follow-up|0|||
164391123|NCT02310750|593799009|FG013|HP Washout 2|Lost to Follow-up|0|||
164391124|NCT02310750|593799010|FG014|HP Washout 2|Lost to Follow-up|0|||
164391125|NCT02310750|593799011|FG015|HP Washout 2|Lost to Follow-up|0|||
164391126|NCT02199028|593799012|FG000|Week 1|Adverse Event|1|||
164391127|NCT02199028|593799013|FG001|Week 1|Adverse Event|0|||
164391128|NCT02199028|593799012|FG000|Week 3|Adverse Event|1|||
164391129|NCT02199028|593799013|FG001|Week 3|Adverse Event|0|||
164391130|NCT01881126|593799016|FG000|Overall Study|Non-compliance|1|||
164391131|NCT01881126|593799017|FG001|Overall Study|Non-compliance|1|||
164391132|NCT01881126|593799016|FG000|Overall Study|Adverse Event|0|||
164391133|NCT01881126|593799017|FG001|Overall Study|Adverse Event|1|||
164391134|NCT05045625|593799018|FG000|Overall Study|Lost to Follow-up|3|||
164391135|NCT03867734|593799019|FG000|Overall Study|Lost to Follow-up|2|||
164391136|NCT01827904|593799020|FG000|Main Study|Withdrawal by Subject|1|||
164391137|NCT01827904|593799021|FG001|Main Study|Withdrawal by Subject|0|||
164391138|NCT01827904|593799022|FG002|Main Study|Withdrawal by Subject|0|||
164391139|NCT01827904|593799020|FG000|Main Study|Adverse Event|1|||
164391140|NCT01827904|593799021|FG001|Main Study|Adverse Event|0|||
164391141|NCT01827904|593799022|FG002|Main Study|Adverse Event|0|||
164391142|NCT01827904|593799020|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
164391143|NCT01827904|593799021|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
164391144|NCT01827904|593799022|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
164391145|NCT01827904|593799020|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
164391146|NCT01827904|593799021|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
164391147|NCT01827904|593799022|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
164391148|NCT01827904|593799020|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
164391149|NCT01827904|593799021|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
164391150|NCT01827904|593799022|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
164391151|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
164391152|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
164391153|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
164391154|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
164391155|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
164391156|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
164391157|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
164391158|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
164391159|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
164391160|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
164391161|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
164391162|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
164391163|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Physician Decision|1|||
164391164|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Physician Decision|0|||
164391165|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Physician Decision|0|||
164391166|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
164016131|NCT00365716|592421822|FG004|Extension 2|Lost to Follow-up|0|||
164391167|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
164391168|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
164391169|NCT01827904|593799020|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
164391170|NCT01827904|593799021|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
164391171|NCT01827904|593799022|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
164391172|NCT04266028|593799023|FG000|Overall Study|Adverse Event|0|||
164391173|NCT04266028|593799024|FG001|Overall Study|Adverse Event|0|||
164391174|NCT04266028|593799025|FG002|Overall Study|Adverse Event|1|||
164391175|NCT04266028|593799026|FG003|Overall Study|Adverse Event|0|||
164391176|NCT04266028|593799027|FG004|Overall Study|Adverse Event|1|||
164391177|NCT04266028|593799028|FG005|Overall Study|Adverse Event|0|||
164391178|NCT04266028|593799029|FG006|Overall Study|Adverse Event|2|||
164391179|NCT04266028|593799030|FG007|Overall Study|Adverse Event|0|||
164391180|NCT04266028|593799023|FG000|Overall Study|temporary halt of the study|0|||
164391181|NCT04266028|593799024|FG001|Overall Study|temporary halt of the study|0|||
164391182|NCT04266028|593799025|FG002|Overall Study|temporary halt of the study|0|||
164391183|NCT04266028|593799026|FG003|Overall Study|temporary halt of the study|0|||
164391184|NCT04266028|593799027|FG004|Overall Study|temporary halt of the study|0|||
164391185|NCT04266028|593799028|FG005|Overall Study|temporary halt of the study|0|||
164391186|NCT04266028|593799029|FG006|Overall Study|temporary halt of the study|2|||
164391187|NCT04266028|593799030|FG007|Overall Study|temporary halt of the study|1|||
164391188|NCT04266028|593799023|FG000|Overall Study|Onset of birch pollen season|0|||
164391189|NCT04266028|593799024|FG001|Overall Study|Onset of birch pollen season|0|||
164391190|NCT04266028|593799025|FG002|Overall Study|Onset of birch pollen season|0|||
164391191|NCT04266028|593799026|FG003|Overall Study|Onset of birch pollen season|0|||
164391192|NCT04266028|593799027|FG004|Overall Study|Onset of birch pollen season|1|||
164391193|NCT04266028|593799028|FG005|Overall Study|Onset of birch pollen season|0|||
164391194|NCT04266028|593799029|FG006|Overall Study|Onset of birch pollen season|0|||
164391195|NCT04266028|593799030|FG007|Overall Study|Onset of birch pollen season|0|||
164391196|NCT01458574|593799031|FG000|Overall Study|Adverse Event|5|||
164391197|NCT01458574|593799032|FG001|Overall Study|Adverse Event|9|||
164391198|NCT01458574|593799033|FG002|Overall Study|Adverse Event|7|||
164391199|NCT01458574|593799031|FG000|Overall Study|Lack of Efficacy|70|||
164391200|NCT01458574|593799032|FG001|Overall Study|Lack of Efficacy|53|||
164391201|NCT01458574|593799033|FG002|Overall Study|Lack of Efficacy|132|||
164391202|NCT01458574|593799031|FG000|Overall Study|Lost to Follow-up|3|||
164391203|NCT01458574|593799032|FG001|Overall Study|Lost to Follow-up|2|||
164391204|NCT01458574|593799033|FG002|Overall Study|Lost to Follow-up|1|||
164391205|NCT01458574|593799031|FG000|Overall Study|Pregnancy|1|||
164391206|NCT01458574|593799032|FG001|Overall Study|Pregnancy|1|||
164391207|NCT01458574|593799033|FG002|Overall Study|Pregnancy|0|||
164391208|NCT01458574|593799031|FG000|Overall Study|Protocol Violation|0|||
164391209|NCT01458574|593799032|FG001|Overall Study|Protocol Violation|1|||
164391210|NCT01458574|593799033|FG002|Overall Study|Protocol Violation|0|||
164391211|NCT01458574|593799031|FG000|Overall Study|Withdrawal by Subject|6|||
164391212|NCT01458574|593799032|FG001|Overall Study|Withdrawal by Subject|3|||
164391213|NCT01458574|593799033|FG002|Overall Study|Withdrawal by Subject|5|||
164391214|NCT01458574|593799031|FG000|Overall Study|Other|2|||
164391215|NCT01458574|593799032|FG001|Overall Study|Other|1|||
164391216|NCT01458574|593799033|FG002|Overall Study|Other|0|||
164391217|NCT01458574|593799031|FG000|Overall Study|Randomized but not treated|0|||
164391218|NCT01458574|593799032|FG001|Overall Study|Randomized but not treated|1|||
164391219|NCT01458574|593799033|FG002|Overall Study|Randomized but not treated|0|||
164391220|NCT02125786|593799034|FG000|Overall Study|Still in Follow-up|3|||
164391221|NCT02125786|593799034|FG000|Overall Study|Screen Failure|2|||
164391222|NCT02125786|593799034|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
164391223|NCT02125786|593799034|FG000|Overall Study|Progressive Disease|44|||
164391224|NCT02125786|593799034|FG000|Overall Study|Death|8|||
164391225|NCT02663128|593799037|FG000|Period 2|Physician Decision|0|||
164391226|NCT02663128|593799038|FG001|Period 2|Physician Decision|0|||
164391227|NCT02663128|593799039|FG002|Period 2|Physician Decision|0|||
164391228|NCT02663128|593799040|FG003|Period 2|Physician Decision|0|||
164016132|NCT00365716|592421823|FG005|Extension 2|Lost to Follow-up|0|||
164016133|NCT00365716|592421824|FG006|Extension 2|Lost to Follow-up|2|||
164391229|NCT02663128|593799041|FG004|Period 2|Physician Decision|1|||
164391230|NCT02663128|593799042|FG005|Period 2|Physician Decision|0|||
164391231|NCT05070897|593799043|FG000|Overall Study|Protocol Violation|123|||
164391232|NCT05070897|593799044|FG001|Overall Study|Protocol Violation|68|||
164391233|NCT01617629|593799047|FG000|Overall Study|Death|2|||
164391234|NCT01617629|593799047|FG000|Overall Study|Investigator's Clinical Judgement|1|||
164016134|NCT00365716|592421818|FG000|Extension 2|Other|0|||
164391235|NCT01617629|593799047|FG000|Overall Study|Reason Not Specified|1|||
164391236|NCT01617629|593799047|FG000|Overall Study|Participant Withdrew Consent|2|||
164391237|NCT01663636|593799048|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
164391238|NCT01663636|593799049|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
164391239|NCT03394924|593799050|FG000|Overall Study|Adverse Event|0|||
164391240|NCT03394924|593799051|FG001|Overall Study|Adverse Event|5|||
164391241|NCT03394924|593799052|FG002|Overall Study|Adverse Event|0|||
164391242|NCT03394924|593799050|FG000|Overall Study|Withdrawal by Subject|2|||
164391243|NCT03394924|593799051|FG001|Overall Study|Withdrawal by Subject|0|||
164391244|NCT03394924|593799052|FG002|Overall Study|Withdrawal by Subject|0|||
164391245|NCT03394924|593799050|FG000|Overall Study|Lost to Follow-up|0|||
164391246|NCT03394924|593799051|FG001|Overall Study|Lost to Follow-up|1|||
164391247|NCT03394924|593799052|FG002|Overall Study|Lost to Follow-up|0|||
164391248|NCT03394924|593799050|FG000|Overall Study|Did not meet all inclusion criteria|1|||
164391249|NCT03394924|593799051|FG001|Overall Study|Did not meet all inclusion criteria|0|||
164391250|NCT03394924|593799052|FG002|Overall Study|Did not meet all inclusion criteria|0|||
164391251|NCT02663817|593799055|FG000|Overall Study|Screen failure|2|||
164391252|NCT05350449|593799056|FG000|Overall Study|Withdrawal by Subject|4|||
164391253|NCT05350449|593799057|FG001|Overall Study|Withdrawal by Subject|8|||
164391254|NCT01949311|593801815|FG000|Overall Study|Lost to Follow-up|73|||
164391255|NCT01949311|593801815|FG000|Overall Study|Terminated by Sponsor|708|||
164391256|NCT01949311|593801815|FG000|Overall Study|Withdrawal by Subject|375|||
164391257|NCT01949311|593801815|FG000|Overall Study|Lack of Efficacy|50|||
164391258|NCT01949311|593801815|FG000|Overall Study|Protocol Deviation|34|||
164391259|NCT01949311|593801815|FG000|Overall Study|Pregnancy|20|||
164391260|NCT01949311|593801815|FG000|Overall Study|Physician Decision|9|||
164391261|NCT01949311|593801815|FG000|Overall Study|Other|4|||
164391262|NCT01949311|593801815|FG000|Overall Study|Adverse Event|107|||
164391263|NCT01925950|593801818|FG000|Part 2|Withdrawal by Subject|1|||
164391264|NCT01925950|593801819|FG001|Part 2|Withdrawal by Subject|0|||
164391265|NCT03508843|593801821|FG000|Overall Study|Withdrawal by Subject|1|||
164391266|NCT03508843|593801821|FG000|Overall Study|technical difficulties|2|||
164391267|NCT04717596|593801822|FG000|Overall Study|Withdrawal by Subject|4|||
164391268|NCT00765843|593801823|FG000|Overall Study|Lost to Follow-up|1|||
164391269|NCT00765843|593801824|FG001|Overall Study|Lost to Follow-up|3|||
164391270|NCT00765843|593801825|FG002|Overall Study|Lost to Follow-up|2|||
164391271|NCT00765843|593801823|FG000|Overall Study|did not return to receive intervention|0|||
164391272|NCT00765843|593801824|FG001|Overall Study|did not return to receive intervention|1|||
164391273|NCT00765843|593801825|FG002|Overall Study|did not return to receive intervention|0|||
164391274|NCT00765843|593801823|FG000|Overall Study|Adverse Event|0|||
164391275|NCT00765843|593801824|FG001|Overall Study|Adverse Event|0|||
164391276|NCT00765843|593801825|FG002|Overall Study|Adverse Event|1|||
164391277|NCT03555396|593801826|FG000|Overall Study|Death|3|||
164391278|NCT03555396|593801827|FG001|Overall Study|Death|1|||
164391279|NCT03555396|593801826|FG000|Overall Study|Lost to Follow-up|0|||
164391280|NCT03555396|593801827|FG001|Overall Study|Lost to Follow-up|2|||
164391281|NCT04066114|593801828|FG000|Overall Study|Adverse Event|1|||
164391282|NCT04066114|593801829|FG001|Overall Study|Adverse Event|0|||
164391283|NCT04066114|593801830|FG002|Overall Study|Adverse Event|0|||
164391284|NCT04066114|593801828|FG000|Overall Study|Withdrawal by Subject|1|||
164391285|NCT04066114|593801829|FG001|Overall Study|Withdrawal by Subject|0|||
164391286|NCT04066114|593801830|FG002|Overall Study|Withdrawal by Subject|0|||
164391287|NCT04066114|593801828|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164391288|NCT04066114|593801829|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
164391289|NCT04066114|593801830|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
164391290|NCT02460991|593801831|FG000|Overall Study|Withdrawal by Subject|0|||
164391291|NCT02460991|593801832|FG001|Overall Study|Withdrawal by Subject|2|||
164391292|NCT02564523|593801833|FG000|Overall Study|Withdrawal by Subject|3|||
163905045|NCT01079806|592023743|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
163905046|NCT01079806|592023742|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
163905047|NCT01079806|592023743|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
164093129|NCT05014412|592703487|FG003|Overall Study|Death|7|||
164391293|NCT02564523|593801834|FG001|Overall Study|Withdrawal by Subject|0|||
164391294|NCT02564523|593801835|FG002|Overall Study|Withdrawal by Subject|1|||
164391295|NCT02564523|593801836|FG003|Overall Study|Withdrawal by Subject|0|||
164391296|NCT02564523|593801837|FG004|Overall Study|Withdrawal by Subject|1|||
164391297|NCT02564523|593801838|FG005|Overall Study|Withdrawal by Subject|0|||
164391298|NCT02564523|593801839|FG006|Overall Study|Withdrawal by Subject|1|||
164391299|NCT02564523|593801840|FG007|Overall Study|Withdrawal by Subject|0|||
164391300|NCT02564523|593801841|FG008|Overall Study|Withdrawal by Subject|0|||
164391301|NCT02564523|593801842|FG009|Overall Study|Withdrawal by Subject|0|||
164391302|NCT02564523|593801843|FG010|Overall Study|Withdrawal by Subject|1|||
164391303|NCT02564523|593801844|FG011|Overall Study|Withdrawal by Subject|0|||
164391304|NCT02564523|593801845|FG012|Overall Study|Withdrawal by Subject|1|||
163905048|NCT01079806|592023742|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
164391305|NCT02564523|593801846|FG013|Overall Study|Withdrawal by Subject|0|||
164391306|NCT02564523|593801847|FG014|Overall Study|Withdrawal by Subject|0|||
164391307|NCT02564523|593801848|FG015|Overall Study|Withdrawal by Subject|0|||
164391308|NCT02564523|593801849|FG016|Overall Study|Withdrawal by Subject|0|||
164391309|NCT02564523|593801850|FG017|Overall Study|Withdrawal by Subject|0|||
164391310|NCT02564523|593801833|FG000|Overall Study|Adverse Event|0|||
164391311|NCT02564523|593801834|FG001|Overall Study|Adverse Event|0|||
164391312|NCT02564523|593801835|FG002|Overall Study|Adverse Event|0|||
164391313|NCT02564523|593801836|FG003|Overall Study|Adverse Event|0|||
164391314|NCT02564523|593801837|FG004|Overall Study|Adverse Event|0|||
164391315|NCT02564523|593801838|FG005|Overall Study|Adverse Event|0|||
164391316|NCT02564523|593801839|FG006|Overall Study|Adverse Event|0|||
164391317|NCT02564523|593801840|FG007|Overall Study|Adverse Event|0|||
164391318|NCT02564523|593801841|FG008|Overall Study|Adverse Event|0|||
164391319|NCT02564523|593801842|FG009|Overall Study|Adverse Event|0|||
164391320|NCT02564523|593801843|FG010|Overall Study|Adverse Event|0|||
164391321|NCT02564523|593801844|FG011|Overall Study|Adverse Event|0|||
164391322|NCT02564523|593801845|FG012|Overall Study|Adverse Event|0|||
164391323|NCT02564523|593801846|FG013|Overall Study|Adverse Event|0|||
164391324|NCT02564523|593801847|FG014|Overall Study|Adverse Event|0|||
164391325|NCT02564523|593801848|FG015|Overall Study|Adverse Event|0|||
164391326|NCT02564523|593801849|FG016|Overall Study|Adverse Event|0|||
164391327|NCT02564523|593801850|FG017|Overall Study|Adverse Event|1|||
164391328|NCT02564523|593801833|FG000|Overall Study|Death|0|||
164391329|NCT02564523|593801834|FG001|Overall Study|Death|0|||
164391330|NCT02564523|593801835|FG002|Overall Study|Death|0|||
164391331|NCT02564523|593801836|FG003|Overall Study|Death|0|||
164391332|NCT02564523|593801837|FG004|Overall Study|Death|0|||
164391333|NCT02564523|593801838|FG005|Overall Study|Death|0|||
164391334|NCT02564523|593801839|FG006|Overall Study|Death|1|||
164391335|NCT02564523|593801840|FG007|Overall Study|Death|0|||
164391336|NCT02564523|593801841|FG008|Overall Study|Death|0|||
164391337|NCT02564523|593801842|FG009|Overall Study|Death|0|||
164391338|NCT02564523|593801843|FG010|Overall Study|Death|1|||
164391339|NCT02564523|593801844|FG011|Overall Study|Death|0|||
164391340|NCT02564523|593801845|FG012|Overall Study|Death|0|||
164391341|NCT02564523|593801846|FG013|Overall Study|Death|0|||
164391342|NCT02564523|593801847|FG014|Overall Study|Death|0|||
164391343|NCT02564523|593801848|FG015|Overall Study|Death|0|||
164391344|NCT02564523|593801849|FG016|Overall Study|Death|0|||
164391345|NCT02564523|593801850|FG017|Overall Study|Death|0|||
164391346|NCT02564523|593801833|FG000|Overall Study|Lost to Follow-up|2|||
164391347|NCT02564523|593801834|FG001|Overall Study|Lost to Follow-up|1|||
164391348|NCT02564523|593801835|FG002|Overall Study|Lost to Follow-up|4|||
164391349|NCT02564523|593801836|FG003|Overall Study|Lost to Follow-up|0|||
164391350|NCT02564523|593801837|FG004|Overall Study|Lost to Follow-up|1|||
164391351|NCT02564523|593801838|FG005|Overall Study|Lost to Follow-up|0|||
164391352|NCT02564523|593801839|FG006|Overall Study|Lost to Follow-up|1|||
164391353|NCT02564523|593801840|FG007|Overall Study|Lost to Follow-up|0|||
164391354|NCT02564523|593801841|FG008|Overall Study|Lost to Follow-up|0|||
164391355|NCT02564523|593801842|FG009|Overall Study|Lost to Follow-up|0|||
164391356|NCT02564523|593801843|FG010|Overall Study|Lost to Follow-up|0|||
164391357|NCT02564523|593801844|FG011|Overall Study|Lost to Follow-up|1|||
164391358|NCT02564523|593801845|FG012|Overall Study|Lost to Follow-up|1|||
164391359|NCT02564523|593801846|FG013|Overall Study|Lost to Follow-up|0|||
164016135|NCT00365716|592421819|FG001|Extension 2|Other|0|||
164391360|NCT02564523|593801847|FG014|Overall Study|Lost to Follow-up|0|||
164391361|NCT02564523|593801848|FG015|Overall Study|Lost to Follow-up|0|||
164391362|NCT02564523|593801849|FG016|Overall Study|Lost to Follow-up|0|||
164391363|NCT02564523|593801850|FG017|Overall Study|Lost to Follow-up|0|||
164391364|NCT02564523|593801833|FG000|Overall Study|Physician Decision|0|||
164391365|NCT02564523|593801834|FG001|Overall Study|Physician Decision|0|||
164391366|NCT02564523|593801835|FG002|Overall Study|Physician Decision|0|||
164016136|NCT00365716|592421820|FG002|Extension 2|Other|0|||
164016137|NCT00365716|592421821|FG003|Extension 2|Other|0|||
164016138|NCT00365716|592421822|FG004|Extension 2|Other|0|||
164391367|NCT02564523|593801836|FG003|Overall Study|Physician Decision|0|||
164391368|NCT02564523|593801837|FG004|Overall Study|Physician Decision|1|||
164016139|NCT00365716|592421823|FG005|Extension 2|Other|0|||
164391369|NCT02564523|593801838|FG005|Overall Study|Physician Decision|0|||
164391370|NCT02564523|593801839|FG006|Overall Study|Physician Decision|0|||
164391371|NCT02564523|593801840|FG007|Overall Study|Physician Decision|0|||
164391372|NCT02564523|593801841|FG008|Overall Study|Physician Decision|0|||
164391373|NCT02564523|593801842|FG009|Overall Study|Physician Decision|0|||
164391374|NCT02564523|593801843|FG010|Overall Study|Physician Decision|1|||
164391375|NCT02564523|593801844|FG011|Overall Study|Physician Decision|0|||
164391376|NCT02564523|593801845|FG012|Overall Study|Physician Decision|0|||
164016140|NCT00365716|592421824|FG006|Extension 2|Other|3|||
164016141|NCT00365716|592421818|FG000|Extension 2|Withdrawal by Subject|0|||
164391377|NCT02564523|593801846|FG013|Overall Study|Physician Decision|0|||
164391378|NCT02564523|593801847|FG014|Overall Study|Physician Decision|0|||
164391379|NCT02564523|593801848|FG015|Overall Study|Physician Decision|0|||
164391380|NCT02564523|593801849|FG016|Overall Study|Physician Decision|0|||
164391381|NCT02564523|593801850|FG017|Overall Study|Physician Decision|0|||
164391382|NCT02564523|593801833|FG000|Overall Study|Protocol Violation|2|||
164391383|NCT02564523|593801834|FG001|Overall Study|Protocol Violation|2|||
164391384|NCT02564523|593801835|FG002|Overall Study|Protocol Violation|5|||
164391385|NCT02564523|593801836|FG003|Overall Study|Protocol Violation|0|||
164391386|NCT02564523|593801837|FG004|Overall Study|Protocol Violation|1|||
164391387|NCT02564523|593801838|FG005|Overall Study|Protocol Violation|0|||
164391388|NCT02564523|593801839|FG006|Overall Study|Protocol Violation|0|||
164391389|NCT02564523|593801840|FG007|Overall Study|Protocol Violation|0|||
164391390|NCT02564523|593801841|FG008|Overall Study|Protocol Violation|0|||
164391391|NCT02564523|593801842|FG009|Overall Study|Protocol Violation|0|||
164391392|NCT02564523|593801843|FG010|Overall Study|Protocol Violation|0|||
164391393|NCT02564523|593801844|FG011|Overall Study|Protocol Violation|0|||
164391394|NCT02564523|593801845|FG012|Overall Study|Protocol Violation|0|||
164391395|NCT02564523|593801846|FG013|Overall Study|Protocol Violation|0|||
164391396|NCT02564523|593801847|FG014|Overall Study|Protocol Violation|0|||
164391397|NCT02564523|593801848|FG015|Overall Study|Protocol Violation|0|||
164391398|NCT02564523|593801849|FG016|Overall Study|Protocol Violation|0|||
164391399|NCT02564523|593801850|FG017|Overall Study|Protocol Violation|0|||
164391400|NCT02564523|593801833|FG000|Overall Study|Other|3|||
164391401|NCT02564523|593801834|FG001|Overall Study|Other|0|||
164391402|NCT02564523|593801835|FG002|Overall Study|Other|0|||
164391403|NCT02564523|593801836|FG003|Overall Study|Other|1|||
164391404|NCT02564523|593801837|FG004|Overall Study|Other|0|||
164391405|NCT02564523|593801838|FG005|Overall Study|Other|0|||
164391406|NCT02564523|593801839|FG006|Overall Study|Other|0|||
164391407|NCT02564523|593801840|FG007|Overall Study|Other|0|||
164391408|NCT02564523|593801841|FG008|Overall Study|Other|0|||
164391409|NCT02564523|593801842|FG009|Overall Study|Other|0|||
164391410|NCT02564523|593801843|FG010|Overall Study|Other|0|||
164391411|NCT02564523|593801844|FG011|Overall Study|Other|0|||
164391412|NCT02564523|593801845|FG012|Overall Study|Other|0|||
164391413|NCT02564523|593801846|FG013|Overall Study|Other|0|||
164391414|NCT02564523|593801847|FG014|Overall Study|Other|0|||
164391415|NCT02564523|593801848|FG015|Overall Study|Other|0|||
164391416|NCT02564523|593801849|FG016|Overall Study|Other|0|||
164391417|NCT02564523|593801850|FG017|Overall Study|Other|0|||
164391418|NCT03701555|593801856|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
164391419|NCT03701555|593801857|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
164391420|NCT03701555|593801858|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
164391421|NCT03701555|593801859|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
164391422|NCT03701555|593801860|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
164391423|NCT03701555|593801861|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
164391424|NCT03701555|593801862|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
164391425|NCT03701555|593801863|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
164391426|NCT03701555|593801864|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
164391427|NCT03701555|593801865|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
164391428|NCT03701555|593801866|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
164391429|NCT03701555|593801867|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
164391430|NCT03701555|593801868|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
164391431|NCT03701555|593801869|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
164391432|NCT03701555|593801870|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
164391433|NCT03701555|593801871|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
164391434|NCT03701555|593801872|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
164391435|NCT03701555|593801873|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
164391436|NCT03701555|593801874|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
164391437|NCT03701555|593801875|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
164391438|NCT03701555|593801876|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
164391439|NCT03701555|593801877|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
164391440|NCT03701555|593801878|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
164093130|NCT05014412|592703484|FG000|Overall Study|Withdrawal by Subject|1|||
164391441|NCT03701555|593801879|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
164391442|NCT03701555|593801880|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
164391443|NCT03701555|593801881|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
164391444|NCT03701555|593801882|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
164391445|NCT03701555|593801883|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
164391446|NCT03701555|593801884|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
164391447|NCT03701555|593801885|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
164391448|NCT03701555|593801886|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
164391449|NCT03701555|593801887|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
164391450|NCT03701555|593801888|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
164391451|NCT03701555|593801889|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
164391452|NCT03701555|593801890|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
164391453|NCT03701555|593801891|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
164391454|NCT03701555|593801856|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
164391455|NCT03701555|593801857|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
164391456|NCT03701555|593801858|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
164391457|NCT03701555|593801859|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
164391458|NCT03701555|593801860|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
164391459|NCT03701555|593801861|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
164391460|NCT03701555|593801862|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
164391461|NCT03701555|593801863|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
164391462|NCT03701555|593801864|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
164391463|NCT03701555|593801865|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
164391464|NCT03701555|593801866|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
164391465|NCT03701555|593801867|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
164391466|NCT03701555|593801868|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
164391467|NCT03701555|593801869|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
164391468|NCT03701555|593801870|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
164391469|NCT03701555|593801871|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
164391470|NCT03701555|593801872|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
164391471|NCT03701555|593801873|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
164391472|NCT03701555|593801874|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
164391473|NCT03701555|593801875|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
164391474|NCT03701555|593801876|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
164391475|NCT03701555|593801877|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
164391476|NCT03701555|593801878|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
164391477|NCT03701555|593801879|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
164391478|NCT03701555|593801880|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
164391479|NCT03701555|593801881|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
164391480|NCT03701555|593801882|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
164391481|NCT03701555|593801883|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
164391482|NCT03701555|593801884|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
164391483|NCT03701555|593801885|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
164391484|NCT03701555|593801886|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
164391485|NCT03701555|593801887|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
164391486|NCT03701555|593801888|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
164391487|NCT03701555|593801889|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
164391488|NCT03701555|593801890|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
164391489|NCT03701555|593801891|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
164391490|NCT03701555|593801856|FG000|Part 2 (Day 1)|Other|0|||
164391491|NCT03701555|593801857|FG001|Part 2 (Day 1)|Other|0|||
164391492|NCT03701555|593801858|FG002|Part 2 (Day 1)|Other|0|||
164391493|NCT03701555|593801859|FG003|Part 2 (Day 1)|Other|0|||
164391494|NCT03701555|593801860|FG004|Part 2 (Day 1)|Other|0|||
164391495|NCT03701555|593801861|FG005|Part 2 (Day 1)|Other|0|||
164391496|NCT03701555|593801862|FG006|Part 2 (Day 1)|Other|0|||
164391497|NCT03701555|593801863|FG007|Part 2 (Day 1)|Other|0|||
164391498|NCT03701555|593801864|FG008|Part 2 (Day 1)|Other|0|||
164391499|NCT03701555|593801865|FG009|Part 2 (Day 1)|Other|0|||
164391500|NCT03701555|593801866|FG010|Part 2 (Day 1)|Other|3|||
164391501|NCT03701555|593801867|FG011|Part 2 (Day 1)|Other|1|||
164391502|NCT03701555|593801868|FG012|Part 2 (Day 1)|Other|0|||
164391503|NCT03701555|593801869|FG013|Part 2 (Day 1)|Other|1|||
164391504|NCT03701555|593801870|FG014|Part 2 (Day 1)|Other|0|||
164391505|NCT03701555|593801871|FG015|Part 2 (Day 1)|Other|2|||
164391506|NCT03701555|593801872|FG016|Part 2 (Day 1)|Other|2|||
164391507|NCT03701555|593801873|FG017|Part 2 (Day 1)|Other|0|||
164391508|NCT03701555|593801874|FG018|Part 2 (Day 1)|Other|0|||
164391509|NCT03701555|593801875|FG019|Part 2 (Day 1)|Other|0|||
164391510|NCT03701555|593801876|FG020|Part 2 (Day 1)|Other|0|||
164391511|NCT03701555|593801877|FG021|Part 2 (Day 1)|Other|0|||
164391512|NCT03701555|593801878|FG022|Part 2 (Day 1)|Other|0|||
164391513|NCT03701555|593801879|FG023|Part 2 (Day 1)|Other|0|||
164391514|NCT03701555|593801880|FG024|Part 2 (Day 1)|Other|0|||
164391515|NCT03701555|593801881|FG025|Part 2 (Day 1)|Other|0|||
164391516|NCT03701555|593801882|FG026|Part 2 (Day 1)|Other|0|||
164391517|NCT03701555|593801883|FG027|Part 2 (Day 1)|Other|0|||
164391518|NCT03701555|593801884|FG028|Part 2 (Day 1)|Other|0|||
164391519|NCT03701555|593801885|FG029|Part 2 (Day 1)|Other|0|||
164391520|NCT03701555|593801886|FG030|Part 2 (Day 1)|Other|0|||
164093131|NCT05014412|592703485|FG001|Overall Study|Withdrawal by Subject|1|||
164391521|NCT03701555|593801887|FG031|Part 2 (Day 1)|Other|0|||
164391522|NCT03701555|593801888|FG032|Part 2 (Day 1)|Other|0|||
164391523|NCT03701555|593801889|FG033|Part 2 (Day 1)|Other|0|||
164391524|NCT03701555|593801890|FG034|Part 2 (Day 1)|Other|0|||
164391525|NCT03701555|593801891|FG035|Part 2 (Day 1)|Other|0|||
164391526|NCT03701555|593801856|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
164391527|NCT03701555|593801857|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
164391528|NCT03701555|593801858|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
164391529|NCT03701555|593801859|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
164391530|NCT03701555|593801860|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
164391531|NCT03701555|593801861|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
164391532|NCT03701555|593801862|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
164391533|NCT03701555|593801863|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
164391534|NCT03701555|593801864|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
164391535|NCT03701555|593801865|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
164391536|NCT03701555|593801866|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
164391537|NCT03701555|593801867|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
164391538|NCT03701555|593801868|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
164391539|NCT03701555|593801869|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
164391540|NCT03701555|593801870|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
164391541|NCT03701555|593801871|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
164391542|NCT03701555|593801872|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
164391543|NCT03701555|593801873|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
164391544|NCT03701555|593801874|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
164391545|NCT03701555|593801875|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
164391546|NCT03701555|593801876|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
164391547|NCT03701555|593801877|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
164391548|NCT03701555|593801878|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
164391549|NCT03701555|593801879|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
164391550|NCT03701555|593801880|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
164391551|NCT03701555|593801881|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
164391552|NCT03701555|593801882|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
164391553|NCT03701555|593801883|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
164391554|NCT03701555|593801884|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
164391555|NCT03701555|593801885|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
164391556|NCT03701555|593801886|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
164391557|NCT03701555|593801887|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
164391558|NCT03701555|593801888|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
164391559|NCT03701555|593801889|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
164391560|NCT03701555|593801890|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
164391561|NCT03701555|593801891|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
164391562|NCT03701555|593801856|FG000|Part 3 (Day 1)|Subject Decision|0|||
164391563|NCT03701555|593801857|FG001|Part 3 (Day 1)|Subject Decision|0|||
164391564|NCT03701555|593801858|FG002|Part 3 (Day 1)|Subject Decision|0|||
164391565|NCT03701555|593801859|FG003|Part 3 (Day 1)|Subject Decision|0|||
164391566|NCT03701555|593801860|FG004|Part 3 (Day 1)|Subject Decision|0|||
164391567|NCT03701555|593801861|FG005|Part 3 (Day 1)|Subject Decision|0|||
164391568|NCT03701555|593801862|FG006|Part 3 (Day 1)|Subject Decision|0|||
164391569|NCT03701555|593801863|FG007|Part 3 (Day 1)|Subject Decision|0|||
164391570|NCT03701555|593801864|FG008|Part 3 (Day 1)|Subject Decision|0|||
164391571|NCT03701555|593801865|FG009|Part 3 (Day 1)|Subject Decision|0|||
164391572|NCT03701555|593801866|FG010|Part 3 (Day 1)|Subject Decision|0|||
164391573|NCT03701555|593801867|FG011|Part 3 (Day 1)|Subject Decision|0|||
164391574|NCT03701555|593801868|FG012|Part 3 (Day 1)|Subject Decision|0|||
164391575|NCT03701555|593801869|FG013|Part 3 (Day 1)|Subject Decision|0|||
164391576|NCT03701555|593801870|FG014|Part 3 (Day 1)|Subject Decision|0|||
164391577|NCT03701555|593801871|FG015|Part 3 (Day 1)|Subject Decision|0|||
164391578|NCT03701555|593801872|FG016|Part 3 (Day 1)|Subject Decision|0|||
164391579|NCT03701555|593801873|FG017|Part 3 (Day 1)|Subject Decision|0|||
164391580|NCT03701555|593801874|FG018|Part 3 (Day 1)|Subject Decision|0|||
164391581|NCT03701555|593801875|FG019|Part 3 (Day 1)|Subject Decision|0|||
164391582|NCT03701555|593801876|FG020|Part 3 (Day 1)|Subject Decision|0|||
164391583|NCT03701555|593801877|FG021|Part 3 (Day 1)|Subject Decision|0|||
164391584|NCT03701555|593801878|FG022|Part 3 (Day 1)|Subject Decision|0|||
164391585|NCT03701555|593801879|FG023|Part 3 (Day 1)|Subject Decision|0|||
164391586|NCT03701555|593801880|FG024|Part 3 (Day 1)|Subject Decision|0|||
164391587|NCT03701555|593801881|FG025|Part 3 (Day 1)|Subject Decision|0|||
164391588|NCT03701555|593801882|FG026|Part 3 (Day 1)|Subject Decision|1|||
164391589|NCT03701555|593801883|FG027|Part 3 (Day 1)|Subject Decision|0|||
164391590|NCT03701555|593801884|FG028|Part 3 (Day 1)|Subject Decision|0|||
164391591|NCT03701555|593801885|FG029|Part 3 (Day 1)|Subject Decision|0|||
164391592|NCT03701555|593801886|FG030|Part 3 (Day 1)|Subject Decision|0|||
164391593|NCT03701555|593801887|FG031|Part 3 (Day 1)|Subject Decision|2|||
164391594|NCT03701555|593801888|FG032|Part 3 (Day 1)|Subject Decision|1|||
164391595|NCT03701555|593801889|FG033|Part 3 (Day 1)|Subject Decision|1|||
164391596|NCT03701555|593801890|FG034|Part 3 (Day 1)|Subject Decision|0|||
164391597|NCT03701555|593801891|FG035|Part 3 (Day 1)|Subject Decision|0|||
164391598|NCT03701555|593801856|FG000|Part 3 (Day 1)|Other|0|||
164391599|NCT03701555|593801857|FG001|Part 3 (Day 1)|Other|0|||
164391600|NCT03701555|593801858|FG002|Part 3 (Day 1)|Other|0|||
164391601|NCT03701555|593801859|FG003|Part 3 (Day 1)|Other|0|||
164391602|NCT03701555|593801860|FG004|Part 3 (Day 1)|Other|0|||
164391603|NCT03701555|593801861|FG005|Part 3 (Day 1)|Other|0|||
164391604|NCT03701555|593801862|FG006|Part 3 (Day 1)|Other|0|||
164391605|NCT03701555|593801863|FG007|Part 3 (Day 1)|Other|0|||
164391606|NCT03701555|593801864|FG008|Part 3 (Day 1)|Other|0|||
164391607|NCT03701555|593801865|FG009|Part 3 (Day 1)|Other|0|||
164391608|NCT03701555|593801866|FG010|Part 3 (Day 1)|Other|0|||
164391609|NCT03701555|593801867|FG011|Part 3 (Day 1)|Other|0|||
164391610|NCT03701555|593801868|FG012|Part 3 (Day 1)|Other|0|||
164391611|NCT03701555|593801869|FG013|Part 3 (Day 1)|Other|0|||
164391612|NCT03701555|593801870|FG014|Part 3 (Day 1)|Other|0|||
164391613|NCT03701555|593801871|FG015|Part 3 (Day 1)|Other|0|||
164391614|NCT03701555|593801872|FG016|Part 3 (Day 1)|Other|0|||
164391615|NCT03701555|593801873|FG017|Part 3 (Day 1)|Other|0|||
164391616|NCT03701555|593801874|FG018|Part 3 (Day 1)|Other|0|||
164391617|NCT03701555|593801875|FG019|Part 3 (Day 1)|Other|0|||
164391618|NCT03701555|593801876|FG020|Part 3 (Day 1)|Other|0|||
164391619|NCT03701555|593801877|FG021|Part 3 (Day 1)|Other|0|||
164391620|NCT03701555|593801878|FG022|Part 3 (Day 1)|Other|0|||
164391621|NCT03701555|593801879|FG023|Part 3 (Day 1)|Other|0|||
164391622|NCT03701555|593801880|FG024|Part 3 (Day 1)|Other|1|||
164391623|NCT03701555|593801881|FG025|Part 3 (Day 1)|Other|1|||
164391624|NCT03701555|593801882|FG026|Part 3 (Day 1)|Other|0|||
164391625|NCT03701555|593801883|FG027|Part 3 (Day 1)|Other|0|||
164391626|NCT03701555|593801884|FG028|Part 3 (Day 1)|Other|0|||
164391627|NCT03701555|593801885|FG029|Part 3 (Day 1)|Other|1|||
164391628|NCT03701555|593801886|FG030|Part 3 (Day 1)|Other|1|||
164391629|NCT03701555|593801887|FG031|Part 3 (Day 1)|Other|0|||
164391630|NCT03701555|593801888|FG032|Part 3 (Day 1)|Other|1|||
164391631|NCT03701555|593801889|FG033|Part 3 (Day 1)|Other|1|||
164391632|NCT03701555|593801890|FG034|Part 3 (Day 1)|Other|0|||
164391633|NCT03701555|593801891|FG035|Part 3 (Day 1)|Other|0|||
164391634|NCT00448539|593801892|FG000|Overall Study|Medication non-compliance|4|||
164391635|NCT00448539|593801893|FG001|Overall Study|Medication non-compliance|1|||
164391636|NCT00448539|593801892|FG000|Overall Study|Protocol Violation|1|||
164391637|NCT00448539|593801893|FG001|Overall Study|Protocol Violation|0|||
164391638|NCT00448539|593801892|FG000|Overall Study|Request of the investigator or sponsor|67|||
164391639|NCT00448539|593801893|FG001|Overall Study|Request of the investigator or sponsor|54|||
164391640|NCT00448539|593801892|FG000|Overall Study|Withdrawal by Subject|20|||
164391641|NCT00448539|593801893|FG001|Overall Study|Withdrawal by Subject|24|||
164391642|NCT00448539|593801892|FG000|Overall Study|Diary non-compliance|1|||
164391643|NCT00448539|593801893|FG001|Overall Study|Diary non-compliance|0|||
164391644|NCT00448539|593801892|FG000|Overall Study|Adverse Event|9|||
164391645|NCT00448539|593801893|FG001|Overall Study|Adverse Event|26|||
164391646|NCT00448539|593801892|FG000|Overall Study|Lack of Efficacy|27|||
164391647|NCT00448539|593801893|FG001|Overall Study|Lack of Efficacy|40|||
164391648|NCT00448539|593801892|FG000|Overall Study|Miscellaneous|2|||
164391649|NCT00448539|593801893|FG001|Overall Study|Miscellaneous|1|||
164391650|NCT00448539|593801892|FG000|Overall Study|Change of meds|2|||
164391651|NCT00448539|593801893|FG001|Overall Study|Change of meds|3|||
164391652|NCT00448539|593801892|FG000|Overall Study|Lost to Follow-up|1|||
164391653|NCT00448539|593801893|FG001|Overall Study|Lost to Follow-up|3|||
164391654|NCT03349710|593801894|FG000|Treatment Period|Death|0|||
164391655|NCT03349710|593801895|FG001|Treatment Period|Death|0|||
164391656|NCT03349710|593801896|FG002|Treatment Period|Death|1|||
164391657|NCT03349710|593801897|FG003|Treatment Period|Death|0|||
164391658|NCT03349710|593801894|FG000|Treatment Period|Disease Progression|0|||
164391659|NCT03349710|593801895|FG001|Treatment Period|Disease Progression|2|||
164391660|NCT03349710|593801896|FG002|Treatment Period|Disease Progression|0|||
164391661|NCT03349710|593801897|FG003|Treatment Period|Disease Progression|1|||
164391662|NCT03349710|593801894|FG000|Treatment Period|Study Drug Toxicity|1|||
164391663|NCT03349710|593801895|FG001|Treatment Period|Study Drug Toxicity|0|||
164391664|NCT03349710|593801896|FG002|Treatment Period|Study Drug Toxicity|1|||
164391665|NCT03349710|593801897|FG003|Treatment Period|Study Drug Toxicity|1|||
164391666|NCT03349710|593801894|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
164391667|NCT03349710|593801895|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
164391668|NCT03349710|593801896|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
164391669|NCT03349710|593801897|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
164391670|NCT03349710|593801894|FG000|Treatment Period|admin reason by sponsor|0|||
164391671|NCT03349710|593801895|FG001|Treatment Period|admin reason by sponsor|7|||
164391672|NCT03349710|593801896|FG002|Treatment Period|admin reason by sponsor|0|||
164391673|NCT03349710|593801897|FG003|Treatment Period|admin reason by sponsor|19|||
164391674|NCT03349710|593801894|FG000|Treatment Period|Other Reason|2|||
164391675|NCT03349710|593801895|FG001|Treatment Period|Other Reason|0|||
164391676|NCT03349710|593801896|FG002|Treatment Period|Other Reason|2|||
164391677|NCT03349710|593801897|FG003|Treatment Period|Other Reason|1|||
164391678|NCT03349710|593801894|FG000|Treatment Period|completed|6|||
164391679|NCT03349710|593801895|FG001|Treatment Period|completed|0|||
164391680|NCT03349710|593801896|FG002|Treatment Period|completed|18|||
164391681|NCT03349710|593801897|FG003|Treatment Period|completed|1|||
164391682|NCT03349710|593801894|FG000|Treatment Period|participant request to discontinue|0|||
164016142|NCT00365716|592421819|FG001|Extension 2|Withdrawal by Subject|0|||
164391683|NCT03349710|593801895|FG001|Treatment Period|participant request to discontinue|0|||
164391684|NCT03349710|593801896|FG002|Treatment Period|participant request to discontinue|4|||
164391685|NCT03349710|593801897|FG003|Treatment Period|participant request to discontinue|0|||
164391686|NCT03349710|593801894|FG000|Treatment Period|participant withdrew consent|1|||
164391687|NCT03349710|593801895|FG001|Treatment Period|participant withdrew consent|0|||
164391688|NCT03349710|593801896|FG002|Treatment Period|participant withdrew consent|0|||
164391689|NCT03349710|593801897|FG003|Treatment Period|participant withdrew consent|0|||
164391690|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
164391691|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
164391692|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
164391693|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
164391694|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
164391695|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
164391696|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
164391697|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
164391698|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
164391699|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
164391700|NCT00695903|593801898|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
164391701|NCT00695903|593801899|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
164391702|NCT00695903|593801898|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
164391703|NCT00695903|593801899|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
164391704|NCT00695903|593801898|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
164391705|NCT00695903|593801899|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
164391706|NCT00695903|593801898|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
164391707|NCT00695903|593801899|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
164391708|NCT01296568|593801902|FG000|Continued Access Phase|Lost to Follow-up|1|||
164391709|NCT01296568|593801902|FG000|Continued Access Phase|Withdrawal by Subject|1|||
164391710|NCT01296568|593801902|FG000|Continued Access Phase|Disease Progression|1|||
164391711|NCT01369342|593801908|FG000|Overall Study|Withdrawal by Subject|7|||
164391712|NCT01369342|593801909|FG001|Overall Study|Withdrawal by Subject|7|||
164391713|NCT01369342|593801910|FG002|Overall Study|Withdrawal by Subject|2|||
164391714|NCT01369342|593801908|FG000|Overall Study|Lost to Follow-up|5|||
164391715|NCT01369342|593801909|FG001|Overall Study|Lost to Follow-up|2|||
164391716|NCT01369342|593801910|FG002|Overall Study|Lost to Follow-up|1|||
164391717|NCT01369342|593801908|FG000|Overall Study|Not Treated|1|||
164391718|NCT01369342|593801909|FG001|Overall Study|Not Treated|0|||
164391719|NCT01369342|593801910|FG002|Overall Study|Not Treated|0|||
164391720|NCT00321854|593801911|FG000|Overall Study|Adverse Event|41|||
164391721|NCT00321854|593801912|FG001|Overall Study|Adverse Event|43|||
164391722|NCT00321854|593801911|FG000|Overall Study|Lack of Efficacy|9|||
164391723|NCT00321854|593801912|FG001|Overall Study|Lack of Efficacy|14|||
164391724|NCT00321854|593801911|FG000|Overall Study|Protocol Violation|6|||
164391725|NCT00321854|593801912|FG001|Overall Study|Protocol Violation|5|||
164391726|NCT00321854|593801911|FG000|Overall Study|Lost to Follow-up|0|||
164391727|NCT00321854|593801912|FG001|Overall Study|Lost to Follow-up|2|||
164391728|NCT00321854|593801911|FG000|Overall Study|Withdrawal by Subject|6|||
164391729|NCT00321854|593801912|FG001|Overall Study|Withdrawal by Subject|17|||
164391730|NCT00321854|593801911|FG000|Overall Study|Other|1|||
164391731|NCT00321854|593801912|FG001|Overall Study|Other|1|||
164391732|NCT01816594|593801913|FG000|Overall Study|Local Progress|0|||
164391733|NCT01816594|593801914|FG001|Overall Study|Local Progress|2|||
164391734|NCT01816594|593801913|FG000|Overall Study|Adverse Event|9|||
164391735|NCT01816594|593801914|FG001|Overall Study|Adverse Event|0|||
164391736|NCT01816594|593801913|FG000|Overall Study|Withdrawal by Subject|1|||
164391737|NCT01816594|593801914|FG001|Overall Study|Withdrawal by Subject|0|||
164391738|NCT01816594|593801913|FG000|Overall Study|Physician Decision|1|||
164391739|NCT01816594|593801914|FG001|Overall Study|Physician Decision|0|||
164391740|NCT04723576|593801915|FG000|Overall Study|Withdrawal by Subject|2133|||
164391741|NCT04723576|593801916|FG001|Overall Study|Withdrawal by Subject|3234|||
164391742|NCT03905655|593801917|FG000|Overall Study|Adverse Event|1|||
164391743|NCT03905655|593801918|FG001|Overall Study|Adverse Event|0|||
164391744|NCT03905655|593801919|FG002|Overall Study|Adverse Event|1|||
164391745|NCT03905655|593801920|FG003|Overall Study|Adverse Event|1|||
164016143|NCT00365716|592421820|FG002|Extension 2|Withdrawal by Subject|0|||
164391746|NCT03204279|593801924|FG000|Overall Study|Withdrawal by Subject|0|||
164391747|NCT03204279|593801925|FG001|Overall Study|Withdrawal by Subject|1|||
164391748|NCT01064739|593801926|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
164391749|NCT04827212|593801927|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
164391750|NCT04827212|593801928|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
164391751|NCT04827212|593801927|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
164391752|NCT04827212|593801928|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
164391753|NCT00454051|593801929|FG000|Overall Study|Adverse Event|1|||
164391754|NCT00454051|593801930|FG001|Overall Study|Adverse Event|2|||
164391755|NCT00454051|593801929|FG000|Overall Study|Withdrawal by Subject|1|||
164391756|NCT00454051|593801930|FG001|Overall Study|Withdrawal by Subject|0|||
164391757|NCT00454051|593801929|FG000|Overall Study|Protocol Violation|1|||
164391758|NCT00454051|593801930|FG001|Overall Study|Protocol Violation|1|||
164391759|NCT04258020|593801931|FG000|Overall Study|Withdrawal by Subject|1|||
164391760|NCT04258020|593801932|FG001|Overall Study|Withdrawal by Subject|0|||
164391761|NCT02097472|593801935|FG000|Received Vaccination 2|Adverse Event|0|||
164391762|NCT02097472|593801936|FG001|Received Vaccination 2|Adverse Event|0|||
164391763|NCT02097472|593801937|FG002|Received Vaccination 2|Adverse Event|0|||
164391764|NCT02097472|593801938|FG003|Received Vaccination 2|Adverse Event|0|||
164391765|NCT02097472|593801939|FG004|Received Vaccination 2|Adverse Event|0|||
164391766|NCT02097472|593801940|FG005|Received Vaccination 2|Adverse Event|0|||
164391767|NCT02097472|593801941|FG006|Received Vaccination 2|Adverse Event|1|||
164391768|NCT02097472|593801942|FG007|Received Vaccination 2|Adverse Event|0|||
164391769|NCT01669629|593801943|FG000|Period 1|protocol deviation|1|||
164391770|NCT01669629|593801944|FG001|Period 1|protocol deviation|2|||
164391771|NCT04402866|593801947|FG000|Overall Study|Discontinued Prior to Treatment|0|||
164391772|NCT04402866|593801948|FG001|Overall Study|Discontinued Prior to Treatment|0|||
164391773|NCT04402866|593801949|FG002|Overall Study|Discontinued Prior to Treatment|0|||
164391774|NCT04402866|593801950|FG003|Overall Study|Discontinued Prior to Treatment|0|||
164391775|NCT04402866|593801951|FG004|Overall Study|Discontinued Prior to Treatment|2|||
164391776|NCT04402866|593801952|FG005|Overall Study|Discontinued Prior to Treatment|3|||
164391777|NCT04402866|593801947|FG000|Overall Study|Adverse Event|2|||
164391778|NCT04402866|593801948|FG001|Overall Study|Adverse Event|1|||
164391779|NCT04402866|593801949|FG002|Overall Study|Adverse Event|0|||
164391780|NCT04402866|593801950|FG003|Overall Study|Adverse Event|0|||
164391781|NCT04402866|593801951|FG004|Overall Study|Adverse Event|13|||
164391782|NCT04402866|593801952|FG005|Overall Study|Adverse Event|8|||
164391783|NCT04402866|593801947|FG000|Overall Study|Miscellaneous|0|||
164391784|NCT04402866|593801948|FG001|Overall Study|Miscellaneous|0|||
164391785|NCT04402866|593801949|FG002|Overall Study|Miscellaneous|1|||
164391786|NCT04402866|593801950|FG003|Overall Study|Miscellaneous|0|||
164391787|NCT04402866|593801951|FG004|Overall Study|Miscellaneous|0|||
164391788|NCT04402866|593801952|FG005|Overall Study|Miscellaneous|0|||
164391789|NCT04402866|593801947|FG000|Overall Study|Lost to Follow-up|0|||
164391790|NCT04402866|593801948|FG001|Overall Study|Lost to Follow-up|0|||
164391791|NCT04402866|593801949|FG002|Overall Study|Lost to Follow-up|0|||
164391792|NCT04402866|593801950|FG003|Overall Study|Lost to Follow-up|0|||
164391793|NCT04402866|593801951|FG004|Overall Study|Lost to Follow-up|0|||
164391794|NCT04402866|593801952|FG005|Overall Study|Lost to Follow-up|1|||
164391795|NCT04402866|593801947|FG000|Overall Study|Withdrawal by Subject|0|||
164391796|NCT04402866|593801948|FG001|Overall Study|Withdrawal by Subject|0|||
164391797|NCT04402866|593801949|FG002|Overall Study|Withdrawal by Subject|0|||
164391798|NCT04402866|593801950|FG003|Overall Study|Withdrawal by Subject|0|||
164391799|NCT04402866|593801951|FG004|Overall Study|Withdrawal by Subject|0|||
164391800|NCT04402866|593801952|FG005|Overall Study|Withdrawal by Subject|2|||
164093132|NCT05014412|592703486|FG002|Overall Study|Withdrawal by Subject|1|||
164391801|NCT01292928|593801953|FG000|Overall Study|Death|8|||
164391802|NCT01292928|593801953|FG000|Overall Study|Withdrawal by Subject|8|||
164391803|NCT01292928|593801953|FG000|Overall Study|Lost to Follow-up|6|||
164391804|NCT01292928|593801953|FG000|Overall Study|Physician Decision|2|||
164391805|NCT03927950|593801959|FG000|Overall Study|Adverse Event|9|||
164391806|NCT03263429|593801960|FG000|Overall Study|Withdrawal by Subject|0|||
164391807|NCT03263429|593801961|FG001|Overall Study|Withdrawal by Subject|1|||
164391808|NCT03263429|593801962|FG002|Overall Study|Withdrawal by Subject|0|||
164391809|NCT03263429|593801960|FG000|Overall Study|Follow-Up Period Completed|0|||
164391810|NCT03263429|593801961|FG001|Overall Study|Follow-Up Period Completed|2|||
164391811|NCT03263429|593801962|FG002|Overall Study|Follow-Up Period Completed|0|||
164391812|NCT03263429|593801960|FG000|Overall Study|Death|3|||
164391813|NCT03263429|593801961|FG001|Overall Study|Death|5|||
164391814|NCT03263429|593801962|FG002|Overall Study|Death|16|||
164391815|NCT03263429|593801960|FG000|Overall Study|Participant unable to return|0|||
164391816|NCT03263429|593801961|FG001|Overall Study|Participant unable to return|0|||
164093133|NCT05014412|592703487|FG003|Overall Study|Withdrawal by Subject|2|||
164093134|NCT05014412|592703484|FG000|Overall Study|Ongoing|21|||
164391817|NCT03263429|593801962|FG002|Overall Study|Participant unable to return|1|||
164391818|NCT03263429|593801960|FG000|Overall Study|Study Closed|0|||
164391819|NCT03263429|593801961|FG001|Overall Study|Study Closed|0|||
164391820|NCT03263429|593801962|FG002|Overall Study|Study Closed|1|||
164391821|NCT04530448|593801963|FG000|Overall Study|Physician Decision|3|||
164391822|NCT04530448|593801964|FG001|Overall Study|Physician Decision|0|||
164391823|NCT01519206|593801965|FG000|Overall Study|Lost to Follow-up|3|||
164391824|NCT01519206|593801965|FG000|Overall Study|Missed Visit|2|||
164391825|NCT02014116|593801966|FG000|Overall Study|Progressive Disease|3|||
164391826|NCT02014116|593801967|FG001|Overall Study|Progressive Disease|4|||
164391827|NCT02014116|593801968|FG002|Overall Study|Progressive Disease|2|||
164391828|NCT02014116|593801969|FG003|Overall Study|Progressive Disease|6|||
164391829|NCT02014116|593801970|FG004|Overall Study|Progressive Disease|1|||
164391830|NCT02014116|593801971|FG005|Overall Study|Progressive Disease|13|||
164391831|NCT02014116|593801972|FG006|Overall Study|Progressive Disease|1|||
164391832|NCT02014116|593801973|FG007|Overall Study|Progressive Disease|3|||
164391833|NCT02014116|593801974|FG008|Overall Study|Progressive Disease|7|||
164391834|NCT02014116|593801966|FG000|Overall Study|Adverse Event|0|||
164391835|NCT02014116|593801967|FG001|Overall Study|Adverse Event|0|||
164391836|NCT02014116|593801968|FG002|Overall Study|Adverse Event|0|||
164391837|NCT02014116|593801969|FG003|Overall Study|Adverse Event|0|||
164391838|NCT02014116|593801970|FG004|Overall Study|Adverse Event|1|||
164391839|NCT02014116|593801971|FG005|Overall Study|Adverse Event|0|||
164391840|NCT02014116|593801972|FG006|Overall Study|Adverse Event|0|||
164391841|NCT02014116|593801973|FG007|Overall Study|Adverse Event|1|||
164391842|NCT02014116|593801974|FG008|Overall Study|Adverse Event|0|||
164391843|NCT02014116|593801966|FG000|Overall Study|Lost to Follow-up|0|||
164391844|NCT02014116|593801967|FG001|Overall Study|Lost to Follow-up|0|||
164391845|NCT02014116|593801968|FG002|Overall Study|Lost to Follow-up|0|||
164391846|NCT02014116|593801969|FG003|Overall Study|Lost to Follow-up|0|||
164391847|NCT02014116|593801970|FG004|Overall Study|Lost to Follow-up|0|||
164391848|NCT02014116|593801971|FG005|Overall Study|Lost to Follow-up|1|||
164391849|NCT02014116|593801972|FG006|Overall Study|Lost to Follow-up|0|||
164391850|NCT02014116|593801973|FG007|Overall Study|Lost to Follow-up|0|||
164391851|NCT02014116|593801974|FG008|Overall Study|Lost to Follow-up|1|||
164391852|NCT02014116|593801966|FG000|Overall Study|Death|0|||
164391853|NCT02014116|593801967|FG001|Overall Study|Death|0|||
164391854|NCT02014116|593801968|FG002|Overall Study|Death|0|||
164391855|NCT02014116|593801969|FG003|Overall Study|Death|0|||
164391856|NCT02014116|593801970|FG004|Overall Study|Death|0|||
164391857|NCT02014116|593801971|FG005|Overall Study|Death|0|||
164391858|NCT02014116|593801972|FG006|Overall Study|Death|0|||
164391859|NCT02014116|593801973|FG007|Overall Study|Death|1|||
164391860|NCT02014116|593801974|FG008|Overall Study|Death|1|||
164391861|NCT02014116|593801966|FG000|Overall Study|Withdrawal by Subject|0|||
164391862|NCT02014116|593801967|FG001|Overall Study|Withdrawal by Subject|0|||
164391863|NCT02014116|593801968|FG002|Overall Study|Withdrawal by Subject|1|||
164391864|NCT02014116|593801969|FG003|Overall Study|Withdrawal by Subject|1|||
164391865|NCT02014116|593801970|FG004|Overall Study|Withdrawal by Subject|0|||
164391866|NCT02014116|593801971|FG005|Overall Study|Withdrawal by Subject|1|||
164391867|NCT02014116|593801972|FG006|Overall Study|Withdrawal by Subject|0|||
164391868|NCT02014116|593801973|FG007|Overall Study|Withdrawal by Subject|0|||
164391869|NCT02014116|593801974|FG008|Overall Study|Withdrawal by Subject|0|||
164391870|NCT02014116|593801966|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
164391871|NCT02014116|593801967|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
164391872|NCT02014116|593801968|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
164391873|NCT02014116|593801969|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
164391874|NCT02014116|593801970|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
164391875|NCT02014116|593801971|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
164391876|NCT02014116|593801972|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
164391877|NCT02014116|593801973|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
164391878|NCT02014116|593801974|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
164391879|NCT02014116|593801966|FG000|Overall Study|Physician Decision|0|||
164391880|NCT02014116|593801967|FG001|Overall Study|Physician Decision|0|||
164391881|NCT02014116|593801968|FG002|Overall Study|Physician Decision|0|||
164391882|NCT02014116|593801969|FG003|Overall Study|Physician Decision|0|||
164391883|NCT02014116|593801970|FG004|Overall Study|Physician Decision|0|||
164391884|NCT02014116|593801971|FG005|Overall Study|Physician Decision|0|||
164391885|NCT02014116|593801972|FG006|Overall Study|Physician Decision|0|||
164391886|NCT02014116|593801973|FG007|Overall Study|Physician Decision|0|||
164391887|NCT02014116|593801974|FG008|Overall Study|Physician Decision|1|||
164391888|NCT01491854|593801975|FG000|Overall Study|mainly due to premature termination|93|||
164391889|NCT01491854|593801975|FG000|Overall Study|Death|1|||
164391890|NCT01491854|593801975|FG000|Overall Study|Withdrawal by Subject|3|||
164093135|NCT05014412|592703485|FG001|Overall Study|Ongoing|4|||
164093136|NCT05014412|592703486|FG002|Overall Study|Ongoing|6|||
164093137|NCT05014412|592703487|FG003|Overall Study|Ongoing|20|||
164093138|NCT00414765|592703489|FG000|Overall Study|Adverse Event|5|||
164391891|NCT01491854|593801975|FG000|Overall Study|Lost to Follow-up|33|||
164391892|NCT05545072|593801984|FG000|Overall Study|Lost to Follow-up|1|||
164391893|NCT05545072|593801985|FG001|Overall Study|Lost to Follow-up|0|||
164391894|NCT05545072|593801984|FG000|Overall Study|Study ended prematurely due to funding|2|||
164391895|NCT05545072|593801985|FG001|Overall Study|Study ended prematurely due to funding|2|||
164391896|NCT02395042|593801986|FG000|Treatment 1 Period|Adverse Event|1|||
164391897|NCT02395042|593801987|FG001|Treatment 1 Period|Adverse Event|3|||
164391898|NCT02395042|593801988|FG002|Treatment 1 Period|Adverse Event|1|||
164391899|NCT02395042|593801986|FG000|Treatment 1 Period|Lack of Efficacy|1|||
164391900|NCT02395042|593801987|FG001|Treatment 1 Period|Lack of Efficacy|1|||
164391901|NCT02395042|593801988|FG002|Treatment 1 Period|Lack of Efficacy|0|||
164391902|NCT02395042|593801986|FG000|Treatment 1 Period|Lost to Follow-up|1|||
164093139|NCT00414765|592703490|FG001|Overall Study|Adverse Event|9|||
164391903|NCT02395042|593801987|FG001|Treatment 1 Period|Lost to Follow-up|0|||
164391904|NCT02395042|593801988|FG002|Treatment 1 Period|Lost to Follow-up|0|||
164391905|NCT02395042|593801986|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
164391906|NCT02395042|593801987|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
164391907|NCT02395042|593801988|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
164391908|NCT02395042|593801986|FG000|Treatment 2 Period|Lack of Efficacy|1|||
164391909|NCT02395042|593801987|FG001|Treatment 2 Period|Lack of Efficacy|1|||
164391910|NCT02395042|593801988|FG002|Treatment 2 Period|Lack of Efficacy|0|||
164391911|NCT03638141|593801989|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
164391912|NCT03996473|593801990|FG000|Treatment Assignment|Withdrawal by Subject|1|||
164391913|NCT03996473|593801990|FG000|Treatment Assignment|Progressive disease|6|||
164391914|NCT03996473|593801990|FG000|Treatment Assignment|Study drug never administered|1|||
164391915|NCT03996473|593801990|FG000|Active Follow-up|Death|1|||
164391916|NCT03996473|593801990|FG000|Long-term Follow-up|Death|5|||
164391917|NCT03759873|593801991|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
164391918|NCT03759873|593801992|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
164391919|NCT03759873|593801993|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
164391920|NCT03759873|593801994|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
164391921|NCT03759873|593801991|FG000|Overall Study|Moved outside eligible area|0|||
164391922|NCT03759873|593801992|FG001|Overall Study|Moved outside eligible area|2|||
164391923|NCT03759873|593801993|FG002|Overall Study|Moved outside eligible area|0|||
164391924|NCT03759873|593801994|FG003|Overall Study|Moved outside eligible area|0|||
164391925|NCT03759873|593801991|FG000|Overall Study|Withdrawal by Subject|0|||
164391926|NCT03759873|593801992|FG001|Overall Study|Withdrawal by Subject|0|||
164391927|NCT03759873|593801993|FG002|Overall Study|Withdrawal by Subject|1|||
164391928|NCT03759873|593801994|FG003|Overall Study|Withdrawal by Subject|0|||
164391929|NCT03579563|593801997|FG000|Overall Study|Lost to Follow-up|0|||
164391930|NCT03579563|593801998|FG001|Overall Study|Lost to Follow-up|0|||
164391931|NCT03579563|593801999|FG002|Overall Study|Lost to Follow-up|0|||
164391932|NCT03579563|593802000|FG003|Overall Study|Lost to Follow-up|0|||
164391933|NCT03579563|593802001|FG004|Overall Study|Lost to Follow-up|1|||
164391934|NCT03579563|593802002|FG005|Overall Study|Lost to Follow-up|0|||
164391935|NCT03579563|593801997|FG000|Overall Study|Lack of Efficacy|1|||
164391936|NCT03579563|593801998|FG001|Overall Study|Lack of Efficacy|1|||
164391937|NCT03579563|593801999|FG002|Overall Study|Lack of Efficacy|4|||
164391938|NCT03579563|593802000|FG003|Overall Study|Lack of Efficacy|1|||
164391939|NCT03579563|593802001|FG004|Overall Study|Lack of Efficacy|2|||
164391940|NCT03579563|593802002|FG005|Overall Study|Lack of Efficacy|3|||
164391941|NCT03579563|593801997|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
164391942|NCT03579563|593801998|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
164391943|NCT03579563|593801999|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
164391944|NCT03579563|593802000|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
164391945|NCT03579563|593802001|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
164391946|NCT03579563|593802002|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
164391947|NCT03579563|593801997|FG000|Overall Study|Time/distance concern|0|||
164391948|NCT03579563|593801998|FG001|Overall Study|Time/distance concern|0|||
164391949|NCT03579563|593801999|FG002|Overall Study|Time/distance concern|1|||
164391950|NCT03579563|593802000|FG003|Overall Study|Time/distance concern|0|||
164391951|NCT03579563|593802001|FG004|Overall Study|Time/distance concern|0|||
164391952|NCT03579563|593802002|FG005|Overall Study|Time/distance concern|1|||
164391953|NCT03579563|593801997|FG000|Overall Study|COVID shutdown|2|||
164391954|NCT03579563|593801998|FG001|Overall Study|COVID shutdown|3|||
164391955|NCT03579563|593801999|FG002|Overall Study|COVID shutdown|4|||
164391956|NCT03579563|593802000|FG003|Overall Study|COVID shutdown|3|||
164391957|NCT03579563|593802001|FG004|Overall Study|COVID shutdown|1|||
164391958|NCT03579563|593802002|FG005|Overall Study|COVID shutdown|2|||
164391959|NCT03579563|593801997|FG000|Overall Study|Protocol administration error|1|||
164391960|NCT03579563|593801998|FG001|Overall Study|Protocol administration error|0|||
164016144|NCT00365716|592421821|FG003|Extension 2|Withdrawal by Subject|0|||
164016145|NCT00365716|592421822|FG004|Extension 2|Withdrawal by Subject|0|||
164016146|NCT00365716|592421823|FG005|Extension 2|Withdrawal by Subject|0|||
164016147|NCT00365716|592421824|FG006|Extension 2|Withdrawal by Subject|5|||
164391961|NCT03579563|593801999|FG002|Overall Study|Protocol administration error|1|||
164391962|NCT03579563|593802000|FG003|Overall Study|Protocol administration error|0|||
164391963|NCT03579563|593802001|FG004|Overall Study|Protocol administration error|1|||
164391964|NCT03579563|593802002|FG005|Overall Study|Protocol administration error|5|||
164391965|NCT03621696|593802003|FG000|Overall Study|Not eligible|0|||
164016148|NCT02853331|592421825|FG000|Overall Study|Death|59|||
164391966|NCT03621696|593802004|FG001|Overall Study|Not eligible|0|||
164391967|NCT03621696|593802005|FG002|Overall Study|Not eligible|0|||
164391968|NCT03621696|593802006|FG003|Overall Study|Not eligible|5|||
164391969|NCT03621696|593802003|FG000|Overall Study|Withdrawal by Subject|1|||
164391970|NCT03621696|593802004|FG001|Overall Study|Withdrawal by Subject|1|||
164391971|NCT03621696|593802005|FG002|Overall Study|Withdrawal by Subject|1|||
164391972|NCT03621696|593802006|FG003|Overall Study|Withdrawal by Subject|0|||
164391973|NCT03621696|593802003|FG000|Overall Study|Physician Decision|0|||
164391974|NCT03621696|593802004|FG001|Overall Study|Physician Decision|0|||
164391975|NCT03621696|593802005|FG002|Overall Study|Physician Decision|1|||
164391976|NCT03621696|593802006|FG003|Overall Study|Physician Decision|0|||
164391977|NCT01910519|593802007|FG000|Overall Study|Withdrawal by Subject|2|||
164391978|NCT01910519|593802008|FG001|Overall Study|Withdrawal by Subject|0|||
164391979|NCT01910519|593802007|FG000|Overall Study|Adverse Event|2|||
164391980|NCT01910519|593802008|FG001|Overall Study|Adverse Event|0|||
164391981|NCT02720484|593802011|FG000|Treatment on Study|Adverse Event|1|||
164391982|NCT02720484|593802011|FG000|Treatment on Study|Withdrawal by Subject|1|||
164391983|NCT02720484|593802011|FG000|Treatment on Study|Progressive Disease|4|||
164391984|NCT02720484|593802011|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
164391985|NCT02720484|593802011|FG000|Follow Up for 2 Years|Death|3|||
164391986|NCT02720484|593802011|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
164391987|NCT03832946|593802020|FG000|Overall Study|Adverse Event|3|||
164391988|NCT03832946|593802021|FG001|Overall Study|Adverse Event|1|||
164391989|NCT03832946|593802020|FG000|Overall Study|Lost to Follow-up|1|||
164391990|NCT03832946|593802021|FG001|Overall Study|Lost to Follow-up|0|||
164391991|NCT03832946|593802020|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
164391992|NCT03832946|593802021|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
164391993|NCT03832946|593802020|FG000|Overall Study|Lack of Efficacy|1|||
164391994|NCT03832946|593802021|FG001|Overall Study|Lack of Efficacy|0|||
164391995|NCT03832946|593802020|FG000|Overall Study|Withdrawal by Subject|12|||
164391996|NCT03832946|593802021|FG001|Overall Study|Withdrawal by Subject|9|||
163905049|NCT01079806|592023743|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
163905050|NCT01079806|592023742|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
163905051|NCT01079806|592023743|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
164391997|NCT01003249|593802024|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164391998|NCT01003249|593802025|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164391999|NCT01003249|593802024|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
164392000|NCT01003249|593802025|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
164392001|NCT01003249|593802024|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164392002|NCT01003249|593802025|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164392003|NCT01003249|593802024|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
164392004|NCT01003249|593802025|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
164392005|NCT02276482|593802028|FG000|Overall Study|Adverse Event|1|||
164392006|NCT02276482|593802029|FG001|Overall Study|Adverse Event|0|||
164392007|NCT02276482|593802028|FG000|Overall Study|Withdrawal by Subject|1|||
164392008|NCT02276482|593802029|FG001|Overall Study|Withdrawal by Subject|0|||
164392009|NCT02276482|593802028|FG000|Overall Study|Gram-negative infection|1|||
164392010|NCT02276482|593802029|FG001|Overall Study|Gram-negative infection|0|||
164392011|NCT02276482|593802028|FG000|Overall Study|Reason not specified|0|||
164392012|NCT02276482|593802029|FG001|Overall Study|Reason not specified|1|||
164392013|NCT02005471|593802036|FG000|Main Study|Adverse Event|0|||
164392014|NCT02005471|593802037|FG001|Main Study|Adverse Event|1|||
163905052|NCT01079806|592023742|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
164392015|NCT02005471|593802038|FG002|Main Study|Adverse Event|0|||
164392016|NCT02005471|593802039|FG003|Main Study|Adverse Event|0|||
164392017|NCT02005471|593802036|FG000|Main Study|Death|83|||
164392018|NCT02005471|593802037|FG001|Main Study|Death|52|||
164392019|NCT02005471|593802038|FG002|Main Study|Death|0|||
164392020|NCT02005471|593802039|FG003|Main Study|Death|0|||
164392021|NCT02005471|593802036|FG000|Main Study|Lost to Follow-up|4|||
163905053|NCT01079806|592023743|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
164392022|NCT02005471|593802037|FG001|Main Study|Lost to Follow-up|5|||
164392023|NCT02005471|593802038|FG002|Main Study|Lost to Follow-up|0|||
164392024|NCT02005471|593802039|FG003|Main Study|Lost to Follow-up|0|||
164392025|NCT02005471|593802036|FG000|Main Study|Physician Decision|3|||
164392026|NCT02005471|593802037|FG001|Main Study|Physician Decision|1|||
163905054|NCT01079806|592023742|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
164392027|NCT02005471|593802038|FG002|Main Study|Physician Decision|0|||
164392028|NCT02005471|593802039|FG003|Main Study|Physician Decision|0|||
164392029|NCT02005471|593802036|FG000|Main Study|Withdrawal by Subject|26|||
164392030|NCT02005471|593802037|FG001|Main Study|Withdrawal by Subject|11|||
164392031|NCT02005471|593802038|FG002|Main Study|Withdrawal by Subject|0|||
164392032|NCT02005471|593802039|FG003|Main Study|Withdrawal by Subject|0|||
164392033|NCT02005471|593802036|FG000|Main Study|Reason not Specified|0|||
164392034|NCT02005471|593802037|FG001|Main Study|Reason not Specified|6|||
164392035|NCT02005471|593802038|FG002|Main Study|Reason not Specified|0|||
164392036|NCT02005471|593802039|FG003|Main Study|Reason not Specified|0|||
164392037|NCT02005471|593802036|FG000|Main Study|Randomized but not Dosed|8|||
164392038|NCT02005471|593802037|FG001|Main Study|Randomized but not Dosed|0|||
164392039|NCT02005471|593802038|FG002|Main Study|Randomized but not Dosed|0|||
164392040|NCT02005471|593802039|FG003|Main Study|Randomized but not Dosed|0|||
164392041|NCT02005471|593802036|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
164392042|NCT02005471|593802037|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
164392043|NCT02005471|593802038|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
164392044|NCT02005471|593802039|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
164392045|NCT02005471|593802036|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
164392046|NCT02005471|593802037|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
164392047|NCT02005471|593802038|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
164392048|NCT02005471|593802039|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
164392049|NCT02005471|593802036|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
164392050|NCT02005471|593802037|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
164392051|NCT02005471|593802038|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
164392052|NCT02005471|593802039|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
164392053|NCT03712917|593802043|FG000|Overall Study|Pregnancy|0|||
164392054|NCT03712917|593802044|FG001|Overall Study|Pregnancy|0|||
164392055|NCT03712917|593802045|FG002|Overall Study|Pregnancy|1|||
164392056|NCT03712917|593802043|FG000|Overall Study|Adverse Event|0|||
164392057|NCT03712917|593802044|FG001|Overall Study|Adverse Event|4|||
164392058|NCT03712917|593802045|FG002|Overall Study|Adverse Event|3|||
164392059|NCT03712917|593802043|FG000|Overall Study|Lost to Follow-up|9|||
164392060|NCT03712917|593802044|FG001|Overall Study|Lost to Follow-up|4|||
164392061|NCT03712917|593802045|FG002|Overall Study|Lost to Follow-up|5|||
164392062|NCT00110617|593802046|FG000|Overall Study|Adverse Event|2|||
164392063|NCT00110617|593802047|FG001|Overall Study|Adverse Event|4|||
164392064|NCT00110617|593802046|FG000|Overall Study|Abnormal Laboratory Value|4|||
164392065|NCT00110617|593802047|FG001|Overall Study|Abnormal Laboratory Value|2|||
164392066|NCT00110617|593802046|FG000|Overall Study|Lack of Efficacy|1|||
164392067|NCT00110617|593802047|FG001|Overall Study|Lack of Efficacy|0|||
164392068|NCT00110617|593802046|FG000|Overall Study|Patient no longer requires study drug|1|||
164392069|NCT00110617|593802047|FG001|Overall Study|Patient no longer requires study drug|0|||
164392070|NCT00110617|593802046|FG000|Overall Study|Protocol Violation|5|||
164392071|NCT00110617|593802047|FG001|Overall Study|Protocol Violation|0|||
164392072|NCT00110617|593802046|FG000|Overall Study|Withdrawal by Subject|10|||
164392073|NCT00110617|593802047|FG001|Overall Study|Withdrawal by Subject|4|||
164392074|NCT00110617|593802046|FG000|Overall Study|Lost to Follow-up|9|||
164392075|NCT00110617|593802047|FG001|Overall Study|Lost to Follow-up|1|||
164392076|NCT00110617|593802046|FG000|Overall Study|Administrative problems|6|||
164392077|NCT00110617|593802047|FG001|Overall Study|Administrative problems|5|||
164392078|NCT00110617|593802046|FG000|Overall Study|Death|1|||
164392079|NCT00110617|593802047|FG001|Overall Study|Death|1|||
164016149|NCT02853331|592421826|FG001|Overall Study|Death|95|||
164016150|NCT02853331|592421825|FG000|Overall Study|Withdrawal by Subject|5|||
164016151|NCT02853331|592421826|FG001|Overall Study|Withdrawal by Subject|9|||
164016152|NCT02853331|592421825|FG000|Overall Study|Ongoing in study|368|||
164016153|NCT02853331|592421826|FG001|Overall Study|Ongoing in study|325|||
164016154|NCT00844428|592421827|FG000|Screening Period|Screen Failure|3|||
164016155|NCT00844428|592421827|FG000|Extension Treatment Period|Death|1|||
164016156|NCT00844428|592421827|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
164392080|NCT00110617|593802046|FG000|Overall Study|Did not receive study drug|0|||
164392081|NCT00110617|593802047|FG001|Overall Study|Did not receive study drug|12|||
164392082|NCT03230916|593802049|FG000|Overall Study|Withdrawal by Subject|0|||
164392083|NCT03230916|593802050|FG001|Overall Study|Withdrawal by Subject|0|||
164392084|NCT03230916|593802051|FG002|Overall Study|Withdrawal by Subject|0|||
164392085|NCT03230916|593802052|FG003|Overall Study|Withdrawal by Subject|0|||
164392086|NCT03230916|593802053|FG004|Overall Study|Withdrawal by Subject|0|||
164392087|NCT03230916|593802054|FG005|Overall Study|Withdrawal by Subject|1|||
164016157|NCT02375698|592421828|FG000|Overall Study|Withdrawal by Subject|0|||
164016158|NCT02375698|592421829|FG001|Overall Study|Withdrawal by Subject|2|||
164093140|NCT00414765|592703489|FG000|Overall Study|Withdrawal by Subject|1|||
164093141|NCT00414765|592703490|FG001|Overall Study|Withdrawal by Subject|1|||
164392088|NCT03230916|593802055|FG006|Overall Study|Withdrawal by Subject|0|||
164392089|NCT03230916|593802056|FG007|Overall Study|Withdrawal by Subject|0|||
164392090|NCT03230916|593802057|FG008|Overall Study|Withdrawal by Subject|0|||
164392091|NCT03230916|593802058|FG009|Overall Study|Withdrawal by Subject|0|||
164392092|NCT03230916|593802059|FG010|Overall Study|Withdrawal by Subject|0|||
164392093|NCT01438541|593802060|FG000|Overall Study|Physician Decision|1|||
164392094|NCT01438541|593802060|FG000|Overall Study|Withdrawal by Subject|1|||
164016159|NCT02375698|592421828|FG000|Overall Study|Physician Decision|2|||
164392095|NCT01438541|593802060|FG000|Overall Study|discharge from the hospital|5|||
164392096|NCT02091167|593802061|FG000|Overall Study|Lost to Follow-up|0|||
164392097|NCT02091167|593802062|FG001|Overall Study|Lost to Follow-up|2|||
164392098|NCT01559844|593804978|FG000|Overall Study|Consent Withdrawn|7|||
164016160|NCT02375698|592421829|FG001|Overall Study|Physician Decision|0|||
164016161|NCT01595646|592421830|FG000|Overall Study|Withdrawal by Subject|1|||
164016162|NCT01595646|592421831|FG001|Overall Study|Withdrawal by Subject|0|||
164016163|NCT01595646|592421832|FG002|Overall Study|Withdrawal by Subject|0|||
164016164|NCT01161524|592421834|FG000|Core Study (23 Weeks)|Adverse Event|3|||
164016165|NCT01161524|592421835|FG001|Core Study (23 Weeks)|Adverse Event|0|||
164016166|NCT01161524|592421836|FG002|Core Study (23 Weeks)|Adverse Event|0|||
164016167|NCT01161524|592421834|FG000|Core Study (23 Weeks)|Other|1|||
164016168|NCT01161524|592421835|FG001|Core Study (23 Weeks)|Other|0|||
164016169|NCT01161524|592421836|FG002|Core Study (23 Weeks)|Other|0|||
164016170|NCT01161524|592421834|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
164016171|NCT01161524|592421835|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
164016172|NCT01161524|592421836|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
164016173|NCT01161524|592421834|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
164392099|NCT01559844|593804978|FG000|Overall Study|Death|5|||
164392100|NCT01559844|593804978|FG000|Overall Study|Efficacy Failure|10|||
164392101|NCT01559844|593804978|FG000|Overall Study|No Longer A Transplant Candidate|3|||
164392102|NCT02181803|593804979|FG000|Overall Study|Withdrawal by Subject|0|||
164392103|NCT02181803|593804980|FG001|Overall Study|Withdrawal by Subject|2|||
164392104|NCT02181803|593804981|FG002|Overall Study|Withdrawal by Subject|0|||
164392105|NCT02181803|593804982|FG003|Overall Study|Withdrawal by Subject|0|||
164392106|NCT02181803|593804983|FG004|Overall Study|Withdrawal by Subject|0|||
164392107|NCT02181803|593804984|FG005|Overall Study|Withdrawal by Subject|0|||
164392108|NCT02181803|593804985|FG006|Overall Study|Withdrawal by Subject|0|||
164392109|NCT02181803|593804986|FG007|Overall Study|Withdrawal by Subject|0|||
164392110|NCT02181803|593804987|FG008|Overall Study|Withdrawal by Subject|0|||
164392111|NCT02181803|593804979|FG000|Overall Study|Physician Decision|0|||
164392112|NCT02181803|593804980|FG001|Overall Study|Physician Decision|0|||
164392113|NCT02181803|593804981|FG002|Overall Study|Physician Decision|0|||
164392114|NCT02181803|593804982|FG003|Overall Study|Physician Decision|1|||
164392115|NCT02181803|593804983|FG004|Overall Study|Physician Decision|0|||
164392116|NCT02181803|593804984|FG005|Overall Study|Physician Decision|0|||
164392117|NCT02181803|593804985|FG006|Overall Study|Physician Decision|0|||
164392118|NCT02181803|593804986|FG007|Overall Study|Physician Decision|1|||
164392119|NCT02181803|593804987|FG008|Overall Study|Physician Decision|0|||
164392120|NCT02181803|593804979|FG000|Overall Study|Adverse Event|0|||
164392121|NCT02181803|593804980|FG001|Overall Study|Adverse Event|2|||
164392122|NCT02181803|593804981|FG002|Overall Study|Adverse Event|0|||
164392123|NCT02181803|593804982|FG003|Overall Study|Adverse Event|1|||
164392124|NCT02181803|593804983|FG004|Overall Study|Adverse Event|0|||
164392125|NCT02181803|593804984|FG005|Overall Study|Adverse Event|0|||
164392126|NCT02181803|593804985|FG006|Overall Study|Adverse Event|1|||
164392127|NCT02181803|593804986|FG007|Overall Study|Adverse Event|0|||
164392128|NCT02181803|593804987|FG008|Overall Study|Adverse Event|0|||
164392129|NCT00951041|593804988|FG000|Overall Study|Withdrawal by Subject|1|||
164392130|NCT00951041|593804989|FG001|Overall Study|Withdrawal by Subject|1|||
164392131|NCT00951041|593804988|FG000|Overall Study|Lost to Follow-up|1|||
164392132|NCT00951041|593804989|FG001|Overall Study|Lost to Follow-up|0|||
164392133|NCT00951041|593804988|FG000|Overall Study|Other|3|||
164392134|NCT00951041|593804989|FG001|Overall Study|Other|0|||
164392135|NCT02388724|593804993|FG000|Overall Study|Reason not Specified|0|||
164392136|NCT02388724|593804994|FG001|Overall Study|Reason not Specified|1|||
164392137|NCT02388724|593804993|FG000|Overall Study|Major Protocol Deviation|3|||
164392138|NCT02388724|593804994|FG001|Overall Study|Major Protocol Deviation|3|||
164392139|NCT02388724|593804993|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164392140|NCT02388724|593804994|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164016174|NCT01161524|592421835|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
164016175|NCT01161524|592421836|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
164016176|NCT01161524|592421834|FG000|Core Study (23 Weeks)|Subject Choice|3|||
164016177|NCT01161524|592421835|FG001|Core Study (23 Weeks)|Subject Choice|2|||
164016178|NCT01161524|592421836|FG002|Core Study (23 Weeks)|Subject Choice|0|||
164392141|NCT02388724|593804993|FG000|Overall Study|Voluntary Withdrawal|6|||
164392142|NCT02388724|593804994|FG001|Overall Study|Voluntary Withdrawal|5|||
164392143|NCT02388724|593804993|FG000|Overall Study|Randomized but not Treated|0|||
164392144|NCT02388724|593804994|FG001|Overall Study|Randomized but not Treated|2|||
164392145|NCT04786444|593804995|FG000|Overall Study|Withdrawal by Subject|4|||
164392146|NCT04786444|593804996|FG001|Overall Study|Withdrawal by Subject|7|||
164392147|NCT04786444|593804997|FG002|Overall Study|Withdrawal by Subject|2|||
164392148|NCT04786444|593804995|FG000|Overall Study|Lost to Follow-up|11|||
164392149|NCT04786444|593804996|FG001|Overall Study|Lost to Follow-up|9|||
164392150|NCT04786444|593804997|FG002|Overall Study|Lost to Follow-up|10|||
164392151|NCT04786444|593804995|FG000|Overall Study|Subject would like to become pregnant|0|||
164392152|NCT04786444|593804996|FG001|Overall Study|Subject would like to become pregnant|1|||
164392153|NCT04786444|593804997|FG002|Overall Study|Subject would like to become pregnant|0|||
164392154|NCT03166618|593804998|FG000|Overall Study|Study was Terminated|0|||
164392155|NCT03166618|593804999|FG001|Overall Study|Study was Terminated|1|||
164392156|NCT03137303|593805001|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
164392157|NCT03137303|593805002|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
164392158|NCT03137303|593805001|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
164392159|NCT03137303|593805002|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
164392160|NCT03137303|593805001|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
164392161|NCT03137303|593805002|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
164392162|NCT03137303|593805001|FG000|T3: 9-month Follow-up|Death|1|||
164392163|NCT03137303|593805002|FG001|T3: 9-month Follow-up|Death|0|||
164392164|NCT03137303|593805001|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
164392165|NCT03137303|593805002|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
164392166|NCT03137303|593805001|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
164392167|NCT03137303|593805002|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
164392168|NCT03137303|593805001|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
164392169|NCT03137303|593805002|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
164392170|NCT01217073|593805003|FG000|Base Period|Adverse Event|1|||
164392171|NCT01217073|593805004|FG001|Base Period|Adverse Event|0|||
164392172|NCT01217073|593805005|FG002|Base Period|Adverse Event|1|||
164392173|NCT01217073|593805006|FG003|Base Period|Adverse Event|0|||
164392174|NCT01217073|593805007|FG004|Base Period|Adverse Event|4|||
164392175|NCT01217073|593805008|FG005|Base Period|Adverse Event|1|||
164392176|NCT01217073|593805009|FG006|Base Period|Adverse Event|0|||
164392177|NCT01217073|593805010|FG007|Base Period|Adverse Event|0|||
164392178|NCT01217073|593805003|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
164392179|NCT01217073|593805004|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392180|NCT01217073|593805005|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392181|NCT01217073|593805006|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392182|NCT01217073|593805007|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392183|NCT01217073|593805008|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392184|NCT01217073|593805009|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164016179|NCT01161524|592421834|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
164016180|NCT01161524|592421835|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
164016181|NCT01161524|592421836|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
164016182|NCT01161524|592421834|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
164016183|NCT01161524|592421835|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
164016184|NCT01161524|592421836|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
164016185|NCT01161524|592421834|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
164016186|NCT01161524|592421835|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
164016187|NCT01161524|592421836|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
164016188|NCT01161524|592421834|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
164016189|NCT01161524|592421835|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
164093142|NCT00414765|592703489|FG000|Overall Study|Disease Progression|0|||
164093143|NCT00414765|592703490|FG001|Overall Study|Disease Progression|1|||
164093144|NCT05694013|592703493|FG000|Overall Study|Death|6|||
164392185|NCT01217073|593805010|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
164392186|NCT01217073|593805003|FG000|Base Period|Excluded medication|0|||
164392187|NCT01217073|593805004|FG001|Base Period|Excluded medication|0|||
164392188|NCT01217073|593805005|FG002|Base Period|Excluded medication|0|||
164392189|NCT01217073|593805006|FG003|Base Period|Excluded medication|0|||
164392190|NCT01217073|593805007|FG004|Base Period|Excluded medication|1|||
164392191|NCT01217073|593805008|FG005|Base Period|Excluded medication|0|||
164392192|NCT01217073|593805009|FG006|Base Period|Excluded medication|0|||
164392193|NCT01217073|593805010|FG007|Base Period|Excluded medication|0|||
164392194|NCT01217073|593805003|FG000|Base Period|Lack of Efficacy|0|||
164392195|NCT01217073|593805004|FG001|Base Period|Lack of Efficacy|0|||
164392196|NCT01217073|593805005|FG002|Base Period|Lack of Efficacy|0|||
164392197|NCT01217073|593805006|FG003|Base Period|Lack of Efficacy|0|||
164392198|NCT01217073|593805007|FG004|Base Period|Lack of Efficacy|0|||
164392199|NCT01217073|593805008|FG005|Base Period|Lack of Efficacy|1|||
164392200|NCT01217073|593805009|FG006|Base Period|Lack of Efficacy|0|||
164392201|NCT01217073|593805010|FG007|Base Period|Lack of Efficacy|0|||
164392202|NCT01217073|593805003|FG000|Base Period|Lost to Follow-up|0|||
164392203|NCT01217073|593805004|FG001|Base Period|Lost to Follow-up|0|||
164016190|NCT01161524|592421836|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
164392204|NCT01217073|593805005|FG002|Base Period|Lost to Follow-up|1|||
164392205|NCT01217073|593805006|FG003|Base Period|Lost to Follow-up|1|||
164392206|NCT01217073|593805007|FG004|Base Period|Lost to Follow-up|3|||
164392207|NCT01217073|593805008|FG005|Base Period|Lost to Follow-up|0|||
164392208|NCT01217073|593805009|FG006|Base Period|Lost to Follow-up|0|||
164392209|NCT01217073|593805010|FG007|Base Period|Lost to Follow-up|0|||
164392210|NCT01217073|593805003|FG000|Base Period|Physician Decision|0|||
164392211|NCT01217073|593805004|FG001|Base Period|Physician Decision|0|||
164392212|NCT01217073|593805005|FG002|Base Period|Physician Decision|0|||
164392213|NCT01217073|593805006|FG003|Base Period|Physician Decision|0|||
164392214|NCT01217073|593805007|FG004|Base Period|Physician Decision|1|||
164392215|NCT01217073|593805008|FG005|Base Period|Physician Decision|0|||
164392216|NCT01217073|593805009|FG006|Base Period|Physician Decision|0|||
164392217|NCT01217073|593805010|FG007|Base Period|Physician Decision|0|||
164392218|NCT01217073|593805003|FG000|Base Period|Protocol Violation|1|||
164392219|NCT01217073|593805004|FG001|Base Period|Protocol Violation|0|||
164392220|NCT01217073|593805005|FG002|Base Period|Protocol Violation|0|||
164392221|NCT01217073|593805006|FG003|Base Period|Protocol Violation|0|||
164392222|NCT01217073|593805007|FG004|Base Period|Protocol Violation|1|||
164392223|NCT01217073|593805008|FG005|Base Period|Protocol Violation|2|||
164392224|NCT01217073|593805009|FG006|Base Period|Protocol Violation|0|||
164392225|NCT01217073|593805010|FG007|Base Period|Protocol Violation|0|||
164392226|NCT01217073|593805003|FG000|Base Period|Withdrawal by Subject|4|||
164392227|NCT01217073|593805004|FG001|Base Period|Withdrawal by Subject|5|||
164392228|NCT01217073|593805005|FG002|Base Period|Withdrawal by Subject|5|||
164392229|NCT01217073|593805006|FG003|Base Period|Withdrawal by Subject|1|||
164392230|NCT01217073|593805007|FG004|Base Period|Withdrawal by Subject|5|||
164392231|NCT01217073|593805008|FG005|Base Period|Withdrawal by Subject|5|||
164392232|NCT01217073|593805009|FG006|Base Period|Withdrawal by Subject|0|||
164392233|NCT01217073|593805010|FG007|Base Period|Withdrawal by Subject|0|||
164392234|NCT01217073|593805003|FG000|Extension Period|Adverse Event|0|||
164392235|NCT01217073|593805004|FG001|Extension Period|Adverse Event|0|||
164392236|NCT01217073|593805005|FG002|Extension Period|Adverse Event|0|||
164392237|NCT01217073|593805006|FG003|Extension Period|Adverse Event|0|||
164392238|NCT01217073|593805007|FG004|Extension Period|Adverse Event|0|||
164392239|NCT01217073|593805008|FG005|Extension Period|Adverse Event|0|||
164392240|NCT01217073|593805009|FG006|Extension Period|Adverse Event|19|||
164392241|NCT01217073|593805010|FG007|Extension Period|Adverse Event|5|||
164392242|NCT01217073|593805003|FG000|Extension Period|ALT/AST|0|||
164392243|NCT01217073|593805004|FG001|Extension Period|ALT/AST|0|||
164392244|NCT01217073|593805005|FG002|Extension Period|ALT/AST|0|||
164392245|NCT01217073|593805006|FG003|Extension Period|ALT/AST|0|||
164392246|NCT01217073|593805007|FG004|Extension Period|ALT/AST|0|||
164392247|NCT01217073|593805008|FG005|Extension Period|ALT/AST|0|||
164392248|NCT01217073|593805009|FG006|Extension Period|ALT/AST|2|||
164392249|NCT01217073|593805010|FG007|Extension Period|ALT/AST|0|||
164392250|NCT01217073|593805003|FG000|Extension Period|Contraindication to study medication|0|||
164392251|NCT01217073|593805004|FG001|Extension Period|Contraindication to study medication|0|||
164392252|NCT01217073|593805005|FG002|Extension Period|Contraindication to study medication|0|||
164392253|NCT01217073|593805006|FG003|Extension Period|Contraindication to study medication|0|||
164392254|NCT01217073|593805007|FG004|Extension Period|Contraindication to study medication|0|||
164392255|NCT01217073|593805008|FG005|Extension Period|Contraindication to study medication|0|||
164392256|NCT01217073|593805009|FG006|Extension Period|Contraindication to study medication|1|||
164392257|NCT01217073|593805010|FG007|Extension Period|Contraindication to study medication|0|||
164392258|NCT01217073|593805003|FG000|Extension Period|Creatinine/eGFR|0|||
164392259|NCT01217073|593805004|FG001|Extension Period|Creatinine/eGFR|0|||
164016191|NCT01161524|592421834|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
164016192|NCT01161524|592421835|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
164016193|NCT01161524|592421836|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
164016194|NCT01952015|592421840|FG000|Induction|Protocol Violation|1|||
164392260|NCT01217073|593805005|FG002|Extension Period|Creatinine/eGFR|0|||
164392261|NCT01217073|593805006|FG003|Extension Period|Creatinine/eGFR|0|||
164392262|NCT01217073|593805007|FG004|Extension Period|Creatinine/eGFR|0|||
164392263|NCT01217073|593805008|FG005|Extension Period|Creatinine/eGFR|0|||
164016195|NCT01952015|592421840|FG000|Maintenance|Adverse Event|2|||
164392264|NCT01217073|593805009|FG006|Extension Period|Creatinine/eGFR|11|||
164392265|NCT01217073|593805010|FG007|Extension Period|Creatinine/eGFR|1|||
164392266|NCT01217073|593805003|FG000|Extension Period|Death|0|||
164392267|NCT01217073|593805004|FG001|Extension Period|Death|0|||
164392268|NCT01217073|593805005|FG002|Extension Period|Death|0|||
164392269|NCT01217073|593805006|FG003|Extension Period|Death|0|||
164392270|NCT01217073|593805007|FG004|Extension Period|Death|0|||
164392271|NCT01217073|593805008|FG005|Extension Period|Death|0|||
164392272|NCT01217073|593805009|FG006|Extension Period|Death|1|||
164392273|NCT01217073|593805010|FG007|Extension Period|Death|0|||
164392274|NCT01217073|593805003|FG000|Extension Period|Excluded medication|0|||
164392275|NCT01217073|593805004|FG001|Extension Period|Excluded medication|0|||
164016196|NCT01952015|592421840|FG000|Treatment Period 3|Physician Decision|9|||
164392276|NCT01217073|593805005|FG002|Extension Period|Excluded medication|0|||
163905055|NCT01079806|592023743|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
163905056|NCT01079806|592023742|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
163905057|NCT01079806|592023743|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
163905058|NCT03739866|592023749|FG000|Overall Study|Lost to Follow-up|0|||
163905059|NCT03739866|592023750|FG001|Overall Study|Lost to Follow-up|0|||
163905060|NCT03739866|592023751|FG002|Overall Study|Lost to Follow-up|0|||
163905061|NCT03739866|592023752|FG003|Overall Study|Lost to Follow-up|1|||
163905062|NCT03739866|592023753|FG004|Overall Study|Lost to Follow-up|0|||
163905063|NCT03739866|592023754|FG005|Overall Study|Lost to Follow-up|0|||
163905064|NCT03739866|592023755|FG006|Overall Study|Lost to Follow-up|0|||
163905065|NCT03739866|592023756|FG007|Overall Study|Lost to Follow-up|0|||
163905066|NCT03739866|592023749|FG000|Overall Study|Enrolled but not treated|0|||
163905067|NCT03739866|592023750|FG001|Overall Study|Enrolled but not treated|0|||
163905068|NCT03739866|592023751|FG002|Overall Study|Enrolled but not treated|1|||
163905069|NCT03739866|592023752|FG003|Overall Study|Enrolled but not treated|0|||
163905070|NCT03739866|592023753|FG004|Overall Study|Enrolled but not treated|1|||
163905071|NCT03739866|592023754|FG005|Overall Study|Enrolled but not treated|0|||
164016197|NCT00651118|592421844|FG000|Overall Study|Adverse Event|4|||
164392277|NCT01217073|593805006|FG003|Extension Period|Excluded medication|0|||
164392278|NCT01217073|593805007|FG004|Extension Period|Excluded medication|0|||
164392279|NCT01217073|593805008|FG005|Extension Period|Excluded medication|0|||
164392280|NCT01217073|593805009|FG006|Extension Period|Excluded medication|2|||
164392281|NCT01217073|593805010|FG007|Extension Period|Excluded medication|0|||
164392282|NCT01217073|593805003|FG000|Extension Period|Lack of Efficacy|0|||
164392283|NCT01217073|593805004|FG001|Extension Period|Lack of Efficacy|0|||
164392284|NCT01217073|593805005|FG002|Extension Period|Lack of Efficacy|0|||
164392285|NCT01217073|593805006|FG003|Extension Period|Lack of Efficacy|0|||
164392286|NCT01217073|593805007|FG004|Extension Period|Lack of Efficacy|0|||
164392287|NCT01217073|593805008|FG005|Extension Period|Lack of Efficacy|0|||
164392288|NCT01217073|593805009|FG006|Extension Period|Lack of Efficacy|3|||
164392289|NCT01217073|593805010|FG007|Extension Period|Lack of Efficacy|0|||
164392290|NCT01217073|593805003|FG000|Extension Period|Lost to Follow-up|0|||
164392291|NCT01217073|593805004|FG001|Extension Period|Lost to Follow-up|0|||
164392292|NCT01217073|593805005|FG002|Extension Period|Lost to Follow-up|0|||
164392293|NCT01217073|593805006|FG003|Extension Period|Lost to Follow-up|0|||
164392294|NCT01217073|593805007|FG004|Extension Period|Lost to Follow-up|0|||
164392295|NCT01217073|593805008|FG005|Extension Period|Lost to Follow-up|0|||
164392296|NCT01217073|593805009|FG006|Extension Period|Lost to Follow-up|9|||
164392297|NCT01217073|593805010|FG007|Extension Period|Lost to Follow-up|1|||
164392298|NCT01217073|593805003|FG000|Extension Period|Non-compliance with study drug|0|||
164392299|NCT01217073|593805004|FG001|Extension Period|Non-compliance with study drug|0|||
164392300|NCT01217073|593805005|FG002|Extension Period|Non-compliance with study drug|0|||
164392301|NCT01217073|593805006|FG003|Extension Period|Non-compliance with study drug|0|||
164392302|NCT01217073|593805007|FG004|Extension Period|Non-compliance with study drug|0|||
164392303|NCT01217073|593805008|FG005|Extension Period|Non-compliance with study drug|0|||
164392304|NCT01217073|593805009|FG006|Extension Period|Non-compliance with study drug|0|||
164392305|NCT01217073|593805010|FG007|Extension Period|Non-compliance with study drug|1|||
164392306|NCT01217073|593805003|FG000|Extension Period|Physician Decision|0|||
164392307|NCT01217073|593805004|FG001|Extension Period|Physician Decision|0|||
164392308|NCT01217073|593805005|FG002|Extension Period|Physician Decision|0|||
164392309|NCT01217073|593805006|FG003|Extension Period|Physician Decision|0|||
164392310|NCT01217073|593805007|FG004|Extension Period|Physician Decision|0|||
164392311|NCT01217073|593805008|FG005|Extension Period|Physician Decision|0|||
164392312|NCT01217073|593805009|FG006|Extension Period|Physician Decision|4|||
163905072|NCT03739866|592023755|FG006|Overall Study|Enrolled but not treated|0|||
163905073|NCT03739866|592023756|FG007|Overall Study|Enrolled but not treated|0|||
163905074|NCT00836498|592023757|FG000|Overall Study|Adverse Event|1|||
163905075|NCT00836498|592023758|FG001|Overall Study|Adverse Event|0|||
164016198|NCT00651118|592421845|FG001|Overall Study|Adverse Event|0|||
164016199|NCT00651118|592421846|FG002|Overall Study|Adverse Event|1|||
164016200|NCT00651118|592421847|FG003|Overall Study|Adverse Event|1|||
164392313|NCT01217073|593805010|FG007|Extension Period|Physician Decision|1|||
164392314|NCT01217073|593805003|FG000|Extension Period|Protocol Violation|0|||
164392315|NCT01217073|593805004|FG001|Extension Period|Protocol Violation|0|||
164392316|NCT01217073|593805005|FG002|Extension Period|Protocol Violation|0|||
164392317|NCT01217073|593805006|FG003|Extension Period|Protocol Violation|0|||
164392318|NCT01217073|593805007|FG004|Extension Period|Protocol Violation|0|||
164392319|NCT01217073|593805008|FG005|Extension Period|Protocol Violation|0|||
163905076|NCT00836498|592023757|FG000|Overall Study|Lost to Follow-up|1|||
163905077|NCT00836498|592023758|FG001|Overall Study|Lost to Follow-up|0|||
164016201|NCT00651118|592421844|FG000|Overall Study|Protocol Violation|2|||
163905078|NCT00836498|592023757|FG000|Overall Study|Withdrawal by Subject|2|||
163905079|NCT00836498|592023758|FG001|Overall Study|Withdrawal by Subject|1|||
163905080|NCT01034306|592023759|FG000|Overall Study|Adverse Event|1|||
164392320|NCT01217073|593805009|FG006|Extension Period|Protocol Violation|2|||
164392321|NCT01217073|593805010|FG007|Extension Period|Protocol Violation|1|||
164392322|NCT01217073|593805003|FG000|Extension Period|Site discontinued study participation|0|||
164392323|NCT01217073|593805004|FG001|Extension Period|Site discontinued study participation|0|||
164392324|NCT01217073|593805005|FG002|Extension Period|Site discontinued study participation|0|||
164392325|NCT01217073|593805006|FG003|Extension Period|Site discontinued study participation|0|||
164392326|NCT01217073|593805007|FG004|Extension Period|Site discontinued study participation|0|||
164392327|NCT01217073|593805008|FG005|Extension Period|Site discontinued study participation|0|||
164392328|NCT01217073|593805009|FG006|Extension Period|Site discontinued study participation|7|||
164392329|NCT01217073|593805010|FG007|Extension Period|Site discontinued study participation|2|||
164392330|NCT01217073|593805003|FG000|Extension Period|Withdrawal by Subject|0|||
164392331|NCT01217073|593805004|FG001|Extension Period|Withdrawal by Subject|0|||
164392332|NCT01217073|593805005|FG002|Extension Period|Withdrawal by Subject|0|||
164392333|NCT01217073|593805006|FG003|Extension Period|Withdrawal by Subject|0|||
164392334|NCT01217073|593805007|FG004|Extension Period|Withdrawal by Subject|0|||
164392335|NCT01217073|593805008|FG005|Extension Period|Withdrawal by Subject|0|||
164392336|NCT01217073|593805009|FG006|Extension Period|Withdrawal by Subject|30|||
164392337|NCT01217073|593805010|FG007|Extension Period|Withdrawal by Subject|8|||
164392338|NCT03561090|593805011|FG000|Overall Study|Adverse Event|11|||
164392339|NCT03561090|593805012|FG001|Overall Study|Adverse Event|7|||
164392340|NCT03561090|593805011|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164392341|NCT03561090|593805012|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164392342|NCT03561090|593805011|FG000|Overall Study|Protocol Violation|2|||
164392343|NCT03561090|593805012|FG001|Overall Study|Protocol Violation|2|||
164392344|NCT03561090|593805011|FG000|Overall Study|Withdrawal by Subject|7|||
164392345|NCT03561090|593805012|FG001|Overall Study|Withdrawal by Subject|7|||
164392346|NCT03561090|593805011|FG000|Overall Study|Lost to Follow-up|7|||
164392347|NCT03561090|593805012|FG001|Overall Study|Lost to Follow-up|2|||
164392348|NCT03561090|593805011|FG000|Overall Study|Study Terminated by Sponsor|10|||
164392349|NCT03561090|593805012|FG001|Overall Study|Study Terminated by Sponsor|15|||
164392350|NCT03561090|593805011|FG000|Overall Study|Randomized by Mistake|1|||
164392351|NCT03561090|593805012|FG001|Overall Study|Randomized by Mistake|1|||
164392352|NCT03561090|593805011|FG000|Overall Study|Other Not Specified|0|||
164392353|NCT03561090|593805012|FG001|Overall Study|Other Not Specified|2|||
164392354|NCT00725452|593805019|FG000|Overall Study|Adverse Event|3|||
164392355|NCT00725452|593805019|FG000|Overall Study|Lack of Efficacy|2|||
164392356|NCT00725452|593805019|FG000|Overall Study|Reason not specified|1|||
164392357|NCT00725452|593805019|FG000|Overall Study|Physician Decision|1|||
164392358|NCT00725452|593805019|FG000|Overall Study|Withdrawal by Subject|3|||
164392359|NCT00725452|593805019|FG000|Overall Study|Lost to Follow-up|1|||
164392360|NCT00713648|593805021|FG000|Overall Study|Adverse Event|1|||
164392361|NCT00713648|593805021|FG000|Overall Study|Unclassified|2|||
164392362|NCT00713648|593805021|FG000|Overall Study|According to Protocol|2|||
164392363|NCT00713648|593805021|FG000|Overall Study|Development of antibodies|3|||
164392364|NCT02047045|593805022|FG000|Baseline|Withdrawal by Subject|3|||
164392365|NCT02047045|593805023|FG001|Baseline|Withdrawal by Subject|2|||
164392366|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
164392367|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
164392368|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
164392369|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
164392370|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
164016202|NCT00651118|592421845|FG001|Overall Study|Protocol Violation|2|||
164016203|NCT00651118|592421846|FG002|Overall Study|Protocol Violation|6|||
164016204|NCT00651118|592421847|FG003|Overall Study|Protocol Violation|2|||
164016205|NCT00651118|592421844|FG000|Overall Study|Lost to Follow-up|2|||
164016206|NCT00651118|592421845|FG001|Overall Study|Lost to Follow-up|0|||
164016207|NCT00651118|592421846|FG002|Overall Study|Lost to Follow-up|1|||
164016208|NCT00651118|592421847|FG003|Overall Study|Lost to Follow-up|2|||
164392371|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
164392372|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
164392373|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
164016209|NCT00651118|592421844|FG000|Overall Study|administrative|1|||
164392374|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
164392375|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
164392376|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
164392377|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
164392378|NCT02047045|593805022|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
164392379|NCT02047045|593805023|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
164392380|NCT02047045|593805022|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
164016210|NCT00651118|592421845|FG001|Overall Study|administrative|4|||
164016211|NCT00651118|592421846|FG002|Overall Study|administrative|2|||
164016212|NCT00651118|592421847|FG003|Overall Study|administrative|1|||
163905081|NCT01034306|592023760|FG001|Overall Study|Adverse Event|0|||
163905082|NCT01034306|592023759|FG000|Overall Study|Lost to Follow-up|0|||
163905083|NCT01034306|592023760|FG001|Overall Study|Lost to Follow-up|1|||
163905084|NCT01034306|592023759|FG000|Overall Study|Withdrawal by Subject|2|||
164392381|NCT02047045|593805023|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
164392382|NCT01343368|593805026|FG000|Overall Study|Death|1|||
164392383|NCT01343368|593805027|FG001|Overall Study|Death|0|||
164392384|NCT01343368|593805026|FG000|Overall Study|Lost to Follow-up|1|||
164392385|NCT01343368|593805027|FG001|Overall Study|Lost to Follow-up|0|||
164392386|NCT02277106|593805028|FG000|Stage 2|Adverse Event|0|||
164392387|NCT02277106|593805029|FG001|Stage 2|Adverse Event|0|||
164392388|NCT02277106|593805030|FG002|Stage 2|Adverse Event|1|||
164392389|NCT02479412|593805031|FG000|Overall Study|Adverse Event|0|||
164392390|NCT02479412|593805032|FG001|Overall Study|Adverse Event|0|||
164392391|NCT02479412|593805033|FG002|Overall Study|Adverse Event|1|||
164392392|NCT02479412|593805034|FG003|Overall Study|Adverse Event|0|||
164392393|NCT02479412|593805035|FG004|Overall Study|Adverse Event|0|||
164392394|NCT02479412|593805036|FG005|Overall Study|Adverse Event|0|||
164392395|NCT02479412|593805037|FG006|Overall Study|Adverse Event|0|||
164392396|NCT02479412|593805038|FG007|Overall Study|Adverse Event|0|||
164392397|NCT02479412|593805039|FG008|Overall Study|Adverse Event|0|||
164392398|NCT02479412|593805031|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164392399|NCT02479412|593805032|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164392400|NCT02479412|593805033|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164392401|NCT02479412|593805034|FG003|Overall Study|Study-specific withdrawal criteria|1|||
164392402|NCT02479412|593805035|FG004|Overall Study|Study-specific withdrawal criteria|0|||
164392403|NCT02479412|593805036|FG005|Overall Study|Study-specific withdrawal criteria|0|||
164392404|NCT02479412|593805037|FG006|Overall Study|Study-specific withdrawal criteria|0|||
164392405|NCT02479412|593805038|FG007|Overall Study|Study-specific withdrawal criteria|1|||
164392406|NCT02479412|593805039|FG008|Overall Study|Study-specific withdrawal criteria|1|||
164392407|NCT02479412|593805031|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
164392408|NCT02479412|593805032|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
164392409|NCT02479412|593805033|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
163905085|NCT01034306|592023760|FG001|Overall Study|Withdrawal by Subject|2|||
163905086|NCT01034306|592023759|FG000|Overall Study|hospitalized and decided to stop|1|||
163905087|NCT01034306|592023760|FG001|Overall Study|hospitalized and decided to stop|0|||
163905088|NCT01034306|592023759|FG000|Overall Study|Noncomplience|1|||
163905089|NCT01034306|592023760|FG001|Overall Study|Noncomplience|0|||
164392410|NCT02479412|593805034|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
164392411|NCT02479412|593805035|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
164392412|NCT02479412|593805036|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
164392413|NCT02479412|593805037|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
164392414|NCT02479412|593805038|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
164392415|NCT02479412|593805039|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
164392416|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
164392417|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
164392418|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
164392419|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
164392420|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
164392421|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
164392422|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
164392423|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
164392424|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
164392425|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
164392426|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
164392427|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
164392428|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
164392429|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
163905090|NCT03057600|592023761|FG000|Overall Study|Adverse Event|0|||
163905091|NCT03057600|592023762|FG001|Overall Study|Adverse Event|0|||
164016213|NCT00651118|592421844|FG000|Overall Study|Withdrawal by Subject|0|||
164016214|NCT00651118|592421845|FG001|Overall Study|Withdrawal by Subject|1|||
164016215|NCT00651118|592421846|FG002|Overall Study|Withdrawal by Subject|1|||
164016216|NCT00651118|592421847|FG003|Overall Study|Withdrawal by Subject|1|||
164016217|NCT03117049|592421848|FG000|Overall Study|Continued the follow-up period|109|||
164016218|NCT03117049|592421849|FG001|Overall Study|Continued the follow-up period|129|||
164016219|NCT03117049|592421848|FG000|Overall Study|Died|82|||
164016220|NCT03117049|592421849|FG001|Overall Study|Died|93|||
164016221|NCT03117049|592421848|FG000|Overall Study|Consent withdrawal|7|||
164016222|NCT03117049|592421849|FG001|Overall Study|Consent withdrawal|6|||
164016223|NCT03117049|592421848|FG000|Overall Study|Missing contact|3|||
164016224|NCT03117049|592421849|FG001|Overall Study|Missing contact|3|||
164016225|NCT01096550|592421850|FG000|Overall Study|discontinued site|10|||
164016226|NCT01096550|592421851|FG001|Overall Study|discontinued site|11|||
164016227|NCT01096550|592421850|FG000|Overall Study|non-regular treatment track at clinic|1|||
164016228|NCT01096550|592421851|FG001|Overall Study|non-regular treatment track at clinic|1|||
164016229|NCT01096550|592421850|FG000|Overall Study|clinic readmission|1|||
164016230|NCT01096550|592421851|FG001|Overall Study|clinic readmission|1|||
164016231|NCT01096550|592421850|FG000|Overall Study|Withdrawal by Subject|0|||
164016232|NCT01096550|592421851|FG001|Overall Study|Withdrawal by Subject|1|||
164016233|NCT01096550|592421850|FG000|Overall Study|non-African American participant|13|||
164016234|NCT01096550|592421851|FG001|Overall Study|non-African American participant|6|||
164016235|NCT01096550|592421850|FG000|Overall Study|Lost to Follow-up|12|||
164016236|NCT01096550|592421851|FG001|Overall Study|Lost to Follow-up|9|||
164016237|NCT01555463|592421854|FG000|Treatment|Adverse Event|6|||
164016238|NCT01555463|592421855|FG001|Treatment|Adverse Event|12|||
164016239|NCT01555463|592421854|FG000|Treatment|Withdrawal by Subject|24|||
164016240|NCT01555463|592421855|FG001|Treatment|Withdrawal by Subject|36|||
164016241|NCT01555463|592421854|FG000|Treatment|Lost to Follow-up|28|||
164016242|NCT01555463|592421855|FG001|Treatment|Lost to Follow-up|23|||
164016243|NCT01555463|592421854|FG000|Treatment|Protocol Violation|4|||
164016244|NCT01555463|592421855|FG001|Treatment|Protocol Violation|5|||
164016245|NCT01555463|592421854|FG000|Treatment|Other reason|2|||
164016246|NCT01555463|592421855|FG001|Treatment|Other reason|3|||
164392430|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
163905092|NCT03057600|592023763|FG002|Overall Study|Adverse Event|4|||
163905093|NCT03057600|592023764|FG003|Overall Study|Adverse Event|0|||
164016247|NCT01555463|592421854|FG000|Follow up|Adverse Event|2|||
164392431|NCT01571362|593805040|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
163905094|NCT03057600|592023761|FG000|Overall Study|Radiologic Disease Progression|8|||
164016248|NCT01555463|592421855|FG001|Follow up|Adverse Event|5|||
164016249|NCT01555463|592421854|FG000|Follow up|Death|0|||
164016250|NCT01555463|592421855|FG001|Follow up|Death|1|||
164016251|NCT01555463|592421854|FG000|Follow up|Withdrawal by Subject|22|||
164016252|NCT01555463|592421855|FG001|Follow up|Withdrawal by Subject|22|||
164016253|NCT01555463|592421854|FG000|Follow up|Lost to Follow-up|9|||
164392432|NCT01571362|593805041|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
164392433|NCT01571362|593805042|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
164392434|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164392435|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
164392436|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
164392437|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164392438|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
164392439|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
164392440|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164392441|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Adverse Event|9|||
164392442|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Adverse Event|14|||
164392443|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164392444|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
164392445|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
164392446|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
164392447|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
164392448|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
164392449|NCT01571362|593805040|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
164392450|NCT01571362|593805041|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
164392451|NCT01571362|593805042|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
164392452|NCT03667053|593805043|FG000|Overall Study|Withdrawal by Subject|1|||
164392453|NCT03667053|593805044|FG001|Overall Study|Withdrawal by Subject|0|||
164392454|NCT03667053|593805045|FG002|Overall Study|Withdrawal by Subject|0|||
164392455|NCT00130533|593805047|FG000|Overall Study|Withdrawal by Subject|33|||
164392456|NCT00130533|593805048|FG001|Overall Study|Withdrawal by Subject|6|||
164392457|NCT00130533|593805047|FG000|Overall Study|Adverse Event|34|||
164392458|NCT00130533|593805048|FG001|Overall Study|Adverse Event|1|||
163905095|NCT03057600|592023762|FG001|Overall Study|Radiologic Disease Progression|7|||
163905096|NCT03057600|592023763|FG002|Overall Study|Radiologic Disease Progression|13|||
164392459|NCT00130533|593805047|FG000|Overall Study|Disease relapse|9|||
164093145|NCT05694013|592703494|FG001|Overall Study|Death|2|||
164392460|NCT00130533|593805048|FG001|Overall Study|Disease relapse|13|||
164392461|NCT00130533|593805047|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
164392462|NCT00130533|593805048|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
164392463|NCT00130533|593805047|FG000|Overall Study|Death|4|||
163905097|NCT03057600|592023764|FG003|Overall Study|Radiologic Disease Progression|10|||
163905098|NCT03057600|592023761|FG000|Overall Study|Symptomatic Deterioration|0|||
164392464|NCT00130533|593805048|FG001|Overall Study|Death|2|||
164392465|NCT00130533|593805047|FG000|Overall Study|Protocol Violation|5|||
164392466|NCT00130533|593805048|FG001|Overall Study|Protocol Violation|1|||
164392467|NCT00130533|593805047|FG000|Overall Study|Lost to Follow-up|1|||
164392468|NCT00130533|593805048|FG001|Overall Study|Lost to Follow-up|1|||
164392469|NCT00130533|593805047|FG000|Overall Study|Sponsor´s decision|2|||
164392470|NCT00130533|593805048|FG001|Overall Study|Sponsor´s decision|0|||
164392471|NCT00130533|593805047|FG000|Overall Study|Second Primary Malignancy|0|||
164392472|NCT00130533|593805048|FG001|Overall Study|Second Primary Malignancy|1|||
164392473|NCT00130533|593805047|FG000|Overall Study|Other|12|||
164392474|NCT00130533|593805048|FG001|Overall Study|Other|5|||
164392475|NCT01059565|593805049|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
164392476|NCT01059565|593805050|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
164392477|NCT01059565|593805049|FG000|24-Week Randomized Phase|Adverse Event|5|||
164392478|NCT01059565|593805050|FG001|24-Week Randomized Phase|Adverse Event|0|||
164392479|NCT01059565|593805049|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
164392480|NCT01059565|593805050|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
164392481|NCT01059565|593805049|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
164392482|NCT01059565|593805050|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
164392483|NCT01059565|593805049|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
164392484|NCT01059565|593805050|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
164392485|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Adverse Event|2|||
164392486|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Adverse Event|0|||
164392487|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
164392488|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
164392489|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
164392490|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
164392491|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
164392492|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
164392493|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
164392494|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
164392495|NCT01059565|593805049|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
164392496|NCT01059565|593805050|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
164392497|NCT02732938|593805051|FG000|Overall Study|Death|0|||
164392498|NCT02732938|593805052|FG001|Overall Study|Death|11|||
164392499|NCT02732938|593805053|FG002|Overall Study|Death|0|||
164392500|NCT02732938|593805051|FG000|Overall Study|Randomized but did not receive treatment|0|||
164392501|NCT02732938|593805052|FG001|Overall Study|Randomized but did not receive treatment|1|||
164392502|NCT02732938|593805053|FG002|Overall Study|Randomized but did not receive treatment|0|||
164392503|NCT02732938|593805051|FG000|Overall Study|Refused further follow-up|1|||
164392504|NCT02732938|593805052|FG001|Overall Study|Refused further follow-up|0|||
164392505|NCT02732938|593805053|FG002|Overall Study|Refused further follow-up|0|||
164392506|NCT02732938|593805051|FG000|Overall Study|Study terminated by sponsor|3|||
164392507|NCT02732938|593805052|FG001|Overall Study|Study terminated by sponsor|6|||
164392508|NCT02732938|593805053|FG002|Overall Study|Study terminated by sponsor|0|||
164392509|NCT01026974|593805064|FG000|Overall Study|Withdrawal by Subject|0|||
164392510|NCT01026974|593805065|FG001|Overall Study|Withdrawal by Subject|1|||
164392511|NCT01026974|593805066|FG002|Overall Study|Withdrawal by Subject|7|||
164392512|NCT01026974|593805067|FG003|Overall Study|Withdrawal by Subject|2|||
164392513|NCT01026974|593805064|FG000|Overall Study|Lost to Follow-up|1|||
164392514|NCT01026974|593805065|FG001|Overall Study|Lost to Follow-up|1|||
164392515|NCT01026974|593805066|FG002|Overall Study|Lost to Follow-up|4|||
164392516|NCT01026974|593805067|FG003|Overall Study|Lost to Follow-up|0|||
164392517|NCT01026974|593805064|FG000|Overall Study|Adverse Event|0|||
164392518|NCT01026974|593805065|FG001|Overall Study|Adverse Event|0|||
164392519|NCT01026974|593805066|FG002|Overall Study|Adverse Event|0|||
164392520|NCT01026974|593805067|FG003|Overall Study|Adverse Event|1|||
164392521|NCT01026974|593805064|FG000|Overall Study|Inappropriate enrollment|0|||
164392522|NCT01026974|593805065|FG001|Overall Study|Inappropriate enrollment|0|||
164392523|NCT01026974|593805066|FG002|Overall Study|Inappropriate enrollment|1|||
164392524|NCT01026974|593805067|FG003|Overall Study|Inappropriate enrollment|0|||
164392525|NCT02864082|593805074|FG000|Overall Study|Adverse Event|1|||
164392526|NCT02864082|593805075|FG001|Overall Study|Adverse Event|1|||
163905099|NCT03057600|592023762|FG001|Overall Study|Symptomatic Deterioration|1|||
163905100|NCT03057600|592023763|FG002|Overall Study|Symptomatic Deterioration|1|||
164392527|NCT02864082|593805074|FG000|Overall Study|Lost to Follow-up|0|||
164392528|NCT02864082|593805075|FG001|Overall Study|Lost to Follow-up|1|||
164392529|NCT02864082|593805074|FG000|Overall Study|Withdrawal by Subject|2|||
164392530|NCT02864082|593805075|FG001|Overall Study|Withdrawal by Subject|2|||
164392531|NCT04349553|593805076|FG000|Overall Study|Withdrawal by Subject|1|||
164093146|NCT05694013|592703493|FG000|Overall Study|Participant Decision|0|||
164392532|NCT04349553|593805077|FG001|Overall Study|Withdrawal by Subject|0|||
164392533|NCT04349553|593805078|FG002|Overall Study|Withdrawal by Subject|1|||
164392534|NCT04349553|593805079|FG003|Overall Study|Withdrawal by Subject|0|||
163905101|NCT03057600|592023764|FG003|Overall Study|Symptomatic Deterioration|0|||
163905102|NCT03057600|592023761|FG000|Overall Study|Investigator Decision|0|||
163905103|NCT03057600|592023762|FG001|Overall Study|Investigator Decision|0|||
163905104|NCT03057600|592023763|FG002|Overall Study|Investigator Decision|1|||
163905105|NCT03057600|592023764|FG003|Overall Study|Investigator Decision|0|||
163905106|NCT03057600|592023761|FG000|Overall Study|Study Termination by Sponsor|0|||
164392535|NCT01869491|593805082|FG000|Overall Study|Adverse Event|3|||
164392536|NCT01869491|593805083|FG001|Overall Study|Adverse Event|5|||
164392537|NCT01869491|593805082|FG000|Overall Study|Lack of Efficacy|0|||
164392538|NCT01869491|593805083|FG001|Overall Study|Lack of Efficacy|3|||
164392539|NCT01869491|593805082|FG000|Overall Study|Withdrawal by Subject|6|||
164392540|NCT01869491|593805083|FG001|Overall Study|Withdrawal by Subject|7|||
164392541|NCT01869491|593805082|FG000|Overall Study|Lost to Follow-up|11|||
164392542|NCT01869491|593805083|FG001|Overall Study|Lost to Follow-up|9|||
164392543|NCT01869491|593805082|FG000|Overall Study|No further need of investigational product|1|||
164392544|NCT01869491|593805083|FG001|Overall Study|No further need of investigational product|0|||
164392545|NCT05177770|593805084|FG000|Overall Study|Death|4|||
164392546|NCT05177770|593805084|FG000|Overall Study|Withdrawal by Subject|1|||
164392547|NCT05177770|593805084|FG000|Overall Study|Adverse Event prior to dosing|1|||
164392548|NCT00214136|593805088|FG000|Overall Study|Death|5|||
164392549|NCT01272934|593805089|FG000|Overall Study|Adverse Event|0|||
164392550|NCT01272934|593805090|FG001|Overall Study|Adverse Event|1|||
164392551|NCT01272934|593805089|FG000|Overall Study|Abnormal Laboratory Value|0|||
164392552|NCT01272934|593805090|FG001|Overall Study|Abnormal Laboratory Value|1|||
164392553|NCT04313634|593805091|FG000|Overall Study|Adverse Event|2|||
164392554|NCT04313634|593805092|FG001|Overall Study|Adverse Event|2|||
164392555|NCT04313634|593805093|FG002|Overall Study|Adverse Event|0|||
164392556|NCT04313634|593805091|FG000|Overall Study|Withdrawal by Subject|1|||
164392557|NCT04313634|593805092|FG001|Overall Study|Withdrawal by Subject|0|||
164392558|NCT04313634|593805093|FG002|Overall Study|Withdrawal by Subject|1|||
164392559|NCT04313634|593805091|FG000|Overall Study|Protocol Violation|0|||
164392560|NCT04313634|593805092|FG001|Overall Study|Protocol Violation|0|||
164392561|NCT04313634|593805093|FG002|Overall Study|Protocol Violation|1|||
164392562|NCT00319098|593805096|FG000|Overall Study|Serious adverse event|3|||
164392563|NCT00319098|593805097|FG001|Overall Study|Serious adverse event|0|||
164392564|NCT00319098|593805096|FG000|Overall Study|Adverse Event|20|||
164392565|NCT00319098|593805097|FG001|Overall Study|Adverse Event|1|||
164392566|NCT00319098|593805096|FG000|Overall Study|Withdrawal by Subject|37|||
164392567|NCT00319098|593805097|FG001|Overall Study|Withdrawal by Subject|8|||
164392568|NCT00319098|593805096|FG000|Overall Study|Migrated/moved from study area|2|||
164392569|NCT00319098|593805097|FG001|Overall Study|Migrated/moved from study area|1|||
164392570|NCT00319098|593805096|FG000|Overall Study|Lost to Follow-up|37|||
164392571|NCT00319098|593805097|FG001|Overall Study|Lost to Follow-up|13|||
164392572|NCT00319098|593805096|FG000|Overall Study|Others|33|||
164392573|NCT00319098|593805097|FG001|Overall Study|Others|8|||
164392574|NCT00319098|593805096|FG000|Overall Study|Protocol Violation|3|||
164392575|NCT00319098|593805097|FG001|Overall Study|Protocol Violation|1|||
164392576|NCT02105948|593805098|FG000|Overall Study|Adverse Event|10|||
164392577|NCT02105948|593805099|FG001|Overall Study|Adverse Event|7|||
164392578|NCT02105948|593805100|FG002|Overall Study|Adverse Event|11|||
164392579|NCT02105948|593805101|FG003|Overall Study|Adverse Event|11|||
164392580|NCT02105948|593805098|FG000|Overall Study|Lack of Efficacy|0|||
164392581|NCT02105948|593805099|FG001|Overall Study|Lack of Efficacy|1|||
164392582|NCT02105948|593805100|FG002|Overall Study|Lack of Efficacy|3|||
164392583|NCT02105948|593805101|FG003|Overall Study|Lack of Efficacy|2|||
164392584|NCT02105948|593805098|FG000|Overall Study|Lost to Follow-up|0|||
164392585|NCT02105948|593805099|FG001|Overall Study|Lost to Follow-up|0|||
164392586|NCT02105948|593805100|FG002|Overall Study|Lost to Follow-up|2|||
164392587|NCT02105948|593805101|FG003|Overall Study|Lost to Follow-up|1|||
164392588|NCT02105948|593805098|FG000|Overall Study|Physician Decision|2|||
164392589|NCT02105948|593805099|FG001|Overall Study|Physician Decision|2|||
164392590|NCT02105948|593805100|FG002|Overall Study|Physician Decision|2|||
164392591|NCT02105948|593805101|FG003|Overall Study|Physician Decision|2|||
164392592|NCT02105948|593805098|FG000|Overall Study|Withdrawal by Subject|15|||
164392593|NCT02105948|593805099|FG001|Overall Study|Withdrawal by Subject|10|||
164392594|NCT02105948|593805100|FG002|Overall Study|Withdrawal by Subject|10|||
164392595|NCT02105948|593805101|FG003|Overall Study|Withdrawal by Subject|11|||
164392596|NCT03595904|593805102|FG000|Overall Study|Protocol Violation|3|||
164392597|NCT03595904|593805103|FG001|Overall Study|Protocol Violation|1|||
164392598|NCT03595904|593805102|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
164016254|NCT01555463|592421855|FG001|Follow up|Lost to Follow-up|10|||
164392599|NCT03595904|593805103|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
164392600|NCT03595904|593805102|FG000|Overall Study|Insurance complications|1|||
164392601|NCT03595904|593805103|FG001|Overall Study|Insurance complications|0|||
164392602|NCT03595904|593805102|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
163905107|NCT03057600|592023762|FG001|Overall Study|Study Termination by Sponsor|0|||
164392603|NCT03595904|593805103|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
164392604|NCT01358526|593805106|FG000|Open-label Titration Period|Adverse Event|95|||
164392605|NCT01358526|593805107|FG001|Open-label Titration Period|Adverse Event|0|||
164392606|NCT01358526|593805108|FG002|Open-label Titration Period|Adverse Event|0|||
164392607|NCT01358526|593805106|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
164392608|NCT01358526|593805107|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
164392609|NCT01358526|593805108|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
164392610|NCT01358526|593805106|FG000|Open-label Titration Period|Lost to Follow-up|25|||
164392611|NCT01358526|593805107|FG001|Open-label Titration Period|Lost to Follow-up|0|||
164392612|NCT01358526|593805108|FG002|Open-label Titration Period|Lost to Follow-up|0|||
164392613|NCT01358526|593805106|FG000|Open-label Titration Period|Lack of Efficacy|107|||
164392614|NCT01358526|593805107|FG001|Open-label Titration Period|Lack of Efficacy|0|||
164392615|NCT01358526|593805108|FG002|Open-label Titration Period|Lack of Efficacy|0|||
164392616|NCT01358526|593805106|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
164392617|NCT01358526|593805107|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
164392618|NCT01358526|593805108|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
164392619|NCT01358526|593805106|FG000|Open-label Titration Period|Administrative|8|||
164392620|NCT01358526|593805107|FG001|Open-label Titration Period|Administrative|0|||
164392621|NCT01358526|593805108|FG002|Open-label Titration Period|Administrative|0|||
164392622|NCT01358526|593805106|FG000|Open-label Titration Period|Did not qualify|178|||
164392623|NCT01358526|593805107|FG001|Open-label Titration Period|Did not qualify|0|||
164392624|NCT01358526|593805108|FG002|Open-label Titration Period|Did not qualify|0|||
164392625|NCT01358526|593805106|FG000|Double-blind Phase|Adverse Event|0|||
164392626|NCT01358526|593805107|FG001|Double-blind Phase|Adverse Event|24|||
164392627|NCT01358526|593805108|FG002|Double-blind Phase|Adverse Event|23|||
164392628|NCT01358526|593805106|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164392629|NCT01358526|593805107|FG001|Double-blind Phase|Withdrawal by Subject|10|||
164392630|NCT01358526|593805108|FG002|Double-blind Phase|Withdrawal by Subject|8|||
164392631|NCT01358526|593805106|FG000|Double-blind Phase|Lost to Follow-up|0|||
164392632|NCT01358526|593805107|FG001|Double-blind Phase|Lost to Follow-up|4|||
164392633|NCT01358526|593805108|FG002|Double-blind Phase|Lost to Follow-up|1|||
164392634|NCT01358526|593805106|FG000|Double-blind Phase|Lack of Efficacy|0|||
164392635|NCT01358526|593805107|FG001|Double-blind Phase|Lack of Efficacy|31|||
164392636|NCT01358526|593805108|FG002|Double-blind Phase|Lack of Efficacy|73|||
164392637|NCT01358526|593805106|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
164392638|NCT01358526|593805107|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
164392639|NCT01358526|593805108|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
164392640|NCT01358526|593805106|FG000|Double-blind Phase|Administrative|0|||
164392641|NCT01358526|593805107|FG001|Double-blind Phase|Administrative|6|||
164392642|NCT01358526|593805108|FG002|Double-blind Phase|Administrative|10|||
164392643|NCT04558346|593805109|FG000|Overall Study|Withdrawal by Subject|2|||
164392644|NCT04558346|593805110|FG001|Overall Study|Withdrawal by Subject|0|||
164392645|NCT04558346|593805109|FG000|Overall Study|Lost to Follow-up|0|||
164392646|NCT04558346|593805110|FG001|Overall Study|Lost to Follow-up|1|||
164392647|NCT04558346|593805109|FG000|Overall Study|Adverse Event|0|||
164392648|NCT04558346|593805110|FG001|Overall Study|Adverse Event|1|||
164392649|NCT00724971|593805111|FG000|Overall Study|Adverse Event|5|||
164392650|NCT00724971|593805111|FG000|Overall Study|Withdrawal by Subject|1|||
164392651|NCT01962974|593805112|FG000|Overall Study|Study termination|7|||
164392652|NCT00627705|593805114|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
164392653|NCT00627705|593805115|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
164392654|NCT00627705|593805114|FG000|Overall Study|Adverse Event|1|||
164392655|NCT00627705|593805115|FG001|Overall Study|Adverse Event|0|||
164392656|NCT00627705|593805114|FG000|Overall Study|Withdrawal by Subject|0|||
164392657|NCT00627705|593805115|FG001|Overall Study|Withdrawal by Subject|2|||
164392658|NCT00627705|593805114|FG000|Overall Study|Lost to Follow-up|0|||
164392659|NCT00627705|593805115|FG001|Overall Study|Lost to Follow-up|1|||
164392660|NCT01410448|593805119|FG000|Overall Study|No conversion to everolimus|0|||
164392661|NCT01410448|593805120|FG001|Overall Study|No conversion to everolimus|24|||
164392662|NCT01410448|593805119|FG000|Overall Study|Graft loss|4|||
164392663|NCT01410448|593805120|FG001|Overall Study|Graft loss|1|||
164392664|NCT01410448|593805119|FG000|Overall Study|Administrative issues|2|||
164392665|NCT01410448|593805120|FG001|Overall Study|Administrative issues|1|||
164392666|NCT01410448|593805119|FG000|Overall Study|Lost to Follow-up|1|||
164392667|NCT01410448|593805120|FG001|Overall Study|Lost to Follow-up|0|||
164016255|NCT01555463|592421854|FG000|Follow up|Protocol Violation|2|||
164392668|NCT01410448|593805119|FG000|Overall Study|Withdrawal by Subject|3|||
164392669|NCT01410448|593805120|FG001|Overall Study|Withdrawal by Subject|2|||
164392670|NCT01410448|593805119|FG000|Overall Study|Protocol Violation|0|||
164392671|NCT01410448|593805120|FG001|Overall Study|Protocol Violation|4|||
164392672|NCT01410448|593805119|FG000|Overall Study|Death|2|||
164392673|NCT01410448|593805120|FG001|Overall Study|Death|3|||
164392674|NCT02535065|593805121|FG000|Overall Study|Death|13|||
164392675|NCT02535065|593805121|FG000|Overall Study|Lost to Follow-up|1|||
164392676|NCT02535065|593805121|FG000|Overall Study|Withdrawal by Subject|6|||
164392677|NCT04764396|593805122|FG000|Overall Study|Physician Decision|1|||
164392678|NCT04764396|593805123|FG001|Overall Study|Physician Decision|0|||
164392679|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
164392680|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
164392681|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
164392682|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
164392683|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
164392684|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
164392685|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
164392686|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
164392687|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
164392688|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
164392689|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
164392690|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
164392691|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
164392692|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
164392693|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
164392694|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
164392695|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
164392696|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
164392697|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
164392698|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
164392699|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
164392700|NCT01781572|593805125|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
164392701|NCT01781572|593805126|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
164392702|NCT01781572|593805127|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
164392703|NCT01781572|593805125|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
164392704|NCT01781572|593805126|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
164392705|NCT01781572|593805127|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
164392706|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
164392707|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
164392708|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
164392709|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
164392710|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
164392711|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
164392712|NCT01781572|593805125|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
164392713|NCT01781572|593805126|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
164392714|NCT01781572|593805127|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
164392715|NCT01781572|593805125|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
164392716|NCT01781572|593805126|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
164392717|NCT01781572|593805127|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
164392718|NCT01781572|593805125|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
164392719|NCT01781572|593805126|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
164392720|NCT01781572|593805127|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
164392721|NCT01781572|593805125|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
164392722|NCT01781572|593805126|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
164392723|NCT01781572|593805127|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
164392724|NCT01781572|593805125|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
164392725|NCT01781572|593805126|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
164392726|NCT01781572|593805127|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
164392727|NCT01781572|593805125|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
164392728|NCT01781572|593805126|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
164392729|NCT01781572|593805127|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
164392730|NCT01781572|593805125|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
164392731|NCT01781572|593805126|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
164392732|NCT01781572|593805127|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
164392733|NCT01218438|593805128|FG000|Epoch 1|Physician Decision|2|||
164392734|NCT01218438|593805128|FG000|Epoch 1|Adverse Event|1|||
164392735|NCT01218438|593805128|FG000|Epoch 3|Withdrawal by Subject|3|||
164392736|NCT01218438|593805128|FG000|Epoch 3|Adverse Event|1|||
164392737|NCT01218438|593805128|FG000|Epoch 4|Physician Decision|1|||
164392738|NCT01218438|593805128|FG000|Epoch 4|Withdrawal by Subject|2|||
164392739|NCT03762473|593805130|FG000|Overall Study|Death|1|||
164392740|NCT03762473|593805131|FG001|Overall Study|Death|0|||
164392741|NCT00045110|593805133|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
164392742|NCT00045110|593805134|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
164392743|NCT00045110|593805135|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
164392744|NCT00045110|593805133|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
164392745|NCT00045110|593805134|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
164392746|NCT00045110|593805135|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
164392747|NCT00045110|593805133|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
164392748|NCT00045110|593805134|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
164392749|NCT00045110|593805135|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
164392750|NCT01218646|593805138|FG000|Overall Study|Adverse Event|0|||
164392751|NCT01218646|593805139|FG001|Overall Study|Adverse Event|0|||
164392752|NCT01218646|593805140|FG002|Overall Study|Adverse Event|1|||
164392753|NCT01218646|593805141|FG003|Overall Study|Adverse Event|0|||
164392754|NCT01218646|593805138|FG000|Overall Study|Lost to Follow-up|1|||
164392755|NCT01218646|593805139|FG001|Overall Study|Lost to Follow-up|0|||
164392756|NCT01218646|593805140|FG002|Overall Study|Lost to Follow-up|0|||
164392757|NCT01218646|593805141|FG003|Overall Study|Lost to Follow-up|0|||
164392758|NCT01218646|593805138|FG000|Overall Study|Protocol Violation|0|||
164392759|NCT01218646|593805139|FG001|Overall Study|Protocol Violation|0|||
164392760|NCT01218646|593805140|FG002|Overall Study|Protocol Violation|1|||
164392761|NCT01218646|593805141|FG003|Overall Study|Protocol Violation|1|||
164392762|NCT00722761|593805142|FG000|Overall Study|Lost to Follow-up|1|||
164392763|NCT00722761|593805143|FG001|Overall Study|Lost to Follow-up|4|||
164392764|NCT00722761|593805142|FG000|Overall Study|Withdrawal by Subject|5|||
164392765|NCT00722761|593805143|FG001|Overall Study|Withdrawal by Subject|2|||
164392766|NCT02693665|593805148|FG000|Overall Study|Death|3|||
164392767|NCT02693665|593805149|FG001|Overall Study|Death|2|||
164392768|NCT02693665|593805148|FG000|Overall Study|Lost to Follow-up|7|||
164392769|NCT02693665|593805149|FG001|Overall Study|Lost to Follow-up|3|||
164392770|NCT02693665|593805148|FG000|Overall Study|Protocol Violation|1|||
164392771|NCT02693665|593805149|FG001|Overall Study|Protocol Violation|0|||
164392772|NCT02693665|593805148|FG000|Overall Study|Withdrawal by Subject|2|||
164392773|NCT02693665|593805149|FG001|Overall Study|Withdrawal by Subject|0|||
164392774|NCT02693665|593805148|FG000|Overall Study|patient wanted to leave it behind|1|||
164392775|NCT02693665|593805149|FG001|Overall Study|patient wanted to leave it behind|0|||
164392776|NCT02693665|593805148|FG000|Overall Study|anxiety|1|||
164392777|NCT02693665|593805149|FG001|Overall Study|anxiety|0|||
164392778|NCT02693665|593805148|FG000|Overall Study|family issues|1|||
164392779|NCT02693665|593805149|FG001|Overall Study|family issues|0|||
164392780|NCT02693665|593805148|FG000|Overall Study|no reason given|1|||
164392781|NCT02693665|593805149|FG001|Overall Study|no reason given|0|||
164392782|NCT03662750|593805150|FG000|Overall Study|Withdrawal by Subject|1|||
164392783|NCT03096782|593805151|FG000|Overall Study|Death|1|||
164392784|NCT03096782|593805151|FG000|Overall Study|Participant Relapsed|1|||
164392785|NCT02075593|593805152|FG000|Overall Study|Withdrawal by Subject|1|||
164392786|NCT03156023|593805153|FG000|Overall Study|Withdrawal by Subject|1|||
164392787|NCT03156023|593805154|FG001|Overall Study|Withdrawal by Subject|0|||
164392788|NCT03156023|593805155|FG002|Overall Study|Withdrawal by Subject|2|||
164392789|NCT03156023|593805156|FG003|Overall Study|Withdrawal by Subject|1|||
164392790|NCT03156023|593805157|FG004|Overall Study|Withdrawal by Subject|1|||
164392791|NCT03156023|593805153|FG000|Overall Study|Lost to Follow-up|0|||
164392792|NCT03156023|593805154|FG001|Overall Study|Lost to Follow-up|0|||
164392793|NCT03156023|593805155|FG002|Overall Study|Lost to Follow-up|0|||
164392794|NCT03156023|593805156|FG003|Overall Study|Lost to Follow-up|0|||
164392795|NCT03156023|593805157|FG004|Overall Study|Lost to Follow-up|1|||
164392796|NCT02010060|593805162|FG000|Overall Study|Lost to Follow-up|1|||
164392797|NCT02010060|593805163|FG001|Overall Study|Lost to Follow-up|2|||
164392798|NCT02010060|593805164|FG002|Overall Study|Lost to Follow-up|2|||
164392799|NCT02010060|593805162|FG000|Overall Study|Injury|0|||
164392800|NCT02010060|593805163|FG001|Overall Study|Injury|1|||
164392801|NCT02010060|593805164|FG002|Overall Study|Injury|0|||
164392802|NCT05819749|593805165|FG000|Overall Study|Lost to Follow-up|1|||
164392803|NCT00660010|593805166|FG000|Overall Study|Withdrawal by Subject|2|||
164392804|NCT00660010|593805166|FG000|Overall Study|Lost to Follow-up|3|||
164392805|NCT00660010|593805166|FG000|Overall Study|Adverse Event|1|||
164392806|NCT00660010|593805166|FG000|Overall Study|Noncompliance with visit schedule|3|||
164392807|NCT00726752|593805167|FG000|Overall Study|Lack of Efficacy|6|||
164392808|NCT00844857|593807089|FG000|Overall Study|Adverse Event|24|||
164392809|NCT00844857|593807090|FG001|Overall Study|Adverse Event|5|||
164392810|NCT00844857|593807089|FG000|Overall Study|Sponsor Decision|1|||
164392811|NCT00844857|593807090|FG001|Overall Study|Sponsor Decision|1|||
164392812|NCT00844857|593807089|FG000|Overall Study|Physician Decision|2|||
164392813|NCT00844857|593807090|FG001|Overall Study|Physician Decision|0|||
164392814|NCT00844857|593807089|FG000|Overall Study|Parent/Caregiver Decision|6|||
164392815|NCT00844857|593807090|FG001|Overall Study|Parent/Caregiver Decision|2|||
164392816|NCT00844857|593807089|FG000|Overall Study|Withdrawal by Subject|8|||
164392817|NCT00844857|593807090|FG001|Overall Study|Withdrawal by Subject|7|||
164392818|NCT00844857|593807089|FG000|Overall Study|Protocol Violation|6|||
164392819|NCT00844857|593807090|FG001|Overall Study|Protocol Violation|0|||
164392820|NCT00844857|593807089|FG000|Overall Study|Lack of Efficacy|5|||
164392821|NCT00844857|593807090|FG001|Overall Study|Lack of Efficacy|5|||
164392822|NCT00844857|593807089|FG000|Overall Study|Clinical Relapse|0|||
164392823|NCT00844857|593807090|FG001|Overall Study|Clinical Relapse|1|||
164392824|NCT00844857|593807089|FG000|Overall Study|Entry Criteria Not Met|0|||
164392825|NCT00844857|593807090|FG001|Overall Study|Entry Criteria Not Met|1|||
164392826|NCT00844857|593807089|FG000|Overall Study|Lost to Follow-up|2|||
164392827|NCT00844857|593807090|FG001|Overall Study|Lost to Follow-up|3|||
164392828|NCT00844857|593807089|FG000|Overall Study|Did Not Take Study Drug|3|||
164392829|NCT00844857|593807090|FG001|Overall Study|Did Not Take Study Drug|1|||
164392830|NCT00844857|593807089|FG000|Overall Study|Good Clinical Practice Violations|21|||
164392831|NCT00844857|593807090|FG001|Overall Study|Good Clinical Practice Violations|11|||
164392832|NCT00570674|593807091|FG000|Overall Study|Withdrawal by Subject|0|||
164392833|NCT00570674|593807092|FG001|Overall Study|Withdrawal by Subject|0|||
164392834|NCT00570674|593807093|FG002|Overall Study|Withdrawal by Subject|1|||
164392835|NCT00570674|593807094|FG003|Overall Study|Withdrawal by Subject|0|||
164392836|NCT00570674|593807095|FG004|Overall Study|Withdrawal by Subject|0|||
164392837|NCT00570674|593807096|FG005|Overall Study|Withdrawal by Subject|0|||
164392838|NCT00570674|593807097|FG006|Overall Study|Withdrawal by Subject|0|||
164392839|NCT03069482|593807098|FG000|Overall Study|Lost to Follow-up|0|||
164392840|NCT03069482|593807099|FG001|Overall Study|Lost to Follow-up|1|||
164392841|NCT03069482|593807098|FG000|Overall Study|Physician Decision|1|||
164392842|NCT03069482|593807099|FG001|Overall Study|Physician Decision|0|||
164392843|NCT00907153|593807108|FG000|Overall Study|Lost to Follow-up|1|||
164392844|NCT00907153|593807109|FG001|Overall Study|Lost to Follow-up|1|||
164392845|NCT00907153|593807108|FG000|Overall Study|Withdrawal by Subject|1|||
164392846|NCT00907153|593807109|FG001|Overall Study|Withdrawal by Subject|3|||
164392847|NCT02338154|593807116|FG000|Overall Study|Death|46|||
164392848|NCT02338154|593807116|FG000|Overall Study|Valve Implant Failure|17|||
164392849|NCT02338154|593807116|FG000|Overall Study|Valve Explant|11|||
164392850|NCT02338154|593807116|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
164392851|NCT02338154|593807116|FG000|Overall Study|Lost to Follow-up|8|||
164392852|NCT02338154|593807116|FG000|Overall Study|Other Reason|3|||
164392853|NCT02338154|593807116|FG000|Overall Study|Patients Without Exit Form|47|||
164392854|NCT02338154|593807116|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
164392855|NCT03393000|593807119|FG000|Overall Study|Death|11|||
164392856|NCT03393000|593807119|FG000|Overall Study|Withdrawal by Subject|2|||
164392857|NCT03393000|593807119|FG000|Overall Study|Physician Decision|1|||
164392858|NCT01773070|593807120|FG000|Overall Study|Withdrawal by Subject|24|||
164392859|NCT01773070|593807120|FG000|Overall Study|Lost to Follow-up|39|||
164392860|NCT01773070|593807120|FG000|Overall Study|Other|15|||
164392861|NCT01773070|593807120|FG000|Overall Study|Death (unrelated to study procedures)|3|||
164392862|NCT02696317|593807124|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
164392863|NCT02696317|593807125|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
164392864|NCT02696317|593807124|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
164392865|NCT02696317|593807125|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
164392866|NCT00237744|593807126|FG000|Overall Study|Withdrawal by Subject|3|||
164392867|NCT00237744|593807127|FG001|Overall Study|Withdrawal by Subject|1|||
164392868|NCT00237744|593807128|FG002|Overall Study|Withdrawal by Subject|0|||
164392869|NCT02566031|593807129|FG000|Overall Study|Patient/guardian decision|14|||
164392870|NCT02566031|593807130|FG001|Overall Study|Patient/guardian decision|7|||
164392871|NCT02566031|593807129|FG000|Overall Study|Protocol deviation|2|||
164392872|NCT02566031|593807130|FG001|Overall Study|Protocol deviation|3|||
164392873|NCT02566031|593807129|FG000|Overall Study|Adverse Event|3|||
164392874|NCT02566031|593807130|FG001|Overall Study|Adverse Event|1|||
164392875|NCT02566031|593807129|FG000|Overall Study|Lost to Follow-up|1|||
164392876|NCT02566031|593807130|FG001|Overall Study|Lost to Follow-up|1|||
164392877|NCT03031938|593807131|FG000|Overall Study|Death|1|||
164392878|NCT03031938|593807132|FG001|Overall Study|Death|0|||
164392879|NCT03117738|593807139|FG000|Overall Study|Withdrawal by Subject|3|||
164392880|NCT03117738|593807140|FG001|Overall Study|Withdrawal by Subject|1|||
164392881|NCT03117738|593807139|FG000|Overall Study|Lost to Follow-up|1|||
164392882|NCT03117738|593807140|FG001|Overall Study|Lost to Follow-up|4|||
164392883|NCT02015676|593807141|FG000|Overall Study|Adverse Event|2|||
164392884|NCT02015676|593807142|FG001|Overall Study|Adverse Event|18|||
164392885|NCT02015676|593807143|FG002|Overall Study|Adverse Event|0|||
164392886|NCT02015676|593807141|FG000|Overall Study|Lack of Efficacy|2|||
164392887|NCT02015676|593807142|FG001|Overall Study|Lack of Efficacy|4|||
164392888|NCT02015676|593807143|FG002|Overall Study|Lack of Efficacy|0|||
164392889|NCT02015676|593807141|FG000|Overall Study|Protocol Violation|1|||
164392890|NCT02015676|593807142|FG001|Overall Study|Protocol Violation|0|||
164392891|NCT02015676|593807143|FG002|Overall Study|Protocol Violation|0|||
164392892|NCT02015676|593807141|FG000|Overall Study|Withdrawal by Subject|1|||
164392893|NCT02015676|593807142|FG001|Overall Study|Withdrawal by Subject|7|||
164392894|NCT02015676|593807143|FG002|Overall Study|Withdrawal by Subject|1|||
164392895|NCT02015676|593807141|FG000|Overall Study|Administrative reasons|0|||
164392896|NCT02015676|593807142|FG001|Overall Study|Administrative reasons|3|||
164392897|NCT02015676|593807143|FG002|Overall Study|Administrative reasons|1|||
164392898|NCT02015676|593807141|FG000|Overall Study|Death|0|||
164392899|NCT02015676|593807142|FG001|Overall Study|Death|1|||
164392900|NCT02015676|593807143|FG002|Overall Study|Death|0|||
164392901|NCT02015676|593807141|FG000|Overall Study|Disease progression|3|||
164392902|NCT02015676|593807142|FG001|Overall Study|Disease progression|1|||
164392903|NCT02015676|593807143|FG002|Overall Study|Disease progression|1|||
164392904|NCT00476476|593807145|FG000|Overall Study|Adverse Event|2|||
164392905|NCT00476476|593807146|FG001|Overall Study|Adverse Event|7|||
164392906|NCT00476476|593807145|FG000|Overall Study|Progressive Disease|0|||
164392907|NCT00476476|593807146|FG001|Overall Study|Progressive Disease|17|||
164392908|NCT00971048|593807150|FG000|Overall Study|Protocol Violation|1|||
164392909|NCT00971048|593807151|FG001|Overall Study|Protocol Violation|2|||
164392910|NCT00971048|593807152|FG002|Overall Study|Protocol Violation|0|||
164392911|NCT00971048|593807153|FG003|Overall Study|Protocol Violation|1|||
164392912|NCT00971048|593807150|FG000|Overall Study|Adverse Event|0|||
164392913|NCT00971048|593807151|FG001|Overall Study|Adverse Event|0|||
164392914|NCT00971048|593807152|FG002|Overall Study|Adverse Event|1|||
164392915|NCT00971048|593807153|FG003|Overall Study|Adverse Event|0|||
164392916|NCT00971048|593807150|FG000|Overall Study|Physician Decision|0|||
164392917|NCT00971048|593807151|FG001|Overall Study|Physician Decision|0|||
164392918|NCT00971048|593807152|FG002|Overall Study|Physician Decision|0|||
164392919|NCT00971048|593807153|FG003|Overall Study|Physician Decision|1|||
164392920|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
164392921|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
164392922|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
164392923|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
164392924|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
164392925|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
164392926|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
164392927|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
164392928|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
164392929|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
164392930|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
164392931|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
164392932|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
164392933|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
164392934|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
164392935|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
164392936|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
164392937|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
164392938|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
164392939|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
164392940|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
164392941|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
164392942|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
164392943|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
164392944|NCT01715805|593807157|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
164392945|NCT01715805|593807158|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
164392946|NCT01715805|593807159|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
164392947|NCT01715805|593807160|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
164392948|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
164392949|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
164392950|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
164392951|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
164392952|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
164392953|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
164392954|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
164392955|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
164392956|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
164392957|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
164392958|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
164392959|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
164392960|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
164392961|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
164392962|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
164392963|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
164392964|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
164392965|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
164392966|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
164392967|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
164392968|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
164392969|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
164392970|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
164392971|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
164392972|NCT01715805|593807157|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
164392973|NCT01715805|593807158|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
164392974|NCT01715805|593807159|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
164392975|NCT01715805|593807160|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
164392976|NCT02647359|593807163|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
164392977|NCT02647359|593807164|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
164392978|NCT02647359|593807163|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
164392979|NCT02647359|593807164|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
164392980|NCT02647359|593807163|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
164392981|NCT02647359|593807164|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
164392982|NCT02647359|593807163|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
164392983|NCT02647359|593807164|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
164392984|NCT02647359|593807163|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
164392985|NCT02647359|593807164|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
164392986|NCT02647359|593807163|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
164392987|NCT02647359|593807164|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
164392988|NCT00413413|593807165|FG000|Single-Blind|Adverse Event|0|||
164392989|NCT00413413|593807166|FG001|Single-Blind|Adverse Event|9|||
164392990|NCT00413413|593807167|FG002|Single-Blind|Adverse Event|0|||
164392991|NCT00413413|593807165|FG000|Single-Blind|Lack of Efficacy|0|||
164392992|NCT00413413|593807166|FG001|Single-Blind|Lack of Efficacy|5|||
164392993|NCT00413413|593807167|FG002|Single-Blind|Lack of Efficacy|0|||
164392994|NCT00413413|593807165|FG000|Single-Blind|Subject no longer requires study drug|0|||
164392995|NCT00413413|593807166|FG001|Single-Blind|Subject no longer requires study drug|151|||
164392996|NCT00413413|593807167|FG002|Single-Blind|Subject no longer requires study drug|0|||
164392997|NCT00413413|593807165|FG000|Single-Blind|Protocol Violation|0|||
164392998|NCT00413413|593807166|FG001|Single-Blind|Protocol Violation|16|||
164392999|NCT00413413|593807167|FG002|Single-Blind|Protocol Violation|0|||
164393000|NCT00413413|593807165|FG000|Single-Blind|Withdrawal by Subject|0|||
164393001|NCT00413413|593807166|FG001|Single-Blind|Withdrawal by Subject|27|||
164393002|NCT00413413|593807167|FG002|Single-Blind|Withdrawal by Subject|0|||
164393003|NCT00413413|593807165|FG000|Single-Blind|Lost to Follow-up|0|||
164393004|NCT00413413|593807166|FG001|Single-Blind|Lost to Follow-up|8|||
164393005|NCT00413413|593807167|FG002|Single-Blind|Lost to Follow-up|0|||
164393006|NCT00413413|593807165|FG000|Double-Blind|Adverse Event|6|||
164393007|NCT00413413|593807166|FG001|Double-Blind|Adverse Event|0|||
164393008|NCT00413413|593807167|FG002|Double-Blind|Adverse Event|5|||
164393009|NCT00413413|593807165|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
164393010|NCT00413413|593807166|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
164393011|NCT00413413|593807167|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
164393012|NCT00413413|593807165|FG000|Double-Blind|Protocol deviation|1|||
164393013|NCT00413413|593807166|FG001|Double-Blind|Protocol deviation|2|||
163905108|NCT03057600|592023763|FG002|Overall Study|Study Termination by Sponsor|0|||
164393014|NCT00413413|593807167|FG002|Double-Blind|Protocol deviation|1|||
164393015|NCT00413413|593807165|FG000|Double-Blind|Subject withdrew consent|4|||
164393016|NCT00413413|593807166|FG001|Double-Blind|Subject withdrew consent|6|||
164393017|NCT00413413|593807167|FG002|Double-Blind|Subject withdrew consent|9|||
164393018|NCT00413413|593807165|FG000|Double-Blind|Lost to Follow-up|3|||
164393019|NCT00413413|593807166|FG001|Double-Blind|Lost to Follow-up|4|||
164393020|NCT00413413|593807167|FG002|Double-Blind|Lost to Follow-up|2|||
164393021|NCT02219932|593807174|FG000|Overall Study|Other|5|||
164393022|NCT02219932|593807175|FG001|Overall Study|Other|11|||
164393023|NCT02219932|593807174|FG000|Overall Study|Death|1|||
164393024|NCT02219932|593807175|FG001|Overall Study|Death|1|||
164393025|NCT02219932|593807174|FG000|Overall Study|Investigator Decision|0|||
164393026|NCT02219932|593807175|FG001|Overall Study|Investigator Decision|1|||
163905109|NCT03057600|592023764|FG003|Overall Study|Study Termination by Sponsor|2|||
164393027|NCT02219932|593807174|FG000|Overall Study|Consent Withdrawn|11|||
164393028|NCT02219932|593807175|FG001|Overall Study|Consent Withdrawn|7|||
164393029|NCT02219932|593807174|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
164393030|NCT02219932|593807175|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
164393031|NCT02219932|593807174|FG000|Overall Study|Protocol Violation|10|||
163905110|NCT03057600|592023761|FG000|Overall Study|Withdrawal by Subject|0|||
164393032|NCT02219932|593807175|FG001|Overall Study|Protocol Violation|6|||
164393033|NCT02219932|593807174|FG000|Overall Study|Pregnancy|1|||
164393034|NCT02219932|593807175|FG001|Overall Study|Pregnancy|0|||
164393035|NCT02219932|593807174|FG000|Overall Study|Lost to Follow-up|4|||
164393036|NCT02219932|593807175|FG001|Overall Study|Lost to Follow-up|2|||
164393037|NCT02219932|593807174|FG000|Overall Study|Adverse Event|23|||
164393038|NCT02219932|593807175|FG001|Overall Study|Adverse Event|21|||
164393039|NCT00511004|593807178|FG000|Overall Study|Lost to Follow-up|0|||
164393040|NCT00511004|593807179|FG001|Overall Study|Lost to Follow-up|0|||
164393041|NCT00511004|593807180|FG002|Overall Study|Lost to Follow-up|4|||
164393042|NCT04642638|593807181|FG000|Overall Study|Withdrawal by Subject|23|||
164393043|NCT04642638|593807182|FG001|Overall Study|Withdrawal by Subject|29|||
164393044|NCT04642638|593807183|FG002|Overall Study|Withdrawal by Subject|9|||
164393045|NCT04642638|593807184|FG003|Overall Study|Withdrawal by Subject|7|||
164393046|NCT04642638|593807185|FG004|Overall Study|Withdrawal by Subject|61|||
164393047|NCT04642638|593807186|FG005|Overall Study|Withdrawal by Subject|27|||
164393048|NCT04642638|593807181|FG000|Overall Study|Lost to Follow-up|17|||
164393049|NCT04642638|593807182|FG001|Overall Study|Lost to Follow-up|18|||
164393050|NCT04642638|593807183|FG002|Overall Study|Lost to Follow-up|5|||
164393051|NCT04642638|593807184|FG003|Overall Study|Lost to Follow-up|5|||
164393052|NCT04642638|593807185|FG004|Overall Study|Lost to Follow-up|6|||
164393053|NCT04642638|593807186|FG005|Overall Study|Lost to Follow-up|3|||
164393054|NCT04642638|593807181|FG000|Overall Study|Adverse Event|0|||
164393055|NCT04642638|593807182|FG001|Overall Study|Adverse Event|0|||
164393056|NCT04642638|593807183|FG002|Overall Study|Adverse Event|1|||
164393057|NCT04642638|593807184|FG003|Overall Study|Adverse Event|0|||
164393058|NCT04642638|593807185|FG004|Overall Study|Adverse Event|10|||
164393059|NCT04642638|593807186|FG005|Overall Study|Adverse Event|3|||
164393060|NCT04642638|593807181|FG000|Overall Study|Reason Not Specified|1|||
164393061|NCT04642638|593807182|FG001|Overall Study|Reason Not Specified|4|||
164393062|NCT04642638|593807183|FG002|Overall Study|Reason Not Specified|0|||
164393063|NCT04642638|593807184|FG003|Overall Study|Reason Not Specified|0|||
164393064|NCT04642638|593807185|FG004|Overall Study|Reason Not Specified|38|||
164393065|NCT04642638|593807186|FG005|Overall Study|Reason Not Specified|16|||
164393066|NCT04642638|593807181|FG000|Overall Study|Physician Decision|0|||
164393067|NCT04642638|593807182|FG001|Overall Study|Physician Decision|0|||
164393068|NCT04642638|593807183|FG002|Overall Study|Physician Decision|0|||
164393069|NCT04642638|593807184|FG003|Overall Study|Physician Decision|0|||
164393070|NCT04642638|593807185|FG004|Overall Study|Physician Decision|2|||
164393071|NCT04642638|593807186|FG005|Overall Study|Physician Decision|1|||
164393072|NCT04642638|593807181|FG000|Overall Study|Protocol Deviation|0|||
164393073|NCT04642638|593807182|FG001|Overall Study|Protocol Deviation|0|||
164393074|NCT04642638|593807183|FG002|Overall Study|Protocol Deviation|0|||
164393075|NCT04642638|593807184|FG003|Overall Study|Protocol Deviation|0|||
164393076|NCT04642638|593807185|FG004|Overall Study|Protocol Deviation|1|||
164393077|NCT04642638|593807186|FG005|Overall Study|Protocol Deviation|3|||
164393078|NCT04642638|593807181|FG000|Overall Study|Study Terminated|0|||
164393079|NCT04642638|593807182|FG001|Overall Study|Study Terminated|0|||
164393080|NCT04642638|593807183|FG002|Overall Study|Study Terminated|0|||
164393081|NCT04642638|593807184|FG003|Overall Study|Study Terminated|0|||
164393082|NCT04642638|593807185|FG004|Overall Study|Study Terminated|484|||
164393083|NCT04642638|593807186|FG005|Overall Study|Study Terminated|250|||
164393084|NCT04642638|593807181|FG000|Overall Study|Pregnancy|0|||
164393085|NCT04642638|593807182|FG001|Overall Study|Pregnancy|0|||
164393086|NCT04642638|593807183|FG002|Overall Study|Pregnancy|0|||
164393087|NCT04642638|593807184|FG003|Overall Study|Pregnancy|0|||
164393088|NCT04642638|593807185|FG004|Overall Study|Pregnancy|1|||
164393089|NCT04642638|593807186|FG005|Overall Study|Pregnancy|0|||
163905111|NCT03057600|592023762|FG001|Overall Study|Withdrawal by Subject|1|||
164393090|NCT00990652|593807187|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
164393091|NCT00990652|593807187|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
164393092|NCT01672801|593807189|FG000|Overall Study|Screen Failure|0|||
164393093|NCT01672801|593807190|FG001|Overall Study|Screen Failure|1|||
164393094|NCT06476366|593807191|FG000|Overall Study|Lost to Follow-up|1|||
164393095|NCT06476366|593807192|FG001|Overall Study|Lost to Follow-up|3|||
164393096|NCT06476366|593807191|FG000|Overall Study|Adverse Event|1|||
164393097|NCT06476366|593807192|FG001|Overall Study|Adverse Event|0|||
164393098|NCT04313881|593807197|FG000|Overall Study|Death|138|||
163905112|NCT03057600|592023763|FG002|Overall Study|Withdrawal by Subject|0|||
164393099|NCT04313881|593807198|FG001|Overall Study|Death|126|||
164393100|NCT04313881|593807197|FG000|Overall Study|Study terminated by sponsor|108|||
163905113|NCT03057600|592023764|FG003|Overall Study|Withdrawal by Subject|0|||
163905114|NCT03057600|592023761|FG000|Overall Study|Other, Not Specified|1|||
163905115|NCT03057600|592023762|FG001|Overall Study|Other, Not Specified|1|||
163905116|NCT03057600|592023763|FG002|Overall Study|Other, Not Specified|1|||
163905117|NCT03057600|592023764|FG003|Overall Study|Other, Not Specified|1|||
163905118|NCT02091752|592023765|FG000|Overall Study|Study terminated by Sponsor|2|||
163905119|NCT02091752|592023765|FG000|Overall Study|Adverse Event|1|||
163905120|NCT01604824|592023772|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164393101|NCT04313881|593807198|FG001|Overall Study|Study terminated by sponsor|129|||
164393102|NCT04313881|593807197|FG000|Overall Study|Consent withdrawn|19|||
164393103|NCT04313881|593807198|FG001|Overall Study|Consent withdrawn|15|||
164393104|NCT04313881|593807197|FG000|Overall Study|Reason not Specified|3|||
164393105|NCT04313881|593807198|FG001|Overall Study|Reason not Specified|1|||
164393106|NCT00727272|593807199|FG000|Washout Period A|Adverse Event|0|||
164393107|NCT00727272|593807200|FG001|Washout Period A|Adverse Event|0|||
164393108|NCT00727272|593807201|FG002|Washout Period A|Adverse Event|1|||
164393109|NCT00727272|593807199|FG000|Washout Period B|Withdrawal by Subject|0|||
164393110|NCT00727272|593807200|FG001|Washout Period B|Withdrawal by Subject|0|||
164393111|NCT00727272|593807201|FG002|Washout Period B|Withdrawal by Subject|1|||
164393112|NCT00651664|593807202|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
164393113|NCT00651664|593807203|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
164393114|NCT00651664|593807204|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
164393115|NCT00651664|593807205|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
164393116|NCT00651664|593807206|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
164393117|NCT00651664|593807207|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
164393118|NCT00651664|593807208|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
164393119|NCT00651664|593807209|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
164393120|NCT00651664|593807210|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
164393121|NCT00651664|593807211|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
164393122|NCT00651664|593807202|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393123|NCT00651664|593807203|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393124|NCT00651664|593807204|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393125|NCT00651664|593807205|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393126|NCT00651664|593807206|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393127|NCT00651664|593807207|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393128|NCT00651664|593807208|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393129|NCT00651664|593807209|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393130|NCT00651664|593807210|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
164393131|NCT00651664|593807211|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
164393132|NCT00651664|593807202|FG000|Overall Study|Progressive Disease|3|||
164393133|NCT00651664|593807203|FG001|Overall Study|Progressive Disease|3|||
164393134|NCT00651664|593807204|FG002|Overall Study|Progressive Disease|3|||
164393135|NCT00651664|593807205|FG003|Overall Study|Progressive Disease|12|||
164393136|NCT00651664|593807206|FG004|Overall Study|Progressive Disease|4|||
164393137|NCT00651664|593807207|FG005|Overall Study|Progressive Disease|1|||
164393138|NCT00651664|593807208|FG006|Overall Study|Progressive Disease|3|||
164393139|NCT00651664|593807209|FG007|Overall Study|Progressive Disease|6|||
164393140|NCT00651664|593807210|FG008|Overall Study|Progressive Disease|5|||
164393141|NCT00651664|593807211|FG009|Overall Study|Progressive Disease|5|||
164393142|NCT00651664|593807202|FG000|Overall Study|Patient Declined Further Treatment|0|||
164393143|NCT00651664|593807203|FG001|Overall Study|Patient Declined Further Treatment|0|||
164393144|NCT00651664|593807204|FG002|Overall Study|Patient Declined Further Treatment|0|||
164393145|NCT00651664|593807205|FG003|Overall Study|Patient Declined Further Treatment|1|||
164393146|NCT00651664|593807206|FG004|Overall Study|Patient Declined Further Treatment|1|||
164393147|NCT00651664|593807207|FG005|Overall Study|Patient Declined Further Treatment|1|||
164393148|NCT00651664|593807208|FG006|Overall Study|Patient Declined Further Treatment|0|||
164393149|NCT00651664|593807209|FG007|Overall Study|Patient Declined Further Treatment|0|||
164393150|NCT00651664|593807210|FG008|Overall Study|Patient Declined Further Treatment|0|||
164393151|NCT00651664|593807211|FG009|Overall Study|Patient Declined Further Treatment|1|||
164393152|NCT00651664|593807202|FG000|Overall Study|Symptomatic Deterioration|0|||
164393153|NCT00651664|593807203|FG001|Overall Study|Symptomatic Deterioration|0|||
164393154|NCT00651664|593807204|FG002|Overall Study|Symptomatic Deterioration|0|||
164393155|NCT00651664|593807205|FG003|Overall Study|Symptomatic Deterioration|1|||
164393156|NCT00651664|593807206|FG004|Overall Study|Symptomatic Deterioration|0|||
164393157|NCT00651664|593807207|FG005|Overall Study|Symptomatic Deterioration|0|||
164393158|NCT00651664|593807208|FG006|Overall Study|Symptomatic Deterioration|1|||
164393159|NCT00651664|593807209|FG007|Overall Study|Symptomatic Deterioration|0|||
164393160|NCT00651664|593807210|FG008|Overall Study|Symptomatic Deterioration|1|||
164393161|NCT00651664|593807211|FG009|Overall Study|Symptomatic Deterioration|0|||
164393162|NCT00651664|593807202|FG000|Overall Study|Reason not Specified|0|||
164393163|NCT00651664|593807203|FG001|Overall Study|Reason not Specified|0|||
164393164|NCT00651664|593807204|FG002|Overall Study|Reason not Specified|0|||
164393165|NCT00651664|593807205|FG003|Overall Study|Reason not Specified|0|||
164393166|NCT00651664|593807206|FG004|Overall Study|Reason not Specified|0|||
164093147|NCT05694013|592703494|FG001|Overall Study|Participant Decision|1|||
164093148|NCT05694013|592703493|FG000|Overall Study|Physician Decision|1|||
164393167|NCT00651664|593807207|FG005|Overall Study|Reason not Specified|0|||
164393168|NCT00651664|593807208|FG006|Overall Study|Reason not Specified|1|||
164393169|NCT00651664|593807209|FG007|Overall Study|Reason not Specified|0|||
164393170|NCT00651664|593807210|FG008|Overall Study|Reason not Specified|0|||
164393171|NCT00651664|593807211|FG009|Overall Study|Reason not Specified|0|||
164393172|NCT03449030|593807212|FG000|Overall Study|Withdrawal by Subject|0|||
164393173|NCT03449030|593807213|FG001|Overall Study|Withdrawal by Subject|0|||
164393174|NCT03449030|593807214|FG002|Overall Study|Withdrawal by Subject|0|||
164393175|NCT03449030|593807215|FG003|Overall Study|Withdrawal by Subject|1|||
164393176|NCT03449030|593807216|FG004|Overall Study|Withdrawal by Subject|1|||
164393177|NCT03449030|593807217|FG005|Overall Study|Withdrawal by Subject|1|||
164393178|NCT03449030|593807218|FG006|Overall Study|Withdrawal by Subject|1|||
164393179|NCT03449030|593807219|FG007|Overall Study|Withdrawal by Subject|2|||
164393180|NCT03449030|593807220|FG008|Overall Study|Withdrawal by Subject|0|||
164393181|NCT03449030|593807221|FG009|Overall Study|Withdrawal by Subject|0|||
164393182|NCT03449030|593807212|FG000|Overall Study|Symptomatic Deterioration|0|||
164393183|NCT03449030|593807213|FG001|Overall Study|Symptomatic Deterioration|1|||
164393184|NCT03449030|593807214|FG002|Overall Study|Symptomatic Deterioration|0|||
164393185|NCT03449030|593807215|FG003|Overall Study|Symptomatic Deterioration|0|||
164393186|NCT03449030|593807216|FG004|Overall Study|Symptomatic Deterioration|0|||
164393187|NCT03449030|593807217|FG005|Overall Study|Symptomatic Deterioration|1|||
164393188|NCT03449030|593807218|FG006|Overall Study|Symptomatic Deterioration|1|||
164393189|NCT03449030|593807219|FG007|Overall Study|Symptomatic Deterioration|0|||
164393190|NCT03449030|593807220|FG008|Overall Study|Symptomatic Deterioration|2|||
164393191|NCT03449030|593807221|FG009|Overall Study|Symptomatic Deterioration|0|||
164393192|NCT03449030|593807212|FG000|Overall Study|Progressive Disease|1|||
164393193|NCT03449030|593807213|FG001|Overall Study|Progressive Disease|0|||
164393194|NCT03449030|593807214|FG002|Overall Study|Progressive Disease|1|||
164393195|NCT03449030|593807215|FG003|Overall Study|Progressive Disease|4|||
164393196|NCT03449030|593807216|FG004|Overall Study|Progressive Disease|5|||
164393197|NCT03449030|593807217|FG005|Overall Study|Progressive Disease|3|||
164393198|NCT03449030|593807218|FG006|Overall Study|Progressive Disease|0|||
164393199|NCT03449030|593807219|FG007|Overall Study|Progressive Disease|1|||
164393200|NCT03449030|593807220|FG008|Overall Study|Progressive Disease|1|||
164393201|NCT03449030|593807221|FG009|Overall Study|Progressive Disease|1|||
164393202|NCT03449030|593807212|FG000|Overall Study|Adverse Event|0|||
164393203|NCT03449030|593807213|FG001|Overall Study|Adverse Event|0|||
164393204|NCT03449030|593807214|FG002|Overall Study|Adverse Event|0|||
164393205|NCT03449030|593807215|FG003|Overall Study|Adverse Event|0|||
164393206|NCT03449030|593807216|FG004|Overall Study|Adverse Event|0|||
164393207|NCT03449030|593807217|FG005|Overall Study|Adverse Event|2|||
164393208|NCT03449030|593807218|FG006|Overall Study|Adverse Event|0|||
164393209|NCT03449030|593807219|FG007|Overall Study|Adverse Event|0|||
164393210|NCT03449030|593807220|FG008|Overall Study|Adverse Event|0|||
164393211|NCT03449030|593807221|FG009|Overall Study|Adverse Event|0|||
164393212|NCT03449030|593807212|FG000|Overall Study|Death|0|||
164393213|NCT03449030|593807213|FG001|Overall Study|Death|0|||
164393214|NCT03449030|593807214|FG002|Overall Study|Death|0|||
164393215|NCT03449030|593807215|FG003|Overall Study|Death|0|||
164393216|NCT03449030|593807216|FG004|Overall Study|Death|1|||
164393217|NCT03449030|593807217|FG005|Overall Study|Death|0|||
164393218|NCT03449030|593807218|FG006|Overall Study|Death|0|||
164393219|NCT03449030|593807219|FG007|Overall Study|Death|0|||
164393220|NCT03449030|593807220|FG008|Overall Study|Death|0|||
164393221|NCT03449030|593807221|FG009|Overall Study|Death|0|||
164393222|NCT02187991|593807224|FG000|Overall Study|Adverse Event|13|||
164393223|NCT02187991|593807225|FG001|Overall Study|Adverse Event|14|||
164393224|NCT02187991|593807226|FG002|Overall Study|Adverse Event|3|||
164393225|NCT02187991|593807227|FG003|Overall Study|Adverse Event|2|||
164393226|NCT02187991|593807224|FG000|Overall Study|Withdrawal by Subject|9|||
164393227|NCT02187991|593807225|FG001|Overall Study|Withdrawal by Subject|6|||
164393228|NCT02187991|593807226|FG002|Overall Study|Withdrawal by Subject|3|||
164393229|NCT02187991|593807227|FG003|Overall Study|Withdrawal by Subject|2|||
164393230|NCT02187991|593807224|FG000|Overall Study|Physician Decision|4|||
164393231|NCT02187991|593807225|FG001|Overall Study|Physician Decision|4|||
164393232|NCT02187991|593807226|FG002|Overall Study|Physician Decision|0|||
164393233|NCT02187991|593807227|FG003|Overall Study|Physician Decision|2|||
164393234|NCT02187991|593807224|FG000|Overall Study|Other, unrelated complication|7|||
164393235|NCT02187991|593807225|FG001|Overall Study|Other, unrelated complication|1|||
164393236|NCT02187991|593807226|FG002|Overall Study|Other, unrelated complication|1|||
164093149|NCT05694013|592703494|FG001|Overall Study|Physician Decision|0|||
164393237|NCT02187991|593807227|FG003|Overall Study|Other, unrelated complication|2|||
164393238|NCT02187991|593807224|FG000|Overall Study|Death|1|||
164393239|NCT02187991|593807225|FG001|Overall Study|Death|3|||
164393240|NCT02187991|593807226|FG002|Overall Study|Death|0|||
164393241|NCT02187991|593807227|FG003|Overall Study|Death|0|||
164393242|NCT01392560|593807228|FG000|Overall Study|Adverse Event|2|||
164393243|NCT01392560|593807228|FG000|Overall Study|not entered|8|||
164393244|NCT01392560|593807228|FG000|Overall Study|discontinued during placebo run-in|2|||
164393245|NCT00522275|593807232|FG000|Overall Study|Adverse Event|35|||
164393246|NCT00522275|593807232|FG000|Overall Study|Lack of Efficacy|80|||
164393247|NCT00522275|593807232|FG000|Overall Study|Subject withdrew consent|16|||
164393248|NCT00522275|593807232|FG000|Overall Study|Protocol deviation|1|||
164393249|NCT00522275|593807232|FG000|Overall Study|Unsatisfactory compliance|11|||
164393250|NCT00522275|593807232|FG000|Overall Study|Lost to Follow-up|8|||
164393251|NCT00522275|593807232|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
164393252|NCT00522275|593807232|FG000|Overall Study|Other: Subject is pregnant|2|||
164393253|NCT00522275|593807232|FG000|Overall Study|Other: Subject relocated|2|||
164393254|NCT00522275|593807232|FG000|Overall Study|Other: Subject arrested|1|||
164393255|NCT00522275|593807232|FG000|Overall Study|Other: Site / clinic closed|4|||
164393256|NCT00522275|593807232|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
164393257|NCT00522275|593807232|FG000|Overall Study|Other: Sponsor request|2|||
164393258|NCT00522275|593807232|FG000|Overall Study|Other: Subject ran out of medication|1|||
164393259|NCT00522275|593807232|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
164393260|NCT04656847|593807234|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
164393261|NCT03301051|593807235|FG000|Overall Study|Adverse Event|0|||
164393262|NCT03301051|593807236|FG001|Overall Study|Adverse Event|4|||
164393263|NCT03301051|593807235|FG000|Overall Study|Withdrawal by Subject|59|||
164393264|NCT03301051|593807236|FG001|Overall Study|Withdrawal by Subject|65|||
164393265|NCT03301051|593807235|FG000|Overall Study|Lost to Follow-up|263|||
164393266|NCT03301051|593807236|FG001|Overall Study|Lost to Follow-up|282|||
164393267|NCT03301051|593807235|FG000|Overall Study|Protocol Violation|1|||
164393268|NCT03301051|593807236|FG001|Overall Study|Protocol Violation|3|||
164393269|NCT03301051|593807235|FG000|Overall Study|Physician Decision|1|||
164393270|NCT03301051|593807236|FG001|Overall Study|Physician Decision|3|||
164393271|NCT03301051|593807235|FG000|Overall Study|Death|1|||
164393272|NCT03301051|593807236|FG001|Overall Study|Death|1|||
164393273|NCT03301051|593807235|FG000|Overall Study|Miscellaneous|8|||
164393274|NCT03301051|593807236|FG001|Overall Study|Miscellaneous|4|||
164393275|NCT03301051|593807235|FG000|Overall Study|Randomized, not vaccinated|13|||
164393276|NCT03301051|593807236|FG001|Overall Study|Randomized, not vaccinated|10|||
164393277|NCT00047879|593807237|FG000|Overall Study|Progressive disease|4|||
164393278|NCT00047879|593807238|FG001|Overall Study|Progressive disease|3|||
164393279|NCT01196975|593807239|FG000|Overall Study|Adverse Event|2|||
164393280|NCT01196975|593807240|FG001|Overall Study|Adverse Event|2|||
164393281|NCT01196975|593807241|FG002|Overall Study|Adverse Event|0|||
164393282|NCT01196975|593807242|FG003|Overall Study|Adverse Event|0|||
164393283|NCT01196975|593807243|FG004|Overall Study|Adverse Event|2|||
164393284|NCT01196975|593807239|FG000|Overall Study|Withdrawal by Subject|2|||
164393285|NCT01196975|593807240|FG001|Overall Study|Withdrawal by Subject|1|||
164393286|NCT01196975|593807241|FG002|Overall Study|Withdrawal by Subject|0|||
164393287|NCT01196975|593807242|FG003|Overall Study|Withdrawal by Subject|1|||
164393288|NCT01196975|593807243|FG004|Overall Study|Withdrawal by Subject|0|||
164393289|NCT01196975|593807239|FG000|Overall Study|Lost to Follow-up|11|||
164393290|NCT01196975|593807240|FG001|Overall Study|Lost to Follow-up|6|||
164393291|NCT01196975|593807241|FG002|Overall Study|Lost to Follow-up|5|||
164393292|NCT01196975|593807242|FG003|Overall Study|Lost to Follow-up|5|||
164393293|NCT01196975|593807243|FG004|Overall Study|Lost to Follow-up|11|||
164393294|NCT01462344|593807247|FG000|Overall Study|Withdrawal by Subject|245|||
164393295|NCT01462344|593807248|FG001|Overall Study|Withdrawal by Subject|226|||
164393296|NCT01462344|593807247|FG000|Overall Study|Adverse Event|24|||
164393297|NCT01462344|593807248|FG001|Overall Study|Adverse Event|23|||
164393298|NCT01462344|593807247|FG000|Overall Study|Asthma Exacerbation|34|||
164393299|NCT01462344|593807248|FG001|Overall Study|Asthma Exacerbation|35|||
164393300|NCT01462344|593807247|FG000|Overall Study|Lack of Efficacy|5|||
164393301|NCT01462344|593807248|FG001|Overall Study|Lack of Efficacy|6|||
164393302|NCT01462344|593807247|FG000|Overall Study|Protocol Violation|68|||
164393303|NCT01462344|593807248|FG001|Overall Study|Protocol Violation|53|||
164393304|NCT01462344|593807247|FG000|Overall Study|Lost to Follow-up|7|||
164393305|NCT01462344|593807248|FG001|Overall Study|Lost to Follow-up|7|||
164393306|NCT00360529|593807249|FG000|Overall Study|Adverse Event|10|||
164393307|NCT00360529|593807250|FG001|Overall Study|Adverse Event|23|||
163905121|NCT01604824|592023773|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164393308|NCT00360529|593807251|FG002|Overall Study|Adverse Event|33|||
164393309|NCT00360529|593807249|FG000|Overall Study|Protocol Violation|3|||
164093150|NCT05694013|592703493|FG000|Overall Study|Progressive Disease|0|||
163905122|NCT01604824|592023774|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
164393310|NCT00360529|593807250|FG001|Overall Study|Protocol Violation|3|||
164393311|NCT00360529|593807251|FG002|Overall Study|Protocol Violation|11|||
164393312|NCT00360529|593807249|FG000|Overall Study|Lost to Follow-up|14|||
164393313|NCT00360529|593807250|FG001|Overall Study|Lost to Follow-up|10|||
164393314|NCT00360529|593807251|FG002|Overall Study|Lost to Follow-up|13|||
164393315|NCT00360529|593807249|FG000|Overall Study|Withdrawal by Subject|22|||
164393316|NCT00360529|593807250|FG001|Overall Study|Withdrawal by Subject|14|||
164393317|NCT00360529|593807251|FG002|Overall Study|Withdrawal by Subject|18|||
164393318|NCT00360529|593807249|FG000|Overall Study|Lack of Efficacy|8|||
164393319|NCT00360529|593807250|FG001|Overall Study|Lack of Efficacy|6|||
164393320|NCT00360529|593807251|FG002|Overall Study|Lack of Efficacy|5|||
164393321|NCT00360529|593807249|FG000|Overall Study|Reason discontinued not explained above|4|||
164393322|NCT00360529|593807250|FG001|Overall Study|Reason discontinued not explained above|9|||
164393323|NCT00360529|593807251|FG002|Overall Study|Reason discontinued not explained above|11|||
164393324|NCT01453595|593807256|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164393325|NCT01453595|593807257|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164393326|NCT01453595|593807258|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
164393327|NCT01128413|593807259|FG000|Overall Study|Withdrawal by Subject|1|||
164393328|NCT01128413|593807260|FG001|Overall Study|Withdrawal by Subject|0|||
164393329|NCT01128413|593807259|FG000|Overall Study|NICOM Monitor Problems|2|||
164393330|NCT01128413|593807260|FG001|Overall Study|NICOM Monitor Problems|1|||
164393331|NCT01128413|593807259|FG000|Overall Study|Pt made DNR|1|||
164393332|NCT01128413|593807260|FG001|Overall Study|Pt made DNR|0|||
164393333|NCT06167031|593807261|FG000|Overall Study|Lost to Follow-up|5|||
164393334|NCT06167031|593807262|FG001|Overall Study|Lost to Follow-up|1|||
164393335|NCT02384954|593809098|FG000|Phase 1|Progressive Disease|2|||
164393336|NCT02384954|593809099|FG001|Phase 1|Progressive Disease|0|||
164393337|NCT02384954|593809100|FG002|Phase 1|Progressive Disease|1|||
164393338|NCT02384954|593809101|FG003|Phase 1|Progressive Disease|1|||
164393339|NCT02384954|593809102|FG004|Phase 1|Progressive Disease|0|||
164393340|NCT02384954|593809103|FG005|Phase 1|Progressive Disease|0|||
164393341|NCT02384954|593809104|FG006|Phase 1|Progressive Disease|0|||
164393342|NCT02384954|593809105|FG007|Phase 1|Progressive Disease|0|||
164393343|NCT02384954|593809106|FG008|Phase 1|Progressive Disease|0|||
164393344|NCT02384954|593809098|FG000|Phase 1|Adverse Event|0|||
164393345|NCT02384954|593809099|FG001|Phase 1|Adverse Event|0|||
164393346|NCT02384954|593809100|FG002|Phase 1|Adverse Event|1|||
164393347|NCT02384954|593809101|FG003|Phase 1|Adverse Event|0|||
164393348|NCT02384954|593809102|FG004|Phase 1|Adverse Event|0|||
164393349|NCT02384954|593809103|FG005|Phase 1|Adverse Event|0|||
164393350|NCT02384954|593809104|FG006|Phase 1|Adverse Event|0|||
164016256|NCT01555463|592421855|FG001|Follow up|Protocol Violation|4|||
164016257|NCT01555463|592421854|FG000|Follow up|Other reason|3|||
164016258|NCT01555463|592421855|FG001|Follow up|Other reason|3|||
164016259|NCT03844633|592421858|FG000|1 Week FU|Lost to Follow-up|0|||
164393351|NCT02384954|593809105|FG007|Phase 1|Adverse Event|0|||
164016260|NCT03844633|592421859|FG001|1 Week FU|Lost to Follow-up|1|||
164016261|NCT03844633|592421860|FG002|1 Week FU|Lost to Follow-up|4|||
164393352|NCT02384954|593809106|FG008|Phase 1|Adverse Event|0|||
164393353|NCT02384954|593809098|FG000|Phase 2|Progressive Disease|0|||
164393354|NCT02384954|593809099|FG001|Phase 2|Progressive Disease|0|||
164393355|NCT02384954|593809100|FG002|Phase 2|Progressive Disease|0|||
164393356|NCT02384954|593809101|FG003|Phase 2|Progressive Disease|0|||
164393357|NCT02384954|593809102|FG004|Phase 2|Progressive Disease|0|||
164393358|NCT02384954|593809103|FG005|Phase 2|Progressive Disease|0|||
164016262|NCT03844633|592421858|FG000|12-month Follow-up|Lost to Follow-up|7|||
164393359|NCT02384954|593809104|FG006|Phase 2|Progressive Disease|0|||
164393360|NCT02384954|593809105|FG007|Phase 2|Progressive Disease|1|||
164393361|NCT02384954|593809106|FG008|Phase 2|Progressive Disease|2|||
164393362|NCT02384954|593809098|FG000|Phase 2|Adverse Event|0|||
164393363|NCT02384954|593809099|FG001|Phase 2|Adverse Event|0|||
164393364|NCT02384954|593809100|FG002|Phase 2|Adverse Event|0|||
164393365|NCT02384954|593809101|FG003|Phase 2|Adverse Event|0|||
164393366|NCT02384954|593809102|FG004|Phase 2|Adverse Event|0|||
164393367|NCT02384954|593809103|FG005|Phase 2|Adverse Event|0|||
164393368|NCT02384954|593809104|FG006|Phase 2|Adverse Event|0|||
164393369|NCT02384954|593809105|FG007|Phase 2|Adverse Event|1|||
164393370|NCT02384954|593809106|FG008|Phase 2|Adverse Event|1|||
164393371|NCT02384954|593809098|FG000|Phase 2|Failure to meet continuation criteria|0|||
164393372|NCT02384954|593809099|FG001|Phase 2|Failure to meet continuation criteria|0|||
164393373|NCT02384954|593809100|FG002|Phase 2|Failure to meet continuation criteria|0|||
164393374|NCT02384954|593809101|FG003|Phase 2|Failure to meet continuation criteria|0|||
164393375|NCT02384954|593809102|FG004|Phase 2|Failure to meet continuation criteria|0|||
164393376|NCT02384954|593809103|FG005|Phase 2|Failure to meet continuation criteria|0|||
164393377|NCT02384954|593809104|FG006|Phase 2|Failure to meet continuation criteria|0|||
164393378|NCT02384954|593809105|FG007|Phase 2|Failure to meet continuation criteria|1|||
164393379|NCT02384954|593809106|FG008|Phase 2|Failure to meet continuation criteria|0|||
164393380|NCT01474681|593809110|FG000|Overall Study|Death|0|||
164393381|NCT01474681|593809111|FG001|Overall Study|Death|3|||
164393382|NCT01474681|593809112|FG002|Overall Study|Death|2|||
164393383|NCT01474681|593809113|FG003|Overall Study|Death|6|||
164393384|NCT02372396|593809121|FG000|Overall Study|Lost to Follow-up|7|||
164393385|NCT02372396|593809122|FG001|Overall Study|Lost to Follow-up|9|||
164393386|NCT01483924|593809123|FG000|Overall Study|Withdrawal by Subject|2|||
164393387|NCT01483924|593809124|FG001|Overall Study|Withdrawal by Subject|0|||
164393388|NCT01483924|593809125|FG002|Overall Study|Withdrawal by Subject|0|||
164393389|NCT01483924|593809126|FG003|Overall Study|Withdrawal by Subject|1|||
164393390|NCT01483924|593809127|FG004|Overall Study|Withdrawal by Subject|1|||
164393391|NCT01483924|593809123|FG000|Overall Study|Adverse Event|0|||
164393392|NCT01483924|593809124|FG001|Overall Study|Adverse Event|0|||
164393393|NCT01483924|593809125|FG002|Overall Study|Adverse Event|1|||
164393394|NCT01483924|593809126|FG003|Overall Study|Adverse Event|1|||
164393395|NCT01483924|593809127|FG004|Overall Study|Adverse Event|0|||
164393396|NCT01483924|593809123|FG000|Overall Study|Non-compliance|0|||
164393397|NCT01483924|593809124|FG001|Overall Study|Non-compliance|0|||
164393398|NCT01483924|593809125|FG002|Overall Study|Non-compliance|0|||
164393399|NCT01483924|593809126|FG003|Overall Study|Non-compliance|1|||
164393400|NCT01483924|593809127|FG004|Overall Study|Non-compliance|1|||
164393401|NCT01483924|593809123|FG000|Overall Study|Sponsor concern over ECG result|0|||
164393402|NCT01483924|593809124|FG001|Overall Study|Sponsor concern over ECG result|0|||
164393403|NCT01483924|593809125|FG002|Overall Study|Sponsor concern over ECG result|0|||
164393404|NCT01483924|593809126|FG003|Overall Study|Sponsor concern over ECG result|1|||
164393405|NCT01483924|593809127|FG004|Overall Study|Sponsor concern over ECG result|0|||
164393406|NCT00003298|593809130|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
164393407|NCT00003298|593809130|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
164393408|NCT00003298|593809130|FG000|Surgery|Unresectable at surgery|3|||
164393409|NCT00003298|593809130|FG000|Surgery|Progression before surgery|2|||
164393410|NCT00003298|593809130|FG000|Surgery|Unevaluable and off study|2|||
164016263|NCT03844633|592421859|FG001|12-month Follow-up|Lost to Follow-up|5|||
164393411|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
164393412|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
164393413|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
164393414|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
164393415|NCT00003298|593809130|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
164393416|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
164393417|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
164393418|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
164393419|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
164016264|NCT03844633|592421860|FG002|12-month Follow-up|Lost to Follow-up|8|||
164393420|NCT00003298|593809130|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
164393421|NCT01910129|593809132|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
164393422|NCT01910129|593809133|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
164393423|NCT01910129|593809134|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
164393424|NCT01910129|593809132|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
164393425|NCT01910129|593809133|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
164393426|NCT01910129|593809134|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
164393427|NCT00965523|593809137|FG000|Study 221|Progressive Disease|4|||
164016265|NCT02588248|592421865|FG000|Overall Study|Physician Decision|4|||
164393428|NCT00965523|593809137|FG000|Study 221|Physician Decision|3|||
164393429|NCT00965523|593809137|FG000|Study 224|Progressive Disease|5|||
164393430|NCT00965523|593809137|FG000|Study 224|Physician Decision|1|||
164393431|NCT02415400|593809140|FG000|Overall Study|Adverse Event|0|||
164393432|NCT02415400|593809141|FG001|Overall Study|Adverse Event|1|||
164393433|NCT02415400|593809142|FG002|Overall Study|Adverse Event|1|||
164393434|NCT02415400|593809143|FG003|Overall Study|Adverse Event|2|||
164393435|NCT02415400|593809140|FG000|Overall Study|Participant request to stop therapy|4|||
164393436|NCT02415400|593809141|FG001|Overall Study|Participant request to stop therapy|3|||
164393437|NCT02415400|593809142|FG002|Overall Study|Participant request to stop therapy|8|||
164393438|NCT02415400|593809143|FG003|Overall Study|Participant request to stop therapy|6|||
164393439|NCT02415400|593809140|FG000|Overall Study|Participant withdrew consent|14|||
164393440|NCT02415400|593809141|FG001|Overall Study|Participant withdrew consent|12|||
164393441|NCT02415400|593809142|FG002|Overall Study|Participant withdrew consent|30|||
164393442|NCT02415400|593809143|FG003|Overall Study|Participant withdrew consent|21|||
164393443|NCT02415400|593809140|FG000|Overall Study|Death|39|||
164393444|NCT02415400|593809141|FG001|Overall Study|Death|41|||
164393445|NCT02415400|593809142|FG002|Overall Study|Death|35|||
164393446|NCT02415400|593809143|FG003|Overall Study|Death|42|||
164393447|NCT02415400|593809140|FG000|Overall Study|Lost to Follow-up|3|||
164393448|NCT02415400|593809141|FG001|Overall Study|Lost to Follow-up|3|||
164393449|NCT02415400|593809142|FG002|Overall Study|Lost to Follow-up|2|||
164393450|NCT02415400|593809143|FG003|Overall Study|Lost to Follow-up|5|||
164393451|NCT02415400|593809140|FG000|Overall Study|Poor/Non-Compliance|0|||
164393452|NCT02415400|593809141|FG001|Overall Study|Poor/Non-Compliance|1|||
164393453|NCT02415400|593809142|FG002|Overall Study|Poor/Non-Compliance|3|||
164393454|NCT02415400|593809143|FG003|Overall Study|Poor/Non-Compliance|4|||
164393455|NCT02415400|593809140|FG000|Overall Study|Participant no longer meets criteria|2|||
164393456|NCT02415400|593809141|FG001|Overall Study|Participant no longer meets criteria|0|||
164393457|NCT02415400|593809142|FG002|Overall Study|Participant no longer meets criteria|0|||
164393458|NCT02415400|593809143|FG003|Overall Study|Participant no longer meets criteria|1|||
164393459|NCT02415400|593809140|FG000|Overall Study|Participant doesn't answer phone|1|||
164393460|NCT02415400|593809141|FG001|Overall Study|Participant doesn't answer phone|0|||
164393461|NCT02415400|593809142|FG002|Overall Study|Participant doesn't answer phone|0|||
164393462|NCT02415400|593809143|FG003|Overall Study|Participant doesn't answer phone|0|||
164393463|NCT02415400|593809140|FG000|Overall Study|Participant wanted home visits|1|||
164393464|NCT02415400|593809141|FG001|Overall Study|Participant wanted home visits|0|||
164393465|NCT02415400|593809142|FG002|Overall Study|Participant wanted home visits|0|||
164393466|NCT02415400|593809143|FG003|Overall Study|Participant wanted home visits|0|||
164393467|NCT02415400|593809140|FG000|Overall Study|Randomized in error|2|||
164393468|NCT02415400|593809141|FG001|Overall Study|Randomized in error|0|||
164393469|NCT02415400|593809142|FG002|Overall Study|Randomized in error|0|||
164393470|NCT02415400|593809143|FG003|Overall Study|Randomized in error|0|||
164393471|NCT02415400|593809140|FG000|Overall Study|No study drug on site|0|||
164393472|NCT02415400|593809141|FG001|Overall Study|No study drug on site|1|||
164393473|NCT02415400|593809142|FG002|Overall Study|No study drug on site|0|||
164393474|NCT02415400|593809143|FG003|Overall Study|No study drug on site|0|||
164393475|NCT02415400|593809140|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
164393476|NCT02415400|593809141|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
164393477|NCT02415400|593809142|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
164393478|NCT02415400|593809143|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
164393479|NCT02415400|593809140|FG000|Overall Study|Coagulation values cannot be set|0|||
164393480|NCT02415400|593809141|FG001|Overall Study|Coagulation values cannot be set|0|||
164393481|NCT02415400|593809142|FG002|Overall Study|Coagulation values cannot be set|1|||
164393482|NCT02415400|593809143|FG003|Overall Study|Coagulation values cannot be set|0|||
164393483|NCT02415400|593809140|FG000|Overall Study|State regulations prevent participation|0|||
164393484|NCT02415400|593809141|FG001|Overall Study|State regulations prevent participation|0|||
164393485|NCT02415400|593809142|FG002|Overall Study|State regulations prevent participation|1|||
164393486|NCT02415400|593809143|FG003|Overall Study|State regulations prevent participation|0|||
164393487|NCT02415400|593809140|FG000|Overall Study|Poor treatment monitoring|0|||
164393488|NCT02415400|593809141|FG001|Overall Study|Poor treatment monitoring|0|||
164393489|NCT02415400|593809142|FG002|Overall Study|Poor treatment monitoring|1|||
164393490|NCT02415400|593809143|FG003|Overall Study|Poor treatment monitoring|0|||
164016266|NCT02588248|592421866|FG001|Overall Study|Physician Decision|3|||
164393491|NCT02415400|593809140|FG000|Overall Study|Participant in jail|0|||
164393492|NCT02415400|593809141|FG001|Overall Study|Participant in jail|0|||
164016267|NCT01355068|592421867|FG000|First Intervention Period|Adverse Event|0|||
164393493|NCT02415400|593809142|FG002|Overall Study|Participant in jail|1|||
164393494|NCT02415400|593809143|FG003|Overall Study|Participant in jail|0|||
164016268|NCT01355068|592421868|FG001|First Intervention Period|Adverse Event|1|||
164393495|NCT02415400|593809140|FG000|Overall Study|Investigator decision|0|||
164393496|NCT02415400|593809141|FG001|Overall Study|Investigator decision|0|||
164393497|NCT02415400|593809142|FG002|Overall Study|Investigator decision|1|||
164393498|NCT02415400|593809143|FG003|Overall Study|Investigator decision|1|||
164393499|NCT02415400|593809140|FG000|Overall Study|Site closure; participant won't transfer|0|||
164393500|NCT02415400|593809141|FG001|Overall Study|Site closure; participant won't transfer|0|||
164393501|NCT02415400|593809142|FG002|Overall Study|Site closure; participant won't transfer|0|||
164393502|NCT02415400|593809143|FG003|Overall Study|Site closure; participant won't transfer|1|||
164393503|NCT01226745|593809144|FG000|Overall Study|Did not complete schedule of assessments|8|||
164393504|NCT01226745|593809145|FG001|Overall Study|Did not complete schedule of assessments|3|||
164393505|NCT01226745|593809146|FG002|Overall Study|Did not complete schedule of assessments|6|||
164393506|NCT01226745|593809147|FG003|Overall Study|Did not complete schedule of assessments|0|||
164393507|NCT01226745|593809148|FG004|Overall Study|Did not complete schedule of assessments|0|||
164393508|NCT01226745|593809149|FG005|Overall Study|Did not complete schedule of assessments|1|||
164393509|NCT01226745|593809144|FG000|Overall Study|Lost to Follow-up|2|||
164393510|NCT01226745|593809145|FG001|Overall Study|Lost to Follow-up|6|||
164393511|NCT01226745|593809146|FG002|Overall Study|Lost to Follow-up|6|||
164393512|NCT01226745|593809147|FG003|Overall Study|Lost to Follow-up|1|||
164393513|NCT01226745|593809148|FG004|Overall Study|Lost to Follow-up|1|||
164393514|NCT01226745|593809149|FG005|Overall Study|Lost to Follow-up|2|||
164393515|NCT01226745|593809144|FG000|Overall Study|Death|1|||
164393516|NCT01226745|593809145|FG001|Overall Study|Death|0|||
164393517|NCT01226745|593809146|FG002|Overall Study|Death|0|||
164393518|NCT01226745|593809147|FG003|Overall Study|Death|0|||
164393519|NCT01226745|593809148|FG004|Overall Study|Death|0|||
164393520|NCT01226745|593809149|FG005|Overall Study|Death|1|||
164393521|NCT01226745|593809144|FG000|Overall Study|Other|6|||
164393522|NCT01226745|593809145|FG001|Overall Study|Other|7|||
164393523|NCT01226745|593809146|FG002|Overall Study|Other|8|||
164393524|NCT01226745|593809147|FG003|Overall Study|Other|4|||
164393525|NCT01226745|593809148|FG004|Overall Study|Other|3|||
164393526|NCT01226745|593809149|FG005|Overall Study|Other|1|||
164393527|NCT02270450|593809154|FG000|Overall Study|Refusal unrelated to adverse event|3|||
164393528|NCT02270450|593809155|FG001|Overall Study|Refusal unrelated to adverse event|1|||
164393529|NCT02270450|593809156|FG002|Overall Study|Refusal unrelated to adverse event|5|||
164393530|NCT02270450|593809157|FG003|Overall Study|Refusal unrelated to adverse event|14|||
164393531|NCT02270450|593809154|FG000|Overall Study|Progression/relapse|1|||
164393532|NCT02270450|593809155|FG001|Overall Study|Progression/relapse|2|||
164393533|NCT02270450|593809156|FG002|Overall Study|Progression/relapse|4|||
164393534|NCT02270450|593809157|FG003|Overall Study|Progression/relapse|9|||
164393535|NCT02270450|593809154|FG000|Overall Study|Death|19|||
164393536|NCT02270450|593809155|FG001|Overall Study|Death|19|||
164393537|NCT02270450|593809156|FG002|Overall Study|Death|31|||
164393538|NCT02270450|593809157|FG003|Overall Study|Death|59|||
164016269|NCT01355068|592421867|FG000|First Intervention Period|Withdrawal by Subject|0|||
164016270|NCT01355068|592421868|FG001|First Intervention Period|Withdrawal by Subject|1|||
164016271|NCT00336492|592421869|FG000|Overall Study|Adverse Event|4|||
164016272|NCT00336492|592421870|FG001|Overall Study|Adverse Event|3|||
164016273|NCT00336492|592421871|FG002|Overall Study|Adverse Event|6|||
164016274|NCT00336492|592421869|FG000|Overall Study|Lack of Efficacy|6|||
164016275|NCT00336492|592421870|FG001|Overall Study|Lack of Efficacy|1|||
164016276|NCT00336492|592421871|FG002|Overall Study|Lack of Efficacy|4|||
164016277|NCT00336492|592421869|FG000|Overall Study|Other|5|||
164016278|NCT00336492|592421870|FG001|Overall Study|Other|0|||
164016279|NCT00336492|592421871|FG002|Overall Study|Other|1|||
164016280|NCT04229446|592421874|FG000|Overall Study|Death|12|||
164016281|NCT04229446|592421875|FG001|Overall Study|Death|10|||
164016282|NCT04229446|592421874|FG000|Overall Study|Lost to Follow-up|5|||
164016283|NCT04229446|592421875|FG001|Overall Study|Lost to Follow-up|8|||
164016284|NCT01781026|592421876|FG000|Overall Study|Lack of Efficacy|2|||
164016285|NCT03141307|592421877|FG000|In-Hospital|Withdrawal by Subject|0|||
164016286|NCT03141307|592421878|FG001|In-Hospital|Withdrawal by Subject|2|||
164016287|NCT03141307|592421877|FG000|In-Hospital|Protocol Violation|4|||
164393539|NCT02363738|593809158|FG000|Overall Study|Adverse Event|5|||
164016288|NCT03141307|592421878|FG001|In-Hospital|Protocol Violation|0|||
164016289|NCT03141307|592421877|FG000|Follow-Up|Lost to Follow-up|97|||
164016290|NCT03141307|592421878|FG001|Follow-Up|Lost to Follow-up|54|||
164016291|NCT01937130|592423850|FG000|Overall Study|Withdrawal by Subject|0|||
164016292|NCT01937130|592423851|FG001|Overall Study|Withdrawal by Subject|0|||
164393540|NCT02363738|593809159|FG001|Overall Study|Adverse Event|2|||
164393541|NCT02363738|593809158|FG000|Overall Study|Lack of Efficacy|1|||
164393542|NCT02363738|593809159|FG001|Overall Study|Lack of Efficacy|2|||
164393543|NCT02363738|593809158|FG000|Overall Study|Lost to Follow-up|2|||
164393544|NCT02363738|593809159|FG001|Overall Study|Lost to Follow-up|1|||
164393545|NCT01581281|593809168|FG000|Overall Study|Early Study Closure|15|||
164393546|NCT01581281|593809169|FG001|Overall Study|Early Study Closure|6|||
164393547|NCT01581281|593809170|FG002|Overall Study|Early Study Closure|12|||
164393548|NCT02081846|593809173|FG000|Overall Study|Withdrawal by Subject|1|||
164393549|NCT02081846|593809174|FG001|Overall Study|Withdrawal by Subject|0|||
164393550|NCT02081846|593809173|FG000|Overall Study|invalid consent|1|||
164393551|NCT02081846|593809174|FG001|Overall Study|invalid consent|0|||
164393552|NCT03265600|593809175|FG000|Overall Study|Lost to Follow-up|17|||
164393553|NCT03265600|593809176|FG001|Overall Study|Lost to Follow-up|5|||
164393554|NCT03265600|593809175|FG000|Overall Study|Withdrawal by Subject|4|||
164393555|NCT03265600|593809176|FG001|Overall Study|Withdrawal by Subject|2|||
164393556|NCT03265600|593809175|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
164393557|NCT03265600|593809176|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
164393558|NCT00535730|593809177|FG000|Overall Study|Adverse Event|1|||
164393559|NCT00535730|593809178|FG001|Overall Study|Adverse Event|1|||
164393560|NCT00535730|593809177|FG000|Overall Study|Lost to Follow-up|0|||
164393561|NCT00535730|593809178|FG001|Overall Study|Lost to Follow-up|1|||
164393562|NCT00535730|593809177|FG000|Overall Study|Physician Decision|0|||
164393563|NCT00535730|593809178|FG001|Overall Study|Physician Decision|1|||
164393564|NCT00535730|593809177|FG000|Overall Study|Protocol Violation|1|||
164393565|NCT00535730|593809178|FG001|Overall Study|Protocol Violation|0|||
164393566|NCT00535730|593809177|FG000|Overall Study|Withdrawal by Subject|0|||
164393567|NCT00535730|593809178|FG001|Overall Study|Withdrawal by Subject|4|||
164393568|NCT00295750|593809179|FG000|Overall Study|Adverse Event|19|||
164393569|NCT00295750|593809180|FG001|Overall Study|Adverse Event|15|||
164393570|NCT00295750|593809181|FG002|Overall Study|Adverse Event|12|||
164393571|NCT00295750|593809179|FG000|Overall Study|Lack of Efficacy|1|||
164393572|NCT00295750|593809180|FG001|Overall Study|Lack of Efficacy|1|||
164393573|NCT00295750|593809181|FG002|Overall Study|Lack of Efficacy|0|||
164393574|NCT00295750|593809179|FG000|Overall Study|Lost to Follow-up|1|||
164393575|NCT00295750|593809180|FG001|Overall Study|Lost to Follow-up|4|||
164393576|NCT00295750|593809181|FG002|Overall Study|Lost to Follow-up|1|||
164393577|NCT00295750|593809179|FG000|Overall Study|Taking prohibited therapy|2|||
164393578|NCT00295750|593809180|FG001|Overall Study|Taking prohibited therapy|3|||
164393579|NCT00295750|593809181|FG002|Overall Study|Taking prohibited therapy|2|||
164393580|NCT00295750|593809179|FG000|Overall Study|Administrative errors|2|||
164393581|NCT00295750|593809180|FG001|Overall Study|Administrative errors|4|||
164393582|NCT00295750|593809181|FG002|Overall Study|Administrative errors|5|||
164393583|NCT00295750|593809179|FG000|Overall Study|Trial drug errors|1|||
164393584|NCT00295750|593809180|FG001|Overall Study|Trial drug errors|1|||
164393585|NCT00295750|593809181|FG002|Overall Study|Trial drug errors|0|||
164393586|NCT00295750|593809179|FG000|Overall Study|Disease progression|2|||
164393587|NCT00295750|593809180|FG001|Overall Study|Disease progression|1|||
164393588|NCT00295750|593809181|FG002|Overall Study|Disease progression|0|||
164393589|NCT00295750|593809179|FG000|Overall Study|Personal reasons|0|||
163905123|NCT01604824|592023775|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163905124|NCT01604824|592023776|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
163905125|NCT01604824|592023777|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
163905126|NCT01604824|592023772|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
163905127|NCT01604824|592023773|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
163905128|NCT01604824|592023774|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
163905129|NCT01604824|592023775|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
163905130|NCT01604824|592023776|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
163905131|NCT01604824|592023777|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
163905132|NCT02630966|592023778|FG000|Overall Study|Adverse Event|1|||
163905133|NCT02630966|592023779|FG001|Overall Study|Adverse Event|3|||
163905134|NCT02630966|592023778|FG000|Overall Study|Significant Protocol Deviation|0|||
163905135|NCT02630966|592023779|FG001|Overall Study|Significant Protocol Deviation|2|||
163905136|NCT02630966|592023778|FG000|Overall Study|Voluntary Withdrawal|1|||
163905137|NCT02630966|592023779|FG001|Overall Study|Voluntary Withdrawal|1|||
163905138|NCT02630966|592023778|FG000|Overall Study|Lack of Efficacy|0|||
163905139|NCT02630966|592023779|FG001|Overall Study|Lack of Efficacy|2|||
163905140|NCT02060487|592023808|FG000|Overall Study|Other|1|||
163905141|NCT02060487|592023809|FG001|Overall Study|Other|2|||
163905142|NCT02060487|592023810|FG002|Overall Study|Other|1|||
163905143|NCT02060487|592023808|FG000|Overall Study|Lack of Efficacy|0|||
163905144|NCT02060487|592023809|FG001|Overall Study|Lack of Efficacy|1|||
163905145|NCT02060487|592023810|FG002|Overall Study|Lack of Efficacy|0|||
163905146|NCT02060487|592023808|FG000|Overall Study|Withdrawal by Subject|3|||
163905147|NCT02060487|592023809|FG001|Overall Study|Withdrawal by Subject|10|||
163905148|NCT02060487|592023810|FG002|Overall Study|Withdrawal by Subject|4|||
163905149|NCT02060487|592023808|FG000|Overall Study|Study Terminated By Sponsor|87|||
164393590|NCT00295750|593809180|FG001|Overall Study|Personal reasons|1|||
164393591|NCT00295750|593809181|FG002|Overall Study|Personal reasons|0|||
164393592|NCT00295750|593809179|FG000|Overall Study|Randomized but never received trial drug|4|||
164393593|NCT00295750|593809180|FG001|Overall Study|Randomized but never received trial drug|3|||
164393594|NCT00295750|593809181|FG002|Overall Study|Randomized but never received trial drug|3|||
164393595|NCT00295750|593809179|FG000|Overall Study|Withdrawal by Subject|9|||
164393596|NCT00295750|593809180|FG001|Overall Study|Withdrawal by Subject|4|||
164393597|NCT00295750|593809181|FG002|Overall Study|Withdrawal by Subject|7|||
164393598|NCT00295750|593809179|FG000|Overall Study|Protocol Violation|2|||
164393599|NCT00295750|593809180|FG001|Overall Study|Protocol Violation|4|||
164393600|NCT00295750|593809181|FG002|Overall Study|Protocol Violation|2|||
164393601|NCT01650259|593809182|FG000|Overall Study|Improvement|105|||
164393602|NCT01650259|593809183|FG001|Overall Study|Improvement|0|||
163905150|NCT02060487|592023809|FG001|Overall Study|Study Terminated By Sponsor|89|||
163905151|NCT02060487|592023810|FG002|Overall Study|Study Terminated By Sponsor|100|||
163905152|NCT02060487|592023808|FG000|Overall Study|Randomized in error|1|||
163905153|NCT02060487|592023809|FG001|Overall Study|Randomized in error|0|||
163905154|NCT02060487|592023810|FG002|Overall Study|Randomized in error|0|||
163905155|NCT02060487|592023808|FG000|Overall Study|Protocol Violation|0|||
163905156|NCT02060487|592023809|FG001|Overall Study|Protocol Violation|1|||
163905157|NCT02060487|592023810|FG002|Overall Study|Protocol Violation|1|||
163905158|NCT02060487|592023808|FG000|Overall Study|Lost to Follow-up|3|||
163905159|NCT02060487|592023809|FG001|Overall Study|Lost to Follow-up|0|||
163905160|NCT02060487|592023810|FG002|Overall Study|Lost to Follow-up|2|||
163905161|NCT02060487|592023808|FG000|Overall Study|Death|34|||
163905162|NCT02060487|592023809|FG001|Overall Study|Death|25|||
163905163|NCT02060487|592023810|FG002|Overall Study|Death|19|||
163905164|NCT02060487|592023808|FG000|Overall Study|Adverse Event|0|||
163905165|NCT02060487|592023809|FG001|Overall Study|Adverse Event|0|||
163905166|NCT02060487|592023810|FG002|Overall Study|Adverse Event|1|||
163905167|NCT03697603|592023815|FG000|Overall Study|Adverse Event|3|||
163905168|NCT03697603|592023816|FG001|Overall Study|Adverse Event|18|||
163905169|NCT03697603|592023817|FG002|Overall Study|Adverse Event|3|||
163905170|NCT03697603|592023815|FG000|Overall Study|Physician Decision|1|||
163905171|NCT03697603|592023816|FG001|Overall Study|Physician Decision|0|||
163905172|NCT03697603|592023817|FG002|Overall Study|Physician Decision|2|||
163905173|NCT03697603|592023815|FG000|Overall Study|Protocol Violation|3|||
163905174|NCT03697603|592023816|FG001|Overall Study|Protocol Violation|8|||
163905175|NCT03697603|592023817|FG002|Overall Study|Protocol Violation|5|||
163905176|NCT03697603|592023815|FG000|Overall Study|Withdrawal by Subject|5|||
163905177|NCT03697603|592023816|FG001|Overall Study|Withdrawal by Subject|1|||
163905178|NCT03697603|592023817|FG002|Overall Study|Withdrawal by Subject|1|||
163905179|NCT03697603|592023815|FG000|Overall Study|Protocol Violation|0|||
163905180|NCT03697603|592023816|FG001|Overall Study|Protocol Violation|0|||
163905181|NCT03697603|592023817|FG002|Overall Study|Protocol Violation|1|||
163905182|NCT04218864|592023818|FG000|Overall Study|Lost to Follow-up|8|||
163905183|NCT04218864|592023819|FG001|Overall Study|Lost to Follow-up|4|||
163905184|NCT04218864|592023818|FG000|Overall Study|Withdrawal by Subject|1|||
163905185|NCT04218864|592023819|FG001|Overall Study|Withdrawal by Subject|3|||
163905186|NCT03683030|592023820|FG000|Overall Study|Enrolled but screen failures|12|||
163905187|NCT03683030|592023821|FG001|Overall Study|Enrolled but screen failures|7|||
163905188|NCT03683030|592023820|FG000|Overall Study|Enrolled but no catheter inserted|11|||
163905189|NCT03683030|592023821|FG001|Overall Study|Enrolled but no catheter inserted|13|||
163905190|NCT03683030|592023820|FG000|Overall Study|Withdrawal by Subject|0|||
163905191|NCT03683030|592023821|FG001|Overall Study|Withdrawal by Subject|2|||
163905192|NCT03683030|592023820|FG000|Overall Study|Early termination by subject|1|||
163905193|NCT03683030|592023821|FG001|Overall Study|Early termination by subject|0|||
163905194|NCT03683030|592023820|FG000|Overall Study|Lost to Follow-up|0|||
163905195|NCT03683030|592023821|FG001|Overall Study|Lost to Follow-up|6|||
164016293|NCT01937130|592423852|FG002|Overall Study|Withdrawal by Subject|0|||
164016294|NCT01937130|592423853|FG003|Overall Study|Withdrawal by Subject|1|||
164393603|NCT01650259|593809182|FG000|Overall Study|Adverse Event|127|||
164393604|NCT01650259|593809183|FG001|Overall Study|Adverse Event|0|||
164393605|NCT01650259|593809182|FG000|Overall Study|Lack of Efficacy|143|||
164393606|NCT01650259|593809183|FG001|Overall Study|Lack of Efficacy|0|||
164393607|NCT01650259|593809182|FG000|Overall Study|Lost to Follow-up|435|||
164393608|NCT01650259|593809183|FG001|Overall Study|Lost to Follow-up|0|||
164393609|NCT01650259|593809182|FG000|Overall Study|Patients had no visit after entry|70|||
164393610|NCT01650259|593809183|FG001|Overall Study|Patients had no visit after entry|0|||
164393611|NCT01650259|593809182|FG000|Overall Study|CRF not collected|98|||
164393612|NCT01650259|593809183|FG001|Overall Study|CRF not collected|82|||
164393613|NCT01650259|593809182|FG000|Overall Study|Not treated|1|||
164393614|NCT01650259|593809183|FG001|Overall Study|Not treated|7|||
164393615|NCT01650259|593809182|FG000|Overall Study|Other than listed|64|||
164393616|NCT01650259|593809183|FG001|Overall Study|Other than listed|146|||
164393617|NCT00936858|593809184|FG000|Overall Study|Death|3|||
164393618|NCT00936858|593809184|FG000|Overall Study|Progression|29|||
163905196|NCT03683030|592023820|FG000|Overall Study|Death|0|||
163905197|NCT03683030|592023821|FG001|Overall Study|Death|2|||
164393619|NCT00936858|593809184|FG000|Overall Study|Withdrawal by Subject|5|||
164393620|NCT00936858|593809184|FG000|Overall Study|Adverse Event|1|||
164393621|NCT00936858|593809184|FG000|Overall Study|Physician Decision|7|||
164393622|NCT00936858|593809184|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
164393623|NCT00936858|593809184|FG000|Overall Study|Lost to Follow-up|1|||
164393624|NCT00584727|593809195|FG000|First Intervention|Discontinuation|0|||
164393625|NCT00584727|593809196|FG001|First Intervention|Discontinuation|0|||
164393626|NCT00584727|593809197|FG002|First Intervention|Discontinuation|1|||
164393627|NCT00584727|593809198|FG003|First Intervention|Discontinuation|0|||
164393628|NCT00584727|593809199|FG004|First Intervention|Discontinuation|0|||
164393629|NCT00584727|593809200|FG005|First Intervention|Discontinuation|0|||
164393630|NCT00584727|593809195|FG000|Third Intervention|Protocol Violation|0|||
164393631|NCT00584727|593809196|FG001|Third Intervention|Protocol Violation|0|||
164393632|NCT00584727|593809197|FG002|Third Intervention|Protocol Violation|1|||
164393633|NCT00584727|593809198|FG003|Third Intervention|Protocol Violation|0|||
164393634|NCT00584727|593809199|FG004|Third Intervention|Protocol Violation|4|||
164393635|NCT00584727|593809200|FG005|Third Intervention|Protocol Violation|2|||
164393636|NCT04072159|593809201|FG000|Overall Study|Lost to Follow-up|6|||
164393637|NCT04072159|593809202|FG001|Overall Study|Lost to Follow-up|6|||
164393638|NCT04072159|593809201|FG000|Overall Study|Withdrawal by Subject|2|||
164393639|NCT04072159|593809202|FG001|Overall Study|Withdrawal by Subject|0|||
164393640|NCT00989287|593809206|FG000|Overall Study|Adverse Event|1|||
164393641|NCT00989287|593809207|FG001|Overall Study|Adverse Event|0|||
164393642|NCT00989287|593809206|FG000|Overall Study|Lost to Follow-up|0|||
164393643|NCT00989287|593809207|FG001|Overall Study|Lost to Follow-up|1|||
164393644|NCT00695669|593809208|FG000|Overall Study|Adverse Event|0|||
164393645|NCT00695669|593809209|FG001|Overall Study|Adverse Event|0|||
164393646|NCT00695669|593809210|FG002|Overall Study|Adverse Event|2|||
164393647|NCT00695669|593809211|FG003|Overall Study|Adverse Event|0|||
164393648|NCT00695669|593809208|FG000|Overall Study|Lost to Follow-up|4|||
164393649|NCT00695669|593809209|FG001|Overall Study|Lost to Follow-up|4|||
164393650|NCT00695669|593809210|FG002|Overall Study|Lost to Follow-up|1|||
164393651|NCT00695669|593809211|FG003|Overall Study|Lost to Follow-up|4|||
164393652|NCT00092131|593809212|FG000|Treatment Period I|Adverse Event|1|||
164393653|NCT00092131|593809213|FG001|Treatment Period I|Adverse Event|0|||
164393654|NCT00092131|593809212|FG000|Treatment Period II|Adverse Event|0|||
164393655|NCT00092131|593809213|FG001|Treatment Period II|Adverse Event|1|||
164393656|NCT02341417|593809214|FG000|Overall Study|Withdrawal by Subject|0|||
164393657|NCT02341417|593809215|FG001|Overall Study|Withdrawal by Subject|2|||
164393658|NCT02341417|593809216|FG002|Overall Study|Withdrawal by Subject|0|||
164393659|NCT02341417|593809214|FG000|Overall Study|Decision by sponsor|2|||
164393660|NCT02341417|593809215|FG001|Overall Study|Decision by sponsor|0|||
164393661|NCT02341417|593809216|FG002|Overall Study|Decision by sponsor|0|||
164393662|NCT02341417|593809214|FG000|Overall Study|Death|0|||
164393663|NCT02341417|593809215|FG001|Overall Study|Death|0|||
164393664|NCT02341417|593809216|FG002|Overall Study|Death|1|||
164393665|NCT03570619|593809232|FG000|Overall Study|Adverse Event|2|||
164393666|NCT03570619|593809233|FG001|Overall Study|Adverse Event|0|||
164393667|NCT03570619|593809234|FG002|Overall Study|Adverse Event|1|||
164393668|NCT03570619|593809232|FG000|Overall Study|new diagnosis of new malignancy|1|||
164393669|NCT03570619|593809233|FG001|Overall Study|new diagnosis of new malignancy|0|||
164393670|NCT03570619|593809234|FG002|Overall Study|new diagnosis of new malignancy|0|||
164393671|NCT03570619|593809232|FG000|Overall Study|Physician Decision|1|||
164393672|NCT03570619|593809233|FG001|Overall Study|Physician Decision|1|||
164393673|NCT03570619|593809234|FG002|Overall Study|Physician Decision|0|||
164393674|NCT03570619|593809232|FG000|Overall Study|Withdrawal by Subject|0|||
164393675|NCT03570619|593809233|FG001|Overall Study|Withdrawal by Subject|2|||
164393676|NCT03570619|593809234|FG002|Overall Study|Withdrawal by Subject|0|||
164393677|NCT04773587|593809235|FG000|Overall Study|Lost to Follow-up|11|||
164393678|NCT04773587|593809236|FG001|Overall Study|Lost to Follow-up|3|||
164393679|NCT04773587|593809235|FG000|Overall Study|Adverse Event|6|||
164393680|NCT04773587|593809236|FG001|Overall Study|Adverse Event|3|||
164393681|NCT04773587|593809235|FG000|Overall Study|Lack of Efficacy|5|||
164393682|NCT04773587|593809236|FG001|Overall Study|Lack of Efficacy|2|||
164393683|NCT04773587|593809235|FG000|Overall Study|Withdrawal by Subject|4|||
164393684|NCT04773587|593809236|FG001|Overall Study|Withdrawal by Subject|5|||
164393685|NCT04773587|593809235|FG000|Overall Study|Noncompliance|1|||
164393686|NCT04773587|593809236|FG001|Overall Study|Noncompliance|0|||
164393687|NCT04773587|593809235|FG000|Overall Study|Protocol Violation|1|||
164393688|NCT04773587|593809236|FG001|Overall Study|Protocol Violation|0|||
164393689|NCT04773587|593809235|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
164393690|NCT04773587|593809236|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
164393691|NCT00435370|593809246|FG000|Overall Study|Adverse Event|8|||
164393692|NCT00435370|593809247|FG001|Overall Study|Adverse Event|8|||
164393693|NCT00435370|593809246|FG000|Overall Study|Withdrawal by Subject|10|||
164393694|NCT00435370|593809247|FG001|Overall Study|Withdrawal by Subject|10|||
164393695|NCT00435370|593809246|FG000|Overall Study|Antipsychotic medication changed|4|||
164393696|NCT00435370|593809247|FG001|Overall Study|Antipsychotic medication changed|2|||
164393697|NCT02132611|593809249|FG000|Overall Study|Death|2|||
163905198|NCT03683030|592023820|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
163905199|NCT03683030|592023821|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
163905200|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
163905201|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
163905202|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
163905203|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
164393698|NCT01965834|593809251|FG000|Overall Study|Lack of Efficacy|4|||
164393699|NCT03674177|593809254|FG000|Overall Study|Lost to Follow-up|2|||
164393700|NCT03674177|593809255|FG001|Overall Study|Lost to Follow-up|1|||
164393701|NCT03674177|593809256|FG002|Overall Study|Lost to Follow-up|0|||
164393702|NCT03674177|593809257|FG003|Overall Study|Lost to Follow-up|2|||
164393703|NCT02493127|593809258|FG000|Overall Study|Lost to Follow-up|1|||
164393704|NCT02493127|593809259|FG001|Overall Study|Lost to Follow-up|1|||
164393705|NCT00809757|593809265|FG000|Overall Study|Adverse Event|2|||
164393706|NCT00809757|593809266|FG001|Overall Study|Adverse Event|3|||
164393707|NCT00809757|593809267|FG002|Overall Study|Adverse Event|3|||
164393708|NCT00809757|593809265|FG000|Overall Study|Lost to Follow-up|0|||
164393709|NCT00809757|593809266|FG001|Overall Study|Lost to Follow-up|0|||
164393710|NCT00809757|593809267|FG002|Overall Study|Lost to Follow-up|1|||
164393711|NCT00809757|593809265|FG000|Overall Study|Protocol Violation|1|||
164393712|NCT00809757|593809266|FG001|Overall Study|Protocol Violation|1|||
164393713|NCT00809757|593809267|FG002|Overall Study|Protocol Violation|1|||
164393714|NCT00809757|593809265|FG000|Overall Study|Withdrawal by Subject|2|||
164393715|NCT00809757|593809266|FG001|Overall Study|Withdrawal by Subject|1|||
164393716|NCT00809757|593809267|FG002|Overall Study|Withdrawal by Subject|3|||
164393717|NCT00809757|593809265|FG000|Overall Study|Subject Uncooperative|1|||
164393718|NCT00809757|593809266|FG001|Overall Study|Subject Uncooperative|0|||
164393719|NCT00809757|593809267|FG002|Overall Study|Subject Uncooperative|2|||
164393720|NCT00809757|593809265|FG000|Overall Study|Noncompliance with Medication|0|||
164393721|NCT00809757|593809266|FG001|Overall Study|Noncompliance with Medication|0|||
164393722|NCT00809757|593809267|FG002|Overall Study|Noncompliance with Medication|1|||
164393723|NCT00253864|593809268|FG000|Overall Study|Lost to Follow-up|5|||
164393724|NCT00253864|593809269|FG001|Overall Study|Lost to Follow-up|8|||
164393725|NCT00659334|593809270|FG000|Overall Study|Screen Failure|8|||
164393726|NCT00659334|593809271|FG001|Overall Study|Screen Failure|5|||
164393727|NCT00659334|593809272|FG002|Overall Study|Screen Failure|0|||
164393728|NCT00659334|593809273|FG003|Overall Study|Screen Failure|0|||
164393729|NCT00659334|593809274|FG004|Overall Study|Screen Failure|0|||
164393730|NCT00659334|593809275|FG005|Overall Study|Screen Failure|0|||
164393731|NCT00659334|593809276|FG006|Overall Study|Screen Failure|1|||
164393732|NCT03034577|593809277|FG000|Overall Study|Withdrawal by Subject|6|||
164393733|NCT03034577|593809278|FG001|Overall Study|Withdrawal by Subject|9|||
164393734|NCT03034577|593809277|FG000|Overall Study|Lost to Follow-up|25|||
164393735|NCT03034577|593809278|FG001|Overall Study|Lost to Follow-up|26|||
164393736|NCT01174342|593809279|FG000|Overall Study|Conversion to cesarean section|4|||
164393737|NCT02625623|593809280|FG000|Overall Study|Participants randomized but not treated|9|||
164393738|NCT02625623|593809281|FG001|Overall Study|Participants randomized but not treated|1|||
164393739|NCT00744653|593809282|FG000|Overall Study|antineoplastic treatment|11|||
164393740|NCT00744653|593809282|FG000|Overall Study|Death|1|||
164393741|NCT00744653|593809282|FG000|Overall Study|Lost to Follow-up|1|||
164393742|NCT00744653|593809282|FG000|Overall Study|Physician Decision|3|||
164393743|NCT03826667|593809288|FG000|Overall Study|Protocol deviation|21|||
164393744|NCT00808808|593809289|FG000|Overall Study|Vaccinated; survey not completed|131|||
164393745|NCT00808808|593809290|FG001|Overall Study|Vaccinated; survey not completed|169|||
164393746|NCT00808808|593809291|FG002|Overall Study|Vaccinated; survey not completed|302|||
164393747|NCT00808808|593809289|FG000|Overall Study|Employee was not vaccinated.|2686|||
164393748|NCT00808808|593809290|FG001|Overall Study|Employee was not vaccinated.|2268|||
164393749|NCT00808808|593809291|FG002|Overall Study|Employee was not vaccinated.|2255|||
164393750|NCT02298192|593809295|FG000|Overall Study|Unclassified|3|||
164393751|NCT02298192|593809296|FG001|Overall Study|Unclassified|2|||
164393752|NCT02298192|593809295|FG000|Overall Study|Withdrawal criteria|2|||
163905204|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
163905205|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
164393753|NCT02298192|593809296|FG001|Overall Study|Withdrawal criteria|0|||
164393754|NCT02298192|593809295|FG000|Overall Study|Withdrawal by Subject|6|||
164093151|NCT05694013|592703494|FG001|Overall Study|Progressive Disease|1|||
164393755|NCT02298192|593809296|FG001|Overall Study|Withdrawal by Subject|1|||
164393756|NCT02298192|593809295|FG000|Overall Study|Lost to Follow-up|2|||
164393757|NCT02298192|593809296|FG001|Overall Study|Lost to Follow-up|1|||
164393758|NCT02298192|593809295|FG000|Overall Study|Adverse Event|6|||
164393759|NCT02298192|593809296|FG001|Overall Study|Adverse Event|2|||
164393760|NCT02352948|593809298|FG000|Overall Study|Death|47|||
164393761|NCT02352948|593809299|FG001|Overall Study|Death|48|||
164393762|NCT02352948|593809300|FG002|Overall Study|Death|114|||
164393763|NCT02352948|593809301|FG003|Overall Study|Death|74|||
164393764|NCT02352948|593809302|FG004|Overall Study|Death|77|||
164393765|NCT02352948|593809303|FG005|Overall Study|Death|44|||
164393766|NCT02352948|593809298|FG000|Overall Study|Lost to Follow-up|1|||
164393767|NCT02352948|593809299|FG001|Overall Study|Lost to Follow-up|0|||
164393768|NCT02352948|593809300|FG002|Overall Study|Lost to Follow-up|2|||
164393769|NCT02352948|593809301|FG003|Overall Study|Lost to Follow-up|1|||
164393770|NCT02352948|593809302|FG004|Overall Study|Lost to Follow-up|2|||
164393771|NCT02352948|593809303|FG005|Overall Study|Lost to Follow-up|1|||
164393772|NCT02352948|593809298|FG000|Overall Study|Withdrawal by Subject|1|||
164393773|NCT02352948|593809299|FG001|Overall Study|Withdrawal by Subject|10|||
164393774|NCT02352948|593809300|FG002|Overall Study|Withdrawal by Subject|11|||
164393775|NCT02352948|593809301|FG003|Overall Study|Withdrawal by Subject|23|||
164393776|NCT02352948|593809302|FG004|Overall Study|Withdrawal by Subject|9|||
164393777|NCT02352948|593809303|FG005|Overall Study|Withdrawal by Subject|4|||
164393778|NCT02352948|593809298|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164393779|NCT02352948|593809299|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164393780|NCT02352948|593809300|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164393781|NCT02352948|593809301|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164393782|NCT02352948|593809302|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164393783|NCT02352948|593809303|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
164393784|NCT02352948|593809298|FG000|Overall Study|Other|0|||
164393785|NCT02352948|593809299|FG001|Overall Study|Other|0|||
164393786|NCT02352948|593809300|FG002|Overall Study|Other|2|||
164393787|NCT02352948|593809301|FG003|Overall Study|Other|0|||
164393788|NCT02352948|593809302|FG004|Overall Study|Other|0|||
163905206|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
163905207|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
163905208|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
163905209|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
163905210|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
163905211|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
163905212|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
163905213|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
163905214|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
163905215|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
163905216|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
163905217|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
164016295|NCT01937130|592423850|FG000|Overall Study|Adverse Event|0|||
164393789|NCT02352948|593809303|FG005|Overall Study|Other|0|||
164393790|NCT00234065|593809310|FG000|Overall Study|Adverse Event|268|||
164393791|NCT00234065|593809311|FG001|Overall Study|Adverse Event|166|||
164393792|NCT00234065|593809310|FG000|Overall Study|Withdrawal by Subject|73|||
164393793|NCT00234065|593809311|FG001|Overall Study|Withdrawal by Subject|56|||
164393794|NCT00234065|593809310|FG000|Overall Study|Physician Decision|23|||
164393795|NCT00234065|593809311|FG001|Overall Study|Physician Decision|22|||
164393796|NCT00234065|593809310|FG000|Overall Study|Not Classified|111|||
164393797|NCT00234065|593809311|FG001|Overall Study|Not Classified|112|||
164393798|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393799|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393800|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393801|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
164393802|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393803|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
164393804|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
164393805|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
164393806|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
164393807|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
164393808|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
164393809|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
164393810|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393811|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393812|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393813|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
164393814|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393815|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
164393816|NCT01292603|593811272|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393817|NCT01292603|593811273|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393818|NCT01292603|593811274|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393819|NCT01292603|593811275|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
164393820|NCT01292603|593811276|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393821|NCT01292603|593811277|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
164393822|NCT01292603|593811272|FG000|Part 1: Regular Follow-Up Period|Death|3|||
164393823|NCT01292603|593811273|FG001|Part 1: Regular Follow-Up Period|Death|1|||
164393824|NCT01292603|593811274|FG002|Part 1: Regular Follow-Up Period|Death|3|||
164393825|NCT01292603|593811275|FG003|Part 1: Regular Follow-Up Period|Death|1|||
164393826|NCT01292603|593811276|FG004|Part 1: Regular Follow-Up Period|Death|0|||
164393827|NCT01292603|593811277|FG005|Part 1: Regular Follow-Up Period|Death|0|||
164393828|NCT01292603|593811272|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
164393829|NCT01292603|593811273|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
164393830|NCT01292603|593811274|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
164393831|NCT01292603|593811275|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
164393832|NCT01292603|593811276|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
164393833|NCT01292603|593811277|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
164393834|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Death|0|||
164393835|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Death|0|||
164393836|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Death|0|||
164393837|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Death|0|||
164393838|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Death|1|||
164393839|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Death|0|||
164393840|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393841|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393842|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393843|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393844|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
164393845|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
164393846|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393847|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393848|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393849|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
164393850|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
164393851|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
164393852|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393853|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393854|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393855|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
164393856|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
164393857|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
164393858|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393859|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393860|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393861|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
164393862|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
164393863|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
164393864|NCT01292603|593811272|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393865|NCT01292603|593811273|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393866|NCT01292603|593811274|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393867|NCT01292603|593811275|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393868|NCT01292603|593811276|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
164393869|NCT01292603|593811277|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
164393870|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Death|0|||
164393871|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Death|0|||
164393872|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Death|0|||
164393873|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Death|0|||
164393874|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Death|6|||
164393875|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Death|3|||
164393876|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
164393877|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
164393878|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
164393879|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
164393880|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
164393881|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
164393882|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
164393883|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
164393884|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
164393885|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
164393886|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
164393887|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
164393888|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393889|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393890|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393891|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393892|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
164393893|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
164393894|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393895|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393896|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393897|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393898|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
164393899|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
164393900|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
164393901|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
164393902|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
164393903|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
164016296|NCT01937130|592423851|FG001|Overall Study|Adverse Event|1|||
164393904|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
164393905|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
164393906|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393907|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393908|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393909|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
164393910|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
164393911|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
164393912|NCT01292603|593811272|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
164393913|NCT01292603|593811273|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
164393914|NCT01292603|593811274|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
164393915|NCT01292603|593811275|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
164393916|NCT01292603|593811276|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
164393917|NCT01292603|593811277|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
164393918|NCT01292603|593811272|FG000|Overall Survival Status|Death|3|||
164393919|NCT01292603|593811273|FG001|Overall Survival Status|Death|1|||
164393920|NCT01292603|593811274|FG002|Overall Survival Status|Death|3|||
164393921|NCT01292603|593811275|FG003|Overall Survival Status|Death|1|||
164393922|NCT01292603|593811276|FG004|Overall Survival Status|Death|16|||
164393923|NCT01292603|593811277|FG005|Overall Survival Status|Death|10|||
164393924|NCT03912259|593811278|FG000|Overall Study|Adverse Event (AE)|2|||
164393925|NCT03912259|593811279|FG001|Overall Study|Adverse Event (AE)|4|||
164393926|NCT03912259|593811278|FG000|Overall Study|Lack of Efficacy|4|||
164393927|NCT03912259|593811279|FG001|Overall Study|Lack of Efficacy|1|||
164393928|NCT03912259|593811278|FG000|Overall Study|Withdrawal by Subject|11|||
164393929|NCT03912259|593811279|FG001|Overall Study|Withdrawal by Subject|1|||
164393930|NCT00381940|593811280|FG000|Overall Study|Lack of Efficacy|3|||
164393931|NCT00381940|593811280|FG000|Overall Study|Protocol Violation|1|||
164393932|NCT00381940|593811280|FG000|Overall Study|Ineligible|1|||
164393933|NCT03162224|593811281|FG000|Overall Study|Death|4|||
164393934|NCT03162224|593811282|FG001|Overall Study|Death|5|||
164393935|NCT03162224|593811283|FG002|Overall Study|Death|8|||
164393936|NCT03162224|593811281|FG000|Overall Study|Withdrawal by Subject|1|||
164393937|NCT03162224|593811282|FG001|Overall Study|Withdrawal by Subject|0|||
164393938|NCT03162224|593811283|FG002|Overall Study|Withdrawal by Subject|1|||
164393939|NCT03162224|593811281|FG000|Overall Study|Lost to Follow-up|0|||
164393940|NCT03162224|593811282|FG001|Overall Study|Lost to Follow-up|1|||
164393941|NCT03162224|593811283|FG002|Overall Study|Lost to Follow-up|0|||
164393942|NCT03162224|593811281|FG000|Overall Study|Other|6|||
164393943|NCT03162224|593811282|FG001|Overall Study|Other|2|||
164393944|NCT03162224|593811283|FG002|Overall Study|Other|1|||
164393945|NCT00082173|593811284|FG000|Overall Study|Withdrawal by Subject|3|||
164393946|NCT00082173|593811285|FG001|Overall Study|Withdrawal by Subject|5|||
164393947|NCT00082173|593811284|FG000|Overall Study|Lost to Follow-up|1|||
164393948|NCT00082173|593811285|FG001|Overall Study|Lost to Follow-up|0|||
164393949|NCT00082173|593811284|FG000|Overall Study|Adverse Event|1|||
164393950|NCT00082173|593811285|FG001|Overall Study|Adverse Event|0|||
164393951|NCT00082173|593811284|FG000|Overall Study|Culture negative or resistant at baselin|5|||
164393952|NCT00082173|593811285|FG001|Overall Study|Culture negative or resistant at baselin|6|||
164393953|NCT02633137|593811294|FG000|Overall Study|Adverse Event|1|||
164393954|NCT02633137|593811294|FG000|Overall Study|Lack of Efficacy|2|||
164393955|NCT02633137|593811294|FG000|Overall Study|Withdrawal by Subject|1|||
164393956|NCT04307004|593811295|FG000|Randomization 1|Withdrawal by Subject|25|||
163905218|NCT02222493|592023824|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
163905219|NCT02222493|592023825|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
163905220|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
164393957|NCT04307004|593811296|FG001|Randomization 1|Withdrawal by Subject|26|||
164393958|NCT04307004|593811297|FG002|Randomization 1|Withdrawal by Subject|0|||
164393959|NCT04307004|593811298|FG003|Randomization 1|Withdrawal by Subject|0|||
164393960|NCT04307004|593811295|FG000|Randomization 2|Withdrawal by Subject|0|||
164393961|NCT04307004|593811296|FG001|Randomization 2|Withdrawal by Subject|0|||
164393962|NCT04307004|593811297|FG002|Randomization 2|Withdrawal by Subject|28|||
164393963|NCT04307004|593811298|FG003|Randomization 2|Withdrawal by Subject|23|||
164393964|NCT02807558|593811299|FG000|Overall Study|Consent withdrawn by participant|4|||
164393965|NCT02807558|593811300|FG001|Overall Study|Consent withdrawn by participant|0|||
164393966|NCT02807558|593811301|FG002|Overall Study|Consent withdrawn by participant|4|||
164393967|NCT02807558|593811302|FG003|Overall Study|Consent withdrawn by participant|2|||
164393968|NCT02807558|593811303|FG004|Overall Study|Consent withdrawn by participant|1|||
164393969|NCT02807558|593811304|FG005|Overall Study|Consent withdrawn by participant|0|||
164393970|NCT02807558|593811299|FG000|Overall Study|Non-compliance with Study Drug|0|||
164393971|NCT02807558|593811300|FG001|Overall Study|Non-compliance with Study Drug|0|||
164393972|NCT02807558|593811301|FG002|Overall Study|Non-compliance with Study Drug|1|||
164393973|NCT02807558|593811302|FG003|Overall Study|Non-compliance with Study Drug|0|||
164393974|NCT02807558|593811303|FG004|Overall Study|Non-compliance with Study Drug|0|||
164393975|NCT02807558|593811304|FG005|Overall Study|Non-compliance with Study Drug|0|||
164393976|NCT02807558|593811299|FG000|Overall Study|Adverse Event|0|||
164393977|NCT02807558|593811300|FG001|Overall Study|Adverse Event|0|||
164393978|NCT02807558|593811301|FG002|Overall Study|Adverse Event|9|||
164393979|NCT02807558|593811302|FG003|Overall Study|Adverse Event|0|||
164393980|NCT02807558|593811303|FG004|Overall Study|Adverse Event|0|||
163905221|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
163905222|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
164016297|NCT01937130|592423852|FG002|Overall Study|Adverse Event|0|||
164393981|NCT02807558|593811304|FG005|Overall Study|Adverse Event|0|||
164393982|NCT02807558|593811299|FG000|Overall Study|Death|23|||
164393983|NCT02807558|593811300|FG001|Overall Study|Death|2|||
164393984|NCT02807558|593811301|FG002|Overall Study|Death|3|||
164393985|NCT02807558|593811302|FG003|Overall Study|Death|43|||
164393986|NCT02807558|593811303|FG004|Overall Study|Death|24|||
164393987|NCT02807558|593811304|FG005|Overall Study|Death|15|||
164393988|NCT02807558|593811299|FG000|Overall Study|Progressive Disease|0|||
164393989|NCT02807558|593811300|FG001|Overall Study|Progressive Disease|0|||
164393990|NCT02807558|593811301|FG002|Overall Study|Progressive Disease|1|||
164393991|NCT02807558|593811302|FG003|Overall Study|Progressive Disease|0|||
164393992|NCT02807558|593811303|FG004|Overall Study|Progressive Disease|0|||
164393993|NCT02807558|593811304|FG005|Overall Study|Progressive Disease|0|||
164393994|NCT02807558|593811299|FG000|Overall Study|Other than specified|1|||
164393995|NCT02807558|593811300|FG001|Overall Study|Other than specified|0|||
164393996|NCT02807558|593811301|FG002|Overall Study|Other than specified|2|||
164393997|NCT02807558|593811302|FG003|Overall Study|Other than specified|0|||
164393998|NCT02807558|593811303|FG004|Overall Study|Other than specified|1|||
164393999|NCT02807558|593811304|FG005|Overall Study|Other than specified|1|||
164394000|NCT02807558|593811299|FG000|Overall Study|Lack of Efficacy|0|||
164394001|NCT02807558|593811300|FG001|Overall Study|Lack of Efficacy|0|||
163905223|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
163905224|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
163905225|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
163905226|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
163905227|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
163905228|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
163905229|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
163905230|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
164394002|NCT02807558|593811301|FG002|Overall Study|Lack of Efficacy|9|||
164394003|NCT02807558|593811302|FG003|Overall Study|Lack of Efficacy|0|||
164394004|NCT02807558|593811303|FG004|Overall Study|Lack of Efficacy|0|||
164394005|NCT02807558|593811304|FG005|Overall Study|Lack of Efficacy|0|||
164394006|NCT01972841|593811305|FG000|Overall Study|Randomized but Never Received Treatment|2|||
164394007|NCT01972841|593811306|FG001|Overall Study|Randomized but Never Received Treatment|5|||
164394008|NCT01972841|593811307|FG002|Overall Study|Randomized but Never Received Treatment|4|||
164394009|NCT01972841|593811308|FG003|Overall Study|Randomized but Never Received Treatment|2|||
164394010|NCT01972841|593811309|FG004|Overall Study|Randomized but Never Received Treatment|6|||
164394011|NCT01972841|593811310|FG005|Overall Study|Randomized but Never Received Treatment|13|||
164394012|NCT01972841|593811305|FG000|Overall Study|Adverse Event|13|||
164394013|NCT01972841|593811306|FG001|Overall Study|Adverse Event|8|||
164394014|NCT01972841|593811307|FG002|Overall Study|Adverse Event|12|||
164394015|NCT01972841|593811308|FG003|Overall Study|Adverse Event|9|||
164394016|NCT01972841|593811309|FG004|Overall Study|Adverse Event|21|||
164394017|NCT01972841|593811310|FG005|Overall Study|Adverse Event|26|||
164394018|NCT01972841|593811305|FG000|Overall Study|Lack of Efficacy|1|||
164394019|NCT01972841|593811306|FG001|Overall Study|Lack of Efficacy|0|||
164394020|NCT01972841|593811307|FG002|Overall Study|Lack of Efficacy|0|||
164394021|NCT01972841|593811308|FG003|Overall Study|Lack of Efficacy|2|||
164394022|NCT01972841|593811309|FG004|Overall Study|Lack of Efficacy|4|||
164394023|NCT01972841|593811310|FG005|Overall Study|Lack of Efficacy|1|||
164394024|NCT01972841|593811305|FG000|Overall Study|Lost to Follow-up|4|||
164394025|NCT01972841|593811306|FG001|Overall Study|Lost to Follow-up|2|||
164394026|NCT01972841|593811307|FG002|Overall Study|Lost to Follow-up|4|||
164394027|NCT01972841|593811308|FG003|Overall Study|Lost to Follow-up|2|||
164394028|NCT01972841|593811309|FG004|Overall Study|Lost to Follow-up|9|||
164394029|NCT01972841|593811310|FG005|Overall Study|Lost to Follow-up|3|||
164394030|NCT01972841|593811305|FG000|Overall Study|Protocol Violation|2|||
164394031|NCT01972841|593811306|FG001|Overall Study|Protocol Violation|2|||
164394032|NCT01972841|593811307|FG002|Overall Study|Protocol Violation|3|||
164394033|NCT01972841|593811308|FG003|Overall Study|Protocol Violation|5|||
164394034|NCT01972841|593811309|FG004|Overall Study|Protocol Violation|9|||
164394035|NCT01972841|593811310|FG005|Overall Study|Protocol Violation|4|||
164394036|NCT01972841|593811305|FG000|Overall Study|Withdrawal by participants|21|||
164394037|NCT01972841|593811306|FG001|Overall Study|Withdrawal by participants|27|||
164394038|NCT01972841|593811307|FG002|Overall Study|Withdrawal by participants|23|||
164394039|NCT01972841|593811308|FG003|Overall Study|Withdrawal by participants|16|||
164394040|NCT01972841|593811309|FG004|Overall Study|Withdrawal by participants|33|||
164394041|NCT01972841|593811310|FG005|Overall Study|Withdrawal by participants|34|||
164394042|NCT01972841|593811305|FG000|Overall Study|Miscellaneous|0|||
164394043|NCT01972841|593811306|FG001|Overall Study|Miscellaneous|0|||
164394044|NCT01972841|593811307|FG002|Overall Study|Miscellaneous|4|||
163905231|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
164394045|NCT01972841|593811308|FG003|Overall Study|Miscellaneous|1|||
164394046|NCT01972841|593811309|FG004|Overall Study|Miscellaneous|0|||
164394047|NCT01972841|593811310|FG005|Overall Study|Miscellaneous|4|||
164394048|NCT01972841|593811305|FG000|Overall Study|Did not have end of treatment page|0|||
164394049|NCT01972841|593811306|FG001|Overall Study|Did not have end of treatment page|0|||
164394050|NCT01972841|593811307|FG002|Overall Study|Did not have end of treatment page|0|||
164394051|NCT01972841|593811308|FG003|Overall Study|Did not have end of treatment page|0|||
164394052|NCT01972841|593811309|FG004|Overall Study|Did not have end of treatment page|1|||
164394053|NCT01972841|593811310|FG005|Overall Study|Did not have end of treatment page|0|||
164394054|NCT04391023|593811313|FG000|Overall Study|Withdrawal by Subject|2|||
164394055|NCT04391023|593811314|FG001|Overall Study|Withdrawal by Subject|2|||
164394056|NCT01270347|593811316|FG000|Core Phase|Adverse Event|1|||
164394057|NCT01270347|593811317|FG001|Core Phase|Adverse Event|6|||
164394058|NCT01270347|593811316|FG000|Core Phase|Withdrawal by Subject|1|||
164394059|NCT01270347|593811317|FG001|Core Phase|Withdrawal by Subject|2|||
164394060|NCT01270347|593811316|FG000|Core Phase|Lost to Follow-up|0|||
164394061|NCT01270347|593811317|FG001|Core Phase|Lost to Follow-up|1|||
164394062|NCT01270347|593811316|FG000|Core Phase|Miscellaneous|8|||
164394063|NCT01270347|593811317|FG001|Core Phase|Miscellaneous|14|||
164394064|NCT01270347|593811316|FG000|Extension Phase|Adverse Event|1|||
164394065|NCT01270347|593811317|FG001|Extension Phase|Adverse Event|3|||
164394066|NCT01270347|593811316|FG000|Extension Phase|Withdrawal by Subject|3|||
164394067|NCT01270347|593811317|FG001|Extension Phase|Withdrawal by Subject|4|||
164394068|NCT01270347|593811316|FG000|Extension Phase|Miscellaneous|2|||
164394069|NCT01270347|593811317|FG001|Extension Phase|Miscellaneous|2|||
164394070|NCT02085408|593811318|FG000|Step 1: Induction|Disease Progression|19|||
164394071|NCT02085408|593811319|FG001|Step 1: Induction|Disease Progression|19|||
164394072|NCT02085408|593811318|FG000|Step 1: Induction|Adverse Event|18|||
164394073|NCT02085408|593811319|FG001|Step 1: Induction|Adverse Event|17|||
164394074|NCT02085408|593811318|FG000|Step 1: Induction|Death|33|||
164394075|NCT02085408|593811319|FG001|Step 1: Induction|Death|30|||
163905232|NCT02222493|592023824|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
163905233|NCT02222493|592023825|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
163905234|NCT02222493|592023824|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
163905235|NCT02222493|592023825|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
163905236|NCT02222493|592023824|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
163905237|NCT02222493|592023825|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
163905238|NCT02222493|592023824|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
163905239|NCT02222493|592023825|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
163905240|NCT02222493|592023824|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
163905241|NCT02222493|592023825|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
163905242|NCT02222493|592023824|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
163905243|NCT02222493|592023825|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
163905244|NCT00933270|592023828|FG000|Overall Study|Withdrawal by Subject|26|||
163905245|NCT00933270|592023828|FG000|Overall Study|Insufficient Follow-up|10|||
163905246|NCT00933270|592023828|FG000|Overall Study|Lost to Follow-up|14|||
163905247|NCT00933270|592023828|FG000|Overall Study|Adverse Event|1|||
163905248|NCT00933270|592023828|FG000|Overall Study|Missed Visit|2|||
163905249|NCT00933270|592023828|FG000|Overall Study|Death|24|||
164394076|NCT02085408|593811318|FG000|Step 1: Induction|Withdrawal by Subject|16|||
164394077|NCT02085408|593811319|FG001|Step 1: Induction|Withdrawal by Subject|8|||
163905250|NCT00933270|592023828|FG000|Overall Study|Moved or would not return|10|||
164394078|NCT02085408|593811318|FG000|Step 1: Induction|Alternative Therapy|15|||
164394079|NCT02085408|593811319|FG001|Step 1: Induction|Alternative Therapy|19|||
164394080|NCT02085408|593811318|FG000|Step 1: Induction|Complicating Disease|2|||
164394081|NCT02085408|593811319|FG001|Step 1: Induction|Complicating Disease|3|||
164394082|NCT02085408|593811318|FG000|Step 1: Induction|Other|27|||
164394083|NCT02085408|593811319|FG001|Step 1: Induction|Other|39|||
164394084|NCT02085408|593811318|FG000|Step 1: Induction|Never started treatment|6|||
164394085|NCT02085408|593811319|FG001|Step 1: Induction|Never started treatment|4|||
164394086|NCT02085408|593811318|FG000|Step 2: Consolidation|Disease Progression|5|||
164394087|NCT02085408|593811319|FG001|Step 2: Consolidation|Disease Progression|20|||
164394088|NCT02085408|593811318|FG000|Step 2: Consolidation|Adverse Event|9|||
164394089|NCT02085408|593811319|FG001|Step 2: Consolidation|Adverse Event|8|||
164394090|NCT02085408|593811318|FG000|Step 2: Consolidation|Death|4|||
164394091|NCT02085408|593811319|FG001|Step 2: Consolidation|Death|3|||
164394092|NCT02085408|593811318|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
164394093|NCT02085408|593811319|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
164394094|NCT02085408|593811318|FG000|Step 2: Consolidation|Alternative Therapy|9|||
164394095|NCT02085408|593811319|FG001|Step 2: Consolidation|Alternative Therapy|3|||
164394096|NCT02085408|593811318|FG000|Step 2: Consolidation|Complicating Disease|0|||
164394097|NCT02085408|593811319|FG001|Step 2: Consolidation|Complicating Disease|2|||
164394098|NCT02085408|593811318|FG000|Step 2: Consolidation|Other|6|||
164394099|NCT02085408|593811319|FG001|Step 2: Consolidation|Other|6|||
164394100|NCT02085408|593811318|FG000|Step 2: Consolidation|Never started treatment|4|||
164394101|NCT02085408|593811319|FG001|Step 2: Consolidation|Never started treatment|3|||
164394102|NCT02085408|593811318|FG000|Step 3: Maintenance|Disease Progression|13|||
164394103|NCT02085408|593811319|FG001|Step 3: Maintenance|Disease Progression|11|||
164394104|NCT02085408|593811318|FG000|Step 3: Maintenance|Adverse Event|2|||
164394105|NCT02085408|593811319|FG001|Step 3: Maintenance|Adverse Event|4|||
164394106|NCT02085408|593811318|FG000|Step 3: Maintenance|Death|1|||
164394107|NCT02085408|593811319|FG001|Step 3: Maintenance|Death|2|||
164394108|NCT02085408|593811318|FG000|Step 3: Maintenance|Alternative Therapy|1|||
164394109|NCT02085408|593811319|FG001|Step 3: Maintenance|Alternative Therapy|1|||
164394110|NCT02085408|593811318|FG000|Step 3: Maintenance|Complicating Disease|0|||
164394111|NCT02085408|593811319|FG001|Step 3: Maintenance|Complicating Disease|1|||
164394112|NCT02085408|593811318|FG000|Step 3: Maintenance|Other|3|||
164394113|NCT02085408|593811319|FG001|Step 3: Maintenance|Other|2|||
164394114|NCT02085408|593811318|FG000|Step 3: Maintenance|Never started treatment|5|||
164394115|NCT02085408|593811319|FG001|Step 3: Maintenance|Never started treatment|1|||
164394116|NCT00688636|593811324|FG000|Overall Study|Adverse Event|2|||
163905251|NCT02542943|592023829|FG000|Overall Study|Lost to Follow-up|1|||
163905252|NCT02542943|592023830|FG001|Overall Study|Lost to Follow-up|0|||
164394117|NCT00688636|593811325|FG001|Overall Study|Adverse Event|1|||
164394118|NCT01572727|593811326|FG000|Overall Study|Adverse Event|43|||
164394119|NCT01572727|593811327|FG001|Overall Study|Adverse Event|15|||
164394120|NCT01572727|593811326|FG000|Overall Study|Lost to Follow-up|1|||
164394121|NCT01572727|593811327|FG001|Overall Study|Lost to Follow-up|1|||
164394122|NCT01572727|593811326|FG000|Overall Study|Physician Decision|23|||
164394123|NCT01572727|593811327|FG001|Overall Study|Physician Decision|9|||
164394124|NCT01572727|593811326|FG000|Overall Study|Progressive disease|59|||
164394125|NCT01572727|593811327|FG001|Overall Study|Progressive disease|82|||
164394126|NCT01572727|593811326|FG000|Overall Study|Protocol Violation|0|||
164394127|NCT01572727|593811327|FG001|Overall Study|Protocol Violation|1|||
164394128|NCT01572727|593811326|FG000|Overall Study|Study terminated by sponsor|61|||
164394129|NCT01572727|593811327|FG001|Overall Study|Study terminated by sponsor|83|||
164394130|NCT01572727|593811326|FG000|Overall Study|Parent/guardian decision|14|||
164394131|NCT01572727|593811327|FG001|Overall Study|Parent/guardian decision|9|||
164394132|NCT01572727|593811326|FG000|Overall Study|Death|2|||
164394133|NCT01572727|593811327|FG001|Overall Study|Death|2|||
164394134|NCT01572727|593811326|FG000|Overall Study|Untreated|4|||
164394135|NCT01572727|593811327|FG001|Overall Study|Untreated|7|||
164394136|NCT04053764|593811328|FG000|Overall Study|Withdrawal by Subject|6|||
164394137|NCT04053764|593811329|FG001|Overall Study|Withdrawal by Subject|2|||
164394138|NCT04053764|593811328|FG000|Overall Study|Physician Decision|2|||
164394139|NCT04053764|593811329|FG001|Overall Study|Physician Decision|1|||
164394140|NCT04053764|593811328|FG000|Overall Study|Adverse Event|1|||
164394141|NCT04053764|593811329|FG001|Overall Study|Adverse Event|0|||
164394142|NCT04053764|593811328|FG000|Overall Study|Pregnancy|1|||
164394143|NCT04053764|593811329|FG001|Overall Study|Pregnancy|0|||
164394144|NCT04732286|593811333|FG000|Overall Study|Progressive Disease|2|||
164394145|NCT04732286|593811333|FG000|Overall Study|Physician Decision|1|||
164394146|NCT04732286|593811333|FG000|Overall Study|Study Terminated by Sponsor|31|||
164394147|NCT04732286|593811333|FG000|Overall Study|Withdrawal by Subject|10|||
164394148|NCT04732286|593811333|FG000|Overall Study|Non-compliance With Study Drug|1|||
164394149|NCT04732286|593811333|FG000|Overall Study|Lost to Follow-up|4|||
164394150|NCT04732286|593811333|FG000|Overall Study|Death|51|||
164394151|NCT00335322|593811335|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
164394152|NCT00335322|593811336|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
164394153|NCT00335322|593811337|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
164394154|NCT02195986|593811340|FG000|Overall Study|Adverse Event|3|||
164394155|NCT02195986|593811341|FG001|Overall Study|Adverse Event|0|||
164394156|NCT02195986|593811342|FG002|Overall Study|Adverse Event|0|||
164394157|NCT02195986|593811340|FG000|Overall Study|Withdrawal by Subject|0|||
164394158|NCT02195986|593811341|FG001|Overall Study|Withdrawal by Subject|3|||
164394159|NCT02195986|593811342|FG002|Overall Study|Withdrawal by Subject|0|||
164394160|NCT02195986|593811340|FG000|Overall Study|Family Emergency|0|||
164394161|NCT02195986|593811341|FG001|Overall Study|Family Emergency|0|||
164394162|NCT02195986|593811342|FG002|Overall Study|Family Emergency|1|||
164394163|NCT02195986|593811340|FG000|Overall Study|Protocol Violation|0|||
164394164|NCT02195986|593811341|FG001|Overall Study|Protocol Violation|1|||
164394165|NCT02195986|593811342|FG002|Overall Study|Protocol Violation|1|||
164394166|NCT02195986|593811340|FG000|Overall Study|Non-compliance|0|||
164394167|NCT02195986|593811341|FG001|Overall Study|Non-compliance|1|||
164394168|NCT02195986|593811342|FG002|Overall Study|Non-compliance|0|||
164394169|NCT02834780|593811343|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
164394170|NCT02834780|593811344|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
164394171|NCT02834780|593811345|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
164394172|NCT02834780|593811346|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
164394173|NCT02834780|593811347|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
164394174|NCT02834780|593811348|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
164394175|NCT02834780|593811349|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
164394176|NCT02834780|593811350|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
164394177|NCT02834780|593811351|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
164394178|NCT02834780|593811352|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
164394179|NCT02834780|593811353|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
164394180|NCT02834780|593811354|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
164394181|NCT02834780|593811355|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
164394182|NCT02834780|593811343|FG000|Overall Study|Withdrawal by Subject|0|||
164394183|NCT02834780|593811344|FG001|Overall Study|Withdrawal by Subject|0|||
164394184|NCT02834780|593811345|FG002|Overall Study|Withdrawal by Subject|1|||
164394185|NCT02834780|593811346|FG003|Overall Study|Withdrawal by Subject|0|||
164394186|NCT02834780|593811347|FG004|Overall Study|Withdrawal by Subject|0|||
164394187|NCT02834780|593811348|FG005|Overall Study|Withdrawal by Subject|0|||
164394188|NCT02834780|593811349|FG006|Overall Study|Withdrawal by Subject|0|||
164394189|NCT02834780|593811350|FG007|Overall Study|Withdrawal by Subject|0|||
164394190|NCT02834780|593811351|FG008|Overall Study|Withdrawal by Subject|0|||
164394191|NCT02834780|593811352|FG009|Overall Study|Withdrawal by Subject|0|||
164394192|NCT02834780|593811353|FG010|Overall Study|Withdrawal by Subject|1|||
164016298|NCT01937130|592423853|FG003|Overall Study|Adverse Event|1|||
164016299|NCT01937130|592423850|FG000|Overall Study|Death|1|||
164016300|NCT01937130|592423851|FG001|Overall Study|Death|1|||
164016301|NCT01937130|592423852|FG002|Overall Study|Death|1|||
164016302|NCT01937130|592423853|FG003|Overall Study|Death|0|||
164394193|NCT02834780|593811354|FG011|Overall Study|Withdrawal by Subject|0|||
164394194|NCT02834780|593811355|FG012|Overall Study|Withdrawal by Subject|0|||
164394195|NCT02834780|593811343|FG000|Overall Study|Adverse Event|0|||
164394196|NCT02834780|593811344|FG001|Overall Study|Adverse Event|0|||
164394197|NCT02834780|593811345|FG002|Overall Study|Adverse Event|0|||
164394198|NCT02834780|593811346|FG003|Overall Study|Adverse Event|0|||
164394199|NCT02834780|593811347|FG004|Overall Study|Adverse Event|1|||
164394200|NCT02834780|593811348|FG005|Overall Study|Adverse Event|0|||
164394201|NCT02834780|593811349|FG006|Overall Study|Adverse Event|1|||
164394202|NCT02834780|593811350|FG007|Overall Study|Adverse Event|1|||
164394203|NCT02834780|593811351|FG008|Overall Study|Adverse Event|0|||
164394204|NCT02834780|593811352|FG009|Overall Study|Adverse Event|2|||
164394205|NCT02834780|593811353|FG010|Overall Study|Adverse Event|0|||
164394206|NCT02834780|593811354|FG011|Overall Study|Adverse Event|3|||
164394207|NCT02834780|593811355|FG012|Overall Study|Adverse Event|2|||
164394208|NCT02834780|593811343|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394209|NCT02834780|593811344|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
164394210|NCT02834780|593811345|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
164394211|NCT02834780|593811346|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394212|NCT02834780|593811347|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394213|NCT02834780|593811348|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394214|NCT02834780|593811349|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394215|NCT02834780|593811350|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
164394216|NCT02834780|593811351|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
164394217|NCT02834780|593811352|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
164394218|NCT02834780|593811353|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
164394219|NCT02834780|593811354|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
164394220|NCT02834780|593811355|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
164394221|NCT02834780|593811343|FG000|Overall Study|Other|1|||
164394222|NCT02834780|593811344|FG001|Overall Study|Other|0|||
164394223|NCT02834780|593811345|FG002|Overall Study|Other|1|||
164394224|NCT02834780|593811346|FG003|Overall Study|Other|2|||
164394225|NCT02834780|593811347|FG004|Overall Study|Other|0|||
164394226|NCT02834780|593811348|FG005|Overall Study|Other|0|||
164394227|NCT02834780|593811349|FG006|Overall Study|Other|0|||
164394228|NCT02834780|593811350|FG007|Overall Study|Other|0|||
164394229|NCT02834780|593811351|FG008|Overall Study|Other|0|||
164394230|NCT02834780|593811352|FG009|Overall Study|Other|0|||
164394231|NCT02834780|593811353|FG010|Overall Study|Other|0|||
164394232|NCT02834780|593811354|FG011|Overall Study|Other|0|||
164394233|NCT02834780|593811355|FG012|Overall Study|Other|1|||
164394234|NCT03150056|593811356|FG000|Overall Study|Withdrawal by Subject|0|||
164394235|NCT03150056|593811357|FG001|Overall Study|Withdrawal by Subject|0|||
164394236|NCT03150056|593811358|FG002|Overall Study|Withdrawal by Subject|0|||
164394237|NCT03150056|593811359|FG003|Overall Study|Withdrawal by Subject|0|||
164394238|NCT03150056|593811360|FG004|Overall Study|Withdrawal by Subject|0|||
164394239|NCT03150056|593811361|FG005|Overall Study|Withdrawal by Subject|2|||
164394240|NCT03150056|593811356|FG000|Overall Study|Study terminated by Sponsor|1|||
164394241|NCT03150056|593811357|FG001|Overall Study|Study terminated by Sponsor|3|||
164394242|NCT03150056|593811358|FG002|Overall Study|Study terminated by Sponsor|1|||
164394243|NCT03150056|593811359|FG003|Overall Study|Study terminated by Sponsor|1|||
164394244|NCT03150056|593811360|FG004|Overall Study|Study terminated by Sponsor|5|||
164394245|NCT03150056|593811361|FG005|Overall Study|Study terminated by Sponsor|6|||
164394246|NCT03150056|593811356|FG000|Overall Study|Death|9|||
164394247|NCT03150056|593811357|FG001|Overall Study|Death|2|||
164394248|NCT03150056|593811358|FG002|Overall Study|Death|2|||
164394249|NCT03150056|593811359|FG003|Overall Study|Death|7|||
164394250|NCT03150056|593811360|FG004|Overall Study|Death|8|||
164394251|NCT03150056|593811361|FG005|Overall Study|Death|10|||
164394252|NCT01939028|593811364|FG000|Overall Study|Withdrawal by Subject|5|||
164394253|NCT01939028|593811364|FG000|Overall Study|Physician Decision|7|||
164394254|NCT03282227|593811367|FG000|Overall Study|Exposure Goals Achieved|60|||
164394255|NCT03282227|593811367|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
164394256|NCT03282227|593811367|FG000|Overall Study|Adverse Event|15|||
164394257|NCT03282227|593811367|FG000|Overall Study|Lost to Follow-up|21|||
164394258|NCT03282227|593811367|FG000|Overall Study|Withdrawal by Subject|20|||
164394259|NCT03282227|593811367|FG000|Overall Study|Lack of Efficacy|12|||
164394260|NCT03282227|593811367|FG000|Overall Study|Sponsor decision|3|||
164394261|NCT03282227|593811367|FG000|Overall Study|Physician Decision|2|||
164394262|NCT03282227|593811367|FG000|Overall Study|Pregnancy|2|||
164394263|NCT03282227|593811367|FG000|Overall Study|Other|1|||
164394264|NCT02576678|593811368|FG000|Overall Study|Adverse Event|0|||
164394265|NCT02576678|593811369|FG001|Overall Study|Adverse Event|0|||
164394266|NCT02576678|593811370|FG002|Overall Study|Adverse Event|2|||
164394267|NCT02576678|593811368|FG000|Overall Study|Withdrawal by Subject|3|||
164394268|NCT02576678|593811369|FG001|Overall Study|Withdrawal by Subject|1|||
164394269|NCT02576678|593811370|FG002|Overall Study|Withdrawal by Subject|2|||
164394270|NCT02576678|593811368|FG000|Overall Study|Lost to Follow-up|0|||
164394271|NCT02576678|593811369|FG001|Overall Study|Lost to Follow-up|0|||
164394272|NCT02576678|593811370|FG002|Overall Study|Lost to Follow-up|1|||
164394273|NCT02576678|593811368|FG000|Overall Study|Miscellaneous|2|||
164394274|NCT02576678|593811369|FG001|Overall Study|Miscellaneous|0|||
164394275|NCT02576678|593811370|FG002|Overall Study|Miscellaneous|0|||
164394276|NCT03240692|593811375|FG000|Overall Study|Physician Decision|1|||
164394277|NCT03240692|593811375|FG000|Overall Study|Withdrawal by Subject|1|||
164394278|NCT00683644|593811376|FG000|Overall Study|Withdrawal by Subject|4|||
164394279|NCT00683644|593811377|FG001|Overall Study|Withdrawal by Subject|2|||
164394280|NCT00683644|593811376|FG000|Overall Study|Lost to Follow-up|1|||
164394281|NCT00683644|593811377|FG001|Overall Study|Lost to Follow-up|4|||
164394282|NCT00683644|593811376|FG000|Overall Study|Adverse Event|1|||
164394283|NCT00683644|593811377|FG001|Overall Study|Adverse Event|2|||
164394284|NCT00683644|593811376|FG000|Overall Study|Low copper, other health problems,|7|||
164394285|NCT00683644|593811377|FG001|Overall Study|Low copper, other health problems,|6|||
164394286|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
164394287|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
164394288|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
164394289|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
164394290|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
164394291|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
164394292|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
164394293|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
164394294|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
164394295|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
164394296|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
164394297|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
164394298|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
164394299|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
164394300|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
164394301|NCT00355082|593811378|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
164394302|NCT00355082|593811379|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
164394303|NCT00355082|593811380|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
164394304|NCT00355082|593811378|FG000|Continuation Phase|Adverse Event|2|||
164394305|NCT00355082|593811379|FG001|Continuation Phase|Adverse Event|0|||
164394306|NCT00355082|593811380|FG002|Continuation Phase|Adverse Event|1|||
164394307|NCT00355082|593811378|FG000|Continuation Phase|Lost to Follow-up|2|||
164394308|NCT00355082|593811379|FG001|Continuation Phase|Lost to Follow-up|0|||
164394309|NCT00355082|593811380|FG002|Continuation Phase|Lost to Follow-up|1|||
164394310|NCT00355082|593811378|FG000|Continuation Phase|Protocol Violation|1|||
164394311|NCT00355082|593811379|FG001|Continuation Phase|Protocol Violation|0|||
164394312|NCT00355082|593811380|FG002|Continuation Phase|Protocol Violation|1|||
164394313|NCT00355082|593811378|FG000|Continuation Phase|Withdrawal by Subject|4|||
164394314|NCT00355082|593811379|FG001|Continuation Phase|Withdrawal by Subject|0|||
164394315|NCT00355082|593811380|FG002|Continuation Phase|Withdrawal by Subject|0|||
164394316|NCT00355082|593811378|FG000|Continuation Phase|Lack of Efficacy|5|||
164394317|NCT00355082|593811379|FG001|Continuation Phase|Lack of Efficacy|0|||
164394318|NCT00355082|593811380|FG002|Continuation Phase|Lack of Efficacy|0|||
164394319|NCT00355082|593811378|FG000|Continuation Phase|Site Closed by Sponsor|8|||
164394320|NCT00355082|593811379|FG001|Continuation Phase|Site Closed by Sponsor|0|||
164394321|NCT00355082|593811380|FG002|Continuation Phase|Site Closed by Sponsor|0|||
164394322|NCT00355082|593811378|FG000|Continuation Phase|Scheduling Error|1|||
164394323|NCT00355082|593811379|FG001|Continuation Phase|Scheduling Error|0|||
164394324|NCT00355082|593811380|FG002|Continuation Phase|Scheduling Error|0|||
164394325|NCT00355082|593811378|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
164394326|NCT00355082|593811379|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
164394327|NCT00355082|593811380|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
164394328|NCT02576067|593811381|FG000|Overall Study|Death|0|||
164394329|NCT02576067|593811382|FG001|Overall Study|Death|1|||
164394330|NCT02576067|593811381|FG000|Overall Study|Lack of Efficacy|1|||
164394331|NCT02576067|593811382|FG001|Overall Study|Lack of Efficacy|0|||
164394332|NCT02576067|593811381|FG000|Overall Study|Lost to Follow-up|11|||
164394333|NCT02576067|593811382|FG001|Overall Study|Lost to Follow-up|0|||
164394334|NCT02576067|593811381|FG000|Overall Study|Withdrawal by Subject|11|||
164394335|NCT02576067|593811382|FG001|Overall Study|Withdrawal by Subject|2|||
164394336|NCT02576067|593811381|FG000|Overall Study|study closure of main CIRT trial)|0|||
164394337|NCT02576067|593811382|FG001|Overall Study|study closure of main CIRT trial)|8|||
164394338|NCT02576067|593811381|FG000|Overall Study|not randomized, failed run-in|7|||
164394339|NCT02576067|593811382|FG001|Overall Study|not randomized, failed run-in|0|||
164394340|NCT02576067|593811381|FG000|Overall Study|screen failure/ re-enrolled|0|||
164394341|NCT02576067|593811382|FG001|Overall Study|screen failure/ re-enrolled|25|||
164394342|NCT02576067|593811381|FG000|Overall Study|Physician Decision|4|||
163905253|NCT02542943|592023831|FG002|Overall Study|Lost to Follow-up|0|||
163905254|NCT02542943|592023829|FG000|Overall Study|Withdrawal by Subject|0|||
163905255|NCT02542943|592023830|FG001|Overall Study|Withdrawal by Subject|1|||
164394343|NCT02576067|593811382|FG001|Overall Study|Physician Decision|0|||
164394344|NCT02372409|593811383|FG000|Overall Study|Lost to Follow-up|1|||
164394345|NCT02372409|593811384|FG001|Overall Study|Lost to Follow-up|0|||
164394346|NCT02372409|593811383|FG000|Overall Study|Disease progression|1|||
164394347|NCT02372409|593811384|FG001|Overall Study|Disease progression|1|||
164394348|NCT01808313|593811387|FG000|Overall Study|Adverse Event|5|||
164394349|NCT01808313|593811387|FG000|Overall Study|Protocol Violation|2|||
164394350|NCT01808313|593811387|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
164394351|NCT01808313|593811387|FG000|Overall Study|Lost to Follow-up|1|||
164394352|NCT01808313|593811387|FG000|Overall Study|Physician Decision|1|||
164394353|NCT04084314|593811389|FG000|Overall Study|Subject/guardian decision|91|||
164394354|NCT04084314|593811389|FG000|Overall Study|Adverse Event|24|||
164394355|NCT04084314|593811389|FG000|Overall Study|Lost to Follow-up|19|||
164394356|NCT04084314|593811389|FG000|Overall Study|New therapy for study indication|9|||
164394357|NCT04084314|593811389|FG000|Overall Study|Pregnancy|9|||
164394358|NCT04084314|593811389|FG000|Overall Study|Withdrawal of informed consent|8|||
164394359|NCT04084314|593811389|FG000|Overall Study|Physician Decision|4|||
164394360|NCT04084314|593811389|FG000|Overall Study|Protocol Deviation|3|||
164394361|NCT00622167|593811390|FG000|Overall Study|Did not meet angiographic criteria|20|||
164394362|NCT03738150|593811394|FG000|Base Study|Withdrawal by Subject|1|||
164394363|NCT03738150|593811394|FG000|Extension Study|Withdrawal by Subject|1|||
164394364|NCT03086447|593811400|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164394365|NCT03086447|593811401|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
164394366|NCT03086447|593811400|FG000|Overall Study|Lost Lens|2|||
164394367|NCT03086447|593811401|FG001|Overall Study|Lost Lens|5|||
164394368|NCT03086447|593811400|FG000|Overall Study|Product quality complaint|0|||
164394369|NCT03086447|593811401|FG001|Overall Study|Product quality complaint|1|||
164394370|NCT03086447|593811400|FG000|Overall Study|Lens Damage|1|||
164394371|NCT03086447|593811401|FG001|Overall Study|Lens Damage|6|||
164394372|NCT03086447|593811400|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
164394373|NCT03086447|593811401|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
164394374|NCT03086447|593811400|FG000|Overall Study|Test Article No Longer Available|1|||
164394375|NCT03086447|593811401|FG001|Overall Study|Test Article No Longer Available|0|||
164394376|NCT03086447|593811400|FG000|Overall Study|Protocol Violation|2|||
164394377|NCT03086447|593811401|FG001|Overall Study|Protocol Violation|4|||
164394378|NCT03086447|593811400|FG000|Overall Study|Lost to Follow-up|0|||
164394379|NCT03086447|593811401|FG001|Overall Study|Lost to Follow-up|1|||
164394380|NCT03086447|593811400|FG000|Overall Study|Adverse Event|3|||
164394381|NCT03086447|593811401|FG001|Overall Study|Adverse Event|0|||
164394382|NCT03086447|593811400|FG000|Overall Study|Lens Discomfort|2|||
164394383|NCT03086447|593811401|FG001|Overall Study|Lens Discomfort|1|||
164394384|NCT03387852|593811402|FG000|Overall Study|Adverse event (AE)|3|||
164394385|NCT03387852|593811403|FG001|Overall Study|Adverse event (AE)|0|||
164394386|NCT03387852|593811404|FG002|Overall Study|Adverse event (AE)|2|||
164394387|NCT03387852|593811405|FG003|Overall Study|Adverse event (AE)|0|||
164394388|NCT03387852|593811402|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
164394389|NCT03387852|593811403|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
164394390|NCT03387852|593811404|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
164394391|NCT03387852|593811405|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
164394392|NCT03387852|593811402|FG000|Overall Study|Withdrawal by participant|1|||
164394393|NCT03387852|593811403|FG001|Overall Study|Withdrawal by participant|1|||
164394394|NCT03387852|593811404|FG002|Overall Study|Withdrawal by participant|3|||
164394395|NCT03387852|593811405|FG003|Overall Study|Withdrawal by participant|2|||
164394396|NCT03387852|593811402|FG000|Overall Study|Other- Unspecified|1|||
164394397|NCT03387852|593811403|FG001|Overall Study|Other- Unspecified|1|||
164394398|NCT03387852|593811404|FG002|Overall Study|Other- Unspecified|2|||
164394399|NCT03387852|593811405|FG003|Overall Study|Other- Unspecified|1|||
164394400|NCT03387852|593811402|FG000|Overall Study|Poor compliance to protocol|0|||
164394401|NCT03387852|593811403|FG001|Overall Study|Poor compliance to protocol|0|||
164093152|NCT05694013|592703493|FG000|Overall Study|Study Terminated by Sponsor|12|||
163905256|NCT02542943|592023831|FG002|Overall Study|Withdrawal by Subject|0|||
164394402|NCT03387852|593811404|FG002|Overall Study|Poor compliance to protocol|0|||
164394403|NCT03387852|593811405|FG003|Overall Study|Poor compliance to protocol|1|||
164394404|NCT03387852|593811402|FG000|Overall Study|Randomized and not treated|0|||
164394405|NCT03387852|593811403|FG001|Overall Study|Randomized and not treated|0|||
164394406|NCT03387852|593811404|FG002|Overall Study|Randomized and not treated|0|||
164394407|NCT03387852|593811405|FG003|Overall Study|Randomized and not treated|1|||
164394408|NCT02194621|593811406|FG000|Overall Study|6 withdrew prior to randomization|2|||
164394409|NCT02194621|593811407|FG001|Overall Study|6 withdrew prior to randomization|2|||
164394410|NCT02194621|593811408|FG002|Overall Study|6 withdrew prior to randomization|2|||
164394411|NCT02194621|593811406|FG000|Overall Study|Withdrawal by Subject|4|||
164394412|NCT02194621|593811407|FG001|Overall Study|Withdrawal by Subject|4|||
164394413|NCT02194621|593811408|FG002|Overall Study|Withdrawal by Subject|7|||
164394414|NCT00714168|593811409|FG000|Overall Study|Pregnancy|5|||
164394415|NCT00714168|593811410|FG001|Overall Study|Pregnancy|4|||
164394416|NCT00714168|593811409|FG000|Overall Study|Lost to Follow-up|32|||
164394417|NCT00714168|593811410|FG001|Overall Study|Lost to Follow-up|50|||
164394418|NCT00714168|593811409|FG000|Overall Study|Relocation|4|||
164394419|NCT00714168|593811410|FG001|Overall Study|Relocation|3|||
164394420|NCT00714168|593811409|FG000|Overall Study|Non-study medical condition|3|||
164394421|NCT00714168|593811410|FG001|Overall Study|Non-study medical condition|2|||
164394422|NCT01864564|593811413|FG000|Overall Study|Lost to Follow-up|17|||
164394423|NCT01864564|593811414|FG001|Overall Study|Lost to Follow-up|23|||
164394424|NCT01864564|593811413|FG000|Overall Study|Withdrawal by Subject|20|||
164394425|NCT01864564|593811414|FG001|Overall Study|Withdrawal by Subject|11|||
164394426|NCT01864564|593811413|FG000|Overall Study|Protocol Violation|0|||
164394427|NCT01864564|593811414|FG001|Overall Study|Protocol Violation|27|||
164394428|NCT01864564|593811413|FG000|Overall Study|not reported|0|||
164394429|NCT01864564|593811414|FG001|Overall Study|not reported|34|||
163905257|NCT05824559|592023834|FG000|Overall Study|Adverse Event|2|||
163905258|NCT05824559|592023834|FG000|Overall Study|Physician Decision|2|||
163905259|NCT05824559|592023834|FG000|Overall Study|Progressive Disease|16|||
164394430|NCT03077724|593811415|FG000|Overall Study|Lost to Follow-up|5|||
164394431|NCT03077724|593811416|FG001|Overall Study|Lost to Follow-up|1|||
164394432|NCT03077724|593811415|FG000|Overall Study|Withdrawal by Subject|3|||
164394433|NCT03077724|593811416|FG001|Overall Study|Withdrawal by Subject|1|||
163905260|NCT05824559|592023834|FG000|Overall Study|Study Terminated by Sponsor|1|||
164394434|NCT02269670|593811417|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
164394435|NCT00126438|593811418|FG000|Overall Study|Withdrawal due to adverse event|1|||
164394436|NCT00126438|593811419|FG001|Overall Study|Withdrawal due to adverse event|0|||
164394437|NCT00126438|593811418|FG000|Overall Study|Lost to Follow-up|22|||
164394438|NCT00126438|593811419|FG001|Overall Study|Lost to Follow-up|0|||
163905261|NCT05824559|592023834|FG000|Overall Study|Withdrawal by Subject|2|||
164394439|NCT00126438|593811418|FG000|Overall Study|Protocol Violation|8|||
164394440|NCT00126438|593811419|FG001|Overall Study|Protocol Violation|8|||
164394441|NCT00126438|593811418|FG000|Overall Study|Withdrawal by Subject|3|||
164394442|NCT00126438|593811419|FG001|Overall Study|Withdrawal by Subject|2|||
164394443|NCT02313428|593811420|FG000|Overall Study|Lost to Follow-up|1|||
164394444|NCT02313428|593811421|FG001|Overall Study|Lost to Follow-up|1|||
164394445|NCT04414696|593811423|FG000|3-month Follow up|Withdrawal by Subject|1|||
164394446|NCT04414696|593811424|FG001|3-month Follow up|Withdrawal by Subject|0|||
164394447|NCT04414696|593811423|FG000|3-month Follow up|Lost to Follow-up|22|||
164394448|NCT04414696|593811424|FG001|3-month Follow up|Lost to Follow-up|23|||
164394449|NCT04414696|593811423|FG000|6-month Follow up|Withdrawal by Subject|1|||
164394450|NCT04414696|593811424|FG001|6-month Follow up|Withdrawal by Subject|2|||
164394451|NCT04414696|593811423|FG000|6-month Follow up|Lost to Follow-up|5|||
164394452|NCT04414696|593811424|FG001|6-month Follow up|Lost to Follow-up|2|||
164394453|NCT02160314|593813673|FG000|Overall Study|Adverse Event|0|||
164394454|NCT02160314|593813674|FG001|Overall Study|Adverse Event|6|||
164394455|NCT02160314|593813673|FG000|Overall Study|Protocol Violation|0|||
164394456|NCT02160314|593813674|FG001|Overall Study|Protocol Violation|4|||
164394457|NCT02160314|593813673|FG000|Overall Study|Withdrawal by Subject|1|||
164394458|NCT02160314|593813674|FG001|Overall Study|Withdrawal by Subject|2|||
164394459|NCT02160314|593813673|FG000|Overall Study|Lost to Follow-up|0|||
164394460|NCT02160314|593813674|FG001|Overall Study|Lost to Follow-up|1|||
164394461|NCT00593567|593813675|FG000|Overall Study|Adverse Event|2|||
164394462|NCT00593567|593813676|FG001|Overall Study|Adverse Event|0|||
164394463|NCT00593567|593813675|FG000|Overall Study|Physician Decision|2|||
164394464|NCT00593567|593813676|FG001|Overall Study|Physician Decision|0|||
164394465|NCT00593567|593813675|FG000|Overall Study|Protocol Violation|13|||
164394466|NCT00593567|593813676|FG001|Overall Study|Protocol Violation|7|||
164394467|NCT00593567|593813675|FG000|Overall Study|Lack of Efficacy|2|||
164394468|NCT00593567|593813676|FG001|Overall Study|Lack of Efficacy|1|||
163905262|NCT04701203|592023839|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
163905263|NCT04701203|592023840|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
163905264|NCT04701203|592023841|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
163905265|NCT04701203|592023839|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
163905266|NCT04701203|592023840|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
163905267|NCT04701203|592023841|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
163905268|NCT04701203|592023839|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
163905269|NCT04701203|592023840|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
163905270|NCT04701203|592023841|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
164394469|NCT00593567|593813675|FG000|Overall Study|Withdrawal by Subject|1|||
164394470|NCT00593567|593813676|FG001|Overall Study|Withdrawal by Subject|2|||
164394471|NCT00785291|593813681|FG000|Overall Study|Never began treatment|8|||
164394472|NCT00785291|593813682|FG001|Overall Study|Never began treatment|4|||
164394473|NCT00785291|593813683|FG002|Overall Study|Never began treatment|4|||
164394474|NCT00785291|593813681|FG000|Overall Study|Adverse Event|39|||
164394475|NCT00785291|593813682|FG001|Overall Study|Adverse Event|70|||
164394476|NCT00785291|593813683|FG002|Overall Study|Adverse Event|56|||
164394477|NCT00785291|593813681|FG000|Overall Study|Death|7|||
164394478|NCT00785291|593813682|FG001|Overall Study|Death|4|||
164394479|NCT00785291|593813683|FG002|Overall Study|Death|3|||
164394480|NCT00785291|593813681|FG000|Overall Study|Withdrawal by Subject|35|||
164394481|NCT00785291|593813682|FG001|Overall Study|Withdrawal by Subject|36|||
164394482|NCT00785291|593813683|FG002|Overall Study|Withdrawal by Subject|17|||
164394483|NCT00785291|593813681|FG000|Overall Study|Alternative Therapy|12|||
164394484|NCT00785291|593813682|FG001|Overall Study|Alternative Therapy|6|||
164394485|NCT00785291|593813683|FG002|Overall Study|Alternative Therapy|7|||
164394486|NCT00785291|593813681|FG000|Overall Study|Complicating illness|6|||
164394487|NCT00785291|593813682|FG001|Overall Study|Complicating illness|4|||
164394488|NCT00785291|593813683|FG002|Overall Study|Complicating illness|4|||
164394489|NCT00785291|593813681|FG000|Overall Study|Other Medical Reasons|29|||
164394490|NCT00785291|593813682|FG001|Overall Study|Other Medical Reasons|25|||
164394491|NCT00785291|593813683|FG002|Overall Study|Other Medical Reasons|15|||
164394492|NCT02119260|593813684|FG000|Overall Study|Adverse Event|1|||
164394493|NCT02119260|593813685|FG001|Overall Study|Adverse Event|0|||
164394494|NCT02119260|593813686|FG002|Overall Study|Adverse Event|0|||
164394495|NCT02119260|593813687|FG003|Overall Study|Adverse Event|0|||
164394496|NCT02119260|593813688|FG004|Overall Study|Adverse Event|0|||
164394497|NCT02119260|593813689|FG005|Overall Study|Adverse Event|0|||
164394498|NCT02119260|593813690|FG006|Overall Study|Adverse Event|0|||
164394499|NCT02119260|593813684|FG000|Overall Study|Withdrew consent|0|||
164394500|NCT02119260|593813685|FG001|Overall Study|Withdrew consent|1|||
164394501|NCT02119260|593813686|FG002|Overall Study|Withdrew consent|1|||
164394502|NCT02119260|593813687|FG003|Overall Study|Withdrew consent|0|||
164394503|NCT02119260|593813688|FG004|Overall Study|Withdrew consent|0|||
164394504|NCT02119260|593813689|FG005|Overall Study|Withdrew consent|0|||
164394505|NCT02119260|593813690|FG006|Overall Study|Withdrew consent|0|||
164394506|NCT01877408|593813695|FG000|Overall Study|Lost to Follow-up|0|||
164394507|NCT01877408|593813696|FG001|Overall Study|Lost to Follow-up|2|||
164394508|NCT03870763|593813699|FG000|Overall Study|Study terminated by sponsor|0|||
164394509|NCT03870763|593813700|FG001|Overall Study|Study terminated by sponsor|2|||
164394510|NCT03870763|593813701|FG002|Overall Study|Study terminated by sponsor|0|||
164394511|NCT03870763|593813699|FG000|Overall Study|Withdrawal by Subject|0|||
164394512|NCT03870763|593813700|FG001|Overall Study|Withdrawal by Subject|1|||
164394513|NCT03870763|593813701|FG002|Overall Study|Withdrawal by Subject|0|||
164394514|NCT03870763|593813699|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
164394515|NCT03870763|593813700|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
164394516|NCT03870763|593813701|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
164394517|NCT03224182|593813702|FG000|Overall Study|Study Drug Not Instilled|6|||
164394518|NCT03224182|593813703|FG001|Overall Study|Study Drug Not Instilled|1|||
164394519|NCT03224182|593813702|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
164394520|NCT03224182|593813703|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
164394521|NCT03224182|593813702|FG000|Overall Study|Withdrew of Consent|4|||
164394522|NCT03224182|593813703|FG001|Overall Study|Withdrew of Consent|2|||
164394523|NCT03224182|593813702|FG000|Overall Study|Investigator Decision|3|||
164394524|NCT03224182|593813703|FG001|Overall Study|Investigator Decision|1|||
164394525|NCT03224182|593813702|FG000|Overall Study|Sponsor Decision|26|||
164394526|NCT03224182|593813703|FG001|Overall Study|Sponsor Decision|12|||
164394527|NCT03224182|593813702|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
164394528|NCT03224182|593813703|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
164394529|NCT03224182|593813702|FG000|Overall Study|Lost to Follow-up|1|||
164394530|NCT03224182|593813703|FG001|Overall Study|Lost to Follow-up|0|||
164394531|NCT03224182|593813702|FG000|Overall Study|Participant Had Recurrence|11|||
164394532|NCT03224182|593813703|FG001|Overall Study|Participant Had Recurrence|5|||
164394533|NCT03224182|593813702|FG000|Overall Study|Death|0|||
164394534|NCT03224182|593813703|FG001|Overall Study|Death|1|||
164394535|NCT03224182|593813702|FG000|Overall Study|Reason not Specified|3|||
164394536|NCT03224182|593813703|FG001|Overall Study|Reason not Specified|3|||
164093153|NCT05694013|592703494|FG001|Overall Study|Study Terminated by Sponsor|17|||
164093154|NCT05694013|592703493|FG000|Overall Study|Withdrawal by Subject|3|||
164093155|NCT05694013|592703494|FG001|Overall Study|Withdrawal by Subject|0|||
164093156|NCT04817891|592703495|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
164394537|NCT03224182|593813702|FG000|Overall Study|Other|1|||
164394538|NCT03224182|593813703|FG001|Overall Study|Other|0|||
164394539|NCT04279314|593813704|FG000|Overall Study|Adverse Event|55|||
164394540|NCT04279314|593813704|FG000|Overall Study|Withdrawal by Subject|5|||
164394541|NCT04279314|593813704|FG000|Overall Study|Lack of Efficacy|5|||
164394542|NCT04279314|593813704|FG000|Overall Study|Protocol Violation|3|||
164394543|NCT04279314|593813704|FG000|Overall Study|Other (not COVID-19 related)|2|||
164394544|NCT02120027|593813705|FG000|Overall Study|Adverse Event|4|||
164394545|NCT02120027|593813706|FG001|Overall Study|Adverse Event|5|||
164394546|NCT02120027|593813705|FG000|Overall Study|Lack of Efficacy|3|||
164394547|NCT02120027|593813706|FG001|Overall Study|Lack of Efficacy|5|||
164394548|NCT02120027|593813705|FG000|Overall Study|Lost to Follow-up|5|||
164394549|NCT02120027|593813706|FG001|Overall Study|Lost to Follow-up|13|||
164394550|NCT02120027|593813705|FG000|Overall Study|Other|4|||
164394551|NCT02120027|593813706|FG001|Overall Study|Other|0|||
164394552|NCT02120027|593813705|FG000|Overall Study|Physician Decision|4|||
164394553|NCT02120027|593813706|FG001|Overall Study|Physician Decision|3|||
164394554|NCT02120027|593813705|FG000|Overall Study|Protocol Violation|18|||
164394555|NCT02120027|593813706|FG001|Overall Study|Protocol Violation|21|||
164394556|NCT02120027|593813705|FG000|Overall Study|Study terminated by Sponsor|45|||
164394557|NCT02120027|593813706|FG001|Overall Study|Study terminated by Sponsor|47|||
164394558|NCT02120027|593813705|FG000|Overall Study|Withdrawal by Subject|33|||
164394559|NCT02120027|593813706|FG001|Overall Study|Withdrawal by Subject|25|||
164394560|NCT01471054|593813714|FG000|Overall Study|Study terminated prematurely|4|||
164093157|NCT04817891|592703495|FG000|Overall Study|Adverse Event|1|||
164093158|NCT04817891|592703495|FG000|Overall Study|Withdrawal by Subject|1|||
164093159|NCT03982433|592703496|FG000|Overall Study|Lost to Follow-up|1|||
164093160|NCT00368277|592703497|FG000|Overall Study|Adverse Event|33|||
164093161|NCT00368277|592703498|FG001|Overall Study|Adverse Event|49|||
164093162|NCT00368277|592703497|FG000|Overall Study|Death|2|||
164093163|NCT00368277|592703498|FG001|Overall Study|Death|1|||
164093164|NCT00368277|592703497|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
164093165|NCT00368277|592703498|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
164093166|NCT00368277|592703497|FG000|Overall Study|Protocol deviation|7|||
164394561|NCT01471054|593813715|FG001|Overall Study|Study terminated prematurely|0|||
164394562|NCT00686166|593813716|FG000|Overall Study|Adverse Event|7|||
164394563|NCT00686166|593813716|FG000|Overall Study|Withdrawal by Subject|1|||
164394564|NCT00686166|593813716|FG000|Overall Study|Progression/Relapse|1|||
164394565|NCT00686166|593813716|FG000|Overall Study|Death|1|||
164394566|NCT00686166|593813716|FG000|Overall Study|Not Protocol Specified|1|||
164394567|NCT00686166|593813716|FG000|Overall Study|Ineligible|5|||
164394568|NCT00686166|593813716|FG000|Overall Study|Did not begin protocol therapy|4|||
164394569|NCT00985725|593813717|FG000|Overall Study|Adverse Event|4|||
164394570|NCT00985725|593813718|FG001|Overall Study|Adverse Event|1|||
164394571|NCT00985725|593813717|FG000|Overall Study|Protocol Violation|1|||
164394572|NCT00985725|593813718|FG001|Overall Study|Protocol Violation|3|||
164394573|NCT00985725|593813717|FG000|Overall Study|Withdrawal by Subject|4|||
164394574|NCT00985725|593813718|FG001|Overall Study|Withdrawal by Subject|4|||
164394575|NCT00985725|593813717|FG000|Overall Study|Lost to Follow-up|1|||
164394576|NCT00985725|593813718|FG001|Overall Study|Lost to Follow-up|1|||
164394577|NCT00985725|593813717|FG000|Overall Study|Lack of Efficacy|0|||
164394578|NCT00985725|593813718|FG001|Overall Study|Lack of Efficacy|1|||
164394579|NCT00985725|593813717|FG000|Overall Study|Non-compliance|1|||
164394580|NCT00985725|593813718|FG001|Overall Study|Non-compliance|2|||
164394581|NCT00985725|593813717|FG000|Overall Study|Out-of-window visits|0|||
164394582|NCT00985725|593813718|FG001|Overall Study|Out-of-window visits|1|||
164394583|NCT02314624|593813722|FG000|Overall Study|No participating patient|16|||
164394584|NCT02314624|593813723|FG001|Overall Study|No participating patient|13|||
163905271|NCT04701203|592023839|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
163905272|NCT04701203|592023840|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
163905273|NCT04701203|592023841|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
163905274|NCT01563185|592023844|FG000|Overall Study|Withdrawal by Subject|1|||
163905275|NCT01563185|592023844|FG000|Overall Study|Non-Compliance with study drug|1|||
163905276|NCT04577651|592023845|FG000|Overall Study|Screen Failure|7|||
163905277|NCT04577651|592023845|FG000|Overall Study|Adverse Event|1|||
163905278|NCT04577651|592023845|FG000|Overall Study|Death|1|||
163905279|NCT04577651|592023845|FG000|Overall Study|Physician Decision|1|||
163905280|NCT04577651|592023845|FG000|Overall Study|Withdrawal by Subject|3|||
163905281|NCT00647387|592023848|FG000|Overall Study|Lost to Follow-up|6|||
163905282|NCT00647387|592023848|FG000|Overall Study|Unsuccessful implant|5|||
163905283|NCT00647387|592023848|FG000|Overall Study|Device explanted|3|||
163905284|NCT00647387|592023848|FG000|Overall Study|Other Reason|3|||
163905285|NCT00647387|592023848|FG000|Overall Study|Death|2|||
163905286|NCT03147287|592023849|FG000|Overall Study|Randomized Not Treated|2|||
163905287|NCT03147287|592023850|FG001|Overall Study|Randomized Not Treated|1|||
163905288|NCT03147287|592023851|FG002|Overall Study|Randomized Not Treated|1|||
163905289|NCT03147287|592023849|FG000|Overall Study|Progressive Disease RECIST|31|||
163905290|NCT03147287|592023850|FG001|Overall Study|Progressive Disease RECIST|72|||
163905291|NCT03147287|592023851|FG002|Overall Study|Progressive Disease RECIST|32|||
163905292|NCT03147287|592023849|FG000|Overall Study|Progressive Disease not RECIST|13|||
163905293|NCT03147287|592023850|FG001|Overall Study|Progressive Disease not RECIST|21|||
163905294|NCT03147287|592023851|FG002|Overall Study|Progressive Disease not RECIST|13|||
163905295|NCT03147287|592023849|FG000|Overall Study|Physician Decision|1|||
163905296|NCT03147287|592023850|FG001|Overall Study|Physician Decision|2|||
163905297|NCT03147287|592023851|FG002|Overall Study|Physician Decision|1|||
163905298|NCT03147287|592023849|FG000|Overall Study|Intercurrent illness|0|||
163905299|NCT03147287|592023850|FG001|Overall Study|Intercurrent illness|1|||
163905300|NCT03147287|592023851|FG002|Overall Study|Intercurrent illness|0|||
163905301|NCT03147287|592023849|FG000|Overall Study|Withdrawal by Subject|2|||
164394585|NCT02314624|593813722|FG000|Overall Study|Participant withdrew|7|||
164394586|NCT02314624|593813723|FG001|Overall Study|Participant withdrew|2|||
164394587|NCT02314624|593813722|FG000|Overall Study|Lost to Follow-up|2|||
164394588|NCT02314624|593813723|FG001|Overall Study|Lost to Follow-up|5|||
164394589|NCT02314624|593813722|FG000|Overall Study|Dropped/Excluded by PI|6|||
164394590|NCT02314624|593813723|FG001|Overall Study|Dropped/Excluded by PI|6|||
164394591|NCT03151005|593813724|FG000|Overall Study|Lost to Follow-up|5|||
164394592|NCT03151005|593813725|FG001|Overall Study|Lost to Follow-up|5|||
164394593|NCT00360308|593813728|FG000|Overall Study|Adverse Event|15|||
164394594|NCT00360308|593813729|FG001|Overall Study|Adverse Event|14|||
164394595|NCT00360308|593813730|FG002|Overall Study|Adverse Event|25|||
164394596|NCT00360308|593813728|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
164394597|NCT00360308|593813729|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
164394598|NCT00360308|593813730|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
164394599|NCT00360308|593813728|FG000|Overall Study|Protocol Violation|2|||
164394600|NCT00360308|593813729|FG001|Overall Study|Protocol Violation|1|||
164394601|NCT00360308|593813730|FG002|Overall Study|Protocol Violation|2|||
164394602|NCT00360308|593813728|FG000|Overall Study|Withdrawal by Subject|11|||
164394603|NCT00360308|593813729|FG001|Overall Study|Withdrawal by Subject|7|||
164394604|NCT00360308|593813730|FG002|Overall Study|Withdrawal by Subject|14|||
164394605|NCT00360308|593813728|FG000|Overall Study|Lack of Efficacy|3|||
164394606|NCT00360308|593813729|FG001|Overall Study|Lack of Efficacy|0|||
164394607|NCT00360308|593813730|FG002|Overall Study|Lack of Efficacy|2|||
164394608|NCT00360308|593813728|FG000|Overall Study|Other|2|||
164394609|NCT00360308|593813729|FG001|Overall Study|Other|1|||
164394610|NCT00360308|593813730|FG002|Overall Study|Other|1|||
164394611|NCT00360308|593813728|FG000|Overall Study|Study termination by sponsor|43|||
164093167|NCT00368277|592703498|FG001|Overall Study|Protocol deviation|0|||
164093168|NCT00368277|592703497|FG000|Overall Study|Patient withdrew consent|32|||
164093169|NCT00368277|592703498|FG001|Overall Study|Patient withdrew consent|28|||
164093170|NCT00368277|592703497|FG000|Overall Study|Lost to Follow-up|8|||
164093171|NCT00368277|592703498|FG001|Overall Study|Lost to Follow-up|6|||
164093172|NCT00475020|592703507|FG000|Overall Study|Physician Decision|3|||
164093173|NCT00475020|592703507|FG000|Overall Study|Insurance Denial|1|||
164093174|NCT00475020|592703507|FG000|Overall Study|Donor not able to donate the last minute|1|||
164093175|NCT01575054|592703508|FG000|Overall Study|Other Reasons|5|||
164093176|NCT01575054|592703509|FG001|Overall Study|Other Reasons|3|||
164093177|NCT01575054|592703508|FG000|Overall Study|Protocol Violation|2|||
164093178|NCT01575054|592703509|FG001|Overall Study|Protocol Violation|1|||
164093179|NCT01575054|592703508|FG000|Overall Study|Personal Reasons|10|||
164093180|NCT01575054|592703509|FG001|Overall Study|Personal Reasons|11|||
164093181|NCT01575054|592703508|FG000|Overall Study|Lost to Follow-up|3|||
164093182|NCT01575054|592703509|FG001|Overall Study|Lost to Follow-up|3|||
164093183|NCT01575054|592703508|FG000|Overall Study|Adverse Event|9|||
164093184|NCT01575054|592703509|FG001|Overall Study|Adverse Event|8|||
164093185|NCT03481309|592703510|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
164093186|NCT03481309|592703511|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164093187|NCT03481309|592703512|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164093188|NCT03481309|592703513|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164093189|NCT03481309|592703514|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164093190|NCT03481309|592703515|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
164093191|NCT03309956|592703516|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
164093192|NCT02768298|592703519|FG000|Overall Study|Adverse Event|1|||
164093193|NCT02768298|592703520|FG001|Overall Study|Adverse Event|4|||
164093194|NCT02768298|592703519|FG000|Overall Study|Death|2|||
164093195|NCT02768298|592703520|FG001|Overall Study|Death|1|||
164093196|NCT02768298|592703519|FG000|Overall Study|Non-compliance with study treatment|0|||
164093197|NCT02768298|592703520|FG001|Overall Study|Non-compliance with study treatment|1|||
164093198|NCT02768298|592703519|FG000|Overall Study|Subject/guardian decision|1|||
164394612|NCT00360308|593813729|FG001|Overall Study|Study termination by sponsor|55|||
164394613|NCT00360308|593813730|FG002|Overall Study|Study termination by sponsor|44|||
164394614|NCT01549613|593813731|FG000|Overall Study|Lost to Follow-up|11|||
164394615|NCT01549613|593813732|FG001|Overall Study|Lost to Follow-up|11|||
164394616|NCT02131272|593813733|FG000|Overall Study|Withdrawal by parent|0|||
164093199|NCT02768298|592703520|FG001|Overall Study|Subject/guardian decision|0|||
164093200|NCT02768298|592703519|FG000|Overall Study|Withdrawal of informed consent|0|||
164093201|NCT02768298|592703520|FG001|Overall Study|Withdrawal of informed consent|1|||
164093202|NCT04256421|592703522|FG000|Overall Study|Death|171|||
164093203|NCT04256421|592703523|FG001|Overall Study|Death|180|||
164093204|NCT04256421|592703522|FG000|Overall Study|Lost to Follow-up|1|||
164093205|NCT04256421|592703523|FG001|Overall Study|Lost to Follow-up|1|||
164093206|NCT04256421|592703522|FG000|Overall Study|Withdrawal by Subject|9|||
164394617|NCT02131272|593813734|FG001|Overall Study|Withdrawal by parent|1|||
164394618|NCT02131272|593813733|FG000|Overall Study|Withdrawal by Subject|0|||
164394619|NCT02131272|593813734|FG001|Overall Study|Withdrawal by Subject|1|||
164394620|NCT02131272|593813733|FG000|Overall Study|Withdrawal Criteria|1|||
164394621|NCT02131272|593813734|FG001|Overall Study|Withdrawal Criteria|0|||
164144035|NCT00086281|592888574|FG003|Phase 2|Adverse Event|0|||
164394622|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
164394623|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
164394624|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
164394625|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
164394626|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
164394627|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
164394628|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
164394629|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
164394630|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
164394631|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
164394632|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
164394633|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
164394634|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
164394635|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
164394636|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
164394637|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
164394638|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
164394639|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
164394640|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
164394641|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
164394642|NCT04162769|593813735|FG000|Double-blind Treatment (12-Week)|Other|0|||
164394643|NCT04162769|593813736|FG001|Double-blind Treatment (12-Week)|Other|1|||
164394644|NCT04162769|593813737|FG002|Double-blind Treatment (12-Week)|Other|1|||
164394645|NCT04162769|593813738|FG003|Double-blind Treatment (12-Week)|Other|0|||
164394646|NCT04162769|593813735|FG000|OLE Period (52-Week)|Adverse Event|0|||
164394647|NCT04162769|593813736|FG001|OLE Period (52-Week)|Adverse Event|0|||
164394648|NCT04162769|593813737|FG002|OLE Period (52-Week)|Adverse Event|0|||
164394649|NCT04162769|593813738|FG003|OLE Period (52-Week)|Adverse Event|5|||
164394650|NCT04162769|593813735|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
164394651|NCT04162769|593813736|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
164394652|NCT04162769|593813737|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
164394653|NCT04162769|593813738|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
164394654|NCT04162769|593813735|FG000|OLE Period (52-Week)|Physician Decision|0|||
164394655|NCT04162769|593813736|FG001|OLE Period (52-Week)|Physician Decision|0|||
164394656|NCT04162769|593813737|FG002|OLE Period (52-Week)|Physician Decision|0|||
164394657|NCT04162769|593813738|FG003|OLE Period (52-Week)|Physician Decision|1|||
164394658|NCT04162769|593813735|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
164394659|NCT04162769|593813736|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
164394660|NCT04162769|593813737|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
164394661|NCT04162769|593813738|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
164394662|NCT04162769|593813735|FG000|OLE Period (52-Week)|Protocol deviation|0|||
164394663|NCT04162769|593813736|FG001|OLE Period (52-Week)|Protocol deviation|0|||
164394664|NCT04162769|593813737|FG002|OLE Period (52-Week)|Protocol deviation|0|||
164394665|NCT04162769|593813738|FG003|OLE Period (52-Week)|Protocol deviation|2|||
164394666|NCT01733732|593813739|FG000|Overall Study|Adverse Event|1|||
164394667|NCT01733732|593813740|FG001|Overall Study|Adverse Event|0|||
164394668|NCT01733732|593813739|FG000|Overall Study|Did not attend all study visits|1|||
164394669|NCT01733732|593813740|FG001|Overall Study|Did not attend all study visits|0|||
164394670|NCT00464815|593813741|FG000|Overall Study|Withdrawal by Subject|6|||
164394671|NCT00464815|593813742|FG001|Overall Study|Withdrawal by Subject|3|||
164394672|NCT00515502|593813745|FG000|Treatment Period 1|Adverse Event|0|||
164394673|NCT00515502|593813746|FG001|Treatment Period 1|Adverse Event|0|||
164394674|NCT00515502|593813747|FG002|Treatment Period 1|Adverse Event|0|||
164394675|NCT00515502|593813748|FG003|Treatment Period 1|Adverse Event|0|||
164394676|NCT00515502|593813749|FG004|Treatment Period 1|Adverse Event|0|||
164394677|NCT00515502|593813750|FG005|Treatment Period 1|Adverse Event|0|||
164394678|NCT00515502|593813751|FG006|Treatment Period 1|Adverse Event|1|||
164394679|NCT00515502|593813752|FG007|Treatment Period 1|Adverse Event|0|||
164394680|NCT00515502|593813753|FG008|Treatment Period 1|Adverse Event|1|||
164394681|NCT00515502|593813754|FG009|Treatment Period 1|Adverse Event|0|||
164394682|NCT00515502|593813755|FG010|Treatment Period 1|Adverse Event|0|||
164394683|NCT00515502|593813756|FG011|Treatment Period 1|Adverse Event|1|||
164394684|NCT00515502|593813745|FG000|Treatment Period 2|Adverse Event|0|||
164394685|NCT00515502|593813746|FG001|Treatment Period 2|Adverse Event|1|||
164394686|NCT00515502|593813747|FG002|Treatment Period 2|Adverse Event|0|||
164394687|NCT00515502|593813748|FG003|Treatment Period 2|Adverse Event|0|||
164394688|NCT00515502|593813749|FG004|Treatment Period 2|Adverse Event|0|||
164093207|NCT04256421|592703523|FG001|Overall Study|Withdrawal by Subject|10|||
164394689|NCT00515502|593813750|FG005|Treatment Period 2|Adverse Event|0|||
164394690|NCT00515502|593813751|FG006|Treatment Period 2|Adverse Event|0|||
164394691|NCT00515502|593813752|FG007|Treatment Period 2|Adverse Event|0|||
164394692|NCT00515502|593813753|FG008|Treatment Period 2|Adverse Event|0|||
164394693|NCT00515502|593813754|FG009|Treatment Period 2|Adverse Event|0|||
164394694|NCT00515502|593813755|FG010|Treatment Period 2|Adverse Event|0|||
164394695|NCT00515502|593813756|FG011|Treatment Period 2|Adverse Event|0|||
164394696|NCT03252587|593813759|FG000|Overall Study|Adverse Event|3|||
164394697|NCT03252587|593813760|FG001|Overall Study|Adverse Event|8|||
164394698|NCT03252587|593813761|FG002|Overall Study|Adverse Event|6|||
164394699|NCT03252587|593813762|FG003|Overall Study|Adverse Event|12|||
164394700|NCT03252587|593813759|FG000|Overall Study|Lack of Efficacy|7|||
164394701|NCT03252587|593813760|FG001|Overall Study|Lack of Efficacy|2|||
164394702|NCT03252587|593813761|FG002|Overall Study|Lack of Efficacy|2|||
164394703|NCT03252587|593813762|FG003|Overall Study|Lack of Efficacy|4|||
164394704|NCT03252587|593813759|FG000|Overall Study|Lost to Follow-up|2|||
164394705|NCT03252587|593813760|FG001|Overall Study|Lost to Follow-up|0|||
164394706|NCT03252587|593813761|FG002|Overall Study|Lost to Follow-up|0|||
164394707|NCT03252587|593813762|FG003|Overall Study|Lost to Follow-up|2|||
164394708|NCT03252587|593813759|FG000|Overall Study|Pregnancy|2|||
164394709|NCT03252587|593813760|FG001|Overall Study|Pregnancy|1|||
164394710|NCT03252587|593813761|FG002|Overall Study|Pregnancy|0|||
164394711|NCT03252587|593813762|FG003|Overall Study|Pregnancy|1|||
164394712|NCT03252587|593813759|FG000|Overall Study|Withdrawal by Subject|8|||
164394713|NCT03252587|593813760|FG001|Overall Study|Withdrawal by Subject|4|||
164394714|NCT03252587|593813761|FG002|Overall Study|Withdrawal by Subject|4|||
164394715|NCT03252587|593813762|FG003|Overall Study|Withdrawal by Subject|4|||
164394716|NCT03252587|593813759|FG000|Overall Study|Other Reasons|2|||
164093208|NCT04256421|592703522|FG000|Overall Study|Ongoing in Study|66|||
164093209|NCT04256421|592703523|FG001|Overall Study|Ongoing in Study|52|||
164093210|NCT00419770|592705255|FG000|Overall Study|Withdrawal by Subject|5|||
164093211|NCT00419770|592705256|FG001|Overall Study|Withdrawal by Subject|1|||
164093212|NCT02424188|592705264|FG000|Overall Study|Death|2|||
164093213|NCT02424188|592705265|FG001|Overall Study|Death|2|||
164093214|NCT02424188|592705264|FG000|Overall Study|Lost to Follow-up|1|||
164093215|NCT02424188|592705265|FG001|Overall Study|Lost to Follow-up|3|||
164093216|NCT02424188|592705264|FG000|Overall Study|Incarceration|1|||
164093217|NCT02424188|592705265|FG001|Overall Study|Incarceration|0|||
164093218|NCT00453362|592705270|FG000|Overall Study|Adverse Event|5|||
164093219|NCT00453362|592705270|FG000|Overall Study|Death|7|||
164093220|NCT00453362|592705270|FG000|Overall Study|Physician Decision|2|||
164093221|NCT00453362|592705270|FG000|Overall Study|Withdrawal by Subject|3|||
164093222|NCT00453362|592705270|FG000|Overall Study|Progression of disease|56|||
164093223|NCT00453362|592705270|FG000|Overall Study|Screening Failure|14|||
164093224|NCT04885296|592705271|FG000|Period 1|Covid-19 Related|1|||
164093225|NCT04885296|592705272|FG001|Period 1|Covid-19 Related|0|||
164093226|NCT04885296|592705271|FG000|Period 1|Adverse Event|0|||
164093227|NCT04885296|592705272|FG001|Period 1|Adverse Event|1|||
164093228|NCT04885296|592705271|FG000|Period 1|Withdrawal by Subject|1|||
164093229|NCT04885296|592705272|FG001|Period 1|Withdrawal by Subject|1|||
164093230|NCT04885296|592705271|FG000|Period 1|Test Article No Longer Available|1|||
164093231|NCT04885296|592705272|FG001|Period 1|Test Article No Longer Available|0|||
164093232|NCT04885296|592705271|FG000|Period 1|Dispensed Study lens in Error|1|||
164093233|NCT04885296|592705272|FG001|Period 1|Dispensed Study lens in Error|0|||
164093234|NCT04885296|592705271|FG000|Period 1|Lost to Follow-up|1|||
164093235|NCT04885296|592705272|FG001|Period 1|Lost to Follow-up|0|||
164093236|NCT04885296|592705271|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
164093237|NCT04885296|592705272|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
164093238|NCT00433147|592705273|FG000|Overall Study|Adverse Event|0|||
164093239|NCT00433147|592705274|FG001|Overall Study|Adverse Event|1|||
164093240|NCT00433147|592705275|FG002|Overall Study|Adverse Event|0|||
164093241|NCT00433147|592705276|FG003|Overall Study|Adverse Event|0|||
164093242|NCT01124149|592705282|FG000|Acute Phase|Withdrawal by Subject|22|||
164093243|NCT01124149|592705282|FG000|Acute Phase|Adverse Event|21|||
164093244|NCT01124149|592705282|FG000|Acute Phase|Lack of Efficacy|17|||
164093245|NCT01124149|592705282|FG000|Acute Phase|Protocol Violation|14|||
164093246|NCT01124149|592705282|FG000|Acute Phase|Lost to Follow-up|2|||
164093247|NCT01124149|592705282|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
164394717|NCT03252587|593813760|FG001|Overall Study|Other Reasons|5|||
164093248|NCT01124149|592705282|FG000|Acute Phase|Sponsor request|1|||
164093249|NCT01124149|592705282|FG000|Acute Phase|UC symptoms not ameliorated|1|||
164093250|NCT01124149|592705282|FG000|Acute Phase|Non-compliance|1|||
164093251|NCT01124149|592705282|FG000|Acute Phase|Low hemoglobin|1|||
164093252|NCT01124149|592705282|FG000|Acute Phase|Travelling to another country|1|||
164093253|NCT01124149|592705282|FG000|Acute Phase|Sponsor decision|1|||
164093254|NCT01124149|592705282|FG000|Maintenance Phase|Lack of Efficacy|40|||
164093255|NCT01124149|592705282|FG000|Maintenance Phase|Adverse Event|24|||
164093256|NCT01124149|592705282|FG000|Maintenance Phase|Lost to Follow-up|15|||
164093257|NCT01124149|592705282|FG000|Maintenance Phase|Withdrawal by Subject|10|||
164093258|NCT01124149|592705282|FG000|Maintenance Phase|Protocol Violation|5|||
164394718|NCT03252587|593813761|FG002|Overall Study|Other Reasons|5|||
164394719|NCT03252587|593813762|FG003|Overall Study|Other Reasons|4|||
164394720|NCT04052204|593813763|FG000|Overall Study|Death|1|||
164394721|NCT04052204|593813764|FG001|Overall Study|Death|0|||
164394722|NCT04052204|593813765|FG002|Overall Study|Death|0|||
164394723|NCT04052204|593813763|FG000|Overall Study|Progressive disease|1|||
164394724|NCT04052204|593813764|FG001|Overall Study|Progressive disease|0|||
164394725|NCT04052204|593813765|FG002|Overall Study|Progressive disease|0|||
164394726|NCT04052204|593813763|FG000|Overall Study|Other|1|||
164394727|NCT04052204|593813764|FG001|Overall Study|Other|0|||
164394728|NCT04052204|593813765|FG002|Overall Study|Other|0|||
164394729|NCT03647501|593813766|FG000|Overall Study|Lost to Follow-up|1|||
164394730|NCT03647501|593813767|FG001|Overall Study|Lost to Follow-up|1|||
164394731|NCT03647501|593813766|FG000|Overall Study|Withdrawal by Subject|0|||
164394732|NCT03647501|593813767|FG001|Overall Study|Withdrawal by Subject|1|||
164394733|NCT03945188|593813768|FG000|Overall Study|Protocol Violation|1|||
164394734|NCT03945188|593813769|FG001|Overall Study|Protocol Violation|0|||
164394735|NCT03945188|593813768|FG000|Overall Study|Disease worsening|79|||
164394736|NCT03945188|593813769|FG001|Overall Study|Disease worsening|73|||
164394737|NCT03945188|593813768|FG000|Overall Study|Physician Decision|2|||
164394738|NCT03945188|593813769|FG001|Overall Study|Physician Decision|2|||
164394739|NCT03945188|593813768|FG000|Overall Study|Lack of Efficacy|7|||
164394740|NCT03945188|593813769|FG001|Overall Study|Lack of Efficacy|4|||
164394741|NCT03945188|593813768|FG000|Overall Study|Pregnancy|2|||
164394742|NCT03945188|593813769|FG001|Overall Study|Pregnancy|0|||
164394743|NCT03945188|593813768|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
164394744|NCT03945188|593813769|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
163905302|NCT03147287|592023850|FG001|Overall Study|Withdrawal by Subject|3|||
163905303|NCT03147287|592023851|FG002|Overall Study|Withdrawal by Subject|2|||
163905304|NCT03147287|592023849|FG000|Overall Study|Patient Non-Compliance|0|||
163905305|NCT03147287|592023850|FG001|Overall Study|Patient Non-Compliance|2|||
163905306|NCT03147287|592023851|FG002|Overall Study|Patient Non-Compliance|0|||
163905307|NCT03147287|592023849|FG000|Overall Study|Patient moved|0|||
163905308|NCT03147287|592023850|FG001|Overall Study|Patient moved|1|||
163905309|NCT03147287|592023851|FG002|Overall Study|Patient moved|0|||
163905310|NCT03147287|592023849|FG000|Overall Study|Arm A crossover without PD|1|||
163905311|NCT03147287|592023850|FG001|Overall Study|Arm A crossover without PD|0|||
163905312|NCT03147287|592023851|FG002|Overall Study|Arm A crossover without PD|0|||
163905313|NCT03147287|592023849|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
163905314|NCT03147287|592023850|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
163905315|NCT03147287|592023851|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
163905316|NCT00302211|592023852|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
163905317|NCT00302211|592023853|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
163905318|NCT00302211|592023854|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
163905319|NCT00302211|592023855|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
163905320|NCT00302211|592023856|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
163905321|NCT00302211|592023852|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
163905322|NCT00302211|592023853|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
163905323|NCT00302211|592023854|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
163905324|NCT00302211|592023855|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
163905325|NCT00302211|592023856|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
163905326|NCT00302211|592023852|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
163905327|NCT00302211|592023853|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
163905328|NCT00302211|592023854|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
163905329|NCT00302211|592023855|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
163905330|NCT00302211|592023856|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
163905331|NCT00302211|592023852|FG000|Double Blind Period (New Patients)|Disease progression|0|||
163905332|NCT00302211|592023853|FG001|Double Blind Period (New Patients)|Disease progression|1|||
163905333|NCT00302211|592023854|FG002|Double Blind Period (New Patients)|Disease progression|1|||
163905334|NCT00302211|592023855|FG003|Double Blind Period (New Patients)|Disease progression|0|||
163905335|NCT00302211|592023856|FG004|Double Blind Period (New Patients)|Disease progression|0|||
163905336|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
163905337|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
163905338|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
163905339|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
163905340|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
163905341|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
163905342|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
164016303|NCT01937130|592423850|FG000|Overall Study|Lost to Follow-up|2|||
164394745|NCT03945188|593813768|FG000|Overall Study|Adverse Event|10|||
164394746|NCT03945188|593813769|FG001|Overall Study|Adverse Event|5|||
164394747|NCT03945188|593813768|FG000|Overall Study|Other|2|||
164394748|NCT03945188|593813769|FG001|Overall Study|Other|2|||
164394749|NCT03945188|593813768|FG000|Overall Study|Lost to Follow-up|1|||
164394750|NCT03945188|593813769|FG001|Overall Study|Lost to Follow-up|2|||
164394751|NCT01613248|593813770|FG000|Overall Study|Adverse Event|0|||
164394752|NCT01613248|593813771|FG001|Overall Study|Adverse Event|0|||
164394753|NCT01613248|593813772|FG002|Overall Study|Adverse Event|0|||
164394754|NCT01613248|593813773|FG003|Overall Study|Adverse Event|1|||
164394755|NCT01613248|593813774|FG004|Overall Study|Adverse Event|0|||
164394756|NCT01613248|593813775|FG005|Overall Study|Adverse Event|0|||
164394757|NCT01613248|593813770|FG000|Overall Study|Withdrawal by Subject|3|||
164394758|NCT01613248|593813771|FG001|Overall Study|Withdrawal by Subject|2|||
164394759|NCT01613248|593813772|FG002|Overall Study|Withdrawal by Subject|2|||
164394760|NCT01613248|593813773|FG003|Overall Study|Withdrawal by Subject|5|||
164394761|NCT01613248|593813774|FG004|Overall Study|Withdrawal by Subject|0|||
164394762|NCT01613248|593813775|FG005|Overall Study|Withdrawal by Subject|1|||
164394763|NCT01613248|593813770|FG000|Overall Study|Lost to Follow-up|5|||
164394764|NCT01613248|593813771|FG001|Overall Study|Lost to Follow-up|7|||
164394765|NCT01613248|593813772|FG002|Overall Study|Lost to Follow-up|4|||
164394766|NCT01613248|593813773|FG003|Overall Study|Lost to Follow-up|8|||
164394767|NCT01613248|593813774|FG004|Overall Study|Lost to Follow-up|4|||
164394768|NCT01613248|593813775|FG005|Overall Study|Lost to Follow-up|2|||
164394769|NCT01613248|593813770|FG000|Overall Study|Study Terminated by Sponsor|4|||
164394770|NCT01613248|593813771|FG001|Overall Study|Study Terminated by Sponsor|6|||
164394771|NCT01613248|593813772|FG002|Overall Study|Study Terminated by Sponsor|8|||
164394772|NCT01613248|593813773|FG003|Overall Study|Study Terminated by Sponsor|8|||
164394773|NCT01613248|593813774|FG004|Overall Study|Study Terminated by Sponsor|9|||
164394774|NCT01613248|593813775|FG005|Overall Study|Study Terminated by Sponsor|11|||
164394775|NCT01613248|593813770|FG000|Overall Study|Physician Decision|8|||
164394776|NCT01613248|593813771|FG001|Overall Study|Physician Decision|8|||
164394777|NCT01613248|593813772|FG002|Overall Study|Physician Decision|9|||
164394778|NCT01613248|593813773|FG003|Overall Study|Physician Decision|4|||
164394779|NCT01613248|593813774|FG004|Overall Study|Physician Decision|7|||
164394780|NCT01613248|593813775|FG005|Overall Study|Physician Decision|6|||
164394781|NCT01613248|593813770|FG000|Overall Study|Lack of Qualifying Event|9|||
164394782|NCT01613248|593813771|FG001|Overall Study|Lack of Qualifying Event|11|||
164394783|NCT01613248|593813772|FG002|Overall Study|Lack of Qualifying Event|10|||
164016304|NCT01937130|592423851|FG001|Overall Study|Lost to Follow-up|0|||
164016305|NCT01937130|592423852|FG002|Overall Study|Lost to Follow-up|2|||
164394784|NCT01613248|593813773|FG003|Overall Study|Lack of Qualifying Event|11|||
164394785|NCT01613248|593813774|FG004|Overall Study|Lack of Qualifying Event|15|||
164394786|NCT01613248|593813775|FG005|Overall Study|Lack of Qualifying Event|18|||
164394787|NCT01613248|593813770|FG000|Overall Study|Pregnancy|0|||
164394788|NCT01613248|593813771|FG001|Overall Study|Pregnancy|0|||
164394789|NCT01613248|593813772|FG002|Overall Study|Pregnancy|0|||
164394790|NCT01613248|593813773|FG003|Overall Study|Pregnancy|1|||
164394791|NCT01613248|593813774|FG004|Overall Study|Pregnancy|0|||
164394792|NCT01613248|593813775|FG005|Overall Study|Pregnancy|0|||
164394793|NCT01433354|593813777|FG000|Overall Study|Adverse Event|6|||
164394794|NCT01433354|593813777|FG000|Overall Study|Lost to Follow-up|1|||
164394795|NCT01433354|593813777|FG000|Overall Study|Administrative problems|90|||
164394796|NCT01433354|593813777|FG000|Overall Study|Protocol Violation|2|||
164394797|NCT01433354|593813777|FG000|Overall Study|Lack of Efficacy|17|||
164394798|NCT01433354|593813777|FG000|Overall Study|Subject Withdrew Consent|3|||
164394799|NCT04794803|593813786|FG000|Overall Study|Death|1|||
164394800|NCT04794803|593813787|FG001|Overall Study|Death|3|||
164394801|NCT04794803|593813786|FG000|Overall Study|Lost to Follow-up|2|||
163905343|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
164016306|NCT01937130|592423853|FG003|Overall Study|Lost to Follow-up|0|||
164016307|NCT01937130|592423850|FG000|Overall Study|Physician Decision|0|||
164016308|NCT01937130|592423851|FG001|Overall Study|Physician Decision|1|||
164016309|NCT01937130|592423852|FG002|Overall Study|Physician Decision|0|||
164016310|NCT01937130|592423853|FG003|Overall Study|Physician Decision|0|||
164016311|NCT01937130|592423850|FG000|Overall Study|Patients unable to swallow|0|||
164016312|NCT01937130|592423851|FG001|Overall Study|Patients unable to swallow|1|||
164016313|NCT01937130|592423852|FG002|Overall Study|Patients unable to swallow|0|||
164394802|NCT04794803|593813787|FG001|Overall Study|Lost to Follow-up|2|||
164394803|NCT04794803|593813786|FG000|Overall Study|Withdrawal by Subject|1|||
164394804|NCT04794803|593813787|FG001|Overall Study|Withdrawal by Subject|0|||
164394805|NCT04794803|593813786|FG000|Overall Study|Physician Decision|1|||
164394806|NCT04794803|593813787|FG001|Overall Study|Physician Decision|1|||
164394807|NCT04794803|593813786|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
164394808|NCT04794803|593813787|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
163905344|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
163905345|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
163905346|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163905347|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163905348|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163905349|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
164016314|NCT01937130|592423853|FG003|Overall Study|Patients unable to swallow|0|||
164394809|NCT04794803|593813786|FG000|Overall Study|Refused to continue the treatment|1|||
164394810|NCT04794803|593813787|FG001|Overall Study|Refused to continue the treatment|0|||
164394811|NCT04794803|593813786|FG000|Overall Study|Patient admitted to ICU|0|||
164093259|NCT01124149|592705282|FG000|Maintenance Phase|Coordinator error|1|||
164093260|NCT01124149|592705282|FG000|Maintenance Phase|Non-compliance|1|||
164093261|NCT01644500|592705283|FG000|Overall Study|Adverse Event|6|||
164093262|NCT01644500|592705284|FG001|Overall Study|Adverse Event|1|||
164093263|NCT01644500|592705285|FG002|Overall Study|Adverse Event|2|||
164093264|NCT01644500|592705283|FG000|Overall Study|Death|0|||
164093265|NCT01644500|592705284|FG001|Overall Study|Death|1|||
164093266|NCT01644500|592705285|FG002|Overall Study|Death|0|||
164093267|NCT01644500|592705283|FG000|Overall Study|Lost to Follow-up|3|||
164093268|NCT01644500|592705284|FG001|Overall Study|Lost to Follow-up|8|||
164093269|NCT01644500|592705285|FG002|Overall Study|Lost to Follow-up|0|||
164093270|NCT01644500|592705283|FG000|Overall Study|Protocol Violation|1|||
164093271|NCT01644500|592705284|FG001|Overall Study|Protocol Violation|1|||
164093272|NCT01644500|592705285|FG002|Overall Study|Protocol Violation|0|||
164093273|NCT01644500|592705283|FG000|Overall Study|Withdrawal by Subject|11|||
164093274|NCT01644500|592705284|FG001|Overall Study|Withdrawal by Subject|12|||
164093275|NCT01644500|592705285|FG002|Overall Study|Withdrawal by Subject|12|||
164093276|NCT01644500|592705283|FG000|Overall Study|Physician Decision|1|||
164093277|NCT01644500|592705284|FG001|Overall Study|Physician Decision|1|||
164093278|NCT01644500|592705285|FG002|Overall Study|Physician Decision|1|||
164093279|NCT00001849|592705288|FG000|Overall Study|Death|4|||
164093280|NCT00001849|592705288|FG000|Overall Study|Lost to Follow-up|2|||
164093281|NCT00001849|592705288|FG000|Overall Study|Withdrawal by Subject|2|||
164093282|NCT00001849|592705288|FG000|Overall Study|tumor remained occult|6|||
164093283|NCT05518487|592705289|FG000|Overall Study|Withdrawal by Subject|3|||
164093284|NCT00543309|592705290|FG000|Overall Study|Physician Decision|0|||
164093285|NCT00543309|592705291|FG001|Overall Study|Physician Decision|1|||
164093286|NCT00543309|592705292|FG002|Overall Study|Physician Decision|0|||
164093287|NCT02194998|592705297|FG000|On-HCV Treatment|Did not pick up study medication|0|||
164093288|NCT02194998|592705298|FG001|On-HCV Treatment|Did not pick up study medication|1|||
164093289|NCT02194998|592705299|FG002|On-HCV Treatment|Did not pick up study medication|0|||
164093290|NCT02194998|592705300|FG003|On-HCV Treatment|Did not pick up study medication|0|||
164093291|NCT02194998|592705297|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
164093292|NCT02194998|592705298|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
164093293|NCT02194998|592705299|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
164093294|NCT02194998|592705300|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
164093295|NCT01400113|592705301|FG000|Overall Study|Withdrawal by Subject|1|||
164093296|NCT01400113|592705302|FG001|Overall Study|Withdrawal by Subject|1|||
164093297|NCT00282256|592705303|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
164093298|NCT00282256|592705303|FG000|Extension Treatment Period|Adverse Event|2|||
164093299|NCT02636907|592705308|FG000|Autoinjector Assessment Period|Adverse Event|2|||
164394812|NCT04794803|593813787|FG001|Overall Study|Patient admitted to ICU|1|||
164394813|NCT04124926|593813792|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
164394814|NCT04124926|593813793|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
164394815|NCT04124926|593813794|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
164394816|NCT04124926|593813795|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
164394817|NCT04124926|593813796|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
164394818|NCT04124926|593813792|FG000|Healing Phase|Protocol Violation|0|||
164394819|NCT04124926|593813793|FG001|Healing Phase|Protocol Violation|1|||
163905350|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
163905351|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
163905352|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
164093300|NCT02636907|592705308|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
164093301|NCT02636907|592705308|FG000|Extension Phase|Adverse Event|2|||
164093302|NCT02636907|592705308|FG000|Extension Phase|Withdrawal by Subject|4|||
164093303|NCT02636907|592705308|FG000|Extension Phase|Physician Decision|1|||
164093304|NCT02636907|592705308|FG000|Extension Phase|Lost to Follow-up|2|||
164093305|NCT02636907|592705308|FG000|Extension Phase|Lack of Efficacy|1|||
164093306|NCT00762086|592705309|FG000|Overall Study|Adverse Event|2|||
164093307|NCT00762086|592705310|FG001|Overall Study|Adverse Event|0|||
164093308|NCT00762086|592705309|FG000|Overall Study|Lost to Follow-up|0|||
164093309|NCT00762086|592705310|FG001|Overall Study|Lost to Follow-up|2|||
164394820|NCT04124926|593813794|FG002|Healing Phase|Protocol Violation|0|||
164394821|NCT04124926|593813795|FG003|Healing Phase|Protocol Violation|0|||
164394822|NCT04124926|593813796|FG004|Healing Phase|Protocol Violation|0|||
164394823|NCT04124926|593813792|FG000|Healing Phase|Lost to Follow-up|5|||
164394824|NCT04124926|593813793|FG001|Healing Phase|Lost to Follow-up|4|||
164394825|NCT04124926|593813794|FG002|Healing Phase|Lost to Follow-up|0|||
164394826|NCT04124926|593813795|FG003|Healing Phase|Lost to Follow-up|0|||
164394827|NCT04124926|593813796|FG004|Healing Phase|Lost to Follow-up|0|||
164394828|NCT04124926|593813792|FG000|Healing Phase|Voluntary Withdrawal|10|||
164394829|NCT04124926|593813793|FG001|Healing Phase|Voluntary Withdrawal|7|||
164394830|NCT04124926|593813794|FG002|Healing Phase|Voluntary Withdrawal|0|||
164394831|NCT04124926|593813795|FG003|Healing Phase|Voluntary Withdrawal|0|||
164394832|NCT04124926|593813796|FG004|Healing Phase|Voluntary Withdrawal|0|||
164394833|NCT04124926|593813792|FG000|Healing Phase|Withdrawal of Consent|5|||
164394834|NCT04124926|593813793|FG001|Healing Phase|Withdrawal of Consent|3|||
164394835|NCT04124926|593813794|FG002|Healing Phase|Withdrawal of Consent|0|||
164394836|NCT04124926|593813795|FG003|Healing Phase|Withdrawal of Consent|0|||
164394837|NCT04124926|593813796|FG004|Healing Phase|Withdrawal of Consent|0|||
164394838|NCT04124926|593813792|FG000|Healing Phase|Miscellaneous|8|||
164394839|NCT04124926|593813793|FG001|Healing Phase|Miscellaneous|7|||
164394840|NCT04124926|593813794|FG002|Healing Phase|Miscellaneous|0|||
164394841|NCT04124926|593813795|FG003|Healing Phase|Miscellaneous|0|||
164394842|NCT04124926|593813796|FG004|Healing Phase|Miscellaneous|0|||
164394843|NCT04124926|593813792|FG000|Healing Phase|Randomized but not Treated|0|||
164394844|NCT04124926|593813793|FG001|Healing Phase|Randomized but not Treated|3|||
164394845|NCT04124926|593813794|FG002|Healing Phase|Randomized but not Treated|0|||
164394846|NCT04124926|593813795|FG003|Healing Phase|Randomized but not Treated|0|||
164394847|NCT04124926|593813796|FG004|Healing Phase|Randomized but not Treated|0|||
164394848|NCT04124926|593813792|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
164394849|NCT04124926|593813793|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
164394850|NCT04124926|593813794|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
164394851|NCT04124926|593813795|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
164394852|NCT04124926|593813796|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
164394853|NCT04124926|593813792|FG000|Maintenance Phase|Protocol Violation|0|||
164394854|NCT04124926|593813793|FG001|Maintenance Phase|Protocol Violation|0|||
164394855|NCT04124926|593813794|FG002|Maintenance Phase|Protocol Violation|3|||
164394856|NCT04124926|593813795|FG003|Maintenance Phase|Protocol Violation|0|||
164016315|NCT01937130|592423850|FG000|Overall Study|Patient lost to FU due to death|2|||
164016316|NCT01937130|592423851|FG001|Overall Study|Patient lost to FU due to death|0|||
164016317|NCT01937130|592423852|FG002|Overall Study|Patient lost to FU due to death|0|||
164016318|NCT01937130|592423853|FG003|Overall Study|Patient lost to FU due to death|0|||
164016319|NCT01431144|592423854|FG000|Overall Study|Implant mobility and removal|2|||
164016320|NCT01431144|592423855|FG001|Overall Study|Implant mobility and removal|0|||
164016321|NCT01104558|592423856|FG000|Overall Study|Protocol Violation|6|||
164016322|NCT01104558|592423856|FG000|Overall Study|Missing of primary efficacy assessment|10|||
164016323|NCT01104558|592423856|FG000|Overall Study|Missing of genetic analysis results|1|||
164016324|NCT00696657|592423857|FG000|Overall Study|Protocol Violation|0|||
164016325|NCT00696657|592423858|FG001|Overall Study|Protocol Violation|0|||
164016326|NCT00696657|592423859|FG002|Overall Study|Protocol Violation|0|||
164016327|NCT00696657|592423860|FG003|Overall Study|Protocol Violation|0|||
164016328|NCT00696657|592423861|FG004|Overall Study|Protocol Violation|0|||
164016329|NCT00696657|592423862|FG005|Overall Study|Protocol Violation|1|||
164016330|NCT00696657|592423863|FG006|Overall Study|Protocol Violation|0|||
164016331|NCT00696657|592423864|FG007|Overall Study|Protocol Violation|0|||
164016332|NCT00696657|592423865|FG008|Overall Study|Protocol Violation|1|||
164016333|NCT00696657|592423857|FG000|Overall Study|Lack of Efficacy|0|||
164016334|NCT00696657|592423858|FG001|Overall Study|Lack of Efficacy|1|||
164016335|NCT00696657|592423859|FG002|Overall Study|Lack of Efficacy|0|||
164016336|NCT00696657|592423860|FG003|Overall Study|Lack of Efficacy|0|||
164016337|NCT00696657|592423861|FG004|Overall Study|Lack of Efficacy|0|||
164016338|NCT00696657|592423862|FG005|Overall Study|Lack of Efficacy|0|||
164016339|NCT00696657|592423863|FG006|Overall Study|Lack of Efficacy|0|||
164016340|NCT00696657|592423864|FG007|Overall Study|Lack of Efficacy|0|||
164016341|NCT00696657|592423865|FG008|Overall Study|Lack of Efficacy|0|||
164016342|NCT00696657|592423857|FG000|Overall Study|Withdrawal criteria|1|||
164016343|NCT00696657|592423858|FG001|Overall Study|Withdrawal criteria|3|||
164016344|NCT00696657|592423859|FG002|Overall Study|Withdrawal criteria|2|||
164016345|NCT00696657|592423860|FG003|Overall Study|Withdrawal criteria|2|||
164016346|NCT00696657|592423861|FG004|Overall Study|Withdrawal criteria|0|||
164016347|NCT00696657|592423862|FG005|Overall Study|Withdrawal criteria|0|||
164016348|NCT00696657|592423863|FG006|Overall Study|Withdrawal criteria|1|||
164016349|NCT00696657|592423864|FG007|Overall Study|Withdrawal criteria|1|||
164016350|NCT00696657|592423865|FG008|Overall Study|Withdrawal criteria|2|||
164016351|NCT00696657|592423857|FG000|Overall Study|Unclassified|0|||
164016352|NCT00696657|592423858|FG001|Overall Study|Unclassified|1|||
164016353|NCT00696657|592423859|FG002|Overall Study|Unclassified|3|||
164016354|NCT00696657|592423860|FG003|Overall Study|Unclassified|2|||
164394857|NCT04124926|593813796|FG004|Maintenance Phase|Protocol Violation|0|||
164394858|NCT04124926|593813792|FG000|Maintenance Phase|Lost to Follow-up|0|||
164394859|NCT04124926|593813793|FG001|Maintenance Phase|Lost to Follow-up|0|||
164394860|NCT04124926|593813794|FG002|Maintenance Phase|Lost to Follow-up|7|||
164394861|NCT04124926|593813795|FG003|Maintenance Phase|Lost to Follow-up|8|||
164394862|NCT04124926|593813796|FG004|Maintenance Phase|Lost to Follow-up|9|||
164394863|NCT04124926|593813792|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
164394864|NCT04124926|593813793|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
164394865|NCT04124926|593813794|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
164394866|NCT04124926|593813795|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
164394867|NCT04124926|593813796|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
164394868|NCT04124926|593813792|FG000|Maintenance Phase|Pregnancy|0|||
164394869|NCT04124926|593813793|FG001|Maintenance Phase|Pregnancy|0|||
164394870|NCT04124926|593813794|FG002|Maintenance Phase|Pregnancy|0|||
164394871|NCT04124926|593813795|FG003|Maintenance Phase|Pregnancy|1|||
164394872|NCT04124926|593813796|FG004|Maintenance Phase|Pregnancy|0|||
164394873|NCT04124926|593813792|FG000|Maintenance Phase|Lack of Efficacy|0|||
164394874|NCT04124926|593813793|FG001|Maintenance Phase|Lack of Efficacy|0|||
164394875|NCT04124926|593813794|FG002|Maintenance Phase|Lack of Efficacy|0|||
164394876|NCT04124926|593813795|FG003|Maintenance Phase|Lack of Efficacy|0|||
164394877|NCT04124926|593813796|FG004|Maintenance Phase|Lack of Efficacy|1|||
164394878|NCT04124926|593813792|FG000|Maintenance Phase|Withdrawal of Consent|0|||
164394879|NCT04124926|593813793|FG001|Maintenance Phase|Withdrawal of Consent|0|||
164394880|NCT04124926|593813794|FG002|Maintenance Phase|Withdrawal of Consent|5|||
164394881|NCT04124926|593813795|FG003|Maintenance Phase|Withdrawal of Consent|5|||
164394882|NCT04124926|593813796|FG004|Maintenance Phase|Withdrawal of Consent|5|||
163905353|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
163905354|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
163905355|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
163905356|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Death|0|||
163905357|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Death|0|||
163905358|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Death|0|||
163905359|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Death|1|||
163905360|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Death|1|||
164016355|NCT00696657|592423861|FG004|Overall Study|Unclassified|4|||
164016356|NCT00696657|592423862|FG005|Overall Study|Unclassified|2|||
164016357|NCT00696657|592423863|FG006|Overall Study|Unclassified|0|||
164016358|NCT00696657|592423864|FG007|Overall Study|Unclassified|0|||
164016359|NCT00696657|592423865|FG008|Overall Study|Unclassified|1|||
164016360|NCT00696657|592423857|FG000|Overall Study|Adverse Event|0|||
164016361|NCT00696657|592423858|FG001|Overall Study|Adverse Event|0|||
164016362|NCT00696657|592423859|FG002|Overall Study|Adverse Event|3|||
164016363|NCT00696657|592423860|FG003|Overall Study|Adverse Event|7|||
164016364|NCT00696657|592423861|FG004|Overall Study|Adverse Event|6|||
164016365|NCT00696657|592423862|FG005|Overall Study|Adverse Event|9|||
164016366|NCT00696657|592423863|FG006|Overall Study|Adverse Event|14|||
164016367|NCT00696657|592423864|FG007|Overall Study|Adverse Event|2|||
164016368|NCT00696657|592423865|FG008|Overall Study|Adverse Event|5|||
164016369|NCT00523341|592423867|FG000|Overall Study|Withdrawal by Subject|399|||
164016370|NCT00523341|592423868|FG001|Overall Study|Withdrawal by Subject|427|||
164394883|NCT04124926|593813792|FG000|Maintenance Phase|Miscellaneous|0|||
164394884|NCT04124926|593813793|FG001|Maintenance Phase|Miscellaneous|0|||
164394885|NCT04124926|593813794|FG002|Maintenance Phase|Miscellaneous|1|||
164394886|NCT04124926|593813795|FG003|Maintenance Phase|Miscellaneous|2|||
164394887|NCT04124926|593813796|FG004|Maintenance Phase|Miscellaneous|4|||
164394888|NCT04124926|593813792|FG000|Maintenance Phase|Randomized but not Treated|0|||
164394889|NCT04124926|593813793|FG001|Maintenance Phase|Randomized but not Treated|0|||
164394890|NCT04124926|593813794|FG002|Maintenance Phase|Randomized but not Treated|2|||
164394891|NCT04124926|593813795|FG003|Maintenance Phase|Randomized but not Treated|2|||
164394892|NCT04124926|593813796|FG004|Maintenance Phase|Randomized but not Treated|0|||
164394893|NCT03280121|593813803|FG000|Overall Study|Physician Decision|1|||
164394894|NCT03280121|593813803|FG000|Overall Study|Lost to Follow-up|1|||
164394895|NCT03280121|593813803|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
164394896|NCT01324271|593813816|FG000|Overall Study|Lost to Follow-up|3|||
164394897|NCT01324271|593813817|FG001|Overall Study|Lost to Follow-up|0|||
164394898|NCT01324271|593813816|FG000|Overall Study|Physician Decision|1|||
164394899|NCT01324271|593813817|FG001|Overall Study|Physician Decision|0|||
164394900|NCT06116591|593813818|FG000|Overall Study|No longer met eligibility criteria|0|||
164394901|NCT06116591|593813819|FG001|Overall Study|No longer met eligibility criteria|1|||
164394902|NCT06116591|593813818|FG000|Overall Study|Other: Change in life situation|0|||
164394903|NCT06116591|593813819|FG001|Overall Study|Other: Change in life situation|1|||
164394904|NCT05585307|593813820|FG000|Overall Study|Lost to Follow-up|0|||
164394905|NCT05585307|593813821|FG001|Overall Study|Lost to Follow-up|0|||
164394906|NCT05585307|593813822|FG002|Overall Study|Lost to Follow-up|0|||
164394907|NCT05585307|593813823|FG003|Overall Study|Lost to Follow-up|0|||
164394908|NCT05585307|593813824|FG004|Overall Study|Lost to Follow-up|0|||
164394909|NCT05585307|593813825|FG005|Overall Study|Lost to Follow-up|0|||
164394910|NCT05585307|593813826|FG006|Overall Study|Lost to Follow-up|1|||
164394911|NCT05585307|593813827|FG007|Overall Study|Lost to Follow-up|0|||
164394912|NCT04009291|593813828|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394913|NCT04009291|593813829|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394914|NCT04009291|593813830|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394915|NCT04009291|593813831|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
164394916|NCT04009291|593813832|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
164394917|NCT04009291|593813828|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394918|NCT04009291|593813829|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394919|NCT04009291|593813830|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394920|NCT04009291|593813831|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
164394921|NCT04009291|593813832|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
164093310|NCT00762086|592705309|FG000|Overall Study|Non compliance|1|||
164093311|NCT00762086|592705310|FG001|Overall Study|Non compliance|0|||
164093312|NCT00762086|592705309|FG000|Overall Study|Withdrawal by Subject|2|||
164093313|NCT00762086|592705310|FG001|Overall Study|Withdrawal by Subject|2|||
164093314|NCT00762086|592705309|FG000|Overall Study|Ineligible to participate in the study|1|||
164093315|NCT00762086|592705310|FG001|Overall Study|Ineligible to participate in the study|0|||
164093316|NCT01074554|592705316|FG000|Overall Study|Adverse Event|3|||
164093317|NCT01074554|592705317|FG001|Overall Study|Adverse Event|3|||
164394922|NCT00492284|593813835|FG000|Overall Study|Adverse Event|0|||
164394923|NCT00492284|593813836|FG001|Overall Study|Adverse Event|1|||
164394924|NCT00492284|593813837|FG002|Overall Study|Adverse Event|1|||
164394925|NCT00492284|593813838|FG003|Overall Study|Adverse Event|2|||
164394926|NCT00492284|593813835|FG000|Overall Study|Lost to Follow-up|0|||
164394927|NCT00492284|593813836|FG001|Overall Study|Lost to Follow-up|0|||
164394928|NCT00492284|593813837|FG002|Overall Study|Lost to Follow-up|3|||
164394929|NCT00492284|593813838|FG003|Overall Study|Lost to Follow-up|1|||
164394930|NCT00492284|593813835|FG000|Overall Study|Death|0|||
164394931|NCT00492284|593813836|FG001|Overall Study|Death|3|||
164394932|NCT00492284|593813837|FG002|Overall Study|Death|2|||
164394933|NCT00492284|593813838|FG003|Overall Study|Death|5|||
164394934|NCT00492284|593813835|FG000|Overall Study|Withdrawal by Subject|1|||
164394935|NCT00492284|593813836|FG001|Overall Study|Withdrawal by Subject|0|||
164394936|NCT00492284|593813837|FG002|Overall Study|Withdrawal by Subject|0|||
164394937|NCT00492284|593813838|FG003|Overall Study|Withdrawal by Subject|2|||
164394938|NCT02734212|593813839|FG000|Overall Study|Lost to Follow-up|5|||
164394939|NCT02734212|593813840|FG001|Overall Study|Lost to Follow-up|10|||
164394940|NCT00700401|593813851|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
164394941|NCT00700401|593813851|FG000|Overall Study|Adverse Event|5|||
164394942|NCT00700401|593813851|FG000|Overall Study|Refused Treatment|2|||
164394943|NCT00700401|593813851|FG000|Overall Study|Lost to Follow-up|1|||
164394944|NCT00700401|593813851|FG000|Overall Study|Treatment never started|1|||
164394945|NCT00700401|593813851|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
164394946|NCT00700401|593813851|FG000|Overall Study|Withdrawal by Subject|2|||
164394947|NCT02491671|593813852|FG000|Overall Study|Adverse Event|6|||
164394948|NCT02491671|593813853|FG001|Overall Study|Adverse Event|8|||
164394949|NCT02491671|593813852|FG000|Overall Study|Death|0|||
164394950|NCT02491671|593813853|FG001|Overall Study|Death|2|||
164394951|NCT02491671|593813852|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
164394952|NCT02491671|593813853|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
164394953|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
164394954|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
164394955|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
164394956|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
164394957|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
164394958|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
164394959|NCT02251990|593813857|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
164394960|NCT02251990|593813858|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
164394961|NCT02251990|593813857|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
164394962|NCT02251990|593813858|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
164394963|NCT02251990|593813857|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
164394964|NCT02251990|593813858|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
164394965|NCT02293538|593813859|FG000|Overall Study|Adverse Event|0|||
164394966|NCT02293538|593813860|FG001|Overall Study|Adverse Event|1|||
164394967|NCT02293538|593813859|FG000|Overall Study|Lost to Follow-up|1|||
164394968|NCT02293538|593813860|FG001|Overall Study|Lost to Follow-up|0|||
164093318|NCT01074554|592705316|FG000|Overall Study|Lost to Follow-up|0|||
164093319|NCT01074554|592705317|FG001|Overall Study|Lost to Follow-up|1|||
164394969|NCT02293538|593813859|FG000|Overall Study|Withdrawal by Subject|0|||
164093320|NCT00497796|592705318|FG000|Overall Study|Adverse event (not related)|9|||
164093321|NCT00497796|592705319|FG001|Overall Study|Adverse event (not related)|9|||
164093322|NCT00497796|592705318|FG000|Overall Study|Adverse event (related)|5|||
164394970|NCT02293538|593813860|FG001|Overall Study|Withdrawal by Subject|1|||
164394971|NCT00322348|593813861|FG000|Overall Study|Adverse Event|0|||
164394972|NCT00322348|593813862|FG001|Overall Study|Adverse Event|1|||
164394973|NCT00322348|593813861|FG000|Overall Study|Withdrawal by Subject|1|||
164394974|NCT00322348|593813862|FG001|Overall Study|Withdrawal by Subject|4|||
164394975|NCT00322348|593813861|FG000|Overall Study|Lost to Follow-up|1|||
164394976|NCT00322348|593813862|FG001|Overall Study|Lost to Follow-up|0|||
164394977|NCT00322348|593813861|FG000|Overall Study|Death|0|||
164394978|NCT00322348|593813862|FG001|Overall Study|Death|2|||
164394979|NCT00322348|593813861|FG000|Overall Study|Disease Progression|30|||
164394980|NCT00322348|593813862|FG001|Overall Study|Disease Progression|25|||
164394981|NCT00322348|593813861|FG000|Overall Study|Reasons not specified|5|||
164394982|NCT00322348|593813862|FG001|Overall Study|Reasons not specified|1|||
164394983|NCT01041638|593813864|FG000|Overall Study|Adverse Event|4|||
164394984|NCT01041638|593813864|FG000|Overall Study|Death|1|||
164394985|NCT01041638|593813864|FG000|Overall Study|Lack of Efficacy|7|||
164394986|NCT01041638|593813864|FG000|Overall Study|Physician Decision|4|||
164394987|NCT01041638|593813864|FG000|Overall Study|Withdrawal by Subject|11|||
164394988|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
164394989|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
164394990|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
164394991|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
164016371|NCT00523341|592423867|FG000|Overall Study|Other|181|||
164016372|NCT00523341|592423868|FG001|Overall Study|Other|198|||
164394992|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
164394993|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164394994|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
164394995|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164394996|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164394997|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
164394998|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
164394999|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
164395000|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
164395001|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
164395002|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
164395003|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395004|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395005|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164093323|NCT00497796|592705319|FG001|Overall Study|Adverse event (related)|4|||
164093324|NCT00497796|592705318|FG000|Overall Study|CMV infection or disease treatment|30|||
164093325|NCT00497796|592705319|FG001|Overall Study|CMV infection or disease treatment|4|||
164093326|NCT00497796|592705318|FG000|Overall Study|Consent withdrawn|10|||
164395006|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395007|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164395008|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395009|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395010|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
164395011|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395012|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
164395013|NCT03152552|593813865|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164395014|NCT03152552|593813866|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
163905361|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163905362|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163905363|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163905364|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
163905365|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
163905366|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163905367|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163905368|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163905369|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
163905370|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
163905371|NCT00302211|592023852|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163905372|NCT00302211|592023853|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163905373|NCT00302211|592023854|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163905374|NCT00302211|592023855|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
163905375|NCT00302211|592023856|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
163905376|NCT03137459|592025778|FG000|2-month Assessment|Withdrawal by Subject|13|||
163905377|NCT03137459|592025779|FG001|2-month Assessment|Withdrawal by Subject|3|||
163905378|NCT03137459|592025778|FG000|2-month Assessment|Unable to reach|42|||
163905379|NCT03137459|592025779|FG001|2-month Assessment|Unable to reach|32|||
163905380|NCT03137459|592025778|FG000|2-month Assessment|Refused assessment|7|||
163905381|NCT03137459|592025779|FG001|2-month Assessment|Refused assessment|5|||
163905382|NCT03137459|592025778|FG000|2-month Assessment|Acutely ill|6|||
163905383|NCT03137459|592025779|FG001|2-month Assessment|Acutely ill|2|||
163905384|NCT03137459|592025778|FG000|4-month Assessment|Death|4|||
163905385|NCT03137459|592025779|FG001|4-month Assessment|Death|2|||
163905386|NCT03137459|592025778|FG000|4-month Assessment|Withdrawal by Subject|4|||
163905387|NCT03137459|592025779|FG001|4-month Assessment|Withdrawal by Subject|2|||
163905388|NCT03137459|592025778|FG000|4-month Assessment|Unable to reach|44|||
163905389|NCT03137459|592025779|FG001|4-month Assessment|Unable to reach|29|||
163905390|NCT03137459|592025778|FG000|4-month Assessment|Refused assessment|24|||
163905391|NCT03137459|592025779|FG001|4-month Assessment|Refused assessment|10|||
163905392|NCT03137459|592025778|FG000|4-month Assessment|Acutely ill|2|||
163905393|NCT03137459|592025779|FG001|4-month Assessment|Acutely ill|3|||
163905394|NCT03137459|592025778|FG000|6-months|Lost to Follow-up|14|||
163905395|NCT03137459|592025779|FG001|6-months|Lost to Follow-up|11|||
163905396|NCT03137459|592025778|FG000|6-months|Death|0|||
163905397|NCT03137459|592025779|FG001|6-months|Death|2|||
163905398|NCT03137459|592025778|FG000|6-months|Refused assessment|6|||
163905399|NCT03137459|592025779|FG001|6-months|Refused assessment|3|||
163905400|NCT03137459|592025778|FG000|6-months|Acutely ill|1|||
163905401|NCT03137459|592025779|FG001|6-months|Acutely ill|1|||
163905402|NCT06571695|592025780|FG000|Overall Study|Lost to Follow-up|1|||
163905403|NCT06571695|592025781|FG001|Overall Study|Lost to Follow-up|6|||
163905404|NCT04921358|592025782|FG000|Overall Study|Withdrawal by Subject|6|||
164093327|NCT00497796|592705319|FG001|Overall Study|Consent withdrawn|3|||
164093328|NCT00497796|592705318|FG000|Overall Study|Investigator/sponsor discretion|31|||
164093329|NCT00497796|592705319|FG001|Overall Study|Investigator/sponsor discretion|34|||
164093330|NCT00497796|592705318|FG000|Overall Study|Lost to Follow-up|0|||
164093331|NCT00497796|592705319|FG001|Overall Study|Lost to Follow-up|1|||
164093332|NCT00497796|592705318|FG000|Overall Study|Not applicable (randomized not treated)|0|||
164093333|NCT00497796|592705319|FG001|Overall Study|Not applicable (randomized not treated)|4|||
164093334|NCT01856309|592705321|FG000|Overall Study|Death|4|||
164093335|NCT01856309|592705322|FG001|Overall Study|Death|6|||
164093336|NCT01856309|592705323|FG002|Overall Study|Death|11|||
164093337|NCT01856309|592705324|FG003|Overall Study|Death|6|||
164093338|NCT01856309|592705321|FG000|Overall Study|Lost to Follow-up|6|||
164093339|NCT01856309|592705322|FG001|Overall Study|Lost to Follow-up|2|||
164093340|NCT01856309|592705323|FG002|Overall Study|Lost to Follow-up|4|||
164093341|NCT01856309|592705324|FG003|Overall Study|Lost to Follow-up|8|||
164093342|NCT01856309|592705321|FG000|Overall Study|Withdrawal by Subject|11|||
164093343|NCT01856309|592705322|FG001|Overall Study|Withdrawal by Subject|13|||
164093344|NCT01856309|592705323|FG002|Overall Study|Withdrawal by Subject|28|||
164093345|NCT01856309|592705324|FG003|Overall Study|Withdrawal by Subject|26|||
164093346|NCT01856309|592705321|FG000|Overall Study|Other|227|||
164093347|NCT01856309|592705322|FG001|Overall Study|Other|225|||
164093348|NCT01856309|592705323|FG002|Overall Study|Other|447|||
164093349|NCT01856309|592705324|FG003|Overall Study|Other|469|||
164093350|NCT01856309|592705321|FG000|Overall Study|Lack of Efficacy|14|||
164093351|NCT01856309|592705322|FG001|Overall Study|Lack of Efficacy|9|||
164093352|NCT01856309|592705323|FG002|Overall Study|Lack of Efficacy|40|||
164093353|NCT01856309|592705324|FG003|Overall Study|Lack of Efficacy|25|||
164093354|NCT01856309|592705321|FG000|Overall Study|Adverse Event|31|||
164093355|NCT01856309|592705322|FG001|Overall Study|Adverse Event|31|||
164093356|NCT01856309|592705323|FG002|Overall Study|Adverse Event|55|||
164093357|NCT01856309|592705324|FG003|Overall Study|Adverse Event|65|||
164093358|NCT01856309|592705321|FG000|Overall Study|Pregnancy|0|||
164093359|NCT01856309|592705322|FG001|Overall Study|Pregnancy|0|||
164093360|NCT01856309|592705323|FG002|Overall Study|Pregnancy|0|||
164093361|NCT01856309|592705324|FG003|Overall Study|Pregnancy|1|||
164093362|NCT01856309|592705321|FG000|Overall Study|Physician Decision|6|||
164093363|NCT01856309|592705322|FG001|Overall Study|Physician Decision|1|||
164093364|NCT01856309|592705323|FG002|Overall Study|Physician Decision|6|||
164093365|NCT01856309|592705324|FG003|Overall Study|Physician Decision|8|||
164093366|NCT01856309|592705321|FG000|Overall Study|Noncompliance With Study Drug|0|||
164093367|NCT01856309|592705322|FG001|Overall Study|Noncompliance With Study Drug|1|||
164093368|NCT01856309|592705323|FG002|Overall Study|Noncompliance With Study Drug|4|||
164093369|NCT01856309|592705324|FG003|Overall Study|Noncompliance With Study Drug|1|||
164093370|NCT00220337|592705325|FG000|Overall Study|Adverse Event|70|||
164093371|NCT00220337|592705325|FG000|Overall Study|Lack of Efficacy|17|||
164093372|NCT00220337|592705325|FG000|Overall Study|Withdrawal by Subject|68|||
164093373|NCT00220337|592705325|FG000|Overall Study|Protocol Violation|2|||
164093374|NCT00220337|592705325|FG000|Overall Study|Lost to Follow-up|5|||
164093375|NCT00220337|592705325|FG000|Overall Study|Other|12|||
164093376|NCT00220337|592705325|FG000|Overall Study|Unsatisfactory compliance|5|||
164093377|NCT00832377|592705326|FG000|Overall Study|Protocol Violation|1|||
164093378|NCT00944697|592705327|FG000|Overall Study|Withdrawal by Subject|1|||
164093379|NCT00944697|592705328|FG001|Overall Study|Withdrawal by Subject|1|||
164093380|NCT00944697|592705327|FG000|Overall Study|Adverse Event|0|||
164093381|NCT00944697|592705328|FG001|Overall Study|Adverse Event|3|||
164093382|NCT00944697|592705327|FG000|Overall Study|Administrative|1|||
164093383|NCT00944697|592705328|FG001|Overall Study|Administrative|1|||
164093384|NCT03661528|592705329|FG000|Overall Study|Death|1|||
164093385|NCT03661528|592705330|FG001|Overall Study|Death|0|||
164093386|NCT03661528|592705329|FG000|Overall Study|Physician Decision|3|||
164093387|NCT03661528|592705330|FG001|Overall Study|Physician Decision|1|||
164093388|NCT03661528|592705329|FG000|Overall Study|Other than Specified|5|||
164093389|NCT03661528|592705330|FG001|Overall Study|Other than Specified|2|||
164093390|NCT03661528|592705329|FG000|Overall Study|Withdrawal by Subject|5|||
164093391|NCT03661528|592705330|FG001|Overall Study|Withdrawal by Subject|3|||
164093392|NCT03661528|592705329|FG000|Overall Study|Disease Progression|8|||
164093393|NCT03661528|592705330|FG001|Overall Study|Disease Progression|13|||
164093394|NCT03661528|592705329|FG000|Overall Study|Adverse Event|61|||
164093395|NCT03661528|592705330|FG001|Overall Study|Adverse Event|55|||
164093396|NCT02353169|592705333|FG000|Overall Study|QTc > 450 msec|1|||
164093397|NCT02353169|592705334|FG001|Overall Study|QTc > 450 msec|1|||
164093398|NCT02353169|592705335|FG002|Overall Study|QTc > 450 msec|1|||
164093399|NCT02353169|592705336|FG003|Overall Study|QTc > 450 msec|1|||
164093400|NCT02353169|592705333|FG000|Overall Study|OR team declined|2|||
164093401|NCT02353169|592705334|FG001|Overall Study|OR team declined|0|||
164093402|NCT02353169|592705335|FG002|Overall Study|OR team declined|0|||
164093403|NCT02353169|592705336|FG003|Overall Study|OR team declined|0|||
164093404|NCT02353169|592705333|FG000|Overall Study|Inhalational induction|0|||
164093405|NCT02353169|592705334|FG001|Overall Study|Inhalational induction|2|||
164395015|NCT03152552|593813867|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164395016|NCT03152552|593813868|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
164395017|NCT03152552|593813869|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
164395018|NCT03152552|593813865|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
164395019|NCT03152552|593813866|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
164395020|NCT03152552|593813867|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
164395021|NCT03152552|593813868|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
164395022|NCT03152552|593813869|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
164395023|NCT01857531|593813871|FG000|Overall Study|Withdrawal by Subject|4|||
164395024|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
164016373|NCT00523341|592423867|FG000|Overall Study|Adverse Event|122|||
164016374|NCT00523341|592423868|FG001|Overall Study|Adverse Event|155|||
164093406|NCT02353169|592705335|FG002|Overall Study|Inhalational induction|0|||
164093407|NCT02353169|592705336|FG003|Overall Study|Inhalational induction|0|||
164093408|NCT02353169|592705333|FG000|Overall Study|ECG data error|0|||
164093409|NCT02353169|592705334|FG001|Overall Study|ECG data error|3|||
164093410|NCT02353169|592705335|FG002|Overall Study|ECG data error|2|||
164093411|NCT02353169|592705336|FG003|Overall Study|ECG data error|2|||
164093412|NCT02353169|592705333|FG000|Overall Study|Pre-op medication|0|||
164093413|NCT02353169|592705334|FG001|Overall Study|Pre-op medication|0|||
164093414|NCT02353169|592705335|FG002|Overall Study|Pre-op medication|1|||
164093415|NCT02353169|592705336|FG003|Overall Study|Pre-op medication|0|||
164093416|NCT00486837|592705337|FG000|Overall Study|Withdrawal by Subject|1|||
164093417|NCT00486837|592705338|FG001|Overall Study|Withdrawal by Subject|0|||
164093418|NCT00486837|592705337|FG000|Overall Study|Adverse Event|1|||
164093419|NCT00486837|592705338|FG001|Overall Study|Adverse Event|1|||
164093420|NCT00486837|592705337|FG000|Overall Study|Protocol Violation|4|||
164093421|NCT00486837|592705338|FG001|Overall Study|Protocol Violation|2|||
164093422|NCT00486837|592705337|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
164093423|NCT00486837|592705338|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
164093424|NCT05295953|592705339|FG000|Overall Study|Withdrawal by Subject|0|||
164093425|NCT05295953|592705340|FG001|Overall Study|Withdrawal by Subject|1|||
164093426|NCT01199861|592705341|FG000|Overall Study|Administrative problems|1|||
164093427|NCT01199861|592705342|FG001|Overall Study|Administrative problems|0|||
164093428|NCT01199861|592705341|FG000|Overall Study|Adverse Event|1|||
164093429|NCT01199861|592705342|FG001|Overall Study|Adverse Event|0|||
164093430|NCT04981912|592705343|FG000|Overall Study|Physician Decision|2|||
164093431|NCT05630547|592705346|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
164093432|NCT05630547|592705347|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
164093433|NCT05630547|592705348|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
164093434|NCT05630547|592705349|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
164093435|NCT05630547|592705346|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
164093436|NCT05630547|592705347|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
164093437|NCT05630547|592705348|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
164093438|NCT05630547|592705349|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
164093439|NCT05630547|592705346|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
164093440|NCT05630547|592705347|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
164016375|NCT00523341|592423867|FG000|Overall Study|Death|101|||
164016376|NCT00523341|592423868|FG001|Overall Study|Death|110|||
164016377|NCT00523341|592423867|FG000|Overall Study|Lost to Follow-up|73|||
164016378|NCT00523341|592423868|FG001|Overall Study|Lost to Follow-up|61|||
164016379|NCT00523341|592423867|FG000|Overall Study|Non-compliance|20|||
164016380|NCT00523341|592423868|FG001|Overall Study|Non-compliance|13|||
164016381|NCT00523341|592423867|FG000|Overall Study|Physician Decision|14|||
164016382|NCT00523341|592423868|FG001|Overall Study|Physician Decision|13|||
164016383|NCT00523341|592423867|FG000|Overall Study|Requirement for Alternative Therapy|4|||
164016384|NCT00523341|592423868|FG001|Overall Study|Requirement for Alternative Therapy|14|||
164016385|NCT00523341|592423867|FG000|Overall Study|Protocol Deviation|6|||
164093441|NCT05630547|592705348|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
164093442|NCT05630547|592705349|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
164093443|NCT05630547|592705346|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
164395025|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
164395026|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
164395027|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
164395028|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
164395029|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
164016386|NCT00523341|592423868|FG001|Overall Study|Protocol Deviation|5|||
164016387|NCT00523341|592423867|FG000|Overall Study|Ineligibility Determined|3|||
164016388|NCT00523341|592423868|FG001|Overall Study|Ineligibility Determined|4|||
164093444|NCT05630547|592705347|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
164016389|NCT00523341|592423867|FG000|Overall Study|Disease Progression|1|||
164016390|NCT00523341|592423868|FG001|Overall Study|Disease Progression|0|||
164093445|NCT05630547|592705348|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
163905405|NCT04921358|592025783|FG001|Overall Study|Withdrawal by Subject|13|||
163905406|NCT04921358|592025782|FG000|Overall Study|Lost to Follow-up|3|||
163905407|NCT04921358|592025783|FG001|Overall Study|Lost to Follow-up|6|||
163905408|NCT04921358|592025782|FG000|Overall Study|Study Terminated by Sponsor|86|||
163905409|NCT04921358|592025783|FG001|Overall Study|Study Terminated by Sponsor|89|||
163905410|NCT04921358|592025782|FG000|Overall Study|Death|92|||
163905411|NCT04921358|592025783|FG001|Overall Study|Death|82|||
163905412|NCT02278796|592025784|FG000|Overall Study|Death|2|||
163905413|NCT02278796|592025785|FG001|Overall Study|Death|3|||
164395030|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
164395031|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
164395032|NCT00679939|593813879|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
164395033|NCT00679939|593813880|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
164395034|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
164395035|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
164395036|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
164395037|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
164395038|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
164395039|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
164395040|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
163905414|NCT04926857|592025786|FG000|Overall Study|Withdrawal by Subject|40|||
163905415|NCT04926857|592025786|FG000|Overall Study|Death|9|||
164395041|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
164395042|NCT00679939|593813879|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
164395043|NCT00679939|593813880|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
164395044|NCT05374421|593813881|FG000|Overall Study|Withdrawal by Subject|3|||
164395045|NCT05374421|593813882|FG001|Overall Study|Withdrawal by Subject|4|||
164395046|NCT02763384|593813883|FG000|Overall Study|Physician Decision|1|||
164395047|NCT02763384|593813883|FG000|Overall Study|Rapid decline - went on hospice|1|||
164395048|NCT04657211|593813884|FG000|Overall Study|Withdrawal by Subject|21|||
164395049|NCT04657211|593813884|FG000|Overall Study|Lost to Follow-up|113|||
164395050|NCT04657211|593813884|FG000|Overall Study|Death|47|||
164395051|NCT04657211|593813884|FG000|Overall Study|Transfer to another institution|21|||
164395052|NCT04657211|593813884|FG000|Overall Study|Other|29|||
164395053|NCT00003508|593815696|FG000|Overall Study|Not evaluable|5|||
164395054|NCT03576768|593815698|FG000|Overall Study|Lost to Follow-up|3|||
164395055|NCT03576768|593815699|FG001|Overall Study|Lost to Follow-up|3|||
163905416|NCT04926857|592025786|FG000|Overall Study|Study product no longer in use|44|||
163905417|NCT04926857|592025786|FG000|Overall Study|Inadequate data to address primary objective|16|||
163905418|NCT00670449|592025790|FG000|Overall Study|Adverse Event|6|||
163905419|NCT00670449|592025791|FG001|Overall Study|Adverse Event|2|||
163905420|NCT00670449|592025792|FG002|Overall Study|Adverse Event|8|||
163905421|NCT00670449|592025793|FG003|Overall Study|Adverse Event|5|||
163905422|NCT00670449|592025790|FG000|Overall Study|Protocol Deviation|1|||
163905423|NCT00670449|592025791|FG001|Overall Study|Protocol Deviation|2|||
163905424|NCT00670449|592025792|FG002|Overall Study|Protocol Deviation|0|||
163905425|NCT00670449|592025793|FG003|Overall Study|Protocol Deviation|1|||
163905426|NCT00670449|592025790|FG000|Overall Study|Administrative Problems|0|||
163905427|NCT00670449|592025791|FG001|Overall Study|Administrative Problems|2|||
163905428|NCT00670449|592025792|FG002|Overall Study|Administrative Problems|0|||
163905429|NCT00670449|592025793|FG003|Overall Study|Administrative Problems|1|||
163905430|NCT00670449|592025790|FG000|Overall Study|Subject Withdrew Consent|0|||
163905431|NCT00670449|592025791|FG001|Overall Study|Subject Withdrew Consent|2|||
163905432|NCT00670449|592025792|FG002|Overall Study|Subject Withdrew Consent|0|||
163905433|NCT00670449|592025793|FG003|Overall Study|Subject Withdrew Consent|1|||
163905434|NCT00670449|592025790|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
163905435|NCT00670449|592025791|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163905436|NCT00670449|592025792|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
163905437|NCT00670449|592025793|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
163905438|NCT00670449|592025790|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
163905439|NCT00670449|592025791|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
163905440|NCT00670449|592025792|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163905441|NCT00670449|592025793|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
163905442|NCT02637063|592025794|FG000|Overall Study|Lost to Follow-up|3|||
163905443|NCT02637063|592025795|FG001|Overall Study|Lost to Follow-up|2|||
163905444|NCT02637063|592025796|FG002|Overall Study|Lost to Follow-up|3|||
163905445|NCT02637063|592025794|FG000|Overall Study|Withdrawal by Subject|2|||
163905446|NCT02637063|592025795|FG001|Overall Study|Withdrawal by Subject|2|||
163905447|NCT02637063|592025796|FG002|Overall Study|Withdrawal by Subject|3|||
163905448|NCT00491400|592025797|FG000|Overall Study|Withdrawal by Subject|5|||
163905449|NCT00491400|592025798|FG001|Overall Study|Withdrawal by Subject|4|||
163905450|NCT00597376|592025799|FG000|Overall Study|Withdrawal by Subject|4|||
164395056|NCT03576768|593815700|FG002|Overall Study|Lost to Follow-up|0|||
164395057|NCT03576768|593815701|FG003|Overall Study|Lost to Follow-up|0|||
164395058|NCT00590902|593815702|FG000|Overall Study|Death|1|||
164395059|NCT02057874|593815703|FG000|Overall Study|participant did not return for scan|1|||
164395060|NCT02979639|593815704|FG000|Overall Study|Withdrawal based on medical judgement|1|||
164395061|NCT02979639|593815704|FG000|Overall Study|Lost to Follow-up|8|||
164395062|NCT02979639|593815704|FG000|Overall Study|Withdrawal by Subject|3|||
164395063|NCT02979639|593815704|FG000|Overall Study|Adverse Event|2|||
164395064|NCT01738984|593815707|FG000|Overall Study|Pregnancy|4|||
164395065|NCT01738984|593815708|FG001|Overall Study|Pregnancy|0|||
164395066|NCT01738984|593815707|FG000|Overall Study|Withdrawal by Subject|1|||
164395067|NCT01738984|593815708|FG001|Overall Study|Withdrawal by Subject|0|||
164395068|NCT01738984|593815707|FG000|Overall Study|Lost to Follow-up|59|||
164395069|NCT01738984|593815708|FG001|Overall Study|Lost to Follow-up|39|||
164395070|NCT02621931|593815713|FG000|Overall Study|Death|0|||
164395071|NCT02621931|593815714|FG001|Overall Study|Death|1|||
164395072|NCT02621931|593815715|FG002|Overall Study|Death|0|||
164395073|NCT02621931|593815713|FG000|Overall Study|Adverse Event|8|||
164395074|NCT02621931|593815714|FG001|Overall Study|Adverse Event|5|||
164395075|NCT02621931|593815715|FG002|Overall Study|Adverse Event|7|||
164395076|NCT02621931|593815713|FG000|Overall Study|Withdrawal by Subject|12|||
164395077|NCT02621931|593815714|FG001|Overall Study|Withdrawal by Subject|10|||
164395078|NCT02621931|593815715|FG002|Overall Study|Withdrawal by Subject|11|||
164395079|NCT02621931|593815713|FG000|Overall Study|Protocol Violation|2|||
164395080|NCT02621931|593815714|FG001|Overall Study|Protocol Violation|2|||
164395081|NCT02621931|593815715|FG002|Overall Study|Protocol Violation|2|||
164395082|NCT02621931|593815713|FG000|Overall Study|Pregnancy|2|||
164395083|NCT02621931|593815714|FG001|Overall Study|Pregnancy|0|||
164395084|NCT02621931|593815715|FG002|Overall Study|Pregnancy|0|||
164395085|NCT02621931|593815713|FG000|Overall Study|Noncompliance to study procedures|0|||
164395086|NCT02621931|593815714|FG001|Overall Study|Noncompliance to study procedures|1|||
164395087|NCT02621931|593815715|FG002|Overall Study|Noncompliance to study procedures|2|||
164395088|NCT02621931|593815713|FG000|Overall Study|Lost to Follow-up|8|||
164395089|NCT02621931|593815714|FG001|Overall Study|Lost to Follow-up|7|||
164395090|NCT02621931|593815715|FG002|Overall Study|Lost to Follow-up|10|||
164395091|NCT02621931|593815713|FG000|Overall Study|Lack of Efficacy|0|||
164395092|NCT02621931|593815714|FG001|Overall Study|Lack of Efficacy|0|||
164395093|NCT02621931|593815715|FG002|Overall Study|Lack of Efficacy|1|||
164395094|NCT02621931|593815713|FG000|Overall Study|Other|1|||
164395095|NCT02621931|593815714|FG001|Overall Study|Other|1|||
164395096|NCT02621931|593815715|FG002|Overall Study|Other|3|||
164395097|NCT00920426|593815716|FG000|ITZ111451|Adverse Event|1|||
164395098|NCT00920426|593815717|FG001|ITZ111451|Adverse Event|0|||
164395099|NCT00920426|593815718|FG002|ITZ111451|Adverse Event|0|||
164395100|NCT00920426|593815719|FG003|ITZ111451|Adverse Event|0|||
164395101|NCT00955357|593815724|FG000|Titration Phase|Adverse Event|9|||
164395102|NCT00955357|593815725|FG001|Titration Phase|Adverse Event|46|||
164395103|NCT00955357|593815724|FG000|Titration Phase|Lack of Efficacy|0|||
164395104|NCT00955357|593815725|FG001|Titration Phase|Lack of Efficacy|2|||
164395105|NCT00955357|593815724|FG000|Titration Phase|Protocol Violation|3|||
164395106|NCT00955357|593815725|FG001|Titration Phase|Protocol Violation|7|||
164395107|NCT00955357|593815724|FG000|Titration Phase|Lost to Follow-up|1|||
164395108|NCT00955357|593815725|FG001|Titration Phase|Lost to Follow-up|3|||
164395109|NCT00955357|593815724|FG000|Titration Phase|Withdrawal by Subject|3|||
164395110|NCT00955357|593815725|FG001|Titration Phase|Withdrawal by Subject|5|||
164395111|NCT00955357|593815724|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
164395112|NCT00955357|593815725|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
164395113|NCT00955357|593815724|FG000|Titration Phase|Study medication not tolerated|0|||
164395114|NCT00955357|593815725|FG001|Titration Phase|Study medication not tolerated|1|||
164395115|NCT00955357|593815724|FG000|Titration Phase|Non compliance to study procedures|0|||
164395116|NCT00955357|593815725|FG001|Titration Phase|Non compliance to study procedures|1|||
164395117|NCT00955357|593815724|FG000|Maintenance Phase|Adverse Event|3|||
164395118|NCT00955357|593815725|FG001|Maintenance Phase|Adverse Event|23|||
164395119|NCT00955357|593815724|FG000|Maintenance Phase|Lack of Efficacy|0|||
164395120|NCT00955357|593815725|FG001|Maintenance Phase|Lack of Efficacy|4|||
164395121|NCT00955357|593815724|FG000|Maintenance Phase|Protocol Violation|2|||
164395122|NCT00955357|593815725|FG001|Maintenance Phase|Protocol Violation|6|||
164395123|NCT00955357|593815724|FG000|Maintenance Phase|Lost to Follow-up|2|||
164395124|NCT00955357|593815725|FG001|Maintenance Phase|Lost to Follow-up|7|||
164395125|NCT00955357|593815724|FG000|Maintenance Phase|Withdrawal by Subject|4|||
164395126|NCT00955357|593815725|FG001|Maintenance Phase|Withdrawal by Subject|4|||
164395127|NCT00955357|593815724|FG000|Maintenance Phase|Patient moving out of area|0|||
164395128|NCT00955357|593815725|FG001|Maintenance Phase|Patient moving out of area|1|||
164395129|NCT00955357|593815724|FG000|Maintenance Phase|Non compliance to study procedures|1|||
164395130|NCT00955357|593815725|FG001|Maintenance Phase|Non compliance to study procedures|0|||
164395131|NCT02943408|593815726|FG000|Overall Study|Lost to Follow-up|7|||
164395132|NCT02943408|593815727|FG001|Overall Study|Lost to Follow-up|1|||
164395133|NCT02943408|593815726|FG000|Overall Study|Withdrawal by Subject|0|||
164395134|NCT02943408|593815727|FG001|Overall Study|Withdrawal by Subject|1|||
164395135|NCT01621126|593815730|FG000|Overall Study|Physician Decision|6|||
164395136|NCT00886340|593815731|FG000|Overall Study|Withdrawal by Subject|0|||
164395137|NCT00886340|593815732|FG001|Overall Study|Withdrawal by Subject|7|||
164395138|NCT02985866|593815733|FG000|Overall Study|Poor CGM data|1|||
164395139|NCT02985866|593815734|FG001|Overall Study|Poor CGM data|1|||
164395140|NCT03751631|593815735|FG000|Overall Study|Withdrawal by Subject|0|||
164395141|NCT03751631|593815736|FG001|Overall Study|Withdrawal by Subject|0|||
164395142|NCT03751631|593815737|FG002|Overall Study|Withdrawal by Subject|1|||
164395143|NCT03751631|593815738|FG003|Overall Study|Withdrawal by Subject|1|||
164395144|NCT03751631|593815739|FG004|Overall Study|Withdrawal by Subject|0|||
164395145|NCT03751631|593815740|FG005|Overall Study|Withdrawal by Subject|0|||
164395146|NCT02481310|593815741|FG000|Follow up|Still in follow up|0|||
164395147|NCT02481310|593815742|FG001|Follow up|Still in follow up|3|||
164395148|NCT02481310|593815743|FG002|Follow up|Still in follow up|0|||
164395149|NCT00643916|593815745|FG000|Overall Study|Protocol Violation|0|||
164395150|NCT00643916|593815746|FG001|Overall Study|Protocol Violation|1|||
164395151|NCT00643916|593815747|FG002|Overall Study|Protocol Violation|1|||
164395152|NCT00643916|593815748|FG003|Overall Study|Protocol Violation|1|||
164395153|NCT00643916|593815749|FG004|Overall Study|Protocol Violation|0|||
164395154|NCT00643916|593815750|FG005|Overall Study|Protocol Violation|0|||
163905451|NCT00597376|592025800|FG001|Overall Study|Withdrawal by Subject|3|||
163905452|NCT00597376|592025799|FG000|Overall Study|Adverse Event|4|||
163905453|NCT00597376|592025800|FG001|Overall Study|Adverse Event|1|||
163905454|NCT01380145|592025801|FG000|Overall Study|Progressive disease|4|||
163905455|NCT02634307|592025802|FG000|Overall Study|Adverse Event|50|||
163905456|NCT02634307|592025803|FG001|Overall Study|Adverse Event|24|||
163905457|NCT02634307|592025804|FG002|Overall Study|Adverse Event|14|||
163905458|NCT02634307|592025802|FG000|Overall Study|Lost to Follow-up|21|||
163905459|NCT02634307|592025803|FG001|Overall Study|Lost to Follow-up|5|||
163905460|NCT02634307|592025804|FG002|Overall Study|Lost to Follow-up|6|||
163905461|NCT02634307|592025802|FG000|Overall Study|Pregnancy|5|||
163905462|NCT02634307|592025803|FG001|Overall Study|Pregnancy|1|||
163905463|NCT02634307|592025804|FG002|Overall Study|Pregnancy|3|||
163905464|NCT02634307|592025802|FG000|Overall Study|Withdrawal by Subject|38|||
163905465|NCT02634307|592025803|FG001|Overall Study|Withdrawal by Subject|24|||
163905466|NCT02634307|592025804|FG002|Overall Study|Withdrawal by Subject|18|||
163905467|NCT02634307|592025802|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163905468|NCT02634307|592025803|FG001|Overall Study|Non-Compliance with Study Drug|2|||
163905469|NCT02634307|592025804|FG002|Overall Study|Non-Compliance with Study Drug|2|||
163905470|NCT02634307|592025802|FG000|Overall Study|Lack of Efficacy|1|||
163905471|NCT02634307|592025803|FG001|Overall Study|Lack of Efficacy|5|||
163905472|NCT02634307|592025804|FG002|Overall Study|Lack of Efficacy|3|||
163905473|NCT02634307|592025802|FG000|Overall Study|Physician Decision|7|||
163905474|NCT02634307|592025803|FG001|Overall Study|Physician Decision|5|||
163905475|NCT02634307|592025804|FG002|Overall Study|Physician Decision|5|||
163905476|NCT02634307|592025802|FG000|Overall Study|Reason not Specified|3|||
163905477|NCT02634307|592025803|FG001|Overall Study|Reason not Specified|5|||
163905478|NCT02634307|592025804|FG002|Overall Study|Reason not Specified|10|||
163905479|NCT01256359|592025806|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
163905480|NCT01256359|592025807|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
163905481|NCT01256359|592025806|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
163905482|NCT01256359|592025807|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
163905483|NCT03737110|592025812|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
163905484|NCT03737110|592025813|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
163905485|NCT03737110|592025814|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
163905486|NCT03737110|592025815|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
163905487|NCT03737110|592025816|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
163905488|NCT03737110|592025817|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
163905489|NCT03737110|592025812|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
163905490|NCT03737110|592025813|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163905491|NCT03737110|592025814|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163905492|NCT03737110|592025815|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163905493|NCT03737110|592025816|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163905494|NCT03737110|592025817|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
163905495|NCT03737110|592025812|FG000|Run-in (RI) Period|Adverse Event|4|||
163905496|NCT03737110|592025813|FG001|Run-in (RI) Period|Adverse Event|0|||
163905497|NCT03737110|592025814|FG002|Run-in (RI) Period|Adverse Event|0|||
163905498|NCT03737110|592025815|FG003|Run-in (RI) Period|Adverse Event|0|||
163905499|NCT03737110|592025816|FG004|Run-in (RI) Period|Adverse Event|0|||
163905500|NCT03737110|592025817|FG005|Run-in (RI) Period|Adverse Event|0|||
163905501|NCT03737110|592025812|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163905502|NCT03737110|592025813|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
164016391|NCT00912015|592423869|FG000|Overall Study|Lack of Efficacy|1|||
164016392|NCT00912015|592423870|FG001|Overall Study|Lack of Efficacy|0|||
164016393|NCT00912015|592423871|FG002|Overall Study|Lack of Efficacy|0|||
164093446|NCT05630547|592705349|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
164093447|NCT05630547|592705346|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
164093448|NCT05630547|592705347|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
164093449|NCT05630547|592705348|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
164093450|NCT05630547|592705349|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
164093451|NCT05630547|592705346|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
164093452|NCT05630547|592705347|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
164093453|NCT05630547|592705348|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
164093454|NCT05630547|592705349|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
164093455|NCT05630547|592705346|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
164093456|NCT05630547|592705347|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
164093457|NCT05630547|592705348|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
164144036|NCT00086281|592888575|FG004|Phase 2|Adverse Event|0|||
164395155|NCT00643916|593815745|FG000|Overall Study|Lost to Follow-up|0|||
164395156|NCT00643916|593815746|FG001|Overall Study|Lost to Follow-up|1|||
164395157|NCT00643916|593815747|FG002|Overall Study|Lost to Follow-up|0|||
164395158|NCT00643916|593815748|FG003|Overall Study|Lost to Follow-up|0|||
164395159|NCT00643916|593815749|FG004|Overall Study|Lost to Follow-up|0|||
164395160|NCT00643916|593815750|FG005|Overall Study|Lost to Follow-up|0|||
164395161|NCT00643916|593815745|FG000|Overall Study|Withdrawal by Subject|2|||
164395162|NCT00643916|593815746|FG001|Overall Study|Withdrawal by Subject|2|||
164016394|NCT00912015|592423872|FG003|Overall Study|Lack of Efficacy|0|||
164016395|NCT00912015|592423869|FG000|Overall Study|Withdrawal by Subject|8|||
164016396|NCT00912015|592423870|FG001|Overall Study|Withdrawal by Subject|8|||
164016397|NCT00912015|592423871|FG002|Overall Study|Withdrawal by Subject|3|||
164016398|NCT00912015|592423872|FG003|Overall Study|Withdrawal by Subject|0|||
164016399|NCT00912015|592423869|FG000|Overall Study|Protocol Violation|1|||
164016400|NCT00912015|592423870|FG001|Overall Study|Protocol Violation|0|||
164016401|NCT00912015|592423871|FG002|Overall Study|Protocol Violation|0|||
164016402|NCT00912015|592423872|FG003|Overall Study|Protocol Violation|1|||
164016403|NCT00912015|592423869|FG000|Overall Study|Adverse Event|6|||
164016404|NCT00912015|592423870|FG001|Overall Study|Adverse Event|0|||
164016405|NCT00912015|592423871|FG002|Overall Study|Adverse Event|0|||
164016406|NCT00912015|592423872|FG003|Overall Study|Adverse Event|1|||
164016407|NCT01790438|592423873|FG000|Overall Study|Adverse Event|3|||
164016408|NCT01790438|592423874|FG001|Overall Study|Adverse Event|2|||
164016409|NCT01790438|592423873|FG000|Overall Study|Death|4|||
164016410|NCT01790438|592423874|FG001|Overall Study|Death|0|||
164016411|NCT01790438|592423873|FG000|Overall Study|Lost to Follow-up|5|||
164016412|NCT01790438|592423874|FG001|Overall Study|Lost to Follow-up|2|||
164395163|NCT00643916|593815747|FG002|Overall Study|Withdrawal by Subject|2|||
164395164|NCT00643916|593815748|FG003|Overall Study|Withdrawal by Subject|1|||
164395165|NCT00643916|593815749|FG004|Overall Study|Withdrawal by Subject|0|||
164395166|NCT00643916|593815750|FG005|Overall Study|Withdrawal by Subject|1|||
164395167|NCT00643916|593815745|FG000|Overall Study|Not Vaccinated|2|||
164395168|NCT00643916|593815746|FG001|Overall Study|Not Vaccinated|2|||
164395169|NCT00643916|593815747|FG002|Overall Study|Not Vaccinated|3|||
164395170|NCT00643916|593815748|FG003|Overall Study|Not Vaccinated|0|||
164395171|NCT00643916|593815749|FG004|Overall Study|Not Vaccinated|2|||
164395172|NCT00643916|593815750|FG005|Overall Study|Not Vaccinated|0|||
164395173|NCT02184611|593815752|FG000|Overall Study|Lack of Efficacy|11|||
164395174|NCT02184611|593815753|FG001|Overall Study|Lack of Efficacy|15|||
164395175|NCT02184611|593815752|FG000|Overall Study|Withdrawal by Subject|5|||
164395176|NCT02184611|593815753|FG001|Overall Study|Withdrawal by Subject|6|||
164395177|NCT02184611|593815752|FG000|Overall Study|Adverse Event|4|||
164395178|NCT02184611|593815753|FG001|Overall Study|Adverse Event|5|||
164395179|NCT02184611|593815752|FG000|Overall Study|Protocol Violation|1|||
164395180|NCT02184611|593815753|FG001|Overall Study|Protocol Violation|1|||
164395181|NCT02184611|593815752|FG000|Overall Study|Protocol defined stopping criteria|0|||
164395182|NCT02184611|593815753|FG001|Overall Study|Protocol defined stopping criteria|1|||
164395183|NCT02925455|593815754|FG000|Overall Study|Withdrawal by Subject|2|||
164395184|NCT02925455|593815755|FG001|Overall Study|Withdrawal by Subject|0|||
164395185|NCT01514448|593815759|FG000|Overall Study|Death|7|||
164395186|NCT01514448|593815760|FG001|Overall Study|Death|8|||
164395187|NCT01514448|593815759|FG000|Overall Study|Withdrawal by Subject|2|||
164395188|NCT01514448|593815760|FG001|Overall Study|Withdrawal by Subject|0|||
164395189|NCT01514448|593815759|FG000|Overall Study|Lost to Follow-up|2|||
164016413|NCT01790438|592423873|FG000|Overall Study|Withdrawal by Subject|13|||
164016414|NCT01790438|592423874|FG001|Overall Study|Withdrawal by Subject|2|||
164395190|NCT01514448|593815760|FG001|Overall Study|Lost to Follow-up|0|||
164395191|NCT01514448|593815759|FG000|Overall Study|New Cancer Therapy|1|||
164395192|NCT01514448|593815760|FG001|Overall Study|New Cancer Therapy|0|||
164016415|NCT01790438|592423873|FG000|Overall Study|Physician Decision|3|||
164016416|NCT01790438|592423874|FG001|Overall Study|Physician Decision|1|||
164016417|NCT01790438|592423873|FG000|Overall Study|Sponsor Decision|0|||
164395193|NCT05159622|593815761|FG000|Overall Study|Lost to Follow-up|4|||
164395194|NCT05159622|593815762|FG001|Overall Study|Lost to Follow-up|5|||
164395195|NCT02723864|593815763|FG000|Overall Study|Refused further treatment|1|||
164395196|NCT02723864|593815764|FG001|Overall Study|Refused further treatment|0|||
164395197|NCT02723864|593815765|FG002|Overall Study|Refused further treatment|0|||
164016418|NCT01790438|592423874|FG001|Overall Study|Sponsor Decision|3|||
164016419|NCT01790438|592423873|FG000|Overall Study|Protocol Required Discontinuation|7|||
164016420|NCT01790438|592423874|FG001|Overall Study|Protocol Required Discontinuation|1|||
164016421|NCT02090114|592423875|FG000|Overall Study|Withdrawal by Subject|3|||
164016422|NCT02090114|592423876|FG001|Overall Study|Withdrawal by Subject|6|||
164016423|NCT02090114|592423877|FG002|Overall Study|Withdrawal by Subject|2|||
164016424|NCT02090114|592423878|FG003|Overall Study|Withdrawal by Subject|1|||
164016425|NCT02090114|592423875|FG000|Overall Study|Physician Decision|5|||
164016426|NCT02090114|592423876|FG001|Overall Study|Physician Decision|0|||
164016427|NCT02090114|592423877|FG002|Overall Study|Physician Decision|1|||
164016428|NCT02090114|592423878|FG003|Overall Study|Physician Decision|1|||
164016429|NCT02090114|592423875|FG000|Overall Study|Adverse Event|1|||
164016430|NCT02090114|592423876|FG001|Overall Study|Adverse Event|2|||
164016431|NCT02090114|592423877|FG002|Overall Study|Adverse Event|2|||
164016432|NCT02090114|592423878|FG003|Overall Study|Adverse Event|0|||
164016433|NCT02090114|592423875|FG000|Overall Study|Progressive Disease|20|||
164016434|NCT02090114|592423876|FG001|Overall Study|Progressive Disease|21|||
164016435|NCT02090114|592423877|FG002|Overall Study|Progressive Disease|23|||
164016436|NCT02090114|592423878|FG003|Overall Study|Progressive Disease|6|||
164016437|NCT02090114|592423875|FG000|Overall Study|Death|1|||
164016438|NCT02090114|592423876|FG001|Overall Study|Death|0|||
164016439|NCT02090114|592423877|FG002|Overall Study|Death|1|||
164016440|NCT02090114|592423878|FG003|Overall Study|Death|0|||
164016441|NCT01605071|592423879|FG000|Overall Study|Withdrawal by Subject|3|||
164016442|NCT01605071|592423880|FG001|Overall Study|Withdrawal by Subject|2|||
164016443|NCT03123354|592423881|FG000|Overall Study|Physician Decision|6|||
164016444|NCT01345123|592423887|FG000|Overall Study|participants no longer with health plan|79|||
164016445|NCT01345123|592423888|FG001|Overall Study|participants no longer with health plan|85|||
164016446|NCT01345123|592423889|FG002|Overall Study|participants no longer with health plan|88|||
164016447|NCT01798134|592423890|FG000|Overall Study|Lost to Follow-up|1|||
164016448|NCT01798134|592423890|FG000|Overall Study|Withdrawal by Subject|3|||
164016449|NCT01798134|592423890|FG000|Overall Study|Death|2|||
164016450|NCT01798134|592423890|FG000|Overall Study|Adverse Event|3|||
164016451|NCT01798134|592423890|FG000|Overall Study|Physician Decision|3|||
164016452|NCT01798134|592423890|FG000|Overall Study|Liver transplant/surgery|4|||
164016453|NCT02653976|592423891|FG000|Overall Study|Withdrawal by Subject|5|||
164016454|NCT02653976|592423891|FG000|Overall Study|Death|4|||
164016455|NCT02436577|592423892|FG000|Overall Study|Protocol Deviation|0|||
164016456|NCT02436577|592423893|FG001|Overall Study|Protocol Deviation|1|||
164016457|NCT02436577|592423894|FG002|Overall Study|Protocol Deviation|0|||
164016458|NCT02436577|592423895|FG003|Overall Study|Protocol Deviation|0|||
164016459|NCT02436577|592423896|FG004|Overall Study|Protocol Deviation|0|||
164016460|NCT02436577|592423897|FG005|Overall Study|Protocol Deviation|0|||
164016461|NCT00366548|592423898|FG000|Infant Series|Adverse Event|1|||
164016462|NCT00366548|592423899|FG001|Infant Series|Adverse Event|3|||
164016463|NCT00366548|592423898|FG000|Infant Series|Protocol Violation|0|||
164016464|NCT00366548|592423899|FG001|Infant Series|Protocol Violation|1|||
164016465|NCT00366548|592423898|FG000|Infant Series|Withdrawal by Subject|3|||
164016466|NCT00366548|592423899|FG001|Infant Series|Withdrawal by Subject|1|||
164016467|NCT00366548|592423898|FG000|After Infant Series|Withdrawal by Subject|3|||
164016468|NCT00366548|592423899|FG001|After Infant Series|Withdrawal by Subject|1|||
164016469|NCT00366548|592423898|FG000|After Infant Series|Adverse Event|2|||
164016470|NCT00366548|592423899|FG001|After Infant Series|Adverse Event|0|||
164016471|NCT00366548|592423898|FG000|After Infant Series|Lost to Follow-up|1|||
164016472|NCT00366548|592423899|FG001|After Infant Series|Lost to Follow-up|0|||
164016473|NCT03650452|592423900|FG000|Overall Study|Physician Decision|1|||
164016474|NCT03650452|592423901|FG001|Overall Study|Physician Decision|0|||
164093458|NCT05630547|592705349|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
164093459|NCT05630547|592705346|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
164395198|NCT02723864|593815766|FG003|Overall Study|Refused further treatment|0|||
164016475|NCT03650452|592423900|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
164016476|NCT03650452|592423901|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164016477|NCT03650452|592423900|FG000|Overall Study|Adverse Event|3|||
164016478|NCT03650452|592423901|FG001|Overall Study|Adverse Event|4|||
164016479|NCT03650452|592423900|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
164016480|NCT03650452|592423901|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
164016481|NCT02042404|592423903|FG000|Overall Study|Death|1|||
164016482|NCT02042404|592423904|FG001|Overall Study|Death|0|||
164016483|NCT02042404|592423903|FG000|Overall Study|Unrelated Adverse Event|3|||
164016484|NCT02042404|592423904|FG001|Overall Study|Unrelated Adverse Event|0|||
164016485|NCT02042404|592423903|FG000|Overall Study|Inability to meet time requirements|1|||
164016486|NCT02042404|592423904|FG001|Overall Study|Inability to meet time requirements|0|||
164395199|NCT02723864|593815767|FG004|Overall Study|Refused further treatment|1|||
164395200|NCT02723864|593815768|FG005|Overall Study|Refused further treatment|2|||
164395201|NCT02723864|593815769|FG006|Overall Study|Refused further treatment|0|||
164395202|NCT02723864|593815763|FG000|Overall Study|Exceed treatment hold time|0|||
164395203|NCT02723864|593815764|FG001|Overall Study|Exceed treatment hold time|1|||
164395204|NCT02723864|593815765|FG002|Overall Study|Exceed treatment hold time|0|||
164395205|NCT02723864|593815766|FG003|Overall Study|Exceed treatment hold time|0|||
164395206|NCT02723864|593815767|FG004|Overall Study|Exceed treatment hold time|0|||
164395207|NCT02723864|593815768|FG005|Overall Study|Exceed treatment hold time|0|||
164395208|NCT02723864|593815769|FG006|Overall Study|Exceed treatment hold time|0|||
164395209|NCT02723864|593815763|FG000|Overall Study|Clinical progression|0|||
164395210|NCT02723864|593815764|FG001|Overall Study|Clinical progression|0|||
164395211|NCT02723864|593815765|FG002|Overall Study|Clinical progression|1|||
164395212|NCT02723864|593815766|FG003|Overall Study|Clinical progression|0|||
164395213|NCT02723864|593815767|FG004|Overall Study|Clinical progression|0|||
164395214|NCT02723864|593815768|FG005|Overall Study|Clinical progression|3|||
164395215|NCT02723864|593815769|FG006|Overall Study|Clinical progression|1|||
164395216|NCT02723864|593815763|FG000|Overall Study|Physician Decision|0|||
164395217|NCT02723864|593815764|FG001|Overall Study|Physician Decision|0|||
164395218|NCT02723864|593815765|FG002|Overall Study|Physician Decision|0|||
164395219|NCT02723864|593815766|FG003|Overall Study|Physician Decision|0|||
164395220|NCT02723864|593815767|FG004|Overall Study|Physician Decision|0|||
164395221|NCT02723864|593815768|FG005|Overall Study|Physician Decision|0|||
164395222|NCT02723864|593815769|FG006|Overall Study|Physician Decision|1|||
164395223|NCT02723864|593815763|FG000|Overall Study|Changes in patient condition|0|||
164395224|NCT02723864|593815764|FG001|Overall Study|Changes in patient condition|0|||
164395225|NCT02723864|593815765|FG002|Overall Study|Changes in patient condition|0|||
164395226|NCT02723864|593815766|FG003|Overall Study|Changes in patient condition|0|||
164395227|NCT02723864|593815767|FG004|Overall Study|Changes in patient condition|0|||
164395228|NCT02723864|593815768|FG005|Overall Study|Changes in patient condition|1|||
164395229|NCT02723864|593815769|FG006|Overall Study|Changes in patient condition|0|||
164395230|NCT02723864|593815763|FG000|Overall Study|Patient choice|0|||
164395231|NCT02723864|593815764|FG001|Overall Study|Patient choice|0|||
164395232|NCT02723864|593815765|FG002|Overall Study|Patient choice|0|||
164395233|NCT02723864|593815766|FG003|Overall Study|Patient choice|0|||
164395234|NCT02723864|593815767|FG004|Overall Study|Patient choice|0|||
164395235|NCT02723864|593815768|FG005|Overall Study|Patient choice|1|||
164395236|NCT02723864|593815769|FG006|Overall Study|Patient choice|0|||
164395237|NCT02723864|593815763|FG000|Overall Study|Adverse Event|0|||
164395238|NCT02723864|593815764|FG001|Overall Study|Adverse Event|0|||
164395239|NCT02723864|593815765|FG002|Overall Study|Adverse Event|0|||
164395240|NCT02723864|593815766|FG003|Overall Study|Adverse Event|0|||
164395241|NCT02723864|593815767|FG004|Overall Study|Adverse Event|0|||
164395242|NCT02723864|593815768|FG005|Overall Study|Adverse Event|1|||
164395243|NCT02723864|593815769|FG006|Overall Study|Adverse Event|0|||
164395244|NCT02723864|593815763|FG000|Overall Study|Started new treatment|0|||
164395245|NCT02723864|593815764|FG001|Overall Study|Started new treatment|0|||
164395246|NCT02723864|593815765|FG002|Overall Study|Started new treatment|0|||
163905503|NCT03737110|592025814|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163905504|NCT03737110|592025815|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163905505|NCT03737110|592025816|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163905506|NCT03737110|592025817|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
163905507|NCT03737110|592025812|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164016487|NCT04184622|592423909|FG000|Primary Treatment Period|Adverse Event|6|||
164073023|NCT00552617|592632767|FG004|Overall Study|Lost to Follow-up|0|||
164395247|NCT02723864|593815766|FG003|Overall Study|Started new treatment|0|||
164395248|NCT02723864|593815767|FG004|Overall Study|Started new treatment|0|||
164395249|NCT02723864|593815768|FG005|Overall Study|Started new treatment|1|||
163905508|NCT03737110|592025813|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163905509|NCT03737110|592025814|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
163905510|NCT03737110|592025815|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163905511|NCT03737110|592025816|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163905512|NCT03737110|592025817|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
163905513|NCT03737110|592025812|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163905514|NCT03737110|592025813|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163905515|NCT03737110|592025814|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163905516|NCT03737110|592025815|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
163905517|NCT03737110|592025816|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163905518|NCT03737110|592025817|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
163905519|NCT03737110|592025812|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163905520|NCT03737110|592025813|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163905521|NCT03737110|592025814|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163905522|NCT03737110|592025815|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
164395250|NCT02723864|593815769|FG006|Overall Study|Started new treatment|0|||
164395251|NCT02723864|593815763|FG000|Overall Study|Switched to alternative treatment|0|||
164395252|NCT02723864|593815764|FG001|Overall Study|Switched to alternative treatment|0|||
164395253|NCT02723864|593815765|FG002|Overall Study|Switched to alternative treatment|0|||
164395254|NCT02723864|593815766|FG003|Overall Study|Switched to alternative treatment|0|||
164395255|NCT02723864|593815767|FG004|Overall Study|Switched to alternative treatment|0|||
164395256|NCT02723864|593815768|FG005|Overall Study|Switched to alternative treatment|1|||
164395257|NCT02723864|593815769|FG006|Overall Study|Switched to alternative treatment|0|||
164395258|NCT02723864|593815763|FG000|Overall Study|Late determination of ineligibility|0|||
164395259|NCT02723864|593815764|FG001|Overall Study|Late determination of ineligibility|0|||
164395260|NCT02723864|593815765|FG002|Overall Study|Late determination of ineligibility|0|||
164395261|NCT02723864|593815766|FG003|Overall Study|Late determination of ineligibility|0|||
164395262|NCT02723864|593815767|FG004|Overall Study|Late determination of ineligibility|0|||
164395263|NCT02723864|593815768|FG005|Overall Study|Late determination of ineligibility|1|||
164395264|NCT02723864|593815769|FG006|Overall Study|Late determination of ineligibility|0|||
164395265|NCT03232983|593815770|FG000|Period 1|Physician Decision|0|||
164395266|NCT03232983|593815771|FG001|Period 1|Physician Decision|0|||
164395267|NCT03232983|593815772|FG002|Period 1|Physician Decision|1|||
164395268|NCT03232983|593815773|FG003|Period 1|Physician Decision|0|||
164395269|NCT03232983|593815770|FG000|Washout Period 2|Physician Decision|0|||
164395270|NCT03232983|593815771|FG001|Washout Period 2|Physician Decision|0|||
164395271|NCT03232983|593815772|FG002|Washout Period 2|Physician Decision|1|||
164395272|NCT03232983|593815773|FG003|Washout Period 2|Physician Decision|0|||
164395273|NCT03232983|593815770|FG000|Washout Period 2|Withdrawal by Subject|0|||
164395274|NCT03232983|593815771|FG001|Washout Period 2|Withdrawal by Subject|0|||
164395275|NCT03232983|593815772|FG002|Washout Period 2|Withdrawal by Subject|0|||
164395276|NCT03232983|593815773|FG003|Washout Period 2|Withdrawal by Subject|1|||
164395277|NCT03232983|593815770|FG000|Period 4|Withdrawal by Subject|1|||
164395278|NCT03232983|593815771|FG001|Period 4|Withdrawal by Subject|0|||
164395279|NCT03232983|593815772|FG002|Period 4|Withdrawal by Subject|0|||
164395280|NCT03232983|593815773|FG003|Period 4|Withdrawal by Subject|0|||
164093460|NCT05630547|592705347|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
164093461|NCT05630547|592705348|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
164093462|NCT05630547|592705349|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
164093463|NCT05630547|592705346|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
164093464|NCT05630547|592705347|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
164093465|NCT05630547|592705348|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
164093466|NCT05630547|592705349|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
164093467|NCT05630547|592705346|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
164093468|NCT05630547|592705347|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
164093469|NCT05630547|592705348|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
164093470|NCT05630547|592705349|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
164093471|NCT05049460|592705350|FG000|Overall Study|Withdrawal by Subject|2|||
164093472|NCT05049460|592705351|FG001|Overall Study|Withdrawal by Subject|2|||
164093473|NCT05049460|592705350|FG000|Overall Study|Lost to Follow-up|2|||
164093474|NCT05049460|592705351|FG001|Overall Study|Lost to Follow-up|2|||
164093475|NCT00117949|592705354|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
164093476|NCT00117949|592705355|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
164093477|NCT00117949|592705356|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
164093478|NCT00117949|592705357|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
164093479|NCT00117949|592705354|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
164093480|NCT00117949|592705355|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
164093481|NCT00117949|592705356|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
164093482|NCT00117949|592705357|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
164093483|NCT00117949|592705354|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
164093484|NCT00117949|592705355|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
164093485|NCT00117949|592705356|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
164395281|NCT00746590|593815774|FG000|Overall Study|Death|1|||
164395282|NCT03643952|593815779|FG000|Overall Study|Lack of Efficacy|1|||
164395283|NCT01358968|593815780|FG000|Period 2|Adverse Event|0|||
164093486|NCT00117949|592705357|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
164093487|NCT00117949|592705354|FG000|Overall Study|PSA increase >=10ng/mL|0|||
164093488|NCT00117949|592705355|FG001|Overall Study|PSA increase >=10ng/mL|1|||
164093489|NCT00117949|592705356|FG002|Overall Study|PSA increase >=10ng/mL|1|||
164395284|NCT01358968|593815781|FG001|Period 2|Adverse Event|1|||
164395285|NCT01358968|593815782|FG002|Period 2|Adverse Event|0|||
164016488|NCT04184622|592423910|FG001|Primary Treatment Period|Adverse Event|4|||
164016489|NCT04184622|592423911|FG002|Primary Treatment Period|Adverse Event|8|||
164016490|NCT04184622|592423912|FG003|Primary Treatment Period|Adverse Event|6|||
164016491|NCT04184622|592423909|FG000|Primary Treatment Period|Death|4|||
164016492|NCT04184622|592423910|FG001|Primary Treatment Period|Death|4|||
164016493|NCT04184622|592423911|FG002|Primary Treatment Period|Death|2|||
164016494|NCT04184622|592423912|FG003|Primary Treatment Period|Death|1|||
164016495|NCT04184622|592423909|FG000|Primary Treatment Period|Lost to Follow-up|41|||
164016496|NCT04184622|592423910|FG001|Primary Treatment Period|Lost to Follow-up|17|||
164016497|NCT04184622|592423911|FG002|Primary Treatment Period|Lost to Follow-up|15|||
164016498|NCT04184622|592423912|FG003|Primary Treatment Period|Lost to Follow-up|13|||
164016499|NCT04184622|592423909|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
164016500|NCT04184622|592423910|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
164016501|NCT04184622|592423911|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
164016502|NCT04184622|592423912|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
164016503|NCT04184622|592423909|FG000|Primary Treatment Period|Physician Decision|0|||
164016504|NCT04184622|592423910|FG001|Primary Treatment Period|Physician Decision|0|||
164016505|NCT04184622|592423911|FG002|Primary Treatment Period|Physician Decision|3|||
164016506|NCT04184622|592423912|FG003|Primary Treatment Period|Physician Decision|1|||
164016507|NCT04184622|592423909|FG000|Primary Treatment Period|Pregnancy|4|||
164016508|NCT04184622|592423910|FG001|Primary Treatment Period|Pregnancy|3|||
164016509|NCT04184622|592423911|FG002|Primary Treatment Period|Pregnancy|4|||
164016510|NCT04184622|592423912|FG003|Primary Treatment Period|Pregnancy|1|||
164016511|NCT04184622|592423909|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
164016512|NCT04184622|592423910|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
164016513|NCT04184622|592423911|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
164016514|NCT04184622|592423912|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
164016515|NCT04184622|592423909|FG000|Additional Treatment Period|Adverse Event|1|||
164016516|NCT04184622|592423910|FG001|Additional Treatment Period|Adverse Event|2|||
164016517|NCT04184622|592423911|FG002|Additional Treatment Period|Adverse Event|1|||
164016518|NCT04184622|592423912|FG003|Additional Treatment Period|Adverse Event|0|||
164016519|NCT04184622|592423909|FG000|Additional Treatment Period|Death|0|||
164016520|NCT04184622|592423910|FG001|Additional Treatment Period|Death|0|||
164016521|NCT04184622|592423911|FG002|Additional Treatment Period|Death|1|||
164016522|NCT04184622|592423912|FG003|Additional Treatment Period|Death|1|||
164016523|NCT04184622|592423909|FG000|Additional Treatment Period|Lost to Follow-up|6|||
164016524|NCT04184622|592423910|FG001|Additional Treatment Period|Lost to Follow-up|4|||
164016525|NCT04184622|592423911|FG002|Additional Treatment Period|Lost to Follow-up|8|||
164016526|NCT04184622|592423912|FG003|Additional Treatment Period|Lost to Follow-up|6|||
164016527|NCT04184622|592423909|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
164016528|NCT04184622|592423910|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
164016529|NCT04184622|592423911|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
164016530|NCT04184622|592423912|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
164016531|NCT04184622|592423909|FG000|Additional Treatment Period|Physician Decision|0|||
164016532|NCT04184622|592423910|FG001|Additional Treatment Period|Physician Decision|0|||
164016533|NCT04184622|592423911|FG002|Additional Treatment Period|Physician Decision|1|||
164016534|NCT04184622|592423912|FG003|Additional Treatment Period|Physician Decision|0|||
164016535|NCT04184622|592423909|FG000|Additional Treatment Period|Pregnancy|0|||
164016536|NCT04184622|592423910|FG001|Additional Treatment Period|Pregnancy|0|||
164016537|NCT04184622|592423911|FG002|Additional Treatment Period|Pregnancy|0|||
164016538|NCT04184622|592423912|FG003|Additional Treatment Period|Pregnancy|1|||
164016539|NCT04184622|592423909|FG000|Additional Treatment Period|Protocol deviation|0|||
164016540|NCT04184622|592423910|FG001|Additional Treatment Period|Protocol deviation|0|||
164016541|NCT04184622|592423911|FG002|Additional Treatment Period|Protocol deviation|1|||
164016542|NCT04184622|592423912|FG003|Additional Treatment Period|Protocol deviation|0|||
164016543|NCT04184622|592423909|FG000|Additional Treatment Period|Site closed|1|||
164016544|NCT04184622|592423910|FG001|Additional Treatment Period|Site closed|0|||
164016545|NCT04184622|592423911|FG002|Additional Treatment Period|Site closed|1|||
164016546|NCT04184622|592423912|FG003|Additional Treatment Period|Site closed|0|||
164016547|NCT04184622|592423909|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
164016548|NCT04184622|592423910|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
164016549|NCT04184622|592423911|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
164016550|NCT04184622|592423912|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
164016551|NCT04184622|592423909|FG000|Safety Follow-up Period|Adverse Event|6|||
164016552|NCT04184622|592423910|FG001|Safety Follow-up Period|Adverse Event|8|||
164016553|NCT04184622|592423911|FG002|Safety Follow-up Period|Adverse Event|9|||
164016554|NCT04184622|592423912|FG003|Safety Follow-up Period|Adverse Event|16|||
164016555|NCT04184622|592423909|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
164016556|NCT04184622|592423910|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
164016557|NCT04184622|592423911|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
164016558|NCT04184622|592423912|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
164016559|NCT04184622|592423909|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
164016560|NCT04184622|592423910|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
164016561|NCT04184622|592423911|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
164016562|NCT04184622|592423912|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
164016563|NCT04184622|592423909|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
164016564|NCT04184622|592423910|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
164016565|NCT04184622|592423911|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
164016566|NCT04184622|592423912|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
164016567|NCT04184622|592423909|FG000|Safety Follow-up Period|Physician Decision|1|||
164016568|NCT04184622|592423910|FG001|Safety Follow-up Period|Physician Decision|0|||
164016569|NCT04184622|592423911|FG002|Safety Follow-up Period|Physician Decision|0|||
164016570|NCT04184622|592423912|FG003|Safety Follow-up Period|Physician Decision|1|||
164016571|NCT04184622|592423909|FG000|Safety Follow-up Period|Pregnancy|1|||
164016572|NCT04184622|592423910|FG001|Safety Follow-up Period|Pregnancy|3|||
164016573|NCT04184622|592423911|FG002|Safety Follow-up Period|Pregnancy|0|||
164016574|NCT04184622|592423912|FG003|Safety Follow-up Period|Pregnancy|6|||
164016575|NCT04184622|592423909|FG000|Safety Follow-up Period|Protocol deviation|1|||
164016576|NCT04184622|592423910|FG001|Safety Follow-up Period|Protocol deviation|0|||
164016577|NCT04184622|592423911|FG002|Safety Follow-up Period|Protocol deviation|0|||
164016578|NCT04184622|592423912|FG003|Safety Follow-up Period|Protocol deviation|0|||
164016579|NCT04184622|592423909|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
164016580|NCT04184622|592423910|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
164016581|NCT04184622|592423911|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
164016582|NCT04184622|592423912|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
164016583|NCT02795988|592423917|FG000|Phase 1b|Withdrawal by Subject|0|||
164016584|NCT02795988|592423918|FG001|Phase 1b|Withdrawal by Subject|1|||
164016585|NCT02795988|592423919|FG002|Phase 1b|Withdrawal by Subject|0|||
164016586|NCT02795988|592423920|FG003|Phase 1b|Withdrawal by Subject|0|||
164016587|NCT02795988|592423921|FG004|Phase 1b|Withdrawal by Subject|0|||
164016588|NCT02795988|592423922|FG005|Phase 1b|Withdrawal by Subject|0|||
164016589|NCT02795988|592423923|FG006|Phase 1b|Withdrawal by Subject|0|||
164016590|NCT02795988|592423917|FG000|Phase 1b|Death|1|||
164016591|NCT02795988|592423918|FG001|Phase 1b|Death|2|||
164016592|NCT02795988|592423919|FG002|Phase 1b|Death|1|||
164016593|NCT02795988|592423920|FG003|Phase 1b|Death|0|||
164016594|NCT02795988|592423921|FG004|Phase 1b|Death|0|||
164016595|NCT02795988|592423922|FG005|Phase 1b|Death|0|||
164016596|NCT02795988|592423923|FG006|Phase 1b|Death|0|||
164016597|NCT02795988|592423917|FG000|Phase 1b|Physician Decision|0|||
164016598|NCT02795988|592423918|FG001|Phase 1b|Physician Decision|0|||
164016599|NCT02795988|592423919|FG002|Phase 1b|Physician Decision|1|||
164016600|NCT02795988|592423920|FG003|Phase 1b|Physician Decision|0|||
164016601|NCT02795988|592423921|FG004|Phase 1b|Physician Decision|0|||
164016602|NCT02795988|592423922|FG005|Phase 1b|Physician Decision|0|||
164016603|NCT02795988|592423923|FG006|Phase 1b|Physician Decision|0|||
164093490|NCT00117949|592705357|FG003|Overall Study|PSA increase >=10ng/mL|0|||
164093491|NCT00117949|592705354|FG000|Overall Study|PSA reduction <=50%|0|||
164093492|NCT00117949|592705355|FG001|Overall Study|PSA reduction <=50%|2|||
164016604|NCT02795988|592423917|FG000|Phase 1b|Progressive Disease|2|||
164016605|NCT02795988|592423918|FG001|Phase 1b|Progressive Disease|2|||
164016606|NCT02795988|592423919|FG002|Phase 1b|Progressive Disease|0|||
164016607|NCT02795988|592423920|FG003|Phase 1b|Progressive Disease|0|||
164016608|NCT02795988|592423921|FG004|Phase 1b|Progressive Disease|0|||
164016609|NCT02795988|592423922|FG005|Phase 1b|Progressive Disease|0|||
164016610|NCT02795988|592423923|FG006|Phase 1b|Progressive Disease|0|||
164016611|NCT02795988|592423917|FG000|Phase 2|Withdrawal by Subject|0|||
164016612|NCT02795988|592423918|FG001|Phase 2|Withdrawal by Subject|0|||
164016613|NCT02795988|592423919|FG002|Phase 2|Withdrawal by Subject|0|||
164016614|NCT02795988|592423920|FG003|Phase 2|Withdrawal by Subject|1|||
164016615|NCT02795988|592423921|FG004|Phase 2|Withdrawal by Subject|0|||
164093493|NCT00117949|592705356|FG002|Overall Study|PSA reduction <=50%|2|||
164093494|NCT00117949|592705357|FG003|Overall Study|PSA reduction <=50%|4|||
164093495|NCT00117949|592705354|FG000|Overall Study|Hepatic abnormalities|0|||
164093496|NCT00117949|592705355|FG001|Overall Study|Hepatic abnormalities|1|||
164093497|NCT00117949|592705356|FG002|Overall Study|Hepatic abnormalities|0|||
164093498|NCT00117949|592705357|FG003|Overall Study|Hepatic abnormalities|1|||
164093499|NCT01974141|592705358|FG000|Overall Study|Other Reasons|28|||
164093500|NCT01974141|592705359|FG001|Overall Study|Other Reasons|18|||
164093501|NCT01974141|592705358|FG000|Overall Study|Protocol Violation|2|||
164093502|NCT01974141|592705359|FG001|Overall Study|Protocol Violation|6|||
164093503|NCT01974141|592705358|FG000|Overall Study|Personal Reasons|21|||
164093504|NCT01974141|592705359|FG001|Overall Study|Personal Reasons|20|||
164093505|NCT01974141|592705358|FG000|Overall Study|Lost to Follow-up|38|||
164093506|NCT01974141|592705359|FG001|Overall Study|Lost to Follow-up|29|||
164093507|NCT01974141|592705358|FG000|Overall Study|Pregnancy|3|||
164093508|NCT01974141|592705359|FG001|Overall Study|Pregnancy|3|||
164093509|NCT01974141|592705358|FG000|Overall Study|Lack of Efficacy|0|||
164093510|NCT01974141|592705359|FG001|Overall Study|Lack of Efficacy|1|||
164093511|NCT01974141|592705358|FG000|Overall Study|Adverse Event|4|||
164093512|NCT01974141|592705359|FG001|Overall Study|Adverse Event|5|||
164093513|NCT01867242|592705364|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
164093514|NCT01867242|592705365|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
164093515|NCT01867242|592705366|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
164093516|NCT00406848|592705367|FG000|Overall Study|Withdrawal by Subject|27|||
164093517|NCT00406848|592705368|FG001|Overall Study|Withdrawal by Subject|22|||
164093518|NCT00406848|592705367|FG000|Overall Study|Adverse Event|38|||
164093519|NCT00406848|592705368|FG001|Overall Study|Adverse Event|7|||
164093520|NCT00406848|592705367|FG000|Overall Study|Lack of Efficacy|9|||
164093521|NCT00406848|592705368|FG001|Overall Study|Lack of Efficacy|14|||
164093522|NCT00406848|592705367|FG000|Overall Study|Protocol Violation|10|||
164093523|NCT00406848|592705368|FG001|Overall Study|Protocol Violation|6|||
164093524|NCT00406848|592705367|FG000|Overall Study|Lost to Follow-up|6|||
164093525|NCT00406848|592705368|FG001|Overall Study|Lost to Follow-up|2|||
164093526|NCT00406848|592705367|FG000|Overall Study|Physician Decision|2|||
164093527|NCT00406848|592705368|FG001|Overall Study|Physician Decision|2|||
164093528|NCT00406848|592705367|FG000|Overall Study|Sponsor Decision|1|||
164093529|NCT00406848|592705368|FG001|Overall Study|Sponsor Decision|1|||
164093530|NCT04803357|592705369|FG000|Overall Study|Withdrawal by Subject|31|||
164093531|NCT04803357|592705370|FG001|Overall Study|Withdrawal by Subject|5|||
164093532|NCT02879643|592705372|FG000|Overall Study|Adverse Event|0|||
164093533|NCT02879643|592705373|FG001|Overall Study|Adverse Event|0|||
164093534|NCT02879643|592705374|FG002|Overall Study|Adverse Event|1|||
164093535|NCT02879643|592705375|FG003|Overall Study|Adverse Event|1|||
164093536|NCT02879643|592705376|FG004|Overall Study|Adverse Event|0|||
164093537|NCT00182091|592705377|FG000|Overall Study|Withdrawal by Subject|1|||
164093538|NCT00182091|592705378|FG001|Overall Study|Withdrawal by Subject|0|||
164093539|NCT00182091|592705379|FG002|Overall Study|Withdrawal by Subject|0|||
164093540|NCT00182091|592705380|FG003|Overall Study|Withdrawal by Subject|0|||
164093541|NCT01046253|592705381|FG000|Second Intervention|Adverse Event|0|||
164395286|NCT01358968|593815783|FG003|Period 2|Adverse Event|0|||
164395287|NCT01358968|593815780|FG000|Continued Access Phase|Progression of Disease|0|||
164395288|NCT01358968|593815781|FG001|Continued Access Phase|Progression of Disease|0|||
164395289|NCT01358968|593815782|FG002|Continued Access Phase|Progression of Disease|8|||
164093542|NCT01046253|592705382|FG001|Second Intervention|Adverse Event|1|||
164093543|NCT01046253|592705381|FG000|Second Intervention|Protocol Violation|0|||
164093544|NCT01046253|592705382|FG001|Second Intervention|Protocol Violation|1|||
164093545|NCT02339909|592705383|FG000|Overall Study|Became ineligible after randomisation|89|||
164093546|NCT02339909|592705384|FG001|Overall Study|Became ineligible after randomisation|63|||
164093547|NCT02339909|592705385|FG002|Overall Study|Became ineligible after randomisation|71|||
164093548|NCT00860028|592705386|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
164093549|NCT00860028|592705387|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
164395290|NCT01358968|593815783|FG003|Continued Access Phase|Progression of Disease|4|||
164395291|NCT01358968|593815780|FG000|Continued Access Phase|Protocol Violation|0|||
164395292|NCT01358968|593815781|FG001|Continued Access Phase|Protocol Violation|0|||
164395293|NCT01358968|593815782|FG002|Continued Access Phase|Protocol Violation|0|||
164395294|NCT01358968|593815783|FG003|Continued Access Phase|Protocol Violation|2|||
164395295|NCT01358968|593815780|FG000|Continued Access Phase|Withdrawal by Subject|0|||
164395296|NCT01358968|593815781|FG001|Continued Access Phase|Withdrawal by Subject|0|||
164093550|NCT02576990|592705388|FG000|Overall Study|Death|29|||
164093551|NCT02576990|592705389|FG001|Overall Study|Death|18|||
164093552|NCT02576990|592705388|FG000|Overall Study|Physician Decision|1|||
164093553|NCT02576990|592705389|FG001|Overall Study|Physician Decision|0|||
164395297|NCT01358968|593815782|FG002|Continued Access Phase|Withdrawal by Subject|3|||
164395298|NCT01358968|593815783|FG003|Continued Access Phase|Withdrawal by Subject|0|||
164395299|NCT01358968|593815780|FG000|Continued Access Phase|Death|0|||
164395300|NCT01358968|593815781|FG001|Continued Access Phase|Death|0|||
164395301|NCT01358968|593815782|FG002|Continued Access Phase|Death|1|||
164395302|NCT01358968|593815783|FG003|Continued Access Phase|Death|1|||
164395303|NCT01597050|593815784|FG000|Overall Study|Withdrawal by Subject|1|||
164395304|NCT01597050|593815785|FG001|Overall Study|Withdrawal by Subject|0|||
164395305|NCT00483184|593815786|FG000|Overall Study|Withdrawal by Subject|2|||
164395306|NCT00483184|593815787|FG001|Overall Study|Withdrawal by Subject|2|||
164395307|NCT00483184|593815788|FG002|Overall Study|Withdrawal by Subject|0|||
164395308|NCT00483184|593815786|FG000|Overall Study|Lost to Follow-up|1|||
164395309|NCT00483184|593815787|FG001|Overall Study|Lost to Follow-up|0|||
164395310|NCT00483184|593815788|FG002|Overall Study|Lost to Follow-up|0|||
164395311|NCT00483184|593815786|FG000|Overall Study|Adverse Event|1|||
164395312|NCT00483184|593815787|FG001|Overall Study|Adverse Event|2|||
164395313|NCT00483184|593815788|FG002|Overall Study|Adverse Event|2|||
164395314|NCT00483184|593815786|FG000|Overall Study|Protocol Violation|1|||
164395315|NCT00483184|593815787|FG001|Overall Study|Protocol Violation|0|||
164395316|NCT00483184|593815788|FG002|Overall Study|Protocol Violation|1|||
164395317|NCT00815295|593815794|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
164395318|NCT00815295|593815795|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
164093554|NCT02576990|592705388|FG000|Overall Study|Screen failure|2|||
164093555|NCT02576990|592705389|FG001|Overall Study|Screen failure|0|||
164093556|NCT02576990|592705388|FG000|Overall Study|Sponsor's decision|24|||
164093557|NCT02576990|592705389|FG001|Overall Study|Sponsor's decision|4|||
164093558|NCT02576990|592705388|FG000|Overall Study|Withdrawal by Subject|0|||
164093559|NCT02576990|592705389|FG001|Overall Study|Withdrawal by Subject|2|||
164093560|NCT00936390|592705390|FG000|Overall Study|Protocol Violation|21|||
164093561|NCT00936390|592705391|FG001|Overall Study|Protocol Violation|25|||
164093562|NCT02093689|592705392|FG000|Overall Study|Physician Decision|4|||
164093563|NCT02093689|592705393|FG001|Overall Study|Physician Decision|0|||
164093564|NCT02093689|592705394|FG002|Overall Study|Physician Decision|0|||
164093565|NCT03365947|592705395|FG000|Overall Study|Lost to Follow-up|0|||
164093566|NCT03365947|592705396|FG001|Overall Study|Lost to Follow-up|0|||
164093567|NCT03365947|592705397|FG002|Overall Study|Lost to Follow-up|0|||
164093568|NCT03365947|592705398|FG003|Overall Study|Lost to Follow-up|0|||
164093569|NCT03365947|592705399|FG004|Overall Study|Lost to Follow-up|0|||
164093570|NCT03365947|592705400|FG005|Overall Study|Lost to Follow-up|1|||
164093571|NCT03365947|592705401|FG006|Overall Study|Lost to Follow-up|0|||
164093572|NCT03365947|592705402|FG007|Overall Study|Lost to Follow-up|0|||
164093573|NCT03365947|592705403|FG008|Overall Study|Lost to Follow-up|0|||
164093574|NCT03365947|592705404|FG009|Overall Study|Lost to Follow-up|0|||
164093575|NCT03365947|592705405|FG010|Overall Study|Lost to Follow-up|0|||
164093576|NCT03365947|592705406|FG011|Overall Study|Lost to Follow-up|0|||
164093577|NCT03365947|592705407|FG012|Overall Study|Lost to Follow-up|0|||
164093578|NCT03365947|592705408|FG013|Overall Study|Lost to Follow-up|0|||
164093579|NCT03365947|592705409|FG014|Overall Study|Lost to Follow-up|0|||
164093580|NCT03365947|592705410|FG015|Overall Study|Lost to Follow-up|0|||
164093581|NCT03365947|592705411|FG016|Overall Study|Lost to Follow-up|0|||
164093582|NCT03365947|592705412|FG017|Overall Study|Lost to Follow-up|0|||
164093583|NCT03365947|592705413|FG018|Overall Study|Lost to Follow-up|0|||
164093584|NCT02518685|592705414|FG000|Overall Study|Adverse Event|29|||
164093585|NCT02518685|592705415|FG001|Overall Study|Adverse Event|1|||
164093586|NCT02518685|592705414|FG000|Overall Study|Withdrawal by Subject|10|||
164093587|NCT02518685|592705415|FG001|Overall Study|Withdrawal by Subject|3|||
164093588|NCT02518685|592705414|FG000|Overall Study|relocation, study fatigue|7|||
164093589|NCT02518685|592705415|FG001|Overall Study|relocation, study fatigue|2|||
164093590|NCT02518685|592705414|FG000|Overall Study|Pregnancy|1|||
164093591|NCT02518685|592705415|FG001|Overall Study|Pregnancy|0|||
164093592|NCT02518685|592705414|FG000|Overall Study|Physician Decision|1|||
164093593|NCT02518685|592705415|FG001|Overall Study|Physician Decision|0|||
164395319|NCT00815295|593815796|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
164093594|NCT02518685|592705414|FG000|Overall Study|Lost to Follow-up|1|||
164395320|NCT01618162|593815799|FG000|Overall Study|Protocol Violation|13|||
164395321|NCT01618162|593815800|FG001|Overall Study|Protocol Violation|10|||
164395322|NCT01618162|593815799|FG000|Overall Study|Adverse Event|9|||
164395323|NCT01618162|593815800|FG001|Overall Study|Adverse Event|2|||
164395324|NCT01618162|593815799|FG000|Overall Study|Withdrawal Criteria|2|||
164395325|NCT01618162|593815800|FG001|Overall Study|Withdrawal Criteria|10|||
164093595|NCT02518685|592705415|FG001|Overall Study|Lost to Follow-up|4|||
164093596|NCT01922349|592705416|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
164093597|NCT01922349|592705417|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
164093598|NCT01922349|592705418|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
164093599|NCT01922349|592705419|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
164093600|NCT05109234|592705420|FG000|Overall Study|Adverse Event|2|||
164395326|NCT01618162|593815799|FG000|Overall Study|Unclassified|14|||
164395327|NCT01618162|593815800|FG001|Overall Study|Unclassified|13|||
164395328|NCT03321396|593815801|FG000|Overall Study|Physician Decision|1|||
164395329|NCT00937924|593815803|FG000|Overall Study|Lost to Follow-up|44|||
163905523|NCT03737110|592025816|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
163905524|NCT03737110|592025817|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
163905525|NCT03737110|592025812|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163905526|NCT03737110|592025813|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163905527|NCT03737110|592025814|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163905528|NCT03737110|592025815|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163905529|NCT03737110|592025816|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
163905530|NCT03737110|592025817|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
163905531|NCT00599196|592025822|FG000|Overall Study|Lack of Efficacy|22|||
163905532|NCT00599196|592025822|FG000|Overall Study|Adverse Event|93|||
163905533|NCT00599196|592025822|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
163905534|NCT00599196|592025822|FG000|Overall Study|Subject withdrew consent|43|||
163905535|NCT00599196|592025822|FG000|Overall Study|Study ended per sponsor|197|||
163905536|NCT00599196|592025822|FG000|Overall Study|Lost to Follow-up|17|||
163905537|NCT00599196|592025822|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
163905538|NCT00599196|592025822|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
163905539|NCT00599196|592025822|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
163905540|NCT00599196|592025822|FG000|Overall Study|Other: Pt Moved To Australia|1|||
163905541|NCT00599196|592025822|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
163905542|NCT00599196|592025822|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
163905543|NCT01009645|592025827|FG000|Overall Study|Lost to Follow-up|2|||
163905544|NCT01009645|592025828|FG001|Overall Study|Lost to Follow-up|8|||
163905545|NCT01009645|592025829|FG002|Overall Study|Lost to Follow-up|4|||
163905546|NCT01009645|592025830|FG003|Overall Study|Lost to Follow-up|5|||
163905547|NCT04237792|592025833|FG000|Treatment (Day 1)|Adverse Event|1|||
163905548|NCT04237792|592025834|FG001|Treatment (Day 1)|Adverse Event|0|||
163905549|NCT04237792|592025835|FG002|Treatment (Day 1)|Adverse Event|0|||
163905550|NCT04237792|592025836|FG003|Treatment (Day 1)|Adverse Event|0|||
164016616|NCT02795988|592423922|FG005|Phase 2|Withdrawal by Subject|0|||
164016617|NCT02795988|592423923|FG006|Phase 2|Withdrawal by Subject|0|||
164016618|NCT02795988|592423917|FG000|Phase 2|Death|0|||
164016619|NCT02795988|592423918|FG001|Phase 2|Death|0|||
164016620|NCT02795988|592423919|FG002|Phase 2|Death|0|||
164016621|NCT02795988|592423920|FG003|Phase 2|Death|17|||
164016622|NCT02795988|592423921|FG004|Phase 2|Death|17|||
164016623|NCT02795988|592423922|FG005|Phase 2|Death|0|||
164016624|NCT02795988|592423923|FG006|Phase 2|Death|0|||
164016625|NCT02795988|592423917|FG000|Phase 2|Other|0|||
164016626|NCT02795988|592423918|FG001|Phase 2|Other|0|||
164016627|NCT02795988|592423919|FG002|Phase 2|Other|0|||
164016628|NCT02795988|592423920|FG003|Phase 2|Other|1|||
164016629|NCT02795988|592423921|FG004|Phase 2|Other|0|||
164016630|NCT02795988|592423922|FG005|Phase 2|Other|0|||
164016631|NCT02795988|592423923|FG006|Phase 2|Other|0|||
164016632|NCT02795988|592423917|FG000|Phase 2 Extension|Death|0|||
164016633|NCT02795988|592423918|FG001|Phase 2 Extension|Death|0|||
164016634|NCT02795988|592423919|FG002|Phase 2 Extension|Death|0|||
164016635|NCT02795988|592423920|FG003|Phase 2 Extension|Death|0|||
164016636|NCT02795988|592423921|FG004|Phase 2 Extension|Death|0|||
164016637|NCT02795988|592423922|FG005|Phase 2 Extension|Death|5|||
164016638|NCT02795988|592423923|FG006|Phase 2 Extension|Death|6|||
164016639|NCT02795988|592423917|FG000|Phase 2 Extension|Other reasons|0|||
164016640|NCT02795988|592423918|FG001|Phase 2 Extension|Other reasons|0|||
164016641|NCT02795988|592423919|FG002|Phase 2 Extension|Other reasons|0|||
164016642|NCT02795988|592423920|FG003|Phase 2 Extension|Other reasons|0|||
164093601|NCT05109234|592705421|FG001|Overall Study|Adverse Event|2|||
164395330|NCT00937924|593815804|FG001|Overall Study|Lost to Follow-up|44|||
164395331|NCT00937924|593815805|FG002|Overall Study|Lost to Follow-up|41|||
164395332|NCT00224874|593815806|FG000|Overall Study|Withdrawal by Subject|0|||
163905551|NCT04237792|592025837|FG004|Treatment (Day 1)|Adverse Event|1|||
163905552|NCT04237792|592025838|FG005|Treatment (Day 1)|Adverse Event|1|||
163905553|NCT04237792|592025833|FG000|Treatment (Day 1)|Other|0|||
164016643|NCT02795988|592423921|FG004|Phase 2 Extension|Other reasons|0|||
164016644|NCT02795988|592423922|FG005|Phase 2 Extension|Other reasons|2|||
164016645|NCT02795988|592423923|FG006|Phase 2 Extension|Other reasons|1|||
164016646|NCT02341014|592423924|FG000|Overall Study|Adverse Event|0|||
164016647|NCT02341014|592423925|FG001|Overall Study|Adverse Event|1|||
164016648|NCT02341014|592423926|FG002|Overall Study|Adverse Event|0|||
164016649|NCT02341014|592423927|FG003|Overall Study|Adverse Event|0|||
164016650|NCT02341014|592423928|FG004|Overall Study|Adverse Event|2|||
164016651|NCT00726323|592423929|FG000|Overall Study|Withdrawal by Subject|3|||
164016652|NCT00726323|592423930|FG001|Overall Study|Withdrawal by Subject|1|||
164016653|NCT00726323|592423929|FG000|Overall Study|Physician Decision|1|||
164093602|NCT05109234|592705420|FG000|Overall Study|Lack of Efficacy|5|||
164395333|NCT00224874|593815807|FG001|Overall Study|Withdrawal by Subject|0|||
164395334|NCT00224874|593815808|FG002|Overall Study|Withdrawal by Subject|1|||
164395335|NCT00224874|593815809|FG003|Overall Study|Withdrawal by Subject|0|||
164093603|NCT05109234|592705421|FG001|Overall Study|Lack of Efficacy|0|||
164093604|NCT05109234|592705420|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
164093605|NCT05109234|592705421|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
164093606|NCT05109234|592705420|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
164093607|NCT05109234|592705421|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
164093608|NCT05109234|592705420|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
164093609|NCT05109234|592705421|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
164093610|NCT05109234|592705420|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
164093611|NCT05109234|592705421|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
164093612|NCT05067504|592705423|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
164093613|NCT05067504|592705424|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
164093614|NCT05067504|592705423|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
164093615|NCT05067504|592705424|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
164093616|NCT05067504|592705423|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
164093617|NCT05067504|592705424|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
164093618|NCT03805438|592707245|FG000|Overall Study|Lack of Efficacy|1|||
164093619|NCT03805438|592707245|FG000|Overall Study|Protocol Violation|1|||
164093620|NCT02684344|592707246|FG000|Overall Study|Withdrawal by Subject|0|||
164093621|NCT02684344|592707247|FG001|Overall Study|Withdrawal by Subject|1|||
164093622|NCT01494506|592707251|FG000|Overall Study|Lack of Efficacy|77|||
164093623|NCT01494506|592707252|FG001|Overall Study|Lack of Efficacy|83|||
164093624|NCT01494506|592707253|FG002|Overall Study|Lack of Efficacy|57|||
164093625|NCT01494506|592707251|FG000|Overall Study|Adverse Event|17|||
164093626|NCT01494506|592707252|FG001|Overall Study|Adverse Event|10|||
164093627|NCT01494506|592707253|FG002|Overall Study|Adverse Event|11|||
164093628|NCT01494506|592707251|FG000|Overall Study|Death|9|||
164093629|NCT01494506|592707252|FG001|Overall Study|Death|5|||
164093630|NCT01494506|592707253|FG002|Overall Study|Death|2|||
164093631|NCT01494506|592707251|FG000|Overall Study|Physician Decision|7|||
164093632|NCT01494506|592707252|FG001|Overall Study|Physician Decision|5|||
164093633|NCT01494506|592707253|FG002|Overall Study|Physician Decision|4|||
164093634|NCT01494506|592707251|FG000|Overall Study|Withdrawal by Subject|17|||
164093635|NCT01494506|592707252|FG001|Overall Study|Withdrawal by Subject|20|||
164093636|NCT01494506|592707253|FG002|Overall Study|Withdrawal by Subject|14|||
164093637|NCT01494506|592707251|FG000|Overall Study|Clinical Deterioration|21|||
164093638|NCT01494506|592707252|FG001|Overall Study|Clinical Deterioration|17|||
164093639|NCT01494506|592707253|FG002|Overall Study|Clinical Deterioration|13|||
164395336|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
164395337|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
164395338|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
164395339|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
164395340|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
164395341|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
164395342|NCT02355002|593815810|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
164395343|NCT02355002|593815811|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
164395344|NCT02355002|593815810|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
164395345|NCT02355002|593815811|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
164395346|NCT02355002|593815810|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
164395347|NCT02355002|593815811|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
164395348|NCT02355002|593815810|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
164395349|NCT02355002|593815811|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
164395350|NCT05554237|593815812|FG000|Part 2 (7 Days)|Adverse Event|0|||
164395351|NCT05554237|593815813|FG001|Part 2 (7 Days)|Adverse Event|0|||
164395352|NCT05554237|593815814|FG002|Part 2 (7 Days)|Adverse Event|0|||
164395353|NCT05554237|593815815|FG003|Part 2 (7 Days)|Adverse Event|0|||
164395354|NCT05554237|593815816|FG004|Part 2 (7 Days)|Adverse Event|2|||
164395355|NCT05554237|593815817|FG005|Part 2 (7 Days)|Adverse Event|0|||
164395356|NCT05554237|593815818|FG006|Part 2 (7 Days)|Adverse Event|0|||
164395357|NCT05554237|593815819|FG007|Part 2 (7 Days)|Adverse Event|0|||
164093640|NCT01494506|592707251|FG000|Overall Study|Sponsor Decision|0|||
164093641|NCT01494506|592707252|FG001|Overall Study|Sponsor Decision|0|||
164395358|NCT05554237|593815820|FG008|Part 2 (7 Days)|Adverse Event|0|||
164093642|NCT01494506|592707253|FG002|Overall Study|Sponsor Decision|1|||
164093643|NCT01494506|592707251|FG000|Overall Study|Other|0|||
164093644|NCT01494506|592707252|FG001|Overall Study|Other|3|||
164093645|NCT01494506|592707253|FG002|Overall Study|Other|1|||
164093646|NCT02777528|592707255|FG000|Overall Study|Still in study|24|||
164093647|NCT02777528|592707256|FG001|Overall Study|Still in study|10|||
164093648|NCT02777528|592707257|FG002|Overall Study|Still in study|1|||
163905554|NCT04237792|592025834|FG001|Treatment (Day 1)|Other|0|||
163905555|NCT04237792|592025835|FG002|Treatment (Day 1)|Other|1|||
163905556|NCT04237792|592025836|FG003|Treatment (Day 1)|Other|0|||
163905557|NCT04237792|592025837|FG004|Treatment (Day 1)|Other|0|||
163905558|NCT04237792|592025838|FG005|Treatment (Day 1)|Other|1|||
163905559|NCT04237792|592025833|FG000|Treatment (Day 1)|Not treated|1|||
163905560|NCT04237792|592025834|FG001|Treatment (Day 1)|Not treated|1|||
163905561|NCT04237792|592025835|FG002|Treatment (Day 1)|Not treated|2|||
164016654|NCT00726323|592423930|FG001|Overall Study|Physician Decision|0|||
164016655|NCT00726323|592423929|FG000|Overall Study|Progressive disease|23|||
164016656|NCT00726323|592423930|FG001|Overall Study|Progressive disease|16|||
164016657|NCT00726323|592423929|FG000|Overall Study|Clinical progression|0|||
164395359|NCT05554237|593815821|FG009|Part 2 (7 Days)|Adverse Event|1|||
164395360|NCT05554237|593815822|FG010|Part 2 (7 Days)|Adverse Event|0|||
164395361|NCT05554237|593815823|FG011|Part 2 (7 Days)|Adverse Event|0|||
164395362|NCT05554237|593815824|FG012|Part 2 (7 Days)|Adverse Event|1|||
164395363|NCT05554237|593815825|FG013|Part 2 (7 Days)|Adverse Event|0|||
164395364|NCT03644186|593815826|FG000|Overall Study|Withdrawal by Subject|1|||
164395365|NCT03644186|593815827|FG001|Overall Study|Withdrawal by Subject|1|||
164395366|NCT02192502|593815829|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
164395367|NCT02192502|593815830|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
164395368|NCT02192502|593815829|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
164395369|NCT02192502|593815830|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
164395370|NCT02192502|593815829|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
164395371|NCT02192502|593815830|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
164395372|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
164395373|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
164395374|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
164016658|NCT00726323|592423930|FG001|Overall Study|Clinical progression|3|||
164016659|NCT00726323|592423929|FG000|Overall Study|Adverse Event|9|||
164395375|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
164395376|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
164395377|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
164395378|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
164395379|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
164395380|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
164395381|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
164395382|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
164395383|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
164395384|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
164395385|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
164395386|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
164395387|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
164395388|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
164395389|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
164395390|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
164395391|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
164395392|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
164395393|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
164395394|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
164395395|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
164395396|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
164395397|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
164395398|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
164395399|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
164395400|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
164395401|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
164395402|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
163905562|NCT04237792|592025836|FG003|Treatment (Day 1)|Not treated|1|||
163905563|NCT04237792|592025837|FG004|Treatment (Day 1)|Not treated|0|||
163905564|NCT04237792|592025838|FG005|Treatment (Day 1)|Not treated|1|||
164016660|NCT00726323|592423930|FG001|Overall Study|Adverse Event|9|||
164016661|NCT00726323|592423929|FG000|Overall Study|Death|1|||
164016662|NCT00726323|592423930|FG001|Overall Study|Death|0|||
163905565|NCT02788981|592025840|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
164016663|NCT00726323|592423929|FG000|Overall Study|Participant wished to discontinue|0|||
164016664|NCT00726323|592423930|FG001|Overall Study|Participant wished to discontinue|1|||
164395403|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
164395404|NCT04818346|593815834|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
164395405|NCT04818346|593815835|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
164395406|NCT04818346|593815836|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
164395407|NCT04818346|593815837|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
164395408|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
164395409|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
164395410|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
164395411|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
164395412|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
164395413|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
164395414|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
164395415|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
164395416|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
164395417|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
164395418|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
164395419|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
164395420|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
164395421|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
164395422|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
164395423|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
164395424|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
164395425|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
164395426|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
164395427|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
164395428|NCT04818346|593815834|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
164395429|NCT04818346|593815835|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
164395430|NCT04818346|593815836|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
164395431|NCT04818346|593815837|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
164395432|NCT05553808|593815838|FG000|Overall Study|Death|25|||
164395433|NCT05553808|593815839|FG001|Overall Study|Death|62|||
164395434|NCT05553808|593815838|FG000|Overall Study|Site Closed|6|||
164395435|NCT05553808|593815839|FG001|Overall Study|Site Closed|6|||
164395436|NCT05553808|593815838|FG000|Overall Study|Lost to Follow-up|1|||
164395437|NCT05553808|593815839|FG001|Overall Study|Lost to Follow-up|0|||
164395438|NCT05553808|593815838|FG000|Overall Study|Withdrawal by Subject|3|||
164395439|NCT05553808|593815839|FG001|Overall Study|Withdrawal by Subject|2|||
164395440|NCT02273141|593815840|FG000|Overall Study|Adverse Event|0|||
164395441|NCT02273141|593815841|FG001|Overall Study|Adverse Event|1|||
164395442|NCT02273141|593815840|FG000|Overall Study|Lost to Follow-up|1|||
164395443|NCT02273141|593815841|FG001|Overall Study|Lost to Follow-up|3|||
164395444|NCT02273141|593815840|FG000|Overall Study|Withdrawal by Subject|10|||
164395445|NCT02273141|593815841|FG001|Overall Study|Withdrawal by Subject|15|||
164395446|NCT02273141|593815840|FG000|Overall Study|Various|6|||
164395447|NCT02273141|593815841|FG001|Overall Study|Various|6|||
164395448|NCT04575467|593815845|FG000|Overall Study|Adverse Event|0|||
164395449|NCT04575467|593815846|FG001|Overall Study|Adverse Event|1|||
164395450|NCT04575467|593815847|FG002|Overall Study|Adverse Event|0|||
164395451|NCT04575467|593815848|FG003|Overall Study|Adverse Event|0|||
164395452|NCT01328574|593815849|FG000|Overall Study|Refused further treatment|1|||
164395453|NCT00729833|593815852|FG000|Overall Study|Death|5|||
164395454|NCT00729833|593815853|FG001|Overall Study|Death|1|||
164395455|NCT00729833|593815854|FG002|Overall Study|Death|3|||
164395456|NCT00729833|593815855|FG003|Overall Study|Death|5|||
164395457|NCT00729833|593815852|FG000|Overall Study|Study Terminated by Sponsor|0|||
164395458|NCT00729833|593815853|FG001|Overall Study|Study Terminated by Sponsor|0|||
164395459|NCT00729833|593815854|FG002|Overall Study|Study Terminated by Sponsor|1|||
163905566|NCT02788981|592025841|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
163905567|NCT05553366|592025842|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
163905568|NCT05553366|592025843|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
163905569|NCT05553366|592025844|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
163905570|NCT05553366|592025842|FG000|Overall Study|Lost to Follow-up|3|||
163905571|NCT05553366|592025843|FG001|Overall Study|Lost to Follow-up|3|||
163905572|NCT05553366|592025844|FG002|Overall Study|Lost to Follow-up|3|||
163905573|NCT05553366|592025842|FG000|Overall Study|Other non-compliance|1|||
163905574|NCT05553366|592025843|FG001|Overall Study|Other non-compliance|1|||
163905575|NCT05553366|592025844|FG002|Overall Study|Other non-compliance|0|||
163905576|NCT05553366|592025842|FG000|Overall Study|Randomized but not dosed|0|||
163905577|NCT05553366|592025843|FG001|Overall Study|Randomized but not dosed|0|||
164395460|NCT00729833|593815855|FG003|Overall Study|Study Terminated by Sponsor|0|||
164395461|NCT00729833|593815852|FG000|Overall Study|Lost to Follow-up|1|||
164395462|NCT00729833|593815853|FG001|Overall Study|Lost to Follow-up|0|||
164395463|NCT00729833|593815854|FG002|Overall Study|Lost to Follow-up|0|||
164395464|NCT00729833|593815855|FG003|Overall Study|Lost to Follow-up|0|||
164395465|NCT00729833|593815852|FG000|Overall Study|Withdrawal by Subject|3|||
164395466|NCT00729833|593815853|FG001|Overall Study|Withdrawal by Subject|1|||
164395467|NCT00729833|593815854|FG002|Overall Study|Withdrawal by Subject|3|||
164395468|NCT00729833|593815855|FG003|Overall Study|Withdrawal by Subject|0|||
163905578|NCT05553366|592025844|FG002|Overall Study|Randomized but not dosed|2|||
163905579|NCT00249769|592025845|FG000|Overall Study|Withdrawal by Subject|1|||
163905580|NCT00249769|592025846|FG001|Overall Study|Withdrawal by Subject|10|||
163905581|NCT00249769|592025847|FG002|Overall Study|Withdrawal by Subject|6|||
163905582|NCT00249769|592025845|FG000|Overall Study|Migration from Study Area|1|||
163905583|NCT00249769|592025846|FG001|Overall Study|Migration from Study Area|3|||
163905584|NCT00249769|592025847|FG002|Overall Study|Migration from Study Area|14|||
163905585|NCT00249769|592025845|FG000|Overall Study|Miscellaneous|0|||
163905586|NCT00249769|592025846|FG001|Overall Study|Miscellaneous|2|||
164395469|NCT00729833|593815852|FG000|Overall Study|Unspecified Reasons|11|||
164395470|NCT00729833|593815853|FG001|Overall Study|Unspecified Reasons|5|||
164395471|NCT00729833|593815854|FG002|Overall Study|Unspecified Reasons|5|||
163905587|NCT00249769|592025847|FG002|Overall Study|Miscellaneous|2|||
164395472|NCT00729833|593815855|FG003|Overall Study|Unspecified Reasons|1|||
164395473|NCT01922076|593815857|FG000|Overall Study|Adverse Event|0|||
164395474|NCT01922076|593815858|FG001|Overall Study|Adverse Event|0|||
164395475|NCT01922076|593815859|FG002|Overall Study|Adverse Event|0|||
164395476|NCT01922076|593815860|FG003|Overall Study|Adverse Event|0|||
164395477|NCT01922076|593815861|FG004|Overall Study|Adverse Event|1|||
164395478|NCT01922076|593815862|FG005|Overall Study|Adverse Event|0|||
164395479|NCT01922076|593815863|FG006|Overall Study|Adverse Event|0|||
164395480|NCT01922076|593815857|FG000|Overall Study|Physician Decision|0|||
164395481|NCT01922076|593815858|FG001|Overall Study|Physician Decision|0|||
164395482|NCT01922076|593815859|FG002|Overall Study|Physician Decision|1|||
164395483|NCT01922076|593815860|FG003|Overall Study|Physician Decision|0|||
164395484|NCT01922076|593815861|FG004|Overall Study|Physician Decision|0|||
164395485|NCT01922076|593815862|FG005|Overall Study|Physician Decision|0|||
164395486|NCT01922076|593815863|FG006|Overall Study|Physician Decision|0|||
164395487|NCT01922076|593815857|FG000|Overall Study|Withdrawal by Subject|0|||
164395488|NCT01922076|593815858|FG001|Overall Study|Withdrawal by Subject|0|||
164395489|NCT01922076|593815859|FG002|Overall Study|Withdrawal by Subject|0|||
164395490|NCT01922076|593815860|FG003|Overall Study|Withdrawal by Subject|1|||
164395491|NCT01922076|593815861|FG004|Overall Study|Withdrawal by Subject|0|||
164395492|NCT01922076|593815862|FG005|Overall Study|Withdrawal by Subject|1|||
164395493|NCT01922076|593815863|FG006|Overall Study|Withdrawal by Subject|1|||
164395494|NCT04598152|593815872|FG000|Overall Study|Lost to Follow-up|0|||
164395495|NCT04598152|593815873|FG001|Overall Study|Lost to Follow-up|1|||
164395496|NCT03346759|593815878|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
164395497|NCT03346759|593815879|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
164395498|NCT03346759|593815878|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
164395499|NCT03346759|593815879|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
164395500|NCT03346759|593815878|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
164395501|NCT03346759|593815879|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
164395502|NCT03943095|593815880|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
164395503|NCT03943095|593815881|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
164395504|NCT03943095|593815880|FG000|Overall Study|Withdrawal by Subject|1|||
164395505|NCT03943095|593815881|FG001|Overall Study|Withdrawal by Subject|0|||
164395506|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
164395507|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
164395508|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
164395509|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164395510|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164395511|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
164395512|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395513|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395514|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
164395515|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395516|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395517|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
164395518|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
164395519|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
164395520|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395521|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395522|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395523|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
164395524|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
164395525|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
164395526|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
164395527|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164395528|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164395529|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
164395530|NCT04988308|593815882|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
164395531|NCT04988308|593815883|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
164395532|NCT04988308|593815884|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
164395533|NCT04988308|593815885|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
164395534|NCT04988308|593815886|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
164395535|NCT04988308|593815887|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
164395536|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164395537|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164395538|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
164395539|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
164395540|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
164395541|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
164395542|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164395543|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164395544|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
164395545|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
164395546|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
164395547|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
164395548|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164395549|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164395550|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
164395551|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
164395552|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
164395553|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
164395554|NCT04988308|593815882|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
164395555|NCT04988308|593815883|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
164395556|NCT04988308|593815884|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
164395557|NCT04988308|593815885|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
164395558|NCT04988308|593815886|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
164395559|NCT04988308|593815887|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
164395560|NCT04177758|593815897|FG000|Overall Study|Lost to Follow-up|19|||
164395561|NCT04177758|593815898|FG001|Overall Study|Lost to Follow-up|11|||
164395562|NCT04918784|593817862|FG000|Overall Study|Amputation - no longer eligible|1|||
164395563|NCT04918784|593817863|FG001|Overall Study|Amputation - no longer eligible|2|||
164395564|NCT04918784|593817862|FG000|Overall Study|Death|1|||
164395565|NCT04918784|593817863|FG001|Overall Study|Death|0|||
164395566|NCT04918784|593817862|FG000|Overall Study|patient non-compliance|3|||
164395567|NCT04918784|593817863|FG001|Overall Study|patient non-compliance|1|||
164395568|NCT04918784|593817862|FG000|Overall Study|Adverse Event|1|||
164395569|NCT04918784|593817863|FG001|Overall Study|Adverse Event|0|||
164395570|NCT01712009|593817864|FG000|Overall Study|Withdrawal by Subject|24|||
164395571|NCT01712009|593817865|FG001|Overall Study|Withdrawal by Subject|15|||
164395572|NCT01712009|593817866|FG002|Overall Study|Withdrawal by Subject|8|||
164395573|NCT01712009|593817864|FG000|Overall Study|Lost to Follow-up|2|||
164395574|NCT01712009|593817865|FG001|Overall Study|Lost to Follow-up|0|||
164395575|NCT01712009|593817866|FG002|Overall Study|Lost to Follow-up|1|||
164395576|NCT01712009|593817864|FG000|Overall Study|Decision by Sponsor|12|||
164395577|NCT01712009|593817865|FG001|Overall Study|Decision by Sponsor|14|||
164395578|NCT01712009|593817866|FG002|Overall Study|Decision by Sponsor|12|||
164395579|NCT01111123|593817868|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
164395580|NCT01111123|593817869|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
164395581|NCT01111123|593817868|FG000|Maintenance Phase|Lost to Follow-up|0|||
164395582|NCT01111123|593817869|FG001|Maintenance Phase|Lost to Follow-up|2|||
164395583|NCT01986881|593817870|FG000|Overall Study|Death|228|||
164395584|NCT01986881|593817871|FG001|Overall Study|Death|233|||
164395585|NCT01986881|593817872|FG002|Overall Study|Death|247|||
164395586|NCT01986881|593817870|FG000|Overall Study|Lost to Follow-up|51|||
164395587|NCT01986881|593817871|FG001|Overall Study|Lost to Follow-up|44|||
164395588|NCT01986881|593817872|FG002|Overall Study|Lost to Follow-up|55|||
164395589|NCT01986881|593817870|FG000|Overall Study|Physician Decision|7|||
164395590|NCT01986881|593817871|FG001|Overall Study|Physician Decision|4|||
164395591|NCT01986881|593817872|FG002|Overall Study|Physician Decision|6|||
164395592|NCT01986881|593817870|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
164395593|NCT01986881|593817871|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
164395594|NCT01986881|593817872|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
164395595|NCT01986881|593817870|FG000|Overall Study|Withdrawal by Subject|41|||
164395596|NCT01986881|593817871|FG001|Overall Study|Withdrawal by Subject|60|||
163905588|NCT00249769|592025845|FG000|Overall Study|Adverse Event|0|||
163905589|NCT00249769|592025846|FG001|Overall Study|Adverse Event|0|||
163905590|NCT00249769|592025847|FG002|Overall Study|Adverse Event|1|||
164395597|NCT01986881|593817872|FG002|Overall Study|Withdrawal by Subject|45|||
164395598|NCT01986881|593817870|FG000|Overall Study|Subject Moved|0|||
164395599|NCT01986881|593817871|FG001|Overall Study|Subject Moved|1|||
164395600|NCT01986881|593817872|FG002|Overall Study|Subject Moved|0|||
163905591|NCT00249769|592025845|FG000|Overall Study|Physician Decision|0|||
163905592|NCT00249769|592025846|FG001|Overall Study|Physician Decision|0|||
164395601|NCT01986881|593817870|FG000|Overall Study|Other|1|||
164395602|NCT01986881|593817871|FG001|Overall Study|Other|2|||
164395603|NCT01986881|593817872|FG002|Overall Study|Other|2|||
164395604|NCT00677833|593817877|FG000|Overall Study|Withdrawal by Subject|4|||
164395605|NCT00677833|593817878|FG001|Overall Study|Withdrawal by Subject|0|||
163905593|NCT00249769|592025847|FG002|Overall Study|Physician Decision|2|||
163905594|NCT00249769|592025845|FG000|Overall Study|Lost to Follow-up|0|||
163905595|NCT00249769|592025846|FG001|Overall Study|Lost to Follow-up|0|||
163905596|NCT00249769|592025847|FG002|Overall Study|Lost to Follow-up|3|||
163905597|NCT02022657|592025852|FG000|Overall Study|Withdrawal by Subject|2|||
163905598|NCT02022657|592025853|FG001|Overall Study|Withdrawal by Subject|0|||
163905599|NCT02022657|592025854|FG002|Overall Study|Withdrawal by Subject|1|||
163905600|NCT02022657|592025855|FG003|Overall Study|Withdrawal by Subject|0|||
163905601|NCT02022657|592025856|FG004|Overall Study|Withdrawal by Subject|0|||
163905602|NCT02022657|592025857|FG005|Overall Study|Withdrawal by Subject|0|||
164395606|NCT00677833|593817879|FG002|Overall Study|Withdrawal by Subject|1|||
164395607|NCT00677833|593817880|FG003|Overall Study|Withdrawal by Subject|3|||
164395608|NCT00677833|593817877|FG000|Overall Study|Lost to Follow-up|0|||
164395609|NCT00677833|593817878|FG001|Overall Study|Lost to Follow-up|0|||
164395610|NCT00677833|593817879|FG002|Overall Study|Lost to Follow-up|1|||
164395611|NCT00677833|593817880|FG003|Overall Study|Lost to Follow-up|0|||
164395612|NCT02606279|593817881|FG000|Overall Study|Lost to Follow-up|0|||
164395613|NCT02606279|593817882|FG001|Overall Study|Lost to Follow-up|1|||
164395614|NCT01690130|593817885|FG000|Overall Study|Subject have cancelled visit.|1|||
163905603|NCT02022657|592025852|FG000|Overall Study|Physician Decision|0|||
163905604|NCT02022657|592025853|FG001|Overall Study|Physician Decision|0|||
163905605|NCT02022657|592025854|FG002|Overall Study|Physician Decision|0|||
163905606|NCT02022657|592025855|FG003|Overall Study|Physician Decision|0|||
163905607|NCT02022657|592025856|FG004|Overall Study|Physician Decision|0|||
163905608|NCT02022657|592025857|FG005|Overall Study|Physician Decision|1|||
163905609|NCT03274076|592025858|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
163905610|NCT03274076|592025859|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
163905611|NCT03274076|592025860|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
163905612|NCT03274076|592025861|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
164395615|NCT01690130|593817886|FG001|Overall Study|Subject have cancelled visit.|0|||
164395616|NCT02633800|593817887|FG000|Overall Study|Death|3|||
164395617|NCT02633800|593817888|FG001|Overall Study|Death|3|||
164395618|NCT02633800|593817887|FG000|Overall Study|Reason not provided|1|||
164395619|NCT02633800|593817888|FG001|Overall Study|Reason not provided|0|||
164395620|NCT02633800|593817887|FG000|Overall Study|Radiologic(al) progression|23|||
164395621|NCT02633800|593817888|FG001|Overall Study|Radiologic(al) progression|23|||
164395622|NCT02633800|593817887|FG000|Overall Study|Clinical progression|3|||
164395623|NCT02633800|593817888|FG001|Overall Study|Clinical progression|6|||
164395624|NCT02633800|593817887|FG000|Overall Study|Study terminated by sponsor|6|||
164395625|NCT02633800|593817888|FG001|Overall Study|Study terminated by sponsor|5|||
164395626|NCT02633800|593817887|FG000|Overall Study|Adverse event, non-fatal|7|||
164395627|NCT02633800|593817888|FG001|Overall Study|Adverse event, non-fatal|2|||
164395628|NCT02633800|593817887|FG000|Overall Study|Withdrawal by Subject|0|||
164395629|NCT02633800|593817888|FG001|Overall Study|Withdrawal by Subject|3|||
164395630|NCT02633800|593817887|FG000|Overall Study|Patient Request|1|||
164395631|NCT02633800|593817888|FG001|Overall Study|Patient Request|1|||
164395632|NCT02013622|593817889|FG000|Overall Study|Lost to Follow-up|10|||
164395633|NCT02013622|593817889|FG000|Overall Study|Adverse Event|3|||
164395634|NCT02013622|593817889|FG000|Overall Study|Met Withdrawal Criteria|3|||
164395635|NCT02013622|593817889|FG000|Overall Study|Withdrawal by Subject|6|||
164395636|NCT02013622|593817889|FG000|Overall Study|Protocol Deviation|1|||
164395637|NCT02013622|593817889|FG000|Overall Study|Lack of Efficacy|1|||
164395638|NCT04969198|593817892|FG000|Overall Study|Withdrawal by Subject|20|||
164395639|NCT04969198|593817892|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
164395640|NCT04969198|593817892|FG000|Overall Study|Lost to Follow-up|20|||
164395641|NCT01640808|593817893|FG000|Overall Study|Unable to continue dynamic CT|14|||
164395642|NCT01640808|593817894|FG001|Overall Study|Unable to continue dynamic CT|4|||
164395643|NCT01640808|593817893|FG000|Overall Study|Withdrawal by Subject|12|||
164395644|NCT01640808|593817894|FG001|Overall Study|Withdrawal by Subject|4|||
164395645|NCT01640808|593817893|FG000|Overall Study|Lost to Follow-up|4|||
164395646|NCT01640808|593817894|FG001|Overall Study|Lost to Follow-up|0|||
164395647|NCT01640808|593817893|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
164395648|NCT01640808|593817894|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
164395649|NCT01640808|593817893|FG000|Overall Study|Administration of anticancer drugs|2|||
164395650|NCT01640808|593817894|FG001|Overall Study|Administration of anticancer drugs|1|||
164395651|NCT01640808|593817893|FG000|Overall Study|Physician Decision|19|||
164395652|NCT01640808|593817894|FG001|Overall Study|Physician Decision|5|||
164395653|NCT01640808|593817893|FG000|Overall Study|Randomized but not treated|4|||
164395654|NCT01640808|593817894|FG001|Overall Study|Randomized but not treated|2|||
164395655|NCT02477111|593817895|FG000|Overall Study|Death|28|||
164395656|NCT02477111|593817895|FG000|Overall Study|Withdrawal by Subject|19|||
164395657|NCT02477111|593817895|FG000|Overall Study|Lost to Follow-up|4|||
164395658|NCT01381692|593817896|FG000|Overall Study|Adverse Event|1|||
164395659|NCT01381692|593817897|FG001|Overall Study|Adverse Event|0|||
164395660|NCT01381692|593817898|FG002|Overall Study|Adverse Event|0|||
164395661|NCT01381692|593817899|FG003|Overall Study|Adverse Event|0|||
164395662|NCT01381692|593817900|FG004|Overall Study|Adverse Event|0|||
164395663|NCT01381692|593817901|FG005|Overall Study|Adverse Event|0|||
164395664|NCT02189798|593817902|FG000|Extended Use Phase|Withdrawal by Subject|0|||
164395665|NCT02189798|593817903|FG001|Extended Use Phase|Withdrawal by Subject|4|||
164395666|NCT02189798|593817902|FG000|Extended Use Phase|Physician Decision|1|||
164395667|NCT02189798|593817903|FG001|Extended Use Phase|Physician Decision|0|||
164395668|NCT02189798|593817902|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
164395669|NCT02189798|593817903|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
164395670|NCT02189798|593817902|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
164395671|NCT02189798|593817903|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
164395672|NCT02189798|593817902|FG000|Extended Use Phase|Travel Issues|2|||
164395673|NCT02189798|593817903|FG001|Extended Use Phase|Travel Issues|1|||
164395674|NCT02189798|593817902|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
164395675|NCT02189798|593817903|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
164395676|NCT00529399|593817906|FG000|Overall Study|Lost to Follow-up|1|||
164395677|NCT00529399|593817907|FG001|Overall Study|Lost to Follow-up|0|||
164395678|NCT00529399|593817908|FG002|Overall Study|Lost to Follow-up|1|||
164395679|NCT00529399|593817906|FG000|Overall Study|Withdrawal by Subject|1|||
164395680|NCT00529399|593817907|FG001|Overall Study|Withdrawal by Subject|0|||
164395681|NCT00529399|593817908|FG002|Overall Study|Withdrawal by Subject|1|||
164395682|NCT00529399|593817906|FG000|Overall Study|Non-compliant|0|||
164395683|NCT00529399|593817907|FG001|Overall Study|Non-compliant|1|||
164395684|NCT00529399|593817908|FG002|Overall Study|Non-compliant|0|||
164395685|NCT03695172|593817909|FG000|Overall Study|Withdrawal by Subject|1|||
164395686|NCT03695172|593817910|FG001|Overall Study|Withdrawal by Subject|1|||
163905613|NCT03274076|592025858|FG000|24 Weeks Open Label|Adverse Event|0|||
163905614|NCT03274076|592025859|FG001|24 Weeks Open Label|Adverse Event|0|||
163905615|NCT03274076|592025860|FG002|24 Weeks Open Label|Adverse Event|2|||
163905616|NCT03274076|592025861|FG003|24 Weeks Open Label|Adverse Event|0|||
163905617|NCT03274076|592025858|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
163905618|NCT03274076|592025859|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
164395687|NCT03695172|593817911|FG002|Overall Study|Withdrawal by Subject|0|||
164395688|NCT01506193|593817912|FG000|Overall Study|Protocol Violation|1|||
164395689|NCT01506193|593817913|FG001|Overall Study|Protocol Violation|0|||
164395690|NCT01506193|593817914|FG002|Overall Study|Protocol Violation|1|||
164395691|NCT01506193|593817912|FG000|Overall Study|Migrated/moved from study area|0|||
164395692|NCT01506193|593817913|FG001|Overall Study|Migrated/moved from study area|0|||
164395693|NCT01506193|593817914|FG002|Overall Study|Migrated/moved from study area|1|||
164395694|NCT01506193|593817912|FG000|Overall Study|Adverse event, non-fatal|0|||
164395695|NCT01506193|593817913|FG001|Overall Study|Adverse event, non-fatal|0|||
164395696|NCT01506193|593817914|FG002|Overall Study|Adverse event, non-fatal|1|||
164395697|NCT01506193|593817912|FG000|Overall Study|Withdrawal by Subject|5|||
164395698|NCT01506193|593817913|FG001|Overall Study|Withdrawal by Subject|1|||
164395699|NCT01506193|593817914|FG002|Overall Study|Withdrawal by Subject|8|||
164395700|NCT01506193|593817912|FG000|Overall Study|Lost to Follow-up|8|||
164395701|NCT01506193|593817913|FG001|Overall Study|Lost to Follow-up|3|||
164395702|NCT01506193|593817914|FG002|Overall Study|Lost to Follow-up|3|||
164395703|NCT03206203|593817928|FG000|Treatment|Death|38|||
164395704|NCT03206203|593817929|FG001|Treatment|Death|26|||
164395705|NCT03206203|593817930|FG002|Treatment|Death|0|||
164395706|NCT03206203|593817928|FG000|Treatment|Withdrawal by Subject|1|||
164395707|NCT03206203|593817929|FG001|Treatment|Withdrawal by Subject|0|||
164395708|NCT03206203|593817930|FG002|Treatment|Withdrawal by Subject|0|||
164395709|NCT03206203|593817928|FG000|Treatment|Lost to Follow-up|4|||
164395710|NCT03206203|593817929|FG001|Treatment|Lost to Follow-up|0|||
164395711|NCT03206203|593817930|FG002|Treatment|Lost to Follow-up|0|||
164395712|NCT03206203|593817928|FG000|Treatment|N/A in Follow-Up|8|||
164395713|NCT03206203|593817929|FG001|Treatment|N/A in Follow-Up|1|||
164395714|NCT03206203|593817930|FG002|Treatment|N/A in Follow-Up|0|||
164395715|NCT03206203|593817928|FG000|Treatment|Disease progression|0|||
164395716|NCT03206203|593817929|FG001|Treatment|Disease progression|1|||
164395717|NCT03206203|593817930|FG002|Treatment|Disease progression|0|||
164395718|NCT03206203|593817928|FG000|Treatment|Refused follow-up|0|||
164395719|NCT03206203|593817929|FG001|Treatment|Refused follow-up|1|||
164395720|NCT03206203|593817930|FG002|Treatment|Refused follow-up|0|||
164395721|NCT03206203|593817928|FG000|Treatment|Cross over to Arm 1|0|||
164395722|NCT03206203|593817929|FG001|Treatment|Cross over to Arm 1|19|||
164395723|NCT03206203|593817930|FG002|Treatment|Cross over to Arm 1|0|||
164395724|NCT03206203|593817928|FG000|Optional Cross-Over|Death|0|||
164395725|NCT03206203|593817929|FG001|Optional Cross-Over|Death|0|||
164395726|NCT03206203|593817930|FG002|Optional Cross-Over|Death|14|||
164395727|NCT03206203|593817928|FG000|Optional Cross-Over|Refused follow-up|0|||
164395728|NCT03206203|593817929|FG001|Optional Cross-Over|Refused follow-up|0|||
164395729|NCT03206203|593817930|FG002|Optional Cross-Over|Refused follow-up|2|||
164395730|NCT01454583|593817939|FG000|1st Year|Lost to Follow-up|1057|||
164395731|NCT01454583|593817940|FG001|1st Year|Lost to Follow-up|318|||
164395732|NCT01454583|593817941|FG002|1st Year|Lost to Follow-up|180|||
164395733|NCT01454583|593817939|FG000|2nd Year|Lost to Follow-up|3965|||
164395734|NCT01454583|593817940|FG001|2nd Year|Lost to Follow-up|1049|||
164395735|NCT01454583|593817941|FG002|2nd Year|Lost to Follow-up|737|||
164395736|NCT01454583|593817939|FG000|3rd Year|Lost to Follow-up|1959|||
164395737|NCT01454583|593817940|FG001|3rd Year|Lost to Follow-up|512|||
164395738|NCT01454583|593817941|FG002|3rd Year|Lost to Follow-up|297|||
164395739|NCT04330638|593817942|FG000|Overall Study|Adverse Event|9|||
164395740|NCT04330638|593817943|FG001|Overall Study|Adverse Event|10|||
164395741|NCT04330638|593817944|FG002|Overall Study|Adverse Event|15|||
164395742|NCT04330638|593817945|FG003|Overall Study|Adverse Event|6|||
164395743|NCT04330638|593817946|FG004|Overall Study|Adverse Event|10|||
164395744|NCT04330638|593817947|FG005|Overall Study|Adverse Event|5|||
164395745|NCT04330638|593817942|FG000|Overall Study|Other|2|||
164395746|NCT04330638|593817943|FG001|Overall Study|Other|2|||
164395747|NCT04330638|593817944|FG002|Overall Study|Other|5|||
164395748|NCT04330638|593817945|FG003|Overall Study|Other|1|||
164093649|NCT02777528|592707255|FG000|Overall Study|Study Device Explanted|1|||
164093650|NCT02777528|592707256|FG001|Overall Study|Study Device Explanted|0|||
164093651|NCT02777528|592707257|FG002|Overall Study|Study Device Explanted|0|||
164395749|NCT04330638|593817946|FG004|Overall Study|Other|3|||
164395750|NCT04330638|593817947|FG005|Overall Study|Other|2|||
164395751|NCT04330638|593817942|FG000|Overall Study|Withdrawal by Subject|4|||
164395752|NCT04330638|593817943|FG001|Overall Study|Withdrawal by Subject|0|||
164395753|NCT04330638|593817944|FG002|Overall Study|Withdrawal by Subject|0|||
164395754|NCT04330638|593817945|FG003|Overall Study|Withdrawal by Subject|0|||
164395755|NCT04330638|593817946|FG004|Overall Study|Withdrawal by Subject|0|||
164395756|NCT04330638|593817947|FG005|Overall Study|Withdrawal by Subject|0|||
164395757|NCT04330638|593817942|FG000|Overall Study|Lost to Follow-up|3|||
164395758|NCT04330638|593817943|FG001|Overall Study|Lost to Follow-up|2|||
164395759|NCT04330638|593817944|FG002|Overall Study|Lost to Follow-up|3|||
164395760|NCT04330638|593817945|FG003|Overall Study|Lost to Follow-up|2|||
164395761|NCT04330638|593817946|FG004|Overall Study|Lost to Follow-up|3|||
164395762|NCT04330638|593817947|FG005|Overall Study|Lost to Follow-up|0|||
164395763|NCT01988779|593817951|FG000|Overall Study|Withdrawal by Subject|2|||
164395764|NCT01988779|593817952|FG001|Overall Study|Withdrawal by Subject|2|||
164395765|NCT01988779|593817951|FG000|Overall Study|Protocol Violation|1|||
164395766|NCT01988779|593817952|FG001|Overall Study|Protocol Violation|0|||
164395767|NCT00377403|593817955|FG000|Overall Study|Unable to contact for telephone intervie|4|||
164395768|NCT00377403|593817956|FG001|Overall Study|Unable to contact for telephone intervie|7|||
164395769|NCT02275065|593817957|FG000|Overall Study|Randomized but not treated|1|||
164395770|NCT02275065|593817958|FG001|Overall Study|Randomized but not treated|0|||
164395771|NCT02275065|593817959|FG002|Overall Study|Randomized but not treated|1|||
164395772|NCT02275065|593817960|FG003|Overall Study|Randomized but not treated|1|||
164395773|NCT02275065|593817961|FG004|Overall Study|Randomized but not treated|0|||
164395774|NCT00417079|593817963|FG000|Overall Study|Disease progression|267|||
164395775|NCT00417079|593817964|FG001|Overall Study|Disease progression|180|||
164395776|NCT00417079|593817963|FG000|Overall Study|Adverse Event|32|||
164395777|NCT00417079|593817964|FG001|Overall Study|Adverse Event|67|||
164395778|NCT00417079|593817963|FG000|Overall Study|Non-compliance to protocol|0|||
164395779|NCT00417079|593817964|FG001|Overall Study|Non-compliance to protocol|1|||
164395780|NCT00417079|593817963|FG000|Overall Study|Lost to Follow-up|2|||
164395781|NCT00417079|593817964|FG001|Overall Study|Lost to Follow-up|0|||
164395782|NCT00417079|593817963|FG000|Overall Study|Withdrawal by Subject|17|||
164395783|NCT00417079|593817964|FG001|Overall Study|Withdrawal by Subject|8|||
164395784|NCT00417079|593817963|FG000|Overall Study|Not treated|6|||
164395785|NCT00417079|593817964|FG001|Overall Study|Not treated|7|||
164395786|NCT00417079|593817963|FG000|Overall Study|Screened failure|2|||
164395787|NCT00417079|593817964|FG001|Overall Study|Screened failure|1|||
164395788|NCT00417079|593817963|FG000|Overall Study|Investigator's decision|1|||
164395789|NCT00417079|593817964|FG001|Overall Study|Investigator's decision|4|||
164395790|NCT00417079|593817963|FG000|Overall Study|Non-confirmed Disease progression|1|||
164395791|NCT00417079|593817964|FG001|Overall Study|Non-confirmed Disease progression|1|||
164395792|NCT00417079|593817963|FG000|Overall Study|Clinical deterioration|1|||
164395793|NCT00417079|593817964|FG001|Overall Study|Clinical deterioration|0|||
164395794|NCT00417079|593817963|FG000|Overall Study|Screening error|2|||
164395795|NCT00417079|593817964|FG001|Overall Study|Screening error|1|||
164395796|NCT00417079|593817963|FG000|Overall Study|Withdrawal by subject's family|0|||
164395797|NCT00417079|593817964|FG001|Overall Study|Withdrawal by subject's family|1|||
164395798|NCT00417079|593817963|FG000|Overall Study|Patient unable to come to the clinic|0|||
164395799|NCT00417079|593817964|FG001|Overall Study|Patient unable to come to the clinic|1|||
164395800|NCT00417079|593817963|FG000|Overall Study|abnormal liver function tests|0|||
164395801|NCT00417079|593817964|FG001|Overall Study|abnormal liver function tests|1|||
164395802|NCT01687257|593817965|FG000|Overall Study|Efficacy Failure|6|||
164395803|NCT01687257|593817966|FG001|Overall Study|Efficacy Failure|0|||
164395804|NCT01687257|593817967|FG002|Overall Study|Efficacy Failure|5|||
164395805|NCT01687257|593817965|FG000|Overall Study|Subject Withdrew Consent|1|||
164395806|NCT01687257|593817966|FG001|Overall Study|Subject Withdrew Consent|1|||
164395807|NCT01687257|593817967|FG002|Overall Study|Subject Withdrew Consent|1|||
164395808|NCT01687257|593817965|FG000|Overall Study|Adverse Event|1|||
164395809|NCT01687257|593817966|FG001|Overall Study|Adverse Event|0|||
164395810|NCT01687257|593817967|FG002|Overall Study|Adverse Event|0|||
164395811|NCT01687257|593817965|FG000|Overall Study|Investigator's Discretion|0|||
164395812|NCT01687257|593817966|FG001|Overall Study|Investigator's Discretion|3|||
164395813|NCT01687257|593817967|FG002|Overall Study|Investigator's Discretion|0|||
164395814|NCT04899349|593817968|FG000|Overall Study|Study terminated by Sponsor|2|||
164395815|NCT04899349|593817969|FG001|Overall Study|Study terminated by Sponsor|0|||
164395816|NCT03336619|593817971|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
164395817|NCT03336619|593817972|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
164395818|NCT03336619|593817971|FG000|Overall Study|Withdrawal by Subject|17|||
164395819|NCT03336619|593817972|FG001|Overall Study|Withdrawal by Subject|16|||
164395820|NCT03336619|593817971|FG000|Overall Study|Adverse Event|2|||
164395821|NCT03336619|593817972|FG001|Overall Study|Adverse Event|5|||
164395822|NCT03336619|593817971|FG000|Overall Study|Physician Decision|3|||
164395823|NCT03336619|593817972|FG001|Overall Study|Physician Decision|0|||
164395824|NCT01300546|593817973|FG000|Overall Study|Withdrawal by Subject|1|||
164395825|NCT01300546|593817974|FG001|Overall Study|Withdrawal by Subject|0|||
164395826|NCT01300546|593817973|FG000|Overall Study|Lost to Follow-up|0|||
164395827|NCT01300546|593817974|FG001|Overall Study|Lost to Follow-up|2|||
164093652|NCT02777528|592707255|FG000|Overall Study|Death|14|||
164395828|NCT01300546|593817973|FG000|Overall Study|Lack of Efficacy|0|||
164395829|NCT01300546|593817974|FG001|Overall Study|Lack of Efficacy|3|||
164395830|NCT01300546|593817973|FG000|Overall Study|Adverse Event|0|||
164395831|NCT01300546|593817974|FG001|Overall Study|Adverse Event|1|||
164395832|NCT02820623|593817975|FG000|Overall Study|Withdrawal by Subject|1|||
164395833|NCT02820623|593817976|FG001|Overall Study|Withdrawal by Subject|3|||
164395834|NCT02820623|593817977|FG002|Overall Study|Withdrawal by Subject|3|||
164395835|NCT02820623|593817975|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
164395836|NCT02820623|593817976|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
164093653|NCT02777528|592707256|FG001|Overall Study|Death|7|||
164395837|NCT02820623|593817977|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
164395838|NCT02820623|593817975|FG000|Overall Study|Therapist unable to enroll clients|1|||
164395839|NCT02820623|593817976|FG001|Overall Study|Therapist unable to enroll clients|1|||
164395840|NCT02820623|593817977|FG002|Overall Study|Therapist unable to enroll clients|3|||
164395841|NCT02820623|593817975|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
164395842|NCT02820623|593817976|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
164395843|NCT02820623|593817977|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
164395844|NCT05207813|593817980|FG000|Overall Study|Lost to Follow-up|2|||
164395845|NCT01954017|593817981|FG000|Overall Study|Adverse Event|0|||
164395846|NCT01954017|593817982|FG001|Overall Study|Adverse Event|0|||
164395847|NCT01954017|593817983|FG002|Overall Study|Adverse Event|1|||
164395848|NCT01954017|593817981|FG000|Overall Study|Death|2|||
164395849|NCT01954017|593817982|FG001|Overall Study|Death|1|||
164395850|NCT01954017|593817983|FG002|Overall Study|Death|1|||
164395851|NCT01954017|593817981|FG000|Overall Study|Withdrawal by Subject|0|||
164395852|NCT01954017|593817982|FG001|Overall Study|Withdrawal by Subject|1|||
164395853|NCT01954017|593817983|FG002|Overall Study|Withdrawal by Subject|0|||
164395854|NCT01954017|593817981|FG000|Overall Study|Protocol Violation|0|||
164395855|NCT01954017|593817982|FG001|Overall Study|Protocol Violation|3|||
164395856|NCT01954017|593817983|FG002|Overall Study|Protocol Violation|2|||
164395857|NCT01954017|593817981|FG000|Overall Study|Necrotizing enterocolitis|1|||
164395858|NCT01954017|593817982|FG001|Overall Study|Necrotizing enterocolitis|0|||
164395859|NCT01954017|593817983|FG002|Overall Study|Necrotizing enterocolitis|1|||
164395860|NCT01954017|593817981|FG000|Overall Study|Enteral intake stopped >7 days|0|||
164395861|NCT01954017|593817982|FG001|Overall Study|Enteral intake stopped >7 days|1|||
164395862|NCT01954017|593817983|FG002|Overall Study|Enteral intake stopped >7 days|1|||
164395863|NCT01954017|593817981|FG000|Overall Study|All other reasons|2|||
164395864|NCT01954017|593817982|FG001|Overall Study|All other reasons|2|||
164395865|NCT01954017|593817983|FG002|Overall Study|All other reasons|7|||
164395866|NCT02653482|593817986|FG000|Overall Study|Death|1|||
164395867|NCT02653482|593817987|FG001|Overall Study|Death|1|||
164395868|NCT01669122|593817988|FG000|Period I|Lost to Follow-up|1|||
164395869|NCT01669122|593817988|FG000|Washout Period II|Protocol Violation|2|||
164395870|NCT05132699|593817990|FG000|Overall Study|Withdrawal by Subject|3|||
164395871|NCT05132699|593817991|FG001|Overall Study|Withdrawal by Subject|0|||
164395872|NCT04370054|593817992|FG000|Treatment Phase|Lost to Follow-up|1|||
164395873|NCT04370054|593817992|FG000|Treatment Phase|Withdrawal by Subject|1|||
164395874|NCT04370054|593817992|FG000|Follow-Up Phase|Ongoing|75|||
164395875|NCT02096900|593817993|FG000|Overall Study|Did not receive medication|3|||
164395876|NCT02096900|593817994|FG001|Overall Study|Did not receive medication|1|||
164395877|NCT02096900|593817993|FG000|Overall Study|Surgery cancelled- medication received|1|||
164395878|NCT02096900|593817994|FG001|Overall Study|Surgery cancelled- medication received|1|||
164395879|NCT05557942|593817995|FG000|Overall Study|Death|0|||
164395880|NCT05557942|593817996|FG001|Overall Study|Death|0|||
164395881|NCT05557942|593817997|FG002|Overall Study|Death|0|||
164395882|NCT05557942|593817998|FG003|Overall Study|Death|2|||
164395883|NCT05557942|593817999|FG004|Overall Study|Death|1|||
164395884|NCT05557942|593818000|FG005|Overall Study|Death|1|||
164395885|NCT05557942|593817995|FG000|Overall Study|Physician Decision|1|||
164395886|NCT05557942|593817996|FG001|Overall Study|Physician Decision|1|||
164395887|NCT05557942|593817997|FG002|Overall Study|Physician Decision|2|||
164395888|NCT05557942|593817998|FG003|Overall Study|Physician Decision|3|||
164395889|NCT05557942|593817999|FG004|Overall Study|Physician Decision|0|||
164395890|NCT05557942|593818000|FG005|Overall Study|Physician Decision|2|||
164395891|NCT05557942|593817995|FG000|Overall Study|Study terminated by sponsor|17|||
164395892|NCT05557942|593817996|FG001|Overall Study|Study terminated by sponsor|17|||
164395893|NCT05557942|593817997|FG002|Overall Study|Study terminated by sponsor|14|||
164395894|NCT05557942|593817998|FG003|Overall Study|Study terminated by sponsor|40|||
164395895|NCT05557942|593817999|FG004|Overall Study|Study terminated by sponsor|45|||
164073024|NCT00552617|592632768|FG005|Overall Study|Lost to Follow-up|2|||
164395896|NCT05557942|593818000|FG005|Overall Study|Study terminated by sponsor|37|||
164395897|NCT05557942|593817995|FG000|Overall Study|Protocol Violation|0|||
164395898|NCT05557942|593817996|FG001|Overall Study|Protocol Violation|0|||
164395899|NCT05557942|593817997|FG002|Overall Study|Protocol Violation|0|||
164073025|NCT00552617|592632769|FG006|Overall Study|Lost to Follow-up|0|||
164395900|NCT05557942|593817998|FG003|Overall Study|Protocol Violation|0|||
164395901|NCT05557942|593817999|FG004|Overall Study|Protocol Violation|0|||
164395902|NCT05557942|593818000|FG005|Overall Study|Protocol Violation|1|||
164395903|NCT05557942|593817995|FG000|Overall Study|Withdrawal by Subject|0|||
164395904|NCT05557942|593817996|FG001|Overall Study|Withdrawal by Subject|0|||
164395905|NCT05557942|593817997|FG002|Overall Study|Withdrawal by Subject|0|||
164395906|NCT05557942|593817998|FG003|Overall Study|Withdrawal by Subject|0|||
164395907|NCT05557942|593817999|FG004|Overall Study|Withdrawal by Subject|2|||
164395908|NCT05557942|593818000|FG005|Overall Study|Withdrawal by Subject|0|||
164395909|NCT00710424|593818003|FG000|Overall Study|Adverse Event|30|||
164395910|NCT00710424|593818004|FG001|Overall Study|Adverse Event|12|||
164395911|NCT00710424|593818003|FG000|Overall Study|Lack of Efficacy|4|||
164395912|NCT00710424|593818004|FG001|Overall Study|Lack of Efficacy|5|||
164395913|NCT00710424|593818003|FG000|Overall Study|Withdrawal by Subject|5|||
164395914|NCT00710424|593818004|FG001|Overall Study|Withdrawal by Subject|3|||
164395915|NCT00710424|593818003|FG000|Overall Study|Lost to Follow-up|0|||
164395916|NCT00710424|593818004|FG001|Overall Study|Lost to Follow-up|1|||
164395917|NCT00710424|593818003|FG000|Overall Study|Refused medication, no side effects|1|||
164395918|NCT00710424|593818004|FG001|Overall Study|Refused medication, no side effects|0|||
164395919|NCT00710424|593818003|FG000|Overall Study|Non-compliance with stable analgesia|1|||
164395920|NCT00710424|593818004|FG001|Overall Study|Non-compliance with stable analgesia|0|||
164395921|NCT00710424|593818003|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
164395922|NCT00710424|593818004|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
164395923|NCT00710424|593818003|FG000|Overall Study|Subject thought medication changed|1|||
164395924|NCT00710424|593818004|FG001|Overall Study|Subject thought medication changed|0|||
164395925|NCT00710424|593818003|FG000|Overall Study|Ceased treatment due to travel|1|||
164395926|NCT00710424|593818004|FG001|Overall Study|Ceased treatment due to travel|0|||
164395927|NCT00710424|593818003|FG000|Overall Study|Subject preferred paracetamol|0|||
164395928|NCT00710424|593818004|FG001|Overall Study|Subject preferred paracetamol|1|||
164395929|NCT00710424|593818003|FG000|Overall Study|Felt good so stopped treatment|0|||
164395930|NCT00710424|593818004|FG001|Overall Study|Felt good so stopped treatment|1|||
164395931|NCT06273774|593818005|FG000|Overall Study|Participant was out of state.|0|||
164395932|NCT06273774|593818006|FG001|Overall Study|Participant was out of state.|0|||
164395933|NCT06273774|593818007|FG002|Overall Study|Participant was out of state.|0|||
164395934|NCT06273774|593818008|FG003|Overall Study|Participant was out of state.|0|||
164395935|NCT06273774|593818009|FG004|Overall Study|Participant was out of state.|0|||
164395936|NCT06273774|593818010|FG005|Overall Study|Participant was out of state.|1|||
164395937|NCT06273774|593818005|FG000|Overall Study|Lost to Follow-up|0|||
164395938|NCT06273774|593818006|FG001|Overall Study|Lost to Follow-up|0|||
164395939|NCT06273774|593818007|FG002|Overall Study|Lost to Follow-up|0|||
164395940|NCT06273774|593818008|FG003|Overall Study|Lost to Follow-up|0|||
164395941|NCT06273774|593818009|FG004|Overall Study|Lost to Follow-up|1|||
164395942|NCT06273774|593818010|FG005|Overall Study|Lost to Follow-up|0|||
164395943|NCT02097108|593818011|FG000|Overall Study|Adverse Event|1|||
164395944|NCT02097108|593818011|FG000|Overall Study|patient was abroad for 6 months|1|||
164395945|NCT00127608|593818014|FG000|Overall Study|VZV DNA negative|1|||
164395946|NCT04050865|593819600|FG000|Overall Study|Adverse Event|1|||
164395947|NCT04050865|593819601|FG001|Overall Study|Adverse Event|0|||
164395948|NCT04050865|593819600|FG000|Overall Study|no insert|1|||
164395949|NCT04050865|593819601|FG001|Overall Study|no insert|0|||
164395950|NCT04050865|593819600|FG000|Overall Study|Only 1 insert|2|||
164395951|NCT04050865|593819601|FG001|Overall Study|Only 1 insert|3|||
164395952|NCT04050865|593819600|FG000|Overall Study|Physician Decision|0|||
164395953|NCT04050865|593819601|FG001|Overall Study|Physician Decision|1|||
164395954|NCT04050865|593819600|FG000|Overall Study|Withdrawal by Subject|0|||
164395955|NCT04050865|593819601|FG001|Overall Study|Withdrawal by Subject|1|||
164395956|NCT02035332|593819603|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
164395957|NCT01258608|593819605|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
164395958|NCT01258608|593819606|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
164395959|NCT01258608|593819605|FG000|Overall Study|Clinical progression|1|||
164395960|NCT01258608|593819606|FG001|Overall Study|Clinical progression|0|||
164395961|NCT01258608|593819605|FG000|Overall Study|Sponsor decision|0|||
164395962|NCT01258608|593819606|FG001|Overall Study|Sponsor decision|1|||
164395963|NCT01258608|593819605|FG000|Overall Study|Physician Decision|6|||
164395964|NCT01258608|593819606|FG001|Overall Study|Physician Decision|1|||
164395965|NCT01258608|593819605|FG000|Overall Study|Lost to Follow-up|0|||
164395966|NCT01258608|593819606|FG001|Overall Study|Lost to Follow-up|1|||
164395967|NCT01258608|593819605|FG000|Overall Study|Lack of compliance|1|||
164395968|NCT01258608|593819606|FG001|Overall Study|Lack of compliance|0|||
164395969|NCT01258608|593819605|FG000|Overall Study|Lack of Efficacy|0|||
164395970|NCT01258608|593819606|FG001|Overall Study|Lack of Efficacy|1|||
164395971|NCT01258608|593819605|FG000|Overall Study|Adverse Event|6|||
164395972|NCT01258608|593819606|FG001|Overall Study|Adverse Event|10|||
164395973|NCT01258608|593819605|FG000|Overall Study|Withdrawal by Subject|6|||
164395974|NCT01258608|593819606|FG001|Overall Study|Withdrawal by Subject|5|||
164395975|NCT04205630|593819607|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
164395976|NCT04205630|593819607|FG000|Overall Study|Disease clinical progression|7|||
164395977|NCT04205630|593819607|FG000|Overall Study|Withdrawal by Subject|2|||
164395978|NCT04205630|593819607|FG000|Overall Study|Adverse Event|17|||
164395979|NCT04205630|593819607|FG000|Overall Study|Other|1|||
164395980|NCT00440531|593819615|FG000|Overall Study|Adverse Event|1|||
164395981|NCT00440531|593819616|FG001|Overall Study|Adverse Event|0|||
164395982|NCT00440531|593819617|FG002|Overall Study|Adverse Event|2|||
164395983|NCT00440531|593819615|FG000|Overall Study|Withdrawal by Subject|2|||
164395984|NCT00440531|593819616|FG001|Overall Study|Withdrawal by Subject|0|||
164395985|NCT00440531|593819617|FG002|Overall Study|Withdrawal by Subject|0|||
164395986|NCT00440531|593819615|FG000|Overall Study|Protocol Violation|1|||
164395987|NCT00440531|593819616|FG001|Overall Study|Protocol Violation|2|||
164395988|NCT00440531|593819617|FG002|Overall Study|Protocol Violation|0|||
164395989|NCT00440531|593819615|FG000|Overall Study|Lost to Follow-up|4|||
164395990|NCT00440531|593819616|FG001|Overall Study|Lost to Follow-up|3|||
164395991|NCT00440531|593819617|FG002|Overall Study|Lost to Follow-up|5|||
164395992|NCT00440531|593819615|FG000|Overall Study|see pre-assignment details|2|||
164395993|NCT00440531|593819616|FG001|Overall Study|see pre-assignment details|0|||
164395994|NCT00440531|593819617|FG002|Overall Study|see pre-assignment details|0|||
164395995|NCT00447057|593819618|FG000|Overall Study|Adverse Event|4|||
164395996|NCT00447057|593819619|FG001|Overall Study|Adverse Event|10|||
164395997|NCT00447057|593819620|FG002|Overall Study|Adverse Event|0|||
164395998|NCT00447057|593819621|FG003|Overall Study|Adverse Event|3|||
164395999|NCT00447057|593819618|FG000|Overall Study|Death due to study disease|6|||
164396000|NCT00447057|593819619|FG001|Overall Study|Death due to study disease|4|||
164396001|NCT00447057|593819620|FG002|Overall Study|Death due to study disease|1|||
164396002|NCT00447057|593819621|FG003|Overall Study|Death due to study disease|1|||
164396003|NCT00447057|593819618|FG000|Overall Study|Lost to Follow-up|0|||
164396004|NCT00447057|593819619|FG001|Overall Study|Lost to Follow-up|1|||
164396005|NCT00447057|593819620|FG002|Overall Study|Lost to Follow-up|0|||
164396006|NCT00447057|593819621|FG003|Overall Study|Lost to Follow-up|0|||
164396007|NCT00447057|593819618|FG000|Overall Study|Entry criteria not met|1|||
164396008|NCT00447057|593819619|FG001|Overall Study|Entry criteria not met|1|||
164396009|NCT00447057|593819620|FG002|Overall Study|Entry criteria not met|0|||
164396010|NCT00447057|593819621|FG003|Overall Study|Entry criteria not met|0|||
164396011|NCT00447057|593819618|FG000|Overall Study|Protocol Violation|0|||
164396012|NCT00447057|593819619|FG001|Overall Study|Protocol Violation|1|||
164396013|NCT00447057|593819620|FG002|Overall Study|Protocol Violation|0|||
164396014|NCT00447057|593819621|FG003|Overall Study|Protocol Violation|0|||
164396015|NCT00447057|593819618|FG000|Overall Study|Withdrawal by Subject|4|||
164396016|NCT00447057|593819619|FG001|Overall Study|Withdrawal by Subject|5|||
164396017|NCT00447057|593819620|FG002|Overall Study|Withdrawal by Subject|1|||
164396018|NCT00447057|593819621|FG003|Overall Study|Withdrawal by Subject|1|||
164396019|NCT00447057|593819618|FG000|Overall Study|Physician Decision|9|||
164396020|NCT00447057|593819619|FG001|Overall Study|Physician Decision|6|||
164396021|NCT00447057|593819620|FG002|Overall Study|Physician Decision|3|||
164396022|NCT00447057|593819621|FG003|Overall Study|Physician Decision|1|||
164396023|NCT00447057|593819618|FG000|Overall Study|Sponsor decision|1|||
164396024|NCT00447057|593819619|FG001|Overall Study|Sponsor decision|1|||
164396025|NCT00447057|593819620|FG002|Overall Study|Sponsor decision|0|||
164396026|NCT00447057|593819621|FG003|Overall Study|Sponsor decision|0|||
164396027|NCT00447057|593819618|FG000|Overall Study|Progressive disease|58|||
164396028|NCT00447057|593819619|FG001|Overall Study|Progressive disease|43|||
164396029|NCT00447057|593819620|FG002|Overall Study|Progressive disease|13|||
164396030|NCT00447057|593819621|FG003|Overall Study|Progressive disease|18|||
164396031|NCT00447057|593819618|FG000|Overall Study|Death due to adverse event|0|||
164396032|NCT00447057|593819619|FG001|Overall Study|Death due to adverse event|0|||
164396033|NCT00447057|593819620|FG002|Overall Study|Death due to adverse event|1|||
164396034|NCT00447057|593819621|FG003|Overall Study|Death due to adverse event|2|||
164396035|NCT00447057|593819618|FG000|Overall Study|Death, study drug related|0|||
164396036|NCT00447057|593819619|FG001|Overall Study|Death, study drug related|1|||
164396037|NCT00447057|593819620|FG002|Overall Study|Death, study drug related|0|||
164396038|NCT00447057|593819621|FG003|Overall Study|Death, study drug related|0|||
164396039|NCT00512148|593819622|FG000|Primay Study Period|Withdrawal by Subject|1|||
164396040|NCT00160680|593819629|FG000|Overall Study|Adverse Event|0|||
164396041|NCT00160680|593819630|FG001|Overall Study|Adverse Event|1|||
164396042|NCT00160680|593819629|FG000|Overall Study|Lack of Efficacy|2|||
164396043|NCT00160680|593819630|FG001|Overall Study|Lack of Efficacy|1|||
164396044|NCT00160680|593819629|FG000|Overall Study|Lost to Follow-up|3|||
163905619|NCT03274076|592025860|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
164396045|NCT00160680|593819630|FG001|Overall Study|Lost to Follow-up|2|||
164396046|NCT00160680|593819629|FG000|Overall Study|Withdrawal by Subject|4|||
164396047|NCT00160680|593819630|FG001|Overall Study|Withdrawal by Subject|9|||
164396048|NCT04493216|593819631|FG000|Overall Study|Study terminated by sponsor|30|||
164396049|NCT04493216|593819632|FG001|Overall Study|Study terminated by sponsor|33|||
164396050|NCT04493216|593819633|FG002|Overall Study|Study terminated by sponsor|28|||
164396051|NCT04493216|593819634|FG003|Overall Study|Study terminated by sponsor|27|||
164396052|NCT04493216|593819631|FG000|Overall Study|Withdrawal by Subject|2|||
164396053|NCT04493216|593819632|FG001|Overall Study|Withdrawal by Subject|1|||
164396054|NCT04493216|593819633|FG002|Overall Study|Withdrawal by Subject|1|||
164396055|NCT04493216|593819634|FG003|Overall Study|Withdrawal by Subject|2|||
164396056|NCT04493216|593819631|FG000|Overall Study|Protocol Violation|1|||
164396057|NCT04493216|593819632|FG001|Overall Study|Protocol Violation|2|||
164396058|NCT04493216|593819633|FG002|Overall Study|Protocol Violation|0|||
164396059|NCT04493216|593819634|FG003|Overall Study|Protocol Violation|2|||
164396060|NCT04493216|593819631|FG000|Overall Study|Physician Decision|0|||
164396061|NCT04493216|593819632|FG001|Overall Study|Physician Decision|0|||
164396062|NCT04493216|593819633|FG002|Overall Study|Physician Decision|1|||
164396063|NCT04493216|593819634|FG003|Overall Study|Physician Decision|0|||
164396064|NCT04493216|593819631|FG000|Overall Study|Lost to Follow-up|2|||
164396065|NCT04493216|593819632|FG001|Overall Study|Lost to Follow-up|1|||
164396066|NCT04493216|593819633|FG002|Overall Study|Lost to Follow-up|0|||
164396067|NCT04493216|593819634|FG003|Overall Study|Lost to Follow-up|1|||
164396068|NCT04493216|593819631|FG000|Overall Study|Adverse Event|1|||
164396069|NCT04493216|593819632|FG001|Overall Study|Adverse Event|4|||
164396070|NCT04493216|593819633|FG002|Overall Study|Adverse Event|5|||
164396071|NCT04493216|593819634|FG003|Overall Study|Adverse Event|2|||
164396072|NCT04493216|593819631|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
164396073|NCT04493216|593819632|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
164396074|NCT04493216|593819633|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
164396075|NCT04493216|593819634|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
164396076|NCT04605978|593819647|FG000|Overall Study|Adverse Event|2|||
164396077|NCT04605978|593819648|FG001|Overall Study|Adverse Event|1|||
164396078|NCT04605978|593819647|FG000|Overall Study|Withdrawal nonmedical reason|1|||
164016665|NCT00726323|592423929|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
164396079|NCT04605978|593819648|FG001|Overall Study|Withdrawal nonmedical reason|1|||
164396080|NCT02583425|593819649|FG000|Screening|Did not meet entry criteria|12|||
164396081|NCT02583425|593819649|FG000|Baseline|Did not meet continued criteria|5|||
164396082|NCT02583425|593819649|FG000|Treatment Period|Adverse Event|1|||
164396083|NCT01644734|593819650|FG000|Overall Study|Adverse Event|4|||
164396084|NCT01644734|593819650|FG000|Overall Study|Lost to Follow-up|17|||
164396085|NCT01644734|593819650|FG000|Overall Study|Reasons other than stated above|7|||
164396086|NCT01644734|593819650|FG000|Overall Study|Missing documentation|238|||
164396087|NCT02216123|593819651|FG000|Overall Study|Lost to Follow-up|4|||
164396088|NCT02216123|593819652|FG001|Overall Study|Lost to Follow-up|2|||
164396089|NCT02216123|593819651|FG000|Overall Study|Withdrawal by Subject|2|||
164396090|NCT02216123|593819652|FG001|Overall Study|Withdrawal by Subject|0|||
164396091|NCT03318523|593819657|FG000|PC Period: Up to Year 1|Adverse Event|1|||
164396092|NCT03318523|593819658|FG001|PC Period: Up to Year 1|Adverse Event|0|||
164396093|NCT03318523|593819659|FG002|PC Period: Up to Year 1|Adverse Event|2|||
164396094|NCT03318523|593819660|FG003|PC Period: Up to Year 1|Adverse Event|0|||
164396095|NCT03318523|593819661|FG004|PC Period: Up to Year 1|Adverse Event|0|||
164016666|NCT00726323|592423930|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
164016667|NCT05058664|592423931|FG000|Overall Study|No follow-up data provided|4|||
164396096|NCT03318523|593819662|FG005|PC Period: Up to Year 1|Adverse Event|0|||
164396097|NCT03318523|593819663|FG006|PC Period: Up to Year 1|Adverse Event|0|||
164396098|NCT03318523|593819664|FG007|PC Period: Up to Year 1|Adverse Event|0|||
164396099|NCT03318523|593819665|FG008|PC Period: Up to Year 1|Adverse Event|0|||
164396100|NCT03318523|593819666|FG009|PC Period: Up to Year 1|Adverse Event|0|||
164396101|NCT03318523|593819657|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
164396102|NCT03318523|593819658|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
164396103|NCT03318523|593819659|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396104|NCT03318523|593819660|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
164396105|NCT03318523|593819661|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396106|NCT03318523|593819662|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396107|NCT03318523|593819663|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396108|NCT03318523|593819664|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396109|NCT03318523|593819665|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396110|NCT03318523|593819666|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
164396111|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396112|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164016668|NCT05058664|592423932|FG001|Overall Study|No follow-up data provided|0|||
164396113|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396114|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396115|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
164396116|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396117|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396118|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
164396119|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
164396120|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
164396121|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396122|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396123|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396124|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396125|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
164396126|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396127|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
164396128|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
164396129|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
164396130|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
164396131|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396132|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396133|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396134|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396135|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396136|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
164396137|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396138|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396139|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396140|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
164396141|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396142|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396143|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396144|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396145|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396146|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396147|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396148|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396149|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
164396150|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
164396151|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396152|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396153|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396154|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
164396155|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
164396156|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
164396157|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
164396158|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
164396159|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
164396160|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
164396161|NCT03318523|593819657|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396162|NCT03318523|593819658|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396163|NCT03318523|593819659|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396164|NCT03318523|593819660|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396165|NCT03318523|593819661|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
164396166|NCT03318523|593819662|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396167|NCT03318523|593819663|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
164396168|NCT03318523|593819664|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
164396169|NCT03318523|593819665|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
164396170|NCT03318523|593819666|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
163905620|NCT03274076|592025861|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
163905621|NCT00795184|592025863|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
163905622|NCT00795184|592025864|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
163905623|NCT03781375|592025865|FG000|Double-blind Phase|Adverse Event|0|||
163905624|NCT03781375|592025866|FG001|Double-blind Phase|Adverse Event|1|||
163905625|NCT03781375|592025865|FG000|Double-blind Phase|Lack of Response|6|||
163905626|NCT03781375|592025866|FG001|Double-blind Phase|Lack of Response|2|||
163905627|NCT03781375|592025865|FG000|Double-blind Phase|Other|1|||
163905628|NCT03781375|592025866|FG001|Double-blind Phase|Other|3|||
163905629|NCT03781375|592025865|FG000|Open-label Phase|Protocol Issues|0|||
163905630|NCT03781375|592025866|FG001|Open-label Phase|Protocol Issues|1|||
163905631|NCT03781375|592025865|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
163905632|NCT03781375|592025866|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
163905633|NCT03781375|592025865|FG000|Open-label Phase|Other|2|||
163905634|NCT03781375|592025866|FG001|Open-label Phase|Other|2|||
163905635|NCT01629589|592025867|FG000|Overall Study|Protocol Violation|4|||
163905636|NCT01629589|592025868|FG001|Overall Study|Protocol Violation|2|||
163905637|NCT01629589|592025867|FG000|Overall Study|Lost to Follow-up|2|||
163905638|NCT01629589|592025868|FG001|Overall Study|Lost to Follow-up|1|||
163905639|NCT01629589|592025867|FG000|Overall Study|Withdrawal by Subject|2|||
163905640|NCT01629589|592025868|FG001|Overall Study|Withdrawal by Subject|3|||
163905641|NCT01629589|592025867|FG000|Overall Study|Did not receive study vaccine|0|||
163905642|NCT01629589|592025868|FG001|Overall Study|Did not receive study vaccine|1|||
163905643|NCT01530334|592025869|FG000|Overall Study|Adverse Event|3|||
163905644|NCT01530334|592025869|FG000|Overall Study|unknown reason|1|||
163905645|NCT01530334|592025869|FG000|Overall Study|Progressive disease|47|||
163905646|NCT01303510|592025871|FG000|Overall Study|Lost to Follow-up|1|||
163905647|NCT01303510|592025872|FG001|Overall Study|Lost to Follow-up|0|||
163905648|NCT02079649|592025873|FG000|Overall Study|Lost to Follow-up|0|||
163905649|NCT02079649|592025874|FG001|Overall Study|Lost to Follow-up|0|||
163905650|NCT02079649|592025875|FG002|Overall Study|Lost to Follow-up|0|||
163905651|NCT02079649|592025876|FG003|Overall Study|Lost to Follow-up|1|||
163905652|NCT02079649|592025873|FG000|Overall Study|Withdrawal by Subject|0|||
163905653|NCT02079649|592025874|FG001|Overall Study|Withdrawal by Subject|0|||
163905654|NCT02079649|592025875|FG002|Overall Study|Withdrawal by Subject|0|||
163905655|NCT02079649|592025876|FG003|Overall Study|Withdrawal by Subject|1|||
163905656|NCT02079649|592025873|FG000|Overall Study|Randomization error (prior to treatment)|1|||
163905657|NCT02079649|592025874|FG001|Overall Study|Randomization error (prior to treatment)|0|||
163905658|NCT02079649|592025875|FG002|Overall Study|Randomization error (prior to treatment)|1|||
163905659|NCT02079649|592025876|FG003|Overall Study|Randomization error (prior to treatment)|0|||
163905660|NCT01932970|592025899|FG000|Overall Study|Withdrawal by Subject|5|||
163905661|NCT01932970|592025899|FG000|Overall Study|Death|1|||
163905662|NCT01932970|592025899|FG000|Overall Study|Lost to Follow-up|2|||
163905663|NCT01932970|592025899|FG000|Overall Study|Protocol Specified Criteria|10|||
164396171|NCT02163733|593819672|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
164396172|NCT02163733|593819673|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
164396173|NCT02163733|593819674|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
164396174|NCT02163733|593819672|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
164396175|NCT02163733|593819673|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
164396176|NCT02163733|593819674|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
164396177|NCT01615328|593819677|FG000|Overall Study|Lost to Follow-up|3|||
164396178|NCT01615328|593819678|FG001|Overall Study|Lost to Follow-up|5|||
164396179|NCT02157779|593819679|FG000|Overall Study|Logistical|9|||
164396180|NCT02157779|593819680|FG001|Overall Study|Logistical|3|||
164396181|NCT02157779|593819679|FG000|Overall Study|Stopped attending, reason unknown|11|||
164396182|NCT02157779|593819680|FG001|Overall Study|Stopped attending, reason unknown|7|||
164396183|NCT02157779|593819679|FG000|Overall Study|No response to outreach after Baseline|1|||
164396184|NCT02157779|593819680|FG001|Overall Study|No response to outreach after Baseline|1|||
164396185|NCT02157779|593819679|FG000|Overall Study|Moved|1|||
164396186|NCT02157779|593819680|FG001|Overall Study|Moved|0|||
163905664|NCT00822900|592025900|FG000|Overall Study|Withdrawal by Subject|14|||
163905665|NCT00822900|592025901|FG001|Overall Study|Withdrawal by Subject|14|||
163905666|NCT00822900|592025900|FG000|Overall Study|Lost to Follow-up|9|||
163905667|NCT00822900|592025901|FG001|Overall Study|Lost to Follow-up|9|||
163905668|NCT00822900|592025900|FG000|Overall Study|Death|83|||
163905669|NCT00822900|592025901|FG001|Overall Study|Death|69|||
163905670|NCT00822900|592025900|FG000|Overall Study|Became a ward of the state|2|||
163905671|NCT00822900|592025901|FG001|Overall Study|Became a ward of the state|1|||
163905672|NCT01968967|592025902|FG000|Treatment Period|Other|22|||
163905673|NCT01968967|592025903|FG001|Treatment Period|Other|22|||
164396187|NCT02157779|593819679|FG000|Overall Study|Medical|1|||
163905674|NCT01968967|592025904|FG002|Treatment Period|Other|0|||
163905675|NCT01968967|592025905|FG003|Treatment Period|Other|0|||
163905676|NCT01968967|592025906|FG004|Treatment Period|Other|0|||
163905677|NCT01968967|592025902|FG000|Treatment Period|Withdrawal by Subject|71|||
163905678|NCT01968967|592025903|FG001|Treatment Period|Withdrawal by Subject|61|||
163905679|NCT01968967|592025904|FG002|Treatment Period|Withdrawal by Subject|0|||
164396188|NCT02157779|593819680|FG001|Overall Study|Medical|0|||
164396189|NCT02157779|593819679|FG000|Overall Study|Legal issue|1|||
164396190|NCT02157779|593819680|FG001|Overall Study|Legal issue|0|||
164396191|NCT00487162|593819684|FG000|Overall Study|Adverse Event|0|||
164396192|NCT00487162|593819685|FG001|Overall Study|Adverse Event|1|||
164396193|NCT00487162|593819684|FG000|Overall Study|Physician Decision|0|||
164396194|NCT00487162|593819685|FG001|Overall Study|Physician Decision|1|||
164396195|NCT00487162|593819684|FG000|Overall Study|Withdrawal by Subject|2|||
164396196|NCT00487162|593819685|FG001|Overall Study|Withdrawal by Subject|3|||
164396197|NCT00530855|593819686|FG000|Overall Study|Lack of Efficacy|20|||
164396198|NCT00530855|593819686|FG000|Overall Study|Withdrawal by Subject|30|||
164396199|NCT00530855|593819686|FG000|Overall Study|Fatal Serious AE|3|||
164396200|NCT00530855|593819686|FG000|Overall Study|Non Fatal Serious AE|7|||
164396201|NCT00530855|593819686|FG000|Overall Study|Non Fatal Non Serious AE|12|||
164396202|NCT00530855|593819686|FG000|Overall Study|Protocol Violation|3|||
164396203|NCT00530855|593819686|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
164396204|NCT00530855|593819686|FG000|Overall Study|Lost to Follow-up|9|||
164396205|NCT00530855|593819686|FG000|Overall Study|Other reason for premature termination|17|||
164396206|NCT01654549|593819705|FG000|Overall Study|H.pylori eradication not successful|0|||
164396207|NCT01654549|593819706|FG001|Overall Study|H.pylori eradication not successful|1|||
164396208|NCT03152526|593819707|FG000|Overall Study|Withdrawal by Subject|0|||
164396209|NCT03152526|593819708|FG001|Overall Study|Withdrawal by Subject|1|||
164396210|NCT05130970|593819709|FG000|Overall Study|Adverse Event|1|||
164396211|NCT05130970|593819710|FG001|Overall Study|Adverse Event|1|||
164396212|NCT05130970|593819709|FG000|Overall Study|Death|0|||
164396213|NCT05130970|593819710|FG001|Overall Study|Death|1|||
164396214|NCT05130970|593819709|FG000|Overall Study|Lost to Follow-up|0|||
164396215|NCT05130970|593819710|FG001|Overall Study|Lost to Follow-up|1|||
164396216|NCT05130970|593819709|FG000|Overall Study|Physician Decision|0|||
164396217|NCT05130970|593819710|FG001|Overall Study|Physician Decision|1|||
164396218|NCT05130970|593819709|FG000|Overall Study|Withdrawal by Subject|1|||
164396219|NCT05130970|593819710|FG001|Overall Study|Withdrawal by Subject|1|||
164396220|NCT02701985|593819711|FG000|Overall Study|Withdrawal by Subject|1|||
164396221|NCT02701985|593819712|FG001|Overall Study|Withdrawal by Subject|1|||
164396222|NCT02701985|593819711|FG000|Overall Study|Lost to Follow-up|1|||
164396223|NCT02701985|593819712|FG001|Overall Study|Lost to Follow-up|0|||
164396224|NCT02701985|593819711|FG000|Overall Study|Death|1|||
164396225|NCT02701985|593819712|FG001|Overall Study|Death|0|||
164396226|NCT02701985|593819711|FG000|Overall Study|Adverse Event|0|||
164396227|NCT02701985|593819712|FG001|Overall Study|Adverse Event|5|||
164396228|NCT01362140|593819714|FG000|Overall Study|Noncompliance|1|||
164396229|NCT01362140|593819715|FG001|Overall Study|Noncompliance|0|||
164396230|NCT01362140|593819714|FG000|Overall Study|Adverse Event|2|||
164396231|NCT01362140|593819715|FG001|Overall Study|Adverse Event|2|||
164396232|NCT01362140|593819714|FG000|Overall Study|Withdrawal by Subject|3|||
164396233|NCT01362140|593819715|FG001|Overall Study|Withdrawal by Subject|3|||
164396234|NCT01362140|593819714|FG000|Overall Study|Administrative Decision|0|||
164396235|NCT01362140|593819715|FG001|Overall Study|Administrative Decision|1|||
164396236|NCT01362140|593819714|FG000|Overall Study|Death|2|||
164396237|NCT01362140|593819715|FG001|Overall Study|Death|1|||
164396238|NCT01362140|593819714|FG000|Overall Study|Other|1|||
164396239|NCT01362140|593819715|FG001|Overall Study|Other|1|||
164396240|NCT01362140|593819714|FG000|Overall Study|Protocol-specified Criteria|1|||
164396241|NCT01362140|593819715|FG001|Overall Study|Protocol-specified Criteria|2|||
164396242|NCT01362140|593819714|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
164396243|NCT01362140|593819715|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
164396244|NCT01556438|593819716|FG000|Overall Study|Adverse Event|4|||
164396245|NCT01556438|593819717|FG001|Overall Study|Adverse Event|2|||
164396246|NCT01556438|593819716|FG000|Overall Study|Sponsor Decision|0|||
164396247|NCT01556438|593819717|FG001|Overall Study|Sponsor Decision|2|||
164396248|NCT01556438|593819716|FG000|Overall Study|Progressive Disease|0|||
164396249|NCT01556438|593819717|FG001|Overall Study|Progressive Disease|6|||
164396250|NCT01556438|593819716|FG000|Overall Study|Death|0|||
164396251|NCT01556438|593819717|FG001|Overall Study|Death|1|||
164396252|NCT01388816|593819718|FG000|Overall Study|Adverse Event|0|||
164396253|NCT01388816|593819719|FG001|Overall Study|Adverse Event|2|||
164396254|NCT01388816|593819720|FG002|Overall Study|Adverse Event|0|||
164396255|NCT01388816|593819721|FG003|Overall Study|Adverse Event|0|||
164396256|NCT01388816|593819718|FG000|Overall Study|Lost to Follow-up|0|||
164396257|NCT01388816|593819719|FG001|Overall Study|Lost to Follow-up|1|||
164396258|NCT01388816|593819720|FG002|Overall Study|Lost to Follow-up|0|||
164396259|NCT01388816|593819721|FG003|Overall Study|Lost to Follow-up|0|||
164396260|NCT01388816|593819718|FG000|Overall Study|Withdrawal by Subject|2|||
164093654|NCT02777528|592707257|FG002|Overall Study|Death|1|||
164396261|NCT01388816|593819719|FG001|Overall Study|Withdrawal by Subject|1|||
164396262|NCT01388816|593819720|FG002|Overall Study|Withdrawal by Subject|1|||
164396263|NCT01388816|593819721|FG003|Overall Study|Withdrawal by Subject|0|||
164396264|NCT01388816|593819718|FG000|Overall Study|Protocol Violation|0|||
164396265|NCT01388816|593819719|FG001|Overall Study|Protocol Violation|0|||
164396266|NCT01388816|593819720|FG002|Overall Study|Protocol Violation|2|||
164396267|NCT01388816|593819721|FG003|Overall Study|Protocol Violation|0|||
164396268|NCT00743366|593819722|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
164396269|NCT00743366|593819723|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
164396270|NCT03998618|593819724|FG000|Overall Study|Death|7|||
164396271|NCT03998618|593819725|FG001|Overall Study|Death|11|||
164396272|NCT03998618|593819724|FG000|Overall Study|hospice enrollment|3|||
164396273|NCT03998618|593819725|FG001|Overall Study|hospice enrollment|3|||
164396274|NCT03998618|593819724|FG000|Overall Study|Not feeling well/health problems|3|||
164396275|NCT03998618|593819725|FG001|Overall Study|Not feeling well/health problems|5|||
164396276|NCT03998618|593819724|FG000|Overall Study|Lost to Follow-up|6|||
164396277|NCT03998618|593819725|FG001|Overall Study|Lost to Follow-up|6|||
164396278|NCT03998618|593819724|FG000|Overall Study|Withdrawal by Subject|0|||
164396279|NCT03998618|593819725|FG001|Overall Study|Withdrawal by Subject|4|||
164396280|NCT02308748|593819726|FG000|Period 1|Withdrawal by Subject|0|||
164396281|NCT02308748|593819727|FG001|Period 1|Withdrawal by Subject|0|||
164396282|NCT02308748|593819728|FG002|Period 1|Withdrawal by Subject|1|||
164396283|NCT02308748|593819729|FG003|Period 1|Withdrawal by Subject|0|||
164396284|NCT02308748|593819730|FG004|Period 1|Withdrawal by Subject|0|||
164396285|NCT02308748|593819731|FG005|Period 1|Withdrawal by Subject|0|||
164396286|NCT02308748|593819732|FG006|Period 1|Withdrawal by Subject|0|||
164396287|NCT02308748|593819733|FG007|Period 1|Withdrawal by Subject|0|||
164396288|NCT02308748|593819734|FG008|Period 1|Withdrawal by Subject|0|||
164396289|NCT02308748|593819735|FG009|Period 1|Withdrawal by Subject|0|||
164396290|NCT02308748|593819726|FG000|Period 2|Adverse Event|0|||
164396291|NCT02308748|593819727|FG001|Period 2|Adverse Event|0|||
164396292|NCT02308748|593819728|FG002|Period 2|Adverse Event|0|||
164396293|NCT02308748|593819729|FG003|Period 2|Adverse Event|0|||
164396294|NCT02308748|593819730|FG004|Period 2|Adverse Event|0|||
164396295|NCT02308748|593819731|FG005|Period 2|Adverse Event|0|||
164396296|NCT02308748|593819732|FG006|Period 2|Adverse Event|0|||
164396297|NCT02308748|593819733|FG007|Period 2|Adverse Event|1|||
164396298|NCT02308748|593819734|FG008|Period 2|Adverse Event|0|||
164396299|NCT02308748|593819735|FG009|Period 2|Adverse Event|0|||
164396300|NCT02308748|593819726|FG000|Period 3|Protocol Violation|0|||
164396301|NCT02308748|593819727|FG001|Period 3|Protocol Violation|0|||
164396302|NCT02308748|593819728|FG002|Period 3|Protocol Violation|0|||
164396303|NCT02308748|593819729|FG003|Period 3|Protocol Violation|0|||
164396304|NCT02308748|593819730|FG004|Period 3|Protocol Violation|0|||
164396305|NCT02308748|593819731|FG005|Period 3|Protocol Violation|0|||
164396306|NCT02308748|593819732|FG006|Period 3|Protocol Violation|0|||
164396307|NCT02308748|593819733|FG007|Period 3|Protocol Violation|0|||
164396308|NCT02308748|593819734|FG008|Period 3|Protocol Violation|0|||
164396309|NCT02308748|593819735|FG009|Period 3|Protocol Violation|1|||
164396310|NCT02308748|593819726|FG000|Period 5|Adverse Event|1|||
164396311|NCT02308748|593819727|FG001|Period 5|Adverse Event|0|||
164396312|NCT02308748|593819728|FG002|Period 5|Adverse Event|0|||
164396313|NCT02308748|593819729|FG003|Period 5|Adverse Event|0|||
164396314|NCT02308748|593819730|FG004|Period 5|Adverse Event|0|||
164396315|NCT02308748|593819731|FG005|Period 5|Adverse Event|0|||
164396316|NCT02308748|593819732|FG006|Period 5|Adverse Event|0|||
163905680|NCT01968967|592025905|FG003|Treatment Period|Withdrawal by Subject|0|||
163905681|NCT01968967|592025906|FG004|Treatment Period|Withdrawal by Subject|0|||
164396317|NCT02308748|593819733|FG007|Period 5|Adverse Event|0|||
164396318|NCT02308748|593819734|FG008|Period 5|Adverse Event|1|||
164396319|NCT02308748|593819735|FG009|Period 5|Adverse Event|0|||
164396320|NCT01152580|593819736|FG000|Overall Study|Withdrawal by Subject|0|||
164396321|NCT01152580|593819737|FG001|Overall Study|Withdrawal by Subject|1|||
164396322|NCT01994954|593819739|FG000|Overall Study|Death|1|||
164396323|NCT01994954|593819740|FG001|Overall Study|Death|0|||
164396324|NCT01994954|593819739|FG000|Overall Study|Withdrawal by Subject|9|||
164396325|NCT01994954|593819740|FG001|Overall Study|Withdrawal by Subject|14|||
164396326|NCT01994954|593819739|FG000|Overall Study|Physician Decision|2|||
164396327|NCT01994954|593819740|FG001|Overall Study|Physician Decision|2|||
163905682|NCT01968967|592025902|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
163905683|NCT01968967|592025903|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
163905684|NCT01968967|592025904|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
163905685|NCT01968967|592025905|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
164073026|NCT00552617|592632770|FG007|Overall Study|Lost to Follow-up|0|||
164396328|NCT01994954|593819739|FG000|Overall Study|Lost to Follow-up|8|||
164396329|NCT01994954|593819740|FG001|Overall Study|Lost to Follow-up|10|||
164396330|NCT01994954|593819739|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
164396331|NCT01994954|593819740|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
164396332|NCT00449176|593819741|FG000|Overall Study|Withdrawal by Subject|39|||
164396333|NCT00449176|593819742|FG001|Overall Study|Withdrawal by Subject|43|||
164396334|NCT00449176|593819743|FG002|Overall Study|Withdrawal by Subject|59|||
164396335|NCT00449176|593819741|FG000|Overall Study|Lost to Follow-up|13|||
164396336|NCT00449176|593819742|FG001|Overall Study|Lost to Follow-up|8|||
164396337|NCT00449176|593819743|FG002|Overall Study|Lost to Follow-up|12|||
164396338|NCT00449176|593819741|FG000|Overall Study|Adverse Event|51|||
164396339|NCT00449176|593819742|FG001|Overall Study|Adverse Event|107|||
164396340|NCT00449176|593819743|FG002|Overall Study|Adverse Event|15|||
164396341|NCT00449176|593819741|FG000|Overall Study|Lack of Efficacy|13|||
164396342|NCT00449176|593819742|FG001|Overall Study|Lack of Efficacy|7|||
164396343|NCT00449176|593819743|FG002|Overall Study|Lack of Efficacy|50|||
164396344|NCT00449176|593819741|FG000|Overall Study|Study drug non-compliant|14|||
164396345|NCT00449176|593819742|FG001|Overall Study|Study drug non-compliant|11|||
164396346|NCT00449176|593819743|FG002|Overall Study|Study drug non-compliant|11|||
164396347|NCT00449176|593819741|FG000|Overall Study|all other|22|||
164396348|NCT00449176|593819742|FG001|Overall Study|all other|19|||
164396349|NCT00449176|593819743|FG002|Overall Study|all other|20|||
164396350|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
164396351|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
164396352|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|disease progression|58|||
164396353|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|disease progression|47|||
164396354|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Death|3|||
164396355|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Death|6|||
164396356|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
164396357|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
164396358|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
164396359|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
164396360|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
164396361|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
164396362|NCT02472964|593819744|FG000|Part 1 (up to Week 24)|Other|2|||
164396363|NCT02472964|593819745|FG001|Part 1 (up to Week 24)|Other|1|||
164396364|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
164396365|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
164396366|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
164396367|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
164396368|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Death|0|||
164396369|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Death|1|||
164396370|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
164396371|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
164396372|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
164396373|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
164396374|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
164396375|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
164396376|NCT02472964|593819744|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
164396377|NCT02472964|593819745|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
164396378|NCT01967732|593819748|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
164396379|NCT01967732|593819749|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
164396380|NCT01967732|593819750|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
164396381|NCT01967732|593819751|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
164396382|NCT01967732|593819748|FG000|First Intervention (Day 1)|Poor venous access|0|||
164396383|NCT01967732|593819749|FG001|First Intervention (Day 1)|Poor venous access|1|||
164396384|NCT01967732|593819750|FG002|First Intervention (Day 1)|Poor venous access|0|||
164396385|NCT01967732|593819751|FG003|First Intervention (Day 1)|Poor venous access|0|||
164396386|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
164396387|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
164396388|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
164396389|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
164396390|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
164396391|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
164396392|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
164396393|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
164396394|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
164396395|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
164396396|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
164396397|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
164396398|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
164396399|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
164396400|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
164396401|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
164396402|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
164396403|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
164396404|NCT00833638|593819759|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
164396405|NCT00833638|593819760|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
164396406|NCT00833638|593819761|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
164396407|NCT00833638|593819759|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
164396408|NCT00833638|593819760|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
164396409|NCT00833638|593819761|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
164396410|NCT00833638|593819759|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
164396411|NCT00833638|593819760|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
164396412|NCT00833638|593819761|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
164396413|NCT01178086|593819762|FG000|Overall Study|Participant refusal|7|||
164396414|NCT01178086|593819762|FG000|Overall Study|Physician Decision|44|||
164396415|NCT01178086|593819762|FG000|Overall Study|Switch to other CLL therapy|113|||
164396416|NCT01178086|593819762|FG000|Overall Study|Death|59|||
164396417|NCT01178086|593819762|FG000|Overall Study|Other unspecified|89|||
164396418|NCT01178086|593819762|FG000|Overall Study|Excluded from EAS|20|||
164396419|NCT01400503|593819763|FG000|Overall Study|Withdrawal by Subject|1|||
164396420|NCT01400503|593819763|FG000|Overall Study|Study Terminated by Sponsor|58|||
164396421|NCT01400503|593819763|FG000|Overall Study|Other|1|||
164396422|NCT01261338|593819764|FG000|Overall Study|Withdrawal by Subject|3|||
164396423|NCT01261338|593819765|FG001|Overall Study|Withdrawal by Subject|2|||
164396424|NCT04725890|593820931|FG000|Overall Study|Lost to Follow-up|2|||
164396425|NCT04725890|593820931|FG000|Overall Study|Withdrawal by Subject|3|||
164396426|NCT04725890|593820931|FG000|Overall Study|Physician Decision|1|||
164396427|NCT04480840|593820937|FG000|Overall Study|Adverse Event|2|||
164396428|NCT04480840|593820938|FG001|Overall Study|Adverse Event|1|||
164396429|NCT04480840|593820939|FG002|Overall Study|Adverse Event|1|||
164396430|NCT04480840|593820940|FG003|Overall Study|Adverse Event|1|||
164396431|NCT04480840|593820941|FG004|Overall Study|Adverse Event|1|||
164396432|NCT04480840|593820937|FG000|Overall Study|Withdrawal by Subject|0|||
164396433|NCT04480840|593820938|FG001|Overall Study|Withdrawal by Subject|0|||
164396434|NCT04480840|593820939|FG002|Overall Study|Withdrawal by Subject|0|||
164396435|NCT04480840|593820940|FG003|Overall Study|Withdrawal by Subject|0|||
164396436|NCT04480840|593820941|FG004|Overall Study|Withdrawal by Subject|2|||
164396437|NCT04480840|593820937|FG000|Overall Study|Protocol Violation|0|||
164396438|NCT04480840|593820938|FG001|Overall Study|Protocol Violation|1|||
164396439|NCT04480840|593820939|FG002|Overall Study|Protocol Violation|0|||
164396440|NCT04480840|593820940|FG003|Overall Study|Protocol Violation|0|||
164396441|NCT04480840|593820941|FG004|Overall Study|Protocol Violation|0|||
164396442|NCT04480840|593820937|FG000|Overall Study|illicit drug use|0|||
164396443|NCT04480840|593820938|FG001|Overall Study|illicit drug use|0|||
164396444|NCT04480840|593820939|FG002|Overall Study|illicit drug use|0|||
164396445|NCT04480840|593820940|FG003|Overall Study|illicit drug use|0|||
164396446|NCT04480840|593820941|FG004|Overall Study|illicit drug use|1|||
164396447|NCT03246347|593820949|FG000|Overall Study|On Study|23|||
164396448|NCT03291067|593820950|FG000|Overall Study|Adverse Event|0|||
164396449|NCT03291067|593820951|FG001|Overall Study|Adverse Event|2|||
164396450|NCT03291067|593820952|FG002|Overall Study|Adverse Event|17|||
164396451|NCT03291067|593820953|FG003|Overall Study|Adverse Event|3|||
164396452|NCT03291067|593820950|FG000|Overall Study|Lost to Follow-up|2|||
164396453|NCT03291067|593820951|FG001|Overall Study|Lost to Follow-up|1|||
164396454|NCT03291067|593820952|FG002|Overall Study|Lost to Follow-up|0|||
164396455|NCT03291067|593820953|FG003|Overall Study|Lost to Follow-up|1|||
164396456|NCT03291067|593820950|FG000|Overall Study|Physician Decision|0|||
164396457|NCT03291067|593820951|FG001|Overall Study|Physician Decision|0|||
164396458|NCT03291067|593820952|FG002|Overall Study|Physician Decision|1|||
164396459|NCT03291067|593820953|FG003|Overall Study|Physician Decision|0|||
164396460|NCT03291067|593820950|FG000|Overall Study|Protocol Violation|5|||
164396461|NCT03291067|593820951|FG001|Overall Study|Protocol Violation|3|||
164396462|NCT03291067|593820952|FG002|Overall Study|Protocol Violation|4|||
164396463|NCT03291067|593820953|FG003|Overall Study|Protocol Violation|2|||
164396464|NCT03291067|593820950|FG000|Overall Study|Withdrawal by Subject|3|||
164396465|NCT03291067|593820951|FG001|Overall Study|Withdrawal by Subject|4|||
164396466|NCT03291067|593820952|FG002|Overall Study|Withdrawal by Subject|7|||
164396467|NCT03291067|593820953|FG003|Overall Study|Withdrawal by Subject|5|||
164396468|NCT03291067|593820950|FG000|Overall Study|Other|0|||
164396469|NCT03291067|593820951|FG001|Overall Study|Other|4|||
164396470|NCT03291067|593820952|FG002|Overall Study|Other|4|||
164396471|NCT03291067|593820953|FG003|Overall Study|Other|6|||
164396472|NCT02255435|593820954|FG000|Overall Study|Patient's Limited Time Availability|0|||
164396473|NCT02255435|593820955|FG001|Overall Study|Patient's Limited Time Availability|0|||
164396474|NCT02255435|593820956|FG002|Overall Study|Patient's Limited Time Availability|0|||
164396475|NCT02255435|593820957|FG003|Overall Study|Patient's Limited Time Availability|0|||
164396476|NCT02255435|593820958|FG004|Overall Study|Patient's Limited Time Availability|0|||
164396477|NCT02255435|593820959|FG005|Overall Study|Patient's Limited Time Availability|0|||
164396478|NCT02255435|593820960|FG006|Overall Study|Patient's Limited Time Availability|0|||
164396479|NCT02255435|593820961|FG007|Overall Study|Patient's Limited Time Availability|1|||
164396480|NCT02255435|593820962|FG008|Overall Study|Patient's Limited Time Availability|0|||
164396481|NCT02255435|593820963|FG009|Overall Study|Patient's Limited Time Availability|0|||
164396482|NCT02255435|593820954|FG000|Overall Study|Withdrawal by Subject|0|||
164396483|NCT02255435|593820955|FG001|Overall Study|Withdrawal by Subject|0|||
163905686|NCT01968967|592025906|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
163905687|NCT01968967|592025902|FG000|Treatment Period|Lost to Follow-up|26|||
163905688|NCT01968967|592025903|FG001|Treatment Period|Lost to Follow-up|31|||
163905689|NCT01968967|592025904|FG002|Treatment Period|Lost to Follow-up|0|||
163905690|NCT01968967|592025905|FG003|Treatment Period|Lost to Follow-up|0|||
164396484|NCT02255435|593820956|FG002|Overall Study|Withdrawal by Subject|0|||
164396485|NCT02255435|593820957|FG003|Overall Study|Withdrawal by Subject|0|||
164396486|NCT02255435|593820958|FG004|Overall Study|Withdrawal by Subject|0|||
164396487|NCT02255435|593820959|FG005|Overall Study|Withdrawal by Subject|0|||
164396488|NCT02255435|593820960|FG006|Overall Study|Withdrawal by Subject|0|||
164396489|NCT02255435|593820961|FG007|Overall Study|Withdrawal by Subject|0|||
164396490|NCT02255435|593820962|FG008|Overall Study|Withdrawal by Subject|1|||
164396491|NCT02255435|593820963|FG009|Overall Study|Withdrawal by Subject|4|||
164396492|NCT02255435|593820954|FG000|Overall Study|Administrative reasons|0|||
164396493|NCT02255435|593820955|FG001|Overall Study|Administrative reasons|0|||
164396494|NCT02255435|593820956|FG002|Overall Study|Administrative reasons|0|||
164396495|NCT02255435|593820957|FG003|Overall Study|Administrative reasons|0|||
164396496|NCT02255435|593820958|FG004|Overall Study|Administrative reasons|0|||
164396497|NCT02255435|593820959|FG005|Overall Study|Administrative reasons|0|||
164396498|NCT02255435|593820960|FG006|Overall Study|Administrative reasons|0|||
164396499|NCT02255435|593820961|FG007|Overall Study|Administrative reasons|0|||
164396500|NCT02255435|593820962|FG008|Overall Study|Administrative reasons|0|||
164396501|NCT02255435|593820963|FG009|Overall Study|Administrative reasons|2|||
164396502|NCT03945773|593820964|FG000|Overall Study|Consent Withdrawn|1|||
164396503|NCT03945773|593820965|FG001|Overall Study|Consent Withdrawn|1|||
164396504|NCT03945773|593820964|FG000|Overall Study|Lost to Follow-up|1|||
164396505|NCT03945773|593820965|FG001|Overall Study|Lost to Follow-up|0|||
164396506|NCT03945773|593820964|FG000|Overall Study|Death|46|||
164396507|NCT03945773|593820965|FG001|Overall Study|Death|22|||
164396508|NCT03945773|593820964|FG000|Overall Study|Physician Decision|1|||
164396509|NCT03945773|593820965|FG001|Overall Study|Physician Decision|0|||
164396510|NCT03945773|593820964|FG000|Overall Study|Other|1|||
164396511|NCT03945773|593820965|FG001|Overall Study|Other|0|||
164396512|NCT03945773|593820964|FG000|Overall Study|Ongoing at the time of DCO|4|||
164396513|NCT03945773|593820965|FG001|Overall Study|Ongoing at the time of DCO|3|||
164396514|NCT04165317|593820968|FG000|Treatment Phase|Adverse Event|131|||
164396515|NCT04165317|593820969|FG001|Treatment Phase|Adverse Event|89|||
164396516|NCT04165317|593820970|FG002|Treatment Phase|Adverse Event|37|||
164396517|NCT04165317|593820971|FG003|Treatment Phase|Adverse Event|0|||
164396518|NCT04165317|593820972|FG004|Treatment Phase|Adverse Event|2|||
164396519|NCT04165317|593820968|FG000|Treatment Phase|Death|8|||
164396520|NCT04165317|593820969|FG001|Treatment Phase|Death|8|||
164396521|NCT04165317|593820970|FG002|Treatment Phase|Death|6|||
164396522|NCT04165317|593820971|FG003|Treatment Phase|Death|0|||
164396523|NCT04165317|593820972|FG004|Treatment Phase|Death|0|||
164396524|NCT04165317|593820968|FG000|Treatment Phase|Lack of Efficacy|32|||
164396525|NCT04165317|593820969|FG001|Treatment Phase|Lack of Efficacy|50|||
164396526|NCT04165317|593820970|FG002|Treatment Phase|Lack of Efficacy|54|||
164396527|NCT04165317|593820971|FG003|Treatment Phase|Lack of Efficacy|3|||
164396528|NCT04165317|593820972|FG004|Treatment Phase|Lack of Efficacy|2|||
164396529|NCT04165317|593820968|FG000|Treatment Phase|Lost to Follow-up|3|||
164396530|NCT04165317|593820969|FG001|Treatment Phase|Lost to Follow-up|0|||
164396531|NCT04165317|593820970|FG002|Treatment Phase|Lost to Follow-up|2|||
164396532|NCT04165317|593820971|FG003|Treatment Phase|Lost to Follow-up|0|||
164396533|NCT04165317|593820972|FG004|Treatment Phase|Lost to Follow-up|0|||
164396534|NCT04165317|593820968|FG000|Treatment Phase|Withdrawal by Subject|41|||
164396535|NCT04165317|593820969|FG001|Treatment Phase|Withdrawal by Subject|26|||
164396536|NCT04165317|593820970|FG002|Treatment Phase|Withdrawal by Subject|29|||
163905691|NCT01968967|592025906|FG004|Treatment Period|Lost to Follow-up|0|||
163905692|NCT01968967|592025902|FG000|Treatment Period|Protocol Violation|1|||
163905693|NCT01968967|592025903|FG001|Treatment Period|Protocol Violation|2|||
164396537|NCT04165317|593820971|FG003|Treatment Phase|Withdrawal by Subject|1|||
164396538|NCT04165317|593820972|FG004|Treatment Phase|Withdrawal by Subject|0|||
163905694|NCT01968967|592025904|FG002|Treatment Period|Protocol Violation|0|||
163905695|NCT01968967|592025905|FG003|Treatment Period|Protocol Violation|0|||
163905696|NCT01968967|592025906|FG004|Treatment Period|Protocol Violation|0|||
164073027|NCT00552617|592632771|FG008|Overall Study|Lost to Follow-up|2|||
164396539|NCT04165317|593820968|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
164396540|NCT04165317|593820969|FG001|Treatment Phase|Global Deterioration of Health Status|2|||
164396541|NCT04165317|593820970|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
164396542|NCT04165317|593820971|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
164396543|NCT04165317|593820972|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
164396544|NCT04165317|593820968|FG000|Treatment Phase|Other|14|||
164396545|NCT04165317|593820969|FG001|Treatment Phase|Other|13|||
164396546|NCT04165317|593820970|FG002|Treatment Phase|Other|18|||
163905697|NCT01968967|592025902|FG000|Treatment Period|Adverse Event|9|||
164396547|NCT04165317|593820971|FG003|Treatment Phase|Other|0|||
164396548|NCT04165317|593820972|FG004|Treatment Phase|Other|0|||
164396549|NCT04165317|593820968|FG000|Treatment Phase|Randomized, not treated|2|||
164396550|NCT04165317|593820969|FG001|Treatment Phase|Randomized, not treated|4|||
164396551|NCT04165317|593820970|FG002|Treatment Phase|Randomized, not treated|2|||
164396552|NCT04165317|593820971|FG003|Treatment Phase|Randomized, not treated|0|||
164396553|NCT04165317|593820972|FG004|Treatment Phase|Randomized, not treated|0|||
164396554|NCT04165317|593820968|FG000|Follow up Phase|Death|23|||
164396555|NCT04165317|593820969|FG001|Follow up Phase|Death|20|||
164396556|NCT04165317|593820970|FG002|Follow up Phase|Death|23|||
164396557|NCT04165317|593820971|FG003|Follow up Phase|Death|0|||
164396558|NCT04165317|593820972|FG004|Follow up Phase|Death|0|||
164396559|NCT04165317|593820968|FG000|Follow up Phase|Lost to Follow-up|4|||
164396560|NCT04165317|593820969|FG001|Follow up Phase|Lost to Follow-up|6|||
164396561|NCT04165317|593820970|FG002|Follow up Phase|Lost to Follow-up|1|||
164396562|NCT04165317|593820971|FG003|Follow up Phase|Lost to Follow-up|0|||
164396563|NCT04165317|593820972|FG004|Follow up Phase|Lost to Follow-up|0|||
164396564|NCT04165317|593820968|FG000|Follow up Phase|Withdrawal by Subject|12|||
164396565|NCT04165317|593820969|FG001|Follow up Phase|Withdrawal by Subject|27|||
164396566|NCT04165317|593820970|FG002|Follow up Phase|Withdrawal by Subject|21|||
164396567|NCT04165317|593820971|FG003|Follow up Phase|Withdrawal by Subject|0|||
164396568|NCT04165317|593820972|FG004|Follow up Phase|Withdrawal by Subject|0|||
164396569|NCT04165317|593820968|FG000|Follow up Phase|Ongoing|280|||
164396570|NCT04165317|593820969|FG001|Follow up Phase|Ongoing|277|||
164396571|NCT04165317|593820970|FG002|Follow up Phase|Ongoing|289|||
164396572|NCT04165317|593820971|FG003|Follow up Phase|Ongoing|0|||
164396573|NCT04165317|593820972|FG004|Follow up Phase|Ongoing|0|||
164396574|NCT04165317|593820968|FG000|Follow up Phase|Other|0|||
164396575|NCT04165317|593820969|FG001|Follow up Phase|Other|0|||
164396576|NCT04165317|593820970|FG002|Follow up Phase|Other|0|||
164396577|NCT04165317|593820971|FG003|Follow up Phase|Other|5|||
164396578|NCT04165317|593820972|FG004|Follow up Phase|Other|7|||
164396579|NCT03377491|593820975|FG000|Overall Study|Death|193|||
164396580|NCT03377491|593820976|FG001|Overall Study|Death|211|||
164396581|NCT03377491|593820975|FG000|Overall Study|Lost to Follow-up|2|||
164396582|NCT03377491|593820976|FG001|Overall Study|Lost to Follow-up|3|||
164396583|NCT03377491|593820975|FG000|Overall Study|Withdrawal by Subject|42|||
164396584|NCT03377491|593820976|FG001|Overall Study|Withdrawal by Subject|26|||
164396585|NCT03377491|593820975|FG000|Overall Study|Study closure|40|||
164396586|NCT03377491|593820976|FG001|Overall Study|Study closure|37|||
164396587|NCT03377491|593820975|FG000|Overall Study|Other|8|||
164396588|NCT03377491|593820976|FG001|Overall Study|Other|9|||
164396589|NCT04377932|593820986|FG000|Dose Level 1|Death|7|||
164396590|NCT04377932|593820987|FG001|Dose Level 1|Death|0|||
164396591|NCT04377932|593820988|FG002|Dose Level 1|Death|0|||
164396592|NCT04377932|593820986|FG000|Dose Level 1|On long term follow up|1|||
164396593|NCT04377932|593820987|FG001|Dose Level 1|On long term follow up|0|||
164396594|NCT04377932|593820988|FG002|Dose Level 1|On long term follow up|0|||
164396595|NCT04377932|593820986|FG000|Dose Level 2|Death|0|||
164396596|NCT04377932|593820987|FG001|Dose Level 2|Death|3|||
164396597|NCT04377932|593820988|FG002|Dose Level 2|Death|0|||
164396598|NCT04377932|593820986|FG000|Dose Level 3|Death|0|||
164396599|NCT04377932|593820987|FG001|Dose Level 3|Death|0|||
164396600|NCT04377932|593820988|FG002|Dose Level 3|Death|2|||
164396601|NCT04377932|593820986|FG000|Dose Level 3|On long term follow up|0|||
164396602|NCT04377932|593820987|FG001|Dose Level 3|On long term follow up|0|||
164396603|NCT04377932|593820988|FG002|Dose Level 3|On long term follow up|1|||
164396604|NCT03729830|593820990|FG000|Overall Study|Active at study close|136|||
164396605|NCT03729830|593820990|FG000|Overall Study|Subject withdrew consent|40|||
164396606|NCT03729830|593820990|FG000|Overall Study|Intent|32|||
164396607|NCT03729830|593820990|FG000|Overall Study|Lost to Follow-up|31|||
164396608|NCT03729830|593820990|FG000|Overall Study|research facility closed down|9|||
164396609|NCT03729830|593820990|FG000|Overall Study|Death|5|||
164396610|NCT03729830|593820990|FG000|Overall Study|Physician Decision|4|||
164396611|NCT03729830|593820990|FG000|Overall Study|No longer meets protocol criteria|3|||
164396612|NCT03729830|593820990|FG000|Overall Study|Protocol Violation|6|||
164396613|NCT03729830|593820990|FG000|Overall Study|Sponsor withdrew subject|1|||
164396614|NCT04249596|593820991|FG000|Overall Study|Withdrawal by Subject|5|||
164396615|NCT04249596|593820991|FG000|Overall Study|Lost to Follow-up|3|||
164396616|NCT03289039|593820992|FG000|Overall Study|Withdrawal by Subject|0|||
164396617|NCT03289039|593820993|FG001|Overall Study|Withdrawal by Subject|1|||
163905698|NCT01968967|592025903|FG001|Treatment Period|Adverse Event|8|||
164396618|NCT03289039|593820992|FG000|Overall Study|Became ineligible prior to treatment start|0|||
164396619|NCT03289039|593820993|FG001|Overall Study|Became ineligible prior to treatment start|1|||
164396620|NCT03289039|593820992|FG000|Overall Study|progressed before treatment start|1|||
164396621|NCT03289039|593820993|FG001|Overall Study|progressed before treatment start|0|||
164396622|NCT03563716|593820999|FG000|Overall Study|Death|20|||
164396623|NCT03563716|593821000|FG001|Overall Study|Death|14|||
164396624|NCT03563716|593820999|FG000|Overall Study|Withdrawal by Subject|3|||
164396625|NCT03563716|593821000|FG001|Overall Study|Withdrawal by Subject|3|||
164396626|NCT03563716|593820999|FG000|Overall Study|Still on Study|45|||
164396627|NCT03563716|593821000|FG001|Overall Study|Still on Study|50|||
164396628|NCT06492226|593821008|FG000|Overall Study|Protocol Violation|1|||
164396629|NCT06492226|593821009|FG001|Overall Study|Protocol Violation|0|||
164396630|NCT06492226|593821010|FG002|Overall Study|Protocol Violation|1|||
164396631|NCT06492226|593821011|FG003|Overall Study|Protocol Violation|0|||
164396632|NCT06492226|593821012|FG004|Overall Study|Protocol Violation|0|||
164396633|NCT06492226|593821013|FG005|Overall Study|Protocol Violation|0|||
164396634|NCT05016960|593821016|FG000|Overall Study|Withdrawal by Subject|1|||
164396635|NCT05016960|593821017|FG001|Overall Study|Withdrawal by Subject|9|||
164396636|NCT04825275|593821018|FG000|Overall Study|Withdrawal by Subject|1|||
164396637|NCT04825275|593821019|FG001|Overall Study|Withdrawal by Subject|0|||
164396638|NCT04993079|593821020|FG000|Overall Study|Screen Failure|4|||
164396639|NCT04993079|593821020|FG000|Overall Study|Failure to provide full consent|2|||
164396640|NCT05569174|593821032|FG000|Overall Study|Adverse Event|0|||
164396641|NCT05569174|593821033|FG001|Overall Study|Adverse Event|1|||
164396642|NCT05569174|593821032|FG000|Overall Study|Lack of compliance|0|||
164396643|NCT05569174|593821033|FG001|Overall Study|Lack of compliance|1|||
164396644|NCT05569174|593821032|FG000|Overall Study|Withdrawal of consent|0|||
164396645|NCT05569174|593821033|FG001|Overall Study|Withdrawal of consent|1|||
164396646|NCT05569174|593821032|FG000|Overall Study|Participant wish|0|||
164396647|NCT05569174|593821033|FG001|Overall Study|Participant wish|1|||
164396648|NCT05569174|593821032|FG000|Overall Study|Lost to Follow-up|0|||
164396649|NCT05569174|593821033|FG001|Overall Study|Lost to Follow-up|1|||
164396650|NCT00364286|593821038|FG000|Overall Study|Withdrawal by Subject|1|||
163905699|NCT01968967|592025904|FG002|Treatment Period|Adverse Event|0|||
163905700|NCT01968967|592025905|FG003|Treatment Period|Adverse Event|0|||
163905701|NCT01968967|592025906|FG004|Treatment Period|Adverse Event|0|||
163905702|NCT01968967|592025902|FG000|Treatment Period|Death|9|||
163905703|NCT01968967|592025903|FG001|Treatment Period|Death|2|||
163905704|NCT01968967|592025904|FG002|Treatment Period|Death|0|||
163905705|NCT01968967|592025905|FG003|Treatment Period|Death|0|||
164396651|NCT00364286|593821038|FG000|Overall Study|Adverse Event|2|||
164396652|NCT03794349|593821039|FG000|Overall Study|Adverse Event|2|||
164396653|NCT03794349|593821040|FG001|Overall Study|Adverse Event|3|||
164396654|NCT03794349|593821039|FG000|Overall Study|Death|0|||
164396655|NCT03794349|593821040|FG001|Overall Study|Death|2|||
164396656|NCT03794349|593821039|FG000|Overall Study|Physician Decision|10|||
164396657|NCT03794349|593821040|FG001|Overall Study|Physician Decision|8|||
164396658|NCT03794349|593821039|FG000|Overall Study|Withdrawal by Subject|1|||
164396659|NCT03794349|593821040|FG001|Overall Study|Withdrawal by Subject|3|||
164396660|NCT03794349|593821039|FG000|Overall Study|Ineligible|2|||
164396661|NCT03794349|593821040|FG001|Overall Study|Ineligible|1|||
164396662|NCT03794349|593821039|FG000|Overall Study|Refusal|2|||
164396663|NCT03794349|593821040|FG001|Overall Study|Refusal|3|||
164396664|NCT03794349|593821039|FG000|Overall Study|Progressive Disease|7|||
164396665|NCT03794349|593821040|FG001|Overall Study|Progressive Disease|10|||
164396666|NCT03794349|593821039|FG000|Overall Study|Stable Disease after 6 Cycles|4|||
164396667|NCT03794349|593821040|FG001|Overall Study|Stable Disease after 6 Cycles|1|||
164396668|NCT03794349|593821039|FG000|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|4|||
164396669|NCT03794349|593821040|FG001|Overall Study|Did not meet criteria to start next treatment cycle within 21 days after planned start of next cycle|1|||
164396670|NCT03794349|593821039|FG000|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|1|||
164396671|NCT03794349|593821040|FG001|Overall Study|Repeat eligibility studies before start of protocol therapy outside required eligibility parameters|0|||
164396672|NCT00430989|593821042|FG000|Overall Study|Lost to Follow-up|2|||
164396673|NCT00430989|593821043|FG001|Overall Study|Lost to Follow-up|3|||
164396674|NCT00430989|593821042|FG000|Overall Study|Withdrawal by Subject|15|||
164396675|NCT00430989|593821043|FG001|Overall Study|Withdrawal by Subject|14|||
164396676|NCT00430989|593821042|FG000|Overall Study|Protocol Violation|30|||
164396677|NCT00430989|593821043|FG001|Overall Study|Protocol Violation|37|||
164396678|NCT00430989|593821042|FG000|Overall Study|Not eligible|13|||
164396679|NCT00430989|593821043|FG001|Overall Study|Not eligible|6|||
164396680|NCT05755711|593821044|FG000|Overall Study|Death|8|||
164396681|NCT05755711|593821044|FG000|Overall Study|Withdrawal by Subject|2|||
164396682|NCT05467397|593821050|FG000|Overall Study|One patient became ineligible after undergoing a renal procedure.|1|||
164396683|NCT01494662|593821054|FG000|Overall Study|Withdrawal by Subject|0|||
164396684|NCT01494662|593821055|FG001|Overall Study|Withdrawal by Subject|0|||
164396685|NCT01494662|593821056|FG002|Overall Study|Withdrawal by Subject|1|||
164396686|NCT01494662|593821057|FG003|Overall Study|Withdrawal by Subject|0|||
164396687|NCT01494662|593821058|FG004|Overall Study|Withdrawal by Subject|0|||
164396688|NCT01494662|593821059|FG005|Overall Study|Withdrawal by Subject|0|||
164396689|NCT01494662|593821060|FG006|Overall Study|Withdrawal by Subject|0|||
164396690|NCT01494662|593821054|FG000|Overall Study|Physician Decision|0|||
164396691|NCT01494662|593821055|FG001|Overall Study|Physician Decision|0|||
164396692|NCT01494662|593821056|FG002|Overall Study|Physician Decision|1|||
164396693|NCT01494662|593821057|FG003|Overall Study|Physician Decision|0|||
164396694|NCT01494662|593821058|FG004|Overall Study|Physician Decision|0|||
164396695|NCT01494662|593821059|FG005|Overall Study|Physician Decision|0|||
164396696|NCT01494662|593821060|FG006|Overall Study|Physician Decision|0|||
164396697|NCT03361306|593821066|FG000|Overall Study|Death|6|||
164396698|NCT04530552|593821069|FG000|Overall Study|Physician Decision|0|||
164396699|NCT04530552|593821070|FG001|Overall Study|Physician Decision|1|||
164396700|NCT04530552|593821069|FG000|Overall Study|Withdrawal by Subject|0|||
164396701|NCT04530552|593821070|FG001|Overall Study|Withdrawal by Subject|1|||
164396702|NCT04530552|593821069|FG000|Overall Study|Adverse Event|0|||
164396703|NCT04530552|593821070|FG001|Overall Study|Adverse Event|1|||
164396704|NCT04530552|593821069|FG000|Overall Study|No surgery|0|||
164396705|NCT04530552|593821070|FG001|Overall Study|No surgery|1|||
164396706|NCT03468218|593821071|FG000|Overall Study|Adverse Event|5|||
164396707|NCT03468218|593821071|FG000|Overall Study|Progressive Disease|16|||
164396708|NCT03468218|593821071|FG000|Overall Study|Death|1|||
164396709|NCT03468218|593821071|FG000|Overall Study|Alternate therapy|1|||
164396710|NCT03468218|593821071|FG000|Overall Study|Withdrawal by Subject|2|||
164396711|NCT05297786|593821073|FG000|Overall Study|Withdrawal by Subject|3|||
164396712|NCT05297786|593821074|FG001|Overall Study|Withdrawal by Subject|0|||
164396713|NCT05297786|593821073|FG000|Overall Study|Renal transplantation|1|||
164396714|NCT05297786|593821074|FG001|Overall Study|Renal transplantation|0|||
164396715|NCT05297786|593821073|FG000|Overall Study|Physician Decision|1|||
164396716|NCT05297786|593821074|FG001|Overall Study|Physician Decision|0|||
164396717|NCT05297786|593821073|FG000|Overall Study|Adverse Event|0|||
164396718|NCT05297786|593821074|FG001|Overall Study|Adverse Event|1|||
163905706|NCT01968967|592025906|FG004|Treatment Period|Death|0|||
163905707|NCT01968967|592025902|FG000|Treatment Period|Randomized Not Treated|6|||
164396719|NCT05297786|593821073|FG000|Overall Study|Withdrawal by Subject|0|||
163905708|NCT01968967|592025903|FG001|Treatment Period|Randomized Not Treated|5|||
163905709|NCT01968967|592025904|FG002|Treatment Period|Randomized Not Treated|0|||
164396720|NCT05297786|593821074|FG001|Overall Study|Withdrawal by Subject|1|||
163905710|NCT01968967|592025905|FG003|Treatment Period|Randomized Not Treated|0|||
164396721|NCT02503657|593821075|FG000|Open-label Period|Physician Decision|0|||
164396722|NCT02503657|593821076|FG001|Open-label Period|Physician Decision|1|||
164396723|NCT04757519|593821077|FG000|Overall Study|Lost to Follow-up|17|||
164396724|NCT04757519|593821078|FG001|Overall Study|Lost to Follow-up|18|||
164396725|NCT03829722|593821079|FG000|Overall Study|Adverse Event|1|||
164396726|NCT03829722|593821079|FG000|Overall Study|Withdrawal by Subject|7|||
164396727|NCT03829722|593821079|FG000|Overall Study|Physician Decision|5|||
164396728|NCT05402137|593821080|FG000|Overall Study|Lost to Follow-up|42|||
164396729|NCT05402137|593821081|FG001|Overall Study|Lost to Follow-up|40|||
164396730|NCT04933474|593821082|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
164396731|NCT04933474|593821083|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
164396732|NCT04933474|593821082|FG000|Overall Study|Lost to Follow-up|19|||
164396733|NCT04933474|593821083|FG001|Overall Study|Lost to Follow-up|9|||
164396734|NCT04933474|593821082|FG000|Overall Study|Life Burden - unable to participate|6|||
164396735|NCT04933474|593821083|FG001|Overall Study|Life Burden - unable to participate|2|||
164396736|NCT04933474|593821082|FG000|Overall Study|Disease Burden - unable to participate|4|||
164396737|NCT04933474|593821083|FG001|Overall Study|Disease Burden - unable to participate|1|||
164396738|NCT04933474|593821082|FG000|Overall Study|Surgery/Hospitalization|1|||
164396739|NCT04933474|593821083|FG001|Overall Study|Surgery/Hospitalization|2|||
164396740|NCT04933474|593821082|FG000|Overall Study|Dissatisfied with Intervention|1|||
164396741|NCT04933474|593821083|FG001|Overall Study|Dissatisfied with Intervention|1|||
164396742|NCT04933474|593821082|FG000|Overall Study|Withdrew interest in participation|1|||
164396743|NCT04933474|593821083|FG001|Overall Study|Withdrew interest in participation|0|||
164396744|NCT04933474|593821082|FG000|Overall Study|Had previously enrolled in the study|0|||
164396745|NCT04933474|593821083|FG001|Overall Study|Had previously enrolled in the study|1|||
164396746|NCT03701308|593821086|FG000|Overall Study|Ineligible|2|||
164396747|NCT03701308|593821087|FG001|Overall Study|Ineligible|2|||
164396748|NCT04504942|593821088|FG000|Overall Study|Withdrawal by Subject|2|||
164396749|NCT04504942|593821088|FG000|Overall Study|7 patients were on-going at the time when study was closed by sponsor.|7|||
164396750|NCT04504942|593821088|FG000|Overall Study|Disease Progression|1|||
164396751|NCT04118088|593821091|FG000|Overall Study|Study Terminated by Sponsor|38|||
164396752|NCT04118088|593821091|FG000|Overall Study|Lost to Follow-up|2|||
164396753|NCT04118088|593821091|FG000|Overall Study|Withdrawal by Subject|1|||
164396754|NCT04118088|593821091|FG000|Overall Study|Reason Not Specified|1|||
164396755|NCT06269484|593823353|FG000|Overall Study|Withdrawal by Subject|3|||
164396756|NCT06269484|593823354|FG001|Overall Study|Withdrawal by Subject|0|||
164396757|NCT06269484|593823355|FG002|Overall Study|Withdrawal by Subject|2|||
164396758|NCT06269484|593823353|FG000|Overall Study|All other reasons apart from specified|1|||
164396759|NCT06269484|593823354|FG001|Overall Study|All other reasons apart from specified|0|||
164396760|NCT06269484|593823355|FG002|Overall Study|All other reasons apart from specified|0|||
164396761|NCT06269484|593823353|FG000|Overall Study|Randomised but not started treatment|0|||
164396762|NCT06269484|593823354|FG001|Overall Study|Randomised but not started treatment|1|||
164396763|NCT06269484|593823355|FG002|Overall Study|Randomised but not started treatment|0|||
164396764|NCT05411393|593823362|FG000|Overall Study|Illness or loss of interest|2|||
164396765|NCT05411393|593823363|FG001|Overall Study|Illness or loss of interest|0|||
164396766|NCT05411393|593823362|FG000|Overall Study|Withdrawal by Subject|1|||
164396767|NCT05411393|593823363|FG001|Overall Study|Withdrawal by Subject|0|||
164396768|NCT05411393|593823362|FG000|Overall Study|Lost to Follow-up|3|||
164396769|NCT05411393|593823363|FG001|Overall Study|Lost to Follow-up|2|||
164396770|NCT04035499|593823364|FG000|Overall Study|Death|2|||
164396771|NCT04035499|593823364|FG000|Overall Study|Withdrawal by Subject|1|||
164396772|NCT06507566|593823374|FG000|Overall Study|Lost to Follow-up|9|||
164396773|NCT06507566|593823375|FG001|Overall Study|Lost to Follow-up|7|||
164396774|NCT06507566|593823374|FG000|Overall Study|Withdrawal by Subject|5|||
164396775|NCT06507566|593823375|FG001|Overall Study|Withdrawal by Subject|2|||
164396776|NCT05101317|593823376|FG000|Week1-13|Adverse Event|0|||
164396777|NCT05101317|593823377|FG001|Week1-13|Adverse Event|1|||
164396778|NCT05101317|593823378|FG002|Week1-13|Adverse Event|0|||
164396779|NCT05101317|593823379|FG003|Week1-13|Adverse Event|0|||
164396780|NCT05101317|593823376|FG000|Week1-13|Withdrawal by Subject|0|||
164396781|NCT05101317|593823377|FG001|Week1-13|Withdrawal by Subject|2|||
163905711|NCT01968967|592025906|FG004|Treatment Period|Randomized Not Treated|0|||
163905712|NCT01968967|592025902|FG000|Extension Period|Withdrew Consent|0|||
163905713|NCT01968967|592025903|FG001|Extension Period|Withdrew Consent|0|||
163905714|NCT01968967|592025904|FG002|Extension Period|Withdrew Consent|2|||
164396782|NCT05101317|593823378|FG002|Week1-13|Withdrawal by Subject|0|||
164396783|NCT05101317|593823379|FG003|Week1-13|Withdrawal by Subject|0|||
164396784|NCT05101317|593823376|FG000|Week1-13|Early Withdrawl|0|||
164396785|NCT05101317|593823377|FG001|Week1-13|Early Withdrawl|0|||
164396786|NCT05101317|593823378|FG002|Week1-13|Early Withdrawl|0|||
164396787|NCT05101317|593823379|FG003|Week1-13|Early Withdrawl|1|||
164396788|NCT05101317|593823376|FG000|Week 13-25|Lost to Follow-up|0|||
164396789|NCT05101317|593823377|FG001|Week 13-25|Lost to Follow-up|0|||
164396790|NCT05101317|593823378|FG002|Week 13-25|Lost to Follow-up|1|||
164396791|NCT05101317|593823379|FG003|Week 13-25|Lost to Follow-up|0|||
164396792|NCT05101317|593823376|FG000|Week 13-25|Withdrawal by Subject|1|||
164396793|NCT05101317|593823377|FG001|Week 13-25|Withdrawal by Subject|1|||
164396794|NCT05101317|593823378|FG002|Week 13-25|Withdrawal by Subject|0|||
164396795|NCT05101317|593823379|FG003|Week 13-25|Withdrawal by Subject|0|||
164396796|NCT05101317|593823376|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
164396797|NCT05101317|593823377|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
164396798|NCT05101317|593823378|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
164396799|NCT05101317|593823379|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
164396800|NCT03541200|593823380|FG000|Overall Study|Adverse Event|19|||
164396801|NCT03541200|593823380|FG000|Overall Study|Death|1|||
164396802|NCT03541200|593823380|FG000|Overall Study|Lost to Follow-up|10|||
164396803|NCT03541200|593823380|FG000|Overall Study|Physician Decision|1|||
164396804|NCT03541200|593823380|FG000|Overall Study|Protocol Violation|51|||
164396805|NCT03541200|593823380|FG000|Overall Study|Withdrawal by Subject|23|||
164396806|NCT03541200|593823380|FG000|Overall Study|other|8|||
164396807|NCT04338893|593823382|FG000|Overall Study|Withdrawal by Subject|10|||
164396808|NCT04338893|593823383|FG001|Overall Study|Withdrawal by Subject|10|||
164396809|NCT04338893|593823382|FG000|Overall Study|Death|0|||
164396810|NCT04338893|593823383|FG001|Overall Study|Death|1|||
164396811|NCT04338893|593823382|FG000|Overall Study|Adverse Event|2|||
164396812|NCT04338893|593823383|FG001|Overall Study|Adverse Event|0|||
164396813|NCT04338893|593823382|FG000|Overall Study|Lost to Follow-up|23|||
164396814|NCT04338893|593823383|FG001|Overall Study|Lost to Follow-up|15|||
164396815|NCT03994601|593823390|FG000|Overall Study|Adverse Event|0|||
164396816|NCT03994601|593823391|FG001|Overall Study|Adverse Event|0|||
164396817|NCT03994601|593823392|FG002|Overall Study|Adverse Event|0|||
164396818|NCT03994601|593823393|FG003|Overall Study|Adverse Event|0|||
164396819|NCT03994601|593823394|FG004|Overall Study|Adverse Event|0|||
164396820|NCT03994601|593823395|FG005|Overall Study|Adverse Event|0|||
164396821|NCT03994601|593823396|FG006|Overall Study|Adverse Event|0|||
164396822|NCT03994601|593823397|FG007|Overall Study|Adverse Event|2|||
164396823|NCT03994601|593823398|FG008|Overall Study|Adverse Event|2|||
164396824|NCT03994601|593823399|FG009|Overall Study|Adverse Event|7|||
164396825|NCT03994601|593823400|FG010|Overall Study|Adverse Event|4|||
164396826|NCT03994601|593823401|FG011|Overall Study|Adverse Event|1|||
164396827|NCT03994601|593823402|FG012|Overall Study|Adverse Event|0|||
164396828|NCT03994601|593823390|FG000|Overall Study|Withdrew Consent|0|||
164396829|NCT03994601|593823391|FG001|Overall Study|Withdrew Consent|0|||
164396830|NCT03994601|593823392|FG002|Overall Study|Withdrew Consent|0|||
164396831|NCT03994601|593823393|FG003|Overall Study|Withdrew Consent|0|||
164396832|NCT03994601|593823394|FG004|Overall Study|Withdrew Consent|0|||
164396833|NCT03994601|593823395|FG005|Overall Study|Withdrew Consent|0|||
164396834|NCT03994601|593823396|FG006|Overall Study|Withdrew Consent|1|||
164396835|NCT03994601|593823397|FG007|Overall Study|Withdrew Consent|2|||
164396836|NCT03994601|593823398|FG008|Overall Study|Withdrew Consent|0|||
164396837|NCT03994601|593823399|FG009|Overall Study|Withdrew Consent|3|||
164396838|NCT03994601|593823400|FG010|Overall Study|Withdrew Consent|0|||
164396839|NCT03994601|593823401|FG011|Overall Study|Withdrew Consent|0|||
164396840|NCT03994601|593823402|FG012|Overall Study|Withdrew Consent|0|||
164396841|NCT03994601|593823390|FG000|Overall Study|Death|1|||
163905715|NCT01968967|592025905|FG003|Extension Period|Withdrew Consent|0|||
163905716|NCT01968967|592025906|FG004|Extension Period|Withdrew Consent|5|||
163905717|NCT03489369|592025907|FG000|Overall Study|Documented Progressive Disease|3|||
163905718|NCT03489369|592025908|FG001|Overall Study|Documented Progressive Disease|2|||
163905719|NCT03489369|592025909|FG002|Overall Study|Documented Progressive Disease|3|||
163905720|NCT03489369|592025910|FG003|Overall Study|Documented Progressive Disease|6|||
163905721|NCT03489369|592025907|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
163905722|NCT03489369|592025908|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
163905723|NCT03489369|592025909|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
163905724|NCT03489369|592025910|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
164396842|NCT03994601|593823391|FG001|Overall Study|Death|0|||
164396843|NCT03994601|593823392|FG002|Overall Study|Death|0|||
164396844|NCT03994601|593823393|FG003|Overall Study|Death|0|||
164396845|NCT03994601|593823394|FG004|Overall Study|Death|0|||
164396846|NCT03994601|593823395|FG005|Overall Study|Death|0|||
164396847|NCT03994601|593823396|FG006|Overall Study|Death|1|||
164396848|NCT03994601|593823397|FG007|Overall Study|Death|2|||
164396849|NCT03994601|593823398|FG008|Overall Study|Death|0|||
164396850|NCT03994601|593823399|FG009|Overall Study|Death|5|||
164396851|NCT03994601|593823400|FG010|Overall Study|Death|4|||
164396852|NCT03994601|593823401|FG011|Overall Study|Death|1|||
164396853|NCT03994601|593823402|FG012|Overall Study|Death|3|||
164396854|NCT03994601|593823390|FG000|Overall Study|Other Reasons|0|||
164396855|NCT03994601|593823391|FG001|Overall Study|Other Reasons|1|||
164396856|NCT03994601|593823392|FG002|Overall Study|Other Reasons|0|||
164396857|NCT03994601|593823393|FG003|Overall Study|Other Reasons|0|||
164396858|NCT03994601|593823394|FG004|Overall Study|Other Reasons|1|||
164396859|NCT03994601|593823395|FG005|Overall Study|Other Reasons|0|||
164396860|NCT03994601|593823396|FG006|Overall Study|Other Reasons|0|||
164396861|NCT03994601|593823397|FG007|Overall Study|Other Reasons|4|||
164396862|NCT03994601|593823398|FG008|Overall Study|Other Reasons|0|||
164396863|NCT03994601|593823399|FG009|Overall Study|Other Reasons|4|||
164396864|NCT03994601|593823400|FG010|Overall Study|Other Reasons|3|||
164396865|NCT03994601|593823401|FG011|Overall Study|Other Reasons|4|||
164396866|NCT03994601|593823402|FG012|Overall Study|Other Reasons|2|||
164396867|NCT03994601|593823390|FG000|Overall Study|Disease Progression|3|||
164396868|NCT03994601|593823391|FG001|Overall Study|Disease Progression|3|||
164396869|NCT03994601|593823392|FG002|Overall Study|Disease Progression|4|||
164396870|NCT03994601|593823393|FG003|Overall Study|Disease Progression|6|||
164396871|NCT03994601|593823394|FG004|Overall Study|Disease Progression|3|||
164396872|NCT03994601|593823395|FG005|Overall Study|Disease Progression|5|||
164396873|NCT03994601|593823396|FG006|Overall Study|Disease Progression|7|||
164396874|NCT03994601|593823397|FG007|Overall Study|Disease Progression|25|||
164396875|NCT03994601|593823398|FG008|Overall Study|Disease Progression|1|||
164396876|NCT03994601|593823399|FG009|Overall Study|Disease Progression|24|||
164396877|NCT03994601|593823400|FG010|Overall Study|Disease Progression|20|||
164396878|NCT03994601|593823401|FG011|Overall Study|Disease Progression|24|||
164396879|NCT03994601|593823402|FG012|Overall Study|Disease Progression|7|||
164396880|NCT03994601|593823390|FG000|Overall Study|Study Drug Toxicity|0|||
164396881|NCT03994601|593823391|FG001|Overall Study|Study Drug Toxicity|0|||
164396882|NCT03994601|593823392|FG002|Overall Study|Study Drug Toxicity|0|||
164396883|NCT03994601|593823393|FG003|Overall Study|Study Drug Toxicity|0|||
164396884|NCT03994601|593823394|FG004|Overall Study|Study Drug Toxicity|1|||
164396885|NCT03994601|593823395|FG005|Overall Study|Study Drug Toxicity|0|||
164396886|NCT03994601|593823396|FG006|Overall Study|Study Drug Toxicity|0|||
164396887|NCT03994601|593823397|FG007|Overall Study|Study Drug Toxicity|3|||
164396888|NCT03994601|593823398|FG008|Overall Study|Study Drug Toxicity|0|||
164396889|NCT03994601|593823399|FG009|Overall Study|Study Drug Toxicity|0|||
164396890|NCT03994601|593823400|FG010|Overall Study|Study Drug Toxicity|3|||
164396891|NCT03994601|593823401|FG011|Overall Study|Study Drug Toxicity|3|||
164396892|NCT03994601|593823402|FG012|Overall Study|Study Drug Toxicity|0|||
164396893|NCT03994601|593823390|FG000|Overall Study|AE Unrelated to Study Drug|0|||
164396894|NCT03994601|593823391|FG001|Overall Study|AE Unrelated to Study Drug|0|||
164396895|NCT03994601|593823392|FG002|Overall Study|AE Unrelated to Study Drug|1|||
164396896|NCT03994601|593823393|FG003|Overall Study|AE Unrelated to Study Drug|0|||
164396897|NCT03994601|593823394|FG004|Overall Study|AE Unrelated to Study Drug|0|||
164396898|NCT03994601|593823395|FG005|Overall Study|AE Unrelated to Study Drug|0|||
164396899|NCT03994601|593823396|FG006|Overall Study|AE Unrelated to Study Drug|0|||
164396900|NCT03994601|593823397|FG007|Overall Study|AE Unrelated to Study Drug|1|||
164396901|NCT03994601|593823398|FG008|Overall Study|AE Unrelated to Study Drug|0|||
164396902|NCT03994601|593823399|FG009|Overall Study|AE Unrelated to Study Drug|4|||
164396903|NCT03994601|593823400|FG010|Overall Study|AE Unrelated to Study Drug|5|||
164396904|NCT03994601|593823401|FG011|Overall Study|AE Unrelated to Study Drug|0|||
164396905|NCT03994601|593823402|FG012|Overall Study|AE Unrelated to Study Drug|0|||
164396906|NCT03994601|593823390|FG000|Overall Study|Request to Discontinue|0|||
164396907|NCT03994601|593823391|FG001|Overall Study|Request to Discontinue|0|||
164396908|NCT03994601|593823392|FG002|Overall Study|Request to Discontinue|0|||
164396909|NCT03994601|593823393|FG003|Overall Study|Request to Discontinue|0|||
164396910|NCT03994601|593823394|FG004|Overall Study|Request to Discontinue|0|||
164396911|NCT03994601|593823395|FG005|Overall Study|Request to Discontinue|0|||
164396912|NCT03994601|593823396|FG006|Overall Study|Request to Discontinue|0|||
164396913|NCT03994601|593823397|FG007|Overall Study|Request to Discontinue|1|||
164396914|NCT03994601|593823398|FG008|Overall Study|Request to Discontinue|0|||
164396915|NCT03994601|593823399|FG009|Overall Study|Request to Discontinue|0|||
164396916|NCT03994601|593823400|FG010|Overall Study|Request to Discontinue|0|||
164396917|NCT03994601|593823401|FG011|Overall Study|Request to Discontinue|0|||
164396918|NCT03994601|593823402|FG012|Overall Study|Request to Discontinue|0|||
164396919|NCT04221438|593823403|FG000|Overall Study|Adverse Event|1|||
164396920|NCT04221438|593823403|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
164396921|NCT01175356|593823424|FG000|Overall Study|Death|1|||
164396922|NCT01175356|593823424|FG000|Overall Study|Lack of Efficacy|12|||
164396923|NCT01175356|593823424|FG000|Overall Study|Lost to Follow-up|1|||
164396924|NCT01175356|593823424|FG000|Overall Study|Physician Decision|23|||
164396925|NCT01175356|593823424|FG000|Overall Study|Ineligible|1|||
164396926|NCT01175356|593823424|FG000|Overall Study|Treatment Slot Not Available|18|||
164396927|NCT01175356|593823424|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
164396928|NCT01175356|593823424|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
164396929|NCT01175356|593823424|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
164396930|NCT01175356|593823424|FG000|Overall Study|Inadequate stem cell for transplant|1|||
164396931|NCT01175356|593823424|FG000|Overall Study|Initiation other tx prior to completion|9|||
164396932|NCT02750202|593823425|FG000|Overall Study|Lost to Follow-up|3|||
164396933|NCT02750202|593823426|FG001|Overall Study|Lost to Follow-up|1|||
164396934|NCT06379893|593823427|FG000|Overall Study|Withdrawal by Subject|1|||
164396935|NCT06379893|593823427|FG000|Overall Study|Sponsors' decision|1|||
164396936|NCT07265245|593823438|FG000|Overall Study|Lost to Follow-up|17|||
164396937|NCT05770895|593823441|FG000|Overall Study|Randomized but never treated|0|||
164396938|NCT05770895|593823442|FG001|Overall Study|Randomized but never treated|0|||
163905725|NCT02022670|592025913|FG000|Overall Study|Adverse Event|1|||
163905726|NCT02022670|592025914|FG001|Overall Study|Adverse Event|0|||
163905727|NCT02022670|592025915|FG002|Overall Study|Adverse Event|1|||
163905728|NCT02113449|592025916|FG000|Overall Study|Adverse Event|4|||
163905729|NCT00109031|592025917|FG000|Overall Study|Adverse Event|0|||
163905730|NCT00109031|592025918|FG001|Overall Study|Adverse Event|0|||
164396939|NCT05770895|593823443|FG002|Overall Study|Randomized but never treated|2|||
164396940|NCT05770895|593823444|FG003|Overall Study|Randomized but never treated|0|||
164396941|NCT05770895|593823445|FG004|Overall Study|Randomized but never treated|0|||
164396942|NCT05770895|593823446|FG005|Overall Study|Randomized but never treated|0|||
164396943|NCT05770895|593823447|FG006|Overall Study|Randomized but never treated|0|||
164396944|NCT05770895|593823448|FG007|Overall Study|Randomized but never treated|0|||
164396945|NCT05770895|593823449|FG008|Overall Study|Randomized but never treated|0|||
164396946|NCT05770895|593823450|FG009|Overall Study|Randomized but never treated|0|||
164396947|NCT05770895|593823441|FG000|Overall Study|Withdrew consent|0|||
164396948|NCT05770895|593823442|FG001|Overall Study|Withdrew consent|0|||
164396949|NCT05770895|593823443|FG002|Overall Study|Withdrew consent|0|||
164396950|NCT05770895|593823444|FG003|Overall Study|Withdrew consent|0|||
164396951|NCT05770895|593823445|FG004|Overall Study|Withdrew consent|2|||
164396952|NCT05770895|593823446|FG005|Overall Study|Withdrew consent|0|||
164396953|NCT05770895|593823447|FG006|Overall Study|Withdrew consent|0|||
164396954|NCT05770895|593823448|FG007|Overall Study|Withdrew consent|0|||
164396955|NCT05770895|593823449|FG008|Overall Study|Withdrew consent|0|||
164396956|NCT05770895|593823450|FG009|Overall Study|Withdrew consent|0|||
164396957|NCT04523714|593823451|FG000|Overall Study|Death|3|||
164396958|NCT04523714|593823452|FG001|Overall Study|Death|7|||
164396959|NCT04523714|593823453|FG002|Overall Study|Death|7|||
164396960|NCT04523714|593823451|FG000|Overall Study|Withdrawal by Subject|43|||
164396961|NCT04523714|593823452|FG001|Overall Study|Withdrawal by Subject|45|||
164396962|NCT04523714|593823453|FG002|Overall Study|Withdrawal by Subject|16|||
164396963|NCT04523714|593823451|FG000|Overall Study|Randomized in error|0|||
164396964|NCT04523714|593823452|FG001|Overall Study|Randomized in error|0|||
164396965|NCT04523714|593823453|FG002|Overall Study|Randomized in error|2|||
164396966|NCT04233424|593823454|FG000|Overall Study|Death|15|||
164396967|NCT04233424|593823455|FG001|Overall Study|Death|16|||
164396968|NCT04233424|593823454|FG000|Overall Study|Withdrawal by Subject|2|||
164396969|NCT04233424|593823455|FG001|Overall Study|Withdrawal by Subject|8|||
163905731|NCT00109031|592025919|FG002|Overall Study|Adverse Event|1|||
163905732|NCT00109031|592025920|FG003|Overall Study|Adverse Event|0|||
163905733|NCT00109031|592025917|FG000|Overall Study|Withdrawal by Subject|0|||
163905734|NCT00109031|592025918|FG001|Overall Study|Withdrawal by Subject|1|||
163905735|NCT00109031|592025919|FG002|Overall Study|Withdrawal by Subject|0|||
163905736|NCT00109031|592025920|FG003|Overall Study|Withdrawal by Subject|0|||
163905737|NCT00109031|592025917|FG000|Overall Study|Physician Decision|0|||
163905738|NCT00109031|592025918|FG001|Overall Study|Physician Decision|1|||
163905739|NCT00109031|592025919|FG002|Overall Study|Physician Decision|0|||
163905740|NCT00109031|592025920|FG003|Overall Study|Physician Decision|0|||
163905741|NCT00109031|592025917|FG000|Overall Study|Protocol Violation|0|||
163905742|NCT00109031|592025918|FG001|Overall Study|Protocol Violation|0|||
163905743|NCT00109031|592025919|FG002|Overall Study|Protocol Violation|1|||
163905744|NCT00109031|592025920|FG003|Overall Study|Protocol Violation|0|||
163905745|NCT02208843|592025921|FG000|Overall Study|Clinical symptoms of progression|2|||
163905746|NCT02208843|592025921|FG000|Overall Study|Progression disease according to RECIST|24|||
164396970|NCT04233424|593823454|FG000|Overall Study|Physician Decision|1|||
164396971|NCT04233424|593823455|FG001|Overall Study|Physician Decision|3|||
164396972|NCT04233424|593823454|FG000|Overall Study|Protocol Violation|3|||
164396973|NCT04233424|593823455|FG001|Overall Study|Protocol Violation|1|||
164396974|NCT04233424|593823454|FG000|Overall Study|Lost to Follow-up|1|||
163905747|NCT02208843|592025921|FG000|Overall Study|Adverse Event|12|||
163905748|NCT02208843|592025921|FG000|Overall Study|Protocol Violation|1|||
164396975|NCT04233424|593823455|FG001|Overall Study|Lost to Follow-up|3|||
164396976|NCT04233424|593823454|FG000|Overall Study|subject refuse to visit site|2|||
164396977|NCT04233424|593823455|FG001|Overall Study|subject refuse to visit site|0|||
164396978|NCT02971748|593823456|FG000|Overall Study|Adverse Event|12|||
164396979|NCT02971748|593823456|FG000|Overall Study|Withdrawal by Subject|1|||
164396980|NCT02971748|593823456|FG000|Overall Study|Financial issue|2|||
164396981|NCT02971748|593823456|FG000|Overall Study|Clinical progression|8|||
164396982|NCT05965778|593823457|FG000|Overall Study|Adverse Event|2|||
164396983|NCT05965778|593823458|FG001|Overall Study|Adverse Event|3|||
164396984|NCT05965778|593823457|FG000|Overall Study|Lack of Efficacy|0|||
164396985|NCT05965778|593823458|FG001|Overall Study|Lack of Efficacy|2|||
164396986|NCT05965778|593823457|FG000|Overall Study|Protocol Violation|1|||
164396987|NCT05965778|593823458|FG001|Overall Study|Protocol Violation|1|||
164396988|NCT05965778|593823457|FG000|Overall Study|Withdrawal by Subject|0|||
164396989|NCT05965778|593823458|FG001|Overall Study|Withdrawal by Subject|2|||
164396990|NCT05965778|593823457|FG000|Overall Study|divers reasons(patient or doctor not available for visit...),|9|||
164396991|NCT05965778|593823458|FG001|Overall Study|divers reasons(patient or doctor not available for visit...),|7|||
164396992|NCT04803214|593823459|FG000|Overall Study|Adverse Event|1|||
164396993|NCT04803214|593823460|FG001|Overall Study|Adverse Event|0|||
164396994|NCT04803214|593823459|FG000|Overall Study|Withdrawal by Subject|1|||
164396995|NCT04803214|593823460|FG001|Overall Study|Withdrawal by Subject|2|||
164396996|NCT04803214|593823459|FG000|Overall Study|Lost to Follow-up|2|||
164396997|NCT04803214|593823460|FG001|Overall Study|Lost to Follow-up|4|||
164396998|NCT04803214|593823459|FG000|Overall Study|Physician Decision|1|||
164396999|NCT04803214|593823460|FG001|Overall Study|Physician Decision|1|||
164397000|NCT04803214|593823459|FG000|Overall Study|Missed 12 month visit|0|||
164397001|NCT04803214|593823460|FG001|Overall Study|Missed 12 month visit|3|||
164397002|NCT02389517|593823461|FG000|Overall Study|Withdrawal by Subject|3|||
164397003|NCT02389517|593823462|FG001|Overall Study|Withdrawal by Subject|2|||
164397004|NCT02389517|593823461|FG000|Overall Study|Adverse Event|3|||
164397005|NCT02389517|593823462|FG001|Overall Study|Adverse Event|1|||
164397006|NCT02389517|593823461|FG000|Overall Study|Physician Decision|0|||
164397007|NCT02389517|593823462|FG001|Overall Study|Physician Decision|1|||
164397008|NCT02389517|593823461|FG000|Overall Study|Progressive disease|0|||
164397009|NCT02389517|593823462|FG001|Overall Study|Progressive disease|1|||
164397010|NCT01208662|593823464|FG000|Induction and Consolidation|Disease Progression|23|||
164397011|NCT01208662|593823465|FG001|Induction and Consolidation|Disease Progression|13|||
164397012|NCT01208662|593823466|FG002|Induction and Consolidation|Disease Progression|0|||
164397013|NCT01208662|593823464|FG000|Induction and Consolidation|Adverse Event|16|||
164397014|NCT01208662|593823465|FG001|Induction and Consolidation|Adverse Event|18|||
164397015|NCT01208662|593823466|FG002|Induction and Consolidation|Adverse Event|2|||
164397016|NCT01208662|593823464|FG000|Induction and Consolidation|MD or Participant Decision|16|||
164397017|NCT01208662|593823465|FG001|Induction and Consolidation|MD or Participant Decision|34|||
164397018|NCT01208662|593823466|FG002|Induction and Consolidation|MD or Participant Decision|4|||
164397019|NCT01208662|593823464|FG000|Induction and Consolidation|Death|1|||
164397020|NCT01208662|593823465|FG001|Induction and Consolidation|Death|3|||
164397021|NCT01208662|593823466|FG002|Induction and Consolidation|Death|1|||
164397022|NCT01208662|593823464|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
164397023|NCT01208662|593823465|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
164397024|NCT01208662|593823466|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
164397025|NCT01208662|593823464|FG000|Maintenance|Disease Progression|156|||
164397026|NCT01208662|593823465|FG001|Maintenance|Disease Progression|102|||
164397027|NCT01208662|593823466|FG002|Maintenance|Disease Progression|0|||
164397028|NCT01208662|593823464|FG000|Maintenance|Adverse Event|12|||
164397029|NCT01208662|593823465|FG001|Maintenance|Adverse Event|28|||
164397030|NCT01208662|593823466|FG002|Maintenance|Adverse Event|0|||
164397031|NCT01208662|593823464|FG000|Maintenance|MD or Participant Decision|24|||
164397032|NCT01208662|593823465|FG001|Maintenance|MD or Participant Decision|36|||
164397033|NCT01208662|593823466|FG002|Maintenance|MD or Participant Decision|0|||
164397034|NCT01208662|593823464|FG000|Maintenance|Death|0|||
164397035|NCT01208662|593823465|FG001|Maintenance|Death|3|||
164397036|NCT01208662|593823466|FG002|Maintenance|Death|0|||
164397037|NCT01208662|593823464|FG000|Maintenance|Discontinued for other reasons|21|||
164397038|NCT01208662|593823465|FG001|Maintenance|Discontinued for other reasons|31|||
164397039|NCT01208662|593823466|FG002|Maintenance|Discontinued for other reasons|0|||
164397040|NCT01208662|593823464|FG000|Maintenance|Still on Treatment|78|||
164397041|NCT01208662|593823465|FG001|Maintenance|Still on Treatment|89|||
163905749|NCT02208843|592025921|FG000|Overall Study|Withdrawal by Subject|1|||
163905750|NCT02208843|592025921|FG000|Overall Study|Switched to commercial afatinib|20|||
163905751|NCT00665392|592025923|FG000|Overall Study|not treated|1|||
163905752|NCT00243867|592025924|FG000|Overall Study|Adverse Event|24|||
163905753|NCT00243867|592025925|FG001|Overall Study|Adverse Event|34|||
163905754|NCT00243867|592025924|FG000|Overall Study|Lack of Efficacy|115|||
163905755|NCT00243867|592025925|FG001|Overall Study|Lack of Efficacy|78|||
164397042|NCT01208662|593823466|FG002|Maintenance|Still on Treatment|0|||
164397043|NCT06232018|593823469|FG000|Overall Study|withdrew due to trauma|0|||
164397044|NCT06232018|593823470|FG001|Overall Study|withdrew due to trauma|2|||
164397045|NCT00880594|593823472|FG000|Overall Study|Subject did not initiate desipramine therapy|5|||
164397046|NCT00880594|593823473|FG001|Overall Study|Subject did not initiate desipramine therapy|4|||
164073028|NCT00552617|592632772|FG009|Overall Study|Lost to Follow-up|0|||
163905756|NCT00243867|592025924|FG000|Overall Study|Withdrawal by Subject|11|||
163905757|NCT00243867|592025925|FG001|Overall Study|Withdrawal by Subject|23|||
163905758|NCT00243867|592025924|FG000|Overall Study|Lost to Follow-up|2|||
163905759|NCT00243867|592025925|FG001|Overall Study|Lost to Follow-up|1|||
163905760|NCT00243867|592025924|FG000|Overall Study|Physician Decision|2|||
163905761|NCT00243867|592025925|FG001|Overall Study|Physician Decision|7|||
163905762|NCT00243867|592025924|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
163905763|NCT00243867|592025925|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
163905764|NCT04399837|592025926|FG000|Overall Study|Other than listed|0|||
163905765|NCT04399837|592025927|FG001|Overall Study|Other than listed|2|||
164397047|NCT05071209|593823474|FG000|Overall Study|Lack of Efficacy|8|||
164397048|NCT05071209|593823475|FG001|Overall Study|Lack of Efficacy|1|||
164397049|NCT05071209|593823476|FG002|Overall Study|Lack of Efficacy|9|||
164397050|NCT05071209|593823477|FG003|Overall Study|Lack of Efficacy|8|||
164397051|NCT05071209|593823478|FG004|Overall Study|Lack of Efficacy|2|||
164397052|NCT05071209|593823474|FG000|Overall Study|Withdrawal by Subject|0|||
164397053|NCT05071209|593823475|FG001|Overall Study|Withdrawal by Subject|0|||
164397054|NCT05071209|593823476|FG002|Overall Study|Withdrawal by Subject|1|||
164397055|NCT05071209|593823477|FG003|Overall Study|Withdrawal by Subject|1|||
164397056|NCT05071209|593823478|FG004|Overall Study|Withdrawal by Subject|1|||
164397057|NCT04294641|593823479|FG000|Overall Study|Screen failure|4|||
164397058|NCT02411656|593823480|FG000|Overall Study|Adverse Event|4|||
164397059|NCT02411656|593823480|FG000|Overall Study|Clinical Progression|33|||
164397060|NCT04588428|593823484|FG000|Overall Study|Withdrawal by Subject|0|||
164397061|NCT04588428|593823485|FG001|Overall Study|Withdrawal by Subject|0|||
164397062|NCT04588428|593823486|FG002|Overall Study|Withdrawal by Subject|1|||
164397063|NCT04588428|593823487|FG003|Overall Study|Withdrawal by Subject|0|||
164397064|NCT04588428|593823488|FG004|Overall Study|Withdrawal by Subject|0|||
164397065|NCT04588428|593823489|FG005|Overall Study|Withdrawal by Subject|1|||
164397066|NCT04588428|593823490|FG006|Overall Study|Withdrawal by Subject|0|||
164397067|NCT04588428|593823491|FG007|Overall Study|Withdrawal by Subject|0|||
164397068|NCT04588428|593823492|FG008|Overall Study|Withdrawal by Subject|0|||
164397069|NCT04588428|593823484|FG000|Overall Study|Protocol Deviation|0|||
164397070|NCT04588428|593823485|FG001|Overall Study|Protocol Deviation|0|||
164397071|NCT04588428|593823486|FG002|Overall Study|Protocol Deviation|2|||
164397072|NCT04588428|593823487|FG003|Overall Study|Protocol Deviation|0|||
164397073|NCT04588428|593823488|FG004|Overall Study|Protocol Deviation|0|||
164397074|NCT04588428|593823489|FG005|Overall Study|Protocol Deviation|0|||
164397075|NCT04588428|593823490|FG006|Overall Study|Protocol Deviation|0|||
164397076|NCT04588428|593823491|FG007|Overall Study|Protocol Deviation|0|||
164397077|NCT04588428|593823492|FG008|Overall Study|Protocol Deviation|0|||
164397078|NCT04588428|593823484|FG000|Overall Study|Reason Not Specified|0|||
164397079|NCT04588428|593823485|FG001|Overall Study|Reason Not Specified|0|||
164397080|NCT04588428|593823486|FG002|Overall Study|Reason Not Specified|0|||
164397081|NCT04588428|593823487|FG003|Overall Study|Reason Not Specified|1|||
164397082|NCT04588428|593823488|FG004|Overall Study|Reason Not Specified|0|||
164397083|NCT04588428|593823489|FG005|Overall Study|Reason Not Specified|0|||
164397084|NCT04588428|593823490|FG006|Overall Study|Reason Not Specified|0|||
164397085|NCT04588428|593823491|FG007|Overall Study|Reason Not Specified|0|||
164397086|NCT04588428|593823492|FG008|Overall Study|Reason Not Specified|0|||
164397087|NCT04050293|593823493|FG000|Overall Study|Lost to Follow-up|1|||
164397088|NCT04050293|593823494|FG001|Overall Study|Lost to Follow-up|2|||
164397089|NCT04050293|593823493|FG000|Overall Study|Withdrawal by Subject|2|||
164397090|NCT04050293|593823494|FG001|Overall Study|Withdrawal by Subject|0|||
163905766|NCT04399837|592025928|FG002|Overall Study|Other than listed|2|||
163905767|NCT04399837|592025929|FG003|Overall Study|Other than listed|3|||
163905768|NCT04399837|592025926|FG000|Overall Study|Withdrawal by Subject|1|||
163905769|NCT04399837|592025927|FG001|Overall Study|Withdrawal by Subject|2|||
164016669|NCT05058664|592423933|FG002|Overall Study|No follow-up data provided|2|||
164016670|NCT05058664|592423931|FG000|Overall Study|Withdrawal by Subject|0|||
164016671|NCT05058664|592423932|FG001|Overall Study|Withdrawal by Subject|0|||
164016672|NCT05058664|592423933|FG002|Overall Study|Withdrawal by Subject|1|||
164016673|NCT01617681|592423934|FG000|Period 1 Double Blind|Adverse Event|2|||
164016674|NCT01617681|592423935|FG001|Period 1 Double Blind|Adverse Event|0|||
164016675|NCT01617681|592423936|FG002|Period 1 Double Blind|Adverse Event|0|||
164397091|NCT03575793|593823495|FG000|Overall Study|Withdrawal by Subject|0|||
164397092|NCT03575793|593823496|FG001|Overall Study|Withdrawal by Subject|1|||
164397093|NCT03575793|593823495|FG000|Overall Study|Never Treated|0|||
164397094|NCT03575793|593823496|FG001|Overall Study|Never Treated|2|||
164397095|NCT05339087|593823497|FG000|Overall Study|Withdrawal by Subject|1|||
163905770|NCT04399837|592025928|FG002|Overall Study|Withdrawal by Subject|1|||
163905771|NCT04399837|592025929|FG003|Overall Study|Withdrawal by Subject|1|||
164016676|NCT01617681|592423937|FG003|Period 1 Double Blind|Adverse Event|2|||
164397096|NCT05339087|593823498|FG001|Overall Study|Withdrawal by Subject|1|||
164397097|NCT05339087|593823497|FG000|Overall Study|Early study termination|0|||
164397098|NCT05339087|593823498|FG001|Overall Study|Early study termination|1|||
164397099|NCT04751383|593823499|FG000|Overall Study|Adverse Event|1|||
164397100|NCT04751383|593823500|FG001|Overall Study|Adverse Event|1|||
164397101|NCT04751383|593823501|FG002|Overall Study|Adverse Event|0|||
164397102|NCT04751383|593823502|FG003|Overall Study|Adverse Event|0|||
164397103|NCT04751383|593823503|FG004|Overall Study|Adverse Event|0|||
164397104|NCT04751383|593823504|FG005|Overall Study|Adverse Event|0|||
164397105|NCT04751383|593823499|FG000|Overall Study|Lack of Efficacy|6|||
164397106|NCT04751383|593823500|FG001|Overall Study|Lack of Efficacy|3|||
164397107|NCT04751383|593823501|FG002|Overall Study|Lack of Efficacy|0|||
164397108|NCT04751383|593823502|FG003|Overall Study|Lack of Efficacy|0|||
164397109|NCT04751383|593823503|FG004|Overall Study|Lack of Efficacy|0|||
164397110|NCT04751383|593823504|FG005|Overall Study|Lack of Efficacy|0|||
164397111|NCT04751383|593823499|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164397112|NCT04751383|593823500|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164397113|NCT04751383|593823501|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164397114|NCT04751383|593823502|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164397115|NCT04751383|593823503|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164397116|NCT04751383|593823504|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164397117|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
164397118|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
164397119|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
164397120|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
164397121|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
164397122|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
164397123|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
164397124|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
164397125|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
163905772|NCT04224272|592025936|FG000|Part 1 - Dose Finding|Death|4|||
163905773|NCT04224272|592025936|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
163905774|NCT04224272|592025936|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
163905775|NCT04224272|592025936|FG000|Part 2 - Dose Expansion|Death|10|||
163905776|NCT04224272|592025936|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
163905777|NCT02609048|592025937|FG000|Overall Study|Adverse Event|3|||
163905778|NCT02609048|592025938|FG001|Overall Study|Adverse Event|0|||
163905779|NCT02609048|592025939|FG002|Overall Study|Adverse Event|0|||
163905780|NCT02609048|592025937|FG000|Overall Study|Randomized but never treated|1|||
163905781|NCT02609048|592025938|FG001|Overall Study|Randomized but never treated|1|||
163905782|NCT02609048|592025939|FG002|Overall Study|Randomized but never treated|1|||
163905783|NCT02609048|592025937|FG000|Overall Study|Withdrawal of informed consent|1|||
163905784|NCT02609048|592025938|FG001|Overall Study|Withdrawal of informed consent|0|||
163905785|NCT02609048|592025939|FG002|Overall Study|Withdrawal of informed consent|0|||
163905786|NCT02609048|592025937|FG000|Overall Study|Reason not specified|6|||
163905787|NCT02609048|592025938|FG001|Overall Study|Reason not specified|9|||
163905788|NCT02609048|592025939|FG002|Overall Study|Reason not specified|9|||
163905789|NCT04445831|592025940|FG000|Overall Study|Withdrawal by Subject|2|||
163905790|NCT04445831|592025941|FG001|Overall Study|Withdrawal by Subject|1|||
163905791|NCT04445831|592025942|FG002|Overall Study|Withdrawal by Subject|1|||
163905792|NCT04445831|592025943|FG003|Overall Study|Withdrawal by Subject|0|||
163905793|NCT04445831|592025944|FG004|Overall Study|Withdrawal by Subject|0|||
163905794|NCT04445831|592025945|FG005|Overall Study|Withdrawal by Subject|0|||
163905795|NCT04445831|592025946|FG006|Overall Study|Withdrawal by Subject|0|||
163905796|NCT04445831|592025940|FG000|Overall Study|Subject withdrawal by caregiver|0|||
163905797|NCT04445831|592025941|FG001|Overall Study|Subject withdrawal by caregiver|1|||
163905798|NCT04445831|592025942|FG002|Overall Study|Subject withdrawal by caregiver|0|||
163905799|NCT04445831|592025943|FG003|Overall Study|Subject withdrawal by caregiver|0|||
163905800|NCT04445831|592025944|FG004|Overall Study|Subject withdrawal by caregiver|0|||
163905801|NCT04445831|592025945|FG005|Overall Study|Subject withdrawal by caregiver|0|||
163905802|NCT04445831|592025946|FG006|Overall Study|Subject withdrawal by caregiver|0|||
163905803|NCT04912856|592025950|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
163905804|NCT04912856|592025951|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
163905805|NCT04912856|592025950|FG000|Overall Study|Not reported in synoptic CSR.|0|||
163905806|NCT04912856|592025951|FG001|Overall Study|Not reported in synoptic CSR.|1|||
163905807|NCT02434328|592025952|FG000|Overall Study|Adverse Event|9|||
163905808|NCT02434328|592025953|FG001|Overall Study|Adverse Event|4|||
163905809|NCT02434328|592025952|FG000|Overall Study|Lack of Efficacy|0|||
163905810|NCT02434328|592025953|FG001|Overall Study|Lack of Efficacy|2|||
163905811|NCT02434328|592025952|FG000|Overall Study|Physician Decision|0|||
163905812|NCT02434328|592025953|FG001|Overall Study|Physician Decision|1|||
163905813|NCT02434328|592025952|FG000|Overall Study|Withdrawal by Subject|12|||
163905814|NCT02434328|592025953|FG001|Overall Study|Withdrawal by Subject|21|||
163905815|NCT02434328|592025952|FG000|Overall Study|Death|4|||
163905816|NCT02434328|592025953|FG001|Overall Study|Death|7|||
163905817|NCT02434328|592025952|FG000|Overall Study|Lost to Follow-up|1|||
163905818|NCT02434328|592025953|FG001|Overall Study|Lost to Follow-up|6|||
164397126|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
164397127|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
164397128|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
164397129|NCT03659916|593823505|FG000|Treatment Period (72 Weeks)|Other|1|||
164397130|NCT03659916|593823506|FG001|Treatment Period (72 Weeks)|Other|3|||
164397131|NCT03659916|593823507|FG002|Treatment Period (72 Weeks)|Other|9|||
164397132|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
164397133|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
164016677|NCT01617681|592423938|FG004|Period 1 Double Blind|Adverse Event|0|||
164016678|NCT01617681|592423934|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
164016679|NCT01617681|592423935|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
164016680|NCT01617681|592423936|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
164016681|NCT01617681|592423937|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
164016682|NCT01617681|592423938|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
164016683|NCT01617681|592423934|FG000|Period 2 Open Label|Adverse Event|0|||
164016684|NCT01617681|592423935|FG001|Period 2 Open Label|Adverse Event|0|||
164016685|NCT01617681|592423936|FG002|Period 2 Open Label|Adverse Event|0|||
164016686|NCT01617681|592423937|FG003|Period 2 Open Label|Adverse Event|0|||
164016687|NCT01617681|592423938|FG004|Period 2 Open Label|Adverse Event|3|||
164016688|NCT01617681|592423934|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
164016689|NCT01617681|592423935|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
164016690|NCT01617681|592423936|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
164016691|NCT01617681|592423937|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
164016692|NCT01617681|592423938|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
164016693|NCT00109733|592423945|FG000|Overall Study|Protocol Violation|0|||
164016694|NCT00109733|592423946|FG001|Overall Study|Protocol Violation|1|||
164016695|NCT00109733|592423945|FG000|Overall Study|Stopped taking study drug|1|||
164016696|NCT00109733|592423946|FG001|Overall Study|Stopped taking study drug|1|||
164016697|NCT00109733|592423945|FG000|Overall Study|Non-compliant|0|||
164016698|NCT00109733|592423946|FG001|Overall Study|Non-compliant|1|||
164016699|NCT00109733|592423945|FG000|Overall Study|Could not commit time for study|1|||
164016700|NCT00109733|592423946|FG001|Overall Study|Could not commit time for study|1|||
164016701|NCT05628181|592423952|FG000|Overall Study|Death|2|||
164016702|NCT05628181|592423953|FG001|Overall Study|Death|4|||
164016703|NCT05628181|592423954|FG002|Overall Study|Death|0|||
164016704|NCT01234402|592423955|FG000|Overall Study|Lost to Follow-up|0|||
164016705|NCT01234402|592423956|FG001|Overall Study|Lost to Follow-up|1|||
164016706|NCT01234402|592423957|FG002|Overall Study|Lost to Follow-up|3|||
164016707|NCT01234402|592423955|FG000|Overall Study|Withdrawal by Subject|1|||
164016708|NCT01234402|592423956|FG001|Overall Study|Withdrawal by Subject|3|||
164016709|NCT01234402|592423957|FG002|Overall Study|Withdrawal by Subject|4|||
164016710|NCT01234402|592423955|FG000|Overall Study|Never treated: Death|0|||
164016711|NCT01234402|592423956|FG001|Overall Study|Never treated: Death|0|||
164016712|NCT01234402|592423957|FG002|Overall Study|Never treated: Death|1|||
164016713|NCT01234402|592423955|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
164016714|NCT01234402|592423956|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
164016715|NCT01234402|592423957|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
164016716|NCT01234402|592423955|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
164016717|NCT01234402|592423956|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
164016718|NCT01234402|592423957|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
164016719|NCT02280291|592423959|FG000|Overall Study|Lost to Follow-up|2|||
164016720|NCT02280291|592423960|FG001|Overall Study|Lost to Follow-up|1|||
164016721|NCT02280291|592423961|FG002|Overall Study|Lost to Follow-up|3|||
164016722|NCT02280291|592423962|FG003|Overall Study|Lost to Follow-up|8|||
164016723|NCT02280291|592423959|FG000|Overall Study|Protocol Violation|1|||
164016724|NCT02280291|592423960|FG001|Overall Study|Protocol Violation|0|||
164016725|NCT02280291|592423961|FG002|Overall Study|Protocol Violation|0|||
164016726|NCT02280291|592423962|FG003|Overall Study|Protocol Violation|0|||
164093655|NCT02777528|592707255|FG000|Overall Study|Withdrawal by Subject|2|||
164093656|NCT02777528|592707256|FG001|Overall Study|Withdrawal by Subject|2|||
164397134|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
164397135|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
164397136|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
164397137|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
164397138|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
164397139|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
164397140|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
164397141|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
164016727|NCT02280291|592423959|FG000|Overall Study|Other|1|||
164016728|NCT02280291|592423960|FG001|Overall Study|Other|1|||
164016729|NCT02280291|592423961|FG002|Overall Study|Other|0|||
164016730|NCT02280291|592423962|FG003|Overall Study|Other|0|||
164016731|NCT03508622|592423963|FG000|Overall Study|Protocol Violation|1|||
164016732|NCT03508622|592423964|FG001|Overall Study|Protocol Violation|0|||
164397142|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
164397143|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
164397144|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
164397145|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
164397146|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
164397147|NCT03659916|593823505|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
164397148|NCT03659916|593823506|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
164397149|NCT03659916|593823507|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
164397150|NCT04619004|593823511|FG000|Overall Study|Death|114|||
164397151|NCT04619004|593823512|FG001|Overall Study|Death|28|||
163905819|NCT02434328|592025952|FG000|Overall Study|Other|4|||
163905820|NCT02434328|592025953|FG001|Overall Study|Other|1|||
163905821|NCT01276509|592027999|FG000|Overall Study|Adverse Event|9|||
163905822|NCT01276509|592028000|FG001|Overall Study|Adverse Event|8|||
163905823|NCT01276509|592028001|FG002|Overall Study|Adverse Event|4|||
163905824|NCT01276509|592028002|FG003|Overall Study|Adverse Event|3|||
163905825|NCT01276509|592027999|FG000|Overall Study|Lack of Efficacy|2|||
163905826|NCT01276509|592028000|FG001|Overall Study|Lack of Efficacy|1|||
163905827|NCT01276509|592028001|FG002|Overall Study|Lack of Efficacy|1|||
163905828|NCT01276509|592028002|FG003|Overall Study|Lack of Efficacy|2|||
163905829|NCT01276509|592027999|FG000|Overall Study|Pregnancy|1|||
163905830|NCT01276509|592028000|FG001|Overall Study|Pregnancy|0|||
163905831|NCT01276509|592028001|FG002|Overall Study|Pregnancy|0|||
163905832|NCT01276509|592028002|FG003|Overall Study|Pregnancy|0|||
163905833|NCT01276509|592027999|FG000|Overall Study|Withdrawal by Subject|1|||
163905834|NCT01276509|592028000|FG001|Overall Study|Withdrawal by Subject|2|||
163905835|NCT01276509|592028001|FG002|Overall Study|Withdrawal by Subject|0|||
163905836|NCT01276509|592028002|FG003|Overall Study|Withdrawal by Subject|0|||
163905837|NCT01276509|592027999|FG000|Overall Study|Other|0|||
163905838|NCT01276509|592028000|FG001|Overall Study|Other|1|||
163905839|NCT01276509|592028001|FG002|Overall Study|Other|0|||
163905840|NCT01276509|592028002|FG003|Overall Study|Other|0|||
163905841|NCT00949117|592028004|FG000|Overall Study|Lack of Efficacy|2|||
163905842|NCT00949117|592028005|FG001|Overall Study|Lack of Efficacy|3|||
163905843|NCT00949117|592028004|FG000|Overall Study|Protocol Violation|1|||
163905844|NCT00949117|592028005|FG001|Overall Study|Protocol Violation|1|||
163905845|NCT00949117|592028004|FG000|Overall Study|Adverse Event|0|||
163905846|NCT00949117|592028005|FG001|Overall Study|Adverse Event|1|||
163905847|NCT00985088|592028006|FG000|Overall Study|Serious Adverse Event|1|||
163905848|NCT00985088|592028007|FG001|Overall Study|Serious Adverse Event|1|||
163905849|NCT00985088|592028008|FG002|Overall Study|Serious Adverse Event|0|||
163905850|NCT00985088|592028009|FG003|Overall Study|Serious Adverse Event|0|||
163905851|NCT00985088|592028010|FG004|Overall Study|Serious Adverse Event|0|||
163905852|NCT00985088|592028011|FG005|Overall Study|Serious Adverse Event|0|||
163905853|NCT00985088|592028012|FG006|Overall Study|Serious Adverse Event|0|||
163905854|NCT00985088|592028013|FG007|Overall Study|Serious Adverse Event|1|||
163905855|NCT00985088|592028006|FG000|Overall Study|Adverse Event|0|||
163905856|NCT00985088|592028007|FG001|Overall Study|Adverse Event|0|||
163905857|NCT00985088|592028008|FG002|Overall Study|Adverse Event|1|||
163905858|NCT00985088|592028009|FG003|Overall Study|Adverse Event|0|||
163905859|NCT00985088|592028010|FG004|Overall Study|Adverse Event|0|||
163905860|NCT00985088|592028011|FG005|Overall Study|Adverse Event|0|||
163905861|NCT00985088|592028012|FG006|Overall Study|Adverse Event|0|||
163905862|NCT00985088|592028013|FG007|Overall Study|Adverse Event|0|||
163905863|NCT00985088|592028006|FG000|Overall Study|Withdrawal by Subject|4|||
163905864|NCT00985088|592028007|FG001|Overall Study|Withdrawal by Subject|0|||
163905865|NCT00985088|592028008|FG002|Overall Study|Withdrawal by Subject|0|||
163905866|NCT00985088|592028009|FG003|Overall Study|Withdrawal by Subject|1|||
163905867|NCT00985088|592028010|FG004|Overall Study|Withdrawal by Subject|3|||
163905868|NCT00985088|592028011|FG005|Overall Study|Withdrawal by Subject|2|||
163905869|NCT00985088|592028012|FG006|Overall Study|Withdrawal by Subject|1|||
163905870|NCT00985088|592028013|FG007|Overall Study|Withdrawal by Subject|2|||
163905871|NCT00985088|592028006|FG000|Overall Study|Migrated/moved from study area|0|||
163905872|NCT00985088|592028007|FG001|Overall Study|Migrated/moved from study area|0|||
163905873|NCT00985088|592028008|FG002|Overall Study|Migrated/moved from study area|1|||
163905874|NCT00985088|592028009|FG003|Overall Study|Migrated/moved from study area|0|||
163905875|NCT00985088|592028010|FG004|Overall Study|Migrated/moved from study area|0|||
163905876|NCT00985088|592028011|FG005|Overall Study|Migrated/moved from study area|0|||
163905877|NCT00985088|592028012|FG006|Overall Study|Migrated/moved from study area|0|||
163905878|NCT00985088|592028013|FG007|Overall Study|Migrated/moved from study area|1|||
163905879|NCT00985088|592028006|FG000|Overall Study|Lost to Follow-up|6|||
163905880|NCT00985088|592028007|FG001|Overall Study|Lost to Follow-up|1|||
163905881|NCT00985088|592028008|FG002|Overall Study|Lost to Follow-up|2|||
163905882|NCT00985088|592028009|FG003|Overall Study|Lost to Follow-up|6|||
163905883|NCT00985088|592028010|FG004|Overall Study|Lost to Follow-up|6|||
163905884|NCT00985088|592028011|FG005|Overall Study|Lost to Follow-up|5|||
163905885|NCT00985088|592028012|FG006|Overall Study|Lost to Follow-up|3|||
164397152|NCT04619004|593823511|FG000|Overall Study|Lost to Follow-up|1|||
164397153|NCT04619004|593823512|FG001|Overall Study|Lost to Follow-up|1|||
164397154|NCT04619004|593823511|FG000|Overall Study|Withdrawal by Subject|24|||
164397155|NCT04619004|593823512|FG001|Overall Study|Withdrawal by Subject|7|||
164397156|NCT04619004|593823511|FG000|Overall Study|Other - Not specified|0|||
164397157|NCT04619004|593823512|FG001|Overall Study|Other - Not specified|1|||
164397158|NCT05763576|593823513|FG000|Overall Study|Study Terminated by Sponsor|0|||
164397159|NCT05763576|593823514|FG001|Overall Study|Study Terminated by Sponsor|0|||
164397160|NCT05763576|593823515|FG002|Overall Study|Study Terminated by Sponsor|0|||
164397161|NCT05763576|593823516|FG003|Overall Study|Study Terminated by Sponsor|0|||
164397162|NCT05763576|593823517|FG004|Overall Study|Study Terminated by Sponsor|0|||
164397163|NCT05763576|593823518|FG005|Overall Study|Study Terminated by Sponsor|0|||
164397164|NCT05763576|593823519|FG006|Overall Study|Study Terminated by Sponsor|0|||
164397165|NCT05763576|593823520|FG007|Overall Study|Study Terminated by Sponsor|2|||
164397166|NCT05763576|593823521|FG008|Overall Study|Study Terminated by Sponsor|6|||
164397167|NCT05763576|593823513|FG000|Overall Study|Withdrawal by Subject|0|||
164397168|NCT05763576|593823514|FG001|Overall Study|Withdrawal by Subject|0|||
164397169|NCT05763576|593823515|FG002|Overall Study|Withdrawal by Subject|0|||
164397170|NCT05763576|593823516|FG003|Overall Study|Withdrawal by Subject|0|||
164397171|NCT05763576|593823517|FG004|Overall Study|Withdrawal by Subject|0|||
164397172|NCT05763576|593823518|FG005|Overall Study|Withdrawal by Subject|1|||
164397173|NCT05763576|593823519|FG006|Overall Study|Withdrawal by Subject|0|||
164397174|NCT05763576|593823520|FG007|Overall Study|Withdrawal by Subject|0|||
164397175|NCT05763576|593823521|FG008|Overall Study|Withdrawal by Subject|0|||
164397176|NCT06187909|593823522|FG000|Overall Study|Withdrawal by Subject|2|||
164397177|NCT06187909|593823523|FG001|Overall Study|Withdrawal by Subject|2|||
164397178|NCT04818671|593823529|FG000|Overall Study|Withdrawal by Subject|16|||
164397179|NCT04818671|593823529|FG000|Overall Study|Adverse Event|5|||
164397180|NCT04818671|593823529|FG000|Overall Study|Lack of Efficacy|5|||
163905886|NCT00985088|592028013|FG007|Overall Study|Lost to Follow-up|2|||
163905887|NCT03964974|592028014|FG000|Overall Study|Lost to Follow-up|3|||
163905888|NCT03964974|592028015|FG001|Overall Study|Lost to Follow-up|2|||
163905889|NCT03964974|592028014|FG000|Overall Study|Withdrawal by Subject|0|||
163905890|NCT03964974|592028015|FG001|Overall Study|Withdrawal by Subject|3|||
163905891|NCT01970878|592028017|FG000|Overall Study|Withdrawal by Subject|11|||
163905892|NCT01970878|592028018|FG001|Overall Study|Withdrawal by Subject|10|||
163905893|NCT01970878|592028019|FG002|Overall Study|Withdrawal by Subject|14|||
163905894|NCT01970878|592028020|FG003|Overall Study|Withdrawal by Subject|7|||
163905895|NCT01970878|592028017|FG000|Overall Study|Lost to Follow-up|1|||
163905896|NCT01970878|592028018|FG001|Overall Study|Lost to Follow-up|3|||
163905897|NCT01970878|592028019|FG002|Overall Study|Lost to Follow-up|2|||
163905898|NCT01970878|592028020|FG003|Overall Study|Lost to Follow-up|4|||
163905899|NCT01970878|592028017|FG000|Overall Study|Administrative Reasons|1|||
163905900|NCT01970878|592028018|FG001|Overall Study|Administrative Reasons|0|||
163905901|NCT01970878|592028019|FG002|Overall Study|Administrative Reasons|0|||
163905902|NCT01970878|592028020|FG003|Overall Study|Administrative Reasons|4|||
163905903|NCT01970878|592028017|FG000|Overall Study|Lack of Efficacy|2|||
163905904|NCT01970878|592028018|FG001|Overall Study|Lack of Efficacy|1|||
163905905|NCT01970878|592028019|FG002|Overall Study|Lack of Efficacy|2|||
163905906|NCT01970878|592028020|FG003|Overall Study|Lack of Efficacy|0|||
163905907|NCT01970878|592028017|FG000|Overall Study|Adverse Event|12|||
163905908|NCT01970878|592028018|FG001|Overall Study|Adverse Event|7|||
163905909|NCT01970878|592028019|FG002|Overall Study|Adverse Event|4|||
163905910|NCT01970878|592028020|FG003|Overall Study|Adverse Event|3|||
163905911|NCT01970878|592028017|FG000|Overall Study|Protocol Specified Criteria|10|||
163905912|NCT01970878|592028018|FG001|Overall Study|Protocol Specified Criteria|4|||
163905913|NCT01970878|592028019|FG002|Overall Study|Protocol Specified Criteria|3|||
163905914|NCT01970878|592028020|FG003|Overall Study|Protocol Specified Criteria|6|||
163905915|NCT01970878|592028017|FG000|Overall Study|Physician Decision|0|||
163905916|NCT01970878|592028018|FG001|Overall Study|Physician Decision|1|||
163905917|NCT01970878|592028019|FG002|Overall Study|Physician Decision|1|||
163905918|NCT01970878|592028020|FG003|Overall Study|Physician Decision|0|||
163905919|NCT01970878|592028017|FG000|Overall Study|No Completion Status|0|||
163905920|NCT01970878|592028018|FG001|Overall Study|No Completion Status|1|||
163905921|NCT01970878|592028019|FG002|Overall Study|No Completion Status|0|||
163905922|NCT01970878|592028020|FG003|Overall Study|No Completion Status|0|||
163905923|NCT02014402|592028024|FG000|Overall Study|Adverse Event|1|||
163905924|NCT02014402|592028025|FG001|Overall Study|Adverse Event|0|||
163905925|NCT02014402|592028026|FG002|Overall Study|Adverse Event|0|||
163905926|NCT02014402|592028027|FG003|Overall Study|Adverse Event|0|||
163905927|NCT02014402|592028024|FG000|Overall Study|Withdrawal by Subject|1|||
163905928|NCT02014402|592028025|FG001|Overall Study|Withdrawal by Subject|2|||
163905929|NCT02014402|592028026|FG002|Overall Study|Withdrawal by Subject|2|||
163905930|NCT02014402|592028027|FG003|Overall Study|Withdrawal by Subject|1|||
163905931|NCT02014402|592028024|FG000|Overall Study|Subject did not have transportation|0|||
164397181|NCT04818671|593823529|FG000|Overall Study|Death|4|||
164397182|NCT04818671|593823529|FG000|Overall Study|Physician Decision|4|||
164016733|NCT03508622|592423963|FG000|Overall Study|Withdrawal by Subject|1|||
164016734|NCT03508622|592423964|FG001|Overall Study|Withdrawal by Subject|0|||
164016735|NCT03508622|592423963|FG000|Overall Study|Lost to Follow-up|16|||
164016736|NCT03508622|592423964|FG001|Overall Study|Lost to Follow-up|0|||
164016737|NCT03508622|592423963|FG000|Overall Study|Incomplete data|0|||
164016738|NCT03508622|592423964|FG001|Overall Study|Incomplete data|24|||
164397183|NCT04818671|593823529|FG000|Overall Study|Requires Prohibited Medication|4|||
164397184|NCT04818671|593823529|FG000|Overall Study|Lost to Follow-up|2|||
164397185|NCT04818671|593823529|FG000|Overall Study|Approved Drug Available for Indication|1|||
164397186|NCT04818671|593823529|FG000|Overall Study|Sponsor Request|1|||
164397187|NCT04745676|593823530|FG000|Overall Study|Death|1|||
164397188|NCT04745676|593823531|FG001|Overall Study|Death|0|||
164397189|NCT04745676|593823532|FG002|Overall Study|Death|0|||
164397190|NCT04158648|593823537|FG000|Overall Study|Ongoing in the Study|69|||
164397191|NCT04158648|593823537|FG000|Overall Study|Withdrawal by Subject|4|||
164397192|NCT04625413|593823543|FG000|Overall Study|Hospice|2|||
164397193|NCT04625413|593823543|FG000|Overall Study|Distress|1|||
164397194|NCT04625413|593823543|FG000|Overall Study|Not feeling well|1|||
164397195|NCT02617563|593823544|FG000|4 Weeks|Withdrawal by Subject|2|||
164397196|NCT02617563|593823545|FG001|4 Weeks|Withdrawal by Subject|0|||
164397197|NCT02617563|593823544|FG000|3 Months|Lost to Follow-up|1|||
164397198|NCT02617563|593823545|FG001|3 Months|Lost to Follow-up|0|||
164397199|NCT02617563|593823544|FG000|3 Months|Withdrawal by Subject|0|||
164397200|NCT02617563|593823545|FG001|3 Months|Withdrawal by Subject|1|||
164397201|NCT02617563|593823544|FG000|1 Year|Lost to Follow-up|1|||
164397202|NCT02617563|593823545|FG001|1 Year|Lost to Follow-up|2|||
164397203|NCT02617563|593823544|FG000|2 Year|Death|1|||
164397204|NCT02617563|593823545|FG001|2 Year|Death|0|||
164397205|NCT02617563|593823544|FG000|2 Year|Lost to Follow-up|2|||
164397206|NCT02617563|593823545|FG001|2 Year|Lost to Follow-up|1|||
164397207|NCT02617563|593823544|FG000|2 Year|Withdrawal by Subject|0|||
164397208|NCT02617563|593823545|FG001|2 Year|Withdrawal by Subject|4|||
164397209|NCT02617563|593823544|FG000|3 Year|Death|2|||
164397210|NCT02617563|593823545|FG001|3 Year|Death|1|||
164397211|NCT02617563|593823544|FG000|3 Year|Lost to Follow-up|1|||
164397212|NCT02617563|593823545|FG001|3 Year|Lost to Follow-up|3|||
164397213|NCT02617563|593823544|FG000|3 Year|Withdrawal by Subject|1|||
164397214|NCT02617563|593823545|FG001|3 Year|Withdrawal by Subject|1|||
164397215|NCT02617563|593823544|FG000|4 Year|Death|1|||
164397216|NCT02617563|593823545|FG001|4 Year|Death|0|||
164016739|NCT00506077|592423966|FG000|Treatment Period 1|Adverse Event|2|||
164016740|NCT00506077|592423967|FG001|Treatment Period 1|Adverse Event|1|||
164016741|NCT00506077|592423966|FG000|Treatment Period 1|Lost to Follow-up|0|||
164016742|NCT00506077|592423967|FG001|Treatment Period 1|Lost to Follow-up|2|||
164016743|NCT00506077|592423966|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164016744|NCT00506077|592423967|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164016745|NCT00506077|592423966|FG000|Treatment Period 2|Adverse Event|0|||
164016746|NCT00506077|592423967|FG001|Treatment Period 2|Adverse Event|1|||
164016747|NCT00506077|592423966|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164016748|NCT00506077|592423967|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164016749|NCT00316303|592423968|FG000|Overall Study|Lost to Follow-up|11|||
164016750|NCT00316303|592423969|FG001|Overall Study|Lost to Follow-up|16|||
164016751|NCT01106534|592423972|FG000|Overall Study|Withdrawal by Subject|18|||
164016752|NCT01106534|592423972|FG000|Overall Study|Lost to Follow-up|2|||
164016753|NCT01106534|592423972|FG000|Overall Study|Death|16|||
164016754|NCT01106534|592423972|FG000|Overall Study|Physician Decision|1|||
164016755|NCT00570739|592423977|FG000|Overall Study|Adverse Event|8|||
164016756|NCT00570739|592423978|FG001|Overall Study|Adverse Event|6|||
164016757|NCT00570739|592423979|FG002|Overall Study|Adverse Event|2|||
164016758|NCT00570739|592423980|FG003|Overall Study|Adverse Event|2|||
164397217|NCT02617563|593823544|FG000|4 Year|Lost to Follow-up|3|||
164016759|NCT00570739|592423977|FG000|Overall Study|Lost to Follow-up|4|||
164016760|NCT00570739|592423978|FG001|Overall Study|Lost to Follow-up|5|||
164016761|NCT00570739|592423979|FG002|Overall Study|Lost to Follow-up|4|||
164016762|NCT00570739|592423980|FG003|Overall Study|Lost to Follow-up|1|||
164016763|NCT00570739|592423977|FG000|Overall Study|Physician Decision|1|||
164093657|NCT02777528|592707257|FG002|Overall Study|Withdrawal by Subject|1|||
164093658|NCT02777528|592707255|FG000|Overall Study|Physician Decision|2|||
164093659|NCT02777528|592707256|FG001|Overall Study|Physician Decision|1|||
164093660|NCT02777528|592707257|FG002|Overall Study|Physician Decision|0|||
164093661|NCT02777528|592707255|FG000|Overall Study|Lost to Follow-up|2|||
164397218|NCT02617563|593823545|FG001|4 Year|Lost to Follow-up|1|||
164397219|NCT02617563|593823544|FG000|4 Year|Withdrawal by Subject|3|||
164016764|NCT00570739|592423978|FG001|Overall Study|Physician Decision|1|||
164016765|NCT00570739|592423979|FG002|Overall Study|Physician Decision|0|||
164016766|NCT00570739|592423980|FG003|Overall Study|Physician Decision|0|||
164397220|NCT02617563|593823545|FG001|4 Year|Withdrawal by Subject|1|||
164397221|NCT02617563|593823544|FG000|5 Year|Death|0|||
164397222|NCT02617563|593823545|FG001|5 Year|Death|1|||
164397223|NCT02617563|593823544|FG000|5 Year|Lost to Follow-up|9|||
164397224|NCT02617563|593823545|FG001|5 Year|Lost to Follow-up|5|||
164397225|NCT02617563|593823544|FG000|5 Year|Withdrawal by Subject|1|||
164016767|NCT00570739|592423977|FG000|Overall Study|Withdrawal by Subject|7|||
164016768|NCT00570739|592423978|FG001|Overall Study|Withdrawal by Subject|7|||
164016769|NCT00570739|592423979|FG002|Overall Study|Withdrawal by Subject|3|||
164016770|NCT00570739|592423980|FG003|Overall Study|Withdrawal by Subject|5|||
164016771|NCT00570739|592423977|FG000|Overall Study|Required restricted medication|0|||
164016772|NCT00570739|592423978|FG001|Overall Study|Required restricted medication|0|||
164016773|NCT00570739|592423979|FG002|Overall Study|Required restricted medication|1|||
164016774|NCT00570739|592423980|FG003|Overall Study|Required restricted medication|0|||
164016775|NCT00570739|592423977|FG000|Overall Study|Met discontinuation criteria|1|||
164016776|NCT00570739|592423978|FG001|Overall Study|Met discontinuation criteria|0|||
164016777|NCT00570739|592423979|FG002|Overall Study|Met discontinuation criteria|1|||
164016778|NCT00570739|592423980|FG003|Overall Study|Met discontinuation criteria|1|||
164016779|NCT00570739|592423977|FG000|Overall Study|Other|0|||
164016780|NCT00570739|592423978|FG001|Overall Study|Other|2|||
164016781|NCT00570739|592423979|FG002|Overall Study|Other|5|||
164016782|NCT00570739|592423980|FG003|Overall Study|Other|3|||
164016783|NCT00739297|592423982|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
164016784|NCT00739297|592423983|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
164016785|NCT00739297|592423984|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
164016786|NCT00739297|592423985|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
164016787|NCT00739297|592423986|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
164016788|NCT00739297|592423987|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
164016789|NCT00739297|592423988|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
164016790|NCT00739297|592423982|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164016791|NCT00739297|592423983|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164016792|NCT00739297|592423984|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164016793|NCT00739297|592423985|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164016794|NCT00739297|592423986|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
164016795|NCT00739297|592423987|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
164016796|NCT00739297|592423988|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
164016797|NCT01400971|592423989|FG000|Overall Study|Death|82|||
164016798|NCT01400971|592423989|FG000|Overall Study|Lost to Follow-up|196|||
164016799|NCT01400971|592423989|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
164016800|NCT01400971|592423989|FG000|Overall Study|Physician Decision|57|||
164016801|NCT01400971|592423989|FG000|Overall Study|Withdrawal by Subject|158|||
164016802|NCT01400971|592423989|FG000|Overall Study|Other|422|||
164016803|NCT01041573|592423992|FG000|Overall Study|Withdrawal by Subject|2|||
164016804|NCT01041573|592423993|FG001|Overall Study|Withdrawal by Subject|5|||
164016805|NCT01041573|592423994|FG002|Overall Study|Withdrawal by Subject|2|||
164016806|NCT01041573|592423995|FG003|Overall Study|Withdrawal by Subject|0|||
164016807|NCT01041573|592423992|FG000|Overall Study|Death|1|||
164016808|NCT01041573|592423993|FG001|Overall Study|Death|0|||
164016809|NCT01041573|592423994|FG002|Overall Study|Death|0|||
164016810|NCT01041573|592423995|FG003|Overall Study|Death|0|||
164016811|NCT01041573|592423992|FG000|Overall Study|Lost to Follow-up|0|||
164016812|NCT01041573|592423993|FG001|Overall Study|Lost to Follow-up|1|||
164016813|NCT01041573|592423994|FG002|Overall Study|Lost to Follow-up|2|||
164016814|NCT01041573|592423995|FG003|Overall Study|Lost to Follow-up|1|||
164016815|NCT01041573|592423992|FG000|Overall Study|Adverse Event|0|||
164016816|NCT01041573|592423993|FG001|Overall Study|Adverse Event|2|||
164016817|NCT01041573|592423994|FG002|Overall Study|Adverse Event|0|||
164016818|NCT01041573|592423995|FG003|Overall Study|Adverse Event|0|||
164016819|NCT01041573|592423992|FG000|Overall Study|relocation|1|||
164016820|NCT01041573|592423993|FG001|Overall Study|relocation|4|||
164016821|NCT01041573|592423994|FG002|Overall Study|relocation|3|||
164016822|NCT01041573|592423995|FG003|Overall Study|relocation|1|||
164016823|NCT01041573|592423992|FG000|Overall Study|further blood extraction|0|||
164016824|NCT01041573|592423993|FG001|Overall Study|further blood extraction|1|||
164016825|NCT01041573|592423994|FG002|Overall Study|further blood extraction|0|||
164016826|NCT01041573|592423995|FG003|Overall Study|further blood extraction|0|||
164016827|NCT01041573|592423992|FG000|Overall Study|positive to anti-HCV|1|||
164016828|NCT01041573|592423993|FG001|Overall Study|positive to anti-HCV|0|||
164016829|NCT01041573|592423994|FG002|Overall Study|positive to anti-HCV|0|||
164016830|NCT01041573|592423995|FG003|Overall Study|positive to anti-HCV|0|||
164016831|NCT01632878|592423999|FG000|Screening|Physician Decision|268|||
164016832|NCT01632878|592423999|FG000|Treatment|Lost to Follow-up|41|||
164016833|NCT01632878|592423999|FG000|Treatment|Withdrawal by Subject|36|||
164016834|NCT01632878|592423999|FG000|Treatment|Physician Decision|34|||
164016835|NCT01632878|592423999|FG000|Treatment|missing information|4|||
164016836|NCT01632878|592423999|FG000|Treatment|no information on study completion|43|||
164016837|NCT02698423|592424000|FG000|Overall Study|Lost to Follow-up|19|||
163905932|NCT02014402|592028025|FG001|Overall Study|Subject did not have transportation|1|||
163905933|NCT02014402|592028026|FG002|Overall Study|Subject did not have transportation|0|||
163905934|NCT02014402|592028027|FG003|Overall Study|Subject did not have transportation|0|||
163905935|NCT02014402|592028024|FG000|Overall Study|Lost to Follow-up|0|||
164016838|NCT02698423|592424001|FG001|Overall Study|Lost to Follow-up|24|||
164016839|NCT03634072|592424002|FG000|Overall Study|Early termination of overall study|1|||
164016840|NCT03634072|592424003|FG001|Overall Study|Early termination of overall study|0|||
164016841|NCT01765764|592424004|FG000|Treatment Period|Adverse Event|1|||
164016842|NCT01765764|592424005|FG001|Treatment Period|Adverse Event|2|||
164016843|NCT01765764|592424006|FG002|Treatment Period|Adverse Event|1|||
164016844|NCT01765764|592424004|FG000|Treatment Period|Lost to Follow-up|0|||
164016845|NCT01765764|592424005|FG001|Treatment Period|Lost to Follow-up|3|||
164016846|NCT01765764|592424006|FG002|Treatment Period|Lost to Follow-up|2|||
164016847|NCT01765764|592424004|FG000|Treatment Period|Personal Reasons|1|||
164016848|NCT01765764|592424005|FG001|Treatment Period|Personal Reasons|2|||
164016849|NCT01765764|592424006|FG002|Treatment Period|Personal Reasons|1|||
164016850|NCT01765764|592424004|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
164016851|NCT01765764|592424005|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
164016852|NCT01765764|592424006|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
164016853|NCT00064662|592424011|FG000|Overall Study|Death|1|||
164016854|NCT00064662|592424012|FG001|Overall Study|Death|1|||
164016855|NCT00064662|592424011|FG000|Overall Study|Lost to Follow-up|57|||
164016856|NCT00064662|592424012|FG001|Overall Study|Lost to Follow-up|44|||
164016857|NCT00064662|592424011|FG000|Overall Study|Withdrawal by Subject|14|||
164016858|NCT00064662|592424012|FG001|Overall Study|Withdrawal by Subject|14|||
164016859|NCT00064662|592424011|FG000|Overall Study|Administratively withdrawn|2|||
164016860|NCT00064662|592424012|FG001|Overall Study|Administratively withdrawn|2|||
164016861|NCT01165203|592424017|FG000|Active Phase|Serious Adverse Event|1|||
163905936|NCT02014402|592028025|FG001|Overall Study|Lost to Follow-up|0|||
163905937|NCT02014402|592028026|FG002|Overall Study|Lost to Follow-up|1|||
163905938|NCT02014402|592028027|FG003|Overall Study|Lost to Follow-up|2|||
163905939|NCT04992273|592028031|FG000|Overall Study|Lost to Follow-up|0|||
163905940|NCT04992273|592028032|FG001|Overall Study|Lost to Follow-up|1|||
163905941|NCT01364597|592028033|FG000|Overall Study|Adverse Event|4|||
163905942|NCT01364597|592028034|FG001|Overall Study|Adverse Event|5|||
163905943|NCT01364597|592028035|FG002|Overall Study|Adverse Event|16|||
163905944|NCT01364597|592028036|FG003|Overall Study|Adverse Event|7|||
163905945|NCT01364597|592028033|FG000|Overall Study|Lack of Efficacy|4|||
163905946|NCT01364597|592028034|FG001|Overall Study|Lack of Efficacy|4|||
163905947|NCT01364597|592028035|FG002|Overall Study|Lack of Efficacy|23|||
163905948|NCT01364597|592028036|FG003|Overall Study|Lack of Efficacy|8|||
163905949|NCT01364597|592028033|FG000|Overall Study|Protocol Violation|0|||
164016862|NCT01165203|592424018|FG001|Active Phase|Serious Adverse Event|0|||
164016863|NCT01165203|592424017|FG000|Active Phase|Withdrawal by Subject|2|||
164016864|NCT01165203|592424018|FG001|Active Phase|Withdrawal by Subject|1|||
163905950|NCT01364597|592028034|FG001|Overall Study|Protocol Violation|0|||
163905951|NCT01364597|592028035|FG002|Overall Study|Protocol Violation|2|||
163905952|NCT01364597|592028036|FG003|Overall Study|Protocol Violation|0|||
163905953|NCT01364597|592028033|FG000|Overall Study|Lost to Follow-up|0|||
163905954|NCT01364597|592028034|FG001|Overall Study|Lost to Follow-up|0|||
163905955|NCT01364597|592028035|FG002|Overall Study|Lost to Follow-up|5|||
163905956|NCT01364597|592028036|FG003|Overall Study|Lost to Follow-up|3|||
163905957|NCT01364597|592028033|FG000|Overall Study|Withdrawal by Subject|4|||
163905958|NCT01364597|592028034|FG001|Overall Study|Withdrawal by Subject|1|||
163905959|NCT01364597|592028035|FG002|Overall Study|Withdrawal by Subject|18|||
163905960|NCT01364597|592028036|FG003|Overall Study|Withdrawal by Subject|6|||
163905961|NCT01364597|592028033|FG000|Overall Study|Non compliance|1|||
163905962|NCT01364597|592028034|FG001|Overall Study|Non compliance|0|||
163905963|NCT01364597|592028035|FG002|Overall Study|Non compliance|1|||
163905964|NCT01364597|592028036|FG003|Overall Study|Non compliance|0|||
164016865|NCT01165203|592424017|FG000|Active Phase|Migrated/moved from study area|0|||
164016866|NCT01165203|592424018|FG001|Active Phase|Migrated/moved from study area|1|||
163905965|NCT01364597|592028033|FG000|Overall Study|Lack of compliance|1|||
164093662|NCT02777528|592707256|FG001|Overall Study|Lost to Follow-up|0|||
163905966|NCT01364597|592028034|FG001|Overall Study|Lack of compliance|0|||
163905967|NCT01364597|592028035|FG002|Overall Study|Lack of compliance|0|||
163905968|NCT01364597|592028036|FG003|Overall Study|Lack of compliance|0|||
163905969|NCT01364597|592028033|FG000|Overall Study|End of treatment epilepsy|1|||
163905970|NCT01364597|592028034|FG001|Overall Study|End of treatment epilepsy|0|||
163905971|NCT01364597|592028035|FG002|Overall Study|End of treatment epilepsy|0|||
163905972|NCT01364597|592028036|FG003|Overall Study|End of treatment epilepsy|0|||
164016867|NCT01165203|592424017|FG000|Active Phase|Lost to Follow-up|2|||
164016868|NCT01165203|592424018|FG001|Active Phase|Lost to Follow-up|0|||
164016869|NCT01165203|592424017|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
164016870|NCT01165203|592424018|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
164016871|NCT01165203|592424017|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
164016872|NCT01165203|592424018|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
164016873|NCT01165203|592424017|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
164397226|NCT02617563|593823545|FG001|5 Year|Withdrawal by Subject|0|||
164397227|NCT03003468|593823546|FG000|Overall Study|Withdrawal by Subject|0|||
164397228|NCT03003468|593823547|FG001|Overall Study|Withdrawal by Subject|0|||
164397229|NCT03003468|593823548|FG002|Overall Study|Withdrawal by Subject|1|||
164397230|NCT03003468|593823546|FG000|Overall Study|No measurable lesions|0|||
164397231|NCT03003468|593823547|FG001|Overall Study|No measurable lesions|0|||
164397232|NCT03003468|593823548|FG002|Overall Study|No measurable lesions|1|||
164397233|NCT03879577|593823549|FG000|Overall Study|Withdrawal by Subject|4|||
164397234|NCT03879577|593823549|FG000|Overall Study|Declined surgery|2|||
164397235|NCT01231906|593823550|FG000|Overall Study|Lack of Efficacy|75|||
164397236|NCT01231906|593823551|FG001|Overall Study|Lack of Efficacy|68|||
164397237|NCT01231906|593823550|FG000|Overall Study|Lost to Follow-up|1|||
164397238|NCT01231906|593823551|FG001|Overall Study|Lost to Follow-up|0|||
164397239|NCT01231906|593823550|FG000|Overall Study|Physician Decision|34|||
164397240|NCT01231906|593823551|FG001|Overall Study|Physician Decision|24|||
164397241|NCT01231906|593823550|FG000|Overall Study|Withdrawal by Subject|0|||
164397242|NCT01231906|593823551|FG001|Overall Study|Withdrawal by Subject|4|||
164397243|NCT01231906|593823550|FG000|Overall Study|Ineligible|10|||
164397244|NCT01231906|593823551|FG001|Overall Study|Ineligible|3|||
164397245|NCT01231906|593823550|FG000|Overall Study|No treatment|1|||
164397246|NCT01231906|593823551|FG001|Overall Study|No treatment|2|||
164397247|NCT04564339|593823552|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164397248|NCT04564339|593823553|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164397249|NCT04564339|593823554|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164397250|NCT04564339|593823555|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164397251|NCT04564339|593823552|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
164397252|NCT04564339|593823553|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164397253|NCT04564339|593823554|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164397254|NCT04564339|593823555|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164397255|NCT04564339|593823552|FG000|Extension Period (Week 26 to Week 50)|Physician Decision|1|||
164397256|NCT04564339|593823553|FG001|Extension Period (Week 26 to Week 50)|Physician Decision|0|||
164397257|NCT04564339|593823554|FG002|Extension Period (Week 26 to Week 50)|Physician Decision|1|||
164397258|NCT04564339|593823555|FG003|Extension Period (Week 26 to Week 50)|Physician Decision|0|||
164397259|NCT04564339|593823552|FG000|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|1|||
164397260|NCT04564339|593823553|FG001|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
164397261|NCT04564339|593823554|FG002|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
164397262|NCT04564339|593823555|FG003|Extension Period (Week 26 to Week 50)|Withdrawal by Subject|0|||
164397263|NCT04564339|593823552|FG000|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
164397264|NCT04564339|593823553|FG001|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|1|||
164397265|NCT04564339|593823554|FG002|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
164397266|NCT04564339|593823555|FG003|Extension Period (Week 26 to Week 50)|Study Terminated by Sponsor|0|||
164397267|NCT06286332|593823559|FG000|Overall Study|Death|1|||
164397268|NCT06286332|593823560|FG001|Overall Study|Death|2|||
164397269|NCT06286332|593823559|FG000|Overall Study|Transfer to ICU|2|||
164397270|NCT06286332|593823560|FG001|Overall Study|Transfer to ICU|0|||
164397271|NCT04158739|593823562|FG000|Overall Study|Adverse Event|1|||
164397272|NCT04158739|593823563|FG001|Overall Study|Adverse Event|0|||
164397273|NCT04158739|593823562|FG000|Overall Study|Death|0|||
164397274|NCT04158739|593823563|FG001|Overall Study|Death|1|||
164397275|NCT04158739|593823562|FG000|Overall Study|Lack of Efficacy|3|||
164397276|NCT04158739|593823563|FG001|Overall Study|Lack of Efficacy|7|||
164397277|NCT04158739|593823562|FG000|Overall Study|Physician Decision|0|||
164397278|NCT04158739|593823563|FG001|Overall Study|Physician Decision|1|||
164397279|NCT04158739|593823562|FG000|Overall Study|Withdrawal by Subject|3|||
164397280|NCT04158739|593823563|FG001|Overall Study|Withdrawal by Subject|0|||
164397281|NCT06070987|593823564|FG000|first treatment|Withdrawal by Subject|1|||
164397282|NCT06070987|593823565|FG001|first treatment|Withdrawal by Subject|0|||
164397283|NCT06070987|593823564|FG000|first treatment|Lost to Follow-up|1|||
164397284|NCT06070987|593823565|FG001|first treatment|Lost to Follow-up|1|||
164397285|NCT06070987|593823564|FG000|first treatment|Protocol Violation|1|||
164397286|NCT06070987|593823565|FG001|first treatment|Protocol Violation|1|||
164016874|NCT01165203|592424018|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
164016875|NCT01165203|592424017|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
164016876|NCT01165203|592424018|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
164397287|NCT06070987|593823564|FG000|wash out|did not participate in second treatment|2|||
164397288|NCT06070987|593823565|FG001|wash out|did not participate in second treatment|2|||
164397289|NCT06070987|593823564|FG000|second treatment|Withdrawal by Subject|1|||
164397290|NCT06070987|593823565|FG001|second treatment|Withdrawal by Subject|0|||
164397291|NCT06070987|593823564|FG000|second treatment|Lost to Follow-up|1|||
164016877|NCT01165203|592424017|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
164016878|NCT01165203|592424018|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
164397292|NCT06070987|593823565|FG001|second treatment|Lost to Follow-up|1|||
164397293|NCT02405221|593824495|FG000|Overall Study|Adverse Event|1|||
164397294|NCT02405221|593824496|FG001|Overall Study|Adverse Event|0|||
164397295|NCT02405221|593824495|FG000|Overall Study|Lost to Follow-up|1|||
164397296|NCT02405221|593824496|FG001|Overall Study|Lost to Follow-up|1|||
164397297|NCT03972488|593824497|FG000|Overall Study|Progressive disease|42|||
164397298|NCT03972488|593824498|FG001|Overall Study|Progressive disease|44|||
164397299|NCT03972488|593824497|FG000|Overall Study|Physician Decision|13|||
164397300|NCT03972488|593824498|FG001|Overall Study|Physician Decision|7|||
164397301|NCT03972488|593824497|FG000|Overall Study|Adverse Event|8|||
164397302|NCT03972488|593824498|FG001|Overall Study|Adverse Event|1|||
164397303|NCT03972488|593824497|FG000|Overall Study|Death|4|||
164397304|NCT03972488|593824498|FG001|Overall Study|Death|4|||
164397305|NCT03972488|593824497|FG000|Overall Study|Withdrawal by Subject|3|||
164397306|NCT03972488|593824498|FG001|Overall Study|Withdrawal by Subject|4|||
164397307|NCT03972488|593824497|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
164397308|NCT03972488|593824498|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
164397309|NCT04526665|593824500|FG000|Overall Study|Withdrawal by Subject|6|||
164397310|NCT04526665|593824501|FG001|Overall Study|Withdrawal by Subject|3|||
164397311|NCT04526665|593824500|FG000|Overall Study|Adverse Event|4|||
164397312|NCT04526665|593824501|FG001|Overall Study|Adverse Event|1|||
164397313|NCT04526665|593824500|FG000|Overall Study|Physician Decision|2|||
164397314|NCT04526665|593824501|FG001|Overall Study|Physician Decision|2|||
164397315|NCT04526665|593824500|FG000|Overall Study|Death|2|||
164397316|NCT04526665|593824501|FG001|Overall Study|Death|0|||
164397317|NCT04526665|593824500|FG000|Overall Study|Other|0|||
164397318|NCT04526665|593824501|FG001|Overall Study|Other|1|||
164397319|NCT05070247|593824502|FG000|Overall Study|Death|1|||
164397320|NCT05070247|593824503|FG001|Overall Study|Death|1|||
164397321|NCT05070247|593824504|FG002|Overall Study|Death|1|||
164397322|NCT05070247|593824505|FG003|Overall Study|Death|1|||
164397323|NCT05070247|593824506|FG004|Overall Study|Death|0|||
164397324|NCT05070247|593824507|FG005|Overall Study|Death|2|||
164397325|NCT05070247|593824508|FG006|Overall Study|Death|0|||
164397326|NCT05070247|593824509|FG007|Overall Study|Death|0|||
164397327|NCT05070247|593824510|FG008|Overall Study|Death|2|||
164397328|NCT05070247|593824511|FG009|Overall Study|Death|1|||
164397329|NCT05070247|593824512|FG010|Overall Study|Death|2|||
164397330|NCT05070247|593824513|FG011|Overall Study|Death|2|||
164397331|NCT05070247|593824514|FG012|Overall Study|Death|1|||
164397332|NCT05070247|593824515|FG013|Overall Study|Death|0|||
164016879|NCT01323673|592424019|FG000|Overall Study|Adverse Event|0|||
164016880|NCT01323673|592424020|FG001|Overall Study|Adverse Event|1|||
164016881|NCT01323673|592424019|FG000|Overall Study|Lost to Follow-up|0|||
164016882|NCT01323673|592424020|FG001|Overall Study|Lost to Follow-up|1|||
164016883|NCT01323673|592424019|FG000|Overall Study|Protocol Violation|1|||
164016884|NCT01323673|592424020|FG001|Overall Study|Protocol Violation|0|||
164016885|NCT01323673|592424019|FG000|Overall Study|Withdrawal by Subject|2|||
164016886|NCT01323673|592424020|FG001|Overall Study|Withdrawal by Subject|3|||
164073029|NCT04651218|592632773|FG000|Overall Study|Withdrawal by Subject|0|||
164073030|NCT04651218|592632774|FG001|Overall Study|Withdrawal by Subject|2|||
164073031|NCT02476851|592632775|FG000|Overall Study|Protocol Violation|1|||
164073032|NCT02476851|592632776|FG001|Overall Study|Protocol Violation|1|||
164073033|NCT01399125|592632779|FG000|Overall Study|Adverse Event|32|||
164073034|NCT01399125|592632780|FG001|Overall Study|Adverse Event|30|||
164073035|NCT01399125|592632779|FG000|Overall Study|Abnormal Lab values|0|||
164073036|NCT01399125|592632780|FG001|Overall Study|Abnormal Lab values|1|||
164073037|NCT01399125|592632779|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164073038|NCT01399125|592632780|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
164073039|NCT01399125|592632779|FG000|Overall Study|Withdrawal by Subject|5|||
164397333|NCT05070247|593824516|FG014|Overall Study|Death|0|||
164397334|NCT05070247|593824502|FG000|Overall Study|Withdrawal by Subject|1|||
164397335|NCT05070247|593824503|FG001|Overall Study|Withdrawal by Subject|1|||
164397336|NCT05070247|593824504|FG002|Overall Study|Withdrawal by Subject|1|||
164397337|NCT05070247|593824505|FG003|Overall Study|Withdrawal by Subject|1|||
164397338|NCT05070247|593824506|FG004|Overall Study|Withdrawal by Subject|0|||
164397339|NCT05070247|593824507|FG005|Overall Study|Withdrawal by Subject|4|||
164073040|NCT01399125|592632780|FG001|Overall Study|Withdrawal by Subject|8|||
164073041|NCT01399125|592632779|FG000|Overall Study|Lost to Follow-up|2|||
164073042|NCT01399125|592632780|FG001|Overall Study|Lost to Follow-up|3|||
164073043|NCT01399125|592632779|FG000|Overall Study|Administrative Problems|7|||
164073044|NCT01399125|592632780|FG001|Overall Study|Administrative Problems|11|||
164073045|NCT01399125|592632779|FG000|Overall Study|Death|0|||
164073046|NCT01399125|592632780|FG001|Overall Study|Death|1|||
164073047|NCT01399125|592632779|FG000|Overall Study|Protocol Deviation|5|||
164073048|NCT01399125|592632780|FG001|Overall Study|Protocol Deviation|2|||
164073049|NCT01902134|592632781|FG000|Overall Study|Adverse Event|3|||
164073050|NCT01902134|592632782|FG001|Overall Study|Adverse Event|1|||
164073051|NCT01902134|592632783|FG002|Overall Study|Adverse Event|2|||
164073052|NCT01902134|592632784|FG003|Overall Study|Adverse Event|1|||
164073053|NCT01902134|592632785|FG004|Overall Study|Adverse Event|1|||
164073054|NCT01902134|592632786|FG005|Overall Study|Adverse Event|3|||
164073055|NCT01902134|592632781|FG000|Overall Study|Lack of Efficacy|0|||
164073056|NCT01902134|592632782|FG001|Overall Study|Lack of Efficacy|0|||
164073057|NCT01902134|592632783|FG002|Overall Study|Lack of Efficacy|2|||
164073058|NCT01902134|592632784|FG003|Overall Study|Lack of Efficacy|0|||
164073059|NCT01902134|592632785|FG004|Overall Study|Lack of Efficacy|0|||
164073060|NCT01902134|592632786|FG005|Overall Study|Lack of Efficacy|1|||
164073061|NCT01902134|592632781|FG000|Overall Study|Physician Decision|0|||
164073062|NCT01902134|592632782|FG001|Overall Study|Physician Decision|1|||
164073063|NCT01902134|592632783|FG002|Overall Study|Physician Decision|0|||
164073064|NCT01902134|592632784|FG003|Overall Study|Physician Decision|0|||
164073065|NCT01902134|592632785|FG004|Overall Study|Physician Decision|0|||
164073066|NCT01902134|592632786|FG005|Overall Study|Physician Decision|0|||
164073067|NCT01902134|592632781|FG000|Overall Study|Protocol Violation|0|||
164073068|NCT01902134|592632782|FG001|Overall Study|Protocol Violation|0|||
164073069|NCT01902134|592632783|FG002|Overall Study|Protocol Violation|0|||
164073070|NCT01902134|592632784|FG003|Overall Study|Protocol Violation|0|||
164397340|NCT05070247|593824508|FG006|Overall Study|Withdrawal by Subject|0|||
164397341|NCT05070247|593824509|FG007|Overall Study|Withdrawal by Subject|1|||
164397342|NCT05070247|593824510|FG008|Overall Study|Withdrawal by Subject|2|||
164397343|NCT05070247|593824511|FG009|Overall Study|Withdrawal by Subject|1|||
164397344|NCT05070247|593824512|FG010|Overall Study|Withdrawal by Subject|0|||
164073071|NCT01902134|592632785|FG004|Overall Study|Protocol Violation|0|||
164073072|NCT01902134|592632786|FG005|Overall Study|Protocol Violation|1|||
164073073|NCT01902134|592632781|FG000|Overall Study|Withdrawal by Subject|4|||
164073074|NCT01902134|592632782|FG001|Overall Study|Withdrawal by Subject|8|||
164073075|NCT01902134|592632783|FG002|Overall Study|Withdrawal by Subject|9|||
164073076|NCT01902134|592632784|FG003|Overall Study|Withdrawal by Subject|1|||
164073077|NCT01902134|592632785|FG004|Overall Study|Withdrawal by Subject|5|||
164397345|NCT05070247|593824513|FG011|Overall Study|Withdrawal by Subject|0|||
164397346|NCT05070247|593824514|FG012|Overall Study|Withdrawal by Subject|3|||
164073078|NCT01902134|592632786|FG005|Overall Study|Withdrawal by Subject|4|||
164073079|NCT01902134|592632781|FG000|Overall Study|no compliance|1|||
164073080|NCT01902134|592632782|FG001|Overall Study|no compliance|0|||
164397347|NCT05070247|593824515|FG013|Overall Study|Withdrawal by Subject|4|||
164073081|NCT01902134|592632783|FG002|Overall Study|no compliance|0|||
164073082|NCT01902134|592632784|FG003|Overall Study|no compliance|0|||
164397348|NCT05070247|593824516|FG014|Overall Study|Withdrawal by Subject|0|||
164397349|NCT05070247|593824502|FG000|Overall Study|Reason Not Specified|0|||
164397350|NCT05070247|593824503|FG001|Overall Study|Reason Not Specified|0|||
164397351|NCT05070247|593824504|FG002|Overall Study|Reason Not Specified|2|||
164397352|NCT05070247|593824505|FG003|Overall Study|Reason Not Specified|0|||
164397353|NCT05070247|593824506|FG004|Overall Study|Reason Not Specified|0|||
164397354|NCT05070247|593824507|FG005|Overall Study|Reason Not Specified|0|||
164397355|NCT05070247|593824508|FG006|Overall Study|Reason Not Specified|1|||
164397356|NCT05070247|593824509|FG007|Overall Study|Reason Not Specified|1|||
164397357|NCT05070247|593824510|FG008|Overall Study|Reason Not Specified|1|||
164397358|NCT05070247|593824511|FG009|Overall Study|Reason Not Specified|1|||
164397359|NCT05070247|593824512|FG010|Overall Study|Reason Not Specified|2|||
164397360|NCT05070247|593824513|FG011|Overall Study|Reason Not Specified|2|||
164397361|NCT05070247|593824514|FG012|Overall Study|Reason Not Specified|2|||
164397362|NCT05070247|593824515|FG013|Overall Study|Reason Not Specified|0|||
164397363|NCT05070247|593824516|FG014|Overall Study|Reason Not Specified|0|||
164397364|NCT04544995|593824518|FG000|Overall Study|Death|7|||
164397365|NCT04544995|593824519|FG001|Overall Study|Death|3|||
164397366|NCT04544995|593824520|FG002|Overall Study|Death|3|||
164397367|NCT04544995|593824521|FG003|Overall Study|Death|3|||
164397368|NCT04544995|593824522|FG004|Overall Study|Death|1|||
164397369|NCT04544995|593824523|FG005|Overall Study|Death|2|||
164397370|NCT04544995|593824524|FG006|Overall Study|Death|1|||
164397371|NCT04544995|593824518|FG000|Overall Study|Lost to Follow-up|0|||
164397372|NCT04544995|593824519|FG001|Overall Study|Lost to Follow-up|0|||
164397373|NCT04544995|593824520|FG002|Overall Study|Lost to Follow-up|0|||
164397374|NCT04544995|593824521|FG003|Overall Study|Lost to Follow-up|0|||
164397375|NCT04544995|593824522|FG004|Overall Study|Lost to Follow-up|1|||
164397376|NCT04544995|593824523|FG005|Overall Study|Lost to Follow-up|0|||
164397377|NCT04544995|593824524|FG006|Overall Study|Lost to Follow-up|0|||
164397378|NCT04544995|593824518|FG000|Overall Study|Physician Decision|0|||
164397379|NCT04544995|593824519|FG001|Overall Study|Physician Decision|0|||
164397380|NCT04544995|593824520|FG002|Overall Study|Physician Decision|0|||
164397381|NCT04544995|593824521|FG003|Overall Study|Physician Decision|0|||
164397382|NCT04544995|593824522|FG004|Overall Study|Physician Decision|5|||
164397383|NCT04544995|593824523|FG005|Overall Study|Physician Decision|0|||
164397384|NCT04544995|593824524|FG006|Overall Study|Physician Decision|0|||
164397385|NCT04544995|593824518|FG000|Overall Study|Withdrawal by Subject|0|||
164397386|NCT04544995|593824519|FG001|Overall Study|Withdrawal by Subject|0|||
164397387|NCT04544995|593824520|FG002|Overall Study|Withdrawal by Subject|0|||
164397388|NCT04544995|593824521|FG003|Overall Study|Withdrawal by Subject|0|||
164397389|NCT04544995|593824522|FG004|Overall Study|Withdrawal by Subject|0|||
164397390|NCT04544995|593824523|FG005|Overall Study|Withdrawal by Subject|1|||
164397391|NCT04544995|593824524|FG006|Overall Study|Withdrawal by Subject|0|||
164397392|NCT04544995|593824518|FG000|Overall Study|Study Terminated by Sponsor|1|||
164397393|NCT04544995|593824519|FG001|Overall Study|Study Terminated by Sponsor|0|||
164397394|NCT04544995|593824520|FG002|Overall Study|Study Terminated by Sponsor|0|||
164397395|NCT04544995|593824521|FG003|Overall Study|Study Terminated by Sponsor|0|||
164397396|NCT04544995|593824522|FG004|Overall Study|Study Terminated by Sponsor|0|||
164397397|NCT04544995|593824523|FG005|Overall Study|Study Terminated by Sponsor|0|||
164397398|NCT04544995|593824524|FG006|Overall Study|Study Terminated by Sponsor|1|||
164397399|NCT04544995|593824518|FG000|Overall Study|Reached protocol-defined stopping criteria|3|||
164397400|NCT04544995|593824519|FG001|Overall Study|Reached protocol-defined stopping criteria|4|||
164397401|NCT04544995|593824520|FG002|Overall Study|Reached protocol-defined stopping criteria|2|||
164397402|NCT04544995|593824521|FG003|Overall Study|Reached protocol-defined stopping criteria|0|||
164397403|NCT04544995|593824522|FG004|Overall Study|Reached protocol-defined stopping criteria|4|||
164397404|NCT04544995|593824523|FG005|Overall Study|Reached protocol-defined stopping criteria|4|||
164397405|NCT04544995|593824524|FG006|Overall Study|Reached protocol-defined stopping criteria|1|||
164397406|NCT06865677|593824525|FG000|Overall Study|Screen failure|1|||
164397407|NCT06865677|593824526|FG001|Overall Study|Screen failure|0|||
164397408|NCT06865677|593824525|FG000|Overall Study|Participant no longer eligible before start of conditioning|0|||
164397409|NCT06865677|593824526|FG001|Overall Study|Participant no longer eligible before start of conditioning|1|||
164397410|NCT03299166|593824533|FG000|Overall Study|Adverse Event|9|||
164397411|NCT03299166|593824534|FG001|Overall Study|Adverse Event|4|||
164397412|NCT03299166|593824533|FG000|Overall Study|Withdrawal by Subject|6|||
164397413|NCT03299166|593824534|FG001|Overall Study|Withdrawal by Subject|5|||
164397414|NCT03299166|593824533|FG000|Overall Study|Physician Decision|1|||
164397415|NCT03299166|593824534|FG001|Overall Study|Physician Decision|1|||
164397416|NCT03299166|593824533|FG000|Overall Study|Sponsor Decision|3|||
164397417|NCT03299166|593824534|FG001|Overall Study|Sponsor Decision|0|||
164397418|NCT03299166|593824533|FG000|Overall Study|Lost to Follow-up|2|||
164397419|NCT03299166|593824534|FG001|Overall Study|Lost to Follow-up|4|||
164397420|NCT03299166|593824533|FG000|Overall Study|Randomization Error|0|||
164397421|NCT03299166|593824534|FG001|Overall Study|Randomization Error|1|||
164397422|NCT03299166|593824533|FG000|Overall Study|Subject unable to return due to COVID|1|||
164397423|NCT03299166|593824534|FG001|Overall Study|Subject unable to return due to COVID|0|||
164397424|NCT03299166|593824533|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
164093663|NCT02777528|592707257|FG002|Overall Study|Lost to Follow-up|0|||
163905973|NCT01364597|592028033|FG000|Overall Study|No Seizures|1|||
163905974|NCT01364597|592028034|FG001|Overall Study|No Seizures|0|||
163905975|NCT01364597|592028035|FG002|Overall Study|No Seizures|0|||
163905976|NCT01364597|592028036|FG003|Overall Study|No Seizures|0|||
163905977|NCT01364597|592028033|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
163905978|NCT01364597|592028034|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
163905979|NCT01364597|592028035|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
163905980|NCT01364597|592028036|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
163905981|NCT01364597|592028033|FG000|Overall Study|Cure|1|||
163905982|NCT01364597|592028034|FG001|Overall Study|Cure|0|||
163905983|NCT01364597|592028035|FG002|Overall Study|Cure|0|||
163905984|NCT01364597|592028036|FG003|Overall Study|Cure|0|||
163905985|NCT01364597|592028033|FG000|Overall Study|Patient was moving|0|||
163905986|NCT01364597|592028034|FG001|Overall Study|Patient was moving|1|||
163905987|NCT01364597|592028035|FG002|Overall Study|Patient was moving|0|||
163905988|NCT01364597|592028036|FG003|Overall Study|Patient was moving|0|||
163905989|NCT01364597|592028033|FG000|Overall Study|Seizures resolved|0|||
164397425|NCT03299166|593824534|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
164397426|NCT02408861|593824535|FG000|Overall Study|Death|0|||
164397427|NCT02408861|593824536|FG001|Overall Study|Death|3|||
164397428|NCT02408861|593824537|FG002|Overall Study|Death|1|||
164397429|NCT02408861|593824538|FG003|Overall Study|Death|2|||
164397430|NCT02408861|593824539|FG004|Overall Study|Death|4|||
164397431|NCT02408861|593824540|FG005|Overall Study|Death|1|||
164397432|NCT02408861|593824541|FG006|Overall Study|Death|0|||
164016887|NCT04907539|592425747|FG000|Overall Study|Consent withdrawn|1|||
164016888|NCT04907539|592425748|FG001|Overall Study|Consent withdrawn|0|||
164016889|NCT04907539|592425747|FG000|Overall Study|Death|14|||
164016890|NCT04907539|592425748|FG001|Overall Study|Death|3|||
164016891|NCT00051558|592425749|FG000|Overall Study|Adverse Event|30|||
164016892|NCT00051558|592425750|FG001|Overall Study|Adverse Event|18|||
164016893|NCT00051558|592425749|FG000|Overall Study|Withdrawal by Subject|29|||
164016894|NCT00051558|592425750|FG001|Overall Study|Withdrawal by Subject|42|||
164016895|NCT00051558|592425749|FG000|Overall Study|Death|9|||
164016896|NCT00051558|592425750|FG001|Overall Study|Death|15|||
164016897|NCT00051558|592425749|FG000|Overall Study|Lost to Follow-up|4|||
164016898|NCT00051558|592425750|FG001|Overall Study|Lost to Follow-up|13|||
164016899|NCT00051558|592425749|FG000|Overall Study|Protocol Violation|3|||
164016900|NCT00051558|592425750|FG001|Overall Study|Protocol Violation|4|||
164016901|NCT00051558|592425749|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
164016902|NCT00051558|592425750|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
164016903|NCT00051558|592425749|FG000|Overall Study|Sponsor Decision|6|||
164016904|NCT00051558|592425750|FG001|Overall Study|Sponsor Decision|1|||
164016905|NCT00051558|592425749|FG000|Overall Study|Other|2|||
164016906|NCT00051558|592425750|FG001|Overall Study|Other|1|||
164016907|NCT00051558|592425749|FG000|Overall Study|Significant Lab Value|2|||
164016908|NCT00051558|592425750|FG001|Overall Study|Significant Lab Value|0|||
164016909|NCT00051558|592425749|FG000|Overall Study|Physician Decision|5|||
164016910|NCT00051558|592425750|FG001|Overall Study|Physician Decision|0|||
164016911|NCT02163993|592425752|FG000|Treatment Period|Adverse Event|0|||
164016912|NCT02163993|592425753|FG001|Treatment Period|Adverse Event|1|||
164016913|NCT02163993|592425754|FG002|Treatment Period|Adverse Event|0|||
164016914|NCT02163993|592425755|FG003|Treatment Period|Adverse Event|0|||
164016915|NCT02163993|592425756|FG004|Treatment Period|Adverse Event|1|||
164016916|NCT02163993|592425752|FG000|Treatment Period|Lost to Follow-up|2|||
164016917|NCT02163993|592425753|FG001|Treatment Period|Lost to Follow-up|3|||
164016918|NCT02163993|592425754|FG002|Treatment Period|Lost to Follow-up|1|||
164016919|NCT02163993|592425755|FG003|Treatment Period|Lost to Follow-up|3|||
164016920|NCT02163993|592425756|FG004|Treatment Period|Lost to Follow-up|1|||
164016921|NCT02163993|592425752|FG000|Treatment Period|Physician Decision|1|||
164016922|NCT02163993|592425753|FG001|Treatment Period|Physician Decision|0|||
164016923|NCT02163993|592425754|FG002|Treatment Period|Physician Decision|0|||
164016924|NCT02163993|592425755|FG003|Treatment Period|Physician Decision|0|||
164016925|NCT02163993|592425756|FG004|Treatment Period|Physician Decision|0|||
164016926|NCT02163993|592425752|FG000|Treatment Period|Protocol Violation|2|||
164016927|NCT02163993|592425753|FG001|Treatment Period|Protocol Violation|1|||
164016928|NCT02163993|592425754|FG002|Treatment Period|Protocol Violation|0|||
164016929|NCT02163993|592425755|FG003|Treatment Period|Protocol Violation|1|||
164016930|NCT02163993|592425756|FG004|Treatment Period|Protocol Violation|2|||
164016931|NCT02163993|592425752|FG000|Treatment Period|Withdrawal by Subject|6|||
164016932|NCT02163993|592425753|FG001|Treatment Period|Withdrawal by Subject|4|||
164016933|NCT02163993|592425754|FG002|Treatment Period|Withdrawal by Subject|1|||
164016934|NCT02163993|592425755|FG003|Treatment Period|Withdrawal by Subject|4|||
164397433|NCT02408861|593824535|FG000|Overall Study|Lost to Follow-up|0|||
164016935|NCT02163993|592425756|FG004|Treatment Period|Withdrawal by Subject|1|||
164016936|NCT02163993|592425752|FG000|Treatment Period|Not treated|1|||
164016937|NCT02163993|592425753|FG001|Treatment Period|Not treated|0|||
164016938|NCT02163993|592425754|FG002|Treatment Period|Not treated|0|||
164016939|NCT02163993|592425755|FG003|Treatment Period|Not treated|1|||
164016940|NCT02163993|592425756|FG004|Treatment Period|Not treated|2|||
164397434|NCT02408861|593824536|FG001|Overall Study|Lost to Follow-up|0|||
164397435|NCT02408861|593824537|FG002|Overall Study|Lost to Follow-up|1|||
164016941|NCT02163993|592425752|FG000|Post-treatment Period|Adverse Event|0|||
164016942|NCT02163993|592425753|FG001|Post-treatment Period|Adverse Event|0|||
164016943|NCT02163993|592425754|FG002|Post-treatment Period|Adverse Event|1|||
164016944|NCT02163993|592425755|FG003|Post-treatment Period|Adverse Event|0|||
164016945|NCT02163993|592425756|FG004|Post-treatment Period|Adverse Event|0|||
164016946|NCT02163993|592425752|FG000|Post-treatment Period|Lost to Follow-up|2|||
164016947|NCT02163993|592425753|FG001|Post-treatment Period|Lost to Follow-up|2|||
164016948|NCT02163993|592425754|FG002|Post-treatment Period|Lost to Follow-up|3|||
164016949|NCT02163993|592425755|FG003|Post-treatment Period|Lost to Follow-up|1|||
164016950|NCT02163993|592425756|FG004|Post-treatment Period|Lost to Follow-up|0|||
164016951|NCT02163993|592425752|FG000|Post-treatment Period|Protocol Violation|0|||
164016952|NCT02163993|592425753|FG001|Post-treatment Period|Protocol Violation|0|||
164016953|NCT02163993|592425754|FG002|Post-treatment Period|Protocol Violation|0|||
164016954|NCT02163993|592425755|FG003|Post-treatment Period|Protocol Violation|0|||
164093664|NCT02777528|592707255|FG000|Overall Study|Discontinued due to Other|1|||
164016955|NCT02163993|592425756|FG004|Post-treatment Period|Protocol Violation|1|||
164016956|NCT02163993|592425752|FG000|Post-treatment Period|Withdrawal by Subject|2|||
164016957|NCT02163993|592425753|FG001|Post-treatment Period|Withdrawal by Subject|4|||
164016958|NCT02163993|592425754|FG002|Post-treatment Period|Withdrawal by Subject|0|||
164016959|NCT02163993|592425755|FG003|Post-treatment Period|Withdrawal by Subject|1|||
164016960|NCT02163993|592425756|FG004|Post-treatment Period|Withdrawal by Subject|2|||
164016961|NCT01808118|592425757|FG000|Period 1|Adverse Event|15|||
164016962|NCT01808118|592425758|FG001|Period 1|Adverse Event|0|||
164016963|NCT01808118|592425759|FG002|Period 1|Adverse Event|0|||
164016964|NCT01808118|592425757|FG000|Period 1|Withdrew consent|24|||
164016965|NCT01808118|592425758|FG001|Period 1|Withdrew consent|0|||
164016966|NCT01808118|592425759|FG002|Period 1|Withdrew consent|0|||
164016967|NCT01808118|592425757|FG000|Period 1|Lost to Follow-up|9|||
164016968|NCT01808118|592425758|FG001|Period 1|Lost to Follow-up|0|||
164016969|NCT01808118|592425759|FG002|Period 1|Lost to Follow-up|0|||
164016970|NCT01808118|592425757|FG000|Period 1|Did not meet criteria for remission|303|||
164016971|NCT01808118|592425758|FG001|Period 1|Did not meet criteria for remission|0|||
164016972|NCT01808118|592425759|FG002|Period 1|Did not meet criteria for remission|0|||
164016973|NCT01808118|592425757|FG000|Period 1|Enrolled in error|7|||
164397436|NCT02408861|593824538|FG003|Overall Study|Lost to Follow-up|1|||
164016974|NCT01808118|592425758|FG001|Period 1|Enrolled in error|0|||
164016975|NCT01808118|592425759|FG002|Period 1|Enrolled in error|0|||
164016976|NCT01808118|592425757|FG000|Period 1|Did not meet inclusion criteria|3|||
164016977|NCT01808118|592425758|FG001|Period 1|Did not meet inclusion criteria|0|||
164016978|NCT01808118|592425759|FG002|Period 1|Did not meet inclusion criteria|0|||
164016979|NCT01808118|592425757|FG000|Period 1|Non-conformance with inclusion criteria|3|||
164016980|NCT01808118|592425758|FG001|Period 1|Non-conformance with inclusion criteria|0|||
164016981|NCT01808118|592425759|FG002|Period 1|Non-conformance with inclusion criteria|0|||
164016982|NCT01808118|592425757|FG000|Period 1|Investigator decision: site closure|2|||
164016983|NCT01808118|592425758|FG001|Period 1|Investigator decision: site closure|0|||
164016984|NCT01808118|592425759|FG002|Period 1|Investigator decision: site closure|0|||
164016985|NCT01808118|592425757|FG000|Period 1|Non-compliance per sponsor|1|||
164016986|NCT01808118|592425758|FG001|Period 1|Non-compliance per sponsor|0|||
164016987|NCT01808118|592425759|FG002|Period 1|Non-compliance per sponsor|0|||
164016988|NCT01808118|592425757|FG000|Period 1|Lack of Efficacy|1|||
164016989|NCT01808118|592425758|FG001|Period 1|Lack of Efficacy|0|||
164016990|NCT01808118|592425759|FG002|Period 1|Lack of Efficacy|0|||
164016991|NCT01808118|592425757|FG000|Period 2|Adverse Event|0|||
164016992|NCT01808118|592425758|FG001|Period 2|Adverse Event|4|||
164016993|NCT01808118|592425759|FG002|Period 2|Adverse Event|0|||
164016994|NCT01808118|592425757|FG000|Period 2|Withdrew consent|0|||
164016995|NCT01808118|592425758|FG001|Period 2|Withdrew consent|7|||
164016996|NCT01808118|592425759|FG002|Period 2|Withdrew consent|6|||
164016997|NCT01808118|592425757|FG000|Period 2|Lost to Follow-up|0|||
164016998|NCT01808118|592425758|FG001|Period 2|Lost to Follow-up|0|||
164016999|NCT01808118|592425759|FG002|Period 2|Lost to Follow-up|2|||
164017000|NCT01808118|592425757|FG000|Period 2|Investigator no longer conducting trials|0|||
164017001|NCT01808118|592425758|FG001|Period 2|Investigator no longer conducting trials|1|||
164017002|NCT01808118|592425759|FG002|Period 2|Investigator no longer conducting trials|0|||
164017003|NCT01808118|592425757|FG000|Period 2|Switched to other therapy|0|||
164017004|NCT01808118|592425758|FG001|Period 2|Switched to other therapy|1|||
164017005|NCT01808118|592425759|FG002|Period 2|Switched to other therapy|0|||
164017006|NCT03041116|592425767|FG000|Double-blind|Death|0|||
164017007|NCT03041116|592425768|FG001|Double-blind|Death|2|||
164017008|NCT03041116|592425767|FG000|Double-blind|Withdrawal by Subject|0|||
164017009|NCT03041116|592425768|FG001|Double-blind|Withdrawal by Subject|4|||
164017010|NCT03041116|592425767|FG000|Open-label|Death|1|||
164017011|NCT03041116|592425768|FG001|Open-label|Death|0|||
164017012|NCT03041116|592425767|FG000|Open-label|Termination of the study by Sponsor|39|||
164017013|NCT03041116|592425768|FG001|Open-label|Termination of the study by Sponsor|37|||
164017014|NCT03041116|592425767|FG000|Open-label|Withdrawal by Subject|1|||
164017015|NCT03041116|592425768|FG001|Open-label|Withdrawal by Subject|0|||
164017016|NCT03097328|592425769|FG000|Overall Study|Still on Therapy|2|||
164017017|NCT03097328|592425769|FG000|Overall Study|Progressive Disease|29|||
164397437|NCT02408861|593824539|FG004|Overall Study|Lost to Follow-up|4|||
164397438|NCT02408861|593824540|FG005|Overall Study|Lost to Follow-up|2|||
164017018|NCT03097328|592425769|FG000|Overall Study|Adverse Event|4|||
164017019|NCT03097328|592425769|FG000|Overall Study|Withdrawal by Subject|1|||
164017020|NCT03097328|592425769|FG000|Overall Study|Physician Decision|1|||
164017021|NCT03097328|592425769|FG000|Overall Study|Patient Decision|1|||
164017022|NCT03097328|592425769|FG000|Overall Study|Ineligible for Study Drug|1|||
164017023|NCT02023164|592425770|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
164017024|NCT02023164|592425771|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
164017025|NCT01675011|592425772|FG000|Overall Study|Trial terminated by Sponsor|3|||
164017026|NCT01675011|592425773|FG001|Overall Study|Trial terminated by Sponsor|1|||
164017027|NCT01984346|592425779|FG000|Overall Study|Physician Decision|4|||
164017028|NCT01984346|592425780|FG001|Overall Study|Physician Decision|2|||
164017029|NCT01984346|592425779|FG000|Overall Study|Withdrawal by Subject|2|||
164017030|NCT01984346|592425780|FG001|Overall Study|Withdrawal by Subject|2|||
163905990|NCT01364597|592028034|FG001|Overall Study|Seizures resolved|0|||
164093665|NCT02777528|592707256|FG001|Overall Study|Discontinued due to Other|0|||
164397439|NCT02408861|593824541|FG006|Overall Study|Lost to Follow-up|1|||
164397440|NCT02408861|593824535|FG000|Overall Study|Disease Progression|0|||
164397441|NCT02408861|593824536|FG001|Overall Study|Disease Progression|0|||
164397442|NCT02408861|593824537|FG002|Overall Study|Disease Progression|1|||
164397443|NCT02408861|593824538|FG003|Overall Study|Disease Progression|0|||
164397444|NCT02408861|593824539|FG004|Overall Study|Disease Progression|3|||
164397445|NCT02408861|593824540|FG005|Overall Study|Disease Progression|1|||
164397446|NCT02408861|593824541|FG006|Overall Study|Disease Progression|1|||
164397447|NCT02408861|593824535|FG000|Overall Study|Adverse Event|1|||
164397448|NCT02408861|593824536|FG001|Overall Study|Adverse Event|0|||
164093666|NCT02777528|592707257|FG002|Overall Study|Discontinued due to Other|0|||
164397449|NCT02408861|593824537|FG002|Overall Study|Adverse Event|1|||
164397450|NCT02408861|593824538|FG003|Overall Study|Adverse Event|0|||
164397451|NCT02408861|593824539|FG004|Overall Study|Adverse Event|2|||
164397452|NCT02408861|593824540|FG005|Overall Study|Adverse Event|0|||
164397453|NCT02408861|593824541|FG006|Overall Study|Adverse Event|0|||
164397454|NCT02408861|593824535|FG000|Overall Study|Physician Decision|1|||
164397455|NCT02408861|593824536|FG001|Overall Study|Physician Decision|1|||
164397456|NCT02408861|593824537|FG002|Overall Study|Physician Decision|1|||
164397457|NCT02408861|593824538|FG003|Overall Study|Physician Decision|0|||
164397458|NCT02408861|593824539|FG004|Overall Study|Physician Decision|0|||
164397459|NCT02408861|593824540|FG005|Overall Study|Physician Decision|1|||
164397460|NCT02408861|593824541|FG006|Overall Study|Physician Decision|0|||
164397461|NCT02408861|593824535|FG000|Overall Study|Protocol Violation|1|||
164397462|NCT02408861|593824536|FG001|Overall Study|Protocol Violation|0|||
164397463|NCT02408861|593824537|FG002|Overall Study|Protocol Violation|0|||
164397464|NCT02408861|593824538|FG003|Overall Study|Protocol Violation|0|||
164397465|NCT02408861|593824539|FG004|Overall Study|Protocol Violation|0|||
164397466|NCT02408861|593824540|FG005|Overall Study|Protocol Violation|0|||
164397467|NCT02408861|593824541|FG006|Overall Study|Protocol Violation|0|||
164397468|NCT02408861|593824535|FG000|Overall Study|Withdrawal by Subject|0|||
164397469|NCT02408861|593824536|FG001|Overall Study|Withdrawal by Subject|0|||
164397470|NCT02408861|593824537|FG002|Overall Study|Withdrawal by Subject|0|||
164397471|NCT02408861|593824538|FG003|Overall Study|Withdrawal by Subject|0|||
164397472|NCT02408861|593824539|FG004|Overall Study|Withdrawal by Subject|1|||
163905991|NCT01364597|592028035|FG002|Overall Study|Seizures resolved|1|||
163905992|NCT01364597|592028036|FG003|Overall Study|Seizures resolved|0|||
163905993|NCT01364597|592028033|FG000|Overall Study|Patient became seizure-free after surgery|0|||
163905994|NCT01364597|592028034|FG001|Overall Study|Patient became seizure-free after surgery|0|||
163905995|NCT01364597|592028035|FG002|Overall Study|Patient became seizure-free after surgery|1|||
163905996|NCT01364597|592028036|FG003|Overall Study|Patient became seizure-free after surgery|0|||
163905997|NCT01364597|592028033|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
163905998|NCT01364597|592028034|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
163905999|NCT01364597|592028035|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
163906000|NCT01364597|592028036|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
163906001|NCT01364597|592028033|FG000|Overall Study|Patient cured from Epilepsy|0|||
163906002|NCT01364597|592028034|FG001|Overall Study|Patient cured from Epilepsy|0|||
163906003|NCT01364597|592028035|FG002|Overall Study|Patient cured from Epilepsy|1|||
163906004|NCT01364597|592028036|FG003|Overall Study|Patient cured from Epilepsy|0|||
163906005|NCT01364597|592028033|FG000|Overall Study|Investigator decision|0|||
163906006|NCT01364597|592028034|FG001|Overall Study|Investigator decision|0|||
163906007|NCT01364597|592028035|FG002|Overall Study|Investigator decision|1|||
163906008|NCT01364597|592028036|FG003|Overall Study|Investigator decision|0|||
163906009|NCT01364597|592028033|FG000|Overall Study|Sponsor recommended discontinuation|0|||
163906010|NCT01364597|592028034|FG001|Overall Study|Sponsor recommended discontinuation|0|||
163906011|NCT01364597|592028035|FG002|Overall Study|Sponsor recommended discontinuation|0|||
163906012|NCT01364597|592028036|FG003|Overall Study|Sponsor recommended discontinuation|1|||
163906013|NCT01364597|592028033|FG000|Overall Study|Parents went abroad with the patient|0|||
163906014|NCT01364597|592028034|FG001|Overall Study|Parents went abroad with the patient|0|||
163906015|NCT01364597|592028035|FG002|Overall Study|Parents went abroad with the patient|1|||
163906016|NCT01364597|592028036|FG003|Overall Study|Parents went abroad with the patient|0|||
163906017|NCT01364597|592028033|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
163906018|NCT01364597|592028034|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
163906019|NCT01364597|592028035|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
163906020|NCT01364597|592028036|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
163906021|NCT01364597|592028033|FG000|Overall Study|BRV administration dropout|0|||
163906022|NCT01364597|592028034|FG001|Overall Study|BRV administration dropout|0|||
163906023|NCT01364597|592028035|FG002|Overall Study|BRV administration dropout|1|||
164397473|NCT02408861|593824540|FG005|Overall Study|Withdrawal by Subject|1|||
164397474|NCT02408861|593824541|FG006|Overall Study|Withdrawal by Subject|0|||
164397475|NCT02408861|593824535|FG000|Overall Study|Other Treatment|0|||
164397476|NCT02408861|593824536|FG001|Overall Study|Other Treatment|0|||
164397477|NCT02408861|593824537|FG002|Overall Study|Other Treatment|0|||
164397478|NCT02408861|593824538|FG003|Overall Study|Other Treatment|0|||
164397479|NCT02408861|593824539|FG004|Overall Study|Other Treatment|0|||
164397480|NCT02408861|593824540|FG005|Overall Study|Other Treatment|1|||
164397481|NCT02408861|593824541|FG006|Overall Study|Other Treatment|1|||
164397482|NCT04814654|593824542|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
164397483|NCT04814654|593824543|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
164397484|NCT04814654|593824544|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
164397485|NCT05147662|593824548|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164397486|NCT05147662|593824548|FG000|Overall Study|Assigned to treatment but never treated|1|||
164397487|NCT00826540|593824549|FG000|Overall Study|ineligible|3|||
164397488|NCT00826540|593824549|FG000|Overall Study|Withdrawal by Subject|1|||
164397489|NCT03091192|593824785|FG000|Overall Study|Study terminated by sponsor|21|||
164397490|NCT03091192|593824786|FG001|Overall Study|Study terminated by sponsor|14|||
164397491|NCT03091192|593824785|FG000|Overall Study|Death|9|||
163906024|NCT01364597|592028036|FG003|Overall Study|BRV administration dropout|0|||
163906025|NCT01364597|592028033|FG000|Overall Study|Dropout|0|||
163906026|NCT01364597|592028034|FG001|Overall Study|Dropout|0|||
163906027|NCT01364597|592028035|FG002|Overall Study|Dropout|3|||
163906028|NCT01364597|592028036|FG003|Overall Study|Dropout|1|||
163906029|NCT01364597|592028033|FG000|Overall Study|Unreliable subject|0|||
163906030|NCT01364597|592028034|FG001|Overall Study|Unreliable subject|0|||
163906031|NCT01364597|592028035|FG002|Overall Study|Unreliable subject|0|||
163906032|NCT01364597|592028036|FG003|Overall Study|Unreliable subject|1|||
163906033|NCT01364597|592028033|FG000|Overall Study|Other|0|||
163906034|NCT01364597|592028034|FG001|Overall Study|Other|0|||
163906035|NCT01364597|592028035|FG002|Overall Study|Other|0|||
163906036|NCT01364597|592028036|FG003|Overall Study|Other|1|||
163906037|NCT03214081|592028037|FG000|Overall Study|Case Report Forms Uncollected|9|||
163906038|NCT03214081|592028037|FG000|Overall Study|Protocol Deviation|54|||
163906039|NCT02962284|592028038|FG000|Overall Study|Death|2|||
163906040|NCT02962284|592028039|FG001|Overall Study|Death|0|||
163906041|NCT02962284|592028038|FG000|Overall Study|Progressive disease|2|||
163906042|NCT02962284|592028039|FG001|Overall Study|Progressive disease|3|||
163906043|NCT02962284|592028038|FG000|Overall Study|Withdrawal by Subject|1|||
163906044|NCT02962284|592028039|FG001|Overall Study|Withdrawal by Subject|0|||
163906045|NCT03493282|592028040|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
163906046|NCT03493282|592028041|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
163906047|NCT03493282|592028042|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
163906048|NCT03493282|592028040|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
163906049|NCT03493282|592028041|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
163906050|NCT03493282|592028042|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
163906051|NCT00413283|592028047|FG000|Overall Study|Withdrawal by Subject|1|||
164017031|NCT01984346|592425779|FG000|Overall Study|Enrollment Closed|8|||
164017032|NCT01984346|592425780|FG001|Overall Study|Enrollment Closed|1|||
164017033|NCT01984346|592425779|FG000|Overall Study|Insurance Coverage|1|||
164017034|NCT01984346|592425780|FG001|Overall Study|Insurance Coverage|0|||
164017035|NCT01984346|592425779|FG000|Overall Study|Intra-operative Exclusion|2|||
164017036|NCT01984346|592425780|FG001|Overall Study|Intra-operative Exclusion|0|||
164017037|NCT03100942|592425781|FG000|Randomized Treatment Period|Withdrew Consent|4|||
164017038|NCT03100942|592425782|FG001|Randomized Treatment Period|Withdrew Consent|5|||
164017039|NCT03100942|592425783|FG002|Randomized Treatment Period|Withdrew Consent|3|||
164017040|NCT03100942|592425784|FG003|Randomized Treatment Period|Withdrew Consent|3|||
164017041|NCT03100942|592425785|FG004|Randomized Treatment Period|Withdrew Consent|0|||
164017042|NCT03100942|592425786|FG005|Randomized Treatment Period|Withdrew Consent|0|||
164017043|NCT03100942|592425787|FG006|Randomized Treatment Period|Withdrew Consent|0|||
164017044|NCT03100942|592425781|FG000|Randomized Treatment Period|Adverse Event|5|||
164017045|NCT03100942|592425782|FG001|Randomized Treatment Period|Adverse Event|2|||
164017046|NCT03100942|592425783|FG002|Randomized Treatment Period|Adverse Event|1|||
164017047|NCT03100942|592425784|FG003|Randomized Treatment Period|Adverse Event|0|||
164017048|NCT03100942|592425785|FG004|Randomized Treatment Period|Adverse Event|0|||
164017049|NCT03100942|592425786|FG005|Randomized Treatment Period|Adverse Event|0|||
164017050|NCT03100942|592425787|FG006|Randomized Treatment Period|Adverse Event|0|||
164017051|NCT03100942|592425781|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
164017052|NCT03100942|592425782|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
164017053|NCT03100942|592425783|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
164017054|NCT03100942|592425784|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
164017055|NCT03100942|592425785|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
164017056|NCT03100942|592425786|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
164017057|NCT03100942|592425787|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
163906052|NCT00413283|592028048|FG001|Overall Study|Withdrawal by Subject|0|||
163906053|NCT00413283|592028049|FG002|Overall Study|Withdrawal by Subject|0|||
163906054|NCT00413283|592028050|FG003|Overall Study|Withdrawal by Subject|1|||
164397492|NCT03091192|593824786|FG001|Overall Study|Death|13|||
164397493|NCT03091192|593824785|FG000|Overall Study|Withdrawal by Subject|2|||
164397494|NCT03091192|593824786|FG001|Overall Study|Withdrawal by Subject|0|||
164397495|NCT03091192|593824785|FG000|Overall Study|Lost to Follow-up|1|||
164397496|NCT03091192|593824786|FG001|Overall Study|Lost to Follow-up|0|||
164397497|NCT03222609|593824791|FG000|Overall Study|Withdrew consent|3|||
164397498|NCT03222609|593824792|FG001|Overall Study|Withdrew consent|9|||
164397499|NCT03222609|593824793|FG002|Overall Study|Withdrew consent|4|||
164397500|NCT03222609|593824794|FG003|Overall Study|Withdrew consent|2|||
164397501|NCT03222609|593824791|FG000|Overall Study|Lost to Follow-up|2|||
164397502|NCT03222609|593824792|FG001|Overall Study|Lost to Follow-up|2|||
164397503|NCT03222609|593824793|FG002|Overall Study|Lost to Follow-up|1|||
164397504|NCT03222609|593824794|FG003|Overall Study|Lost to Follow-up|0|||
164397505|NCT03222609|593824791|FG000|Overall Study|Death|20|||
164397506|NCT03222609|593824792|FG001|Overall Study|Death|38|||
164397507|NCT03222609|593824793|FG002|Overall Study|Death|18|||
164397508|NCT03222609|593824794|FG003|Overall Study|Death|10|||
163906055|NCT00413283|592028047|FG000|Overall Study|Death|0|||
163906056|NCT00413283|592028048|FG001|Overall Study|Death|0|||
163906057|NCT00413283|592028049|FG002|Overall Study|Death|1|||
163906058|NCT00413283|592028050|FG003|Overall Study|Death|1|||
163906059|NCT00413283|592028047|FG000|Overall Study|Adverse Event|0|||
163906060|NCT00413283|592028048|FG001|Overall Study|Adverse Event|0|||
163906061|NCT00413283|592028049|FG002|Overall Study|Adverse Event|0|||
163906062|NCT00413283|592028050|FG003|Overall Study|Adverse Event|1|||
163906063|NCT00413283|592028047|FG000|Overall Study|Ineligibility determined|0|||
163906064|NCT00413283|592028048|FG001|Overall Study|Ineligibility determined|0|||
163906065|NCT00413283|592028049|FG002|Overall Study|Ineligibility determined|0|||
163906066|NCT00413283|592028050|FG003|Overall Study|Ineligibility determined|1|||
163906067|NCT00413283|592028047|FG000|Overall Study|Protocol deviation|0|||
163906068|NCT00413283|592028048|FG001|Overall Study|Protocol deviation|1|||
163906069|NCT00413283|592028049|FG002|Overall Study|Protocol deviation|0|||
163906070|NCT00413283|592028050|FG003|Overall Study|Protocol deviation|0|||
163906071|NCT00413283|592028047|FG000|Overall Study|Requirement for alternative therapy|0|||
163906072|NCT00413283|592028048|FG001|Overall Study|Requirement for alternative therapy|2|||
163906073|NCT00413283|592028049|FG002|Overall Study|Requirement for alternative therapy|0|||
163906074|NCT00413283|592028050|FG003|Overall Study|Requirement for alternative therapy|0|||
163906075|NCT00413283|592028047|FG000|Overall Study|Other|0|||
163906076|NCT00413283|592028048|FG001|Overall Study|Other|0|||
163906077|NCT00413283|592028049|FG002|Overall Study|Other|1|||
163906078|NCT00413283|592028050|FG003|Overall Study|Other|0|||
163906079|NCT00667017|592028051|FG000|Overall Study|Withdrawal by Subject|1|||
163906080|NCT01823224|592028052|FG000|Overall Study|Lost to Follow-up|5|||
163906081|NCT01823224|592028053|FG001|Overall Study|Lost to Follow-up|6|||
163906082|NCT01823224|592028052|FG000|Overall Study|didn't qualify|1|||
163906083|NCT01823224|592028053|FG001|Overall Study|didn't qualify|2|||
163906084|NCT01823224|592028052|FG000|Overall Study|pharmacy error|0|||
163906085|NCT01823224|592028053|FG001|Overall Study|pharmacy error|1|||
163906086|NCT01823224|592028052|FG000|Overall Study|missed med dose|0|||
163906087|NCT01823224|592028053|FG001|Overall Study|missed med dose|1|||
163906088|NCT01823224|592028052|FG000|Overall Study|Withdrawal by Subject|0|||
163906089|NCT01823224|592028053|FG001|Overall Study|Withdrawal by Subject|1|||
163906090|NCT01532648|592028062|FG000|Overall Study|Lost to Follow-up|3|||
163906091|NCT01532648|592028063|FG001|Overall Study|Lost to Follow-up|4|||
163906092|NCT01532648|592028062|FG000|Overall Study|Lack of Efficacy|4|||
163906093|NCT01532648|592028063|FG001|Overall Study|Lack of Efficacy|1|||
163906094|NCT01532648|592028062|FG000|Overall Study|Protocol Violation|1|||
163906095|NCT01532648|592028063|FG001|Overall Study|Protocol Violation|1|||
163906096|NCT01532648|592028062|FG000|Overall Study|Adverse Event|12|||
163906097|NCT01532648|592028063|FG001|Overall Study|Adverse Event|9|||
163906098|NCT01532648|592028062|FG000|Overall Study|Withdrawal by Subject|16|||
163906099|NCT01532648|592028063|FG001|Overall Study|Withdrawal by Subject|2|||
163906100|NCT02148705|592028064|FG000|Overall Study|Death|2|||
163906101|NCT02148705|592028065|FG001|Overall Study|Death|0|||
163906102|NCT02148705|592028066|FG002|Overall Study|Death|0|||
163906103|NCT02148705|592028064|FG000|Overall Study|Lost to Follow-up|13|||
163906104|NCT02148705|592028065|FG001|Overall Study|Lost to Follow-up|4|||
163906105|NCT02148705|592028066|FG002|Overall Study|Lost to Follow-up|10|||
163906106|NCT02148705|592028064|FG000|Overall Study|Withdrawal by Subject|3|||
163906107|NCT02148705|592028065|FG001|Overall Study|Withdrawal by Subject|0|||
163906108|NCT02148705|592028066|FG002|Overall Study|Withdrawal by Subject|2|||
163906109|NCT02148705|592028064|FG000|Overall Study|Not Treated|0|||
163906110|NCT02148705|592028065|FG001|Overall Study|Not Treated|1|||
163906111|NCT02148705|592028066|FG002|Overall Study|Not Treated|5|||
163906112|NCT01737021|592028069|FG000|Overall Study|Lost to Follow-up|5|||
163906113|NCT01737021|592028070|FG001|Overall Study|Lost to Follow-up|3|||
163906114|NCT01673594|592028071|FG000|Overall Study|Adverse Event|3|||
163906115|NCT01673594|592028072|FG001|Overall Study|Adverse Event|1|||
164397509|NCT03222609|593824791|FG000|Overall Study|Other, not specified|9|||
163906116|NCT01673594|592028071|FG000|Overall Study|Lost to Follow-up|1|||
164397510|NCT03222609|593824792|FG001|Overall Study|Other, not specified|42|||
164397511|NCT03222609|593824793|FG002|Overall Study|Other, not specified|11|||
164397512|NCT03222609|593824794|FG003|Overall Study|Other, not specified|20|||
164397513|NCT06602466|593825227|FG000|Overall Study|Adverse Event|2|||
164397514|NCT06602466|593825228|FG001|Overall Study|Adverse Event|0|||
164397515|NCT06602466|593825227|FG000|Overall Study|Lost to Follow-up|1|||
164397516|NCT06602466|593825228|FG001|Overall Study|Lost to Follow-up|3|||
164397517|NCT06602466|593825227|FG000|Overall Study|Withdrawal by Subject|1|||
164397518|NCT06602466|593825228|FG001|Overall Study|Withdrawal by Subject|0|||
164397519|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|3|||
164397520|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397521|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397522|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397523|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397524|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397525|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397526|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Lack of Efficacy|0|||
164397527|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|10|||
164397528|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397529|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397530|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397531|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397532|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397533|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397534|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Lost to Follow-up|0|||
164397535|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|11|||
164397536|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397537|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397538|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397539|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397540|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397541|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397542|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Protocol Violation|0|||
164397543|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|8|||
164397544|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397545|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397546|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397547|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397548|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397549|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397550|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Withdrawal by Subject|0|||
164397551|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|1|||
164397552|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397553|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397554|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397555|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397556|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397557|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397558|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Worsening of Psoriasis|0|||
164397559|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|16|||
164397560|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164397561|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164397562|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164397563|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164397564|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164397565|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
163906117|NCT01673594|592028072|FG001|Overall Study|Lost to Follow-up|0|||
163906118|NCT01673594|592028071|FG000|Overall Study|Physician Decision|2|||
163906119|NCT01673594|592028072|FG001|Overall Study|Physician Decision|4|||
164397566|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Adverse Event - Other|0|||
164397567|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|1|||
164397568|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397569|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397570|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397571|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397572|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397573|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397574|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Non-Compliance with Study Drug|0|||
164397575|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Other|7|||
164397576|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397577|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397578|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397579|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397580|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397581|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397582|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Other|0|||
164397583|NCT03818035|593825229|FG000|Part 1: Open-label (Week 0 to Week 8)|Death|1|||
164397584|NCT03818035|593825230|FG001|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397585|NCT03818035|593825231|FG002|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397586|NCT03818035|593825232|FG003|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397587|NCT03818035|593825233|FG004|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397588|NCT03818035|593825234|FG005|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397589|NCT03818035|593825235|FG006|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397590|NCT03818035|593825236|FG007|Part 1: Open-label (Week 0 to Week 8)|Death|0|||
164397591|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397592|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397593|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397594|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|4|||
164397595|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397596|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397597|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397598|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Lack of Efficacy|0|||
164397599|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164397600|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|6|||
164397601|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|1|||
164397602|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|9|||
164397603|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164397604|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164397605|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164397606|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Lost to Follow-up|0|||
164397607|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397608|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397609|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397610|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|8|||
164397611|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397612|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397613|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397614|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Withdrawal by Subject|0|||
164397615|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164397616|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|3|||
164397617|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|4|||
164397618|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|6|||
164397619|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164397620|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164397621|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164397622|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Other Adverse Events|0|||
164397623|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164397624|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164397625|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164397626|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|1|||
164397627|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164073083|NCT01902134|592632785|FG004|Overall Study|no compliance|0|||
164073084|NCT01902134|592632786|FG005|Overall Study|no compliance|0|||
164397628|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164397629|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164397630|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Adverse Event, serious fatal|0|||
164397631|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164397632|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|1|||
164397633|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|2|||
164397634|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164397635|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164397636|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164397637|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164397638|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Participants Started Retreatment Phase Within Study Part 2 before Week 68|0|||
164397639|NCT03818035|593825229|FG000|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164397640|NCT03818035|593825230|FG001|Part 2: Double-blind (Week28 to Week68)|Other|1|||
164397641|NCT03818035|593825231|FG002|Part 2: Double-blind (Week28 to Week68)|Other|1|||
164397642|NCT03818035|593825232|FG003|Part 2: Double-blind (Week28 to Week68)|Other|1|||
164397643|NCT03818035|593825233|FG004|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164397644|NCT03818035|593825234|FG005|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164397645|NCT03818035|593825235|FG006|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164397646|NCT03818035|593825236|FG007|Part 2: Double-blind (Week28 to Week68)|Other|0|||
164397647|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397648|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397649|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397650|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397651|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397652|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397653|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|5|||
164397654|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Lost to Follow-up|0|||
164397655|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164397656|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164397657|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164397658|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164397659|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164397660|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|9|||
164397661|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|3|||
164397662|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Withdrawal by Subject|0|||
164397663|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397664|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397665|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397666|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397667|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397668|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397669|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|2|||
164397670|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Other Adverse Events|0|||
164397671|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397672|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397673|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397674|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397675|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397676|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|3|||
163906120|NCT01673594|592028071|FG000|Overall Study|Withdrawal by Subject|0|||
163906121|NCT01673594|592028072|FG001|Overall Study|Withdrawal by Subject|1|||
163906122|NCT02824198|592028073|FG000|Overall Study|Non-compliance with the protocol|5|||
163906123|NCT02824198|592028074|FG001|Overall Study|Non-compliance with the protocol|1|||
163906124|NCT02824198|592028073|FG000|Overall Study|Lost to Follow-up|5|||
163906125|NCT02824198|592028074|FG001|Overall Study|Lost to Follow-up|2|||
163906126|NCT02824198|592028073|FG000|Overall Study|Withdrawal by Subject|5|||
163906127|NCT02824198|592028074|FG001|Overall Study|Withdrawal by Subject|0|||
163906128|NCT03883828|592028075|FG000|Overall Study|Did not start radiotherapy|1|||
163906129|NCT03883828|592028076|FG001|Overall Study|Did not start radiotherapy|2|||
163906130|NCT02575365|592028081|FG000|Overall Study|Lost to Follow-up|4|||
163906131|NCT02736188|592028092|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
163906132|NCT02736188|592028092|FG000|Overall Study|Adverse Event|1|||
163906133|NCT02736188|592028092|FG000|Overall Study|Withdrawal by Subject|1|||
163906134|NCT02736188|592028092|FG000|Overall Study|Other|6|||
163906135|NCT01698918|592028093|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
163906136|NCT01698918|592028093|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
163906137|NCT01698918|592028093|FG000|First Line Treatment (Core+Extension)|Death|2|||
163906138|NCT01698918|592028093|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
163906139|NCT01698918|592028093|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
163906140|NCT01698918|592028093|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
163906141|NCT01698918|592028093|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
163906142|NCT01698918|592028093|FG000|Second Line Treatment (Core+Extension)|Death|1|||
163906143|NCT01698918|592028093|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
163906144|NCT01698918|592028093|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
163906145|NCT03176407|592028094|FG000|Overall Study|Protocol Violation|1|||
163906146|NCT03176407|592028094|FG000|Overall Study|human failure|1|||
163906147|NCT03176407|592028094|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
163906148|NCT01428583|592028096|FG000|Overall Study|Adverse Event|75|||
163906149|NCT01428583|592028096|FG000|Overall Study|Withdrawal by Subject|51|||
163906150|NCT01428583|592028096|FG000|Overall Study|Lack of Efficacy|37|||
163906151|NCT01428583|592028096|FG000|Overall Study|Lost to Follow-up|17|||
163906152|NCT01428583|592028096|FG000|Overall Study|Death|1|||
163906153|NCT01428583|592028096|FG000|Overall Study|Pregnancy|1|||
163906154|NCT01428583|592028096|FG000|Overall Study|Protocol Violation|1|||
163906155|NCT01428583|592028096|FG000|Overall Study|Physician Decision|12|||
163906156|NCT01428583|592028096|FG000|Overall Study|Non-compliant|25|||
163906157|NCT01428583|592028096|FG000|Overall Study|Confirmed positive urine drug test|8|||
163906158|NCT01428583|592028096|FG000|Overall Study|Sponsor's request|3|||
163906159|NCT01428583|592028096|FG000|Overall Study|Other|6|||
163906160|NCT00768755|592028100|FG000|Phase 1|Death|6|||
163906161|NCT00768755|592028101|FG001|Phase 1|Death|0|||
163906162|NCT00768755|592028102|FG002|Phase 1|Death|0|||
163906163|NCT00768755|592028103|FG003|Phase 1|Death|0|||
163906164|NCT00768755|592028100|FG000|Phase 1|Other|4|||
163906165|NCT00768755|592028101|FG001|Phase 1|Other|0|||
163906166|NCT00768755|592028102|FG002|Phase 1|Other|0|||
163906167|NCT00768755|592028103|FG003|Phase 1|Other|0|||
163906168|NCT00768755|592028100|FG000|Phase 2|Death|0|||
163906169|NCT00768755|592028101|FG001|Phase 2|Death|37|||
163906170|NCT00768755|592028102|FG002|Phase 2|Death|48|||
163906171|NCT00768755|592028103|FG003|Phase 2|Death|31|||
163906172|NCT00768755|592028100|FG000|Phase 2|Protocol Violation|0|||
163906173|NCT00768755|592028101|FG001|Phase 2|Protocol Violation|2|||
163906174|NCT00768755|592028102|FG002|Phase 2|Protocol Violation|0|||
163906175|NCT00768755|592028103|FG003|Phase 2|Protocol Violation|1|||
163906176|NCT00768755|592028100|FG000|Phase 2|Lost to Follow-up|0|||
163906177|NCT00768755|592028101|FG001|Phase 2|Lost to Follow-up|1|||
163906178|NCT00768755|592028102|FG002|Phase 2|Lost to Follow-up|1|||
163906179|NCT00768755|592028103|FG003|Phase 2|Lost to Follow-up|4|||
163906180|NCT00768755|592028100|FG000|Phase 2|Withdrawal by Subject|0|||
163906181|NCT00768755|592028101|FG001|Phase 2|Withdrawal by Subject|1|||
163906182|NCT00768755|592028102|FG002|Phase 2|Withdrawal by Subject|0|||
164017058|NCT03100942|592425781|FG000|Randomized Treatment Period|Protocol Violation|0|||
164017059|NCT03100942|592425782|FG001|Randomized Treatment Period|Protocol Violation|1|||
164017060|NCT03100942|592425783|FG002|Randomized Treatment Period|Protocol Violation|1|||
164017061|NCT03100942|592425784|FG003|Randomized Treatment Period|Protocol Violation|1|||
164017062|NCT03100942|592425785|FG004|Randomized Treatment Period|Protocol Violation|0|||
164017063|NCT03100942|592425786|FG005|Randomized Treatment Period|Protocol Violation|0|||
164017064|NCT03100942|592425787|FG006|Randomized Treatment Period|Protocol Violation|0|||
164017065|NCT03100942|592425781|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
164017066|NCT03100942|592425782|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
164017067|NCT03100942|592425783|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
164017068|NCT03100942|592425784|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
164017069|NCT03100942|592425785|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
164017070|NCT03100942|592425786|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
164017071|NCT03100942|592425787|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
164017072|NCT03100942|592425781|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
164017073|NCT03100942|592425782|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164017074|NCT03100942|592425783|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164017075|NCT03100942|592425784|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
164017076|NCT03100942|592425785|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164017077|NCT03100942|592425786|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164017078|NCT03100942|592425787|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
164017079|NCT03100942|592425781|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164017080|NCT03100942|592425782|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164017081|NCT03100942|592425783|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164397677|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397678|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Non-compliance with study drug|0|||
164397679|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164397680|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164397681|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164397682|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164397683|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164397684|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|5|||
164397685|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|4|||
164397686|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Not Signed ICF|0|||
164397687|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164397688|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164017082|NCT03100942|592425784|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164017083|NCT03100942|592425785|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164017084|NCT03100942|592425786|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
164017085|NCT03100942|592425787|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
164017086|NCT01876732|592425788|FG000|Overall Study|MMA was not over 800mg/dL|75|||
164017087|NCT00536731|592425789|FG000|Overall Study|Adverse Event|3|||
164093667|NCT02127281|592707258|FG000|Overall Study|Lost to Follow-up|1|||
164093668|NCT02127281|592707259|FG001|Overall Study|Lost to Follow-up|0|||
164397689|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164397690|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164397691|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164017088|NCT00536731|592425790|FG001|Overall Study|Adverse Event|2|||
164017089|NCT00536731|592425791|FG002|Overall Study|Adverse Event|3|||
164017090|NCT00536731|592425789|FG000|Overall Study|Withdrawal by Subject|0|||
164017091|NCT00536731|592425790|FG001|Overall Study|Withdrawal by Subject|2|||
164017092|NCT00536731|592425791|FG002|Overall Study|Withdrawal by Subject|0|||
164093669|NCT01882647|592707261|FG000|Overall Study|Lost to Follow-up|2|||
164397692|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164397693|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Other|2|||
164397694|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Other|0|||
164017093|NCT00536731|592425789|FG000|Overall Study|Intake of prohibited conc. medication|0|||
164017094|NCT00536731|592425790|FG001|Overall Study|Intake of prohibited conc. medication|0|||
164017095|NCT00536731|592425791|FG002|Overall Study|Intake of prohibited conc. medication|1|||
164017096|NCT00536731|592425789|FG000|Overall Study|Safety reasons|0|||
164017097|NCT00536731|592425790|FG001|Overall Study|Safety reasons|0|||
164017098|NCT00536731|592425791|FG002|Overall Study|Safety reasons|1|||
164017099|NCT00536731|592425789|FG000|Overall Study|Other|1|||
164017100|NCT00536731|592425790|FG001|Overall Study|Other|1|||
164017101|NCT00536731|592425791|FG002|Overall Study|Other|0|||
164017102|NCT00718419|592425792|FG000|Overall Study|Adverse Event|2|||
164017103|NCT00718419|592425793|FG001|Overall Study|Adverse Event|1|||
164017104|NCT00718419|592425792|FG000|Overall Study|Physician Decision|1|||
164017105|NCT00718419|592425793|FG001|Overall Study|Physician Decision|6|||
164017106|NCT00718419|592425792|FG000|Overall Study|Sponsor decision|0|||
164017107|NCT00718419|592425793|FG001|Overall Study|Sponsor decision|1|||
164017108|NCT00718419|592425792|FG000|Overall Study|Withdrawal by Subject|0|||
164017109|NCT00718419|592425793|FG001|Overall Study|Withdrawal by Subject|5|||
164017110|NCT00718419|592425792|FG000|Overall Study|Progressive Disease|7|||
164017111|NCT00718419|592425793|FG001|Overall Study|Progressive Disease|25|||
164017112|NCT00718419|592425792|FG000|Overall Study|Death Due to Progressive Disease|2|||
164017113|NCT00718419|592425793|FG001|Overall Study|Death Due to Progressive Disease|0|||
164017114|NCT00718419|592425792|FG000|Overall Study|Death Due to Study Drug Related|0|||
164017115|NCT00718419|592425793|FG001|Overall Study|Death Due to Study Drug Related|1|||
164017116|NCT00718419|592425792|FG000|Overall Study|Death Due to Adverse Events|1|||
164017117|NCT00718419|592425793|FG001|Overall Study|Death Due to Adverse Events|0|||
164017118|NCT00879814|592425806|FG000|Overall Study|Adverse Event|0|||
164017119|NCT00879814|592425807|FG001|Overall Study|Adverse Event|1|||
164017120|NCT00879814|592425808|FG002|Overall Study|Adverse Event|0|||
164017121|NCT00879814|592425809|FG003|Overall Study|Adverse Event|0|||
164017122|NCT00879814|592425806|FG000|Overall Study|Lost to Follow-up|1|||
164017123|NCT00879814|592425807|FG001|Overall Study|Lost to Follow-up|0|||
164017124|NCT00879814|592425808|FG002|Overall Study|Lost to Follow-up|0|||
164017125|NCT00879814|592425809|FG003|Overall Study|Lost to Follow-up|2|||
164017126|NCT00879814|592425806|FG000|Overall Study|Participant Failed to Return|0|||
164017127|NCT00879814|592425807|FG001|Overall Study|Participant Failed to Return|0|||
164017128|NCT00879814|592425808|FG002|Overall Study|Participant Failed to Return|0|||
164017129|NCT00879814|592425809|FG003|Overall Study|Participant Failed to Return|1|||
164017130|NCT00879814|592425806|FG000|Overall Study|Withdrawal by Subject|3|||
164017131|NCT00879814|592425807|FG001|Overall Study|Withdrawal by Subject|1|||
164017132|NCT00879814|592425808|FG002|Overall Study|Withdrawal by Subject|1|||
164017133|NCT00879814|592425809|FG003|Overall Study|Withdrawal by Subject|2|||
164017134|NCT00879814|592425806|FG000|Overall Study|Physician Decision|0|||
164017135|NCT00879814|592425807|FG001|Overall Study|Physician Decision|0|||
164017136|NCT00879814|592425808|FG002|Overall Study|Physician Decision|1|||
164017137|NCT00879814|592425809|FG003|Overall Study|Physician Decision|0|||
164017138|NCT00879814|592425806|FG000|Overall Study|Other|0|||
164017139|NCT00879814|592425807|FG001|Overall Study|Other|0|||
164017140|NCT00879814|592425808|FG002|Overall Study|Other|1|||
164017141|NCT00879814|592425809|FG003|Overall Study|Other|0|||
164017142|NCT01005719|592425810|FG000|Period 1|Adverse Event|0|||
164017143|NCT01005719|592425811|FG001|Period 1|Adverse Event|0|||
164017144|NCT01005719|592425812|FG002|Period 1|Adverse Event|0|||
164017145|NCT01005719|592425813|FG003|Period 1|Adverse Event|1|||
164397695|NCT03818035|593825229|FG000|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164397696|NCT03818035|593825230|FG001|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164017146|NCT01005719|592425814|FG004|Period 1|Adverse Event|0|||
164017147|NCT01005719|592425815|FG005|Period 1|Adverse Event|0|||
164397697|NCT03818035|593825231|FG002|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164397698|NCT03818035|593825232|FG003|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164397699|NCT03818035|593825233|FG004|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164397700|NCT03818035|593825234|FG005|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|112|||
164017148|NCT01005719|592425810|FG000|Period 1|Delay in completing study procedures|0|||
164017149|NCT01005719|592425811|FG001|Period 1|Delay in completing study procedures|0|||
164017150|NCT01005719|592425812|FG002|Period 1|Delay in completing study procedures|0|||
164017151|NCT01005719|592425813|FG003|Period 1|Delay in completing study procedures|0|||
164017152|NCT01005719|592425814|FG004|Period 1|Delay in completing study procedures|0|||
164017153|NCT01005719|592425815|FG005|Period 1|Delay in completing study procedures|1|||
164017154|NCT01005719|592425810|FG000|Period 2|Adverse Event|0|||
164017155|NCT01005719|592425811|FG001|Period 2|Adverse Event|0|||
164017156|NCT01005719|592425812|FG002|Period 2|Adverse Event|0|||
164017157|NCT01005719|592425813|FG003|Period 2|Adverse Event|0|||
164017158|NCT01005719|592425814|FG004|Period 2|Adverse Event|1|||
164017159|NCT01005719|592425815|FG005|Period 2|Adverse Event|1|||
164397701|NCT03818035|593825235|FG006|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|115|||
164397702|NCT03818035|593825236|FG007|Part3: Withdrawal (Week 68 to Week 220)|Retreatment started|0|||
164397703|NCT03818035|593825229|FG000|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397704|NCT03818035|593825230|FG001|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397705|NCT03818035|593825231|FG002|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397706|NCT03818035|593825232|FG003|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397707|NCT03818035|593825233|FG004|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397708|NCT03818035|593825234|FG005|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397709|NCT03818035|593825235|FG006|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|0|||
164397710|NCT03818035|593825236|FG007|Re-treatment (Week R0 Through Week R28)|Lost to Follow-up|3|||
164397711|NCT03818035|593825229|FG000|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397712|NCT03818035|593825230|FG001|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397713|NCT03818035|593825231|FG002|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397714|NCT03818035|593825232|FG003|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397715|NCT03818035|593825233|FG004|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397716|NCT03818035|593825234|FG005|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397717|NCT03818035|593825235|FG006|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|0|||
164397718|NCT03818035|593825236|FG007|Re-treatment (Week R0 Through Week R28)|Withdrawal by Subject|1|||
164397719|NCT03818035|593825229|FG000|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397720|NCT03818035|593825230|FG001|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397721|NCT03818035|593825231|FG002|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397722|NCT03818035|593825232|FG003|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397723|NCT03818035|593825233|FG004|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397724|NCT03818035|593825234|FG005|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397725|NCT03818035|593825235|FG006|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|0|||
164397726|NCT03818035|593825236|FG007|Re-treatment (Week R0 Through Week R28)|Other Adverse Events|1|||
164397727|NCT03818035|593825229|FG000|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397728|NCT03818035|593825230|FG001|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397729|NCT03818035|593825231|FG002|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397730|NCT03818035|593825232|FG003|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397731|NCT03818035|593825233|FG004|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397732|NCT03818035|593825234|FG005|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397733|NCT03818035|593825235|FG006|Re-treatment (Week R0 Through Week R28)|Other|0|||
164397734|NCT03818035|593825236|FG007|Re-treatment (Week R0 Through Week R28)|Other|3|||
164397735|NCT00336024|593825238|FG000|Overall Study|Death|2|||
164397736|NCT00336024|593825239|FG001|Overall Study|Death|1|||
164397737|NCT00336024|593825238|FG000|Overall Study|Physician Decision|4|||
164397738|NCT00336024|593825239|FG001|Overall Study|Physician Decision|1|||
164397739|NCT00336024|593825238|FG000|Overall Study|Protocol Violation|1|||
164397740|NCT00336024|593825239|FG001|Overall Study|Protocol Violation|0|||
164397741|NCT00336024|593825238|FG000|Overall Study|Withdrawal by Subject|1|||
164397742|NCT00336024|593825239|FG001|Overall Study|Withdrawal by Subject|2|||
164397743|NCT00336024|593825238|FG000|Overall Study|Failure to fulfill consolidation|1|||
164397744|NCT00336024|593825239|FG001|Overall Study|Failure to fulfill consolidation|1|||
164397745|NCT00336024|593825238|FG000|Overall Study|Progressive Disease|4|||
164397746|NCT00336024|593825239|FG001|Overall Study|Progressive Disease|7|||
164397747|NCT00336024|593825238|FG000|Overall Study|Ineligible|7|||
164397748|NCT00336024|593825239|FG001|Overall Study|Ineligible|7|||
164397749|NCT05008484|593825246|FG000|Overall Study|Withdrawal by Subject|1|||
164397750|NCT05008484|593825247|FG001|Overall Study|Withdrawal by Subject|1|||
164397751|NCT00756509|593825251|FG000|Core Phase|Adverse Event|2|||
164397752|NCT00756509|593825251|FG000|Core Phase|Lack of Efficacy|2|||
164397753|NCT00756509|593825251|FG000|Core Phase|Disease progression|6|||
164397754|NCT00756509|593825251|FG000|Follow-Up Phase|Missing values|2|||
164397755|NCT00756509|593825251|FG000|Follow-Up Phase|Disease progression|9|||
163906183|NCT00768755|592028103|FG003|Phase 2|Withdrawal by Subject|1|||
163906184|NCT00768755|592028100|FG000|Phase 2|Other|0|||
163906185|NCT00768755|592028101|FG001|Phase 2|Other|1|||
163906186|NCT00768755|592028102|FG002|Phase 2|Other|2|||
163906187|NCT00768755|592028103|FG003|Phase 2|Other|4|||
163906188|NCT00768755|592028100|FG000|Phase 2|Study Terminated by Sponsor|0|||
163906189|NCT00768755|592028101|FG001|Phase 2|Study Terminated by Sponsor|13|||
163906190|NCT00768755|592028102|FG002|Phase 2|Study Terminated by Sponsor|7|||
163906191|NCT00768755|592028103|FG003|Phase 2|Study Terminated by Sponsor|14|||
163906192|NCT00768755|592028100|FG000|Phase 2|Randomized but not treated|0|||
163906193|NCT00768755|592028101|FG001|Phase 2|Randomized but not treated|0|||
163906194|NCT00768755|592028102|FG002|Phase 2|Randomized but not treated|0|||
163906195|NCT00768755|592028103|FG003|Phase 2|Randomized but not treated|2|||
163906196|NCT00670488|592028104|FG000|Overall Study|Adverse Event|0|||
163906197|NCT00670488|592028105|FG001|Overall Study|Adverse Event|7|||
163906198|NCT00670488|592028106|FG002|Overall Study|Adverse Event|0|||
163906199|NCT00670488|592028107|FG003|Overall Study|Adverse Event|3|||
164397756|NCT00756509|593825251|FG000|Follow-Up Phase|Administrative problems|3|||
164397757|NCT00756509|593825251|FG000|Follow-Up Phase|Lost to Follow-up|1|||
164397758|NCT00756509|593825251|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
164397759|NCT00756509|593825251|FG000|Follow-Up Phase|Subject's condition no longer requires study drug|1|||
164397760|NCT00756509|593825251|FG000|Follow-Up Phase|Adverse Event|7|||
164397761|NCT04095689|593825252|FG000|Overall Study|Adverse Event|3|||
164397762|NCT04095689|593825252|FG000|Overall Study|Lack of Efficacy|1|||
164397763|NCT04095689|593825252|FG000|Overall Study|Death|1|||
164397764|NCT05985304|593825253|FG000|Overall Study|Protocol Violation|1|||
164397765|NCT05985304|593825254|FG001|Overall Study|Protocol Violation|0|||
164397766|NCT05985304|593825253|FG000|Overall Study|Withdrawal by Subject|0|||
164397767|NCT05985304|593825254|FG001|Overall Study|Withdrawal by Subject|2|||
164397768|NCT05985304|593825253|FG000|Overall Study|Subject was not implanted with the study device|0|||
164397769|NCT05985304|593825254|FG001|Overall Study|Subject was not implanted with the study device|2|||
164397770|NCT04497844|593825255|FG000|Overall Study|Ongoing|231|||
164397771|NCT04497844|593825256|FG001|Overall Study|Ongoing|249|||
164397772|NCT04497844|593825255|FG000|Overall Study|Death|106|||
164397773|NCT04497844|593825256|FG001|Overall Study|Death|84|||
164397774|NCT04497844|593825255|FG000|Overall Study|Lost to Follow-up|2|||
164397775|NCT04497844|593825256|FG001|Overall Study|Lost to Follow-up|0|||
164397776|NCT04497844|593825255|FG000|Overall Study|Withdrawal by Subject|6|||
163906200|NCT00670488|592028108|FG004|Overall Study|Adverse Event|1|||
163906201|NCT00670488|592028109|FG005|Overall Study|Adverse Event|1|||
163906202|NCT00670488|592028110|FG006|Overall Study|Adverse Event|5|||
163906203|NCT00670488|592028111|FG007|Overall Study|Adverse Event|1|||
163906204|NCT00670488|592028112|FG008|Overall Study|Adverse Event|0|||
164397777|NCT04497844|593825256|FG001|Overall Study|Withdrawal by Subject|14|||
163906205|NCT00670488|592028113|FG009|Overall Study|Adverse Event|1|||
164397778|NCT04497844|593825255|FG000|Overall Study|Regional Crisis|3|||
163906206|NCT00670488|592028104|FG000|Overall Study|Physician Decision|1|||
164397779|NCT04497844|593825256|FG001|Overall Study|Regional Crisis|1|||
163906207|NCT00670488|592028105|FG001|Overall Study|Physician Decision|9|||
164017160|NCT01753076|592425816|FG000|Overall Study|Adverse Event|17|||
164017161|NCT01753076|592425817|FG001|Overall Study|Adverse Event|18|||
164017162|NCT01753076|592425816|FG000|Overall Study|Lack of Efficacy|3|||
164017163|NCT01753076|592425817|FG001|Overall Study|Lack of Efficacy|1|||
164017164|NCT01753076|592425816|FG000|Overall Study|Lost to Follow-up|2|||
164017165|NCT01753076|592425817|FG001|Overall Study|Lost to Follow-up|1|||
164017166|NCT01753076|592425816|FG000|Overall Study|Physician Decision|4|||
164017167|NCT01753076|592425817|FG001|Overall Study|Physician Decision|2|||
164017168|NCT01753076|592425816|FG000|Overall Study|Withdrawal by Subject|14|||
164017169|NCT01753076|592425817|FG001|Overall Study|Withdrawal by Subject|24|||
164017170|NCT01753076|592425816|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
164017171|NCT01753076|592425817|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
164017172|NCT02985450|592425823|FG000|Overall Study|Lost to Follow-up|7|||
164017173|NCT00069576|592425824|FG000|Original Trial|Lost to Follow-up|25|||
164017174|NCT00069576|592425825|FG001|Original Trial|Lost to Follow-up|33|||
163906208|NCT00670488|592028106|FG002|Overall Study|Physician Decision|0|||
163906209|NCT00670488|592028107|FG003|Overall Study|Physician Decision|1|||
163906210|NCT00670488|592028108|FG004|Overall Study|Physician Decision|0|||
163906211|NCT00670488|592028109|FG005|Overall Study|Physician Decision|0|||
163906212|NCT00670488|592028110|FG006|Overall Study|Physician Decision|0|||
163906213|NCT00670488|592028111|FG007|Overall Study|Physician Decision|0|||
163906214|NCT00670488|592028112|FG008|Overall Study|Physician Decision|0|||
163906215|NCT00670488|592028113|FG009|Overall Study|Physician Decision|0|||
163906216|NCT00670488|592028104|FG000|Overall Study|Progressive Disease|2|||
163906217|NCT00670488|592028105|FG001|Overall Study|Progressive Disease|41|||
163906218|NCT00670488|592028106|FG002|Overall Study|Progressive Disease|3|||
163906219|NCT00670488|592028107|FG003|Overall Study|Progressive Disease|2|||
163906220|NCT00670488|592028108|FG004|Overall Study|Progressive Disease|2|||
163906221|NCT00670488|592028109|FG005|Overall Study|Progressive Disease|4|||
163906222|NCT00670488|592028110|FG006|Overall Study|Progressive Disease|11|||
163906223|NCT00670488|592028111|FG007|Overall Study|Progressive Disease|2|||
163906224|NCT00670488|592028112|FG008|Overall Study|Progressive Disease|2|||
163906225|NCT00670488|592028113|FG009|Overall Study|Progressive Disease|1|||
163906226|NCT00670488|592028104|FG000|Overall Study|Withdrawal by Subject|0|||
163906227|NCT00670488|592028105|FG001|Overall Study|Withdrawal by Subject|1|||
163906228|NCT00670488|592028106|FG002|Overall Study|Withdrawal by Subject|0|||
164017175|NCT00069576|592425824|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
164017176|NCT00069576|592425825|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
164017177|NCT00905307|592425826|FG000|Overall Study|Switched to Open Label Rescue|7|||
164017178|NCT00905307|592425827|FG001|Overall Study|Switched to Open Label Rescue|17|||
164017179|NCT00905307|592425828|FG002|Overall Study|Switched to Open Label Rescue|11|||
164017180|NCT00905307|592425829|FG003|Overall Study|Switched to Open Label Rescue|11|||
164017181|NCT00905307|592425830|FG004|Overall Study|Switched to Open Label Rescue|4|||
164017182|NCT00905307|592425831|FG005|Overall Study|Switched to Open Label Rescue|15|||
164017183|NCT00905307|592425826|FG000|Overall Study|Lost to Follow-up|0|||
163906229|NCT00670488|592028107|FG003|Overall Study|Withdrawal by Subject|1|||
163906230|NCT00670488|592028108|FG004|Overall Study|Withdrawal by Subject|0|||
163906231|NCT00670488|592028109|FG005|Overall Study|Withdrawal by Subject|0|||
163906232|NCT00670488|592028110|FG006|Overall Study|Withdrawal by Subject|1|||
163906233|NCT00670488|592028111|FG007|Overall Study|Withdrawal by Subject|0|||
163906234|NCT00670488|592028112|FG008|Overall Study|Withdrawal by Subject|1|||
163906235|NCT00670488|592028113|FG009|Overall Study|Withdrawal by Subject|0|||
163906236|NCT00878189|592028114|FG000|Overall Study|Death|0|||
163906237|NCT00878189|592028115|FG001|Overall Study|Death|1|||
163906238|NCT00878189|592028116|FG002|Overall Study|Death|0|||
163906239|NCT00878189|592028117|FG003|Overall Study|Death|1|||
163906240|NCT00878189|592028118|FG004|Overall Study|Death|0|||
163906241|NCT00878189|592028119|FG005|Overall Study|Death|0|||
163906242|NCT00878189|592028120|FG006|Overall Study|Death|0|||
163906243|NCT00878189|592028121|FG007|Overall Study|Death|0|||
163906244|NCT00878189|592028122|FG008|Overall Study|Death|1|||
163906245|NCT00878189|592028114|FG000|Overall Study|Participant Refused to Follow-up|0|||
163906246|NCT00878189|592028115|FG001|Overall Study|Participant Refused to Follow-up|0|||
163906247|NCT00878189|592028116|FG002|Overall Study|Participant Refused to Follow-up|0|||
163906248|NCT00878189|592028117|FG003|Overall Study|Participant Refused to Follow-up|0|||
163906249|NCT00878189|592028118|FG004|Overall Study|Participant Refused to Follow-up|0|||
163906250|NCT00878189|592028119|FG005|Overall Study|Participant Refused to Follow-up|4|||
163906251|NCT00878189|592028120|FG006|Overall Study|Participant Refused to Follow-up|0|||
163906252|NCT00878189|592028121|FG007|Overall Study|Participant Refused to Follow-up|0|||
163906253|NCT00878189|592028122|FG008|Overall Study|Participant Refused to Follow-up|0|||
163906254|NCT00878189|592028114|FG000|Overall Study|Other|3|||
163906255|NCT00878189|592028115|FG001|Overall Study|Other|2|||
163906256|NCT00878189|592028116|FG002|Overall Study|Other|4|||
163906257|NCT00878189|592028117|FG003|Overall Study|Other|7|||
163906258|NCT00878189|592028118|FG004|Overall Study|Other|4|||
163906259|NCT00878189|592028119|FG005|Overall Study|Other|18|||
163906260|NCT00878189|592028120|FG006|Overall Study|Other|15|||
163906261|NCT00878189|592028121|FG007|Overall Study|Other|3|||
163906262|NCT00878189|592028122|FG008|Overall Study|Other|4|||
163906263|NCT00878189|592028114|FG000|Overall Study|Lost to Follow-up|0|||
163906264|NCT00878189|592028115|FG001|Overall Study|Lost to Follow-up|0|||
163906265|NCT00878189|592028116|FG002|Overall Study|Lost to Follow-up|0|||
163906266|NCT00878189|592028117|FG003|Overall Study|Lost to Follow-up|0|||
163906267|NCT00878189|592028118|FG004|Overall Study|Lost to Follow-up|0|||
163906268|NCT00878189|592028119|FG005|Overall Study|Lost to Follow-up|1|||
163906269|NCT00878189|592028120|FG006|Overall Study|Lost to Follow-up|1|||
163906270|NCT00878189|592028121|FG007|Overall Study|Lost to Follow-up|0|||
163906271|NCT00878189|592028122|FG008|Overall Study|Lost to Follow-up|0|||
163906272|NCT00878189|592028114|FG000|Overall Study|Objection Progression or Relapse|0|||
163906273|NCT00878189|592028115|FG001|Overall Study|Objection Progression or Relapse|0|||
163906274|NCT00878189|592028116|FG002|Overall Study|Objection Progression or Relapse|0|||
163906275|NCT00878189|592028117|FG003|Overall Study|Objection Progression or Relapse|0|||
163906276|NCT00878189|592028118|FG004|Overall Study|Objection Progression or Relapse|0|||
163906277|NCT00878189|592028119|FG005|Overall Study|Objection Progression or Relapse|0|||
163906278|NCT00878189|592028120|FG006|Overall Study|Objection Progression or Relapse|0|||
163906279|NCT00878189|592028121|FG007|Overall Study|Objection Progression or Relapse|0|||
163906280|NCT00878189|592028122|FG008|Overall Study|Objection Progression or Relapse|3|||
163906281|NCT02708498|592028123|FG000|Overall Study|Death|20|||
163906282|NCT02708498|592028124|FG001|Overall Study|Death|19|||
163906283|NCT02708498|592028125|FG002|Overall Study|Death|0|||
163906284|NCT02708498|592028126|FG003|Overall Study|Death|0|||
163906285|NCT02708498|592028127|FG004|Overall Study|Death|1|||
163906286|NCT02708498|592028128|FG005|Overall Study|Death|0|||
163906287|NCT02708498|592028129|FG006|Overall Study|Death|0|||
163906288|NCT02708498|592028130|FG007|Overall Study|Death|0|||
163906289|NCT02708498|592028123|FG000|Overall Study|Unknown reason, missing data|0|||
163906290|NCT02708498|592028124|FG001|Overall Study|Unknown reason, missing data|0|||
163906291|NCT02708498|592028125|FG002|Overall Study|Unknown reason, missing data|62|||
163906292|NCT02708498|592028126|FG003|Overall Study|Unknown reason, missing data|51|||
163906293|NCT02708498|592028127|FG004|Overall Study|Unknown reason, missing data|195|||
163906294|NCT02708498|592028128|FG005|Overall Study|Unknown reason, missing data|132|||
163906295|NCT02708498|592028129|FG006|Overall Study|Unknown reason, missing data|0|||
163906296|NCT02708498|592028130|FG007|Overall Study|Unknown reason, missing data|0|||
163906297|NCT01829711|592028131|FG000|Overall Study|Lost to Follow-up|2|||
163906298|NCT01829711|592028131|FG000|Overall Study|Withdrawal by Subject|3|||
163906299|NCT01829711|592028131|FG000|Overall Study|Death|4|||
164017184|NCT00905307|592425827|FG001|Overall Study|Lost to Follow-up|0|||
164017185|NCT00905307|592425828|FG002|Overall Study|Lost to Follow-up|0|||
164017186|NCT00905307|592425829|FG003|Overall Study|Lost to Follow-up|0|||
164017187|NCT00905307|592425830|FG004|Overall Study|Lost to Follow-up|1|||
164017188|NCT00905307|592425831|FG005|Overall Study|Lost to Follow-up|1|||
164017189|NCT00905307|592425826|FG000|Overall Study|Adverse Event|3|||
164017190|NCT00905307|592425827|FG001|Overall Study|Adverse Event|4|||
164017191|NCT00905307|592425828|FG002|Overall Study|Adverse Event|5|||
164017192|NCT00905307|592425829|FG003|Overall Study|Adverse Event|11|||
164017193|NCT00905307|592425830|FG004|Overall Study|Adverse Event|3|||
164017194|NCT00905307|592425831|FG005|Overall Study|Adverse Event|5|||
164017195|NCT00905307|592425826|FG000|Overall Study|Withdrawal by Subject|5|||
163906300|NCT01829711|592028131|FG000|Overall Study|Started new therapies|17|||
163906301|NCT01829711|592028131|FG000|Overall Study|Adverse Event|3|||
163906302|NCT01829711|592028131|FG000|Overall Study|Due to progression of disease|13|||
163906303|NCT01829711|592028131|FG000|Overall Study|Due to lack of response|1|||
163906304|NCT01480258|592028132|FG000|Infant Series|Protocol Violation|2|||
163906305|NCT01480258|592028133|FG001|Infant Series|Protocol Violation|0|||
163906306|NCT01480258|592028132|FG000|Infant Series|Physician Decision|0|||
163906307|NCT01480258|592028133|FG001|Infant Series|Physician Decision|1|||
163906308|NCT01480258|592028132|FG000|Infant Series|Not Vaccinated|3|||
163906309|NCT01480258|592028133|FG001|Infant Series|Not Vaccinated|0|||
163906310|NCT01480258|592028132|FG000|Infant Series|Adverse Event|1|||
163906311|NCT01480258|592028133|FG001|Infant Series|Adverse Event|1|||
163906312|NCT01480258|592028132|FG000|Infant Series|Withdrawal by Subject|1|||
163906313|NCT01480258|592028133|FG001|Infant Series|Withdrawal by Subject|6|||
163906314|NCT01480258|592028132|FG000|Interim Period|Lost to Follow-up|0|||
163906315|NCT01480258|592028133|FG001|Interim Period|Lost to Follow-up|2|||
163906316|NCT01480258|592028132|FG000|Interim Period|Physician Decision|1|||
163906317|NCT01480258|592028133|FG001|Interim Period|Physician Decision|0|||
163906318|NCT01480258|592028132|FG000|Interim Period|Protocol Violation|0|||
163906319|NCT01480258|592028133|FG001|Interim Period|Protocol Violation|1|||
163906320|NCT01480258|592028132|FG000|Interim Period|Withdrawal by Subject|9|||
163906321|NCT01480258|592028133|FG001|Interim Period|Withdrawal by Subject|6|||
163906322|NCT00701415|592028144|FG000|Overall Study|Adverse Event|0|||
163906323|NCT00701415|592028145|FG001|Overall Study|Adverse Event|1|||
163906324|NCT00701415|592028144|FG000|Overall Study|Social/family issues and needle phobia|1|||
163906325|NCT00701415|592028145|FG001|Overall Study|Social/family issues and needle phobia|0|||
163906326|NCT02106884|592028154|FG000|Overall Study|Change of diagnosis/exclusion|0|||
163906327|NCT02106884|592028155|FG001|Overall Study|Change of diagnosis/exclusion|1|||
163906328|NCT00659373|592028157|FG000|Overall Study|Withdrawal by Subject|3|||
163906329|NCT00659373|592028158|FG001|Overall Study|Withdrawal by Subject|5|||
163906330|NCT00659373|592028157|FG000|Overall Study|Assessment Missed|2|||
163906331|NCT00659373|592028158|FG001|Overall Study|Assessment Missed|2|||
163906332|NCT03042767|592028161|FG000|Overall Study|Lost to Follow-up|1|||
163906333|NCT03042767|592028162|FG001|Overall Study|Lost to Follow-up|2|||
163906334|NCT01543204|592028164|FG000|Overall Study|Non-compliance|1|||
163906335|NCT01543204|592028164|FG000|Overall Study|Adverse Event|1|||
163906336|NCT01543204|592028164|FG000|Overall Study|Withdrawal by Subject|4|||
163906337|NCT01543204|592028164|FG000|Overall Study|Requirement for Alternative Therapy|1|||
163906338|NCT01543204|592028164|FG000|Overall Study|Lost to Follow-up|1|||
163906339|NCT04638816|592028165|FG000|Overall Study|Withdrawal by Subject|0|||
163906340|NCT04638816|592028166|FG001|Overall Study|Withdrawal by Subject|1|||
163906341|NCT04638816|592028165|FG000|Overall Study|Lost to Follow-up|0|||
163906342|NCT04638816|592028166|FG001|Overall Study|Lost to Follow-up|1|||
163906343|NCT01328496|592028169|FG000|Overall Study|Significant Change in Health Status|1|||
163906344|NCT01328496|592028170|FG001|Overall Study|Significant Change in Health Status|0|||
163906345|NCT02686658|592028173|FG000|Overall Study|Adverse Event|0|||
163906346|NCT02686658|592028174|FG001|Overall Study|Adverse Event|0|||
163906347|NCT02686658|592028175|FG002|Overall Study|Adverse Event|1|||
163906348|NCT02686658|592028176|FG003|Overall Study|Adverse Event|1|||
163906349|NCT02686658|592028177|FG004|Overall Study|Adverse Event|2|||
163906350|NCT02686658|592028178|FG005|Overall Study|Adverse Event|1|||
163906351|NCT02686658|592028173|FG000|Overall Study|Investigator decision|0|||
163906352|NCT02686658|592028174|FG001|Overall Study|Investigator decision|0|||
163906353|NCT02686658|592028175|FG002|Overall Study|Investigator decision|0|||
163906354|NCT02686658|592028176|FG003|Overall Study|Investigator decision|1|||
163906355|NCT02686658|592028177|FG004|Overall Study|Investigator decision|2|||
163906356|NCT02686658|592028178|FG005|Overall Study|Investigator decision|1|||
163906357|NCT02686658|592028173|FG000|Overall Study|Sponsor decision|1|||
163906358|NCT02686658|592028174|FG001|Overall Study|Sponsor decision|2|||
163906359|NCT02686658|592028175|FG002|Overall Study|Sponsor decision|1|||
163906360|NCT02686658|592028176|FG003|Overall Study|Sponsor decision|5|||
163906361|NCT02686658|592028177|FG004|Overall Study|Sponsor decision|13|||
163906362|NCT02686658|592028178|FG005|Overall Study|Sponsor decision|2|||
163906363|NCT02686658|592028173|FG000|Overall Study|Lost to Follow-up|0|||
163906364|NCT02686658|592028174|FG001|Overall Study|Lost to Follow-up|0|||
163906365|NCT02686658|592028175|FG002|Overall Study|Lost to Follow-up|2|||
163906366|NCT02686658|592028176|FG003|Overall Study|Lost to Follow-up|0|||
163906367|NCT02686658|592028177|FG004|Overall Study|Lost to Follow-up|0|||
163906368|NCT02686658|592028178|FG005|Overall Study|Lost to Follow-up|1|||
163906369|NCT02686658|592028173|FG000|Overall Study|Death|1|||
163906370|NCT02686658|592028174|FG001|Overall Study|Death|0|||
163906371|NCT02686658|592028175|FG002|Overall Study|Death|0|||
163906372|NCT02686658|592028176|FG003|Overall Study|Death|1|||
163906373|NCT02686658|592028177|FG004|Overall Study|Death|1|||
163906374|NCT02686658|592028178|FG005|Overall Study|Death|1|||
163906375|NCT02686658|592028173|FG000|Overall Study|Withdrawal by Subject|2|||
163906376|NCT02686658|592028174|FG001|Overall Study|Withdrawal by Subject|5|||
163906377|NCT02686658|592028175|FG002|Overall Study|Withdrawal by Subject|4|||
163906378|NCT02686658|592028176|FG003|Overall Study|Withdrawal by Subject|4|||
163906379|NCT02686658|592028177|FG004|Overall Study|Withdrawal by Subject|17|||
163906380|NCT02686658|592028178|FG005|Overall Study|Withdrawal by Subject|8|||
163906381|NCT02686658|592028173|FG000|Overall Study|Placed in hospice care|0|||
163906382|NCT02686658|592028174|FG001|Overall Study|Placed in hospice care|0|||
163906383|NCT02686658|592028175|FG002|Overall Study|Placed in hospice care|1|||
163906384|NCT02686658|592028176|FG003|Overall Study|Placed in hospice care|0|||
163906385|NCT02686658|592028177|FG004|Overall Study|Placed in hospice care|0|||
163906386|NCT02686658|592028178|FG005|Overall Study|Placed in hospice care|0|||
163906387|NCT02686658|592028173|FG000|Overall Study|Participant non-compliance|0|||
163906388|NCT02686658|592028174|FG001|Overall Study|Participant non-compliance|0|||
163906389|NCT02686658|592028175|FG002|Overall Study|Participant non-compliance|0|||
163906390|NCT02686658|592028176|FG003|Overall Study|Participant non-compliance|0|||
163906391|NCT02686658|592028177|FG004|Overall Study|Participant non-compliance|0|||
163906392|NCT02686658|592028178|FG005|Overall Study|Participant non-compliance|1|||
163906393|NCT02686658|592028173|FG000|Overall Study|Concern over coronavirus disease care|0|||
163906394|NCT02686658|592028174|FG001|Overall Study|Concern over coronavirus disease care|0|||
163906395|NCT02686658|592028175|FG002|Overall Study|Concern over coronavirus disease care|0|||
163906396|NCT02686658|592028176|FG003|Overall Study|Concern over coronavirus disease care|0|||
163906397|NCT02686658|592028177|FG004|Overall Study|Concern over coronavirus disease care|2|||
163906398|NCT02686658|592028178|FG005|Overall Study|Concern over coronavirus disease care|1|||
163906399|NCT03476798|592028182|FG000|Overall Study|Death|1|||
163906400|NCT03476798|592028182|FG000|Overall Study|Withdrawal by Subject|2|||
163906401|NCT03476798|592028182|FG000|Overall Study|Protocol Violation|2|||
163906402|NCT06269003|592028183|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
163906403|NCT06269003|592028184|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
163906404|NCT06269003|592028185|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
163906405|NCT06269003|592028186|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
163906406|NCT02698475|592029314|FG000|Main Study Period|Lack of Efficacy|1|||
163906407|NCT02698475|592029314|FG000|Main Study Period|Protocol Violation|2|||
163906408|NCT02698475|592029314|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
163906409|NCT02698475|592029314|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
163906410|NCT02698475|592029314|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
163906411|NCT02698475|592029314|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
163906412|NCT02698475|592029314|FG000|Long-Term Extension Period|Other|1|||
163906413|NCT02038049|592029315|FG000|Overall Study|Lost to Follow-up|1|||
163906414|NCT02038049|592029316|FG001|Overall Study|Lost to Follow-up|0|||
163906415|NCT02660086|592029318|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
163906416|NCT02660086|592029319|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
163906417|NCT02660086|592029318|FG000|Overall Study- 12-month|Left full-time employment|12|||
163906418|NCT02660086|592029319|FG001|Overall Study- 12-month|Left full-time employment|20|||
163906419|NCT02660086|592029318|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
163906420|NCT02660086|592029319|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
163906421|NCT02660086|592029318|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
163906422|NCT02660086|592029319|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
163906423|NCT02660086|592029318|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
163906424|NCT02660086|592029319|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
163906425|NCT02660086|592029318|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
163906426|NCT02660086|592029319|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
163906427|NCT01377844|592029320|FG000|Overall Study|Withdrawal by Subject|25|||
163906428|NCT01377844|592029321|FG001|Overall Study|Withdrawal by Subject|28|||
164017196|NCT00905307|592425827|FG001|Overall Study|Withdrawal by Subject|13|||
164017197|NCT00905307|592425828|FG002|Overall Study|Withdrawal by Subject|15|||
164017198|NCT00905307|592425829|FG003|Overall Study|Withdrawal by Subject|11|||
164017199|NCT00905307|592425830|FG004|Overall Study|Withdrawal by Subject|4|||
164017200|NCT00905307|592425831|FG005|Overall Study|Withdrawal by Subject|13|||
164017201|NCT00905307|592425826|FG000|Overall Study|Protocol Violation|1|||
164017202|NCT00905307|592425827|FG001|Overall Study|Protocol Violation|0|||
164017203|NCT00905307|592425828|FG002|Overall Study|Protocol Violation|1|||
164017204|NCT00905307|592425829|FG003|Overall Study|Protocol Violation|0|||
164017205|NCT00905307|592425830|FG004|Overall Study|Protocol Violation|0|||
164017206|NCT00905307|592425831|FG005|Overall Study|Protocol Violation|0|||
164017207|NCT00905307|592425826|FG000|Overall Study|Lack of Efficacy|6|||
164017208|NCT00905307|592425827|FG001|Overall Study|Lack of Efficacy|3|||
164017209|NCT00905307|592425828|FG002|Overall Study|Lack of Efficacy|5|||
164017210|NCT00905307|592425829|FG003|Overall Study|Lack of Efficacy|4|||
164017211|NCT00905307|592425830|FG004|Overall Study|Lack of Efficacy|4|||
164017212|NCT00905307|592425831|FG005|Overall Study|Lack of Efficacy|8|||
164017213|NCT05590793|592425832|FG000|Overall Study|Withdrawal by Subject|6|||
164017214|NCT05590793|592425832|FG000|Overall Study|Physician Decision|1|||
164017215|NCT04060667|592425833|FG000|Overall Study|Lost to Follow-up|75|||
164017216|NCT04060667|592425834|FG001|Overall Study|Lost to Follow-up|10|||
164017217|NCT03015610|592425835|FG000|Overall Study|Lost to Follow-up|1|||
164017218|NCT03015610|592425836|FG001|Overall Study|Lost to Follow-up|5|||
164017219|NCT01603641|592425837|FG000|Overall Study|Did not Receive Treatment|3|||
164017220|NCT01603641|592425837|FG000|Overall Study|Adverse Event|1|||
164017221|NCT01603641|592425837|FG000|Overall Study|Lack of Efficacy|1|||
164017222|NCT01603641|592425837|FG000|Overall Study|Lost to Follow-up|6|||
164017223|NCT01603641|592425837|FG000|Overall Study|Personal Reasons|18|||
164017224|NCT01603641|592425837|FG000|Overall Study|Other Miscellaneous Reasons|6|||
164017225|NCT00114972|592425838|FG000|Overall Study|Withdrawal by Subject|40|||
164017226|NCT00114972|592425839|FG001|Overall Study|Withdrawal by Subject|7|||
164017227|NCT00114972|592425838|FG000|Overall Study|Lost to Follow-up|8|||
164017228|NCT00114972|592425839|FG001|Overall Study|Lost to Follow-up|5|||
164017229|NCT02086565|592425843|FG000|Overall Study|Lost to Follow-up|9|||
164017230|NCT02086565|592425844|FG001|Overall Study|Lost to Follow-up|7|||
164017231|NCT02086565|592425843|FG000|Overall Study|Withdrawal by Subject|2|||
164017232|NCT02086565|592425844|FG001|Overall Study|Withdrawal by Subject|1|||
164017233|NCT02086565|592425843|FG000|Overall Study|Death|3|||
164017234|NCT02086565|592425844|FG001|Overall Study|Death|2|||
164017235|NCT02086565|592425843|FG000|Overall Study|withdrawn by research team|2|||
164017236|NCT02086565|592425844|FG001|Overall Study|withdrawn by research team|2|||
164017237|NCT01757704|592425845|FG000|Overall Study|Protocol Violation|1|||
164017238|NCT01757704|592425846|FG001|Overall Study|Protocol Violation|3|||
164017239|NCT02890329|592425849|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164017240|NCT02890329|592425850|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
164017241|NCT02890329|592425851|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164017242|NCT02890329|592425852|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164017243|NCT02890329|592425853|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164017244|NCT02890329|592425854|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
164017245|NCT02890329|592425849|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
164017246|NCT02890329|592425850|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
164017247|NCT02890329|592425851|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164017248|NCT02890329|592425852|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164017249|NCT02890329|592425853|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164017250|NCT02890329|592425854|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
164017251|NCT02890329|592425849|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164017252|NCT02890329|592425850|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164017253|NCT02890329|592425851|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164017254|NCT02890329|592425852|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
164017255|NCT02890329|592425853|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164017256|NCT02890329|592425854|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
164017257|NCT02890329|592425849|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164017258|NCT02890329|592425850|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164017259|NCT02890329|592425851|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
164017260|NCT02890329|592425852|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164017261|NCT02890329|592425853|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164017262|NCT02890329|592425854|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
164017263|NCT01035255|592425855|FG000|Overall Study|Death|724|||
164017264|NCT01035255|592425856|FG001|Overall Study|Death|844|||
164017265|NCT01035255|592425855|FG000|Overall Study|Lost to Follow-up|2|||
164017266|NCT01035255|592425856|FG001|Overall Study|Lost to Follow-up|5|||
164017267|NCT01035255|592425855|FG000|Overall Study|patient's request|15|||
164017268|NCT01035255|592425856|FG001|Overall Study|patient's request|13|||
164017269|NCT01379534|592425859|FG000|Treatment Phase|Withdrawal by Subject|2|||
164017270|NCT01379534|592425860|FG001|Treatment Phase|Withdrawal by Subject|2|||
164017271|NCT01379534|592425859|FG000|Treatment Phase|Progressive disease|13|||
164017272|NCT01379534|592425860|FG001|Treatment Phase|Progressive disease|22|||
164017273|NCT01379534|592425859|FG000|Treatment Phase|Adverse Event|7|||
164017274|NCT01379534|592425860|FG001|Treatment Phase|Adverse Event|7|||
164017275|NCT01379534|592425859|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
164017276|NCT01379534|592425860|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
164017277|NCT01379534|592425859|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
164017278|NCT01379534|592425860|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
164017279|NCT01379534|592425859|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
164017280|NCT01379534|592425860|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
164017281|NCT01379534|592425859|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
164017282|NCT01379534|592425860|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
164017283|NCT00616239|592425866|FG000|Overall Study|Withdrawal by Subject|2|||
164017284|NCT01558089|592425869|FG000|Overall Study|Adverse Event|1|||
164017285|NCT01558089|592425869|FG000|Overall Study|Lack of Efficacy|1|||
164017286|NCT01558089|592425869|FG000|Overall Study|Lost to Follow-up|5|||
164017287|NCT01558089|592425869|FG000|Overall Study|Withdrawal by Subject|6|||
164017288|NCT01597193|592425870|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
164017289|NCT01597193|592425871|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
164017290|NCT01597193|592425872|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164017291|NCT01597193|592425873|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164017292|NCT01597193|592425874|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164017293|NCT01597193|592425875|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164017294|NCT01597193|592425876|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
164017295|NCT01597193|592425870|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164017296|NCT01597193|592425871|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164017297|NCT01597193|592425872|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164017298|NCT01597193|592425873|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
164017299|NCT01597193|592425874|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
164017300|NCT01597193|592425875|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
164017301|NCT01597193|592425876|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
164017302|NCT01597193|592425870|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
164017303|NCT01597193|592425871|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
164017304|NCT01597193|592425872|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
164017305|NCT01597193|592425873|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
164017306|NCT01597193|592425874|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
164017307|NCT01597193|592425875|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
164017308|NCT01597193|592425876|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
164017309|NCT01597193|592425870|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164017310|NCT01597193|592425871|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164017311|NCT01597193|592425872|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164017312|NCT01597193|592425873|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164017313|NCT01597193|592425874|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164017314|NCT01597193|592425875|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
164017315|NCT01597193|592425876|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
164017316|NCT01597193|592425870|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164017317|NCT01597193|592425871|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164093670|NCT01882647|592707262|FG001|Overall Study|Lost to Follow-up|2|||
164093671|NCT01882647|592707261|FG000|Overall Study|Withdrawal by Subject|0|||
164093672|NCT01882647|592707262|FG001|Overall Study|Withdrawal by Subject|4|||
163906429|NCT01377844|592029320|FG000|Overall Study|Protocol Violation|2|||
163906430|NCT01377844|592029321|FG001|Overall Study|Protocol Violation|3|||
163906431|NCT01377844|592029320|FG000|Overall Study|Adverse Event|3|||
163906432|NCT01377844|592029321|FG001|Overall Study|Adverse Event|0|||
163906433|NCT01377844|592029320|FG000|Overall Study|Physician Decision|6|||
163906434|NCT01377844|592029321|FG001|Overall Study|Physician Decision|3|||
163906435|NCT01377844|592029320|FG000|Overall Study|Study terminated by Sponsor|0|||
163906436|NCT01377844|592029321|FG001|Overall Study|Study terminated by Sponsor|1|||
163906437|NCT01214200|592029325|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
163906438|NCT01214200|592029325|FG000|Overall Study|Withdrawal by Subject|2|||
163906439|NCT00587171|592029326|FG000|Overall Study|Lost to Follow-up|1|||
163906440|NCT00587171|592029327|FG001|Overall Study|Lost to Follow-up|1|||
163906441|NCT02310581|592029328|FG000|Overall Study|Adverse Event|1|||
163906442|NCT02310581|592029329|FG001|Overall Study|Adverse Event|1|||
163906443|NCT02310581|592029330|FG002|Overall Study|Adverse Event|1|||
163906444|NCT02310581|592029331|FG003|Overall Study|Adverse Event|0|||
163906445|NCT02310581|592029328|FG000|Overall Study|Withdrawal by Subject|2|||
163906446|NCT02310581|592029329|FG001|Overall Study|Withdrawal by Subject|1|||
163906447|NCT02310581|592029330|FG002|Overall Study|Withdrawal by Subject|0|||
163906448|NCT02310581|592029331|FG003|Overall Study|Withdrawal by Subject|1|||
163906449|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
163906450|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
163906451|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
163906452|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
163906453|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
163906454|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
163906455|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
163906456|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
163906457|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
164093673|NCT01108094|592707263|FG000|Overall Study|Adverse Event|2|||
164093674|NCT01108094|592707264|FG001|Overall Study|Adverse Event|0|||
164093675|NCT01108094|592707265|FG002|Overall Study|Adverse Event|0|||
163906458|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
163906459|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
163906460|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
163906461|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Other|1|||
163906462|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Other|0|||
163906463|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Other|0|||
163906464|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
163906465|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
163906466|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
163906467|NCT00887224|592029332|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
163906468|NCT00887224|592029333|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
163906469|NCT00887224|592029334|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
163906470|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
163906471|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
163906472|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
163906473|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
163906474|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
163906475|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
163906476|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
163906477|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
163906478|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
163906479|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
163906480|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
163906481|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
163906482|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Other|1|||
163906483|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Other|0|||
163906484|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Other|0|||
163906485|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
163906486|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
163906487|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
163906488|NCT00887224|592029332|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
163906489|NCT00887224|592029333|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
163906490|NCT00887224|592029334|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
163906491|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
163906492|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
163906493|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
163906494|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
164017318|NCT01597193|592425872|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164017319|NCT01597193|592425873|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
164017320|NCT01597193|592425874|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164017321|NCT01597193|592425875|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
164017322|NCT01597193|592425876|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
164017323|NCT03184701|592425878|FG000|Overall Study|Death|3|||
164017324|NCT03184701|592425878|FG000|Overall Study|Physician Decision|3|||
164017325|NCT03184701|592425878|FG000|Overall Study|Withdrawal by Subject|6|||
164017326|NCT03184701|592425878|FG000|Overall Study|Lost to Follow-up|5|||
164017327|NCT00590681|592425881|FG000|Overall Study|Withdrawal by Subject|7|||
164017328|NCT00590681|592425881|FG000|Overall Study|Adverse Event|8|||
164017329|NCT00590681|592425881|FG000|Overall Study|Death|3|||
164017330|NCT00590681|592425881|FG000|Overall Study|Lost to Follow-up|1|||
164017331|NCT00590681|592425881|FG000|Overall Study|disease progression|1|||
164017332|NCT01259297|592425882|FG000|Double Blind Randomized Period|Death|1|||
164017333|NCT01259297|592425883|FG001|Double Blind Randomized Period|Death|1|||
164017334|NCT01259297|592425884|FG002|Double Blind Randomized Period|Death|1|||
164017335|NCT01259297|592425885|FG003|Double Blind Randomized Period|Death|2|||
164017336|NCT01259297|592425886|FG004|Double Blind Randomized Period|Death|1|||
164017337|NCT01259297|592425887|FG005|Double Blind Randomized Period|Death|5|||
164017338|NCT01259297|592425888|FG006|Double Blind Randomized Period|Death|2|||
164017339|NCT01259297|592425889|FG007|Double Blind Randomized Period|Death|1|||
164017340|NCT01259297|592425882|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164017341|NCT01259297|592425883|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164017342|NCT01259297|592425884|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
164017343|NCT01259297|592425885|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
164017344|NCT01259297|592425886|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
164017345|NCT01259297|592425887|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
163906495|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
163906496|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
163906497|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
163906498|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
163906499|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
164017346|NCT01259297|592425888|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164017347|NCT01259297|592425889|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
164017348|NCT01259297|592425882|FG000|Double Blind Randomized Period|Other reasons|0|||
164017349|NCT01259297|592425883|FG001|Double Blind Randomized Period|Other reasons|1|||
164017350|NCT01259297|592425884|FG002|Double Blind Randomized Period|Other reasons|0|||
164017351|NCT01259297|592425885|FG003|Double Blind Randomized Period|Other reasons|0|||
164017352|NCT01259297|592425886|FG004|Double Blind Randomized Period|Other reasons|1|||
164017353|NCT01259297|592425887|FG005|Double Blind Randomized Period|Other reasons|2|||
163906500|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
163906501|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
163906502|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
163906503|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Other|30|||
163906504|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Other|0|||
163906505|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Other|0|||
163906506|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
163906507|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
163906508|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
163906509|NCT00887224|592029332|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
163906510|NCT00887224|592029333|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
163906511|NCT00887224|592029334|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
163906512|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Adverse Event|0|||
163906513|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Adverse Event|7|||
163906514|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Adverse Event|2|||
163906515|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Failed to return|0|||
163906516|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Failed to return|2|||
163906517|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Failed to return|2|||
163906518|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
163906519|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
163906520|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
163906521|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
163906522|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
163906523|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
163906524|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Other|0|||
163906525|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Other|2|||
163906526|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Other|0|||
163906527|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
163906528|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
163906529|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
163906530|NCT00887224|592029332|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
163906531|NCT00887224|592029333|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
163906532|NCT00887224|592029334|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
163906533|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
163906534|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
163906535|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
163906536|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
164017354|NCT01259297|592425888|FG006|Double Blind Randomized Period|Other reasons|3|||
164017355|NCT01259297|592425889|FG007|Double Blind Randomized Period|Other reasons|1|||
164017356|NCT00933335|592425890|FG000|Overall Study|Lost to Follow-up|1|||
164017357|NCT00933335|592425891|FG001|Overall Study|Lost to Follow-up|3|||
164017358|NCT00933335|592425890|FG000|Overall Study|Withdrawal by Subject|0|||
164017359|NCT00933335|592425891|FG001|Overall Study|Withdrawal by Subject|1|||
164017360|NCT00933335|592425890|FG000|Overall Study|Progressive Disease|0|||
164017361|NCT00933335|592425891|FG001|Overall Study|Progressive Disease|11|||
164017362|NCT00933335|592425890|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
164017363|NCT00933335|592425891|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
164017364|NCT00933335|592425890|FG000|Overall Study|Co-morbid Illness|1|||
164017365|NCT00933335|592425891|FG001|Overall Study|Co-morbid Illness|0|||
164017366|NCT02229864|592425892|FG000|Overall Study|Death|2|||
164017367|NCT02229864|592425892|FG000|Overall Study|Lost to Follow-up|1|||
164017368|NCT02650284|592425895|FG000|Overall Study|Lost to Follow-up|3|||
164017369|NCT02650284|592425896|FG001|Overall Study|Lost to Follow-up|3|||
164017370|NCT02650284|592425895|FG000|Overall Study|Consent incorrectly taken|0|||
164017371|NCT02650284|592425896|FG001|Overall Study|Consent incorrectly taken|1|||
164017372|NCT00374907|592425901|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
164017373|NCT00374907|592425902|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
164017374|NCT00374907|592425901|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
164017375|NCT00374907|592425902|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
164017376|NCT00374907|592425901|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
164017377|NCT00374907|592425902|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
164017378|NCT00374907|592425901|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
164017379|NCT00374907|592425902|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
164017380|NCT00374907|592425901|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
164017381|NCT00374907|592425902|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
164017382|NCT04598165|592425907|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
164017383|NCT04598165|592425908|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
164017384|NCT04598165|592425907|FG000|Completed 6-week Follow-up|Death|2|||
164017385|NCT04598165|592425908|FG001|Completed 6-week Follow-up|Death|1|||
164017386|NCT04598165|592425907|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
164017387|NCT04598165|592425908|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
164017388|NCT04598165|592425907|FG000|Completed 6-week Follow-up|Ineligible|4|||
164017389|NCT04598165|592425908|FG001|Completed 6-week Follow-up|Ineligible|3|||
164017390|NCT04598165|592425907|FG000|Completed 6-week Follow-up|Partner refusal|0|||
164017391|NCT04598165|592425908|FG001|Completed 6-week Follow-up|Partner refusal|1|||
164017392|NCT04598165|592425907|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
164017393|NCT04598165|592425908|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
164017394|NCT00426751|592425909|FG000|Overall Study|Adverse Event|8|||
164017395|NCT00426751|592425910|FG001|Overall Study|Adverse Event|1|||
164017396|NCT00426751|592425909|FG000|Overall Study|Lost to Follow-up|7|||
164017397|NCT00426751|592425910|FG001|Overall Study|Lost to Follow-up|6|||
164017398|NCT00426751|592425909|FG000|Overall Study|Consent Withdrawn|0|||
164017399|NCT00426751|592425910|FG001|Overall Study|Consent Withdrawn|1|||
164017400|NCT00426751|592425909|FG000|Overall Study|Other Reasons|7|||
164017401|NCT00426751|592425910|FG001|Overall Study|Other Reasons|12|||
164017402|NCT01721408|592425911|FG000|Overall Study|Adverse Event|6|||
164017403|NCT01721408|592425912|FG001|Overall Study|Adverse Event|1|||
164017404|NCT01721408|592425911|FG000|Overall Study|Death|1|||
164017405|NCT01721408|592425912|FG001|Overall Study|Death|0|||
164017406|NCT01721408|592425911|FG000|Overall Study|Insufficient clinical response|15|||
164017407|NCT01721408|592425912|FG001|Overall Study|Insufficient clinical response|6|||
164017408|NCT01721408|592425911|FG000|Overall Study|No longer willing to participate study|9|||
164017409|NCT01721408|592425912|FG001|Overall Study|No longer willing to participate study|10|||
164017410|NCT01721408|592425911|FG000|Overall Study|Protocol Violation|0|||
164017411|NCT01721408|592425912|FG001|Overall Study|Protocol Violation|2|||
164017412|NCT01721408|592425911|FG000|Overall Study|Other|3|||
164017413|NCT01721408|592425912|FG001|Overall Study|Other|3|||
164017414|NCT01721408|592425911|FG000|Overall Study|Lost to Follow-up|1|||
164017415|NCT01721408|592425912|FG001|Overall Study|Lost to Follow-up|2|||
164017416|NCT01721408|592425911|FG000|Overall Study|Does not meet entrance criteria|1|||
164017417|NCT01721408|592425912|FG001|Overall Study|Does not meet entrance criteria|0|||
164017418|NCT04160468|592425913|FG000|Overall Study|Lost to Follow-up|19|||
164017419|NCT04160468|592425914|FG001|Overall Study|Lost to Follow-up|4|||
164017420|NCT04160468|592425913|FG000|Overall Study|Randomized but not dosed|6|||
164017421|NCT04160468|592425914|FG001|Overall Study|Randomized but not dosed|0|||
164017422|NCT04160468|592425913|FG000|Overall Study|Withdrawal by Subject|4|||
164017423|NCT04160468|592425914|FG001|Overall Study|Withdrawal by Subject|1|||
164017424|NCT04160468|592425913|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
164017425|NCT04160468|592425914|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
164017426|NCT04160468|592425913|FG000|Overall Study|Participant incarcerated|1|||
164017427|NCT04160468|592425914|FG001|Overall Study|Participant incarcerated|0|||
164017428|NCT03987620|592425915|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
164017429|NCT03987620|592425916|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
164017430|NCT03987620|592425915|FG000|Overall Study|Adverse Event|3|||
164017431|NCT03987620|592425916|FG001|Overall Study|Adverse Event|0|||
164017432|NCT03987620|592425915|FG000|Overall Study|Lost to Follow-up|1|||
164017433|NCT03987620|592425916|FG001|Overall Study|Lost to Follow-up|2|||
164017434|NCT03987620|592425915|FG000|Overall Study|Physician Decision|0|||
164017435|NCT03987620|592425916|FG001|Overall Study|Physician Decision|1|||
164017436|NCT03987620|592425915|FG000|Overall Study|Pregnancy|1|||
164017437|NCT03987620|592425916|FG001|Overall Study|Pregnancy|0|||
164017438|NCT03987620|592425915|FG000|Overall Study|Withdrawal by Subject|7|||
164017439|NCT03987620|592425916|FG001|Overall Study|Withdrawal by Subject|1|||
164017440|NCT03987620|592425915|FG000|Overall Study|Other|2|||
164017441|NCT03987620|592425916|FG001|Overall Study|Other|5|||
164017442|NCT05128162|592425917|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
164017443|NCT05128162|592425917|FG000|Overall Study|Physician Decision|1|||
164017444|NCT00370149|592425918|FG000|Overall Study|Physician Decision|16|||
164017445|NCT00370149|592425919|FG001|Overall Study|Physician Decision|16|||
164017446|NCT00370149|592425918|FG000|Overall Study|Protocol Violation|1|||
164017447|NCT00370149|592425919|FG001|Overall Study|Protocol Violation|0|||
164017448|NCT00370149|592425918|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
164017449|NCT00370149|592425919|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
164017450|NCT00370149|592425918|FG000|Overall Study|Pre-existing infection|0|||
164017451|NCT00370149|592425919|FG001|Overall Study|Pre-existing infection|1|||
164017452|NCT00370149|592425918|FG000|Overall Study|Antibiotic coated dressing placed|0|||
164017453|NCT00370149|592425919|FG001|Overall Study|Antibiotic coated dressing placed|1|||
164017454|NCT04920084|592427191|FG000|Overall Study|Adverse Event|1|||
164017455|NCT04920084|592427191|FG000|Overall Study|Lost to Follow-up|2|||
164017456|NCT04920084|592427191|FG000|Overall Study|Withdrawal by Subject|2|||
164017457|NCT01096446|592427192|FG000|Overall Study|Death|1|||
164017458|NCT01096446|592427193|FG001|Overall Study|Death|0|||
164017459|NCT01096446|592427192|FG000|Overall Study|Protocol Violation|2|||
164017460|NCT01096446|592427193|FG001|Overall Study|Protocol Violation|0|||
164017461|NCT00620321|592427194|FG000|Overall Study|Adverse Event|1|||
164017462|NCT00620321|592427195|FG001|Overall Study|Adverse Event|1|||
164017463|NCT00620321|592427194|FG000|Overall Study|Death|1|||
164017464|NCT00620321|592427195|FG001|Overall Study|Death|1|||
164017465|NCT00620321|592427194|FG000|Overall Study|Physician Decision|0|||
164017466|NCT00620321|592427195|FG001|Overall Study|Physician Decision|7|||
164017467|NCT00620321|592427194|FG000|Overall Study|Progressive Disease|5|||
164017468|NCT00620321|592427195|FG001|Overall Study|Progressive Disease|5|||
164017469|NCT00620321|592427194|FG000|Overall Study|Sponsor Decision|0|||
164017470|NCT00620321|592427195|FG001|Overall Study|Sponsor Decision|1|||
164017471|NCT00620321|592427194|FG000|Overall Study|Withdrawal by Subject|1|||
164017472|NCT00620321|592427195|FG001|Overall Study|Withdrawal by Subject|1|||
164017473|NCT02279524|592427197|FG000|Overall Study|Withdrawal by Subject|3|||
164017474|NCT02279524|592427198|FG001|Overall Study|Withdrawal by Subject|6|||
164017475|NCT02279524|592427199|FG002|Overall Study|Withdrawal by Subject|3|||
164017476|NCT02279524|592427197|FG000|Overall Study|Adverse Event|4|||
164017477|NCT02279524|592427198|FG001|Overall Study|Adverse Event|3|||
164017478|NCT02279524|592427199|FG002|Overall Study|Adverse Event|2|||
164017479|NCT02279524|592427197|FG000|Overall Study|Lost to Follow-up|1|||
164017480|NCT02279524|592427198|FG001|Overall Study|Lost to Follow-up|1|||
164017481|NCT02279524|592427199|FG002|Overall Study|Lost to Follow-up|0|||
164017482|NCT02279524|592427197|FG000|Overall Study|Disallowed medication|1|||
164017483|NCT02279524|592427198|FG001|Overall Study|Disallowed medication|1|||
164017484|NCT02279524|592427199|FG002|Overall Study|Disallowed medication|2|||
164017485|NCT02279524|592427197|FG000|Overall Study|Bariatric surgery|1|||
164017486|NCT02279524|592427198|FG001|Overall Study|Bariatric surgery|0|||
164017487|NCT02279524|592427199|FG002|Overall Study|Bariatric surgery|0|||
164017488|NCT01043185|592427200|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
164017489|NCT01043185|592427201|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
164017490|NCT01043185|592427202|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
164017491|NCT01043185|592427203|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
164017492|NCT01043185|592427204|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
164017493|NCT01043185|592427205|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
164017494|NCT01043185|592427206|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
164017495|NCT01043185|592427207|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
164017496|NCT01043185|592427208|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
164017497|NCT01043185|592427209|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
164017498|NCT05137041|592427212|FG000|Overall Study|Lost to Follow-up|1|||
164017499|NCT05137041|592427213|FG001|Overall Study|Lost to Follow-up|1|||
164017500|NCT05137041|592427212|FG000|Overall Study|Withdrawal by Subject|0|||
164017501|NCT05137041|592427213|FG001|Overall Study|Withdrawal by Subject|2|||
164017502|NCT05137041|592427212|FG000|Overall Study|Reason not Specified|0|||
164017503|NCT05137041|592427213|FG001|Overall Study|Reason not Specified|1|||
164017504|NCT02433210|592427214|FG000|Overall Study|Physician Decision|1|||
164017505|NCT02433210|592427215|FG001|Overall Study|Physician Decision|0|||
164017506|NCT02433210|592427216|FG002|Overall Study|Physician Decision|0|||
164017507|NCT03488472|592427217|FG000|Overall Study|disease progression additional mets|1|||
164017508|NCT00414310|592427223|FG000|Overall Study|Not treated|1|||
164017509|NCT00414310|592427224|FG001|Overall Study|Not treated|0|||
164017510|NCT01441440|592427228|FG000|Overall Study|Death|1|||
164017511|NCT01441440|592427229|FG001|Overall Study|Death|0|||
164017512|NCT01441440|592427230|FG002|Overall Study|Death|1|||
164017513|NCT01441440|592427228|FG000|Overall Study|Adverse Event|2|||
164017514|NCT01441440|592427229|FG001|Overall Study|Adverse Event|9|||
164017515|NCT01441440|592427230|FG002|Overall Study|Adverse Event|9|||
164017516|NCT01441440|592427228|FG000|Overall Study|Lost to Follow-up|0|||
164017517|NCT01441440|592427229|FG001|Overall Study|Lost to Follow-up|2|||
164017518|NCT01441440|592427230|FG002|Overall Study|Lost to Follow-up|1|||
164017519|NCT01441440|592427228|FG000|Overall Study|Withdrawal by Subject|11|||
164017520|NCT01441440|592427229|FG001|Overall Study|Withdrawal by Subject|9|||
164017521|NCT01441440|592427230|FG002|Overall Study|Withdrawal by Subject|9|||
164017522|NCT01441440|592427228|FG000|Overall Study|Pregnancy|1|||
164017523|NCT01441440|592427229|FG001|Overall Study|Pregnancy|0|||
164017524|NCT01441440|592427230|FG002|Overall Study|Pregnancy|0|||
164017525|NCT01441440|592427228|FG000|Overall Study|Lack of Efficacy|1|||
164017526|NCT01441440|592427229|FG001|Overall Study|Lack of Efficacy|0|||
164017527|NCT01441440|592427230|FG002|Overall Study|Lack of Efficacy|1|||
164017528|NCT01441440|592427228|FG000|Overall Study|Moving|0|||
164093676|NCT01108094|592707266|FG003|Overall Study|Adverse Event|0|||
164017529|NCT01441440|592427229|FG001|Overall Study|Moving|1|||
164017530|NCT01441440|592427230|FG002|Overall Study|Moving|1|||
164017531|NCT01441440|592427228|FG000|Overall Study|Work-related matter|0|||
164017532|NCT01441440|592427229|FG001|Overall Study|Work-related matter|1|||
164017533|NCT01441440|592427230|FG002|Overall Study|Work-related matter|0|||
164017534|NCT01441440|592427228|FG000|Overall Study|Difficllty in keeping the schedule|1|||
164017535|NCT01441440|592427229|FG001|Overall Study|Difficllty in keeping the schedule|1|||
164017536|NCT01441440|592427230|FG002|Overall Study|Difficllty in keeping the schedule|0|||
164017537|NCT01993329|592427231|FG000|Period 2|Adverse Event|0|||
164017538|NCT01993329|592427232|FG001|Period 2|Adverse Event|0|||
164017539|NCT01993329|592427233|FG002|Period 2|Adverse Event|0|||
164017540|NCT01993329|592427234|FG003|Period 2|Adverse Event|0|||
164017541|NCT01993329|592427235|FG004|Period 2|Adverse Event|0|||
164017542|NCT01993329|592427236|FG005|Period 2|Adverse Event|1|||
164017543|NCT01993329|592427231|FG000|Wash-out|Personal reasons|0|||
164017544|NCT01993329|592427232|FG001|Wash-out|Personal reasons|1|||
164017545|NCT01993329|592427233|FG002|Wash-out|Personal reasons|0|||
164017546|NCT01993329|592427234|FG003|Wash-out|Personal reasons|0|||
164017547|NCT01993329|592427235|FG004|Wash-out|Personal reasons|0|||
164017548|NCT01993329|592427236|FG005|Wash-out|Personal reasons|0|||
164017549|NCT00883558|592427237|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
164017550|NCT00883558|592427238|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
164017551|NCT00883558|592427239|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
164017552|NCT00883558|592427237|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
164017553|NCT00883558|592427238|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
164017554|NCT00883558|592427239|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
164017555|NCT00883558|592427237|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
164017556|NCT00883558|592427238|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
164017557|NCT00883558|592427239|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
164017558|NCT00883558|592427237|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
164017559|NCT00883558|592427238|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
164017560|NCT00883558|592427239|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
164017561|NCT00883558|592427237|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
164017562|NCT00883558|592427238|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
164017563|NCT00883558|592427239|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
164017564|NCT03539458|592427240|FG000|Overall Study|Death|1|||
164017565|NCT02750800|592427245|FG000|Overall Study|Adverse Event|18|||
164017566|NCT02750800|592427245|FG000|Overall Study|Lost to Follow-up|12|||
164017567|NCT02750800|592427245|FG000|Overall Study|Investigator decision|53|||
164017568|NCT02750800|592427245|FG000|Overall Study|Patient request|12|||
164017569|NCT02750800|592427245|FG000|Overall Study|Other, not specified|3|||
164017570|NCT00643487|592427246|FG000|Overall Study|Technical difficulty|3|||
164017571|NCT00972478|592427247|FG000|Overall Study|Adverse Event|3|||
164017572|NCT00972478|592427248|FG001|Overall Study|Adverse Event|16|||
164017573|NCT00972478|592427247|FG000|Overall Study|Withdrawal by Subject|1|||
164017574|NCT00972478|592427248|FG001|Overall Study|Withdrawal by Subject|8|||
164017575|NCT00972478|592427247|FG000|Overall Study|Progression/Relapse|0|||
164017576|NCT00972478|592427248|FG001|Overall Study|Progression/Relapse|2|||
164017577|NCT00972478|592427247|FG000|Overall Study|Death|0|||
164017578|NCT00972478|592427248|FG001|Overall Study|Death|2|||
164017579|NCT00972478|592427247|FG000|Overall Study|Not protocol specified|1|||
164017580|NCT00972478|592427248|FG001|Overall Study|Not protocol specified|1|||
164017581|NCT00972478|592427247|FG000|Overall Study|Ineligible|1|||
164017582|NCT00972478|592427248|FG001|Overall Study|Ineligible|7|||
164017583|NCT00972478|592427247|FG000|Overall Study|Not start protocol treatment|1|||
164017584|NCT00972478|592427248|FG001|Overall Study|Not start protocol treatment|2|||
164017585|NCT04742907|592427249|FG000|Overall Study|Adverse Event|1|||
164017586|NCT04742907|592427250|FG001|Overall Study|Adverse Event|0|||
164017587|NCT04742907|592427251|FG002|Overall Study|Adverse Event|1|||
164017588|NCT04742907|592427249|FG000|Overall Study|Lost to Follow-up|3|||
164017589|NCT04742907|592427250|FG001|Overall Study|Lost to Follow-up|3|||
164017590|NCT04742907|592427251|FG002|Overall Study|Lost to Follow-up|2|||
164017591|NCT04742907|592427249|FG000|Overall Study|Physician Decision|0|||
164093677|NCT01108094|592707263|FG000|Overall Study|Withdrawal by Subject|1|||
164093678|NCT01108094|592707264|FG001|Overall Study|Withdrawal by Subject|0|||
164017592|NCT04742907|592427250|FG001|Overall Study|Physician Decision|1|||
164017593|NCT04742907|592427251|FG002|Overall Study|Physician Decision|0|||
164017594|NCT04742907|592427249|FG000|Overall Study|Protocol Violation|1|||
164017595|NCT04742907|592427250|FG001|Overall Study|Protocol Violation|1|||
164017596|NCT04742907|592427251|FG002|Overall Study|Protocol Violation|1|||
164017597|NCT04742907|592427249|FG000|Overall Study|Withdrawal by Subject|5|||
164017598|NCT04742907|592427250|FG001|Overall Study|Withdrawal by Subject|6|||
164017599|NCT04742907|592427251|FG002|Overall Study|Withdrawal by Subject|4|||
163906537|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
163906538|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
163906539|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
163906540|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
163906541|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
163906542|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
163906543|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
163906544|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
163906545|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
163906546|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
163906547|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
164073085|NCT01902134|592632781|FG000|Overall Study|Other|0|||
164017600|NCT04742907|592427249|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
164017601|NCT04742907|592427250|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
164017602|NCT04742907|592427251|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
164017603|NCT04742907|592427249|FG000|Overall Study|Did Not Receive the Study Drug|2|||
164017604|NCT04742907|592427250|FG001|Overall Study|Did Not Receive the Study Drug|4|||
164017605|NCT04742907|592427251|FG002|Overall Study|Did Not Receive the Study Drug|4|||
164017606|NCT01259856|592427252|FG000|Overall Study|Adverse Event|12|||
164017607|NCT01259856|592427253|FG001|Overall Study|Adverse Event|9|||
164017608|NCT01259856|592427252|FG000|Overall Study|Death|0|||
164017609|NCT01259856|592427253|FG001|Overall Study|Death|1|||
164017610|NCT01259856|592427252|FG000|Overall Study|Lack of Efficacy|3|||
164017611|NCT01259856|592427253|FG001|Overall Study|Lack of Efficacy|1|||
164017612|NCT01259856|592427252|FG000|Overall Study|Lost to Follow-up|1|||
164017613|NCT01259856|592427253|FG001|Overall Study|Lost to Follow-up|1|||
164017614|NCT01259856|592427252|FG000|Overall Study|Physician Decision|2|||
164017615|NCT01259856|592427253|FG001|Overall Study|Physician Decision|1|||
164017616|NCT01259856|592427252|FG000|Overall Study|Withdrawal by Subject|9|||
164017617|NCT01259856|592427253|FG001|Overall Study|Withdrawal by Subject|10|||
164017618|NCT01259856|592427252|FG000|Overall Study|Treatment never started|0|||
164017619|NCT01259856|592427253|FG001|Overall Study|Treatment never started|6|||
164017620|NCT01259856|592427252|FG000|Overall Study|Study closure by sponsor|40|||
164017621|NCT01259856|592427253|FG001|Overall Study|Study closure by sponsor|41|||
164017622|NCT01259856|592427252|FG000|Overall Study|Patient developed other disease|0|||
164017623|NCT01259856|592427253|FG001|Overall Study|Patient developed other disease|1|||
164017624|NCT01259856|592427252|FG000|Overall Study|Transfer to another study|0|||
164017625|NCT01259856|592427253|FG001|Overall Study|Transfer to another study|1|||
164017626|NCT01259856|592427252|FG000|Overall Study|Unknown/missing|2|||
164017627|NCT01259856|592427253|FG001|Overall Study|Unknown/missing|2|||
164017628|NCT03406104|592427256|FG000|Overall Study|Lost to Follow-up|2|||
164017629|NCT03406104|592427256|FG000|Overall Study|Withdrawal by Subject|2|||
164017630|NCT03406104|592427256|FG000|Overall Study|due to Covid patient did not want to travel|1|||
164017631|NCT03406104|592427256|FG000|Overall Study|Death|2|||
164017632|NCT00358917|592427257|FG000|Overall Study|Adverse Event|14|||
164017633|NCT00358917|592427258|FG001|Overall Study|Adverse Event|21|||
164017634|NCT00358917|592427257|FG000|Overall Study|Withdrawal by Subject|5|||
164017635|NCT00358917|592427258|FG001|Overall Study|Withdrawal by Subject|7|||
164017636|NCT00358917|592427257|FG000|Overall Study|Lost to Follow-up|20|||
164017637|NCT00358917|592427258|FG001|Overall Study|Lost to Follow-up|17|||
164017638|NCT00358917|592427257|FG000|Overall Study|Noncompliance|12|||
164017639|NCT00358917|592427258|FG001|Overall Study|Noncompliance|11|||
164017640|NCT00358917|592427257|FG000|Overall Study|Death|2|||
164017641|NCT00358917|592427258|FG001|Overall Study|Death|3|||
164017642|NCT00358917|592427257|FG000|Overall Study|Virologic failure|11|||
164017643|NCT00358917|592427258|FG001|Overall Study|Virologic failure|8|||
164017644|NCT00358917|592427257|FG000|Overall Study|Unable to Continue Participation|2|||
164017645|NCT00358917|592427258|FG001|Overall Study|Unable to Continue Participation|2|||
164017646|NCT00772967|592427266|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
164017647|NCT00772967|592427267|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
164017648|NCT00772967|592427268|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
164017649|NCT00772967|592427269|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
164017650|NCT00772967|592427270|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
164017651|NCT00772967|592427271|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
164017652|NCT00772967|592427266|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164017653|NCT00772967|592427267|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
164017654|NCT00772967|592427268|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164017655|NCT00772967|592427269|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164017656|NCT00772967|592427270|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164017657|NCT00772967|592427271|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
164017658|NCT00772967|592427266|FG000|Crossover Treatment 3|Adverse Event|0|||
164017659|NCT00772967|592427267|FG001|Crossover Treatment 3|Adverse Event|0|||
164017660|NCT00772967|592427268|FG002|Crossover Treatment 3|Adverse Event|0|||
164017661|NCT00772967|592427269|FG003|Crossover Treatment 3|Adverse Event|0|||
164017662|NCT00772967|592427270|FG004|Crossover Treatment 3|Adverse Event|1|||
164017663|NCT00772967|592427271|FG005|Crossover Treatment 3|Adverse Event|0|||
164017664|NCT00231062|592427274|FG000|Overall Study|Physician Decision|6|||
164017665|NCT00803244|592427275|FG000|Overall Study|Adverse Event|1|||
164017666|NCT00803244|592427276|FG001|Overall Study|Adverse Event|2|||
164017667|NCT00803244|592427275|FG000|Overall Study|Withdrawal by Subject|2|||
164017668|NCT00803244|592427276|FG001|Overall Study|Withdrawal by Subject|3|||
164017669|NCT00803244|592427275|FG000|Overall Study|Any other reason not above-mentioned|4|||
164017670|NCT00803244|592427276|FG001|Overall Study|Any other reason not above-mentioned|10|||
164017671|NCT03321929|592427277|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
164017672|NCT00443430|592427280|FG000|Overall Study|Lack of Efficacy|3|||
164017673|NCT00443430|592427281|FG001|Overall Study|Lack of Efficacy|3|||
164017674|NCT00443430|592427280|FG000|Overall Study|Adverse Event|1|||
164017675|NCT00443430|592427281|FG001|Overall Study|Adverse Event|1|||
164017676|NCT00053846|592427282|FG000|Overall Study|Changed mind|8|||
164017677|NCT00053846|592427283|FG001|Overall Study|Changed mind|13|||
164017678|NCT00053846|592427282|FG000|Overall Study|Became too ill|8|||
164017679|NCT00053846|592427283|FG001|Overall Study|Became too ill|7|||
164093679|NCT01108094|592707265|FG002|Overall Study|Withdrawal by Subject|0|||
164017680|NCT00053846|592427282|FG000|Overall Study|Expired|5|||
164017681|NCT00053846|592427283|FG001|Overall Study|Expired|0|||
164017682|NCT00053846|592427282|FG000|Overall Study|Became ineligible|3|||
164017683|NCT00053846|592427283|FG001|Overall Study|Became ineligible|1|||
164017684|NCT00053846|592427282|FG000|Overall Study|Did not return data|1|||
164017685|NCT00053846|592427283|FG001|Overall Study|Did not return data|2|||
164017686|NCT00053846|592427282|FG000|Overall Study|Quit due to side effects|1|||
164017687|NCT00053846|592427283|FG001|Overall Study|Quit due to side effects|3|||
164017688|NCT00053846|592427282|FG000|Overall Study|Pills too large|0|||
164017689|NCT00053846|592427283|FG001|Overall Study|Pills too large|1|||
164017690|NCT03880227|592427284|FG000|First Visit|Withdrawal by Subject|1|||
164017691|NCT03880227|592427285|FG001|First Visit|Withdrawal by Subject|0|||
164017692|NCT03880227|592427286|FG002|First Visit|Withdrawal by Subject|0|||
164017693|NCT03880227|592427287|FG003|First Visit|Withdrawal by Subject|0|||
164017694|NCT03880227|592427284|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
164017695|NCT03880227|592427285|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
164017696|NCT03880227|592427286|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
164017697|NCT03880227|592427287|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
164017698|NCT03880227|592427284|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
164017699|NCT03880227|592427285|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
164017700|NCT03880227|592427286|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
164017701|NCT03880227|592427287|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
164017702|NCT03880227|592427284|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
164017703|NCT03880227|592427285|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
164017704|NCT03880227|592427286|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
164017705|NCT03880227|592427287|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
164017706|NCT02815397|592427288|FG000|Overall Study|Physician Decision|2|||
164017707|NCT00085540|592427291|FG000|Overall Study|Withdrawal by Subject|0|||
164017708|NCT00085540|592427292|FG001|Overall Study|Withdrawal by Subject|1|||
164017709|NCT00085540|592427291|FG000|Overall Study|Protocol Violation|0|||
164017710|NCT00085540|592427292|FG001|Overall Study|Protocol Violation|1|||
164017711|NCT01605396|592427293|FG000|Overall Study|Adverse Event|5|||
164017712|NCT01605396|592427294|FG001|Overall Study|Adverse Event|3|||
164017713|NCT01605396|592427293|FG000|Overall Study|Lost to Follow-up|1|||
164017714|NCT01605396|592427294|FG001|Overall Study|Lost to Follow-up|0|||
164017715|NCT01605396|592427293|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164017716|NCT01605396|592427294|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164017717|NCT01605396|592427293|FG000|Overall Study|Physician Decision|2|||
164017718|NCT01605396|592427294|FG001|Overall Study|Physician Decision|2|||
164017719|NCT01605396|592427293|FG000|Overall Study|Progressive Disease|23|||
164017720|NCT01605396|592427294|FG001|Overall Study|Progressive Disease|27|||
164017721|NCT01605396|592427293|FG000|Overall Study|Withdrawal by Subject|4|||
164017722|NCT01605396|592427294|FG001|Overall Study|Withdrawal by Subject|2|||
164017723|NCT01605396|592427293|FG000|Overall Study|Transfer Off Study|4|||
164017724|NCT01605396|592427294|FG001|Overall Study|Transfer Off Study|5|||
164017725|NCT00705224|592427298|FG000|Overall Study|Adverse Event|1|||
164017726|NCT00705224|592427298|FG000|Overall Study|Lack of Efficacy|2|||
164017727|NCT00705224|592427298|FG000|Overall Study|Withdrawal by Subject|3|||
164017728|NCT00705224|592427298|FG000|Overall Study|Lost to Follow-up|5|||
164017729|NCT03283163|592427299|FG000|Overall Study|Lost to Follow-up|1|||
164017730|NCT03283163|592427299|FG000|Overall Study|other life commitments|6|||
164017731|NCT03283163|592427299|FG000|Overall Study|COVID-19 institution wide halting|1|||
164017732|NCT03283163|592427299|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
164017733|NCT03283163|592427299|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
164017734|NCT00237796|592427300|FG000|Overall Study|Baseline and one other ILSS required|10|||
164017735|NCT00237796|592427301|FG001|Overall Study|Baseline and one other ILSS required|5|||
164017736|NCT04238663|592427302|FG000|Overall Study|Lost to Follow-up|0|||
164017737|NCT04238663|592427303|FG001|Overall Study|Lost to Follow-up|1|||
164017738|NCT04238663|592427304|FG002|Overall Study|Lost to Follow-up|0|||
164017739|NCT02566525|592427305|FG000|Overall Study|Protocol Violation|3|||
164017740|NCT02566525|592427306|FG001|Overall Study|Protocol Violation|5|||
164017741|NCT02149836|592427307|FG000|Overall Study|Withdrawal by Subject|1|||
164017742|NCT04430582|592427309|FG000|Overall Study|Found to meet exclusionary criteria|1|||
164017743|NCT04430582|592427310|FG001|Overall Study|Found to meet exclusionary criteria|0|||
164017744|NCT04430582|592427309|FG000|Overall Study|Withdrawal by Subject|0|||
164017745|NCT04430582|592427310|FG001|Overall Study|Withdrawal by Subject|1|||
164017746|NCT01770353|592427311|FG000|Overall Study|Progressive disease|2|||
164017747|NCT01770353|592427312|FG001|Overall Study|Progressive disease|1|||
164017748|NCT01770353|592427311|FG000|Overall Study|Adverse Event|0|||
164017749|NCT01770353|592427312|FG001|Overall Study|Adverse Event|1|||
164017750|NCT01770353|592427311|FG000|Overall Study|Protocol Violation|1|||
164017751|NCT01770353|592427312|FG001|Overall Study|Protocol Violation|0|||
163906548|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
163906549|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
163906550|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
163906551|NCT00887224|592029332|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
163906552|NCT00887224|592029333|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
163906553|NCT00887224|592029334|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
163906554|NCT01353274|592029335|FG000|Overall Study|No case report form (CRF) collected|28|||
163906555|NCT00022672|592029337|FG000|Main Phase: 24 Months|Adverse Event|6|||
163906556|NCT00022672|592029338|FG001|Main Phase: 24 Months|Adverse Event|0|||
163906557|NCT00022672|592029337|FG000|Main Phase: 24 Months|Death|0|||
163906558|NCT00022672|592029338|FG001|Main Phase: 24 Months|Death|3|||
163906559|NCT00022672|592029337|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
163906560|NCT00022672|592029338|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
163906561|NCT00022672|592029337|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
163906562|NCT00022672|592029338|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
163906563|NCT00022672|592029337|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
163906564|NCT00022672|592029338|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
163906565|NCT00022672|592029337|FG000|Main Phase: 24 Months|Refused Treatment|3|||
163906566|NCT00022672|592029338|FG001|Main Phase: 24 Months|Refused Treatment|4|||
163906567|NCT00022672|592029337|FG000|Main Phase: 24 Months|Failure to Return|1|||
163906568|NCT00022672|592029338|FG001|Main Phase: 24 Months|Failure to Return|1|||
163906569|NCT00022672|592029337|FG000|Main Phase: 24 Months|Other|1|||
163906570|NCT00022672|592029338|FG001|Main Phase: 24 Months|Other|0|||
163906571|NCT00022672|592029337|FG000|Extension Phase|Adverse Event|1|||
163906572|NCT00022672|592029338|FG001|Extension Phase|Adverse Event|3|||
163906573|NCT00022672|592029337|FG000|Extension Phase|Death|0|||
163906574|NCT00022672|592029338|FG001|Extension Phase|Death|1|||
164093680|NCT01108094|592707266|FG003|Overall Study|Withdrawal by Subject|0|||
164093681|NCT05037097|592707269|FG000|Overall Study|Withdrawal by Subject|0|||
164093682|NCT05037097|592707270|FG001|Overall Study|Withdrawal by Subject|1|||
164093683|NCT05037097|592707271|FG002|Overall Study|Withdrawal by Subject|0|||
164093684|NCT05037097|592707272|FG003|Overall Study|Withdrawal by Subject|1|||
164017752|NCT01770353|592427311|FG000|Overall Study|Physician Decision|0|||
164017753|NCT01770353|592427312|FG001|Overall Study|Physician Decision|3|||
164017754|NCT01770353|592427311|FG000|Overall Study|Clinical deterioration|3|||
164017755|NCT01770353|592427312|FG001|Overall Study|Clinical deterioration|6|||
164017756|NCT01770353|592427311|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
164017757|NCT01770353|592427312|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
164017758|NCT00376688|592427313|FG000|Overall Study|Adverse Event|3|||
164017759|NCT00376688|592427313|FG000|Overall Study|Death|1|||
164017760|NCT00074412|592428587|FG000|Overall Study|Death|30|||
164017761|NCT00074412|592428588|FG001|Overall Study|Death|26|||
164017762|NCT00074412|592428587|FG000|Overall Study|Lost to Follow-up|52|||
164017763|NCT00074412|592428588|FG001|Overall Study|Lost to Follow-up|58|||
164017764|NCT00392171|592428591|FG000|Overall Study|Did not meet inclusion criteria|4|||
164017765|NCT00392171|592428591|FG000|Overall Study|Disease progression|101|||
164017766|NCT00028002|592428592|FG000|Overall Study|Withdrawal by Subject|3|||
164017767|NCT00028002|592428592|FG000|Overall Study|Ineligible|8|||
164017768|NCT02561000|592428594|FG000|Overall Study|Withdrawal by Subject|2|||
164017769|NCT02561000|592428595|FG001|Overall Study|Withdrawal by Subject|3|||
164017770|NCT02561000|592428596|FG002|Overall Study|Withdrawal by Subject|0|||
164017771|NCT02561000|592428594|FG000|Overall Study|Adverse Event|0|||
164017772|NCT02561000|592428595|FG001|Overall Study|Adverse Event|1|||
164017773|NCT02561000|592428596|FG002|Overall Study|Adverse Event|0|||
164017774|NCT03430245|592428599|FG000|Overall Study|Withdrawal by Subject|6|||
164017775|NCT03430245|592428599|FG000|Overall Study|Lost to Follow-up|1|||
163906575|NCT00022672|592029337|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
163906576|NCT00022672|592029338|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
163906577|NCT00022672|592029337|FG000|Extension Phase|Refused Treatment|0|||
163906578|NCT00022672|592029338|FG001|Extension Phase|Refused Treatment|2|||
163906579|NCT00022672|592029337|FG000|Extension Phase|Other|1|||
164017776|NCT03656926|592428606|FG000|Overall Study|Adverse Event|5|||
164017777|NCT03656926|592428607|FG001|Overall Study|Adverse Event|4|||
164017778|NCT03656926|592428606|FG000|Overall Study|Withdrawal by Subject|7|||
164017779|NCT03656926|592428607|FG001|Overall Study|Withdrawal by Subject|2|||
164017780|NCT03656926|592428606|FG000|Overall Study|Screen fail after randomization|1|||
164017781|NCT03656926|592428607|FG001|Overall Study|Screen fail after randomization|0|||
164017782|NCT03656926|592428606|FG000|Overall Study|PI decision due to patient condition|1|||
164017783|NCT03656926|592428607|FG001|Overall Study|PI decision due to patient condition|0|||
164017784|NCT03656926|592428606|FG000|Overall Study|Patient unresponsiveness|1|||
164017785|NCT03656926|592428607|FG001|Overall Study|Patient unresponsiveness|0|||
164017786|NCT01428063|592428608|FG000|Overall Study|Lack of Efficacy|8|||
163906580|NCT00022672|592029338|FG001|Extension Phase|Other|1|||
163906581|NCT00403494|592029339|FG000|Overall Study|Adverse Event|10|||
164017787|NCT01428063|592428609|FG001|Overall Study|Lack of Efficacy|4|||
164017788|NCT01428063|592428610|FG002|Overall Study|Lack of Efficacy|1|||
164017789|NCT01428063|592428608|FG000|Overall Study|Adverse Event|2|||
163906582|NCT00403494|592029340|FG001|Overall Study|Adverse Event|8|||
163906583|NCT00403494|592029339|FG000|Overall Study|Withdrew Consent|3|||
164017790|NCT01428063|592428609|FG001|Overall Study|Adverse Event|3|||
164017791|NCT01428063|592428610|FG002|Overall Study|Adverse Event|0|||
164017792|NCT01428063|592428608|FG000|Overall Study|Lost to Follow-up|0|||
164017793|NCT01428063|592428609|FG001|Overall Study|Lost to Follow-up|2|||
164017794|NCT01428063|592428610|FG002|Overall Study|Lost to Follow-up|0|||
164017795|NCT01428063|592428608|FG000|Overall Study|No longer meets study criteria|0|||
164017796|NCT01428063|592428609|FG001|Overall Study|No longer meets study criteria|1|||
164017797|NCT01428063|592428610|FG002|Overall Study|No longer meets study criteria|0|||
164017798|NCT03196505|592428615|FG000|Overall Study|Physician Decision|26|||
164017799|NCT03196505|592428616|FG001|Overall Study|Physician Decision|26|||
164017800|NCT02575079|592428618|FG000|Overall Study|Death|3|||
164017801|NCT02575079|592428619|FG001|Overall Study|Death|0|||
164017802|NCT02575079|592428618|FG000|Overall Study|Withdrawal by Subject|3|||
164017803|NCT02575079|592428619|FG001|Overall Study|Withdrawal by Subject|0|||
164017804|NCT02918266|592428620|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
164017805|NCT02918266|592428621|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017806|NCT02918266|592428622|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017807|NCT02918266|592428623|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017808|NCT02918266|592428624|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017809|NCT02918266|592428625|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017810|NCT02918266|592428626|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
164017811|NCT02918266|592428627|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
163906584|NCT00403494|592029340|FG001|Overall Study|Withdrew Consent|2|||
163906585|NCT00403494|592029339|FG000|Overall Study|Inappropriately enrolled|0|||
163906586|NCT00403494|592029340|FG001|Overall Study|Inappropriately enrolled|1|||
163906587|NCT00403494|592029339|FG000|Overall Study|Lost to Follow-up|0|||
163906588|NCT00403494|592029340|FG001|Overall Study|Lost to Follow-up|2|||
163906589|NCT00403494|592029339|FG000|Overall Study|Protocol noncompliance|0|||
163906590|NCT00403494|592029340|FG001|Overall Study|Protocol noncompliance|1|||
163906591|NCT00403494|592029339|FG000|Overall Study|Death|1|||
163906592|NCT00403494|592029340|FG001|Overall Study|Death|0|||
163906593|NCT00403494|592029339|FG000|Overall Study|Sponsor Request|1|||
163906594|NCT00403494|592029340|FG001|Overall Study|Sponsor Request|0|||
163906595|NCT05005247|592029341|FG000|Overall Study|Withdrawal by Subject|0|||
163906596|NCT05005247|592029342|FG001|Overall Study|Withdrawal by Subject|1|||
163906597|NCT05005247|592029343|FG002|Overall Study|Withdrawal by Subject|0|||
164093685|NCT05037097|592707273|FG004|Overall Study|Withdrawal by Subject|0|||
164093686|NCT05037097|592707274|FG005|Overall Study|Withdrawal by Subject|2|||
164093687|NCT05037097|592707275|FG006|Overall Study|Withdrawal by Subject|0|||
164093688|NCT05037097|592707276|FG007|Overall Study|Withdrawal by Subject|0|||
164093689|NCT05037097|592707269|FG000|Overall Study|Lost to Follow-up|0|||
164093690|NCT05037097|592707270|FG001|Overall Study|Lost to Follow-up|1|||
164093691|NCT05037097|592707271|FG002|Overall Study|Lost to Follow-up|0|||
164093692|NCT05037097|592707272|FG003|Overall Study|Lost to Follow-up|0|||
164093693|NCT05037097|592707273|FG004|Overall Study|Lost to Follow-up|1|||
164093694|NCT05037097|592707274|FG005|Overall Study|Lost to Follow-up|1|||
164093695|NCT05037097|592707275|FG006|Overall Study|Lost to Follow-up|0|||
164093696|NCT05037097|592707276|FG007|Overall Study|Lost to Follow-up|0|||
164093697|NCT02918877|592707277|FG000|Overall Study|Withdrawal by Subject|2|||
164093698|NCT02918877|592707278|FG001|Overall Study|Withdrawal by Subject|2|||
164093699|NCT02918877|592707277|FG000|Overall Study|Surgery cancelled|1|||
164093700|NCT02918877|592707278|FG001|Overall Study|Surgery cancelled|0|||
164093701|NCT02918877|592707277|FG000|Overall Study|Physician Decision|1|||
164093702|NCT02918877|592707278|FG001|Overall Study|Physician Decision|0|||
164093703|NCT02918877|592707277|FG000|Overall Study|Received intraoperative steroids|1|||
164093704|NCT02918877|592707278|FG001|Overall Study|Received intraoperative steroids|0|||
164093705|NCT02918877|592707277|FG000|Overall Study|Unable to obtain lab samples|1|||
164093706|NCT02918877|592707278|FG001|Overall Study|Unable to obtain lab samples|0|||
164093707|NCT02918877|592707277|FG000|Overall Study|Unsafe to perform BAL|0|||
164093708|NCT02918877|592707278|FG001|Overall Study|Unsafe to perform BAL|1|||
164093709|NCT04510857|592707279|FG000|Overall Study|Withdrawal by Subject|1|||
164093710|NCT04510857|592707280|FG001|Overall Study|Withdrawal by Subject|2|||
164093711|NCT05346055|592707281|FG000|Overall Study|Withdrawal by Subject|1|||
164093712|NCT05346055|592707281|FG000|Overall Study|Protocol Violation|1|||
164093713|NCT05346055|592707281|FG000|Overall Study|Therapist decision|1|||
164093714|NCT00376220|592707282|FG000|Overall Study|Lost to Follow-up|7|||
164093715|NCT00376220|592707283|FG001|Overall Study|Lost to Follow-up|10|||
164093716|NCT00376220|592707282|FG000|Overall Study|Withdrawal by Subject|3|||
164093717|NCT00376220|592707283|FG001|Overall Study|Withdrawal by Subject|2|||
164093718|NCT02564263|592707284|FG000|Overall Study|Adverse Event|31|||
164093719|NCT02564263|592707285|FG001|Overall Study|Adverse Event|29|||
164093720|NCT02564263|592707284|FG000|Overall Study|Death|270|||
164093721|NCT02564263|592707285|FG001|Overall Study|Death|262|||
164093722|NCT02564263|592707284|FG000|Overall Study|Withdrawal by Subject|4|||
164093723|NCT02564263|592707285|FG001|Overall Study|Withdrawal by Subject|19|||
164093724|NCT02564263|592707284|FG000|Overall Study|Sponsor's decision|9|||
164093725|NCT02564263|592707285|FG001|Overall Study|Sponsor's decision|4|||
164093726|NCT02906709|592707286|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
164093727|NCT02906709|592707287|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
164093728|NCT02906709|592707286|FG000|Phase A (Week 0 to Week 16)|Death|0|||
164093729|NCT02906709|592707287|FG001|Phase A (Week 0 to Week 16)|Death|1|||
164093730|NCT02906709|592707286|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
164093731|NCT02906709|592707287|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
164093732|NCT02906709|592707286|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
164093733|NCT02906709|592707287|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
164093734|NCT00977106|592707288|FG000|Overall Study|Adverse Event|5|||
164093735|NCT00977106|592707289|FG001|Overall Study|Adverse Event|6|||
164093736|NCT00977106|592707288|FG000|Overall Study|Withdrawal by Subject|2|||
164093737|NCT00977106|592707289|FG001|Overall Study|Withdrawal by Subject|2|||
164093738|NCT00977106|592707288|FG000|Overall Study|Lack of Efficacy|2|||
164093739|NCT00977106|592707289|FG001|Overall Study|Lack of Efficacy|2|||
164093740|NCT00977106|592707288|FG000|Overall Study|Protocol Violation|0|||
164093741|NCT00977106|592707289|FG001|Overall Study|Protocol Violation|1|||
164093742|NCT00977106|592707288|FG000|Overall Study|Other|1|||
164093743|NCT00977106|592707289|FG001|Overall Study|Other|0|||
164093744|NCT02419313|592707290|FG000|First Intervention|Lost to Follow-up|2|||
164093745|NCT02419313|592707291|FG001|First Intervention|Lost to Follow-up|0|||
164093746|NCT02419313|592707290|FG000|Second Intervention|Lost to Follow-up|1|||
163906598|NCT03648541|592029344|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
163906599|NCT03648541|592029345|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
163906600|NCT03648541|592029344|FG000|Re-induction Period Only|Lack of Efficacy|7|||
163906601|NCT03648541|592029345|FG001|Re-induction Period Only|Lack of Efficacy|0|||
163906602|NCT03648541|592029344|FG000|Maintenance Period Only|Missing|0|||
163906603|NCT03648541|592029345|FG001|Maintenance Period Only|Missing|1|||
163906604|NCT03648541|592029344|FG000|Maintenance Period Only|Other not listed below|0|||
163906605|NCT03648541|592029345|FG001|Maintenance Period Only|Other not listed below|4|||
163906606|NCT03648541|592029344|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
163906607|NCT03648541|592029345|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
163906608|NCT03648541|592029344|FG000|Maintenance Period Only|Protocol Violation|0|||
163906609|NCT03648541|592029345|FG001|Maintenance Period Only|Protocol Violation|1|||
163906610|NCT03648541|592029344|FG000|Maintenance Period Only|Lack of Efficacy|0|||
164017812|NCT02918266|592428628|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
164017813|NCT02918266|592428629|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017814|NCT02918266|592428630|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
164017815|NCT00788775|592428633|FG000|Overall Study|Progressive Disease|8|||
164017816|NCT00788775|592428634|FG001|Overall Study|Progressive Disease|6|||
164017817|NCT00788775|592428633|FG000|Overall Study|Withdrawal by Subject|0|||
164017818|NCT00788775|592428634|FG001|Overall Study|Withdrawal by Subject|2|||
164017819|NCT00788775|592428633|FG000|Overall Study|Patient Non-Compliance|1|||
164017820|NCT00788775|592428634|FG001|Overall Study|Patient Non-Compliance|0|||
164017821|NCT00788775|592428633|FG000|Overall Study|Patient's measurable disease resected.|1|||
164017822|NCT00788775|592428634|FG001|Overall Study|Patient's measurable disease resected.|0|||
164017823|NCT01293032|592428638|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
164017824|NCT01293032|592428639|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
164017825|NCT01293032|592428640|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
164017826|NCT01293032|592428641|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
164017827|NCT01293032|592428638|FG000|Treatment|Adverse Event|0|||
164017828|NCT01293032|592428639|FG001|Treatment|Adverse Event|0|||
164017829|NCT01293032|592428640|FG002|Treatment|Adverse Event|1|||
164017830|NCT01293032|592428641|FG003|Treatment|Adverse Event|1|||
164017831|NCT01293032|592428638|FG000|Treatment|Withdrawal by Subject|2|||
164017832|NCT01293032|592428639|FG001|Treatment|Withdrawal by Subject|4|||
163906611|NCT03648541|592029345|FG001|Maintenance Period Only|Lack of Efficacy|18|||
163906612|NCT03648541|592029344|FG000|Maintenance Period Only|Adverse Event|0|||
163906613|NCT03648541|592029345|FG001|Maintenance Period Only|Adverse Event|4|||
163906614|NCT03648541|592029344|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
163906615|NCT03648541|592029345|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
163906616|NCT03490032|592029348|FG000|Overall Study|family issue (child custody)|1|||
163906617|NCT03490032|592029349|FG001|Overall Study|family issue (child custody)|0|||
163906618|NCT03490032|592029350|FG002|Overall Study|family issue (child custody)|0|||
163906619|NCT00487240|592029353|FG000|Overall Study|Withdrawal by Subject|12|||
163906620|NCT00487240|592029354|FG001|Overall Study|Withdrawal by Subject|6|||
163906621|NCT00487240|592029353|FG000|Overall Study|Lost to Follow-up|7|||
163906622|NCT00487240|592029354|FG001|Overall Study|Lost to Follow-up|6|||
163906623|NCT00487240|592029353|FG000|Overall Study|Adverse Event|0|||
163906624|NCT00487240|592029354|FG001|Overall Study|Adverse Event|4|||
163906625|NCT00487240|592029353|FG000|Overall Study|Protocol Violation|5|||
163906626|NCT00487240|592029354|FG001|Overall Study|Protocol Violation|5|||
163906627|NCT00487240|592029353|FG000|Overall Study|Entry Criteria Not Met|3|||
163906628|NCT00487240|592029354|FG001|Overall Study|Entry Criteria Not Met|4|||
163906629|NCT00487240|592029353|FG000|Overall Study|Sponsor Decision|2|||
163906630|NCT00487240|592029354|FG001|Overall Study|Sponsor Decision|1|||
163906631|NCT00487240|592029353|FG000|Overall Study|Physician Decision|2|||
163906632|NCT00487240|592029354|FG001|Overall Study|Physician Decision|0|||
163906633|NCT01858688|592029355|FG000|Overall Study|Withdrawal by Subject|8|||
163906634|NCT01858688|592029355|FG000|Overall Study|Participant began another therapy|3|||
163906635|NCT01858688|592029355|FG000|Overall Study|Physician Decision|2|||
163906636|NCT01858688|592029355|FG000|Overall Study|Progressive Disease|2|||
163906637|NCT01858688|592029355|FG000|Overall Study|Reason not reproted|5|||
163906638|NCT04248868|592029356|FG000|Overall Study|Death|1|||
163906639|NCT04248868|592029356|FG000|Overall Study|Lost to Follow-up|3|||
163906640|NCT04248868|592029356|FG000|Overall Study|Protocol Violation|2|||
163906641|NCT01074242|592029364|FG000|Overall Study|Case report before date of contract|40|||
163906642|NCT01074242|592029364|FG000|Overall Study|Lost to Follow-up|1|||
163906643|NCT01074242|592029364|FG000|Overall Study|Case report unclear|6|||
163906644|NCT01074242|592029364|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
163906645|NCT01074242|592029364|FG000|Overall Study|Duplicate Case Report Form|5|||
163906646|NCT01957163|592029365|FG000|Overall Study|Adverse Event|5|||
163906647|NCT01957163|592029366|FG001|Overall Study|Adverse Event|2|||
163906648|NCT01957163|592029367|FG002|Overall Study|Adverse Event|4|||
163906649|NCT01957163|592029365|FG000|Overall Study|Lack of Efficacy|5|||
163906650|NCT01957163|592029366|FG001|Overall Study|Lack of Efficacy|4|||
163906651|NCT01957163|592029367|FG002|Overall Study|Lack of Efficacy|9|||
163906652|NCT01957163|592029365|FG000|Overall Study|Protocol Violation|1|||
163906653|NCT01957163|592029366|FG001|Overall Study|Protocol Violation|2|||
163906654|NCT01957163|592029367|FG002|Overall Study|Protocol Violation|0|||
163906655|NCT01957163|592029365|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
163906656|NCT01957163|592029366|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
163906657|NCT01957163|592029367|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
163906658|NCT01957163|592029365|FG000|Overall Study|Lost to Follow-up|0|||
163906659|NCT01957163|592029366|FG001|Overall Study|Lost to Follow-up|1|||
163906660|NCT01957163|592029367|FG002|Overall Study|Lost to Follow-up|0|||
163906661|NCT01957163|592029365|FG000|Overall Study|Withdrawal by Subject|4|||
163906662|NCT01957163|592029366|FG001|Overall Study|Withdrawal by Subject|2|||
163906663|NCT01957163|592029367|FG002|Overall Study|Withdrawal by Subject|4|||
163906664|NCT03822832|592029372|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
163906665|NCT03822832|592029373|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
163906666|NCT03822832|592029372|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
163906667|NCT03822832|592029373|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
163906668|NCT03822832|592029372|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
163906669|NCT03822832|592029373|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
163906670|NCT03822832|592029372|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
163906671|NCT03822832|592029373|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
163906672|NCT03822832|592029372|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
163906673|NCT03822832|592029373|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
163906674|NCT03822832|592029372|FG000|Re-allocation|Not re-allocated to open label period|2|||
163906675|NCT03822832|592029373|FG001|Re-allocation|Not re-allocated to open label period|6|||
163906676|NCT03822832|592029372|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
163906677|NCT03822832|592029373|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
163906678|NCT03822832|592029372|FG000|Period 2 - Open Label Period|Adverse Event|0|||
163906679|NCT03822832|592029373|FG001|Period 2 - Open Label Period|Adverse Event|3|||
163906680|NCT01668719|592029374|FG000|Phase I|On treatment|1|||
163906681|NCT01668719|592029375|FG001|Phase I|On treatment|0|||
163906682|NCT01668719|592029376|FG002|Phase I|On treatment|0|||
163906683|NCT01668719|592029374|FG000|Phase I|Adverse Event|2|||
164093747|NCT02419313|592707291|FG001|Second Intervention|Lost to Follow-up|0|||
164093748|NCT00322491|592707298|FG000|Overall Study|Adverse Event|1|||
164093749|NCT00322491|592707299|FG001|Overall Study|Adverse Event|0|||
164093750|NCT00322491|592707298|FG000|Overall Study|Death|1|||
164093751|NCT00322491|592707299|FG001|Overall Study|Death|2|||
164093752|NCT00688064|592707300|FG000|Overall Study|Protocol Violation|0|||
164093753|NCT00688064|592707301|FG001|Overall Study|Protocol Violation|1|||
164093754|NCT00688064|592707300|FG000|Overall Study|Adverse Event|2|||
164093755|NCT00688064|592707301|FG001|Overall Study|Adverse Event|4|||
164093756|NCT00688064|592707300|FG000|Overall Study|Withdrawal by Subject|7|||
164093757|NCT00688064|592707301|FG001|Overall Study|Withdrawal by Subject|7|||
164093758|NCT00688064|592707300|FG000|Overall Study|Lost to Follow-up|10|||
164093759|NCT00688064|592707301|FG001|Overall Study|Lost to Follow-up|10|||
164093760|NCT00688064|592707300|FG000|Overall Study|Lack of Efficacy|0|||
164093761|NCT00688064|592707301|FG001|Overall Study|Lack of Efficacy|1|||
164093762|NCT00688064|592707300|FG000|Overall Study|Pregnancy|1|||
164093763|NCT00688064|592707301|FG001|Overall Study|Pregnancy|0|||
164093764|NCT00688064|592707300|FG000|Overall Study|Any other reasons|1|||
164093765|NCT00688064|592707301|FG001|Overall Study|Any other reasons|3|||
164093766|NCT00524459|592707305|FG000|Overall Study|Withdrawal by Subject|1|||
164093767|NCT00524459|592707305|FG000|Overall Study|Other|1|||
164093768|NCT00728949|592707306|FG000|Overall Study|Adverse Event|8|||
164093769|NCT00728949|592707307|FG001|Overall Study|Adverse Event|0|||
164093770|NCT00728949|592707306|FG000|Overall Study|Withdrawal by Subject|2|||
164093771|NCT00728949|592707307|FG001|Overall Study|Withdrawal by Subject|2|||
164093772|NCT00728949|592707306|FG000|Overall Study|Abnormal Lab Results|0|||
164093773|NCT00728949|592707307|FG001|Overall Study|Abnormal Lab Results|2|||
164093774|NCT00728949|592707306|FG000|Overall Study|On treatment at cutoff date|1|||
164093775|NCT00728949|592707307|FG001|Overall Study|On treatment at cutoff date|0|||
164093776|NCT02319148|592707312|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
164093777|NCT02319148|592707313|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
164093778|NCT02319148|592707314|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
164093779|NCT02319148|592707315|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
164093780|NCT02319148|592707312|FG000|Second Intervention Period|No longer willing to participate|0|||
164093781|NCT02319148|592707313|FG001|Second Intervention Period|No longer willing to participate|1|||
164093782|NCT02319148|592707314|FG002|Second Intervention Period|No longer willing to participate|0|||
163906684|NCT01668719|592029375|FG001|Phase I|Adverse Event|0|||
163906685|NCT01668719|592029376|FG002|Phase I|Adverse Event|0|||
163906686|NCT01668719|592029374|FG000|Phase I|Progression/relapse|1|||
164093783|NCT02319148|592707315|FG003|Second Intervention Period|No longer willing to participate|0|||
164093784|NCT02319148|592707312|FG000|Second Intervention Period|Other|0|||
163906687|NCT01668719|592029375|FG001|Phase I|Progression/relapse|0|||
164093785|NCT02319148|592707313|FG001|Second Intervention Period|Other|0|||
164093786|NCT02319148|592707314|FG002|Second Intervention Period|Other|0|||
164093787|NCT02319148|592707315|FG003|Second Intervention Period|Other|1|||
164093788|NCT01574248|592707316|FG000|Overall Study|Withdrawal by Subject|2|||
164093789|NCT01574248|592707317|FG001|Overall Study|Withdrawal by Subject|0|||
164093790|NCT01574248|592707316|FG000|Overall Study|Missing primary endpoint data|1|||
164093791|NCT01574248|592707317|FG001|Overall Study|Missing primary endpoint data|0|||
164093792|NCT00048048|592707320|FG000|Core Treatment|Withdrawal by Subject|0|||
164093793|NCT00048048|592707321|FG001|Core Treatment|Withdrawal by Subject|0|||
164093794|NCT00048048|592707322|FG002|Core Treatment|Withdrawal by Subject|1|||
164093795|NCT00048048|592707323|FG003|Core Treatment|Withdrawal by Subject|0|||
164093796|NCT00048048|592707324|FG004|Core Treatment|Withdrawal by Subject|0|||
164093797|NCT00048048|592707325|FG005|Core Treatment|Withdrawal by Subject|0|||
164093798|NCT00048048|592707326|FG006|Core Treatment|Withdrawal by Subject|0|||
164093799|NCT00048048|592707327|FG007|Core Treatment|Withdrawal by Subject|0|||
164093800|NCT00048048|592707328|FG008|Core Treatment|Withdrawal by Subject|0|||
164093801|NCT00048048|592707329|FG009|Core Treatment|Withdrawal by Subject|0|||
164093802|NCT00048048|592707330|FG010|Core Treatment|Withdrawal by Subject|0|||
164093803|NCT00048048|592707331|FG011|Core Treatment|Withdrawal by Subject|0|||
164093804|NCT00048048|592707320|FG000|Core Treatment|Adverse Event|0|||
164093805|NCT00048048|592707321|FG001|Core Treatment|Adverse Event|0|||
164093806|NCT00048048|592707322|FG002|Core Treatment|Adverse Event|0|||
164093807|NCT00048048|592707323|FG003|Core Treatment|Adverse Event|0|||
164093808|NCT00048048|592707324|FG004|Core Treatment|Adverse Event|0|||
164093809|NCT00048048|592707325|FG005|Core Treatment|Adverse Event|0|||
164093810|NCT00048048|592707326|FG006|Core Treatment|Adverse Event|0|||
164093811|NCT00048048|592707327|FG007|Core Treatment|Adverse Event|1|||
164093812|NCT00048048|592707328|FG008|Core Treatment|Adverse Event|0|||
164093813|NCT00048048|592707329|FG009|Core Treatment|Adverse Event|0|||
164093814|NCT00048048|592707330|FG010|Core Treatment|Adverse Event|0|||
164093815|NCT00048048|592707331|FG011|Core Treatment|Adverse Event|0|||
164093816|NCT00048048|592707320|FG000|Extension Year 1|Early withdrawals|0|||
164093817|NCT00048048|592707321|FG001|Extension Year 1|Early withdrawals|0|||
164093818|NCT00048048|592707322|FG002|Extension Year 1|Early withdrawals|0|||
164093819|NCT00048048|592707323|FG003|Extension Year 1|Early withdrawals|0|||
164093820|NCT00048048|592707324|FG004|Extension Year 1|Early withdrawals|0|||
164093821|NCT00048048|592707325|FG005|Extension Year 1|Early withdrawals|0|||
164093822|NCT00048048|592707326|FG006|Extension Year 1|Early withdrawals|0|||
164093823|NCT00048048|592707327|FG007|Extension Year 1|Early withdrawals|0|||
164093824|NCT00048048|592707328|FG008|Extension Year 1|Early withdrawals|0|||
164093825|NCT00048048|592707329|FG009|Extension Year 1|Early withdrawals|2|||
164093826|NCT00048048|592707330|FG010|Extension Year 1|Early withdrawals|2|||
164093827|NCT00048048|592707331|FG011|Extension Year 1|Early withdrawals|4|||
164093828|NCT00048048|592707320|FG000|Extension Year 2|Early withdrawals|0|||
164093829|NCT00048048|592707321|FG001|Extension Year 2|Early withdrawals|0|||
164093830|NCT00048048|592707322|FG002|Extension Year 2|Early withdrawals|0|||
164093831|NCT00048048|592707323|FG003|Extension Year 2|Early withdrawals|0|||
164093832|NCT00048048|592707324|FG004|Extension Year 2|Early withdrawals|0|||
164093833|NCT00048048|592707325|FG005|Extension Year 2|Early withdrawals|0|||
164093834|NCT00048048|592707326|FG006|Extension Year 2|Early withdrawals|0|||
164093835|NCT00048048|592707327|FG007|Extension Year 2|Early withdrawals|0|||
164093836|NCT00048048|592707328|FG008|Extension Year 2|Early withdrawals|0|||
164093837|NCT00048048|592707329|FG009|Extension Year 2|Early withdrawals|0|||
164093838|NCT00048048|592707330|FG010|Extension Year 2|Early withdrawals|4|||
164093839|NCT00048048|592707331|FG011|Extension Year 2|Early withdrawals|2|||
164093840|NCT01345019|592707350|FG000|Blinded Treatment Phase|Death|147|||
164093841|NCT01345019|592707351|FG001|Blinded Treatment Phase|Death|137|||
164093842|NCT01345019|592707350|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
164093843|NCT01345019|592707351|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
164093844|NCT01345019|592707350|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
164093845|NCT01345019|592707351|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
164093846|NCT01345019|592707350|FG000|Blinded Treatment Phase|Disease Progression|12|||
164093847|NCT01345019|592707351|FG001|Blinded Treatment Phase|Disease Progression|10|||
164093848|NCT01345019|592707350|FG000|Blinded Treatment Phase|Adverse Event|6|||
164093849|NCT01345019|592707351|FG001|Blinded Treatment Phase|Adverse Event|13|||
164093850|NCT01345019|592707350|FG000|Blinded Treatment Phase|Administrative Decision|10|||
164093851|NCT01345019|592707351|FG001|Blinded Treatment Phase|Administrative Decision|8|||
164093852|NCT01345019|592707350|FG000|Blinded Treatment Phase|Noncompliance|5|||
164093853|NCT01345019|592707351|FG001|Blinded Treatment Phase|Noncompliance|3|||
164093854|NCT01345019|592707350|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
164093855|NCT01345019|592707351|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
164093856|NCT01345019|592707350|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
164093857|NCT01345019|592707351|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
164093858|NCT01345019|592707350|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
164093859|NCT01345019|592707351|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
164093860|NCT01345019|592707350|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
164093861|NCT01345019|592707351|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
164093862|NCT01345019|592707350|FG000|Open Label Treatment Phase|Death|49|||
164093863|NCT01345019|592707351|FG001|Open Label Treatment Phase|Death|48|||
164093864|NCT01345019|592707350|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
164017833|NCT01293032|592428640|FG002|Treatment|Withdrawal by Subject|0|||
164017834|NCT01293032|592428641|FG003|Treatment|Withdrawal by Subject|0|||
164017835|NCT01293032|592428638|FG000|Treatment|Disease Progression, relapse|0|||
164017836|NCT01293032|592428639|FG001|Treatment|Disease Progression, relapse|1|||
164017837|NCT01293032|592428640|FG002|Treatment|Disease Progression, relapse|0|||
164017838|NCT01293032|592428641|FG003|Treatment|Disease Progression, relapse|0|||
164017839|NCT01253044|592428642|FG000|Overall Study|Lost to Follow-up|38|||
164017840|NCT01253044|592428643|FG001|Overall Study|Lost to Follow-up|29|||
164017841|NCT03116399|592428646|FG000|Overall Study|Death|8|||
164017842|NCT03116399|592428647|FG001|Overall Study|Death|3|||
164017843|NCT03116399|592428646|FG000|Overall Study|Lost to Follow-up|7|||
164017844|NCT03116399|592428647|FG001|Overall Study|Lost to Follow-up|11|||
164017845|NCT03116399|592428646|FG000|Overall Study|Investigator Decision|1|||
164017846|NCT03116399|592428647|FG001|Overall Study|Investigator Decision|1|||
164017847|NCT03116399|592428646|FG000|Overall Study|Withdrawal by Subject|24|||
164017848|NCT03116399|592428647|FG001|Overall Study|Withdrawal by Subject|9|||
164017849|NCT00987623|592428648|FG000|Overall Study|Lost to Follow-up|2|||
164017850|NCT00987623|592428649|FG001|Overall Study|Lost to Follow-up|1|||
164017851|NCT00987623|592428648|FG000|Overall Study|Time/job conflict|2|||
164017852|NCT00987623|592428649|FG001|Overall Study|Time/job conflict|0|||
164017853|NCT00987623|592428648|FG000|Overall Study|Discomfort|1|||
164017854|NCT00987623|592428649|FG001|Overall Study|Discomfort|0|||
164017855|NCT00987623|592428648|FG000|Overall Study|Biomicroscopy|0|||
164017856|NCT00987623|592428649|FG001|Overall Study|Biomicroscopy|1|||
164017857|NCT00987623|592428648|FG000|Overall Study|Influenza|0|||
164017858|NCT00987623|592428649|FG001|Overall Study|Influenza|1|||
164017859|NCT04488822|592428650|FG000|Overall Study|Adverse Event|8|||
164017860|NCT04488822|592428650|FG000|Overall Study|Withdrawal by Subject|1|||
164017861|NCT03838367|592428651|FG000|Overall Study|Early termination of study|3|||
164017862|NCT03838367|592428652|FG001|Overall Study|Early termination of study|4|||
164017863|NCT03838367|592428653|FG002|Overall Study|Early termination of study|3|||
164017864|NCT03838367|592428654|FG003|Overall Study|Early termination of study|0|||
164017865|NCT00195260|592428667|FG000|Part 1: Dose Escalation|Adverse Event|0|||
164017866|NCT00195260|592428668|FG001|Part 1: Dose Escalation|Adverse Event|1|||
164017867|NCT00195260|592428669|FG002|Part 1: Dose Escalation|Adverse Event|0|||
164017868|NCT00195260|592428670|FG003|Part 1: Dose Escalation|Adverse Event|1|||
164017869|NCT00195260|592428671|FG004|Part 1: Dose Escalation|Adverse Event|1|||
164017870|NCT00195260|592428672|FG005|Part 1: Dose Escalation|Adverse Event|0|||
164017871|NCT00195260|592428673|FG006|Part 1: Dose Escalation|Adverse Event|3|||
164017872|NCT00195260|592428674|FG007|Part 1: Dose Escalation|Adverse Event|0|||
164017873|NCT00195260|592428675|FG008|Part 1: Dose Escalation|Adverse Event|0|||
164017874|NCT00195260|592428676|FG009|Part 1: Dose Escalation|Adverse Event|0|||
164017875|NCT00195260|592428677|FG010|Part 1: Dose Escalation|Adverse Event|0|||
164017876|NCT00195260|592428667|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017877|NCT00195260|592428668|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017878|NCT00195260|592428669|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017879|NCT00195260|592428670|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017880|NCT00195260|592428671|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
164017881|NCT00195260|592428672|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017882|NCT00195260|592428673|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017883|NCT00195260|592428674|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
164017884|NCT00195260|592428675|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017885|NCT00195260|592428676|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017886|NCT00195260|592428677|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
164017887|NCT00195260|592428667|FG000|Part 1: Dose Escalation|Death|0|||
164017888|NCT00195260|592428668|FG001|Part 1: Dose Escalation|Death|0|||
164017889|NCT00195260|592428669|FG002|Part 1: Dose Escalation|Death|0|||
164017890|NCT00195260|592428670|FG003|Part 1: Dose Escalation|Death|0|||
164017891|NCT00195260|592428671|FG004|Part 1: Dose Escalation|Death|0|||
164017892|NCT00195260|592428672|FG005|Part 1: Dose Escalation|Death|0|||
164017893|NCT00195260|592428673|FG006|Part 1: Dose Escalation|Death|0|||
164017894|NCT00195260|592428674|FG007|Part 1: Dose Escalation|Death|1|||
164017895|NCT00195260|592428675|FG008|Part 1: Dose Escalation|Death|0|||
164017896|NCT00195260|592428676|FG009|Part 1: Dose Escalation|Death|0|||
164017897|NCT00195260|592428677|FG010|Part 1: Dose Escalation|Death|0|||
164017898|NCT00195260|592428667|FG000|Part 1: Dose Escalation|Disease Progression|3|||
164017899|NCT00195260|592428668|FG001|Part 1: Dose Escalation|Disease Progression|2|||
164093865|NCT01345019|592707351|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
164093866|NCT01345019|592707350|FG000|Open Label Treatment Phase|Adverse Event|30|||
164093867|NCT01345019|592707351|FG001|Open Label Treatment Phase|Adverse Event|51|||
164093868|NCT01345019|592707350|FG000|Open Label Treatment Phase|Administrative Decision|30|||
164093869|NCT01345019|592707351|FG001|Open Label Treatment Phase|Administrative Decision|15|||
164093870|NCT01345019|592707350|FG000|Open Label Treatment Phase|Disease Progression|17|||
164093871|NCT01345019|592707351|FG001|Open Label Treatment Phase|Disease Progression|18|||
164093872|NCT01345019|592707350|FG000|Open Label Treatment Phase|Noncompliance|5|||
164093873|NCT01345019|592707351|FG001|Open Label Treatment Phase|Noncompliance|4|||
164093874|NCT01345019|592707350|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
164093875|NCT01345019|592707351|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
164093876|NCT01345019|592707350|FG000|Open Label Treatment Phase|Pregnancy|1|||
164093877|NCT01345019|592707351|FG001|Open Label Treatment Phase|Pregnancy|0|||
164093878|NCT01345019|592707350|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
164093879|NCT01345019|592707351|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
164093880|NCT01345019|592707350|FG000|Open Label Treatment Phase|Protocol Violation|0|||
164093881|NCT01345019|592707351|FG001|Open Label Treatment Phase|Protocol Violation|1|||
164093882|NCT03130699|592707361|FG000|Overall Study|Lost to Follow-up|34|||
164093883|NCT03130699|592707362|FG001|Overall Study|Lost to Follow-up|37|||
164093884|NCT03130699|592707363|FG002|Overall Study|Lost to Follow-up|26|||
164093885|NCT03130699|592707361|FG000|Overall Study|Withdrawal by Subject|5|||
164093886|NCT03130699|592707362|FG001|Overall Study|Withdrawal by Subject|1|||
164093887|NCT03130699|592707363|FG002|Overall Study|Withdrawal by Subject|0|||
164093888|NCT03130699|592707361|FG000|Overall Study|Withdrawal by PI|1|||
164093889|NCT03130699|592707362|FG001|Overall Study|Withdrawal by PI|2|||
164093890|NCT03130699|592707363|FG002|Overall Study|Withdrawal by PI|5|||
164093891|NCT03130699|592707361|FG000|Overall Study|Death|0|||
164093892|NCT03130699|592707362|FG001|Overall Study|Death|0|||
164093893|NCT03130699|592707363|FG002|Overall Study|Death|1|||
164093894|NCT04534283|592707364|FG000|Overall Study|Physician Decision|2|||
164093895|NCT04534283|592707364|FG000|Overall Study|Withdrawal by Subject|1|||
164093896|NCT04534283|592707364|FG000|Overall Study|Disease Progression|12|||
164093897|NCT04534283|592707364|FG000|Overall Study|Adverse Event|1|||
164093898|NCT00661505|592707365|FG000|Overall Study|Adverse Event|3|||
164093899|NCT00661505|592707365|FG000|Overall Study|Protocol Violation|14|||
164093900|NCT00661505|592707365|FG000|Overall Study|Withdrawal by Subject|8|||
164093901|NCT00661505|592707365|FG000|Overall Study|Lost to Follow-up|3|||
164093902|NCT00661505|592707365|FG000|Overall Study|Other|2|||
164093903|NCT05956665|592707366|FG000|Overall Study|Death|1|||
164093904|NCT05956665|592707366|FG000|Overall Study|Withdrawal by Subject|1|||
164093905|NCT00977470|592707367|FG000|Overall Study|Lack of Efficacy|32|||
164093906|NCT00977470|592707368|FG001|Overall Study|Lack of Efficacy|30|||
164093907|NCT00977470|592707367|FG000|Overall Study|Physician Decision|2|||
164093908|NCT00977470|592707368|FG001|Overall Study|Physician Decision|0|||
164093909|NCT00977470|592707367|FG000|Overall Study|Adverse Event|1|||
164093910|NCT00977470|592707368|FG001|Overall Study|Adverse Event|2|||
164093911|NCT00977470|592707367|FG000|Overall Study|Protocol Violation|1|||
164093912|NCT00977470|592707368|FG001|Overall Study|Protocol Violation|0|||
164093913|NCT00977470|592707367|FG000|Overall Study|Withdrawal by Subject|0|||
164093914|NCT00977470|592707368|FG001|Overall Study|Withdrawal by Subject|2|||
164093915|NCT00977470|592707367|FG000|Overall Study|Death|0|||
164017900|NCT00195260|592428669|FG002|Part 1: Dose Escalation|Disease Progression|5|||
164017901|NCT00195260|592428670|FG003|Part 1: Dose Escalation|Disease Progression|6|||
164017902|NCT00195260|592428671|FG004|Part 1: Dose Escalation|Disease Progression|4|||
164017903|NCT00195260|592428672|FG005|Part 1: Dose Escalation|Disease Progression|6|||
164017904|NCT00195260|592428673|FG006|Part 1: Dose Escalation|Disease Progression|7|||
164017905|NCT00195260|592428674|FG007|Part 1: Dose Escalation|Disease Progression|4|||
164017906|NCT00195260|592428675|FG008|Part 1: Dose Escalation|Disease Progression|0|||
164017907|NCT00195260|592428676|FG009|Part 1: Dose Escalation|Disease Progression|0|||
164017908|NCT00195260|592428677|FG010|Part 1: Dose Escalation|Disease Progression|0|||
164017909|NCT00195260|592428667|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164017910|NCT00195260|592428668|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164017911|NCT00195260|592428669|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164017912|NCT00195260|592428670|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164093916|NCT00977470|592707368|FG001|Overall Study|Death|2|||
164093917|NCT00977470|592707367|FG000|Overall Study|clinical decline|0|||
164093918|NCT00977470|592707368|FG001|Overall Study|clinical decline|1|||
164093919|NCT00977470|592707367|FG000|Overall Study|prolonged recovery post-surgery|0|||
164093920|NCT00977470|592707368|FG001|Overall Study|prolonged recovery post-surgery|1|||
164017913|NCT00195260|592428671|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164093921|NCT00977470|592707367|FG000|Overall Study|Still on-study|2|||
164093922|NCT00977470|592707368|FG001|Overall Study|Still on-study|0|||
164093923|NCT03257462|592707371|FG000|Cohort A|Lost to Follow-up|1|||
164093924|NCT03257462|592707372|FG001|Cohort A|Lost to Follow-up|0|||
164093925|NCT03257462|592707373|FG002|Cohort A|Lost to Follow-up|0|||
164093926|NCT03257462|592707374|FG003|Cohort A|Lost to Follow-up|0|||
163906688|NCT01668719|592029376|FG002|Phase I|Progression/relapse|0|||
163906689|NCT01668719|592029374|FG000|Phase I|not protocol specified|2|||
163906690|NCT01668719|592029375|FG001|Phase I|not protocol specified|0|||
163906691|NCT01668719|592029376|FG002|Phase I|not protocol specified|0|||
163906692|NCT01668719|592029374|FG000|Phase II|On treatment|0|||
163906693|NCT01668719|592029375|FG001|Phase II|On treatment|4|||
163906694|NCT01668719|592029376|FG002|Phase II|On treatment|3|||
163906695|NCT01668719|592029374|FG000|Phase II|Adverse Event|0|||
163906696|NCT01668719|592029375|FG001|Phase II|Adverse Event|18|||
163906697|NCT01668719|592029376|FG002|Phase II|Adverse Event|18|||
163906698|NCT01668719|592029374|FG000|Phase II|Refusal unrelated to adverse event|0|||
163906699|NCT01668719|592029375|FG001|Phase II|Refusal unrelated to adverse event|4|||
163906700|NCT01668719|592029376|FG002|Phase II|Refusal unrelated to adverse event|1|||
163906701|NCT01668719|592029374|FG000|Phase II|Progression/relapse|0|||
163906702|NCT01668719|592029375|FG001|Phase II|Progression/relapse|13|||
163906703|NCT01668719|592029376|FG002|Phase II|Progression/relapse|17|||
163906704|NCT01668719|592029374|FG000|Phase II|Death|0|||
163906705|NCT01668719|592029375|FG001|Phase II|Death|0|||
163906706|NCT01668719|592029376|FG002|Phase II|Death|2|||
163906707|NCT01668719|592029374|FG000|Phase II|not protocol specified|0|||
163906708|NCT01668719|592029375|FG001|Phase II|not protocol specified|13|||
163906709|NCT01668719|592029376|FG002|Phase II|not protocol specified|7|||
163906710|NCT03539055|592029377|FG000|Overall Study|Death|4|||
163906711|NCT03539055|592029377|FG000|Overall Study|Lost to Follow-up|1|||
163906712|NCT03539055|592029377|FG000|Overall Study|Withdrawal by Subject|2|||
163906713|NCT03539055|592029377|FG000|Overall Study|Screen Fail|7|||
163906714|NCT03539055|592029377|FG000|Overall Study|Drug Intolerance|2|||
163906715|NCT01321073|592029379|FG000|Overall Study|Did not attempt implant|4|||
163906716|NCT01321073|592029379|FG000|Overall Study|Death|3|||
163906717|NCT01638000|592029380|FG000|Overall Study|Randomized but Never Received Drug|7|||
163906718|NCT01638000|592029381|FG001|Overall Study|Randomized but Never Received Drug|10|||
163906719|NCT01638000|592029380|FG000|Overall Study|Adverse Event|14|||
163906720|NCT01638000|592029381|FG001|Overall Study|Adverse Event|16|||
163906721|NCT01638000|592029380|FG000|Overall Study|Lack of Efficacy|5|||
163906722|NCT01638000|592029381|FG001|Overall Study|Lack of Efficacy|6|||
163906723|NCT01638000|592029380|FG000|Overall Study|Protocol Violation|11|||
163906724|NCT01638000|592029381|FG001|Overall Study|Protocol Violation|13|||
163906725|NCT01638000|592029380|FG000|Overall Study|Withdrawal by Subject|21|||
163906726|NCT01638000|592029381|FG001|Overall Study|Withdrawal by Subject|24|||
163906727|NCT01638000|592029380|FG000|Overall Study|Miscellaneous|2|||
163906728|NCT01638000|592029381|FG001|Overall Study|Miscellaneous|2|||
163906729|NCT04248803|592029382|FG000|Overall Study|Lost to Follow-up|7|||
163906730|NCT04248803|592029383|FG001|Overall Study|Lost to Follow-up|7|||
163906731|NCT04248803|592029384|FG002|Overall Study|Lost to Follow-up|7|||
163906732|NCT04248803|592029385|FG003|Overall Study|Lost to Follow-up|7|||
163906733|NCT04248803|592029386|FG004|Overall Study|Lost to Follow-up|7|||
163906734|NCT04248803|592029387|FG005|Overall Study|Lost to Follow-up|7|||
163906735|NCT02309294|592029390|FG000|Overall Study|Withdrawal by Subject|2|||
163906736|NCT01227421|592029391|FG000|Overall Study|Lost to Follow-up|6|||
163906737|NCT01227421|592029392|FG001|Overall Study|Lost to Follow-up|7|||
163906738|NCT01227421|592029393|FG002|Overall Study|Lost to Follow-up|5|||
163906739|NCT01227421|592029391|FG000|Overall Study|Adverse Event|2|||
163906740|NCT01227421|592029392|FG001|Overall Study|Adverse Event|7|||
163906741|NCT01227421|592029393|FG002|Overall Study|Adverse Event|2|||
163906742|NCT01227421|592029391|FG000|Overall Study|Withdrawal by Subject|1|||
163906743|NCT01227421|592029392|FG001|Overall Study|Withdrawal by Subject|2|||
163906744|NCT01227421|592029393|FG002|Overall Study|Withdrawal by Subject|1|||
163906745|NCT01227421|592029391|FG000|Overall Study|Protocol Violation|1|||
163906746|NCT01227421|592029392|FG001|Overall Study|Protocol Violation|1|||
163906747|NCT01227421|592029393|FG002|Overall Study|Protocol Violation|2|||
163906748|NCT01227421|592029391|FG000|Overall Study|Randomized in error|1|||
163906749|NCT01227421|592029392|FG001|Overall Study|Randomized in error|1|||
163906750|NCT01227421|592029393|FG002|Overall Study|Randomized in error|0|||
163906751|NCT01000805|592029397|FG000|Overall Study|Adverse Event|21|||
163906752|NCT01000805|592029398|FG001|Overall Study|Adverse Event|9|||
163906753|NCT01000805|592029397|FG000|Overall Study|Lack of Efficacy|5|||
164093927|NCT03257462|592707371|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
164093928|NCT03257462|592707372|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
164093929|NCT03257462|592707373|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
164093930|NCT03257462|592707374|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
164093931|NCT00796822|592707375|FG000|Overall Study|Lost to Follow-up|2|||
164093932|NCT00796822|592707376|FG001|Overall Study|Lost to Follow-up|0|||
164093933|NCT00796822|592707375|FG000|Overall Study|Adverse Event|1|||
164093934|NCT00796822|592707376|FG001|Overall Study|Adverse Event|0|||
164093935|NCT06354270|592707382|FG000|Overall Study|Withdrawal by Subject|1|||
164093936|NCT06354270|592707383|FG001|Overall Study|Withdrawal by Subject|0|||
164093937|NCT05097989|592707384|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093938|NCT05097989|592707385|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093939|NCT05097989|592707386|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093940|NCT05097989|592707387|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093941|NCT05097989|592707388|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093942|NCT05097989|592707389|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
164093943|NCT05097989|592707390|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093944|NCT05097989|592707391|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093945|NCT05097989|592707392|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
164093946|NCT05097989|592707384|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
164093947|NCT05097989|592707385|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
164093948|NCT05097989|592707386|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
164093949|NCT05097989|592707387|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
164093950|NCT05097989|592707388|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
164093951|NCT05097989|592707389|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
164093952|NCT05097989|592707390|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
164093953|NCT05097989|592707391|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
164093954|NCT05097989|592707392|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
164093955|NCT05097989|592707384|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164093956|NCT05097989|592707385|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164093957|NCT05097989|592707386|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164093958|NCT05097989|592707387|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164093959|NCT05097989|592707388|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164093960|NCT05097989|592707389|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
164093961|NCT05097989|592707390|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
164093962|NCT05097989|592707391|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
164093963|NCT05097989|592707392|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
164093964|NCT05097989|592707384|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164093965|NCT05097989|592707385|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164093966|NCT05097989|592707386|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164093967|NCT05097989|592707387|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164093968|NCT05097989|592707388|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164093969|NCT05097989|592707389|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
164093970|NCT05097989|592707390|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164093971|NCT05097989|592707391|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
163906754|NCT01000805|592029398|FG001|Overall Study|Lack of Efficacy|16|||
164093972|NCT05097989|592707392|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
164093973|NCT05097989|592707384|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
163906755|NCT01000805|592029397|FG000|Overall Study|Lost to Follow-up|16|||
164093974|NCT05097989|592707385|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093975|NCT05097989|592707386|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
164093976|NCT05097989|592707387|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093977|NCT05097989|592707388|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093978|NCT05097989|592707389|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093979|NCT05097989|592707390|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093980|NCT05097989|592707391|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093981|NCT05097989|592707392|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
164093982|NCT05097989|592707384|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093983|NCT05097989|592707385|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
164093984|NCT05097989|592707386|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093985|NCT05097989|592707387|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093986|NCT05097989|592707388|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093987|NCT05097989|592707389|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093988|NCT05097989|592707390|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093989|NCT05097989|592707391|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093990|NCT05097989|592707392|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
164093991|NCT05097989|592707384|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093992|NCT05097989|592707385|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093993|NCT05097989|592707386|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093994|NCT05097989|592707387|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093995|NCT05097989|592707388|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164093996|NCT05097989|592707389|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093997|NCT05097989|592707390|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093998|NCT05097989|592707391|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164093999|NCT05097989|592707392|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164094000|NCT05097989|592707384|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094001|NCT05097989|592707385|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094002|NCT05097989|592707386|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094003|NCT05097989|592707387|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094004|NCT05097989|592707388|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
164094005|NCT05097989|592707389|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094006|NCT05097989|592707390|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094007|NCT05097989|592707391|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094008|NCT05097989|592707392|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
164094009|NCT05097989|592707384|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164094010|NCT05097989|592707385|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
164094011|NCT05097989|592707386|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164094012|NCT05097989|592707387|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
163906756|NCT01000805|592029398|FG001|Overall Study|Lost to Follow-up|21|||
163906757|NCT01000805|592029397|FG000|Overall Study|Physician Decision|0|||
164094013|NCT05097989|592707388|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164094014|NCT05097989|592707389|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163906758|NCT01000805|592029398|FG001|Overall Study|Physician Decision|1|||
163906759|NCT01000805|592029397|FG000|Overall Study|Protocol Violation|12|||
163906760|NCT01000805|592029398|FG001|Overall Study|Protocol Violation|8|||
163906761|NCT01000805|592029397|FG000|Overall Study|Withdrawal by Subject|16|||
163906762|NCT01000805|592029398|FG001|Overall Study|Withdrawal by Subject|6|||
163906763|NCT01000805|592029397|FG000|Overall Study|Sponsor Decision|0|||
163906764|NCT01000805|592029398|FG001|Overall Study|Sponsor Decision|1|||
163906765|NCT03343704|592029401|FG000|Overall Study|Refused to complete follow up|0|||
164094015|NCT05097989|592707390|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164094016|NCT05097989|592707391|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164094017|NCT05097989|592707392|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164094018|NCT05097989|592707384|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
164094019|NCT05097989|592707385|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
164094020|NCT05097989|592707386|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
164094021|NCT05097989|592707387|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
164094022|NCT05097989|592707388|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
164094023|NCT05097989|592707389|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
164094024|NCT05097989|592707390|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
164094025|NCT05097989|592707391|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
164094026|NCT05097989|592707392|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
164094027|NCT05097989|592707384|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
164094028|NCT05097989|592707385|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
164094029|NCT05097989|592707386|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
164094030|NCT05097989|592707387|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
164094031|NCT05097989|592707388|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
164094032|NCT05097989|592707389|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
164094033|NCT05097989|592707390|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
164094034|NCT05097989|592707391|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
164094035|NCT05097989|592707392|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
164094036|NCT05097989|592707384|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094037|NCT05097989|592707385|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094038|NCT05097989|592707386|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094039|NCT05097989|592707387|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094040|NCT05097989|592707388|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
164094041|NCT05097989|592707389|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094042|NCT05097989|592707390|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094043|NCT05097989|592707391|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094044|NCT05097989|592707392|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
164094045|NCT05097989|592707384|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
164094046|NCT05097989|592707385|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
164094047|NCT05097989|592707386|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094048|NCT05097989|592707387|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094049|NCT05097989|592707388|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094050|NCT05097989|592707389|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094051|NCT05097989|592707390|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094052|NCT05097989|592707391|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094053|NCT05097989|592707392|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
164094054|NCT05097989|592707384|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
164094055|NCT05097989|592707385|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
164094056|NCT05097989|592707386|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
164094057|NCT05097989|592707387|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
164094058|NCT05097989|592707388|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
164094059|NCT05097989|592707389|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
164094060|NCT05097989|592707390|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
164094061|NCT05097989|592707391|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
164094062|NCT05097989|592707392|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
164094063|NCT00918567|592707401|FG000|Overall Study|Lack of Efficacy|3|||
164094064|NCT00918567|592707402|FG001|Overall Study|Lack of Efficacy|1|||
164094065|NCT00918567|592707401|FG000|Overall Study|Withdrawal by Subject|1|||
164094066|NCT00918567|592707402|FG001|Overall Study|Withdrawal by Subject|1|||
164094067|NCT00918567|592707401|FG000|Overall Study|Adverse Event|1|||
164094068|NCT00918567|592707402|FG001|Overall Study|Adverse Event|0|||
164094069|NCT03283709|592707405|FG000|Overall Study|trial terminated|0|||
164094070|NCT03283709|592707406|FG001|Overall Study|trial terminated|1|||
164094071|NCT05275998|592707407|FG000|Overall Study|Adverse Event|0|||
164094072|NCT05275998|592707408|FG001|Overall Study|Adverse Event|0|||
164094073|NCT05275998|592707409|FG002|Overall Study|Adverse Event|0|||
164094074|NCT05275998|592707410|FG003|Overall Study|Adverse Event|1|||
164094075|NCT05275998|592707407|FG000|Overall Study|Withdrawal by Subject|0|||
164094076|NCT05275998|592707408|FG001|Overall Study|Withdrawal by Subject|0|||
163906766|NCT03343704|592029402|FG001|Overall Study|Refused to complete follow up|1|||
163906767|NCT03343704|592029401|FG000|Overall Study|Death|0|||
164094077|NCT05275998|592707409|FG002|Overall Study|Withdrawal by Subject|0|||
164094078|NCT05275998|592707410|FG003|Overall Study|Withdrawal by Subject|1|||
164094079|NCT05275998|592707407|FG000|Overall Study|Physician Decision|0|||
164094080|NCT05275998|592707408|FG001|Overall Study|Physician Decision|0|||
164094081|NCT05275998|592707409|FG002|Overall Study|Physician Decision|0|||
164094082|NCT05275998|592707410|FG003|Overall Study|Physician Decision|1|||
164094083|NCT05275998|592707407|FG000|Overall Study|Protocol Violation|0|||
164094084|NCT05275998|592707408|FG001|Overall Study|Protocol Violation|0|||
164094085|NCT05275998|592707409|FG002|Overall Study|Protocol Violation|1|||
164094086|NCT05275998|592707410|FG003|Overall Study|Protocol Violation|0|||
164094087|NCT01936948|592707414|FG000|Overall Study|no 30-day follow-up data|0|||
164094088|NCT01936948|592707415|FG001|Overall Study|no 30-day follow-up data|3|||
164094089|NCT01936948|592707416|FG002|Overall Study|no 30-day follow-up data|3|||
164094090|NCT01936948|592707417|FG003|Overall Study|no 30-day follow-up data|3|||
164094091|NCT02327130|592707421|FG000|Overall Study|Discharged in less than 5 days|5|||
164094092|NCT02327130|592707421|FG000|Overall Study|Physician Decision|2|||
164094093|NCT02327130|592707421|FG000|Overall Study|Unable to provide breath sample|1|||
164094094|NCT02327130|592707421|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
164094095|NCT02327130|592707421|FG000|Overall Study|Met exclusion criteria|3|||
164094096|NCT04028843|592707423|FG000|Overall Study|Lost to Follow-up|32|||
164094097|NCT04028843|592707424|FG001|Overall Study|Lost to Follow-up|39|||
164094098|NCT04028843|592707423|FG000|Overall Study|Adverse Event|1|||
164094099|NCT04028843|592707424|FG001|Overall Study|Adverse Event|0|||
164094100|NCT04028843|592707423|FG000|Overall Study|Non-viable Pregnancy|0|||
164094101|NCT04028843|592707424|FG001|Overall Study|Non-viable Pregnancy|1|||
164094102|NCT04028843|592707423|FG000|Overall Study|Withdrawal by Subject|4|||
164094103|NCT04028843|592707424|FG001|Overall Study|Withdrawal by Subject|2|||
164094104|NCT01347710|592707425|FG000|Overall Study|Withdrawal by Subject|2|||
164094105|NCT01347710|592707425|FG000|Overall Study|Adverse Event|4|||
164094106|NCT01347710|592707425|FG000|Overall Study|Angio or SPECT not completed|18|||
164094107|NCT01347710|592707425|FG000|Overall Study|issue with vitals prior to dosing|1|||
164094108|NCT01347710|592707425|FG000|Overall Study|Lost to Follow-up|1|||
164094109|NCT01347710|592707425|FG000|Overall Study|Physician Decision|2|||
164094110|NCT01347710|592707425|FG000|Overall Study|Other|3|||
164094111|NCT02003183|592707433|FG000|Overall Study|Lost to Follow-up|0|||
164094112|NCT02003183|592707434|FG001|Overall Study|Lost to Follow-up|2|||
164094113|NCT00841100|592707435|FG000|Phase 1 (28 Days)|Adverse Event|1|||
164094114|NCT00841100|592707435|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
164094115|NCT03338972|592707436|FG000|Overall Study|Death|1|||
164094116|NCT03338972|592707437|FG001|Overall Study|Death|1|||
164094117|NCT03338972|592707438|FG002|Overall Study|Death|0|||
164094118|NCT03338972|592707439|FG003|Overall Study|Death|0|||
164094119|NCT03338972|592707436|FG000|Overall Study|Withdrawal by Subject|1|||
164094120|NCT03338972|592707437|FG001|Overall Study|Withdrawal by Subject|0|||
164094121|NCT03338972|592707438|FG002|Overall Study|Withdrawal by Subject|0|||
164094122|NCT03338972|592707439|FG003|Overall Study|Withdrawal by Subject|0|||
164094123|NCT01355081|592707440|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
164094124|NCT01355081|592707441|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
164094125|NCT01355081|592707442|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
164094126|NCT01355081|592707440|FG000|Overall Study|Major Protocol Deviation|0|||
164094127|NCT01355081|592707441|FG001|Overall Study|Major Protocol Deviation|1|||
164094128|NCT01355081|592707442|FG002|Overall Study|Major Protocol Deviation|0|||
164094129|NCT01355081|592707440|FG000|Overall Study|Lost to Follow-up|0|||
164094130|NCT01355081|592707441|FG001|Overall Study|Lost to Follow-up|0|||
164094131|NCT01355081|592707442|FG002|Overall Study|Lost to Follow-up|1|||
164094132|NCT01355081|592707440|FG000|Overall Study|Withdrawal of Consent|2|||
164094133|NCT01355081|592707441|FG001|Overall Study|Withdrawal of Consent|3|||
164094134|NCT01355081|592707442|FG002|Overall Study|Withdrawal of Consent|3|||
164094135|NCT01355081|592707440|FG000|Overall Study|Lack of Efficacy|2|||
164094136|NCT01355081|592707441|FG001|Overall Study|Lack of Efficacy|1|||
164094137|NCT01355081|592707442|FG002|Overall Study|Lack of Efficacy|1|||
164094138|NCT01355081|592707440|FG000|Overall Study|Non Compliance with Study Medication|0|||
164094139|NCT01355081|592707441|FG001|Overall Study|Non Compliance with Study Medication|1|||
164094140|NCT01355081|592707442|FG002|Overall Study|Non Compliance with Study Medication|0|||
164094141|NCT02719522|592707445|FG000|Overall Study|Implant Failure|4|||
164094142|NCT02719522|592707445|FG000|Overall Study|Death|2|||
164094143|NCT02719522|592707445|FG000|Overall Study|Lost to Follow-up|5|||
164094144|NCT01868009|592707446|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
164094145|NCT01868009|592707447|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
164094146|NCT01868009|592707446|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
163906768|NCT03343704|592029402|FG001|Overall Study|Death|1|||
164094147|NCT01868009|592707447|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
164094148|NCT01868009|592707446|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
164094149|NCT01868009|592707447|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
163906769|NCT03343704|592029401|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
164094150|NCT01451762|592708506|FG000|Overall Study|Lost to Follow-up|3|||
164094151|NCT01451762|592708507|FG001|Overall Study|Lost to Follow-up|6|||
164094152|NCT01451762|592708508|FG002|Overall Study|Lost to Follow-up|6|||
164094153|NCT04349917|592708516|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
164094154|NCT04349917|592708517|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
164094155|NCT04349917|592708516|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
164094156|NCT04349917|592708517|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
164094157|NCT00441467|592708521|FG000|Overall Study|Adverse Event|6|||
164094158|NCT00441467|592708521|FG000|Overall Study|Withdrawal by Subject|3|||
164094159|NCT00441467|592708521|FG000|Overall Study|Progressive disease|9|||
164094160|NCT01042522|592708523|FG000|Overall Study|Adverse Event|1|||
164094161|NCT01042522|592708524|FG001|Overall Study|Adverse Event|2|||
164094162|NCT01042522|592708523|FG000|Overall Study|Disease Progression|5|||
164094163|NCT01042522|592708524|FG001|Overall Study|Disease Progression|0|||
164094164|NCT01042522|592708523|FG000|Overall Study|Death|1|||
164094165|NCT01042522|592708524|FG001|Overall Study|Death|0|||
164094166|NCT01042522|592708523|FG000|Overall Study|Patient Refused|0|||
164094167|NCT01042522|592708524|FG001|Overall Study|Patient Refused|3|||
164094168|NCT01042522|592708523|FG000|Overall Study|Withdrawal by Subject|1|||
164094169|NCT01042522|592708524|FG001|Overall Study|Withdrawal by Subject|1|||
164094170|NCT00088829|592708532|FG000|Overall Study|PI left institution and study was close|22|||
164094171|NCT00525590|592708538|FG000|Overall Study|Adverse Event|3|||
164094172|NCT00525590|592708538|FG000|Overall Study|Physician Decision|3|||
164094173|NCT00525590|592708538|FG000|Overall Study|Withdrawal by Subject|16|||
164094174|NCT00525590|592708538|FG000|Overall Study|Lost to Follow-up|1|||
164094175|NCT00525590|592708538|FG000|Overall Study|Death|9|||
164094176|NCT00525590|592708538|FG000|Overall Study|Other|13|||
164094177|NCT03830164|592708543|FG000|Overall Study|Adverse Event|0|||
164094178|NCT03830164|592708544|FG001|Overall Study|Adverse Event|2|||
164094179|NCT03830164|592708545|FG002|Overall Study|Adverse Event|0|||
164094180|NCT03830164|592708543|FG000|Overall Study|Lack of Efficacy|1|||
164094181|NCT03830164|592708544|FG001|Overall Study|Lack of Efficacy|5|||
164094182|NCT03830164|592708545|FG002|Overall Study|Lack of Efficacy|0|||
164094183|NCT03830164|592708543|FG000|Overall Study|Lost to Follow-up|0|||
164094184|NCT03830164|592708544|FG001|Overall Study|Lost to Follow-up|1|||
164094185|NCT03830164|592708545|FG002|Overall Study|Lost to Follow-up|0|||
164094186|NCT03830164|592708543|FG000|Overall Study|Withdrawal by Subject|1|||
164094187|NCT03830164|592708544|FG001|Overall Study|Withdrawal by Subject|0|||
164094188|NCT03830164|592708545|FG002|Overall Study|Withdrawal by Subject|0|||
164094189|NCT04099888|592708546|FG000|Overall Study|Study terminated by sponsor|9|||
164094190|NCT04099888|592708547|FG001|Overall Study|Study terminated by sponsor|11|||
164094191|NCT04099888|592708546|FG000|Overall Study|Lost to Follow-up|1|||
164094192|NCT04099888|592708547|FG001|Overall Study|Lost to Follow-up|1|||
164094193|NCT04099888|592708546|FG000|Overall Study|Withdrawal by Subject|5|||
164094194|NCT04099888|592708547|FG001|Overall Study|Withdrawal by Subject|6|||
164094195|NCT04099888|592708546|FG000|Overall Study|Death|5|||
164094196|NCT04099888|592708547|FG001|Overall Study|Death|2|||
164094197|NCT04099888|592708546|FG000|Overall Study|Other|1|||
164094198|NCT04099888|592708547|FG001|Overall Study|Other|0|||
164094199|NCT01273181|592708553|FG000|Phase I, Dose 1|Study termination|1|||
164094200|NCT01273181|592708554|FG001|Phase I, Dose 1|Study termination|0|||
164094201|NCT01273181|592708555|FG002|Phase I, Dose 1|Study termination|0|||
164094202|NCT01273181|592708556|FG003|Phase I, Dose 1|Study termination|0|||
164094203|NCT01273181|592708553|FG000|Phase I, Dose 2|Death during treatment|0|||
164094204|NCT01273181|592708554|FG001|Phase I, Dose 2|Death during treatment|1|||
164094205|NCT01273181|592708555|FG002|Phase I, Dose 2|Death during treatment|0|||
164094206|NCT01273181|592708556|FG003|Phase I, Dose 2|Death during treatment|0|||
164094207|NCT01273181|592708553|FG000|Phase 2, Dose 1|Study termination|0|||
164094208|NCT01273181|592708554|FG001|Phase 2, Dose 1|Study termination|0|||
164094209|NCT01273181|592708555|FG002|Phase 2, Dose 1|Study termination|1|||
164094210|NCT01273181|592708556|FG003|Phase 2, Dose 1|Study termination|0|||
164094211|NCT01273181|592708553|FG000|Phase 2, Dose 2|Death during treatment|0|||
164094212|NCT01273181|592708554|FG001|Phase 2, Dose 2|Death during treatment|0|||
164094213|NCT01273181|592708555|FG002|Phase 2, Dose 2|Death during treatment|0|||
163906770|NCT03343704|592029402|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
164094214|NCT01273181|592708556|FG003|Phase 2, Dose 2|Death during treatment|1|||
163906771|NCT02969356|592029404|FG000|Overall Study|Adverse Event|7|||
163906772|NCT02969356|592029404|FG000|Overall Study|Consent withdrawn|2|||
163906773|NCT02969356|592029404|FG000|Overall Study|Lost to Follow-up|3|||
164094215|NCT04276883|592708557|FG000|Overall Study|Withdrawal by Subject|2|||
164094216|NCT04276883|592708558|FG001|Overall Study|Withdrawal by Subject|3|||
164094217|NCT04276883|592708559|FG002|Overall Study|Withdrawal by Subject|6|||
164094218|NCT04276883|592708557|FG000|Overall Study|Lost to Follow-up|1|||
164094219|NCT04276883|592708558|FG001|Overall Study|Lost to Follow-up|3|||
164094220|NCT04276883|592708559|FG002|Overall Study|Lost to Follow-up|0|||
163906774|NCT02969356|592029404|FG000|Overall Study|Did not need to be reinjected|6|||
164094221|NCT04276883|592708557|FG000|Overall Study|Adverse Event|0|||
164094222|NCT04276883|592708558|FG001|Overall Study|Adverse Event|1|||
164094223|NCT04276883|592708559|FG002|Overall Study|Adverse Event|0|||
164017914|NCT00195260|592428672|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
164017915|NCT00195260|592428673|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164017916|NCT00195260|592428674|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164017917|NCT00195260|592428675|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164017918|NCT00195260|592428676|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164017919|NCT00195260|592428677|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
164017920|NCT00195260|592428667|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017921|NCT00195260|592428668|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017922|NCT00195260|592428669|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017923|NCT00195260|592428670|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017924|NCT00195260|592428671|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017925|NCT00195260|592428672|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017926|NCT00195260|592428673|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017927|NCT00195260|592428674|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
164017928|NCT00195260|592428675|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
164017929|NCT00195260|592428676|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
164017930|NCT00195260|592428677|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
164017931|NCT00195260|592428667|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017932|NCT00195260|592428668|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017933|NCT00195260|592428669|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017934|NCT00195260|592428670|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017935|NCT00195260|592428671|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017936|NCT00195260|592428672|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017937|NCT00195260|592428673|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017938|NCT00195260|592428674|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
164017939|NCT00195260|592428675|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
164017940|NCT00195260|592428676|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
164017941|NCT00195260|592428677|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
164017942|NCT00195260|592428667|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017943|NCT00195260|592428668|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017944|NCT00195260|592428669|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017945|NCT00195260|592428670|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017946|NCT00195260|592428671|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017947|NCT00195260|592428672|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017948|NCT00195260|592428673|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017949|NCT00195260|592428674|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
164017950|NCT00195260|592428675|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
164017951|NCT00195260|592428676|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
164017952|NCT00195260|592428677|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
164017953|NCT00195260|592428667|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017954|NCT00195260|592428668|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017955|NCT00195260|592428669|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017956|NCT00195260|592428670|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017957|NCT00195260|592428671|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017958|NCT00195260|592428672|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017959|NCT00195260|592428673|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017960|NCT00195260|592428674|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
164017961|NCT00195260|592428675|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
164017962|NCT00195260|592428676|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
164017963|NCT00195260|592428677|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
164017964|NCT02749721|592428678|FG000|Screening|Withdrawal by Subject|1|||
164017965|NCT02749721|592428678|FG000|Screening|Lost to Follow-up|2|||
164017966|NCT02749721|592428678|FG000|Screening|Protocol Violation|3|||
164017967|NCT02749721|592428678|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
164017968|NCT02749721|592428678|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
164017969|NCT02691247|592428679|FG000|Overall Study|Withdrawal by Subject|1|||
164017970|NCT02691247|592428680|FG001|Overall Study|Withdrawal by Subject|2|||
164017971|NCT02691247|592428681|FG002|Overall Study|Withdrawal by Subject|2|||
164017972|NCT02691247|592428679|FG000|Overall Study|Lost to Follow-up|2|||
164017973|NCT02691247|592428680|FG001|Overall Study|Lost to Follow-up|0|||
164017974|NCT02691247|592428681|FG002|Overall Study|Lost to Follow-up|1|||
164017975|NCT04590937|592428682|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
164017976|NCT01635933|592428683|FG000|Overall Study|Adverse Event|1|||
164017977|NCT01635933|592428684|FG001|Overall Study|Adverse Event|0|||
164017978|NCT01635933|592428683|FG000|Overall Study|Lost to Follow-up|0|||
164017979|NCT01635933|592428684|FG001|Overall Study|Lost to Follow-up|5|||
164017980|NCT01635933|592428683|FG000|Overall Study|Subject decision|1|||
164017981|NCT01635933|592428684|FG001|Overall Study|Subject decision|1|||
164017982|NCT01635933|592428683|FG000|Overall Study|Noncompliance|0|||
164017983|NCT01635933|592428684|FG001|Overall Study|Noncompliance|1|||
164094224|NCT04276883|592708557|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
164094225|NCT04276883|592708558|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
164094226|NCT04276883|592708559|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
164094227|NCT02458469|592708561|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164094228|NCT02458469|592708562|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164094229|NCT02458469|592708563|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164094230|NCT02458469|592708564|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164094231|NCT02458469|592708565|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164094232|NCT02458469|592708566|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164094233|NCT02458469|592708561|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
164094234|NCT02458469|592708562|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
164094235|NCT02458469|592708563|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
164094236|NCT02458469|592708564|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
164094237|NCT02458469|592708565|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
164094238|NCT02458469|592708566|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
164094239|NCT02458469|592708561|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164094240|NCT02458469|592708562|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164094241|NCT02458469|592708563|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164094242|NCT02458469|592708564|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164094243|NCT02458469|592708565|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
164094244|NCT02458469|592708566|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
164094245|NCT02603952|592708571|FG000|Overall Study|Withdrawal by Subject|1|||
164094246|NCT02603952|592708572|FG001|Overall Study|Withdrawal by Subject|0|||
164094247|NCT02603952|592708573|FG002|Overall Study|Withdrawal by Subject|0|||
164094248|NCT02603952|592708574|FG003|Overall Study|Withdrawal by Subject|0|||
164094249|NCT02603952|592708571|FG000|Overall Study|Received oseltamivir by error|0|||
164094250|NCT02603952|592708572|FG001|Overall Study|Received oseltamivir by error|0|||
164094251|NCT02603952|592708573|FG002|Overall Study|Received oseltamivir by error|0|||
164094252|NCT02603952|592708574|FG003|Overall Study|Received oseltamivir by error|1|||
164094253|NCT00958243|592708582|FG000|Overall Study|Withdrawal by Subject|0|||
164094254|NCT00958243|592708583|FG001|Overall Study|Withdrawal by Subject|1|||
164094255|NCT00958243|592708584|FG002|Overall Study|Withdrawal by Subject|3|||
164094256|NCT00958243|592708585|FG003|Overall Study|Withdrawal by Subject|1|||
164094257|NCT00958243|592708586|FG004|Overall Study|Withdrawal by Subject|1|||
164094258|NCT00958243|592708587|FG005|Overall Study|Withdrawal by Subject|5|||
164094259|NCT00958243|592708582|FG000|Overall Study|Lost to Follow-up|2|||
164094260|NCT00958243|592708583|FG001|Overall Study|Lost to Follow-up|5|||
164094261|NCT00958243|592708584|FG002|Overall Study|Lost to Follow-up|11|||
164094262|NCT00958243|592708585|FG003|Overall Study|Lost to Follow-up|2|||
164094263|NCT00958243|592708586|FG004|Overall Study|Lost to Follow-up|8|||
164094264|NCT00958243|592708587|FG005|Overall Study|Lost to Follow-up|5|||
164094265|NCT04591626|592708596|FG000|Overall Study|Adverse Event|4|||
164094266|NCT04591626|592708597|FG001|Overall Study|Adverse Event|0|||
164094267|NCT04591626|592708596|FG000|Overall Study|Withdrawal by Subject|5|||
164094268|NCT04591626|592708597|FG001|Overall Study|Withdrawal by Subject|3|||
164094269|NCT04591626|592708596|FG000|Overall Study|Physician Decision|0|||
164094270|NCT04591626|592708597|FG001|Overall Study|Physician Decision|1|||
164094271|NCT04591626|592708596|FG000|Overall Study|Death|0|||
164094272|NCT04591626|592708597|FG001|Overall Study|Death|1|||
164094273|NCT04591626|592708596|FG000|Overall Study|Non-Compliance with Study Drug|1|||
164094274|NCT04591626|592708597|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164094275|NCT02672553|592708599|FG000|Overall Study|Death|3|||
164094276|NCT02672553|592708600|FG001|Overall Study|Death|5|||
164094277|NCT02672553|592708599|FG000|Overall Study|Valve Explant|1|||
164094278|NCT02672553|592708600|FG001|Overall Study|Valve Explant|0|||
164094279|NCT02672553|592708599|FG000|Overall Study|Conversion to Commercial Valve|3|||
164094280|NCT02672553|592708600|FG001|Overall Study|Conversion to Commercial Valve|0|||
164094281|NCT02672553|592708599|FG000|Overall Study|Withdrawal by Subject|3|||
164094282|NCT02672553|592708600|FG001|Overall Study|Withdrawal by Subject|3|||
164094283|NCT02672553|592708599|FG000|Overall Study|Intraoperative screen failure|2|||
164094284|NCT02672553|592708600|FG001|Overall Study|Intraoperative screen failure|0|||
164094285|NCT01004172|592708601|FG000|Overall Study|Progressive Disease in CNS Only|16|||
164094286|NCT01004172|592708601|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
164094287|NCT01004172|592708601|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
164094288|NCT01004172|592708601|FG000|Overall Study|Adverse Event|1|||
164094289|NCT01004172|592708601|FG000|Overall Study|Physician Decision|1|||
164094290|NCT01004172|592708601|FG000|Overall Study|Symptomatic Deterioration|2|||
164094291|NCT00950872|592708602|FG000|Overall Study|Withdrawal by Subject|1|||
164094292|NCT00950872|592708602|FG000|Overall Study|Did not have surgery|2|||
164094293|NCT00970281|592708603|FG000|Overall Study|Lack of Efficacy|1|||
164094294|NCT00970281|592708604|FG001|Overall Study|Lack of Efficacy|14|||
164094295|NCT00970281|592708603|FG000|Overall Study|Withdrawal by Subject|0|||
164094296|NCT00970281|592708604|FG001|Overall Study|Withdrawal by Subject|1|||
164094297|NCT00970281|592708603|FG000|Overall Study|Physician Decision|1|||
163906775|NCT02969356|592029404|FG000|Overall Study|Personal reasons|5|||
163906776|NCT05432986|592029417|FG000|Overall Study|Withdrawal by Subject|2|||
163906777|NCT05432986|592029417|FG000|Overall Study|incomplete measurement|7|||
163906778|NCT04493424|592031165|FG000|Overall Study|Termination of the trial by the sponsor|89|||
163906779|NCT04493424|592031165|FG000|Overall Study|Withdrawal by Subject|9|||
163906780|NCT04493424|592031165|FG000|Overall Study|Lost to Follow-up|2|||
163906781|NCT04493424|592031165|FG000|Overall Study|Lack of Efficacy|3|||
163906782|NCT04493424|592031165|FG000|Overall Study|Adverse Event|5|||
163906783|NCT03769090|592031167|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
163906784|NCT03769090|592031168|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
163906785|NCT03769090|592031169|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
163906786|NCT03769090|592031167|FG000|Overall Study|Withdrawal by Subject|52|||
163906787|NCT03769090|592031168|FG001|Overall Study|Withdrawal by Subject|62|||
163906788|NCT03769090|592031169|FG002|Overall Study|Withdrawal by Subject|74|||
163906789|NCT03769090|592031167|FG000|Overall Study|Death|4|||
163906790|NCT03769090|592031168|FG001|Overall Study|Death|2|||
163906791|NCT03769090|592031169|FG002|Overall Study|Death|2|||
163906792|NCT03769090|592031167|FG000|Overall Study|Adverse Event|7|||
163906793|NCT03769090|592031168|FG001|Overall Study|Adverse Event|7|||
163906794|NCT03769090|592031169|FG002|Overall Study|Adverse Event|8|||
163906795|NCT03769090|592031167|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
163906796|NCT03769090|592031168|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
163906797|NCT03769090|592031169|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
163906798|NCT03769090|592031167|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
163906799|NCT03769090|592031168|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
163906800|NCT03769090|592031169|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
163906801|NCT03769090|592031167|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
163906802|NCT03769090|592031168|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
163906803|NCT03769090|592031169|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
163906804|NCT03769090|592031167|FG000|Overall Study|Protocol Violation|5|||
163906805|NCT03769090|592031168|FG001|Overall Study|Protocol Violation|6|||
163906806|NCT03769090|592031169|FG002|Overall Study|Protocol Violation|8|||
163906807|NCT03769090|592031167|FG000|Overall Study|Pregnancy|1|||
163906808|NCT03769090|592031168|FG001|Overall Study|Pregnancy|0|||
163906809|NCT03769090|592031169|FG002|Overall Study|Pregnancy|3|||
163906810|NCT03769090|592031167|FG000|Overall Study|Lost to Follow-up|19|||
163906811|NCT03769090|592031168|FG001|Overall Study|Lost to Follow-up|25|||
163906812|NCT03769090|592031169|FG002|Overall Study|Lost to Follow-up|21|||
163906813|NCT03769090|592031167|FG000|Overall Study|Condition under investigation worsened|2|||
163906814|NCT03769090|592031168|FG001|Overall Study|Condition under investigation worsened|0|||
163906815|NCT03769090|592031169|FG002|Overall Study|Condition under investigation worsened|1|||
163906816|NCT03769090|592031167|FG000|Overall Study|Lack of Efficacy|1|||
163906817|NCT03769090|592031168|FG001|Overall Study|Lack of Efficacy|2|||
163906818|NCT03769090|592031169|FG002|Overall Study|Lack of Efficacy|2|||
163906819|NCT03769090|592031167|FG000|Overall Study|Other reasons|8|||
163906820|NCT03769090|592031168|FG001|Overall Study|Other reasons|12|||
163906821|NCT03769090|592031169|FG002|Overall Study|Other reasons|15|||
163906822|NCT02830893|592031175|FG000|Overall Study|Relocation to out of the country|1|||
163906823|NCT02830893|592031176|FG001|Overall Study|Relocation to out of the country|0|||
163906824|NCT02830893|592031175|FG000|Overall Study|Lost to Follow-up|0|||
163906825|NCT02830893|592031176|FG001|Overall Study|Lost to Follow-up|2|||
163906826|NCT02830893|592031175|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
163906827|NCT02830893|592031176|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
163906828|NCT01277302|592031177|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
163906829|NCT01277302|592031178|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
163906830|NCT01277302|592031179|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
163906831|NCT01277302|592031177|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
163906832|NCT01277302|592031178|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
163906833|NCT01277302|592031179|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
163906834|NCT01277302|592031177|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
163906835|NCT01277302|592031178|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
163906836|NCT01277302|592031179|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
163906837|NCT01277302|592031177|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
163906838|NCT01277302|592031178|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
163906839|NCT01277302|592031179|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
163906840|NCT01277302|592031177|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
163906841|NCT01277302|592031178|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
163906842|NCT01277302|592031179|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
163906843|NCT01277302|592031177|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
163906844|NCT01277302|592031178|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
163906845|NCT01277302|592031179|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
163906846|NCT01277302|592031177|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
163906847|NCT01277302|592031178|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
163906848|NCT01277302|592031179|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
163906849|NCT01277302|592031177|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
163906850|NCT01277302|592031178|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
163906851|NCT01277302|592031179|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
163906852|NCT01277302|592031177|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
163906853|NCT01277302|592031178|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
163906854|NCT01277302|592031179|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
163906855|NCT02710669|592031180|FG000|Overall Study|Physician Decision|2|||
163906856|NCT02710669|592031181|FG001|Overall Study|Physician Decision|1|||
163906857|NCT02710669|592031182|FG002|Overall Study|Physician Decision|0|||
163906858|NCT02710669|592031180|FG000|Overall Study|Institutional delays (including COVID)|2|||
163906859|NCT02710669|592031181|FG001|Overall Study|Institutional delays (including COVID)|2|||
163906860|NCT02710669|592031182|FG002|Overall Study|Institutional delays (including COVID)|0|||
163906861|NCT02710669|592031180|FG000|Overall Study|arrived in afib/aflutter|10|||
163906862|NCT02710669|592031181|FG001|Overall Study|arrived in afib/aflutter|8|||
163906863|NCT02710669|592031182|FG002|Overall Study|arrived in afib/aflutter|2|||
163906864|NCT01567852|592031185|FG000|Overall Study|Withdrawal by Subject|3|||
163906865|NCT01567852|592031186|FG001|Overall Study|Withdrawal by Subject|6|||
163906866|NCT01567852|592031185|FG000|Overall Study|ECT discontinued|1|||
163906867|NCT01567852|592031186|FG001|Overall Study|ECT discontinued|1|||
163906868|NCT03332589|592031187|FG000|Overall Study|Lack of Efficacy|2|||
163906869|NCT03332589|592031188|FG001|Overall Study|Lack of Efficacy|0|||
163906870|NCT03332589|592031189|FG002|Overall Study|Lack of Efficacy|0|||
163906871|NCT03332589|592031187|FG000|Overall Study|Adverse Event|1|||
163906872|NCT03332589|592031188|FG001|Overall Study|Adverse Event|0|||
163906873|NCT03332589|592031189|FG002|Overall Study|Adverse Event|0|||
163906874|NCT03332589|592031187|FG000|Overall Study|Death|1|||
163906875|NCT03332589|592031188|FG001|Overall Study|Death|0|||
163906876|NCT03332589|592031189|FG002|Overall Study|Death|0|||
163906877|NCT01190124|592031191|FG000|Overall Study|Death|3|||
163906878|NCT01190124|592031192|FG001|Overall Study|Death|0|||
163906879|NCT01190124|592031193|FG002|Overall Study|Death|0|||
163906880|NCT01190124|592031191|FG000|Overall Study|Therapeutic Failure|12|||
163906881|NCT01190124|592031192|FG001|Overall Study|Therapeutic Failure|0|||
163906882|NCT01190124|592031193|FG002|Overall Study|Therapeutic Failure|1|||
163906883|NCT01190124|592031191|FG000|Overall Study|Lost to Follow-up|2|||
163906884|NCT01190124|592031192|FG001|Overall Study|Lost to Follow-up|0|||
163906885|NCT01190124|592031193|FG002|Overall Study|Lost to Follow-up|0|||
163906886|NCT01719172|592031194|FG000|Overall Study|Lost to Follow-up|1|||
163906887|NCT01719172|592031194|FG000|Overall Study|Death|1|||
163906888|NCT03469258|592031197|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
163906889|NCT02605174|592031204|FG000|Overall Study|Adverse Event|0|||
163906890|NCT02605174|592031205|FG001|Overall Study|Adverse Event|0|||
163906891|NCT02605174|592031206|FG002|Overall Study|Adverse Event|1|||
163906892|NCT02605174|592031207|FG003|Overall Study|Adverse Event|0|||
163906893|NCT02605174|592031208|FG004|Overall Study|Adverse Event|4|||
163906894|NCT02605174|592031209|FG005|Overall Study|Adverse Event|0|||
163906895|NCT02605174|592031210|FG006|Overall Study|Adverse Event|0|||
163906896|NCT02605174|592031204|FG000|Overall Study|Lost to Follow-up|20|||
163906897|NCT02605174|592031205|FG001|Overall Study|Lost to Follow-up|7|||
163906898|NCT02605174|592031206|FG002|Overall Study|Lost to Follow-up|27|||
163906899|NCT02605174|592031207|FG003|Overall Study|Lost to Follow-up|10|||
163906900|NCT02605174|592031208|FG004|Overall Study|Lost to Follow-up|20|||
163906901|NCT02605174|592031209|FG005|Overall Study|Lost to Follow-up|10|||
163906902|NCT02605174|592031210|FG006|Overall Study|Lost to Follow-up|29|||
163906903|NCT02605174|592031204|FG000|Overall Study|Protocol Violation|10|||
163906904|NCT02605174|592031205|FG001|Overall Study|Protocol Violation|4|||
163906905|NCT02605174|592031206|FG002|Overall Study|Protocol Violation|14|||
163906906|NCT02605174|592031207|FG003|Overall Study|Protocol Violation|6|||
163906907|NCT02605174|592031208|FG004|Overall Study|Protocol Violation|7|||
163906908|NCT02605174|592031209|FG005|Overall Study|Protocol Violation|7|||
163906909|NCT02605174|592031210|FG006|Overall Study|Protocol Violation|12|||
163906910|NCT02605174|592031204|FG000|Overall Study|Pregnancy|1|||
163906911|NCT02605174|592031205|FG001|Overall Study|Pregnancy|0|||
163906912|NCT02605174|592031206|FG002|Overall Study|Pregnancy|0|||
163906913|NCT02605174|592031207|FG003|Overall Study|Pregnancy|2|||
163906914|NCT02605174|592031208|FG004|Overall Study|Pregnancy|0|||
163906915|NCT02605174|592031209|FG005|Overall Study|Pregnancy|0|||
163906916|NCT02605174|592031210|FG006|Overall Study|Pregnancy|0|||
163906917|NCT02605174|592031204|FG000|Overall Study|Withdrawal by Subject|9|||
163906918|NCT02605174|592031205|FG001|Overall Study|Withdrawal by Subject|6|||
163906919|NCT02605174|592031206|FG002|Overall Study|Withdrawal by Subject|14|||
163906920|NCT02605174|592031207|FG003|Overall Study|Withdrawal by Subject|11|||
163906921|NCT02605174|592031208|FG004|Overall Study|Withdrawal by Subject|6|||
163906922|NCT02605174|592031209|FG005|Overall Study|Withdrawal by Subject|4|||
163906923|NCT02605174|592031210|FG006|Overall Study|Withdrawal by Subject|15|||
164094298|NCT00970281|592708604|FG001|Overall Study|Physician Decision|1|||
164094299|NCT06096168|592708609|FG000|Overall Study|Death|30|||
164094300|NCT06096168|592708609|FG000|Overall Study|Revision|2|||
164094301|NCT04603937|592708614|FG000|Overall Study|Adverse Event|9|||
164094302|NCT04603937|592708615|FG001|Overall Study|Adverse Event|10|||
164094303|NCT04603937|592708614|FG000|Overall Study|Withdrawal by Subject|7|||
164094304|NCT04603937|592708615|FG001|Overall Study|Withdrawal by Subject|6|||
164094305|NCT04603937|592708614|FG000|Overall Study|Lost to Follow-up|5|||
164094306|NCT04603937|592708615|FG001|Overall Study|Lost to Follow-up|6|||
164094307|NCT04603937|592708614|FG000|Overall Study|Physician Decision|0|||
164094308|NCT04603937|592708615|FG001|Overall Study|Physician Decision|1|||
164094309|NCT04603937|592708614|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
164094310|NCT04603937|592708615|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
164094311|NCT00993616|592708616|FG000|Overall Study|No tumor at entry|1|||
164094312|NCT00993616|592708616|FG000|Overall Study|Never treated|1|||
164094313|NCT02585258|592708617|FG000|Overall Study|Adverse Event|28|||
164094314|NCT02585258|592708618|FG001|Overall Study|Adverse Event|29|||
164094315|NCT02585258|592708617|FG000|Overall Study|Death|3|||
164094316|NCT02585258|592708618|FG001|Overall Study|Death|2|||
164094317|NCT02585258|592708617|FG000|Overall Study|Lack of Efficacy|7|||
164094318|NCT02585258|592708618|FG001|Overall Study|Lack of Efficacy|9|||
164094319|NCT02585258|592708617|FG000|Overall Study|includes covid-related access problems|42|||
164094320|NCT02585258|592708618|FG001|Overall Study|includes covid-related access problems|46|||
164094321|NCT02585258|592708617|FG000|Overall Study|Lost to Follow-up|5|||
164094322|NCT02585258|592708618|FG001|Overall Study|Lost to Follow-up|2|||
164094323|NCT05125952|592708619|FG000|Overall Study|Physician Decision|1|||
164094324|NCT03946449|592708620|FG000|Treatment Extension II|Rolled over to another study|0|||
164094325|NCT03946449|592708621|FG001|Treatment Extension II|Rolled over to another study|0|||
164094326|NCT03946449|592708622|FG002|Treatment Extension II|Rolled over to another study|2|||
164094327|NCT03946449|592708620|FG000|Treatment Extension II|Withdrawal by Subject|0|||
164094328|NCT03946449|592708621|FG001|Treatment Extension II|Withdrawal by Subject|0|||
164094329|NCT03946449|592708622|FG002|Treatment Extension II|Withdrawal by Subject|1|||
164094330|NCT02848326|592710169|FG000|Treatment Period|Adverse Event|5|||
164094331|NCT02848326|592710170|FG001|Treatment Period|Adverse Event|4|||
164094332|NCT02848326|592710171|FG002|Treatment Period|Adverse Event|11|||
164094333|NCT02848326|592710172|FG003|Treatment Period|Adverse Event|6|||
164094334|NCT02848326|592710173|FG004|Treatment Period|Adverse Event|5|||
164094335|NCT02848326|592710174|FG005|Treatment Period|Adverse Event|7|||
164094336|NCT02848326|592710169|FG000|Treatment Period|Withdrawal of Consent|20|||
164094337|NCT02848326|592710170|FG001|Treatment Period|Withdrawal of Consent|6|||
164094338|NCT02848326|592710171|FG002|Treatment Period|Withdrawal of Consent|9|||
164094339|NCT02848326|592710172|FG003|Treatment Period|Withdrawal of Consent|6|||
164094340|NCT02848326|592710173|FG004|Treatment Period|Withdrawal of Consent|9|||
164094341|NCT02848326|592710174|FG005|Treatment Period|Withdrawal of Consent|6|||
164094342|NCT02848326|592710169|FG000|Treatment Period|Lost to Follow-up|5|||
164094343|NCT02848326|592710170|FG001|Treatment Period|Lost to Follow-up|1|||
164094344|NCT02848326|592710171|FG002|Treatment Period|Lost to Follow-up|11|||
164094345|NCT02848326|592710172|FG003|Treatment Period|Lost to Follow-up|7|||
164094346|NCT02848326|592710173|FG004|Treatment Period|Lost to Follow-up|2|||
164094347|NCT02848326|592710174|FG005|Treatment Period|Lost to Follow-up|3|||
164094348|NCT02848326|592710169|FG000|Treatment Period|Pregnancy|0|||
164094349|NCT02848326|592710170|FG001|Treatment Period|Pregnancy|0|||
164094350|NCT02848326|592710171|FG002|Treatment Period|Pregnancy|1|||
164094351|NCT02848326|592710172|FG003|Treatment Period|Pregnancy|1|||
164094352|NCT02848326|592710173|FG004|Treatment Period|Pregnancy|0|||
164094353|NCT02848326|592710174|FG005|Treatment Period|Pregnancy|1|||
164094354|NCT02848326|592710169|FG000|Treatment Period|Protocol Violation|4|||
164094355|NCT02848326|592710170|FG001|Treatment Period|Protocol Violation|3|||
164094356|NCT02848326|592710171|FG002|Treatment Period|Protocol Violation|4|||
164094357|NCT02848326|592710172|FG003|Treatment Period|Protocol Violation|2|||
164094358|NCT02848326|592710173|FG004|Treatment Period|Protocol Violation|3|||
164094359|NCT02848326|592710174|FG005|Treatment Period|Protocol Violation|3|||
164094360|NCT02848326|592710169|FG000|Treatment Period|Non-compliance with Study Drug|4|||
164094361|NCT02848326|592710170|FG001|Treatment Period|Non-compliance with Study Drug|0|||
163906924|NCT02605174|592031204|FG000|Overall Study|Physician Decision|2|||
164094362|NCT02848326|592710171|FG002|Treatment Period|Non-compliance with Study Drug|0|||
164094363|NCT02848326|592710172|FG003|Treatment Period|Non-compliance with Study Drug|1|||
164094364|NCT02848326|592710173|FG004|Treatment Period|Non-compliance with Study Drug|0|||
164094365|NCT02848326|592710174|FG005|Treatment Period|Non-compliance with Study Drug|0|||
164094366|NCT02848326|592710169|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
164094367|NCT02848326|592710170|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
164094368|NCT02848326|592710171|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
164144037|NCT00086281|592888576|FG005|Phase 2|Adverse Event|0|||
163906925|NCT02605174|592031205|FG001|Overall Study|Physician Decision|0|||
163906926|NCT02605174|592031206|FG002|Overall Study|Physician Decision|0|||
164094369|NCT02848326|592710172|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
164094370|NCT02848326|592710173|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
164094371|NCT02848326|592710174|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
164094372|NCT02848326|592710169|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
164094373|NCT02848326|592710170|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
164094374|NCT02848326|592710171|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
164094375|NCT02848326|592710172|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
164094376|NCT02848326|592710173|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
164094377|NCT02848326|592710174|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
164094378|NCT00745420|592710189|FG000|Overall Study|Ineligible|1|||
164094379|NCT01367275|592710194|FG000|Overall Study|Ineligible|1|||
164094380|NCT01367275|592710194|FG000|Overall Study|Disease Progression|2|||
164094381|NCT02532764|592710195|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094382|NCT02532764|592710196|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094383|NCT02532764|592710197|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094384|NCT02532764|592710198|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094385|NCT02532764|592710199|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094386|NCT02532764|592710200|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094387|NCT02532764|592710201|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
164094388|NCT02532764|592710202|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
164094389|NCT02532764|592710203|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
164094390|NCT02532764|592710204|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
164094391|NCT00048568|592710214|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
164094392|NCT00048568|592710215|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
164094393|NCT00048568|592710216|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
164094394|NCT00048568|592710214|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
164094395|NCT00048568|592710215|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
164094396|NCT00048568|592710216|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
164094397|NCT00048568|592710214|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
164094398|NCT00048568|592710215|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
164094399|NCT00048568|592710216|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
164094400|NCT00048568|592710214|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
164094401|NCT00048568|592710215|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
164094402|NCT00048568|592710216|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
164094403|NCT00048568|592710214|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
164094404|NCT00048568|592710215|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
164094405|NCT00048568|592710216|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
164094406|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|Death|1|||
164094407|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|Death|1|||
164094408|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|Death|0|||
164094409|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
164094410|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
164094411|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
164094412|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
164094413|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
164094414|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
164094415|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
164094416|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
164094417|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
164094418|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
164094419|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
164094420|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
164094421|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
164094422|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
164094423|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
164094424|NCT00048568|592710214|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
164094425|NCT00048568|592710215|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
164094426|NCT00048568|592710216|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
164094427|NCT00048568|592710214|FG000|Open-Label Period|Death|0|||
164094428|NCT00048568|592710215|FG001|Open-Label Period|Death|0|||
164094429|NCT00048568|592710216|FG002|Open-Label Period|Death|13|||
164094430|NCT00048568|592710214|FG000|Open-Label Period|Adverse Event|0|||
164094431|NCT00048568|592710215|FG001|Open-Label Period|Adverse Event|0|||
164094432|NCT00048568|592710216|FG002|Open-Label Period|Adverse Event|49|||
164094433|NCT00048568|592710214|FG000|Open-Label Period|Lack of Efficacy|0|||
164094434|NCT00048568|592710215|FG001|Open-Label Period|Lack of Efficacy|0|||
164094435|NCT00048568|592710216|FG002|Open-Label Period|Lack of Efficacy|32|||
164094436|NCT00048568|592710214|FG000|Open-Label Period|Withdrawal by Subject|0|||
164094437|NCT00048568|592710215|FG001|Open-Label Period|Withdrawal by Subject|0|||
164094438|NCT00048568|592710216|FG002|Open-Label Period|Withdrawal by Subject|26|||
164094439|NCT00048568|592710214|FG000|Open-Label Period|Pregnancy|0|||
164094440|NCT00048568|592710215|FG001|Open-Label Period|Pregnancy|0|||
164094441|NCT00048568|592710216|FG002|Open-Label Period|Pregnancy|5|||
164094442|NCT00048568|592710214|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
164094443|NCT00048568|592710215|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
164094444|NCT00048568|592710216|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
164094445|NCT00048568|592710214|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
164094446|NCT00048568|592710215|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
164094447|NCT00048568|592710216|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
164094448|NCT00048568|592710214|FG000|Open-Label Period|Unknown Reasons|0|||
164094449|NCT00048568|592710215|FG001|Open-Label Period|Unknown Reasons|0|||
164094450|NCT00048568|592710216|FG002|Open-Label Period|Unknown Reasons|25|||
164094451|NCT00048568|592710214|FG000|Open-Label Period|Lost to Follow-up|0|||
164094452|NCT00048568|592710215|FG001|Open-Label Period|Lost to Follow-up|0|||
164094453|NCT00048568|592710216|FG002|Open-Label Period|Lost to Follow-up|7|||
164094454|NCT01717976|592710217|FG000|Overall Study|Protocol Violation|0|||
164094455|NCT01717976|592710218|FG001|Overall Study|Protocol Violation|1|||
164094456|NCT03831048|592710219|FG000|Overall Study|Protocol Violation|9|||
164094457|NCT03831048|592710220|FG001|Overall Study|Protocol Violation|3|||
164094458|NCT03831048|592710219|FG000|Overall Study|Death|4|||
164094459|NCT03831048|592710220|FG001|Overall Study|Death|9|||
164094460|NCT03831048|592710219|FG000|Overall Study|Re-transplant|0|||
164094461|NCT03831048|592710220|FG001|Overall Study|Re-transplant|2|||
164094462|NCT03831048|592710219|FG000|Overall Study|Protocol violation and death|1|||
164094463|NCT03831048|592710220|FG001|Overall Study|Protocol violation and death|1|||
164094464|NCT01996033|592710223|FG000|Overall Study|Death|1|||
164094465|NCT01996033|592710223|FG000|Overall Study|Physician Decision|1|||
164094466|NCT01996033|592710223|FG000|Overall Study|Withdrawal by Subject|4|||
164094467|NCT01996033|592710223|FG000|Overall Study|Lost to Follow-up|3|||
164094468|NCT02896361|592710226|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
164094469|NCT02896361|592710227|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
164094470|NCT02896361|592710228|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
164094471|NCT02896361|592710226|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
164094472|NCT02896361|592710227|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
164094473|NCT02896361|592710228|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
164094474|NCT02143102|592710233|FG000|Overall Study|Lost to Follow-up|11|||
164094475|NCT02143102|592710234|FG001|Overall Study|Lost to Follow-up|0|||
164094476|NCT03164772|592710237|FG000|Overall Study|Death|4|||
164094477|NCT03164772|592710238|FG001|Overall Study|Death|2|||
164094478|NCT03164772|592710237|FG000|Overall Study|Adverse Event|1|||
164094479|NCT03164772|592710238|FG001|Overall Study|Adverse Event|4|||
164094480|NCT03164772|592710237|FG000|Overall Study|Progressive Disease|11|||
164094481|NCT03164772|592710238|FG001|Overall Study|Progressive Disease|21|||
164094482|NCT03164772|592710237|FG000|Overall Study|Physician Decision|2|||
164094483|NCT03164772|592710238|FG001|Overall Study|Physician Decision|0|||
164094484|NCT03164772|592710237|FG000|Overall Study|Withdrawal by Subject|0|||
164094485|NCT03164772|592710238|FG001|Overall Study|Withdrawal by Subject|4|||
164094486|NCT00324168|592710241|FG000|Overall Study|Lost to Follow-up|19|||
164094487|NCT00324168|592710242|FG001|Overall Study|Lost to Follow-up|18|||
164094488|NCT00324168|592710241|FG000|Overall Study|Death|3|||
164094489|NCT00324168|592710242|FG001|Overall Study|Death|3|||
164094490|NCT00324168|592710241|FG000|Overall Study|Patient did not visit in f/u window|6|||
164094491|NCT00324168|592710242|FG001|Overall Study|Patient did not visit in f/u window|9|||
164094492|NCT01203878|592710243|FG000|Overall Study|Withdrawal by Subject|0|||
164094493|NCT01203878|592710244|FG001|Overall Study|Withdrawal by Subject|0|||
164094494|NCT01203878|592710245|FG002|Overall Study|Withdrawal by Subject|1|||
164094495|NCT01203878|592710243|FG000|Overall Study|Adverse Event|0|||
164094496|NCT01203878|592710244|FG001|Overall Study|Adverse Event|0|||
164094497|NCT01203878|592710245|FG002|Overall Study|Adverse Event|2|||
164094498|NCT01682083|592710246|FG000|Overall Study|Lost to Follow-up|11|||
164094499|NCT01682083|592710247|FG001|Overall Study|Lost to Follow-up|18|||
164094500|NCT01682083|592710246|FG000|Overall Study|Withdrawal by Subject|31|||
164094501|NCT01682083|592710247|FG001|Overall Study|Withdrawal by Subject|40|||
164094502|NCT01682083|592710246|FG000|Overall Study|Death|60|||
164094503|NCT01682083|592710247|FG001|Overall Study|Death|93|||
164094504|NCT01682083|592710246|FG000|Overall Study|Physician Decision|5|||
164094505|NCT01682083|592710247|FG001|Overall Study|Physician Decision|4|||
164094506|NCT02731157|592710248|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
164094507|NCT03657160|592710251|FG000|Overall Study|Adverse Event|5|||
164094508|NCT03657160|592710252|FG001|Overall Study|Adverse Event|6|||
164094509|NCT03657160|592710251|FG000|Overall Study|Protocol Deviation|3|||
164094510|NCT03657160|592710252|FG001|Overall Study|Protocol Deviation|0|||
164094511|NCT03657160|592710251|FG000|Overall Study|Withdrawal by Subject|18|||
164094512|NCT03657160|592710252|FG001|Overall Study|Withdrawal by Subject|16|||
164094513|NCT03657160|592710251|FG000|Overall Study|Site Termination|1|||
164094514|NCT03657160|592710252|FG001|Overall Study|Site Termination|0|||
164094515|NCT03657160|592710251|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
164094516|NCT03657160|592710252|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
164094517|NCT03657160|592710251|FG000|Overall Study|Death|33|||
164094518|NCT03657160|592710252|FG001|Overall Study|Death|26|||
164094519|NCT03657160|592710251|FG000|Overall Study|Death (COVID-19-Related)|1|||
164094520|NCT03657160|592710252|FG001|Overall Study|Death (COVID-19-Related)|0|||
164094521|NCT03657160|592710251|FG000|Overall Study|Reason Not Specified|5|||
164094522|NCT03657160|592710252|FG001|Overall Study|Reason Not Specified|5|||
164094523|NCT03657160|592710251|FG000|Overall Study|Other (COVID-19-Related)|0|||
164094524|NCT03657160|592710252|FG001|Overall Study|Other (COVID-19-Related)|1|||
164094525|NCT02732210|592710254|FG000|Overall Study|Site Closed|0|||
164094526|NCT02732210|592710255|FG001|Overall Study|Site Closed|11|||
164094527|NCT02732210|592710254|FG000|Overall Study|Study Ended|13|||
164094528|NCT02732210|592710255|FG001|Overall Study|Study Ended|13|||
164094529|NCT02732210|592710254|FG000|Overall Study|Withdrawal by Subject|28|||
164094530|NCT02732210|592710255|FG001|Overall Study|Withdrawal by Subject|87|||
164094531|NCT02732210|592710254|FG000|Overall Study|Lost to Follow-up|5|||
164094532|NCT02732210|592710255|FG001|Overall Study|Lost to Follow-up|57|||
164094533|NCT02732210|592710254|FG000|Overall Study|Death|4|||
164094534|NCT02732210|592710255|FG001|Overall Study|Death|15|||
164094535|NCT02732210|592710254|FG000|Overall Study|Other|35|||
164094536|NCT02732210|592710255|FG001|Overall Study|Other|103|||
164094537|NCT02732210|592710254|FG000|Overall Study|Missing|0|||
164094538|NCT02732210|592710255|FG001|Overall Study|Missing|8|||
164094539|NCT00686959|592710256|FG000|Overall Study|Participants censored (no death events)|124|||
164094540|NCT00686959|592710257|FG001|Overall Study|Participants censored (no death events)|117|||
164094541|NCT01876706|592710258|FG000|Overall Study|BPH Intervention|9|||
164094542|NCT01876706|592710258|FG000|Overall Study|Lost to Follow-up|7|||
164094543|NCT01876706|592710258|FG000|Overall Study|Withdrawals|6|||
164094544|NCT01876706|592710258|FG000|Overall Study|Death|3|||
164094545|NCT00604500|592710259|FG000|Overall Study|Adverse Event|2|||
164094546|NCT00604500|592710259|FG000|Overall Study|Protocol Violation|2|||
164094547|NCT00604500|592710259|FG000|Overall Study|Treatment Failure|1|||
164094548|NCT00604500|592710259|FG000|Overall Study|Withdrawal by Subject|4|||
164094549|NCT00604500|592710259|FG000|Overall Study|Administrative|1|||
164094550|NCT00604500|592710259|FG000|Overall Study|Did not meet protocol eligibility|1|||
164094551|NCT02191891|592710260|FG000|Overall Study|Withdrawal by Subject|0|||
164094552|NCT02191891|592710261|FG001|Overall Study|Withdrawal by Subject|1|||
164094553|NCT02191891|592710262|FG002|Overall Study|Withdrawal by Subject|0|||
164094554|NCT02191891|592710263|FG003|Overall Study|Withdrawal by Subject|0|||
164094555|NCT02191891|592710264|FG004|Overall Study|Withdrawal by Subject|1|||
164094556|NCT02191891|592710260|FG000|Overall Study|Adverse Event|0|||
164094557|NCT02191891|592710261|FG001|Overall Study|Adverse Event|1|||
164094558|NCT02191891|592710262|FG002|Overall Study|Adverse Event|0|||
164094559|NCT02191891|592710263|FG003|Overall Study|Adverse Event|0|||
164094560|NCT02191891|592710264|FG004|Overall Study|Adverse Event|2|||
164094561|NCT02191891|592710260|FG000|Overall Study|Disease Progression|4|||
164094562|NCT02191891|592710261|FG001|Overall Study|Disease Progression|10|||
164094563|NCT02191891|592710262|FG002|Overall Study|Disease Progression|4|||
164094564|NCT02191891|592710263|FG003|Overall Study|Disease Progression|2|||
164094565|NCT02191891|592710264|FG004|Overall Study|Disease Progression|7|||
164094566|NCT03099538|592710266|FG000|Overall Study|Lack of Efficacy|3|||
164094567|NCT01448057|592710267|FG000|Overall Study|Protocol Violation|3|||
164094568|NCT01448057|592710268|FG001|Overall Study|Protocol Violation|2|||
164094569|NCT01448057|592710267|FG000|Overall Study|Lost to Follow-up|3|||
164094570|NCT01448057|592710268|FG001|Overall Study|Lost to Follow-up|0|||
164094571|NCT01448057|592710267|FG000|Overall Study|Adverse Event|0|||
164094572|NCT01448057|592710268|FG001|Overall Study|Adverse Event|2|||
164094573|NCT01448057|592710267|FG000|Overall Study|Withdrawal by Subject|2|||
164094574|NCT01448057|592710268|FG001|Overall Study|Withdrawal by Subject|0|||
164094575|NCT02468778|592710271|FG000|Overall Study|Death|2|||
164094576|NCT02468778|592710272|FG001|Overall Study|Death|1|||
163906927|NCT02605174|592031207|FG003|Overall Study|Physician Decision|0|||
163906928|NCT02605174|592031208|FG004|Overall Study|Physician Decision|0|||
163906929|NCT02605174|592031209|FG005|Overall Study|Physician Decision|0|||
163906930|NCT02605174|592031210|FG006|Overall Study|Physician Decision|3|||
163906931|NCT02605174|592031204|FG000|Overall Study|Randomization Failure|22|||
163906932|NCT02605174|592031205|FG001|Overall Study|Randomization Failure|6|||
163906933|NCT02605174|592031206|FG002|Overall Study|Randomization Failure|20|||
164094577|NCT02468778|592710273|FG002|Overall Study|Death|0|||
164094578|NCT02468778|592710271|FG000|Overall Study|Lost to Follow-up|1|||
164094579|NCT02468778|592710272|FG001|Overall Study|Lost to Follow-up|2|||
164094580|NCT02468778|592710273|FG002|Overall Study|Lost to Follow-up|2|||
164094581|NCT02468778|592710271|FG000|Overall Study|Withdrawal by Subject|0|||
164094582|NCT02468778|592710272|FG001|Overall Study|Withdrawal by Subject|1|||
164094583|NCT02468778|592710273|FG002|Overall Study|Withdrawal by Subject|1|||
164094584|NCT03912337|592710287|FG000|Overall Study|Withdrawal of Consent From Study|1|||
164094585|NCT03912337|592710288|FG001|Overall Study|Withdrawal of Consent From Study|0|||
164094586|NCT03912337|592710287|FG000|Overall Study|Lost to Follow-up|1|||
164094587|NCT03912337|592710288|FG001|Overall Study|Lost to Follow-up|1|||
163906934|NCT02605174|592031207|FG003|Overall Study|Randomization Failure|7|||
163906935|NCT02605174|592031208|FG004|Overall Study|Randomization Failure|16|||
163906936|NCT02605174|592031209|FG005|Overall Study|Randomization Failure|11|||
163906937|NCT02605174|592031210|FG006|Overall Study|Randomization Failure|30|||
164017984|NCT01635933|592428683|FG000|Overall Study|No longer had transportation|0|||
164017985|NCT01635933|592428684|FG001|Overall Study|No longer had transportation|1|||
164017986|NCT01544595|592428685|FG000|Status at Week 68|Adverse Event|3|||
163906938|NCT04250636|592031213|FG000|Overall Study|Lost to Follow-up|2|||
163906939|NCT01128959|592031214|FG000|Lead in Period|Adverse Event|3|||
163906940|NCT01128959|592031214|FG000|Treatment Period|Adverse Event|3|||
163906941|NCT01128959|592031214|FG000|Treatment Period|Withdrawal by Subject|1|||
163906942|NCT01409837|592031215|FG000|Overall Study|Withdrawal by Subject|2|||
163906943|NCT01409837|592031216|FG001|Overall Study|Withdrawal by Subject|1|||
163906944|NCT01409837|592031215|FG000|Overall Study|Lost to Follow-up|1|||
163906945|NCT01409837|592031216|FG001|Overall Study|Lost to Follow-up|0|||
163906946|NCT01409837|592031215|FG000|Overall Study|Physician Decision|0|||
163906947|NCT01409837|592031216|FG001|Overall Study|Physician Decision|1|||
163906948|NCT04938453|592031219|FG000|Washout Period 1|Adverse Event|1|||
163906949|NCT04938453|592031220|FG001|Washout Period 1|Adverse Event|0|||
163906950|NCT04938453|592031219|FG000|Washout Period 1|Physician Decision|0|||
163906951|NCT04938453|592031220|FG001|Washout Period 1|Physician Decision|1|||
163906952|NCT03292406|592031222|FG000|Overall Study|Progressive Disease|6|||
163906953|NCT03292406|592031223|FG001|Overall Study|Progressive Disease|3|||
163906954|NCT03292406|592031224|FG002|Overall Study|Progressive Disease|4|||
163906955|NCT03292406|592031222|FG000|Overall Study|Adverse Event|7|||
163906956|NCT03292406|592031223|FG001|Overall Study|Adverse Event|1|||
163906957|NCT03292406|592031224|FG002|Overall Study|Adverse Event|4|||
163906958|NCT03292406|592031222|FG000|Overall Study|Withdrawal by Subject|0|||
163906959|NCT03292406|592031223|FG001|Overall Study|Withdrawal by Subject|7|||
163906960|NCT03292406|592031224|FG002|Overall Study|Withdrawal by Subject|2|||
163906961|NCT03292406|592031222|FG000|Overall Study|Protocol Violation|0|||
163906962|NCT03292406|592031223|FG001|Overall Study|Protocol Violation|1|||
163906963|NCT03292406|592031224|FG002|Overall Study|Protocol Violation|1|||
163906964|NCT03292406|592031222|FG000|Overall Study|Other|0|||
163906965|NCT03292406|592031223|FG001|Overall Study|Other|1|||
163906966|NCT03292406|592031224|FG002|Overall Study|Other|2|||
163906967|NCT00308308|592031225|FG000|Overall Study|Adverse Event|17|||
163906968|NCT00308308|592031226|FG001|Overall Study|Adverse Event|2|||
163906969|NCT00308308|592031225|FG000|Overall Study|Lost to Follow-up|5|||
163906970|NCT00308308|592031226|FG001|Overall Study|Lost to Follow-up|5|||
163906971|NCT00308308|592031225|FG000|Overall Study|Physician Decision|15|||
163906972|NCT00308308|592031226|FG001|Overall Study|Physician Decision|7|||
163906973|NCT00308308|592031225|FG000|Overall Study|Protocol Violation|3|||
163906974|NCT00308308|592031226|FG001|Overall Study|Protocol Violation|14|||
163906975|NCT00308308|592031225|FG000|Overall Study|Withdrawal by Subject|47|||
163906976|NCT00308308|592031226|FG001|Overall Study|Withdrawal by Subject|19|||
163906977|NCT00308308|592031225|FG000|Overall Study|Various|7|||
163906978|NCT00308308|592031226|FG001|Overall Study|Various|5|||
163906979|NCT00308308|592031225|FG000|Overall Study|Randomized but not dosed|8|||
163906980|NCT00308308|592031226|FG001|Overall Study|Randomized but not dosed|16|||
163906981|NCT00308308|592031225|FG000|Overall Study|Other|1|||
163906982|NCT00308308|592031226|FG001|Overall Study|Other|0|||
163906983|NCT01852045|592031229|FG000|Overall Study|Adverse Event|1|||
163906984|NCT01852045|592031230|FG001|Overall Study|Adverse Event|0|||
163906985|NCT01852045|592031231|FG002|Overall Study|Adverse Event|0|||
163906986|NCT01852045|592031229|FG000|Overall Study|Lack of Efficacy|3|||
163906987|NCT01852045|592031230|FG001|Overall Study|Lack of Efficacy|0|||
163906988|NCT01852045|592031231|FG002|Overall Study|Lack of Efficacy|0|||
163906989|NCT01852045|592031229|FG000|Overall Study|Lost to Follow-up|0|||
163906990|NCT01852045|592031230|FG001|Overall Study|Lost to Follow-up|1|||
163906991|NCT01852045|592031231|FG002|Overall Study|Lost to Follow-up|1|||
163906992|NCT01852045|592031229|FG000|Overall Study|Withdrawal by Subject|1|||
163906993|NCT01852045|592031230|FG001|Overall Study|Withdrawal by Subject|0|||
163906994|NCT01852045|592031231|FG002|Overall Study|Withdrawal by Subject|1|||
163906995|NCT01852045|592031229|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163906996|NCT01852045|592031230|FG001|Overall Study|Other Miscellaneous Reasons|3|||
163906997|NCT01852045|592031231|FG002|Overall Study|Other Miscellaneous Reasons|2|||
163906998|NCT01951703|592031232|FG000|First Intervention|Withdrawal by Subject|1|||
163906999|NCT01951703|592031233|FG001|First Intervention|Withdrawal by Subject|0|||
163907000|NCT01951703|592031232|FG000|First Intervention|Subject was not compliant|1|||
163907001|NCT01951703|592031233|FG001|First Intervention|Subject was not compliant|1|||
163907002|NCT01951703|592031232|FG000|First Intervention|Physician Decision|1|||
163907003|NCT01951703|592031233|FG001|First Intervention|Physician Decision|0|||
163907004|NCT01951703|592031232|FG000|Second Intervention|Protocol Violation|0|||
163907005|NCT01951703|592031233|FG001|Second Intervention|Protocol Violation|1|||
163907006|NCT01951703|592031232|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
163907007|NCT01951703|592031233|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
164017987|NCT01544595|592428686|FG001|Status at Week 68|Adverse Event|2|||
164017988|NCT01544595|592428687|FG002|Status at Week 68|Adverse Event|1|||
164017989|NCT01544595|592428688|FG003|Status at Week 68|Adverse Event|0|||
164017990|NCT01544595|592428689|FG004|Status at Week 68|Adverse Event|0|||
164017991|NCT01544595|592428690|FG005|Status at Week 68|Adverse Event|0|||
164017992|NCT01544595|592428685|FG000|Status at Week 68|Lack of Efficacy|1|||
164017993|NCT01544595|592428686|FG001|Status at Week 68|Lack of Efficacy|0|||
164017994|NCT01544595|592428687|FG002|Status at Week 68|Lack of Efficacy|0|||
164017995|NCT01544595|592428688|FG003|Status at Week 68|Lack of Efficacy|0|||
164017996|NCT01544595|592428689|FG004|Status at Week 68|Lack of Efficacy|0|||
164017997|NCT01544595|592428690|FG005|Status at Week 68|Lack of Efficacy|0|||
164017998|NCT01544595|592428685|FG000|Status at Week 68|Lost to Follow-up|1|||
164017999|NCT01544595|592428686|FG001|Status at Week 68|Lost to Follow-up|1|||
164018000|NCT01544595|592428687|FG002|Status at Week 68|Lost to Follow-up|0|||
164018001|NCT01544595|592428688|FG003|Status at Week 68|Lost to Follow-up|0|||
164018002|NCT01544595|592428689|FG004|Status at Week 68|Lost to Follow-up|0|||
164018003|NCT01544595|592428690|FG005|Status at Week 68|Lost to Follow-up|0|||
164018004|NCT01544595|592428685|FG000|Status at Week 68|Non-compliance with study treatment|1|||
164018005|NCT01544595|592428686|FG001|Status at Week 68|Non-compliance with study treatment|0|||
164018006|NCT01544595|592428687|FG002|Status at Week 68|Non-compliance with study treatment|0|||
164018007|NCT01544595|592428688|FG003|Status at Week 68|Non-compliance with study treatment|1|||
164018008|NCT01544595|592428689|FG004|Status at Week 68|Non-compliance with study treatment|0|||
164018009|NCT01544595|592428690|FG005|Status at Week 68|Non-compliance with study treatment|0|||
164018010|NCT01544595|592428685|FG000|Status at Week 68|Protocol Violation|2|||
164018011|NCT01544595|592428686|FG001|Status at Week 68|Protocol Violation|0|||
164018012|NCT01544595|592428687|FG002|Status at Week 68|Protocol Violation|1|||
164018013|NCT01544595|592428688|FG003|Status at Week 68|Protocol Violation|1|||
164018014|NCT01544595|592428689|FG004|Status at Week 68|Protocol Violation|0|||
164018015|NCT01544595|592428690|FG005|Status at Week 68|Protocol Violation|0|||
164018016|NCT01544595|592428685|FG000|Status at Week 68|Technical problems|1|||
164018017|NCT01544595|592428686|FG001|Status at Week 68|Technical problems|0|||
164018018|NCT01544595|592428687|FG002|Status at Week 68|Technical problems|0|||
164018019|NCT01544595|592428688|FG003|Status at Week 68|Technical problems|1|||
164018020|NCT01544595|592428689|FG004|Status at Week 68|Technical problems|0|||
164018021|NCT01544595|592428690|FG005|Status at Week 68|Technical problems|0|||
164018022|NCT01544595|592428685|FG000|Status at Week 68|Withdrawal by Subject|0|||
164018023|NCT01544595|592428686|FG001|Status at Week 68|Withdrawal by Subject|1|||
164018024|NCT01544595|592428687|FG002|Status at Week 68|Withdrawal by Subject|1|||
164018025|NCT01544595|592428688|FG003|Status at Week 68|Withdrawal by Subject|2|||
164018026|NCT01544595|592428689|FG004|Status at Week 68|Withdrawal by Subject|0|||
164018027|NCT01544595|592428690|FG005|Status at Week 68|Withdrawal by Subject|0|||
164018028|NCT01544595|592428685|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
164018029|NCT01544595|592428686|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
164018030|NCT01544595|592428687|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
164018031|NCT01544595|592428688|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
164018032|NCT01544595|592428689|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
164018033|NCT01544595|592428690|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
164018034|NCT01544595|592428685|FG000|Status at Week 156|Withdrawal by Subject|9|||
164018035|NCT01544595|592428686|FG001|Status at Week 156|Withdrawal by Subject|10|||
164018036|NCT01544595|592428687|FG002|Status at Week 156|Withdrawal by Subject|4|||
164018037|NCT01544595|592428688|FG003|Status at Week 156|Withdrawal by Subject|9|||
164018038|NCT01544595|592428689|FG004|Status at Week 156|Withdrawal by Subject|20|||
164018039|NCT01544595|592428690|FG005|Status at Week 156|Withdrawal by Subject|6|||
164018040|NCT01544595|592428685|FG000|Status at Week 156|Adverse Event|9|||
164018041|NCT01544595|592428686|FG001|Status at Week 156|Adverse Event|11|||
164018042|NCT01544595|592428687|FG002|Status at Week 156|Adverse Event|1|||
164018043|NCT01544595|592428688|FG003|Status at Week 156|Adverse Event|3|||
164018044|NCT01544595|592428689|FG004|Status at Week 156|Adverse Event|4|||
164018045|NCT01544595|592428690|FG005|Status at Week 156|Adverse Event|2|||
164018046|NCT01544595|592428685|FG000|Status at Week 156|Lost to Follow-up|4|||
164018047|NCT01544595|592428686|FG001|Status at Week 156|Lost to Follow-up|4|||
164018048|NCT01544595|592428687|FG002|Status at Week 156|Lost to Follow-up|0|||
164018049|NCT01544595|592428688|FG003|Status at Week 156|Lost to Follow-up|1|||
164018050|NCT01544595|592428689|FG004|Status at Week 156|Lost to Follow-up|4|||
164018051|NCT01544595|592428690|FG005|Status at Week 156|Lost to Follow-up|1|||
164018052|NCT01544595|592428685|FG000|Status at Week 156|Non-compliance with study treatement|0|||
164018053|NCT01544595|592428686|FG001|Status at Week 156|Non-compliance with study treatement|1|||
164018054|NCT01544595|592428687|FG002|Status at Week 156|Non-compliance with study treatement|0|||
164018055|NCT01544595|592428688|FG003|Status at Week 156|Non-compliance with study treatement|1|||
164018056|NCT01544595|592428689|FG004|Status at Week 156|Non-compliance with study treatement|0|||
164018057|NCT01544595|592428690|FG005|Status at Week 156|Non-compliance with study treatement|1|||
164018058|NCT01544595|592428685|FG000|Status at Week 156|Physician Decision|0|||
164018059|NCT01544595|592428686|FG001|Status at Week 156|Physician Decision|3|||
164018060|NCT01544595|592428687|FG002|Status at Week 156|Physician Decision|1|||
164094588|NCT03561883|592710291|FG000|Overall Study|Adverse Event|10|||
164094589|NCT03561883|592710292|FG001|Overall Study|Adverse Event|13|||
164094590|NCT03561883|592710291|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164094591|NCT03561883|592710292|FG001|Overall Study|Non-Compliance With Study Drug|2|||
164094592|NCT03561883|592710291|FG000|Overall Study|Protocol Violation|2|||
164094593|NCT03561883|592710292|FG001|Overall Study|Protocol Violation|3|||
164094594|NCT03561883|592710291|FG000|Overall Study|Withdrawal by Subject|14|||
164094595|NCT03561883|592710292|FG001|Overall Study|Withdrawal by Subject|6|||
164094596|NCT03561883|592710291|FG000|Overall Study|Lost to Follow-up|2|||
164094597|NCT03561883|592710292|FG001|Overall Study|Lost to Follow-up|6|||
164094598|NCT03561883|592710291|FG000|Overall Study|Study Terminated by Sponsor|12|||
164094599|NCT03561883|592710292|FG001|Overall Study|Study Terminated by Sponsor|11|||
164094600|NCT03561883|592710291|FG000|Overall Study|Physician Decision|1|||
164094601|NCT03561883|592710292|FG001|Overall Study|Physician Decision|0|||
164094602|NCT03561883|592710291|FG000|Overall Study|Randomized by Mistake|1|||
164094603|NCT03561883|592710292|FG001|Overall Study|Randomized by Mistake|0|||
164094604|NCT03561883|592710291|FG000|Overall Study|Other, Not Specified|3|||
164094605|NCT03561883|592710292|FG001|Overall Study|Other, Not Specified|2|||
164094606|NCT03978624|592710293|FG000|Overall Study|Protocol Violation|1|||
164094607|NCT03978624|592710294|FG001|Overall Study|Protocol Violation|0|||
164094608|NCT04646109|592710296|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
164094609|NCT04646109|592710297|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
164094610|NCT06176768|592710298|FG000|Overall Study|Adverse Event|1|||
164094611|NCT06176768|592710299|FG001|Overall Study|Adverse Event|0|||
164094612|NCT06176768|592710298|FG000|Overall Study|Assigned treatment by mistake|1|||
164094613|NCT06176768|592710299|FG001|Overall Study|Assigned treatment by mistake|0|||
164094614|NCT06176768|592710298|FG000|Overall Study|Lost to Follow-up|0|||
164094615|NCT06176768|592710299|FG001|Overall Study|Lost to Follow-up|3|||
164094616|NCT06176768|592710298|FG000|Overall Study|Physician Decision|1|||
164094617|NCT06176768|592710299|FG001|Overall Study|Physician Decision|0|||
164094618|NCT06176768|592710298|FG000|Overall Study|Protocol deviation|3|||
164094619|NCT06176768|592710299|FG001|Overall Study|Protocol deviation|1|||
164094620|NCT06176768|592710298|FG000|Overall Study|Other|1|||
164094621|NCT06176768|592710299|FG001|Overall Study|Other|0|||
164094622|NCT06176768|592710298|FG000|Overall Study|Withdrawal by Subject|6|||
164094623|NCT06176768|592710299|FG001|Overall Study|Withdrawal by Subject|9|||
164094624|NCT01606306|592710304|FG000|Overall Study|Lack of Efficacy|2|||
164094625|NCT01606306|592710305|FG001|Overall Study|Lack of Efficacy|1|||
164094626|NCT01606306|592710306|FG002|Overall Study|Lack of Efficacy|4|||
164094627|NCT01606306|592710307|FG003|Overall Study|Lack of Efficacy|4|||
164094628|NCT01606306|592710308|FG004|Overall Study|Lack of Efficacy|1|||
164094629|NCT01606306|592710309|FG005|Overall Study|Lack of Efficacy|2|||
164094630|NCT01606306|592710304|FG000|Overall Study|Adverse Event|1|||
164094631|NCT01606306|592710305|FG001|Overall Study|Adverse Event|0|||
164094632|NCT01606306|592710306|FG002|Overall Study|Adverse Event|1|||
164094633|NCT01606306|592710307|FG003|Overall Study|Adverse Event|1|||
164094634|NCT01606306|592710308|FG004|Overall Study|Adverse Event|2|||
164094635|NCT01606306|592710309|FG005|Overall Study|Adverse Event|0|||
164094636|NCT01606306|592710304|FG000|Overall Study|Lost to Follow-up|7|||
164094637|NCT01606306|592710305|FG001|Overall Study|Lost to Follow-up|4|||
164094638|NCT01606306|592710306|FG002|Overall Study|Lost to Follow-up|5|||
164094639|NCT01606306|592710307|FG003|Overall Study|Lost to Follow-up|4|||
164094640|NCT01606306|592710308|FG004|Overall Study|Lost to Follow-up|3|||
164094641|NCT01606306|592710309|FG005|Overall Study|Lost to Follow-up|5|||
164094642|NCT01606306|592710304|FG000|Overall Study|Withdrawal by Subject|4|||
164094643|NCT01606306|592710305|FG001|Overall Study|Withdrawal by Subject|3|||
164094644|NCT01606306|592710306|FG002|Overall Study|Withdrawal by Subject|4|||
164094645|NCT01606306|592710307|FG003|Overall Study|Withdrawal by Subject|4|||
164094646|NCT01606306|592710308|FG004|Overall Study|Withdrawal by Subject|5|||
164094647|NCT01606306|592710309|FG005|Overall Study|Withdrawal by Subject|4|||
163907008|NCT02827201|592031234|FG000|Overall Study|Death|1|||
164094648|NCT01606306|592710304|FG000|Overall Study|Physician Decision|1|||
164094649|NCT01606306|592710305|FG001|Overall Study|Physician Decision|2|||
163907009|NCT02827201|592031235|FG001|Overall Study|Death|2|||
164094650|NCT01606306|592710306|FG002|Overall Study|Physician Decision|0|||
164094651|NCT01606306|592710307|FG003|Overall Study|Physician Decision|0|||
164094652|NCT01606306|592710308|FG004|Overall Study|Physician Decision|0|||
164094653|NCT01606306|592710309|FG005|Overall Study|Physician Decision|0|||
164094654|NCT01759290|592710312|FG000|Overall Study|Subjects withdrawn consent|5|||
164094655|NCT01759290|592710312|FG000|Overall Study|Physician Decision|2|||
164094656|NCT01759290|592710312|FG000|Overall Study|Death|17|||
164094657|NCT01759290|592710312|FG000|Overall Study|Lost to Follow-up|53|||
164094658|NCT01759290|592710312|FG000|Overall Study|Unknown reason|4|||
164094659|NCT01766778|592710320|FG000|Overall Study|Adverse Event|4|||
164094660|NCT01766778|592710321|FG001|Overall Study|Adverse Event|4|||
164094661|NCT01766778|592710320|FG000|Overall Study|Withdrawal by Subject|1|||
164094662|NCT01766778|592710321|FG001|Overall Study|Withdrawal by Subject|0|||
164094663|NCT02888171|592710327|FG000|Overall Study|Lost to Follow-up|2|||
164094664|NCT02888171|592710328|FG001|Overall Study|Lost to Follow-up|1|||
164094665|NCT02888171|592710327|FG000|Overall Study|Withdrawal by Subject|3|||
164094666|NCT02888171|592710328|FG001|Overall Study|Withdrawal by Subject|2|||
164094667|NCT02888171|592710327|FG000|Overall Study|Adverse Event|0|||
164094668|NCT02888171|592710328|FG001|Overall Study|Adverse Event|1|||
164094669|NCT02937701|592712144|FG000|Day 1 to Week 22|Adverse Event|11|||
164094670|NCT02937701|592712145|FG001|Day 1 to Week 22|Adverse Event|14|||
164094671|NCT02937701|592712146|FG002|Day 1 to Week 22|Adverse Event|0|||
164094672|NCT02937701|592712147|FG003|Day 1 to Week 22|Adverse Event|0|||
164094673|NCT02937701|592712148|FG004|Day 1 to Week 22|Adverse Event|0|||
164094674|NCT02937701|592712144|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
164094675|NCT02937701|592712145|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
164094676|NCT02937701|592712146|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
164094677|NCT02937701|592712147|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
164094678|NCT02937701|592712148|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
164094679|NCT02937701|592712144|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
164094680|NCT02937701|592712145|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
164094681|NCT02937701|592712146|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
164094682|NCT02937701|592712147|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
164094683|NCT02937701|592712148|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
164094684|NCT02937701|592712144|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
164094685|NCT02937701|592712145|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
164094686|NCT02937701|592712146|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
164094687|NCT02937701|592712147|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
164094688|NCT02937701|592712148|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
164094689|NCT02937701|592712144|FG000|Day 1 to Week 22|Death|1|||
164094690|NCT02937701|592712145|FG001|Day 1 to Week 22|Death|1|||
164094691|NCT02937701|592712146|FG002|Day 1 to Week 22|Death|0|||
164094692|NCT02937701|592712147|FG003|Day 1 to Week 22|Death|0|||
164094693|NCT02937701|592712148|FG004|Day 1 to Week 22|Death|0|||
164094694|NCT02937701|592712144|FG000|Day 1 to Week 22|Protocol Violation|1|||
164094695|NCT02937701|592712145|FG001|Day 1 to Week 22|Protocol Violation|1|||
164094696|NCT02937701|592712146|FG002|Day 1 to Week 22|Protocol Violation|0|||
164094697|NCT02937701|592712147|FG003|Day 1 to Week 22|Protocol Violation|0|||
164094698|NCT02937701|592712148|FG004|Day 1 to Week 22|Protocol Violation|0|||
164094699|NCT02937701|592712144|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
164094700|NCT02937701|592712145|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
164094701|NCT02937701|592712146|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
164094702|NCT02937701|592712147|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
164094703|NCT02937701|592712148|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
164094704|NCT02937701|592712144|FG000|Day 1 to Week 22|Physician Decision|2|||
164094705|NCT02937701|592712145|FG001|Day 1 to Week 22|Physician Decision|0|||
164094706|NCT02937701|592712146|FG002|Day 1 to Week 22|Physician Decision|0|||
164094707|NCT02937701|592712147|FG003|Day 1 to Week 22|Physician Decision|0|||
164094708|NCT02937701|592712148|FG004|Day 1 to Week 22|Physician Decision|0|||
164094709|NCT02937701|592712144|FG000|Day 1 to Week 22|Other|1|||
164094710|NCT02937701|592712145|FG001|Day 1 to Week 22|Other|0|||
164094711|NCT02937701|592712146|FG002|Day 1 to Week 22|Other|0|||
164094712|NCT02937701|592712147|FG003|Day 1 to Week 22|Other|0|||
164094713|NCT02937701|592712148|FG004|Day 1 to Week 22|Other|0|||
164094714|NCT02937701|592712144|FG000|Week 22 to Week 50|Adverse Event|0|||
164094715|NCT02937701|592712145|FG001|Week 22 to Week 50|Adverse Event|0|||
164094716|NCT02937701|592712146|FG002|Week 22 to Week 50|Adverse Event|10|||
164094717|NCT02937701|592712147|FG003|Week 22 to Week 50|Adverse Event|3|||
164094718|NCT02937701|592712148|FG004|Week 22 to Week 50|Adverse Event|3|||
164094719|NCT02937701|592712144|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
164094720|NCT02937701|592712145|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
164094721|NCT02937701|592712146|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
164094722|NCT02937701|592712147|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
164094723|NCT02937701|592712148|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
164094724|NCT02937701|592712144|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
164094725|NCT02937701|592712145|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
164094726|NCT02937701|592712146|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
164094727|NCT02937701|592712147|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
164094728|NCT02937701|592712148|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
164094729|NCT02937701|592712144|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
164094730|NCT02937701|592712145|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
164094731|NCT02937701|592712146|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
164094732|NCT02937701|592712147|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
164094733|NCT02937701|592712148|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
164094734|NCT02937701|592712144|FG000|Week 22 to Week 50|Physician Decision|0|||
164094735|NCT02937701|592712145|FG001|Week 22 to Week 50|Physician Decision|0|||
164094736|NCT02937701|592712146|FG002|Week 22 to Week 50|Physician Decision|2|||
164094737|NCT02937701|592712147|FG003|Week 22 to Week 50|Physician Decision|0|||
164094738|NCT02937701|592712148|FG004|Week 22 to Week 50|Physician Decision|1|||
164094739|NCT02937701|592712144|FG000|Week 22 to Week 50|Other|0|||
164094740|NCT02937701|592712145|FG001|Week 22 to Week 50|Other|0|||
164094741|NCT02937701|592712146|FG002|Week 22 to Week 50|Other|0|||
164094742|NCT02937701|592712147|FG003|Week 22 to Week 50|Other|0|||
164094743|NCT02937701|592712148|FG004|Week 22 to Week 50|Other|1|||
164094744|NCT01507051|592712149|FG000|Overall Study|Withdrawal by Subject|1|||
164094745|NCT01507051|592712150|FG001|Overall Study|Withdrawal by Subject|3|||
164094746|NCT01507051|592712151|FG002|Overall Study|Withdrawal by Subject|1|||
164094747|NCT01507051|592712152|FG003|Overall Study|Withdrawal by Subject|6|||
164094748|NCT01507051|592712149|FG000|Overall Study|Physician Decision|0|||
164094749|NCT01507051|592712150|FG001|Overall Study|Physician Decision|0|||
164094750|NCT01507051|592712151|FG002|Overall Study|Physician Decision|0|||
164094751|NCT01507051|592712152|FG003|Overall Study|Physician Decision|1|||
164094752|NCT01507051|592712149|FG000|Overall Study|Adverse Event|1|||
164094753|NCT01507051|592712150|FG001|Overall Study|Adverse Event|0|||
164094754|NCT01507051|592712151|FG002|Overall Study|Adverse Event|0|||
164094755|NCT01507051|592712152|FG003|Overall Study|Adverse Event|0|||
164094756|NCT01101022|592712153|FG000|Overall Study|Adverse Event|6|||
164094757|NCT01101022|592712154|FG001|Overall Study|Adverse Event|2|||
164094758|NCT01101022|592712153|FG000|Overall Study|Protocol Violation|4|||
164094759|NCT01101022|592712154|FG001|Overall Study|Protocol Violation|3|||
164094760|NCT01101022|592712153|FG000|Overall Study|Withdrawal by Subject|3|||
164094761|NCT01101022|592712154|FG001|Overall Study|Withdrawal by Subject|8|||
164094762|NCT01101022|592712153|FG000|Overall Study|Lost to Follow-up|1|||
164094763|NCT01101022|592712154|FG001|Overall Study|Lost to Follow-up|4|||
164094764|NCT01101022|592712153|FG000|Overall Study|Lack of Efficacy|0|||
164094765|NCT01101022|592712154|FG001|Overall Study|Lack of Efficacy|7|||
164094766|NCT01101022|592712153|FG000|Overall Study|Sponsor decision|1|||
164094767|NCT01101022|592712154|FG001|Overall Study|Sponsor decision|1|||
164094768|NCT01101022|592712153|FG000|Overall Study|Non-compliance|1|||
164094769|NCT01101022|592712154|FG001|Overall Study|Non-compliance|0|||
164094770|NCT01101022|592712153|FG000|Overall Study|Work schedule|1|||
164094771|NCT01101022|592712154|FG001|Overall Study|Work schedule|1|||
164094772|NCT01101022|592712153|FG000|Overall Study|Vacation|0|||
164094773|NCT01101022|592712154|FG001|Overall Study|Vacation|1|||
164094774|NCT03075761|592712155|FG000|Overall Study|Lost to Follow-up|1|||
164094775|NCT03075761|592712156|FG001|Overall Study|Lost to Follow-up|6|||
164094776|NCT01139047|592712157|FG000|Overall Study|Withdrawal by Subject|1|||
164094777|NCT00420303|592712162|FG000|Overall Study|Serious Adverse Event|1|||
164094778|NCT00420303|592712163|FG001|Overall Study|Serious Adverse Event|0|||
164094779|NCT00420303|592712162|FG000|Overall Study|Lack of Efficacy|0|||
164094780|NCT00420303|592712163|FG001|Overall Study|Lack of Efficacy|3|||
164094781|NCT00420303|592712162|FG000|Overall Study|Physician Decision|0|||
164094782|NCT00420303|592712163|FG001|Overall Study|Physician Decision|1|||
164094783|NCT01941095|592712164|FG000|Overall Study|Insufficient therapeutic response|13|||
164094784|NCT01941095|592712164|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
164094785|NCT01941095|592712164|FG000|Overall Study|Adverse Event|11|||
164094786|NCT01941095|592712164|FG000|Overall Study|Physician Decision|3|||
164094787|NCT01941095|592712164|FG000|Overall Study|Withdrawal by Subject|17|||
164094788|NCT01941095|592712164|FG000|Overall Study|Lost to Follow-up|10|||
164094789|NCT04455633|592712166|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
164094790|NCT04455633|592712167|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
164094791|NCT04455633|592712168|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
164094792|NCT04455633|592712166|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
164094793|NCT04455633|592712167|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
164094794|NCT04455633|592712168|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
164094795|NCT04455633|592712166|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
164094796|NCT04455633|592712167|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
164094797|NCT04455633|592712168|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
164094798|NCT04455633|592712166|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
164094799|NCT04455633|592712167|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
164094800|NCT04455633|592712168|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
164094801|NCT01648166|592712169|FG000|Overall Study|inadequate toenail samples|53|||
164094802|NCT01648166|592712170|FG001|Overall Study|inadequate toenail samples|100|||
164094803|NCT00883090|592712171|FG000|Overall Study|Sponsor's decision|1|||
164094804|NCT00883090|592712171|FG000|Overall Study|Withdrawal by Subject|1|||
164094805|NCT03527745|592712172|FG000|Overall Study|Lost to Follow-up|3|||
164094806|NCT03527745|592712173|FG001|Overall Study|Lost to Follow-up|6|||
164094807|NCT03527745|592712174|FG002|Overall Study|Lost to Follow-up|7|||
164094808|NCT03527745|592712175|FG003|Overall Study|Lost to Follow-up|9|||
164018061|NCT01544595|592428688|FG003|Status at Week 156|Physician Decision|0|||
164018062|NCT01544595|592428689|FG004|Status at Week 156|Physician Decision|0|||
164018063|NCT01544595|592428690|FG005|Status at Week 156|Physician Decision|0|||
164018064|NCT01544595|592428685|FG000|Status at Week 156|Pregnancy|2|||
164018065|NCT01544595|592428686|FG001|Status at Week 156|Pregnancy|3|||
164018066|NCT01544595|592428687|FG002|Status at Week 156|Pregnancy|0|||
164018067|NCT01544595|592428688|FG003|Status at Week 156|Pregnancy|0|||
164018068|NCT01544595|592428689|FG004|Status at Week 156|Pregnancy|0|||
164018069|NCT01544595|592428690|FG005|Status at Week 156|Pregnancy|0|||
164018070|NCT01544595|592428685|FG000|Status at Week 156|Protocol Violation|3|||
164018071|NCT01544595|592428686|FG001|Status at Week 156|Protocol Violation|1|||
164018072|NCT01544595|592428687|FG002|Status at Week 156|Protocol Violation|2|||
164018073|NCT01544595|592428688|FG003|Status at Week 156|Protocol Violation|2|||
164018074|NCT01544595|592428689|FG004|Status at Week 156|Protocol Violation|0|||
164018075|NCT01544595|592428690|FG005|Status at Week 156|Protocol Violation|0|||
164018076|NCT01544595|592428685|FG000|Status at Week 156|Technical problems|3|||
164018077|NCT01544595|592428686|FG001|Status at Week 156|Technical problems|1|||
164018078|NCT01544595|592428687|FG002|Status at Week 156|Technical problems|0|||
164018079|NCT01544595|592428688|FG003|Status at Week 156|Technical problems|1|||
164018080|NCT01544595|592428689|FG004|Status at Week 156|Technical problems|0|||
164018081|NCT01544595|592428690|FG005|Status at Week 156|Technical problems|0|||
164018082|NCT01544595|592428685|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
164018083|NCT01544595|592428686|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
164018084|NCT01544595|592428687|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
164018085|NCT01544595|592428688|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
164018086|NCT01544595|592428689|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
164018087|NCT01544595|592428690|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
164018088|NCT01544595|592428685|FG000|Status at Week 156|Lack of Efficacy|1|||
164018089|NCT01544595|592428686|FG001|Status at Week 156|Lack of Efficacy|0|||
164018090|NCT01544595|592428687|FG002|Status at Week 156|Lack of Efficacy|1|||
164018091|NCT01544595|592428688|FG003|Status at Week 156|Lack of Efficacy|4|||
164018092|NCT01544595|592428689|FG004|Status at Week 156|Lack of Efficacy|10|||
164018093|NCT01544595|592428690|FG005|Status at Week 156|Lack of Efficacy|5|||
164018094|NCT01929044|592428691|FG000|Overall Study|Adverse Event|1|||
164018095|NCT01929044|592428692|FG001|Overall Study|Adverse Event|0|||
164018096|NCT01929044|592428691|FG000|Overall Study|Protocol Violation|9|||
164018097|NCT01929044|592428692|FG001|Overall Study|Protocol Violation|14|||
164018098|NCT01929044|592428691|FG000|Overall Study|Not Treated|1|||
164018099|NCT01929044|592428692|FG001|Overall Study|Not Treated|3|||
164018100|NCT02275026|592428699|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
164018101|NCT02275026|592428699|FG000|Overall Study|Withdrawal by Subject|4|||
164018102|NCT02275026|592428699|FG000|Overall Study|Ineligible due to medical history|13|||
164018103|NCT02275026|592428699|FG000|Overall Study|MRI malfunction precluded testing|1|||
164018104|NCT02275026|592428699|FG000|Overall Study|Ineligible after MRI findings|1|||
164018105|NCT02275026|592428699|FG000|Overall Study|Lost to Follow-up|2|||
164018106|NCT02275026|592428699|FG000|Overall Study|Scanner failure|1|||
164018107|NCT00878072|592428700|FG000|Overall Study|Withdrew consent|2|||
164018108|NCT01200511|592428712|FG000|Overall Study|Lost to Follow-up|3|||
164018109|NCT01200511|592428712|FG000|Overall Study|Withdrawal by Subject|1|||
164018110|NCT01200511|592428712|FG000|Overall Study|Adverse Event|1|||
164018111|NCT03288779|592428713|FG000|Overall Study|Withdrawal by Subject|3|||
164018112|NCT03382899|592428714|FG000|Overall Study|Ineligibility Determined|0|||
164018113|NCT03382899|592428715|FG001|Overall Study|Ineligibility Determined|1|||
164018114|NCT03382899|592428714|FG000|Overall Study|Lost to Follow-up|0|||
164018115|NCT03382899|592428715|FG001|Overall Study|Lost to Follow-up|1|||
164018116|NCT03382899|592428714|FG000|Overall Study|Sponsor's decision|31|||
164018117|NCT03382899|592428715|FG001|Overall Study|Sponsor's decision|28|||
164018118|NCT03382899|592428714|FG000|Overall Study|Withdrawal by Subject|0|||
164018119|NCT03382899|592428715|FG001|Overall Study|Withdrawal by Subject|5|||
164018120|NCT02504892|592428717|FG000|Overall Study|Adverse event-pneumonitis|2|||
164018121|NCT00524745|592428718|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
164018122|NCT00524745|592428719|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
164018123|NCT00524745|592428720|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
164018124|NCT00524745|592428721|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
164018125|NCT00576693|592428722|FG000|Overall Study|Lost to Follow-up|7|||
164018126|NCT00576693|592428723|FG001|Overall Study|Lost to Follow-up|11|||
164018127|NCT00576693|592428722|FG000|Overall Study|Withdrawal by Subject|3|||
164018128|NCT00576693|592428723|FG001|Overall Study|Withdrawal by Subject|13|||
164018129|NCT01413178|592428724|FG000|Overall Study|Toxicity|1|||
164018130|NCT01413178|592428725|FG001|Overall Study|Toxicity|0|||
164018131|NCT01413178|592428724|FG000|Overall Study|Ineligible|0|||
164018132|NCT01413178|592428725|FG001|Overall Study|Ineligible|2|||
164018133|NCT00540449|592428726|FG000|Overall Study|Adverse Event|12|||
164018134|NCT00540449|592428727|FG001|Overall Study|Adverse Event|32|||
164018135|NCT00540449|592428726|FG000|Overall Study|Sponsor's Decision|1|||
164018136|NCT00540449|592428727|FG001|Overall Study|Sponsor's Decision|1|||
164094809|NCT03527745|592712176|FG004|Overall Study|Lost to Follow-up|0|||
164094810|NCT03527745|592712177|FG005|Overall Study|Lost to Follow-up|2|||
164094811|NCT03527745|592712178|FG006|Overall Study|Lost to Follow-up|3|||
164094812|NCT03527745|592712179|FG007|Overall Study|Lost to Follow-up|2|||
164094813|NCT03527745|592712180|FG008|Overall Study|Lost to Follow-up|3|||
164094814|NCT03527745|592712181|FG009|Overall Study|Lost to Follow-up|2|||
164094815|NCT03527745|592712182|FG010|Overall Study|Lost to Follow-up|1|||
164094816|NCT03527745|592712183|FG011|Overall Study|Lost to Follow-up|1|||
164094817|NCT03527745|592712184|FG012|Overall Study|Lost to Follow-up|0|||
164094818|NCT03527745|592712185|FG013|Overall Study|Lost to Follow-up|0|||
164094819|NCT03527745|592712186|FG014|Overall Study|Lost to Follow-up|0|||
164094820|NCT03527745|592712187|FG015|Overall Study|Lost to Follow-up|0|||
164094821|NCT03527745|592712188|FG016|Overall Study|Lost to Follow-up|1|||
164094822|NCT03527745|592712189|FG017|Overall Study|Lost to Follow-up|0|||
164094823|NCT03527745|592712190|FG018|Overall Study|Lost to Follow-up|0|||
164094824|NCT03527745|592712191|FG019|Overall Study|Lost to Follow-up|1|||
164094825|NCT03527745|592712192|FG020|Overall Study|Lost to Follow-up|1|||
164094826|NCT03527745|592712193|FG021|Overall Study|Lost to Follow-up|5|||
164094827|NCT03527745|592712194|FG022|Overall Study|Lost to Follow-up|6|||
164094828|NCT03527745|592712195|FG023|Overall Study|Lost to Follow-up|8|||
164094829|NCT03527745|592712196|FG024|Overall Study|Lost to Follow-up|1|||
164094830|NCT03527745|592712197|FG025|Overall Study|Lost to Follow-up|3|||
164094831|NCT00560235|592712203|FG000|Phase 1|Discontinued|8|||
164094832|NCT00560235|592712204|FG001|Phase 1|Discontinued|0|||
164094833|NCT00560235|592712205|FG002|Phase 1|Discontinued|0|||
164094834|NCT00560235|592712203|FG000|Phase 1B|Discontinued|0|||
164094835|NCT00560235|592712204|FG001|Phase 1B|Discontinued|19|||
163907010|NCT02827201|592031234|FG000|Overall Study|Patients not treated|1|||
163907011|NCT02827201|592031235|FG001|Overall Study|Patients not treated|1|||
163907012|NCT00240994|592031236|FG000|Overall Study|Lost to Follow-up|1|||
163907013|NCT00240994|592031236|FG000|Overall Study|Protocol Violation|1|||
163907014|NCT00240994|592031236|FG000|Overall Study|Graft failure|1|||
163907015|NCT02630186|592031238|FG000|Overall Study|Withdrawal by Subject|1|||
163907016|NCT00439218|592031239|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
163907017|NCT03142932|592031240|FG000|Overall Study|Lost to Follow-up|2|||
163907018|NCT03142932|592031241|FG001|Overall Study|Lost to Follow-up|11|||
164018137|NCT00540449|592428726|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
164018138|NCT00540449|592428727|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
164018139|NCT00540449|592428726|FG000|Overall Study|Lost to Follow-up|19|||
164018140|NCT00540449|592428727|FG001|Overall Study|Lost to Follow-up|17|||
164018141|NCT00540449|592428726|FG000|Overall Study|Subject Non-Compliant|7|||
164018142|NCT00540449|592428727|FG001|Overall Study|Subject Non-Compliant|5|||
164018143|NCT00540449|592428726|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
164018144|NCT00540449|592428727|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
164018145|NCT00540449|592428726|FG000|Overall Study|Withdrawal by Subject|10|||
164018146|NCT00540449|592428727|FG001|Overall Study|Withdrawal by Subject|10|||
164018147|NCT00540449|592428726|FG000|Overall Study|Other|1|||
164018148|NCT00540449|592428727|FG001|Overall Study|Other|4|||
164018149|NCT03643432|592428728|FG000|Overall Study|Lost to Follow-up|1|||
164018150|NCT03643432|592428729|FG001|Overall Study|Lost to Follow-up|0|||
164094836|NCT00560235|592712205|FG002|Phase 1B|Discontinued|0|||
164094837|NCT00560235|592712203|FG000|Phase 2|Discontinued|0|||
163907019|NCT02128269|592031242|FG000|Treatment Period|Adverse Event|1|||
163907020|NCT02128269|592031242|FG000|Treatment Period|Physician Decision|1|||
163907021|NCT01021748|592031243|FG000|Overall Study|Adverse Event|2|||
163907022|NCT01021748|592031244|FG001|Overall Study|Adverse Event|1|||
163907023|NCT01021748|592031245|FG002|Overall Study|Adverse Event|2|||
163907024|NCT01021748|592031246|FG003|Overall Study|Adverse Event|0|||
163907025|NCT01021748|592031247|FG004|Overall Study|Adverse Event|2|||
163907026|NCT01021748|592031248|FG005|Overall Study|Adverse Event|0|||
164094838|NCT00560235|592712204|FG001|Phase 2|Discontinued|0|||
164094839|NCT00560235|592712205|FG002|Phase 2|Discontinued|96|||
164094840|NCT00560235|592712203|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
164094841|NCT00560235|592712204|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
164094842|NCT00560235|592712205|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
164018151|NCT00337467|592428730|FG000|Overall Study|Adverse Event|3|||
163907027|NCT01021748|592031249|FG006|Overall Study|Adverse Event|1|||
163907028|NCT01021748|592031250|FG007|Overall Study|Adverse Event|0|||
163907029|NCT01021748|592031251|FG008|Overall Study|Adverse Event|7|||
163907030|NCT01021748|592031243|FG000|Overall Study|Physician Decision|1|||
163907031|NCT01021748|592031244|FG001|Overall Study|Physician Decision|0|||
163907032|NCT01021748|592031245|FG002|Overall Study|Physician Decision|1|||
163907033|NCT01021748|592031246|FG003|Overall Study|Physician Decision|1|||
164073086|NCT01902134|592632782|FG001|Overall Study|Other|1|||
163907034|NCT01021748|592031247|FG004|Overall Study|Physician Decision|0|||
163907035|NCT01021748|592031248|FG005|Overall Study|Physician Decision|0|||
163907036|NCT01021748|592031249|FG006|Overall Study|Physician Decision|1|||
163907037|NCT01021748|592031250|FG007|Overall Study|Physician Decision|1|||
163907038|NCT01021748|592031251|FG008|Overall Study|Physician Decision|2|||
163907039|NCT01021748|592031243|FG000|Overall Study|Progressive Disease|3|||
163907040|NCT01021748|592031244|FG001|Overall Study|Progressive Disease|3|||
163907041|NCT01021748|592031245|FG002|Overall Study|Progressive Disease|4|||
163907042|NCT01021748|592031246|FG003|Overall Study|Progressive Disease|6|||
164094843|NCT04015232|592712206|FG000|Overall Study|Withdrawal by Subject|7|||
164094844|NCT04015232|592712207|FG001|Overall Study|Withdrawal by Subject|4|||
163907043|NCT01021748|592031247|FG004|Overall Study|Progressive Disease|7|||
163907044|NCT01021748|592031248|FG005|Overall Study|Progressive Disease|3|||
163907045|NCT01021748|592031249|FG006|Overall Study|Progressive Disease|0|||
163907046|NCT01021748|592031250|FG007|Overall Study|Progressive Disease|5|||
163907047|NCT01021748|592031251|FG008|Overall Study|Progressive Disease|6|||
163907048|NCT01021748|592031243|FG000|Overall Study|Withdrawal by Subject|0|||
163907049|NCT01021748|592031244|FG001|Overall Study|Withdrawal by Subject|0|||
163907050|NCT01021748|592031245|FG002|Overall Study|Withdrawal by Subject|0|||
163907051|NCT01021748|592031246|FG003|Overall Study|Withdrawal by Subject|0|||
163907052|NCT01021748|592031247|FG004|Overall Study|Withdrawal by Subject|0|||
163907053|NCT01021748|592031248|FG005|Overall Study|Withdrawal by Subject|0|||
163907054|NCT01021748|592031249|FG006|Overall Study|Withdrawal by Subject|1|||
163907055|NCT01021748|592031250|FG007|Overall Study|Withdrawal by Subject|0|||
163907056|NCT01021748|592031251|FG008|Overall Study|Withdrawal by Subject|1|||
163907057|NCT01021748|592031243|FG000|Overall Study|Not Treated|0|||
163907058|NCT01021748|592031244|FG001|Overall Study|Not Treated|1|||
163907059|NCT01021748|592031245|FG002|Overall Study|Not Treated|0|||
163907060|NCT01021748|592031246|FG003|Overall Study|Not Treated|0|||
163907061|NCT01021748|592031247|FG004|Overall Study|Not Treated|0|||
163907062|NCT01021748|592031248|FG005|Overall Study|Not Treated|0|||
163907063|NCT01021748|592031249|FG006|Overall Study|Not Treated|0|||
163907064|NCT01021748|592031250|FG007|Overall Study|Not Treated|0|||
163907065|NCT01021748|592031251|FG008|Overall Study|Not Treated|0|||
163907066|NCT01640288|592031254|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
163907067|NCT01640288|592031255|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
163907068|NCT01640288|592031254|FG000|Overall Study|Screen Failure|20|||
163907069|NCT01640288|592031255|FG001|Overall Study|Screen Failure|18|||
164094845|NCT04015232|592712206|FG000|Overall Study|Protocol Violation|1|||
163907070|NCT01640288|592031254|FG000|Overall Study|Withdrawn by PI|5|||
164094846|NCT04015232|592712207|FG001|Overall Study|Protocol Violation|0|||
163907071|NCT01640288|592031255|FG001|Overall Study|Withdrawn by PI|0|||
163907072|NCT01640288|592031254|FG000|Overall Study|Withdrawal by Subject|1|||
163907073|NCT01640288|592031255|FG001|Overall Study|Withdrawal by Subject|0|||
163907074|NCT01485887|592031258|FG000|Overall Study|Withdrawal by Subject|2|||
163907075|NCT01485887|592031258|FG000|Overall Study|Adverse Event|8|||
163907076|NCT01485887|592031258|FG000|Overall Study|Deterioration of primary disease|1|||
163907077|NCT01485887|592031258|FG000|Overall Study|Primary disease markedly improved|1|||
163907078|NCT02234141|592031259|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
163907079|NCT02234141|592031260|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
163907080|NCT02234141|592031261|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
163907081|NCT02234141|592031262|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
163907082|NCT02234141|592031263|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
164018152|NCT00337467|592428730|FG000|Overall Study|Subject Withdrew Consent|2|||
164018153|NCT00337467|592428730|FG000|Overall Study|Pregnancy|1|||
164018154|NCT00337467|592428730|FG000|Overall Study|Lost to Follow-up|2|||
164018155|NCT00337467|592428730|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
164018156|NCT01187901|592428733|FG000|Overall Study|Protocol Violation|1|||
164018157|NCT01187901|592428734|FG001|Overall Study|Protocol Violation|0|||
164018158|NCT01187901|592428733|FG000|Overall Study|Lost to Follow-up|1|||
164018159|NCT01187901|592428734|FG001|Overall Study|Lost to Follow-up|2|||
164018160|NCT01187901|592428733|FG000|Overall Study|Unrelated Health Reasons|1|||
163907083|NCT02234141|592031264|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
163907084|NCT02234141|592031265|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
163907085|NCT02234141|592031259|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163907086|NCT02234141|592031260|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
163907087|NCT02234141|592031261|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163907088|NCT02234141|592031262|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163907089|NCT02234141|592031263|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163907090|NCT02234141|592031264|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163907091|NCT02234141|592031265|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
163907092|NCT02234141|592031259|FG000|Treatment Period (24 Weeks)|Death|1|||
163907093|NCT02234141|592031260|FG001|Treatment Period (24 Weeks)|Death|2|||
163907094|NCT02234141|592031261|FG002|Treatment Period (24 Weeks)|Death|0|||
163907095|NCT02234141|592031262|FG003|Treatment Period (24 Weeks)|Death|1|||
163907096|NCT02234141|592031263|FG004|Treatment Period (24 Weeks)|Death|0|||
163907097|NCT02234141|592031264|FG005|Treatment Period (24 Weeks)|Death|0|||
163907098|NCT02234141|592031265|FG006|Treatment Period (24 Weeks)|Death|0|||
163907099|NCT02234141|592031259|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
163907100|NCT02234141|592031260|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
163907101|NCT02234141|592031261|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
163907102|NCT02234141|592031262|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
163907103|NCT02234141|592031263|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
163907104|NCT02234141|592031264|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
163907105|NCT02234141|592031265|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
163907106|NCT02234141|592031259|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163907107|NCT02234141|592031260|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
163907108|NCT02234141|592031261|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163907109|NCT02234141|592031262|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163907110|NCT02234141|592031263|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163907111|NCT02234141|592031264|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163907112|NCT02234141|592031265|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
163907113|NCT02234141|592031259|FG000|Long-Term Treatment Period|Death|0|||
163907114|NCT02234141|592031260|FG001|Long-Term Treatment Period|Death|0|||
163907115|NCT02234141|592031261|FG002|Long-Term Treatment Period|Death|0|||
164018161|NCT01187901|592428734|FG001|Overall Study|Unrelated Health Reasons|2|||
163907116|NCT02234141|592031262|FG003|Long-Term Treatment Period|Death|0|||
164018162|NCT01187901|592428733|FG000|Overall Study|Suspected Allergic Reaction|1|||
164018163|NCT01187901|592428734|FG001|Overall Study|Suspected Allergic Reaction|1|||
164018164|NCT01187901|592428733|FG000|Overall Study|Adverse Event|3|||
164018165|NCT01187901|592428734|FG001|Overall Study|Adverse Event|0|||
164018166|NCT01187901|592428733|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
164018167|NCT01187901|592428734|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
164018168|NCT01187901|592428733|FG000|Overall Study|Pregnancy|0|||
164018169|NCT01187901|592428734|FG001|Overall Study|Pregnancy|2|||
164018170|NCT03141086|592428735|FG000|Overall Study|Study Terminated By Sponsor|1|||
163907117|NCT02234141|592031263|FG004|Long-Term Treatment Period|Death|0|||
163907118|NCT02234141|592031264|FG005|Long-Term Treatment Period|Death|1|||
163907119|NCT02234141|592031265|FG006|Long-Term Treatment Period|Death|0|||
163907120|NCT02234141|592031259|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
163907121|NCT02234141|592031260|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
163907122|NCT02234141|592031261|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
164018171|NCT03141086|592428736|FG001|Overall Study|Study Terminated By Sponsor|1|||
164018172|NCT03141086|592428735|FG000|Overall Study|Withdrawal by Subject|0|||
164018173|NCT03141086|592428736|FG001|Overall Study|Withdrawal by Subject|1|||
164018174|NCT03141086|592428735|FG000|Overall Study|Protocol Violation|0|||
164018175|NCT03141086|592428736|FG001|Overall Study|Protocol Violation|1|||
164018176|NCT03141086|592428735|FG000|Overall Study|Adverse Event|0|||
164018177|NCT03141086|592428736|FG001|Overall Study|Adverse Event|2|||
164018178|NCT03607682|592428744|FG000|Overall Study|Withdrawal by Subject|1|||
164018179|NCT03607682|592428744|FG000|Overall Study|Disease progression|1|||
164073087|NCT01902134|592632783|FG002|Overall Study|Other|2|||
164018180|NCT02574312|592428745|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
164018181|NCT02574312|592428746|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
164018182|NCT02410902|592429866|FG000|Overall Study|Adverse Event|2|||
164018183|NCT02410902|592429867|FG001|Overall Study|Adverse Event|3|||
164018184|NCT02410902|592429866|FG000|Overall Study|Lost to Follow-up|4|||
164018185|NCT02410902|592429867|FG001|Overall Study|Lost to Follow-up|1|||
164018186|NCT02410902|592429866|FG000|Overall Study|Protocol Violation|1|||
164018187|NCT02410902|592429867|FG001|Overall Study|Protocol Violation|4|||
164018188|NCT02410902|592429866|FG000|Overall Study|Withdrawal by Subject|6|||
163907123|NCT02234141|592031262|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
163907124|NCT02234141|592031263|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
163907125|NCT02234141|592031264|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
163907126|NCT02234141|592031265|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
163907127|NCT02234141|592031259|FG000|Long-Term Treatment Period|Adverse Event|4|||
163907128|NCT02234141|592031260|FG001|Long-Term Treatment Period|Adverse Event|0|||
163907129|NCT02234141|592031261|FG002|Long-Term Treatment Period|Adverse Event|5|||
163907130|NCT02234141|592031262|FG003|Long-Term Treatment Period|Adverse Event|0|||
163907131|NCT02234141|592031263|FG004|Long-Term Treatment Period|Adverse Event|1|||
163907132|NCT02234141|592031264|FG005|Long-Term Treatment Period|Adverse Event|1|||
163907133|NCT02234141|592031265|FG006|Long-Term Treatment Period|Adverse Event|1|||
163907134|NCT02234141|592031259|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
163907135|NCT02234141|592031260|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
163907136|NCT02234141|592031261|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
163907137|NCT02234141|592031262|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
163907138|NCT02234141|592031263|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
163907139|NCT02234141|592031264|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
163907140|NCT02234141|592031265|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
163907141|NCT02234141|592031259|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
163907142|NCT02234141|592031260|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
163907143|NCT02234141|592031261|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
163907144|NCT02234141|592031262|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
163907145|NCT02234141|592031263|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
163907146|NCT02234141|592031264|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
163907147|NCT02234141|592031265|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
163907148|NCT00895245|592031266|FG000|Overall Study|Lack of Efficacy|6|||
163907149|NCT01972776|592031267|FG000|Part 1|Withdrawal by Subject|0|||
163907150|NCT01972776|592031268|FG001|Part 1|Withdrawal by Subject|0|||
163907151|NCT01972776|592031269|FG002|Part 1|Withdrawal by Subject|1|||
163907152|NCT01972776|592031270|FG003|Part 1|Withdrawal by Subject|0|||
163907153|NCT01972776|592031271|FG004|Part 1|Withdrawal by Subject|0|||
163907154|NCT01972776|592031272|FG005|Part 1|Withdrawal by Subject|0|||
163907155|NCT01972776|592031267|FG000|Part 1|Adverse Event|0|||
164073088|NCT01902134|592632784|FG003|Overall Study|Other|0|||
164073089|NCT01902134|592632785|FG004|Overall Study|Other|1|||
163907156|NCT01972776|592031268|FG001|Part 1|Adverse Event|0|||
163907157|NCT01972776|592031269|FG002|Part 1|Adverse Event|1|||
163907158|NCT01972776|592031270|FG003|Part 1|Adverse Event|1|||
163907159|NCT01972776|592031271|FG004|Part 1|Adverse Event|0|||
163907160|NCT01972776|592031272|FG005|Part 1|Adverse Event|0|||
163907161|NCT01972776|592031267|FG000|Part 2|Adverse Event|0|||
163907162|NCT01972776|592031268|FG001|Part 2|Adverse Event|0|||
163907163|NCT01972776|592031269|FG002|Part 2|Adverse Event|0|||
163907164|NCT01972776|592031270|FG003|Part 2|Adverse Event|0|||
163907165|NCT01972776|592031271|FG004|Part 2|Adverse Event|3|||
163907166|NCT01972776|592031272|FG005|Part 2|Adverse Event|0|||
163907167|NCT01972776|592031267|FG000|Part 2|Administrative problems|0|||
163907168|NCT01972776|592031268|FG001|Part 2|Administrative problems|0|||
164073090|NCT01902134|592632786|FG005|Overall Study|Other|0|||
163907169|NCT01972776|592031269|FG002|Part 2|Administrative problems|0|||
163907170|NCT01972776|592031270|FG003|Part 2|Administrative problems|0|||
163907171|NCT01972776|592031271|FG004|Part 2|Administrative problems|10|||
164018189|NCT02410902|592429867|FG001|Overall Study|Withdrawal by Subject|8|||
164018190|NCT02410902|592429866|FG000|Overall Study|Non-Compliance|8|||
164018191|NCT02410902|592429867|FG001|Overall Study|Non-Compliance|2|||
163907172|NCT01972776|592031272|FG005|Part 2|Administrative problems|7|||
163907173|NCT01228734|592031273|FG000|Overall Study|Randomized, but not treated|0|||
163907174|NCT01228734|592031274|FG001|Overall Study|Randomized, but not treated|4|||
163907175|NCT02382640|592031278|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
163907176|NCT02382640|592031279|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
163907177|NCT02382640|592031280|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
163907178|NCT02382640|592031281|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
163907179|NCT01220999|592031282|FG000|Overall Study|Progressive disease|0|||
163907180|NCT01220999|592031283|FG001|Overall Study|Progressive disease|0|||
163907181|NCT01220999|592031284|FG002|Overall Study|Progressive disease|1|||
163907182|NCT01220999|592031285|FG003|Overall Study|Progressive disease|0|||
163907183|NCT01220999|592031286|FG004|Overall Study|Progressive disease|0|||
163907184|NCT01560429|592031287|FG000|Overall Study|Protocol Violation|3|||
163907185|NCT01560429|592031288|FG001|Overall Study|Protocol Violation|6|||
163907186|NCT02449902|592031289|FG000|Overall Study|Adverse Event|0|||
163907187|NCT02449902|592031290|FG001|Overall Study|Adverse Event|1|||
163907188|NCT02449902|592031289|FG000|Overall Study|Withdrawal by Subject|0|||
163907189|NCT02449902|592031290|FG001|Overall Study|Withdrawal by Subject|1|||
163907190|NCT01365546|592031291|FG000|Overall Study|Withdrawal by Subject|1|||
163907191|NCT01365546|592031291|FG000|Overall Study|Screen failure|9|||
163907192|NCT01365546|592031291|FG000|Overall Study|Study termination|1|||
163907193|NCT03326856|592031292|FG000|Overall Study|Lost to Follow-up|1|||
163907194|NCT03326856|592031293|FG001|Overall Study|Lost to Follow-up|1|||
163907195|NCT03326856|592031294|FG002|Overall Study|Lost to Follow-up|0|||
163907196|NCT03326856|592031295|FG003|Overall Study|Lost to Follow-up|0|||
163907197|NCT03326856|592031296|FG004|Overall Study|Lost to Follow-up|0|||
163907198|NCT03162614|592031297|FG000|Overall Study|Lost to Follow-up|2|||
163907199|NCT03162614|592031298|FG001|Overall Study|Lost to Follow-up|1|||
164018192|NCT01881620|592429868|FG000|Overall Study|Protocol Violation|4|||
164018193|NCT01429792|592429869|FG000|Overall Study|Other Reasons|67|||
164018194|NCT01429792|592429869|FG000|Overall Study|Unknown Disposition|94|||
164018195|NCT01429792|592429869|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
164018196|NCT01429792|592429869|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
164018197|NCT01429792|592429869|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
164018198|NCT01429792|592429869|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
163907200|NCT03162614|592031299|FG002|Overall Study|Lost to Follow-up|1|||
163907201|NCT03162614|592031300|FG003|Overall Study|Lost to Follow-up|1|||
163907202|NCT03162614|592031301|FG004|Overall Study|Lost to Follow-up|2|||
163907203|NCT03162614|592031302|FG005|Overall Study|Lost to Follow-up|0|||
164018199|NCT01429792|592429869|FG000|Overall Study|Withdrawal by Subject|70|||
163907204|NCT03162614|592031297|FG000|Overall Study|Protocol Violation|0|||
163907205|NCT03162614|592031298|FG001|Overall Study|Protocol Violation|1|||
163907206|NCT03162614|592031299|FG002|Overall Study|Protocol Violation|0|||
164018200|NCT01429792|592429869|FG000|Overall Study|Lost to Follow-up|88|||
164018201|NCT01457118|592429879|FG000|Overall Study|Adverse Event|1|||
164018202|NCT01457118|592429880|FG001|Overall Study|Adverse Event|0|||
164018203|NCT01457118|592429881|FG002|Overall Study|Adverse Event|0|||
164018204|NCT01457118|592429882|FG003|Overall Study|Adverse Event|1|||
164018205|NCT01457118|592429879|FG000|Overall Study|Clinical Progression|0|||
164018206|NCT01457118|592429880|FG001|Overall Study|Clinical Progression|1|||
163907207|NCT03162614|592031300|FG003|Overall Study|Protocol Violation|1|||
163907208|NCT03162614|592031301|FG004|Overall Study|Protocol Violation|0|||
163907209|NCT03162614|592031302|FG005|Overall Study|Protocol Violation|0|||
163907210|NCT03162614|592031297|FG000|Overall Study|Withdrawal by Subject|2|||
163907211|NCT03162614|592031298|FG001|Overall Study|Withdrawal by Subject|1|||
163907212|NCT03162614|592031299|FG002|Overall Study|Withdrawal by Subject|1|||
163907213|NCT03162614|592031300|FG003|Overall Study|Withdrawal by Subject|1|||
163907214|NCT03162614|592031301|FG004|Overall Study|Withdrawal by Subject|0|||
163907215|NCT03162614|592031302|FG005|Overall Study|Withdrawal by Subject|0|||
163907216|NCT03162614|592031297|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
163907217|NCT03162614|592031298|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
163907218|NCT03162614|592031299|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
163907219|NCT03162614|592031300|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
163907220|NCT03162614|592031301|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
163907221|NCT03162614|592031302|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
163907222|NCT03861234|592031303|FG000|Overall Study|Not treated|0|||
163907223|NCT03861234|592031304|FG001|Overall Study|Not treated|0|||
163907224|NCT03861234|592031305|FG002|Overall Study|Not treated|0|||
163907225|NCT03861234|592031306|FG003|Overall Study|Not treated|0|||
163907226|NCT03861234|592031307|FG004|Overall Study|Not treated|0|||
163907227|NCT03861234|592031308|FG005|Overall Study|Not treated|1|||
163907228|NCT03861234|592031309|FG006|Overall Study|Not treated|0|||
163907229|NCT03861234|592031310|FG007|Overall Study|Not treated|0|||
163907230|NCT03861234|592031303|FG000|Overall Study|Adverse Event|0|||
163907231|NCT03861234|592031304|FG001|Overall Study|Adverse Event|0|||
163907232|NCT03861234|592031305|FG002|Overall Study|Adverse Event|0|||
163907233|NCT03861234|592031306|FG003|Overall Study|Adverse Event|0|||
163907234|NCT03861234|592031307|FG004|Overall Study|Adverse Event|0|||
163907235|NCT03861234|592031308|FG005|Overall Study|Adverse Event|1|||
163907236|NCT03861234|592031309|FG006|Overall Study|Adverse Event|0|||
163907237|NCT03861234|592031310|FG007|Overall Study|Adverse Event|0|||
163907238|NCT03861234|592031303|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
163907239|NCT03861234|592031304|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
163907240|NCT03861234|592031305|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
163907241|NCT03861234|592031306|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
163907242|NCT03861234|592031307|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
163907243|NCT03861234|592031308|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
163907244|NCT03861234|592031309|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
163907245|NCT03861234|592031310|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
163907246|NCT03861234|592031303|FG000|Overall Study|As per sponsor decision|0|||
163907247|NCT03861234|592031304|FG001|Overall Study|As per sponsor decision|0|||
163907248|NCT03861234|592031305|FG002|Overall Study|As per sponsor decision|0|||
163907249|NCT03861234|592031306|FG003|Overall Study|As per sponsor decision|0|||
164018207|NCT01457118|592429881|FG002|Overall Study|Clinical Progression|0|||
164018208|NCT01457118|592429882|FG003|Overall Study|Clinical Progression|1|||
164018209|NCT01457118|592429879|FG000|Overall Study|Physician Decision|2|||
164018210|NCT01457118|592429880|FG001|Overall Study|Physician Decision|0|||
164018211|NCT01457118|592429881|FG002|Overall Study|Physician Decision|0|||
164018212|NCT01457118|592429882|FG003|Overall Study|Physician Decision|0|||
164018213|NCT01457118|592429879|FG000|Overall Study|Progressive Disease by RECIST|12|||
164018214|NCT01457118|592429880|FG001|Overall Study|Progressive Disease by RECIST|3|||
164018215|NCT01457118|592429881|FG002|Overall Study|Progressive Disease by RECIST|1|||
164018216|NCT01457118|592429882|FG003|Overall Study|Progressive Disease by RECIST|0|||
164018217|NCT01457118|592429879|FG000|Overall Study|Withdrawal by Subject|5|||
164018218|NCT01457118|592429880|FG001|Overall Study|Withdrawal by Subject|0|||
164018219|NCT01457118|592429881|FG002|Overall Study|Withdrawal by Subject|0|||
164018220|NCT01457118|592429882|FG003|Overall Study|Withdrawal by Subject|0|||
164018221|NCT02324842|592429883|FG000|Overall Study|Lost to Follow-up|1|||
164018222|NCT02324842|592429884|FG001|Overall Study|Lost to Follow-up|1|||
164018223|NCT02324842|592429885|FG002|Overall Study|Lost to Follow-up|2|||
164018224|NCT00630812|592429886|FG000|Randomisation to First Dose|Adverse Event|1|||
164018225|NCT00630812|592429887|FG001|Randomisation to First Dose|Adverse Event|1|||
164018226|NCT00630812|592429886|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
164018227|NCT00630812|592429887|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
164073091|NCT00305110|592632787|FG000|Overall Study|Missing data|29|||
164018228|NCT00630812|592429886|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
164018229|NCT00630812|592429887|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
164018230|NCT00630812|592429886|FG000|Randomisation to First Dose|Protocol Violation|4|||
164018231|NCT00630812|592429887|FG001|Randomisation to First Dose|Protocol Violation|1|||
164018232|NCT00630812|592429886|FG000|Double Blind Treatment Period|Adverse Event|13|||
164018233|NCT00630812|592429887|FG001|Double Blind Treatment Period|Adverse Event|5|||
164018234|NCT00630812|592429886|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
163907250|NCT03861234|592031307|FG004|Overall Study|As per sponsor decision|0|||
163907251|NCT03861234|592031308|FG005|Overall Study|As per sponsor decision|0|||
163907252|NCT03861234|592031309|FG006|Overall Study|As per sponsor decision|1|||
163907253|NCT03861234|592031310|FG007|Overall Study|As per sponsor decision|0|||
163907254|NCT03861234|592031303|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
163907255|NCT03861234|592031304|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
163907256|NCT03861234|592031305|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
163907257|NCT03861234|592031306|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
163907258|NCT03861234|592031307|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
163907259|NCT03861234|592031308|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
163907260|NCT03861234|592031309|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
163907261|NCT03861234|592031310|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
163907262|NCT00621842|592031311|FG000|Overall Study|Adverse Event|6|||
163907263|NCT00621842|592031311|FG000|Overall Study|Withdrawal by Subject|7|||
163907264|NCT00621842|592031311|FG000|Overall Study|Protocol Violation|4|||
163907265|NCT00621842|592031311|FG000|Overall Study|Lack of Efficacy|2|||
163907266|NCT05169684|592031314|FG000|Overall Study|Adverse Event|1|||
163907267|NCT05169684|592031315|FG001|Overall Study|Adverse Event|3|||
163907268|NCT05169684|592031314|FG000|Overall Study|Physician Decision|0|||
163907269|NCT05169684|592031315|FG001|Overall Study|Physician Decision|1|||
163907270|NCT05169684|592031314|FG000|Overall Study|Progressive Disease|1|||
163907271|NCT05169684|592031315|FG001|Overall Study|Progressive Disease|1|||
164073092|NCT00337129|592632788|FG000|Overall Study|Adverse Event|4|||
163907272|NCT05169684|592031314|FG000|Overall Study|Participant request to discontinue treatment|0|||
163907273|NCT05169684|592031315|FG001|Overall Study|Participant request to discontinue treatment|1|||
163907274|NCT05169684|592031314|FG000|Overall Study|Other Reason|0|||
163907275|NCT05169684|592031315|FG001|Overall Study|Other Reason|1|||
163907276|NCT05352230|592031316|FG000|First Intervention (3 Months)|study terminated|2|||
163907277|NCT05352230|592031317|FG001|First Intervention (3 Months)|study terminated|2|||
163907278|NCT00875706|592031324|FG000|Overall Study|Withdrawal by Subject|1|||
164018235|NCT00630812|592429887|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164018236|NCT00630812|592429886|FG000|Double Blind Treatment Period|Physician Decision|2|||
164018237|NCT00630812|592429887|FG001|Double Blind Treatment Period|Physician Decision|1|||
164018238|NCT00630812|592429886|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164018239|NCT00630812|592429887|FG001|Double Blind Treatment Period|Protocol Violation|0|||
163907279|NCT00875706|592031325|FG001|Overall Study|Withdrawal by Subject|0|||
163907280|NCT00875706|592031326|FG002|Overall Study|Withdrawal by Subject|0|||
163907281|NCT03775213|592031327|FG000|Overall Study|Withdrawal by Subject|51|||
163907282|NCT03775213|592031328|FG001|Overall Study|Withdrawal by Subject|53|||
163907283|NCT03775213|592031327|FG000|Overall Study|Incomplete Survey|7|||
163907284|NCT03775213|592031328|FG001|Overall Study|Incomplete Survey|7|||
163907285|NCT00786188|592031329|FG000|Overall Study|Adverse Event|3|||
163907286|NCT00786188|592031330|FG001|Overall Study|Adverse Event|1|||
163907287|NCT00786188|592031329|FG000|Overall Study|Withdrawal by Subject|2|||
163907288|NCT00786188|592031330|FG001|Overall Study|Withdrawal by Subject|0|||
163907289|NCT00326183|592031331|FG000|Overall Study|Lost to Follow-up|104|||
163907290|NCT00326183|592031332|FG001|Overall Study|Lost to Follow-up|56|||
163907291|NCT00326183|592031331|FG000|Overall Study|Protocol Violation|6|||
163907292|NCT00326183|592031332|FG001|Overall Study|Protocol Violation|3|||
163907293|NCT00326183|592031331|FG000|Overall Study|Withdrawal by Subject|35|||
163907294|NCT00326183|592031332|FG001|Overall Study|Withdrawal by Subject|7|||
164018240|NCT00630812|592429886|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
164018241|NCT00630812|592429887|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
164018242|NCT00630812|592429886|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
163907295|NCT00326183|592031331|FG000|Overall Study|Subject Moved|7|||
163907296|NCT00326183|592031332|FG001|Overall Study|Subject Moved|4|||
163907297|NCT00326183|592031331|FG000|Overall Study|Other|47|||
163907298|NCT00326183|592031332|FG001|Overall Study|Other|13|||
163907299|NCT00326183|592031331|FG000|Overall Study|Adverse Event|1|||
163907300|NCT00326183|592031332|FG001|Overall Study|Adverse Event|0|||
163907301|NCT01827839|592031336|FG000|Overall Study|Adverse Event|1|||
163907302|NCT01827839|592031336|FG000|Overall Study|Consent Withdrawal|2|||
163907303|NCT00570505|592031337|FG000|Overall Study|Adverse Event|7|||
163907304|NCT00570505|592031337|FG000|Overall Study|Withdrawal by Subject|7|||
163907305|NCT00570505|592031337|FG000|Overall Study|Lost to Follow-up|23|||
163907306|NCT00570505|592031337|FG000|Overall Study|Other loss to follow-up|4|||
163907307|NCT00614614|592031338|FG000|Primary Vaccination Phase|Adverse Event|6|||
163907308|NCT00614614|592031339|FG001|Primary Vaccination Phase|Adverse Event|0|||
163907309|NCT00614614|592031340|FG002|Primary Vaccination Phase|Adverse Event|0|||
163907310|NCT00614614|592031341|FG003|Primary Vaccination Phase|Adverse Event|0|||
163907311|NCT00614614|592031342|FG004|Primary Vaccination Phase|Adverse Event|0|||
163907312|NCT00614614|592031338|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
163907313|NCT00614614|592031339|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
163907314|NCT00614614|592031340|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
163907315|NCT00614614|592031341|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
163907316|NCT00614614|592031342|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
163907317|NCT00614614|592031338|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
163907318|NCT00614614|592031339|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
164018243|NCT00630812|592429887|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
164018244|NCT00630812|592429886|FG000|Double Blind Treatment Period|Non-compliance|0|||
164018245|NCT00630812|592429887|FG001|Double Blind Treatment Period|Non-compliance|1|||
164018246|NCT01554956|592429888|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
163907319|NCT00614614|592031340|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
163907320|NCT00614614|592031341|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
163907321|NCT00614614|592031342|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
163907322|NCT00614614|592031338|FG000|Primary Vaccination Phase|Protocol Violation|9|||
163907323|NCT00614614|592031339|FG001|Primary Vaccination Phase|Protocol Violation|3|||
163907324|NCT00614614|592031340|FG002|Primary Vaccination Phase|Protocol Violation|0|||
163907325|NCT00614614|592031341|FG003|Primary Vaccination Phase|Protocol Violation|0|||
163907326|NCT00614614|592031342|FG004|Primary Vaccination Phase|Protocol Violation|0|||
164018247|NCT01554956|592429889|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
164018248|NCT01554956|592429890|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
164018249|NCT01554956|592429888|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
164018250|NCT01554956|592429889|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
164018251|NCT01554956|592429890|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
164018252|NCT01554956|592429888|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
164018253|NCT01554956|592429889|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
164018254|NCT01554956|592429890|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
164018255|NCT05761444|592429891|FG000|Overall Study|Protocol Violation|2|||
164018256|NCT05761444|592429892|FG001|Overall Study|Protocol Violation|1|||
164018257|NCT05761444|592429891|FG000|Overall Study|Adverse Event|2|||
164018258|NCT05761444|592429892|FG001|Overall Study|Adverse Event|2|||
164018259|NCT05761444|592429891|FG000|Overall Study|Withdrawal by Subject|3|||
164018260|NCT05761444|592429892|FG001|Overall Study|Withdrawal by Subject|2|||
164018261|NCT05761444|592429891|FG000|Overall Study|Other|1|||
164018262|NCT05761444|592429892|FG001|Overall Study|Other|0|||
164018263|NCT05610176|592429893|FG000|Overall Study|Death|6|||
164018264|NCT00850759|592429895|FG000|Overall Study|Lost to Follow-up|7|||
164018265|NCT00850759|592429896|FG001|Overall Study|Lost to Follow-up|5|||
164018266|NCT00850759|592429897|FG002|Overall Study|Lost to Follow-up|5|||
164018267|NCT00850759|592429898|FG003|Overall Study|Lost to Follow-up|3|||
164018268|NCT00578864|592429899|FG000|Overall Study|Death|1|||
164018269|NCT00578864|592429900|FG001|Overall Study|Death|0|||
164018270|NCT01087528|592429901|FG000|Overall Study|Withdrawal by Subject|1|||
164018271|NCT01087528|592429901|FG000|Overall Study|Incomplete CE procedure|6|||
164018272|NCT02868216|592429903|FG000|Overall Study|Death|0|||
164018273|NCT02868216|592429904|FG001|Overall Study|Death|1|||
164094847|NCT04015232|592712206|FG000|Overall Study|Medical Grounds|3|||
164094848|NCT04015232|592712207|FG001|Overall Study|Medical Grounds|3|||
164094849|NCT01087970|592712210|FG000|Overall Study|Protocol Violation|2|||
164094850|NCT03655106|592712211|FG000|Overall Study|Withdrawal by Subject|3|||
163907327|NCT00614614|592031338|FG000|Primary Vaccination Phase|Other|4|||
163907328|NCT00614614|592031339|FG001|Primary Vaccination Phase|Other|0|||
163907329|NCT00614614|592031340|FG002|Primary Vaccination Phase|Other|0|||
163907330|NCT00614614|592031341|FG003|Primary Vaccination Phase|Other|0|||
163907331|NCT00614614|592031342|FG004|Primary Vaccination Phase|Other|0|||
163907332|NCT00614614|592031338|FG000|Booster Vaccination Phase|Adverse Event|0|||
163907333|NCT00614614|592031339|FG001|Booster Vaccination Phase|Adverse Event|0|||
163907334|NCT00614614|592031340|FG002|Booster Vaccination Phase|Adverse Event|1|||
164018274|NCT02868216|592429903|FG000|Overall Study|coronary artery bypass|1|||
164018275|NCT02868216|592429904|FG001|Overall Study|coronary artery bypass|0|||
164018276|NCT02868216|592429903|FG000|Overall Study|Withdrawal by Subject|7|||
164018277|NCT02868216|592429904|FG001|Overall Study|Withdrawal by Subject|5|||
164018278|NCT00938327|592429905|FG000|Overall Study|Adverse Event|2|||
164018279|NCT00938327|592429905|FG000|Overall Study|Protocol Violation|1|||
164018280|NCT00938327|592429905|FG000|Overall Study|Withdrawal by Subject|4|||
164018281|NCT00938327|592429905|FG000|Overall Study|Lost to Follow-up|37|||
164018282|NCT00938327|592429905|FG000|Overall Study|2nd dose received outside of the study|7|||
164018283|NCT00938327|592429905|FG000|Overall Study|Vaccine not received as out of stock|9|||
164018284|NCT01425190|592429906|FG000|Overall Study|Full dose not consumed.|1|||
164018285|NCT01425190|592429907|FG001|Overall Study|Full dose not consumed.|0|||
164018286|NCT01425190|592429908|FG002|Overall Study|Full dose not consumed.|0|||
164018287|NCT02552355|592429910|FG000|Overall Study|Adverse Event|0|||
164018288|NCT02552355|592429911|FG001|Overall Study|Adverse Event|2|||
164018289|NCT02552355|592429912|FG002|Overall Study|Adverse Event|2|||
164018290|NCT02552355|592429913|FG003|Overall Study|Adverse Event|0|||
164018291|NCT02552355|592429910|FG000|Overall Study|Withdrawal by Subject|0|||
164018292|NCT02552355|592429911|FG001|Overall Study|Withdrawal by Subject|0|||
164018293|NCT02552355|592429912|FG002|Overall Study|Withdrawal by Subject|0|||
164018294|NCT02552355|592429913|FG003|Overall Study|Withdrawal by Subject|1|||
164018295|NCT01519245|592429914|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
163907335|NCT00614614|592031341|FG003|Booster Vaccination Phase|Adverse Event|1|||
163907336|NCT00614614|592031342|FG004|Booster Vaccination Phase|Adverse Event|0|||
163907337|NCT00614614|592031338|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
163907338|NCT00614614|592031339|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
163907339|NCT00614614|592031340|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
163907340|NCT00614614|592031341|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
163907341|NCT00614614|592031342|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
163907342|NCT00614614|592031338|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
163907343|NCT00614614|592031339|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
163907344|NCT00614614|592031340|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
163907345|NCT00614614|592031341|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
163907346|NCT00614614|592031342|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
163907347|NCT00614614|592031338|FG000|Booster Vaccination Phase|Protocol Violation|0|||
163907348|NCT00614614|592031339|FG001|Booster Vaccination Phase|Protocol Violation|0|||
163907349|NCT00614614|592031340|FG002|Booster Vaccination Phase|Protocol Violation|2|||
163907350|NCT00614614|592031341|FG003|Booster Vaccination Phase|Protocol Violation|3|||
163907351|NCT00614614|592031342|FG004|Booster Vaccination Phase|Protocol Violation|0|||
163907352|NCT00614614|592031338|FG000|Booster Vaccination Phase|Other|0|||
163907353|NCT00614614|592031339|FG001|Booster Vaccination Phase|Other|1|||
163907354|NCT00614614|592031340|FG002|Booster Vaccination Phase|Other|3|||
163907355|NCT00614614|592031341|FG003|Booster Vaccination Phase|Other|2|||
163907356|NCT00614614|592031342|FG004|Booster Vaccination Phase|Other|1|||
163907357|NCT05426109|592031343|FG000|Overall Study|Withdrawal by Subject|0|||
163907358|NCT05426109|592031344|FG001|Overall Study|Withdrawal by Subject|1|||
163907359|NCT05212285|592031345|FG000|Overall Study|Lack of Efficacy|12|||
163907360|NCT05212285|592031346|FG001|Overall Study|Lack of Efficacy|8|||
163907361|NCT05212285|592031345|FG000|Overall Study|Withdrawal by Subject|8|||
163907362|NCT05212285|592031346|FG001|Overall Study|Withdrawal by Subject|1|||
163907363|NCT05212285|592031345|FG000|Overall Study|Lost to Follow-up|13|||
163907364|NCT05212285|592031346|FG001|Overall Study|Lost to Follow-up|1|||
163907365|NCT05212285|592031345|FG000|Overall Study|miss data|21|||
163907366|NCT05212285|592031346|FG001|Overall Study|miss data|2|||
163907367|NCT04118894|592031350|FG000|Overall Study|Lost to Follow-up|21|||
163907368|NCT04118894|592031350|FG000|Overall Study|Withdrawal by Subject|10|||
163907369|NCT04118894|592031350|FG000|Overall Study|Adverse Event|4|||
163907370|NCT02713594|592032484|FG000|Overall Study|Withdrawal by Subject|32|||
163907371|NCT02713594|592032485|FG001|Overall Study|Withdrawal by Subject|22|||
163907372|NCT02713594|592032484|FG000|Overall Study|Lost to Follow-up|358|||
163907373|NCT02713594|592032485|FG001|Overall Study|Lost to Follow-up|374|||
163907374|NCT03690219|592032486|FG000|Overall Study|no injuries|9|||
163907375|NCT03690219|592032487|FG001|Overall Study|no injuries|20|||
163907376|NCT03690219|592032486|FG000|Overall Study|missing information|7|||
163907377|NCT03690219|592032487|FG001|Overall Study|missing information|7|||
163907378|NCT01523392|592032488|FG000|Treatment Period 1|Withdrawal by Subject|2|||
163907379|NCT01523392|592032489|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163907380|NCT01523392|592032488|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
163907381|NCT01523392|592032489|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
163907382|NCT01523392|592032488|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
163907383|NCT01523392|592032489|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
163907384|NCT02771366|592032490|FG000|Period 1|Withdrawal by Subject|0|||
163907385|NCT02771366|592032491|FG001|Period 1|Withdrawal by Subject|2|||
164094851|NCT03655106|592712212|FG001|Overall Study|Withdrawal by Subject|2|||
163907386|NCT02771366|592032490|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
163907387|NCT02771366|592032491|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
163907388|NCT02092285|592032493|FG000|Induction Phase|Adverse Event|7|||
163907389|NCT02092285|592032493|FG000|Induction Phase|Physician Decision|4|||
163907390|NCT02092285|592032493|FG000|Induction Phase|Pregnancy|1|||
163907391|NCT02092285|592032493|FG000|Induction Phase|Relapse/Recurrence|7|||
163907392|NCT02092285|592032493|FG000|Induction Phase|Withdrawal by Subject|2|||
164094852|NCT03655106|592712211|FG000|Overall Study|Lost to Follow-up|2|||
164094853|NCT03655106|592712212|FG001|Overall Study|Lost to Follow-up|1|||
164094854|NCT03655106|592712211|FG000|Overall Study|Duplicate Enrollment|1|||
164094855|NCT03655106|592712212|FG001|Overall Study|Duplicate Enrollment|1|||
164018296|NCT01519245|592429915|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
164018297|NCT02873715|592429918|FG000|Overall Study|Lost to Follow-up|84|||
164018298|NCT02873715|592429919|FG001|Overall Study|Lost to Follow-up|94|||
164018299|NCT02873715|592429918|FG000|Overall Study|Withdrawal by Subject|7|||
164018300|NCT02873715|592429919|FG001|Overall Study|Withdrawal by Subject|26|||
164018301|NCT02144220|592429923|FG000|Overall Study|technology incompatibility|9|||
164018302|NCT02144220|592429923|FG000|Overall Study|Lack of Efficacy|4|||
164094856|NCT03655106|592712211|FG000|Overall Study|Protocol Violation|3|||
164094857|NCT03655106|592712212|FG001|Overall Study|Protocol Violation|0|||
164018303|NCT02144220|592429923|FG000|Overall Study|Physician Decision|3|||
164094858|NCT00365300|592712213|FG000|Open-label Phase|Adverse Event|4|||
164094859|NCT00365300|592712214|FG001|Open-label Phase|Adverse Event|0|||
164094860|NCT00365300|592712213|FG000|Open-label Phase|Failed to Return|1|||
164094861|NCT00365300|592712214|FG001|Open-label Phase|Failed to Return|0|||
163907393|NCT02092285|592032493|FG000|Induction Phase|Lack of Efficacy|14|||
163907394|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
163907395|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
163907396|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
163907397|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
163907398|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
163907399|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
163907400|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
164144038|NCT00086281|592888577|FG006|Phase 2|Adverse Event|0|||
163907401|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
163907402|NCT02092285|592032493|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
163907403|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
163907404|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163907405|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
164018304|NCT02144220|592429923|FG000|Overall Study|Withdrawal by Subject|2|||
164018305|NCT02144220|592429923|FG000|Overall Study|Protocol Violation|1|||
164018306|NCT00592501|592429926|FG000|Overall Study|Withdrawal by Subject|1|||
164018307|NCT00592501|592429926|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
164018308|NCT02084134|592429927|FG000|Overall Study|Protocol Violation|4|||
164018309|NCT02084134|592429928|FG001|Overall Study|Protocol Violation|2|||
164018310|NCT02084134|592429927|FG000|Overall Study|Death|0|||
164018311|NCT02084134|592429928|FG001|Overall Study|Death|1|||
164018312|NCT04333433|592429929|FG000|Overall Study|Withdrawal by Subject|6|||
164018313|NCT04333433|592429930|FG001|Overall Study|Withdrawal by Subject|3|||
164018314|NCT04333433|592429929|FG000|Overall Study|Death|3|||
164018315|NCT04333433|592429930|FG001|Overall Study|Death|0|||
164018316|NCT04333433|592429929|FG000|Overall Study|Lost to Follow-up|6|||
164018317|NCT04333433|592429930|FG001|Overall Study|Lost to Follow-up|1|||
164018318|NCT04333433|592429929|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
164018319|NCT04333433|592429930|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
164018320|NCT02026271|592429931|FG000|Overall Study|Adverse Event|2|||
164018321|NCT02026271|592429932|FG001|Overall Study|Adverse Event|3|||
164018322|NCT02026271|592429933|FG002|Overall Study|Adverse Event|2|||
164018323|NCT02026271|592429934|FG003|Overall Study|Adverse Event|3|||
163907406|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163907407|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
163907408|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163907409|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163907410|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163907411|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
163907412|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163907413|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163907414|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163907415|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
163907416|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163907417|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163907418|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163907419|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
163907420|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163907421|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163907422|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163907423|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
163907424|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163907425|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163907426|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163907427|NCT01185340|592032496|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
163907428|NCT01185340|592032497|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163907429|NCT01185340|592032498|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163907430|NCT01185340|592032499|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163907431|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
163907432|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
163907433|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
163907434|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
163907435|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
163907436|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
163907437|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
163907438|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
163907439|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163907440|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
163907441|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
163907442|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
163907443|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163907444|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163907445|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163907446|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163907447|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
163907448|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
163907449|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
164094862|NCT00365300|592712213|FG000|Open-label Phase|Physician Decision|1|||
164094863|NCT00365300|592712214|FG001|Open-label Phase|Physician Decision|0|||
163907450|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164018324|NCT02026271|592429935|FG004|Overall Study|Adverse Event|0|||
164018325|NCT02026271|592429931|FG000|Overall Study|Withdrawal by Subject|0|||
164018326|NCT02026271|592429932|FG001|Overall Study|Withdrawal by Subject|0|||
164018327|NCT02026271|592429933|FG002|Overall Study|Withdrawal by Subject|0|||
164018328|NCT02026271|592429934|FG003|Overall Study|Withdrawal by Subject|0|||
164018329|NCT02026271|592429935|FG004|Overall Study|Withdrawal by Subject|1|||
164018330|NCT02807454|592429936|FG000|Overall Study|Adverse Event|1|||
164018331|NCT02807454|592429937|FG001|Overall Study|Adverse Event|0|||
164018332|NCT02807454|592429936|FG000|Overall Study|Withdrawal by Subject|0|||
164018333|NCT02807454|592429937|FG001|Overall Study|Withdrawal by Subject|1|||
164018334|NCT02807454|592429936|FG000|Overall Study|Progressive Disease|30|||
164018335|NCT02807454|592429937|FG001|Overall Study|Progressive Disease|3|||
164018336|NCT02807454|592429936|FG000|Overall Study|Other Reasons|1|||
164018337|NCT02807454|592429937|FG001|Overall Study|Other Reasons|1|||
164018338|NCT05468086|592429940|FG000|Overall Study|Withdrawal by Subject|3|||
164018339|NCT05468086|592429940|FG000|Overall Study|Subject was found ineligible after consent|1|||
164018340|NCT01108809|592429941|FG000|Overall Study|Adverse Event|3|||
164018341|NCT01108809|592429941|FG000|Overall Study|Lost to Follow-up|1|||
164018342|NCT00001262|592429947|FG000|Overall Study|Death|10|||
164018343|NCT00001262|592429948|FG001|Overall Study|Death|11|||
164018344|NCT00001262|592429949|FG002|Overall Study|Death|0|||
164018345|NCT00001262|592429947|FG000|Overall Study|Withdrawal by Subject|0|||
164018346|NCT00001262|592429948|FG001|Overall Study|Withdrawal by Subject|3|||
164018347|NCT00001262|592429949|FG002|Overall Study|Withdrawal by Subject|0|||
164018348|NCT00783705|592429950|FG000|Overall Study|Adverse Event|2|||
164018349|NCT00783705|592429951|FG001|Overall Study|Adverse Event|0|||
164018350|NCT00783705|592429950|FG000|Overall Study|Withdrawal by Subject|3|||
164018351|NCT00783705|592429951|FG001|Overall Study|Withdrawal by Subject|2|||
164018352|NCT00783705|592429950|FG000|Overall Study|Lost to Follow-up|1|||
164094864|NCT00365300|592712213|FG000|Open-label Phase|Noncompliance|9|||
164094865|NCT00365300|592712214|FG001|Open-label Phase|Noncompliance|0|||
164018353|NCT00783705|592429951|FG001|Overall Study|Lost to Follow-up|3|||
164018354|NCT00748540|592429953|FG000|Overall Study|Physician Decision|1|||
164144039|NCT00086281|592888578|FG007|Phase 2|Adverse Event|0|||
164018355|NCT04743635|592429954|FG000|Overall Study|Lost to Follow-up|2|||
164018356|NCT04743635|592429955|FG001|Overall Study|Lost to Follow-up|0|||
164018357|NCT02379923|592429956|FG000|Overall Study|Death|5|||
164018358|NCT00804193|592429957|FG000|Overall Study|Lack of baseline fungus|32|||
163907451|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
163907452|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
164018359|NCT00804193|592429958|FG001|Overall Study|Lack of baseline fungus|31|||
164018360|NCT00804193|592429959|FG002|Overall Study|Lack of baseline fungus|19|||
164018361|NCT00804193|592429957|FG000|Overall Study|Adverse Event|0|||
164018362|NCT00804193|592429958|FG001|Overall Study|Adverse Event|0|||
164018363|NCT00804193|592429959|FG002|Overall Study|Adverse Event|2|||
164018364|NCT00804193|592429957|FG000|Overall Study|Lack of Efficacy|1|||
164018365|NCT00804193|592429958|FG001|Overall Study|Lack of Efficacy|1|||
164018366|NCT00804193|592429959|FG002|Overall Study|Lack of Efficacy|3|||
164018367|NCT00804193|592429957|FG000|Overall Study|Protocol Violation|0|||
164018368|NCT00804193|592429958|FG001|Overall Study|Protocol Violation|8|||
163907453|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
163907454|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
163907455|NCT01185340|592032496|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163907456|NCT01185340|592032497|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163907457|NCT01185340|592032498|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
164018369|NCT00804193|592429959|FG002|Overall Study|Protocol Violation|2|||
164018370|NCT00804193|592429957|FG000|Overall Study|Lost to Follow-up|3|||
164018371|NCT00804193|592429958|FG001|Overall Study|Lost to Follow-up|3|||
164018372|NCT00804193|592429959|FG002|Overall Study|Lost to Follow-up|4|||
164018373|NCT00804193|592429957|FG000|Overall Study|Withdrawal by Subject|3|||
164018374|NCT00804193|592429958|FG001|Overall Study|Withdrawal by Subject|1|||
164018375|NCT00804193|592429959|FG002|Overall Study|Withdrawal by Subject|2|||
164018376|NCT01193348|592429960|FG000|Screening Period|Screen Failure|5|||
164018377|NCT01193348|592429960|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
164018378|NCT01193348|592429960|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
164018379|NCT01193348|592429960|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
164018380|NCT01193348|592429960|FG000|Extension Treatment Period|Physician Decision|1|||
164018381|NCT01193348|592429960|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
164018382|NCT00968253|592429961|FG000|Overall Study|Death|0|||
164018383|NCT00968253|592429962|FG001|Overall Study|Death|0|||
164018384|NCT00968253|592429963|FG002|Overall Study|Death|2|||
164018385|NCT00968253|592429961|FG000|Overall Study|Withdrawal by Subject|0|||
164018386|NCT00968253|592429962|FG001|Overall Study|Withdrawal by Subject|0|||
164018387|NCT00968253|592429963|FG002|Overall Study|Withdrawal by Subject|1|||
164018388|NCT00968253|592429961|FG000|Overall Study|Disease Progression|0|||
164018389|NCT00968253|592429962|FG001|Overall Study|Disease Progression|3|||
164018390|NCT00968253|592429963|FG002|Overall Study|Disease Progression|3|||
164018391|NCT00968253|592429961|FG000|Overall Study|Adverse Event|0|||
164018392|NCT00968253|592429962|FG001|Overall Study|Adverse Event|0|||
164018393|NCT00968253|592429963|FG002|Overall Study|Adverse Event|1|||
163907458|NCT01185340|592032499|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
163907459|NCT00087516|592032500|FG000|Overall Study|Adverse Event|10|||
163907460|NCT00087516|592032501|FG001|Overall Study|Adverse Event|10|||
163907461|NCT00087516|592032502|FG002|Overall Study|Adverse Event|3|||
163907462|NCT00087516|592032503|FG003|Overall Study|Adverse Event|6|||
164018394|NCT02488759|592429965|FG000|Overall Study|Disease progression|73|||
164018395|NCT02488759|592429966|FG001|Overall Study|Disease progression|111|||
164018396|NCT02488759|592429967|FG002|Overall Study|Disease progression|62|||
164018397|NCT02488759|592429968|FG003|Overall Study|Disease progression|7|||
164018398|NCT02488759|592429969|FG004|Overall Study|Disease progression|4|||
164018399|NCT02488759|592429970|FG005|Overall Study|Disease progression|2|||
164018400|NCT02488759|592429965|FG000|Overall Study|Study drug toxicity|11|||
164018401|NCT02488759|592429966|FG001|Overall Study|Study drug toxicity|33|||
164018402|NCT02488759|592429967|FG002|Overall Study|Study drug toxicity|31|||
164018403|NCT02488759|592429968|FG003|Overall Study|Study drug toxicity|0|||
164018404|NCT02488759|592429969|FG004|Overall Study|Study drug toxicity|0|||
164018405|NCT02488759|592429970|FG005|Overall Study|Study drug toxicity|2|||
164018406|NCT02488759|592429965|FG000|Overall Study|Adverse event unrelated to study drug|9|||
164018407|NCT02488759|592429966|FG001|Overall Study|Adverse event unrelated to study drug|11|||
164144040|NCT00086281|592888579|FG008|Phase 2|Adverse Event|0|||
164144041|NCT00086281|592888580|FG009|Phase 2|Adverse Event|0|||
164018408|NCT02488759|592429967|FG002|Overall Study|Adverse event unrelated to study drug|7|||
164018409|NCT02488759|592429968|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164018410|NCT02488759|592429969|FG004|Overall Study|Adverse event unrelated to study drug|1|||
164018411|NCT02488759|592429970|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164018412|NCT02488759|592429965|FG000|Overall Study|Participant request to discontinue study treatment|6|||
164018413|NCT02488759|592429966|FG001|Overall Study|Participant request to discontinue study treatment|8|||
164018414|NCT02488759|592429967|FG002|Overall Study|Participant request to discontinue study treatment|4|||
164018415|NCT02488759|592429968|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164018416|NCT02488759|592429969|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164018417|NCT02488759|592429970|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164018418|NCT02488759|592429965|FG000|Overall Study|Withdrawal by Subject|4|||
164018419|NCT02488759|592429966|FG001|Overall Study|Withdrawal by Subject|0|||
164018420|NCT02488759|592429967|FG002|Overall Study|Withdrawal by Subject|3|||
164018421|NCT02488759|592429968|FG003|Overall Study|Withdrawal by Subject|0|||
163907463|NCT00087516|592032500|FG000|Overall Study|Lack of Efficacy|82|||
163907464|NCT00087516|592032501|FG001|Overall Study|Lack of Efficacy|80|||
163907465|NCT00087516|592032502|FG002|Overall Study|Lack of Efficacy|39|||
163907466|NCT00087516|592032503|FG003|Overall Study|Lack of Efficacy|29|||
163907467|NCT00087516|592032500|FG000|Overall Study|Lost to Follow-up|8|||
163907468|NCT00087516|592032501|FG001|Overall Study|Lost to Follow-up|6|||
164018422|NCT02488759|592429969|FG004|Overall Study|Withdrawal by Subject|0|||
164018423|NCT02488759|592429970|FG005|Overall Study|Withdrawal by Subject|2|||
163907469|NCT00087516|592032502|FG002|Overall Study|Lost to Follow-up|5|||
163907470|NCT00087516|592032503|FG003|Overall Study|Lost to Follow-up|5|||
164018424|NCT02488759|592429965|FG000|Overall Study|Lost to Follow-up|0|||
164018425|NCT02488759|592429966|FG001|Overall Study|Lost to Follow-up|0|||
164018426|NCT02488759|592429967|FG002|Overall Study|Lost to Follow-up|2|||
164018427|NCT02488759|592429968|FG003|Overall Study|Lost to Follow-up|0|||
164018428|NCT02488759|592429969|FG004|Overall Study|Lost to Follow-up|0|||
164018429|NCT02488759|592429970|FG005|Overall Study|Lost to Follow-up|0|||
164018430|NCT02488759|592429965|FG000|Overall Study|Maximum clinical benefit|3|||
164018431|NCT02488759|592429966|FG001|Overall Study|Maximum clinical benefit|0|||
164018432|NCT02488759|592429967|FG002|Overall Study|Maximum clinical benefit|1|||
164018433|NCT02488759|592429968|FG003|Overall Study|Maximum clinical benefit|0|||
164018434|NCT02488759|592429969|FG004|Overall Study|Maximum clinical benefit|0|||
164018435|NCT02488759|592429970|FG005|Overall Study|Maximum clinical benefit|0|||
164018436|NCT02488759|592429965|FG000|Overall Study|Other reasons|7|||
164018437|NCT02488759|592429966|FG001|Overall Study|Other reasons|32|||
163907471|NCT00087516|592032500|FG000|Overall Study|Protocol Violation|4|||
163907472|NCT00087516|592032501|FG001|Overall Study|Protocol Violation|8|||
163907473|NCT00087516|592032502|FG002|Overall Study|Protocol Violation|3|||
163907474|NCT00087516|592032503|FG003|Overall Study|Protocol Violation|6|||
163907475|NCT00087516|592032500|FG000|Overall Study|Withdrawal by Subject|16|||
164018438|NCT02488759|592429967|FG002|Overall Study|Other reasons|23|||
164018439|NCT02488759|592429968|FG003|Overall Study|Other reasons|1|||
164018440|NCT02488759|592429969|FG004|Overall Study|Other reasons|1|||
164018441|NCT02488759|592429970|FG005|Overall Study|Other reasons|1|||
164018442|NCT03860844|592429971|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
164018443|NCT03860844|592429972|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
164018444|NCT03860844|592429973|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
164018445|NCT03860844|592429971|FG000|Overall Study|Progressive disease|5|||
163907476|NCT00087516|592032501|FG001|Overall Study|Withdrawal by Subject|27|||
163907477|NCT00087516|592032502|FG002|Overall Study|Withdrawal by Subject|11|||
163907478|NCT00087516|592032503|FG003|Overall Study|Withdrawal by Subject|12|||
163907479|NCT00087516|592032500|FG000|Overall Study|Site terminated|0|||
163907480|NCT00087516|592032501|FG001|Overall Study|Site terminated|2|||
163907481|NCT00087516|592032502|FG002|Overall Study|Site terminated|1|||
163907482|NCT00087516|592032503|FG003|Overall Study|Site terminated|0|||
163907483|NCT00087516|592032500|FG000|Overall Study|Protocol specified discontinuation|35|||
163907484|NCT00087516|592032501|FG001|Overall Study|Protocol specified discontinuation|33|||
163907485|NCT00087516|592032502|FG002|Overall Study|Protocol specified discontinuation|33|||
163907486|NCT00087516|592032503|FG003|Overall Study|Protocol specified discontinuation|26|||
163907487|NCT00087516|592032500|FG000|Overall Study|Patient moved|3|||
163907488|NCT00087516|592032501|FG001|Overall Study|Patient moved|2|||
163907489|NCT00087516|592032502|FG002|Overall Study|Patient moved|1|||
163907490|NCT00087516|592032503|FG003|Overall Study|Patient moved|0|||
163907491|NCT00087516|592032500|FG000|Overall Study|Patient was non-compliant|3|||
163907492|NCT00087516|592032501|FG001|Overall Study|Patient was non-compliant|1|||
163907493|NCT00087516|592032502|FG002|Overall Study|Patient was non-compliant|0|||
163907494|NCT00087516|592032503|FG003|Overall Study|Patient was non-compliant|0|||
163907495|NCT00087516|592032500|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
163907496|NCT00087516|592032501|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
163907497|NCT00087516|592032502|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
163907498|NCT00087516|592032503|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
163907499|NCT00087516|592032500|FG000|Overall Study|Other|0|||
163907500|NCT00087516|592032501|FG001|Overall Study|Other|0|||
163907501|NCT00087516|592032502|FG002|Overall Study|Other|1|||
163907502|NCT00087516|592032503|FG003|Overall Study|Other|0|||
163907503|NCT00246129|592032504|FG000|Overall Study|Lost to Follow-up|1|||
163907504|NCT00246129|592032505|FG001|Overall Study|Lost to Follow-up|0|||
163907505|NCT00246129|592032504|FG000|Overall Study|Death|2|||
163907506|NCT00246129|592032505|FG001|Overall Study|Death|1|||
163907507|NCT00246129|592032504|FG000|Overall Study|suffered primary non-function|1|||
164018446|NCT03860844|592429972|FG001|Overall Study|Progressive disease|3|||
164018447|NCT03860844|592429973|FG002|Overall Study|Progressive disease|4|||
163907508|NCT00246129|592032505|FG001|Overall Study|suffered primary non-function|0|||
163907509|NCT00246129|592032504|FG000|Overall Study|grafts failed|3|||
163907510|NCT00246129|592032505|FG001|Overall Study|grafts failed|1|||
163907511|NCT01779050|592032506|FG000|Overall Study|Withdrawal by Subject|1|||
163907512|NCT01779050|592032507|FG001|Overall Study|Withdrawal by Subject|0|||
163907513|NCT03403036|592032508|FG000|Overall Study|Lack of Efficacy|5|||
163907514|NCT02392507|592032516|FG000|Induction Regimen|Death|3|||
164018448|NCT03860844|592429971|FG000|Overall Study|Other, Not related to COVID-19|0|||
164018449|NCT03860844|592429972|FG001|Overall Study|Other, Not related to COVID-19|1|||
164018450|NCT03860844|592429973|FG002|Overall Study|Other, Not related to COVID-19|0|||
164018451|NCT01678807|592429976|FG000|Overall Study|Adverse Event|4|||
164018452|NCT01678807|592429977|FG001|Overall Study|Adverse Event|4|||
164018453|NCT01678807|592429978|FG002|Overall Study|Adverse Event|0|||
164018454|NCT01678807|592429976|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
164018455|NCT01678807|592429977|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
164018456|NCT01678807|592429978|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
164018457|NCT05281523|592429979|FG000|Overall Study|Adverse Event|1|||
163907515|NCT02392507|592032516|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
163907516|NCT02392507|592032516|FG000|Induction Regimen|Physician Decision|1|||
163907517|NCT02392507|592032516|FG000|Induction Regimen|Withdrawal by Subject|2|||
163907518|NCT02392507|592032516|FG000|Maintenance Regimen|Death|1|||
163907519|NCT02392507|592032516|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
163907520|NCT00273052|592032517|FG000|Overall Study|Withdrawal by Subject|16|||
163907521|NCT00273052|592032518|FG001|Overall Study|Withdrawal by Subject|19|||
163907522|NCT00273052|592032517|FG000|Overall Study|Adverse Event|21|||
163907523|NCT00273052|592032518|FG001|Overall Study|Adverse Event|19|||
163907524|NCT00273052|592032517|FG000|Overall Study|Protocol Violation|14|||
163907525|NCT00273052|592032518|FG001|Overall Study|Protocol Violation|18|||
163907526|NCT00273052|592032517|FG000|Overall Study|Lost to Follow-up|7|||
163907527|NCT00273052|592032518|FG001|Overall Study|Lost to Follow-up|25|||
163907528|NCT00273052|592032517|FG000|Overall Study|Lack of Efficacy|6|||
163907529|NCT00273052|592032518|FG001|Overall Study|Lack of Efficacy|4|||
163907530|NCT00273052|592032517|FG000|Overall Study|Non-Compliance|3|||
163907531|NCT00273052|592032518|FG001|Overall Study|Non-Compliance|1|||
164018458|NCT05281523|592429980|FG001|Overall Study|Adverse Event|1|||
164018459|NCT05281523|592429979|FG000|Overall Study|Physician Decision|1|||
164018460|NCT05281523|592429980|FG001|Overall Study|Physician Decision|1|||
164018461|NCT05281523|592429979|FG000|Overall Study|Withdrawal by Subject|5|||
164018462|NCT05281523|592429980|FG001|Overall Study|Withdrawal by Subject|15|||
164018463|NCT05281523|592429979|FG000|Overall Study|GCP violations|3|||
164018464|NCT05281523|592429980|FG001|Overall Study|GCP violations|4|||
164018465|NCT04038255|592431694|FG000|Overall Study|Lost to Follow-up|0|||
164018466|NCT04038255|592431695|FG001|Overall Study|Lost to Follow-up|9|||
164018467|NCT04038255|592431696|FG002|Overall Study|Lost to Follow-up|5|||
164018468|NCT04038255|592431694|FG000|Overall Study|Withdrawal by Subject|0|||
164018469|NCT04038255|592431695|FG001|Overall Study|Withdrawal by Subject|0|||
164018470|NCT04038255|592431696|FG002|Overall Study|Withdrawal by Subject|1|||
164018471|NCT05183867|592431697|FG000|Overall Study|Withdrawal by Subject|3|||
164018472|NCT05183867|592431698|FG001|Overall Study|Withdrawal by Subject|2|||
164018473|NCT05183867|592431699|FG002|Overall Study|Withdrawal by Subject|0|||
164018474|NCT05306873|592431700|FG000|Stage 2|Study stopped|1|||
164018475|NCT05306873|592431701|FG001|Stage 2|Study stopped|1|||
164018476|NCT05306873|592431702|FG002|Stage 2|Study stopped|0|||
164018477|NCT05306873|592431703|FG003|Stage 2|Study stopped|0|||
164018478|NCT05306873|592431700|FG000|Stage 2|Stage 2 Treatment Failure|2|||
164018479|NCT05306873|592431701|FG001|Stage 2|Stage 2 Treatment Failure|3|||
164018480|NCT05306873|592431702|FG002|Stage 2|Stage 2 Treatment Failure|0|||
164018481|NCT05306873|592431703|FG003|Stage 2|Stage 2 Treatment Failure|0|||
164018482|NCT05306873|592431700|FG000|Stage 2|Logistical issues due to participant moving|1|||
164018483|NCT05306873|592431701|FG001|Stage 2|Logistical issues due to participant moving|0|||
164018484|NCT05306873|592431702|FG002|Stage 2|Logistical issues due to participant moving|0|||
164018485|NCT05306873|592431703|FG003|Stage 2|Logistical issues due to participant moving|0|||
164018486|NCT05306873|592431700|FG000|Stage 3|Stage 3 Treatment Failure|0|||
164018487|NCT05306873|592431701|FG001|Stage 3|Stage 3 Treatment Failure|0|||
164018488|NCT05306873|592431702|FG002|Stage 3|Stage 3 Treatment Failure|0|||
164018489|NCT05306873|592431703|FG003|Stage 3|Stage 3 Treatment Failure|1|||
164018490|NCT05306873|592431700|FG000|Stage 3|Study Stopped|0|||
164018491|NCT05306873|592431701|FG001|Stage 3|Study Stopped|0|||
164018492|NCT05306873|592431702|FG002|Stage 3|Study Stopped|1|||
164018493|NCT05306873|592431703|FG003|Stage 3|Study Stopped|0|||
164018494|NCT01953328|592431704|FG000|Overall Study|Withdrawal by Subject|0|||
164018495|NCT01953328|592431705|FG001|Overall Study|Withdrawal by Subject|0|||
164018496|NCT01953328|592431706|FG002|Overall Study|Withdrawal by Subject|0|||
164018497|NCT01953328|592431707|FG003|Overall Study|Withdrawal by Subject|0|||
164018498|NCT01953328|592431708|FG004|Overall Study|Withdrawal by Subject|1|||
164018499|NCT01953328|592431709|FG005|Overall Study|Withdrawal by Subject|0|||
164018500|NCT01953328|592431710|FG006|Overall Study|Withdrawal by Subject|0|||
164018501|NCT01953328|592431711|FG007|Overall Study|Withdrawal by Subject|0|||
164018502|NCT01953328|592431704|FG000|Overall Study|Lost to Follow-up|0|||
164018503|NCT01953328|592431705|FG001|Overall Study|Lost to Follow-up|0|||
164018504|NCT01953328|592431706|FG002|Overall Study|Lost to Follow-up|0|||
164018505|NCT01953328|592431707|FG003|Overall Study|Lost to Follow-up|0|||
164018506|NCT01953328|592431708|FG004|Overall Study|Lost to Follow-up|1|||
164018507|NCT01953328|592431709|FG005|Overall Study|Lost to Follow-up|0|||
164018508|NCT01953328|592431710|FG006|Overall Study|Lost to Follow-up|0|||
164018509|NCT01953328|592431711|FG007|Overall Study|Lost to Follow-up|0|||
164018510|NCT01755195|592431714|FG000|Overall Study|Participant noncompliance|2|||
164018511|NCT01755195|592431714|FG000|Overall Study|Switched to alternative treatment|4|||
164018512|NCT01755195|592431714|FG000|Overall Study|Withdrawal by Subject|1|||
164018513|NCT01755195|592431714|FG000|Overall Study|Participant refused to start treatment|1|||
164018514|NCT01755195|592431714|FG000|Overall Study|Participant has been consented for another trial|1|||
164018515|NCT01755195|592431714|FG000|Overall Study|Refused further treatment|3|||
164018516|NCT01755195|592431714|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
164018517|NCT05113953|592431715|FG000|Overall Study|Adverse Event|5|||
163907532|NCT00273052|592032517|FG000|Overall Study|Other|2|||
163907533|NCT00273052|592032518|FG001|Overall Study|Other|0|||
163907534|NCT00273052|592032517|FG000|Overall Study|Worsening serum lipid levels|0|||
164094866|NCT00365300|592712213|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
164018518|NCT05113953|592431716|FG001|Overall Study|Adverse Event|0|||
164018519|NCT05113953|592431717|FG002|Overall Study|Adverse Event|3|||
164018520|NCT05113953|592431715|FG000|Overall Study|Lost to Follow-up|3|||
164018521|NCT05113953|592431716|FG001|Overall Study|Lost to Follow-up|4|||
164018522|NCT05113953|592431717|FG002|Overall Study|Lost to Follow-up|2|||
164018523|NCT05113953|592431715|FG000|Overall Study|Non-compliance with Study Drug|1|||
164018524|NCT05113953|592431716|FG001|Overall Study|Non-compliance with Study Drug|0|||
164018525|NCT05113953|592431717|FG002|Overall Study|Non-compliance with Study Drug|0|||
164018526|NCT05113953|592431715|FG000|Overall Study|Withdrawal by Subject|2|||
164018527|NCT05113953|592431716|FG001|Overall Study|Withdrawal by Subject|6|||
164018528|NCT05113953|592431717|FG002|Overall Study|Withdrawal by Subject|4|||
164018529|NCT05113953|592431715|FG000|Overall Study|Reason not Specified|2|||
164018530|NCT05113953|592431716|FG001|Overall Study|Reason not Specified|0|||
164018531|NCT05113953|592431717|FG002|Overall Study|Reason not Specified|0|||
164018532|NCT02340819|592431719|FG000|Overall Study|Adverse Event|1|||
164018533|NCT02340819|592431719|FG000|Overall Study|Withdrawal by Subject|2|||
164018534|NCT02340819|592431719|FG000|Overall Study|Discontinued with other reason|1|||
164018535|NCT01328249|592431720|FG000|Overall Study|Adverse Event|3|||
164018536|NCT01328249|592431721|FG001|Overall Study|Adverse Event|0|||
164018537|NCT01328249|592431720|FG000|Overall Study|Disease progression|1|||
164018538|NCT01328249|592431721|FG001|Overall Study|Disease progression|0|||
164018539|NCT01328249|592431720|FG000|Overall Study|Withdrawal by Subject|1|||
164144042|NCT00086281|592888581|FG010|Phase 2|Adverse Event|0|||
164144043|NCT00086281|592888582|FG011|Phase 2|Adverse Event|0|||
163907535|NCT00273052|592032518|FG001|Overall Study|Worsening serum lipid levels|2|||
163907536|NCT00704340|592032519|FG000|Overall Study|Lost to Follow-up|2|||
163907537|NCT00704340|592032520|FG001|Overall Study|Lost to Follow-up|1|||
163907538|NCT00704340|592032519|FG000|Overall Study|Death|0|||
163907539|NCT00704340|592032520|FG001|Overall Study|Death|1|||
163907540|NCT00403845|592032529|FG000|Treatment Period 1|Subject withdrew consent|1|||
163907541|NCT00403845|592032530|FG001|Treatment Period 1|Subject withdrew consent|0|||
163907542|NCT00403845|592032531|FG002|Treatment Period 1|Subject withdrew consent|0|||
163907543|NCT00403845|592032532|FG003|Treatment Period 1|Subject withdrew consent|0|||
163907544|NCT00403845|592032529|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
163907545|NCT00403845|592032530|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
163907546|NCT00403845|592032531|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
163907547|NCT00403845|592032532|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
163907548|NCT00403845|592032529|FG000|Treatment Period 2|Subject withdrew consent|1|||
163907549|NCT00403845|592032530|FG001|Treatment Period 2|Subject withdrew consent|0|||
163907550|NCT00403845|592032531|FG002|Treatment Period 2|Subject withdrew consent|0|||
163907551|NCT00403845|592032532|FG003|Treatment Period 2|Subject withdrew consent|0|||
163907552|NCT00403845|592032529|FG000|Treatment Period 3|Subject withdrew consent|0|||
163907553|NCT00403845|592032530|FG001|Treatment Period 3|Subject withdrew consent|0|||
163907554|NCT00403845|592032531|FG002|Treatment Period 3|Subject withdrew consent|0|||
163907555|NCT00403845|592032532|FG003|Treatment Period 3|Subject withdrew consent|1|||
163907556|NCT00403845|592032529|FG000|Treatment Period 3|Adverse Event|0|||
163907557|NCT00403845|592032530|FG001|Treatment Period 3|Adverse Event|0|||
163907558|NCT00403845|592032531|FG002|Treatment Period 3|Adverse Event|0|||
164094867|NCT00365300|592712214|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
163907559|NCT00403845|592032532|FG003|Treatment Period 3|Adverse Event|1|||
163907560|NCT03316170|592032533|FG000|Overall Study|Death|1|||
163907561|NCT03316170|592032534|FG001|Overall Study|Death|0|||
163907562|NCT03316170|592032533|FG000|Overall Study|Lost to Follow-up|6|||
163907563|NCT03316170|592032534|FG001|Overall Study|Lost to Follow-up|7|||
163907564|NCT02935673|592032535|FG000|Overall Study|Adverse Event|0|||
163907565|NCT02935673|592032536|FG001|Overall Study|Adverse Event|1|||
163907566|NCT02935673|592032537|FG002|Overall Study|Adverse Event|0|||
163907567|NCT02935673|592032535|FG000|Overall Study|Withdrawal by Subject|1|||
163907568|NCT02935673|592032536|FG001|Overall Study|Withdrawal by Subject|2|||
163907569|NCT02935673|592032537|FG002|Overall Study|Withdrawal by Subject|0|||
163907570|NCT01836523|592032538|FG000|Overall Study|Adverse Event|15|||
163907571|NCT01836523|592032539|FG001|Overall Study|Adverse Event|41|||
163907572|NCT01836523|592032540|FG002|Overall Study|Adverse Event|49|||
163907573|NCT01836523|592032541|FG003|Overall Study|Adverse Event|14|||
163907574|NCT01836523|592032538|FG000|Overall Study|Protocol Violation|6|||
163907575|NCT01836523|592032539|FG001|Overall Study|Protocol Violation|3|||
163907576|NCT01836523|592032540|FG002|Overall Study|Protocol Violation|2|||
163907577|NCT01836523|592032541|FG003|Overall Study|Protocol Violation|4|||
163907578|NCT01836523|592032538|FG000|Overall Study|Met Withdrawal Criteria|13|||
163907579|NCT01836523|592032539|FG001|Overall Study|Met Withdrawal Criteria|13|||
163907580|NCT01836523|592032540|FG002|Overall Study|Met Withdrawal Criteria|21|||
163907581|NCT01836523|592032541|FG003|Overall Study|Met Withdrawal Criteria|27|||
163907582|NCT01836523|592032538|FG000|Overall Study|Unclassified|17|||
164018540|NCT01328249|592431721|FG001|Overall Study|Withdrawal by Subject|1|||
164018541|NCT01328249|592431720|FG000|Overall Study|Moved before end of treatment visit|1|||
164018542|NCT01328249|592431721|FG001|Overall Study|Moved before end of treatment visit|0|||
164018543|NCT01328249|592431720|FG000|Overall Study|Subject choice|1|||
164018544|NCT01328249|592431721|FG001|Overall Study|Subject choice|1|||
164018545|NCT01328249|592431720|FG000|Overall Study|Protocol Violation|0|||
164018546|NCT01328249|592431721|FG001|Overall Study|Protocol Violation|1|||
164018547|NCT03331666|592431722|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
164018548|NCT03331666|592431723|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
163907583|NCT01836523|592032539|FG001|Overall Study|Unclassified|28|||
163907584|NCT01836523|592032540|FG002|Overall Study|Unclassified|19|||
163907585|NCT01836523|592032541|FG003|Overall Study|Unclassified|29|||
163907586|NCT02095678|592032542|FG000|Overall Study|Withdrawal by Subject|0|||
163907587|NCT02095678|592032543|FG001|Overall Study|Withdrawal by Subject|1|||
163907588|NCT02095678|592032542|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
163907589|NCT02095678|592032543|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
163907590|NCT02095678|592032542|FG000|Overall Study|lesion impacted by previous treatment|1|||
163907591|NCT02095678|592032543|FG001|Overall Study|lesion impacted by previous treatment|1|||
163907592|NCT02095678|592032542|FG000|Overall Study|No Confirmed Diagnosis|0|||
163907593|NCT02095678|592032543|FG001|Overall Study|No Confirmed Diagnosis|3|||
163907594|NCT02095678|592032542|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
163907595|NCT02095678|592032543|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
163907596|NCT02095678|592032542|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
163907597|NCT02095678|592032543|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
163907598|NCT03418545|592032544|FG000|Overall Study|Withdrawal by Participant|2|||
163907599|NCT03418545|592032545|FG001|Overall Study|Withdrawal by Participant|4|||
163907600|NCT03418545|592032544|FG000|Overall Study|Lost to Follow-up|3|||
163907601|NCT03418545|592032545|FG001|Overall Study|Lost to Follow-up|5|||
163907602|NCT03418545|592032544|FG000|Overall Study|Reason Not Specified|0|||
163907603|NCT03418545|592032545|FG001|Overall Study|Reason Not Specified|1|||
163907604|NCT03418545|592032544|FG000|Overall Study|Missing Completion Status|0|||
163907605|NCT03418545|592032545|FG001|Overall Study|Missing Completion Status|1|||
163907606|NCT04660799|592032546|FG000|Overall Study|Progressive Disease|1|||
163907607|NCT04660799|592032547|FG001|Overall Study|Progressive Disease|1|||
163907608|NCT04660799|592032546|FG000|Overall Study|Death|2|||
163907609|NCT04660799|592032547|FG001|Overall Study|Death|1|||
163907610|NCT04660799|592032546|FG000|Overall Study|Adverse Event|2|||
163907611|NCT04660799|592032547|FG001|Overall Study|Adverse Event|1|||
163907612|NCT04660799|592032546|FG000|Overall Study|Withdrawal by Subject|2|||
163907613|NCT04660799|592032547|FG001|Overall Study|Withdrawal by Subject|5|||
163907614|NCT02706483|592032548|FG000|Overall Study|Adverse Event|97|||
163907615|NCT02706483|592032548|FG000|Overall Study|Death|1|||
163907616|NCT02706483|592032548|FG000|Overall Study|Lack of Efficacy|39|||
163907617|NCT02706483|592032548|FG000|Overall Study|Lost to Follow-up|101|||
163907618|NCT02706483|592032548|FG000|Overall Study|Non-compliance with study drug|15|||
163907619|NCT02706483|592032548|FG000|Overall Study|Physician Decision|6|||
163907620|NCT02706483|592032548|FG000|Overall Study|Pregnancy|6|||
163907621|NCT02706483|592032548|FG000|Overall Study|Protocol Violation|18|||
163907622|NCT02706483|592032548|FG000|Overall Study|Withdrawal by Subject|136|||
163907623|NCT02706483|592032548|FG000|Overall Study|Non-compliance with visits|6|||
163907624|NCT02706483|592032548|FG000|Overall Study|Site closure|4|||
163907625|NCT02706483|592032548|FG000|Overall Study|Subject moved|1|||
163907626|NCT03131713|592032549|FG000|Overall Study|Lost to Follow-up|5|||
163907627|NCT03131713|592032550|FG001|Overall Study|Lost to Follow-up|0|||
163907628|NCT05484661|592032561|FG000|Overall Study|Withdrawal by Subject|1|||
163907629|NCT05484661|592032562|FG001|Overall Study|Withdrawal by Subject|0|||
163907630|NCT04748341|592032564|FG000|Overall Study|Lost to Follow-up|1|||
164018549|NCT02326467|592431724|FG000|Overall Study|Withdrawal by Subject|1|||
164018550|NCT00434512|592431725|FG000|Overall Study|Migrated/moved from study area|0|||
164018551|NCT00434512|592431726|FG001|Overall Study|Migrated/moved from study area|0|||
164018552|NCT00434512|592431727|FG002|Overall Study|Migrated/moved from study area|0|||
164018553|NCT00434512|592431728|FG003|Overall Study|Migrated/moved from study area|1|||
164018554|NCT00434512|592431729|FG004|Overall Study|Migrated/moved from study area|1|||
164018555|NCT00434512|592431730|FG005|Overall Study|Migrated/moved from study area|1|||
164018556|NCT00434512|592431725|FG000|Overall Study|Other|0|||
164018557|NCT00434512|592431726|FG001|Overall Study|Other|1|||
164018558|NCT00434512|592431727|FG002|Overall Study|Other|0|||
164018559|NCT00434512|592431728|FG003|Overall Study|Other|0|||
164018560|NCT00434512|592431729|FG004|Overall Study|Other|0|||
164018561|NCT00434512|592431730|FG005|Overall Study|Other|0|||
164018562|NCT04467164|592431732|FG000|Washout (1 Week)|Lost to Follow-up|2|||
164018563|NCT04467164|592431733|FG001|Washout (1 Week)|Lost to Follow-up|0|||
164018564|NCT01998581|592431734|FG000|Overall Study|Refused repeat treatment|20|||
164018565|NCT01998581|592431735|FG001|Overall Study|Refused repeat treatment|4|||
164018566|NCT01998581|592431734|FG000|Overall Study|Protocol Violation|1|||
164018567|NCT01998581|592431735|FG001|Overall Study|Protocol Violation|0|||
164018568|NCT01998581|592431734|FG000|Overall Study|Withdrawal by Subject|8|||
164018569|NCT01998581|592431735|FG001|Overall Study|Withdrawal by Subject|1|||
164018570|NCT01998581|592431734|FG000|Overall Study|Lost to Follow-up|12|||
164018571|NCT01998581|592431735|FG001|Overall Study|Lost to Follow-up|4|||
163907631|NCT04748341|592032565|FG001|Overall Study|Lost to Follow-up|1|||
163907632|NCT02334215|592032568|FG000|Overall Study|Death|1|||
163907633|NCT02334215|592032569|FG001|Overall Study|Death|1|||
163907634|NCT02334215|592032570|FG002|Overall Study|Death|0|||
163907635|NCT02334215|592032568|FG000|Overall Study|Lost to Follow-up|1|||
163907636|NCT02334215|592032569|FG001|Overall Study|Lost to Follow-up|0|||
163907637|NCT02334215|592032570|FG002|Overall Study|Lost to Follow-up|4|||
163907638|NCT02334215|592032568|FG000|Overall Study|Withdrawal by Subject|2|||
163907639|NCT02334215|592032569|FG001|Overall Study|Withdrawal by Subject|2|||
163907640|NCT02334215|592032570|FG002|Overall Study|Withdrawal by Subject|1|||
163907641|NCT02334215|592032568|FG000|Overall Study|Not released from incarceration on time|3|||
163907642|NCT02334215|592032569|FG001|Overall Study|Not released from incarceration on time|3|||
163907643|NCT02334215|592032570|FG002|Overall Study|Not released from incarceration on time|3|||
163907644|NCT02334215|592032568|FG000|Overall Study|Incarcerated|0|||
163907645|NCT02334215|592032569|FG001|Overall Study|Incarcerated|0|||
163907646|NCT02334215|592032570|FG002|Overall Study|Incarcerated|7|||
163907647|NCT05865392|592032573|FG000|Overall Study|Withdrawal by Subject|4|||
163907648|NCT05865392|592032574|FG001|Overall Study|Withdrawal by Subject|0|||
163907649|NCT05865392|592032573|FG000|Overall Study|Didn't meet inclusion criteria|4|||
163907650|NCT05865392|592032574|FG001|Overall Study|Didn't meet inclusion criteria|0|||
163907651|NCT02159989|592032575|FG000|Overall Study|Adverse Event|1|||
163907652|NCT02159989|592032576|FG001|Overall Study|Adverse Event|0|||
163907653|NCT02159989|592032577|FG002|Overall Study|Adverse Event|0|||
163907654|NCT02159989|592032578|FG003|Overall Study|Adverse Event|0|||
163907655|NCT02159989|592032579|FG004|Overall Study|Adverse Event|1|||
163907656|NCT02159989|592032580|FG005|Overall Study|Adverse Event|0|||
163907657|NCT02159989|592032581|FG006|Overall Study|Adverse Event|1|||
163907658|NCT02159989|592032582|FG007|Overall Study|Adverse Event|2|||
163907659|NCT02159989|592032583|FG008|Overall Study|Adverse Event|0|||
163907660|NCT02159989|592032584|FG009|Overall Study|Adverse Event|2|||
163907661|NCT02159989|592032585|FG010|Overall Study|Adverse Event|1|||
163907662|NCT02159989|592032575|FG000|Overall Study|Death|0|||
163907663|NCT02159989|592032576|FG001|Overall Study|Death|0|||
163907664|NCT02159989|592032577|FG002|Overall Study|Death|0|||
163907665|NCT02159989|592032578|FG003|Overall Study|Death|0|||
164018572|NCT01998581|592431734|FG000|Overall Study|Adverse Event|1|||
163907666|NCT02159989|592032579|FG004|Overall Study|Death|0|||
163907667|NCT02159989|592032580|FG005|Overall Study|Death|0|||
163907668|NCT02159989|592032581|FG006|Overall Study|Death|0|||
163907669|NCT02159989|592032582|FG007|Overall Study|Death|0|||
163907670|NCT02159989|592032583|FG008|Overall Study|Death|0|||
163907671|NCT02159989|592032584|FG009|Overall Study|Death|0|||
163907672|NCT02159989|592032585|FG010|Overall Study|Death|1|||
163907673|NCT02159989|592032575|FG000|Overall Study|Lack of Efficacy|2|||
163907674|NCT02159989|592032576|FG001|Overall Study|Lack of Efficacy|3|||
163907675|NCT02159989|592032577|FG002|Overall Study|Lack of Efficacy|3|||
163907676|NCT02159989|592032578|FG003|Overall Study|Lack of Efficacy|0|||
163907677|NCT02159989|592032579|FG004|Overall Study|Lack of Efficacy|2|||
163907678|NCT02159989|592032580|FG005|Overall Study|Lack of Efficacy|3|||
164018573|NCT01998581|592431735|FG001|Overall Study|Adverse Event|1|||
164018574|NCT01998581|592431734|FG000|Overall Study|Other reasons|3|||
164018575|NCT01998581|592431735|FG001|Overall Study|Other reasons|2|||
163907679|NCT02159989|592032581|FG006|Overall Study|Lack of Efficacy|3|||
163907680|NCT02159989|592032582|FG007|Overall Study|Lack of Efficacy|1|||
163907681|NCT02159989|592032583|FG008|Overall Study|Lack of Efficacy|3|||
163907682|NCT02159989|592032584|FG009|Overall Study|Lack of Efficacy|6|||
164018576|NCT01998581|592431734|FG000|Overall Study|Randomized but withdrew before treatment|1|||
163907683|NCT02159989|592032585|FG010|Overall Study|Lack of Efficacy|7|||
164018577|NCT01998581|592431735|FG001|Overall Study|Randomized but withdrew before treatment|0|||
163907684|NCT02159989|592032575|FG000|Overall Study|Lost to Follow-up|0|||
163907685|NCT02159989|592032576|FG001|Overall Study|Lost to Follow-up|0|||
163907686|NCT02159989|592032577|FG002|Overall Study|Lost to Follow-up|0|||
163907687|NCT02159989|592032578|FG003|Overall Study|Lost to Follow-up|1|||
163907688|NCT02159989|592032579|FG004|Overall Study|Lost to Follow-up|0|||
163907689|NCT02159989|592032580|FG005|Overall Study|Lost to Follow-up|0|||
163907690|NCT02159989|592032581|FG006|Overall Study|Lost to Follow-up|0|||
163907691|NCT02159989|592032582|FG007|Overall Study|Lost to Follow-up|0|||
163907692|NCT02159989|592032583|FG008|Overall Study|Lost to Follow-up|0|||
163907693|NCT02159989|592032584|FG009|Overall Study|Lost to Follow-up|0|||
164018578|NCT02273050|592431738|FG000|Overall Study|Adverse Event|4|||
164018579|NCT02273050|592431739|FG001|Overall Study|Adverse Event|3|||
164018580|NCT02273050|592431740|FG002|Overall Study|Adverse Event|3|||
164018581|NCT02273050|592431738|FG000|Overall Study|Death|0|||
164018582|NCT02273050|592431739|FG001|Overall Study|Death|0|||
164018583|NCT02273050|592431740|FG002|Overall Study|Death|1|||
164018584|NCT02273050|592431738|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
164018585|NCT02273050|592431739|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
164018586|NCT02273050|592431740|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
164018587|NCT02273050|592431738|FG000|Overall Study|Lack of Efficacy|0|||
164018588|NCT02273050|592431739|FG001|Overall Study|Lack of Efficacy|1|||
164018589|NCT02273050|592431740|FG002|Overall Study|Lack of Efficacy|1|||
164018590|NCT02273050|592431738|FG000|Overall Study|Withdrawal by Subject|17|||
164018591|NCT02273050|592431739|FG001|Overall Study|Withdrawal by Subject|14|||
164018592|NCT02273050|592431740|FG002|Overall Study|Withdrawal by Subject|16|||
164018593|NCT02273050|592431738|FG000|Overall Study|Lost to Follow-up|0|||
164018594|NCT02273050|592431739|FG001|Overall Study|Lost to Follow-up|2|||
164018595|NCT02273050|592431740|FG002|Overall Study|Lost to Follow-up|3|||
164018596|NCT02273050|592431738|FG000|Overall Study|Protocol Violation|3|||
164018597|NCT02273050|592431739|FG001|Overall Study|Protocol Violation|1|||
164018598|NCT02273050|592431740|FG002|Overall Study|Protocol Violation|4|||
164018599|NCT02273752|592431741|FG000|Overall Study|Trial was terminated early|2|||
164018600|NCT00903032|592431742|FG000|Overall Study|Withdrawal by Subject|5|||
164018601|NCT00903032|592431743|FG001|Overall Study|Withdrawal by Subject|3|||
164018602|NCT00903032|592431742|FG000|Overall Study|Lost to Follow-up|2|||
164018603|NCT00903032|592431743|FG001|Overall Study|Lost to Follow-up|2|||
164018604|NCT05619172|592431744|FG000|Safety Cohort 1|Death|7|||
164018605|NCT05619172|592431745|FG001|Safety Cohort 1|Death|0|||
164144044|NCT00086281|592888583|FG012|Phase 2|Adverse Event|1|||
163907694|NCT02159989|592032585|FG010|Overall Study|Lost to Follow-up|1|||
164018606|NCT05619172|592431744|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
164018607|NCT05619172|592431745|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
164018608|NCT05619172|592431744|FG000|Safety Cohort 2|Death|0|||
164018609|NCT05619172|592431745|FG001|Safety Cohort 2|Death|1|||
164018610|NCT05619172|592431744|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
164018611|NCT05619172|592431745|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
164018612|NCT01763905|592431746|FG000|Overall Study|Withdrawal by Subject|1|||
164018613|NCT01763905|592431747|FG001|Overall Study|Withdrawal by Subject|1|||
164018614|NCT01763905|592431748|FG002|Overall Study|Withdrawal by Subject|0|||
164018615|NCT01763905|592431749|FG003|Overall Study|Withdrawal by Subject|1|||
164018616|NCT01763905|592431746|FG000|Overall Study|Decision by sponsor|5|||
164018617|NCT01763905|592431747|FG001|Overall Study|Decision by sponsor|0|||
164018618|NCT01763905|592431748|FG002|Overall Study|Decision by sponsor|8|||
164018619|NCT01763905|592431749|FG003|Overall Study|Decision by sponsor|0|||
164018620|NCT01763905|592431746|FG000|Overall Study|Lost to Follow-up|0|||
164094868|NCT00365300|592712213|FG000|Open-label Phase|Protocol Violation|1|||
164094869|NCT00365300|592712214|FG001|Open-label Phase|Protocol Violation|0|||
164094870|NCT00365300|592712213|FG000|Open-label Phase|Lack of Efficacy|1|||
164094871|NCT00365300|592712214|FG001|Open-label Phase|Lack of Efficacy|0|||
164094872|NCT00365300|592712213|FG000|Open-label Phase|Patient skipped open label phase|1|||
164018621|NCT01763905|592431747|FG001|Overall Study|Lost to Follow-up|0|||
164018622|NCT01763905|592431748|FG002|Overall Study|Lost to Follow-up|1|||
164018623|NCT01763905|592431749|FG003|Overall Study|Lost to Follow-up|0|||
164018624|NCT04346628|592431750|FG000|Overall Study|Lost to Follow-up|4|||
164018625|NCT04346628|592431751|FG001|Overall Study|Lost to Follow-up|4|||
164018626|NCT04346628|592431750|FG000|Overall Study|Withdrew (had personal reasons)|2|||
164018627|NCT04346628|592431751|FG001|Overall Study|Withdrew (had personal reasons)|5|||
164018628|NCT04346628|592431750|FG000|Overall Study|Withdrew (medication intolerant)|0|||
164018629|NCT04346628|592431751|FG001|Overall Study|Withdrew (medication intolerant)|3|||
163907695|NCT02159989|592032575|FG000|Overall Study|Withdrawal by Subject|2|||
163907696|NCT02159989|592032576|FG001|Overall Study|Withdrawal by Subject|0|||
163907697|NCT02159989|592032577|FG002|Overall Study|Withdrawal by Subject|0|||
163907698|NCT02159989|592032578|FG003|Overall Study|Withdrawal by Subject|2|||
163907699|NCT02159989|592032579|FG004|Overall Study|Withdrawal by Subject|1|||
163907700|NCT02159989|592032580|FG005|Overall Study|Withdrawal by Subject|0|||
163907701|NCT02159989|592032581|FG006|Overall Study|Withdrawal by Subject|3|||
163907702|NCT02159989|592032582|FG007|Overall Study|Withdrawal by Subject|1|||
163907703|NCT02159989|592032583|FG008|Overall Study|Withdrawal by Subject|0|||
163907704|NCT02159989|592032584|FG009|Overall Study|Withdrawal by Subject|0|||
163907705|NCT02159989|592032585|FG010|Overall Study|Withdrawal by Subject|0|||
164144045|NCT00086281|592888584|FG013|Phase 2|Adverse Event|1|||
163907706|NCT02159989|592032575|FG000|Overall Study|New treatment|0|||
163907707|NCT02159989|592032576|FG001|Overall Study|New treatment|1|||
163907708|NCT02159989|592032577|FG002|Overall Study|New treatment|0|||
163907709|NCT02159989|592032578|FG003|Overall Study|New treatment|0|||
163907710|NCT02159989|592032579|FG004|Overall Study|New treatment|0|||
163907711|NCT02159989|592032580|FG005|Overall Study|New treatment|0|||
163907712|NCT02159989|592032581|FG006|Overall Study|New treatment|0|||
163907713|NCT02159989|592032582|FG007|Overall Study|New treatment|0|||
163907714|NCT02159989|592032583|FG008|Overall Study|New treatment|0|||
163907715|NCT02159989|592032584|FG009|Overall Study|New treatment|0|||
163907716|NCT02159989|592032585|FG010|Overall Study|New treatment|0|||
163907717|NCT02159989|592032575|FG000|Overall Study|Insurance Issues|0|||
163907718|NCT02159989|592032576|FG001|Overall Study|Insurance Issues|0|||
163907719|NCT02159989|592032577|FG002|Overall Study|Insurance Issues|0|||
164018630|NCT04346628|592431750|FG000|Overall Study|Withdrew (declined intervention)|0|||
164018631|NCT04346628|592431751|FG001|Overall Study|Withdrew (declined intervention)|1|||
164018632|NCT03165721|592431752|FG000|Overall Study|Refused further treatment|3|||
164018633|NCT03165721|592431753|FG001|Overall Study|Refused further treatment|0|||
163907720|NCT02159989|592032578|FG003|Overall Study|Insurance Issues|0|||
163907721|NCT02159989|592032579|FG004|Overall Study|Insurance Issues|0|||
163907722|NCT02159989|592032580|FG005|Overall Study|Insurance Issues|0|||
163907723|NCT02159989|592032581|FG006|Overall Study|Insurance Issues|0|||
164094873|NCT00365300|592712214|FG001|Open-label Phase|Patient skipped open label phase|0|||
163907724|NCT02159989|592032582|FG007|Overall Study|Insurance Issues|0|||
163907725|NCT02159989|592032583|FG008|Overall Study|Insurance Issues|0|||
163907726|NCT02159989|592032584|FG009|Overall Study|Insurance Issues|1|||
163907727|NCT02159989|592032585|FG010|Overall Study|Insurance Issues|0|||
164300200|NCT05966142|593475159|FG000|Overall Study|Study Logistical Reason|1|||
164300201|NCT05966142|593475160|FG001|Overall Study|Study Logistical Reason|0|||
163907730|NCT02485925|592032589|FG000|Overall Study|Withdrawal by Subject|3|||
163907731|NCT02485925|592032589|FG000|Overall Study|Death|1|||
164144046|NCT00086281|592888585|FG014|Phase 2|Adverse Event|0|||
163907732|NCT02485925|592032589|FG000|Overall Study|Lost to Follow-up|11|||
163907733|NCT05995977|592032590|FG000|Overall Study|Withdrawal by Subject|1|||
163907734|NCT05995977|592032591|FG001|Overall Study|Withdrawal by Subject|4|||
163907735|NCT05995977|592032590|FG000|Overall Study|Lost to Follow-up|2|||
163907736|NCT05995977|592032591|FG001|Overall Study|Lost to Follow-up|0|||
163907737|NCT04181788|592032592|FG000|TREATMENT|Adverse Event|0|||
163907738|NCT04181788|592032593|FG001|TREATMENT|Adverse Event|2|||
163907739|NCT04181788|592032594|FG002|TREATMENT|Adverse Event|1|||
163907740|NCT04181788|592032595|FG003|TREATMENT|Adverse Event|0|||
163907741|NCT04181788|592032596|FG004|TREATMENT|Adverse Event|1|||
163907742|NCT04181788|592032597|FG005|TREATMENT|Adverse Event|3|||
164094874|NCT00365300|592712213|FG000|Double-blind Phase|Failed to return|1|||
164094875|NCT00365300|592712214|FG001|Double-blind Phase|Failed to return|0|||
164094876|NCT00365300|592712213|FG000|Double-blind Phase|Noncompliance|1|||
164094877|NCT00365300|592712214|FG001|Double-blind Phase|Noncompliance|1|||
164094878|NCT00365300|592712213|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164094879|NCT00365300|592712214|FG001|Double-blind Phase|Withdrawal by Subject|1|||
164144047|NCT00908310|592888589|FG000|Overall Study|Death|37|||
164094880|NCT00365300|592712213|FG000|Double-blind Phase|Protocol Violation|3|||
164094881|NCT00365300|592712214|FG001|Double-blind Phase|Protocol Violation|1|||
163907743|NCT04181788|592032592|FG000|TREATMENT|Death|0|||
163907744|NCT04181788|592032593|FG001|TREATMENT|Death|0|||
163907745|NCT04181788|592032594|FG002|TREATMENT|Death|0|||
163907746|NCT04181788|592032595|FG003|TREATMENT|Death|0|||
163907747|NCT04181788|592032596|FG004|TREATMENT|Death|8|||
163907748|NCT04181788|592032597|FG005|TREATMENT|Death|8|||
163907749|NCT04181788|592032592|FG000|TREATMENT|Physician Decision|0|||
163907750|NCT04181788|592032593|FG001|TREATMENT|Physician Decision|0|||
163907751|NCT04181788|592032594|FG002|TREATMENT|Physician Decision|0|||
163907752|NCT04181788|592032595|FG003|TREATMENT|Physician Decision|0|||
163907753|NCT04181788|592032596|FG004|TREATMENT|Physician Decision|0|||
163907754|NCT04181788|592032597|FG005|TREATMENT|Physician Decision|1|||
163907755|NCT04181788|592032592|FG000|TREATMENT|Progressive disease|3|||
163907756|NCT04181788|592032593|FG001|TREATMENT|Progressive disease|3|||
163907757|NCT04181788|592032594|FG002|TREATMENT|Progressive disease|5|||
163907758|NCT04181788|592032595|FG003|TREATMENT|Progressive disease|7|||
163907759|NCT04181788|592032596|FG004|TREATMENT|Progressive disease|20|||
163907760|NCT04181788|592032597|FG005|TREATMENT|Progressive disease|38|||
164144347|NCT02954991|592889833|FG001|Overall Study|Lost to Follow-up|2|||
164094882|NCT00365300|592712213|FG000|Double-blind Phase|Lack of Efficacy|6|||
164094883|NCT00365300|592712214|FG001|Double-blind Phase|Lack of Efficacy|6|||
164094884|NCT01029353|592712215|FG000|Overall Study|Lost to Follow-up|4|||
164018634|NCT03165721|592431754|FG002|Overall Study|Refused further treatment|0|||
163907761|NCT04181788|592032592|FG000|TREATMENT|Global deterioration of health status|0|||
163907762|NCT04181788|592032593|FG001|TREATMENT|Global deterioration of health status|2|||
163907763|NCT04181788|592032594|FG002|TREATMENT|Global deterioration of health status|0|||
163907764|NCT04181788|592032595|FG003|TREATMENT|Global deterioration of health status|0|||
164018635|NCT03165721|592431752|FG000|Overall Study|Physician Decision|1|||
164018636|NCT03165721|592431753|FG001|Overall Study|Physician Decision|0|||
164018637|NCT03165721|592431754|FG002|Overall Study|Physician Decision|0|||
164018638|NCT01263691|592431755|FG000|Overall Study|Lost to Follow-up|1|||
164018639|NCT01263691|592431756|FG001|Overall Study|Lost to Follow-up|0|||
164018640|NCT01263691|592431757|FG002|Overall Study|Lost to Follow-up|1|||
164018641|NCT01263691|592431758|FG003|Overall Study|Lost to Follow-up|1|||
164018642|NCT01263691|592431759|FG004|Overall Study|Lost to Follow-up|0|||
164018643|NCT01263691|592431760|FG005|Overall Study|Lost to Follow-up|0|||
164018644|NCT01263691|592431755|FG000|Overall Study|Withdrawal by Subject|1|||
164018645|NCT01263691|592431756|FG001|Overall Study|Withdrawal by Subject|0|||
164018646|NCT01263691|592431757|FG002|Overall Study|Withdrawal by Subject|0|||
164018647|NCT01263691|592431758|FG003|Overall Study|Withdrawal by Subject|0|||
164018648|NCT01263691|592431759|FG004|Overall Study|Withdrawal by Subject|0|||
164018649|NCT01263691|592431760|FG005|Overall Study|Withdrawal by Subject|0|||
164018650|NCT01263691|592431755|FG000|Overall Study|Adverse Event|1|||
164018651|NCT01263691|592431756|FG001|Overall Study|Adverse Event|0|||
163907765|NCT04181788|592032596|FG004|TREATMENT|Global deterioration of health status|2|||
163907766|NCT04181788|592032597|FG005|TREATMENT|Global deterioration of health status|8|||
163907767|NCT04181788|592032592|FG000|TREATMENT|Withdrawal by Subject|1|||
163907768|NCT04181788|592032593|FG001|TREATMENT|Withdrawal by Subject|2|||
163907769|NCT04181788|592032594|FG002|TREATMENT|Withdrawal by Subject|0|||
163907770|NCT04181788|592032595|FG003|TREATMENT|Withdrawal by Subject|0|||
163907771|NCT04181788|592032596|FG004|TREATMENT|Withdrawal by Subject|3|||
163907772|NCT04181788|592032597|FG005|TREATMENT|Withdrawal by Subject|5|||
163907773|NCT04181788|592032592|FG000|TREATMENT|Other unspecified|0|||
163907774|NCT04181788|592032593|FG001|TREATMENT|Other unspecified|0|||
163907775|NCT04181788|592032594|FG002|TREATMENT|Other unspecified|0|||
163907776|NCT04181788|592032595|FG003|TREATMENT|Other unspecified|0|||
163907777|NCT04181788|592032596|FG004|TREATMENT|Other unspecified|0|||
163907778|NCT04181788|592032597|FG005|TREATMENT|Other unspecified|2|||
163907779|NCT04181788|592032592|FG000|TREATMENT|Ongoing|0|||
163907780|NCT04181788|592032593|FG001|TREATMENT|Ongoing|3|||
163907781|NCT04181788|592032594|FG002|TREATMENT|Ongoing|0|||
163907782|NCT04181788|592032595|FG003|TREATMENT|Ongoing|5|||
163907783|NCT04181788|592032596|FG004|TREATMENT|Ongoing|7|||
163907784|NCT04181788|592032597|FG005|TREATMENT|Ongoing|15|||
163907785|NCT04181788|592032592|FG000|FOLLOW-UP|Death|0|||
163907786|NCT04181788|592032593|FG001|FOLLOW-UP|Death|0|||
163907787|NCT04181788|592032594|FG002|FOLLOW-UP|Death|1|||
163907788|NCT04181788|592032595|FG003|FOLLOW-UP|Death|2|||
163907789|NCT04181788|592032596|FG004|FOLLOW-UP|Death|8|||
163907790|NCT04181788|592032597|FG005|FOLLOW-UP|Death|20|||
163907791|NCT04181788|592032592|FG000|FOLLOW-UP|Lost to Follow-up|0|||
163907792|NCT04181788|592032593|FG001|FOLLOW-UP|Lost to Follow-up|0|||
163907793|NCT04181788|592032594|FG002|FOLLOW-UP|Lost to Follow-up|0|||
163907794|NCT04181788|592032595|FG003|FOLLOW-UP|Lost to Follow-up|0|||
163907795|NCT04181788|592032596|FG004|FOLLOW-UP|Lost to Follow-up|0|||
163907796|NCT04181788|592032597|FG005|FOLLOW-UP|Lost to Follow-up|2|||
163907797|NCT04181788|592032592|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
163907798|NCT04181788|592032593|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
163907799|NCT04181788|592032594|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
163907800|NCT04181788|592032595|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
164018652|NCT01263691|592431757|FG002|Overall Study|Adverse Event|0|||
164018653|NCT01263691|592431758|FG003|Overall Study|Adverse Event|0|||
164018654|NCT01263691|592431759|FG004|Overall Study|Adverse Event|0|||
164018655|NCT01263691|592431760|FG005|Overall Study|Adverse Event|0|||
164018656|NCT01202227|592431761|FG000|Overall Study|Adverse Event|16|||
164018657|NCT01202227|592431761|FG000|Overall Study|Withdrawal by Subject|2|||
164018658|NCT01202227|592431761|FG000|Overall Study|Lack of Efficacy|1|||
164018659|NCT01894477|592431762|FG000|Overall Study|Protocol Violation|0|||
164018660|NCT01894477|592431763|FG001|Overall Study|Protocol Violation|1|||
164018661|NCT01894477|592431762|FG000|Overall Study|protocol changed due SC changed to cord|0|||
164018662|NCT01894477|592431763|FG001|Overall Study|protocol changed due SC changed to cord|1|||
164018663|NCT01533935|592431765|FG000|Overall Study|Adverse Event|5|||
164018664|NCT01533935|592431766|FG001|Overall Study|Adverse Event|7|||
164018665|NCT01533935|592431767|FG002|Overall Study|Adverse Event|1|||
164018666|NCT01533935|592431768|FG003|Overall Study|Adverse Event|5|||
164018667|NCT01533935|592431769|FG004|Overall Study|Adverse Event|3|||
164018668|NCT01533935|592431765|FG000|Overall Study|Protocol Violation|0|||
164018669|NCT01533935|592431766|FG001|Overall Study|Protocol Violation|2|||
164018670|NCT01533935|592431767|FG002|Overall Study|Protocol Violation|0|||
164018671|NCT01533935|592431768|FG003|Overall Study|Protocol Violation|0|||
164018672|NCT01533935|592431769|FG004|Overall Study|Protocol Violation|0|||
164018673|NCT01533935|592431765|FG000|Overall Study|Lost to Follow-up|0|||
164018674|NCT01533935|592431766|FG001|Overall Study|Lost to Follow-up|0|||
164018675|NCT01533935|592431767|FG002|Overall Study|Lost to Follow-up|1|||
164018676|NCT01533935|592431768|FG003|Overall Study|Lost to Follow-up|0|||
164018677|NCT01533935|592431769|FG004|Overall Study|Lost to Follow-up|0|||
164018678|NCT01533935|592431765|FG000|Overall Study|Withdrawal by Subject|0|||
164018679|NCT01533935|592431766|FG001|Overall Study|Withdrawal by Subject|4|||
164018680|NCT01533935|592431767|FG002|Overall Study|Withdrawal by Subject|5|||
163907801|NCT04181788|592032596|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
163907802|NCT04181788|592032597|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
164018681|NCT01533935|592431768|FG003|Overall Study|Withdrawal by Subject|2|||
164018682|NCT01533935|592431769|FG004|Overall Study|Withdrawal by Subject|4|||
164018683|NCT01533935|592431765|FG000|Overall Study|Other reason not defined above|1|||
164018684|NCT01533935|592431766|FG001|Overall Study|Other reason not defined above|0|||
164018685|NCT01533935|592431767|FG002|Overall Study|Other reason not defined above|1|||
164018686|NCT01533935|592431768|FG003|Overall Study|Other reason not defined above|0|||
164018687|NCT01533935|592431769|FG004|Overall Study|Other reason not defined above|1|||
164018688|NCT00069095|592431782|FG000|Primary Treatment Phase|Ongoing|0|||
164018689|NCT00069095|592431783|FG001|Primary Treatment Phase|Ongoing|0|||
164018690|NCT00069095|592431784|FG002|Primary Treatment Phase|Ongoing|5|||
163907803|NCT04181788|592032592|FG000|FOLLOW-UP|Other unspecified|0|||
163907804|NCT04181788|592032593|FG001|FOLLOW-UP|Other unspecified|1|||
163907805|NCT04181788|592032594|FG002|FOLLOW-UP|Other unspecified|0|||
163907806|NCT04181788|592032595|FG003|FOLLOW-UP|Other unspecified|0|||
163907807|NCT04181788|592032596|FG004|FOLLOW-UP|Other unspecified|0|||
163907808|NCT04181788|592032597|FG005|FOLLOW-UP|Other unspecified|3|||
163907809|NCT04181788|592032592|FG000|FOLLOW-UP|Ongoing|0|||
163907810|NCT04181788|592032593|FG001|FOLLOW-UP|Ongoing|0|||
163907811|NCT04181788|592032594|FG002|FOLLOW-UP|Ongoing|1|||
163907812|NCT04181788|592032595|FG003|FOLLOW-UP|Ongoing|3|||
163907813|NCT04181788|592032596|FG004|FOLLOW-UP|Ongoing|2|||
163907814|NCT04181788|592032597|FG005|FOLLOW-UP|Ongoing|2|||
163907815|NCT04937504|592032598|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
163907816|NCT04937504|592032599|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
163907817|NCT04937504|592032598|FG000|9 Months Assessment|Lost to Follow-up|3|||
163907818|NCT04937504|592032599|FG001|9 Months Assessment|Lost to Follow-up|2|||
163907819|NCT04535414|592032600|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
163907820|NCT04535414|592032601|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
164018691|NCT00069095|592431785|FG003|Primary Treatment Phase|Ongoing|7|||
164018692|NCT00069095|592431786|FG004|Primary Treatment Phase|Ongoing|7|||
163907821|NCT04535414|592032600|FG000|Overall Study|Cancelled appointment|1|||
163907822|NCT04535414|592032601|FG001|Overall Study|Cancelled appointment|0|||
163907823|NCT04535414|592032600|FG000|Overall Study|cancelled - food in stomach|2|||
163907824|NCT04535414|592032601|FG001|Overall Study|cancelled - food in stomach|0|||
163907825|NCT04535414|592032600|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
163907826|NCT04535414|592032601|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
163907827|NCT04535414|592032600|FG000|Overall Study|Withdrawal by Subject|0|||
163907828|NCT04535414|592032601|FG001|Overall Study|Withdrawal by Subject|1|||
163907829|NCT03662659|592032602|FG000|Pre-treatment|Participant no longer met study criteria|1|||
163907830|NCT03662659|592032603|FG001|Pre-treatment|Participant no longer met study criteria|1|||
163907831|NCT03662659|592032602|FG000|Pre-treatment|Other reasons|1|||
163907832|NCT03662659|592032603|FG001|Pre-treatment|Other reasons|0|||
164018693|NCT00069095|592431787|FG005|Primary Treatment Phase|Ongoing|4|||
164018694|NCT00069095|592431782|FG000|Primary Treatment Phase|Admin/Other|29|||
163907833|NCT03662659|592032602|FG000|Treatment|Completed Treatment|0|||
164018695|NCT00069095|592431783|FG001|Primary Treatment Phase|Admin/Other|38|||
164018696|NCT00069095|592431784|FG002|Primary Treatment Phase|Admin/Other|31|||
164018697|NCT00069095|592431785|FG003|Primary Treatment Phase|Admin/Other|45|||
164018698|NCT00069095|592431786|FG004|Primary Treatment Phase|Admin/Other|48|||
163907834|NCT03662659|592032603|FG001|Treatment|Completed Treatment|2|||
163907835|NCT03662659|592032602|FG000|Treatment|Disease Progression|85|||
163907836|NCT03662659|592032603|FG001|Treatment|Disease Progression|97|||
163907837|NCT03662659|592032602|FG000|Treatment|Study Drug Toxicity|19|||
163907838|NCT03662659|592032603|FG001|Treatment|Study Drug Toxicity|9|||
163907839|NCT03662659|592032602|FG000|Treatment|Death|11|||
163907840|NCT03662659|592032603|FG001|Treatment|Death|9|||
163907841|NCT03662659|592032602|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
163907842|NCT03662659|592032603|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
163907843|NCT03662659|592032602|FG000|Treatment|Withdrawal by Subject|1|||
163907844|NCT03662659|592032603|FG001|Treatment|Withdrawal by Subject|1|||
163907845|NCT03662659|592032602|FG000|Treatment|Poor/Non-compliance|1|||
164018699|NCT00069095|592431787|FG005|Primary Treatment Phase|Admin/Other|42|||
164018700|NCT00069095|592431782|FG000|Primary Treatment Phase|Adverse Event|99|||
164018701|NCT00069095|592431783|FG001|Primary Treatment Phase|Adverse Event|92|||
164018702|NCT00069095|592431784|FG002|Primary Treatment Phase|Adverse Event|71|||
164018703|NCT00069095|592431785|FG003|Primary Treatment Phase|Adverse Event|72|||
164018704|NCT00069095|592431786|FG004|Primary Treatment Phase|Adverse Event|109|||
164018705|NCT00069095|592431787|FG005|Primary Treatment Phase|Adverse Event|101|||
164018706|NCT00069095|592431782|FG000|Primary Treatment Phase|Death|14|||
164018707|NCT00069095|592431783|FG001|Primary Treatment Phase|Death|8|||
164018708|NCT00069095|592431784|FG002|Primary Treatment Phase|Death|2|||
164018709|NCT00069095|592431785|FG003|Primary Treatment Phase|Death|5|||
164018710|NCT00069095|592431786|FG004|Primary Treatment Phase|Death|8|||
164018711|NCT00069095|592431787|FG005|Primary Treatment Phase|Death|8|||
164018712|NCT00069095|592431782|FG000|Primary Treatment Phase|Failure to return|5|||
164018713|NCT00069095|592431783|FG001|Primary Treatment Phase|Failure to return|5|||
164018714|NCT00069095|592431784|FG002|Primary Treatment Phase|Failure to return|0|||
163907846|NCT03662659|592032603|FG001|Treatment|Poor/Non-compliance|0|||
163907847|NCT03662659|592032602|FG000|Treatment|Participant no longer meets study criteria|1|||
163907848|NCT03662659|592032603|FG001|Treatment|Participant no longer meets study criteria|0|||
163907849|NCT03662659|592032602|FG000|Treatment|Other reasons|10|||
163907850|NCT03662659|592032603|FG001|Treatment|Other reasons|8|||
163907851|NCT03662659|592032602|FG000|Treatment|Administrative reasons by sponsor|1|||
163907852|NCT03662659|592032603|FG001|Treatment|Administrative reasons by sponsor|0|||
163907853|NCT03662659|592032602|FG000|Treatment|maximum clinical benefit|0|||
163907854|NCT03662659|592032603|FG001|Treatment|maximum clinical benefit|2|||
164018715|NCT00069095|592431785|FG003|Primary Treatment Phase|Failure to return|0|||
164018716|NCT00069095|592431786|FG004|Primary Treatment Phase|Failure to return|0|||
164018717|NCT00069095|592431787|FG005|Primary Treatment Phase|Failure to return|2|||
164018718|NCT00069095|592431782|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
164018719|NCT00069095|592431783|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
164018720|NCT00069095|592431784|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
164018721|NCT00069095|592431785|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
164018722|NCT00069095|592431786|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
164018723|NCT00069095|592431787|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
164018724|NCT00069095|592431782|FG000|Primary Treatment Phase|Refused treatment|15|||
164018725|NCT00069095|592431783|FG001|Primary Treatment Phase|Refused treatment|26|||
163907855|NCT04369664|592034252|FG000|Overall Study|Physician Decision|1|||
163907856|NCT04369664|592034253|FG001|Overall Study|Physician Decision|0|||
163907857|NCT03840200|592034254|FG000|Overall Study|Death|6|||
163907858|NCT03840200|592034255|FG001|Overall Study|Death|3|||
163907859|NCT03840200|592034256|FG002|Overall Study|Death|6|||
163907860|NCT03840200|592034257|FG003|Overall Study|Death|10|||
164018726|NCT00069095|592431784|FG002|Primary Treatment Phase|Refused treatment|17|||
164018727|NCT00069095|592431785|FG003|Primary Treatment Phase|Refused treatment|31|||
164018728|NCT00069095|592431786|FG004|Primary Treatment Phase|Refused treatment|24|||
164018729|NCT00069095|592431787|FG005|Primary Treatment Phase|Refused treatment|27|||
164018730|NCT00069095|592431782|FG000|Primary Treatment Phase|Withdrew|2|||
164018731|NCT00069095|592431783|FG001|Primary Treatment Phase|Withdrew|3|||
164018732|NCT00069095|592431784|FG002|Primary Treatment Phase|Withdrew|8|||
164018733|NCT00069095|592431785|FG003|Primary Treatment Phase|Withdrew|2|||
164018734|NCT00069095|592431786|FG004|Primary Treatment Phase|Withdrew|4|||
164018735|NCT00069095|592431787|FG005|Primary Treatment Phase|Withdrew|9|||
164018736|NCT00069095|592431782|FG000|Primary Treatment Phase|Other Violation|0|||
164018737|NCT00069095|592431783|FG001|Primary Treatment Phase|Other Violation|1|||
164018738|NCT00069095|592431784|FG002|Primary Treatment Phase|Other Violation|1|||
164018739|NCT00069095|592431785|FG003|Primary Treatment Phase|Other Violation|1|||
164018740|NCT00069095|592431786|FG004|Primary Treatment Phase|Other Violation|0|||
164018741|NCT00069095|592431787|FG005|Primary Treatment Phase|Other Violation|1|||
164018742|NCT00069095|592431782|FG000|Primary Treatment Phase|Violation criteria|0|||
164094885|NCT01029353|592712216|FG001|Overall Study|Lost to Follow-up|5|||
164018743|NCT00069095|592431783|FG001|Primary Treatment Phase|Violation criteria|2|||
164018744|NCT00069095|592431784|FG002|Primary Treatment Phase|Violation criteria|4|||
164018745|NCT00069095|592431785|FG003|Primary Treatment Phase|Violation criteria|3|||
164018746|NCT00069095|592431786|FG004|Primary Treatment Phase|Violation criteria|1|||
164018747|NCT00069095|592431787|FG005|Primary Treatment Phase|Violation criteria|5|||
164018748|NCT00069095|592431782|FG000|Post-study Treatment Phase|Missing reason|1|||
164018749|NCT00069095|592431783|FG001|Post-study Treatment Phase|Missing reason|3|||
164018750|NCT00069095|592431784|FG002|Post-study Treatment Phase|Missing reason|12|||
164018751|NCT00069095|592431785|FG003|Post-study Treatment Phase|Missing reason|8|||
164018752|NCT00069095|592431786|FG004|Post-study Treatment Phase|Missing reason|18|||
164018753|NCT00069095|592431787|FG005|Post-study Treatment Phase|Missing reason|17|||
164018754|NCT00069095|592431782|FG000|Post-study Treatment Phase|Adverse Event|2|||
164018755|NCT00069095|592431783|FG001|Post-study Treatment Phase|Adverse Event|3|||
164018756|NCT00069095|592431784|FG002|Post-study Treatment Phase|Adverse Event|1|||
164018757|NCT00069095|592431785|FG003|Post-study Treatment Phase|Adverse Event|0|||
164018758|NCT00069095|592431786|FG004|Post-study Treatment Phase|Adverse Event|5|||
164018759|NCT00069095|592431787|FG005|Post-study Treatment Phase|Adverse Event|1|||
164018760|NCT00069095|592431782|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
164018761|NCT00069095|592431783|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
164018762|NCT00069095|592431784|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
164018763|NCT00069095|592431785|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
163907861|NCT03840200|592034254|FG000|Overall Study|Reason Not Specified|2|||
163907862|NCT03840200|592034255|FG001|Overall Study|Reason Not Specified|2|||
163907863|NCT03840200|592034256|FG002|Overall Study|Reason Not Specified|1|||
163907864|NCT03840200|592034257|FG003|Overall Study|Reason Not Specified|15|||
163907865|NCT03840200|592034254|FG000|Overall Study|Physician Decision|0|||
164094886|NCT01029353|592712217|FG002|Overall Study|Lost to Follow-up|5|||
164094887|NCT01029353|592712218|FG003|Overall Study|Lost to Follow-up|4|||
164094888|NCT01029353|592712215|FG000|Overall Study|Consent Withdrawn|2|||
163907866|NCT03840200|592034255|FG001|Overall Study|Physician Decision|0|||
164018764|NCT00069095|592431786|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
164018765|NCT00069095|592431787|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
164018766|NCT00069095|592431782|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
164018767|NCT00069095|592431783|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
164018768|NCT00069095|592431784|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
164018769|NCT00069095|592431785|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
164018770|NCT00069095|592431786|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
164018771|NCT00069095|592431787|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
164018772|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
164018773|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164018774|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164018775|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164018776|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
164018777|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
164018778|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant had complete response|1|||
164018779|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant had complete response|1|||
164018780|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant had complete response|0|||
164018781|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant had complete response|0|||
164018782|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant had complete response|0|||
164018783|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant had complete response|0|||
164018784|NCT00069095|592431782|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164018785|NCT00069095|592431783|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
164018786|NCT00069095|592431784|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164018787|NCT00069095|592431785|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164018788|NCT00069095|592431786|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164018789|NCT00069095|592431787|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
164018790|NCT00069095|592431782|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
164018791|NCT00069095|592431783|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
164018792|NCT00069095|592431784|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
164018793|NCT00069095|592431785|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
164018794|NCT00069095|592431786|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
164018795|NCT00069095|592431787|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
164018796|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
164018797|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
164018798|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
164018799|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
164018800|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
164018801|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
164018802|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
164018803|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
164018804|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
164094889|NCT01029353|592712216|FG001|Overall Study|Consent Withdrawn|0|||
163907867|NCT03840200|592034256|FG002|Overall Study|Physician Decision|0|||
163907868|NCT03840200|592034257|FG003|Overall Study|Physician Decision|2|||
163907869|NCT03840200|592034254|FG000|Overall Study|Progressive Disease|0|||
163907870|NCT03840200|592034255|FG001|Overall Study|Progressive Disease|0|||
163907871|NCT03840200|592034256|FG002|Overall Study|Progressive Disease|0|||
163907872|NCT03840200|592034257|FG003|Overall Study|Progressive Disease|1|||
163907873|NCT03840200|592034254|FG000|Overall Study|Withdrawal by Subject|0|||
163907874|NCT03840200|592034255|FG001|Overall Study|Withdrawal by Subject|1|||
163907875|NCT03840200|592034256|FG002|Overall Study|Withdrawal by Subject|0|||
163907876|NCT03840200|592034257|FG003|Overall Study|Withdrawal by Subject|2|||
163907877|NCT00671853|592034258|FG000|Overall Study|Lack of Efficacy|3|||
163907878|NCT00671853|592034259|FG001|Overall Study|Lack of Efficacy|7|||
163907879|NCT00671853|592034258|FG000|Overall Study|Adverse Event|7|||
163907880|NCT00671853|592034259|FG001|Overall Study|Adverse Event|1|||
163907881|NCT00671853|592034258|FG000|Overall Study|Withdrawal by Subject|1|||
163907882|NCT00671853|592034259|FG001|Overall Study|Withdrawal by Subject|5|||
163907883|NCT00671853|592034258|FG000|Overall Study|Lost to Follow-up|8|||
163907884|NCT00671853|592034259|FG001|Overall Study|Lost to Follow-up|8|||
163907885|NCT00671853|592034258|FG000|Overall Study|Physician Decision|0|||
163907886|NCT00671853|592034259|FG001|Overall Study|Physician Decision|2|||
163907887|NCT00671853|592034258|FG000|Overall Study|Non-adherence with study procedures|1|||
163907888|NCT00671853|592034259|FG001|Overall Study|Non-adherence with study procedures|4|||
163907889|NCT02354417|592034260|FG000|Overall Study|Physician Decision|1|||
163907890|NCT01848483|592034261|FG000|Overall Study|Death|2|||
163907891|NCT01848483|592034262|FG001|Overall Study|Death|1|||
163907892|NCT01848483|592034261|FG000|Overall Study|Lost to Follow-up|6|||
163907893|NCT01848483|592034262|FG001|Overall Study|Lost to Follow-up|8|||
163907894|NCT01848483|592034261|FG000|Overall Study|Withdrawal by Subject|1|||
163907895|NCT01848483|592034262|FG001|Overall Study|Withdrawal by Subject|0|||
163907896|NCT01848483|592034261|FG000|Overall Study|Incarceration|2|||
163907897|NCT01848483|592034262|FG001|Overall Study|Incarceration|2|||
163907898|NCT01450007|592034266|FG000|Overall Study|Late exclusion before treatment|2|||
163907899|NCT01450007|592034267|FG001|Overall Study|Late exclusion before treatment|3|||
163907900|NCT01450007|592034268|FG002|Overall Study|Late exclusion before treatment|2|||
163907901|NCT01450007|592034266|FG000|Overall Study|Protocol Violation|0|||
163907902|NCT01450007|592034267|FG001|Overall Study|Protocol Violation|1|||
163907903|NCT01450007|592034268|FG002|Overall Study|Protocol Violation|1|||
163907904|NCT01450007|592034266|FG000|Overall Study|Adverse Event|0|||
163907905|NCT01450007|592034267|FG001|Overall Study|Adverse Event|1|||
163907906|NCT01450007|592034268|FG002|Overall Study|Adverse Event|0|||
163907907|NCT03851094|592034269|FG000|Overall Study|Withdrawal by Subject|0|||
163907908|NCT03851094|592034270|FG001|Overall Study|Withdrawal by Subject|1|||
163907909|NCT03851094|592034269|FG000|Overall Study|Participant lost device|0|||
163907910|NCT03851094|592034270|FG001|Overall Study|Participant lost device|1|||
163907911|NCT03851094|592034269|FG000|Overall Study|Participant returned device|0|||
163907912|NCT03851094|592034270|FG001|Overall Study|Participant returned device|2|||
163907913|NCT00484198|592034271|FG000|Overall Study|Participant Withdrew Consent|12|||
163907914|NCT00484198|592034272|FG001|Overall Study|Participant Withdrew Consent|21|||
163907915|NCT00484198|592034273|FG002|Overall Study|Participant Withdrew Consent|47|||
163907916|NCT00484198|592034274|FG003|Overall Study|Participant Withdrew Consent|59|||
163907917|NCT00484198|592034271|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
163907918|NCT00484198|592034272|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
163907919|NCT00484198|592034273|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
163907920|NCT00484198|592034274|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
163907921|NCT00484198|592034271|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
163907922|NCT00484198|592034272|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
163907923|NCT00484198|592034273|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
163907924|NCT00484198|592034274|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
163907925|NCT00484198|592034271|FG000|Overall Study|Adverse Event|3|||
163907926|NCT00484198|592034272|FG001|Overall Study|Adverse Event|11|||
163907927|NCT00484198|592034273|FG002|Overall Study|Adverse Event|32|||
163907928|NCT00484198|592034274|FG003|Overall Study|Adverse Event|31|||
163907929|NCT00484198|592034271|FG000|Overall Study|Protocol Violation|0|||
163907930|NCT00484198|592034272|FG001|Overall Study|Protocol Violation|5|||
163907931|NCT00484198|592034273|FG002|Overall Study|Protocol Violation|6|||
163907932|NCT00484198|592034274|FG003|Overall Study|Protocol Violation|8|||
163907933|NCT00484198|592034271|FG000|Overall Study|Other|7|||
163907934|NCT00484198|592034272|FG001|Overall Study|Other|10|||
163907935|NCT00484198|592034273|FG002|Overall Study|Other|31|||
163907936|NCT00484198|592034274|FG003|Overall Study|Other|28|||
163907937|NCT01536704|592034275|FG000|Washout Period 1|Withdrawal by Subject|1|||
163907938|NCT01536704|592034276|FG001|Washout Period 1|Withdrawal by Subject|2|||
163907939|NCT01536704|592034277|FG002|Washout Period 1|Withdrawal by Subject|0|||
163907940|NCT01536704|592034278|FG003|Washout Period 1|Withdrawal by Subject|0|||
163907941|NCT01536704|592034275|FG000|Washout Period 2|Adverse Event|1|||
163907942|NCT01536704|592034276|FG001|Washout Period 2|Adverse Event|0|||
163907943|NCT01536704|592034277|FG002|Washout Period 2|Adverse Event|0|||
163907944|NCT01536704|592034278|FG003|Washout Period 2|Adverse Event|0|||
163907945|NCT01536704|592034275|FG000|Washout Period 2|Withdrawal by Subject|0|||
163907946|NCT01536704|592034276|FG001|Washout Period 2|Withdrawal by Subject|0|||
163907947|NCT01536704|592034277|FG002|Washout Period 2|Withdrawal by Subject|0|||
163907948|NCT01536704|592034278|FG003|Washout Period 2|Withdrawal by Subject|1|||
163907949|NCT01536704|592034275|FG000|Period 3|Adverse Event|0|||
163907950|NCT01536704|592034276|FG001|Period 3|Adverse Event|0|||
163907951|NCT01536704|592034277|FG002|Period 3|Adverse Event|0|||
163907952|NCT01536704|592034278|FG003|Period 3|Adverse Event|1|||
163907953|NCT01536704|592034275|FG000|Washout Period 3|Adverse Event|0|||
163907954|NCT01536704|592034276|FG001|Washout Period 3|Adverse Event|0|||
163907955|NCT01536704|592034277|FG002|Washout Period 3|Adverse Event|1|||
163907956|NCT01536704|592034278|FG003|Washout Period 3|Adverse Event|0|||
163907957|NCT04658784|592034279|FG000|6-month Follow-up|Lost to Follow-up|2|||
164018805|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
163907958|NCT04658784|592034280|FG001|6-month Follow-up|Lost to Follow-up|5|||
163907959|NCT02958553|592034281|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
164018806|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
164018807|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
164018808|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164018809|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164018810|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164018811|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
163907960|NCT02958553|592034281|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
163907961|NCT04311983|592034283|FG000|Overall Study|Lost to Follow-up|421|||
163907962|NCT04311983|592034284|FG001|Overall Study|Lost to Follow-up|456|||
163907963|NCT04311983|592034283|FG000|Overall Study|Incomplete survey|7|||
163907964|NCT04311983|592034284|FG001|Overall Study|Incomplete survey|9|||
163907965|NCT04311983|592034283|FG000|Overall Study|Death|1|||
163907966|NCT04311983|592034284|FG001|Overall Study|Death|0|||
163907967|NCT02007070|592034285|FG000|Overall Study|Adverse Event|4|||
163907968|NCT02007070|592034285|FG000|Overall Study|Clinical Progression|4|||
163907969|NCT02007070|592034285|FG000|Overall Study|Death|1|||
163907970|NCT02007070|592034285|FG000|Overall Study|Protocol Violation|2|||
163907971|NCT02007070|592034285|FG000|Overall Study|Physician Decision|1|||
163907972|NCT02007070|592034285|FG000|Overall Study|Progressive Disease|21|||
163907973|NCT00703092|592034286|FG000|Overall Study|Withdrawal by Subject|2|||
163907974|NCT04070105|592034287|FG000|Overall Study|Lost to Follow-up|0|||
163907975|NCT04070105|592034288|FG001|Overall Study|Lost to Follow-up|0|||
163907976|NCT04070105|592034289|FG002|Overall Study|Lost to Follow-up|0|||
163907977|NCT04070105|592034290|FG003|Overall Study|Lost to Follow-up|0|||
163907978|NCT04070105|592034291|FG004|Overall Study|Lost to Follow-up|0|||
163907979|NCT04070105|592034292|FG005|Overall Study|Lost to Follow-up|1|||
163907980|NCT00749944|592034293|FG000|Overall Study|Lost to Follow-up|2|||
163907981|NCT00749944|592034294|FG001|Overall Study|Lost to Follow-up|1|||
163907982|NCT00749944|592034293|FG000|Overall Study|Other|1|||
163907983|NCT00749944|592034294|FG001|Overall Study|Other|0|||
163907984|NCT00749944|592034293|FG000|Overall Study|Withdrawal by Subject|2|||
163907985|NCT00749944|592034294|FG001|Overall Study|Withdrawal by Subject|0|||
163907986|NCT00624377|592034295|FG000|Overall Study|Lost to Follow-up|355|||
163907987|NCT00624377|592034295|FG000|Overall Study|Withdrawal by Subject|100|||
163907988|NCT00624377|592034295|FG000|Overall Study|Adverse Event|14|||
163907989|NCT00624377|592034295|FG000|Overall Study|Other|91|||
163907990|NCT00624377|592034295|FG000|Overall Study|Non-evaluable population|84|||
163907991|NCT00089791|592034304|FG000|Overall Study|Physician Decision|6|||
164018812|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164018813|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
164018814|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
164018815|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
164018816|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
164018817|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
164018818|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
164018819|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
164018820|NCT00069095|592431782|FG000|Post-study Treatment Phase|Surgery|0|||
163907992|NCT00089791|592034305|FG001|Overall Study|Physician Decision|3|||
163907993|NCT00089791|592034304|FG000|Overall Study|Adverse Event|81|||
163907994|NCT00089791|592034305|FG001|Overall Study|Adverse Event|93|||
163907995|NCT00089791|592034304|FG000|Overall Study|Withdrawal by Subject|403|||
163907996|NCT00089791|592034305|FG001|Overall Study|Withdrawal by Subject|344|||
163907997|NCT00089791|592034304|FG000|Overall Study|Death|78|||
163907998|NCT00089791|592034305|FG001|Overall Study|Death|62|||
163907999|NCT00089791|592034304|FG000|Overall Study|Disease progression|7|||
163908000|NCT00089791|592034305|FG001|Overall Study|Disease progression|3|||
163908001|NCT00089791|592034304|FG000|Overall Study|Ineligibility determined|12|||
163908002|NCT00089791|592034305|FG001|Overall Study|Ineligibility determined|9|||
163908003|NCT00089791|592034304|FG000|Overall Study|Lost to Follow-up|57|||
163908004|NCT00089791|592034305|FG001|Overall Study|Lost to Follow-up|57|||
163908005|NCT00089791|592034304|FG000|Overall Study|Noncompliance|17|||
163908006|NCT00089791|592034305|FG001|Overall Study|Noncompliance|13|||
163908007|NCT00089791|592034304|FG000|Overall Study|Other|20|||
163908008|NCT00089791|592034305|FG001|Overall Study|Other|32|||
163908009|NCT00089791|592034304|FG000|Overall Study|Protocol deviation|12|||
163908010|NCT00089791|592034305|FG001|Overall Study|Protocol deviation|10|||
164018821|NCT00069095|592431783|FG001|Post-study Treatment Phase|Surgery|0|||
164094890|NCT01029353|592712217|FG002|Overall Study|Consent Withdrawn|0|||
163908011|NCT00089791|592034304|FG000|Overall Study|Requirement for alternative therapy|7|||
163908012|NCT00089791|592034305|FG001|Overall Study|Requirement for alternative therapy|4|||
163908013|NCT02161458|592034306|FG000|Overall Study|Withdrawal by Subject|0|||
163908014|NCT02161458|592034307|FG001|Overall Study|Withdrawal by Subject|4|||
163908015|NCT02161458|592034308|FG002|Overall Study|Withdrawal by Subject|4|||
163908016|NCT02161458|592034309|FG003|Overall Study|Withdrawal by Subject|0|||
163908017|NCT02161458|592034306|FG000|Overall Study|Lost to Follow-up|0|||
163908018|NCT02161458|592034307|FG001|Overall Study|Lost to Follow-up|2|||
163908019|NCT02161458|592034308|FG002|Overall Study|Lost to Follow-up|1|||
163908020|NCT02161458|592034309|FG003|Overall Study|Lost to Follow-up|0|||
163908021|NCT02362789|592034317|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
163908022|NCT02362789|592034318|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
163908023|NCT02362789|592034319|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
163908024|NCT02362789|592034317|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
163908025|NCT02362789|592034318|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
163908026|NCT02362789|592034319|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
163908027|NCT02362789|592034317|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
163908028|NCT02362789|592034318|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
163908029|NCT02362789|592034319|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
163908030|NCT02362789|592034317|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
163908031|NCT02362789|592034318|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
163908032|NCT02362789|592034319|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
163908033|NCT02362789|592034317|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
163908034|NCT02362789|592034318|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
163908035|NCT02362789|592034319|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
163908036|NCT02037568|592034320|FG000|Overall Study|Withdrawal by Subject|17|||
163908037|NCT02037568|592034321|FG001|Overall Study|Withdrawal by Subject|24|||
163908038|NCT02037568|592034320|FG000|Overall Study|Lost to Follow-up|16|||
163908039|NCT02037568|592034321|FG001|Overall Study|Lost to Follow-up|13|||
163908040|NCT02037568|592034320|FG000|Overall Study|Screen Failure|3|||
163908041|NCT02037568|592034321|FG001|Overall Study|Screen Failure|1|||
163908042|NCT02037568|592034320|FG000|Overall Study|Patient did not receive transplant|0|||
163908043|NCT02037568|592034321|FG001|Overall Study|Patient did not receive transplant|1|||
163908044|NCT05074433|592034326|FG000|Overall Study|Adverse Event|0|||
163908045|NCT05074433|592034327|FG001|Overall Study|Adverse Event|2|||
163908046|NCT05074433|592034328|FG002|Overall Study|Adverse Event|0|||
164094891|NCT01029353|592712218|FG003|Overall Study|Consent Withdrawn|0|||
164094892|NCT01029353|592712215|FG000|Overall Study|Primary Outcome Indeterminate|1|||
164018822|NCT00069095|592431784|FG002|Post-study Treatment Phase|Surgery|0|||
164018823|NCT00069095|592431785|FG003|Post-study Treatment Phase|Surgery|1|||
164018824|NCT00069095|592431786|FG004|Post-study Treatment Phase|Surgery|1|||
164018825|NCT00069095|592431787|FG005|Post-study Treatment Phase|Surgery|0|||
164018826|NCT00069095|592431782|FG000|Post-study Treatment Phase|Death|0|||
164018827|NCT00069095|592431783|FG001|Post-study Treatment Phase|Death|0|||
164018828|NCT00069095|592431784|FG002|Post-study Treatment Phase|Death|0|||
164018829|NCT00069095|592431785|FG003|Post-study Treatment Phase|Death|0|||
164018830|NCT00069095|592431786|FG004|Post-study Treatment Phase|Death|1|||
164018831|NCT00069095|592431787|FG005|Post-study Treatment Phase|Death|0|||
164018832|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
164018833|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
164018834|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
164018835|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
164018836|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
164018837|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
163908047|NCT05074433|592034329|FG003|Overall Study|Adverse Event|1|||
163908048|NCT05074433|592034326|FG000|Overall Study|Sponsor Request|0|||
163908049|NCT05074433|592034327|FG001|Overall Study|Sponsor Request|1|||
163908050|NCT05074433|592034328|FG002|Overall Study|Sponsor Request|1|||
163908051|NCT05074433|592034329|FG003|Overall Study|Sponsor Request|0|||
163908052|NCT05074433|592034326|FG000|Overall Study|Death|1|||
163908053|NCT05074433|592034327|FG001|Overall Study|Death|0|||
163908054|NCT05074433|592034328|FG002|Overall Study|Death|0|||
163908055|NCT05074433|592034329|FG003|Overall Study|Death|0|||
163908056|NCT05074433|592034326|FG000|Overall Study|Lost to Follow-up|0|||
163908057|NCT05074433|592034327|FG001|Overall Study|Lost to Follow-up|0|||
163908058|NCT05074433|592034328|FG002|Overall Study|Lost to Follow-up|2|||
163908059|NCT05074433|592034329|FG003|Overall Study|Lost to Follow-up|0|||
163908060|NCT05074433|592034326|FG000|Overall Study|Subject Decision|8|||
163908061|NCT05074433|592034327|FG001|Overall Study|Subject Decision|6|||
163908062|NCT05074433|592034328|FG002|Overall Study|Subject Decision|4|||
163908063|NCT05074433|592034329|FG003|Overall Study|Subject Decision|5|||
163908064|NCT04397263|592034330|FG000|Overall Study|Withdrawal by Subject|2|||
163908065|NCT01989689|592034331|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
163908066|NCT01989689|592034332|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
163908067|NCT01989689|592034331|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
163908068|NCT01989689|592034332|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
163908069|NCT02066636|592034333|FG000|Overall Study|Disease progression|51|||
163908070|NCT02066636|592034334|FG001|Overall Study|Disease progression|60|||
163908071|NCT02066636|592034335|FG002|Overall Study|Disease progression|700|||
163908072|NCT02066636|592034333|FG000|Overall Study|Study drug toxicity|13|||
163908073|NCT02066636|592034334|FG001|Overall Study|Study drug toxicity|2|||
163908074|NCT02066636|592034335|FG002|Overall Study|Study drug toxicity|58|||
163908075|NCT02066636|592034333|FG000|Overall Study|Death|4|||
163908076|NCT02066636|592034334|FG001|Overall Study|Death|2|||
163908077|NCT02066636|592034335|FG002|Overall Study|Death|158|||
163908078|NCT02066636|592034333|FG000|Overall Study|Adverse event unrelated to study drug|6|||
163908079|NCT02066636|592034334|FG001|Overall Study|Adverse event unrelated to study drug|4|||
163908080|NCT02066636|592034335|FG002|Overall Study|Adverse event unrelated to study drug|45|||
163908081|NCT02066636|592034333|FG000|Overall Study|Participant request to discontinue treatment|12|||
163908082|NCT02066636|592034334|FG001|Overall Study|Participant request to discontinue treatment|12|||
163908083|NCT02066636|592034335|FG002|Overall Study|Participant request to discontinue treatment|70|||
163908084|NCT02066636|592034333|FG000|Overall Study|Participant withdrew consent|10|||
163908085|NCT02066636|592034334|FG001|Overall Study|Participant withdrew consent|18|||
164144348|NCT02954991|592889834|FG002|Overall Study|Lost to Follow-up|0|||
163908086|NCT02066636|592034335|FG002|Overall Study|Participant withdrew consent|61|||
163908087|NCT02066636|592034333|FG000|Overall Study|Lost to Follow-up|0|||
163908088|NCT02066636|592034334|FG001|Overall Study|Lost to Follow-up|2|||
163908089|NCT02066636|592034335|FG002|Overall Study|Lost to Follow-up|2|||
163908090|NCT02066636|592034333|FG000|Overall Study|Maximum clinical benefit|2|||
163908091|NCT02066636|592034334|FG001|Overall Study|Maximum clinical benefit|2|||
163908092|NCT02066636|592034335|FG002|Overall Study|Maximum clinical benefit|3|||
163908093|NCT02066636|592034333|FG000|Overall Study|Poor/non-compliance|2|||
163908094|NCT02066636|592034334|FG001|Overall Study|Poor/non-compliance|1|||
163908095|NCT02066636|592034335|FG002|Overall Study|Poor/non-compliance|1|||
163908096|NCT02066636|592034333|FG000|Overall Study|Participant no loner meets study criteria|3|||
163908097|NCT02066636|592034334|FG001|Overall Study|Participant no loner meets study criteria|2|||
163908098|NCT02066636|592034335|FG002|Overall Study|Participant no loner meets study criteria|28|||
164018838|NCT00069095|592431782|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164018839|NCT00069095|592431783|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164018840|NCT00069095|592431784|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164018841|NCT00069095|592431785|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164018842|NCT00069095|592431786|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
164018843|NCT00069095|592431787|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
164018844|NCT00069095|592431782|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164018845|NCT00069095|592431783|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164094893|NCT01029353|592712216|FG001|Overall Study|Primary Outcome Indeterminate|3|||
164018846|NCT00069095|592431784|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164018847|NCT00069095|592431785|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164018848|NCT00069095|592431786|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
164018849|NCT00069095|592431787|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
164018850|NCT00069095|592431782|FG000|Post-study Treatment Phase|Investigator decision|0|||
164018851|NCT00069095|592431783|FG001|Post-study Treatment Phase|Investigator decision|0|||
164018852|NCT00069095|592431784|FG002|Post-study Treatment Phase|Investigator decision|0|||
164018853|NCT00069095|592431785|FG003|Post-study Treatment Phase|Investigator decision|0|||
164018854|NCT00069095|592431786|FG004|Post-study Treatment Phase|Investigator decision|0|||
164018855|NCT00069095|592431787|FG005|Post-study Treatment Phase|Investigator decision|1|||
164018856|NCT00069095|592431782|FG000|Follow-up Phase|Death|174|||
164018857|NCT00069095|592431783|FG001|Follow-up Phase|Death|206|||
164018858|NCT00069095|592431784|FG002|Follow-up Phase|Death|120|||
164018859|NCT00069095|592431785|FG003|Follow-up Phase|Death|112|||
164018860|NCT00069095|592431786|FG004|Follow-up Phase|Death|92|||
164018861|NCT00069095|592431787|FG005|Follow-up Phase|Death|101|||
164018862|NCT01727713|592431792|FG000|Overall Study|Lost to Follow-up|5|||
164018863|NCT01727713|592431792|FG000|Overall Study|Adverse Event|10|||
164018864|NCT01727713|592431792|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
164018865|NCT01727713|592431792|FG000|Overall Study|Withdrawal by Subject|13|||
164018866|NCT01727713|592431792|FG000|Overall Study|Protocol Deviation|2|||
164018867|NCT02389816|592431793|FG000|Overall Study|Randomized but Not Treated|1|||
164018868|NCT02389816|592431794|FG001|Overall Study|Randomized but Not Treated|0|||
164018869|NCT02389816|592431795|FG002|Overall Study|Randomized but Not Treated|0|||
164018870|NCT02389816|592431793|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
164018871|NCT02389816|592431794|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
164018872|NCT02389816|592431795|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
164018873|NCT02389816|592431793|FG000|Overall Study|Major Protocol Deviation|1|||
164018874|NCT02389816|592431794|FG001|Overall Study|Major Protocol Deviation|0|||
164018875|NCT02389816|592431795|FG002|Overall Study|Major Protocol Deviation|0|||
164018876|NCT02389816|592431793|FG000|Overall Study|Lost to Follow-up|1|||
163908099|NCT02066636|592034333|FG000|Overall Study|Administrative reasons by sponsor|8|||
163908100|NCT02066636|592034334|FG001|Overall Study|Administrative reasons by sponsor|5|||
163908101|NCT02066636|592034335|FG002|Overall Study|Administrative reasons by sponsor|0|||
163908102|NCT02066636|592034333|FG000|Overall Study|Other reasons|16|||
163908103|NCT02066636|592034334|FG001|Overall Study|Other reasons|15|||
163908104|NCT02066636|592034335|FG002|Overall Study|Other reasons|50|||
163908105|NCT00391170|592034342|FG000|Overall Study|Withdrawal by Subject|1|||
163908106|NCT00391170|592034343|FG001|Overall Study|Withdrawal by Subject|0|||
163908107|NCT00391170|592034342|FG000|Overall Study|Adverse Event|3|||
163908108|NCT00391170|592034343|FG001|Overall Study|Adverse Event|2|||
163908109|NCT00391170|592034342|FG000|Overall Study|Physician Decision|2|||
163908110|NCT00391170|592034343|FG001|Overall Study|Physician Decision|2|||
163908111|NCT03567616|592034344|FG000|Overall Study|Disease progression|4|||
163908112|NCT03567616|592034344|FG000|Overall Study|Withdrawal by Subject|1|||
163908113|NCT03567616|592034344|FG000|Overall Study|Physician Decision|1|||
163908114|NCT03567616|592034344|FG000|Overall Study|Death|1|||
163908115|NCT03567616|592034344|FG000|Overall Study|Adverse Event|1|||
163908116|NCT00380250|592034346|FG000|Overall Study|Withdrawal by Subject|39|||
163908117|NCT00380250|592034347|FG001|Overall Study|Withdrawal by Subject|28|||
163908118|NCT00380250|592034346|FG000|Overall Study|Adverse Event|20|||
163908119|NCT00380250|592034347|FG001|Overall Study|Adverse Event|9|||
163908120|NCT00380250|592034346|FG000|Overall Study|Lack of Efficacy|10|||
163908121|NCT00380250|592034347|FG001|Overall Study|Lack of Efficacy|8|||
163908122|NCT00380250|592034346|FG000|Overall Study|Protocol Violation|15|||
163908123|NCT00380250|592034347|FG001|Overall Study|Protocol Violation|5|||
163908124|NCT00380250|592034346|FG000|Overall Study|Lost to Follow-up|14|||
163908125|NCT00380250|592034347|FG001|Overall Study|Lost to Follow-up|5|||
163908126|NCT00380250|592034346|FG000|Overall Study|Physician Decision|1|||
163908127|NCT00380250|592034347|FG001|Overall Study|Physician Decision|0|||
163908128|NCT01989104|592034348|FG000|Overall Study|Withdrawal by Subject|3|||
163908129|NCT01989104|592034349|FG001|Overall Study|Withdrawal by Subject|0|||
163908130|NCT01989104|592034350|FG002|Overall Study|Withdrawal by Subject|0|||
163908131|NCT01989104|592034351|FG003|Overall Study|Withdrawal by Subject|0|||
163908132|NCT01989104|592034352|FG004|Overall Study|Withdrawal by Subject|0|||
163908133|NCT02833948|592034353|FG000|Overall Study|Death|2|||
163908134|NCT02833948|592034354|FG001|Overall Study|Death|3|||
164094894|NCT01029353|592712217|FG002|Overall Study|Primary Outcome Indeterminate|2|||
163908135|NCT02833948|592034353|FG000|Overall Study|were not scanned|8|||
163908136|NCT02833948|592034354|FG001|Overall Study|were not scanned|13|||
163908137|NCT02833948|592034353|FG000|Overall Study|scans could not be evaluated|5|||
163908138|NCT02833948|592034354|FG001|Overall Study|scans could not be evaluated|2|||
163908139|NCT00680771|592034357|FG000|Overall Study|Withdrawal by Subject|1|||
163908140|NCT00680771|592034358|FG001|Overall Study|Withdrawal by Subject|0|||
163908141|NCT00680771|592034357|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
163908142|NCT00680771|592034358|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
163908143|NCT00680771|592034357|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
163908144|NCT00680771|592034358|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
163908145|NCT02691702|592034359|FG000|Overall Study|Adverse Event|1|||
163908146|NCT02691702|592034360|FG001|Overall Study|Adverse Event|0|||
163908147|NCT02691702|592034361|FG002|Overall Study|Adverse Event|0|||
163908148|NCT02691702|592034362|FG003|Overall Study|Adverse Event|0|||
163908149|NCT02691702|592034363|FG004|Overall Study|Adverse Event|0|||
163908150|NCT02691702|592034364|FG005|Overall Study|Adverse Event|0|||
163908151|NCT02691702|592034365|FG006|Overall Study|Adverse Event|0|||
163908152|NCT02691702|592034366|FG007|Overall Study|Adverse Event|0|||
163908153|NCT02691702|592034367|FG008|Overall Study|Adverse Event|1|||
163908154|NCT02691702|592034368|FG009|Overall Study|Adverse Event|0|||
163908155|NCT02691702|592034369|FG010|Overall Study|Adverse Event|1|||
163908156|NCT02691702|592034359|FG000|Overall Study|Lost to Follow-up|0|||
163908157|NCT02691702|592034360|FG001|Overall Study|Lost to Follow-up|0|||
163908158|NCT02691702|592034361|FG002|Overall Study|Lost to Follow-up|1|||
163908159|NCT02691702|592034362|FG003|Overall Study|Lost to Follow-up|0|||
163908160|NCT02691702|592034363|FG004|Overall Study|Lost to Follow-up|0|||
163908161|NCT02691702|592034364|FG005|Overall Study|Lost to Follow-up|2|||
163908162|NCT02691702|592034365|FG006|Overall Study|Lost to Follow-up|0|||
163908163|NCT02691702|592034366|FG007|Overall Study|Lost to Follow-up|0|||
163908164|NCT02691702|592034367|FG008|Overall Study|Lost to Follow-up|0|||
164018877|NCT02389816|592431794|FG001|Overall Study|Lost to Follow-up|0|||
164018878|NCT02389816|592431795|FG002|Overall Study|Lost to Follow-up|0|||
164018879|NCT02389816|592431793|FG000|Overall Study|Withdrawal of Consent|6|||
164018880|NCT02389816|592431794|FG001|Overall Study|Withdrawal of Consent|4|||
164018881|NCT02389816|592431795|FG002|Overall Study|Withdrawal of Consent|4|||
164018882|NCT02389816|592431793|FG000|Overall Study|Lack of Efficacy|1|||
164018883|NCT02389816|592431794|FG001|Overall Study|Lack of Efficacy|0|||
164018884|NCT02389816|592431795|FG002|Overall Study|Lack of Efficacy|0|||
164018885|NCT02389816|592431793|FG000|Overall Study|Non Compliance with Study Drug|1|||
164018886|NCT02389816|592431794|FG001|Overall Study|Non Compliance with Study Drug|1|||
164018887|NCT02389816|592431795|FG002|Overall Study|Non Compliance with Study Drug|1|||
164018888|NCT02389816|592431793|FG000|Overall Study|Reason not Specified|0|||
164018889|NCT02389816|592431794|FG001|Overall Study|Reason not Specified|2|||
164018890|NCT02389816|592431795|FG002|Overall Study|Reason not Specified|0|||
164018891|NCT01842308|592431796|FG000|Overall Study|Withdrawal by Subject|0|||
164018892|NCT01842308|592431797|FG001|Overall Study|Withdrawal by Subject|0|||
164018893|NCT01842308|592431798|FG002|Overall Study|Withdrawal by Subject|0|||
164018894|NCT01842308|592431799|FG003|Overall Study|Withdrawal by Subject|0|||
164018895|NCT01842308|592431800|FG004|Overall Study|Withdrawal by Subject|1|||
164018896|NCT01594476|592431801|FG000|Overall Study|Protocol Violation|1|||
164018897|NCT01594476|592431802|FG001|Overall Study|Protocol Violation|3|||
164018898|NCT03161678|592431803|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164018899|NCT03161678|592431804|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164018900|NCT03161678|592431805|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164018901|NCT03161678|592431806|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
164018902|NCT03161678|592431807|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
164018903|NCT03161678|592431808|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
164018904|NCT03161678|592431803|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
164018905|NCT03161678|592431804|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
164018906|NCT03161678|592431805|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
164018907|NCT03161678|592431806|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
164018908|NCT03161678|592431807|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
164144429|NCT00134901|592889869|FG001|Overall Study|Lost to Follow-up|5|||
164018909|NCT03161678|592431808|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
164018910|NCT03161678|592431803|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
164018911|NCT03161678|592431804|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
164018912|NCT03161678|592431805|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
164018913|NCT03161678|592431806|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
164018914|NCT03161678|592431807|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
164018915|NCT03161678|592431808|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
164018916|NCT03161678|592431803|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164018917|NCT03161678|592431804|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164018918|NCT03161678|592431805|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164018919|NCT03161678|592431806|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
164018920|NCT03161678|592431807|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164018921|NCT03161678|592431808|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
164018922|NCT00752609|592431809|FG000|Overall Study|Adverse Event|2|||
164018923|NCT00752609|592431810|FG001|Overall Study|Adverse Event|2|||
164018924|NCT00752609|592431809|FG000|Overall Study|Withdrawal by Subject|3|||
164018925|NCT00752609|592431810|FG001|Overall Study|Withdrawal by Subject|0|||
164018926|NCT00752609|592431809|FG000|Overall Study|Physician Decision|1|||
163908165|NCT02691702|592034368|FG009|Overall Study|Lost to Follow-up|0|||
164144507|NCT04123561|592889897|FG001|Overall Study|Protocol Violation|1|||
163908166|NCT02691702|592034369|FG010|Overall Study|Lost to Follow-up|1|||
163908167|NCT02691702|592034359|FG000|Overall Study|Withdrawal by Subject|1|||
163908168|NCT02691702|592034360|FG001|Overall Study|Withdrawal by Subject|1|||
163908169|NCT02691702|592034361|FG002|Overall Study|Withdrawal by Subject|0|||
163908170|NCT02691702|592034362|FG003|Overall Study|Withdrawal by Subject|0|||
163908171|NCT02691702|592034363|FG004|Overall Study|Withdrawal by Subject|0|||
163908172|NCT02691702|592034364|FG005|Overall Study|Withdrawal by Subject|1|||
163908173|NCT02691702|592034365|FG006|Overall Study|Withdrawal by Subject|2|||
163908174|NCT02691702|592034366|FG007|Overall Study|Withdrawal by Subject|0|||
163908175|NCT02691702|592034367|FG008|Overall Study|Withdrawal by Subject|0|||
163908176|NCT02691702|592034368|FG009|Overall Study|Withdrawal by Subject|0|||
164018927|NCT00752609|592431810|FG001|Overall Study|Physician Decision|0|||
164018928|NCT00752609|592431809|FG000|Overall Study|Death|1|||
164018929|NCT00752609|592431810|FG001|Overall Study|Death|0|||
164018930|NCT00752609|592431809|FG000|Overall Study|Met exclusion criteria|1|||
164018931|NCT00752609|592431810|FG001|Overall Study|Met exclusion criteria|0|||
164018932|NCT00752609|592431809|FG000|Overall Study|Received Aranesp in error|1|||
164094895|NCT01029353|592712218|FG003|Overall Study|Primary Outcome Indeterminate|0|||
164094896|NCT04538170|592712221|FG000|Overall Study|Withdrawal by Subject|104|||
163908177|NCT02691702|592034369|FG010|Overall Study|Withdrawal by Subject|0|||
163908178|NCT02691702|592034359|FG000|Overall Study|Other|0|||
163908179|NCT02691702|592034360|FG001|Overall Study|Other|0|||
163908180|NCT02691702|592034361|FG002|Overall Study|Other|0|||
163908181|NCT02691702|592034362|FG003|Overall Study|Other|0|||
163908182|NCT02691702|592034363|FG004|Overall Study|Other|0|||
163908183|NCT02691702|592034364|FG005|Overall Study|Other|0|||
163908184|NCT02691702|592034365|FG006|Overall Study|Other|1|||
163908185|NCT02691702|592034366|FG007|Overall Study|Other|0|||
163908186|NCT02691702|592034367|FG008|Overall Study|Other|1|||
163908187|NCT02691702|592034368|FG009|Overall Study|Other|0|||
163908188|NCT02691702|592034369|FG010|Overall Study|Other|0|||
163908189|NCT02691702|592034359|FG000|Overall Study|Protocol Violation|0|||
163908190|NCT02691702|592034360|FG001|Overall Study|Protocol Violation|0|||
163908191|NCT02691702|592034361|FG002|Overall Study|Protocol Violation|0|||
163908192|NCT02691702|592034362|FG003|Overall Study|Protocol Violation|0|||
163908193|NCT02691702|592034363|FG004|Overall Study|Protocol Violation|0|||
163908194|NCT02691702|592034364|FG005|Overall Study|Protocol Violation|0|||
163908195|NCT02691702|592034365|FG006|Overall Study|Protocol Violation|0|||
163908196|NCT02691702|592034366|FG007|Overall Study|Protocol Violation|0|||
163908197|NCT02691702|592034367|FG008|Overall Study|Protocol Violation|0|||
163908198|NCT02691702|592034368|FG009|Overall Study|Protocol Violation|2|||
163908199|NCT02691702|592034369|FG010|Overall Study|Protocol Violation|0|||
163908200|NCT05613088|592034370|FG000|Treatment|Ongoing Study Treatment|9|||
164018933|NCT00752609|592431810|FG001|Overall Study|Received Aranesp in error|0|||
164018934|NCT05114590|592431811|FG000|Overall Study|Adverse Event|1|||
164018935|NCT05114590|592431811|FG000|Overall Study|Investigator decision|1|||
164018936|NCT05114590|592431811|FG000|Overall Study|Lost to Follow-up|5|||
164018937|NCT05114590|592431811|FG000|Overall Study|Withdrawal by Subject|5|||
164018938|NCT05114590|592431811|FG000|Overall Study|Other|2|||
164018939|NCT00850460|592431812|FG000|Overall Study|Lost to Follow-up|4|||
164018940|NCT00850460|592431813|FG001|Overall Study|Lost to Follow-up|4|||
164018941|NCT03007953|592431816|FG000|Overall Study|Withdrawal by Subject|5|||
164018942|NCT03007953|592431817|FG001|Overall Study|Withdrawal by Subject|2|||
164018943|NCT03007953|592431816|FG000|Overall Study|Death|5|||
164018944|NCT03007953|592431817|FG001|Overall Study|Death|7|||
164018945|NCT03007953|592431816|FG000|Overall Study|Lost to Follow-up|3|||
164018946|NCT03007953|592431817|FG001|Overall Study|Lost to Follow-up|2|||
164018947|NCT03007953|592431816|FG000|Overall Study|Enrolled in Hospice|3|||
164018948|NCT03007953|592431817|FG001|Overall Study|Enrolled in Hospice|2|||
164018949|NCT02224846|592431820|FG000|Period 1 (Month 3)|Adverse Event|2|||
164018950|NCT02224846|592431821|FG001|Period 1 (Month 3)|Adverse Event|1|||
164018951|NCT02224846|592431820|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
164018952|NCT02224846|592431821|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
164018953|NCT02224846|592431820|FG000|Period 1 (Month 3)|Protocol Violation|4|||
164018954|NCT02224846|592431821|FG001|Period 1 (Month 3)|Protocol Violation|8|||
164018955|NCT02224846|592431820|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
164018956|NCT02224846|592431821|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
164018957|NCT02224846|592431820|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
164018958|NCT02224846|592431821|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
164018959|NCT02224846|592431820|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
164018960|NCT02224846|592431821|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
164018961|NCT02224846|592431820|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
164018962|NCT02224846|592431821|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
164018963|NCT02224846|592431820|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
164018964|NCT02224846|592431821|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
164018965|NCT02224846|592431820|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
164018966|NCT02224846|592431821|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
164018967|NCT02224846|592431820|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
164018968|NCT02224846|592431821|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
164018969|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
164018970|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
164018971|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
164018972|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
164018973|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
164018974|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
163908201|NCT05613088|592034371|FG001|Treatment|Ongoing Study Treatment|2|||
163908202|NCT05613088|592034370|FG000|Treatment|Adverse Event|3|||
163908203|NCT05613088|592034371|FG001|Treatment|Adverse Event|1|||
164018975|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
164018976|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
164018977|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
164018978|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
164018979|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
164018980|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
164018981|NCT02224846|592431820|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
164018982|NCT02224846|592431821|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
164018983|NCT00872170|592431824|FG000|Overall Study|Adverse Event|1|||
164018984|NCT00872170|592431825|FG001|Overall Study|Adverse Event|0|||
164018985|NCT01402284|592431826|FG000|Overall Study|Withdrawal consent|2|||
164018986|NCT01402284|592431826|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
164018987|NCT01402284|592431826|FG000|Overall Study|Physician Decision|1|||
164018988|NCT01402284|592431826|FG000|Overall Study|Disease progression on study|10|||
164094897|NCT04538170|592712222|FG001|Overall Study|Withdrawal by Subject|210|||
164094898|NCT00274937|592712225|FG000|Overall Study|Physician Decision|10|||
164144508|NCT04123561|592889898|FG002|Overall Study|Protocol Violation|0|||
163908204|NCT05613088|592034370|FG000|Treatment|Other Reasons|0|||
163908205|NCT05613088|592034371|FG001|Treatment|Other Reasons|1|||
163908206|NCT05613088|592034370|FG000|Treatment|Progressive Disease|58|||
163908207|NCT05613088|592034371|FG001|Treatment|Progressive Disease|26|||
163908208|NCT05613088|592034370|FG000|Treatment|Withdrawal by Subject|0|||
163908209|NCT05613088|592034371|FG001|Treatment|Withdrawal by Subject|4|||
163908210|NCT03652610|592034379|FG000|Overall Study|Lost to Follow-up|1|||
163908211|NCT03652610|592034380|FG001|Overall Study|Lost to Follow-up|0|||
163908212|NCT03652610|592034379|FG000|Overall Study|Withdrawal by Subject|3|||
163908213|NCT03652610|592034380|FG001|Overall Study|Withdrawal by Subject|5|||
163908214|NCT05615363|592034381|FG000|Overall Study|Adverse Event|0|||
163908215|NCT05615363|592034382|FG001|Overall Study|Adverse Event|4|||
163908216|NCT05615363|592034383|FG002|Overall Study|Adverse Event|4|||
163908217|NCT05615363|592034384|FG003|Overall Study|Adverse Event|3|||
163908218|NCT05615363|592034385|FG004|Overall Study|Adverse Event|1|||
163908219|NCT05615363|592034381|FG000|Overall Study|Physician Decision|2|||
163908220|NCT05615363|592034382|FG001|Overall Study|Physician Decision|0|||
163908221|NCT05615363|592034383|FG002|Overall Study|Physician Decision|4|||
163908222|NCT05615363|592034384|FG003|Overall Study|Physician Decision|1|||
163908223|NCT05615363|592034385|FG004|Overall Study|Physician Decision|3|||
163908224|NCT05615363|592034381|FG000|Overall Study|Protocol Violation|2|||
163908225|NCT05615363|592034382|FG001|Overall Study|Protocol Violation|0|||
163908226|NCT05615363|592034383|FG002|Overall Study|Protocol Violation|0|||
163908227|NCT05615363|592034384|FG003|Overall Study|Protocol Violation|0|||
163908228|NCT05615363|592034385|FG004|Overall Study|Protocol Violation|1|||
163908229|NCT05615363|592034381|FG000|Overall Study|Withdrawal by Subject|0|||
163908230|NCT05615363|592034382|FG001|Overall Study|Withdrawal by Subject|0|||
163908231|NCT05615363|592034383|FG002|Overall Study|Withdrawal by Subject|1|||
163908232|NCT05615363|592034384|FG003|Overall Study|Withdrawal by Subject|0|||
163908233|NCT05615363|592034385|FG004|Overall Study|Withdrawal by Subject|0|||
163908234|NCT03905642|592034386|FG000|Overall Study|Withdrawal by Subject|3|||
163908235|NCT03905642|592034386|FG000|Overall Study|Pregnancy|1|||
163908236|NCT03905642|592034386|FG000|Overall Study|Adverse Event|1|||
163908237|NCT03905642|592034386|FG000|Overall Study|Lack of Efficacy|1|||
164094899|NCT00274937|592712225|FG000|Overall Study|Withdrawal by Subject|6|||
164094900|NCT00274937|592712225|FG000|Overall Study|Progressive Disease|4|||
163908238|NCT03905642|592034386|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
164094901|NCT02932878|592712227|FG000|Overall Study|Due to Lab Results|2|||
163908239|NCT04447027|592034391|FG000|Dose Escalation|Withdrawal by Subject|1|||
163908240|NCT04447027|592034392|FG001|Dose Escalation|Withdrawal by Subject|4|||
163908241|NCT04447027|592034393|FG002|Dose Escalation|Withdrawal by Subject|3|||
163908242|NCT04447027|592034394|FG003|Dose Escalation|Withdrawal by Subject|3|||
163908243|NCT04447027|592034395|FG004|Dose Escalation|Withdrawal by Subject|1|||
163908244|NCT04447027|592034396|FG005|Dose Escalation|Withdrawal by Subject|0|||
163908245|NCT04447027|592034397|FG006|Dose Escalation|Withdrawal by Subject|0|||
164094902|NCT02932878|592712228|FG001|Overall Study|Due to Lab Results|1|||
164094903|NCT01918397|592712230|FG000|Overall Study|Never started treatment|2|||
163908246|NCT04447027|592034398|FG007|Dose Escalation|Withdrawal by Subject|0|||
163908247|NCT04447027|592034399|FG008|Dose Escalation|Withdrawal by Subject|0|||
163908248|NCT04447027|592034391|FG000|Dose Escalation|Refused further treatment|0|||
163908249|NCT04447027|592034392|FG001|Dose Escalation|Refused further treatment|1|||
163908250|NCT04447027|592034393|FG002|Dose Escalation|Refused further treatment|1|||
163908251|NCT04447027|592034394|FG003|Dose Escalation|Refused further treatment|0|||
163908252|NCT04447027|592034395|FG004|Dose Escalation|Refused further treatment|0|||
163908253|NCT04447027|592034396|FG005|Dose Escalation|Refused further treatment|0|||
163908254|NCT04447027|592034397|FG006|Dose Escalation|Refused further treatment|0|||
163908255|NCT04447027|592034398|FG007|Dose Escalation|Refused further treatment|0|||
163908256|NCT04447027|592034399|FG008|Dose Escalation|Refused further treatment|0|||
163908257|NCT04447027|592034391|FG000|Dose Expansion|Withdrawal by Subject|0|||
163908258|NCT04447027|592034392|FG001|Dose Expansion|Withdrawal by Subject|0|||
163908259|NCT04447027|592034393|FG002|Dose Expansion|Withdrawal by Subject|0|||
163908260|NCT04447027|592034394|FG003|Dose Expansion|Withdrawal by Subject|0|||
163908261|NCT04447027|592034395|FG004|Dose Expansion|Withdrawal by Subject|0|||
163908262|NCT04447027|592034396|FG005|Dose Expansion|Withdrawal by Subject|2|||
163908263|NCT04447027|592034397|FG006|Dose Expansion|Withdrawal by Subject|0|||
163908264|NCT04447027|592034398|FG007|Dose Expansion|Withdrawal by Subject|2|||
163908265|NCT04447027|592034399|FG008|Dose Expansion|Withdrawal by Subject|0|||
163908266|NCT02196259|592036964|FG000|Overall Study|Researcher choice|0|||
163908267|NCT02196259|592036965|FG001|Overall Study|Researcher choice|0|||
163908268|NCT02196259|592036966|FG002|Overall Study|Researcher choice|1|||
163908269|NCT02196259|592036964|FG000|Overall Study|Partial data analysis|0|||
163908270|NCT02196259|592036965|FG001|Overall Study|Partial data analysis|3|||
163908271|NCT02196259|592036966|FG002|Overall Study|Partial data analysis|0|||
164018989|NCT00905021|592431832|FG000|Overall Study|Adverse Event|2|||
164018990|NCT00786838|592431833|FG000|Overall Study|Physician Decision|4|||
164018991|NCT00786838|592431833|FG000|Overall Study|Death|4|||
164018992|NCT00786838|592431833|FG000|Overall Study|Adverse Event|6|||
164018993|NCT00786838|592431833|FG000|Overall Study|Progressive disease|31|||
164018994|NCT00786838|592431833|FG000|Overall Study|Withdrawal by Subject|4|||
164018995|NCT04937816|592431834|FG000|Overall Study|Study drug stopped, reason missing|5|||
164018996|NCT04937816|592431835|FG001|Overall Study|Study drug stopped, reason missing|3|||
164018997|NCT04937816|592431836|FG002|Overall Study|Study drug stopped, reason missing|4|||
164018998|NCT04937816|592431837|FG003|Overall Study|Study drug stopped, reason missing|6|||
164018999|NCT04937816|592431838|FG004|Overall Study|Study drug stopped, reason missing|1|||
164019000|NCT04937816|592431839|FG005|Overall Study|Study drug stopped, reason missing|0|||
164019001|NCT04937816|592431840|FG006|Overall Study|Study drug stopped, reason missing|0|||
164019002|NCT04937816|592431834|FG000|Overall Study|Other than stated below|173|||
164019003|NCT04937816|592431835|FG001|Overall Study|Other than stated below|143|||
164019004|NCT04937816|592431836|FG002|Overall Study|Other than stated below|125|||
164019005|NCT04937816|592431837|FG003|Overall Study|Other than stated below|44|||
164019006|NCT04937816|592431838|FG004|Overall Study|Other than stated below|45|||
164019007|NCT04937816|592431839|FG005|Overall Study|Other than stated below|28|||
164019008|NCT04937816|592431840|FG006|Overall Study|Other than stated below|31|||
164019009|NCT04937816|592431834|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
164019010|NCT04937816|592431835|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
164019011|NCT04937816|592431836|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
164019012|NCT04937816|592431837|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
164019013|NCT04937816|592431838|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
164019014|NCT04937816|592431839|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
164019015|NCT04937816|592431840|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
164019016|NCT04937816|592431834|FG000|Overall Study|Lost to Follow-up|15|||
164019017|NCT04937816|592431835|FG001|Overall Study|Lost to Follow-up|9|||
163908272|NCT00264576|592036967|FG000|Overall Study|Lost to Follow-up|1|||
163908273|NCT00264576|592036968|FG001|Overall Study|Lost to Follow-up|1|||
163908274|NCT01668355|592036970|FG000|Overall Study|Death|3|||
163908275|NCT01668355|592036971|FG001|Overall Study|Death|1|||
164019018|NCT04937816|592431836|FG002|Overall Study|Lost to Follow-up|6|||
164019019|NCT04937816|592431837|FG003|Overall Study|Lost to Follow-up|6|||
164019020|NCT04937816|592431838|FG004|Overall Study|Lost to Follow-up|16|||
163908276|NCT01668355|592036970|FG000|Overall Study|Withdrawal by Subject|6|||
163908277|NCT01668355|592036971|FG001|Overall Study|Withdrawal by Subject|1|||
163908278|NCT02659059|592036972|FG000|Overall Study|Other reasons|6|||
163908279|NCT02659059|592036973|FG001|Overall Study|Other reasons|1|||
163908280|NCT02659059|592036972|FG000|Overall Study|Disease Progression|143|||
163908281|NCT02659059|592036973|FG001|Overall Study|Disease Progression|16|||
164144656|NCT01495702|592891745|FG000|Randomized Phase|Adverse Event|2|||
163908282|NCT02659059|592036972|FG000|Overall Study|Study Drug toxicity|56|||
163908283|NCT02659059|592036973|FG001|Overall Study|Study Drug toxicity|9|||
164019021|NCT04937816|592431839|FG005|Overall Study|Lost to Follow-up|11|||
164019022|NCT04937816|592431840|FG006|Overall Study|Lost to Follow-up|17|||
164019023|NCT04937816|592431834|FG000|Overall Study|Protocol Violation|15|||
164019024|NCT04937816|592431835|FG001|Overall Study|Protocol Violation|15|||
163908284|NCT02659059|592036972|FG000|Overall Study|Death|3|||
163908285|NCT02659059|592036973|FG001|Overall Study|Death|1|||
163908286|NCT02659059|592036972|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
163908287|NCT02659059|592036973|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
163908288|NCT02659059|592036972|FG000|Overall Study|Participant request to discontinue study treatment|5|||
163908289|NCT02659059|592036973|FG001|Overall Study|Participant request to discontinue study treatment|0|||
163908290|NCT02659059|592036972|FG000|Overall Study|Participant withdrew consent|6|||
163908291|NCT02659059|592036973|FG001|Overall Study|Participant withdrew consent|1|||
163908292|NCT02236611|592036974|FG000|Overall Study|Adverse Event|10|||
163908293|NCT02236611|592036975|FG001|Overall Study|Adverse Event|16|||
163908294|NCT02236611|592036974|FG000|Overall Study|Lack of Efficacy|4|||
164019025|NCT04937816|592431836|FG002|Overall Study|Protocol Violation|12|||
164019026|NCT04937816|592431837|FG003|Overall Study|Protocol Violation|30|||
164019027|NCT04937816|592431838|FG004|Overall Study|Protocol Violation|24|||
164019028|NCT04937816|592431839|FG005|Overall Study|Protocol Violation|5|||
164019029|NCT04937816|592431840|FG006|Overall Study|Protocol Violation|5|||
164019030|NCT04937816|592431834|FG000|Overall Study|Adverse Event|303|||
164019031|NCT04937816|592431835|FG001|Overall Study|Adverse Event|267|||
164019032|NCT04937816|592431836|FG002|Overall Study|Adverse Event|273|||
164019033|NCT04937816|592431837|FG003|Overall Study|Adverse Event|553|||
164019034|NCT04937816|592431838|FG004|Overall Study|Adverse Event|575|||
164019035|NCT04937816|592431839|FG005|Overall Study|Adverse Event|343|||
164019036|NCT04937816|592431840|FG006|Overall Study|Adverse Event|337|||
164019037|NCT04937816|592431834|FG000|Overall Study|Not treated|4|||
164019038|NCT04937816|592431835|FG001|Overall Study|Not treated|2|||
164019039|NCT04937816|592431836|FG002|Overall Study|Not treated|2|||
164019040|NCT04937816|592431837|FG003|Overall Study|Not treated|2|||
164019041|NCT04937816|592431838|FG004|Overall Study|Not treated|1|||
164019042|NCT04937816|592431839|FG005|Overall Study|Not treated|4|||
164019043|NCT04937816|592431840|FG006|Overall Study|Not treated|0|||
164019044|NCT00436215|592431841|FG000|Overall Study|Refused further treatment|3|||
164019045|NCT00436215|592431841|FG000|Overall Study|Small bowel obstruction|1|||
164019046|NCT05513053|592431842|FG000|Overall Study|Lost to Follow-up|9|||
164019047|NCT05513053|592431843|FG001|Overall Study|Lost to Follow-up|11|||
164019048|NCT05513053|592431842|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164019049|NCT05513053|592431843|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164019050|NCT05513053|592431842|FG000|Overall Study|Withdrawal by Subject|2|||
164019051|NCT05513053|592431843|FG001|Overall Study|Withdrawal by Subject|9|||
164019052|NCT05513053|592431842|FG000|Overall Study|Protocol Violation|6|||
164019053|NCT05513053|592431843|FG001|Overall Study|Protocol Violation|3|||
164019054|NCT05513053|592431842|FG000|Overall Study|Adverse Event|0|||
164019055|NCT05513053|592431843|FG001|Overall Study|Adverse Event|2|||
164019056|NCT04491877|592433344|FG000|Overall Study|Protocol Deviation|1|||
164019057|NCT04491877|592433345|FG001|Overall Study|Protocol Deviation|0|||
164019058|NCT04491877|592433346|FG002|Overall Study|Protocol Deviation|2|||
164019059|NCT04491877|592433347|FG003|Overall Study|Protocol Deviation|0|||
164019060|NCT04491877|592433348|FG004|Overall Study|Protocol Deviation|0|||
164019061|NCT04491877|592433349|FG005|Overall Study|Protocol Deviation|0|||
164019062|NCT04491877|592433350|FG006|Overall Study|Protocol Deviation|1|||
164019063|NCT04491877|592433351|FG007|Overall Study|Protocol Deviation|1|||
164019064|NCT04491877|592433352|FG008|Overall Study|Protocol Deviation|0|||
164094904|NCT01918397|592712231|FG001|Overall Study|Never started treatment|1|||
163908295|NCT02236611|592036975|FG001|Overall Study|Lack of Efficacy|7|||
163908296|NCT02236611|592036974|FG000|Overall Study|Lost to Follow-up|0|||
164094905|NCT01918397|592712232|FG002|Overall Study|Never started treatment|0|||
164094906|NCT01918397|592712233|FG003|Overall Study|Never started treatment|0|||
163908297|NCT02236611|592036975|FG001|Overall Study|Lost to Follow-up|2|||
163908298|NCT02236611|592036974|FG000|Overall Study|Protocol deviation|3|||
163908299|NCT02236611|592036975|FG001|Overall Study|Protocol deviation|5|||
163908300|NCT02236611|592036974|FG000|Overall Study|Withdrew consent|9|||
163908301|NCT02236611|592036975|FG001|Overall Study|Withdrew consent|4|||
163908302|NCT03041090|592036976|FG000|Overall Study|technical error|0|||
163908303|NCT03041090|592036977|FG001|Overall Study|technical error|3|||
164019065|NCT04491877|592433344|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164019066|NCT04491877|592433345|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163908304|NCT02202317|592036978|FG000|Overall Study|Lost to Follow-up|1|||
163908305|NCT02338999|592036979|FG000|First Intervention|Withdrawal by Subject|3|||
163908306|NCT02338999|592036980|FG001|First Intervention|Withdrawal by Subject|1|||
163908307|NCT02338999|592036979|FG000|Washout Period|Withdrawal by Subject|0|||
163908308|NCT02338999|592036980|FG001|Washout Period|Withdrawal by Subject|2|||
163908309|NCT02338999|592036979|FG000|Second Intervention|Withdrawal by Subject|0|||
163908310|NCT02338999|592036980|FG001|Second Intervention|Withdrawal by Subject|2|||
163908311|NCT02701296|592036981|FG000|Overall Study|Incomplete Data|0|||
163908312|NCT02701296|592036982|FG001|Overall Study|Incomplete Data|2|||
163908313|NCT01332266|592036983|FG000|Phase 1b|Death|3|||
163908314|NCT01332266|592036984|FG001|Phase 1b|Death|3|||
163908315|NCT01332266|592036985|FG002|Phase 1b|Death|2|||
163908316|NCT01332266|592036986|FG003|Phase 1b|Death|0|||
163908317|NCT01332266|592036987|FG004|Phase 1b|Death|0|||
163908318|NCT01332266|592036983|FG000|Phase 1b|Lost to Follow-up|0|||
163908319|NCT01332266|592036984|FG001|Phase 1b|Lost to Follow-up|1|||
163908320|NCT01332266|592036985|FG002|Phase 1b|Lost to Follow-up|0|||
163908321|NCT01332266|592036986|FG003|Phase 1b|Lost to Follow-up|0|||
163908322|NCT01332266|592036987|FG004|Phase 1b|Lost to Follow-up|0|||
163908323|NCT01332266|592036983|FG000|Phase 1b|Withdrawal by Subject|1|||
163908324|NCT01332266|592036984|FG001|Phase 1b|Withdrawal by Subject|1|||
163908325|NCT01332266|592036985|FG002|Phase 1b|Withdrawal by Subject|1|||
163908326|NCT01332266|592036986|FG003|Phase 1b|Withdrawal by Subject|0|||
163908327|NCT01332266|592036987|FG004|Phase 1b|Withdrawal by Subject|0|||
163908328|NCT01332266|592036983|FG000|Phase 2|Death|0|||
163908329|NCT01332266|592036984|FG001|Phase 2|Death|0|||
163908330|NCT01332266|592036985|FG002|Phase 2|Death|0|||
163908331|NCT01332266|592036986|FG003|Phase 2|Death|33|||
163908332|NCT01332266|592036987|FG004|Phase 2|Death|36|||
163908333|NCT01332266|592036983|FG000|Phase 2|Lost to Follow-up|0|||
163908334|NCT01332266|592036984|FG001|Phase 2|Lost to Follow-up|0|||
163908335|NCT01332266|592036985|FG002|Phase 2|Lost to Follow-up|0|||
163908336|NCT01332266|592036986|FG003|Phase 2|Lost to Follow-up|2|||
163908337|NCT01332266|592036987|FG004|Phase 2|Lost to Follow-up|0|||
163908338|NCT01332266|592036983|FG000|Phase 2|Physician Decision|0|||
163908339|NCT01332266|592036984|FG001|Phase 2|Physician Decision|0|||
163908340|NCT01332266|592036985|FG002|Phase 2|Physician Decision|0|||
163908341|NCT01332266|592036986|FG003|Phase 2|Physician Decision|3|||
163908342|NCT01332266|592036987|FG004|Phase 2|Physician Decision|1|||
163908343|NCT01332266|592036983|FG000|Phase 2|Symptomatic deterioration|0|||
163908344|NCT01332266|592036984|FG001|Phase 2|Symptomatic deterioration|0|||
163908345|NCT01332266|592036985|FG002|Phase 2|Symptomatic deterioration|0|||
163908346|NCT01332266|592036986|FG003|Phase 2|Symptomatic deterioration|0|||
163908347|NCT01332266|592036987|FG004|Phase 2|Symptomatic deterioration|1|||
163908348|NCT01332266|592036983|FG000|Phase 2|Progression Disease|0|||
163908349|NCT01332266|592036984|FG001|Phase 2|Progression Disease|0|||
163908350|NCT01332266|592036985|FG002|Phase 2|Progression Disease|0|||
163908351|NCT01332266|592036986|FG003|Phase 2|Progression Disease|2|||
163908352|NCT01332266|592036987|FG004|Phase 2|Progression Disease|1|||
163908353|NCT01332266|592036983|FG000|Phase 2|Withdrawal by Subject|0|||
163908354|NCT01332266|592036984|FG001|Phase 2|Withdrawal by Subject|0|||
163908355|NCT01332266|592036985|FG002|Phase 2|Withdrawal by Subject|0|||
163908356|NCT01332266|592036986|FG003|Phase 2|Withdrawal by Subject|2|||
163908357|NCT01332266|592036987|FG004|Phase 2|Withdrawal by Subject|2|||
163908358|NCT01686152|592036990|FG000|Overall Study|Withdrawal by Subject|11|||
163908359|NCT01686152|592036991|FG001|Overall Study|Withdrawal by Subject|11|||
163908360|NCT01686152|592036992|FG002|Overall Study|Withdrawal by Subject|3|||
163908361|NCT01686152|592036990|FG000|Overall Study|Drug Code Unblinded|0|||
163908362|NCT01686152|592036991|FG001|Overall Study|Drug Code Unblinded|1|||
163908363|NCT01686152|592036992|FG002|Overall Study|Drug Code Unblinded|0|||
163908364|NCT01686152|592036990|FG000|Overall Study|Protocol Violation|6|||
163908365|NCT01686152|592036991|FG001|Overall Study|Protocol Violation|1|||
163908366|NCT01686152|592036992|FG002|Overall Study|Protocol Violation|0|||
163908367|NCT01686152|592036990|FG000|Overall Study|Adverse Event|12|||
163908368|NCT01686152|592036991|FG001|Overall Study|Adverse Event|11|||
163908369|NCT01686152|592036992|FG002|Overall Study|Adverse Event|0|||
163908370|NCT01686152|592036990|FG000|Overall Study|Lack of Efficacy|0|||
163908371|NCT01686152|592036991|FG001|Overall Study|Lack of Efficacy|0|||
163908372|NCT01686152|592036992|FG002|Overall Study|Lack of Efficacy|1|||
163908373|NCT01686152|592036990|FG000|Overall Study|IP Non-compliance|5|||
163908374|NCT01686152|592036991|FG001|Overall Study|IP Non-compliance|5|||
163908375|NCT01686152|592036992|FG002|Overall Study|IP Non-compliance|0|||
163908376|NCT01686152|592036990|FG000|Overall Study|Lost to Follow-up|7|||
163908377|NCT01686152|592036991|FG001|Overall Study|Lost to Follow-up|6|||
163908378|NCT01686152|592036992|FG002|Overall Study|Lost to Follow-up|5|||
163908379|NCT01802333|592036993|FG000|Overall Study|Ineligible|2|||
163908380|NCT01802333|592036994|FG001|Overall Study|Ineligible|6|||
163908381|NCT01802333|592036995|FG002|Overall Study|Ineligible|8|||
163908382|NCT01802333|592036993|FG000|Overall Study|Adverse Event|1|||
163908383|NCT01802333|592036994|FG001|Overall Study|Adverse Event|8|||
163908384|NCT01802333|592036995|FG002|Overall Study|Adverse Event|8|||
163908385|NCT01802333|592036993|FG000|Overall Study|Withdrawal by Subject|6|||
163908386|NCT01802333|592036994|FG001|Overall Study|Withdrawal by Subject|6|||
163908387|NCT01802333|592036995|FG002|Overall Study|Withdrawal by Subject|5|||
163908388|NCT01802333|592036993|FG000|Overall Study|Progression/relapse|1|||
163908389|NCT01802333|592036994|FG001|Overall Study|Progression/relapse|3|||
163908390|NCT01802333|592036995|FG002|Overall Study|Progression/relapse|0|||
163908391|NCT01802333|592036993|FG000|Overall Study|Death|7|||
163908392|NCT01802333|592036994|FG001|Overall Study|Death|14|||
163908393|NCT01802333|592036995|FG002|Overall Study|Death|13|||
163908394|NCT01802333|592036993|FG000|Overall Study|Other - not protocol specified|32|||
163908395|NCT01802333|592036994|FG001|Overall Study|Other - not protocol specified|22|||
163908396|NCT01802333|592036995|FG002|Overall Study|Other - not protocol specified|24|||
163908397|NCT01802333|592036993|FG000|Overall Study|Did not start treatment|0|||
163908398|NCT01802333|592036994|FG001|Overall Study|Did not start treatment|2|||
163908399|NCT01802333|592036995|FG002|Overall Study|Did not start treatment|5|||
163908400|NCT01947491|592036999|FG000|Overall Study|Lost to Follow-up|5|||
163908401|NCT01947491|592037000|FG001|Overall Study|Lost to Follow-up|3|||
163908402|NCT01947491|592037001|FG002|Overall Study|Lost to Follow-up|1|||
163908403|NCT01947491|592037002|FG003|Overall Study|Lost to Follow-up|2|||
163908404|NCT01947491|592036999|FG000|Overall Study|Lack of Efficacy|1|||
163908405|NCT01947491|592037000|FG001|Overall Study|Lack of Efficacy|0|||
163908406|NCT01947491|592037001|FG002|Overall Study|Lack of Efficacy|0|||
163908407|NCT01947491|592037002|FG003|Overall Study|Lack of Efficacy|1|||
163908408|NCT01947491|592036999|FG000|Overall Study|Protocol Violation|1|||
163908409|NCT01947491|592037000|FG001|Overall Study|Protocol Violation|0|||
163908410|NCT01947491|592037001|FG002|Overall Study|Protocol Violation|0|||
163908411|NCT01947491|592037002|FG003|Overall Study|Protocol Violation|0|||
163908412|NCT01947491|592036999|FG000|Overall Study|Withdrawal by Subject|1|||
163908413|NCT01947491|592037000|FG001|Overall Study|Withdrawal by Subject|1|||
163908414|NCT01947491|592037001|FG002|Overall Study|Withdrawal by Subject|1|||
163908415|NCT01947491|592037002|FG003|Overall Study|Withdrawal by Subject|0|||
163908416|NCT01947491|592036999|FG000|Overall Study|Worsening of condition|0|||
163908417|NCT01947491|592037000|FG001|Overall Study|Worsening of condition|1|||
163908418|NCT01947491|592037001|FG002|Overall Study|Worsening of condition|0|||
163908419|NCT01947491|592037002|FG003|Overall Study|Worsening of condition|0|||
163908420|NCT01947491|592036999|FG000|Overall Study|Adverse Event|0|||
163908421|NCT01947491|592037000|FG001|Overall Study|Adverse Event|1|||
163908422|NCT01947491|592037001|FG002|Overall Study|Adverse Event|0|||
163908423|NCT01947491|592037002|FG003|Overall Study|Adverse Event|2|||
163908424|NCT02224755|592037003|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
163908425|NCT02224755|592037004|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
163908426|NCT02224755|592037003|FG000|Two Year Follow up Post-implant|Death|103|||
163908427|NCT02224755|592037004|FG001|Two Year Follow up Post-implant|Death|98|||
163908428|NCT02224755|592037003|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
163908429|NCT02224755|592037004|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
163908430|NCT02224755|592037003|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
163908431|NCT02224755|592037004|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
163908432|NCT02224755|592037003|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
163908433|NCT02224755|592037004|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
163908434|NCT02067663|592037005|FG000|Overall Study|Lost to Follow-up|13|||
163908435|NCT02067663|592037006|FG001|Overall Study|Lost to Follow-up|14|||
163908436|NCT01205126|592037007|FG000|Titration Phase|Adverse Event|5|||
163908437|NCT01205126|592037008|FG001|Titration Phase|Adverse Event|3|||
163908438|NCT01205126|592037007|FG000|Titration Phase|Withdrawal by Subject|5|||
163908439|NCT01205126|592037008|FG001|Titration Phase|Withdrawal by Subject|5|||
163908440|NCT01205126|592037007|FG000|Titration Phase|Lost to Follow-up|2|||
163908441|NCT01205126|592037008|FG001|Titration Phase|Lost to Follow-up|2|||
163908442|NCT01205126|592037007|FG000|Titration Phase|No stable titration dose|1|||
163908443|NCT01205126|592037008|FG001|Titration Phase|No stable titration dose|0|||
163908444|NCT01205126|592037007|FG000|Titration Phase|More than maximum dosage required|2|||
163908445|NCT01205126|592037008|FG001|Titration Phase|More than maximum dosage required|3|||
163908446|NCT01205126|592037007|FG000|Titration Phase|Other|8|||
163908447|NCT01205126|592037008|FG001|Titration Phase|Other|6|||
163908448|NCT01205126|592037007|FG000|Between Titration & Maintenance Phase|Other|0|||
163908449|NCT01205126|592037008|FG001|Between Titration & Maintenance Phase|Other|4|||
163908450|NCT01205126|592037007|FG000|Maintenance Phase|Adverse Event|3|||
163908451|NCT01205126|592037008|FG001|Maintenance Phase|Adverse Event|7|||
163908452|NCT01205126|592037007|FG000|Maintenance Phase|Death|4|||
163908453|NCT01205126|592037008|FG001|Maintenance Phase|Death|4|||
163908454|NCT01205126|592037007|FG000|Maintenance Phase|More than the maximum dosage required|5|||
163908455|NCT01205126|592037008|FG001|Maintenance Phase|More than the maximum dosage required|5|||
163908456|NCT01205126|592037007|FG000|Maintenance Phase|Prohibited drugs used|1|||
163908457|NCT01205126|592037008|FG001|Maintenance Phase|Prohibited drugs used|0|||
163908458|NCT01205126|592037007|FG000|Maintenance Phase|Other|11|||
163908459|NCT01205126|592037008|FG001|Maintenance Phase|Other|8|||
163908460|NCT01205126|592037007|FG000|Maintenance Phase|Lost to Follow-up|5|||
163908461|NCT01205126|592037008|FG001|Maintenance Phase|Lost to Follow-up|5|||
163908462|NCT01205126|592037007|FG000|Maintenance Phase|Withdrawal by Subject|8|||
163908463|NCT01205126|592037008|FG001|Maintenance Phase|Withdrawal by Subject|11|||
163908464|NCT00923078|592037014|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
163908465|NCT00923078|592037015|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
163908466|NCT00923078|592037016|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
163908467|NCT00923078|592037014|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
163908468|NCT00923078|592037015|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
163908469|NCT00923078|592037016|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
163908470|NCT01072149|592037020|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908471|NCT01072149|592037021|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908472|NCT01072149|592037022|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
163908473|NCT01072149|592037023|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908474|NCT01072149|592037024|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908475|NCT01072149|592037025|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908476|NCT01072149|592037026|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908477|NCT01072149|592037027|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908478|NCT01072149|592037028|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908479|NCT01072149|592037029|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908480|NCT01072149|592037030|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908481|NCT01072149|592037031|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908482|NCT01072149|592037032|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908483|NCT01072149|592037033|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908484|NCT01072149|592037034|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908485|NCT01072149|592037035|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908486|NCT01072149|592037036|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908487|NCT01072149|592037037|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
163908488|NCT01072149|592037020|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908489|NCT01072149|592037021|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908490|NCT01072149|592037022|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908491|NCT01072149|592037023|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
164019067|NCT04491877|592433346|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164019068|NCT04491877|592433347|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
164019069|NCT04491877|592433348|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164019070|NCT04491877|592433349|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
164019071|NCT04491877|592433350|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
164019072|NCT04491877|592433351|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
164019073|NCT04491877|592433352|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
164019074|NCT04491877|592433344|FG000|Overall Study|Lost to Follow-up|0|||
164019075|NCT04491877|592433345|FG001|Overall Study|Lost to Follow-up|2|||
164019076|NCT04491877|592433346|FG002|Overall Study|Lost to Follow-up|0|||
164019077|NCT04491877|592433347|FG003|Overall Study|Lost to Follow-up|0|||
164019078|NCT04491877|592433348|FG004|Overall Study|Lost to Follow-up|0|||
164019079|NCT04491877|592433349|FG005|Overall Study|Lost to Follow-up|0|||
164019080|NCT04491877|592433350|FG006|Overall Study|Lost to Follow-up|2|||
164019081|NCT04491877|592433351|FG007|Overall Study|Lost to Follow-up|1|||
164019082|NCT04491877|592433352|FG008|Overall Study|Lost to Follow-up|1|||
164019083|NCT02614287|592433353|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
164019084|NCT02614287|592433354|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
163908492|NCT01072149|592037024|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908493|NCT01072149|592037025|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908494|NCT01072149|592037026|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908495|NCT01072149|592037027|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908496|NCT01072149|592037028|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908497|NCT01072149|592037029|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908498|NCT01072149|592037030|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908499|NCT01072149|592037031|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908500|NCT01072149|592037032|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908501|NCT01072149|592037033|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908502|NCT01072149|592037034|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908503|NCT01072149|592037035|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908504|NCT01072149|592037036|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
163908505|NCT01072149|592037037|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
163908506|NCT01072149|592037020|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908507|NCT01072149|592037021|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908508|NCT01072149|592037022|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908509|NCT01072149|592037023|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908510|NCT01072149|592037024|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908511|NCT01072149|592037025|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908512|NCT01072149|592037026|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908513|NCT01072149|592037027|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908514|NCT01072149|592037028|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908515|NCT01072149|592037029|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908516|NCT01072149|592037030|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
163908517|NCT01072149|592037031|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908518|NCT01072149|592037032|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908519|NCT01072149|592037033|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908520|NCT01072149|592037034|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908521|NCT01072149|592037035|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908522|NCT01072149|592037036|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908523|NCT01072149|592037037|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
163908524|NCT01072149|592037020|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908525|NCT01072149|592037021|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
163908526|NCT01072149|592037022|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908527|NCT01072149|592037023|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908528|NCT01072149|592037024|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908529|NCT01072149|592037025|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908530|NCT01072149|592037026|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908531|NCT01072149|592037027|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908532|NCT01072149|592037028|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908533|NCT01072149|592037029|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908534|NCT01072149|592037030|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908535|NCT01072149|592037031|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908536|NCT01072149|592037032|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908537|NCT01072149|592037033|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908538|NCT01072149|592037034|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908539|NCT01072149|592037035|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164019085|NCT02614287|592433353|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
163908540|NCT01072149|592037036|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
164019086|NCT02614287|592433354|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
164019087|NCT02614287|592433353|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
164019088|NCT02614287|592433354|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
164019089|NCT02614287|592433353|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
164019090|NCT02614287|592433354|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
164019091|NCT02614287|592433353|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
164019092|NCT02614287|592433354|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
164019093|NCT02614287|592433353|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
164019094|NCT02614287|592433354|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
164019095|NCT02614287|592433353|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
164019096|NCT02614287|592433354|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
164019097|NCT02614287|592433353|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
164019098|NCT02614287|592433354|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
164019099|NCT00418834|592433355|FG000|Overall Study|Adverse Event|16|||
164019100|NCT00418834|592433356|FG001|Overall Study|Adverse Event|9|||
164019101|NCT00418834|592433355|FG000|Overall Study|Lost to Follow-up|0|||
164019102|NCT00418834|592433356|FG001|Overall Study|Lost to Follow-up|1|||
164019103|NCT00418834|592433355|FG000|Overall Study|Protocol Violation|4|||
164019104|NCT00418834|592433356|FG001|Overall Study|Protocol Violation|3|||
164019105|NCT00418834|592433355|FG000|Overall Study|Withdrawal by Subject|3|||
164019106|NCT00418834|592433356|FG001|Overall Study|Withdrawal by Subject|7|||
164019107|NCT02429258|592433357|FG000|Overall Study|Withdrawal by Subject|2|||
164019108|NCT02429258|592433358|FG001|Overall Study|Withdrawal by Subject|0|||
164019109|NCT02429258|592433357|FG000|Overall Study|Protocol Violation|0|||
164019110|NCT02429258|592433358|FG001|Overall Study|Protocol Violation|1|||
164019111|NCT00492856|592433360|FG000|Induction|Adverse Event|2|||
164019112|NCT00492856|592433361|FG001|Induction|Adverse Event|0|||
164019113|NCT00492856|592433362|FG002|Induction|Adverse Event|0|||
164019114|NCT00492856|592433363|FG003|Induction|Adverse Event|0|||
164019115|NCT00492856|592433360|FG000|Induction|Withdrawal by Subject|1|||
164019116|NCT00492856|592433361|FG001|Induction|Withdrawal by Subject|0|||
164019117|NCT00492856|592433362|FG002|Induction|Withdrawal by Subject|0|||
164019118|NCT00492856|592433363|FG003|Induction|Withdrawal by Subject|0|||
164019119|NCT00492856|592433360|FG000|Induction|Death|3|||
164019120|NCT00492856|592433361|FG001|Induction|Death|0|||
164019121|NCT00492856|592433362|FG002|Induction|Death|0|||
164019122|NCT00492856|592433363|FG003|Induction|Death|0|||
164019123|NCT00492856|592433360|FG000|Consolidation|Adverse Event|6|||
164019124|NCT00492856|592433361|FG001|Consolidation|Adverse Event|0|||
164019125|NCT00492856|592433362|FG002|Consolidation|Adverse Event|0|||
164019126|NCT00492856|592433363|FG003|Consolidation|Adverse Event|0|||
164019127|NCT00492856|592433360|FG000|Consolidation|Not protocol specified|2|||
164019128|NCT00492856|592433361|FG001|Consolidation|Not protocol specified|0|||
164019129|NCT00492856|592433362|FG002|Consolidation|Not protocol specified|0|||
164019130|NCT00492856|592433363|FG003|Consolidation|Not protocol specified|0|||
164019131|NCT00492856|592433360|FG000|Consolidation|Lost to Follow-up|1|||
164019132|NCT00492856|592433361|FG001|Consolidation|Lost to Follow-up|0|||
164019133|NCT00492856|592433362|FG002|Consolidation|Lost to Follow-up|0|||
164019134|NCT00492856|592433363|FG003|Consolidation|Lost to Follow-up|0|||
164019135|NCT00492856|592433360|FG000|Post-consolidation|Adverse Event|0|||
164019136|NCT00492856|592433361|FG001|Post-consolidation|Adverse Event|4|||
164019137|NCT00492856|592433362|FG002|Post-consolidation|Adverse Event|0|||
164019138|NCT00492856|592433363|FG003|Post-consolidation|Adverse Event|1|||
164019139|NCT00492856|592433360|FG000|Post-consolidation|Withdrawal by Subject|0|||
164019140|NCT00492856|592433361|FG001|Post-consolidation|Withdrawal by Subject|4|||
164019141|NCT00492856|592433362|FG002|Post-consolidation|Withdrawal by Subject|0|||
164019142|NCT00492856|592433363|FG003|Post-consolidation|Withdrawal by Subject|0|||
164019143|NCT00492856|592433360|FG000|Post-consolidation|Death|0|||
164019144|NCT00492856|592433361|FG001|Post-consolidation|Death|1|||
164019145|NCT00492856|592433362|FG002|Post-consolidation|Death|0|||
164019146|NCT00492856|592433363|FG003|Post-consolidation|Death|0|||
164019147|NCT00492856|592433360|FG000|Post-consolidation|Not protocol specified|0|||
164019148|NCT00492856|592433361|FG001|Post-consolidation|Not protocol specified|1|||
164019149|NCT00492856|592433362|FG002|Post-consolidation|Not protocol specified|0|||
164019150|NCT00492856|592433363|FG003|Post-consolidation|Not protocol specified|0|||
164019151|NCT00492856|592433360|FG000|Post-consolidation|Lost to Follow-up|0|||
164019152|NCT00492856|592433361|FG001|Post-consolidation|Lost to Follow-up|2|||
164019153|NCT00492856|592433362|FG002|Post-consolidation|Lost to Follow-up|0|||
164019154|NCT00492856|592433363|FG003|Post-consolidation|Lost to Follow-up|0|||
164019155|NCT00492856|592433360|FG000|Post-consolidation|Observation Arm|0|||
164019156|NCT00492856|592433361|FG001|Post-consolidation|Observation Arm|0|||
164019157|NCT00492856|592433362|FG002|Post-consolidation|Observation Arm|27|||
164019158|NCT00492856|592433363|FG003|Post-consolidation|Observation Arm|0|||
164019159|NCT03987919|592433364|FG000|Overall Study|Adverse Event|1|||
164019160|NCT03987919|592433365|FG001|Overall Study|Adverse Event|4|||
164019161|NCT03987919|592433366|FG002|Overall Study|Adverse Event|1|||
164019162|NCT03987919|592433367|FG003|Overall Study|Adverse Event|3|||
164019163|NCT03987919|592433364|FG000|Overall Study|Death|4|||
164019164|NCT03987919|592433365|FG001|Overall Study|Death|4|||
164019165|NCT03987919|592433366|FG002|Overall Study|Death|4|||
164019166|NCT03987919|592433367|FG003|Overall Study|Death|1|||
164019167|NCT03987919|592433364|FG000|Overall Study|Lost to Follow-up|5|||
163908541|NCT01072149|592037037|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
163908542|NCT01072149|592037020|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908543|NCT01072149|592037021|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908544|NCT01072149|592037022|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
164094907|NCT01918397|592712230|FG000|Overall Study|Adverse Event|1|||
163908545|NCT01072149|592037023|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908546|NCT01072149|592037024|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908547|NCT01072149|592037025|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908548|NCT01072149|592037026|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908549|NCT01072149|592037027|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908550|NCT01072149|592037028|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908551|NCT01072149|592037029|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908552|NCT01072149|592037030|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164019168|NCT03987919|592433365|FG001|Overall Study|Lost to Follow-up|6|||
164019169|NCT03987919|592433366|FG002|Overall Study|Lost to Follow-up|8|||
164019170|NCT03987919|592433367|FG003|Overall Study|Lost to Follow-up|12|||
163908553|NCT01072149|592037031|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
164019171|NCT03987919|592433364|FG000|Overall Study|Physician Decision|0|||
164019172|NCT03987919|592433365|FG001|Overall Study|Physician Decision|2|||
164019173|NCT03987919|592433366|FG002|Overall Study|Physician Decision|0|||
164019174|NCT03987919|592433367|FG003|Overall Study|Physician Decision|4|||
164019175|NCT03987919|592433364|FG000|Overall Study|Pregnancy|1|||
164019176|NCT03987919|592433365|FG001|Overall Study|Pregnancy|0|||
164019177|NCT03987919|592433366|FG002|Overall Study|Pregnancy|1|||
164019178|NCT03987919|592433367|FG003|Overall Study|Pregnancy|1|||
164019179|NCT03987919|592433364|FG000|Overall Study|Protocol Violation|0|||
164019180|NCT03987919|592433365|FG001|Overall Study|Protocol Violation|1|||
164019181|NCT03987919|592433366|FG002|Overall Study|Protocol Violation|0|||
164019182|NCT03987919|592433367|FG003|Overall Study|Protocol Violation|0|||
164019183|NCT03987919|592433364|FG000|Overall Study|Site terminated by Sponsor|0|||
164019184|NCT03987919|592433365|FG001|Overall Study|Site terminated by Sponsor|0|||
164019185|NCT03987919|592433366|FG002|Overall Study|Site terminated by Sponsor|0|||
164019186|NCT03987919|592433367|FG003|Overall Study|Site terminated by Sponsor|1|||
164019187|NCT03987919|592433364|FG000|Overall Study|Withdrawal by Subject|7|||
164019188|NCT03987919|592433365|FG001|Overall Study|Withdrawal by Subject|7|||
164019189|NCT03987919|592433366|FG002|Overall Study|Withdrawal by Subject|8|||
164019190|NCT03987919|592433367|FG003|Overall Study|Withdrawal by Subject|4|||
164019191|NCT03987919|592433364|FG000|Overall Study|Other - as reported by the investigator|1|||
164019192|NCT03987919|592433365|FG001|Overall Study|Other - as reported by the investigator|3|||
164019193|NCT03987919|592433366|FG002|Overall Study|Other - as reported by the investigator|2|||
164019194|NCT03987919|592433367|FG003|Overall Study|Other - as reported by the investigator|0|||
164019195|NCT01520324|592433372|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
164019196|NCT03470922|592433373|FG000|Overall Study|Death|107|||
164019197|NCT03470922|592433374|FG001|Overall Study|Death|118|||
164019198|NCT03470922|592433373|FG000|Overall Study|Lost to Follow-up|5|||
164019199|NCT03470922|592433374|FG001|Overall Study|Lost to Follow-up|5|||
164094908|NCT01918397|592712231|FG001|Overall Study|Adverse Event|1|||
163908554|NCT01072149|592037032|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908555|NCT01072149|592037033|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908556|NCT01072149|592037034|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908557|NCT01072149|592037035|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908558|NCT01072149|592037036|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908559|NCT01072149|592037037|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
163908560|NCT01072149|592037020|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908561|NCT01072149|592037021|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908562|NCT01072149|592037022|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
164019200|NCT03470922|592433373|FG000|Overall Study|Participant Withdrew Consent|4|||
164019201|NCT03470922|592433374|FG001|Overall Study|Participant Withdrew Consent|9|||
164019202|NCT03470922|592433373|FG000|Overall Study|Other reasons|1|||
164019203|NCT03470922|592433374|FG001|Overall Study|Other reasons|0|||
164019204|NCT03470922|592433373|FG000|Overall Study|Not reported|1|||
164019205|NCT03470922|592433374|FG001|Overall Study|Not reported|0|||
164019206|NCT02626819|592433375|FG000|Overall Study|Lost to Follow-up|3|||
164019207|NCT02626819|592433376|FG001|Overall Study|Lost to Follow-up|2|||
164019208|NCT02626819|592433375|FG000|Overall Study|Withdrawal by Subject|1|||
164019209|NCT02626819|592433376|FG001|Overall Study|Withdrawal by Subject|0|||
164019210|NCT02626819|592433375|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
164019211|NCT02626819|592433376|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
164019212|NCT00502307|592433379|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
164019213|NCT00502307|592433380|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
164019214|NCT00502307|592433381|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
164019215|NCT00502307|592433379|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
164019216|NCT00502307|592433380|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
164019217|NCT00502307|592433381|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
164019218|NCT00502307|592433379|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
164019219|NCT00502307|592433380|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
164019220|NCT00502307|592433381|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
164019221|NCT00502307|592433379|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
164019222|NCT00502307|592433380|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
164019223|NCT00502307|592433381|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
164019224|NCT00502307|592433379|FG000|Maintenance Period|Progressive disease|80|||
164019225|NCT00502307|592433380|FG001|Maintenance Period|Progressive disease|0|||
164019226|NCT00502307|592433381|FG002|Maintenance Period|Progressive disease|0|||
164019227|NCT00502307|592433379|FG000|Maintenance Period|Discontinued due to other reasons|68|||
164019228|NCT00502307|592433380|FG001|Maintenance Period|Discontinued due to other reasons|0|||
164019229|NCT00502307|592433381|FG002|Maintenance Period|Discontinued due to other reasons|0|||
164019230|NCT00748553|592433382|FG000|Overall Study|Adverse Event|0|||
164019231|NCT00748553|592433383|FG001|Overall Study|Adverse Event|1|||
163908563|NCT01072149|592037023|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908564|NCT01072149|592037024|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908565|NCT01072149|592037025|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908566|NCT01072149|592037026|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908567|NCT01072149|592037027|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
163908568|NCT01072149|592037028|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908569|NCT01072149|592037029|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
164019232|NCT00748553|592433382|FG000|Overall Study|disease progression|2|||
164019233|NCT00748553|592433383|FG001|Overall Study|disease progression|0|||
164019234|NCT00748553|592433382|FG000|Overall Study|noncompliance|1|||
163908570|NCT01072149|592037030|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908571|NCT01072149|592037031|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
164019235|NCT00748553|592433383|FG001|Overall Study|noncompliance|0|||
164019236|NCT02330549|592433384|FG000|Overall Study|Adverse Event|1|||
164019237|NCT02330549|592433385|FG001|Overall Study|Adverse Event|0|||
164019238|NCT02330549|592433384|FG000|Overall Study|Subject withdrew consent|2|||
164019239|NCT02330549|592433385|FG001|Overall Study|Subject withdrew consent|1|||
164019240|NCT02330549|592433384|FG000|Overall Study|Failure to meet randomization criteria|1|||
164019241|NCT02330549|592433385|FG001|Overall Study|Failure to meet randomization criteria|0|||
164019242|NCT00495495|592433387|FG000|Overall Study|Protocol Violation|99|||
164019243|NCT00423085|592433388|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
164019244|NCT00423085|592433389|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
164019245|NCT00423085|592433390|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
164019246|NCT00423085|592433391|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
164019247|NCT00423085|592433388|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
164019248|NCT00423085|592433389|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
164019249|NCT00423085|592433390|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
164019250|NCT00423085|592433391|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164019251|NCT00423085|592433388|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
164019252|NCT00423085|592433389|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
164019253|NCT00423085|592433390|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
164019254|NCT00423085|592433391|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
164019255|NCT00423085|592433388|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
164019256|NCT00423085|592433389|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
164019257|NCT00423085|592433390|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
164019258|NCT00423085|592433391|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
164019259|NCT00423085|592433388|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
164019260|NCT00423085|592433389|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
164019261|NCT00423085|592433390|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
163908572|NCT01072149|592037032|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908573|NCT01072149|592037033|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
164019262|NCT00423085|592433391|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
164019263|NCT00423085|592433388|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
164019264|NCT00423085|592433389|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
164019265|NCT00423085|592433390|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
164019266|NCT00423085|592433391|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
164019267|NCT00423085|592433388|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
164019268|NCT00423085|592433389|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
164019269|NCT00423085|592433390|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
164019270|NCT00423085|592433391|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
164019271|NCT00423085|592433388|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
164019272|NCT00423085|592433389|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
164019273|NCT00423085|592433390|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
164019274|NCT00423085|592433391|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
164019275|NCT00423085|592433388|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
164019276|NCT00423085|592433389|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
164019277|NCT00423085|592433390|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
164019278|NCT00423085|592433391|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
164019279|NCT00423085|592433388|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
164019280|NCT00423085|592433389|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
164019281|NCT00423085|592433390|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
164019282|NCT00423085|592433391|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
164019283|NCT00423085|592433388|FG000|52-Week Open-Label Extension Phase|Death|0|||
164019284|NCT00423085|592433389|FG001|52-Week Open-Label Extension Phase|Death|0|||
164019285|NCT00423085|592433390|FG002|52-Week Open-Label Extension Phase|Death|0|||
164019286|NCT00423085|592433391|FG003|52-Week Open-Label Extension Phase|Death|2|||
164019287|NCT02750813|592433394|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
164019288|NCT02750813|592433395|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
164019289|NCT02750813|592433394|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
164019290|NCT02750813|592433395|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
164019291|NCT02245568|592433396|FG000|Overall Study|Study terminated by Sponsor|346|||
164019292|NCT02245568|592433396|FG000|Overall Study|Adverse Event|144|||
164019293|NCT02245568|592433396|FG000|Overall Study|Lack of Efficacy|98|||
164019294|NCT02245568|592433396|FG000|Overall Study|Withdrawal by Caregiver|85|||
164019295|NCT02245568|592433396|FG000|Overall Study|Withdrawal by Subject|77|||
164019296|NCT02245568|592433396|FG000|Overall Study|Withdrawal by Legal Representative|31|||
164019297|NCT02245568|592433396|FG000|Overall Study|Missing (Site closure)|16|||
164094909|NCT01918397|592712232|FG002|Overall Study|Adverse Event|1|||
163908574|NCT01072149|592037034|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908575|NCT01072149|592037035|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908576|NCT01072149|592037036|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908577|NCT01072149|592037037|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
163908578|NCT01072149|592037020|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
163908579|NCT01072149|592037021|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
163908580|NCT01072149|592037022|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
163908581|NCT01072149|592037023|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
163908582|NCT01072149|592037024|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
164019298|NCT02245568|592433396|FG000|Overall Study|Physician Decision|14|||
164019299|NCT02245568|592433396|FG000|Overall Study|Non-compliance with study drug|11|||
164019300|NCT02245568|592433396|FG000|Overall Study|Death|9|||
164019301|NCT02245568|592433396|FG000|Overall Study|Blue staining|6|||
164019302|NCT02245568|592433396|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
164019303|NCT02245568|592433396|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
164019304|NCT02245568|592433396|FG000|Overall Study|Lost to Follow-up|5|||
164019305|NCT00441441|592433397|FG000|Overall Study|Adverse Event|2|||
164019306|NCT00441441|592433398|FG001|Overall Study|Adverse Event|1|||
164019307|NCT00441441|592433397|FG000|Overall Study|Protocol Violation|4|||
164019308|NCT00441441|592433398|FG001|Overall Study|Protocol Violation|6|||
164019309|NCT00441441|592433397|FG000|Overall Study|Exacerbation of asthma|1|||
164019310|NCT00441441|592433398|FG001|Overall Study|Exacerbation of asthma|2|||
164019311|NCT00441441|592433397|FG000|Overall Study|Withdrawal by Subject|1|||
164019312|NCT00441441|592433398|FG001|Overall Study|Withdrawal by Subject|2|||
164019313|NCT00441441|592433397|FG000|Overall Study|Other|3|||
164019314|NCT00441441|592433398|FG001|Overall Study|Other|3|||
164019315|NCT04009096|592433405|FG000|Overall Study|Withdrawal by Subject|0|||
164019316|NCT04009096|592433406|FG001|Overall Study|Withdrawal by Subject|7|||
164019317|NCT04009096|592433407|FG002|Overall Study|Withdrawal by Subject|0|||
164019318|NCT04009096|592433405|FG000|Overall Study|Physician Decision|0|||
164019319|NCT04009096|592433406|FG001|Overall Study|Physician Decision|1|||
164019320|NCT04009096|592433407|FG002|Overall Study|Physician Decision|0|||
164019321|NCT00450372|592433408|FG000|Overall Study|Physician Decision|1|||
164094910|NCT01918397|592712233|FG003|Overall Study|Adverse Event|0|||
164094911|NCT01918397|592712230|FG000|Overall Study|Lack of compliance|2|||
164019322|NCT00769704|592433409|FG000|Overall Study|Lost to Follow-up|3|||
164019323|NCT00769704|592433410|FG001|Overall Study|Lost to Follow-up|2|||
164094912|NCT01918397|592712231|FG001|Overall Study|Lack of compliance|2|||
164019324|NCT00769704|592433409|FG000|Overall Study|Death|95|||
164019325|NCT00769704|592433410|FG001|Overall Study|Death|190|||
164094913|NCT01918397|592712232|FG002|Overall Study|Lack of compliance|3|||
164019326|NCT00769704|592433409|FG000|Overall Study|Withdrawal by Subject|12|||
164019327|NCT00769704|592433410|FG001|Overall Study|Withdrawal by Subject|5|||
163908583|NCT01072149|592037025|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
163908584|NCT01072149|592037026|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
164094914|NCT01918397|592712233|FG003|Overall Study|Lack of compliance|0|||
164094915|NCT01918397|592712230|FG000|Overall Study|Pregnancy|0|||
163908585|NCT01072149|592037027|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
163908586|NCT01072149|592037028|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
163908587|NCT01072149|592037029|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
163908588|NCT01072149|592037030|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
163908589|NCT01072149|592037031|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
163908590|NCT01072149|592037032|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
163908591|NCT01072149|592037033|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
164094916|NCT01918397|592712231|FG001|Overall Study|Pregnancy|1|||
164094917|NCT01918397|592712232|FG002|Overall Study|Pregnancy|0|||
163908592|NCT01072149|592037034|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
163908593|NCT01072149|592037035|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
163908594|NCT01072149|592037036|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
163908595|NCT01072149|592037037|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
163908596|NCT01072149|592037020|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908597|NCT01072149|592037021|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908598|NCT01072149|592037022|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908599|NCT01072149|592037023|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908600|NCT01072149|592037024|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908601|NCT01072149|592037025|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908602|NCT01072149|592037026|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908603|NCT01072149|592037027|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908604|NCT01072149|592037028|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908605|NCT01072149|592037029|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908606|NCT01072149|592037030|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
164019328|NCT00769704|592433409|FG000|Overall Study|Other|1|||
164019329|NCT00769704|592433410|FG001|Overall Study|Other|2|||
164019330|NCT00520676|592433411|FG000|Overall Study|Death|84|||
164019331|NCT00520676|592433412|FG001|Overall Study|Death|81|||
164019332|NCT00520676|592433411|FG000|Overall Study|Lost to Follow-up|6|||
164019333|NCT00520676|592433412|FG001|Overall Study|Lost to Follow-up|10|||
164019334|NCT00520676|592433411|FG000|Overall Study|Physician Decision|4|||
164019335|NCT00520676|592433412|FG001|Overall Study|Physician Decision|1|||
164019336|NCT00520676|592433411|FG000|Overall Study|Withdrawal by Subject|7|||
164019337|NCT00520676|592433412|FG001|Overall Study|Withdrawal by Subject|11|||
164019338|NCT05131451|592433413|FG000|Overall Study|Protocol Violation|1|||
164019339|NCT05131451|592433414|FG001|Overall Study|Protocol Violation|0|||
164019340|NCT04426825|592433422|FG000|Overall Study|Death|17|||
164019341|NCT04426825|592433422|FG000|Overall Study|Lost to Follow-up|1|||
164019342|NCT04426825|592433422|FG000|Overall Study|Study terminated by sponsor|5|||
164019343|NCT03298412|592433430|FG000|Run-in Period|Other, Not Specified|1|||
164019344|NCT03298412|592433430|FG000|Run-in Period|Disease Progression|1|||
164019345|NCT03298412|592433430|FG000|Run-in Period|Ineligibility Determined|1|||
164019346|NCT03298412|592433430|FG000|Run-in Period|Decision by Sponsor|6|||
164019347|NCT03456713|592433433|FG000|Overall Study|Lost to Follow-up|1|||
164019348|NCT03456713|592433434|FG001|Overall Study|Lost to Follow-up|0|||
164019349|NCT03456713|592433435|FG002|Overall Study|Lost to Follow-up|0|||
164019350|NCT03456713|592433436|FG003|Overall Study|Lost to Follow-up|0|||
164019351|NCT01217190|592433443|FG000|Second Dosing|Withdrawal by Subject|0|||
164019352|NCT01217190|592433444|FG001|Second Dosing|Withdrawal by Subject|2|||
164019353|NCT03196297|592433445|FG000|Main Period|Withdrawal by Subject|4|||
164019354|NCT03196297|592433445|FG000|Extension Period|Withdrawal by Subject|1|||
164019355|NCT03196297|592433445|FG000|Extension Period|Lack of Efficacy|2|||
164019356|NCT02213198|592433448|FG000|Baseline|No show for intake|7|||
164019357|NCT02213198|592433449|FG001|Baseline|No show for intake|9|||
164019358|NCT02213198|592433448|FG000|Baseline|Withdrawal by Subject|34|||
164019359|NCT02213198|592433449|FG001|Baseline|Withdrawal by Subject|11|||
164019360|NCT02213198|592433448|FG000|Baseline|transferred out of clinic|7|||
163908607|NCT01072149|592037031|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908608|NCT01072149|592037032|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908609|NCT01072149|592037033|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908610|NCT01072149|592037034|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908611|NCT01072149|592037035|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
163908612|NCT01072149|592037036|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908613|NCT01072149|592037037|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
163908614|NCT01072149|592037020|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
163908615|NCT01072149|592037021|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
163908616|NCT01072149|592037022|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
163908617|NCT01072149|592037023|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
163908618|NCT01072149|592037024|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
163908619|NCT01072149|592037025|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
163908620|NCT01072149|592037026|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
163908621|NCT01072149|592037027|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
163908622|NCT01072149|592037028|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
163908623|NCT01072149|592037029|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
163908624|NCT01072149|592037030|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
163908625|NCT01072149|592037031|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
163908626|NCT01072149|592037032|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
163908627|NCT01072149|592037033|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
163908628|NCT01072149|592037034|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
163908629|NCT01072149|592037035|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
163908630|NCT01072149|592037036|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
163908631|NCT01072149|592037037|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
163908632|NCT01072149|592037020|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908633|NCT01072149|592037021|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908634|NCT01072149|592037022|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908635|NCT01072149|592037023|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908636|NCT01072149|592037024|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908637|NCT01072149|592037025|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908638|NCT01072149|592037026|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
164019361|NCT02213198|592433449|FG001|Baseline|transferred out of clinic|9|||
164019362|NCT02213198|592433448|FG000|Baseline|Lost to Follow-up|40|||
164019363|NCT02213198|592433449|FG001|Baseline|Lost to Follow-up|21|||
164019364|NCT02213198|592433448|FG000|Baseline|incarcerated,violent|0|||
164019365|NCT02213198|592433449|FG001|Baseline|incarcerated,violent|1|||
164019366|NCT02213198|592433448|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
164019367|NCT02213198|592433449|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
164019368|NCT02213198|592433448|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
164019369|NCT02213198|592433449|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
164019370|NCT02213198|592433448|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
164019371|NCT02213198|592433449|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
163908639|NCT01072149|592037027|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908640|NCT01072149|592037028|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908641|NCT01072149|592037029|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908642|NCT01072149|592037030|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908643|NCT01072149|592037031|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908644|NCT01072149|592037032|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
163908645|NCT01072149|592037033|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908646|NCT01072149|592037034|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908647|NCT01072149|592037035|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908648|NCT01072149|592037036|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908649|NCT01072149|592037037|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
163908650|NCT01072149|592037020|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908651|NCT01072149|592037021|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908652|NCT01072149|592037022|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
164019372|NCT02213198|592433448|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
164019373|NCT02213198|592433449|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
164094918|NCT01918397|592712233|FG003|Overall Study|Pregnancy|0|||
164094919|NCT01918397|592712230|FG000|Overall Study|Rifampin susceptible|0|||
164019374|NCT02213198|592433448|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
164144657|NCT01495702|592891746|FG001|Randomized Phase|Adverse Event|2|||
164094920|NCT01918397|592712231|FG001|Overall Study|Rifampin susceptible|0|||
164094921|NCT01918397|592712232|FG002|Overall Study|Rifampin susceptible|0|||
164094922|NCT01918397|592712233|FG003|Overall Study|Rifampin susceptible|2|||
163908653|NCT01072149|592037023|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908654|NCT01072149|592037024|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908655|NCT01072149|592037025|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908656|NCT01072149|592037026|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908657|NCT01072149|592037027|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908658|NCT01072149|592037028|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908659|NCT01072149|592037029|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908660|NCT01072149|592037030|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908661|NCT01072149|592037031|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908662|NCT01072149|592037032|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908663|NCT01072149|592037033|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
163908664|NCT01072149|592037034|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908665|NCT01072149|592037035|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908666|NCT01072149|592037036|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908667|NCT01072149|592037037|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
163908668|NCT01768572|592037038|FG000|Overall Study|Adverse Event|7|||
163908669|NCT01768572|592037039|FG001|Overall Study|Adverse Event|8|||
163908670|NCT01768572|592037040|FG002|Overall Study|Adverse Event|4|||
163908671|NCT01768572|592037038|FG000|Overall Study|Lack of Efficacy|1|||
163908672|NCT01768572|592037039|FG001|Overall Study|Lack of Efficacy|3|||
163908673|NCT01768572|592037040|FG002|Overall Study|Lack of Efficacy|1|||
163908674|NCT01768572|592037038|FG000|Overall Study|Other, Not due to an adverse event|1|||
163908675|NCT01768572|592037039|FG001|Overall Study|Other, Not due to an adverse event|1|||
163908676|NCT01768572|592037040|FG002|Overall Study|Other, Not due to an adverse event|1|||
163908677|NCT04766996|592037043|FG000|Overall Study|Withdrawal by Subject|1|||
163908678|NCT04766996|592037044|FG001|Overall Study|Withdrawal by Subject|0|||
163908679|NCT04766996|592037045|FG002|Overall Study|Withdrawal by Subject|13|||
163908680|NCT01322386|592037046|FG000|Overall Study|Protocol Violation|0|||
163908681|NCT01322386|592037047|FG001|Overall Study|Protocol Violation|1|||
163908682|NCT01322386|592037046|FG000|Overall Study|Physician Decision|0|||
163908683|NCT01322386|592037047|FG001|Overall Study|Physician Decision|1|||
163908684|NCT01102426|592037048|FG000|Overall Study|Randomized but not treated|4|||
163908685|NCT01102426|592037049|FG001|Overall Study|Randomized but not treated|1|||
163908686|NCT01102426|592037048|FG000|Overall Study|Adverse Events (treatment-related)|15|||
163908687|NCT01102426|592037049|FG001|Overall Study|Adverse Events (treatment-related)|8|||
163908688|NCT01102426|592037048|FG000|Overall Study|Physician Decision|9|||
163908689|NCT01102426|592037049|FG001|Overall Study|Physician Decision|6|||
163908690|NCT01102426|592037048|FG000|Overall Study|Progressive Disease|85|||
163908691|NCT01102426|592037049|FG001|Overall Study|Progressive Disease|44|||
163908692|NCT01102426|592037048|FG000|Overall Study|Adverse Events (unrelated to|9|||
163908693|NCT01102426|592037049|FG001|Overall Study|Adverse Events (unrelated to|1|||
163908694|NCT01102426|592037048|FG000|Overall Study|Patient Refusal|24|||
163908695|NCT01102426|592037049|FG001|Overall Study|Patient Refusal|12|||
163908696|NCT01102426|592037048|FG000|Overall Study|Death (due to adverse events|0|||
163908697|NCT01102426|592037049|FG001|Overall Study|Death (due to adverse events|1|||
163908698|NCT01102426|592037048|FG000|Overall Study|Death (non-related to the study|19|||
163908699|NCT01102426|592037049|FG001|Overall Study|Death (non-related to the study|8|||
164094923|NCT01918397|592712230|FG000|Overall Study|Treatment failure|0|||
163908700|NCT00871494|592037050|FG000|Overall Study|Protocol Violation|5|||
163908701|NCT00871494|592037050|FG000|Overall Study|Lack of Efficacy|4|||
163908702|NCT00871494|592037050|FG000|Overall Study|Adverse Event|4|||
163908703|NCT00871494|592037050|FG000|Overall Study|Lost to Follow-up|1|||
164094924|NCT01918397|592712231|FG001|Overall Study|Treatment failure|0|||
163908704|NCT03265132|592037062|FG000|Overall Study|Adverse Event|0|||
163908705|NCT03265132|592037063|FG001|Overall Study|Adverse Event|1|||
163908706|NCT03265132|592037062|FG000|Overall Study|Lack of Efficacy|0|||
163908707|NCT03265132|592037063|FG001|Overall Study|Lack of Efficacy|2|||
163908708|NCT03265132|592037062|FG000|Overall Study|Progressive disease|0|||
163908709|NCT03265132|592037063|FG001|Overall Study|Progressive disease|2|||
163908710|NCT03265132|592037062|FG000|Overall Study|Withdrawal by Subject|0|||
163908711|NCT03265132|592037063|FG001|Overall Study|Withdrawal by Subject|1|||
163908712|NCT00681109|592037064|FG000|Overall Study|Lost to Follow-up|2|||
163908713|NCT00681109|592037065|FG001|Overall Study|Lost to Follow-up|6|||
164094925|NCT01918397|592712232|FG002|Overall Study|Treatment failure|0|||
164019375|NCT02213198|592433449|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
164019376|NCT02213198|592433448|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
164019377|NCT02213198|592433449|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
164019378|NCT01954121|592433450|FG000|Overall Study|Lack of Efficacy|94|||
164019379|NCT01954121|592433451|FG001|Overall Study|Lack of Efficacy|41|||
164019380|NCT01954121|592433450|FG000|Overall Study|Protocol Violation|0|||
164019381|NCT01954121|592433451|FG001|Overall Study|Protocol Violation|2|||
164019382|NCT01954121|592433450|FG000|Overall Study|Lost to Follow-up|5|||
164019383|NCT01954121|592433451|FG001|Overall Study|Lost to Follow-up|6|||
164019384|NCT01954121|592433450|FG000|Overall Study|Withdrawal by Subject|18|||
164019385|NCT01954121|592433451|FG001|Overall Study|Withdrawal by Subject|12|||
164019386|NCT01954121|592433450|FG000|Overall Study|Pregnancy|1|||
164019387|NCT01954121|592433451|FG001|Overall Study|Pregnancy|1|||
164019388|NCT01954121|592433450|FG000|Overall Study|AE, serious fatal|1|||
164019389|NCT01954121|592433451|FG001|Overall Study|AE, serious fatal|0|||
164019390|NCT01954121|592433450|FG000|Overall Study|AE, non-serious non-fatal|5|||
164019391|NCT01954121|592433451|FG001|Overall Study|AE, non-serious non-fatal|22|||
164019392|NCT01954121|592433450|FG000|Overall Study|SAE, non-fatal|1|||
164019393|NCT01954121|592433451|FG001|Overall Study|SAE, non-fatal|4|||
164019394|NCT01954121|592433450|FG000|Overall Study|Non-compliant with study procedures|1|||
164019395|NCT01954121|592433451|FG001|Overall Study|Non-compliant with study procedures|0|||
164019396|NCT01954121|592433450|FG000|Overall Study|Non-compliant patient|1|||
164019397|NCT01954121|592433451|FG001|Overall Study|Non-compliant patient|1|||
164019398|NCT01954121|592433450|FG000|Overall Study|Subject did not follow instructions|0|||
164019399|NCT01954121|592433451|FG001|Overall Study|Subject did not follow instructions|2|||
164019400|NCT00601523|592433452|FG000|Overall Study|Adverse Event|42|||
164019401|NCT00601523|592433453|FG001|Overall Study|Adverse Event|14|||
164019402|NCT00601523|592433452|FG000|Overall Study|Lack of Efficacy|3|||
164019403|NCT00601523|592433453|FG001|Overall Study|Lack of Efficacy|0|||
164019404|NCT00601523|592433452|FG000|Overall Study|Protocol Violation|5|||
164019405|NCT00601523|592433453|FG001|Overall Study|Protocol Violation|1|||
164019406|NCT00601523|592433452|FG000|Overall Study|Lost to Follow-up|0|||
164019407|NCT00601523|592433453|FG001|Overall Study|Lost to Follow-up|1|||
164019408|NCT00601523|592433452|FG000|Overall Study|Withdrawal by Subject|18|||
164019409|NCT00601523|592433453|FG001|Overall Study|Withdrawal by Subject|9|||
164019410|NCT00601523|592433452|FG000|Overall Study|Other|9|||
164019411|NCT00601523|592433453|FG001|Overall Study|Other|1|||
164019412|NCT01987986|592433456|FG000|Overall Study|Lost to Follow-up|1|||
164019413|NCT01987986|592433457|FG001|Overall Study|Lost to Follow-up|0|||
164019414|NCT01987986|592433458|FG002|Overall Study|Lost to Follow-up|0|||
164019415|NCT01987986|592433459|FG003|Overall Study|Lost to Follow-up|0|||
164019416|NCT01987986|592433456|FG000|Overall Study|Adverse Event|1|||
164094926|NCT01918397|592712233|FG003|Overall Study|Treatment failure|1|||
164094927|NCT01918397|592712230|FG000|Overall Study|Withdrawal by Subject|3|||
164094928|NCT01918397|592712231|FG001|Overall Study|Withdrawal by Subject|2|||
164094929|NCT01918397|592712232|FG002|Overall Study|Withdrawal by Subject|1|||
164094930|NCT01918397|592712233|FG003|Overall Study|Withdrawal by Subject|1|||
164094931|NCT01918397|592712230|FG000|Overall Study|XDR at baseline|0|||
164094932|NCT01918397|592712231|FG001|Overall Study|XDR at baseline|0|||
164094933|NCT01918397|592712232|FG002|Overall Study|XDR at baseline|1|||
164094934|NCT01918397|592712233|FG003|Overall Study|XDR at baseline|0|||
164094935|NCT01918397|592712230|FG000|Overall Study|Lost to Follow-up|2|||
164094936|NCT01918397|592712231|FG001|Overall Study|Lost to Follow-up|1|||
163908714|NCT00681109|592037066|FG002|Overall Study|Lost to Follow-up|0|||
163908715|NCT03259568|592037067|FG000|Overall Study|Participant performance was low|3|||
163908716|NCT03128099|592037070|FG000|Overall Study|High dose task was too long|0|||
164094937|NCT01918397|592712232|FG002|Overall Study|Lost to Follow-up|1|||
164094938|NCT01918397|592712233|FG003|Overall Study|Lost to Follow-up|1|||
163908717|NCT03128099|592037071|FG001|Overall Study|High dose task was too long|4|||
163908718|NCT03128099|592037072|FG002|Overall Study|High dose task was too long|0|||
163908719|NCT03128099|592037070|FG000|Overall Study|Participant got a full time job.|1|||
163908720|NCT03128099|592037071|FG001|Overall Study|Participant got a full time job.|0|||
164019417|NCT01987986|592433457|FG001|Overall Study|Adverse Event|0|||
164019418|NCT01987986|592433458|FG002|Overall Study|Adverse Event|2|||
164019419|NCT01987986|592433459|FG003|Overall Study|Adverse Event|0|||
164019420|NCT03342469|592433460|FG000|Overall Study|Withdrawal by Subject|0|||
164019421|NCT03342469|592433461|FG001|Overall Study|Withdrawal by Subject|1|||
164094939|NCT01918397|592712230|FG000|Overall Study|Increased QTc|1|||
164019422|NCT03342469|592433462|FG002|Overall Study|Withdrawal by Subject|0|||
164019423|NCT03342469|592433463|FG003|Overall Study|Withdrawal by Subject|0|||
164019424|NCT05515601|592433464|FG000|Overall Study|Withdrawal by Subject|1|||
164019425|NCT05515601|592433465|FG001|Overall Study|Withdrawal by Subject|3|||
164019426|NCT05515601|592433466|FG002|Overall Study|Withdrawal by Subject|2|||
164094940|NCT01918397|592712231|FG001|Overall Study|Increased QTc|0|||
163908721|NCT03128099|592037072|FG002|Overall Study|Participant got a full time job.|0|||
164094941|NCT01918397|592712232|FG002|Overall Study|Increased QTc|0|||
164094942|NCT01918397|592712233|FG003|Overall Study|Increased QTc|1|||
164094943|NCT01918397|592712230|FG000|Overall Study|Death|0|||
163908722|NCT03128099|592037070|FG000|Overall Study|Became homeless and lost contact|1|||
163908723|NCT03128099|592037071|FG001|Overall Study|Became homeless and lost contact|0|||
163908724|NCT03128099|592037072|FG002|Overall Study|Became homeless and lost contact|0|||
163908725|NCT03128099|592037070|FG000|Overall Study|Did not complete all the assessments|0|||
163908726|NCT03128099|592037071|FG001|Overall Study|Did not complete all the assessments|0|||
163908727|NCT03128099|592037072|FG002|Overall Study|Did not complete all the assessments|1|||
163908728|NCT00148122|592037073|FG000|Overall Study|Withdrawal by Subject|2|||
163908729|NCT00721734|592037074|FG000|Overall Study|Progressive Disease|3|||
163908730|NCT00721734|592037075|FG001|Overall Study|Progressive Disease|10|||
163908731|NCT00721734|592037076|FG002|Overall Study|Progressive Disease|4|||
163908732|NCT00721734|592037077|FG003|Overall Study|Progressive Disease|5|||
163908733|NCT00721734|592037078|FG004|Overall Study|Progressive Disease|2|||
163908734|NCT00721734|592037074|FG000|Overall Study|Adverse Event|3|||
163908735|NCT00721734|592037075|FG001|Overall Study|Adverse Event|1|||
163908736|NCT00721734|592037076|FG002|Overall Study|Adverse Event|4|||
163908737|NCT00721734|592037077|FG003|Overall Study|Adverse Event|0|||
163908738|NCT00721734|592037078|FG004|Overall Study|Adverse Event|3|||
163908739|NCT00721734|592037074|FG000|Overall Study|Withdrawal by Subject|2|||
163908740|NCT00721734|592037075|FG001|Overall Study|Withdrawal by Subject|1|||
163908741|NCT00721734|592037076|FG002|Overall Study|Withdrawal by Subject|0|||
163908742|NCT00721734|592037077|FG003|Overall Study|Withdrawal by Subject|0|||
163908743|NCT00721734|592037078|FG004|Overall Study|Withdrawal by Subject|1|||
163908744|NCT00721734|592037074|FG000|Overall Study|Other|0|||
163908745|NCT00721734|592037075|FG001|Overall Study|Other|0|||
163908746|NCT00721734|592037076|FG002|Overall Study|Other|0|||
163908747|NCT00721734|592037077|FG003|Overall Study|Other|1|||
163908748|NCT00721734|592037078|FG004|Overall Study|Other|0|||
163908749|NCT02251652|592037079|FG000|Overall Study|Withdrawal by Subject|1|||
163908750|NCT04492475|592037080|FG000|Overall Study|Enrolled but not treated|8|||
163908751|NCT04492475|592037081|FG001|Overall Study|Enrolled but not treated|8|||
163908752|NCT04492475|592037080|FG000|Overall Study|Withdrawal by Subject|4|||
163908753|NCT04492475|592037081|FG001|Overall Study|Withdrawal by Subject|0|||
163908754|NCT04492475|592037080|FG000|Overall Study|Became ineligible after enrollment|2|||
163908755|NCT04492475|592037081|FG001|Overall Study|Became ineligible after enrollment|0|||
163908756|NCT03035942|592037086|FG000|Overall Study|Adverse Event|8|||
163908757|NCT03035942|592037087|FG001|Overall Study|Adverse Event|4|||
163908758|NCT03035942|592037088|FG002|Overall Study|Adverse Event|5|||
163908759|NCT05270460|592037089|FG000|Overall Study|Adverse Event|0|||
163908760|NCT05270460|592037090|FG001|Overall Study|Adverse Event|1|||
163908761|NCT05270460|592037091|FG002|Overall Study|Adverse Event|0|||
163908762|NCT05270460|592037089|FG000|Overall Study|Early Termination|0|||
163908763|NCT05270460|592037090|FG001|Overall Study|Early Termination|1|||
164019427|NCT05515601|592433467|FG003|Overall Study|Withdrawal by Subject|1|||
164019428|NCT05515601|592433468|FG004|Overall Study|Withdrawal by Subject|1|||
164019429|NCT05515601|592433469|FG005|Overall Study|Withdrawal by Subject|1|||
164019430|NCT05515601|592433464|FG000|Overall Study|Lost to Follow-up|0|||
164019431|NCT05515601|592433465|FG001|Overall Study|Lost to Follow-up|0|||
164019432|NCT05515601|592433466|FG002|Overall Study|Lost to Follow-up|0|||
164019433|NCT05515601|592433467|FG003|Overall Study|Lost to Follow-up|0|||
164019434|NCT05515601|592433468|FG004|Overall Study|Lost to Follow-up|1|||
164019435|NCT05515601|592433469|FG005|Overall Study|Lost to Follow-up|0|||
164019436|NCT02928406|592433470|FG000|Overall Study|Death|780|||
164019437|NCT02928406|592433470|FG000|Overall Study|Progressive disease|3|||
164019438|NCT02928406|592433470|FG000|Overall Study|Lost to Follow-up|49|||
164019439|NCT02928406|592433470|FG000|Overall Study|Non-compliance|2|||
164019440|NCT02928406|592433470|FG000|Overall Study|Withdrawal by Subject|40|||
164019441|NCT02928406|592433470|FG000|Overall Study|Study terminated by sponsor|57|||
164019442|NCT02928406|592433470|FG000|Overall Study|Physician Decision|1|||
164019443|NCT02928406|592433470|FG000|Overall Study|Various reasons|72|||
164019444|NCT01745393|592433471|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
164019445|NCT01745393|592433472|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
164019446|NCT01745393|592433471|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
164019447|NCT01745393|592433472|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
164019448|NCT01745393|592433471|FG000|12-month Follow-up|Lost to Follow-up|6|||
164019449|NCT01745393|592433472|FG001|12-month Follow-up|Lost to Follow-up|5|||
164019450|NCT02678780|592433474|FG000|Overall Study|Adverse Event|11|||
164019451|NCT02678780|592433475|FG001|Overall Study|Adverse Event|14|||
164019452|NCT02678780|592433474|FG000|Overall Study|Withdrawal by Subject|2|||
164019453|NCT02678780|592433475|FG001|Overall Study|Withdrawal by Subject|1|||
164019454|NCT02678780|592433474|FG000|Overall Study|Sponsor discontinuation|7|||
164019455|NCT02678780|592433475|FG001|Overall Study|Sponsor discontinuation|4|||
164019456|NCT02678780|592433474|FG000|Overall Study|Death|1|||
164019457|NCT02678780|592433475|FG001|Overall Study|Death|1|||
164019458|NCT02678780|592433474|FG000|Overall Study|Other|6|||
164019459|NCT02678780|592433475|FG001|Overall Study|Other|8|||
164019460|NCT01064648|592433488|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
164019461|NCT01064648|592433489|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
164019462|NCT01064648|592433490|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
164019463|NCT01064648|592433491|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
164019464|NCT01064648|592433488|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
164019465|NCT01064648|592433489|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
164019466|NCT01064648|592433490|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
164019467|NCT01064648|592433491|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
164019468|NCT01064648|592433488|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
164019469|NCT01064648|592433489|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
164019470|NCT01064648|592433490|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
164019471|NCT01064648|592433491|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
164019472|NCT01064648|592433488|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
164019473|NCT01064648|592433489|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
164019474|NCT01064648|592433490|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
164019475|NCT01064648|592433491|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
164019476|NCT01064648|592433488|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
164019477|NCT01064648|592433489|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
164019478|NCT01064648|592433490|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
164019479|NCT01064648|592433491|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
164019480|NCT01064648|592433488|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
164019481|NCT01064648|592433489|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
164019482|NCT01064648|592433490|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
164019483|NCT01064648|592433491|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
164019484|NCT01064648|592433488|FG000|Phase II|Adverse Event|0|||
164019485|NCT01064648|592433489|FG001|Phase II|Adverse Event|0|||
164019486|NCT01064648|592433490|FG002|Phase II|Adverse Event|15|||
164019487|NCT01064648|592433491|FG003|Phase II|Adverse Event|8|||
164019488|NCT01064648|592433488|FG000|Phase II|Death|0|||
164019489|NCT01064648|592433489|FG001|Phase II|Death|0|||
164019490|NCT01064648|592433490|FG002|Phase II|Death|4|||
164019491|NCT01064648|592433491|FG003|Phase II|Death|5|||
164019492|NCT01064648|592433488|FG000|Phase II|Withdrawal by Subject|0|||
164019493|NCT01064648|592433489|FG001|Phase II|Withdrawal by Subject|0|||
164019494|NCT01064648|592433490|FG002|Phase II|Withdrawal by Subject|2|||
164019495|NCT01064648|592433491|FG003|Phase II|Withdrawal by Subject|5|||
164019496|NCT01064648|592433488|FG000|Phase II|Progression|0|||
164019497|NCT01064648|592433489|FG001|Phase II|Progression|0|||
164019498|NCT01064648|592433490|FG002|Phase II|Progression|21|||
164019499|NCT01064648|592433491|FG003|Phase II|Progression|27|||
164019500|NCT01064648|592433488|FG000|Phase II|Non-protocol specified|0|||
164019501|NCT01064648|592433489|FG001|Phase II|Non-protocol specified|0|||
164019502|NCT01064648|592433490|FG002|Phase II|Non-protocol specified|5|||
164019503|NCT01064648|592433491|FG003|Phase II|Non-protocol specified|3|||
164019504|NCT01064648|592433488|FG000|Phase II|Under Review|0|||
164019505|NCT01064648|592433489|FG001|Phase II|Under Review|0|||
164019506|NCT01064648|592433490|FG002|Phase II|Under Review|2|||
164019507|NCT01064648|592433491|FG003|Phase II|Under Review|0|||
164019508|NCT05513391|592433492|FG000|Overall Study|Adverse Event|1|||
164019509|NCT05513391|592433493|FG001|Overall Study|Adverse Event|0|||
164019510|NCT05513391|592433492|FG000|Overall Study|Protocol Deviation|0|||
164019511|NCT05513391|592433493|FG001|Overall Study|Protocol Deviation|1|||
164019512|NCT05513391|592433492|FG000|Overall Study|Withdrawal by Subject|3|||
164019513|NCT05513391|592433493|FG001|Overall Study|Withdrawal by Subject|1|||
164019514|NCT05513391|592433492|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164019515|NCT05513391|592433493|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164019516|NCT05513391|592433492|FG000|Overall Study|Lost to Follow-up|0|||
164019517|NCT05513391|592433493|FG001|Overall Study|Lost to Follow-up|2|||
164019518|NCT02429427|592433494|FG000|Overall Study|Adverse Event|220|||
164019519|NCT02429427|592433495|FG001|Overall Study|Adverse Event|92|||
164019520|NCT02429427|592433494|FG000|Overall Study|Protocol Violation|10|||
164019521|NCT02429427|592433495|FG001|Overall Study|Protocol Violation|6|||
164019522|NCT02429427|592433494|FG000|Overall Study|Lost to Follow-up|15|||
164019523|NCT02429427|592433495|FG001|Overall Study|Lost to Follow-up|6|||
164019524|NCT02429427|592433494|FG000|Overall Study|Withdrawal by Subject|64|||
164019525|NCT02429427|592433495|FG001|Overall Study|Withdrawal by Subject|34|||
164019526|NCT02429427|592433494|FG000|Overall Study|Other|62|||
164019527|NCT02429427|592433495|FG001|Overall Study|Other|41|||
164019528|NCT00719732|592433496|FG000|Overall Study|Lost to Follow-up|20|||
164019529|NCT00719732|592433496|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
164019530|NCT00719732|592433496|FG000|Overall Study|Illness not associated with device|1|||
164019531|NCT00309777|592433501|FG000|Overall Study|Adverse Event|13|||
164019532|NCT00309777|592433502|FG001|Overall Study|Adverse Event|2|||
164019533|NCT00309777|592433503|FG002|Overall Study|Adverse Event|8|||
164019534|NCT00309777|592433504|FG003|Overall Study|Adverse Event|1|||
164019535|NCT00309777|592433501|FG000|Overall Study|Protocol Violation|4|||
164019536|NCT00309777|592433502|FG001|Overall Study|Protocol Violation|1|||
164019537|NCT00309777|592433503|FG002|Overall Study|Protocol Violation|3|||
164019538|NCT00309777|592433504|FG003|Overall Study|Protocol Violation|1|||
164019539|NCT00309777|592433501|FG000|Overall Study|Withdrawal by Subject|6|||
164019540|NCT00309777|592433502|FG001|Overall Study|Withdrawal by Subject|5|||
164019541|NCT00309777|592433503|FG002|Overall Study|Withdrawal by Subject|7|||
164019542|NCT00309777|592433504|FG003|Overall Study|Withdrawal by Subject|2|||
164019543|NCT00309777|592433501|FG000|Overall Study|Lost to Follow-up|0|||
164019544|NCT00309777|592433502|FG001|Overall Study|Lost to Follow-up|0|||
164019545|NCT00309777|592433503|FG002|Overall Study|Lost to Follow-up|1|||
164019546|NCT00309777|592433504|FG003|Overall Study|Lost to Follow-up|0|||
164019547|NCT00309777|592433501|FG000|Overall Study|Death|0|||
164019548|NCT00309777|592433502|FG001|Overall Study|Death|1|||
164019549|NCT00309777|592433503|FG002|Overall Study|Death|0|||
164019550|NCT00309777|592433504|FG003|Overall Study|Death|0|||
164019551|NCT02361762|592435860|FG000|Overall Study|Withdrawal by Subject|0|||
164019552|NCT02361762|592435861|FG001|Overall Study|Withdrawal by Subject|1|||
164019553|NCT02361762|592435860|FG000|Overall Study|Lost to Follow-up|0|||
164019554|NCT02361762|592435861|FG001|Overall Study|Lost to Follow-up|1|||
164019555|NCT00948818|592435863|FG000|Overall Study|Adverse Event|10|||
164019556|NCT00948818|592435864|FG001|Overall Study|Adverse Event|32|||
164019557|NCT00948818|592435863|FG000|Overall Study|Protocol Violation|9|||
164019558|NCT00948818|592435864|FG001|Overall Study|Protocol Violation|10|||
164019559|NCT00948818|592435863|FG000|Overall Study|Withdrawal by Subject|25|||
164019560|NCT00948818|592435864|FG001|Overall Study|Withdrawal by Subject|25|||
164019561|NCT00948818|592435863|FG000|Overall Study|Lost to Follow-up|10|||
164019562|NCT00948818|592435864|FG001|Overall Study|Lost to Follow-up|17|||
164019563|NCT00948818|592435863|FG000|Overall Study|Lack of Efficacy|4|||
164019564|NCT00948818|592435864|FG001|Overall Study|Lack of Efficacy|5|||
164019565|NCT00948818|592435863|FG000|Overall Study|Other Reason|4|||
164019566|NCT00948818|592435864|FG001|Overall Study|Other Reason|5|||
164019567|NCT00745368|592435865|FG000|Overall Study|Unable to provide sample|3|||
164019568|NCT02364947|592435868|FG000|Overall Study|Withdrawal by Subject|10|||
164019569|NCT02364947|592435869|FG001|Overall Study|Withdrawal by Subject|8|||
164019570|NCT02364947|592435870|FG002|Overall Study|Withdrawal by Subject|9|||
164019571|NCT02364947|592435868|FG000|Overall Study|Adverse Event|45|||
164019572|NCT02364947|592435869|FG001|Overall Study|Adverse Event|33|||
164019573|NCT02364947|592435870|FG002|Overall Study|Adverse Event|11|||
164019574|NCT02364947|592435868|FG000|Overall Study|Protocol Violation|1|||
164019575|NCT02364947|592435869|FG001|Overall Study|Protocol Violation|1|||
164019576|NCT02364947|592435870|FG002|Overall Study|Protocol Violation|1|||
164019577|NCT02364947|592435868|FG000|Overall Study|Physician Decision|3|||
164019578|NCT02364947|592435869|FG001|Overall Study|Physician Decision|2|||
164019579|NCT02364947|592435870|FG002|Overall Study|Physician Decision|5|||
164019580|NCT02364947|592435868|FG000|Overall Study|Death|0|||
164019581|NCT02364947|592435869|FG001|Overall Study|Death|1|||
164019582|NCT02364947|592435870|FG002|Overall Study|Death|0|||
164094944|NCT01918397|592712231|FG001|Overall Study|Death|0|||
164094945|NCT01918397|592712232|FG002|Overall Study|Death|1|||
164094946|NCT01918397|592712233|FG003|Overall Study|Death|0|||
164019583|NCT02702518|592435871|FG000|Overall Study|Lost to Follow-up|3|||
164019584|NCT02702518|592435872|FG001|Overall Study|Lost to Follow-up|4|||
164019585|NCT00853489|592435873|FG000|Overall Study|Lost to Follow-up|5|||
164019586|NCT00853489|592435874|FG001|Overall Study|Lost to Follow-up|2|||
164019587|NCT01251276|592435876|FG000|Overall Study|Protocol Violation|1|||
163908764|NCT05270460|592037091|FG002|Overall Study|Early Termination|0|||
163908765|NCT03205488|592037092|FG000|Overall Study|Adverse Event|1|||
163908766|NCT03205488|592037093|FG001|Overall Study|Adverse Event|2|||
163908767|NCT03205488|592037094|FG002|Overall Study|Adverse Event|4|||
163908768|NCT03205488|592037092|FG000|Overall Study|Protocol Violation|0|||
163908769|NCT03205488|592037093|FG001|Overall Study|Protocol Violation|0|||
163908770|NCT03205488|592037094|FG002|Overall Study|Protocol Violation|1|||
163908771|NCT05163353|592037097|FG000|Overall Study|Adverse Event|1|||
163908772|NCT05163353|592037098|FG001|Overall Study|Adverse Event|0|||
163908773|NCT05163353|592037097|FG000|Overall Study|Withdrawal by Subject|21|||
163908774|NCT05163353|592037098|FG001|Overall Study|Withdrawal by Subject|6|||
163908775|NCT05163353|592037097|FG000|Overall Study|Protocol Violation|0|||
163908776|NCT05163353|592037098|FG001|Overall Study|Protocol Violation|1|||
163908777|NCT05163353|592037097|FG000|Overall Study|Lost to Follow-up|13|||
163908778|NCT05163353|592037098|FG001|Overall Study|Lost to Follow-up|2|||
163908779|NCT06086028|592037100|FG000|Overall Study|Withdrawal by Subject|1|||
164019588|NCT01251276|592435877|FG001|Overall Study|Protocol Violation|0|||
164019589|NCT01251276|592435876|FG000|Overall Study|Lost to Follow-up|0|||
164019590|NCT01251276|592435877|FG001|Overall Study|Lost to Follow-up|1|||
164019591|NCT01725152|592435879|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
164019592|NCT01725152|592435880|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
163908780|NCT06086028|592037101|FG001|Overall Study|Withdrawal by Subject|1|||
163908781|NCT06086028|592037100|FG000|Overall Study|Lost to Follow-up|2|||
164019593|NCT01725152|592435879|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
164019594|NCT01725152|592435880|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
164019595|NCT01725152|592435879|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
164019596|NCT01725152|592435880|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
164019597|NCT01725152|592435879|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
164019598|NCT01725152|592435880|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
164019599|NCT02420223|592435883|FG000|Overall Study|Adverse Event|1|||
164019600|NCT02420223|592435884|FG001|Overall Study|Adverse Event|0|||
164019601|NCT02420223|592435883|FG000|Overall Study|Physician Decision|0|||
164019602|NCT02420223|592435884|FG001|Overall Study|Physician Decision|2|||
164019603|NCT01826422|592435885|FG000|Overall Study|Withdrawal by Subject|1|||
164019604|NCT01826422|592435886|FG001|Overall Study|Withdrawal by Subject|3|||
164019605|NCT04263142|592435887|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164019606|NCT04263142|592435888|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164019607|NCT04263142|592435889|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164019608|NCT04263142|592435890|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
164019609|NCT04263142|592435891|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
164019610|NCT04263142|592435887|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164019611|NCT04263142|592435888|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164019612|NCT04263142|592435889|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164019613|NCT04263142|592435890|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
164019614|NCT04263142|592435891|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
164019615|NCT03010423|592435893|FG000|Overall Study|Study termination|8|||
164019616|NCT03484923|592435898|FG000|Overall Study|Adverse Event|3|||
164019617|NCT03484923|592435899|FG001|Overall Study|Adverse Event|3|||
164019618|NCT03484923|592435900|FG002|Overall Study|Adverse Event|5|||
164019619|NCT03484923|592435901|FG003|Overall Study|Adverse Event|11|||
164019620|NCT03484923|592435902|FG004|Overall Study|Adverse Event|1|||
164019621|NCT03484923|592435898|FG000|Overall Study|Death|2|||
164019622|NCT03484923|592435899|FG001|Overall Study|Death|2|||
164019623|NCT03484923|592435900|FG002|Overall Study|Death|3|||
164019624|NCT03484923|592435901|FG003|Overall Study|Death|0|||
164019625|NCT03484923|592435902|FG004|Overall Study|Death|1|||
164019626|NCT03484923|592435898|FG000|Overall Study|Physician Decision|6|||
164019627|NCT03484923|592435899|FG001|Overall Study|Physician Decision|7|||
163908782|NCT06086028|592037101|FG001|Overall Study|Lost to Follow-up|3|||
163908783|NCT00824408|592037102|FG000|Run-in Phase|Progressive disease|4|||
163908784|NCT00824408|592037103|FG001|Run-in Phase|Progressive disease|4|||
163908785|NCT00824408|592037104|FG002|Run-in Phase|Progressive disease|0|||
163908786|NCT00824408|592037105|FG003|Run-in Phase|Progressive disease|0|||
163908787|NCT00824408|592037106|FG004|Run-in Phase|Progressive disease|0|||
163908788|NCT00824408|592037102|FG000|Run-in Phase|Adverse Event|1|||
163908789|NCT00824408|592037103|FG001|Run-in Phase|Adverse Event|1|||
163908790|NCT00824408|592037104|FG002|Run-in Phase|Adverse Event|0|||
163908791|NCT00824408|592037105|FG003|Run-in Phase|Adverse Event|0|||
163908792|NCT00824408|592037106|FG004|Run-in Phase|Adverse Event|0|||
163908793|NCT00824408|592037102|FG000|Run-in Phase|Refused to continue medication|1|||
164019628|NCT03484923|592435900|FG002|Overall Study|Physician Decision|6|||
164019629|NCT03484923|592435901|FG003|Overall Study|Physician Decision|3|||
164019630|NCT03484923|592435902|FG004|Overall Study|Physician Decision|2|||
164019631|NCT03484923|592435898|FG000|Overall Study|Progressive disease|33|||
164019632|NCT03484923|592435899|FG001|Overall Study|Progressive disease|28|||
164019633|NCT03484923|592435900|FG002|Overall Study|Progressive disease|26|||
164019634|NCT03484923|592435901|FG003|Overall Study|Progressive disease|30|||
164019635|NCT03484923|592435902|FG004|Overall Study|Progressive disease|16|||
164019636|NCT03484923|592435898|FG000|Overall Study|Subject Decision|1|||
164019637|NCT03484923|592435899|FG001|Overall Study|Subject Decision|3|||
164019638|NCT03484923|592435900|FG002|Overall Study|Subject Decision|3|||
164019639|NCT03484923|592435901|FG003|Overall Study|Subject Decision|0|||
164019640|NCT03484923|592435902|FG004|Overall Study|Subject Decision|1|||
164094947|NCT01918397|592712230|FG000|Overall Study|Involved in another investigative trial|0|||
164094948|NCT01918397|592712231|FG001|Overall Study|Involved in another investigative trial|0|||
164019641|NCT03439748|592435903|FG000|Overall Study|Withdrawal by Subject|11|||
164019642|NCT03439748|592435904|FG001|Overall Study|Withdrawal by Subject|17|||
164019643|NCT01856595|592435905|FG000|Overall Study|Withdrawal by Subject|0|||
163908794|NCT00824408|592037103|FG001|Run-in Phase|Refused to continue medication|0|||
163908795|NCT00824408|592037104|FG002|Run-in Phase|Refused to continue medication|0|||
163908796|NCT00824408|592037105|FG003|Run-in Phase|Refused to continue medication|0|||
163908797|NCT00824408|592037106|FG004|Run-in Phase|Refused to continue medication|0|||
163908798|NCT00824408|592037102|FG000|Run-in Phase|Other reason not defined above|0|||
164019644|NCT01856595|592435906|FG001|Overall Study|Withdrawal by Subject|1|||
164019645|NCT01856595|592435907|FG002|Overall Study|Withdrawal by Subject|0|||
164019646|NCT01856595|592435908|FG003|Overall Study|Withdrawal by Subject|0|||
164019647|NCT01856595|592435909|FG004|Overall Study|Withdrawal by Subject|0|||
164019648|NCT01856595|592435910|FG005|Overall Study|Withdrawal by Subject|0|||
164019649|NCT01856595|592435911|FG006|Overall Study|Withdrawal by Subject|1|||
164019650|NCT01856595|592435912|FG007|Overall Study|Withdrawal by Subject|0|||
164019651|NCT01856595|592435913|FG008|Overall Study|Withdrawal by Subject|0|||
164019652|NCT01863849|592435916|FG000|Overall Study|Lost to Follow-up|1|||
164019653|NCT01863849|592435917|FG001|Overall Study|Lost to Follow-up|0|||
164019654|NCT04402008|592435920|FG000|Overall Study|Adverse Event|0|||
164019655|NCT04402008|592435921|FG001|Overall Study|Adverse Event|0|||
164019656|NCT04402008|592435922|FG002|Overall Study|Adverse Event|0|||
164019657|NCT04402008|592435923|FG003|Overall Study|Adverse Event|1|||
164019658|NCT04402008|592435924|FG004|Overall Study|Adverse Event|0|||
164019659|NCT04402008|592435925|FG005|Overall Study|Adverse Event|0|||
164019660|NCT04402008|592435926|FG006|Overall Study|Adverse Event|0|||
164019661|NCT04402008|592435920|FG000|Overall Study|Disease Progression|3|||
164019662|NCT04402008|592435921|FG001|Overall Study|Disease Progression|2|||
164019663|NCT04402008|592435922|FG002|Overall Study|Disease Progression|3|||
164019664|NCT04402008|592435923|FG003|Overall Study|Disease Progression|3|||
164019665|NCT04402008|592435924|FG004|Overall Study|Disease Progression|4|||
164019666|NCT04402008|592435925|FG005|Overall Study|Disease Progression|3|||
164019667|NCT04402008|592435926|FG006|Overall Study|Disease Progression|10|||
164019668|NCT04402008|592435920|FG000|Overall Study|Withdrawal by Subject|0|||
164019669|NCT04402008|592435921|FG001|Overall Study|Withdrawal by Subject|1|||
164019670|NCT04402008|592435922|FG002|Overall Study|Withdrawal by Subject|0|||
164019671|NCT04402008|592435923|FG003|Overall Study|Withdrawal by Subject|0|||
164019672|NCT04402008|592435924|FG004|Overall Study|Withdrawal by Subject|1|||
164019673|NCT04402008|592435925|FG005|Overall Study|Withdrawal by Subject|0|||
164019674|NCT04402008|592435926|FG006|Overall Study|Withdrawal by Subject|0|||
164019675|NCT04402008|592435920|FG000|Overall Study|Sponsor Decision|0|||
164019676|NCT04402008|592435921|FG001|Overall Study|Sponsor Decision|0|||
164019677|NCT04402008|592435922|FG002|Overall Study|Sponsor Decision|0|||
164019678|NCT04402008|592435923|FG003|Overall Study|Sponsor Decision|0|||
164019679|NCT04402008|592435924|FG004|Overall Study|Sponsor Decision|0|||
164019680|NCT04402008|592435925|FG005|Overall Study|Sponsor Decision|0|||
164019681|NCT04402008|592435926|FG006|Overall Study|Sponsor Decision|3|||
164019682|NCT04402008|592435920|FG000|Overall Study|Death|0|||
164019683|NCT04402008|592435921|FG001|Overall Study|Death|0|||
164019684|NCT04402008|592435922|FG002|Overall Study|Death|0|||
164019685|NCT04402008|592435923|FG003|Overall Study|Death|0|||
164019686|NCT04402008|592435924|FG004|Overall Study|Death|1|||
164019687|NCT04402008|592435925|FG005|Overall Study|Death|0|||
164019688|NCT04402008|592435926|FG006|Overall Study|Death|2|||
164019689|NCT04402008|592435920|FG000|Overall Study|Other|0|||
164019690|NCT04402008|592435921|FG001|Overall Study|Other|0|||
164019691|NCT04402008|592435922|FG002|Overall Study|Other|0|||
164019692|NCT04402008|592435923|FG003|Overall Study|Other|0|||
164019693|NCT04402008|592435924|FG004|Overall Study|Other|0|||
164019694|NCT04402008|592435925|FG005|Overall Study|Other|0|||
164019695|NCT04402008|592435926|FG006|Overall Study|Other|5|||
164019696|NCT00913978|592435927|FG000|Overall Study|Surgeon choice|1|||
164019697|NCT00913978|592435928|FG001|Overall Study|Surgeon choice|3|||
164019698|NCT04716933|592435929|FG000|Overall Study|Sponsor Decision|36|||
164019699|NCT04716933|592435930|FG001|Overall Study|Sponsor Decision|33|||
164019700|NCT04716933|592435929|FG000|Overall Study|Death|65|||
164019701|NCT04716933|592435930|FG001|Overall Study|Death|67|||
164019702|NCT01327651|592435931|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
164019703|NCT01327651|592435932|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
164019704|NCT01327651|592435933|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
164019705|NCT01327651|592435934|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
164019706|NCT01327651|592435935|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
164019707|NCT01327651|592435936|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
164019708|NCT01327651|592435937|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
164019709|NCT01327651|592435938|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
164019710|NCT01327651|592435939|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
164019711|NCT01327651|592435931|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
164019712|NCT01327651|592435932|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019713|NCT01327651|592435933|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019714|NCT01327651|592435934|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019715|NCT01327651|592435935|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019716|NCT01327651|592435936|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
163908799|NCT00824408|592037103|FG001|Run-in Phase|Other reason not defined above|1|||
163908800|NCT00824408|592037104|FG002|Run-in Phase|Other reason not defined above|0|||
163908801|NCT00824408|592037105|FG003|Run-in Phase|Other reason not defined above|0|||
163908802|NCT00824408|592037106|FG004|Run-in Phase|Other reason not defined above|0|||
163908803|NCT00824408|592037102|FG000|Randomized Phase|Not treated|0|||
163908804|NCT00824408|592037103|FG001|Randomized Phase|Not treated|0|||
163908805|NCT00824408|592037104|FG002|Randomized Phase|Not treated|1|||
163908806|NCT00824408|592037105|FG003|Randomized Phase|Not treated|1|||
163908807|NCT00824408|592037106|FG004|Randomized Phase|Not treated|1|||
163908808|NCT00824408|592037102|FG000|Randomized Phase|Progressive disease|0|||
163908809|NCT00824408|592037103|FG001|Randomized Phase|Progressive disease|0|||
163908810|NCT00824408|592037104|FG002|Randomized Phase|Progressive disease|25|||
163908811|NCT00824408|592037105|FG003|Randomized Phase|Progressive disease|36|||
163908812|NCT00824408|592037106|FG004|Randomized Phase|Progressive disease|34|||
163908813|NCT00824408|592037102|FG000|Randomized Phase|Adverse Event|0|||
163908814|NCT00824408|592037103|FG001|Randomized Phase|Adverse Event|0|||
163908815|NCT00824408|592037104|FG002|Randomized Phase|Adverse Event|4|||
163908816|NCT00824408|592037105|FG003|Randomized Phase|Adverse Event|5|||
163908817|NCT00824408|592037106|FG004|Randomized Phase|Adverse Event|5|||
163908818|NCT00824408|592037102|FG000|Randomized Phase|Refused to continue medication|0|||
163908819|NCT00824408|592037103|FG001|Randomized Phase|Refused to continue medication|0|||
163908820|NCT00824408|592037104|FG002|Randomized Phase|Refused to continue medication|2|||
163908821|NCT00824408|592037105|FG003|Randomized Phase|Refused to continue medication|2|||
163908822|NCT00824408|592037106|FG004|Randomized Phase|Refused to continue medication|2|||
163908823|NCT00824408|592037102|FG000|Randomized Phase|Other reason not defined above|0|||
163908824|NCT00824408|592037103|FG001|Randomized Phase|Other reason not defined above|0|||
164019717|NCT01327651|592435937|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019718|NCT01327651|592435938|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019719|NCT01327651|592435939|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
164019720|NCT01327651|592435931|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
164019721|NCT01327651|592435932|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
164019722|NCT01327651|592435933|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
164019723|NCT01327651|592435934|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
164019724|NCT01327651|592435935|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
164019725|NCT01327651|592435936|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
164019726|NCT01327651|592435937|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
164019727|NCT01327651|592435938|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
164019728|NCT01327651|592435939|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
164019729|NCT01327651|592435931|FG000|Post Study Follow-up|Lost to Follow-up|0|||
164144658|NCT01495702|592891745|FG000|Randomized Phase|Death|1|||
163908825|NCT00824408|592037104|FG002|Randomized Phase|Other reason not defined above|4|||
163908826|NCT00824408|592037105|FG003|Randomized Phase|Other reason not defined above|2|||
163908827|NCT00824408|592037106|FG004|Randomized Phase|Other reason not defined above|4|||
163908828|NCT01263496|592037113|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
163908829|NCT01263496|592037114|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908830|NCT01263496|592037115|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908831|NCT01263496|592037116|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908832|NCT01263496|592037117|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908833|NCT01263496|592037118|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908834|NCT01263496|592037119|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908835|NCT01263496|592037120|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908836|NCT01263496|592037121|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
163908837|NCT01263496|592037113|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908838|NCT01263496|592037114|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908839|NCT01263496|592037115|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908840|NCT01263496|592037116|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
163908841|NCT01263496|592037117|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
163908842|NCT01263496|592037118|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908843|NCT01263496|592037119|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908844|NCT01263496|592037120|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908845|NCT01263496|592037121|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
163908846|NCT01263496|592037113|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
163908847|NCT01263496|592037114|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
163908848|NCT01263496|592037115|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
163908849|NCT01263496|592037116|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
163908850|NCT01263496|592037117|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
163908851|NCT01263496|592037118|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
163908852|NCT01263496|592037119|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
163908853|NCT01263496|592037120|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
163908854|NCT01263496|592037121|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
163908855|NCT01263496|592037113|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908856|NCT01263496|592037114|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
163908857|NCT01263496|592037115|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908858|NCT01263496|592037116|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908859|NCT01263496|592037117|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908860|NCT01263496|592037118|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908861|NCT01263496|592037119|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908862|NCT01263496|592037120|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908863|NCT01263496|592037121|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
163908864|NCT01263496|592037113|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163908865|NCT01263496|592037114|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
164019730|NCT01327651|592435932|FG001|Post Study Follow-up|Lost to Follow-up|1|||
164019731|NCT01327651|592435933|FG002|Post Study Follow-up|Lost to Follow-up|1|||
163908866|NCT01263496|592037115|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163908867|NCT01263496|592037116|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163908868|NCT01263496|592037117|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
163908869|NCT01263496|592037118|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163908870|NCT01263496|592037119|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163908871|NCT01263496|592037120|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163908872|NCT01263496|592037121|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163908873|NCT01263496|592037113|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
163908874|NCT01263496|592037114|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
164019732|NCT01327651|592435934|FG003|Post Study Follow-up|Lost to Follow-up|0|||
163908875|NCT01263496|592037115|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
163908876|NCT01263496|592037116|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163908877|NCT01263496|592037117|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
163908878|NCT01263496|592037118|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163908879|NCT01263496|592037119|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163908880|NCT01263496|592037120|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163908881|NCT01263496|592037121|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163908882|NCT01263496|592037113|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908883|NCT01263496|592037114|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908884|NCT01263496|592037115|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908885|NCT01263496|592037116|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908886|NCT01263496|592037117|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908887|NCT01263496|592037118|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908888|NCT01263496|592037119|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908889|NCT01263496|592037120|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
163908890|NCT01263496|592037121|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163908891|NCT01218594|592037122|FG000|Overall Study|Death|1|||
163908892|NCT01218594|592037122|FG000|Overall Study|Withdrawal by Subject|3|||
163908893|NCT01218594|592037122|FG000|Overall Study|Adverse Event|2|||
163908894|NCT01218594|592037122|FG000|Overall Study|Physician Decision|6|||
163908895|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
163908896|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
163908897|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
163908898|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
163908899|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
163908900|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
163908901|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
163908902|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
163908903|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
163908904|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
163908905|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
163908906|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
163908907|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
163908908|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
163908909|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
163908910|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
163908911|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
163908912|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
163908913|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
163908914|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
163908915|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
163908916|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
163908917|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
163908918|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
163908919|NCT02203032|592037123|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
163908920|NCT02203032|592037124|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
163908921|NCT02203032|592037125|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
163908922|NCT02203032|592037126|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
163908923|NCT02203032|592037123|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
163908924|NCT02203032|592037124|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
163908925|NCT02203032|592037125|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
163908926|NCT02203032|592037126|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
163908927|NCT02203032|592037123|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
163908928|NCT02203032|592037124|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
163908929|NCT02203032|592037125|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
163908930|NCT02203032|592037126|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
163908931|NCT02203032|592037123|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
163908932|NCT02203032|592037124|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
163908933|NCT02203032|592037125|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
163908934|NCT02203032|592037126|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
163908935|NCT02203032|592037123|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
164019733|NCT01327651|592435935|FG004|Post Study Follow-up|Lost to Follow-up|0|||
164019734|NCT01327651|592435936|FG005|Post Study Follow-up|Lost to Follow-up|0|||
164019735|NCT01327651|592435937|FG006|Post Study Follow-up|Lost to Follow-up|4|||
164019736|NCT01327651|592435938|FG007|Post Study Follow-up|Lost to Follow-up|1|||
163908936|NCT02203032|592037124|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
163908937|NCT02203032|592037125|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
163908938|NCT02203032|592037126|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
163908939|NCT02203032|592037123|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
163908940|NCT02203032|592037124|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
163908941|NCT02203032|592037125|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
163908942|NCT02203032|592037126|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
163908943|NCT02241785|592037129|FG000|Overall Study|Sponsor Termination|43|||
163908944|NCT02241785|592037129|FG000|Overall Study|Withdrawal by Subject|1|||
163908945|NCT02241785|592037129|FG000|Overall Study|Lost to Follow-up|2|||
163908946|NCT02241785|592037129|FG000|Overall Study|Adverse Event|1|||
163908947|NCT05289037|592037132|FG000|Overall Study|Withdrawal by Subject|7|||
163908948|NCT05289037|592037133|FG001|Overall Study|Withdrawal by Subject|0|||
163908949|NCT05289037|592037134|FG002|Overall Study|Withdrawal by Subject|3|||
163908950|NCT05289037|592037135|FG003|Overall Study|Withdrawal by Subject|3|||
163908951|NCT05289037|592037136|FG004|Overall Study|Withdrawal by Subject|1|||
163908952|NCT05289037|592037137|FG005|Overall Study|Withdrawal by Subject|5|||
163908953|NCT05289037|592037138|FG006|Overall Study|Withdrawal by Subject|2|||
163908954|NCT05289037|592037139|FG007|Overall Study|Withdrawal by Subject|1|||
163908955|NCT05289037|592037140|FG008|Overall Study|Withdrawal by Subject|2|||
163908956|NCT05289037|592037141|FG009|Overall Study|Withdrawal by Subject|2|||
163908957|NCT05289037|592037142|FG010|Overall Study|Withdrawal by Subject|1|||
163908958|NCT05289037|592037143|FG011|Overall Study|Withdrawal by Subject|0|||
163908959|NCT05289037|592037144|FG012|Overall Study|Withdrawal by Subject|1|||
163908960|NCT05289037|592037145|FG013|Overall Study|Withdrawal by Subject|2|||
163908961|NCT05289037|592037146|FG014|Overall Study|Withdrawal by Subject|0|||
163908962|NCT05289037|592037147|FG015|Overall Study|Withdrawal by Subject|3|||
164019737|NCT01327651|592435939|FG008|Post Study Follow-up|Lost to Follow-up|2|||
163908963|NCT05289037|592037148|FG016|Overall Study|Withdrawal by Subject|3|||
163908964|NCT05289037|592037132|FG000|Overall Study|Lost to Follow-up|1|||
163908965|NCT05289037|592037133|FG001|Overall Study|Lost to Follow-up|4|||
163908966|NCT05289037|592037134|FG002|Overall Study|Lost to Follow-up|3|||
163908967|NCT05289037|592037135|FG003|Overall Study|Lost to Follow-up|3|||
163908968|NCT05289037|592037136|FG004|Overall Study|Lost to Follow-up|3|||
163908969|NCT05289037|592037137|FG005|Overall Study|Lost to Follow-up|2|||
163908970|NCT05289037|592037138|FG006|Overall Study|Lost to Follow-up|3|||
163908971|NCT05289037|592037139|FG007|Overall Study|Lost to Follow-up|2|||
163908972|NCT05289037|592037140|FG008|Overall Study|Lost to Follow-up|2|||
163908973|NCT05289037|592037141|FG009|Overall Study|Lost to Follow-up|1|||
163908974|NCT05289037|592037142|FG010|Overall Study|Lost to Follow-up|3|||
163908975|NCT05289037|592037143|FG011|Overall Study|Lost to Follow-up|4|||
163908976|NCT05289037|592037144|FG012|Overall Study|Lost to Follow-up|2|||
163908977|NCT05289037|592037145|FG013|Overall Study|Lost to Follow-up|7|||
163908978|NCT05289037|592037146|FG014|Overall Study|Lost to Follow-up|4|||
163908979|NCT05289037|592037147|FG015|Overall Study|Lost to Follow-up|6|||
163908980|NCT05289037|592037148|FG016|Overall Study|Lost to Follow-up|4|||
163908981|NCT05289037|592037132|FG000|Overall Study|Death|0|||
163908982|NCT05289037|592037133|FG001|Overall Study|Death|0|||
163908983|NCT05289037|592037134|FG002|Overall Study|Death|0|||
163908984|NCT05289037|592037135|FG003|Overall Study|Death|0|||
163908985|NCT05289037|592037136|FG004|Overall Study|Death|0|||
163908986|NCT05289037|592037137|FG005|Overall Study|Death|1|||
163908987|NCT05289037|592037138|FG006|Overall Study|Death|0|||
163908988|NCT05289037|592037139|FG007|Overall Study|Death|0|||
163908989|NCT05289037|592037140|FG008|Overall Study|Death|0|||
163908990|NCT05289037|592037141|FG009|Overall Study|Death|0|||
163908991|NCT05289037|592037142|FG010|Overall Study|Death|0|||
163908992|NCT05289037|592037143|FG011|Overall Study|Death|0|||
163908993|NCT05289037|592037144|FG012|Overall Study|Death|0|||
163908994|NCT05289037|592037145|FG013|Overall Study|Death|0|||
163908995|NCT05289037|592037146|FG014|Overall Study|Death|1|||
163908996|NCT05289037|592037147|FG015|Overall Study|Death|0|||
163908997|NCT05289037|592037148|FG016|Overall Study|Death|0|||
163908998|NCT05289037|592037132|FG000|Overall Study|Did not receive vaccine|0|||
163908999|NCT05289037|592037133|FG001|Overall Study|Did not receive vaccine|3|||
163909000|NCT05289037|592037134|FG002|Overall Study|Did not receive vaccine|0|||
163909001|NCT05289037|592037135|FG003|Overall Study|Did not receive vaccine|0|||
163909002|NCT05289037|592037136|FG004|Overall Study|Did not receive vaccine|1|||
163909003|NCT05289037|592037137|FG005|Overall Study|Did not receive vaccine|1|||
163909004|NCT05289037|592037138|FG006|Overall Study|Did not receive vaccine|1|||
163909005|NCT05289037|592037139|FG007|Overall Study|Did not receive vaccine|0|||
163909006|NCT05289037|592037140|FG008|Overall Study|Did not receive vaccine|0|||
163909007|NCT05289037|592037141|FG009|Overall Study|Did not receive vaccine|0|||
163909008|NCT05289037|592037142|FG010|Overall Study|Did not receive vaccine|0|||
163909009|NCT05289037|592037143|FG011|Overall Study|Did not receive vaccine|0|||
163909010|NCT05289037|592037144|FG012|Overall Study|Did not receive vaccine|0|||
163909011|NCT05289037|592037145|FG013|Overall Study|Did not receive vaccine|0|||
163909012|NCT05289037|592037146|FG014|Overall Study|Did not receive vaccine|1|||
163909013|NCT05289037|592037147|FG015|Overall Study|Did not receive vaccine|0|||
163909014|NCT05289037|592037148|FG016|Overall Study|Did not receive vaccine|0|||
163909015|NCT05289037|592037132|FG000|Overall Study|Unable to make last visit|0|||
163909016|NCT05289037|592037133|FG001|Overall Study|Unable to make last visit|0|||
163909017|NCT05289037|592037134|FG002|Overall Study|Unable to make last visit|1|||
163909018|NCT05289037|592037135|FG003|Overall Study|Unable to make last visit|0|||
163909019|NCT05289037|592037136|FG004|Overall Study|Unable to make last visit|0|||
163909020|NCT05289037|592037137|FG005|Overall Study|Unable to make last visit|0|||
163909021|NCT05289037|592037138|FG006|Overall Study|Unable to make last visit|0|||
163909022|NCT05289037|592037139|FG007|Overall Study|Unable to make last visit|0|||
163909023|NCT05289037|592037140|FG008|Overall Study|Unable to make last visit|0|||
163909024|NCT05289037|592037141|FG009|Overall Study|Unable to make last visit|0|||
163909025|NCT05289037|592037142|FG010|Overall Study|Unable to make last visit|0|||
163909026|NCT05289037|592037143|FG011|Overall Study|Unable to make last visit|0|||
163909027|NCT05289037|592037144|FG012|Overall Study|Unable to make last visit|0|||
163909028|NCT05289037|592037145|FG013|Overall Study|Unable to make last visit|0|||
163909029|NCT05289037|592037146|FG014|Overall Study|Unable to make last visit|0|||
163909030|NCT05289037|592037147|FG015|Overall Study|Unable to make last visit|0|||
163909031|NCT05289037|592037148|FG016|Overall Study|Unable to make last visit|0|||
163909032|NCT05289037|592037132|FG000|Overall Study|Protocol deviation|0|||
163909033|NCT05289037|592037133|FG001|Overall Study|Protocol deviation|0|||
163909034|NCT05289037|592037134|FG002|Overall Study|Protocol deviation|0|||
163909035|NCT05289037|592037135|FG003|Overall Study|Protocol deviation|0|||
163909036|NCT05289037|592037136|FG004|Overall Study|Protocol deviation|0|||
163909037|NCT05289037|592037137|FG005|Overall Study|Protocol deviation|0|||
163909038|NCT05289037|592037138|FG006|Overall Study|Protocol deviation|0|||
163909039|NCT05289037|592037139|FG007|Overall Study|Protocol deviation|0|||
163909040|NCT05289037|592037140|FG008|Overall Study|Protocol deviation|0|||
163909041|NCT05289037|592037141|FG009|Overall Study|Protocol deviation|0|||
163909042|NCT05289037|592037142|FG010|Overall Study|Protocol deviation|0|||
163909043|NCT05289037|592037143|FG011|Overall Study|Protocol deviation|0|||
163909044|NCT05289037|592037144|FG012|Overall Study|Protocol deviation|0|||
163909045|NCT05289037|592037145|FG013|Overall Study|Protocol deviation|0|||
163909046|NCT05289037|592037146|FG014|Overall Study|Protocol deviation|0|||
163909047|NCT05289037|592037147|FG015|Overall Study|Protocol deviation|1|||
163909048|NCT05289037|592037148|FG016|Overall Study|Protocol deviation|0|||
163909049|NCT04186247|592037149|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
163909050|NCT04186247|592037150|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163909051|NCT04186247|592037151|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163909052|NCT04186247|592037152|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163909053|NCT04186247|592037153|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
163909054|NCT04852978|592037154|FG000|Overall Study|Physician Decision|0|||
163909055|NCT04852978|592037155|FG001|Overall Study|Physician Decision|1|||
163909056|NCT04852978|592037156|FG002|Overall Study|Physician Decision|0|||
163909057|NCT04852978|592037157|FG003|Overall Study|Physician Decision|0|||
163909058|NCT04852978|592037158|FG004|Overall Study|Physician Decision|0|||
163909059|NCT04852978|592037159|FG005|Overall Study|Physician Decision|0|||
163909060|NCT04852978|592037160|FG006|Overall Study|Physician Decision|0|||
164019738|NCT03249792|592435940|FG000|Arms 1, 2, and 4|Death|1|||
164019739|NCT03249792|592435941|FG001|Arms 1, 2, and 4|Death|1|||
163909061|NCT04852978|592037161|FG007|Overall Study|Physician Decision|2|||
163909062|NCT04852978|592037162|FG008|Overall Study|Physician Decision|0|||
163909063|NCT04852978|592037154|FG000|Overall Study|Sponsor request|0|||
163909064|NCT04852978|592037155|FG001|Overall Study|Sponsor request|0|||
163909065|NCT04852978|592037156|FG002|Overall Study|Sponsor request|1|||
164019740|NCT03249792|592435942|FG002|Arms 1, 2, and 4|Death|0|||
163909066|NCT04852978|592037157|FG003|Overall Study|Sponsor request|0|||
163909067|NCT04852978|592037158|FG004|Overall Study|Sponsor request|0|||
163909068|NCT04852978|592037159|FG005|Overall Study|Sponsor request|0|||
163909069|NCT04852978|592037160|FG006|Overall Study|Sponsor request|0|||
163909070|NCT04852978|592037161|FG007|Overall Study|Sponsor request|0|||
163909071|NCT04852978|592037162|FG008|Overall Study|Sponsor request|0|||
163909072|NCT04852978|592037154|FG000|Overall Study|Death|0|||
163909073|NCT04852978|592037155|FG001|Overall Study|Death|0|||
163909074|NCT04852978|592037156|FG002|Overall Study|Death|0|||
163909075|NCT04852978|592037157|FG003|Overall Study|Death|0|||
163909076|NCT04852978|592037158|FG004|Overall Study|Death|0|||
163909077|NCT04852978|592037159|FG005|Overall Study|Death|0|||
163909078|NCT04852978|592037160|FG006|Overall Study|Death|1|||
163909079|NCT04852978|592037161|FG007|Overall Study|Death|0|||
163909080|NCT04852978|592037162|FG008|Overall Study|Death|0|||
163909081|NCT04852978|592037154|FG000|Overall Study|Lost to Follow-up|3|||
163909082|NCT04852978|592037155|FG001|Overall Study|Lost to Follow-up|2|||
163909083|NCT04852978|592037156|FG002|Overall Study|Lost to Follow-up|2|||
163909084|NCT04852978|592037157|FG003|Overall Study|Lost to Follow-up|0|||
164019741|NCT03249792|592435943|FG003|Arms 1, 2, and 4|Death|2|||
164019742|NCT03249792|592435944|FG004|Arms 1, 2, and 4|Death|3|||
164019743|NCT03249792|592435945|FG005|Arms 1, 2, and 4|Death|2|||
164019744|NCT03249792|592435946|FG006|Arms 1, 2, and 4|Death|2|||
164019745|NCT03249792|592435947|FG007|Arms 1, 2, and 4|Death|4|||
164019746|NCT03249792|592435948|FG008|Arms 1, 2, and 4|Death|2|||
164019747|NCT03249792|592435949|FG009|Arms 1, 2, and 4|Death|1|||
163909085|NCT04852978|592037158|FG004|Overall Study|Lost to Follow-up|2|||
163909086|NCT04852978|592037159|FG005|Overall Study|Lost to Follow-up|4|||
163909087|NCT04852978|592037160|FG006|Overall Study|Lost to Follow-up|1|||
163909088|NCT04852978|592037161|FG007|Overall Study|Lost to Follow-up|2|||
163909089|NCT04852978|592037162|FG008|Overall Study|Lost to Follow-up|2|||
163909090|NCT04852978|592037154|FG000|Overall Study|Withdrawal by Subject|4|||
163909091|NCT04852978|592037155|FG001|Overall Study|Withdrawal by Subject|2|||
164019748|NCT03249792|592435950|FG010|Arms 1, 2, and 4|Death|7|||
164019749|NCT03249792|592435951|FG011|Arms 1, 2, and 4|Death|7|||
163909092|NCT04852978|592037156|FG002|Overall Study|Withdrawal by Subject|2|||
163909093|NCT04852978|592037157|FG003|Overall Study|Withdrawal by Subject|1|||
163909094|NCT04852978|592037158|FG004|Overall Study|Withdrawal by Subject|5|||
163909095|NCT04852978|592037159|FG005|Overall Study|Withdrawal by Subject|3|||
163909096|NCT04852978|592037160|FG006|Overall Study|Withdrawal by Subject|2|||
163909097|NCT04852978|592037161|FG007|Overall Study|Withdrawal by Subject|2|||
163909098|NCT04852978|592037162|FG008|Overall Study|Withdrawal by Subject|1|||
163909099|NCT00535626|592038799|FG000|Overall Study|Death|15|||
163909100|NCT00535626|592038799|FG000|Overall Study|Lost to Follow-up|29|||
163909101|NCT00535626|592038799|FG000|Overall Study|Withdrawal by Subject|20|||
163909102|NCT00535626|592038799|FG000|Overall Study|Removal/revision of study component|8|||
163909103|NCT00535626|592038799|FG000|Overall Study|Subject terminated|31|||
163909104|NCT00535626|592038799|FG000|Overall Study|Unable to return|2|||
163909105|NCT04633200|592038800|FG000|Overall Study|Lost to Follow-up|3|||
163909106|NCT04633200|592038801|FG001|Overall Study|Lost to Follow-up|5|||
163909107|NCT04809623|592038802|FG000|Overall Study|Study Terminated by Sponsor|1|||
163909108|NCT04809623|592038803|FG001|Overall Study|Study Terminated by Sponsor|0|||
163909109|NCT01808534|592038804|FG000|Overall Study|Disease progression|3|||
163909110|NCT01808534|592038804|FG000|Overall Study|Physician Decision|1|||
163909111|NCT00638456|592038807|FG000|Overall Study|Withdrawal by Subject|6|||
163909112|NCT00638456|592038808|FG001|Overall Study|Withdrawal by Subject|2|||
163909113|NCT03236779|592038809|FG000|Overall Study|Lost to Follow-up|13|||
163909114|NCT03236779|592038810|FG001|Overall Study|Lost to Follow-up|21|||
163909115|NCT00929526|592038812|FG000|Overall Study|Withdrawal by Subject|1|||
163909116|NCT00929526|592038813|FG001|Overall Study|Withdrawal by Subject|11|||
163909117|NCT00929526|592038812|FG000|Overall Study|Lost to Follow-up|8|||
163909118|NCT00929526|592038813|FG001|Overall Study|Lost to Follow-up|12|||
163909119|NCT00929526|592038812|FG000|Overall Study|Other|8|||
163909120|NCT00929526|592038813|FG001|Overall Study|Other|6|||
163909121|NCT00578344|592038814|FG000|Overall Study|Insurance problems|1|||
163909122|NCT00578344|592038814|FG000|Overall Study|Graft failure|1|||
163909123|NCT02169414|592038815|FG000|Overall Study|Withdrawal by Subject|1|||
163909124|NCT02169414|592038816|FG001|Overall Study|Withdrawal by Subject|0|||
163909125|NCT02169414|592038817|FG002|Overall Study|Withdrawal by Subject|0|||
163909126|NCT02169414|592038818|FG003|Overall Study|Withdrawal by Subject|0|||
163909127|NCT02169414|592038815|FG000|Overall Study|Adverse Event|0|||
163909128|NCT02169414|592038816|FG001|Overall Study|Adverse Event|1|||
163909129|NCT02169414|592038817|FG002|Overall Study|Adverse Event|0|||
163909130|NCT02169414|592038818|FG003|Overall Study|Adverse Event|0|||
163909131|NCT03374254|592038821|FG000|Overall Study|Death|5|||
163909132|NCT03374254|592038822|FG001|Overall Study|Death|16|||
163909133|NCT03374254|592038823|FG002|Overall Study|Death|13|||
163909134|NCT03374254|592038824|FG003|Overall Study|Death|11|||
163909135|NCT03374254|592038825|FG004|Overall Study|Death|9|||
163909136|NCT03374254|592038826|FG005|Overall Study|Death|12|||
163909137|NCT03374254|592038827|FG006|Overall Study|Death|11|||
163909138|NCT03374254|592038828|FG007|Overall Study|Death|6|||
163909139|NCT03374254|592038829|FG008|Overall Study|Death|7|||
163909140|NCT03374254|592038821|FG000|Overall Study|Lost to Follow-up|0|||
164019750|NCT03249792|592435952|FG012|Arms 1, 2, and 4|Death|12|||
164019751|NCT03249792|592435953|FG013|Arms 1, 2, and 4|Death|7|||
164019752|NCT03249792|592435954|FG014|Arms 1, 2, and 4|Death|0|||
164019753|NCT03249792|592435955|FG015|Arms 1, 2, and 4|Death|4|||
164019754|NCT03249792|592435956|FG016|Arms 1, 2, and 4|Death|4|||
164019755|NCT03249792|592435957|FG017|Arms 1, 2, and 4|Death|12|||
164019756|NCT03249792|592435958|FG018|Arms 1, 2, and 4|Death|6|||
164019757|NCT03249792|592435959|FG019|Arms 1, 2, and 4|Death|4|||
164019758|NCT03249792|592435960|FG020|Arms 1, 2, and 4|Death|2|||
164019759|NCT03249792|592435961|FG021|Arms 1, 2, and 4|Death|3|||
164019760|NCT03249792|592435962|FG022|Arms 1, 2, and 4|Death|1|||
164019761|NCT03249792|592435963|FG023|Arms 1, 2, and 4|Death|1|||
164019762|NCT03249792|592435964|FG024|Arms 1, 2, and 4|Death|4|||
164019763|NCT03249792|592435965|FG025|Arms 1, 2, and 4|Death|0|||
164019764|NCT03249792|592435966|FG026|Arms 1, 2, and 4|Death|0|||
164019765|NCT03249792|592435967|FG027|Arms 1, 2, and 4|Death|0|||
164019766|NCT03249792|592435968|FG028|Arms 1, 2, and 4|Death|0|||
164019767|NCT03249792|592435969|FG029|Arms 1, 2, and 4|Death|0|||
164019768|NCT03249792|592435970|FG030|Arms 1, 2, and 4|Death|0|||
164019769|NCT03249792|592435971|FG031|Arms 1, 2, and 4|Death|0|||
164019770|NCT03249792|592435972|FG032|Arms 1, 2, and 4|Death|0|||
164019771|NCT03249792|592435940|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019772|NCT03249792|592435941|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019773|NCT03249792|592435942|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164019774|NCT03249792|592435943|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019775|NCT03249792|592435944|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019776|NCT03249792|592435945|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164019777|NCT03249792|592435946|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
164019778|NCT03249792|592435947|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019779|NCT03249792|592435948|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
164019780|NCT03249792|592435949|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164019781|NCT03249792|592435950|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
164019782|NCT03249792|592435951|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
164019783|NCT03249792|592435952|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
164019784|NCT03249792|592435953|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
164019785|NCT03249792|592435954|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019786|NCT03249792|592435955|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019787|NCT03249792|592435956|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
164019788|NCT03249792|592435957|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019789|NCT03249792|592435958|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164019790|NCT03249792|592435959|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019791|NCT03249792|592435960|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019792|NCT03249792|592435961|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019793|NCT03249792|592435962|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164019794|NCT03249792|592435963|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
164019795|NCT03249792|592435964|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019796|NCT03249792|592435965|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019797|NCT03249792|592435966|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019798|NCT03249792|592435967|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019799|NCT03249792|592435968|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019800|NCT03249792|592435969|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019801|NCT03249792|592435970|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019802|NCT03249792|592435971|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019803|NCT03249792|592435972|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
164019804|NCT03249792|592435940|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
164019805|NCT03249792|592435941|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
164019806|NCT03249792|592435942|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
164019807|NCT03249792|592435943|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
164019808|NCT03249792|592435944|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
164019809|NCT03249792|592435945|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
164019810|NCT03249792|592435946|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
164019811|NCT03249792|592435947|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
164019812|NCT03249792|592435948|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
164019813|NCT03249792|592435949|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
164019814|NCT03249792|592435950|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
164019815|NCT03249792|592435951|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
164019816|NCT03249792|592435952|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
164019817|NCT03249792|592435953|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
164019818|NCT03249792|592435954|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
164019819|NCT03249792|592435955|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
163909141|NCT03374254|592038822|FG001|Overall Study|Lost to Follow-up|0|||
163909142|NCT03374254|592038823|FG002|Overall Study|Lost to Follow-up|0|||
164019820|NCT03249792|592435956|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
164019821|NCT03249792|592435957|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
164019822|NCT03249792|592435958|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
164019823|NCT03249792|592435959|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
164019824|NCT03249792|592435960|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
164019825|NCT03249792|592435961|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
164019826|NCT03249792|592435962|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
164019827|NCT03249792|592435963|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
164019828|NCT03249792|592435964|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
164019829|NCT03249792|592435965|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
164019830|NCT03249792|592435966|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
163909143|NCT03374254|592038824|FG003|Overall Study|Lost to Follow-up|0|||
163909144|NCT03374254|592038825|FG004|Overall Study|Lost to Follow-up|0|||
163909145|NCT03374254|592038826|FG005|Overall Study|Lost to Follow-up|0|||
163909146|NCT03374254|592038827|FG006|Overall Study|Lost to Follow-up|2|||
163909147|NCT03374254|592038828|FG007|Overall Study|Lost to Follow-up|0|||
163909148|NCT03374254|592038829|FG008|Overall Study|Lost to Follow-up|0|||
163909149|NCT03374254|592038821|FG000|Overall Study|Sponsor Decision|1|||
163909150|NCT03374254|592038822|FG001|Overall Study|Sponsor Decision|0|||
163909151|NCT03374254|592038823|FG002|Overall Study|Sponsor Decision|2|||
163909152|NCT03374254|592038824|FG003|Overall Study|Sponsor Decision|3|||
163909153|NCT03374254|592038825|FG004|Overall Study|Sponsor Decision|2|||
163909154|NCT03374254|592038826|FG005|Overall Study|Sponsor Decision|3|||
163909155|NCT03374254|592038827|FG006|Overall Study|Sponsor Decision|3|||
163909156|NCT03374254|592038828|FG007|Overall Study|Sponsor Decision|3|||
163909157|NCT03374254|592038829|FG008|Overall Study|Sponsor Decision|4|||
163909158|NCT03374254|592038821|FG000|Overall Study|Withdrawal by Subject|0|||
163909159|NCT03374254|592038822|FG001|Overall Study|Withdrawal by Subject|0|||
163909160|NCT03374254|592038823|FG002|Overall Study|Withdrawal by Subject|0|||
163909161|NCT03374254|592038824|FG003|Overall Study|Withdrawal by Subject|2|||
163909162|NCT03374254|592038825|FG004|Overall Study|Withdrawal by Subject|0|||
164019831|NCT03249792|592435967|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
163909163|NCT03374254|592038826|FG005|Overall Study|Withdrawal by Subject|1|||
163909164|NCT03374254|592038827|FG006|Overall Study|Withdrawal by Subject|0|||
163909165|NCT03374254|592038828|FG007|Overall Study|Withdrawal by Subject|0|||
163909166|NCT03374254|592038829|FG008|Overall Study|Withdrawal by Subject|0|||
163909167|NCT02309515|592038831|FG000|Overall Study|Withdrawal by Subject|0|||
163909168|NCT02309515|592038832|FG001|Overall Study|Withdrawal by Subject|1|||
163909169|NCT02547974|592038835|FG000|Overall Study|Withdrawal by Subject|1|||
163909170|NCT02547974|592038836|FG001|Overall Study|Withdrawal by Subject|0|||
163909171|NCT02547974|592038837|FG002|Overall Study|Withdrawal by Subject|0|||
163909172|NCT02547974|592038838|FG003|Overall Study|Withdrawal by Subject|0|||
163909173|NCT02784834|592038840|FG000|Overall Study|Lack of Efficacy|1|||
163909174|NCT02245620|592038841|FG000|Overall Study|Physician Decision|1|||
163909175|NCT02245620|592038842|FG001|Overall Study|Physician Decision|1|||
163909176|NCT01999335|592038843|FG000|Overall Study|Discontinued before receiving treatment|0|||
163909177|NCT01999335|592038844|FG001|Overall Study|Discontinued before receiving treatment|0|||
163909178|NCT01999335|592038845|FG002|Overall Study|Discontinued before receiving treatment|0|||
163909179|NCT01999335|592038846|FG003|Overall Study|Discontinued before receiving treatment|0|||
163909180|NCT01999335|592038847|FG004|Overall Study|Discontinued before receiving treatment|2|||
163909181|NCT02988713|592038858|FG000|Overall Study|Withdrawal by Subject|1|||
163909182|NCT02988713|592038858|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
163909183|NCT02404441|592038859|FG000|Phase 1 Part|Adverse Event|1|||
163909184|NCT02404441|592038860|FG001|Phase 1 Part|Adverse Event|0|||
163909185|NCT02404441|592038861|FG002|Phase 1 Part|Adverse Event|0|||
163909186|NCT02404441|592038862|FG003|Phase 1 Part|Adverse Event|0|||
163909187|NCT02404441|592038863|FG004|Phase 1 Part|Adverse Event|0|||
163909188|NCT02404441|592038864|FG005|Phase 1 Part|Adverse Event|0|||
163909189|NCT02404441|592038865|FG006|Phase 1 Part|Adverse Event|0|||
163909190|NCT02404441|592038866|FG007|Phase 1 Part|Adverse Event|0|||
163909191|NCT02404441|592038867|FG008|Phase 1 Part|Adverse Event|0|||
163909192|NCT02404441|592038868|FG009|Phase 1 Part|Adverse Event|0|||
163909193|NCT02404441|592038859|FG000|Phase 1 Part|Physician Decision|0|||
163909194|NCT02404441|592038860|FG001|Phase 1 Part|Physician Decision|1|||
163909195|NCT02404441|592038861|FG002|Phase 1 Part|Physician Decision|0|||
163909196|NCT02404441|592038862|FG003|Phase 1 Part|Physician Decision|0|||
163909197|NCT02404441|592038863|FG004|Phase 1 Part|Physician Decision|0|||
163909198|NCT02404441|592038864|FG005|Phase 1 Part|Physician Decision|0|||
163909199|NCT02404441|592038865|FG006|Phase 1 Part|Physician Decision|0|||
163909200|NCT02404441|592038866|FG007|Phase 1 Part|Physician Decision|0|||
163909201|NCT02404441|592038867|FG008|Phase 1 Part|Physician Decision|0|||
163909202|NCT02404441|592038868|FG009|Phase 1 Part|Physician Decision|0|||
163909203|NCT02404441|592038859|FG000|Phase 1 Part|Progressive Disease|14|||
163909204|NCT02404441|592038860|FG001|Phase 1 Part|Progressive Disease|11|||
163909205|NCT02404441|592038861|FG002|Phase 1 Part|Progressive Disease|7|||
164019832|NCT03249792|592435968|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
164019833|NCT03249792|592435969|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
164019834|NCT03249792|592435970|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
164019835|NCT03249792|592435971|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
163909206|NCT02404441|592038862|FG003|Phase 1 Part|Progressive Disease|6|||
163909207|NCT02404441|592038863|FG004|Phase 1 Part|Progressive Disease|9|||
163909208|NCT02404441|592038864|FG005|Phase 1 Part|Progressive Disease|0|||
163909209|NCT02404441|592038865|FG006|Phase 1 Part|Progressive Disease|0|||
163909210|NCT02404441|592038866|FG007|Phase 1 Part|Progressive Disease|0|||
163909211|NCT02404441|592038867|FG008|Phase 1 Part|Progressive Disease|0|||
163909212|NCT02404441|592038868|FG009|Phase 1 Part|Progressive Disease|0|||
163909213|NCT02404441|592038859|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
163909214|NCT02404441|592038860|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
163909215|NCT02404441|592038861|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
163909216|NCT02404441|592038862|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
163909217|NCT02404441|592038863|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
163909218|NCT02404441|592038864|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
163909219|NCT02404441|592038865|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
163909220|NCT02404441|592038866|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
163909221|NCT02404441|592038867|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
163909222|NCT02404441|592038868|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
163909223|NCT02404441|592038859|FG000|Phase 1 Part|Death|1|||
164019836|NCT03249792|592435972|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
164019837|NCT03249792|592435940|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019838|NCT03249792|592435941|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019839|NCT03249792|592435942|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019840|NCT03249792|592435943|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019841|NCT03249792|592435944|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019842|NCT03249792|592435945|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019843|NCT03249792|592435946|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019844|NCT03249792|592435947|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019845|NCT03249792|592435948|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
164019846|NCT03249792|592435949|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019847|NCT03249792|592435950|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019848|NCT03249792|592435951|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019849|NCT03249792|592435952|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019850|NCT03249792|592435953|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019851|NCT03249792|592435954|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019852|NCT03249792|592435955|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019853|NCT03249792|592435956|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
164019854|NCT03249792|592435957|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
164019855|NCT03249792|592435958|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019856|NCT03249792|592435959|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
164019857|NCT03249792|592435960|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019858|NCT03249792|592435961|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019859|NCT03249792|592435962|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019860|NCT03249792|592435963|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019861|NCT03249792|592435964|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019862|NCT03249792|592435965|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019863|NCT03249792|592435966|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019864|NCT03249792|592435967|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019865|NCT03249792|592435968|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019866|NCT03249792|592435969|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019867|NCT03249792|592435970|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019868|NCT03249792|592435971|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019869|NCT03249792|592435972|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
164019870|NCT03249792|592435940|FG000|Switch Over Period|Withdrawal by Subject|0|||
164019871|NCT03249792|592435941|FG001|Switch Over Period|Withdrawal by Subject|0|||
164019872|NCT03249792|592435942|FG002|Switch Over Period|Withdrawal by Subject|0|||
164019873|NCT03249792|592435943|FG003|Switch Over Period|Withdrawal by Subject|0|||
164019874|NCT03249792|592435944|FG004|Switch Over Period|Withdrawal by Subject|0|||
164019875|NCT03249792|592435945|FG005|Switch Over Period|Withdrawal by Subject|0|||
164019876|NCT03249792|592435946|FG006|Switch Over Period|Withdrawal by Subject|0|||
164019877|NCT03249792|592435947|FG007|Switch Over Period|Withdrawal by Subject|0|||
164019878|NCT03249792|592435948|FG008|Switch Over Period|Withdrawal by Subject|0|||
164019879|NCT03249792|592435949|FG009|Switch Over Period|Withdrawal by Subject|0|||
164019880|NCT03249792|592435950|FG010|Switch Over Period|Withdrawal by Subject|0|||
164019881|NCT03249792|592435951|FG011|Switch Over Period|Withdrawal by Subject|0|||
164019882|NCT03249792|592435952|FG012|Switch Over Period|Withdrawal by Subject|0|||
164019883|NCT03249792|592435953|FG013|Switch Over Period|Withdrawal by Subject|0|||
164019884|NCT03249792|592435954|FG014|Switch Over Period|Withdrawal by Subject|0|||
164019885|NCT03249792|592435955|FG015|Switch Over Period|Withdrawal by Subject|0|||
164019886|NCT03249792|592435956|FG016|Switch Over Period|Withdrawal by Subject|0|||
164019887|NCT03249792|592435957|FG017|Switch Over Period|Withdrawal by Subject|0|||
164019888|NCT03249792|592435958|FG018|Switch Over Period|Withdrawal by Subject|0|||
164019889|NCT03249792|592435959|FG019|Switch Over Period|Withdrawal by Subject|0|||
164019890|NCT03249792|592435960|FG020|Switch Over Period|Withdrawal by Subject|0|||
164019891|NCT03249792|592435961|FG021|Switch Over Period|Withdrawal by Subject|0|||
164019892|NCT03249792|592435962|FG022|Switch Over Period|Withdrawal by Subject|0|||
163909224|NCT02404441|592038860|FG001|Phase 1 Part|Death|1|||
163909225|NCT02404441|592038861|FG002|Phase 1 Part|Death|1|||
163909226|NCT02404441|592038862|FG003|Phase 1 Part|Death|0|||
163909227|NCT02404441|592038863|FG004|Phase 1 Part|Death|1|||
163909228|NCT02404441|592038864|FG005|Phase 1 Part|Death|0|||
163909229|NCT02404441|592038865|FG006|Phase 1 Part|Death|0|||
163909230|NCT02404441|592038866|FG007|Phase 1 Part|Death|0|||
163909231|NCT02404441|592038867|FG008|Phase 1 Part|Death|0|||
163909232|NCT02404441|592038868|FG009|Phase 1 Part|Death|0|||
163909233|NCT02404441|592038859|FG000|Phase 2 Part|Adverse Event|0|||
163909234|NCT02404441|592038860|FG001|Phase 2 Part|Adverse Event|0|||
163909235|NCT02404441|592038861|FG002|Phase 2 Part|Adverse Event|0|||
163909236|NCT02404441|592038862|FG003|Phase 2 Part|Adverse Event|0|||
163909237|NCT02404441|592038863|FG004|Phase 2 Part|Adverse Event|0|||
163909238|NCT02404441|592038864|FG005|Phase 2 Part|Adverse Event|2|||
163909239|NCT02404441|592038865|FG006|Phase 2 Part|Adverse Event|3|||
163909240|NCT02404441|592038866|FG007|Phase 2 Part|Adverse Event|3|||
163909241|NCT02404441|592038867|FG008|Phase 2 Part|Adverse Event|6|||
163909242|NCT02404441|592038868|FG009|Phase 2 Part|Adverse Event|1|||
163909243|NCT02404441|592038859|FG000|Phase 2 Part|Physician Decision|0|||
163909244|NCT02404441|592038860|FG001|Phase 2 Part|Physician Decision|0|||
163909245|NCT02404441|592038861|FG002|Phase 2 Part|Physician Decision|0|||
163909246|NCT02404441|592038862|FG003|Phase 2 Part|Physician Decision|0|||
163909247|NCT02404441|592038863|FG004|Phase 2 Part|Physician Decision|0|||
163909248|NCT02404441|592038864|FG005|Phase 2 Part|Physician Decision|7|||
163909249|NCT02404441|592038865|FG006|Phase 2 Part|Physician Decision|9|||
163909250|NCT02404441|592038866|FG007|Phase 2 Part|Physician Decision|2|||
163909251|NCT02404441|592038867|FG008|Phase 2 Part|Physician Decision|1|||
163909252|NCT02404441|592038868|FG009|Phase 2 Part|Physician Decision|3|||
163909253|NCT02404441|592038859|FG000|Phase 2 Part|Progressive disease|0|||
163909254|NCT02404441|592038860|FG001|Phase 2 Part|Progressive disease|0|||
163909255|NCT02404441|592038861|FG002|Phase 2 Part|Progressive disease|0|||
163909256|NCT02404441|592038862|FG003|Phase 2 Part|Progressive disease|0|||
163909257|NCT02404441|592038863|FG004|Phase 2 Part|Progressive disease|0|||
163909258|NCT02404441|592038864|FG005|Phase 2 Part|Progressive disease|43|||
163909259|NCT02404441|592038865|FG006|Phase 2 Part|Progressive disease|32|||
163909260|NCT02404441|592038866|FG007|Phase 2 Part|Progressive disease|31|||
163909261|NCT02404441|592038867|FG008|Phase 2 Part|Progressive disease|39|||
163909262|NCT02404441|592038868|FG009|Phase 2 Part|Progressive disease|27|||
163909263|NCT02404441|592038859|FG000|Phase 2 Part|Subject/guardian decision|0|||
163909264|NCT02404441|592038860|FG001|Phase 2 Part|Subject/guardian decision|0|||
163909265|NCT02404441|592038861|FG002|Phase 2 Part|Subject/guardian decision|0|||
163909266|NCT02404441|592038862|FG003|Phase 2 Part|Subject/guardian decision|0|||
163909267|NCT02404441|592038863|FG004|Phase 2 Part|Subject/guardian decision|0|||
163909268|NCT02404441|592038864|FG005|Phase 2 Part|Subject/guardian decision|3|||
163909269|NCT02404441|592038865|FG006|Phase 2 Part|Subject/guardian decision|9|||
163909270|NCT02404441|592038866|FG007|Phase 2 Part|Subject/guardian decision|0|||
163909271|NCT02404441|592038867|FG008|Phase 2 Part|Subject/guardian decision|3|||
163909272|NCT02404441|592038868|FG009|Phase 2 Part|Subject/guardian decision|2|||
163909273|NCT02404441|592038859|FG000|Phase 2 Part|Death|0|||
163909274|NCT02404441|592038860|FG001|Phase 2 Part|Death|0|||
163909275|NCT02404441|592038861|FG002|Phase 2 Part|Death|0|||
163909276|NCT02404441|592038862|FG003|Phase 2 Part|Death|0|||
163909277|NCT02404441|592038863|FG004|Phase 2 Part|Death|0|||
164019893|NCT03249792|592435963|FG023|Switch Over Period|Withdrawal by Subject|0|||
164019894|NCT03249792|592435964|FG024|Switch Over Period|Withdrawal by Subject|0|||
164019895|NCT03249792|592435965|FG025|Switch Over Period|Withdrawal by Subject|0|||
164019896|NCT03249792|592435966|FG026|Switch Over Period|Withdrawal by Subject|0|||
164019897|NCT03249792|592435967|FG027|Switch Over Period|Withdrawal by Subject|0|||
163909278|NCT02404441|592038864|FG005|Phase 2 Part|Death|4|||
163909279|NCT02404441|592038865|FG006|Phase 2 Part|Death|8|||
163909280|NCT02404441|592038866|FG007|Phase 2 Part|Death|4|||
163909281|NCT02404441|592038867|FG008|Phase 2 Part|Death|10|||
163909282|NCT02404441|592038868|FG009|Phase 2 Part|Death|9|||
163909283|NCT00088166|592038870|FG000|Overall Study|Adverse Event|11|||
163909284|NCT00088166|592038871|FG001|Overall Study|Adverse Event|9|||
163909285|NCT00088166|592038870|FG000|Overall Study|Death|3|||
163909286|NCT00088166|592038871|FG001|Overall Study|Death|1|||
164019898|NCT03249792|592435968|FG028|Switch Over Period|Withdrawal by Subject|0|||
164019899|NCT03249792|592435969|FG029|Switch Over Period|Withdrawal by Subject|0|||
164019900|NCT03249792|592435970|FG030|Switch Over Period|Withdrawal by Subject|0|||
164019901|NCT03249792|592435971|FG031|Switch Over Period|Withdrawal by Subject|1|||
164019902|NCT03249792|592435972|FG032|Switch Over Period|Withdrawal by Subject|0|||
164019903|NCT03249792|592435940|FG000|Switch Over Period|Progressive Disease|0|||
164019904|NCT03249792|592435941|FG001|Switch Over Period|Progressive Disease|0|||
164019905|NCT03249792|592435942|FG002|Switch Over Period|Progressive Disease|0|||
164019906|NCT03249792|592435943|FG003|Switch Over Period|Progressive Disease|0|||
164019907|NCT03249792|592435944|FG004|Switch Over Period|Progressive Disease|0|||
164019908|NCT03249792|592435945|FG005|Switch Over Period|Progressive Disease|0|||
164019909|NCT03249792|592435946|FG006|Switch Over Period|Progressive Disease|0|||
163909287|NCT00088166|592038870|FG000|Overall Study|Lost to Follow-up|0|||
164019910|NCT03249792|592435947|FG007|Switch Over Period|Progressive Disease|0|||
164019911|NCT03249792|592435948|FG008|Switch Over Period|Progressive Disease|0|||
164019912|NCT03249792|592435949|FG009|Switch Over Period|Progressive Disease|0|||
163909288|NCT00088166|592038871|FG001|Overall Study|Lost to Follow-up|1|||
163909289|NCT00088166|592038870|FG000|Overall Study|Physician Decision|4|||
163909290|NCT00088166|592038871|FG001|Overall Study|Physician Decision|1|||
163909291|NCT00088166|592038870|FG000|Overall Study|Protocol Violation|1|||
163909292|NCT00088166|592038871|FG001|Overall Study|Protocol Violation|5|||
163909293|NCT00088166|592038870|FG000|Overall Study|Patient deterioration|29|||
163909294|NCT00088166|592038871|FG001|Overall Study|Patient deterioration|39|||
163909295|NCT00088166|592038870|FG000|Overall Study|Withdrawal by Subject|5|||
163909296|NCT00088166|592038871|FG001|Overall Study|Withdrawal by Subject|5|||
163909297|NCT02671266|592038872|FG000|Overall Study|Withdrawal by Subject|1|||
163909298|NCT02671266|592038873|FG001|Overall Study|Withdrawal by Subject|1|||
163909299|NCT00666705|592038874|FG000|Overall Study|Withdrawal by Subject|1|||
163909300|NCT01976507|592038877|FG000|Overall Study|Adverse Event|6|||
164019913|NCT03249792|592435950|FG010|Switch Over Period|Progressive Disease|0|||
163909301|NCT01976507|592038877|FG000|Overall Study|ablation not done, drug not given|1|||
164019914|NCT03249792|592435951|FG011|Switch Over Period|Progressive Disease|0|||
163909302|NCT01029704|592038879|FG000|Overall Study|Adverse Event|0|||
163909303|NCT01029704|592038880|FG001|Overall Study|Adverse Event|0|||
164094949|NCT01918397|592712232|FG002|Overall Study|Involved in another investigative trial|0|||
163909304|NCT01029704|592038881|FG002|Overall Study|Adverse Event|0|||
163909305|NCT01029704|592038882|FG003|Overall Study|Adverse Event|0|||
163909306|NCT01029704|592038883|FG004|Overall Study|Adverse Event|0|||
163909307|NCT01029704|592038884|FG005|Overall Study|Adverse Event|0|||
163909308|NCT01029704|592038885|FG006|Overall Study|Adverse Event|1|||
163909309|NCT01029704|592038886|FG007|Overall Study|Adverse Event|1|||
163909310|NCT01029704|592038887|FG008|Overall Study|Adverse Event|0|||
163909311|NCT01029704|592038879|FG000|Overall Study|Withdrawal by Subject|0|||
163909312|NCT01029704|592038880|FG001|Overall Study|Withdrawal by Subject|0|||
163909313|NCT01029704|592038881|FG002|Overall Study|Withdrawal by Subject|0|||
163909314|NCT01029704|592038882|FG003|Overall Study|Withdrawal by Subject|0|||
163909315|NCT01029704|592038883|FG004|Overall Study|Withdrawal by Subject|2|||
163909316|NCT01029704|592038884|FG005|Overall Study|Withdrawal by Subject|1|||
163909317|NCT01029704|592038885|FG006|Overall Study|Withdrawal by Subject|1|||
163909318|NCT01029704|592038886|FG007|Overall Study|Withdrawal by Subject|1|||
164144659|NCT01495702|592891746|FG001|Randomized Phase|Death|0|||
163909319|NCT01029704|592038887|FG008|Overall Study|Withdrawal by Subject|0|||
163909320|NCT01029704|592038879|FG000|Overall Study|Lost to Follow-up|0|||
163909321|NCT01029704|592038880|FG001|Overall Study|Lost to Follow-up|0|||
163909322|NCT01029704|592038881|FG002|Overall Study|Lost to Follow-up|0|||
163909323|NCT01029704|592038882|FG003|Overall Study|Lost to Follow-up|0|||
163909324|NCT01029704|592038883|FG004|Overall Study|Lost to Follow-up|0|||
163909325|NCT01029704|592038884|FG005|Overall Study|Lost to Follow-up|0|||
163909326|NCT01029704|592038885|FG006|Overall Study|Lost to Follow-up|1|||
163909327|NCT01029704|592038886|FG007|Overall Study|Lost to Follow-up|1|||
163909328|NCT01029704|592038887|FG008|Overall Study|Lost to Follow-up|1|||
163909329|NCT01029704|592038879|FG000|Overall Study|Lack of Efficacy|0|||
163909330|NCT01029704|592038880|FG001|Overall Study|Lack of Efficacy|0|||
163909331|NCT01029704|592038881|FG002|Overall Study|Lack of Efficacy|0|||
163909332|NCT01029704|592038882|FG003|Overall Study|Lack of Efficacy|0|||
163909333|NCT01029704|592038883|FG004|Overall Study|Lack of Efficacy|2|||
163909334|NCT01029704|592038884|FG005|Overall Study|Lack of Efficacy|3|||
163909335|NCT01029704|592038885|FG006|Overall Study|Lack of Efficacy|1|||
164019915|NCT03249792|592435952|FG012|Switch Over Period|Progressive Disease|0|||
164019916|NCT03249792|592435953|FG013|Switch Over Period|Progressive Disease|0|||
164019917|NCT03249792|592435954|FG014|Switch Over Period|Progressive Disease|0|||
164019918|NCT03249792|592435955|FG015|Switch Over Period|Progressive Disease|0|||
164019919|NCT03249792|592435956|FG016|Switch Over Period|Progressive Disease|0|||
164019920|NCT03249792|592435957|FG017|Switch Over Period|Progressive Disease|0|||
164019921|NCT03249792|592435958|FG018|Switch Over Period|Progressive Disease|0|||
164019922|NCT03249792|592435959|FG019|Switch Over Period|Progressive Disease|0|||
164019923|NCT03249792|592435960|FG020|Switch Over Period|Progressive Disease|0|||
164019924|NCT03249792|592435961|FG021|Switch Over Period|Progressive Disease|0|||
164019925|NCT03249792|592435962|FG022|Switch Over Period|Progressive Disease|0|||
164019926|NCT03249792|592435963|FG023|Switch Over Period|Progressive Disease|0|||
164019927|NCT03249792|592435964|FG024|Switch Over Period|Progressive Disease|0|||
163909336|NCT01029704|592038886|FG007|Overall Study|Lack of Efficacy|2|||
163909337|NCT01029704|592038887|FG008|Overall Study|Lack of Efficacy|0|||
163909338|NCT01029704|592038879|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
163909339|NCT01029704|592038880|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
164019928|NCT03249792|592435965|FG025|Switch Over Period|Progressive Disease|0|||
164019929|NCT03249792|592435966|FG026|Switch Over Period|Progressive Disease|1|||
164019930|NCT03249792|592435967|FG027|Switch Over Period|Progressive Disease|0|||
164019931|NCT03249792|592435968|FG028|Switch Over Period|Progressive Disease|1|||
164019932|NCT03249792|592435969|FG029|Switch Over Period|Progressive Disease|2|||
163909340|NCT01029704|592038881|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
163909341|NCT01029704|592038882|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
163909342|NCT01029704|592038883|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
163909343|NCT01029704|592038884|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
163909344|NCT01029704|592038885|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
163909345|NCT01029704|592038886|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
163909346|NCT01029704|592038887|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
163909347|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
163909348|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
163909349|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
163909350|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
163909351|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Death|0|||
163909352|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Death|0|||
163909353|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Death|1|||
163909354|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Death|0|||
163909355|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
163909356|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
163909357|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
163909358|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
163909359|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163909360|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
163909361|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
163909362|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
163909363|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
163909364|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
163909365|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
163909366|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
163909367|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
163909368|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
163909369|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
163909370|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
163909371|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
163909372|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
163909373|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
163909374|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
163909375|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Other|2|||
163909376|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Other|0|||
163909377|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Other|0|||
163909378|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Other|0|||
163909379|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
163909380|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
163909381|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
163909382|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
163909383|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
163909384|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
163909385|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
164019933|NCT03249792|592435970|FG030|Switch Over Period|Progressive Disease|1|||
164019934|NCT03249792|592435971|FG031|Switch Over Period|Progressive Disease|0|||
164019935|NCT03249792|592435972|FG032|Switch Over Period|Progressive Disease|1|||
164019936|NCT03249792|592435940|FG000|Switch Over Period|Adverse Event|0|||
164019937|NCT03249792|592435941|FG001|Switch Over Period|Adverse Event|0|||
164019938|NCT03249792|592435942|FG002|Switch Over Period|Adverse Event|0|||
164019939|NCT03249792|592435943|FG003|Switch Over Period|Adverse Event|0|||
164019940|NCT03249792|592435944|FG004|Switch Over Period|Adverse Event|0|||
164019941|NCT03249792|592435945|FG005|Switch Over Period|Adverse Event|0|||
164019942|NCT03249792|592435946|FG006|Switch Over Period|Adverse Event|0|||
164019943|NCT03249792|592435947|FG007|Switch Over Period|Adverse Event|0|||
164019944|NCT03249792|592435948|FG008|Switch Over Period|Adverse Event|0|||
164019945|NCT03249792|592435949|FG009|Switch Over Period|Adverse Event|0|||
164019946|NCT03249792|592435950|FG010|Switch Over Period|Adverse Event|0|||
164019947|NCT03249792|592435951|FG011|Switch Over Period|Adverse Event|0|||
164019948|NCT03249792|592435952|FG012|Switch Over Period|Adverse Event|0|||
164019949|NCT03249792|592435953|FG013|Switch Over Period|Adverse Event|0|||
164019950|NCT03249792|592435954|FG014|Switch Over Period|Adverse Event|0|||
164019951|NCT03249792|592435955|FG015|Switch Over Period|Adverse Event|0|||
164019952|NCT03249792|592435956|FG016|Switch Over Period|Adverse Event|0|||
164019953|NCT03249792|592435957|FG017|Switch Over Period|Adverse Event|0|||
164019954|NCT03249792|592435958|FG018|Switch Over Period|Adverse Event|0|||
164019955|NCT03249792|592435959|FG019|Switch Over Period|Adverse Event|0|||
164019956|NCT03249792|592435960|FG020|Switch Over Period|Adverse Event|0|||
164019957|NCT03249792|592435961|FG021|Switch Over Period|Adverse Event|0|||
164019958|NCT03249792|592435962|FG022|Switch Over Period|Adverse Event|0|||
164019959|NCT03249792|592435963|FG023|Switch Over Period|Adverse Event|0|||
164019960|NCT03249792|592435964|FG024|Switch Over Period|Adverse Event|0|||
164019961|NCT03249792|592435965|FG025|Switch Over Period|Adverse Event|1|||
164019962|NCT03249792|592435966|FG026|Switch Over Period|Adverse Event|0|||
164019963|NCT03249792|592435967|FG027|Switch Over Period|Adverse Event|1|||
164019964|NCT03249792|592435968|FG028|Switch Over Period|Adverse Event|0|||
164019965|NCT03249792|592435969|FG029|Switch Over Period|Adverse Event|0|||
164019966|NCT03249792|592435970|FG030|Switch Over Period|Adverse Event|0|||
164019967|NCT03249792|592435971|FG031|Switch Over Period|Adverse Event|0|||
164019968|NCT03249792|592435972|FG032|Switch Over Period|Adverse Event|0|||
164019969|NCT01409031|592435976|FG000|Overall Study|transferred to other hosp|1|||
164019970|NCT01409031|592435977|FG001|Overall Study|transferred to other hosp|0|||
164019971|NCT00532948|592435978|FG000|Overall Study|Protocol Violation|1|||
164019972|NCT00532948|592435979|FG001|Overall Study|Protocol Violation|0|||
164019973|NCT00532948|592435980|FG002|Overall Study|Protocol Violation|0|||
164019974|NCT00532948|592435978|FG000|Overall Study|Death|3|||
164019975|NCT00532948|592435979|FG001|Overall Study|Death|3|||
164019976|NCT00532948|592435980|FG002|Overall Study|Death|4|||
164019977|NCT00532948|592435978|FG000|Overall Study|Violation of selection criteria at entry|0|||
163909386|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
163909387|NCT03845517|592038888|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
163909388|NCT03845517|592038889|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
163909389|NCT03845517|592038890|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
163909390|NCT03845517|592038891|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
164019978|NCT00532948|592435979|FG001|Overall Study|Violation of selection criteria at entry|1|||
164019979|NCT00532948|592435980|FG002|Overall Study|Violation of selection criteria at entry|0|||
164019980|NCT00532948|592435978|FG000|Overall Study|Failure to return|0|||
164019981|NCT00532948|592435979|FG001|Overall Study|Failure to return|1|||
164019982|NCT00532948|592435980|FG002|Overall Study|Failure to return|0|||
164019983|NCT00995345|592435981|FG000|Overall Study|Withdrawal by Subject|4|||
164019984|NCT00995345|592435982|FG001|Overall Study|Withdrawal by Subject|2|||
164019985|NCT00995345|592435983|FG002|Overall Study|Withdrawal by Subject|1|||
164019986|NCT00995345|592435984|FG003|Overall Study|Withdrawal by Subject|3|||
164019987|NCT00995345|592435985|FG004|Overall Study|Withdrawal by Subject|1|||
164019988|NCT00995345|592435981|FG000|Overall Study|Adverse Event|3|||
164019989|NCT00995345|592435982|FG001|Overall Study|Adverse Event|1|||
164019990|NCT00995345|592435983|FG002|Overall Study|Adverse Event|2|||
164019991|NCT00995345|592435984|FG003|Overall Study|Adverse Event|0|||
164019992|NCT00995345|592435985|FG004|Overall Study|Adverse Event|1|||
164019993|NCT00995345|592435981|FG000|Overall Study|Lost to Follow-up|2|||
164019994|NCT00995345|592435982|FG001|Overall Study|Lost to Follow-up|2|||
164019995|NCT00995345|592435983|FG002|Overall Study|Lost to Follow-up|2|||
163909391|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
163909392|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
163909393|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
163909394|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
163909395|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Death|0|||
163909396|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Death|0|||
163909397|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Death|1|||
163909398|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Death|1|||
163909399|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
163909400|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
164019996|NCT00995345|592435984|FG003|Overall Study|Lost to Follow-up|1|||
164019997|NCT00995345|592435985|FG004|Overall Study|Lost to Follow-up|0|||
163909401|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
163909402|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
163909403|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
163909404|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
163909405|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
164094950|NCT01918397|592712233|FG003|Overall Study|Involved in another investigative trial|1|||
164094951|NCT00849901|592712240|FG000|Acute Treatment Phase|Adverse Event|9|||
163909406|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
163909407|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
163909408|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
163909409|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
163909410|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
163909411|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Other|1|||
163909412|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Other|0|||
163909413|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Other|1|||
163909414|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Other|0|||
163909415|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
163909416|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
163909417|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
163909418|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
163909419|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
163909420|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
163909421|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
163909422|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
163909423|NCT03845517|592038888|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
163909424|NCT03845517|592038889|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
163909425|NCT03845517|592038890|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
163909426|NCT03845517|592038891|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
163909427|NCT01109979|592038892|FG000|Overall Study|Physician Decision|2|||
163909428|NCT01109979|592038893|FG001|Overall Study|Physician Decision|0|||
163909429|NCT01109979|592038892|FG000|Overall Study|Withdrawal by Subject|0|||
163909430|NCT01109979|592038893|FG001|Overall Study|Withdrawal by Subject|1|||
163909431|NCT03136861|592038896|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
163909432|NCT03136861|592038897|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
163909433|NCT03136861|592038898|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163909434|NCT03136861|592038899|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163909435|NCT03136861|592038900|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163909436|NCT03136861|592038901|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163909437|NCT03136861|592038902|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
163909438|NCT03136861|592038896|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
163909439|NCT03136861|592038897|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
164019998|NCT00995345|592435981|FG000|Overall Study|all other reasons combined|2|||
164019999|NCT00995345|592435982|FG001|Overall Study|all other reasons combined|2|||
164020000|NCT00995345|592435983|FG002|Overall Study|all other reasons combined|2|||
164020001|NCT00995345|592435984|FG003|Overall Study|all other reasons combined|1|||
164020002|NCT00995345|592435985|FG004|Overall Study|all other reasons combined|3|||
164020003|NCT02509598|592435990|FG000|Overall Study|Withdrawal by Subject|1|||
164020004|NCT01201798|592435991|FG000|Overall Study|Adverse Event|2|||
163909440|NCT03136861|592038898|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163909441|NCT03136861|592038899|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163909442|NCT03136861|592038900|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163909443|NCT03136861|592038901|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
163909444|NCT03136861|592038902|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
164020005|NCT01201798|592435992|FG001|Overall Study|Adverse Event|0|||
164020006|NCT01201798|592435991|FG000|Overall Study|Lost to Follow-up|3|||
164020007|NCT01201798|592435992|FG001|Overall Study|Lost to Follow-up|5|||
164020008|NCT01201798|592435991|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
164144660|NCT01495702|592891745|FG000|Randomized Phase|Lack of Efficacy|2|||
163909445|NCT03136861|592038896|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
163909446|NCT03136861|592038897|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
163909447|NCT03136861|592038898|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163909448|NCT03136861|592038899|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163909449|NCT03136861|592038900|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163909450|NCT03136861|592038901|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
163909451|NCT03136861|592038902|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
164144661|NCT01495702|592891746|FG001|Randomized Phase|Lack of Efficacy|0|||
163909452|NCT03136861|592038896|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163909453|NCT03136861|592038897|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
164094952|NCT00849901|592712241|FG001|Acute Treatment Phase|Adverse Event|1|||
163909454|NCT03136861|592038898|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
164020009|NCT01201798|592435992|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
164020010|NCT01201798|592435991|FG000|Overall Study|Noncompliance|1|||
164020011|NCT01201798|592435992|FG001|Overall Study|Noncompliance|0|||
164020012|NCT01201798|592435991|FG000|Overall Study|Protocol Violation|1|||
164020013|NCT01201798|592435992|FG001|Overall Study|Protocol Violation|1|||
164020014|NCT01201798|592435991|FG000|Overall Study|Treatment Failure|1|||
164020015|NCT01201798|592435992|FG001|Overall Study|Treatment Failure|8|||
164020016|NCT03521687|592435997|FG000|Overall Study|Adverse Event|4|||
164020017|NCT03521687|592435997|FG000|Overall Study|Physician Decision|1|||
164020018|NCT04891770|592436001|FG000|Overall Study|Withdrew consent|1|||
164020019|NCT04891770|592436002|FG001|Overall Study|Withdrew consent|3|||
164020020|NCT04891770|592436003|FG002|Overall Study|Withdrew consent|0|||
164020021|NCT04891770|592436001|FG000|Overall Study|Enrolled but never treated|0|||
164020022|NCT04891770|592436002|FG001|Overall Study|Enrolled but never treated|0|||
164020023|NCT04891770|592436003|FG002|Overall Study|Enrolled but never treated|1|||
164020024|NCT04891770|592436001|FG000|Overall Study|Investigator's discretion|0|||
163909455|NCT03136861|592038899|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163909456|NCT03136861|592038900|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163909457|NCT03136861|592038901|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163909458|NCT03136861|592038902|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
163909459|NCT03136861|592038896|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
163909460|NCT03136861|592038897|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
163909461|NCT03136861|592038898|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163909462|NCT03136861|592038899|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163909463|NCT03136861|592038900|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163909464|NCT03136861|592038901|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163909465|NCT03136861|592038902|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
163909466|NCT03136861|592038896|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163909467|NCT03136861|592038897|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163909468|NCT03136861|592038898|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163909469|NCT03136861|592038899|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
163909470|NCT03136861|592038900|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
164020025|NCT04891770|592436002|FG001|Overall Study|Investigator's discretion|1|||
164020026|NCT04891770|592436003|FG002|Overall Study|Investigator's discretion|0|||
164020027|NCT05692154|592436005|FG000|Overall Study|Adverse Event|0|||
164020028|NCT05692154|592436006|FG001|Overall Study|Adverse Event|1|||
164020029|NCT03609359|592436009|FG000|Overall Study|Progression of primary disease (PD)|25|||
164020030|NCT03609359|592436009|FG000|Overall Study|Patient's refusal|1|||
164020031|NCT03609359|592436009|FG000|Overall Study|Physician Decision|1|||
164020032|NCT03609359|592436009|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
164020033|NCT01912729|592436010|FG000|Overall Study|Withdrawal by Subject|0|||
164094953|NCT00849901|592712242|FG002|Acute Treatment Phase|Adverse Event|3|||
164094954|NCT00849901|592712240|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
163909471|NCT03136861|592038901|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
163909472|NCT03136861|592038902|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
163909473|NCT03136861|592038896|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163909474|NCT03136861|592038897|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163909475|NCT03136861|592038898|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
163909476|NCT03136861|592038899|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163909477|NCT03136861|592038900|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163909478|NCT03136861|592038901|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163909479|NCT03136861|592038902|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
163909480|NCT03136861|592038896|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163909481|NCT03136861|592038897|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163909482|NCT03136861|592038898|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
163909483|NCT03136861|592038899|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163909484|NCT03136861|592038900|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163909485|NCT03136861|592038901|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163909486|NCT03136861|592038902|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
163909487|NCT03390166|592038903|FG000|Overall Study|Death|0|||
163909488|NCT03390166|592038904|FG001|Overall Study|Death|1|||
163909489|NCT03390166|592038903|FG000|Overall Study|Lost to Follow-up|6|||
163909490|NCT03390166|592038904|FG001|Overall Study|Lost to Follow-up|4|||
163909491|NCT03390166|592038903|FG000|Overall Study|Physician Decision|2|||
163909492|NCT03390166|592038904|FG001|Overall Study|Physician Decision|1|||
163909493|NCT03390166|592038903|FG000|Overall Study|Move from study area|3|||
163909494|NCT03390166|592038904|FG001|Overall Study|Move from study area|2|||
163909495|NCT03390166|592038903|FG000|Overall Study|To militarycamp for conscript|1|||
163909496|NCT03390166|592038904|FG001|Overall Study|To militarycamp for conscript|0|||
163909497|NCT03390166|592038903|FG000|Overall Study|To drug therapy course|0|||
163909498|NCT03390166|592038904|FG001|Overall Study|To drug therapy course|1|||
163909499|NCT03390166|592038903|FG000|Overall Study|Move to work oversea|0|||
163909500|NCT03390166|592038904|FG001|Overall Study|Move to work oversea|1|||
163909501|NCT01328756|592038910|FG000|Overall Study|Protocol Violation|4|||
163909502|NCT01328756|592038910|FG000|Overall Study|Adverse Event|39|||
163909503|NCT01328756|592038910|FG000|Overall Study|Lack of Efficacy|5|||
163909504|NCT01328756|592038910|FG000|Overall Study|Withdrawal by Subject|41|||
163909505|NCT01328756|592038910|FG000|Overall Study|Lost to Follow-up|5|||
163909506|NCT01328756|592038910|FG000|Overall Study|Other|29|||
163909507|NCT03200574|592038925|FG000|Overall Study|Death|4|||
163909508|NCT03200574|592038925|FG000|Overall Study|Withdrawal by Subject|8|||
163909509|NCT03200574|592038925|FG000|Overall Study|Long-Term need for anticoagulation|1|||
163909510|NCT03200574|592038925|FG000|Overall Study|Relocation|2|||
163909511|NCT03200574|592038925|FG000|Overall Study|Lost to Follow-up|2|||
163909512|NCT00705159|592038929|FG000|Overall Study|Withdrawal by Subject|0|||
163909513|NCT00705159|592038930|FG001|Overall Study|Withdrawal by Subject|1|||
163909514|NCT00705159|592038931|FG002|Overall Study|Withdrawal by Subject|1|||
163909515|NCT00705159|592038932|FG003|Overall Study|Withdrawal by Subject|1|||
163909516|NCT00705159|592038929|FG000|Overall Study|Protocol Violation|0|||
163909517|NCT00705159|592038930|FG001|Overall Study|Protocol Violation|1|||
163909518|NCT00705159|592038931|FG002|Overall Study|Protocol Violation|0|||
163909519|NCT00705159|592038932|FG003|Overall Study|Protocol Violation|0|||
163909520|NCT00705159|592038929|FG000|Overall Study|Adverse Event|0|||
163909521|NCT00705159|592038930|FG001|Overall Study|Adverse Event|0|||
163909522|NCT00705159|592038931|FG002|Overall Study|Adverse Event|1|||
163909523|NCT00705159|592038932|FG003|Overall Study|Adverse Event|0|||
163909524|NCT00705159|592038929|FG000|Overall Study|Lost to Follow-up|0|||
163909525|NCT00705159|592038930|FG001|Overall Study|Lost to Follow-up|0|||
163909526|NCT00705159|592038931|FG002|Overall Study|Lost to Follow-up|3|||
164020034|NCT01912729|592436011|FG001|Overall Study|Withdrawal by Subject|1|||
164020035|NCT01952834|592436018|FG000|Overall Study|Adverse Event|1|||
164020036|NCT01975272|592436021|FG000|Overall Study|Excluded after protocol amendment|1|||
164020037|NCT01975272|592436022|FG001|Overall Study|Excluded after protocol amendment|1|||
164020038|NCT01975272|592436023|FG002|Overall Study|Excluded after protocol amendment|2|||
164020039|NCT00740779|592436030|FG000|Overall Study|Adverse Event|4|||
164020040|NCT00740779|592436031|FG001|Overall Study|Adverse Event|6|||
164020041|NCT00740779|592436032|FG002|Overall Study|Adverse Event|3|||
164020042|NCT00740779|592436030|FG000|Overall Study|Protocol Violation|1|||
164020043|NCT00740779|592436031|FG001|Overall Study|Protocol Violation|1|||
164020044|NCT00740779|592436032|FG002|Overall Study|Protocol Violation|1|||
164020045|NCT00740779|592436030|FG000|Overall Study|Lack of Efficacy|0|||
164020046|NCT00740779|592436031|FG001|Overall Study|Lack of Efficacy|0|||
164020047|NCT00740779|592436032|FG002|Overall Study|Lack of Efficacy|2|||
164020048|NCT00740779|592436030|FG000|Overall Study|Withdrawal by Subject|2|||
164020049|NCT00740779|592436031|FG001|Overall Study|Withdrawal by Subject|4|||
164020050|NCT00740779|592436032|FG002|Overall Study|Withdrawal by Subject|2|||
164020051|NCT00740779|592436030|FG000|Overall Study|Lost to Follow-up|2|||
163909527|NCT00705159|592038932|FG003|Overall Study|Lost to Follow-up|2|||
163909528|NCT00705159|592038929|FG000|Overall Study|Screen Failure|0|||
163909529|NCT00705159|592038930|FG001|Overall Study|Screen Failure|0|||
163909530|NCT00705159|592038931|FG002|Overall Study|Screen Failure|0|||
163909531|NCT00705159|592038932|FG003|Overall Study|Screen Failure|1|||
163909532|NCT00526994|592038933|FG000|Overall Study|Lost to Follow-up|98|||
163909533|NCT00526994|592038934|FG001|Overall Study|Lost to Follow-up|108|||
163909534|NCT00526994|592038935|FG002|Overall Study|Lost to Follow-up|96|||
163909535|NCT00526994|592038933|FG000|Overall Study|Death|4|||
164020052|NCT00740779|592436031|FG001|Overall Study|Lost to Follow-up|3|||
164020053|NCT00740779|592436032|FG002|Overall Study|Lost to Follow-up|5|||
164020054|NCT00988559|592436036|FG000|Overall Study|Withdrawal by Subject|1|||
164020055|NCT00988559|592436037|FG001|Overall Study|Withdrawal by Subject|1|||
164020056|NCT00988559|592436038|FG002|Overall Study|Withdrawal by Subject|0|||
164020057|NCT00988559|592436039|FG003|Overall Study|Withdrawal by Subject|1|||
164020058|NCT00988559|592436036|FG000|Overall Study|Pregnancy|0|||
164020059|NCT00988559|592436037|FG001|Overall Study|Pregnancy|1|||
164020060|NCT00988559|592436038|FG002|Overall Study|Pregnancy|1|||
164020061|NCT00988559|592436039|FG003|Overall Study|Pregnancy|0|||
164020062|NCT00988559|592436036|FG000|Overall Study|Lost to Follow-up|0|||
164020063|NCT00988559|592436037|FG001|Overall Study|Lost to Follow-up|0|||
164020064|NCT00988559|592436038|FG002|Overall Study|Lost to Follow-up|1|||
164020065|NCT00988559|592436039|FG003|Overall Study|Lost to Follow-up|0|||
164020066|NCT01052012|592436040|FG000|Overall Study|Not treated|2|||
164020067|NCT01052012|592436041|FG001|Overall Study|Not treated|5|||
164020068|NCT01052012|592436042|FG002|Overall Study|Not treated|0|||
164020069|NCT01052012|592436043|FG003|Overall Study|Not treated|0|||
164020070|NCT01052012|592436044|FG004|Overall Study|Not treated|11|||
164020071|NCT01052012|592436045|FG005|Overall Study|Not treated|8|||
164020072|NCT01052012|592436040|FG000|Overall Study|Adverse Event|1|||
164020073|NCT01052012|592436041|FG001|Overall Study|Adverse Event|0|||
164020074|NCT01052012|592436042|FG002|Overall Study|Adverse Event|0|||
164020075|NCT01052012|592436043|FG003|Overall Study|Adverse Event|1|||
164020076|NCT01052012|592436044|FG004|Overall Study|Adverse Event|0|||
164020077|NCT01052012|592436045|FG005|Overall Study|Adverse Event|0|||
164020078|NCT01052012|592436040|FG000|Overall Study|Lost to Follow-up|0|||
164020079|NCT01052012|592436041|FG001|Overall Study|Lost to Follow-up|0|||
164020080|NCT01052012|592436042|FG002|Overall Study|Lost to Follow-up|0|||
164020081|NCT01052012|592436043|FG003|Overall Study|Lost to Follow-up|0|||
164020082|NCT01052012|592436044|FG004|Overall Study|Lost to Follow-up|1|||
164020083|NCT01052012|592436045|FG005|Overall Study|Lost to Follow-up|0|||
164020084|NCT01052012|592436040|FG000|Overall Study|Withdrawal by Subject|1|||
164020085|NCT01052012|592436041|FG001|Overall Study|Withdrawal by Subject|1|||
164020086|NCT01052012|592436042|FG002|Overall Study|Withdrawal by Subject|0|||
164020087|NCT01052012|592436043|FG003|Overall Study|Withdrawal by Subject|0|||
164020088|NCT01052012|592436044|FG004|Overall Study|Withdrawal by Subject|3|||
164020089|NCT01052012|592436045|FG005|Overall Study|Withdrawal by Subject|1|||
164020090|NCT01052012|592436040|FG000|Overall Study|Physician Decision|0|||
164020091|NCT01052012|592436041|FG001|Overall Study|Physician Decision|0|||
164020092|NCT01052012|592436042|FG002|Overall Study|Physician Decision|0|||
164020093|NCT01052012|592436043|FG003|Overall Study|Physician Decision|0|||
164020094|NCT01052012|592436044|FG004|Overall Study|Physician Decision|0|||
164020095|NCT01052012|592436045|FG005|Overall Study|Physician Decision|1|||
164020096|NCT01052012|592436040|FG000|Overall Study|Other|0|||
164020097|NCT01052012|592436041|FG001|Overall Study|Other|0|||
164020098|NCT01052012|592436042|FG002|Overall Study|Other|0|||
164020099|NCT01052012|592436043|FG003|Overall Study|Other|0|||
164020100|NCT01052012|592436044|FG004|Overall Study|Other|1|||
164020101|NCT01052012|592436045|FG005|Overall Study|Other|0|||
164020102|NCT00829166|592436049|FG000|Overall Study|Death|305|||
163909536|NCT00526994|592038934|FG001|Overall Study|Death|3|||
163909537|NCT00526994|592038935|FG002|Overall Study|Death|3|||
163909538|NCT00526994|592038933|FG000|Overall Study|Withdrawal by Subject|2|||
163909539|NCT00526994|592038934|FG001|Overall Study|Withdrawal by Subject|7|||
163909540|NCT00526994|592038935|FG002|Overall Study|Withdrawal by Subject|5|||
163909541|NCT00526994|592038933|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
163909542|NCT00526994|592038934|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
163909543|NCT00526994|592038935|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
163909544|NCT03026166|592038936|FG000|Overall Study|Death|22|||
163909545|NCT03026166|592038937|FG001|Overall Study|Death|7|||
163909546|NCT03026166|592038936|FG000|Overall Study|Physician Decision|2|||
163909547|NCT03026166|592038937|FG001|Overall Study|Physician Decision|0|||
163909548|NCT03026166|592038936|FG000|Overall Study|Withdrawal by Subject|1|||
163909549|NCT03026166|592038937|FG001|Overall Study|Withdrawal by Subject|2|||
163909550|NCT03026166|592038936|FG000|Overall Study|Lost to Follow-up|1|||
163909551|NCT03026166|592038937|FG001|Overall Study|Lost to Follow-up|0|||
163909552|NCT03026166|592038936|FG000|Overall Study|Study Terminated by Sponsor|3|||
163909553|NCT03026166|592038937|FG001|Overall Study|Study Terminated by Sponsor|3|||
163909554|NCT03026166|592038936|FG000|Overall Study|Other|1|||
163909555|NCT03026166|592038937|FG001|Overall Study|Other|0|||
163909556|NCT00266656|592038945|FG000|Overall Study|Death|1|||
163909557|NCT00266656|592038946|FG001|Overall Study|Death|0|||
163909558|NCT00266656|592038945|FG000|Overall Study|Lost to Follow-up|4|||
163909559|NCT00266656|592038946|FG001|Overall Study|Lost to Follow-up|1|||
163909560|NCT00266656|592038945|FG000|Overall Study|Withdrawal by Subject|4|||
163909561|NCT00266656|592038946|FG001|Overall Study|Withdrawal by Subject|2|||
163909562|NCT00266656|592038945|FG000|Overall Study|Did Not Reach Final Height|4|||
163909563|NCT00266656|592038946|FG001|Overall Study|Did Not Reach Final Height|8|||
163909564|NCT00266656|592038945|FG000|Overall Study|Parent/Caregiver Decision|1|||
163909565|NCT00266656|592038946|FG001|Overall Study|Parent/Caregiver Decision|2|||
163909566|NCT01915914|592038947|FG000|Acute Phase|Withdrawal by Subject|4|||
163909567|NCT01915914|592038948|FG001|Acute Phase|Withdrawal by Subject|0|||
163909568|NCT01915914|592038949|FG002|Acute Phase|Withdrawal by Subject|0|||
163909569|NCT01915914|592038950|FG003|Acute Phase|Withdrawal by Subject|0|||
163909570|NCT01915914|592038947|FG000|Acute Phase|Lost to Follow-up|4|||
163909571|NCT01915914|592038948|FG001|Acute Phase|Lost to Follow-up|0|||
163909572|NCT01915914|592038949|FG002|Acute Phase|Lost to Follow-up|0|||
163909573|NCT01915914|592038950|FG003|Acute Phase|Lost to Follow-up|0|||
163909574|NCT01915914|592038947|FG000|Acute Phase|Physician Decision|1|||
163909575|NCT01915914|592038948|FG001|Acute Phase|Physician Decision|0|||
163909576|NCT01915914|592038949|FG002|Acute Phase|Physician Decision|0|||
163909577|NCT01915914|592038950|FG003|Acute Phase|Physician Decision|0|||
163909578|NCT01915914|592038947|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
163909579|NCT01915914|592038948|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
163909580|NCT01915914|592038949|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
163909581|NCT01915914|592038950|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
163909582|NCT01915914|592038947|FG000|Acute Phase|"Not Achieved treatment success"|1|||
163909583|NCT01915914|592038948|FG001|Acute Phase|"Not Achieved treatment success"|0|||
163909584|NCT01915914|592038949|FG002|Acute Phase|"Not Achieved treatment success"|0|||
163909585|NCT01915914|592038950|FG003|Acute Phase|"Not Achieved treatment success"|0|||
163909586|NCT01915914|592038947|FG000|Acute Phase|Missing|1|||
163909587|NCT01915914|592038948|FG001|Acute Phase|Missing|0|||
163909588|NCT01915914|592038949|FG002|Acute Phase|Missing|0|||
163909589|NCT01915914|592038950|FG003|Acute Phase|Missing|0|||
163909590|NCT01915914|592038947|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163909591|NCT01915914|592038948|FG001|Maintenance Phase|Withdrawal by Subject|1|||
163909592|NCT01915914|592038949|FG002|Maintenance Phase|Withdrawal by Subject|1|||
163909593|NCT01915914|592038950|FG003|Maintenance Phase|Withdrawal by Subject|0|||
163909594|NCT01915914|592038947|FG000|Maintenance Phase|Lost to Follow-up|0|||
163909595|NCT01915914|592038948|FG001|Maintenance Phase|Lost to Follow-up|4|||
163909596|NCT01915914|592038949|FG002|Maintenance Phase|Lost to Follow-up|1|||
163909597|NCT01915914|592038950|FG003|Maintenance Phase|Lost to Follow-up|0|||
164144807|NCT01524978|592891777|FG003|Overall Study|Lost to Follow-up|0|||
163909598|NCT01915914|592038947|FG000|Maintenance Phase|Missing|0|||
163909599|NCT01915914|592038948|FG001|Maintenance Phase|Missing|1|||
163909600|NCT01915914|592038949|FG002|Maintenance Phase|Missing|0|||
163909601|NCT01915914|592038950|FG003|Maintenance Phase|Missing|0|||
163909602|NCT01915914|592038947|FG000|Follow-up Phase|Withdrawal by Subject|0|||
163909603|NCT01915914|592038948|FG001|Follow-up Phase|Withdrawal by Subject|0|||
163909604|NCT01915914|592038949|FG002|Follow-up Phase|Withdrawal by Subject|0|||
163909605|NCT01915914|592038950|FG003|Follow-up Phase|Withdrawal by Subject|1|||
163909606|NCT01915914|592038947|FG000|Follow-up Phase|Physician Decision|0|||
163909607|NCT01915914|592038948|FG001|Follow-up Phase|Physician Decision|0|||
163909608|NCT01915914|592038949|FG002|Follow-up Phase|Physician Decision|0|||
163909609|NCT01915914|592038950|FG003|Follow-up Phase|Physician Decision|1|||
163909610|NCT00667732|592038952|FG000|Run -In (8 Weeks)|Adverse Event|4|||
163909611|NCT00667732|592038953|FG001|Run -In (8 Weeks)|Adverse Event|0|||
163909612|NCT00667732|592038954|FG002|Run -In (8 Weeks)|Adverse Event|0|||
163909613|NCT00667732|592038952|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
163909614|NCT00667732|592038953|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
164144808|NCT01524978|592891778|FG004|Overall Study|Lost to Follow-up|1|||
163909615|NCT00667732|592038954|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
163909616|NCT00667732|592038952|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
164020103|NCT00829166|592436050|FG001|Overall Study|Death|333|||
164020104|NCT00829166|592436049|FG000|Overall Study|Lost to Follow-up|5|||
164020105|NCT00829166|592436050|FG001|Overall Study|Lost to Follow-up|4|||
164020106|NCT00829166|592436049|FG000|Overall Study|Physician's Decision|4|||
164020107|NCT00829166|592436050|FG001|Overall Study|Physician's Decision|3|||
164020108|NCT00829166|592436049|FG000|Overall Study|Subject's Decision|41|||
164020109|NCT00829166|592436050|FG001|Overall Study|Subject's Decision|55|||
164020110|NCT00829166|592436049|FG000|Overall Study|Sponsor's Decision|137|||
164020111|NCT00829166|592436050|FG001|Overall Study|Sponsor's Decision|98|||
164020112|NCT00829166|592436049|FG000|Overall Study|Reason Not Specified|3|||
164020113|NCT00829166|592436050|FG001|Overall Study|Reason Not Specified|3|||
164020114|NCT02538666|592436051|FG000|Pre-Treatment|Disease progression|1|||
164020115|NCT02538666|592436052|FG001|Pre-Treatment|Disease progression|0|||
164020116|NCT02538666|592436053|FG002|Pre-Treatment|Disease progression|0|||
164020117|NCT02538666|592436051|FG000|Pre-Treatment|no longer meets study criteria|1|||
164020118|NCT02538666|592436052|FG001|Pre-Treatment|no longer meets study criteria|0|||
164020119|NCT02538666|592436053|FG002|Pre-Treatment|no longer meets study criteria|0|||
164020120|NCT02538666|592436051|FG000|Pre-Treatment|Withdrew Consent|0|||
164020121|NCT02538666|592436052|FG001|Pre-Treatment|Withdrew Consent|1|||
164020122|NCT02538666|592436053|FG002|Pre-Treatment|Withdrew Consent|1|||
164020123|NCT02538666|592436051|FG000|Treatment|Disease progression|270|||
164020124|NCT02538666|592436052|FG001|Treatment|Disease progression|227|||
164020125|NCT02538666|592436053|FG002|Treatment|Disease progression|165|||
164020126|NCT02538666|592436051|FG000|Treatment|Study drug toxicity|1|||
164020127|NCT02538666|592436052|FG001|Treatment|Study drug toxicity|29|||
164020128|NCT02538666|592436053|FG002|Treatment|Study drug toxicity|92|||
164020129|NCT02538666|592436051|FG000|Treatment|Death|0|||
164020130|NCT02538666|592436052|FG001|Treatment|Death|2|||
164020131|NCT02538666|592436053|FG002|Treatment|Death|3|||
164020132|NCT02538666|592436051|FG000|Treatment|Adverse event unrelated to study drug|8|||
164020133|NCT02538666|592436052|FG001|Treatment|Adverse event unrelated to study drug|10|||
164020134|NCT02538666|592436053|FG002|Treatment|Adverse event unrelated to study drug|15|||
164020135|NCT02538666|592436051|FG000|Treatment|Participant request to discontinue study treatment|3|||
164020136|NCT02538666|592436052|FG001|Treatment|Participant request to discontinue study treatment|6|||
164020137|NCT02538666|592436053|FG002|Treatment|Participant request to discontinue study treatment|11|||
164020138|NCT02538666|592436051|FG000|Treatment|Participant withdrew consent|2|||
164020139|NCT02538666|592436052|FG001|Treatment|Participant withdrew consent|5|||
164020140|NCT02538666|592436053|FG002|Treatment|Participant withdrew consent|3|||
164020141|NCT02538666|592436051|FG000|Treatment|Lost to Follow-up|0|||
164020142|NCT02538666|592436052|FG001|Treatment|Lost to Follow-up|1|||
164094955|NCT00849901|592712241|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
164020143|NCT02538666|592436053|FG002|Treatment|Lost to Follow-up|1|||
164020144|NCT02538666|592436051|FG000|Treatment|Maximum clinical benefit|4|||
164020145|NCT02538666|592436052|FG001|Treatment|Maximum clinical benefit|3|||
164020146|NCT02538666|592436053|FG002|Treatment|Maximum clinical benefit|4|||
164020147|NCT02538666|592436051|FG000|Treatment|Poor/non-compliance|0|||
164020148|NCT02538666|592436052|FG001|Treatment|Poor/non-compliance|1|||
164094956|NCT00849901|592712242|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
164020149|NCT02538666|592436053|FG002|Treatment|Poor/non-compliance|0|||
164020150|NCT02538666|592436051|FG000|Treatment|Participant no longer meets study criteria|0|||
164020151|NCT02538666|592436052|FG001|Treatment|Participant no longer meets study criteria|2|||
164020152|NCT02538666|592436053|FG002|Treatment|Participant no longer meets study criteria|0|||
164020153|NCT02538666|592436051|FG000|Treatment|Administrative reason by sponsor|0|||
164020154|NCT02538666|592436052|FG001|Treatment|Administrative reason by sponsor|0|||
164020155|NCT02538666|592436053|FG002|Treatment|Administrative reason by sponsor|1|||
164020156|NCT02538666|592436051|FG000|Treatment|Other reasons|8|||
164020157|NCT02538666|592436052|FG001|Treatment|Other reasons|15|||
164020158|NCT02538666|592436053|FG002|Treatment|Other reasons|5|||
164020159|NCT02538666|592436051|FG000|Treatment|Not reported|2|||
164020160|NCT02538666|592436052|FG001|Treatment|Not reported|2|||
164020161|NCT02538666|592436053|FG002|Treatment|Not reported|2|||
164020162|NCT00320385|592436057|FG000|Overall Study|Lost to Follow-up|7|||
164020163|NCT00320385|592436058|FG001|Overall Study|Lost to Follow-up|10|||
164020164|NCT00320385|592436057|FG000|Overall Study|Withdrawal by Subject|6|||
164020165|NCT00320385|592436058|FG001|Overall Study|Withdrawal by Subject|7|||
164020166|NCT00320385|592436057|FG000|Overall Study|Sponsor Terminated Study|2|||
164020167|NCT00320385|592436058|FG001|Overall Study|Sponsor Terminated Study|1|||
164020168|NCT00320385|592436057|FG000|Overall Study|Investigator Decision|0|||
164020169|NCT00320385|592436058|FG001|Overall Study|Investigator Decision|1|||
164020170|NCT00320385|592436057|FG000|Overall Study|Death|1|||
164020171|NCT00320385|592436058|FG001|Overall Study|Death|2|||
164020172|NCT00320385|592436057|FG000|Overall Study|Serious Adverse Event|1|||
163909617|NCT00667732|592038953|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
163909618|NCT00667732|592038954|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
163909619|NCT03786471|592038959|FG000|Overall Study|Death|254|||
163909620|NCT03786471|592038960|FG001|Overall Study|Death|223|||
163909621|NCT03786471|592038961|FG002|Overall Study|Death|37|||
163909622|NCT03786471|592038959|FG000|Overall Study|Lost to Follow-up|63|||
163909623|NCT03786471|592038960|FG001|Overall Study|Lost to Follow-up|50|||
163909624|NCT03786471|592038961|FG002|Overall Study|Lost to Follow-up|15|||
163909625|NCT03786471|592038959|FG000|Overall Study|Withdrawal by Subject|99|||
164094957|NCT00849901|592712240|FG000|Acute Treatment Phase|Protocol Violation|0|||
164094958|NCT00849901|592712241|FG001|Acute Treatment Phase|Protocol Violation|2|||
164094959|NCT00849901|592712242|FG002|Acute Treatment Phase|Protocol Violation|1|||
164094960|NCT00849901|592712240|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
164094961|NCT00849901|592712241|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
164094962|NCT00849901|592712242|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
164094963|NCT00849901|592712240|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
163909626|NCT03786471|592038960|FG001|Overall Study|Withdrawal by Subject|81|||
163909627|NCT03786471|592038961|FG002|Overall Study|Withdrawal by Subject|11|||
163909628|NCT05006703|592040516|FG000|Overall Study|Withdrawal by Subject|1|||
163909629|NCT05006703|592040517|FG001|Overall Study|Withdrawal by Subject|0|||
163909630|NCT05006703|592040516|FG000|Overall Study|Lost to Follow-up|13|||
163909631|NCT05006703|592040517|FG001|Overall Study|Lost to Follow-up|5|||
163909632|NCT03924193|592040518|FG000|Overall Study|Adverse Event|10|||
163909633|NCT03924193|592040519|FG001|Overall Study|Adverse Event|0|||
163909634|NCT03924193|592040520|FG002|Overall Study|Adverse Event|10|||
163909635|NCT03924193|592040518|FG000|Overall Study|Withdrawal by Subject|5|||
163909636|NCT03924193|592040519|FG001|Overall Study|Withdrawal by Subject|10|||
163909637|NCT03924193|592040520|FG002|Overall Study|Withdrawal by Subject|2|||
163909638|NCT02489799|592040521|FG000|Overall Study|Lost to Follow-up|4|||
163909639|NCT02489799|592040522|FG001|Overall Study|Lost to Follow-up|1|||
163909640|NCT02489799|592040521|FG000|Overall Study|Failure to Maintain Eligibility|4|||
163909641|NCT02489799|592040522|FG001|Overall Study|Failure to Maintain Eligibility|6|||
163909642|NCT02489799|592040521|FG000|Overall Study|Withdrawal by Subject|1|||
164020173|NCT00320385|592436058|FG001|Overall Study|Serious Adverse Event|0|||
163909643|NCT02489799|592040522|FG001|Overall Study|Withdrawal by Subject|1|||
163909644|NCT02489799|592040521|FG000|Overall Study|Death|0|||
163909645|NCT02489799|592040522|FG001|Overall Study|Death|1|||
163909646|NCT00515112|592040524|FG000|Overall Study|Death|0|||
163909647|NCT00515112|592040525|FG001|Overall Study|Death|1|||
163909648|NCT00515112|592040524|FG000|Overall Study|The study was terminated|3|||
163909649|NCT00515112|592040525|FG001|Overall Study|The study was terminated|2|||
163909650|NCT02002689|592040531|FG000|Overall Study|Disease Progression|7|||
163909651|NCT02002689|592040531|FG000|Overall Study|Adverse Event|3|||
163909652|NCT00278395|592040534|FG000|Overall Study|Adverse Event|2|||
163909653|NCT00278395|592040534|FG000|Overall Study|Nonevaluable|1|||
163909654|NCT01148017|592040535|FG000|Overall Study|Withdrawal by Subject|31|||
163909655|NCT01148017|592040536|FG001|Overall Study|Withdrawal by Subject|14|||
163909656|NCT01148017|592040537|FG002|Overall Study|Withdrawal by Subject|0|||
163909657|NCT01148017|592040538|FG003|Overall Study|Withdrawal by Subject|0|||
163909658|NCT01148017|592040535|FG000|Overall Study|Lost to Follow-up|23|||
163909659|NCT01148017|592040536|FG001|Overall Study|Lost to Follow-up|10|||
163909660|NCT01148017|592040537|FG002|Overall Study|Lost to Follow-up|0|||
163909661|NCT01148017|592040538|FG003|Overall Study|Lost to Follow-up|0|||
163909662|NCT01148017|592040535|FG000|Overall Study|Inappropriate enrollment|1|||
163909663|NCT01148017|592040536|FG001|Overall Study|Inappropriate enrollment|0|||
163909664|NCT01148017|592040537|FG002|Overall Study|Inappropriate enrollment|0|||
163909665|NCT01148017|592040538|FG003|Overall Study|Inappropriate enrollment|0|||
163909666|NCT01148017|592040535|FG000|Overall Study|Administrative reason|22|||
163909667|NCT01148017|592040536|FG001|Overall Study|Administrative reason|9|||
163909668|NCT01148017|592040537|FG002|Overall Study|Administrative reason|0|||
163909669|NCT01148017|592040538|FG003|Overall Study|Administrative reason|0|||
163909670|NCT01148017|592040535|FG000|Overall Study|Unable to classify|3|||
163909671|NCT01148017|592040536|FG001|Overall Study|Unable to classify|1|||
163909672|NCT01148017|592040537|FG002|Overall Study|Unable to classify|0|||
163909673|NCT01148017|592040538|FG003|Overall Study|Unable to classify|0|||
163909674|NCT00569166|592040541|FG000|Overall Study|Withdrawal by Subject|7|||
163909675|NCT00569166|592040542|FG001|Overall Study|Withdrawal by Subject|5|||
163909676|NCT00569166|592040543|FG002|Overall Study|Withdrawal by Subject|3|||
163909677|NCT00569166|592040541|FG000|Overall Study|Lost to Follow-up|2|||
163909678|NCT00569166|592040542|FG001|Overall Study|Lost to Follow-up|1|||
163909679|NCT00569166|592040543|FG002|Overall Study|Lost to Follow-up|1|||
163909680|NCT01853384|592040544|FG000|Randomized|Adverse Event|5|||
163909681|NCT01853384|592040545|FG001|Randomized|Adverse Event|3|||
163909682|NCT01853384|592040544|FG000|Randomized|Death|1|||
163909683|NCT01853384|592040545|FG001|Randomized|Death|2|||
163909684|NCT01853384|592040544|FG000|Randomized|Lost to Follow-up|1|||
163909685|NCT01853384|592040545|FG001|Randomized|Lost to Follow-up|1|||
163909686|NCT01853384|592040544|FG000|Randomized|Withdrawal by Subject|5|||
163909687|NCT01853384|592040545|FG001|Randomized|Withdrawal by Subject|3|||
163909688|NCT01853384|592040544|FG000|Randomized|Sponsor Decision|47|||
163909689|NCT01853384|592040545|FG001|Randomized|Sponsor Decision|34|||
163909690|NCT01853384|592040544|FG000|Randomized|Other|3|||
164020174|NCT00320385|592436057|FG000|Overall Study|Withdrew Consent|1|||
164020175|NCT00320385|592436058|FG001|Overall Study|Withdrew Consent|0|||
164020176|NCT00320385|592436057|FG000|Overall Study|Adverse Event|0|||
164020177|NCT00320385|592436058|FG001|Overall Study|Adverse Event|1|||
164020178|NCT04370028|592436059|FG000|Overall Study|Withdrawal by Subject|695|||
164020179|NCT04370028|592436059|FG000|Overall Study|Protocol Violation|9|||
164020180|NCT04370028|592436059|FG000|Overall Study|Adverse Event|3|||
164020181|NCT02582749|592436065|FG000|Overall Study|Study terminated by funder|5|||
164020182|NCT02582749|592436066|FG001|Overall Study|Study terminated by funder|10|||
164020183|NCT02582749|592436065|FG000|Overall Study|Withdrawal by Subject|0|||
164020184|NCT02582749|592436066|FG001|Overall Study|Withdrawal by Subject|1|||
164020185|NCT01518192|592436067|FG000|Overall Study|Lost to Follow-up|29|||
163909691|NCT01853384|592040545|FG001|Randomized|Other|3|||
163909692|NCT01853384|592040544|FG000|Completed Follow up Visit 1|Early Termination|13|||
163909693|NCT01853384|592040545|FG001|Completed Follow up Visit 1|Early Termination|9|||
163909694|NCT01853384|592040544|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
163909695|NCT01853384|592040545|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
163909696|NCT01853384|592040544|FG000|Completed Follow up Visit 2|Adverse Event|1|||
163909697|NCT01853384|592040545|FG001|Completed Follow up Visit 2|Adverse Event|0|||
163909698|NCT01853384|592040544|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
163909699|NCT01853384|592040545|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
163909700|NCT01853384|592040544|FG000|Completed Follow up Visit 2|Death|1|||
163909701|NCT01853384|592040545|FG001|Completed Follow up Visit 2|Death|0|||
163909702|NCT01853384|592040544|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
163909703|NCT01853384|592040545|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
163909704|NCT01019135|592040549|FG000|Overall Study|Did not receive allocated intervention|12|||
163909705|NCT01019135|592040550|FG001|Overall Study|Did not receive allocated intervention|6|||
163909706|NCT01019135|592040551|FG002|Overall Study|Did not receive allocated intervention|25|||
163909707|NCT01019135|592040549|FG000|Overall Study|Did not attend CR|8|||
163909708|NCT01019135|592040550|FG001|Overall Study|Did not attend CR|13|||
163909709|NCT01019135|592040551|FG002|Overall Study|Did not attend CR|6|||
163909710|NCT00486954|592040552|FG000|Pilot Part|Adverse Event|4|||
163909711|NCT00486954|592040553|FG001|Pilot Part|Adverse Event|0|||
163909712|NCT00486954|592040554|FG002|Pilot Part|Adverse Event|5|||
163909713|NCT00486954|592040555|FG003|Pilot Part|Adverse Event|0|||
163909714|NCT00486954|592040556|FG004|Pilot Part|Adverse Event|0|||
163909715|NCT00486954|592040552|FG000|Pilot Part|Disease Progression|2|||
163909716|NCT00486954|592040553|FG001|Pilot Part|Disease Progression|0|||
163909717|NCT00486954|592040554|FG002|Pilot Part|Disease Progression|1|||
163909718|NCT00486954|592040555|FG003|Pilot Part|Disease Progression|0|||
163909719|NCT00486954|592040556|FG004|Pilot Part|Disease Progression|0|||
163909720|NCT00486954|592040552|FG000|Randomized Part|Lost to Follow-up|0|||
163909721|NCT00486954|592040553|FG001|Randomized Part|Lost to Follow-up|0|||
163909722|NCT00486954|592040554|FG002|Randomized Part|Lost to Follow-up|0|||
164020186|NCT01518192|592436068|FG001|Overall Study|Lost to Follow-up|26|||
164020187|NCT01518192|592436069|FG002|Overall Study|Lost to Follow-up|35|||
164020188|NCT00540436|592436075|FG000|First 12-Week Treatment Period|Adverse Event|1|||
164020189|NCT00540436|592436075|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
164020190|NCT00540436|592436075|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
164020191|NCT00540436|592436075|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
164020192|NCT01515306|592436076|FG000|Overall Study|Adverse Event|3|||
164020193|NCT01515306|592436077|FG001|Overall Study|Adverse Event|2|||
164020194|NCT01515306|592436076|FG000|Overall Study|Progressive Disease|19|||
164020195|NCT01515306|592436077|FG001|Overall Study|Progressive Disease|9|||
164020196|NCT01515306|592436076|FG000|Overall Study|Withdrawal by Subject|1|||
164020197|NCT01515306|592436077|FG001|Overall Study|Withdrawal by Subject|2|||
164020198|NCT01515306|592436076|FG000|Overall Study|Physician Decision|1|||
164020199|NCT01515306|592436077|FG001|Overall Study|Physician Decision|1|||
164020200|NCT00683475|592437656|FG000|Overall Study|Withdrawal by Subject|1|||
164020201|NCT00683475|592437657|FG001|Overall Study|Withdrawal by Subject|0|||
164020202|NCT00683475|592437656|FG000|Overall Study|Never Treated: Adverse Event|2|||
164020203|NCT00683475|592437657|FG001|Overall Study|Never Treated: Adverse Event|3|||
164020204|NCT00683475|592437656|FG000|Overall Study|Never Treated: Progressive Disease|1|||
164020205|NCT00683475|592437657|FG001|Overall Study|Never Treated: Progressive Disease|0|||
164020206|NCT03364335|592437659|FG000|Overall Study|Adverse Event|3|||
164020207|NCT03364335|592437660|FG001|Overall Study|Adverse Event|4|||
164020208|NCT03364335|592437661|FG002|Overall Study|Adverse Event|1|||
164020209|NCT03364335|592437662|FG003|Overall Study|Adverse Event|2|||
164020210|NCT03364335|592437663|FG004|Overall Study|Adverse Event|0|||
164020211|NCT03364335|592437659|FG000|Overall Study|Lost to Follow-up|7|||
164020212|NCT03364335|592437660|FG001|Overall Study|Lost to Follow-up|7|||
164020213|NCT03364335|592437661|FG002|Overall Study|Lost to Follow-up|10|||
164020214|NCT03364335|592437662|FG003|Overall Study|Lost to Follow-up|11|||
164020215|NCT03364335|592437663|FG004|Overall Study|Lost to Follow-up|11|||
164020216|NCT03725202|592437664|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
164020217|NCT03725202|592437665|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
164020218|NCT03725202|592437666|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
164020219|NCT03725202|592437667|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164020220|NCT03725202|592437668|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164020221|NCT03725202|592437669|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164020222|NCT03725202|592437670|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164020223|NCT03725202|592437671|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
164020224|NCT03725202|592437664|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
164020225|NCT03725202|592437665|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
164020226|NCT03725202|592437666|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
164020227|NCT03725202|592437667|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164020228|NCT03725202|592437668|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164020229|NCT03725202|592437669|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164020230|NCT03725202|592437670|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164020231|NCT03725202|592437671|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
164094964|NCT00849901|592712241|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
164020232|NCT03725202|592437664|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
164020233|NCT03725202|592437665|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164020234|NCT03725202|592437666|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164020235|NCT03725202|592437667|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164020236|NCT03725202|592437668|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164020237|NCT03725202|592437669|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164020238|NCT03725202|592437670|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164144809|NCT01524978|592891779|FG005|Overall Study|Lost to Follow-up|1|||
163909723|NCT00486954|592040555|FG003|Randomized Part|Lost to Follow-up|0|||
163909724|NCT00486954|592040556|FG004|Randomized Part|Lost to Follow-up|1|||
163909725|NCT00486954|592040552|FG000|Randomized Part|Withdrawal by Subject|0|||
163909726|NCT00486954|592040553|FG001|Randomized Part|Withdrawal by Subject|0|||
163909727|NCT00486954|592040554|FG002|Randomized Part|Withdrawal by Subject|0|||
163909728|NCT00486954|592040555|FG003|Randomized Part|Withdrawal by Subject|1|||
163909729|NCT00486954|592040556|FG004|Randomized Part|Withdrawal by Subject|0|||
163909730|NCT00486954|592040552|FG000|Randomized Part|Sponsor Terminated Study|0|||
163909731|NCT00486954|592040553|FG001|Randomized Part|Sponsor Terminated Study|0|||
163909732|NCT00486954|592040554|FG002|Randomized Part|Sponsor Terminated Study|0|||
163909733|NCT00486954|592040555|FG003|Randomized Part|Sponsor Terminated Study|19|||
163909734|NCT00486954|592040556|FG004|Randomized Part|Sponsor Terminated Study|13|||
163909735|NCT05124210|592040557|FG000|Overall Study|Lost to Follow-up|1|||
163909736|NCT05124210|592040558|FG001|Overall Study|Lost to Follow-up|0|||
163909737|NCT05124210|592040557|FG000|Overall Study|Withdrawal by Subject|1|||
164020239|NCT03725202|592437671|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
164020240|NCT03725202|592437664|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
164020241|NCT03725202|592437665|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020242|NCT03725202|592437666|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020243|NCT03725202|592437667|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020244|NCT03725202|592437668|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020245|NCT03725202|592437669|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020246|NCT03725202|592437670|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020247|NCT03725202|592437671|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
164020248|NCT03725202|592437664|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
164020249|NCT03725202|592437665|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
164020250|NCT03725202|592437666|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
164020251|NCT03725202|592437667|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164020252|NCT03725202|592437668|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164020253|NCT03725202|592437669|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164094965|NCT00849901|592712242|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
164094966|NCT00849901|592712240|FG000|Acute Treatment Phase|Physician Decision|1|||
164094967|NCT00849901|592712241|FG001|Acute Treatment Phase|Physician Decision|1|||
164094968|NCT00849901|592712242|FG002|Acute Treatment Phase|Physician Decision|1|||
164094969|NCT00849901|592712240|FG000|Acute Treatment Phase|Sponsor Decision|1|||
164094970|NCT00849901|592712241|FG001|Acute Treatment Phase|Sponsor Decision|0|||
164094971|NCT00849901|592712242|FG002|Acute Treatment Phase|Sponsor Decision|0|||
164094972|NCT00849901|592712240|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
164094973|NCT00849901|592712241|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
164094974|NCT00849901|592712242|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
164094975|NCT00849901|592712240|FG000|Extension Phase|Adverse Event|2|||
164094976|NCT00849901|592712241|FG001|Extension Phase|Adverse Event|8|||
164094977|NCT00849901|592712242|FG002|Extension Phase|Adverse Event|4|||
164094978|NCT00849901|592712240|FG000|Extension Phase|Lost to Follow-up|3|||
164094979|NCT00849901|592712241|FG001|Extension Phase|Lost to Follow-up|0|||
164094980|NCT00849901|592712242|FG002|Extension Phase|Lost to Follow-up|1|||
164094981|NCT00849901|592712240|FG000|Extension Phase|Protocol Violation|2|||
164094982|NCT00849901|592712241|FG001|Extension Phase|Protocol Violation|2|||
164094983|NCT00849901|592712242|FG002|Extension Phase|Protocol Violation|4|||
164094984|NCT00849901|592712240|FG000|Extension Phase|Withdrawal by Subject|7|||
164094985|NCT00849901|592712241|FG001|Extension Phase|Withdrawal by Subject|6|||
164094986|NCT00849901|592712242|FG002|Extension Phase|Withdrawal by Subject|3|||
164094987|NCT00849901|592712240|FG000|Extension Phase|Parent or Caregiver Decision|10|||
164094988|NCT00849901|592712241|FG001|Extension Phase|Parent or Caregiver Decision|4|||
164094989|NCT00849901|592712242|FG002|Extension Phase|Parent or Caregiver Decision|4|||
164094990|NCT00849901|592712240|FG000|Extension Phase|Physician Decision|1|||
164020254|NCT03725202|592437670|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164020255|NCT03725202|592437671|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
164094991|NCT00849901|592712241|FG001|Extension Phase|Physician Decision|2|||
164094992|NCT00849901|592712242|FG002|Extension Phase|Physician Decision|0|||
164094993|NCT00849901|592712240|FG000|Extension Phase|Lack of Efficacy|2|||
164020256|NCT03725202|592437664|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164094994|NCT00849901|592712241|FG001|Extension Phase|Lack of Efficacy|4|||
164094995|NCT00849901|592712242|FG002|Extension Phase|Lack of Efficacy|1|||
164020257|NCT03725202|592437665|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164020258|NCT03725202|592437666|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
164020259|NCT03725202|592437667|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164020260|NCT03725202|592437668|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164020261|NCT03725202|592437669|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164020262|NCT03725202|592437670|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
164020263|NCT03725202|592437671|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
163909738|NCT05124210|592040558|FG001|Overall Study|Withdrawal by Subject|0|||
163909739|NCT02753075|592040559|FG000|Overall Study|Adverse Event|2|||
163909740|NCT02753075|592040560|FG001|Overall Study|Adverse Event|1|||
163909741|NCT02753075|592040561|FG002|Overall Study|Adverse Event|0|||
163909742|NCT02753075|592040559|FG000|Overall Study|Lost to Follow-up|2|||
163909743|NCT02753075|592040560|FG001|Overall Study|Lost to Follow-up|0|||
163909744|NCT02753075|592040561|FG002|Overall Study|Lost to Follow-up|0|||
163909745|NCT02753075|592040559|FG000|Overall Study|Withdrawal of Consent|1|||
163909746|NCT02753075|592040560|FG001|Overall Study|Withdrawal of Consent|1|||
163909747|NCT02753075|592040561|FG002|Overall Study|Withdrawal of Consent|3|||
163909748|NCT02753075|592040559|FG000|Overall Study|Physician Decision|3|||
163909749|NCT02753075|592040560|FG001|Overall Study|Physician Decision|1|||
163909750|NCT02753075|592040561|FG002|Overall Study|Physician Decision|0|||
163909751|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
163909752|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
163909753|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
163909754|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
163909755|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Adverse Event|7|||
163909756|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Adverse Event|8|||
163909757|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Adverse Event|8|||
163909758|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Adverse Event|9|||
163909759|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
163909760|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
163909761|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
163909762|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
163909763|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
163909764|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
163909765|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
163909766|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
163909767|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Pregnancy|0|||
163909768|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Pregnancy|2|||
163909769|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Pregnancy|2|||
163909770|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Pregnancy|0|||
163909771|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Non-compliance|1|||
163909772|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Non-compliance|0|||
163909773|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Non-compliance|0|||
163909774|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Non-compliance|3|||
163909775|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Other|3|||
164020264|NCT03725202|592437664|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
164020265|NCT03725202|592437665|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
164020266|NCT03725202|592437666|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
164020267|NCT03725202|592437667|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
164020268|NCT03725202|592437668|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
163909776|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Other|0|||
163909777|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Other|3|||
163909778|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Other|2|||
163909779|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
163909780|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
163909781|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
164144810|NCT01524978|592891780|FG006|Overall Study|Lost to Follow-up|2|||
163909782|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
163909783|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
163909784|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
163909785|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
163909786|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
163909787|NCT02143713|592040562|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
163909788|NCT02143713|592040563|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
163909789|NCT02143713|592040564|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
163909790|NCT02143713|592040565|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
163909791|NCT02143713|592040562|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
163909792|NCT02143713|592040563|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
163909793|NCT02143713|592040564|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
163909794|NCT02143713|592040565|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
163909795|NCT02143713|592040562|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
163909796|NCT02143713|592040563|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
163909797|NCT02143713|592040564|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
163909798|NCT02143713|592040565|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
163909799|NCT02143713|592040562|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
163909800|NCT02143713|592040563|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
163909801|NCT02143713|592040564|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
163909802|NCT02143713|592040565|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
163909803|NCT02143713|592040562|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
163909804|NCT02143713|592040563|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
163909805|NCT02143713|592040564|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
163909806|NCT02143713|592040565|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
163909807|NCT02143713|592040562|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
163909808|NCT02143713|592040563|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
163909809|NCT02143713|592040564|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
163909810|NCT02143713|592040565|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
163909811|NCT02143713|592040562|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
163909812|NCT02143713|592040563|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
163909813|NCT02143713|592040564|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
163909814|NCT02143713|592040565|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
163909815|NCT01215253|592040566|FG000|Overall Study|Withdrawal by Subject|57|||
163909816|NCT01215253|592040567|FG001|Overall Study|Withdrawal by Subject|35|||
163909817|NCT01215253|592040566|FG000|Overall Study|Physician Decision|9|||
163909818|NCT01215253|592040567|FG001|Overall Study|Physician Decision|12|||
163909819|NCT01215253|592040566|FG000|Overall Study|Lost to Follow-up|6|||
163909820|NCT01215253|592040567|FG001|Overall Study|Lost to Follow-up|4|||
164020269|NCT03725202|592437669|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
164020270|NCT03725202|592437670|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
164020271|NCT03725202|592437671|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
164020272|NCT03725202|592437664|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
164020273|NCT03725202|592437665|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
164020274|NCT03725202|592437666|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
164020275|NCT03725202|592437667|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
164020276|NCT03725202|592437668|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
164020277|NCT03725202|592437669|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
164020278|NCT03725202|592437670|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
164020279|NCT03725202|592437671|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
164020280|NCT03725202|592437664|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164020281|NCT03725202|592437665|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164020282|NCT03725202|592437666|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164020283|NCT03725202|592437667|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
164020284|NCT03725202|592437668|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164020285|NCT03725202|592437669|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
164020286|NCT03725202|592437670|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
164020287|NCT03725202|592437671|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
164020288|NCT03725202|592437664|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020289|NCT03725202|592437665|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020290|NCT03725202|592437666|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020291|NCT03725202|592437667|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020292|NCT03725202|592437668|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020293|NCT03725202|592437669|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020294|NCT03725202|592437670|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
164020295|NCT03725202|592437671|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
164020296|NCT03725202|592437664|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020297|NCT03725202|592437665|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020298|NCT03725202|592437666|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020299|NCT03725202|592437667|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020300|NCT03725202|592437668|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020301|NCT03725202|592437669|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
164020302|NCT03725202|592437670|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020303|NCT03725202|592437671|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
164020304|NCT03725202|592437664|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164020305|NCT03725202|592437665|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164020306|NCT03725202|592437666|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164020307|NCT03725202|592437667|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
164020308|NCT03725202|592437668|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
164020309|NCT03725202|592437669|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
163909821|NCT01215253|592040566|FG000|Overall Study|Other|14|||
163909822|NCT01215253|592040567|FG001|Overall Study|Other|12|||
164020310|NCT03725202|592437670|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
164020311|NCT03725202|592437671|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
164020312|NCT00262080|592437680|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
164144811|NCT01524978|592891781|FG007|Overall Study|Lost to Follow-up|0|||
164020313|NCT00262080|592437681|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
164020314|NCT00262080|592437682|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
164020315|NCT00262080|592437680|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
164020316|NCT00262080|592437681|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
164020317|NCT00262080|592437682|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
164020318|NCT00262080|592437680|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
164020319|NCT00262080|592437681|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
164020320|NCT00262080|592437682|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
164020321|NCT00262080|592437680|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
164020322|NCT00262080|592437681|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
164020323|NCT00262080|592437682|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
164020324|NCT00262080|592437680|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
164020325|NCT00262080|592437681|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
164020326|NCT00262080|592437682|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
164020327|NCT00262080|592437680|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
164020328|NCT00262080|592437681|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
164020329|NCT00262080|592437682|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
164020330|NCT01051986|592437683|FG000|Overall Study|Death|1|||
164020331|NCT01051986|592437684|FG001|Overall Study|Death|0|||
164020332|NCT01051986|592437683|FG000|Overall Study|Withdrawal by Subject|2|||
164020333|NCT01051986|592437684|FG001|Overall Study|Withdrawal by Subject|1|||
164020334|NCT01051986|592437683|FG000|Overall Study|Protocol Violation|2|||
164020335|NCT01051986|592437684|FG001|Overall Study|Protocol Violation|3|||
164020336|NCT02044159|592437685|FG000|Overall Study|Consent declined (deferred consent)|2|||
164020337|NCT02044159|592437686|FG001|Overall Study|Consent declined (deferred consent)|4|||
164020338|NCT02044159|592437685|FG000|Overall Study|No longer eligible, drug not given|1|||
164020339|NCT02044159|592437686|FG001|Overall Study|No longer eligible, drug not given|0|||
164020340|NCT02044159|592437685|FG000|Overall Study|Nurse declined to give study drug|1|||
164020341|NCT02044159|592437686|FG001|Overall Study|Nurse declined to give study drug|0|||
164020342|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
164020343|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164020344|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164020345|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164020346|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
164020347|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
164020348|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164020349|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164020350|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164020351|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
164020352|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
164020353|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164020354|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164020355|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164020356|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
164094996|NCT00262223|592712245|FG000|Treatment Phase|Withdrawal by Subject|3|||
164020357|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
164020358|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164020359|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164020360|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164020361|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
164020362|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
164020363|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164020364|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164020365|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164020366|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
164020367|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
164020368|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164020369|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164020370|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164020371|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
164020372|NCT01111539|592437687|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
164020373|NCT01111539|592437688|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164020374|NCT01111539|592437689|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164020375|NCT01111539|592437690|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164020376|NCT01111539|592437691|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
164020377|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164020378|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164020379|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
164020380|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
164020381|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
164020382|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164020383|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164020384|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
164020385|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
164020386|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
164020387|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
164020388|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
164020389|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
164020390|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164020391|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
164020392|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164020393|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164020394|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
164020395|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
163909823|NCT00080119|592040568|FG000|Overall Study|Discontinued because of study closure|0|||
163909824|NCT00080119|592040569|FG001|Overall Study|Discontinued because of study closure|0|||
163909825|NCT00080119|592040570|FG002|Overall Study|Discontinued because of study closure|130|||
163909826|NCT00080119|592040571|FG003|Overall Study|Discontinued because of study closure|141|||
163909827|NCT00080119|592040568|FG000|Overall Study|Unable to get to clinic|24|||
163909828|NCT00080119|592040569|FG001|Overall Study|Unable to get to clinic|24|||
163909829|NCT00080119|592040570|FG002|Overall Study|Unable to get to clinic|7|||
163909830|NCT00080119|592040571|FG003|Overall Study|Unable to get to clinic|1|||
163909831|NCT00080119|592040568|FG000|Overall Study|Consent withdrawn|13|||
163909832|NCT00080119|592040569|FG001|Overall Study|Consent withdrawn|17|||
163909833|NCT00080119|592040570|FG002|Overall Study|Consent withdrawn|4|||
163909834|NCT00080119|592040571|FG003|Overall Study|Consent withdrawn|6|||
163909835|NCT00080119|592040568|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
163909836|NCT00080119|592040569|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
163909837|NCT00080119|592040570|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
163909838|NCT00080119|592040571|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
163909839|NCT00080119|592040568|FG000|Overall Study|Lost to Follow-up|16|||
163909840|NCT00080119|592040569|FG001|Overall Study|Lost to Follow-up|19|||
163909841|NCT00080119|592040570|FG002|Overall Study|Lost to Follow-up|19|||
163909842|NCT00080119|592040571|FG003|Overall Study|Lost to Follow-up|14|||
163909843|NCT00889863|592040573|FG000|Part I: Open Label|Death|1|||
164144812|NCT01524978|592891782|FG008|Overall Study|Lost to Follow-up|1|||
163909844|NCT00889863|592040574|FG001|Part I: Open Label|Death|0|||
163909845|NCT00889863|592040573|FG000|Part I: Open Label|Adverse Event|4|||
163909846|NCT00889863|592040574|FG001|Part I: Open Label|Adverse Event|0|||
164094997|NCT00262223|592712246|FG001|Treatment Phase|Withdrawal by Subject|6|||
164094998|NCT00262223|592712245|FG000|Treatment Phase|Adverse Event|1|||
164094999|NCT00262223|592712246|FG001|Treatment Phase|Adverse Event|2|||
164020396|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
164020397|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
163909847|NCT00889863|592040573|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
163909848|NCT00889863|592040574|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
163909849|NCT00889863|592040573|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
163909850|NCT00889863|592040574|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
163909851|NCT00889863|592040573|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
163909852|NCT00889863|592040574|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
163909853|NCT00889863|592040573|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
163909854|NCT00889863|592040574|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
163909855|NCT00889863|592040573|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
163909856|NCT00889863|592040574|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
163909857|NCT01090739|592040575|FG000|Enrollment|Withdrawal by Subject|24|||
163909858|NCT01090739|592040575|FG000|Enrollment|Protocol Violation|14|||
163909859|NCT01090739|592040575|FG000|Enrollment|Lost to Follow-up|5|||
163909860|NCT01090739|592040575|FG000|Enrollment|Physician Decision|5|||
163909861|NCT01090739|592040575|FG000|Enrollment|Sponsor termination of site|4|||
163909862|NCT01090739|592040575|FG000|Enrollment|Study implant limit reached|2|||
163909863|NCT01090739|592040575|FG000|Enrollment|Adverse Event|1|||
163909864|NCT01090739|592040575|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
163909865|NCT01090739|592040575|FG000|12 Month Follow-up|Lost to Follow-up|1|||
163909866|NCT01090739|592040575|FG000|12 Month Follow-up|Physician Decision|1|||
163909867|NCT01090739|592040575|FG000|12 Month Follow-up|Death|1|||
163909868|NCT01090739|592040575|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
163909869|NCT01090739|592040575|FG000|24 Month Follow-up|Lost to Follow-up|1|||
163909870|NCT01090739|592040575|FG000|24 Month Follow-up|Death|1|||
163909871|NCT01090739|592040575|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
163909872|NCT01090739|592040575|FG000|36 Month Follow-up|Visit still pending|17|||
163909873|NCT00441168|592040576|FG000|Treatment Period|Death|3|||
163909874|NCT00441168|592040577|FG001|Treatment Period|Death|0|||
163909875|NCT00441168|592040576|FG000|Treatment Period|Adverse Event|1|||
163909876|NCT00441168|592040577|FG001|Treatment Period|Adverse Event|2|||
163909877|NCT00441168|592040576|FG000|Treatment Period|Progressive Disease|0|||
163909878|NCT00441168|592040577|FG001|Treatment Period|Progressive Disease|2|||
163909879|NCT00441168|592040576|FG000|Treatment Period|Protocol Violation|0|||
163909880|NCT00441168|592040577|FG001|Treatment Period|Protocol Violation|1|||
163909881|NCT00441168|592040576|FG000|Treatment Period|Lost to Follow-up|0|||
163909882|NCT00441168|592040577|FG001|Treatment Period|Lost to Follow-up|1|||
163909883|NCT00441168|592040576|FG000|Treatment Period|Withdrawal by Subject|3|||
163909884|NCT00441168|592040577|FG001|Treatment Period|Withdrawal by Subject|0|||
163909885|NCT00441168|592040576|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
163909886|NCT00441168|592040577|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
163909887|NCT00441168|592040576|FG000|Treatment Period|refractory disease|1|||
163909888|NCT00441168|592040577|FG001|Treatment Period|refractory disease|0|||
163909889|NCT00441168|592040576|FG000|Follow-up Period|Death|3|||
163909890|NCT00441168|592040577|FG001|Follow-up Period|Death|0|||
163909891|NCT00441168|592040576|FG000|Follow-up Period|Lost to Follow-up|5|||
163909892|NCT00441168|592040577|FG001|Follow-up Period|Lost to Follow-up|6|||
163909893|NCT00441168|592040576|FG000|Follow-up Period|Withdrawal by Subject|3|||
163909894|NCT00441168|592040577|FG001|Follow-up Period|Withdrawal by Subject|0|||
163909895|NCT00441168|592040576|FG000|Follow-up Period|Other|1|||
163909896|NCT00441168|592040577|FG001|Follow-up Period|Other|3|||
163909897|NCT04410445|592040579|FG000|Overall Study|Lost to Follow-up|3|||
163909898|NCT04410445|592040580|FG001|Overall Study|Lost to Follow-up|9|||
163909899|NCT04410445|592040579|FG000|Overall Study|Withdrawal by Subject|27|||
163909900|NCT04410445|592040580|FG001|Overall Study|Withdrawal by Subject|15|||
163909901|NCT02291861|592040581|FG000|Overall Study|Adverse Event|2|||
163909902|NCT02291861|592040582|FG001|Overall Study|Adverse Event|4|||
163909903|NCT02291861|592040583|FG002|Overall Study|Adverse Event|1|||
163909904|NCT02291861|592040584|FG003|Overall Study|Adverse Event|2|||
163909905|NCT02291861|592040581|FG000|Overall Study|Death|0|||
163909906|NCT02291861|592040582|FG001|Overall Study|Death|0|||
163909907|NCT02291861|592040583|FG002|Overall Study|Death|1|||
163909908|NCT02291861|592040584|FG003|Overall Study|Death|1|||
163909909|NCT02291861|592040581|FG000|Overall Study|Protocol Violation|1|||
163909910|NCT02291861|592040582|FG001|Overall Study|Protocol Violation|0|||
163909911|NCT02291861|592040583|FG002|Overall Study|Protocol Violation|0|||
163909912|NCT02291861|592040584|FG003|Overall Study|Protocol Violation|1|||
163909913|NCT02291861|592040581|FG000|Overall Study|Withdrawal by Subject|1|||
163909914|NCT02291861|592040582|FG001|Overall Study|Withdrawal by Subject|2|||
163909915|NCT02291861|592040583|FG002|Overall Study|Withdrawal by Subject|1|||
163909916|NCT02291861|592040584|FG003|Overall Study|Withdrawal by Subject|4|||
163909917|NCT02291861|592040581|FG000|Overall Study|Noncompliance|1|||
163909918|NCT02291861|592040582|FG001|Overall Study|Noncompliance|1|||
163909919|NCT02291861|592040583|FG002|Overall Study|Noncompliance|2|||
163909920|NCT02291861|592040584|FG003|Overall Study|Noncompliance|1|||
163909921|NCT02291861|592040581|FG000|Overall Study|Lost to Follow-up|2|||
163909922|NCT02291861|592040582|FG001|Overall Study|Lost to Follow-up|1|||
163909923|NCT02291861|592040583|FG002|Overall Study|Lost to Follow-up|4|||
163909924|NCT02291861|592040584|FG003|Overall Study|Lost to Follow-up|0|||
163909925|NCT02291861|592040581|FG000|Overall Study|Other|0|||
163909926|NCT02291861|592040582|FG001|Overall Study|Other|0|||
163909927|NCT02291861|592040583|FG002|Overall Study|Other|0|||
163909928|NCT02291861|592040584|FG003|Overall Study|Other|1|||
163909929|NCT02005484|592040587|FG000|Overall Study|Death|1|||
163909930|NCT02005484|592040587|FG000|Overall Study|Disease progression|1|||
163909931|NCT02005484|592040587|FG000|Overall Study|Changed to a Different Study|1|||
163909932|NCT02005484|592040587|FG000|Overall Study|Sponsor decision|1|||
163909933|NCT03547154|592040591|FG000|Overall Study|Disease Progression/Recurrence|6|||
163909934|NCT03547154|592040592|FG001|Overall Study|Disease Progression/Recurrence|14|||
163909935|NCT03547154|592040591|FG000|Overall Study|Adverse Event|26|||
163909936|NCT03547154|592040592|FG001|Overall Study|Adverse Event|31|||
163909937|NCT03547154|592040591|FG000|Overall Study|Protocol Violation|6|||
163909938|NCT03547154|592040592|FG001|Overall Study|Protocol Violation|1|||
163909939|NCT03547154|592040591|FG000|Overall Study|Physician Decision|4|||
163909940|NCT03547154|592040592|FG001|Overall Study|Physician Decision|3|||
163909941|NCT03547154|592040591|FG000|Overall Study|Insufficient Therapeutic Response|13|||
163909942|NCT03547154|592040592|FG001|Overall Study|Insufficient Therapeutic Response|10|||
163909943|NCT03547154|592040591|FG000|Overall Study|Withdrawal by Subject|10|||
163909944|NCT03547154|592040592|FG001|Overall Study|Withdrawal by Subject|6|||
163909945|NCT03547154|592040591|FG000|Overall Study|Not Selected|0|||
164020398|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
164020399|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
164020400|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
163909946|NCT03547154|592040592|FG001|Overall Study|Not Selected|1|||
164020401|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
163909947|NCT03547154|592040591|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
164020402|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164020403|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164020404|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164020405|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
164020406|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
164020407|NCT01111539|592437687|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164020408|NCT01111539|592437688|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164020409|NCT01111539|592437689|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164020410|NCT01111539|592437690|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
164020411|NCT01111539|592437691|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
164020412|NCT03580382|592437696|FG000|Overall Study|Early Termination of Study|0|||
164020413|NCT03580382|592437697|FG001|Overall Study|Early Termination of Study|3|||
164020414|NCT02808312|592437698|FG000|Overall Study|Enrolled but Never Treated|0|||
164020415|NCT02808312|592437699|FG001|Overall Study|Enrolled but Never Treated|0|||
164020416|NCT02808312|592437700|FG002|Overall Study|Enrolled but Never Treated|1|||
164020417|NCT02808312|592437701|FG003|Overall Study|Enrolled but Never Treated|0|||
164020418|NCT02808312|592437702|FG004|Overall Study|Enrolled but Never Treated|0|||
164020419|NCT03628417|592437703|FG000|Overall Study|Death|1|||
164020420|NCT03628417|592437704|FG001|Overall Study|Death|1|||
164020421|NCT01361009|592437705|FG000|Overall Study|Protocol Violation|116|||
164020422|NCT01597557|592437709|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
164020423|NCT01597557|592437710|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
164020424|NCT02935634|592437714|FG000|Randomization|Participant withdrew consent|0|||
164020425|NCT02935634|592437715|FG001|Randomization|Participant withdrew consent|1|||
164020426|NCT02935634|592437716|FG002|Randomization|Participant withdrew consent|0|||
164020427|NCT02935634|592437717|FG003|Randomization|Participant withdrew consent|0|||
164020428|NCT02935634|592437718|FG004|Randomization|Participant withdrew consent|0|||
164020429|NCT02935634|592437719|FG005|Randomization|Participant withdrew consent|0|||
164020430|NCT02935634|592437714|FG000|Randomization|Death|2|||
164020431|NCT02935634|592437715|FG001|Randomization|Death|1|||
164020432|NCT02935634|592437716|FG002|Randomization|Death|1|||
164020433|NCT02935634|592437717|FG003|Randomization|Death|0|||
164020434|NCT02935634|592437718|FG004|Randomization|Death|0|||
164020435|NCT02935634|592437719|FG005|Randomization|Death|0|||
164020436|NCT02935634|592437714|FG000|Randomization|Other reasons|0|||
164020437|NCT02935634|592437715|FG001|Randomization|Other reasons|2|||
164020438|NCT02935634|592437716|FG002|Randomization|Other reasons|2|||
164020439|NCT02935634|592437717|FG003|Randomization|Other reasons|0|||
164020440|NCT02935634|592437718|FG004|Randomization|Other reasons|0|||
164020441|NCT02935634|592437719|FG005|Randomization|Other reasons|0|||
164020442|NCT02935634|592437714|FG000|Treatment: Track 1|Disease progression|15|||
164020443|NCT02935634|592437715|FG001|Treatment: Track 1|Disease progression|17|||
164020444|NCT02935634|592437716|FG002|Treatment: Track 1|Disease progression|28|||
164020445|NCT02935634|592437717|FG003|Treatment: Track 1|Disease progression|4|||
164020446|NCT02935634|592437718|FG004|Treatment: Track 1|Disease progression|6|||
164095000|NCT00262223|592712245|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
164095001|NCT00262223|592712246|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
164095002|NCT00262223|592712245|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
164095003|NCT00262223|592712246|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
164095004|NCT00262223|592712245|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
164095005|NCT00262223|592712246|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
164095006|NCT00437658|592712247|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
164095007|NCT00437658|592712248|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
164095008|NCT00437658|592712249|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
164095009|NCT00437658|592712247|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
164095010|NCT00437658|592712248|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
164095011|NCT00437658|592712249|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
164095012|NCT00437658|592712247|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
164095013|NCT00437658|592712248|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
164095014|NCT00437658|592712249|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
164095015|NCT00437658|592712247|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
164095016|NCT00437658|592712248|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
164095017|NCT00437658|592712249|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
164095018|NCT00437658|592712247|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
164095019|NCT00437658|592712248|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
164095020|NCT00437658|592712249|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
164095021|NCT00437658|592712247|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
164095022|NCT00437658|592712248|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
164095023|NCT00437658|592712249|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
164095024|NCT00437658|592712247|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
164095025|NCT00437658|592712248|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
164095026|NCT00437658|592712249|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
164095027|NCT00437658|592712247|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
164095028|NCT00437658|592712248|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
164095029|NCT00437658|592712249|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
164095030|NCT00437658|592712247|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
164095031|NCT00437658|592712248|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
164095032|NCT00437658|592712249|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
164095033|NCT00437658|592712247|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
164095034|NCT00437658|592712248|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
164095035|NCT00437658|592712249|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
164095036|NCT00437658|592712247|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
164095037|NCT00437658|592712248|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
164095038|NCT00437658|592712249|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
164095039|NCT00437658|592712247|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
164095040|NCT00437658|592712248|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
164095041|NCT00437658|592712249|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
164095042|NCT03952143|592712250|FG000|Lead-In Period|Adverse Event|2|||
164095043|NCT03952143|592712251|FG001|Lead-In Period|Adverse Event|0|||
164095044|NCT03952143|592712252|FG002|Lead-In Period|Adverse Event|0|||
164095045|NCT03952143|592712250|FG000|Lead-In Period|Lack of Efficacy|2|||
164095046|NCT03952143|592712251|FG001|Lead-In Period|Lack of Efficacy|0|||
164095047|NCT03952143|592712252|FG002|Lead-In Period|Lack of Efficacy|0|||
164095048|NCT03952143|592712250|FG000|Lead-In Period|Physician Decision|5|||
164095049|NCT03952143|592712251|FG001|Lead-In Period|Physician Decision|0|||
164095050|NCT03952143|592712252|FG002|Lead-In Period|Physician Decision|0|||
164095051|NCT03952143|592712250|FG000|Lead-In Period|Protocol Violation|5|||
164095052|NCT03952143|592712251|FG001|Lead-In Period|Protocol Violation|0|||
164095053|NCT03952143|592712252|FG002|Lead-In Period|Protocol Violation|0|||
164095054|NCT03952143|592712250|FG000|Lead-In Period|Withdrawal by Subject|19|||
163909948|NCT03547154|592040592|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
163909949|NCT03909100|592040593|FG000|Overall Study|Protocol Deviation|2|||
163909950|NCT03909100|592040593|FG000|Overall Study|Technical Problems|4|||
163909951|NCT03909100|592040593|FG000|Overall Study|Withdrawal by Subject|4|||
163909952|NCT03909100|592040593|FG000|Overall Study|Lost to Follow-up|1|||
163909953|NCT03909100|592040593|FG000|Overall Study|Reason not Specified|4|||
163909954|NCT01794299|592040595|FG000|Overall Study|ATIR manufacturing not possible|1|||
163909955|NCT01794299|592040595|FG000|Overall Study|Death|14|||
163909956|NCT01794299|592040595|FG000|Overall Study|Graft failure|1|||
163909957|NCT01794299|592040595|FG000|Overall Study|ATIR batch rejected|2|||
163909958|NCT01794299|592040595|FG000|Overall Study|Relapse|2|||
163909959|NCT01794299|592040595|FG000|Overall Study|Discontinued from active follow-up|1|||
163909960|NCT01794299|592040595|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
163909961|NCT03006393|592040596|FG000|Overall Study|Withdrawal by Subject|1|||
163909962|NCT03006393|592040597|FG001|Overall Study|Withdrawal by Subject|1|||
163909963|NCT03006393|592040596|FG000|Overall Study|Pregnancy|0|||
163909964|NCT03006393|592040597|FG001|Overall Study|Pregnancy|1|||
163909965|NCT03006393|592040596|FG000|Overall Study|Lost to Follow-up|0|||
163909966|NCT03006393|592040597|FG001|Overall Study|Lost to Follow-up|1|||
163909967|NCT00807599|592040600|FG000|Overall Study|Not treated on protocol study|0|||
163909968|NCT00807599|592040601|FG001|Overall Study|Not treated on protocol study|0|||
163909969|NCT00807599|592040602|FG002|Overall Study|Not treated on protocol study|2|||
163909970|NCT00807599|592040600|FG000|Overall Study|Adverse Event|0|||
163909971|NCT00807599|592040601|FG001|Overall Study|Adverse Event|0|||
163909972|NCT00807599|592040602|FG002|Overall Study|Adverse Event|5|||
163909973|NCT00807599|592040600|FG000|Overall Study|Inadequate response to induction|0|||
163909974|NCT00807599|592040601|FG001|Overall Study|Inadequate response to induction|0|||
163909975|NCT00807599|592040602|FG002|Overall Study|Inadequate response to induction|9|||
163909976|NCT00807599|592040600|FG000|Overall Study|Withdrawal by Subject|0|||
163909977|NCT00807599|592040601|FG001|Overall Study|Withdrawal by Subject|0|||
163909978|NCT00807599|592040602|FG002|Overall Study|Withdrawal by Subject|1|||
163909979|NCT01262456|592040603|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
163909980|NCT01262456|592040604|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
164020447|NCT02935634|592437719|FG005|Treatment: Track 1|Disease progression|2|||
164020448|NCT02935634|592437714|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
164020449|NCT02935634|592437715|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
164020450|NCT02935634|592437716|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
164020451|NCT02935634|592437717|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
164020452|NCT02935634|592437718|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
163909981|NCT01262456|592040605|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
164020453|NCT02935634|592437719|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
164020454|NCT02935634|592437714|FG000|Treatment: Track 1|Lost to Follow-up|1|||
164020455|NCT02935634|592437715|FG001|Treatment: Track 1|Lost to Follow-up|0|||
164020456|NCT02935634|592437716|FG002|Treatment: Track 1|Lost to Follow-up|0|||
164020457|NCT02935634|592437717|FG003|Treatment: Track 1|Lost to Follow-up|0|||
164020458|NCT02935634|592437718|FG004|Treatment: Track 1|Lost to Follow-up|0|||
164020459|NCT02935634|592437719|FG005|Treatment: Track 1|Lost to Follow-up|0|||
164020460|NCT02935634|592437714|FG000|Treatment: Track 1|Study drug toxicity|2|||
163909982|NCT01262456|592040603|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
163909983|NCT01262456|592040604|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
164020461|NCT02935634|592437715|FG001|Treatment: Track 1|Study drug toxicity|1|||
164020462|NCT02935634|592437716|FG002|Treatment: Track 1|Study drug toxicity|3|||
164020463|NCT02935634|592437717|FG003|Treatment: Track 1|Study drug toxicity|0|||
163909984|NCT01262456|592040605|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
163909985|NCT01262456|592040603|FG000|3-Month Double-Blind Period|Adverse Event|6|||
163909986|NCT01262456|592040604|FG001|3-Month Double-Blind Period|Adverse Event|4|||
163909987|NCT01262456|592040605|FG002|3-Month Double-Blind Period|Adverse Event|8|||
164020464|NCT02935634|592437718|FG004|Treatment: Track 1|Study drug toxicity|0|||
164020465|NCT02935634|592437719|FG005|Treatment: Track 1|Study drug toxicity|1|||
164020466|NCT02935634|592437714|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
164020467|NCT02935634|592437715|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
164020468|NCT02935634|592437716|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
164020469|NCT02935634|592437717|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
164020470|NCT02935634|592437718|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
164020471|NCT02935634|592437719|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
164020472|NCT02935634|592437714|FG000|Treatment: Track 1|Participant withdrew consent|2|||
164020473|NCT02935634|592437715|FG001|Treatment: Track 1|Participant withdrew consent|0|||
164020474|NCT02935634|592437716|FG002|Treatment: Track 1|Participant withdrew consent|1|||
164020475|NCT02935634|592437717|FG003|Treatment: Track 1|Participant withdrew consent|0|||
164020476|NCT02935634|592437718|FG004|Treatment: Track 1|Participant withdrew consent|1|||
164020477|NCT02935634|592437719|FG005|Treatment: Track 1|Participant withdrew consent|0|||
164020478|NCT02935634|592437714|FG000|Treatment: Track 1|Other reasons|0|||
164020479|NCT02935634|592437715|FG001|Treatment: Track 1|Other reasons|0|||
164020480|NCT02935634|592437716|FG002|Treatment: Track 1|Other reasons|2|||
164020481|NCT02935634|592437717|FG003|Treatment: Track 1|Other reasons|0|||
164020482|NCT02935634|592437718|FG004|Treatment: Track 1|Other reasons|0|||
164020483|NCT02935634|592437719|FG005|Treatment: Track 1|Other reasons|0|||
164020484|NCT02935634|592437714|FG000|Treatment: Track 2|Disease progression|13|||
164020485|NCT02935634|592437715|FG001|Treatment: Track 2|Disease progression|26|||
164020486|NCT02935634|592437716|FG002|Treatment: Track 2|Disease progression|20|||
164020487|NCT02935634|592437717|FG003|Treatment: Track 2|Disease progression|5|||
164020488|NCT02935634|592437718|FG004|Treatment: Track 2|Disease progression|1|||
164020489|NCT02935634|592437719|FG005|Treatment: Track 2|Disease progression|4|||
164020490|NCT02935634|592437714|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
164020491|NCT02935634|592437715|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
164020492|NCT02935634|592437716|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164020493|NCT02935634|592437717|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164020494|NCT02935634|592437718|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164020495|NCT02935634|592437719|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
164020496|NCT02935634|592437714|FG000|Treatment: Track 2|Study drug toxicity|7|||
164020497|NCT02935634|592437715|FG001|Treatment: Track 2|Study drug toxicity|3|||
164020498|NCT02935634|592437716|FG002|Treatment: Track 2|Study drug toxicity|0|||
164020499|NCT02935634|592437717|FG003|Treatment: Track 2|Study drug toxicity|0|||
164020500|NCT02935634|592437718|FG004|Treatment: Track 2|Study drug toxicity|0|||
164020501|NCT02935634|592437719|FG005|Treatment: Track 2|Study drug toxicity|0|||
164020502|NCT02935634|592437714|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
164020503|NCT02935634|592437715|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
164020504|NCT02935634|592437716|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
164020505|NCT02935634|592437717|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
164020506|NCT02935634|592437718|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
164020507|NCT02935634|592437719|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
164020508|NCT02935634|592437714|FG000|Treatment: Track 2|Participant withdrew consent|0|||
164020509|NCT02935634|592437715|FG001|Treatment: Track 2|Participant withdrew consent|1|||
164020510|NCT02935634|592437716|FG002|Treatment: Track 2|Participant withdrew consent|1|||
164020511|NCT02935634|592437717|FG003|Treatment: Track 2|Participant withdrew consent|0|||
164020512|NCT02935634|592437718|FG004|Treatment: Track 2|Participant withdrew consent|1|||
164020513|NCT02935634|592437719|FG005|Treatment: Track 2|Participant withdrew consent|0|||
164020514|NCT06150573|592437722|FG000|Overall Study|Did not meet study criteria|1|||
164020515|NCT06150573|592437723|FG001|Overall Study|Did not meet study criteria|0|||
164020516|NCT06150573|592437722|FG000|Overall Study|Adverse Event|1|||
164020517|NCT06150573|592437723|FG001|Overall Study|Adverse Event|0|||
164020518|NCT06150573|592437722|FG000|Overall Study|Lost to Follow-up|0|||
164020519|NCT06150573|592437723|FG001|Overall Study|Lost to Follow-up|1|||
164020520|NCT06150573|592437722|FG000|Overall Study|Protocol Violation|0|||
164095055|NCT03952143|592712251|FG001|Lead-In Period|Withdrawal by Subject|0|||
164020521|NCT06150573|592437723|FG001|Overall Study|Protocol Violation|1|||
164020522|NCT06150573|592437722|FG000|Overall Study|Withdrawal by Subject|2|||
164020523|NCT06150573|592437723|FG001|Overall Study|Withdrawal by Subject|0|||
164020524|NCT00210158|592437724|FG000|Overall Study|Protocol Violation|0|||
164020525|NCT00210158|592437725|FG001|Overall Study|Protocol Violation|2|||
164020526|NCT02284906|592437730|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164020527|NCT02284906|592437731|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
164095056|NCT03952143|592712252|FG002|Lead-In Period|Withdrawal by Subject|0|||
164095057|NCT03952143|592712250|FG000|Treatment Period|Adverse Event|0|||
164095058|NCT03952143|592712251|FG001|Treatment Period|Adverse Event|0|||
164095059|NCT03952143|592712252|FG002|Treatment Period|Adverse Event|1|||
164095060|NCT03952143|592712250|FG000|Treatment Period|Lost to Follow-up|0|||
164095061|NCT03952143|592712251|FG001|Treatment Period|Lost to Follow-up|2|||
164095062|NCT03952143|592712252|FG002|Treatment Period|Lost to Follow-up|0|||
164095063|NCT03952143|592712250|FG000|Treatment Period|Physician Decision|0|||
164095064|NCT03952143|592712251|FG001|Treatment Period|Physician Decision|0|||
164095065|NCT03952143|592712252|FG002|Treatment Period|Physician Decision|2|||
164095066|NCT03952143|592712250|FG000|Treatment Period|Protocol Violation|0|||
164095067|NCT03952143|592712251|FG001|Treatment Period|Protocol Violation|0|||
164095068|NCT03952143|592712252|FG002|Treatment Period|Protocol Violation|1|||
164095069|NCT03952143|592712250|FG000|Treatment Period|Withdrawal by Subject|0|||
164095070|NCT03952143|592712251|FG001|Treatment Period|Withdrawal by Subject|5|||
164095071|NCT03952143|592712252|FG002|Treatment Period|Withdrawal by Subject|26|||
164095072|NCT03952143|592712250|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
164095073|NCT03952143|592712251|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
164095074|NCT03952143|592712252|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
164020528|NCT02284906|592437732|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164020529|NCT02284906|592437730|FG000|Overall Study|Major Protocol Deviation|0|||
164020530|NCT02284906|592437731|FG001|Overall Study|Major Protocol Deviation|1|||
164020531|NCT02284906|592437732|FG002|Overall Study|Major Protocol Deviation|0|||
164020532|NCT02284906|592437730|FG000|Overall Study|Voluntary Withdrawal|2|||
164020533|NCT02284906|592437731|FG001|Overall Study|Voluntary Withdrawal|4|||
164020534|NCT02284906|592437732|FG002|Overall Study|Voluntary Withdrawal|5|||
164020535|NCT02284906|592437730|FG000|Overall Study|Study Termination|0|||
164020536|NCT02284906|592437731|FG001|Overall Study|Study Termination|11|||
164020537|NCT02284906|592437732|FG002|Overall Study|Study Termination|14|||
164020538|NCT02284906|592437730|FG000|Overall Study|Reason not Specified|1|||
164020539|NCT02284906|592437731|FG001|Overall Study|Reason not Specified|1|||
164020540|NCT02284906|592437732|FG002|Overall Study|Reason not Specified|0|||
164020541|NCT03885726|592437734|FG000|Overall Study|Staffing issues/lost interest|1|||
164020542|NCT03885726|592437734|FG000|Overall Study|Early discharge from hospital|3|||
164020543|NCT04096326|592437735|FG000|Overall Study|Withdrawal by Subject|0|||
164020544|NCT04096326|592437736|FG001|Overall Study|Withdrawal by Subject|0|||
164020545|NCT04096326|592437737|FG002|Overall Study|Withdrawal by Subject|0|||
164020546|NCT04096326|592437738|FG003|Overall Study|Withdrawal by Subject|0|||
164020547|NCT04096326|592437739|FG004|Overall Study|Withdrawal by Subject|0|||
164020548|NCT04096326|592437740|FG005|Overall Study|Withdrawal by Subject|0|||
164020549|NCT04096326|592437741|FG006|Overall Study|Withdrawal by Subject|1|||
164020550|NCT04096326|592437742|FG007|Overall Study|Withdrawal by Subject|0|||
164020551|NCT04096326|592437743|FG008|Overall Study|Withdrawal by Subject|0|||
164020552|NCT04096326|592437744|FG009|Overall Study|Withdrawal by Subject|0|||
164020553|NCT04096326|592437735|FG000|Overall Study|Lost to Follow-up|0|||
164020554|NCT04096326|592437736|FG001|Overall Study|Lost to Follow-up|1|||
164020555|NCT04096326|592437737|FG002|Overall Study|Lost to Follow-up|0|||
164095075|NCT03952143|592712250|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
164095076|NCT03952143|592712251|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
164095077|NCT03952143|592712252|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
164020556|NCT04096326|592437738|FG003|Overall Study|Lost to Follow-up|0|||
164020557|NCT04096326|592437739|FG004|Overall Study|Lost to Follow-up|0|||
164020558|NCT04096326|592437740|FG005|Overall Study|Lost to Follow-up|0|||
164020559|NCT04096326|592437741|FG006|Overall Study|Lost to Follow-up|0|||
164020560|NCT04096326|592437742|FG007|Overall Study|Lost to Follow-up|0|||
164020561|NCT04096326|592437743|FG008|Overall Study|Lost to Follow-up|0|||
164020562|NCT04096326|592437744|FG009|Overall Study|Lost to Follow-up|0|||
164020563|NCT04096326|592437735|FG000|Overall Study|COVID-19-related reasons|0|||
164020564|NCT04096326|592437736|FG001|Overall Study|COVID-19-related reasons|0|||
164095078|NCT02152566|592712253|FG000|Overall Study|Lost to Follow-up|1|||
164095079|NCT02152566|592712253|FG000|Overall Study|Withdrawal by Subject|2|||
164095080|NCT01866319|592712254|FG000|Overall Study|Adverse Event|12|||
164095081|NCT01866319|592712255|FG001|Overall Study|Adverse Event|5|||
164095082|NCT01866319|592712256|FG002|Overall Study|Adverse Event|9|||
164095083|NCT01866319|592712254|FG000|Overall Study|Clinical progression|3|||
164095084|NCT01866319|592712255|FG001|Overall Study|Clinical progression|2|||
164095085|NCT01866319|592712256|FG002|Overall Study|Clinical progression|2|||
164095086|NCT01866319|592712254|FG000|Overall Study|Death|153|||
164095087|NCT01866319|592712255|FG001|Overall Study|Death|154|||
164095088|NCT01866319|592712256|FG002|Overall Study|Death|147|||
164095089|NCT01866319|592712254|FG000|Overall Study|Lost to Follow-up|6|||
164095090|NCT01866319|592712255|FG001|Overall Study|Lost to Follow-up|3|||
164095091|NCT01866319|592712256|FG002|Overall Study|Lost to Follow-up|8|||
164095092|NCT01866319|592712254|FG000|Overall Study|Physician Decision|1|||
164095093|NCT01866319|592712255|FG001|Overall Study|Physician Decision|0|||
164095094|NCT01866319|592712256|FG002|Overall Study|Physician Decision|1|||
164095095|NCT01866319|592712254|FG000|Overall Study|Protocol Violation|0|||
164095096|NCT01866319|592712255|FG001|Overall Study|Protocol Violation|0|||
164095097|NCT01866319|592712256|FG002|Overall Study|Protocol Violation|1|||
164095098|NCT01866319|592712254|FG000|Overall Study|Withdrawal by Subject|32|||
164095099|NCT01866319|592712255|FG001|Overall Study|Withdrawal by Subject|14|||
164095100|NCT01866319|592712256|FG002|Overall Study|Withdrawal by Subject|12|||
164095101|NCT00496964|592712257|FG000|Overall Study|Withdrawal by Subject|0|||
164095102|NCT00496964|592712258|FG001|Overall Study|Withdrawal by Subject|1|||
164095103|NCT02942264|592712259|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095104|NCT02942264|592712260|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
164095105|NCT02942264|592712261|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095106|NCT02942264|592712262|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095107|NCT02942264|592712263|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095108|NCT02942264|592712264|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095109|NCT02942264|592712265|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
164095110|NCT02942264|592712266|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095111|NCT02942264|592712267|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
164095112|NCT02942264|592712259|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095113|NCT02942264|592712260|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095114|NCT02942264|592712261|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095115|NCT02942264|592712262|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095116|NCT02942264|592712263|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095117|NCT02942264|592712264|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095118|NCT02942264|592712265|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095119|NCT02942264|592712266|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
164095120|NCT02942264|592712267|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
164095121|NCT01328093|592712268|FG000|Double-Blind Phase|Adverse Event|78|||
164095122|NCT01328093|592712269|FG001|Double-Blind Phase|Adverse Event|15|||
164095123|NCT01328093|592712268|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
164095124|NCT01328093|592712269|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
164095125|NCT01328093|592712268|FG000|Double-Blind Phase|Lost to Follow-up|39|||
164095126|NCT01328093|592712269|FG001|Double-Blind Phase|Lost to Follow-up|14|||
164095127|NCT01328093|592712268|FG000|Double-Blind Phase|Protocol Violation|30|||
164095128|NCT01328093|592712269|FG001|Double-Blind Phase|Protocol Violation|10|||
164095129|NCT01328093|592712268|FG000|Double-Blind Phase|Lack of Efficacy|55|||
164095130|NCT01328093|592712269|FG001|Double-Blind Phase|Lack of Efficacy|13|||
164095131|NCT01328093|592712268|FG000|Double-Blind Phase|Sponsor Decision|17|||
164095132|NCT01328093|592712269|FG001|Double-Blind Phase|Sponsor Decision|3|||
164095133|NCT01328093|592712268|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
164095134|NCT01328093|592712269|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
164095135|NCT01328093|592712268|FG000|Double-Blind Phase|Scheduling conflict|8|||
164095136|NCT01328093|592712269|FG001|Double-Blind Phase|Scheduling conflict|3|||
164095137|NCT01328093|592712268|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
164095138|NCT01328093|592712269|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
164095139|NCT01328093|592712268|FG000|Double-Blind Phase|Death|1|||
164095140|NCT01328093|592712269|FG001|Double-Blind Phase|Death|0|||
164095141|NCT01328093|592712268|FG000|Open-Label Phase|Sponsor Decision|98|||
164095142|NCT01328093|592712269|FG001|Open-Label Phase|Sponsor Decision|34|||
163909988|NCT01262456|592040603|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
163909989|NCT01262456|592040604|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
163909990|NCT01262456|592040605|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
163909991|NCT01262456|592040603|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
163909992|NCT01262456|592040604|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
163909993|NCT01262456|592040605|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
163909994|NCT01262456|592040603|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
163909995|NCT01262456|592040604|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
163909996|NCT01262456|592040605|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
163909997|NCT01262456|592040603|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
163909998|NCT01262456|592040604|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
163909999|NCT01262456|592040605|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
163910000|NCT01262456|592040603|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
163910001|NCT01262456|592040604|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
163910002|NCT01262456|592040605|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
163910003|NCT01262456|592040603|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
163910004|NCT01262456|592040604|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
163910005|NCT01262456|592040605|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
163910006|NCT03938272|592040606|FG000|Overall Study|Withdrawal by Subject|1|||
163910007|NCT03938272|592040607|FG001|Overall Study|Withdrawal by Subject|0|||
163910008|NCT03938272|592040606|FG000|Overall Study|Physician Decision|0|||
163910009|NCT03938272|592040607|FG001|Overall Study|Physician Decision|2|||
163910010|NCT03938272|592040606|FG000|Overall Study|Study termination by sponsor|10|||
163910011|NCT03938272|592040607|FG001|Overall Study|Study termination by sponsor|8|||
163910012|NCT02102724|592040609|FG000|Overall Study|Lost to Follow-up|1|||
163910013|NCT02102724|592040610|FG001|Overall Study|Lost to Follow-up|0|||
164020565|NCT04096326|592437737|FG002|Overall Study|COVID-19-related reasons|0|||
164020566|NCT04096326|592437738|FG003|Overall Study|COVID-19-related reasons|0|||
163910014|NCT02102724|592040609|FG000|Overall Study|surgery for brain aneurysm|1|||
164020567|NCT04096326|592437739|FG004|Overall Study|COVID-19-related reasons|1|||
164020568|NCT04096326|592437740|FG005|Overall Study|COVID-19-related reasons|5|||
164020569|NCT04096326|592437741|FG006|Overall Study|COVID-19-related reasons|0|||
164020570|NCT04096326|592437742|FG007|Overall Study|COVID-19-related reasons|0|||
164020571|NCT04096326|592437743|FG008|Overall Study|COVID-19-related reasons|0|||
164020572|NCT04096326|592437744|FG009|Overall Study|COVID-19-related reasons|0|||
164020573|NCT02496585|592437747|FG000|Overall Study|Death|3|||
164020574|NCT02496585|592437748|FG001|Overall Study|Death|0|||
164020575|NCT02496585|592437747|FG000|Overall Study|Lost to Follow-up|2|||
164020576|NCT02496585|592437748|FG001|Overall Study|Lost to Follow-up|0|||
164020577|NCT02496585|592437747|FG000|Overall Study|Withdrawal by Subject|1|||
164020578|NCT02496585|592437748|FG001|Overall Study|Withdrawal by Subject|2|||
164020579|NCT02496585|592437747|FG000|Overall Study|Progression of Malignancy|4|||
164020580|NCT02496585|592437748|FG001|Overall Study|Progression of Malignancy|1|||
164020581|NCT01276457|592437752|FG000|Core Study|Adverse Event|6|||
164020582|NCT01276457|592437753|FG001|Core Study|Adverse Event|3|||
164020583|NCT01276457|592437752|FG000|Core Study|Lost to Follow-up|1|||
164020584|NCT01276457|592437753|FG001|Core Study|Lost to Follow-up|2|||
164020585|NCT01276457|592437752|FG000|Core Study|Administrative problems|1|||
164020586|NCT01276457|592437753|FG001|Core Study|Administrative problems|1|||
164020587|NCT01276457|592437752|FG000|Core Study|Death|2|||
164020588|NCT01276457|592437753|FG001|Core Study|Death|2|||
164020589|NCT01276457|592437752|FG000|Core Study|Lack of Efficacy|3|||
164020590|NCT01276457|592437753|FG001|Core Study|Lack of Efficacy|12|||
164020591|NCT01276457|592437752|FG000|Extension Study|Lost to Follow-up|3|||
164020592|NCT01276457|592437753|FG001|Extension Study|Lost to Follow-up|0|||
164020593|NCT01276457|592437752|FG000|Extension Study|Death|0|||
164020594|NCT01276457|592437753|FG001|Extension Study|Death|1|||
164020595|NCT01276457|592437752|FG000|Extension Study|Lack of Efficacy|3|||
164020596|NCT01276457|592437753|FG001|Extension Study|Lack of Efficacy|1|||
164020597|NCT05122650|592437755|FG000|Overall Study|Adverse Event|4|||
164020598|NCT05122650|592437756|FG001|Overall Study|Adverse Event|16|||
164020599|NCT05122650|592437757|FG002|Overall Study|Adverse Event|11|||
164020600|NCT05122650|592437758|FG003|Overall Study|Adverse Event|12|||
164020601|NCT05122650|592437755|FG000|Overall Study|Lack of Efficacy|0|||
164020602|NCT05122650|592437756|FG001|Overall Study|Lack of Efficacy|1|||
164020603|NCT05122650|592437757|FG002|Overall Study|Lack of Efficacy|1|||
164020604|NCT05122650|592437758|FG003|Overall Study|Lack of Efficacy|2|||
164020605|NCT05122650|592437755|FG000|Overall Study|Lost to Follow-up|1|||
164020606|NCT05122650|592437756|FG001|Overall Study|Lost to Follow-up|1|||
164020607|NCT05122650|592437757|FG002|Overall Study|Lost to Follow-up|3|||
164020608|NCT05122650|592437758|FG003|Overall Study|Lost to Follow-up|0|||
164020609|NCT05122650|592437755|FG000|Overall Study|Non-compliance with study intervention|0|||
164020610|NCT05122650|592437756|FG001|Overall Study|Non-compliance with study intervention|0|||
164020611|NCT05122650|592437757|FG002|Overall Study|Non-compliance with study intervention|0|||
164020612|NCT05122650|592437758|FG003|Overall Study|Non-compliance with study intervention|2|||
164020613|NCT05122650|592437755|FG000|Overall Study|Protocol Violation|0|||
164020614|NCT05122650|592437756|FG001|Overall Study|Protocol Violation|1|||
164020615|NCT05122650|592437757|FG002|Overall Study|Protocol Violation|0|||
164020616|NCT05122650|592437758|FG003|Overall Study|Protocol Violation|1|||
164020617|NCT05122650|592437755|FG000|Overall Study|Randomized by mistake|0|||
164095143|NCT01328093|592712268|FG000|Open-Label Phase|Protocol Violation|8|||
164095144|NCT01328093|592712269|FG001|Open-Label Phase|Protocol Violation|3|||
164095145|NCT01328093|592712268|FG000|Open-Label Phase|Lost to Follow-up|10|||
164095146|NCT01328093|592712269|FG001|Open-Label Phase|Lost to Follow-up|1|||
164095147|NCT01328093|592712268|FG000|Open-Label Phase|Adverse Event|10|||
164020618|NCT05122650|592437756|FG001|Overall Study|Randomized by mistake|0|||
164020619|NCT05122650|592437757|FG002|Overall Study|Randomized by mistake|3|||
164020620|NCT05122650|592437758|FG003|Overall Study|Randomized by mistake|2|||
164020621|NCT05122650|592437755|FG000|Overall Study|Sponsor request|0|||
164020622|NCT05122650|592437756|FG001|Overall Study|Sponsor request|1|||
164020623|NCT05122650|592437757|FG002|Overall Study|Sponsor request|1|||
164020624|NCT05122650|592437758|FG003|Overall Study|Sponsor request|2|||
164020625|NCT05122650|592437755|FG000|Overall Study|Withdrawal by Subject|3|||
164020626|NCT05122650|592437756|FG001|Overall Study|Withdrawal by Subject|7|||
164020627|NCT05122650|592437757|FG002|Overall Study|Withdrawal by Subject|4|||
164020628|NCT05122650|592437758|FG003|Overall Study|Withdrawal by Subject|8|||
164020629|NCT05122650|592437755|FG000|Overall Study|Other|5|||
164020630|NCT05122650|592437756|FG001|Overall Study|Other|0|||
164020631|NCT05122650|592437757|FG002|Overall Study|Other|0|||
164020632|NCT05122650|592437758|FG003|Overall Study|Other|0|||
164020633|NCT03280550|592437763|FG000|Overall Study|Withdrawal by Subject|2|||
164020634|NCT03280550|592437764|FG001|Overall Study|Withdrawal by Subject|2|||
164020635|NCT03280550|592437763|FG000|Overall Study|Physician Decision|0|||
164020636|NCT03280550|592437764|FG001|Overall Study|Physician Decision|1|||
164020637|NCT05896761|592437765|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
164020638|NCT05896761|592437766|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
164020639|NCT05896761|592437765|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
164020640|NCT05896761|592437766|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
164020641|NCT01318083|592437767|FG000|Overall Study|Adverse Event|4|||
164020642|NCT01318083|592437768|FG001|Overall Study|Adverse Event|1|||
164020643|NCT01318083|592437769|FG002|Overall Study|Adverse Event|2|||
164020644|NCT01318083|592437767|FG000|Overall Study|Withdrawal by Subject|1|||
164020645|NCT01318083|592437768|FG001|Overall Study|Withdrawal by Subject|0|||
164020646|NCT01318083|592437769|FG002|Overall Study|Withdrawal by Subject|2|||
164020647|NCT01318083|592437767|FG000|Overall Study|Lack of Efficacy|0|||
164020648|NCT01318083|592437768|FG001|Overall Study|Lack of Efficacy|0|||
164020649|NCT01318083|592437769|FG002|Overall Study|Lack of Efficacy|1|||
164020650|NCT01318083|592437767|FG000|Overall Study|Treatment Complications|1|||
164020651|NCT01318083|592437768|FG001|Overall Study|Treatment Complications|0|||
164020652|NCT01318083|592437769|FG002|Overall Study|Treatment Complications|0|||
164020653|NCT01318083|592437767|FG000|Overall Study|Lack of Study Medication Compliance|0|||
164020654|NCT01318083|592437768|FG001|Overall Study|Lack of Study Medication Compliance|1|||
164020655|NCT01318083|592437769|FG002|Overall Study|Lack of Study Medication Compliance|0|||
164020656|NCT02028338|592437772|FG000|Overall Study|Withdrawal by Subject|3|||
164020657|NCT02028338|592437773|FG001|Overall Study|Withdrawal by Subject|1|||
164020658|NCT02028338|592437772|FG000|Overall Study|Unable to contact participant|1|||
164020659|NCT02028338|592437773|FG001|Overall Study|Unable to contact participant|0|||
164020660|NCT03552549|592437775|FG000|Overall Study|Disease progression|25|||
164020661|NCT03552549|592437776|FG001|Overall Study|Disease progression|17|||
164020662|NCT03552549|592437775|FG000|Overall Study|Adverse event in first 12 months|12|||
164020663|NCT03552549|592437776|FG001|Overall Study|Adverse event in first 12 months|8|||
164020664|NCT03552549|592437775|FG000|Overall Study|Withdrawal by Subject|7|||
164020665|NCT03552549|592437776|FG001|Overall Study|Withdrawal by Subject|7|||
164020666|NCT03552549|592437775|FG000|Overall Study|Unknown (no reason provided)|4|||
164020667|NCT03552549|592437776|FG001|Overall Study|Unknown (no reason provided)|2|||
164020668|NCT03552549|592437775|FG000|Overall Study|Not in participant's best interest|2|||
164020669|NCT03552549|592437776|FG001|Overall Study|Not in participant's best interest|1|||
164020670|NCT03552549|592437775|FG000|Overall Study|Did not complete study treatment|2|||
164020671|NCT03552549|592437776|FG001|Overall Study|Did not complete study treatment|3|||
164020672|NCT03552549|592437775|FG000|Overall Study|Did not meet eligibility criteria|1|||
164020673|NCT03552549|592437776|FG001|Overall Study|Did not meet eligibility criteria|0|||
164020674|NCT03552549|592437775|FG000|Overall Study|Administrative|0|||
164095148|NCT01328093|592712269|FG001|Open-Label Phase|Adverse Event|4|||
164020675|NCT03552549|592437776|FG001|Overall Study|Administrative|14|||
164020676|NCT02761993|592437785|FG000|Overall Study|Adverse Event|0|||
164020677|NCT02761993|592437786|FG001|Overall Study|Adverse Event|2|||
164020678|NCT02761993|592437787|FG002|Overall Study|Adverse Event|0|||
164020679|NCT02761993|592437785|FG000|Overall Study|Lost to Follow-up|1|||
164020680|NCT02761993|592437786|FG001|Overall Study|Lost to Follow-up|3|||
164020681|NCT02761993|592437787|FG002|Overall Study|Lost to Follow-up|2|||
164020682|NCT02761993|592437785|FG000|Overall Study|Withdrawal by Subject|1|||
164020683|NCT02761993|592437786|FG001|Overall Study|Withdrawal by Subject|1|||
164020684|NCT02761993|592437787|FG002|Overall Study|Withdrawal by Subject|2|||
164020685|NCT00527111|592437792|FG000|Overall Study|Adverse Event|14|||
164020686|NCT00527111|592437793|FG001|Overall Study|Adverse Event|13|||
164020687|NCT00527111|592437792|FG000|Overall Study|Death|0|||
163910015|NCT02102724|592040610|FG001|Overall Study|surgery for brain aneurysm|1|||
164020688|NCT00527111|592437793|FG001|Overall Study|Death|1|||
164020689|NCT00527111|592437792|FG000|Overall Study|Investigator Request|2|||
164020690|NCT00527111|592437793|FG001|Overall Study|Investigator Request|1|||
164020691|NCT00527111|592437792|FG000|Overall Study|Patient Request|2|||
164020692|NCT00527111|592437793|FG001|Overall Study|Patient Request|5|||
164020693|NCT00527111|592437792|FG000|Overall Study|Other|2|||
164020694|NCT00527111|592437793|FG001|Overall Study|Other|2|||
164020695|NCT04072146|592437794|FG000|Overall Study|Adverse Event|0|||
164020696|NCT04072146|592437795|FG001|Overall Study|Adverse Event|1|||
164020697|NCT01617434|592437796|FG000|Overall Study|Adverse Event|12|||
164020698|NCT01617434|592437797|FG001|Overall Study|Adverse Event|3|||
164020699|NCT01617434|592437796|FG000|Overall Study|Protocol Violation|8|||
164020700|NCT01617434|592437797|FG001|Overall Study|Protocol Violation|7|||
164020701|NCT01617434|592437796|FG000|Overall Study|Withdrawal Criteria|12|||
164020702|NCT01617434|592437797|FG001|Overall Study|Withdrawal Criteria|37|||
164020703|NCT01617434|592437796|FG000|Overall Study|Unclassified|3|||
164020704|NCT01617434|592437797|FG001|Overall Study|Unclassified|4|||
164020705|NCT02993224|592437798|FG000|Core Phase - Period 1|Adverse Event|4|||
164020706|NCT02993224|592437798|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
164020707|NCT02993224|592437798|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
164020708|NCT02993224|592437798|FG000|Core Phase- Period 2|Adverse Event|1|||
164020709|NCT02993224|592437798|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
164020710|NCT02993224|592437798|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
164020711|NCT02993224|592437798|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
164020712|NCT02993224|592437798|FG000|Extension Phase|Adverse Event|3|||
164020713|NCT02993224|592437798|FG000|Extension Phase|Withdrawal by Subject|3|||
164020714|NCT02993224|592437798|FG000|Extension Phase|Lost to Follow-up|2|||
164020715|NCT02993224|592437798|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
164020716|NCT02689219|592437806|FG000|Overall Study|Death|1|||
164020717|NCT02689219|592437807|FG001|Overall Study|Death|1|||
164020718|NCT02689219|592437806|FG000|Overall Study|Disease Progression|10|||
164020719|NCT02689219|592437807|FG001|Overall Study|Disease Progression|6|||
164020720|NCT01921257|592437811|FG000|Overall Study|Adverse Event|1|||
164095149|NCT01328093|592712268|FG000|Open-Label Phase|Lack of Efficacy|5|||
164095150|NCT01328093|592712269|FG001|Open-Label Phase|Lack of Efficacy|6|||
164020721|NCT01921257|592437811|FG000|Overall Study|Protocol Violation|1|||
164020722|NCT01921257|592437811|FG000|Overall Study|Withdrawal by Subject|1|||
164020723|NCT02426658|592437813|FG000|Overall Study|Withdrawal by Subject|1|||
164020724|NCT02426658|592437813|FG000|Overall Study|Patient expired before treatment|2|||
164020725|NCT03050359|592439561|FG000|Overall Study|Randomized But Not Treated|2|||
164020726|NCT03050359|592439562|FG001|Overall Study|Randomized But Not Treated|0|||
164020727|NCT03050359|592439561|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
164020728|NCT03050359|592439562|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
164020729|NCT03050359|592439561|FG000|Overall Study|Significant Protocol Deviation|2|||
164020730|NCT03050359|592439562|FG001|Overall Study|Significant Protocol Deviation|3|||
164020731|NCT03050359|592439561|FG000|Overall Study|Lost to Follow-up|2|||
164020732|NCT03050359|592439562|FG001|Overall Study|Lost to Follow-up|1|||
164020733|NCT03050359|592439561|FG000|Overall Study|Voluntary Withdrawal|4|||
164020734|NCT03050359|592439562|FG001|Overall Study|Voluntary Withdrawal|6|||
164020735|NCT03050359|592439561|FG000|Overall Study|Pregnancy|1|||
164020736|NCT03050359|592439562|FG001|Overall Study|Pregnancy|0|||
164020737|NCT03050359|592439561|FG000|Overall Study|Reason Not Specified|1|||
164020738|NCT03050359|592439562|FG001|Overall Study|Reason Not Specified|0|||
164020739|NCT02020031|592439563|FG000|Overall Study|Physician Decision|1|||
164020740|NCT02020031|592439564|FG001|Overall Study|Physician Decision|1|||
164020741|NCT00755846|592439567|FG000|Overall Study|Adverse Event|0|||
164020742|NCT00755846|592439568|FG001|Overall Study|Adverse Event|0|||
164020743|NCT00755846|592439569|FG002|Overall Study|Adverse Event|0|||
164020744|NCT00755846|592439570|FG003|Overall Study|Adverse Event|1|||
164020745|NCT00755846|592439571|FG004|Overall Study|Adverse Event|3|||
164020746|NCT00755846|592439572|FG005|Overall Study|Adverse Event|2|||
164020747|NCT00755846|592439567|FG000|Overall Study|Protocol Violation|1|||
164020748|NCT00755846|592439568|FG001|Overall Study|Protocol Violation|1|||
164020749|NCT00755846|592439569|FG002|Overall Study|Protocol Violation|1|||
164020750|NCT00755846|592439570|FG003|Overall Study|Protocol Violation|1|||
164020751|NCT00755846|592439571|FG004|Overall Study|Protocol Violation|1|||
164020752|NCT00755846|592439572|FG005|Overall Study|Protocol Violation|1|||
164020753|NCT00755846|592439567|FG000|Overall Study|Lost to Follow-up|0|||
164020754|NCT00755846|592439568|FG001|Overall Study|Lost to Follow-up|2|||
164020755|NCT00755846|592439569|FG002|Overall Study|Lost to Follow-up|1|||
164020756|NCT00755846|592439570|FG003|Overall Study|Lost to Follow-up|0|||
164020757|NCT00755846|592439571|FG004|Overall Study|Lost to Follow-up|4|||
164020758|NCT00755846|592439572|FG005|Overall Study|Lost to Follow-up|2|||
164020759|NCT00755846|592439567|FG000|Overall Study|Withdrawal by Subject|2|||
164020760|NCT00755846|592439568|FG001|Overall Study|Withdrawal by Subject|3|||
164020761|NCT00755846|592439569|FG002|Overall Study|Withdrawal by Subject|5|||
164020762|NCT00755846|592439570|FG003|Overall Study|Withdrawal by Subject|2|||
164020763|NCT00755846|592439571|FG004|Overall Study|Withdrawal by Subject|0|||
164020764|NCT00755846|592439572|FG005|Overall Study|Withdrawal by Subject|1|||
164020765|NCT00755846|592439567|FG000|Overall Study|Hyperglycemic Rescue|21|||
164020766|NCT00755846|592439568|FG001|Overall Study|Hyperglycemic Rescue|7|||
164020767|NCT00755846|592439569|FG002|Overall Study|Hyperglycemic Rescue|5|||
164020768|NCT00755846|592439570|FG003|Overall Study|Hyperglycemic Rescue|8|||
164020769|NCT00755846|592439571|FG004|Overall Study|Hyperglycemic Rescue|8|||
164020770|NCT00755846|592439572|FG005|Overall Study|Hyperglycemic Rescue|7|||
164020771|NCT00755846|592439567|FG000|Overall Study|Physician Decision|1|||
164020772|NCT00755846|592439568|FG001|Overall Study|Physician Decision|3|||
164020773|NCT00755846|592439569|FG002|Overall Study|Physician Decision|0|||
164020774|NCT00755846|592439570|FG003|Overall Study|Physician Decision|1|||
164020775|NCT00755846|592439571|FG004|Overall Study|Physician Decision|0|||
164020776|NCT00755846|592439572|FG005|Overall Study|Physician Decision|1|||
164020777|NCT00755846|592439567|FG000|Overall Study|Administrative Error|0|||
164020778|NCT00755846|592439568|FG001|Overall Study|Administrative Error|1|||
164020779|NCT00755846|592439569|FG002|Overall Study|Administrative Error|0|||
164020780|NCT00755846|592439570|FG003|Overall Study|Administrative Error|0|||
164020781|NCT00755846|592439571|FG004|Overall Study|Administrative Error|0|||
164020782|NCT00755846|592439572|FG005|Overall Study|Administrative Error|0|||
164020783|NCT00755846|592439567|FG000|Overall Study|Participant Non-compliance|0|||
164020784|NCT00755846|592439568|FG001|Overall Study|Participant Non-compliance|0|||
164020785|NCT00755846|592439569|FG002|Overall Study|Participant Non-compliance|0|||
164020786|NCT00755846|592439570|FG003|Overall Study|Participant Non-compliance|0|||
164020787|NCT00755846|592439571|FG004|Overall Study|Participant Non-compliance|1|||
164020788|NCT00755846|592439572|FG005|Overall Study|Participant Non-compliance|0|||
164020789|NCT02723604|592439583|FG000|Overall Study|ineligible|1|||
164095151|NCT01328093|592712268|FG000|Open-Label Phase|Withdrawal by Subject|4|||
164095152|NCT01328093|592712269|FG001|Open-Label Phase|Withdrawal by Subject|1|||
164095153|NCT01328093|592712268|FG000|Open-Label Phase|Scheduling conflict|2|||
164020790|NCT02723604|592439583|FG000|Overall Study|never received treatment|1|||
164020791|NCT01369849|592439585|FG000|Overall Study|Ineligible prior to treatment|0|||
164020792|NCT01369849|592439586|FG001|Overall Study|Ineligible prior to treatment|0|||
164020793|NCT01369849|592439587|FG002|Overall Study|Ineligible prior to treatment|1|||
164020794|NCT01369849|592439585|FG000|Overall Study|Ineligible after receiving treatment|0|||
164020795|NCT01369849|592439586|FG001|Overall Study|Ineligible after receiving treatment|1|||
164020796|NCT01369849|592439587|FG002|Overall Study|Ineligible after receiving treatment|0|||
164020797|NCT00115349|592439590|FG000|Overall Study|Study closed due to low enrollment.|11|||
164020798|NCT00115349|592439591|FG001|Overall Study|Study closed due to low enrollment.|9|||
164020799|NCT01028651|592439596|FG000|Overall Study|Death|2|||
164020800|NCT01028651|592439596|FG000|Overall Study|Adverse Event|1|||
164020801|NCT00390416|592439598|FG000|Overall Study|Withdrawal by Subject|1|||
164020802|NCT00390416|592439598|FG000|Overall Study|Not treated|3|||
164020803|NCT01592409|592439599|FG000|Overall Study|Withdrawal by Subject|0|||
164020804|NCT01592409|592439600|FG001|Overall Study|Withdrawal by Subject|1|||
164020805|NCT01728584|592439601|FG000|Overall Study|Adverse Event|1|||
164020806|NCT01728584|592439602|FG001|Overall Study|Adverse Event|0|||
164020807|NCT01728584|592439603|FG002|Overall Study|Adverse Event|0|||
164020808|NCT01728584|592439604|FG003|Overall Study|Adverse Event|0|||
164020809|NCT01728584|592439601|FG000|Overall Study|Physician Decision|4|||
164020810|NCT01728584|592439602|FG001|Overall Study|Physician Decision|0|||
164020811|NCT01728584|592439603|FG002|Overall Study|Physician Decision|1|||
164020812|NCT01728584|592439604|FG003|Overall Study|Physician Decision|0|||
164020813|NCT01728584|592439601|FG000|Overall Study|Withdrawal by Subject|1|||
164020814|NCT01728584|592439602|FG001|Overall Study|Withdrawal by Subject|0|||
164020815|NCT01728584|592439603|FG002|Overall Study|Withdrawal by Subject|0|||
164020816|NCT01728584|592439604|FG003|Overall Study|Withdrawal by Subject|0|||
164020817|NCT01728584|592439601|FG000|Overall Study|Screen failure|1|||
164020818|NCT01728584|592439602|FG001|Overall Study|Screen failure|0|||
164020819|NCT01728584|592439603|FG002|Overall Study|Screen failure|0|||
164095154|NCT01328093|592712269|FG001|Open-Label Phase|Scheduling conflict|1|||
164095155|NCT01328093|592712268|FG000|Open-Label Phase|Subject is moving or has moved|2|||
164095156|NCT01328093|592712269|FG001|Open-Label Phase|Subject is moving or has moved|0|||
164095157|NCT01328093|592712268|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
164095158|NCT01328093|592712269|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
164095159|NCT03980483|592712272|FG000|Overall Study|Adverse Event|13|||
164095160|NCT03980483|592712273|FG001|Overall Study|Adverse Event|29|||
164095161|NCT03980483|592712274|FG002|Overall Study|Adverse Event|11|||
164095162|NCT03980483|592712275|FG003|Overall Study|Adverse Event|2|||
164095163|NCT03980483|592712276|FG004|Overall Study|Adverse Event|2|||
164095164|NCT03980483|592712277|FG005|Overall Study|Adverse Event|2|||
164095165|NCT03980483|592712272|FG000|Overall Study|Lack of Efficacy|7|||
164095166|NCT03980483|592712273|FG001|Overall Study|Lack of Efficacy|6|||
164095167|NCT03980483|592712274|FG002|Overall Study|Lack of Efficacy|0|||
164095168|NCT03980483|592712275|FG003|Overall Study|Lack of Efficacy|3|||
164095169|NCT03980483|592712276|FG004|Overall Study|Lack of Efficacy|1|||
164095170|NCT03980483|592712277|FG005|Overall Study|Lack of Efficacy|1|||
164095171|NCT03980483|592712272|FG000|Overall Study|Lost to Follow-up|2|||
164095172|NCT03980483|592712273|FG001|Overall Study|Lost to Follow-up|4|||
164095173|NCT03980483|592712274|FG002|Overall Study|Lost to Follow-up|2|||
164095174|NCT03980483|592712275|FG003|Overall Study|Lost to Follow-up|1|||
164095175|NCT03980483|592712276|FG004|Overall Study|Lost to Follow-up|2|||
164095176|NCT03980483|592712277|FG005|Overall Study|Lost to Follow-up|0|||
164095177|NCT03980483|592712272|FG000|Overall Study|Protocol Violation|4|||
164095178|NCT03980483|592712273|FG001|Overall Study|Protocol Violation|2|||
164095179|NCT03980483|592712274|FG002|Overall Study|Protocol Violation|1|||
164095180|NCT03980483|592712275|FG003|Overall Study|Protocol Violation|1|||
164095181|NCT03980483|592712276|FG004|Overall Study|Protocol Violation|0|||
164095182|NCT03980483|592712277|FG005|Overall Study|Protocol Violation|0|||
164095183|NCT03980483|592712272|FG000|Overall Study|Physician Decision|14|||
164020820|NCT01728584|592439604|FG003|Overall Study|Screen failure|0|||
164020821|NCT01728584|592439601|FG000|Overall Study|Other reason (not specified)|1|||
164020822|NCT01728584|592439602|FG001|Overall Study|Other reason (not specified)|0|||
164095184|NCT03980483|592712273|FG001|Overall Study|Physician Decision|10|||
164095185|NCT03980483|592712274|FG002|Overall Study|Physician Decision|7|||
164095186|NCT03980483|592712275|FG003|Overall Study|Physician Decision|4|||
164095187|NCT03980483|592712276|FG004|Overall Study|Physician Decision|4|||
164095188|NCT03980483|592712277|FG005|Overall Study|Physician Decision|2|||
164095189|NCT03980483|592712272|FG000|Overall Study|Withdrawal by Subject|38|||
164095190|NCT03980483|592712273|FG001|Overall Study|Withdrawal by Subject|21|||
164020823|NCT01728584|592439603|FG002|Overall Study|Other reason (not specified)|0|||
164095191|NCT03980483|592712274|FG002|Overall Study|Withdrawal by Subject|15|||
164020824|NCT01728584|592439604|FG003|Overall Study|Other reason (not specified)|1|||
164020825|NCT05132569|592439606|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
164020826|NCT05132569|592439607|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
164020827|NCT05132569|592439606|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
164020828|NCT05132569|592439607|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
164020829|NCT05132569|592439606|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
164020830|NCT05132569|592439607|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
164020831|NCT00471536|592439620|FG000|Overall Study|Withdrawal by Subject|1|||
164020832|NCT01188564|592439623|FG000|Double-blind Phase|randomized not treated|1|||
164020833|NCT01188564|592439624|FG001|Double-blind Phase|randomized not treated|0|||
164020834|NCT01094730|592439627|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
164020835|NCT01094730|592439628|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
164020836|NCT01094730|592439627|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
164020837|NCT01094730|592439628|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
164020838|NCT01094730|592439627|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
164020839|NCT01094730|592439628|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
164020840|NCT01094730|592439627|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
164095192|NCT03980483|592712275|FG003|Overall Study|Withdrawal by Subject|5|||
164095193|NCT03980483|592712276|FG004|Overall Study|Withdrawal by Subject|3|||
164095194|NCT03980483|592712277|FG005|Overall Study|Withdrawal by Subject|4|||
164095195|NCT03980483|592712272|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
164095196|NCT03980483|592712273|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164095197|NCT03980483|592712274|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164095198|NCT03980483|592712275|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164095199|NCT03980483|592712276|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164095200|NCT03980483|592712277|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164095201|NCT03980483|592712272|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164095202|NCT03980483|592712273|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
164095203|NCT03980483|592712274|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164095204|NCT03980483|592712275|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164095205|NCT03980483|592712276|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164095206|NCT03980483|592712277|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
164095207|NCT03980483|592712272|FG000|Overall Study|Other|0|||
164095208|NCT03980483|592712273|FG001|Overall Study|Other|1|||
164095209|NCT03980483|592712274|FG002|Overall Study|Other|0|||
164095210|NCT03980483|592712275|FG003|Overall Study|Other|0|||
164095211|NCT03980483|592712276|FG004|Overall Study|Other|0|||
164095212|NCT03980483|592712277|FG005|Overall Study|Other|0|||
164020841|NCT01094730|592439628|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
164020842|NCT01094730|592439627|FG000|Period 2 (14 Days)|Protocol Violation|2|||
164020843|NCT01094730|592439628|FG001|Period 2 (14 Days)|Protocol Violation|0|||
164020844|NCT01094730|592439627|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
164020845|NCT01094730|592439628|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
164020846|NCT01094730|592439627|FG000|Period 2 (14 Days)|Adverse Event|0|||
164020847|NCT01094730|592439628|FG001|Period 2 (14 Days)|Adverse Event|1|||
164020848|NCT01094730|592439627|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
164020849|NCT01094730|592439628|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
164020850|NCT04171037|592439629|FG000|Overall Study|Lost to Follow-up|1|||
164020851|NCT04171037|592439630|FG001|Overall Study|Lost to Follow-up|0|||
164020852|NCT04171037|592439629|FG000|Overall Study|Physician Decision|3|||
164020853|NCT04171037|592439630|FG001|Overall Study|Physician Decision|3|||
164020854|NCT01934894|592439631|FG000|Overall Study|Adverse Event|1|||
164020855|NCT01934894|592439632|FG001|Overall Study|Adverse Event|2|||
164020856|NCT01934894|592439631|FG000|Overall Study|Death|2|||
164020857|NCT01934894|592439632|FG001|Overall Study|Death|0|||
164020858|NCT01934894|592439631|FG000|Overall Study|Withdrawal by Subject|0|||
164020859|NCT01934894|592439632|FG001|Overall Study|Withdrawal by Subject|1|||
164020860|NCT01934894|592439631|FG000|Overall Study|Progressive Disease|3|||
164020861|NCT01934894|592439632|FG001|Overall Study|Progressive Disease|2|||
164020862|NCT01954251|592439633|FG000|Overall Study|Adverse Event|5|||
164020863|NCT01954251|592439634|FG001|Overall Study|Adverse Event|7|||
164020864|NCT01954251|592439633|FG000|Overall Study|Lost to Follow-up|6|||
164020865|NCT01954251|592439634|FG001|Overall Study|Lost to Follow-up|6|||
164020866|NCT01954251|592439633|FG000|Overall Study|Withdrawal by Subject|2|||
164020867|NCT01954251|592439634|FG001|Overall Study|Withdrawal by Subject|6|||
164020868|NCT04804033|592439635|FG000|Period 1: DBT Phase|Adverse Event|1|||
164020869|NCT04804033|592439636|FG001|Period 1: DBT Phase|Adverse Event|5|||
164020870|NCT04804033|592439637|FG002|Period 1: DBT Phase|Adverse Event|3|||
164020871|NCT04804033|592439638|FG003|Period 1: DBT Phase|Adverse Event|4|||
164020872|NCT04804033|592439635|FG000|Period 1: DBT Phase|Death|1|||
164020873|NCT04804033|592439636|FG001|Period 1: DBT Phase|Death|0|||
164020874|NCT04804033|592439637|FG002|Period 1: DBT Phase|Death|0|||
164020875|NCT04804033|592439638|FG003|Period 1: DBT Phase|Death|0|||
164020876|NCT04804033|592439635|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
164020877|NCT04804033|592439636|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
164020878|NCT04804033|592439637|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
164020879|NCT04804033|592439638|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
164020880|NCT04804033|592439635|FG000|Period 1: DBT Phase|Non-compliance|1|||
164020881|NCT04804033|592439636|FG001|Period 1: DBT Phase|Non-compliance|0|||
164020882|NCT04804033|592439637|FG002|Period 1: DBT Phase|Non-compliance|1|||
164020883|NCT04804033|592439638|FG003|Period 1: DBT Phase|Non-compliance|2|||
164020884|NCT04804033|592439635|FG000|Period 1: DBT Phase|Other|0|||
164020885|NCT04804033|592439636|FG001|Period 1: DBT Phase|Other|1|||
164020886|NCT04804033|592439637|FG002|Period 1: DBT Phase|Other|0|||
164020887|NCT04804033|592439638|FG003|Period 1: DBT Phase|Other|0|||
164020888|NCT04804033|592439635|FG000|Period 1: DBT Phase|Pregnancy|2|||
164020889|NCT04804033|592439636|FG001|Period 1: DBT Phase|Pregnancy|0|||
164020890|NCT04804033|592439637|FG002|Period 1: DBT Phase|Pregnancy|0|||
164020891|NCT04804033|592439638|FG003|Period 1: DBT Phase|Pregnancy|0|||
164020892|NCT04804033|592439635|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
164020893|NCT04804033|592439636|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
164020894|NCT04804033|592439637|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
164020895|NCT04804033|592439638|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
164020896|NCT04804033|592439635|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
164020897|NCT04804033|592439636|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
164020898|NCT04804033|592439637|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
164020899|NCT04804033|592439638|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
164020900|NCT04804033|592439635|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
164020901|NCT04804033|592439636|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
164020902|NCT04804033|592439637|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
164020903|NCT04804033|592439638|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
164020904|NCT04804033|592439635|FG000|Period 2: OLE Phase|Adverse Event|3|||
164020905|NCT04804033|592439636|FG001|Period 2: OLE Phase|Adverse Event|4|||
164020906|NCT04804033|592439637|FG002|Period 2: OLE Phase|Adverse Event|2|||
164020907|NCT04804033|592439638|FG003|Period 2: OLE Phase|Adverse Event|0|||
164020908|NCT04804033|592439635|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
164020909|NCT04804033|592439636|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
164020910|NCT04804033|592439637|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
164020911|NCT04804033|592439638|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
164020912|NCT04804033|592439635|FG000|Period 2: OLE Phase|Non-compliance|2|||
164020913|NCT04804033|592439636|FG001|Period 2: OLE Phase|Non-compliance|2|||
164020914|NCT04804033|592439637|FG002|Period 2: OLE Phase|Non-compliance|0|||
164020915|NCT04804033|592439638|FG003|Period 2: OLE Phase|Non-compliance|1|||
164020916|NCT04804033|592439635|FG000|Period 2: OLE Phase|Other|0|||
164020917|NCT04804033|592439636|FG001|Period 2: OLE Phase|Other|2|||
164020918|NCT04804033|592439637|FG002|Period 2: OLE Phase|Other|0|||
164020919|NCT04804033|592439638|FG003|Period 2: OLE Phase|Other|0|||
164020920|NCT04804033|592439635|FG000|Period 2: OLE Phase|Physician Decision|1|||
164020921|NCT04804033|592439636|FG001|Period 2: OLE Phase|Physician Decision|1|||
164020922|NCT04804033|592439637|FG002|Period 2: OLE Phase|Physician Decision|0|||
164020923|NCT04804033|592439638|FG003|Period 2: OLE Phase|Physician Decision|0|||
164020924|NCT04804033|592439635|FG000|Period 2: OLE Phase|Pregnancy|0|||
164020925|NCT04804033|592439636|FG001|Period 2: OLE Phase|Pregnancy|0|||
164020926|NCT04804033|592439637|FG002|Period 2: OLE Phase|Pregnancy|2|||
164020927|NCT04804033|592439638|FG003|Period 2: OLE Phase|Pregnancy|0|||
164020928|NCT04804033|592439635|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
164020929|NCT04804033|592439636|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
164020930|NCT04804033|592439637|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
164020931|NCT04804033|592439638|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
164020932|NCT04804033|592439635|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
164020933|NCT04804033|592439636|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
164020934|NCT04804033|592439637|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
164020935|NCT04804033|592439638|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
164020936|NCT04804033|592439635|FG000|Period 2: OLE Phase|Not reported|0|||
164020937|NCT04804033|592439636|FG001|Period 2: OLE Phase|Not reported|2|||
164020938|NCT04804033|592439637|FG002|Period 2: OLE Phase|Not reported|0|||
164020939|NCT04804033|592439638|FG003|Period 2: OLE Phase|Not reported|0|||
164020940|NCT04804033|592439635|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
164020941|NCT04804033|592439636|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
164020942|NCT04804033|592439637|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
164020943|NCT04804033|592439638|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
164020944|NCT04804033|592439635|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
164020945|NCT04804033|592439636|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
164020946|NCT04804033|592439637|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
164020947|NCT04804033|592439638|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
164020948|NCT04804033|592439635|FG000|Period 3: Follow-up Phase|Other|0|||
164020949|NCT04804033|592439636|FG001|Period 3: Follow-up Phase|Other|1|||
164020950|NCT04804033|592439637|FG002|Period 3: Follow-up Phase|Other|2|||
164020951|NCT04804033|592439638|FG003|Period 3: Follow-up Phase|Other|1|||
164020952|NCT04804033|592439635|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
164020953|NCT04804033|592439636|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
164020954|NCT04804033|592439637|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
164020955|NCT04804033|592439638|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
164020956|NCT04804033|592439635|FG000|Period 3: Follow-up Phase|Not reported|18|||
164020957|NCT04804033|592439636|FG001|Period 3: Follow-up Phase|Not reported|15|||
164020958|NCT04804033|592439637|FG002|Period 3: Follow-up Phase|Not reported|1|||
164020959|NCT04804033|592439638|FG003|Period 3: Follow-up Phase|Not reported|4|||
164020960|NCT01864018|592439639|FG000|Overall Study|Ineligible|3|||
164020961|NCT01864018|592439640|FG001|Overall Study|Ineligible|1|||
164020962|NCT02702193|592439641|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
164020963|NCT02702193|592439642|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
164020964|NCT02702193|592439641|FG000|4 Month Follow up|Withdrawal by Subject|1|||
164020965|NCT02702193|592439642|FG001|4 Month Follow up|Withdrawal by Subject|0|||
164020966|NCT02702193|592439641|FG000|4 Month Follow up|Lost to Follow-up|17|||
164020967|NCT02702193|592439642|FG001|4 Month Follow up|Lost to Follow-up|18|||
164020968|NCT02702193|592439641|FG000|8 Month Follow up|Withdrawal by Subject|1|||
164020969|NCT02702193|592439642|FG001|8 Month Follow up|Withdrawal by Subject|0|||
164020970|NCT02702193|592439641|FG000|8 Month Follow up|Lost to Follow-up|14|||
164020971|NCT02702193|592439642|FG001|8 Month Follow up|Lost to Follow-up|18|||
164020972|NCT02702193|592439641|FG000|12 Month Follow up|Withdrawal by Subject|1|||
164020973|NCT02702193|592439642|FG001|12 Month Follow up|Withdrawal by Subject|0|||
164020974|NCT02702193|592439641|FG000|12 Month Follow up|Lost to Follow-up|16|||
164020975|NCT02702193|592439642|FG001|12 Month Follow up|Lost to Follow-up|18|||
164020976|NCT03510663|592439648|FG000|Overall Study|Withdrawal by Subject|0|||
164020977|NCT03510663|592439649|FG001|Overall Study|Withdrawal by Subject|1|||
164020978|NCT03510663|592439650|FG002|Overall Study|Withdrawal by Subject|0|||
164020979|NCT03510663|592439651|FG003|Overall Study|Withdrawal by Subject|0|||
164020980|NCT03510663|592439652|FG004|Overall Study|Withdrawal by Subject|0|||
164020981|NCT03510663|592439653|FG005|Overall Study|Withdrawal by Subject|0|||
164020982|NCT03510663|592439654|FG006|Overall Study|Withdrawal by Subject|0|||
164020983|NCT03510663|592439655|FG007|Overall Study|Withdrawal by Subject|0|||
164020984|NCT00222729|592439658|FG000|Overall Study|Adverse Event|3|||
164020985|NCT01915849|592439661|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
164020986|NCT01915849|592439662|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
164020987|NCT01915849|592439663|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
164020988|NCT01915849|592439664|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
164020989|NCT01915849|592439661|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
164020990|NCT01915849|592439662|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164020991|NCT01915849|592439663|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164020992|NCT01915849|592439664|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
164020993|NCT01798706|592439665|FG000|Overall Study|Adverse Event|15|||
164020994|NCT01798706|592439666|FG001|Overall Study|Adverse Event|10|||
164020995|NCT01798706|592439665|FG000|Overall Study|Lack of Efficacy|0|||
164020996|NCT01798706|592439666|FG001|Overall Study|Lack of Efficacy|2|||
164020997|NCT01798706|592439665|FG000|Overall Study|Poor compliance to protocol|1|||
164020998|NCT01798706|592439666|FG001|Overall Study|Poor compliance to protocol|0|||
164020999|NCT01798706|592439665|FG000|Overall Study|Other than specified above|5|||
164021000|NCT01798706|592439666|FG001|Overall Study|Other than specified above|9|||
164021001|NCT02775864|592439667|FG000|Overall Study|Data ended end of 2010|1764|||
164021002|NCT02775864|592439668|FG001|Overall Study|Data ended end of 2010|2880|||
164021003|NCT02775864|592439669|FG002|Overall Study|Data ended end of 2010|1140|||
164021004|NCT02775864|592439670|FG003|Overall Study|Data ended end of 2010|1194|||
164021005|NCT02775864|592439667|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
164021006|NCT02775864|592439668|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
164021007|NCT02775864|592439669|FG002|Overall Study|Medicaid eligibility discontinued|720|||
164021008|NCT02775864|592439670|FG003|Overall Study|Medicaid eligibility discontinued|890|||
164021009|NCT00256867|592439671|FG000|Overall Study|Adverse Event|0|||
164021010|NCT00256867|592439672|FG001|Overall Study|Adverse Event|1|||
164021011|NCT00256867|592439673|FG002|Overall Study|Adverse Event|1|||
164021012|NCT00256867|592439674|FG003|Overall Study|Adverse Event|1|||
164021013|NCT00256867|592439675|FG004|Overall Study|Adverse Event|2|||
164021014|NCT00256867|592439676|FG005|Overall Study|Adverse Event|2|||
164021015|NCT00256867|592439677|FG006|Overall Study|Adverse Event|1|||
164021016|NCT00256867|592439678|FG007|Overall Study|Adverse Event|4|||
164021017|NCT00256867|592439671|FG000|Overall Study|Lost to Follow-up|2|||
164021018|NCT00256867|592439672|FG001|Overall Study|Lost to Follow-up|2|||
164021019|NCT00256867|592439673|FG002|Overall Study|Lost to Follow-up|2|||
164021020|NCT00256867|592439674|FG003|Overall Study|Lost to Follow-up|3|||
164021021|NCT00256867|592439675|FG004|Overall Study|Lost to Follow-up|2|||
164021022|NCT00256867|592439676|FG005|Overall Study|Lost to Follow-up|0|||
164021023|NCT00256867|592439677|FG006|Overall Study|Lost to Follow-up|1|||
164021024|NCT00256867|592439678|FG007|Overall Study|Lost to Follow-up|2|||
164021025|NCT00256867|592439671|FG000|Overall Study|Protocol Violation|0|||
164095213|NCT05150964|592712278|FG000|Overall Study|Lost to Follow-up|2|||
164095214|NCT01062256|592712283|FG000|Overall Study|Adverse Event|1|||
164021026|NCT00256867|592439672|FG001|Overall Study|Protocol Violation|0|||
164021027|NCT00256867|592439673|FG002|Overall Study|Protocol Violation|0|||
164021028|NCT00256867|592439674|FG003|Overall Study|Protocol Violation|1|||
164021029|NCT00256867|592439675|FG004|Overall Study|Protocol Violation|0|||
164021030|NCT00256867|592439676|FG005|Overall Study|Protocol Violation|1|||
164021031|NCT00256867|592439677|FG006|Overall Study|Protocol Violation|0|||
164021032|NCT00256867|592439678|FG007|Overall Study|Protocol Violation|1|||
164021033|NCT00256867|592439671|FG000|Overall Study|Withdrawal by Subject|0|||
164021034|NCT00256867|592439672|FG001|Overall Study|Withdrawal by Subject|0|||
164095215|NCT01062256|592712284|FG001|Overall Study|Adverse Event|0|||
164021035|NCT00256867|592439673|FG002|Overall Study|Withdrawal by Subject|1|||
164021036|NCT00256867|592439674|FG003|Overall Study|Withdrawal by Subject|1|||
164021037|NCT00256867|592439675|FG004|Overall Study|Withdrawal by Subject|2|||
164021038|NCT00256867|592439676|FG005|Overall Study|Withdrawal by Subject|2|||
164021039|NCT00256867|592439677|FG006|Overall Study|Withdrawal by Subject|3|||
164021040|NCT00256867|592439678|FG007|Overall Study|Withdrawal by Subject|2|||
164021041|NCT00256867|592439671|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164021042|NCT00256867|592439672|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
164021043|NCT00256867|592439673|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164021044|NCT00256867|592439674|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164095216|NCT01062256|592712285|FG002|Overall Study|Adverse Event|0|||
164021045|NCT00256867|592439675|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164021046|NCT00256867|592439676|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164021047|NCT00256867|592439677|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164021048|NCT00256867|592439678|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
164021049|NCT00256867|592439671|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021050|NCT00256867|592439672|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021051|NCT00256867|592439673|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021052|NCT00256867|592439674|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021053|NCT00256867|592439675|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021054|NCT00256867|592439676|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021055|NCT00256867|592439677|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
164021056|NCT00256867|592439678|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
164021057|NCT00256867|592439671|FG000|Overall Study|Investigator's Decision|0|||
164021058|NCT00256867|592439672|FG001|Overall Study|Investigator's Decision|0|||
164021059|NCT00256867|592439673|FG002|Overall Study|Investigator's Decision|0|||
164021060|NCT00256867|592439674|FG003|Overall Study|Investigator's Decision|0|||
164021061|NCT00256867|592439675|FG004|Overall Study|Investigator's Decision|1|||
164021062|NCT00256867|592439676|FG005|Overall Study|Investigator's Decision|0|||
164021063|NCT00256867|592439677|FG006|Overall Study|Investigator's Decision|0|||
164021064|NCT00256867|592439678|FG007|Overall Study|Investigator's Decision|0|||
164021065|NCT00256867|592439671|FG000|Overall Study|Non-compliance with study medication|0|||
164021066|NCT00256867|592439672|FG001|Overall Study|Non-compliance with study medication|0|||
164021067|NCT00256867|592439673|FG002|Overall Study|Non-compliance with study medication|0|||
164021068|NCT00256867|592439674|FG003|Overall Study|Non-compliance with study medication|0|||
164021069|NCT00256867|592439675|FG004|Overall Study|Non-compliance with study medication|0|||
164021070|NCT00256867|592439676|FG005|Overall Study|Non-compliance with study medication|0|||
164021071|NCT00256867|592439677|FG006|Overall Study|Non-compliance with study medication|0|||
164021072|NCT00256867|592439678|FG007|Overall Study|Non-compliance with study medication|1|||
164021073|NCT00256867|592439671|FG000|Overall Study|Participant travelled Overseas|0|||
164021074|NCT00256867|592439672|FG001|Overall Study|Participant travelled Overseas|1|||
164021075|NCT00256867|592439673|FG002|Overall Study|Participant travelled Overseas|0|||
164021076|NCT00256867|592439674|FG003|Overall Study|Participant travelled Overseas|0|||
164021077|NCT00256867|592439675|FG004|Overall Study|Participant travelled Overseas|0|||
164021078|NCT00256867|592439676|FG005|Overall Study|Participant travelled Overseas|0|||
164021079|NCT00256867|592439677|FG006|Overall Study|Participant travelled Overseas|0|||
164021080|NCT00256867|592439678|FG007|Overall Study|Participant travelled Overseas|0|||
164021081|NCT00256867|592439671|FG000|Overall Study|Participant out of assessment window|0|||
164021082|NCT00256867|592439672|FG001|Overall Study|Participant out of assessment window|0|||
164021083|NCT00256867|592439673|FG002|Overall Study|Participant out of assessment window|1|||
164144813|NCT01524978|592891783|FG009|Overall Study|Lost to Follow-up|1|||
163910016|NCT04821271|592040611|FG000|Period 1|Withdrawal by Subject|2|||
164021084|NCT00256867|592439674|FG003|Overall Study|Participant out of assessment window|0|||
164021085|NCT00256867|592439675|FG004|Overall Study|Participant out of assessment window|0|||
164021086|NCT00256867|592439676|FG005|Overall Study|Participant out of assessment window|0|||
164021087|NCT00256867|592439677|FG006|Overall Study|Participant out of assessment window|0|||
164021088|NCT00256867|592439678|FG007|Overall Study|Participant out of assessment window|0|||
164021089|NCT00256867|592439671|FG000|Overall Study|Withdrawal by participant|0|||
164021090|NCT00256867|592439672|FG001|Overall Study|Withdrawal by participant|0|||
164021091|NCT00256867|592439673|FG002|Overall Study|Withdrawal by participant|0|||
164021092|NCT00256867|592439674|FG003|Overall Study|Withdrawal by participant|0|||
164021093|NCT00256867|592439675|FG004|Overall Study|Withdrawal by participant|0|||
164021094|NCT00256867|592439676|FG005|Overall Study|Withdrawal by participant|1|||
164021095|NCT00256867|592439677|FG006|Overall Study|Withdrawal by participant|0|||
164021096|NCT00256867|592439678|FG007|Overall Study|Withdrawal by participant|0|||
164021097|NCT01465178|592439679|FG000|Overall Study|Withdrawal by Subject|1|||
164021098|NCT01465178|592439680|FG001|Overall Study|Withdrawal by Subject|0|||
164021099|NCT01930799|592439685|FG000|Overall Study|Withdrawal by Subject|3|||
164021100|NCT01930799|592439685|FG000|Overall Study|Lost to Follow-up|5|||
164021101|NCT00875017|592439686|FG000|First Intervention|Withdrawal by Subject|1|||
164021102|NCT00875017|592439687|FG001|First Intervention|Withdrawal by Subject|0|||
164021103|NCT00875017|592439688|FG002|First Intervention|Withdrawal by Subject|1|||
164021104|NCT00875017|592439689|FG003|First Intervention|Withdrawal by Subject|0|||
164021105|NCT00875017|592439690|FG004|First Intervention|Withdrawal by Subject|0|||
164021106|NCT00875017|592439691|FG005|First Intervention|Withdrawal by Subject|0|||
164021107|NCT00875017|592439686|FG000|First Intervention|Adverse Event|0|||
164021108|NCT00875017|592439687|FG001|First Intervention|Adverse Event|0|||
164021109|NCT00875017|592439688|FG002|First Intervention|Adverse Event|0|||
164021110|NCT00875017|592439689|FG003|First Intervention|Adverse Event|1|||
164021111|NCT00875017|592439690|FG004|First Intervention|Adverse Event|0|||
164021112|NCT00875017|592439691|FG005|First Intervention|Adverse Event|0|||
164021113|NCT00875017|592439686|FG000|First Intervention|Problems collecting rectal effluent|1|||
164021114|NCT00875017|592439687|FG001|First Intervention|Problems collecting rectal effluent|0|||
164021115|NCT00875017|592439688|FG002|First Intervention|Problems collecting rectal effluent|0|||
164021116|NCT00875017|592439689|FG003|First Intervention|Problems collecting rectal effluent|0|||
164021117|NCT00875017|592439690|FG004|First Intervention|Problems collecting rectal effluent|0|||
164021118|NCT00875017|592439691|FG005|First Intervention|Problems collecting rectal effluent|0|||
164021119|NCT00875017|592439686|FG000|First Intervention|Intolerance to nasogastric tube|0|||
164021120|NCT00875017|592439687|FG001|First Intervention|Intolerance to nasogastric tube|0|||
164021121|NCT00875017|592439688|FG002|First Intervention|Intolerance to nasogastric tube|0|||
164021122|NCT00875017|592439689|FG003|First Intervention|Intolerance to nasogastric tube|0|||
164021123|NCT00875017|592439690|FG004|First Intervention|Intolerance to nasogastric tube|1|||
164021124|NCT00875017|592439691|FG005|First Intervention|Intolerance to nasogastric tube|0|||
164021125|NCT00875017|592439686|FG000|Washout|Problem collecting rectal effluent|0|||
164021126|NCT00875017|592439687|FG001|Washout|Problem collecting rectal effluent|0|||
164021127|NCT00875017|592439688|FG002|Washout|Problem collecting rectal effluent|1|||
164021128|NCT00875017|592439689|FG003|Washout|Problem collecting rectal effluent|0|||
164021129|NCT00875017|592439690|FG004|Washout|Problem collecting rectal effluent|0|||
164021130|NCT00875017|592439691|FG005|Washout|Problem collecting rectal effluent|0|||
164021131|NCT00875017|592439686|FG000|Second Intervention|Adverse Event|0|||
164021132|NCT00875017|592439687|FG001|Second Intervention|Adverse Event|0|||
164021133|NCT00875017|592439688|FG002|Second Intervention|Adverse Event|0|||
164021134|NCT00875017|592439689|FG003|Second Intervention|Adverse Event|1|||
164021135|NCT00875017|592439690|FG004|Second Intervention|Adverse Event|0|||
164021136|NCT00875017|592439691|FG005|Second Intervention|Adverse Event|0|||
164021137|NCT00875017|592439686|FG000|Washout|Problems collecting rectal effluent|0|||
164021138|NCT00875017|592439687|FG001|Washout|Problems collecting rectal effluent|1|||
164021139|NCT00875017|592439688|FG002|Washout|Problems collecting rectal effluent|0|||
164021140|NCT00875017|592439689|FG003|Washout|Problems collecting rectal effluent|0|||
164021141|NCT00875017|592439690|FG004|Washout|Problems collecting rectal effluent|0|||
164021142|NCT00875017|592439691|FG005|Washout|Problems collecting rectal effluent|0|||
164021143|NCT00875017|592439686|FG000|Third Intervention|Adverse Event|0|||
164021144|NCT00875017|592439687|FG001|Third Intervention|Adverse Event|1|||
164021145|NCT00875017|592439688|FG002|Third Intervention|Adverse Event|1|||
164021146|NCT00875017|592439689|FG003|Third Intervention|Adverse Event|0|||
164021147|NCT00875017|592439690|FG004|Third Intervention|Adverse Event|0|||
164021148|NCT00875017|592439691|FG005|Third Intervention|Adverse Event|0|||
164021149|NCT00875017|592439686|FG000|Washout|Withdrawal by Subject|0|||
164021150|NCT00875017|592439687|FG001|Washout|Withdrawal by Subject|0|||
164021151|NCT00875017|592439688|FG002|Washout|Withdrawal by Subject|0|||
164021152|NCT00875017|592439689|FG003|Washout|Withdrawal by Subject|0|||
164021153|NCT00875017|592439690|FG004|Washout|Withdrawal by Subject|1|||
164021154|NCT00875017|592439691|FG005|Washout|Withdrawal by Subject|0|||
164021155|NCT00875017|592439686|FG000|Fourth Intervention|Inability to comply with fasting|0|||
164021156|NCT00875017|592439687|FG001|Fourth Intervention|Inability to comply with fasting|0|||
164021157|NCT00875017|592439688|FG002|Fourth Intervention|Inability to comply with fasting|0|||
164021158|NCT00875017|592439689|FG003|Fourth Intervention|Inability to comply with fasting|0|||
164021159|NCT00875017|592439690|FG004|Fourth Intervention|Inability to comply with fasting|0|||
164021160|NCT00875017|592439691|FG005|Fourth Intervention|Inability to comply with fasting|1|||
164021161|NCT01477892|592439692|FG000|Overall Study|Withdrawal by Subject|0|||
164021162|NCT01477892|592439693|FG001|Overall Study|Withdrawal by Subject|2|||
164021163|NCT00364845|592439696|FG000|Overall Study|Adverse Event|1|||
164021164|NCT00364845|592439697|FG001|Overall Study|Adverse Event|0|||
164021165|NCT00364845|592439696|FG000|Overall Study|Withdrawal by Subject|2|||
164021166|NCT00364845|592439697|FG001|Overall Study|Withdrawal by Subject|1|||
164021167|NCT00364845|592439696|FG000|Overall Study|Physician Decision|8|||
164021168|NCT00364845|592439697|FG001|Overall Study|Physician Decision|8|||
164021169|NCT00364845|592439696|FG000|Overall Study|Lost to Follow-up|0|||
164021170|NCT00364845|592439697|FG001|Overall Study|Lost to Follow-up|1|||
164021171|NCT00364845|592439696|FG000|Overall Study|Death|0|||
164021172|NCT00364845|592439697|FG001|Overall Study|Death|1|||
164021173|NCT01912768|592439698|FG000|Overall Study|Adverse Event|2|||
164021174|NCT01912768|592439699|FG001|Overall Study|Adverse Event|0|||
164021175|NCT01912768|592439698|FG000|Overall Study|Lost to Follow-up|2|||
164021176|NCT01912768|592439699|FG001|Overall Study|Lost to Follow-up|1|||
164021177|NCT01912768|592439698|FG000|Overall Study|Withdrawal by Subject|5|||
164021178|NCT01912768|592439699|FG001|Overall Study|Withdrawal by Subject|3|||
164021179|NCT01912768|592439698|FG000|Overall Study|Randomized in error|1|||
164021180|NCT01912768|592439699|FG001|Overall Study|Randomized in error|0|||
164021181|NCT01423617|592439700|FG000|Overall Study|Lost to Follow-up|0|||
164021182|NCT01423617|592439701|FG001|Overall Study|Lost to Follow-up|1|||
164021183|NCT03255291|592439702|FG000|Overall Study|Determined to be ineligible|10|||
164021184|NCT03255291|592439703|FG001|Overall Study|Determined to be ineligible|12|||
164021185|NCT03255291|592439704|FG002|Overall Study|Determined to be ineligible|6|||
164021186|NCT03255291|592439705|FG003|Overall Study|Determined to be ineligible|6|||
164021187|NCT03255291|592439706|FG004|Overall Study|Determined to be ineligible|5|||
164021188|NCT03255291|592439707|FG005|Overall Study|Determined to be ineligible|10|||
164021189|NCT03255291|592439702|FG000|Overall Study|Baseline data collection issues|3|||
164021190|NCT03255291|592439703|FG001|Overall Study|Baseline data collection issues|0|||
164021191|NCT03255291|592439704|FG002|Overall Study|Baseline data collection issues|0|||
164021192|NCT03255291|592439705|FG003|Overall Study|Baseline data collection issues|0|||
164021193|NCT03255291|592439706|FG004|Overall Study|Baseline data collection issues|2|||
164021194|NCT03255291|592439707|FG005|Overall Study|Baseline data collection issues|0|||
164021195|NCT00634244|592439708|FG000|Overall Study|Never started treatment|0|||
164021196|NCT00634244|592439709|FG001|Overall Study|Never started treatment|1|||
164021197|NCT00634244|592439710|FG002|Overall Study|Never started treatment|0|||
164021198|NCT00634244|592439708|FG000|Overall Study|Death|1|||
164021199|NCT00634244|592439709|FG001|Overall Study|Death|6|||
164021200|NCT00634244|592439710|FG002|Overall Study|Death|0|||
164021201|NCT00634244|592439708|FG000|Overall Study|Adverse Event|0|||
164021202|NCT00634244|592439709|FG001|Overall Study|Adverse Event|2|||
164021203|NCT00634244|592439710|FG002|Overall Study|Adverse Event|0|||
164021204|NCT00634244|592439708|FG000|Overall Study|Withdrawal by Subject|0|||
164021205|NCT00634244|592439709|FG001|Overall Study|Withdrawal by Subject|1|||
164021206|NCT00634244|592439710|FG002|Overall Study|Withdrawal by Subject|0|||
164021207|NCT00634244|592439708|FG000|Overall Study|Physician Decision|0|||
164021208|NCT00634244|592439709|FG001|Overall Study|Physician Decision|1|||
164021209|NCT00634244|592439710|FG002|Overall Study|Physician Decision|0|||
164021210|NCT00634244|592439708|FG000|Overall Study|Disease progression/relapse|0|||
164021211|NCT00634244|592439709|FG001|Overall Study|Disease progression/relapse|1|||
164021212|NCT00634244|592439710|FG002|Overall Study|Disease progression/relapse|0|||
164021213|NCT00634244|592439708|FG000|Overall Study|Other complicating disease|0|||
164021214|NCT00634244|592439709|FG001|Overall Study|Other complicating disease|1|||
164021215|NCT00634244|592439710|FG002|Overall Study|Other complicating disease|0|||
164021216|NCT04369430|592439719|FG000|Overall Study|Adverse Event|2|||
164021217|NCT04369430|592439720|FG001|Overall Study|Adverse Event|3|||
164021218|NCT04369430|592439719|FG000|Overall Study|Death|1|||
164021219|NCT04369430|592439720|FG001|Overall Study|Death|0|||
164021220|NCT04369430|592439719|FG000|Overall Study|Withdrawal by Subject|4|||
164021221|NCT04369430|592439720|FG001|Overall Study|Withdrawal by Subject|3|||
164021222|NCT04369430|592439719|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
164021223|NCT04369430|592439720|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
164021224|NCT04369430|592439719|FG000|Overall Study|Lost to Follow-up|0|||
164021225|NCT04369430|592439720|FG001|Overall Study|Lost to Follow-up|1|||
164021226|NCT03453151|592439721|FG000|Overall Study|Withdrawal by Subject|1|||
164021227|NCT03453151|592439721|FG000|Overall Study|Physician Decision|3|||
164021228|NCT01468909|592439722|FG000|Overall Study|Never Treated|2|||
164021229|NCT01468909|592439723|FG001|Overall Study|Never Treated|2|||
164021230|NCT01204658|592439724|FG000|Primary Phase|Adverse Event|0|||
164021231|NCT01204658|592439725|FG001|Primary Phase|Adverse Event|0|||
164021232|NCT01204658|592439726|FG002|Primary Phase|Adverse Event|1|||
164021233|NCT01204658|592439727|FG003|Primary Phase|Adverse Event|0|||
164021234|NCT04594239|592439732|FG000|Overall Study|Withdrawal by Subject|3|||
164021235|NCT04594239|592439733|FG001|Overall Study|Withdrawal by Subject|4|||
164021236|NCT04594239|592439734|FG002|Overall Study|Withdrawal by Subject|2|||
164021237|NCT04594239|592439735|FG003|Overall Study|Withdrawal by Subject|4|||
164021238|NCT04594239|592439732|FG000|Overall Study|Lost to Follow-up|8|||
164021239|NCT04594239|592439733|FG001|Overall Study|Lost to Follow-up|5|||
164021240|NCT04594239|592439734|FG002|Overall Study|Lost to Follow-up|4|||
164021241|NCT04594239|592439735|FG003|Overall Study|Lost to Follow-up|6|||
164021242|NCT04594239|592439732|FG000|Overall Study|Subject relocated|0|||
164021243|NCT04594239|592439733|FG001|Overall Study|Subject relocated|0|||
164021244|NCT04594239|592439734|FG002|Overall Study|Subject relocated|0|||
164021245|NCT04594239|592439735|FG003|Overall Study|Subject relocated|1|||
164021246|NCT03229759|592439736|FG000|Overall Study|Screen Failure|30|||
164021247|NCT00818207|592441754|FG000|Overall Study|Adverse Event|6|||
164021248|NCT00818207|592441755|FG001|Overall Study|Adverse Event|0|||
164021249|NCT00818207|592441754|FG000|Overall Study|Lost to Follow-up|160|||
164021250|NCT00818207|592441755|FG001|Overall Study|Lost to Follow-up|146|||
164021251|NCT00818207|592441754|FG000|Overall Study|Multiple reasons|11|||
164021252|NCT00818207|592441755|FG001|Overall Study|Multiple reasons|12|||
164021253|NCT00818207|592441754|FG000|Overall Study|Withdrawal by Subject|42|||
164021254|NCT00818207|592441755|FG001|Overall Study|Withdrawal by Subject|104|||
164021255|NCT00818207|592441754|FG000|Overall Study|Death|3|||
164021256|NCT00818207|592441755|FG001|Overall Study|Death|5|||
164021257|NCT02616185|592441756|FG000|Overall Study|Death|0|||
164021258|NCT02616185|592441757|FG001|Overall Study|Death|0|||
164021259|NCT02616185|592441758|FG002|Overall Study|Death|0|||
164021260|NCT02616185|592441759|FG003|Overall Study|Death|1|||
164021261|NCT02616185|592441760|FG004|Overall Study|Death|2|||
164021262|NCT02616185|592441761|FG005|Overall Study|Death|0|||
164021263|NCT02616185|592441762|FG006|Overall Study|Death|0|||
164021264|NCT02616185|592441763|FG007|Overall Study|Death|2|||
164021265|NCT02616185|592441764|FG008|Overall Study|Death|1|||
164021266|NCT02616185|592441756|FG000|Overall Study|Study terminated by sponsor|0|||
164021267|NCT02616185|592441757|FG001|Overall Study|Study terminated by sponsor|0|||
164021268|NCT02616185|592441758|FG002|Overall Study|Study terminated by sponsor|1|||
164021269|NCT02616185|592441759|FG003|Overall Study|Study terminated by sponsor|0|||
164021270|NCT02616185|592441760|FG004|Overall Study|Study terminated by sponsor|0|||
164021271|NCT02616185|592441761|FG005|Overall Study|Study terminated by sponsor|0|||
164021272|NCT02616185|592441762|FG006|Overall Study|Study terminated by sponsor|5|||
164021273|NCT02616185|592441763|FG007|Overall Study|Study terminated by sponsor|2|||
164021274|NCT02616185|592441764|FG008|Overall Study|Study terminated by sponsor|0|||
164021275|NCT02616185|592441756|FG000|Overall Study|Participant refused further follow-up|1|||
164021276|NCT02616185|592441757|FG001|Overall Study|Participant refused further follow-up|1|||
164021277|NCT02616185|592441758|FG002|Overall Study|Participant refused further follow-up|2|||
164021278|NCT02616185|592441759|FG003|Overall Study|Participant refused further follow-up|3|||
164021279|NCT02616185|592441760|FG004|Overall Study|Participant refused further follow-up|4|||
164021280|NCT02616185|592441761|FG005|Overall Study|Participant refused further follow-up|0|||
164021281|NCT02616185|592441762|FG006|Overall Study|Participant refused further follow-up|3|||
164021282|NCT02616185|592441763|FG007|Overall Study|Participant refused further follow-up|4|||
164021283|NCT02616185|592441764|FG008|Overall Study|Participant refused further follow-up|3|||
164021284|NCT02616185|592441756|FG000|Overall Study|Not reported|0|||
164021285|NCT02616185|592441757|FG001|Overall Study|Not reported|0|||
164021286|NCT02616185|592441758|FG002|Overall Study|Not reported|0|||
164021287|NCT02616185|592441759|FG003|Overall Study|Not reported|1|||
164021288|NCT02616185|592441760|FG004|Overall Study|Not reported|3|||
164021289|NCT02616185|592441761|FG005|Overall Study|Not reported|1|||
164021290|NCT02616185|592441762|FG006|Overall Study|Not reported|0|||
164021291|NCT02616185|592441763|FG007|Overall Study|Not reported|5|||
164021292|NCT02616185|592441764|FG008|Overall Study|Not reported|2|||
164021293|NCT01303380|592441765|FG000|Overall Study|Lack of compliance to study procedures|1|||
164021294|NCT00967226|592441766|FG000|Overall Study|Adverse Event|0|||
164021295|NCT00967226|592441767|FG001|Overall Study|Adverse Event|5|||
164021296|NCT00967226|592441766|FG000|Overall Study|Protocol Violation|2|||
164021297|NCT00967226|592441767|FG001|Overall Study|Protocol Violation|0|||
164021298|NCT00967226|592441766|FG000|Overall Study|Physician Decision|0|||
164021299|NCT00967226|592441767|FG001|Overall Study|Physician Decision|1|||
164021300|NCT01670656|592441768|FG000|Overall Study|Non-compliance with study drug|0|||
164021301|NCT01670656|592441769|FG001|Overall Study|Non-compliance with study drug|0|||
164021302|NCT01670656|592441770|FG002|Overall Study|Non-compliance with study drug|3|||
164021303|NCT01670656|592441771|FG003|Overall Study|Non-compliance with study drug|0|||
164021304|NCT01670656|592441772|FG004|Overall Study|Non-compliance with study drug|1|||
164021305|NCT01670656|592441768|FG000|Overall Study|Pregnancy|0|||
164021306|NCT01670656|592441769|FG001|Overall Study|Pregnancy|0|||
164021307|NCT01670656|592441770|FG002|Overall Study|Pregnancy|0|||
164021308|NCT01670656|592441771|FG003|Overall Study|Pregnancy|0|||
164021309|NCT01670656|592441772|FG004|Overall Study|Pregnancy|1|||
164021310|NCT01670656|592441768|FG000|Overall Study|Withdrawal by Subject|1|||
164021311|NCT01670656|592441769|FG001|Overall Study|Withdrawal by Subject|1|||
164021312|NCT01670656|592441770|FG002|Overall Study|Withdrawal by Subject|0|||
164021313|NCT01670656|592441771|FG003|Overall Study|Withdrawal by Subject|0|||
164021314|NCT01670656|592441772|FG004|Overall Study|Withdrawal by Subject|0|||
164021315|NCT01670656|592441768|FG000|Overall Study|Non-compliance with protocol|0|||
164021316|NCT01670656|592441769|FG001|Overall Study|Non-compliance with protocol|3|||
164021317|NCT01670656|592441770|FG002|Overall Study|Non-compliance with protocol|1|||
164021318|NCT01670656|592441771|FG003|Overall Study|Non-compliance with protocol|1|||
164021319|NCT01670656|592441772|FG004|Overall Study|Non-compliance with protocol|2|||
164021320|NCT01670656|592441768|FG000|Overall Study|Adverse Event|2|||
164021321|NCT01670656|592441769|FG001|Overall Study|Adverse Event|2|||
164021322|NCT01670656|592441770|FG002|Overall Study|Adverse Event|2|||
164021323|NCT01670656|592441771|FG003|Overall Study|Adverse Event|3|||
164021324|NCT01670656|592441772|FG004|Overall Study|Adverse Event|3|||
164021325|NCT01670656|592441768|FG000|Overall Study|Subject withdrew consent|0|||
164021326|NCT01670656|592441769|FG001|Overall Study|Subject withdrew consent|1|||
164021327|NCT01670656|592441770|FG002|Overall Study|Subject withdrew consent|2|||
164021328|NCT01670656|592441771|FG003|Overall Study|Subject withdrew consent|1|||
164095217|NCT01062256|592712283|FG000|Overall Study|Withdrawal by Subject|1|||
164021329|NCT01670656|592441772|FG004|Overall Study|Subject withdrew consent|1|||
164021330|NCT01670656|592441768|FG000|Overall Study|Lost to Follow-up|0|||
164021331|NCT01670656|592441769|FG001|Overall Study|Lost to Follow-up|0|||
164095218|NCT01062256|592712284|FG001|Overall Study|Withdrawal by Subject|1|||
164021332|NCT01670656|592441770|FG002|Overall Study|Lost to Follow-up|0|||
164021333|NCT01670656|592441771|FG003|Overall Study|Lost to Follow-up|0|||
164021334|NCT01670656|592441772|FG004|Overall Study|Lost to Follow-up|3|||
164021335|NCT01670656|592441768|FG000|Overall Study|Subject moved|0|||
164021336|NCT01670656|592441769|FG001|Overall Study|Subject moved|0|||
164021337|NCT01670656|592441770|FG002|Overall Study|Subject moved|0|||
164021338|NCT01670656|592441771|FG003|Overall Study|Subject moved|1|||
164021339|NCT01670656|592441772|FG004|Overall Study|Subject moved|0|||
164021340|NCT00789958|592441773|FG000|Overall Study|Adverse Event|3|||
164021341|NCT00789958|592441773|FG000|Overall Study|Withdrawal by Subject|4|||
164021342|NCT00789958|592441773|FG000|Overall Study|Progression|3|||
164021343|NCT00789958|592441773|FG000|Overall Study|not protocol specified|1|||
164021344|NCT00789958|592441773|FG000|Overall Study|Not eligible/not analyzable|26|||
164021345|NCT00487084|592441774|FG000|Overall Study|Did not receive intervention|4|||
164021346|NCT00487084|592441775|FG001|Overall Study|Did not receive intervention|3|||
164021347|NCT00487084|592441776|FG002|Overall Study|Did not receive intervention|5|||
164021348|NCT00111475|592441777|FG000|Overall Study|Lost to Follow-up|0|||
164021349|NCT00111475|592441778|FG001|Overall Study|Lost to Follow-up|0|||
164021350|NCT00111475|592441779|FG002|Overall Study|Lost to Follow-up|0|||
164021351|NCT00111475|592441780|FG003|Overall Study|Lost to Follow-up|0|||
164021352|NCT00111475|592441781|FG004|Overall Study|Lost to Follow-up|0|||
164021353|NCT00111475|592441782|FG005|Overall Study|Lost to Follow-up|1|||
164021354|NCT00111475|592441783|FG006|Overall Study|Lost to Follow-up|0|||
164021355|NCT00111475|592441784|FG007|Overall Study|Lost to Follow-up|0|||
164021356|NCT00111475|592441785|FG008|Overall Study|Lost to Follow-up|0|||
164021357|NCT00111475|592441786|FG009|Overall Study|Lost to Follow-up|0|||
164021358|NCT03303092|592441787|FG000|Overall Study|Adverse Event|1|||
164021359|NCT03303092|592441788|FG001|Overall Study|Adverse Event|0|||
164021360|NCT03303092|592441789|FG002|Overall Study|Adverse Event|1|||
164021361|NCT03303092|592441787|FG000|Overall Study|Protocol Violation|1|||
164021362|NCT03303092|592441788|FG001|Overall Study|Protocol Violation|5|||
164021363|NCT03303092|592441789|FG002|Overall Study|Protocol Violation|1|||
164021364|NCT03303092|592441787|FG000|Overall Study|Withdrawal by Subject|1|||
164021365|NCT03303092|592441788|FG001|Overall Study|Withdrawal by Subject|1|||
164021366|NCT03303092|592441789|FG002|Overall Study|Withdrawal by Subject|3|||
164021367|NCT01697267|592441793|FG000|Overall Study|Death|3|||
164021368|NCT01697267|592441794|FG001|Overall Study|Death|1|||
164021369|NCT01697267|592441793|FG000|Overall Study|Withdrawal by Subject|5|||
164021370|NCT01697267|592441794|FG001|Overall Study|Withdrawal by Subject|5|||
164021371|NCT01697267|592441793|FG000|Overall Study|Adverse Event|2|||
164021372|NCT01697267|592441794|FG001|Overall Study|Adverse Event|1|||
164021373|NCT01697267|592441793|FG000|Overall Study|Lost to Follow-up|2|||
164021374|NCT01697267|592441794|FG001|Overall Study|Lost to Follow-up|4|||
164021375|NCT01697267|592441793|FG000|Overall Study|Physician Decision|2|||
164021376|NCT01697267|592441794|FG001|Overall Study|Physician Decision|4|||
164021377|NCT00833248|592441797|FG000|Overall Study|Adverse Event|3|||
164021378|NCT00833248|592441798|FG001|Overall Study|Adverse Event|0|||
164021379|NCT00833248|592441797|FG000|Overall Study|Protocol Violation|1|||
164021380|NCT00833248|592441798|FG001|Overall Study|Protocol Violation|2|||
164021381|NCT00833248|592441797|FG000|Overall Study|Withdrawal by Subject|0|||
164021382|NCT00833248|592441798|FG001|Overall Study|Withdrawal by Subject|1|||
164021383|NCT01830543|592441799|FG000|Overall Study|Subject Decision|19|||
164021384|NCT01830543|592441800|FG001|Overall Study|Subject Decision|21|||
164021385|NCT01830543|592441801|FG002|Overall Study|Subject Decision|57|||
164021386|NCT01830543|592441799|FG000|Overall Study|Adverse Event|91|||
164021387|NCT01830543|592441800|FG001|Overall Study|Adverse Event|77|||
164021388|NCT01830543|592441801|FG002|Overall Study|Adverse Event|76|||
164021389|NCT01830543|592441799|FG000|Overall Study|Death|20|||
164021390|NCT01830543|592441800|FG001|Overall Study|Death|22|||
164021391|NCT01830543|592441801|FG002|Overall Study|Death|22|||
164021392|NCT01830543|592441799|FG000|Overall Study|Protocol Violation|3|||
164021393|NCT01830543|592441800|FG001|Overall Study|Protocol Violation|7|||
164021394|NCT01830543|592441801|FG002|Overall Study|Protocol Violation|7|||
164021395|NCT01830543|592441799|FG000|Overall Study|Physician Decision|11|||
164021396|NCT01830543|592441800|FG001|Overall Study|Physician Decision|5|||
164021397|NCT01830543|592441801|FG002|Overall Study|Physician Decision|12|||
164021398|NCT01830543|592441799|FG000|Overall Study|Withdrawal by consent|3|||
164021399|NCT01830543|592441800|FG001|Overall Study|Withdrawal by consent|3|||
164021400|NCT01830543|592441801|FG002|Overall Study|Withdrawal by consent|3|||
164021401|NCT01830543|592441799|FG000|Overall Study|Other|12|||
164021402|NCT01830543|592441800|FG001|Overall Study|Other|17|||
164021403|NCT01830543|592441801|FG002|Overall Study|Other|37|||
164021404|NCT02681055|592441804|FG000|Weeks 5-12|Adverse Event|1|||
164021405|NCT00377611|592441809|FG000|Overall Study|Adverse Event|2|||
164021406|NCT00377611|592441810|FG001|Overall Study|Adverse Event|9|||
164021407|NCT00377611|592441809|FG000|Overall Study|Protocol Violation|2|||
164021408|NCT00377611|592441810|FG001|Overall Study|Protocol Violation|0|||
164021409|NCT00377611|592441809|FG000|Overall Study|Withdrawal by Subject|0|||
164021410|NCT00377611|592441810|FG001|Overall Study|Withdrawal by Subject|5|||
164021411|NCT00377611|592441809|FG000|Overall Study|Lost to Follow-up|18|||
164021412|NCT00377611|592441810|FG001|Overall Study|Lost to Follow-up|16|||
164021413|NCT00377611|592441809|FG000|Overall Study|Other|0|||
164021414|NCT00377611|592441810|FG001|Overall Study|Other|3|||
164021415|NCT01030458|592441811|FG000|Overall Study|Lost to Follow-up|9|||
164021416|NCT01030458|592441812|FG001|Overall Study|Lost to Follow-up|10|||
164021417|NCT01030458|592441811|FG000|Overall Study|Withdrawal by Subject|2|||
164021418|NCT01030458|592441812|FG001|Overall Study|Withdrawal by Subject|3|||
164021419|NCT01030458|592441811|FG000|Overall Study|Logistical reasons|9|||
164021420|NCT01030458|592441812|FG001|Overall Study|Logistical reasons|5|||
164021421|NCT01030458|592441811|FG000|Overall Study|Moved or changed job|6|||
164021422|NCT01030458|592441812|FG001|Overall Study|Moved or changed job|13|||
164021423|NCT01030458|592441811|FG000|Overall Study|Side effect of medication|1|||
164021424|NCT01030458|592441812|FG001|Overall Study|Side effect of medication|1|||
164021425|NCT00839423|592441815|FG000|Overall Study|Adverse Event|4|||
164021426|NCT00839423|592441816|FG001|Overall Study|Adverse Event|3|||
164021427|NCT00839423|592441817|FG002|Overall Study|Adverse Event|7|||
164021428|NCT00839423|592441818|FG003|Overall Study|Adverse Event|16|||
164021429|NCT00839423|592441815|FG000|Overall Study|Lack of Efficacy|6|||
164021430|NCT00839423|592441816|FG001|Overall Study|Lack of Efficacy|6|||
164021431|NCT00839423|592441817|FG002|Overall Study|Lack of Efficacy|3|||
164021432|NCT00839423|592441818|FG003|Overall Study|Lack of Efficacy|2|||
164021433|NCT00839423|592441815|FG000|Overall Study|Non-compliance|0|||
164021434|NCT00839423|592441816|FG001|Overall Study|Non-compliance|0|||
164021435|NCT00839423|592441817|FG002|Overall Study|Non-compliance|0|||
164021436|NCT00839423|592441818|FG003|Overall Study|Non-compliance|1|||
164021437|NCT00839423|592441815|FG000|Overall Study|Protocol Violation|0|||
164021438|NCT00839423|592441816|FG001|Overall Study|Protocol Violation|1|||
164021439|NCT00839423|592441817|FG002|Overall Study|Protocol Violation|2|||
164021440|NCT00839423|592441818|FG003|Overall Study|Protocol Violation|0|||
164021441|NCT00839423|592441815|FG000|Overall Study|Withdrawal of consent|4|||
164021442|NCT00839423|592441816|FG001|Overall Study|Withdrawal of consent|0|||
164021443|NCT00839423|592441817|FG002|Overall Study|Withdrawal of consent|4|||
164021444|NCT00839423|592441818|FG003|Overall Study|Withdrawal of consent|1|||
164021445|NCT00839423|592441815|FG000|Overall Study|Lost to Follow-up|1|||
164021446|NCT00839423|592441816|FG001|Overall Study|Lost to Follow-up|0|||
164021447|NCT00839423|592441817|FG002|Overall Study|Lost to Follow-up|1|||
164021448|NCT00839423|592441818|FG003|Overall Study|Lost to Follow-up|0|||
164021449|NCT00839423|592441815|FG000|Overall Study|Administrative or other reasons|3|||
164021450|NCT00839423|592441816|FG001|Overall Study|Administrative or other reasons|0|||
164021451|NCT00839423|592441817|FG002|Overall Study|Administrative or other reasons|1|||
164021452|NCT00839423|592441818|FG003|Overall Study|Administrative or other reasons|0|||
164021453|NCT01071096|592441819|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
164021454|NCT01071096|592441820|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
164021455|NCT02585999|592441821|FG000|Overall Study|Lost to Follow-up|1|||
164021456|NCT02585999|592441821|FG000|Overall Study|Protocol Violation|1|||
164021457|NCT00756886|592441822|FG000|Overall Study|Lost to Follow-up|1|||
164021458|NCT00756886|592441823|FG001|Overall Study|Lost to Follow-up|0|||
164021459|NCT00756886|592441822|FG000|Overall Study|Adverse Event|0|||
164021460|NCT00756886|592441823|FG001|Overall Study|Adverse Event|3|||
164021461|NCT00756886|592441822|FG000|Overall Study|Lack of Efficacy|1|||
164021462|NCT00756886|592441823|FG001|Overall Study|Lack of Efficacy|0|||
164021463|NCT00756886|592441822|FG000|Overall Study|Ineligible|9|||
164021464|NCT00756886|592441823|FG001|Overall Study|Ineligible|4|||
164021465|NCT00871377|592441828|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164021466|NCT00871377|592441829|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164021467|NCT00871377|592441830|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
164021468|NCT00871377|592441831|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164021469|NCT00871377|592441832|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164021470|NCT00871377|592441833|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
164021471|NCT00871377|592441828|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164021472|NCT00871377|592441829|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164021473|NCT00871377|592441830|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164021474|NCT00871377|592441831|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164021475|NCT00871377|592441832|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
164021476|NCT00871377|592441833|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
164021477|NCT00871377|592441828|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
164021478|NCT00871377|592441829|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021479|NCT00871377|592441830|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021480|NCT00871377|592441831|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021481|NCT00871377|592441832|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021482|NCT00871377|592441833|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021483|NCT00871377|592441828|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021484|NCT00871377|592441829|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021485|NCT00871377|592441830|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021486|NCT00871377|592441831|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021487|NCT00871377|592441832|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
164021488|NCT00871377|592441833|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
164021489|NCT00871377|592441828|FG000|Third Intervention (10 Weeks)|Death|0|||
164021490|NCT00871377|592441829|FG001|Third Intervention (10 Weeks)|Death|0|||
164095219|NCT01062256|592712285|FG002|Overall Study|Withdrawal by Subject|1|||
164095220|NCT01062256|592712283|FG000|Overall Study|Ineligible|1|||
164095221|NCT01062256|592712284|FG001|Overall Study|Ineligible|4|||
164095222|NCT01062256|592712285|FG002|Overall Study|Ineligible|3|||
164095223|NCT01062256|592712283|FG000|Overall Study|Administrative|0|||
164021491|NCT00871377|592441830|FG002|Third Intervention (10 Weeks)|Death|0|||
164021492|NCT00871377|592441831|FG003|Third Intervention (10 Weeks)|Death|1|||
164021493|NCT00871377|592441832|FG004|Third Intervention (10 Weeks)|Death|0|||
164021494|NCT00871377|592441833|FG005|Third Intervention (10 Weeks)|Death|0|||
164021495|NCT04348656|592441834|FG000|Overall Study|Withdrawal by Subject|2|||
164095224|NCT01062256|592712284|FG001|Overall Study|Administrative|2|||
164021496|NCT04348656|592441835|FG001|Overall Study|Withdrawal by Subject|0|||
164021497|NCT04348656|592441834|FG000|Overall Study|Lost to Follow-up|11|||
164021498|NCT04348656|592441835|FG001|Overall Study|Lost to Follow-up|6|||
164021499|NCT00288860|592441840|FG000|Overall Study|Did not complete intake|4|||
164021500|NCT00288860|592441841|FG001|Overall Study|Did not complete intake|8|||
164021501|NCT00288860|592441840|FG000|Overall Study|Death|4|||
164021502|NCT00288860|592441841|FG001|Overall Study|Death|3|||
163910017|NCT04821271|592040612|FG001|Period 1|Withdrawal by Subject|0|||
163910018|NCT02521493|592040615|FG000|Overall Study|Death|3|||
163910019|NCT02521493|592040616|FG001|Overall Study|Death|4|||
163910020|NCT02521493|592040617|FG002|Overall Study|Death|1|||
163910021|NCT02521493|592040615|FG000|Overall Study|Physician Decision|19|||
163910022|NCT02521493|592040616|FG001|Overall Study|Physician Decision|1|||
163910023|NCT02521493|592040617|FG002|Overall Study|Physician Decision|2|||
163910024|NCT02521493|592040615|FG000|Overall Study|Withdrawal by Subject|3|||
163910025|NCT02521493|592040616|FG001|Overall Study|Withdrawal by Subject|0|||
163910026|NCT02521493|592040617|FG002|Overall Study|Withdrawal by Subject|0|||
163910027|NCT02521493|592040615|FG000|Overall Study|Ineligible|0|||
163910028|NCT02521493|592040616|FG001|Overall Study|Ineligible|1|||
163910029|NCT02521493|592040617|FG002|Overall Study|Ineligible|0|||
163910030|NCT02521493|592040615|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
163910031|NCT02521493|592040616|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
163910032|NCT02521493|592040617|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
163910033|NCT02521493|592040615|FG000|Overall Study|No MRD result|0|||
163910034|NCT02521493|592040616|FG001|Overall Study|No MRD result|0|||
163910035|NCT02521493|592040617|FG002|Overall Study|No MRD result|4|||
163910036|NCT02008916|592040618|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
163910037|NCT02008916|592040619|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
163910038|NCT02008916|592040620|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
163910039|NCT02008916|592040618|FG000|Week 16 - 156|Adverse Event|4|||
163910040|NCT02008916|592040619|FG001|Week 16 - 156|Adverse Event|2|||
163910041|NCT02008916|592040620|FG002|Week 16 - 156|Adverse Event|3|||
163910042|NCT02008916|592040618|FG000|Week 16 - 156|Withdrawal by Subject|7|||
163910043|NCT02008916|592040619|FG001|Week 16 - 156|Withdrawal by Subject|3|||
163910044|NCT02008916|592040620|FG002|Week 16 - 156|Withdrawal by Subject|5|||
163910045|NCT02008916|592040618|FG000|Week 16 - 156|No longer requires treatment|0|||
163910046|NCT02008916|592040619|FG001|Week 16 - 156|No longer requires treatment|1|||
163910047|NCT02008916|592040620|FG002|Week 16 - 156|No longer requires treatment|0|||
163910048|NCT02008916|592040618|FG000|Week 16 - 156|Lost to Follow-up|5|||
163910049|NCT02008916|592040619|FG001|Week 16 - 156|Lost to Follow-up|0|||
163910050|NCT02008916|592040620|FG002|Week 16 - 156|Lost to Follow-up|0|||
163910051|NCT02008916|592040618|FG000|Week 16 - 156|Lack of Efficacy|3|||
163910052|NCT02008916|592040619|FG001|Week 16 - 156|Lack of Efficacy|5|||
163910053|NCT02008916|592040620|FG002|Week 16 - 156|Lack of Efficacy|2|||
163910054|NCT02008916|592040618|FG000|Week 16 - 156|Pregnancy|0|||
163910055|NCT02008916|592040619|FG001|Week 16 - 156|Pregnancy|1|||
163910056|NCT02008916|592040620|FG002|Week 16 - 156|Pregnancy|0|||
163910057|NCT02008916|592040618|FG000|Week 16 - 156|Physician Decision|0|||
163910058|NCT02008916|592040619|FG001|Week 16 - 156|Physician Decision|1|||
163910059|NCT02008916|592040620|FG002|Week 16 - 156|Physician Decision|0|||
163910060|NCT01880736|592040621|FG000|Overall Study|Adverse Event|0|||
163910061|NCT01880736|592040622|FG001|Overall Study|Adverse Event|0|||
163910062|NCT01880736|592040623|FG002|Overall Study|Adverse Event|0|||
163910063|NCT01880736|592040624|FG003|Overall Study|Adverse Event|1|||
163910064|NCT01880736|592040621|FG000|Overall Study|Withdrawal Criteria|1|||
163910065|NCT01880736|592040622|FG001|Overall Study|Withdrawal Criteria|2|||
163910066|NCT01880736|592040623|FG002|Overall Study|Withdrawal Criteria|1|||
163910067|NCT01880736|592040624|FG003|Overall Study|Withdrawal Criteria|5|||
163910068|NCT00428714|592040629|FG000|Overall Study|Progressive Disease|28|||
163910069|NCT00428714|592040630|FG001|Overall Study|Progressive Disease|36|||
163910070|NCT00428714|592040629|FG000|Overall Study|Withdrawal by Subject|0|||
163910071|NCT00428714|592040630|FG001|Overall Study|Withdrawal by Subject|3|||
163910072|NCT00428714|592040629|FG000|Overall Study|Adverse Event|0|||
163910073|NCT00428714|592040630|FG001|Overall Study|Adverse Event|2|||
163910074|NCT00428714|592040629|FG000|Overall Study|Physician Decision|1|||
163910075|NCT00428714|592040630|FG001|Overall Study|Physician Decision|1|||
163910076|NCT00428714|592040629|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
163910077|NCT00428714|592040630|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
164021503|NCT00288860|592441840|FG000|Overall Study|Withdrawal by Subject|20|||
164021504|NCT00288860|592441841|FG001|Overall Study|Withdrawal by Subject|15|||
164021505|NCT00288860|592441840|FG000|Overall Study|Lost to Follow-up|74|||
164021506|NCT00288860|592441841|FG001|Overall Study|Lost to Follow-up|71|||
164021507|NCT05142332|592441846|FG000|Overall Study|Withdrawal by Subject|0|||
164021508|NCT05142332|592441847|FG001|Overall Study|Withdrawal by Subject|1|||
164021509|NCT05142332|592441848|FG002|Overall Study|Withdrawal by Subject|2|||
164021510|NCT05142332|592441849|FG003|Overall Study|Withdrawal by Subject|0|||
164021511|NCT05142332|592441850|FG004|Overall Study|Withdrawal by Subject|0|||
164021512|NCT05142332|592441851|FG005|Overall Study|Withdrawal by Subject|2|||
164021513|NCT05142332|592441852|FG006|Overall Study|Withdrawal by Subject|6|||
164021514|NCT05142332|592441846|FG000|Overall Study|Left ED|3|||
164021515|NCT05142332|592441847|FG001|Overall Study|Left ED|0|||
164021516|NCT05142332|592441848|FG002|Overall Study|Left ED|4|||
164021517|NCT05142332|592441849|FG003|Overall Study|Left ED|6|||
164021518|NCT05142332|592441850|FG004|Overall Study|Left ED|1|||
164021519|NCT05142332|592441851|FG005|Overall Study|Left ED|2|||
164021520|NCT05142332|592441852|FG006|Overall Study|Left ED|6|||
164021521|NCT05142332|592441846|FG000|Overall Study|Physician Decision|0|||
164021522|NCT05142332|592441847|FG001|Overall Study|Physician Decision|0|||
164021523|NCT05142332|592441848|FG002|Overall Study|Physician Decision|2|||
164021524|NCT05142332|592441849|FG003|Overall Study|Physician Decision|1|||
164021525|NCT05142332|592441850|FG004|Overall Study|Physician Decision|0|||
164021526|NCT05142332|592441851|FG005|Overall Study|Physician Decision|0|||
164021527|NCT05142332|592441852|FG006|Overall Study|Physician Decision|3|||
164021528|NCT05142332|592441846|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
164021529|NCT05142332|592441847|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
164021530|NCT05142332|592441848|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
164021531|NCT05142332|592441849|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
164021532|NCT05142332|592441850|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
164021533|NCT05142332|592441851|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
164021534|NCT05142332|592441852|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
164021535|NCT02116660|592441853|FG000|Overall Study|Deteriorating renal function|0|||
164021536|NCT02116660|592441854|FG001|Overall Study|Deteriorating renal function|1|||
164021537|NCT02116660|592441853|FG000|Overall Study|Adverse Event|1|||
164021538|NCT02116660|592441854|FG001|Overall Study|Adverse Event|1|||
164021539|NCT02116660|592441853|FG000|Overall Study|Withdrawal by Subject|0|||
164021540|NCT02116660|592441854|FG001|Overall Study|Withdrawal by Subject|2|||
164021541|NCT02116660|592441853|FG000|Overall Study|Organization reason|1|||
164021542|NCT02116660|592441854|FG001|Overall Study|Organization reason|0|||
164021543|NCT00411788|592441858|FG000|Overall Study|Protocol Violation|1|||
164021544|NCT00411788|592441858|FG000|Overall Study|Adverse Event|1|||
164021545|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
164021546|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
164021547|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
164021548|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
164021549|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
164021550|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
164021551|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
164021552|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
164021553|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
164021554|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
164021555|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
164021556|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
164021557|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
164021558|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
164021559|NCT00848549|592441859|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
164021560|NCT00848549|592441860|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
164021561|NCT00848549|592441859|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
164021562|NCT00848549|592441860|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
164021563|NCT00848549|592441859|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
164021564|NCT00848549|592441860|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
164021565|NCT00848549|592441859|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
164021566|NCT00848549|592441860|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
164021567|NCT00848549|592441859|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
164021568|NCT00848549|592441860|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
164021569|NCT00848549|592441859|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
164021570|NCT00848549|592441860|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
164021571|NCT00848549|592441859|FG000|E2090-E044-314 (Extension Study)|Other|5|||
164021572|NCT00848549|592441860|FG001|E2090-E044-314 (Extension Study)|Other|6|||
164021573|NCT02561299|592441861|FG000|Overall Study|Death|2|||
164021574|NCT02561299|592441862|FG001|Overall Study|Death|4|||
164021575|NCT02561299|592441861|FG000|Overall Study|Lost to Follow-up|1|||
164021576|NCT02561299|592441862|FG001|Overall Study|Lost to Follow-up|0|||
164021577|NCT02561299|592441861|FG000|Overall Study|Withdrawal by Subject|2|||
164021578|NCT02561299|592441862|FG001|Overall Study|Withdrawal by Subject|2|||
164021579|NCT05631548|592441863|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
164021580|NCT05631548|592441864|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
164021581|NCT02345252|592441871|FG000|Double-Blind Phase|Adverse Event|2|||
164021582|NCT02345252|592441872|FG001|Double-Blind Phase|Adverse Event|3|||
164021583|NCT02345252|592441871|FG000|Double-Blind Phase|Death|1|||
164021584|NCT02345252|592441872|FG001|Double-Blind Phase|Death|2|||
164021585|NCT02345252|592441871|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164021586|NCT02345252|592441872|FG001|Double-Blind Phase|Lack of Efficacy|0|||
164021587|NCT02345252|592441871|FG000|Double-Blind Phase|Investigator's Discretion|4|||
164021588|NCT02345252|592441872|FG001|Double-Blind Phase|Investigator's Discretion|6|||
164021589|NCT02345252|592441871|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
164021590|NCT02345252|592441872|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
164021591|NCT02345252|592441871|FG000|Double-Blind Phase|Protocol Violation|2|||
164021592|NCT02345252|592441872|FG001|Double-Blind Phase|Protocol Violation|1|||
164021593|NCT02345252|592441871|FG000|Double-Blind Phase|Withdrew Consent|21|||
164021594|NCT02345252|592441872|FG001|Double-Blind Phase|Withdrew Consent|23|||
164021595|NCT02345252|592441871|FG000|Double-Blind Phase|Lost to Follow-up|8|||
164021596|NCT02345252|592441872|FG001|Double-Blind Phase|Lost to Follow-up|10|||
164021597|NCT02345252|592441871|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
164021598|NCT02345252|592441872|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
164021599|NCT02864940|592441879|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
164021600|NCT02864940|592441880|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
164021601|NCT04285346|592441881|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
164021602|NCT04285346|592441882|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
164021603|NCT04285346|592441881|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
164021604|NCT04285346|592441882|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164021605|NCT04285346|592441881|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
164021606|NCT04285346|592441882|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164021607|NCT00610935|592441883|FG000|Overall Study|Lost to Follow-up|0|||
164021608|NCT00610935|592441884|FG001|Overall Study|Lost to Follow-up|1|||
164021609|NCT00610935|592441883|FG000|Overall Study|Withdrawal by Subject|0|||
164021610|NCT00610935|592441884|FG001|Overall Study|Withdrawal by Subject|2|||
164021611|NCT00610935|592441883|FG000|Overall Study|Sponsor Discontinuation|1|||
164021612|NCT00610935|592441884|FG001|Overall Study|Sponsor Discontinuation|0|||
164021613|NCT04360187|592441885|FG000|Double-Blind Treatment|Adverse Event|9|||
164021614|NCT04360187|592441886|FG001|Double-Blind Treatment|Adverse Event|11|||
164021615|NCT04360187|592441885|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
164021616|NCT04360187|592441886|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
164021617|NCT04360187|592441885|FG000|Double-Blind Treatment|Physician Decision|1|||
164021618|NCT04360187|592441886|FG001|Double-Blind Treatment|Physician Decision|0|||
164021619|NCT04360187|592441885|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
164021620|NCT04360187|592441886|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
164021621|NCT04360187|592441885|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
164021622|NCT04360187|592441886|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
164021623|NCT04360187|592441885|FG000|Follow-Up|Lost to Follow-up|1|||
164021624|NCT04360187|592441886|FG001|Follow-Up|Lost to Follow-up|0|||
164021625|NCT02399813|592441887|FG000|Overall Study|Progressive Disease-Radiographic|2|||
164021626|NCT02399813|592441887|FG000|Overall Study|Death|20|||
164021627|NCT02399813|592441887|FG000|Overall Study|Withdrawal by Subject|3|||
164021628|NCT02399813|592441887|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
164095225|NCT01062256|592712285|FG002|Overall Study|Administrative|0|||
164095226|NCT03883906|592712289|FG000|Overall Study|Withdrawal by Subject|2|||
164095227|NCT03883906|592712289|FG000|Overall Study|Physician Decision|5|||
164095228|NCT01629381|592712292|FG000|Overall Study|Withdrawal by Subject|2|||
164095229|NCT01629381|592712293|FG001|Overall Study|Withdrawal by Subject|5|||
164095230|NCT00745095|592712297|FG000|Overall Study|Declined to participate|1|||
164021629|NCT02399813|592441887|FG000|Overall Study|Lost to Follow-up|2|||
164021630|NCT02399813|592441887|FG000|Overall Study|Other than specified|5|||
164021631|NCT05372575|592441888|FG000|Overall Study|Protocol Violation|7|||
164095231|NCT00745095|592712298|FG001|Overall Study|Declined to participate|0|||
164021632|NCT05372575|592441889|FG001|Overall Study|Protocol Violation|16|||
164021633|NCT02203838|592441892|FG000|Overall Study|Lack of Efficacy|7|||
164021634|NCT02203838|592441893|FG001|Overall Study|Lack of Efficacy|0|||
164021635|NCT02203838|592441894|FG002|Overall Study|Lack of Efficacy|1|||
164021636|NCT02203838|592441895|FG003|Overall Study|Lack of Efficacy|1|||
164021637|NCT02203838|592441892|FG000|Overall Study|Adverse Event|46|||
164021638|NCT02203838|592441893|FG001|Overall Study|Adverse Event|6|||
164021639|NCT02203838|592441894|FG002|Overall Study|Adverse Event|3|||
164021640|NCT02203838|592441895|FG003|Overall Study|Adverse Event|2|||
164021641|NCT02203838|592441892|FG000|Overall Study|Lost to Follow-up|39|||
164021642|NCT02203838|592441893|FG001|Overall Study|Lost to Follow-up|3|||
164021643|NCT02203838|592441894|FG002|Overall Study|Lost to Follow-up|2|||
164021644|NCT02203838|592441895|FG003|Overall Study|Lost to Follow-up|1|||
164021645|NCT02203838|592441892|FG000|Overall Study|Protocol Violation|7|||
164021646|NCT02203838|592441893|FG001|Overall Study|Protocol Violation|3|||
164021647|NCT02203838|592441894|FG002|Overall Study|Protocol Violation|0|||
164021648|NCT02203838|592441895|FG003|Overall Study|Protocol Violation|0|||
164021649|NCT02203838|592441892|FG000|Overall Study|Withdrawal by Subject|83|||
164021650|NCT02203838|592441893|FG001|Overall Study|Withdrawal by Subject|10|||
164021651|NCT02203838|592441894|FG002|Overall Study|Withdrawal by Subject|8|||
164021652|NCT02203838|592441895|FG003|Overall Study|Withdrawal by Subject|11|||
164021653|NCT02203838|592441892|FG000|Overall Study|Physician Decision|27|||
164021654|NCT02203838|592441893|FG001|Overall Study|Physician Decision|0|||
164021655|NCT02203838|592441894|FG002|Overall Study|Physician Decision|2|||
164021656|NCT02203838|592441895|FG003|Overall Study|Physician Decision|3|||
164021657|NCT02203838|592441892|FG000|Overall Study|Other|1|||
164021658|NCT02203838|592441893|FG001|Overall Study|Other|0|||
164021659|NCT02203838|592441894|FG002|Overall Study|Other|0|||
164021660|NCT02203838|592441895|FG003|Overall Study|Other|0|||
164021661|NCT03345836|592441898|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
164021662|NCT03345836|592441899|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
164021663|NCT03345836|592441900|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
164021664|NCT03345836|592441901|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
164021665|NCT03345836|592441902|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
164021666|NCT03345836|592441903|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
164021667|NCT03345836|592441898|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
164021668|NCT03345836|592441899|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
164021669|NCT03345836|592441900|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
164021670|NCT03345836|592441901|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
164021671|NCT03345836|592441902|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
164021672|NCT03345836|592441903|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
164021673|NCT03345836|592441898|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164021674|NCT03345836|592441899|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
164021675|NCT03345836|592441900|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164021676|NCT03345836|592441901|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164021677|NCT03345836|592441902|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164021678|NCT03345836|592441903|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
164021679|NCT03345836|592441898|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
164021680|NCT03345836|592441899|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
164021681|NCT03345836|592441900|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164021682|NCT03345836|592441901|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164021683|NCT03345836|592441902|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164021684|NCT03345836|592441903|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
164021685|NCT03345836|592441898|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
164021686|NCT03345836|592441899|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
164021687|NCT03345836|592441900|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
164021688|NCT03345836|592441901|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
164021689|NCT03345836|592441902|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
164021690|NCT03345836|592441903|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
164021691|NCT03345836|592441898|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164021692|NCT03345836|592441899|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164021693|NCT03345836|592441900|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164021694|NCT03345836|592441901|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
164021695|NCT03345836|592441902|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
164021696|NCT03345836|592441903|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
164021697|NCT03345836|592441898|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164021698|NCT03345836|592441899|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164021699|NCT03345836|592441900|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164021700|NCT03345836|592441901|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
164021701|NCT03345836|592441902|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
164021702|NCT03345836|592441903|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
164021703|NCT03345836|592441898|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164021704|NCT03345836|592441899|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164021705|NCT03345836|592441900|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164021706|NCT03345836|592441901|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164021707|NCT03345836|592441902|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
164021708|NCT03345836|592441903|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
164021709|NCT03345836|592441898|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
164021710|NCT03345836|592441899|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
164021711|NCT03345836|592441900|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
164021712|NCT03345836|592441901|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
164021713|NCT03345836|592441902|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
164021714|NCT03345836|592441903|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
164021715|NCT03345836|592441898|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164021716|NCT03345836|592441899|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164021717|NCT03345836|592441900|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164021718|NCT03345836|592441901|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164021719|NCT03345836|592441902|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
164021720|NCT03345836|592441903|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
164021721|NCT03345836|592441898|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
164021722|NCT03345836|592441899|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
164021723|NCT03345836|592441900|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
164021724|NCT03345836|592441901|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
164021725|NCT03345836|592441902|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
164021726|NCT03345836|592441903|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
164021727|NCT05091060|592441904|FG000|Overall Study|Lost to Follow-up|1|||
164021728|NCT02739594|592441905|FG000|Overall Study|Undesired Event|3|||
164021729|NCT02739594|592441906|FG001|Overall Study|Undesired Event|4|||
164021730|NCT02739594|592441905|FG000|Overall Study|Violation of Eligibility Criteria|1|||
164021731|NCT02739594|592441906|FG001|Overall Study|Violation of Eligibility Criteria|2|||
164021732|NCT02739594|592441905|FG000|Overall Study|Protocol Violation|5|||
164021733|NCT02739594|592441906|FG001|Overall Study|Protocol Violation|6|||
164021734|NCT02739594|592441905|FG000|Overall Study|Death|4|||
164021735|NCT02739594|592441906|FG001|Overall Study|Death|2|||
164021736|NCT02739594|592441905|FG000|Overall Study|Renal Insufficiency|4|||
164021737|NCT02739594|592441906|FG001|Overall Study|Renal Insufficiency|6|||
164021738|NCT02739594|592441905|FG000|Overall Study|Administrative Reasons|1|||
164021739|NCT02739594|592441906|FG001|Overall Study|Administrative Reasons|3|||
164021740|NCT02739594|592441905|FG000|Overall Study|Withdrawal by Subject|1|||
164021741|NCT02739594|592441906|FG001|Overall Study|Withdrawal by Subject|1|||
164021742|NCT02739594|592441905|FG000|Overall Study|Lost to Follow-up|0|||
164021743|NCT02739594|592441906|FG001|Overall Study|Lost to Follow-up|1|||
164021744|NCT02739594|592441905|FG000|Overall Study|Elevated Serum Creatinine|0|||
164021745|NCT02739594|592441906|FG001|Overall Study|Elevated Serum Creatinine|1|||
164021746|NCT02739594|592441905|FG000|Overall Study|Other|6|||
164021747|NCT02739594|592441906|FG001|Overall Study|Other|2|||
164021748|NCT00952289|592441909|FG000|All Participants|Death|9|||
164021749|NCT00952289|592441910|FG001|All Participants|Death|9|||
164021750|NCT00952289|592441909|FG000|All Participants|Adverse Event|8|||
164021751|NCT00952289|592441910|FG001|All Participants|Adverse Event|8|||
164021752|NCT00952289|592441909|FG000|All Participants|Disease progression|3|||
164021753|NCT00952289|592441910|FG001|All Participants|Disease progression|12|||
164021754|NCT00952289|592441909|FG000|All Participants|Withdrawal by Subject|1|||
164021755|NCT00952289|592441910|FG001|All Participants|Withdrawal by Subject|10|||
164021756|NCT00952289|592441909|FG000|All Participants|Data lost during site relocation|0|||
164021757|NCT00952289|592441910|FG001|All Participants|Data lost during site relocation|1|||
164021758|NCT00952289|592441909|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
164021759|NCT00952289|592441910|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
164021760|NCT00952289|592441909|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
164021761|NCT00952289|592441910|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
164021762|NCT00952289|592441909|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
164021763|NCT00952289|592441910|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
164021764|NCT00952289|592441909|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
164021765|NCT00952289|592441910|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
164021766|NCT00952289|592441909|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
164021767|NCT00952289|592441910|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
164021768|NCT03259334|592441911|FG000|Overall Study|Adverse Event|3|||
164021769|NCT03259334|592441912|FG001|Overall Study|Adverse Event|8|||
164021770|NCT03259334|592441913|FG002|Overall Study|Adverse Event|5|||
164021771|NCT03259334|592441911|FG000|Overall Study|Withdrawal by Subject|4|||
164021772|NCT03259334|592441912|FG001|Overall Study|Withdrawal by Subject|2|||
164021773|NCT03259334|592441913|FG002|Overall Study|Withdrawal by Subject|4|||
164021774|NCT03259334|592441911|FG000|Overall Study|Physician Decision|1|||
164021775|NCT03259334|592441912|FG001|Overall Study|Physician Decision|0|||
164021776|NCT03259334|592441913|FG002|Overall Study|Physician Decision|0|||
164021777|NCT03259334|592441911|FG000|Overall Study|Lost to Follow-up|0|||
164021778|NCT03259334|592441912|FG001|Overall Study|Lost to Follow-up|2|||
164021779|NCT03259334|592441913|FG002|Overall Study|Lost to Follow-up|1|||
164021780|NCT03259334|592441911|FG000|Overall Study|Protocol Deviation|0|||
164021781|NCT03259334|592441912|FG001|Overall Study|Protocol Deviation|3|||
164021782|NCT03259334|592441913|FG002|Overall Study|Protocol Deviation|2|||
164021783|NCT03259334|592441911|FG000|Overall Study|Lack of Efficacy|2|||
164021784|NCT03259334|592441912|FG001|Overall Study|Lack of Efficacy|0|||
164021785|NCT03259334|592441913|FG002|Overall Study|Lack of Efficacy|1|||
164021786|NCT03259334|592441911|FG000|Overall Study|Randomized but never treated|0|||
164021787|NCT03259334|592441912|FG001|Overall Study|Randomized but never treated|2|||
164021788|NCT03259334|592441913|FG002|Overall Study|Randomized but never treated|0|||
164021789|NCT03375112|592441914|FG000|Overall Study|Withdrawal by Subject|3|||
164021790|NCT03375112|592441915|FG001|Overall Study|Withdrawal by Subject|0|||
164095232|NCT00745095|592712299|FG002|Overall Study|Declined to participate|0|||
164095233|NCT00745095|592712300|FG003|Overall Study|Declined to participate|0|||
164095234|NCT00745095|592712301|FG004|Overall Study|Declined to participate|92|||
164095235|NCT00745095|592712302|FG005|Overall Study|Declined to participate|95|||
164095236|NCT00745095|592712297|FG000|Overall Study|Ineligible due to GFR criteria|0|||
164021791|NCT03599141|592441916|FG000|Overall Study|Lost to Follow-up|3|||
164021792|NCT03599141|592441917|FG001|Overall Study|Lost to Follow-up|1|||
164021793|NCT00777491|592441918|FG000|Overall Study|Protocol Violation|0|||
164021794|NCT00777491|592441919|FG001|Overall Study|Protocol Violation|2|||
164021795|NCT00777491|592441918|FG000|Overall Study|Did not receive any protocol treatment|2|||
164021796|NCT00777491|592441919|FG001|Overall Study|Did not receive any protocol treatment|0|||
164021797|NCT01689207|592441920|FG000|Overall Study|Adverse Event|0|||
164021798|NCT01689207|592441921|FG001|Overall Study|Adverse Event|1|||
164021799|NCT01689207|592441922|FG002|Overall Study|Adverse Event|0|||
164021800|NCT01689207|592441923|FG003|Overall Study|Adverse Event|0|||
164021801|NCT01689207|592441924|FG004|Overall Study|Adverse Event|2|||
164095237|NCT00745095|592712298|FG001|Overall Study|Ineligible due to GFR criteria|2|||
164021802|NCT01689207|592441925|FG005|Overall Study|Adverse Event|1|||
164021803|NCT01689207|592441926|FG006|Overall Study|Adverse Event|0|||
164021804|NCT01689207|592441927|FG007|Overall Study|Adverse Event|0|||
164021805|NCT01689207|592441928|FG008|Overall Study|Adverse Event|1|||
164021806|NCT01689207|592441929|FG009|Overall Study|Adverse Event|0|||
164021807|NCT01689207|592441930|FG010|Overall Study|Adverse Event|0|||
164021808|NCT03591146|592441931|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164021809|NCT03591146|592441932|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164021810|NCT03591146|592441933|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164021811|NCT03591146|592441934|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
164021812|NCT03591146|592441935|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
164021813|NCT03591146|592441931|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164021814|NCT03591146|592441932|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
164021815|NCT03591146|592441933|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164021816|NCT03591146|592441934|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164021817|NCT03591146|592441935|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
164021818|NCT03591146|592441931|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164021819|NCT03591146|592441932|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164021820|NCT03591146|592441933|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164021821|NCT03591146|592441934|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
164021822|NCT03591146|592441935|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
164021823|NCT03591146|592441931|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
164021824|NCT03591146|592441932|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
164021825|NCT03591146|592441933|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
164021826|NCT03591146|592441934|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
164021827|NCT03591146|592441935|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
164021828|NCT04737031|592441936|FG000|Overall Study|Patients who did not have a treatment visit|0|||
164021829|NCT04737031|592441937|FG001|Overall Study|Patients who did not have a treatment visit|31|||
164021830|NCT04737031|592441938|FG002|Overall Study|Patients who did not have a treatment visit|93|||
164021831|NCT04737031|592441939|FG003|Overall Study|Patients who did not have a treatment visit|227|||
164021832|NCT00142519|592441942|FG000|Overall Study|Not Treated|7|||
164021833|NCT00142519|592441943|FG001|Overall Study|Not Treated|9|||
164021834|NCT00142519|592441942|FG000|Overall Study|Protocol Violation|1|||
164021835|NCT00142519|592441943|FG001|Overall Study|Protocol Violation|0|||
164021836|NCT00142519|592441942|FG000|Overall Study|Withdrawal by Subject|10|||
164021837|NCT00142519|592441943|FG001|Overall Study|Withdrawal by Subject|7|||
164021838|NCT01511419|592441949|FG000|Dose 2|Physician Decision|1|||
164021839|NCT01511419|592441950|FG001|Dose 2|Physician Decision|0|||
164021840|NCT00937768|592441951|FG000|Overall Study|Refused Further Treatment|3|||
164021841|NCT00937768|592441952|FG001|Overall Study|Refused Further Treatment|2|||
164021842|NCT00937768|592441951|FG000|Overall Study|Disease Progression|1|||
164021843|NCT00937768|592441952|FG001|Overall Study|Disease Progression|1|||
164021844|NCT00937768|592441951|FG000|Overall Study|Alternate Treatment|0|||
164021845|NCT00937768|592441952|FG001|Overall Study|Alternate Treatment|1|||
164021846|NCT00937768|592441951|FG000|Overall Study|No Further Funding|4|||
164021847|NCT00937768|592441952|FG001|Overall Study|No Further Funding|4|||
164021848|NCT00762372|592443676|FG000|Overall Study|Adverse Event|1|||
164021849|NCT00762372|592443677|FG001|Overall Study|Adverse Event|0|||
164021850|NCT00762372|592443678|FG002|Overall Study|Adverse Event|0|||
164021851|NCT01194804|592443679|FG000|Overall Study|Withdrawal by Subject|1|||
164021852|NCT02670915|592443680|FG000|Overall Study|Withdrawal by Subject|0|||
164021853|NCT02670915|592443681|FG001|Overall Study|Withdrawal by Subject|1|||
164021854|NCT02670915|592443682|FG002|Overall Study|Withdrawal by Subject|4|||
164021855|NCT02670915|592443680|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164021856|NCT02670915|592443681|FG001|Overall Study|Withdrawal by parent/guardian|4|||
164021857|NCT02670915|592443682|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164021858|NCT02670915|592443680|FG000|Overall Study|Unclassified|0|||
164021859|NCT02670915|592443681|FG001|Overall Study|Unclassified|3|||
164021860|NCT02670915|592443682|FG002|Overall Study|Unclassified|0|||
164021861|NCT00165841|592443683|FG000|Overall Study|Adverse Event|2|||
164021862|NCT00165841|592443684|FG001|Overall Study|Adverse Event|3|||
164021863|NCT00165841|592443683|FG000|Overall Study|Lack of Efficacy|6|||
164021864|NCT00165841|592443684|FG001|Overall Study|Lack of Efficacy|33|||
164021865|NCT00165841|592443683|FG000|Overall Study|Lost to Follow-up|4|||
164021866|NCT00165841|592443684|FG001|Overall Study|Lost to Follow-up|4|||
164021867|NCT00165841|592443683|FG000|Overall Study|Withdrawal by Subject|7|||
164021868|NCT00165841|592443684|FG001|Overall Study|Withdrawal by Subject|8|||
164095238|NCT00745095|592712299|FG002|Overall Study|Ineligible due to GFR criteria|3|||
164021869|NCT00165841|592443683|FG000|Overall Study|Physician Decision|1|||
164021870|NCT00165841|592443684|FG001|Overall Study|Physician Decision|0|||
164021871|NCT00165841|592443683|FG000|Overall Study|Protocol Violation|6|||
164021872|NCT00165841|592443684|FG001|Overall Study|Protocol Violation|8|||
164021873|NCT00165841|592443683|FG000|Overall Study|Other|3|||
164021874|NCT00165841|592443684|FG001|Overall Study|Other|5|||
164021875|NCT00165841|592443683|FG000|Overall Study|Medication Noncompliance|1|||
164021876|NCT00165841|592443684|FG001|Overall Study|Medication Noncompliance|1|||
164021877|NCT01000727|592443685|FG000|Overall Study|Lost to Follow-up|41|||
164095239|NCT00745095|592712300|FG003|Overall Study|Ineligible due to GFR criteria|3|||
164095240|NCT00745095|592712301|FG004|Overall Study|Ineligible due to GFR criteria|30|||
164095241|NCT00745095|592712302|FG005|Overall Study|Ineligible due to GFR criteria|28|||
164095242|NCT00162123|592712303|FG000|Overall Study|Disease progression|27|||
164095243|NCT00162123|592712304|FG001|Overall Study|Disease progression|19|||
164095244|NCT00162123|592712305|FG002|Overall Study|Disease progression|10|||
164095245|NCT00162123|592712306|FG003|Overall Study|Disease progression|4|||
164095246|NCT00162123|592712307|FG004|Overall Study|Disease progression|8|||
164095247|NCT00162123|592712308|FG005|Overall Study|Disease progression|3|||
164095248|NCT00162123|592712309|FG006|Overall Study|Disease progression|1|||
164095249|NCT00162123|592712310|FG007|Overall Study|Disease progression|0|||
164095250|NCT00162123|592712303|FG000|Overall Study|Study drug toxicity|6|||
164095251|NCT00162123|592712304|FG001|Overall Study|Study drug toxicity|1|||
164095252|NCT00162123|592712305|FG002|Overall Study|Study drug toxicity|5|||
164095253|NCT00162123|592712306|FG003|Overall Study|Study drug toxicity|0|||
164095254|NCT00162123|592712307|FG004|Overall Study|Study drug toxicity|4|||
164095255|NCT00162123|592712308|FG005|Overall Study|Study drug toxicity|1|||
164095256|NCT00162123|592712309|FG006|Overall Study|Study drug toxicity|1|||
164095257|NCT00162123|592712310|FG007|Overall Study|Study drug toxicity|0|||
164095258|NCT00162123|592712303|FG000|Overall Study|Death|3|||
164095259|NCT00162123|592712304|FG001|Overall Study|Death|3|||
164095260|NCT00162123|592712305|FG002|Overall Study|Death|1|||
164095261|NCT00162123|592712306|FG003|Overall Study|Death|1|||
164095262|NCT00162123|592712307|FG004|Overall Study|Death|1|||
164095263|NCT00162123|592712308|FG005|Overall Study|Death|1|||
164095264|NCT00162123|592712309|FG006|Overall Study|Death|0|||
164095265|NCT00162123|592712310|FG007|Overall Study|Death|0|||
164095266|NCT00162123|592712303|FG000|Overall Study|Withdrawal by Subject|2|||
164095267|NCT00162123|592712304|FG001|Overall Study|Withdrawal by Subject|0|||
164095268|NCT00162123|592712305|FG002|Overall Study|Withdrawal by Subject|2|||
164095269|NCT00162123|592712306|FG003|Overall Study|Withdrawal by Subject|1|||
164095270|NCT00162123|592712307|FG004|Overall Study|Withdrawal by Subject|1|||
164095271|NCT00162123|592712308|FG005|Overall Study|Withdrawal by Subject|2|||
164095272|NCT00162123|592712309|FG006|Overall Study|Withdrawal by Subject|1|||
164021878|NCT01000727|592443686|FG001|Overall Study|Lost to Follow-up|43|||
164021879|NCT01000727|592443685|FG000|Overall Study|Withdrawal by Subject|111|||
164021880|NCT01000727|592443686|FG001|Overall Study|Withdrawal by Subject|109|||
164021881|NCT01000727|592443685|FG000|Overall Study|Study closed/terminated|23|||
164021882|NCT01000727|592443686|FG001|Overall Study|Study closed/terminated|24|||
164021883|NCT01026389|592443689|FG000|Overall Study|Withdrawal by Subject|1|||
164021884|NCT01026389|592443690|FG001|Overall Study|Withdrawal by Subject|3|||
164021885|NCT01026389|592443689|FG000|Overall Study|change of treatment, patient moved|4|||
164021886|NCT01026389|592443690|FG001|Overall Study|change of treatment, patient moved|2|||
164095273|NCT00162123|592712310|FG007|Overall Study|Withdrawal by Subject|0|||
164021887|NCT01995136|592443691|FG000|Overall Study|Change in residence|1|||
164095274|NCT00162123|592712303|FG000|Overall Study|Deterioration without progression|2|||
164095275|NCT00162123|592712304|FG001|Overall Study|Deterioration without progression|2|||
164095276|NCT00162123|592712305|FG002|Overall Study|Deterioration without progression|3|||
164095277|NCT00162123|592712306|FG003|Overall Study|Deterioration without progression|0|||
164095278|NCT00162123|592712307|FG004|Overall Study|Deterioration without progression|1|||
164021888|NCT01626352|592443695|FG000|Overall Study|Disease Progression|3|||
164021889|NCT01626352|592443695|FG000|Overall Study|Intercurrent Illness|2|||
164021890|NCT01626352|592443695|FG000|Overall Study|Death|2|||
164021891|NCT01626352|592443695|FG000|Overall Study|Withdrawal by Subject|1|||
164021892|NCT01626352|592443695|FG000|Overall Study|Non-Compliance|1|||
164021893|NCT01626352|592443695|FG000|Overall Study|Never Treated|1|||
164021894|NCT02338492|592443700|FG000|Overall Study|Death|32|||
164021895|NCT02338492|592443700|FG000|Overall Study|Adverse Event|3|||
164021896|NCT02338492|592443700|FG000|Overall Study|Lost to Follow-up|4|||
164021897|NCT02338492|592443700|FG000|Overall Study|Reason not captured above|6|||
164021898|NCT04281030|592443703|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
164021899|NCT04281030|592443704|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
164073093|NCT00337129|592632788|FG000|Overall Study|Withdrawal by Subject|1|||
164021900|NCT04281030|592443703|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
164021901|NCT04281030|592443704|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
164021902|NCT01395368|592443705|FG000|Overall Study|Physician Decision|14|||
164021903|NCT01395368|592443705|FG000|Overall Study|Withdrawal by Subject|2|||
164021904|NCT00310388|592443706|FG000|Primary Reporting Phase|Adverse Event|101|||
164021905|NCT00310388|592443707|FG001|Primary Reporting Phase|Adverse Event|0|||
164021906|NCT00310388|592443706|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
164021907|NCT00310388|592443707|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
164021908|NCT00310388|592443706|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
164021909|NCT00310388|592443707|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
164021910|NCT00310388|592443706|FG000|Primary Reporting Phase|Protocol Violation|10|||
164021911|NCT00310388|592443707|FG001|Primary Reporting Phase|Protocol Violation|0|||
164021912|NCT00310388|592443706|FG000|Primary Reporting Phase|Pregnancy|3|||
164021913|NCT00310388|592443707|FG001|Primary Reporting Phase|Pregnancy|0|||
164021914|NCT00310388|592443706|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
164021915|NCT00310388|592443707|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
164021916|NCT00310388|592443706|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
164021917|NCT00310388|592443707|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
164021918|NCT00310388|592443706|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
164021919|NCT00310388|592443707|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
164021920|NCT00310388|592443706|FG000|Primary Reporting Phase|Physician Decision|2|||
164021921|NCT00310388|592443707|FG001|Primary Reporting Phase|Physician Decision|0|||
164021922|NCT00310388|592443706|FG000|Primary Reporting Phase|Request of the sponsor|19|||
164021923|NCT00310388|592443707|FG001|Primary Reporting Phase|Request of the sponsor|0|||
164021924|NCT00310388|592443706|FG000|Primary Reporting Phase|Failed to return|8|||
164021925|NCT00310388|592443707|FG001|Primary Reporting Phase|Failed to return|0|||
164021926|NCT00310388|592443706|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
164021927|NCT00310388|592443707|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
164021928|NCT00310388|592443706|FG000|Primary Reporting Phase|Participant request|2|||
164021929|NCT00310388|592443707|FG001|Primary Reporting Phase|Participant request|0|||
164021930|NCT00310388|592443706|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
164021931|NCT00310388|592443707|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
164021932|NCT00310388|592443706|FG000|Primary Reporting Phase|Discontinuation of study|1|||
164021933|NCT00310388|592443707|FG001|Primary Reporting Phase|Discontinuation of study|0|||
164073094|NCT00337129|592632788|FG000|Overall Study|Lack of Efficacy|32|||
164073095|NCT00337129|592632788|FG000|Overall Study|Death|2|||
164073096|NCT00337129|592632788|FG000|Overall Study|not protocol specified|1|||
164073097|NCT01272193|592632794|FG000|Overall Study|Adverse Event|1|||
164073098|NCT01272193|592632795|FG001|Overall Study|Adverse Event|1|||
164073099|NCT01272193|592632794|FG000|Overall Study|Lack of Efficacy|0|||
164073100|NCT01272193|592632795|FG001|Overall Study|Lack of Efficacy|3|||
164073101|NCT01272193|592632794|FG000|Overall Study|Withdrawal Criteria|1|||
164073102|NCT01272193|592632795|FG001|Overall Study|Withdrawal Criteria|1|||
164073103|NCT01272193|592632794|FG000|Overall Study|Unclassified|8|||
164073104|NCT01272193|592632795|FG001|Overall Study|Unclassified|7|||
164073105|NCT03578276|592632802|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
164073106|NCT03578276|592632803|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
164073107|NCT02626182|592632804|FG000|Overall Study|Adverse Event|2|||
164073108|NCT02626182|592632805|FG001|Overall Study|Adverse Event|0|||
164073109|NCT01084603|592632810|FG000|Baseline|Withdrawal by Subject|2|||
164073110|NCT01084603|592632810|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
164073111|NCT01084603|592632810|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
164073112|NCT01084603|592632810|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
164073113|NCT01084603|592632810|FG000|Washout Period 4|Adverse Event|1|||
164073114|NCT02766088|592632812|FG000|Overall Study|Sponsor study termination|498|||
164073115|NCT02766088|592632812|FG000|Overall Study|Migrated/moved from the study area|1|||
164073116|NCT02766088|592632812|FG000|Overall Study|Lost to Follow-up|5|||
164073117|NCT02766088|592632812|FG000|Overall Study|Other|1|||
164073118|NCT02766088|592632812|FG000|Overall Study|Death|1|||
164073119|NCT02360397|592632813|FG000|Overall Study|Incomplete screening|3|||
164073120|NCT02360397|592632813|FG000|Overall Study|Adverse Event|1|||
164073121|NCT01508325|592632814|FG000|Overall Study|Withdrawal by Subject|8|||
164073122|NCT01508325|592632815|FG001|Overall Study|Withdrawal by Subject|9|||
164073123|NCT01508325|592632814|FG000|Overall Study|Protocol Violation|0|||
164073124|NCT01508325|592632815|FG001|Overall Study|Protocol Violation|3|||
164073125|NCT01508325|592632814|FG000|Overall Study|Physician Decision|2|||
164073126|NCT01508325|592632815|FG001|Overall Study|Physician Decision|1|||
164073127|NCT01508325|592632814|FG000|Overall Study|Adverse Event|1|||
164073128|NCT01508325|592632815|FG001|Overall Study|Adverse Event|0|||
164073129|NCT01508325|592632814|FG000|Overall Study|Lost to Follow-up|5|||
164073130|NCT01508325|592632815|FG001|Overall Study|Lost to Follow-up|6|||
164073131|NCT01508325|592632814|FG000|Overall Study|Other|2|||
164073132|NCT01508325|592632815|FG001|Overall Study|Other|2|||
164073133|NCT00763269|592632822|FG000|Overall Study|Lost to Follow-up|12|||
164073134|NCT00763269|592632823|FG001|Overall Study|Lost to Follow-up|13|||
164073135|NCT03543046|592632824|FG000|Overall Study|Adverse Event|1|||
164073136|NCT03543046|592632825|FG001|Overall Study|Adverse Event|1|||
164073137|NCT03543046|592632824|FG000|Overall Study|Physician Decision|1|||
164073138|NCT03543046|592632825|FG001|Overall Study|Physician Decision|1|||
164073139|NCT03543046|592632824|FG000|Overall Study|Protocol Violation|1|||
164073140|NCT03543046|592632825|FG001|Overall Study|Protocol Violation|0|||
164073141|NCT04936334|592632828|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
164073142|NCT04057118|592632831|FG000|Overall Study|Adverse Event|1|||
164073143|NCT04057118|592632832|FG001|Overall Study|Adverse Event|0|||
164073144|NCT04057118|592632833|FG002|Overall Study|Adverse Event|1|||
164073145|NCT04057118|592632834|FG003|Overall Study|Adverse Event|1|||
164073146|NCT04057118|592632831|FG000|Overall Study|Physician Decision|0|||
164073147|NCT04057118|592632832|FG001|Overall Study|Physician Decision|0|||
164073148|NCT04057118|592632833|FG002|Overall Study|Physician Decision|1|||
164073149|NCT04057118|592632834|FG003|Overall Study|Physician Decision|1|||
164073150|NCT04057118|592632831|FG000|Overall Study|Withdrawal by Subject|2|||
164073151|NCT04057118|592632832|FG001|Overall Study|Withdrawal by Subject|2|||
164073152|NCT04057118|592632833|FG002|Overall Study|Withdrawal by Subject|0|||
164073153|NCT04057118|592632834|FG003|Overall Study|Withdrawal by Subject|2|||
164073154|NCT04057118|592632831|FG000|Overall Study|Not Specific|0|||
164073155|NCT04057118|592632832|FG001|Overall Study|Not Specific|0|||
164073156|NCT04057118|592632833|FG002|Overall Study|Not Specific|1|||
164073157|NCT04057118|592632834|FG003|Overall Study|Not Specific|1|||
164073158|NCT03402126|592632835|FG000|Overall Study|Lost to Follow-up|6|||
164073159|NCT03402126|592632835|FG000|Overall Study|Protocol Violation|10|||
164073160|NCT03402126|592632835|FG000|Overall Study|Sponsor request/Study termination|29|||
164021934|NCT00310388|592443706|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
164021935|NCT00310388|592443707|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
164021936|NCT00310388|592443706|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
164021937|NCT00310388|592443707|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
164021938|NCT00310388|592443706|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
164021939|NCT00310388|592443707|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
164021940|NCT00310388|592443706|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
164021941|NCT00310388|592443707|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
164021942|NCT00310388|592443706|FG000|Primary Reporting Phase|Participant passed away|1|||
164021943|NCT00310388|592443707|FG001|Primary Reporting Phase|Participant passed away|0|||
164021944|NCT00310388|592443706|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
164021945|NCT00310388|592443707|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
164021946|NCT00310388|592443706|FG000|Primary Reporting Phase|Missing|1|||
164021947|NCT00310388|592443707|FG001|Primary Reporting Phase|Missing|0|||
164021948|NCT00310388|592443706|FG000|Primary Reporting Phase|Other|1|||
164021949|NCT00310388|592443707|FG001|Primary Reporting Phase|Other|0|||
164021950|NCT00310388|592443706|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
164021951|NCT00310388|592443707|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
164021952|NCT00310388|592443706|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
164021953|NCT00310388|592443707|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
164021954|NCT00310388|592443706|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
164021955|NCT00310388|592443707|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
164021956|NCT00310388|592443706|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
164021957|NCT00310388|592443707|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
164021958|NCT00882999|592443712|FG000|Overall Study|Adverse Event|0|||
164021959|NCT00882999|592443713|FG001|Overall Study|Adverse Event|0|||
164021960|NCT00882999|592443714|FG002|Overall Study|Adverse Event|0|||
164021961|NCT00882999|592443715|FG003|Overall Study|Adverse Event|0|||
164021962|NCT00882999|592443716|FG004|Overall Study|Adverse Event|1|||
164021963|NCT00882999|592443717|FG005|Overall Study|Adverse Event|0|||
164021964|NCT00882999|592443718|FG006|Overall Study|Adverse Event|0|||
164021965|NCT00882999|592443712|FG000|Overall Study|Death|0|||
164021966|NCT00882999|592443713|FG001|Overall Study|Death|1|||
164021967|NCT00882999|592443714|FG002|Overall Study|Death|0|||
164021968|NCT00882999|592443715|FG003|Overall Study|Death|0|||
164021969|NCT00882999|592443716|FG004|Overall Study|Death|0|||
164021970|NCT00882999|592443717|FG005|Overall Study|Death|0|||
164021971|NCT00882999|592443718|FG006|Overall Study|Death|0|||
164021972|NCT00882999|592443712|FG000|Overall Study|Withdrawal by Subject|7|||
164021973|NCT00882999|592443713|FG001|Overall Study|Withdrawal by Subject|6|||
164021974|NCT00882999|592443714|FG002|Overall Study|Withdrawal by Subject|3|||
164021975|NCT00882999|592443715|FG003|Overall Study|Withdrawal by Subject|3|||
164021976|NCT00882999|592443716|FG004|Overall Study|Withdrawal by Subject|6|||
164021977|NCT00882999|592443717|FG005|Overall Study|Withdrawal by Subject|5|||
164021978|NCT00882999|592443718|FG006|Overall Study|Withdrawal by Subject|5|||
164021979|NCT00882999|592443712|FG000|Overall Study|Lost to Follow-up|0|||
164021980|NCT00882999|592443713|FG001|Overall Study|Lost to Follow-up|1|||
164021981|NCT00882999|592443714|FG002|Overall Study|Lost to Follow-up|1|||
164021982|NCT00882999|592443715|FG003|Overall Study|Lost to Follow-up|2|||
164021983|NCT00882999|592443716|FG004|Overall Study|Lost to Follow-up|1|||
164021984|NCT00882999|592443717|FG005|Overall Study|Lost to Follow-up|1|||
164021985|NCT00882999|592443718|FG006|Overall Study|Lost to Follow-up|2|||
164021986|NCT00882999|592443712|FG000|Overall Study|Physician Decision|1|||
164021987|NCT00882999|592443713|FG001|Overall Study|Physician Decision|0|||
164021988|NCT00882999|592443714|FG002|Overall Study|Physician Decision|0|||
164021989|NCT00882999|592443715|FG003|Overall Study|Physician Decision|0|||
164021990|NCT00882999|592443716|FG004|Overall Study|Physician Decision|0|||
164021991|NCT00882999|592443717|FG005|Overall Study|Physician Decision|1|||
164021992|NCT00882999|592443718|FG006|Overall Study|Physician Decision|1|||
164021993|NCT01757405|592443721|FG000|Overall Study|Lost to Follow-up|1|||
164021994|NCT01757405|592443722|FG001|Overall Study|Lost to Follow-up|1|||
164021995|NCT01757405|592443721|FG000|Overall Study|Withdrawal by Subject|0|||
164021996|NCT01757405|592443722|FG001|Overall Study|Withdrawal by Subject|1|||
164021997|NCT00082758|592443723|FG000|Overall Study|Adverse Event|0|||
164021998|NCT00082758|592443724|FG001|Overall Study|Adverse Event|2|||
164021999|NCT00082758|592443725|FG002|Overall Study|Adverse Event|0|||
164022000|NCT00082758|592443723|FG000|Overall Study|Lack of Efficacy|12|||
164022001|NCT00082758|592443724|FG001|Overall Study|Lack of Efficacy|13|||
164022002|NCT00082758|592443725|FG002|Overall Study|Lack of Efficacy|0|||
164022003|NCT00082758|592443723|FG000|Overall Study|Physician Decision|0|||
164022004|NCT00082758|592443724|FG001|Overall Study|Physician Decision|1|||
164022005|NCT00082758|592443725|FG002|Overall Study|Physician Decision|0|||
164022006|NCT00082758|592443723|FG000|Overall Study|Withdrawal by Subject|3|||
164022007|NCT00082758|592443724|FG001|Overall Study|Withdrawal by Subject|0|||
164022008|NCT00082758|592443725|FG002|Overall Study|Withdrawal by Subject|0|||
164022009|NCT00082758|592443723|FG000|Overall Study|Protocol Violation|0|||
164022010|NCT00082758|592443724|FG001|Overall Study|Protocol Violation|1|||
164022011|NCT00082758|592443725|FG002|Overall Study|Protocol Violation|0|||
164022012|NCT00937560|592443726|FG000|Initial Treatment|Death|6|||
164022013|NCT00937560|592443726|FG000|Initial Treatment|Withdraw consent|3|||
164022014|NCT00937560|592443726|FG000|Initial Treatment|Adverse Event|1|||
164022015|NCT00937560|592443726|FG000|Initial Treatment|Lost to Follow-up|1|||
164022016|NCT00937560|592443726|FG000|Initial Treatment|No end of study page|10|||
164022017|NCT00937560|592443726|FG000|Maintenance Treatment|Death|12|||
164022018|NCT00937560|592443726|FG000|Maintenance Treatment|Withdraw consent|5|||
164022019|NCT00937560|592443726|FG000|Maintenance Treatment|According to protocol|1|||
164022020|NCT01219959|592443727|FG000|Overall Study|Adverse Event|6|||
164022021|NCT01219959|592443728|FG001|Overall Study|Adverse Event|14|||
164022022|NCT01219959|592443727|FG000|Overall Study|Physician Decision|0|||
164022023|NCT01219959|592443728|FG001|Overall Study|Physician Decision|4|||
164022024|NCT01219959|592443727|FG000|Overall Study|Withdrawal by Subject|0|||
164022025|NCT01219959|592443728|FG001|Overall Study|Withdrawal by Subject|2|||
164022026|NCT01219959|592443727|FG000|Overall Study|Renal Transplantation|0|||
164022027|NCT01219959|592443728|FG001|Overall Study|Renal Transplantation|3|||
164022028|NCT01219959|592443727|FG000|Overall Study|Other|1|||
164022029|NCT01219959|592443728|FG001|Overall Study|Other|0|||
164022030|NCT05906732|592443729|FG000|Overall Study|Withdrawal by Subject|1|||
164022031|NCT05906732|592443730|FG001|Overall Study|Withdrawal by Subject|0|||
164022032|NCT05906732|592443731|FG002|Overall Study|Withdrawal by Subject|0|||
164022033|NCT05906732|592443732|FG003|Overall Study|Withdrawal by Subject|0|||
164022034|NCT05906732|592443729|FG000|Overall Study|Physician Decision|2|||
164022035|NCT05906732|592443730|FG001|Overall Study|Physician Decision|4|||
164022036|NCT05906732|592443731|FG002|Overall Study|Physician Decision|0|||
164022037|NCT05906732|592443732|FG003|Overall Study|Physician Decision|0|||
164022038|NCT00436566|592443733|FG000|Overall Study|Withdrawal by Subject|2|||
164022039|NCT00436566|592443733|FG000|Overall Study|Protocol Violation|1|||
164022040|NCT02651194|592443734|FG000|Overall Study|Lost to Follow-up|3|||
164022041|NCT02651194|592443734|FG000|Overall Study|Other|2|||
164022042|NCT01980706|592443735|FG000|Overall Study|Withdrawal by Subject|9|||
164022043|NCT01980706|592443736|FG001|Overall Study|Withdrawal by Subject|6|||
164022044|NCT01980706|592443737|FG002|Overall Study|Withdrawal by Subject|2|||
164022045|NCT01980706|592443735|FG000|Overall Study|Adverse Event|1|||
164022046|NCT01980706|592443736|FG001|Overall Study|Adverse Event|2|||
164022047|NCT01980706|592443737|FG002|Overall Study|Adverse Event|5|||
164022048|NCT01980706|592443735|FG000|Overall Study|Lost to Follow-up|3|||
164022049|NCT01980706|592443736|FG001|Overall Study|Lost to Follow-up|4|||
164022050|NCT01980706|592443737|FG002|Overall Study|Lost to Follow-up|3|||
164022051|NCT01980706|592443735|FG000|Overall Study|miscellaneous|4|||
164022052|NCT01980706|592443736|FG001|Overall Study|miscellaneous|5|||
164022053|NCT01980706|592443737|FG002|Overall Study|miscellaneous|3|||
164022054|NCT02546674|592443738|FG000|Overall Study|Adverse Event|19|||
164022055|NCT02546674|592443738|FG000|Overall Study|Death|1|||
164022056|NCT02546674|592443738|FG000|Overall Study|Lost to Follow-up|1|||
164095279|NCT00162123|592712308|FG005|Overall Study|Deterioration without progression|0|||
164095280|NCT00162123|592712309|FG006|Overall Study|Deterioration without progression|0|||
164022057|NCT02546674|592443738|FG000|Overall Study|Physician Decision|13|||
164022058|NCT02546674|592443738|FG000|Overall Study|Pregnancy|1|||
164022059|NCT02546674|592443738|FG000|Overall Study|Progressive Disease|2|||
164022060|NCT02546674|592443738|FG000|Overall Study|Protocol Deviation|2|||
164022061|NCT02546674|592443738|FG000|Overall Study|Subject/Guardian Decision|6|||
164022062|NCT02546674|592443738|FG000|Overall Study|Withdrawal of Informed Consent|3|||
164022063|NCT02232087|592443739|FG000|Overall Study|Withdrawal by Subject|2|||
164022064|NCT02232087|592443740|FG001|Overall Study|Withdrawal by Subject|0|||
164022065|NCT02232087|592443741|FG002|Overall Study|Withdrawal by Subject|0|||
164022066|NCT02232087|592443742|FG003|Overall Study|Withdrawal by Subject|0|||
164022067|NCT02232087|592443743|FG004|Overall Study|Withdrawal by Subject|0|||
164022068|NCT02232087|592443744|FG005|Overall Study|Withdrawal by Subject|1|||
164022069|NCT02232087|592443739|FG000|Overall Study|poor inhalation technique|0|||
164022070|NCT02232087|592443740|FG001|Overall Study|poor inhalation technique|1|||
164022071|NCT02232087|592443741|FG002|Overall Study|poor inhalation technique|0|||
164022072|NCT02232087|592443742|FG003|Overall Study|poor inhalation technique|0|||
164022073|NCT02232087|592443743|FG004|Overall Study|poor inhalation technique|0|||
164022074|NCT02232087|592443744|FG005|Overall Study|poor inhalation technique|2|||
164022075|NCT02232087|592443739|FG000|Overall Study|protocol stop criteria|0|||
164022076|NCT02232087|592443740|FG001|Overall Study|protocol stop criteria|1|||
164022077|NCT02232087|592443741|FG002|Overall Study|protocol stop criteria|0|||
164022078|NCT02232087|592443742|FG003|Overall Study|protocol stop criteria|1|||
164022079|NCT02232087|592443743|FG004|Overall Study|protocol stop criteria|0|||
164022080|NCT02232087|592443744|FG005|Overall Study|protocol stop criteria|0|||
164095281|NCT00162123|592712310|FG007|Overall Study|Deterioration without progression|0|||
164022081|NCT02232087|592443739|FG000|Overall Study|Adverse Event|0|||
164022082|NCT02232087|592443740|FG001|Overall Study|Adverse Event|0|||
164022083|NCT02232087|592443741|FG002|Overall Study|Adverse Event|0|||
164022084|NCT02232087|592443742|FG003|Overall Study|Adverse Event|0|||
164022085|NCT02232087|592443743|FG004|Overall Study|Adverse Event|1|||
164022086|NCT02232087|592443744|FG005|Overall Study|Adverse Event|0|||
164022087|NCT02208024|592443745|FG000|Overall Study|Withdrawal by Subject|1|||
164022088|NCT01958125|592443746|FG000|Overall Study|Missing diary data|2|||
164022089|NCT01958125|592443747|FG001|Overall Study|Missing diary data|6|||
164022090|NCT01958125|592443746|FG000|Overall Study|No headache attacks|0|||
164022091|NCT01958125|592443747|FG001|Overall Study|No headache attacks|2|||
164022092|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
164022093|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
164022094|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
164022095|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
164022096|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
164022097|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
164022098|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
164022099|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
164022100|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
164022101|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
164022102|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
164022103|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
164022104|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
164095282|NCT00162123|592712303|FG000|Overall Study|Adverse Event|1|||
164022105|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
164022106|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
164022107|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
164022108|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
164022109|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164022110|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
164022111|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
164022112|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
164022113|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164022114|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164022115|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164022116|NCT01106625|592443755|FG000|Core Period: Baseline to Week 26|Other|8|||
164022117|NCT01106625|592443756|FG001|Core Period: Baseline to Week 26|Other|7|||
164022118|NCT01106625|592443757|FG002|Core Period: Baseline to Week 26|Other|4|||
164022119|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164022120|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
164022121|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
164022122|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
164022123|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
164022124|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164022125|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164022126|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164022127|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
164022128|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164022129|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164022130|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164022131|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
164095283|NCT00162123|592712304|FG001|Overall Study|Adverse Event|2|||
164095284|NCT00162123|592712305|FG002|Overall Study|Adverse Event|0|||
164095285|NCT00162123|592712306|FG003|Overall Study|Adverse Event|2|||
164095286|NCT00162123|592712307|FG004|Overall Study|Adverse Event|1|||
164095287|NCT00162123|592712308|FG005|Overall Study|Adverse Event|0|||
164095288|NCT00162123|592712309|FG006|Overall Study|Adverse Event|0|||
164095289|NCT00162123|592712310|FG007|Overall Study|Adverse Event|0|||
164095290|NCT00162123|592712303|FG000|Overall Study|Not specified (before treatment)|2|||
164095291|NCT00162123|592712304|FG001|Overall Study|Not specified (before treatment)|0|||
164095292|NCT00162123|592712305|FG002|Overall Study|Not specified (before treatment)|0|||
164095293|NCT00162123|592712306|FG003|Overall Study|Not specified (before treatment)|0|||
164095294|NCT00162123|592712307|FG004|Overall Study|Not specified (before treatment)|12|||
164095295|NCT00162123|592712308|FG005|Overall Study|Not specified (before treatment)|1|||
164095296|NCT00162123|592712309|FG006|Overall Study|Not specified (before treatment)|0|||
164095297|NCT00162123|592712310|FG007|Overall Study|Not specified (before treatment)|0|||
164095298|NCT00162123|592712303|FG000|Overall Study|Not specified (after start of treatment)|0|||
164095299|NCT00162123|592712304|FG001|Overall Study|Not specified (after start of treatment)|0|||
164095300|NCT00162123|592712305|FG002|Overall Study|Not specified (after start of treatment)|0|||
164095301|NCT00162123|592712306|FG003|Overall Study|Not specified (after start of treatment)|0|||
164095302|NCT00162123|592712307|FG004|Overall Study|Not specified (after start of treatment)|3|||
164095303|NCT00162123|592712308|FG005|Overall Study|Not specified (after start of treatment)|0|||
164095304|NCT00162123|592712309|FG006|Overall Study|Not specified (after start of treatment)|0|||
164022132|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164022133|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164022134|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
164022135|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
164022136|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
164022137|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
164022138|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
164022139|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
164022140|NCT01106625|592443755|FG000|Extension Period: Week 26 to Week 52|Other|5|||
164022141|NCT01106625|592443756|FG001|Extension Period: Week 26 to Week 52|Other|5|||
164022142|NCT01106625|592443757|FG002|Extension Period: Week 26 to Week 52|Other|4|||
164095305|NCT00162123|592712310|FG007|Overall Study|Not specified (after start of treatment)|0|||
164095306|NCT00162123|592712303|FG000|Overall Study|Physician Decision|1|||
164095307|NCT00162123|592712304|FG001|Overall Study|Physician Decision|2|||
164095308|NCT00162123|592712305|FG002|Overall Study|Physician Decision|0|||
164095309|NCT00162123|592712306|FG003|Overall Study|Physician Decision|0|||
164095310|NCT00162123|592712307|FG004|Overall Study|Physician Decision|0|||
164095311|NCT00162123|592712308|FG005|Overall Study|Physician Decision|1|||
164095312|NCT00162123|592712309|FG006|Overall Study|Physician Decision|1|||
164095313|NCT00162123|592712310|FG007|Overall Study|Physician Decision|0|||
164095314|NCT00162123|592712303|FG000|Overall Study|Tumor assessment only (not treated)|0|||
164095315|NCT00162123|592712304|FG001|Overall Study|Tumor assessment only (not treated)|0|||
164095316|NCT00162123|592712305|FG002|Overall Study|Tumor assessment only (not treated)|0|||
164095317|NCT00162123|592712306|FG003|Overall Study|Tumor assessment only (not treated)|0|||
164095318|NCT00162123|592712307|FG004|Overall Study|Tumor assessment only (not treated)|0|||
164095319|NCT00162123|592712308|FG005|Overall Study|Tumor assessment only (not treated)|0|||
164095320|NCT00162123|592712309|FG006|Overall Study|Tumor assessment only (not treated)|0|||
164095321|NCT00162123|592712310|FG007|Overall Study|Tumor assessment only (not treated)|1|||
164095322|NCT00162123|592712303|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
164095323|NCT00162123|592712304|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
164095324|NCT00162123|592712305|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
164095325|NCT00162123|592712306|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
164095326|NCT00162123|592712307|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
164095327|NCT00162123|592712308|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
164095328|NCT00162123|592712309|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
164095329|NCT00162123|592712310|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
164095330|NCT01318499|592712311|FG000|Overall Study|Adverse Event|16|||
164022143|NCT04056455|592443761|FG000|Overall Study|Adverse Event|1|||
164022144|NCT04056455|592443762|FG001|Overall Study|Adverse Event|0|||
164022145|NCT02512068|592443763|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
164022146|NCT02512068|592443764|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
164022147|NCT02512068|592443763|FG000|Overall Study|Major Protocol Deviation|1|||
164022148|NCT02512068|592443764|FG001|Overall Study|Major Protocol Deviation|0|||
164022149|NCT02512068|592443763|FG000|Overall Study|Voluntary Withdrawal|0|||
164022150|NCT02512068|592443764|FG001|Overall Study|Voluntary Withdrawal|1|||
164022151|NCT02512068|592443763|FG000|Overall Study|Lack of Efficacy|0|||
164022152|NCT02512068|592443764|FG001|Overall Study|Lack of Efficacy|1|||
164022153|NCT02512068|592443763|FG000|Overall Study|Reason Not Specified|3|||
164022154|NCT02512068|592443764|FG001|Overall Study|Reason Not Specified|5|||
164022155|NCT00830037|592443771|FG000|Overall Study|Withdrawal by Subject|2|||
164022156|NCT00830037|592443772|FG001|Overall Study|Withdrawal by Subject|3|||
164022157|NCT00830037|592443771|FG000|Overall Study|Lost to Follow-up|1|||
164022158|NCT00830037|592443772|FG001|Overall Study|Lost to Follow-up|2|||
164022159|NCT00830037|592443771|FG000|Overall Study|Active when terminated by DSMB|15|||
164022160|NCT00830037|592443772|FG001|Overall Study|Active when terminated by DSMB|14|||
164022161|NCT01401010|592443773|FG000|Overall Study|Could not interpret assay results|1|||
164022162|NCT01401010|592443774|FG001|Overall Study|Could not interpret assay results|0|||
164022163|NCT02841787|592443777|FG000|Overall Study|Lost to Follow-up|1|||
164022164|NCT02841787|592443778|FG001|Overall Study|Lost to Follow-up|0|||
164022165|NCT02841787|592443779|FG002|Overall Study|Lost to Follow-up|0|||
164022166|NCT02841787|592443777|FG000|Overall Study|Symptoms dropped below threshold|1|||
164022167|NCT02841787|592443778|FG001|Overall Study|Symptoms dropped below threshold|0|||
164022168|NCT02841787|592443779|FG002|Overall Study|Symptoms dropped below threshold|0|||
164022169|NCT02841787|592443777|FG000|Overall Study|Withdrawal by Subject|1|||
164022170|NCT02841787|592443778|FG001|Overall Study|Withdrawal by Subject|4|||
164022171|NCT02841787|592443779|FG002|Overall Study|Withdrawal by Subject|0|||
164022172|NCT01474746|592443780|FG000|Overall Study|Lost to Follow-up|1|||
164022173|NCT01474746|592443781|FG001|Overall Study|Lost to Follow-up|1|||
164022174|NCT01474746|592443780|FG000|Overall Study|Withdrawal by Subject|2|||
164022175|NCT01474746|592443781|FG001|Overall Study|Withdrawal by Subject|1|||
164022176|NCT00524316|592443785|FG000|Overall Study|Withdrawal by Subject|2|||
164022177|NCT00524316|592443785|FG000|Overall Study|Adverse Event|7|||
164022178|NCT00524316|592443785|FG000|Overall Study|Disease Progression|7|||
164022179|NCT01199263|592443786|FG000|Overall Study|Ineligible|0|||
164022180|NCT01199263|592443787|FG001|Overall Study|Ineligible|2|||
164022181|NCT01199263|592443786|FG000|Overall Study|Never Treated|6|||
164022182|NCT01199263|592443787|FG001|Overall Study|Never Treated|0|||
164022183|NCT01687413|592443792|FG000|Overall Study|Withdrawal by Subject|0|||
164022184|NCT01687413|592443793|FG001|Overall Study|Withdrawal by Subject|2|||
164022185|NCT01687413|592443792|FG000|Overall Study|Not eligible|0|||
164022186|NCT01687413|592443793|FG001|Overall Study|Not eligible|2|||
164095331|NCT01318499|592712312|FG001|Overall Study|Adverse Event|11|||
164095332|NCT01318499|592712313|FG002|Overall Study|Adverse Event|6|||
164095333|NCT01318499|592712311|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
164095334|NCT01318499|592712312|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
164095335|NCT01318499|592712313|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
164095336|NCT01318499|592712311|FG000|Overall Study|Noncompliance|2|||
164095337|NCT01318499|592712312|FG001|Overall Study|Noncompliance|3|||
164095338|NCT01318499|592712313|FG002|Overall Study|Noncompliance|0|||
164095339|NCT01318499|592712311|FG000|Overall Study|Treatment Failure|19|||
164095340|NCT01318499|592712312|FG001|Overall Study|Treatment Failure|19|||
164095341|NCT01318499|592712313|FG002|Overall Study|Treatment Failure|101|||
164095342|NCT01318499|592712311|FG000|Overall Study|Protocol Violation|2|||
164095343|NCT01318499|592712312|FG001|Overall Study|Protocol Violation|4|||
164095344|NCT01318499|592712313|FG002|Overall Study|Protocol Violation|2|||
164095345|NCT01318499|592712311|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
164095346|NCT01318499|592712312|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
164095347|NCT01318499|592712313|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
164095348|NCT01318499|592712311|FG000|Overall Study|Other|7|||
164095349|NCT01318499|592712312|FG001|Overall Study|Other|10|||
164095350|NCT01318499|592712313|FG002|Overall Study|Other|22|||
164095351|NCT01395030|592712314|FG000|Overall Study|Did not complete FCH PET/CT|7|||
164095352|NCT03629249|592712315|FG000|Overall Study|Study terminated by sponsor|197|||
164095353|NCT03629249|592712316|FG001|Overall Study|Study terminated by sponsor|197|||
164095354|NCT03629249|592712317|FG002|Overall Study|Study terminated by sponsor|194|||
164095355|NCT03629249|592712315|FG000|Overall Study|Protocol deviation|0|||
164095356|NCT03629249|592712316|FG001|Overall Study|Protocol deviation|2|||
164095357|NCT03629249|592712317|FG002|Overall Study|Protocol deviation|5|||
164095358|NCT03629249|592712315|FG000|Overall Study|Subject decision|1|||
164095359|NCT03629249|592712316|FG001|Overall Study|Subject decision|1|||
164095360|NCT03629249|592712317|FG002|Overall Study|Subject decision|3|||
164095361|NCT03629249|592712315|FG000|Overall Study|Adverse Event|1|||
164095362|NCT03629249|592712316|FG001|Overall Study|Adverse Event|1|||
164095363|NCT03629249|592712317|FG002|Overall Study|Adverse Event|0|||
164095364|NCT03629249|592712315|FG000|Overall Study|Death|1|||
164095365|NCT03629249|592712316|FG001|Overall Study|Death|0|||
164095366|NCT03629249|592712317|FG002|Overall Study|Death|0|||
164095367|NCT03629249|592712315|FG000|Overall Study|Physician Decision|1|||
164095368|NCT03629249|592712316|FG001|Overall Study|Physician Decision|0|||
164095369|NCT03629249|592712317|FG002|Overall Study|Physician Decision|0|||
164095370|NCT02534493|592712319|FG000|Overall Study|Lost to Follow-up|1|||
164095371|NCT02534493|592712319|FG000|Overall Study|Withdrawal by Subject|1|||
164095372|NCT01478620|592712320|FG000|Overall Study|Lost to Follow-up|6|||
164095373|NCT02817841|592713883|FG000|Overall Study|Lost to Follow-up|287|||
164095374|NCT02817841|592713883|FG000|Overall Study|Withdrawal by Subject|183|||
164095375|NCT02817841|592713883|FG000|Overall Study|Adverse event not related to bleeding|131|||
164095376|NCT02817841|592713883|FG000|Overall Study|Adverse event related to bleeding|51|||
164095377|NCT02817841|592713883|FG000|Overall Study|Pregnancy|32|||
164095378|NCT02817841|592713883|FG000|Overall Study|Pregnancy wish|17|||
164095379|NCT02817841|592713883|FG000|Overall Study|Other reasons|53|||
164095380|NCT02817841|592713883|FG000|Overall Study|Protocol Violation|94|||
164095381|NCT04188106|592713884|FG000|Overall Study|Lost to Follow-up|5|||
164095382|NCT04188106|592713884|FG000|Overall Study|Non-Compliance|1|||
164095383|NCT00705536|592713885|FG000|Start Period 1|Withdrawal by Subject|0|||
164095384|NCT00705536|592713886|FG001|Start Period 1|Withdrawal by Subject|0|||
164095385|NCT00705536|592713887|FG002|Start Period 1|Withdrawal by Subject|0|||
164095386|NCT00705536|592713888|FG003|Start Period 1|Withdrawal by Subject|1|||
164095387|NCT02289963|592713889|FG000|Overall Study|Adverse Event|1|||
164095388|NCT02289963|592713890|FG001|Overall Study|Adverse Event|2|||
164095389|NCT02289963|592713889|FG000|Overall Study|Poor compliance to protocol|1|||
164095390|NCT02289963|592713890|FG001|Overall Study|Poor compliance to protocol|0|||
164095391|NCT02289963|592713889|FG000|Overall Study|Withdrawal by Subject|1|||
164095392|NCT02289963|592713890|FG001|Overall Study|Withdrawal by Subject|0|||
164095393|NCT02289963|592713889|FG000|Overall Study|Last injection missed|2|||
164095394|NCT02289963|592713890|FG001|Overall Study|Last injection missed|2|||
164095395|NCT02289963|592713889|FG000|Overall Study|End treatment visit outside visit window|0|||
164095396|NCT02289963|592713890|FG001|Overall Study|End treatment visit outside visit window|4|||
164095397|NCT02289963|592713889|FG000|Overall Study|Other than specified above|0|||
164095398|NCT02289963|592713890|FG001|Overall Study|Other than specified above|2|||
164095399|NCT01746017|592713892|FG000|Period 1|Withdrawal by Subject|0|||
164095400|NCT01746017|592713893|FG001|Period 1|Withdrawal by Subject|0|||
164095401|NCT01746017|592713894|FG002|Period 1|Withdrawal by Subject|0|||
164022187|NCT01687413|592443792|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
164022188|NCT01687413|592443793|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
164022189|NCT00091390|592443795|FG000|Overall Study|Protocol Violation|1|||
164022190|NCT00091390|592443795|FG000|Overall Study|No protocol treatment|3|||
164022191|NCT02349789|592445576|FG000|Overall Study|Withdrawal by Subject|2|||
164022192|NCT00311181|592445577|FG000|Overall Study|Final DFTs were not obtained|96|||
164022193|NCT02669862|592445578|FG000|Overall Study|Lost to Follow-up|0|||
164022194|NCT02669862|592445579|FG001|Overall Study|Lost to Follow-up|2|||
164022195|NCT02669862|592445580|FG002|Overall Study|Lost to Follow-up|1|||
164022196|NCT02669862|592445578|FG000|Overall Study|Withdrawal by Subject|2|||
164022197|NCT02669862|592445579|FG001|Overall Study|Withdrawal by Subject|2|||
164022198|NCT02669862|592445580|FG002|Overall Study|Withdrawal by Subject|3|||
164022199|NCT02669862|592445578|FG000|Overall Study|moved|0|||
164022200|NCT02669862|592445579|FG001|Overall Study|moved|1|||
164022201|NCT02669862|592445580|FG002|Overall Study|moved|0|||
164022202|NCT02669862|592445578|FG000|Overall Study|Protocol Violation|0|||
164022203|NCT02669862|592445579|FG001|Overall Study|Protocol Violation|0|||
164095402|NCT01746017|592713895|FG003|Period 1|Withdrawal by Subject|0|||
164095403|NCT01746017|592713896|FG004|Period 1|Withdrawal by Subject|0|||
164095404|NCT01746017|592713897|FG005|Period 1|Withdrawal by Subject|0|||
164095405|NCT01746017|592713898|FG006|Period 1|Withdrawal by Subject|1|||
164095406|NCT01746017|592713899|FG007|Period 1|Withdrawal by Subject|0|||
164095407|NCT01746017|592713900|FG008|Period 1|Withdrawal by Subject|0|||
164095408|NCT01746017|592713901|FG009|Period 1|Withdrawal by Subject|0|||
164095409|NCT01746017|592713902|FG010|Period 1|Withdrawal by Subject|0|||
164095410|NCT01746017|592713892|FG000|Period 3|Withdrawal by Subject|0|||
164095411|NCT01746017|592713893|FG001|Period 3|Withdrawal by Subject|0|||
164095412|NCT01746017|592713894|FG002|Period 3|Withdrawal by Subject|0|||
164095413|NCT01746017|592713895|FG003|Period 3|Withdrawal by Subject|0|||
164095414|NCT01746017|592713896|FG004|Period 3|Withdrawal by Subject|0|||
164095415|NCT01746017|592713897|FG005|Period 3|Withdrawal by Subject|1|||
164095416|NCT01746017|592713898|FG006|Period 3|Withdrawal by Subject|0|||
164095417|NCT01746017|592713899|FG007|Period 3|Withdrawal by Subject|0|||
164095418|NCT01746017|592713900|FG008|Period 3|Withdrawal by Subject|0|||
164095419|NCT01746017|592713901|FG009|Period 3|Withdrawal by Subject|0|||
164095420|NCT01746017|592713902|FG010|Period 3|Withdrawal by Subject|0|||
164095421|NCT00397488|592713905|FG000|Overall Study|Withdrawal by Subject|3|||
164095422|NCT00397488|592713905|FG000|Overall Study|Adverse Event|3|||
164095423|NCT00397488|592713905|FG000|Overall Study|Death|1|||
164095424|NCT02424097|592713906|FG000|Overall Study|Lost to Follow-up|1|||
164095425|NCT02424097|592713907|FG001|Overall Study|Lost to Follow-up|2|||
164095426|NCT01675622|592713908|FG000|Overall Study|Withdrawal by Subject|2|||
164095427|NCT01675622|592713909|FG001|Overall Study|Withdrawal by Subject|2|||
164095428|NCT01675622|592713908|FG000|Overall Study|Adverse Event|12|||
164095429|NCT01675622|592713909|FG001|Overall Study|Adverse Event|10|||
164095430|NCT01675622|592713908|FG000|Overall Study|Protocol Violation|4|||
164095431|NCT01675622|592713909|FG001|Overall Study|Protocol Violation|1|||
164095432|NCT01675622|592713908|FG000|Overall Study|Lack of Efficacy|2|||
164095433|NCT01675622|592713909|FG001|Overall Study|Lack of Efficacy|4|||
164095434|NCT01675622|592713908|FG000|Overall Study|Lost to Follow-up|1|||
164095435|NCT01675622|592713909|FG001|Overall Study|Lost to Follow-up|3|||
164095436|NCT01675622|592713908|FG000|Overall Study|Other|5|||
164095437|NCT01675622|592713909|FG001|Overall Study|Other|4|||
164095438|NCT04032977|592713910|FG000|Overall Study|Withdrawal by Subject|6|||
164095439|NCT04032977|592713911|FG001|Overall Study|Withdrawal by Subject|1|||
164095440|NCT04032977|592713910|FG000|Overall Study|Lost to Follow-up|2|||
164095441|NCT04032977|592713911|FG001|Overall Study|Lost to Follow-up|7|||
164095442|NCT04032977|592713910|FG000|Overall Study|Pregnancy|1|||
164095443|NCT04032977|592713911|FG001|Overall Study|Pregnancy|0|||
164095444|NCT02880761|592713913|FG000|Overall Study|Death|6|||
164095445|NCT02880761|592713914|FG001|Overall Study|Death|8|||
164095446|NCT02880761|592713913|FG000|Overall Study|Withdrawal by Subject|3|||
164095447|NCT02880761|592713914|FG001|Overall Study|Withdrawal by Subject|6|||
164095448|NCT02880761|592713913|FG000|Overall Study|Protocol Violation|4|||
164095449|NCT02880761|592713914|FG001|Overall Study|Protocol Violation|3|||
164095450|NCT02880761|592713913|FG000|Overall Study|Lost to Follow-up|3|||
164095451|NCT02880761|592713914|FG001|Overall Study|Lost to Follow-up|4|||
164095452|NCT01519661|592713915|FG000|Overall Study|Protocol deviation|6|||
164095453|NCT01519661|592713915|FG000|Overall Study|Lost to Follow-up|3|||
164095454|NCT01519661|592713915|FG000|Overall Study|Withdrawal by Subject|17|||
164095455|NCT01519661|592713915|FG000|Overall Study|Lack of Efficacy|6|||
164022204|NCT02669862|592445580|FG002|Overall Study|Protocol Violation|1|||
164022205|NCT02294318|592445581|FG000|Overall Study|Worsening of drinking|3|||
164022206|NCT02294318|592445582|FG001|Overall Study|Worsening of drinking|0|||
164022207|NCT02294318|592445581|FG000|Overall Study|Not exposed to intervention|0|||
164022208|NCT02294318|592445582|FG001|Overall Study|Not exposed to intervention|2|||
164022209|NCT01116687|592445586|FG000|Overall Study|Withdrawal by Subject|4|||
164022210|NCT01694420|592445587|FG000|Overall Study|Lost to Follow-up|3|||
164022211|NCT03497429|592445589|FG000|Overall Study|Progressive disease|3|||
164022212|NCT03497429|592445590|FG001|Overall Study|Progressive disease|4|||
164022213|NCT03497429|592445589|FG000|Overall Study|Adverse Event|0|||
164022214|NCT03497429|592445590|FG001|Overall Study|Adverse Event|2|||
164022215|NCT00506948|592445591|FG000|Overall Study|Death|4|||
164022216|NCT00506948|592445591|FG000|Overall Study|Adverse Event|5|||
164022217|NCT00506948|592445591|FG000|Overall Study|Physician Decision|1|||
164022218|NCT02395653|592445592|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
164022219|NCT02395653|592445592|FG000|Overall Study|Consent Withdrawn at Screening|1|||
164022220|NCT02395653|592445592|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
164022221|NCT02395653|592445592|FG000|Overall Study|Investigator Decision at Screening|1|||
164022222|NCT02395653|592445592|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
164022223|NCT02395653|592445592|FG000|Overall Study|Withdrawal by Subject|1|||
164022224|NCT02395653|592445592|FG000|Overall Study|Lost to Follow-up|1|||
164022225|NCT02494778|592445593|FG000|Overall Study|Death|3|||
164022226|NCT02494778|592445593|FG000|Overall Study|Other|173|||
164022227|NCT02494778|592445593|FG000|Overall Study|Lack of Efficacy|4|||
164022228|NCT02494778|592445593|FG000|Overall Study|Adverse Event|18|||
164022229|NCT02494778|592445593|FG000|Overall Study|Withdrawal by Subject|20|||
164022230|NCT02494778|592445593|FG000|Overall Study|Lost to Follow-up|2|||
164022231|NCT02494778|592445593|FG000|Overall Study|Noncompliant with study drug admin.|1|||
164022232|NCT03621943|592445594|FG000|First Randomized Intervention|Lost to Follow-up|51|||
164022233|NCT03621943|592445595|FG001|First Randomized Intervention|Lost to Follow-up|54|||
164022234|NCT03621943|592445594|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
164022235|NCT03621943|592445595|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
164022236|NCT03621943|592445594|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
164022237|NCT03621943|592445595|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
164022238|NCT03621943|592445594|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
164022239|NCT03621943|592445595|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
164022240|NCT02174861|592445596|FG000|Overall Study|Decision by sponsor|8|||
164022241|NCT02174861|592445596|FG000|Overall Study|Withdrawal by Subject|124|||
164022242|NCT02174861|592445596|FG000|Overall Study|Lost to Follow-up|26|||
164022243|NCT01215734|592445597|FG000|Overall Study|Death|0|||
164022244|NCT01215734|592445598|FG001|Overall Study|Death|1|||
164022245|NCT00315705|592445599|FG000|Phase 1|Refused further treatment|1|||
164022246|NCT00315705|592445599|FG000|Phase 1|Failure to achieve response|8|||
164022247|NCT00315705|592445599|FG000|Phase 1|Disease relapse|4|||
164022248|NCT00315705|592445599|FG000|Phase 1|Scheduled for transplant|9|||
164022249|NCT00315705|592445599|FG000|Phase 1|Death|3|||
164022250|NCT00315705|592445599|FG000|Phase 2|Physician Decision|4|||
164022251|NCT00315705|592445599|FG000|Phase 2|Adverse Event|1|||
164022252|NCT00315705|592445599|FG000|Phase 2|Failure to achieve response|3|||
164022253|NCT00315705|592445599|FG000|Phase 2|Disease relapse|1|||
164022254|NCT00315705|592445599|FG000|Phase 2|Scheduled for transplant|8|||
164022255|NCT00315705|592445599|FG000|Phase 2|Other|1|||
164022256|NCT00315705|592445599|FG000|Phase 2|Death|7|||
164022257|NCT01346371|592445600|FG000|Overall Study|Lost to Follow-up|2|||
164022258|NCT01346371|592445601|FG001|Overall Study|Lost to Follow-up|0|||
164022259|NCT01716533|592445602|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
164022260|NCT01716533|592445603|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
164022261|NCT01716533|592445604|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
164022262|NCT01716533|592445605|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
164022263|NCT01716533|592445602|FG000|Overall Study|Withdrawal by Subject|0|||
164022264|NCT01716533|592445603|FG001|Overall Study|Withdrawal by Subject|0|||
164022265|NCT01716533|592445604|FG002|Overall Study|Withdrawal by Subject|0|||
164095456|NCT01519661|592713915|FG000|Overall Study|Adverse Event|29|||
163910078|NCT00428714|592040629|FG000|Overall Study|Death due to other then PD|1|||
163910079|NCT00428714|592040630|FG001|Overall Study|Death due to other then PD|0|||
163910080|NCT00513071|592040632|FG000|Overall Study|Adverse Event|1|||
163910081|NCT00513071|592040632|FG000|Overall Study|Withdrawal by Subject|1|||
163910082|NCT00513071|592040632|FG000|Overall Study|Physician Decision|3|||
163910083|NCT02106325|592040635|FG000|Phase 1|Lost to Follow-up|2|||
163910084|NCT02106325|592040636|FG001|Phase 1|Lost to Follow-up|2|||
163910085|NCT02106325|592040635|FG000|Phase 2|Lost to Follow-up|2|||
163910086|NCT02106325|592040636|FG001|Phase 2|Lost to Follow-up|3|||
163910087|NCT02106325|592040635|FG000|Phase 3|Lost to Follow-up|2|||
163910088|NCT02106325|592040636|FG001|Phase 3|Lost to Follow-up|1|||
163910089|NCT00452114|592040638|FG000|Overall Study|Physician Decision|3|||
163910090|NCT00452114|592040639|FG001|Overall Study|Physician Decision|3|||
163910091|NCT03242863|592040640|FG000|Study Week 1|Withdrawal by Subject|0|||
163910092|NCT03242863|592040641|FG001|Study Week 1|Withdrawal by Subject|1|||
163910093|NCT03242863|592040642|FG002|Study Week 1|Withdrawal by Subject|0|||
163910094|NCT03242863|592040643|FG003|Study Week 1|Withdrawal by Subject|0|||
163910095|NCT03242863|592040644|FG004|Study Week 1|Withdrawal by Subject|3|||
163910096|NCT03242863|592040645|FG005|Study Week 1|Withdrawal by Subject|0|||
163910097|NCT04602728|592040650|FG000|Overall Study|Lost to Follow-up|4|||
163910098|NCT04602728|592040651|FG001|Overall Study|Lost to Follow-up|4|||
163910099|NCT05338476|592040656|FG000|Period 2|Adverse Event|0|||
163910100|NCT05338476|592040657|FG001|Period 2|Adverse Event|1|||
163910101|NCT02831049|592040660|FG000|Overall Study|Lost to Follow-up|0|||
163910102|NCT02831049|592040661|FG001|Overall Study|Lost to Follow-up|0|||
163910103|NCT02831049|592040662|FG002|Overall Study|Lost to Follow-up|1|||
163910104|NCT02831049|592040660|FG000|Overall Study|Withdrawal by Subject|0|||
163910105|NCT02831049|592040661|FG001|Overall Study|Withdrawal by Subject|1|||
163910106|NCT02831049|592040662|FG002|Overall Study|Withdrawal by Subject|1|||
163910107|NCT02831049|592040660|FG000|Overall Study|Pandemic shutdown|1|||
163910108|NCT02831049|592040661|FG001|Overall Study|Pandemic shutdown|0|||
163910109|NCT02831049|592040662|FG002|Overall Study|Pandemic shutdown|0|||
163910110|NCT00747149|592041706|FG000|Overall Study|Adverse Event|0|||
163910111|NCT00747149|592041707|FG001|Overall Study|Adverse Event|15|||
163910112|NCT00747149|592041706|FG000|Overall Study|Lost to Follow-up|0|||
163910113|NCT00747149|592041707|FG001|Overall Study|Lost to Follow-up|10|||
163910114|NCT00747149|592041706|FG000|Overall Study|Withdrawal by Subject|0|||
163910115|NCT00747149|592041707|FG001|Overall Study|Withdrawal by Subject|6|||
163910116|NCT00747149|592041706|FG000|Overall Study|Did not receive treatment|0|||
163910117|NCT00747149|592041707|FG001|Overall Study|Did not receive treatment|1|||
163910118|NCT00747149|592041706|FG000|Overall Study|Incorrect enrollment|0|||
163910119|NCT00747149|592041707|FG001|Overall Study|Incorrect enrollment|6|||
163910120|NCT00747149|592041706|FG000|Overall Study|Severe non-compliance to protocol|0|||
163910121|NCT00747149|592041707|FG001|Overall Study|Severe non-compliance to protocol|1|||
163910122|NCT00747149|592041706|FG000|Overall Study|Not reported|1|||
163910123|NCT00747149|592041707|FG001|Overall Study|Not reported|4|||
163910124|NCT03141177|592041710|FG000|Overall Study|Death|62|||
163910125|NCT03141177|592041711|FG001|Overall Study|Death|13|||
163910126|NCT03141177|592041712|FG002|Overall Study|Death|84|||
163910127|NCT03141177|592041710|FG000|Overall Study|Participant withdrew consent|9|||
163910128|NCT03141177|592041711|FG001|Overall Study|Participant withdrew consent|2|||
163910129|NCT03141177|592041712|FG002|Overall Study|Participant withdrew consent|13|||
163910130|NCT03141177|592041710|FG000|Overall Study|Not reported|1|||
163910131|NCT03141177|592041711|FG001|Overall Study|Not reported|0|||
163910132|NCT03141177|592041712|FG002|Overall Study|Not reported|1|||
163910133|NCT03141177|592041710|FG000|Overall Study|Lost to Follow-up|2|||
163910134|NCT03141177|592041711|FG001|Overall Study|Lost to Follow-up|1|||
163910135|NCT03141177|592041712|FG002|Overall Study|Lost to Follow-up|1|||
163910136|NCT03141177|592041710|FG000|Overall Study|Other reasons|4|||
163910137|NCT03141177|592041711|FG001|Overall Study|Other reasons|0|||
163910138|NCT03141177|592041712|FG002|Overall Study|Other reasons|11|||
163910139|NCT03141177|592041710|FG000|Overall Study|Participants did not start treatment period|3|||
163910140|NCT03141177|592041711|FG001|Overall Study|Participants did not start treatment period|0|||
163910141|NCT03141177|592041712|FG002|Overall Study|Participants did not start treatment period|8|||
164095457|NCT02106156|592713916|FG000|Overall Study|Patient Died|19|||
164095458|NCT02106156|592713917|FG001|Overall Study|Patient Died|0|||
164095459|NCT02106156|592713918|FG002|Overall Study|Patient Died|0|||
164095460|NCT02106156|592713916|FG000|Overall Study|Lack of Tolerability|305|||
164095461|NCT02106156|592713917|FG001|Overall Study|Lack of Tolerability|3|||
164095462|NCT02106156|592713918|FG002|Overall Study|Lack of Tolerability|0|||
164095463|NCT02106156|592713916|FG000|Overall Study|Lack of Virological Response|1044|||
164095464|NCT02106156|592713917|FG001|Overall Study|Lack of Virological Response|8|||
164095465|NCT02106156|592713918|FG002|Overall Study|Lack of Virological Response|0|||
164095466|NCT02106156|592713916|FG000|Overall Study|Concomitant Disease|74|||
164095467|NCT02106156|592713917|FG001|Overall Study|Concomitant Disease|2|||
164095468|NCT02106156|592713918|FG002|Overall Study|Concomitant Disease|0|||
164095469|NCT02106156|592713916|FG000|Overall Study|Lack of Compliance|211|||
164095470|NCT02106156|592713917|FG001|Overall Study|Lack of Compliance|7|||
164095471|NCT02106156|592713918|FG002|Overall Study|Lack of Compliance|0|||
164095472|NCT02106156|592713916|FG000|Overall Study|Patients Request|307|||
164095473|NCT02106156|592713917|FG001|Overall Study|Patients Request|9|||
164095474|NCT02106156|592713918|FG002|Overall Study|Patients Request|0|||
164095475|NCT02106156|592713916|FG000|Overall Study|Lost to Follow-up|451|||
164095476|NCT02106156|592713917|FG001|Overall Study|Lost to Follow-up|8|||
164095477|NCT02106156|592713918|FG002|Overall Study|Lost to Follow-up|0|||
164095478|NCT02106156|592713916|FG000|Overall Study|Unplanned Event|82|||
164095479|NCT02106156|592713917|FG001|Overall Study|Unplanned Event|2|||
164095480|NCT02106156|592713918|FG002|Overall Study|Unplanned Event|0|||
164095481|NCT02106156|592713916|FG000|Overall Study|Change of Laboratory Parameter|10|||
164095482|NCT02106156|592713917|FG001|Overall Study|Change of Laboratory Parameter|0|||
164095483|NCT02106156|592713918|FG002|Overall Study|Change of Laboratory Parameter|0|||
164095484|NCT02106156|592713916|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
164095485|NCT02106156|592713917|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
164095486|NCT02106156|592713918|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
164095487|NCT02106156|592713916|FG000|Overall Study|Relocation/Change of Physician|40|||
163910142|NCT00092456|592041715|FG000|Overall Study|Adverse Event|0|||
164095488|NCT02106156|592713917|FG001|Overall Study|Relocation/Change of Physician|1|||
164095489|NCT02106156|592713918|FG002|Overall Study|Relocation/Change of Physician|0|||
164095490|NCT00840632|592713920|FG000|First Intervention|Withdrawal by Subject|0|||
164095491|NCT00840632|592713921|FG001|First Intervention|Withdrawal by Subject|1|||
164095492|NCT00840632|592713920|FG000|Washout|Withdrawal by Subject|1|||
164095493|NCT00840632|592713921|FG001|Washout|Withdrawal by Subject|1|||
164095494|NCT05017480|592713922|FG000|Stage 1 Study|Withdrawal by Subject|8|||
164095495|NCT05017480|592713923|FG001|Stage 1 Study|Withdrawal by Subject|6|||
164095496|NCT05017480|592713924|FG002|Stage 1 Study|Withdrawal by Subject|0|||
164022266|NCT01716533|592445605|FG003|Overall Study|Withdrawal by Subject|5|||
164022267|NCT01716533|592445602|FG000|Overall Study|Death|0|||
164022268|NCT01716533|592445603|FG001|Overall Study|Death|0|||
164022269|NCT01716533|592445604|FG002|Overall Study|Death|0|||
164022270|NCT01716533|592445605|FG003|Overall Study|Death|2|||
164022271|NCT01716533|592445602|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
164144814|NCT01524978|592891784|FG010|Overall Study|Lost to Follow-up|1|||
164095497|NCT05017480|592713925|FG003|Stage 1 Study|Withdrawal by Subject|0|||
164095498|NCT05017480|592713926|FG004|Stage 1 Study|Withdrawal by Subject|0|||
164095499|NCT05017480|592713922|FG000|Stage 1 Study|Adverse Event|1|||
164095500|NCT05017480|592713923|FG001|Stage 1 Study|Adverse Event|1|||
164095501|NCT05017480|592713924|FG002|Stage 1 Study|Adverse Event|0|||
164095502|NCT05017480|592713925|FG003|Stage 1 Study|Adverse Event|0|||
164095503|NCT05017480|592713926|FG004|Stage 1 Study|Adverse Event|0|||
164095504|NCT05017480|592713922|FG000|Stage 1 Study|Poor Compliance|1|||
164095505|NCT05017480|592713923|FG001|Stage 1 Study|Poor Compliance|1|||
164095506|NCT05017480|592713924|FG002|Stage 1 Study|Poor Compliance|0|||
164095507|NCT05017480|592713925|FG003|Stage 1 Study|Poor Compliance|0|||
164095508|NCT05017480|592713926|FG004|Stage 1 Study|Poor Compliance|0|||
164095509|NCT05017480|592713922|FG000|Stage 1 Study|Physician Decision|0|||
164095510|NCT05017480|592713923|FG001|Stage 1 Study|Physician Decision|1|||
164095511|NCT05017480|592713924|FG002|Stage 1 Study|Physician Decision|0|||
164095512|NCT05017480|592713925|FG003|Stage 1 Study|Physician Decision|0|||
164095513|NCT05017480|592713926|FG004|Stage 1 Study|Physician Decision|0|||
164095514|NCT05017480|592713922|FG000|Stage 2 Study|Withdrawal by Subject|0|||
164095515|NCT05017480|592713923|FG001|Stage 2 Study|Withdrawal by Subject|0|||
164095516|NCT05017480|592713924|FG002|Stage 2 Study|Withdrawal by Subject|6|||
164095517|NCT05017480|592713925|FG003|Stage 2 Study|Withdrawal by Subject|9|||
164095518|NCT05017480|592713926|FG004|Stage 2 Study|Withdrawal by Subject|11|||
164095519|NCT05017480|592713922|FG000|Stage 2 Study|Lost to Follow-up|0|||
164095520|NCT05017480|592713923|FG001|Stage 2 Study|Lost to Follow-up|0|||
164095521|NCT05017480|592713924|FG002|Stage 2 Study|Lost to Follow-up|0|||
164095522|NCT05017480|592713925|FG003|Stage 2 Study|Lost to Follow-up|2|||
164095523|NCT05017480|592713926|FG004|Stage 2 Study|Lost to Follow-up|1|||
164095524|NCT05017480|592713922|FG000|Stage 2 Study|Adverse Event|0|||
164022272|NCT01716533|592445603|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
164022273|NCT01716533|592445604|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
164022274|NCT01716533|592445605|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
164022275|NCT02622724|592445615|FG000|Overall Study|Death|51|||
164022276|NCT02622724|592445616|FG001|Overall Study|Death|53|||
164022277|NCT02622724|592445615|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
164022278|NCT02622724|592445616|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
164022279|NCT02622724|592445615|FG000|Overall Study|Early termination of study|38|||
163910143|NCT00092456|592041716|FG001|Overall Study|Adverse Event|0|||
164022280|NCT02622724|592445616|FG001|Overall Study|Early termination of study|43|||
164022281|NCT00254293|592445617|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164022282|NCT00254293|592445618|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
164022283|NCT00254293|592445619|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164022284|NCT00254293|592445620|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
164022285|NCT00254293|592445621|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164022286|NCT00254293|592445622|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164022287|NCT00254293|592445623|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
164022288|NCT00254293|592445617|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164022289|NCT00254293|592445618|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164022290|NCT00254293|592445619|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
164022291|NCT00254293|592445620|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164022292|NCT00254293|592445621|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164022293|NCT00254293|592445622|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164022294|NCT00254293|592445623|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
164022295|NCT00254293|592445617|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164022296|NCT00254293|592445618|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164022297|NCT00254293|592445619|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
164022298|NCT00254293|592445620|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164022299|NCT00254293|592445621|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164022300|NCT00254293|592445622|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164022301|NCT00254293|592445623|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
164022302|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Death|0|||
164022303|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Death|0|||
164022304|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Death|1|||
164022305|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Death|0|||
164022306|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Death|0|||
164022307|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Death|0|||
164022308|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Death|0|||
164022309|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
164022310|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164022311|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
164022312|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164022313|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
164022314|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164022315|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
164022316|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
164022317|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164022318|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
164022319|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164022320|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
164022321|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164022322|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
164022323|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164022324|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164022325|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
164022326|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164022327|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164022328|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164022329|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
164022330|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164022331|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164022332|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
164022333|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164022334|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164022335|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164022336|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
164022337|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164022338|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164022339|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
164022340|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164022341|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164022342|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164022343|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
164022344|NCT00254293|592445617|FG000|LTE Open Label Variable SC Dosing|Other|0|||
164022345|NCT00254293|592445618|FG001|LTE Open Label Variable SC Dosing|Other|0|||
164022346|NCT00254293|592445619|FG002|LTE Open Label Variable SC Dosing|Other|2|||
164022347|NCT00254293|592445620|FG003|LTE Open Label Variable SC Dosing|Other|0|||
164022348|NCT00254293|592445621|FG004|LTE Open Label Variable SC Dosing|Other|0|||
164022349|NCT00254293|592445622|FG005|LTE Open Label Variable SC Dosing|Other|0|||
164022350|NCT00254293|592445623|FG006|LTE Open Label Variable SC Dosing|Other|0|||
164022351|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Death|0|||
164022352|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Death|0|||
164022353|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Death|0|||
164022354|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Death|0|||
164022355|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Death|0|||
164022356|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Death|0|||
164022357|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Death|3|||
164022358|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
164022359|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
164022360|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
164022361|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
164022362|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
164022363|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
164022364|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
164022365|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164022366|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164022367|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164022368|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164022369|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164022370|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
164095525|NCT05017480|592713923|FG001|Stage 2 Study|Adverse Event|0|||
164022371|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
164022372|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164022373|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164022374|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164022375|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164022376|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164022377|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
164022378|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
164022379|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164022380|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164022381|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164022382|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164022383|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164022384|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
164022385|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
164022386|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164022387|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164022388|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164022389|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164022390|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164022391|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
164022392|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
164022393|NCT00254293|592445617|FG000|LTE Open Label Fixed Dosing|Other|0|||
164022394|NCT00254293|592445618|FG001|LTE Open Label Fixed Dosing|Other|0|||
164022395|NCT00254293|592445619|FG002|LTE Open Label Fixed Dosing|Other|0|||
164022396|NCT00254293|592445620|FG003|LTE Open Label Fixed Dosing|Other|0|||
164022397|NCT00254293|592445621|FG004|LTE Open Label Fixed Dosing|Other|0|||
164022398|NCT00254293|592445622|FG005|LTE Open Label Fixed Dosing|Other|0|||
164022399|NCT00254293|592445623|FG006|LTE Open Label Fixed Dosing|Other|1|||
164022400|NCT01575197|592445624|FG000|Overall Study|Migration out of study area|1|||
164022401|NCT01575197|592445625|FG001|Overall Study|Migration out of study area|5|||
164022402|NCT01575197|592445626|FG002|Overall Study|Migration out of study area|4|||
164022403|NCT01575197|592445624|FG000|Overall Study|SAE|0|||
164022404|NCT01575197|592445625|FG001|Overall Study|SAE|1|||
164022405|NCT01575197|592445626|FG002|Overall Study|SAE|0|||
164022406|NCT01575197|592445624|FG000|Overall Study|Lost to Follow-up|0|||
164022407|NCT01575197|592445625|FG001|Overall Study|Lost to Follow-up|1|||
164022408|NCT01575197|592445626|FG002|Overall Study|Lost to Follow-up|0|||
164022409|NCT01575197|592445624|FG000|Overall Study|Withdrawal by Subject|0|||
164022410|NCT01575197|592445625|FG001|Overall Study|Withdrawal by Subject|1|||
164022411|NCT01575197|592445626|FG002|Overall Study|Withdrawal by Subject|1|||
164022412|NCT01575197|592445624|FG000|Overall Study|Protocol Violation|2|||
164022413|NCT01575197|592445625|FG001|Overall Study|Protocol Violation|1|||
164022414|NCT01575197|592445626|FG002|Overall Study|Protocol Violation|1|||
164022415|NCT03196193|592445627|FG000|Overall Study|Adverse Event|1|||
164022416|NCT03196193|592445628|FG001|Overall Study|Adverse Event|0|||
164022417|NCT03196193|592445627|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
164022418|NCT03196193|592445628|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
164022419|NCT02709083|592445632|FG000|Overall Study|Original PI left institution|7|||
164022420|NCT03544268|592445633|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
164022421|NCT03544268|592445634|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
164022422|NCT03583372|592445635|FG000|Overall Study|Withdrawal by Subject|6|||
164022423|NCT03583372|592445636|FG001|Overall Study|Withdrawal by Subject|11|||
164022424|NCT03583372|592445637|FG002|Overall Study|Withdrawal by Subject|7|||
164022425|NCT03583372|592445638|FG003|Overall Study|Withdrawal by Subject|8|||
164022426|NCT03583372|592445635|FG000|Overall Study|Lost to Follow-up|4|||
164022427|NCT03583372|592445636|FG001|Overall Study|Lost to Follow-up|6|||
164022428|NCT03583372|592445637|FG002|Overall Study|Lost to Follow-up|3|||
164022429|NCT03583372|592445638|FG003|Overall Study|Lost to Follow-up|2|||
164095526|NCT05017480|592713924|FG002|Stage 2 Study|Adverse Event|0|||
164095527|NCT05017480|592713925|FG003|Stage 2 Study|Adverse Event|1|||
164095528|NCT05017480|592713926|FG004|Stage 2 Study|Adverse Event|0|||
164095529|NCT05017480|592713922|FG000|Stage 2 Study|COVID-19|0|||
164095530|NCT05017480|592713923|FG001|Stage 2 Study|COVID-19|0|||
164095531|NCT05017480|592713924|FG002|Stage 2 Study|COVID-19|0|||
164095532|NCT05017480|592713925|FG003|Stage 2 Study|COVID-19|1|||
164095533|NCT05017480|592713926|FG004|Stage 2 Study|COVID-19|0|||
164095534|NCT05017480|592713922|FG000|Stage 2 Study|Pregnancy|0|||
164095535|NCT05017480|592713923|FG001|Stage 2 Study|Pregnancy|0|||
164095536|NCT05017480|592713924|FG002|Stage 2 Study|Pregnancy|0|||
164095537|NCT05017480|592713925|FG003|Stage 2 Study|Pregnancy|0|||
164095538|NCT05017480|592713926|FG004|Stage 2 Study|Pregnancy|1|||
164095539|NCT01136382|592713927|FG000|Overall Study|Other|8|||
164095540|NCT01136382|592713928|FG001|Overall Study|Other|3|||
164095541|NCT01136382|592713927|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
164095542|NCT01136382|592713928|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
164095543|NCT01136382|592713927|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
164095544|NCT01136382|592713928|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164095545|NCT01136382|592713927|FG000|Overall Study|Withdrawal by Subject|4|||
164095546|NCT01136382|592713928|FG001|Overall Study|Withdrawal by Subject|1|||
164095547|NCT02311361|592713929|FG000|Overall Study|Did not receive treatment|0|||
164095548|NCT02311361|592713930|FG001|Overall Study|Did not receive treatment|1|||
164095549|NCT02311361|592713931|FG002|Overall Study|Did not receive treatment|0|||
164095550|NCT02311361|592713932|FG003|Overall Study|Did not receive treatment|1|||
164095551|NCT05628675|592713937|FG000|Overall Study|Lost to Follow-up|2|||
164095552|NCT05628675|592713937|FG000|Overall Study|Withdrawal by Subject|1|||
164095553|NCT00633594|592713940|FG000|Overall Study|Adverse Event|0|||
164095554|NCT00633594|592713941|FG001|Overall Study|Adverse Event|4|||
164095555|NCT00633594|592713942|FG002|Overall Study|Adverse Event|7|||
164095556|NCT00633594|592713940|FG000|Overall Study|Death|0|||
164095557|NCT00633594|592713941|FG001|Overall Study|Death|1|||
164095558|NCT00633594|592713942|FG002|Overall Study|Death|2|||
164095559|NCT00633594|592713940|FG000|Overall Study|Disease Progression|0|||
164095560|NCT00633594|592713941|FG001|Overall Study|Disease Progression|0|||
164095561|NCT00633594|592713942|FG002|Overall Study|Disease Progression|1|||
164095562|NCT02028715|592713943|FG000|Overall Study|Adverse Event|2|||
164095563|NCT02028715|592713944|FG001|Overall Study|Adverse Event|2|||
164095564|NCT02028715|592713943|FG000|Overall Study|Physician Decision|1|||
164095565|NCT02028715|592713944|FG001|Overall Study|Physician Decision|0|||
164095566|NCT02028715|592713943|FG000|Overall Study|Did not complete satisfaction surveys|2|||
164095567|NCT02028715|592713944|FG001|Overall Study|Did not complete satisfaction surveys|2|||
164095568|NCT01492361|592713945|FG000|Overall Study|Withdrawal by Subject|281|||
164095569|NCT01492361|592713946|FG001|Overall Study|Withdrawal by Subject|297|||
164095570|NCT01492361|592713945|FG000|Overall Study|Physician Decision|12|||
164095571|NCT01492361|592713946|FG001|Overall Study|Physician Decision|12|||
164095572|NCT01492361|592713945|FG000|Overall Study|Lost to Follow-up|6|||
164095573|NCT01492361|592713946|FG001|Overall Study|Lost to Follow-up|13|||
164095574|NCT01492361|592713945|FG000|Overall Study|Other than specified above|106|||
164095575|NCT01492361|592713946|FG001|Overall Study|Other than specified above|138|||
164095576|NCT01475838|592713947|FG000|Randomized Phase|Randomized but Not Treated|0|||
164095577|NCT01475838|592713948|FG001|Randomized Phase|Randomized but Not Treated|5|||
164095578|NCT01475838|592713947|FG000|Randomized Phase|Adverse Event|6|||
164095579|NCT01475838|592713948|FG001|Randomized Phase|Adverse Event|1|||
164095580|NCT01475838|592713947|FG000|Randomized Phase|Pregnancy|0|||
164095581|NCT01475838|592713948|FG001|Randomized Phase|Pregnancy|1|||
164095582|NCT01475838|592713947|FG000|Randomized Phase|Investigators Discretion|1|||
164095583|NCT01475838|592713948|FG001|Randomized Phase|Investigators Discretion|2|||
164095584|NCT01475838|592713947|FG000|Randomized Phase|Withdrew Consent|10|||
164095585|NCT01475838|592713948|FG001|Randomized Phase|Withdrew Consent|14|||
164095586|NCT01475838|592713947|FG000|Randomized Phase|Lost to Follow-up|3|||
164095587|NCT01475838|592713948|FG001|Randomized Phase|Lost to Follow-up|4|||
164095588|NCT01475838|592713947|FG000|Randomized Phase|Participant Noncompliance|1|||
164095589|NCT01475838|592713948|FG001|Randomized Phase|Participant Noncompliance|5|||
164095590|NCT01475838|592713947|FG000|Randomized Phase|Protocol Violation|9|||
164095591|NCT01475838|592713948|FG001|Randomized Phase|Protocol Violation|4|||
164095592|NCT01475838|592713947|FG000|Extension Phase|Participant Noncompliance|1|||
164095593|NCT01475838|592713948|FG001|Extension Phase|Participant Noncompliance|0|||
164095594|NCT03227445|592713950|FG000|Period 1 (28 Days)|Adverse Event|1|||
164095595|NCT03227445|592713951|FG001|Period 1 (28 Days)|Adverse Event|2|||
164095596|NCT03227445|592713952|FG002|Period 1 (28 Days)|Adverse Event|0|||
164095597|NCT03227445|592713953|FG003|Period 1 (28 Days)|Adverse Event|1|||
164095598|NCT03227445|592713950|FG000|Period 1 (28 Days)|Protocol Violation|1|||
164095599|NCT03227445|592713951|FG001|Period 1 (28 Days)|Protocol Violation|0|||
164095600|NCT03227445|592713952|FG002|Period 1 (28 Days)|Protocol Violation|0|||
164095601|NCT03227445|592713953|FG003|Period 1 (28 Days)|Protocol Violation|0|||
164095602|NCT03227445|592713950|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
164095603|NCT03227445|592713951|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
164095604|NCT03227445|592713952|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
164095605|NCT03227445|592713953|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
164095606|NCT03227445|592713950|FG000|Period 2 (28 Days)|Adverse Event|1|||
164095607|NCT03227445|592713951|FG001|Period 2 (28 Days)|Adverse Event|0|||
164095608|NCT03227445|592713952|FG002|Period 2 (28 Days)|Adverse Event|2|||
164095609|NCT03227445|592713953|FG003|Period 2 (28 Days)|Adverse Event|1|||
164095610|NCT03227445|592713950|FG000|Period 2 (28 Days)|Protocol Violation|0|||
164095611|NCT03227445|592713951|FG001|Period 2 (28 Days)|Protocol Violation|0|||
164095612|NCT03227445|592713952|FG002|Period 2 (28 Days)|Protocol Violation|0|||
164095613|NCT03227445|592713953|FG003|Period 2 (28 Days)|Protocol Violation|1|||
164095614|NCT03227445|592713950|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
164095615|NCT03227445|592713951|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
164095616|NCT03227445|592713952|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
164095617|NCT03227445|592713953|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
164022430|NCT03583372|592445635|FG000|Overall Study|Adverse Event|1|||
164022431|NCT03583372|592445636|FG001|Overall Study|Adverse Event|3|||
164022432|NCT03583372|592445637|FG002|Overall Study|Adverse Event|4|||
164022433|NCT03583372|592445638|FG003|Overall Study|Adverse Event|4|||
164022434|NCT03583372|592445635|FG000|Overall Study|Physician Decision|0|||
164022435|NCT03583372|592445636|FG001|Overall Study|Physician Decision|1|||
164022436|NCT03583372|592445637|FG002|Overall Study|Physician Decision|1|||
164022437|NCT03583372|592445638|FG003|Overall Study|Physician Decision|1|||
164022438|NCT03583372|592445635|FG000|Overall Study|Lack of Efficacy|0|||
164022439|NCT03583372|592445636|FG001|Overall Study|Lack of Efficacy|1|||
164022440|NCT03583372|592445637|FG002|Overall Study|Lack of Efficacy|0|||
164022441|NCT03583372|592445638|FG003|Overall Study|Lack of Efficacy|1|||
164022442|NCT03583372|592445635|FG000|Overall Study|Death|1|||
164022443|NCT03583372|592445636|FG001|Overall Study|Death|0|||
164022444|NCT03583372|592445637|FG002|Overall Study|Death|0|||
164022445|NCT03583372|592445638|FG003|Overall Study|Death|0|||
164022446|NCT03583372|592445635|FG000|Overall Study|Protocol Violation|0|||
164022447|NCT03583372|592445636|FG001|Overall Study|Protocol Violation|1|||
164022448|NCT03583372|592445637|FG002|Overall Study|Protocol Violation|0|||
164022449|NCT03583372|592445638|FG003|Overall Study|Protocol Violation|0|||
164022450|NCT03583372|592445635|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
164022451|NCT03583372|592445636|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
164022452|NCT03583372|592445637|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
164022453|NCT03583372|592445638|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
164022454|NCT03583372|592445635|FG000|Overall Study|Did Not Receive Study Drug|0|||
164022455|NCT03583372|592445636|FG001|Overall Study|Did Not Receive Study Drug|1|||
164022456|NCT03583372|592445637|FG002|Overall Study|Did Not Receive Study Drug|0|||
164022457|NCT03583372|592445638|FG003|Overall Study|Did Not Receive Study Drug|0|||
164022458|NCT03583372|592445635|FG000|Overall Study|Captured as Other in the Database|1|||
164022459|NCT03583372|592445636|FG001|Overall Study|Captured as Other in the Database|2|||
164022460|NCT03583372|592445637|FG002|Overall Study|Captured as Other in the Database|4|||
164022461|NCT03583372|592445638|FG003|Overall Study|Captured as Other in the Database|1|||
164022462|NCT02796391|592445639|FG000|Overall Study|Lost to Follow-up|2|||
164022463|NCT02796391|592445640|FG001|Overall Study|Lost to Follow-up|2|||
164022464|NCT02796391|592445641|FG002|Overall Study|Lost to Follow-up|13|||
164022465|NCT02796391|592445642|FG003|Overall Study|Lost to Follow-up|8|||
164022466|NCT02796391|592445643|FG004|Overall Study|Lost to Follow-up|14|||
164022467|NCT02796391|592445644|FG005|Overall Study|Lost to Follow-up|13|||
164022468|NCT02796391|592445639|FG000|Overall Study|COVID|0|||
164022469|NCT02796391|592445640|FG001|Overall Study|COVID|0|||
164022470|NCT02796391|592445641|FG002|Overall Study|COVID|5|||
164022471|NCT02796391|592445642|FG003|Overall Study|COVID|5|||
164022472|NCT02796391|592445643|FG004|Overall Study|COVID|2|||
164022473|NCT02796391|592445644|FG005|Overall Study|COVID|4|||
164022474|NCT02796391|592445639|FG000|Overall Study|Participant did not like study cigarettes|0|||
164022475|NCT02796391|592445640|FG001|Overall Study|Participant did not like study cigarettes|0|||
164022476|NCT02796391|592445641|FG002|Overall Study|Participant did not like study cigarettes|3|||
164095618|NCT01991470|592713956|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
164095619|NCT01991470|592713956|FG000|Enlite 1 Period|Adverse Event|1|||
164095620|NCT01991470|592713956|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
164095621|NCT01991470|592713956|FG000|Enlite 3 Period|Lost to Follow-up|1|||
164095622|NCT01991470|592713956|FG000|Enlite 3 Period|Physician Decision|2|||
164095623|NCT01991470|592713956|FG000|Enlite 3 Period|Physician Decision|8|||
164095624|NCT01991470|592713956|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
164095625|NCT00760266|592713959|FG000|Overall Study|Adverse Event|13|||
164095626|NCT00760266|592713960|FG001|Overall Study|Adverse Event|7|||
163910144|NCT00092456|592041717|FG002|Overall Study|Adverse Event|1|||
163910145|NCT00092456|592041718|FG003|Overall Study|Adverse Event|1|||
163910146|NCT00092456|592041715|FG000|Overall Study|Lost to Follow-up|2|||
164022477|NCT02796391|592445642|FG003|Overall Study|Participant did not like study cigarettes|0|||
164022478|NCT02796391|592445643|FG004|Overall Study|Participant did not like study cigarettes|0|||
164022479|NCT02796391|592445644|FG005|Overall Study|Participant did not like study cigarettes|0|||
164022480|NCT02796391|592445639|FG000|Overall Study|Withdrawal by Subject|1|||
164022481|NCT02796391|592445640|FG001|Overall Study|Withdrawal by Subject|1|||
163910147|NCT00092456|592041716|FG001|Overall Study|Lost to Follow-up|2|||
163910148|NCT00092456|592041717|FG002|Overall Study|Lost to Follow-up|1|||
163910149|NCT00092456|592041718|FG003|Overall Study|Lost to Follow-up|2|||
163910150|NCT00092456|592041715|FG000|Overall Study|Protocol Violation|5|||
163910151|NCT00092456|592041716|FG001|Overall Study|Protocol Violation|7|||
163910152|NCT00092456|592041717|FG002|Overall Study|Protocol Violation|8|||
163910153|NCT00092456|592041718|FG003|Overall Study|Protocol Violation|6|||
164022482|NCT02796391|592445641|FG002|Overall Study|Withdrawal by Subject|4|||
164022483|NCT02796391|592445642|FG003|Overall Study|Withdrawal by Subject|3|||
164022484|NCT02796391|592445643|FG004|Overall Study|Withdrawal by Subject|4|||
164022485|NCT02796391|592445644|FG005|Overall Study|Withdrawal by Subject|3|||
164022486|NCT02796391|592445639|FG000|Overall Study|Adverse Event|0|||
164022487|NCT02796391|592445640|FG001|Overall Study|Adverse Event|0|||
164022488|NCT02796391|592445641|FG002|Overall Study|Adverse Event|0|||
164022489|NCT02796391|592445642|FG003|Overall Study|Adverse Event|1|||
164022490|NCT02796391|592445643|FG004|Overall Study|Adverse Event|0|||
164022491|NCT02796391|592445644|FG005|Overall Study|Adverse Event|0|||
164022492|NCT02796391|592445639|FG000|Overall Study|Protocol Violation|0|||
164022493|NCT02796391|592445640|FG001|Overall Study|Protocol Violation|0|||
164022494|NCT02796391|592445641|FG002|Overall Study|Protocol Violation|0|||
164022495|NCT02796391|592445642|FG003|Overall Study|Protocol Violation|1|||
164022496|NCT02796391|592445643|FG004|Overall Study|Protocol Violation|0|||
164022497|NCT02796391|592445644|FG005|Overall Study|Protocol Violation|0|||
164022498|NCT02695524|592445645|FG000|Overall Study|Lost to Follow-up|3|||
164022499|NCT02695524|592445646|FG001|Overall Study|Lost to Follow-up|2|||
164022500|NCT02695524|592445645|FG000|Overall Study|Death|0|||
164022501|NCT02695524|592445646|FG001|Overall Study|Death|1|||
164022502|NCT03446651|592445654|FG000|Overall Study|Lost to Follow-up|4|||
164022503|NCT03446651|592445655|FG001|Overall Study|Lost to Follow-up|0|||
164022504|NCT03446651|592445654|FG000|Overall Study|Open Label Participants|5|||
164144815|NCT01524978|592891774|FG000|Overall Study|Death|34|||
164095627|NCT00760266|592713959|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164095628|NCT00760266|592713960|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164095629|NCT00760266|592713959|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164095630|NCT00760266|592713960|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164095631|NCT00760266|592713959|FG000|Overall Study|Lack of Efficacy|2|||
164095632|NCT00760266|592713960|FG001|Overall Study|Lack of Efficacy|2|||
164095633|NCT00760266|592713959|FG000|Overall Study|Protocol deviation|2|||
164095634|NCT00760266|592713960|FG001|Overall Study|Protocol deviation|4|||
164095635|NCT00760266|592713959|FG000|Overall Study|Patient withdrew consent|3|||
164095636|NCT00760266|592713960|FG001|Overall Study|Patient withdrew consent|3|||
164095637|NCT00760266|592713959|FG000|Overall Study|Lost to Follow-up|2|||
164095638|NCT00760266|592713960|FG001|Overall Study|Lost to Follow-up|1|||
164095639|NCT00760266|592713959|FG000|Overall Study|Administrative Problems|0|||
164095640|NCT00760266|592713960|FG001|Overall Study|Administrative Problems|1|||
164095641|NCT01225146|592713961|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
164095642|NCT01225146|592713962|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
164095643|NCT01239121|592713963|FG000|Overall Study|Withdrawal by Subject|2|||
164095644|NCT01239121|592713964|FG001|Overall Study|Withdrawal by Subject|4|||
164095645|NCT01239121|592713965|FG002|Overall Study|Withdrawal by Subject|0|||
164095646|NCT00623779|592713966|FG000|Overall Study|Adverse Event|1|||
164095647|NCT00623779|592713967|FG001|Overall Study|Adverse Event|3|||
164095648|NCT00623779|592713968|FG002|Overall Study|Adverse Event|0|||
164095649|NCT00623779|592713966|FG000|Overall Study|Criteria from CSR|2|||
164095650|NCT00623779|592713967|FG001|Overall Study|Criteria from CSR|0|||
164095651|NCT00623779|592713968|FG002|Overall Study|Criteria from CSR|1|||
164095652|NCT00906347|592713974|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
164095653|NCT00906347|592713975|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
164095654|NCT00906347|592713974|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
164095655|NCT00906347|592713975|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
164095656|NCT00906347|592713974|FG000|Received Study Drug|Refused study drug|1|||
164095657|NCT00906347|592713975|FG001|Received Study Drug|Refused study drug|0|||
164095658|NCT00906347|592713974|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
164095659|NCT00906347|592713975|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
164095660|NCT00472290|592713978|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
164095661|NCT00472290|592713978|FG000|Overall Study|Protocol Specified Criteria|7|||
164095662|NCT00472290|592713978|FG000|Overall Study|Administrative Decision|37|||
164095663|NCT00472290|592713978|FG000|Overall Study|Death|3|||
164095664|NCT00472290|592713978|FG000|Overall Study|Lost to Follow-up|1|||
164095665|NCT00472290|592713978|FG000|Overall Study|Lack of Efficacy|1|||
164095666|NCT00472290|592713978|FG000|Overall Study|Disease Progression|4|||
164095667|NCT00472290|592713978|FG000|Overall Study|Withdrawal by Subject|5|||
164095668|NCT00472290|592713978|FG000|Overall Study|Adverse Event|6|||
164095669|NCT00472290|592713978|FG000|Overall Study|Requirement for alternative therapy|7|||
164095670|NCT00777829|592713979|FG000|Overall Study|Withdrawal by Subject|0|||
164095671|NCT00777829|592713980|FG001|Overall Study|Withdrawal by Subject|2|||
164095672|NCT00577460|592713986|FG000|Overall Study|Adverse Event|11|||
164095673|NCT00577460|592713987|FG001|Overall Study|Adverse Event|7|||
164095674|NCT00577460|592713988|FG002|Overall Study|Adverse Event|14|||
164095675|NCT00577460|592713986|FG000|Overall Study|Protocol Violation|0|||
164022505|NCT03446651|592445655|FG001|Overall Study|Open Label Participants|0|||
164022506|NCT00343291|592445656|FG000|Overall Study|Adverse Event|13|||
164022507|NCT00343291|592445657|FG001|Overall Study|Adverse Event|13|||
164022508|NCT00343291|592445656|FG000|Overall Study|Death|3|||
164022509|NCT00343291|592445657|FG001|Overall Study|Death|2|||
164022510|NCT00343291|592445656|FG000|Overall Study|Progressive disease|33|||
164022511|NCT00343291|592445657|FG001|Overall Study|Progressive disease|34|||
164022512|NCT00343291|592445656|FG000|Overall Study|Withdrawal by Subject|0|||
164022513|NCT00343291|592445657|FG001|Overall Study|Withdrawal by Subject|2|||
164022514|NCT00343291|592445656|FG000|Overall Study|Other|8|||
164022515|NCT00343291|592445657|FG001|Overall Study|Other|5|||
164022516|NCT04831515|592445658|FG000|First Intervention|Adverse Event|0|||
164022517|NCT04831515|592445659|FG001|First Intervention|Adverse Event|1|||
164022518|NCT03712345|592445660|FG000|Overall Study|Failure to meet randomization criteria|0|||
164022519|NCT03712345|592445661|FG001|Overall Study|Failure to meet randomization criteria|0|||
164022520|NCT03712345|592445662|FG002|Overall Study|Failure to meet randomization criteria|1|||
164022521|NCT00960934|592445665|FG000|Overall Study|Adverse Event|2|||
164022522|NCT00960934|592445666|FG001|Overall Study|Adverse Event|3|||
164022523|NCT00960934|592445667|FG002|Overall Study|Adverse Event|3|||
164022524|NCT00960934|592445668|FG003|Overall Study|Adverse Event|2|||
164022525|NCT00960934|592445669|FG004|Overall Study|Adverse Event|4|||
164022526|NCT00960934|592445670|FG005|Overall Study|Adverse Event|3|||
164022527|NCT00960934|592445665|FG000|Overall Study|Lack of Efficacy|1|||
164022528|NCT00960934|592445666|FG001|Overall Study|Lack of Efficacy|0|||
164022529|NCT00960934|592445667|FG002|Overall Study|Lack of Efficacy|0|||
164022530|NCT00960934|592445668|FG003|Overall Study|Lack of Efficacy|0|||
164022531|NCT00960934|592445669|FG004|Overall Study|Lack of Efficacy|0|||
164022532|NCT00960934|592445670|FG005|Overall Study|Lack of Efficacy|0|||
164022533|NCT00960934|592445665|FG000|Overall Study|Lost to Follow-up|0|||
164095676|NCT00577460|592713987|FG001|Overall Study|Protocol Violation|1|||
164022534|NCT00960934|592445666|FG001|Overall Study|Lost to Follow-up|1|||
164022535|NCT00960934|592445667|FG002|Overall Study|Lost to Follow-up|0|||
164022536|NCT00960934|592445668|FG003|Overall Study|Lost to Follow-up|0|||
164022537|NCT00960934|592445669|FG004|Overall Study|Lost to Follow-up|0|||
164022538|NCT00960934|592445670|FG005|Overall Study|Lost to Follow-up|0|||
164022539|NCT00960934|592445665|FG000|Overall Study|Other|2|||
164022540|NCT00960934|592445666|FG001|Overall Study|Other|1|||
163910154|NCT00092456|592041715|FG000|Overall Study|Withdrawal by Subject|13|||
164022541|NCT00960934|592445667|FG002|Overall Study|Other|5|||
164022542|NCT00960934|592445668|FG003|Overall Study|Other|4|||
164022543|NCT00960934|592445669|FG004|Overall Study|Other|2|||
164022544|NCT00960934|592445670|FG005|Overall Study|Other|2|||
164095677|NCT00577460|592713988|FG002|Overall Study|Protocol Violation|1|||
164095678|NCT00577460|592713986|FG000|Overall Study|Lost to Follow-up|0|||
164095679|NCT00577460|592713987|FG001|Overall Study|Lost to Follow-up|3|||
164095680|NCT00577460|592713988|FG002|Overall Study|Lost to Follow-up|4|||
164095681|NCT00577460|592713986|FG000|Overall Study|Withdrawal by Subject|5|||
164095682|NCT00577460|592713987|FG001|Overall Study|Withdrawal by Subject|5|||
164095683|NCT00577460|592713988|FG002|Overall Study|Withdrawal by Subject|6|||
164095684|NCT00577460|592713986|FG000|Overall Study|Other|0|||
164095685|NCT00577460|592713987|FG001|Overall Study|Other|3|||
164095686|NCT00577460|592713988|FG002|Overall Study|Other|2|||
164095687|NCT02016170|592713989|FG000|Overall Study|Adverse Event|1|||
164095688|NCT02016170|592713990|FG001|Overall Study|Adverse Event|1|||
164095689|NCT02016170|592713991|FG002|Overall Study|Adverse Event|0|||
164022545|NCT00960934|592445665|FG000|Overall Study|Physician Decision|0|||
164022546|NCT00960934|592445666|FG001|Overall Study|Physician Decision|1|||
164022547|NCT00960934|592445667|FG002|Overall Study|Physician Decision|0|||
164022548|NCT00960934|592445668|FG003|Overall Study|Physician Decision|0|||
164022549|NCT00960934|592445669|FG004|Overall Study|Physician Decision|0|||
164022550|NCT00960934|592445670|FG005|Overall Study|Physician Decision|0|||
164022551|NCT00960934|592445665|FG000|Overall Study|Progressive Disease|1|||
164022552|NCT00960934|592445666|FG001|Overall Study|Progressive Disease|1|||
164022553|NCT00960934|592445667|FG002|Overall Study|Progressive Disease|0|||
164022554|NCT00960934|592445668|FG003|Overall Study|Progressive Disease|0|||
164022555|NCT00960934|592445669|FG004|Overall Study|Progressive Disease|1|||
164022556|NCT00960934|592445670|FG005|Overall Study|Progressive Disease|1|||
164022557|NCT00960934|592445665|FG000|Overall Study|Protocol Violation|3|||
164022558|NCT00960934|592445666|FG001|Overall Study|Protocol Violation|4|||
164022559|NCT00960934|592445667|FG002|Overall Study|Protocol Violation|0|||
164022560|NCT00960934|592445668|FG003|Overall Study|Protocol Violation|3|||
164022561|NCT00960934|592445669|FG004|Overall Study|Protocol Violation|3|||
164022562|NCT00960934|592445670|FG005|Overall Study|Protocol Violation|2|||
164022563|NCT00960934|592445665|FG000|Overall Study|Withdrawal by Subject|5|||
164022564|NCT00960934|592445666|FG001|Overall Study|Withdrawal by Subject|6|||
164022565|NCT00960934|592445667|FG002|Overall Study|Withdrawal by Subject|4|||
164022566|NCT00960934|592445668|FG003|Overall Study|Withdrawal by Subject|5|||
164022567|NCT00960934|592445669|FG004|Overall Study|Withdrawal by Subject|5|||
164022568|NCT00960934|592445670|FG005|Overall Study|Withdrawal by Subject|7|||
164022569|NCT00960934|592445665|FG000|Overall Study|Study Terminated by Sponsor|50|||
164022570|NCT00960934|592445666|FG001|Overall Study|Study Terminated by Sponsor|46|||
164022571|NCT00960934|592445667|FG002|Overall Study|Study Terminated by Sponsor|52|||
164022572|NCT00960934|592445668|FG003|Overall Study|Study Terminated by Sponsor|50|||
164022573|NCT00960934|592445669|FG004|Overall Study|Study Terminated by Sponsor|49|||
164022574|NCT00960934|592445670|FG005|Overall Study|Study Terminated by Sponsor|49|||
164022575|NCT01332019|592445678|FG000|Overall Study|Was Not Dosed|1|||
164022576|NCT01332019|592445679|FG001|Overall Study|Was Not Dosed|0|||
164022577|NCT01332019|592445678|FG000|Overall Study|Other|16|||
164022578|NCT01332019|592445679|FG001|Overall Study|Other|18|||
164022579|NCT01332019|592445678|FG000|Overall Study|Death|2|||
164022580|NCT01332019|592445679|FG001|Overall Study|Death|1|||
164022581|NCT01332019|592445678|FG000|Overall Study|Physician Decision|4|||
164022582|NCT01332019|592445679|FG001|Overall Study|Physician Decision|3|||
164022583|NCT01332019|592445678|FG000|Overall Study|Withdrawal by Subject|73|||
164022584|NCT01332019|592445679|FG001|Overall Study|Withdrawal by Subject|71|||
164022585|NCT01332019|592445678|FG000|Overall Study|Lost to Follow-up|4|||
164022586|NCT01332019|592445679|FG001|Overall Study|Lost to Follow-up|7|||
164022587|NCT01332019|592445678|FG000|Overall Study|Adverse Event|13|||
164022588|NCT01332019|592445679|FG001|Overall Study|Adverse Event|22|||
164022589|NCT00174785|592445680|FG000|Overall Study|Adverse Event|293|||
164022590|NCT00174785|592445681|FG001|Overall Study|Adverse Event|191|||
164022591|NCT00174785|592445680|FG000|Overall Study|Protocol Violation|14|||
164022592|NCT00174785|592445681|FG001|Overall Study|Protocol Violation|14|||
164095690|NCT02016170|592713989|FG000|Overall Study|Protocol Violation|1|||
164095691|NCT02016170|592713990|FG001|Overall Study|Protocol Violation|0|||
164095692|NCT02016170|592713991|FG002|Overall Study|Protocol Violation|0|||
164022593|NCT00174785|592445680|FG000|Overall Study|Withdrawal by Subject|173|||
164022594|NCT00174785|592445681|FG001|Overall Study|Withdrawal by Subject|175|||
164095693|NCT02365207|592713992|FG000|Overall Study|Withdrawal by Subject|1|||
164095694|NCT02365207|592713992|FG000|Overall Study|Physician Decision|1|||
163910155|NCT00092456|592041716|FG001|Overall Study|Withdrawal by Subject|5|||
163910156|NCT00092456|592041717|FG002|Overall Study|Withdrawal by Subject|16|||
163910157|NCT00092456|592041718|FG003|Overall Study|Withdrawal by Subject|6|||
164095695|NCT05214560|592713995|FG000|Overall Study|Screening Failure|1|||
164022595|NCT00174785|592445680|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
164022596|NCT00174785|592445681|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
164022597|NCT00174785|592445680|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
164022598|NCT00174785|592445681|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
164022599|NCT00174785|592445680|FG000|Overall Study|Other prohibited medication|5|||
164022600|NCT00174785|592445681|FG001|Overall Study|Other prohibited medication|3|||
164022601|NCT00174785|592445680|FG000|Overall Study|Family request|6|||
164022602|NCT00174785|592445681|FG001|Overall Study|Family request|8|||
164022603|NCT00174785|592445680|FG000|Overall Study|Not pre-specified/Not coded|56|||
164022604|NCT00174785|592445681|FG001|Overall Study|Not pre-specified/Not coded|70|||
164022605|NCT00120289|592445682|FG000|Overall Study|Death|96|||
164022606|NCT00120289|592445683|FG001|Overall Study|Death|82|||
164022607|NCT00120289|592445682|FG000|Overall Study|Lost to Follow-up|11|||
164022608|NCT00120289|592445683|FG001|Overall Study|Lost to Follow-up|14|||
164022609|NCT00120289|592445682|FG000|Overall Study|Withdrawal by Subject|14|||
164022610|NCT00120289|592445683|FG001|Overall Study|Withdrawal by Subject|13|||
164022611|NCT00782418|592445687|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
164022612|NCT00782418|592445688|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164022613|NCT00782418|592445689|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164022614|NCT00782418|592445690|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164022615|NCT00782418|592445691|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164022616|NCT00782418|592445692|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164022617|NCT00782418|592445693|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
164022618|NCT00782418|592445687|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
164022619|NCT00782418|592445688|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164095696|NCT05214560|592713995|FG000|Overall Study|Physician Decision|4|||
164022620|NCT00782418|592445689|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164022621|NCT00782418|592445690|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164022622|NCT00782418|592445691|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
164022623|NCT00782418|592445692|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
164022624|NCT00782418|592445693|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
164022625|NCT01718509|592445694|FG000|Overall Study|Lost to Follow-up|18|||
164022626|NCT01718509|592445695|FG001|Overall Study|Lost to Follow-up|15|||
164022627|NCT01718509|592445694|FG000|Overall Study|Withdrawal by Subject|7|||
164022628|NCT01718509|592445695|FG001|Overall Study|Withdrawal by Subject|13|||
164022629|NCT01718509|592445694|FG000|Overall Study|Adverse Event|5|||
164022630|NCT01718509|592445695|FG001|Overall Study|Adverse Event|7|||
164022631|NCT01718509|592445694|FG000|Overall Study|Other|13|||
164022632|NCT01718509|592445695|FG001|Overall Study|Other|11|||
164022633|NCT01718509|592445694|FG000|Overall Study|Protocol Violation|4|||
164022634|NCT01718509|592445695|FG001|Overall Study|Protocol Violation|2|||
164022635|NCT01718509|592445694|FG000|Overall Study|Lack of Efficacy|1|||
164022636|NCT01718509|592445695|FG001|Overall Study|Lack of Efficacy|0|||
164022637|NCT00238303|592445696|FG000|Overall Study|Withdrawal by Subject|11|||
164022638|NCT00238303|592445697|FG001|Overall Study|Withdrawal by Subject|1|||
164022639|NCT00238303|592445698|FG002|Overall Study|Withdrawal by Subject|2|||
164022640|NCT00238303|592445696|FG000|Overall Study|Death|1|||
164022641|NCT00238303|592445697|FG001|Overall Study|Death|0|||
164022642|NCT00238303|592445698|FG002|Overall Study|Death|1|||
164022643|NCT00238303|592445696|FG000|Overall Study|Other Medical Problems|2|||
164022644|NCT00238303|592445697|FG001|Overall Study|Other Medical Problems|0|||
164022645|NCT00238303|592445698|FG002|Overall Study|Other Medical Problems|2|||
164022646|NCT00238303|592445696|FG000|Overall Study|Poor tolerance of study treatment|1|||
164022647|NCT00238303|592445697|FG001|Overall Study|Poor tolerance of study treatment|0|||
164022648|NCT00238303|592445698|FG002|Overall Study|Poor tolerance of study treatment|1|||
164022649|NCT00238303|592445696|FG000|Overall Study|Adverse Event|0|||
164022650|NCT00238303|592445697|FG001|Overall Study|Adverse Event|1|||
164022651|NCT00238303|592445698|FG002|Overall Study|Adverse Event|3|||
164022652|NCT01248130|592445700|FG000|Overall Study|Protocol Violation|1|||
164022653|NCT01248130|592445701|FG001|Overall Study|Protocol Violation|0|||
164022654|NCT01248130|592445700|FG000|Overall Study|Ineligible|1|||
164022655|NCT01248130|592445701|FG001|Overall Study|Ineligible|0|||
164022656|NCT02052778|592445702|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
164022657|NCT02052778|592445703|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
164022658|NCT02052778|592445704|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
164022659|NCT02052778|592445705|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
164022660|NCT02052778|592445706|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
164022661|NCT02052778|592445707|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
164022662|NCT02052778|592445708|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022663|NCT02052778|592445709|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
164022664|NCT02052778|592445710|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
164022665|NCT02052778|592445711|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
164022666|NCT02052778|592445712|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
164022667|NCT02052778|592445713|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
164095697|NCT05214560|592713995|FG000|Overall Study|Withdrawal by Subject|1|||
164095698|NCT05214560|592713995|FG000|Overall Study|Lost to Follow-up|2|||
164022668|NCT02052778|592445714|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
164022669|NCT02052778|592445715|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
164022670|NCT02052778|592445716|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022671|NCT02052778|592445717|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022672|NCT02052778|592445718|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022673|NCT02052778|592445719|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022674|NCT02052778|592445720|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022675|NCT02052778|592445721|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022676|NCT02052778|592445722|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022677|NCT02052778|592445723|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022678|NCT02052778|592445724|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
164022679|NCT02052778|592445702|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164022680|NCT02052778|592445703|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164022681|NCT02052778|592445704|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164022682|NCT02052778|592445705|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164022683|NCT02052778|592445706|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164022684|NCT02052778|592445707|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164022685|NCT02052778|592445708|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
164022686|NCT02052778|592445709|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164022687|NCT02052778|592445710|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
164022688|NCT02052778|592445711|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022689|NCT02052778|592445712|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022690|NCT02052778|592445713|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164022691|NCT02052778|592445714|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
164022692|NCT02052778|592445715|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
164022693|NCT02052778|592445716|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022694|NCT02052778|592445717|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022695|NCT02052778|592445718|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022696|NCT02052778|592445719|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022697|NCT02052778|592445720|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022698|NCT02052778|592445721|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022699|NCT02052778|592445722|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022700|NCT02052778|592445723|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022701|NCT02052778|592445724|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
164022702|NCT02052778|592445702|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022703|NCT02052778|592445703|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022704|NCT02052778|592445704|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022705|NCT02052778|592445705|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022706|NCT02052778|592445706|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022707|NCT02052778|592445707|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022708|NCT02052778|592445708|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022709|NCT02052778|592445709|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022710|NCT02052778|592445710|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022711|NCT02052778|592445711|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022712|NCT02052778|592445712|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022713|NCT02052778|592445713|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022714|NCT02052778|592445714|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022715|NCT02052778|592445715|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
164022716|NCT02052778|592445716|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022717|NCT02052778|592445717|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022718|NCT02052778|592445718|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022719|NCT02052778|592445719|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022720|NCT02052778|592445720|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022721|NCT02052778|592445721|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022722|NCT02052778|592445722|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
163910158|NCT00092456|592041715|FG000|Overall Study|Moved|1|||
163910159|NCT00092456|592041716|FG001|Overall Study|Moved|1|||
163910160|NCT00092456|592041717|FG002|Overall Study|Moved|0|||
163910161|NCT00092456|592041718|FG003|Overall Study|Moved|1|||
164095699|NCT05214560|592713995|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
163910162|NCT00092456|592041715|FG000|Overall Study|Other|4|||
163910163|NCT00092456|592041716|FG001|Overall Study|Other|2|||
164022723|NCT02052778|592445723|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022724|NCT02052778|592445724|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
164022725|NCT02052778|592445702|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
164022726|NCT02052778|592445703|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
164022727|NCT02052778|592445704|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
164022728|NCT02052778|592445705|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
164022729|NCT02052778|592445706|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
164022730|NCT02052778|592445707|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
164022731|NCT02052778|592445708|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
164022732|NCT02052778|592445709|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
164022733|NCT02052778|592445710|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
164022734|NCT02052778|592445711|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
164022735|NCT02052778|592445712|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
164022736|NCT02052778|592445713|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
164022737|NCT02052778|592445714|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
164022738|NCT02052778|592445715|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
164022739|NCT02052778|592445716|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
164022740|NCT02052778|592445717|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
164022741|NCT02052778|592445718|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
164022742|NCT02052778|592445719|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
164022743|NCT02052778|592445720|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
164022744|NCT02052778|592445721|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
164022745|NCT02052778|592445722|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
164022746|NCT02052778|592445723|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
164022747|NCT02052778|592445724|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
164022748|NCT02052778|592445702|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022749|NCT02052778|592445703|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022750|NCT02052778|592445704|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022751|NCT02052778|592445705|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022752|NCT02052778|592445706|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022753|NCT02052778|592445707|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022754|NCT02052778|592445708|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022755|NCT02052778|592445709|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022756|NCT02052778|592445710|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
164022757|NCT02052778|592445711|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022758|NCT02052778|592445712|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164095700|NCT05214560|592713995|FG000|Overall Study|Study physician not available for the anesthesia|3|||
164095701|NCT05214560|592713995|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
164144816|NCT01524978|592891775|FG001|Overall Study|Death|2|||
164022759|NCT02052778|592445713|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022760|NCT02052778|592445714|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022761|NCT02052778|592445715|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
164022762|NCT02052778|592445716|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022763|NCT02052778|592445717|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022764|NCT02052778|592445718|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022765|NCT02052778|592445719|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022766|NCT02052778|592445720|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022767|NCT02052778|592445721|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022768|NCT02052778|592445722|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022769|NCT02052778|592445723|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022770|NCT02052778|592445724|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
164022771|NCT02052778|592445702|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022772|NCT02052778|592445703|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022773|NCT02052778|592445704|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022774|NCT02052778|592445705|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022775|NCT02052778|592445706|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022776|NCT02052778|592445707|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
164022777|NCT02052778|592445708|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022778|NCT02052778|592445709|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022779|NCT02052778|592445710|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022780|NCT02052778|592445711|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022781|NCT02052778|592445712|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022782|NCT02052778|592445713|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022783|NCT02052778|592445714|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
164022784|NCT02052778|592445715|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022785|NCT02052778|592445716|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022786|NCT02052778|592445717|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022787|NCT02052778|592445718|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022788|NCT02052778|592445719|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022789|NCT02052778|592445720|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022790|NCT02052778|592445721|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022791|NCT02052778|592445722|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022792|NCT02052778|592445723|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022793|NCT02052778|592445724|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
164022794|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022795|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022796|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022797|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022798|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022799|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022800|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022801|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022802|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022803|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022804|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022805|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022806|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022807|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022808|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
164022809|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
164022810|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
164022811|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
164022812|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
164022813|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
164022814|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
164144817|NCT01524978|592891776|FG002|Overall Study|Death|5|||
164022815|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
164022816|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
164022817|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022818|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022819|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022820|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022821|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022822|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022823|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022824|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022825|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022826|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022827|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022828|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022829|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022830|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022831|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
164022832|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
164022833|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022834|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
164022835|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
164022836|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
164022837|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
164022838|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
164022839|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
164022840|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022841|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022842|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022843|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022844|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022845|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022846|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022847|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022848|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022849|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022850|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022851|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022852|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022853|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022854|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
164022855|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
164022856|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
164022857|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022858|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
164022859|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
164022860|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022861|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022862|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
164022863|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022864|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022865|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022866|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022867|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022868|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022869|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022870|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022871|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164144818|NCT01524978|592891777|FG003|Overall Study|Death|24|||
163910164|NCT00092456|592041717|FG002|Overall Study|Other|3|||
163910165|NCT00092456|592041718|FG003|Overall Study|Other|0|||
163910166|NCT00215943|592041719|FG000|Overall Study|Disease Progression|3|||
163910167|NCT00215943|592041720|FG001|Overall Study|Disease Progression|5|||
163910168|NCT00215943|592041719|FG000|Overall Study|Alternate therapy|0|||
163910169|NCT00215943|592041720|FG001|Overall Study|Alternate therapy|1|||
163910170|NCT00215943|592041719|FG000|Overall Study|Adverse Event|3|||
163910171|NCT00215943|592041720|FG001|Overall Study|Adverse Event|6|||
163910172|NCT00215943|592041719|FG000|Overall Study|Other disease|0|||
163910173|NCT00215943|592041720|FG001|Overall Study|Other disease|1|||
163910174|NCT00215943|592041719|FG000|Overall Study|Other complications|3|||
163910175|NCT00215943|592041720|FG001|Overall Study|Other complications|1|||
164022872|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022873|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022874|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022875|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022876|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022877|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
164022878|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
164022879|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022880|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022881|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022882|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022883|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022884|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022885|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
164022886|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022887|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022888|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022889|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022890|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022891|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022892|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022893|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022894|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022895|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022896|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022897|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022898|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022899|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022900|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
164022901|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
164022902|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022903|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022904|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164144819|NCT01524978|592891778|FG004|Overall Study|Death|4|||
164022905|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
164022906|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022907|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022908|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
164022909|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
164022910|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
164022911|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
164022912|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
164022913|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
164022914|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
164022915|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
164022916|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
164022917|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
164022918|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
164022919|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
164022920|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
164022921|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
164022922|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
164022923|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
164022924|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
164022925|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
164022926|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
164022927|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
164022928|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
164022929|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
164022930|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
164022931|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
164022932|NCT02052778|592445702|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022933|NCT02052778|592445703|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022934|NCT02052778|592445704|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022935|NCT02052778|592445705|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022936|NCT02052778|592445706|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022937|NCT02052778|592445707|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
163910176|NCT00443820|592041721|FG000|Overall Study|Adverse Event|1|||
163910177|NCT00443820|592041722|FG001|Overall Study|Adverse Event|1|||
163910178|NCT00443820|592041723|FG002|Overall Study|Adverse Event|0|||
164022938|NCT02052778|592445708|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022939|NCT02052778|592445709|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022940|NCT02052778|592445710|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022941|NCT02052778|592445711|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022942|NCT02052778|592445712|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022943|NCT02052778|592445713|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022944|NCT02052778|592445714|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022945|NCT02052778|592445715|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022946|NCT02052778|592445716|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164022947|NCT02052778|592445717|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164022948|NCT02052778|592445718|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164022949|NCT02052778|592445719|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022950|NCT02052778|592445720|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
164022951|NCT02052778|592445721|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022952|NCT02052778|592445722|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022953|NCT02052778|592445723|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022954|NCT02052778|592445724|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
164022955|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022956|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022957|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022958|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022959|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022960|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022961|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022962|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022963|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022964|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022965|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022966|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022967|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022968|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022969|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022970|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022971|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022972|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022973|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022974|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022975|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022976|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
164022977|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
164022978|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022979|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022980|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022981|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022982|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022983|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022984|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022985|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022986|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022987|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022988|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022989|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022990|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022991|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022992|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022993|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022994|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022995|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022996|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022997|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022998|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164022999|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
164023000|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
164023001|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023002|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023003|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023004|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164095702|NCT05214560|592713995|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
164144820|NCT01524978|592891779|FG005|Overall Study|Death|4|||
164023005|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023006|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023007|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023008|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023009|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023010|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023011|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023012|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023013|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023014|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023015|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023016|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023017|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023018|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023019|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023020|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023021|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023022|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
164023023|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
164023024|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023025|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023026|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023027|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023028|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023029|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023030|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023031|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023032|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023033|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023034|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023035|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023036|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023037|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023038|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023039|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023040|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023041|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023042|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023043|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023044|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023045|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
164023046|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
164023047|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023048|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023049|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023050|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023051|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023052|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023053|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023054|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023055|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023056|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023057|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023058|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023059|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023060|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023061|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023062|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023063|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023064|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023065|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023066|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023067|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023068|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
164023069|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
164023070|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
164023071|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
164023072|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
164023073|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
164023074|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
164023075|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
164023076|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
164023077|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
164023078|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
164023079|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
164023080|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
164023081|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
164023082|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
164023083|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
164023084|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
164023085|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
164023086|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
164023087|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
164023088|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
164023089|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
164023090|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
164023091|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
164023092|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
164023093|NCT02052778|592445702|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023094|NCT02052778|592445703|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
164144821|NCT01524978|592891780|FG006|Overall Study|Death|1|||
164023095|NCT02052778|592445704|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023096|NCT02052778|592445705|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023097|NCT02052778|592445706|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023098|NCT02052778|592445707|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023099|NCT02052778|592445708|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023100|NCT02052778|592445709|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023101|NCT02052778|592445710|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023102|NCT02052778|592445711|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023103|NCT02052778|592445712|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023104|NCT02052778|592445713|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023105|NCT02052778|592445714|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023106|NCT02052778|592445715|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023107|NCT02052778|592445716|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023108|NCT02052778|592445717|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023109|NCT02052778|592445718|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023110|NCT02052778|592445719|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023111|NCT02052778|592445720|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023112|NCT02052778|592445721|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023113|NCT02052778|592445722|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023114|NCT02052778|592445723|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
164023115|NCT02052778|592445724|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
164023116|NCT01994226|592445731|FG000|Overall Study|Protocol Violation|13|||
164023117|NCT01994226|592445732|FG001|Overall Study|Protocol Violation|10|||
164023118|NCT01994226|592445731|FG000|Overall Study|Early Cessation of treatment|6|||
164023119|NCT01994226|592445732|FG001|Overall Study|Early Cessation of treatment|11|||
164023120|NCT02488551|592445733|FG000|Overall Study|Lost to Follow-up|4|||
164023121|NCT02488551|592445734|FG001|Overall Study|Lost to Follow-up|7|||
164023122|NCT02488551|592445735|FG002|Overall Study|Lost to Follow-up|0|||
164023123|NCT02488551|592445736|FG003|Overall Study|Lost to Follow-up|0|||
164023124|NCT02488551|592445733|FG000|Overall Study|Military Deployment|1|||
164023125|NCT02488551|592445734|FG001|Overall Study|Military Deployment|1|||
164023126|NCT02488551|592445735|FG002|Overall Study|Military Deployment|0|||
164023127|NCT02488551|592445736|FG003|Overall Study|Military Deployment|0|||
164023128|NCT01860534|592445737|FG000|ROP #1|Needed treatment for ROP|0|||
164023129|NCT01860534|592445738|FG001|ROP #1|Needed treatment for ROP|1|||
164023130|NCT01860534|592445737|FG000|ROP #2|discharged prior to ROP #2|1|||
164023131|NCT01860534|592445738|FG001|ROP #2|discharged prior to ROP #2|0|||
164023132|NCT03364673|592445744|FG000|Overall Study|Withdrawal by Subject|2|||
164023133|NCT03364673|592445744|FG000|Overall Study|Injury unrelated to study|3|||
164023134|NCT00779324|592445745|FG000|Overall Study|Lost to Follow-up|2|||
164023135|NCT00779324|592445746|FG001|Overall Study|Lost to Follow-up|1|||
164023136|NCT00779324|592445745|FG000|Overall Study|Withdrawal by Subject|4|||
164023137|NCT00779324|592445746|FG001|Overall Study|Withdrawal by Subject|2|||
164023138|NCT00779324|592445745|FG000|Overall Study|Missed visit|1|||
164023139|NCT00779324|592445746|FG001|Overall Study|Missed visit|1|||
164023140|NCT02207556|592445747|FG000|Overall Study|Physician Decision|1|||
164023141|NCT02207556|592445748|FG001|Overall Study|Physician Decision|0|||
164023142|NCT02207556|592445747|FG000|Overall Study|Withdrawal by Subject|1|||
164023143|NCT02207556|592445748|FG001|Overall Study|Withdrawal by Subject|0|||
164023144|NCT02207556|592445747|FG000|Overall Study|Death|0|||
164023145|NCT02207556|592445748|FG001|Overall Study|Death|5|||
164023146|NCT03558555|592445749|FG000|Overall Study|Lost to Follow-up|2|||
164023147|NCT03558555|592445750|FG001|Overall Study|Lost to Follow-up|1|||
164023148|NCT00194025|592445751|FG000|Overall Study|Adverse Event|1|||
164023149|NCT00194025|592445751|FG000|Overall Study|non-adherence with study medication|4|||
164023150|NCT01199055|592445760|FG000|Overall Study|Death|0|||
164023151|NCT01199055|592445761|FG001|Overall Study|Death|1|||
164023152|NCT01199055|592445762|FG002|Overall Study|Death|0|||
164023153|NCT01199055|592445760|FG000|Overall Study|Physician Decision|0|||
164023154|NCT01199055|592445761|FG001|Overall Study|Physician Decision|1|||
164023155|NCT01199055|592445762|FG002|Overall Study|Physician Decision|1|||
164023156|NCT01199055|592445760|FG000|Overall Study|Progressive disease|2|||
164023157|NCT01199055|592445761|FG001|Overall Study|Progressive disease|1|||
164023158|NCT01199055|592445762|FG002|Overall Study|Progressive disease|2|||
164023159|NCT01199055|592445760|FG000|Overall Study|Withdrawal by Subject|0|||
164023160|NCT01199055|592445761|FG001|Overall Study|Withdrawal by Subject|0|||
164023161|NCT01199055|592445762|FG002|Overall Study|Withdrawal by Subject|1|||
164023162|NCT00511342|592445763|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
164023163|NCT00511342|592445764|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
164023164|NCT00511342|592445763|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
164023165|NCT00511342|592445764|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
164023166|NCT00511342|592445763|FG000|Overall Study|Pregnancy|0|||
164023167|NCT00511342|592445764|FG001|Overall Study|Pregnancy|1|||
164023168|NCT00511342|592445763|FG000|Overall Study|Pregnancy wish|0|||
164023169|NCT00511342|592445764|FG001|Overall Study|Pregnancy wish|1|||
164023170|NCT00511342|592445763|FG000|Overall Study|Lost to Follow-up|1|||
164023171|NCT00511342|592445764|FG001|Overall Study|Lost to Follow-up|5|||
164023172|NCT00511342|592445763|FG000|Overall Study|Other Reason|2|||
164023173|NCT00511342|592445764|FG001|Overall Study|Other Reason|2|||
164023174|NCT02432040|592445765|FG000|Overall Study|Lack of Efficacy|3|||
164023175|NCT02432040|592445766|FG001|Overall Study|Lack of Efficacy|0|||
164023176|NCT02432040|592445765|FG000|Overall Study|Lost to Follow-up|4|||
164023177|NCT02432040|592445766|FG001|Overall Study|Lost to Follow-up|5|||
164023178|NCT02432040|592445765|FG000|Overall Study|Physician Decision|1|||
164023179|NCT02432040|592445766|FG001|Overall Study|Physician Decision|1|||
164023180|NCT00369668|592445767|FG000|Overall Study|Lack of Efficacy|4|||
164023181|NCT00369668|592445768|FG001|Overall Study|Lack of Efficacy|5|||
164023182|NCT00369668|592445769|FG002|Overall Study|Lack of Efficacy|7|||
164023183|NCT00303108|592445772|FG000|Overall Study|Adverse Event|5|||
164023184|NCT00303108|592445773|FG001|Overall Study|Adverse Event|6|||
164023185|NCT00303108|592445774|FG002|Overall Study|Adverse Event|7|||
164023186|NCT00303108|592445772|FG000|Overall Study|Patient Request|4|||
164023187|NCT00303108|592445773|FG001|Overall Study|Patient Request|2|||
164023188|NCT00303108|592445774|FG002|Overall Study|Patient Request|8|||
164023189|NCT00303108|592445772|FG000|Overall Study|Failed Entry|1|||
164023190|NCT00303108|592445773|FG001|Overall Study|Failed Entry|0|||
164023191|NCT00303108|592445774|FG002|Overall Study|Failed Entry|1|||
164023192|NCT00303108|592445772|FG000|Overall Study|ineligible|2|||
164023193|NCT00303108|592445773|FG001|Overall Study|ineligible|1|||
164023194|NCT00303108|592445774|FG002|Overall Study|ineligible|0|||
164023195|NCT03855137|592445775|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
164023196|NCT03855137|592445776|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
164023197|NCT03855137|592445777|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
164023198|NCT03855137|592445775|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
164023199|NCT03855137|592445776|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
164023200|NCT03855137|592445777|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
164023201|NCT03855137|592445775|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
164023202|NCT03855137|592445776|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
164144822|NCT01524978|592891781|FG007|Overall Study|Death|9|||
164023203|NCT03855137|592445777|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
164023204|NCT03855137|592445775|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
164023205|NCT03855137|592445776|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
164023206|NCT03855137|592445777|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
164023207|NCT03855137|592445775|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
164023208|NCT03855137|592445776|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
164023209|NCT03855137|592445777|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
164023210|NCT03855137|592445775|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
164023211|NCT03855137|592445776|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
164023212|NCT03855137|592445777|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
164023213|NCT03855137|592445775|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
164023214|NCT03855137|592445776|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
164023215|NCT03855137|592445777|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
164023216|NCT03855137|592445775|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
164023217|NCT03855137|592445776|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
164023218|NCT03855137|592445777|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
164023219|NCT03855137|592445775|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
164023220|NCT03855137|592445776|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
164023221|NCT03855137|592445777|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
164023222|NCT03855137|592445775|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
164023223|NCT03855137|592445776|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
164023224|NCT03855137|592445777|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
164023225|NCT02427477|592445778|FG000|Period 1|Adverse Event|1|||
164023226|NCT02427477|592445779|FG001|Period 1|Adverse Event|0|||
164023227|NCT02435277|592445780|FG000|Overall Study|Adverse Event|1|||
164023228|NCT02435277|592445781|FG001|Overall Study|Adverse Event|1|||
164023229|NCT02435277|592445782|FG002|Overall Study|Adverse Event|0|||
164023230|NCT02435277|592445783|FG003|Overall Study|Adverse Event|0|||
164023231|NCT02435277|592445780|FG000|Overall Study|Withdrawal by Subject|1|||
164023232|NCT02435277|592445781|FG001|Overall Study|Withdrawal by Subject|0|||
164023233|NCT02435277|592445782|FG002|Overall Study|Withdrawal by Subject|0|||
164023234|NCT02435277|592445783|FG003|Overall Study|Withdrawal by Subject|0|||
164023235|NCT00444626|592445784|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
164023236|NCT00444626|592445784|FG000|Initial Treatment Period|Adverse Event|1|||
164023237|NCT00444626|592445784|FG000|Initial Treatment Period|Lost to Follow-up|9|||
164023238|NCT00008138|592445787|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
164023239|NCT00008138|592445787|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
164023240|NCT00008138|592445787|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
164023241|NCT00008138|592445787|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
164023242|NCT00008138|592445787|FG000|Interval Debulking|Withdrawal by Subject|2|||
164023243|NCT00008138|592445787|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
164023244|NCT00008138|592445787|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
164023245|NCT00008138|592445787|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
164023246|NCT03213626|592445788|FG000|Overall Study|Adverse Event|1|||
164023247|NCT03213626|592445788|FG000|Overall Study|Progressive Disease|6|||
164023248|NCT01005732|592445789|FG000|Overall Study|Lost to Follow-up|10|||
164023249|NCT01005732|592445789|FG000|Overall Study|Death|1|||
164023250|NCT02198651|592447644|FG000|Lead-in Period|Withdrew consent|13|||
164023251|NCT02198651|592447645|FG001|Lead-in Period|Withdrew consent|0|||
164023252|NCT02198651|592447646|FG002|Lead-in Period|Withdrew consent|0|||
164023253|NCT02198651|592447647|FG003|Lead-in Period|Withdrew consent|0|||
164023254|NCT02198651|592447648|FG004|Lead-in Period|Withdrew consent|0|||
164023255|NCT02198651|592447644|FG000|Lead-in Period|Adverse Event|2|||
164023256|NCT02198651|592447645|FG001|Lead-in Period|Adverse Event|0|||
164023257|NCT02198651|592447646|FG002|Lead-in Period|Adverse Event|0|||
164023258|NCT02198651|592447647|FG003|Lead-in Period|Adverse Event|0|||
164023259|NCT02198651|592447648|FG004|Lead-in Period|Adverse Event|0|||
164023260|NCT02198651|592447644|FG000|Lead-in Period|Other, not specified|22|||
164023261|NCT02198651|592447645|FG001|Lead-in Period|Other, not specified|0|||
164023262|NCT02198651|592447646|FG002|Lead-in Period|Other, not specified|0|||
164023263|NCT02198651|592447647|FG003|Lead-in Period|Other, not specified|0|||
164023264|NCT02198651|592447648|FG004|Lead-in Period|Other, not specified|0|||
164023265|NCT02198651|592447644|FG000|Double-blind Period|Withdrew consent|0|||
164023266|NCT02198651|592447645|FG001|Double-blind Period|Withdrew consent|4|||
164023267|NCT02198651|592447646|FG002|Double-blind Period|Withdrew consent|0|||
164144823|NCT01524978|592891782|FG008|Overall Study|Death|5|||
164023268|NCT02198651|592447647|FG003|Double-blind Period|Withdrew consent|0|||
164023269|NCT02198651|592447648|FG004|Double-blind Period|Withdrew consent|0|||
164023270|NCT02198651|592447644|FG000|Double-blind Period|Adverse Event|0|||
164023271|NCT02198651|592447645|FG001|Double-blind Period|Adverse Event|1|||
164023272|NCT02198651|592447646|FG002|Double-blind Period|Adverse Event|0|||
164023273|NCT02198651|592447647|FG003|Double-blind Period|Adverse Event|0|||
164023274|NCT02198651|592447648|FG004|Double-blind Period|Adverse Event|0|||
164023275|NCT02198651|592447644|FG000|Double-blind Period|Other, not specified|0|||
164023276|NCT02198651|592447645|FG001|Double-blind Period|Other, not specified|4|||
164023277|NCT02198651|592447646|FG002|Double-blind Period|Other, not specified|1|||
164023278|NCT02198651|592447647|FG003|Double-blind Period|Other, not specified|0|||
164023279|NCT02198651|592447648|FG004|Double-blind Period|Other, not specified|0|||
164023280|NCT02198651|592447644|FG000|Open-label Rescue Period|Withdrew consent|0|||
164023281|NCT02198651|592447645|FG001|Open-label Rescue Period|Withdrew consent|0|||
164023282|NCT02198651|592447646|FG002|Open-label Rescue Period|Withdrew consent|0|||
164023283|NCT02198651|592447647|FG003|Open-label Rescue Period|Withdrew consent|2|||
164023284|NCT02198651|592447648|FG004|Open-label Rescue Period|Withdrew consent|0|||
164023285|NCT02198651|592447644|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164023286|NCT02198651|592447645|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164023287|NCT02198651|592447646|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164023288|NCT02198651|592447647|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
164023289|NCT02198651|592447648|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
164023290|NCT00786032|592447653|FG000|Overall Study|Death|4|||
164144824|NCT01524978|592891783|FG009|Overall Study|Death|6|||
164023291|NCT00786032|592447653|FG000|Overall Study|Withdrawal by Subject|14|||
164023292|NCT00786032|592447653|FG000|Overall Study|Did not complete in the timeframe|6|||
164023293|NCT02922634|592447654|FG000|Overall Study|Withdrawal by Subject|5|||
164023294|NCT02922634|592447654|FG000|Overall Study|Did not have their surgery|5|||
164023295|NCT02625324|592447655|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
164023296|NCT02625324|592447655|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
164023297|NCT02625324|592447655|FG000|6-Month Follow-up Subject Accountability|Death|5|||
164023298|NCT02625324|592447655|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
164023299|NCT02625324|592447655|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
164023300|NCT02625324|592447655|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
164144825|NCT01524978|592891784|FG010|Overall Study|Death|17|||
164023301|NCT02625324|592447655|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
164023302|NCT02625324|592447655|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
164095703|NCT05214560|592713995|FG000|Overall Study|Surgery not performed|3|||
164095704|NCT04977336|592713996|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
164095705|NCT04977336|592713997|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164095706|NCT04977336|592713998|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
164095707|NCT04977336|592713999|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
164095708|NCT04977336|592714000|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
164095709|NCT04977336|592713996|FG000|Overall Study|Lost to Follow-up|0|||
164095710|NCT04977336|592713997|FG001|Overall Study|Lost to Follow-up|0|||
164095711|NCT04977336|592713998|FG002|Overall Study|Lost to Follow-up|1|||
164095712|NCT04977336|592713999|FG003|Overall Study|Lost to Follow-up|0|||
164095713|NCT04977336|592714000|FG004|Overall Study|Lost to Follow-up|0|||
164095714|NCT00878995|592714004|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
164095715|NCT00878995|592714005|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
164095716|NCT00352690|592714008|FG000|Overall Study|Determined to be ineligible|2|||
164095717|NCT00352690|592714009|FG001|Overall Study|Determined to be ineligible|0|||
164095718|NCT03633721|592714012|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
164095719|NCT03633721|592714013|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
164095720|NCT03633721|592714014|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
164095721|NCT03633721|592714015|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
164095722|NCT01475474|592714019|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
164095723|NCT01475474|592714019|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
164095724|NCT02343120|592714020|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
164095725|NCT02343120|592714021|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
164095726|NCT02343120|592714022|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
164095727|NCT02343120|592714023|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
164095728|NCT02343120|592714024|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
164095729|NCT02343120|592714020|FG000|Part 1: Dose Escalation|Death|1|||
164095730|NCT02343120|592714021|FG001|Part 1: Dose Escalation|Death|2|||
164095731|NCT02343120|592714022|FG002|Part 1: Dose Escalation|Death|2|||
164095732|NCT02343120|592714023|FG003|Part 1: Dose Escalation|Death|2|||
164095733|NCT02343120|592714024|FG004|Part 1: Dose Escalation|Death|1|||
164095734|NCT02343120|592714020|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
164095735|NCT02343120|592714021|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
164095736|NCT02343120|592714022|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
164095737|NCT02343120|592714023|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
164095738|NCT02343120|592714024|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
164095739|NCT02343120|592714020|FG000|Part 2: Expansion|Sponsor decision|0|||
164095740|NCT02343120|592714021|FG001|Part 2: Expansion|Sponsor decision|0|||
164095741|NCT02343120|592714022|FG002|Part 2: Expansion|Sponsor decision|0|||
164095742|NCT02343120|592714023|FG003|Part 2: Expansion|Sponsor decision|165|||
164095743|NCT02343120|592714024|FG004|Part 2: Expansion|Sponsor decision|67|||
164095744|NCT02343120|592714020|FG000|Part 2: Expansion|Death|0|||
164095745|NCT02343120|592714021|FG001|Part 2: Expansion|Death|0|||
164095746|NCT02343120|592714022|FG002|Part 2: Expansion|Death|0|||
164095747|NCT02343120|592714023|FG003|Part 2: Expansion|Death|74|||
164095748|NCT02343120|592714024|FG004|Part 2: Expansion|Death|17|||
164095749|NCT02343120|592714020|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
164095750|NCT02343120|592714021|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
164023303|NCT02625324|592447655|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
164023304|NCT02625324|592447655|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
164023305|NCT02625324|592447655|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
164023306|NCT02625324|592447655|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
164023307|NCT02625324|592447655|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
164023308|NCT02625324|592447655|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
164023309|NCT02625324|592447655|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164023310|NCT02625324|592447655|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
164023311|NCT02625324|592447655|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164023312|NCT02457182|592447656|FG000|Overall Study|Lost to Follow-up|1|||
164023313|NCT02457182|592447657|FG001|Overall Study|Lost to Follow-up|0|||
164095751|NCT02343120|592714022|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
164095752|NCT02343120|592714023|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
164023314|NCT00352755|592447660|FG000|Overall Study|Physician Decision|1|||
164095753|NCT02343120|592714024|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
164095754|NCT02343120|592714020|FG000|Part 2: Expansion|Lost to Follow-up|0|||
164095755|NCT02343120|592714021|FG001|Part 2: Expansion|Lost to Follow-up|0|||
164095756|NCT02343120|592714022|FG002|Part 2: Expansion|Lost to Follow-up|0|||
164095757|NCT02343120|592714023|FG003|Part 2: Expansion|Lost to Follow-up|5|||
164095758|NCT02343120|592714024|FG004|Part 2: Expansion|Lost to Follow-up|2|||
164095759|NCT02343120|592714020|FG000|Part 2: Expansion|Other|0|||
164095760|NCT02343120|592714021|FG001|Part 2: Expansion|Other|0|||
164095761|NCT02343120|592714022|FG002|Part 2: Expansion|Other|0|||
164095762|NCT02343120|592714023|FG003|Part 2: Expansion|Other|1|||
163910179|NCT00443820|592041724|FG003|Overall Study|Adverse Event|0|||
164023315|NCT00352755|592447660|FG000|Overall Study|Adverse Event|1|||
164023316|NCT02397694|592447663|FG000|Double-Blinded Phase|Adverse Event|1|||
164023317|NCT02397694|592447664|FG001|Double-Blinded Phase|Adverse Event|0|||
164023318|NCT02397694|592447663|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
164023319|NCT02397694|592447664|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
164023320|NCT02397694|592447663|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
164023321|NCT02397694|592447664|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
164023322|NCT02397694|592447663|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
164023323|NCT02397694|592447664|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
164023324|NCT02397694|592447663|FG000|Open Label Extension Phase|Protocol Violation|1|||
164023325|NCT02397694|592447664|FG001|Open Label Extension Phase|Protocol Violation|0|||
164023326|NCT02397694|592447663|FG000|Open Label Extension Phase|Withdrew Consent|3|||
164023327|NCT02397694|592447664|FG001|Open Label Extension Phase|Withdrew Consent|1|||
164023328|NCT02397694|592447663|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
164023329|NCT02397694|592447664|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
164023330|NCT00424528|592447665|FG000|Overall Study|Adverse Event|2|||
164023331|NCT00424528|592447666|FG001|Overall Study|Adverse Event|1|||
164023332|NCT00424528|592447667|FG002|Overall Study|Adverse Event|2|||
164023333|NCT00424528|592447665|FG000|Overall Study|Protocol Violation|1|||
164023334|NCT00424528|592447666|FG001|Overall Study|Protocol Violation|1|||
164023335|NCT00424528|592447667|FG002|Overall Study|Protocol Violation|0|||
164023336|NCT00424528|592447665|FG000|Overall Study|Lost to Follow-up|0|||
164023337|NCT00424528|592447666|FG001|Overall Study|Lost to Follow-up|1|||
164023338|NCT00424528|592447667|FG002|Overall Study|Lost to Follow-up|0|||
164023339|NCT00424528|592447665|FG000|Overall Study|noncompliance with study requirements|2|||
164023340|NCT00424528|592447666|FG001|Overall Study|noncompliance with study requirements|1|||
164023341|NCT00424528|592447667|FG002|Overall Study|noncompliance with study requirements|2|||
164023342|NCT02115113|592447668|FG000|Participants in Run-in Period|Death|0|||
164023343|NCT02115113|592447669|FG001|Participants in Run-in Period|Death|0|||
164023344|NCT02115113|592447670|FG002|Participants in Run-in Period|Death|1|||
164023345|NCT02115113|592447668|FG000|Participants in Run-in Period|Administrative problems|0|||
164023346|NCT02115113|592447669|FG001|Participants in Run-in Period|Administrative problems|0|||
164023347|NCT02115113|592447670|FG002|Participants in Run-in Period|Administrative problems|1|||
164023348|NCT02115113|592447668|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
164023349|NCT02115113|592447669|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
164023350|NCT02115113|592447670|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
164023351|NCT02115113|592447668|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
164023352|NCT02115113|592447669|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
164023353|NCT02115113|592447670|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
164023354|NCT02115113|592447668|FG000|Participants Randomized|Lost to Follow-up|1|||
164023355|NCT02115113|592447669|FG001|Participants Randomized|Lost to Follow-up|0|||
164023356|NCT02115113|592447670|FG002|Participants Randomized|Lost to Follow-up|0|||
164023357|NCT02115113|592447668|FG000|Participants Randomized|Death|1|||
164023358|NCT02115113|592447669|FG001|Participants Randomized|Death|0|||
164023359|NCT02115113|592447670|FG002|Participants Randomized|Death|0|||
164023360|NCT01009983|592447673|FG000|Overall Study|necessary scans not completed|1|||
164023361|NCT03137121|592447676|FG000|Overall Study|Withdrawal by Subject|0|||
164023362|NCT03137121|592447677|FG001|Overall Study|Withdrawal by Subject|1|||
164023363|NCT04410198|592447678|FG000|Overall Study|Death|10|||
164023364|NCT04410198|592447678|FG000|Overall Study|Withdrawal by Subject|7|||
164023365|NCT04410198|592447678|FG000|Overall Study|Transferred/Relocation|4|||
164023366|NCT04410198|592447678|FG000|Overall Study|Kidney Transplant|9|||
164023367|NCT04410198|592447678|FG000|Overall Study|Adverse Event|4|||
164023368|NCT04410198|592447678|FG000|Overall Study|Physician Decision|2|||
164023369|NCT04410198|592447678|FG000|Overall Study|Other than specified|1|||
164023370|NCT02871401|592447679|FG000|Overall Study|Adverse Event|1|||
164023371|NCT02871401|592447680|FG001|Overall Study|Adverse Event|0|||
164023372|NCT02282982|592447681|FG000|Overall Study|Lost to Follow-up|15|||
164023373|NCT02282982|592447681|FG000|Overall Study|Withdrew consent|2|||
164023374|NCT02282982|592447681|FG000|Overall Study|Death|4|||
164023375|NCT02282982|592447681|FG000|Overall Study|Lack of product|156|||
164023376|NCT02282982|592447681|FG000|Overall Study|Palivizumab is ended|11|||
164023377|NCT02282982|592447681|FG000|Overall Study|Other, not specified|18|||
164023378|NCT02006667|592447682|FG000|Overall Study|Adverse Event|3|||
164023379|NCT02006667|592447682|FG000|Overall Study|Death|2|||
164023380|NCT02006667|592447682|FG000|Overall Study|Withdrawal by Subject|1|||
164023381|NCT02939937|592447683|FG000|Overall Study|Adverse Event|5|||
164023382|NCT02939937|592447684|FG001|Overall Study|Adverse Event|0|||
164023383|NCT02939937|592447683|FG000|Overall Study|Lost to Follow-up|1|||
164023384|NCT02939937|592447684|FG001|Overall Study|Lost to Follow-up|3|||
164023385|NCT00568958|592447686|FG000|Allocation|Withdrawal by Subject|7|||
164023386|NCT00568958|592447687|FG001|Allocation|Withdrawal by Subject|3|||
164023387|NCT00568958|592447686|FG000|Allocation|Physician Decision|2|||
164023388|NCT00568958|592447687|FG001|Allocation|Physician Decision|0|||
164023389|NCT00568958|592447686|FG000|Follow-Up|Withdrawal by Subject|6|||
164023390|NCT00568958|592447687|FG001|Follow-Up|Withdrawal by Subject|6|||
164023391|NCT00568958|592447686|FG000|Follow-Up|Physician Decision|1|||
164023392|NCT00568958|592447687|FG001|Follow-Up|Physician Decision|1|||
164023393|NCT00568958|592447686|FG000|Follow-Up|Family Emergency|1|||
164023394|NCT00568958|592447687|FG001|Follow-Up|Family Emergency|0|||
164023395|NCT00568958|592447686|FG000|Follow-Up|Adverse Event|1|||
164023396|NCT00568958|592447687|FG001|Follow-Up|Adverse Event|0|||
164023397|NCT00798655|592447691|FG000|Overall Study|Did not receive at least one dose of pan|2|||
164023398|NCT02179515|592447695|FG000|Overall Study|switched to alternative treatment|0|||
164023399|NCT02179515|592447696|FG001|Overall Study|switched to alternative treatment|1|||
164023400|NCT02179515|592447697|FG002|Overall Study|switched to alternative treatment|1|||
164023401|NCT02179515|592447695|FG000|Overall Study|Death|0|||
164023402|NCT02179515|592447696|FG001|Overall Study|Death|1|||
164023403|NCT02179515|592447697|FG002|Overall Study|Death|1|||
164023404|NCT02179515|592447695|FG000|Overall Study|refused further treatment|0|||
164023405|NCT02179515|592447696|FG001|Overall Study|refused further treatment|3|||
164023406|NCT02179515|592447697|FG002|Overall Study|refused further treatment|4|||
164023407|NCT02179515|592447695|FG000|Overall Study|Disease progression on study|2|||
164023408|NCT02179515|592447696|FG001|Overall Study|Disease progression on study|11|||
164023409|NCT02179515|592447697|FG002|Overall Study|Disease progression on study|8|||
164023410|NCT01774344|592447698|FG000|Overall Study|Withdrawal by Subject|3|||
164023411|NCT01774344|592447699|FG001|Overall Study|Withdrawal by Subject|10|||
164023412|NCT01774344|592447698|FG000|Overall Study|Protocol Violation|0|||
164023413|NCT01774344|592447699|FG001|Overall Study|Protocol Violation|1|||
164023414|NCT01774344|592447698|FG000|Overall Study|Lost to Follow-up|4|||
164023415|NCT01774344|592447699|FG001|Overall Study|Lost to Follow-up|10|||
164023416|NCT01774344|592447698|FG000|Overall Study|End of survival follow-up not available|2|||
164023417|NCT01774344|592447699|FG001|Overall Study|End of survival follow-up not available|2|||
164023418|NCT01774344|592447698|FG000|Overall Study|Data collection finished|4|||
164023419|NCT01774344|592447699|FG001|Overall Study|Data collection finished|14|||
164023420|NCT01774344|592447698|FG000|Overall Study|Other|0|||
164023421|NCT01774344|592447699|FG001|Overall Study|Other|1|||
164023422|NCT01774344|592447698|FG000|Overall Study|Did not enter Survival Follow up|49|||
164023423|NCT01774344|592447699|FG001|Overall Study|Did not enter Survival Follow up|83|||
164023424|NCT00502320|592447705|FG000|Overall Study|Lost to Follow-up|1|||
164023425|NCT00502320|592447706|FG001|Overall Study|Lost to Follow-up|1|||
164023426|NCT00502320|592447705|FG000|Overall Study|Withdrew Consent|1|||
164023427|NCT00502320|592447706|FG001|Overall Study|Withdrew Consent|0|||
164023428|NCT00502320|592447705|FG000|Overall Study|No longer met criteria|1|||
164023429|NCT00502320|592447706|FG001|Overall Study|No longer met criteria|0|||
164023430|NCT00502320|592447705|FG000|Overall Study|Screen Failure|0|||
164023431|NCT00502320|592447706|FG001|Overall Study|Screen Failure|1|||
164023432|NCT00502320|592447705|FG000|Overall Study|Adverse Event|3|||
164023433|NCT00502320|592447706|FG001|Overall Study|Adverse Event|5|||
164023434|NCT00543569|592447707|FG000|Overall Study|Death|2|||
164023435|NCT00543569|592447708|FG001|Overall Study|Death|2|||
164023436|NCT00543569|592447709|FG002|Overall Study|Death|3|||
164023437|NCT00543569|592447710|FG003|Overall Study|Death|1|||
164023438|NCT00543569|592447707|FG000|Overall Study|Lost to Follow-up|0|||
164023439|NCT00543569|592447708|FG001|Overall Study|Lost to Follow-up|0|||
164023440|NCT00543569|592447709|FG002|Overall Study|Lost to Follow-up|1|||
164023441|NCT00543569|592447710|FG003|Overall Study|Lost to Follow-up|1|||
164023442|NCT00543569|592447707|FG000|Overall Study|Miscellaneous Reasons|7|||
164023443|NCT00543569|592447708|FG001|Overall Study|Miscellaneous Reasons|3|||
164023444|NCT00543569|592447709|FG002|Overall Study|Miscellaneous Reasons|11|||
164023445|NCT00543569|592447710|FG003|Overall Study|Miscellaneous Reasons|4|||
164023446|NCT00543569|592447707|FG000|Overall Study|Randomized but never received study drug|3|||
164023447|NCT00543569|592447708|FG001|Overall Study|Randomized but never received study drug|3|||
164023448|NCT00543569|592447709|FG002|Overall Study|Randomized but never received study drug|5|||
164023449|NCT00543569|592447710|FG003|Overall Study|Randomized but never received study drug|3|||
164023450|NCT00862849|592447712|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164023451|NCT00862849|592447713|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
164023452|NCT00862849|592447714|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164023453|NCT00862849|592447715|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164023454|NCT00862849|592447716|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164023455|NCT00862849|592447717|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
164023456|NCT00862849|592447712|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164023457|NCT00862849|592447713|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
164023458|NCT00862849|592447714|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164023459|NCT00862849|592447715|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164023460|NCT00862849|592447716|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164023461|NCT00862849|592447717|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
164023462|NCT00617409|592447718|FG000|Overall Study|Withdrawal by Subject|4|||
164023463|NCT00617409|592447719|FG001|Overall Study|Withdrawal by Subject|1|||
164023464|NCT00617409|592447720|FG002|Overall Study|Withdrawal by Subject|2|||
164023465|NCT00617409|592447718|FG000|Overall Study|Adverse Event|0|||
164023466|NCT00617409|592447719|FG001|Overall Study|Adverse Event|2|||
164023467|NCT00617409|592447720|FG002|Overall Study|Adverse Event|3|||
164023468|NCT00617409|592447718|FG000|Overall Study|Disease Progression|8|||
164023469|NCT00617409|592447719|FG001|Overall Study|Disease Progression|8|||
164023470|NCT00617409|592447720|FG002|Overall Study|Disease Progression|18|||
164023471|NCT00617409|592447718|FG000|Overall Study|Death|3|||
164023472|NCT00617409|592447719|FG001|Overall Study|Death|5|||
164023473|NCT00617409|592447720|FG002|Overall Study|Death|4|||
164023474|NCT00617409|592447718|FG000|Overall Study|Alternative Therapy|1|||
164023475|NCT00617409|592447719|FG001|Overall Study|Alternative Therapy|2|||
164023476|NCT00617409|592447720|FG002|Overall Study|Alternative Therapy|0|||
164023477|NCT02124707|592447729|FG000|Overall Study|Adverse Event|5|||
164023478|NCT02124707|592447729|FG000|Overall Study|Physician Decision|1|||
164023479|NCT02124707|592447729|FG000|Overall Study|Death|1|||
164023480|NCT01363713|592447732|FG000|Overall Study|Adverse Event|1|||
164023481|NCT01363713|592447732|FG000|Overall Study|Protocol Violation|3|||
164023482|NCT01363713|592447732|FG000|Overall Study|Withdrawal by Subject|2|||
164023483|NCT00718666|592447733|FG000|Booster Phase Year 5|No active participation request|0|||
164023484|NCT00718666|592447734|FG001|Booster Phase Year 5|No active participation request|0|||
164023485|NCT00718666|592447735|FG002|Booster Phase Year 5|No active participation request|1|||
164023486|NCT00718666|592447733|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
164023487|NCT00718666|592447734|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
164023488|NCT00718666|592447735|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
164023489|NCT00718666|592447733|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
164023490|NCT00718666|592447734|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
164023491|NCT00718666|592447735|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
164023492|NCT00718666|592447733|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
164023493|NCT00718666|592447734|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
164023494|NCT00718666|592447735|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
164023495|NCT02196038|592447736|FG000|Overall Study|Death|16|||
164023496|NCT02196038|592447737|FG001|Overall Study|Death|21|||
164023497|NCT02196038|592447736|FG000|Overall Study|Withdrawal by Subject|0|||
164023498|NCT02196038|592447737|FG001|Overall Study|Withdrawal by Subject|1|||
164023499|NCT02196038|592447736|FG000|Overall Study|Lost to Follow-up|1|||
164023500|NCT02196038|592447737|FG001|Overall Study|Lost to Follow-up|0|||
164023501|NCT01766336|592447750|FG000|Overall Study|Adverse Event|11|||
164023502|NCT01766336|592447751|FG001|Overall Study|Adverse Event|8|||
164023503|NCT01766336|592447750|FG000|Overall Study|Death|4|||
164023504|NCT01766336|592447751|FG001|Overall Study|Death|3|||
164023505|NCT01766336|592447750|FG000|Overall Study|Lost to Follow-up|1|||
164023506|NCT01766336|592447751|FG001|Overall Study|Lost to Follow-up|3|||
164023507|NCT01766336|592447750|FG000|Overall Study|Physician Decision|4|||
164023508|NCT01766336|592447751|FG001|Overall Study|Physician Decision|2|||
164023509|NCT01766336|592447750|FG000|Overall Study|Protocol Violation|0|||
164023510|NCT01766336|592447751|FG001|Overall Study|Protocol Violation|1|||
164023511|NCT01766336|592447750|FG000|Overall Study|Sponsor Decision|52|||
164023512|NCT01766336|592447751|FG001|Overall Study|Sponsor Decision|43|||
164023513|NCT01766336|592447750|FG000|Overall Study|Withdrawal by Subject|18|||
164023514|NCT01766336|592447751|FG001|Overall Study|Withdrawal by Subject|15|||
164023515|NCT03029650|592447752|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
164023516|NCT03029650|592447753|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
164023517|NCT03029650|592447752|FG000|Washout (1 Week)|Physician Decision|0|||
164023518|NCT03029650|592447753|FG001|Washout (1 Week)|Physician Decision|1|||
164023519|NCT04544709|592447754|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
164023520|NCT03135028|592447755|FG000|Overall Study|Death|6|||
164023521|NCT03135028|592447755|FG000|Overall Study|Study Terminated by Sponsor|2|||
164023522|NCT03135028|592447755|FG000|Overall Study|Withdrew Consent|1|||
164023523|NCT00496873|592447756|FG000|Overall Study|Ineligible|2|||
164023524|NCT00496873|592447756|FG000|Overall Study|Death|2|||
164023525|NCT00496873|592447756|FG000|Overall Study|Withdrawal by Subject|3|||
164023526|NCT02065869|592447757|FG000|Overall Study|Death|7|||
164023527|NCT02065869|592447757|FG000|Overall Study|Disease relapse|16|||
164023528|NCT02065869|592447757|FG000|Overall Study|Lost to Follow-up|4|||
164023529|NCT02065869|592447757|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
164023530|NCT02065869|592447757|FG000|Overall Study|Withdrawal by Subject|1|||
164023531|NCT01842620|592447758|FG000|Period 1|Withdrawal by Subject|1|||
164023532|NCT01842620|592447759|FG001|Period 1|Withdrawal by Subject|0|||
164023533|NCT01814800|592447762|FG000|Overall Study|Adverse Event|2|||
164023534|NCT01814800|592447762|FG000|Overall Study|Pregnancy|1|||
164023535|NCT01814800|592447762|FG000|Overall Study|Sponsor decision|1|||
164023536|NCT01814800|592447762|FG000|Overall Study|Subject relocation|1|||
164023537|NCT02402218|592447763|FG000|Overall Study|Did not pickup study medication|12|||
164023538|NCT02402218|592447764|FG001|Overall Study|Did not pickup study medication|9|||
164023539|NCT02402218|592447765|FG002|Overall Study|Did not pickup study medication|13|||
164023540|NCT02402218|592447763|FG000|Overall Study|Lack of Efficacy|0|||
164023541|NCT02402218|592447764|FG001|Overall Study|Lack of Efficacy|1|||
164023542|NCT02402218|592447765|FG002|Overall Study|Lack of Efficacy|1|||
164023543|NCT02402218|592447763|FG000|Overall Study|Death|1|||
164023544|NCT02402218|592447764|FG001|Overall Study|Death|0|||
164023545|NCT02402218|592447765|FG002|Overall Study|Death|0|||
164023546|NCT02402218|592447763|FG000|Overall Study|Reinfection|0|||
164023547|NCT02402218|592447764|FG001|Overall Study|Reinfection|0|||
164023548|NCT02402218|592447765|FG002|Overall Study|Reinfection|1|||
164023549|NCT02402218|592447763|FG000|Overall Study|Adverse Event|0|||
164023550|NCT02402218|592447764|FG001|Overall Study|Adverse Event|2|||
164023551|NCT02402218|592447765|FG002|Overall Study|Adverse Event|1|||
164023552|NCT02402218|592447763|FG000|Overall Study|Withdrawal by Subject|1|||
164023553|NCT02402218|592447764|FG001|Overall Study|Withdrawal by Subject|1|||
164023554|NCT02402218|592447765|FG002|Overall Study|Withdrawal by Subject|1|||
164023555|NCT03827473|592447766|FG000|Overall Study|Withdrawal by Subject|1|||
164023556|NCT03827473|592447767|FG001|Overall Study|Withdrawal by Subject|0|||
164023557|NCT04436822|592447768|FG000|Overall Study|Physician Decision|2|||
164023558|NCT04436822|592447769|FG001|Overall Study|Physician Decision|0|||
164023559|NCT04436822|592447768|FG000|Overall Study|Sponsor request|1|||
164023560|NCT04436822|592447769|FG001|Overall Study|Sponsor request|0|||
164023561|NCT04436822|592447768|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164023562|NCT04436822|592447769|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164023563|NCT04436822|592447768|FG000|Overall Study|Unsuccessful procedure|0|||
164023564|NCT04436822|592447769|FG001|Overall Study|Unsuccessful procedure|1|||
164023565|NCT04436822|592447768|FG000|Overall Study|Withdrawal due to Covid-19|8|||
164023566|NCT04436822|592447769|FG001|Overall Study|Withdrawal due to Covid-19|1|||
164023567|NCT04436822|592447768|FG000|Overall Study|Withdrawal by Subject|1|||
164023568|NCT04436822|592447769|FG001|Overall Study|Withdrawal by Subject|0|||
164023569|NCT04436822|592447768|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
164023570|NCT04436822|592447769|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
164023571|NCT03807739|592447770|FG000|Overall Study|Adverse Event|1|||
164023572|NCT03807739|592447771|FG001|Overall Study|Adverse Event|0|||
164023573|NCT03807739|592447772|FG002|Overall Study|Adverse Event|0|||
164023574|NCT03807739|592447773|FG003|Overall Study|Adverse Event|0|||
164023575|NCT03807739|592447770|FG000|Overall Study|Withdrawal by Subject|1|||
164023576|NCT03807739|592447771|FG001|Overall Study|Withdrawal by Subject|0|||
164023577|NCT03807739|592447772|FG002|Overall Study|Withdrawal by Subject|0|||
164023578|NCT03807739|592447773|FG003|Overall Study|Withdrawal by Subject|0|||
164023579|NCT02371759|592447774|FG000|Overall Study|Protocol Violation|3|||
164023580|NCT02371759|592447775|FG001|Overall Study|Protocol Violation|1|||
164023581|NCT02371759|592447776|FG002|Overall Study|Protocol Violation|1|||
164023582|NCT02371759|592447777|FG003|Overall Study|Protocol Violation|0|||
164023583|NCT02371759|592447778|FG004|Overall Study|Protocol Violation|3|||
164023584|NCT02371759|592447779|FG005|Overall Study|Protocol Violation|1|||
164023585|NCT02371759|592447780|FG006|Overall Study|Protocol Violation|0|||
164023586|NCT02371759|592447781|FG007|Overall Study|Protocol Violation|3|||
164023587|NCT02371759|592447774|FG000|Overall Study|Withdrawal by Subject|0|||
164023588|NCT02371759|592447775|FG001|Overall Study|Withdrawal by Subject|0|||
164023589|NCT02371759|592447776|FG002|Overall Study|Withdrawal by Subject|0|||
164023590|NCT02371759|592447777|FG003|Overall Study|Withdrawal by Subject|0|||
164023591|NCT02371759|592447778|FG004|Overall Study|Withdrawal by Subject|0|||
164023592|NCT02371759|592447779|FG005|Overall Study|Withdrawal by Subject|0|||
164023593|NCT02371759|592447780|FG006|Overall Study|Withdrawal by Subject|0|||
164023594|NCT02371759|592447781|FG007|Overall Study|Withdrawal by Subject|1|||
164023595|NCT03136185|592447786|FG000|Overall Study|Adverse Event|0|||
164023596|NCT03136185|592447787|FG001|Overall Study|Adverse Event|1|||
164023597|NCT03136185|592447788|FG002|Overall Study|Adverse Event|3|||
164023598|NCT03136185|592447789|FG003|Overall Study|Adverse Event|1|||
164023599|NCT03136185|592447790|FG004|Overall Study|Adverse Event|2|||
164023600|NCT03136185|592447791|FG005|Overall Study|Adverse Event|2|||
164023601|NCT03136185|592447792|FG006|Overall Study|Adverse Event|5|||
164023602|NCT03136185|592447793|FG007|Overall Study|Adverse Event|1|||
164023603|NCT03136185|592447794|FG008|Overall Study|Adverse Event|1|||
164095763|NCT02343120|592714024|FG004|Part 2: Expansion|Other|5|||
164023604|NCT03136185|592447786|FG000|Overall Study|Death|0|||
163910180|NCT00443820|592041721|FG000|Overall Study|Lack of Efficacy|3|||
163910181|NCT00443820|592041722|FG001|Overall Study|Lack of Efficacy|2|||
163910182|NCT00443820|592041723|FG002|Overall Study|Lack of Efficacy|1|||
163910183|NCT00443820|592041724|FG003|Overall Study|Lack of Efficacy|1|||
163910184|NCT00443820|592041721|FG000|Overall Study|Protocol Violation|2|||
164023605|NCT03136185|592447787|FG001|Overall Study|Death|0|||
164023606|NCT03136185|592447788|FG002|Overall Study|Death|0|||
164023607|NCT03136185|592447789|FG003|Overall Study|Death|1|||
164023608|NCT03136185|592447790|FG004|Overall Study|Death|1|||
164023609|NCT03136185|592447791|FG005|Overall Study|Death|0|||
164023610|NCT03136185|592447792|FG006|Overall Study|Death|1|||
164023611|NCT03136185|592447793|FG007|Overall Study|Death|0|||
164023612|NCT03136185|592447794|FG008|Overall Study|Death|0|||
164023613|NCT03136185|592447786|FG000|Overall Study|Physician Decision|3|||
164023614|NCT03136185|592447787|FG001|Overall Study|Physician Decision|1|||
164023615|NCT03136185|592447788|FG002|Overall Study|Physician Decision|1|||
164023616|NCT03136185|592447789|FG003|Overall Study|Physician Decision|2|||
164023617|NCT03136185|592447790|FG004|Overall Study|Physician Decision|1|||
164023618|NCT03136185|592447791|FG005|Overall Study|Physician Decision|2|||
164023619|NCT03136185|592447792|FG006|Overall Study|Physician Decision|1|||
164023620|NCT03136185|592447793|FG007|Overall Study|Physician Decision|0|||
164023621|NCT03136185|592447794|FG008|Overall Study|Physician Decision|1|||
164023622|NCT03136185|592447786|FG000|Overall Study|Protocol Defined Disease Progression|0|||
164023623|NCT03136185|592447787|FG001|Overall Study|Protocol Defined Disease Progression|0|||
164023624|NCT03136185|592447788|FG002|Overall Study|Protocol Defined Disease Progression|1|||
164023625|NCT03136185|592447789|FG003|Overall Study|Protocol Defined Disease Progression|0|||
164023626|NCT03136185|592447790|FG004|Overall Study|Protocol Defined Disease Progression|0|||
164023627|NCT03136185|592447791|FG005|Overall Study|Protocol Defined Disease Progression|1|||
164023628|NCT03136185|592447792|FG006|Overall Study|Protocol Defined Disease Progression|0|||
164023629|NCT03136185|592447793|FG007|Overall Study|Protocol Defined Disease Progression|1|||
164023630|NCT03136185|592447794|FG008|Overall Study|Protocol Defined Disease Progression|1|||
164023631|NCT03136185|592447786|FG000|Overall Study|Withdrawal by Subject|1|||
164023632|NCT03136185|592447787|FG001|Overall Study|Withdrawal by Subject|0|||
164023633|NCT03136185|592447788|FG002|Overall Study|Withdrawal by Subject|1|||
164023634|NCT03136185|592447789|FG003|Overall Study|Withdrawal by Subject|1|||
164023635|NCT03136185|592447790|FG004|Overall Study|Withdrawal by Subject|1|||
164023636|NCT03136185|592447791|FG005|Overall Study|Withdrawal by Subject|1|||
164023637|NCT03136185|592447792|FG006|Overall Study|Withdrawal by Subject|2|||
164023638|NCT03136185|592447793|FG007|Overall Study|Withdrawal by Subject|3|||
164023639|NCT03136185|592447794|FG008|Overall Study|Withdrawal by Subject|3|||
164023640|NCT03136185|592447786|FG000|Overall Study|Not Reported|4|||
164023641|NCT03136185|592447787|FG001|Overall Study|Not Reported|1|||
164023642|NCT03136185|592447788|FG002|Overall Study|Not Reported|0|||
164023643|NCT03136185|592447789|FG003|Overall Study|Not Reported|1|||
164023644|NCT03136185|592447790|FG004|Overall Study|Not Reported|0|||
164023645|NCT03136185|592447791|FG005|Overall Study|Not Reported|2|||
164023646|NCT03136185|592447792|FG006|Overall Study|Not Reported|1|||
164023647|NCT03136185|592447793|FG007|Overall Study|Not Reported|1|||
164023648|NCT03136185|592447794|FG008|Overall Study|Not Reported|0|||
164023649|NCT05118386|592447803|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164023650|NCT05118386|592447804|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164023651|NCT05118386|592447805|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
163910185|NCT00443820|592041722|FG001|Overall Study|Protocol Violation|1|||
163910186|NCT00443820|592041723|FG002|Overall Study|Protocol Violation|2|||
163910187|NCT00443820|592041724|FG003|Overall Study|Protocol Violation|1|||
164095764|NCT02343120|592714020|FG000|Part 2: Expansion|Adverse Event|0|||
164095765|NCT02343120|592714021|FG001|Part 2: Expansion|Adverse Event|0|||
164095766|NCT02343120|592714022|FG002|Part 2: Expansion|Adverse Event|0|||
164095767|NCT02343120|592714023|FG003|Part 2: Expansion|Adverse Event|1|||
164095768|NCT02343120|592714024|FG004|Part 2: Expansion|Adverse Event|1|||
164095769|NCT01054599|592714032|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
164095770|NCT01054599|592714033|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
164095771|NCT01054599|592714032|FG000|Overall Study|Protocol Violation|1|||
164095772|NCT01054599|592714033|FG001|Overall Study|Protocol Violation|0|||
164095773|NCT01054599|592714032|FG000|Overall Study|Spells/seizure-like episodes|1|||
164095774|NCT01054599|592714033|FG001|Overall Study|Spells/seizure-like episodes|1|||
164095775|NCT01054599|592714032|FG000|Overall Study|Timing/scheduling difficulties|1|||
164095776|NCT01054599|592714033|FG001|Overall Study|Timing/scheduling difficulties|1|||
164095777|NCT01054599|592714032|FG000|Overall Study|Visual impairment, WTAR <80|0|||
164095778|NCT01054599|592714033|FG001|Overall Study|Visual impairment, WTAR <80|1|||
164095779|NCT01054599|592714032|FG000|Overall Study|Lost to Follow-up|0|||
164095780|NCT01054599|592714033|FG001|Overall Study|Lost to Follow-up|2|||
164095781|NCT01054599|592714032|FG000|Overall Study|Adverse Event|0|||
164095782|NCT01054599|592714033|FG001|Overall Study|Adverse Event|1|||
164095783|NCT01054599|592714032|FG000|Overall Study|Withdrawal by Subject|0|||
164095784|NCT01054599|592714033|FG001|Overall Study|Withdrawal by Subject|1|||
164095785|NCT01104662|592714034|FG000|Overall Study|Adverse Event|2|||
164095786|NCT01104662|592714035|FG001|Overall Study|Adverse Event|2|||
164095787|NCT01104662|592714036|FG002|Overall Study|Adverse Event|0|||
164095788|NCT01104662|592714037|FG003|Overall Study|Adverse Event|1|||
164095789|NCT01104662|592714038|FG004|Overall Study|Adverse Event|1|||
164095790|NCT01104662|592714039|FG005|Overall Study|Adverse Event|1|||
164095791|NCT01104662|592714040|FG006|Overall Study|Adverse Event|0|||
164095792|NCT01104662|592714041|FG007|Overall Study|Adverse Event|0|||
164095793|NCT01104662|592714034|FG000|Overall Study|Clinical Failure|1|||
164095794|NCT01104662|592714035|FG001|Overall Study|Clinical Failure|0|||
164095795|NCT01104662|592714036|FG002|Overall Study|Clinical Failure|0|||
164095796|NCT01104662|592714037|FG003|Overall Study|Clinical Failure|0|||
164095797|NCT01104662|592714038|FG004|Overall Study|Clinical Failure|0|||
164095798|NCT01104662|592714039|FG005|Overall Study|Clinical Failure|1|||
164095799|NCT01104662|592714040|FG006|Overall Study|Clinical Failure|0|||
164095800|NCT01104662|592714041|FG007|Overall Study|Clinical Failure|0|||
164095801|NCT01104662|592714034|FG000|Overall Study|Participant left investigator's care|1|||
164095802|NCT01104662|592714035|FG001|Overall Study|Participant left investigator's care|1|||
164095803|NCT01104662|592714036|FG002|Overall Study|Participant left investigator's care|0|||
164095804|NCT01104662|592714037|FG003|Overall Study|Participant left investigator's care|0|||
164095805|NCT01104662|592714038|FG004|Overall Study|Participant left investigator's care|0|||
164095806|NCT01104662|592714039|FG005|Overall Study|Participant left investigator's care|0|||
164095807|NCT01104662|592714040|FG006|Overall Study|Participant left investigator's care|0|||
164095808|NCT01104662|592714041|FG007|Overall Study|Participant left investigator's care|0|||
164095809|NCT01104662|592714034|FG000|Overall Study|Reason not specified|3|||
164095810|NCT01104662|592714035|FG001|Overall Study|Reason not specified|3|||
164095811|NCT01104662|592714036|FG002|Overall Study|Reason not specified|0|||
164095812|NCT01104662|592714037|FG003|Overall Study|Reason not specified|0|||
164095813|NCT01104662|592714038|FG004|Overall Study|Reason not specified|0|||
164095814|NCT01104662|592714039|FG005|Overall Study|Reason not specified|1|||
164095815|NCT01104662|592714040|FG006|Overall Study|Reason not specified|0|||
164095816|NCT01104662|592714041|FG007|Overall Study|Reason not specified|0|||
164095817|NCT01104662|592714034|FG000|Overall Study|Randomized but not treated|3|||
164095818|NCT01104662|592714035|FG001|Overall Study|Randomized but not treated|4|||
164095819|NCT01104662|592714036|FG002|Overall Study|Randomized but not treated|1|||
164095820|NCT01104662|592714037|FG003|Overall Study|Randomized but not treated|0|||
164095821|NCT01104662|592714038|FG004|Overall Study|Randomized but not treated|0|||
164095822|NCT01104662|592714039|FG005|Overall Study|Randomized but not treated|1|||
164095823|NCT01104662|592714040|FG006|Overall Study|Randomized but not treated|0|||
164095824|NCT01104662|592714041|FG007|Overall Study|Randomized but not treated|0|||
164095825|NCT01691248|592714042|FG000|Overall Study|Protocol Violation|43|||
164095826|NCT01691248|592714043|FG001|Overall Study|Protocol Violation|27|||
164095827|NCT01691248|592714042|FG000|Overall Study|Adverse Event|24|||
164095828|NCT01691248|592714043|FG001|Overall Study|Adverse Event|22|||
164095829|NCT01691248|592714042|FG000|Overall Study|Withdrawal by Subject|20|||
164095830|NCT01691248|592714043|FG001|Overall Study|Withdrawal by Subject|18|||
164095831|NCT01691248|592714042|FG000|Overall Study|Confirmed CDAD|14|||
164095832|NCT01691248|592714043|FG001|Overall Study|Confirmed CDAD|31|||
164095833|NCT01691248|592714042|FG000|Overall Study|Lost to Follow-up|2|||
164095834|NCT01691248|592714043|FG001|Overall Study|Lost to Follow-up|5|||
164095835|NCT01691248|592714042|FG000|Overall Study|Reason not provided|4|||
164095836|NCT01691248|592714043|FG001|Overall Study|Reason not provided|4|||
164095837|NCT01691248|592714042|FG000|Overall Study|Not Treated|4|||
163910188|NCT00443820|592041721|FG000|Overall Study|Withdrawal by Subject|6|||
163910189|NCT00443820|592041722|FG001|Overall Study|Withdrawal by Subject|7|||
163910190|NCT00443820|592041723|FG002|Overall Study|Withdrawal by Subject|8|||
163910191|NCT00443820|592041724|FG003|Overall Study|Withdrawal by Subject|9|||
163910192|NCT00443820|592041721|FG000|Overall Study|Lost to Follow-up|9|||
163910193|NCT00443820|592041722|FG001|Overall Study|Lost to Follow-up|8|||
163910194|NCT00443820|592041723|FG002|Overall Study|Lost to Follow-up|6|||
163910195|NCT00443820|592041724|FG003|Overall Study|Lost to Follow-up|5|||
163910196|NCT00443820|592041721|FG000|Overall Study|Administrative problems|0|||
163910197|NCT00443820|592041722|FG001|Overall Study|Administrative problems|0|||
163910198|NCT00443820|592041723|FG002|Overall Study|Administrative problems|0|||
163910199|NCT00443820|592041724|FG003|Overall Study|Administrative problems|1|||
163910200|NCT00443820|592041721|FG000|Overall Study|Death|0|||
163910201|NCT00443820|592041722|FG001|Overall Study|Death|0|||
163910202|NCT00443820|592041723|FG002|Overall Study|Death|1|||
163910203|NCT00443820|592041724|FG003|Overall Study|Death|0|||
163910204|NCT02121808|592041725|FG000|Overall Study|Technical problem|3|||
163910205|NCT01304940|592041727|FG000|Overall Study|not meet symptom severity requirement|3|||
163910206|NCT01304940|592041728|FG001|Overall Study|not meet symptom severity requirement|0|||
163910207|NCT00304278|592041729|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
163910208|NCT00304278|592041729|FG000|Overall Study|PT had medical condition preventing TX|1|||
163910209|NCT02065895|592041732|FG000|Overall Study|Protocol Violation|1|||
163910210|NCT02065895|592041733|FG001|Overall Study|Protocol Violation|0|||
163910211|NCT02065895|592041734|FG002|Overall Study|Protocol Violation|0|||
163910212|NCT02065895|592041735|FG003|Overall Study|Protocol Violation|1|||
163910213|NCT02065895|592041736|FG004|Overall Study|Protocol Violation|0|||
163910214|NCT02065895|592041737|FG005|Overall Study|Protocol Violation|0|||
163910215|NCT02065895|592041732|FG000|Overall Study|Scheduling conflicts|0|||
163910216|NCT02065895|592041733|FG001|Overall Study|Scheduling conflicts|1|||
163910217|NCT02065895|592041734|FG002|Overall Study|Scheduling conflicts|0|||
163910218|NCT02065895|592041735|FG003|Overall Study|Scheduling conflicts|0|||
163910219|NCT02065895|592041736|FG004|Overall Study|Scheduling conflicts|0|||
163910220|NCT02065895|592041737|FG005|Overall Study|Scheduling conflicts|0|||
163910221|NCT03740737|592041738|FG000|Overall Study|Protocol deviation|13|||
163910222|NCT03740737|592041739|FG001|Overall Study|Protocol deviation|0|||
163910223|NCT03740737|592041738|FG000|Overall Study|Adverse Event|2|||
163910224|NCT03740737|592041739|FG001|Overall Study|Adverse Event|0|||
163910225|NCT03740737|592041738|FG000|Overall Study|Lost to Follow-up|1|||
163910226|NCT03740737|592041739|FG001|Overall Study|Lost to Follow-up|0|||
163910227|NCT03740737|592041738|FG000|Overall Study|Randomization failure|1|||
163910228|NCT03740737|592041739|FG001|Overall Study|Randomization failure|0|||
163910229|NCT03740737|592041738|FG000|Overall Study|Participant withdrew consent|1|||
163910230|NCT03740737|592041739|FG001|Overall Study|Participant withdrew consent|0|||
163910231|NCT03740737|592041738|FG000|Overall Study|Participant withdrew from trial|2|||
163910232|NCT03740737|592041739|FG001|Overall Study|Participant withdrew from trial|1|||
163910233|NCT00507429|592041740|FG000|Treatment Phase|Disease Progression|12|||
163910234|NCT00507429|592041741|FG001|Treatment Phase|Disease Progression|5|||
163910235|NCT00507429|592041740|FG000|Treatment Phase|Adverse Event|12|||
163910236|NCT00507429|592041741|FG001|Treatment Phase|Adverse Event|5|||
163910237|NCT00507429|592041740|FG000|Treatment Phase|Withdrawal by Subject|3|||
163910238|NCT00507429|592041741|FG001|Treatment Phase|Withdrawal by Subject|3|||
163910239|NCT00507429|592041740|FG000|Treatment Phase|Physician Decision|4|||
163910240|NCT00507429|592041741|FG001|Treatment Phase|Physician Decision|2|||
163910241|NCT00507429|592041740|FG000|Treatment Phase|Other|6|||
163910242|NCT00507429|592041741|FG001|Treatment Phase|Other|3|||
163910243|NCT00507429|592041740|FG000|Maintenance Phase|Progressive Disease|14|||
163910244|NCT00507429|592041741|FG001|Maintenance Phase|Progressive Disease|0|||
163910245|NCT04025762|592041744|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
163910246|NCT04025762|592041745|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
164023652|NCT05118386|592447806|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
164023653|NCT05118386|592447807|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164023654|NCT05118386|592447808|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
164023655|NCT05118386|592447803|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164023656|NCT05118386|592447804|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164023657|NCT05118386|592447805|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164023658|NCT05118386|592447806|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164023659|NCT05118386|592447807|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
164023660|NCT05118386|592447808|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
164023661|NCT00488033|592447809|FG000|Overall Study|Withdrawal by Subject|1|||
164023662|NCT00488033|592447810|FG001|Overall Study|Withdrawal by Subject|0|||
164023663|NCT00894413|592447811|FG000|Overall Study|Physician Decision|0|||
164023664|NCT00894413|592447812|FG001|Overall Study|Physician Decision|2|||
164023665|NCT00894413|592447811|FG000|Overall Study|Adverse Event|0|||
164023666|NCT00894413|592447812|FG001|Overall Study|Adverse Event|2|||
164023667|NCT00894413|592447811|FG000|Overall Study|Withdrawal by Subject|0|||
164023668|NCT00894413|592447812|FG001|Overall Study|Withdrawal by Subject|4|||
164023669|NCT02635737|592447819|FG000|Overall Study|Protocol Violation|1|||
164023670|NCT01552928|592447820|FG000|Period 3|Adverse Event|0|||
164023671|NCT01552928|592447821|FG001|Period 3|Adverse Event|0|||
164023672|NCT01552928|592447822|FG002|Period 3|Adverse Event|1|||
164023673|NCT01552928|592447823|FG003|Period 3|Adverse Event|0|||
164023674|NCT00406640|592447832|FG000|Acute Phase|Adverse Event|18|||
164023675|NCT00406640|592447833|FG001|Acute Phase|Adverse Event|13|||
164023676|NCT00406640|592447832|FG000|Acute Phase|Failed to Return|5|||
164023677|NCT00406640|592447833|FG001|Acute Phase|Failed to Return|1|||
164023678|NCT00406640|592447832|FG000|Acute Phase|Physician Decision|0|||
164023679|NCT00406640|592447833|FG001|Acute Phase|Physician Decision|1|||
164023680|NCT00406640|592447832|FG000|Acute Phase|Lost to Follow-up|7|||
164023681|NCT00406640|592447833|FG001|Acute Phase|Lost to Follow-up|4|||
164023682|NCT00406640|592447832|FG000|Acute Phase|Protocol deviation|4|||
164023683|NCT00406640|592447833|FG001|Acute Phase|Protocol deviation|10|||
164023684|NCT00406640|592447832|FG000|Acute Phase|Protocol Violation|3|||
164023685|NCT00406640|592447833|FG001|Acute Phase|Protocol Violation|2|||
164023686|NCT00406640|592447832|FG000|Acute Phase|Withdrawal by Subject|11|||
164023687|NCT00406640|592447833|FG001|Acute Phase|Withdrawal by Subject|9|||
164023688|NCT00406640|592447832|FG000|Acute Phase|Lack of Efficacy|3|||
164023689|NCT00406640|592447833|FG001|Acute Phase|Lack of Efficacy|3|||
164023690|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
164023691|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
164023692|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Death|1|||
164023693|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Death|0|||
164023694|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
164023695|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
164023696|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
164023697|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
164023698|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
164023699|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
164023700|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|non-compliance|7|||
164023701|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|non-compliance|5|||
164023702|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
164023703|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
163910247|NCT03137784|592041747|FG000|Overall Study|Adverse Event|1|||
164095838|NCT01691248|592714043|FG001|Overall Study|Not Treated|7|||
164095839|NCT00549718|592715770|FG000|Overall Study|Insufficient clinical response|20|||
163910248|NCT03137784|592041748|FG001|Overall Study|Adverse Event|1|||
163910249|NCT03137784|592041749|FG002|Overall Study|Adverse Event|0|||
163910250|NCT03137784|592041750|FG003|Overall Study|Adverse Event|0|||
163910251|NCT03137784|592041751|FG004|Overall Study|Adverse Event|0|||
163910252|NCT03137784|592041752|FG005|Overall Study|Adverse Event|0|||
163910253|NCT03137784|592041747|FG000|Overall Study|Subject/guardian decision|1|||
163910254|NCT03137784|592041748|FG001|Overall Study|Subject/guardian decision|0|||
163910255|NCT03137784|592041749|FG002|Overall Study|Subject/guardian decision|0|||
163910256|NCT03137784|592041750|FG003|Overall Study|Subject/guardian decision|0|||
163910257|NCT03137784|592041751|FG004|Overall Study|Subject/guardian decision|0|||
163910258|NCT03137784|592041752|FG005|Overall Study|Subject/guardian decision|0|||
163910259|NCT03137784|592041747|FG000|Overall Study|Non-compliance with study treatment|0|||
163910260|NCT03137784|592041748|FG001|Overall Study|Non-compliance with study treatment|0|||
163910261|NCT03137784|592041749|FG002|Overall Study|Non-compliance with study treatment|0|||
163910262|NCT03137784|592041750|FG003|Overall Study|Non-compliance with study treatment|0|||
163910263|NCT03137784|592041751|FG004|Overall Study|Non-compliance with study treatment|1|||
163910264|NCT03137784|592041752|FG005|Overall Study|Non-compliance with study treatment|0|||
163910265|NCT04803734|592041755|FG000|Overall Study|Withdrawal by Subject|0|||
163910266|NCT04803734|592041756|FG001|Overall Study|Withdrawal by Subject|1|||
163910267|NCT04803734|592041755|FG000|Overall Study|Protocol Violation|0|||
163910268|NCT04803734|592041756|FG001|Overall Study|Protocol Violation|1|||
163910269|NCT01799993|592041770|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
163910270|NCT01799993|592041771|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
163910271|NCT01799993|592041770|FG000|Overall Study|Death|61|||
163910272|NCT01799993|592041771|FG001|Overall Study|Death|45|||
163910273|NCT01799993|592041770|FG000|Overall Study|Withdrawal by Subject|23|||
163910274|NCT01799993|592041771|FG001|Overall Study|Withdrawal by Subject|24|||
163910275|NCT01799993|592041770|FG000|Overall Study|Lost to Follow-up|5|||
163910276|NCT01799993|592041771|FG001|Overall Study|Lost to Follow-up|8|||
163910277|NCT01799993|592041770|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
163910278|NCT01799993|592041771|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
163910279|NCT01799993|592041770|FG000|Overall Study|Protocol driven decision point|0|||
163910280|NCT01799993|592041771|FG001|Overall Study|Protocol driven decision point|3|||
163910281|NCT01799993|592041770|FG000|Overall Study|Protocol Violation|1|||
163910282|NCT01799993|592041771|FG001|Overall Study|Protocol Violation|1|||
163910283|NCT01799993|592041770|FG000|Overall Study|Deterioration of general conditions|2|||
163910284|NCT01799993|592041771|FG001|Overall Study|Deterioration of general conditions|0|||
163910285|NCT01799993|592041770|FG000|Overall Study|Screen failure|0|||
164023704|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
164023705|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
164023706|NCT00406640|592447832|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
164023707|NCT00406640|592447833|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
164023708|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
164023709|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
164023710|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
164023711|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
164023712|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
164023713|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
164023714|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
164023715|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
164144826|NCT05445492|592891790|FG000|Overall Study|Physician Decision|1|||
163910286|NCT01799993|592041771|FG001|Overall Study|Screen failure|1|||
163910287|NCT01799993|592041770|FG000|Overall Study|Adverse Event|1|||
163910288|NCT01799993|592041771|FG001|Overall Study|Adverse Event|0|||
163910289|NCT01799993|592041770|FG000|Overall Study|Lack of Efficacy|1|||
164095840|NCT00549718|592715771|FG001|Overall Study|Insufficient clinical response|7|||
164023716|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
164023717|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
164023718|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
164023719|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
164023720|NCT00406640|592447832|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
164023721|NCT00406640|592447833|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
164023722|NCT00488618|592447834|FG000|Overall Study|Adverse Event|13|||
164023723|NCT00488618|592447835|FG001|Overall Study|Adverse Event|17|||
164023724|NCT00488618|592447834|FG000|Overall Study|Insufficient Therapeutic Response|18|||
164023725|NCT00488618|592447835|FG001|Overall Study|Insufficient Therapeutic Response|11|||
164095841|NCT00549718|592715772|FG002|Overall Study|Insufficient clinical response|18|||
164095842|NCT00549718|592715773|FG003|Overall Study|Insufficient clinical response|32|||
164023726|NCT00488618|592447834|FG000|Overall Study|Protocol Violation|0|||
164023727|NCT00488618|592447835|FG001|Overall Study|Protocol Violation|2|||
164023728|NCT00488618|592447834|FG000|Overall Study|Withdrawal of Consent|15|||
164023729|NCT00488618|592447835|FG001|Overall Study|Withdrawal of Consent|13|||
164095843|NCT00549718|592715770|FG000|Overall Study|Adverse Event|6|||
164095844|NCT00549718|592715771|FG001|Overall Study|Adverse Event|8|||
164095845|NCT00549718|592715772|FG002|Overall Study|Adverse Event|7|||
164095846|NCT00549718|592715773|FG003|Overall Study|Adverse Event|3|||
164095847|NCT00549718|592715770|FG000|Overall Study|Lost to Follow-up|4|||
164095848|NCT00549718|592715771|FG001|Overall Study|Lost to Follow-up|2|||
164095849|NCT00549718|592715772|FG002|Overall Study|Lost to Follow-up|0|||
164095850|NCT00549718|592715773|FG003|Overall Study|Lost to Follow-up|6|||
164095851|NCT00549718|592715770|FG000|Overall Study|Withdrawal by Subject|9|||
164095852|NCT00549718|592715771|FG001|Overall Study|Withdrawal by Subject|18|||
164095853|NCT00549718|592715772|FG002|Overall Study|Withdrawal by Subject|12|||
164095854|NCT00549718|592715773|FG003|Overall Study|Withdrawal by Subject|13|||
164095855|NCT00549718|592715770|FG000|Overall Study|Administrative|2|||
164095856|NCT00549718|592715771|FG001|Overall Study|Administrative|2|||
164095857|NCT00549718|592715772|FG002|Overall Study|Administrative|2|||
164095858|NCT00549718|592715773|FG003|Overall Study|Administrative|1|||
164095859|NCT01725529|592715779|FG000|Overall Study|Adverse Event|1|||
164095860|NCT01725529|592715780|FG001|Overall Study|Adverse Event|0|||
164095861|NCT01725529|592715781|FG002|Overall Study|Adverse Event|0|||
164023730|NCT00488618|592447834|FG000|Overall Study|Lost to Follow-up|1|||
164023731|NCT00488618|592447835|FG001|Overall Study|Lost to Follow-up|0|||
163910290|NCT01799993|592041771|FG001|Overall Study|Lack of Efficacy|0|||
163910291|NCT01799993|592041770|FG000|Overall Study|Recovery|0|||
163910292|NCT01799993|592041771|FG001|Overall Study|Recovery|1|||
163910293|NCT01799993|592041770|FG000|Overall Study|Logistical difficulties|1|||
163910294|NCT01799993|592041771|FG001|Overall Study|Logistical difficulties|0|||
163910295|NCT01799993|592041770|FG000|Overall Study|Protocol deviation|1|||
163910296|NCT01799993|592041771|FG001|Overall Study|Protocol deviation|0|||
163910297|NCT01799993|592041770|FG000|Overall Study|Non-compliance with medical device|1|||
163910298|NCT01799993|592041771|FG001|Overall Study|Non-compliance with medical device|0|||
163910299|NCT01799993|592041770|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163910300|NCT01799993|592041771|FG001|Overall Study|Withdrawal by parent/guardian|1|||
163910301|NCT01799993|592041770|FG000|Overall Study|Other|1|||
163910302|NCT01799993|592041771|FG001|Overall Study|Other|0|||
163910303|NCT01799993|592041770|FG000|Overall Study|Subject didn't return for follow-up|0|||
163910304|NCT01799993|592041771|FG001|Overall Study|Subject didn't return for follow-up|1|||
164023732|NCT00789191|592449691|FG000|Overall Study|Adverse Event|2|||
164023733|NCT00789191|592449692|FG001|Overall Study|Adverse Event|4|||
164023734|NCT00789191|592449691|FG000|Overall Study|Lack of Efficacy|0|||
164023735|NCT00789191|592449692|FG001|Overall Study|Lack of Efficacy|5|||
164023736|NCT00789191|592449691|FG000|Overall Study|Protocol Violation|5|||
164023737|NCT00789191|592449692|FG001|Overall Study|Protocol Violation|3|||
164023738|NCT00789191|592449691|FG000|Overall Study|Withdrawal Criteria|2|||
164023739|NCT00789191|592449692|FG001|Overall Study|Withdrawal Criteria|4|||
164023740|NCT00789191|592449691|FG000|Overall Study|Unclassified|5|||
164023741|NCT00789191|592449692|FG001|Overall Study|Unclassified|3|||
164023742|NCT01911845|592449706|FG000|Overall Study|Adverse Event|2|||
163910305|NCT01320683|592041772|FG000|Overall Study|Positive antibody response|1|||
164095862|NCT01725529|592715779|FG000|Overall Study|Lost to Follow-up|2|||
163910306|NCT04361617|592041773|FG000|Overall Study|Withdrawal by Subject|0|||
164023743|NCT01911845|592449706|FG000|Overall Study|Lost to Follow-up|1|||
164023744|NCT01911845|592449706|FG000|Overall Study|Other (not specified)|3|||
164023745|NCT04507867|592449717|FG000|Overall Study|Death|7|||
164023746|NCT04507867|592449718|FG001|Overall Study|Death|1|||
164023747|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
164023748|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023749|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164095863|NCT01725529|592715780|FG001|Overall Study|Lost to Follow-up|1|||
164095864|NCT01725529|592715781|FG002|Overall Study|Lost to Follow-up|1|||
164095865|NCT01725529|592715779|FG000|Overall Study|Protocol Violation|0|||
164095866|NCT01725529|592715780|FG001|Overall Study|Protocol Violation|1|||
164095867|NCT01725529|592715781|FG002|Overall Study|Protocol Violation|1|||
164095868|NCT01725529|592715779|FG000|Overall Study|Withdrawal by Subject|12|||
164095869|NCT01725529|592715780|FG001|Overall Study|Withdrawal by Subject|14|||
164095870|NCT01725529|592715781|FG002|Overall Study|Withdrawal by Subject|8|||
164095871|NCT01315249|592715783|FG000|Overall Study|Adverse Event|22|||
164095872|NCT01315249|592715784|FG001|Overall Study|Adverse Event|26|||
164095873|NCT01315249|592715783|FG000|Overall Study|Withdrawal by Subject|11|||
164095874|NCT01315249|592715784|FG001|Overall Study|Withdrawal by Subject|10|||
164095875|NCT01315249|592715783|FG000|Overall Study|Protocol Violation|8|||
164095876|NCT01315249|592715784|FG001|Overall Study|Protocol Violation|5|||
164095877|NCT01315249|592715783|FG000|Overall Study|Abnormal test results|1|||
164095878|NCT01315249|592715784|FG001|Overall Study|Abnormal test results|2|||
164095879|NCT01315249|592715783|FG000|Overall Study|Administrative problems|1|||
164095880|NCT01315249|592715784|FG001|Overall Study|Administrative problems|0|||
164095881|NCT01315249|592715783|FG000|Overall Study|inability to use device|1|||
164095882|NCT01315249|592715784|FG001|Overall Study|inability to use device|0|||
164095883|NCT01315249|592715783|FG000|Overall Study|Lack of Efficacy|0|||
164095884|NCT01315249|592715784|FG001|Overall Study|Lack of Efficacy|1|||
164095885|NCT01315249|592715783|FG000|Overall Study|Lost to Follow-up|0|||
164095886|NCT01315249|592715784|FG001|Overall Study|Lost to Follow-up|2|||
164095887|NCT01315249|592715783|FG000|Overall Study|Death|0|||
164095888|NCT01315249|592715784|FG001|Overall Study|Death|1|||
164095889|NCT01287013|592715790|FG000|Overall Study|Non-evaluable|3|||
164095890|NCT01287013|592715791|FG001|Overall Study|Non-evaluable|5|||
164095891|NCT01287013|592715792|FG002|Overall Study|Non-evaluable|21|||
164095892|NCT00051025|592715793|FG000|Overall Study|Progressive Disease|1|||
164095893|NCT00051025|592715794|FG001|Overall Study|Progressive Disease|1|||
164095894|NCT00051025|592715793|FG000|Overall Study|Adverse Event|1|||
164095895|NCT00051025|592715794|FG001|Overall Study|Adverse Event|1|||
164095896|NCT00051025|592715793|FG000|Overall Study|Withdrawal by Subject|0|||
164095897|NCT00051025|592715794|FG001|Overall Study|Withdrawal by Subject|1|||
164095898|NCT00051025|592715793|FG000|Overall Study|Death|0|||
164095899|NCT00051025|592715794|FG001|Overall Study|Death|1|||
164095900|NCT01900730|592715795|FG000|Overall Study|Withdrawal by Subject|1|||
164095901|NCT01900730|592715796|FG001|Overall Study|Withdrawal by Subject|0|||
164095902|NCT01900730|592715795|FG000|Overall Study|Screen Failure|1|||
164095903|NCT01900730|592715796|FG001|Overall Study|Screen Failure|0|||
164095904|NCT01179048|592715797|FG000|Overall Study|Withdrawn - does not allow contact|4|||
164095905|NCT01179048|592715798|FG001|Overall Study|Withdrawn - does not allow contact|8|||
164095906|NCT01179048|592715797|FG000|Overall Study|Lost to Follow-up|8|||
164095907|NCT01179048|592715798|FG001|Overall Study|Lost to Follow-up|9|||
164095908|NCT01179048|592715797|FG000|Overall Study|Alive|127|||
164095909|NCT01179048|592715798|FG001|Overall Study|Alive|142|||
164095910|NCT02109042|592715799|FG000|Overall Study|Sponsor Decision|15|||
164095911|NCT03203447|592715804|FG000|Overall Study|Withdrawal by Subject|2|||
164095912|NCT03203447|592715805|FG001|Overall Study|Withdrawal by Subject|1|||
164095913|NCT03203447|592715804|FG000|Overall Study|Lost to Follow-up|1|||
164095914|NCT03203447|592715805|FG001|Overall Study|Lost to Follow-up|10|||
164023750|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023751|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023752|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023753|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023754|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023755|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164023756|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
164023757|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023758|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023759|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023760|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023761|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023762|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023763|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023764|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164023765|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
164023766|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023767|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023768|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023769|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023770|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023771|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023772|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023773|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164023774|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
164023775|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
164023776|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
164023777|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
164023778|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
164023779|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
164023780|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
164023781|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
164095915|NCT03203447|592715804|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
164095916|NCT03203447|592715805|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
164095917|NCT02189941|592715806|FG000|Overall Study|Non-compliance|0|||
164023782|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
164095918|NCT02189941|592715807|FG001|Overall Study|Non-compliance|0|||
164095919|NCT02189941|592715808|FG002|Overall Study|Non-compliance|1|||
164095920|NCT00445003|592715809|FG000|Overall Study|Death|1|||
164095921|NCT00445003|592715810|FG001|Overall Study|Death|2|||
164095922|NCT00445003|592715811|FG002|Overall Study|Death|1|||
164095923|NCT00445003|592715809|FG000|Overall Study|Missed Visit|3|||
164095924|NCT00445003|592715810|FG001|Overall Study|Missed Visit|5|||
164095925|NCT00445003|592715811|FG002|Overall Study|Missed Visit|1|||
164095926|NCT00445003|592715809|FG000|Overall Study|Dropped|1|||
164095927|NCT00445003|592715810|FG001|Overall Study|Dropped|3|||
164095928|NCT00445003|592715811|FG002|Overall Study|Dropped|2|||
164023783|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
164023784|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023785|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023786|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023787|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023788|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023789|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023790|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023791|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164023792|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
164023793|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023794|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023795|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023796|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023797|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023798|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023799|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023800|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164023801|NCT02175771|592449719|FG000|Run-In Period (Pre-assignment)|Other|8|||
164023802|NCT02175771|592449720|FG001|Run-In Period (Pre-assignment)|Other|0|||
164023803|NCT02175771|592449721|FG002|Run-In Period (Pre-assignment)|Other|0|||
164095929|NCT00528606|592715814|FG000|Overall Study|Withdrew consent|4|||
164023804|NCT02175771|592449722|FG003|Run-In Period (Pre-assignment)|Other|0|||
164023805|NCT02175771|592449723|FG004|Run-In Period (Pre-assignment)|Other|0|||
164023806|NCT02175771|592449724|FG005|Run-In Period (Pre-assignment)|Other|0|||
164023807|NCT02175771|592449725|FG006|Run-In Period (Pre-assignment)|Other|0|||
164023808|NCT02175771|592449726|FG007|Run-In Period (Pre-assignment)|Other|0|||
164023809|NCT02175771|592449727|FG008|Run-In Period (Pre-assignment)|Other|0|||
164023810|NCT02175771|592449719|FG000|Treatment Period|Adverse Event|0|||
164023811|NCT02175771|592449720|FG001|Treatment Period|Adverse Event|2|||
164023812|NCT02175771|592449721|FG002|Treatment Period|Adverse Event|1|||
164023813|NCT02175771|592449722|FG003|Treatment Period|Adverse Event|1|||
164023814|NCT02175771|592449723|FG004|Treatment Period|Adverse Event|1|||
164023815|NCT02175771|592449724|FG005|Treatment Period|Adverse Event|3|||
164023816|NCT02175771|592449725|FG006|Treatment Period|Adverse Event|2|||
164023817|NCT02175771|592449726|FG007|Treatment Period|Adverse Event|0|||
164023818|NCT02175771|592449727|FG008|Treatment Period|Adverse Event|1|||
164023819|NCT02175771|592449719|FG000|Treatment Period|Withdrawal by Subject|0|||
164023820|NCT02175771|592449720|FG001|Treatment Period|Withdrawal by Subject|9|||
164023821|NCT02175771|592449721|FG002|Treatment Period|Withdrawal by Subject|3|||
164023822|NCT02175771|592449722|FG003|Treatment Period|Withdrawal by Subject|6|||
164023823|NCT02175771|592449723|FG004|Treatment Period|Withdrawal by Subject|2|||
164023824|NCT02175771|592449724|FG005|Treatment Period|Withdrawal by Subject|4|||
164023825|NCT02175771|592449725|FG006|Treatment Period|Withdrawal by Subject|2|||
164023826|NCT02175771|592449726|FG007|Treatment Period|Withdrawal by Subject|9|||
164023827|NCT02175771|592449727|FG008|Treatment Period|Withdrawal by Subject|2|||
164023828|NCT02175771|592449719|FG000|Treatment Period|Noncompliance|0|||
164023829|NCT02175771|592449720|FG001|Treatment Period|Noncompliance|1|||
164023830|NCT02175771|592449721|FG002|Treatment Period|Noncompliance|2|||
164023831|NCT02175771|592449722|FG003|Treatment Period|Noncompliance|0|||
164023832|NCT02175771|592449723|FG004|Treatment Period|Noncompliance|0|||
164023833|NCT02175771|592449724|FG005|Treatment Period|Noncompliance|0|||
164023834|NCT02175771|592449725|FG006|Treatment Period|Noncompliance|0|||
164023835|NCT02175771|592449726|FG007|Treatment Period|Noncompliance|0|||
164023836|NCT02175771|592449727|FG008|Treatment Period|Noncompliance|1|||
164023837|NCT02175771|592449719|FG000|Treatment Period|Protocol Violation|0|||
164023838|NCT02175771|592449720|FG001|Treatment Period|Protocol Violation|0|||
164023839|NCT02175771|592449721|FG002|Treatment Period|Protocol Violation|0|||
164023840|NCT02175771|592449722|FG003|Treatment Period|Protocol Violation|0|||
164023841|NCT02175771|592449723|FG004|Treatment Period|Protocol Violation|0|||
164023842|NCT02175771|592449724|FG005|Treatment Period|Protocol Violation|0|||
164023843|NCT02175771|592449725|FG006|Treatment Period|Protocol Violation|0|||
164023844|NCT02175771|592449726|FG007|Treatment Period|Protocol Violation|1|||
164023845|NCT02175771|592449727|FG008|Treatment Period|Protocol Violation|0|||
164023846|NCT02175771|592449719|FG000|Treatment Period|Disease progression|0|||
164023847|NCT02175771|592449720|FG001|Treatment Period|Disease progression|0|||
164023848|NCT02175771|592449721|FG002|Treatment Period|Disease progression|0|||
164023849|NCT02175771|592449722|FG003|Treatment Period|Disease progression|0|||
164023850|NCT02175771|592449723|FG004|Treatment Period|Disease progression|0|||
164023851|NCT02175771|592449724|FG005|Treatment Period|Disease progression|0|||
164023852|NCT02175771|592449725|FG006|Treatment Period|Disease progression|0|||
164023853|NCT02175771|592449726|FG007|Treatment Period|Disease progression|2|||
164023854|NCT02175771|592449727|FG008|Treatment Period|Disease progression|0|||
164023855|NCT02175771|592449719|FG000|Treatment Period|Lost to Follow-up|0|||
164023856|NCT02175771|592449720|FG001|Treatment Period|Lost to Follow-up|3|||
164023857|NCT02175771|592449721|FG002|Treatment Period|Lost to Follow-up|1|||
164023858|NCT02175771|592449722|FG003|Treatment Period|Lost to Follow-up|3|||
164023859|NCT02175771|592449723|FG004|Treatment Period|Lost to Follow-up|1|||
164023860|NCT02175771|592449724|FG005|Treatment Period|Lost to Follow-up|2|||
164023861|NCT02175771|592449725|FG006|Treatment Period|Lost to Follow-up|1|||
164023862|NCT02175771|592449726|FG007|Treatment Period|Lost to Follow-up|2|||
164023863|NCT02175771|592449727|FG008|Treatment Period|Lost to Follow-up|2|||
164023864|NCT02175771|592449719|FG000|Treatment Period|Lack of Efficacy|0|||
164023865|NCT02175771|592449720|FG001|Treatment Period|Lack of Efficacy|0|||
164023866|NCT02175771|592449721|FG002|Treatment Period|Lack of Efficacy|0|||
164023867|NCT02175771|592449722|FG003|Treatment Period|Lack of Efficacy|0|||
164023868|NCT02175771|592449723|FG004|Treatment Period|Lack of Efficacy|0|||
164023869|NCT02175771|592449724|FG005|Treatment Period|Lack of Efficacy|1|||
164023870|NCT02175771|592449725|FG006|Treatment Period|Lack of Efficacy|0|||
164023871|NCT02175771|592449726|FG007|Treatment Period|Lack of Efficacy|1|||
164023872|NCT02175771|592449727|FG008|Treatment Period|Lack of Efficacy|0|||
164023873|NCT02175771|592449719|FG000|Treatment Period|Other|0|||
164023874|NCT02175771|592449720|FG001|Treatment Period|Other|1|||
164023875|NCT02175771|592449721|FG002|Treatment Period|Other|0|||
164023876|NCT02175771|592449722|FG003|Treatment Period|Other|3|||
164023877|NCT02175771|592449723|FG004|Treatment Period|Other|1|||
164023878|NCT02175771|592449724|FG005|Treatment Period|Other|0|||
164023879|NCT02175771|592449725|FG006|Treatment Period|Other|0|||
164023880|NCT02175771|592449726|FG007|Treatment Period|Other|2|||
164023881|NCT02175771|592449727|FG008|Treatment Period|Other|0|||
164023882|NCT02504268|592449728|FG000|Overall Study|Adverse Event|18|||
164023883|NCT02504268|592449729|FG001|Overall Study|Adverse Event|8|||
164023884|NCT02504268|592449730|FG002|Overall Study|Adverse Event|14|||
164023885|NCT02504268|592449731|FG003|Overall Study|Adverse Event|0|||
164023886|NCT02504268|592449732|FG004|Overall Study|Adverse Event|0|||
164023887|NCT02504268|592449733|FG005|Overall Study|Adverse Event|0|||
164023888|NCT02504268|592449734|FG006|Overall Study|Adverse Event|0|||
164023889|NCT02504268|592449735|FG007|Overall Study|Adverse Event|0|||
164023890|NCT02504268|592449736|FG008|Overall Study|Adverse Event|0|||
164023891|NCT02504268|592449728|FG000|Overall Study|Withdrawal of Consent|11|||
164023892|NCT02504268|592449729|FG001|Overall Study|Withdrawal of Consent|10|||
164023893|NCT02504268|592449730|FG002|Overall Study|Withdrawal of Consent|3|||
164023894|NCT02504268|592449731|FG003|Overall Study|Withdrawal of Consent|0|||
164023895|NCT02504268|592449732|FG004|Overall Study|Withdrawal of Consent|0|||
164023896|NCT02504268|592449733|FG005|Overall Study|Withdrawal of Consent|0|||
164023897|NCT02504268|592449734|FG006|Overall Study|Withdrawal of Consent|0|||
164023898|NCT02504268|592449735|FG007|Overall Study|Withdrawal of Consent|0|||
164023899|NCT02504268|592449736|FG008|Overall Study|Withdrawal of Consent|0|||
164023900|NCT02504268|592449728|FG000|Overall Study|Pregnancy|2|||
164023901|NCT02504268|592449729|FG001|Overall Study|Pregnancy|0|||
164023902|NCT02504268|592449730|FG002|Overall Study|Pregnancy|0|||
164023903|NCT02504268|592449731|FG003|Overall Study|Pregnancy|0|||
164023904|NCT02504268|592449732|FG004|Overall Study|Pregnancy|0|||
164023905|NCT02504268|592449733|FG005|Overall Study|Pregnancy|0|||
164023906|NCT02504268|592449734|FG006|Overall Study|Pregnancy|0|||
164023907|NCT02504268|592449735|FG007|Overall Study|Pregnancy|0|||
164023908|NCT02504268|592449736|FG008|Overall Study|Pregnancy|0|||
164023909|NCT02504268|592449728|FG000|Overall Study|Lost to Follow-up|3|||
164023910|NCT02504268|592449729|FG001|Overall Study|Lost to Follow-up|6|||
164023911|NCT02504268|592449730|FG002|Overall Study|Lost to Follow-up|4|||
164023912|NCT02504268|592449731|FG003|Overall Study|Lost to Follow-up|0|||
164023913|NCT02504268|592449732|FG004|Overall Study|Lost to Follow-up|0|||
164023914|NCT02504268|592449733|FG005|Overall Study|Lost to Follow-up|0|||
164023915|NCT02504268|592449734|FG006|Overall Study|Lost to Follow-up|0|||
164023916|NCT02504268|592449735|FG007|Overall Study|Lost to Follow-up|0|||
164023917|NCT02504268|592449736|FG008|Overall Study|Lost to Follow-up|0|||
164023918|NCT02504268|592449728|FG000|Overall Study|Death|1|||
164023919|NCT02504268|592449729|FG001|Overall Study|Death|1|||
164023920|NCT02504268|592449730|FG002|Overall Study|Death|0|||
164023921|NCT02504268|592449731|FG003|Overall Study|Death|0|||
164023922|NCT02504268|592449732|FG004|Overall Study|Death|0|||
164023923|NCT02504268|592449733|FG005|Overall Study|Death|0|||
164023924|NCT02504268|592449734|FG006|Overall Study|Death|0|||
164023925|NCT02504268|592449735|FG007|Overall Study|Death|0|||
164023926|NCT02504268|592449736|FG008|Overall Study|Death|0|||
164023927|NCT02504268|592449728|FG000|Overall Study|Subject Request to Discontinue|11|||
164023928|NCT02504268|592449729|FG001|Overall Study|Subject Request to Discontinue|3|||
164023929|NCT02504268|592449730|FG002|Overall Study|Subject Request to Discontinue|6|||
164023930|NCT02504268|592449731|FG003|Overall Study|Subject Request to Discontinue|0|||
164023931|NCT02504268|592449732|FG004|Overall Study|Subject Request to Discontinue|0|||
164023932|NCT02504268|592449733|FG005|Overall Study|Subject Request to Discontinue|0|||
164023933|NCT02504268|592449734|FG006|Overall Study|Subject Request to Discontinue|0|||
164023934|NCT02504268|592449735|FG007|Overall Study|Subject Request to Discontinue|0|||
164023935|NCT02504268|592449736|FG008|Overall Study|Subject Request to Discontinue|0|||
164023936|NCT02504268|592449728|FG000|Overall Study|No Longer Meets Study Criteria|2|||
164023937|NCT02504268|592449729|FG001|Overall Study|No Longer Meets Study Criteria|3|||
164023938|NCT02504268|592449730|FG002|Overall Study|No Longer Meets Study Criteria|0|||
164023939|NCT02504268|592449731|FG003|Overall Study|No Longer Meets Study Criteria|0|||
164023940|NCT02504268|592449732|FG004|Overall Study|No Longer Meets Study Criteria|0|||
164023941|NCT02504268|592449733|FG005|Overall Study|No Longer Meets Study Criteria|0|||
164023942|NCT02504268|592449734|FG006|Overall Study|No Longer Meets Study Criteria|0|||
164023943|NCT02504268|592449735|FG007|Overall Study|No Longer Meets Study Criteria|0|||
164023944|NCT02504268|592449736|FG008|Overall Study|No Longer Meets Study Criteria|0|||
164023945|NCT02504268|592449728|FG000|Overall Study|Lack of Efficacy|11|||
164023946|NCT02504268|592449729|FG001|Overall Study|Lack of Efficacy|35|||
164023947|NCT02504268|592449730|FG002|Overall Study|Lack of Efficacy|9|||
164023948|NCT02504268|592449731|FG003|Overall Study|Lack of Efficacy|0|||
164023949|NCT02504268|592449732|FG004|Overall Study|Lack of Efficacy|0|||
164023950|NCT02504268|592449733|FG005|Overall Study|Lack of Efficacy|0|||
164023951|NCT02504268|592449734|FG006|Overall Study|Lack of Efficacy|0|||
164023952|NCT02504268|592449735|FG007|Overall Study|Lack of Efficacy|0|||
164023953|NCT02504268|592449736|FG008|Overall Study|Lack of Efficacy|0|||
164023954|NCT02504268|592449728|FG000|Overall Study|Poor/Non-Compliance|3|||
164023955|NCT02504268|592449729|FG001|Overall Study|Poor/Non-Compliance|2|||
164023956|NCT02504268|592449730|FG002|Overall Study|Poor/Non-Compliance|3|||
164023957|NCT02504268|592449731|FG003|Overall Study|Poor/Non-Compliance|0|||
164023958|NCT02504268|592449732|FG004|Overall Study|Poor/Non-Compliance|0|||
164023959|NCT02504268|592449733|FG005|Overall Study|Poor/Non-Compliance|0|||
164023960|NCT02504268|592449734|FG006|Overall Study|Poor/Non-Compliance|0|||
164023961|NCT02504268|592449735|FG007|Overall Study|Poor/Non-Compliance|0|||
164023962|NCT02504268|592449736|FG008|Overall Study|Poor/Non-Compliance|0|||
164023963|NCT02504268|592449728|FG000|Overall Study|Not Disclosed|1|||
164023964|NCT02504268|592449729|FG001|Overall Study|Not Disclosed|0|||
164023965|NCT02504268|592449730|FG002|Overall Study|Not Disclosed|2|||
164023966|NCT02504268|592449731|FG003|Overall Study|Not Disclosed|0|||
164023967|NCT02504268|592449732|FG004|Overall Study|Not Disclosed|0|||
164023968|NCT02504268|592449733|FG005|Overall Study|Not Disclosed|0|||
164023969|NCT02504268|592449734|FG006|Overall Study|Not Disclosed|0|||
164023970|NCT02504268|592449735|FG007|Overall Study|Not Disclosed|0|||
164023971|NCT02504268|592449736|FG008|Overall Study|Not Disclosed|0|||
164023972|NCT03198754|592449749|FG000|Overall Study|Withdrawal by Subject|5|||
164023973|NCT03198754|592449750|FG001|Overall Study|Withdrawal by Subject|4|||
164023974|NCT03198754|592449749|FG000|Overall Study|Lost to Follow-up|4|||
164023975|NCT03198754|592449750|FG001|Overall Study|Lost to Follow-up|3|||
164023976|NCT03198754|592449749|FG000|Overall Study|Ineligible|2|||
164023977|NCT03198754|592449750|FG001|Overall Study|Ineligible|1|||
164023978|NCT03247413|592449751|FG000|Overall Study|Lost to Follow-up|28|||
164023979|NCT00668200|592449752|FG000|Overall Study|Withdrawal by Subject|2|||
164023980|NCT00668200|592449752|FG000|Overall Study|Lost to Follow-up|1|||
164023981|NCT00642746|592449753|FG000|Overall Study|Patient unevaluable|1|||
164023982|NCT00642746|592449754|FG001|Overall Study|Patient unevaluable|0|||
164023983|NCT00424294|592449758|FG000|Overall Study|Adverse Event|4|||
164023984|NCT00424294|592449759|FG001|Overall Study|Adverse Event|10|||
164023985|NCT00424294|592449758|FG000|Overall Study|Lack of Efficacy|2|||
164023986|NCT00424294|592449759|FG001|Overall Study|Lack of Efficacy|1|||
164023987|NCT00424294|592449758|FG000|Overall Study|Withdrawal by Subject|1|||
164023988|NCT00424294|592449759|FG001|Overall Study|Withdrawal by Subject|2|||
164023989|NCT00424294|592449758|FG000|Overall Study|Other|0|||
164023990|NCT00424294|592449759|FG001|Overall Study|Other|2|||
164023991|NCT00424294|592449758|FG000|Overall Study|Randomized but not Treated|1|||
164023992|NCT00424294|592449759|FG001|Overall Study|Randomized but not Treated|0|||
164023993|NCT01496430|592449760|FG000|Overall Study|Adverse Event|0|||
164023994|NCT01496430|592449761|FG001|Overall Study|Adverse Event|0|||
164023995|NCT01496430|592449762|FG002|Overall Study|Adverse Event|1|||
164023996|NCT01496430|592449760|FG000|Overall Study|Major Protocol Deviation|0|||
164023997|NCT01496430|592449761|FG001|Overall Study|Major Protocol Deviation|0|||
164023998|NCT01496430|592449762|FG002|Overall Study|Major Protocol Deviation|1|||
164023999|NCT01496430|592449760|FG000|Overall Study|Lost to Follow-up|2|||
164024000|NCT01496430|592449761|FG001|Overall Study|Lost to Follow-up|3|||
164024001|NCT01496430|592449762|FG002|Overall Study|Lost to Follow-up|1|||
164024002|NCT01496430|592449760|FG000|Overall Study|Voluntary Withdrawal|2|||
164024003|NCT01496430|592449761|FG001|Overall Study|Voluntary Withdrawal|1|||
164024004|NCT01496430|592449762|FG002|Overall Study|Voluntary Withdrawal|6|||
164024005|NCT01496430|592449760|FG000|Overall Study|Principal Investigator Discretion|0|||
164024006|NCT01496430|592449761|FG001|Overall Study|Principal Investigator Discretion|1|||
164024007|NCT01496430|592449762|FG002|Overall Study|Principal Investigator Discretion|1|||
164024008|NCT01496430|592449760|FG000|Overall Study|Other|2|||
164024009|NCT01496430|592449761|FG001|Overall Study|Other|0|||
164095930|NCT00528606|592715815|FG001|Overall Study|Withdrew consent|3|||
164024010|NCT01496430|592449762|FG002|Overall Study|Other|0|||
164024011|NCT01100307|592449763|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
164024012|NCT01100307|592449764|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
164024013|NCT01100307|592449763|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
164024014|NCT01100307|592449764|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
164024015|NCT01100307|592449763|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
164024016|NCT01100307|592449764|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
164095931|NCT00528606|592715814|FG000|Overall Study|Lost to Follow-up|4|||
164095932|NCT00528606|592715815|FG001|Overall Study|Lost to Follow-up|1|||
164095933|NCT00528606|592715814|FG000|Overall Study|Adverse Event|3|||
164095934|NCT00528606|592715815|FG001|Overall Study|Adverse Event|0|||
164095935|NCT00528606|592715814|FG000|Overall Study|Other|2|||
164095936|NCT00528606|592715815|FG001|Overall Study|Other|0|||
164095937|NCT01471093|592715816|FG000|Overall Study|Adverse Event|1|||
164095938|NCT01471093|592715817|FG001|Overall Study|Adverse Event|0|||
164095939|NCT01471093|592715818|FG002|Overall Study|Adverse Event|0|||
164095940|NCT01471093|592715819|FG003|Overall Study|Adverse Event|0|||
164095941|NCT02475954|592715820|FG000|Overall Study|Withdrawal by Subject|2|||
164095942|NCT02475954|592715821|FG001|Overall Study|Withdrawal by Subject|2|||
164095943|NCT02475954|592715820|FG000|Overall Study|Lost to Follow-up|11|||
164095944|NCT02475954|592715821|FG001|Overall Study|Lost to Follow-up|9|||
164095945|NCT02475954|592715820|FG000|Overall Study|Death|1|||
164095946|NCT02475954|592715821|FG001|Overall Study|Death|1|||
164095947|NCT00880568|592715823|FG000|Overall Study|Disease progression|3|||
164095948|NCT00880568|592715824|FG001|Overall Study|Disease progression|3|||
164095949|NCT00880568|592715825|FG002|Overall Study|Disease progression|3|||
164095950|NCT00880568|592715826|FG003|Overall Study|Disease progression|1|||
164095951|NCT00880568|592715827|FG004|Overall Study|Disease progression|3|||
164095952|NCT00880568|592715828|FG005|Overall Study|Disease progression|3|||
164095953|NCT00880568|592715829|FG006|Overall Study|Disease progression|5|||
164095954|NCT00880568|592715830|FG007|Overall Study|Disease progression|0|||
164095955|NCT00880568|592715831|FG008|Overall Study|Disease progression|3|||
164095956|NCT00880568|592715823|FG000|Overall Study|Adverse Event|0|||
164095957|NCT00880568|592715824|FG001|Overall Study|Adverse Event|0|||
164095958|NCT00880568|592715825|FG002|Overall Study|Adverse Event|0|||
164095959|NCT00880568|592715826|FG003|Overall Study|Adverse Event|0|||
164095960|NCT00880568|592715827|FG004|Overall Study|Adverse Event|0|||
164095961|NCT00880568|592715828|FG005|Overall Study|Adverse Event|0|||
164095962|NCT00880568|592715829|FG006|Overall Study|Adverse Event|1|||
164095963|NCT00880568|592715830|FG007|Overall Study|Adverse Event|1|||
164095964|NCT00880568|592715831|FG008|Overall Study|Adverse Event|0|||
164095965|NCT00880568|592715823|FG000|Overall Study|Withdrawal by Subject|0|||
164095966|NCT00880568|592715824|FG001|Overall Study|Withdrawal by Subject|0|||
164095967|NCT00880568|592715825|FG002|Overall Study|Withdrawal by Subject|0|||
164095968|NCT00880568|592715826|FG003|Overall Study|Withdrawal by Subject|0|||
164095969|NCT00880568|592715827|FG004|Overall Study|Withdrawal by Subject|0|||
164095970|NCT00880568|592715828|FG005|Overall Study|Withdrawal by Subject|0|||
164095971|NCT00880568|592715829|FG006|Overall Study|Withdrawal by Subject|0|||
164095972|NCT00880568|592715830|FG007|Overall Study|Withdrawal by Subject|1|||
164095973|NCT00880568|592715831|FG008|Overall Study|Withdrawal by Subject|0|||
164095974|NCT00620022|592715832|FG000|Treatment Period 1|Adverse Event|4|||
164095975|NCT00620022|592715833|FG001|Treatment Period 1|Adverse Event|6|||
164095976|NCT00620022|592715832|FG000|Treatment Period 1|Subject withdrew consent|1|||
164095977|NCT00620022|592715833|FG001|Treatment Period 1|Subject withdrew consent|0|||
164095978|NCT00620022|592715832|FG000|Treatment Period 2|Adverse Event|2|||
164024017|NCT01100307|592449763|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
164024018|NCT01100307|592449764|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
164024019|NCT01100307|592449763|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
164024020|NCT01100307|592449764|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
164024021|NCT01100307|592449763|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
164024022|NCT01100307|592449764|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
164024023|NCT02108951|592449765|FG000|Overall Study|Lost to Follow-up|1|||
164024024|NCT02108951|592449765|FG000|Overall Study|Patient's/guardian's decision|1|||
164024025|NCT02108951|592449765|FG000|Overall Study|Study Terminated by Sponsor|14|||
164095979|NCT00620022|592715833|FG001|Treatment Period 2|Adverse Event|2|||
164095980|NCT00925769|592715837|FG000|Overall Study|Major toxicity|1|||
164095981|NCT00925769|592715838|FG001|Overall Study|Major toxicity|0|||
164095982|NCT00925769|592715839|FG002|Overall Study|Major toxicity|1|||
164095983|NCT00925769|592715840|FG003|Overall Study|Major toxicity|1|||
164024026|NCT00997321|592449766|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
164024027|NCT00997321|592449767|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
164024028|NCT01151579|592449776|FG000|Overall Study|Physician Decision|3|||
164024029|NCT01151579|592449777|FG001|Overall Study|Physician Decision|1|||
164024030|NCT01151579|592449776|FG000|Overall Study|Withdrawal by Subject|3|||
164095984|NCT00925769|592715841|FG004|Overall Study|Major toxicity|0|||
164095985|NCT00925769|592715842|FG005|Overall Study|Major toxicity|0|||
164095986|NCT00925769|592715837|FG000|Overall Study|Disease progression|4|||
164095987|NCT00925769|592715838|FG001|Overall Study|Disease progression|5|||
164095988|NCT00925769|592715839|FG002|Overall Study|Disease progression|3|||
164095989|NCT00925769|592715840|FG003|Overall Study|Disease progression|4|||
164095990|NCT00925769|592715841|FG004|Overall Study|Disease progression|2|||
164095991|NCT00925769|592715842|FG005|Overall Study|Disease progression|3|||
164095992|NCT00925769|592715837|FG000|Overall Study|Death|0|||
164024031|NCT01151579|592449777|FG001|Overall Study|Withdrawal by Subject|2|||
164024032|NCT01151579|592449776|FG000|Overall Study|Not meet inclusion criteria|6|||
164024033|NCT01151579|592449777|FG001|Overall Study|Not meet inclusion criteria|4|||
164024034|NCT00608530|592449778|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
164024035|NCT00608530|592449779|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
164024036|NCT00608530|592449780|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
164024037|NCT00608530|592449781|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
164024038|NCT00608530|592449778|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
164024039|NCT00608530|592449779|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
164024040|NCT00608530|592449780|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
164024041|NCT00608530|592449781|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
164024042|NCT00608530|592449778|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
164024043|NCT00608530|592449779|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
164024044|NCT00608530|592449780|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
164024045|NCT00608530|592449781|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
164024046|NCT00608530|592449778|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
164024047|NCT00608530|592449779|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
164024048|NCT00608530|592449780|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
164024049|NCT00608530|592449781|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
164024050|NCT00608530|592449778|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
164024051|NCT00608530|592449779|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
164024052|NCT00608530|592449780|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
164024053|NCT00608530|592449781|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
164024054|NCT00608530|592449778|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
164024055|NCT00608530|592449779|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
164024056|NCT00608530|592449780|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
164024057|NCT00608530|592449781|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
164024058|NCT00077610|592449782|FG000|Overall Study|Adverse Event|9|||
164024059|NCT00077610|592449783|FG001|Overall Study|Adverse Event|7|||
164024060|NCT00077610|592449784|FG002|Overall Study|Adverse Event|1|||
164024061|NCT00077610|592449782|FG000|Overall Study|Lost to Follow-up|0|||
164024062|NCT00077610|592449783|FG001|Overall Study|Lost to Follow-up|1|||
164024063|NCT00077610|592449784|FG002|Overall Study|Lost to Follow-up|2|||
164024064|NCT00077610|592449782|FG000|Overall Study|Withdrawal by Subject|4|||
164024065|NCT00077610|592449783|FG001|Overall Study|Withdrawal by Subject|10|||
164024066|NCT00077610|592449784|FG002|Overall Study|Withdrawal by Subject|6|||
164024067|NCT00077610|592449782|FG000|Overall Study|Death|17|||
164024068|NCT00077610|592449783|FG001|Overall Study|Death|13|||
164024069|NCT00077610|592449784|FG002|Overall Study|Death|13|||
164024070|NCT00077610|592449782|FG000|Overall Study|Renal transplant|12|||
164024071|NCT00077610|592449783|FG001|Overall Study|Renal transplant|15|||
164024072|NCT00077610|592449784|FG002|Overall Study|Renal transplant|11|||
164024073|NCT00077610|592449782|FG000|Overall Study|Withdrew from dialysis care|5|||
164024074|NCT00077610|592449783|FG001|Overall Study|Withdrew from dialysis care|0|||
164024075|NCT00077610|592449784|FG002|Overall Study|Withdrew from dialysis care|3|||
164024076|NCT00077610|592449782|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164024077|NCT00077610|592449783|FG001|Overall Study|Insufficient Therapeutic Response|0|||
164024078|NCT00077610|592449784|FG002|Overall Study|Insufficient Therapeutic Response|0|||
164024079|NCT00077610|592449782|FG000|Overall Study|Multiple blood transfusions|0|||
164024080|NCT00077610|592449783|FG001|Overall Study|Multiple blood transfusions|0|||
164024081|NCT00077610|592449784|FG002|Overall Study|Multiple blood transfusions|1|||
164024082|NCT00077610|592449782|FG000|Overall Study|Principal Investigator's decision|1|||
164024083|NCT00077610|592449783|FG001|Overall Study|Principal Investigator's decision|0|||
164024084|NCT00077610|592449784|FG002|Overall Study|Principal Investigator's decision|1|||
164024085|NCT00077610|592449782|FG000|Overall Study|Worsening of health condition|1|||
164024086|NCT00077610|592449783|FG001|Overall Study|Worsening of health condition|1|||
164024087|NCT00077610|592449784|FG002|Overall Study|Worsening of health condition|0|||
164024088|NCT00077610|592449782|FG000|Overall Study|Given Epogen in hospital|1|||
164024089|NCT00077610|592449783|FG001|Overall Study|Given Epogen in hospital|0|||
164024090|NCT00077610|592449784|FG002|Overall Study|Given Epogen in hospital|0|||
164024091|NCT00077610|592449782|FG000|Overall Study|Transferred to other unit|0|||
164024092|NCT00077610|592449783|FG001|Overall Study|Transferred to other unit|0|||
164095993|NCT00925769|592715838|FG001|Overall Study|Death|0|||
164095994|NCT00925769|592715839|FG002|Overall Study|Death|1|||
164024093|NCT00077610|592449784|FG002|Overall Study|Transferred to other unit|1|||
164024094|NCT00077610|592449782|FG000|Overall Study|Transferred to nursing home|0|||
164024095|NCT00077610|592449783|FG001|Overall Study|Transferred to nursing home|0|||
164024096|NCT00077610|592449784|FG002|Overall Study|Transferred to nursing home|1|||
164024097|NCT00077610|592449782|FG000|Overall Study|Transfer to satellite unit|1|||
164024098|NCT00077610|592449783|FG001|Overall Study|Transfer to satellite unit|0|||
164024099|NCT00077610|592449784|FG002|Overall Study|Transfer to satellite unit|0|||
164024100|NCT00077610|592449782|FG000|Overall Study|Transfer to other center for surgery|1|||
164024101|NCT00077610|592449783|FG001|Overall Study|Transfer to other center for surgery|0|||
164024102|NCT00077610|592449784|FG002|Overall Study|Transfer to other center for surgery|0|||
164024103|NCT00077610|592449782|FG000|Overall Study|Change in dialysis modality|1|||
164024104|NCT00077610|592449783|FG001|Overall Study|Change in dialysis modality|0|||
164024105|NCT00077610|592449784|FG002|Overall Study|Change in dialysis modality|0|||
164024106|NCT00077610|592449782|FG000|Overall Study|Relocation|0|||
164024107|NCT00077610|592449783|FG001|Overall Study|Relocation|8|||
164024108|NCT00077610|592449784|FG002|Overall Study|Relocation|5|||
164024109|NCT00077610|592449782|FG000|Overall Study|Financial issues|0|||
164024110|NCT00077610|592449783|FG001|Overall Study|Financial issues|1|||
164024111|NCT00077610|592449784|FG002|Overall Study|Financial issues|0|||
164024112|NCT00077610|592449782|FG000|Overall Study|Sponsors decision to withdraw|0|||
164024113|NCT00077610|592449783|FG001|Overall Study|Sponsors decision to withdraw|0|||
164024114|NCT00077610|592449784|FG002|Overall Study|Sponsors decision to withdraw|1|||
164024115|NCT01357915|592449788|FG000|Overall Study|Lost to Follow-up|3|||
164024116|NCT01357915|592449789|FG001|Overall Study|Lost to Follow-up|0|||
164024117|NCT00305253|592449792|FG000|Overall Study|Withdrawal by Subject|0|||
164024118|NCT00305253|592449793|FG001|Overall Study|Withdrawal by Subject|1|||
164024119|NCT01098461|592449794|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
164024120|NCT01098461|592449795|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
164024121|NCT01098461|592449796|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
164024122|NCT01098461|592449797|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
164024123|NCT01098461|592449794|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
164024124|NCT01098461|592449795|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
164024125|NCT01098461|592449796|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
164024126|NCT01098461|592449797|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
164024127|NCT01098461|592449794|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
164024128|NCT01098461|592449795|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
164024129|NCT01098461|592449796|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
164024130|NCT01098461|592449797|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
164024131|NCT01098461|592449794|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
164024132|NCT01098461|592449795|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
164024133|NCT01098461|592449796|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
164024134|NCT01098461|592449797|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
164024135|NCT01098461|592449794|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
164095995|NCT00925769|592715840|FG003|Overall Study|Death|0|||
164095996|NCT00925769|592715841|FG004|Overall Study|Death|0|||
164095997|NCT00925769|592715842|FG005|Overall Study|Death|0|||
164095998|NCT00925769|592715837|FG000|Overall Study|Physician Decision|1|||
164095999|NCT00925769|592715838|FG001|Overall Study|Physician Decision|0|||
164096000|NCT00925769|592715839|FG002|Overall Study|Physician Decision|0|||
164096001|NCT00925769|592715840|FG003|Overall Study|Physician Decision|0|||
164096002|NCT00925769|592715841|FG004|Overall Study|Physician Decision|0|||
164096003|NCT00925769|592715842|FG005|Overall Study|Physician Decision|0|||
164096004|NCT00925769|592715837|FG000|Overall Study|Missing documentation|0|||
164096005|NCT00925769|592715838|FG001|Overall Study|Missing documentation|1|||
164096006|NCT00925769|592715839|FG002|Overall Study|Missing documentation|0|||
164096007|NCT00925769|592715840|FG003|Overall Study|Missing documentation|0|||
164096008|NCT00925769|592715841|FG004|Overall Study|Missing documentation|0|||
164096009|NCT00925769|592715842|FG005|Overall Study|Missing documentation|0|||
164096010|NCT00925769|592715837|FG000|Overall Study|End of study visit not done|0|||
164096011|NCT00925769|592715838|FG001|Overall Study|End of study visit not done|0|||
164096012|NCT00925769|592715839|FG002|Overall Study|End of study visit not done|1|||
164096013|NCT00925769|592715840|FG003|Overall Study|End of study visit not done|0|||
164096014|NCT00925769|592715841|FG004|Overall Study|End of study visit not done|0|||
164096015|NCT00925769|592715842|FG005|Overall Study|End of study visit not done|0|||
164096016|NCT00925769|592715837|FG000|Overall Study|Participant is unable to swallow drug|0|||
164096017|NCT00925769|592715838|FG001|Overall Study|Participant is unable to swallow drug|0|||
164096018|NCT00925769|592715839|FG002|Overall Study|Participant is unable to swallow drug|0|||
164096019|NCT00925769|592715840|FG003|Overall Study|Participant is unable to swallow drug|1|||
164096020|NCT00925769|592715841|FG004|Overall Study|Participant is unable to swallow drug|0|||
164096021|NCT00925769|592715842|FG005|Overall Study|Participant is unable to swallow drug|0|||
164096022|NCT00925769|592715837|FG000|Overall Study|Adverse Event|0|||
164096023|NCT00925769|592715838|FG001|Overall Study|Adverse Event|0|||
164096024|NCT00925769|592715839|FG002|Overall Study|Adverse Event|0|||
164096025|NCT00925769|592715840|FG003|Overall Study|Adverse Event|0|||
164096026|NCT00925769|592715841|FG004|Overall Study|Adverse Event|1|||
164096027|NCT00925769|592715842|FG005|Overall Study|Adverse Event|0|||
164096028|NCT04006171|592715843|FG000|Overall Study|Withdrawal by Subject|8|||
164096029|NCT04006171|592715844|FG001|Overall Study|Withdrawal by Subject|7|||
164096030|NCT04006171|592715843|FG000|Overall Study|missing serum samples|2|||
164096031|NCT04006171|592715844|FG001|Overall Study|missing serum samples|2|||
164096032|NCT04006171|592715843|FG000|Overall Study|insufficient sample volume|2|||
164096033|NCT04006171|592715844|FG001|Overall Study|insufficient sample volume|3|||
164096034|NCT03049488|592715846|FG000|Overall Study|Lost to Follow-up|1|||
164096035|NCT03049488|592715847|FG001|Overall Study|Lost to Follow-up|1|||
164096036|NCT03049488|592715848|FG002|Overall Study|Lost to Follow-up|0|||
164096037|NCT03049488|592715849|FG003|Overall Study|Lost to Follow-up|0|||
164024136|NCT01098461|592449795|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
164024137|NCT01098461|592449796|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
164024138|NCT01098461|592449797|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
164024139|NCT01098461|592449794|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
164024140|NCT01098461|592449795|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
164024141|NCT01098461|592449796|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
164024142|NCT01098461|592449797|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
164024143|NCT01098461|592449794|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
164024144|NCT01098461|592449795|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
164024145|NCT01098461|592449796|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
164024146|NCT01098461|592449797|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
164024147|NCT02662985|592449798|FG000|Treatment Period 1|Adverse Event|0|||
164024148|NCT02662985|592449799|FG001|Treatment Period 1|Adverse Event|2|||
164024149|NCT02662985|592449798|FG000|Treatment Period 1|Protocol Violation|0|||
164024150|NCT02662985|592449799|FG001|Treatment Period 1|Protocol Violation|1|||
164024151|NCT02662985|592449798|FG000|Treatment Period 1|Physician Decision|1|||
164024152|NCT02662985|592449799|FG001|Treatment Period 1|Physician Decision|0|||
164024153|NCT02662985|592449798|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164024154|NCT02662985|592449799|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164024155|NCT02662985|592449798|FG000|Treatment Period 2|Lack of Efficacy|0|||
164024156|NCT02662985|592449799|FG001|Treatment Period 2|Lack of Efficacy|1|||
164024157|NCT02662985|592449798|FG000|Treatment Period 2|Lost to Follow-up|1|||
164024158|NCT02662985|592449799|FG001|Treatment Period 2|Lost to Follow-up|0|||
164024159|NCT02662985|592449798|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
163910307|NCT04361617|592041774|FG001|Overall Study|Withdrawal by Subject|1|||
163910308|NCT01263223|592041775|FG000|Period 2|Withdrawal by Subject|0|||
163910309|NCT01263223|592041776|FG001|Period 2|Withdrawal by Subject|1|||
163910310|NCT01263223|592041775|FG000|7-day Follow-up|Withdrawal by Subject|0|||
163910311|NCT01263223|592041776|FG001|7-day Follow-up|Withdrawal by Subject|1|||
163910312|NCT01263223|592041775|FG000|7-day Follow-up|Lost to Follow-up|1|||
163910313|NCT01263223|592041776|FG001|7-day Follow-up|Lost to Follow-up|0|||
163910314|NCT03695185|592041777|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
163910315|NCT03695185|592041777|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
163910316|NCT03695185|592041777|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
163910317|NCT03695185|592041777|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
163910318|NCT03695185|592041777|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
163910319|NCT03695185|592041777|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
164024160|NCT02662985|592449799|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
164024161|NCT02662985|592449798|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
164024162|NCT02662985|592449799|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
164024163|NCT02662985|592449798|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
164024164|NCT02662985|592449799|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
164024165|NCT02662985|592449798|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
164024166|NCT02662985|592449799|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
164024167|NCT02662985|592449798|FG000|Treatment Period 3 (Extension Period)|Death|0|||
164024168|NCT02662985|592449799|FG001|Treatment Period 3 (Extension Period)|Death|1|||
164024169|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
164024170|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
164024171|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Death|2|||
164024172|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Death|1|||
164024173|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
164024174|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
164024175|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
164024176|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
163910320|NCT04183491|592041780|FG000|Overall Study|Withdrawal by Subject|0|||
164096038|NCT03049488|592715850|FG004|Overall Study|Lost to Follow-up|0|||
164096039|NCT03049488|592715851|FG005|Overall Study|Lost to Follow-up|0|||
164096040|NCT03049488|592715846|FG000|Overall Study|Moved from Area|1|||
164024177|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
164024178|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
164024179|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
164024180|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
164024181|NCT03633227|592449800|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
164024182|NCT03633227|592449801|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
164024183|NCT03633227|592449800|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
164024184|NCT03633227|592449801|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
164024185|NCT03633227|592449800|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
164024186|NCT03633227|592449801|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
164024187|NCT03633227|592449800|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
164024188|NCT03633227|592449801|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
164024189|NCT03633227|592449800|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
164024190|NCT03633227|592449801|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
164024191|NCT03633227|592449800|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
164024192|NCT03633227|592449801|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
164024193|NCT01067508|592449811|FG000|Overall Study|Physician Decision|0|||
164024194|NCT01067508|592449812|FG001|Overall Study|Physician Decision|1|||
164024195|NCT01067508|592449811|FG000|Overall Study|Withdrawal by Subject|0|||
164024196|NCT01067508|592449812|FG001|Overall Study|Withdrawal by Subject|1|||
164024197|NCT00632463|592449817|FG000|Overall Study|Adverse Event|0|||
164024198|NCT00632463|592449818|FG001|Overall Study|Adverse Event|1|||
164024199|NCT00632463|592449819|FG002|Overall Study|Adverse Event|0|||
164024200|NCT02065622|592449820|FG000|Induction Study|Adverse Event|13|||
164024201|NCT02065622|592449821|FG001|Induction Study|Adverse Event|19|||
164024202|NCT02065622|592449822|FG002|Induction Study|Adverse Event|0|||
164024203|NCT02065622|592449823|FG003|Induction Study|Adverse Event|0|||
164024204|NCT02065622|592449824|FG004|Induction Study|Adverse Event|0|||
164024205|NCT02065622|592449820|FG000|Induction Study|Withdrawal by Subject|3|||
164024206|NCT02065622|592449821|FG001|Induction Study|Withdrawal by Subject|5|||
164024207|NCT02065622|592449822|FG002|Induction Study|Withdrawal by Subject|0|||
164024208|NCT02065622|592449823|FG003|Induction Study|Withdrawal by Subject|0|||
164024209|NCT02065622|592449824|FG004|Induction Study|Withdrawal by Subject|0|||
164024210|NCT02065622|592449820|FG000|Induction Study|Lost to Follow-up|1|||
164024211|NCT02065622|592449821|FG001|Induction Study|Lost to Follow-up|0|||
164024212|NCT02065622|592449822|FG002|Induction Study|Lost to Follow-up|0|||
164024213|NCT02065622|592449823|FG003|Induction Study|Lost to Follow-up|0|||
164024214|NCT02065622|592449824|FG004|Induction Study|Lost to Follow-up|0|||
164024215|NCT02065622|592449820|FG000|Induction Study|Lack of Efficacy|22|||
164024216|NCT02065622|592449821|FG001|Induction Study|Lack of Efficacy|27|||
164024217|NCT02065622|592449822|FG002|Induction Study|Lack of Efficacy|0|||
164024218|NCT02065622|592449823|FG003|Induction Study|Lack of Efficacy|0|||
164024219|NCT02065622|592449824|FG004|Induction Study|Lack of Efficacy|0|||
164024220|NCT02065622|592449820|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
164024221|NCT02065622|592449821|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
164024222|NCT02065622|592449822|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
164024223|NCT02065622|592449823|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
164024224|NCT02065622|592449824|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
164024225|NCT02065622|592449820|FG000|Induction Study|Subject Noncompliance|1|||
164024226|NCT02065622|592449821|FG001|Induction Study|Subject Noncompliance|1|||
164096041|NCT03049488|592715847|FG001|Overall Study|Moved from Area|0|||
164096042|NCT03049488|592715848|FG002|Overall Study|Moved from Area|0|||
164096043|NCT03049488|592715849|FG003|Overall Study|Moved from Area|1|||
164024227|NCT02065622|592449822|FG002|Induction Study|Subject Noncompliance|0|||
164024228|NCT02065622|592449823|FG003|Induction Study|Subject Noncompliance|0|||
164024229|NCT02065622|592449824|FG004|Induction Study|Subject Noncompliance|0|||
164024230|NCT02065622|592449820|FG000|Induction Study|Other, Not Specified|3|||
164024231|NCT02065622|592449821|FG001|Induction Study|Other, Not Specified|2|||
164024232|NCT02065622|592449822|FG002|Induction Study|Other, Not Specified|0|||
164024233|NCT02065622|592449823|FG003|Induction Study|Other, Not Specified|0|||
164024234|NCT02065622|592449824|FG004|Induction Study|Other, Not Specified|0|||
164024235|NCT02065622|592449820|FG000|Maintenance Study|Adverse Event|0|||
164024236|NCT02065622|592449821|FG001|Maintenance Study|Adverse Event|0|||
164024237|NCT02065622|592449822|FG002|Maintenance Study|Adverse Event|25|||
164024238|NCT02065622|592449823|FG003|Maintenance Study|Adverse Event|22|||
164024239|NCT02065622|592449824|FG004|Maintenance Study|Adverse Event|11|||
164024240|NCT02065622|592449820|FG000|Maintenance Study|Withdrawal by Subject|0|||
164024241|NCT02065622|592449821|FG001|Maintenance Study|Withdrawal by Subject|0|||
164024242|NCT02065622|592449822|FG002|Maintenance Study|Withdrawal by Subject|11|||
164024243|NCT02065622|592449823|FG003|Maintenance Study|Withdrawal by Subject|5|||
164024244|NCT02065622|592449824|FG004|Maintenance Study|Withdrawal by Subject|7|||
164024245|NCT02065622|592449820|FG000|Maintenance Study|Lost to Follow-up|0|||
164024246|NCT02065622|592449821|FG001|Maintenance Study|Lost to Follow-up|0|||
164024247|NCT02065622|592449822|FG002|Maintenance Study|Lost to Follow-up|4|||
164024248|NCT02065622|592449823|FG003|Maintenance Study|Lost to Follow-up|1|||
164024249|NCT02065622|592449824|FG004|Maintenance Study|Lost to Follow-up|1|||
164024250|NCT02065622|592449820|FG000|Maintenance Study|Lack of Efficacy|0|||
164024251|NCT02065622|592449821|FG001|Maintenance Study|Lack of Efficacy|0|||
164024252|NCT02065622|592449822|FG002|Maintenance Study|Lack of Efficacy|70|||
164024253|NCT02065622|592449823|FG003|Maintenance Study|Lack of Efficacy|55|||
164024254|NCT02065622|592449824|FG004|Maintenance Study|Lack of Efficacy|19|||
164024255|NCT02065622|592449820|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
164024256|NCT02065622|592449821|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
164024257|NCT02065622|592449822|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
164024258|NCT02065622|592449823|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
164024259|NCT02065622|592449824|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
164024260|NCT02065622|592449820|FG000|Maintenance Study|Subject Non-Compliance|0|||
164024261|NCT02065622|592449821|FG001|Maintenance Study|Subject Non-Compliance|0|||
164024262|NCT02065622|592449822|FG002|Maintenance Study|Subject Non-Compliance|1|||
164024263|NCT02065622|592449823|FG003|Maintenance Study|Subject Non-Compliance|3|||
164024264|NCT02065622|592449824|FG004|Maintenance Study|Subject Non-Compliance|2|||
164024265|NCT02065622|592449820|FG000|Maintenance Study|Other, Not Specified|0|||
164024266|NCT02065622|592449821|FG001|Maintenance Study|Other, Not Specified|0|||
164024267|NCT02065622|592449822|FG002|Maintenance Study|Other, Not Specified|6|||
164024268|NCT02065622|592449823|FG003|Maintenance Study|Other, Not Specified|14|||
164024269|NCT02065622|592449824|FG004|Maintenance Study|Other, Not Specified|2|||
164024270|NCT02065622|592449820|FG000|Maintenance Study|Unknown Reason|0|||
164024271|NCT02065622|592449821|FG001|Maintenance Study|Unknown Reason|0|||
164024272|NCT02065622|592449822|FG002|Maintenance Study|Unknown Reason|0|||
164024273|NCT02065622|592449823|FG003|Maintenance Study|Unknown Reason|1|||
164024274|NCT02065622|592449824|FG004|Maintenance Study|Unknown Reason|0|||
164024275|NCT04973228|592449833|FG000|Overall Study|Adverse Event|2|||
164024276|NCT04973228|592449834|FG001|Overall Study|Adverse Event|3|||
164024277|NCT04973228|592449833|FG000|Overall Study|Lack of Efficacy|1|||
164024278|NCT04973228|592449834|FG001|Overall Study|Lack of Efficacy|3|||
164024279|NCT04973228|592449833|FG000|Overall Study|Lost to Follow-up|12|||
164024280|NCT04973228|592449834|FG001|Overall Study|Lost to Follow-up|4|||
164024281|NCT04973228|592449833|FG000|Overall Study|Withdrawal by Subject|11|||
164024282|NCT04973228|592449834|FG001|Overall Study|Withdrawal by Subject|4|||
164024283|NCT04973228|592449833|FG000|Overall Study|Did not tolerate application|1|||
164024284|NCT04973228|592449834|FG001|Overall Study|Did not tolerate application|0|||
164024285|NCT04973228|592449833|FG000|Overall Study|Wanted to early terminate and use own product|0|||
164024286|NCT04973228|592449834|FG001|Overall Study|Wanted to early terminate and use own product|1|||
164024287|NCT04973228|592449833|FG000|Overall Study|Missed visits due to new work schedule|1|||
164024288|NCT04973228|592449834|FG001|Overall Study|Missed visits due to new work schedule|0|||
164024289|NCT03073213|592451548|FG000|Multiple Dose Period|Protocol Violation|0|||
164024290|NCT03073213|592451549|FG001|Multiple Dose Period|Protocol Violation|0|||
164024291|NCT03073213|592451550|FG002|Multiple Dose Period|Protocol Violation|1|||
164024292|NCT00296725|592451560|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
164024293|NCT00296725|592451560|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
164024294|NCT00296725|592451560|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
164024295|NCT00356863|592451561|FG000|Overall Study|Death|16|||
164024296|NCT00356863|592451562|FG001|Overall Study|Death|32|||
164024297|NCT00356863|592451561|FG000|Overall Study|Lost to Follow-up|76|||
164024298|NCT00356863|592451562|FG001|Overall Study|Lost to Follow-up|43|||
164024299|NCT00836277|592451573|FG000|Overall Study|Not evaluable for response|6|||
164024300|NCT00333619|592451574|FG000|Overall Study|Death|12|||
164024301|NCT00333619|592451575|FG001|Overall Study|Death|6|||
164024302|NCT00333619|592451574|FG000|Overall Study|Withdrawal by Subject|6|||
164024303|NCT00333619|592451575|FG001|Overall Study|Withdrawal by Subject|1|||
164024304|NCT00333619|592451574|FG000|Overall Study|Lost to Follow-up|3|||
164024305|NCT00333619|592451575|FG001|Overall Study|Lost to Follow-up|3|||
164024306|NCT00280150|592451576|FG000|Overall Study|Adverse Event|0|||
164024307|NCT00280150|592451577|FG001|Overall Study|Adverse Event|1|||
164024308|NCT00280150|592451578|FG002|Overall Study|Adverse Event|2|||
164024309|NCT00280150|592451579|FG003|Overall Study|Adverse Event|3|||
164024310|NCT00280150|592451576|FG000|Overall Study|Lack of Efficacy|0|||
164024311|NCT00280150|592451577|FG001|Overall Study|Lack of Efficacy|0|||
164024312|NCT00280150|592451578|FG002|Overall Study|Lack of Efficacy|0|||
164096044|NCT03049488|592715850|FG004|Overall Study|Moved from Area|1|||
164024313|NCT00280150|592451579|FG003|Overall Study|Lack of Efficacy|3|||
164024314|NCT00280150|592451576|FG000|Overall Study|Physician Decision|0|||
164096045|NCT03049488|592715851|FG005|Overall Study|Moved from Area|0|||
164024315|NCT00280150|592451577|FG001|Overall Study|Physician Decision|0|||
164024316|NCT00280150|592451578|FG002|Overall Study|Physician Decision|0|||
164024317|NCT00280150|592451579|FG003|Overall Study|Physician Decision|1|||
164024318|NCT00280150|592451576|FG000|Overall Study|Protocol Violation|0|||
164024319|NCT00280150|592451577|FG001|Overall Study|Protocol Violation|0|||
164024320|NCT00280150|592451578|FG002|Overall Study|Protocol Violation|0|||
164024321|NCT00280150|592451579|FG003|Overall Study|Protocol Violation|1|||
164024322|NCT00280150|592451576|FG000|Overall Study|Withdrawal by Subject|0|||
164024323|NCT00280150|592451577|FG001|Overall Study|Withdrawal by Subject|0|||
164024324|NCT00280150|592451578|FG002|Overall Study|Withdrawal by Subject|0|||
164024325|NCT00280150|592451579|FG003|Overall Study|Withdrawal by Subject|1|||
164024326|NCT00280150|592451576|FG000|Overall Study|Did not get consolidation therapy|3|||
164024327|NCT00280150|592451577|FG001|Overall Study|Did not get consolidation therapy|0|||
164024328|NCT00280150|592451578|FG002|Overall Study|Did not get consolidation therapy|3|||
164024329|NCT00280150|592451579|FG003|Overall Study|Did not get consolidation therapy|0|||
164024330|NCT00280150|592451576|FG000|Overall Study|Declining Performance Status|0|||
164024331|NCT00280150|592451577|FG001|Overall Study|Declining Performance Status|0|||
164024332|NCT00280150|592451578|FG002|Overall Study|Declining Performance Status|0|||
164024333|NCT00280150|592451579|FG003|Overall Study|Declining Performance Status|1|||
164024334|NCT01120379|592451595|FG000|One Year Timepoint|Withdrawal by Subject|41|||
164024335|NCT01120379|592451595|FG000|One Year Timepoint|Lost to Follow-up|115|||
164024336|NCT01120379|592451595|FG000|One Year Timepoint|Death|108|||
164024337|NCT01120379|592451595|FG000|One Year Timepoint|Physician Decision|9|||
164024338|NCT01120379|592451595|FG000|One Year Timepoint|Any other reason for early termination|5|||
164024339|NCT01120379|592451595|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
164024340|NCT01120379|592451595|FG000|Two Year Timepoint|Lost to Follow-up|87|||
164024341|NCT01120379|592451595|FG000|Two Year Timepoint|Death|123|||
164024342|NCT01120379|592451595|FG000|Two Year Timepoint|Physician Decision|12|||
164024343|NCT01120379|592451595|FG000|Two Year Timepoint|Any other reason for early termination|4|||
164024344|NCT01120379|592451595|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
164024345|NCT01120379|592451595|FG000|Three Year Timepoint|Lost to Follow-up|43|||
164024346|NCT01120379|592451595|FG000|Three Year Timepoint|Death|120|||
164024347|NCT01120379|592451595|FG000|Three Year Timepoint|Physician Decision|9|||
164024348|NCT01120379|592451595|FG000|Three Year Timepoint|Any other reason for early termination|17|||
164024349|NCT01120379|592451595|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
164024350|NCT01120379|592451595|FG000|Four Year Timepoint|Lost to Follow-up|10|||
164024351|NCT01120379|592451595|FG000|Four Year Timepoint|Death|131|||
164024352|NCT01120379|592451595|FG000|Four Year Timepoint|Physician Decision|5|||
164024353|NCT01120379|592451595|FG000|Four Year Timepoint|Any other reason for early termination|217|||
164024354|NCT03162055|592451596|FG000|Overall Study|Adverse Event|6|||
164024355|NCT03162055|592451597|FG001|Overall Study|Adverse Event|5|||
164024356|NCT03162055|592451596|FG000|Overall Study|Death|3|||
164024357|NCT03162055|592451597|FG001|Overall Study|Death|3|||
164024358|NCT03162055|592451596|FG000|Overall Study|Lost to Follow-up|0|||
164024359|NCT03162055|592451597|FG001|Overall Study|Lost to Follow-up|1|||
164024360|NCT03162055|592451596|FG000|Overall Study|Study-specific withdrawal criteria|22|||
164024361|NCT03162055|592451597|FG001|Overall Study|Study-specific withdrawal criteria|14|||
164024362|NCT03162055|592451596|FG000|Overall Study|Withdrawal by Subject|17|||
164024363|NCT03162055|592451597|FG001|Overall Study|Withdrawal by Subject|2|||
164024364|NCT03162055|592451596|FG000|Overall Study|Did not receive treatment|2|||
164024365|NCT03162055|592451597|FG001|Overall Study|Did not receive treatment|0|||
164024366|NCT03162055|592451596|FG000|Overall Study|Incorrect randomization|4|||
164024367|NCT03162055|592451597|FG001|Overall Study|Incorrect randomization|3|||
164024368|NCT03162055|592451596|FG000|Overall Study|Other|8|||
164024369|NCT03162055|592451597|FG001|Overall Study|Other|15|||
164024370|NCT04031404|592451598|FG000|Baseline|Lost to Follow-up|0|||
164024371|NCT04031404|592451599|FG001|Baseline|Lost to Follow-up|1|||
164024372|NCT04031404|592451598|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
164024373|NCT04031404|592451599|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
164024374|NCT04031404|592451598|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
164024375|NCT04031404|592451599|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
164024376|NCT04031404|592451598|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
164024377|NCT04031404|592451599|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
164024378|NCT04031404|592451598|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
164024379|NCT04031404|592451599|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
164024380|NCT01993615|592451603|FG000|Overall Study|Death|1|||
164024381|NCT01993615|592451604|FG001|Overall Study|Death|0|||
164024382|NCT02064205|592451607|FG000|Overall Study|Withdrawal by Subject|1|||
164024383|NCT01354353|592451611|FG000|Overall Study|Adverse Event|1|||
164024384|NCT01354353|592451612|FG001|Overall Study|Adverse Event|0|||
164024385|NCT01354353|592451613|FG002|Overall Study|Adverse Event|0|||
164024386|NCT01354353|592451614|FG003|Overall Study|Adverse Event|4|||
164024387|NCT01354353|592451615|FG004|Overall Study|Adverse Event|0|||
164024388|NCT01354353|592451616|FG005|Overall Study|Adverse Event|5|||
164024389|NCT01354353|592451611|FG000|Overall Study|Entry Criteria Not Met|0|||
164024390|NCT01354353|592451612|FG001|Overall Study|Entry Criteria Not Met|0|||
164024391|NCT01354353|592451613|FG002|Overall Study|Entry Criteria Not Met|0|||
164024392|NCT01354353|592451614|FG003|Overall Study|Entry Criteria Not Met|1|||
164024393|NCT01354353|592451615|FG004|Overall Study|Entry Criteria Not Met|1|||
164024394|NCT01354353|592451616|FG005|Overall Study|Entry Criteria Not Met|0|||
164024395|NCT01354353|592451611|FG000|Overall Study|Physician Decision|0|||
164024396|NCT01354353|592451612|FG001|Overall Study|Physician Decision|1|||
164024397|NCT01354353|592451613|FG002|Overall Study|Physician Decision|1|||
164024398|NCT01354353|592451614|FG003|Overall Study|Physician Decision|0|||
164024399|NCT01354353|592451615|FG004|Overall Study|Physician Decision|0|||
164024400|NCT01354353|592451616|FG005|Overall Study|Physician Decision|0|||
164024401|NCT01354353|592451611|FG000|Overall Study|Withdrawal by Subject|2|||
164024402|NCT01354353|592451612|FG001|Overall Study|Withdrawal by Subject|0|||
164024403|NCT01354353|592451613|FG002|Overall Study|Withdrawal by Subject|1|||
164024404|NCT01354353|592451614|FG003|Overall Study|Withdrawal by Subject|0|||
164024405|NCT01354353|592451615|FG004|Overall Study|Withdrawal by Subject|0|||
164024406|NCT01354353|592451616|FG005|Overall Study|Withdrawal by Subject|1|||
164024407|NCT05674344|592451617|FG000|Overall Study|Screen Fail|21|||
164024408|NCT05674344|592451617|FG000|Overall Study|Incomplete study procedures|3|||
164024409|NCT00111917|592451618|FG000|Overall Study|Withdrawal by Subject|1|||
164024410|NCT00111917|592451619|FG001|Overall Study|Withdrawal by Subject|1|||
164024411|NCT01640925|592451620|FG000|Overall Study|Withdrawal by Subject|1|||
164024412|NCT01640925|592451621|FG001|Overall Study|Withdrawal by Subject|0|||
164024413|NCT01640925|592451620|FG000|Overall Study|Previously enrolled in this trial|13|||
164024414|NCT01640925|592451621|FG001|Overall Study|Previously enrolled in this trial|11|||
164024415|NCT02156492|592451622|FG000|Period 1|No Reason Given|0|||
164024416|NCT02156492|592451623|FG001|Period 1|No Reason Given|1|||
164024417|NCT02156492|592451624|FG002|Period 1|No Reason Given|0|||
164024418|NCT02156492|592451622|FG000|Period 3|Adverse Event|0|||
164024419|NCT02156492|592451623|FG001|Period 3|Adverse Event|1|||
164024420|NCT02156492|592451624|FG002|Period 3|Adverse Event|0|||
164024421|NCT05254613|592451629|FG000|Overall Study|Lost to Follow-up|0|||
164024422|NCT05254613|592451630|FG001|Overall Study|Lost to Follow-up|0|||
164024423|NCT05254613|592451631|FG002|Overall Study|Lost to Follow-up|1|||
164024424|NCT01944969|592451634|FG000|Overall Study|Adverse Event|1|||
164024425|NCT01944969|592451634|FG000|Overall Study|Lack of Efficacy|1|||
164024426|NCT01944969|592451634|FG000|Overall Study|Non-compliance with IMP|1|||
164024427|NCT01944969|592451634|FG000|Overall Study|Administrative or other reasons|23|||
164024428|NCT01104584|592451636|FG000|Overall Study|Study drug never administered|21|||
164024429|NCT01104584|592451636|FG000|Overall Study|Study prematurely discontinued|2|||
164024430|NCT02370498|592451637|FG000|Overall Study|Adverse Event|10|||
164024431|NCT02370498|592451638|FG001|Overall Study|Adverse Event|8|||
164024432|NCT02370498|592451637|FG000|Overall Study|Death|263|||
164024433|NCT02370498|592451638|FG001|Overall Study|Death|265|||
164024434|NCT02370498|592451637|FG000|Overall Study|Protocol Violation|1|||
164024435|NCT02370498|592451638|FG001|Overall Study|Protocol Violation|2|||
164024436|NCT02370498|592451637|FG000|Overall Study|Withdrawal by Subject|7|||
164024437|NCT02370498|592451638|FG001|Overall Study|Withdrawal by Subject|12|||
164024438|NCT02370498|592451637|FG000|Overall Study|Sponsor's decision|15|||
164024439|NCT02370498|592451638|FG001|Overall Study|Sponsor's decision|9|||
164024440|NCT02387372|592451642|FG000|Overall Study|Not Treated|1|||
164024441|NCT02387372|592451643|FG001|Overall Study|Not Treated|0|||
164024442|NCT03225716|592451644|FG000|Overall Study|Withdrawal by Subject|2|||
164024443|NCT03225716|592451645|FG001|Overall Study|Withdrawal by Subject|2|||
164096046|NCT03049488|592715846|FG000|Overall Study|Physician Decision|0|||
164024444|NCT03225716|592451646|FG002|Overall Study|Withdrawal by Subject|0|||
164024445|NCT03225716|592451644|FG000|Overall Study|Lack of Efficacy|1|||
164024446|NCT03225716|592451645|FG001|Overall Study|Lack of Efficacy|0|||
164024447|NCT03225716|592451646|FG002|Overall Study|Lack of Efficacy|0|||
164024448|NCT03225716|592451644|FG000|Overall Study|Adverse Event|2|||
164024449|NCT03225716|592451645|FG001|Overall Study|Adverse Event|0|||
164024450|NCT03225716|592451646|FG002|Overall Study|Adverse Event|1|||
164024451|NCT03225716|592451644|FG000|Overall Study|Study early termination by Sponsor|0|||
164024452|NCT03225716|592451645|FG001|Overall Study|Study early termination by Sponsor|0|||
164024453|NCT03225716|592451646|FG002|Overall Study|Study early termination by Sponsor|2|||
164024454|NCT00848250|592451647|FG000|Overall Study|surgery was completed without cardiopulm|0|||
164024455|NCT00848250|592451648|FG001|Overall Study|surgery was completed without cardiopulm|1|||
164024456|NCT02883049|592451649|FG000|Induction|Adverse Event|52|||
164024457|NCT02883049|592451650|FG001|Induction|Adverse Event|2|||
164024458|NCT02883049|592451651|FG002|Induction|Adverse Event|0|||
164024459|NCT02883049|592451652|FG003|Induction|Adverse Event|0|||
164024460|NCT02883049|592451653|FG004|Induction|Adverse Event|0|||
164024461|NCT02883049|592451654|FG005|Induction|Adverse Event|0|||
164024462|NCT02883049|592451655|FG006|Induction|Adverse Event|0|||
164024463|NCT02883049|592451656|FG007|Induction|Adverse Event|0|||
164024464|NCT02883049|592451657|FG008|Induction|Adverse Event|0|||
164024465|NCT02883049|592451658|FG009|Induction|Adverse Event|0|||
164024466|NCT02883049|592451659|FG010|Induction|Adverse Event|0|||
164024467|NCT02883049|592451660|FG011|Induction|Adverse Event|0|||
164024468|NCT02883049|592451661|FG012|Induction|Adverse Event|0|||
164024469|NCT02883049|592451662|FG013|Induction|Adverse Event|0|||
164024470|NCT02883049|592451663|FG014|Induction|Adverse Event|0|||
164024471|NCT02883049|592451664|FG015|Induction|Adverse Event|0|||
164024472|NCT02883049|592451649|FG000|Induction|Death|76|||
164024473|NCT02883049|592451650|FG001|Induction|Death|8|||
164024474|NCT02883049|592451651|FG002|Induction|Death|0|||
164024475|NCT02883049|592451652|FG003|Induction|Death|0|||
164024476|NCT02883049|592451653|FG004|Induction|Death|0|||
164024477|NCT02883049|592451654|FG005|Induction|Death|0|||
164024478|NCT02883049|592451655|FG006|Induction|Death|0|||
164024479|NCT02883049|592451656|FG007|Induction|Death|0|||
164024480|NCT02883049|592451657|FG008|Induction|Death|0|||
164024481|NCT02883049|592451658|FG009|Induction|Death|0|||
164024482|NCT02883049|592451659|FG010|Induction|Death|0|||
164024483|NCT02883049|592451660|FG011|Induction|Death|0|||
164024484|NCT02883049|592451661|FG012|Induction|Death|0|||
164024485|NCT02883049|592451662|FG013|Induction|Death|0|||
164024486|NCT02883049|592451663|FG014|Induction|Death|0|||
164024487|NCT02883049|592451664|FG015|Induction|Death|0|||
164024488|NCT02883049|592451649|FG000|Induction|Lost to Follow-up|2|||
164024489|NCT02883049|592451650|FG001|Induction|Lost to Follow-up|0|||
164024490|NCT02883049|592451651|FG002|Induction|Lost to Follow-up|0|||
164024491|NCT02883049|592451652|FG003|Induction|Lost to Follow-up|0|||
164024492|NCT02883049|592451653|FG004|Induction|Lost to Follow-up|0|||
164024493|NCT02883049|592451654|FG005|Induction|Lost to Follow-up|0|||
164024494|NCT02883049|592451655|FG006|Induction|Lost to Follow-up|0|||
164024495|NCT02883049|592451656|FG007|Induction|Lost to Follow-up|0|||
164024496|NCT02883049|592451657|FG008|Induction|Lost to Follow-up|0|||
164024497|NCT02883049|592451658|FG009|Induction|Lost to Follow-up|0|||
164024498|NCT02883049|592451659|FG010|Induction|Lost to Follow-up|0|||
164024499|NCT02883049|592451660|FG011|Induction|Lost to Follow-up|0|||
164024500|NCT02883049|592451661|FG012|Induction|Lost to Follow-up|0|||
164024501|NCT02883049|592451662|FG013|Induction|Lost to Follow-up|0|||
164096047|NCT03049488|592715847|FG001|Overall Study|Physician Decision|1|||
164096048|NCT03049488|592715848|FG002|Overall Study|Physician Decision|0|||
164096049|NCT03049488|592715849|FG003|Overall Study|Physician Decision|0|||
164096050|NCT03049488|592715850|FG004|Overall Study|Physician Decision|0|||
164024502|NCT02883049|592451663|FG014|Induction|Lost to Follow-up|0|||
164024503|NCT02883049|592451664|FG015|Induction|Lost to Follow-up|0|||
164024504|NCT02883049|592451649|FG000|Induction|Physician Decision|1407|||
164096051|NCT03049488|592715851|FG005|Overall Study|Physician Decision|0|||
164096052|NCT03049488|592715846|FG000|Overall Study|Withdrawal by Subject|0|||
164024505|NCT02883049|592451650|FG001|Induction|Physician Decision|8|||
164024506|NCT02883049|592451651|FG002|Induction|Physician Decision|0|||
164024507|NCT02883049|592451652|FG003|Induction|Physician Decision|0|||
164024508|NCT02883049|592451653|FG004|Induction|Physician Decision|0|||
164024509|NCT02883049|592451654|FG005|Induction|Physician Decision|0|||
164024510|NCT02883049|592451655|FG006|Induction|Physician Decision|0|||
164024511|NCT02883049|592451656|FG007|Induction|Physician Decision|0|||
164024512|NCT02883049|592451657|FG008|Induction|Physician Decision|0|||
164024513|NCT02883049|592451658|FG009|Induction|Physician Decision|0|||
164024514|NCT02883049|592451659|FG010|Induction|Physician Decision|0|||
164024515|NCT02883049|592451660|FG011|Induction|Physician Decision|0|||
164024516|NCT02883049|592451661|FG012|Induction|Physician Decision|0|||
164024517|NCT02883049|592451662|FG013|Induction|Physician Decision|0|||
164024518|NCT02883049|592451663|FG014|Induction|Physician Decision|0|||
164024519|NCT02883049|592451664|FG015|Induction|Physician Decision|0|||
164024520|NCT02883049|592451649|FG000|Induction|Protocol Violation|6|||
164024521|NCT02883049|592451650|FG001|Induction|Protocol Violation|0|||
164024522|NCT02883049|592451651|FG002|Induction|Protocol Violation|0|||
164024523|NCT02883049|592451652|FG003|Induction|Protocol Violation|0|||
164024524|NCT02883049|592451653|FG004|Induction|Protocol Violation|0|||
164024525|NCT02883049|592451654|FG005|Induction|Protocol Violation|0|||
164024526|NCT02883049|592451655|FG006|Induction|Protocol Violation|0|||
164024527|NCT02883049|592451656|FG007|Induction|Protocol Violation|0|||
164024528|NCT02883049|592451657|FG008|Induction|Protocol Violation|0|||
164024529|NCT02883049|592451658|FG009|Induction|Protocol Violation|0|||
164024530|NCT02883049|592451659|FG010|Induction|Protocol Violation|0|||
164024531|NCT02883049|592451660|FG011|Induction|Protocol Violation|0|||
164024532|NCT02883049|592451661|FG012|Induction|Protocol Violation|0|||
164024533|NCT02883049|592451662|FG013|Induction|Protocol Violation|0|||
164024534|NCT02883049|592451663|FG014|Induction|Protocol Violation|0|||
164024535|NCT02883049|592451664|FG015|Induction|Protocol Violation|0|||
164024536|NCT02883049|592451649|FG000|Induction|Withdrawal by Subject|6|||
164024537|NCT02883049|592451650|FG001|Induction|Withdrawal by Subject|0|||
164024538|NCT02883049|592451651|FG002|Induction|Withdrawal by Subject|0|||
164024539|NCT02883049|592451652|FG003|Induction|Withdrawal by Subject|0|||
164024540|NCT02883049|592451653|FG004|Induction|Withdrawal by Subject|0|||
164024541|NCT02883049|592451654|FG005|Induction|Withdrawal by Subject|0|||
164024542|NCT02883049|592451655|FG006|Induction|Withdrawal by Subject|0|||
164024543|NCT02883049|592451656|FG007|Induction|Withdrawal by Subject|0|||
164024544|NCT02883049|592451657|FG008|Induction|Withdrawal by Subject|0|||
164024545|NCT02883049|592451658|FG009|Induction|Withdrawal by Subject|0|||
164024546|NCT02883049|592451659|FG010|Induction|Withdrawal by Subject|0|||
164024547|NCT02883049|592451660|FG011|Induction|Withdrawal by Subject|0|||
164024548|NCT02883049|592451661|FG012|Induction|Withdrawal by Subject|0|||
164024549|NCT02883049|592451662|FG013|Induction|Withdrawal by Subject|0|||
164024550|NCT02883049|592451663|FG014|Induction|Withdrawal by Subject|0|||
164024551|NCT02883049|592451664|FG015|Induction|Withdrawal by Subject|0|||
164024552|NCT02883049|592451649|FG000|Induction|Ineligible|35|||
164024553|NCT02883049|592451650|FG001|Induction|Ineligible|1|||
164024554|NCT02883049|592451651|FG002|Induction|Ineligible|0|||
164024555|NCT02883049|592451652|FG003|Induction|Ineligible|0|||
164024556|NCT02883049|592451653|FG004|Induction|Ineligible|0|||
164024557|NCT02883049|592451654|FG005|Induction|Ineligible|0|||
164024558|NCT02883049|592451655|FG006|Induction|Ineligible|0|||
164024559|NCT02883049|592451656|FG007|Induction|Ineligible|0|||
164024560|NCT02883049|592451657|FG008|Induction|Ineligible|0|||
164024561|NCT02883049|592451658|FG009|Induction|Ineligible|0|||
164024562|NCT02883049|592451659|FG010|Induction|Ineligible|0|||
164024563|NCT02883049|592451660|FG011|Induction|Ineligible|0|||
164024564|NCT02883049|592451661|FG012|Induction|Ineligible|0|||
164024565|NCT02883049|592451662|FG013|Induction|Ineligible|0|||
164024566|NCT02883049|592451663|FG014|Induction|Ineligible|0|||
164024567|NCT02883049|592451664|FG015|Induction|Ineligible|0|||
164024568|NCT02883049|592451649|FG000|Induction|Refusal of further protocol therapy|466|||
164024569|NCT02883049|592451650|FG001|Induction|Refusal of further protocol therapy|2|||
164024570|NCT02883049|592451651|FG002|Induction|Refusal of further protocol therapy|0|||
164024571|NCT02883049|592451652|FG003|Induction|Refusal of further protocol therapy|0|||
164024572|NCT02883049|592451653|FG004|Induction|Refusal of further protocol therapy|0|||
164024573|NCT02883049|592451654|FG005|Induction|Refusal of further protocol therapy|0|||
164024574|NCT02883049|592451655|FG006|Induction|Refusal of further protocol therapy|0|||
164024575|NCT02883049|592451656|FG007|Induction|Refusal of further protocol therapy|0|||
164024576|NCT02883049|592451657|FG008|Induction|Refusal of further protocol therapy|0|||
164024577|NCT02883049|592451658|FG009|Induction|Refusal of further protocol therapy|0|||
164024578|NCT02883049|592451659|FG010|Induction|Refusal of further protocol therapy|0|||
164024579|NCT02883049|592451660|FG011|Induction|Refusal of further protocol therapy|0|||
164024580|NCT02883049|592451661|FG012|Induction|Refusal of further protocol therapy|0|||
164024581|NCT02883049|592451662|FG013|Induction|Refusal of further protocol therapy|0|||
164024582|NCT02883049|592451663|FG014|Induction|Refusal of further protocol therapy|0|||
164024583|NCT02883049|592451664|FG015|Induction|Refusal of further protocol therapy|0|||
164024584|NCT02883049|592451649|FG000|Induction|Identified as Ph+ patients|279|||
164024585|NCT02883049|592451650|FG001|Induction|Identified as Ph+ patients|1|||
164024586|NCT02883049|592451651|FG002|Induction|Identified as Ph+ patients|0|||
164024587|NCT02883049|592451652|FG003|Induction|Identified as Ph+ patients|0|||
164024588|NCT02883049|592451653|FG004|Induction|Identified as Ph+ patients|0|||
164024589|NCT02883049|592451654|FG005|Induction|Identified as Ph+ patients|0|||
164024590|NCT02883049|592451655|FG006|Induction|Identified as Ph+ patients|0|||
164024591|NCT02883049|592451656|FG007|Induction|Identified as Ph+ patients|0|||
164024592|NCT02883049|592451657|FG008|Induction|Identified as Ph+ patients|0|||
164024593|NCT02883049|592451658|FG009|Induction|Identified as Ph+ patients|0|||
164024594|NCT02883049|592451659|FG010|Induction|Identified as Ph+ patients|0|||
164024595|NCT02883049|592451660|FG011|Induction|Identified as Ph+ patients|0|||
164024596|NCT02883049|592451661|FG012|Induction|Identified as Ph+ patients|0|||
164024597|NCT02883049|592451662|FG013|Induction|Identified as Ph+ patients|0|||
164024598|NCT02883049|592451663|FG014|Induction|Identified as Ph+ patients|0|||
164024599|NCT02883049|592451664|FG015|Induction|Identified as Ph+ patients|0|||
164024600|NCT02883049|592451649|FG000|Induction|M3 Marrow at Day29|8|||
164024601|NCT02883049|592451650|FG001|Induction|M3 Marrow at Day29|1|||
164024602|NCT02883049|592451651|FG002|Induction|M3 Marrow at Day29|0|||
164024603|NCT02883049|592451652|FG003|Induction|M3 Marrow at Day29|0|||
164024604|NCT02883049|592451653|FG004|Induction|M3 Marrow at Day29|0|||
164024605|NCT02883049|592451654|FG005|Induction|M3 Marrow at Day29|0|||
164024606|NCT02883049|592451655|FG006|Induction|M3 Marrow at Day29|0|||
164024607|NCT02883049|592451656|FG007|Induction|M3 Marrow at Day29|0|||
164024608|NCT02883049|592451657|FG008|Induction|M3 Marrow at Day29|0|||
164024609|NCT02883049|592451658|FG009|Induction|M3 Marrow at Day29|0|||
164024610|NCT02883049|592451659|FG010|Induction|M3 Marrow at Day29|0|||
164024611|NCT02883049|592451660|FG011|Induction|M3 Marrow at Day29|0|||
164024612|NCT02883049|592451661|FG012|Induction|M3 Marrow at Day29|0|||
164096053|NCT03049488|592715847|FG001|Overall Study|Withdrawal by Subject|0|||
164096054|NCT03049488|592715848|FG002|Overall Study|Withdrawal by Subject|0|||
164096055|NCT03049488|592715849|FG003|Overall Study|Withdrawal by Subject|1|||
164096056|NCT03049488|592715850|FG004|Overall Study|Withdrawal by Subject|1|||
164024613|NCT02883049|592451662|FG013|Induction|M3 Marrow at Day29|0|||
164024614|NCT02883049|592451663|FG014|Induction|M3 Marrow at Day29|0|||
164024615|NCT02883049|592451664|FG015|Induction|M3 Marrow at Day29|0|||
164024616|NCT02883049|592451649|FG000|Induction|Inevaluable|33|||
164024617|NCT02883049|592451650|FG001|Induction|Inevaluable|1|||
164024618|NCT02883049|592451651|FG002|Induction|Inevaluable|0|||
164024619|NCT02883049|592451652|FG003|Induction|Inevaluable|0|||
164024620|NCT02883049|592451653|FG004|Induction|Inevaluable|0|||
164024621|NCT02883049|592451654|FG005|Induction|Inevaluable|0|||
164024622|NCT02883049|592451655|FG006|Induction|Inevaluable|0|||
164024623|NCT02883049|592451656|FG007|Induction|Inevaluable|0|||
164024624|NCT02883049|592451657|FG008|Induction|Inevaluable|0|||
164024625|NCT02883049|592451658|FG009|Induction|Inevaluable|0|||
164024626|NCT02883049|592451659|FG010|Induction|Inevaluable|0|||
164024627|NCT02883049|592451660|FG011|Induction|Inevaluable|0|||
164024628|NCT02883049|592451661|FG012|Induction|Inevaluable|0|||
164024629|NCT02883049|592451662|FG013|Induction|Inevaluable|0|||
164024630|NCT02883049|592451663|FG014|Induction|Inevaluable|0|||
164024631|NCT02883049|592451664|FG015|Induction|Inevaluable|0|||
164024632|NCT02883049|592451649|FG000|Induction|Identified as VHR at end of Induction|244|||
164024633|NCT02883049|592451650|FG001|Induction|Identified as VHR at end of Induction|0|||
164024634|NCT02883049|592451651|FG002|Induction|Identified as VHR at end of Induction|0|||
164024635|NCT02883049|592451652|FG003|Induction|Identified as VHR at end of Induction|0|||
164024636|NCT02883049|592451653|FG004|Induction|Identified as VHR at end of Induction|0|||
164024637|NCT02883049|592451654|FG005|Induction|Identified as VHR at end of Induction|0|||
164024638|NCT02883049|592451655|FG006|Induction|Identified as VHR at end of Induction|0|||
164024639|NCT02883049|592451656|FG007|Induction|Identified as VHR at end of Induction|0|||
164024640|NCT02883049|592451657|FG008|Induction|Identified as VHR at end of Induction|0|||
164024641|NCT02883049|592451658|FG009|Induction|Identified as VHR at end of Induction|0|||
164024642|NCT02883049|592451659|FG010|Induction|Identified as VHR at end of Induction|0|||
164024643|NCT02883049|592451660|FG011|Induction|Identified as VHR at end of Induction|0|||
164024644|NCT02883049|592451661|FG012|Induction|Identified as VHR at end of Induction|0|||
164024645|NCT02883049|592451662|FG013|Induction|Identified as VHR at end of Induction|0|||
164024646|NCT02883049|592451663|FG014|Induction|Identified as VHR at end of Induction|0|||
164024647|NCT02883049|592451664|FG015|Induction|Identified as VHR at end of Induction|0|||
164024648|NCT02883049|592451649|FG000|Induction|Moved to another non-COG institution|3|||
164024649|NCT02883049|592451650|FG001|Induction|Moved to another non-COG institution|0|||
164024650|NCT02883049|592451651|FG002|Induction|Moved to another non-COG institution|0|||
164024651|NCT02883049|592451652|FG003|Induction|Moved to another non-COG institution|0|||
164024652|NCT02883049|592451653|FG004|Induction|Moved to another non-COG institution|0|||
164024653|NCT02883049|592451654|FG005|Induction|Moved to another non-COG institution|0|||
164024654|NCT02883049|592451655|FG006|Induction|Moved to another non-COG institution|0|||
164024655|NCT02883049|592451656|FG007|Induction|Moved to another non-COG institution|0|||
164024656|NCT02883049|592451657|FG008|Induction|Moved to another non-COG institution|0|||
164024657|NCT02883049|592451658|FG009|Induction|Moved to another non-COG institution|0|||
164024658|NCT02883049|592451659|FG010|Induction|Moved to another non-COG institution|0|||
164024659|NCT02883049|592451660|FG011|Induction|Moved to another non-COG institution|0|||
164096057|NCT03049488|592715851|FG005|Overall Study|Withdrawal by Subject|0|||
164024660|NCT02883049|592451661|FG012|Induction|Moved to another non-COG institution|0|||
164024661|NCT02883049|592451662|FG013|Induction|Moved to another non-COG institution|0|||
164024662|NCT02883049|592451663|FG014|Induction|Moved to another non-COG institution|0|||
164024663|NCT02883049|592451664|FG015|Induction|Moved to another non-COG institution|0|||
164024664|NCT02883049|592451649|FG000|Induction|Randomization closed|41|||
164024665|NCT02883049|592451650|FG001|Induction|Randomization closed|0|||
164024666|NCT02883049|592451651|FG002|Induction|Randomization closed|0|||
164024667|NCT02883049|592451652|FG003|Induction|Randomization closed|0|||
164024668|NCT02883049|592451653|FG004|Induction|Randomization closed|0|||
164024669|NCT02883049|592451654|FG005|Induction|Randomization closed|0|||
164024670|NCT02883049|592451655|FG006|Induction|Randomization closed|0|||
164024671|NCT02883049|592451656|FG007|Induction|Randomization closed|0|||
164024672|NCT02883049|592451657|FG008|Induction|Randomization closed|0|||
164024673|NCT02883049|592451658|FG009|Induction|Randomization closed|0|||
164024674|NCT02883049|592451659|FG010|Induction|Randomization closed|0|||
164024675|NCT02883049|592451660|FG011|Induction|Randomization closed|0|||
164024676|NCT02883049|592451661|FG012|Induction|Randomization closed|0|||
164024677|NCT02883049|592451662|FG013|Induction|Randomization closed|0|||
164024678|NCT02883049|592451663|FG014|Induction|Randomization closed|0|||
164024679|NCT02883049|592451664|FG015|Induction|Randomization closed|0|||
164024680|NCT02883049|592451649|FG000|Induction|MRD negative|36|||
164024681|NCT02883049|592451650|FG001|Induction|MRD negative|0|||
164024682|NCT02883049|592451651|FG002|Induction|MRD negative|0|||
164024683|NCT02883049|592451652|FG003|Induction|MRD negative|0|||
164024684|NCT02883049|592451653|FG004|Induction|MRD negative|0|||
164024685|NCT02883049|592451654|FG005|Induction|MRD negative|0|||
164024686|NCT02883049|592451655|FG006|Induction|MRD negative|0|||
164024687|NCT02883049|592451656|FG007|Induction|MRD negative|0|||
164024688|NCT02883049|592451657|FG008|Induction|MRD negative|0|||
164024689|NCT02883049|592451658|FG009|Induction|MRD negative|0|||
164024690|NCT02883049|592451659|FG010|Induction|MRD negative|0|||
164024691|NCT02883049|592451660|FG011|Induction|MRD negative|0|||
164024692|NCT02883049|592451661|FG012|Induction|MRD negative|0|||
164024693|NCT02883049|592451662|FG013|Induction|MRD negative|0|||
164024694|NCT02883049|592451663|FG014|Induction|MRD negative|0|||
164024695|NCT02883049|592451664|FG015|Induction|MRD negative|0|||
164024696|NCT02883049|592451649|FG000|Induction|Identified as HR patients|165|||
164024697|NCT02883049|592451650|FG001|Induction|Identified as HR patients|0|||
164024698|NCT02883049|592451651|FG002|Induction|Identified as HR patients|0|||
164024699|NCT02883049|592451652|FG003|Induction|Identified as HR patients|0|||
164024700|NCT02883049|592451653|FG004|Induction|Identified as HR patients|0|||
164024701|NCT02883049|592451654|FG005|Induction|Identified as HR patients|0|||
164024702|NCT02883049|592451655|FG006|Induction|Identified as HR patients|0|||
164024703|NCT02883049|592451656|FG007|Induction|Identified as HR patients|0|||
164024704|NCT02883049|592451657|FG008|Induction|Identified as HR patients|0|||
164024705|NCT02883049|592451658|FG009|Induction|Identified as HR patients|0|||
164024706|NCT02883049|592451659|FG010|Induction|Identified as HR patients|0|||
164024707|NCT02883049|592451660|FG011|Induction|Identified as HR patients|0|||
164024708|NCT02883049|592451661|FG012|Induction|Identified as HR patients|0|||
164024709|NCT02883049|592451662|FG013|Induction|Identified as HR patients|0|||
164024710|NCT02883049|592451663|FG014|Induction|Identified as HR patients|0|||
164024711|NCT02883049|592451664|FG015|Induction|Identified as HR patients|0|||
164024712|NCT02883049|592451649|FG000|Induction|Developed SMN|0|||
164024713|NCT02883049|592451650|FG001|Induction|Developed SMN|1|||
164024714|NCT02883049|592451651|FG002|Induction|Developed SMN|0|||
164024715|NCT02883049|592451652|FG003|Induction|Developed SMN|0|||
164024716|NCT02883049|592451653|FG004|Induction|Developed SMN|0|||
164024717|NCT02883049|592451654|FG005|Induction|Developed SMN|0|||
164024718|NCT02883049|592451655|FG006|Induction|Developed SMN|0|||
164024719|NCT02883049|592451656|FG007|Induction|Developed SMN|0|||
164024720|NCT02883049|592451657|FG008|Induction|Developed SMN|0|||
164024721|NCT02883049|592451658|FG009|Induction|Developed SMN|0|||
164024722|NCT02883049|592451659|FG010|Induction|Developed SMN|0|||
164024723|NCT02883049|592451660|FG011|Induction|Developed SMN|0|||
164024724|NCT02883049|592451661|FG012|Induction|Developed SMN|0|||
164024725|NCT02883049|592451662|FG013|Induction|Developed SMN|0|||
164024726|NCT02883049|592451663|FG014|Induction|Developed SMN|0|||
164024727|NCT02883049|592451664|FG015|Induction|Developed SMN|0|||
164024728|NCT02883049|592451649|FG000|Induction|Enrolled onto another COG study|72|||
164024729|NCT02883049|592451650|FG001|Induction|Enrolled onto another COG study|0|||
164024730|NCT02883049|592451651|FG002|Induction|Enrolled onto another COG study|0|||
164024731|NCT02883049|592451652|FG003|Induction|Enrolled onto another COG study|0|||
164024732|NCT02883049|592451653|FG004|Induction|Enrolled onto another COG study|0|||
164024733|NCT02883049|592451654|FG005|Induction|Enrolled onto another COG study|0|||
164024734|NCT02883049|592451655|FG006|Induction|Enrolled onto another COG study|0|||
164024735|NCT02883049|592451656|FG007|Induction|Enrolled onto another COG study|0|||
164024736|NCT02883049|592451657|FG008|Induction|Enrolled onto another COG study|0|||
164024737|NCT02883049|592451658|FG009|Induction|Enrolled onto another COG study|0|||
164024738|NCT02883049|592451659|FG010|Induction|Enrolled onto another COG study|0|||
164024739|NCT02883049|592451660|FG011|Induction|Enrolled onto another COG study|0|||
164024740|NCT02883049|592451661|FG012|Induction|Enrolled onto another COG study|0|||
164024741|NCT02883049|592451662|FG013|Induction|Enrolled onto another COG study|0|||
164024742|NCT02883049|592451663|FG014|Induction|Enrolled onto another COG study|0|||
164024743|NCT02883049|592451664|FG015|Induction|Enrolled onto another COG study|0|||
164024744|NCT02883049|592451649|FG000|Induction|Incomplete induction data|17|||
164024745|NCT02883049|592451650|FG001|Induction|Incomplete induction data|0|||
164024746|NCT02883049|592451651|FG002|Induction|Incomplete induction data|0|||
164024747|NCT02883049|592451652|FG003|Induction|Incomplete induction data|0|||
164024748|NCT02883049|592451653|FG004|Induction|Incomplete induction data|0|||
164024749|NCT02883049|592451654|FG005|Induction|Incomplete induction data|0|||
164024750|NCT02883049|592451655|FG006|Induction|Incomplete induction data|0|||
164024751|NCT02883049|592451656|FG007|Induction|Incomplete induction data|0|||
164024752|NCT02883049|592451657|FG008|Induction|Incomplete induction data|0|||
164024753|NCT02883049|592451658|FG009|Induction|Incomplete induction data|0|||
164024754|NCT02883049|592451659|FG010|Induction|Incomplete induction data|0|||
164024755|NCT02883049|592451660|FG011|Induction|Incomplete induction data|0|||
164024756|NCT02883049|592451661|FG012|Induction|Incomplete induction data|0|||
164024757|NCT02883049|592451662|FG013|Induction|Incomplete induction data|0|||
164024758|NCT02883049|592451663|FG014|Induction|Incomplete induction data|0|||
164024759|NCT02883049|592451664|FG015|Induction|Incomplete induction data|0|||
164024760|NCT02883049|592451649|FG000|Post Induction|Adverse Event|0|||
164024761|NCT02883049|592451650|FG001|Post Induction|Adverse Event|0|||
164024762|NCT02883049|592451651|FG002|Post Induction|Adverse Event|0|||
164024763|NCT02883049|592451652|FG003|Post Induction|Adverse Event|7|||
164024764|NCT02883049|592451653|FG004|Post Induction|Adverse Event|8|||
164024765|NCT02883049|592451654|FG005|Post Induction|Adverse Event|3|||
164024766|NCT02883049|592451655|FG006|Post Induction|Adverse Event|4|||
164024767|NCT02883049|592451656|FG007|Post Induction|Adverse Event|5|||
164024768|NCT02883049|592451657|FG008|Post Induction|Adverse Event|6|||
164024769|NCT02883049|592451658|FG009|Post Induction|Adverse Event|7|||
164024770|NCT02883049|592451659|FG010|Post Induction|Adverse Event|2|||
164024771|NCT02883049|592451660|FG011|Post Induction|Adverse Event|2|||
164024772|NCT02883049|592451661|FG012|Post Induction|Adverse Event|0|||
164024773|NCT02883049|592451662|FG013|Post Induction|Adverse Event|0|||
164024774|NCT02883049|592451663|FG014|Post Induction|Adverse Event|5|||
164024775|NCT02883049|592451664|FG015|Post Induction|Adverse Event|2|||
164024776|NCT02883049|592451649|FG000|Post Induction|Death|0|||
164024777|NCT02883049|592451650|FG001|Post Induction|Death|0|||
164024778|NCT02883049|592451651|FG002|Post Induction|Death|0|||
164024779|NCT02883049|592451652|FG003|Post Induction|Death|9|||
164024780|NCT02883049|592451653|FG004|Post Induction|Death|9|||
164024781|NCT02883049|592451654|FG005|Post Induction|Death|0|||
164024782|NCT02883049|592451655|FG006|Post Induction|Death|1|||
164024783|NCT02883049|592451656|FG007|Post Induction|Death|6|||
164024784|NCT02883049|592451657|FG008|Post Induction|Death|5|||
164024785|NCT02883049|592451658|FG009|Post Induction|Death|3|||
164024786|NCT02883049|592451659|FG010|Post Induction|Death|1|||
164024787|NCT02883049|592451660|FG011|Post Induction|Death|0|||
164024788|NCT02883049|592451661|FG012|Post Induction|Death|1|||
164024789|NCT02883049|592451662|FG013|Post Induction|Death|1|||
164024790|NCT02883049|592451663|FG014|Post Induction|Death|10|||
164024791|NCT02883049|592451664|FG015|Post Induction|Death|2|||
164024792|NCT02883049|592451649|FG000|Post Induction|Lost to Follow-up|0|||
164024793|NCT02883049|592451650|FG001|Post Induction|Lost to Follow-up|0|||
164024794|NCT02883049|592451651|FG002|Post Induction|Lost to Follow-up|0|||
164024795|NCT02883049|592451652|FG003|Post Induction|Lost to Follow-up|0|||
164024796|NCT02883049|592451653|FG004|Post Induction|Lost to Follow-up|1|||
164024797|NCT02883049|592451654|FG005|Post Induction|Lost to Follow-up|1|||
164024798|NCT02883049|592451655|FG006|Post Induction|Lost to Follow-up|0|||
164024799|NCT02883049|592451656|FG007|Post Induction|Lost to Follow-up|0|||
164024800|NCT02883049|592451657|FG008|Post Induction|Lost to Follow-up|3|||
164024801|NCT02883049|592451658|FG009|Post Induction|Lost to Follow-up|0|||
164024802|NCT02883049|592451659|FG010|Post Induction|Lost to Follow-up|1|||
164024803|NCT02883049|592451660|FG011|Post Induction|Lost to Follow-up|0|||
164024804|NCT02883049|592451661|FG012|Post Induction|Lost to Follow-up|0|||
164024805|NCT02883049|592451662|FG013|Post Induction|Lost to Follow-up|0|||
164024806|NCT02883049|592451663|FG014|Post Induction|Lost to Follow-up|0|||
164024807|NCT02883049|592451664|FG015|Post Induction|Lost to Follow-up|0|||
163910321|NCT04183491|592041781|FG001|Overall Study|Withdrawal by Subject|0|||
164024808|NCT02883049|592451649|FG000|Post Induction|Physician Decision|0|||
164024809|NCT02883049|592451650|FG001|Post Induction|Physician Decision|0|||
164024810|NCT02883049|592451651|FG002|Post Induction|Physician Decision|0|||
164024811|NCT02883049|592451652|FG003|Post Induction|Physician Decision|27|||
164024812|NCT02883049|592451653|FG004|Post Induction|Physician Decision|27|||
164024813|NCT02883049|592451654|FG005|Post Induction|Physician Decision|23|||
164024814|NCT02883049|592451655|FG006|Post Induction|Physician Decision|30|||
164024815|NCT02883049|592451656|FG007|Post Induction|Physician Decision|56|||
164024816|NCT02883049|592451657|FG008|Post Induction|Physician Decision|85|||
164024817|NCT02883049|592451658|FG009|Post Induction|Physician Decision|12|||
164024818|NCT02883049|592451659|FG010|Post Induction|Physician Decision|5|||
164024819|NCT02883049|592451660|FG011|Post Induction|Physician Decision|14|||
164024820|NCT02883049|592451661|FG012|Post Induction|Physician Decision|1|||
164024821|NCT02883049|592451662|FG013|Post Induction|Physician Decision|11|||
163910322|NCT04183491|592041782|FG002|Overall Study|Withdrawal by Subject|1|||
164024822|NCT02883049|592451663|FG014|Post Induction|Physician Decision|19|||
164024823|NCT02883049|592451664|FG015|Post Induction|Physician Decision|5|||
164024824|NCT02883049|592451649|FG000|Post Induction|Protocol Violation|0|||
164024825|NCT02883049|592451650|FG001|Post Induction|Protocol Violation|0|||
164024826|NCT02883049|592451651|FG002|Post Induction|Protocol Violation|0|||
164024827|NCT02883049|592451652|FG003|Post Induction|Protocol Violation|0|||
164024828|NCT02883049|592451653|FG004|Post Induction|Protocol Violation|0|||
164024829|NCT02883049|592451654|FG005|Post Induction|Protocol Violation|0|||
164024830|NCT02883049|592451655|FG006|Post Induction|Protocol Violation|0|||
164024831|NCT02883049|592451656|FG007|Post Induction|Protocol Violation|1|||
164024832|NCT02883049|592451657|FG008|Post Induction|Protocol Violation|0|||
164024833|NCT02883049|592451658|FG009|Post Induction|Protocol Violation|0|||
164024834|NCT02883049|592451659|FG010|Post Induction|Protocol Violation|0|||
164024835|NCT02883049|592451660|FG011|Post Induction|Protocol Violation|0|||
164024836|NCT02883049|592451661|FG012|Post Induction|Protocol Violation|0|||
164024837|NCT02883049|592451662|FG013|Post Induction|Protocol Violation|0|||
164024838|NCT02883049|592451663|FG014|Post Induction|Protocol Violation|0|||
164024839|NCT02883049|592451664|FG015|Post Induction|Protocol Violation|0|||
164024840|NCT02883049|592451649|FG000|Post Induction|Withdrawal by Subject|0|||
164024841|NCT02883049|592451650|FG001|Post Induction|Withdrawal by Subject|0|||
164024842|NCT02883049|592451651|FG002|Post Induction|Withdrawal by Subject|0|||
164024843|NCT02883049|592451652|FG003|Post Induction|Withdrawal by Subject|5|||
164024844|NCT02883049|592451653|FG004|Post Induction|Withdrawal by Subject|2|||
164024845|NCT02883049|592451654|FG005|Post Induction|Withdrawal by Subject|1|||
164024846|NCT02883049|592451655|FG006|Post Induction|Withdrawal by Subject|0|||
164024847|NCT02883049|592451656|FG007|Post Induction|Withdrawal by Subject|0|||
164096058|NCT01735630|592715852|FG000|Overall Study|Adverse Event|8|||
164024848|NCT02883049|592451657|FG008|Post Induction|Withdrawal by Subject|2|||
164024849|NCT02883049|592451658|FG009|Post Induction|Withdrawal by Subject|0|||
164024850|NCT02883049|592451659|FG010|Post Induction|Withdrawal by Subject|1|||
164024851|NCT02883049|592451660|FG011|Post Induction|Withdrawal by Subject|1|||
164024852|NCT02883049|592451661|FG012|Post Induction|Withdrawal by Subject|0|||
164024853|NCT02883049|592451662|FG013|Post Induction|Withdrawal by Subject|0|||
164024854|NCT02883049|592451663|FG014|Post Induction|Withdrawal by Subject|1|||
164024855|NCT02883049|592451664|FG015|Post Induction|Withdrawal by Subject|0|||
164024856|NCT02883049|592451649|FG000|Post Induction|Ineligible|0|||
164024857|NCT02883049|592451650|FG001|Post Induction|Ineligible|0|||
164024858|NCT02883049|592451651|FG002|Post Induction|Ineligible|2|||
164024859|NCT02883049|592451652|FG003|Post Induction|Ineligible|0|||
164024860|NCT02883049|592451653|FG004|Post Induction|Ineligible|0|||
164024861|NCT02883049|592451654|FG005|Post Induction|Ineligible|0|||
164024862|NCT02883049|592451655|FG006|Post Induction|Ineligible|1|||
164024863|NCT02883049|592451656|FG007|Post Induction|Ineligible|0|||
164024864|NCT02883049|592451657|FG008|Post Induction|Ineligible|0|||
164024865|NCT02883049|592451658|FG009|Post Induction|Ineligible|0|||
164024866|NCT02883049|592451659|FG010|Post Induction|Ineligible|1|||
164024867|NCT02883049|592451660|FG011|Post Induction|Ineligible|0|||
164024868|NCT02883049|592451661|FG012|Post Induction|Ineligible|0|||
164024869|NCT02883049|592451662|FG013|Post Induction|Ineligible|0|||
164024870|NCT02883049|592451663|FG014|Post Induction|Ineligible|0|||
164024871|NCT02883049|592451664|FG015|Post Induction|Ineligible|1|||
164024872|NCT02883049|592451649|FG000|Post Induction|Refusal of further protocol therapy|0|||
164024873|NCT02883049|592451650|FG001|Post Induction|Refusal of further protocol therapy|0|||
164024874|NCT02883049|592451651|FG002|Post Induction|Refusal of further protocol therapy|0|||
164024875|NCT02883049|592451652|FG003|Post Induction|Refusal of further protocol therapy|11|||
164024876|NCT02883049|592451653|FG004|Post Induction|Refusal of further protocol therapy|15|||
164024877|NCT02883049|592451654|FG005|Post Induction|Refusal of further protocol therapy|9|||
164024878|NCT02883049|592451655|FG006|Post Induction|Refusal of further protocol therapy|13|||
164024879|NCT02883049|592451656|FG007|Post Induction|Refusal of further protocol therapy|5|||
164024880|NCT02883049|592451657|FG008|Post Induction|Refusal of further protocol therapy|21|||
164024881|NCT02883049|592451658|FG009|Post Induction|Refusal of further protocol therapy|7|||
164024882|NCT02883049|592451659|FG010|Post Induction|Refusal of further protocol therapy|0|||
164024883|NCT02883049|592451660|FG011|Post Induction|Refusal of further protocol therapy|7|||
164024884|NCT02883049|592451661|FG012|Post Induction|Refusal of further protocol therapy|3|||
164024885|NCT02883049|592451662|FG013|Post Induction|Refusal of further protocol therapy|0|||
164024886|NCT02883049|592451663|FG014|Post Induction|Refusal of further protocol therapy|4|||
164024887|NCT02883049|592451664|FG015|Post Induction|Refusal of further protocol therapy|1|||
164024888|NCT02883049|592451649|FG000|Post Induction|Inevaluable|0|||
164024889|NCT02883049|592451650|FG001|Post Induction|Inevaluable|0|||
164024890|NCT02883049|592451651|FG002|Post Induction|Inevaluable|0|||
164024891|NCT02883049|592451652|FG003|Post Induction|Inevaluable|1|||
164024892|NCT02883049|592451653|FG004|Post Induction|Inevaluable|1|||
164024893|NCT02883049|592451654|FG005|Post Induction|Inevaluable|2|||
164024894|NCT02883049|592451655|FG006|Post Induction|Inevaluable|7|||
164096059|NCT01735630|592715853|FG001|Overall Study|Adverse Event|7|||
164024895|NCT02883049|592451656|FG007|Post Induction|Inevaluable|6|||
164024896|NCT02883049|592451657|FG008|Post Induction|Inevaluable|4|||
164024897|NCT02883049|592451658|FG009|Post Induction|Inevaluable|4|||
164024898|NCT02883049|592451659|FG010|Post Induction|Inevaluable|1|||
164024899|NCT02883049|592451660|FG011|Post Induction|Inevaluable|1|||
164096060|NCT01735630|592715852|FG000|Overall Study|Lost to Follow-up|1|||
164096061|NCT01735630|592715853|FG001|Overall Study|Lost to Follow-up|0|||
164024900|NCT02883049|592451661|FG012|Post Induction|Inevaluable|2|||
164024901|NCT02883049|592451662|FG013|Post Induction|Inevaluable|0|||
164024902|NCT02883049|592451663|FG014|Post Induction|Inevaluable|0|||
164024903|NCT02883049|592451664|FG015|Post Induction|Inevaluable|1|||
164024904|NCT02883049|592451649|FG000|Post Induction|Moved to another non-COG institution|0|||
164024905|NCT02883049|592451650|FG001|Post Induction|Moved to another non-COG institution|0|||
164024906|NCT02883049|592451651|FG002|Post Induction|Moved to another non-COG institution|0|||
163910323|NCT04183491|592041783|FG003|Overall Study|Withdrawal by Subject|0|||
164024907|NCT02883049|592451652|FG003|Post Induction|Moved to another non-COG institution|0|||
164024908|NCT02883049|592451653|FG004|Post Induction|Moved to another non-COG institution|0|||
164024909|NCT02883049|592451654|FG005|Post Induction|Moved to another non-COG institution|0|||
164024910|NCT02883049|592451655|FG006|Post Induction|Moved to another non-COG institution|0|||
164024911|NCT02883049|592451656|FG007|Post Induction|Moved to another non-COG institution|2|||
164024912|NCT02883049|592451657|FG008|Post Induction|Moved to another non-COG institution|2|||
164024913|NCT02883049|592451658|FG009|Post Induction|Moved to another non-COG institution|0|||
164024914|NCT02883049|592451659|FG010|Post Induction|Moved to another non-COG institution|0|||
164024915|NCT02883049|592451660|FG011|Post Induction|Moved to another non-COG institution|1|||
164024916|NCT02883049|592451661|FG012|Post Induction|Moved to another non-COG institution|0|||
164024917|NCT02883049|592451662|FG013|Post Induction|Moved to another non-COG institution|0|||
164024918|NCT02883049|592451663|FG014|Post Induction|Moved to another non-COG institution|0|||
164024919|NCT02883049|592451664|FG015|Post Induction|Moved to another non-COG institution|0|||
164024920|NCT02883049|592451649|FG000|Post Induction|Randomization closed|0|||
164024921|NCT02883049|592451650|FG001|Post Induction|Randomization closed|0|||
164024922|NCT02883049|592451651|FG002|Post Induction|Randomization closed|0|||
164024923|NCT02883049|592451652|FG003|Post Induction|Randomization closed|0|||
164024924|NCT02883049|592451653|FG004|Post Induction|Randomization closed|0|||
164024925|NCT02883049|592451654|FG005|Post Induction|Randomization closed|0|||
164024926|NCT02883049|592451655|FG006|Post Induction|Randomization closed|0|||
164024927|NCT02883049|592451656|FG007|Post Induction|Randomization closed|20|||
164024928|NCT02883049|592451657|FG008|Post Induction|Randomization closed|0|||
164024929|NCT02883049|592451658|FG009|Post Induction|Randomization closed|0|||
164024930|NCT02883049|592451659|FG010|Post Induction|Randomization closed|0|||
164024931|NCT02883049|592451660|FG011|Post Induction|Randomization closed|0|||
164024932|NCT02883049|592451661|FG012|Post Induction|Randomization closed|0|||
164024933|NCT02883049|592451662|FG013|Post Induction|Randomization closed|0|||
164024934|NCT02883049|592451663|FG014|Post Induction|Randomization closed|0|||
164024935|NCT02883049|592451664|FG015|Post Induction|Randomization closed|0|||
164024936|NCT02883049|592451649|FG000|Post Induction|MRD negative|0|||
164024937|NCT02883049|592451650|FG001|Post Induction|MRD negative|0|||
164024938|NCT02883049|592451651|FG002|Post Induction|MRD negative|0|||
164024939|NCT02883049|592451652|FG003|Post Induction|MRD negative|0|||
164024940|NCT02883049|592451653|FG004|Post Induction|MRD negative|0|||
164024941|NCT02883049|592451654|FG005|Post Induction|MRD negative|0|||
164024942|NCT02883049|592451655|FG006|Post Induction|MRD negative|0|||
164024943|NCT02883049|592451656|FG007|Post Induction|MRD negative|11|||
164024944|NCT02883049|592451657|FG008|Post Induction|MRD negative|0|||
164024945|NCT02883049|592451658|FG009|Post Induction|MRD negative|0|||
164024946|NCT02883049|592451659|FG010|Post Induction|MRD negative|0|||
164024947|NCT02883049|592451660|FG011|Post Induction|MRD negative|0|||
164024948|NCT02883049|592451661|FG012|Post Induction|MRD negative|0|||
164024949|NCT02883049|592451662|FG013|Post Induction|MRD negative|0|||
164024950|NCT02883049|592451663|FG014|Post Induction|MRD negative|0|||
164024951|NCT02883049|592451664|FG015|Post Induction|MRD negative|0|||
164024952|NCT02883049|592451649|FG000|Post Induction|Developed SMN|0|||
164024953|NCT02883049|592451650|FG001|Post Induction|Developed SMN|0|||
164024954|NCT02883049|592451651|FG002|Post Induction|Developed SMN|0|||
164024955|NCT02883049|592451652|FG003|Post Induction|Developed SMN|0|||
164024956|NCT02883049|592451653|FG004|Post Induction|Developed SMN|1|||
164024957|NCT02883049|592451654|FG005|Post Induction|Developed SMN|0|||
164024958|NCT02883049|592451655|FG006|Post Induction|Developed SMN|1|||
164024959|NCT02883049|592451656|FG007|Post Induction|Developed SMN|0|||
164024960|NCT02883049|592451657|FG008|Post Induction|Developed SMN|0|||
164024961|NCT02883049|592451658|FG009|Post Induction|Developed SMN|0|||
164024962|NCT02883049|592451659|FG010|Post Induction|Developed SMN|1|||
164024963|NCT02883049|592451660|FG011|Post Induction|Developed SMN|1|||
164024964|NCT02883049|592451661|FG012|Post Induction|Developed SMN|0|||
164024965|NCT02883049|592451662|FG013|Post Induction|Developed SMN|0|||
164024966|NCT02883049|592451663|FG014|Post Induction|Developed SMN|1|||
164024967|NCT02883049|592451664|FG015|Post Induction|Developed SMN|0|||
164024968|NCT02883049|592451649|FG000|Post Induction|Enrolled onto another COG study|0|||
164024969|NCT02883049|592451650|FG001|Post Induction|Enrolled onto another COG study|0|||
164024970|NCT02883049|592451651|FG002|Post Induction|Enrolled onto another COG study|0|||
164024971|NCT02883049|592451652|FG003|Post Induction|Enrolled onto another COG study|1|||
164024972|NCT02883049|592451653|FG004|Post Induction|Enrolled onto another COG study|1|||
164024973|NCT02883049|592451654|FG005|Post Induction|Enrolled onto another COG study|0|||
164024974|NCT02883049|592451655|FG006|Post Induction|Enrolled onto another COG study|0|||
164024975|NCT02883049|592451656|FG007|Post Induction|Enrolled onto another COG study|4|||
164024976|NCT02883049|592451657|FG008|Post Induction|Enrolled onto another COG study|0|||
164024977|NCT02883049|592451658|FG009|Post Induction|Enrolled onto another COG study|0|||
164024978|NCT02883049|592451659|FG010|Post Induction|Enrolled onto another COG study|0|||
164024979|NCT02883049|592451660|FG011|Post Induction|Enrolled onto another COG study|2|||
164024980|NCT02883049|592451661|FG012|Post Induction|Enrolled onto another COG study|0|||
164024981|NCT02883049|592451662|FG013|Post Induction|Enrolled onto another COG study|1|||
164024982|NCT02883049|592451663|FG014|Post Induction|Enrolled onto another COG study|0|||
164024983|NCT02883049|592451664|FG015|Post Induction|Enrolled onto another COG study|0|||
164024984|NCT02883049|592451649|FG000|Post Induction|Recurrent leukemia|0|||
164024985|NCT02883049|592451650|FG001|Post Induction|Recurrent leukemia|0|||
164024986|NCT02883049|592451651|FG002|Post Induction|Recurrent leukemia|0|||
164024987|NCT02883049|592451652|FG003|Post Induction|Recurrent leukemia|17|||
164024988|NCT02883049|592451653|FG004|Post Induction|Recurrent leukemia|12|||
164024989|NCT02883049|592451654|FG005|Post Induction|Recurrent leukemia|4|||
164024990|NCT02883049|592451655|FG006|Post Induction|Recurrent leukemia|1|||
164024991|NCT02883049|592451656|FG007|Post Induction|Recurrent leukemia|13|||
164024992|NCT02883049|592451657|FG008|Post Induction|Recurrent leukemia|27|||
163910324|NCT04183491|592041784|FG004|Overall Study|Withdrawal by Subject|0|||
164024993|NCT02883049|592451658|FG009|Post Induction|Recurrent leukemia|5|||
164024994|NCT02883049|592451659|FG010|Post Induction|Recurrent leukemia|3|||
164024995|NCT02883049|592451660|FG011|Post Induction|Recurrent leukemia|12|||
164024996|NCT02883049|592451661|FG012|Post Induction|Recurrent leukemia|1|||
164024997|NCT02883049|592451662|FG013|Post Induction|Recurrent leukemia|1|||
164024998|NCT02883049|592451663|FG014|Post Induction|Recurrent leukemia|9|||
164024999|NCT02883049|592451664|FG015|Post Induction|Recurrent leukemia|3|||
164025000|NCT02883049|592451649|FG000|Post Induction|Induction Failure|0|||
164025001|NCT02883049|592451650|FG001|Post Induction|Induction Failure|0|||
163910325|NCT04183491|592041785|FG005|Overall Study|Withdrawal by Subject|1|||
163910326|NCT04183491|592041786|FG006|Overall Study|Withdrawal by Subject|0|||
164025002|NCT02883049|592451651|FG002|Post Induction|Induction Failure|0|||
164025003|NCT02883049|592451652|FG003|Post Induction|Induction Failure|0|||
164025004|NCT02883049|592451653|FG004|Post Induction|Induction Failure|0|||
164025005|NCT02883049|592451654|FG005|Post Induction|Induction Failure|0|||
164025006|NCT02883049|592451655|FG006|Post Induction|Induction Failure|0|||
164025007|NCT02883049|592451656|FG007|Post Induction|Induction Failure|2|||
164025008|NCT02883049|592451657|FG008|Post Induction|Induction Failure|2|||
164025009|NCT02883049|592451658|FG009|Post Induction|Induction Failure|0|||
164025010|NCT02883049|592451659|FG010|Post Induction|Induction Failure|0|||
164025011|NCT02883049|592451660|FG011|Post Induction|Induction Failure|0|||
164025012|NCT02883049|592451661|FG012|Post Induction|Induction Failure|0|||
164025013|NCT02883049|592451662|FG013|Post Induction|Induction Failure|2|||
164025014|NCT02883049|592451663|FG014|Post Induction|Induction Failure|0|||
164025015|NCT02883049|592451664|FG015|Post Induction|Induction Failure|0|||
164025016|NCT03421964|592451665|FG000|Overall Study|Lost to Follow-up|11|||
164025017|NCT03421964|592451666|FG001|Overall Study|Lost to Follow-up|21|||
164025018|NCT03421964|592451665|FG000|Overall Study|Withdrawal by Subject|9|||
164025019|NCT03421964|592451666|FG001|Overall Study|Withdrawal by Subject|3|||
164025020|NCT03421964|592451665|FG000|Overall Study|Incarcerated|1|||
164025021|NCT03421964|592451666|FG001|Overall Study|Incarcerated|0|||
164025022|NCT03421964|592451665|FG000|Overall Study|Inpt Treatment Facility|1|||
164025023|NCT03421964|592451666|FG001|Overall Study|Inpt Treatment Facility|1|||
164025024|NCT03421964|592451665|FG000|Overall Study|Virtual Platform Issues|1|||
164025025|NCT03421964|592451666|FG001|Overall Study|Virtual Platform Issues|1|||
164025026|NCT01576016|592451667|FG000|Lead Safety|Death|132|||
164025027|NCT01576016|592451668|FG001|Lead Safety|Death|0|||
164025028|NCT01576016|592451667|FG000|Lead Safety|Withdrawal by Subject|81|||
164025029|NCT01576016|592451668|FG001|Lead Safety|Withdrawal by Subject|0|||
164025030|NCT01576016|592451667|FG000|Lead Safety|System Explanted without Replacement|24|||
164025031|NCT01576016|592451668|FG001|Lead Safety|System Explanted without Replacement|0|||
164025032|NCT01576016|592451667|FG000|Lead Safety|Physician Decision|14|||
164025033|NCT01576016|592451668|FG001|Lead Safety|Physician Decision|0|||
164025034|NCT01576016|592451667|FG000|Lead Safety|Lost to Follow-up|13|||
164025035|NCT01576016|592451668|FG001|Lead Safety|Lost to Follow-up|0|||
164025036|NCT01576016|592451667|FG000|Lead Safety|Unsuccessful implant|2|||
164025037|NCT01576016|592451668|FG001|Lead Safety|Unsuccessful implant|0|||
164025038|NCT01576016|592451667|FG000|Lead Safety|Sponsor request|1|||
164025039|NCT01576016|592451668|FG001|Lead Safety|Sponsor request|0|||
164025040|NCT01576016|592451667|FG000|Lead Safety|Device replaced with CRT-D|1|||
164025041|NCT01576016|592451668|FG001|Lead Safety|Device replaced with CRT-D|0|||
164025042|NCT01576016|592451667|FG000|Lead Safety|Patient on Palliative Care|1|||
164025043|NCT01576016|592451668|FG001|Lead Safety|Patient on Palliative Care|0|||
164025044|NCT01576016|592451667|FG000|Lead Safety|Patient noncompliance|1|||
164025045|NCT01576016|592451668|FG001|Lead Safety|Patient noncompliance|0|||
164025046|NCT01576016|592451667|FG000|Lead Safety|Too far from study site|1|||
164025047|NCT01576016|592451668|FG001|Lead Safety|Too far from study site|0|||
164025048|NCT01576016|592451667|FG000|Lead Safety|System deactivated|1|||
164025049|NCT01576016|592451668|FG001|Lead Safety|System deactivated|0|||
164025050|NCT01576016|592451667|FG000|Lead Safety|Patient no longer followed by study PI|1|||
164025051|NCT01576016|592451668|FG001|Lead Safety|Patient no longer followed by study PI|0|||
164025052|NCT01576016|592451667|FG000|MRI Safety|Withdrawal by Subject|0|||
164096062|NCT01735630|592715852|FG000|Overall Study|Physician Decision|0|||
164096063|NCT01735630|592715853|FG001|Overall Study|Physician Decision|1|||
164096064|NCT01735630|592715852|FG000|Overall Study|Sponsor Decision|2|||
164025053|NCT01576016|592451668|FG001|MRI Safety|Withdrawal by Subject|10|||
164025054|NCT01576016|592451667|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
164025055|NCT01576016|592451668|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
164025056|NCT01576016|592451667|FG000|MRI Safety|Has not yet completed MRI scan|0|||
164025057|NCT01576016|592451668|FG001|MRI Safety|Has not yet completed MRI scan|56|||
164025058|NCT01576016|592451667|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
164025059|NCT01576016|592451668|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
164025060|NCT03654755|592451671|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
164025061|NCT03654755|592451672|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
164025062|NCT03654755|592451673|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
163910327|NCT02538094|592041787|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
164025063|NCT03654755|592451671|FG000|Overall Study|Withdrawal by Subject|2|||
164025064|NCT03654755|592451672|FG001|Overall Study|Withdrawal by Subject|4|||
164025065|NCT03654755|592451673|FG002|Overall Study|Withdrawal by Subject|8|||
164025066|NCT03654755|592451671|FG000|Overall Study|Lost to Follow-up|1|||
164025067|NCT03654755|592451672|FG001|Overall Study|Lost to Follow-up|3|||
164025068|NCT03654755|592451673|FG002|Overall Study|Lost to Follow-up|7|||
164025069|NCT03654755|592451671|FG000|Overall Study|Physician Decision|0|||
164025070|NCT03654755|592451672|FG001|Overall Study|Physician Decision|1|||
164025071|NCT03654755|592451673|FG002|Overall Study|Physician Decision|0|||
164025072|NCT03654755|592451671|FG000|Overall Study|Adverse Event|0|||
164025073|NCT03654755|592451672|FG001|Overall Study|Adverse Event|0|||
164025074|NCT03654755|592451673|FG002|Overall Study|Adverse Event|4|||
164025075|NCT03654755|592451671|FG000|Overall Study|Lack of Efficacy|0|||
164025076|NCT03654755|592451672|FG001|Overall Study|Lack of Efficacy|0|||
164025077|NCT03654755|592451673|FG002|Overall Study|Lack of Efficacy|1|||
164025078|NCT01153763|592451674|FG000|Overall Study|Study Closed|16|||
164025079|NCT01153763|592451674|FG000|Overall Study|Lost to Follow-up|1|||
164025080|NCT01153763|592451674|FG000|Overall Study|Physician Decision|2|||
164025081|NCT01153763|592451674|FG000|Overall Study|Withdrawal by Subject|2|||
164025082|NCT05373706|592451679|FG000|Overall Study|Lost to Follow-up|2|||
164025083|NCT05373706|592451680|FG001|Overall Study|Lost to Follow-up|2|||
164025084|NCT01486784|592451681|FG000|Overall Study|Withdrawal by Subject|0|||
164025085|NCT01486784|592451682|FG001|Overall Study|Withdrawal by Subject|0|||
164025086|NCT01486784|592451683|FG002|Overall Study|Withdrawal by Subject|1|||
164025087|NCT01486784|592451684|FG003|Overall Study|Withdrawal by Subject|0|||
164025088|NCT01486784|592451685|FG004|Overall Study|Withdrawal by Subject|1|||
164025089|NCT01486784|592451686|FG005|Overall Study|Withdrawal by Subject|2|||
164025090|NCT01486784|592451681|FG000|Overall Study|Subject did not meet entry criteria|0|||
164025091|NCT01486784|592451682|FG001|Overall Study|Subject did not meet entry criteria|0|||
164025092|NCT01486784|592451683|FG002|Overall Study|Subject did not meet entry criteria|0|||
164025093|NCT01486784|592451684|FG003|Overall Study|Subject did not meet entry criteria|0|||
164025094|NCT01486784|592451685|FG004|Overall Study|Subject did not meet entry criteria|1|||
164025095|NCT01486784|592451686|FG005|Overall Study|Subject did not meet entry criteria|0|||
164025096|NCT01486784|592451681|FG000|Overall Study|Death|0|||
164025097|NCT01486784|592451682|FG001|Overall Study|Death|0|||
164025098|NCT01486784|592451683|FG002|Overall Study|Death|0|||
164025099|NCT01486784|592451684|FG003|Overall Study|Death|0|||
164025100|NCT01486784|592451685|FG004|Overall Study|Death|0|||
164025101|NCT01486784|592451686|FG005|Overall Study|Death|1|||
164025102|NCT03491553|592451687|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
164025103|NCT03491553|592451688|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
164025104|NCT03491553|592451689|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
164025105|NCT03491553|592451690|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
164025106|NCT03491553|592451691|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
164025107|NCT03491553|592451692|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
164025108|NCT03491553|592451687|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
164096065|NCT01735630|592715853|FG001|Overall Study|Sponsor Decision|1|||
164025109|NCT03491553|592451688|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
164025110|NCT03491553|592451689|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
164025111|NCT03491553|592451690|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
164025112|NCT03491553|592451691|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
164025113|NCT03491553|592451692|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
164025114|NCT01479374|592451693|FG000|Overall Study|Adverse Event|2|||
164025115|NCT01479374|592451694|FG001|Overall Study|Adverse Event|1|||
164025116|NCT01479374|592451695|FG002|Overall Study|Adverse Event|0|||
164025117|NCT01479374|592451693|FG000|Overall Study|Lost to Follow-up|1|||
164025118|NCT01479374|592451694|FG001|Overall Study|Lost to Follow-up|2|||
164025119|NCT01479374|592451695|FG002|Overall Study|Lost to Follow-up|0|||
164025120|NCT01479374|592451693|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
164025121|NCT01479374|592451694|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
164025122|NCT01479374|592451695|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
164025123|NCT01479374|592451693|FG000|Overall Study|Other|0|||
164025124|NCT01479374|592451694|FG001|Overall Study|Other|4|||
164025125|NCT01479374|592451695|FG002|Overall Study|Other|5|||
164025126|NCT01606761|592451697|FG000|Prior to Week 24|Lost to Follow-up|0|||
164025127|NCT01606761|592451698|FG001|Prior to Week 24|Lost to Follow-up|3|||
164025128|NCT01606761|592451699|FG002|Prior to Week 24|Lost to Follow-up|2|||
164025129|NCT01606761|592451700|FG003|Prior to Week 24|Lost to Follow-up|0|||
164025130|NCT01606761|592451701|FG004|Prior to Week 24|Lost to Follow-up|0|||
164025131|NCT01606761|592451697|FG000|Prior to Week 24|Withdrawal by Subject|12|||
164025132|NCT01606761|592451698|FG001|Prior to Week 24|Withdrawal by Subject|10|||
164025133|NCT01606761|592451699|FG002|Prior to Week 24|Withdrawal by Subject|9|||
164025134|NCT01606761|592451700|FG003|Prior to Week 24|Withdrawal by Subject|0|||
164025135|NCT01606761|592451701|FG004|Prior to Week 24|Withdrawal by Subject|0|||
164025136|NCT01606761|592451697|FG000|Prior to Week 24|Adverse Event|11|||
164025137|NCT01606761|592451698|FG001|Prior to Week 24|Adverse Event|18|||
164025138|NCT01606761|592451699|FG002|Prior to Week 24|Adverse Event|22|||
164025139|NCT01606761|592451700|FG003|Prior to Week 24|Adverse Event|0|||
164025140|NCT01606761|592451701|FG004|Prior to Week 24|Adverse Event|0|||
164025141|NCT01606761|592451697|FG000|Prior to Week 24|Lack of Efficacy|15|||
164025142|NCT01606761|592451698|FG001|Prior to Week 24|Lack of Efficacy|14|||
164025143|NCT01606761|592451699|FG002|Prior to Week 24|Lack of Efficacy|8|||
164025144|NCT01606761|592451700|FG003|Prior to Week 24|Lack of Efficacy|0|||
164025145|NCT01606761|592451701|FG004|Prior to Week 24|Lack of Efficacy|0|||
164025146|NCT01606761|592451697|FG000|Prior to Week 24|Physician Decision|0|||
164025147|NCT01606761|592451698|FG001|Prior to Week 24|Physician Decision|3|||
164025148|NCT01606761|592451699|FG002|Prior to Week 24|Physician Decision|1|||
164025149|NCT01606761|592451700|FG003|Prior to Week 24|Physician Decision|0|||
164025150|NCT01606761|592451701|FG004|Prior to Week 24|Physician Decision|0|||
164025151|NCT01606761|592451697|FG000|Prior to Week 24|Other|4|||
164025152|NCT01606761|592451698|FG001|Prior to Week 24|Other|7|||
164025153|NCT01606761|592451699|FG002|Prior to Week 24|Other|5|||
164025154|NCT01606761|592451700|FG003|Prior to Week 24|Other|0|||
164025155|NCT01606761|592451701|FG004|Prior to Week 24|Other|0|||
164025156|NCT01606761|592451697|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
164025157|NCT01606761|592451698|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
164025158|NCT01606761|592451699|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
164025159|NCT01606761|592451700|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
164096066|NCT01735630|592715852|FG000|Overall Study|Withdrawal by Subject|7|||
164025160|NCT01606761|592451701|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
164025161|NCT01606761|592451697|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
164025162|NCT01606761|592451698|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
164025163|NCT01606761|592451699|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
164025164|NCT01606761|592451700|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
164025165|NCT01606761|592451701|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
164025166|NCT01606761|592451697|FG000|Week 24 to Week 52|Adverse Event|0|||
164025167|NCT01606761|592451698|FG001|Week 24 to Week 52|Adverse Event|11|||
164025168|NCT01606761|592451699|FG002|Week 24 to Week 52|Adverse Event|14|||
164025169|NCT01606761|592451700|FG003|Week 24 to Week 52|Adverse Event|3|||
164025170|NCT01606761|592451701|FG004|Week 24 to Week 52|Adverse Event|15|||
164025171|NCT01606761|592451697|FG000|Week 24 to Week 52|Death|0|||
164025172|NCT01606761|592451698|FG001|Week 24 to Week 52|Death|0|||
164025173|NCT01606761|592451699|FG002|Week 24 to Week 52|Death|2|||
164025174|NCT01606761|592451700|FG003|Week 24 to Week 52|Death|1|||
164025175|NCT01606761|592451701|FG004|Week 24 to Week 52|Death|0|||
164025176|NCT01606761|592451697|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
164025177|NCT01606761|592451698|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
164025178|NCT01606761|592451699|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
164025179|NCT01606761|592451700|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
164025180|NCT01606761|592451701|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
164025181|NCT01606761|592451697|FG000|Week 24 to Week 52|Physician Decision|0|||
164025182|NCT01606761|592451698|FG001|Week 24 to Week 52|Physician Decision|1|||
164025183|NCT01606761|592451699|FG002|Week 24 to Week 52|Physician Decision|1|||
164025184|NCT01606761|592451700|FG003|Week 24 to Week 52|Physician Decision|0|||
164025185|NCT01606761|592451701|FG004|Week 24 to Week 52|Physician Decision|0|||
164025186|NCT01606761|592451697|FG000|Week 24 to Week 52|Other|0|||
164025187|NCT01606761|592451698|FG001|Week 24 to Week 52|Other|1|||
164025188|NCT01606761|592451699|FG002|Week 24 to Week 52|Other|5|||
164025189|NCT01606761|592451700|FG003|Week 24 to Week 52|Other|2|||
164025190|NCT01606761|592451701|FG004|Week 24 to Week 52|Other|2|||
164025191|NCT01606761|592451697|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
164025192|NCT01606761|592451698|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
164025193|NCT01606761|592451699|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
164025194|NCT01606761|592451700|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
164025195|NCT01606761|592451701|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
164025196|NCT01606761|592451697|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
164025197|NCT01606761|592451698|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
164025198|NCT01606761|592451699|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
164025199|NCT01606761|592451700|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
164025200|NCT01606761|592451701|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
164025201|NCT01606761|592451697|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
164025202|NCT01606761|592451698|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
164025203|NCT01606761|592451699|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
164025204|NCT01606761|592451700|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
164025205|NCT01606761|592451701|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
164025206|NCT01606761|592451697|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
164025207|NCT01606761|592451698|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
164025208|NCT01606761|592451699|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
164025209|NCT01606761|592451700|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
164025210|NCT01606761|592451701|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
164025211|NCT05086289|592451702|FG000|Overall Study|Adverse Event|4|||
164025212|NCT05086289|592451703|FG001|Overall Study|Adverse Event|2|||
164025213|NCT05086289|592451702|FG000|Overall Study|Lost to Follow-up|2|||
164025214|NCT05086289|592451703|FG001|Overall Study|Lost to Follow-up|0|||
164025215|NCT05086289|592451702|FG000|Overall Study|Non-compliance with study drug|2|||
164025216|NCT05086289|592451703|FG001|Overall Study|Non-compliance with study drug|1|||
164025217|NCT05086289|592451702|FG000|Overall Study|Physician Decision|2|||
164025218|NCT05086289|592451703|FG001|Overall Study|Physician Decision|0|||
164025219|NCT05086289|592451702|FG000|Overall Study|Withdrawal by Subject|5|||
164025220|NCT05086289|592451703|FG001|Overall Study|Withdrawal by Subject|2|||
164025221|NCT01996748|592451709|FG000|Overall Study|Personal reason|1|||
164025222|NCT01996748|592451710|FG001|Overall Study|Personal reason|0|||
164025223|NCT01996748|592451709|FG000|Overall Study|Physician Decision|2|||
164025224|NCT01996748|592451710|FG001|Overall Study|Physician Decision|0|||
164025225|NCT01996748|592451709|FG000|Overall Study|Adverse Event|1|||
164025226|NCT01996748|592451710|FG001|Overall Study|Adverse Event|4|||
164025227|NCT01996748|592451709|FG000|Overall Study|Withdrawal by Subject|0|||
164025228|NCT01996748|592451710|FG001|Overall Study|Withdrawal by Subject|1|||
164025229|NCT01996748|592451709|FG000|Overall Study|Lost to Follow-up|4|||
164025230|NCT01996748|592451710|FG001|Overall Study|Lost to Follow-up|1|||
164025231|NCT03628508|592451711|FG000|Overall Study|Lost to Follow-up|1|||
164025232|NCT03238235|592451712|FG000|Overall Study|Adverse Event|2|||
164025233|NCT03238235|592451713|FG001|Overall Study|Adverse Event|0|||
164025234|NCT03238235|592451712|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
164025235|NCT03238235|592451713|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
164025236|NCT00243230|592451719|FG000|Double-Blind Period|Adverse Event|0|||
164025237|NCT00243230|592451720|FG001|Double-Blind Period|Adverse Event|2|||
164025238|NCT00243230|592451721|FG002|Double-Blind Period|Adverse Event|2|||
164025239|NCT00243230|592451722|FG003|Double-Blind Period|Adverse Event|0|||
164025240|NCT00243230|592451719|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164025241|NCT00243230|592451720|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164025242|NCT00243230|592451721|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164025243|NCT00243230|592451722|FG003|Double-Blind Period|Withdrawal by Subject|0|||
164025244|NCT00243230|592451719|FG000|Double-Blind Period|Protocol Violation|0|||
164025245|NCT00243230|592451720|FG001|Double-Blind Period|Protocol Violation|0|||
164025246|NCT00243230|592451721|FG002|Double-Blind Period|Protocol Violation|1|||
164025247|NCT00243230|592451722|FG003|Double-Blind Period|Protocol Violation|0|||
164025248|NCT00243230|592451719|FG000|Double-Blind Period|Randomized but Not Treated|0|||
164025249|NCT00243230|592451720|FG001|Double-Blind Period|Randomized but Not Treated|0|||
164025250|NCT00243230|592451721|FG002|Double-Blind Period|Randomized but Not Treated|2|||
164025251|NCT00243230|592451722|FG003|Double-Blind Period|Randomized but Not Treated|0|||
164025252|NCT00243230|592451719|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
164025253|NCT00243230|592451720|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
164025254|NCT00243230|592451721|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
164025255|NCT00243230|592451722|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
164025256|NCT00243230|592451719|FG000|Open Label Period|Adverse Event|0|||
164025257|NCT00243230|592451720|FG001|Open Label Period|Adverse Event|0|||
164025258|NCT00243230|592451721|FG002|Open Label Period|Adverse Event|0|||
164025259|NCT00243230|592451722|FG003|Open Label Period|Adverse Event|2|||
164025260|NCT00243230|592451719|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
164025261|NCT00243230|592451720|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
164025262|NCT00243230|592451721|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
164025263|NCT00243230|592451722|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
164025264|NCT00243230|592451719|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
164025265|NCT00243230|592451720|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
164025266|NCT00243230|592451721|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
164144827|NCT04289363|592891792|FG000|Overall Study|Lost to Follow-up|14|||
164025267|NCT00243230|592451722|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
164025268|NCT00243230|592451719|FG000|Open Label Period|Lost to Follow-up|0|||
164025269|NCT00243230|592451720|FG001|Open Label Period|Lost to Follow-up|0|||
164025270|NCT00243230|592451721|FG002|Open Label Period|Lost to Follow-up|0|||
164025271|NCT00243230|592451722|FG003|Open Label Period|Lost to Follow-up|2|||
164025272|NCT00243230|592451719|FG000|Open Label Period|Withdrawal by Subject|0|||
164025273|NCT00243230|592451720|FG001|Open Label Period|Withdrawal by Subject|0|||
164025274|NCT00243230|592451721|FG002|Open Label Period|Withdrawal by Subject|0|||
164025275|NCT00243230|592451722|FG003|Open Label Period|Withdrawal by Subject|2|||
164025276|NCT00243230|592451719|FG000|Open Label Period|Protocol Violation|0|||
164025277|NCT00243230|592451720|FG001|Open Label Period|Protocol Violation|0|||
164025278|NCT00243230|592451721|FG002|Open Label Period|Protocol Violation|0|||
164025279|NCT00243230|592451722|FG003|Open Label Period|Protocol Violation|2|||
164025280|NCT00243230|592451719|FG000|Open Label Period|Administrative Reason|0|||
164025281|NCT00243230|592451720|FG001|Open Label Period|Administrative Reason|0|||
164025282|NCT00243230|592451721|FG002|Open Label Period|Administrative Reason|0|||
164025283|NCT00243230|592451722|FG003|Open Label Period|Administrative Reason|63|||
164025284|NCT03011840|592451723|FG000|Overall Study|Not received PIL in post PIL phase|0|||
164025285|NCT03011840|592451724|FG001|Overall Study|Not received PIL in post PIL phase|21|||
164025286|NCT03201198|592451730|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
164025287|NCT03201198|592451731|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
164025288|NCT03201198|592451730|FG000|Overall Study|Withdrawal by Subject|2|||
164025289|NCT03201198|592451731|FG001|Overall Study|Withdrawal by Subject|3|||
164025290|NCT00471445|592451732|FG000|Overall Study|Withdrawal by Subject|1|||
164025291|NCT00471445|592451733|FG001|Overall Study|Withdrawal by Subject|1|||
164025292|NCT00471445|592451732|FG000|Overall Study|Ineligible|1|||
164025293|NCT00471445|592451733|FG001|Overall Study|Ineligible|0|||
164025294|NCT00471445|592451732|FG000|Overall Study|Protocol Violation|0|||
164025295|NCT00471445|592451733|FG001|Overall Study|Protocol Violation|1|||
164025296|NCT04715230|592451734|FG000|Overall Study|Withdrawal by Subject|1|||
164025297|NCT04715230|592451735|FG001|Overall Study|Withdrawal by Subject|0|||
164025298|NCT04715230|592451736|FG002|Overall Study|Withdrawal by Subject|0|||
164025299|NCT04715230|592451734|FG000|Overall Study|Lost to Follow-up|0|||
164025300|NCT04715230|592451735|FG001|Overall Study|Lost to Follow-up|5|||
164025301|NCT04715230|592451736|FG002|Overall Study|Lost to Follow-up|1|||
164025302|NCT01927744|592453281|FG000|Overall Study|Death|2|||
164025303|NCT01927744|592453282|FG001|Overall Study|Death|9|||
164025304|NCT00369967|592453283|FG000|Overall Study|Lost to Follow-up|23|||
164025305|NCT00369967|592453284|FG001|Overall Study|Lost to Follow-up|12|||
164025306|NCT00605722|592453289|FG000|Overall Study|Adverse Event|6|||
164025307|NCT00605722|592453289|FG000|Overall Study|Insufficient therapeutic response|44|||
164025308|NCT00605722|592453289|FG000|Overall Study|Failure to return|1|||
164025309|NCT00485589|592453296|FG000|Overall Study|Death|2|||
164025310|NCT00485589|592453297|FG001|Overall Study|Death|2|||
164025311|NCT00485589|592453298|FG002|Overall Study|Death|0|||
164025312|NCT00485589|592453296|FG000|Overall Study|Failure to return|6|||
164025313|NCT00485589|592453297|FG001|Overall Study|Failure to return|5|||
164025314|NCT00485589|592453298|FG002|Overall Study|Failure to return|1|||
164025315|NCT00485589|592453296|FG000|Overall Study|Protocol Violation|1|||
164025316|NCT00485589|592453297|FG001|Overall Study|Protocol Violation|0|||
164025317|NCT00485589|592453298|FG002|Overall Study|Protocol Violation|0|||
164025318|NCT00485589|592453296|FG000|Overall Study|Violation of selection criteria at entry|0|||
164025319|NCT00485589|592453297|FG001|Overall Study|Violation of selection criteria at entry|3|||
164025320|NCT00485589|592453298|FG002|Overall Study|Violation of selection criteria at entry|1|||
164025321|NCT00485589|592453296|FG000|Overall Study|Administrative/Other|1|||
164025322|NCT00485589|592453297|FG001|Overall Study|Administrative/Other|2|||
164025323|NCT00485589|592453298|FG002|Overall Study|Administrative/Other|1|||
164025324|NCT00485589|592453296|FG000|Overall Study|Insufficient therapeutic response|10|||
164025325|NCT00485589|592453297|FG001|Overall Study|Insufficient therapeutic response|3|||
164025326|NCT00485589|592453298|FG002|Overall Study|Insufficient therapeutic response|1|||
164025327|NCT00485589|592453296|FG000|Overall Study|Refused treatment/did not cooperate|1|||
164025328|NCT00485589|592453297|FG001|Overall Study|Refused treatment/did not cooperate|0|||
164025329|NCT00485589|592453298|FG002|Overall Study|Refused treatment/did not cooperate|2|||
164025330|NCT00485589|592453296|FG000|Overall Study|Withdrawal by Subject|3|||
164025331|NCT00485589|592453297|FG001|Overall Study|Withdrawal by Subject|2|||
164025332|NCT00485589|592453298|FG002|Overall Study|Withdrawal by Subject|2|||
164025333|NCT00485589|592453296|FG000|Overall Study|Adverse Event|3|||
164025334|NCT00485589|592453297|FG001|Overall Study|Adverse Event|3|||
164025335|NCT00485589|592453298|FG002|Overall Study|Adverse Event|10|||
164025336|NCT04017442|592453303|FG000|Overall Study|Withdrawal by Subject|0|||
164025337|NCT04017442|592453304|FG001|Overall Study|Withdrawal by Subject|3|||
164025338|NCT04017442|592453303|FG000|Overall Study|Lost to Follow-up|21|||
164025339|NCT04017442|592453304|FG001|Overall Study|Lost to Follow-up|19|||
164025340|NCT01205451|592453312|FG000|Overall Study|Lost to Follow-up|1|||
164025341|NCT01205451|592453313|FG001|Overall Study|Lost to Follow-up|1|||
164025342|NCT01205451|592453312|FG000|Overall Study|Withdrawal by Subject|5|||
164025343|NCT01205451|592453313|FG001|Overall Study|Withdrawal by Subject|9|||
164025344|NCT02226146|592453317|FG000|Overall Study|Received rescue therapy|1|||
164025345|NCT02226146|592453317|FG000|Overall Study|Withdrawal by Subject|2|||
164025346|NCT05464836|592453318|FG000|Overall Study|Progression of Disease|1|||
164025347|NCT05464836|592453318|FG000|Overall Study|Physician Decision|1|||
164025348|NCT01522976|592453319|FG000|Overall Study|Ineligible|4|||
164025349|NCT01522976|592453320|FG001|Overall Study|Ineligible|0|||
164025350|NCT01522976|592453321|FG002|Overall Study|Ineligible|1|||
164025351|NCT01522976|592453319|FG000|Overall Study|Death|7|||
164025352|NCT01522976|592453320|FG001|Overall Study|Death|6|||
164025353|NCT01522976|592453321|FG002|Overall Study|Death|2|||
164025354|NCT01522976|592453319|FG000|Overall Study|Still on treatment|9|||
164025355|NCT01522976|592453320|FG001|Overall Study|Still on treatment|9|||
164025356|NCT01522976|592453321|FG002|Overall Study|Still on treatment|6|||
164025357|NCT01522976|592453319|FG000|Overall Study|Disease progression|28|||
164025358|NCT01522976|592453320|FG001|Overall Study|Disease progression|30|||
164025359|NCT01522976|592453321|FG002|Overall Study|Disease progression|25|||
164025360|NCT01522976|592453319|FG000|Overall Study|Adverse Event|17|||
164025361|NCT01522976|592453320|FG001|Overall Study|Adverse Event|7|||
164025362|NCT01522976|592453321|FG002|Overall Study|Adverse Event|18|||
164025363|NCT01522976|592453319|FG000|Overall Study|Refusal unrelated to adverse event|10|||
164025364|NCT01522976|592453320|FG001|Overall Study|Refusal unrelated to adverse event|13|||
164025365|NCT01522976|592453321|FG002|Overall Study|Refusal unrelated to adverse event|14|||
164025366|NCT01522976|592453319|FG000|Overall Study|Not protocol specified|22|||
164025367|NCT01522976|592453320|FG001|Overall Study|Not protocol specified|27|||
164025368|NCT01522976|592453321|FG002|Overall Study|Not protocol specified|27|||
164025369|NCT02938585|592453324|FG000|Overall Study|Withdrawal by parent or guardian|0|||
164025370|NCT02938585|592453325|FG001|Overall Study|Withdrawal by parent or guardian|1|||
164025371|NCT02938585|592453326|FG002|Overall Study|Withdrawal by parent or guardian|0|||
164025372|NCT02938585|592453327|FG003|Overall Study|Withdrawal by parent or guardian|0|||
164025373|NCT02938585|592453324|FG000|Overall Study|Withdrawal by Subject|0|||
164025374|NCT02938585|592453325|FG001|Overall Study|Withdrawal by Subject|0|||
164025375|NCT02938585|592453326|FG002|Overall Study|Withdrawal by Subject|0|||
164025376|NCT02938585|592453327|FG003|Overall Study|Withdrawal by Subject|5|||
164025377|NCT02106455|592453335|FG000|Overall Study|Case Report Form Uncollected|6|||
164025378|NCT02106455|592453335|FG000|Overall Study|Protocol Deviation|2|||
164025379|NCT00213980|592453336|FG000|Overall Study|Withdrawal by Subject|3|||
164025380|NCT00213980|592453337|FG001|Overall Study|Withdrawal by Subject|1|||
164025381|NCT00213980|592453336|FG000|Overall Study|Adverse Event|1|||
164025382|NCT00213980|592453337|FG001|Overall Study|Adverse Event|1|||
164025383|NCT00213980|592453336|FG000|Overall Study|Disease progression|0|||
164025384|NCT00213980|592453337|FG001|Overall Study|Disease progression|2|||
164025385|NCT00213980|592453336|FG000|Overall Study|Developed ovarian cancer|1|||
164025386|NCT00213980|592453337|FG001|Overall Study|Developed ovarian cancer|0|||
164025387|NCT00213980|592453336|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
164025388|NCT00213980|592453337|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
164025389|NCT03607838|592453338|FG000|Overall Study|Lack of Efficacy|14|||
164025390|NCT03607838|592453339|FG001|Overall Study|Lack of Efficacy|20|||
164025391|NCT03607838|592453338|FG000|Overall Study|Withdrawal by Subject|13|||
164025392|NCT03607838|592453339|FG001|Overall Study|Withdrawal by Subject|8|||
164025393|NCT03607838|592453338|FG000|Overall Study|Lost to Follow-up|6|||
164025394|NCT03607838|592453339|FG001|Overall Study|Lost to Follow-up|11|||
164025395|NCT03607838|592453338|FG000|Overall Study|Adverse Event|2|||
164025396|NCT03607838|592453339|FG001|Overall Study|Adverse Event|2|||
164025397|NCT03607838|592453338|FG000|Overall Study|Physician Decision|2|||
164025398|NCT03607838|592453339|FG001|Overall Study|Physician Decision|0|||
164025399|NCT03607838|592453338|FG000|Overall Study|Failure to meet randomization criteria|1|||
164025400|NCT03607838|592453339|FG001|Overall Study|Failure to meet randomization criteria|2|||
164025401|NCT03607838|592453338|FG000|Overall Study|Pregnancy|1|||
164025402|NCT03607838|592453339|FG001|Overall Study|Pregnancy|0|||
164025403|NCT03607838|592453338|FG000|Overall Study|Protocol Violation|1|||
164025404|NCT03607838|592453339|FG001|Overall Study|Protocol Violation|0|||
164025405|NCT03607838|592453338|FG000|Overall Study|Due to work|1|||
164025406|NCT03607838|592453339|FG001|Overall Study|Due to work|0|||
164025407|NCT03607838|592453338|FG000|Overall Study|Litigation|0|||
164025408|NCT03607838|592453339|FG001|Overall Study|Litigation|1|||
164025409|NCT03607838|592453338|FG000|Overall Study|Temperature excursion for study drug|0|||
164025410|NCT03607838|592453339|FG001|Overall Study|Temperature excursion for study drug|1|||
164025411|NCT03607838|592453338|FG000|Overall Study|Change of mind|0|||
164025412|NCT03607838|592453339|FG001|Overall Study|Change of mind|1|||
164025413|NCT01952730|592453344|FG000|Overall Study|FDA shut down core lab used by study|1|||
164025414|NCT01514188|592453351|FG000|Overall Study|Adverse Event|3|||
164025415|NCT01514188|592453352|FG001|Overall Study|Adverse Event|5|||
164025416|NCT01514188|592453351|FG000|Overall Study|Withdrawal by Subject|2|||
164025417|NCT01514188|592453352|FG001|Overall Study|Withdrawal by Subject|4|||
164025418|NCT01514188|592453351|FG000|Overall Study|Protocol Violation|2|||
164025419|NCT01514188|592453352|FG001|Overall Study|Protocol Violation|4|||
164025420|NCT01514188|592453351|FG000|Overall Study|Physician Decision|0|||
164025421|NCT01514188|592453352|FG001|Overall Study|Physician Decision|2|||
164025422|NCT01514188|592453351|FG000|Overall Study|Disease Progression|13|||
164025423|NCT01514188|592453352|FG001|Overall Study|Disease Progression|14|||
164025424|NCT01514188|592453351|FG000|Overall Study|Death|1|||
164025425|NCT01514188|592453352|FG001|Overall Study|Death|3|||
164025426|NCT01514188|592453351|FG000|Overall Study|Other|2|||
164025427|NCT01514188|592453352|FG001|Overall Study|Other|1|||
164025428|NCT03442829|592453355|FG000|Overall Study|Scheduling clash|3|||
164025429|NCT03442829|592453356|FG001|Overall Study|Scheduling clash|1|||
164025430|NCT03442829|592453355|FG000|Overall Study|Illness unrelated to study|1|||
164025431|NCT03442829|592453356|FG001|Overall Study|Illness unrelated to study|1|||
164025432|NCT02605447|592453359|FG000|Overall Study|Death|66|||
164025433|NCT02605447|592453359|FG000|Overall Study|Physician Decision|1|||
164025434|NCT02605447|592453359|FG000|Overall Study|Lost to Follow-up|24|||
164025435|NCT02605447|592453359|FG000|Overall Study|Withdrawal by Subject|10|||
164025436|NCT02605447|592453359|FG000|Overall Study|Not disclosed|1|||
164025437|NCT02237157|592453360|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
164025438|NCT02237157|592453361|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
164025439|NCT02237157|592453362|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
164025440|NCT02237157|592453363|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
164025441|NCT02237157|592453360|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
164025442|NCT02237157|592453361|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
164025443|NCT02237157|592453362|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
164025444|NCT02237157|592453363|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
164025445|NCT04533815|592453365|FG000|Overall Study|Adverse Event|2|||
164025446|NCT04533815|592453365|FG000|Overall Study|Site withdrew|5|||
164025447|NCT02045212|592453366|FG000|Overall Study|Adverse Event|0|||
164025448|NCT02045212|592453367|FG001|Overall Study|Adverse Event|1|||
164025449|NCT02045212|592453366|FG000|Overall Study|Withdrawal by Subject|1|||
164025450|NCT02045212|592453367|FG001|Overall Study|Withdrawal by Subject|0|||
164025451|NCT02045212|592453366|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
164025452|NCT02045212|592453367|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
164025453|NCT00488592|592453368|FG000|Overall Study|Withdrawal by Subject|1|||
164025454|NCT00488592|592453368|FG000|Overall Study|Disease progression|1|||
164025455|NCT00488592|592453368|FG000|Overall Study|Enrolled but not treated|1|||
164025456|NCT00441103|592453369|FG000|Overall Study|Adverse Event|2|||
164025457|NCT00441103|592453370|FG001|Overall Study|Adverse Event|1|||
164025458|NCT00441103|592453369|FG000|Overall Study|Death|1|||
164025459|NCT00441103|592453370|FG001|Overall Study|Death|0|||
164025460|NCT00441103|592453369|FG000|Overall Study|Disease Progression|2|||
164025461|NCT00441103|592453370|FG001|Overall Study|Disease Progression|0|||
164025462|NCT00441103|592453369|FG000|Overall Study|Lost to Follow-up|1|||
164025463|NCT00441103|592453370|FG001|Overall Study|Lost to Follow-up|0|||
164025464|NCT00441103|592453369|FG000|Overall Study|Protocol Violation|1|||
164025465|NCT00441103|592453370|FG001|Overall Study|Protocol Violation|0|||
164025466|NCT00441103|592453369|FG000|Overall Study|Participant unable to use Rebiject II|1|||
164025467|NCT00441103|592453370|FG001|Overall Study|Participant unable to use Rebiject II|0|||
164025468|NCT00441103|592453369|FG000|Overall Study|Participant refused MRI|1|||
164025469|NCT00441103|592453370|FG001|Overall Study|Participant refused MRI|0|||
164025470|NCT00441103|592453369|FG000|Overall Study|Inclusion criteria absent|1|||
164025471|NCT00441103|592453370|FG001|Overall Study|Inclusion criteria absent|0|||
164025472|NCT00441103|592453369|FG000|Overall Study|Non-compliant|0|||
164025473|NCT00441103|592453370|FG001|Overall Study|Non-compliant|1|||
164025474|NCT00441103|592453369|FG000|Overall Study|Participant decided to withdraw|1|||
164025475|NCT00441103|592453370|FG001|Overall Study|Participant decided to withdraw|0|||
164025476|NCT00441103|592453369|FG000|Overall Study|Participant's reason|0|||
164025477|NCT00441103|592453370|FG001|Overall Study|Participant's reason|1|||
164025478|NCT00441103|592453369|FG000|Overall Study|Participant decided to stop|0|||
164025479|NCT00441103|592453370|FG001|Overall Study|Participant decided to stop|1|||
164025480|NCT05836818|592453371|FG000|Overall Study|Physician Decision|1|||
164025481|NCT05836818|592453372|FG001|Overall Study|Physician Decision|1|||
164025482|NCT05836818|592453373|FG002|Overall Study|Physician Decision|0|||
164025483|NCT05836818|592453371|FG000|Overall Study|Withdrawal by Subject|0|||
164025484|NCT05836818|592453372|FG001|Overall Study|Withdrawal by Subject|0|||
164025485|NCT05836818|592453373|FG002|Overall Study|Withdrawal by Subject|1|||
164025486|NCT05836818|592453371|FG000|Overall Study|Later found to be previously vaccinated|0|||
164025487|NCT05836818|592453372|FG001|Overall Study|Later found to be previously vaccinated|1|||
164025488|NCT05836818|592453373|FG002|Overall Study|Later found to be previously vaccinated|3|||
164025489|NCT05836818|592453371|FG000|Overall Study|Pregnancy|0|||
164025490|NCT05836818|592453372|FG001|Overall Study|Pregnancy|1|||
164025491|NCT05836818|592453373|FG002|Overall Study|Pregnancy|0|||
164025492|NCT05836818|592453371|FG000|Overall Study|Allergic to vaccines|0|||
164025493|NCT05836818|592453372|FG001|Overall Study|Allergic to vaccines|1|||
164025494|NCT05836818|592453373|FG002|Overall Study|Allergic to vaccines|0|||
164025495|NCT03738566|592453374|FG000|Initial Study Phase|Withdrawal by Subject|1|||
164025496|NCT03738566|592453375|FG001|Initial Study Phase|Withdrawal by Subject|1|||
164025497|NCT03738566|592453376|FG002|Initial Study Phase|Withdrawal by Subject|2|||
164025498|NCT03738566|592453377|FG003|Initial Study Phase|Withdrawal by Subject|0|||
164025499|NCT03738566|592453374|FG000|Initial Study Phase|Death|0|||
164025500|NCT03738566|592453375|FG001|Initial Study Phase|Death|1|||
164025501|NCT03738566|592453376|FG002|Initial Study Phase|Death|0|||
164025502|NCT03738566|592453377|FG003|Initial Study Phase|Death|0|||
164025503|NCT03738566|592453374|FG000|Initial Study Phase|Treatment failure|5|||
164025504|NCT03738566|592453375|FG001|Initial Study Phase|Treatment failure|0|||
164025505|NCT03738566|592453376|FG002|Initial Study Phase|Treatment failure|0|||
164025506|NCT03738566|592453377|FG003|Initial Study Phase|Treatment failure|0|||
164025507|NCT03738566|592453374|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
164025508|NCT03738566|592453375|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
164025509|NCT03738566|592453376|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
164025510|NCT03738566|592453377|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
164025511|NCT03126539|592453386|FG000|Overall Study|Lost to Follow-up|1|||
164025512|NCT03126539|592453387|FG001|Overall Study|Lost to Follow-up|1|||
164025513|NCT03126539|592453388|FG002|Overall Study|Lost to Follow-up|1|||
164025514|NCT03126539|592453389|FG003|Overall Study|Lost to Follow-up|0|||
164025515|NCT03126539|592453390|FG004|Overall Study|Lost to Follow-up|0|||
164025516|NCT01627067|592453391|FG000|Overall Study|Screen Failure|1|||
164025517|NCT00926796|592453392|FG000|Overall Study|Did not receive randomized treatment|4|||
164025518|NCT00926796|592453393|FG001|Overall Study|Did not receive randomized treatment|7|||
164025519|NCT00926796|592453392|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
164025520|NCT00926796|592453393|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
164025521|NCT00926796|592453392|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
164025522|NCT00926796|592453393|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
164025523|NCT00926796|592453392|FG000|Overall Study|Adverse Event|7|||
164025524|NCT00926796|592453393|FG001|Overall Study|Adverse Event|14|||
164025525|NCT00926796|592453392|FG000|Overall Study|Lost to Follow-up|22|||
164025526|NCT00926796|592453393|FG001|Overall Study|Lost to Follow-up|13|||
164025527|NCT00926796|592453392|FG000|Overall Study|Protocol Violation|15|||
164025528|NCT00926796|592453393|FG001|Overall Study|Protocol Violation|11|||
164025529|NCT00926796|592453392|FG000|Overall Study|Withdrawal by Subject|1|||
164025530|NCT00926796|592453393|FG001|Overall Study|Withdrawal by Subject|0|||
164025531|NCT02596711|592453399|FG000|Overall Study|Lost to Follow-up|1|||
164025532|NCT02596711|592453400|FG001|Overall Study|Lost to Follow-up|2|||
164025533|NCT02596711|592453401|FG002|Overall Study|Lost to Follow-up|3|||
164025534|NCT00586924|592453402|FG000|Overall Study|Adverse event/serious adverse event|0|||
164025535|NCT00586924|592453403|FG001|Overall Study|Adverse event/serious adverse event|0|||
164025536|NCT00586924|592453404|FG002|Overall Study|Adverse event/serious adverse event|0|||
164025537|NCT00586924|592453405|FG003|Overall Study|Adverse event/serious adverse event|1|||
164025538|NCT00586924|592453406|FG004|Overall Study|Adverse event/serious adverse event|0|||
164025539|NCT00586924|592453407|FG005|Overall Study|Adverse event/serious adverse event|2|||
164025540|NCT00586924|592453402|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
164025541|NCT00586924|592453403|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
164025542|NCT00586924|592453404|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
164025543|NCT00586924|592453405|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
164025544|NCT00586924|592453406|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
164025545|NCT00586924|592453407|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
164025546|NCT00586924|592453402|FG000|Overall Study|Disease progression|0|||
164025547|NCT00586924|592453403|FG001|Overall Study|Disease progression|0|||
164025548|NCT00586924|592453404|FG002|Overall Study|Disease progression|0|||
164025549|NCT00586924|592453405|FG003|Overall Study|Disease progression|1|||
164025550|NCT00586924|592453406|FG004|Overall Study|Disease progression|1|||
164025551|NCT00586924|592453407|FG005|Overall Study|Disease progression|0|||
164025552|NCT00586924|592453402|FG000|Overall Study|Development of neutralizing antibodies|2|||
164025553|NCT00586924|592453403|FG001|Overall Study|Development of neutralizing antibodies|2|||
164025554|NCT00586924|592453404|FG002|Overall Study|Development of neutralizing antibodies|2|||
164025555|NCT00586924|592453405|FG003|Overall Study|Development of neutralizing antibodies|0|||
164025556|NCT00586924|592453406|FG004|Overall Study|Development of neutralizing antibodies|0|||
164025557|NCT00586924|592453407|FG005|Overall Study|Development of neutralizing antibodies|22|||
164025558|NCT00586924|592453402|FG000|Overall Study|Complete response|0|||
164025559|NCT00586924|592453403|FG001|Overall Study|Complete response|1|||
164025560|NCT00586924|592453404|FG002|Overall Study|Complete response|0|||
164025561|NCT00586924|592453405|FG003|Overall Study|Complete response|0|||
164025562|NCT00586924|592453406|FG004|Overall Study|Complete response|2|||
164025563|NCT00586924|592453407|FG005|Overall Study|Complete response|2|||
164025564|NCT00586924|592453402|FG000|Overall Study|Other|1|||
164025565|NCT00586924|592453403|FG001|Overall Study|Other|0|||
164025566|NCT00586924|592453404|FG002|Overall Study|Other|1|||
164025567|NCT00586924|592453405|FG003|Overall Study|Other|1|||
164025568|NCT00586924|592453406|FG004|Overall Study|Other|1|||
164025569|NCT00586924|592453407|FG005|Overall Study|Other|6|||
164025570|NCT01331239|592453410|FG000|Part II: Core Study|Adverse Event|0|||
164025571|NCT01331239|592453411|FG001|Part II: Core Study|Adverse Event|3|||
164025572|NCT01331239|592453412|FG002|Part II: Core Study|Adverse Event|0|||
164025573|NCT01331239|592453410|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
164025574|NCT01331239|592453411|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
164025575|NCT01331239|592453412|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
164025576|NCT01331239|592453410|FG000|Part II: Core Study|Withdrawal by Subject|0|||
164025577|NCT01331239|592453411|FG001|Part II: Core Study|Withdrawal by Subject|2|||
164025578|NCT01331239|592453412|FG002|Part II: Core Study|Withdrawal by Subject|0|||
164025579|NCT01331239|592453410|FG000|Part II: Core Study|Administrative problems|0|||
164025580|NCT01331239|592453411|FG001|Part II: Core Study|Administrative problems|1|||
164025581|NCT01331239|592453412|FG002|Part II: Core Study|Administrative problems|0|||
164025582|NCT01767194|592453414|FG000|Overall Study|Adverse Event|1|||
164025583|NCT01767194|592453415|FG001|Overall Study|Adverse Event|1|||
164025584|NCT01767194|592453414|FG000|Overall Study|Death|0|||
164025585|NCT01767194|592453415|FG001|Overall Study|Death|1|||
164025586|NCT01767194|592453414|FG000|Overall Study|Lack of Efficacy|12|||
164025587|NCT01767194|592453415|FG001|Overall Study|Lack of Efficacy|11|||
164025588|NCT01767194|592453414|FG000|Overall Study|Physician Decision|2|||
164025589|NCT01767194|592453415|FG001|Overall Study|Physician Decision|23|||
164025590|NCT01767194|592453414|FG000|Overall Study|Withdrawal by Subject|0|||
164025591|NCT01767194|592453415|FG001|Overall Study|Withdrawal by Subject|1|||
164025592|NCT01767194|592453414|FG000|Overall Study|Ineligible|1|||
164025593|NCT01767194|592453415|FG001|Overall Study|Ineligible|1|||
164025594|NCT01767194|592453414|FG000|Overall Study|Refusal by patient/parent|2|||
164025595|NCT01767194|592453415|FG001|Overall Study|Refusal by patient/parent|4|||
164025596|NCT01767194|592453414|FG000|Overall Study|Criteria not met on time for next cycle|0|||
164025597|NCT01767194|592453415|FG001|Overall Study|Criteria not met on time for next cycle|1|||
164025598|NCT04191577|592453419|FG000|Overall Study|Withdrawal by Subject|2|||
164025599|NCT04191577|592453420|FG001|Overall Study|Withdrawal by Subject|2|||
164025600|NCT04191577|592453421|FG002|Overall Study|Withdrawal by Subject|1|||
164025601|NCT04191577|592453419|FG000|Overall Study|Physician Decision|1|||
164025602|NCT04191577|592453420|FG001|Overall Study|Physician Decision|1|||
164025603|NCT04191577|592453421|FG002|Overall Study|Physician Decision|0|||
164025604|NCT04191577|592453419|FG000|Overall Study|Adverse Event|0|||
164025605|NCT04191577|592453420|FG001|Overall Study|Adverse Event|0|||
164025606|NCT04191577|592453421|FG002|Overall Study|Adverse Event|1|||
164025607|NCT04191577|592453419|FG000|Overall Study|Death|0|||
164025608|NCT04191577|592453420|FG001|Overall Study|Death|0|||
164025609|NCT04191577|592453421|FG002|Overall Study|Death|1|||
164025610|NCT00992446|592453424|FG000|Overall Study|Disease Progression|1|||
164025611|NCT00992446|592453424|FG000|Overall Study|Withdrawal by Subject|2|||
164025612|NCT00992446|592453424|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
164025613|NCT01274338|592454803|FG000|Overall Study|Lack of Efficacy|72|||
164025614|NCT01274338|592454804|FG001|Overall Study|Lack of Efficacy|108|||
164025615|NCT01274338|592454805|FG002|Overall Study|Lack of Efficacy|116|||
164025616|NCT01274338|592454806|FG003|Overall Study|Lack of Efficacy|0|||
164025617|NCT01274338|592454807|FG004|Overall Study|Lack of Efficacy|0|||
164025618|NCT01274338|592454808|FG005|Overall Study|Lack of Efficacy|0|||
164025619|NCT01274338|592454803|FG000|Overall Study|Adverse Event|272|||
164025620|NCT01274338|592454804|FG001|Overall Study|Adverse Event|105|||
164025621|NCT01274338|592454805|FG002|Overall Study|Adverse Event|180|||
164025622|NCT01274338|592454806|FG003|Overall Study|Adverse Event|1|||
164025623|NCT01274338|592454807|FG004|Overall Study|Adverse Event|0|||
164025624|NCT01274338|592454808|FG005|Overall Study|Adverse Event|0|||
164025625|NCT01274338|592454803|FG000|Overall Study|Death|8|||
164025626|NCT01274338|592454804|FG001|Overall Study|Death|1|||
164025627|NCT01274338|592454805|FG002|Overall Study|Death|0|||
164025628|NCT01274338|592454806|FG003|Overall Study|Death|0|||
164025629|NCT01274338|592454807|FG004|Overall Study|Death|0|||
164025630|NCT01274338|592454808|FG005|Overall Study|Death|0|||
164025631|NCT01274338|592454803|FG000|Overall Study|Withdrawal by Subject|27|||
164025632|NCT01274338|592454804|FG001|Overall Study|Withdrawal by Subject|99|||
164025633|NCT01274338|592454805|FG002|Overall Study|Withdrawal by Subject|17|||
164025634|NCT01274338|592454806|FG003|Overall Study|Withdrawal by Subject|0|||
164025635|NCT01274338|592454807|FG004|Overall Study|Withdrawal by Subject|0|||
164025636|NCT01274338|592454808|FG005|Overall Study|Withdrawal by Subject|0|||
164025637|NCT01274338|592454803|FG000|Overall Study|Did not start treatment|8|||
164025638|NCT01274338|592454804|FG001|Overall Study|Did not start treatment|116|||
164025639|NCT01274338|592454805|FG002|Overall Study|Did not start treatment|7|||
164025640|NCT01274338|592454806|FG003|Overall Study|Did not start treatment|0|||
164025641|NCT01274338|592454807|FG004|Overall Study|Did not start treatment|0|||
164025642|NCT01274338|592454808|FG005|Overall Study|Did not start treatment|0|||
164025643|NCT01274338|592454803|FG000|Overall Study|Alternative therapy|0|||
164025644|NCT01274338|592454804|FG001|Overall Study|Alternative therapy|1|||
164025645|NCT01274338|592454805|FG002|Overall Study|Alternative therapy|0|||
164025646|NCT01274338|592454806|FG003|Overall Study|Alternative therapy|0|||
164025647|NCT01274338|592454807|FG004|Overall Study|Alternative therapy|0|||
164025648|NCT01274338|592454808|FG005|Overall Study|Alternative therapy|0|||
164025649|NCT01274338|592454803|FG000|Overall Study|Other complicating diseases|0|||
164025650|NCT01274338|592454804|FG001|Overall Study|Other complicating diseases|3|||
164025651|NCT01274338|592454805|FG002|Overall Study|Other complicating diseases|1|||
164025652|NCT01274338|592454806|FG003|Overall Study|Other complicating diseases|0|||
164025653|NCT01274338|592454807|FG004|Overall Study|Other complicating diseases|0|||
164025654|NCT01274338|592454808|FG005|Overall Study|Other complicating diseases|0|||
164025655|NCT01274338|592454803|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
164025656|NCT01274338|592454804|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
164025657|NCT01274338|592454805|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
164025658|NCT01274338|592454806|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
164025659|NCT01274338|592454807|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
164025660|NCT01274338|592454808|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
164025661|NCT01274338|592454803|FG000|Overall Study|Pregnancy|0|||
164025662|NCT01274338|592454804|FG001|Overall Study|Pregnancy|0|||
164025663|NCT01274338|592454805|FG002|Overall Study|Pregnancy|1|||
164025664|NCT01274338|592454806|FG003|Overall Study|Pregnancy|0|||
164025665|NCT01274338|592454807|FG004|Overall Study|Pregnancy|0|||
164025666|NCT01274338|592454808|FG005|Overall Study|Pregnancy|0|||
164025667|NCT01274338|592454803|FG000|Overall Study|Reason not reported|12|||
164025668|NCT01274338|592454804|FG001|Overall Study|Reason not reported|21|||
164025669|NCT01274338|592454805|FG002|Overall Study|Reason not reported|3|||
164025670|NCT01274338|592454806|FG003|Overall Study|Reason not reported|0|||
164025671|NCT01274338|592454807|FG004|Overall Study|Reason not reported|1|||
164025672|NCT01274338|592454808|FG005|Overall Study|Reason not reported|0|||
164025673|NCT02411201|592454809|FG000|Overall Study|Adverse Event|2|||
164025674|NCT02411201|592454809|FG000|Overall Study|Withdrawal by Subject|2|||
164025675|NCT02411201|592454809|FG000|Overall Study|Age group completed|2|||
164025676|NCT01260467|592454810|FG000|Overall Study|Withdrawal by Subject|2|||
164025677|NCT00798694|592454811|FG000|Overall Study|Lost to Follow-up|1|||
164025678|NCT00798694|592454812|FG001|Overall Study|Lost to Follow-up|1|||
164025679|NCT00798694|592454811|FG000|Overall Study|Physician Decision|1|||
164025680|NCT00798694|592454812|FG001|Overall Study|Physician Decision|0|||
164025681|NCT03364608|592454816|FG000|Overall Study|Withdrawal by Subject|4|||
164025682|NCT03364608|592454816|FG000|Overall Study|Protocol Violation|2|||
164025683|NCT03364608|592454816|FG000|Overall Study|Lost to Follow-up|2|||
164025684|NCT01163253|592454819|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
164025685|NCT01163253|592454820|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
164025686|NCT01163253|592454819|FG000|Overall Study|Study Terminated by Sponsor|978|||
164025687|NCT01163253|592454820|FG001|Overall Study|Study Terminated by Sponsor|349|||
164025688|NCT01163253|592454819|FG000|Overall Study|Protocol Violation|43|||
164025689|NCT01163253|592454820|FG001|Overall Study|Protocol Violation|12|||
164025690|NCT01163253|592454819|FG000|Overall Study|Withdrawal by Subject|199|||
164025691|NCT01163253|592454820|FG001|Overall Study|Withdrawal by Subject|50|||
164025692|NCT01163253|592454819|FG000|Overall Study|Medication Error|1|||
164025693|NCT01163253|592454820|FG001|Overall Study|Medication Error|0|||
164025694|NCT01163253|592454819|FG000|Overall Study|Lost to Follow-up|125|||
164025695|NCT01163253|592454820|FG001|Overall Study|Lost to Follow-up|23|||
164025696|NCT01163253|592454819|FG000|Overall Study|Insufficient Clinical Response|423|||
164025697|NCT01163253|592454820|FG001|Overall Study|Insufficient Clinical Response|29|||
164025698|NCT01163253|592454819|FG000|Overall Study|Adverse Event|300|||
164025699|NCT01163253|592454820|FG001|Overall Study|Adverse Event|78|||
164025700|NCT01163253|592454819|FG000|Overall Study|Death|17|||
164025701|NCT01163253|592454820|FG001|Overall Study|Death|5|||
164025702|NCT01163253|592454819|FG000|Overall Study|Ongoing|13|||
164025703|NCT01163253|592454820|FG001|Overall Study|Ongoing|4|||
164025704|NCT01163253|592454819|FG000|Overall Study|Other Unspecified|170|||
164025705|NCT01163253|592454820|FG001|Overall Study|Other Unspecified|34|||
164025706|NCT03888391|592454823|FG000|Overall Study|Lost to Follow-up|15|||
164025707|NCT03025217|592454829|FG000|Overall Study|Pregnancy|1|||
164025708|NCT03025217|592454829|FG000|Overall Study|Lost to Follow-up|1|||
164025709|NCT03025217|592454829|FG000|Overall Study|Not eligible, poor English|2|||
164025710|NCT02130427|592454835|FG000|Overall Study|Imaging results not interpretable|30|||
164025711|NCT04032171|592454837|FG000|Overall Study|Study Termination|1|||
164025712|NCT04032171|592454838|FG001|Overall Study|Study Termination|0|||
164025713|NCT00992784|592454839|FG000|Overall Study|Adverse Event|2|||
164025714|NCT00992784|592454840|FG001|Overall Study|Adverse Event|1|||
164025715|NCT00992784|592454841|FG002|Overall Study|Adverse Event|0|||
164025716|NCT00992784|592454839|FG000|Overall Study|Withdrawal by Subject|1|||
164025717|NCT00992784|592454840|FG001|Overall Study|Withdrawal by Subject|1|||
164025718|NCT00992784|592454841|FG002|Overall Study|Withdrawal by Subject|1|||
164025719|NCT00781599|592454842|FG000|Overall Study|Lost to Follow-up|7|||
164025720|NCT00781599|592454843|FG001|Overall Study|Lost to Follow-up|4|||
164025721|NCT01088438|592454844|FG000|Overall Study|Withdrawal by Subject|11|||
164025722|NCT01088438|592454845|FG001|Overall Study|Withdrawal by Subject|6|||
164025723|NCT01088438|592454844|FG000|Overall Study|Lost to Follow-up|18|||
164025724|NCT01088438|592454845|FG001|Overall Study|Lost to Follow-up|30|||
164025725|NCT00089479|592454846|FG000|Overall Study|Death|108|||
164025726|NCT00089479|592454847|FG001|Overall Study|Death|75|||
164025727|NCT00089479|592454846|FG000|Overall Study|Withdrawal by Subject|86|||
164025728|NCT00089479|592454847|FG001|Overall Study|Withdrawal by Subject|107|||
164025729|NCT00089479|592454846|FG000|Overall Study|Lost to Follow-up|137|||
164025730|NCT00089479|592454847|FG001|Overall Study|Lost to Follow-up|107|||
164025731|NCT03337152|592454849|FG000|Overall Study|Physician Decision|1|||
164025732|NCT03337152|592454850|FG001|Overall Study|Physician Decision|0|||
164025733|NCT03337152|592454849|FG000|Overall Study|Lost to Follow-up|1|||
164025734|NCT03337152|592454850|FG001|Overall Study|Lost to Follow-up|3|||
164025735|NCT03337152|592454849|FG000|Overall Study|Adverse Event|3|||
164025736|NCT03337152|592454850|FG001|Overall Study|Adverse Event|1|||
164025737|NCT03337152|592454849|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
164025738|NCT03337152|592454850|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
164025739|NCT00421343|592454851|FG000|Overall Study|Death|1|||
164025740|NCT00421343|592454851|FG000|Overall Study|Withdrawal by Subject|2|||
164025741|NCT00421343|592454851|FG000|Overall Study|Lost to Follow-up|3|||
164025742|NCT00678587|592454852|FG000|Overall Study|Adverse Event|3|||
164025743|NCT00678587|592454853|FG001|Overall Study|Adverse Event|3|||
164025744|NCT00678587|592454852|FG000|Overall Study|Lack of Efficacy|1|||
164025745|NCT00678587|592454853|FG001|Overall Study|Lack of Efficacy|0|||
164025746|NCT00678587|592454852|FG000|Overall Study|Protocol Violation|2|||
164025747|NCT00678587|592454853|FG001|Overall Study|Protocol Violation|1|||
164025748|NCT00678587|592454852|FG000|Overall Study|Study Closed/Terminated|1|||
164025749|NCT00678587|592454853|FG001|Overall Study|Study Closed/Terminated|0|||
164025750|NCT00678587|592454852|FG000|Overall Study|Lost to Follow-up|3|||
164025751|NCT00678587|592454853|FG001|Overall Study|Lost to Follow-up|5|||
164025752|NCT00678587|592454852|FG000|Overall Study|Investigator Discretion|2|||
164025753|NCT00678587|592454853|FG001|Overall Study|Investigator Discretion|6|||
164025754|NCT00678587|592454852|FG000|Overall Study|Withdrew Consent|8|||
164025755|NCT00678587|592454853|FG001|Overall Study|Withdrew Consent|3|||
164025756|NCT00976950|592454854|FG000|Overall Study|Adverse Event|3|||
164025757|NCT00976950|592454854|FG000|Overall Study|Events with no relationship to Aptivus|3|||
164025758|NCT01019486|592454855|FG000|Overall Study|Withdrawal by Subject|1|||
164025759|NCT01019486|592454856|FG001|Overall Study|Withdrawal by Subject|1|||
164025760|NCT01019486|592454857|FG002|Overall Study|Withdrawal by Subject|1|||
164025761|NCT02932332|592454858|FG000|Overall Study|Withdrawal by Subject|1|||
164025762|NCT02932332|592454859|FG001|Overall Study|Withdrawal by Subject|1|||
164025763|NCT02932332|592454860|FG002|Overall Study|Withdrawal by Subject|0|||
164025764|NCT02932332|592454861|FG003|Overall Study|Withdrawal by Subject|1|||
164025765|NCT02932332|592454858|FG000|Overall Study|Chest pain|0|||
164025766|NCT02932332|592454859|FG001|Overall Study|Chest pain|0|||
164025767|NCT02932332|592454860|FG002|Overall Study|Chest pain|0|||
164025768|NCT02932332|592454861|FG003|Overall Study|Chest pain|1|||
164025769|NCT02932332|592454858|FG000|Overall Study|Not Dyspneic cough|1|||
164025770|NCT02932332|592454859|FG001|Overall Study|Not Dyspneic cough|2|||
164025771|NCT02932332|592454860|FG002|Overall Study|Not Dyspneic cough|1|||
164025772|NCT02932332|592454861|FG003|Overall Study|Not Dyspneic cough|0|||
164025773|NCT01069523|592454863|FG000|Overall Study|Withdrawal by Subject|4|||
164025774|NCT01069523|592454864|FG001|Overall Study|Withdrawal by Subject|7|||
164025775|NCT01875367|592454865|FG000|Overall Study|Not complete at least 2 questionaries|4|||
164025776|NCT01875367|592454866|FG001|Overall Study|Not complete at least 2 questionaries|2|||
164025777|NCT01875367|592454865|FG000|Overall Study|Not receive study treatment|1|||
164025778|NCT01875367|592454866|FG001|Overall Study|Not receive study treatment|0|||
164025779|NCT00515008|592454872|FG000|Overall Study|Lost to Follow-up|1|||
164025780|NCT00515008|592454873|FG001|Overall Study|Lost to Follow-up|0|||
164025781|NCT00515008|592454872|FG000|Overall Study|Declined|0|||
164025782|NCT00515008|592454873|FG001|Overall Study|Declined|3|||
164025783|NCT00515008|592454872|FG000|Overall Study|Left the Boston Area|1|||
164025784|NCT00515008|592454873|FG001|Overall Study|Left the Boston Area|1|||
164096067|NCT01735630|592715853|FG001|Overall Study|Withdrawal by Subject|9|||
164096068|NCT00891293|592715855|FG000|Overall Study|Adverse Event|2|||
164025785|NCT00515008|592454872|FG000|Overall Study|Scheduling conflict|1|||
164025786|NCT00515008|592454873|FG001|Overall Study|Scheduling conflict|0|||
164096069|NCT00891293|592715855|FG000|Overall Study|Protocol Violation|2|||
164025787|NCT02951988|592454874|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
164025788|NCT02951988|592454875|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
164025789|NCT02951988|592454876|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
164144828|NCT04289363|592891793|FG001|Overall Study|Lost to Follow-up|0|||
164025790|NCT02951988|592454877|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
164025791|NCT02951988|592454874|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
164025792|NCT02951988|592454875|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
164025793|NCT02951988|592454876|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
164025794|NCT02951988|592454877|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
164025795|NCT02951988|592454874|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
164025796|NCT02951988|592454875|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
164025797|NCT02951988|592454876|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
164025798|NCT02951988|592454877|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
164025799|NCT02951988|592454874|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
164025800|NCT02951988|592454875|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
164025801|NCT02951988|592454876|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
164025802|NCT02951988|592454877|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
164025803|NCT02951988|592454874|FG000|Open-Label Treatment Period|Protocol Violation|22|||
164025804|NCT02951988|592454875|FG001|Open-Label Treatment Period|Protocol Violation|0|||
164025805|NCT02951988|592454876|FG002|Open-Label Treatment Period|Protocol Violation|0|||
164025806|NCT02951988|592454877|FG003|Open-Label Treatment Period|Protocol Violation|0|||
164025807|NCT02951988|592454874|FG000|Open-Label Treatment Period|Pregnancy|2|||
164025808|NCT02951988|592454875|FG001|Open-Label Treatment Period|Pregnancy|0|||
164025809|NCT02951988|592454876|FG002|Open-Label Treatment Period|Pregnancy|0|||
164025810|NCT02951988|592454877|FG003|Open-Label Treatment Period|Pregnancy|0|||
164025811|NCT02951988|592454874|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
164025812|NCT02951988|592454875|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
164025813|NCT02951988|592454876|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
164096070|NCT00891293|592715855|FG000|Overall Study|Laboratory abnormality|4|||
164025814|NCT02951988|592454877|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
164025815|NCT02951988|592454874|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
164025816|NCT02951988|592454875|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
164025817|NCT02951988|592454876|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
164025818|NCT02951988|592454877|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
164025819|NCT02951988|592454874|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
164025820|NCT02951988|592454875|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164025821|NCT02951988|592454876|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
164025822|NCT02951988|592454877|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
164025823|NCT02951988|592454874|FG000|Open-Label Treatment Period|Adverse Event|45|||
164025824|NCT02951988|592454875|FG001|Open-Label Treatment Period|Adverse Event|0|||
164025825|NCT02951988|592454876|FG002|Open-Label Treatment Period|Adverse Event|0|||
164025826|NCT02951988|592454877|FG003|Open-Label Treatment Period|Adverse Event|0|||
164025827|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
164025828|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
164025829|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
164025830|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
164025831|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
164025832|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
164025833|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
164025834|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
164025835|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
164025836|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
164025837|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
164025838|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
164025839|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
164025840|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
164025841|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
164025842|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
164025843|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Pregnancy|0|||
164025844|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Pregnancy|1|||
164025845|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Pregnancy|1|||
164025846|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Pregnancy|0|||
164025847|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164025848|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
164025849|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
164025850|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
164025851|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164025852|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
164025853|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
164025854|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
164025855|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164025856|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Adverse Event|8|||
164025857|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Adverse Event|3|||
164025858|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Adverse Event|6|||
164025859|NCT02951988|592454874|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
164025860|NCT02951988|592454875|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
164025861|NCT02951988|592454876|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
164025862|NCT02951988|592454877|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
164025863|NCT00516269|592454878|FG000|Overall Study|Adverse Event|2|||
164025864|NCT00516269|592454879|FG001|Overall Study|Adverse Event|1|||
164025865|NCT00516269|592454878|FG000|Overall Study|Lost to Follow-up|0|||
164025866|NCT00516269|592454879|FG001|Overall Study|Lost to Follow-up|1|||
163910328|NCT02538094|592041788|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
164025867|NCT00516269|592454878|FG000|Overall Study|Protocol Violation|0|||
164025868|NCT00516269|592454879|FG001|Overall Study|Protocol Violation|1|||
164025869|NCT04570657|592454882|FG000|Overall Study|Adverse Event|0|||
164025870|NCT04570657|592454883|FG001|Overall Study|Adverse Event|0|||
164025871|NCT04570657|592454884|FG002|Overall Study|Adverse Event|1|||
164025872|NCT04570657|592454882|FG000|Overall Study|Lost to Follow-up|0|||
164025873|NCT04570657|592454883|FG001|Overall Study|Lost to Follow-up|0|||
164025874|NCT04570657|592454884|FG002|Overall Study|Lost to Follow-up|1|||
164025875|NCT04570657|592454882|FG000|Overall Study|Physician Decision|0|||
164025876|NCT04570657|592454883|FG001|Overall Study|Physician Decision|1|||
164025877|NCT04570657|592454884|FG002|Overall Study|Physician Decision|0|||
164025878|NCT04570657|592454882|FG000|Overall Study|Withdrawal by Subject|1|||
164025879|NCT04570657|592454883|FG001|Overall Study|Withdrawal by Subject|2|||
164025880|NCT04570657|592454884|FG002|Overall Study|Withdrawal by Subject|2|||
164025881|NCT01079962|592454885|FG000|Overall Study|Adverse Event|2|||
164025882|NCT01079962|592454886|FG001|Overall Study|Adverse Event|2|||
164025883|NCT01079962|592454885|FG000|Overall Study|Withdrawal by Subject|5|||
164025884|NCT01079962|592454886|FG001|Overall Study|Withdrawal by Subject|7|||
164025885|NCT01079962|592454885|FG000|Overall Study|Protocol Violation|2|||
164025886|NCT01079962|592454886|FG001|Overall Study|Protocol Violation|2|||
164025887|NCT01079962|592454885|FG000|Overall Study|No blood pressure (BP) control|3|||
164025888|NCT01079962|592454886|FG001|Overall Study|No blood pressure (BP) control|0|||
164025889|NCT01079962|592454885|FG000|Overall Study|Inclusion/exclusion criteria|1|||
164025890|NCT01079962|592454886|FG001|Overall Study|Inclusion/exclusion criteria|3|||
164025891|NCT01079962|592454885|FG000|Overall Study|Participant not returning for next visit|1|||
164025892|NCT01079962|592454886|FG001|Overall Study|Participant not returning for next visit|0|||
164025893|NCT01079962|592454885|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
164025894|NCT01079962|592454886|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
164025895|NCT01072539|592454887|FG000|Overall Study|Treated prior to the Site Initiation|1|||
164025896|NCT01072539|592454887|FG000|Overall Study|Protocol Violation|2|||
164025897|NCT00946530|592454888|FG000|Overall Study|Withdrawal by Subject|0|||
164025898|NCT00946530|592454889|FG001|Overall Study|Withdrawal by Subject|3|||
164025899|NCT00946530|592454890|FG002|Overall Study|Withdrawal by Subject|0|||
164025900|NCT00946530|592454891|FG003|Overall Study|Withdrawal by Subject|3|||
164025901|NCT00946530|592454888|FG000|Overall Study|Physician Decision|1|||
164025902|NCT00946530|592454889|FG001|Overall Study|Physician Decision|1|||
164025903|NCT00946530|592454890|FG002|Overall Study|Physician Decision|1|||
164025904|NCT00946530|592454891|FG003|Overall Study|Physician Decision|1|||
164025905|NCT04167306|592454892|FG000|Overall Study|Lost to Follow-up|2|||
164025906|NCT04167306|592454893|FG001|Overall Study|Lost to Follow-up|2|||
164025907|NCT04167306|592454894|FG002|Overall Study|Lost to Follow-up|5|||
164025908|NCT04167306|592454895|FG003|Overall Study|Lost to Follow-up|5|||
164025909|NCT04167306|592454892|FG000|Overall Study|Adverse Event|13|||
164025910|NCT04167306|592454893|FG001|Overall Study|Adverse Event|14|||
164025911|NCT04167306|592454894|FG002|Overall Study|Adverse Event|5|||
164025912|NCT04167306|592454895|FG003|Overall Study|Adverse Event|4|||
164025913|NCT04167306|592454892|FG000|Overall Study|Withdrawal by Subject|4|||
164025914|NCT04167306|592454893|FG001|Overall Study|Withdrawal by Subject|6|||
164025915|NCT04167306|592454894|FG002|Overall Study|Withdrawal by Subject|8|||
164025916|NCT04167306|592454895|FG003|Overall Study|Withdrawal by Subject|3|||
164025917|NCT04167306|592454892|FG000|Overall Study|covid|1|||
164025918|NCT04167306|592454893|FG001|Overall Study|covid|1|||
164025919|NCT04167306|592454894|FG002|Overall Study|covid|2|||
164025920|NCT04167306|592454895|FG003|Overall Study|covid|1|||
164025921|NCT04167306|592454892|FG000|Overall Study|concomitant medication|0|||
164025922|NCT04167306|592454893|FG001|Overall Study|concomitant medication|0|||
164025923|NCT04167306|592454894|FG002|Overall Study|concomitant medication|0|||
164025924|NCT04167306|592454895|FG003|Overall Study|concomitant medication|1|||
164025925|NCT04167306|592454892|FG000|Overall Study|Alcohol treatment|0|||
164025926|NCT04167306|592454893|FG001|Overall Study|Alcohol treatment|4|||
164025927|NCT04167306|592454894|FG002|Overall Study|Alcohol treatment|3|||
164025928|NCT04167306|592454895|FG003|Overall Study|Alcohol treatment|2|||
164025929|NCT04167306|592454892|FG000|Overall Study|non-compliance|0|||
164025930|NCT04167306|592454893|FG001|Overall Study|non-compliance|0|||
164025931|NCT04167306|592454894|FG002|Overall Study|non-compliance|1|||
164025932|NCT04167306|592454895|FG003|Overall Study|non-compliance|0|||
164025933|NCT04167306|592454892|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
164025934|NCT04167306|592454893|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
164025935|NCT04167306|592454894|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
164025936|NCT04167306|592454895|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
164025937|NCT00621855|592454896|FG000|Overall Study|Adverse Event|32|||
164025938|NCT00621855|592454897|FG001|Overall Study|Adverse Event|31|||
164025939|NCT00621855|592454898|FG002|Overall Study|Adverse Event|48|||
164025940|NCT00621855|592454899|FG003|Overall Study|Adverse Event|34|||
164025941|NCT00621855|592454900|FG004|Overall Study|Adverse Event|31|||
164025942|NCT00621855|592454896|FG000|Overall Study|Lost to Follow-up|0|||
164025943|NCT00621855|592454897|FG001|Overall Study|Lost to Follow-up|1|||
164025944|NCT00621855|592454898|FG002|Overall Study|Lost to Follow-up|3|||
164025945|NCT00621855|592454899|FG003|Overall Study|Lost to Follow-up|4|||
164025946|NCT00621855|592454900|FG004|Overall Study|Lost to Follow-up|1|||
164025947|NCT00621855|592454896|FG000|Overall Study|Protocol Violation|16|||
164025948|NCT00621855|592454897|FG001|Overall Study|Protocol Violation|8|||
164025949|NCT00621855|592454898|FG002|Overall Study|Protocol Violation|6|||
164025950|NCT00621855|592454899|FG003|Overall Study|Protocol Violation|7|||
164025951|NCT00621855|592454900|FG004|Overall Study|Protocol Violation|8|||
164025952|NCT00621855|592454896|FG000|Overall Study|Withdrawal by Subject|16|||
164025953|NCT00621855|592454897|FG001|Overall Study|Withdrawal by Subject|11|||
164025954|NCT00621855|592454898|FG002|Overall Study|Withdrawal by Subject|13|||
164025955|NCT00621855|592454899|FG003|Overall Study|Withdrawal by Subject|13|||
164025956|NCT00621855|592454900|FG004|Overall Study|Withdrawal by Subject|9|||
164025957|NCT00621855|592454896|FG000|Overall Study|Other|9|||
164025958|NCT00621855|592454897|FG001|Overall Study|Other|7|||
164025959|NCT00621855|592454898|FG002|Overall Study|Other|6|||
164025960|NCT00621855|592454899|FG003|Overall Study|Other|5|||
164096071|NCT00891293|592715855|FG000|Overall Study|Lost to Follow-up|7|||
164025961|NCT00621855|592454900|FG004|Overall Study|Other|4|||
164025962|NCT00621855|592454896|FG000|Overall Study|Patients did not receive study drug|3|||
164025963|NCT00621855|592454897|FG001|Overall Study|Patients did not receive study drug|3|||
163910329|NCT02538094|592041787|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
164025964|NCT00621855|592454898|FG002|Overall Study|Patients did not receive study drug|5|||
164025965|NCT00621855|592454899|FG003|Overall Study|Patients did not receive study drug|4|||
164025966|NCT00621855|592454900|FG004|Overall Study|Patients did not receive study drug|2|||
164025967|NCT03731364|592454901|FG000|Overall Study|Adverse Event|0|||
164025968|NCT03731364|592454902|FG001|Overall Study|Adverse Event|0|||
164025969|NCT03731364|592454903|FG002|Overall Study|Adverse Event|1|||
164025970|NCT03731364|592454904|FG003|Overall Study|Adverse Event|2|||
164025971|NCT03731364|592454905|FG004|Overall Study|Adverse Event|1|||
164025972|NCT02112994|592454906|FG000|Overall Study|Progressive Disease|0|||
164025973|NCT02112994|592454907|FG001|Overall Study|Progressive Disease|0|||
164025974|NCT02112994|592454908|FG002|Overall Study|Progressive Disease|1|||
164025975|NCT02112994|592454906|FG000|Overall Study|Pregnancy|0|||
164025976|NCT02112994|592454907|FG001|Overall Study|Pregnancy|1|||
164025977|NCT02112994|592454908|FG002|Overall Study|Pregnancy|1|||
164025978|NCT02112994|592454906|FG000|Overall Study|Liver Transplant|0|||
164025979|NCT02112994|592454907|FG001|Overall Study|Liver Transplant|1|||
164025980|NCT02112994|592454908|FG002|Overall Study|Liver Transplant|0|||
164025981|NCT02112994|592454906|FG000|Overall Study|Withdrawal by Subject|0|||
164025982|NCT02112994|592454907|FG001|Overall Study|Withdrawal by Subject|0|||
164025983|NCT02112994|592454908|FG002|Overall Study|Withdrawal by Subject|1|||
164025984|NCT04387136|592454909|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
164025985|NCT04387136|592454910|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
164025986|NCT00417976|592454911|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
164025987|NCT00417976|592454911|FG000|Overall Study|Treatment -related toxicity|2|||
164025988|NCT02358369|592454912|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
164025989|NCT02358369|592454913|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164025990|NCT02358369|592454914|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164025991|NCT02358369|592454915|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164025992|NCT02358369|592454916|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
164025993|NCT02358369|592454912|FG000|Treatment Period A/B|Adverse Event|0|||
164025994|NCT02358369|592454913|FG001|Treatment Period A/B|Adverse Event|0|||
164025995|NCT02358369|592454914|FG002|Treatment Period A/B|Adverse Event|1|||
164025996|NCT02358369|592454915|FG003|Treatment Period A/B|Adverse Event|2|||
164025997|NCT02358369|592454916|FG004|Treatment Period A/B|Adverse Event|0|||
164025998|NCT02358369|592454912|FG000|Treatment Period A/B|Death|0|||
164025999|NCT02358369|592454913|FG001|Treatment Period A/B|Death|0|||
164026000|NCT02358369|592454914|FG002|Treatment Period A/B|Death|1|||
164026001|NCT02358369|592454915|FG003|Treatment Period A/B|Death|0|||
164026002|NCT02358369|592454916|FG004|Treatment Period A/B|Death|0|||
164026003|NCT02358369|592454912|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
164026004|NCT02358369|592454913|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
164026005|NCT02358369|592454914|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
164026006|NCT02358369|592454915|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
164026007|NCT02358369|592454916|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
164026008|NCT02358369|592454912|FG000|Treatment Period C|Adverse Event|0|||
164026009|NCT02358369|592454913|FG001|Treatment Period C|Adverse Event|0|||
164026010|NCT02358369|592454914|FG002|Treatment Period C|Adverse Event|0|||
164026011|NCT02358369|592454915|FG003|Treatment Period C|Adverse Event|0|||
164026012|NCT02358369|592454916|FG004|Treatment Period C|Adverse Event|7|||
164026013|NCT03655717|592454917|FG000|Overall Study|Withdrawal by Subject|4|||
164026014|NCT03655717|592454918|FG001|Overall Study|Withdrawal by Subject|8|||
164026015|NCT03655717|592454919|FG002|Overall Study|Withdrawal by Subject|1|||
164026016|NCT03655717|592454920|FG003|Overall Study|Withdrawal by Subject|0|||
164026017|NCT03655717|592454921|FG004|Overall Study|Withdrawal by Subject|0|||
164026018|NCT03655717|592454922|FG005|Overall Study|Withdrawal by Subject|1|||
164026019|NCT03655717|592454923|FG006|Overall Study|Withdrawal by Subject|3|||
164026020|NCT03655717|592454924|FG007|Overall Study|Withdrawal by Subject|1|||
164026021|NCT03655717|592454925|FG008|Overall Study|Withdrawal by Subject|2|||
164026022|NCT03655717|592454926|FG009|Overall Study|Withdrawal by Subject|0|||
164026023|NCT03655717|592454927|FG010|Overall Study|Withdrawal by Subject|0|||
164026024|NCT03655717|592454928|FG011|Overall Study|Withdrawal by Subject|1|||
164026025|NCT03655717|592454929|FG012|Overall Study|Withdrawal by Subject|0|||
164026026|NCT03655717|592454930|FG013|Overall Study|Withdrawal by Subject|3|||
164026027|NCT03655717|592454931|FG014|Overall Study|Withdrawal by Subject|0|||
164026028|NCT03655717|592454932|FG015|Overall Study|Withdrawal by Subject|1|||
164026029|NCT03655717|592454933|FG016|Overall Study|Withdrawal by Subject|0|||
164026030|NCT03655717|592454934|FG017|Overall Study|Withdrawal by Subject|0|||
164026031|NCT03655717|592454935|FG018|Overall Study|Withdrawal by Subject|1|||
164026032|NCT03655717|592454936|FG019|Overall Study|Withdrawal by Subject|0|||
164026033|NCT03655717|592454937|FG020|Overall Study|Withdrawal by Subject|0|||
164026034|NCT03655717|592454938|FG021|Overall Study|Withdrawal by Subject|1|||
164026035|NCT03655717|592454939|FG022|Overall Study|Withdrawal by Subject|2|||
164026036|NCT03655717|592454940|FG023|Overall Study|Withdrawal by Subject|1|||
164026037|NCT03655717|592454941|FG024|Overall Study|Withdrawal by Subject|1|||
164026038|NCT03655717|592454942|FG025|Overall Study|Withdrawal by Subject|0|||
164026039|NCT03655717|592454917|FG000|Overall Study|Physician Decision|3|||
164026040|NCT03655717|592454918|FG001|Overall Study|Physician Decision|3|||
164026041|NCT03655717|592454919|FG002|Overall Study|Physician Decision|0|||
164026042|NCT03655717|592454920|FG003|Overall Study|Physician Decision|0|||
164026043|NCT03655717|592454921|FG004|Overall Study|Physician Decision|0|||
164026044|NCT03655717|592454922|FG005|Overall Study|Physician Decision|0|||
164026045|NCT03655717|592454923|FG006|Overall Study|Physician Decision|0|||
164026046|NCT03655717|592454924|FG007|Overall Study|Physician Decision|0|||
164026047|NCT03655717|592454925|FG008|Overall Study|Physician Decision|0|||
164026048|NCT03655717|592454926|FG009|Overall Study|Physician Decision|1|||
164026049|NCT03655717|592454927|FG010|Overall Study|Physician Decision|0|||
164026050|NCT03655717|592454928|FG011|Overall Study|Physician Decision|0|||
164026051|NCT03655717|592454929|FG012|Overall Study|Physician Decision|0|||
164026052|NCT03655717|592454930|FG013|Overall Study|Physician Decision|0|||
164026053|NCT03655717|592454931|FG014|Overall Study|Physician Decision|0|||
164026054|NCT03655717|592454932|FG015|Overall Study|Physician Decision|0|||
164026055|NCT03655717|592454933|FG016|Overall Study|Physician Decision|0|||
164026056|NCT03655717|592454934|FG017|Overall Study|Physician Decision|0|||
164026057|NCT03655717|592454935|FG018|Overall Study|Physician Decision|0|||
164026058|NCT03655717|592454936|FG019|Overall Study|Physician Decision|1|||
164026059|NCT03655717|592454937|FG020|Overall Study|Physician Decision|0|||
164026060|NCT03655717|592454938|FG021|Overall Study|Physician Decision|0|||
164026061|NCT03655717|592454939|FG022|Overall Study|Physician Decision|0|||
164026062|NCT03655717|592454940|FG023|Overall Study|Physician Decision|1|||
164026063|NCT03655717|592454941|FG024|Overall Study|Physician Decision|0|||
164026064|NCT03655717|592454942|FG025|Overall Study|Physician Decision|0|||
164026065|NCT03655717|592454917|FG000|Overall Study|Lost to Follow-up|3|||
164026066|NCT03655717|592454918|FG001|Overall Study|Lost to Follow-up|1|||
164026067|NCT03655717|592454919|FG002|Overall Study|Lost to Follow-up|0|||
164026068|NCT03655717|592454920|FG003|Overall Study|Lost to Follow-up|1|||
164026069|NCT03655717|592454921|FG004|Overall Study|Lost to Follow-up|0|||
164026070|NCT03655717|592454922|FG005|Overall Study|Lost to Follow-up|1|||
164026071|NCT03655717|592454923|FG006|Overall Study|Lost to Follow-up|0|||
164026072|NCT03655717|592454924|FG007|Overall Study|Lost to Follow-up|0|||
164026073|NCT03655717|592454925|FG008|Overall Study|Lost to Follow-up|0|||
164026074|NCT03655717|592454926|FG009|Overall Study|Lost to Follow-up|0|||
164026075|NCT03655717|592454927|FG010|Overall Study|Lost to Follow-up|0|||
164026076|NCT03655717|592454928|FG011|Overall Study|Lost to Follow-up|1|||
164026077|NCT03655717|592454929|FG012|Overall Study|Lost to Follow-up|0|||
164026078|NCT03655717|592454930|FG013|Overall Study|Lost to Follow-up|0|||
164026079|NCT03655717|592454931|FG014|Overall Study|Lost to Follow-up|0|||
164026080|NCT03655717|592454932|FG015|Overall Study|Lost to Follow-up|0|||
164026081|NCT03655717|592454933|FG016|Overall Study|Lost to Follow-up|0|||
164026082|NCT03655717|592454934|FG017|Overall Study|Lost to Follow-up|0|||
164026083|NCT03655717|592454935|FG018|Overall Study|Lost to Follow-up|0|||
164026084|NCT03655717|592454936|FG019|Overall Study|Lost to Follow-up|0|||
164026085|NCT03655717|592454937|FG020|Overall Study|Lost to Follow-up|0|||
164026086|NCT03655717|592454938|FG021|Overall Study|Lost to Follow-up|0|||
164026087|NCT03655717|592454939|FG022|Overall Study|Lost to Follow-up|0|||
164026088|NCT03655717|592454940|FG023|Overall Study|Lost to Follow-up|0|||
164026089|NCT03655717|592454941|FG024|Overall Study|Lost to Follow-up|0|||
164026090|NCT03655717|592454942|FG025|Overall Study|Lost to Follow-up|0|||
164026091|NCT01185249|592454943|FG000|Overall Study|Patients discharged or change in status|42|||
164026092|NCT01973452|592454944|FG000|Overall Study|Lack of Efficacy|0|||
164026093|NCT01973452|592454945|FG001|Overall Study|Lack of Efficacy|1|||
164026094|NCT01973452|592454944|FG000|Overall Study|Lost to Follow-up|1|||
164026095|NCT01973452|592454945|FG001|Overall Study|Lost to Follow-up|0|||
164026096|NCT01973452|592454944|FG000|Overall Study|Withdrawal by Subject|10|||
164026097|NCT01973452|592454945|FG001|Overall Study|Withdrawal by Subject|9|||
164026098|NCT01973452|592454944|FG000|Overall Study|Ineligible|1|||
164026099|NCT01973452|592454945|FG001|Overall Study|Ineligible|1|||
164026100|NCT01973452|592454944|FG000|Overall Study|Surgery canceled by participant|5|||
164026101|NCT01973452|592454945|FG001|Overall Study|Surgery canceled by participant|3|||
164026102|NCT00064350|592454947|FG000|Induction Treatment|Disease Progression|5|||
164026103|NCT00064350|592454948|FG001|Induction Treatment|Disease Progression|1|||
164026104|NCT00064350|592454949|FG002|Induction Treatment|Disease Progression|110|||
164026105|NCT00064350|592454947|FG000|Induction Treatment|Adverse Event|0|||
164026106|NCT00064350|592454948|FG001|Induction Treatment|Adverse Event|2|||
164026107|NCT00064350|592454949|FG002|Induction Treatment|Adverse Event|49|||
164026108|NCT00064350|592454947|FG000|Induction Treatment|Death|0|||
164026109|NCT00064350|592454948|FG001|Induction Treatment|Death|0|||
164026110|NCT00064350|592454949|FG002|Induction Treatment|Death|9|||
164026111|NCT00064350|592454947|FG000|Induction Treatment|Withdrawal by Subject|0|||
164026112|NCT00064350|592454948|FG001|Induction Treatment|Withdrawal by Subject|0|||
164026113|NCT00064350|592454949|FG002|Induction Treatment|Withdrawal by Subject|21|||
164026114|NCT00064350|592454947|FG000|Induction Treatment|Ineligible or never started treatment|3|||
164026115|NCT00064350|592454948|FG001|Induction Treatment|Ineligible or never started treatment|6|||
164026116|NCT00064350|592454949|FG002|Induction Treatment|Ineligible or never started treatment|34|||
164026117|NCT00064350|592454947|FG000|Induction Treatment|Other|0|||
164026118|NCT00064350|592454948|FG001|Induction Treatment|Other|0|||
164026119|NCT00064350|592454949|FG002|Induction Treatment|Other|13|||
164026120|NCT00064350|592454947|FG000|Randomization|Adverse Event|8|||
164026121|NCT00064350|592454948|FG001|Randomization|Adverse Event|3|||
164026122|NCT00064350|592454949|FG002|Randomization|Adverse Event|0|||
164026123|NCT00064350|592454947|FG000|Randomization|Death|3|||
164026124|NCT00064350|592454948|FG001|Randomization|Death|0|||
164026125|NCT00064350|592454949|FG002|Randomization|Death|0|||
164026126|NCT00064350|592454947|FG000|Randomization|Withdrawal by Subject|1|||
164026127|NCT00064350|592454948|FG001|Randomization|Withdrawal by Subject|0|||
164026128|NCT00064350|592454949|FG002|Randomization|Withdrawal by Subject|0|||
164026129|NCT00064350|592454947|FG000|Randomization|Ineligible or never started treatment|9|||
164026130|NCT00064350|592454948|FG001|Randomization|Ineligible or never started treatment|15|||
164026131|NCT00064350|592454949|FG002|Randomization|Ineligible or never started treatment|0|||
164026132|NCT00064350|592454947|FG000|Randomization|Other|5|||
164026133|NCT00064350|592454948|FG001|Randomization|Other|0|||
164026134|NCT00064350|592454949|FG002|Randomization|Other|0|||
164026135|NCT00064350|592454947|FG000|Cross-Over|Adverse Event|0|||
164026136|NCT00064350|592454948|FG001|Cross-Over|Adverse Event|1|||
164026137|NCT00064350|592454949|FG002|Cross-Over|Adverse Event|0|||
164026138|NCT00064350|592454947|FG000|Cross-Over|Death|1|||
164026139|NCT00064350|592454948|FG001|Cross-Over|Death|3|||
164026140|NCT00064350|592454949|FG002|Cross-Over|Death|0|||
164026141|NCT00064350|592454947|FG000|Cross-Over|Withdrawal by Subject|2|||
164026142|NCT00064350|592454948|FG001|Cross-Over|Withdrawal by Subject|2|||
164026143|NCT00064350|592454949|FG002|Cross-Over|Withdrawal by Subject|0|||
164026144|NCT00064350|592454947|FG000|Cross-Over|Ineligible or never started treatment|3|||
164026145|NCT00064350|592454948|FG001|Cross-Over|Ineligible or never started treatment|6|||
164026146|NCT00064350|592454949|FG002|Cross-Over|Ineligible or never started treatment|0|||
164026147|NCT00064350|592454947|FG000|Cross-Over|Other|0|||
164026148|NCT00064350|592454948|FG001|Cross-Over|Other|2|||
163910330|NCT02538094|592041788|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
163910331|NCT03288506|592041789|FG000|Overall Study|Withdrawal by Subject|52|||
163910332|NCT03692871|592041790|FG000|Overall Study|Death|1|||
163910333|NCT03692871|592041791|FG001|Overall Study|Death|1|||
163910334|NCT03692871|592041790|FG000|Overall Study|Lost to Follow-up|24|||
163910335|NCT03692871|592041791|FG001|Overall Study|Lost to Follow-up|9|||
163910336|NCT03692871|592041790|FG000|Overall Study|Physician Decision|22|||
163910337|NCT03692871|592041791|FG001|Overall Study|Physician Decision|7|||
163910338|NCT03692871|592041790|FG000|Overall Study|Protocol Deviation|1|||
163910339|NCT03692871|592041791|FG001|Overall Study|Protocol Deviation|0|||
163910340|NCT03692871|592041790|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
163910341|NCT03692871|592041791|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
163910342|NCT02852824|592041794|FG000|Overall Study|Withdrawal by Subject|1|||
163910343|NCT02852824|592041795|FG001|Overall Study|Withdrawal by Subject|0|||
163910344|NCT02852824|592041796|FG002|Overall Study|Withdrawal by Subject|0|||
163910345|NCT02852824|592041797|FG003|Overall Study|Withdrawal by Subject|0|||
163910346|NCT02852824|592041798|FG004|Overall Study|Withdrawal by Subject|0|||
163910347|NCT02852824|592041799|FG005|Overall Study|Withdrawal by Subject|0|||
163910348|NCT02852824|592041800|FG006|Overall Study|Withdrawal by Subject|0|||
163910349|NCT02852824|592041794|FG000|Overall Study|Adverse Event|0|||
163910350|NCT02852824|592041795|FG001|Overall Study|Adverse Event|0|||
163910351|NCT02852824|592041796|FG002|Overall Study|Adverse Event|0|||
163910352|NCT02852824|592041797|FG003|Overall Study|Adverse Event|0|||
163910353|NCT02852824|592041798|FG004|Overall Study|Adverse Event|2|||
163910354|NCT02852824|592041799|FG005|Overall Study|Adverse Event|0|||
163910355|NCT02852824|592041800|FG006|Overall Study|Adverse Event|0|||
164026149|NCT00064350|592454949|FG002|Cross-Over|Other|0|||
163910356|NCT01316913|592041801|FG000|Overall Study|Adverse Event|17|||
163910357|NCT01316913|592041802|FG001|Overall Study|Adverse Event|20|||
163910358|NCT01316913|592041803|FG002|Overall Study|Adverse Event|15|||
163910359|NCT01316913|592041804|FG003|Overall Study|Adverse Event|11|||
163910360|NCT01316913|592041801|FG000|Overall Study|Lack of Efficacy|22|||
163910361|NCT01316913|592041802|FG001|Overall Study|Lack of Efficacy|12|||
164026150|NCT00115765|592454950|FG000|Overall Study|Withdrawal by Subject|22|||
164026151|NCT00115765|592454951|FG001|Overall Study|Withdrawal by Subject|53|||
163910362|NCT01316913|592041803|FG002|Overall Study|Lack of Efficacy|9|||
163910363|NCT01316913|592041804|FG003|Overall Study|Lack of Efficacy|13|||
163910364|NCT01316913|592041801|FG000|Overall Study|Protocol Violation|1|||
163910365|NCT01316913|592041802|FG001|Overall Study|Protocol Violation|4|||
163910366|NCT01316913|592041803|FG002|Overall Study|Protocol Violation|4|||
163910367|NCT01316913|592041804|FG003|Overall Study|Protocol Violation|1|||
163910368|NCT01316913|592041801|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
164026152|NCT00115765|592454952|FG002|Overall Study|Withdrawal by Subject|76|||
164026153|NCT00115765|592454953|FG003|Overall Study|Withdrawal by Subject|15|||
164026154|NCT00115765|592454950|FG000|Overall Study|Physician Decision|4|||
164026155|NCT00115765|592454951|FG001|Overall Study|Physician Decision|15|||
164026156|NCT00115765|592454952|FG002|Overall Study|Physician Decision|18|||
164026157|NCT00115765|592454953|FG003|Overall Study|Physician Decision|13|||
164026158|NCT00115765|592454950|FG000|Overall Study|Lost to Follow-up|3|||
164096072|NCT00891293|592715855|FG000|Overall Study|Subject withdrew consent|7|||
164096073|NCT00891293|592715855|FG000|Overall Study|Sponsor termination|62|||
164096074|NCT02178722|592715856|FG000|Overall Study|Withdrawal by Subject|0|||
164096075|NCT02178722|592715857|FG001|Overall Study|Withdrawal by Subject|0|||
164026159|NCT00115765|592454951|FG001|Overall Study|Lost to Follow-up|20|||
164026160|NCT00115765|592454952|FG002|Overall Study|Lost to Follow-up|18|||
164026161|NCT00115765|592454953|FG003|Overall Study|Lost to Follow-up|1|||
164026162|NCT00115765|592454950|FG000|Overall Study|Other|6|||
164026163|NCT00115765|592454951|FG001|Overall Study|Other|12|||
164026164|NCT00115765|592454952|FG002|Overall Study|Other|9|||
164026165|NCT00115765|592454953|FG003|Overall Study|Other|2|||
164026166|NCT01683071|592454956|FG000|Part 1|Lack of Efficacy|1|||
164026167|NCT01683071|592454957|FG001|Part 1|Lack of Efficacy|0|||
164026168|NCT01683071|592454958|FG002|Part 1|Lack of Efficacy|0|||
164026169|NCT01683071|592454959|FG003|Part 1|Lack of Efficacy|3|||
164026170|NCT01683071|592454960|FG004|Part 1|Lack of Efficacy|0|||
164026171|NCT01683071|592454961|FG005|Part 1|Lack of Efficacy|0|||
164026172|NCT01683071|592454956|FG000|Part 1|Withdrawal by Subject|1|||
164026173|NCT01683071|592454957|FG001|Part 1|Withdrawal by Subject|2|||
164026174|NCT01683071|592454958|FG002|Part 1|Withdrawal by Subject|2|||
164026175|NCT01683071|592454959|FG003|Part 1|Withdrawal by Subject|1|||
164026176|NCT01683071|592454960|FG004|Part 1|Withdrawal by Subject|0|||
164026177|NCT01683071|592454961|FG005|Part 1|Withdrawal by Subject|0|||
164026178|NCT01683071|592454956|FG000|Part 1|Surgery Cancelled|1|||
164026179|NCT01683071|592454957|FG001|Part 1|Surgery Cancelled|0|||
164026180|NCT01683071|592454958|FG002|Part 1|Surgery Cancelled|0|||
164026181|NCT01683071|592454959|FG003|Part 1|Surgery Cancelled|0|||
164026182|NCT01683071|592454960|FG004|Part 1|Surgery Cancelled|0|||
164026183|NCT01683071|592454961|FG005|Part 1|Surgery Cancelled|0|||
164026184|NCT01683071|592454956|FG000|Part 1|Did not receive study drug|1|||
164026185|NCT01683071|592454957|FG001|Part 1|Did not receive study drug|0|||
164026186|NCT01683071|592454958|FG002|Part 1|Did not receive study drug|0|||
164026187|NCT01683071|592454959|FG003|Part 1|Did not receive study drug|1|||
164026188|NCT01683071|592454960|FG004|Part 1|Did not receive study drug|0|||
164026189|NCT01683071|592454961|FG005|Part 1|Did not receive study drug|0|||
164026190|NCT01683071|592454956|FG000|Part 1|Early termination; met exclusion criteria|0|||
164026191|NCT01683071|592454957|FG001|Part 1|Early termination; met exclusion criteria|2|||
164026192|NCT01683071|592454958|FG002|Part 1|Early termination; met exclusion criteria|1|||
164026193|NCT01683071|592454959|FG003|Part 1|Early termination; met exclusion criteria|0|||
164026194|NCT01683071|592454960|FG004|Part 1|Early termination; met exclusion criteria|0|||
164026195|NCT01683071|592454961|FG005|Part 1|Early termination; met exclusion criteria|0|||
164026196|NCT01683071|592454956|FG000|Part 2|Lack of Efficacy|0|||
164026197|NCT01683071|592454957|FG001|Part 2|Lack of Efficacy|0|||
164026198|NCT01683071|592454958|FG002|Part 2|Lack of Efficacy|0|||
164026199|NCT01683071|592454959|FG003|Part 2|Lack of Efficacy|0|||
163910369|NCT01316913|592041802|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
163910370|NCT01316913|592041803|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
163910371|NCT01316913|592041804|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
163910372|NCT01316913|592041801|FG000|Overall Study|Lost to Follow-up|0|||
163910373|NCT01316913|592041802|FG001|Overall Study|Lost to Follow-up|1|||
163910374|NCT01316913|592041803|FG002|Overall Study|Lost to Follow-up|0|||
163910375|NCT01316913|592041804|FG003|Overall Study|Lost to Follow-up|2|||
163910376|NCT01316913|592041801|FG000|Overall Study|Withdrawal by Subject|10|||
163910377|NCT01316913|592041802|FG001|Overall Study|Withdrawal by Subject|9|||
163910378|NCT01316913|592041803|FG002|Overall Study|Withdrawal by Subject|10|||
163910379|NCT01316913|592041804|FG003|Overall Study|Withdrawal by Subject|6|||
163910380|NCT01860079|592041805|FG000|Overall Study|Physician Decision|14|||
163910381|NCT01860079|592041806|FG001|Overall Study|Physician Decision|22|||
163910382|NCT02114515|592041808|FG000|Overall Study|Lost to Follow-up|52|||
163910383|NCT02114515|592041809|FG001|Overall Study|Lost to Follow-up|55|||
163910384|NCT02114515|592041808|FG000|Overall Study|Death|12|||
163910385|NCT02114515|592041809|FG001|Overall Study|Death|12|||
163910386|NCT02114515|592041808|FG000|Overall Study|Withdrawal by Subject|4|||
163910387|NCT02114515|592041809|FG001|Overall Study|Withdrawal by Subject|22|||
163910388|NCT02114515|592041808|FG000|Overall Study|Other|65|||
163910389|NCT02114515|592041809|FG001|Overall Study|Other|61|||
163910390|NCT02144285|592041810|FG000|Overall Study|Withdrawal by Subject|0|||
163910391|NCT02144285|592041811|FG001|Overall Study|Withdrawal by Subject|0|||
164026200|NCT01683071|592454960|FG004|Part 2|Lack of Efficacy|3|||
163910392|NCT02144285|592041812|FG002|Overall Study|Withdrawal by Subject|0|||
163910393|NCT02144285|592041813|FG003|Overall Study|Withdrawal by Subject|0|||
163910394|NCT02144285|592041814|FG004|Overall Study|Withdrawal by Subject|1|||
163910395|NCT02144285|592041815|FG005|Overall Study|Withdrawal by Subject|0|||
163910396|NCT02144285|592041816|FG006|Overall Study|Withdrawal by Subject|0|||
163910397|NCT02144285|592041817|FG007|Overall Study|Withdrawal by Subject|0|||
164026201|NCT01683071|592454961|FG005|Part 2|Lack of Efficacy|4|||
164026202|NCT01683071|592454956|FG000|Part 2|Lost to Follow-up|0|||
164026203|NCT01683071|592454957|FG001|Part 2|Lost to Follow-up|0|||
164026204|NCT01683071|592454958|FG002|Part 2|Lost to Follow-up|0|||
164026205|NCT01683071|592454959|FG003|Part 2|Lost to Follow-up|0|||
164026206|NCT01683071|592454960|FG004|Part 2|Lost to Follow-up|2|||
164026207|NCT01683071|592454961|FG005|Part 2|Lost to Follow-up|0|||
164026208|NCT01683071|592454956|FG000|Part 2|Withdrawal by Subject|0|||
164026209|NCT01683071|592454957|FG001|Part 2|Withdrawal by Subject|0|||
164026210|NCT01683071|592454958|FG002|Part 2|Withdrawal by Subject|0|||
164026211|NCT01683071|592454959|FG003|Part 2|Withdrawal by Subject|0|||
164026212|NCT01683071|592454960|FG004|Part 2|Withdrawal by Subject|3|||
164026213|NCT01683071|592454961|FG005|Part 2|Withdrawal by Subject|3|||
164026214|NCT01683071|592454956|FG000|Part 2|Surgery cancelled|0|||
164026215|NCT01683071|592454957|FG001|Part 2|Surgery cancelled|0|||
164026216|NCT01683071|592454958|FG002|Part 2|Surgery cancelled|0|||
164026217|NCT01683071|592454959|FG003|Part 2|Surgery cancelled|0|||
164026218|NCT01683071|592454960|FG004|Part 2|Surgery cancelled|4|||
164026219|NCT01683071|592454961|FG005|Part 2|Surgery cancelled|2|||
164026220|NCT01683071|592454956|FG000|Part 2|Did not receive study drug|0|||
164096076|NCT02178722|592715858|FG002|Overall Study|Withdrawal by Subject|0|||
164026221|NCT01683071|592454957|FG001|Part 2|Did not receive study drug|0|||
164026222|NCT01683071|592454958|FG002|Part 2|Did not receive study drug|0|||
164026223|NCT01683071|592454959|FG003|Part 2|Did not receive study drug|0|||
164026224|NCT01683071|592454960|FG004|Part 2|Did not receive study drug|2|||
164026225|NCT01683071|592454961|FG005|Part 2|Did not receive study drug|1|||
164026226|NCT01683071|592454956|FG000|Part 2|Met exclusion criterion|0|||
164026227|NCT01683071|592454957|FG001|Part 2|Met exclusion criterion|0|||
164026228|NCT01683071|592454958|FG002|Part 2|Met exclusion criterion|0|||
164026229|NCT01683071|592454959|FG003|Part 2|Met exclusion criterion|0|||
164026230|NCT01683071|592454960|FG004|Part 2|Met exclusion criterion|1|||
164026231|NCT01683071|592454961|FG005|Part 2|Met exclusion criterion|1|||
164026232|NCT01683071|592454956|FG000|Part 2|Protocol deviation|0|||
164026233|NCT01683071|592454957|FG001|Part 2|Protocol deviation|0|||
164026234|NCT01683071|592454958|FG002|Part 2|Protocol deviation|0|||
164026235|NCT01683071|592454959|FG003|Part 2|Protocol deviation|0|||
164026236|NCT01683071|592454960|FG004|Part 2|Protocol deviation|1|||
164026237|NCT01683071|592454961|FG005|Part 2|Protocol deviation|2|||
164026238|NCT01683071|592454956|FG000|Part 2|Withdrawal by investigator decision|0|||
164026239|NCT01683071|592454957|FG001|Part 2|Withdrawal by investigator decision|0|||
164026240|NCT01683071|592454958|FG002|Part 2|Withdrawal by investigator decision|0|||
164026241|NCT01683071|592454959|FG003|Part 2|Withdrawal by investigator decision|0|||
164026242|NCT01683071|592454960|FG004|Part 2|Withdrawal by investigator decision|1|||
164026243|NCT01683071|592454961|FG005|Part 2|Withdrawal by investigator decision|2|||
164026244|NCT03707158|592454962|FG000|Midtreatment|Lost to Follow-up|16|||
164026245|NCT03707158|592454963|FG001|Midtreatment|Lost to Follow-up|7|||
164026246|NCT03707158|592454962|FG000|Midtreatment|Withdrawal by Subject|28|||
164026247|NCT03707158|592454963|FG001|Midtreatment|Withdrawal by Subject|19|||
164026248|NCT03707158|592454962|FG000|Posttreatment|Lost to Follow-up|0|||
164026249|NCT03707158|592454963|FG001|Posttreatment|Lost to Follow-up|5|||
164026250|NCT03707158|592454962|FG000|Follow-up|Lost to Follow-up|19|||
164026251|NCT03707158|592454963|FG001|Follow-up|Lost to Follow-up|18|||
164026252|NCT03707158|592454962|FG000|Follow-up|Withdrawal by Subject|13|||
164026253|NCT03707158|592454963|FG001|Follow-up|Withdrawal by Subject|6|||
164026254|NCT01454401|592454964|FG000|Overall Study|Death|1|||
164026255|NCT01454401|592454964|FG000|Overall Study|hospitalised|1|||
164026256|NCT01454401|592454964|FG000|Overall Study|osteomyelitis|2|||
164026257|NCT01454401|592454964|FG000|Overall Study|non-adherence|1|||
164026258|NCT01968187|592454970|FG000|Overall Study|Adverse Event|0|||
164026259|NCT01968187|592454971|FG001|Overall Study|Adverse Event|1|||
164026260|NCT01968187|592454970|FG000|Overall Study|Randomized but not treated|1|||
164026261|NCT01968187|592454971|FG001|Overall Study|Randomized but not treated|0|||
164026262|NCT00831441|592456724|FG000|Randomized|Death|82|||
164026263|NCT00831441|592456725|FG001|Randomized|Death|81|||
164026264|NCT00831441|592456724|FG000|Randomized|Adverse Event|248|||
164026265|NCT00831441|592456725|FG001|Randomized|Adverse Event|321|||
164026266|NCT00831441|592456724|FG000|Randomized|Emergency procedure|2|||
164026267|NCT00831441|592456725|FG001|Randomized|Emergency procedure|2|||
164026268|NCT00831441|592456724|FG000|Randomized|Elective procedure|26|||
164026269|NCT00831441|592456725|FG001|Randomized|Elective procedure|25|||
164026270|NCT00831441|592456724|FG000|Randomized|Physician Decision|26|||
164026271|NCT00831441|592456725|FG001|Randomized|Physician Decision|35|||
164026272|NCT00831441|592456724|FG000|Randomized|No longer met criteria|13|||
164026273|NCT00831441|592456725|FG001|Randomized|No longer met criteria|19|||
164026274|NCT00831441|592456724|FG000|Randomized|Withdrawal by Subject|178|||
164026275|NCT00831441|592456725|FG001|Randomized|Withdrawal by Subject|212|||
164026276|NCT00831441|592456724|FG000|Randomized|Lost to Follow-up|26|||
164026277|NCT00831441|592456725|FG001|Randomized|Lost to Follow-up|35|||
164026278|NCT00831441|592456724|FG000|Randomized|Administrative reason by sponsor|2780|||
164026279|NCT00831441|592456725|FG001|Randomized|Administrative reason by sponsor|2671|||
164026280|NCT00831441|592456724|FG000|Randomized|poor/non-compliance|30|||
164026281|NCT00831441|592456725|FG001|Randomized|poor/non-compliance|38|||
164026282|NCT00831441|592456724|FG000|Randomized|non-specified|276|||
164026283|NCT00831441|592456725|FG001|Randomized|non-specified|266|||
164026284|NCT00831441|592456724|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
164026285|NCT00831441|592456725|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
164026286|NCT00831441|592456724|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
164026287|NCT00831441|592456725|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
164026288|NCT00831441|592456724|FG000|Follow Up (30 Days)|Death|63|||
164026289|NCT00831441|592456725|FG001|Follow Up (30 Days)|Death|86|||
164096077|NCT02178722|592715859|FG003|Overall Study|Withdrawal by Subject|2|||
164026290|NCT00831441|592456724|FG000|Follow Up (30 Days)|non-specified|16|||
164026291|NCT00831441|592456725|FG001|Follow Up (30 Days)|non-specified|26|||
164026292|NCT00831441|592456724|FG000|Follow Up (30 Days)|missing end of study status|0|||
164026293|NCT00831441|592456725|FG001|Follow Up (30 Days)|missing end of study status|1|||
164026294|NCT02924688|592456729|FG000|Overall Study|Adverse Event|9|||
164026295|NCT02924688|592456730|FG001|Overall Study|Adverse Event|3|||
164026296|NCT02924688|592456731|FG002|Overall Study|Adverse Event|2|||
164026297|NCT02924688|592456732|FG003|Overall Study|Adverse Event|2|||
164026298|NCT02924688|592456733|FG004|Overall Study|Adverse Event|3|||
164026299|NCT02924688|592456734|FG005|Overall Study|Adverse Event|2|||
164026300|NCT02924688|592456729|FG000|Overall Study|Lack of Efficacy|2|||
164026301|NCT02924688|592456730|FG001|Overall Study|Lack of Efficacy|3|||
164026302|NCT02924688|592456731|FG002|Overall Study|Lack of Efficacy|4|||
164026303|NCT02924688|592456732|FG003|Overall Study|Lack of Efficacy|2|||
164026304|NCT02924688|592456733|FG004|Overall Study|Lack of Efficacy|1|||
164026305|NCT02924688|592456734|FG005|Overall Study|Lack of Efficacy|1|||
164026306|NCT02924688|592456729|FG000|Overall Study|Protocol Violation|3|||
164026307|NCT02924688|592456730|FG001|Overall Study|Protocol Violation|7|||
164026308|NCT02924688|592456731|FG002|Overall Study|Protocol Violation|5|||
164026309|NCT02924688|592456732|FG003|Overall Study|Protocol Violation|6|||
164026310|NCT02924688|592456733|FG004|Overall Study|Protocol Violation|2|||
164026311|NCT02924688|592456734|FG005|Overall Study|Protocol Violation|2|||
164026312|NCT02924688|592456729|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
164026313|NCT02924688|592456730|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
164026314|NCT02924688|592456731|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
164026315|NCT02924688|592456732|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
164026316|NCT02924688|592456733|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
164026317|NCT02924688|592456734|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
164026318|NCT02924688|592456729|FG000|Overall Study|Lost to Follow-up|2|||
164026319|NCT02924688|592456730|FG001|Overall Study|Lost to Follow-up|4|||
164026320|NCT02924688|592456731|FG002|Overall Study|Lost to Follow-up|2|||
164026321|NCT02924688|592456732|FG003|Overall Study|Lost to Follow-up|4|||
164026322|NCT02924688|592456733|FG004|Overall Study|Lost to Follow-up|2|||
164026323|NCT02924688|592456734|FG005|Overall Study|Lost to Follow-up|4|||
164026324|NCT02924688|592456729|FG000|Overall Study|Physician Decision|2|||
164026325|NCT02924688|592456730|FG001|Overall Study|Physician Decision|1|||
164026326|NCT02924688|592456731|FG002|Overall Study|Physician Decision|0|||
164026327|NCT02924688|592456732|FG003|Overall Study|Physician Decision|1|||
164026328|NCT02924688|592456733|FG004|Overall Study|Physician Decision|1|||
164026329|NCT02924688|592456734|FG005|Overall Study|Physician Decision|1|||
164026330|NCT02924688|592456729|FG000|Overall Study|Withdrawal by Subject|14|||
164026331|NCT02924688|592456730|FG001|Overall Study|Withdrawal by Subject|13|||
164026332|NCT02924688|592456731|FG002|Overall Study|Withdrawal by Subject|9|||
164026333|NCT02924688|592456732|FG003|Overall Study|Withdrawal by Subject|12|||
164026334|NCT02924688|592456733|FG004|Overall Study|Withdrawal by Subject|13|||
164026335|NCT02924688|592456734|FG005|Overall Study|Withdrawal by Subject|14|||
164026336|NCT03072719|592456735|FG000|Overall Study|Adverse Event|1|||
164026337|NCT03072719|592456736|FG001|Overall Study|Adverse Event|1|||
164026338|NCT02586233|592456737|FG000|Overall Study|Randomized but did not receive treatment|0|||
164026339|NCT02586233|592456738|FG001|Overall Study|Randomized but did not receive treatment|1|||
164144829|NCT03790657|592891794|FG000|Overall Study|Adverse Event|1|||
164026340|NCT02586233|592456739|FG002|Overall Study|Randomized but did not receive treatment|0|||
164026341|NCT02586233|592456740|FG003|Overall Study|Randomized but did not receive treatment|0|||
164026342|NCT02586233|592456741|FG004|Overall Study|Randomized but did not receive treatment|0|||
164026343|NCT02586233|592456742|FG005|Overall Study|Randomized but did not receive treatment|2|||
164026344|NCT02586233|592456743|FG006|Overall Study|Randomized but did not receive treatment|2|||
164026345|NCT02586233|592456737|FG000|Overall Study|Death|0|||
164026346|NCT02586233|592456738|FG001|Overall Study|Death|1|||
164026347|NCT02586233|592456739|FG002|Overall Study|Death|0|||
164026348|NCT02586233|592456740|FG003|Overall Study|Death|0|||
164026349|NCT02586233|592456741|FG004|Overall Study|Death|2|||
164026350|NCT02586233|592456742|FG005|Overall Study|Death|0|||
164026351|NCT02586233|592456743|FG006|Overall Study|Death|0|||
164026352|NCT01708941|592456746|FG000|Overall Study|Adverse Event|4|||
164026353|NCT01708941|592456747|FG001|Overall Study|Adverse Event|6|||
164026354|NCT01708941|592456748|FG002|Overall Study|Adverse Event|1|||
164300202|NCT05966142|593475159|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
164300203|NCT05966142|593475160|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
164026355|NCT01708941|592456749|FG003|Overall Study|Adverse Event|0|||
164300204|NCT04849364|593475161|FG000|Overall Study|Eligibility criteria not meet|0|||
164300205|NCT04849364|593475162|FG001|Overall Study|Eligibility criteria not meet|1|||
164300206|NCT04849364|593475163|FG002|Overall Study|Eligibility criteria not meet|0|||
164300207|NCT00894803|593475164|FG000|Overall Study|Death|20|||
164300208|NCT00894803|593475165|FG001|Overall Study|Death|4|||
164300209|NCT00894803|593475164|FG000|Overall Study|Lost to Follow-up|0|||
164300210|NCT00894803|593475165|FG001|Overall Study|Lost to Follow-up|1|||
164300211|NCT00449696|593475172|FG000|Overall Study|Other Treatment Required|6|||
164300212|NCT00449696|593475173|FG001|Overall Study|Other Treatment Required|1|||
164300213|NCT00449696|593475172|FG000|Overall Study|Withdrawal by Subject|5|||
164300214|NCT00449696|593475173|FG001|Overall Study|Withdrawal by Subject|5|||
164300215|NCT00449696|593475172|FG000|Overall Study|Lost to Follow-up|2|||
164300216|NCT00449696|593475173|FG001|Overall Study|Lost to Follow-up|3|||
164300217|NCT00449696|593475172|FG000|Overall Study|Others|7|||
164300218|NCT00449696|593475173|FG001|Overall Study|Others|0|||
164300219|NCT00307801|593475178|FG000|Overall Study|Adverse Event|12|||
164300220|NCT00307801|593475179|FG001|Overall Study|Adverse Event|4|||
164300221|NCT00307801|593475178|FG000|Overall Study|Withdrawal by Subject|9|||
164300222|NCT00307801|593475179|FG001|Overall Study|Withdrawal by Subject|4|||
164300223|NCT00307801|593475178|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
164300224|NCT00307801|593475179|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
164300225|NCT00307801|593475178|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
164300226|NCT00307801|593475179|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
164300227|NCT00307801|593475178|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
164300228|NCT00307801|593475179|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
164300229|NCT00307801|593475178|FG000|Overall Study|Wrong Randomization|1|||
164300230|NCT00307801|593475179|FG001|Overall Study|Wrong Randomization|0|||
164300231|NCT00307801|593475178|FG000|Overall Study|Lack of Efficacy|0|||
164300232|NCT00307801|593475179|FG001|Overall Study|Lack of Efficacy|2|||
164300233|NCT00307801|593475178|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
164300234|NCT00307801|593475179|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
164300235|NCT00307801|593475178|FG000|Overall Study|Frustration with e-diary|1|||
164300236|NCT00307801|593475179|FG001|Overall Study|Frustration with e-diary|0|||
164300237|NCT00307801|593475178|FG000|Overall Study|Protocol Violation|3|||
164300238|NCT00307801|593475179|FG001|Overall Study|Protocol Violation|2|||
164300239|NCT00307801|593475178|FG000|Overall Study|No reason specified|2|||
164300240|NCT00307801|593475179|FG001|Overall Study|No reason specified|0|||
164300241|NCT00307801|593475178|FG000|Overall Study|Pregnancy|0|||
164300242|NCT00307801|593475179|FG001|Overall Study|Pregnancy|1|||
164300243|NCT00577889|593475182|FG000|Overall Study|Withdrawal by Subject|1|||
164300244|NCT00577889|593475183|FG001|Overall Study|Withdrawal by Subject|0|||
164300245|NCT00577889|593475184|FG002|Overall Study|Withdrawal by Subject|0|||
164300246|NCT01523756|593475186|FG000|Baseline Period|Adverse Event|0|||
164300247|NCT01523756|593475187|FG001|Baseline Period|Adverse Event|1|||
164300248|NCT01523756|593475186|FG000|Test Period 1|Adverse Event|1|||
164300249|NCT01523756|593475187|FG001|Test Period 1|Adverse Event|0|||
164300250|NCT01523756|593475186|FG000|Test Period 2|Withdrawal by Subject|0|||
164300251|NCT01523756|593475187|FG001|Test Period 2|Withdrawal by Subject|1|||
164300252|NCT03224819|593475188|FG000|Overall Study|Withdrawal by Subject|0|||
164300253|NCT03224819|593475189|FG001|Overall Study|Withdrawal by Subject|0|||
164300254|NCT03224819|593475190|FG002|Overall Study|Withdrawal by Subject|0|||
164300255|NCT03224819|593475191|FG003|Overall Study|Withdrawal by Subject|0|||
164026356|NCT01708941|592456746|FG000|Overall Study|Death|1|||
164026357|NCT01708941|592456747|FG001|Overall Study|Death|1|||
164026358|NCT01708941|592456748|FG002|Overall Study|Death|2|||
164026359|NCT01708941|592456749|FG003|Overall Study|Death|14|||
164026360|NCT01708941|592456746|FG000|Overall Study|Withdrawal by Subject|1|||
164026361|NCT01708941|592456747|FG001|Overall Study|Withdrawal by Subject|0|||
164026362|NCT01708941|592456748|FG002|Overall Study|Withdrawal by Subject|3|||
164026363|NCT01708941|592456749|FG003|Overall Study|Withdrawal by Subject|4|||
164300256|NCT03224819|593475192|FG004|Overall Study|Withdrawal by Subject|0|||
164300257|NCT03224819|593475193|FG005|Overall Study|Withdrawal by Subject|0|||
164300258|NCT03224819|593475194|FG006|Overall Study|Withdrawal by Subject|0|||
164300259|NCT03224819|593475195|FG007|Overall Study|Withdrawal by Subject|0|||
164300260|NCT03224819|593475196|FG008|Overall Study|Withdrawal by Subject|0|||
164300261|NCT03224819|593475197|FG009|Overall Study|Withdrawal by Subject|0|||
164300262|NCT03224819|593475198|FG010|Overall Study|Withdrawal by Subject|0|||
163910398|NCT02144285|592041818|FG008|Overall Study|Withdrawal by Subject|0|||
164300263|NCT03224819|593475199|FG011|Overall Study|Withdrawal by Subject|0|||
164300264|NCT03224819|593475200|FG012|Overall Study|Withdrawal by Subject|1|||
164300265|NCT03224819|593475201|FG013|Overall Study|Withdrawal by Subject|0|||
164300266|NCT03224819|593475188|FG000|Overall Study|Sponsor Decision|0|||
164300267|NCT03224819|593475189|FG001|Overall Study|Sponsor Decision|0|||
164300268|NCT03224819|593475190|FG002|Overall Study|Sponsor Decision|0|||
164026364|NCT01708941|592456746|FG000|Overall Study|Disease progression|9|||
164026365|NCT01708941|592456747|FG001|Overall Study|Disease progression|10|||
164300269|NCT03224819|593475191|FG003|Overall Study|Sponsor Decision|1|||
164026366|NCT01708941|592456748|FG002|Overall Study|Disease progression|8|||
164026367|NCT01708941|592456749|FG003|Overall Study|Disease progression|0|||
164026368|NCT01708941|592456746|FG000|Overall Study|Alternative therapy|0|||
164026369|NCT01708941|592456747|FG001|Overall Study|Alternative therapy|0|||
164026370|NCT01708941|592456748|FG002|Overall Study|Alternative therapy|2|||
164026371|NCT01708941|592456749|FG003|Overall Study|Alternative therapy|0|||
164026372|NCT01708941|592456746|FG000|Overall Study|Ineligible and never started treatment|1|||
164300270|NCT03224819|593475192|FG004|Overall Study|Sponsor Decision|1|||
164300271|NCT03224819|593475193|FG005|Overall Study|Sponsor Decision|2|||
164300272|NCT03224819|593475194|FG006|Overall Study|Sponsor Decision|1|||
164300273|NCT03224819|593475195|FG007|Overall Study|Sponsor Decision|1|||
164026373|NCT01708941|592456747|FG001|Overall Study|Ineligible and never started treatment|0|||
164026374|NCT01708941|592456748|FG002|Overall Study|Ineligible and never started treatment|1|||
164026375|NCT01708941|592456749|FG003|Overall Study|Ineligible and never started treatment|0|||
164026376|NCT01708941|592456746|FG000|Overall Study|Never started treatment|2|||
164026377|NCT01708941|592456747|FG001|Overall Study|Never started treatment|1|||
164026378|NCT01708941|592456748|FG002|Overall Study|Never started treatment|0|||
164026379|NCT01708941|592456749|FG003|Overall Study|Never started treatment|0|||
164026380|NCT01708941|592456746|FG000|Overall Study|Ineligible|0|||
164026381|NCT01708941|592456747|FG001|Overall Study|Ineligible|0|||
164026382|NCT01708941|592456748|FG002|Overall Study|Ineligible|2|||
164026383|NCT01708941|592456749|FG003|Overall Study|Ineligible|0|||
164026384|NCT00229203|592456750|FG000|Overall Study|Progressive disease|18|||
164026385|NCT00229203|592456751|FG001|Overall Study|Progressive disease|9|||
164026386|NCT00229203|592456750|FG000|Overall Study|Toxicity|6|||
164026387|NCT00229203|592456751|FG001|Overall Study|Toxicity|1|||
164026388|NCT00229203|592456750|FG000|Overall Study|Death|4|||
164026389|NCT00229203|592456751|FG001|Overall Study|Death|2|||
164300274|NCT03224819|593475196|FG008|Overall Study|Sponsor Decision|1|||
164300275|NCT03224819|593475197|FG009|Overall Study|Sponsor Decision|2|||
164300276|NCT03224819|593475198|FG010|Overall Study|Sponsor Decision|1|||
164300277|NCT03224819|593475199|FG011|Overall Study|Sponsor Decision|1|||
164300278|NCT03224819|593475200|FG012|Overall Study|Sponsor Decision|1|||
164300279|NCT03224819|593475201|FG013|Overall Study|Sponsor Decision|0|||
164300280|NCT03224819|593475188|FG000|Overall Study|Lost to Follow-up|0|||
164300281|NCT03224819|593475189|FG001|Overall Study|Lost to Follow-up|0|||
164300282|NCT03224819|593475190|FG002|Overall Study|Lost to Follow-up|0|||
164300283|NCT03224819|593475191|FG003|Overall Study|Lost to Follow-up|0|||
164300284|NCT03224819|593475192|FG004|Overall Study|Lost to Follow-up|0|||
164300285|NCT03224819|593475193|FG005|Overall Study|Lost to Follow-up|0|||
164300286|NCT03224819|593475194|FG006|Overall Study|Lost to Follow-up|0|||
164300287|NCT03224819|593475195|FG007|Overall Study|Lost to Follow-up|0|||
164300288|NCT03224819|593475196|FG008|Overall Study|Lost to Follow-up|1|||
164300289|NCT03224819|593475197|FG009|Overall Study|Lost to Follow-up|0|||
164300290|NCT03224819|593475198|FG010|Overall Study|Lost to Follow-up|0|||
164300291|NCT03224819|593475199|FG011|Overall Study|Lost to Follow-up|0|||
164300292|NCT03224819|593475200|FG012|Overall Study|Lost to Follow-up|0|||
164300293|NCT03224819|593475201|FG013|Overall Study|Lost to Follow-up|0|||
164300294|NCT03224819|593475188|FG000|Overall Study|Death|0|||
164300295|NCT03224819|593475189|FG001|Overall Study|Death|1|||
164300296|NCT03224819|593475190|FG002|Overall Study|Death|0|||
164300297|NCT03224819|593475191|FG003|Overall Study|Death|0|||
164300298|NCT03224819|593475192|FG004|Overall Study|Death|0|||
164300299|NCT03224819|593475193|FG005|Overall Study|Death|0|||
164300300|NCT03224819|593475194|FG006|Overall Study|Death|0|||
164300301|NCT03224819|593475195|FG007|Overall Study|Death|1|||
164300302|NCT03224819|593475196|FG008|Overall Study|Death|0|||
164300303|NCT03224819|593475197|FG009|Overall Study|Death|0|||
164300304|NCT03224819|593475198|FG010|Overall Study|Death|0|||
164300305|NCT03224819|593475199|FG011|Overall Study|Death|1|||
164026390|NCT00229203|592456750|FG000|Overall Study|Other|3|||
164026391|NCT00229203|592456751|FG001|Overall Study|Other|3|||
164026392|NCT00229203|592456750|FG000|Overall Study|Withdrawal by Subject|1|||
164026393|NCT00229203|592456751|FG001|Overall Study|Withdrawal by Subject|4|||
164026394|NCT03457103|592456752|FG000|Overall Study|illness/hospitalization|4|||
164026395|NCT03457103|592456753|FG001|Overall Study|illness/hospitalization|2|||
164026396|NCT03457103|592456752|FG000|Overall Study|Lost to Follow-up|2|||
164300306|NCT03224819|593475200|FG012|Overall Study|Death|0|||
164300307|NCT03224819|593475201|FG013|Overall Study|Death|0|||
164300308|NCT00795535|593475202|FG000|Overall Study|incomplete data and technical problems|20|||
164300309|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
164300310|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
164300311|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
164300312|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
164300313|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Adverse Event|2|||
164026397|NCT03457103|592456753|FG001|Overall Study|Lost to Follow-up|1|||
164026398|NCT03457103|592456752|FG000|Overall Study|Withdrawal by Subject|1|||
164026399|NCT03457103|592456753|FG001|Overall Study|Withdrawal by Subject|2|||
164026400|NCT03457103|592456752|FG000|Overall Study|financial/ insurance issues|1|||
164026401|NCT03457103|592456753|FG001|Overall Study|financial/ insurance issues|1|||
164026402|NCT03004469|592456754|FG000|Overall Study|Adverse Event|6|||
164026403|NCT03004469|592456755|FG001|Overall Study|Adverse Event|4|||
164026404|NCT03004469|592456756|FG002|Overall Study|Adverse Event|6|||
164026405|NCT03004469|592456754|FG000|Overall Study|Lack of Efficacy|1|||
164026406|NCT03004469|592456755|FG001|Overall Study|Lack of Efficacy|0|||
164026407|NCT03004469|592456756|FG002|Overall Study|Lack of Efficacy|1|||
164026408|NCT03004469|592456754|FG000|Overall Study|Lost to Follow-up|23|||
164026409|NCT03004469|592456755|FG001|Overall Study|Lost to Follow-up|14|||
164026410|NCT03004469|592456756|FG002|Overall Study|Lost to Follow-up|6|||
164026411|NCT03004469|592456754|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164026412|NCT03004469|592456755|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164026413|NCT03004469|592456756|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164026414|NCT03004469|592456754|FG000|Overall Study|Protocol Violation|0|||
164026415|NCT03004469|592456755|FG001|Overall Study|Protocol Violation|0|||
164026416|NCT03004469|592456756|FG002|Overall Study|Protocol Violation|1|||
164026417|NCT03004469|592456754|FG000|Overall Study|Withdrawal by Subject|29|||
164026418|NCT03004469|592456755|FG001|Overall Study|Withdrawal by Subject|27|||
164026419|NCT03004469|592456756|FG002|Overall Study|Withdrawal by Subject|10|||
164026420|NCT03004469|592456754|FG000|Overall Study|Other unspecified reason|0|||
164026421|NCT03004469|592456755|FG001|Overall Study|Other unspecified reason|4|||
164026422|NCT03004469|592456756|FG002|Overall Study|Other unspecified reason|1|||
164026423|NCT01397552|592456757|FG000|Overall Study|Adverse Event|1|||
164026424|NCT01397552|592456758|FG001|Overall Study|Adverse Event|0|||
164026425|NCT01397552|592456757|FG000|Overall Study|Withdrawal by Subject|2|||
164026426|NCT01397552|592456758|FG001|Overall Study|Withdrawal by Subject|1|||
164026427|NCT00423735|592456759|FG000|Overall Study|Ineligible / No protocol treatment|8|||
164026428|NCT00423735|592456760|FG001|Overall Study|Ineligible / No protocol treatment|6|||
164026429|NCT00423735|592456761|FG002|Overall Study|Ineligible / No protocol treatment|0|||
164026430|NCT00579501|592456762|FG000|Overall Study|Death|1|||
164026431|NCT00579501|592456762|FG000|Overall Study|End of neoadjuvant therapy|25|||
164026432|NCT00579501|592456762|FG000|Overall Study|toxicity|1|||
164026433|NCT00579501|592456762|FG000|Overall Study|Secondary lesion|1|||
164026434|NCT00579501|592456762|FG000|Overall Study|Radiation therapy before surgery|1|||
164026435|NCT00190983|592456763|FG000|Overall Study|Inevaluable (never treated)|2|||
164026436|NCT02287402|592456764|FG000|Treatment Period|Adverse Event|17|||
164026437|NCT02287402|592456764|FG000|Treatment Period|Voluntary Withdrawal|10|||
164026438|NCT02287402|592456764|FG000|Follow-up|Lost to Follow-up|1|||
164026439|NCT02287402|592456764|FG000|Follow-up|Voluntary Withdrawal|2|||
164026440|NCT04247815|592456765|FG000|Overall Study|Adverse Event|1|||
164026441|NCT04247815|592456766|FG001|Overall Study|Adverse Event|0|||
164026442|NCT04247815|592456765|FG000|Overall Study|Withdrawal by Subject|1|||
164026443|NCT04247815|592456766|FG001|Overall Study|Withdrawal by Subject|0|||
164026444|NCT04247815|592456765|FG000|Overall Study|Protocol Violation|0|||
164026445|NCT04247815|592456766|FG001|Overall Study|Protocol Violation|1|||
164026446|NCT02394808|592456767|FG000|Period 1|Unsatisfactory lens fitting|0|||
164300314|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Adverse Event|5|||
164300315|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Adverse Event|1|||
164300316|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Adverse Event|2|||
164300317|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Death|13|||
164300318|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Death|17|||
164026447|NCT02394808|592456768|FG001|Period 1|Unsatisfactory lens fitting|1|||
164026448|NCT02394808|592456767|FG000|Period 2|Lost to Follow-up|1|||
164026449|NCT02394808|592456768|FG001|Period 2|Lost to Follow-up|0|||
164026450|NCT02108600|592456772|FG000|Overall Study|Withdrawal by Subject|2|||
164026451|NCT02108600|592456773|FG001|Overall Study|Withdrawal by Subject|0|||
164026452|NCT02108600|592456772|FG000|Overall Study|Lost to Follow-up|1|||
164026453|NCT02108600|592456773|FG001|Overall Study|Lost to Follow-up|1|||
164300319|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Death|1|||
164300320|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Death|0|||
164300321|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
164026454|NCT03150095|592456776|FG000|Overall Study|Death|0|||
164026455|NCT03150095|592456777|FG001|Overall Study|Death|1|||
164026456|NCT03150095|592456776|FG000|Overall Study|Lost to Follow-up|1|||
164026457|NCT03150095|592456777|FG001|Overall Study|Lost to Follow-up|1|||
164026458|NCT03150095|592456776|FG000|Overall Study|Withdrawal by Subject|4|||
164026459|NCT03150095|592456777|FG001|Overall Study|Withdrawal by Subject|0|||
164026460|NCT03150095|592456776|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
164300322|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
164026461|NCT03150095|592456777|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
164026462|NCT01295580|592456778|FG000|Overall Study|Protocol Violation|4|||
164026463|NCT01295580|592456779|FG001|Overall Study|Protocol Violation|2|||
164026464|NCT01295580|592456778|FG000|Overall Study|Withdrawal by Subject|1|||
164026465|NCT01295580|592456779|FG001|Overall Study|Withdrawal by Subject|4|||
164026466|NCT01295580|592456778|FG000|Overall Study|Adverse Event|2|||
164026467|NCT01295580|592456779|FG001|Overall Study|Adverse Event|1|||
164026468|NCT01295580|592456778|FG000|Overall Study|Lost to Follow-up|1|||
164300323|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
164300324|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
164300325|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Disease Progression|2|||
164300326|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Disease Progression|0|||
164300327|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Disease Progression|0|||
164300328|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Disease Progression|0|||
164300329|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
164300330|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
164300331|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
164300332|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
164300333|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
164300334|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
164300335|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
164300336|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
164300337|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
164300338|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
164300339|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
164300340|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
164300341|NCT03955146|593475203|FG000|DB Period (48 Weeks)|Participant Decision|9|||
164300342|NCT03955146|593475204|FG001|DB Period (48 Weeks)|Participant Decision|12|||
164300343|NCT03955146|593475205|FG002|DB Period (48 Weeks)|Participant Decision|1|||
164300344|NCT03955146|593475206|FG003|DB Period (48 Weeks)|Participant Decision|1|||
164300345|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
164300346|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
164300347|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
164300348|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
164300349|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
164300350|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
164300351|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
164300352|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
164300353|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
164300354|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
164300355|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
164300356|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
164300357|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
164300358|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
164300359|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
164300360|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
164300361|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
164300362|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
164300363|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
164300364|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
164300365|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
164300366|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
164300367|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
164300368|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
164300369|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
164300370|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
164300371|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
164300372|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
164300373|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
164300374|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
164300375|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
164300376|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
164300377|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
164300378|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
164300379|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
164300380|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
164300381|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
164300382|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
164300383|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
164300384|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
164300385|NCT03955146|593475203|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
164300386|NCT03955146|593475204|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
164300387|NCT03955146|593475205|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
164300388|NCT03955146|593475206|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
164300389|NCT04363320|593475207|FG000|Overall Study|Lost to Follow-up|43|||
164300390|NCT04363320|593475208|FG001|Overall Study|Lost to Follow-up|42|||
164096078|NCT02178722|592715860|FG004|Overall Study|Withdrawal by Subject|33|||
164096079|NCT02178722|592715856|FG000|Overall Study|Death|2|||
164096080|NCT02178722|592715857|FG001|Overall Study|Death|13|||
164096081|NCT02178722|592715858|FG002|Overall Study|Death|12|||
164096082|NCT02178722|592715859|FG003|Overall Study|Death|12|||
164096083|NCT02178722|592715860|FG004|Overall Study|Death|205|||
164096084|NCT02178722|592715856|FG000|Overall Study|Lost to Follow-up|0|||
164096085|NCT02178722|592715857|FG001|Overall Study|Lost to Follow-up|0|||
164096086|NCT02178722|592715858|FG002|Overall Study|Lost to Follow-up|0|||
164096087|NCT02178722|592715859|FG003|Overall Study|Lost to Follow-up|2|||
164096088|NCT02178722|592715860|FG004|Overall Study|Lost to Follow-up|11|||
164096089|NCT02178722|592715856|FG000|Overall Study|Study terminated by Sponsor|2|||
164096090|NCT02178722|592715857|FG001|Overall Study|Study terminated by Sponsor|7|||
164096091|NCT02178722|592715858|FG002|Overall Study|Study terminated by Sponsor|6|||
164096092|NCT02178722|592715859|FG003|Overall Study|Study terminated by Sponsor|4|||
164096093|NCT02178722|592715860|FG004|Overall Study|Study terminated by Sponsor|128|||
164096094|NCT02178722|592715856|FG000|Overall Study|Physician Decision|0|||
164096095|NCT02178722|592715857|FG001|Overall Study|Physician Decision|0|||
164096096|NCT02178722|592715858|FG002|Overall Study|Physician Decision|0|||
164096097|NCT02178722|592715859|FG003|Overall Study|Physician Decision|0|||
164096098|NCT02178722|592715860|FG004|Overall Study|Physician Decision|3|||
164096099|NCT02178722|592715856|FG000|Overall Study|Other|0|||
164096100|NCT02178722|592715857|FG001|Overall Study|Other|0|||
164096101|NCT02178722|592715858|FG002|Overall Study|Other|0|||
164096102|NCT02178722|592715859|FG003|Overall Study|Other|0|||
164096103|NCT02178722|592715860|FG004|Overall Study|Other|2|||
164096104|NCT01572948|592715861|FG000|Overall Study|Lost to Follow-up|1|||
164096105|NCT01572948|592715862|FG001|Overall Study|Lost to Follow-up|0|||
164096106|NCT01572948|592715861|FG000|Overall Study|unable to contact|0|||
164096107|NCT01572948|592715862|FG001|Overall Study|unable to contact|1|||
164096108|NCT00440557|592715863|FG000|Overall Study|Withdrawal by Subject|10|||
164096109|NCT00440557|592715864|FG001|Overall Study|Withdrawal by Subject|5|||
164096110|NCT00440557|592715865|FG002|Overall Study|Withdrawal by Subject|11|||
164096111|NCT00440557|592715863|FG000|Overall Study|Lost to Follow-up|1|||
164096112|NCT00440557|592715864|FG001|Overall Study|Lost to Follow-up|2|||
164096113|NCT00440557|592715865|FG002|Overall Study|Lost to Follow-up|6|||
164096114|NCT00440557|592715863|FG000|Overall Study|Adverse Event|3|||
164096115|NCT00440557|592715864|FG001|Overall Study|Adverse Event|3|||
164096116|NCT00440557|592715865|FG002|Overall Study|Adverse Event|5|||
164096117|NCT00440557|592715863|FG000|Overall Study|Death|2|||
164096118|NCT00440557|592715864|FG001|Overall Study|Death|6|||
164096119|NCT00440557|592715865|FG002|Overall Study|Death|3|||
164096120|NCT00440557|592715863|FG000|Overall Study|Began Dialysis|4|||
164096121|NCT00440557|592715864|FG001|Overall Study|Began Dialysis|1|||
164096122|NCT00440557|592715865|FG002|Overall Study|Began Dialysis|4|||
164096123|NCT00440557|592715863|FG000|Overall Study|Principal Investigator decision|0|||
164096124|NCT00440557|592715864|FG001|Overall Study|Principal Investigator decision|3|||
164096125|NCT00440557|592715865|FG002|Overall Study|Principal Investigator decision|1|||
164096126|NCT00440557|592715863|FG000|Overall Study|Patient moved|1|||
164096127|NCT00440557|592715864|FG001|Overall Study|Patient moved|2|||
164096128|NCT00440557|592715865|FG002|Overall Study|Patient moved|1|||
164096129|NCT00440557|592715863|FG000|Overall Study|Principal Investigator's office closed|3|||
164096130|NCT00440557|592715864|FG001|Overall Study|Principal Investigator's office closed|6|||
164096131|NCT00440557|592715865|FG002|Overall Study|Principal Investigator's office closed|4|||
164096132|NCT00440557|592715863|FG000|Overall Study|Patient transferred to nursing home|0|||
164096133|NCT00440557|592715864|FG001|Overall Study|Patient transferred to nursing home|1|||
164096134|NCT00440557|592715865|FG002|Overall Study|Patient transferred to nursing home|0|||
164096135|NCT00440557|592715863|FG000|Overall Study|Patient had surgery|1|||
164096136|NCT00440557|592715864|FG001|Overall Study|Patient had surgery|0|||
164096137|NCT00440557|592715865|FG002|Overall Study|Patient had surgery|0|||
164096138|NCT00680121|592715869|FG000|Overall Study|Lost to Follow-up|27|||
164096139|NCT00680121|592715870|FG001|Overall Study|Lost to Follow-up|23|||
164096140|NCT01939197|592715871|FG000|Overall Study|Withdrawal by Subject|1|||
164096141|NCT01939197|592715872|FG001|Overall Study|Withdrawal by Subject|0|||
164096142|NCT01939197|592715873|FG002|Overall Study|Withdrawal by Subject|0|||
164096143|NCT01939197|592715874|FG003|Overall Study|Withdrawal by Subject|0|||
164096144|NCT01939197|592715875|FG004|Overall Study|Withdrawal by Subject|1|||
164096145|NCT01939197|592715876|FG005|Overall Study|Withdrawal by Subject|0|||
164096146|NCT01939197|592715877|FG006|Overall Study|Withdrawal by Subject|0|||
164096147|NCT01939197|592715871|FG000|Overall Study|Lost to Follow-up|0|||
164096148|NCT01939197|592715872|FG001|Overall Study|Lost to Follow-up|1|||
164096149|NCT01939197|592715873|FG002|Overall Study|Lost to Follow-up|0|||
164096150|NCT01939197|592715874|FG003|Overall Study|Lost to Follow-up|1|||
164096151|NCT01939197|592715875|FG004|Overall Study|Lost to Follow-up|3|||
164096152|NCT01939197|592715876|FG005|Overall Study|Lost to Follow-up|1|||
164096153|NCT01939197|592715877|FG006|Overall Study|Lost to Follow-up|2|||
164026469|NCT01295580|592456779|FG001|Overall Study|Lost to Follow-up|0|||
164026470|NCT01295580|592456778|FG000|Overall Study|Lack of Efficacy|1|||
164026471|NCT01295580|592456779|FG001|Overall Study|Lack of Efficacy|0|||
164026472|NCT01295580|592456778|FG000|Overall Study|Other: inconvenience|1|||
164026473|NCT01295580|592456779|FG001|Overall Study|Other: inconvenience|0|||
164026474|NCT01295580|592456778|FG000|Overall Study|Other: family objection|0|||
164026475|NCT01295580|592456779|FG001|Overall Study|Other: family objection|1|||
164026476|NCT03943953|592456789|FG000|Trial of ITG 1|Lost to Follow-up|19|||
164026477|NCT03943953|592456790|FG001|Trial of ITG 1|Lost to Follow-up|1|||
164026478|NCT03943953|592456789|FG000|Trial of ITG 2|Lost to Follow-up|8|||
164026479|NCT03943953|592456790|FG001|Trial of ITG 2|Lost to Follow-up|0|||
164026480|NCT03943953|592456789|FG000|Trial of ITG 3|Lost to Follow-up|2|||
164026481|NCT03943953|592456790|FG001|Trial of ITG 3|Lost to Follow-up|0|||
164026482|NCT03943953|592456789|FG000|Trial of ITG 4|Lost to Follow-up|2|||
164026483|NCT03943953|592456790|FG001|Trial of ITG 4|Lost to Follow-up|0|||
164026484|NCT00289185|592456793|FG000|Overall Study|Withdrawal by Subject|4|||
164026485|NCT00289185|592456794|FG001|Overall Study|Withdrawal by Subject|8|||
164026486|NCT00289185|592456793|FG000|Overall Study|Lost to Follow-up|23|||
164026487|NCT00289185|592456794|FG001|Overall Study|Lost to Follow-up|17|||
164300391|NCT04363320|593475209|FG002|Overall Study|Lost to Follow-up|24|||
164300392|NCT04363320|593475210|FG003|Overall Study|Lost to Follow-up|29|||
164300393|NCT04363320|593475207|FG000|Overall Study|Death|0|||
164300394|NCT04363320|593475208|FG001|Overall Study|Death|0|||
164300395|NCT04363320|593475209|FG002|Overall Study|Death|1|||
164300396|NCT04363320|593475210|FG003|Overall Study|Death|0|||
164300397|NCT00604565|593475211|FG000|Overall Study|Study terminated|0|||
164300398|NCT00604565|593475212|FG001|Overall Study|Study terminated|3|||
164300399|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
164300400|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
164300401|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
164300402|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
164300403|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
164300404|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
164300405|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
164300406|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
164300407|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
164300408|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
164300409|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
164300410|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
164300411|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
164300412|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
164300413|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
164300414|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
164300415|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
164300416|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
164300417|NCT03605667|593475213|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
164300418|NCT03605667|593475214|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
164026488|NCT00289185|592456793|FG000|Overall Study|Death|1|||
164026489|NCT00289185|592456794|FG001|Overall Study|Death|1|||
164026490|NCT01742078|592456795|FG000|Overall Study|Withdrawal by Subject|0|||
164026491|NCT01742078|592456796|FG001|Overall Study|Withdrawal by Subject|0|||
164300419|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
164300420|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
164300421|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Other|6|||
164300422|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Other|8|||
164300423|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
164300424|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
164300425|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
164300426|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
164300427|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
164300428|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
164300429|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
164300430|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
164300431|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
164300432|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
164300433|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
164300434|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
164300435|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Death|0|||
164300436|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Death|2|||
164026492|NCT01742078|592456797|FG002|Overall Study|Withdrawal by Subject|0|||
164026493|NCT01742078|592456798|FG003|Overall Study|Withdrawal by Subject|1|||
164026494|NCT01742078|592456799|FG004|Overall Study|Withdrawal by Subject|0|||
164026495|NCT01742078|592456800|FG005|Overall Study|Withdrawal by Subject|0|||
164300437|NCT03605667|593475213|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
164300438|NCT03605667|593475214|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
164300439|NCT05632211|593475215|FG000|Overall Study|Withdrawal by Subject|2|||
164300440|NCT05632211|593475216|FG001|Overall Study|Withdrawal by Subject|0|||
164300441|NCT05632211|593475217|FG002|Overall Study|Withdrawal by Subject|2|||
164300442|NCT05632211|593475215|FG000|Overall Study|Other reasons|1|||
164300443|NCT05632211|593475216|FG001|Overall Study|Other reasons|1|||
164300444|NCT05632211|593475217|FG002|Overall Study|Other reasons|1|||
164300445|NCT00541658|593475218|FG000|Overall Study|Adverse Event|28|||
164300446|NCT00541658|593475219|FG001|Overall Study|Adverse Event|37|||
164300447|NCT00541658|593475220|FG002|Overall Study|Adverse Event|25|||
164300448|NCT00541658|593475218|FG000|Overall Study|Physician Decision|0|||
164300449|NCT00541658|593475219|FG001|Overall Study|Physician Decision|0|||
164300450|NCT00541658|593475220|FG002|Overall Study|Physician Decision|4|||
164300451|NCT00541658|593475218|FG000|Overall Study|Lost to Follow-up|3|||
164300452|NCT00541658|593475219|FG001|Overall Study|Lost to Follow-up|3|||
164300453|NCT00541658|593475220|FG002|Overall Study|Lost to Follow-up|6|||
164300454|NCT00541658|593475218|FG000|Overall Study|Protocol Violation|0|||
164300455|NCT00541658|593475219|FG001|Overall Study|Protocol Violation|1|||
164300456|NCT00541658|593475220|FG002|Overall Study|Protocol Violation|1|||
164300457|NCT00541658|593475218|FG000|Overall Study|Withdrawal by Subject|28|||
164300458|NCT00541658|593475219|FG001|Overall Study|Withdrawal by Subject|32|||
164300459|NCT00541658|593475220|FG002|Overall Study|Withdrawal by Subject|32|||
164300460|NCT00541658|593475218|FG000|Overall Study|Took No Study Drug|1|||
164300461|NCT00541658|593475219|FG001|Overall Study|Took No Study Drug|0|||
164300462|NCT00541658|593475220|FG002|Overall Study|Took No Study Drug|0|||
164300463|NCT05194124|593475234|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300464|NCT05194124|593475235|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300465|NCT05194124|593475236|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300466|NCT05194124|593475237|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
164300467|NCT05194124|593475238|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300468|NCT05194124|593475239|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
164300469|NCT05194124|593475240|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300470|NCT05194124|593475241|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300471|NCT05194124|593475242|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300472|NCT05194124|593475243|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
164300473|NCT05194124|593475234|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300474|NCT05194124|593475235|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300475|NCT05194124|593475236|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300476|NCT05194124|593475237|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300477|NCT05194124|593475238|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300478|NCT05194124|593475239|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300479|NCT05194124|593475240|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300480|NCT05194124|593475241|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300481|NCT05194124|593475242|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
164300482|NCT05194124|593475243|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
164300483|NCT05408429|593475248|FG000|Overall Study|Lost to Follow-up|1|||
164300484|NCT05408429|593475249|FG001|Overall Study|Lost to Follow-up|1|||
164300485|NCT05408429|593475250|FG002|Overall Study|Lost to Follow-up|0|||
164300486|NCT05408429|593475248|FG000|Overall Study|Withdrawal by Subject|5|||
164300487|NCT05408429|593475249|FG001|Overall Study|Withdrawal by Subject|0|||
164300488|NCT05408429|593475250|FG002|Overall Study|Withdrawal by Subject|1|||
164300489|NCT03642873|593475251|FG000|Third Intervention (1 Day)|Screen failure|0|||
164300490|NCT03642873|593475252|FG001|Third Intervention (1 Day)|Screen failure|0|||
164300491|NCT03642873|593475253|FG002|Third Intervention (1 Day)|Screen failure|0|||
164300492|NCT03642873|593475254|FG003|Third Intervention (1 Day)|Screen failure|0|||
164300493|NCT03642873|593475255|FG004|Third Intervention (1 Day)|Screen failure|1|||
164300494|NCT03642873|593475256|FG005|Third Intervention (1 Day)|Screen failure|0|||
164300495|NCT01253291|593475258|FG000|Overall Study|Withdrawal by Subject|1|||
164300496|NCT01253291|593475259|FG001|Overall Study|Withdrawal by Subject|1|||
164300497|NCT01253291|593475260|FG002|Overall Study|Withdrawal by Subject|0|||
164300498|NCT01253291|593475261|FG003|Overall Study|Withdrawal by Subject|0|||
164300499|NCT01253291|593475262|FG004|Overall Study|Withdrawal by Subject|0|||
164300500|NCT01253291|593475258|FG000|Overall Study|Adverse Event|0|||
164300501|NCT01253291|593475259|FG001|Overall Study|Adverse Event|1|||
164300502|NCT01253291|593475260|FG002|Overall Study|Adverse Event|0|||
164300503|NCT01253291|593475261|FG003|Overall Study|Adverse Event|0|||
164300504|NCT01253291|593475262|FG004|Overall Study|Adverse Event|0|||
164300505|NCT01253291|593475258|FG000|Overall Study|Lack of Efficacy|1|||
164300506|NCT01253291|593475259|FG001|Overall Study|Lack of Efficacy|0|||
164300507|NCT01253291|593475260|FG002|Overall Study|Lack of Efficacy|0|||
164300508|NCT01253291|593475261|FG003|Overall Study|Lack of Efficacy|0|||
164300509|NCT01253291|593475262|FG004|Overall Study|Lack of Efficacy|0|||
164300510|NCT01253291|593475258|FG000|Overall Study|Physician Decision|2|||
164300511|NCT01253291|593475259|FG001|Overall Study|Physician Decision|0|||
164300512|NCT01253291|593475260|FG002|Overall Study|Physician Decision|0|||
164300513|NCT01253291|593475261|FG003|Overall Study|Physician Decision|0|||
164300514|NCT01253291|593475262|FG004|Overall Study|Physician Decision|2|||
164300515|NCT03312231|593475266|FG000|Overall Study|Lost to Follow-up|2|||
164300516|NCT03312231|593475267|FG001|Overall Study|Lost to Follow-up|6|||
164300517|NCT03312231|593475268|FG002|Overall Study|Lost to Follow-up|1|||
164300518|NCT03312231|593475269|FG003|Overall Study|Lost to Follow-up|3|||
164300519|NCT03312231|593475270|FG004|Overall Study|Lost to Follow-up|1|||
164300520|NCT03312231|593475266|FG000|Overall Study|Withdrawal by Subject|0|||
164300521|NCT03312231|593475267|FG001|Overall Study|Withdrawal by Subject|3|||
164300522|NCT03312231|593475268|FG002|Overall Study|Withdrawal by Subject|1|||
164300523|NCT03312231|593475269|FG003|Overall Study|Withdrawal by Subject|0|||
164300524|NCT03312231|593475270|FG004|Overall Study|Withdrawal by Subject|0|||
164300525|NCT03312231|593475266|FG000|Overall Study|Death|0|||
164300526|NCT03312231|593475267|FG001|Overall Study|Death|1|||
164300527|NCT03312231|593475268|FG002|Overall Study|Death|1|||
164300528|NCT03312231|593475269|FG003|Overall Study|Death|0|||
164300529|NCT03312231|593475270|FG004|Overall Study|Death|0|||
164300530|NCT03312231|593475266|FG000|Overall Study|Study Vaccination not Received|1|||
164300531|NCT03312231|593475267|FG001|Overall Study|Study Vaccination not Received|1|||
164300532|NCT03312231|593475268|FG002|Overall Study|Study Vaccination not Received|1|||
164300533|NCT03312231|593475269|FG003|Overall Study|Study Vaccination not Received|0|||
164300534|NCT03312231|593475270|FG004|Overall Study|Study Vaccination not Received|0|||
164300535|NCT03157830|593475274|FG000|Overall Study|Lost to Follow-up|1|||
164300536|NCT03157830|593475274|FG000|Overall Study|Withdrawal by Subject|1|||
164300537|NCT02195518|593475275|FG000|Overall Study|Adverse Event|1|||
164300538|NCT02195518|593475275|FG000|Overall Study|Protocol Violation|4|||
164300539|NCT02195518|593475275|FG000|Overall Study|Pregnancy|2|||
164300540|NCT02195518|593475275|FG000|Overall Study|Withdrawal by Subject|1|||
164300541|NCT02195518|593475275|FG000|Overall Study|Lost to Follow-up|1|||
164300542|NCT03694353|593475276|FG000|Overall Study|Withdrawal by Subject|1|||
164300543|NCT03694353|593475276|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
164300544|NCT03804528|593475281|FG000|Overall Study|Time Commitment|18|||
164300545|NCT03804528|593475281|FG000|Overall Study|Health Reasons|5|||
164300546|NCT00651742|593475283|FG000|Overall Study|Objective Disease Progression|22|||
164300547|NCT00651742|593475283|FG000|Overall Study|Toxicity|3|||
164300548|NCT00651742|593475283|FG000|Overall Study|Investigator Judgment|1|||
164300549|NCT00651742|593475283|FG000|Overall Study|Withdrawal of Consent|1|||
164300550|NCT00651742|593475283|FG000|Overall Study|Enrolled but not treated|1|||
164300551|NCT01074970|593475284|FG000|Overall Study|Never Treated|0|||
164300552|NCT01074970|593475285|FG001|Overall Study|Never Treated|0|||
164300553|NCT01074970|593475286|FG002|Overall Study|Never Treated|8|||
164300554|NCT01074970|593475287|FG003|Overall Study|Never Treated|1|||
164300555|NCT01074970|593475284|FG000|Overall Study|Adverse Event|1|||
164300556|NCT01074970|593475285|FG001|Overall Study|Adverse Event|0|||
164300557|NCT01074970|593475286|FG002|Overall Study|Adverse Event|4|||
164300558|NCT01074970|593475287|FG003|Overall Study|Adverse Event|3|||
164300559|NCT01074970|593475284|FG000|Overall Study|Disease progression during treatment|3|||
164300560|NCT01074970|593475285|FG001|Overall Study|Disease progression during treatment|1|||
164300561|NCT01074970|593475286|FG002|Overall Study|Disease progression during treatment|2|||
164300562|NCT01074970|593475287|FG003|Overall Study|Disease progression during treatment|9|||
164300563|NCT01074970|593475284|FG000|Overall Study|Lost to Follow-up|0|||
164300564|NCT01074970|593475285|FG001|Overall Study|Lost to Follow-up|0|||
164300565|NCT01074970|593475286|FG002|Overall Study|Lost to Follow-up|1|||
164300566|NCT01074970|593475287|FG003|Overall Study|Lost to Follow-up|0|||
164300567|NCT01074970|593475284|FG000|Overall Study|Withdrawal by Subject|0|||
164300568|NCT01074970|593475285|FG001|Overall Study|Withdrawal by Subject|0|||
164300569|NCT01074970|593475286|FG002|Overall Study|Withdrawal by Subject|6|||
164300570|NCT01074970|593475287|FG003|Overall Study|Withdrawal by Subject|4|||
164300571|NCT00734149|593475289|FG000|Overall Study|Withdrawal by Subject|1|||
164300572|NCT04314284|593475290|FG000|Overall Study|Withdrawal by Subject|4|||
164300573|NCT04314284|593475291|FG001|Overall Study|Withdrawal by Subject|7|||
164300574|NCT04314284|593475290|FG000|Overall Study|Consented but did not complete survey|0|||
164300575|NCT04314284|593475291|FG001|Overall Study|Consented but did not complete survey|6|||
164300576|NCT03312634|593476496|FG000|Overall Study|Adverse Event|11|||
164300577|NCT03312634|593476497|FG001|Overall Study|Adverse Event|0|||
164300578|NCT03312634|593476496|FG000|Overall Study|Sponsor request|2|||
164300579|NCT03312634|593476497|FG001|Overall Study|Sponsor request|0|||
164300580|NCT03312634|593476496|FG000|Overall Study|Withdrawal by Subject|31|||
164300581|NCT03312634|593476497|FG001|Overall Study|Withdrawal by Subject|9|||
164300582|NCT03312634|593476496|FG000|Overall Study|Enrolled in an interventional study|0|||
164300583|NCT03312634|593476497|FG001|Overall Study|Enrolled in an interventional study|52|||
164300584|NCT03312634|593476496|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
164300585|NCT03312634|593476497|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
164300586|NCT03312634|593476496|FG000|Overall Study|Death|0|||
164300587|NCT03312634|593476497|FG001|Overall Study|Death|1|||
164300588|NCT03312634|593476496|FG000|Overall Study|Non-compliance|0|||
164300589|NCT03312634|593476497|FG001|Overall Study|Non-compliance|2|||
164300590|NCT03312634|593476496|FG000|Overall Study|Lost to Follow-up|0|||
164300591|NCT03312634|593476497|FG001|Overall Study|Lost to Follow-up|1|||
164300592|NCT03312634|593476496|FG000|Overall Study|Enrolled into non-interventional study|0|||
164300593|NCT03312634|593476497|FG001|Overall Study|Enrolled into non-interventional study|5|||
164300594|NCT03312634|593476496|FG000|Overall Study|Worsening clinical condition|0|||
164300595|NCT03312634|593476497|FG001|Overall Study|Worsening clinical condition|1|||
164300596|NCT03312634|593476496|FG000|Overall Study|Participant did not want to travel|0|||
164300597|NCT03312634|593476497|FG001|Overall Study|Participant did not want to travel|1|||
164300598|NCT03312634|593476496|FG000|Overall Study|Physician Decision|1|||
164300599|NCT03312634|593476497|FG001|Overall Study|Physician Decision|0|||
164300600|NCT03312634|593476496|FG000|Overall Study|Other|13|||
164300601|NCT03312634|593476497|FG001|Overall Study|Other|0|||
164300602|NCT04610281|593476498|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
164300603|NCT04610281|593476499|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
164300604|NCT01942837|593476500|FG000|Overall Study|Death|1|||
164300605|NCT01942837|593476500|FG000|Overall Study|Symptomatic or radiographic progression|49|||
164300606|NCT01942837|593476500|FG000|Overall Study|Adverse Event|6|||
164300607|NCT01942837|593476500|FG000|Overall Study|Physician Decision|3|||
164300608|NCT01942837|593476500|FG000|Overall Study|Withdrawal by Subject|2|||
164300609|NCT01942837|593476500|FG000|Overall Study|Intercurrent Illness|1|||
164300610|NCT01942837|593476500|FG000|Overall Study|On treatment|3|||
164300611|NCT01942837|593476500|FG000|Overall Study|Never initiate the treatment|2|||
164300612|NCT01298648|593476501|FG000|Overall Study|Withdrawal by Subject|2|||
164300613|NCT01298648|593476501|FG000|Overall Study|Lost to Follow-up|21|||
164300614|NCT01458392|593476506|FG000|Overall Study|Death|2|||
164300615|NCT01458392|593476507|FG001|Overall Study|Death|11|||
164300616|NCT01458392|593476508|FG002|Overall Study|Death|22|||
164300617|NCT01458392|593476506|FG000|Overall Study|At the discretion of the sponsor|0|||
164300618|NCT01458392|593476507|FG001|Overall Study|At the discretion of the sponsor|2|||
164300619|NCT01458392|593476508|FG002|Overall Study|At the discretion of the sponsor|7|||
164300620|NCT01458392|593476506|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
164300621|NCT01458392|593476507|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
164300622|NCT01458392|593476508|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
164300623|NCT02038933|593476509|FG000|Overall Study|Disease progression|104|||
164300624|NCT02038933|593476509|FG000|Overall Study|Study drug toxicity|6|||
164300625|NCT02038933|593476509|FG000|Overall Study|Adverse event unrelated to study drug|6|||
164300626|NCT02038933|593476509|FG000|Overall Study|Participant request to discontinue treatment|2|||
164300627|NCT02038933|593476509|FG000|Overall Study|Lost to Follow-up|1|||
164300628|NCT02038933|593476509|FG000|Overall Study|Other reasons|2|||
164300629|NCT03250273|593476542|FG000|Overall Study|Disease Progression|2|||
164300630|NCT03250273|593476543|FG001|Overall Study|Disease Progression|11|||
164300631|NCT03250273|593476542|FG000|Overall Study|Death|0|||
164300632|NCT03250273|593476543|FG001|Overall Study|Death|1|||
164300633|NCT04154904|593476544|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
164300634|NCT04154904|593476545|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
164300635|NCT04154904|593476546|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
164300636|NCT00936715|593476547|FG000|Overall Study|Investigators Discretion|1|||
164300637|NCT00936715|593476547|FG000|Overall Study|Protocol Violation|1|||
164026496|NCT01742078|592456801|FG006|Overall Study|Withdrawal by Subject|0|||
164026497|NCT01742078|592456802|FG007|Overall Study|Withdrawal by Subject|0|||
164026498|NCT01742078|592456803|FG008|Overall Study|Withdrawal by Subject|0|||
164026499|NCT05025787|592456806|FG000|Overall Study|Lack of Efficacy|0|||
164026500|NCT05025787|592456807|FG001|Overall Study|Lack of Efficacy|1|||
164026501|NCT05025787|592456806|FG000|Overall Study|Adverse Event|2|||
164026502|NCT05025787|592456807|FG001|Overall Study|Adverse Event|4|||
164026503|NCT05025787|592456806|FG000|Overall Study|Non compliance|0|||
164026504|NCT05025787|592456807|FG001|Overall Study|Non compliance|1|||
164026505|NCT05025787|592456806|FG000|Overall Study|Protocol Violation|3|||
164026506|NCT05025787|592456807|FG001|Overall Study|Protocol Violation|1|||
164026507|NCT05025787|592456806|FG000|Overall Study|Stopping criteria met|1|||
164026508|NCT05025787|592456807|FG001|Overall Study|Stopping criteria met|1|||
164026509|NCT05025787|592456806|FG000|Overall Study|Withdrawal by Subject|3|||
164300638|NCT00936715|593476547|FG000|Overall Study|Safety or Tolerability Reasons|4|||
164300639|NCT03040336|593476549|FG000|Overall Study|Death|1|||
164300640|NCT03040336|593476550|FG001|Overall Study|Death|0|||
164026510|NCT05025787|592456807|FG001|Overall Study|Withdrawal by Subject|1|||
164026511|NCT03471767|592456808|FG000|Overall Study|Withdrawal by Subject|3|||
164026512|NCT03471767|592456809|FG001|Overall Study|Withdrawal by Subject|1|||
164300641|NCT03040336|593476549|FG000|Overall Study|Withdrawal by Subject|2|||
164300642|NCT03040336|593476550|FG001|Overall Study|Withdrawal by Subject|3|||
164300643|NCT02000440|593476551|FG000|Overall Study|Adverse Event|3|||
164300644|NCT02000440|593476551|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
164026513|NCT03471767|592456808|FG000|Overall Study|Adverse Event|1|||
164026514|NCT03471767|592456809|FG001|Overall Study|Adverse Event|0|||
164026515|NCT03471767|592456808|FG000|Overall Study|Lost to Follow-up|1|||
164026516|NCT03471767|592456809|FG001|Overall Study|Lost to Follow-up|0|||
164026517|NCT03471767|592456808|FG000|Overall Study|PI Withdrawal|1|||
164026518|NCT03471767|592456809|FG001|Overall Study|PI Withdrawal|3|||
164300645|NCT02383576|593476553|FG000|Overall Study|Death|53|||
164300646|NCT02383576|593476554|FG001|Overall Study|Death|33|||
164300647|NCT02383576|593476553|FG000|Overall Study|Lost to Follow-up|7|||
164300648|NCT02383576|593476554|FG001|Overall Study|Lost to Follow-up|1|||
164300649|NCT02383576|593476553|FG000|Overall Study|Withdrew Consent|1|||
164300650|NCT02383576|593476554|FG001|Overall Study|Withdrew Consent|6|||
164300651|NCT02383576|593476553|FG000|Overall Study|Investigator's Decision|0|||
164300652|NCT02383576|593476554|FG001|Overall Study|Investigator's Decision|1|||
164300653|NCT02383576|593476553|FG000|Overall Study|Administrative/Other|2|||
164300654|NCT02383576|593476554|FG001|Overall Study|Administrative/Other|4|||
164300655|NCT00871975|593476555|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
164300656|NCT00871975|593476555|FG000|Overall Study|Catheters could not be inserted|1|||
164300657|NCT00871975|593476555|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
164300658|NCT00871975|593476555|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
164300659|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
164300660|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
164300661|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
164300662|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
164300663|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
164300664|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
164300665|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
164300666|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164300667|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
164300668|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
164300669|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164300670|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
164300671|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
164300672|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
164300673|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
164300674|NCT01436149|593476556|FG000|Antidepressant Lead-in Phase|Other|119|||
164300675|NCT01436149|593476557|FG001|Antidepressant Lead-in Phase|Other|0|||
164300676|NCT01436149|593476558|FG002|Antidepressant Lead-in Phase|Other|0|||
164300677|NCT01436149|593476556|FG000|Randomized Phase|Adverse Event|9|||
164300678|NCT01436149|593476557|FG001|Randomized Phase|Adverse Event|10|||
164300679|NCT01436149|593476558|FG002|Randomized Phase|Adverse Event|11|||
164300680|NCT01436149|593476556|FG000|Randomized Phase|Protocol Violation|4|||
164300681|NCT01436149|593476557|FG001|Randomized Phase|Protocol Violation|5|||
164300682|NCT01436149|593476558|FG002|Randomized Phase|Protocol Violation|0|||
164300683|NCT01436149|593476556|FG000|Randomized Phase|Withdrawal by Subject|16|||
164300684|NCT01436149|593476557|FG001|Randomized Phase|Withdrawal by Subject|10|||
164300685|NCT01436149|593476558|FG002|Randomized Phase|Withdrawal by Subject|10|||
164300686|NCT01436149|593476556|FG000|Randomized Phase|Lost to Follow-up|34|||
164300687|NCT01436149|593476557|FG001|Randomized Phase|Lost to Follow-up|5|||
164300688|NCT01436149|593476558|FG002|Randomized Phase|Lost to Follow-up|6|||
164300689|NCT01436149|593476556|FG000|Randomized Phase|Lack of Efficacy|0|||
164300690|NCT01436149|593476557|FG001|Randomized Phase|Lack of Efficacy|0|||
164300691|NCT01436149|593476558|FG002|Randomized Phase|Lack of Efficacy|1|||
164300692|NCT01436149|593476556|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
164300693|NCT01436149|593476557|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
164300694|NCT01436149|593476558|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
164300695|NCT01436149|593476556|FG000|Randomized Phase|Other|12|||
164300696|NCT01436149|593476557|FG001|Randomized Phase|Other|5|||
164300697|NCT01436149|593476558|FG002|Randomized Phase|Other|11|||
164300698|NCT01690143|593476559|FG000|Overall Study|Withdrawal by Subject|1|||
164300699|NCT01643668|593476560|FG000|Overall Study|Death|1|||
164300700|NCT01409707|593476561|FG000|Overall Study|Withdrawal by Subject|5|||
164300701|NCT01409707|593476562|FG001|Overall Study|Withdrawal by Subject|17|||
164300702|NCT01409707|593476563|FG002|Overall Study|Withdrawal by Subject|16|||
164300703|NCT00632229|593476564|FG000|Overall Study|Adverse Event|6|||
164300704|NCT00632229|593476565|FG001|Overall Study|Adverse Event|0|||
164300705|NCT00632229|593476564|FG000|Overall Study|Lost to Follow-up|0|||
164300706|NCT00632229|593476565|FG001|Overall Study|Lost to Follow-up|3|||
164300707|NCT00632229|593476564|FG000|Overall Study|Lack of Efficacy|0|||
164300708|NCT00632229|593476565|FG001|Overall Study|Lack of Efficacy|2|||
164300709|NCT00632229|593476564|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
164300710|NCT00632229|593476565|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
164300711|NCT01716234|593476566|FG000|Overall Study|Protocol Violation|0|||
164026519|NCT01081873|592456810|FG000|Overall Study|Death|86|||
164026520|NCT01081873|592456810|FG000|Overall Study|Withdrawal by Subject|10|||
164300712|NCT01716234|593476567|FG001|Overall Study|Protocol Violation|0|||
164300713|NCT01716234|593476568|FG002|Overall Study|Protocol Violation|0|||
164300714|NCT01716234|593476569|FG003|Overall Study|Protocol Violation|1|||
164300715|NCT01716234|593476570|FG004|Overall Study|Protocol Violation|1|||
164026521|NCT01081873|592456810|FG000|Overall Study|Lost to Follow-up|142|||
164026522|NCT01081873|592456810|FG000|Overall Study|Progression of prostate cancer|13|||
164026523|NCT01081873|592456810|FG000|Overall Study|Other|47|||
164300716|NCT01716234|593476571|FG005|Overall Study|Protocol Violation|1|||
164300717|NCT01716234|593476572|FG006|Overall Study|Protocol Violation|0|||
164300718|NCT01716234|593476566|FG000|Overall Study|Lack of Efficacy|0|||
164300719|NCT01716234|593476567|FG001|Overall Study|Lack of Efficacy|0|||
164300720|NCT01716234|593476568|FG002|Overall Study|Lack of Efficacy|0|||
164300721|NCT01716234|593476569|FG003|Overall Study|Lack of Efficacy|1|||
164300722|NCT01716234|593476570|FG004|Overall Study|Lack of Efficacy|0|||
164300723|NCT01716234|593476571|FG005|Overall Study|Lack of Efficacy|0|||
164300724|NCT01716234|593476572|FG006|Overall Study|Lack of Efficacy|0|||
164300725|NCT01716234|593476566|FG000|Overall Study|Did not meet protocol eligibility|0|||
164300726|NCT01716234|593476567|FG001|Overall Study|Did not meet protocol eligibility|0|||
164300727|NCT01716234|593476568|FG002|Overall Study|Did not meet protocol eligibility|1|||
164300728|NCT01716234|593476569|FG003|Overall Study|Did not meet protocol eligibility|0|||
164300729|NCT01716234|593476570|FG004|Overall Study|Did not meet protocol eligibility|0|||
164300730|NCT01716234|593476571|FG005|Overall Study|Did not meet protocol eligibility|4|||
164300731|NCT01716234|593476572|FG006|Overall Study|Did not meet protocol eligibility|0|||
164300732|NCT01716234|593476566|FG000|Overall Study|Adverse Event|7|||
164300733|NCT01716234|593476567|FG001|Overall Study|Adverse Event|10|||
164300734|NCT01716234|593476568|FG002|Overall Study|Adverse Event|2|||
164300735|NCT01716234|593476569|FG003|Overall Study|Adverse Event|8|||
164300736|NCT01716234|593476570|FG004|Overall Study|Adverse Event|3|||
164300737|NCT01716234|593476571|FG005|Overall Study|Adverse Event|6|||
164300738|NCT01716234|593476572|FG006|Overall Study|Adverse Event|0|||
164300739|NCT01716234|593476566|FG000|Overall Study|Withdrawal by Subject|3|||
164300740|NCT01716234|593476567|FG001|Overall Study|Withdrawal by Subject|0|||
164300741|NCT01716234|593476568|FG002|Overall Study|Withdrawal by Subject|2|||
164300742|NCT01716234|593476569|FG003|Overall Study|Withdrawal by Subject|2|||
164300743|NCT01716234|593476570|FG004|Overall Study|Withdrawal by Subject|1|||
164300744|NCT01716234|593476571|FG005|Overall Study|Withdrawal by Subject|3|||
164300745|NCT01716234|593476572|FG006|Overall Study|Withdrawal by Subject|0|||
164300746|NCT01467960|593476573|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
164300747|NCT01467960|593476574|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
164300748|NCT01467960|593476575|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
164300749|NCT01467960|593476576|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
164300750|NCT01467960|593476577|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
164300751|NCT01467960|593476578|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
164300752|NCT00474812|593476579|FG000|Overall Study|Withdrawal by Subject|5|||
164300753|NCT00474812|593476579|FG000|Overall Study|No Initiation of treatment|2|||
164300754|NCT00737672|593476588|FG000|Overall Study|Graft Abandonment|48|||
164300755|NCT00737672|593476589|FG001|Overall Study|Graft Abandonment|56|||
164300756|NCT00737672|593476588|FG000|Overall Study|Death|23|||
164300757|NCT00737672|593476589|FG001|Overall Study|Death|22|||
164300758|NCT00737672|593476588|FG000|Overall Study|Withdrawal by Subject|1|||
164300759|NCT00737672|593476589|FG001|Overall Study|Withdrawal by Subject|2|||
164300760|NCT00737672|593476588|FG000|Overall Study|Lost to Follow-up|1|||
164300761|NCT00737672|593476589|FG001|Overall Study|Lost to Follow-up|0|||
164300762|NCT00737672|593476588|FG000|Overall Study|Miscellaneous|7|||
164300763|NCT00737672|593476589|FG001|Overall Study|Miscellaneous|1|||
164300764|NCT00737672|593476588|FG000|Overall Study|Physician Decision|0|||
164300765|NCT00737672|593476589|FG001|Overall Study|Physician Decision|2|||
164300766|NCT02002598|593476594|FG000|Dose Level 1|Withdrawal by Subject|1|||
164300767|NCT02002598|593476595|FG001|Dose Level 1|Withdrawal by Subject|0|||
164300768|NCT02002598|593476596|FG002|Dose Level 1|Withdrawal by Subject|0|||
164300769|NCT02002598|593476597|FG003|Dose Level 1|Withdrawal by Subject|0|||
164300770|NCT02002598|593476598|FG004|Dose Level 1|Withdrawal by Subject|0|||
164300771|NCT02018562|593476600|FG000|Overall Study|Withdrawal by Subject|2|||
164300772|NCT02018562|593476601|FG001|Overall Study|Withdrawal by Subject|0|||
164300773|NCT02018562|593476600|FG000|Overall Study|Discharged prior to study completion|1|||
164300774|NCT02018562|593476601|FG001|Overall Study|Discharged prior to study completion|0|||
164026524|NCT02491073|592456811|FG000|Overall Study|screen failure|1|||
164026525|NCT02491073|592456812|FG001|Overall Study|screen failure|0|||
164300775|NCT01838395|593476602|FG000|Overall Study|Withdrawal by Subject|0|||
164300776|NCT01838395|593476603|FG001|Overall Study|Withdrawal by Subject|0|||
164026526|NCT00403559|592456822|FG000|Overall Study|Adverse Event|0|||
164300777|NCT01838395|593476604|FG002|Overall Study|Withdrawal by Subject|0|||
164300778|NCT01838395|593476605|FG003|Overall Study|Withdrawal by Subject|0|||
164300779|NCT01838395|593476606|FG004|Overall Study|Withdrawal by Subject|1|||
164300780|NCT01838395|593476607|FG005|Overall Study|Withdrawal by Subject|0|||
164300781|NCT01838395|593476602|FG000|Overall Study|Death|0|||
164300782|NCT01838395|593476603|FG001|Overall Study|Death|0|||
164300783|NCT01838395|593476604|FG002|Overall Study|Death|1|||
164300784|NCT01838395|593476605|FG003|Overall Study|Death|0|||
164300785|NCT01838395|593476606|FG004|Overall Study|Death|0|||
164300786|NCT01838395|593476607|FG005|Overall Study|Death|0|||
164300787|NCT01838395|593476602|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300788|NCT01838395|593476603|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
164300789|NCT01838395|593476604|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300790|NCT01838395|593476605|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300791|NCT01838395|593476606|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300792|NCT01838395|593476607|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
164300793|NCT05720897|593476613|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
164300794|NCT05720897|593476614|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
164300795|NCT00400179|593476615|FG000|Overall Study|Adverse Event|2|||
164300796|NCT00400179|593476616|FG001|Overall Study|Adverse Event|2|||
164300797|NCT00400179|593476615|FG000|Overall Study|Death|1|||
164300798|NCT00400179|593476616|FG001|Overall Study|Death|2|||
164300799|NCT00400179|593476615|FG000|Overall Study|Withdrew Consent|1|||
164300800|NCT00400179|593476616|FG001|Overall Study|Withdrew Consent|5|||
164300801|NCT00400179|593476615|FG000|Overall Study|Disease progression|1|||
164300802|NCT00400179|593476616|FG001|Overall Study|Disease progression|1|||
164300803|NCT00400179|593476615|FG000|Overall Study|Intercurrent illness|0|||
164300804|NCT00400179|593476616|FG001|Overall Study|Intercurrent illness|1|||
164300805|NCT00400179|593476615|FG000|Overall Study|Investigator judgment|0|||
164300806|NCT00400179|593476616|FG001|Overall Study|Investigator judgment|1|||
164300807|NCT00400179|593476615|FG000|Overall Study|Randomization error/patient ineligible|1|||
164300808|NCT00400179|593476616|FG001|Overall Study|Randomization error/patient ineligible|6|||
164300809|NCT04780061|593476617|FG000|Overall Study|Withdrawal by Subject|5|||
164300810|NCT04780061|593476618|FG001|Overall Study|Withdrawal by Subject|8|||
164300811|NCT04780061|593476617|FG000|Overall Study|Adverse Event|2|||
164300812|NCT04780061|593476618|FG001|Overall Study|Adverse Event|2|||
164300813|NCT04780061|593476617|FG000|Overall Study|Lost to Follow-up|1|||
164300814|NCT04780061|593476618|FG001|Overall Study|Lost to Follow-up|5|||
164300815|NCT04050553|593476620|FG000|Period 1|Physician Decision|2|||
164300816|NCT04050553|593476621|FG001|Period 1|Physician Decision|2|||
164300817|NCT04050553|593476620|FG000|Period 1|Adverse Event|1|||
164300818|NCT04050553|593476621|FG001|Period 1|Adverse Event|1|||
164300819|NCT04050553|593476620|FG000|Period 1|Withdrawal by Subject|0|||
164300820|NCT04050553|593476621|FG001|Period 1|Withdrawal by Subject|1|||
164300821|NCT04050553|593476620|FG000|Wash-out|Adverse Event|0|||
164300822|NCT04050553|593476621|FG001|Wash-out|Adverse Event|1|||
164300823|NCT04050553|593476620|FG000|Wash-out|Withdrawal by Subject|0|||
164300824|NCT04050553|593476621|FG001|Wash-out|Withdrawal by Subject|1|||
164300825|NCT01535040|593476622|FG000|Overall Study|Physician Decision|0|||
164300826|NCT01535040|593476623|FG001|Overall Study|Physician Decision|1|||
164300827|NCT01535040|593476622|FG000|Overall Study|Withdrawal by Subject|13|||
164300828|NCT01535040|593476623|FG001|Overall Study|Withdrawal by Subject|10|||
164300829|NCT01535040|593476622|FG000|Overall Study|Never Started|9|||
164300830|NCT01535040|593476623|FG001|Overall Study|Never Started|4|||
164300831|NCT01535040|593476622|FG000|Overall Study|Toxicity|7|||
164300832|NCT01535040|593476623|FG001|Overall Study|Toxicity|5|||
164300833|NCT01535040|593476622|FG000|Overall Study|Multiple Reasons|1|||
164300834|NCT01535040|593476623|FG001|Overall Study|Multiple Reasons|1|||
164300835|NCT02023086|593476629|FG000|Overall Study|Withdrawal by Subject|2|||
164300836|NCT02023086|593476630|FG001|Overall Study|Withdrawal by Subject|0|||
164300837|NCT04607005|593476631|FG000|Overall Study|Adverse Event|0|||
164300838|NCT04607005|593476632|FG001|Overall Study|Adverse Event|1|||
164300839|NCT04607005|593476631|FG000|Overall Study|Lack of Efficacy|1|||
164300840|NCT04607005|593476632|FG001|Overall Study|Lack of Efficacy|6|||
164300841|NCT04607005|593476631|FG000|Overall Study|Withdrawal by Subject|4|||
164300842|NCT04607005|593476632|FG001|Overall Study|Withdrawal by Subject|9|||
164300843|NCT04607005|593476631|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
164300844|NCT04607005|593476632|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
164300845|NCT03589859|593476635|FG000|Overall Study|Withdrawal by Subject|0|||
164300846|NCT03589859|593476636|FG001|Overall Study|Withdrawal by Subject|6|||
164300847|NCT03043794|593476639|FG000|Overall Study|Lost to Follow-up|1|||
164300848|NCT00626106|593476641|FG000|Overall Study|Withdrawal by Subject|2|||
164300849|NCT00626106|593476642|FG001|Overall Study|Withdrawal by Subject|1|||
164300850|NCT00626106|593476641|FG000|Overall Study|Lost to Follow-up|1|||
164300851|NCT00626106|593476642|FG001|Overall Study|Lost to Follow-up|4|||
164300852|NCT00626106|593476641|FG000|Overall Study|Death|64|||
164300853|NCT00626106|593476642|FG001|Overall Study|Death|19|||
164026527|NCT00403559|592456823|FG001|Overall Study|Adverse Event|1|||
164300854|NCT03472885|593476643|FG000|24-Week Treatment Period|Adverse Event|1|||
164300855|NCT05417438|593476644|FG000|Overall Study|Withdrawal by Subject|3|||
164300856|NCT02201953|593476649|FG000|Overall Study|Randomized but Never Treated|1|||
164300857|NCT02201953|593476650|FG001|Overall Study|Randomized but Never Treated|5|||
164300858|NCT02201953|593476649|FG000|Overall Study|Lack of Efficacy|9|||
164300859|NCT02201953|593476650|FG001|Overall Study|Lack of Efficacy|30|||
164300860|NCT02201953|593476649|FG000|Overall Study|Lost to Follow-up|8|||
164300861|NCT02201953|593476650|FG001|Overall Study|Lost to Follow-up|8|||
164300862|NCT02201953|593476649|FG000|Overall Study|Withdrew Consent|2|||
164300863|NCT02201953|593476650|FG001|Overall Study|Withdrew Consent|5|||
164300864|NCT02201953|593476649|FG000|Overall Study|Adverse Event|0|||
164300865|NCT02201953|593476650|FG001|Overall Study|Adverse Event|5|||
164300866|NCT02201953|593476649|FG000|Overall Study|Death|0|||
164300867|NCT02201953|593476650|FG001|Overall Study|Death|3|||
164300868|NCT02079246|593478348|FG000|OLEX|Withdrawal before treatment|1|||
164300869|NCT02079246|593478349|FG001|OLEX|Withdrawal before treatment|0|||
164300870|NCT02079246|593478348|FG000|OLEX|Death|11|||
164300871|NCT02079246|593478349|FG001|OLEX|Death|0|||
164300872|NCT02079246|593478348|FG000|OLEX|Adverse Event|66|||
164300873|NCT02079246|593478349|FG001|OLEX|Adverse Event|0|||
164300874|NCT02079246|593478348|FG000|OLEX|Withdrawal by Subject|60|||
164300875|NCT02079246|593478349|FG001|OLEX|Withdrawal by Subject|0|||
164300876|NCT02079246|593478348|FG000|OLEX|Lost to Follow-up|6|||
164300877|NCT02079246|593478349|FG001|OLEX|Lost to Follow-up|0|||
164300878|NCT02079246|593478348|FG000|OLEX|Protocol Violation|6|||
164300879|NCT02079246|593478349|FG001|OLEX|Protocol Violation|0|||
164300880|NCT02079246|593478348|FG000|OLEX|Lack of Efficacy|3|||
164300881|NCT02079246|593478349|FG001|OLEX|Lack of Efficacy|0|||
164300882|NCT02079246|593478348|FG000|OLEX|Results of the lead-in studies|58|||
164300883|NCT02079246|593478349|FG001|OLEX|Results of the lead-in studies|0|||
164300884|NCT02079246|593478348|FG000|OLEX|Other: Disallowed medication|8|||
164300885|NCT02079246|593478349|FG001|OLEX|Other: Disallowed medication|0|||
164300886|NCT02079246|593478348|FG000|OLEX|Other: Insufficient compliance|2|||
164300887|NCT02079246|593478349|FG001|OLEX|Other: Insufficient compliance|0|||
164300888|NCT02079246|593478348|FG000|OLEX|Other: Caregiver unavailable|3|||
164300889|NCT02079246|593478349|FG001|OLEX|Other: Caregiver unavailable|0|||
164300890|NCT02079246|593478348|FG000|OLEX|Other: Coordinator decision|1|||
164300891|NCT02079246|593478349|FG001|OLEX|Other: Coordinator decision|0|||
164300892|NCT02079246|593478348|FG000|OLEX|Other: Worsening of condition|1|||
164300893|NCT02079246|593478349|FG001|OLEX|Other: Worsening of condition|0|||
164300894|NCT02079246|593478348|FG000|OLEX|Other: Moved to nursing home|1|||
164300895|NCT02079246|593478349|FG001|OLEX|Other: Moved to nursing home|0|||
164300896|NCT02079246|593478348|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
164300897|NCT02079246|593478349|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
164300898|NCT02079246|593478348|FG000|OLEX-MEM|Adverse Event|0|||
164300899|NCT02079246|593478349|FG001|OLEX-MEM|Adverse Event|6|||
164300900|NCT02079246|593478348|FG000|OLEX-MEM|Withdrawal by Subject|0|||
164300901|NCT02079246|593478349|FG001|OLEX-MEM|Withdrawal by Subject|7|||
164300902|NCT02079246|593478348|FG000|OLEX-MEM|Protocol Violation|0|||
164300903|NCT02079246|593478349|FG001|OLEX-MEM|Protocol Violation|2|||
164300904|NCT02079246|593478348|FG000|OLEX-MEM|Lost to Follow-up|0|||
164300905|NCT02079246|593478349|FG001|OLEX-MEM|Lost to Follow-up|1|||
164300906|NCT02079246|593478348|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
164300907|NCT02079246|593478349|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
164300908|NCT01712399|593478358|FG000|Overall Study|Lost to Follow-up|1|||
164300909|NCT01712399|593478358|FG000|Overall Study|Withdrawal by Subject|39|||
164300910|NCT01712399|593478358|FG000|Overall Study|Death|1|||
164300911|NCT01712399|593478358|FG000|Overall Study|Adverse Event|11|||
164300912|NCT01712399|593478358|FG000|Overall Study|Study closure|345|||
164300913|NCT01803607|593478360|FG000|Overall Study|Adverse Event|5|||
164300914|NCT01803607|593478361|FG001|Overall Study|Adverse Event|3|||
164300915|NCT01803607|593478360|FG000|Overall Study|Lack of Efficacy|0|||
164300916|NCT01803607|593478361|FG001|Overall Study|Lack of Efficacy|1|||
164300917|NCT01803607|593478360|FG000|Overall Study|Protocol Violation|3|||
164300918|NCT01803607|593478361|FG001|Overall Study|Protocol Violation|2|||
164300919|NCT01803607|593478360|FG000|Overall Study|Study terminated by sponsor|54|||
164300920|NCT01803607|593478361|FG001|Overall Study|Study terminated by sponsor|56|||
164300921|NCT01803607|593478360|FG000|Overall Study|Withdrawal by Subject|6|||
164300922|NCT01803607|593478361|FG001|Overall Study|Withdrawal by Subject|5|||
164300923|NCT03077412|593478362|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
164300924|NCT03077412|593478363|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
164300925|NCT03077412|593478364|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
164300926|NCT03077412|593478362|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
164300927|NCT03077412|593478363|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
163910399|NCT02144285|592041819|FG009|Overall Study|Withdrawal by Subject|0|||
163910400|NCT00711555|592043522|FG000|Overall Study|Adverse Event|3|||
163910401|NCT05522777|592043527|FG000|Overall Study|Lack of Efficacy|1|||
163910402|NCT05522777|592043527|FG000|Overall Study|Withdrawal by Subject|1|||
163910403|NCT05487300|592043530|FG000|Overall Study|Withdrawal by Subject|1|||
164300928|NCT03077412|593478364|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
164300929|NCT03077412|593478362|FG000|Overall Study|Adverse Event|1|||
164300930|NCT03077412|593478363|FG001|Overall Study|Adverse Event|2|||
164300931|NCT03077412|593478364|FG002|Overall Study|Adverse Event|2|||
164300932|NCT03077412|593478362|FG000|Overall Study|Investigator's Discretion|0|||
164300933|NCT03077412|593478363|FG001|Overall Study|Investigator's Discretion|1|||
164300934|NCT03077412|593478364|FG002|Overall Study|Investigator's Discretion|1|||
164300935|NCT03077412|593478362|FG000|Overall Study|Withdrew Consent|0|||
164300936|NCT03077412|593478363|FG001|Overall Study|Withdrew Consent|2|||
164300937|NCT03077412|593478364|FG002|Overall Study|Withdrew Consent|0|||
164300938|NCT03038100|593478378|FG000|Overall Study|Death|289|||
164300939|NCT03038100|593478379|FG001|Overall Study|Death|272|||
164300940|NCT03038100|593478378|FG000|Overall Study|Lost to Follow-up|9|||
164300941|NCT03038100|593478379|FG001|Overall Study|Lost to Follow-up|10|||
164300942|NCT03038100|593478378|FG000|Overall Study|Protocol Deviation|1|||
164300943|NCT03038100|593478379|FG001|Overall Study|Protocol Deviation|4|||
164300944|NCT03038100|593478378|FG000|Overall Study|Withdrawal by Subject|45|||
164300945|NCT03038100|593478379|FG001|Overall Study|Withdrawal by Subject|51|||
164300946|NCT03038100|593478378|FG000|Overall Study|Study Terminated By Sponsor|305|||
164300947|NCT03038100|593478379|FG001|Overall Study|Study Terminated By Sponsor|311|||
164300948|NCT03038100|593478378|FG000|Overall Study|Physician Decision|1|||
164300949|NCT03038100|593478379|FG001|Overall Study|Physician Decision|3|||
164300950|NCT00918255|593478380|FG000|Overall Study|Adverse Event|1|||
164300951|NCT00918255|593478381|FG001|Overall Study|Adverse Event|0|||
164300952|NCT00918255|593478382|FG002|Overall Study|Adverse Event|0|||
164300953|NCT00918255|593478380|FG000|Overall Study|Withdrawal by Subject|1|||
164300954|NCT00918255|593478381|FG001|Overall Study|Withdrawal by Subject|0|||
164300955|NCT00918255|593478382|FG002|Overall Study|Withdrawal by Subject|2|||
164300956|NCT00918255|593478380|FG000|Overall Study|Lack of Efficacy|1|||
164300957|NCT00918255|593478381|FG001|Overall Study|Lack of Efficacy|0|||
164300958|NCT00918255|593478382|FG002|Overall Study|Lack of Efficacy|0|||
164300959|NCT00918255|593478380|FG000|Overall Study|Lost to Follow-up|1|||
164300960|NCT00918255|593478381|FG001|Overall Study|Lost to Follow-up|0|||
164300961|NCT00918255|593478382|FG002|Overall Study|Lost to Follow-up|2|||
164300962|NCT00918255|593478380|FG000|Overall Study|Exceeded allowed number of interventions|0|||
164300963|NCT00918255|593478381|FG001|Overall Study|Exceeded allowed number of interventions|0|||
164300964|NCT00918255|593478382|FG002|Overall Study|Exceeded allowed number of interventions|1|||
164300965|NCT00918255|593478380|FG000|Overall Study|Non-compliance|1|||
164300966|NCT00918255|593478381|FG001|Overall Study|Non-compliance|0|||
164300967|NCT00918255|593478382|FG002|Overall Study|Non-compliance|0|||
164300968|NCT00918255|593478380|FG000|Overall Study|Investigator discretion|1|||
164300969|NCT00918255|593478381|FG001|Overall Study|Investigator discretion|0|||
164300970|NCT00918255|593478382|FG002|Overall Study|Investigator discretion|0|||
164300971|NCT02392624|593478383|FG000|Overall Study|Withdrawal by Subject|15|||
164300972|NCT02392624|593478384|FG001|Overall Study|Withdrawal by Subject|12|||
164300973|NCT02392624|593478385|FG002|Overall Study|Withdrawal by Subject|9|||
164300974|NCT02392624|593478383|FG000|Overall Study|Adverse Event|4|||
164300975|NCT02392624|593478384|FG001|Overall Study|Adverse Event|1|||
164300976|NCT02392624|593478385|FG002|Overall Study|Adverse Event|2|||
164300977|NCT02392624|593478383|FG000|Overall Study|Pregnancy|1|||
163910404|NCT05487300|592043531|FG001|Overall Study|Withdrawal by Subject|0|||
164026528|NCT00403559|592456822|FG000|Overall Study|Lost to Follow-up|3|||
164026529|NCT00403559|592456823|FG001|Overall Study|Lost to Follow-up|3|||
164026530|NCT00403559|592456822|FG000|Overall Study|Withdrawal by Subject|1|||
164026531|NCT00403559|592456823|FG001|Overall Study|Withdrawal by Subject|0|||
164026532|NCT02768194|592456824|FG000|Period 1|Adverse Event|0|||
164026533|NCT02768194|592456825|FG001|Period 1|Adverse Event|0|||
164026534|NCT02768194|592456826|FG002|Period 1|Adverse Event|0|||
164026535|NCT02768194|592456827|FG003|Period 1|Adverse Event|1|||
164026536|NCT02768194|592456828|FG004|Period 1|Adverse Event|0|||
164026537|NCT02768194|592456829|FG005|Period 1|Adverse Event|0|||
164096154|NCT02849652|592715878|FG000|Overall Study|Lost to Follow-up|104|||
164096155|NCT02849652|592715879|FG001|Overall Study|Lost to Follow-up|35|||
164026538|NCT02768194|592456824|FG000|Period 2|Other (Reason not specified)|1|||
164026539|NCT02768194|592456825|FG001|Period 2|Other (Reason not specified)|0|||
164026540|NCT02768194|592456826|FG002|Period 2|Other (Reason not specified)|0|||
164026541|NCT02768194|592456827|FG003|Period 2|Other (Reason not specified)|0|||
164026542|NCT02768194|592456828|FG004|Period 2|Other (Reason not specified)|0|||
164026543|NCT02768194|592456829|FG005|Period 2|Other (Reason not specified)|0|||
164026544|NCT02768194|592456824|FG000|Period 3|Other (Reason not specified)|0|||
164026545|NCT02768194|592456825|FG001|Period 3|Other (Reason not specified)|1|||
164026546|NCT02768194|592456826|FG002|Period 3|Other (Reason not specified)|0|||
164026547|NCT02768194|592456827|FG003|Period 3|Other (Reason not specified)|0|||
164026548|NCT02768194|592456828|FG004|Period 3|Other (Reason not specified)|0|||
164026549|NCT02768194|592456829|FG005|Period 3|Other (Reason not specified)|0|||
164026550|NCT01982773|592456831|FG000|Overall Study|Withdrawal by Subject|1|||
164026551|NCT01982773|592456832|FG001|Overall Study|Withdrawal by Subject|3|||
164026552|NCT01982773|592456831|FG000|Overall Study|Lost to Follow-up|7|||
164026553|NCT01982773|592456832|FG001|Overall Study|Lost to Follow-up|1|||
164096156|NCT02849652|592715880|FG002|Overall Study|Lost to Follow-up|116|||
164026554|NCT01029886|592456835|FG000|Overall Study|Adverse Event|12|||
164026555|NCT01029886|592456836|FG001|Overall Study|Adverse Event|25|||
164026556|NCT01029886|592456835|FG000|Overall Study|Lost to Follow-up|1|||
164026557|NCT01029886|592456836|FG001|Overall Study|Lost to Follow-up|0|||
164026558|NCT01029886|592456835|FG000|Overall Study|Physician Decision|2|||
164026559|NCT01029886|592456836|FG001|Overall Study|Physician Decision|6|||
164026560|NCT01029886|592456835|FG000|Overall Study|Protocol Violation|17|||
164026561|NCT01029886|592456836|FG001|Overall Study|Protocol Violation|5|||
164026562|NCT01029886|592456835|FG000|Overall Study|Withdrawal by Subject|8|||
164026563|NCT01029886|592456836|FG001|Overall Study|Withdrawal by Subject|18|||
164026564|NCT01029886|592456835|FG000|Overall Study|Entry Criteria Not Met|13|||
164026565|NCT01029886|592456836|FG001|Overall Study|Entry Criteria Not Met|5|||
164096157|NCT02849652|592715881|FG003|Overall Study|Lost to Follow-up|22|||
164096158|NCT02849652|592715878|FG000|Overall Study|Withdrawal by Subject|10|||
164096159|NCT02849652|592715879|FG001|Overall Study|Withdrawal by Subject|2|||
164144830|NCT03790657|592891795|FG001|Overall Study|Adverse Event|1|||
164096160|NCT02849652|592715880|FG002|Overall Study|Withdrawal by Subject|8|||
164026566|NCT01029886|592456835|FG000|Overall Study|Sponsor Decision|1|||
164026567|NCT01029886|592456836|FG001|Overall Study|Sponsor Decision|0|||
164026568|NCT01029886|592456835|FG000|Overall Study|Loss Glucose Control|7|||
164026569|NCT01029886|592456836|FG001|Overall Study|Loss Glucose Control|1|||
164026570|NCT03294681|592456837|FG000|Overall Study|Withdrawal by Subject|1|||
164026571|NCT01553916|592456838|FG000|Overall Study|Withdrawal by Subject|2|||
164026572|NCT01553916|592456838|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
164026573|NCT03089216|592456839|FG000|Overall Study|Adverse Event|0|||
164026574|NCT03089216|592456840|FG001|Overall Study|Adverse Event|0|||
164026575|NCT03089216|592456841|FG002|Overall Study|Adverse Event|0|||
164026576|NCT03089216|592456842|FG003|Overall Study|Adverse Event|1|||
164026577|NCT02720016|592456845|FG000|Overall Study|Separation of couple|6|||
164026578|NCT02720016|592456846|FG001|Overall Study|Separation of couple|8|||
164026579|NCT02720016|592456847|FG002|Overall Study|Separation of couple|2|||
164026580|NCT02720016|592456845|FG000|Overall Study|Withdrawal by Subject|6|||
164026581|NCT02720016|592456846|FG001|Overall Study|Withdrawal by Subject|6|||
164026582|NCT02720016|592456847|FG002|Overall Study|Withdrawal by Subject|4|||
164026583|NCT02720016|592456845|FG000|Overall Study|Scheduling issues|2|||
164026584|NCT02720016|592456846|FG001|Overall Study|Scheduling issues|4|||
164026585|NCT02720016|592456847|FG002|Overall Study|Scheduling issues|7|||
164026586|NCT02720016|592456845|FG000|Overall Study|Childcare|2|||
164026587|NCT02720016|592456846|FG001|Overall Study|Childcare|0|||
164026588|NCT02720016|592456847|FG002|Overall Study|Childcare|2|||
164026589|NCT02720016|592456845|FG000|Overall Study|Withdrawal by PI|2|||
164026590|NCT02720016|592456846|FG001|Overall Study|Withdrawal by PI|2|||
164026591|NCT02720016|592456847|FG002|Overall Study|Withdrawal by PI|0|||
164026592|NCT02720016|592456845|FG000|Overall Study|Moved away|2|||
164026593|NCT02720016|592456846|FG001|Overall Study|Moved away|0|||
164026594|NCT02720016|592456847|FG002|Overall Study|Moved away|0|||
164026595|NCT02720016|592456845|FG000|Overall Study|Not Primary Health Concern|0|||
164026596|NCT02720016|592456846|FG001|Overall Study|Not Primary Health Concern|0|||
164026597|NCT02720016|592456847|FG002|Overall Study|Not Primary Health Concern|2|||
164026598|NCT02720016|592456845|FG000|Overall Study|Transportation issues|0|||
164026599|NCT02720016|592456846|FG001|Overall Study|Transportation issues|0|||
164144907|NCT05199090|592891822|FG000|Overall Study|Physician Decision|0|||
164026600|NCT02720016|592456847|FG002|Overall Study|Transportation issues|1|||
164026601|NCT02720016|592456845|FG000|Overall Study|Other|0|||
164026602|NCT02720016|592456846|FG001|Overall Study|Other|0|||
164026603|NCT02720016|592456847|FG002|Overall Study|Other|2|||
164026604|NCT04501679|592456848|FG000|Overall Study|Pregnancy|0|||
164026605|NCT04501679|592456849|FG001|Overall Study|Pregnancy|1|||
164026606|NCT04501679|592456848|FG000|Overall Study|Adverse Event|4|||
164026607|NCT04501679|592456849|FG001|Overall Study|Adverse Event|2|||
164144908|NCT05199090|592891823|FG001|Overall Study|Physician Decision|0|||
164026608|NCT04501679|592456848|FG000|Overall Study|Withdrawal by Subject|2|||
164026609|NCT04501679|592456849|FG001|Overall Study|Withdrawal by Subject|0|||
164026610|NCT04501679|592456848|FG000|Overall Study|Physician Decision|1|||
164026611|NCT04501679|592456849|FG001|Overall Study|Physician Decision|0|||
164026612|NCT04501679|592456848|FG000|Overall Study|Lost to Follow-up|2|||
164026613|NCT04501679|592456849|FG001|Overall Study|Lost to Follow-up|0|||
164026614|NCT02121756|592456853|FG000|Overall Study|Adverse Event|3|||
164026615|NCT02121756|592456854|FG001|Overall Study|Adverse Event|0|||
164026616|NCT02121756|592456853|FG000|Overall Study|Protocol Violation|1|||
164026617|NCT02121756|592456854|FG001|Overall Study|Protocol Violation|1|||
164026618|NCT02121756|592456853|FG000|Overall Study|Physician Decision|2|||
164026619|NCT02121756|592456854|FG001|Overall Study|Physician Decision|1|||
164026620|NCT05319080|592456855|FG000|Overall Study|Withdrawal by Subject|2|||
164026621|NCT05319080|592456855|FG000|Overall Study|Physician Decision|4|||
164026622|NCT00448916|592456858|FG000|Overall Study|Adverse Event|2|||
164026623|NCT00448916|592456859|FG001|Overall Study|Adverse Event|2|||
164026624|NCT00448916|592456860|FG002|Overall Study|Adverse Event|3|||
164026625|NCT00448916|592456861|FG003|Overall Study|Adverse Event|2|||
164026626|NCT00448916|592456858|FG000|Overall Study|Lack of Efficacy|1|||
164026627|NCT00448916|592456859|FG001|Overall Study|Lack of Efficacy|0|||
164026628|NCT00448916|592456860|FG002|Overall Study|Lack of Efficacy|2|||
164026629|NCT00448916|592456861|FG003|Overall Study|Lack of Efficacy|1|||
164026630|NCT00448916|592456858|FG000|Overall Study|Withdrawal by Subject|3|||
164026631|NCT00448916|592456859|FG001|Overall Study|Withdrawal by Subject|3|||
163910405|NCT02507297|592043537|FG000|Overall Study|Withdrawal by Subject|1|||
163910406|NCT02507297|592043538|FG001|Overall Study|Withdrawal by Subject|0|||
163910407|NCT02507297|592043537|FG000|Overall Study|Lost to Follow-up|0|||
163910408|NCT02507297|592043538|FG001|Overall Study|Lost to Follow-up|1|||
163910409|NCT01562275|592043539|FG000|Stage 1|Adverse Event|0|||
163910410|NCT01562275|592043540|FG001|Stage 1|Adverse Event|0|||
163910411|NCT01562275|592043541|FG002|Stage 1|Adverse Event|0|||
163910412|NCT01562275|592043542|FG003|Stage 1|Adverse Event|1|||
163910413|NCT01562275|592043543|FG004|Stage 1|Adverse Event|1|||
163910414|NCT01562275|592043544|FG005|Stage 1|Adverse Event|0|||
163910415|NCT01562275|592043545|FG006|Stage 1|Adverse Event|0|||
163910416|NCT01562275|592043546|FG007|Stage 1|Adverse Event|0|||
163910417|NCT01562275|592043547|FG008|Stage 1|Adverse Event|0|||
163910418|NCT01562275|592043548|FG009|Stage 1|Adverse Event|1|||
163910419|NCT01562275|592043549|FG010|Stage 1|Adverse Event|0|||
163910420|NCT01562275|592043550|FG011|Stage 1|Adverse Event|0|||
163910421|NCT01562275|592043551|FG012|Stage 1|Adverse Event|0|||
163910422|NCT01562275|592043539|FG000|Stage 1|Death|1|||
163910423|NCT01562275|592043540|FG001|Stage 1|Death|0|||
164026632|NCT00448916|592456860|FG002|Overall Study|Withdrawal by Subject|1|||
164026633|NCT00448916|592456861|FG003|Overall Study|Withdrawal by Subject|1|||
164026634|NCT00448916|592456858|FG000|Overall Study|Other|1|||
164026635|NCT00448916|592456859|FG001|Overall Study|Other|0|||
164026636|NCT00448916|592456860|FG002|Overall Study|Other|0|||
164026637|NCT00448916|592456861|FG003|Overall Study|Other|0|||
164026638|NCT00448916|592456858|FG000|Overall Study|Lost to Follow-up|0|||
164026639|NCT00448916|592456859|FG001|Overall Study|Lost to Follow-up|1|||
164026640|NCT00448916|592456860|FG002|Overall Study|Lost to Follow-up|0|||
164026641|NCT00448916|592456861|FG003|Overall Study|Lost to Follow-up|1|||
164026642|NCT00448916|592456858|FG000|Overall Study|Protocol Violation|0|||
164026643|NCT00448916|592456859|FG001|Overall Study|Protocol Violation|0|||
164026644|NCT00448916|592456860|FG002|Overall Study|Protocol Violation|0|||
164026645|NCT00448916|592456861|FG003|Overall Study|Protocol Violation|1|||
163910424|NCT01562275|592043541|FG002|Stage 1|Death|0|||
163910425|NCT01562275|592043542|FG003|Stage 1|Death|0|||
163910426|NCT01562275|592043543|FG004|Stage 1|Death|0|||
163910427|NCT01562275|592043544|FG005|Stage 1|Death|0|||
163910428|NCT01562275|592043545|FG006|Stage 1|Death|0|||
163910429|NCT01562275|592043546|FG007|Stage 1|Death|0|||
163910430|NCT01562275|592043547|FG008|Stage 1|Death|0|||
163910431|NCT01562275|592043548|FG009|Stage 1|Death|0|||
163910432|NCT01562275|592043549|FG010|Stage 1|Death|0|||
163910433|NCT01562275|592043550|FG011|Stage 1|Death|0|||
163910434|NCT01562275|592043551|FG012|Stage 1|Death|0|||
163910435|NCT01562275|592043539|FG000|Stage 1|Non Compliance|0|||
163910436|NCT01562275|592043540|FG001|Stage 1|Non Compliance|0|||
163910437|NCT01562275|592043541|FG002|Stage 1|Non Compliance|1|||
163910438|NCT01562275|592043542|FG003|Stage 1|Non Compliance|0|||
163910439|NCT01562275|592043543|FG004|Stage 1|Non Compliance|0|||
163910440|NCT01562275|592043544|FG005|Stage 1|Non Compliance|0|||
163910441|NCT01562275|592043545|FG006|Stage 1|Non Compliance|0|||
163910442|NCT01562275|592043546|FG007|Stage 1|Non Compliance|0|||
163910443|NCT01562275|592043547|FG008|Stage 1|Non Compliance|0|||
163910444|NCT01562275|592043548|FG009|Stage 1|Non Compliance|0|||
163910445|NCT01562275|592043549|FG010|Stage 1|Non Compliance|0|||
163910446|NCT01562275|592043550|FG011|Stage 1|Non Compliance|0|||
163910447|NCT01562275|592043551|FG012|Stage 1|Non Compliance|0|||
163910448|NCT01562275|592043539|FG000|Stage 1|Physician Decision|0|||
163910449|NCT01562275|592043540|FG001|Stage 1|Physician Decision|0|||
163910450|NCT01562275|592043541|FG002|Stage 1|Physician Decision|0|||
163910451|NCT01562275|592043542|FG003|Stage 1|Physician Decision|0|||
163910452|NCT01562275|592043543|FG004|Stage 1|Physician Decision|1|||
163910453|NCT01562275|592043544|FG005|Stage 1|Physician Decision|0|||
163910454|NCT01562275|592043545|FG006|Stage 1|Physician Decision|1|||
163910455|NCT01562275|592043546|FG007|Stage 1|Physician Decision|0|||
163910456|NCT01562275|592043547|FG008|Stage 1|Physician Decision|1|||
163910457|NCT01562275|592043548|FG009|Stage 1|Physician Decision|0|||
163910458|NCT01562275|592043549|FG010|Stage 1|Physician Decision|0|||
163910459|NCT01562275|592043550|FG011|Stage 1|Physician Decision|0|||
163910460|NCT01562275|592043551|FG012|Stage 1|Physician Decision|0|||
163910461|NCT01562275|592043539|FG000|Stage 1|Progression of Disease|2|||
163910462|NCT01562275|592043540|FG001|Stage 1|Progression of Disease|6|||
163910463|NCT01562275|592043541|FG002|Stage 1|Progression of Disease|2|||
163910464|NCT01562275|592043542|FG003|Stage 1|Progression of Disease|1|||
163910465|NCT01562275|592043543|FG004|Stage 1|Progression of Disease|2|||
163910466|NCT01562275|592043544|FG005|Stage 1|Progression of Disease|4|||
163910467|NCT01562275|592043545|FG006|Stage 1|Progression of Disease|1|||
163910468|NCT01562275|592043546|FG007|Stage 1|Progression of Disease|7|||
163910469|NCT01562275|592043547|FG008|Stage 1|Progression of Disease|2|||
163910470|NCT01562275|592043548|FG009|Stage 1|Progression of Disease|5|||
163910471|NCT01562275|592043549|FG010|Stage 1|Progression of Disease|3|||
163910472|NCT01562275|592043550|FG011|Stage 1|Progression of Disease|0|||
163910473|NCT01562275|592043551|FG012|Stage 1|Progression of Disease|0|||
163910474|NCT01562275|592043539|FG000|Stage 1|Withdrawal by Subject|0|||
163910475|NCT01562275|592043540|FG001|Stage 1|Withdrawal by Subject|1|||
163910476|NCT01562275|592043541|FG002|Stage 1|Withdrawal by Subject|0|||
163910477|NCT01562275|592043542|FG003|Stage 1|Withdrawal by Subject|2|||
163910478|NCT01562275|592043543|FG004|Stage 1|Withdrawal by Subject|0|||
163910479|NCT01562275|592043544|FG005|Stage 1|Withdrawal by Subject|0|||
163910480|NCT01562275|592043545|FG006|Stage 1|Withdrawal by Subject|1|||
163910481|NCT01562275|592043546|FG007|Stage 1|Withdrawal by Subject|0|||
163910482|NCT01562275|592043547|FG008|Stage 1|Withdrawal by Subject|0|||
163910483|NCT01562275|592043548|FG009|Stage 1|Withdrawal by Subject|1|||
163910484|NCT01562275|592043549|FG010|Stage 1|Withdrawal by Subject|0|||
163910485|NCT01562275|592043550|FG011|Stage 1|Withdrawal by Subject|0|||
163910486|NCT01562275|592043551|FG012|Stage 1|Withdrawal by Subject|0|||
163910487|NCT01562275|592043539|FG000|Stage 2|Death|0|||
163910488|NCT01562275|592043540|FG001|Stage 2|Death|0|||
163910489|NCT01562275|592043541|FG002|Stage 2|Death|0|||
163910490|NCT01562275|592043542|FG003|Stage 2|Death|0|||
163910491|NCT01562275|592043543|FG004|Stage 2|Death|0|||
163910492|NCT01562275|592043544|FG005|Stage 2|Death|0|||
163910493|NCT01562275|592043545|FG006|Stage 2|Death|0|||
163910494|NCT01562275|592043546|FG007|Stage 2|Death|0|||
163910495|NCT01562275|592043547|FG008|Stage 2|Death|0|||
163910496|NCT01562275|592043548|FG009|Stage 2|Death|0|||
163910497|NCT01562275|592043549|FG010|Stage 2|Death|0|||
163910498|NCT01562275|592043550|FG011|Stage 2|Death|2|||
163910499|NCT01562275|592043551|FG012|Stage 2|Death|1|||
163910500|NCT01562275|592043539|FG000|Stage 2|Progression of Disease|0|||
163910501|NCT01562275|592043540|FG001|Stage 2|Progression of Disease|0|||
163910502|NCT01562275|592043541|FG002|Stage 2|Progression of Disease|0|||
163910503|NCT01562275|592043542|FG003|Stage 2|Progression of Disease|0|||
163910504|NCT01562275|592043543|FG004|Stage 2|Progression of Disease|0|||
163910505|NCT01562275|592043544|FG005|Stage 2|Progression of Disease|0|||
163910506|NCT01562275|592043545|FG006|Stage 2|Progression of Disease|0|||
163910507|NCT01562275|592043546|FG007|Stage 2|Progression of Disease|0|||
163910508|NCT01562275|592043547|FG008|Stage 2|Progression of Disease|0|||
163910509|NCT01562275|592043548|FG009|Stage 2|Progression of Disease|0|||
163910510|NCT01562275|592043549|FG010|Stage 2|Progression of Disease|0|||
163910511|NCT01562275|592043550|FG011|Stage 2|Progression of Disease|12|||
163910512|NCT01562275|592043551|FG012|Stage 2|Progression of Disease|4|||
163910513|NCT01863368|592043552|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
163910514|NCT01863368|592043553|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
163910515|NCT01863368|592043552|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
163910516|NCT01863368|592043553|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
163910517|NCT01863368|592043552|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
163910518|NCT01863368|592043553|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
163910519|NCT01863368|592043552|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
163910520|NCT01863368|592043553|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
163910521|NCT01863368|592043552|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
163910522|NCT01863368|592043553|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
163910523|NCT01863368|592043552|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
163910524|NCT01863368|592043553|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
163910525|NCT00070707|592043554|FG000|Overall Study|Adverse Event|1|||
163910526|NCT00070707|592043555|FG001|Overall Study|Adverse Event|2|||
163910527|NCT00070707|592043554|FG000|Overall Study|Lack of Efficacy|4|||
163910528|NCT00070707|592043555|FG001|Overall Study|Lack of Efficacy|1|||
163910529|NCT00070707|592043554|FG000|Overall Study|Protocol Violation|8|||
163910530|NCT00070707|592043555|FG001|Overall Study|Protocol Violation|4|||
163910531|NCT00070707|592043554|FG000|Overall Study|Unrelated to Study Medication|1|||
163910532|NCT00070707|592043555|FG001|Overall Study|Unrelated to Study Medication|0|||
163910533|NCT00647699|592043556|FG000|Overall Study|Lost to Follow-up|5|||
163910534|NCT00647699|592043557|FG001|Overall Study|Lost to Follow-up|4|||
163910535|NCT00647699|592043556|FG000|Overall Study|Withdrawal by Subject|3|||
163910536|NCT00647699|592043557|FG001|Overall Study|Withdrawal by Subject|8|||
163910537|NCT04909593|592043558|FG000|Overall Study|Withdrawal by Subject|1|||
163910538|NCT01018992|592043559|FG000|Overall Study|Adverse Event|8|||
163910539|NCT01018992|592043560|FG001|Overall Study|Adverse Event|3|||
163910540|NCT01018992|592043559|FG000|Overall Study|Withdrawal by Subject|3|||
163910541|NCT01018992|592043560|FG001|Overall Study|Withdrawal by Subject|8|||
163910542|NCT01018992|592043559|FG000|Overall Study|Protocol Violation|0|||
163910543|NCT01018992|592043560|FG001|Overall Study|Protocol Violation|4|||
163910544|NCT01018992|592043559|FG000|Overall Study|Lost to Follow-up|5|||
163910545|NCT01018992|592043560|FG001|Overall Study|Lost to Follow-up|1|||
163910546|NCT03029585|592043563|FG000|Overall Study|Death|1|||
163910547|NCT03029585|592043564|FG001|Overall Study|Death|1|||
163910548|NCT03029585|592043563|FG000|Overall Study|Withdrawal by Subject|1|||
163910549|NCT03029585|592043564|FG001|Overall Study|Withdrawal by Subject|0|||
163910550|NCT01241448|592043569|FG000|Overall Study|Adverse Event|1|||
163910551|NCT01241448|592043570|FG001|Overall Study|Adverse Event|0|||
163910552|NCT01241448|592043571|FG002|Overall Study|Adverse Event|2|||
163910553|NCT01241448|592043572|FG003|Overall Study|Adverse Event|2|||
163910554|NCT01241448|592043569|FG000|Overall Study|Lost to Follow-up|2|||
163910555|NCT01241448|592043570|FG001|Overall Study|Lost to Follow-up|1|||
163910556|NCT01241448|592043571|FG002|Overall Study|Lost to Follow-up|1|||
163910557|NCT01241448|592043572|FG003|Overall Study|Lost to Follow-up|1|||
163910558|NCT01241448|592043569|FG000|Overall Study|Physician Decision|0|||
163910559|NCT01241448|592043570|FG001|Overall Study|Physician Decision|2|||
163910560|NCT01241448|592043571|FG002|Overall Study|Physician Decision|0|||
163910561|NCT01241448|592043572|FG003|Overall Study|Physician Decision|0|||
163910562|NCT01241448|592043569|FG000|Overall Study|Protocol Violation|10|||
164026646|NCT03521193|592456862|FG000|Overall Study|Withdrawal by Subject|8|||
164026647|NCT03521193|592456863|FG001|Overall Study|Withdrawal by Subject|0|||
164026648|NCT03521193|592456862|FG000|Overall Study|non compliant to ASA treatment|8|||
164026649|NCT03521193|592456863|FG001|Overall Study|non compliant to ASA treatment|0|||
164026650|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
164026651|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
164096161|NCT02849652|592715881|FG003|Overall Study|Withdrawal by Subject|4|||
164096162|NCT02545998|592715882|FG000|Overall Study|Lost to Follow-up|12|||
164096163|NCT02545998|592715883|FG001|Overall Study|Lost to Follow-up|3|||
163910563|NCT01241448|592043570|FG001|Overall Study|Protocol Violation|5|||
163910564|NCT01241448|592043571|FG002|Overall Study|Protocol Violation|3|||
163910565|NCT01241448|592043572|FG003|Overall Study|Protocol Violation|6|||
163910566|NCT01241448|592043569|FG000|Overall Study|Sponsor Decision|17|||
163910567|NCT01241448|592043570|FG001|Overall Study|Sponsor Decision|14|||
164026652|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
164026653|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
164096164|NCT02545998|592715882|FG000|Overall Study|Withdrawal by Subject|3|||
164096165|NCT02545998|592715883|FG001|Overall Study|Withdrawal by Subject|2|||
163910568|NCT01241448|592043571|FG002|Overall Study|Sponsor Decision|12|||
163910569|NCT01241448|592043572|FG003|Overall Study|Sponsor Decision|6|||
164096166|NCT01226797|592715884|FG000|Overall Study|Adverse Event|1|||
163910570|NCT01241448|592043569|FG000|Overall Study|Withdrawal by Subject|4|||
163910571|NCT01241448|592043570|FG001|Overall Study|Withdrawal by Subject|5|||
163910572|NCT01241448|592043571|FG002|Overall Study|Withdrawal by Subject|3|||
164096167|NCT01226797|592715885|FG001|Overall Study|Adverse Event|0|||
164096168|NCT01226797|592715884|FG000|Overall Study|No longer willing to participate|1|||
164096169|NCT01226797|592715885|FG001|Overall Study|No longer willing to participate|0|||
164096170|NCT01226797|592715884|FG000|Overall Study|Protocol Violation|0|||
164096171|NCT01226797|592715885|FG001|Overall Study|Protocol Violation|1|||
163910573|NCT01241448|592043572|FG003|Overall Study|Withdrawal by Subject|6|||
164096172|NCT00408902|592715889|FG000|Overall Study|Lack of Efficacy|7|||
164096173|NCT00408902|592715889|FG000|Overall Study|Adverse Event|3|||
164096174|NCT02480764|592715891|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
164096175|NCT02480764|592715892|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
163910574|NCT01241448|592043569|FG000|Overall Study|Excluded due to data integrity issues|3|||
164026654|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
164144909|NCT05199090|592891824|FG002|Overall Study|Physician Decision|0|||
163910575|NCT01241448|592043570|FG001|Overall Study|Excluded due to data integrity issues|2|||
163910576|NCT01241448|592043571|FG002|Overall Study|Excluded due to data integrity issues|2|||
163910577|NCT01241448|592043572|FG003|Overall Study|Excluded due to data integrity issues|2|||
163910578|NCT02400749|592043573|FG000|Week 0 -16|Withdrawal by Subject|5|||
163910579|NCT02400749|592043574|FG001|Week 0 -16|Withdrawal by Subject|5|||
163910580|NCT02400749|592043573|FG000|Week 0 -16|Adverse Event|3|||
163910581|NCT02400749|592043574|FG001|Week 0 -16|Adverse Event|1|||
163910582|NCT02400749|592043573|FG000|Week 0 -16|Lost to Follow-up|2|||
163910583|NCT02400749|592043574|FG001|Week 0 -16|Lost to Follow-up|0|||
163910584|NCT02400749|592043573|FG000|Week 0 -16|Protocol Violation|1|||
163910585|NCT02400749|592043574|FG001|Week 0 -16|Protocol Violation|0|||
163910586|NCT02400749|592043573|FG000|Week 17 - 32|Withdrawal by Subject|3|||
163910587|NCT02400749|592043574|FG001|Week 17 - 32|Withdrawal by Subject|2|||
164026655|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
164026656|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
164026657|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
163910588|NCT02400749|592043573|FG000|Week 17 - 32|Adverse Event|2|||
163910589|NCT02400749|592043574|FG001|Week 17 - 32|Adverse Event|1|||
164026658|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
164026659|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
164026660|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
163910590|NCT01825785|592043575|FG000|Overall Study|Adverse Event|0|||
163910591|NCT01825785|592043576|FG001|Overall Study|Adverse Event|0|||
163910592|NCT01825785|592043577|FG002|Overall Study|Adverse Event|0|||
163910593|NCT01825785|592043578|FG003|Overall Study|Adverse Event|0|||
163910594|NCT01825785|592043579|FG004|Overall Study|Adverse Event|1|||
163910595|NCT01825785|592043580|FG005|Overall Study|Adverse Event|0|||
163910596|NCT01825785|592043581|FG006|Overall Study|Adverse Event|0|||
163910597|NCT01825785|592043575|FG000|Overall Study|Withdrawal by Subject|0|||
163910598|NCT01825785|592043576|FG001|Overall Study|Withdrawal by Subject|0|||
163910599|NCT01825785|592043577|FG002|Overall Study|Withdrawal by Subject|0|||
163910600|NCT01825785|592043578|FG003|Overall Study|Withdrawal by Subject|0|||
163910601|NCT01825785|592043579|FG004|Overall Study|Withdrawal by Subject|1|||
163910602|NCT01825785|592043580|FG005|Overall Study|Withdrawal by Subject|1|||
163910603|NCT01825785|592043581|FG006|Overall Study|Withdrawal by Subject|0|||
163910604|NCT03340961|592043586|FG000|Overall Study|Adverse Event|1|||
163910605|NCT03340961|592043587|FG001|Overall Study|Adverse Event|3|||
163910606|NCT03340961|592043588|FG002|Overall Study|Adverse Event|2|||
163910607|NCT03340961|592043589|FG003|Overall Study|Adverse Event|4|||
163910608|NCT03340961|592043586|FG000|Overall Study|Lost to Follow-up|0|||
163910609|NCT03340961|592043587|FG001|Overall Study|Lost to Follow-up|1|||
163910610|NCT03340961|592043588|FG002|Overall Study|Lost to Follow-up|0|||
163910611|NCT03340961|592043589|FG003|Overall Study|Lost to Follow-up|1|||
163910612|NCT03340961|592043586|FG000|Overall Study|Withdrawal by Subject|3|||
163910613|NCT03340961|592043587|FG001|Overall Study|Withdrawal by Subject|2|||
163910614|NCT03340961|592043588|FG002|Overall Study|Withdrawal by Subject|4|||
163910615|NCT03340961|592043589|FG003|Overall Study|Withdrawal by Subject|7|||
163910616|NCT03340961|592043586|FG000|Overall Study|Use of prohibited treatment|0|||
163910617|NCT03340961|592043587|FG001|Overall Study|Use of prohibited treatment|3|||
163910618|NCT03340961|592043588|FG002|Overall Study|Use of prohibited treatment|2|||
163910619|NCT03340961|592043589|FG003|Overall Study|Use of prohibited treatment|4|||
163910620|NCT03340961|592043586|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
164026661|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
164026662|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
164026663|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
164026664|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
164026665|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
164026666|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Missing|3|||
163910621|NCT03340961|592043587|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
163910622|NCT03340961|592043588|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
164026667|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Missing|1|||
164026668|NCT00838916|592456864|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
164026669|NCT00838916|592456865|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
164026670|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
164026671|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
164026672|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
163910623|NCT03340961|592043589|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
163910624|NCT03340961|592043586|FG000|Overall Study|Subject developed an exclusion criterion|0|||
163910625|NCT03340961|592043587|FG001|Overall Study|Subject developed an exclusion criterion|1|||
163910626|NCT03340961|592043588|FG002|Overall Study|Subject developed an exclusion criterion|0|||
163910627|NCT03340961|592043589|FG003|Overall Study|Subject developed an exclusion criterion|0|||
163910628|NCT03340961|592043586|FG000|Overall Study|Protocol Violation|1|||
163910629|NCT03340961|592043587|FG001|Overall Study|Protocol Violation|0|||
163910630|NCT03340961|592043588|FG002|Overall Study|Protocol Violation|1|||
163910631|NCT03340961|592043589|FG003|Overall Study|Protocol Violation|0|||
163910632|NCT03340961|592043586|FG000|Overall Study|Adverse Event|1|||
163910633|NCT03340961|592043587|FG001|Overall Study|Adverse Event|1|||
163910634|NCT03340961|592043588|FG002|Overall Study|Adverse Event|0|||
163910635|NCT03340961|592043589|FG003|Overall Study|Adverse Event|0|||
163910636|NCT03340961|592043586|FG000|Overall Study|Lack of Efficacy|0|||
163910637|NCT03340961|592043587|FG001|Overall Study|Lack of Efficacy|0|||
163910638|NCT03340961|592043588|FG002|Overall Study|Lack of Efficacy|0|||
163910639|NCT03340961|592043589|FG003|Overall Study|Lack of Efficacy|1|||
163910640|NCT01286311|592043590|FG000|Overall Study|Physician did not want outreach sent|14|||
163910641|NCT01286311|592043591|FG001|Overall Study|Physician did not want outreach sent|0|||
163910642|NCT01437540|592043594|FG000|Overall Study|Not listed below|7|||
163910643|NCT01437540|592043595|FG001|Overall Study|Not listed below|6|||
163910644|NCT01437540|592043594|FG000|Overall Study|COPD exacerbation|13|||
163910645|NCT01437540|592043595|FG001|Overall Study|COPD exacerbation|3|||
163910646|NCT01437540|592043594|FG000|Overall Study|Lost to Follow-up|3|||
163910647|NCT01437540|592043595|FG001|Overall Study|Lost to Follow-up|5|||
163910648|NCT01437540|592043594|FG000|Overall Study|Lack of Efficacy|23|||
163910649|NCT01437540|592043595|FG001|Overall Study|Lack of Efficacy|11|||
163910650|NCT01437540|592043594|FG000|Overall Study|Protocol Violation|24|||
163910651|NCT01437540|592043595|FG001|Overall Study|Protocol Violation|12|||
163910652|NCT01437540|592043594|FG000|Overall Study|Adverse Event|26|||
163910653|NCT01437540|592043595|FG001|Overall Study|Adverse Event|13|||
163910654|NCT01437540|592043594|FG000|Overall Study|Withdrawal by Subject|31|||
164026673|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
164026674|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
163910655|NCT01437540|592043595|FG001|Overall Study|Withdrawal by Subject|15|||
163910656|NCT01381549|592043598|FG000|Overall Study|Ineligible: No organisms isolated|0|||
163910657|NCT01381549|592043599|FG001|Overall Study|Ineligible: No organisms isolated|0|||
163910658|NCT01381549|592043600|FG002|Overall Study|Ineligible: No organisms isolated|1|||
163910659|NCT02152384|592043605|FG000|Period 1|Withdrawal by Subject|0|||
163910660|NCT02152384|592043606|FG001|Period 1|Withdrawal by Subject|1|||
163910661|NCT02152384|592043605|FG000|Period 1|Adverse Event|1|||
164026675|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
163910662|NCT02152384|592043606|FG001|Period 1|Adverse Event|1|||
163910663|NCT02446015|592043607|FG000|Overall Study|Adverse Event|0|||
163910664|NCT02446015|592043608|FG001|Overall Study|Adverse Event|1|||
163910665|NCT02446015|592043607|FG000|Overall Study|Withdrawal by Subject|1|||
163910666|NCT02446015|592043608|FG001|Overall Study|Withdrawal by Subject|0|||
163910667|NCT01393600|592043609|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
164026676|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
164026677|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
164026678|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
164026679|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
164026680|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
164026681|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
164026682|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
164026683|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
164026684|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
164026685|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
163910668|NCT01393600|592043610|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
163910669|NCT01393600|592043611|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
163910670|NCT01393600|592043612|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
163910671|NCT01393600|592043609|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
163910672|NCT01393600|592043610|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
163910673|NCT01393600|592043611|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
163910674|NCT01393600|592043612|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
163910675|NCT01393600|592043609|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
163910676|NCT01393600|592043610|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
163910677|NCT01393600|592043611|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
163910678|NCT01393600|592043612|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
163910679|NCT01393600|592043609|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
163910680|NCT01393600|592043610|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
163910681|NCT01393600|592043611|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
163910682|NCT01393600|592043612|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
163910683|NCT01393600|592043609|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
163910684|NCT01393600|592043610|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
163910685|NCT01393600|592043611|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
163910686|NCT01393600|592043612|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
163910687|NCT01393600|592043609|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
163910688|NCT01393600|592043610|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
163910689|NCT01393600|592043611|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
163910690|NCT01393600|592043612|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
163910691|NCT01393600|592043609|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
163910692|NCT01393600|592043610|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
163910693|NCT01393600|592043611|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
163910694|NCT01393600|592043612|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
163910695|NCT00603798|592043613|FG000|Overall Study|Adverse Event|4|||
163910696|NCT00603798|592043614|FG001|Overall Study|Adverse Event|2|||
163910697|NCT00603798|592043615|FG002|Overall Study|Adverse Event|1|||
163910698|NCT00603798|592043613|FG000|Overall Study|Withdrawal by Subject|4|||
163910699|NCT00603798|592043614|FG001|Overall Study|Withdrawal by Subject|3|||
163910700|NCT00603798|592043615|FG002|Overall Study|Withdrawal by Subject|4|||
163910701|NCT00603798|592043613|FG000|Overall Study|Lost to Follow-up|1|||
163910702|NCT00603798|592043614|FG001|Overall Study|Lost to Follow-up|0|||
163910703|NCT00603798|592043615|FG002|Overall Study|Lost to Follow-up|1|||
163910704|NCT00603798|592043613|FG000|Overall Study|Non-compliance with study procedures|0|||
163910705|NCT00603798|592043614|FG001|Overall Study|Non-compliance with study procedures|1|||
163910706|NCT00603798|592043615|FG002|Overall Study|Non-compliance with study procedures|0|||
163910707|NCT00603798|592043613|FG000|Overall Study|Not due to AE|1|||
163910708|NCT00603798|592043614|FG001|Overall Study|Not due to AE|1|||
163910709|NCT00603798|592043615|FG002|Overall Study|Not due to AE|4|||
163910710|NCT00988429|592043619|FG000|Overall Study|Adverse Event|9|||
163910711|NCT00988429|592043620|FG001|Overall Study|Adverse Event|21|||
163910712|NCT00988429|592043621|FG002|Overall Study|Adverse Event|45|||
163910713|NCT00988429|592043619|FG000|Overall Study|Lack of Efficacy|0|||
163910714|NCT00988429|592043620|FG001|Overall Study|Lack of Efficacy|0|||
164096176|NCT02480764|592715893|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
164096177|NCT02480764|592715891|FG000|Overall Study|Major Protocol Deviation|1|||
163910715|NCT00988429|592043621|FG002|Overall Study|Lack of Efficacy|1|||
163910716|NCT00988429|592043619|FG000|Overall Study|Non-Compliance with Study Drug|5|||
163910717|NCT00988429|592043620|FG001|Overall Study|Non-Compliance with Study Drug|1|||
163910718|NCT00988429|592043621|FG002|Overall Study|Non-Compliance with Study Drug|3|||
163910719|NCT00988429|592043619|FG000|Overall Study|Physician Decision|1|||
163910720|NCT00988429|592043620|FG001|Overall Study|Physician Decision|0|||
163910721|NCT00988429|592043621|FG002|Overall Study|Physician Decision|3|||
163910722|NCT00988429|592043619|FG000|Overall Study|Pregnancy|2|||
163910723|NCT00988429|592043620|FG001|Overall Study|Pregnancy|1|||
163910724|NCT00988429|592043621|FG002|Overall Study|Pregnancy|0|||
163910725|NCT00988429|592043619|FG000|Overall Study|Protocol Violation|4|||
163910726|NCT00988429|592043620|FG001|Overall Study|Protocol Violation|3|||
163910727|NCT00988429|592043621|FG002|Overall Study|Protocol Violation|3|||
164096178|NCT02480764|592715892|FG001|Overall Study|Major Protocol Deviation|4|||
164096179|NCT02480764|592715893|FG002|Overall Study|Major Protocol Deviation|3|||
163910728|NCT00988429|592043619|FG000|Overall Study|Withdrawal by Subject|7|||
163910729|NCT00988429|592043620|FG001|Overall Study|Withdrawal by Subject|7|||
163910730|NCT00988429|592043621|FG002|Overall Study|Withdrawal by Subject|12|||
163910731|NCT00988429|592043619|FG000|Overall Study|Administrative Reasons|1|||
163910732|NCT00988429|592043620|FG001|Overall Study|Administrative Reasons|2|||
163910733|NCT00988429|592043621|FG002|Overall Study|Administrative Reasons|1|||
163910734|NCT00988429|592043619|FG000|Overall Study|other reasons|8|||
163910735|NCT00988429|592043620|FG001|Overall Study|other reasons|8|||
163910736|NCT00988429|592043621|FG002|Overall Study|other reasons|1|||
163910737|NCT02964234|592043622|FG000|Overall Study|Lost to Follow-up|22|||
163910738|NCT02964234|592043623|FG001|Overall Study|Lost to Follow-up|13|||
163910739|NCT01123356|592043624|FG000|Overall Study|Adverse Event|2|||
163910740|NCT01123356|592043624|FG000|Overall Study|Lack of Efficacy|4|||
163910741|NCT01123356|592043624|FG000|Overall Study|Withdrawal by Subject|1|||
163910742|NCT02246647|592043628|FG000|Overall Study|Withdrawal by Subject|1|||
163910743|NCT02246647|592043629|FG001|Overall Study|Withdrawal by Subject|1|||
163910744|NCT01113541|592043634|FG000|Overall Study|Withdrawal by Subject|1|||
163910745|NCT01113541|592043634|FG000|Overall Study|Protocol Violation|1|||
163910746|NCT01113541|592043634|FG000|Overall Study|Study Terminated by Sponsor|7|||
163910747|NCT01113541|592043634|FG000|Overall Study|Adverse Event|4|||
163910748|NCT00687297|592043643|FG000|Randomization|Withdrawal by Subject|2|||
163910749|NCT00687297|592043644|FG001|Randomization|Withdrawal by Subject|0|||
163910750|NCT00687297|592043643|FG000|Randomization|Withdrew before treatment, ineligible|1|||
163910751|NCT00687297|592043644|FG001|Randomization|Withdrew before treatment, ineligible|1|||
163910752|NCT00687297|592043643|FG000|Induction|Withdrawal by Subject|4|||
163910753|NCT00687297|592043644|FG001|Induction|Withdrawal by Subject|4|||
163910754|NCT00687297|592043643|FG000|Induction|Adverse Event|16|||
163910755|NCT00687297|592043644|FG001|Induction|Adverse Event|15|||
163910756|NCT00687297|592043643|FG000|Induction|Death|7|||
163910757|NCT00687297|592043644|FG001|Induction|Death|11|||
163910758|NCT00687297|592043643|FG000|Induction|Lack of Efficacy|17|||
163910759|NCT00687297|592043644|FG001|Induction|Lack of Efficacy|21|||
163910760|NCT00687297|592043643|FG000|Induction|Ineligible|0|||
163910761|NCT00687297|592043644|FG001|Induction|Ineligible|1|||
163910762|NCT00687297|592043643|FG000|Induction|Patient Noncompliance|1|||
163910763|NCT00687297|592043644|FG001|Induction|Patient Noncompliance|0|||
163910764|NCT00687297|592043643|FG000|Induction|Physician Decision|0|||
163910765|NCT00687297|592043644|FG001|Induction|Physician Decision|2|||
163910766|NCT00687297|592043643|FG000|Induction|Other|0|||
163910767|NCT00687297|592043644|FG001|Induction|Other|1|||
163910768|NCT02525744|592043647|FG000|Period 1|Physician Decision|0|||
163910769|NCT02525744|592043648|FG001|Period 1|Physician Decision|0|||
163910770|NCT02525744|592043649|FG002|Period 1|Physician Decision|1|||
163910771|NCT02525744|592043650|FG003|Period 1|Physician Decision|0|||
163910772|NCT02525744|592043647|FG000|Period 3|Adverse Event|0|||
163910773|NCT02525744|592043648|FG001|Period 3|Adverse Event|1|||
163910774|NCT02525744|592043649|FG002|Period 3|Adverse Event|0|||
163910775|NCT02525744|592043650|FG003|Period 3|Adverse Event|0|||
163910776|NCT02525744|592043647|FG000|Period 4|Withdrawal by Subject|1|||
163910777|NCT02525744|592043648|FG001|Period 4|Withdrawal by Subject|0|||
163910778|NCT02525744|592043649|FG002|Period 4|Withdrawal by Subject|0|||
163910779|NCT02525744|592043650|FG003|Period 4|Withdrawal by Subject|0|||
163910780|NCT02525744|592043647|FG000|Period 5|Physician Decision|1|||
163910781|NCT02525744|592043648|FG001|Period 5|Physician Decision|0|||
163910782|NCT02525744|592043649|FG002|Period 5|Physician Decision|0|||
163910783|NCT02525744|592043650|FG003|Period 5|Physician Decision|0|||
163910784|NCT01182285|592043651|FG000|First Intervention Week 1-10|Disease progression|1|||
164096180|NCT02480764|592715891|FG000|Overall Study|Lost to Follow-up|0|||
164026686|NCT00838916|592456864|FG000|Follow-up Period (8 Weeks)|Missing|3|||
164026687|NCT00838916|592456865|FG001|Follow-up Period (8 Weeks)|Missing|0|||
164026688|NCT00430521|592456869|FG000|Overall Study|Adverse Event|0|||
164026689|NCT00430521|592456870|FG001|Overall Study|Adverse Event|0|||
164026690|NCT00430521|592456871|FG002|Overall Study|Adverse Event|0|||
164026691|NCT00430521|592456872|FG003|Overall Study|Adverse Event|0|||
164026692|NCT00430521|592456873|FG004|Overall Study|Adverse Event|0|||
164026693|NCT00430521|592456874|FG005|Overall Study|Adverse Event|2|||
164026694|NCT00430521|592456875|FG006|Overall Study|Adverse Event|1|||
164026695|NCT00430521|592456876|FG007|Overall Study|Adverse Event|0|||
164026696|NCT00430521|592456869|FG000|Overall Study|Lost to Follow-up|7|||
164026697|NCT00430521|592456870|FG001|Overall Study|Lost to Follow-up|8|||
164026698|NCT00430521|592456871|FG002|Overall Study|Lost to Follow-up|3|||
164026699|NCT00430521|592456872|FG003|Overall Study|Lost to Follow-up|5|||
164026700|NCT00430521|592456873|FG004|Overall Study|Lost to Follow-up|5|||
164096181|NCT02480764|592715892|FG001|Overall Study|Lost to Follow-up|1|||
164026701|NCT00430521|592456874|FG005|Overall Study|Lost to Follow-up|2|||
164096182|NCT02480764|592715893|FG002|Overall Study|Lost to Follow-up|2|||
164026702|NCT00430521|592456875|FG006|Overall Study|Lost to Follow-up|8|||
164026703|NCT00430521|592456876|FG007|Overall Study|Lost to Follow-up|10|||
164096183|NCT02480764|592715891|FG000|Overall Study|Voluntary Withdrawal|6|||
164026704|NCT00430521|592456869|FG000|Overall Study|Pregnancy|0|||
164026705|NCT00430521|592456870|FG001|Overall Study|Pregnancy|0|||
164026706|NCT00430521|592456871|FG002|Overall Study|Pregnancy|0|||
163910785|NCT01182285|592043652|FG001|First Intervention Week 1-10|Disease progression|0|||
164026707|NCT00430521|592456872|FG003|Overall Study|Pregnancy|0|||
164026708|NCT00430521|592456873|FG004|Overall Study|Pregnancy|0|||
163910786|NCT01182285|592043653|FG002|First Intervention Week 1-10|Disease progression|0|||
163910787|NCT01182285|592043651|FG000|First Intervention Week 1-10|Adverse Event|1|||
163910788|NCT01182285|592043652|FG001|First Intervention Week 1-10|Adverse Event|0|||
163910789|NCT01182285|592043653|FG002|First Intervention Week 1-10|Adverse Event|0|||
163910790|NCT01182285|592043651|FG000|First Intervention Week 1-10|Non-compliance|1|||
163910791|NCT01182285|592043652|FG001|First Intervention Week 1-10|Non-compliance|0|||
163910792|NCT01182285|592043653|FG002|First Intervention Week 1-10|Non-compliance|0|||
163910793|NCT01182285|592043651|FG000|Third Intervention Week 11-52|Disease Progression|0|||
164096184|NCT02480764|592715892|FG001|Overall Study|Voluntary Withdrawal|5|||
164096185|NCT02480764|592715893|FG002|Overall Study|Voluntary Withdrawal|10|||
164096186|NCT02480764|592715891|FG000|Overall Study|Lack of Efficacy|0|||
164096187|NCT02480764|592715892|FG001|Overall Study|Lack of Efficacy|3|||
164096188|NCT02480764|592715893|FG002|Overall Study|Lack of Efficacy|3|||
164096189|NCT02480764|592715891|FG000|Overall Study|Reason not Specified|0|||
164096190|NCT02480764|592715892|FG001|Overall Study|Reason not Specified|1|||
164096191|NCT02480764|592715893|FG002|Overall Study|Reason not Specified|0|||
164026709|NCT00430521|592456874|FG005|Overall Study|Pregnancy|0|||
164026710|NCT00430521|592456875|FG006|Overall Study|Pregnancy|1|||
164026711|NCT00430521|592456876|FG007|Overall Study|Pregnancy|0|||
164026712|NCT00430521|592456869|FG000|Overall Study|Vaccine Expired|0|||
164026713|NCT00430521|592456870|FG001|Overall Study|Vaccine Expired|0|||
164026714|NCT00430521|592456871|FG002|Overall Study|Vaccine Expired|0|||
164026715|NCT00430521|592456872|FG003|Overall Study|Vaccine Expired|0|||
164026716|NCT00430521|592456873|FG004|Overall Study|Vaccine Expired|0|||
164096192|NCT02457832|592715896|FG000|Training|Lost to Follow-up|10|||
164096193|NCT02457832|592715897|FG001|Training|Lost to Follow-up|6|||
164096194|NCT02457832|592715898|FG002|Training|Lost to Follow-up|3|||
164096195|NCT02457832|592715896|FG000|One Month Washout|Lost to Follow-up|0|||
164096196|NCT02457832|592715897|FG001|One Month Washout|Lost to Follow-up|1|||
164026717|NCT00430521|592456874|FG005|Overall Study|Vaccine Expired|1|||
163910794|NCT01182285|592043652|FG001|Third Intervention Week 11-52|Disease Progression|0|||
163910795|NCT01182285|592043653|FG002|Third Intervention Week 11-52|Disease Progression|6|||
164026718|NCT00430521|592456875|FG006|Overall Study|Vaccine Expired|0|||
164026719|NCT00430521|592456876|FG007|Overall Study|Vaccine Expired|0|||
164026720|NCT00430521|592456869|FG000|Overall Study|Protocol Violation|1|||
164026721|NCT00430521|592456870|FG001|Overall Study|Protocol Violation|0|||
164026722|NCT00430521|592456871|FG002|Overall Study|Protocol Violation|0|||
164026723|NCT00430521|592456872|FG003|Overall Study|Protocol Violation|0|||
164026724|NCT00430521|592456873|FG004|Overall Study|Protocol Violation|0|||
164026725|NCT00430521|592456874|FG005|Overall Study|Protocol Violation|0|||
164026726|NCT00430521|592456875|FG006|Overall Study|Protocol Violation|0|||
164026727|NCT00430521|592456876|FG007|Overall Study|Protocol Violation|0|||
164026728|NCT00430521|592456869|FG000|Overall Study|Withdrawal by Subject|3|||
164026729|NCT00430521|592456870|FG001|Overall Study|Withdrawal by Subject|1|||
163910796|NCT01182285|592043651|FG000|Third Intervention Week 11-52|Other|0|||
163910797|NCT01182285|592043652|FG001|Third Intervention Week 11-52|Other|0|||
164096197|NCT02457832|592715898|FG002|One Month Washout|Lost to Follow-up|1|||
164096198|NCT01044732|592715899|FG000|Overall Study|Lost to Follow-up|2|||
164096199|NCT01044732|592715900|FG001|Overall Study|Lost to Follow-up|1|||
163910798|NCT01182285|592043653|FG002|Third Intervention Week 11-52|Other|2|||
163910799|NCT02069379|592043654|FG000|Baseline Measurements|Lost to Follow-up|1|||
163910800|NCT02069379|592043655|FG001|Baseline Measurements|Lost to Follow-up|0|||
163910801|NCT02069379|592043656|FG002|Baseline Measurements|Lost to Follow-up|0|||
163910802|NCT02069379|592043657|FG003|Baseline Measurements|Lost to Follow-up|0|||
163910803|NCT02069379|592043654|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
163910804|NCT02069379|592043655|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
163910805|NCT02069379|592043656|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
163910806|NCT02069379|592043657|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
163910807|NCT02069379|592043654|FG000|First Treatment Arm|Lost to Follow-up|0|||
163910808|NCT02069379|592043655|FG001|First Treatment Arm|Lost to Follow-up|1|||
163910809|NCT02069379|592043656|FG002|First Treatment Arm|Lost to Follow-up|1|||
163910810|NCT02069379|592043657|FG003|First Treatment Arm|Lost to Follow-up|0|||
163910811|NCT02069379|592043654|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
164026730|NCT00430521|592456871|FG002|Overall Study|Withdrawal by Subject|0|||
164026731|NCT00430521|592456872|FG003|Overall Study|Withdrawal by Subject|3|||
164026732|NCT00430521|592456873|FG004|Overall Study|Withdrawal by Subject|0|||
164026733|NCT00430521|592456874|FG005|Overall Study|Withdrawal by Subject|0|||
163910812|NCT02069379|592043655|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
164096200|NCT01044732|592715899|FG000|Overall Study|Physician Decision|5|||
164096201|NCT01044732|592715900|FG001|Overall Study|Physician Decision|3|||
164096202|NCT01044732|592715899|FG000|Overall Study|Protocol Violation|11|||
164096203|NCT01044732|592715900|FG001|Overall Study|Protocol Violation|12|||
163910813|NCT02069379|592043656|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
163910814|NCT02069379|592043657|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
163910815|NCT02069379|592043654|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
163910816|NCT02069379|592043655|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
163910817|NCT02069379|592043656|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
163910818|NCT02069379|592043657|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
163910819|NCT02069379|592043654|FG000|Second Treatment Arm|Lost to Follow-up|0|||
163910820|NCT02069379|592043655|FG001|Second Treatment Arm|Lost to Follow-up|0|||
163910821|NCT02069379|592043656|FG002|Second Treatment Arm|Lost to Follow-up|1|||
163910822|NCT02069379|592043657|FG003|Second Treatment Arm|Lost to Follow-up|0|||
163910823|NCT00274287|592043660|FG000|Overall Study|Withdrawal by Subject|1|||
163910824|NCT00274287|592043660|FG000|Overall Study|subject non-compliance|1|||
163910825|NCT04617847|592043661|FG000|Overall Study|Withdrawal by Subject|1|||
163910826|NCT04617847|592043662|FG001|Overall Study|Withdrawal by Subject|0|||
163910827|NCT04617847|592043661|FG000|Overall Study|Adverse Event|0|||
163910828|NCT04617847|592043662|FG001|Overall Study|Adverse Event|2|||
163910829|NCT04617847|592043661|FG000|Overall Study|Death|0|||
163910830|NCT04617847|592043662|FG001|Overall Study|Death|1|||
163910831|NCT04617847|592043661|FG000|Overall Study|Termination of Study by Sponsor|2|||
163910832|NCT04617847|592043662|FG001|Overall Study|Termination of Study by Sponsor|21|||
163910833|NCT01525875|592043663|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
163910834|NCT01525875|592043664|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
163910835|NCT01525875|592043663|FG000|Open-label Period|Lost to Follow-up|0|||
163910836|NCT01525875|592043664|FG001|Open-label Period|Lost to Follow-up|2|||
163910837|NCT03031782|592043671|FG000|Treatment Period 1|Lack of Efficacy|3|||
163910838|NCT03031782|592043672|FG001|Treatment Period 1|Lack of Efficacy|0|||
163910839|NCT03031782|592043673|FG002|Treatment Period 1|Lack of Efficacy|0|||
163910840|NCT03031782|592043674|FG003|Treatment Period 1|Lack of Efficacy|0|||
163910841|NCT03031782|592043675|FG004|Treatment Period 1|Lack of Efficacy|0|||
163910842|NCT03031782|592043671|FG000|Treatment Period 2|Physician Decision|0|||
163910843|NCT03031782|592043672|FG001|Treatment Period 2|Physician Decision|1|||
163910844|NCT03031782|592043673|FG002|Treatment Period 2|Physician Decision|0|||
163910845|NCT03031782|592043674|FG003|Treatment Period 2|Physician Decision|0|||
163910846|NCT03031782|592043675|FG004|Treatment Period 2|Physician Decision|3|||
163910847|NCT03031782|592043671|FG000|Treatment Period 2|Lack of Efficacy|0|||
163910848|NCT03031782|592043672|FG001|Treatment Period 2|Lack of Efficacy|1|||
163910849|NCT03031782|592043673|FG002|Treatment Period 2|Lack of Efficacy|0|||
163910850|NCT03031782|592043674|FG003|Treatment Period 2|Lack of Efficacy|0|||
163910851|NCT03031782|592043675|FG004|Treatment Period 2|Lack of Efficacy|1|||
163910852|NCT03031782|592043671|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163910853|NCT03031782|592043672|FG001|Treatment Period 2|Withdrawal by Subject|3|||
163910854|NCT03031782|592043673|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163910855|NCT03031782|592043674|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163910856|NCT03031782|592043675|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163910857|NCT03031782|592043671|FG000|Treatment Period 2|Adverse Event|0|||
163910858|NCT03031782|592043672|FG001|Treatment Period 2|Adverse Event|1|||
163910859|NCT03031782|592043673|FG002|Treatment Period 2|Adverse Event|2|||
163910860|NCT03031782|592043674|FG003|Treatment Period 2|Adverse Event|0|||
163910861|NCT03031782|592043675|FG004|Treatment Period 2|Adverse Event|0|||
163910862|NCT03031782|592043671|FG000|Treatment Period 3|Withdrawal by Subject|0|||
163910863|NCT03031782|592043672|FG001|Treatment Period 3|Withdrawal by Subject|0|||
163910864|NCT03031782|592043673|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164096204|NCT01044732|592715899|FG000|Overall Study|Withdrawal by Subject|0|||
164096205|NCT01044732|592715900|FG001|Overall Study|Withdrawal by Subject|1|||
164096206|NCT01044732|592715899|FG000|Overall Study|Inadequate bowel preparation|11|||
164096207|NCT01044732|592715900|FG001|Overall Study|Inadequate bowel preparation|17|||
164096208|NCT01044732|592715899|FG000|Overall Study|Inability to reach cecum|5|||
164096209|NCT01044732|592715900|FG001|Overall Study|Inability to reach cecum|2|||
164096210|NCT01044732|592715899|FG000|Overall Study|Technical error or malfunction|15|||
164096211|NCT01044732|592715900|FG001|Overall Study|Technical error or malfunction|14|||
164096212|NCT01030965|592715901|FG000|Overall Study|Lack of Efficacy|3|||
163910865|NCT03031782|592043674|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164096213|NCT01030965|592715902|FG001|Overall Study|Lack of Efficacy|2|||
163910866|NCT03031782|592043675|FG004|Treatment Period 3|Withdrawal by Subject|0|||
163910867|NCT04867382|592043678|FG000|Overall Study|Did not complete the survey|2|||
163910868|NCT04867382|592043679|FG001|Overall Study|Did not complete the survey|1|||
163910869|NCT05445557|592043680|FG000|Double Blind Part|Lost to Follow-up|1|||
163910870|NCT03803475|592043681|FG000|Overall Study|Physician Decision|1|||
163910871|NCT01323790|592043682|FG000|Overall Study|Other|3|||
163910872|NCT01323790|592043683|FG001|Overall Study|Other|2|||
163910873|NCT01323790|592043684|FG002|Overall Study|Other|1|||
163910874|NCT01323790|592043682|FG000|Overall Study|Lost to Follow-up|11|||
163910875|NCT01323790|592043683|FG001|Overall Study|Lost to Follow-up|9|||
163910876|NCT01323790|592043684|FG002|Overall Study|Lost to Follow-up|9|||
163910877|NCT01323790|592043682|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
163910878|NCT01323790|592043683|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
163910879|NCT01323790|592043684|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
163910880|NCT01323790|592043682|FG000|Overall Study|Lack of Efficacy|3|||
163910881|NCT01323790|592043683|FG001|Overall Study|Lack of Efficacy|0|||
163910882|NCT01323790|592043684|FG002|Overall Study|Lack of Efficacy|3|||
163910883|NCT01323790|592043682|FG000|Overall Study|Adverse Event|11|||
163910884|NCT01323790|592043683|FG001|Overall Study|Adverse Event|24|||
163910885|NCT01323790|592043684|FG002|Overall Study|Adverse Event|12|||
163910886|NCT01323790|592043682|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163910887|NCT01323790|592043683|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
163910888|NCT01323790|592043684|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
163910889|NCT01323790|592043682|FG000|Overall Study|Withdrawal by Subject|23|||
163910890|NCT01323790|592043683|FG001|Overall Study|Withdrawal by Subject|20|||
163910891|NCT01323790|592043684|FG002|Overall Study|Withdrawal by Subject|13|||
163910892|NCT01323790|592043682|FG000|Overall Study|Did Not Receive Treatment|2|||
163910893|NCT01323790|592043683|FG001|Overall Study|Did Not Receive Treatment|0|||
163910894|NCT01323790|592043684|FG002|Overall Study|Did Not Receive Treatment|1|||
163910895|NCT01323790|592043682|FG000|Overall Study|Severe non-compliance with protocol|2|||
163910896|NCT01323790|592043683|FG001|Overall Study|Severe non-compliance with protocol|2|||
163910897|NCT01323790|592043684|FG002|Overall Study|Severe non-compliance with protocol|2|||
163910898|NCT02915783|592043691|FG000|Overall Study|Death|21|||
163910899|NCT02915783|592043691|FG000|Overall Study|Lost to Follow-up|1|||
163910900|NCT02915783|592043691|FG000|Overall Study|Withdrawal by Subject|2|||
163910901|NCT02950961|592043692|FG000|Overall Study|Study had to stop due to COVID.|7|||
163910902|NCT02432274|592043693|FG000|Overall Study|Death|2|||
163910903|NCT02432274|592043694|FG001|Overall Study|Death|6|||
163910904|NCT02432274|592043695|FG002|Overall Study|Death|7|||
163910905|NCT02432274|592043696|FG003|Overall Study|Death|0|||
163910906|NCT02432274|592043697|FG004|Overall Study|Death|27|||
163910907|NCT02432274|592043698|FG005|Overall Study|Death|7|||
163910908|NCT02432274|592043699|FG006|Overall Study|Death|9|||
163910909|NCT02432274|592043700|FG007|Overall Study|Death|14|||
163910910|NCT02432274|592043693|FG000|Overall Study|Withdrawal of Consent|0|||
163910911|NCT02432274|592043694|FG001|Overall Study|Withdrawal of Consent|0|||
163910912|NCT02432274|592043695|FG002|Overall Study|Withdrawal of Consent|0|||
163910913|NCT02432274|592043696|FG003|Overall Study|Withdrawal of Consent|0|||
164096214|NCT01030965|592715903|FG002|Overall Study|Lack of Efficacy|0|||
163910914|NCT02432274|592043697|FG004|Overall Study|Withdrawal of Consent|2|||
163910915|NCT02432274|592043698|FG005|Overall Study|Withdrawal of Consent|0|||
163910916|NCT02432274|592043699|FG006|Overall Study|Withdrawal of Consent|1|||
163910917|NCT02432274|592043700|FG007|Overall Study|Withdrawal of Consent|2|||
163910918|NCT01736475|592043703|FG000|Overall Study|Adverse Event|4|||
163910919|NCT01736475|592043704|FG001|Overall Study|Adverse Event|0|||
163910920|NCT01736475|592043703|FG000|Overall Study|Withdrawal by Subject|2|||
163910921|NCT01736475|592043704|FG001|Overall Study|Withdrawal by Subject|0|||
163910922|NCT01736475|592043703|FG000|Overall Study|Protocol Violation|4|||
163910923|NCT01736475|592043704|FG001|Overall Study|Protocol Violation|0|||
163910924|NCT01736475|592043703|FG000|Overall Study|Other - Screen failure|1|||
163910925|NCT01736475|592043704|FG001|Overall Study|Other - Screen failure|0|||
163910926|NCT01736475|592043703|FG000|Overall Study|Other - Surgical procedure|1|||
163910927|NCT01736475|592043704|FG001|Overall Study|Other - Surgical procedure|0|||
163910928|NCT02807857|592043705|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
163910929|NCT02807857|592043705|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
163910930|NCT02807857|592043705|FG000|Follow-Up Set|Withdrawal by Subject|8|||
163910931|NCT02807857|592043705|FG000|Follow-Up Set|Lost to Follow-up|7|||
163910932|NCT02807857|592043705|FG000|Follow-Up Set|Physician Decision|6|||
163910933|NCT02807857|592043705|FG000|Follow-Up Set|Adverse Event|3|||
163910934|NCT02807857|592043705|FG000|Follow-Up Set|Death|27|||
163910935|NCT02807857|592043705|FG000|Follow-Up Set|Relocation|2|||
163910936|NCT04197713|592043706|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
163910937|NCT04197713|592043707|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
163910938|NCT01079949|592043708|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
163910939|NCT01079949|592043709|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
163910940|NCT01079949|592043708|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
163910941|NCT01079949|592043709|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
163910942|NCT01079949|592043708|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
163910943|NCT01079949|592043709|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
163910944|NCT01079949|592043708|FG000|Overall Study|Randomized but not treated|1|||
163910945|NCT01079949|592043709|FG001|Overall Study|Randomized but not treated|0|||
163910946|NCT01529632|592043710|FG000|Overall Study|Administrative problem|2|||
163910947|NCT01529632|592043711|FG001|Overall Study|Administrative problem|1|||
163910948|NCT01529632|592043710|FG000|Overall Study|Protocol Violation|0|||
163910949|NCT01529632|592043711|FG001|Overall Study|Protocol Violation|1|||
163910950|NCT01529632|592043710|FG000|Overall Study|Adverse Event|1|||
163910951|NCT01529632|592043711|FG001|Overall Study|Adverse Event|1|||
163910952|NCT05184062|592043712|FG000|Overall Study|Lost to Follow-up|5|||
163910953|NCT05184062|592043713|FG001|Overall Study|Lost to Follow-up|1|||
163910954|NCT05184062|592043712|FG000|Overall Study|Withdrawal by Subject|1|||
163910955|NCT05184062|592043713|FG001|Overall Study|Withdrawal by Subject|0|||
163910956|NCT04914897|592045501|FG000|Overall Study|Withdrawal by Subject|3|||
163910957|NCT04914897|592045502|FG001|Overall Study|Withdrawal by Subject|1|||
163910958|NCT04914897|592045503|FG002|Overall Study|Withdrawal by Subject|1|||
163910959|NCT04914897|592045504|FG003|Overall Study|Withdrawal by Subject|1|||
163910960|NCT04914897|592045501|FG000|Overall Study|Poor compliance to protocol|0|||
163910961|NCT04914897|592045502|FG001|Overall Study|Poor compliance to protocol|0|||
163910962|NCT04914897|592045503|FG002|Overall Study|Poor compliance to protocol|1|||
163910963|NCT04914897|592045504|FG003|Overall Study|Poor compliance to protocol|0|||
163910964|NCT04914897|592045501|FG000|Overall Study|Progressive disease|5|||
163910965|NCT04914897|592045502|FG001|Overall Study|Progressive disease|14|||
163910966|NCT04914897|592045503|FG002|Overall Study|Progressive disease|30|||
163910967|NCT04914897|592045504|FG003|Overall Study|Progressive disease|21|||
163910968|NCT04914897|592045501|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164096215|NCT01030965|592715904|FG003|Overall Study|Lack of Efficacy|3|||
163910969|NCT04914897|592045502|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
163910970|NCT04914897|592045503|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
163910971|NCT04914897|592045504|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
164096216|NCT01030965|592715901|FG000|Overall Study|Protocol Violation|1|||
163910972|NCT04914897|592045501|FG000|Overall Study|Other|1|||
163910973|NCT04914897|592045502|FG001|Overall Study|Other|0|||
164026734|NCT00430521|592456875|FG006|Overall Study|Withdrawal by Subject|0|||
163910974|NCT04914897|592045503|FG002|Overall Study|Other|0|||
163910975|NCT04914897|592045504|FG003|Overall Study|Other|1|||
164026735|NCT00430521|592456876|FG007|Overall Study|Withdrawal by Subject|2|||
164026736|NCT03675737|592456877|FG000|Overall Study|Death|593|||
164026737|NCT03675737|592456878|FG001|Overall Study|Death|660|||
163910976|NCT04783389|592045514|FG000|Overall Study|Withdrawal by Subject|2|||
164026738|NCT03675737|592456877|FG000|Overall Study|Lost to Follow-up|1|||
164026739|NCT03675737|592456878|FG001|Overall Study|Lost to Follow-up|5|||
163910977|NCT04783389|592045515|FG001|Overall Study|Withdrawal by Subject|0|||
164026740|NCT03675737|592456877|FG000|Overall Study|Physician Decision|1|||
164026741|NCT03675737|592456878|FG001|Overall Study|Physician Decision|0|||
163910978|NCT04783389|592045516|FG002|Overall Study|Withdrawal by Subject|0|||
163910979|NCT04783389|592045514|FG000|Overall Study|Termination of Study by Sponsor|10|||
163910980|NCT04783389|592045515|FG001|Overall Study|Termination of Study by Sponsor|12|||
163910981|NCT04783389|592045516|FG002|Overall Study|Termination of Study by Sponsor|14|||
163910982|NCT02164578|592045518|FG000|Treatment Period|Withdrawal by Subject|3|||
163910983|NCT02164578|592045519|FG001|Treatment Period|Withdrawal by Subject|3|||
163910984|NCT02164578|592045518|FG000|Treatment Period|Adverse Event|13|||
163910985|NCT02164578|592045519|FG001|Treatment Period|Adverse Event|6|||
163910986|NCT02164578|592045518|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
163910987|NCT02164578|592045519|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
163910988|NCT02164578|592045518|FG000|Treatment Period|Protocol Violation|0|||
163910989|NCT02164578|592045519|FG001|Treatment Period|Protocol Violation|2|||
163910990|NCT02164578|592045518|FG000|Extension Period|Withdrawal by Subject|2|||
163910991|NCT02164578|592045519|FG001|Extension Period|Withdrawal by Subject|0|||
163910992|NCT02164578|592045518|FG000|Extension Period|Adverse Event|4|||
163910993|NCT02164578|592045519|FG001|Extension Period|Adverse Event|0|||
163910994|NCT02164578|592045518|FG000|Extension Period|Expiry of study medication|1|||
163910995|NCT02164578|592045519|FG001|Extension Period|Expiry of study medication|0|||
163910996|NCT02164578|592045518|FG000|Extension Period|Protocol Violation|0|||
163910997|NCT02164578|592045519|FG001|Extension Period|Protocol Violation|1|||
163910998|NCT04328467|592045520|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
163910999|NCT04328467|592045521|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
163911000|NCT04328467|592045522|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
163911001|NCT00990184|592045523|FG000|Overall Study|Physician Decision|1|||
163911002|NCT01975701|592045524|FG000|Overall Study|Lost to Follow-up|1|||
163911003|NCT01975701|592045524|FG000|Overall Study|Death|23|||
163911004|NCT01975701|592045524|FG000|Overall Study|Physician Decision|1|||
163911005|NCT00376259|592045525|FG000|Overall Study|Sponsor request - study termination|21|||
163911006|NCT00376259|592045526|FG001|Overall Study|Sponsor request - study termination|21|||
163911007|NCT00376259|592045525|FG000|Overall Study|Patient request|1|||
163911008|NCT00376259|592045526|FG001|Overall Study|Patient request|0|||
163911009|NCT01877720|592045528|FG000|Overall Study|Adverse Event|1|||
163911010|NCT01877720|592045529|FG001|Overall Study|Adverse Event|0|||
163911011|NCT00267956|592045532|FG000|Controlled Period|Adverse Event|4|||
163911012|NCT00267956|592045533|FG001|Controlled Period|Adverse Event|1|||
163911013|NCT00267956|592045534|FG002|Controlled Period|Adverse Event|0|||
163911014|NCT00267956|592045535|FG003|Controlled Period|Adverse Event|0|||
163911015|NCT00267956|592045532|FG000|Controlled Period|Lack of Efficacy|4|||
163911016|NCT00267956|592045533|FG001|Controlled Period|Lack of Efficacy|2|||
163911017|NCT00267956|592045534|FG002|Controlled Period|Lack of Efficacy|0|||
163911018|NCT00267956|592045535|FG003|Controlled Period|Lack of Efficacy|0|||
163911019|NCT00267956|592045532|FG000|Controlled Period|Lost to Follow-up|2|||
163911020|NCT00267956|592045533|FG001|Controlled Period|Lost to Follow-up|0|||
163911021|NCT00267956|592045534|FG002|Controlled Period|Lost to Follow-up|0|||
163911022|NCT00267956|592045535|FG003|Controlled Period|Lost to Follow-up|0|||
163911023|NCT00267956|592045532|FG000|Controlled Period|Withdrew consent|3|||
163911024|NCT00267956|592045533|FG001|Controlled Period|Withdrew consent|1|||
163911025|NCT00267956|592045534|FG002|Controlled Period|Withdrew consent|0|||
163911026|NCT00267956|592045535|FG003|Controlled Period|Withdrew consent|0|||
163911027|NCT00267956|592045532|FG000|After Controlled Period|Adverse Event|0|||
163911028|NCT00267956|592045533|FG001|After Controlled Period|Adverse Event|0|||
163911029|NCT00267956|592045534|FG002|After Controlled Period|Adverse Event|2|||
163911030|NCT00267956|592045535|FG003|After Controlled Period|Adverse Event|1|||
163911031|NCT00267956|592045532|FG000|After Controlled Period|Lack of Efficacy|0|||
163911032|NCT00267956|592045533|FG001|After Controlled Period|Lack of Efficacy|0|||
163911033|NCT00267956|592045534|FG002|After Controlled Period|Lack of Efficacy|1|||
163911034|NCT00267956|592045535|FG003|After Controlled Period|Lack of Efficacy|1|||
163911035|NCT00267956|592045532|FG000|After Controlled Period|Lost to Follow-up|0|||
163911036|NCT00267956|592045533|FG001|After Controlled Period|Lost to Follow-up|0|||
163911037|NCT00267956|592045534|FG002|After Controlled Period|Lost to Follow-up|1|||
163911038|NCT00267956|592045535|FG003|After Controlled Period|Lost to Follow-up|0|||
163911039|NCT00267956|592045532|FG000|After Controlled Period|Withdrew consent|0|||
163911040|NCT00267956|592045533|FG001|After Controlled Period|Withdrew consent|0|||
163911041|NCT00267956|592045534|FG002|After Controlled Period|Withdrew consent|1|||
163911042|NCT00267956|592045535|FG003|After Controlled Period|Withdrew consent|0|||
164026742|NCT03675737|592456877|FG000|Overall Study|Withdrawal by Subject|14|||
163911043|NCT01393964|592045536|FG000|Overall Study|Disease Progression|4|||
163911044|NCT01393964|592045537|FG001|Overall Study|Disease Progression|3|||
163911045|NCT01393964|592045538|FG002|Overall Study|Disease Progression|5|||
163911046|NCT01393964|592045536|FG000|Overall Study|Study drug toxicity|1|||
163911047|NCT01393964|592045537|FG001|Overall Study|Study drug toxicity|0|||
163911048|NCT01393964|592045538|FG002|Overall Study|Study drug toxicity|0|||
163911049|NCT01393964|592045536|FG000|Overall Study|Withdrawal by Subject|0|||
163911050|NCT01393964|592045537|FG001|Overall Study|Withdrawal by Subject|0|||
163911051|NCT01393964|592045538|FG002|Overall Study|Withdrawal by Subject|1|||
164026743|NCT03675737|592456878|FG001|Overall Study|Withdrawal by Subject|12|||
164026744|NCT03675737|592456877|FG000|Overall Study|Ongoing in Study|181|||
164026745|NCT03675737|592456878|FG001|Overall Study|Ongoing in Study|112|||
163911052|NCT01393964|592045536|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163911053|NCT01393964|592045537|FG001|Overall Study|Adverse event unrelated to study drug|3|||
163911054|NCT01393964|592045538|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163911055|NCT01393964|592045536|FG000|Overall Study|Subject request stop study treatment|0|||
163911056|NCT01393964|592045537|FG001|Overall Study|Subject request stop study treatment|1|||
163911057|NCT01393964|592045538|FG002|Overall Study|Subject request stop study treatment|0|||
163911058|NCT01393964|592045536|FG000|Overall Study|Subject decided to move to transplant|1|||
163911059|NCT01393964|592045537|FG001|Overall Study|Subject decided to move to transplant|0|||
163911060|NCT01393964|592045538|FG002|Overall Study|Subject decided to move to transplant|0|||
163911061|NCT01393964|592045536|FG000|Overall Study|Subject switched to commercial supply|1|||
163911062|NCT01393964|592045537|FG001|Overall Study|Subject switched to commercial supply|0|||
163911063|NCT01393964|592045538|FG002|Overall Study|Subject switched to commercial supply|2|||
163911064|NCT01393964|592045536|FG000|Overall Study|Subject plateaued in terms of effect|1|||
163911065|NCT01393964|592045537|FG001|Overall Study|Subject plateaued in terms of effect|0|||
163911066|NCT01393964|592045538|FG002|Overall Study|Subject plateaued in terms of effect|0|||
163911067|NCT01393964|592045536|FG000|Overall Study|Investigator removed subject from study|0|||
163911068|NCT01393964|592045537|FG001|Overall Study|Investigator removed subject from study|1|||
163911069|NCT01393964|592045538|FG002|Overall Study|Investigator removed subject from study|0|||
163911070|NCT01393964|592045536|FG000|Overall Study|Subject converted to roll-over study|0|||
163911071|NCT01393964|592045537|FG001|Overall Study|Subject converted to roll-over study|1|||
163911072|NCT01393964|592045538|FG002|Overall Study|Subject converted to roll-over study|0|||
163911073|NCT01393964|592045536|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
163911074|NCT01393964|592045537|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
163911075|NCT01393964|592045538|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
163911076|NCT01918033|592045539|FG000|Overall Study|Adverse Event|1|||
163911077|NCT01918033|592045540|FG001|Overall Study|Adverse Event|0|||
163911078|NCT01918033|592045541|FG002|Overall Study|Adverse Event|2|||
163911079|NCT01918033|592045539|FG000|Overall Study|Lost to Follow-up|0|||
163911080|NCT01918033|592045540|FG001|Overall Study|Lost to Follow-up|1|||
163911081|NCT01918033|592045541|FG002|Overall Study|Lost to Follow-up|0|||
163911082|NCT01918033|592045539|FG000|Overall Study|Protocol Violation|2|||
163911083|NCT01918033|592045540|FG001|Overall Study|Protocol Violation|0|||
163911084|NCT01918033|592045541|FG002|Overall Study|Protocol Violation|1|||
163911085|NCT01918033|592045539|FG000|Overall Study|Withdrawal by Subject|2|||
163911086|NCT01918033|592045540|FG001|Overall Study|Withdrawal by Subject|1|||
163911087|NCT01918033|592045541|FG002|Overall Study|Withdrawal by Subject|0|||
163911088|NCT04679675|592045542|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
163911089|NCT04679675|592045543|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
163911090|NCT04679675|592045544|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
163911091|NCT04679675|592045545|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
163911092|NCT04679675|592045542|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
163911093|NCT04679675|592045543|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
163911094|NCT04679675|592045544|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
163911095|NCT04679675|592045545|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
163911096|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
163911097|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
163911098|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
163911099|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
163911100|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
163911101|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
164026746|NCT03422133|592456883|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
164026747|NCT03422133|592456884|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
164096217|NCT01030965|592715902|FG001|Overall Study|Protocol Violation|1|||
164026748|NCT02180724|592458905|FG000|Overall Study|Death|26|||
163911102|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
163911103|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
163911104|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
163911105|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
163911106|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
163911107|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
163911108|NCT01494467|592045552|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
163911109|NCT01494467|592045553|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
163911110|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
163911111|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
163911112|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
163911113|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
163911114|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
163911115|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
163911116|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
163911117|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
163911118|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
163911119|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
163911120|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
163911121|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
163911122|NCT01494467|592045552|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
163911123|NCT01494467|592045553|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
163911124|NCT02721147|592045558|FG000|Overall Study|Lost to Follow-up|2|||
163911125|NCT02721147|592045559|FG001|Overall Study|Lost to Follow-up|0|||
163911126|NCT02721147|592045560|FG002|Overall Study|Lost to Follow-up|0|||
163911127|NCT01722097|592045561|FG000|Overall Study|Patient sheets not returned|6|||
163911128|NCT01722097|592045562|FG001|Overall Study|Patient sheets not returned|5|||
163911129|NCT01535261|592045563|FG000|Overall Study|Physician Decision|8|||
163911130|NCT01535261|592045563|FG000|Overall Study|Protocol Violation|3|||
163911131|NCT01535261|592045563|FG000|Overall Study|Death|5|||
163911132|NCT01535261|592045563|FG000|Overall Study|Lost to Follow-up|8|||
163911133|NCT01535261|592045563|FG000|Overall Study|Withdrawal by Subject|14|||
163911134|NCT01535261|592045563|FG000|Overall Study|Adverse Event|12|||
163911135|NCT01137682|592045564|FG000|Overall Study|Adverse Event-CORE|2|||
163911136|NCT01137682|592045565|FG001|Overall Study|Adverse Event-CORE|4|||
163911137|NCT01137682|592045566|FG002|Overall Study|Adverse Event-CORE|0|||
163911138|NCT01137682|592045564|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
164026749|NCT02180724|592458906|FG001|Overall Study|Death|1|||
164026750|NCT02180724|592458905|FG000|Overall Study|Lost to Follow-up|3|||
164026751|NCT02180724|592458906|FG001|Overall Study|Lost to Follow-up|1|||
164026752|NCT02180724|592458905|FG000|Overall Study|Withdrawal by Subject|4|||
164026753|NCT02180724|592458906|FG001|Overall Study|Withdrawal by Subject|2|||
164026754|NCT02180724|592458905|FG000|Overall Study|PI Decision|5|||
164026755|NCT02180724|592458906|FG001|Overall Study|PI Decision|2|||
164026756|NCT02180724|592458905|FG000|Overall Study|Study terminated by sponsor|54|||
164026757|NCT02180724|592458906|FG001|Overall Study|Study terminated by sponsor|8|||
164026758|NCT01146951|592458907|FG000|Overall Study|Adverse Event|4|||
164026759|NCT01146951|592458908|FG001|Overall Study|Adverse Event|1|||
164026760|NCT01517412|592458912|FG000|Overall Study|Adverse Event|10|||
164026761|NCT01517412|592458913|FG001|Overall Study|Adverse Event|11|||
164026762|NCT01517412|592458912|FG000|Overall Study|Lack of Efficacy|10|||
164026763|NCT01517412|592458913|FG001|Overall Study|Lack of Efficacy|5|||
164026764|NCT01517412|592458912|FG000|Overall Study|Poor compliance to protocol|8|||
164026765|NCT01517412|592458913|FG001|Overall Study|Poor compliance to protocol|3|||
164026766|NCT01517412|592458912|FG000|Overall Study|Other than specified above|8|||
164026767|NCT01517412|592458913|FG001|Overall Study|Other than specified above|5|||
164026768|NCT01253187|592458914|FG000|Period 2|Withdrawal by Subject|0|||
164026769|NCT01253187|592458915|FG001|Period 2|Withdrawal by Subject|0|||
164026770|NCT01253187|592458916|FG002|Period 2|Withdrawal by Subject|0|||
164026771|NCT01253187|592458917|FG003|Period 2|Withdrawal by Subject|0|||
163911139|NCT01137682|592045565|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
163911140|NCT01137682|592045566|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
164026772|NCT01253187|592458918|FG004|Period 2|Withdrawal by Subject|1|||
163911141|NCT01137682|592045564|FG000|Overall Study|Administrative problems-CORE|2|||
163911142|NCT01137682|592045565|FG001|Overall Study|Administrative problems-CORE|1|||
163911143|NCT01137682|592045566|FG002|Overall Study|Administrative problems-CORE|0|||
163911144|NCT01137682|592045564|FG000|Overall Study|Protocol Violation-CORE|0|||
163911145|NCT01137682|592045565|FG001|Overall Study|Protocol Violation-CORE|1|||
163911146|NCT01137682|592045566|FG002|Overall Study|Protocol Violation-CORE|1|||
163911147|NCT01137682|592045564|FG000|Overall Study|Adverse Event-Extension|4|||
163911148|NCT01137682|592045565|FG001|Overall Study|Adverse Event-Extension|8|||
163911149|NCT01137682|592045566|FG002|Overall Study|Adverse Event-Extension|7|||
163911150|NCT01137682|592045564|FG000|Overall Study|Lack of Efficacy-Extension|15|||
164026773|NCT01253187|592458919|FG005|Period 2|Withdrawal by Subject|0|||
164026774|NCT01253187|592458914|FG000|Period 3|Pregnancy|1|||
164026775|NCT01253187|592458915|FG001|Period 3|Pregnancy|0|||
164026776|NCT01253187|592458916|FG002|Period 3|Pregnancy|0|||
164026777|NCT01253187|592458917|FG003|Period 3|Pregnancy|0|||
164026778|NCT01253187|592458918|FG004|Period 3|Pregnancy|0|||
164026779|NCT01253187|592458919|FG005|Period 3|Pregnancy|0|||
164026780|NCT01253187|592458914|FG000|Period 3|difficulty with blood sampling|0|||
164026781|NCT01253187|592458915|FG001|Period 3|difficulty with blood sampling|1|||
164026782|NCT01253187|592458916|FG002|Period 3|difficulty with blood sampling|0|||
164026783|NCT01253187|592458917|FG003|Period 3|difficulty with blood sampling|0|||
164026784|NCT01253187|592458918|FG004|Period 3|difficulty with blood sampling|0|||
164026785|NCT01253187|592458919|FG005|Period 3|difficulty with blood sampling|0|||
164026786|NCT01253187|592458914|FG000|Period 3|non-compliance|0|||
164026787|NCT01253187|592458915|FG001|Period 3|non-compliance|0|||
164026788|NCT01253187|592458916|FG002|Period 3|non-compliance|0|||
164026789|NCT01253187|592458917|FG003|Period 3|non-compliance|0|||
164026790|NCT01253187|592458918|FG004|Period 3|non-compliance|1|||
164026791|NCT01253187|592458919|FG005|Period 3|non-compliance|0|||
164026792|NCT04124692|592458920|FG000|Overall Study|Medical reason|0|||
164026793|NCT04124692|592458921|FG001|Overall Study|Medical reason|1|||
164026794|NCT04124692|592458920|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
164026795|NCT04124692|592458921|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
164026796|NCT04124692|592458920|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
164026797|NCT04124692|592458921|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
163911151|NCT01137682|592045565|FG001|Overall Study|Lack of Efficacy-Extension|9|||
164026798|NCT04124692|592458920|FG000|Overall Study|Lost to Follow-up|2|||
164026799|NCT04124692|592458921|FG001|Overall Study|Lost to Follow-up|4|||
163911152|NCT01137682|592045566|FG002|Overall Study|Lack of Efficacy-Extension|13|||
163911153|NCT01137682|592045564|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
163911154|NCT01137682|592045565|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
163911155|NCT01137682|592045566|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
163911156|NCT01137682|592045564|FG000|Overall Study|Lost to Follow Up-Extension|0|||
163911157|NCT01137682|592045565|FG001|Overall Study|Lost to Follow Up-Extension|1|||
163911158|NCT01137682|592045566|FG002|Overall Study|Lost to Follow Up-Extension|0|||
163911159|NCT01137682|592045564|FG000|Overall Study|Administrative problems-Extension|0|||
163911160|NCT01137682|592045565|FG001|Overall Study|Administrative problems-Extension|2|||
163911161|NCT01137682|592045566|FG002|Overall Study|Administrative problems-Extension|0|||
163911162|NCT01137682|592045564|FG000|Overall Study|Death-Extension|2|||
163911163|NCT01137682|592045565|FG001|Overall Study|Death-Extension|0|||
163911164|NCT01137682|592045566|FG002|Overall Study|Death-Extension|0|||
163911165|NCT01137682|592045564|FG000|Overall Study|Protocol Violation-Extension|2|||
163911166|NCT01137682|592045565|FG001|Overall Study|Protocol Violation-Extension|1|||
163911167|NCT01137682|592045566|FG002|Overall Study|Protocol Violation-Extension|0|||
163911168|NCT01137682|592045564|FG000|Overall Study|Did not enter extension|2|||
163911169|NCT01137682|592045565|FG001|Overall Study|Did not enter extension|3|||
163911170|NCT01137682|592045566|FG002|Overall Study|Did not enter extension|2|||
163911171|NCT01137682|592045564|FG000|Overall Study|Did not receive treatment in extension|0|||
163911172|NCT01137682|592045565|FG001|Overall Study|Did not receive treatment in extension|0|||
163911173|NCT01137682|592045566|FG002|Overall Study|Did not receive treatment in extension|1|||
163911174|NCT02009332|592045567|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163911175|NCT02009332|592045568|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
163911176|NCT02009332|592045569|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163911177|NCT02009332|592045570|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163911178|NCT02009332|592045571|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163911179|NCT02009332|592045572|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
163911180|NCT02009332|592045567|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163911181|NCT02009332|592045568|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163911182|NCT02009332|592045569|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163911183|NCT02009332|592045570|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163911184|NCT02009332|592045571|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
163911185|NCT02009332|592045572|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
163911186|NCT02009332|592045567|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163911187|NCT02009332|592045568|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163911188|NCT02009332|592045569|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163911189|NCT02009332|592045570|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163911190|NCT02009332|592045571|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
163911191|NCT02009332|592045572|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
163911192|NCT01912599|592045573|FG000|Overall Study|Withdrawal by Subject|0|||
163911193|NCT01912599|592045574|FG001|Overall Study|Withdrawal by Subject|1|||
163911194|NCT01757288|592045576|FG000|Overall Study|Consent withdrawal|0|||
163911195|NCT01757288|592045577|FG001|Overall Study|Consent withdrawal|4|||
163911196|NCT01757288|592045578|FG002|Overall Study|Consent withdrawal|4|||
163911197|NCT01757288|592045576|FG000|Overall Study|Patient off study, IRB hold.|0|||
163911198|NCT01757288|592045577|FG001|Overall Study|Patient off study, IRB hold.|0|||
163911199|NCT01757288|592045578|FG002|Overall Study|Patient off study, IRB hold.|1|||
163911200|NCT01757288|592045576|FG000|Overall Study|Patient death prior to starting treatment|0|||
163911201|NCT01757288|592045577|FG001|Overall Study|Patient death prior to starting treatment|0|||
163911202|NCT01757288|592045578|FG002|Overall Study|Patient death prior to starting treatment|1|||
163911203|NCT01757288|592045576|FG000|Overall Study|Wrong medication administered|0|||
163911204|NCT01757288|592045577|FG001|Overall Study|Wrong medication administered|1|||
163911205|NCT01757288|592045578|FG002|Overall Study|Wrong medication administered|0|||
163911206|NCT01757288|592045576|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
163911207|NCT01757288|592045577|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
163911208|NCT01757288|592045578|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
163911209|NCT01757288|592045576|FG000|Overall Study|Not meeting protocol constraints|0|||
163911210|NCT01757288|592045577|FG001|Overall Study|Not meeting protocol constraints|1|||
163911211|NCT01757288|592045578|FG002|Overall Study|Not meeting protocol constraints|1|||
163911212|NCT01757288|592045576|FG000|Overall Study|Multiple missed appointments|0|||
163911213|NCT01757288|592045577|FG001|Overall Study|Multiple missed appointments|1|||
164026800|NCT04124692|592458920|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
163911214|NCT01757288|592045578|FG002|Overall Study|Multiple missed appointments|0|||
163911215|NCT01757288|592045576|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
163911216|NCT01757288|592045577|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
163911217|NCT01757288|592045578|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
163911218|NCT01757288|592045576|FG000|Overall Study|>2 weeks treatment break|0|||
163911219|NCT01757288|592045577|FG001|Overall Study|>2 weeks treatment break|0|||
163911220|NCT01757288|592045578|FG002|Overall Study|>2 weeks treatment break|1|||
163911221|NCT02825550|592045579|FG000|Overall Study|Physician Decision|1|||
163911222|NCT03386344|592045580|FG000|Overall Study|Adverse Event|6|||
163911223|NCT03386344|592045581|FG001|Overall Study|Adverse Event|3|||
163911224|NCT03386344|592045582|FG002|Overall Study|Adverse Event|1|||
163911225|NCT03386344|592045580|FG000|Overall Study|Poor Compliance to Protocol|0|||
163911226|NCT03386344|592045581|FG001|Overall Study|Poor Compliance to Protocol|1|||
163911227|NCT03386344|592045582|FG002|Overall Study|Poor Compliance to Protocol|0|||
163911228|NCT03386344|592045580|FG000|Overall Study|Study Terminated by Sponsor|101|||
163911229|NCT03386344|592045581|FG001|Overall Study|Study Terminated by Sponsor|102|||
163911230|NCT03386344|592045582|FG002|Overall Study|Study Terminated by Sponsor|106|||
163911231|NCT03386344|592045580|FG000|Overall Study|Lost to Follow-up|3|||
163911232|NCT03386344|592045581|FG001|Overall Study|Lost to Follow-up|2|||
163911233|NCT03386344|592045582|FG002|Overall Study|Lost to Follow-up|1|||
163911234|NCT03386344|592045580|FG000|Overall Study|At the Participant's own Request|7|||
163911235|NCT03386344|592045581|FG001|Overall Study|At the Participant's own Request|7|||
163911236|NCT03386344|592045582|FG002|Overall Study|At the Participant's own Request|8|||
163911237|NCT03386344|592045580|FG000|Overall Study|Reason not Specified|0|||
163911238|NCT03386344|592045581|FG001|Overall Study|Reason not Specified|1|||
163911239|NCT03386344|592045582|FG002|Overall Study|Reason not Specified|0|||
163911240|NCT01077284|592045583|FG000|Overall Study|Adverse Event|2|||
163911241|NCT01077284|592045584|FG001|Overall Study|Adverse Event|0|||
164026801|NCT04124692|592458921|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
164026802|NCT05168813|592458922|FG000|Part A (Open-label)|Lost to Follow-up|21|||
164026803|NCT05168813|592458923|FG001|Part A (Open-label)|Lost to Follow-up|39|||
164026804|NCT05168813|592458924|FG002|Part A (Open-label)|Lost to Follow-up|8|||
163911242|NCT01077284|592045585|FG002|Overall Study|Adverse Event|1|||
163911243|NCT01077284|592045583|FG000|Overall Study|Lost to Follow-up|1|||
163911244|NCT01077284|592045584|FG001|Overall Study|Lost to Follow-up|2|||
163911245|NCT01077284|592045585|FG002|Overall Study|Lost to Follow-up|0|||
163911246|NCT01077284|592045583|FG000|Overall Study|Withdrawal by Subject|2|||
163911247|NCT01077284|592045584|FG001|Overall Study|Withdrawal by Subject|3|||
163911248|NCT01077284|592045585|FG002|Overall Study|Withdrawal by Subject|1|||
163911249|NCT01077284|592045583|FG000|Overall Study|Other|0|||
163911250|NCT01077284|592045584|FG001|Overall Study|Other|0|||
163911251|NCT01077284|592045585|FG002|Overall Study|Other|1|||
163911252|NCT00042939|592045590|FG000|Overall Study|Adverse Event|6|||
163911253|NCT00042939|592045591|FG001|Overall Study|Adverse Event|7|||
163911254|NCT00042939|592045590|FG000|Overall Study|Death|3|||
163911255|NCT00042939|592045591|FG001|Overall Study|Death|2|||
163911256|NCT00042939|592045590|FG000|Overall Study|Withdrawal by Subject|3|||
163911257|NCT00042939|592045591|FG001|Overall Study|Withdrawal by Subject|4|||
163911258|NCT00042939|592045590|FG000|Overall Study|Other disease|1|||
163911259|NCT00042939|592045591|FG001|Overall Study|Other disease|0|||
163911260|NCT00042939|592045590|FG000|Overall Study|Ineligible|2|||
163911261|NCT00042939|592045591|FG001|Overall Study|Ineligible|2|||
163911262|NCT00042939|592045590|FG000|Overall Study|Deterioration of health|3|||
163911263|NCT00042939|592045591|FG001|Overall Study|Deterioration of health|4|||
163911264|NCT00042939|592045590|FG000|Overall Study|QOL diminished|1|||
163911265|NCT00042939|592045591|FG001|Overall Study|QOL diminished|0|||
163911266|NCT00042939|592045590|FG000|Overall Study|Rising ca 19-9|1|||
163911267|NCT00042939|592045591|FG001|Overall Study|Rising ca 19-9|0|||
163911268|NCT00042939|592045590|FG000|Overall Study|Patient non-compliance|1|||
163911269|NCT00042939|592045591|FG001|Overall Study|Patient non-compliance|0|||
163911270|NCT00042939|592045590|FG000|Overall Study|Still on treatment|1|||
163911271|NCT00042939|592045591|FG001|Overall Study|Still on treatment|0|||
163911272|NCT00042939|592045590|FG000|Overall Study|Treatment break > 4 weeks|0|||
163911273|NCT00042939|592045591|FG001|Overall Study|Treatment break > 4 weeks|1|||
163911274|NCT00042939|592045590|FG000|Overall Study|Did not start treatment|2|||
163911275|NCT00042939|592045591|FG001|Overall Study|Did not start treatment|1|||
163911276|NCT03349476|592045592|FG000|Overall Study|Physician Decision|3|||
163911277|NCT00472082|592045593|FG000|Overall Study|Study prematurely terminated|5|||
163911278|NCT01762345|592045596|FG000|Overall Study|Adverse Event|5|||
163911279|NCT01762345|592045596|FG000|Overall Study|Protocol Violation|2|||
163911280|NCT00700999|592045597|FG000|Overall Study|Lost to Follow-up|7|||
163911281|NCT00700999|592045598|FG001|Overall Study|Lost to Follow-up|7|||
163911282|NCT00700999|592045597|FG000|Overall Study|Excluded - did not meet study criteria|0|||
164096218|NCT01030965|592715903|FG002|Overall Study|Protocol Violation|1|||
164096219|NCT01030965|592715904|FG003|Overall Study|Protocol Violation|1|||
164096220|NCT01030965|592715901|FG000|Overall Study|Adverse Event|0|||
164096221|NCT01030965|592715902|FG001|Overall Study|Adverse Event|1|||
164096222|NCT01030965|592715903|FG002|Overall Study|Adverse Event|2|||
164096223|NCT01030965|592715904|FG003|Overall Study|Adverse Event|1|||
164096224|NCT01030965|592715901|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
164096225|NCT01030965|592715902|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
164096226|NCT01030965|592715903|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
164096227|NCT01030965|592715904|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
163911283|NCT00700999|592045598|FG001|Overall Study|Excluded - did not meet study criteria|1|||
163911284|NCT00700999|592045597|FG000|Overall Study|Withdrawal by Subject|8|||
163911285|NCT00700999|592045598|FG001|Overall Study|Withdrawal by Subject|1|||
163911286|NCT02379078|592045599|FG000|Overall Study|Lost to Follow-up|33|||
163911287|NCT02379078|592045600|FG001|Overall Study|Lost to Follow-up|30|||
163911288|NCT02379078|592045599|FG000|Overall Study|Withdrawal by Subject|6|||
163911289|NCT02379078|592045600|FG001|Overall Study|Withdrawal by Subject|5|||
163911290|NCT03481725|592045601|FG000|Overall Study|Withdrawal by Subject|1|||
163911291|NCT03481725|592045602|FG001|Overall Study|Withdrawal by Subject|0|||
163911292|NCT00244751|592045603|FG000|Overall Study|Adverse Event|7|||
164096228|NCT01030965|592715901|FG000|Overall Study|Withdrawal by Subject|0|||
164096229|NCT01030965|592715902|FG001|Overall Study|Withdrawal by Subject|1|||
164096230|NCT01030965|592715903|FG002|Overall Study|Withdrawal by Subject|0|||
164096231|NCT01030965|592715904|FG003|Overall Study|Withdrawal by Subject|2|||
164096232|NCT02097290|592715905|FG000|Overall Study|Death|6|||
164096233|NCT02097290|592715905|FG000|Overall Study|Total Withdrawals|3|||
164096234|NCT02097290|592715905|FG000|Overall Study|Attempt|8|||
163911293|NCT00244751|592045604|FG001|Overall Study|Adverse Event|7|||
163911294|NCT00244751|592045605|FG002|Overall Study|Adverse Event|5|||
163911295|NCT00244751|592045603|FG000|Overall Study|Lost to Follow-up|0|||
163911296|NCT00244751|592045604|FG001|Overall Study|Lost to Follow-up|1|||
163911297|NCT00244751|592045605|FG002|Overall Study|Lost to Follow-up|0|||
163911298|NCT00244751|592045603|FG000|Overall Study|Protocol Violation|1|||
163911299|NCT00244751|592045604|FG001|Overall Study|Protocol Violation|0|||
163911300|NCT00244751|592045605|FG002|Overall Study|Protocol Violation|1|||
163911301|NCT00244751|592045603|FG000|Overall Study|Withdrawal by Subject|7|||
163911302|NCT00244751|592045604|FG001|Overall Study|Withdrawal by Subject|5|||
163911303|NCT00244751|592045605|FG002|Overall Study|Withdrawal by Subject|3|||
164026805|NCT05168813|592458925|FG003|Part A (Open-label)|Lost to Follow-up|26|||
164026806|NCT05168813|592458926|FG004|Part A (Open-label)|Lost to Follow-up|0|||
164026807|NCT05168813|592458927|FG005|Part A (Open-label)|Lost to Follow-up|0|||
164026808|NCT05168813|592458922|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
164026809|NCT05168813|592458923|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
164026810|NCT05168813|592458924|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
163911304|NCT00244751|592045603|FG000|Overall Study|Elevated liver enzymes|1|||
163911305|NCT00244751|592045604|FG001|Overall Study|Elevated liver enzymes|0|||
163911306|NCT00244751|592045605|FG002|Overall Study|Elevated liver enzymes|0|||
163911307|NCT00244751|592045603|FG000|Overall Study|Lack of compliance with protocol|0|||
163911308|NCT00244751|592045604|FG001|Overall Study|Lack of compliance with protocol|1|||
163911309|NCT00244751|592045605|FG002|Overall Study|Lack of compliance with protocol|0|||
163911310|NCT00244751|592045603|FG000|Overall Study|Safety reasons|0|||
163911311|NCT00244751|592045604|FG001|Overall Study|Safety reasons|1|||
163911312|NCT00244751|592045605|FG002|Overall Study|Safety reasons|0|||
163911313|NCT00244751|592045603|FG000|Overall Study|Participant randomized by mistake|0|||
163911314|NCT00244751|592045604|FG001|Overall Study|Participant randomized by mistake|0|||
163911315|NCT00244751|592045605|FG002|Overall Study|Participant randomized by mistake|1|||
163911316|NCT02077374|592045606|FG000|Overall Study|Withdrawal by Subject|0|||
163911317|NCT02077374|592045607|FG001|Overall Study|Withdrawal by Subject|1|||
163911318|NCT02077374|592045606|FG000|Overall Study|Protocol Violation|0|||
163911319|NCT02077374|592045607|FG001|Overall Study|Protocol Violation|1|||
163911320|NCT01777932|592045608|FG000|Overall Study|Disease progression|136|||
163911321|NCT01777932|592045608|FG000|Overall Study|Death|3|||
163911322|NCT01777932|592045608|FG000|Overall Study|Adverse Event|34|||
163911323|NCT01777932|592045608|FG000|Overall Study|Lost to Follow-up|3|||
163911324|NCT01777932|592045608|FG000|Overall Study|Investigator decision|10|||
163911325|NCT01777932|592045608|FG000|Overall Study|Reimbursement limit|9|||
163911326|NCT01777932|592045608|FG000|Overall Study|Patient refused further treatment|10|||
163911327|NCT00068107|592045612|FG000|Overall Study|end-stage renal disease|6|||
163911328|NCT00068107|592045612|FG000|Overall Study|Death|2|||
163911329|NCT00068107|592045612|FG000|Overall Study|Withdrawal by Subject|1|||
163911330|NCT03989232|592045613|FG000|Overall Study|Lost to Follow-up|3|||
163911331|NCT03989232|592045614|FG001|Overall Study|Lost to Follow-up|10|||
163911332|NCT03989232|592045613|FG000|Overall Study|Withdrawal by Subject|6|||
163911333|NCT03989232|592045614|FG001|Overall Study|Withdrawal by Subject|6|||
163911334|NCT03989232|592045613|FG000|Overall Study|Death|1|||
163911335|NCT03989232|592045614|FG001|Overall Study|Death|2|||
163911336|NCT01930188|592045615|FG000|Overall Study|unclassified|4|||
163911337|NCT01930188|592045616|FG001|Overall Study|unclassified|5|||
163911338|NCT01930188|592045617|FG002|Overall Study|unclassified|3|||
163911339|NCT01930188|592045615|FG000|Overall Study|Missing follow-up information|2|||
163911340|NCT01930188|592045616|FG001|Overall Study|Missing follow-up information|2|||
163911341|NCT01930188|592045617|FG002|Overall Study|Missing follow-up information|3|||
163911342|NCT01930188|592045615|FG000|Overall Study|Lost to Follow-up|5|||
163911343|NCT01930188|592045616|FG001|Overall Study|Lost to Follow-up|2|||
163911344|NCT01930188|592045617|FG002|Overall Study|Lost to Follow-up|2|||
164096235|NCT03991494|592715910|FG000|Overall Study|Progressive Disease|4|||
163911345|NCT01930188|592045615|FG000|Overall Study|Death|2|||
163911346|NCT01930188|592045616|FG001|Overall Study|Death|1|||
163911347|NCT01930188|592045617|FG002|Overall Study|Death|3|||
163911348|NCT01930188|592045615|FG000|Overall Study|Withdrawal by Subject|9|||
163911349|NCT01930188|592045616|FG001|Overall Study|Withdrawal by Subject|11|||
163911350|NCT01930188|592045617|FG002|Overall Study|Withdrawal by Subject|8|||
163911351|NCT02170207|592045618|FG000|Overall Study|Case report forms unavailable|5|||
164026811|NCT05168813|592458925|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
164026812|NCT05168813|592458926|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
164026813|NCT05168813|592458927|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
163911352|NCT00657709|592045619|FG000|Overall Study|AE or Death|7|||
163911353|NCT00657709|592045620|FG001|Overall Study|AE or Death|7|||
163911354|NCT00657709|592045621|FG002|Overall Study|AE or Death|6|||
163911355|NCT00657709|592045622|FG003|Overall Study|AE or Death|7|||
163911356|NCT00657709|592045623|FG004|Overall Study|AE or Death|1|||
163911357|NCT00657709|592045619|FG000|Overall Study|Withdrawal by Subject|7|||
163911358|NCT00657709|592045620|FG001|Overall Study|Withdrawal by Subject|15|||
163911359|NCT00657709|592045621|FG002|Overall Study|Withdrawal by Subject|15|||
163911360|NCT00657709|592045622|FG003|Overall Study|Withdrawal by Subject|5|||
163911361|NCT00657709|592045623|FG004|Overall Study|Withdrawal by Subject|9|||
163911362|NCT00657709|592045619|FG000|Overall Study|Lost to Follow-up|9|||
163911363|NCT00657709|592045620|FG001|Overall Study|Lost to Follow-up|9|||
163911364|NCT00657709|592045621|FG002|Overall Study|Lost to Follow-up|7|||
163911365|NCT00657709|592045622|FG003|Overall Study|Lost to Follow-up|1|||
163911366|NCT00657709|592045623|FG004|Overall Study|Lost to Follow-up|21|||
163911367|NCT00657709|592045619|FG000|Overall Study|Protocol Violation|0|||
163911368|NCT00657709|592045620|FG001|Overall Study|Protocol Violation|2|||
163911369|NCT00657709|592045621|FG002|Overall Study|Protocol Violation|0|||
163911370|NCT00657709|592045622|FG003|Overall Study|Protocol Violation|1|||
163911371|NCT00657709|592045623|FG004|Overall Study|Protocol Violation|2|||
163911372|NCT03122860|592045624|FG000|Overall Study|Discontinued Before Treatment|1|||
163911373|NCT03122860|592045625|FG001|Overall Study|Discontinued Before Treatment|1|||
163911374|NCT03122860|592045626|FG002|Overall Study|Discontinued Before Treatment|2|||
163911375|NCT03122860|592045627|FG003|Overall Study|Discontinued Before Treatment|0|||
163911376|NCT03122860|592045628|FG004|Overall Study|Discontinued Before Treatment|1|||
163911377|NCT03122860|592045629|FG005|Overall Study|Discontinued Before Treatment|0|||
163911378|NCT03122860|592045624|FG000|Overall Study|Adverse Event|1|||
163911379|NCT03122860|592045625|FG001|Overall Study|Adverse Event|0|||
163911380|NCT03122860|592045626|FG002|Overall Study|Adverse Event|1|||
163911381|NCT03122860|592045627|FG003|Overall Study|Adverse Event|1|||
163911382|NCT03122860|592045628|FG004|Overall Study|Adverse Event|0|||
163911383|NCT03122860|592045629|FG005|Overall Study|Adverse Event|0|||
163911384|NCT03122860|592045624|FG000|Overall Study|Lost to Follow-up|5|||
163911385|NCT03122860|592045625|FG001|Overall Study|Lost to Follow-up|2|||
163911386|NCT03122860|592045626|FG002|Overall Study|Lost to Follow-up|3|||
163911387|NCT03122860|592045627|FG003|Overall Study|Lost to Follow-up|3|||
163911388|NCT03122860|592045628|FG004|Overall Study|Lost to Follow-up|5|||
163911389|NCT03122860|592045629|FG005|Overall Study|Lost to Follow-up|4|||
163911390|NCT03122860|592045624|FG000|Overall Study|Subject Non-Compliance|0|||
163911391|NCT03122860|592045625|FG001|Overall Study|Subject Non-Compliance|0|||
163911392|NCT03122860|592045626|FG002|Overall Study|Subject Non-Compliance|1|||
163911393|NCT03122860|592045627|FG003|Overall Study|Subject Non-Compliance|0|||
163911394|NCT03122860|592045628|FG004|Overall Study|Subject Non-Compliance|0|||
163911395|NCT03122860|592045629|FG005|Overall Study|Subject Non-Compliance|0|||
163911396|NCT03122860|592045624|FG000|Overall Study|Withdrawal by Subject|3|||
163911397|NCT03122860|592045625|FG001|Overall Study|Withdrawal by Subject|2|||
163911398|NCT03122860|592045626|FG002|Overall Study|Withdrawal by Subject|5|||
163911399|NCT03122860|592045627|FG003|Overall Study|Withdrawal by Subject|7|||
163911400|NCT03122860|592045628|FG004|Overall Study|Withdrawal by Subject|9|||
163911401|NCT03122860|592045629|FG005|Overall Study|Withdrawal by Subject|8|||
163911402|NCT01138657|592045630|FG000|Overall Study|Adverse Event|3|||
163911403|NCT01138657|592045631|FG001|Overall Study|Adverse Event|10|||
163911404|NCT01138657|592045630|FG000|Overall Study|Lack of Efficacy|2|||
163911405|NCT01138657|592045631|FG001|Overall Study|Lack of Efficacy|1|||
163911406|NCT01138657|592045630|FG000|Overall Study|Lost to Follow-up|0|||
163911407|NCT01138657|592045631|FG001|Overall Study|Lost to Follow-up|3|||
163911408|NCT01138657|592045630|FG000|Overall Study|Miscellaneous Reasons|3|||
163911409|NCT01138657|592045631|FG001|Overall Study|Miscellaneous Reasons|4|||
163911410|NCT02574286|592045632|FG000|Overall Study|Adverse Event|3|||
163911411|NCT02574286|592045632|FG000|Overall Study|Withdrawal by Subject|2|||
163911412|NCT02399449|592045635|FG000|Overall Study|Withdrawal by Subject|3|||
163911413|NCT02399449|592045636|FG001|Overall Study|Withdrawal by Subject|9|||
163911414|NCT02399449|592045635|FG000|Overall Study|Physician Decision|0|||
163911415|NCT02399449|592045636|FG001|Overall Study|Physician Decision|1|||
163911416|NCT01020435|592045637|FG000|Overall Study|Lost to Follow-up|0|||
163911417|NCT01020435|592045638|FG001|Overall Study|Lost to Follow-up|1|||
163911418|NCT00346398|592045639|FG000|Overall Study|Lost to Follow-up|3|||
163911419|NCT00346398|592045640|FG001|Overall Study|Lost to Follow-up|0|||
163911420|NCT00346398|592045639|FG000|Overall Study|Withdrawal by Subject|0|||
163911421|NCT00346398|592045640|FG001|Overall Study|Withdrawal by Subject|2|||
163911422|NCT02607956|592045641|FG000|Double-Blinded Phase|Withdrew Consent|17|||
164026814|NCT05168813|592458922|FG000|Part A (Open-label)|Death|23|||
163911423|NCT02607956|592045642|FG001|Double-Blinded Phase|Withdrew Consent|19|||
163911424|NCT02607956|592045643|FG002|Double-Blinded Phase|Withdrew Consent|0|||
163911425|NCT02607956|592045644|FG003|Double-Blinded Phase|Withdrew Consent|0|||
163911426|NCT02607956|592045641|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
163911427|NCT02607956|592045642|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
163911428|NCT02607956|592045643|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
163911429|NCT02607956|592045644|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
163911430|NCT02607956|592045641|FG000|Double-Blinded Phase|Randomized but never treated|7|||
163911431|NCT02607956|592045642|FG001|Double-Blinded Phase|Randomized but never treated|5|||
163911432|NCT02607956|592045643|FG002|Double-Blinded Phase|Randomized but never treated|0|||
163911433|NCT02607956|592045644|FG003|Double-Blinded Phase|Randomized but never treated|0|||
163911434|NCT02607956|592045641|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
163911435|NCT02607956|592045642|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
163911436|NCT02607956|592045643|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
163911437|NCT02607956|592045644|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
163911438|NCT02607956|592045641|FG000|Double-Blinded Phase|Death|4|||
163911439|NCT02607956|592045642|FG001|Double-Blinded Phase|Death|4|||
163911440|NCT02607956|592045643|FG002|Double-Blinded Phase|Death|0|||
163911441|NCT02607956|592045644|FG003|Double-Blinded Phase|Death|0|||
163911442|NCT02607956|592045641|FG000|Double-Blinded Phase|Adverse Event|4|||
163911443|NCT02607956|592045642|FG001|Double-Blinded Phase|Adverse Event|3|||
163911444|NCT02607956|592045643|FG002|Double-Blinded Phase|Adverse Event|0|||
163911445|NCT02607956|592045644|FG003|Double-Blinded Phase|Adverse Event|0|||
163911446|NCT02607956|592045641|FG000|Double-Blinded Phase|Protocol Violation|3|||
163911447|NCT02607956|592045642|FG001|Double-Blinded Phase|Protocol Violation|1|||
163911448|NCT02607956|592045643|FG002|Double-Blinded Phase|Protocol Violation|0|||
163911449|NCT02607956|592045644|FG003|Double-Blinded Phase|Protocol Violation|0|||
163911450|NCT02607956|592045641|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
163911451|NCT02607956|592045642|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
163911452|NCT02607956|592045643|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
163911453|NCT02607956|592045644|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
163911454|NCT02607956|592045641|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
163911455|NCT02607956|592045642|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
163911456|NCT02607956|592045643|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
163911457|NCT02607956|592045644|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
163911458|NCT02607956|592045641|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163911459|NCT02607956|592045642|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
163911460|NCT02607956|592045643|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
163911461|NCT02607956|592045644|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
163911462|NCT02607956|592045641|FG000|Open-Label Extension Phase|Death|0|||
163911463|NCT02607956|592045642|FG001|Open-Label Extension Phase|Death|0|||
163911464|NCT02607956|592045643|FG002|Open-Label Extension Phase|Death|1|||
163911465|NCT02607956|592045644|FG003|Open-Label Extension Phase|Death|3|||
163911466|NCT02607956|592045641|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
163911467|NCT02607956|592045642|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
163911468|NCT02607956|592045643|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
163911469|NCT02607956|592045644|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
163911470|NCT02607956|592045641|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
163911471|NCT02607956|592045642|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
163911472|NCT02607956|592045643|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
163911473|NCT02607956|592045644|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
163911474|NCT02607956|592045641|FG000|Open-Label Extension Phase|Protocol Violation|0|||
163911475|NCT02607956|592045642|FG001|Open-Label Extension Phase|Protocol Violation|0|||
163911476|NCT02607956|592045643|FG002|Open-Label Extension Phase|Protocol Violation|0|||
163911477|NCT02607956|592045644|FG003|Open-Label Extension Phase|Protocol Violation|2|||
163911478|NCT02607956|592045641|FG000|Open-Label Extension Phase|Pregnancy|0|||
163911479|NCT02607956|592045642|FG001|Open-Label Extension Phase|Pregnancy|0|||
163911480|NCT02607956|592045643|FG002|Open-Label Extension Phase|Pregnancy|0|||
163911481|NCT02607956|592045644|FG003|Open-Label Extension Phase|Pregnancy|1|||
163911482|NCT00090519|592045651|FG000|Overall Study|Adverse Event|5|||
164026815|NCT05168813|592458923|FG001|Part A (Open-label)|Death|28|||
164026816|NCT05168813|592458924|FG002|Part A (Open-label)|Death|1|||
164026817|NCT05168813|592458925|FG003|Part A (Open-label)|Death|9|||
164026818|NCT05168813|592458926|FG004|Part A (Open-label)|Death|0|||
164026819|NCT05168813|592458927|FG005|Part A (Open-label)|Death|0|||
164026820|NCT05168813|592458922|FG000|Part A (Open-label)|Physician Decision|0|||
163911483|NCT00090519|592045652|FG001|Overall Study|Adverse Event|4|||
163911484|NCT00090519|592045651|FG000|Overall Study|Death|9|||
163911485|NCT00090519|592045652|FG001|Overall Study|Death|9|||
163911486|NCT00090519|592045651|FG000|Overall Study|Lost to Follow-up|26|||
163911487|NCT00090519|592045652|FG001|Overall Study|Lost to Follow-up|29|||
163911488|NCT00090519|592045651|FG000|Overall Study|Withdrawal by Subject|28|||
164026821|NCT05168813|592458923|FG001|Part A (Open-label)|Physician Decision|1|||
164026822|NCT05168813|592458924|FG002|Part A (Open-label)|Physician Decision|0|||
163911489|NCT00090519|592045652|FG001|Overall Study|Withdrawal by Subject|29|||
163911490|NCT00090519|592045651|FG000|Overall Study|Physician Decision|2|||
163911491|NCT00090519|592045652|FG001|Overall Study|Physician Decision|3|||
163911492|NCT00090519|592045651|FG000|Overall Study|Sponsor Decision|3|||
163911493|NCT00090519|592045652|FG001|Overall Study|Sponsor Decision|1|||
163911494|NCT00960206|592045653|FG000|Overall Study|Death|7|||
163911495|NCT00960206|592045654|FG001|Overall Study|Death|4|||
163911496|NCT00960206|592045655|FG002|Overall Study|Death|1|||
163911497|NCT00960206|592045653|FG000|Overall Study|Unwilling/Unable to return|1|||
163911498|NCT00960206|592045654|FG001|Overall Study|Unwilling/Unable to return|2|||
163911499|NCT00960206|592045655|FG002|Overall Study|Unwilling/Unable to return|0|||
163911500|NCT00960206|592045653|FG000|Overall Study|Lost to Follow-up|8|||
163911501|NCT00960206|592045654|FG001|Overall Study|Lost to Follow-up|14|||
163911502|NCT00960206|592045655|FG002|Overall Study|Lost to Follow-up|8|||
163911503|NCT00960206|592045653|FG000|Overall Study|Withdrawal by Subject|2|||
163911504|NCT00960206|592045654|FG001|Overall Study|Withdrawal by Subject|4|||
163911505|NCT00960206|592045655|FG002|Overall Study|Withdrawal by Subject|0|||
163911506|NCT00960206|592045653|FG000|Overall Study|Revision of study component|2|||
163911507|NCT00960206|592045654|FG001|Overall Study|Revision of study component|2|||
163911508|NCT00960206|592045655|FG002|Overall Study|Revision of study component|2|||
163911509|NCT00960206|592045653|FG000|Overall Study|Missing 10 year data|20|||
163911510|NCT00960206|592045654|FG001|Overall Study|Missing 10 year data|1|||
163911511|NCT00960206|592045655|FG002|Overall Study|Missing 10 year data|1|||
163911512|NCT01240590|592045658|FG000|Phase I|Refused further treatment|0|||
163911513|NCT01240590|592045659|FG001|Phase I|Refused further treatment|0|||
163911514|NCT01240590|592045660|FG002|Phase I|Refused further treatment|3|||
163911515|NCT01240590|592045661|FG003|Phase I|Refused further treatment|0|||
163911516|NCT01240590|592045662|FG004|Phase I|Refused further treatment|0|||
163911517|NCT01240590|592045658|FG000|Phase II|Refused further treatment|0|||
163911518|NCT01240590|592045659|FG001|Phase II|Refused further treatment|0|||
163911519|NCT01240590|592045660|FG002|Phase II|Refused further treatment|0|||
163911520|NCT01240590|592045661|FG003|Phase II|Refused further treatment|2|||
163911521|NCT01240590|592045662|FG004|Phase II|Refused further treatment|1|||
163911522|NCT02548585|592045665|FG000|Overall Study|Withdrawal by Subject|0|||
163911523|NCT02548585|592045666|FG001|Overall Study|Withdrawal by Subject|0|||
163911524|NCT02548585|592045667|FG002|Overall Study|Withdrawal by Subject|0|||
163911525|NCT02548585|592045668|FG003|Overall Study|Withdrawal by Subject|0|||
163911526|NCT02548585|592045669|FG004|Overall Study|Withdrawal by Subject|0|||
163911527|NCT02548585|592045670|FG005|Overall Study|Withdrawal by Subject|1|||
163911528|NCT02548585|592045671|FG006|Overall Study|Withdrawal by Subject|0|||
163911529|NCT02548585|592045665|FG000|Overall Study|Lost to Follow-up|1|||
163911530|NCT02548585|592045666|FG001|Overall Study|Lost to Follow-up|0|||
163911531|NCT02548585|592045667|FG002|Overall Study|Lost to Follow-up|0|||
163911532|NCT02548585|592045668|FG003|Overall Study|Lost to Follow-up|0|||
163911533|NCT02548585|592045669|FG004|Overall Study|Lost to Follow-up|0|||
164096236|NCT05277389|592715911|FG000|Overall Study|Lost to Follow-up|1|||
164096237|NCT05277389|592715912|FG001|Overall Study|Lost to Follow-up|4|||
164096238|NCT03144687|592715913|FG000|Overall Study|Death|0|||
163911534|NCT02548585|592045670|FG005|Overall Study|Lost to Follow-up|0|||
163911535|NCT02548585|592045671|FG006|Overall Study|Lost to Follow-up|0|||
163911536|NCT02548585|592045665|FG000|Overall Study|Other|1|||
163911537|NCT02548585|592045666|FG001|Overall Study|Other|0|||
163911538|NCT02548585|592045667|FG002|Overall Study|Other|0|||
164096239|NCT03144687|592715914|FG001|Overall Study|Death|2|||
164096240|NCT03144687|592715913|FG000|Overall Study|Lost to Follow-up|0|||
163911539|NCT02548585|592045668|FG003|Overall Study|Other|2|||
163911540|NCT02548585|592045669|FG004|Overall Study|Other|3|||
163911541|NCT02548585|592045670|FG005|Overall Study|Other|0|||
163911542|NCT02548585|592045671|FG006|Overall Study|Other|1|||
163911543|NCT02548585|592045665|FG000|Overall Study|Randomized but not treated|0|||
163911544|NCT02548585|592045666|FG001|Overall Study|Randomized but not treated|0|||
163911545|NCT02548585|592045667|FG002|Overall Study|Randomized but not treated|0|||
164096241|NCT03144687|592715914|FG001|Overall Study|Lost to Follow-up|1|||
163911546|NCT02548585|592045668|FG003|Overall Study|Randomized but not treated|0|||
163911547|NCT02548585|592045669|FG004|Overall Study|Randomized but not treated|0|||
163911548|NCT02548585|592045670|FG005|Overall Study|Randomized but not treated|1|||
163911549|NCT02548585|592045671|FG006|Overall Study|Randomized but not treated|0|||
163911550|NCT01075152|592045672|FG000|Overall Study|Withdrawal by Subject|1|||
163911551|NCT01075152|592045673|FG001|Overall Study|Withdrawal by Subject|0|||
163911552|NCT03659136|592045680|FG000|Overall Study|Not treated|2|||
163911553|NCT03659136|592045681|FG001|Overall Study|Not treated|0|||
163911554|NCT03659136|592045680|FG000|Overall Study|Covid-19 related|1|||
163911555|NCT03659136|592045681|FG001|Overall Study|Covid-19 related|1|||
163911556|NCT03659136|592045680|FG000|Overall Study|Withdrawal by Subject|1|||
163911557|NCT03659136|592045681|FG001|Overall Study|Withdrawal by Subject|6|||
163911558|NCT03659136|592045680|FG000|Overall Study|Adverse Event|4|||
163911559|NCT03659136|592045681|FG001|Overall Study|Adverse Event|6|||
163911560|NCT03659136|592045680|FG000|Overall Study|Progressive disease|37|||
163911561|NCT03659136|592045681|FG001|Overall Study|Progressive disease|31|||
163911562|NCT03659136|592045680|FG000|Overall Study|Study closure|2|||
163911563|NCT03659136|592045681|FG001|Overall Study|Study closure|2|||
163911564|NCT03659136|592045680|FG000|Overall Study|Sponsor decision/recommendation|3|||
163911565|NCT03659136|592045681|FG001|Overall Study|Sponsor decision/recommendation|2|||
163911566|NCT03659136|592045680|FG000|Overall Study|Switched to other drug/therapy|2|||
163911567|NCT03659136|592045681|FG001|Overall Study|Switched to other drug/therapy|2|||
163911568|NCT03659136|592045680|FG000|Overall Study|Lack of clinical benefit|0|||
163911569|NCT03659136|592045681|FG001|Overall Study|Lack of clinical benefit|1|||
163911570|NCT05066230|592047184|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
163911571|NCT05066230|592047185|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
163911572|NCT05066230|592047184|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
163911573|NCT05066230|592047185|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
163911574|NCT05066230|592047184|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
163911575|NCT05066230|592047185|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
163911576|NCT05066230|592047184|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
163911577|NCT05066230|592047185|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
163911578|NCT05066230|592047184|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
163911579|NCT05066230|592047185|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
163911580|NCT05066230|592047184|FG000|After Week 48|Adverse Event|1|||
163911581|NCT05066230|592047185|FG001|After Week 48|Adverse Event|0|||
163911582|NCT05066230|592047184|FG000|After Week 48|Non-compliance with study schedule|1|||
163911583|NCT05066230|592047185|FG001|After Week 48|Non-compliance with study schedule|0|||
163911584|NCT05066230|592047184|FG000|After Week 48|Withdrawal by Subject|0|||
163911585|NCT05066230|592047185|FG001|After Week 48|Withdrawal by Subject|1|||
163911586|NCT05066230|592047184|FG000|After Week 48|Lost to Follow-up|3|||
163911587|NCT05066230|592047185|FG001|After Week 48|Lost to Follow-up|3|||
163911588|NCT05066230|592047184|FG000|After Week 48|Sponsor Request|115|||
163911589|NCT05066230|592047185|FG001|After Week 48|Sponsor Request|111|||
163911590|NCT00307489|592047186|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
163911591|NCT00307489|592047187|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
163911592|NCT00307489|592047186|FG000|Baseline Through Week 48|Physician Decision|1|||
164026823|NCT05168813|592458925|FG003|Part A (Open-label)|Physician Decision|2|||
164026824|NCT05168813|592458926|FG004|Part A (Open-label)|Physician Decision|0|||
164026825|NCT05168813|592458927|FG005|Part A (Open-label)|Physician Decision|0|||
164026826|NCT05168813|592458922|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
164026827|NCT05168813|592458923|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
164026828|NCT05168813|592458924|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
164026829|NCT05168813|592458925|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
164026830|NCT05168813|592458926|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
164026831|NCT05168813|592458927|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
164026832|NCT05168813|592458922|FG000|Part A (Open-label)|Protocol Violation|0|||
164026833|NCT05168813|592458923|FG001|Part A (Open-label)|Protocol Violation|1|||
164026834|NCT05168813|592458924|FG002|Part A (Open-label)|Protocol Violation|0|||
164026835|NCT05168813|592458925|FG003|Part A (Open-label)|Protocol Violation|0|||
164026836|NCT05168813|592458926|FG004|Part A (Open-label)|Protocol Violation|0|||
164026837|NCT05168813|592458927|FG005|Part A (Open-label)|Protocol Violation|0|||
164026838|NCT05168813|592458922|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
164026839|NCT05168813|592458923|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
163911593|NCT00307489|592047187|FG001|Baseline Through Week 48|Physician Decision|0|||
164026840|NCT05168813|592458924|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
163911594|NCT00307489|592047186|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
163911595|NCT00307489|592047187|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
163911596|NCT00307489|592047186|FG000|Week 48 Through Week 168|Adverse Event|1|||
163911597|NCT00307489|592047187|FG001|Week 48 Through Week 168|Adverse Event|0|||
163911598|NCT00307489|592047186|FG000|Week 48 Through Week 168|Physician Decision|1|||
163911599|NCT00307489|592047187|FG001|Week 48 Through Week 168|Physician Decision|0|||
163911600|NCT00307489|592047186|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
163911601|NCT00307489|592047187|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
163911602|NCT00307489|592047186|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
163911603|NCT00307489|592047187|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
163911604|NCT00307489|592047186|FG000|Week 48 Through Week 168|Death|0|||
163911605|NCT00307489|592047187|FG001|Week 48 Through Week 168|Death|1|||
163911606|NCT00307489|592047186|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
163911607|NCT00307489|592047187|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
163911608|NCT00307489|592047186|FG000|Week 48 Through Week 168|Seroconversion|1|||
163911609|NCT00307489|592047187|FG001|Week 48 Through Week 168|Seroconversion|0|||
163911610|NCT04425252|592047188|FG000|Overall Study|Withdrawal by Subject|2|||
163911611|NCT04425252|592047189|FG001|Overall Study|Withdrawal by Subject|1|||
163911612|NCT04425252|592047188|FG000|Overall Study|Lost to Follow-up|1|||
163911613|NCT04425252|592047189|FG001|Overall Study|Lost to Follow-up|0|||
163911614|NCT04425252|592047188|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
163911615|NCT04425252|592047189|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
163911616|NCT02981953|592047190|FG000|Overall Study|Death|9|||
163911617|NCT02981953|592047190|FG000|Overall Study|Withdrawal by Subject|1|||
163911618|NCT02981953|592047190|FG000|Overall Study|Withdrawal to non-compliance|1|||
163911619|NCT02165202|592047195|FG000|Oral Phase|Refused further participation|5|||
163911620|NCT02165202|592047196|FG001|Oral Phase|Refused further participation|1|||
163911621|NCT02165202|592047195|FG000|Oral Phase|Study product Related Toxicity|1|||
163911622|NCT02165202|592047196|FG001|Oral Phase|Study product Related Toxicity|0|||
163911623|NCT02165202|592047195|FG000|Oral Phase|Unable to contact Participant|1|||
163911624|NCT02165202|592047196|FG001|Oral Phase|Unable to contact Participant|1|||
163911625|NCT02165202|592047195|FG000|Oral Phase|Clinical reasons|1|||
163911626|NCT02165202|592047196|FG001|Oral Phase|Clinical reasons|0|||
163911627|NCT02165202|592047195|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
163911628|NCT02165202|592047196|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
163911629|NCT02165202|592047195|FG000|Oral Phase|CMC advised termination|1|||
163911630|NCT02165202|592047196|FG001|Oral Phase|CMC advised termination|0|||
163911631|NCT02165202|592047195|FG000|Oral Phase|Relocated, no follow-up planned|1|||
163911632|NCT02165202|592047196|FG001|Oral Phase|Relocated, no follow-up planned|0|||
163911633|NCT02165202|592047195|FG000|Oral Phase|Abnormal EKG|0|||
163911634|NCT02165202|592047196|FG001|Oral Phase|Abnormal EKG|1|||
163911635|NCT02165202|592047195|FG000|Injection Phase|Abnormal Lab Value|5|||
163911636|NCT02165202|592047196|FG001|Injection Phase|Abnormal Lab Value|1|||
163911637|NCT02165202|592047195|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
163911638|NCT02165202|592047196|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
163911639|NCT02165202|592047195|FG000|Injection Phase|Unable to attend within Visit Window|1|||
163911640|NCT02165202|592047196|FG001|Injection Phase|Unable to attend within Visit Window|0|||
163911641|NCT02165202|592047195|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
163911642|NCT02165202|592047196|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
163911643|NCT02165202|592047195|FG000|Injection Phase|End of Study|2|||
163911644|NCT02165202|592047196|FG001|Injection Phase|End of Study|1|||
163911645|NCT02165202|592047195|FG000|Injection Phase|Study Product related Toxicity|1|||
163911646|NCT02165202|592047196|FG001|Injection Phase|Study Product related Toxicity|0|||
163911647|NCT02165202|592047195|FG000|Injection Phase|No longer interested|0|||
163911648|NCT02165202|592047196|FG001|Injection Phase|No longer interested|1|||
163911649|NCT02165202|592047195|FG000|Injection Phase|Participant unwilling to comply|1|||
163911650|NCT02165202|592047196|FG001|Injection Phase|Participant unwilling to comply|0|||
163911651|NCT01655498|592047202|FG000|Overall Study|Unrelated health issue|2|||
163911652|NCT01655498|592047202|FG000|Overall Study|Protocol Violation|2|||
163911653|NCT01655498|592047202|FG000|Overall Study|Withdrawal by Subject|1|||
163911654|NCT01714947|592047205|FG000|Part B|Progressive Disease|3|||
163911655|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
163911656|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
163911657|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
163911658|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
163911659|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
163911660|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
163911661|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
163911662|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
164026841|NCT05168813|592458925|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
164026842|NCT05168813|592458926|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
164026843|NCT05168813|592458927|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
164026844|NCT05168813|592458922|FG000|Part A (Open-label)|Other|0|||
163911663|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
163911664|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
163911665|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
164026845|NCT05168813|592458923|FG001|Part A (Open-label)|Other|1|||
163911666|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
163911667|NCT01345253|592047209|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
163911668|NCT01345253|592047210|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
163911669|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
163911670|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
163911671|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
163911672|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
163911673|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
163911674|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
164026846|NCT05168813|592458924|FG002|Part A (Open-label)|Other|0|||
164026847|NCT05168813|592458925|FG003|Part A (Open-label)|Other|0|||
164026848|NCT05168813|592458926|FG004|Part A (Open-label)|Other|0|||
163911675|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
164026849|NCT05168813|592458927|FG005|Part A (Open-label)|Other|0|||
164026850|NCT05168813|592458922|FG000|Part B (Blinded)|Lost to Follow-up|0|||
164026851|NCT05168813|592458923|FG001|Part B (Blinded)|Lost to Follow-up|0|||
164026852|NCT05168813|592458924|FG002|Part B (Blinded)|Lost to Follow-up|0|||
163911676|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
163911677|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
163911678|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
163911679|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
163911680|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
163911681|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
163911682|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
163911683|NCT01345253|592047209|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
163911684|NCT01345253|592047210|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
163911685|NCT00759681|592047211|FG000|Overall Study|Death|2|||
163911686|NCT00759681|592047212|FG001|Overall Study|Death|5|||
163911687|NCT00759681|592047211|FG000|Overall Study|Lost to Follow-up|8|||
163911688|NCT00759681|592047212|FG001|Overall Study|Lost to Follow-up|5|||
163911689|NCT00930644|592047213|FG000|Overall Study|Withdrawal by Subject|4|||
163911690|NCT00930644|592047213|FG000|Overall Study|Physician Decision|2|||
163911691|NCT00930644|592047213|FG000|Overall Study|Death|1|||
163911692|NCT00930644|592047213|FG000|Overall Study|Adverse Event|16|||
163911693|NCT01012999|592047214|FG000|Overall Study|Protocol Violation|1|||
163911694|NCT02410278|592047215|FG000|Run-in Period|Adverse Event|5|||
163911695|NCT02410278|592047216|FG001|Run-in Period|Adverse Event|0|||
163911696|NCT02410278|592047217|FG002|Run-in Period|Adverse Event|0|||
163911697|NCT02410278|592047215|FG000|Run-in Period|GSRS Threshold Not Met|30|||
163911698|NCT02410278|592047216|FG001|Run-in Period|GSRS Threshold Not Met|0|||
163911699|NCT02410278|592047217|FG002|Run-in Period|GSRS Threshold Not Met|0|||
163911700|NCT02410278|592047215|FG000|Run-in Period|Lost to Follow-up|1|||
163911701|NCT02410278|592047216|FG001|Run-in Period|Lost to Follow-up|0|||
163911702|NCT02410278|592047217|FG002|Run-in Period|Lost to Follow-up|0|||
163911703|NCT02410278|592047215|FG000|Run-in Period|Withdrawal by Subject|1|||
164096242|NCT03144687|592715913|FG000|Overall Study|Physician Decision|0|||
164096243|NCT03144687|592715914|FG001|Overall Study|Physician Decision|1|||
164096244|NCT03144687|592715913|FG000|Overall Study|Withdrawal by Subject|1|||
164096245|NCT03144687|592715914|FG001|Overall Study|Withdrawal by Subject|3|||
164096246|NCT03144687|592715913|FG000|Overall Study|Not Reported|2|||
164096247|NCT03144687|592715914|FG001|Overall Study|Not Reported|0|||
164096248|NCT02514174|592715915|FG000|Overall Study|Patient refused to continue medication|1|||
164096249|NCT02514174|592715915|FG000|Overall Study|Adverse Event|2|||
164096250|NCT02514174|592715915|FG000|Overall Study|Study closed by sponsor|9|||
164096251|NCT02514174|592715915|FG000|Overall Study|Progressive disease|11|||
164096252|NCT02514174|592715915|FG000|Overall Study|Treatment change|1|||
164096253|NCT02514174|592715915|FG000|Overall Study|Treated off study with Afatinib.|1|||
164096254|NCT00824265|592715916|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
164096255|NCT00824265|592715917|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
164096256|NCT00824265|592715916|FG000|Treatment Phase|Protocol Violation|1|||
164096257|NCT00824265|592715917|FG001|Treatment Phase|Protocol Violation|0|||
163911704|NCT02410278|592047216|FG001|Run-in Period|Withdrawal by Subject|0|||
163911705|NCT02410278|592047217|FG002|Run-in Period|Withdrawal by Subject|0|||
163911706|NCT02410278|592047215|FG000|Run-in Period|Pregnancy|1|||
163911707|NCT02410278|592047216|FG001|Run-in Period|Pregnancy|0|||
163911708|NCT02410278|592047217|FG002|Run-in Period|Pregnancy|0|||
163911709|NCT02410278|592047215|FG000|Study Treatment Period|Adverse Event|0|||
163911710|NCT02410278|592047216|FG001|Study Treatment Period|Adverse Event|6|||
164096258|NCT00824265|592715916|FG000|Treatment Phase|Lost to Follow-up|1|||
164096259|NCT00824265|592715917|FG001|Treatment Phase|Lost to Follow-up|1|||
164096260|NCT00824265|592715916|FG000|Treatment Phase|Physician Decision|6|||
164096261|NCT00824265|592715917|FG001|Treatment Phase|Physician Decision|12|||
164096262|NCT00824265|592715916|FG000|Treatment Phase|Withdrawal by Subject|6|||
164096263|NCT00824265|592715917|FG001|Treatment Phase|Withdrawal by Subject|15|||
164096264|NCT00824265|592715916|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
164096265|NCT00824265|592715917|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
164096266|NCT00824265|592715916|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
164096267|NCT00824265|592715917|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
164096268|NCT02170688|592715918|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
164096269|NCT02170688|592715919|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
164096270|NCT02170688|592715920|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
163911711|NCT02410278|592047217|FG002|Study Treatment Period|Adverse Event|3|||
163911712|NCT02410278|592047215|FG000|Study Treatment Period|Physician Decision|0|||
163911713|NCT02410278|592047216|FG001|Study Treatment Period|Physician Decision|0|||
163911714|NCT02410278|592047217|FG002|Study Treatment Period|Physician Decision|1|||
163911715|NCT02410278|592047215|FG000|Study Treatment Period|Withdrawal by Subject|0|||
163911716|NCT02410278|592047216|FG001|Study Treatment Period|Withdrawal by Subject|1|||
163911717|NCT02410278|592047217|FG002|Study Treatment Period|Withdrawal by Subject|0|||
163911718|NCT02410278|592047215|FG000|Study Treatment Period|Other|0|||
163911719|NCT02410278|592047216|FG001|Study Treatment Period|Other|3|||
163911720|NCT02410278|592047217|FG002|Study Treatment Period|Other|0|||
163911721|NCT02410278|592047215|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
163911722|NCT02410278|592047216|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
163911723|NCT02410278|592047217|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
163911724|NCT02584257|592047218|FG000|Period 1|Withdrawal by Subject|0|||
163911725|NCT02584257|592047219|FG001|Period 1|Withdrawal by Subject|0|||
163911726|NCT02584257|592047220|FG002|Period 1|Withdrawal by Subject|0|||
163911727|NCT02584257|592047221|FG003|Period 1|Withdrawal by Subject|0|||
163911728|NCT02584257|592047222|FG004|Period 1|Withdrawal by Subject|0|||
163911729|NCT02584257|592047223|FG005|Period 1|Withdrawal by Subject|0|||
163911730|NCT02584257|592047224|FG006|Period 1|Withdrawal by Subject|1|||
163911731|NCT02584257|592047225|FG007|Period 1|Withdrawal by Subject|0|||
163911732|NCT02584257|592047226|FG008|Period 1|Withdrawal by Subject|0|||
163911733|NCT02584257|592047218|FG000|Period 2|Physician Decision|1|||
163911734|NCT02584257|592047219|FG001|Period 2|Physician Decision|0|||
163911735|NCT02584257|592047220|FG002|Period 2|Physician Decision|0|||
163911736|NCT02584257|592047221|FG003|Period 2|Physician Decision|0|||
163911737|NCT02584257|592047222|FG004|Period 2|Physician Decision|0|||
163911738|NCT02584257|592047223|FG005|Period 2|Physician Decision|0|||
163911739|NCT02584257|592047224|FG006|Period 2|Physician Decision|0|||
163911740|NCT02584257|592047225|FG007|Period 2|Physician Decision|0|||
163911741|NCT02584257|592047226|FG008|Period 2|Physician Decision|0|||
163911742|NCT02584257|592047218|FG000|Period 2|Adverse Event|0|||
163911743|NCT02584257|592047219|FG001|Period 2|Adverse Event|1|||
163911744|NCT02584257|592047220|FG002|Period 2|Adverse Event|0|||
163911745|NCT02584257|592047221|FG003|Period 2|Adverse Event|0|||
163911746|NCT02584257|592047222|FG004|Period 2|Adverse Event|0|||
163911747|NCT02584257|592047223|FG005|Period 2|Adverse Event|0|||
163911748|NCT02584257|592047224|FG006|Period 2|Adverse Event|0|||
163911749|NCT02584257|592047225|FG007|Period 2|Adverse Event|0|||
163911750|NCT02584257|592047226|FG008|Period 2|Adverse Event|0|||
163911751|NCT01670877|592047227|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163911752|NCT01670877|592047228|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
163911753|NCT01670877|592047229|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163911754|NCT01670877|592047230|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163911755|NCT01670877|592047231|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163911756|NCT01670877|592047232|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
163911757|NCT01670877|592047227|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163911758|NCT01670877|592047228|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
164096271|NCT02170688|592715921|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
164096272|NCT02170688|592715922|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
164096273|NCT02170688|592715918|FG000|Overall Study|Full dose not received|0|||
163911759|NCT01670877|592047229|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
163911760|NCT01670877|592047230|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163911761|NCT01670877|592047231|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163911762|NCT01670877|592047232|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
163911763|NCT01670877|592047227|FG000|Part I and Part 2|Grade 2 vomiting|0|||
163911764|NCT01670877|592047228|FG001|Part I and Part 2|Grade 2 vomiting|0|||
163911765|NCT01670877|592047229|FG002|Part I and Part 2|Grade 2 vomiting|0|||
163911766|NCT01670877|592047230|FG003|Part I and Part 2|Grade 2 vomiting|1|||
163911767|NCT01670877|592047231|FG004|Part I and Part 2|Grade 2 vomiting|0|||
163911768|NCT01670877|592047232|FG005|Part I and Part 2|Grade 2 vomiting|0|||
163911769|NCT01670877|592047227|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163911770|NCT01670877|592047228|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163911771|NCT01670877|592047229|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163911772|NCT01670877|592047230|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
163911773|NCT01670877|592047231|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163911774|NCT01670877|592047232|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
163911775|NCT01670877|592047227|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163911776|NCT01670877|592047228|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163911777|NCT01670877|592047229|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163911778|NCT01670877|592047230|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
163911779|NCT01670877|592047231|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163911780|NCT01670877|592047232|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
163911781|NCT00417885|592047233|FG000|Overall Study|Adverse Event|1|||
163911782|NCT00417885|592047233|FG000|Overall Study|Objective Progression or Relapse|3|||
163911783|NCT00417885|592047233|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
163911784|NCT02309892|592047234|FG000|Overall Study|Physician Decision|1|||
163911785|NCT02309892|592047235|FG001|Overall Study|Physician Decision|0|||
163911786|NCT02309892|592047236|FG002|Overall Study|Physician Decision|0|||
164096274|NCT02170688|592715919|FG001|Overall Study|Full dose not received|1|||
164096275|NCT02170688|592715920|FG002|Overall Study|Full dose not received|0|||
163911787|NCT02309892|592047237|FG003|Overall Study|Physician Decision|0|||
164096276|NCT02170688|592715921|FG003|Overall Study|Full dose not received|0|||
164144910|NCT05199090|592891825|FG003|Overall Study|Physician Decision|0|||
164026853|NCT05168813|592458925|FG003|Part B (Blinded)|Lost to Follow-up|0|||
164026854|NCT05168813|592458926|FG004|Part B (Blinded)|Lost to Follow-up|219|||
164026855|NCT05168813|592458927|FG005|Part B (Blinded)|Lost to Follow-up|88|||
163911788|NCT02309892|592047238|FG004|Overall Study|Physician Decision|0|||
163911789|NCT02309892|592047239|FG005|Overall Study|Physician Decision|0|||
164026856|NCT05168813|592458922|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
164026857|NCT05168813|592458923|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
163911790|NCT02309892|592047240|FG006|Overall Study|Physician Decision|0|||
164026858|NCT05168813|592458924|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
164026859|NCT05168813|592458925|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
164026860|NCT05168813|592458926|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
164026861|NCT05168813|592458927|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
164026862|NCT05168813|592458922|FG000|Part B (Blinded)|Death|0|||
164026863|NCT05168813|592458923|FG001|Part B (Blinded)|Death|0|||
164096277|NCT02170688|592715922|FG004|Overall Study|Full dose not received|0|||
164096278|NCT02170688|592715918|FG000|Overall Study|Physician Decision|0|||
164096279|NCT02170688|592715919|FG001|Overall Study|Physician Decision|0|||
164096280|NCT02170688|592715920|FG002|Overall Study|Physician Decision|1|||
164096281|NCT02170688|592715921|FG003|Overall Study|Physician Decision|0|||
164096282|NCT02170688|592715922|FG004|Overall Study|Physician Decision|0|||
164096283|NCT02079532|592715925|FG000|Overall Study|Adverse Event|7|||
164096284|NCT02079532|592715925|FG000|Overall Study|Additional or changed therapy|2|||
164096285|NCT02079532|592715925|FG000|Overall Study|Lack of Efficacy|9|||
164096286|NCT02079532|592715925|FG000|Overall Study|Protocol Violation|3|||
164096287|NCT02079532|592715925|FG000|Overall Study|Withdrawal by Subject|1|||
164096288|NCT02079532|592715925|FG000|Overall Study|Administrative problems|1|||
164096289|NCT02079532|592715925|FG000|Overall Study|Inclusion into ReFIRST|3|||
164096290|NCT02079532|592715925|FG000|Overall Study|Other|3|||
164096291|NCT02920996|592715926|FG000|Overall Study|Adverse Event|8|||
164096292|NCT02920996|592715927|FG001|Overall Study|Adverse Event|0|||
164096293|NCT02920996|592715926|FG000|Overall Study|Physician Decision|1|||
164096294|NCT02920996|592715927|FG001|Overall Study|Physician Decision|0|||
164096295|NCT02920996|592715926|FG000|Overall Study|Death|1|||
164096296|NCT02920996|592715927|FG001|Overall Study|Death|0|||
164096297|NCT02920996|592715926|FG000|Overall Study|Missing|1|||
164096298|NCT02920996|592715927|FG001|Overall Study|Missing|0|||
163911791|NCT02309892|592047234|FG000|Overall Study|Adverse Event|1|||
163911792|NCT02309892|592047235|FG001|Overall Study|Adverse Event|0|||
164096299|NCT02920996|592715926|FG000|Overall Study|Subject Non-Compliance|1|||
164096300|NCT02920996|592715927|FG001|Overall Study|Subject Non-Compliance|0|||
163911793|NCT02309892|592047236|FG002|Overall Study|Adverse Event|1|||
163911794|NCT02309892|592047237|FG003|Overall Study|Adverse Event|0|||
163911795|NCT02309892|592047238|FG004|Overall Study|Adverse Event|0|||
163911796|NCT02309892|592047239|FG005|Overall Study|Adverse Event|0|||
163911797|NCT02309892|592047240|FG006|Overall Study|Adverse Event|0|||
163911798|NCT02309892|592047234|FG000|Overall Study|Progressive Disease|0|||
164096301|NCT01402947|592715928|FG000|First Intervention|Adverse Event|0|||
164096302|NCT01402947|592715929|FG001|First Intervention|Adverse Event|1|||
164096303|NCT00591630|592715930|FG000|Overall Study|Death|0|||
163911799|NCT02309892|592047235|FG001|Overall Study|Progressive Disease|1|||
164026864|NCT05168813|592458924|FG002|Part B (Blinded)|Death|0|||
164026865|NCT05168813|592458925|FG003|Part B (Blinded)|Death|0|||
164026866|NCT05168813|592458926|FG004|Part B (Blinded)|Death|63|||
164026867|NCT05168813|592458927|FG005|Part B (Blinded)|Death|19|||
164026868|NCT05168813|592458922|FG000|Part B (Blinded)|Physician Decision|0|||
164026869|NCT05168813|592458923|FG001|Part B (Blinded)|Physician Decision|0|||
164026870|NCT05168813|592458924|FG002|Part B (Blinded)|Physician Decision|0|||
164026871|NCT05168813|592458925|FG003|Part B (Blinded)|Physician Decision|0|||
164026872|NCT05168813|592458926|FG004|Part B (Blinded)|Physician Decision|6|||
164026873|NCT05168813|592458927|FG005|Part B (Blinded)|Physician Decision|1|||
164026874|NCT05168813|592458922|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164026875|NCT05168813|592458923|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164026876|NCT05168813|592458924|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164026877|NCT05168813|592458925|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
164026878|NCT05168813|592458926|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
164026879|NCT05168813|592458927|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
164026880|NCT05168813|592458922|FG000|Part B (Blinded)|Pregnancy|0|||
164026881|NCT05168813|592458923|FG001|Part B (Blinded)|Pregnancy|0|||
164026882|NCT05168813|592458924|FG002|Part B (Blinded)|Pregnancy|0|||
164026883|NCT05168813|592458925|FG003|Part B (Blinded)|Pregnancy|0|||
164026884|NCT05168813|592458926|FG004|Part B (Blinded)|Pregnancy|1|||
164026885|NCT05168813|592458927|FG005|Part B (Blinded)|Pregnancy|0|||
164026886|NCT05168813|592458922|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
164096304|NCT00591630|592715931|FG001|Overall Study|Death|0|||
164026887|NCT05168813|592458923|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
164026888|NCT05168813|592458924|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
164026889|NCT05168813|592458925|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
164026890|NCT05168813|592458926|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
164026891|NCT05168813|592458927|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
164026892|NCT05168813|592458922|FG000|Part B (Blinded)|Other|0|||
164026893|NCT05168813|592458923|FG001|Part B (Blinded)|Other|0|||
164026894|NCT05168813|592458924|FG002|Part B (Blinded)|Other|0|||
164026895|NCT05168813|592458925|FG003|Part B (Blinded)|Other|0|||
164026896|NCT05168813|592458926|FG004|Part B (Blinded)|Other|41|||
164026897|NCT05168813|592458927|FG005|Part B (Blinded)|Other|27|||
164026898|NCT02492997|592458929|FG000|Overall Study|Withdrawal by Subject|1|||
164096305|NCT00591630|592715932|FG002|Overall Study|Death|1|||
163911800|NCT02309892|592047236|FG002|Overall Study|Progressive Disease|0|||
164026899|NCT02492997|592458930|FG001|Overall Study|Withdrawal by Subject|0|||
164026900|NCT02492997|592458929|FG000|Overall Study|Gained Weight|1|||
164026901|NCT02492997|592458930|FG001|Overall Study|Gained Weight|0|||
164026902|NCT02492997|592458929|FG000|Overall Study|Lost to Follow-up|0|||
164026903|NCT02492997|592458930|FG001|Overall Study|Lost to Follow-up|1|||
163911801|NCT02309892|592047237|FG003|Overall Study|Progressive Disease|0|||
164026904|NCT01089582|592458931|FG000|Overall Study|Death|2|||
164026905|NCT01089582|592458931|FG000|Overall Study|Adverse Event|15|||
164096306|NCT00591630|592715933|FG003|Overall Study|Death|0|||
164096307|NCT01471522|592715937|FG000|Overall Study|Withdrawal by Subject|28|||
163911802|NCT02309892|592047238|FG004|Overall Study|Progressive Disease|1|||
164026906|NCT01089582|592458931|FG000|Overall Study|Lost to Follow-up|8|||
164026907|NCT01089582|592458931|FG000|Overall Study|Other|4|||
164096308|NCT01471522|592715938|FG001|Overall Study|Withdrawal by Subject|22|||
164096309|NCT01471522|592715937|FG000|Overall Study|Lost to Follow-up|36|||
164096310|NCT01471522|592715938|FG001|Overall Study|Lost to Follow-up|26|||
163911803|NCT02309892|592047239|FG005|Overall Study|Progressive Disease|0|||
163911804|NCT02309892|592047240|FG006|Overall Study|Progressive Disease|0|||
163911805|NCT02309892|592047234|FG000|Overall Study|Death|0|||
164096311|NCT01432171|592715940|FG000|Overall Study|Death|1|||
163911806|NCT02309892|592047235|FG001|Overall Study|Death|0|||
164096312|NCT01432171|592715941|FG001|Overall Study|Death|2|||
163911807|NCT02309892|592047236|FG002|Overall Study|Death|0|||
163911808|NCT02309892|592047237|FG003|Overall Study|Death|0|||
163911809|NCT02309892|592047238|FG004|Overall Study|Death|0|||
163911810|NCT02309892|592047239|FG005|Overall Study|Death|1|||
163911811|NCT02309892|592047240|FG006|Overall Study|Death|0|||
163911812|NCT05376397|592047243|FG000|Overall Study|Lost to Follow-up|1|||
163911813|NCT00648895|592047250|FG000|Overall Study|Lack of Efficacy|0|||
163911814|NCT00648895|592047251|FG001|Overall Study|Lack of Efficacy|1|||
163911815|NCT01280721|592047254|FG000|Overall Study|Adverse Event|4|||
163911816|NCT01280721|592047254|FG000|Overall Study|Physician Decision|3|||
163911817|NCT01280721|592047254|FG000|Overall Study|Withdrawal by Subject|6|||
163911818|NCT01280721|592047254|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
163911819|NCT01280721|592047254|FG000|Overall Study|No tolerability for the lowest dose|2|||
163911820|NCT01180400|592047255|FG000|Overall Study|Withdrawal by Subject|5|||
163911821|NCT01180400|592047256|FG001|Overall Study|Withdrawal by Subject|6|||
163911822|NCT01180400|592047255|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
163911823|NCT01180400|592047256|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
163911824|NCT01180400|592047255|FG000|Overall Study|Adverse Event|12|||
163911825|NCT01180400|592047256|FG001|Overall Study|Adverse Event|10|||
163911826|NCT01180400|592047255|FG000|Overall Study|Severe non-compliance to protocol|1|||
163911827|NCT01180400|592047256|FG001|Overall Study|Severe non-compliance to protocol|2|||
163911828|NCT01180400|592047255|FG000|Overall Study|Condition under investigation worsened|2|||
163911829|NCT01180400|592047256|FG001|Overall Study|Condition under investigation worsened|1|||
163911830|NCT01180400|592047255|FG000|Overall Study|Lack of Efficacy|2|||
163911831|NCT01180400|592047256|FG001|Overall Study|Lack of Efficacy|0|||
163911832|NCT01180400|592047255|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163911833|NCT01180400|592047256|FG001|Overall Study|Study-specific withdrawal criteria|2|||
163911834|NCT01180400|592047255|FG000|Overall Study|Lost to Follow-up|2|||
163911835|NCT01180400|592047256|FG001|Overall Study|Lost to Follow-up|3|||
163911836|NCT01180400|592047255|FG000|Overall Study|Other|0|||
163911837|NCT01180400|592047256|FG001|Overall Study|Other|1|||
163911838|NCT00795639|592047257|FG000|Overall Study|Death|1|||
163911839|NCT00795639|592047258|FG001|Overall Study|Death|6|||
163911840|NCT00795639|592047257|FG000|Overall Study|Withdrawal by Subject|1|||
163911841|NCT00795639|592047258|FG001|Overall Study|Withdrawal by Subject|3|||
164026908|NCT01089582|592458931|FG000|Overall Study|Withdrawal by Subject|1|||
164026909|NCT01124448|592458934|FG000|Overall Study|Lost to Follow-up|0|||
164026910|NCT01124448|592458935|FG001|Overall Study|Lost to Follow-up|3|||
164026911|NCT01124448|592458934|FG000|Overall Study|Protocol Violation|2|||
164026912|NCT01124448|592458935|FG001|Overall Study|Protocol Violation|0|||
164026913|NCT05600309|592458941|FG000|Overall Study|Death|41|||
164026914|NCT05600309|592458942|FG001|Overall Study|Death|38|||
164026915|NCT05600309|592458941|FG000|Overall Study|Sponsor Decision|9|||
164026916|NCT05600309|592458942|FG001|Overall Study|Sponsor Decision|6|||
164026917|NCT00807846|592458945|FG000|Overall Study|Adverse Event|5|||
163911842|NCT00795639|592047257|FG000|Overall Study|Pregnancy|1|||
163911843|NCT00795639|592047258|FG001|Overall Study|Pregnancy|0|||
163911844|NCT00795639|592047257|FG000|Overall Study|Adverse Event|5|||
163911845|NCT00795639|592047258|FG001|Overall Study|Adverse Event|2|||
164026918|NCT00807846|592458946|FG001|Overall Study|Adverse Event|0|||
164026919|NCT00807846|592458945|FG000|Overall Study|Lack of Efficacy|2|||
164026920|NCT00807846|592458946|FG001|Overall Study|Lack of Efficacy|0|||
164026921|NCT00807846|592458945|FG000|Overall Study|Protocol Violation|2|||
163911846|NCT00795639|592047257|FG000|Overall Study|Other|0|||
163911847|NCT00795639|592047258|FG001|Overall Study|Other|2|||
163911848|NCT00795639|592047257|FG000|Overall Study|Terminated by sponsor|13|||
164026922|NCT00807846|592458946|FG001|Overall Study|Protocol Violation|1|||
164026923|NCT00807846|592458945|FG000|Overall Study|Withdrawal by Subject|2|||
164026924|NCT00807846|592458946|FG001|Overall Study|Withdrawal by Subject|1|||
164026925|NCT00807846|592458945|FG000|Overall Study|Other|1|||
164026926|NCT00807846|592458946|FG001|Overall Study|Other|2|||
164026927|NCT03977727|592458947|FG000|Second Treatment|Lost to Follow-up|0|||
164026928|NCT03977727|592458948|FG001|Second Treatment|Lost to Follow-up|3|||
164026929|NCT01419665|592458949|FG000|Combination Treatment|Adverse Event|7|||
163911849|NCT00795639|592047258|FG001|Overall Study|Terminated by sponsor|12|||
163911850|NCT00795639|592047257|FG000|Overall Study|Randomized and not treated|0|||
163911851|NCT00795639|592047258|FG001|Overall Study|Randomized and not treated|1|||
163911852|NCT04626128|592047259|FG000|Overall Study|Withdrawal by Subject|0|||
163911853|NCT04626128|592047260|FG001|Overall Study|Withdrawal by Subject|1|||
163911854|NCT04626128|592047261|FG002|Overall Study|Withdrawal by Subject|0|||
163911855|NCT04626128|592047262|FG003|Overall Study|Withdrawal by Subject|0|||
163911856|NCT00248794|592047263|FG000|Overall Study|Lost to Follow-up|6|||
163911857|NCT00248794|592047264|FG001|Overall Study|Lost to Follow-up|8|||
163911858|NCT00248794|592047265|FG002|Overall Study|Lost to Follow-up|3|||
163911859|NCT03449979|592047266|FG000|Overall Study|Technical difficulty|0|||
163911860|NCT03449979|592047267|FG001|Overall Study|Technical difficulty|0|||
163911861|NCT03449979|592047268|FG002|Overall Study|Technical difficulty|0|||
163911862|NCT03449979|592047269|FG003|Overall Study|Technical difficulty|1|||
163911863|NCT01358175|592047270|FG000|Overall Study|Death|1|||
163911864|NCT01358175|592047271|FG001|Overall Study|Death|0|||
163911865|NCT01358175|592047272|FG002|Overall Study|Death|1|||
163911866|NCT01358175|592047270|FG000|Overall Study|Withdrawal by Subject|9|||
163911867|NCT01358175|592047271|FG001|Overall Study|Withdrawal by Subject|5|||
163911868|NCT01358175|592047272|FG002|Overall Study|Withdrawal by Subject|10|||
163911869|NCT01358175|592047270|FG000|Overall Study|Technical issues|0|||
163911870|NCT01358175|592047271|FG001|Overall Study|Technical issues|1|||
163911871|NCT01358175|592047272|FG002|Overall Study|Technical issues|0|||
163911872|NCT01358175|592047270|FG000|Overall Study|Pregnancy|0|||
163911873|NCT01358175|592047271|FG001|Overall Study|Pregnancy|1|||
163911874|NCT01358175|592047272|FG002|Overall Study|Pregnancy|0|||
163911875|NCT01358175|592047270|FG000|Overall Study|Physician Decision|1|||
163911876|NCT01358175|592047271|FG001|Overall Study|Physician Decision|0|||
163911877|NCT01358175|592047272|FG002|Overall Study|Physician Decision|0|||
163911878|NCT01358175|592047270|FG000|Overall Study|Non Compliance with Study Treatment|0|||
163911879|NCT01358175|592047271|FG001|Overall Study|Non Compliance with Study Treatment|1|||
163911880|NCT01358175|592047272|FG002|Overall Study|Non Compliance with Study Treatment|1|||
163911881|NCT01358175|592047270|FG000|Overall Study|Lost to Follow-up|1|||
163911882|NCT01358175|592047271|FG001|Overall Study|Lost to Follow-up|1|||
163911883|NCT01358175|592047272|FG002|Overall Study|Lost to Follow-up|3|||
163911884|NCT01358175|592047270|FG000|Overall Study|Lack of Efficacy|3|||
163911885|NCT01358175|592047271|FG001|Overall Study|Lack of Efficacy|8|||
163911886|NCT01358175|592047272|FG002|Overall Study|Lack of Efficacy|6|||
163911887|NCT01358175|592047270|FG000|Overall Study|Adverse Event|6|||
163911888|NCT01358175|592047271|FG001|Overall Study|Adverse Event|11|||
163911889|NCT01358175|592047272|FG002|Overall Study|Adverse Event|11|||
163911890|NCT04908488|592047273|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
163911891|NCT04908488|592047274|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
163911892|NCT04908488|592047273|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
163911893|NCT04908488|592047274|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
163911894|NCT03444155|592047279|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
164026930|NCT01419665|592458950|FG001|Combination Treatment|Adverse Event|10|||
164026931|NCT01419665|592458949|FG000|Combination Treatment|Physician Decision|5|||
164026932|NCT01419665|592458950|FG001|Combination Treatment|Physician Decision|8|||
163911895|NCT03444155|592047280|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
163911896|NCT02877680|592047281|FG000|Overall Study|Lost to Follow-up|1|||
163911897|NCT02877680|592047282|FG001|Overall Study|Lost to Follow-up|1|||
163911898|NCT01133678|592047283|FG000|Overall Study|Death|1|||
163911899|NCT01133678|592047284|FG001|Overall Study|Death|1|||
163911900|NCT02206607|592047285|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
163911901|NCT02206607|592047286|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
163911902|NCT02206607|592047287|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
163911903|NCT02206607|592047288|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
163911904|NCT02206607|592047289|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
163911905|NCT02206607|592047285|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
163911906|NCT02206607|592047286|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
163911907|NCT02206607|592047287|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
163911908|NCT02206607|592047288|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
164026933|NCT01419665|592458949|FG000|Combination Treatment|Protocol Violation|6|||
163911909|NCT02206607|592047289|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
164026934|NCT01419665|592458950|FG001|Combination Treatment|Protocol Violation|2|||
164096313|NCT01432171|592715940|FG000|Overall Study|Lost to Follow-up|6|||
164026935|NCT01419665|592458949|FG000|Combination Treatment|disease progression|10|||
164026936|NCT01419665|592458950|FG001|Combination Treatment|disease progression|9|||
164026937|NCT01419665|592458949|FG000|Combination Treatment|Death|5|||
164026938|NCT01419665|592458950|FG001|Combination Treatment|Death|7|||
164026939|NCT01419665|592458949|FG000|Combination Treatment|administrative problems|0|||
164026940|NCT01419665|592458950|FG001|Combination Treatment|administrative problems|1|||
164026941|NCT01419665|592458949|FG000|Combination Treatment|Withdrawal by Subject|5|||
164096314|NCT01432171|592715941|FG001|Overall Study|Lost to Follow-up|5|||
163911910|NCT00761267|592047296|FG000|Overall Study|Death|1|||
163911911|NCT00761267|592047297|FG001|Overall Study|Death|2|||
163911912|NCT00761267|592047298|FG002|Overall Study|Death|5|||
163911913|NCT00761267|592047296|FG000|Overall Study|Lost to Follow-up|0|||
163911914|NCT00761267|592047297|FG001|Overall Study|Lost to Follow-up|0|||
163911915|NCT00761267|592047298|FG002|Overall Study|Lost to Follow-up|1|||
163911916|NCT00761267|592047296|FG000|Overall Study|Randomized but not treated|1|||
163911917|NCT00761267|592047297|FG001|Overall Study|Randomized but not treated|1|||
163911918|NCT00761267|592047298|FG002|Overall Study|Randomized but not treated|0|||
163911919|NCT00761267|592047296|FG000|Overall Study|Withdrawal by Subject|0|||
163911920|NCT00761267|592047297|FG001|Overall Study|Withdrawal by Subject|1|||
163911921|NCT00761267|592047298|FG002|Overall Study|Withdrawal by Subject|0|||
164026942|NCT01419665|592458950|FG001|Combination Treatment|Withdrawal by Subject|4|||
163911922|NCT01864200|592047299|FG000|Overall Study|Lost to Follow-up|1|||
163911923|NCT01864200|592047300|FG001|Overall Study|Lost to Follow-up|3|||
163911924|NCT01864200|592047299|FG000|Overall Study|Protocol Violation|1|||
163911925|NCT01864200|592047300|FG001|Overall Study|Protocol Violation|0|||
163911926|NCT00963924|592047309|FG000|Overall Study|Adverse Event|1|||
163911927|NCT00963924|592047310|FG001|Overall Study|Adverse Event|0|||
163911928|NCT00963924|592047309|FG000|Overall Study|Withdrawal by Subject|0|||
163911929|NCT00963924|592047310|FG001|Overall Study|Withdrawal by Subject|1|||
164026943|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
164026944|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
164026945|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
164026946|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
164144911|NCT05199090|592891826|FG004|Overall Study|Physician Decision|0|||
163911930|NCT00963924|592047309|FG000|Overall Study|Changed antipsychotic|0|||
163911931|NCT00963924|592047310|FG001|Overall Study|Changed antipsychotic|1|||
163911932|NCT00963924|592047309|FG000|Overall Study|Lost to Follow-up|0|||
163911933|NCT00963924|592047310|FG001|Overall Study|Lost to Follow-up|1|||
163911934|NCT00446095|592047311|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
163911935|NCT00446095|592047312|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
163911936|NCT00446095|592047313|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
163911937|NCT00446095|592047314|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
164096315|NCT01432171|592715940|FG000|Overall Study|Withdrawal by Subject|3|||
164096316|NCT01432171|592715941|FG001|Overall Study|Withdrawal by Subject|1|||
164096317|NCT01432171|592715940|FG000|Overall Study|Noncompliance|2|||
164096318|NCT01432171|592715941|FG001|Overall Study|Noncompliance|3|||
164026947|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
164026948|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
164026949|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
164026950|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
164026951|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
164026952|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
164026953|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
164026954|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
164026955|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|Death|1|||
164096319|NCT01432171|592715940|FG000|Overall Study|Insurance denial trial coverage|1|||
164096320|NCT01432171|592715941|FG001|Overall Study|Insurance denial trial coverage|0|||
164096321|NCT01432171|592715940|FG000|Overall Study|Patient moved to palliative care|1|||
163911938|NCT00446095|592047315|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
163911939|NCT00446095|592047311|FG000|Phase II (8 Weeks)|Adverse Event|0|||
163911940|NCT00446095|592047312|FG001|Phase II (8 Weeks)|Adverse Event|1|||
163911941|NCT00446095|592047313|FG002|Phase II (8 Weeks)|Adverse Event|1|||
163911942|NCT00446095|592047314|FG003|Phase II (8 Weeks)|Adverse Event|0|||
163911943|NCT00446095|592047315|FG004|Phase II (8 Weeks)|Adverse Event|0|||
163911944|NCT00446095|592047311|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
163911945|NCT00446095|592047312|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163911946|NCT00446095|592047313|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163911947|NCT00446095|592047314|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163911948|NCT00446095|592047315|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
163911949|NCT00446095|592047311|FG000|Phase II (8 Weeks)|Physician Decision|1|||
163911950|NCT00446095|592047312|FG001|Phase II (8 Weeks)|Physician Decision|0|||
163911951|NCT00446095|592047313|FG002|Phase II (8 Weeks)|Physician Decision|0|||
163911952|NCT00446095|592047314|FG003|Phase II (8 Weeks)|Physician Decision|0|||
163911953|NCT00446095|592047315|FG004|Phase II (8 Weeks)|Physician Decision|0|||
163911954|NCT00446095|592047311|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
163911955|NCT00446095|592047312|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
163911956|NCT00446095|592047313|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
163911957|NCT00446095|592047314|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
163911958|NCT00446095|592047315|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
163911959|NCT00446095|592047311|FG000|Phase II (8 Weeks)|Ongoing|0|||
163911960|NCT00446095|592047312|FG001|Phase II (8 Weeks)|Ongoing|0|||
163911961|NCT00446095|592047313|FG002|Phase II (8 Weeks)|Ongoing|1|||
163911962|NCT00446095|592047314|FG003|Phase II (8 Weeks)|Ongoing|0|||
163911963|NCT00446095|592047315|FG004|Phase II (8 Weeks)|Ongoing|0|||
163911964|NCT00446095|592047311|FG000|Phase I (28 Days)|Adverse Event|0|||
163911965|NCT00446095|592047312|FG001|Phase I (28 Days)|Adverse Event|0|||
163911966|NCT00446095|592047313|FG002|Phase I (28 Days)|Adverse Event|0|||
163911967|NCT00446095|592047314|FG003|Phase I (28 Days)|Adverse Event|1|||
163911968|NCT00446095|592047315|FG004|Phase I (28 Days)|Adverse Event|0|||
163911969|NCT00446095|592047311|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
163911970|NCT00446095|592047312|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
163911971|NCT00446095|592047313|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
163911972|NCT00446095|592047314|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
163911973|NCT00446095|592047315|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
163911974|NCT01419184|592047317|FG000|Overall Study|Site data not available|3|||
163911975|NCT01419184|592047318|FG001|Overall Study|Site data not available|2|||
163911976|NCT01419184|592047317|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
163911977|NCT01419184|592047318|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
163911978|NCT01419184|592047317|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
163911979|NCT01419184|592047318|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
163911980|NCT01419184|592047317|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
163911981|NCT01419184|592047318|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
163911982|NCT01419184|592047317|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
163911983|NCT01419184|592047318|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
163911984|NCT01419184|592047317|FG000|Overall Study|Participant randomized, not treated|1|||
163911985|NCT01419184|592047318|FG001|Overall Study|Participant randomized, not treated|0|||
163911986|NCT02644122|592047325|FG000|Overall Study|Withdrawal by Subject|1|||
163911987|NCT00424476|592047328|FG000|Overall Study|Withdrawal by Subject|7|||
163911988|NCT00424476|592047329|FG001|Overall Study|Withdrawal by Subject|6|||
163911989|NCT00424476|592047330|FG002|Overall Study|Withdrawal by Subject|3|||
163911990|NCT00424476|592047328|FG000|Overall Study|Adverse Event|19|||
163911991|NCT00424476|592047329|FG001|Overall Study|Adverse Event|16|||
163911992|NCT00424476|592047330|FG002|Overall Study|Adverse Event|15|||
163911993|NCT00424476|592047328|FG000|Overall Study|Lack of Efficacy|16|||
163911994|NCT00424476|592047329|FG001|Overall Study|Lack of Efficacy|12|||
163911995|NCT00424476|592047330|FG002|Overall Study|Lack of Efficacy|12|||
163911996|NCT00424476|592047328|FG000|Overall Study|Lack of Compliance|1|||
163911997|NCT00424476|592047329|FG001|Overall Study|Lack of Compliance|1|||
163911998|NCT00424476|592047330|FG002|Overall Study|Lack of Compliance|1|||
163911999|NCT00424476|592047328|FG000|Overall Study|Lost to Follow-up|4|||
163912000|NCT00424476|592047329|FG001|Overall Study|Lost to Follow-up|6|||
163912001|NCT00424476|592047330|FG002|Overall Study|Lost to Follow-up|3|||
163912002|NCT00424476|592047328|FG000|Overall Study|Protocol Violation|7|||
163912003|NCT00424476|592047329|FG001|Overall Study|Protocol Violation|2|||
163912004|NCT00424476|592047330|FG002|Overall Study|Protocol Violation|3|||
163912005|NCT00424476|592047328|FG000|Overall Study|Physician Decision|3|||
163912006|NCT00424476|592047329|FG001|Overall Study|Physician Decision|2|||
163912007|NCT00424476|592047330|FG002|Overall Study|Physician Decision|3|||
163912008|NCT00424476|592047328|FG000|Overall Study|Other|4|||
163912009|NCT00424476|592047329|FG001|Overall Study|Other|3|||
163912010|NCT00424476|592047330|FG002|Overall Study|Other|9|||
163912011|NCT02514824|592047331|FG000|Overall Study|Withdrawal by Subject|1|||
163912012|NCT02514824|592047332|FG001|Overall Study|Withdrawal by Subject|0|||
163912013|NCT02514824|592047333|FG002|Overall Study|Withdrawal by Subject|0|||
163912014|NCT02514824|592047334|FG003|Overall Study|Withdrawal by Subject|0|||
163912015|NCT02514824|592047331|FG000|Overall Study|Dose-Limiting Toxicity|0|||
163912016|NCT02514824|592047332|FG001|Overall Study|Dose-Limiting Toxicity|1|||
163912017|NCT02514824|592047333|FG002|Overall Study|Dose-Limiting Toxicity|0|||
163912018|NCT02514824|592047334|FG003|Overall Study|Dose-Limiting Toxicity|0|||
163912019|NCT02159352|592047337|FG000|Overall Study|Adverse Event|3|||
163912020|NCT02159352|592047338|FG001|Overall Study|Adverse Event|1|||
163912021|NCT02159352|592047337|FG000|Overall Study|Withdrawal by Subject|0|||
163912022|NCT02159352|592047338|FG001|Overall Study|Withdrawal by Subject|1|||
163912023|NCT00529529|592047339|FG000|Overall Study|Adverse Event|12|||
163912024|NCT00529529|592047340|FG001|Overall Study|Adverse Event|17|||
163912025|NCT00529529|592047341|FG002|Overall Study|Adverse Event|8|||
163912026|NCT00529529|592047339|FG000|Overall Study|Subject withdrew consent|12|||
163912027|NCT00529529|592047340|FG001|Overall Study|Subject withdrew consent|9|||
163912028|NCT00529529|592047341|FG002|Overall Study|Subject withdrew consent|12|||
163912029|NCT00529529|592047339|FG000|Overall Study|Protocol deviation|8|||
163912030|NCT00529529|592047340|FG001|Overall Study|Protocol deviation|12|||
163912031|NCT00529529|592047341|FG002|Overall Study|Protocol deviation|5|||
163912032|NCT00529529|592047339|FG000|Overall Study|Lost to Follow-up|5|||
163912033|NCT00529529|592047340|FG001|Overall Study|Lost to Follow-up|3|||
163912034|NCT00529529|592047341|FG002|Overall Study|Lost to Follow-up|1|||
163912035|NCT00529529|592047339|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163912036|NCT00529529|592047340|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163912037|NCT00529529|592047341|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
163912038|NCT00529529|592047339|FG000|Overall Study|Death|2|||
163912039|NCT00529529|592047340|FG001|Overall Study|Death|0|||
163912040|NCT00529529|592047341|FG002|Overall Study|Death|0|||
163912041|NCT00529529|592047339|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163912042|NCT00529529|592047340|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163912043|NCT00529529|592047341|FG002|Overall Study|Abnormal test procedure result(s)|0|||
163912044|NCT00529529|592047339|FG000|Overall Study|Administrative problems|1|||
163912045|NCT00529529|592047340|FG001|Overall Study|Administrative problems|0|||
163912046|NCT00529529|592047341|FG002|Overall Study|Administrative problems|3|||
163912047|NCT00337610|592047342|FG000|Overall Study|Adverse Event|2|||
163912048|NCT00337610|592047343|FG001|Overall Study|Adverse Event|2|||
163912049|NCT00337610|592047342|FG000|Overall Study|Death|0|||
163912050|NCT00337610|592047343|FG001|Overall Study|Death|1|||
163912051|NCT00337610|592047342|FG000|Overall Study|Lack of Efficacy|6|||
163912052|NCT00337610|592047343|FG001|Overall Study|Lack of Efficacy|3|||
163912053|NCT00337610|592047342|FG000|Overall Study|Lost to Follow-up|3|||
163912054|NCT00337610|592047343|FG001|Overall Study|Lost to Follow-up|3|||
163912055|NCT00337610|592047342|FG000|Overall Study|Withdrawal by Subject|6|||
163912056|NCT00337610|592047343|FG001|Overall Study|Withdrawal by Subject|5|||
163912057|NCT03979040|592047344|FG000|Overall Study|Withdrawal by Subject|24|||
163912058|NCT03979040|592047345|FG001|Overall Study|Withdrawal by Subject|32|||
163912059|NCT03979040|592047344|FG000|Overall Study|randomized but never started treatment|32|||
163912060|NCT03979040|592047345|FG001|Overall Study|randomized but never started treatment|39|||
163912061|NCT03979040|592047344|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
163912062|NCT03979040|592047345|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
163912063|NCT02279732|592047352|FG000|Overall Study|Death|23|||
163912064|NCT02279732|592047353|FG001|Overall Study|Death|20|||
163912065|NCT02279732|592047352|FG000|Overall Study|Disease Progression|13|||
163912066|NCT02279732|592047353|FG001|Overall Study|Disease Progression|3|||
163912067|NCT02279732|592047352|FG000|Overall Study|Withdrawal by Subject|2|||
163912068|NCT02279732|592047353|FG001|Overall Study|Withdrawal by Subject|7|||
163912069|NCT02279732|592047352|FG000|Overall Study|Adverse Event|1|||
163912070|NCT02279732|592047353|FG001|Overall Study|Adverse Event|2|||
163912071|NCT02279732|592047352|FG000|Overall Study|Administrative Reason By Sponsor|0|||
163912072|NCT02279732|592047353|FG001|Overall Study|Administrative Reason By Sponsor|2|||
163912073|NCT02279732|592047352|FG000|Overall Study|Study Drug Toxicity|2|||
163912074|NCT02279732|592047353|FG001|Overall Study|Study Drug Toxicity|0|||
163912075|NCT02279732|592047352|FG000|Overall Study|Lost to Follow-up|0|||
163912076|NCT02279732|592047353|FG001|Overall Study|Lost to Follow-up|1|||
164026956|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|Death|2|||
163912077|NCT02279732|592047352|FG000|Overall Study|Maximum Clinical Benefit|1|||
163912078|NCT02279732|592047353|FG001|Overall Study|Maximum Clinical Benefit|0|||
163912079|NCT02279732|592047352|FG000|Overall Study|Subject Requested to Discontinue|0|||
163912080|NCT02279732|592047353|FG001|Overall Study|Subject Requested to Discontinue|1|||
163912081|NCT02279732|592047352|FG000|Overall Study|Other|53|||
163912082|NCT02279732|592047353|FG001|Overall Study|Other|67|||
163912083|NCT02279732|592047352|FG000|Overall Study|Other|3|||
163912084|NCT02279732|592047353|FG001|Overall Study|Other|3|||
163912085|NCT03020914|592049280|FG000|Overall Study|Surgery Cancelled|1|||
164026957|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
163912086|NCT03020914|592049281|FG001|Overall Study|Surgery Cancelled|0|||
163912087|NCT04620733|592049282|FG000|Overall Study|Adverse Event|4|||
163912088|NCT04620733|592049283|FG001|Overall Study|Adverse Event|3|||
163912089|NCT04620733|592049282|FG000|Overall Study|Withdrawal by Subject|2|||
163912090|NCT04620733|592049283|FG001|Overall Study|Withdrawal by Subject|5|||
163912091|NCT04620733|592049282|FG000|Overall Study|Lost to Follow-up|1|||
163912092|NCT04620733|592049283|FG001|Overall Study|Lost to Follow-up|1|||
164026958|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
164026959|NCT01419665|592458949|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
164026960|NCT01419665|592458950|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
164026961|NCT01419665|592458949|FG000|Open Label Phase|Death|1|||
164026962|NCT01419665|592458950|FG001|Open Label Phase|Death|0|||
164026963|NCT01419665|592458949|FG000|Open Label Phase|disease progression|0|||
163912093|NCT04620733|592049282|FG000|Overall Study|Protocol Deviation|1|||
164026964|NCT01419665|592458950|FG001|Open Label Phase|disease progression|1|||
164026965|NCT01655823|592458952|FG000|Overall Study|Lost to Follow-up|0|||
164026966|NCT01655823|592458953|FG001|Overall Study|Lost to Follow-up|1|||
163912094|NCT04620733|592049283|FG001|Overall Study|Protocol Deviation|1|||
163912095|NCT04620733|592049282|FG000|Overall Study|Reason Not Specified|0|||
163912096|NCT04620733|592049283|FG001|Overall Study|Reason Not Specified|1|||
164096322|NCT01432171|592715941|FG001|Overall Study|Patient moved to palliative care|0|||
164096323|NCT02863575|592715942|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
164096324|NCT02863575|592715943|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
163912097|NCT03976102|592049287|FG000|Overall Study|Withdrawal by Subject|4|||
163912098|NCT03976102|592049288|FG001|Overall Study|Withdrawal by Subject|4|||
164096325|NCT02863575|592715944|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
163912099|NCT03976102|592049287|FG000|Overall Study|Adverse Event|2|||
163912100|NCT03976102|592049288|FG001|Overall Study|Adverse Event|4|||
163912101|NCT03976102|592049287|FG000|Overall Study|Not related to Covid-19|9|||
163912102|NCT03976102|592049288|FG001|Overall Study|Not related to Covid-19|13|||
163912103|NCT03976102|592049287|FG000|Overall Study|Lost to Follow-up|0|||
163912104|NCT03976102|592049288|FG001|Overall Study|Lost to Follow-up|2|||
163912105|NCT03976102|592049287|FG000|Overall Study|Death|3|||
163912106|NCT03976102|592049288|FG001|Overall Study|Death|2|||
163912107|NCT03976102|592049287|FG000|Overall Study|Physician Decision|1|||
163912108|NCT03976102|592049288|FG001|Overall Study|Physician Decision|1|||
163912109|NCT00451906|592049290|FG000|Overall Study|Adverse Event|515|||
163912110|NCT00451906|592049290|FG000|Overall Study|Lost to Follow-up|31|||
163912111|NCT00451906|592049290|FG000|Overall Study|Withdrawal by Subject|111|||
163912112|NCT00451906|592049290|FG000|Overall Study|Protocol Violation|21|||
163912113|NCT00451906|592049290|FG000|Overall Study|Progressive disease|1328|||
163912114|NCT00451906|592049290|FG000|Overall Study|Termination of the study|108|||
163912115|NCT00451906|592049290|FG000|Overall Study|Other Reasons|121|||
163912116|NCT00451906|592049290|FG000|Overall Study|Did not complete final visit|4|||
163912117|NCT02889900|592049298|FG000|Overall Study|Adverse Event|11|||
163912118|NCT02889900|592049298|FG000|Overall Study|Condition under investigation worsened|32|||
163912119|NCT02889900|592049298|FG000|Overall Study|Other|5|||
163912120|NCT02889900|592049298|FG000|Overall Study|Withdrawal by Subject|7|||
163912121|NCT02889900|592049298|FG000|Overall Study|Not treated|2|||
163912122|NCT00805792|592049299|FG000|Overall Study|Death|3|||
163912123|NCT00805792|592049299|FG000|Overall Study|Lost to Follow-up|2|||
163912124|NCT01416285|592049302|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
163912125|NCT01416285|592049303|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
163912126|NCT01248715|592049310|FG000|Overall Study|Not influenza positive|501|||
163912127|NCT01248715|592049311|FG001|Overall Study|Not influenza positive|510|||
163912128|NCT00813709|592049312|FG000|Double Blind Period|Adverse Event|4|||
163912129|NCT00813709|592049313|FG001|Double Blind Period|Adverse Event|1|||
163912130|NCT00813709|592049314|FG002|Double Blind Period|Adverse Event|4|||
163912131|NCT00813709|592049315|FG003|Double Blind Period|Adverse Event|0|||
163912132|NCT00813709|592049316|FG004|Double Blind Period|Adverse Event|0|||
163912133|NCT00813709|592049317|FG005|Double Blind Period|Adverse Event|0|||
163912134|NCT00813709|592049312|FG000|Double Blind Period|Lost to Follow-up|3|||
163912135|NCT00813709|592049313|FG001|Double Blind Period|Lost to Follow-up|2|||
163912136|NCT00813709|592049314|FG002|Double Blind Period|Lost to Follow-up|2|||
163912137|NCT00813709|592049315|FG003|Double Blind Period|Lost to Follow-up|0|||
164026967|NCT01655823|592458954|FG002|Overall Study|Lost to Follow-up|0|||
163912138|NCT00813709|592049316|FG004|Double Blind Period|Lost to Follow-up|0|||
163912139|NCT00813709|592049317|FG005|Double Blind Period|Lost to Follow-up|0|||
163912140|NCT00813709|592049312|FG000|Double Blind Period|Switched to open label phase|9|||
163912141|NCT00813709|592049313|FG001|Double Blind Period|Switched to open label phase|26|||
164026968|NCT01655823|592458955|FG003|Overall Study|Lost to Follow-up|0|||
164026969|NCT01655823|592458956|FG004|Overall Study|Lost to Follow-up|1|||
164026970|NCT01655823|592458952|FG000|Overall Study|Withdrawal by Subject|0|||
164026971|NCT01655823|592458953|FG001|Overall Study|Withdrawal by Subject|1|||
164026972|NCT01655823|592458954|FG002|Overall Study|Withdrawal by Subject|0|||
164026973|NCT01655823|592458955|FG003|Overall Study|Withdrawal by Subject|1|||
164026974|NCT01655823|592458956|FG004|Overall Study|Withdrawal by Subject|0|||
164026975|NCT03352414|592458960|FG000|Overall Study|Ineligible by operative criteria|12|||
164026976|NCT03352414|592458961|FG001|Overall Study|Ineligible by operative criteria|10|||
164026977|NCT02632110|592458962|FG000|Overall Study|Withdrawal by Subject|1|||
164026978|NCT02632110|592458963|FG001|Overall Study|Withdrawal by Subject|1|||
163912142|NCT00813709|592049314|FG002|Double Blind Period|Switched to open label phase|18|||
163912143|NCT00813709|592049315|FG003|Double Blind Period|Switched to open label phase|0|||
163912144|NCT00813709|592049316|FG004|Double Blind Period|Switched to open label phase|0|||
163912145|NCT00813709|592049317|FG005|Double Blind Period|Switched to open label phase|0|||
163912146|NCT00813709|592049312|FG000|Double Blind Period|Randomized but not treated|1|||
163912147|NCT00813709|592049313|FG001|Double Blind Period|Randomized but not treated|3|||
163912148|NCT00813709|592049314|FG002|Double Blind Period|Randomized but not treated|1|||
163912149|NCT00813709|592049315|FG003|Double Blind Period|Randomized but not treated|0|||
163912150|NCT00813709|592049316|FG004|Double Blind Period|Randomized but not treated|0|||
163912151|NCT00813709|592049317|FG005|Double Blind Period|Randomized but not treated|0|||
163912152|NCT00813709|592049312|FG000|Double Blind Period|Other|14|||
163912153|NCT00813709|592049313|FG001|Double Blind Period|Other|9|||
163912154|NCT00813709|592049314|FG002|Double Blind Period|Other|6|||
163912155|NCT00813709|592049315|FG003|Double Blind Period|Other|0|||
163912156|NCT00813709|592049316|FG004|Double Blind Period|Other|0|||
163912157|NCT00813709|592049317|FG005|Double Blind Period|Other|0|||
163912158|NCT00813709|592049312|FG000|Open Label Period|Adverse Event|0|||
163912159|NCT00813709|592049313|FG001|Open Label Period|Adverse Event|0|||
163912160|NCT00813709|592049314|FG002|Open Label Period|Adverse Event|0|||
163912161|NCT00813709|592049315|FG003|Open Label Period|Adverse Event|5|||
163912162|NCT00813709|592049316|FG004|Open Label Period|Adverse Event|4|||
163912163|NCT00813709|592049317|FG005|Open Label Period|Adverse Event|3|||
163912164|NCT00813709|592049312|FG000|Open Label Period|Lack of Efficacy|0|||
163912165|NCT00813709|592049313|FG001|Open Label Period|Lack of Efficacy|0|||
163912166|NCT00813709|592049314|FG002|Open Label Period|Lack of Efficacy|0|||
163912167|NCT00813709|592049315|FG003|Open Label Period|Lack of Efficacy|3|||
163912168|NCT00813709|592049316|FG004|Open Label Period|Lack of Efficacy|1|||
163912169|NCT00813709|592049317|FG005|Open Label Period|Lack of Efficacy|1|||
163912170|NCT00813709|592049312|FG000|Open Label Period|Randomized but not treated|0|||
163912171|NCT00813709|592049313|FG001|Open Label Period|Randomized but not treated|0|||
163912172|NCT00813709|592049314|FG002|Open Label Period|Randomized but not treated|0|||
163912173|NCT00813709|592049315|FG003|Open Label Period|Randomized but not treated|1|||
163912174|NCT00813709|592049316|FG004|Open Label Period|Randomized but not treated|0|||
163912175|NCT00813709|592049317|FG005|Open Label Period|Randomized but not treated|1|||
163912176|NCT00813709|592049312|FG000|Open Label Period|Other|0|||
163912177|NCT00813709|592049313|FG001|Open Label Period|Other|0|||
163912178|NCT00813709|592049314|FG002|Open Label Period|Other|0|||
163912179|NCT00813709|592049315|FG003|Open Label Period|Other|11|||
163912180|NCT00813709|592049316|FG004|Open Label Period|Other|5|||
163912181|NCT00813709|592049317|FG005|Open Label Period|Other|6|||
163912182|NCT01807234|592049318|FG000|Overall Study|Lost to Follow-up|2|||
163912183|NCT01807234|592049319|FG001|Overall Study|Lost to Follow-up|5|||
163912184|NCT01807234|592049320|FG002|Overall Study|Lost to Follow-up|1|||
163912185|NCT01807234|592049321|FG003|Overall Study|Lost to Follow-up|1|||
163912186|NCT01807234|592049322|FG004|Overall Study|Lost to Follow-up|1|||
163912187|NCT01807234|592049323|FG005|Overall Study|Lost to Follow-up|2|||
164026979|NCT02632110|592458964|FG002|Overall Study|Withdrawal by Subject|0|||
164026980|NCT02632110|592458965|FG003|Overall Study|Withdrawal by Subject|0|||
164026981|NCT02632110|592458966|FG004|Overall Study|Withdrawal by Subject|1|||
164026982|NCT02632110|592458967|FG005|Overall Study|Withdrawal by Subject|1|||
164026983|NCT02632110|592458968|FG006|Overall Study|Withdrawal by Subject|3|||
163912188|NCT01807234|592049318|FG000|Overall Study|Withdrawal by Subject|3|||
163912189|NCT01807234|592049319|FG001|Overall Study|Withdrawal by Subject|1|||
163912190|NCT01807234|592049320|FG002|Overall Study|Withdrawal by Subject|1|||
163912191|NCT01807234|592049321|FG003|Overall Study|Withdrawal by Subject|1|||
164026984|NCT02632110|592458969|FG007|Overall Study|Withdrawal by Subject|3|||
163912192|NCT01807234|592049322|FG004|Overall Study|Withdrawal by Subject|2|||
163912193|NCT01807234|592049323|FG005|Overall Study|Withdrawal by Subject|1|||
163912194|NCT01807234|592049318|FG000|Overall Study|Lack of Efficacy|0|||
163912195|NCT01807234|592049319|FG001|Overall Study|Lack of Efficacy|0|||
163912196|NCT01807234|592049320|FG002|Overall Study|Lack of Efficacy|0|||
163912197|NCT01807234|592049321|FG003|Overall Study|Lack of Efficacy|0|||
163912198|NCT01807234|592049322|FG004|Overall Study|Lack of Efficacy|1|||
163912199|NCT01807234|592049323|FG005|Overall Study|Lack of Efficacy|1|||
164026985|NCT02632110|592458970|FG008|Overall Study|Withdrawal by Subject|1|||
163912200|NCT01540474|592049324|FG000|Vaccination Period|Lost to Follow-up|0|||
163912201|NCT01540474|592049325|FG001|Vaccination Period|Lost to Follow-up|1|||
163912202|NCT01540474|592049326|FG002|Vaccination Period|Lost to Follow-up|0|||
163912203|NCT01540474|592049327|FG003|Vaccination Period|Lost to Follow-up|0|||
163912204|NCT00857311|592049328|FG000|Overall Study|Lost to Follow-up|1|||
163912205|NCT00857311|592049329|FG001|Overall Study|Lost to Follow-up|0|||
163912206|NCT00857311|592049330|FG002|Overall Study|Lost to Follow-up|0|||
163912207|NCT00857311|592049331|FG003|Overall Study|Lost to Follow-up|0|||
163912208|NCT01587703|592049332|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
163912209|NCT01587703|592049333|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912210|NCT01587703|592049334|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912211|NCT01587703|592049335|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912212|NCT01587703|592049336|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912213|NCT01587703|592049337|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912214|NCT01587703|592049338|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912215|NCT01587703|592049339|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912216|NCT01587703|592049340|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912217|NCT01587703|592049341|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912218|NCT01587703|592049342|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912219|NCT01587703|592049343|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912220|NCT01587703|592049344|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912221|NCT01587703|592049345|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912222|NCT01587703|592049346|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912223|NCT01587703|592049347|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912224|NCT01587703|592049348|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912225|NCT01587703|592049349|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912226|NCT01587703|592049350|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
163912227|NCT01587703|592049332|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912228|NCT01587703|592049333|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912229|NCT01587703|592049334|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912230|NCT01587703|592049335|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912231|NCT01587703|592049336|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912232|NCT01587703|592049337|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
163912233|NCT01587703|592049338|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912234|NCT01587703|592049339|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
163912235|NCT01587703|592049340|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912236|NCT01587703|592049341|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912237|NCT01587703|592049342|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912238|NCT01587703|592049343|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912239|NCT01587703|592049344|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912240|NCT01587703|592049345|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912241|NCT01587703|592049346|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912242|NCT01587703|592049347|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912243|NCT01587703|592049348|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912244|NCT01587703|592049349|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912245|NCT01587703|592049350|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
163912246|NCT01587703|592049332|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912247|NCT01587703|592049333|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912248|NCT01587703|592049334|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912249|NCT01587703|592049335|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164026986|NCT02632110|592458971|FG009|Overall Study|Withdrawal by Subject|1|||
164026987|NCT00115804|592458973|FG000|Overall Study|Adverse Event|2|||
164026988|NCT00547378|592458974|FG000|Randomized Cohort|Withdrawal by Subject|7|||
164026989|NCT00547378|592458975|FG001|Randomized Cohort|Withdrawal by Subject|5|||
164026990|NCT00547378|592458976|FG002|Randomized Cohort|Withdrawal by Subject|0|||
164026991|NCT00547378|592458974|FG000|Randomized Cohort|Death|0|||
164026992|NCT00547378|592458975|FG001|Randomized Cohort|Death|1|||
164026993|NCT00547378|592458976|FG002|Randomized Cohort|Death|0|||
164026994|NCT00547378|592458974|FG000|Randomized Cohort|Lost to Follow-up|1|||
164096326|NCT02863575|592715942|FG000|Overall Study|Withdrawal by Subject|0|||
164026995|NCT00547378|592458975|FG001|Randomized Cohort|Lost to Follow-up|0|||
164026996|NCT00547378|592458976|FG002|Randomized Cohort|Lost to Follow-up|0|||
164026997|NCT00547378|592458974|FG000|Randomized Cohort|Adverse Event|1|||
164026998|NCT00547378|592458975|FG001|Randomized Cohort|Adverse Event|0|||
164026999|NCT00547378|592458976|FG002|Randomized Cohort|Adverse Event|0|||
164027000|NCT00547378|592458974|FG000|Randomized Cohort|Other reasons|2|||
164027001|NCT00547378|592458975|FG001|Randomized Cohort|Other reasons|0|||
164027002|NCT00547378|592458976|FG002|Randomized Cohort|Other reasons|0|||
164027003|NCT00547378|592458974|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
164027004|NCT00547378|592458975|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
164027005|NCT00547378|592458976|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
164027006|NCT00547378|592458974|FG000|All Implanted Cohort|Adverse Event|4|||
164027007|NCT00547378|592458975|FG001|All Implanted Cohort|Adverse Event|10|||
164027008|NCT00547378|592458976|FG002|All Implanted Cohort|Adverse Event|17|||
164027009|NCT00547378|592458974|FG000|All Implanted Cohort|Lost to Follow-up|0|||
164027010|NCT00547378|592458975|FG001|All Implanted Cohort|Lost to Follow-up|1|||
163912250|NCT01587703|592049336|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912251|NCT01587703|592049337|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164096327|NCT02863575|592715943|FG001|Overall Study|Withdrawal by Subject|1|||
164096328|NCT02863575|592715944|FG002|Overall Study|Withdrawal by Subject|1|||
164096329|NCT02863575|592715942|FG000|Overall Study|Adverse Event|0|||
164096330|NCT02863575|592715943|FG001|Overall Study|Adverse Event|1|||
164096331|NCT02863575|592715944|FG002|Overall Study|Adverse Event|0|||
164096332|NCT01706926|592715945|FG000|Overall Study|Lost to Follow-up|0|||
164096333|NCT01706926|592715946|FG001|Overall Study|Lost to Follow-up|0|||
164096334|NCT01706926|592715947|FG002|Overall Study|Lost to Follow-up|1|||
164096335|NCT01706926|592715948|FG003|Overall Study|Lost to Follow-up|0|||
164096336|NCT01706926|592715945|FG000|Overall Study|Withdrawal by Subject|2|||
164096337|NCT01706926|592715946|FG001|Overall Study|Withdrawal by Subject|0|||
164096338|NCT01706926|592715947|FG002|Overall Study|Withdrawal by Subject|1|||
164096339|NCT01706926|592715948|FG003|Overall Study|Withdrawal by Subject|2|||
164096340|NCT01706926|592715945|FG000|Overall Study|Other|4|||
164096341|NCT01706926|592715946|FG001|Overall Study|Other|4|||
164096342|NCT01706926|592715947|FG002|Overall Study|Other|4|||
164096343|NCT01706926|592715948|FG003|Overall Study|Other|3|||
164096344|NCT01248247|592717259|FG000|Overall Study|Adverse Event|2|||
164096345|NCT01248247|592717260|FG001|Overall Study|Adverse Event|4|||
164096346|NCT01248247|592717261|FG002|Overall Study|Adverse Event|4|||
164096347|NCT01248247|592717262|FG003|Overall Study|Adverse Event|2|||
164096348|NCT01248247|592717259|FG000|Overall Study|Death|0|||
164096349|NCT01248247|592717260|FG001|Overall Study|Death|1|||
164096350|NCT01248247|592717261|FG002|Overall Study|Death|4|||
164096351|NCT01248247|592717262|FG003|Overall Study|Death|7|||
164096352|NCT01248247|592717259|FG000|Overall Study|Lost to Follow-up|0|||
164096353|NCT01248247|592717260|FG001|Overall Study|Lost to Follow-up|1|||
164096354|NCT01248247|592717261|FG002|Overall Study|Lost to Follow-up|1|||
164096355|NCT01248247|592717262|FG003|Overall Study|Lost to Follow-up|0|||
163912252|NCT01587703|592049338|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
164096356|NCT01248247|592717259|FG000|Overall Study|Alternative treatment|0|||
164096357|NCT01248247|592717260|FG001|Overall Study|Alternative treatment|1|||
164096358|NCT01248247|592717261|FG002|Overall Study|Alternative treatment|0|||
164096359|NCT01248247|592717262|FG003|Overall Study|Alternative treatment|0|||
164096360|NCT01248247|592717259|FG000|Overall Study|Other|2|||
164096361|NCT01248247|592717260|FG001|Overall Study|Other|8|||
164096362|NCT01248247|592717261|FG002|Overall Study|Other|8|||
164096363|NCT01248247|592717262|FG003|Overall Study|Other|5|||
164096364|NCT01248247|592717259|FG000|Overall Study|Progression|18|||
163912253|NCT01587703|592049339|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164096365|NCT01248247|592717260|FG001|Overall Study|Progression|27|||
164096366|NCT01248247|592717261|FG002|Overall Study|Progression|56|||
164096367|NCT01248247|592717262|FG003|Overall Study|Progression|44|||
164096368|NCT01248247|592717259|FG000|Overall Study|Refuse further treatment|0|||
164096369|NCT01248247|592717260|FG001|Overall Study|Refuse further treatment|0|||
164096370|NCT01248247|592717261|FG002|Overall Study|Refuse further treatment|1|||
164096371|NCT01248247|592717262|FG003|Overall Study|Refuse further treatment|2|||
164096372|NCT01248247|592717259|FG000|Overall Study|Complicating disease|0|||
164096373|NCT01248247|592717260|FG001|Overall Study|Complicating disease|0|||
164096374|NCT01248247|592717261|FG002|Overall Study|Complicating disease|1|||
164096375|NCT01248247|592717262|FG003|Overall Study|Complicating disease|1|||
164096376|NCT01215981|592717263|FG000|Overall Study|Physician Decision|0|||
164096377|NCT01215981|592717264|FG001|Overall Study|Physician Decision|1|||
164096378|NCT01215981|592717263|FG000|Overall Study|Protocol Violation|1|||
164096379|NCT01215981|592717264|FG001|Overall Study|Protocol Violation|0|||
164096380|NCT01215981|592717263|FG000|Overall Study|Withdrawal by Subject|1|||
164096381|NCT01215981|592717264|FG001|Overall Study|Withdrawal by Subject|0|||
164096382|NCT03597256|592717265|FG000|Overall Study|Lost to Follow-up|3|||
164096383|NCT03597256|592717266|FG001|Overall Study|Lost to Follow-up|1|||
164096384|NCT03597256|592717265|FG000|Overall Study|Withdrawal by Subject|0|||
164096385|NCT03597256|592717266|FG001|Overall Study|Withdrawal by Subject|1|||
164096386|NCT03597256|592717265|FG000|Overall Study|Could not return for treatment|0|||
163912254|NCT01587703|592049340|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164027011|NCT00547378|592458976|FG002|All Implanted Cohort|Lost to Follow-up|14|||
164027012|NCT00547378|592458974|FG000|All Implanted Cohort|Death|3|||
164027013|NCT00547378|592458975|FG001|All Implanted Cohort|Death|1|||
164027014|NCT00547378|592458976|FG002|All Implanted Cohort|Death|4|||
164027015|NCT00547378|592458974|FG000|All Implanted Cohort|Physician Decision|0|||
164027016|NCT00547378|592458975|FG001|All Implanted Cohort|Physician Decision|2|||
164027017|NCT00547378|592458976|FG002|All Implanted Cohort|Physician Decision|6|||
164027018|NCT00547378|592458974|FG000|All Implanted Cohort|Site closure|2|||
164027019|NCT00547378|592458975|FG001|All Implanted Cohort|Site closure|0|||
164027020|NCT00547378|592458976|FG002|All Implanted Cohort|Site closure|1|||
164027021|NCT00547378|592458974|FG000|All Implanted Cohort|Other reasons|1|||
164027022|NCT00547378|592458975|FG001|All Implanted Cohort|Other reasons|0|||
164027023|NCT00547378|592458976|FG002|All Implanted Cohort|Other reasons|1|||
164027024|NCT01449682|592458977|FG000|Overall Study|Death|0|||
164027025|NCT01449682|592458978|FG001|Overall Study|Death|1|||
164027026|NCT01449682|592458977|FG000|Overall Study|Adverse Event|1|||
164027027|NCT01449682|592458978|FG001|Overall Study|Adverse Event|0|||
164027028|NCT04633473|592458983|FG000|Overall Study|Withdrawal by Subject|6|||
164027029|NCT01822691|592458984|FG000|Overall Study|Withdrawal by Subject|2|||
164027030|NCT00751114|592458985|FG000|Overall Study|Adverse Event|2|||
164027031|NCT00751114|592458986|FG001|Overall Study|Adverse Event|4|||
163912255|NCT01587703|592049341|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912256|NCT01587703|592049342|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164027032|NCT00751114|592458985|FG000|Overall Study|Protocol Violation|8|||
163912257|NCT01587703|592049343|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912258|NCT01587703|592049344|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912259|NCT01587703|592049345|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
164027033|NCT00751114|592458986|FG001|Overall Study|Protocol Violation|9|||
163912260|NCT01587703|592049346|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912261|NCT01587703|592049347|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912262|NCT01587703|592049348|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912263|NCT01587703|592049349|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912264|NCT01587703|592049350|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
163912265|NCT01587703|592049332|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
163912266|NCT01587703|592049333|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
163912267|NCT01587703|592049334|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
163912268|NCT01587703|592049335|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
163912269|NCT01587703|592049336|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
163912270|NCT01587703|592049337|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
163912271|NCT01587703|592049338|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
163912272|NCT01587703|592049339|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
163912273|NCT01587703|592049340|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912274|NCT01587703|592049341|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912275|NCT01587703|592049342|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912276|NCT01587703|592049343|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912277|NCT01587703|592049344|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912278|NCT01587703|592049345|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912279|NCT01587703|592049346|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912280|NCT01587703|592049347|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912281|NCT01587703|592049348|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
163912282|NCT01587703|592049349|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164027034|NCT00751114|592458985|FG000|Overall Study|Withdrawal by Subject|9|||
163912283|NCT01587703|592049350|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
164027035|NCT00751114|592458986|FG001|Overall Study|Withdrawal by Subject|4|||
164027036|NCT00751114|592458985|FG000|Overall Study|Lost to Follow-up|4|||
164027037|NCT00751114|592458986|FG001|Overall Study|Lost to Follow-up|7|||
164027038|NCT00751114|592458985|FG000|Overall Study|Lack of Efficacy|0|||
164027039|NCT00751114|592458986|FG001|Overall Study|Lack of Efficacy|7|||
164027040|NCT00751114|592458985|FG000|Overall Study|Not Treated|13|||
164027041|NCT00751114|592458986|FG001|Overall Study|Not Treated|1|||
164027042|NCT00751114|592458985|FG000|Overall Study|Out of country for 2 months|1|||
164027043|NCT00751114|592458986|FG001|Overall Study|Out of country for 2 months|0|||
164027044|NCT00751114|592458985|FG000|Overall Study|Move to another city|1|||
164027045|NCT00751114|592458986|FG001|Overall Study|Move to another city|0|||
164027046|NCT03095521|592458987|FG000|Overall Study|Withdrawal by Subject|0|||
164027047|NCT03095521|592458988|FG001|Overall Study|Withdrawal by Subject|1|||
164027048|NCT03095521|592458987|FG000|Overall Study|Lost to Follow-up|0|||
164027049|NCT03095521|592458988|FG001|Overall Study|Lost to Follow-up|1|||
164027050|NCT03259490|592458989|FG000|Period 1|Withdrawal by Subject|0|||
164027051|NCT03259490|592458990|FG001|Period 1|Withdrawal by Subject|1|||
164027052|NCT03259490|592458989|FG000|Period 2|Protocol Violation|1|||
164027053|NCT03259490|592458990|FG001|Period 2|Protocol Violation|0|||
164027054|NCT01536119|592458993|FG000|Overall Study|Lost to Follow-up|17|||
164027055|NCT01536119|592458994|FG001|Overall Study|Lost to Follow-up|14|||
164027056|NCT02365584|592458995|FG000|Overall Study|Adverse Event|2|||
164027057|NCT02365584|592458996|FG001|Overall Study|Adverse Event|2|||
164027058|NCT02365584|592458995|FG000|Overall Study|Withdrawal by Subject|1|||
164027059|NCT02365584|592458996|FG001|Overall Study|Withdrawal by Subject|0|||
164027060|NCT02365584|592458995|FG000|Overall Study|Disease Progression|9|||
164027061|NCT02365584|592458996|FG001|Overall Study|Disease Progression|12|||
164027062|NCT00819585|592458997|FG000|Core Study|Adverse Event|2|||
164027063|NCT00819585|592458998|FG001|Core Study|Adverse Event|1|||
164027064|NCT00819585|592458999|FG002|Core Study|Adverse Event|1|||
164027065|NCT00819585|592459000|FG003|Core Study|Adverse Event|4|||
164027066|NCT00819585|592459001|FG004|Core Study|Adverse Event|1|||
164027067|NCT00819585|592459002|FG005|Core Study|Adverse Event|0|||
164027068|NCT00819585|592459003|FG006|Core Study|Adverse Event|2|||
164027069|NCT00819585|592459004|FG007|Core Study|Adverse Event|0|||
164027070|NCT00819585|592459005|FG008|Core Study|Adverse Event|0|||
164027071|NCT00819585|592459006|FG009|Core Study|Adverse Event|0|||
164027072|NCT00819585|592459007|FG010|Core Study|Adverse Event|0|||
164027073|NCT00819585|592458997|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
164027074|NCT00819585|592458998|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
164027075|NCT00819585|592458999|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
164027076|NCT00819585|592459000|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
164027077|NCT00819585|592459001|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
164027078|NCT00819585|592459002|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
164027079|NCT00819585|592459003|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
164027080|NCT00819585|592459004|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
164096387|NCT03597256|592717266|FG001|Overall Study|Could not return for treatment|1|||
164096388|NCT03597256|592717265|FG000|Overall Study|Moved from location|0|||
164096389|NCT03597256|592717266|FG001|Overall Study|Moved from location|1|||
164096390|NCT03597256|592717265|FG000|Overall Study|Not accepted the treatment|0|||
164096391|NCT03597256|592717266|FG001|Overall Study|Not accepted the treatment|1|||
164096392|NCT02943447|592717267|FG000|Blinded Study Phase|Withdrew Consent|1|||
164096393|NCT02943447|592717268|FG001|Blinded Study Phase|Withdrew Consent|2|||
164096394|NCT02943447|592717269|FG002|Blinded Study Phase|Withdrew Consent|1|||
164096395|NCT02943447|592717267|FG000|Blinded Study Phase|Adverse Event|3|||
164096396|NCT02943447|592717268|FG001|Blinded Study Phase|Adverse Event|0|||
164096397|NCT02943447|592717269|FG002|Blinded Study Phase|Adverse Event|0|||
164096398|NCT02943447|592717267|FG000|Blinded Study Phase|Investigator's discretion|1|||
164096399|NCT02943447|592717268|FG001|Blinded Study Phase|Investigator's discretion|0|||
164096400|NCT02943447|592717269|FG002|Blinded Study Phase|Investigator's discretion|0|||
164096401|NCT02943447|592717267|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
164096402|NCT02943447|592717268|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
164096403|NCT02943447|592717269|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
163912284|NCT01587703|592049332|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912285|NCT01587703|592049333|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912286|NCT01587703|592049334|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912287|NCT01587703|592049335|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912288|NCT01587703|592049336|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912289|NCT01587703|592049337|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912290|NCT01587703|592049338|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912291|NCT01587703|592049339|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912292|NCT01587703|592049340|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
163912293|NCT01587703|592049341|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
163912294|NCT01587703|592049342|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
163912295|NCT01587703|592049343|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912296|NCT01587703|592049344|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912297|NCT01587703|592049345|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912298|NCT01587703|592049346|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912299|NCT01587703|592049347|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912300|NCT01587703|592049348|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912301|NCT01587703|592049349|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912302|NCT01587703|592049350|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
163912303|NCT01587703|592049332|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912304|NCT01587703|592049333|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912305|NCT01587703|592049334|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912306|NCT01587703|592049335|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912307|NCT01587703|592049336|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912308|NCT01587703|592049337|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912309|NCT01587703|592049338|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912310|NCT01587703|592049339|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912311|NCT01587703|592049340|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
163912312|NCT01587703|592049341|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912313|NCT01587703|592049342|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
163912314|NCT01587703|592049343|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912315|NCT01587703|592049344|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912316|NCT01587703|592049345|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912317|NCT01587703|592049346|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912318|NCT01587703|592049347|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912319|NCT01587703|592049348|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912320|NCT01587703|592049349|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912321|NCT01587703|592049350|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
163912322|NCT01587703|592049332|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912323|NCT01587703|592049333|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912324|NCT01587703|592049334|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912325|NCT01587703|592049335|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912326|NCT01587703|592049336|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912327|NCT01587703|592049337|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912328|NCT01587703|592049338|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164027081|NCT00819585|592459005|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
164027082|NCT00819585|592459006|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
164027083|NCT00819585|592459007|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
164027084|NCT00819585|592458997|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027085|NCT00819585|592458998|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
164027086|NCT00819585|592458999|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027087|NCT00819585|592459000|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027088|NCT00819585|592459001|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027089|NCT00819585|592459002|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027090|NCT00819585|592459003|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
164027091|NCT00819585|592459004|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027092|NCT00819585|592459005|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027093|NCT00819585|592459006|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
164096404|NCT02943447|592717267|FG000|Open-Label Extension Phase|Adverse Event|4|||
163912329|NCT01587703|592049339|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
164027094|NCT00819585|592459007|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
164027095|NCT00819585|592458997|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
164027096|NCT00819585|592458998|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
164027097|NCT00819585|592458999|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
164096405|NCT02943447|592717268|FG001|Open-Label Extension Phase|Adverse Event|7|||
164096406|NCT02943447|592717269|FG002|Open-Label Extension Phase|Adverse Event|3|||
164096407|NCT02943447|592717267|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
163912330|NCT01587703|592049340|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912331|NCT01587703|592049341|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
163912332|NCT01587703|592049342|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
163912333|NCT01587703|592049343|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912334|NCT01587703|592049344|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912335|NCT01587703|592049345|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912336|NCT01587703|592049346|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912337|NCT01587703|592049347|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912338|NCT01587703|592049348|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912339|NCT01587703|592049349|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912340|NCT01587703|592049350|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
163912341|NCT01587703|592049332|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912342|NCT01587703|592049333|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912343|NCT01587703|592049334|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912344|NCT01587703|592049335|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912345|NCT01587703|592049336|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912346|NCT01587703|592049337|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912347|NCT01587703|592049338|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912348|NCT01587703|592049339|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912349|NCT01587703|592049340|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
163912350|NCT01587703|592049341|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912351|NCT01587703|592049342|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912352|NCT01587703|592049343|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912353|NCT01587703|592049344|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912354|NCT01587703|592049345|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912355|NCT01587703|592049346|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912356|NCT01587703|592049347|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912357|NCT01587703|592049348|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
164027098|NCT00819585|592459000|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
164027099|NCT00819585|592459001|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
164027100|NCT00819585|592459002|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
164027101|NCT00819585|592459003|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
164027102|NCT00819585|592459004|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
164027103|NCT00819585|592459005|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
164027104|NCT00819585|592459006|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
164027105|NCT00819585|592459007|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
164096408|NCT02943447|592717268|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
164096409|NCT02943447|592717269|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
163912358|NCT01587703|592049349|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912359|NCT01587703|592049350|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
163912360|NCT01587703|592049332|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912361|NCT01587703|592049333|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912362|NCT01587703|592049334|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912363|NCT01587703|592049335|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912364|NCT01587703|592049336|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912365|NCT01587703|592049337|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912366|NCT01587703|592049338|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912367|NCT01587703|592049339|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912368|NCT01587703|592049340|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912369|NCT01587703|592049341|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912370|NCT01587703|592049342|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912371|NCT01587703|592049343|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912372|NCT01587703|592049344|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912373|NCT01587703|592049345|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912374|NCT01587703|592049346|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912375|NCT01587703|592049347|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912376|NCT01587703|592049348|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912377|NCT01587703|592049349|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
163912378|NCT01587703|592049350|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
163912379|NCT01587703|592049332|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912380|NCT01587703|592049333|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912381|NCT01587703|592049334|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912382|NCT01587703|592049335|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912383|NCT01587703|592049336|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164027106|NCT00819585|592458997|FG000|Core Study|Subject Withdrew Consent|0|||
164027107|NCT00819585|592458998|FG001|Core Study|Subject Withdrew Consent|3|||
164027108|NCT00819585|592458999|FG002|Core Study|Subject Withdrew Consent|2|||
164027109|NCT00819585|592459000|FG003|Core Study|Subject Withdrew Consent|1|||
163912384|NCT01587703|592049337|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912385|NCT01587703|592049338|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912386|NCT01587703|592049339|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
164096410|NCT02943447|592717267|FG000|Open-Label Extension Phase|Withdrew consent|1|||
163912387|NCT01587703|592049340|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912388|NCT01587703|592049341|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912389|NCT01587703|592049342|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912390|NCT01587703|592049343|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912391|NCT01587703|592049344|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912392|NCT01587703|592049345|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912393|NCT01587703|592049346|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912394|NCT01587703|592049347|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912395|NCT01587703|592049348|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
163912396|NCT01587703|592049349|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
163912397|NCT01587703|592049350|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
163912398|NCT01587703|592049332|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912399|NCT01587703|592049333|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912400|NCT01587703|592049334|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912401|NCT01587703|592049335|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912402|NCT01587703|592049336|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912403|NCT01587703|592049337|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912404|NCT01587703|592049338|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912405|NCT01587703|592049339|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912406|NCT01587703|592049340|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912407|NCT01587703|592049341|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912408|NCT01587703|592049342|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912409|NCT01587703|592049343|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912410|NCT01587703|592049344|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912411|NCT01587703|592049345|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912412|NCT01587703|592049346|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912413|NCT01587703|592049347|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
163912414|NCT01587703|592049348|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912415|NCT01587703|592049349|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912416|NCT01587703|592049350|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
163912417|NCT01587703|592049332|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912418|NCT01587703|592049333|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912419|NCT01587703|592049334|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912420|NCT01587703|592049335|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912421|NCT01587703|592049336|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912422|NCT01587703|592049337|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912423|NCT01587703|592049338|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912424|NCT01587703|592049339|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912425|NCT01587703|592049340|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912426|NCT01587703|592049341|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912427|NCT01587703|592049342|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912428|NCT01587703|592049343|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
163912429|NCT01587703|592049344|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912430|NCT01587703|592049345|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912431|NCT01587703|592049346|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
163912432|NCT01587703|592049347|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912433|NCT01587703|592049348|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912434|NCT01587703|592049349|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
163912435|NCT01587703|592049350|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
164027110|NCT00819585|592459001|FG004|Core Study|Subject Withdrew Consent|0|||
164027111|NCT00819585|592459002|FG005|Core Study|Subject Withdrew Consent|0|||
164027112|NCT00819585|592459003|FG006|Core Study|Subject Withdrew Consent|3|||
164027113|NCT00819585|592459004|FG007|Core Study|Subject Withdrew Consent|0|||
164027114|NCT00819585|592459005|FG008|Core Study|Subject Withdrew Consent|0|||
164027115|NCT00819585|592459006|FG009|Core Study|Subject Withdrew Consent|0|||
164027116|NCT00819585|592459007|FG010|Core Study|Subject Withdrew Consent|0|||
164027117|NCT00819585|592458997|FG000|Core Study|Lost to Follow-up|2|||
164027118|NCT00819585|592458998|FG001|Core Study|Lost to Follow-up|1|||
164027119|NCT00819585|592458999|FG002|Core Study|Lost to Follow-up|2|||
164027120|NCT00819585|592459000|FG003|Core Study|Lost to Follow-up|0|||
163912436|NCT01587703|592049332|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164027121|NCT00819585|592459001|FG004|Core Study|Lost to Follow-up|1|||
163912437|NCT01587703|592049333|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912438|NCT01587703|592049334|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912439|NCT01587703|592049335|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164027122|NCT00819585|592459002|FG005|Core Study|Lost to Follow-up|1|||
164027123|NCT00819585|592459003|FG006|Core Study|Lost to Follow-up|1|||
164027124|NCT00819585|592459004|FG007|Core Study|Lost to Follow-up|0|||
164027125|NCT00819585|592459005|FG008|Core Study|Lost to Follow-up|0|||
164096411|NCT02943447|592717268|FG001|Open-Label Extension Phase|Withdrew consent|1|||
164027126|NCT00819585|592459006|FG009|Core Study|Lost to Follow-up|0|||
164027127|NCT00819585|592459007|FG010|Core Study|Lost to Follow-up|0|||
164027128|NCT00819585|592458997|FG000|Core Study|Administrative Problems|0|||
164027129|NCT00819585|592458998|FG001|Core Study|Administrative Problems|0|||
164027130|NCT00819585|592458999|FG002|Core Study|Administrative Problems|0|||
164027131|NCT00819585|592459000|FG003|Core Study|Administrative Problems|0|||
164027132|NCT00819585|592459001|FG004|Core Study|Administrative Problems|0|||
164027133|NCT00819585|592459002|FG005|Core Study|Administrative Problems|0|||
164027134|NCT00819585|592459003|FG006|Core Study|Administrative Problems|2|||
164027135|NCT00819585|592459004|FG007|Core Study|Administrative Problems|0|||
163912440|NCT01587703|592049336|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912441|NCT01587703|592049337|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912442|NCT01587703|592049338|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912443|NCT01587703|592049339|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164027136|NCT00819585|592459005|FG008|Core Study|Administrative Problems|0|||
164027137|NCT00819585|592459006|FG009|Core Study|Administrative Problems|0|||
163912444|NCT01587703|592049340|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
164027138|NCT00819585|592459007|FG010|Core Study|Administrative Problems|0|||
164027139|NCT00819585|592458997|FG000|Core Study|Death|0|||
164027140|NCT00819585|592458998|FG001|Core Study|Death|0|||
164027141|NCT00819585|592458999|FG002|Core Study|Death|0|||
164027142|NCT00819585|592459000|FG003|Core Study|Death|0|||
164027143|NCT00819585|592459001|FG004|Core Study|Death|0|||
164027144|NCT00819585|592459002|FG005|Core Study|Death|0|||
164027145|NCT00819585|592459003|FG006|Core Study|Death|1|||
164027146|NCT00819585|592459004|FG007|Core Study|Death|0|||
164027147|NCT00819585|592459005|FG008|Core Study|Death|0|||
164027148|NCT00819585|592459006|FG009|Core Study|Death|0|||
164027149|NCT00819585|592459007|FG010|Core Study|Death|0|||
164027150|NCT00819585|592458997|FG000|Core Study|Protocol Violation|0|||
163912445|NCT01587703|592049341|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912446|NCT01587703|592049342|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912447|NCT01587703|592049343|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
163912448|NCT01587703|592049344|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
163912449|NCT01587703|592049345|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
163912450|NCT01587703|592049346|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
163912451|NCT01587703|592049347|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
163912452|NCT01587703|592049348|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
163912453|NCT01587703|592049349|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912454|NCT01587703|592049350|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
163912455|NCT01587703|592049332|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912456|NCT01587703|592049333|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912457|NCT01587703|592049334|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912458|NCT01587703|592049335|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912459|NCT01587703|592049336|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912460|NCT01587703|592049337|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912461|NCT01587703|592049338|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912462|NCT01587703|592049339|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912463|NCT01587703|592049340|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912464|NCT01587703|592049341|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912465|NCT01587703|592049342|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912466|NCT01587703|592049343|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
163912467|NCT01587703|592049344|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
163912468|NCT01587703|592049345|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
163912469|NCT01587703|592049346|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
164027151|NCT00819585|592458998|FG001|Core Study|Protocol Violation|0|||
164027152|NCT00819585|592458999|FG002|Core Study|Protocol Violation|1|||
164027153|NCT00819585|592459000|FG003|Core Study|Protocol Violation|0|||
164027154|NCT00819585|592459001|FG004|Core Study|Protocol Violation|0|||
164027155|NCT00819585|592459002|FG005|Core Study|Protocol Violation|1|||
164027156|NCT00819585|592459003|FG006|Core Study|Protocol Violation|3|||
164027157|NCT00819585|592459004|FG007|Core Study|Protocol Violation|0|||
164027158|NCT00819585|592459005|FG008|Core Study|Protocol Violation|0|||
164027159|NCT00819585|592459006|FG009|Core Study|Protocol Violation|0|||
163912470|NCT01587703|592049347|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
163912471|NCT01587703|592049348|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
163912472|NCT01587703|592049349|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912473|NCT01587703|592049350|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
163912474|NCT01587703|592049332|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912475|NCT01587703|592049333|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912476|NCT01587703|592049334|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164027160|NCT00819585|592459007|FG010|Core Study|Protocol Violation|0|||
164027161|NCT00819585|592458997|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
163912477|NCT01587703|592049335|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912478|NCT01587703|592049336|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912479|NCT01587703|592049337|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912480|NCT01587703|592049338|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912481|NCT01587703|592049339|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912482|NCT01587703|592049340|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912483|NCT01587703|592049341|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912484|NCT01587703|592049342|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912485|NCT01587703|592049343|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
163912486|NCT01587703|592049344|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912487|NCT01587703|592049345|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912488|NCT01587703|592049346|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912489|NCT01587703|592049347|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912490|NCT01587703|592049348|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912491|NCT01587703|592049349|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
164027162|NCT00819585|592458998|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
163912492|NCT01587703|592049350|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
163912493|NCT01129011|592049351|FG000|Overall Study|Adverse Event|20|||
163912494|NCT01129011|592049352|FG001|Overall Study|Adverse Event|30|||
163912495|NCT01129011|592049351|FG000|Overall Study|Withdrawal by Subject|24|||
163912496|NCT01129011|592049352|FG001|Overall Study|Withdrawal by Subject|8|||
164027163|NCT00819585|592458999|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
164027164|NCT00819585|592459000|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
164027165|NCT00819585|592459001|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
163912497|NCT01129011|592049351|FG000|Overall Study|Lost to Follow-up|6|||
163912498|NCT01129011|592049352|FG001|Overall Study|Lost to Follow-up|7|||
163912499|NCT01129011|592049351|FG000|Overall Study|Duodenal Ulcer|2|||
163912500|NCT01129011|592049352|FG001|Overall Study|Duodenal Ulcer|8|||
163912501|NCT01129011|592049351|FG000|Overall Study|misc|7|||
163912502|NCT01129011|592049352|FG001|Overall Study|misc|4|||
163912503|NCT03209492|592049353|FG000|Overall Study|Case Report Forms Uncollected|5|||
163912504|NCT01894620|592049358|FG000|Overall Study|Withdrawal by Subject|0|||
163912505|NCT01894620|592049359|FG001|Overall Study|Withdrawal by Subject|1|||
163912506|NCT01124916|592049360|FG000|Overall Study|Lost to Follow-up|3|||
163912507|NCT01124916|592049361|FG001|Overall Study|Lost to Follow-up|2|||
163912508|NCT00879710|592049362|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
163912509|NCT00879710|592049363|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
163912510|NCT00879710|592049364|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
163912511|NCT00879710|592049365|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
163912512|NCT00879710|592049362|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
163912513|NCT00879710|592049363|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
163912514|NCT00879710|592049364|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
163912515|NCT00879710|592049365|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
163912516|NCT00753896|592049366|FG000|Overall Study|Adverse Event|4|||
163912517|NCT00753896|592049366|FG000|Overall Study|Death|1|||
163912518|NCT00753896|592049366|FG000|Overall Study|Lost to Follow-up|2|||
163912519|NCT00753896|592049366|FG000|Overall Study|Protocol Violation|1|||
163912520|NCT00753896|592049366|FG000|Overall Study|Withdrawal by Subject|4|||
163912521|NCT00753896|592049366|FG000|Overall Study|Entry Criteria Not Met|4|||
163912522|NCT00952523|592049367|FG000|Overall Study|Withdrawal by Subject|7|||
163912523|NCT02707952|592049368|FG000|Overall Study|Adverse Event|1|||
163912524|NCT02707952|592049369|FG001|Overall Study|Adverse Event|0|||
163912525|NCT02707952|592049370|FG002|Overall Study|Adverse Event|0|||
163912526|NCT02707952|592049371|FG003|Overall Study|Adverse Event|0|||
163912527|NCT02707952|592049368|FG000|Overall Study|Lost to Follow-up|1|||
163912528|NCT02707952|592049369|FG001|Overall Study|Lost to Follow-up|0|||
163912529|NCT02707952|592049370|FG002|Overall Study|Lost to Follow-up|0|||
163912530|NCT02707952|592049371|FG003|Overall Study|Lost to Follow-up|0|||
163912531|NCT02707952|592049368|FG000|Overall Study|Withdrawal by Subject|0|||
163912532|NCT02707952|592049369|FG001|Overall Study|Withdrawal by Subject|1|||
163912533|NCT02707952|592049370|FG002|Overall Study|Withdrawal by Subject|2|||
163912534|NCT02707952|592049371|FG003|Overall Study|Withdrawal by Subject|0|||
163912535|NCT03072862|592049376|FG000|Overall Study|Withdrawal by Subject|4|||
163912536|NCT03072862|592049376|FG000|Overall Study|Lost to Follow-up|6|||
163912537|NCT03072862|592049376|FG000|Overall Study|Protocol Violation|4|||
163912538|NCT03072862|592049376|FG000|Overall Study|Physician Decision|2|||
163912539|NCT03072862|592049376|FG000|Overall Study|Death|1|||
163912540|NCT03072862|592049376|FG000|Overall Study|Adverse Event|1|||
163912541|NCT02203513|592049377|FG000|Overall Study|Refused further treatment|2|||
163912542|NCT02203513|592049378|FG001|Overall Study|Refused further treatment|0|||
163912543|NCT02203513|592049379|FG002|Overall Study|Refused further treatment|1|||
163912544|NCT02203513|592049380|FG003|Overall Study|Refused further treatment|0|||
163912545|NCT02203513|592049381|FG004|Overall Study|Refused further treatment|0|||
163912546|NCT02203513|592049377|FG000|Overall Study|Switched to alternative treatment|3|||
163912547|NCT02203513|592049378|FG001|Overall Study|Switched to alternative treatment|4|||
163912548|NCT02203513|592049379|FG002|Overall Study|Switched to alternative treatment|0|||
163912549|NCT02203513|592049380|FG003|Overall Study|Switched to alternative treatment|0|||
163912550|NCT02203513|592049381|FG004|Overall Study|Switched to alternative treatment|4|||
163912551|NCT02203513|592049377|FG000|Overall Study|Did not receive investigational product (IP)|0|||
163912552|NCT02203513|592049378|FG001|Overall Study|Did not receive investigational product (IP)|1|||
163912553|NCT02203513|592049379|FG002|Overall Study|Did not receive investigational product (IP)|0|||
164027166|NCT00819585|592459002|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
164027167|NCT00819585|592459003|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
163912554|NCT02203513|592049380|FG003|Overall Study|Did not receive investigational product (IP)|0|||
164027168|NCT00819585|592459004|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
163912555|NCT02203513|592049381|FG004|Overall Study|Did not receive investigational product (IP)|0|||
163912556|NCT02203513|592049377|FG000|Overall Study|Death (unrelated to study therapy)|1|||
163912557|NCT02203513|592049378|FG001|Overall Study|Death (unrelated to study therapy)|3|||
163912558|NCT02203513|592049379|FG002|Overall Study|Death (unrelated to study therapy)|1|||
163912559|NCT02203513|592049380|FG003|Overall Study|Death (unrelated to study therapy)|0|||
163912560|NCT02203513|592049381|FG004|Overall Study|Death (unrelated to study therapy)|2|||
163912561|NCT02203513|592049377|FG000|Overall Study|Lost to Follow-up|0|||
163912562|NCT02203513|592049378|FG001|Overall Study|Lost to Follow-up|0|||
163912563|NCT02203513|592049379|FG002|Overall Study|Lost to Follow-up|1|||
163912564|NCT02203513|592049380|FG003|Overall Study|Lost to Follow-up|1|||
163912565|NCT02203513|592049381|FG004|Overall Study|Lost to Follow-up|0|||
163912566|NCT01441596|592049382|FG000|Overall Study|Other reason not defined below|0|||
163912567|NCT01441596|592049383|FG001|Overall Study|Other reason not defined below|2|||
163912568|NCT01441596|592049384|FG002|Overall Study|Other reason not defined below|1|||
163912569|NCT01441596|592049382|FG000|Overall Study|Withdrawal by Subject|4|||
163912570|NCT01441596|592049383|FG001|Overall Study|Withdrawal by Subject|0|||
163912571|NCT01441596|592049384|FG002|Overall Study|Withdrawal by Subject|2|||
163912572|NCT01441596|592049382|FG000|Overall Study|Not treated|0|||
163912573|NCT01441596|592049383|FG001|Overall Study|Not treated|1|||
163912574|NCT01441596|592049384|FG002|Overall Study|Not treated|1|||
163912575|NCT03015220|592049387|FG000|Overall Study|Withdrawal by Subject|3|||
163912576|NCT03015220|592049388|FG001|Overall Study|Withdrawal by Subject|2|||
163912577|NCT03015220|592049389|FG002|Overall Study|Withdrawal by Subject|2|||
163912578|NCT03015220|592049390|FG003|Overall Study|Withdrawal by Subject|2|||
163912579|NCT03015220|592049387|FG000|Overall Study|Lost to Follow-up|0|||
163912580|NCT03015220|592049388|FG001|Overall Study|Lost to Follow-up|0|||
163912581|NCT03015220|592049389|FG002|Overall Study|Lost to Follow-up|1|||
163912582|NCT03015220|592049390|FG003|Overall Study|Lost to Follow-up|0|||
163912583|NCT01670526|592049391|FG000|Overall Study|Withdrawal by Subject|3|||
163912584|NCT01670526|592049392|FG001|Overall Study|Withdrawal by Subject|1|||
163912585|NCT01670526|592049391|FG000|Overall Study|Lost to Follow-up|9|||
163912586|NCT01670526|592049392|FG001|Overall Study|Lost to Follow-up|5|||
163912587|NCT03055988|592049393|FG000|Period 1|Adverse Event|0|||
163912588|NCT03055988|592049394|FG001|Period 1|Adverse Event|1|||
163912589|NCT03055988|592049393|FG000|Period 1|Lost to Follow-up|1|||
163912590|NCT03055988|592049394|FG001|Period 1|Lost to Follow-up|0|||
163912591|NCT03055988|592049393|FG000|Period 1|Withdrawal by Subject|0|||
163912592|NCT03055988|592049394|FG001|Period 1|Withdrawal by Subject|4|||
163912593|NCT03055988|592049393|FG000|Period 2|Adverse Event|0|||
163912594|NCT03055988|592049394|FG001|Period 2|Adverse Event|1|||
163912595|NCT03055988|592049393|FG000|Period 2|Other than listed|1|||
163912596|NCT03055988|592049394|FG001|Period 2|Other than listed|1|||
163912597|NCT00392197|592049395|FG000|Overall Study|Adverse Event|4|||
163912598|NCT00392197|592049396|FG001|Overall Study|Adverse Event|12|||
163912599|NCT00392197|592049395|FG000|Overall Study|Lack of Efficacy|3|||
163912600|NCT00392197|592049396|FG001|Overall Study|Lack of Efficacy|4|||
163912601|NCT00392197|592049395|FG000|Overall Study|Lost to Follow-up|0|||
163912602|NCT00392197|592049396|FG001|Overall Study|Lost to Follow-up|1|||
163912603|NCT00392197|592049395|FG000|Overall Study|Physician Decision|3|||
163912604|NCT00392197|592049396|FG001|Overall Study|Physician Decision|2|||
163912605|NCT00392197|592049395|FG000|Overall Study|Protocol Violation|7|||
163912606|NCT00392197|592049396|FG001|Overall Study|Protocol Violation|5|||
163912607|NCT00392197|592049395|FG000|Overall Study|Withdrawal by Subject|4|||
163912608|NCT00392197|592049396|FG001|Overall Study|Withdrawal by Subject|6|||
163912609|NCT02312258|592049397|FG000|Overall Study|Lost to Follow-up|8|||
163912610|NCT02312258|592049398|FG001|Overall Study|Lost to Follow-up|8|||
163912611|NCT02312258|592049397|FG000|Overall Study|Withdrawal by Patient|49|||
163912612|NCT02312258|592049398|FG001|Overall Study|Withdrawal by Patient|76|||
163912613|NCT02312258|592049397|FG000|Overall Study|Reason not Specified|107|||
163912614|NCT02312258|592049398|FG001|Overall Study|Reason not Specified|159|||
163912615|NCT02312258|592049397|FG000|Overall Study|Missing|2|||
163912616|NCT02312258|592049398|FG001|Overall Study|Missing|1|||
163912617|NCT02312258|592049397|FG000|Overall Study|Death|115|||
163912618|NCT02312258|592049398|FG001|Overall Study|Death|181|||
163912619|NCT01528605|592049399|FG000|Overall Study|Lost to Follow-up|1|||
163912620|NCT01528605|592049400|FG001|Overall Study|Lost to Follow-up|0|||
163912621|NCT01528605|592049401|FG002|Overall Study|Lost to Follow-up|1|||
163912622|NCT01528605|592049402|FG003|Overall Study|Lost to Follow-up|1|||
163912623|NCT01528605|592049403|FG004|Overall Study|Lost to Follow-up|0|||
163912624|NCT01528605|592049404|FG005|Overall Study|Lost to Follow-up|0|||
163912625|NCT01528605|592049399|FG000|Overall Study|Death|1|||
163912626|NCT01528605|592049400|FG001|Overall Study|Death|0|||
163912627|NCT01528605|592049401|FG002|Overall Study|Death|0|||
163912628|NCT01528605|592049402|FG003|Overall Study|Death|0|||
163912629|NCT01528605|592049403|FG004|Overall Study|Death|0|||
163912630|NCT01528605|592049404|FG005|Overall Study|Death|0|||
163912631|NCT01681511|592049406|FG000|Overall Study|No Treatment Received|1|||
163912632|NCT01681511|592049407|FG001|Overall Study|No Treatment Received|3|||
163912633|NCT01681511|592049406|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
163912634|NCT01681511|592049407|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
163912635|NCT01681511|592049406|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
163912636|NCT01681511|592049407|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
163912637|NCT01681511|592049406|FG000|Overall Study|No Daily Urine Sample Collected|0|||
163912638|NCT01681511|592049407|FG001|Overall Study|No Daily Urine Sample Collected|1|||
163912639|NCT01681511|592049406|FG000|Overall Study|No post-catheter sample collected|11|||
163912640|NCT01681511|592049407|FG001|Overall Study|No post-catheter sample collected|4|||
163912641|NCT01156675|592049408|FG000|Overall Study|Death|5|||
164027169|NCT00819585|592459005|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
164096412|NCT02943447|592717269|FG002|Open-Label Extension Phase|Withdrew consent|1|||
164096413|NCT02943447|592717267|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
164096414|NCT02943447|592717268|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
164096415|NCT02943447|592717269|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
163912642|NCT01156675|592049409|FG001|Overall Study|Death|3|||
163912643|NCT01156675|592049410|FG002|Overall Study|Death|0|||
163912644|NCT01156675|592049408|FG000|Overall Study|No data|29|||
163912645|NCT01156675|592049409|FG001|Overall Study|No data|22|||
163912646|NCT01156675|592049410|FG002|Overall Study|No data|2|||
163912647|NCT01970527|592049411|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
163912648|NCT01970527|592049412|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
163912649|NCT01970527|592049411|FG000|Treatment|Disease progression|0|||
163912650|NCT01970527|592049412|FG001|Treatment|Disease progression|1|||
163912651|NCT01970527|592049411|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
163912652|NCT01970527|592049412|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
163912653|NCT01970527|592049411|FG000|Treatment|Death|0|||
163912654|NCT01970527|592049412|FG001|Treatment|Death|1|||
163912655|NCT01970527|592049411|FG000|Follow-up Clinic Visit|Disease progression|1|||
164096416|NCT02653664|592717283|FG000|Post-Treatment|Withdrawal by Subject|6|||
164096417|NCT02653664|592717284|FG001|Post-Treatment|Withdrawal by Subject|5|||
163912656|NCT01970527|592049412|FG001|Follow-up Clinic Visit|Disease progression|1|||
164027170|NCT00819585|592459006|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
164027171|NCT00819585|592459007|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
164027172|NCT00819585|592458997|FG000|Extension Study|Subject Withdrew Consent|0|||
164027173|NCT00819585|592458998|FG001|Extension Study|Subject Withdrew Consent|0|||
164027174|NCT00819585|592458999|FG002|Extension Study|Subject Withdrew Consent|0|||
163912657|NCT01970527|592049411|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
164144912|NCT05199090|592891827|FG005|Overall Study|Physician Decision|1|||
164145217|NCT02125877|592894246|FG001|Overall Study|Death|1|||
164096418|NCT02653664|592717285|FG002|Post-Treatment|Withdrawal by Subject|7|||
164096419|NCT02653664|592717283|FG000|Post-Treatment|Lost to Follow-up|8|||
164096420|NCT02653664|592717284|FG001|Post-Treatment|Lost to Follow-up|1|||
164096421|NCT02653664|592717285|FG002|Post-Treatment|Lost to Follow-up|7|||
164027175|NCT00819585|592459000|FG003|Extension Study|Subject Withdrew Consent|0|||
164027176|NCT00819585|592459001|FG004|Extension Study|Subject Withdrew Consent|0|||
164027177|NCT00819585|592459002|FG005|Extension Study|Subject Withdrew Consent|0|||
164027178|NCT00819585|592459003|FG006|Extension Study|Subject Withdrew Consent|0|||
164027179|NCT00819585|592459004|FG007|Extension Study|Subject Withdrew Consent|0|||
164027180|NCT00819585|592459005|FG008|Extension Study|Subject Withdrew Consent|3|||
164027181|NCT00819585|592459006|FG009|Extension Study|Subject Withdrew Consent|0|||
164027182|NCT00819585|592459007|FG010|Extension Study|Subject Withdrew Consent|1|||
164027183|NCT00819585|592458997|FG000|Extension Study|Lost to Follow-up|0|||
164027184|NCT00819585|592458998|FG001|Extension Study|Lost to Follow-up|0|||
163912658|NCT01970527|592049412|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
164027185|NCT00819585|592458999|FG002|Extension Study|Lost to Follow-up|0|||
163912659|NCT01970527|592049411|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
163912660|NCT01970527|592049412|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
163912661|NCT00116649|592049428|FG000|Overall Study|Adverse Event|20|||
164145296|NCT00025259|592894263|FG000|Overall Study|Protocol Violation|3|||
163912662|NCT00116649|592049428|FG000|Overall Study|Lack of Efficacy|1|||
163912663|NCT00116649|592049428|FG000|Overall Study|Lost to Follow-up|32|||
164027186|NCT00819585|592459000|FG003|Extension Study|Lost to Follow-up|0|||
164027187|NCT00819585|592459001|FG004|Extension Study|Lost to Follow-up|0|||
164027188|NCT00819585|592459002|FG005|Extension Study|Lost to Follow-up|0|||
164027189|NCT00819585|592459003|FG006|Extension Study|Lost to Follow-up|0|||
164027190|NCT00819585|592459004|FG007|Extension Study|Lost to Follow-up|0|||
163912664|NCT00116649|592049428|FG000|Overall Study|Withdrawal by Subject|68|||
163912665|NCT00116649|592049428|FG000|Overall Study|Local Skin Reaction|9|||
163912666|NCT00116649|592049428|FG000|Overall Study|Various Reasons|18|||
164096422|NCT02653664|592717283|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
164096423|NCT02653664|592717284|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
163912667|NCT00116649|592049428|FG000|Overall Study|Protocol Specified|7|||
163912668|NCT02161146|592049429|FG000|Overall Study|Adverse Event|1|||
163912669|NCT02161146|592049430|FG001|Overall Study|Adverse Event|1|||
163912670|NCT02161146|592049431|FG002|Overall Study|Adverse Event|0|||
163912671|NCT02161146|592049432|FG003|Overall Study|Adverse Event|1|||
164027191|NCT00819585|592459005|FG008|Extension Study|Lost to Follow-up|2|||
163912672|NCT02161146|592049433|FG004|Overall Study|Adverse Event|0|||
163912673|NCT02161146|592049429|FG000|Overall Study|Lost to Follow-up|0|||
163912674|NCT02161146|592049430|FG001|Overall Study|Lost to Follow-up|1|||
163912675|NCT02161146|592049431|FG002|Overall Study|Lost to Follow-up|0|||
163912676|NCT02161146|592049432|FG003|Overall Study|Lost to Follow-up|0|||
164027192|NCT00819585|592459006|FG009|Extension Study|Lost to Follow-up|1|||
164027193|NCT00819585|592459007|FG010|Extension Study|Lost to Follow-up|1|||
164027194|NCT00819585|592458997|FG000|Extension Study|Death|0|||
164027195|NCT00819585|592458998|FG001|Extension Study|Death|0|||
164027196|NCT00819585|592458999|FG002|Extension Study|Death|0|||
164027197|NCT00819585|592459000|FG003|Extension Study|Death|0|||
164027198|NCT00819585|592459001|FG004|Extension Study|Death|0|||
164027199|NCT00819585|592459002|FG005|Extension Study|Death|0|||
164027200|NCT00819585|592459003|FG006|Extension Study|Death|0|||
164027201|NCT00819585|592459004|FG007|Extension Study|Death|0|||
164027202|NCT00819585|592459005|FG008|Extension Study|Death|2|||
164027203|NCT00819585|592459006|FG009|Extension Study|Death|0|||
164027204|NCT00819585|592459007|FG010|Extension Study|Death|0|||
163912677|NCT02161146|592049433|FG004|Overall Study|Lost to Follow-up|0|||
163912678|NCT02161146|592049429|FG000|Overall Study|Personal Reasons|0|||
163912679|NCT02161146|592049430|FG001|Overall Study|Personal Reasons|1|||
163912680|NCT02161146|592049431|FG002|Overall Study|Personal Reasons|0|||
163912681|NCT02161146|592049432|FG003|Overall Study|Personal Reasons|2|||
164027205|NCT01927419|592459008|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
163912682|NCT02161146|592049433|FG004|Overall Study|Personal Reasons|1|||
164027206|NCT01927419|592459009|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
164027207|NCT01927419|592459008|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
164027208|NCT01927419|592459009|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
164027209|NCT01927419|592459008|FG000|Treatment Period|Disease progression|17|||
164027210|NCT01927419|592459009|FG001|Treatment Period|Disease progression|20|||
164027211|NCT01927419|592459008|FG000|Treatment Period|Study drug toxicity|48|||
164027212|NCT01927419|592459009|FG001|Treatment Period|Study drug toxicity|10|||
163912683|NCT02161146|592049429|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163912684|NCT02161146|592049430|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163912685|NCT02161146|592049431|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163912686|NCT02161146|592049432|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163912687|NCT02161146|592049433|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163912688|NCT00845520|592049434|FG000|Overall Study|Death|1|||
163912689|NCT00845520|592049435|FG001|Overall Study|Death|2|||
163912690|NCT00845520|592049436|FG002|Overall Study|Death|0|||
163912691|NCT00845520|592049434|FG000|Overall Study|Lost to Follow-up|1|||
164096424|NCT02653664|592717285|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
163912692|NCT00845520|592049435|FG001|Overall Study|Lost to Follow-up|0|||
164027213|NCT01927419|592459008|FG000|Treatment Period|Death|0|||
164027214|NCT01927419|592459009|FG001|Treatment Period|Death|1|||
164027215|NCT01927419|592459008|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
164027216|NCT01927419|592459009|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
164027217|NCT01927419|592459008|FG000|Treatment Period|Participant request to discontinue|12|||
164027218|NCT01927419|592459009|FG001|Treatment Period|Participant request to discontinue|4|||
164027219|NCT01927419|592459008|FG000|Treatment Period|Withdrawal by Subject|1|||
164027220|NCT01927419|592459009|FG001|Treatment Period|Withdrawal by Subject|1|||
164027221|NCT01927419|592459008|FG000|Treatment Period|Maximum Clinical Benefit|6|||
164027222|NCT01927419|592459009|FG001|Treatment Period|Maximum Clinical Benefit|2|||
164027223|NCT01927419|592459008|FG000|Treatment Period|Other reasons|3|||
163912693|NCT00845520|592049436|FG002|Overall Study|Lost to Follow-up|0|||
163912694|NCT00845520|592049434|FG000|Overall Study|Adverse Event|0|||
163912695|NCT00845520|592049435|FG001|Overall Study|Adverse Event|0|||
163912696|NCT00845520|592049436|FG002|Overall Study|Adverse Event|1|||
163912697|NCT02613403|592049437|FG000|Overall Study|Lost to Follow-up|0|||
163912698|NCT02613403|592049438|FG001|Overall Study|Lost to Follow-up|1|||
163912699|NCT02613403|592049439|FG002|Overall Study|Lost to Follow-up|0|||
163912700|NCT02613403|592049440|FG003|Overall Study|Lost to Follow-up|0|||
163912701|NCT02613403|592049441|FG004|Overall Study|Lost to Follow-up|0|||
163912702|NCT02613403|592049437|FG000|Overall Study|Withdrawal by Subject|2|||
163912703|NCT02613403|592049438|FG001|Overall Study|Withdrawal by Subject|0|||
163912704|NCT02613403|592049439|FG002|Overall Study|Withdrawal by Subject|0|||
163912705|NCT02613403|592049440|FG003|Overall Study|Withdrawal by Subject|0|||
164027224|NCT01927419|592459009|FG001|Treatment Period|Other reasons|4|||
164027225|NCT01927419|592459008|FG000|Treatment Period|Not Reported|1|||
164027226|NCT01927419|592459009|FG001|Treatment Period|Not Reported|1|||
164027227|NCT01935336|592459012|FG000|Overall Study|Adverse Event|1|||
164027228|NCT01935336|592459013|FG001|Overall Study|Adverse Event|0|||
164027229|NCT01935336|592459014|FG002|Overall Study|Adverse Event|0|||
164027230|NCT01935336|592459015|FG003|Overall Study|Adverse Event|0|||
164027231|NCT01935336|592459012|FG000|Overall Study|Progressive disease|5|||
164027232|NCT01935336|592459013|FG001|Overall Study|Progressive disease|3|||
164027233|NCT01935336|592459014|FG002|Overall Study|Progressive disease|47|||
164027234|NCT01935336|592459015|FG003|Overall Study|Progressive disease|66|||
164027235|NCT02773238|592459016|FG000|Overall Study|Lack of Efficacy|4|||
164027236|NCT03260205|592459017|FG000|Overall Study|Adverse Event|2|||
164027237|NCT03260205|592459018|FG001|Overall Study|Adverse Event|0|||
164027238|NCT03260205|592459019|FG002|Overall Study|Adverse Event|2|||
164027239|NCT03260205|592459020|FG003|Overall Study|Adverse Event|2|||
164027240|NCT03260205|592459021|FG004|Overall Study|Adverse Event|4|||
164027241|NCT03260205|592459017|FG000|Overall Study|Lost to Follow-up|2|||
164027242|NCT03260205|592459018|FG001|Overall Study|Lost to Follow-up|2|||
164027243|NCT03260205|592459019|FG002|Overall Study|Lost to Follow-up|1|||
164027244|NCT03260205|592459020|FG003|Overall Study|Lost to Follow-up|1|||
164027245|NCT03260205|592459021|FG004|Overall Study|Lost to Follow-up|5|||
164027246|NCT03260205|592459017|FG000|Overall Study|Protocol Violation|0|||
164027247|NCT03260205|592459018|FG001|Overall Study|Protocol Violation|0|||
164027248|NCT03260205|592459019|FG002|Overall Study|Protocol Violation|2|||
164027249|NCT03260205|592459020|FG003|Overall Study|Protocol Violation|0|||
164027250|NCT03260205|592459021|FG004|Overall Study|Protocol Violation|1|||
164027251|NCT03260205|592459017|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
164027252|NCT03260205|592459018|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
164027253|NCT03260205|592459019|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
164027254|NCT03260205|592459020|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
163912706|NCT02613403|592049441|FG004|Overall Study|Withdrawal by Subject|0|||
163912707|NCT00800176|592049445|FG000|Overall Study|Adverse Event|2|||
163912708|NCT00800176|592049446|FG001|Overall Study|Adverse Event|1|||
163912709|NCT00800176|592049447|FG002|Overall Study|Adverse Event|0|||
163912710|NCT00800176|592049448|FG003|Overall Study|Adverse Event|2|||
163912711|NCT00800176|592049449|FG004|Overall Study|Adverse Event|1|||
163912712|NCT00800176|592049450|FG005|Overall Study|Adverse Event|1|||
164027255|NCT03260205|592459021|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
164027256|NCT03260205|592459017|FG000|Overall Study|Other: Unspecified|0|||
164027257|NCT03260205|592459018|FG001|Overall Study|Other: Unspecified|0|||
164027258|NCT03260205|592459019|FG002|Overall Study|Other: Unspecified|3|||
164027259|NCT03260205|592459020|FG003|Overall Study|Other: Unspecified|1|||
163912713|NCT00800176|592049445|FG000|Overall Study|Refused treatment|3|||
163912714|NCT00800176|592049446|FG001|Overall Study|Refused treatment|2|||
164027260|NCT03260205|592459021|FG004|Overall Study|Other: Unspecified|1|||
164027261|NCT03260205|592459017|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
164027262|NCT03260205|592459018|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
163912715|NCT00800176|592049447|FG002|Overall Study|Refused treatment|0|||
163912716|NCT00800176|592049448|FG003|Overall Study|Refused treatment|0|||
163912717|NCT00800176|592049449|FG004|Overall Study|Refused treatment|1|||
163912718|NCT00800176|592049450|FG005|Overall Study|Refused treatment|4|||
163912719|NCT00800176|592049445|FG000|Overall Study|Failure to return|3|||
163912720|NCT00800176|592049446|FG001|Overall Study|Failure to return|3|||
163912721|NCT00800176|592049447|FG002|Overall Study|Failure to return|0|||
163912722|NCT00800176|592049448|FG003|Overall Study|Failure to return|2|||
163912723|NCT00800176|592049449|FG004|Overall Study|Failure to return|0|||
163912724|NCT00800176|592049450|FG005|Overall Study|Failure to return|0|||
163912725|NCT00800176|592049445|FG000|Overall Study|Other|1|||
163912726|NCT00800176|592049446|FG001|Overall Study|Other|0|||
163912727|NCT00800176|592049447|FG002|Overall Study|Other|0|||
163912728|NCT00800176|592049448|FG003|Overall Study|Other|0|||
163912729|NCT00800176|592049449|FG004|Overall Study|Other|2|||
163912730|NCT00800176|592049450|FG005|Overall Study|Other|0|||
163912731|NCT02326220|592049453|FG000|Double-blind Treatment Period|Adverse Event|1|||
163912732|NCT02326220|592049454|FG001|Double-blind Treatment Period|Adverse Event|2|||
163912733|NCT02326220|592049455|FG002|Double-blind Treatment Period|Adverse Event|0|||
163912734|NCT02326220|592049453|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163912735|NCT02326220|592049454|FG001|Double-blind Treatment Period|Protocol Violation|1|||
163912736|NCT02326220|592049455|FG002|Double-blind Treatment Period|Protocol Violation|0|||
163912737|NCT02326220|592049453|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164027263|NCT03260205|592459019|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
164027264|NCT03260205|592459020|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
164027265|NCT03260205|592459021|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
163912738|NCT02326220|592049454|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
163912739|NCT02326220|592049455|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164027266|NCT01877382|592459022|FG000|Dose Escalation|Progressive disease|2|||
164096425|NCT02653664|592717283|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
164096426|NCT02653664|592717284|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
164096427|NCT02653664|592717285|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
163912740|NCT02326220|592049453|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
163912741|NCT02326220|592049454|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
163912742|NCT02326220|592049455|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
163912743|NCT02326220|592049453|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163912744|NCT02326220|592049454|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
163912745|NCT02326220|592049455|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
163912746|NCT02699099|592049456|FG000|Overall Study|Adverse Event|1|||
163912747|NCT02699099|592049457|FG001|Overall Study|Adverse Event|0|||
163912748|NCT02699099|592049458|FG002|Overall Study|Adverse Event|2|||
163912749|NCT02699099|592049456|FG000|Overall Study|Lost to Follow-up|0|||
163912750|NCT02699099|592049457|FG001|Overall Study|Lost to Follow-up|1|||
163912751|NCT02699099|592049458|FG002|Overall Study|Lost to Follow-up|0|||
163912752|NCT02699099|592049456|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
163912753|NCT02699099|592049457|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
163912754|NCT02699099|592049458|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
163912755|NCT02659540|592049461|FG000|Overall Study|Adverse Event|3|||
163912756|NCT02659540|592049462|FG001|Overall Study|Adverse Event|2|||
163912757|NCT02659540|592049461|FG000|Overall Study|Death|1|||
163912758|NCT02659540|592049462|FG001|Overall Study|Death|0|||
163912759|NCT02659540|592049461|FG000|Overall Study|Progressive disease|2|||
163912760|NCT02659540|592049462|FG001|Overall Study|Progressive disease|6|||
163912761|NCT00824850|592049463|FG000|Overall Study|Withdrawal by Subject|0|||
163912762|NCT00824850|592049464|FG001|Overall Study|Withdrawal by Subject|1|||
163912763|NCT00882050|592049465|FG000|Overall Study|Physician Decision|1|||
163912764|NCT00882050|592049466|FG001|Overall Study|Physician Decision|0|||
163912765|NCT00882050|592049467|FG002|Overall Study|Physician Decision|0|||
163912766|NCT04820491|592049472|FG000|Overall Study|Withdrawal by Subject|1|||
163912767|NCT04820491|592049473|FG001|Overall Study|Withdrawal by Subject|0|||
163912768|NCT00452452|592049474|FG000|Overall Study|Protocol Violation|0|||
163912769|NCT00452452|592049475|FG001|Overall Study|Protocol Violation|0|||
163912770|NCT00452452|592049476|FG002|Overall Study|Protocol Violation|1|||
163912771|NCT00452452|592049474|FG000|Overall Study|Withdrawal by Subject|1|||
163912772|NCT00452452|592049475|FG001|Overall Study|Withdrawal by Subject|0|||
163912773|NCT00452452|592049476|FG002|Overall Study|Withdrawal by Subject|0|||
163912774|NCT00452452|592049474|FG000|Overall Study|Lost to Follow-up|1|||
163912775|NCT00452452|592049475|FG001|Overall Study|Lost to Follow-up|0|||
163912776|NCT00452452|592049476|FG002|Overall Study|Lost to Follow-up|0|||
163912777|NCT03072238|592051235|FG000|Overall Study|Withdrawal by Subject|44|||
163912778|NCT03072238|592051236|FG001|Overall Study|Withdrawal by Subject|64|||
163912779|NCT03072238|592051235|FG000|Overall Study|Lost to Follow-up|14|||
163912780|NCT03072238|592051236|FG001|Overall Study|Lost to Follow-up|5|||
163912781|NCT03072238|592051235|FG000|Overall Study|Physician Decision|4|||
163912782|NCT03072238|592051236|FG001|Overall Study|Physician Decision|6|||
163912783|NCT03072238|592051235|FG000|Overall Study|Death|351|||
163912784|NCT03072238|592051236|FG001|Overall Study|Death|318|||
163912785|NCT03072238|592051235|FG000|Overall Study|Progressive Disease|3|||
163912786|NCT03072238|592051236|FG001|Overall Study|Progressive Disease|4|||
163912787|NCT03072238|592051235|FG000|Overall Study|Reason Not Specified|138|||
163912788|NCT03072238|592051236|FG001|Overall Study|Reason Not Specified|150|||
163912789|NCT00608959|592051239|FG000|Part 1|Did not meet eligibility criteria|1|||
164027267|NCT01877382|592459023|FG001|Dose Escalation|Progressive disease|0|||
164027268|NCT01877382|592459024|FG002|Dose Escalation|Progressive disease|1|||
164027269|NCT01877382|592459025|FG003|Dose Escalation|Progressive disease|6|||
164027270|NCT01877382|592459026|FG004|Dose Escalation|Progressive disease|1|||
164027271|NCT01877382|592459027|FG005|Dose Escalation|Progressive disease|0|||
164027272|NCT01877382|592459028|FG006|Dose Escalation|Progressive disease|3|||
164027273|NCT01877382|592459029|FG007|Dose Escalation|Progressive disease|10|||
164027274|NCT01877382|592459030|FG008|Dose Escalation|Progressive disease|4|||
164027275|NCT01877382|592459031|FG009|Dose Escalation|Progressive disease|2|||
164027276|NCT01877382|592459032|FG010|Dose Escalation|Progressive disease|3|||
164027277|NCT01877382|592459033|FG011|Dose Escalation|Progressive disease|3|||
164027278|NCT01877382|592459034|FG012|Dose Escalation|Progressive disease|13|||
163912790|NCT01005602|592051240|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
163912791|NCT01005602|592051241|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
163912792|NCT01919489|592051247|FG000|Overall Study|Rejected the need of injections|4|||
163912793|NCT01919489|592051248|FG001|Overall Study|Rejected the need of injections|7|||
163912794|NCT01919489|592051247|FG000|Overall Study|Adverse Event|10|||
163912795|NCT01919489|592051248|FG001|Overall Study|Adverse Event|0|||
163912796|NCT01919489|592051247|FG000|Overall Study|Hospital readmission|2|||
163912797|NCT01919489|592051248|FG001|Overall Study|Hospital readmission|9|||
163912798|NCT01919489|592051247|FG000|Overall Study|Death|2|||
164027279|NCT01877382|592459035|FG013|Dose Escalation|Progressive disease|1|||
163912799|NCT01919489|592051248|FG001|Overall Study|Death|1|||
163912800|NCT01919489|592051247|FG000|Overall Study|Lost to Follow-up|38|||
163912801|NCT01919489|592051248|FG001|Overall Study|Lost to Follow-up|27|||
163912802|NCT03884478|592051249|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
164027280|NCT01877382|592459036|FG014|Dose Escalation|Progressive disease|0|||
164145297|NCT00025259|592894264|FG001|Overall Study|Protocol Violation|2|||
164027281|NCT01877382|592459022|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164027282|NCT01877382|592459023|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027283|NCT01877382|592459024|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027284|NCT01877382|592459025|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
163912803|NCT03884478|592051250|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
164027285|NCT01877382|592459026|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027286|NCT01877382|592459027|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027287|NCT01877382|592459028|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164027288|NCT01877382|592459029|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163912804|NCT03884478|592051251|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
163912805|NCT03884478|592051249|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
163912806|NCT03884478|592051250|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
163912807|NCT03884478|592051251|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
163912808|NCT03884478|592051249|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
163912809|NCT03884478|592051250|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
163912810|NCT03884478|592051251|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
163912811|NCT03884478|592051249|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
163912812|NCT03884478|592051250|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
163912813|NCT03884478|592051251|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
163912814|NCT00828139|592051252|FG000|Overall Study|Adverse Event|8|||
163912815|NCT00828139|592051253|FG001|Overall Study|Adverse Event|1|||
163912816|NCT00828139|592051254|FG002|Overall Study|Adverse Event|10|||
163912817|NCT00828139|592051255|FG003|Overall Study|Adverse Event|5|||
163912818|NCT00828139|592051252|FG000|Overall Study|Death|2|||
163912819|NCT00828139|592051253|FG001|Overall Study|Death|1|||
163912820|NCT00828139|592051254|FG002|Overall Study|Death|0|||
163912821|NCT00828139|592051255|FG003|Overall Study|Death|2|||
163912822|NCT00828139|592051252|FG000|Overall Study|Refusal unrelated to toxicity|3|||
163912823|NCT00828139|592051253|FG001|Overall Study|Refusal unrelated to toxicity|4|||
164027289|NCT01877382|592459030|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027290|NCT01877382|592459031|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027291|NCT01877382|592459032|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027292|NCT01877382|592459033|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027293|NCT01877382|592459034|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163912824|NCT00828139|592051254|FG002|Overall Study|Refusal unrelated to toxicity|5|||
163912825|NCT00828139|592051255|FG003|Overall Study|Refusal unrelated to toxicity|3|||
163912826|NCT00828139|592051252|FG000|Overall Study|Disease Progression|24|||
163912827|NCT00828139|592051253|FG001|Overall Study|Disease Progression|33|||
163912828|NCT00828139|592051254|FG002|Overall Study|Disease Progression|35|||
164073161|NCT03402126|592632835|FG000|Overall Study|Study product no longer in use|1|||
164027294|NCT01877382|592459035|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027295|NCT01877382|592459036|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027296|NCT01877382|592459022|FG000|Dose Escalation|Clinical progression|0|||
164027297|NCT01877382|592459023|FG001|Dose Escalation|Clinical progression|1|||
164027298|NCT01877382|592459024|FG002|Dose Escalation|Clinical progression|0|||
164027299|NCT01877382|592459025|FG003|Dose Escalation|Clinical progression|2|||
164027300|NCT01877382|592459026|FG004|Dose Escalation|Clinical progression|0|||
164027301|NCT01877382|592459027|FG005|Dose Escalation|Clinical progression|0|||
164027302|NCT01877382|592459028|FG006|Dose Escalation|Clinical progression|1|||
164300978|NCT02392624|593478384|FG001|Overall Study|Pregnancy|0|||
164300979|NCT02392624|593478385|FG002|Overall Study|Pregnancy|0|||
164300980|NCT02392624|593478383|FG000|Overall Study|Protocol Violation|0|||
164300981|NCT02392624|593478384|FG001|Overall Study|Protocol Violation|0|||
164300982|NCT02392624|593478385|FG002|Overall Study|Protocol Violation|1|||
164300983|NCT02392624|593478383|FG000|Overall Study|Sponsor/Investigator Decision|2|||
164300984|NCT02392624|593478384|FG001|Overall Study|Sponsor/Investigator Decision|1|||
164300985|NCT02392624|593478385|FG002|Overall Study|Sponsor/Investigator Decision|0|||
163912829|NCT00828139|592051255|FG003|Overall Study|Disease Progression|39|||
163912830|NCT00828139|592051252|FG000|Overall Study|Other|4|||
163912831|NCT00828139|592051253|FG001|Overall Study|Other|2|||
163912832|NCT00828139|592051254|FG002|Overall Study|Other|5|||
163912833|NCT00828139|592051255|FG003|Overall Study|Other|2|||
163912834|NCT04271254|592051256|FG000|Overall Study|Withdrawal by Subject|3|||
163912835|NCT04751929|592051257|FG000|Overall Study|Withdrawal by Subject|2|||
163912836|NCT04751929|592051258|FG001|Overall Study|Withdrawal by Subject|0|||
163912837|NCT04751929|592051259|FG002|Overall Study|Withdrawal by Subject|0|||
163912838|NCT04751929|592051260|FG003|Overall Study|Withdrawal by Subject|0|||
163912839|NCT04751929|592051257|FG000|Overall Study|Rising PSA|0|||
163912840|NCT04751929|592051258|FG001|Overall Study|Rising PSA|1|||
163912841|NCT04751929|592051259|FG002|Overall Study|Rising PSA|0|||
163912842|NCT04751929|592051260|FG003|Overall Study|Rising PSA|0|||
163912843|NCT04751929|592051257|FG000|Overall Study|Adverse Event|1|||
163912844|NCT04751929|592051258|FG001|Overall Study|Adverse Event|2|||
163912845|NCT04751929|592051259|FG002|Overall Study|Adverse Event|0|||
163912846|NCT04751929|592051260|FG003|Overall Study|Adverse Event|0|||
163912847|NCT04751929|592051257|FG000|Overall Study|Progressive Disease|3|||
163912848|NCT04751929|592051258|FG001|Overall Study|Progressive Disease|4|||
163912849|NCT04751929|592051259|FG002|Overall Study|Progressive Disease|4|||
163912850|NCT04751929|592051260|FG003|Overall Study|Progressive Disease|0|||
163912851|NCT04751929|592051257|FG000|Overall Study|Death|1|||
163912852|NCT04751929|592051258|FG001|Overall Study|Death|1|||
163912853|NCT04751929|592051259|FG002|Overall Study|Death|0|||
163912854|NCT04751929|592051260|FG003|Overall Study|Death|0|||
163912855|NCT00473512|592051265|FG000|Period 1 (Phase 1)|Adverse Event|0|||
163912856|NCT00473512|592051266|FG001|Period 1 (Phase 1)|Adverse Event|0|||
163912857|NCT00473512|592051267|FG002|Period 1 (Phase 1)|Adverse Event|0|||
163912858|NCT00473512|592051268|FG003|Period 1 (Phase 1)|Adverse Event|5|||
163912859|NCT00473512|592051269|FG004|Period 1 (Phase 1)|Adverse Event|0|||
163912860|NCT00473512|592051265|FG000|Period 1 (Phase 1)|Death|0|||
163912861|NCT00473512|592051266|FG001|Period 1 (Phase 1)|Death|0|||
163912862|NCT00473512|592051267|FG002|Period 1 (Phase 1)|Death|0|||
163912863|NCT00473512|592051268|FG003|Period 1 (Phase 1)|Death|1|||
163912864|NCT00473512|592051269|FG004|Period 1 (Phase 1)|Death|0|||
163912865|NCT00473512|592051265|FG000|Period 1 (Phase 1)|Disease Progression|1|||
163912866|NCT00473512|592051266|FG001|Period 1 (Phase 1)|Disease Progression|1|||
163912867|NCT00473512|592051267|FG002|Period 1 (Phase 1)|Disease Progression|0|||
163912868|NCT00473512|592051268|FG003|Period 1 (Phase 1)|Disease Progression|10|||
163912869|NCT00473512|592051269|FG004|Period 1 (Phase 1)|Disease Progression|1|||
163912870|NCT00473512|592051265|FG000|Period 1 (Phase 1)|Other|0|||
163912871|NCT00473512|592051266|FG001|Period 1 (Phase 1)|Other|0|||
163912872|NCT00473512|592051267|FG002|Period 1 (Phase 1)|Other|0|||
163912873|NCT00473512|592051268|FG003|Period 1 (Phase 1)|Other|1|||
163912874|NCT00473512|592051269|FG004|Period 1 (Phase 1)|Other|0|||
163912875|NCT00473512|592051265|FG000|Period 2 (Phase 2)|Adverse Event|0|||
163912876|NCT00473512|592051266|FG001|Period 2 (Phase 2)|Adverse Event|0|||
163912877|NCT00473512|592051267|FG002|Period 2 (Phase 2)|Adverse Event|0|||
163912878|NCT00473512|592051268|FG003|Period 2 (Phase 2)|Adverse Event|1|||
163912879|NCT00473512|592051269|FG004|Period 2 (Phase 2)|Adverse Event|0|||
163912880|NCT00473512|592051265|FG000|Period 2 (Phase 2)|Death|0|||
163912881|NCT00473512|592051266|FG001|Period 2 (Phase 2)|Death|0|||
163912882|NCT00473512|592051267|FG002|Period 2 (Phase 2)|Death|0|||
163912883|NCT00473512|592051268|FG003|Period 2 (Phase 2)|Death|1|||
163912884|NCT00473512|592051269|FG004|Period 2 (Phase 2)|Death|1|||
163912885|NCT00473512|592051265|FG000|Period 2 (Phase 2)|Disease Progression|0|||
163912886|NCT00473512|592051266|FG001|Period 2 (Phase 2)|Disease Progression|2|||
163912887|NCT00473512|592051267|FG002|Period 2 (Phase 2)|Disease Progression|2|||
164073162|NCT03402126|592632835|FG000|Overall Study|Technical problems|1|||
163912888|NCT00473512|592051268|FG003|Period 2 (Phase 2)|Disease Progression|17|||
164027303|NCT01877382|592459029|FG007|Dose Escalation|Clinical progression|0|||
164027304|NCT01877382|592459030|FG008|Dose Escalation|Clinical progression|0|||
164027305|NCT01877382|592459031|FG009|Dose Escalation|Clinical progression|1|||
163912889|NCT00473512|592051269|FG004|Period 2 (Phase 2)|Disease Progression|1|||
163912890|NCT00473512|592051265|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163912891|NCT00473512|592051266|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163912892|NCT00473512|592051267|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163912893|NCT00473512|592051268|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
163912894|NCT00473512|592051269|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
163912895|NCT00473512|592051265|FG000|Period 2 (Phase 2)|Other|1|||
163912896|NCT00473512|592051266|FG001|Period 2 (Phase 2)|Other|0|||
163912897|NCT00473512|592051267|FG002|Period 2 (Phase 2)|Other|0|||
163912898|NCT00473512|592051268|FG003|Period 2 (Phase 2)|Other|3|||
163912899|NCT00473512|592051269|FG004|Period 2 (Phase 2)|Other|0|||
163912900|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
163912901|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
163912902|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
163912903|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
163912904|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
163912905|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
163912906|NCT03557307|592051274|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
163912907|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
163912908|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|Death|3|||
164027306|NCT01877382|592459032|FG010|Dose Escalation|Clinical progression|0|||
164027307|NCT01877382|592459033|FG011|Dose Escalation|Clinical progression|0|||
164027308|NCT01877382|592459034|FG012|Dose Escalation|Clinical progression|2|||
164027309|NCT01877382|592459035|FG013|Dose Escalation|Clinical progression|1|||
164027310|NCT01877382|592459036|FG014|Dose Escalation|Clinical progression|0|||
164027311|NCT01877382|592459022|FG000|Dose Escalation|Adverse Event|0|||
164096428|NCT02653664|592717283|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
163912909|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
163912910|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
164027312|NCT01877382|592459023|FG001|Dose Escalation|Adverse Event|0|||
164096429|NCT02653664|592717284|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
163912911|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
164027313|NCT01877382|592459024|FG002|Dose Escalation|Adverse Event|0|||
164027314|NCT01877382|592459025|FG003|Dose Escalation|Adverse Event|4|||
163912912|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
163912913|NCT03557307|592051274|FG000|Period 2: Maintenance Phase|other|3|||
163912914|NCT03745651|592051275|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
163912915|NCT03745651|592051276|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
163912916|NCT03745651|592051277|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163912917|NCT03745651|592051278|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163912918|NCT03745651|592051279|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163912919|NCT03745651|592051280|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163912920|NCT03745651|592051281|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
163912921|NCT03745651|592051275|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
163912922|NCT03745651|592051276|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
163912923|NCT03745651|592051277|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
163912924|NCT03745651|592051278|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163912925|NCT03745651|592051279|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163912926|NCT03745651|592051280|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163912927|NCT03745651|592051281|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163912928|NCT03745651|592051275|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
163912929|NCT03745651|592051276|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163912930|NCT03745651|592051277|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
163912931|NCT03745651|592051278|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163912932|NCT03745651|592051279|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163912933|NCT03745651|592051280|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163912934|NCT03745651|592051281|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
163912935|NCT03745651|592051275|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163912936|NCT03745651|592051276|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
163912937|NCT03745651|592051277|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163912938|NCT03745651|592051278|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163912939|NCT03745651|592051279|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163912940|NCT03745651|592051280|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163912941|NCT03745651|592051281|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
163912942|NCT03745651|592051275|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
163912943|NCT03745651|592051276|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
163912944|NCT03745651|592051277|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
163912945|NCT03745651|592051278|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163912946|NCT03745651|592051279|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163912947|NCT03745651|592051280|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163912948|NCT03745651|592051281|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163912949|NCT03745651|592051275|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
163912950|NCT03745651|592051276|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
163912951|NCT03745651|592051277|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
163912952|NCT03745651|592051278|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163912953|NCT03745651|592051279|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163912954|NCT03745651|592051280|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
164027315|NCT01877382|592459026|FG004|Dose Escalation|Adverse Event|1|||
164027316|NCT01877382|592459027|FG005|Dose Escalation|Adverse Event|2|||
164027317|NCT01877382|592459028|FG006|Dose Escalation|Adverse Event|1|||
164027318|NCT01877382|592459029|FG007|Dose Escalation|Adverse Event|2|||
164027319|NCT01877382|592459030|FG008|Dose Escalation|Adverse Event|0|||
164027320|NCT01877382|592459031|FG009|Dose Escalation|Adverse Event|0|||
164027321|NCT01877382|592459032|FG010|Dose Escalation|Adverse Event|0|||
164027322|NCT01877382|592459033|FG011|Dose Escalation|Adverse Event|0|||
164027323|NCT01877382|592459034|FG012|Dose Escalation|Adverse Event|1|||
164027324|NCT01877382|592459035|FG013|Dose Escalation|Adverse Event|0|||
164027325|NCT01877382|592459036|FG014|Dose Escalation|Adverse Event|0|||
164027326|NCT01877382|592459022|FG000|Dose Escalation|Withdrawal by Subject|0|||
164027327|NCT01877382|592459023|FG001|Dose Escalation|Withdrawal by Subject|0|||
164027328|NCT01877382|592459024|FG002|Dose Escalation|Withdrawal by Subject|0|||
164027329|NCT01877382|592459025|FG003|Dose Escalation|Withdrawal by Subject|0|||
164027330|NCT01877382|592459026|FG004|Dose Escalation|Withdrawal by Subject|0|||
164027331|NCT01877382|592459027|FG005|Dose Escalation|Withdrawal by Subject|3|||
164027332|NCT01877382|592459028|FG006|Dose Escalation|Withdrawal by Subject|2|||
164027333|NCT01877382|592459029|FG007|Dose Escalation|Withdrawal by Subject|1|||
164027334|NCT01877382|592459030|FG008|Dose Escalation|Withdrawal by Subject|1|||
164027335|NCT01877382|592459031|FG009|Dose Escalation|Withdrawal by Subject|0|||
164027336|NCT01877382|592459032|FG010|Dose Escalation|Withdrawal by Subject|0|||
164027337|NCT01877382|592459033|FG011|Dose Escalation|Withdrawal by Subject|0|||
164027338|NCT01877382|592459034|FG012|Dose Escalation|Withdrawal by Subject|0|||
163912955|NCT03745651|592051281|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
163912956|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163912957|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163912958|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
164027339|NCT01877382|592459035|FG013|Dose Escalation|Withdrawal by Subject|0|||
164027340|NCT01877382|592459036|FG014|Dose Escalation|Withdrawal by Subject|0|||
164027341|NCT01877382|592459022|FG000|Dose Escalation|Protocol Violation|0|||
164027342|NCT01877382|592459023|FG001|Dose Escalation|Protocol Violation|0|||
164027343|NCT01877382|592459024|FG002|Dose Escalation|Protocol Violation|0|||
163912959|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163912960|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163912961|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
163912962|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
163912963|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163912964|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163912965|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163912966|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
163912967|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163912968|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
163912969|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
164027344|NCT01877382|592459025|FG003|Dose Escalation|Protocol Violation|0|||
164027345|NCT01877382|592459026|FG004|Dose Escalation|Protocol Violation|0|||
164096430|NCT02653664|592717285|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164096431|NCT02653664|592717283|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
164027346|NCT01877382|592459027|FG005|Dose Escalation|Protocol Violation|0|||
164027347|NCT01877382|592459028|FG006|Dose Escalation|Protocol Violation|1|||
164027348|NCT01877382|592459029|FG007|Dose Escalation|Protocol Violation|0|||
164027349|NCT01877382|592459030|FG008|Dose Escalation|Protocol Violation|0|||
164027350|NCT01877382|592459031|FG009|Dose Escalation|Protocol Violation|0|||
164027351|NCT01877382|592459032|FG010|Dose Escalation|Protocol Violation|0|||
164027352|NCT01877382|592459033|FG011|Dose Escalation|Protocol Violation|0|||
164027353|NCT01877382|592459034|FG012|Dose Escalation|Protocol Violation|0|||
164027354|NCT01877382|592459035|FG013|Dose Escalation|Protocol Violation|0|||
164027355|NCT01877382|592459036|FG014|Dose Escalation|Protocol Violation|0|||
164096432|NCT02653664|592717284|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
164096433|NCT02653664|592717285|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
164096434|NCT02653664|592717283|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
164096435|NCT02653664|592717284|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
164096436|NCT02653664|592717285|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
164096437|NCT02653664|592717283|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
164096438|NCT02653664|592717284|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
164096439|NCT02653664|592717285|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
164096440|NCT02653664|592717283|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164096441|NCT02653664|592717284|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
164096442|NCT02653664|592717285|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
164096443|NCT02653664|592717283|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
164096444|NCT02653664|592717284|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
164096445|NCT02653664|592717285|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
164096446|NCT04657770|592717286|FG000|Overall Study|Withdrawal by Subject|3|||
164112593|NCT01460628|592774039|FG000|Overall Study|Withdrawal by Subject|2|||
163912970|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163912971|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163912972|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163912973|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
163912974|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
163912975|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
163912976|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
163912977|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163912978|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163912979|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163912980|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
163912981|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
163912982|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
163912983|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
163912984|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163912985|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163912986|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163912987|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
163912988|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163912989|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
163912990|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
163912991|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163912992|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163912993|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163912994|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163912995|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163912996|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
163912997|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
163912998|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163912999|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163913000|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163913001|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
163913002|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
163913003|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
163913004|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
163913005|NCT03745651|592051275|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163913006|NCT03745651|592051276|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163913007|NCT03745651|592051277|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163913008|NCT03745651|592051278|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
163913009|NCT03745651|592051279|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
163913010|NCT03745651|592051280|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
163913011|NCT03745651|592051281|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
163913012|NCT04175834|592051282|FG000|Overall Study|Withdrawal by Subject|1|||
163913013|NCT04175834|592051283|FG001|Overall Study|Withdrawal by Subject|0|||
163913014|NCT00946088|592051284|FG000|Overall Study|Withdrawal by Subject|0|||
163913015|NCT00946088|592051285|FG001|Overall Study|Withdrawal by Subject|1|||
163913016|NCT01322347|592051289|FG000|Overall Study|Adverse Event|7|||
163913017|NCT01322347|592051290|FG001|Overall Study|Adverse Event|2|||
163913018|NCT01322347|592051289|FG000|Overall Study|Death|5|||
163913019|NCT01322347|592051290|FG001|Overall Study|Death|3|||
163913020|NCT01322347|592051289|FG000|Overall Study|Physician Decision|2|||
164096447|NCT04657770|592717286|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
164096448|NCT00485472|592717287|FG000|Overall Study|Adverse Event|8|||
163913021|NCT01322347|592051290|FG001|Overall Study|Physician Decision|1|||
163913022|NCT01322347|592051289|FG000|Overall Study|Protocol Violation|5|||
163913023|NCT01322347|592051290|FG001|Overall Study|Protocol Violation|2|||
163913024|NCT01322347|592051289|FG000|Overall Study|Withdrawal by Subject|1|||
164096449|NCT00485472|592717288|FG001|Overall Study|Adverse Event|5|||
163913025|NCT01322347|592051290|FG001|Overall Study|Withdrawal by Subject|4|||
164096450|NCT00485472|592717287|FG000|Overall Study|Lack of Efficacy|5|||
164096451|NCT00485472|592717288|FG001|Overall Study|Lack of Efficacy|4|||
163913026|NCT01322347|592051289|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
163913027|NCT01322347|592051290|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
163913028|NCT01322347|592051289|FG000|Overall Study|blood transfusion|5|||
164027356|NCT01877382|592459022|FG000|Dose Escalation|Study terminated by sponsor|0|||
164027357|NCT01877382|592459023|FG001|Dose Escalation|Study terminated by sponsor|0|||
164027358|NCT01877382|592459024|FG002|Dose Escalation|Study terminated by sponsor|0|||
163913029|NCT01322347|592051290|FG001|Overall Study|blood transfusion|5|||
163913030|NCT01322347|592051289|FG000|Overall Study|sponsor decision|1|||
164027359|NCT01877382|592459025|FG003|Dose Escalation|Study terminated by sponsor|0|||
164027360|NCT01877382|592459026|FG004|Dose Escalation|Study terminated by sponsor|0|||
164027361|NCT01877382|592459027|FG005|Dose Escalation|Study terminated by sponsor|0|||
164027362|NCT01877382|592459028|FG006|Dose Escalation|Study terminated by sponsor|0|||
164027363|NCT01877382|592459029|FG007|Dose Escalation|Study terminated by sponsor|1|||
164027364|NCT01877382|592459030|FG008|Dose Escalation|Study terminated by sponsor|1|||
164027365|NCT01877382|592459031|FG009|Dose Escalation|Study terminated by sponsor|0|||
164027366|NCT01877382|592459032|FG010|Dose Escalation|Study terminated by sponsor|0|||
164027367|NCT01877382|592459033|FG011|Dose Escalation|Study terminated by sponsor|0|||
163913031|NCT01322347|592051290|FG001|Overall Study|sponsor decision|3|||
163913032|NCT01322347|592051289|FG000|Overall Study|ineligible|6|||
163913033|NCT01322347|592051290|FG001|Overall Study|ineligible|3|||
163913034|NCT01322347|592051289|FG000|Overall Study|kidney transplant|3|||
163913035|NCT01322347|592051290|FG001|Overall Study|kidney transplant|1|||
163913036|NCT01322347|592051289|FG000|Overall Study|study drug withheld > 12 wks|0|||
163913037|NCT01322347|592051290|FG001|Overall Study|study drug withheld > 12 wks|1|||
163913038|NCT01322347|592051289|FG000|Overall Study|moved/changed dialysis|2|||
163913039|NCT01322347|592051290|FG001|Overall Study|moved/changed dialysis|4|||
163913040|NCT01193283|592051291|FG000|Overall Study|Death|1|||
163913041|NCT04239911|592051292|FG000|Overall Study|Lost to Follow-up|2|||
163913042|NCT04239911|592051293|FG001|Overall Study|Lost to Follow-up|1|||
163913043|NCT02137785|592051294|FG000|Overall Study|Lost to Follow-up|1|||
163913044|NCT02137785|592051295|FG001|Overall Study|Lost to Follow-up|0|||
163913045|NCT02137785|592051294|FG000|Overall Study|Withdrawal by Subject|1|||
163913046|NCT02137785|592051295|FG001|Overall Study|Withdrawal by Subject|4|||
163913047|NCT02137785|592051294|FG000|Overall Study|subject moved out of state|1|||
163913048|NCT02137785|592051295|FG001|Overall Study|subject moved out of state|0|||
163913049|NCT03345407|592051297|FG000|Overall Study|Withdrawal by Subject|11|||
163913050|NCT03345407|592051298|FG001|Overall Study|Withdrawal by Subject|1|||
163913051|NCT03345407|592051299|FG002|Overall Study|Withdrawal by Subject|5|||
163913052|NCT03345407|592051300|FG003|Overall Study|Withdrawal by Subject|6|||
163913053|NCT03345407|592051301|FG004|Overall Study|Withdrawal by Subject|3|||
163913054|NCT03345407|592051302|FG005|Overall Study|Withdrawal by Subject|6|||
163913055|NCT03345407|592051303|FG006|Overall Study|Withdrawal by Subject|16|||
163913056|NCT03345407|592051297|FG000|Overall Study|Physician Decision|3|||
163913057|NCT03345407|592051298|FG001|Overall Study|Physician Decision|1|||
163913058|NCT03345407|592051299|FG002|Overall Study|Physician Decision|0|||
163913059|NCT03345407|592051300|FG003|Overall Study|Physician Decision|0|||
163913060|NCT03345407|592051301|FG004|Overall Study|Physician Decision|1|||
163913061|NCT03345407|592051302|FG005|Overall Study|Physician Decision|2|||
163913062|NCT03345407|592051303|FG006|Overall Study|Physician Decision|3|||
163913063|NCT03345407|592051297|FG000|Overall Study|Lost to Follow-up|2|||
163913064|NCT03345407|592051298|FG001|Overall Study|Lost to Follow-up|0|||
163913065|NCT03345407|592051299|FG002|Overall Study|Lost to Follow-up|1|||
163913066|NCT03345407|592051300|FG003|Overall Study|Lost to Follow-up|0|||
163913067|NCT03345407|592051301|FG004|Overall Study|Lost to Follow-up|1|||
163913068|NCT03345407|592051302|FG005|Overall Study|Lost to Follow-up|2|||
163913069|NCT03345407|592051303|FG006|Overall Study|Lost to Follow-up|3|||
163913070|NCT03345407|592051297|FG000|Overall Study|Protocol-defined stopping criteria|9|||
163913071|NCT03345407|592051298|FG001|Overall Study|Protocol-defined stopping criteria|0|||
163913072|NCT03345407|592051299|FG002|Overall Study|Protocol-defined stopping criteria|0|||
163913073|NCT03345407|592051300|FG003|Overall Study|Protocol-defined stopping criteria|0|||
163913074|NCT03345407|592051301|FG004|Overall Study|Protocol-defined stopping criteria|2|||
163913075|NCT03345407|592051302|FG005|Overall Study|Protocol-defined stopping criteria|1|||
163913076|NCT03345407|592051303|FG006|Overall Study|Protocol-defined stopping criteria|1|||
163913077|NCT03345407|592051297|FG000|Overall Study|Protocol Violation|2|||
163913078|NCT03345407|592051298|FG001|Overall Study|Protocol Violation|0|||
163913079|NCT03345407|592051299|FG002|Overall Study|Protocol Violation|0|||
163913080|NCT03345407|592051300|FG003|Overall Study|Protocol Violation|0|||
163913081|NCT03345407|592051301|FG004|Overall Study|Protocol Violation|1|||
163913082|NCT03345407|592051302|FG005|Overall Study|Protocol Violation|0|||
163913083|NCT03345407|592051303|FG006|Overall Study|Protocol Violation|3|||
163913084|NCT03345407|592051297|FG000|Overall Study|Lack of Efficacy|1|||
163913085|NCT03345407|592051298|FG001|Overall Study|Lack of Efficacy|1|||
163913086|NCT03345407|592051299|FG002|Overall Study|Lack of Efficacy|1|||
163913087|NCT03345407|592051300|FG003|Overall Study|Lack of Efficacy|1|||
163913088|NCT03345407|592051301|FG004|Overall Study|Lack of Efficacy|1|||
163913089|NCT03345407|592051302|FG005|Overall Study|Lack of Efficacy|0|||
163913090|NCT03345407|592051303|FG006|Overall Study|Lack of Efficacy|3|||
163913091|NCT03345407|592051297|FG000|Overall Study|Adverse Event|4|||
163913092|NCT03345407|592051298|FG001|Overall Study|Adverse Event|0|||
163913093|NCT03345407|592051299|FG002|Overall Study|Adverse Event|5|||
163913094|NCT03345407|592051300|FG003|Overall Study|Adverse Event|4|||
163913095|NCT03345407|592051301|FG004|Overall Study|Adverse Event|6|||
163913096|NCT03345407|592051302|FG005|Overall Study|Adverse Event|5|||
163913097|NCT03345407|592051303|FG006|Overall Study|Adverse Event|16|||
163913098|NCT01584648|592051304|FG000|Overall Study|Death|136|||
163913099|NCT01584648|592051305|FG001|Overall Study|Death|146|||
163913100|NCT01584648|592051304|FG000|Overall Study|Lost to Follow-up|9|||
163913101|NCT01584648|592051305|FG001|Overall Study|Lost to Follow-up|9|||
163913102|NCT01584648|592051304|FG000|Overall Study|Investigator discretion|3|||
163913103|NCT01584648|592051305|FG001|Overall Study|Investigator discretion|2|||
163913104|NCT01584648|592051304|FG000|Overall Study|Withdrew consent|13|||
163913105|NCT01584648|592051305|FG001|Overall Study|Withdrew consent|4|||
163913106|NCT01584648|592051304|FG000|Overall Study|Study closed/terminated|50|||
163913107|NCT01584648|592051305|FG001|Overall Study|Study closed/terminated|23|||
163913108|NCT01584648|592051304|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
163913109|NCT01584648|592051305|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
163913110|NCT03693989|592051308|FG000|Overall Study|Protocol Violation|3|||
163913111|NCT03693989|592051309|FG001|Overall Study|Protocol Violation|4|||
163913112|NCT01190436|592051310|FG000|Overall Study|Lost to Follow-up|35|||
163913113|NCT01190436|592051310|FG000|Overall Study|Other|4|||
163913114|NCT03146845|592051311|FG000|Overall Study|Reference ulcer healed|1|||
163913115|NCT03146845|592051312|FG001|Overall Study|Reference ulcer healed|0|||
163913116|NCT03146845|592051311|FG000|Overall Study|Physician Decision|1|||
163913117|NCT03146845|592051312|FG001|Overall Study|Physician Decision|0|||
163913118|NCT03146845|592051311|FG000|Overall Study|Adverse Event|1|||
163913119|NCT03146845|592051312|FG001|Overall Study|Adverse Event|0|||
163913120|NCT03146845|592051311|FG000|Overall Study|Withdrawal by Subject|2|||
163913121|NCT03146845|592051312|FG001|Overall Study|Withdrawal by Subject|0|||
163913122|NCT03146845|592051311|FG000|Overall Study|Noncompliance|0|||
163913123|NCT03146845|592051312|FG001|Overall Study|Noncompliance|1|||
163913124|NCT03146845|592051311|FG000|Overall Study|Protocol Violation|0|||
163913125|NCT03146845|592051312|FG001|Overall Study|Protocol Violation|2|||
163913126|NCT03146845|592051311|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
163913127|NCT03146845|592051312|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
163913128|NCT01052272|592051315|FG000|Overall Study|Death|0|||
163913129|NCT01052272|592051316|FG001|Overall Study|Death|0|||
163913130|NCT01052272|592051317|FG002|Overall Study|Death|1|||
163913131|NCT01052272|592051318|FG003|Overall Study|Death|1|||
163913132|NCT01052272|592051315|FG000|Overall Study|Physician Decision|0|||
163913133|NCT01052272|592051316|FG001|Overall Study|Physician Decision|1|||
163913134|NCT01052272|592051317|FG002|Overall Study|Physician Decision|0|||
163913135|NCT01052272|592051318|FG003|Overall Study|Physician Decision|0|||
163913136|NCT01052272|592051315|FG000|Overall Study|patient refuses follow-up|5|||
163913137|NCT01052272|592051316|FG001|Overall Study|patient refuses follow-up|4|||
163913138|NCT01052272|592051317|FG002|Overall Study|patient refuses follow-up|2|||
163913139|NCT01052272|592051318|FG003|Overall Study|patient refuses follow-up|4|||
163913140|NCT01052272|592051315|FG000|Overall Study|Withdrawal by Subject|0|||
163913141|NCT01052272|592051316|FG001|Overall Study|Withdrawal by Subject|2|||
163913142|NCT01052272|592051317|FG002|Overall Study|Withdrawal by Subject|3|||
163913143|NCT01052272|592051318|FG003|Overall Study|Withdrawal by Subject|2|||
163913144|NCT01052272|592051315|FG000|Overall Study|placed in long-term care|0|||
163913145|NCT01052272|592051316|FG001|Overall Study|placed in long-term care|0|||
163913146|NCT01052272|592051317|FG002|Overall Study|placed in long-term care|1|||
163913147|NCT01052272|592051318|FG003|Overall Study|placed in long-term care|0|||
163913148|NCT01052272|592051315|FG000|Overall Study|decline in health|0|||
163913149|NCT01052272|592051316|FG001|Overall Study|decline in health|0|||
163913150|NCT01052272|592051317|FG002|Overall Study|decline in health|1|||
163913151|NCT01052272|592051318|FG003|Overall Study|decline in health|0|||
163913152|NCT00113529|592051320|FG000|Overall Study|Adverse Event|4|||
163913153|NCT00113529|592051320|FG000|Overall Study|Lack of Efficacy|20|||
163913154|NCT00113529|592051320|FG000|Overall Study|Decision of sponsor|6|||
163913155|NCT00113529|592051320|FG000|Overall Study|Withdrawal by Subject|4|||
163913156|NCT00841321|592051327|FG000|Overall Study|Lost to Follow-up|1|||
163913157|NCT00841321|592051328|FG001|Overall Study|Lost to Follow-up|1|||
163913158|NCT00841321|592051327|FG000|Overall Study|Adverse Event|0|||
163913159|NCT00841321|592051328|FG001|Overall Study|Adverse Event|2|||
163913160|NCT02632747|592051331|FG000|Wash-out Period|Adverse Event|1|||
163913161|NCT02632747|592051332|FG001|Wash-out Period|Adverse Event|0|||
163913162|NCT03651271|592051333|FG000|Overall Study|Death|4|||
164027368|NCT01877382|592459034|FG012|Dose Escalation|Study terminated by sponsor|3|||
164027369|NCT01877382|592459035|FG013|Dose Escalation|Study terminated by sponsor|0|||
164027370|NCT01877382|592459036|FG014|Dose Escalation|Study terminated by sponsor|0|||
163913163|NCT03651271|592051334|FG001|Overall Study|Death|37|||
163913164|NCT03651271|592051335|FG002|Overall Study|Death|0|||
163913165|NCT03651271|592051336|FG003|Overall Study|Death|2|||
163913166|NCT03651271|592051337|FG004|Overall Study|Death|6|||
163913167|NCT03651271|592051333|FG000|Overall Study|Lost to Follow-up|1|||
164027371|NCT01877382|592459022|FG000|Dose Escalation|Death|0|||
163913168|NCT03651271|592051334|FG001|Overall Study|Lost to Follow-up|5|||
163913169|NCT03651271|592051335|FG002|Overall Study|Lost to Follow-up|0|||
163913170|NCT03651271|592051336|FG003|Overall Study|Lost to Follow-up|1|||
163913171|NCT03651271|592051337|FG004|Overall Study|Lost to Follow-up|0|||
164027372|NCT01877382|592459023|FG001|Dose Escalation|Death|0|||
163913172|NCT03651271|592051333|FG000|Overall Study|Physician Decision|0|||
163913173|NCT03651271|592051334|FG001|Overall Study|Physician Decision|2|||
163913174|NCT03651271|592051335|FG002|Overall Study|Physician Decision|0|||
163913175|NCT03651271|592051336|FG003|Overall Study|Physician Decision|0|||
163913176|NCT03651271|592051337|FG004|Overall Study|Physician Decision|0|||
163913177|NCT03651271|592051333|FG000|Overall Study|Withdrawal by Subject|1|||
163913178|NCT03651271|592051334|FG001|Overall Study|Withdrawal by Subject|15|||
163913179|NCT03651271|592051335|FG002|Overall Study|Withdrawal by Subject|0|||
163913180|NCT03651271|592051336|FG003|Overall Study|Withdrawal by Subject|0|||
163913181|NCT03651271|592051337|FG004|Overall Study|Withdrawal by Subject|1|||
163913182|NCT03651271|592051333|FG000|Overall Study|Patient medically unable to continue|0|||
163913183|NCT03651271|592051334|FG001|Overall Study|Patient medically unable to continue|0|||
163913184|NCT03651271|592051335|FG002|Overall Study|Patient medically unable to continue|0|||
163913185|NCT03651271|592051336|FG003|Overall Study|Patient medically unable to continue|1|||
163913186|NCT03651271|592051337|FG004|Overall Study|Patient medically unable to continue|0|||
163913187|NCT00821093|592051338|FG000|Overall Study|Adverse Event|20|||
163913188|NCT00821093|592051339|FG001|Overall Study|Adverse Event|12|||
163913189|NCT00821093|592051338|FG000|Overall Study|Withdrawal by Subject|9|||
163913190|NCT00821093|592051339|FG001|Overall Study|Withdrawal by Subject|13|||
163913191|NCT00821093|592051338|FG000|Overall Study|Lost to Follow-up|9|||
163913192|NCT00821093|592051339|FG001|Overall Study|Lost to Follow-up|3|||
163913193|NCT00821093|592051338|FG000|Overall Study|Protocol deviation|3|||
163913194|NCT00821093|592051339|FG001|Overall Study|Protocol deviation|6|||
163913195|NCT00821093|592051338|FG000|Overall Study|Abnormal laboratory value(s)|2|||
163913196|NCT00821093|592051339|FG001|Overall Study|Abnormal laboratory value(s)|0|||
163913197|NCT00821093|592051338|FG000|Overall Study|Lack of Efficacy|2|||
163913198|NCT00821093|592051339|FG001|Overall Study|Lack of Efficacy|2|||
163913199|NCT00821093|592051338|FG000|Overall Study|Death|2|||
163913200|NCT00821093|592051339|FG001|Overall Study|Death|1|||
163913201|NCT00821093|592051338|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163913202|NCT00821093|592051339|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163913203|NCT00821093|592051338|FG000|Overall Study|Administrative problems|1|||
163913204|NCT00821093|592051339|FG001|Overall Study|Administrative problems|2|||
163913205|NCT01107912|592051340|FG000|Period 1|Adverse Event|0|||
163913206|NCT01107912|592051341|FG001|Period 1|Adverse Event|0|||
163913207|NCT01107912|592051342|FG002|Period 1|Adverse Event|0|||
163913208|NCT01107912|592051343|FG003|Period 1|Adverse Event|0|||
163913209|NCT01107912|592051344|FG004|Period 1|Adverse Event|2|||
163913210|NCT01107912|592051345|FG005|Period 1|Adverse Event|0|||
163913211|NCT01107912|592051340|FG000|Period 1|Physician Decision|0|||
163913212|NCT01107912|592051341|FG001|Period 1|Physician Decision|0|||
163913213|NCT01107912|592051342|FG002|Period 1|Physician Decision|0|||
163913214|NCT01107912|592051343|FG003|Period 1|Physician Decision|0|||
163913215|NCT01107912|592051344|FG004|Period 1|Physician Decision|1|||
163913216|NCT01107912|592051345|FG005|Period 1|Physician Decision|0|||
163913217|NCT01107912|592051340|FG000|Period 1|Withdrawal by Subject|1|||
163913218|NCT01107912|592051341|FG001|Period 1|Withdrawal by Subject|0|||
163913219|NCT01107912|592051342|FG002|Period 1|Withdrawal by Subject|0|||
163913220|NCT01107912|592051343|FG003|Period 1|Withdrawal by Subject|0|||
163913221|NCT01107912|592051344|FG004|Period 1|Withdrawal by Subject|0|||
163913222|NCT01107912|592051345|FG005|Period 1|Withdrawal by Subject|0|||
164027373|NCT01877382|592459024|FG002|Dose Escalation|Death|0|||
163913223|NCT01107912|592051340|FG000|Period 2|Physician Decision|0|||
163913224|NCT01107912|592051341|FG001|Period 2|Physician Decision|0|||
163913225|NCT01107912|592051342|FG002|Period 2|Physician Decision|1|||
163913226|NCT01107912|592051343|FG003|Period 2|Physician Decision|0|||
163913227|NCT01107912|592051344|FG004|Period 2|Physician Decision|0|||
163913228|NCT01107912|592051345|FG005|Period 2|Physician Decision|0|||
163913229|NCT01107912|592051340|FG000|Period 3|Adverse Event|0|||
163913230|NCT01107912|592051341|FG001|Period 3|Adverse Event|1|||
163913231|NCT01107912|592051342|FG002|Period 3|Adverse Event|1|||
163913232|NCT01107912|592051343|FG003|Period 3|Adverse Event|0|||
163913233|NCT01107912|592051344|FG004|Period 3|Adverse Event|0|||
163913234|NCT01107912|592051345|FG005|Period 3|Adverse Event|0|||
163913235|NCT01107912|592051340|FG000|Period 3|Withdrawal by Subject|0|||
163913236|NCT01107912|592051341|FG001|Period 3|Withdrawal by Subject|0|||
163913237|NCT01107912|592051342|FG002|Period 3|Withdrawal by Subject|0|||
164096452|NCT00485472|592717287|FG000|Overall Study|Withdrawal by Subject|1|||
164096453|NCT00485472|592717288|FG001|Overall Study|Withdrawal by Subject|0|||
163913238|NCT01107912|592051343|FG003|Period 3|Withdrawal by Subject|1|||
163913239|NCT01107912|592051344|FG004|Period 3|Withdrawal by Subject|0|||
163913240|NCT01107912|592051345|FG005|Period 3|Withdrawal by Subject|0|||
163913241|NCT00595959|592051346|FG000|Overall Study|Withdrawal by Subject|1|||
163913242|NCT00595959|592051346|FG000|Overall Study|Lost to Follow-up|1|||
163913243|NCT00886834|592051347|FG000|Overall Study|Protocol Violation|0|||
163913244|NCT00886834|592051348|FG001|Overall Study|Protocol Violation|3|||
163913245|NCT03875729|592051349|FG000|Overall Study|Adverse Event|0|||
163913246|NCT03875729|592051350|FG001|Overall Study|Adverse Event|5|||
163913247|NCT03875729|592051349|FG000|Overall Study|Withdrawal by Subject|8|||
163913248|NCT03875729|592051350|FG001|Overall Study|Withdrawal by Subject|11|||
163913249|NCT03875729|592051349|FG000|Overall Study|Pregnancy|0|||
163913250|NCT03875729|592051350|FG001|Overall Study|Pregnancy|1|||
163913251|NCT03875729|592051349|FG000|Overall Study|Lost to Follow-up|0|||
163913252|NCT03875729|592051350|FG001|Overall Study|Lost to Follow-up|5|||
163913253|NCT03875729|592051349|FG000|Overall Study|Personal reasons|2|||
164096454|NCT00485472|592717287|FG000|Overall Study|Protocol Violation|0|||
163913254|NCT03875729|592051350|FG001|Overall Study|Personal reasons|0|||
163913255|NCT01280656|592051351|FG000|Overall Study|Adverse Event|1|||
163913256|NCT01280656|592051352|FG001|Overall Study|Adverse Event|14|||
163913257|NCT01280656|592051353|FG002|Overall Study|Adverse Event|13|||
163913258|NCT01280656|592051351|FG000|Overall Study|Lack of Efficacy|1|||
163913259|NCT01280656|592051352|FG001|Overall Study|Lack of Efficacy|22|||
163913260|NCT01280656|592051353|FG002|Overall Study|Lack of Efficacy|38|||
163913261|NCT01280656|592051351|FG000|Overall Study|Treatment shortening (RGT)|0|||
163913262|NCT01280656|592051352|FG001|Overall Study|Treatment shortening (RGT)|4|||
163913263|NCT01280656|592051353|FG002|Overall Study|Treatment shortening (RGT)|5|||
163913264|NCT01280656|592051351|FG000|Overall Study|Other|1|||
163913265|NCT01280656|592051352|FG001|Overall Study|Other|7|||
163913266|NCT01280656|592051353|FG002|Overall Study|Other|7|||
163913267|NCT04085614|592051354|FG000|Overall Study|Protocol Violation|9|||
163913268|NCT04085614|592051355|FG001|Overall Study|Protocol Violation|6|||
163913269|NCT01029925|592051356|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
163913270|NCT01029925|592051356|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
163913271|NCT01029925|592051356|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
163913272|NCT05265247|592051357|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
163913273|NCT05265247|592051358|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
163913274|NCT05265247|592051357|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
163913275|NCT05265247|592051358|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
163913276|NCT05265247|592051357|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
163913277|NCT05265247|592051358|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
163913278|NCT00476957|592051359|FG000|Overall Study|Lost to Follow-up|176|||
163913279|NCT00476957|592051360|FG001|Overall Study|Lost to Follow-up|193|||
163913280|NCT02516202|592051361|FG000|Overall Study|Withdrawal by Subject|1|||
163913281|NCT02516202|592051362|FG001|Overall Study|Withdrawal by Subject|0|||
163913282|NCT02516202|592051363|FG002|Overall Study|Withdrawal by Subject|1|||
164096455|NCT00485472|592717288|FG001|Overall Study|Protocol Violation|1|||
164096456|NCT00485472|592717287|FG000|Overall Study|Other|2|||
163913283|NCT02516202|592051361|FG000|Overall Study|Lost to Follow-up|1|||
164096457|NCT00485472|592717288|FG001|Overall Study|Other|1|||
163913284|NCT02516202|592051362|FG001|Overall Study|Lost to Follow-up|1|||
163913285|NCT02516202|592051363|FG002|Overall Study|Lost to Follow-up|1|||
164096458|NCT00485472|592717287|FG000|Overall Study|Lost to Follow-up|0|||
163913286|NCT02516202|592051361|FG000|Overall Study|Stopped Follow-up|0|||
163913287|NCT02516202|592051362|FG001|Overall Study|Stopped Follow-up|0|||
163913288|NCT02516202|592051363|FG002|Overall Study|Stopped Follow-up|1|||
163913289|NCT01000649|592051366|FG000|Overall Study|Adverse Event|5|||
163913290|NCT01000649|592051367|FG001|Overall Study|Adverse Event|1|||
163913291|NCT01000649|592051368|FG002|Overall Study|Adverse Event|2|||
163913292|NCT01000649|592051369|FG003|Overall Study|Adverse Event|4|||
163913293|NCT01000649|592051366|FG000|Overall Study|Lost to Follow-up|0|||
163913294|NCT01000649|592051367|FG001|Overall Study|Lost to Follow-up|2|||
163913295|NCT01000649|592051368|FG002|Overall Study|Lost to Follow-up|0|||
163913296|NCT01000649|592051369|FG003|Overall Study|Lost to Follow-up|2|||
163913297|NCT01916109|592051370|FG000|Overall Study|Withdrawal by Subject|1|||
163913298|NCT00103857|592051371|FG000|54-Week Base Study|Adverse Event|12|||
163913299|NCT00103857|592051372|FG001|54-Week Base Study|Adverse Event|9|||
163913300|NCT00103857|592051373|FG002|54-Week Base Study|Adverse Event|11|||
163913301|NCT00103857|592051374|FG003|54-Week Base Study|Adverse Event|6|||
163913302|NCT00103857|592051375|FG004|54-Week Base Study|Adverse Event|5|||
163913303|NCT00103857|592051376|FG005|54-Week Base Study|Adverse Event|11|||
163913304|NCT00103857|592051377|FG006|54-Week Base Study|Adverse Event|3|||
163913305|NCT00103857|592051371|FG000|54-Week Base Study|Death|0|||
163913306|NCT00103857|592051372|FG001|54-Week Base Study|Death|0|||
163913307|NCT00103857|592051373|FG002|54-Week Base Study|Death|0|||
163913308|NCT00103857|592051374|FG003|54-Week Base Study|Death|0|||
163913309|NCT00103857|592051375|FG004|54-Week Base Study|Death|1|||
163913310|NCT00103857|592051376|FG005|54-Week Base Study|Death|1|||
163913311|NCT00103857|592051377|FG006|54-Week Base Study|Death|0|||
163913312|NCT00103857|592051371|FG000|54-Week Base Study|Lack of Efficacy|11|||
163913313|NCT00103857|592051372|FG001|54-Week Base Study|Lack of Efficacy|14|||
163913314|NCT00103857|592051373|FG002|54-Week Base Study|Lack of Efficacy|8|||
163913315|NCT00103857|592051374|FG003|54-Week Base Study|Lack of Efficacy|4|||
163913316|NCT00103857|592051375|FG004|54-Week Base Study|Lack of Efficacy|3|||
163913317|NCT00103857|592051376|FG005|54-Week Base Study|Lack of Efficacy|14|||
163913318|NCT00103857|592051377|FG006|54-Week Base Study|Lack of Efficacy|19|||
163913319|NCT00103857|592051371|FG000|54-Week Base Study|Lost to Follow-up|5|||
163913320|NCT00103857|592051372|FG001|54-Week Base Study|Lost to Follow-up|4|||
163913321|NCT00103857|592051373|FG002|54-Week Base Study|Lost to Follow-up|7|||
163913322|NCT00103857|592051374|FG003|54-Week Base Study|Lost to Follow-up|5|||
163913323|NCT00103857|592051375|FG004|54-Week Base Study|Lost to Follow-up|10|||
163913324|NCT00103857|592051376|FG005|54-Week Base Study|Lost to Follow-up|9|||
163913325|NCT00103857|592051377|FG006|54-Week Base Study|Lost to Follow-up|3|||
163913326|NCT00103857|592051371|FG000|54-Week Base Study|Physician Decision|1|||
163913327|NCT00103857|592051372|FG001|54-Week Base Study|Physician Decision|1|||
163913328|NCT00103857|592051373|FG002|54-Week Base Study|Physician Decision|0|||
163913329|NCT00103857|592051374|FG003|54-Week Base Study|Physician Decision|0|||
163913330|NCT00103857|592051375|FG004|54-Week Base Study|Physician Decision|1|||
163913331|NCT00103857|592051376|FG005|54-Week Base Study|Physician Decision|0|||
163913332|NCT00103857|592051377|FG006|54-Week Base Study|Physician Decision|0|||
163913333|NCT00103857|592051371|FG000|54-Week Base Study|Pregnancy|1|||
163913334|NCT00103857|592051372|FG001|54-Week Base Study|Pregnancy|0|||
163913335|NCT00103857|592051373|FG002|54-Week Base Study|Pregnancy|0|||
163913336|NCT00103857|592051374|FG003|54-Week Base Study|Pregnancy|0|||
164027374|NCT01877382|592459025|FG003|Dose Escalation|Death|0|||
164027375|NCT01877382|592459026|FG004|Dose Escalation|Death|0|||
164027376|NCT01877382|592459027|FG005|Dose Escalation|Death|0|||
164027377|NCT01877382|592459028|FG006|Dose Escalation|Death|0|||
164027378|NCT01877382|592459029|FG007|Dose Escalation|Death|1|||
163913337|NCT00103857|592051375|FG004|54-Week Base Study|Pregnancy|1|||
164027379|NCT01877382|592459030|FG008|Dose Escalation|Death|0|||
164027380|NCT01877382|592459031|FG009|Dose Escalation|Death|0|||
163913338|NCT00103857|592051376|FG005|54-Week Base Study|Pregnancy|0|||
163913339|NCT00103857|592051377|FG006|54-Week Base Study|Pregnancy|1|||
163913340|NCT00103857|592051371|FG000|54-Week Base Study|Protocol Violation|6|||
163913341|NCT00103857|592051372|FG001|54-Week Base Study|Protocol Violation|4|||
163913342|NCT00103857|592051373|FG002|54-Week Base Study|Protocol Violation|2|||
163913343|NCT00103857|592051374|FG003|54-Week Base Study|Protocol Violation|4|||
163913344|NCT00103857|592051375|FG004|54-Week Base Study|Protocol Violation|0|||
163913345|NCT00103857|592051376|FG005|54-Week Base Study|Protocol Violation|3|||
163913346|NCT00103857|592051377|FG006|54-Week Base Study|Protocol Violation|3|||
163913347|NCT00103857|592051371|FG000|54-Week Base Study|Withdrawal by Subject|17|||
164027381|NCT01877382|592459032|FG010|Dose Escalation|Death|0|||
164027382|NCT01877382|592459033|FG011|Dose Escalation|Death|0|||
164027383|NCT01877382|592459034|FG012|Dose Escalation|Death|1|||
164027384|NCT01877382|592459035|FG013|Dose Escalation|Death|1|||
164027385|NCT01877382|592459036|FG014|Dose Escalation|Death|0|||
164027386|NCT01877382|592459022|FG000|Dose Expansion|Progressive disease|0|||
164027387|NCT01877382|592459023|FG001|Dose Expansion|Progressive disease|0|||
164027388|NCT01877382|592459024|FG002|Dose Expansion|Progressive disease|0|||
164027389|NCT01877382|592459025|FG003|Dose Expansion|Progressive disease|0|||
164027390|NCT01877382|592459026|FG004|Dose Expansion|Progressive disease|0|||
164027391|NCT01877382|592459027|FG005|Dose Expansion|Progressive disease|0|||
164027392|NCT01877382|592459028|FG006|Dose Expansion|Progressive disease|0|||
163913348|NCT00103857|592051372|FG001|54-Week Base Study|Withdrawal by Subject|16|||
164096459|NCT00485472|592717288|FG001|Overall Study|Lost to Follow-up|1|||
164027393|NCT01877382|592459029|FG007|Dose Expansion|Progressive disease|0|||
164027394|NCT01877382|592459030|FG008|Dose Expansion|Progressive disease|0|||
164027395|NCT01877382|592459031|FG009|Dose Expansion|Progressive disease|0|||
164027396|NCT01877382|592459032|FG010|Dose Expansion|Progressive disease|0|||
164027397|NCT01877382|592459033|FG011|Dose Expansion|Progressive disease|0|||
164027398|NCT01877382|592459034|FG012|Dose Expansion|Progressive disease|0|||
164027399|NCT01877382|592459035|FG013|Dose Expansion|Progressive disease|0|||
164027400|NCT01877382|592459036|FG014|Dose Expansion|Progressive disease|11|||
164027401|NCT01877382|592459022|FG000|Dose Expansion|Clinical progression|0|||
164027402|NCT01877382|592459023|FG001|Dose Expansion|Clinical progression|0|||
164027403|NCT01877382|592459024|FG002|Dose Expansion|Clinical progression|0|||
164027404|NCT01877382|592459025|FG003|Dose Expansion|Clinical progression|0|||
164027405|NCT01877382|592459026|FG004|Dose Expansion|Clinical progression|0|||
164027406|NCT01877382|592459027|FG005|Dose Expansion|Clinical progression|0|||
164027407|NCT01877382|592459028|FG006|Dose Expansion|Clinical progression|0|||
163913349|NCT00103857|592051373|FG002|54-Week Base Study|Withdrawal by Subject|16|||
163913350|NCT00103857|592051374|FG003|54-Week Base Study|Withdrawal by Subject|15|||
163913351|NCT00103857|592051375|FG004|54-Week Base Study|Withdrawal by Subject|10|||
163913352|NCT00103857|592051376|FG005|54-Week Base Study|Withdrawal by Subject|15|||
163913353|NCT00103857|592051377|FG006|54-Week Base Study|Withdrawal by Subject|4|||
163913354|NCT00103857|592051371|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
163913355|NCT00103857|592051372|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
163913356|NCT00103857|592051373|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
163913357|NCT00103857|592051374|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
163913358|NCT00103857|592051375|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
163913359|NCT00103857|592051376|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
163913360|NCT00103857|592051377|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
163913361|NCT00103857|592051371|FG000|54-Week Base Study|patient moved|0|||
163913362|NCT00103857|592051372|FG001|54-Week Base Study|patient moved|1|||
163913363|NCT00103857|592051373|FG002|54-Week Base Study|patient moved|1|||
163913364|NCT00103857|592051374|FG003|54-Week Base Study|patient moved|2|||
163913365|NCT00103857|592051375|FG004|54-Week Base Study|patient moved|3|||
163913366|NCT00103857|592051376|FG005|54-Week Base Study|patient moved|1|||
163913367|NCT00103857|592051377|FG006|54-Week Base Study|patient moved|0|||
163913368|NCT00103857|592051371|FG000|54-Week Base Study|non-compliance with study procedures|1|||
163913369|NCT00103857|592051372|FG001|54-Week Base Study|non-compliance with study procedures|2|||
163913370|NCT00103857|592051373|FG002|54-Week Base Study|non-compliance with study procedures|0|||
163913371|NCT00103857|592051374|FG003|54-Week Base Study|non-compliance with study procedures|0|||
163913372|NCT00103857|592051375|FG004|54-Week Base Study|non-compliance with study procedures|0|||
163913373|NCT00103857|592051376|FG005|54-Week Base Study|non-compliance with study procedures|2|||
163913374|NCT00103857|592051377|FG006|54-Week Base Study|non-compliance with study procedures|0|||
163913375|NCT00103857|592051371|FG000|54-Week Base Study|patient incarcerated|0|||
163913376|NCT00103857|592051372|FG001|54-Week Base Study|patient incarcerated|0|||
163913377|NCT00103857|592051373|FG002|54-Week Base Study|patient incarcerated|0|||
163913378|NCT00103857|592051374|FG003|54-Week Base Study|patient incarcerated|0|||
163913379|NCT00103857|592051375|FG004|54-Week Base Study|patient incarcerated|1|||
163913380|NCT00103857|592051376|FG005|54-Week Base Study|patient incarcerated|1|||
163913381|NCT00103857|592051377|FG006|54-Week Base Study|patient incarcerated|0|||
163913382|NCT00103857|592051371|FG000|54-Week Base Study|laboratory reporting error|0|||
163913383|NCT00103857|592051372|FG001|54-Week Base Study|laboratory reporting error|0|||
163913384|NCT00103857|592051373|FG002|54-Week Base Study|laboratory reporting error|0|||
163913385|NCT00103857|592051374|FG003|54-Week Base Study|laboratory reporting error|0|||
163913386|NCT00103857|592051375|FG004|54-Week Base Study|laboratory reporting error|1|||
163913387|NCT00103857|592051376|FG005|54-Week Base Study|laboratory reporting error|0|||
163913388|NCT00103857|592051377|FG006|54-Week Base Study|laboratory reporting error|0|||
163913389|NCT00103857|592051371|FG000|54-Week Base Study|site error|0|||
163913390|NCT00103857|592051372|FG001|54-Week Base Study|site error|0|||
163913391|NCT00103857|592051373|FG002|54-Week Base Study|site error|0|||
163913392|NCT00103857|592051374|FG003|54-Week Base Study|site error|0|||
163913393|NCT00103857|592051375|FG004|54-Week Base Study|site error|0|||
163913394|NCT00103857|592051376|FG005|54-Week Base Study|site error|1|||
164027408|NCT01877382|592459029|FG007|Dose Expansion|Clinical progression|0|||
164027409|NCT01877382|592459030|FG008|Dose Expansion|Clinical progression|0|||
164027410|NCT01877382|592459031|FG009|Dose Expansion|Clinical progression|0|||
164027411|NCT01877382|592459032|FG010|Dose Expansion|Clinical progression|0|||
163913395|NCT00103857|592051377|FG006|54-Week Base Study|site error|0|||
163913396|NCT00103857|592051371|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
163913397|NCT00103857|592051372|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
163913398|NCT00103857|592051373|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
163913399|NCT00103857|592051374|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
163913400|NCT00103857|592051375|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
163913401|NCT00103857|592051376|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
163913402|NCT00103857|592051377|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
163913403|NCT00103857|592051371|FG000|50-Week Extension Study|Adverse Event|2|||
164027412|NCT01877382|592459033|FG011|Dose Expansion|Clinical progression|0|||
164027413|NCT01877382|592459034|FG012|Dose Expansion|Clinical progression|0|||
164027414|NCT01877382|592459035|FG013|Dose Expansion|Clinical progression|0|||
164027415|NCT01877382|592459036|FG014|Dose Expansion|Clinical progression|6|||
164027416|NCT01877382|592459022|FG000|Dose Expansion|Adverse Event|0|||
164027417|NCT01877382|592459023|FG001|Dose Expansion|Adverse Event|0|||
164027418|NCT01877382|592459024|FG002|Dose Expansion|Adverse Event|0|||
163913404|NCT00103857|592051372|FG001|50-Week Extension Study|Adverse Event|3|||
163913405|NCT00103857|592051373|FG002|50-Week Extension Study|Adverse Event|2|||
163913406|NCT00103857|592051374|FG003|50-Week Extension Study|Adverse Event|0|||
163913407|NCT00103857|592051375|FG004|50-Week Extension Study|Adverse Event|1|||
163913408|NCT00103857|592051376|FG005|50-Week Extension Study|Adverse Event|1|||
164027419|NCT01877382|592459025|FG003|Dose Expansion|Adverse Event|0|||
164027420|NCT01877382|592459026|FG004|Dose Expansion|Adverse Event|0|||
164027421|NCT01877382|592459027|FG005|Dose Expansion|Adverse Event|0|||
164027422|NCT01877382|592459028|FG006|Dose Expansion|Adverse Event|0|||
164027423|NCT01877382|592459029|FG007|Dose Expansion|Adverse Event|0|||
164027424|NCT01877382|592459030|FG008|Dose Expansion|Adverse Event|0|||
164027425|NCT01877382|592459031|FG009|Dose Expansion|Adverse Event|0|||
164027426|NCT01877382|592459032|FG010|Dose Expansion|Adverse Event|0|||
164027427|NCT01877382|592459033|FG011|Dose Expansion|Adverse Event|0|||
164027428|NCT01877382|592459034|FG012|Dose Expansion|Adverse Event|0|||
164027429|NCT01877382|592459035|FG013|Dose Expansion|Adverse Event|0|||
164027430|NCT01877382|592459036|FG014|Dose Expansion|Adverse Event|1|||
164027431|NCT01877382|592459022|FG000|Dose Expansion|Death|0|||
164027432|NCT01877382|592459023|FG001|Dose Expansion|Death|0|||
164027433|NCT01877382|592459024|FG002|Dose Expansion|Death|0|||
163913409|NCT00103857|592051377|FG006|50-Week Extension Study|Adverse Event|0|||
163913410|NCT00103857|592051371|FG000|50-Week Extension Study|Death|0|||
163913411|NCT00103857|592051372|FG001|50-Week Extension Study|Death|0|||
163913412|NCT00103857|592051373|FG002|50-Week Extension Study|Death|0|||
163913413|NCT00103857|592051374|FG003|50-Week Extension Study|Death|1|||
163913414|NCT00103857|592051375|FG004|50-Week Extension Study|Death|0|||
163913415|NCT00103857|592051376|FG005|50-Week Extension Study|Death|1|||
163913416|NCT00103857|592051377|FG006|50-Week Extension Study|Death|0|||
163913417|NCT00103857|592051371|FG000|50-Week Extension Study|Lack of Efficacy|26|||
163913418|NCT00103857|592051372|FG001|50-Week Extension Study|Lack of Efficacy|15|||
163913419|NCT00103857|592051373|FG002|50-Week Extension Study|Lack of Efficacy|13|||
163913420|NCT00103857|592051374|FG003|50-Week Extension Study|Lack of Efficacy|16|||
163913421|NCT00103857|592051375|FG004|50-Week Extension Study|Lack of Efficacy|8|||
163913422|NCT00103857|592051376|FG005|50-Week Extension Study|Lack of Efficacy|8|||
163913423|NCT00103857|592051377|FG006|50-Week Extension Study|Lack of Efficacy|0|||
163913424|NCT00103857|592051371|FG000|50-Week Extension Study|Lost to Follow-up|4|||
163913425|NCT00103857|592051372|FG001|50-Week Extension Study|Lost to Follow-up|0|||
163913426|NCT00103857|592051373|FG002|50-Week Extension Study|Lost to Follow-up|1|||
163913427|NCT00103857|592051374|FG003|50-Week Extension Study|Lost to Follow-up|4|||
163913428|NCT00103857|592051375|FG004|50-Week Extension Study|Lost to Follow-up|3|||
163913429|NCT00103857|592051376|FG005|50-Week Extension Study|Lost to Follow-up|3|||
163913430|NCT00103857|592051377|FG006|50-Week Extension Study|Lost to Follow-up|0|||
163913431|NCT00103857|592051371|FG000|50-Week Extension Study|Physician Decision|0|||
163913432|NCT00103857|592051372|FG001|50-Week Extension Study|Physician Decision|1|||
163913433|NCT00103857|592051373|FG002|50-Week Extension Study|Physician Decision|1|||
163913434|NCT00103857|592051374|FG003|50-Week Extension Study|Physician Decision|0|||
163913435|NCT00103857|592051375|FG004|50-Week Extension Study|Physician Decision|0|||
163913436|NCT00103857|592051376|FG005|50-Week Extension Study|Physician Decision|0|||
163913437|NCT00103857|592051377|FG006|50-Week Extension Study|Physician Decision|0|||
163913438|NCT00103857|592051371|FG000|50-Week Extension Study|Pregnancy|0|||
163913439|NCT00103857|592051372|FG001|50-Week Extension Study|Pregnancy|0|||
163913440|NCT00103857|592051373|FG002|50-Week Extension Study|Pregnancy|1|||
163913441|NCT00103857|592051374|FG003|50-Week Extension Study|Pregnancy|0|||
163913442|NCT00103857|592051375|FG004|50-Week Extension Study|Pregnancy|1|||
163913443|NCT00103857|592051376|FG005|50-Week Extension Study|Pregnancy|0|||
163913444|NCT00103857|592051377|FG006|50-Week Extension Study|Pregnancy|0|||
164027434|NCT01877382|592459025|FG003|Dose Expansion|Death|0|||
164027435|NCT01877382|592459026|FG004|Dose Expansion|Death|0|||
164027436|NCT01877382|592459027|FG005|Dose Expansion|Death|0|||
164027437|NCT01877382|592459028|FG006|Dose Expansion|Death|0|||
164027438|NCT01877382|592459029|FG007|Dose Expansion|Death|0|||
164027439|NCT01877382|592459030|FG008|Dose Expansion|Death|0|||
164027440|NCT01877382|592459031|FG009|Dose Expansion|Death|0|||
163913445|NCT00103857|592051371|FG000|50-Week Extension Study|Protocol Violation|1|||
163913446|NCT00103857|592051372|FG001|50-Week Extension Study|Protocol Violation|1|||
163913447|NCT00103857|592051373|FG002|50-Week Extension Study|Protocol Violation|1|||
163913448|NCT00103857|592051374|FG003|50-Week Extension Study|Protocol Violation|2|||
163913449|NCT00103857|592051375|FG004|50-Week Extension Study|Protocol Violation|0|||
163913450|NCT00103857|592051376|FG005|50-Week Extension Study|Protocol Violation|1|||
163913451|NCT00103857|592051377|FG006|50-Week Extension Study|Protocol Violation|0|||
163913452|NCT00103857|592051371|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
163913453|NCT00103857|592051372|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
163913454|NCT00103857|592051373|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
163913455|NCT00103857|592051374|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
163913456|NCT00103857|592051375|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
163913457|NCT00103857|592051376|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
163913458|NCT00103857|592051377|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
163913459|NCT00103857|592051371|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
163913460|NCT00103857|592051372|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
163913461|NCT00103857|592051373|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
163913462|NCT00103857|592051374|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
163913463|NCT00103857|592051375|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
164027441|NCT01877382|592459032|FG010|Dose Expansion|Death|0|||
164027442|NCT01877382|592459033|FG011|Dose Expansion|Death|0|||
164027443|NCT01877382|592459034|FG012|Dose Expansion|Death|0|||
164027444|NCT01877382|592459035|FG013|Dose Expansion|Death|0|||
164027445|NCT01877382|592459036|FG014|Dose Expansion|Death|1|||
164027446|NCT01877382|592459022|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
163913464|NCT00103857|592051376|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
163913465|NCT00103857|592051377|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
163913466|NCT00103857|592051371|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
163913467|NCT00103857|592051372|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
163913468|NCT00103857|592051373|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
163913469|NCT00103857|592051374|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
163913470|NCT00103857|592051375|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
163913471|NCT00103857|592051376|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
163913472|NCT00103857|592051377|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
163913473|NCT00103857|592051371|FG000|50-Week Extension Study|patient moved|0|||
163913474|NCT00103857|592051372|FG001|50-Week Extension Study|patient moved|0|||
163913475|NCT00103857|592051373|FG002|50-Week Extension Study|patient moved|1|||
163913476|NCT00103857|592051374|FG003|50-Week Extension Study|patient moved|2|||
163913477|NCT00103857|592051375|FG004|50-Week Extension Study|patient moved|0|||
163913478|NCT00103857|592051376|FG005|50-Week Extension Study|patient moved|0|||
163913479|NCT00103857|592051377|FG006|50-Week Extension Study|patient moved|0|||
163913480|NCT00103857|592051371|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
163913481|NCT00103857|592051372|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
163913482|NCT00103857|592051373|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
163913483|NCT00103857|592051374|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
163913484|NCT00103857|592051375|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
163913485|NCT00103857|592051376|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
163913486|NCT00103857|592051377|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
163913487|NCT00103857|592051371|FG000|50-Week Extension Study|reason unspecified|0|||
163913488|NCT00103857|592051372|FG001|50-Week Extension Study|reason unspecified|0|||
163913489|NCT00103857|592051373|FG002|50-Week Extension Study|reason unspecified|0|||
163913490|NCT00103857|592051374|FG003|50-Week Extension Study|reason unspecified|0|||
163913491|NCT00103857|592051375|FG004|50-Week Extension Study|reason unspecified|1|||
163913492|NCT00103857|592051376|FG005|50-Week Extension Study|reason unspecified|0|||
163913493|NCT00103857|592051377|FG006|50-Week Extension Study|reason unspecified|0|||
163913494|NCT01287832|592051380|FG000|Overall Study|Adverse Event|1|||
163913495|NCT01287832|592051381|FG001|Overall Study|Adverse Event|0|||
163913496|NCT01287832|592051380|FG000|Overall Study|Death|0|||
163913497|NCT01287832|592051381|FG001|Overall Study|Death|1|||
163913498|NCT03065400|592051384|FG000|Overall Study|Adverse Event|1|||
163913499|NCT03065400|592051384|FG000|Overall Study|Physician Decision|3|||
163913500|NCT03065400|592051384|FG000|Overall Study|Withdrawal by Subject|1|||
163913501|NCT03065400|592051384|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
163913502|NCT00632736|592051385|FG000|Overall Study|Adverse Event|104|||
163913503|NCT00632736|592051385|FG000|Overall Study|Lost to Follow-up|15|||
163913504|NCT00632736|592051385|FG000|Overall Study|Protocol Violation|14|||
163913505|NCT00632736|592051385|FG000|Overall Study|Withdrawal by Subject|99|||
163913506|NCT00632736|592051385|FG000|Overall Study|Lack of Efficacy|5|||
163913507|NCT00632736|592051385|FG000|Overall Study|Sponsor terminated study|5|||
163913508|NCT00632736|592051385|FG000|Overall Study|Non-compliance|10|||
163913509|NCT00632736|592051385|FG000|Overall Study|Other|16|||
163913510|NCT03347396|592051386|FG000|Part A (26 Weeks)|Adverse Event|1|||
163913511|NCT03347396|592051387|FG001|Part A (26 Weeks)|Adverse Event|0|||
163913512|NCT03347396|592051386|FG000|Part A (26 Weeks)|Death|0|||
163913513|NCT03347396|592051387|FG001|Part A (26 Weeks)|Death|1|||
163913514|NCT03347396|592051386|FG000|Part B (149 Weeks)|Adverse Event|1|||
163913515|NCT03347396|592051387|FG001|Part B (149 Weeks)|Adverse Event|1|||
163913516|NCT03347396|592051386|FG000|Part B (149 Weeks)|Death|1|||
163913517|NCT03347396|592051387|FG001|Part B (149 Weeks)|Death|0|||
163913518|NCT00946998|592053003|FG000|Overall Study|Exited prior to first outcome assessment|5|||
163913519|NCT00946998|592053004|FG001|Overall Study|Exited prior to first outcome assessment|3|||
163913520|NCT01945593|592053005|FG000|Overall Study|Adverse Event|0|||
164096460|NCT00746798|592717289|FG000|Overall Study|Protocol Violation|0|||
163913521|NCT01945593|592053006|FG001|Overall Study|Adverse Event|0|||
163913522|NCT01945593|592053007|FG002|Overall Study|Adverse Event|0|||
163913523|NCT01945593|592053008|FG003|Overall Study|Adverse Event|5|||
163913524|NCT01945593|592053005|FG000|Overall Study|Physician Decision|0|||
163913525|NCT01945593|592053006|FG001|Overall Study|Physician Decision|0|||
163913526|NCT01945593|592053007|FG002|Overall Study|Physician Decision|1|||
163913527|NCT01945593|592053008|FG003|Overall Study|Physician Decision|1|||
163913528|NCT01945593|592053005|FG000|Overall Study|Withdrawal by Subject|0|||
163913529|NCT01945593|592053006|FG001|Overall Study|Withdrawal by Subject|2|||
163913530|NCT01945593|592053007|FG002|Overall Study|Withdrawal by Subject|0|||
163913531|NCT01945593|592053008|FG003|Overall Study|Withdrawal by Subject|4|||
163913532|NCT01945593|592053005|FG000|Overall Study|Protocol Violation|0|||
163913533|NCT01945593|592053006|FG001|Overall Study|Protocol Violation|2|||
163913534|NCT01945593|592053007|FG002|Overall Study|Protocol Violation|1|||
163913535|NCT01945593|592053008|FG003|Overall Study|Protocol Violation|3|||
163913536|NCT01945593|592053005|FG000|Overall Study|Death|0|||
163913537|NCT01945593|592053006|FG001|Overall Study|Death|0|||
163913538|NCT01945593|592053007|FG002|Overall Study|Death|1|||
163913539|NCT01945593|592053008|FG003|Overall Study|Death|0|||
163913540|NCT01945593|592053005|FG000|Overall Study|Other: Terminated|0|||
163913541|NCT01945593|592053006|FG001|Overall Study|Other: Terminated|0|||
163913542|NCT01945593|592053007|FG002|Overall Study|Other: Terminated|0|||
163913543|NCT01945593|592053008|FG003|Overall Study|Other: Terminated|1|||
163913544|NCT01945593|592053005|FG000|Overall Study|Other: Surgical Procedure|0|||
163913545|NCT01945593|592053006|FG001|Overall Study|Other: Surgical Procedure|2|||
163913546|NCT01945593|592053007|FG002|Overall Study|Other: Surgical Procedure|0|||
163913547|NCT01945593|592053008|FG003|Overall Study|Other: Surgical Procedure|6|||
163913548|NCT01945593|592053005|FG000|Overall Study|Other: Screen Failure|0|||
163913549|NCT01945593|592053006|FG001|Overall Study|Other: Screen Failure|2|||
163913550|NCT01945593|592053007|FG002|Overall Study|Other: Screen Failure|0|||
163913551|NCT01945593|592053008|FG003|Overall Study|Other: Screen Failure|0|||
163913552|NCT00228813|592053009|FG000|Overall Study|Death|4|||
163913553|NCT03761849|592053014|FG000|Overall Study|transferred to OpenLabelExtension|35|||
163913554|NCT03761849|592053015|FG001|Overall Study|transferred to OpenLabelExtension|34|||
163913555|NCT03761849|592053016|FG002|Overall Study|transferred to OpenLabelExtension|36|||
163913556|NCT03761849|592053017|FG003|Overall Study|transferred to OpenLabelExtension|0|||
163913557|NCT03761849|592053018|FG004|Overall Study|transferred to OpenLabelExtension|0|||
163913558|NCT03761849|592053019|FG005|Overall Study|transferred to OpenLabelExtension|0|||
163913559|NCT03761849|592053014|FG000|Overall Study|Adverse Event|1|||
163913560|NCT03761849|592053015|FG001|Overall Study|Adverse Event|0|||
163913561|NCT03761849|592053016|FG002|Overall Study|Adverse Event|0|||
163913562|NCT03761849|592053017|FG003|Overall Study|Adverse Event|0|||
163913563|NCT03761849|592053018|FG004|Overall Study|Adverse Event|2|||
163913564|NCT03761849|592053019|FG005|Overall Study|Adverse Event|3|||
163913565|NCT03761849|592053014|FG000|Overall Study|Withdrawal by Subject|0|||
163913566|NCT03761849|592053015|FG001|Overall Study|Withdrawal by Subject|0|||
163913567|NCT03761849|592053016|FG002|Overall Study|Withdrawal by Subject|0|||
163913568|NCT03761849|592053017|FG003|Overall Study|Withdrawal by Subject|41|||
163913569|NCT03761849|592053018|FG004|Overall Study|Withdrawal by Subject|43|||
163913570|NCT03761849|592053019|FG005|Overall Study|Withdrawal by Subject|35|||
163913571|NCT03761849|592053014|FG000|Overall Study|Lost to Follow-up|0|||
163913572|NCT03761849|592053015|FG001|Overall Study|Lost to Follow-up|1|||
163913573|NCT03761849|592053016|FG002|Overall Study|Lost to Follow-up|0|||
163913574|NCT03761849|592053017|FG003|Overall Study|Lost to Follow-up|2|||
163913575|NCT03761849|592053018|FG004|Overall Study|Lost to Follow-up|4|||
163913576|NCT03761849|592053019|FG005|Overall Study|Lost to Follow-up|5|||
163913577|NCT03761849|592053014|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
163913578|NCT03761849|592053015|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
163913579|NCT03761849|592053016|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
163913580|NCT03761849|592053017|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
163913581|NCT03761849|592053018|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
163913582|NCT03761849|592053019|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
163913583|NCT03761849|592053014|FG000|Overall Study|Physician Decision|0|||
163913584|NCT03761849|592053015|FG001|Overall Study|Physician Decision|0|||
163913585|NCT03761849|592053016|FG002|Overall Study|Physician Decision|0|||
163913586|NCT03761849|592053017|FG003|Overall Study|Physician Decision|1|||
163913587|NCT03761849|592053018|FG004|Overall Study|Physician Decision|4|||
163913588|NCT03761849|592053019|FG005|Overall Study|Physician Decision|4|||
163913589|NCT03761849|592053014|FG000|Overall Study|Death|0|||
163913590|NCT03761849|592053015|FG001|Overall Study|Death|0|||
163913591|NCT03761849|592053016|FG002|Overall Study|Death|0|||
163913592|NCT03761849|592053017|FG003|Overall Study|Death|1|||
163913593|NCT03761849|592053018|FG004|Overall Study|Death|1|||
163913594|NCT03761849|592053019|FG005|Overall Study|Death|3|||
163913595|NCT03761849|592053014|FG000|Overall Study|Protocol Violation|0|||
163913596|NCT03761849|592053015|FG001|Overall Study|Protocol Violation|0|||
163913597|NCT03761849|592053016|FG002|Overall Study|Protocol Violation|0|||
163913598|NCT03761849|592053017|FG003|Overall Study|Protocol Violation|2|||
163913599|NCT03761849|592053018|FG004|Overall Study|Protocol Violation|2|||
163913600|NCT03761849|592053019|FG005|Overall Study|Protocol Violation|1|||
163913601|NCT03761849|592053014|FG000|Overall Study|Participant could not come to site|0|||
163913602|NCT03761849|592053015|FG001|Overall Study|Participant could not come to site|0|||
163913603|NCT03761849|592053016|FG002|Overall Study|Participant could not come to site|0|||
163913604|NCT03761849|592053017|FG003|Overall Study|Participant could not come to site|0|||
163913605|NCT03761849|592053018|FG004|Overall Study|Participant could not come to site|1|||
163913606|NCT03761849|592053019|FG005|Overall Study|Participant could not come to site|0|||
163913607|NCT03761849|592053014|FG000|Overall Study|SF- safety Finding|0|||
163913608|NCT03761849|592053015|FG001|Overall Study|SF- safety Finding|0|||
163913609|NCT03761849|592053016|FG002|Overall Study|SF- safety Finding|0|||
163913610|NCT03761849|592053017|FG003|Overall Study|SF- safety Finding|0|||
163913611|NCT03761849|592053018|FG004|Overall Study|SF- safety Finding|0|||
163913612|NCT03761849|592053019|FG005|Overall Study|SF- safety Finding|1|||
163913613|NCT03761849|592053014|FG000|Overall Study|Patient did not attend visit|0|||
163913614|NCT03761849|592053015|FG001|Overall Study|Patient did not attend visit|0|||
163913615|NCT03761849|592053016|FG002|Overall Study|Patient did not attend visit|0|||
163913616|NCT03761849|592053017|FG003|Overall Study|Patient did not attend visit|0|||
163913617|NCT03761849|592053018|FG004|Overall Study|Patient did not attend visit|0|||
163913618|NCT03761849|592053019|FG005|Overall Study|Patient did not attend visit|1|||
163913619|NCT01131325|592053020|FG000|Overall Study|Adverse Event|1|||
163913620|NCT01131325|592053020|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
163913621|NCT02213094|592053023|FG000|Overall Study|Adverse Event|1|||
163913622|NCT02213094|592053024|FG001|Overall Study|Adverse Event|0|||
163913623|NCT00538629|592053025|FG000|Overall Study|At subject's request|1|||
163913624|NCT00538629|592053025|FG000|Overall Study|Adverse Event|2|||
163913625|NCT00538629|592053025|FG000|Overall Study|Lack of Efficacy|12|||
163913626|NCT00538629|592053025|FG000|Overall Study|Lost to Follow-up|6|||
163913627|NCT00538629|592053025|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
163913628|NCT02163499|592053028|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
163913629|NCT02163499|592053028|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
163913630|NCT02163499|592053028|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
163913631|NCT02163499|592053028|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
163913632|NCT02163499|592053028|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
163913633|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
163913634|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
163913635|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
163913636|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
163913637|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
163913638|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
163913639|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
163913640|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
163913641|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
163913642|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Death|8|||
163913643|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
163913644|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
163913645|NCT02163499|592053028|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
163913646|NCT04454125|592053031|FG000|Overall Study|Lost to Follow-up|0|||
163913647|NCT04454125|592053032|FG001|Overall Study|Lost to Follow-up|1|||
163913648|NCT00555620|592053034|FG000|Overall Study|Death|0|||
163913649|NCT00555620|592053035|FG001|Overall Study|Death|1|||
163913650|NCT00555620|592053036|FG002|Overall Study|Death|0|||
163913651|NCT00555620|592053037|FG003|Overall Study|Death|0|||
163913652|NCT00555620|592053038|FG004|Overall Study|Death|0|||
163913653|NCT00555620|592053039|FG005|Overall Study|Death|1|||
163913654|NCT00555620|592053034|FG000|Overall Study|Study terminated by sponsor|0|||
163913655|NCT00555620|592053035|FG001|Overall Study|Study terminated by sponsor|0|||
163913656|NCT00555620|592053036|FG002|Overall Study|Study terminated by sponsor|1|||
163913657|NCT00555620|592053037|FG003|Overall Study|Study terminated by sponsor|0|||
163913658|NCT00555620|592053038|FG004|Overall Study|Study terminated by sponsor|0|||
163913659|NCT00555620|592053039|FG005|Overall Study|Study terminated by sponsor|0|||
163913660|NCT00555620|592053034|FG000|Overall Study|Adverse Event|0|||
163913661|NCT00555620|592053035|FG001|Overall Study|Adverse Event|0|||
163913662|NCT00555620|592053036|FG002|Overall Study|Adverse Event|1|||
163913663|NCT00555620|592053037|FG003|Overall Study|Adverse Event|5|||
163913664|NCT00555620|592053038|FG004|Overall Study|Adverse Event|0|||
163913665|NCT00555620|592053039|FG005|Overall Study|Adverse Event|1|||
163913666|NCT00555620|592053034|FG000|Overall Study|Objective progression or relapse|6|||
163913667|NCT00555620|592053035|FG001|Overall Study|Objective progression or relapse|5|||
163913668|NCT00555620|592053036|FG002|Overall Study|Objective progression or relapse|12|||
163913669|NCT00555620|592053037|FG003|Overall Study|Objective progression or relapse|17|||
163913670|NCT00555620|592053038|FG004|Overall Study|Objective progression or relapse|3|||
163913671|NCT00555620|592053039|FG005|Overall Study|Objective progression or relapse|16|||
163913672|NCT00555620|592053034|FG000|Overall Study|Participant refused treatment|0|||
163913673|NCT00555620|592053035|FG001|Overall Study|Participant refused treatment|1|||
163913674|NCT00555620|592053036|FG002|Overall Study|Participant refused treatment|1|||
163913675|NCT00555620|592053037|FG003|Overall Study|Participant refused treatment|0|||
163913676|NCT00555620|592053038|FG004|Overall Study|Participant refused treatment|0|||
163913677|NCT00555620|592053039|FG005|Overall Study|Participant refused treatment|1|||
163913678|NCT00555620|592053034|FG000|Overall Study|Other|0|||
163913679|NCT00555620|592053035|FG001|Overall Study|Other|0|||
163913680|NCT00555620|592053036|FG002|Overall Study|Other|0|||
163913681|NCT00555620|592053037|FG003|Overall Study|Other|1|||
163913682|NCT00555620|592053038|FG004|Overall Study|Other|0|||
163913683|NCT00555620|592053039|FG005|Overall Study|Other|3|||
163913684|NCT00476151|592053040|FG000|Overall Study|Adverse Event|0|||
163913685|NCT00476151|592053041|FG001|Overall Study|Adverse Event|2|||
163913686|NCT00476151|592053040|FG000|Overall Study|Protocol Violation|1|||
163913687|NCT00476151|592053041|FG001|Overall Study|Protocol Violation|3|||
163913688|NCT00476151|592053040|FG000|Overall Study|Withdrawal by Subject|2|||
163913689|NCT00476151|592053041|FG001|Overall Study|Withdrawal by Subject|0|||
163913690|NCT00476151|592053040|FG000|Overall Study|Physician Decision|0|||
163913691|NCT00476151|592053041|FG001|Overall Study|Physician Decision|2|||
163913692|NCT02068352|592053043|FG000|Overall Study|Lost to Follow-up|0|||
163913693|NCT02068352|592053044|FG001|Overall Study|Lost to Follow-up|2|||
163913694|NCT02068352|592053045|FG002|Overall Study|Lost to Follow-up|0|||
163913695|NCT02068352|592053043|FG000|Overall Study|Adverse Event|4|||
163913696|NCT02068352|592053044|FG001|Overall Study|Adverse Event|2|||
163913697|NCT02068352|592053045|FG002|Overall Study|Adverse Event|7|||
163913698|NCT02068352|592053043|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
163913699|NCT02068352|592053044|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
163913700|NCT02068352|592053045|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
163913701|NCT02068352|592053043|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
163913702|NCT02068352|592053044|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
163913703|NCT02068352|592053045|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
163913704|NCT02068352|592053043|FG000|Overall Study|Protocol Deviation|0|||
163913705|NCT02068352|592053044|FG001|Overall Study|Protocol Deviation|0|||
163913706|NCT02068352|592053045|FG002|Overall Study|Protocol Deviation|1|||
163913707|NCT01767376|592053049|FG000|Overall Study|Lost to Follow-up|3|||
163913708|NCT01767376|592053050|FG001|Overall Study|Lost to Follow-up|2|||
163913709|NCT01767376|592053051|FG002|Overall Study|Lost to Follow-up|0|||
163913710|NCT01767376|592053049|FG000|Overall Study|Withdrawal by Subject|1|||
163913711|NCT01767376|592053050|FG001|Overall Study|Withdrawal by Subject|1|||
163913712|NCT01767376|592053051|FG002|Overall Study|Withdrawal by Subject|0|||
163913713|NCT04883541|592053052|FG000|Overall Study|Not attending regular yoga class|16|||
163913714|NCT04883541|592053053|FG001|Overall Study|Not attending regular yoga class|0|||
163913715|NCT04883541|592053052|FG000|Overall Study|Not attending the pregnancy school|0|||
163913716|NCT04883541|592053053|FG001|Overall Study|Not attending the pregnancy school|9|||
163913717|NCT01369147|592053054|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
163913718|NCT01369147|592053055|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
163913719|NCT01369147|592053056|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
163913720|NCT03456856|592053057|FG000|Overall Study|Lost to Follow-up|2|||
163913721|NCT03456856|592053057|FG000|Overall Study|Withdrawal by Subject|1|||
163913722|NCT02542696|592053059|FG000|Overall Study|Adverse Event|167|||
163913723|NCT02542696|592053059|FG000|Overall Study|Lack of Efficacy|26|||
163913724|NCT02542696|592053059|FG000|Overall Study|Lost to Follow-up|6|||
163913725|NCT02542696|592053059|FG000|Overall Study|Withdrawal by Subject|104|||
163913726|NCT02542696|592053059|FG000|Overall Study|Protocol Violation|5|||
163913727|NCT02542696|592053059|FG000|Overall Study|Death|8|||
163913728|NCT02542696|592053059|FG000|Overall Study|DECREASED OFF TIME|1|||
163913729|NCT02542696|592053059|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
163913730|NCT02542696|592053059|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
163913731|NCT02542696|592053059|FG000|Overall Study|MEDICAL HISTORY|1|||
163913732|NCT02542696|592053059|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
163913733|NCT02542696|592053059|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
163913734|NCT02542696|592053059|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
163913735|NCT02542696|592053059|FG000|Overall Study|SPONSOR DECISION|3|||
163913736|NCT02542696|592053059|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
163913737|NCT02542696|592053059|FG000|Overall Study|SUBJECT DECISION|2|||
164096461|NCT00746798|592717290|FG001|Overall Study|Protocol Violation|1|||
164096462|NCT00746798|592717291|FG002|Overall Study|Protocol Violation|0|||
163913738|NCT03262389|592053060|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
163913739|NCT03262389|592053060|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
163913740|NCT03262389|592053060|FG000|Overall Study|opted out of PET/MR|1|||
163913741|NCT02256553|592053062|FG000|Period I|Adverse Event|5|||
163913742|NCT02256553|592053062|FG000|Period I|Protocol Violation|1|||
163913743|NCT02256553|592053062|FG000|Period II|Adverse Event|1|||
163913744|NCT02256553|592053062|FG000|Period II|Subject Moved|1|||
163913745|NCT02256553|592053062|FG000|Period III|Adverse Event|3|||
163913746|NCT04421456|592053065|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
163913747|NCT04421456|592053066|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
163913748|NCT04421456|592053067|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
164096463|NCT00746798|592717292|FG003|Overall Study|Protocol Violation|0|||
164096464|NCT00746798|592717289|FG000|Overall Study|Withdrawal by Subject|0|||
163913749|NCT04421456|592053065|FG000|Randomized Treatment Period|Adverse Event|0|||
163913750|NCT04421456|592053066|FG001|Randomized Treatment Period|Adverse Event|1|||
163913751|NCT04421456|592053067|FG002|Randomized Treatment Period|Adverse Event|0|||
163913752|NCT04421456|592053065|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
163913753|NCT04421456|592053066|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
163913754|NCT04421456|592053067|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
163913755|NCT04421456|592053065|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
163913756|NCT04421456|592053066|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
163913757|NCT04421456|592053067|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
163913758|NCT04421456|592053065|FG000|Randomized Treatment Period|Participant non-compliance|1|||
163913759|NCT04421456|592053066|FG001|Randomized Treatment Period|Participant non-compliance|1|||
163913760|NCT04421456|592053067|FG002|Randomized Treatment Period|Participant non-compliance|2|||
163913761|NCT04421456|592053065|FG000|Randomized Treatment Period|Other|0|||
163913762|NCT04421456|592053066|FG001|Randomized Treatment Period|Other|1|||
163913763|NCT04421456|592053067|FG002|Randomized Treatment Period|Other|3|||
163913764|NCT00379210|592053068|FG000|Overall Study|Withdrawal by Subject|10|||
163913765|NCT00379210|592053069|FG001|Overall Study|Withdrawal by Subject|7|||
163913766|NCT05104242|592053070|FG000|Overall Study|Withdrawal by Subject|1|||
163913767|NCT05104242|592053071|FG001|Overall Study|Withdrawal by Subject|5|||
163913768|NCT05104242|592053070|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
163913769|NCT05104242|592053071|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
163913770|NCT02469155|592053076|FG000|Overall Study|Adverse Event|6|||
163913771|NCT02469155|592053077|FG001|Overall Study|Adverse Event|0|||
163913772|NCT02469155|592053078|FG002|Overall Study|Adverse Event|1|||
163913773|NCT02469155|592053079|FG003|Overall Study|Adverse Event|10|||
163913774|NCT02469155|592053076|FG000|Overall Study|Lack of Efficacy|13|||
163913775|NCT02469155|592053077|FG001|Overall Study|Lack of Efficacy|10|||
163913776|NCT02469155|592053078|FG002|Overall Study|Lack of Efficacy|10|||
163913777|NCT02469155|592053079|FG003|Overall Study|Lack of Efficacy|8|||
163913778|NCT02469155|592053076|FG000|Overall Study|Death|0|||
163913779|NCT02469155|592053077|FG001|Overall Study|Death|0|||
163913780|NCT02469155|592053078|FG002|Overall Study|Death|0|||
163913781|NCT02469155|592053079|FG003|Overall Study|Death|1|||
163913782|NCT02469155|592053076|FG000|Overall Study|Lost to Follow-up|5|||
163913783|NCT02469155|592053077|FG001|Overall Study|Lost to Follow-up|2|||
163913784|NCT02469155|592053078|FG002|Overall Study|Lost to Follow-up|7|||
163913785|NCT02469155|592053079|FG003|Overall Study|Lost to Follow-up|2|||
163913786|NCT02469155|592053076|FG000|Overall Study|Physician Decision|0|||
163913787|NCT02469155|592053077|FG001|Overall Study|Physician Decision|0|||
163913788|NCT02469155|592053078|FG002|Overall Study|Physician Decision|1|||
163913789|NCT02469155|592053079|FG003|Overall Study|Physician Decision|0|||
163913790|NCT02469155|592053076|FG000|Overall Study|Withdrawal by Subject|34|||
163913791|NCT02469155|592053077|FG001|Overall Study|Withdrawal by Subject|30|||
163913792|NCT02469155|592053078|FG002|Overall Study|Withdrawal by Subject|20|||
163913793|NCT02469155|592053079|FG003|Overall Study|Withdrawal by Subject|37|||
163913794|NCT02469155|592053076|FG000|Overall Study|Other|3|||
163913795|NCT02469155|592053077|FG001|Overall Study|Other|3|||
163913796|NCT02469155|592053078|FG002|Overall Study|Other|2|||
163913797|NCT02469155|592053079|FG003|Overall Study|Other|10|||
163913798|NCT02469155|592053076|FG000|Overall Study|Protocol Violation|0|||
163913799|NCT02469155|592053077|FG001|Overall Study|Protocol Violation|1|||
163913800|NCT02469155|592053078|FG002|Overall Study|Protocol Violation|0|||
163913801|NCT02469155|592053079|FG003|Overall Study|Protocol Violation|1|||
163913802|NCT02991118|592053080|FG000|Overall Study|Death|3|||
163913803|NCT02991118|592053081|FG001|Overall Study|Death|8|||
163913804|NCT02991118|592053080|FG000|Overall Study|Protocol Violation|0|||
163913805|NCT02991118|592053081|FG001|Overall Study|Protocol Violation|3|||
163913806|NCT02991118|592053080|FG000|Overall Study|Physician Decision|0|||
163913807|NCT02991118|592053081|FG001|Overall Study|Physician Decision|1|||
163913808|NCT02991118|592053080|FG000|Overall Study|Moved out of the country|0|||
163913809|NCT02991118|592053081|FG001|Overall Study|Moved out of the country|1|||
163913810|NCT02991118|592053080|FG000|Overall Study|Adverse Event|2|||
163913811|NCT02991118|592053081|FG001|Overall Study|Adverse Event|2|||
163913812|NCT02991118|592053080|FG000|Overall Study|Withdrawal by Subject|1|||
163913813|NCT02991118|592053081|FG001|Overall Study|Withdrawal by Subject|7|||
163913814|NCT02991118|592053080|FG000|Overall Study|Could not attend study visits|0|||
163913815|NCT02991118|592053081|FG001|Overall Study|Could not attend study visits|1|||
163913816|NCT02991118|592053080|FG000|Overall Study|Lost to Follow-up|1|||
163913817|NCT02991118|592053081|FG001|Overall Study|Lost to Follow-up|9|||
163913818|NCT02764320|592053089|FG000|Overall Study|Withdrawal by Subject|35|||
163913819|NCT02764320|592053090|FG001|Overall Study|Withdrawal by Subject|38|||
163913820|NCT02764320|592053089|FG000|Overall Study|Protocol Violation|11|||
164096465|NCT00746798|592717290|FG001|Overall Study|Withdrawal by Subject|1|||
163913821|NCT02764320|592053090|FG001|Overall Study|Protocol Violation|6|||
163913822|NCT02764320|592053089|FG000|Overall Study|Adverse Event|2|||
163913823|NCT02764320|592053090|FG001|Overall Study|Adverse Event|0|||
163913824|NCT02764320|592053089|FG000|Overall Study|Health Issues unable to continue|2|||
163913825|NCT02764320|592053090|FG001|Overall Study|Health Issues unable to continue|0|||
164096466|NCT00746798|592717291|FG002|Overall Study|Withdrawal by Subject|1|||
163913826|NCT02764320|592053089|FG000|Overall Study|Did not meet inclusion criteria|1|||
163913827|NCT02764320|592053090|FG001|Overall Study|Did not meet inclusion criteria|0|||
163913828|NCT02764320|592053089|FG000|Overall Study|Subject moved|0|||
163913829|NCT02764320|592053090|FG001|Overall Study|Subject moved|2|||
163913830|NCT02764320|592053089|FG000|Overall Study|Overused medication unavailable|0|||
163913831|NCT02764320|592053090|FG001|Overall Study|Overused medication unavailable|1|||
163913832|NCT02764320|592053089|FG000|Overall Study|Seeking care outside site|0|||
163913833|NCT02764320|592053090|FG001|Overall Study|Seeking care outside site|1|||
163913834|NCT02764320|592053089|FG000|Overall Study|Technology barriers|0|||
163913835|NCT02764320|592053090|FG001|Overall Study|Technology barriers|1|||
163913836|NCT04765046|592053091|FG000|Overall Study|Screen Failure|2|||
163913837|NCT04765046|592053091|FG000|Overall Study|Withdrawal by Subject|4|||
163913838|NCT04765046|592053091|FG000|Overall Study|Physician Decision|4|||
163913839|NCT04765046|592053091|FG000|Overall Study|Surgery Cancelled|8|||
163913840|NCT03150589|592053093|FG000|Overall Study|Withdrawal by Subject|16|||
163913841|NCT03150589|592053094|FG001|Overall Study|Withdrawal by Subject|9|||
163913842|NCT03150589|592053093|FG000|Overall Study|Adverse Event|7|||
163913843|NCT03150589|592053094|FG001|Overall Study|Adverse Event|6|||
163913844|NCT03150589|592053093|FG000|Overall Study|Protocol Violation|4|||
163913845|NCT03150589|592053094|FG001|Overall Study|Protocol Violation|3|||
163913846|NCT03150589|592053093|FG000|Overall Study|Lost to Follow-up|3|||
163913847|NCT03150589|592053094|FG001|Overall Study|Lost to Follow-up|3|||
163913848|NCT03150589|592053093|FG000|Overall Study|Death|2|||
163913849|NCT03150589|592053094|FG001|Overall Study|Death|3|||
163913850|NCT03150589|592053093|FG000|Overall Study|IP non-compliance and other reasons|12|||
163913851|NCT03150589|592053094|FG001|Overall Study|IP non-compliance and other reasons|3|||
163913852|NCT01405508|592053095|FG000|Overall Study|AE, non-serious non-fatal|1|||
163913853|NCT01405508|592053096|FG001|Overall Study|AE, non-serious non-fatal|1|||
164027447|NCT01877382|592459023|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027448|NCT01877382|592459024|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027449|NCT01877382|592459025|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027450|NCT01877382|592459026|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027451|NCT01877382|592459027|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027452|NCT01877382|592459028|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027453|NCT01877382|592459029|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027454|NCT01877382|592459030|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027455|NCT01877382|592459031|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027456|NCT01877382|592459032|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027457|NCT01877382|592459033|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027458|NCT01877382|592459034|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027459|NCT01877382|592459035|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
164027460|NCT01877382|592459036|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
164027461|NCT03423979|592459037|FG000|Overall Study|Death|5|||
164027462|NCT03423979|592459037|FG000|Overall Study|Adverse Event|4|||
164027463|NCT03423979|592459037|FG000|Overall Study|Withdrawal by Subject|3|||
164027464|NCT03423979|592459037|FG000|Overall Study|Lost to Follow-up|16|||
164096467|NCT00746798|592717292|FG003|Overall Study|Withdrawal by Subject|0|||
163913854|NCT01405508|592053097|FG002|Overall Study|AE, non-serious non-fatal|0|||
163913855|NCT01405508|592053098|FG003|Overall Study|AE, non-serious non-fatal|0|||
163913856|NCT03529942|592053099|FG000|Overall Study|Withdrawal by Subject|13|||
163913857|NCT03529942|592053099|FG000|Overall Study|Physician Decision|1|||
163913858|NCT03529942|592053099|FG000|Overall Study|Lost to Follow-up|7|||
163913859|NCT03529942|592053099|FG000|Overall Study|Needle inserted but no drug administered|1|||
163913860|NCT03529942|592053099|FG000|Overall Study|Personal reasons|1|||
163913861|NCT00409747|592053110|FG000|Overall Study|Withdrawal by Subject|1|||
163913862|NCT01989156|592053113|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
163913863|NCT01989156|592053114|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
163913864|NCT01989156|592053115|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
163913865|NCT01989156|592053113|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
163913866|NCT01989156|592053114|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
163913867|NCT01989156|592053115|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
163913868|NCT01989156|592053113|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
163913869|NCT01989156|592053114|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
163913870|NCT01989156|592053115|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
163913871|NCT01989156|592053113|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
163913872|NCT01989156|592053114|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
163913873|NCT01989156|592053115|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
163913874|NCT01989156|592053113|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
163913875|NCT01989156|592053114|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
163913876|NCT01989156|592053115|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
163913877|NCT01989156|592053113|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
163913878|NCT01989156|592053114|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
163913879|NCT01989156|592053115|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
163913880|NCT01989156|592053113|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
163913881|NCT01989156|592053114|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
163913882|NCT01989156|592053115|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
163913883|NCT01989156|592053113|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
163913884|NCT01989156|592053114|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
164027465|NCT00808249|592459040|FG000|Overall Study|Adverse Event|4|||
164027466|NCT00808249|592459041|FG001|Overall Study|Adverse Event|7|||
163913885|NCT01989156|592053115|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
163913886|NCT03839355|592053116|FG000|Overall Study|Withdrawal by Subject|1|||
163913887|NCT03839355|592053117|FG001|Overall Study|Withdrawal by Subject|0|||
163913888|NCT01794689|592053120|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
163913889|NCT01794689|592053121|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
163913890|NCT01794689|592053122|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
163913891|NCT01794689|592053123|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
163913892|NCT01794689|592053120|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
163913893|NCT01794689|592053121|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
163913894|NCT01794689|592053122|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
163913895|NCT01794689|592053123|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
163913896|NCT01794689|592053120|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
163913897|NCT01794689|592053121|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
163913898|NCT01794689|592053122|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
163913899|NCT01794689|592053123|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
163913900|NCT01794689|592053120|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
163913901|NCT01794689|592053121|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
163913902|NCT01794689|592053122|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
164027467|NCT00808249|592459042|FG002|Overall Study|Adverse Event|10|||
164027468|NCT00808249|592459043|FG003|Overall Study|Adverse Event|6|||
164027469|NCT00808249|592459040|FG000|Overall Study|Lost to Follow-up|2|||
164027470|NCT00808249|592459041|FG001|Overall Study|Lost to Follow-up|3|||
164027471|NCT00808249|592459042|FG002|Overall Study|Lost to Follow-up|3|||
164027472|NCT00808249|592459043|FG003|Overall Study|Lost to Follow-up|5|||
163913903|NCT01794689|592053123|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
163913904|NCT01697956|592053124|FG000|Overall Study|Protocol Violation|1|||
163913905|NCT01697956|592053125|FG001|Overall Study|Protocol Violation|1|||
163913906|NCT03060525|592053126|FG000|Overall Study|moved out of state|1|||
163913907|NCT03060525|592053127|FG001|Overall Study|moved out of state|1|||
163913908|NCT03060525|592053128|FG002|Overall Study|moved out of state|1|||
163913909|NCT03060525|592053129|FG003|Overall Study|moved out of state|1|||
163913910|NCT03060525|592053126|FG000|Overall Study|unable to meet time commitment required of study|2|||
163913911|NCT03060525|592053127|FG001|Overall Study|unable to meet time commitment required of study|3|||
163913912|NCT03060525|592053128|FG002|Overall Study|unable to meet time commitment required of study|3|||
163913913|NCT03060525|592053129|FG003|Overall Study|unable to meet time commitment required of study|1|||
163913914|NCT03060525|592053126|FG000|Overall Study|no longer interested in doing intervention|0|||
164027473|NCT00808249|592459040|FG000|Overall Study|Withdrawal by Subject|4|||
164027474|NCT00808249|592459041|FG001|Overall Study|Withdrawal by Subject|0|||
164096468|NCT00746798|592717289|FG000|Overall Study|Death|0|||
164096469|NCT00746798|592717290|FG001|Overall Study|Death|0|||
164096470|NCT00746798|592717291|FG002|Overall Study|Death|2|||
164096471|NCT00746798|592717292|FG003|Overall Study|Death|0|||
164096472|NCT00746798|592717289|FG000|Overall Study|Participant unable to return for visit|1|||
164112594|NCT00210639|592774044|FG000|Overall Study|Lost to Follow-up|37|||
163913915|NCT03060525|592053127|FG001|Overall Study|no longer interested in doing intervention|0|||
163913916|NCT03060525|592053128|FG002|Overall Study|no longer interested in doing intervention|0|||
163913917|NCT03060525|592053129|FG003|Overall Study|no longer interested in doing intervention|1|||
163913918|NCT01964547|592053130|FG000|Overall Study|Adverse Event|8|||
163913919|NCT01964547|592053131|FG001|Overall Study|Adverse Event|2|||
163913920|NCT01964547|592053130|FG000|Overall Study|Withdrawal by Subject|4|||
163913921|NCT01964547|592053131|FG001|Overall Study|Withdrawal by Subject|7|||
163913922|NCT01964547|592053130|FG000|Overall Study|Lost to Follow-up|0|||
163913923|NCT01964547|592053131|FG001|Overall Study|Lost to Follow-up|1|||
163913924|NCT01964547|592053130|FG000|Overall Study|Withdrawal by Investigator|0|||
163913925|NCT01964547|592053131|FG001|Overall Study|Withdrawal by Investigator|1|||
163913926|NCT01115309|592053132|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
163913927|NCT01115309|592053132|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
163913928|NCT01115309|592053132|FG000|Long-term Follow-up|Lost to Follow-up|6|||
163913929|NCT04447287|592053133|FG000|Period 1: Run-in Period|Adverse Event|3|||
163913930|NCT04447287|592053134|FG001|Period 1: Run-in Period|Adverse Event|0|||
163913931|NCT04447287|592053135|FG002|Period 1: Run-in Period|Adverse Event|0|||
163913932|NCT04447287|592053133|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
163913933|NCT04447287|592053134|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
164027475|NCT00808249|592459042|FG002|Overall Study|Withdrawal by Subject|2|||
164027476|NCT00808249|592459043|FG003|Overall Study|Withdrawal by Subject|4|||
164027477|NCT00808249|592459040|FG000|Overall Study|Protocol Violation|3|||
164027478|NCT00808249|592459041|FG001|Overall Study|Protocol Violation|3|||
164027479|NCT00808249|592459042|FG002|Overall Study|Protocol Violation|3|||
164027480|NCT00808249|592459043|FG003|Overall Study|Protocol Violation|0|||
164027481|NCT00808249|592459040|FG000|Overall Study|Lack of Efficacy|1|||
164027482|NCT00808249|592459041|FG001|Overall Study|Lack of Efficacy|1|||
163913934|NCT04447287|592053135|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
163913935|NCT04447287|592053133|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
163913936|NCT04447287|592053134|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
163913937|NCT04447287|592053135|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
163913938|NCT05700851|592053136|FG000|Overall Study|Received a kidney transplant|1|||
163913939|NCT05700851|592053136|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
163913940|NCT05700851|592053136|FG000|Overall Study|Withdrawal by Subject|1|||
163913941|NCT02147093|592053137|FG000|Period 1|Lost to Follow-up|0|||
163913942|NCT02147093|592053138|FG001|Period 1|Lost to Follow-up|1|||
163913943|NCT02147093|592053137|FG000|Period 2|Protocol Violation|2|||
163913944|NCT02147093|592053138|FG001|Period 2|Protocol Violation|0|||
163913945|NCT03246724|592053139|FG000|Overall Study|Withdrawal by Subject|5|||
163913946|NCT03246724|592053140|FG001|Overall Study|Withdrawal by Subject|2|||
163913947|NCT03246724|592053141|FG002|Overall Study|Withdrawal by Subject|4|||
163913948|NCT03246724|592053142|FG003|Overall Study|Withdrawal by Subject|2|||
163913949|NCT03246724|592053139|FG000|Overall Study|Ineligible on day of surgery|7|||
163913950|NCT03246724|592053140|FG001|Overall Study|Ineligible on day of surgery|2|||
163913951|NCT03246724|592053141|FG002|Overall Study|Ineligible on day of surgery|0|||
163913952|NCT03246724|592053142|FG003|Overall Study|Ineligible on day of surgery|3|||
163913953|NCT03246724|592053139|FG000|Overall Study|Study completed before surgical date|2|||
163913954|NCT03246724|592053140|FG001|Overall Study|Study completed before surgical date|1|||
163913955|NCT03246724|592053141|FG002|Overall Study|Study completed before surgical date|8|||
163913956|NCT03246724|592053142|FG003|Overall Study|Study completed before surgical date|1|||
163913957|NCT03246724|592053139|FG000|Overall Study|Transferred to other arm|0|||
163913958|NCT03246724|592053140|FG001|Overall Study|Transferred to other arm|0|||
163913959|NCT03246724|592053141|FG002|Overall Study|Transferred to other arm|1|||
163913960|NCT03246724|592053142|FG003|Overall Study|Transferred to other arm|0|||
163913961|NCT03246724|592053139|FG000|Overall Study|Unable to obtain medication timely|0|||
163913962|NCT03246724|592053140|FG001|Overall Study|Unable to obtain medication timely|2|||
163913963|NCT03246724|592053141|FG002|Overall Study|Unable to obtain medication timely|2|||
163913964|NCT03246724|592053142|FG003|Overall Study|Unable to obtain medication timely|1|||
163913965|NCT03246724|592053139|FG000|Overall Study|Re-consented to participate|0|||
163913966|NCT03246724|592053140|FG001|Overall Study|Re-consented to participate|0|||
163913967|NCT03246724|592053141|FG002|Overall Study|Re-consented to participate|0|||
163913968|NCT03246724|592053142|FG003|Overall Study|Re-consented to participate|1|||
163913969|NCT00655824|592053143|FG000|Overall Study|Adverse Event|3|||
163913970|NCT00655824|592053143|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
163913971|NCT00655824|592053143|FG000|Overall Study|Protocol Violation|1|||
163913972|NCT00655824|592053143|FG000|Overall Study|Withdrawal by Subject|4|||
163913973|NCT00655824|592053143|FG000|Overall Study|Deterioration of Trial Disease|2|||
163913974|NCT02978716|592053144|FG000|Overall Study|Death|25|||
163913975|NCT02978716|592053145|FG001|Overall Study|Death|13|||
163913976|NCT02978716|592053146|FG002|Overall Study|Death|20|||
163913977|NCT02978716|592053144|FG000|Overall Study|Lost to Follow-up|0|||
163913978|NCT02978716|592053145|FG001|Overall Study|Lost to Follow-up|0|||
163913979|NCT02978716|592053146|FG002|Overall Study|Lost to Follow-up|1|||
163913980|NCT02978716|592053144|FG000|Overall Study|Withdrawal by Subject|6|||
163913981|NCT02978716|592053145|FG001|Overall Study|Withdrawal by Subject|4|||
163913982|NCT02978716|592053146|FG002|Overall Study|Withdrawal by Subject|5|||
163913983|NCT02978716|592053144|FG000|Overall Study|Sponsor terminated|2|||
163913984|NCT02978716|592053145|FG001|Overall Study|Sponsor terminated|13|||
163913985|NCT02978716|592053146|FG002|Overall Study|Sponsor terminated|9|||
163913986|NCT02978716|592053144|FG000|Overall Study|Other|1|||
163913987|NCT02978716|592053145|FG001|Overall Study|Other|3|||
163913988|NCT02978716|592053146|FG002|Overall Study|Other|0|||
163913989|NCT00589628|592053147|FG000|Overall Study|Lost to Follow-up|0|||
163913990|NCT00589628|592053148|FG001|Overall Study|Lost to Follow-up|1|||
163913991|NCT01922102|592055003|FG000|Overall Study|Withdrawal by Subject|7|||
163913992|NCT01922102|592055004|FG001|Overall Study|Withdrawal by Subject|3|||
163913993|NCT01922102|592055005|FG002|Overall Study|Withdrawal by Subject|7|||
164027483|NCT00808249|592459042|FG002|Overall Study|Lack of Efficacy|0|||
164027484|NCT00808249|592459043|FG003|Overall Study|Lack of Efficacy|0|||
164027485|NCT00808249|592459040|FG000|Overall Study|study specific discontinuation criteria|1|||
163913994|NCT01922102|592055003|FG000|Overall Study|Physician Decision|0|||
163913995|NCT01922102|592055004|FG001|Overall Study|Physician Decision|2|||
163913996|NCT01922102|592055005|FG002|Overall Study|Physician Decision|1|||
163913997|NCT01922102|592055003|FG000|Overall Study|Adverse Event|1|||
163913998|NCT01922102|592055004|FG001|Overall Study|Adverse Event|2|||
163913999|NCT01922102|592055005|FG002|Overall Study|Adverse Event|0|||
163914000|NCT01922102|592055003|FG000|Overall Study|Lost to Follow-up|1|||
163914001|NCT01922102|592055004|FG001|Overall Study|Lost to Follow-up|0|||
163914002|NCT01922102|592055005|FG002|Overall Study|Lost to Follow-up|0|||
164027486|NCT00808249|592459041|FG001|Overall Study|study specific discontinuation criteria|0|||
164027487|NCT00808249|592459042|FG002|Overall Study|study specific discontinuation criteria|1|||
164027488|NCT00808249|592459043|FG003|Overall Study|study specific discontinuation criteria|0|||
164027489|NCT00808249|592459040|FG000|Overall Study|All other reasons|2|||
164027490|NCT00808249|592459041|FG001|Overall Study|All other reasons|1|||
164027491|NCT00808249|592459042|FG002|Overall Study|All other reasons|3|||
164027492|NCT00808249|592459043|FG003|Overall Study|All other reasons|1|||
164027493|NCT05108805|592459047|FG000|Overall Study|T-cell expansion was not successful.|5|||
164027494|NCT04095286|592459048|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027495|NCT04095286|592459049|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
164027496|NCT04095286|592459050|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027497|NCT04095286|592459051|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027498|NCT04095286|592459052|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027499|NCT04095286|592459053|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027500|NCT04095286|592459048|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
163914003|NCT01922102|592055003|FG000|Overall Study|Administrative problems|0|||
163914004|NCT01922102|592055004|FG001|Overall Study|Administrative problems|2|||
163914005|NCT01922102|592055005|FG002|Overall Study|Administrative problems|0|||
163914006|NCT05203822|592055006|FG000|Overall Study|Adverse Event|1|||
163914007|NCT05203822|592055006|FG000|Overall Study|Withdrawal by Subject|1|||
163914008|NCT01816165|592055013|FG000|Overall Study|Adverse Event|1|||
163914009|NCT01816165|592055014|FG001|Overall Study|Adverse Event|0|||
163914010|NCT01816165|592055015|FG002|Overall Study|Adverse Event|0|||
163914011|NCT01816165|592055016|FG003|Overall Study|Adverse Event|0|||
163914012|NCT00447499|592055017|FG000|Overall Study|Adverse Event|1|||
163914013|NCT00447499|592055017|FG000|Overall Study|Patient Decision|4|||
163914014|NCT00447499|592055017|FG000|Overall Study|Sponsor Decision|1|||
163914015|NCT00447499|592055017|FG000|Overall Study|Physician Decision|1|||
163914016|NCT02092909|592055019|FG000|Overall Study|Adverse Event|0|||
163914017|NCT02092909|592055020|FG001|Overall Study|Adverse Event|0|||
163914018|NCT02092909|592055021|FG002|Overall Study|Adverse Event|4|||
163914019|NCT02092909|592055022|FG003|Overall Study|Adverse Event|2|||
163914020|NCT02092909|592055019|FG000|Overall Study|Lack of Efficacy|0|||
163914021|NCT02092909|592055020|FG001|Overall Study|Lack of Efficacy|2|||
164027501|NCT04095286|592459049|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164027502|NCT04095286|592459050|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164027503|NCT04095286|592459051|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164027504|NCT04095286|592459052|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
163914022|NCT02092909|592055021|FG002|Overall Study|Lack of Efficacy|1|||
163914023|NCT02092909|592055022|FG003|Overall Study|Lack of Efficacy|0|||
163914024|NCT02092909|592055019|FG000|Overall Study|Withdrawal by Subject|0|||
163914025|NCT02092909|592055020|FG001|Overall Study|Withdrawal by Subject|0|||
163914026|NCT02092909|592055021|FG002|Overall Study|Withdrawal by Subject|2|||
163914027|NCT02092909|592055022|FG003|Overall Study|Withdrawal by Subject|1|||
164027505|NCT04095286|592459053|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
164027506|NCT04095286|592459048|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164027507|NCT04095286|592459049|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164027508|NCT04095286|592459050|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
164027509|NCT04095286|592459051|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164027510|NCT04095286|592459052|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164027511|NCT04095286|592459053|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
164027512|NCT04095286|592459048|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027513|NCT04095286|592459049|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027514|NCT04095286|592459050|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
164027515|NCT04095286|592459051|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027516|NCT04095286|592459052|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027517|NCT04095286|592459053|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
164027518|NCT04095286|592459048|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164027519|NCT04095286|592459049|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164027520|NCT04095286|592459050|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164027521|NCT04095286|592459051|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164027522|NCT04095286|592459052|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
164027523|NCT04095286|592459053|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
164027524|NCT00479557|592459054|FG000|Overall Study|Death|0|||
164027525|NCT00479557|592459055|FG001|Overall Study|Death|0|||
164027526|NCT00479557|592459056|FG002|Overall Study|Death|0|||
164027527|NCT00479557|592459057|FG003|Overall Study|Death|0|||
164027528|NCT00479557|592459058|FG004|Overall Study|Death|0|||
164027529|NCT00479557|592459059|FG005|Overall Study|Death|1|||
164027530|NCT00479557|592459060|FG006|Overall Study|Death|0|||
164027531|NCT00479557|592459054|FG000|Overall Study|Lack of Efficacy|1|||
164027532|NCT00479557|592459055|FG001|Overall Study|Lack of Efficacy|0|||
164027533|NCT00479557|592459056|FG002|Overall Study|Lack of Efficacy|0|||
164027534|NCT00479557|592459057|FG003|Overall Study|Lack of Efficacy|0|||
164027535|NCT00479557|592459058|FG004|Overall Study|Lack of Efficacy|0|||
164027536|NCT00479557|592459059|FG005|Overall Study|Lack of Efficacy|0|||
164027537|NCT00479557|592459060|FG006|Overall Study|Lack of Efficacy|0|||
164027538|NCT00479557|592459054|FG000|Overall Study|Lost to Follow-up|0|||
164027539|NCT00479557|592459055|FG001|Overall Study|Lost to Follow-up|2|||
164027540|NCT00479557|592459056|FG002|Overall Study|Lost to Follow-up|0|||
164027541|NCT00479557|592459057|FG003|Overall Study|Lost to Follow-up|2|||
164027542|NCT00479557|592459058|FG004|Overall Study|Lost to Follow-up|0|||
164027543|NCT00479557|592459059|FG005|Overall Study|Lost to Follow-up|0|||
164027544|NCT00479557|592459060|FG006|Overall Study|Lost to Follow-up|0|||
164027545|NCT00479557|592459054|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164027546|NCT00479557|592459055|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164027547|NCT00479557|592459056|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
164027548|NCT00479557|592459057|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
164027549|NCT00479557|592459058|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164027550|NCT00479557|592459059|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
164027551|NCT00479557|592459060|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
164027552|NCT00479557|592459054|FG000|Overall Study|AE not related to Study Drug|1|||
164027553|NCT00479557|592459055|FG001|Overall Study|AE not related to Study Drug|3|||
164027554|NCT00479557|592459056|FG002|Overall Study|AE not related to Study Drug|0|||
164027555|NCT00479557|592459057|FG003|Overall Study|AE not related to Study Drug|0|||
164027556|NCT00479557|592459058|FG004|Overall Study|AE not related to Study Drug|2|||
164027557|NCT00479557|592459059|FG005|Overall Study|AE not related to Study Drug|2|||
164027558|NCT00479557|592459060|FG006|Overall Study|AE not related to Study Drug|1|||
164027559|NCT00479557|592459054|FG000|Overall Study|Caregiver Request|2|||
164027560|NCT00479557|592459055|FG001|Overall Study|Caregiver Request|2|||
164027561|NCT00479557|592459056|FG002|Overall Study|Caregiver Request|2|||
163914028|NCT02092909|592055019|FG000|Overall Study|Study terminated by Sponsor|0|||
163914029|NCT02092909|592055020|FG001|Overall Study|Study terminated by Sponsor|0|||
163914030|NCT02092909|592055021|FG002|Overall Study|Study terminated by Sponsor|0|||
163914031|NCT02092909|592055022|FG003|Overall Study|Study terminated by Sponsor|2|||
163914032|NCT02092909|592055019|FG000|Overall Study|Miscellaneous|1|||
163914033|NCT02092909|592055020|FG001|Overall Study|Miscellaneous|1|||
163914034|NCT02092909|592055021|FG002|Overall Study|Miscellaneous|2|||
163914035|NCT02092909|592055022|FG003|Overall Study|Miscellaneous|1|||
163914036|NCT02865083|592055023|FG000|Overall Study|Early Termination|3|||
163914037|NCT02865083|592055024|FG001|Overall Study|Early Termination|1|||
163914038|NCT00096278|592055025|FG000|Overall Study|No follow-up data|15|||
163914039|NCT00096278|592055026|FG001|Overall Study|No follow-up data|18|||
163914040|NCT00096278|592055025|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
163914041|NCT00096278|592055026|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
163914042|NCT02105688|592055027|FG000|Part A: Double-Blind|Adverse Event|1|||
163914043|NCT02105688|592055028|FG001|Part A: Double-Blind|Adverse Event|0|||
163914044|NCT02105688|592055027|FG000|Part A: Double-Blind|Death|0|||
163914045|NCT02105688|592055028|FG001|Part A: Double-Blind|Death|1|||
163914046|NCT02105688|592055027|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
163914047|NCT02105688|592055028|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
163914048|NCT02105688|592055027|FG000|Part A: Double-Blind|Physician Decision|0|||
163914049|NCT02105688|592055028|FG001|Part A: Double-Blind|Physician Decision|1|||
163914050|NCT02105688|592055027|FG000|Part A: Double-Blind|Status Unknown|0|||
163914051|NCT02105688|592055028|FG001|Part A: Double-Blind|Status Unknown|2|||
163914052|NCT02105688|592055027|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
163914053|NCT02105688|592055028|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
163914054|NCT02105688|592055027|FG000|Part B: Observational Follow-up|Death|2|||
163914055|NCT02105688|592055028|FG001|Part B: Observational Follow-up|Death|1|||
163914056|NCT02105688|592055027|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
163914057|NCT02105688|592055028|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
163914058|NCT02105688|592055027|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
163914059|NCT02105688|592055028|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
163914060|NCT02105688|592055027|FG000|Part B: Observational Follow-up|Physician Decision|3|||
163914061|NCT02105688|592055028|FG001|Part B: Observational Follow-up|Physician Decision|1|||
163914062|NCT02959866|592055037|FG000|Overall Study|Withdrawal by Subject|1|||
163914063|NCT03541369|592055041|FG000|Overall Study|Death|0|||
163914064|NCT03541369|592055042|FG001|Overall Study|Death|0|||
163914065|NCT03541369|592055043|FG002|Overall Study|Death|0|||
163914066|NCT03541369|592055044|FG003|Overall Study|Death|0|||
163914067|NCT03541369|592055045|FG004|Overall Study|Death|1|||
163914068|NCT03541369|592055046|FG005|Overall Study|Death|1|||
163914069|NCT03541369|592055047|FG006|Overall Study|Death|0|||
163914070|NCT03541369|592055048|FG007|Overall Study|Death|2|||
163914071|NCT03541369|592055049|FG008|Overall Study|Death|1|||
163914072|NCT03541369|592055050|FG009|Overall Study|Death|2|||
163914073|NCT03541369|592055051|FG010|Overall Study|Death|1|||
163914074|NCT03541369|592055052|FG011|Overall Study|Death|0|||
163914075|NCT03541369|592055053|FG012|Overall Study|Death|2|||
163914076|NCT03541369|592055054|FG013|Overall Study|Death|1|||
163914077|NCT03541369|592055055|FG014|Overall Study|Death|1|||
163914078|NCT03541369|592055056|FG015|Overall Study|Death|1|||
163914079|NCT03541369|592055057|FG016|Overall Study|Death|0|||
163914080|NCT03541369|592055058|FG017|Overall Study|Death|1|||
163914081|NCT03541369|592055041|FG000|Overall Study|Decision by sponsor|0|||
164027562|NCT00479557|592459057|FG003|Overall Study|Caregiver Request|0|||
164027563|NCT00479557|592459058|FG004|Overall Study|Caregiver Request|1|||
164027564|NCT00479557|592459059|FG005|Overall Study|Caregiver Request|2|||
164027565|NCT00479557|592459060|FG006|Overall Study|Caregiver Request|0|||
164027566|NCT00479557|592459054|FG000|Overall Study|Investigator Request|0|||
164027567|NCT00479557|592459055|FG001|Overall Study|Investigator Request|0|||
164027568|NCT00479557|592459056|FG002|Overall Study|Investigator Request|1|||
164027569|NCT00479557|592459057|FG003|Overall Study|Investigator Request|0|||
164027570|NCT00479557|592459058|FG004|Overall Study|Investigator Request|0|||
163914082|NCT03541369|592055042|FG001|Overall Study|Decision by sponsor|0|||
163914083|NCT03541369|592055043|FG002|Overall Study|Decision by sponsor|0|||
163914084|NCT03541369|592055044|FG003|Overall Study|Decision by sponsor|1|||
163914085|NCT03541369|592055045|FG004|Overall Study|Decision by sponsor|0|||
163914086|NCT03541369|592055046|FG005|Overall Study|Decision by sponsor|2|||
163914087|NCT03541369|592055047|FG006|Overall Study|Decision by sponsor|0|||
163914088|NCT03541369|592055048|FG007|Overall Study|Decision by sponsor|1|||
163914089|NCT03541369|592055049|FG008|Overall Study|Decision by sponsor|2|||
163914090|NCT03541369|592055050|FG009|Overall Study|Decision by sponsor|0|||
163914091|NCT03541369|592055051|FG010|Overall Study|Decision by sponsor|0|||
163914092|NCT03541369|592055052|FG011|Overall Study|Decision by sponsor|0|||
163914093|NCT03541369|592055053|FG012|Overall Study|Decision by sponsor|2|||
163914094|NCT03541369|592055054|FG013|Overall Study|Decision by sponsor|2|||
163914095|NCT03541369|592055055|FG014|Overall Study|Decision by sponsor|0|||
163914096|NCT03541369|592055056|FG015|Overall Study|Decision by sponsor|1|||
164027571|NCT00479557|592459059|FG005|Overall Study|Investigator Request|0|||
164027572|NCT00479557|592459060|FG006|Overall Study|Investigator Request|0|||
164027573|NCT00479557|592459054|FG000|Overall Study|Subject Request|3|||
164027574|NCT00479557|592459055|FG001|Overall Study|Subject Request|0|||
164027575|NCT00479557|592459056|FG002|Overall Study|Subject Request|1|||
163914097|NCT03541369|592055057|FG016|Overall Study|Decision by sponsor|1|||
163914098|NCT03541369|592055058|FG017|Overall Study|Decision by sponsor|1|||
163914099|NCT03541369|592055041|FG000|Overall Study|Withdrawal by Subject|0|||
163914100|NCT03541369|592055042|FG001|Overall Study|Withdrawal by Subject|0|||
163914101|NCT03541369|592055043|FG002|Overall Study|Withdrawal by Subject|0|||
163914102|NCT03541369|592055044|FG003|Overall Study|Withdrawal by Subject|0|||
163914103|NCT03541369|592055045|FG004|Overall Study|Withdrawal by Subject|0|||
163914104|NCT03541369|592055046|FG005|Overall Study|Withdrawal by Subject|0|||
163914105|NCT03541369|592055047|FG006|Overall Study|Withdrawal by Subject|1|||
163914106|NCT03541369|592055048|FG007|Overall Study|Withdrawal by Subject|0|||
163914107|NCT03541369|592055049|FG008|Overall Study|Withdrawal by Subject|0|||
163914108|NCT03541369|592055050|FG009|Overall Study|Withdrawal by Subject|0|||
163914109|NCT03541369|592055051|FG010|Overall Study|Withdrawal by Subject|0|||
163914110|NCT03541369|592055052|FG011|Overall Study|Withdrawal by Subject|1|||
163914111|NCT03541369|592055053|FG012|Overall Study|Withdrawal by Subject|0|||
163914112|NCT03541369|592055054|FG013|Overall Study|Withdrawal by Subject|0|||
163914113|NCT03541369|592055055|FG014|Overall Study|Withdrawal by Subject|3|||
163914114|NCT03541369|592055056|FG015|Overall Study|Withdrawal by Subject|0|||
163914115|NCT03541369|592055057|FG016|Overall Study|Withdrawal by Subject|4|||
163914116|NCT03541369|592055058|FG017|Overall Study|Withdrawal by Subject|2|||
163914117|NCT03541369|592055041|FG000|Overall Study|Lost to Follow-up|0|||
163914118|NCT03541369|592055042|FG001|Overall Study|Lost to Follow-up|0|||
163914119|NCT03541369|592055043|FG002|Overall Study|Lost to Follow-up|0|||
163914120|NCT03541369|592055044|FG003|Overall Study|Lost to Follow-up|0|||
163914121|NCT03541369|592055045|FG004|Overall Study|Lost to Follow-up|1|||
163914122|NCT03541369|592055046|FG005|Overall Study|Lost to Follow-up|0|||
163914123|NCT03541369|592055047|FG006|Overall Study|Lost to Follow-up|0|||
163914124|NCT03541369|592055048|FG007|Overall Study|Lost to Follow-up|0|||
163914125|NCT03541369|592055049|FG008|Overall Study|Lost to Follow-up|1|||
164027576|NCT00479557|592459057|FG003|Overall Study|Subject Request|1|||
163914126|NCT03541369|592055050|FG009|Overall Study|Lost to Follow-up|0|||
163914127|NCT03541369|592055051|FG010|Overall Study|Lost to Follow-up|0|||
163914128|NCT03541369|592055052|FG011|Overall Study|Lost to Follow-up|0|||
163914129|NCT03541369|592055053|FG012|Overall Study|Lost to Follow-up|1|||
164027577|NCT00479557|592459058|FG004|Overall Study|Subject Request|1|||
164027578|NCT00479557|592459059|FG005|Overall Study|Subject Request|4|||
164027579|NCT00479557|592459060|FG006|Overall Study|Subject Request|1|||
164027580|NCT00479557|592459054|FG000|Overall Study|Other|2|||
164027581|NCT00479557|592459055|FG001|Overall Study|Other|3|||
164027582|NCT00479557|592459056|FG002|Overall Study|Other|1|||
164027583|NCT00479557|592459057|FG003|Overall Study|Other|0|||
164027584|NCT00479557|592459058|FG004|Overall Study|Other|0|||
164027585|NCT00479557|592459059|FG005|Overall Study|Other|3|||
164027586|NCT00479557|592459060|FG006|Overall Study|Other|0|||
164027587|NCT02509494|592459063|FG000|Overall Study|Lost to Follow-up|8|||
164027588|NCT02509494|592459064|FG001|Overall Study|Lost to Follow-up|47|||
164027589|NCT02509494|592459065|FG002|Overall Study|Lost to Follow-up|19|||
164027590|NCT02509494|592459066|FG003|Overall Study|Lost to Follow-up|6|||
164027591|NCT02509494|592459067|FG004|Overall Study|Lost to Follow-up|3|||
164027592|NCT02509494|592459068|FG005|Overall Study|Lost to Follow-up|3|||
164027593|NCT02509494|592459069|FG006|Overall Study|Lost to Follow-up|1|||
164027594|NCT02509494|592459070|FG007|Overall Study|Lost to Follow-up|3|||
164027595|NCT02509494|592459071|FG008|Overall Study|Lost to Follow-up|1|||
164027596|NCT02509494|592459063|FG000|Overall Study|Physician Decision|2|||
164027597|NCT02509494|592459064|FG001|Overall Study|Physician Decision|1|||
164027598|NCT02509494|592459065|FG002|Overall Study|Physician Decision|0|||
164027599|NCT02509494|592459066|FG003|Overall Study|Physician Decision|0|||
164027600|NCT02509494|592459067|FG004|Overall Study|Physician Decision|0|||
164027601|NCT02509494|592459068|FG005|Overall Study|Physician Decision|0|||
164027602|NCT02509494|592459069|FG006|Overall Study|Physician Decision|0|||
164027603|NCT02509494|592459070|FG007|Overall Study|Physician Decision|0|||
164027604|NCT02509494|592459071|FG008|Overall Study|Physician Decision|0|||
164027605|NCT02509494|592459063|FG000|Overall Study|Withdrawal by Subject|4|||
164027606|NCT02509494|592459064|FG001|Overall Study|Withdrawal by Subject|17|||
164027607|NCT02509494|592459065|FG002|Overall Study|Withdrawal by Subject|7|||
164027608|NCT02509494|592459066|FG003|Overall Study|Withdrawal by Subject|5|||
164027609|NCT02509494|592459067|FG004|Overall Study|Withdrawal by Subject|0|||
164096473|NCT00746798|592717290|FG001|Overall Study|Participant unable to return for visit|0|||
164027610|NCT02509494|592459068|FG005|Overall Study|Withdrawal by Subject|6|||
164027611|NCT02509494|592459069|FG006|Overall Study|Withdrawal by Subject|1|||
164027612|NCT02509494|592459070|FG007|Overall Study|Withdrawal by Subject|2|||
164027613|NCT02509494|592459071|FG008|Overall Study|Withdrawal by Subject|1|||
164027614|NCT02509494|592459063|FG000|Overall Study|Death|0|||
164027615|NCT02509494|592459064|FG001|Overall Study|Death|1|||
164027616|NCT02509494|592459065|FG002|Overall Study|Death|0|||
164027617|NCT02509494|592459066|FG003|Overall Study|Death|0|||
164027618|NCT02509494|592459067|FG004|Overall Study|Death|1|||
164027619|NCT02509494|592459068|FG005|Overall Study|Death|0|||
164027620|NCT02509494|592459069|FG006|Overall Study|Death|0|||
164027621|NCT02509494|592459070|FG007|Overall Study|Death|1|||
164027622|NCT02509494|592459071|FG008|Overall Study|Death|0|||
164027623|NCT02509494|592459063|FG000|Overall Study|Other|0|||
164027624|NCT02509494|592459064|FG001|Overall Study|Other|4|||
164027625|NCT02509494|592459065|FG002|Overall Study|Other|5|||
164027626|NCT02509494|592459066|FG003|Overall Study|Other|0|||
164027627|NCT02509494|592459067|FG004|Overall Study|Other|0|||
164027628|NCT02509494|592459068|FG005|Overall Study|Other|0|||
164027629|NCT02509494|592459069|FG006|Overall Study|Other|0|||
164027630|NCT02509494|592459070|FG007|Overall Study|Other|0|||
164027631|NCT02509494|592459071|FG008|Overall Study|Other|0|||
164027632|NCT02509494|592459063|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164027633|NCT02509494|592459064|FG001|Overall Study|Non-Compliance With Study Drug|11|||
164027634|NCT02509494|592459065|FG002|Overall Study|Non-Compliance With Study Drug|7|||
164027635|NCT02509494|592459066|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164027636|NCT02509494|592459067|FG004|Overall Study|Non-Compliance With Study Drug|1|||
164027637|NCT02509494|592459068|FG005|Overall Study|Non-Compliance With Study Drug|2|||
164027638|NCT02509494|592459069|FG006|Overall Study|Non-Compliance With Study Drug|1|||
164027639|NCT02509494|592459070|FG007|Overall Study|Non-Compliance With Study Drug|1|||
164027640|NCT02509494|592459071|FG008|Overall Study|Non-Compliance With Study Drug|0|||
164027641|NCT01511107|592459072|FG000|Overall Study|Ineligible|3|||
164027642|NCT01511107|592459073|FG001|Overall Study|Ineligible|2|||
164027643|NCT01511107|592459072|FG000|Overall Study|Lost to Follow-up|10|||
164027644|NCT01511107|592459073|FG001|Overall Study|Lost to Follow-up|19|||
164027645|NCT01511107|592459072|FG000|Overall Study|Withdrawal by Subject|9|||
164027646|NCT01511107|592459073|FG001|Overall Study|Withdrawal by Subject|20|||
164027647|NCT05371912|592459074|FG000|Overall Study|Lost to Follow-up|3|||
164027648|NCT05371912|592459075|FG001|Overall Study|Lost to Follow-up|2|||
164027649|NCT04752189|592459076|FG000|Overall Study|Withdrawal by Subject|0|||
164027650|NCT04752189|592459077|FG001|Overall Study|Withdrawal by Subject|150|||
164027651|NCT04752189|592459076|FG000|Overall Study|Lost to Follow-up|261|||
164027652|NCT04752189|592459077|FG001|Overall Study|Lost to Follow-up|126|||
164027653|NCT00975195|592459078|FG000|Overall Study|Adverse Event|108|||
164027654|NCT00975195|592459079|FG001|Overall Study|Adverse Event|101|||
164027655|NCT00975195|592459078|FG000|Overall Study|Lack of Efficacy|6|||
164027656|NCT00975195|592459079|FG001|Overall Study|Lack of Efficacy|6|||
164027657|NCT00975195|592459078|FG000|Overall Study|Protocol Violation|27|||
164027658|NCT00975195|592459079|FG001|Overall Study|Protocol Violation|23|||
164027659|NCT00975195|592459078|FG000|Overall Study|Lost to Follow-up|9|||
164027660|NCT00975195|592459079|FG001|Overall Study|Lost to Follow-up|7|||
164027661|NCT00975195|592459078|FG000|Overall Study|Withdrawal by Subject|48|||
164027662|NCT00975195|592459079|FG001|Overall Study|Withdrawal by Subject|61|||
164027663|NCT00975195|592459078|FG000|Overall Study|Other reason not defined above|29|||
164027664|NCT00975195|592459079|FG001|Overall Study|Other reason not defined above|33|||
164027665|NCT00975195|592459078|FG000|Overall Study|Not treated|1|||
164027666|NCT00975195|592459079|FG001|Overall Study|Not treated|2|||
164027667|NCT03003403|592459080|FG000|Overall Study|Ineligible|8|||
164027668|NCT03003403|592459081|FG001|Overall Study|Ineligible|7|||
164027669|NCT03003403|592459080|FG000|Overall Study|Withdrawal by Subject|3|||
164027670|NCT03003403|592459081|FG001|Overall Study|Withdrawal by Subject|1|||
164027671|NCT01255306|592461050|FG000|Overall Study|Physician Decision|1|||
164027672|NCT01255306|592461051|FG001|Overall Study|Physician Decision|1|||
164027673|NCT05195359|592461052|FG000|Overall Study|Lost to Follow-up|124|||
164027674|NCT05195359|592461053|FG001|Overall Study|Lost to Follow-up|34|||
164027675|NCT01677624|592461059|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
164027676|NCT01747811|592461060|FG000|Overall Study|Lack of Efficacy|2|||
164027677|NCT01747811|592461061|FG001|Overall Study|Lack of Efficacy|4|||
164027678|NCT01617655|592461065|FG000|Overall Study|Adverse Event|2|||
164027679|NCT01617655|592461066|FG001|Overall Study|Adverse Event|3|||
164027680|NCT01617655|592461065|FG000|Overall Study|Poor compliance to protocol|1|||
164027681|NCT01617655|592461066|FG001|Overall Study|Poor compliance to protocol|4|||
164027682|NCT01617655|592461065|FG000|Overall Study|Participants moved|0|||
164027683|NCT01617655|592461066|FG001|Overall Study|Participants moved|4|||
164027684|NCT01617655|592461065|FG000|Overall Study|Consent withdrawn by participant|1|||
164027685|NCT01617655|592461066|FG001|Overall Study|Consent withdrawn by participant|1|||
164027686|NCT01617655|592461065|FG000|Overall Study|Last visit outside protocol visit window|1|||
164027687|NCT01617655|592461066|FG001|Overall Study|Last visit outside protocol visit window|10|||
164027688|NCT01617655|592461065|FG000|Overall Study|Site closure|3|||
164027689|NCT01617655|592461066|FG001|Overall Study|Site closure|5|||
164027690|NCT01617655|592461065|FG000|Overall Study|Other than specified above|1|||
164027691|NCT01617655|592461066|FG001|Overall Study|Other than specified above|2|||
164027692|NCT01175213|592461067|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
164027693|NCT01175213|592461068|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
164027694|NCT01175213|592461067|FG000|IGSC, 10%/rHuPH20|Death|1|||
164027695|NCT01175213|592461068|FG001|IGSC, 10%/rHuPH20|Death|0|||
164027696|NCT01175213|592461067|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
164027697|NCT01175213|592461068|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
163914130|NCT03541369|592055054|FG013|Overall Study|Lost to Follow-up|0|||
163914131|NCT03541369|592055055|FG014|Overall Study|Lost to Follow-up|0|||
163914132|NCT03541369|592055056|FG015|Overall Study|Lost to Follow-up|0|||
163914133|NCT03541369|592055057|FG016|Overall Study|Lost to Follow-up|0|||
163914134|NCT03541369|592055058|FG017|Overall Study|Lost to Follow-up|0|||
163914135|NCT01856569|592055059|FG000|Overall Study|Other|1|||
164027698|NCT01175213|592461067|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
164027699|NCT01175213|592461068|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
164027700|NCT01175213|592461067|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
164027701|NCT01175213|592461068|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
164027702|NCT01175213|592461067|FG000|Safety Follow-up|Adverse Event|1|||
164027703|NCT01175213|592461068|FG001|Safety Follow-up|Adverse Event|0|||
164027704|NCT03569449|592461074|FG000|Overall Study|Lost to Follow-up|0|||
164027705|NCT03569449|592461075|FG001|Overall Study|Lost to Follow-up|1|||
164027706|NCT03569449|592461076|FG002|Overall Study|Lost to Follow-up|0|||
164027707|NCT03569449|592461077|FG003|Overall Study|Lost to Follow-up|2|||
164027708|NCT03569449|592461078|FG004|Overall Study|Lost to Follow-up|0|||
164027709|NCT03569449|592461079|FG005|Overall Study|Lost to Follow-up|0|||
164027710|NCT03569449|592461080|FG006|Overall Study|Lost to Follow-up|0|||
164027711|NCT03569449|592461081|FG007|Overall Study|Lost to Follow-up|0|||
164027712|NCT03569449|592461082|FG008|Overall Study|Lost to Follow-up|0|||
164027713|NCT03569449|592461083|FG009|Overall Study|Lost to Follow-up|0|||
164027714|NCT03569449|592461084|FG010|Overall Study|Lost to Follow-up|0|||
164027715|NCT03569449|592461085|FG011|Overall Study|Lost to Follow-up|0|||
164027716|NCT03569449|592461086|FG012|Overall Study|Lost to Follow-up|0|||
164027717|NCT03569449|592461087|FG013|Overall Study|Lost to Follow-up|0|||
164027718|NCT03569449|592461088|FG014|Overall Study|Lost to Follow-up|1|||
164027719|NCT03569449|592461089|FG015|Overall Study|Lost to Follow-up|0|||
164027720|NCT03569449|592461074|FG000|Overall Study|Withdrawal by Subject|0|||
164027721|NCT03569449|592461075|FG001|Overall Study|Withdrawal by Subject|1|||
164027722|NCT03569449|592461076|FG002|Overall Study|Withdrawal by Subject|0|||
164027723|NCT03569449|592461077|FG003|Overall Study|Withdrawal by Subject|0|||
164027724|NCT03569449|592461078|FG004|Overall Study|Withdrawal by Subject|1|||
164027725|NCT03569449|592461079|FG005|Overall Study|Withdrawal by Subject|0|||
164027726|NCT03569449|592461080|FG006|Overall Study|Withdrawal by Subject|0|||
164027727|NCT03569449|592461081|FG007|Overall Study|Withdrawal by Subject|0|||
164027728|NCT03569449|592461082|FG008|Overall Study|Withdrawal by Subject|0|||
164027729|NCT03569449|592461083|FG009|Overall Study|Withdrawal by Subject|0|||
164027730|NCT03569449|592461084|FG010|Overall Study|Withdrawal by Subject|0|||
164027731|NCT03569449|592461085|FG011|Overall Study|Withdrawal by Subject|0|||
164027732|NCT03569449|592461086|FG012|Overall Study|Withdrawal by Subject|0|||
164027733|NCT03569449|592461087|FG013|Overall Study|Withdrawal by Subject|0|||
164027734|NCT03569449|592461088|FG014|Overall Study|Withdrawal by Subject|0|||
164027735|NCT03569449|592461089|FG015|Overall Study|Withdrawal by Subject|0|||
164027736|NCT05279898|592461101|FG000|Overall Study|Withdrawal by Subject|1|||
164027737|NCT05279898|592461102|FG001|Overall Study|Withdrawal by Subject|0|||
164027738|NCT05279898|592461101|FG000|Overall Study|Physician Decision|1|||
164027739|NCT05279898|592461102|FG001|Overall Study|Physician Decision|1|||
164027740|NCT05136170|592461103|FG000|Overall Study|Withdrawal by Subject|2|||
164027741|NCT05136170|592461104|FG001|Overall Study|Withdrawal by Subject|2|||
164027742|NCT05136170|592461103|FG000|Overall Study|Can no longer make office visits|1|||
164027743|NCT05136170|592461104|FG001|Overall Study|Can no longer make office visits|0|||
164027744|NCT04393038|592461105|FG000|Overall Study|Adverse Event|11|||
164027745|NCT04393038|592461106|FG001|Overall Study|Adverse Event|2|||
164027746|NCT04393038|592461105|FG000|Overall Study|Protocol Violation|1|||
164027747|NCT04393038|592461106|FG001|Overall Study|Protocol Violation|0|||
164027748|NCT04393038|592461105|FG000|Overall Study|Death|6|||
164027749|NCT04393038|592461106|FG001|Overall Study|Death|4|||
164027750|NCT04393038|592461105|FG000|Overall Study|Withdrawal by Subject|24|||
164027751|NCT04393038|592461106|FG001|Overall Study|Withdrawal by Subject|8|||
164027752|NCT04393038|592461105|FG000|Overall Study|Lost to Follow-up|5|||
164027753|NCT04393038|592461106|FG001|Overall Study|Lost to Follow-up|4|||
164027754|NCT04393038|592461105|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
164027755|NCT04393038|592461106|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
164027756|NCT04393038|592461105|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
164027757|NCT04393038|592461106|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
164027758|NCT04069156|592461107|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
164027759|NCT04069156|592461108|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
164096474|NCT00746798|592717291|FG002|Overall Study|Participant unable to return for visit|0|||
164096475|NCT00746798|592717292|FG003|Overall Study|Participant unable to return for visit|0|||
164096476|NCT04915755|592717295|FG000|Overall Study|Physician Decision|3|||
164096477|NCT04915755|592717296|FG001|Overall Study|Physician Decision|2|||
164096478|NCT04915755|592717295|FG000|Overall Study|Withdrawal by Subject|1|||
164027760|NCT04069156|592461107|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
164027761|NCT04069156|592461108|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
164027762|NCT04069156|592461107|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
164027763|NCT04069156|592461108|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
164027764|NCT04069156|592461107|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
164027765|NCT04069156|592461108|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
164096479|NCT04915755|592717296|FG001|Overall Study|Withdrawal by Subject|1|||
164096480|NCT04915755|592717295|FG000|Overall Study|Ongoing for PACT|3|||
164096481|NCT04915755|592717296|FG001|Overall Study|Ongoing for PACT|2|||
164096482|NCT04915755|592717295|FG000|Overall Study|Other|7|||
164096483|NCT04915755|592717296|FG001|Overall Study|Other|11|||
164096484|NCT00727571|592717298|FG000|Overall Study|Ineligibility determined|1|||
164096485|NCT00727571|592717299|FG001|Overall Study|Ineligibility determined|1|||
164096486|NCT00727571|592717300|FG002|Overall Study|Ineligibility determined|1|||
164096487|NCT00727571|592717301|FG003|Overall Study|Ineligibility determined|0|||
164096488|NCT00727571|592717298|FG000|Overall Study|Death|0|||
164096489|NCT00727571|592717299|FG001|Overall Study|Death|19|||
164096490|NCT00727571|592717300|FG002|Overall Study|Death|5|||
164096491|NCT00727571|592717301|FG003|Overall Study|Death|1|||
164096492|NCT00727571|592717298|FG000|Overall Study|Physician Decision|0|||
164096493|NCT00727571|592717299|FG001|Overall Study|Physician Decision|5|||
164096494|NCT00727571|592717300|FG002|Overall Study|Physician Decision|0|||
164096495|NCT00727571|592717301|FG003|Overall Study|Physician Decision|0|||
164096496|NCT00727571|592717298|FG000|Overall Study|Withdrawal by Subject|0|||
164096497|NCT00727571|592717299|FG001|Overall Study|Withdrawal by Subject|10|||
164096498|NCT00727571|592717300|FG002|Overall Study|Withdrawal by Subject|11|||
164096499|NCT00727571|592717301|FG003|Overall Study|Withdrawal by Subject|0|||
164096500|NCT00727571|592717298|FG000|Overall Study|Subject Non Compliance|0|||
164096501|NCT00727571|592717299|FG001|Overall Study|Subject Non Compliance|6|||
164096502|NCT00727571|592717300|FG002|Overall Study|Subject Non Compliance|0|||
164096503|NCT00727571|592717301|FG003|Overall Study|Subject Non Compliance|4|||
164096504|NCT00727571|592717298|FG000|Overall Study|Dismissed from nursing home|0|||
164096505|NCT00727571|592717299|FG001|Overall Study|Dismissed from nursing home|9|||
164096506|NCT00727571|592717300|FG002|Overall Study|Dismissed from nursing home|5|||
164096507|NCT00727571|592717301|FG003|Overall Study|Dismissed from nursing home|0|||
164096508|NCT00727571|592717298|FG000|Overall Study|Hospitalization|0|||
164096509|NCT00727571|592717299|FG001|Overall Study|Hospitalization|1|||
164096510|NCT00727571|592717300|FG002|Overall Study|Hospitalization|0|||
164096511|NCT00727571|592717301|FG003|Overall Study|Hospitalization|1|||
164096512|NCT00727571|592717298|FG000|Overall Study|AE not leading to hospitalization|0|||
164096513|NCT00727571|592717299|FG001|Overall Study|AE not leading to hospitalization|0|||
164096514|NCT00727571|592717300|FG002|Overall Study|AE not leading to hospitalization|2|||
164096515|NCT00727571|592717301|FG003|Overall Study|AE not leading to hospitalization|0|||
164096516|NCT00727571|592717298|FG000|Overall Study|Other|0|||
164096517|NCT00727571|592717299|FG001|Overall Study|Other|4|||
164096518|NCT00727571|592717300|FG002|Overall Study|Other|6|||
164096519|NCT00727571|592717301|FG003|Overall Study|Other|0|||
164096520|NCT03247556|592717302|FG000|Overall Study|Adverse Event|1|||
164096521|NCT03247556|592717303|FG001|Overall Study|Adverse Event|4|||
164096522|NCT03247556|592717304|FG002|Overall Study|Adverse Event|5|||
164096523|NCT03247556|592717302|FG000|Overall Study|Lost to Follow-up|5|||
164096524|NCT03247556|592717303|FG001|Overall Study|Lost to Follow-up|5|||
164096525|NCT03247556|592717304|FG002|Overall Study|Lost to Follow-up|4|||
164096526|NCT03247556|592717302|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
164096527|NCT03247556|592717303|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
164096528|NCT03247556|592717304|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
164096529|NCT03247556|592717302|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
164096530|NCT03247556|592717303|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
164096531|NCT03247556|592717304|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
164096532|NCT03247556|592717302|FG000|Overall Study|Protocol Violation|2|||
164096533|NCT03247556|592717303|FG001|Overall Study|Protocol Violation|0|||
164096534|NCT03247556|592717304|FG002|Overall Study|Protocol Violation|1|||
164096535|NCT03247556|592717302|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
164096536|NCT03247556|592717303|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
164096537|NCT03247556|592717304|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
164096538|NCT00358449|592717306|FG000|Overall Study|Adverse Event|1|||
164096539|NCT00358449|592717307|FG001|Overall Study|Adverse Event|0|||
164096540|NCT00358449|592717308|FG002|Overall Study|Adverse Event|1|||
164096541|NCT00358449|592717306|FG000|Overall Study|Lost to Follow-up|1|||
164096542|NCT00358449|592717307|FG001|Overall Study|Lost to Follow-up|0|||
164096543|NCT00358449|592717308|FG002|Overall Study|Lost to Follow-up|0|||
164096544|NCT00358449|592717306|FG000|Overall Study|Withdrawal by Subject|2|||
164096545|NCT00358449|592717307|FG001|Overall Study|Withdrawal by Subject|0|||
164096546|NCT00358449|592717308|FG002|Overall Study|Withdrawal by Subject|0|||
164096547|NCT00358449|592717306|FG000|Overall Study|Lack of Efficacy|0|||
164096548|NCT00358449|592717307|FG001|Overall Study|Lack of Efficacy|1|||
164096549|NCT00358449|592717308|FG002|Overall Study|Lack of Efficacy|0|||
164096550|NCT00358449|592717306|FG000|Overall Study|Steriod Inhaler was Increased|0|||
164096551|NCT00358449|592717307|FG001|Overall Study|Steriod Inhaler was Increased|0|||
164096552|NCT00358449|592717308|FG002|Overall Study|Steriod Inhaler was Increased|1|||
164096553|NCT01804270|592717309|FG000|Overall Study|Withdrawal by Subject|1|||
164096554|NCT01804270|592717310|FG001|Overall Study|Withdrawal by Subject|1|||
164096555|NCT02334722|592717312|FG000|Overall Study|Lost to Follow-up|4|||
164096556|NCT02334722|592717313|FG001|Overall Study|Lost to Follow-up|0|||
164112595|NCT00210639|592774045|FG001|Overall Study|Lost to Follow-up|29|||
164027766|NCT04580394|592461113|FG000|First Intervention|Incorrectly Randomized|1|||
164027767|NCT04580394|592461113|FG000|First Intervention|Physician Decision|1|||
164027768|NCT04580394|592461113|FG000|First Intervention|Lost to Follow-up|1|||
164027769|NCT04580394|592461113|FG000|Washout (One Week)|Withdrawal by Subject|1|||
164027770|NCT04580394|592461113|FG000|Washout (One Week)|Adverse Event|1|||
164027771|NCT04580394|592461113|FG000|Washout (One Week)|Withdrawal by Subject|2|||
164027772|NCT04580394|592461113|FG000|Third Intervention|Adverse Event|1|||
164027773|NCT04580394|592461113|FG000|Third Intervention|Withdrawal by Subject|1|||
164027774|NCT04580394|592461113|FG000|Washout (One Week)|Withdrawal by Subject|2|||
164027775|NCT03806179|592461114|FG000|Overall Study|Progressive disease|0|||
164027776|NCT03806179|592461115|FG001|Overall Study|Progressive disease|2|||
164027777|NCT05822830|592461116|FG000|Overall Study|Adverse Event|6|||
164027778|NCT05822830|592461117|FG001|Overall Study|Adverse Event|6|||
164027779|NCT05822830|592461116|FG000|Overall Study|Assigned Treatment by Mistake|5|||
164027780|NCT05822830|592461117|FG001|Overall Study|Assigned Treatment by Mistake|3|||
164027781|NCT05822830|592461116|FG000|Overall Study|Lost to Follow-up|16|||
164027782|NCT05822830|592461117|FG001|Overall Study|Lost to Follow-up|18|||
164027783|NCT05822830|592461116|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164027784|NCT05822830|592461117|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164027785|NCT05822830|592461116|FG000|Overall Study|Participant was Out of the Country|0|||
164027786|NCT05822830|592461117|FG001|Overall Study|Participant was Out of the Country|1|||
164027787|NCT05822830|592461116|FG000|Overall Study|Pregnancy|1|||
164027788|NCT05822830|592461117|FG001|Overall Study|Pregnancy|2|||
164027789|NCT05822830|592461116|FG000|Overall Study|Withdrawal by Subject|27|||
164027790|NCT05822830|592461117|FG001|Overall Study|Withdrawal by Subject|26|||
164027791|NCT03201965|592461126|FG000|Overall Study|Death|5|||
164027792|NCT03201965|592461127|FG001|Overall Study|Death|65|||
164027793|NCT03201965|592461128|FG002|Overall Study|Death|47|||
164027794|NCT03201965|592461126|FG000|Overall Study|Lost to Follow-up|0|||
164027795|NCT03201965|592461127|FG001|Overall Study|Lost to Follow-up|6|||
164027796|NCT03201965|592461128|FG002|Overall Study|Lost to Follow-up|0|||
164027797|NCT03201965|592461126|FG000|Overall Study|Withdrawal by Subject|3|||
164027798|NCT03201965|592461127|FG001|Overall Study|Withdrawal by Subject|23|||
164027799|NCT03201965|592461128|FG002|Overall Study|Withdrawal by Subject|8|||
164027800|NCT03201965|592461126|FG000|Overall Study|Sponsor's Decision|20|||
164027801|NCT03201965|592461127|FG001|Overall Study|Sponsor's Decision|99|||
164027802|NCT03201965|592461128|FG002|Overall Study|Sponsor's Decision|140|||
164027803|NCT03368664|592461129|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
164027804|NCT03368664|592461129|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
164027805|NCT03368664|592461129|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
164027806|NCT03368664|592461129|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
164027807|NCT05441592|592461130|FG000|Overall Study|Lost to Follow-up|1|||
164027808|NCT05441592|592461131|FG001|Overall Study|Lost to Follow-up|5|||
164027809|NCT01021852|592461132|FG000|Treatment Period 1|Adverse Event|3|||
164027810|NCT01021852|592461133|FG001|Treatment Period 1|Adverse Event|1|||
164027811|NCT01021852|592461134|FG002|Treatment Period 1|Adverse Event|1|||
164027812|NCT01021852|592461135|FG003|Treatment Period 1|Adverse Event|0|||
164027813|NCT01021852|592461136|FG004|Treatment Period 1|Adverse Event|2|||
164027814|NCT01021852|592461137|FG005|Treatment Period 1|Adverse Event|2|||
164027815|NCT01021852|592461138|FG006|Treatment Period 1|Adverse Event|0|||
164027816|NCT01021852|592461139|FG007|Treatment Period 1|Adverse Event|0|||
164027817|NCT01021852|592461132|FG000|Treatment Period 1|Pregnancy|0|||
164027818|NCT01021852|592461133|FG001|Treatment Period 1|Pregnancy|0|||
164027819|NCT01021852|592461134|FG002|Treatment Period 1|Pregnancy|1|||
164027820|NCT01021852|592461135|FG003|Treatment Period 1|Pregnancy|0|||
164027821|NCT01021852|592461136|FG004|Treatment Period 1|Pregnancy|0|||
164027822|NCT01021852|592461137|FG005|Treatment Period 1|Pregnancy|0|||
164027823|NCT01021852|592461138|FG006|Treatment Period 1|Pregnancy|0|||
164027824|NCT01021852|592461139|FG007|Treatment Period 1|Pregnancy|0|||
164027825|NCT01021852|592461132|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164027826|NCT01021852|592461133|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164027827|NCT01021852|592461134|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164027828|NCT01021852|592461135|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164027829|NCT01021852|592461136|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164027830|NCT01021852|592461137|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164027831|NCT01021852|592461138|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164027832|NCT01021852|592461139|FG007|Treatment Period 1|Withdrawal by Subject|1|||
164027833|NCT01021852|592461132|FG000|Treatment Period 1|Not Treated|0|||
164027834|NCT01021852|592461133|FG001|Treatment Period 1|Not Treated|0|||
164027835|NCT01021852|592461134|FG002|Treatment Period 1|Not Treated|0|||
164027836|NCT01021852|592461135|FG003|Treatment Period 1|Not Treated|2|||
164027837|NCT01021852|592461136|FG004|Treatment Period 1|Not Treated|0|||
164027838|NCT01021852|592461137|FG005|Treatment Period 1|Not Treated|0|||
164027839|NCT01021852|592461138|FG006|Treatment Period 1|Not Treated|0|||
164027840|NCT01021852|592461139|FG007|Treatment Period 1|Not Treated|0|||
164027841|NCT01021852|592461132|FG000|Washout Period-Placebo|Adverse Event|0|||
164027842|NCT01021852|592461133|FG001|Washout Period-Placebo|Adverse Event|0|||
164027843|NCT01021852|592461134|FG002|Washout Period-Placebo|Adverse Event|0|||
164027844|NCT01021852|592461135|FG003|Washout Period-Placebo|Adverse Event|1|||
164027845|NCT01021852|592461136|FG004|Washout Period-Placebo|Adverse Event|0|||
164027846|NCT01021852|592461137|FG005|Washout Period-Placebo|Adverse Event|1|||
164027847|NCT01021852|592461138|FG006|Washout Period-Placebo|Adverse Event|0|||
164027848|NCT01021852|592461139|FG007|Washout Period-Placebo|Adverse Event|0|||
164027849|NCT01021852|592461132|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
164027850|NCT01021852|592461133|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
164027851|NCT01021852|592461134|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
164027852|NCT01021852|592461135|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
164027853|NCT01021852|592461136|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
163914136|NCT01856569|592055059|FG000|Overall Study|Changed Site/Structure|1|||
163914137|NCT01856569|592055059|FG000|Overall Study|Lost to Follow-up|3|||
163914138|NCT01856569|592055059|FG000|Overall Study|Did not met inclusion criteria|8|||
163914139|NCT00696241|592055060|FG000|Overall Study|Adverse Event|11|||
163914140|NCT00696241|592055061|FG001|Overall Study|Adverse Event|3|||
163914141|NCT00696241|592055062|FG002|Overall Study|Adverse Event|6|||
163914142|NCT00696241|592055063|FG003|Overall Study|Adverse Event|4|||
163914143|NCT00696241|592055064|FG004|Overall Study|Adverse Event|5|||
163914144|NCT00696241|592055060|FG000|Overall Study|Protocol Violation|1|||
163914145|NCT00696241|592055061|FG001|Overall Study|Protocol Violation|1|||
163914146|NCT00696241|592055062|FG002|Overall Study|Protocol Violation|2|||
163914147|NCT00696241|592055063|FG003|Overall Study|Protocol Violation|0|||
163914148|NCT00696241|592055064|FG004|Overall Study|Protocol Violation|3|||
163914149|NCT00696241|592055060|FG000|Overall Study|Lost to Follow-up|1|||
163914150|NCT00696241|592055061|FG001|Overall Study|Lost to Follow-up|4|||
163914151|NCT00696241|592055062|FG002|Overall Study|Lost to Follow-up|1|||
163914152|NCT00696241|592055063|FG003|Overall Study|Lost to Follow-up|2|||
163914153|NCT00696241|592055064|FG004|Overall Study|Lost to Follow-up|0|||
163914154|NCT00696241|592055060|FG000|Overall Study|Withdrawal by Subject|4|||
163914155|NCT00696241|592055061|FG001|Overall Study|Withdrawal by Subject|8|||
163914156|NCT00696241|592055062|FG002|Overall Study|Withdrawal by Subject|6|||
163914157|NCT00696241|592055063|FG003|Overall Study|Withdrawal by Subject|1|||
163914158|NCT00696241|592055064|FG004|Overall Study|Withdrawal by Subject|0|||
163914159|NCT00696241|592055060|FG000|Overall Study|Lack of Efficacy|1|||
163914160|NCT00696241|592055061|FG001|Overall Study|Lack of Efficacy|5|||
163914161|NCT00696241|592055062|FG002|Overall Study|Lack of Efficacy|4|||
163914162|NCT00696241|592055063|FG003|Overall Study|Lack of Efficacy|5|||
163914163|NCT00696241|592055064|FG004|Overall Study|Lack of Efficacy|3|||
163914164|NCT00696241|592055060|FG000|Overall Study|Other|6|||
163914165|NCT00696241|592055061|FG001|Overall Study|Other|1|||
163914166|NCT00696241|592055062|FG002|Overall Study|Other|5|||
163914167|NCT00696241|592055063|FG003|Overall Study|Other|2|||
163914168|NCT00696241|592055064|FG004|Overall Study|Other|1|||
163914169|NCT01613599|592055065|FG000|Overall Study|Death|9|||
163914170|NCT01613599|592055065|FG000|Overall Study|Lost to Follow-up|5|||
163914171|NCT01613599|592055065|FG000|Overall Study|Withdrawal by Subject|8|||
163914172|NCT01613599|592055065|FG000|Overall Study|Reason not specified|3|||
163914173|NCT04749797|592055070|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
163914174|NCT04749797|592055071|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
163914175|NCT04749797|592055072|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
163914176|NCT02513667|592055073|FG000|Overall Study|Withdrawal by Subject|0|||
163914177|NCT02513667|592055074|FG001|Overall Study|Withdrawal by Subject|1|||
163914178|NCT00871715|592055083|FG000|Overall Study|Withdrawal by Subject|6|||
163914179|NCT00871715|592055084|FG001|Overall Study|Withdrawal by Subject|10|||
163914180|NCT00871715|592055085|FG002|Overall Study|Withdrawal by Subject|15|||
163914181|NCT00871715|592055083|FG000|Overall Study|Physician Decision|6|||
163914182|NCT00871715|592055084|FG001|Overall Study|Physician Decision|0|||
163914183|NCT00871715|592055085|FG002|Overall Study|Physician Decision|2|||
163914184|NCT00871715|592055083|FG000|Overall Study|Lost to Follow-up|3|||
163914185|NCT00871715|592055084|FG001|Overall Study|Lost to Follow-up|6|||
163914186|NCT00871715|592055085|FG002|Overall Study|Lost to Follow-up|9|||
163914187|NCT02291549|592055088|FG000|Overall Study|Lost to Follow-up|1|||
164145298|NCT00025259|592894265|FG002|Overall Study|Protocol Violation|2|||
163914188|NCT02291549|592055089|FG001|Overall Study|Lost to Follow-up|0|||
163914189|NCT02291549|592055088|FG000|Overall Study|Withdrawal by Subject|0|||
163914190|NCT02291549|592055089|FG001|Overall Study|Withdrawal by Subject|1|||
163914191|NCT00537914|592055090|FG000|Overall Study|Death|1|||
163914192|NCT00537914|592055090|FG000|Overall Study|Adverse Event|7|||
163914193|NCT00537914|592055090|FG000|Overall Study|Treatment failure|10|||
163914194|NCT00537914|592055090|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
163914195|NCT00537914|592055090|FG000|Overall Study|Lost to Follow-up|19|||
163914196|NCT00537914|592055090|FG000|Overall Study|Withdrawal of informed consent|59|||
163914197|NCT02189759|592055106|FG000|Overall Study|Lost to Follow-up|0|||
163914198|NCT02189759|592055107|FG001|Overall Study|Lost to Follow-up|0|||
163914199|NCT02189759|592055108|FG002|Overall Study|Lost to Follow-up|2|||
163914200|NCT02189759|592055109|FG003|Overall Study|Lost to Follow-up|5|||
163914201|NCT03032198|592055110|FG000|Overall Study|Screen Fail|1|||
163914202|NCT02470806|592055111|FG000|Overall Study|Lost to Follow-up|1|||
163914203|NCT02470806|592055112|FG001|Overall Study|Lost to Follow-up|1|||
163914204|NCT02470806|592055111|FG000|Overall Study|Adverse Event|5|||
163914205|NCT02470806|592055112|FG001|Overall Study|Adverse Event|2|||
163914206|NCT02470806|592055111|FG000|Overall Study|Protocol Violation|4|||
163914207|NCT02470806|592055112|FG001|Overall Study|Protocol Violation|11|||
163914208|NCT02470806|592055111|FG000|Overall Study|Physician Decision|0|||
163914209|NCT02470806|592055112|FG001|Overall Study|Physician Decision|3|||
163914210|NCT02470806|592055111|FG000|Overall Study|Withdrawal by Subject|3|||
163914211|NCT02470806|592055112|FG001|Overall Study|Withdrawal by Subject|10|||
163914212|NCT02470806|592055111|FG000|Overall Study|Lack of Efficacy|5|||
163914213|NCT02470806|592055112|FG001|Overall Study|Lack of Efficacy|15|||
163914214|NCT01147471|592055113|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
163914215|NCT01147471|592055114|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
163914216|NCT01147471|592055113|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
163914217|NCT01147471|592055114|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
163914218|NCT01147471|592055113|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
163914219|NCT01147471|592055114|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
163914220|NCT01147471|592055113|FG000|3 Month Follow Up|Lost to Follow-up|1|||
163914221|NCT01147471|592055114|FG001|3 Month Follow Up|Lost to Follow-up|1|||
163914222|NCT01147471|592055113|FG000|3 Month Follow Up|Physician Decision|0|||
163914223|NCT01147471|592055114|FG001|3 Month Follow Up|Physician Decision|1|||
163914224|NCT01147471|592055113|FG000|6 Month Follow Up|Lost to Follow-up|4|||
163914225|NCT01147471|592055114|FG001|6 Month Follow Up|Lost to Follow-up|2|||
163914226|NCT00866619|592055115|FG000|Overall Study|Adverse Event|112|||
163914227|NCT00866619|592055116|FG001|Overall Study|Adverse Event|106|||
163914228|NCT00866619|592055117|FG002|Overall Study|Adverse Event|47|||
163914229|NCT00866619|592055118|FG003|Overall Study|Adverse Event|44|||
163914230|NCT00866619|592055115|FG000|Overall Study|Protocol Violation|2|||
163914231|NCT00866619|592055116|FG001|Overall Study|Protocol Violation|39|||
163914232|NCT00866619|592055117|FG002|Overall Study|Protocol Violation|2|||
163914233|NCT00866619|592055118|FG003|Overall Study|Protocol Violation|17|||
163914234|NCT00866619|592055115|FG000|Overall Study|Withdrawal by Subject|587|||
163914235|NCT00866619|592055116|FG001|Overall Study|Withdrawal by Subject|295|||
163914236|NCT00866619|592055117|FG002|Overall Study|Withdrawal by Subject|272|||
163914237|NCT00866619|592055118|FG003|Overall Study|Withdrawal by Subject|144|||
163914238|NCT00866619|592055115|FG000|Overall Study|Lost to Follow-up|1145|||
163914239|NCT00866619|592055116|FG001|Overall Study|Lost to Follow-up|830|||
163914240|NCT00866619|592055117|FG002|Overall Study|Lost to Follow-up|568|||
163914241|NCT00866619|592055118|FG003|Overall Study|Lost to Follow-up|425|||
163914242|NCT01307800|592055125|FG000|Overall Study|Adverse Event|9|||
163914243|NCT01307800|592055126|FG001|Overall Study|Adverse Event|8|||
163914244|NCT01307800|592055127|FG002|Overall Study|Adverse Event|10|||
163914245|NCT01307800|592055128|FG003|Overall Study|Adverse Event|14|||
163914246|NCT01307800|592055125|FG000|Overall Study|Entry Criteria Not Met|0|||
163914247|NCT01307800|592055126|FG001|Overall Study|Entry Criteria Not Met|0|||
163914248|NCT01307800|592055127|FG002|Overall Study|Entry Criteria Not Met|0|||
163914249|NCT01307800|592055128|FG003|Overall Study|Entry Criteria Not Met|2|||
163914250|NCT01307800|592055125|FG000|Overall Study|Lost to Follow-up|5|||
163914251|NCT01307800|592055126|FG001|Overall Study|Lost to Follow-up|6|||
163914252|NCT01307800|592055127|FG002|Overall Study|Lost to Follow-up|2|||
163914253|NCT01307800|592055128|FG003|Overall Study|Lost to Follow-up|8|||
163914254|NCT01307800|592055125|FG000|Overall Study|Perceived Lack of Efficacy|24|||
163914255|NCT01307800|592055126|FG001|Overall Study|Perceived Lack of Efficacy|23|||
163914256|NCT01307800|592055127|FG002|Overall Study|Perceived Lack of Efficacy|20|||
163914257|NCT01307800|592055128|FG003|Overall Study|Perceived Lack of Efficacy|33|||
163914258|NCT01307800|592055125|FG000|Overall Study|Protocol Violation|0|||
163914259|NCT01307800|592055126|FG001|Overall Study|Protocol Violation|3|||
163914260|NCT01307800|592055127|FG002|Overall Study|Protocol Violation|4|||
163914261|NCT01307800|592055128|FG003|Overall Study|Protocol Violation|5|||
163914262|NCT01307800|592055125|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
163914263|NCT01307800|592055126|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
163914264|NCT01307800|592055127|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
163914265|NCT01307800|592055128|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
163914266|NCT01307800|592055125|FG000|Overall Study|Sponsor Decision|6|||
163914267|NCT01307800|592055126|FG001|Overall Study|Sponsor Decision|9|||
163914268|NCT01307800|592055127|FG002|Overall Study|Sponsor Decision|12|||
163914269|NCT01307800|592055128|FG003|Overall Study|Sponsor Decision|28|||
163914270|NCT01307800|592055125|FG000|Overall Study|Withdrawal by Subject|10|||
163914271|NCT01307800|592055126|FG001|Overall Study|Withdrawal by Subject|11|||
164096557|NCT02334722|592717312|FG000|Overall Study|6 week questionnaire not completed|2|||
163914272|NCT01307800|592055127|FG002|Overall Study|Withdrawal by Subject|8|||
163914273|NCT01307800|592055128|FG003|Overall Study|Withdrawal by Subject|15|||
163914274|NCT01307800|592055125|FG000|Overall Study|Participant Moved|0|||
163914275|NCT01307800|592055126|FG001|Overall Study|Participant Moved|2|||
163914276|NCT01307800|592055127|FG002|Overall Study|Participant Moved|1|||
163914277|NCT01307800|592055128|FG003|Overall Study|Participant Moved|3|||
163914278|NCT02892019|592055129|FG000|Overall Study|randomized but not treated|0|||
163914279|NCT02892019|592055130|FG001|Overall Study|randomized but not treated|1|||
163914280|NCT02892019|592055129|FG000|Overall Study|Withdrawal by Subject|0|||
163914281|NCT02892019|592055130|FG001|Overall Study|Withdrawal by Subject|1|||
163914282|NCT02892019|592055129|FG000|Overall Study|Adverse Event|1|||
163914283|NCT02892019|592055130|FG001|Overall Study|Adverse Event|1|||
163914284|NCT00689351|592055131|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
163914285|NCT00689351|592055132|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
163914286|NCT00689351|592055131|FG000|Infant Series of Dosing|Adverse Event|1|||
163914287|NCT00689351|592055132|FG001|Infant Series of Dosing|Adverse Event|0|||
163914288|NCT00689351|592055131|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
163914289|NCT00689351|592055132|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
163914290|NCT00689351|592055131|FG000|After Infant Series|Parent/legal guardian request|1|||
163914291|NCT00689351|592055132|FG001|After Infant Series|Parent/legal guardian request|0|||
163914292|NCT01766206|592055133|FG000|Overall Study|Withdrawal by Subject|22|||
163914293|NCT01766206|592055133|FG000|Overall Study|Lost to Follow-up|10|||
163914294|NCT01766206|592055133|FG000|Overall Study|Inappropriate enrollment|18|||
163914295|NCT01766206|592055133|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
163914296|NCT01662505|592055134|FG000|Overall Study|Progressive disease|6|||
163914297|NCT01662505|592055135|FG001|Overall Study|Progressive disease|1|||
163914298|NCT01662505|592055136|FG002|Overall Study|Progressive disease|5|||
163914299|NCT01662505|592055134|FG000|Overall Study|Refused cont. medication|0|||
164145299|NCT00025259|592894266|FG003|Overall Study|Protocol Violation|1|||
163914300|NCT01662505|592055135|FG001|Overall Study|Refused cont. medication|0|||
163914301|NCT01662505|592055136|FG002|Overall Study|Refused cont. medication|1|||
164027854|NCT01021852|592461137|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
164027855|NCT01021852|592461138|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
164027856|NCT01021852|592461139|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
164027857|NCT01021852|592461132|FG000|Washout Period-Placebo|Protocol Violation|0|||
164027858|NCT01021852|592461133|FG001|Washout Period-Placebo|Protocol Violation|0|||
164027859|NCT01021852|592461134|FG002|Washout Period-Placebo|Protocol Violation|0|||
164027860|NCT01021852|592461135|FG003|Washout Period-Placebo|Protocol Violation|0|||
164027861|NCT01021852|592461136|FG004|Washout Period-Placebo|Protocol Violation|0|||
164027862|NCT01021852|592461137|FG005|Washout Period-Placebo|Protocol Violation|0|||
164027863|NCT01021852|592461138|FG006|Washout Period-Placebo|Protocol Violation|1|||
164027864|NCT01021852|592461139|FG007|Washout Period-Placebo|Protocol Violation|0|||
164027865|NCT01021852|592461132|FG000|Washout Period-No Drug|Adverse Event|1|||
164027866|NCT01021852|592461133|FG001|Washout Period-No Drug|Adverse Event|0|||
164027867|NCT01021852|592461134|FG002|Washout Period-No Drug|Adverse Event|0|||
164027868|NCT01021852|592461135|FG003|Washout Period-No Drug|Adverse Event|0|||
164027869|NCT01021852|592461136|FG004|Washout Period-No Drug|Adverse Event|0|||
164027870|NCT01021852|592461137|FG005|Washout Period-No Drug|Adverse Event|1|||
164027871|NCT01021852|592461138|FG006|Washout Period-No Drug|Adverse Event|0|||
164027872|NCT01021852|592461139|FG007|Washout Period-No Drug|Adverse Event|0|||
164027873|NCT01021852|592461132|FG000|Treatment Period 2|Adverse Event|0|||
164027874|NCT01021852|592461133|FG001|Treatment Period 2|Adverse Event|1|||
164027875|NCT01021852|592461134|FG002|Treatment Period 2|Adverse Event|0|||
164027876|NCT01021852|592461135|FG003|Treatment Period 2|Adverse Event|0|||
164027877|NCT01021852|592461136|FG004|Treatment Period 2|Adverse Event|1|||
164027878|NCT01021852|592461137|FG005|Treatment Period 2|Adverse Event|0|||
163914302|NCT01662505|592055134|FG000|Overall Study|Not specified above|1|||
163914303|NCT01662505|592055135|FG001|Overall Study|Not specified above|3|||
163914304|NCT01662505|592055136|FG002|Overall Study|Not specified above|2|||
163914305|NCT01313663|592055137|FG000|Overall Study|Study Closed/Terminated|2|||
163914306|NCT01313663|592055138|FG001|Overall Study|Study Closed/Terminated|4|||
163914307|NCT01313663|592055137|FG000|Overall Study|Lost to Follow-up|0|||
163914308|NCT01313663|592055138|FG001|Overall Study|Lost to Follow-up|1|||
163914309|NCT01313663|592055137|FG000|Overall Study|Physician Decision|0|||
163914310|NCT01313663|592055138|FG001|Overall Study|Physician Decision|2|||
163914311|NCT01313663|592055137|FG000|Overall Study|Withdrawal by Subject|2|||
163914312|NCT01313663|592055138|FG001|Overall Study|Withdrawal by Subject|1|||
163914313|NCT01229176|592055139|FG000|Overall Study|Withdrawal by Subject|0|||
163914314|NCT01229176|592055140|FG001|Overall Study|Withdrawal by Subject|0|||
163914315|NCT01229176|592055141|FG002|Overall Study|Withdrawal by Subject|0|||
163914316|NCT01229176|592055142|FG003|Overall Study|Withdrawal by Subject|1|||
163914317|NCT01229176|592055143|FG004|Overall Study|Withdrawal by Subject|1|||
163914318|NCT01229176|592055144|FG005|Overall Study|Withdrawal by Subject|1|||
163914319|NCT01229176|592055145|FG006|Overall Study|Withdrawal by Subject|0|||
163914320|NCT01229176|592055146|FG007|Overall Study|Withdrawal by Subject|1|||
163914321|NCT01229176|592055139|FG000|Overall Study|Lost to Follow-up|0|||
163914322|NCT01229176|592055140|FG001|Overall Study|Lost to Follow-up|3|||
163914323|NCT01229176|592055141|FG002|Overall Study|Lost to Follow-up|0|||
163914324|NCT01229176|592055142|FG003|Overall Study|Lost to Follow-up|0|||
163914325|NCT01229176|592055143|FG004|Overall Study|Lost to Follow-up|1|||
163914326|NCT01229176|592055144|FG005|Overall Study|Lost to Follow-up|1|||
163914327|NCT01229176|592055145|FG006|Overall Study|Lost to Follow-up|0|||
163914328|NCT01229176|592055146|FG007|Overall Study|Lost to Follow-up|2|||
163914329|NCT03890484|592055150|FG000|Overall Study|Lost to Follow-up|1|||
163914330|NCT03890484|592055151|FG001|Overall Study|Lost to Follow-up|1|||
163914331|NCT00518206|592055154|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
163914332|NCT00518206|592055155|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
163914333|NCT00518206|592055154|FG000|Overall Study|Withdrawal by Subject|2|||
163914334|NCT00518206|592055155|FG001|Overall Study|Withdrawal by Subject|0|||
163914335|NCT00518206|592055154|FG000|Overall Study|Drug Supply Issue|1|||
163914336|NCT00518206|592055155|FG001|Overall Study|Drug Supply Issue|0|||
163914337|NCT00518206|592055154|FG000|Overall Study|Reason Unknown|1|||
163914338|NCT00518206|592055155|FG001|Overall Study|Reason Unknown|0|||
163914339|NCT00518206|592055154|FG000|Overall Study|Completion Status Unknown|1|||
163914340|NCT00518206|592055155|FG001|Overall Study|Completion Status Unknown|0|||
163914341|NCT03075878|592055156|FG000|Overall Study|Physician Decision|1|||
163914342|NCT02188459|592055157|FG000|Overall Study|Lost to Follow-up|3|||
163914343|NCT02188459|592055158|FG001|Overall Study|Lost to Follow-up|4|||
163914344|NCT02188459|592055157|FG000|Overall Study|Early Termination|0|||
163914345|NCT02188459|592055158|FG001|Overall Study|Early Termination|3|||
163914346|NCT02367794|592055163|FG000|Overall Study|Death|252|||
163914347|NCT02367794|592055164|FG001|Overall Study|Death|245|||
163914348|NCT02367794|592055165|FG002|Overall Study|Death|243|||
163914349|NCT02367794|592055163|FG000|Overall Study|Lost to Follow-up|1|||
163914350|NCT02367794|592055164|FG001|Overall Study|Lost to Follow-up|2|||
163914351|NCT02367794|592055165|FG002|Overall Study|Lost to Follow-up|2|||
163914352|NCT02367794|592055163|FG000|Overall Study|Physician Decision|0|||
163914353|NCT02367794|592055164|FG001|Overall Study|Physician Decision|5|||
163914354|NCT02367794|592055165|FG002|Overall Study|Physician Decision|3|||
163914355|NCT02367794|592055163|FG000|Overall Study|Protocol Violation|1|||
163914356|NCT02367794|592055164|FG001|Overall Study|Protocol Violation|0|||
163914357|NCT02367794|592055165|FG002|Overall Study|Protocol Violation|1|||
163914358|NCT02367794|592055163|FG000|Overall Study|Withdrawal by Subject|25|||
163914359|NCT02367794|592055164|FG001|Overall Study|Withdrawal by Subject|12|||
163914360|NCT02367794|592055165|FG002|Overall Study|Withdrawal by Subject|20|||
163914361|NCT02367794|592055163|FG000|Overall Study|Brain metastasis|1|||
163914362|NCT02367794|592055164|FG001|Overall Study|Brain metastasis|0|||
163914363|NCT02367794|592055165|FG002|Overall Study|Brain metastasis|0|||
163914364|NCT02367794|592055163|FG000|Overall Study|Randomized in error|0|||
163914365|NCT02367794|592055164|FG001|Overall Study|Randomized in error|0|||
163914366|NCT02367794|592055165|FG002|Overall Study|Randomized in error|1|||
164027879|NCT01021852|592461138|FG006|Treatment Period 2|Adverse Event|1|||
163914367|NCT02367794|592055163|FG000|Overall Study|Patient unable to receive carboplatin|0|||
163914368|NCT02367794|592055164|FG001|Overall Study|Patient unable to receive carboplatin|0|||
163914369|NCT02367794|592055165|FG002|Overall Study|Patient unable to receive carboplatin|1|||
163914370|NCT02367794|592055163|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
163914371|NCT02367794|592055164|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
163914372|NCT02367794|592055165|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
163914373|NCT02367794|592055163|FG000|Overall Study|Adverse Event|0|||
163914374|NCT02367794|592055164|FG001|Overall Study|Adverse Event|0|||
163914375|NCT02367794|592055165|FG002|Overall Study|Adverse Event|2|||
163914376|NCT02367794|592055163|FG000|Overall Study|Study Terminated By Sponsor|0|||
163914377|NCT02367794|592055164|FG001|Overall Study|Study Terminated By Sponsor|1|||
163914378|NCT02367794|592055165|FG002|Overall Study|Study Terminated By Sponsor|1|||
163914379|NCT02367794|592055163|FG000|Overall Study|Moved to Roll-Over Study|0|||
163914380|NCT02367794|592055164|FG001|Overall Study|Moved to Roll-Over Study|15|||
163914381|NCT02367794|592055165|FG002|Overall Study|Moved to Roll-Over Study|13|||
163914382|NCT02367794|592055163|FG000|Overall Study|Sponsor Request|60|||
163914383|NCT02367794|592055164|FG001|Overall Study|Sponsor Request|57|||
163914384|NCT02367794|592055165|FG002|Overall Study|Sponsor Request|45|||
163914385|NCT02367794|592055163|FG000|Overall Study|Moved into PTAP Study|0|||
163914386|NCT02367794|592055164|FG001|Overall Study|Moved into PTAP Study|2|||
163914387|NCT02367794|592055165|FG002|Overall Study|Moved into PTAP Study|3|||
163914388|NCT02367794|592055163|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
163914389|NCT02367794|592055164|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
163914390|NCT02367794|592055165|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
163914391|NCT02367794|592055163|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
163914392|NCT02367794|592055164|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
163914393|NCT02367794|592055165|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
163914394|NCT02367794|592055163|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
163914395|NCT02367794|592055164|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
163914396|NCT02367794|592055165|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
163914397|NCT02367794|592055163|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
163914398|NCT02367794|592055164|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
163914399|NCT02367794|592055165|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
163914400|NCT01986348|592055166|FG000|Overall Study|Death|8|||
163914401|NCT01986348|592055167|FG001|Overall Study|Death|22|||
163914402|NCT01986348|592055168|FG002|Overall Study|Death|10|||
163914403|NCT01986348|592055169|FG003|Overall Study|Death|21|||
163914404|NCT01986348|592055166|FG000|Overall Study|Lost to Follow-up|0|||
163914405|NCT01986348|592055167|FG001|Overall Study|Lost to Follow-up|0|||
163914406|NCT01986348|592055168|FG002|Overall Study|Lost to Follow-up|0|||
163914407|NCT01986348|592055169|FG003|Overall Study|Lost to Follow-up|2|||
163914408|NCT01986348|592055166|FG000|Overall Study|Physician Decision|0|||
163914409|NCT01986348|592055167|FG001|Overall Study|Physician Decision|0|||
163914410|NCT01986348|592055168|FG002|Overall Study|Physician Decision|0|||
163914411|NCT01986348|592055169|FG003|Overall Study|Physician Decision|1|||
163914412|NCT01986348|592055166|FG000|Overall Study|Progressive Disease|0|||
163914413|NCT01986348|592055167|FG001|Overall Study|Progressive Disease|0|||
163914414|NCT01986348|592055168|FG002|Overall Study|Progressive Disease|2|||
163914415|NCT01986348|592055169|FG003|Overall Study|Progressive Disease|0|||
163914416|NCT01986348|592055166|FG000|Overall Study|Withdrawal by Participant|0|||
163914417|NCT01986348|592055167|FG001|Overall Study|Withdrawal by Participant|1|||
163914418|NCT01986348|592055168|FG002|Overall Study|Withdrawal by Participant|2|||
163914419|NCT01986348|592055169|FG003|Overall Study|Withdrawal by Participant|1|||
163914420|NCT01986348|592055166|FG000|Overall Study|Study Terminated by Sponsor|0|||
163914421|NCT01986348|592055167|FG001|Overall Study|Study Terminated by Sponsor|0|||
163914422|NCT01986348|592055168|FG002|Overall Study|Study Terminated by Sponsor|0|||
163914423|NCT01986348|592055169|FG003|Overall Study|Study Terminated by Sponsor|3|||
163914424|NCT01986348|592055166|FG000|Overall Study|Other-unspecified|0|||
163914425|NCT01986348|592055167|FG001|Overall Study|Other-unspecified|1|||
163914426|NCT01986348|592055168|FG002|Overall Study|Other-unspecified|0|||
163914427|NCT01986348|592055169|FG003|Overall Study|Other-unspecified|2|||
163914428|NCT02612285|592055170|FG000|Overall Study|Withdrawal by Subject|1|||
163914429|NCT02010684|592055171|FG000|Overall Study|Lost to Follow-up|8|||
163914430|NCT02010684|592055172|FG001|Overall Study|Lost to Follow-up|18|||
163914431|NCT02010684|592055171|FG000|Overall Study|Withdrawal by Subject|4|||
163914432|NCT02010684|592055172|FG001|Overall Study|Withdrawal by Subject|5|||
163914433|NCT00805441|592055173|FG000|Overall Study|Adverse Event|5|||
163914434|NCT00805441|592055174|FG001|Overall Study|Adverse Event|2|||
163914435|NCT00805441|592055173|FG000|Overall Study|Lack of Efficacy|0|||
163914436|NCT00805441|592055174|FG001|Overall Study|Lack of Efficacy|2|||
163914437|NCT00805441|592055173|FG000|Overall Study|Protocol Violation|4|||
163914438|NCT00805441|592055174|FG001|Overall Study|Protocol Violation|8|||
163914439|NCT00805441|592055173|FG000|Overall Study|Lost to Follow-up|10|||
163914440|NCT00805441|592055174|FG001|Overall Study|Lost to Follow-up|13|||
163914441|NCT00805441|592055173|FG000|Overall Study|Withdrawal by Subject|15|||
163914442|NCT00805441|592055174|FG001|Overall Study|Withdrawal by Subject|9|||
163914443|NCT00805441|592055173|FG000|Overall Study|Physician Decision|0|||
163914444|NCT00805441|592055174|FG001|Overall Study|Physician Decision|1|||
163914445|NCT00805441|592055173|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
163914446|NCT00805441|592055174|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
163914447|NCT05379400|592056362|FG000|Overall Study|Lost to Follow-up|1|||
163914448|NCT05379400|592056363|FG001|Overall Study|Lost to Follow-up|1|||
163914449|NCT05356130|592056364|FG000|Overall Study|Withdrawal by Subject|0|||
163914450|NCT05356130|592056365|FG001|Overall Study|Withdrawal by Subject|0|||
163914451|NCT05356130|592056366|FG002|Overall Study|Withdrawal by Subject|3|||
163914452|NCT04851587|592056367|FG000|Overall Study|Lost to Follow-up|18|||
164027880|NCT01021852|592461139|FG007|Treatment Period 2|Adverse Event|0|||
164027881|NCT01021852|592461132|FG000|Treatment Period 2|Lack of Efficacy|0|||
164027882|NCT01021852|592461133|FG001|Treatment Period 2|Lack of Efficacy|0|||
164027883|NCT01021852|592461134|FG002|Treatment Period 2|Lack of Efficacy|0|||
164027884|NCT01021852|592461135|FG003|Treatment Period 2|Lack of Efficacy|0|||
164027885|NCT01021852|592461136|FG004|Treatment Period 2|Lack of Efficacy|0|||
163914453|NCT04820023|592056370|FG000|Overall Study|Death|0|||
164027886|NCT01021852|592461137|FG005|Treatment Period 2|Lack of Efficacy|1|||
164027887|NCT01021852|592461138|FG006|Treatment Period 2|Lack of Efficacy|0|||
164027888|NCT01021852|592461139|FG007|Treatment Period 2|Lack of Efficacy|0|||
163914454|NCT04820023|592056371|FG001|Overall Study|Death|0|||
163914455|NCT04820023|592056372|FG002|Overall Study|Death|0|||
163914456|NCT04820023|592056373|FG003|Overall Study|Death|0|||
163914457|NCT04820023|592056374|FG004|Overall Study|Death|0|||
163914458|NCT04820023|592056375|FG005|Overall Study|Death|0|||
164027889|NCT01021852|592461132|FG000|Treatment Period 2|Physician Decision|0|||
163914459|NCT04820023|592056376|FG006|Overall Study|Death|1|||
163914460|NCT04820023|592056377|FG007|Overall Study|Death|0|||
163914461|NCT04820023|592056378|FG008|Overall Study|Death|1|||
163914462|NCT04820023|592056370|FG000|Overall Study|Withdrawal by Subject|1|||
163914463|NCT04820023|592056371|FG001|Overall Study|Withdrawal by Subject|2|||
163914464|NCT04820023|592056372|FG002|Overall Study|Withdrawal by Subject|2|||
163914465|NCT04820023|592056373|FG003|Overall Study|Withdrawal by Subject|1|||
163914466|NCT04820023|592056374|FG004|Overall Study|Withdrawal by Subject|4|||
163914467|NCT04820023|592056375|FG005|Overall Study|Withdrawal by Subject|3|||
163914468|NCT04820023|592056376|FG006|Overall Study|Withdrawal by Subject|3|||
163914469|NCT04820023|592056377|FG007|Overall Study|Withdrawal by Subject|6|||
163914470|NCT04820023|592056378|FG008|Overall Study|Withdrawal by Subject|5|||
163914471|NCT04820023|592056370|FG000|Overall Study|Progressive Disease|3|||
163914472|NCT04820023|592056371|FG001|Overall Study|Progressive Disease|0|||
163914473|NCT04820023|592056372|FG002|Overall Study|Progressive Disease|2|||
163914474|NCT04820023|592056373|FG003|Overall Study|Progressive Disease|2|||
163914475|NCT04820023|592056374|FG004|Overall Study|Progressive Disease|2|||
163914476|NCT04820023|592056375|FG005|Overall Study|Progressive Disease|0|||
163914477|NCT04820023|592056376|FG006|Overall Study|Progressive Disease|1|||
163914478|NCT04820023|592056377|FG007|Overall Study|Progressive Disease|1|||
163914479|NCT04820023|592056378|FG008|Overall Study|Progressive Disease|0|||
163914480|NCT04820023|592056370|FG000|Overall Study|New anti-cancer therapy|0|||
163914481|NCT04820023|592056371|FG001|Overall Study|New anti-cancer therapy|0|||
163914482|NCT04820023|592056372|FG002|Overall Study|New anti-cancer therapy|0|||
163914483|NCT04820023|592056373|FG003|Overall Study|New anti-cancer therapy|0|||
163914484|NCT04820023|592056374|FG004|Overall Study|New anti-cancer therapy|2|||
163914485|NCT04820023|592056375|FG005|Overall Study|New anti-cancer therapy|0|||
163914486|NCT04820023|592056376|FG006|Overall Study|New anti-cancer therapy|0|||
163914487|NCT04820023|592056377|FG007|Overall Study|New anti-cancer therapy|0|||
164027890|NCT01021852|592461133|FG001|Treatment Period 2|Physician Decision|0|||
163914488|NCT04820023|592056378|FG008|Overall Study|New anti-cancer therapy|0|||
163914489|NCT04820023|592056370|FG000|Overall Study|Other|0|||
163914490|NCT04820023|592056371|FG001|Overall Study|Other|1|||
163914491|NCT04820023|592056372|FG002|Overall Study|Other|0|||
163914492|NCT04820023|592056373|FG003|Overall Study|Other|0|||
163914493|NCT04820023|592056374|FG004|Overall Study|Other|0|||
163914494|NCT04820023|592056375|FG005|Overall Study|Other|0|||
163914495|NCT04820023|592056376|FG006|Overall Study|Other|0|||
163914496|NCT04820023|592056377|FG007|Overall Study|Other|2|||
163914497|NCT04820023|592056378|FG008|Overall Study|Other|0|||
163914498|NCT01020487|592056379|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
164145300|NCT00025259|592894267|FG004|Overall Study|Protocol Violation|2|||
164027891|NCT01021852|592461134|FG002|Treatment Period 2|Physician Decision|1|||
164027892|NCT01021852|592461135|FG003|Treatment Period 2|Physician Decision|0|||
164027893|NCT01021852|592461136|FG004|Treatment Period 2|Physician Decision|0|||
164027894|NCT01021852|592461137|FG005|Treatment Period 2|Physician Decision|0|||
164027895|NCT01021852|592461138|FG006|Treatment Period 2|Physician Decision|0|||
164027896|NCT01021852|592461139|FG007|Treatment Period 2|Physician Decision|0|||
164027897|NCT01021852|592461132|FG000|Treatment Period 2|Protocol Violation|0|||
164027898|NCT01021852|592461133|FG001|Treatment Period 2|Protocol Violation|0|||
164027899|NCT01021852|592461134|FG002|Treatment Period 2|Protocol Violation|0|||
164027900|NCT01021852|592461135|FG003|Treatment Period 2|Protocol Violation|0|||
164027901|NCT01021852|592461136|FG004|Treatment Period 2|Protocol Violation|1|||
163914499|NCT01020487|592056380|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
163914500|NCT01020487|592056381|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
163914501|NCT01020487|592056379|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
163914502|NCT01020487|592056380|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
163914503|NCT01020487|592056381|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
163914504|NCT01020487|592056379|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
163914505|NCT01020487|592056380|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
163914506|NCT01020487|592056381|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
163914507|NCT01020487|592056379|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
163914508|NCT01020487|592056380|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
163914509|NCT01020487|592056381|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
163914510|NCT01020487|592056379|FG000|Part 2 Open-label Period|Adverse Event|0|||
163914511|NCT01020487|592056380|FG001|Part 2 Open-label Period|Adverse Event|4|||
163914512|NCT01020487|592056381|FG002|Part 2 Open-label Period|Adverse Event|1|||
163914513|NCT02109172|592056392|FG000|Overall Study|Withdrawal by Subject|1|||
163914514|NCT02109172|592056393|FG001|Overall Study|Withdrawal by Subject|0|||
163914515|NCT02109172|592056394|FG002|Overall Study|Withdrawal by Subject|0|||
163914516|NCT02109172|592056395|FG003|Overall Study|Withdrawal by Subject|1|||
163914517|NCT02109172|592056396|FG004|Overall Study|Withdrawal by Subject|0|||
163914518|NCT02109172|592056397|FG005|Overall Study|Withdrawal by Subject|0|||
163914519|NCT02109172|592056392|FG000|Overall Study|Adverse Event|0|||
163914520|NCT02109172|592056393|FG001|Overall Study|Adverse Event|0|||
163914521|NCT02109172|592056394|FG002|Overall Study|Adverse Event|1|||
163914522|NCT02109172|592056395|FG003|Overall Study|Adverse Event|0|||
163914523|NCT02109172|592056396|FG004|Overall Study|Adverse Event|0|||
163914524|NCT02109172|592056397|FG005|Overall Study|Adverse Event|1|||
163914525|NCT02109172|592056392|FG000|Overall Study|Death|0|||
163914526|NCT02109172|592056393|FG001|Overall Study|Death|0|||
163914527|NCT02109172|592056394|FG002|Overall Study|Death|0|||
163914528|NCT02109172|592056395|FG003|Overall Study|Death|0|||
163914529|NCT02109172|592056396|FG004|Overall Study|Death|1|||
163914530|NCT02109172|592056397|FG005|Overall Study|Death|0|||
163914531|NCT01279447|592056398|FG000|Overall Study|Lost to Follow-up|3|||
163914532|NCT01279447|592056399|FG001|Overall Study|Lost to Follow-up|1|||
163914533|NCT03360071|592056400|FG000|Overall Study|Lost to Follow-up|1|||
163914534|NCT03360071|592056401|FG001|Overall Study|Lost to Follow-up|0|||
163914535|NCT03184519|592056410|FG000|Overall Study|Lost to Follow-up|6|||
163914536|NCT03184519|592056410|FG000|Overall Study|Physician Decision|21|||
163914537|NCT02823574|592056414|FG000|Randomization|Disease Progression|0|||
163914538|NCT02823574|592056415|FG001|Randomization|Disease Progression|0|||
163914539|NCT02823574|592056416|FG002|Randomization|Disease Progression|1|||
163914540|NCT02823574|592056417|FG003|Randomization|Disease Progression|0|||
163914541|NCT02823574|592056414|FG000|Randomization|AE unrelated to Study Drug|1|||
163914542|NCT02823574|592056415|FG001|Randomization|AE unrelated to Study Drug|0|||
163914543|NCT02823574|592056416|FG002|Randomization|AE unrelated to Study Drug|0|||
163914544|NCT02823574|592056417|FG003|Randomization|AE unrelated to Study Drug|0|||
163914545|NCT02823574|592056414|FG000|Treatment Period|Poor/Non Compliance|1|||
163914546|NCT02823574|592056415|FG001|Treatment Period|Poor/Non Compliance|0|||
163914547|NCT02823574|592056416|FG002|Treatment Period|Poor/Non Compliance|0|||
163914548|NCT02823574|592056417|FG003|Treatment Period|Poor/Non Compliance|1|||
163914549|NCT02823574|592056414|FG000|Treatment Period|Maximum Clinical Benefit|8|||
163914550|NCT02823574|592056415|FG001|Treatment Period|Maximum Clinical Benefit|4|||
163914551|NCT02823574|592056416|FG002|Treatment Period|Maximum Clinical Benefit|7|||
163914552|NCT02823574|592056417|FG003|Treatment Period|Maximum Clinical Benefit|1|||
163914553|NCT02823574|592056414|FG000|Treatment Period|Lost to Follow-up|1|||
163914554|NCT02823574|592056415|FG001|Treatment Period|Lost to Follow-up|1|||
163914555|NCT02823574|592056416|FG002|Treatment Period|Lost to Follow-up|0|||
163914556|NCT02823574|592056417|FG003|Treatment Period|Lost to Follow-up|0|||
163914557|NCT02823574|592056414|FG000|Treatment Period|Participant withdrew consent|4|||
163914558|NCT02823574|592056415|FG001|Treatment Period|Participant withdrew consent|0|||
163914559|NCT02823574|592056416|FG002|Treatment Period|Participant withdrew consent|0|||
163914560|NCT02823574|592056417|FG003|Treatment Period|Participant withdrew consent|1|||
163914561|NCT02823574|592056414|FG000|Treatment Period|Participant request to discontinue|5|||
163914562|NCT02823574|592056415|FG001|Treatment Period|Participant request to discontinue|0|||
163914563|NCT02823574|592056416|FG002|Treatment Period|Participant request to discontinue|3|||
163914564|NCT02823574|592056417|FG003|Treatment Period|Participant request to discontinue|2|||
163914565|NCT02823574|592056414|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
163914566|NCT02823574|592056415|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
164027902|NCT01021852|592461137|FG005|Treatment Period 2|Protocol Violation|0|||
164027903|NCT01021852|592461138|FG006|Treatment Period 2|Protocol Violation|1|||
164027904|NCT01021852|592461139|FG007|Treatment Period 2|Protocol Violation|0|||
163914567|NCT02823574|592056416|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
163914568|NCT02823574|592056417|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
163914569|NCT02823574|592056414|FG000|Treatment Period|Study Drug Toxicity|11|||
163914570|NCT02823574|592056415|FG001|Treatment Period|Study Drug Toxicity|2|||
163914571|NCT02823574|592056416|FG002|Treatment Period|Study Drug Toxicity|14|||
163914572|NCT02823574|592056417|FG003|Treatment Period|Study Drug Toxicity|4|||
163914573|NCT02823574|592056414|FG000|Treatment Period|Disease Progression|113|||
163914574|NCT02823574|592056415|FG001|Treatment Period|Disease Progression|64|||
163914575|NCT02823574|592056416|FG002|Treatment Period|Disease Progression|82|||
163914576|NCT02823574|592056417|FG003|Treatment Period|Disease Progression|43|||
163914577|NCT02823574|592056414|FG000|Treatment Period|Other reasons|5|||
163914578|NCT02823574|592056415|FG001|Treatment Period|Other reasons|9|||
163914579|NCT02823574|592056416|FG002|Treatment Period|Other reasons|3|||
163914580|NCT02823574|592056417|FG003|Treatment Period|Other reasons|6|||
163914581|NCT02823574|592056414|FG000|Treatment Period|Participant no longer meets study criteria|0|||
163914582|NCT02823574|592056415|FG001|Treatment Period|Participant no longer meets study criteria|0|||
163914583|NCT02823574|592056416|FG002|Treatment Period|Participant no longer meets study criteria|1|||
163914584|NCT02823574|592056417|FG003|Treatment Period|Participant no longer meets study criteria|0|||
163914585|NCT02823574|592056414|FG000|Treatment Period|Death|0|||
163914586|NCT02823574|592056415|FG001|Treatment Period|Death|0|||
164096558|NCT02334722|592717313|FG001|Overall Study|6 week questionnaire not completed|0|||
164096559|NCT02334722|592717312|FG000|Overall Study|Unable to obtain medication|1|||
163914587|NCT02823574|592056416|FG002|Treatment Period|Death|3|||
163914588|NCT02823574|592056417|FG003|Treatment Period|Death|1|||
163914589|NCT00590759|592056418|FG000|Overall Study|Death|52|||
163914590|NCT00590759|592056418|FG000|Overall Study|Lost to Follow-up|28|||
163914591|NCT00901459|592056423|FG000|Overall Study|Withdrawal by Subject|6|||
163914592|NCT00910871|592056430|FG000|Overall Study|Adverse Event|5|||
163914593|NCT00910871|592056430|FG000|Overall Study|Death|12|||
163914594|NCT00910871|592056430|FG000|Overall Study|Lost to Follow-up|8|||
163914595|NCT00910871|592056430|FG000|Overall Study|Protocol Violation|11|||
163914596|NCT00910871|592056430|FG000|Overall Study|Withdrawal by Subject|12|||
163914597|NCT00910871|592056430|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
163914598|NCT00910871|592056430|FG000|Overall Study|Undefined|1|||
163914599|NCT00850993|592056431|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
163914600|NCT00850993|592056432|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
163914601|NCT00850993|592056433|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
163914602|NCT00850993|592056434|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
163914603|NCT00636168|592056440|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
163914604|NCT00636168|592056441|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
163914605|NCT00636168|592056440|FG000|Randomized to Study Drug|Adverse Event|1|||
163914606|NCT00636168|592056441|FG001|Randomized to Study Drug|Adverse Event|0|||
163914607|NCT00636168|592056440|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
163914608|NCT00636168|592056441|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
163914609|NCT00636168|592056440|FG000|Treated With Study Drug|Recurrence of disease|135|||
163914610|NCT00636168|592056441|FG001|Treated With Study Drug|Recurrence of disease|282|||
163914611|NCT00636168|592056440|FG000|Treated With Study Drug|Adverse Event|250|||
163914612|NCT00636168|592056441|FG001|Treated With Study Drug|Adverse Event|22|||
163914613|NCT00636168|592056440|FG000|Treated With Study Drug|Participant withdrew consent|16|||
163914614|NCT00636168|592056441|FG001|Treated With Study Drug|Participant withdrew consent|21|||
163914615|NCT00636168|592056440|FG000|Treated With Study Drug|Poor/non-compliance|1|||
163914616|NCT00636168|592056441|FG001|Treated With Study Drug|Poor/non-compliance|3|||
163914617|NCT00636168|592056440|FG000|Treated With Study Drug|Death|3|||
163914618|NCT00636168|592056441|FG001|Treated With Study Drug|Death|0|||
163914619|NCT00636168|592056440|FG000|Treated With Study Drug|Pregnancy|1|||
163914620|NCT00636168|592056441|FG001|Treated With Study Drug|Pregnancy|0|||
163914621|NCT00636168|592056440|FG000|Treated With Study Drug|No longer meets study criteria|1|||
163914622|NCT00636168|592056441|FG001|Treated With Study Drug|No longer meets study criteria|0|||
163914623|NCT00636168|592056440|FG000|Treated With Study Drug|Other reason|1|||
163914624|NCT00636168|592056441|FG001|Treated With Study Drug|Other reason|3|||
163914625|NCT00636168|592056440|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
163914626|NCT00636168|592056441|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
163914627|NCT00636168|592056440|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
163914628|NCT00636168|592056441|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
163914629|NCT00636168|592056440|FG000|Long Term Follow-Up|Death|8|||
163914630|NCT00636168|592056441|FG001|Long Term Follow-Up|Death|9|||
163914631|NCT04501614|592056445|FG000|Overall Study|Study Terminated by Sponsor|6|||
163914632|NCT04501614|592056446|FG001|Overall Study|Study Terminated by Sponsor|3|||
163914633|NCT04501614|592056445|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
163914634|NCT04501614|592056446|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
163914635|NCT02555397|592056450|FG000|Overall Study|Withdrawal by Subject|1|||
163914636|NCT02555397|592056451|FG001|Overall Study|Withdrawal by Subject|0|||
163914637|NCT02555397|592056452|FG002|Overall Study|Withdrawal by Subject|0|||
163914638|NCT02555397|592056453|FG003|Overall Study|Withdrawal by Subject|0|||
163914639|NCT02555397|592056454|FG004|Overall Study|Withdrawal by Subject|0|||
163914640|NCT04529941|592056457|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
163914641|NCT04529941|592056458|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
163914642|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
163914643|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
163914644|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
163914645|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
164027905|NCT01021852|592461132|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164027906|NCT01021852|592461133|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164027907|NCT01021852|592461134|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164027908|NCT01021852|592461135|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164027909|NCT01021852|592461136|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164027910|NCT01021852|592461137|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164027911|NCT01021852|592461138|FG006|Treatment Period 2|Withdrawal by Subject|1|||
164027912|NCT01021852|592461139|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164027913|NCT01025817|592461141|FG000|Completed Study Medication|Adverse Event|66|||
164027914|NCT01025817|592461142|FG001|Completed Study Medication|Adverse Event|39|||
164027915|NCT01025817|592461141|FG000|Completed Study Medication|Protocol Deviation|9|||
164027916|NCT01025817|592461142|FG001|Completed Study Medication|Protocol Deviation|8|||
164027917|NCT01025817|592461141|FG000|Completed Study Medication|Withdrawal by Subject|8|||
164027918|NCT01025817|592461142|FG001|Completed Study Medication|Withdrawal by Subject|9|||
164027919|NCT01025817|592461141|FG000|Completed Study Medication|Administrative problems|7|||
164027920|NCT01025817|592461142|FG001|Completed Study Medication|Administrative problems|5|||
164027921|NCT01025817|592461141|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
164027922|NCT01025817|592461142|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
164027923|NCT01025817|592461141|FG000|Completed Study Medication|Abnormal test procedure|4|||
164027924|NCT01025817|592461142|FG001|Completed Study Medication|Abnormal test procedure|0|||
164027925|NCT01025817|592461141|FG000|Completed Study Medication|Graft loss|2|||
164096560|NCT02334722|592717313|FG001|Overall Study|Unable to obtain medication|1|||
164096561|NCT02334722|592717312|FG000|Overall Study|Withdrawal by Subject|0|||
163914646|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
163914647|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
163914648|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
163914649|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
163914650|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
163914651|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
163914652|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
163914653|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
163914654|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
163914655|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
163914656|NCT02971683|592056460|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
163914657|NCT02971683|592056461|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
163914658|NCT02971683|592056460|FG000|Open-Label|Lost to Follow-up|1|||
163914659|NCT02971683|592056461|FG001|Open-Label|Lost to Follow-up|0|||
163914660|NCT02971683|592056460|FG000|Open-Label|Participants withdrew consent|0|||
163914661|NCT02971683|592056461|FG001|Open-Label|Participants withdrew consent|2|||
163914662|NCT02971683|592056460|FG000|Open-Label|Participant request to discontinue study treatment|1|||
163914663|NCT02971683|592056461|FG001|Open-Label|Participant request to discontinue study treatment|0|||
163914664|NCT02971683|592056460|FG000|Open-Label|Lack of Efficacy|2|||
163914665|NCT02971683|592056461|FG001|Open-Label|Lack of Efficacy|0|||
163914666|NCT02971683|592056460|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
163914667|NCT02971683|592056461|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
163914668|NCT02971683|592056460|FG000|Long-Term Open Label|Participant withdrew consent|1|||
163914669|NCT02971683|592056461|FG001|Long-Term Open Label|Participant withdrew consent|0|||
163914670|NCT02971683|592056460|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
163914671|NCT02971683|592056461|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
163914672|NCT02971683|592056460|FG000|Long-Term Open Label|Adverse Event|1|||
163914673|NCT02971683|592056461|FG001|Long-Term Open Label|Adverse Event|2|||
163914674|NCT02971683|592056460|FG000|Long-Term Open Label|Lack of Efficacy|1|||
163914675|NCT02971683|592056461|FG001|Long-Term Open Label|Lack of Efficacy|1|||
163914676|NCT01005914|592056462|FG000|Overall Study|Adverse Event|4|||
163914677|NCT01005914|592056462|FG000|Overall Study|Death|4|||
163914678|NCT01005914|592056462|FG000|Overall Study|Lack of Efficacy|1|||
163914679|NCT01005914|592056462|FG000|Overall Study|Withdrawal by Subject|1|||
163914680|NCT01240785|592056465|FG000|Overall Study|Lost to Follow-up|1|||
163914681|NCT01240785|592056466|FG001|Overall Study|Lost to Follow-up|0|||
164096562|NCT02334722|592717313|FG001|Overall Study|Withdrawal by Subject|3|||
164096563|NCT02334722|592717312|FG000|Overall Study|Adverse Event|0|||
164027926|NCT01025817|592461142|FG001|Completed Study Medication|Graft loss|5|||
164027927|NCT01025817|592461141|FG000|Completed Study Medication|Death|2|||
164027928|NCT01025817|592461142|FG001|Completed Study Medication|Death|2|||
164027929|NCT01025817|592461141|FG000|Completed Study Medication|Abnormal lab values|0|||
164027930|NCT01025817|592461142|FG001|Completed Study Medication|Abnormal lab values|2|||
164027931|NCT01025817|592461141|FG000|Completed Study Medication|Subject no longer required study drug|0|||
164027932|NCT01025817|592461142|FG001|Completed Study Medication|Subject no longer required study drug|1|||
164027933|NCT01025817|592461141|FG000|Completed Study Medication|Lost to Follow-up|0|||
164027934|NCT01025817|592461142|FG001|Completed Study Medication|Lost to Follow-up|1|||
164027935|NCT01025817|592461141|FG000|Completed Study|Withdrawal by Subject|8|||
164027936|NCT01025817|592461142|FG001|Completed Study|Withdrawal by Subject|16|||
164027937|NCT01025817|592461141|FG000|Completed Study|Death|6|||
164027938|NCT01025817|592461142|FG001|Completed Study|Death|5|||
164027939|NCT01025817|592461141|FG000|Completed Study|Missing|2|||
164027940|NCT01025817|592461142|FG001|Completed Study|Missing|0|||
164027941|NCT01025817|592461141|FG000|Completed Study|Lost to Follow-up|0|||
164027942|NCT01025817|592461142|FG001|Completed Study|Lost to Follow-up|1|||
164027943|NCT01165021|592461144|FG000|Overall Study|Death|1|||
164027944|NCT04799405|592461145|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
164027945|NCT00603980|592461146|FG000|Study Qualification|Protocol Violation|3|||
164027946|NCT00603980|592461146|FG000|Study Qualification|Inconsistent data reporting|13|||
164027947|NCT00603980|592461146|FG000|Main Study|14th subject completed trial|1|||
164027948|NCT01029002|592461147|FG000|Overall Study|Lost to Follow-up|2|||
164027949|NCT01029002|592461148|FG001|Overall Study|Lost to Follow-up|4|||
164027950|NCT02683525|592461149|FG000|Overall Study|Lost to Follow-up|1|||
164027951|NCT02683525|592461149|FG000|Overall Study|Physician Decision|1|||
164027952|NCT02683525|592461149|FG000|Overall Study|Disease Progression|6|||
163914682|NCT01240785|592056465|FG000|Overall Study|Protocol Violation|0|||
163914683|NCT01240785|592056466|FG001|Overall Study|Protocol Violation|3|||
163914684|NCT02066389|592056467|FG000|Overall Study|Adverse Event|1|||
163914685|NCT02066389|592056468|FG001|Overall Study|Adverse Event|1|||
163914686|NCT02066389|592056469|FG002|Overall Study|Adverse Event|1|||
163914687|NCT02066389|592056470|FG003|Overall Study|Adverse Event|1|||
163914688|NCT02066389|592056471|FG004|Overall Study|Adverse Event|5|||
163914689|NCT02066389|592056472|FG005|Overall Study|Adverse Event|1|||
163914690|NCT02066389|592056467|FG000|Overall Study|Withdrawal by Subject|4|||
163914691|NCT02066389|592056468|FG001|Overall Study|Withdrawal by Subject|0|||
163914692|NCT02066389|592056469|FG002|Overall Study|Withdrawal by Subject|5|||
163914693|NCT02066389|592056470|FG003|Overall Study|Withdrawal by Subject|1|||
163914694|NCT02066389|592056471|FG004|Overall Study|Withdrawal by Subject|1|||
163914695|NCT02066389|592056472|FG005|Overall Study|Withdrawal by Subject|2|||
163914696|NCT02066389|592056467|FG000|Overall Study|Lost to Follow-up|0|||
163914697|NCT02066389|592056468|FG001|Overall Study|Lost to Follow-up|0|||
163914698|NCT02066389|592056469|FG002|Overall Study|Lost to Follow-up|0|||
163914699|NCT02066389|592056470|FG003|Overall Study|Lost to Follow-up|1|||
163914700|NCT02066389|592056471|FG004|Overall Study|Lost to Follow-up|1|||
163914701|NCT02066389|592056472|FG005|Overall Study|Lost to Follow-up|1|||
163914702|NCT02066389|592056467|FG000|Overall Study|Randomized in Error|0|||
163914703|NCT02066389|592056468|FG001|Overall Study|Randomized in Error|0|||
163914704|NCT02066389|592056469|FG002|Overall Study|Randomized in Error|0|||
163914705|NCT02066389|592056470|FG003|Overall Study|Randomized in Error|0|||
163914706|NCT02066389|592056471|FG004|Overall Study|Randomized in Error|0|||
163914707|NCT02066389|592056472|FG005|Overall Study|Randomized in Error|1|||
163914708|NCT01468597|592056473|FG000|Overall Study|Found ineligible|17|||
163914709|NCT01468597|592056473|FG000|Overall Study|concomitant valves|12|||
163914710|NCT01468597|592056473|FG000|Overall Study|off-pump CABG|1|||
163914711|NCT01468597|592056473|FG000|Overall Study|no platelet function data|5|||
163914712|NCT00736502|592056474|FG000|Overall Study|Adverse Event|22|||
163914713|NCT00736502|592056474|FG000|Overall Study|Lack of Efficacy|16|||
163914714|NCT00736502|592056474|FG000|Overall Study|Lost to Follow-up|27|||
163914715|NCT02935894|592056479|FG000|Overall Study|Subject dismissed|1|||
163914716|NCT00853957|592056482|FG000|Overall Study|Adverse Event|9|||
164027953|NCT01577160|592461150|FG000|Overall Study|Adverse Event|9|||
164027954|NCT01577160|592461150|FG000|Overall Study|Lack of Efficacy|15|||
164027955|NCT01577160|592461150|FG000|Overall Study|Lost to Follow-up|40|||
164027956|NCT01577160|592461150|FG000|Overall Study|Withdrawal by Subject|18|||
164027957|NCT01577160|592461150|FG000|Overall Study|Subject Uncooperative|7|||
164027958|NCT01577160|592461150|FG000|Overall Study|Other|9|||
164027959|NCT01341652|592461151|FG000|Overall Study|Incorrect Random Assignment|0|||
164027960|NCT01341652|592461152|FG001|Overall Study|Incorrect Random Assignment|1|||
164027961|NCT01341652|592461151|FG000|Overall Study|ineligible; presence metastatic disease|0|||
164027962|NCT01341652|592461152|FG001|Overall Study|ineligible; presence metastatic disease|1|||
164027963|NCT02618928|592461153|FG000|Overall Study|Failure to Return|28|||
164027964|NCT02618928|592461153|FG000|Overall Study|Insufficient Virological Response|1|||
164027965|NCT02618928|592461153|FG000|Overall Study|Withdrawal by Subject|2|||
164027966|NCT02618928|592461153|FG000|Overall Study|Death|3|||
164027967|NCT02618928|592461153|FG000|Overall Study|Other|11|||
164027968|NCT02618928|592461153|FG000|Overall Study|Missing|6|||
164027969|NCT02618928|592461153|FG000|Overall Study|Treatment Never Started|7|||
164027970|NCT01096849|592461158|FG000|Overall Study|Consent Withdrawn|1|||
164027971|NCT01096849|592461159|FG001|Overall Study|Consent Withdrawn|4|||
164027972|NCT01096849|592461160|FG002|Overall Study|Consent Withdrawn|2|||
164027973|NCT01096849|592461158|FG000|Overall Study|Lack of Efficacy|0|||
164027974|NCT01096849|592461159|FG001|Overall Study|Lack of Efficacy|2|||
163914717|NCT00853957|592056483|FG001|Overall Study|Adverse Event|3|||
163914718|NCT00853957|592056482|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163914719|NCT00853957|592056483|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163914720|NCT00853957|592056482|FG000|Overall Study|Subject withdrew consent|4|||
163914721|NCT00853957|592056483|FG001|Overall Study|Subject withdrew consent|5|||
163914722|NCT00853957|592056482|FG000|Overall Study|Lost to Follow-up|1|||
163914723|NCT00853957|592056483|FG001|Overall Study|Lost to Follow-up|6|||
163914724|NCT00853957|592056482|FG000|Overall Study|Protocol deviation|0|||
163914725|NCT00853957|592056483|FG001|Overall Study|Protocol deviation|3|||
163914726|NCT01884571|592056484|FG000|Overall Study|Adverse Event|1|||
163914727|NCT01884571|592056484|FG000|Overall Study|Death|2|||
163914728|NCT01884571|592056484|FG000|Overall Study|Withdrawal by Subject|2|||
163914729|NCT01884571|592056484|FG000|Overall Study|Disease progression|3|||
163914730|NCT01186809|592056487|FG000|Overall Study|Death|30|||
163914731|NCT04895085|592056488|FG000|Overall Study|Death|1|||
163914732|NCT04895085|592056488|FG000|Overall Study|Withdrawal by Subject|1|||
163914733|NCT04895085|592056488|FG000|Overall Study|No longer eligible: Moved from area|1|||
163914734|NCT01159600|592056494|FG000|Overall Study|Not treated|0|||
163914735|NCT01159600|592056495|FG001|Overall Study|Not treated|0|||
163914736|NCT01159600|592056496|FG002|Overall Study|Not treated|1|||
163914737|NCT01159600|592056497|FG003|Overall Study|Not treated|0|||
163914738|NCT01159600|592056498|FG004|Overall Study|Not treated|0|||
163914739|NCT01159600|592056499|FG005|Overall Study|Not treated|1|||
163914740|NCT01159600|592056500|FG006|Overall Study|Not treated|2|||
163914741|NCT01159600|592056501|FG007|Overall Study|Not treated|2|||
163914742|NCT01159600|592056494|FG000|Overall Study|Adverse Event|7|||
163914743|NCT01159600|592056495|FG001|Overall Study|Adverse Event|2|||
163914744|NCT01159600|592056496|FG002|Overall Study|Adverse Event|5|||
163914745|NCT01159600|592056497|FG003|Overall Study|Adverse Event|1|||
163914746|NCT01159600|592056498|FG004|Overall Study|Adverse Event|8|||
163914747|NCT01159600|592056499|FG005|Overall Study|Adverse Event|6|||
163914748|NCT01159600|592056500|FG006|Overall Study|Adverse Event|7|||
163914749|NCT01159600|592056501|FG007|Overall Study|Adverse Event|5|||
163914750|NCT01159600|592056494|FG000|Overall Study|Lack of Efficacy|0|||
163914751|NCT01159600|592056495|FG001|Overall Study|Lack of Efficacy|0|||
163914752|NCT01159600|592056496|FG002|Overall Study|Lack of Efficacy|0|||
163914753|NCT01159600|592056497|FG003|Overall Study|Lack of Efficacy|0|||
163914754|NCT01159600|592056498|FG004|Overall Study|Lack of Efficacy|2|||
163914755|NCT01159600|592056499|FG005|Overall Study|Lack of Efficacy|0|||
163914756|NCT01159600|592056500|FG006|Overall Study|Lack of Efficacy|0|||
163914757|NCT01159600|592056501|FG007|Overall Study|Lack of Efficacy|1|||
163914758|NCT01159600|592056494|FG000|Overall Study|Non compliant with protocol|2|||
163914759|NCT01159600|592056495|FG001|Overall Study|Non compliant with protocol|1|||
163914760|NCT01159600|592056496|FG002|Overall Study|Non compliant with protocol|0|||
163914761|NCT01159600|592056497|FG003|Overall Study|Non compliant with protocol|0|||
163914762|NCT01159600|592056498|FG004|Overall Study|Non compliant with protocol|2|||
163914763|NCT01159600|592056499|FG005|Overall Study|Non compliant with protocol|0|||
163914764|NCT01159600|592056500|FG006|Overall Study|Non compliant with protocol|2|||
163914765|NCT01159600|592056501|FG007|Overall Study|Non compliant with protocol|0|||
163914766|NCT01159600|592056494|FG000|Overall Study|Lost to Follow-up|2|||
163914767|NCT01159600|592056495|FG001|Overall Study|Lost to Follow-up|3|||
163914768|NCT01159600|592056496|FG002|Overall Study|Lost to Follow-up|4|||
163914769|NCT01159600|592056497|FG003|Overall Study|Lost to Follow-up|3|||
163914770|NCT01159600|592056498|FG004|Overall Study|Lost to Follow-up|3|||
163914771|NCT01159600|592056499|FG005|Overall Study|Lost to Follow-up|0|||
163914772|NCT01159600|592056500|FG006|Overall Study|Lost to Follow-up|3|||
163914773|NCT01159600|592056501|FG007|Overall Study|Lost to Follow-up|2|||
163914774|NCT01159600|592056494|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
163914775|NCT01159600|592056495|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
163914776|NCT01159600|592056496|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
163914777|NCT01159600|592056497|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
163914778|NCT01159600|592056498|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
163914779|NCT01159600|592056499|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
163914780|NCT01159600|592056500|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
163914781|NCT01159600|592056501|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
163914782|NCT01159600|592056494|FG000|Overall Study|Other reason not defined above|3|||
163914783|NCT01159600|592056495|FG001|Overall Study|Other reason not defined above|0|||
163914784|NCT01159600|592056496|FG002|Overall Study|Other reason not defined above|4|||
163914785|NCT01159600|592056497|FG003|Overall Study|Other reason not defined above|2|||
163914786|NCT01159600|592056498|FG004|Overall Study|Other reason not defined above|5|||
163914787|NCT01159600|592056499|FG005|Overall Study|Other reason not defined above|7|||
163914788|NCT01159600|592056500|FG006|Overall Study|Other reason not defined above|3|||
163914789|NCT01159600|592056501|FG007|Overall Study|Other reason not defined above|3|||
163914790|NCT04919499|592056502|FG000|Overall Study|Adverse Event|0|||
163914791|NCT04919499|592056503|FG001|Overall Study|Adverse Event|0|||
163914792|NCT04919499|592056504|FG002|Overall Study|Adverse Event|0|||
163914793|NCT04919499|592056505|FG003|Overall Study|Adverse Event|0|||
164027975|NCT01096849|592461160|FG002|Overall Study|Lack of Efficacy|0|||
164027976|NCT01096849|592461158|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
164027977|NCT01096849|592461159|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
164027978|NCT01096849|592461160|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
164027979|NCT01096849|592461158|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
164027980|NCT01096849|592461159|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
164027981|NCT01096849|592461160|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
164027982|NCT01096849|592461158|FG000|Overall Study|Administrative Reasons|0|||
164027983|NCT01096849|592461159|FG001|Overall Study|Administrative Reasons|1|||
164027984|NCT01096849|592461160|FG002|Overall Study|Administrative Reasons|2|||
164027985|NCT01096849|592461158|FG000|Overall Study|Lost to Follow-up|1|||
164027986|NCT01096849|592461159|FG001|Overall Study|Lost to Follow-up|3|||
164027987|NCT01096849|592461160|FG002|Overall Study|Lost to Follow-up|1|||
164096564|NCT02334722|592717313|FG001|Overall Study|Adverse Event|2|||
164096565|NCT02334722|592717312|FG000|Overall Study|Physician Decision|0|||
164027988|NCT00118482|592461161|FG000|Overall Study|Lost to Follow-up|7|||
164027989|NCT00118482|592461162|FG001|Overall Study|Lost to Follow-up|7|||
164027990|NCT00118482|592461161|FG000|Overall Study|Withdrawal by Subject|23|||
164096566|NCT02334722|592717313|FG001|Overall Study|Physician Decision|1|||
163914794|NCT04919499|592056506|FG004|Overall Study|Adverse Event|2|||
163914795|NCT04919499|592056502|FG000|Overall Study|Not treated|0|||
163914796|NCT04919499|592056503|FG001|Overall Study|Not treated|0|||
163914797|NCT04919499|592056504|FG002|Overall Study|Not treated|0|||
163914798|NCT04919499|592056505|FG003|Overall Study|Not treated|1|||
163914799|NCT04919499|592056506|FG004|Overall Study|Not treated|0|||
163914800|NCT00760877|592057742|FG000|Overall Study|Protocol Violation|1|||
163914801|NCT00760877|592057743|FG001|Overall Study|Protocol Violation|0|||
163914802|NCT00760877|592057742|FG000|Overall Study|Non-compliance with protocol treatment|2|||
164096567|NCT03988803|592717314|FG000|Period 2|Prematurely discontinued from medication|2|||
164096568|NCT03988803|592717314|FG000|Period 2|Adverse Event|1|||
164096569|NCT01666730|592717317|FG000|Overall Study|Adverse Event|16|||
164096570|NCT01666730|592717317|FG000|Overall Study|Death|2|||
164096571|NCT01666730|592717317|FG000|Overall Study|Physician Decision|5|||
164096572|NCT01666730|592717317|FG000|Overall Study|Withdrawal by Subject|9|||
164096573|NCT01666730|592717317|FG000|Overall Study|Disease progression/relapse|18|||
164096574|NCT01434693|592717318|FG000|Overall Study|Adverse Event|1|||
164096575|NCT01434693|592717319|FG001|Overall Study|Adverse Event|0|||
164096576|NCT01434693|592717320|FG002|Overall Study|Adverse Event|0|||
164096577|NCT01434693|592717321|FG003|Overall Study|Adverse Event|0|||
164096578|NCT01434693|592717318|FG000|Overall Study|Withdrawal by Subject|1|||
164096579|NCT01434693|592717319|FG001|Overall Study|Withdrawal by Subject|0|||
164096580|NCT01434693|592717320|FG002|Overall Study|Withdrawal by Subject|1|||
164096581|NCT01434693|592717321|FG003|Overall Study|Withdrawal by Subject|1|||
164096582|NCT01434693|592717318|FG000|Overall Study|Lost to Follow-up|1|||
164096583|NCT01434693|592717319|FG001|Overall Study|Lost to Follow-up|0|||
164096584|NCT01434693|592717320|FG002|Overall Study|Lost to Follow-up|0|||
164096585|NCT01434693|592717321|FG003|Overall Study|Lost to Follow-up|0|||
164096586|NCT02087904|592717322|FG000|Overall Study|Did Not Receive Study Drug|0|||
164096587|NCT02087904|592717323|FG001|Overall Study|Did Not Receive Study Drug|0|||
164096588|NCT02087904|592717324|FG002|Overall Study|Did Not Receive Study Drug|2|||
164096589|NCT02087904|592717325|FG003|Overall Study|Did Not Receive Study Drug|1|||
164096590|NCT02087904|592717322|FG000|Overall Study|Adverse Event|8|||
164096591|NCT02087904|592717323|FG001|Overall Study|Adverse Event|4|||
164096592|NCT02087904|592717324|FG002|Overall Study|Adverse Event|4|||
163914803|NCT00760877|592057743|FG001|Overall Study|Non-compliance with protocol treatment|1|||
163914804|NCT00760877|592057742|FG000|Overall Study|Pregnancy|1|||
163914805|NCT00760877|592057743|FG001|Overall Study|Pregnancy|4|||
164096593|NCT02087904|592717325|FG003|Overall Study|Adverse Event|12|||
164096594|NCT02087904|592717322|FG000|Overall Study|Lack of Efficacy|3|||
164096595|NCT02087904|592717323|FG001|Overall Study|Lack of Efficacy|6|||
164096596|NCT02087904|592717324|FG002|Overall Study|Lack of Efficacy|3|||
164096597|NCT02087904|592717325|FG003|Overall Study|Lack of Efficacy|2|||
164096598|NCT02087904|592717322|FG000|Overall Study|Other|6|||
163914806|NCT00760877|592057742|FG000|Overall Study|Death|2|||
163914807|NCT00760877|592057743|FG001|Overall Study|Death|1|||
163914808|NCT00760877|592057742|FG000|Overall Study|Withdrawal by Subject|7|||
164096599|NCT02087904|592717323|FG001|Overall Study|Other|2|||
164096600|NCT02087904|592717324|FG002|Overall Study|Other|4|||
164096601|NCT02087904|592717325|FG003|Overall Study|Other|4|||
164096602|NCT02087904|592717322|FG000|Overall Study|Withdrawal by Subject|8|||
164096603|NCT02087904|592717323|FG001|Overall Study|Withdrawal by Subject|3|||
164027991|NCT00118482|592461162|FG001|Overall Study|Withdrawal by Subject|22|||
164027992|NCT01008995|592461163|FG000|Controlled Period|Adverse Event|1|||
164027993|NCT01008995|592461164|FG001|Controlled Period|Adverse Event|2|||
164027994|NCT01008995|592461165|FG002|Controlled Period|Adverse Event|0|||
164027995|NCT01008995|592461166|FG003|Controlled Period|Adverse Event|0|||
164027996|NCT01008995|592461163|FG000|Controlled Period|Other|2|||
164027997|NCT01008995|592461164|FG001|Controlled Period|Other|1|||
164027998|NCT01008995|592461165|FG002|Controlled Period|Other|0|||
164027999|NCT01008995|592461166|FG003|Controlled Period|Other|0|||
164028000|NCT01008995|592461163|FG000|After Controlled Period|Adverse Event|0|||
164028001|NCT01008995|592461164|FG001|After Controlled Period|Adverse Event|0|||
164028002|NCT01008995|592461165|FG002|After Controlled Period|Adverse Event|1|||
164028003|NCT01008995|592461166|FG003|After Controlled Period|Adverse Event|1|||
164028004|NCT01008995|592461163|FG000|After Controlled Period|Other|0|||
164028005|NCT01008995|592461164|FG001|After Controlled Period|Other|0|||
164028006|NCT01008995|592461165|FG002|After Controlled Period|Other|1|||
164028007|NCT01008995|592461166|FG003|After Controlled Period|Other|0|||
164028008|NCT04146467|592461171|FG000|Overall Study|Adverse Event|0|||
164028009|NCT04146467|592461172|FG001|Overall Study|Adverse Event|1|||
164028010|NCT04146467|592461171|FG000|Overall Study|Lost to Follow-up|0|||
164028011|NCT04146467|592461172|FG001|Overall Study|Lost to Follow-up|2|||
164028012|NCT02128763|592461175|FG000|Overall Study|Death|1|||
164028013|NCT02128763|592461176|FG001|Overall Study|Death|0|||
164028014|NCT02128763|592461175|FG000|Overall Study|Lost to Follow-up|19|||
164028015|NCT02128763|592461176|FG001|Overall Study|Lost to Follow-up|16|||
164028016|NCT02953782|592461177|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
163914809|NCT00760877|592057743|FG001|Overall Study|Withdrawal by Subject|3|||
163914810|NCT00760877|592057742|FG000|Overall Study|Adverse Event|19|||
163914811|NCT00760877|592057743|FG001|Overall Study|Adverse Event|12|||
163914812|NCT00760877|592057742|FG000|Overall Study|Participant diagnosed with AML|0|||
163914813|NCT00760877|592057743|FG001|Overall Study|Participant diagnosed with AML|1|||
163914814|NCT00760877|592057742|FG000|Overall Study|Participant not eligible to cross-over|0|||
163914815|NCT00760877|592057743|FG001|Overall Study|Participant not eligible to cross-over|1|||
163914816|NCT00760877|592057742|FG000|Overall Study|Physician Decision|1|||
163914817|NCT00760877|592057743|FG001|Overall Study|Physician Decision|2|||
163914818|NCT00760877|592057742|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
163914819|NCT00760877|592057743|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
163914820|NCT00760877|592057742|FG000|Overall Study|Treatment failure|1|||
163914821|NCT00760877|592057743|FG001|Overall Study|Treatment failure|0|||
163914822|NCT04413149|592057746|FG000|Overall Study|Death|10|||
163914823|NCT04413149|592057747|FG001|Overall Study|Death|5|||
163914824|NCT04413149|592057746|FG000|Overall Study|Lung transplantation|1|||
163914825|NCT04413149|592057747|FG001|Overall Study|Lung transplantation|0|||
163914826|NCT00676195|592057748|FG000|Overall Study|Lost to Follow-up|1|||
163914827|NCT00676195|592057748|FG000|Overall Study|Adverse Event|1|||
163914828|NCT00676195|592057748|FG000|Overall Study|Physician Decision|1|||
163914829|NCT05878990|592057754|FG000|Overall Study|Lost to Follow-up|7|||
163914830|NCT05878990|592057754|FG000|Overall Study|Withdrawal by Subject|1|||
163914831|NCT03605745|592057755|FG000|Overall Study|Study was terminated for business reasons|47|||
163914832|NCT01074229|592057756|FG000|Overall Study|Lost to Follow-up|1|||
163914833|NCT01074229|592057757|FG001|Overall Study|Lost to Follow-up|0|||
163914834|NCT01074229|592057758|FG002|Overall Study|Lost to Follow-up|0|||
163914835|NCT01074229|592057756|FG000|Overall Study|Change to open surgical procedure|1|||
163914836|NCT01074229|592057757|FG001|Overall Study|Change to open surgical procedure|3|||
163914837|NCT01074229|592057758|FG002|Overall Study|Change to open surgical procedure|4|||
163914838|NCT00584909|592057759|FG000|Overall Study|Adverse Event|4|||
163914839|NCT03436797|592057760|FG000|Main Study|Withdrawal by Subject|2|||
163914840|NCT03436797|592057760|FG000|Main Study|Adverse Event|4|||
163914841|NCT03436797|592057760|FG000|Main Study|Lost to Follow-up|1|||
163914842|NCT03436797|592057760|FG000|Main Study|Death|1|||
163914843|NCT03436797|592057760|FG000|Main Study|Non-Specific|2|||
163914844|NCT03436797|592057760|FG000|Extended Dosing|Patient decision|1|||
163914845|NCT01951105|592057763|FG000|Overall Study|Adverse Event|0|||
163914846|NCT01951105|592057764|FG001|Overall Study|Adverse Event|5|||
163914847|NCT01951105|592057765|FG002|Overall Study|Adverse Event|0|||
163914848|NCT01951105|592057763|FG000|Overall Study|Lost to Follow-up|0|||
163914849|NCT01951105|592057764|FG001|Overall Study|Lost to Follow-up|1|||
163914850|NCT01951105|592057765|FG002|Overall Study|Lost to Follow-up|0|||
163914851|NCT01951105|592057763|FG000|Overall Study|Protocol Violation|1|||
163914852|NCT01951105|592057764|FG001|Overall Study|Protocol Violation|1|||
163914853|NCT01951105|592057765|FG002|Overall Study|Protocol Violation|1|||
163914854|NCT01951105|592057763|FG000|Overall Study|Withdrawal by Subject|0|||
163914855|NCT01951105|592057764|FG001|Overall Study|Withdrawal by Subject|3|||
163914856|NCT01951105|592057765|FG002|Overall Study|Withdrawal by Subject|1|||
163914857|NCT02727998|592057766|FG000|Overall Study|Lost to Follow-up|3|||
163914858|NCT02727998|592057767|FG001|Overall Study|Lost to Follow-up|3|||
163914859|NCT02727998|592057766|FG000|Overall Study|Withdrawal by Subject|0|||
163914860|NCT02727998|592057767|FG001|Overall Study|Withdrawal by Subject|1|||
163914861|NCT05072795|592057770|FG000|Overall Study|Lost to Follow-up|5|||
163914862|NCT00422162|592057773|FG000|Overall Study|Adverse Event|11|||
163914863|NCT00422162|592057774|FG001|Overall Study|Adverse Event|9|||
163914864|NCT00422162|592057773|FG000|Overall Study|Lack of Efficacy|4|||
163914865|NCT00422162|592057774|FG001|Overall Study|Lack of Efficacy|10|||
163914866|NCT00422162|592057773|FG000|Overall Study|Withdrawal by Subject|7|||
163914867|NCT00422162|592057774|FG001|Overall Study|Withdrawal by Subject|6|||
163914868|NCT00422162|592057773|FG000|Overall Study|Lost to Follow-up|1|||
163914869|NCT00422162|592057774|FG001|Overall Study|Lost to Follow-up|2|||
163914870|NCT00422162|592057773|FG000|Overall Study|Non-Compliant with Protocol|1|||
163914871|NCT00422162|592057774|FG001|Overall Study|Non-Compliant with Protocol|1|||
163914872|NCT00422162|592057773|FG000|Overall Study|Other|0|||
163914873|NCT00422162|592057774|FG001|Overall Study|Other|1|||
163914874|NCT00422162|592057773|FG000|Overall Study|Didn't Receive Treatment|0|||
163914875|NCT00422162|592057774|FG001|Overall Study|Didn't Receive Treatment|1|||
163914876|NCT05274906|592057775|FG000|Overall Study|Withdrawal by Subject|2|||
163914877|NCT05274906|592057776|FG001|Overall Study|Withdrawal by Subject|1|||
163914878|NCT01622088|592057780|FG000|Overall Study|Adverse Event|20|||
163914879|NCT01622088|592057780|FG000|Overall Study|Lost to Follow-up|1|||
163914880|NCT01622088|592057780|FG000|Overall Study|Withdrawal by Subject|20|||
163914881|NCT01622088|592057780|FG000|Overall Study|Investigator Decision|1|||
163914882|NCT01622088|592057780|FG000|Overall Study|Death|53|||
163914883|NCT01622088|592057780|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
163914884|NCT00237809|592057781|FG000|Overall Study|Lost to Follow-up|11|||
163914885|NCT00237809|592057782|FG001|Overall Study|Lost to Follow-up|10|||
163914886|NCT00237809|592057783|FG002|Overall Study|Lost to Follow-up|9|||
163914887|NCT00237809|592057784|FG003|Overall Study|Lost to Follow-up|9|||
163914888|NCT02006641|592057785|FG000|Overall Study|Withdrawal before treatment|2|||
163914889|NCT02006641|592057786|FG001|Overall Study|Withdrawal before treatment|5|||
163914890|NCT02006641|592057787|FG002|Overall Study|Withdrawal before treatment|3|||
163914891|NCT02006641|592057785|FG000|Overall Study|Adverse Event|15|||
163914892|NCT02006641|592057786|FG001|Overall Study|Adverse Event|11|||
163914893|NCT02006641|592057787|FG002|Overall Study|Adverse Event|15|||
163914894|NCT02006641|592057785|FG000|Overall Study|Protocol Violation|0|||
163914895|NCT02006641|592057786|FG001|Overall Study|Protocol Violation|2|||
163914896|NCT02006641|592057787|FG002|Overall Study|Protocol Violation|2|||
163914897|NCT02006641|592057785|FG000|Overall Study|Lost to Follow-up|0|||
163914898|NCT02006641|592057786|FG001|Overall Study|Lost to Follow-up|1|||
163914899|NCT02006641|592057787|FG002|Overall Study|Lost to Follow-up|0|||
163914900|NCT02006641|592057785|FG000|Overall Study|Withdrawal by Subject|7|||
163914901|NCT02006641|592057786|FG001|Overall Study|Withdrawal by Subject|12|||
163914902|NCT02006641|592057787|FG002|Overall Study|Withdrawal by Subject|11|||
163914903|NCT02006641|592057785|FG000|Overall Study|Other reason: patient didn't show up|1|||
163914904|NCT02006641|592057786|FG001|Overall Study|Other reason: patient didn't show up|0|||
163914905|NCT02006641|592057787|FG002|Overall Study|Other reason: patient didn't show up|0|||
163914906|NCT02006641|592057785|FG000|Overall Study|Other reason:patient didn't want to come|0|||
163914907|NCT02006641|592057786|FG001|Overall Study|Other reason:patient didn't want to come|0|||
163914908|NCT02006641|592057787|FG002|Overall Study|Other reason:patient didn't want to come|1|||
163914909|NCT02006641|592057785|FG000|Overall Study|Other reason: patient has moved|1|||
163914910|NCT02006641|592057786|FG001|Overall Study|Other reason: patient has moved|0|||
163914911|NCT02006641|592057787|FG002|Overall Study|Other reason: patient has moved|1|||
163914912|NCT02006641|592057785|FG000|Overall Study|Other reason: caregiver in hospital|0|||
163914913|NCT02006641|592057786|FG001|Overall Study|Other reason: caregiver in hospital|1|||
163914914|NCT02006641|592057787|FG002|Overall Study|Other reason: caregiver in hospital|0|||
163914915|NCT02006641|592057785|FG000|Overall Study|Other reason: patient's wife has died|0|||
163914916|NCT02006641|592057786|FG001|Overall Study|Other reason: patient's wife has died|0|||
163914917|NCT02006641|592057787|FG002|Overall Study|Other reason: patient's wife has died|1|||
163914918|NCT02006641|592057785|FG000|Overall Study|Other reason: hospitalisation|0|||
163914919|NCT02006641|592057786|FG001|Overall Study|Other reason: hospitalisation|1|||
163914920|NCT02006641|592057787|FG002|Overall Study|Other reason: hospitalisation|0|||
163914921|NCT02006641|592057785|FG000|Overall Study|Other reason: caregiver impossibility|0|||
163914922|NCT02006641|592057786|FG001|Overall Study|Other reason: caregiver impossibility|0|||
163914923|NCT02006641|592057787|FG002|Overall Study|Other reason: caregiver impossibility|1|||
163914924|NCT02006641|592057785|FG000|Overall Study|Other reason: protocol non-compliance|0|||
163914925|NCT02006641|592057786|FG001|Overall Study|Other reason: protocol non-compliance|0|||
163914926|NCT02006641|592057787|FG002|Overall Study|Other reason: protocol non-compliance|1|||
163914927|NCT02132195|592057793|FG000|Initial Assignment|Relapsed|14|||
163914928|NCT02132195|592057794|FG001|Initial Assignment|Relapsed|0|||
163914929|NCT02132195|592057795|FG002|Initial Assignment|Relapsed|0|||
163914930|NCT02132195|592057793|FG000|Rescue Therapy|Relapsed|0|||
163914931|NCT02132195|592057794|FG001|Rescue Therapy|Relapsed|0|||
163914932|NCT02132195|592057795|FG002|Rescue Therapy|Relapsed|7|||
163914933|NCT02132195|592057793|FG000|Rescue Therapy|Physician Decision|0|||
163914934|NCT02132195|592057794|FG001|Rescue Therapy|Physician Decision|0|||
163914935|NCT02132195|592057795|FG002|Rescue Therapy|Physician Decision|1|||
163914936|NCT02132195|592057793|FG000|Rescue Therapy|Withdrawal by Subject|0|||
163914937|NCT02132195|592057794|FG001|Rescue Therapy|Withdrawal by Subject|0|||
163914938|NCT02132195|592057795|FG002|Rescue Therapy|Withdrawal by Subject|1|||
163914939|NCT02132195|592057793|FG000|Rescue Therapy|Adverse Event|0|||
163914940|NCT02132195|592057794|FG001|Rescue Therapy|Adverse Event|0|||
163914941|NCT02132195|592057795|FG002|Rescue Therapy|Adverse Event|2|||
163914942|NCT00321555|592057796|FG000|Overall Study|Developed antibodies|1|||
163914943|NCT00321555|592057796|FG000|Overall Study|Switched to alternative treatment|3|||
163914944|NCT00321555|592057796|FG000|Overall Study|Physician Decision|1|||
163914945|NCT00321555|592057796|FG000|Overall Study|Disease progression on study|1|||
163914946|NCT00912964|592057799|FG000|Overall Study|Eligibility criterion not met|1|||
163914947|NCT00912964|592057800|FG001|Overall Study|Eligibility criterion not met|1|||
163914948|NCT00912964|592057801|FG002|Overall Study|Eligibility criterion not met|0|||
163914949|NCT00912964|592057799|FG000|Overall Study|Adverse Event|15|||
163914950|NCT00912964|592057800|FG001|Overall Study|Adverse Event|18|||
163914951|NCT00912964|592057801|FG002|Overall Study|Adverse Event|12|||
163914952|NCT00912964|592057799|FG000|Overall Study|Lack of Efficacy|11|||
163914953|NCT00912964|592057800|FG001|Overall Study|Lack of Efficacy|4|||
163914954|NCT00912964|592057801|FG002|Overall Study|Lack of Efficacy|3|||
163914955|NCT00912964|592057799|FG000|Overall Study|Withdrawal by Subject|20|||
163914956|NCT00912964|592057800|FG001|Overall Study|Withdrawal by Subject|12|||
163914957|NCT00912964|592057801|FG002|Overall Study|Withdrawal by Subject|18|||
163914958|NCT00912964|592057799|FG000|Overall Study|Lost to Follow-up|4|||
164096604|NCT02087904|592717324|FG002|Overall Study|Withdrawal by Subject|7|||
163914959|NCT00912964|592057800|FG001|Overall Study|Lost to Follow-up|3|||
163914960|NCT00912964|592057801|FG002|Overall Study|Lost to Follow-up|3|||
163914961|NCT00912964|592057799|FG000|Overall Study|Protocol Violation|5|||
164096605|NCT02087904|592717325|FG003|Overall Study|Withdrawal by Subject|4|||
163914962|NCT00912964|592057800|FG001|Overall Study|Protocol Violation|3|||
163914963|NCT00912964|592057801|FG002|Overall Study|Protocol Violation|8|||
163914964|NCT00912964|592057799|FG000|Overall Study|Taking exclusionary medications|7|||
163914965|NCT00912964|592057800|FG001|Overall Study|Taking exclusionary medications|4|||
163914966|NCT00912964|592057801|FG002|Overall Study|Taking exclusionary medications|8|||
163914967|NCT00912964|592057799|FG000|Overall Study|Medical History|1|||
163914968|NCT00912964|592057800|FG001|Overall Study|Medical History|0|||
163914969|NCT00912964|592057801|FG002|Overall Study|Medical History|0|||
164028017|NCT02953782|592461178|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
164028018|NCT02953782|592461179|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
164028019|NCT02953782|592461180|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
164028020|NCT02953782|592461181|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
164028021|NCT02953782|592461182|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
164028022|NCT02953782|592461183|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
164028023|NCT02953782|592461184|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
164028024|NCT02953782|592461177|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
164028025|NCT02953782|592461178|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164028026|NCT02953782|592461179|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
164028027|NCT02953782|592461180|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
163914970|NCT00912964|592057799|FG000|Overall Study|Non-compliance with study procedures|2|||
163914971|NCT00912964|592057800|FG001|Overall Study|Non-compliance with study procedures|0|||
163914972|NCT00912964|592057801|FG002|Overall Study|Non-compliance with study procedures|0|||
163914973|NCT00912964|592057799|FG000|Overall Study|Violation of exclusion criterion|0|||
163914974|NCT00912964|592057800|FG001|Overall Study|Violation of exclusion criterion|0|||
163914975|NCT00912964|592057801|FG002|Overall Study|Violation of exclusion criterion|2|||
163914976|NCT00912964|592057799|FG000|Overall Study|Randomized but never received study drug|0|||
163914977|NCT00912964|592057800|FG001|Overall Study|Randomized but never received study drug|1|||
163914978|NCT00912964|592057801|FG002|Overall Study|Randomized but never received study drug|0|||
163914979|NCT02561195|592057803|FG000|Vaccination 1 to 3|Adverse Event|4|||
163914980|NCT02561195|592057804|FG001|Vaccination 1 to 3|Adverse Event|5|||
163914981|NCT02561195|592057805|FG002|Vaccination 1 to 3|Adverse Event|0|||
163914982|NCT02561195|592057806|FG003|Vaccination 1 to 3|Adverse Event|3|||
163914983|NCT02561195|592057807|FG004|Vaccination 1 to 3|Adverse Event|4|||
163914984|NCT02561195|592057808|FG005|Vaccination 1 to 3|Adverse Event|0|||
163914985|NCT02561195|592057809|FG006|Vaccination 1 to 3|Adverse Event|0|||
163914986|NCT02561195|592057810|FG007|Vaccination 1 to 3|Adverse Event|0|||
163914987|NCT02561195|592057811|FG008|Vaccination 1 to 3|Adverse Event|0|||
163914988|NCT02561195|592057812|FG009|Vaccination 1 to 3|Adverse Event|0|||
163914989|NCT02561195|592057813|FG010|Vaccination 1 to 3|Adverse Event|0|||
163914990|NCT02561195|592057814|FG011|Vaccination 1 to 3|Adverse Event|0|||
163914991|NCT02561195|592057815|FG012|Vaccination 1 to 3|Adverse Event|0|||
163914992|NCT02561195|592057816|FG013|Vaccination 1 to 3|Adverse Event|0|||
163914993|NCT02561195|592057803|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
163914994|NCT02561195|592057804|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
163914995|NCT02561195|592057805|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
163914996|NCT02561195|592057806|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
163914997|NCT02561195|592057807|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
163914998|NCT02561195|592057808|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
163914999|NCT02561195|592057809|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
163915000|NCT02561195|592057810|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
163915001|NCT02561195|592057811|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
163915002|NCT02561195|592057812|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
163915003|NCT02561195|592057813|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
163915004|NCT02561195|592057814|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
163915005|NCT02561195|592057815|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
163915006|NCT02561195|592057816|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
163915007|NCT02561195|592057803|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915008|NCT02561195|592057804|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
163915009|NCT02561195|592057805|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915010|NCT02561195|592057806|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
163915011|NCT02561195|592057807|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
163915012|NCT02561195|592057808|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
163915013|NCT02561195|592057809|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915014|NCT02561195|592057810|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915015|NCT02561195|592057811|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915016|NCT02561195|592057812|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915017|NCT02561195|592057813|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
164028028|NCT02953782|592461181|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
164028029|NCT02953782|592461182|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164028030|NCT02953782|592461183|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164028031|NCT02953782|592461184|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
164028032|NCT02953782|592461177|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164028033|NCT02953782|592461178|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
164028034|NCT02953782|592461179|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164028035|NCT02953782|592461180|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
164028036|NCT02953782|592461181|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
164028037|NCT02953782|592461182|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164028038|NCT02953782|592461183|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164028039|NCT02953782|592461184|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
164096606|NCT02087904|592717322|FG000|Overall Study|Lost to Follow-up|0|||
163915018|NCT02561195|592057814|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915019|NCT02561195|592057815|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915020|NCT02561195|592057816|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
163915021|NCT02561195|592057803|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
163915022|NCT02561195|592057804|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
163915023|NCT02561195|592057805|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
163915024|NCT02561195|592057806|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
163915025|NCT02561195|592057807|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
163915026|NCT02561195|592057808|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
164028040|NCT02953782|592461177|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164028041|NCT02953782|592461178|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164028042|NCT02953782|592461179|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
164028043|NCT02953782|592461180|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
164028044|NCT02953782|592461181|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164028045|NCT02953782|592461182|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164028046|NCT02953782|592461183|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164028047|NCT02953782|592461184|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
164028048|NCT02953782|592461177|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164028049|NCT02953782|592461178|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164028050|NCT02953782|592461179|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164028051|NCT02953782|592461180|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164028052|NCT02953782|592461181|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
164028053|NCT02953782|592461182|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
164028054|NCT02953782|592461183|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
164028055|NCT02953782|592461184|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
164028056|NCT02953782|592461177|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164028057|NCT02953782|592461178|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164028058|NCT02953782|592461179|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164028059|NCT02953782|592461180|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164028060|NCT02953782|592461181|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
164028061|NCT02953782|592461182|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
164028062|NCT02953782|592461183|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
164028063|NCT02953782|592461184|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
164028064|NCT02953782|592461177|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164028065|NCT02953782|592461178|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164028066|NCT02953782|592461179|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164028067|NCT02953782|592461180|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164028068|NCT02953782|592461181|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
164028069|NCT02953782|592461182|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
164028070|NCT02953782|592461183|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
164028071|NCT02953782|592461184|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
164028072|NCT02953782|592461177|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028073|NCT02953782|592461178|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028074|NCT02953782|592461179|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028075|NCT02953782|592461180|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028076|NCT02953782|592461181|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028077|NCT02953782|592461182|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028078|NCT02953782|592461183|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
164028079|NCT02953782|592461184|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
164028080|NCT01934192|592461187|FG000|Overall Study|Protocol Violation|0|||
164028081|NCT01934192|592461188|FG001|Overall Study|Protocol Violation|0|||
164028082|NCT01934192|592461189|FG002|Overall Study|Protocol Violation|0|||
164028083|NCT01934192|592461190|FG003|Overall Study|Protocol Violation|1|||
164028084|NCT01934192|592461187|FG000|Overall Study|Other: reached stopping criteria|6|||
164028085|NCT01934192|592461188|FG001|Overall Study|Other: reached stopping criteria|5|||
164028086|NCT01934192|592461189|FG002|Overall Study|Other: reached stopping criteria|1|||
164028087|NCT01934192|592461190|FG003|Overall Study|Other: reached stopping criteria|0|||
164028088|NCT01934192|592461187|FG000|Overall Study|Physician Decision|3|||
164028089|NCT01934192|592461188|FG001|Overall Study|Physician Decision|2|||
164028090|NCT01934192|592461189|FG002|Overall Study|Physician Decision|0|||
164028091|NCT01934192|592461190|FG003|Overall Study|Physician Decision|0|||
164028092|NCT01737840|592461191|FG000|Overall Study|Diagnosed with an other pathology|2|||
164028093|NCT01737840|592461192|FG001|Overall Study|Diagnosed with an other pathology|2|||
164028094|NCT01189435|592461193|FG000|Overall Study|Withdrawal by Subject|1|||
164028095|NCT01189435|592461193|FG000|Overall Study|Physician Decision|1|||
164028096|NCT02357849|592461196|FG000|Overall Study|Withdrawal by Subject|2|||
164028097|NCT02357849|592461197|FG001|Overall Study|Withdrawal by Subject|3|||
164028098|NCT03105700|592461200|FG000|Overall Study|screen fail|3|||
164028099|NCT03105700|592461200|FG000|Overall Study|Lost to Follow-up|4|||
164096607|NCT02087904|592717323|FG001|Overall Study|Lost to Follow-up|4|||
164096608|NCT02087904|592717324|FG002|Overall Study|Lost to Follow-up|2|||
164096609|NCT02087904|592717325|FG003|Overall Study|Lost to Follow-up|2|||
164096610|NCT00874237|592717331|FG000|Overall Study|Physician Decision|0|||
164096611|NCT00874237|592717332|FG001|Overall Study|Physician Decision|1|||
163915027|NCT02561195|592057809|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
163915028|NCT02561195|592057810|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
163915029|NCT02561195|592057811|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
163915030|NCT02561195|592057812|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
163915031|NCT02561195|592057813|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
163915032|NCT02561195|592057814|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
163915033|NCT02561195|592057815|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
163915034|NCT02561195|592057816|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
163915035|NCT02561195|592057803|FG000|Vaccination 1 to 3|Other|7|||
163915036|NCT02561195|592057804|FG001|Vaccination 1 to 3|Other|3|||
163915037|NCT02561195|592057805|FG002|Vaccination 1 to 3|Other|1|||
163915038|NCT02561195|592057806|FG003|Vaccination 1 to 3|Other|7|||
163915039|NCT02561195|592057807|FG004|Vaccination 1 to 3|Other|5|||
163915040|NCT02561195|592057808|FG005|Vaccination 1 to 3|Other|1|||
163915041|NCT02561195|592057809|FG006|Vaccination 1 to 3|Other|0|||
163915042|NCT02561195|592057810|FG007|Vaccination 1 to 3|Other|0|||
163915043|NCT02561195|592057811|FG008|Vaccination 1 to 3|Other|0|||
163915044|NCT02561195|592057812|FG009|Vaccination 1 to 3|Other|0|||
163915045|NCT02561195|592057813|FG010|Vaccination 1 to 3|Other|0|||
163915046|NCT02561195|592057814|FG011|Vaccination 1 to 3|Other|0|||
163915047|NCT02561195|592057815|FG012|Vaccination 1 to 3|Other|0|||
163915048|NCT02561195|592057816|FG013|Vaccination 1 to 3|Other|0|||
163915049|NCT02561195|592057803|FG000|Vaccination 1 to 3|Protocol Violation|1|||
163915050|NCT02561195|592057804|FG001|Vaccination 1 to 3|Protocol Violation|0|||
163915051|NCT02561195|592057805|FG002|Vaccination 1 to 3|Protocol Violation|1|||
163915052|NCT02561195|592057806|FG003|Vaccination 1 to 3|Protocol Violation|2|||
163915053|NCT02561195|592057807|FG004|Vaccination 1 to 3|Protocol Violation|5|||
163915054|NCT02561195|592057808|FG005|Vaccination 1 to 3|Protocol Violation|2|||
163915055|NCT02561195|592057809|FG006|Vaccination 1 to 3|Protocol Violation|0|||
163915056|NCT02561195|592057810|FG007|Vaccination 1 to 3|Protocol Violation|0|||
163915057|NCT02561195|592057811|FG008|Vaccination 1 to 3|Protocol Violation|0|||
163915058|NCT02561195|592057812|FG009|Vaccination 1 to 3|Protocol Violation|0|||
163915059|NCT02561195|592057813|FG010|Vaccination 1 to 3|Protocol Violation|0|||
163915060|NCT02561195|592057814|FG011|Vaccination 1 to 3|Protocol Violation|0|||
163915061|NCT02561195|592057815|FG012|Vaccination 1 to 3|Protocol Violation|0|||
163915062|NCT02561195|592057816|FG013|Vaccination 1 to 3|Protocol Violation|0|||
163915063|NCT02561195|592057803|FG000|Vaccination 1 to 3|Death|2|||
163915064|NCT02561195|592057804|FG001|Vaccination 1 to 3|Death|1|||
163915065|NCT02561195|592057805|FG002|Vaccination 1 to 3|Death|0|||
163915066|NCT02561195|592057806|FG003|Vaccination 1 to 3|Death|2|||
163915067|NCT02561195|592057807|FG004|Vaccination 1 to 3|Death|0|||
163915068|NCT02561195|592057808|FG005|Vaccination 1 to 3|Death|0|||
163915069|NCT02561195|592057809|FG006|Vaccination 1 to 3|Death|0|||
163915070|NCT02561195|592057810|FG007|Vaccination 1 to 3|Death|0|||
163915071|NCT02561195|592057811|FG008|Vaccination 1 to 3|Death|0|||
163915072|NCT02561195|592057812|FG009|Vaccination 1 to 3|Death|0|||
163915073|NCT02561195|592057813|FG010|Vaccination 1 to 3|Death|0|||
163915074|NCT02561195|592057814|FG011|Vaccination 1 to 3|Death|0|||
163915075|NCT02561195|592057815|FG012|Vaccination 1 to 3|Death|0|||
163915076|NCT02561195|592057816|FG013|Vaccination 1 to 3|Death|0|||
163915077|NCT02561195|592057803|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
163915078|NCT02561195|592057804|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
163915079|NCT02561195|592057805|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
163915080|NCT02561195|592057806|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
163915081|NCT02561195|592057807|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
163915082|NCT02561195|592057808|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915083|NCT02561195|592057809|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915084|NCT02561195|592057810|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915085|NCT02561195|592057811|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915086|NCT02561195|592057812|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915087|NCT02561195|592057813|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915088|NCT02561195|592057814|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915089|NCT02561195|592057815|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
163915090|NCT02561195|592057816|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
164028100|NCT01253421|592461201|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
164028101|NCT01253421|592461202|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
164028102|NCT01253421|592461203|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
164028103|NCT01253421|592461204|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
164028104|NCT01253421|592461205|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
164028105|NCT01253421|592461201|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
164028106|NCT01253421|592461202|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
164028107|NCT01253421|592461203|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
164028108|NCT01253421|592461204|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
164028109|NCT01253421|592461205|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
164028110|NCT01253421|592461201|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
164028111|NCT01253421|592461202|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
164028112|NCT01253421|592461203|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
164028113|NCT01253421|592461204|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
164028114|NCT01253421|592461205|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
164028115|NCT01253421|592461201|FG000|Assessment and Scheduling|Physician Decision|1|||
164028116|NCT01253421|592461202|FG001|Assessment and Scheduling|Physician Decision|0|||
164028117|NCT01253421|592461203|FG002|Assessment and Scheduling|Physician Decision|0|||
164028118|NCT01253421|592461204|FG003|Assessment and Scheduling|Physician Decision|0|||
164028119|NCT01253421|592461205|FG004|Assessment and Scheduling|Physician Decision|0|||
164028120|NCT01253421|592461201|FG000|Drug+Scanning Visit|Physician Decision|0|||
164028121|NCT01253421|592461202|FG001|Drug+Scanning Visit|Physician Decision|0|||
164028122|NCT01253421|592461203|FG002|Drug+Scanning Visit|Physician Decision|0|||
164028123|NCT01253421|592461204|FG003|Drug+Scanning Visit|Physician Decision|0|||
164028124|NCT01253421|592461205|FG004|Drug+Scanning Visit|Physician Decision|1|||
164028125|NCT04105244|592461207|FG000|Overall Study|Withdrawal by Subject|10|||
164028126|NCT04105244|592461208|FG001|Overall Study|Withdrawal by Subject|12|||
164028127|NCT04105244|592461207|FG000|Overall Study|Lost to Follow-up|20|||
164028128|NCT04105244|592461208|FG001|Overall Study|Lost to Follow-up|15|||
164028129|NCT04105244|592461207|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
164028130|NCT04105244|592461208|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
164028131|NCT04105244|592461207|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
164028132|NCT04105244|592461208|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
164028133|NCT04863014|592461209|FG000|Overall Study|Lost to Follow-up|3|||
164028134|NCT04863014|592461210|FG001|Overall Study|Lost to Follow-up|2|||
164028135|NCT04863014|592461209|FG000|Overall Study|Subject Decision|0|||
164028136|NCT04863014|592461210|FG001|Overall Study|Subject Decision|4|||
164028137|NCT01608724|592461211|FG000|Overall Study|Withdrawal by Subject|131|||
164028138|NCT01608724|592461211|FG000|Overall Study|Lost to Follow-up|41|||
164028139|NCT01608724|592461211|FG000|Overall Study|Study-specific discontinuation criteria|32|||
164028140|NCT01608724|592461211|FG000|Overall Study|Adverse Event|29|||
164028141|NCT01608724|592461211|FG000|Overall Study|Protocol Violation|6|||
164028142|NCT01608724|592461211|FG000|Overall Study|bood sugar too high, etc.|3|||
164028143|NCT01608724|592461211|FG000|Overall Study|Safety reasons|1|||
164028144|NCT00099359|592461212|FG000|Overall Study|Death|11|||
164028145|NCT00099359|592461213|FG001|Overall Study|Death|15|||
164028146|NCT00099359|592461214|FG002|Overall Study|Death|17|||
164028147|NCT00099359|592461212|FG000|Overall Study|Withdrawal by Subject|19|||
164028148|NCT00099359|592461213|FG001|Overall Study|Withdrawal by Subject|19|||
164028149|NCT00099359|592461214|FG002|Overall Study|Withdrawal by Subject|23|||
164028150|NCT00099359|592461212|FG000|Overall Study|Lost to Follow-up|15|||
164028151|NCT00099359|592461213|FG001|Overall Study|Lost to Follow-up|24|||
164028152|NCT00099359|592461214|FG002|Overall Study|Lost to Follow-up|24|||
164028153|NCT00099359|592461212|FG000|Overall Study|moved out of area|9|||
164028154|NCT00099359|592461213|FG001|Overall Study|moved out of area|7|||
164028155|NCT00099359|592461214|FG002|Overall Study|moved out of area|4|||
164028156|NCT00717366|592461215|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
164028157|NCT00717366|592461216|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
164028158|NCT00717366|592461215|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
164028159|NCT00717366|592461216|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
164028160|NCT00717366|592461215|FG000|Core Study Period (20 Weeks)|Death|0|||
164028161|NCT00717366|592461216|FG001|Core Study Period (20 Weeks)|Death|1|||
164028162|NCT00717366|592461215|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
164028163|NCT00717366|592461216|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
164028164|NCT00717366|592461215|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
164028165|NCT00717366|592461216|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
164028166|NCT00717366|592461215|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
164028167|NCT00717366|592461216|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
164028168|NCT00717366|592461215|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
164028169|NCT00717366|592461216|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
164028170|NCT02104804|592461219|FG000|Overall Study|Did not take study medication|0|||
164096612|NCT00874237|592717333|FG002|Overall Study|Physician Decision|0|||
164096613|NCT00874237|592717334|FG003|Overall Study|Physician Decision|0|||
163915091|NCT02561195|592057803|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
163915092|NCT02561195|592057804|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
163915093|NCT02561195|592057805|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
163915094|NCT02561195|592057806|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
163915095|NCT02561195|592057807|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
163915096|NCT02561195|592057808|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
163915097|NCT02561195|592057809|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
163915098|NCT02561195|592057810|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
163915099|NCT02561195|592057811|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
163915100|NCT02561195|592057812|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
163915101|NCT02561195|592057813|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
163915102|NCT02561195|592057814|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
163915103|NCT02561195|592057815|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
163915104|NCT02561195|592057816|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
163915105|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915106|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915107|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915108|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915109|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915110|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915111|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915112|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915113|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
163915114|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
163915115|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
163915116|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
163915117|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
163915118|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
163915119|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915120|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915121|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915122|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915123|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915124|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915125|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915126|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915127|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915128|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915129|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915130|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915131|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
163915132|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
163915133|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|Death|0|||
163915134|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|Death|0|||
163915135|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|Death|0|||
163915136|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|Death|0|||
163915137|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|Death|0|||
163915138|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|Death|0|||
163915139|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|Death|0|||
163915140|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|Death|0|||
163915141|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|Death|0|||
163915142|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|Death|1|||
163915143|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|Death|0|||
163915144|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|Death|0|||
163915145|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|Death|0|||
163915146|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|Death|0|||
163915147|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915148|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915149|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915150|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915151|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915152|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915153|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163915154|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163915155|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915156|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
163915157|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
163915158|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163915159|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
163915160|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
163915161|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915162|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915163|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915164|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915165|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915166|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915167|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915168|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915169|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915170|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915171|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
163915172|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
163915173|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
163915174|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
163915175|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|Other|0|||
163915176|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|Other|0|||
163915177|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|Other|0|||
163915178|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|Other|0|||
163915179|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|Other|0|||
163915180|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|Other|0|||
163915181|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|Other|0|||
163915182|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|Other|0|||
163915183|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|Other|0|||
163915184|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|Other|0|||
163915185|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|Other|2|||
163915186|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|Other|2|||
163915187|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|Other|1|||
163915188|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|Other|0|||
163915189|NCT02561195|592057803|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915190|NCT02561195|592057804|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915191|NCT02561195|592057805|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915192|NCT02561195|592057806|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915193|NCT02561195|592057807|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915194|NCT02561195|592057808|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915195|NCT02561195|592057809|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
163915196|NCT02561195|592057810|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915197|NCT02561195|592057811|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915198|NCT02561195|592057812|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915199|NCT02561195|592057813|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
163915200|NCT02561195|592057814|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
163915201|NCT02561195|592057815|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
163915202|NCT02561195|592057816|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
163915203|NCT03905512|592057817|FG000|Overall Study|Withdrawal by Subject|9|||
163915204|NCT03905512|592057818|FG001|Overall Study|Withdrawal by Subject|8|||
163915205|NCT03905512|592057817|FG000|Overall Study|Adverse Event|1|||
163915206|NCT03905512|592057818|FG001|Overall Study|Adverse Event|2|||
163915207|NCT03905512|592057817|FG000|Overall Study|Lost to Follow-up|4|||
163915208|NCT03905512|592057818|FG001|Overall Study|Lost to Follow-up|3|||
163915209|NCT03905512|592057817|FG000|Overall Study|Other than Specified|7|||
163915210|NCT03905512|592057818|FG001|Overall Study|Other than Specified|4|||
163915211|NCT00070317|592057825|FG000|Overall Study|Inevaluable (Never Treated)|1|||
163915212|NCT00070317|592057825|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
163915213|NCT00070317|592057825|FG000|Overall Study|Ineligible required test not done|1|||
163915214|NCT00070317|592057825|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
163915215|NCT00070317|592057825|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
163915216|NCT03987074|592057827|FG000|Overall Study|Withdrew Consent|1|||
163915217|NCT03987074|592057828|FG001|Overall Study|Withdrew Consent|1|||
163915218|NCT03987074|592057829|FG002|Overall Study|Withdrew Consent|0|||
163915219|NCT03987074|592057830|FG003|Overall Study|Withdrew Consent|2|||
163915220|NCT03987074|592057831|FG004|Overall Study|Withdrew Consent|1|||
163915221|NCT03987074|592057827|FG000|Overall Study|Adverse Event|2|||
163915222|NCT03987074|592057828|FG001|Overall Study|Adverse Event|1|||
163915223|NCT03987074|592057829|FG002|Overall Study|Adverse Event|0|||
163915224|NCT03987074|592057830|FG003|Overall Study|Adverse Event|0|||
163915225|NCT03987074|592057831|FG004|Overall Study|Adverse Event|1|||
163915226|NCT03987074|592057827|FG000|Overall Study|Lost to Follow-up|0|||
163915227|NCT03987074|592057828|FG001|Overall Study|Lost to Follow-up|0|||
163915228|NCT03987074|592057829|FG002|Overall Study|Lost to Follow-up|1|||
163915229|NCT03987074|592057830|FG003|Overall Study|Lost to Follow-up|1|||
163915230|NCT03987074|592057831|FG004|Overall Study|Lost to Follow-up|0|||
163915231|NCT03987074|592057827|FG000|Overall Study|Investigator's Discretion|0|||
163915232|NCT03987074|592057828|FG001|Overall Study|Investigator's Discretion|0|||
163915233|NCT03987074|592057829|FG002|Overall Study|Investigator's Discretion|0|||
163915234|NCT03987074|592057830|FG003|Overall Study|Investigator's Discretion|1|||
163915235|NCT03987074|592057831|FG004|Overall Study|Investigator's Discretion|0|||
163915236|NCT00508144|592057832|FG000|Overall Study|Not eligible|6|||
163915237|NCT00508144|592057832|FG000|Overall Study|Death|5|||
163915238|NCT01661972|592057833|FG000|Overall Study|Adverse Event|1|||
163915239|NCT01661972|592057834|FG001|Overall Study|Adverse Event|2|||
163915240|NCT01661972|592057833|FG000|Overall Study|Death during Treatment period|1|||
163915241|NCT01661972|592057834|FG001|Overall Study|Death during Treatment period|1|||
163915242|NCT01661972|592057833|FG000|Overall Study|Withdrawal by Subject|0|||
163915243|NCT01661972|592057834|FG001|Overall Study|Withdrawal by Subject|1|||
163915244|NCT01084772|592057835|FG000|Baseline|Withdrawal by Subject|7|||
163915245|NCT01084772|592057836|FG001|Baseline|Withdrawal by Subject|6|||
163915246|NCT01084772|592057835|FG000|3 Months|Death|1|||
163915247|NCT01084772|592057836|FG001|3 Months|Death|0|||
163915248|NCT01084772|592057835|FG000|3 Months|Study Termination|2|||
163915249|NCT01084772|592057836|FG001|3 Months|Study Termination|2|||
163915250|NCT01084772|592057835|FG000|1 Year|Withdrawal by Subject|0|||
163915251|NCT01084772|592057836|FG001|1 Year|Withdrawal by Subject|1|||
163915252|NCT01084772|592057835|FG000|1 Year|Lost to Follow-up|3|||
163915253|NCT01084772|592057836|FG001|1 Year|Lost to Follow-up|0|||
163915254|NCT01084772|592057835|FG000|1 Year|Study Termination|0|||
163915255|NCT01084772|592057836|FG001|1 Year|Study Termination|7|||
163915256|NCT01084772|592057835|FG000|2 Years|Withdrawal by Subject|1|||
163915257|NCT01084772|592057836|FG001|2 Years|Withdrawal by Subject|0|||
164028171|NCT02104804|592461220|FG001|Overall Study|Did not take study medication|1|||
164028172|NCT02104804|592461219|FG000|Overall Study|Study specific discontinuation criteria|6|||
164028173|NCT02104804|592461220|FG001|Overall Study|Study specific discontinuation criteria|1|||
164028174|NCT02104804|592461219|FG000|Overall Study|Other listed|2|||
164028175|NCT02104804|592461220|FG001|Overall Study|Other listed|1|||
164028176|NCT02104804|592461219|FG000|Overall Study|Protocol Violation|0|||
164028177|NCT02104804|592461220|FG001|Overall Study|Protocol Violation|1|||
164028178|NCT02104804|592461219|FG000|Overall Study|Adverse Event|4|||
164028179|NCT02104804|592461220|FG001|Overall Study|Adverse Event|3|||
164028180|NCT02104804|592461219|FG000|Overall Study|Withdrawal by Subject|4|||
164028181|NCT02104804|592461220|FG001|Overall Study|Withdrawal by Subject|12|||
164028182|NCT00645567|592461221|FG000|Overall Study|Adverse Event|1|||
164028183|NCT01208038|592461224|FG000|Overall Study|Withdrawal by Subject|1|||
164028184|NCT05084053|592463283|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
163915258|NCT01084772|592057835|FG000|2 Years|Lost to Follow-up|5|||
164028185|NCT05084053|592463284|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
164028186|NCT05084053|592463285|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
164028187|NCT05084053|592463286|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
164028188|NCT05084053|592463283|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
164028189|NCT05084053|592463284|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
164028190|NCT05084053|592463285|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
164028191|NCT05084053|592463286|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
163915259|NCT01084772|592057836|FG001|2 Years|Lost to Follow-up|2|||
163915260|NCT01084772|592057835|FG000|2 Years|Study Termination|3|||
163915261|NCT01084772|592057836|FG001|2 Years|Study Termination|2|||
163915262|NCT01294644|592057837|FG000|Overall Study|Adverse Event|2|||
164028192|NCT05084053|592463283|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
164028193|NCT05084053|592463284|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
163915263|NCT01294644|592057838|FG001|Overall Study|Adverse Event|0|||
163915264|NCT01294644|592057839|FG002|Overall Study|Adverse Event|1|||
163915265|NCT01294644|592057837|FG000|Overall Study|Withdrawal by Subject|3|||
163915266|NCT01294644|592057838|FG001|Overall Study|Withdrawal by Subject|7|||
163915267|NCT01294644|592057839|FG002|Overall Study|Withdrawal by Subject|4|||
163915268|NCT01294644|592057837|FG000|Overall Study|Lost to Follow-up|3|||
164096614|NCT00874237|592717335|FG004|Overall Study|Physician Decision|0|||
164096615|NCT00874237|592717336|FG005|Overall Study|Physician Decision|0|||
164096616|NCT00874237|592717331|FG000|Overall Study|Withdrawal by Subject|0|||
164096617|NCT00874237|592717332|FG001|Overall Study|Withdrawal by Subject|0|||
164096618|NCT00874237|592717333|FG002|Overall Study|Withdrawal by Subject|1|||
164096619|NCT00874237|592717334|FG003|Overall Study|Withdrawal by Subject|0|||
164096620|NCT00874237|592717335|FG004|Overall Study|Withdrawal by Subject|0|||
164096621|NCT00874237|592717336|FG005|Overall Study|Withdrawal by Subject|0|||
164096622|NCT00877032|592717339|FG000|Overall Study|Did not meet entrance criteria|0|||
164096623|NCT00877032|592717340|FG001|Overall Study|Did not meet entrance criteria|0|||
164096624|NCT00877032|592717341|FG002|Overall Study|Did not meet entrance criteria|0|||
164096625|NCT00877032|592717342|FG003|Overall Study|Did not meet entrance criteria|1|||
164096626|NCT00877032|592717343|FG004|Overall Study|Did not meet entrance criteria|0|||
164096627|NCT00877032|592717344|FG005|Overall Study|Did not meet entrance criteria|0|||
164096628|NCT00877032|592717345|FG006|Overall Study|Did not meet entrance criteria|2|||
164096629|NCT02107092|592717347|FG000|Overall Study|Miscellaneous|3|||
164096630|NCT02107092|592717347|FG000|Overall Study|Subject compliance|3|||
164096631|NCT02107092|592717347|FG000|Overall Study|Hypo-or hyperkalemia|2|||
164096632|NCT02107092|592717347|FG000|Overall Study|Met ECG withdrawal criteria|3|||
164096633|NCT02107092|592717347|FG000|Overall Study|Physician Decision|3|||
164096634|NCT02107092|592717347|FG000|Overall Study|Lost to Follow-up|2|||
164096635|NCT02107092|592717347|FG000|Overall Study|Withdrawal by Subject|9|||
164096636|NCT02107092|592717347|FG000|Overall Study|Adverse Event|7|||
164096637|NCT02107092|592717347|FG000|Overall Study|Expected progression of CKD|12|||
164096638|NCT00537030|592717348|FG000|Overall Study|Physician Decision|2|||
164096639|NCT00537030|592717348|FG000|Overall Study|Withdrawal by Subject|2|||
164096640|NCT00537030|592717348|FG000|Overall Study|≥ Grade 2 allergy|7|||
164145301|NCT00025259|592894268|FG005|Overall Study|Protocol Violation|1|||
163915269|NCT01294644|592057838|FG001|Overall Study|Lost to Follow-up|2|||
163915270|NCT01294644|592057839|FG002|Overall Study|Lost to Follow-up|5|||
163915271|NCT01294644|592057837|FG000|Overall Study|Miscellaneous Reason|2|||
163915272|NCT01294644|592057838|FG001|Overall Study|Miscellaneous Reason|1|||
163915273|NCT01294644|592057839|FG002|Overall Study|Miscellaneous Reason|4|||
163915274|NCT01517282|592057840|FG000|Overall Study|Consent withdrawn|0|||
163915275|NCT01517282|592057841|FG001|Overall Study|Consent withdrawn|1|||
163915276|NCT01517282|592057842|FG002|Overall Study|Consent withdrawn|1|||
163915277|NCT01517282|592057843|FG003|Overall Study|Consent withdrawn|1|||
163915278|NCT01517282|592057840|FG000|Overall Study|Physician Decision|1|||
163915279|NCT01517282|592057841|FG001|Overall Study|Physician Decision|0|||
163915280|NCT01517282|592057842|FG002|Overall Study|Physician Decision|0|||
163915281|NCT01517282|592057843|FG003|Overall Study|Physician Decision|0|||
163915282|NCT02942771|592057846|FG000|Overall Study|Adverse Event|1|||
163915283|NCT02942771|592057847|FG001|Overall Study|Adverse Event|0|||
163915284|NCT02942771|592057848|FG002|Overall Study|Adverse Event|0|||
164028194|NCT05084053|592463285|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
164028195|NCT05084053|592463286|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
163915285|NCT02942771|592057849|FG003|Overall Study|Adverse Event|0|||
163915286|NCT02942771|592057850|FG004|Overall Study|Adverse Event|2|||
163915287|NCT02942771|592057846|FG000|Overall Study|Lost to Follow-up|1|||
163915288|NCT02942771|592057847|FG001|Overall Study|Lost to Follow-up|0|||
163915289|NCT02942771|592057848|FG002|Overall Study|Lost to Follow-up|0|||
163915290|NCT02942771|592057849|FG003|Overall Study|Lost to Follow-up|0|||
163915291|NCT02942771|592057850|FG004|Overall Study|Lost to Follow-up|0|||
163915292|NCT02942771|592057846|FG000|Overall Study|Withdrawal by Subject|1|||
164028196|NCT01179347|592463290|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
164028197|NCT01179347|592463291|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
164028198|NCT01179347|592463290|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
164028199|NCT01179347|592463291|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
163915293|NCT02942771|592057847|FG001|Overall Study|Withdrawal by Subject|0|||
163915294|NCT02942771|592057848|FG002|Overall Study|Withdrawal by Subject|0|||
163915295|NCT02942771|592057849|FG003|Overall Study|Withdrawal by Subject|0|||
163915296|NCT02942771|592057850|FG004|Overall Study|Withdrawal by Subject|2|||
163915297|NCT02158806|592057851|FG000|Overall Study|Death|2|||
163915298|NCT02158806|592057852|FG001|Overall Study|Death|0|||
164028200|NCT01179347|592463290|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
164028201|NCT01179347|592463291|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
164028202|NCT01179347|592463290|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
164028203|NCT01179347|592463291|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
164028204|NCT01179347|592463290|FG000|Double-blind Period (12 Weeks)|Other|2|||
164028205|NCT01179347|592463291|FG001|Double-blind Period (12 Weeks)|Other|4|||
164028206|NCT01179347|592463290|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
164028207|NCT01179347|592463291|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
164028208|NCT01179347|592463290|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
164028209|NCT01179347|592463291|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
163915299|NCT02158806|592057851|FG000|Overall Study|Withdrawal by Subject|2|||
163915300|NCT02158806|592057852|FG001|Overall Study|Withdrawal by Subject|0|||
163915301|NCT02158806|592057851|FG000|Overall Study|Lost to Follow-up|0|||
163915302|NCT02158806|592057852|FG001|Overall Study|Lost to Follow-up|3|||
163915303|NCT02158806|592057851|FG000|Overall Study|Moved out of area|0|||
163915304|NCT02158806|592057852|FG001|Overall Study|Moved out of area|1|||
163915305|NCT02158806|592057851|FG000|Overall Study|Transferred to palliative care|0|||
163915306|NCT02158806|592057852|FG001|Overall Study|Transferred to palliative care|1|||
164028210|NCT01179347|592463290|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
163915307|NCT01898299|592057856|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
163915308|NCT01898299|592057857|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
163915309|NCT02340806|592057858|FG000|Overall Study|Protocol Violation|2|||
163915310|NCT02340806|592057859|FG001|Overall Study|Protocol Violation|0|||
164028211|NCT01179347|592463291|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
164028212|NCT01179347|592463290|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
163915311|NCT02340806|592057858|FG000|Overall Study|epidural catheter replaced|2|||
163915312|NCT02340806|592057859|FG001|Overall Study|epidural catheter replaced|1|||
163915313|NCT02340806|592057858|FG000|Overall Study|history of chronic pain medication|1|||
163915314|NCT02340806|592057859|FG001|Overall Study|history of chronic pain medication|0|||
163915315|NCT02340806|592057858|FG000|Overall Study|re-dose < 90 min of CSE|1|||
163915316|NCT02340806|592057859|FG001|Overall Study|re-dose < 90 min of CSE|3|||
163915317|NCT04520256|592057860|FG000|Overall Study|Lost to Follow-up|6|||
163915318|NCT04520256|592057861|FG001|Overall Study|Lost to Follow-up|4|||
163915319|NCT04520256|592057862|FG002|Overall Study|Lost to Follow-up|2|||
163915320|NCT04520256|592057863|FG003|Overall Study|Lost to Follow-up|3|||
163915321|NCT04520256|592057864|FG004|Overall Study|Lost to Follow-up|6|||
163915322|NCT04520256|592057865|FG005|Overall Study|Lost to Follow-up|6|||
163915323|NCT04520256|592057866|FG006|Overall Study|Lost to Follow-up|4|||
163915324|NCT04520256|592057867|FG007|Overall Study|Lost to Follow-up|6|||
164096641|NCT00537030|592717348|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
164096642|NCT00537030|592717348|FG000|Overall Study|Ineligible|2|||
164096643|NCT00537030|592717348|FG000|Overall Study|Inevaluable|2|||
163915325|NCT04520256|592057868|FG008|Overall Study|Lost to Follow-up|1|||
163915326|NCT04520256|592057869|FG009|Overall Study|Lost to Follow-up|3|||
163915327|NCT04520256|592057870|FG010|Overall Study|Lost to Follow-up|3|||
164096644|NCT04213326|592717350|FG000|Overall Study|Consent withdrawn|51|||
164096645|NCT04213326|592717351|FG001|Overall Study|Consent withdrawn|241|||
164096646|NCT04213326|592717350|FG000|Overall Study|Lost to Follow-up|50|||
164096647|NCT04213326|592717351|FG001|Overall Study|Lost to Follow-up|902|||
164096648|NCT04213326|592717350|FG000|Overall Study|Protocol Violation|3|||
163915328|NCT04520256|592057871|FG011|Overall Study|Lost to Follow-up|2|||
163915329|NCT04520256|592057872|FG012|Overall Study|Lost to Follow-up|5|||
163915330|NCT04520256|592057873|FG013|Overall Study|Lost to Follow-up|3|||
163915331|NCT04520256|592057874|FG014|Overall Study|Lost to Follow-up|3|||
163915332|NCT04520256|592057875|FG015|Overall Study|Lost to Follow-up|6|||
163915333|NCT04520256|592057876|FG016|Overall Study|Lost to Follow-up|6|||
163915334|NCT04520256|592057877|FG017|Overall Study|Lost to Follow-up|4|||
163915335|NCT04520256|592057878|FG018|Overall Study|Lost to Follow-up|3|||
163915336|NCT04520256|592057879|FG019|Overall Study|Lost to Follow-up|3|||
163915337|NCT04520256|592057880|FG020|Overall Study|Lost to Follow-up|7|||
163915338|NCT04520256|592057881|FG021|Overall Study|Lost to Follow-up|3|||
163915339|NCT04520256|592057882|FG022|Overall Study|Lost to Follow-up|3|||
163915340|NCT04520256|592057883|FG023|Overall Study|Lost to Follow-up|8|||
163915341|NCT04520256|592057884|FG024|Overall Study|Lost to Follow-up|5|||
163915342|NCT04520256|592057885|FG025|Overall Study|Lost to Follow-up|4|||
163915343|NCT04520256|592057886|FG026|Overall Study|Lost to Follow-up|3|||
163915344|NCT04520256|592057887|FG027|Overall Study|Lost to Follow-up|4|||
163915345|NCT04520256|592057888|FG028|Overall Study|Lost to Follow-up|3|||
163915346|NCT04520256|592057889|FG029|Overall Study|Lost to Follow-up|4|||
163915347|NCT04520256|592057890|FG030|Overall Study|Lost to Follow-up|4|||
163915348|NCT04520256|592057891|FG031|Overall Study|Lost to Follow-up|4|||
163915349|NCT02878590|592059398|FG000|Overall Study|Withdrawal by Subject|2|||
163915350|NCT01730118|592059399|FG000|Dose Escalation|Death on study|5|||
163915351|NCT01730118|592059400|FG001|Dose Escalation|Death on study|7|||
163915352|NCT01730118|592059401|FG002|Dose Escalation|Death on study|2|||
163915353|NCT01730118|592059402|FG003|Dose Escalation|Death on study|6|||
163915354|NCT01730118|592059403|FG004|Dose Escalation|Death on study|0|||
163915355|NCT01730118|592059404|FG005|Dose Escalation|Death on study|0|||
163915356|NCT01730118|592059405|FG006|Dose Escalation|Death on study|0|||
163915357|NCT01730118|592059399|FG000|Dose Escalation|Died before treatment|0|||
163915358|NCT01730118|592059400|FG001|Dose Escalation|Died before treatment|0|||
163915359|NCT01730118|592059401|FG002|Dose Escalation|Died before treatment|0|||
163915360|NCT01730118|592059402|FG003|Dose Escalation|Died before treatment|0|||
163915361|NCT01730118|592059403|FG004|Dose Escalation|Died before treatment|0|||
163915362|NCT01730118|592059404|FG005|Dose Escalation|Died before treatment|0|||
163915363|NCT01730118|592059405|FG006|Dose Escalation|Died before treatment|1|||
163915364|NCT01730118|592059399|FG000|Dose Escalation|Chose to start a different treatment|1|||
163915365|NCT01730118|592059400|FG001|Dose Escalation|Chose to start a different treatment|0|||
163915366|NCT01730118|592059401|FG002|Dose Escalation|Chose to start a different treatment|0|||
163915367|NCT01730118|592059402|FG003|Dose Escalation|Chose to start a different treatment|0|||
163915368|NCT01730118|592059403|FG004|Dose Escalation|Chose to start a different treatment|0|||
163915369|NCT01730118|592059404|FG005|Dose Escalation|Chose to start a different treatment|0|||
163915370|NCT01730118|592059405|FG006|Dose Escalation|Chose to start a different treatment|0|||
163915371|NCT01730118|592059399|FG000|Dose Escalation|Withdrawal by Subject|0|||
163915372|NCT01730118|592059400|FG001|Dose Escalation|Withdrawal by Subject|0|||
163915373|NCT01730118|592059401|FG002|Dose Escalation|Withdrawal by Subject|1|||
163915374|NCT01730118|592059402|FG003|Dose Escalation|Withdrawal by Subject|0|||
163915375|NCT01730118|592059403|FG004|Dose Escalation|Withdrawal by Subject|0|||
163915376|NCT01730118|592059404|FG005|Dose Escalation|Withdrawal by Subject|0|||
163915377|NCT01730118|592059405|FG006|Dose Escalation|Withdrawal by Subject|0|||
163915378|NCT01730118|592059399|FG000|Dose Escalation|Disease progression prior to treatment|0|||
163915379|NCT01730118|592059400|FG001|Dose Escalation|Disease progression prior to treatment|0|||
163915380|NCT01730118|592059401|FG002|Dose Escalation|Disease progression prior to treatment|0|||
163915381|NCT01730118|592059402|FG003|Dose Escalation|Disease progression prior to treatment|0|||
163915382|NCT01730118|592059403|FG004|Dose Escalation|Disease progression prior to treatment|0|||
163915383|NCT01730118|592059404|FG005|Dose Escalation|Disease progression prior to treatment|0|||
163915384|NCT01730118|592059405|FG006|Dose Escalation|Disease progression prior to treatment|1|||
163915385|NCT01730118|592059399|FG000|Dose Expansion|Death|0|||
163915386|NCT01730118|592059400|FG001|Dose Expansion|Death|0|||
163915387|NCT01730118|592059401|FG002|Dose Expansion|Death|0|||
163915388|NCT01730118|592059402|FG003|Dose Expansion|Death|0|||
163915389|NCT01730118|592059403|FG004|Dose Expansion|Death|1|||
163915390|NCT01730118|592059404|FG005|Dose Expansion|Death|0|||
163915391|NCT01730118|592059405|FG006|Dose Expansion|Death|0|||
163915392|NCT01730118|592059399|FG000|Dose Expansion|Other medical condition|0|||
163915393|NCT01730118|592059400|FG001|Dose Expansion|Other medical condition|0|||
163915394|NCT01730118|592059401|FG002|Dose Expansion|Other medical condition|0|||
163915395|NCT01730118|592059402|FG003|Dose Expansion|Other medical condition|0|||
163915396|NCT01730118|592059403|FG004|Dose Expansion|Other medical condition|1|||
163915397|NCT01730118|592059404|FG005|Dose Expansion|Other medical condition|0|||
163915398|NCT01730118|592059405|FG006|Dose Expansion|Other medical condition|0|||
163915399|NCT01730118|592059399|FG000|Dose Expansion|Withdrawal by Subject|0|||
163915400|NCT01730118|592059400|FG001|Dose Expansion|Withdrawal by Subject|0|||
163915401|NCT01730118|592059401|FG002|Dose Expansion|Withdrawal by Subject|0|||
163915402|NCT01730118|592059402|FG003|Dose Expansion|Withdrawal by Subject|0|||
163915403|NCT01730118|592059403|FG004|Dose Expansion|Withdrawal by Subject|1|||
163915404|NCT01730118|592059404|FG005|Dose Expansion|Withdrawal by Subject|0|||
163915405|NCT01730118|592059405|FG006|Dose Expansion|Withdrawal by Subject|0|||
163915406|NCT01730118|592059399|FG000|Dose Expansion|Disease progression|0|||
163915407|NCT01730118|592059400|FG001|Dose Expansion|Disease progression|0|||
163915408|NCT01730118|592059401|FG002|Dose Expansion|Disease progression|0|||
164028213|NCT01179347|592463291|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
163915409|NCT01730118|592059402|FG003|Dose Expansion|Disease progression|0|||
163915410|NCT01730118|592059403|FG004|Dose Expansion|Disease progression|0|||
163915411|NCT01730118|592059404|FG005|Dose Expansion|Disease progression|1|||
163915412|NCT01730118|592059405|FG006|Dose Expansion|Disease progression|0|||
163915413|NCT01730118|592059399|FG000|Dose Expansion|Inability to return|0|||
164028214|NCT01179347|592463290|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
164028215|NCT01179347|592463291|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
164028216|NCT01179347|592463290|FG000|Open-label Period (12 Weeks)|Other|7|||
164028217|NCT01179347|592463291|FG001|Open-label Period (12 Weeks)|Other|4|||
164028218|NCT04092816|592463292|FG000|Overall Study|Lost to Follow-up|1|||
164028219|NCT04092816|592463293|FG001|Overall Study|Lost to Follow-up|2|||
164028220|NCT03833817|592463294|FG000|Overall Study|Withdrawal by Subject|3|||
164028221|NCT03833817|592463295|FG001|Overall Study|Withdrawal by Subject|3|||
164028222|NCT03833817|592463294|FG000|Overall Study|Lost to Follow-up|3|||
164028223|NCT03833817|592463295|FG001|Overall Study|Lost to Follow-up|3|||
164028224|NCT03363919|592463302|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
164028225|NCT03363919|592463303|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
164028226|NCT03363919|592463302|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
164028227|NCT03363919|592463303|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
164028228|NCT01975246|592463304|FG000|Overall Study|Adverse Event|2|||
164028229|NCT01975246|592463305|FG001|Overall Study|Adverse Event|1|||
164028230|NCT01975246|592463304|FG000|Overall Study|Lack of Efficacy|1|||
164028231|NCT01975246|592463305|FG001|Overall Study|Lack of Efficacy|0|||
164028232|NCT01975246|592463304|FG000|Overall Study|Protocol Violation|1|||
164028233|NCT01975246|592463305|FG001|Overall Study|Protocol Violation|0|||
164028234|NCT01975246|592463304|FG000|Overall Study|Other than stated|0|||
163915414|NCT01730118|592059400|FG001|Dose Expansion|Inability to return|0|||
163915415|NCT01730118|592059401|FG002|Dose Expansion|Inability to return|0|||
163915416|NCT01730118|592059402|FG003|Dose Expansion|Inability to return|0|||
163915417|NCT01730118|592059403|FG004|Dose Expansion|Inability to return|0|||
163915418|NCT01730118|592059404|FG005|Dose Expansion|Inability to return|1|||
163915419|NCT01730118|592059405|FG006|Dose Expansion|Inability to return|0|||
163915420|NCT01730118|592059399|FG000|Dose Expansion|Physician Decision|0|||
163915421|NCT01730118|592059400|FG001|Dose Expansion|Physician Decision|0|||
163915422|NCT01730118|592059401|FG002|Dose Expansion|Physician Decision|0|||
163915423|NCT01730118|592059402|FG003|Dose Expansion|Physician Decision|0|||
163915424|NCT01730118|592059403|FG004|Dose Expansion|Physician Decision|0|||
163915425|NCT01730118|592059404|FG005|Dose Expansion|Physician Decision|1|||
163915426|NCT01730118|592059405|FG006|Dose Expansion|Physician Decision|0|||
163915427|NCT03978130|592059410|FG000|Overall Study|Lost to Follow-up|13|||
163915428|NCT03978130|592059411|FG001|Overall Study|Lost to Follow-up|14|||
163915429|NCT03978130|592059410|FG000|Overall Study|Withdrawal by Subject|12|||
163915430|NCT03978130|592059411|FG001|Overall Study|Withdrawal by Subject|2|||
163915431|NCT03978130|592059410|FG000|Overall Study|Adverse Event|2|||
163915432|NCT03978130|592059411|FG001|Overall Study|Adverse Event|1|||
163915433|NCT04049578|592059417|FG000|Overall Study|Physician Decision|1|||
163915434|NCT00668746|592059418|FG000|Overall Study|Lost to Follow-up|2|||
163915435|NCT00668746|592059419|FG001|Overall Study|Lost to Follow-up|1|||
163915436|NCT03409276|592059420|FG000|Overall Study|Withdrawal by Subject|0|||
163915437|NCT03409276|592059421|FG001|Overall Study|Withdrawal by Subject|0|||
163915438|NCT03409276|592059422|FG002|Overall Study|Withdrawal by Subject|0|||
164028235|NCT01975246|592463305|FG001|Overall Study|Other than stated|1|||
164028236|NCT00574119|592463306|FG000|Overall Study|Adverse Event|1|||
164028237|NCT00574119|592463306|FG000|Overall Study|Protocol Violation|1|||
164028238|NCT00574119|592463306|FG000|Overall Study|Withdrawal by Subject|1|||
164028239|NCT00574119|592463306|FG000|Overall Study|Physician Decision|1|||
164028240|NCT03287245|592463307|FG000|Overall Study|Study terminated by sponsor|3|||
164028241|NCT03287245|592463308|FG001|Overall Study|Study terminated by sponsor|0|||
164028242|NCT03287245|592463309|FG002|Overall Study|Study terminated by sponsor|3|||
164028243|NCT03287245|592463310|FG003|Overall Study|Study terminated by sponsor|1|||
164028244|NCT03287245|592463307|FG000|Overall Study|Adverse Event|1|||
164028245|NCT03287245|592463308|FG001|Overall Study|Adverse Event|0|||
164028246|NCT03287245|592463309|FG002|Overall Study|Adverse Event|0|||
164028247|NCT03287245|592463310|FG003|Overall Study|Adverse Event|0|||
164028248|NCT03287245|592463307|FG000|Overall Study|Withdrawal by Subject|8|||
164028249|NCT03287245|592463308|FG001|Overall Study|Withdrawal by Subject|3|||
164028250|NCT03287245|592463309|FG002|Overall Study|Withdrawal by Subject|3|||
164028251|NCT03287245|592463310|FG003|Overall Study|Withdrawal by Subject|0|||
164028252|NCT03287245|592463307|FG000|Overall Study|Physician Decision|3|||
164028253|NCT03287245|592463308|FG001|Overall Study|Physician Decision|2|||
164028254|NCT03287245|592463309|FG002|Overall Study|Physician Decision|0|||
164028255|NCT03287245|592463310|FG003|Overall Study|Physician Decision|0|||
164028256|NCT02862548|592463311|FG000|Randomized Phase (Up to Week 48)|Death|0|||
164028257|NCT02862548|592463312|FG001|Randomized Phase (Up to Week 48)|Death|1|||
164028258|NCT02862548|592463311|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
164028259|NCT02862548|592463312|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
164028260|NCT02862548|592463311|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
164096649|NCT04213326|592717351|FG001|Overall Study|Protocol Violation|25|||
164028261|NCT02862548|592463312|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
163915439|NCT03409276|592059423|FG003|Overall Study|Withdrawal by Subject|0|||
163915440|NCT03409276|592059424|FG004|Overall Study|Withdrawal by Subject|1|||
163915441|NCT03409276|592059420|FG000|Overall Study|Lost to Follow-up|0|||
163915442|NCT03409276|592059421|FG001|Overall Study|Lost to Follow-up|0|||
163915443|NCT03409276|592059422|FG002|Overall Study|Lost to Follow-up|0|||
163915444|NCT03409276|592059423|FG003|Overall Study|Lost to Follow-up|2|||
163915445|NCT03409276|592059424|FG004|Overall Study|Lost to Follow-up|2|||
163915446|NCT05361304|592059434|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
163915447|NCT05361304|592059435|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
163915448|NCT05361304|592059434|FG000|Overall Study|COVID-19 Related|1|||
163915449|NCT05361304|592059435|FG001|Overall Study|COVID-19 Related|2|||
163915450|NCT05361304|592059434|FG000|Overall Study|Withdrawal by Subject|1|||
163915451|NCT05361304|592059435|FG001|Overall Study|Withdrawal by Subject|0|||
163915452|NCT03320941|592059436|FG000|Overall Study|subject/guardian decision|0|||
163915453|NCT03320941|592059437|FG001|Overall Study|subject/guardian decision|0|||
163915454|NCT03320941|592059438|FG002|Overall Study|subject/guardian decision|0|||
163915455|NCT03320941|592059439|FG003|Overall Study|subject/guardian decision|1|||
163915456|NCT03320941|592059440|FG004|Overall Study|subject/guardian decision|0|||
163915457|NCT02368691|592059442|FG000|Overall Study|Death|13|||
163915458|NCT02368691|592059442|FG000|Overall Study|Lack of Efficacy|15|||
163915459|NCT02368691|592059442|FG000|Overall Study|Physician Decision|4|||
163915460|NCT02069366|592059443|FG000|Overall Study|Lost to Follow-up|0|||
163915461|NCT02069366|592059444|FG001|Overall Study|Lost to Follow-up|0|||
163915462|NCT02069366|592059445|FG002|Overall Study|Lost to Follow-up|1|||
163915463|NCT02069366|592059446|FG003|Overall Study|Lost to Follow-up|0|||
163915464|NCT02069366|592059447|FG004|Overall Study|Lost to Follow-up|0|||
163915465|NCT02069366|592059448|FG005|Overall Study|Lost to Follow-up|2|||
163915466|NCT02069366|592059443|FG000|Overall Study|Protocol Violation|0|||
163915467|NCT02069366|592059444|FG001|Overall Study|Protocol Violation|0|||
163915468|NCT02069366|592059445|FG002|Overall Study|Protocol Violation|1|||
163915469|NCT02069366|592059446|FG003|Overall Study|Protocol Violation|0|||
163915470|NCT02069366|592059447|FG004|Overall Study|Protocol Violation|0|||
163915471|NCT02069366|592059448|FG005|Overall Study|Protocol Violation|0|||
163915472|NCT02069366|592059443|FG000|Overall Study|Withdrawal by Subject|1|||
163915473|NCT02069366|592059444|FG001|Overall Study|Withdrawal by Subject|0|||
163915474|NCT02069366|592059445|FG002|Overall Study|Withdrawal by Subject|1|||
163915475|NCT02069366|592059446|FG003|Overall Study|Withdrawal by Subject|2|||
163915476|NCT02069366|592059447|FG004|Overall Study|Withdrawal by Subject|0|||
163915477|NCT02069366|592059448|FG005|Overall Study|Withdrawal by Subject|0|||
163915478|NCT03314233|592059449|FG000|Overall Study|No longer eligible at time of delivery|1|||
163915479|NCT01797705|592059450|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
163915480|NCT01797705|592059450|FG000|Overall Study|Withdrawal by Subject|1|||
163915481|NCT01838447|592059451|FG000|Overall Study|Change in surgical plan|1|||
163915482|NCT01838447|592059452|FG001|Overall Study|Change in surgical plan|2|||
163915483|NCT01838447|592059451|FG000|Overall Study|Withdrawal by Subject|1|||
163915484|NCT01838447|592059452|FG001|Overall Study|Withdrawal by Subject|1|||
163915485|NCT02030847|592059454|FG000|Overall Study|Death|10|||
163915486|NCT02030847|592059454|FG000|Overall Study|Disease Progression|15|||
163915487|NCT02030847|592059454|FG000|Overall Study|New Cancer Therapy|8|||
163915488|NCT02030847|592059454|FG000|Overall Study|Physician Decision|3|||
163915489|NCT02030847|592059454|FG000|Overall Study|Withdrawal by Subject|1|||
164096650|NCT04213326|592717350|FG000|Overall Study|Participant eligibility changed|106|||
163915490|NCT00168805|592059455|FG000|Overall Study|Adverse Event|7|||
163915491|NCT00168805|592059456|FG001|Overall Study|Adverse Event|11|||
163915492|NCT00168805|592059457|FG002|Overall Study|Adverse Event|16|||
163915493|NCT00168805|592059455|FG000|Overall Study|Protocol Violation|12|||
163915494|NCT00168805|592059456|FG001|Overall Study|Protocol Violation|11|||
163915495|NCT00168805|592059457|FG002|Overall Study|Protocol Violation|8|||
163915496|NCT00168805|592059455|FG000|Overall Study|Lost to Follow-up|12|||
163915497|NCT00168805|592059456|FG001|Overall Study|Lost to Follow-up|17|||
163915498|NCT00168805|592059457|FG002|Overall Study|Lost to Follow-up|11|||
164096651|NCT04213326|592717351|FG001|Overall Study|Participant eligibility changed|19|||
163915499|NCT00168805|592059455|FG000|Overall Study|Withdrawal by Subject|16|||
164028262|NCT02862548|592463311|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
164028263|NCT02862548|592463312|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
164028264|NCT00880763|592463313|FG000|Extension Period (Part 2)|Adverse Event|0|||
164028265|NCT00880763|592463314|FG001|Extension Period (Part 2)|Adverse Event|0|||
164028266|NCT00880763|592463315|FG002|Extension Period (Part 2)|Adverse Event|1|||
164028267|NCT00880763|592463316|FG003|Extension Period (Part 2)|Adverse Event|1|||
164028268|NCT00880763|592463313|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
164096652|NCT04213326|592717350|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
164096653|NCT04213326|592717351|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
164096654|NCT04213326|592717350|FG000|Overall Study|Incomplete study visit|0|||
163915500|NCT00168805|592059456|FG001|Overall Study|Withdrawal by Subject|18|||
164028269|NCT00880763|592463314|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
164028270|NCT00880763|592463315|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
164145302|NCT00025259|592894269|FG006|Overall Study|Protocol Violation|3|||
164028271|NCT00880763|592463316|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
164028272|NCT00880763|592463313|FG000|Extension Period (Part 2)|Physician Decision|0|||
164028273|NCT00880763|592463314|FG001|Extension Period (Part 2)|Physician Decision|1|||
163915501|NCT00168805|592059457|FG002|Overall Study|Withdrawal by Subject|21|||
163915502|NCT00168805|592059455|FG000|Overall Study|Other|24|||
163915503|NCT00168805|592059456|FG001|Overall Study|Other|21|||
163915504|NCT00168805|592059457|FG002|Overall Study|Other|22|||
164028274|NCT00880763|592463315|FG002|Extension Period (Part 2)|Physician Decision|1|||
164028275|NCT00880763|592463316|FG003|Extension Period (Part 2)|Physician Decision|0|||
164028276|NCT00880763|592463313|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
164028277|NCT00880763|592463314|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
163915505|NCT00168805|592059455|FG000|Treatment|Adverse Event|25|||
163915506|NCT00168805|592059456|FG001|Treatment|Adverse Event|26|||
163915507|NCT00168805|592059457|FG002|Treatment|Adverse Event|32|||
163915508|NCT00168805|592059455|FG000|Treatment|Protocol Violation|3|||
163915509|NCT00168805|592059456|FG001|Treatment|Protocol Violation|5|||
163915510|NCT00168805|592059457|FG002|Treatment|Protocol Violation|5|||
163915511|NCT00168805|592059455|FG000|Treatment|Withdrawal by Subject|3|||
163915512|NCT00168805|592059456|FG001|Treatment|Withdrawal by Subject|7|||
163915513|NCT00168805|592059457|FG002|Treatment|Withdrawal by Subject|8|||
163915514|NCT00168805|592059455|FG000|Treatment|Other|18|||
163915515|NCT00168805|592059456|FG001|Treatment|Other|18|||
163915516|NCT00168805|592059457|FG002|Treatment|Other|17|||
163915517|NCT01114217|592059458|FG000|Overall Study|Adverse Event|5|||
163915518|NCT01114217|592059459|FG001|Overall Study|Adverse Event|3|||
163915519|NCT01114217|592059458|FG000|Overall Study|Lost to Follow-up|17|||
163915520|NCT01114217|592059459|FG001|Overall Study|Lost to Follow-up|33|||
163915521|NCT01114217|592059458|FG000|Overall Study|Withdrawal by Subject|21|||
163915522|NCT01114217|592059459|FG001|Overall Study|Withdrawal by Subject|28|||
163915523|NCT01114217|592059458|FG000|Overall Study|Other-Clerical Error|3|||
163915524|NCT01114217|592059459|FG001|Overall Study|Other-Clerical Error|0|||
163915525|NCT01114217|592059458|FG000|Overall Study|Other-Early termination|6|||
163915526|NCT01114217|592059459|FG001|Overall Study|Other-Early termination|10|||
163915527|NCT01114217|592059458|FG000|Overall Study|Other-Procedure|1|||
163915528|NCT01114217|592059459|FG001|Overall Study|Other-Procedure|1|||
163915529|NCT01114217|592059458|FG000|Overall Study|Other-Pregnancy|2|||
163915530|NCT01114217|592059459|FG001|Overall Study|Other-Pregnancy|4|||
163915531|NCT01114217|592059458|FG000|Overall Study|Other-Protocol Violation|1|||
163915532|NCT01114217|592059459|FG001|Overall Study|Other-Protocol Violation|3|||
163915533|NCT01114217|592059458|FG000|Overall Study|Other-Lack of Efficacy|1|||
163915534|NCT01114217|592059459|FG001|Overall Study|Other-Lack of Efficacy|0|||
163915535|NCT01114217|592059458|FG000|Overall Study|Other-Non Compliance|2|||
163915536|NCT01114217|592059459|FG001|Overall Study|Other-Non Compliance|0|||
163915537|NCT01114217|592059458|FG000|Overall Study|Other-Physician Decision|1|||
163915538|NCT01114217|592059459|FG001|Overall Study|Other-Physician Decision|1|||
163915539|NCT01114217|592059458|FG000|Overall Study|Other-Sponsor Decision|10|||
163915540|NCT01114217|592059459|FG001|Overall Study|Other-Sponsor Decision|12|||
163915541|NCT01114217|592059458|FG000|Overall Study|Other-Study Termination|0|||
163915542|NCT01114217|592059459|FG001|Overall Study|Other-Study Termination|1|||
163915543|NCT01114217|592059458|FG000|Overall Study|Other-Study Withdrawn|1|||
163915544|NCT01114217|592059459|FG001|Overall Study|Other-Study Withdrawn|1|||
163915545|NCT01114217|592059458|FG000|Overall Study|Other-Site Stopped Communicating|2|||
163915546|NCT01114217|592059459|FG001|Overall Study|Other-Site Stopped Communicating|0|||
163915547|NCT01114217|592059458|FG000|Overall Study|Other-Lost to Follow-up|1|||
163915548|NCT01114217|592059459|FG001|Overall Study|Other-Lost to Follow-up|0|||
163915549|NCT01114217|592059458|FG000|Overall Study|Other-Withdrawal by Subject|1|||
163915550|NCT01114217|592059459|FG001|Overall Study|Other-Withdrawal by Subject|1|||
163915551|NCT01837719|592059460|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
163915552|NCT01837719|592059460|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
163915553|NCT01703988|592059461|FG000|Overall Study|Investigator Judgment|0|||
163915554|NCT01703988|592059462|FG001|Overall Study|Investigator Judgment|0|||
163915555|NCT01703988|592059463|FG002|Overall Study|Investigator Judgment|0|||
163915556|NCT01703988|592059464|FG003|Overall Study|Investigator Judgment|1|||
163915557|NCT06247488|592059465|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
163915558|NCT06247488|592059466|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163915559|NCT06247488|592059467|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163915560|NCT06247488|592059468|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163915561|NCT06247488|592059469|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163915562|NCT06247488|592059470|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
163915563|NCT06247488|592059465|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163915564|NCT06247488|592059466|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163915565|NCT06247488|592059467|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163915566|NCT06247488|592059468|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
163915567|NCT06247488|592059469|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163915568|NCT06247488|592059470|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
163915569|NCT06247488|592059465|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
163915570|NCT06247488|592059466|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163915571|NCT06247488|592059467|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163915572|NCT06247488|592059468|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163915573|NCT06247488|592059469|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163915574|NCT06247488|592059470|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
163915575|NCT06247488|592059465|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163915576|NCT06247488|592059466|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163915577|NCT06247488|592059467|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163915578|NCT06247488|592059468|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
164028278|NCT00880763|592463315|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
164028279|NCT00880763|592463316|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
163915579|NCT06247488|592059469|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163915580|NCT06247488|592059470|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
163915581|NCT06247488|592059465|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163915582|NCT06247488|592059466|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163915583|NCT06247488|592059467|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163915584|NCT06247488|592059468|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163915585|NCT06247488|592059469|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
163915586|NCT06247488|592059470|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
163915587|NCT06247488|592059465|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
163915588|NCT06247488|592059466|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
163915589|NCT06247488|592059467|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
163915590|NCT06247488|592059468|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
163915591|NCT06247488|592059469|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
163915592|NCT06247488|592059470|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
163915593|NCT06247488|592059465|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163915594|NCT06247488|592059466|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163915595|NCT06247488|592059467|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163915596|NCT06247488|592059468|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163915597|NCT06247488|592059469|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
163915598|NCT06247488|592059470|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
163915599|NCT02995733|592059471|FG000|Overall Study|Study site closed|9|||
163915600|NCT02995733|592059472|FG001|Overall Study|Study site closed|10|||
163915601|NCT02995733|592059471|FG000|Overall Study|Death|3|||
163915602|NCT02995733|592059472|FG001|Overall Study|Death|4|||
163915603|NCT02995733|592059471|FG000|Overall Study|Withdrawal by Subject|6|||
163915604|NCT02995733|592059472|FG001|Overall Study|Withdrawal by Subject|2|||
163915605|NCT02995733|592059471|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
163915606|NCT02995733|592059472|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
163915607|NCT02995733|592059471|FG000|Overall Study|Lost to Follow-up|48|||
163915608|NCT02995733|592059472|FG001|Overall Study|Lost to Follow-up|37|||
163915609|NCT02995733|592059471|FG000|Overall Study|Other|0|||
163915610|NCT02995733|592059472|FG001|Overall Study|Other|1|||
163915611|NCT01183013|592059475|FG000|Overall Study|Adverse Event|6|||
163915612|NCT01183013|592059476|FG001|Overall Study|Adverse Event|8|||
163915613|NCT01183013|592059477|FG002|Overall Study|Adverse Event|5|||
163915614|NCT01183013|592059478|FG003|Overall Study|Adverse Event|5|||
163915615|NCT01183013|592059479|FG004|Overall Study|Adverse Event|10|||
163915616|NCT01183013|592059480|FG005|Overall Study|Adverse Event|10|||
163915617|NCT01183013|592059481|FG006|Overall Study|Adverse Event|6|||
163915618|NCT01183013|592059475|FG000|Overall Study|Lack of Efficacy|3|||
163915619|NCT01183013|592059476|FG001|Overall Study|Lack of Efficacy|2|||
163915620|NCT01183013|592059477|FG002|Overall Study|Lack of Efficacy|1|||
163915621|NCT01183013|592059478|FG003|Overall Study|Lack of Efficacy|2|||
163915622|NCT01183013|592059479|FG004|Overall Study|Lack of Efficacy|1|||
163915623|NCT01183013|592059480|FG005|Overall Study|Lack of Efficacy|2|||
163915624|NCT01183013|592059481|FG006|Overall Study|Lack of Efficacy|0|||
163915625|NCT01183013|592059475|FG000|Overall Study|Protocol Violation|5|||
163915626|NCT01183013|592059476|FG001|Overall Study|Protocol Violation|2|||
163915627|NCT01183013|592059477|FG002|Overall Study|Protocol Violation|4|||
163915628|NCT01183013|592059478|FG003|Overall Study|Protocol Violation|0|||
163915629|NCT01183013|592059479|FG004|Overall Study|Protocol Violation|4|||
163915630|NCT01183013|592059480|FG005|Overall Study|Protocol Violation|3|||
163915631|NCT01183013|592059481|FG006|Overall Study|Protocol Violation|3|||
163915632|NCT01183013|592059475|FG000|Overall Study|Lost to Follow-up|7|||
163915633|NCT01183013|592059476|FG001|Overall Study|Lost to Follow-up|3|||
163915634|NCT01183013|592059477|FG002|Overall Study|Lost to Follow-up|4|||
163915635|NCT01183013|592059478|FG003|Overall Study|Lost to Follow-up|3|||
163915636|NCT01183013|592059479|FG004|Overall Study|Lost to Follow-up|2|||
163915637|NCT01183013|592059480|FG005|Overall Study|Lost to Follow-up|6|||
163915638|NCT01183013|592059481|FG006|Overall Study|Lost to Follow-up|5|||
163915639|NCT01183013|592059475|FG000|Overall Study|Withdrawal by Subject|9|||
163915640|NCT01183013|592059476|FG001|Overall Study|Withdrawal by Subject|13|||
163915641|NCT01183013|592059477|FG002|Overall Study|Withdrawal by Subject|10|||
163915642|NCT01183013|592059478|FG003|Overall Study|Withdrawal by Subject|8|||
163915643|NCT01183013|592059479|FG004|Overall Study|Withdrawal by Subject|7|||
163915644|NCT01183013|592059480|FG005|Overall Study|Withdrawal by Subject|9|||
163915645|NCT01183013|592059481|FG006|Overall Study|Withdrawal by Subject|10|||
163915646|NCT01183013|592059475|FG000|Overall Study|Reasons other than stated above|15|||
163915647|NCT01183013|592059476|FG001|Overall Study|Reasons other than stated above|11|||
163915648|NCT01183013|592059477|FG002|Overall Study|Reasons other than stated above|17|||
163915649|NCT01183013|592059478|FG003|Overall Study|Reasons other than stated above|12|||
163915650|NCT01183013|592059479|FG004|Overall Study|Reasons other than stated above|12|||
163915651|NCT01183013|592059480|FG005|Overall Study|Reasons other than stated above|15|||
163915652|NCT01183013|592059481|FG006|Overall Study|Reasons other than stated above|13|||
163915653|NCT04468633|592059485|FG000|Overall Study|Withdrawal by Subject|4|||
163915654|NCT04468633|592059486|FG001|Overall Study|Withdrawal by Subject|0|||
163915655|NCT00460434|592059489|FG000|Overall Study|Lost to Follow-up|3|||
163915656|NCT00460434|592059490|FG001|Overall Study|Lost to Follow-up|7|||
163915657|NCT01498445|592059491|FG000|Overall Study|Lack of Efficacy|0|||
163915658|NCT01498445|592059492|FG001|Overall Study|Lack of Efficacy|0|||
163915659|NCT01498445|592059493|FG002|Overall Study|Lack of Efficacy|1|||
163915660|NCT01498445|592059494|FG003|Overall Study|Lack of Efficacy|2|||
163915661|NCT01498445|592059495|FG004|Overall Study|Lack of Efficacy|0|||
163915662|NCT01498445|592059496|FG005|Overall Study|Lack of Efficacy|0|||
163915663|NCT01498445|592059491|FG000|Overall Study|Screen Failure|0|||
163915664|NCT01498445|592059492|FG001|Overall Study|Screen Failure|0|||
163915665|NCT01498445|592059493|FG002|Overall Study|Screen Failure|0|||
163915666|NCT01498445|592059494|FG003|Overall Study|Screen Failure|0|||
163915667|NCT01498445|592059495|FG004|Overall Study|Screen Failure|1|||
163915668|NCT01498445|592059496|FG005|Overall Study|Screen Failure|1|||
164028280|NCT00600028|592463321|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164028281|NCT00600028|592463322|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
164028282|NCT00600028|592463321|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
164028283|NCT00600028|592463322|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
164028284|NCT00600028|592463321|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
164028285|NCT00600028|592463322|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
164028286|NCT01830816|592463323|FG000|Overall Study|Progressive Disease|12|||
164028287|NCT01830816|592463324|FG001|Overall Study|Progressive Disease|7|||
164028288|NCT01830816|592463325|FG002|Overall Study|Progressive Disease|7|||
164028289|NCT01830816|592463323|FG000|Overall Study|Adverse Event|3|||
164028290|NCT01830816|592463324|FG001|Overall Study|Adverse Event|4|||
164028291|NCT01830816|592463325|FG002|Overall Study|Adverse Event|0|||
164028292|NCT01830816|592463323|FG000|Overall Study|Study Terminated by Sponsor|1|||
164028293|NCT01830816|592463324|FG001|Overall Study|Study Terminated by Sponsor|1|||
164028294|NCT01830816|592463325|FG002|Overall Study|Study Terminated by Sponsor|0|||
164028295|NCT01830816|592463323|FG000|Overall Study|Withdrawal by Subject|1|||
164028296|NCT01830816|592463324|FG001|Overall Study|Withdrawal by Subject|1|||
164028297|NCT01830816|592463325|FG002|Overall Study|Withdrawal by Subject|0|||
164028298|NCT01830816|592463323|FG000|Overall Study|Lost to Follow-up|0|||
164096655|NCT04213326|592717351|FG001|Overall Study|Incomplete study visit|367|||
164096656|NCT01496183|592717353|FG000|Overall Study|Physician Decision|3|||
164028299|NCT01830816|592463324|FG001|Overall Study|Lost to Follow-up|1|||
164096657|NCT01496183|592717354|FG001|Overall Study|Physician Decision|1|||
164096658|NCT01496183|592717353|FG000|Overall Study|Withdrawal by Subject|0|||
164096659|NCT01496183|592717354|FG001|Overall Study|Withdrawal by Subject|1|||
164096660|NCT01173692|592717357|FG000|Overall Study|Adverse Event|1|||
164028300|NCT01830816|592463325|FG002|Overall Study|Lost to Follow-up|0|||
164028301|NCT01830816|592463323|FG000|Overall Study|Symptomatic Deterioration|1|||
164028302|NCT01830816|592463324|FG001|Overall Study|Symptomatic Deterioration|0|||
164096661|NCT01173692|592717358|FG001|Overall Study|Adverse Event|2|||
164028303|NCT01830816|592463325|FG002|Overall Study|Symptomatic Deterioration|0|||
164028304|NCT01830816|592463323|FG000|Overall Study|Reason not Specified|2|||
164028305|NCT01830816|592463324|FG001|Overall Study|Reason not Specified|0|||
164145461|NCT01198132|592894312|FG001|Overall Study|Lack of Efficacy|3|||
164028306|NCT01830816|592463325|FG002|Overall Study|Reason not Specified|0|||
163915669|NCT04739306|592059497|FG000|Main Study Period|Adverse Event|6|||
163915670|NCT04739306|592059498|FG001|Main Study Period|Adverse Event|7|||
163915671|NCT04739306|592059497|FG000|Main Study Period|Lost to Follow-up|4|||
163915672|NCT04739306|592059498|FG001|Main Study Period|Lost to Follow-up|6|||
163915673|NCT04739306|592059497|FG000|Main Study Period|Physician Decision|1|||
163915674|NCT04739306|592059498|FG001|Main Study Period|Physician Decision|1|||
163915675|NCT04739306|592059497|FG000|Main Study Period|Withdrawal by Subject|8|||
163915676|NCT04739306|592059498|FG001|Main Study Period|Withdrawal by Subject|6|||
163915677|NCT04739306|592059497|FG000|Main Study Period|Protocol Violation|0|||
163915678|NCT04739306|592059498|FG001|Main Study Period|Protocol Violation|1|||
163915679|NCT04739306|592059497|FG000|Main Study Period|War in Ukraine|1|||
163915680|NCT04739306|592059498|FG001|Main Study Period|War in Ukraine|1|||
163915681|NCT02722278|592059501|FG000|Overall Study|Withdrawal by Subject|5|||
163915682|NCT02722278|592059502|FG001|Overall Study|Withdrawal by Subject|3|||
163915683|NCT02722278|592059501|FG000|Overall Study|Adverse Event|4|||
163915684|NCT02722278|592059502|FG001|Overall Study|Adverse Event|1|||
163915685|NCT02722278|592059501|FG000|Overall Study|Lost to Follow-up|2|||
163915686|NCT02722278|592059502|FG001|Overall Study|Lost to Follow-up|0|||
163915687|NCT02722278|592059501|FG000|Overall Study|Protocol Violation|1|||
163915688|NCT02722278|592059502|FG001|Overall Study|Protocol Violation|0|||
163915689|NCT02722278|592059501|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
163915690|NCT02722278|592059502|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
163915691|NCT02722278|592059501|FG000|Overall Study|Subject declined after tx assignment|0|||
163915692|NCT02722278|592059502|FG001|Overall Study|Subject declined after tx assignment|1|||
163915693|NCT02722278|592059501|FG000|Overall Study|Site closure not study related|0|||
163915694|NCT02722278|592059502|FG001|Overall Study|Site closure not study related|1|||
163915695|NCT02465866|592059503|FG000|Period 3|Withdrawal by Subject|0|||
163915696|NCT02465866|592059504|FG001|Period 3|Withdrawal by Subject|1|||
163915697|NCT02465866|592059505|FG002|Period 3|Withdrawal by Subject|0|||
163915698|NCT02465866|592059506|FG003|Period 3|Withdrawal by Subject|0|||
163915699|NCT00203502|592059507|FG000|Overall Study|Death|1|||
163915700|NCT02023099|592059508|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
163915701|NCT02023099|592059509|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
163915702|NCT02023099|592059510|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
163915703|NCT02023099|592059508|FG000|Overall Study|Withdrawn Consent|3|||
163915704|NCT02023099|592059509|FG001|Overall Study|Withdrawn Consent|0|||
163915705|NCT02023099|592059510|FG002|Overall Study|Withdrawn Consent|1|||
163915706|NCT02023099|592059508|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
163915707|NCT02023099|592059509|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
163915708|NCT02023099|592059510|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
163915709|NCT04175392|592059511|FG000|Overall Study|Withdrawal by Subject|3|||
163915710|NCT04175392|592059512|FG001|Overall Study|Withdrawal by Subject|2|||
163915711|NCT01469819|592059513|FG000|Overall Study|Withdrawal by Subject|1|||
163915712|NCT01469819|592059513|FG000|Overall Study|Did not meet inclusionary criteria|2|||
163915713|NCT01469819|592059513|FG000|Overall Study|Could not swallow SmartPill|2|||
163915714|NCT01469819|592059513|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
163915715|NCT00561678|592059514|FG000|Overall Study|Withdrawal by Subject|4|||
163915716|NCT00561678|592059515|FG001|Overall Study|Withdrawal by Subject|3|||
163915717|NCT00561678|592059514|FG000|Overall Study|surgery cancelled|1|||
163915718|NCT00561678|592059515|FG001|Overall Study|surgery cancelled|1|||
163915719|NCT00561678|592059514|FG000|Overall Study|surgery rescheduled to different site|2|||
163915720|NCT00561678|592059515|FG001|Overall Study|surgery rescheduled to different site|2|||
164028307|NCT01754922|592463331|FG000|Overall Study|Adverse Event|0|||
164028308|NCT01754922|592463332|FG001|Overall Study|Adverse Event|1|||
164028309|NCT01885078|592463335|FG000|Treatment Period|Adverse Event|52|||
164028310|NCT01885078|592463336|FG001|Treatment Period|Adverse Event|136|||
164028311|NCT01885078|592463337|FG002|Treatment Period|Adverse Event|30|||
164028312|NCT01885078|592463338|FG003|Treatment Period|Adverse Event|73|||
164028313|NCT01885078|592463339|FG004|Treatment Period|Adverse Event|17|||
164028314|NCT01885078|592463340|FG005|Treatment Period|Adverse Event|72|||
164028315|NCT01885078|592463341|FG006|Treatment Period|Adverse Event|24|||
164028316|NCT01885078|592463342|FG007|Treatment Period|Adverse Event|5|||
164028317|NCT01885078|592463343|FG008|Treatment Period|Adverse Event|0|||
164028318|NCT01885078|592463344|FG009|Treatment Period|Adverse Event|0|||
164028319|NCT01885078|592463335|FG000|Treatment Period|Death|13|||
164028320|NCT01885078|592463336|FG001|Treatment Period|Death|33|||
164028321|NCT01885078|592463337|FG002|Treatment Period|Death|5|||
164028322|NCT01885078|592463338|FG003|Treatment Period|Death|9|||
164028323|NCT01885078|592463339|FG004|Treatment Period|Death|2|||
164028324|NCT01885078|592463340|FG005|Treatment Period|Death|10|||
164028325|NCT01885078|592463341|FG006|Treatment Period|Death|3|||
164028326|NCT01885078|592463342|FG007|Treatment Period|Death|2|||
164028327|NCT01885078|592463343|FG008|Treatment Period|Death|0|||
164028328|NCT01885078|592463344|FG009|Treatment Period|Death|0|||
164028329|NCT01885078|592463335|FG000|Treatment Period|Lack of Efficacy|12|||
164028330|NCT01885078|592463336|FG001|Treatment Period|Lack of Efficacy|33|||
164028331|NCT01885078|592463337|FG002|Treatment Period|Lack of Efficacy|10|||
164028332|NCT01885078|592463338|FG003|Treatment Period|Lack of Efficacy|23|||
164028333|NCT01885078|592463339|FG004|Treatment Period|Lack of Efficacy|24|||
164028334|NCT01885078|592463340|FG005|Treatment Period|Lack of Efficacy|58|||
164028335|NCT01885078|592463341|FG006|Treatment Period|Lack of Efficacy|9|||
164028336|NCT01885078|592463342|FG007|Treatment Period|Lack of Efficacy|5|||
164028337|NCT01885078|592463343|FG008|Treatment Period|Lack of Efficacy|0|||
164028338|NCT01885078|592463344|FG009|Treatment Period|Lack of Efficacy|0|||
164028339|NCT01885078|592463335|FG000|Treatment Period|Lost to Follow-up|16|||
164028340|NCT01885078|592463336|FG001|Treatment Period|Lost to Follow-up|19|||
164028341|NCT01885078|592463337|FG002|Treatment Period|Lost to Follow-up|7|||
164028342|NCT01885078|592463338|FG003|Treatment Period|Lost to Follow-up|9|||
164028343|NCT01885078|592463339|FG004|Treatment Period|Lost to Follow-up|2|||
164028344|NCT01885078|592463340|FG005|Treatment Period|Lost to Follow-up|8|||
164028345|NCT01885078|592463341|FG006|Treatment Period|Lost to Follow-up|2|||
164028346|NCT01885078|592463342|FG007|Treatment Period|Lost to Follow-up|0|||
163915721|NCT00561678|592059514|FG000|Overall Study|anesthesia provider refusal|1|||
163915722|NCT00561678|592059515|FG001|Overall Study|anesthesia provider refusal|0|||
163915723|NCT01103141|592059516|FG000|Overall Study|Death|0|||
163915724|NCT01103141|592059517|FG001|Overall Study|Death|1|||
163915725|NCT01103141|592059516|FG000|Overall Study|Lost to Follow-up|2|||
163915726|NCT01103141|592059517|FG001|Overall Study|Lost to Follow-up|1|||
163915727|NCT01403805|592059520|FG000|Overall Study|Withdrawal by Subject|0|||
163915728|NCT01403805|592059521|FG001|Overall Study|Withdrawal by Subject|4|||
163915729|NCT01403805|592059520|FG000|Overall Study|Lost to Follow-up|0|||
163915730|NCT01403805|592059521|FG001|Overall Study|Lost to Follow-up|2|||
163915731|NCT01403805|592059520|FG000|Overall Study|Death|0|||
163915732|NCT01403805|592059521|FG001|Overall Study|Death|1|||
163915733|NCT01695993|592059522|FG000|Overall Study|Lost to Follow-up|2|||
163915734|NCT01695993|592059523|FG001|Overall Study|Lost to Follow-up|1|||
163915735|NCT01695993|592059524|FG002|Overall Study|Lost to Follow-up|3|||
163915736|NCT01695993|592059522|FG000|Overall Study|Withdrawal by Subject|2|||
163915737|NCT01695993|592059523|FG001|Overall Study|Withdrawal by Subject|2|||
163915738|NCT01695993|592059524|FG002|Overall Study|Withdrawal by Subject|2|||
163915739|NCT01695993|592059522|FG000|Overall Study|To ill to continue|1|||
163915740|NCT01695993|592059523|FG001|Overall Study|To ill to continue|2|||
163915741|NCT01695993|592059524|FG002|Overall Study|To ill to continue|0|||
163915742|NCT01695993|592059522|FG000|Overall Study|Changed Medical Facility|0|||
163915743|NCT01695993|592059523|FG001|Overall Study|Changed Medical Facility|0|||
163915744|NCT01695993|592059524|FG002|Overall Study|Changed Medical Facility|1|||
163915745|NCT00472199|592059525|FG000|Overall Study|Adverse Event|19|||
163915746|NCT00472199|592059526|FG001|Overall Study|Adverse Event|23|||
163915747|NCT00472199|592059525|FG000|Overall Study|Lack of Efficacy|4|||
163915748|NCT00472199|592059526|FG001|Overall Study|Lack of Efficacy|25|||
163915749|NCT00472199|592059525|FG000|Overall Study|Lost to Follow-up|2|||
163915750|NCT00472199|592059526|FG001|Overall Study|Lost to Follow-up|4|||
163915751|NCT00472199|592059525|FG000|Overall Study|Protocol Violation|3|||
163915752|NCT00472199|592059526|FG001|Overall Study|Protocol Violation|2|||
163915753|NCT00472199|592059525|FG000|Overall Study|Withdrawal by Subject|6|||
163915754|NCT00472199|592059526|FG001|Overall Study|Withdrawal by Subject|5|||
163915755|NCT00472199|592059525|FG000|Overall Study|personal reason|0|||
163915756|NCT00472199|592059526|FG001|Overall Study|personal reason|1|||
163915757|NCT00472199|592059525|FG000|Overall Study|patient was asymptomatic|1|||
163915758|NCT00472199|592059526|FG001|Overall Study|patient was asymptomatic|0|||
163915759|NCT01601821|592059530|FG000|Overall Study|Death|2|||
163915760|NCT01601821|592059531|FG001|Overall Study|Death|5|||
163915761|NCT01601821|592059530|FG000|Overall Study|Protocol Violation|2|||
163915762|NCT01601821|592059531|FG001|Overall Study|Protocol Violation|2|||
163915763|NCT01601821|592059530|FG000|Overall Study|Lost to Follow-up|6|||
163915764|NCT01601821|592059531|FG001|Overall Study|Lost to Follow-up|14|||
163915765|NCT01601821|592059530|FG000|Overall Study|Withdrawal by Subject|1|||
163915766|NCT01601821|592059531|FG001|Overall Study|Withdrawal by Subject|0|||
163915767|NCT01601821|592059530|FG000|Overall Study|Graft Loss|6|||
163915768|NCT01601821|592059531|FG001|Overall Study|Graft Loss|6|||
163915769|NCT01601821|592059530|FG000|Overall Study|Study Events|7|||
163915770|NCT01601821|592059531|FG001|Overall Study|Study Events|1|||
163915771|NCT01601821|592059530|FG000|Overall Study|Other|5|||
163915772|NCT01601821|592059531|FG001|Overall Study|Other|1|||
163915773|NCT01901302|592059535|FG000|Overall Study|Adverse Event|2|||
164028347|NCT01885078|592463343|FG008|Treatment Period|Lost to Follow-up|0|||
164028348|NCT01885078|592463344|FG009|Treatment Period|Lost to Follow-up|0|||
164028349|NCT01885078|592463335|FG000|Treatment Period|Physician Decision|19|||
163915774|NCT01901302|592059536|FG001|Overall Study|Adverse Event|1|||
163915775|NCT01901302|592059535|FG000|Overall Study|Lack of Efficacy|0|||
163915776|NCT01901302|592059536|FG001|Overall Study|Lack of Efficacy|2|||
163915777|NCT01901302|592059535|FG000|Overall Study|Study Terminated by Sponsor|23|||
163915778|NCT01901302|592059536|FG001|Overall Study|Study Terminated by Sponsor|20|||
163915779|NCT01901302|592059535|FG000|Overall Study|Withdrawal by Subject|2|||
163915780|NCT01901302|592059536|FG001|Overall Study|Withdrawal by Subject|0|||
163915781|NCT00848198|592059538|FG000|Overall Study|Incomplete Case Report Forms|15|||
163915782|NCT03708744|592059539|FG000|Overall Study|Withdrawal by Subject|0|||
163915783|NCT03708744|592059540|FG001|Overall Study|Withdrawal by Subject|0|||
164028350|NCT01885078|592463336|FG001|Treatment Period|Physician Decision|21|||
163915784|NCT03708744|592059541|FG002|Overall Study|Withdrawal by Subject|1|||
163915785|NCT03708744|592059542|FG003|Overall Study|Withdrawal by Subject|0|||
163915786|NCT02062827|592059543|FG000|Overall Study|Death|1|||
163915787|NCT02062827|592059544|FG001|Overall Study|Death|0|||
163915788|NCT02062827|592059545|FG002|Overall Study|Death|0|||
163915789|NCT02062827|592059546|FG003|Overall Study|Death|0|||
163915790|NCT02062827|592059547|FG004|Overall Study|Death|0|||
163915791|NCT02062827|592059548|FG005|Overall Study|Death|0|||
163915792|NCT02062827|592059549|FG006|Overall Study|Death|0|||
163915793|NCT02062827|592059550|FG007|Overall Study|Death|0|||
164028351|NCT01885078|592463337|FG002|Treatment Period|Physician Decision|5|||
163915794|NCT02062827|592059543|FG000|Overall Study|Withdrawal by Subject|3|||
163915795|NCT02062827|592059544|FG001|Overall Study|Withdrawal by Subject|1|||
164028352|NCT01885078|592463338|FG003|Treatment Period|Physician Decision|12|||
164028353|NCT01885078|592463339|FG004|Treatment Period|Physician Decision|9|||
164028354|NCT01885078|592463340|FG005|Treatment Period|Physician Decision|24|||
164028355|NCT01885078|592463341|FG006|Treatment Period|Physician Decision|4|||
164028356|NCT01885078|592463342|FG007|Treatment Period|Physician Decision|3|||
163915796|NCT02062827|592059545|FG002|Overall Study|Withdrawal by Subject|1|||
163915797|NCT02062827|592059546|FG003|Overall Study|Withdrawal by Subject|2|||
163915798|NCT02062827|592059547|FG004|Overall Study|Withdrawal by Subject|6|||
163915799|NCT02062827|592059548|FG005|Overall Study|Withdrawal by Subject|0|||
163915800|NCT02062827|592059549|FG006|Overall Study|Withdrawal by Subject|5|||
163915801|NCT02062827|592059550|FG007|Overall Study|Withdrawal by Subject|0|||
163915802|NCT02062827|592059543|FG000|Overall Study|Screen Fail|0|||
163915803|NCT02062827|592059544|FG001|Overall Study|Screen Fail|0|||
163915804|NCT02062827|592059545|FG002|Overall Study|Screen Fail|0|||
163915805|NCT02062827|592059546|FG003|Overall Study|Screen Fail|0|||
163915806|NCT02062827|592059547|FG004|Overall Study|Screen Fail|0|||
163915807|NCT02062827|592059548|FG005|Overall Study|Screen Fail|0|||
163915808|NCT02062827|592059549|FG006|Overall Study|Screen Fail|0|||
163915809|NCT02062827|592059550|FG007|Overall Study|Screen Fail|8|||
163915810|NCT04930263|592059551|FG000|Overall Study|Withdrawal by Subject|3|||
163915811|NCT04930263|592059552|FG001|Overall Study|Withdrawal by Subject|5|||
163915812|NCT02812706|592059554|FG000|Phase 1|Adverse Event|0|||
163915813|NCT02812706|592059555|FG001|Phase 1|Adverse Event|2|||
163915814|NCT02812706|592059556|FG002|Phase 1|Adverse Event|0|||
164028357|NCT01885078|592463343|FG008|Treatment Period|Physician Decision|0|||
164028358|NCT01885078|592463344|FG009|Treatment Period|Physician Decision|0|||
164028359|NCT01885078|592463335|FG000|Treatment Period|Protocol Violation|3|||
164028360|NCT01885078|592463336|FG001|Treatment Period|Protocol Violation|5|||
164028361|NCT01885078|592463337|FG002|Treatment Period|Protocol Violation|0|||
164028362|NCT01885078|592463338|FG003|Treatment Period|Protocol Violation|3|||
164028363|NCT01885078|592463339|FG004|Treatment Period|Protocol Violation|1|||
164028364|NCT01885078|592463340|FG005|Treatment Period|Protocol Violation|6|||
164028365|NCT01885078|592463341|FG006|Treatment Period|Protocol Violation|0|||
164028366|NCT01885078|592463342|FG007|Treatment Period|Protocol Violation|0|||
164028367|NCT01885078|592463343|FG008|Treatment Period|Protocol Violation|0|||
164028368|NCT01885078|592463344|FG009|Treatment Period|Protocol Violation|0|||
164028369|NCT01885078|592463335|FG000|Treatment Period|Sponsor Decision|245|||
164028370|NCT01885078|592463336|FG001|Treatment Period|Sponsor Decision|648|||
164028371|NCT01885078|592463337|FG002|Treatment Period|Sponsor Decision|49|||
164028372|NCT01885078|592463338|FG003|Treatment Period|Sponsor Decision|90|||
164028373|NCT01885078|592463339|FG004|Treatment Period|Sponsor Decision|20|||
164028374|NCT01885078|592463340|FG005|Treatment Period|Sponsor Decision|38|||
164028375|NCT01885078|592463341|FG006|Treatment Period|Sponsor Decision|162|||
164028376|NCT01885078|592463342|FG007|Treatment Period|Sponsor Decision|3|||
164028377|NCT01885078|592463343|FG008|Treatment Period|Sponsor Decision|0|||
164028378|NCT01885078|592463344|FG009|Treatment Period|Sponsor Decision|0|||
164028379|NCT01885078|592463335|FG000|Treatment Period|Withdrawal by Subject|72|||
164028380|NCT01885078|592463336|FG001|Treatment Period|Withdrawal by Subject|132|||
164028381|NCT01885078|592463337|FG002|Treatment Period|Withdrawal by Subject|25|||
163915815|NCT02812706|592059554|FG000|Phase 1|Progressive disease|3|||
163915816|NCT02812706|592059555|FG001|Phase 1|Progressive disease|3|||
163915817|NCT02812706|592059556|FG002|Phase 1|Progressive disease|0|||
163915818|NCT02812706|592059554|FG000|Phase 2|Adverse Event|0|||
163915819|NCT02812706|592059555|FG001|Phase 2|Adverse Event|0|||
163915820|NCT02812706|592059556|FG002|Phase 2|Adverse Event|2|||
163915821|NCT02812706|592059554|FG000|Phase 2|Progressive disease|0|||
163915822|NCT02812706|592059555|FG001|Phase 2|Progressive disease|0|||
163915823|NCT02812706|592059556|FG002|Phase 2|Progressive disease|22|||
163915824|NCT02812706|592059554|FG000|Phase 2|Other-Unspecified|0|||
163915825|NCT02812706|592059555|FG001|Phase 2|Other-Unspecified|0|||
163915826|NCT02812706|592059556|FG002|Phase 2|Other-Unspecified|4|||
163915827|NCT01699178|592059559|FG000|Overall Study|Adverse Event|1|||
163915828|NCT01699178|592059560|FG001|Overall Study|Adverse Event|5|||
163915829|NCT01699178|592059559|FG000|Overall Study|Lost to Follow-up|1|||
163915830|NCT01699178|592059560|FG001|Overall Study|Lost to Follow-up|6|||
163915831|NCT01699178|592059559|FG000|Overall Study|Non-compliance with Study Drug|3|||
163915832|NCT01699178|592059560|FG001|Overall Study|Non-compliance with Study Drug|1|||
163915833|NCT01699178|592059559|FG000|Overall Study|Physician Decision|1|||
163915834|NCT01699178|592059560|FG001|Overall Study|Physician Decision|0|||
163915835|NCT01699178|592059559|FG000|Overall Study|Withdrawal by Subject|4|||
163915836|NCT01699178|592059560|FG001|Overall Study|Withdrawal by Subject|12|||
163915837|NCT01699178|592059559|FG000|Overall Study|Hematocrit >54%|1|||
163915838|NCT01699178|592059560|FG001|Overall Study|Hematocrit >54%|1|||
163915839|NCT01699178|592059559|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
163915840|NCT01699178|592059560|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
163915841|NCT01699178|592059559|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
163915842|NCT01699178|592059560|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
163915843|NCT02138838|592059563|FG000|Overall Study|Study Closure|7|||
163915844|NCT02138838|592059564|FG001|Overall Study|Study Closure|6|||
163915845|NCT02138838|592059563|FG000|Overall Study|Withdrawal by Subject|1|||
163915846|NCT02138838|592059564|FG001|Overall Study|Withdrawal by Subject|5|||
163915847|NCT04433091|592059568|FG000|Overall Study|Lost to Follow-up|1|||
163915848|NCT04433091|592059569|FG001|Overall Study|Lost to Follow-up|0|||
164028382|NCT01885078|592463338|FG003|Treatment Period|Withdrawal by Subject|63|||
164028383|NCT01885078|592463339|FG004|Treatment Period|Withdrawal by Subject|15|||
164028384|NCT01885078|592463340|FG005|Treatment Period|Withdrawal by Subject|34|||
164028385|NCT01885078|592463341|FG006|Treatment Period|Withdrawal by Subject|17|||
164028386|NCT01885078|592463342|FG007|Treatment Period|Withdrawal by Subject|10|||
164028387|NCT01885078|592463343|FG008|Treatment Period|Withdrawal by Subject|0|||
164028388|NCT01885078|592463344|FG009|Treatment Period|Withdrawal by Subject|0|||
164028389|NCT01885078|592463335|FG000|Treatment Period|Other|0|||
163915849|NCT04433091|592059568|FG000|Overall Study|Withdrawn .|2|||
163915850|NCT04433091|592059569|FG001|Overall Study|Withdrawn .|4|||
163915851|NCT02880293|592060933|FG000|Overall Study|Inevaluable|5|||
164028390|NCT01885078|592463336|FG001|Treatment Period|Other|0|||
164028391|NCT01885078|592463337|FG002|Treatment Period|Other|0|||
164028392|NCT01885078|592463338|FG003|Treatment Period|Other|1|||
164028393|NCT01885078|592463339|FG004|Treatment Period|Other|0|||
164028394|NCT01885078|592463340|FG005|Treatment Period|Other|0|||
164028395|NCT01885078|592463341|FG006|Treatment Period|Other|0|||
164028396|NCT01885078|592463342|FG007|Treatment Period|Other|0|||
164028397|NCT01885078|592463343|FG008|Treatment Period|Other|0|||
164028398|NCT01885078|592463344|FG009|Treatment Period|Other|0|||
164028399|NCT01885078|592463335|FG000|Step-down Period|Sponsor Decision|0|||
164028400|NCT01885078|592463336|FG001|Step-down Period|Sponsor Decision|0|||
164028401|NCT01885078|592463337|FG002|Step-down Period|Sponsor Decision|0|||
164028402|NCT01885078|592463338|FG003|Step-down Period|Sponsor Decision|0|||
164028403|NCT01885078|592463339|FG004|Step-down Period|Sponsor Decision|0|||
164028404|NCT01885078|592463340|FG005|Step-down Period|Sponsor Decision|0|||
164028405|NCT01885078|592463341|FG006|Step-down Period|Sponsor Decision|0|||
163915852|NCT02101554|592060934|FG000|Overall Study|Protocol Violation|0|||
163915853|NCT02101554|592060935|FG001|Overall Study|Protocol Violation|1|||
163915854|NCT02101554|592060936|FG002|Overall Study|Protocol Violation|0|||
163915855|NCT02101554|592060934|FG000|Overall Study|Insufficient Clinical Response|0|||
163915856|NCT02101554|592060935|FG001|Overall Study|Insufficient Clinical Response|2|||
163915857|NCT02101554|592060936|FG002|Overall Study|Insufficient Clinical Response|0|||
163915858|NCT02101554|592060934|FG000|Overall Study|Adverse Event|2|||
163915859|NCT02101554|592060935|FG001|Overall Study|Adverse Event|1|||
163915860|NCT02101554|592060936|FG002|Overall Study|Adverse Event|1|||
163915861|NCT02101554|592060934|FG000|Overall Study|Lost to Follow-up|0|||
163915862|NCT02101554|592060935|FG001|Overall Study|Lost to Follow-up|1|||
163915863|NCT02101554|592060936|FG002|Overall Study|Lost to Follow-up|0|||
164096662|NCT01173692|592717357|FG000|Overall Study|Withdrawal by Subject|1|||
163915864|NCT02101554|592060934|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
164028406|NCT01885078|592463342|FG007|Step-down Period|Sponsor Decision|0|||
164028407|NCT01885078|592463343|FG008|Step-down Period|Sponsor Decision|1|||
164028408|NCT01885078|592463344|FG009|Step-down Period|Sponsor Decision|1|||
164028409|NCT01885078|592463335|FG000|Step-down Period|Adverse Event|0|||
164028410|NCT01885078|592463336|FG001|Step-down Period|Adverse Event|0|||
164028411|NCT01885078|592463337|FG002|Step-down Period|Adverse Event|0|||
164028412|NCT01885078|592463338|FG003|Step-down Period|Adverse Event|0|||
164028413|NCT01885078|592463339|FG004|Step-down Period|Adverse Event|0|||
164028414|NCT01885078|592463340|FG005|Step-down Period|Adverse Event|0|||
164028415|NCT01885078|592463341|FG006|Step-down Period|Adverse Event|0|||
164028416|NCT01885078|592463342|FG007|Step-down Period|Adverse Event|0|||
164028417|NCT01885078|592463343|FG008|Step-down Period|Adverse Event|29|||
164028418|NCT01885078|592463344|FG009|Step-down Period|Adverse Event|38|||
164028419|NCT01885078|592463335|FG000|Step-down Period|Withdrawal by Subject|0|||
164028420|NCT01885078|592463336|FG001|Step-down Period|Withdrawal by Subject|0|||
164028421|NCT01885078|592463337|FG002|Step-down Period|Withdrawal by Subject|0|||
164028422|NCT01885078|592463338|FG003|Step-down Period|Withdrawal by Subject|0|||
164028423|NCT01885078|592463339|FG004|Step-down Period|Withdrawal by Subject|0|||
164028424|NCT01885078|592463340|FG005|Step-down Period|Withdrawal by Subject|0|||
164028425|NCT01885078|592463341|FG006|Step-down Period|Withdrawal by Subject|0|||
164028426|NCT01885078|592463342|FG007|Step-down Period|Withdrawal by Subject|0|||
164028427|NCT01885078|592463343|FG008|Step-down Period|Withdrawal by Subject|25|||
164028428|NCT01885078|592463344|FG009|Step-down Period|Withdrawal by Subject|15|||
164028429|NCT01885078|592463335|FG000|Step-down Period|Physician Decision|0|||
164028430|NCT01885078|592463336|FG001|Step-down Period|Physician Decision|0|||
164028431|NCT01885078|592463337|FG002|Step-down Period|Physician Decision|0|||
164028432|NCT01885078|592463338|FG003|Step-down Period|Physician Decision|0|||
164028433|NCT01885078|592463339|FG004|Step-down Period|Physician Decision|0|||
164028434|NCT01885078|592463340|FG005|Step-down Period|Physician Decision|0|||
164028435|NCT01885078|592463341|FG006|Step-down Period|Physician Decision|0|||
164028436|NCT01885078|592463342|FG007|Step-down Period|Physician Decision|0|||
164028437|NCT01885078|592463343|FG008|Step-down Period|Physician Decision|7|||
164028438|NCT01885078|592463344|FG009|Step-down Period|Physician Decision|2|||
164028439|NCT01885078|592463335|FG000|Step-down Period|Death|0|||
164028440|NCT01885078|592463336|FG001|Step-down Period|Death|0|||
164028441|NCT01885078|592463337|FG002|Step-down Period|Death|0|||
164028442|NCT01885078|592463338|FG003|Step-down Period|Death|0|||
163915865|NCT02101554|592060935|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
163915866|NCT02101554|592060936|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
163915867|NCT04385849|592060937|FG000|Overall Study|Lost to Follow-up|1|||
163915868|NCT04385849|592060938|FG001|Overall Study|Lost to Follow-up|0|||
163915869|NCT02011568|592060939|FG000|Overall Study|Withdrawal by Subject|8|||
163915870|NCT02011568|592060940|FG001|Overall Study|Withdrawal by Subject|10|||
163915871|NCT02011568|592060939|FG000|Overall Study|Physician Decision|1|||
163915872|NCT02011568|592060940|FG001|Overall Study|Physician Decision|3|||
163915873|NCT01038128|592060942|FG000|Overall Study|Lack of Efficacy|1|||
163915874|NCT01038128|592060942|FG000|Overall Study|Lost to Follow-up|1|||
163915875|NCT01038128|592060942|FG000|Overall Study|Withdrawal by Subject|2|||
163915876|NCT03344458|592060947|FG000|Overall Study|Physician Decision|1|||
163915877|NCT03344458|592060947|FG000|Overall Study|Withdrawal by Subject|16|||
163915878|NCT03344458|592060947|FG000|Overall Study|Other reasons|10|||
163915879|NCT03344458|592060947|FG000|Overall Study|Lost to Follow-up|9|||
163915880|NCT03344458|592060947|FG000|Overall Study|Protocol Violation|3|||
163915881|NCT00396409|592060952|FG000|Period 1 - 2007|Adverse Event|0|||
163915882|NCT00396409|592060953|FG001|Period 1 - 2007|Adverse Event|1|||
163915883|NCT00396409|592060952|FG000|Period 1 - 2007|Lack of Efficacy|0|||
163915884|NCT00396409|592060953|FG001|Period 1 - 2007|Lack of Efficacy|1|||
163915885|NCT00396409|592060952|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
163915886|NCT00396409|592060953|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
163915887|NCT00396409|592060952|FG000|Period 1 - 2007|Lost to Follow-up|2|||
163915888|NCT00396409|592060953|FG001|Period 1 - 2007|Lost to Follow-up|3|||
163915889|NCT00396409|592060952|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
163915890|NCT00396409|592060953|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
163915891|NCT00396409|592060952|FG000|Period 2 - 2008|Protocol Violation|1|||
163915892|NCT00396409|592060953|FG001|Period 2 - 2008|Protocol Violation|0|||
164028443|NCT01885078|592463339|FG004|Step-down Period|Death|0|||
164028444|NCT01885078|592463340|FG005|Step-down Period|Death|0|||
163915893|NCT00396409|592060952|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
163915894|NCT00396409|592060953|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
163915895|NCT00396409|592060952|FG000|Period 2 - 2008|Lost to Follow-up|3|||
163915896|NCT00396409|592060953|FG001|Period 2 - 2008|Lost to Follow-up|1|||
163915897|NCT00331799|592060954|FG000|Overall Study|Withdrawal by Subject|2|||
164028445|NCT01885078|592463341|FG006|Step-down Period|Death|0|||
164028446|NCT01885078|592463342|FG007|Step-down Period|Death|0|||
164028447|NCT01885078|592463343|FG008|Step-down Period|Death|4|||
163915898|NCT00331799|592060954|FG000|Overall Study|Sedation|1|||
163915899|NCT02889809|592060955|FG000|Overall Study|Withdrawal by Subject|30|||
163915900|NCT02889809|592060956|FG001|Overall Study|Withdrawal by Subject|21|||
163915901|NCT02889809|592060955|FG000|Overall Study|Lost to Follow-up|1|||
163915902|NCT02889809|592060956|FG001|Overall Study|Lost to Follow-up|1|||
163915903|NCT02889809|592060955|FG000|Overall Study|Site Closed|12|||
163915904|NCT02889809|592060956|FG001|Overall Study|Site Closed|11|||
163915905|NCT03960437|592060959|FG000|Overall Study|Removed by PI|4|||
163915906|NCT03960437|592060959|FG000|Overall Study|Lost to Follow-up|2|||
163915907|NCT03960437|592060959|FG000|Overall Study|Withdrawal by Subject|1|||
163915908|NCT03960437|592060959|FG000|Overall Study|Death|2|||
163915909|NCT03785210|592060966|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
163915910|NCT03785210|592060967|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
163915911|NCT02213458|592060968|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
163915912|NCT02213458|592060969|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
163915913|NCT02213458|592060968|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
163915914|NCT02213458|592060969|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
164028448|NCT01885078|592463344|FG009|Step-down Period|Death|3|||
164028449|NCT01885078|592463335|FG000|Step-down Period|Lost to Follow-up|0|||
164028450|NCT01885078|592463336|FG001|Step-down Period|Lost to Follow-up|0|||
164028451|NCT01885078|592463337|FG002|Step-down Period|Lost to Follow-up|0|||
164028452|NCT01885078|592463338|FG003|Step-down Period|Lost to Follow-up|0|||
164028453|NCT01885078|592463339|FG004|Step-down Period|Lost to Follow-up|0|||
164028454|NCT01885078|592463340|FG005|Step-down Period|Lost to Follow-up|0|||
164028455|NCT01885078|592463341|FG006|Step-down Period|Lost to Follow-up|0|||
164028456|NCT01885078|592463342|FG007|Step-down Period|Lost to Follow-up|0|||
164028457|NCT01885078|592463343|FG008|Step-down Period|Lost to Follow-up|1|||
164028458|NCT01885078|592463344|FG009|Step-down Period|Lost to Follow-up|1|||
164028459|NCT01885078|592463335|FG000|Step-down Period|Lack of Efficacy|0|||
164028460|NCT01885078|592463336|FG001|Step-down Period|Lack of Efficacy|0|||
164028461|NCT01885078|592463337|FG002|Step-down Period|Lack of Efficacy|0|||
164028462|NCT01885078|592463338|FG003|Step-down Period|Lack of Efficacy|0|||
164028463|NCT01885078|592463339|FG004|Step-down Period|Lack of Efficacy|0|||
164028464|NCT01885078|592463340|FG005|Step-down Period|Lack of Efficacy|0|||
164028465|NCT01885078|592463341|FG006|Step-down Period|Lack of Efficacy|0|||
164028466|NCT01885078|592463342|FG007|Step-down Period|Lack of Efficacy|0|||
164028467|NCT01885078|592463343|FG008|Step-down Period|Lack of Efficacy|1|||
164028468|NCT01885078|592463344|FG009|Step-down Period|Lack of Efficacy|0|||
164028469|NCT01885078|592463335|FG000|Step-down Period|Protocol Violation|0|||
164028470|NCT01885078|592463336|FG001|Step-down Period|Protocol Violation|0|||
164028471|NCT01885078|592463337|FG002|Step-down Period|Protocol Violation|0|||
164028472|NCT01885078|592463338|FG003|Step-down Period|Protocol Violation|0|||
164028473|NCT01885078|592463339|FG004|Step-down Period|Protocol Violation|0|||
164028474|NCT01885078|592463340|FG005|Step-down Period|Protocol Violation|0|||
164028475|NCT01885078|592463341|FG006|Step-down Period|Protocol Violation|0|||
164028476|NCT01885078|592463342|FG007|Step-down Period|Protocol Violation|0|||
164028477|NCT01885078|592463343|FG008|Step-down Period|Protocol Violation|1|||
164028478|NCT01885078|592463344|FG009|Step-down Period|Protocol Violation|1|||
164028479|NCT02680587|592463345|FG000|Overall Study|Withdrawal by Subject|1|||
164028480|NCT02680587|592463346|FG001|Overall Study|Withdrawal by Subject|0|||
164028481|NCT00571688|592463350|FG000|Overall Study|Lost to Follow-up|3|||
164028482|NCT00571688|592463351|FG001|Overall Study|Lost to Follow-up|6|||
164028483|NCT00571688|592463350|FG000|Overall Study|subject did not tolerate Consta|1|||
164028484|NCT00571688|592463351|FG001|Overall Study|subject did not tolerate Consta|0|||
164028485|NCT00571688|592463350|FG000|Overall Study|subject moved out of the area|1|||
164028486|NCT00571688|592463351|FG001|Overall Study|subject moved out of the area|0|||
164028487|NCT00259740|592463352|FG000|Overall Study|Physician Decision|1|||
164028488|NCT00259740|592463353|FG001|Overall Study|Physician Decision|1|||
164028489|NCT00259740|592463352|FG000|Overall Study|Adverse Event|0|||
164028490|NCT00259740|592463353|FG001|Overall Study|Adverse Event|2|||
164028491|NCT00259740|592463352|FG000|Overall Study|Withdrawal by Subject|2|||
164028492|NCT00259740|592463353|FG001|Overall Study|Withdrawal by Subject|6|||
164028493|NCT00259740|592463352|FG000|Overall Study|Death|1|||
164028494|NCT00259740|592463353|FG001|Overall Study|Death|1|||
164028495|NCT00259740|592463352|FG000|Overall Study|Disease progression|19|||
164028496|NCT00259740|592463353|FG001|Overall Study|Disease progression|36|||
164028497|NCT00259740|592463352|FG000|Overall Study|Ongoing|17|||
164028498|NCT00259740|592463353|FG001|Overall Study|Ongoing|3|||
164028499|NCT00259740|592463352|FG000|Overall Study|Other|3|||
164028500|NCT00259740|592463353|FG001|Overall Study|Other|0|||
164028501|NCT00259740|592463352|FG000|Overall Study|Requirement for alternative therapy|0|||
164145680|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Death|0|||
164028502|NCT00259740|592463353|FG001|Overall Study|Requirement for alternative therapy|4|||
164028503|NCT01844830|592463358|FG000|Overall Study|Withdrawal by Subject|1|||
164028504|NCT01844830|592463359|FG001|Overall Study|Withdrawal by Subject|0|||
164028505|NCT04735393|592463363|FG000|Overall Study|Lost to Follow-up|46|||
164028506|NCT04735393|592463364|FG001|Overall Study|Lost to Follow-up|24|||
164028507|NCT04735393|592463363|FG000|Overall Study|Physician Decision|2|||
164028508|NCT04735393|592463364|FG001|Overall Study|Physician Decision|1|||
164028509|NCT04735393|592463363|FG000|Overall Study|Not Detailed|1|||
164028510|NCT04735393|592463364|FG001|Overall Study|Not Detailed|2|||
164028511|NCT04735393|592463363|FG000|Overall Study|Withdrawal by Subject|71|||
164028512|NCT04735393|592463364|FG001|Overall Study|Withdrawal by Subject|28|||
164028513|NCT04735393|592463363|FG000|Overall Study|Adverse Event|56|||
164028514|NCT04735393|592463364|FG001|Overall Study|Adverse Event|7|||
164028515|NCT04735393|592463363|FG000|Overall Study|Protocol Violation|6|||
164028516|NCT04735393|592463364|FG001|Overall Study|Protocol Violation|1|||
164028517|NCT04735393|592463363|FG000|Overall Study|Trial terminated by Sponsor|49|||
164028518|NCT04735393|592463364|FG001|Overall Study|Trial terminated by Sponsor|29|||
164028519|NCT00209170|592463365|FG000|Overall Study|Adverse Event|0|||
164028520|NCT00209170|592463366|FG001|Overall Study|Adverse Event|1|||
164028521|NCT00209170|592463365|FG000|Overall Study|Withdrawal by Subject|2|||
164028522|NCT00209170|592463366|FG001|Overall Study|Withdrawal by Subject|1|||
164028523|NCT00209170|592463365|FG000|Overall Study|Lack of Efficacy|0|||
164028524|NCT00209170|592463366|FG001|Overall Study|Lack of Efficacy|1|||
164028525|NCT03224104|592463370|FG000|Overall Study|Lack of Efficacy|2|||
164028526|NCT03224104|592463371|FG001|Overall Study|Lack of Efficacy|6|||
164028527|NCT03224104|592463372|FG002|Overall Study|Lack of Efficacy|3|||
164028528|NCT03224104|592463373|FG003|Overall Study|Lack of Efficacy|4|||
164028529|NCT03224104|592463374|FG004|Overall Study|Lack of Efficacy|42|||
164028530|NCT03224104|592463370|FG000|Overall Study|Withdrawal by Subject|0|||
164028531|NCT03224104|592463371|FG001|Overall Study|Withdrawal by Subject|2|||
164028532|NCT03224104|592463372|FG002|Overall Study|Withdrawal by Subject|0|||
164028533|NCT03224104|592463373|FG003|Overall Study|Withdrawal by Subject|1|||
164028534|NCT03224104|592463374|FG004|Overall Study|Withdrawal by Subject|3|||
164028535|NCT03224104|592463370|FG000|Overall Study|Death|0|||
164028536|NCT03224104|592463371|FG001|Overall Study|Death|1|||
164028537|NCT03224104|592463372|FG002|Overall Study|Death|0|||
164028538|NCT03224104|592463373|FG003|Overall Study|Death|0|||
164028539|NCT03224104|592463374|FG004|Overall Study|Death|0|||
164028540|NCT03224104|592463370|FG000|Overall Study|Adverse Event|1|||
164028541|NCT03224104|592463371|FG001|Overall Study|Adverse Event|0|||
164028542|NCT03224104|592463372|FG002|Overall Study|Adverse Event|0|||
164028543|NCT03224104|592463373|FG003|Overall Study|Adverse Event|1|||
164028544|NCT03224104|592463374|FG004|Overall Study|Adverse Event|3|||
164028545|NCT03224104|592463370|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
163915915|NCT02213458|592060968|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
163915916|NCT02213458|592060969|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
163915917|NCT02213458|592060968|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
163915918|NCT02213458|592060969|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
163915919|NCT02213458|592060968|FG000|Overall Study|Refused re-consent|6|||
163915920|NCT02213458|592060969|FG001|Overall Study|Refused re-consent|0|||
163915921|NCT02213458|592060968|FG000|Overall Study|Lost to Follow-up|2|||
163915922|NCT02213458|592060969|FG001|Overall Study|Lost to Follow-up|2|||
163915923|NCT02213458|592060968|FG000|Overall Study|Withdrawal by Subject|26|||
163915924|NCT02213458|592060969|FG001|Overall Study|Withdrawal by Subject|8|||
163915925|NCT04043806|592060970|FG000|Overall Study|Commercial drug is available for participants|13|||
163915926|NCT04043806|592060970|FG000|Overall Study|Physician Decision|2|||
163915927|NCT04043806|592060970|FG000|Overall Study|Other|12|||
164028546|NCT03224104|592463371|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
164028547|NCT03224104|592463372|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
164028548|NCT03224104|592463373|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
164028549|NCT03224104|592463374|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
164028550|NCT03224104|592463370|FG000|Overall Study|Treatment ongoing|0|||
164028551|NCT03224104|592463371|FG001|Overall Study|Treatment ongoing|0|||
164028552|NCT03224104|592463372|FG002|Overall Study|Treatment ongoing|0|||
164028553|NCT03224104|592463373|FG003|Overall Study|Treatment ongoing|0|||
164028554|NCT03224104|592463374|FG004|Overall Study|Treatment ongoing|1|||
164028555|NCT04397718|592463375|FG000|Overall Study|Death|7|||
164096663|NCT01173692|592717358|FG001|Overall Study|Withdrawal by Subject|3|||
164096664|NCT00669864|592717361|FG000|Overall Study|Lost to Follow-up|2|||
164096665|NCT00669864|592717361|FG000|Overall Study|Protocol Violation|2|||
163915928|NCT04043806|592060970|FG000|Overall Study|Adverse Event|2|||
163915929|NCT04043806|592060970|FG000|Overall Study|Lost to Follow-up|6|||
163915930|NCT04043806|592060970|FG000|Overall Study|Other non-compliance|2|||
163915931|NCT04043806|592060970|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
163915932|NCT04043806|592060970|FG000|Overall Study|Never Dosed|1|||
163915933|NCT03166215|592060975|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
163915934|NCT03166215|592060976|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
163915935|NCT03166215|592060977|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
163915936|NCT03166215|592060975|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
163915937|NCT03166215|592060976|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
163915938|NCT03166215|592060977|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
163915939|NCT04362176|592060980|FG000|Overall Study|Lost to Follow-up|5|||
163915940|NCT04362176|592060981|FG001|Overall Study|Lost to Follow-up|8|||
163915941|NCT04362176|592060980|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
163915942|NCT04362176|592060981|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
163915943|NCT04985604|592060982|FG000|Overall Study|Death|4|||
163915944|NCT04985604|592060983|FG001|Overall Study|Death|6|||
163915945|NCT04985604|592060982|FG000|Overall Study|Withdrawal by Subject|0|||
163915946|NCT04985604|592060983|FG001|Overall Study|Withdrawal by Subject|1|||
163915947|NCT04598776|592060984|FG000|Overall Study|Protocol Violation|5|||
163915948|NCT04598776|592060984|FG000|Overall Study|Physician Decision|4|||
163915949|NCT02282761|592060985|FG000|Overall Study|Death|0|||
163915950|NCT02282761|592060986|FG001|Overall Study|Death|0|||
163915951|NCT02282761|592060987|FG002|Overall Study|Death|1|||
163915952|NCT02282761|592060985|FG000|Overall Study|Adverse Event|6|||
163915953|NCT02282761|592060986|FG001|Overall Study|Adverse Event|2|||
164028556|NCT04397718|592463376|FG001|Overall Study|Death|11|||
164028557|NCT04397718|592463375|FG000|Overall Study|Lost to Follow-up|0|||
164028558|NCT04397718|592463376|FG001|Overall Study|Lost to Follow-up|4|||
164028559|NCT01371981|592463377|FG000|Overall Study|Adverse Event|12|||
164028560|NCT01371981|592463378|FG001|Overall Study|Adverse Event|17|||
164028561|NCT01371981|592463379|FG002|Overall Study|Adverse Event|0|||
164028562|NCT01371981|592463380|FG003|Overall Study|Adverse Event|4|||
164028563|NCT01371981|592463381|FG004|Overall Study|Adverse Event|1|||
164028564|NCT01371981|592463382|FG005|Overall Study|Adverse Event|0|||
164028565|NCT01371981|592463377|FG000|Overall Study|Death|22|||
164028566|NCT01371981|592463378|FG001|Overall Study|Death|16|||
164028567|NCT01371981|592463379|FG002|Overall Study|Death|0|||
164028568|NCT01371981|592463380|FG003|Overall Study|Death|0|||
164028569|NCT01371981|592463381|FG004|Overall Study|Death|2|||
164028570|NCT01371981|592463382|FG005|Overall Study|Death|2|||
164028571|NCT01371981|592463377|FG000|Overall Study|Lack of Efficacy|69|||
163915954|NCT02282761|592060987|FG002|Overall Study|Adverse Event|0|||
164096666|NCT00669864|592717361|FG000|Overall Study|Withdrawal by Subject|3|||
164096667|NCT00669864|592717361|FG000|Overall Study|Other|2|||
163915955|NCT02282761|592060985|FG000|Overall Study|Lack of Efficacy|11|||
163915956|NCT02282761|592060986|FG001|Overall Study|Lack of Efficacy|6|||
163915957|NCT02282761|592060987|FG002|Overall Study|Lack of Efficacy|17|||
163915958|NCT02282761|592060985|FG000|Overall Study|Lost to Follow-up|2|||
163915959|NCT02282761|592060986|FG001|Overall Study|Lost to Follow-up|2|||
163915960|NCT02282761|592060987|FG002|Overall Study|Lost to Follow-up|1|||
163915961|NCT02282761|592060985|FG000|Overall Study|Physician Decision|0|||
163915962|NCT02282761|592060986|FG001|Overall Study|Physician Decision|0|||
163915963|NCT02282761|592060987|FG002|Overall Study|Physician Decision|2|||
163915964|NCT02282761|592060985|FG000|Overall Study|Withdrawal by Subject|8|||
163915965|NCT02282761|592060986|FG001|Overall Study|Withdrawal by Subject|10|||
163915966|NCT02282761|592060987|FG002|Overall Study|Withdrawal by Subject|16|||
163915967|NCT02282761|592060985|FG000|Overall Study|Other|3|||
163915968|NCT02282761|592060986|FG001|Overall Study|Other|2|||
163915969|NCT02282761|592060987|FG002|Overall Study|Other|1|||
163915970|NCT00658632|592060990|FG000|Overall Study|Adverse Event|13|||
163915971|NCT00658632|592060991|FG001|Overall Study|Adverse Event|11|||
163915972|NCT00658632|592060990|FG000|Overall Study|Lost to Follow-up|25|||
163915973|NCT00658632|592060991|FG001|Overall Study|Lost to Follow-up|23|||
163915974|NCT00658632|592060990|FG000|Overall Study|Withdrawal by Subject|10|||
163915975|NCT00658632|592060991|FG001|Overall Study|Withdrawal by Subject|7|||
163915976|NCT00658632|592060990|FG000|Overall Study|Lack of Efficacy|0|||
163915977|NCT00658632|592060991|FG001|Overall Study|Lack of Efficacy|1|||
163915978|NCT00658632|592060990|FG000|Overall Study|Withdrawal of consent|8|||
163915979|NCT00658632|592060991|FG001|Overall Study|Withdrawal of consent|14|||
163915980|NCT00658632|592060990|FG000|Overall Study|Pregnancy|1|||
163915981|NCT00658632|592060991|FG001|Overall Study|Pregnancy|1|||
163915982|NCT00658632|592060990|FG000|Overall Study|Other|7|||
163915983|NCT00658632|592060991|FG001|Overall Study|Other|8|||
163915984|NCT06312566|592060992|FG000|Overall Study|Protocol Violation|0|||
163915985|NCT06312566|592060993|FG001|Overall Study|Protocol Violation|1|||
163915986|NCT02632045|592060994|FG000|Overall Study|Withdrawal by Subject|1|||
163915987|NCT02632045|592060995|FG001|Overall Study|Withdrawal by Subject|2|||
163915988|NCT04551053|592060996|FG000|Overall Study|Death|10|||
163915989|NCT04551053|592060997|FG001|Overall Study|Death|9|||
163915990|NCT04551053|592060996|FG000|Overall Study|Lost to Follow-up|0|||
163915991|NCT04551053|592060997|FG001|Overall Study|Lost to Follow-up|2|||
163915992|NCT04551053|592060996|FG000|Overall Study|Study Terminated by Sponsor|57|||
163915993|NCT04551053|592060997|FG001|Overall Study|Study Terminated by Sponsor|65|||
163915994|NCT04551053|592060996|FG000|Overall Study|Withdrawal by Subject|12|||
163915995|NCT04551053|592060997|FG001|Overall Study|Withdrawal by Subject|5|||
163915996|NCT04551053|592060996|FG000|Overall Study|Adverse Event|2|||
163915997|NCT04551053|592060997|FG001|Overall Study|Adverse Event|0|||
163915998|NCT04551053|592060996|FG000|Overall Study|Lack of Efficacy|2|||
163915999|NCT04551053|592060997|FG001|Overall Study|Lack of Efficacy|1|||
163916000|NCT04551053|592060996|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
163916001|NCT04551053|592060997|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
163916002|NCT04551053|592060996|FG000|Overall Study|Splenapendectomi|1|||
163916003|NCT04551053|592060997|FG001|Overall Study|Splenapendectomi|0|||
163916004|NCT04551053|592060996|FG000|Overall Study|Medical Decision|1|||
163916005|NCT04551053|592060997|FG001|Overall Study|Medical Decision|1|||
163916006|NCT03861078|592060998|FG000|Overall Study|COVID-19 shut down|4|||
163916007|NCT03861078|592060998|FG000|Overall Study|Lost to Follow-up|1|||
163916008|NCT03861078|592060998|FG000|Overall Study|Protocol Violation|2|||
163916009|NCT03861078|592060998|FG000|Overall Study|lack of venous access|1|||
163916010|NCT03503188|592060999|FG000|Overall Study|Non eligible in the sub study|0|||
163916011|NCT03503188|592061000|FG001|Overall Study|Non eligible in the sub study|1|||
163916012|NCT03547167|592061006|FG000|Overall Study|Withdrawal by Subject|34|||
163916013|NCT03547167|592061007|FG001|Overall Study|Withdrawal by Subject|12|||
163916014|NCT03547167|592061006|FG000|Overall Study|Screen Failure|0|||
164028572|NCT01371981|592463378|FG001|Overall Study|Lack of Efficacy|61|||
164028573|NCT01371981|592463379|FG002|Overall Study|Lack of Efficacy|4|||
164028574|NCT01371981|592463380|FG003|Overall Study|Lack of Efficacy|8|||
163916015|NCT03547167|592061007|FG001|Overall Study|Screen Failure|1|||
163916016|NCT03547167|592061006|FG000|Overall Study|Lost to Follow-up|59|||
163916017|NCT03547167|592061007|FG001|Overall Study|Lost to Follow-up|15|||
163916018|NCT03547167|592061006|FG000|Overall Study|Death|4|||
163916019|NCT03547167|592061007|FG001|Overall Study|Death|2|||
163916020|NCT00645411|592061008|FG000|Overall Study|Adverse Event|0|||
163916021|NCT00645411|592061009|FG001|Overall Study|Adverse Event|0|||
163916022|NCT00645411|592061010|FG002|Overall Study|Adverse Event|0|||
163916023|NCT00645411|592061011|FG003|Overall Study|Adverse Event|2|||
163916024|NCT00645411|592061008|FG000|Overall Study|Withdrawal by Subject|2|||
163916025|NCT00645411|592061009|FG001|Overall Study|Withdrawal by Subject|1|||
163916026|NCT00645411|592061010|FG002|Overall Study|Withdrawal by Subject|19|||
163916027|NCT00645411|592061011|FG003|Overall Study|Withdrawal by Subject|21|||
163916028|NCT00645411|592061008|FG000|Overall Study|Lost to Follow-up|10|||
163916029|NCT00645411|592061009|FG001|Overall Study|Lost to Follow-up|5|||
164028575|NCT01371981|592463381|FG004|Overall Study|Lack of Efficacy|5|||
164028576|NCT01371981|592463382|FG005|Overall Study|Lack of Efficacy|0|||
163916030|NCT00645411|592061010|FG002|Overall Study|Lost to Follow-up|124|||
163916031|NCT00645411|592061011|FG003|Overall Study|Lost to Follow-up|75|||
163916032|NCT00645411|592061008|FG000|Overall Study|Protocol Violation|1|||
163916033|NCT00645411|592061009|FG001|Overall Study|Protocol Violation|0|||
163916034|NCT00645411|592061010|FG002|Overall Study|Protocol Violation|1|||
163916035|NCT00645411|592061011|FG003|Overall Study|Protocol Violation|0|||
163916036|NCT00645411|592061008|FG000|Overall Study|Inappropriate enrollment|0|||
163916037|NCT00645411|592061009|FG001|Overall Study|Inappropriate enrollment|0|||
163916038|NCT00645411|592061010|FG002|Overall Study|Inappropriate enrollment|4|||
163916039|NCT00645411|592061011|FG003|Overall Study|Inappropriate enrollment|1|||
163916040|NCT00645411|592061008|FG000|Overall Study|Unable to classify|0|||
163916041|NCT00645411|592061009|FG001|Overall Study|Unable to classify|0|||
163916042|NCT00645411|592061010|FG002|Overall Study|Unable to classify|3|||
163916043|NCT00645411|592061011|FG003|Overall Study|Unable to classify|4|||
163916044|NCT03100370|592061015|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163916045|NCT03100370|592061016|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163916046|NCT03100370|592061017|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163916047|NCT03100370|592061018|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
163916048|NCT03100370|592061019|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163916049|NCT03100370|592061020|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
163916050|NCT02674399|592061021|FG000|Overall Study|Lost to Follow-up|2|||
163916051|NCT02674399|592061022|FG001|Overall Study|Lost to Follow-up|0|||
163916052|NCT01867307|592061023|FG000|Overall Study|Protocol Violation|2|||
163916053|NCT01867307|592061024|FG001|Overall Study|Protocol Violation|0|||
163916054|NCT01867307|592061023|FG000|Overall Study|Other Adverse Event|1|||
163916055|NCT01867307|592061024|FG001|Overall Study|Other Adverse Event|3|||
163916056|NCT00091572|592061036|FG000|Overall Study|Lost to Follow-up|1|||
163916057|NCT00091572|592061037|FG001|Overall Study|Lost to Follow-up|1|||
163916058|NCT00091572|592061036|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
163916059|NCT00091572|592061037|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
163916060|NCT00091572|592061036|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
163916061|NCT00091572|592061037|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
163916062|NCT00091572|592061036|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
163916063|NCT00091572|592061037|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
163916064|NCT00091572|592061036|FG000|Overall Study|Other Reason|6|||
163916065|NCT00091572|592061037|FG001|Overall Study|Other Reason|13|||
163916066|NCT00091572|592061036|FG000|Overall Study|Ongoing (still on treatment)|8|||
163916067|NCT00091572|592061037|FG001|Overall Study|Ongoing (still on treatment)|12|||
163916068|NCT00091572|592061036|FG000|Overall Study|Major Protocol Violation|2|||
163916069|NCT00091572|592061037|FG001|Overall Study|Major Protocol Violation|0|||
163916070|NCT00091572|592061036|FG000|Overall Study|Toxicity (Related AE)|53|||
163916071|NCT00091572|592061037|FG001|Overall Study|Toxicity (Related AE)|9|||
163916072|NCT03122548|592061042|FG000|Overall Study|Death|2|||
163916073|NCT03122548|592061042|FG000|Overall Study|Progression - subject went into hospice|1|||
163916074|NCT03122548|592061042|FG000|Overall Study|Study Terminated by Sponsor|2|||
163916075|NCT01199302|592061048|FG000|Overall Study|Adverse Event|1|||
163916076|NCT01199302|592061049|FG001|Overall Study|Adverse Event|1|||
163916077|NCT01199302|592061050|FG002|Overall Study|Adverse Event|2|||
163916078|NCT01199302|592061051|FG003|Overall Study|Adverse Event|0|||
163916079|NCT01199302|592061048|FG000|Overall Study|Withdrawal by Subject|2|||
163916080|NCT01199302|592061049|FG001|Overall Study|Withdrawal by Subject|2|||
163916081|NCT01199302|592061050|FG002|Overall Study|Withdrawal by Subject|3|||
163916082|NCT01199302|592061051|FG003|Overall Study|Withdrawal by Subject|0|||
163916083|NCT01199302|592061048|FG000|Overall Study|Disease Progression|3|||
163916084|NCT01199302|592061049|FG001|Overall Study|Disease Progression|4|||
164096668|NCT01941030|592717365|FG000|Overall Study|Death|3|||
164096669|NCT01941030|592717366|FG001|Overall Study|Death|2|||
164096670|NCT01941030|592717365|FG000|Overall Study|Lost to Follow-up|6|||
164096671|NCT01941030|592717366|FG001|Overall Study|Lost to Follow-up|5|||
164096672|NCT01941030|592717365|FG000|Overall Study|Withdrawal by Subject|4|||
163916085|NCT01199302|592061050|FG002|Overall Study|Disease Progression|4|||
163916086|NCT01199302|592061051|FG003|Overall Study|Disease Progression|2|||
163916087|NCT01199302|592061048|FG000|Overall Study|Study Termination|13|||
163916088|NCT01199302|592061049|FG001|Overall Study|Study Termination|8|||
163916089|NCT01199302|592061050|FG002|Overall Study|Study Termination|11|||
163916090|NCT01199302|592061051|FG003|Overall Study|Study Termination|9|||
163916091|NCT01199302|592061048|FG000|Overall Study|Lost to Follow-up|0|||
163916092|NCT01199302|592061049|FG001|Overall Study|Lost to Follow-up|1|||
163916093|NCT01199302|592061050|FG002|Overall Study|Lost to Follow-up|0|||
163916094|NCT01199302|592061051|FG003|Overall Study|Lost to Follow-up|0|||
163916095|NCT01199302|592061048|FG000|Overall Study|Other|1|||
163916096|NCT01199302|592061049|FG001|Overall Study|Other|0|||
163916097|NCT01199302|592061050|FG002|Overall Study|Other|0|||
163916098|NCT01199302|592061051|FG003|Overall Study|Other|0|||
163916099|NCT01634165|592061053|FG000|Period 2|Adverse Event|0|||
163916100|NCT01634165|592061054|FG001|Period 2|Adverse Event|1|||
163916101|NCT01634165|592061055|FG002|Period 2|Adverse Event|0|||
163916102|NCT01634165|592061056|FG003|Period 2|Adverse Event|0|||
163916103|NCT04097535|592061059|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
163916104|NCT03070301|592061060|FG000|Overall Study|Progression of disease|16|||
163916105|NCT03070301|592061060|FG000|Overall Study|Physician Decision|3|||
163916106|NCT03070301|592061060|FG000|Overall Study|Withdrawal by Subject|1|||
163916107|NCT03820024|592061061|FG000|Overall Study|Physician Decision|1|||
163916108|NCT03820024|592061062|FG001|Overall Study|Physician Decision|2|||
164028577|NCT01371981|592463377|FG000|Overall Study|Physician Decision|48|||
164028578|NCT01371981|592463378|FG001|Overall Study|Physician Decision|63|||
164028579|NCT01371981|592463379|FG002|Overall Study|Physician Decision|1|||
164028580|NCT01371981|592463380|FG003|Overall Study|Physician Decision|7|||
164028581|NCT01371981|592463381|FG004|Overall Study|Physician Decision|14|||
164028582|NCT01371981|592463382|FG005|Overall Study|Physician Decision|3|||
163916109|NCT03322514|592062438|FG000|Overall Study|Withdrawal by Subject|1|||
163916110|NCT03322514|592062439|FG001|Overall Study|Withdrawal by Subject|1|||
163916111|NCT00088452|592062440|FG000|Overall Study|Did not receive intervention|1|||
163916112|NCT00088452|592062441|FG001|Overall Study|Did not receive intervention|0|||
163916113|NCT00088452|592062442|FG002|Overall Study|Did not receive intervention|1|||
163916114|NCT02081196|592062444|FG000|Overall Study|Lost to Follow-up|1|||
163916115|NCT00961298|592062445|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
163916116|NCT00961298|592062445|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
163916117|NCT00961298|592062445|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
163916118|NCT04044352|592062448|FG000|Overall Study|Lost to Follow-up|9|||
163916119|NCT04044352|592062448|FG000|Overall Study|Withdrawal by Subject|2|||
163916120|NCT00814632|592062452|FG000|Overall Study|Lack of Efficacy|2|||
163916121|NCT02514577|592062461|FG000|Overall Study|Lost to Follow-up|6|||
163916122|NCT02514577|592062462|FG001|Overall Study|Lost to Follow-up|6|||
163916123|NCT02514577|592062461|FG000|Overall Study|Protocol Violation|1|||
163916124|NCT02514577|592062462|FG001|Overall Study|Protocol Violation|0|||
163916125|NCT02514577|592062461|FG000|Overall Study|Withdrawal by Subject|6|||
163916126|NCT02514577|592062462|FG001|Overall Study|Withdrawal by Subject|6|||
163916127|NCT02514577|592062461|FG000|Overall Study|Adverse Event|1|||
163916128|NCT02514577|592062462|FG001|Overall Study|Adverse Event|1|||
163916129|NCT00489489|592062463|FG000|Overall Study|Not treated due to protocol violation|0|||
163916130|NCT00489489|592062464|FG001|Overall Study|Not treated due to protocol violation|1|||
163916131|NCT00489489|592062465|FG002|Overall Study|Not treated due to protocol violation|1|||
163916132|NCT00489489|592062463|FG000|Overall Study|Adverse Event|1|||
163916133|NCT00489489|592062464|FG001|Overall Study|Adverse Event|1|||
163916134|NCT00489489|592062465|FG002|Overall Study|Adverse Event|1|||
163916135|NCT00489489|592062463|FG000|Overall Study|Protocol Violation|1|||
163916136|NCT00489489|592062464|FG001|Overall Study|Protocol Violation|0|||
163916137|NCT00489489|592062465|FG002|Overall Study|Protocol Violation|1|||
163916138|NCT00489489|592062463|FG000|Overall Study|Progressive disease|0|||
163916139|NCT00489489|592062464|FG001|Overall Study|Progressive disease|1|||
163916140|NCT00489489|592062465|FG002|Overall Study|Progressive disease|0|||
163916141|NCT00489489|592062463|FG000|Overall Study|Participant did not wish to continue|1|||
163916142|NCT00489489|592062464|FG001|Overall Study|Participant did not wish to continue|1|||
163916143|NCT00489489|592062465|FG002|Overall Study|Participant did not wish to continue|0|||
163916144|NCT00489489|592062463|FG000|Overall Study|Other than above|0|||
163916145|NCT00489489|592062464|FG001|Overall Study|Other than above|1|||
163916146|NCT00489489|592062465|FG002|Overall Study|Other than above|0|||
163916147|NCT02136797|592062468|FG000|Overall Study|Not Treated|8|||
163916148|NCT04523571|592062469|FG000|Received 2 Doses|Withdrawal by Subject|0|||
163916149|NCT04523571|592062470|FG001|Received 2 Doses|Withdrawal by Subject|0|||
163916150|NCT04523571|592062471|FG002|Received 2 Doses|Withdrawal by Subject|0|||
163916151|NCT04523571|592062472|FG003|Received 2 Doses|Withdrawal by Subject|1|||
163916152|NCT04523571|592062473|FG004|Received 2 Doses|Withdrawal by Subject|1|||
164028583|NCT01371981|592463377|FG000|Overall Study|Withdrawal by Subject|12|||
164146139|NCT02439970|592896043|FG001|Overall Study|Study Terminated|3|||
163916153|NCT04523571|592062474|FG005|Received 2 Doses|Withdrawal by Subject|0|||
163916154|NCT04523571|592062469|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
163916155|NCT04523571|592062470|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163916156|NCT04523571|592062471|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
163916157|NCT04523571|592062472|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163916158|NCT04523571|592062473|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
164028584|NCT01371981|592463378|FG001|Overall Study|Withdrawal by Subject|19|||
164028585|NCT01371981|592463379|FG002|Overall Study|Withdrawal by Subject|1|||
164028586|NCT01371981|592463380|FG003|Overall Study|Withdrawal by Subject|2|||
164028587|NCT01371981|592463381|FG004|Overall Study|Withdrawal by Subject|10|||
163916159|NCT04523571|592062474|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
163916160|NCT04523571|592062469|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163916161|NCT04523571|592062470|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163916162|NCT04523571|592062471|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163916163|NCT04523571|592062472|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163916164|NCT04523571|592062473|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
163916165|NCT04523571|592062474|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
163916166|NCT04523571|592062469|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163916167|NCT04523571|592062470|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163916168|NCT04523571|592062471|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163916169|NCT04523571|592062472|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
163916170|NCT04523571|592062473|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
163916171|NCT04523571|592062474|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
163916172|NCT04198428|592062475|FG000|Overall Study|Withdrawal by Subject|150|||
164028588|NCT01371981|592463382|FG005|Overall Study|Withdrawal by Subject|3|||
164028589|NCT01371981|592463377|FG000|Overall Study|Ineligible|19|||
164028590|NCT01371981|592463378|FG001|Overall Study|Ineligible|13|||
164028591|NCT01371981|592463379|FG002|Overall Study|Ineligible|0|||
164028592|NCT01371981|592463380|FG003|Overall Study|Ineligible|0|||
164028593|NCT01371981|592463381|FG004|Overall Study|Ineligible|0|||
164028594|NCT01371981|592463382|FG005|Overall Study|Ineligible|4|||
163916173|NCT04198428|592062476|FG001|Overall Study|Withdrawal by Subject|156|||
163916174|NCT00627523|592062478|FG000|Overall Study|Lack of Efficacy|1|||
163916175|NCT00627523|592062479|FG001|Overall Study|Lack of Efficacy|0|||
163916176|NCT00627523|592062478|FG000|Overall Study|Withdrawal by Subject|0|||
163916177|NCT00627523|592062479|FG001|Overall Study|Withdrawal by Subject|2|||
163916178|NCT00627523|592062478|FG000|Overall Study|Other|1|||
163916179|NCT00627523|592062479|FG001|Overall Study|Other|0|||
163916180|NCT04203199|592062484|FG000|First Intervention Period|Lost to Follow-up|0|||
163916181|NCT04203199|592062485|FG001|First Intervention Period|Lost to Follow-up|1|||
163916182|NCT04203199|592062484|FG000|Second Intervention Period|Medication change|1|||
163916183|NCT04203199|592062485|FG001|Second Intervention Period|Medication change|0|||
163916184|NCT01136733|592062486|FG000|Phase 1b|Adverse Event|0|||
163916185|NCT01136733|592062487|FG001|Phase 1b|Adverse Event|3|||
163916186|NCT01136733|592062488|FG002|Phase 1b|Adverse Event|1|||
163916187|NCT01136733|592062489|FG003|Phase 1b|Adverse Event|0|||
163916188|NCT01136733|592062490|FG004|Phase 1b|Adverse Event|0|||
163916189|NCT01136733|592062491|FG005|Phase 1b|Adverse Event|0|||
163916190|NCT01136733|592062492|FG006|Phase 1b|Adverse Event|0|||
163916191|NCT01136733|592062486|FG000|Phase 1b|Participant Choice|0|||
163916192|NCT01136733|592062487|FG001|Phase 1b|Participant Choice|0|||
163916193|NCT01136733|592062488|FG002|Phase 1b|Participant Choice|1|||
163916194|NCT01136733|592062489|FG003|Phase 1b|Participant Choice|0|||
163916195|NCT01136733|592062490|FG004|Phase 1b|Participant Choice|0|||
163916196|NCT01136733|592062491|FG005|Phase 1b|Participant Choice|0|||
163916197|NCT01136733|592062492|FG006|Phase 1b|Participant Choice|0|||
163916198|NCT01136733|592062486|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
163916199|NCT01136733|592062487|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
163916200|NCT01136733|592062488|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
163916201|NCT01136733|592062489|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
163916202|NCT01136733|592062490|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
163916203|NCT01136733|592062491|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
163916204|NCT01136733|592062492|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
163916205|NCT01136733|592062486|FG000|Phase 1b|Clinical Progression|1|||
163916206|NCT01136733|592062487|FG001|Phase 1b|Clinical Progression|1|||
163916207|NCT01136733|592062488|FG002|Phase 1b|Clinical Progression|0|||
163916208|NCT01136733|592062489|FG003|Phase 1b|Clinical Progression|0|||
163916209|NCT01136733|592062490|FG004|Phase 1b|Clinical Progression|0|||
163916210|NCT01136733|592062491|FG005|Phase 1b|Clinical Progression|0|||
163916211|NCT01136733|592062492|FG006|Phase 1b|Clinical Progression|0|||
163916212|NCT01136733|592062486|FG000|Phase 2|Disease Progression|0|||
163916213|NCT01136733|592062487|FG001|Phase 2|Disease Progression|0|||
163916214|NCT01136733|592062488|FG002|Phase 2|Disease Progression|0|||
164028595|NCT01371981|592463377|FG000|Overall Study|Did not start treatment|2|||
164028596|NCT01371981|592463378|FG001|Overall Study|Did not start treatment|3|||
164096673|NCT01941030|592717366|FG001|Overall Study|Withdrawal by Subject|6|||
163916215|NCT01136733|592062489|FG003|Phase 2|Disease Progression|0|||
163916216|NCT01136733|592062490|FG004|Phase 2|Disease Progression|30|||
163916217|NCT01136733|592062491|FG005|Phase 2|Disease Progression|32|||
163916218|NCT01136733|592062492|FG006|Phase 2|Disease Progression|38|||
163916219|NCT01136733|592062486|FG000|Phase 2|Adverse Event|0|||
164028597|NCT01371981|592463379|FG002|Overall Study|Did not start treatment|0|||
164028598|NCT01371981|592463380|FG003|Overall Study|Did not start treatment|0|||
164028599|NCT01371981|592463381|FG004|Overall Study|Did not start treatment|0|||
164028600|NCT01371981|592463382|FG005|Overall Study|Did not start treatment|2|||
164096674|NCT05067647|592717369|FG000|Overall Study|Lost to Follow-up|1|||
163916220|NCT01136733|592062487|FG001|Phase 2|Adverse Event|0|||
163916221|NCT01136733|592062488|FG002|Phase 2|Adverse Event|0|||
163916222|NCT01136733|592062489|FG003|Phase 2|Adverse Event|0|||
163916223|NCT01136733|592062490|FG004|Phase 2|Adverse Event|11|||
163916224|NCT01136733|592062491|FG005|Phase 2|Adverse Event|13|||
163916225|NCT01136733|592062492|FG006|Phase 2|Adverse Event|5|||
163916226|NCT01136733|592062486|FG000|Phase 2|Participant Choice|0|||
163916227|NCT01136733|592062487|FG001|Phase 2|Participant Choice|0|||
163916228|NCT01136733|592062488|FG002|Phase 2|Participant Choice|0|||
163916229|NCT01136733|592062489|FG003|Phase 2|Participant Choice|0|||
163916230|NCT01136733|592062490|FG004|Phase 2|Participant Choice|3|||
163916231|NCT01136733|592062491|FG005|Phase 2|Participant Choice|0|||
163916232|NCT01136733|592062492|FG006|Phase 2|Participant Choice|1|||
163916233|NCT01136733|592062486|FG000|Phase 2|Administrative-Withdrew Consent|0|||
163916234|NCT01136733|592062487|FG001|Phase 2|Administrative-Withdrew Consent|0|||
163916235|NCT01136733|592062488|FG002|Phase 2|Administrative-Withdrew Consent|0|||
163916236|NCT01136733|592062489|FG003|Phase 2|Administrative-Withdrew Consent|0|||
163916237|NCT01136733|592062490|FG004|Phase 2|Administrative-Withdrew Consent|1|||
163916238|NCT01136733|592062491|FG005|Phase 2|Administrative-Withdrew Consent|0|||
163916239|NCT01136733|592062492|FG006|Phase 2|Administrative-Withdrew Consent|0|||
163916240|NCT01136733|592062486|FG000|Phase 2|Other|0|||
163916241|NCT01136733|592062487|FG001|Phase 2|Other|0|||
163916242|NCT01136733|592062488|FG002|Phase 2|Other|0|||
163916243|NCT01136733|592062489|FG003|Phase 2|Other|0|||
163916244|NCT01136733|592062490|FG004|Phase 2|Other|6|||
163916245|NCT01136733|592062491|FG005|Phase 2|Other|7|||
163916246|NCT01136733|592062492|FG006|Phase 2|Other|6|||
163916247|NCT01882088|592062494|FG000|Overall Study|Intolerance of esophageal manometry|1|||
163916248|NCT01882088|592062494|FG000|Overall Study|no possibility to place the catheter|1|||
163916249|NCT01882088|592062494|FG000|Overall Study|Protocol Violation|1|||
163916250|NCT01882088|592062494|FG000|Overall Study|inadequate pH-impedance tracings|2|||
163916251|NCT02186015|592062495|FG000|Overall Study|Physician Decision|1|||
163916252|NCT02186015|592062496|FG001|Overall Study|Physician Decision|0|||
163916253|NCT01533181|592062499|FG000|Overall Study|Disease progression pre-active treatment|0|||
163916254|NCT01533181|592062500|FG001|Overall Study|Disease progression pre-active treatment|1|||
163916255|NCT01533181|592062499|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
163916256|NCT01533181|592062500|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
163916257|NCT02720198|592062501|FG000|Overall Study|Withdrawal by Subject|0|||
163916258|NCT02720198|592062502|FG001|Overall Study|Withdrawal by Subject|1|||
163916259|NCT02592434|592062505|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
163916260|NCT02592434|592062506|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
163916261|NCT02592434|592062507|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
163916262|NCT02592434|592062505|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
163916263|NCT02592434|592062506|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
163916264|NCT02592434|592062507|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
163916265|NCT02592434|592062505|FG000|Open-Label Phase (18 Weeks)|Other|3|||
163916266|NCT02592434|592062506|FG001|Open-Label Phase (18 Weeks)|Other|0|||
163916267|NCT02592434|592062507|FG002|Open-Label Phase (18 Weeks)|Other|0|||
163916268|NCT02592434|592062505|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
163916269|NCT02592434|592062506|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
163916270|NCT02592434|592062507|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
163916271|NCT02592434|592062505|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
163916272|NCT02592434|592062506|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
163916273|NCT02592434|592062507|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
163916274|NCT02592434|592062505|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
163916275|NCT02592434|592062506|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
163916276|NCT02592434|592062507|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
163916277|NCT02592434|592062505|FG000|Double Blind Phase (26 Weeks)|Other|0|||
163916278|NCT02592434|592062506|FG001|Double Blind Phase (26 Weeks)|Other|1|||
163916279|NCT02592434|592062507|FG002|Double Blind Phase (26 Weeks)|Other|0|||
163916280|NCT02592434|592062505|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
163916281|NCT02592434|592062506|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
164096675|NCT02781727|592717371|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
163916282|NCT02592434|592062507|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
163916283|NCT02592434|592062505|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
163916284|NCT02592434|592062506|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
164096676|NCT02781727|592717372|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
164096677|NCT02781727|592717371|FG000|Treatment Period|Withdrawal by Subject|1|||
164096678|NCT02781727|592717372|FG001|Treatment Period|Withdrawal by Subject|0|||
164096679|NCT02781727|592717371|FG000|Treatment Period|Lost to Follow-up|0|||
163916285|NCT02592434|592062507|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
163916286|NCT02592434|592062505|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
163916287|NCT02592434|592062506|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
163916288|NCT02592434|592062507|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
163916289|NCT00147745|592062508|FG000|Overall Study|Withdrawal by Subject|1|||
163916290|NCT00147745|592062509|FG001|Overall Study|Withdrawal by Subject|0|||
163916291|NCT00147745|592062510|FG002|Overall Study|Withdrawal by Subject|0|||
163916292|NCT01757171|592062511|FG000|Overall Study|Adverse Event|5|||
163916293|NCT01757171|592062512|FG001|Overall Study|Adverse Event|1|||
163916294|NCT01757171|592062511|FG000|Overall Study|Disease Progression|1|||
163916295|NCT01757171|592062512|FG001|Overall Study|Disease Progression|0|||
163916296|NCT01757171|592062511|FG000|Overall Study|Hospitalization|1|||
163916297|NCT01757171|592062512|FG001|Overall Study|Hospitalization|0|||
163916298|NCT01757171|592062511|FG000|Overall Study|ECOG decline|1|||
163916299|NCT01757171|592062512|FG001|Overall Study|ECOG decline|0|||
163916300|NCT00105521|592062514|FG000|Overall Study|Other|1|||
163916301|NCT00105521|592062515|FG001|Overall Study|Other|1|||
163916302|NCT00105521|592062516|FG002|Overall Study|Other|2|||
163916303|NCT00105521|592062517|FG003|Overall Study|Other|0|||
163916304|NCT00105521|592062514|FG000|Overall Study|Adverse Event|10|||
163916305|NCT00105521|592062515|FG001|Overall Study|Adverse Event|4|||
163916306|NCT00105521|592062516|FG002|Overall Study|Adverse Event|10|||
163916307|NCT00105521|592062517|FG003|Overall Study|Adverse Event|8|||
163916308|NCT00105521|592062514|FG000|Overall Study|Withdrawal by Subject|1|||
163916309|NCT00105521|592062515|FG001|Overall Study|Withdrawal by Subject|0|||
163916310|NCT00105521|592062516|FG002|Overall Study|Withdrawal by Subject|1|||
163916311|NCT00105521|592062517|FG003|Overall Study|Withdrawal by Subject|4|||
163916312|NCT00105521|592062514|FG000|Overall Study|Lack of Efficacy|0|||
163916313|NCT00105521|592062515|FG001|Overall Study|Lack of Efficacy|0|||
163916314|NCT00105521|592062516|FG002|Overall Study|Lack of Efficacy|0|||
163916315|NCT00105521|592062517|FG003|Overall Study|Lack of Efficacy|1|||
163916316|NCT00105521|592062514|FG000|Overall Study|Protocol Violation|3|||
163916317|NCT00105521|592062515|FG001|Overall Study|Protocol Violation|5|||
163916318|NCT00105521|592062516|FG002|Overall Study|Protocol Violation|4|||
163916319|NCT00105521|592062517|FG003|Overall Study|Protocol Violation|4|||
163916320|NCT00105521|592062514|FG000|Overall Study|Lost to Follow-up|0|||
163916321|NCT00105521|592062515|FG001|Overall Study|Lost to Follow-up|1|||
163916322|NCT00105521|592062516|FG002|Overall Study|Lost to Follow-up|0|||
163916323|NCT00105521|592062517|FG003|Overall Study|Lost to Follow-up|0|||
163916324|NCT00385697|592062520|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
163916325|NCT00385697|592062521|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
163916326|NCT00385697|592062522|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
163916327|NCT00385697|592062523|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
163916328|NCT00385697|592062524|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
163916329|NCT00385697|592062520|FG000|Open-label Segment 1|Lost to Follow-up|1|||
163916330|NCT00385697|592062521|FG001|Open-label Segment 1|Lost to Follow-up|0|||
163916331|NCT00385697|592062522|FG002|Open-label Segment 1|Lost to Follow-up|0|||
163916332|NCT00385697|592062523|FG003|Open-label Segment 1|Lost to Follow-up|0|||
163916333|NCT00385697|592062524|FG004|Open-label Segment 1|Lost to Follow-up|0|||
163916334|NCT00385697|592062520|FG000|Double-blind Segment 2|Adverse Event|0|||
163916335|NCT00385697|592062521|FG001|Double-blind Segment 2|Adverse Event|3|||
163916336|NCT00385697|592062522|FG002|Double-blind Segment 2|Adverse Event|1|||
163916337|NCT00385697|592062523|FG003|Double-blind Segment 2|Adverse Event|0|||
163916338|NCT00385697|592062524|FG004|Double-blind Segment 2|Adverse Event|0|||
163916339|NCT00385697|592062520|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
163916340|NCT00385697|592062521|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
163916341|NCT00385697|592062522|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
163916342|NCT00385697|592062523|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
163916343|NCT00385697|592062524|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
163916344|NCT00385697|592062520|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
163916345|NCT00385697|592062521|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
163916346|NCT00385697|592062522|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
163916347|NCT00385697|592062523|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
163916348|NCT00385697|592062524|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
163916349|NCT00385697|592062520|FG000|Double-blind Segment 2|Other|0|||
163916350|NCT00385697|592062521|FG001|Double-blind Segment 2|Other|2|||
163916351|NCT00385697|592062522|FG002|Double-blind Segment 2|Other|0|||
163916352|NCT00385697|592062523|FG003|Double-blind Segment 2|Other|0|||
163916353|NCT00385697|592062524|FG004|Double-blind Segment 2|Other|0|||
164028601|NCT02493426|592463383|FG000|Overall Study|Withdrawal by Subject|0|||
163916354|NCT00510783|592062528|FG000|Overall Study|Lost to Follow-up|29|||
163916355|NCT00510783|592062529|FG001|Overall Study|Lost to Follow-up|25|||
163916356|NCT00510783|592062528|FG000|Overall Study|Withdrawal by Subject|2|||
163916357|NCT00510783|592062529|FG001|Overall Study|Withdrawal by Subject|3|||
163916358|NCT00510783|592062528|FG000|Overall Study|Protocol Violation|0|||
163916359|NCT00510783|592062529|FG001|Overall Study|Protocol Violation|1|||
163916360|NCT00316121|592062530|FG000|Overall Study|Death|1|||
163916361|NCT00316121|592062531|FG001|Overall Study|Death|0|||
163916362|NCT00316121|592062530|FG000|Overall Study|Lost to Follow-up|14|||
163916363|NCT00316121|592062531|FG001|Overall Study|Lost to Follow-up|8|||
163916364|NCT00316121|592062530|FG000|Overall Study|Withdrawal by Subject|2|||
163916365|NCT00316121|592062531|FG001|Overall Study|Withdrawal by Subject|0|||
163916366|NCT00316121|592062530|FG000|Overall Study|Reason is missing|1|||
163916367|NCT00316121|592062531|FG001|Overall Study|Reason is missing|0|||
163916368|NCT00316121|592062530|FG000|Overall Study|Subject relocated|1|||
163916369|NCT00316121|592062531|FG001|Overall Study|Subject relocated|1|||
163916370|NCT00316121|592062530|FG000|Overall Study|Subject refused to return|1|||
163916371|NCT00316121|592062531|FG001|Overall Study|Subject refused to return|0|||
163916372|NCT00316121|592062530|FG000|Overall Study|Subject no show for visit x 3|1|||
163916373|NCT00316121|592062531|FG001|Overall Study|Subject no show for visit x 3|0|||
163916374|NCT00316121|592062530|FG000|Overall Study|Subject did not have 24 month visit|1|||
163916375|NCT00316121|592062531|FG001|Overall Study|Subject did not have 24 month visit|0|||
163916376|NCT00460577|592062539|FG000|Overall Study|Protocol Violation|2|||
163916377|NCT00460577|592062540|FG001|Overall Study|Protocol Violation|6|||
163916378|NCT01721109|592062546|FG000|Overall Study|Lack of Efficacy|1|||
163916379|NCT01721109|592062546|FG000|Overall Study|Non- Compliance with Study Drug|3|||
163916380|NCT01721109|592062546|FG000|Overall Study|Withdrew Consent|1|||
163916381|NCT01721109|592062546|FG000|Overall Study|Lost to Follow-up|2|||
163916382|NCT00134056|592062547|FG000|Randomization|Not eligible for assigned treatment|22|||
163916383|NCT00134056|592062548|FG001|Randomization|Not eligible for assigned treatment|20|||
163916384|NCT00134056|592062547|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
163916385|NCT00134056|592062548|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
163916386|NCT00134056|592062547|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
163916387|NCT00134056|592062548|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
163916388|NCT00134056|592062547|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
163916389|NCT00134056|592062548|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
163916390|NCT00134056|592062547|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
163916391|NCT00134056|592062548|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
163916392|NCT00742560|592062550|FG000|Overall Study|Adverse Event|0|||
163916393|NCT00742560|592062551|FG001|Overall Study|Adverse Event|0|||
163916394|NCT00742560|592062552|FG002|Overall Study|Adverse Event|1|||
163916395|NCT00742560|592062553|FG003|Overall Study|Adverse Event|1|||
163916396|NCT00742560|592062554|FG004|Overall Study|Adverse Event|1|||
163916397|NCT00742560|592062550|FG000|Overall Study|Death|0|||
163916398|NCT00742560|592062551|FG001|Overall Study|Death|2|||
163916399|NCT00742560|592062552|FG002|Overall Study|Death|0|||
163916400|NCT00742560|592062553|FG003|Overall Study|Death|2|||
163916401|NCT00742560|592062554|FG004|Overall Study|Death|3|||
163916402|NCT00742560|592062550|FG000|Overall Study|Subject's Decision|1|||
163916403|NCT00742560|592062551|FG001|Overall Study|Subject's Decision|0|||
163916404|NCT00742560|592062552|FG002|Overall Study|Subject's Decision|2|||
163916405|NCT00742560|592062553|FG003|Overall Study|Subject's Decision|3|||
163916406|NCT00742560|592062554|FG004|Overall Study|Subject's Decision|3|||
163916407|NCT00742560|592062550|FG000|Overall Study|Investigator's Decision|0|||
163916408|NCT00742560|592062551|FG001|Overall Study|Investigator's Decision|0|||
163916409|NCT00742560|592062552|FG002|Overall Study|Investigator's Decision|4|||
163916410|NCT00742560|592062553|FG003|Overall Study|Investigator's Decision|1|||
163916411|NCT00742560|592062554|FG004|Overall Study|Investigator's Decision|0|||
163916412|NCT00742560|592062550|FG000|Overall Study|Disease Progression|1|||
163916413|NCT00742560|592062551|FG001|Overall Study|Disease Progression|0|||
163916414|NCT00742560|592062552|FG002|Overall Study|Disease Progression|5|||
163916415|NCT00742560|592062553|FG003|Overall Study|Disease Progression|17|||
163916416|NCT00742560|592062554|FG004|Overall Study|Disease Progression|16|||
163916417|NCT00742560|592062550|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
163916418|NCT00742560|592062551|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
163916419|NCT00742560|592062552|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
163916420|NCT00742560|592062553|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
163916421|NCT00742560|592062554|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
163916422|NCT00742560|592062550|FG000|Overall Study|Other|0|||
163916423|NCT00742560|592062551|FG001|Overall Study|Other|1|||
163916424|NCT00742560|592062552|FG002|Overall Study|Other|8|||
163916425|NCT00742560|592062553|FG003|Overall Study|Other|9|||
164028602|NCT02493426|592463384|FG001|Overall Study|Withdrawal by Subject|1|||
164028603|NCT01153893|592463385|FG000|Overall Study|Adverse Event|1|||
164028604|NCT01153893|592463386|FG001|Overall Study|Adverse Event|0|||
163916426|NCT00742560|592062554|FG004|Overall Study|Other|9|||
163916427|NCT00742560|592062550|FG000|Overall Study|MIssing|0|||
163916428|NCT00742560|592062551|FG001|Overall Study|MIssing|0|||
163916429|NCT00742560|592062552|FG002|Overall Study|MIssing|0|||
163916430|NCT00742560|592062553|FG003|Overall Study|MIssing|0|||
163916431|NCT00742560|592062554|FG004|Overall Study|MIssing|1|||
163916432|NCT01536795|592062556|FG000|Overall Study|Lost to Follow-up|0|||
163916433|NCT01536795|592062557|FG001|Overall Study|Lost to Follow-up|2|||
163916434|NCT01536795|592062556|FG000|Overall Study|Lack of Efficacy|1|||
163916435|NCT01536795|592062557|FG001|Overall Study|Lack of Efficacy|0|||
163916436|NCT02267746|592062558|FG000|Overall Study|Adverse Event|0|||
163916437|NCT02267746|592062559|FG001|Overall Study|Adverse Event|2|||
163916438|NCT02267746|592062560|FG002|Overall Study|Adverse Event|1|||
163916439|NCT02267746|592062558|FG000|Overall Study|Protocol Violation|8|||
163916440|NCT02267746|592062559|FG001|Overall Study|Protocol Violation|7|||
163916441|NCT02267746|592062560|FG002|Overall Study|Protocol Violation|3|||
163916442|NCT02267746|592062558|FG000|Overall Study|Lack of Efficacy|11|||
163916443|NCT02267746|592062559|FG001|Overall Study|Lack of Efficacy|11|||
163916444|NCT02267746|592062560|FG002|Overall Study|Lack of Efficacy|15|||
163916445|NCT02267746|592062558|FG000|Overall Study|Protocol Violation|1|||
163916446|NCT02267746|592062559|FG001|Overall Study|Protocol Violation|2|||
163916447|NCT02267746|592062560|FG002|Overall Study|Protocol Violation|1|||
163916448|NCT02267746|592062558|FG000|Overall Study|Miscellaneous|1|||
163916449|NCT02267746|592062559|FG001|Overall Study|Miscellaneous|0|||
163916450|NCT02267746|592062560|FG002|Overall Study|Miscellaneous|1|||
163916451|NCT05008224|592062561|FG000|Overall Study|Death|3|||
163916452|NCT05008224|592062561|FG000|Overall Study|Lost to Follow-up|2|||
163916453|NCT05008224|592062561|FG000|Overall Study|Did Not Continue on Extension Study|39|||
163916454|NCT05008224|592062561|FG000|Overall Study|Transferred to Extension Study|100|||
163916455|NCT05008224|592062561|FG000|Overall Study|Withdrawal by Subject|2|||
163916456|NCT00348283|592062562|FG000|Induction|Adverse Event|0|||
163916457|NCT00348283|592062563|FG001|Induction|Adverse Event|2|||
163916458|NCT00348283|592062562|FG000|Induction|Protocol Violation|0|||
163916459|NCT00348283|592062563|FG001|Induction|Protocol Violation|4|||
163916460|NCT00348283|592062562|FG000|Double Blind|Adverse Event|2|||
163916461|NCT00348283|592062563|FG001|Double Blind|Adverse Event|5|||
163916462|NCT00348283|592062562|FG000|Double Blind|Withdrawal by Subject|1|||
163916463|NCT00348283|592062563|FG001|Double Blind|Withdrawal by Subject|1|||
163916464|NCT00348283|592062562|FG000|Double Blind|Protocol Violation|0|||
163916465|NCT00348283|592062563|FG001|Double Blind|Protocol Violation|1|||
163916466|NCT00348283|592062562|FG000|Double Blind|Lack of Efficacy|2|||
163916467|NCT00348283|592062563|FG001|Double Blind|Lack of Efficacy|2|||
163916468|NCT00348283|592062562|FG000|Double Blind|Pregnancy|0|||
163916469|NCT00348283|592062563|FG001|Double Blind|Pregnancy|1|||
163916470|NCT00348283|592062562|FG000|Open Label|Adverse Event|0|||
163916471|NCT00348283|592062563|FG001|Open Label|Adverse Event|8|||
163916472|NCT00348283|592062562|FG000|Open Label|Withdrawal by Subject|0|||
163916473|NCT00348283|592062563|FG001|Open Label|Withdrawal by Subject|4|||
163916474|NCT00348283|592062562|FG000|Open Label|Lost to Follow-up|0|||
163916475|NCT00348283|592062563|FG001|Open Label|Lost to Follow-up|1|||
163916476|NCT00348283|592062562|FG000|Open Label|Lack of Efficacy|0|||
163916477|NCT00348283|592062563|FG001|Open Label|Lack of Efficacy|13|||
163916478|NCT00348283|592062562|FG000|Open Label|Administrative reasons|0|||
163916479|NCT00348283|592062563|FG001|Open Label|Administrative reasons|5|||
163916480|NCT00348283|592062562|FG000|Open Label|Subject moved to the United States|0|||
163916481|NCT00348283|592062563|FG001|Open Label|Subject moved to the United States|1|||
163916482|NCT00348283|592062562|FG000|Open Label|Pregnancy|0|||
163916483|NCT00348283|592062563|FG001|Open Label|Pregnancy|1|||
163916484|NCT00348283|592062562|FG000|Open Label|Sponsor decision|0|||
163916485|NCT00348283|592062563|FG001|Open Label|Sponsor decision|1|||
163916486|NCT00596960|592062566|FG000|Overall Study|Death|1|||
163916487|NCT00596960|592062567|FG001|Overall Study|Death|2|||
163916488|NCT00596960|592062566|FG000|Overall Study|Lost to Follow-up|6|||
163916489|NCT00596960|592062567|FG001|Overall Study|Lost to Follow-up|5|||
163916490|NCT00596960|592062566|FG000|Overall Study|Withdrawal by Subject|1|||
163916491|NCT00596960|592062567|FG001|Overall Study|Withdrawal by Subject|0|||
163916492|NCT00596960|592062566|FG000|Overall Study|Incarcerated|2|||
163916493|NCT00596960|592062567|FG001|Overall Study|Incarcerated|0|||
163916494|NCT00596960|592062566|FG000|Overall Study|Physician Decision|1|||
163916495|NCT00596960|592062567|FG001|Overall Study|Physician Decision|0|||
163916496|NCT00596960|592062566|FG000|Overall Study|Protocol Violation|0|||
163916497|NCT00596960|592062567|FG001|Overall Study|Protocol Violation|1|||
163916498|NCT00596960|592062566|FG000|Overall Study|No alcohol use data|0|||
163916499|NCT00596960|592062567|FG001|Overall Study|No alcohol use data|1|||
163916500|NCT04016415|592062568|FG000|Overall Study|Adverse Event|2|||
163916501|NCT04016415|592062569|FG001|Overall Study|Adverse Event|1|||
163916502|NCT04016415|592062568|FG000|Overall Study|Lost to Follow-up|6|||
163916503|NCT04016415|592062569|FG001|Overall Study|Lost to Follow-up|2|||
163916504|NCT04016415|592062568|FG000|Overall Study|Physician Decision|5|||
163916505|NCT04016415|592062569|FG001|Overall Study|Physician Decision|1|||
163916506|NCT04016415|592062568|FG000|Overall Study|Pregnancy|0|||
163916507|NCT04016415|592062569|FG001|Overall Study|Pregnancy|1|||
163916508|NCT04016415|592062568|FG000|Overall Study|Withdrawal by Subject|24|||
163916509|NCT04016415|592062569|FG001|Overall Study|Withdrawal by Subject|27|||
163916510|NCT04016415|592062568|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
163916511|NCT04016415|592062569|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
163916512|NCT01885559|592062570|FG000|Overall Study|Lost to Follow-up|15|||
163916513|NCT01885559|592062571|FG001|Overall Study|Lost to Follow-up|16|||
163916514|NCT01885559|592062570|FG000|Overall Study|Less than full participation|9|||
163916515|NCT01885559|592062571|FG001|Overall Study|Less than full participation|19|||
163916516|NCT01885559|592062570|FG000|Overall Study|Protocol Violation|0|||
163916517|NCT01885559|592062571|FG001|Overall Study|Protocol Violation|1|||
163916518|NCT00732498|592062574|FG000|Overall Study|Ineligible|1|||
163916519|NCT00732498|592062574|FG000|Overall Study|Adverse Event|2|||
163916520|NCT00732498|592062574|FG000|Overall Study|Physician Decision|3|||
164028605|NCT02998554|592463389|FG000|Overall Study|Adverse Event|8|||
164028606|NCT02998554|592463390|FG001|Overall Study|Adverse Event|3|||
164028607|NCT02998554|592463389|FG000|Overall Study|Protocol deviation|1|||
164028608|NCT02998554|592463390|FG001|Overall Study|Protocol deviation|0|||
164028609|NCT02998554|592463389|FG000|Overall Study|Withdrawal by Subject|2|||
164028610|NCT02998554|592463390|FG001|Overall Study|Withdrawal by Subject|6|||
164028611|NCT02998554|592463389|FG000|Overall Study|Lost to Follow-up|0|||
163916521|NCT04295499|592062575|FG000|Overall Study|moving out of state|1|||
163916522|NCT04295499|592062576|FG001|Overall Study|moving out of state|0|||
163916523|NCT04295499|592062575|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
163916524|NCT04295499|592062576|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
163916525|NCT00308113|592062577|FG000|Overall Study|Protocol closure|0|||
163916526|NCT00308113|592062578|FG001|Overall Study|Protocol closure|0|||
163916527|NCT00308113|592062579|FG002|Overall Study|Protocol closure|0|||
163916528|NCT00308113|592062580|FG003|Overall Study|Protocol closure|1|||
163916529|NCT00705614|592064563|FG000|Initial Intervention|Adverse Event|40|||
163916530|NCT00705614|592064564|FG001|Initial Intervention|Adverse Event|21|||
163916531|NCT00705614|592064563|FG000|Initial Intervention|Lost to Follow-up|310|||
163916532|NCT00705614|592064564|FG001|Initial Intervention|Lost to Follow-up|191|||
163916533|NCT00705614|592064563|FG000|Initial Intervention|Withdrawal by Subject|114|||
163916534|NCT00705614|592064564|FG001|Initial Intervention|Withdrawal by Subject|71|||
163916535|NCT00705614|592064563|FG000|Initial Intervention|Administrative Reason|51|||
163916536|NCT00705614|592064564|FG001|Initial Intervention|Administrative Reason|38|||
163916537|NCT00705614|592064563|FG000|Initial Intervention|Status completion unknown|3|||
163916538|NCT00705614|592064564|FG001|Initial Intervention|Status completion unknown|0|||
163916539|NCT00705614|592064563|FG000|Switch to Remicade|Adverse Event|0|||
163916540|NCT00705614|592064564|FG001|Switch to Remicade|Adverse Event|5|||
163916541|NCT00705614|592064563|FG000|Switch to Remicade|Lost to Follow-up|0|||
163916542|NCT00705614|592064564|FG001|Switch to Remicade|Lost to Follow-up|23|||
163916543|NCT00705614|592064563|FG000|Switch to Remicade|Withdrawal by Subject|0|||
163916544|NCT00705614|592064564|FG001|Switch to Remicade|Withdrawal by Subject|12|||
163916545|NCT00705614|592064563|FG000|Switch to Remicade|Administrative Reason|0|||
163916546|NCT00705614|592064564|FG001|Switch to Remicade|Administrative Reason|9|||
163916547|NCT02661490|592064565|FG000|Overall Study|Lost to Follow-up|0|||
163916548|NCT02661490|592064566|FG001|Overall Study|Lost to Follow-up|1|||
163916549|NCT02661490|592064567|FG002|Overall Study|Lost to Follow-up|0|||
163916550|NCT02661490|592064568|FG003|Overall Study|Lost to Follow-up|0|||
163916551|NCT02661490|592064569|FG004|Overall Study|Lost to Follow-up|2|||
163916552|NCT02661490|592064565|FG000|Overall Study|Withdrawal by Subject|2|||
163916553|NCT02661490|592064566|FG001|Overall Study|Withdrawal by Subject|0|||
163916554|NCT02661490|592064567|FG002|Overall Study|Withdrawal by Subject|2|||
163916555|NCT02661490|592064568|FG003|Overall Study|Withdrawal by Subject|0|||
163916556|NCT02661490|592064569|FG004|Overall Study|Withdrawal by Subject|0|||
163916557|NCT02661490|592064565|FG000|Overall Study|Death|1|||
163916558|NCT02661490|592064566|FG001|Overall Study|Death|1|||
163916559|NCT02661490|592064567|FG002|Overall Study|Death|0|||
163916560|NCT02661490|592064568|FG003|Overall Study|Death|1|||
163916561|NCT02661490|592064569|FG004|Overall Study|Death|0|||
163916562|NCT02661490|592064565|FG000|Overall Study|Reason not Specified|0|||
163916563|NCT02661490|592064566|FG001|Overall Study|Reason not Specified|0|||
163916564|NCT02661490|592064567|FG002|Overall Study|Reason not Specified|0|||
163916565|NCT02661490|592064568|FG003|Overall Study|Reason not Specified|0|||
163916566|NCT02661490|592064569|FG004|Overall Study|Reason not Specified|1|||
163916567|NCT01232569|592064570|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
163916568|NCT01232569|592064571|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163916569|NCT01232569|592064572|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163916570|NCT01232569|592064573|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
163916571|NCT01232569|592064570|FG000|Double-blind Treatment Period|Escape|2|||
163916572|NCT01232569|592064571|FG001|Double-blind Treatment Period|Escape|2|||
163916573|NCT01232569|592064572|FG002|Double-blind Treatment Period|Escape|0|||
163916574|NCT01232569|592064573|FG003|Double-blind Treatment Period|Escape|0|||
163916575|NCT01232569|592064570|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
163916576|NCT01232569|592064571|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
163916577|NCT01232569|592064572|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
163916578|NCT01232569|592064573|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
163916579|NCT01232569|592064570|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
163916580|NCT01232569|592064571|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
163916581|NCT01232569|592064572|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
163916582|NCT01232569|592064573|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
163916583|NCT01232569|592064570|FG000|Double-blind Treatment Period|Physician Decision|1|||
164096680|NCT02781727|592717372|FG001|Treatment Period|Lost to Follow-up|1|||
164096681|NCT03069937|592717374|FG000|Overall Study|Second primary malignancy noted|1|||
164096682|NCT01569152|592717378|FG000|Phase IIa, Period 1|Early Escape|5|||
163916584|NCT01232569|592064571|FG001|Double-blind Treatment Period|Physician Decision|0|||
163916585|NCT01232569|592064572|FG002|Double-blind Treatment Period|Physician Decision|0|||
163916586|NCT01232569|592064573|FG003|Double-blind Treatment Period|Physician Decision|0|||
163916587|NCT01232569|592064570|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
163916588|NCT01232569|592064571|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
163916589|NCT01232569|592064572|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
163916590|NCT01232569|592064573|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
164028612|NCT02998554|592463390|FG001|Overall Study|Lost to Follow-up|1|||
164028613|NCT02998554|592463389|FG000|Overall Study|Lack of Efficacy|0|||
164028614|NCT02998554|592463390|FG001|Overall Study|Lack of Efficacy|1|||
164028615|NCT01778127|592463391|FG000|Overall Study|Lost to Follow-up|5|||
164028616|NCT01778127|592463392|FG001|Overall Study|Lost to Follow-up|1|||
164028617|NCT01778127|592463393|FG002|Overall Study|Lost to Follow-up|2|||
164028618|NCT01778127|592463391|FG000|Overall Study|Withdrawal by Subject|3|||
164028619|NCT01778127|592463392|FG001|Overall Study|Withdrawal by Subject|1|||
164028620|NCT01778127|592463393|FG002|Overall Study|Withdrawal by Subject|4|||
164028621|NCT01348425|592463399|FG000|Overall Study|Imaging was not taken.|1|||
164028622|NCT01348425|592463400|FG001|Overall Study|Imaging was not taken.|1|||
164028623|NCT01968954|592463407|FG000|Overall Study|Adverse Event|6|||
164028624|NCT01968954|592463408|FG001|Overall Study|Adverse Event|3|||
164028625|NCT01968954|592463407|FG000|Overall Study|Death|1|||
164028626|NCT01968954|592463408|FG001|Overall Study|Death|2|||
164028627|NCT01968954|592463407|FG000|Overall Study|Lost to Follow-up|6|||
164028628|NCT01968954|592463408|FG001|Overall Study|Lost to Follow-up|4|||
164028629|NCT01968954|592463407|FG000|Overall Study|Withdrawal by Subject|20|||
164028630|NCT01968954|592463408|FG001|Overall Study|Withdrawal by Subject|23|||
164028631|NCT01968954|592463407|FG000|Overall Study|Other|7|||
164028632|NCT01968954|592463408|FG001|Overall Study|Other|8|||
164028633|NCT01968954|592463407|FG000|Overall Study|Protocol Violation|0|||
164028634|NCT01968954|592463408|FG001|Overall Study|Protocol Violation|1|||
164028635|NCT01968954|592463407|FG000|Overall Study|Did not met inclusion criteria|0|||
164028636|NCT01968954|592463408|FG001|Overall Study|Did not met inclusion criteria|2|||
164028637|NCT00255086|592463414|FG000|Overall Study|Adverse Event|1|||
164028638|NCT00255086|592463415|FG001|Overall Study|Adverse Event|1|||
164028639|NCT00255086|592463414|FG000|Overall Study|Protocol Violation|1|||
164028640|NCT00255086|592463415|FG001|Overall Study|Protocol Violation|1|||
164028641|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
164028642|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
164028643|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
164028644|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
164028645|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
164028646|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
164028647|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
164028648|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
164028649|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
164028650|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
164028651|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
164028652|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
164028653|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164028654|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164028655|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
163916591|NCT01232569|592064570|FG000|Double-blind Treatment Period|Death|2|||
163916592|NCT01232569|592064571|FG001|Double-blind Treatment Period|Death|0|||
163916593|NCT01232569|592064572|FG002|Double-blind Treatment Period|Death|0|||
163916594|NCT01232569|592064573|FG003|Double-blind Treatment Period|Death|0|||
163916595|NCT02388932|592064574|FG000|Overall Study|Death|1|||
163916596|NCT05335005|592064577|FG000|Overall Study|Lost to Follow-up|1|||
163916597|NCT05927753|592064578|FG000|Overall Study|Withdrawal by Subject|0|||
163916598|NCT05927753|592064579|FG001|Overall Study|Withdrawal by Subject|2|||
163916599|NCT05927753|592064578|FG000|Overall Study|Physician Decision|0|||
163916600|NCT05927753|592064579|FG001|Overall Study|Physician Decision|1|||
163916601|NCT02123797|592064580|FG000|Baseline Intervention|Death|9|||
163916602|NCT02123797|592064581|FG001|Baseline Intervention|Death|16|||
163916603|NCT02123797|592064582|FG002|Baseline Intervention|Death|0|||
163916604|NCT02123797|592064583|FG003|Baseline Intervention|Death|0|||
163916605|NCT02123797|592064584|FG004|Baseline Intervention|Death|0|||
163916606|NCT02123797|592064580|FG000|Baseline Intervention|Withdrawal by Subject|2|||
163916607|NCT02123797|592064581|FG001|Baseline Intervention|Withdrawal by Subject|8|||
163916608|NCT02123797|592064582|FG002|Baseline Intervention|Withdrawal by Subject|0|||
163916609|NCT02123797|592064583|FG003|Baseline Intervention|Withdrawal by Subject|0|||
163916610|NCT02123797|592064584|FG004|Baseline Intervention|Withdrawal by Subject|0|||
163916611|NCT02123797|592064580|FG000|Baseline Intervention|Relocation|2|||
163916612|NCT02123797|592064581|FG001|Baseline Intervention|Relocation|0|||
163916613|NCT02123797|592064582|FG002|Baseline Intervention|Relocation|0|||
163916614|NCT02123797|592064583|FG003|Baseline Intervention|Relocation|0|||
163916615|NCT02123797|592064584|FG004|Baseline Intervention|Relocation|0|||
163916616|NCT02123797|592064580|FG000|Baseline Intervention|Out of window for initial survey|6|||
163916617|NCT02123797|592064581|FG001|Baseline Intervention|Out of window for initial survey|13|||
163916618|NCT02123797|592064582|FG002|Baseline Intervention|Out of window for initial survey|0|||
163916619|NCT02123797|592064583|FG003|Baseline Intervention|Out of window for initial survey|0|||
163916620|NCT02123797|592064584|FG004|Baseline Intervention|Out of window for initial survey|0|||
163916621|NCT02123797|592064580|FG000|Baseline Intervention|Lost to Follow-up|0|||
163916622|NCT02123797|592064581|FG001|Baseline Intervention|Lost to Follow-up|5|||
163916623|NCT02123797|592064582|FG002|Baseline Intervention|Lost to Follow-up|0|||
163916624|NCT02123797|592064583|FG003|Baseline Intervention|Lost to Follow-up|0|||
163916625|NCT02123797|592064584|FG004|Baseline Intervention|Lost to Follow-up|0|||
163916626|NCT02123797|592064580|FG000|Baseline Intervention|Other Disease|3|||
163916627|NCT02123797|592064581|FG001|Baseline Intervention|Other Disease|0|||
163916628|NCT02123797|592064582|FG002|Baseline Intervention|Other Disease|0|||
163916629|NCT02123797|592064583|FG003|Baseline Intervention|Other Disease|0|||
163916630|NCT02123797|592064584|FG004|Baseline Intervention|Other Disease|0|||
163916631|NCT02123797|592064580|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
163916632|NCT02123797|592064581|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
163916633|NCT02123797|592064582|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
163916634|NCT02123797|592064583|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
163916635|NCT02123797|592064584|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
163916636|NCT02123797|592064580|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
163916637|NCT02123797|592064581|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
163916638|NCT02123797|592064582|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
163916639|NCT02123797|592064583|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
163916640|NCT02123797|592064584|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
163916641|NCT02123797|592064580|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
163916642|NCT02123797|592064581|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
163916643|NCT02123797|592064582|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163916644|NCT02123797|592064583|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163916645|NCT02123797|592064584|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163916646|NCT02123797|592064580|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
163916647|NCT02123797|592064581|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
163916648|NCT02123797|592064582|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
163916649|NCT02123797|592064583|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
163916650|NCT02123797|592064584|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
163916651|NCT02123797|592064580|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
163916652|NCT02123797|592064581|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
163916653|NCT02123797|592064582|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
163916654|NCT02123797|592064583|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
163916655|NCT02123797|592064584|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
163916656|NCT02123797|592064580|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
163916657|NCT02123797|592064581|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
163916658|NCT02123797|592064582|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
163916659|NCT02123797|592064583|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
163916660|NCT02123797|592064584|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
163916661|NCT02123797|592064580|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
163916662|NCT02123797|592064581|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
163916663|NCT02123797|592064582|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
163916664|NCT02123797|592064583|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
163916665|NCT02123797|592064584|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
163916666|NCT02123797|592064580|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
163916667|NCT02123797|592064581|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
163916668|NCT02123797|592064582|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163916669|NCT02123797|592064583|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163916670|NCT02123797|592064584|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
163916671|NCT02123797|592064580|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
163916672|NCT02123797|592064581|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
163916673|NCT02123797|592064582|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
163916674|NCT02123797|592064583|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
163916675|NCT02123797|592064584|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
163916676|NCT01375777|592064586|FG000|Overall Study|Withdrawal by Subject|0|||
163916677|NCT01375777|592064587|FG001|Overall Study|Withdrawal by Subject|2|||
163916678|NCT01375777|592064588|FG002|Overall Study|Withdrawal by Subject|1|||
163916679|NCT01375777|592064589|FG003|Overall Study|Withdrawal by Subject|0|||
163916680|NCT01375777|592064590|FG004|Overall Study|Withdrawal by Subject|1|||
163916681|NCT01375777|592064591|FG005|Overall Study|Withdrawal by Subject|1|||
163916682|NCT01375777|592064592|FG006|Overall Study|Withdrawal by Subject|1|||
163916683|NCT01375777|592064593|FG007|Overall Study|Withdrawal by Subject|2|||
163916684|NCT01375777|592064594|FG008|Overall Study|Withdrawal by Subject|1|||
163916685|NCT01375777|592064586|FG000|Overall Study|Lost to Follow-up|1|||
163916686|NCT01375777|592064587|FG001|Overall Study|Lost to Follow-up|0|||
163916687|NCT01375777|592064588|FG002|Overall Study|Lost to Follow-up|0|||
163916688|NCT01375777|592064589|FG003|Overall Study|Lost to Follow-up|0|||
163916689|NCT01375777|592064590|FG004|Overall Study|Lost to Follow-up|0|||
163916690|NCT01375777|592064591|FG005|Overall Study|Lost to Follow-up|0|||
163916691|NCT01375777|592064592|FG006|Overall Study|Lost to Follow-up|1|||
163916692|NCT01375777|592064593|FG007|Overall Study|Lost to Follow-up|0|||
163916693|NCT01375777|592064594|FG008|Overall Study|Lost to Follow-up|0|||
163916694|NCT01375777|592064586|FG000|Overall Study|Other|1|||
163916695|NCT01375777|592064587|FG001|Overall Study|Other|1|||
163916696|NCT01375777|592064588|FG002|Overall Study|Other|0|||
163916697|NCT01375777|592064589|FG003|Overall Study|Other|0|||
163916698|NCT01375777|592064590|FG004|Overall Study|Other|0|||
163916699|NCT01375777|592064591|FG005|Overall Study|Other|0|||
163916700|NCT01375777|592064592|FG006|Overall Study|Other|0|||
163916701|NCT01375777|592064593|FG007|Overall Study|Other|0|||
163916702|NCT01375777|592064594|FG008|Overall Study|Other|1|||
163916703|NCT00355784|592064595|FG000|Overall Study|Withdrawal by Subject|0|||
163916704|NCT00355784|592064596|FG001|Overall Study|Withdrawal by Subject|0|||
163916705|NCT00355784|592064597|FG002|Overall Study|Withdrawal by Subject|2|||
163916706|NCT03602053|592064604|FG000|Overall Study|Withdrawal by Subject|7|||
163916707|NCT03602053|592064605|FG001|Overall Study|Withdrawal by Subject|9|||
163916708|NCT03602053|592064606|FG002|Overall Study|Withdrawal by Subject|7|||
163916709|NCT03602053|592064604|FG000|Overall Study|Lost to Follow-up|5|||
163916710|NCT03602053|592064605|FG001|Overall Study|Lost to Follow-up|6|||
163916711|NCT03602053|592064606|FG002|Overall Study|Lost to Follow-up|0|||
163916712|NCT03602053|592064604|FG000|Overall Study|Protocol Violation|3|||
163916713|NCT03602053|592064605|FG001|Overall Study|Protocol Violation|0|||
163916714|NCT03602053|592064606|FG002|Overall Study|Protocol Violation|4|||
163916715|NCT03602053|592064604|FG000|Overall Study|Physician Decision|1|||
163916716|NCT03602053|592064605|FG001|Overall Study|Physician Decision|0|||
163916717|NCT03602053|592064606|FG002|Overall Study|Physician Decision|0|||
163916718|NCT03602053|592064604|FG000|Overall Study|migration|2|||
163916719|NCT03602053|592064605|FG001|Overall Study|migration|3|||
163916720|NCT03602053|592064606|FG002|Overall Study|migration|0|||
163916721|NCT03602053|592064604|FG000|Overall Study|Other|1|||
163916722|NCT03602053|592064605|FG001|Overall Study|Other|0|||
163916723|NCT03602053|592064606|FG002|Overall Study|Other|0|||
164028656|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164028657|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
163916724|NCT03672188|592064613|FG000|Overall Study|Withdrawal by Subject|0|||
163916725|NCT03672188|592064614|FG001|Overall Study|Withdrawal by Subject|0|||
163916726|NCT03672188|592064615|FG002|Overall Study|Withdrawal by Subject|0|||
163916727|NCT03672188|592064616|FG003|Overall Study|Withdrawal by Subject|3|||
163916728|NCT03672188|592064617|FG004|Overall Study|Withdrawal by Subject|0|||
163916729|NCT03672188|592064618|FG005|Overall Study|Withdrawal by Subject|0|||
163916730|NCT03672188|592064619|FG006|Overall Study|Withdrawal by Subject|0|||
163916731|NCT03672188|592064620|FG007|Overall Study|Withdrawal by Subject|0|||
163916732|NCT03672188|592064621|FG008|Overall Study|Withdrawal by Subject|0|||
163916733|NCT03672188|592064622|FG009|Overall Study|Withdrawal by Subject|0|||
164028658|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
164028659|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164028660|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164028661|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
164028662|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
164028663|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164028664|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
164028665|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
164028666|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
164028667|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
164028668|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
164028669|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
164028670|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
164028671|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163916734|NCT03672188|592064623|FG010|Overall Study|Withdrawal by Subject|0|||
163916735|NCT03672188|592064624|FG011|Overall Study|Withdrawal by Subject|0|||
163916736|NCT03672188|592064625|FG012|Overall Study|Withdrawal by Subject|0|||
163916737|NCT03672188|592064626|FG013|Overall Study|Withdrawal by Subject|0|||
163916738|NCT03672188|592064627|FG014|Overall Study|Withdrawal by Subject|0|||
163916739|NCT03672188|592064613|FG000|Overall Study|Death|0|||
163916740|NCT03672188|592064614|FG001|Overall Study|Death|0|||
163916741|NCT03672188|592064615|FG002|Overall Study|Death|0|||
163916742|NCT03672188|592064616|FG003|Overall Study|Death|0|||
163916743|NCT03672188|592064617|FG004|Overall Study|Death|0|||
163916744|NCT03672188|592064618|FG005|Overall Study|Death|0|||
163916745|NCT03672188|592064619|FG006|Overall Study|Death|0|||
163916746|NCT03672188|592064620|FG007|Overall Study|Death|0|||
163916747|NCT03672188|592064621|FG008|Overall Study|Death|0|||
164028672|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163916748|NCT03672188|592064622|FG009|Overall Study|Death|0|||
163916749|NCT03672188|592064623|FG010|Overall Study|Death|0|||
163916750|NCT03672188|592064624|FG011|Overall Study|Death|0|||
163916751|NCT03672188|592064625|FG012|Overall Study|Death|1|||
163916752|NCT03672188|592064626|FG013|Overall Study|Death|0|||
163916753|NCT03672188|592064627|FG014|Overall Study|Death|0|||
163916754|NCT03672188|592064613|FG000|Overall Study|Lost to Follow-up|0|||
163916755|NCT03672188|592064614|FG001|Overall Study|Lost to Follow-up|0|||
163916756|NCT03672188|592064615|FG002|Overall Study|Lost to Follow-up|1|||
164028673|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
163916757|NCT03672188|592064616|FG003|Overall Study|Lost to Follow-up|0|||
163916758|NCT03672188|592064617|FG004|Overall Study|Lost to Follow-up|0|||
163916759|NCT03672188|592064618|FG005|Overall Study|Lost to Follow-up|0|||
163916760|NCT03672188|592064619|FG006|Overall Study|Lost to Follow-up|0|||
163916761|NCT03672188|592064620|FG007|Overall Study|Lost to Follow-up|0|||
163916762|NCT03672188|592064621|FG008|Overall Study|Lost to Follow-up|0|||
163916763|NCT03672188|592064622|FG009|Overall Study|Lost to Follow-up|0|||
163916764|NCT03672188|592064623|FG010|Overall Study|Lost to Follow-up|0|||
163916765|NCT03672188|592064624|FG011|Overall Study|Lost to Follow-up|0|||
163916766|NCT03672188|592064625|FG012|Overall Study|Lost to Follow-up|0|||
163916767|NCT03672188|592064626|FG013|Overall Study|Lost to Follow-up|0|||
163916768|NCT03672188|592064627|FG014|Overall Study|Lost to Follow-up|0|||
163916769|NCT01234675|592064628|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
163916770|NCT01234675|592064629|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164028674|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
164028675|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164028676|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
164028677|NCT01963208|592463416|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164028678|NCT01963208|592463417|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164028679|NCT01963208|592463418|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164028680|NCT01963208|592463419|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
164028681|NCT01963208|592463420|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164028682|NCT01963208|592463421|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
164028683|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164028684|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164028685|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164028686|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
164028687|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
164028688|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
164028689|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164028690|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164028691|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164028692|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
164028693|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
164028694|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
164028695|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164028696|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164028697|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164028698|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164028699|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
164028700|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
164028701|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163916771|NCT01234675|592064628|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
163916772|NCT01234675|592064629|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
164028702|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164028703|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163916773|NCT03997409|592064630|FG000|Overall Study|Protocol Violation|1|||
163916774|NCT03997409|592064631|FG001|Overall Study|Protocol Violation|1|||
163916775|NCT03997409|592064632|FG002|Overall Study|Protocol Violation|0|||
164028704|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
164028705|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
163916776|NCT03997409|592064630|FG000|Overall Study|Withdrawal by Subject|3|||
164028706|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
164028707|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
164028708|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
164028709|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
164028710|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
164028711|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
164028712|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
164028713|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164028714|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164028715|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164096683|NCT01569152|592717379|FG001|Phase IIa, Period 1|Early Escape|22|||
164096684|NCT01569152|592717380|FG002|Phase IIa, Period 1|Early Escape|0|||
164028716|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
164096685|NCT01569152|592717378|FG000|Phase IIa, Period 1|Adverse Event|4|||
164096686|NCT01569152|592717379|FG001|Phase IIa, Period 1|Adverse Event|0|||
164096687|NCT01569152|592717380|FG002|Phase IIa, Period 1|Adverse Event|0|||
164096688|NCT01569152|592717378|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
164096689|NCT01569152|592717379|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
164096690|NCT01569152|592717380|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
164096691|NCT01569152|592717378|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
164096692|NCT01569152|592717379|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
164028717|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
164028718|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
164028719|NCT01963208|592463416|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
164028720|NCT01963208|592463417|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
164028721|NCT01963208|592463418|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
164028722|NCT01963208|592463419|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
164028723|NCT01963208|592463420|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
164028724|NCT01963208|592463421|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
164028725|NCT00438399|592463422|FG000|Overall Study|Lost to Follow-up|2|||
164028726|NCT00438399|592463423|FG001|Overall Study|Lost to Follow-up|2|||
164028727|NCT00438399|592463424|FG002|Overall Study|Lost to Follow-up|1|||
164028728|NCT00438399|592463425|FG003|Overall Study|Lost to Follow-up|1|||
164028729|NCT00438399|592463426|FG004|Overall Study|Lost to Follow-up|1|||
164028730|NCT00438399|592463427|FG005|Overall Study|Lost to Follow-up|1|||
164028731|NCT00438399|592463422|FG000|Overall Study|Adverse Event|0|||
164028732|NCT00438399|592463423|FG001|Overall Study|Adverse Event|0|||
164028733|NCT00438399|592463424|FG002|Overall Study|Adverse Event|1|||
164028734|NCT00438399|592463425|FG003|Overall Study|Adverse Event|1|||
164028735|NCT00438399|592463426|FG004|Overall Study|Adverse Event|0|||
164028736|NCT00438399|592463427|FG005|Overall Study|Adverse Event|1|||
164028737|NCT00438399|592463422|FG000|Overall Study|Withdrawal by Subject|5|||
164028738|NCT00438399|592463423|FG001|Overall Study|Withdrawal by Subject|6|||
164028739|NCT00438399|592463424|FG002|Overall Study|Withdrawal by Subject|3|||
164028740|NCT00438399|592463425|FG003|Overall Study|Withdrawal by Subject|2|||
164028741|NCT00438399|592463426|FG004|Overall Study|Withdrawal by Subject|2|||
164028742|NCT00438399|592463427|FG005|Overall Study|Withdrawal by Subject|2|||
164028743|NCT00438399|592463422|FG000|Overall Study|Protocol Violation|0|||
164028744|NCT00438399|592463423|FG001|Overall Study|Protocol Violation|0|||
164028745|NCT00438399|592463424|FG002|Overall Study|Protocol Violation|1|||
164028746|NCT00438399|592463425|FG003|Overall Study|Protocol Violation|0|||
164028747|NCT00438399|592463426|FG004|Overall Study|Protocol Violation|0|||
164028748|NCT00438399|592463427|FG005|Overall Study|Protocol Violation|1|||
164028749|NCT00438399|592463422|FG000|Overall Study|Subje stopped study|0|||
164028750|NCT00438399|592463423|FG001|Overall Study|Subje stopped study|0|||
164028751|NCT00438399|592463424|FG002|Overall Study|Subje stopped study|1|||
164028752|NCT00438399|592463425|FG003|Overall Study|Subje stopped study|0|||
164028753|NCT00438399|592463426|FG004|Overall Study|Subje stopped study|0|||
164028754|NCT00438399|592463427|FG005|Overall Study|Subje stopped study|0|||
164028755|NCT00438399|592463422|FG000|Overall Study|Pregnancy|0|||
164028756|NCT00438399|592463423|FG001|Overall Study|Pregnancy|0|||
164028757|NCT00438399|592463424|FG002|Overall Study|Pregnancy|0|||
164028758|NCT00438399|592463425|FG003|Overall Study|Pregnancy|0|||
164028759|NCT00438399|592463426|FG004|Overall Study|Pregnancy|0|||
164028760|NCT00438399|592463427|FG005|Overall Study|Pregnancy|1|||
164028761|NCT00438399|592463422|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
164028762|NCT00438399|592463423|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
164028763|NCT00438399|592463424|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
164028764|NCT00438399|592463425|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
164028765|NCT00438399|592463426|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
164028766|NCT00438399|592463427|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
164028767|NCT01364233|592463428|FG000|Overall Study|Lost to Follow-up|1|||
164028768|NCT00406783|592463430|FG000|Overall Study|Adverse Event|4|||
164028769|NCT00406783|592463431|FG001|Overall Study|Adverse Event|4|||
164028770|NCT00406783|592463430|FG000|Overall Study|Treatment Failure|2|||
164028771|NCT00406783|592463431|FG001|Overall Study|Treatment Failure|3|||
164028772|NCT00406783|592463430|FG000|Overall Study|Lost to Follow-up|3|||
164028773|NCT00406783|592463431|FG001|Overall Study|Lost to Follow-up|0|||
164028774|NCT00406783|592463430|FG000|Overall Study|Withdrawal by Subject|1|||
164028775|NCT00406783|592463431|FG001|Overall Study|Withdrawal by Subject|4|||
164028776|NCT00406783|592463430|FG000|Overall Study|Protocol Violation|4|||
164028777|NCT00406783|592463431|FG001|Overall Study|Protocol Violation|4|||
164028778|NCT02034474|592463432|FG000|Overall Study|Adverse Event|3|||
164028779|NCT02034474|592463433|FG001|Overall Study|Adverse Event|2|||
163916777|NCT03997409|592064631|FG001|Overall Study|Withdrawal by Subject|0|||
163916778|NCT03997409|592064632|FG002|Overall Study|Withdrawal by Subject|0|||
163916779|NCT03997409|592064630|FG000|Overall Study|Lost to Follow-up|0|||
163916780|NCT03997409|592064631|FG001|Overall Study|Lost to Follow-up|0|||
163916781|NCT03997409|592064632|FG002|Overall Study|Lost to Follow-up|1|||
163916782|NCT03696342|592064633|FG000|Overall Study|Lost to Follow-up|1|||
163916783|NCT03696342|592064634|FG001|Overall Study|Lost to Follow-up|0|||
163916784|NCT02409732|592064637|FG000|Overall Study|Withdrawal by Subject|4|||
163916785|NCT02409732|592064637|FG000|Overall Study|Lost to Follow-up|2|||
163916786|NCT01753323|592064639|FG000|Overall Study|Lack of Efficacy|0|||
163916787|NCT01753323|592064640|FG001|Overall Study|Lack of Efficacy|0|||
163916788|NCT01753323|592064641|FG002|Overall Study|Lack of Efficacy|8|||
163916789|NCT01753323|592064639|FG000|Overall Study|Protocol deviation|1|||
163916790|NCT01753323|592064640|FG001|Overall Study|Protocol deviation|0|||
163916791|NCT01753323|592064641|FG002|Overall Study|Protocol deviation|0|||
163916792|NCT01753323|592064639|FG000|Overall Study|Adverse Event|0|||
163916793|NCT01753323|592064640|FG001|Overall Study|Adverse Event|0|||
163916794|NCT01753323|592064641|FG002|Overall Study|Adverse Event|1|||
163916795|NCT01870999|592064642|FG000|Overall Study|Adverse Event|0|||
163916796|NCT01870999|592064643|FG001|Overall Study|Adverse Event|4|||
163916797|NCT01870999|592064644|FG002|Overall Study|Adverse Event|1|||
163916798|NCT01870999|592064642|FG000|Overall Study|Subject met withdrawal criteria|3|||
163916799|NCT01870999|592064643|FG001|Overall Study|Subject met withdrawal criteria|2|||
163916800|NCT01870999|592064644|FG002|Overall Study|Subject met withdrawal criteria|0|||
163916801|NCT01870999|592064642|FG000|Overall Study|Subject withdrawn by Investigator|1|||
163916802|NCT01870999|592064643|FG001|Overall Study|Subject withdrawn by Investigator|0|||
163916803|NCT01870999|592064644|FG002|Overall Study|Subject withdrawn by Investigator|0|||
163916804|NCT01870999|592064642|FG000|Overall Study|Withdrawal by Subject|0|||
163916805|NCT01870999|592064643|FG001|Overall Study|Withdrawal by Subject|2|||
163916806|NCT01870999|592064644|FG002|Overall Study|Withdrawal by Subject|5|||
163916807|NCT01870999|592064642|FG000|Overall Study|Protocol Violation|0|||
163916808|NCT01870999|592064643|FG001|Overall Study|Protocol Violation|0|||
163916809|NCT01870999|592064644|FG002|Overall Study|Protocol Violation|1|||
163916810|NCT01636258|592064645|FG000|Overall Study|Lost to Follow-up|1|||
163916811|NCT01636258|592064646|FG001|Overall Study|Lost to Follow-up|0|||
163916812|NCT01838499|592064647|FG000|Overall Study|Protocol Violation|0|||
163916813|NCT01838499|592064648|FG001|Overall Study|Protocol Violation|1|||
163916814|NCT01838499|592064647|FG000|Overall Study|Lost to Follow-up|2|||
163916815|NCT01838499|592064648|FG001|Overall Study|Lost to Follow-up|4|||
163916816|NCT01838499|592064647|FG000|Overall Study|Lack of Efficacy|1|||
163916817|NCT01838499|592064648|FG001|Overall Study|Lack of Efficacy|2|||
163916818|NCT01838499|592064647|FG000|Overall Study|Adverse Event|2|||
163916819|NCT01838499|592064648|FG001|Overall Study|Adverse Event|1|||
163916820|NCT01838499|592064647|FG000|Overall Study|Withdrawal by Subject|19|||
163916821|NCT01838499|592064648|FG001|Overall Study|Withdrawal by Subject|9|||
163916822|NCT03614923|592064649|FG000|Overall Study|Withdrawal by Subject|2|||
163916823|NCT03614923|592064650|FG001|Overall Study|Withdrawal by Subject|1|||
163916824|NCT03614923|592064651|FG002|Overall Study|Withdrawal by Subject|1|||
163916825|NCT03614923|592064649|FG000|Overall Study|Adverse Event|0|||
163916826|NCT03614923|592064650|FG001|Overall Study|Adverse Event|2|||
163916827|NCT03614923|592064651|FG002|Overall Study|Adverse Event|1|||
163916828|NCT03614923|592064649|FG000|Overall Study|Lost to Follow-up|1|||
163916829|NCT03614923|592064650|FG001|Overall Study|Lost to Follow-up|0|||
163916830|NCT03614923|592064651|FG002|Overall Study|Lost to Follow-up|1|||
163916831|NCT03614923|592064649|FG000|Overall Study|Lack of Efficacy|2|||
163916832|NCT03614923|592064650|FG001|Overall Study|Lack of Efficacy|0|||
163916833|NCT03614923|592064651|FG002|Overall Study|Lack of Efficacy|1|||
163916834|NCT03614923|592064649|FG000|Overall Study|Non-compliance|0|||
164028780|NCT02034474|592463432|FG000|Overall Study|Withdrawal by Subject|1|||
164028781|NCT02034474|592463433|FG001|Overall Study|Withdrawal by Subject|2|||
164028782|NCT01391819|592463434|FG000|Overall Study|Withdrawal by Subject|56|||
164028783|NCT01391819|592463434|FG000|Overall Study|Migrated/moved from study area|82|||
164028784|NCT01391819|592463434|FG000|Overall Study|Lost to Follow-up|252|||
164028785|NCT01391819|592463434|FG000|Overall Study|Death|3|||
164028786|NCT01391819|592463434|FG000|Overall Study|Other|9|||
163916835|NCT03614923|592064650|FG001|Overall Study|Non-compliance|1|||
163916836|NCT03614923|592064651|FG002|Overall Study|Non-compliance|0|||
163916837|NCT03614923|592064649|FG000|Overall Study|Other|0|||
163916838|NCT03614923|592064650|FG001|Overall Study|Other|1|||
164028787|NCT00995670|592463436|FG000|Overall Study|Failed arterial cannulation|1|||
163916839|NCT03614923|592064651|FG002|Overall Study|Other|1|||
163916840|NCT03034772|592064662|FG000|Overall Study|Adverse Event|0|||
164028788|NCT00995670|592463437|FG001|Overall Study|Failed arterial cannulation|0|||
164028789|NCT00995670|592463438|FG002|Overall Study|Failed arterial cannulation|3|||
163916841|NCT03034772|592064663|FG001|Overall Study|Adverse Event|1|||
163916842|NCT03034772|592064662|FG000|Overall Study|Withdrawal by Subject|0|||
163916843|NCT03034772|592064663|FG001|Overall Study|Withdrawal by Subject|1|||
163916844|NCT00116584|592064664|FG000|Overall Study|Withdrawal by Subject|1|||
163916845|NCT00116584|592064665|FG001|Overall Study|Withdrawal by Subject|0|||
164028790|NCT00675103|592463439|FG000|Overall Study|Lack of Efficacy|2|||
164028791|NCT00675103|592463439|FG000|Overall Study|Adverse Event|1|||
164028792|NCT01810042|592463442|FG000|Overall Study|Lost to Follow-up|10|||
164028793|NCT01337167|592465609|FG000|Infant Series|Adverse Event|1|||
164028794|NCT01337167|592465610|FG001|Infant Series|Adverse Event|1|||
164028795|NCT01337167|592465609|FG000|Infant Series|Death|1|||
164028796|NCT01337167|592465610|FG001|Infant Series|Death|1|||
164028797|NCT01337167|592465609|FG000|Infant Series|Lost to Follow-up|13|||
164028798|NCT01337167|592465610|FG001|Infant Series|Lost to Follow-up|7|||
164028799|NCT01337167|592465609|FG000|Infant Series|Non-compliance with study drug|2|||
164028800|NCT01337167|592465610|FG001|Infant Series|Non-compliance with study drug|1|||
164028801|NCT01337167|592465609|FG000|Infant Series|Physician Decision|3|||
164028802|NCT01337167|592465610|FG001|Infant Series|Physician Decision|1|||
164028803|NCT01337167|592465609|FG000|Infant Series|Protocol Violation|22|||
164028804|NCT01337167|592465610|FG001|Infant Series|Protocol Violation|9|||
164028805|NCT01337167|592465609|FG000|Infant Series|Withdrawal by Subject|15|||
164028806|NCT01337167|592465610|FG001|Infant Series|Withdrawal by Subject|4|||
164028807|NCT01337167|592465609|FG000|Infant Series|Randomized but not vaccinated|5|||
164028808|NCT01337167|592465610|FG001|Infant Series|Randomized but not vaccinated|3|||
164028809|NCT01337167|592465609|FG000|Interim Period|Lost to Follow-up|51|||
164028810|NCT01337167|592465610|FG001|Interim Period|Lost to Follow-up|23|||
164096693|NCT01569152|592717380|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
164096694|NCT01569152|592717378|FG000|Phase IIa, Period 1|Protocol Violation|0|||
164096695|NCT01569152|592717379|FG001|Phase IIa, Period 1|Protocol Violation|1|||
164028811|NCT01337167|592465609|FG000|Interim Period|Non-compliance with study drug|1|||
164028812|NCT01337167|592465610|FG001|Interim Period|Non-compliance with study drug|0|||
164028813|NCT01337167|592465609|FG000|Interim Period|Physician Decision|6|||
164028814|NCT01337167|592465610|FG001|Interim Period|Physician Decision|3|||
164028815|NCT01337167|592465609|FG000|Interim Period|Protocol Violation|5|||
164028816|NCT01337167|592465610|FG001|Interim Period|Protocol Violation|3|||
164028817|NCT01337167|592465609|FG000|Interim Period|Withdrawal by Subject|18|||
164028818|NCT01337167|592465610|FG001|Interim Period|Withdrawal by Subject|10|||
164028819|NCT01337167|592465609|FG000|Interim Period|Other protocol criterion not met|0|||
164028820|NCT01337167|592465610|FG001|Interim Period|Other protocol criterion not met|1|||
164028821|NCT01337167|592465609|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
164028822|NCT01337167|592465610|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
164028823|NCT01337167|592465609|FG000|Toddler Vaccinations|Protocol Violation|0|||
164028824|NCT01337167|592465610|FG001|Toddler Vaccinations|Protocol Violation|1|||
164028825|NCT01337167|592465609|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
164028826|NCT01337167|592465610|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
164028827|NCT02126670|592465611|FG000|Overall Study|Withdrawal by Subject|1|||
164028828|NCT02126670|592465612|FG001|Overall Study|Withdrawal by Subject|0|||
164028829|NCT02126670|592465613|FG002|Overall Study|Withdrawal by Subject|0|||
164028830|NCT02126670|592465614|FG003|Overall Study|Withdrawal by Subject|1|||
164028831|NCT01646398|592465615|FG000|Overall Study|Withdrawal by Subject|1|||
164028832|NCT01646398|592465616|FG001|Overall Study|Withdrawal by Subject|0|||
164028833|NCT00424346|592465617|FG000|Core Study|Adverse Event|5|||
164028834|NCT00424346|592465618|FG001|Core Study|Adverse Event|3|||
164028835|NCT00424346|592465619|FG002|Core Study|Adverse Event|1|||
164028836|NCT00424346|592465620|FG003|Core Study|Adverse Event|1|||
164028837|NCT00424346|592465617|FG000|Core Study|Abnormal Laboratory Values|0|||
164028838|NCT00424346|592465618|FG001|Core Study|Abnormal Laboratory Values|1|||
164028839|NCT00424346|592465619|FG002|Core Study|Abnormal Laboratory Values|0|||
164028840|NCT00424346|592465620|FG003|Core Study|Abnormal Laboratory Values|0|||
164028841|NCT00424346|592465617|FG000|Core Study|Lack of Efficacy|1|||
164028842|NCT00424346|592465618|FG001|Core Study|Lack of Efficacy|3|||
164028843|NCT00424346|592465619|FG002|Core Study|Lack of Efficacy|0|||
164028844|NCT00424346|592465620|FG003|Core Study|Lack of Efficacy|4|||
164028845|NCT00424346|592465617|FG000|Core Study|Withdrawal by Subject|1|||
164028846|NCT00424346|592465618|FG001|Core Study|Withdrawal by Subject|0|||
164028847|NCT00424346|592465619|FG002|Core Study|Withdrawal by Subject|0|||
164028848|NCT00424346|592465620|FG003|Core Study|Withdrawal by Subject|2|||
164028849|NCT00424346|592465617|FG000|Core Study|Lost to Follow-up|1|||
164028850|NCT00424346|592465618|FG001|Core Study|Lost to Follow-up|1|||
164028851|NCT00424346|592465619|FG002|Core Study|Lost to Follow-up|0|||
164028852|NCT00424346|592465620|FG003|Core Study|Lost to Follow-up|0|||
163916846|NCT00116584|592064664|FG000|Overall Study|Protocol Violation|1|||
163916847|NCT00116584|592064665|FG001|Overall Study|Protocol Violation|1|||
163916848|NCT01745380|592064666|FG000|Overall Study|Lost to Follow-up|1|||
163916849|NCT01745380|592064667|FG001|Overall Study|Lost to Follow-up|0|||
163916850|NCT01745380|592064666|FG000|Overall Study|Lack of Efficacy|0|||
163916851|NCT01745380|592064667|FG001|Overall Study|Lack of Efficacy|1|||
163916852|NCT02660034|592064668|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
163916853|NCT02660034|592064669|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
163916854|NCT02660034|592064670|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
163916855|NCT02660034|592064671|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
163916856|NCT02660034|592064672|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
163916857|NCT02660034|592064673|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
163916858|NCT02660034|592064674|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
163916859|NCT02660034|592064675|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
163916860|NCT02660034|592064676|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
163916861|NCT02660034|592064677|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
163916862|NCT02660034|592064678|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
163916863|NCT02660034|592064679|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
163916864|NCT02660034|592064680|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
163916865|NCT02660034|592064681|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
163916866|NCT02660034|592064668|FG000|Overall Study|Progressive Disease (Clinical)|7|||
163916867|NCT02660034|592064669|FG001|Overall Study|Progressive Disease (Clinical)|8|||
163916868|NCT02660034|592064670|FG002|Overall Study|Progressive Disease (Clinical)|3|||
163916869|NCT02660034|592064671|FG003|Overall Study|Progressive Disease (Clinical)|9|||
163916870|NCT02660034|592064672|FG004|Overall Study|Progressive Disease (Clinical)|3|||
163916871|NCT02660034|592064673|FG005|Overall Study|Progressive Disease (Clinical)|0|||
163916872|NCT02660034|592064674|FG006|Overall Study|Progressive Disease (Clinical)|0|||
163916873|NCT02660034|592064675|FG007|Overall Study|Progressive Disease (Clinical)|0|||
163916874|NCT02660034|592064676|FG008|Overall Study|Progressive Disease (Clinical)|0|||
163916875|NCT02660034|592064677|FG009|Overall Study|Progressive Disease (Clinical)|0|||
163916876|NCT02660034|592064678|FG010|Overall Study|Progressive Disease (Clinical)|0|||
163916877|NCT02660034|592064679|FG011|Overall Study|Progressive Disease (Clinical)|0|||
163916878|NCT02660034|592064680|FG012|Overall Study|Progressive Disease (Clinical)|0|||
163916879|NCT02660034|592064681|FG013|Overall Study|Progressive Disease (Clinical)|0|||
163916880|NCT02660034|592064668|FG000|Overall Study|Lost to Follow-up|0|||
164028853|NCT00424346|592465617|FG000|Core Study|Administrative Problems|1|||
164028854|NCT00424346|592465618|FG001|Core Study|Administrative Problems|0|||
164028855|NCT00424346|592465619|FG002|Core Study|Administrative Problems|1|||
164028856|NCT00424346|592465620|FG003|Core Study|Administrative Problems|0|||
164028857|NCT00424346|592465617|FG000|Core Study|Protocol Violation|0|||
164028858|NCT00424346|592465618|FG001|Core Study|Protocol Violation|0|||
164028859|NCT00424346|592465619|FG002|Core Study|Protocol Violation|2|||
164028860|NCT00424346|592465620|FG003|Core Study|Protocol Violation|0|||
164028861|NCT00424346|592465617|FG000|Extension Phase|Adverse Event|0|||
163916881|NCT02660034|592064669|FG001|Overall Study|Lost to Follow-up|0|||
163916882|NCT02660034|592064670|FG002|Overall Study|Lost to Follow-up|1|||
163916883|NCT02660034|592064671|FG003|Overall Study|Lost to Follow-up|1|||
163916884|NCT02660034|592064672|FG004|Overall Study|Lost to Follow-up|0|||
163916885|NCT02660034|592064673|FG005|Overall Study|Lost to Follow-up|0|||
163916886|NCT02660034|592064674|FG006|Overall Study|Lost to Follow-up|0|||
163916887|NCT02660034|592064675|FG007|Overall Study|Lost to Follow-up|0|||
163916888|NCT02660034|592064676|FG008|Overall Study|Lost to Follow-up|0|||
163916889|NCT02660034|592064677|FG009|Overall Study|Lost to Follow-up|1|||
163916890|NCT02660034|592064678|FG010|Overall Study|Lost to Follow-up|1|||
163916891|NCT02660034|592064679|FG011|Overall Study|Lost to Follow-up|1|||
163916892|NCT02660034|592064680|FG012|Overall Study|Lost to Follow-up|0|||
163916893|NCT02660034|592064681|FG013|Overall Study|Lost to Follow-up|0|||
163916894|NCT02660034|592064668|FG000|Overall Study|Participant moved into special access scheme|1|||
163916895|NCT02660034|592064669|FG001|Overall Study|Participant moved into special access scheme|2|||
163916896|NCT02660034|592064670|FG002|Overall Study|Participant moved into special access scheme|0|||
163916897|NCT02660034|592064671|FG003|Overall Study|Participant moved into special access scheme|0|||
163916898|NCT02660034|592064672|FG004|Overall Study|Participant moved into special access scheme|0|||
163916899|NCT02660034|592064673|FG005|Overall Study|Participant moved into special access scheme|0|||
163916900|NCT02660034|592064674|FG006|Overall Study|Participant moved into special access scheme|0|||
163916901|NCT02660034|592064675|FG007|Overall Study|Participant moved into special access scheme|0|||
163916902|NCT02660034|592064676|FG008|Overall Study|Participant moved into special access scheme|0|||
163916903|NCT02660034|592064677|FG009|Overall Study|Participant moved into special access scheme|0|||
163916904|NCT02660034|592064678|FG010|Overall Study|Participant moved into special access scheme|0|||
163916905|NCT02660034|592064679|FG011|Overall Study|Participant moved into special access scheme|0|||
163916906|NCT02660034|592064680|FG012|Overall Study|Participant moved into special access scheme|0|||
163916907|NCT02660034|592064681|FG013|Overall Study|Participant moved into special access scheme|0|||
163916908|NCT02660034|592064668|FG000|Overall Study|Adverse Event|1|||
163916909|NCT02660034|592064669|FG001|Overall Study|Adverse Event|0|||
163916910|NCT02660034|592064670|FG002|Overall Study|Adverse Event|0|||
163916911|NCT02660034|592064671|FG003|Overall Study|Adverse Event|0|||
163916912|NCT02660034|592064672|FG004|Overall Study|Adverse Event|0|||
163916913|NCT02660034|592064673|FG005|Overall Study|Adverse Event|0|||
163916914|NCT02660034|592064674|FG006|Overall Study|Adverse Event|0|||
163916915|NCT02660034|592064675|FG007|Overall Study|Adverse Event|0|||
163916916|NCT02660034|592064676|FG008|Overall Study|Adverse Event|0|||
163916917|NCT02660034|592064677|FG009|Overall Study|Adverse Event|0|||
163916918|NCT02660034|592064678|FG010|Overall Study|Adverse Event|0|||
163916919|NCT02660034|592064679|FG011|Overall Study|Adverse Event|0|||
163916920|NCT02660034|592064680|FG012|Overall Study|Adverse Event|0|||
163916921|NCT02660034|592064681|FG013|Overall Study|Adverse Event|0|||
163916922|NCT02660034|592064668|FG000|Overall Study|Sponsor Decision|0|||
163916923|NCT02660034|592064669|FG001|Overall Study|Sponsor Decision|1|||
163916924|NCT02660034|592064670|FG002|Overall Study|Sponsor Decision|2|||
163916925|NCT02660034|592064671|FG003|Overall Study|Sponsor Decision|2|||
163916926|NCT02660034|592064672|FG004|Overall Study|Sponsor Decision|3|||
163916927|NCT02660034|592064673|FG005|Overall Study|Sponsor Decision|0|||
163916928|NCT02660034|592064674|FG006|Overall Study|Sponsor Decision|0|||
163916929|NCT02660034|592064675|FG007|Overall Study|Sponsor Decision|0|||
163916930|NCT02660034|592064676|FG008|Overall Study|Sponsor Decision|0|||
163916931|NCT02660034|592064677|FG009|Overall Study|Sponsor Decision|0|||
163916932|NCT02660034|592064678|FG010|Overall Study|Sponsor Decision|0|||
163916933|NCT02660034|592064679|FG011|Overall Study|Sponsor Decision|0|||
163916934|NCT02660034|592064680|FG012|Overall Study|Sponsor Decision|0|||
163916935|NCT02660034|592064681|FG013|Overall Study|Sponsor Decision|1|||
163916936|NCT02660034|592064668|FG000|Overall Study|Withdrawal by Subject|0|||
163916937|NCT02660034|592064669|FG001|Overall Study|Withdrawal by Subject|0|||
163916938|NCT02660034|592064670|FG002|Overall Study|Withdrawal by Subject|0|||
163916939|NCT02660034|592064671|FG003|Overall Study|Withdrawal by Subject|0|||
163916940|NCT02660034|592064672|FG004|Overall Study|Withdrawal by Subject|0|||
163916941|NCT02660034|592064673|FG005|Overall Study|Withdrawal by Subject|0|||
163916942|NCT02660034|592064674|FG006|Overall Study|Withdrawal by Subject|1|||
163916943|NCT02660034|592064675|FG007|Overall Study|Withdrawal by Subject|1|||
163916944|NCT02660034|592064676|FG008|Overall Study|Withdrawal by Subject|1|||
163916945|NCT02660034|592064677|FG009|Overall Study|Withdrawal by Subject|0|||
164028862|NCT00424346|592465618|FG001|Extension Phase|Adverse Event|9|||
163916946|NCT02660034|592064678|FG010|Overall Study|Withdrawal by Subject|0|||
163916947|NCT02660034|592064679|FG011|Overall Study|Withdrawal by Subject|1|||
163916948|NCT02660034|592064680|FG012|Overall Study|Withdrawal by Subject|2|||
163916949|NCT02660034|592064681|FG013|Overall Study|Withdrawal by Subject|0|||
163916950|NCT02660034|592064668|FG000|Overall Study|Death|0|||
164028863|NCT00424346|592465619|FG002|Extension Phase|Adverse Event|5|||
163916951|NCT02660034|592064669|FG001|Overall Study|Death|0|||
163916952|NCT02660034|592064670|FG002|Overall Study|Death|0|||
163916953|NCT02660034|592064671|FG003|Overall Study|Death|0|||
164028864|NCT00424346|592465620|FG003|Extension Phase|Adverse Event|4|||
164028865|NCT00424346|592465617|FG000|Extension Phase|Lack of Efficacy|0|||
163916954|NCT02660034|592064672|FG004|Overall Study|Death|0|||
163916955|NCT02660034|592064673|FG005|Overall Study|Death|13|||
163916956|NCT02660034|592064674|FG006|Overall Study|Death|14|||
163916957|NCT02660034|592064675|FG007|Overall Study|Death|10|||
163916958|NCT02660034|592064676|FG008|Overall Study|Death|9|||
163916959|NCT02660034|592064677|FG009|Overall Study|Death|21|||
163916960|NCT02660034|592064678|FG010|Overall Study|Death|17|||
163916961|NCT02660034|592064679|FG011|Overall Study|Death|15|||
163916962|NCT02660034|592064680|FG012|Overall Study|Death|18|||
163916963|NCT02660034|592064681|FG013|Overall Study|Death|7|||
163916964|NCT02660034|592064668|FG000|Overall Study|Physician Decision|0|||
163916965|NCT02660034|592064669|FG001|Overall Study|Physician Decision|0|||
163916966|NCT02660034|592064670|FG002|Overall Study|Physician Decision|0|||
163916967|NCT02660034|592064671|FG003|Overall Study|Physician Decision|0|||
163916968|NCT02660034|592064672|FG004|Overall Study|Physician Decision|0|||
163916969|NCT02660034|592064673|FG005|Overall Study|Physician Decision|0|||
163916970|NCT02660034|592064674|FG006|Overall Study|Physician Decision|0|||
163916971|NCT02660034|592064675|FG007|Overall Study|Physician Decision|0|||
163916972|NCT02660034|592064676|FG008|Overall Study|Physician Decision|0|||
163916973|NCT02660034|592064677|FG009|Overall Study|Physician Decision|0|||
163916974|NCT02660034|592064678|FG010|Overall Study|Physician Decision|0|||
163916975|NCT02660034|592064679|FG011|Overall Study|Physician Decision|0|||
163916976|NCT02660034|592064680|FG012|Overall Study|Physician Decision|0|||
163916977|NCT02660034|592064681|FG013|Overall Study|Physician Decision|1|||
163916978|NCT02660034|592064668|FG000|Overall Study|Participants transferred to LTE|0|||
163916979|NCT02660034|592064669|FG001|Overall Study|Participants transferred to LTE|0|||
163916980|NCT02660034|592064670|FG002|Overall Study|Participants transferred to LTE|0|||
163916981|NCT02660034|592064671|FG003|Overall Study|Participants transferred to LTE|0|||
163916982|NCT02660034|592064672|FG004|Overall Study|Participants transferred to LTE|0|||
163916983|NCT02660034|592064673|FG005|Overall Study|Participants transferred to LTE|10|||
163916984|NCT02660034|592064674|FG006|Overall Study|Participants transferred to LTE|8|||
163916985|NCT02660034|592064675|FG007|Overall Study|Participants transferred to LTE|8|||
163916986|NCT02660034|592064676|FG008|Overall Study|Participants transferred to LTE|10|||
163916987|NCT02660034|592064677|FG009|Overall Study|Participants transferred to LTE|1|||
163916988|NCT02660034|592064678|FG010|Overall Study|Participants transferred to LTE|2|||
163916989|NCT02660034|592064679|FG011|Overall Study|Participants transferred to LTE|4|||
163916990|NCT02660034|592064680|FG012|Overall Study|Participants transferred to LTE|1|||
163916991|NCT02660034|592064681|FG013|Overall Study|Participants transferred to LTE|1|||
163916992|NCT01106586|592064688|FG000|Overall Study|Adverse Event|9|||
164028866|NCT00424346|592465618|FG001|Extension Phase|Lack of Efficacy|16|||
163916993|NCT01106586|592064689|FG001|Overall Study|Adverse Event|15|||
163916994|NCT01106586|592064688|FG000|Overall Study|Death|1|||
163916995|NCT01106586|592064689|FG001|Overall Study|Death|3|||
163916996|NCT01106586|592064688|FG000|Overall Study|Pregnancy|2|||
163916997|NCT01106586|592064689|FG001|Overall Study|Pregnancy|2|||
163916998|NCT01106586|592064688|FG000|Overall Study|Lack of Efficacy|1|||
163916999|NCT01106586|592064689|FG001|Overall Study|Lack of Efficacy|0|||
163917000|NCT01106586|592064688|FG000|Overall Study|Investigator's Discretion|5|||
163917001|NCT01106586|592064689|FG001|Overall Study|Investigator's Discretion|8|||
163917002|NCT01106586|592064688|FG000|Overall Study|Withdrew Consent|18|||
163917003|NCT01106586|592064689|FG001|Overall Study|Withdrew Consent|30|||
163917004|NCT01106586|592064688|FG000|Overall Study|Lost to Follow-up|24|||
163917005|NCT01106586|592064689|FG001|Overall Study|Lost to Follow-up|20|||
163917006|NCT01106586|592064688|FG000|Overall Study|Participant Noncompliance|12|||
163917007|NCT01106586|592064689|FG001|Overall Study|Participant Noncompliance|10|||
163917008|NCT01106586|592064688|FG000|Overall Study|Protocol Violation|1|||
163917009|NCT01106586|592064689|FG001|Overall Study|Protocol Violation|0|||
163917010|NCT01106586|592064688|FG000|Overall Study|Participant Transferred to Another Study|212|||
163917011|NCT01106586|592064689|FG001|Overall Study|Participant Transferred to Another Study|197|||
163917012|NCT03045302|592064693|FG000|Overall Study|Pre-treatment adverse event|1|||
163917013|NCT05878522|592064697|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917014|NCT05878522|592064698|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917015|NCT05878522|592064699|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917016|NCT05878522|592064700|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917017|NCT05878522|592064701|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917018|NCT05878522|592064702|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917019|NCT05878522|592064703|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917020|NCT05878522|592064704|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917021|NCT05878522|592064705|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
163917022|NCT05878522|592064706|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917023|NCT05878522|592064707|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917024|NCT05878522|592064708|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
163917025|NCT05878522|592064697|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
163917026|NCT05878522|592064698|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917027|NCT05878522|592064699|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917028|NCT05878522|592064700|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917029|NCT05878522|592064701|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917030|NCT05878522|592064702|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917031|NCT05878522|592064703|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917032|NCT05878522|592064704|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917033|NCT05878522|592064705|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917034|NCT05878522|592064706|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
163917035|NCT05878522|592064707|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917036|NCT05878522|592064708|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
163917037|NCT05878522|592064697|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917038|NCT05878522|592064698|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
163917039|NCT05878522|592064699|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917040|NCT05878522|592064700|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
163917041|NCT05878522|592064701|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917042|NCT05878522|592064702|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917043|NCT05878522|592064703|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917044|NCT05878522|592064704|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917045|NCT05878522|592064705|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917046|NCT05878522|592064706|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917047|NCT05878522|592064707|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917048|NCT05878522|592064708|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
163917049|NCT05878522|592064697|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917050|NCT05878522|592064698|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164028867|NCT00424346|592465619|FG002|Extension Phase|Lack of Efficacy|14|||
164028868|NCT00424346|592465620|FG003|Extension Phase|Lack of Efficacy|11|||
164028869|NCT00424346|592465617|FG000|Extension Phase|Withdrawal by Subject|0|||
164028870|NCT00424346|592465618|FG001|Extension Phase|Withdrawal by Subject|5|||
164028871|NCT00424346|592465619|FG002|Extension Phase|Withdrawal by Subject|3|||
163917051|NCT05878522|592064699|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917052|NCT05878522|592064700|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917053|NCT05878522|592064701|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
163917054|NCT05878522|592064702|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917055|NCT05878522|592064703|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917056|NCT05878522|592064704|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917057|NCT05878522|592064705|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917058|NCT05878522|592064706|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917059|NCT05878522|592064707|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
164028872|NCT00424346|592465620|FG003|Extension Phase|Withdrawal by Subject|4|||
164028873|NCT00424346|592465617|FG000|Extension Phase|Lost to Follow-up|0|||
163917060|NCT05878522|592064708|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
163917061|NCT05263492|592064709|FG000|Overall Study|Adverse Event|1|||
163917062|NCT05263492|592064709|FG000|Overall Study|Disease progression during active treatment|3|||
163917063|NCT03747575|592064710|FG000|Overall Study|Withdrawal by Subject|6|||
163917064|NCT03747575|592064711|FG001|Overall Study|Withdrawal by Subject|3|||
163917065|NCT03747575|592064710|FG000|Overall Study|Lost to Follow-up|3|||
163917066|NCT03747575|592064711|FG001|Overall Study|Lost to Follow-up|3|||
163917067|NCT03747575|592064710|FG000|Overall Study|Adverse Event|0|||
163917068|NCT03747575|592064711|FG001|Overall Study|Adverse Event|1|||
163917069|NCT03953079|592064713|FG000|Core Study|Withdrawal by Subject|1|||
163917070|NCT03953079|592064714|FG001|Core Study|Withdrawal by Subject|2|||
163917071|NCT03953079|592064715|FG002|Core Study|Withdrawal by Subject|1|||
163917072|NCT03953079|592064713|FG000|Core Study|COVID-19|0|||
163917073|NCT03953079|592064714|FG001|Core Study|COVID-19|1|||
163917074|NCT03953079|592064715|FG002|Core Study|COVID-19|0|||
163917075|NCT03953079|592064713|FG000|Core Study|Difficulties leaving the house|0|||
163917076|NCT03953079|592064714|FG001|Core Study|Difficulties leaving the house|1|||
163917077|NCT03953079|592064715|FG002|Core Study|Difficulties leaving the house|0|||
163917078|NCT03953079|592064713|FG000|Extension Study|Withdrawal by Subject|1|||
163917079|NCT03953079|592064714|FG001|Extension Study|Withdrawal by Subject|0|||
163917080|NCT03953079|592064715|FG002|Extension Study|Withdrawal by Subject|0|||
163917081|NCT03953079|592064713|FG000|Extension Study|Received Rescue Treatment|5|||
163917082|NCT03953079|592064714|FG001|Extension Study|Received Rescue Treatment|6|||
163917083|NCT03953079|592064715|FG002|Extension Study|Received Rescue Treatment|5|||
163917084|NCT00936065|592064716|FG000|Overall Study|Adverse Event|1|||
163917085|NCT00936065|592064717|FG001|Overall Study|Adverse Event|0|||
163917086|NCT00936065|592064718|FG002|Overall Study|Adverse Event|1|||
163917087|NCT00936065|592064716|FG000|Overall Study|Lack of Efficacy|1|||
163917088|NCT00936065|592064717|FG001|Overall Study|Lack of Efficacy|0|||
163917089|NCT00936065|592064718|FG002|Overall Study|Lack of Efficacy|1|||
163917090|NCT00936065|592064716|FG000|Overall Study|Lost to Follow-up|1|||
163917091|NCT00936065|592064717|FG001|Overall Study|Lost to Follow-up|0|||
163917092|NCT00936065|592064718|FG002|Overall Study|Lost to Follow-up|0|||
163917093|NCT00936065|592064716|FG000|Overall Study|Protocol Violation|1|||
163917094|NCT00936065|592064717|FG001|Overall Study|Protocol Violation|2|||
163917095|NCT00936065|592064718|FG002|Overall Study|Protocol Violation|1|||
163917096|NCT00936065|592064716|FG000|Overall Study|Withdrawal by Subject|0|||
163917097|NCT00936065|592064717|FG001|Overall Study|Withdrawal by Subject|2|||
163917098|NCT00936065|592064718|FG002|Overall Study|Withdrawal by Subject|4|||
163917099|NCT02260154|592064722|FG000|Overall Study|Screening failure|2|||
163917100|NCT03560206|592064723|FG000|Overall Study|Lost to Follow-up|19|||
163917101|NCT03560206|592064724|FG001|Overall Study|Lost to Follow-up|11|||
163917102|NCT03560206|592064723|FG000|Overall Study|Withdrawal by Subject|2|||
163917103|NCT03560206|592064724|FG001|Overall Study|Withdrawal by Subject|4|||
163917104|NCT03560206|592064723|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
163917105|NCT03560206|592064724|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
163917106|NCT03560206|592064723|FG000|Overall Study|Busy schedule|14|||
163917107|NCT03560206|592064724|FG001|Overall Study|Busy schedule|2|||
163917108|NCT03560206|592064723|FG000|Overall Study|patients' new health condition such as cancer|10|||
163917109|NCT03560206|592064724|FG001|Overall Study|patients' new health condition such as cancer|1|||
163917110|NCT01549951|592064725|FG000|Overall Study|Adverse Event|15|||
163917111|NCT01549951|592064725|FG000|Overall Study|Withdrawal by Subject|2|||
163917112|NCT01549951|592064725|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
163917113|NCT01549951|592064725|FG000|Overall Study|Progressive disease|29|||
163917114|NCT01549951|592064725|FG000|Overall Study|Symptomatic deterioration|1|||
163917115|NCT01549951|592064725|FG000|Overall Study|Other|2|||
163917116|NCT00738400|592064728|FG000|Overall Study|Adverse Event|3|||
164028874|NCT00424346|592465618|FG001|Extension Phase|Lost to Follow-up|2|||
164028875|NCT00424346|592465619|FG002|Extension Phase|Lost to Follow-up|0|||
164028876|NCT00424346|592465620|FG003|Extension Phase|Lost to Follow-up|0|||
164028877|NCT00424346|592465617|FG000|Extension Phase|Administrative Problems|0|||
164028878|NCT00424346|592465618|FG001|Extension Phase|Administrative Problems|69|||
164028879|NCT00424346|592465619|FG002|Extension Phase|Administrative Problems|32|||
164096696|NCT01569152|592717380|FG002|Phase IIa, Period 1|Protocol Violation|0|||
164146442|NCT05026177|592898060|FG002|Overall Study|Adverse Event|17|||
163917117|NCT00738400|592064729|FG001|Overall Study|Adverse Event|1|||
163917118|NCT00738400|592064728|FG000|Overall Study|Withdrawal by Subject|0|||
163917119|NCT00738400|592064729|FG001|Overall Study|Withdrawal by Subject|1|||
163917120|NCT00738400|592064728|FG000|Overall Study|Lack of Efficacy|0|||
163917121|NCT00738400|592064729|FG001|Overall Study|Lack of Efficacy|1|||
163917122|NCT00738400|592064728|FG000|Overall Study|Lost to Follow-up|0|||
163917123|NCT00738400|592064729|FG001|Overall Study|Lost to Follow-up|3|||
163917124|NCT00738400|592064728|FG000|Overall Study|Protocol Violation|1|||
163917125|NCT00738400|592064729|FG001|Overall Study|Protocol Violation|0|||
163917126|NCT00738400|592064728|FG000|Overall Study|Non-compliant with study medication|0|||
163917127|NCT00738400|592064729|FG001|Overall Study|Non-compliant with study medication|1|||
163917128|NCT02255474|592064730|FG000|Overall Study|Lost to Follow-up|1|||
163917129|NCT02255474|592064731|FG001|Overall Study|Lost to Follow-up|1|||
163917130|NCT02255474|592064732|FG002|Overall Study|Lost to Follow-up|3|||
163917131|NCT02255474|592064730|FG000|Overall Study|Withdrawal by Subject|1|||
163917132|NCT02255474|592064731|FG001|Overall Study|Withdrawal by Subject|1|||
163917133|NCT02255474|592064732|FG002|Overall Study|Withdrawal by Subject|0|||
163917134|NCT02993926|592064736|FG000|Enantone Treatment Phase|Adverse Event|1|||
163917135|NCT02993926|592064737|FG001|Enantone Treatment Phase|Adverse Event|0|||
163917136|NCT02993926|592064738|FG002|Enantone Treatment Phase|Adverse Event|0|||
163917137|NCT02993926|592064736|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
163917138|NCT02993926|592064737|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
163917139|NCT02993926|592064738|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
163917140|NCT02993926|592064736|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
163917141|NCT02993926|592064737|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
163917142|NCT02993926|592064738|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
163917143|NCT02993926|592064736|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
163917144|NCT02993926|592064737|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
163917145|NCT02993926|592064738|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
163917146|NCT02009865|592064742|FG000|Overall Study|Adverse Event|0|||
163917147|NCT02009865|592064743|FG001|Overall Study|Adverse Event|2|||
163917148|NCT02009865|592064742|FG000|Overall Study|Protocol Violation|0|||
163917149|NCT02009865|592064743|FG001|Overall Study|Protocol Violation|2|||
163917150|NCT02009865|592064742|FG000|Overall Study|Withdrawal by Subject|1|||
163917151|NCT02009865|592064743|FG001|Overall Study|Withdrawal by Subject|1|||
163917152|NCT01760876|592064744|FG000|Overall Study|Non-cardiac death (head injury)|1|||
163917153|NCT01760876|592064744|FG000|Overall Study|Carcinoma of prostate|1|||
163917154|NCT01760876|592064744|FG000|Overall Study|Impaired renal function|1|||
163917155|NCT01760876|592064744|FG000|Overall Study|Major depression|1|||
163917156|NCT01760876|592064744|FG000|Overall Study|Very poor baseline OCT quality|2|||
163917157|NCT03394508|592064747|FG000|Overall Study|Protocol Violation|0|||
163917158|NCT03394508|592064748|FG001|Overall Study|Protocol Violation|3|||
163917159|NCT03394508|592064747|FG000|Overall Study|Lost to Follow-up|1|||
163917160|NCT03394508|592064748|FG001|Overall Study|Lost to Follow-up|0|||
163917161|NCT03556891|592064749|FG000|Initial Pivotal Study|Adverse Event|4|||
163917162|NCT03556891|592064749|FG000|Initial Pivotal Study|MRI Need|3|||
163917163|NCT03556891|592064749|FG000|Initial Pivotal Study|Device Failure|1|||
163917164|NCT03556891|592064749|FG000|Initial Pivotal Study|Death|1|||
163917165|NCT03556891|592064749|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
163917166|NCT03556891|592064749|FG000|Initial Pivotal Study|Missing at random|1|||
163917167|NCT03556891|592064749|FG000|Initial Pivotal Study|Missing due to COVID|1|||
163917168|NCT03556891|592064749|FG000|Initial Pivotal Study|Protocol Violation|1|||
163917169|NCT01002547|592066555|FG000|Overall Study|Withdrawal by Subject|4|||
163917170|NCT01002547|592066556|FG001|Overall Study|Withdrawal by Subject|0|||
163917171|NCT01002547|592066557|FG002|Overall Study|Withdrawal by Subject|5|||
163917172|NCT01002547|592066555|FG000|Overall Study|Lost to Follow-up|2|||
163917173|NCT01002547|592066556|FG001|Overall Study|Lost to Follow-up|1|||
163917174|NCT01002547|592066557|FG002|Overall Study|Lost to Follow-up|1|||
163917175|NCT01002547|592066555|FG000|Overall Study|Physician Decision|1|||
163917176|NCT01002547|592066556|FG001|Overall Study|Physician Decision|0|||
163917177|NCT01002547|592066557|FG002|Overall Study|Physician Decision|0|||
164096697|NCT01569152|592717378|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
164096698|NCT01569152|592717379|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
164096699|NCT01569152|592717380|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
164096700|NCT01569152|592717378|FG000|Safety Extension, Period 3|Adverse Event|0|||
164096701|NCT01569152|592717379|FG001|Safety Extension, Period 3|Adverse Event|0|||
164096702|NCT01569152|592717380|FG002|Safety Extension, Period 3|Adverse Event|4|||
164096703|NCT01569152|592717378|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
164096704|NCT01569152|592717379|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
164096705|NCT01569152|592717380|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
164096706|NCT01569152|592717378|FG000|Safety Extension, Period 3|Physician Decision|0|||
164096707|NCT01569152|592717379|FG001|Safety Extension, Period 3|Physician Decision|0|||
164096708|NCT01569152|592717380|FG002|Safety Extension, Period 3|Physician Decision|2|||
164096709|NCT01569152|592717378|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
164096710|NCT01569152|592717379|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
164096711|NCT01569152|592717380|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
164096712|NCT00683293|592717387|FG000|Overall Study|Withdrawal by Subject|2|||
164096713|NCT00683293|592717388|FG001|Overall Study|Withdrawal by Subject|3|||
164096714|NCT00743197|592717391|FG000|Overall Study|Study terminated due to departure of PI.|1|||
164096715|NCT00743197|592717392|FG001|Overall Study|Study terminated due to departure of PI.|2|||
164096716|NCT01411332|592717397|FG000|Enrollment|Protocol Violation|0|||
164096717|NCT01411332|592717398|FG001|Enrollment|Protocol Violation|1|||
164096718|NCT01411332|592717397|FG000|Enrollment|Withdrawal by Subject|0|||
164096719|NCT01411332|592717398|FG001|Enrollment|Withdrawal by Subject|1|||
164096720|NCT01411332|592717397|FG000|Treatment|Lost to Follow-up|1|||
164096721|NCT01411332|592717398|FG001|Treatment|Lost to Follow-up|0|||
163917178|NCT01002547|592066555|FG000|Overall Study|Death|0|||
163917179|NCT01002547|592066556|FG001|Overall Study|Death|2|||
163917180|NCT01002547|592066557|FG002|Overall Study|Death|2|||
163917181|NCT01002547|592066555|FG000|Overall Study|Adverse Event|1|||
163917182|NCT01002547|592066556|FG001|Overall Study|Adverse Event|0|||
163917183|NCT01002547|592066557|FG002|Overall Study|Adverse Event|0|||
163917184|NCT01184859|592066565|FG000|Period 1: Single Dose|Insufficient urine production|0|||
163917185|NCT01184859|592066566|FG001|Period 1: Single Dose|Insufficient urine production|1|||
163917186|NCT01184859|592066567|FG002|Period 1: Single Dose|Insufficient urine production|0|||
163917187|NCT01184859|592066568|FG003|Period 1: Single Dose|Insufficient urine production|0|||
163917188|NCT01184859|592066569|FG004|Period 1: Single Dose|Insufficient urine production|0|||
163917189|NCT01184859|592066565|FG000|Period 1: Single Dose|Protocol Violation|0|||
163917190|NCT01184859|592066566|FG001|Period 1: Single Dose|Protocol Violation|1|||
163917191|NCT01184859|592066567|FG002|Period 1: Single Dose|Protocol Violation|0|||
163917192|NCT01184859|592066568|FG003|Period 1: Single Dose|Protocol Violation|0|||
163917193|NCT01184859|592066569|FG004|Period 1: Single Dose|Protocol Violation|0|||
163917194|NCT01184859|592066565|FG000|Period 1: Single Dose|Adverse Event|0|||
163917195|NCT01184859|592066566|FG001|Period 1: Single Dose|Adverse Event|0|||
163917196|NCT01184859|592066567|FG002|Period 1: Single Dose|Adverse Event|0|||
163917197|NCT01184859|592066568|FG003|Period 1: Single Dose|Adverse Event|0|||
163917198|NCT01184859|592066569|FG004|Period 1: Single Dose|Adverse Event|1|||
163917199|NCT01184859|592066565|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163917200|NCT01184859|592066566|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163917201|NCT01184859|592066567|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163917202|NCT01184859|592066568|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
163917203|NCT01184859|592066569|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
163917204|NCT01184859|592066565|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
163917205|NCT01184859|592066566|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163917206|NCT01184859|592066567|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163917207|NCT01184859|592066568|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163917208|NCT01184859|592066569|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
163917209|NCT00434577|592066572|FG000|Months 0-3|Serious Adverse Event|0|||
163917210|NCT00434577|592066573|FG001|Months 0-3|Serious Adverse Event|0|||
163917211|NCT00434577|592066574|FG002|Months 0-3|Serious Adverse Event|1|||
163917212|NCT00434577|592066575|FG003|Months 0-3|Serious Adverse Event|0|||
163917213|NCT00434577|592066576|FG004|Months 0-3|Serious Adverse Event|0|||
164028880|NCT00424346|592465620|FG003|Extension Phase|Administrative Problems|35|||
164028881|NCT00424346|592465617|FG000|Extension Phase|Death|0|||
164028882|NCT00424346|592465618|FG001|Extension Phase|Death|0|||
164028883|NCT00424346|592465619|FG002|Extension Phase|Death|0|||
164028884|NCT00424346|592465620|FG003|Extension Phase|Death|1|||
164028885|NCT00424346|592465617|FG000|Extension Phase|Protocol Violation|0|||
164028886|NCT00424346|592465618|FG001|Extension Phase|Protocol Violation|1|||
164028887|NCT00424346|592465619|FG002|Extension Phase|Protocol Violation|1|||
164028888|NCT00424346|592465620|FG003|Extension Phase|Protocol Violation|0|||
164028889|NCT01827319|592465621|FG000|Overall Study|Lost to Follow-up|3|||
164028890|NCT00571519|592465622|FG000|Overall Study|Subject withdrew consent|0|||
164028891|NCT00571519|592465623|FG001|Overall Study|Subject withdrew consent|1|||
164028892|NCT00571519|592465624|FG002|Overall Study|Subject withdrew consent|0|||
164028893|NCT00571519|592465625|FG003|Overall Study|Subject withdrew consent|2|||
164028894|NCT00571519|592465626|FG004|Overall Study|Subject withdrew consent|1|||
164028895|NCT00571519|592465627|FG005|Overall Study|Subject withdrew consent|1|||
164028896|NCT00571519|592465628|FG006|Overall Study|Subject withdrew consent|2|||
164028897|NCT00571519|592465622|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
164028898|NCT00571519|592465623|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164028899|NCT00571519|592465624|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
164028900|NCT00571519|592465625|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
164028901|NCT00571519|592465626|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164028902|NCT00571519|592465627|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164028903|NCT00571519|592465628|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
164028904|NCT00571519|592465622|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
164028905|NCT00571519|592465623|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
164028906|NCT00571519|592465624|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
164028907|NCT00571519|592465625|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
164028908|NCT00571519|592465626|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
163917214|NCT00434577|592066572|FG000|Months 0-3|Adverse Event|0|||
163917215|NCT00434577|592066573|FG001|Months 0-3|Adverse Event|1|||
163917216|NCT00434577|592066574|FG002|Months 0-3|Adverse Event|1|||
163917217|NCT00434577|592066575|FG003|Months 0-3|Adverse Event|0|||
163917218|NCT00434577|592066576|FG004|Months 0-3|Adverse Event|0|||
163917219|NCT00434577|592066572|FG000|Months 0-3|Lost to Follow-up|0|||
164028909|NCT00571519|592465627|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
164028910|NCT00571519|592465628|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
164028911|NCT00571519|592465622|FG000|Overall Study|Termination of study by Sponsor|2|||
164028912|NCT00571519|592465623|FG001|Overall Study|Termination of study by Sponsor|7|||
164028913|NCT00571519|592465624|FG002|Overall Study|Termination of study by Sponsor|10|||
164028914|NCT00571519|592465625|FG003|Overall Study|Termination of study by Sponsor|24|||
164028915|NCT00571519|592465626|FG004|Overall Study|Termination of study by Sponsor|8|||
164028916|NCT00571519|592465627|FG005|Overall Study|Termination of study by Sponsor|9|||
164028917|NCT00571519|592465628|FG006|Overall Study|Termination of study by Sponsor|22|||
164028918|NCT00571519|592465622|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164028919|NCT00571519|592465623|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164028920|NCT00571519|592465624|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
164028921|NCT00571519|592465625|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164028922|NCT00571519|592465626|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164028923|NCT00571519|592465627|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164028924|NCT00571519|592465628|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
164028925|NCT03057951|592465634|FG000|Overall Study|Adverse Event|553|||
164028926|NCT03057951|592465635|FG001|Overall Study|Adverse Event|575|||
164028927|NCT03057951|592465634|FG000|Overall Study|Protocol Violation|30|||
164028928|NCT03057951|592465635|FG001|Overall Study|Protocol Violation|24|||
164028929|NCT03057951|592465634|FG000|Overall Study|Lost to Follow-up|6|||
164028930|NCT03057951|592465635|FG001|Overall Study|Lost to Follow-up|16|||
164028931|NCT03057951|592465634|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
164028932|NCT03057951|592465635|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
164028933|NCT03057951|592465634|FG000|Overall Study|Study drug stopped, reason missing|6|||
164028934|NCT03057951|592465635|FG001|Overall Study|Study drug stopped, reason missing|1|||
164028935|NCT03057951|592465634|FG000|Overall Study|Medical advice|6|||
164028936|NCT03057951|592465635|FG001|Overall Study|Medical advice|2|||
164028937|NCT03057951|592465634|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
164028938|NCT03057951|592465635|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
164028939|NCT03057951|592465634|FG000|Overall Study|Investigator decision|2|||
164028940|NCT03057951|592465635|FG001|Overall Study|Investigator decision|0|||
164028941|NCT03057951|592465634|FG000|Overall Study|Patient decision|5|||
164028942|NCT03057951|592465635|FG001|Overall Study|Patient decision|2|||
164028943|NCT03057951|592465634|FG000|Overall Study|Not attending study visits|3|||
164028944|NCT03057951|592465635|FG001|Overall Study|Not attending study visits|0|||
164028945|NCT03057951|592465634|FG000|Overall Study|Patient moved away|3|||
164028946|NCT03057951|592465635|FG001|Overall Study|Patient moved away|4|||
164028947|NCT03057951|592465634|FG000|Overall Study|Other reason than stated above|23|||
164028948|NCT03057951|592465635|FG001|Overall Study|Other reason than stated above|29|||
164028949|NCT03057951|592465634|FG000|Overall Study|Not treated|2|||
164028950|NCT03057951|592465635|FG001|Overall Study|Not treated|1|||
164028951|NCT03434418|592465636|FG000|Overall Study|Disease Progression|11|||
164028952|NCT03434418|592465636|FG000|Overall Study|Adverse Event|2|||
164028953|NCT03434418|592465636|FG000|Overall Study|Physician Decision|1|||
164028954|NCT03434418|592465636|FG000|Overall Study|Decline in Performance Status (PS)|1|||
164028955|NCT00696436|592465638|FG000|Overall Study|Adverse Event|7|||
164028956|NCT00696436|592465639|FG001|Overall Study|Adverse Event|9|||
164028957|NCT00696436|592465640|FG002|Overall Study|Adverse Event|8|||
164028958|NCT00696436|592465641|FG003|Overall Study|Adverse Event|6|||
164028959|NCT00696436|592465642|FG004|Overall Study|Adverse Event|4|||
164028960|NCT00696436|592465638|FG000|Overall Study|Protocol Violation|3|||
164028961|NCT00696436|592465639|FG001|Overall Study|Protocol Violation|2|||
164028962|NCT00696436|592465640|FG002|Overall Study|Protocol Violation|2|||
164028963|NCT00696436|592465641|FG003|Overall Study|Protocol Violation|0|||
164028964|NCT00696436|592465642|FG004|Overall Study|Protocol Violation|1|||
164028965|NCT00696436|592465638|FG000|Overall Study|Lost to Follow-up|1|||
164028966|NCT00696436|592465639|FG001|Overall Study|Lost to Follow-up|6|||
164028967|NCT00696436|592465640|FG002|Overall Study|Lost to Follow-up|2|||
164028968|NCT00696436|592465641|FG003|Overall Study|Lost to Follow-up|4|||
164028969|NCT00696436|592465642|FG004|Overall Study|Lost to Follow-up|3|||
164028970|NCT00696436|592465638|FG000|Overall Study|Withdrawal by Subject|4|||
164028971|NCT00696436|592465639|FG001|Overall Study|Withdrawal by Subject|11|||
164028972|NCT00696436|592465640|FG002|Overall Study|Withdrawal by Subject|5|||
164028973|NCT00696436|592465641|FG003|Overall Study|Withdrawal by Subject|7|||
164028974|NCT00696436|592465642|FG004|Overall Study|Withdrawal by Subject|1|||
164028975|NCT00696436|592465638|FG000|Overall Study|Lack of Efficacy|3|||
164028976|NCT00696436|592465639|FG001|Overall Study|Lack of Efficacy|1|||
164028977|NCT00696436|592465640|FG002|Overall Study|Lack of Efficacy|5|||
164028978|NCT00696436|592465641|FG003|Overall Study|Lack of Efficacy|2|||
164028979|NCT00696436|592465642|FG004|Overall Study|Lack of Efficacy|4|||
164028980|NCT00696436|592465638|FG000|Overall Study|Participant Unavailability|2|||
164028981|NCT00696436|592465639|FG001|Overall Study|Participant Unavailability|0|||
164028982|NCT00696436|592465640|FG002|Overall Study|Participant Unavailability|2|||
164028983|NCT00696436|592465641|FG003|Overall Study|Participant Unavailability|1|||
163917220|NCT00434577|592066573|FG001|Months 0-3|Lost to Follow-up|0|||
163917221|NCT00434577|592066574|FG002|Months 0-3|Lost to Follow-up|0|||
163917222|NCT00434577|592066575|FG003|Months 0-3|Lost to Follow-up|0|||
163917223|NCT00434577|592066576|FG004|Months 0-3|Lost to Follow-up|2|||
163917224|NCT00434577|592066572|FG000|Months 0-3|Protocol Violation|1|||
163917225|NCT00434577|592066573|FG001|Months 0-3|Protocol Violation|0|||
163917226|NCT00434577|592066574|FG002|Months 0-3|Protocol Violation|1|||
163917227|NCT00434577|592066575|FG003|Months 0-3|Protocol Violation|0|||
163917228|NCT00434577|592066576|FG004|Months 0-3|Protocol Violation|0|||
163917229|NCT00434577|592066572|FG000|Months 0-3|Withdrawal by Subject|2|||
163917230|NCT00434577|592066573|FG001|Months 0-3|Withdrawal by Subject|1|||
163917231|NCT00434577|592066574|FG002|Months 0-3|Withdrawal by Subject|1|||
163917232|NCT00434577|592066575|FG003|Months 0-3|Withdrawal by Subject|1|||
163917233|NCT00434577|592066576|FG004|Months 0-3|Withdrawal by Subject|1|||
163917234|NCT00635570|592066581|FG000|Overall Study|Lost to Follow-up|8|||
163917235|NCT00635570|592066582|FG001|Overall Study|Lost to Follow-up|8|||
163917236|NCT00635570|592066581|FG000|Overall Study|Withdrawal by Subject|1|||
163917237|NCT00635570|592066582|FG001|Overall Study|Withdrawal by Subject|1|||
163917238|NCT00635570|592066581|FG000|Overall Study|Adverse Event|2|||
163917239|NCT00635570|592066582|FG001|Overall Study|Adverse Event|0|||
163917240|NCT00635570|592066581|FG000|Overall Study|Physician Decision|1|||
163917241|NCT00635570|592066582|FG001|Overall Study|Physician Decision|0|||
163917242|NCT00635570|592066581|FG000|Overall Study|Did not complete survey|2|||
163917243|NCT00635570|592066582|FG001|Overall Study|Did not complete survey|1|||
163917244|NCT00635570|592066581|FG000|Overall Study|Early termination(No sexual activity)|1|||
163917245|NCT00635570|592066582|FG001|Overall Study|Early termination(No sexual activity)|1|||
163917246|NCT02176356|592066583|FG000|Overall Study|Screen Failure|14|||
163917247|NCT02176356|592066583|FG000|Overall Study|Lost to Follow-up|4|||
163917248|NCT02176356|592066583|FG000|Overall Study|Personal Reasons|3|||
163917249|NCT02176356|592066583|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163917250|NCT00381888|592066587|FG000|Overall Study|Death|1|||
163917251|NCT00381888|592066587|FG000|Overall Study|Withdrawal by Subject|1|||
163917252|NCT00381888|592066587|FG000|Overall Study|Physician Decision|1|||
163917253|NCT00381888|592066587|FG000|Overall Study|Protocol Violation|9|||
163917254|NCT00381888|592066587|FG000|Overall Study|Had laparoscopic surgery|2|||
164096722|NCT01710657|592718936|FG000|Overall Study|Lost to Follow-up|2|||
164096723|NCT01710657|592718937|FG001|Overall Study|Lost to Follow-up|0|||
163917255|NCT00381888|592066587|FG000|Overall Study|Surgery was cancelled|2|||
163917256|NCT00381888|592066587|FG000|Overall Study|Adverse Event|1|||
163917257|NCT01537120|592066591|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
163917258|NCT01537120|592066591|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
164300986|NCT02392624|593478383|FG000|Overall Study|Other|49|||
164300987|NCT02392624|593478384|FG001|Overall Study|Other|1|||
164300988|NCT02392624|593478385|FG002|Overall Study|Other|1|||
164300989|NCT03841604|593478388|FG000|Overall Study|Withdrawal by Subject|3|||
164300990|NCT03841604|593478389|FG001|Overall Study|Withdrawal by Subject|1|||
164300991|NCT03841604|593478388|FG000|Overall Study|Adverse Event|4|||
164300992|NCT03841604|593478389|FG001|Overall Study|Adverse Event|2|||
164300993|NCT03841604|593478388|FG000|Overall Study|Physician Decision|1|||
164300994|NCT03841604|593478389|FG001|Overall Study|Physician Decision|0|||
164300995|NCT01337960|593478390|FG000|Overall Study|Lost to Follow-up|1|||
164300996|NCT01337960|593478391|FG001|Overall Study|Lost to Follow-up|0|||
164300997|NCT01337960|593478392|FG002|Overall Study|Lost to Follow-up|0|||
164300998|NCT01337960|593478390|FG000|Overall Study|Withdrawal by Subject|1|||
164300999|NCT01337960|593478391|FG001|Overall Study|Withdrawal by Subject|0|||
164301000|NCT01337960|593478392|FG002|Overall Study|Withdrawal by Subject|0|||
164301001|NCT03877510|593478393|FG000|Overall Study|Death|6|||
164301002|NCT03877510|593478393|FG000|Overall Study|Lost to Follow-up|2|||
164301003|NCT03877510|593478393|FG000|Overall Study|Non-compliance with study drug|2|||
164301004|NCT03877510|593478393|FG000|Overall Study|Lack of Efficacy|14|||
164301005|NCT03877510|593478393|FG000|Overall Study|Adverse Event|20|||
164301006|NCT03877510|593478393|FG000|Overall Study|Withdrawal by Subject|22|||
164301007|NCT03877510|593478393|FG000|Overall Study|Miscellaneous|1|||
164301008|NCT03763877|593478394|FG000|Overall Study|Withdrawal by Subject|3|||
164301009|NCT03763877|593478395|FG001|Overall Study|Withdrawal by Subject|1|||
164028984|NCT00696436|592465642|FG004|Overall Study|Participant Unavailability|0|||
164028985|NCT00696436|592465638|FG000|Overall Study|Administrative Error|2|||
164301010|NCT03763877|593478396|FG002|Overall Study|Withdrawal by Subject|3|||
164028986|NCT00696436|592465639|FG001|Overall Study|Administrative Error|0|||
164028987|NCT00696436|592465640|FG002|Overall Study|Administrative Error|2|||
164028988|NCT00696436|592465641|FG003|Overall Study|Administrative Error|0|||
164028989|NCT00696436|592465642|FG004|Overall Study|Administrative Error|0|||
164028990|NCT00696436|592465638|FG000|Overall Study|Participant Non-compliance|0|||
164028991|NCT00696436|592465639|FG001|Overall Study|Participant Non-compliance|0|||
164028992|NCT00696436|592465640|FG002|Overall Study|Participant Non-compliance|1|||
164301011|NCT03763877|593478397|FG003|Overall Study|Withdrawal by Subject|4|||
164301012|NCT03763877|593478394|FG000|Overall Study|Adverse Event|1|||
164301013|NCT03763877|593478395|FG001|Overall Study|Adverse Event|1|||
164301014|NCT03763877|593478396|FG002|Overall Study|Adverse Event|3|||
164301015|NCT03763877|593478397|FG003|Overall Study|Adverse Event|1|||
163917289|NCT00958711|592066605|FG000|Overall Study|Withdrawal by Subject|0|||
163917290|NCT00958711|592066606|FG001|Overall Study|Withdrawal by Subject|4|||
163917291|NCT00958711|592066605|FG000|Overall Study|Physician Decision|5|||
164028993|NCT00696436|592465641|FG003|Overall Study|Participant Non-compliance|2|||
164028994|NCT00696436|592465642|FG004|Overall Study|Participant Non-compliance|0|||
164301016|NCT03763877|593478394|FG000|Overall Study|Protocol Violation|1|||
164301017|NCT03763877|593478395|FG001|Overall Study|Protocol Violation|1|||
164028995|NCT00696436|592465638|FG000|Overall Study|Administrative Decision|1|||
164028996|NCT00696436|592465639|FG001|Overall Study|Administrative Decision|0|||
164028997|NCT00696436|592465640|FG002|Overall Study|Administrative Decision|0|||
164028998|NCT00696436|592465641|FG003|Overall Study|Administrative Decision|0|||
164028999|NCT00696436|592465642|FG004|Overall Study|Administrative Decision|0|||
164029000|NCT00696436|592465638|FG000|Overall Study|Missing|0|||
164029001|NCT00696436|592465639|FG001|Overall Study|Missing|1|||
164029002|NCT00696436|592465640|FG002|Overall Study|Missing|1|||
164029003|NCT00696436|592465641|FG003|Overall Study|Missing|0|||
164029004|NCT00696436|592465642|FG004|Overall Study|Missing|0|||
164029005|NCT03039738|592465644|FG000|Overall Study|Incomplete data sets|54|||
164029006|NCT03039738|592465645|FG001|Overall Study|Incomplete data sets|0|||
164029007|NCT01293006|592465649|FG000|Period 2|Lost to Follow-up|1|||
164029008|NCT01293006|592465650|FG001|Period 2|Lost to Follow-up|0|||
164029009|NCT01293006|592465651|FG002|Period 2|Lost to Follow-up|0|||
164029010|NCT01293006|592465652|FG003|Period 2|Lost to Follow-up|0|||
164029011|NCT01494987|592465653|FG000|Overall Study|Adverse Event|6|||
164029012|NCT01494987|592465654|FG001|Overall Study|Adverse Event|5|||
164029013|NCT01494987|592465653|FG000|Overall Study|Hyperglycemia|6|||
164029014|NCT01494987|592465654|FG001|Overall Study|Hyperglycemia|4|||
164029015|NCT01494987|592465653|FG000|Overall Study|Investigator's Discretion|1|||
164029016|NCT01494987|592465654|FG001|Overall Study|Investigator's Discretion|2|||
164029017|NCT01494987|592465653|FG000|Overall Study|Lost to Follow-up|1|||
164029018|NCT01494987|592465654|FG001|Overall Study|Lost to Follow-up|1|||
164029019|NCT01494987|592465653|FG000|Overall Study|Protocol Violation|3|||
164029020|NCT01494987|592465654|FG001|Overall Study|Protocol Violation|3|||
164029021|NCT01494987|592465653|FG000|Overall Study|Subject Non-Compliance|9|||
164029022|NCT01494987|592465654|FG001|Overall Study|Subject Non-Compliance|10|||
164029023|NCT01494987|592465653|FG000|Overall Study|Subject Withdrew Consent|2|||
164029024|NCT01494987|592465654|FG001|Overall Study|Subject Withdrew Consent|3|||
164029025|NCT02716194|592465660|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
163917292|NCT00958711|592066606|FG001|Overall Study|Physician Decision|7|||
163917293|NCT00958711|592066605|FG000|Overall Study|Lost to Follow-up|4|||
163917294|NCT00958711|592066606|FG001|Overall Study|Lost to Follow-up|1|||
163917295|NCT00958711|592066605|FG000|Overall Study|Other|2|||
163917296|NCT00958711|592066606|FG001|Overall Study|Other|5|||
163917297|NCT00958711|592066605|FG000|Overall Study|Death|1|||
163917298|NCT00958711|592066606|FG001|Overall Study|Death|2|||
163917299|NCT00958711|592066605|FG000|Overall Study|Adverse Event|1|||
163917300|NCT00958711|592066606|FG001|Overall Study|Adverse Event|2|||
163917301|NCT03722485|592066607|FG000|Overall Study|Withdrawal by Subject|1|||
163917302|NCT03722485|592066608|FG001|Overall Study|Withdrawal by Subject|0|||
164029026|NCT02716194|592465661|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
164029027|NCT02716194|592465662|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
164029028|NCT00363051|592465663|FG000|Overall Study|Adminstrative problems|1|||
164029029|NCT00363051|592465664|FG001|Overall Study|Adminstrative problems|1|||
164029030|NCT00363051|592465663|FG000|Overall Study|Adverse Event|21|||
164029031|NCT00363051|592465664|FG001|Overall Study|Adverse Event|12|||
164029032|NCT00363051|592465663|FG000|Overall Study|New Cancer Therapy|2|||
164029033|NCT00363051|592465664|FG001|Overall Study|New Cancer Therapy|1|||
164029034|NCT00363051|592465663|FG000|Overall Study|Withdrawal by Subject|11|||
164029035|NCT00363051|592465664|FG001|Overall Study|Withdrawal by Subject|3|||
164029036|NCT00363051|592465663|FG000|Overall Study|Lost to Follow-up|0|||
164029037|NCT00363051|592465664|FG001|Overall Study|Lost to Follow-up|1|||
164029038|NCT00363051|592465663|FG000|Overall Study|Protocol Violation|0|||
164029039|NCT00363051|592465664|FG001|Overall Study|Protocol Violation|2|||
164029040|NCT00363051|592465663|FG000|Overall Study|Death|3|||
164029041|NCT00363051|592465664|FG001|Overall Study|Death|2|||
164029042|NCT02293993|592465665|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
164029043|NCT02293993|592465666|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
164029044|NCT02293993|592465667|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
164029045|NCT02293993|592465668|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
164029046|NCT02293993|592465665|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
164029047|NCT02293993|592465666|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
164029048|NCT02293993|592465667|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
164029049|NCT02293993|592465668|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
164029050|NCT02293993|592465665|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
164029051|NCT02293993|592465666|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
164029052|NCT02293993|592465667|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
164029053|NCT02293993|592465668|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
164029054|NCT02293993|592465665|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
164029055|NCT02293993|592465666|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
164029056|NCT02293993|592465667|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
164029057|NCT02293993|592465668|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
164029058|NCT02293993|592465665|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
164029059|NCT02293993|592465666|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
164029060|NCT02293993|592465667|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
164029061|NCT02293993|592465668|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
164029062|NCT00205699|592465669|FG000|Overall Study|Lost to Follow-up|1|||
164029063|NCT00205699|592465670|FG001|Overall Study|Lost to Follow-up|3|||
164029064|NCT00205699|592465671|FG002|Overall Study|Lost to Follow-up|5|||
164029065|NCT00205699|592465669|FG000|Overall Study|Adverse Event|1|||
164029066|NCT00205699|592465670|FG001|Overall Study|Adverse Event|0|||
164029067|NCT00205699|592465671|FG002|Overall Study|Adverse Event|0|||
164029068|NCT00205699|592465669|FG000|Overall Study|Withdrawal by Subject|1|||
164029069|NCT00205699|592465670|FG001|Overall Study|Withdrawal by Subject|2|||
164029070|NCT00205699|592465671|FG002|Overall Study|Withdrawal by Subject|1|||
164029071|NCT00205699|592465669|FG000|Overall Study|Lack of Efficacy|0|||
164029072|NCT00205699|592465670|FG001|Overall Study|Lack of Efficacy|1|||
164029073|NCT00205699|592465671|FG002|Overall Study|Lack of Efficacy|0|||
164029074|NCT03587584|592465672|FG000|Overall Study|SOC deviations|4|||
164029075|NCT03587584|592465673|FG001|Overall Study|SOC deviations|6|||
164029076|NCT03587584|592465672|FG000|Overall Study|Incomplete data|0|||
164029077|NCT03587584|592465673|FG001|Overall Study|Incomplete data|3|||
164029078|NCT01207388|592465680|FG000|Overall Study|Death|67|||
164029079|NCT01207388|592465680|FG000|Overall Study|Withdrawal by Subject|1|||
164029080|NCT01677507|592465681|FG000|Initial Assignment|Adverse Event|0|||
164029081|NCT01677507|592465682|FG001|Initial Assignment|Adverse Event|1|||
164029082|NCT01677507|592465681|FG000|Initial Assignment|Protocol Violation|0|||
164029083|NCT01677507|592465682|FG001|Initial Assignment|Protocol Violation|1|||
164029084|NCT01677507|592465681|FG000|Second Assigment|Withdrawal by Subject|2|||
164029085|NCT01677507|592465682|FG001|Second Assigment|Withdrawal by Subject|2|||
164029086|NCT01677507|592465681|FG000|Second Assigment|Adverse Event|1|||
164029087|NCT01677507|592465682|FG001|Second Assigment|Adverse Event|3|||
164029088|NCT00469209|592465683|FG000|Overall Study|Adverse Event|1|||
164029089|NCT00469209|592465684|FG001|Overall Study|Adverse Event|0|||
164029090|NCT00469209|592465685|FG002|Overall Study|Adverse Event|1|||
164029091|NCT01194869|592465688|FG000|Overall Study|Disease Progression|2|||
164029092|NCT01194869|592465688|FG000|Overall Study|Toxicity|2|||
164029093|NCT06087328|592465692|FG000|28-Day Treatment|Lost to Follow-up|7|||
164029094|NCT06087328|592465693|FG001|28-Day Treatment|Lost to Follow-up|3|||
164029095|NCT06087328|592465694|FG002|28-Day Treatment|Lost to Follow-up|4|||
164029096|NCT06087328|592465692|FG000|1-month Follow-up|Lost to Follow-up|0|||
164029097|NCT06087328|592465693|FG001|1-month Follow-up|Lost to Follow-up|1|||
164029098|NCT06087328|592465694|FG002|1-month Follow-up|Lost to Follow-up|1|||
164029099|NCT03589326|592465695|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
164029100|NCT03589326|592465696|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
164096724|NCT01710657|592718938|FG002|Overall Study|Lost to Follow-up|1|||
164029101|NCT03589326|592465695|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
164029102|NCT03589326|592465696|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
164029103|NCT03589326|592465695|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
164096725|NCT01710657|592718936|FG000|Overall Study|Protocol Violation|2|||
164096726|NCT01710657|592718937|FG001|Overall Study|Protocol Violation|2|||
164096727|NCT01710657|592718938|FG002|Overall Study|Protocol Violation|0|||
164029104|NCT03589326|592465696|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
164029105|NCT03589326|592465695|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
164029106|NCT03589326|592465696|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
164029107|NCT03589326|592465695|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
164029108|NCT03589326|592465696|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
164029109|NCT04465396|592465699|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
164029110|NCT04465396|592465700|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
164029111|NCT04465396|592465701|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
164029112|NCT04465396|592465702|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
164029113|NCT00434122|592465703|FG000|Overall Study|Non-compliance with protocol|0|||
164029114|NCT00434122|592465704|FG001|Overall Study|Non-compliance with protocol|1|||
164029115|NCT00434122|592465703|FG000|Overall Study|loss of subject contact|1|||
164096728|NCT01710657|592718936|FG000|Overall Study|Adverse Event|14|||
163917303|NCT03722485|592066607|FG000|Overall Study|Adverse Event|0|||
163917304|NCT03722485|592066608|FG001|Overall Study|Adverse Event|2|||
163917305|NCT03722485|592066607|FG000|Overall Study|subject discharged prior to study completion|1|||
163917306|NCT03722485|592066608|FG001|Overall Study|subject discharged prior to study completion|5|||
163917307|NCT03722485|592066607|FG000|Overall Study|eligibility criteria not met|2|||
163917308|NCT03722485|592066608|FG001|Overall Study|eligibility criteria not met|0|||
164029116|NCT00434122|592465704|FG001|Overall Study|loss of subject contact|1|||
164029117|NCT00434122|592465703|FG000|Overall Study|Personal reasons|1|||
164029118|NCT00434122|592465704|FG001|Overall Study|Personal reasons|1|||
164029119|NCT00434122|592465703|FG000|Overall Study|Large follicle size|2|||
164029120|NCT00434122|592465704|FG001|Overall Study|Large follicle size|2|||
164029121|NCT00434122|592465703|FG000|Overall Study|Low follicular response.|1|||
164029122|NCT00434122|592465704|FG001|Overall Study|Low follicular response.|2|||
164096729|NCT01710657|592718937|FG001|Overall Study|Adverse Event|8|||
164096730|NCT01710657|592718938|FG002|Overall Study|Adverse Event|28|||
164096731|NCT01710657|592718936|FG000|Overall Study|Withdrawal by Subject|0|||
164096732|NCT01710657|592718937|FG001|Overall Study|Withdrawal by Subject|1|||
164096733|NCT01710657|592718938|FG002|Overall Study|Withdrawal by Subject|2|||
164096734|NCT01710657|592718936|FG000|Overall Study|Lack of Efficacy|0|||
164096735|NCT01710657|592718937|FG001|Overall Study|Lack of Efficacy|1|||
164096736|NCT01710657|592718938|FG002|Overall Study|Lack of Efficacy|1|||
164096737|NCT02495857|592718948|FG000|Overall Study|Adverse Event|5|||
164096738|NCT02495857|592718949|FG001|Overall Study|Adverse Event|0|||
164096739|NCT02495857|592718950|FG002|Overall Study|Adverse Event|1|||
164096740|NCT02495857|592718948|FG000|Overall Study|Withdrawal by Subject|9|||
164096741|NCT02495857|592718949|FG001|Overall Study|Withdrawal by Subject|6|||
164096742|NCT02495857|592718950|FG002|Overall Study|Withdrawal by Subject|10|||
164096743|NCT02495857|592718948|FG000|Overall Study|Physician Decision|0|||
164096744|NCT02495857|592718949|FG001|Overall Study|Physician Decision|1|||
164096745|NCT02495857|592718950|FG002|Overall Study|Physician Decision|0|||
164096746|NCT02495857|592718948|FG000|Overall Study|Protocol Violation|1|||
164096747|NCT02495857|592718949|FG001|Overall Study|Protocol Violation|1|||
164096748|NCT02495857|592718950|FG002|Overall Study|Protocol Violation|2|||
164096749|NCT02495857|592718948|FG000|Overall Study|Lost to Follow-up|4|||
164096750|NCT02495857|592718949|FG001|Overall Study|Lost to Follow-up|5|||
164096751|NCT02495857|592718950|FG002|Overall Study|Lost to Follow-up|3|||
164096752|NCT02495857|592718948|FG000|Overall Study|Other|3|||
164096753|NCT02495857|592718949|FG001|Overall Study|Other|3|||
164096754|NCT02495857|592718950|FG002|Overall Study|Other|2|||
164096755|NCT01367457|592718951|FG000|Overall Study|Death|2|||
164096756|NCT01367457|592718952|FG001|Overall Study|Death|0|||
164096757|NCT01367457|592718953|FG002|Overall Study|Death|0|||
164096758|NCT01367457|592718951|FG000|Overall Study|Investigator's decision|2|||
164096759|NCT01367457|592718952|FG001|Overall Study|Investigator's decision|0|||
164096760|NCT01367457|592718953|FG002|Overall Study|Investigator's decision|0|||
164096761|NCT01367457|592718951|FG000|Overall Study|Clinical decline (CD)|2|||
164096762|NCT01367457|592718952|FG001|Overall Study|Clinical decline (CD)|0|||
164096763|NCT01367457|592718953|FG002|Overall Study|Clinical decline (CD)|0|||
164096764|NCT01367457|592718951|FG000|Overall Study|Progression and death|8|||
164096765|NCT01367457|592718952|FG001|Overall Study|Progression and death|0|||
164096766|NCT01367457|592718953|FG002|Overall Study|Progression and death|0|||
164096767|NCT01367457|592718951|FG000|Overall Study|Toxicity|16|||
164096768|NCT01367457|592718952|FG001|Overall Study|Toxicity|0|||
164096769|NCT01367457|592718953|FG002|Overall Study|Toxicity|0|||
164096770|NCT01367457|592718951|FG000|Overall Study|Progression|137|||
164096771|NCT01367457|592718952|FG001|Overall Study|Progression|0|||
164096772|NCT01367457|592718953|FG002|Overall Study|Progression|0|||
164096773|NCT01367457|592718951|FG000|Overall Study|Patient asks for rest + slow progression|1|||
164096774|NCT01367457|592718952|FG001|Overall Study|Patient asks for rest + slow progression|0|||
164096775|NCT01367457|592718953|FG002|Overall Study|Patient asks for rest + slow progression|0|||
164096776|NCT01367457|592718951|FG000|Overall Study|Investigator's opinion, stable disease|1|||
164096777|NCT01367457|592718952|FG001|Overall Study|Investigator's opinion, stable disease|0|||
164096778|NCT01367457|592718953|FG002|Overall Study|Investigator's opinion, stable disease|0|||
164096779|NCT01367457|592718951|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
164096780|NCT01367457|592718952|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
164096781|NCT01367457|592718953|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
164096782|NCT01367457|592718951|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
164096783|NCT01367457|592718952|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
164096784|NCT01367457|592718953|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
164096785|NCT01367457|592718951|FG000|Overall Study|low grade toxicities + stable disease|1|||
164029123|NCT00434122|592465703|FG000|Overall Study|Travelling of subject.|1|||
164029124|NCT00434122|592465704|FG001|Overall Study|Travelling of subject.|0|||
164096786|NCT01367457|592718952|FG001|Overall Study|low grade toxicities + stable disease|0|||
164096787|NCT01367457|592718953|FG002|Overall Study|low grade toxicities + stable disease|0|||
164096788|NCT01367457|592718951|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
164096789|NCT01367457|592718952|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
164029125|NCT00349752|592465706|FG000|Overall Study|Adverse Event|8|||
164096790|NCT01367457|592718953|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
164096791|NCT01367457|592718951|FG000|Overall Study|Withdrawal by Subject|1|||
164096792|NCT01367457|592718952|FG001|Overall Study|Withdrawal by Subject|0|||
164029126|NCT00349752|592465707|FG001|Overall Study|Adverse Event|12|||
164029127|NCT00349752|592465706|FG000|Overall Study|Lack of Efficacy|37|||
164029128|NCT00349752|592465707|FG001|Overall Study|Lack of Efficacy|42|||
164029129|NCT00349752|592465706|FG000|Overall Study|Lost to Follow-up|4|||
164029130|NCT00349752|592465707|FG001|Overall Study|Lost to Follow-up|2|||
164029131|NCT00349752|592465706|FG000|Overall Study|Personal reasons|6|||
164029132|NCT00349752|592465707|FG001|Overall Study|Personal reasons|5|||
164029133|NCT00349752|592465706|FG000|Overall Study|Other: Required exclusionary medication|0|||
164029134|NCT00349752|592465707|FG001|Overall Study|Other: Required exclusionary medication|1|||
164029135|NCT00349752|592465706|FG000|Overall Study|Other: Non compliance|0|||
164029136|NCT00349752|592465707|FG001|Overall Study|Other: Non compliance|1|||
164029137|NCT00349752|592465706|FG000|Overall Study|Other: Patient stopped steroids|0|||
164029138|NCT00349752|592465707|FG001|Overall Study|Other: Patient stopped steroids|1|||
164029139|NCT00349752|592465706|FG000|Overall Study|Other: Patient's steroid use|1|||
164029140|NCT00349752|592465707|FG001|Overall Study|Other: Patient's steroid use|0|||
164029141|NCT00349752|592465706|FG000|Overall Study|Other: Ineligible|1|||
164029142|NCT00349752|592465707|FG001|Overall Study|Other: Ineligible|0|||
164029143|NCT00349752|592465706|FG000|Overall Study|Other: Inadvertently unblinded|1|||
164029144|NCT00349752|592465707|FG001|Overall Study|Other: Inadvertently unblinded|0|||
164029145|NCT00349752|592465706|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
164029146|NCT00349752|592465707|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
164029147|NCT05294211|592465708|FG000|Overall Study|Withdrawal by Subject|3|||
164029148|NCT05294211|592465708|FG000|Overall Study|Physician Decision|2|||
164029149|NCT05294211|592465708|FG000|Overall Study|Progressed to active labor|1|||
164029150|NCT05294211|592465708|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
164029151|NCT05294211|592465708|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
164029152|NCT03334396|592465709|FG000|Overall Study|Adverse Event|1|||
164029153|NCT03334396|592465710|FG001|Overall Study|Adverse Event|0|||
164029154|NCT03334396|592465711|FG002|Overall Study|Adverse Event|1|||
164029155|NCT03334396|592465712|FG003|Overall Study|Adverse Event|0|||
164029156|NCT03334396|592465713|FG004|Overall Study|Adverse Event|0|||
164029157|NCT03334396|592465714|FG005|Overall Study|Adverse Event|0|||
164029158|NCT03334396|592465715|FG006|Overall Study|Adverse Event|0|||
164029159|NCT03334396|592465716|FG007|Overall Study|Adverse Event|0|||
164029160|NCT03334396|592465709|FG000|Overall Study|Lack of Efficacy|10|||
164029161|NCT03334396|592465710|FG001|Overall Study|Lack of Efficacy|4|||
164029162|NCT03334396|592465711|FG002|Overall Study|Lack of Efficacy|1|||
164029163|NCT03334396|592465712|FG003|Overall Study|Lack of Efficacy|3|||
164029164|NCT03334396|592465713|FG004|Overall Study|Lack of Efficacy|1|||
164029165|NCT03334396|592465714|FG005|Overall Study|Lack of Efficacy|0|||
164029166|NCT03334396|592465715|FG006|Overall Study|Lack of Efficacy|0|||
164029167|NCT03334396|592465716|FG007|Overall Study|Lack of Efficacy|1|||
164029168|NCT03334396|592465709|FG000|Overall Study|Lost to Follow-up|0|||
164029169|NCT03334396|592465710|FG001|Overall Study|Lost to Follow-up|0|||
164029170|NCT03334396|592465711|FG002|Overall Study|Lost to Follow-up|1|||
164029171|NCT03334396|592465712|FG003|Overall Study|Lost to Follow-up|0|||
164029172|NCT03334396|592465713|FG004|Overall Study|Lost to Follow-up|0|||
164029173|NCT03334396|592465714|FG005|Overall Study|Lost to Follow-up|0|||
164029174|NCT03334396|592465715|FG006|Overall Study|Lost to Follow-up|1|||
164029175|NCT03334396|592465716|FG007|Overall Study|Lost to Follow-up|0|||
164029176|NCT03334396|592465709|FG000|Overall Study|Physician Decision|1|||
164029177|NCT03334396|592465710|FG001|Overall Study|Physician Decision|0|||
164029178|NCT03334396|592465711|FG002|Overall Study|Physician Decision|0|||
164029179|NCT03334396|592465712|FG003|Overall Study|Physician Decision|0|||
164029180|NCT03334396|592465713|FG004|Overall Study|Physician Decision|0|||
164029181|NCT03334396|592465714|FG005|Overall Study|Physician Decision|0|||
164029182|NCT03334396|592465715|FG006|Overall Study|Physician Decision|0|||
164029183|NCT03334396|592465716|FG007|Overall Study|Physician Decision|0|||
164029184|NCT03334396|592465709|FG000|Overall Study|Withdrawal by Subject|10|||
164029185|NCT03334396|592465710|FG001|Overall Study|Withdrawal by Subject|5|||
164029186|NCT03334396|592465711|FG002|Overall Study|Withdrawal by Subject|7|||
164029187|NCT03334396|592465712|FG003|Overall Study|Withdrawal by Subject|2|||
164029188|NCT03334396|592465713|FG004|Overall Study|Withdrawal by Subject|2|||
164029189|NCT03334396|592465714|FG005|Overall Study|Withdrawal by Subject|1|||
164029190|NCT03334396|592465715|FG006|Overall Study|Withdrawal by Subject|2|||
164029191|NCT03334396|592465716|FG007|Overall Study|Withdrawal by Subject|0|||
164029192|NCT03334396|592465709|FG000|Overall Study|Pregnancy|0|||
164029193|NCT03334396|592465710|FG001|Overall Study|Pregnancy|1|||
164029194|NCT03334396|592465711|FG002|Overall Study|Pregnancy|0|||
164029195|NCT03334396|592465712|FG003|Overall Study|Pregnancy|0|||
164029196|NCT03334396|592465713|FG004|Overall Study|Pregnancy|0|||
164029197|NCT03334396|592465714|FG005|Overall Study|Pregnancy|0|||
164029198|NCT03334396|592465715|FG006|Overall Study|Pregnancy|0|||
164029199|NCT03334396|592465716|FG007|Overall Study|Pregnancy|0|||
164029200|NCT03334396|592465709|FG000|Overall Study|Ineligible|0|||
164029201|NCT03334396|592465710|FG001|Overall Study|Ineligible|1|||
164029202|NCT03334396|592465711|FG002|Overall Study|Ineligible|0|||
164029203|NCT03334396|592465712|FG003|Overall Study|Ineligible|0|||
164029204|NCT03334396|592465713|FG004|Overall Study|Ineligible|0|||
164029205|NCT03334396|592465714|FG005|Overall Study|Ineligible|0|||
164029206|NCT03334396|592465715|FG006|Overall Study|Ineligible|0|||
164029207|NCT03334396|592465716|FG007|Overall Study|Ineligible|0|||
164029208|NCT03334396|592465709|FG000|Overall Study|Started New Job|1|||
164029209|NCT03334396|592465710|FG001|Overall Study|Started New Job|0|||
164029210|NCT03334396|592465711|FG002|Overall Study|Started New Job|0|||
164029211|NCT03334396|592465712|FG003|Overall Study|Started New Job|0|||
164029212|NCT03334396|592465713|FG004|Overall Study|Started New Job|0|||
164029213|NCT03334396|592465714|FG005|Overall Study|Started New Job|0|||
164029214|NCT03334396|592465715|FG006|Overall Study|Started New Job|0|||
164029215|NCT03334396|592465716|FG007|Overall Study|Started New Job|0|||
164029216|NCT01842607|592465718|FG000|Overall Study|Adverse Event|11|||
164029217|NCT01842607|592465718|FG000|Overall Study|Lack of Efficacy|19|||
164029218|NCT01842607|592465718|FG000|Overall Study|Protocol Violation|8|||
164029219|NCT01842607|592465718|FG000|Overall Study|Protocol defined stopping criteria|2|||
164029220|NCT01842607|592465718|FG000|Overall Study|Lost to Follow-up|3|||
164029221|NCT01842607|592465718|FG000|Overall Study|Physician Decision|9|||
164029222|NCT01842607|592465718|FG000|Overall Study|Withdrawal by Subject|14|||
164029223|NCT00012012|592465719|FG000|Overall Study|Protocol Violation|1|||
164029224|NCT00012012|592465720|FG001|Overall Study|Protocol Violation|1|||
164029225|NCT00012012|592465719|FG000|Overall Study|Withdrawal by Subject|0|||
164029226|NCT00012012|592465720|FG001|Overall Study|Withdrawal by Subject|2|||
164029227|NCT02159469|592465721|FG000|Overall Study|Missing Completion status|1|||
164029228|NCT02159469|592465721|FG000|Overall Study|Adverse Event|5|||
163917309|NCT03087851|592066613|FG000|Overall Study|Withdraw on medical grounds|0|||
163917310|NCT03087851|592066614|FG001|Overall Study|Withdraw on medical grounds|1|||
163917311|NCT03087851|592066615|FG002|Overall Study|Withdraw on medical grounds|2|||
163917312|NCT00644332|592066616|FG000|Overall Study|Adverse Event|11|||
163917313|NCT00644332|592066616|FG000|Overall Study|Withdrawal by Subject|6|||
163917314|NCT00644332|592066616|FG000|Overall Study|Completion Status Unknown|2|||
163917315|NCT00644332|592066616|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
163917316|NCT00644332|592066616|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
163917317|NCT00409006|592066618|FG000|Overall Study|Death|15|||
163917318|NCT00409006|592066619|FG001|Overall Study|Death|6|||
163917319|NCT00409006|592066618|FG000|Overall Study|Lost to Follow-up|1|||
163917320|NCT00409006|592066619|FG001|Overall Study|Lost to Follow-up|2|||
163917321|NCT00409006|592066618|FG000|Overall Study|Withdrawal by Subject|3|||
163917322|NCT00409006|592066619|FG001|Overall Study|Withdrawal by Subject|2|||
163917323|NCT00409006|592066618|FG000|Overall Study|Physician Decision|1|||
163917324|NCT00409006|592066619|FG001|Overall Study|Physician Decision|2|||
163917325|NCT03050372|592066620|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
163917326|NCT03050372|592066621|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
163917327|NCT03050372|592066620|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
163917328|NCT03050372|592066621|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
164029229|NCT02159469|592465721|FG000|Overall Study|Non-compliance|2|||
164029230|NCT02159469|592465721|FG000|Overall Study|Withdrawal by Subject|9|||
164029231|NCT02159469|592465721|FG000|Overall Study|Lost to Follow-up|1|||
164029232|NCT02159469|592465721|FG000|Overall Study|Sponsor's request|2|||
164029233|NCT02159469|592465721|FG000|Overall Study|Met Stopping Criteria|3|||
164029234|NCT02159469|592465721|FG000|Overall Study|Other|1|||
164029235|NCT02159469|592465721|FG000|Overall Study|Multiple|29|||
164029236|NCT03629041|592465727|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
164029237|NCT03629041|592465728|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
164029238|NCT03629041|592465729|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
164029239|NCT03629041|592465730|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
164029240|NCT03488251|592465731|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
164029241|NCT03488251|592465732|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
164029242|NCT03488251|592465733|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
164029243|NCT03488251|592465734|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
164029244|NCT03488251|592465731|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
164029245|NCT03488251|592465732|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
164029246|NCT03488251|592465733|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
164029247|NCT03488251|592465734|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
164029248|NCT03488251|592465731|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
164029249|NCT03488251|592465732|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
164029250|NCT03488251|592465733|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
164029251|NCT03488251|592465734|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
164029252|NCT03488251|592465731|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
164029253|NCT03488251|592465732|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
164029254|NCT03488251|592465733|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
164029255|NCT03488251|592465734|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
164029256|NCT03488251|592465731|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
164029257|NCT03488251|592465732|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
164029258|NCT03488251|592465733|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
164029259|NCT03488251|592465734|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
164029260|NCT03730194|592465735|FG000|First Stage Treatment|Withdrawal by Subject|1|||
164029261|NCT03730194|592465736|FG001|First Stage Treatment|Withdrawal by Subject|1|||
164029262|NCT03730194|592465737|FG002|First Stage Treatment|Withdrawal by Subject|0|||
164029263|NCT03730194|592465738|FG003|First Stage Treatment|Withdrawal by Subject|0|||
164029264|NCT03730194|592465739|FG004|First Stage Treatment|Withdrawal by Subject|0|||
164029265|NCT03730194|592465740|FG005|First Stage Treatment|Withdrawal by Subject|0|||
164029266|NCT03730194|592465735|FG000|First Stage Treatment|Protocol Violation|3|||
164029267|NCT03730194|592465736|FG001|First Stage Treatment|Protocol Violation|3|||
164029268|NCT03730194|592465737|FG002|First Stage Treatment|Protocol Violation|0|||
164029269|NCT03730194|592465738|FG003|First Stage Treatment|Protocol Violation|0|||
164029270|NCT03730194|592465739|FG004|First Stage Treatment|Protocol Violation|0|||
164029271|NCT03730194|592465740|FG005|First Stage Treatment|Protocol Violation|0|||
164029272|NCT01766817|592465743|FG000|Overall Study|Drug-related adverse event|1|||
164029273|NCT01766817|592465744|FG001|Overall Study|Drug-related adverse event|2|||
164029274|NCT01766817|592465745|FG002|Overall Study|Drug-related adverse event|1|||
164029275|NCT01766817|592465743|FG000|Overall Study|Drug-unrelated adverse event|3|||
164029276|NCT01766817|592465744|FG001|Overall Study|Drug-unrelated adverse event|3|||
164029277|NCT01766817|592465745|FG002|Overall Study|Drug-unrelated adverse event|3|||
164029278|NCT01766817|592465743|FG000|Overall Study|Death|1|||
164029279|NCT01766817|592465744|FG001|Overall Study|Death|1|||
164029280|NCT01766817|592465745|FG002|Overall Study|Death|0|||
164029281|NCT01766817|592465743|FG000|Overall Study|Unable to take study drug|0|||
164029282|NCT01766817|592465744|FG001|Overall Study|Unable to take study drug|1|||
164029283|NCT01766817|592465745|FG002|Overall Study|Unable to take study drug|0|||
164029284|NCT01766817|592465743|FG000|Overall Study|Withdrawal by Subject|2|||
164029285|NCT01766817|592465744|FG001|Overall Study|Withdrawal by Subject|0|||
164029286|NCT01766817|592465745|FG002|Overall Study|Withdrawal by Subject|3|||
164029287|NCT01766817|592465743|FG000|Overall Study|Subject non-compliance|0|||
164029288|NCT01766817|592465744|FG001|Overall Study|Subject non-compliance|1|||
164029289|NCT01766817|592465745|FG002|Overall Study|Subject non-compliance|2|||
164029290|NCT01766817|592465743|FG000|Overall Study|Physician Decision|3|||
164029291|NCT01766817|592465744|FG001|Overall Study|Physician Decision|3|||
164029292|NCT01766817|592465745|FG002|Overall Study|Physician Decision|4|||
164029293|NCT01766817|592465743|FG000|Overall Study|Other|1|||
164029294|NCT01766817|592465744|FG001|Overall Study|Other|0|||
164029295|NCT01766817|592465745|FG002|Overall Study|Other|0|||
164029296|NCT03600714|592465746|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
164029297|NCT03814590|592465747|FG000|Overall Study|Adverse Event|0|||
164029298|NCT03814590|592465748|FG001|Overall Study|Adverse Event|0|||
164029299|NCT03814590|592465749|FG002|Overall Study|Adverse Event|0|||
164029300|NCT03814590|592465750|FG003|Overall Study|Adverse Event|0|||
164029301|NCT03814590|592465751|FG004|Overall Study|Adverse Event|0|||
164029302|NCT03814590|592465752|FG005|Overall Study|Adverse Event|1|||
164029303|NCT03814590|592465753|FG006|Overall Study|Adverse Event|1|||
164029304|NCT03814590|592465754|FG007|Overall Study|Adverse Event|1|||
164029305|NCT03814590|592465755|FG008|Overall Study|Adverse Event|0|||
164029306|NCT03814590|592465756|FG009|Overall Study|Adverse Event|0|||
164029307|NCT03814590|592465757|FG010|Overall Study|Adverse Event|1|||
164029308|NCT03814590|592465758|FG011|Overall Study|Adverse Event|0|||
164029309|NCT03814590|592465759|FG012|Overall Study|Adverse Event|3|||
164029310|NCT03814590|592465760|FG013|Overall Study|Adverse Event|0|||
164029311|NCT03814590|592465747|FG000|Overall Study|Lost to Follow-up|0|||
164029312|NCT03814590|592465748|FG001|Overall Study|Lost to Follow-up|2|||
164029313|NCT03814590|592465749|FG002|Overall Study|Lost to Follow-up|1|||
164029314|NCT03814590|592465750|FG003|Overall Study|Lost to Follow-up|0|||
164029315|NCT03814590|592465751|FG004|Overall Study|Lost to Follow-up|1|||
164029316|NCT03814590|592465752|FG005|Overall Study|Lost to Follow-up|1|||
164029317|NCT03814590|592465753|FG006|Overall Study|Lost to Follow-up|1|||
164029318|NCT03814590|592465754|FG007|Overall Study|Lost to Follow-up|1|||
164029319|NCT03814590|592465755|FG008|Overall Study|Lost to Follow-up|0|||
164029320|NCT03814590|592465756|FG009|Overall Study|Lost to Follow-up|0|||
164029321|NCT03814590|592465757|FG010|Overall Study|Lost to Follow-up|1|||
164029322|NCT03814590|592465758|FG011|Overall Study|Lost to Follow-up|0|||
164029323|NCT03814590|592465759|FG012|Overall Study|Lost to Follow-up|0|||
164029324|NCT03814590|592465760|FG013|Overall Study|Lost to Follow-up|1|||
164029325|NCT03814590|592465747|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163917329|NCT00443755|592066624|FG000|Overall Study|Withdrawal by Subject|2|||
163917330|NCT00443755|592066625|FG001|Overall Study|Withdrawal by Subject|1|||
163917331|NCT02775214|592066626|FG000|Overall Study|Withdrawal by Subject|2|||
163917332|NCT02775214|592066627|FG001|Overall Study|Withdrawal by Subject|0|||
163917333|NCT02706834|592066629|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164029326|NCT03814590|592465748|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
163917334|NCT02706834|592066630|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163917335|NCT02706834|592066631|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163917336|NCT02706834|592066632|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
163917337|NCT02706834|592066633|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
163917338|NCT02706834|592066634|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
164029327|NCT03814590|592465749|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029328|NCT03814590|592465750|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029329|NCT03814590|592465751|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029330|NCT03814590|592465752|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029331|NCT03814590|592465753|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029332|NCT03814590|592465754|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029333|NCT03814590|592465755|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029334|NCT03814590|592465756|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
164029335|NCT03814590|592465757|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029336|NCT03814590|592465758|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029337|NCT03814590|592465759|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029338|NCT03814590|592465760|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
164029339|NCT03814590|592465747|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164029340|NCT03814590|592465748|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164029341|NCT03814590|592465749|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164073163|NCT03402126|592632835|FG000|Overall Study|Withdrawal by Subject|6|||
164073164|NCT03402126|592632835|FG000|Overall Study|Physician Decision|2|||
164073165|NCT03402126|592632835|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
164073166|NCT03402126|592632835|FG000|Overall Study|Death|4|||
164029342|NCT03814590|592465750|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164029343|NCT03814590|592465751|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164029344|NCT03814590|592465752|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
164029345|NCT03814590|592465753|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
164029346|NCT03814590|592465754|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
164029347|NCT03814590|592465755|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164029348|NCT03814590|592465756|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
164029349|NCT03814590|592465757|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
164029350|NCT03814590|592465758|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
164029351|NCT03814590|592465759|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
164029352|NCT03814590|592465760|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
164029353|NCT03814590|592465747|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029354|NCT03814590|592465748|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029355|NCT03814590|592465749|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029356|NCT03814590|592465750|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029357|NCT03814590|592465751|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029358|NCT03814590|592465752|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029359|NCT03814590|592465753|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164096793|NCT01367457|592718953|FG002|Overall Study|Withdrawal by Subject|0|||
164096794|NCT01367457|592718951|FG000|Overall Study|CD, associated leukaemia|1|||
164096795|NCT01367457|592718952|FG001|Overall Study|CD, associated leukaemia|0|||
164096796|NCT01367457|592718953|FG002|Overall Study|CD, associated leukaemia|0|||
164096797|NCT01367457|592718951|FG000|Overall Study|Uncontrolled pain|1|||
164096798|NCT01367457|592718952|FG001|Overall Study|Uncontrolled pain|0|||
164096799|NCT01367457|592718953|FG002|Overall Study|Uncontrolled pain|0|||
164096800|NCT01367457|592718951|FG000|Overall Study|Overall status worsens to grade 4|1|||
164096801|NCT01367457|592718952|FG001|Overall Study|Overall status worsens to grade 4|0|||
164096802|NCT01367457|592718953|FG002|Overall Study|Overall status worsens to grade 4|0|||
164096803|NCT01367457|592718951|FG000|Overall Study|Stabilisation + frequent infections|1|||
164096804|NCT01367457|592718952|FG001|Overall Study|Stabilisation + frequent infections|0|||
164096805|NCT01367457|592718953|FG002|Overall Study|Stabilisation + frequent infections|0|||
164096806|NCT01367457|592718951|FG000|Overall Study|No clinical benefit|1|||
164096807|NCT01367457|592718952|FG001|Overall Study|No clinical benefit|0|||
164096808|NCT01367457|592718953|FG002|Overall Study|No clinical benefit|0|||
164096809|NCT01367457|592718951|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
164096810|NCT01367457|592718952|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
164096811|NCT01367457|592718953|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
164096812|NCT01367457|592718951|FG000|Overall Study|Overall decline|1|||
164029360|NCT03814590|592465754|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164029361|NCT03814590|592465755|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029362|NCT03814590|592465756|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164029363|NCT03814590|592465757|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164096813|NCT01367457|592718952|FG001|Overall Study|Overall decline|0|||
164096814|NCT01367457|592718953|FG002|Overall Study|Overall decline|0|||
164096815|NCT01367457|592718951|FG000|Overall Study|Rejection of treatment|1|||
164096816|NCT01367457|592718952|FG001|Overall Study|Rejection of treatment|0|||
164096817|NCT01367457|592718953|FG002|Overall Study|Rejection of treatment|0|||
164096818|NCT01367457|592718951|FG000|Overall Study|Lost to Follow-up|1|||
163917339|NCT02706834|592066635|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
163917340|NCT02706834|592066636|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
163917341|NCT02706834|592066637|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
163917342|NCT02706834|592066638|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
163917343|NCT02706834|592066639|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
164029364|NCT03814590|592465758|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029365|NCT03814590|592465759|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029366|NCT03814590|592465760|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164029367|NCT03814590|592465747|FG000|Overall Study|UNKNOWN REASON|0|||
164029368|NCT03814590|592465748|FG001|Overall Study|UNKNOWN REASON|0|||
164029369|NCT03814590|592465749|FG002|Overall Study|UNKNOWN REASON|0|||
164029370|NCT03814590|592465750|FG003|Overall Study|UNKNOWN REASON|0|||
164029371|NCT03814590|592465751|FG004|Overall Study|UNKNOWN REASON|0|||
164029372|NCT03814590|592465752|FG005|Overall Study|UNKNOWN REASON|0|||
164029373|NCT03814590|592465753|FG006|Overall Study|UNKNOWN REASON|0|||
164029374|NCT03814590|592465754|FG007|Overall Study|UNKNOWN REASON|1|||
164029375|NCT03814590|592465755|FG008|Overall Study|UNKNOWN REASON|0|||
164029376|NCT03814590|592465756|FG009|Overall Study|UNKNOWN REASON|0|||
164029377|NCT03814590|592465757|FG010|Overall Study|UNKNOWN REASON|0|||
164029378|NCT03814590|592465758|FG011|Overall Study|UNKNOWN REASON|0|||
164029379|NCT03814590|592465759|FG012|Overall Study|UNKNOWN REASON|0|||
164029380|NCT03814590|592465760|FG013|Overall Study|UNKNOWN REASON|0|||
164029381|NCT00592553|592465764|FG000|Overall Study|Protocol Noncompliance|1|||
164029382|NCT00592553|592465765|FG001|Overall Study|Protocol Noncompliance|0|||
164029383|NCT00592553|592465766|FG002|Overall Study|Protocol Noncompliance|0|||
164029384|NCT01244191|592465769|FG000|Overall Study|Progressive disease|295|||
164029385|NCT01244191|592465770|FG001|Overall Study|Progressive disease|350|||
164029386|NCT01244191|592465769|FG000|Overall Study|Clinical disease progression|54|||
164029387|NCT01244191|592465770|FG001|Overall Study|Clinical disease progression|36|||
164029388|NCT01244191|592465769|FG000|Overall Study|Adverse Event|65|||
164029389|NCT01244191|592465770|FG001|Overall Study|Adverse Event|48|||
164029390|NCT01244191|592465769|FG000|Overall Study|Death|22|||
164029391|NCT01244191|592465770|FG001|Overall Study|Death|29|||
164029392|NCT01244191|592465769|FG000|Overall Study|Lost to Follow-up|0|||
164029393|NCT01244191|592465770|FG001|Overall Study|Lost to Follow-up|2|||
164029394|NCT01244191|592465769|FG000|Overall Study|Protocol Violation|1|||
164029395|NCT01244191|592465770|FG001|Overall Study|Protocol Violation|2|||
164029396|NCT01244191|592465769|FG000|Overall Study|Withdrawal by Subject|31|||
164029397|NCT01244191|592465770|FG001|Overall Study|Withdrawal by Subject|23|||
164029398|NCT01244191|592465769|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
164029399|NCT01244191|592465770|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
164029400|NCT01752842|592465771|FG000|Overall Study|Adverse Event|3|||
164029401|NCT01752842|592465772|FG001|Overall Study|Adverse Event|0|||
164029402|NCT01752842|592465771|FG000|Overall Study|Withdrawal by Subject|0|||
164029403|NCT01752842|592465772|FG001|Overall Study|Withdrawal by Subject|2|||
164029404|NCT02164513|592465773|FG000|Overall Study|Adverse Event|162|||
164029405|NCT02164513|592465774|FG001|Overall Study|Adverse Event|180|||
164029406|NCT02164513|592465775|FG002|Overall Study|Adverse Event|111|||
164029407|NCT02164513|592465773|FG000|Overall Study|Other: Study Closed or terminated|5|||
164029408|NCT02164513|592465774|FG001|Overall Study|Other: Study Closed or terminated|2|||
164029409|NCT02164513|592465775|FG002|Overall Study|Other: Study Closed or terminated|4|||
164029410|NCT02164513|592465773|FG000|Overall Study|Lost to Follow-up|30|||
164029411|NCT02164513|592465774|FG001|Overall Study|Lost to Follow-up|36|||
164029412|NCT02164513|592465775|FG002|Overall Study|Lost to Follow-up|22|||
164029413|NCT02164513|592465773|FG000|Overall Study|Physician Decision|47|||
164029414|NCT02164513|592465774|FG001|Overall Study|Physician Decision|57|||
164029415|NCT02164513|592465775|FG002|Overall Study|Physician Decision|28|||
164029416|NCT02164513|592465773|FG000|Overall Study|Withdrawal by Subject|192|||
164029417|NCT02164513|592465774|FG001|Overall Study|Withdrawal by Subject|261|||
164029418|NCT02164513|592465775|FG002|Overall Study|Withdrawal by Subject|130|||
164029419|NCT02164513|592465773|FG000|Overall Study|Other: Reason not provided by site|1|||
164029420|NCT02164513|592465774|FG001|Overall Study|Other: Reason not provided by site|0|||
164029421|NCT02164513|592465775|FG002|Overall Study|Other: Reason not provided by site|0|||
164029422|NCT05301322|592465776|FG000|Overall Study|Adverse Event|7|||
164029423|NCT05301322|592465777|FG001|Overall Study|Adverse Event|3|||
164029424|NCT05301322|592465776|FG000|Overall Study|Death|0|||
164029425|NCT05301322|592465777|FG001|Overall Study|Death|1|||
164029426|NCT05301322|592465776|FG000|Overall Study|Lost to Follow-up|2|||
164029427|NCT05301322|592465777|FG001|Overall Study|Lost to Follow-up|1|||
164029428|NCT05301322|592465776|FG000|Overall Study|Protocol Violation|3|||
164029429|NCT05301322|592465777|FG001|Overall Study|Protocol Violation|1|||
164029430|NCT05301322|592465776|FG000|Overall Study|Withdrawal by Subject|3|||
164029431|NCT05301322|592465777|FG001|Overall Study|Withdrawal by Subject|0|||
164029432|NCT05301322|592465776|FG000|Overall Study|Other|4|||
164029433|NCT05301322|592465777|FG001|Overall Study|Other|0|||
164029434|NCT04971785|592465778|FG000|Overall Study|Withdrew Consent|5|||
164029435|NCT04971785|592465779|FG001|Overall Study|Withdrew Consent|5|||
164029436|NCT04971785|592465780|FG002|Overall Study|Withdrew Consent|17|||
164029437|NCT04971785|592465781|FG003|Overall Study|Withdrew Consent|7|||
164029438|NCT04971785|592465778|FG000|Overall Study|Adverse Event|7|||
164029439|NCT04971785|592465779|FG001|Overall Study|Adverse Event|8|||
164029440|NCT04971785|592465780|FG002|Overall Study|Adverse Event|6|||
164029441|NCT04971785|592465781|FG003|Overall Study|Adverse Event|3|||
164029442|NCT04971785|592465778|FG000|Overall Study|Lost to Follow-up|2|||
164029443|NCT04971785|592465779|FG001|Overall Study|Lost to Follow-up|1|||
164029444|NCT04971785|592465780|FG002|Overall Study|Lost to Follow-up|6|||
164029445|NCT04971785|592465781|FG003|Overall Study|Lost to Follow-up|7|||
164029446|NCT04971785|592465778|FG000|Overall Study|Protocol Violation|3|||
164029447|NCT04971785|592465779|FG001|Overall Study|Protocol Violation|1|||
164029448|NCT04971785|592465780|FG002|Overall Study|Protocol Violation|1|||
164029449|NCT04971785|592465781|FG003|Overall Study|Protocol Violation|2|||
164029450|NCT04971785|592465778|FG000|Overall Study|Investigator's Discretion|3|||
164029451|NCT04971785|592465779|FG001|Overall Study|Investigator's Discretion|1|||
164029452|NCT04971785|592465780|FG002|Overall Study|Investigator's Discretion|1|||
164029453|NCT04971785|592465781|FG003|Overall Study|Investigator's Discretion|0|||
164029454|NCT04971785|592465778|FG000|Overall Study|Randomized but Never Treated|1|||
164029455|NCT04971785|592465779|FG001|Overall Study|Randomized but Never Treated|2|||
164029456|NCT04971785|592465780|FG002|Overall Study|Randomized but Never Treated|0|||
164029457|NCT04971785|592465781|FG003|Overall Study|Randomized but Never Treated|1|||
164029458|NCT04971785|592465778|FG000|Overall Study|Death|0|||
164029459|NCT04971785|592465779|FG001|Overall Study|Death|1|||
164029460|NCT04971785|592465780|FG002|Overall Study|Death|1|||
164029461|NCT04971785|592465781|FG003|Overall Study|Death|0|||
164029462|NCT04971785|592465778|FG000|Overall Study|Site Terminated by Sponsor|1|||
164029463|NCT04971785|592465779|FG001|Overall Study|Site Terminated by Sponsor|1|||
164029464|NCT04971785|592465780|FG002|Overall Study|Site Terminated by Sponsor|0|||
164029465|NCT04971785|592465781|FG003|Overall Study|Site Terminated by Sponsor|0|||
164029466|NCT03829332|592465782|FG000|Overall Study|Death|225|||
164029467|NCT03829332|592465783|FG001|Overall Study|Death|230|||
164029468|NCT03829332|592465782|FG000|Overall Study|Lost to Follow-up|1|||
164029469|NCT03829332|592465783|FG001|Overall Study|Lost to Follow-up|3|||
164029470|NCT03829332|592465782|FG000|Overall Study|Physician Decision|1|||
164029471|NCT03829332|592465783|FG001|Overall Study|Physician Decision|0|||
164029472|NCT03829332|592465782|FG000|Overall Study|Sponsor Decision|71|||
164029473|NCT03829332|592465783|FG001|Overall Study|Sponsor Decision|72|||
164029474|NCT03829332|592465782|FG000|Overall Study|Withdrawal by Subject|11|||
164029475|NCT03829332|592465783|FG001|Overall Study|Withdrawal by Subject|9|||
164029476|NCT01283997|592467114|FG000|Overall Study|Physician Decision|8|||
164029477|NCT01283997|592467115|FG001|Overall Study|Physician Decision|10|||
164029478|NCT01283997|592467114|FG000|Overall Study|Withdrawal by Subject|3|||
164029479|NCT01283997|592467115|FG001|Overall Study|Withdrawal by Subject|2|||
164029480|NCT01283997|592467114|FG000|Overall Study|Physically unable to continue|0|||
164029481|NCT01283997|592467115|FG001|Overall Study|Physically unable to continue|1|||
164029482|NCT01283997|592467114|FG000|Overall Study|Progressive disease|1|||
164029483|NCT01283997|592467115|FG001|Overall Study|Progressive disease|0|||
164029484|NCT01283997|592467114|FG000|Overall Study|Other|4|||
164029485|NCT01283997|592467115|FG001|Overall Study|Other|4|||
164029486|NCT02109744|592467116|FG000|Overall Study|Death|1|||
164029487|NCT02109744|592467117|FG001|Overall Study|Death|1|||
164029488|NCT02109744|592467116|FG000|Overall Study|no marrow exam|1|||
164029489|NCT02109744|592467117|FG001|Overall Study|no marrow exam|0|||
164029490|NCT04095442|592467121|FG000|Overall Study|Lost to Follow-up|0|||
164029491|NCT04095442|592467122|FG001|Overall Study|Lost to Follow-up|1|||
164029492|NCT04095442|592467121|FG000|Overall Study|Screen failure|1|||
164029493|NCT04095442|592467122|FG001|Overall Study|Screen failure|0|||
164029494|NCT00884221|592467127|FG000|Overall Study|Withdrawal by Subject|0|||
164029495|NCT00884221|592467128|FG001|Overall Study|Withdrawal by Subject|3|||
164029496|NCT00884221|592467127|FG000|Overall Study|Adverse Event|6|||
164029497|NCT00884221|592467128|FG001|Overall Study|Adverse Event|3|||
164029498|NCT00884221|592467127|FG000|Overall Study|Protocol Violation|16|||
164029499|NCT00884221|592467128|FG001|Overall Study|Protocol Violation|13|||
164029500|NCT00884221|592467127|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
164029501|NCT00884221|592467128|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
164029502|NCT00255034|592467129|FG000|Overall Study|Withdrawal by Subject|15|||
164029503|NCT00255034|592467130|FG001|Overall Study|Withdrawal by Subject|38|||
164029504|NCT01263093|592467131|FG000|Washout|Physician Decision|1|||
164029505|NCT01263093|592467132|FG001|Washout|Physician Decision|0|||
164029506|NCT01263093|592467131|FG000|Period 2|Adverse Event|1|||
164029507|NCT01263093|592467132|FG001|Period 2|Adverse Event|0|||
164029508|NCT03947255|592467134|FG000|Overall Study|Study Closure by Sponsor|2|||
164029509|NCT03947255|592467135|FG001|Overall Study|Study Closure by Sponsor|2|||
164029510|NCT03947255|592467134|FG000|Overall Study|Withdrawal by Subject|2|||
164029511|NCT03947255|592467135|FG001|Overall Study|Withdrawal by Subject|2|||
164029512|NCT03947255|592467134|FG000|Overall Study|Lost to Follow-up|2|||
164029513|NCT03947255|592467135|FG001|Overall Study|Lost to Follow-up|0|||
164029514|NCT03947255|592467134|FG000|Overall Study|Death|0|||
164029515|NCT03947255|592467135|FG001|Overall Study|Death|2|||
164029516|NCT02499575|592467136|FG000|Overall Study|Protocol Violation|0|||
164029517|NCT02499575|592467137|FG001|Overall Study|Protocol Violation|1|||
164029518|NCT02690207|592467139|FG000|Overall Study|Lost to Follow-up|48|||
164029519|NCT02690207|592467139|FG000|Overall Study|Withdrawal by Subject|46|||
164029520|NCT02690207|592467139|FG000|Overall Study|Protocol Violation|2|||
164029521|NCT02690207|592467139|FG000|Overall Study|Serious adverse event|110|||
164029522|NCT02690207|592467139|FG000|Overall Study|Non-serious Adverse Event|18|||
164029523|NCT02690207|592467139|FG000|Overall Study|Migrated/moved from study area|5|||
164029524|NCT02690207|592467139|FG000|Overall Study|Suspected HZ Episode|1|||
164029525|NCT02690207|592467139|FG000|Overall Study|Other reasons for withdrawal|23|||
164029526|NCT04656418|592467142|FG000|Overall Study|Withdrawal by Subject|1|||
164029527|NCT04656418|592467143|FG001|Overall Study|Withdrawal by Subject|3|||
164029528|NCT02586077|592467144|FG000|Overall Study|Withdrawal by Subject|1|||
164029529|NCT02586077|592467144|FG000|Overall Study|Physician Decision|4|||
164029530|NCT02586077|592467144|FG000|Overall Study|Lost to Follow-up|3|||
164029531|NCT02701192|592467145|FG000|Overall Study|Protocol Violation|2|||
164029532|NCT02701192|592467145|FG000|Overall Study|Lost to Follow-up|4|||
164029533|NCT01245764|592467147|FG000|Study Phase A|Other|3|||
164029534|NCT01245764|592467148|FG001|Study Phase A|Other|2|||
164029535|NCT01245764|592467149|FG002|Study Phase A|Other|3|||
164029536|NCT01245764|592467150|FG003|Study Phase A|Other|1|||
164029537|NCT01245764|592467147|FG000|Study Phase A|Protocol Violation|6|||
164029538|NCT01245764|592467148|FG001|Study Phase A|Protocol Violation|3|||
164029539|NCT01245764|592467149|FG002|Study Phase A|Protocol Violation|2|||
164029540|NCT01245764|592467150|FG003|Study Phase A|Protocol Violation|2|||
164029541|NCT01245764|592467147|FG000|Study Phase A|Lost to Follow-up|0|||
164029542|NCT01245764|592467148|FG001|Study Phase A|Lost to Follow-up|0|||
164029543|NCT01245764|592467149|FG002|Study Phase A|Lost to Follow-up|5|||
164029544|NCT01245764|592467150|FG003|Study Phase A|Lost to Follow-up|0|||
164029545|NCT00003476|592467151|FG000|Overall Study|Not evaluable|1|||
164029546|NCT02667457|592467152|FG000|Overall Study|Withdrawal by Subject|1|||
164029547|NCT02667457|592467153|FG001|Overall Study|Withdrawal by Subject|0|||
164029548|NCT02667457|592467152|FG000|Overall Study|Other Reason|0|||
164029549|NCT02667457|592467153|FG001|Overall Study|Other Reason|2|||
164029550|NCT02475850|592467154|FG000|Overall Study|Death|155|||
164029551|NCT02475850|592467155|FG001|Overall Study|Death|141|||
164029552|NCT02475850|592467154|FG000|Overall Study|Lost to Follow-up|217|||
164029553|NCT02475850|592467155|FG001|Overall Study|Lost to Follow-up|188|||
164029554|NCT02475850|592467154|FG000|Overall Study|Withdrawal by Subject|221|||
164029555|NCT02475850|592467155|FG001|Overall Study|Withdrawal by Subject|155|||
164029556|NCT00912340|592467156|FG000|Overall Study|Adverse Event|2|||
164029557|NCT00912340|592467157|FG001|Overall Study|Adverse Event|4|||
164029558|NCT00912340|592467158|FG002|Overall Study|Adverse Event|0|||
164029559|NCT00912340|592467156|FG000|Overall Study|Protocol revised to remove arm|0|||
164029560|NCT00912340|592467157|FG001|Overall Study|Protocol revised to remove arm|0|||
164029561|NCT00912340|592467158|FG002|Overall Study|Protocol revised to remove arm|4|||
164029562|NCT00436982|592467161|FG000|Overall Study|Withdrawal by Subject|3|||
164029563|NCT00436982|592467162|FG001|Overall Study|Withdrawal by Subject|1|||
164096819|NCT01367457|592718952|FG001|Overall Study|Lost to Follow-up|0|||
164029564|NCT00436982|592467161|FG000|Overall Study|Did not receive allocated intervention|0|||
164029565|NCT00436982|592467162|FG001|Overall Study|Did not receive allocated intervention|1|||
164029566|NCT00436982|592467161|FG000|Overall Study|no RSA data|1|||
164029567|NCT00436982|592467162|FG001|Overall Study|no RSA data|2|||
164029568|NCT00953225|592467163|FG000|Overall Study|Withdrawal by Subject|2|||
164029569|NCT00953225|592467164|FG001|Overall Study|Withdrawal by Subject|0|||
164029570|NCT02254551|592467168|FG000|Dose Escalation|Physician Decision|1|||
164029571|NCT02254551|592467168|FG000|Dose Escalation|Dose-limiting toxicity|2|||
164029572|NCT04058158|592467169|FG000|Period 1|Death|1|||
164029573|NCT04058158|592467170|FG001|Period 1|Death|0|||
164029574|NCT04058158|592467169|FG000|Period 1|Adverse Event|1|||
164029575|NCT04058158|592467170|FG001|Period 1|Adverse Event|1|||
164029576|NCT04058158|592467169|FG000|Period 1|Pregnancy|0|||
164029577|NCT04058158|592467170|FG001|Period 1|Pregnancy|1|||
164029578|NCT02215616|592467171|FG000|Overall Study|Sponsor requested to stop study drug|0|||
164029579|NCT02215616|592467172|FG001|Overall Study|Sponsor requested to stop study drug|0|||
164029580|NCT02215616|592467173|FG002|Overall Study|Sponsor requested to stop study drug|1|||
164029581|NCT02215616|592467174|FG003|Overall Study|Sponsor requested to stop study drug|4|||
164029582|NCT02215616|592467171|FG000|Overall Study|Death|1|||
164029583|NCT02215616|592467172|FG001|Overall Study|Death|0|||
164029584|NCT02215616|592467173|FG002|Overall Study|Death|0|||
164029585|NCT02215616|592467174|FG003|Overall Study|Death|0|||
164029586|NCT02215616|592467171|FG000|Overall Study|Adverse Event|7|||
164029587|NCT02215616|592467172|FG001|Overall Study|Adverse Event|4|||
164029588|NCT02215616|592467173|FG002|Overall Study|Adverse Event|9|||
164029589|NCT02215616|592467174|FG003|Overall Study|Adverse Event|2|||
164029590|NCT02215616|592467171|FG000|Overall Study|Withdrawal by Subject|1|||
164029591|NCT02215616|592467172|FG001|Overall Study|Withdrawal by Subject|8|||
164029592|NCT02215616|592467173|FG002|Overall Study|Withdrawal by Subject|2|||
164029593|NCT02215616|592467174|FG003|Overall Study|Withdrawal by Subject|5|||
164029594|NCT02215616|592467171|FG000|Overall Study|Non-compliance|0|||
164029595|NCT02215616|592467172|FG001|Overall Study|Non-compliance|2|||
164029596|NCT02215616|592467173|FG002|Overall Study|Non-compliance|1|||
164029597|NCT02215616|592467174|FG003|Overall Study|Non-compliance|0|||
164029598|NCT02215616|592467171|FG000|Overall Study|Protocol Violation|0|||
164029599|NCT02215616|592467172|FG001|Overall Study|Protocol Violation|2|||
164029600|NCT02215616|592467173|FG002|Overall Study|Protocol Violation|0|||
164029601|NCT02215616|592467174|FG003|Overall Study|Protocol Violation|0|||
164029602|NCT02215616|592467171|FG000|Overall Study|Lost to Follow-up|1|||
164029603|NCT02215616|592467172|FG001|Overall Study|Lost to Follow-up|1|||
164029604|NCT02215616|592467173|FG002|Overall Study|Lost to Follow-up|0|||
164029605|NCT02215616|592467174|FG003|Overall Study|Lost to Follow-up|1|||
164029606|NCT02215616|592467171|FG000|Overall Study|Other than specified|1|||
164029607|NCT02215616|592467172|FG001|Overall Study|Other than specified|0|||
164029608|NCT02215616|592467173|FG002|Overall Study|Other than specified|1|||
164029609|NCT02215616|592467174|FG003|Overall Study|Other than specified|1|||
164029610|NCT01634113|592467175|FG000|Overall Study|Not treated|0|||
164029611|NCT01634113|592467176|FG001|Overall Study|Not treated|0|||
164029612|NCT01634113|592467177|FG002|Overall Study|Not treated|1|||
164029613|NCT00520299|592467180|FG000|Overall Study|Withdrawal by Subject|0|||
164029614|NCT00520299|592467181|FG001|Overall Study|Withdrawal by Subject|0|||
164029615|NCT00520299|592467182|FG002|Overall Study|Withdrawal by Subject|2|||
164029616|NCT00520299|592467180|FG000|Overall Study|Progressive disease|0|||
164029617|NCT00520299|592467181|FG001|Overall Study|Progressive disease|3|||
164029618|NCT00520299|592467182|FG002|Overall Study|Progressive disease|4|||
164029619|NCT01352845|592467183|FG000|Overall Study|Lost to Follow-up|313|||
164029620|NCT01352845|592467184|FG001|Overall Study|Lost to Follow-up|92|||
164029621|NCT01352845|592467183|FG000|Overall Study|No Longer Willing to Participate|205|||
164029622|NCT01352845|592467184|FG001|Overall Study|No Longer Willing to Participate|58|||
164029623|NCT01352845|592467183|FG000|Overall Study|Withdrawal by Subject|48|||
164029624|NCT01352845|592467184|FG001|Overall Study|Withdrawal by Subject|16|||
164029625|NCT01352845|592467183|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
164029626|NCT01352845|592467184|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
164029627|NCT01352845|592467183|FG000|Overall Study|Pregnancy|27|||
164029628|NCT01352845|592467184|FG001|Overall Study|Pregnancy|7|||
164029629|NCT01352845|592467183|FG000|Overall Study|Adverse Event|22|||
164029630|NCT01352845|592467184|FG001|Overall Study|Adverse Event|6|||
164029631|NCT01352845|592467183|FG000|Overall Study|Other|17|||
164029632|NCT01352845|592467184|FG001|Overall Study|Other|7|||
164029633|NCT01352845|592467183|FG000|Overall Study|Protocol Violation|12|||
164029634|NCT01352845|592467184|FG001|Overall Study|Protocol Violation|6|||
164029635|NCT01352845|592467183|FG000|Overall Study|Death|3|||
164029636|NCT01352845|592467184|FG001|Overall Study|Death|0|||
164029637|NCT02062463|592467185|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
164029638|NCT02062463|592467186|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
164029639|NCT02062463|592467187|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
164029640|NCT02062463|592467188|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
164029641|NCT02062463|592467185|FG000|Stage 2|Adverse Event|0|||
164029642|NCT02062463|592467186|FG001|Stage 2|Adverse Event|0|||
164029643|NCT02062463|592467187|FG002|Stage 2|Adverse Event|12|||
164029644|NCT02062463|592467188|FG003|Stage 2|Adverse Event|20|||
164029645|NCT02062463|592467185|FG000|Stage 2|Lack of Efficacy|0|||
163917344|NCT02706834|592066629|FG000|Overall Study|Lost to Follow-up|0|||
164029646|NCT02062463|592467186|FG001|Stage 2|Lack of Efficacy|0|||
164029647|NCT02062463|592467187|FG002|Stage 2|Lack of Efficacy|3|||
163917345|NCT02706834|592066630|FG001|Overall Study|Lost to Follow-up|0|||
163917346|NCT02706834|592066631|FG002|Overall Study|Lost to Follow-up|1|||
163917347|NCT02706834|592066632|FG003|Overall Study|Lost to Follow-up|0|||
163917348|NCT02706834|592066633|FG004|Overall Study|Lost to Follow-up|0|||
163917349|NCT02706834|592066634|FG005|Overall Study|Lost to Follow-up|0|||
163917350|NCT02706834|592066635|FG006|Overall Study|Lost to Follow-up|0|||
163917351|NCT02706834|592066636|FG007|Overall Study|Lost to Follow-up|0|||
164029648|NCT02062463|592467188|FG003|Stage 2|Lack of Efficacy|4|||
164029649|NCT02062463|592467185|FG000|Stage 2|Lost to Follow-up|0|||
164029650|NCT02062463|592467186|FG001|Stage 2|Lost to Follow-up|0|||
164029651|NCT02062463|592467187|FG002|Stage 2|Lost to Follow-up|20|||
164029652|NCT02062463|592467188|FG003|Stage 2|Lost to Follow-up|20|||
164029653|NCT02062463|592467185|FG000|Stage 2|Non-Compliance|0|||
164029654|NCT02062463|592467186|FG001|Stage 2|Non-Compliance|0|||
164029655|NCT02062463|592467187|FG002|Stage 2|Non-Compliance|0|||
164029656|NCT02062463|592467188|FG003|Stage 2|Non-Compliance|1|||
164029657|NCT02062463|592467185|FG000|Stage 2|Other than specified|0|||
164029658|NCT02062463|592467186|FG001|Stage 2|Other than specified|0|||
164029659|NCT02062463|592467187|FG002|Stage 2|Other than specified|3|||
164029660|NCT02062463|592467188|FG003|Stage 2|Other than specified|1|||
164029661|NCT02062463|592467185|FG000|Stage 2|Withdrawal by Subject|0|||
164029662|NCT02062463|592467186|FG001|Stage 2|Withdrawal by Subject|0|||
164029663|NCT02062463|592467187|FG002|Stage 2|Withdrawal by Subject|15|||
164029664|NCT02062463|592467188|FG003|Stage 2|Withdrawal by Subject|10|||
164029665|NCT01956240|592467197|FG000|Overall Study|Lost to Follow-up|6|||
164029666|NCT01956240|592467198|FG001|Overall Study|Lost to Follow-up|20|||
164029667|NCT01956240|592467197|FG000|Overall Study|Adverse Event|17|||
164029668|NCT01956240|592467198|FG001|Overall Study|Adverse Event|4|||
164029669|NCT03172481|592467202|FG000|Double-blind|Withdrawal by Subject|1|||
164029670|NCT03172481|592467203|FG001|Double-blind|Withdrawal by Subject|0|||
164029671|NCT02759562|592467207|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
164029672|NCT02759562|592467208|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
164029673|NCT02759562|592467207|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
164029674|NCT02759562|592467208|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
164029675|NCT01957709|592467209|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
164029676|NCT00830115|592467210|FG000|Overall Study|Adverse Event|2|||
164029677|NCT00830115|592467210|FG000|Overall Study|Improvement/recovery|1|||
164029678|NCT01061736|592467212|FG000|Overall Study|Dose regimen not selected|0|||
164029679|NCT01061736|592467213|FG001|Overall Study|Dose regimen not selected|0|||
164029680|NCT01061736|592467214|FG002|Overall Study|Dose regimen not selected|0|||
164029681|NCT01061736|592467215|FG003|Overall Study|Dose regimen not selected|0|||
164029682|NCT01061736|592467216|FG004|Overall Study|Dose regimen not selected|0|||
164029683|NCT01061736|592467217|FG005|Overall Study|Dose regimen not selected|0|||
164029684|NCT01061736|592467218|FG006|Overall Study|Dose regimen not selected|79|||
164029685|NCT01061736|592467219|FG007|Overall Study|Dose regimen not selected|0|||
164029686|NCT01061736|592467220|FG008|Overall Study|Dose regimen not selected|0|||
164029687|NCT01061736|592467221|FG009|Overall Study|Dose regimen not selected|0|||
164029688|NCT01061736|592467212|FG000|Overall Study|Adverse Event|13|||
164029689|NCT01061736|592467213|FG001|Overall Study|Adverse Event|1|||
164029690|NCT01061736|592467214|FG002|Overall Study|Adverse Event|3|||
164029691|NCT01061736|592467215|FG003|Overall Study|Adverse Event|2|||
164029692|NCT01061736|592467216|FG004|Overall Study|Adverse Event|4|||
164029693|NCT01061736|592467217|FG005|Overall Study|Adverse Event|1|||
164029694|NCT01061736|592467218|FG006|Overall Study|Adverse Event|4|||
164029695|NCT01061736|592467219|FG007|Overall Study|Adverse Event|63|||
164029696|NCT01061736|592467220|FG008|Overall Study|Adverse Event|67|||
164029697|NCT01061736|592467221|FG009|Overall Study|Adverse Event|34|||
164029698|NCT01061736|592467212|FG000|Overall Study|Lack of Efficacy|0|||
164029699|NCT01061736|592467213|FG001|Overall Study|Lack of Efficacy|2|||
164029700|NCT01061736|592467214|FG002|Overall Study|Lack of Efficacy|1|||
164029701|NCT01061736|592467215|FG003|Overall Study|Lack of Efficacy|1|||
164029702|NCT01061736|592467216|FG004|Overall Study|Lack of Efficacy|1|||
164029703|NCT01061736|592467217|FG005|Overall Study|Lack of Efficacy|2|||
164029704|NCT01061736|592467218|FG006|Overall Study|Lack of Efficacy|1|||
164029705|NCT01061736|592467219|FG007|Overall Study|Lack of Efficacy|9|||
164029706|NCT01061736|592467220|FG008|Overall Study|Lack of Efficacy|9|||
164029707|NCT01061736|592467221|FG009|Overall Study|Lack of Efficacy|10|||
164029708|NCT01061736|592467212|FG000|Overall Study|Poor compliance to protocol|0|||
164029709|NCT01061736|592467213|FG001|Overall Study|Poor compliance to protocol|0|||
164029710|NCT01061736|592467214|FG002|Overall Study|Poor compliance to protocol|0|||
164029711|NCT01061736|592467215|FG003|Overall Study|Poor compliance to protocol|0|||
164029712|NCT01061736|592467216|FG004|Overall Study|Poor compliance to protocol|0|||
164029713|NCT01061736|592467217|FG005|Overall Study|Poor compliance to protocol|0|||
164029714|NCT01061736|592467218|FG006|Overall Study|Poor compliance to protocol|0|||
164029715|NCT01061736|592467219|FG007|Overall Study|Poor compliance to protocol|2|||
164029716|NCT01061736|592467220|FG008|Overall Study|Poor compliance to protocol|5|||
164029717|NCT01061736|592467221|FG009|Overall Study|Poor compliance to protocol|9|||
164029718|NCT01061736|592467212|FG000|Overall Study|Not treated|0|||
164029719|NCT01061736|592467213|FG001|Overall Study|Not treated|0|||
164029720|NCT01061736|592467214|FG002|Overall Study|Not treated|0|||
164029721|NCT01061736|592467215|FG003|Overall Study|Not treated|0|||
164029722|NCT01061736|592467216|FG004|Overall Study|Not treated|1|||
164029723|NCT01061736|592467217|FG005|Overall Study|Not treated|0|||
164029724|NCT01061736|592467218|FG006|Overall Study|Not treated|0|||
164029725|NCT01061736|592467219|FG007|Overall Study|Not treated|2|||
164029726|NCT01061736|592467220|FG008|Overall Study|Not treated|1|||
164029727|NCT01061736|592467221|FG009|Overall Study|Not treated|0|||
164029728|NCT01061736|592467212|FG000|Overall Study|Other than specified above|0|||
164029729|NCT01061736|592467213|FG001|Overall Study|Other than specified above|1|||
164029730|NCT01061736|592467214|FG002|Overall Study|Other than specified above|2|||
164029731|NCT01061736|592467215|FG003|Overall Study|Other than specified above|0|||
164029732|NCT01061736|592467216|FG004|Overall Study|Other than specified above|1|||
164029733|NCT01061736|592467217|FG005|Overall Study|Other than specified above|0|||
164029734|NCT01061736|592467218|FG006|Overall Study|Other than specified above|0|||
164029735|NCT01061736|592467219|FG007|Overall Study|Other than specified above|18|||
164029736|NCT01061736|592467220|FG008|Overall Study|Other than specified above|15|||
164029737|NCT01061736|592467221|FG009|Overall Study|Other than specified above|21|||
164029738|NCT01925612|592467222|FG000|Overall Study|Progressive Disease|1|||
164029739|NCT01925612|592467223|FG001|Overall Study|Progressive Disease|1|||
164029740|NCT01925612|592467224|FG002|Overall Study|Progressive Disease|1|||
164029741|NCT01925612|592467225|FG003|Overall Study|Progressive Disease|0|||
164029742|NCT01925612|592467226|FG004|Overall Study|Progressive Disease|0|||
164029743|NCT01925612|592467222|FG000|Overall Study|Adverse Event|3|||
164029744|NCT01925612|592467223|FG001|Overall Study|Adverse Event|3|||
164029745|NCT01925612|592467224|FG002|Overall Study|Adverse Event|0|||
164029746|NCT01925612|592467225|FG003|Overall Study|Adverse Event|1|||
164029747|NCT01925612|592467226|FG004|Overall Study|Adverse Event|2|||
164029748|NCT01107405|592467228|FG000|Overall Study|Adverse Event|1|||
164029749|NCT01107405|592467229|FG001|Overall Study|Adverse Event|1|||
164029750|NCT01107405|592467230|FG002|Overall Study|Adverse Event|0|||
164029751|NCT01107405|592467231|FG003|Overall Study|Adverse Event|0|||
164029752|NCT01107405|592467232|FG004|Overall Study|Adverse Event|2|||
164029753|NCT01107405|592467228|FG000|Overall Study|Withdrawal by Subject|1|||
164029754|NCT01107405|592467229|FG001|Overall Study|Withdrawal by Subject|0|||
164029755|NCT01107405|592467230|FG002|Overall Study|Withdrawal by Subject|1|||
164029756|NCT01107405|592467231|FG003|Overall Study|Withdrawal by Subject|2|||
164029757|NCT01107405|592467232|FG004|Overall Study|Withdrawal by Subject|1|||
164029758|NCT01107405|592467228|FG000|Overall Study|Protocol Violation|0|||
164029759|NCT01107405|592467229|FG001|Overall Study|Protocol Violation|0|||
164029760|NCT01107405|592467230|FG002|Overall Study|Protocol Violation|1|||
164029761|NCT01107405|592467231|FG003|Overall Study|Protocol Violation|1|||
164029762|NCT01107405|592467232|FG004|Overall Study|Protocol Violation|0|||
164029763|NCT01895452|592467239|FG000|Overall Study|Adverse Event|1|||
164029764|NCT01895452|592467240|FG001|Overall Study|Adverse Event|4|||
164096820|NCT01367457|592718953|FG002|Overall Study|Lost to Follow-up|0|||
164029765|NCT01895452|592467239|FG000|Overall Study|Lost to Follow-up|1|||
164029766|NCT01895452|592467240|FG001|Overall Study|Lost to Follow-up|5|||
164029767|NCT01895452|592467239|FG000|Overall Study|Pregnancy|0|||
164029768|NCT01895452|592467240|FG001|Overall Study|Pregnancy|1|||
164029769|NCT01895452|592467239|FG000|Overall Study|Withdrawal by Subject|2|||
164029770|NCT01895452|592467240|FG001|Overall Study|Withdrawal by Subject|14|||
164029771|NCT01895452|592467239|FG000|Overall Study|Underlying disease|0|||
164029772|NCT01895452|592467240|FG001|Overall Study|Underlying disease|3|||
164029773|NCT01895452|592467239|FG000|Overall Study|Noncompliance with study drug|0|||
164029774|NCT01895452|592467240|FG001|Overall Study|Noncompliance with study drug|1|||
164029775|NCT00980343|592467241|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
164029776|NCT00980343|592467242|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
164029777|NCT01188538|592467247|FG000|Overall Study|Lost to Follow-up|0|||
164029778|NCT01188538|592467248|FG001|Overall Study|Lost to Follow-up|1|||
164029779|NCT01170702|592467251|FG000|Overall Study|Exclusion criteria met after consent|1|||
164029780|NCT01170702|592467252|FG001|Overall Study|Exclusion criteria met after consent|2|||
164029781|NCT01170702|592467253|FG002|Overall Study|Exclusion criteria met after consent|0|||
164029782|NCT01170702|592467254|FG003|Overall Study|Exclusion criteria met after consent|2|||
164029783|NCT04999969|592467255|FG000|Overall Study|Death|76|||
164029784|NCT04999969|592467255|FG000|Overall Study|Progressive Disease|1|||
164029785|NCT04999969|592467255|FG000|Overall Study|Withdrawal by Subject|8|||
164029786|NCT06964165|592467256|FG000|Overall Study|Death|4|||
164096821|NCT01367457|592718951|FG000|Overall Study|Death from septic shock|1|||
164029787|NCT06964165|592467257|FG001|Overall Study|Death|4|||
164029788|NCT06964165|592467256|FG000|Overall Study|Physician Decision|1|||
164029789|NCT06964165|592467257|FG001|Overall Study|Physician Decision|1|||
164029790|NCT06964165|592467256|FG000|Overall Study|Withdrawal by Subject|0|||
164029791|NCT06964165|592467257|FG001|Overall Study|Withdrawal by Subject|2|||
164096822|NCT01367457|592718952|FG001|Overall Study|Death from septic shock|0|||
164096823|NCT01367457|592718953|FG002|Overall Study|Death from septic shock|0|||
164029792|NCT06964165|592467256|FG000|Overall Study|Study terminated by sponsor|12|||
164146443|NCT05026177|592898058|FG000|Overall Study|Lost to Follow-up|7|||
164029793|NCT06964165|592467257|FG001|Overall Study|Study terminated by sponsor|10|||
164029794|NCT06964165|592467256|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
164029795|NCT06964165|592467257|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
164029796|NCT06964165|592467256|FG000|Overall Study|Participant removed due to non-compliance|0|||
163917352|NCT02706834|592066637|FG008|Overall Study|Lost to Follow-up|0|||
163917353|NCT02706834|592066638|FG009|Overall Study|Lost to Follow-up|0|||
163917354|NCT02706834|592066639|FG010|Overall Study|Lost to Follow-up|0|||
164029797|NCT06964165|592467257|FG001|Overall Study|Participant removed due to non-compliance|1|||
164029798|NCT01551758|592467258|FG000|Overall Study|Adverse Event|29|||
164029799|NCT01551758|592467259|FG001|Overall Study|Adverse Event|43|||
164029800|NCT01551758|592467258|FG000|Overall Study|Lack of Efficacy|0|||
164029801|NCT01551758|592467259|FG001|Overall Study|Lack of Efficacy|1|||
164029802|NCT01551758|592467258|FG000|Overall Study|Protocol Violation|5|||
164029803|NCT01551758|592467259|FG001|Overall Study|Protocol Violation|6|||
164029804|NCT01551758|592467258|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
164029805|NCT01551758|592467259|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
164029806|NCT01551758|592467258|FG000|Overall Study|Lost to Follow-up|29|||
164029807|NCT01551758|592467259|FG001|Overall Study|Lost to Follow-up|25|||
164029808|NCT01551758|592467258|FG000|Overall Study|Physician Decision|9|||
164029809|NCT01551758|592467259|FG001|Overall Study|Physician Decision|3|||
164029810|NCT01551758|592467258|FG000|Overall Study|Withdrawal by Subject|14|||
164029811|NCT01551758|592467259|FG001|Overall Study|Withdrawal by Subject|17|||
164029812|NCT01586156|592467261|FG000|Overall Study|Pregnancy|0|||
164029813|NCT01586156|592467262|FG001|Overall Study|Pregnancy|1|||
164029814|NCT01586156|592467263|FG002|Overall Study|Pregnancy|0|||
164029815|NCT03519516|592467266|FG000|Overall Study|Adverse Event|0|||
164029816|NCT03519516|592467267|FG001|Overall Study|Adverse Event|1|||
164029817|NCT05584202|592467269|FG000|Overall Study|Withdrawal of Consent|3|||
164029818|NCT05584202|592467270|FG001|Overall Study|Withdrawal of Consent|2|||
164029819|NCT05584202|592467269|FG000|Overall Study|Lost to Follow-up|2|||
164029820|NCT05584202|592467270|FG001|Overall Study|Lost to Follow-up|1|||
164029821|NCT05584202|592467269|FG000|Overall Study|Death|0|||
164029822|NCT05584202|592467270|FG001|Overall Study|Death|1|||
164029823|NCT00646113|592468744|FG000|Overall Study|Lost to Follow-up|5|||
164029824|NCT00646113|592468744|FG000|Overall Study|Adverse Event|3|||
164029825|NCT05458011|592468745|FG000|DB Period (12 Weeks)|Adverse Event|2|||
164029826|NCT05458011|592468746|FG001|DB Period (12 Weeks)|Adverse Event|1|||
164029827|NCT05458011|592468747|FG002|DB Period (12 Weeks)|Adverse Event|1|||
164029828|NCT05458011|592468745|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
164029829|NCT05458011|592468746|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
164029830|NCT05458011|592468747|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
164029831|NCT05458011|592468745|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
164073167|NCT01347879|592632836|FG000|Overall Study|Adverse Event|0|||
163917355|NCT02706834|592066629|FG000|Overall Study|Voluntary Withdrawal|1|||
163917356|NCT02706834|592066630|FG001|Overall Study|Voluntary Withdrawal|0|||
163917357|NCT02706834|592066631|FG002|Overall Study|Voluntary Withdrawal|0|||
164029832|NCT05458011|592468746|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
164029833|NCT05458011|592468747|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
164029834|NCT05458011|592468745|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
164029835|NCT05458011|592468746|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
164029836|NCT05458011|592468747|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
164029837|NCT05458011|592468745|FG000|OL Period (12 Weeks)|Adverse Event|1|||
164029838|NCT05458011|592468746|FG001|OL Period (12 Weeks)|Adverse Event|2|||
164029839|NCT05458011|592468747|FG002|OL Period (12 Weeks)|Adverse Event|1|||
164029840|NCT05458011|592468745|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
164029841|NCT05458011|592468746|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
164029842|NCT05458011|592468747|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
164029843|NCT03097614|592468756|FG000|Overall Study|Adverse Event|3|||
164029844|NCT03297216|592468757|FG000|Overall Study|Death|0|||
164029845|NCT03297216|592468758|FG001|Overall Study|Death|1|||
164029846|NCT03297216|592468757|FG000|Overall Study|Miscarriage|0|||
164029847|NCT03297216|592468758|FG001|Overall Study|Miscarriage|2|||
164029848|NCT03297216|592468757|FG000|Overall Study|Lost to Follow-up|3|||
164029849|NCT03297216|592468758|FG001|Overall Study|Lost to Follow-up|2|||
164029850|NCT00603733|592468762|FG000|Active Phase ITT|Adverse Event|8|||
164029851|NCT00603733|592468763|FG001|Active Phase ITT|Adverse Event|7|||
164029852|NCT00603733|592468762|FG000|Active Phase ITT|Withdrawal by Subject|0|||
164029853|NCT00603733|592468763|FG001|Active Phase ITT|Withdrawal by Subject|3|||
164029854|NCT00603733|592468762|FG000|Active Phase ITT|Lost to Follow-up|0|||
164029855|NCT00603733|592468763|FG001|Active Phase ITT|Lost to Follow-up|1|||
164029856|NCT00603733|592468762|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
164029857|NCT00603733|592468763|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
164029858|NCT00603733|592468762|FG000|Active Phase ITT|Lack of Efficacy|1|||
164029859|NCT00603733|592468763|FG001|Active Phase ITT|Lack of Efficacy|2|||
164029860|NCT00603733|592468762|FG000|Active Phase ITT|Subject moved, site closed|1|||
164029861|NCT00603733|592468763|FG001|Active Phase ITT|Subject moved, site closed|1|||
164029862|NCT00603733|592468762|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
164029863|NCT00603733|592468763|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
164029864|NCT00603733|592468762|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
164029865|NCT00603733|592468763|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
164029866|NCT00603733|592468762|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
164029867|NCT00603733|592468763|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
164029868|NCT00603733|592468762|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
164029869|NCT00603733|592468763|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
164029870|NCT00603733|592468762|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
164029871|NCT00603733|592468763|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
164029872|NCT00603733|592468762|FG000|Maintenance Phase ITT|Adverse Event|3|||
164029873|NCT00603733|592468763|FG001|Maintenance Phase ITT|Adverse Event|6|||
164029874|NCT00603733|592468762|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
164029875|NCT00603733|592468763|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
164029876|NCT00603733|592468762|FG000|Maintenance Phase ITT|Protocol Violation|1|||
164029877|NCT00603733|592468763|FG001|Maintenance Phase ITT|Protocol Violation|1|||
164029878|NCT00603733|592468762|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
164029879|NCT00603733|592468763|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
164029880|NCT00603733|592468762|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
164029881|NCT00603733|592468763|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
164029882|NCT00603733|592468762|FG000|Maintenance Phase ITT|Physician Decision|0|||
164029883|NCT00603733|592468763|FG001|Maintenance Phase ITT|Physician Decision|1|||
164029884|NCT00603733|592468762|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
164029885|NCT00603733|592468763|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
164096824|NCT01367457|592718951|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
164029886|NCT01093755|592468769|FG000|Overall Study|Withdrawal by Subject|3|||
164029887|NCT01093755|592468770|FG001|Overall Study|Withdrawal by Subject|4|||
164029888|NCT03115112|592468771|FG000|Overall Study|Adverse Event|5|||
164029889|NCT03115112|592468772|FG001|Overall Study|Adverse Event|1|||
164029890|NCT03115112|592468771|FG000|Overall Study|Withdrawal by Subject|4|||
164029891|NCT03115112|592468772|FG001|Overall Study|Withdrawal by Subject|2|||
164029892|NCT03115112|592468771|FG000|Overall Study|Lost to Follow-up|0|||
164029893|NCT03115112|592468772|FG001|Overall Study|Lost to Follow-up|1|||
164029894|NCT03115112|592468771|FG000|Overall Study|Death|1|||
164029895|NCT03115112|592468772|FG001|Overall Study|Death|0|||
164029896|NCT03115112|592468771|FG000|Overall Study|Pregnancy|1|||
164029897|NCT03115112|592468772|FG001|Overall Study|Pregnancy|0|||
164029898|NCT03115112|592468771|FG000|Overall Study|Site closure|1|||
164029899|NCT03115112|592468772|FG001|Overall Study|Site closure|1|||
164029900|NCT01610076|592468773|FG000|Overall Study|Technical issue with video|0|||
164029901|NCT01610076|592468774|FG001|Overall Study|Technical issue with video|1|||
164029902|NCT01610076|592468773|FG000|Overall Study|Lost to Follow-up|3|||
164029903|NCT01610076|592468774|FG001|Overall Study|Lost to Follow-up|4|||
164029904|NCT02168803|592468778|FG000|Overall Study|Lost to Follow-up|1|||
164029905|NCT02168803|592468779|FG001|Overall Study|Lost to Follow-up|0|||
164029906|NCT02168803|592468780|FG002|Overall Study|Lost to Follow-up|1|||
164029907|NCT02168803|592468778|FG000|Overall Study|Withdrawal by Subject|1|||
164029908|NCT02168803|592468779|FG001|Overall Study|Withdrawal by Subject|1|||
164029909|NCT02168803|592468780|FG002|Overall Study|Withdrawal by Subject|2|||
164029910|NCT02168803|592468778|FG000|Overall Study|Physician Decision|0|||
164029911|NCT02168803|592468779|FG001|Overall Study|Physician Decision|1|||
164029912|NCT02168803|592468780|FG002|Overall Study|Physician Decision|0|||
164029913|NCT02168803|592468778|FG000|Overall Study|Adverse Event|0|||
164029914|NCT02168803|592468779|FG001|Overall Study|Adverse Event|1|||
164029915|NCT02168803|592468780|FG002|Overall Study|Adverse Event|1|||
164029916|NCT02168803|592468778|FG000|Overall Study|Death|0|||
164029917|NCT02168803|592468779|FG001|Overall Study|Death|0|||
164029918|NCT02168803|592468780|FG002|Overall Study|Death|1|||
164029919|NCT02168803|592468778|FG000|Overall Study|Sponsor Decision|0|||
164029920|NCT02168803|592468779|FG001|Overall Study|Sponsor Decision|0|||
164029921|NCT02168803|592468780|FG002|Overall Study|Sponsor Decision|1|||
164029922|NCT02310906|592468791|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
164029923|NCT02310906|592468792|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
164029924|NCT02310906|592468793|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
164029925|NCT02310906|592468794|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
164029926|NCT02310906|592468791|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
164096825|NCT01367457|592718952|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
164029927|NCT02310906|592468792|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
164029928|NCT02310906|592468793|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
164029929|NCT02310906|592468794|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
164029930|NCT02310906|592468791|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
164029931|NCT02310906|592468792|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
164029932|NCT02310906|592468793|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
164029933|NCT02310906|592468794|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
164029934|NCT02310906|592468791|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
164029935|NCT02310906|592468792|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
164029936|NCT02310906|592468793|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
164029937|NCT02310906|592468794|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
164029938|NCT00433446|592468795|FG000|Overall Study|Adverse Event|4|||
164029939|NCT00433446|592468795|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164029940|NCT00433446|592468795|FG000|Overall Study|Progression|44|||
164029941|NCT00433446|592468795|FG000|Overall Study|Other - Not Protocol specified|3|||
164029942|NCT00433446|592468795|FG000|Overall Study|Ineligible|9|||
164029943|NCT02899377|592468796|FG000|Overall Study|Adverse Event|1|||
164029944|NCT02899377|592468797|FG001|Overall Study|Adverse Event|0|||
164029945|NCT01231607|592468798|FG000|Overall Study|Adverse Event|0|||
164029946|NCT01231607|592468799|FG001|Overall Study|Adverse Event|8|||
164029947|NCT01231607|592468800|FG002|Overall Study|Adverse Event|4|||
164029948|NCT01231607|592468801|FG003|Overall Study|Adverse Event|4|||
164029949|NCT01231607|592468802|FG004|Overall Study|Adverse Event|5|||
164029950|NCT01231607|592468798|FG000|Overall Study|Lost to Follow-up|13|||
164029951|NCT01231607|592468799|FG001|Overall Study|Lost to Follow-up|11|||
164029952|NCT01231607|592468800|FG002|Overall Study|Lost to Follow-up|10|||
164029953|NCT01231607|592468801|FG003|Overall Study|Lost to Follow-up|10|||
164029954|NCT01231607|592468802|FG004|Overall Study|Lost to Follow-up|4|||
164029955|NCT01231607|592468798|FG000|Overall Study|Physician Decision|4|||
164029956|NCT01231607|592468799|FG001|Overall Study|Physician Decision|4|||
164029957|NCT01231607|592468800|FG002|Overall Study|Physician Decision|3|||
164029958|NCT01231607|592468801|FG003|Overall Study|Physician Decision|5|||
164029959|NCT01231607|592468802|FG004|Overall Study|Physician Decision|4|||
164029960|NCT01231607|592468798|FG000|Overall Study|Protocol Violation|3|||
164029961|NCT01231607|592468799|FG001|Overall Study|Protocol Violation|2|||
164029962|NCT01231607|592468800|FG002|Overall Study|Protocol Violation|0|||
164029963|NCT01231607|592468801|FG003|Overall Study|Protocol Violation|2|||
164029964|NCT01231607|592468802|FG004|Overall Study|Protocol Violation|2|||
164029965|NCT01231607|592468798|FG000|Overall Study|Withdrawal by Subject|9|||
164029966|NCT01231607|592468799|FG001|Overall Study|Withdrawal by Subject|9|||
164029967|NCT01231607|592468800|FG002|Overall Study|Withdrawal by Subject|14|||
164029968|NCT01231607|592468801|FG003|Overall Study|Withdrawal by Subject|17|||
164029969|NCT01231607|592468802|FG004|Overall Study|Withdrawal by Subject|9|||
164029970|NCT04321252|592468807|FG000|Overall Study|Withdrawal by Subject|0|||
164029971|NCT04321252|592468808|FG001|Overall Study|Withdrawal by Subject|0|||
164029972|NCT04321252|592468809|FG002|Overall Study|Withdrawal by Subject|0|||
164029973|NCT04321252|592468810|FG003|Overall Study|Withdrawal by Subject|0|||
164029974|NCT04321252|592468811|FG004|Overall Study|Withdrawal by Subject|0|||
164029975|NCT04321252|592468812|FG005|Overall Study|Withdrawal by Subject|1|||
164029976|NCT04321252|592468813|FG006|Overall Study|Withdrawal by Subject|0|||
164029977|NCT04321252|592468814|FG007|Overall Study|Withdrawal by Subject|0|||
164029978|NCT04321252|592468815|FG008|Overall Study|Withdrawal by Subject|0|||
164029979|NCT06245044|592468816|FG000|No MI help|Technical issues|18|||
164029980|NCT01082367|592468819|FG000|Double-blind Period|Administrative problems|0|||
164029981|NCT01082367|592468820|FG001|Double-blind Period|Administrative problems|1|||
164029982|NCT01082367|592468819|FG000|Double-blind Period|Lack of Efficacy|5|||
164029983|NCT01082367|592468820|FG001|Double-blind Period|Lack of Efficacy|11|||
164029984|NCT01082367|592468819|FG000|Double-blind Period|Adverse Event|0|||
164029985|NCT01082367|592468820|FG001|Double-blind Period|Adverse Event|1|||
164029986|NCT01082367|592468819|FG000|Follow-up (F-U) Period|Administrative problems|1|||
164029987|NCT01082367|592468820|FG001|Follow-up (F-U) Period|Administrative problems|0|||
164029988|NCT01082367|592468819|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
164029989|NCT01082367|592468820|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
164029990|NCT01082367|592468819|FG000|Follow-up (F-U) Period|Adverse Event|0|||
164029991|NCT01082367|592468820|FG001|Follow-up (F-U) Period|Adverse Event|1|||
164029992|NCT00098020|592468823|FG000|Overall Study|Adverse Event|2|||
164029993|NCT00098020|592468823|FG000|Overall Study|Lost to Follow-up|1|||
164029994|NCT00098020|592468823|FG000|Overall Study|elevated liver enzymes|1|||
164029995|NCT00098020|592468823|FG000|Overall Study|Low urine PCR|1|||
164029996|NCT00098020|592468823|FG000|Overall Study|Low epidermal growth factor receptor|1|||
164029997|NCT00085917|592468830|FG000|Overall Study|Adverse Event|4|||
164029998|NCT00085917|592468831|FG001|Overall Study|Adverse Event|3|||
164029999|NCT00865189|592468832|FG000|Overall Study|Other|1|||
164030000|NCT00865189|592468833|FG001|Overall Study|Other|2|||
164030001|NCT00865189|592468832|FG000|Overall Study|Death|4|||
164030002|NCT00865189|592468833|FG001|Overall Study|Death|11|||
164030003|NCT00865189|592468832|FG000|Overall Study|Lost to Follow-up|6|||
164030004|NCT00865189|592468833|FG001|Overall Study|Lost to Follow-up|6|||
164030005|NCT00865189|592468832|FG000|Overall Study|Withdrawal by Subject|1|||
164030006|NCT00865189|592468833|FG001|Overall Study|Withdrawal by Subject|0|||
164030007|NCT01658579|592468835|FG000|Treatment Period A|Other|0|||
164030008|NCT01658579|592468836|FG001|Treatment Period A|Other|0|||
164030009|NCT01658579|592468837|FG002|Treatment Period A|Other|1|||
164030010|NCT01658579|592468838|FG003|Treatment Period A|Other|1|||
164030011|NCT01658579|592468835|FG000|Treatment Period A|Adverse Event|1|||
164030012|NCT01658579|592468836|FG001|Treatment Period A|Adverse Event|0|||
164030013|NCT01658579|592468837|FG002|Treatment Period A|Adverse Event|0|||
164030014|NCT01658579|592468838|FG003|Treatment Period A|Adverse Event|0|||
164030015|NCT01658579|592468835|FG000|Treatment Period B|Other|0|||
164030016|NCT01658579|592468836|FG001|Treatment Period B|Other|0|||
164030017|NCT01658579|592468837|FG002|Treatment Period B|Other|0|||
164030018|NCT01658579|592468838|FG003|Treatment Period B|Other|1|||
164030019|NCT01464788|592468839|FG000|Overall Study|Lost to Follow-up|0|||
164030020|NCT01464788|592468840|FG001|Overall Study|Lost to Follow-up|1|||
164030021|NCT01464788|592468841|FG002|Overall Study|Lost to Follow-up|0|||
164030022|NCT01464788|592468839|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
164030023|NCT01464788|592468840|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
164030024|NCT01464788|592468841|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
164030025|NCT00418379|592468844|FG000|Year 1|Adverse Event|9|||
164030026|NCT00418379|592468845|FG001|Year 1|Adverse Event|15|||
164030027|NCT00418379|592468846|FG002|Year 1|Adverse Event|3|||
164030028|NCT00418379|592468844|FG000|Year 1|Withdrawal by Subject|7|||
164030029|NCT00418379|592468845|FG001|Year 1|Withdrawal by Subject|8|||
164030030|NCT00418379|592468846|FG002|Year 1|Withdrawal by Subject|5|||
164030031|NCT00418379|592468844|FG000|Year 1|Any other reason not above-mentioned|2|||
164030032|NCT00418379|592468845|FG001|Year 1|Any other reason not above-mentioned|5|||
164030033|NCT00418379|592468846|FG002|Year 1|Any other reason not above-mentioned|7|||
164030034|NCT00418379|592468844|FG000|Year 2|Adverse Event|5|||
164030035|NCT00418379|592468845|FG001|Year 2|Adverse Event|2|||
164030036|NCT00418379|592468846|FG002|Year 2|Adverse Event|1|||
164030037|NCT00418379|592468844|FG000|Year 2|Withdrawal by Subject|1|||
164030038|NCT00418379|592468845|FG001|Year 2|Withdrawal by Subject|1|||
164030039|NCT00418379|592468846|FG002|Year 2|Withdrawal by Subject|3|||
164030040|NCT00418379|592468844|FG000|Year 2|Any other reason not above-mentioned|2|||
164030041|NCT00418379|592468845|FG001|Year 2|Any other reason not above-mentioned|1|||
164030042|NCT00418379|592468846|FG002|Year 2|Any other reason not above-mentioned|6|||
164030043|NCT00418379|592468844|FG000|Year 3|Withdrawal by Subject|1|||
164030044|NCT00418379|592468845|FG001|Year 3|Withdrawal by Subject|1|||
164030045|NCT00418379|592468846|FG002|Year 3|Withdrawal by Subject|2|||
164030046|NCT00418379|592468844|FG000|Year 3|Any other reason not above-mentioned|2|||
164030047|NCT00418379|592468845|FG001|Year 3|Any other reason not above-mentioned|1|||
164030048|NCT00418379|592468846|FG002|Year 3|Any other reason not above-mentioned|1|||
164030049|NCT00418379|592468844|FG000|Year 4|Adverse Event|0|||
164030050|NCT00418379|592468845|FG001|Year 4|Adverse Event|1|||
164030051|NCT00418379|592468846|FG002|Year 4|Adverse Event|0|||
164030052|NCT00418379|592468844|FG000|Year 4|Withdrawal by Subject|2|||
164030053|NCT00418379|592468845|FG001|Year 4|Withdrawal by Subject|3|||
164030054|NCT00418379|592468846|FG002|Year 4|Withdrawal by Subject|2|||
164030055|NCT00418379|592468844|FG000|Year 4|Any other reason not above-mentioned|1|||
164030056|NCT00418379|592468845|FG001|Year 4|Any other reason not above-mentioned|1|||
164030057|NCT00418379|592468846|FG002|Year 4|Any other reason not above-mentioned|0|||
164030058|NCT00418379|592468844|FG000|Year 5|Adverse Event|0|||
164030059|NCT00418379|592468845|FG001|Year 5|Adverse Event|1|||
164030060|NCT00418379|592468846|FG002|Year 5|Adverse Event|0|||
164030061|NCT00418379|592468844|FG000|Year 5|Any other reason not above-mentioned|2|||
164030062|NCT00418379|592468845|FG001|Year 5|Any other reason not above-mentioned|4|||
164030063|NCT00418379|592468846|FG002|Year 5|Any other reason not above-mentioned|3|||
164096826|NCT01367457|592718953|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
164096827|NCT01367457|592718951|FG000|Overall Study|Patient's Wish|1|||
164030064|NCT00843843|592468847|FG000|Overall Study|Physician Decision|1|||
164030065|NCT00843843|592468848|FG001|Overall Study|Physician Decision|1|||
164030066|NCT00843843|592468847|FG000|Overall Study|Protocol Violation|1|||
164030067|NCT00843843|592468848|FG001|Overall Study|Protocol Violation|1|||
164030068|NCT00565058|592468849|FG000|Overall Study|Adverse Event|1|||
164096828|NCT01367457|592718952|FG001|Overall Study|Patient's Wish|0|||
164030069|NCT00565058|592468850|FG001|Overall Study|Adverse Event|0|||
164030070|NCT00400712|592468869|FG000|Overall Study|Death|1|||
164030071|NCT00400712|592468870|FG001|Overall Study|Death|0|||
164030072|NCT00400712|592468869|FG000|Overall Study|Withdrawal by Subject|11|||
164030073|NCT00400712|592468870|FG001|Overall Study|Withdrawal by Subject|12|||
164030074|NCT00400712|592468869|FG000|Overall Study|Physician Decision|5|||
164030075|NCT00400712|592468870|FG001|Overall Study|Physician Decision|4|||
164030076|NCT02670330|592468871|FG000|Overall Study|Protocol Deviation|1|||
164030077|NCT02670330|592468872|FG001|Overall Study|Protocol Deviation|0|||
164030078|NCT02670330|592468871|FG000|Overall Study|Study Terminated By Sponsor|36|||
164096829|NCT01367457|592718953|FG002|Overall Study|Patient's Wish|0|||
164096830|NCT01367457|592718951|FG000|Overall Study|Palliative. Overall decline|1|||
164096831|NCT01367457|592718952|FG001|Overall Study|Palliative. Overall decline|0|||
164096832|NCT01367457|592718953|FG002|Overall Study|Palliative. Overall decline|0|||
164096833|NCT01367457|592718951|FG000|Overall Study|Suspected DP/suspected active infection|1|||
164096834|NCT01367457|592718952|FG001|Overall Study|Suspected DP/suspected active infection|0|||
164096835|NCT01367457|592718953|FG002|Overall Study|Suspected DP/suspected active infection|0|||
164096836|NCT04407806|592718958|FG000|Overall Study|Withdrawal by Subject|1|||
164096837|NCT04407806|592718959|FG001|Overall Study|Withdrawal by Subject|2|||
164096838|NCT03447262|592718960|FG000|Overall Study|Adverse Event|7|||
164096839|NCT03447262|592718960|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
164096840|NCT03447262|592718960|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
164096841|NCT03447262|592718960|FG000|Overall Study|Death|2|||
164096842|NCT03447262|592718960|FG000|Overall Study|Study Termination by Sponsor|455|||
164096843|NCT03447262|592718960|FG000|Overall Study|Other|4|||
164096844|NCT02058498|592718966|FG000|Overall Study|Withdrawal by Subject|4|||
164096845|NCT04605094|592718967|FG000|Overall Study|Adverse Event|2|||
164096846|NCT04605094|592718968|FG001|Overall Study|Adverse Event|2|||
164096847|NCT04605094|592718967|FG000|Overall Study|Lost to Follow-up|1|||
164096848|NCT04605094|592718968|FG001|Overall Study|Lost to Follow-up|4|||
164096849|NCT04605094|592718967|FG000|Overall Study|Physician Decision|2|||
164096850|NCT04605094|592718968|FG001|Overall Study|Physician Decision|2|||
164096851|NCT04605094|592718967|FG000|Overall Study|Study terminated by Sponsor|31|||
164096852|NCT04605094|592718968|FG001|Overall Study|Study terminated by Sponsor|33|||
164096853|NCT04605094|592718967|FG000|Overall Study|Withdrawal by Subject|22|||
164096854|NCT04605094|592718968|FG001|Overall Study|Withdrawal by Subject|19|||
164096855|NCT04605094|592718967|FG000|Overall Study|Other|1|||
164096856|NCT04605094|592718968|FG001|Overall Study|Other|1|||
164096857|NCT02724462|592718969|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
164096858|NCT02724462|592718970|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
164096859|NCT02724462|592718969|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
164096860|NCT02724462|592718970|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
164096861|NCT02724462|592718969|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
164096862|NCT02724462|592718970|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
164096863|NCT02724462|592718969|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
164096864|NCT02724462|592718970|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
164096865|NCT02724462|592718969|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
164096866|NCT02724462|592718970|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
164096867|NCT02724462|592718969|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
164096868|NCT02724462|592718970|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
164096869|NCT00469417|592718973|FG000|Overall Study|Treatment failure all lesions|18|||
164096870|NCT00469417|592718974|FG001|Overall Study|Treatment failure all lesions|11|||
164096871|NCT00469417|592718973|FG000|Overall Study|Consent withdrawn|1|||
164096872|NCT00469417|592718974|FG001|Overall Study|Consent withdrawn|1|||
164096873|NCT00469417|592718973|FG000|Overall Study|Adverse Event|8|||
164096874|NCT00469417|592718974|FG001|Overall Study|Adverse Event|2|||
164096875|NCT00469417|592718973|FG000|Overall Study|Lost to Follow-up|1|||
164096876|NCT00469417|592718974|FG001|Overall Study|Lost to Follow-up|2|||
164096877|NCT00469417|592718973|FG000|Overall Study|Intercurrent disease|0|||
164096878|NCT00469417|592718974|FG001|Overall Study|Intercurrent disease|1|||
164096879|NCT00469417|592718973|FG000|Overall Study|Randomized but not treated|2|||
164096880|NCT00469417|592718974|FG001|Overall Study|Randomized but not treated|0|||
164096881|NCT02188303|592718977|FG000|Overall Study|Adverse Event|0|||
164030079|NCT02670330|592468872|FG001|Overall Study|Study Terminated By Sponsor|43|||
164030080|NCT02670330|592468871|FG000|Overall Study|Adverse Event|1|||
164030081|NCT02670330|592468872|FG001|Overall Study|Adverse Event|3|||
164096882|NCT02188303|592718978|FG001|Overall Study|Adverse Event|0|||
164030082|NCT02670330|592468871|FG000|Overall Study|Withdrawal by Subject|34|||
164030083|NCT02670330|592468872|FG001|Overall Study|Withdrawal by Subject|29|||
164030084|NCT02670330|592468871|FG000|Overall Study|Lost to Follow-up|3|||
164030085|NCT02670330|592468872|FG001|Overall Study|Lost to Follow-up|2|||
164030086|NCT00634114|592468873|FG000|Overall Study|Adverse Event|6|||
164030087|NCT00634114|592468874|FG001|Overall Study|Adverse Event|8|||
164030088|NCT00634114|592468875|FG002|Overall Study|Adverse Event|3|||
164030089|NCT00634114|592468873|FG000|Overall Study|Withdrawal by Subject|9|||
164030090|NCT00634114|592468874|FG001|Overall Study|Withdrawal by Subject|6|||
164030091|NCT00634114|592468875|FG002|Overall Study|Withdrawal by Subject|11|||
164030092|NCT00634114|592468873|FG000|Overall Study|Lost to Follow-up|0|||
164030093|NCT00634114|592468874|FG001|Overall Study|Lost to Follow-up|0|||
163917358|NCT02706834|592066632|FG003|Overall Study|Voluntary Withdrawal|0|||
163917359|NCT02706834|592066633|FG004|Overall Study|Voluntary Withdrawal|0|||
163917360|NCT02706834|592066634|FG005|Overall Study|Voluntary Withdrawal|0|||
163917361|NCT02706834|592066635|FG006|Overall Study|Voluntary Withdrawal|0|||
163917362|NCT02706834|592066636|FG007|Overall Study|Voluntary Withdrawal|0|||
163917363|NCT02706834|592066637|FG008|Overall Study|Voluntary Withdrawal|0|||
163917364|NCT02706834|592066638|FG009|Overall Study|Voluntary Withdrawal|1|||
163917365|NCT02706834|592066639|FG010|Overall Study|Voluntary Withdrawal|0|||
163917366|NCT02706834|592066629|FG000|Overall Study|Other Reason Not Specified|1|||
163917367|NCT02706834|592066630|FG001|Overall Study|Other Reason Not Specified|0|||
164030094|NCT00634114|592468875|FG002|Overall Study|Lost to Follow-up|1|||
164030095|NCT00634114|592468873|FG000|Overall Study|Protocol Violation|3|||
163917368|NCT02706834|592066631|FG002|Overall Study|Other Reason Not Specified|0|||
163917369|NCT02706834|592066632|FG003|Overall Study|Other Reason Not Specified|0|||
164030096|NCT00634114|592468874|FG001|Overall Study|Protocol Violation|3|||
163917370|NCT02706834|592066633|FG004|Overall Study|Other Reason Not Specified|1|||
163917371|NCT02706834|592066634|FG005|Overall Study|Other Reason Not Specified|0|||
163917372|NCT02706834|592066635|FG006|Overall Study|Other Reason Not Specified|0|||
163917373|NCT02706834|592066636|FG007|Overall Study|Other Reason Not Specified|0|||
163917374|NCT02706834|592066637|FG008|Overall Study|Other Reason Not Specified|0|||
163917375|NCT02706834|592066638|FG009|Overall Study|Other Reason Not Specified|0|||
163917376|NCT02706834|592066639|FG010|Overall Study|Other Reason Not Specified|0|||
163917377|NCT00678899|592066644|FG000|Overall Study|Adverse Event|1|||
163917378|NCT02543294|592066645|FG000|Overall Study|Lost to Follow-up|3|||
163917379|NCT02543294|592066645|FG000|Overall Study|Physician Decision|2|||
163917380|NCT02543294|592066645|FG000|Overall Study|Withdrawal by Subject|7|||
163917381|NCT01107353|592066649|FG000|Overall Study|Positive Drug Screen|1|||
163917382|NCT01107353|592066650|FG001|Overall Study|Positive Drug Screen|0|||
163917383|NCT02798861|592066653|FG000|Overall Study|Lost to Follow-up|22|||
163917384|NCT02798861|592066653|FG000|Overall Study|Withdrawal by Subject|1|||
163917385|NCT04879823|592066661|FG000|Overall Study|Physician Decision|3|||
163917386|NCT04879823|592066662|FG001|Overall Study|Physician Decision|1|||
163917387|NCT04879823|592066661|FG000|Overall Study|Protocol Violation|2|||
163917388|NCT04879823|592066662|FG001|Overall Study|Protocol Violation|3|||
163917389|NCT04879823|592066661|FG000|Overall Study|Lost to Follow-up|43|||
163917390|NCT04879823|592066662|FG001|Overall Study|Lost to Follow-up|35|||
163917391|NCT00730925|592066663|FG000|Overall Study|Progressive Disease|21|||
163917392|NCT00730925|592066663|FG000|Overall Study|Dose reducing Event|2|||
163917393|NCT00730925|592066663|FG000|Overall Study|Other Averse Event|7|||
163917394|NCT00730925|592066663|FG000|Overall Study|Protocol Violation|1|||
163917395|NCT00730925|592066663|FG000|Overall Study|Withdrawal by Subject|1|||
163917396|NCT00730925|592066663|FG000|Overall Study|Switch to combination therapy|8|||
163917397|NCT00730925|592066663|FG000|Overall Study|Other|1|||
163917398|NCT02137239|592066664|FG000|Overall Study|Discontinued Study Treatment|0|||
163917399|NCT02137239|592066665|FG001|Overall Study|Discontinued Study Treatment|3|||
163917400|NCT02137239|592066664|FG000|Overall Study|Withdrew Consent|1|||
163917401|NCT02137239|592066665|FG001|Overall Study|Withdrew Consent|1|||
163917402|NCT02137239|592066664|FG000|Overall Study|Adverse Event|2|||
163917403|NCT02137239|592066665|FG001|Overall Study|Adverse Event|2|||
163917404|NCT04057937|592066666|FG000|Placebo-controlled Phase|Adverse Event|3|||
163917405|NCT04057937|592066667|FG001|Placebo-controlled Phase|Adverse Event|0|||
163917406|NCT04057937|592066666|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
163917407|NCT04057937|592066667|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
163917408|NCT04057937|592066666|FG000|Active-treatment Phase|Pregnancy|0|||
163917409|NCT04057937|592066667|FG001|Active-treatment Phase|Pregnancy|1|||
163917410|NCT04057937|592066666|FG000|Active-treatment Phase|Physician Decision|0|||
163917411|NCT04057937|592066667|FG001|Active-treatment Phase|Physician Decision|1|||
163917412|NCT02029521|592066668|FG000|Overall Study|Protocol Violation|1|||
163917413|NCT02029521|592066669|FG001|Overall Study|Protocol Violation|0|||
163917414|NCT02029521|592066668|FG000|Overall Study|Withdrawal by Subject|1|||
163917415|NCT02029521|592066669|FG001|Overall Study|Withdrawal by Subject|1|||
163917416|NCT01072396|592066670|FG000|Period One|Adverse Event|1|||
163917417|NCT01072396|592066671|FG001|Period One|Adverse Event|1|||
163917418|NCT01072396|592066670|FG000|Period One|Protocol Violation|2|||
163917419|NCT01072396|592066671|FG001|Period One|Protocol Violation|1|||
163917420|NCT01072396|592066670|FG000|Period One|Withdrawal by Subject|2|||
163917421|NCT01072396|592066671|FG001|Period One|Withdrawal by Subject|0|||
163917422|NCT01072396|592066670|FG000|Washout Period|Missing termination information|0|||
163917423|NCT01072396|592066671|FG001|Washout Period|Missing termination information|1|||
163917424|NCT01072396|592066670|FG000|Period Two|Adverse Event|0|||
163917425|NCT01072396|592066671|FG001|Period Two|Adverse Event|3|||
163917426|NCT01072396|592066670|FG000|Period Two|Lost to Follow-up|1|||
163917427|NCT01072396|592066671|FG001|Period Two|Lost to Follow-up|0|||
163917428|NCT02446912|592066672|FG000|Overall Study|Adverse Event|3|||
163917429|NCT02446912|592066673|FG001|Overall Study|Adverse Event|13|||
163917430|NCT02446912|592066674|FG002|Overall Study|Adverse Event|5|||
163917431|NCT02446912|592066672|FG000|Overall Study|Condition under investigation worsened|0|||
163917432|NCT02446912|592066673|FG001|Overall Study|Condition under investigation worsened|1|||
163917433|NCT02446912|592066674|FG002|Overall Study|Condition under investigation worsened|1|||
163917434|NCT02446912|592066672|FG000|Overall Study|Study-specific withdrawal criteria|1|||
163917435|NCT02446912|592066673|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163917436|NCT02446912|592066674|FG002|Overall Study|Study-specific withdrawal criteria|0|||
163917437|NCT02446912|592066672|FG000|Overall Study|Lack of Efficacy|1|||
163917438|NCT02446912|592066673|FG001|Overall Study|Lack of Efficacy|4|||
163917439|NCT02446912|592066674|FG002|Overall Study|Lack of Efficacy|7|||
163917440|NCT02446912|592066672|FG000|Overall Study|Lost to Follow-up|0|||
163917441|NCT02446912|592066673|FG001|Overall Study|Lost to Follow-up|0|||
163917442|NCT02446912|592066674|FG002|Overall Study|Lost to Follow-up|2|||
163917443|NCT02446912|592066672|FG000|Overall Study|Severe non-compliance to protocol|1|||
163917444|NCT02446912|592066673|FG001|Overall Study|Severe non-compliance to protocol|0|||
163917445|NCT02446912|592066674|FG002|Overall Study|Severe non-compliance to protocol|1|||
163917446|NCT02446912|592066672|FG000|Overall Study|Withdrawal by Subject|10|||
163917447|NCT02446912|592066673|FG001|Overall Study|Withdrawal by Subject|15|||
163917448|NCT02446912|592066674|FG002|Overall Study|Withdrawal by Subject|15|||
164096883|NCT02188303|592718979|FG002|Overall Study|Adverse Event|0|||
164096884|NCT02188303|592718980|FG003|Overall Study|Adverse Event|0|||
164096885|NCT02188303|592718981|FG004|Overall Study|Adverse Event|0|||
163917449|NCT02446912|592066672|FG000|Overall Study|Miscellaneous|2|||
163917450|NCT02446912|592066673|FG001|Overall Study|Miscellaneous|2|||
163917451|NCT02446912|592066674|FG002|Overall Study|Miscellaneous|4|||
163917452|NCT01268488|592066675|FG000|Overall Study|Adverse Event|3|||
163917453|NCT01268488|592066675|FG000|Overall Study|Physician Decision|2|||
163917454|NCT02991456|592066681|FG000|Overall Study|Adverse Event|2|||
163917455|NCT02991456|592066682|FG001|Overall Study|Adverse Event|0|||
163917456|NCT02991456|592066681|FG000|Overall Study|Lost to Follow-up|0|||
163917457|NCT02991456|592066682|FG001|Overall Study|Lost to Follow-up|2|||
163917458|NCT02991456|592066681|FG000|Overall Study|Withdrawal by Subject|1|||
163917459|NCT02991456|592066682|FG001|Overall Study|Withdrawal by Subject|0|||
163917460|NCT02058992|592066683|FG000|Overall Study|Lost to Follow-up|4|||
163917461|NCT02058992|592066683|FG000|Overall Study|Protocol Violation|92|||
163917462|NCT02058992|592066683|FG000|Overall Study|CRF Uncollected|20|||
163917463|NCT03689452|592066685|FG000|Overall Study|Lost to Follow-up|1|||
163917464|NCT03689452|592066686|FG001|Overall Study|Lost to Follow-up|1|||
163917465|NCT00525915|592066687|FG000|Overall Study|Non-Compliance|0|||
163917466|NCT00525915|592066688|FG001|Overall Study|Non-Compliance|1|||
163917467|NCT00525915|592066687|FG000|Overall Study|Disease Progression|5|||
163917468|NCT00525915|592066688|FG001|Overall Study|Disease Progression|6|||
163917469|NCT00525915|592066687|FG000|Overall Study|Withdrawal by Subject|1|||
163917470|NCT00525915|592066688|FG001|Overall Study|Withdrawal by Subject|0|||
163917471|NCT00525915|592066687|FG000|Overall Study|Refused Surgery|1|||
163917472|NCT00525915|592066688|FG001|Overall Study|Refused Surgery|2|||
163917473|NCT00525915|592066687|FG000|Overall Study|Unrelated illness|1|||
163917474|NCT00525915|592066688|FG001|Overall Study|Unrelated illness|0|||
163917475|NCT00267865|592066691|FG000|Induction Treatment|Died before completing.|2|||
163917476|NCT00267865|592066691|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
163917477|NCT01755598|592066695|FG000|Overall Study|Other|109|||
163917478|NCT01755598|592066696|FG001|Overall Study|Other|109|||
163917479|NCT01755598|592066695|FG000|Overall Study|Lost to Follow-up|32|||
163917480|NCT01755598|592066696|FG001|Overall Study|Lost to Follow-up|43|||
163917481|NCT01755598|592066695|FG000|Overall Study|Migrated/moved from study area|76|||
163917482|NCT01755598|592066696|FG001|Overall Study|Migrated/moved from study area|65|||
163917483|NCT01755598|592066695|FG000|Overall Study|Withdrawal by Subject|22|||
163917484|NCT01755598|592066696|FG001|Overall Study|Withdrawal by Subject|31|||
163917485|NCT01755598|592066695|FG000|Overall Study|Protocol Violation|7|||
163917486|NCT01755598|592066696|FG001|Overall Study|Protocol Violation|7|||
163917487|NCT01755598|592066695|FG000|Overall Study|Adverse Event|19|||
163917488|NCT01755598|592066696|FG001|Overall Study|Adverse Event|28|||
163917489|NCT02332889|592066697|FG000|Overall Study|Physician Decision|1|||
163917490|NCT02135445|592066698|FG000|Overall Study|Lost to Follow-up|1|||
163917491|NCT02135445|592066699|FG001|Overall Study|Lost to Follow-up|0|||
163917492|NCT02135445|592066698|FG000|Overall Study|Withdrawal by Subject|1|||
163917493|NCT02135445|592066699|FG001|Overall Study|Withdrawal by Subject|0|||
163917494|NCT02819141|592066700|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
163917495|NCT02819141|592066701|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
163917496|NCT01809691|592068589|FG000|Overall Study|Currently on Treatment|192|||
163917497|NCT01809691|592068590|FG001|Overall Study|Currently on Treatment|100|||
163917498|NCT01809691|592068589|FG000|Overall Study|No Protocol Treatment|10|||
163917499|NCT01809691|592068590|FG001|Overall Study|No Protocol Treatment|11|||
163917500|NCT01809691|592068589|FG000|Overall Study|Adverse Event|80|||
163917501|NCT01809691|592068590|FG001|Overall Study|Adverse Event|21|||
163917502|NCT01809691|592068589|FG000|Overall Study|Disease Progression|226|||
163917503|NCT01809691|592068590|FG001|Overall Study|Disease Progression|372|||
163917504|NCT01809691|592068589|FG000|Overall Study|Death|26|||
163917505|NCT01809691|592068590|FG001|Overall Study|Death|13|||
163917506|NCT01809691|592068589|FG000|Overall Study|Participant Refusal|70|||
163917507|NCT01809691|592068590|FG001|Overall Study|Participant Refusal|72|||
163917508|NCT01809691|592068589|FG000|Overall Study|Other, Not Specified|34|||
163917509|NCT01809691|592068590|FG001|Overall Study|Other, Not Specified|52|||
163917510|NCT03694210|592068591|FG000|Overall Study|Death|1|||
163917511|NCT03694210|592068591|FG000|Overall Study|Screen Failure|7|||
163917512|NCT00907517|592068596|FG000|Overall Study|Progressive Disease|3|||
164030097|NCT00634114|592468875|FG002|Overall Study|Protocol Violation|1|||
164030098|NCT00634114|592468873|FG000|Overall Study|Pregnancy|1|||
164030099|NCT00634114|592468874|FG001|Overall Study|Pregnancy|0|||
164030100|NCT00634114|592468875|FG002|Overall Study|Pregnancy|0|||
163917513|NCT00907517|592068597|FG001|Overall Study|Progressive Disease|3|||
163917514|NCT00907517|592068598|FG002|Overall Study|Progressive Disease|4|||
163917515|NCT00907517|592068599|FG003|Overall Study|Progressive Disease|4|||
163917516|NCT00907517|592068600|FG004|Overall Study|Progressive Disease|4|||
164030101|NCT00634114|592468873|FG000|Overall Study|Incorrect enrolment|0|||
164030102|NCT00634114|592468874|FG001|Overall Study|Incorrect enrolment|1|||
164030103|NCT00634114|592468875|FG002|Overall Study|Incorrect enrolment|0|||
164030104|NCT00634114|592468873|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
164030105|NCT00634114|592468874|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
164030106|NCT00634114|592468875|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
164030107|NCT00634114|592468873|FG000|Overall Study|Difficult to continue|3|||
164030108|NCT00634114|592468874|FG001|Overall Study|Difficult to continue|1|||
164030109|NCT00634114|592468875|FG002|Overall Study|Difficult to continue|1|||
164030110|NCT00634114|592468873|FG000|Overall Study|Other reason|1|||
164030111|NCT00634114|592468874|FG001|Overall Study|Other reason|1|||
164030112|NCT00634114|592468875|FG002|Overall Study|Other reason|1|||
164030113|NCT03670641|592468880|FG000|Overall Study|Lost to Follow-up|3|||
164030114|NCT00916370|592468886|FG000|Overall Study|Death|3|||
164030115|NCT00916370|592468887|FG001|Overall Study|Death|1|||
164030116|NCT00916370|592468886|FG000|Overall Study|Withdrawal by Subject|2|||
164030117|NCT00916370|592468887|FG001|Overall Study|Withdrawal by Subject|0|||
163917517|NCT00907517|592068596|FG000|Overall Study|Symptomatic Deterioration|0|||
163917518|NCT00907517|592068597|FG001|Overall Study|Symptomatic Deterioration|0|||
163917519|NCT00907517|592068598|FG002|Overall Study|Symptomatic Deterioration|0|||
163917520|NCT00907517|592068599|FG003|Overall Study|Symptomatic Deterioration|0|||
163917521|NCT00907517|592068600|FG004|Overall Study|Symptomatic Deterioration|1|||
163917522|NCT02475733|592068623|FG000|Overall Study|Withdrawal by Subject|1|||
163917523|NCT02475733|592068624|FG001|Overall Study|Withdrawal by Subject|0|||
164030118|NCT00916370|592468886|FG000|Overall Study|Physician Decision|0|||
163917524|NCT02475733|592068623|FG000|Overall Study|Physician Decision|1|||
163917525|NCT02475733|592068624|FG001|Overall Study|Physician Decision|0|||
163917526|NCT02131155|592068625|FG000|Overall Study|Adverse Event|1|||
163917527|NCT02131155|592068626|FG001|Overall Study|Adverse Event|0|||
163917528|NCT02131155|592068625|FG000|Overall Study|Treatment completed|1|||
164030119|NCT00916370|592468887|FG001|Overall Study|Physician Decision|1|||
164030120|NCT00264849|592468889|FG000|Overall Study|Adverse Event|7|||
164030121|NCT00264849|592468890|FG001|Overall Study|Adverse Event|2|||
164030122|NCT00264849|592468889|FG000|Overall Study|Withdrawal by Subject|7|||
163917529|NCT02131155|592068626|FG001|Overall Study|Treatment completed|0|||
163917530|NCT02131155|592068625|FG000|Overall Study|Primary tumour recurrence|2|||
163917531|NCT02131155|592068626|FG001|Overall Study|Primary tumour recurrence|1|||
163917532|NCT02131155|592068625|FG000|Overall Study|Refused to continue study medication|1|||
163917533|NCT02131155|592068626|FG001|Overall Study|Refused to continue study medication|0|||
163917534|NCT02131155|592068625|FG000|Overall Study|Study early termination|20|||
163917535|NCT02131155|592068626|FG001|Overall Study|Study early termination|10|||
163917536|NCT01887418|592068627|FG000|Overall Study|Travelling difficulties|0|||
163917537|NCT01887418|592068628|FG001|Overall Study|Travelling difficulties|0|||
163917538|NCT01887418|592068629|FG002|Overall Study|Travelling difficulties|1|||
163917539|NCT01014013|592068632|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
163917540|NCT01014013|592068633|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
163917541|NCT01014013|592068632|FG000|Overall Study|Clinical adverse experience|4|||
163917542|NCT01014013|592068633|FG001|Overall Study|Clinical adverse experience|2|||
163917543|NCT01014013|592068632|FG000|Overall Study|Laboratory adverse experience|1|||
163917544|NCT01014013|592068633|FG001|Overall Study|Laboratory adverse experience|1|||
163917545|NCT01014013|592068632|FG000|Overall Study|Protocol Violation|1|||
163917546|NCT01014013|592068633|FG001|Overall Study|Protocol Violation|3|||
163917547|NCT01014013|592068632|FG000|Overall Study|Withdrawal by Subject|7|||
163917548|NCT01014013|592068633|FG001|Overall Study|Withdrawal by Subject|4|||
163917549|NCT01014013|592068632|FG000|Overall Study|Clinical/microbiologic failure|1|||
163917550|NCT01014013|592068633|FG001|Overall Study|Clinical/microbiologic failure|2|||
163917551|NCT01014013|592068632|FG000|Overall Study|Pathogen culture = no growth|26|||
163917552|NCT01014013|592068633|FG001|Overall Study|Pathogen culture = no growth|34|||
163917553|NCT01014013|592068632|FG000|Overall Study|Negative urine culture|2|||
163917554|NCT01014013|592068633|FG001|Overall Study|Negative urine culture|0|||
163917555|NCT01014013|592068632|FG000|Overall Study|Pathogen resistant|7|||
163917556|NCT01014013|592068633|FG001|Overall Study|Pathogen resistant|4|||
163917557|NCT01014013|592068632|FG000|Overall Study|Physician Decision|0|||
163917558|NCT01014013|592068633|FG001|Overall Study|Physician Decision|1|||
163917559|NCT01014013|592068632|FG000|Overall Study|Another antibiotic therapy required|0|||
163917560|NCT01014013|592068633|FG001|Overall Study|Another antibiotic therapy required|1|||
163917561|NCT01014013|592068632|FG000|Overall Study|Appendectomy|1|||
163917562|NCT01014013|592068633|FG001|Overall Study|Appendectomy|0|||
163917563|NCT01014013|592068632|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
163917564|NCT01014013|592068633|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
163917565|NCT00442559|592068643|FG000|Overall Study|Lost to Follow-up|32|||
163917566|NCT00442559|592068644|FG001|Overall Study|Lost to Follow-up|34|||
163917567|NCT00442559|592068643|FG000|Overall Study|Protocol Violation|1|||
163917568|NCT00442559|592068644|FG001|Overall Study|Protocol Violation|1|||
163917569|NCT00442559|592068643|FG000|Overall Study|Withdrawal by Subject|1|||
163917570|NCT00442559|592068644|FG001|Overall Study|Withdrawal by Subject|0|||
163917571|NCT03508830|592068645|FG000|Overall Study|Withdrawal by Subject|3|||
163917572|NCT03508830|592068646|FG001|Overall Study|Withdrawal by Subject|4|||
163917573|NCT03508830|592068645|FG000|Overall Study|Physician Decision|2|||
163917574|NCT03508830|592068646|FG001|Overall Study|Physician Decision|2|||
163917575|NCT03906240|592068647|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
163917576|NCT03906240|592068648|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
163917577|NCT03906240|592068647|FG000|Overall Study|Lost to Follow-up|1|||
163917578|NCT03906240|592068648|FG001|Overall Study|Lost to Follow-up|0|||
163917579|NCT03906240|592068647|FG000|Overall Study|Withdrawal by Subject|0|||
163917580|NCT03906240|592068648|FG001|Overall Study|Withdrawal by Subject|1|||
163917581|NCT03575572|592068649|FG000|Overall Study|Withdrawal by Subject|2|||
163917582|NCT03575572|592068649|FG000|Overall Study|Physician Decision|2|||
163917583|NCT04908800|592068650|FG000|Overall Study|Adverse Event|0|||
163917584|NCT04908800|592068651|FG001|Overall Study|Adverse Event|0|||
163917585|NCT04908800|592068652|FG002|Overall Study|Adverse Event|0|||
163917586|NCT04908800|592068653|FG003|Overall Study|Adverse Event|0|||
163917587|NCT04908800|592068654|FG004|Overall Study|Adverse Event|0|||
163917588|NCT04908800|592068655|FG005|Overall Study|Adverse Event|0|||
163917589|NCT04908800|592068656|FG006|Overall Study|Adverse Event|0|||
163917590|NCT04908800|592068657|FG007|Overall Study|Adverse Event|0|||
163917591|NCT04908800|592068658|FG008|Overall Study|Adverse Event|0|||
163917592|NCT04908800|592068659|FG009|Overall Study|Adverse Event|0|||
163917593|NCT04908800|592068660|FG010|Overall Study|Adverse Event|1|||
163917594|NCT04908800|592068661|FG011|Overall Study|Adverse Event|0|||
163917595|NCT04908800|592068662|FG012|Overall Study|Adverse Event|0|||
163917596|NCT02162771|592068663|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
163917597|NCT02162771|592068664|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
163917598|NCT02162771|592068663|FG000|Core Study Period (Part 2)|Adverse Event|4|||
163917599|NCT02162771|592068664|FG001|Core Study Period (Part 2)|Adverse Event|1|||
163917600|NCT02162771|592068663|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
163917601|NCT02162771|592068664|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
163917602|NCT02162771|592068663|FG000|Core Study Period (Part 2)|Physician Decision|0|||
163917603|NCT02162771|592068664|FG001|Core Study Period (Part 2)|Physician Decision|2|||
163917604|NCT02162771|592068663|FG000|Core Study Period (Part 2)|Death|1|||
163917605|NCT02162771|592068664|FG001|Core Study Period (Part 2)|Death|0|||
163917606|NCT02162771|592068663|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
163917607|NCT02162771|592068664|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
164096886|NCT02188303|592718982|FG005|Overall Study|Adverse Event|2|||
164096887|NCT02188303|592718983|FG006|Overall Study|Adverse Event|0|||
164096888|NCT02188303|592718984|FG007|Overall Study|Adverse Event|2|||
163917608|NCT02162771|592068663|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
163917609|NCT02162771|592068664|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
163917610|NCT02162771|592068663|FG000|Maintenance Study Period (Part 2)|Death|2|||
163917611|NCT02162771|592068664|FG001|Maintenance Study Period (Part 2)|Death|1|||
163917612|NCT02162771|592068663|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
163917613|NCT02162771|592068664|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
163917614|NCT02162771|592068663|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
163917615|NCT02162771|592068664|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
163917616|NCT02162771|592068663|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
163917617|NCT02162771|592068664|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
163917618|NCT01047306|592068665|FG000|Overall Study|Withdrawal by Subject|2|||
163917619|NCT01047306|592068666|FG001|Overall Study|Withdrawal by Subject|0|||
163917620|NCT01047306|592068665|FG000|Overall Study|Lost to Follow-up|1|||
163917621|NCT01047306|592068666|FG001|Overall Study|Lost to Follow-up|0|||
163917622|NCT03647709|592068668|FG000|Overall Study|Lost to Follow-up|5|||
163917623|NCT03647709|592068668|FG000|Overall Study|Physician Decision|6|||
163917624|NCT03647709|592068668|FG000|Overall Study|Withdrawal by Subject|3|||
163917625|NCT05287178|592068669|FG000|Overall Study|Lost to Follow-up|2|||
163917626|NCT01426217|592068670|FG000|Overall Study|lost sample|8|||
163917627|NCT01426217|592068671|FG001|Overall Study|lost sample|14|||
163917628|NCT01920178|592068672|FG000|Overall Study|Lost to Follow-up|2|||
163917629|NCT01920178|592068673|FG001|Overall Study|Lost to Follow-up|1|||
163917630|NCT03023878|592068674|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
163917631|NCT03023878|592068674|FG000|Pre-Study Run-In Period|Death|1|||
163917632|NCT03023878|592068674|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
163917633|NCT03023878|592068674|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
163917634|NCT03023878|592068674|FG000|Treatment Period|Disease Progression|1|||
163917635|NCT03023878|592068674|FG000|Treatment Period|Withdrawal by Subject|1|||
163917636|NCT03023878|592068674|FG000|Treatment Period|Adverse Event|1|||
163917637|NCT03023878|592068674|FG000|Long Term Follow-Up Period|Death|2|||
163917638|NCT01812837|592068675|FG000|Overall Study|Lost to Follow-up|1|||
163917639|NCT01812837|592068676|FG001|Overall Study|Lost to Follow-up|1|||
163917640|NCT01812837|592068677|FG002|Overall Study|Lost to Follow-up|0|||
163917641|NCT01812837|592068675|FG000|Overall Study|Protocol Violation|1|||
163917642|NCT01812837|592068676|FG001|Overall Study|Protocol Violation|0|||
163917643|NCT01812837|592068677|FG002|Overall Study|Protocol Violation|0|||
163917644|NCT00288353|592068682|FG000|Overall Study|Lack of Efficacy|2|||
163917645|NCT00288353|592068683|FG001|Overall Study|Lack of Efficacy|2|||
163917646|NCT00288353|592068682|FG000|Overall Study|Withdrawal by Subject|5|||
163917647|NCT00288353|592068683|FG001|Overall Study|Withdrawal by Subject|5|||
163917648|NCT05234632|592068684|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
163917649|NCT05234632|592068685|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
163917650|NCT05234632|592068684|FG000|Overall Study|Withdrawal by Subject|2|||
163917651|NCT05234632|592068685|FG001|Overall Study|Withdrawal by Subject|0|||
163917652|NCT05234632|592068684|FG000|Overall Study|Adverse Event|0|||
163917653|NCT05234632|592068685|FG001|Overall Study|Adverse Event|4|||
163917654|NCT05234632|592068684|FG000|Overall Study|Physician Decision|1|||
163917655|NCT05234632|592068685|FG001|Overall Study|Physician Decision|1|||
163917656|NCT05234632|592068684|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
163917657|NCT05234632|592068685|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
163917658|NCT05234632|592068684|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
163917659|NCT05234632|592068685|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
163917660|NCT04799587|592068686|FG000|Overall Study|Withdrawal by Subject|0|||
163917661|NCT04799587|592068687|FG001|Overall Study|Withdrawal by Subject|1|||
163917662|NCT00728884|592068688|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
163917663|NCT00728884|592068688|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
163917664|NCT05216835|592068690|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163917665|NCT05216835|592068691|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163917666|NCT05216835|592068692|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
163917667|NCT05216835|592068693|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
164096889|NCT02188303|592718977|FG000|Overall Study|Dose Termination Criteria Met|0|||
164096890|NCT02188303|592718978|FG001|Overall Study|Dose Termination Criteria Met|0|||
163917668|NCT05216835|592068694|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
163917669|NCT05216835|592068695|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
163917670|NCT05216835|592068696|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
163917671|NCT05216835|592068697|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
164096891|NCT02188303|592718979|FG002|Overall Study|Dose Termination Criteria Met|0|||
163917672|NCT05216835|592068690|FG000|Overall Study|Death|0|||
163917673|NCT05216835|592068691|FG001|Overall Study|Death|0|||
163917674|NCT05216835|592068692|FG002|Overall Study|Death|0|||
163917675|NCT05216835|592068693|FG003|Overall Study|Death|1|||
163917676|NCT05216835|592068694|FG004|Overall Study|Death|1|||
163917677|NCT05216835|592068695|FG005|Overall Study|Death|1|||
163917678|NCT05216835|592068696|FG006|Overall Study|Death|1|||
163917679|NCT05216835|592068697|FG007|Overall Study|Death|1|||
163917680|NCT05216835|592068690|FG000|Overall Study|Physician Decision|0|||
163917681|NCT05216835|592068691|FG001|Overall Study|Physician Decision|0|||
163917682|NCT05216835|592068692|FG002|Overall Study|Physician Decision|0|||
163917683|NCT05216835|592068693|FG003|Overall Study|Physician Decision|0|||
163917684|NCT05216835|592068694|FG004|Overall Study|Physician Decision|0|||
163917685|NCT05216835|592068695|FG005|Overall Study|Physician Decision|1|||
163917686|NCT05216835|592068696|FG006|Overall Study|Physician Decision|1|||
163917687|NCT05216835|592068697|FG007|Overall Study|Physician Decision|0|||
163917688|NCT05216835|592068690|FG000|Overall Study|Study terminated by Sponsor|0|||
163917689|NCT05216835|592068691|FG001|Overall Study|Study terminated by Sponsor|0|||
163917690|NCT05216835|592068692|FG002|Overall Study|Study terminated by Sponsor|0|||
163917691|NCT05216835|592068693|FG003|Overall Study|Study terminated by Sponsor|0|||
163917692|NCT05216835|592068694|FG004|Overall Study|Study terminated by Sponsor|0|||
163917693|NCT05216835|592068695|FG005|Overall Study|Study terminated by Sponsor|0|||
163917694|NCT05216835|592068696|FG006|Overall Study|Study terminated by Sponsor|0|||
163917695|NCT05216835|592068697|FG007|Overall Study|Study terminated by Sponsor|1|||
163917696|NCT05216835|592068690|FG000|Overall Study|Withdrawal by Subject|1|||
163917697|NCT05216835|592068691|FG001|Overall Study|Withdrawal by Subject|0|||
163917698|NCT05216835|592068692|FG002|Overall Study|Withdrawal by Subject|1|||
163917699|NCT05216835|592068693|FG003|Overall Study|Withdrawal by Subject|0|||
163917700|NCT05216835|592068694|FG004|Overall Study|Withdrawal by Subject|1|||
163917701|NCT05216835|592068695|FG005|Overall Study|Withdrawal by Subject|0|||
163917702|NCT05216835|592068696|FG006|Overall Study|Withdrawal by Subject|0|||
163917703|NCT05216835|592068697|FG007|Overall Study|Withdrawal by Subject|1|||
163917704|NCT05216835|592068690|FG000|Overall Study|Other|0|||
163917705|NCT05216835|592068691|FG001|Overall Study|Other|1|||
163917706|NCT05216835|592068692|FG002|Overall Study|Other|0|||
163917707|NCT05216835|592068693|FG003|Overall Study|Other|0|||
163917708|NCT05216835|592068694|FG004|Overall Study|Other|0|||
163917709|NCT05216835|592068695|FG005|Overall Study|Other|0|||
163917710|NCT05216835|592068696|FG006|Overall Study|Other|0|||
163917711|NCT05216835|592068697|FG007|Overall Study|Other|0|||
163917712|NCT02849509|592068698|FG000|Overall Study|Worsening of disease under study|1|||
163917713|NCT02849509|592068699|FG001|Overall Study|Worsening of disease under study|1|||
163917714|NCT02849509|592068700|FG002|Overall Study|Worsening of disease under study|1|||
163917715|NCT02849509|592068698|FG000|Overall Study|Worsening of other pre-existing disease|0|||
163917716|NCT02849509|592068699|FG001|Overall Study|Worsening of other pre-existing disease|1|||
163917717|NCT02849509|592068700|FG002|Overall Study|Worsening of other pre-existing disease|2|||
163917718|NCT02849509|592068698|FG000|Overall Study|Other adverse event|36|||
163917719|NCT02849509|592068699|FG001|Overall Study|Other adverse event|41|||
163917720|NCT02849509|592068700|FG002|Overall Study|Other adverse event|8|||
163917721|NCT02849509|592068698|FG000|Overall Study|Withdrawal by Subject|6|||
163917722|NCT02849509|592068699|FG001|Overall Study|Withdrawal by Subject|17|||
163917723|NCT02849509|592068700|FG002|Overall Study|Withdrawal by Subject|12|||
163917724|NCT02849509|592068698|FG000|Overall Study|Lost to Follow-up|27|||
163917725|NCT02849509|592068699|FG001|Overall Study|Lost to Follow-up|67|||
163917726|NCT02849509|592068700|FG002|Overall Study|Lost to Follow-up|36|||
163917727|NCT02849509|592068698|FG000|Overall Study|Other, reason not specified|14|||
163917728|NCT02849509|592068699|FG001|Overall Study|Other, reason not specified|29|||
163917729|NCT02849509|592068700|FG002|Overall Study|Other, reason not specified|25|||
163917730|NCT02849509|592068698|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
163917731|NCT02849509|592068699|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
163917732|NCT02849509|592068700|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
163917733|NCT04930445|592068701|FG000|Overall Study|Adverse Event|7|||
164030123|NCT00264849|592468890|FG001|Overall Study|Withdrawal by Subject|11|||
164030124|NCT00264849|592468889|FG000|Overall Study|Protocol Violation|5|||
163917734|NCT04930445|592068701|FG000|Overall Study|Lost to Follow-up|1|||
163917735|NCT04930445|592068701|FG000|Overall Study|Physician Decision|1|||
163917736|NCT04930445|592068701|FG000|Overall Study|Lack of Efficacy|1|||
163917737|NCT04930445|592068701|FG000|Overall Study|Study Terminated by Sponsor|245|||
163917738|NCT04930445|592068701|FG000|Overall Study|Screen Failure|8|||
163917739|NCT04930445|592068701|FG000|Overall Study|Other|2|||
163917740|NCT00975130|592068702|FG000|Study Part 1|Adverse Event|150|||
163917741|NCT00975130|592068703|FG001|Study Part 1|Adverse Event|0|||
164030125|NCT00264849|592468890|FG001|Overall Study|Protocol Violation|3|||
163917742|NCT00975130|592068704|FG002|Study Part 1|Adverse Event|0|||
163917743|NCT00975130|592068702|FG000|Study Part 1|Lost to Follow-up|19|||
163917744|NCT00975130|592068703|FG001|Study Part 1|Lost to Follow-up|0|||
163917745|NCT00975130|592068704|FG002|Study Part 1|Lost to Follow-up|0|||
164030126|NCT00264849|592468889|FG000|Overall Study|Lack of Efficacy|1|||
164030127|NCT00264849|592468890|FG001|Overall Study|Lack of Efficacy|6|||
163917746|NCT00975130|592068702|FG000|Study Part 1|Withdrawal by Subject|61|||
163917747|NCT00975130|592068703|FG001|Study Part 1|Withdrawal by Subject|0|||
163917748|NCT00975130|592068704|FG002|Study Part 1|Withdrawal by Subject|0|||
163917749|NCT00975130|592068702|FG000|Study Part 1|Protocol Violation|13|||
163917750|NCT00975130|592068703|FG001|Study Part 1|Protocol Violation|0|||
163917751|NCT00975130|592068704|FG002|Study Part 1|Protocol Violation|0|||
163917752|NCT00975130|592068702|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
163917753|NCT00975130|592068703|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
163917754|NCT00975130|592068704|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
163917755|NCT00975130|592068702|FG000|Study Part 1|Administrative|4|||
163917756|NCT00975130|592068703|FG001|Study Part 1|Administrative|0|||
163917757|NCT00975130|592068704|FG002|Study Part 1|Administrative|0|||
163917758|NCT00975130|592068702|FG000|Study Part 1|Withdrew Consent|24|||
163917759|NCT00975130|592068703|FG001|Study Part 1|Withdrew Consent|0|||
163917760|NCT00975130|592068704|FG002|Study Part 1|Withdrew Consent|0|||
163917761|NCT00975130|592068702|FG000|Study Part 2|Adverse Event|0|||
163917762|NCT00975130|592068703|FG001|Study Part 2|Adverse Event|14|||
163917763|NCT00975130|592068704|FG002|Study Part 2|Adverse Event|7|||
163917764|NCT00975130|592068702|FG000|Study Part 2|Lost to Follow-up|0|||
163917765|NCT00975130|592068703|FG001|Study Part 2|Lost to Follow-up|0|||
163917766|NCT00975130|592068704|FG002|Study Part 2|Lost to Follow-up|1|||
163917767|NCT00975130|592068702|FG000|Study Part 2|Withdrawal by Subject|0|||
163917768|NCT00975130|592068703|FG001|Study Part 2|Withdrawal by Subject|13|||
163917769|NCT00975130|592068704|FG002|Study Part 2|Withdrawal by Subject|5|||
163917770|NCT00975130|592068702|FG000|Study Part 2|Withdrew Consent|0|||
163917771|NCT00975130|592068703|FG001|Study Part 2|Withdrew Consent|6|||
163917772|NCT00975130|592068704|FG002|Study Part 2|Withdrew Consent|2|||
163917773|NCT00975130|592068702|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
163917774|NCT00975130|592068703|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
163917775|NCT00975130|592068704|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
163917776|NCT00975130|592068702|FG000|Study Part 2|Administrative|0|||
163917777|NCT00975130|592068703|FG001|Study Part 2|Administrative|1|||
163917778|NCT00975130|592068704|FG002|Study Part 2|Administrative|0|||
163917779|NCT00975130|592068702|FG000|Study Part 2|Protocol Violation|0|||
163917780|NCT00975130|592068703|FG001|Study Part 2|Protocol Violation|0|||
163917781|NCT00975130|592068704|FG002|Study Part 2|Protocol Violation|1|||
163917782|NCT00617708|592068705|FG000|Overall Study|Adverse Event|0|||
163917783|NCT00617708|592068706|FG001|Overall Study|Adverse Event|6|||
163917784|NCT00617708|592068707|FG002|Overall Study|Adverse Event|9|||
163917785|NCT00617708|592068705|FG000|Overall Study|Withdrawal by Subject|1|||
163917786|NCT00617708|592068706|FG001|Overall Study|Withdrawal by Subject|1|||
163917787|NCT00617708|592068707|FG002|Overall Study|Withdrawal by Subject|7|||
163917788|NCT00617708|592068705|FG000|Overall Study|Death|0|||
163917789|NCT00617708|592068706|FG001|Overall Study|Death|6|||
163917790|NCT00617708|592068707|FG002|Overall Study|Death|5|||
163917791|NCT00617708|592068705|FG000|Overall Study|Progression/Relapse|7|||
163917792|NCT00617708|592068706|FG001|Overall Study|Progression/Relapse|40|||
163917793|NCT00617708|592068707|FG002|Overall Study|Progression/Relapse|36|||
163917794|NCT00617708|592068705|FG000|Overall Study|Not protocol specified|1|||
163917795|NCT00617708|592068706|FG001|Overall Study|Not protocol specified|4|||
163917796|NCT00617708|592068707|FG002|Overall Study|Not protocol specified|2|||
163917797|NCT00617708|592068705|FG000|Overall Study|Not eligible|1|||
163917798|NCT00617708|592068706|FG001|Overall Study|Not eligible|3|||
163917799|NCT00617708|592068707|FG002|Overall Study|Not eligible|5|||
163917800|NCT01075815|592068708|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
163917801|NCT01075815|592068709|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
163917802|NCT01075815|592068708|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
163917803|NCT01075815|592068709|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
163917804|NCT01075815|592068708|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
163917805|NCT01075815|592068709|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
163917806|NCT01261793|592068716|FG000|Overall Study|Lack of Efficacy|44|||
163917807|NCT01261793|592068717|FG001|Overall Study|Lack of Efficacy|37|||
163917808|NCT01261793|592068718|FG002|Overall Study|Lack of Efficacy|32|||
163917809|NCT01261793|592068716|FG000|Overall Study|Protocol Violation|3|||
163917810|NCT01261793|592068717|FG001|Overall Study|Protocol Violation|5|||
164030128|NCT00264849|592468889|FG000|Overall Study|Lost to Follow-up|0|||
164030129|NCT00264849|592468890|FG001|Overall Study|Lost to Follow-up|2|||
164030130|NCT00264849|592468889|FG000|Overall Study|Death|0|||
163917811|NCT01261793|592068718|FG002|Overall Study|Protocol Violation|6|||
163917812|NCT01261793|592068716|FG000|Overall Study|Lost to Follow-up|10|||
163917813|NCT01261793|592068717|FG001|Overall Study|Lost to Follow-up|3|||
163917814|NCT01261793|592068718|FG002|Overall Study|Lost to Follow-up|7|||
163917815|NCT01261793|592068716|FG000|Overall Study|Withdrawal by Subject|12|||
163917816|NCT01261793|592068717|FG001|Overall Study|Withdrawal by Subject|14|||
163917817|NCT01261793|592068718|FG002|Overall Study|Withdrawal by Subject|14|||
163917818|NCT01261793|592068716|FG000|Overall Study|Death|3|||
163917819|NCT01261793|592068717|FG001|Overall Study|Death|1|||
163917820|NCT01261793|592068718|FG002|Overall Study|Death|0|||
164030131|NCT00264849|592468890|FG001|Overall Study|Death|1|||
164030132|NCT00264849|592468889|FG000|Overall Study|Administrative Problems|2|||
164030133|NCT00264849|592468890|FG001|Overall Study|Administrative Problems|0|||
164030134|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
164030135|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
164030136|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
163917821|NCT01261793|592068716|FG000|Overall Study|Adverse Event|9|||
163917822|NCT01261793|592068717|FG001|Overall Study|Adverse Event|24|||
163917823|NCT01261793|592068718|FG002|Overall Study|Adverse Event|19|||
163917824|NCT01261793|592068716|FG000|Overall Study|Patient non-availability|1|||
163917825|NCT01261793|592068717|FG001|Overall Study|Patient non-availability|1|||
163917826|NCT01261793|592068718|FG002|Overall Study|Patient non-availability|1|||
163917827|NCT01261793|592068716|FG000|Overall Study|Suspected pregnancy|1|||
163917828|NCT01261793|592068717|FG001|Overall Study|Suspected pregnancy|1|||
163917829|NCT01261793|592068718|FG002|Overall Study|Suspected pregnancy|0|||
163917830|NCT01261793|592068716|FG000|Overall Study|Patient non-compliance|1|||
163917831|NCT01261793|592068717|FG001|Overall Study|Patient non-compliance|0|||
163917832|NCT01261793|592068718|FG002|Overall Study|Patient non-compliance|1|||
163917833|NCT01261793|592068716|FG000|Overall Study|Patient pregnant|1|||
163917834|NCT01261793|592068717|FG001|Overall Study|Patient pregnant|0|||
163917835|NCT01261793|592068718|FG002|Overall Study|Patient pregnant|0|||
163917836|NCT01261793|592068716|FG000|Overall Study|Outside the study area|0|||
163917837|NCT01261793|592068717|FG001|Overall Study|Outside the study area|2|||
163917838|NCT01261793|592068718|FG002|Overall Study|Outside the study area|1|||
163917839|NCT01261793|592068716|FG000|Overall Study|Lack of efficacy & patient not available|0|||
163917840|NCT01261793|592068717|FG001|Overall Study|Lack of efficacy & patient not available|1|||
163917841|NCT01261793|592068718|FG002|Overall Study|Lack of efficacy & patient not available|0|||
163917842|NCT01261793|592068716|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
163917843|NCT01261793|592068717|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
163917844|NCT01261793|592068718|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
163917845|NCT01261793|592068716|FG000|Overall Study|Randomization error|0|||
163917846|NCT01261793|592068717|FG001|Overall Study|Randomization error|1|||
163917847|NCT01261793|592068718|FG002|Overall Study|Randomization error|0|||
163917848|NCT01261793|592068716|FG000|Overall Study|Patient unable to start IV line|0|||
163917849|NCT01261793|592068717|FG001|Overall Study|Patient unable to start IV line|0|||
163917850|NCT01261793|592068718|FG002|Overall Study|Patient unable to start IV line|1|||
163917851|NCT02374476|592068721|FG000|VT Induced Ablation|Screening Failures|36|||
163917852|NCT02374476|592068722|FG001|VT Induced Ablation|Screening Failures|0|||
163917853|NCT02374476|592068723|FG002|VT Induced Ablation|Screening Failures|0|||
163917854|NCT02374476|592068721|FG000|Arm Assignment|Withdrawal by Subject|0|||
163917855|NCT02374476|592068722|FG001|Arm Assignment|Withdrawal by Subject|0|||
163917856|NCT02374476|592068723|FG002|Arm Assignment|Withdrawal by Subject|1|||
163917857|NCT05431543|592068726|FG000|Overall Study|Medical History|1|||
163917858|NCT05431543|592068727|FG001|Overall Study|Medical History|0|||
163917859|NCT05431543|592068728|FG002|Overall Study|Medical History|0|||
163917860|NCT02924051|592068729|FG000|Overall Study|Withdrawal by Subject|1|||
163917861|NCT02924051|592068730|FG001|Overall Study|Withdrawal by Subject|9|||
163917862|NCT02784535|592068731|FG000|Overall Study|Adverse Event|1|||
163917863|NCT02784535|592068732|FG001|Overall Study|Adverse Event|0|||
163917864|NCT02784535|592068731|FG000|Overall Study|Withdrawal by Subject|0|||
163917865|NCT02784535|592068732|FG001|Overall Study|Withdrawal by Subject|1|||
163917866|NCT02784535|592068731|FG000|Overall Study|Physician Decision|0|||
163917867|NCT02784535|592068732|FG001|Overall Study|Physician Decision|1|||
163917868|NCT00914732|592068733|FG000|Overall Study|Lost to Follow-up|6|||
163917869|NCT00914732|592068734|FG001|Overall Study|Lost to Follow-up|7|||
163917870|NCT00914732|592068735|FG002|Overall Study|Lost to Follow-up|9|||
163917871|NCT00914732|592068733|FG000|Overall Study|Withdrawal by Subject|3|||
164030137|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
164030138|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
164030139|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
164030140|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164030141|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
164030142|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
164030143|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
164030144|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
164030145|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
163917872|NCT00914732|592068734|FG001|Overall Study|Withdrawal by Subject|0|||
163917873|NCT00914732|592068735|FG002|Overall Study|Withdrawal by Subject|2|||
163917874|NCT00914732|592068733|FG000|Overall Study|Adverse Event|1|||
163917875|NCT00914732|592068734|FG001|Overall Study|Adverse Event|0|||
163917876|NCT00914732|592068735|FG002|Overall Study|Adverse Event|0|||
163917877|NCT02130401|592068736|FG000|Overall Study|Poor enrollment|6|||
163917878|NCT03005106|592068737|FG000|Overall Study|Lost to Follow-up|16|||
163917879|NCT03005106|592068737|FG000|Overall Study|Adverse Event|1|||
164073168|NCT01347879|592632837|FG001|Overall Study|Adverse Event|12|||
163917880|NCT03005106|592068737|FG000|Overall Study|Physician Decision|1|||
163917881|NCT03005106|592068737|FG000|Overall Study|Death|2|||
163917882|NCT00321672|592068740|FG000|Overall Study|Withdrawal by Subject|5|||
163917883|NCT00321672|592068741|FG001|Overall Study|Withdrawal by Subject|1|||
164030146|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
164030147|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
164030148|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
164030149|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
164030150|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
164030151|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
164030152|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
164030153|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
164030154|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
164030155|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
164030156|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
164030157|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
164030158|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
164030159|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
164030160|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
164030161|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
164030162|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
164030163|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
164030164|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
164030165|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
164030166|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
164030167|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
164030168|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
164030169|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
164030170|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
164030171|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
164030172|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
164030173|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
164030174|NCT00383721|592468894|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
164030175|NCT00383721|592468895|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
164030176|NCT00383721|592468896|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
164030177|NCT00383721|592468897|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
164030178|NCT00383721|592468898|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
164030179|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
164030180|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
164030181|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
164030182|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
164030183|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
164030184|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
164030185|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
164030186|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
164030187|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
164030188|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
164030189|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
164030190|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164030191|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164030192|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
164030193|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
164030194|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
164030195|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
164030196|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
164030197|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
164030198|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
164030199|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164096892|NCT02188303|592718980|FG003|Overall Study|Dose Termination Criteria Met|0|||
164096893|NCT02188303|592718981|FG004|Overall Study|Dose Termination Criteria Met|0|||
164146444|NCT05026177|592898059|FG001|Overall Study|Lost to Follow-up|6|||
163917884|NCT00321672|592068742|FG002|Overall Study|Withdrawal by Subject|2|||
163917885|NCT00321672|592068743|FG003|Overall Study|Withdrawal by Subject|0|||
163917886|NCT00321672|592068740|FG000|Overall Study|Noncompliance|1|||
163917887|NCT00321672|592068741|FG001|Overall Study|Noncompliance|2|||
163917888|NCT00321672|592068742|FG002|Overall Study|Noncompliance|1|||
163917889|NCT00321672|592068743|FG003|Overall Study|Noncompliance|0|||
163917890|NCT00321672|592068740|FG000|Overall Study|Adverse Event|1|||
163917891|NCT00321672|592068741|FG001|Overall Study|Adverse Event|1|||
163917892|NCT00321672|592068742|FG002|Overall Study|Adverse Event|0|||
163917893|NCT00321672|592068743|FG003|Overall Study|Adverse Event|0|||
163917894|NCT00321672|592068740|FG000|Overall Study|Lack of Efficacy|1|||
163917895|NCT00321672|592068741|FG001|Overall Study|Lack of Efficacy|1|||
163917896|NCT00321672|592068742|FG002|Overall Study|Lack of Efficacy|0|||
163917897|NCT00321672|592068743|FG003|Overall Study|Lack of Efficacy|0|||
163917898|NCT00321672|592068740|FG000|Overall Study|Lost to Follow-up|2|||
163917899|NCT00321672|592068741|FG001|Overall Study|Lost to Follow-up|0|||
164030200|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164030201|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
164030202|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
163917900|NCT00321672|592068742|FG002|Overall Study|Lost to Follow-up|4|||
163917901|NCT00321672|592068743|FG003|Overall Study|Lost to Follow-up|2|||
163917902|NCT00321672|592068740|FG000|Overall Study|Death|1|||
163917903|NCT00321672|592068741|FG001|Overall Study|Death|0|||
163917904|NCT00321672|592068742|FG002|Overall Study|Death|0|||
163917905|NCT00321672|592068743|FG003|Overall Study|Death|0|||
163917906|NCT00321672|592068740|FG000|Overall Study|Too far to travel for visits|1|||
163917907|NCT00321672|592068741|FG001|Overall Study|Too far to travel for visits|0|||
163917908|NCT00321672|592068742|FG002|Overall Study|Too far to travel for visits|0|||
163917909|NCT00321672|592068743|FG003|Overall Study|Too far to travel for visits|0|||
163917910|NCT00321672|592068740|FG000|Overall Study|Incarcerated|0|||
163917911|NCT00321672|592068741|FG001|Overall Study|Incarcerated|0|||
163917912|NCT00321672|592068742|FG002|Overall Study|Incarcerated|2|||
163917913|NCT00321672|592068743|FG003|Overall Study|Incarcerated|0|||
163917914|NCT00321672|592068740|FG000|Overall Study|Moved out of state|0|||
163917915|NCT00321672|592068741|FG001|Overall Study|Moved out of state|1|||
163917916|NCT00321672|592068742|FG002|Overall Study|Moved out of state|1|||
163917917|NCT00321672|592068743|FG003|Overall Study|Moved out of state|0|||
163917918|NCT00321672|592068740|FG000|Overall Study|Protocol Violation|0|||
163917919|NCT00321672|592068741|FG001|Overall Study|Protocol Violation|0|||
163917920|NCT00321672|592068742|FG002|Overall Study|Protocol Violation|1|||
163917921|NCT00321672|592068743|FG003|Overall Study|Protocol Violation|0|||
163917922|NCT00321672|592068740|FG000|Overall Study|Diagnosis of testicular cancer|0|||
163917923|NCT00321672|592068741|FG001|Overall Study|Diagnosis of testicular cancer|1|||
163917924|NCT00321672|592068742|FG002|Overall Study|Diagnosis of testicular cancer|0|||
163917925|NCT00321672|592068743|FG003|Overall Study|Diagnosis of testicular cancer|0|||
163917926|NCT00321672|592068740|FG000|Overall Study|Extensive travel required for new job|0|||
163917927|NCT00321672|592068741|FG001|Overall Study|Extensive travel required for new job|1|||
163917928|NCT00321672|592068742|FG002|Overall Study|Extensive travel required for new job|0|||
163917929|NCT00321672|592068743|FG003|Overall Study|Extensive travel required for new job|0|||
163917930|NCT00512902|592068744|FG000|Overall Study|Adverse Event|7|||
163917931|NCT00512902|592068744|FG000|Overall Study|Lost to Follow-up|1|||
163917932|NCT02389894|592068745|FG000|Overall Study|Death|4|||
163917933|NCT02389894|592068746|FG001|Overall Study|Death|5|||
163917934|NCT02389894|592068747|FG002|Overall Study|Death|3|||
163917935|NCT02389894|592068745|FG000|Overall Study|Withdrawal by Subject|2|||
163917936|NCT02389894|592068746|FG001|Overall Study|Withdrawal by Subject|4|||
164030203|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
164030204|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
164030205|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
164030206|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
163917937|NCT02389894|592068747|FG002|Overall Study|Withdrawal by Subject|5|||
163917938|NCT02389894|592068745|FG000|Overall Study|Lost to Follow-up|2|||
163917939|NCT02389894|592068746|FG001|Overall Study|Lost to Follow-up|1|||
163917940|NCT02389894|592068747|FG002|Overall Study|Lost to Follow-up|1|||
163917941|NCT00145496|592068748|FG000|Overall Study|Adverse Event|42|||
163917942|NCT00145496|592068749|FG001|Overall Study|Adverse Event|30|||
163917943|NCT00145496|592068748|FG000|Overall Study|Lack of Efficacy|12|||
163917944|NCT00145496|592068749|FG001|Overall Study|Lack of Efficacy|7|||
163917945|NCT00145496|592068748|FG000|Overall Study|Withdrawal by Subject|32|||
163917946|NCT00145496|592068749|FG001|Overall Study|Withdrawal by Subject|26|||
163917947|NCT00145496|592068748|FG000|Overall Study|Lost to Follow-up|12|||
163917948|NCT00145496|592068749|FG001|Overall Study|Lost to Follow-up|5|||
163917949|NCT00145496|592068748|FG000|Overall Study|Other|25|||
163917950|NCT00145496|592068749|FG001|Overall Study|Other|13|||
163917951|NCT01429285|592068754|FG000|Overall Study|Protocol Violation|9|||
163917952|NCT01429285|592068755|FG001|Overall Study|Protocol Violation|4|||
163917953|NCT01429285|592068754|FG000|Overall Study|Missing Data|5|||
163917954|NCT01429285|592068755|FG001|Overall Study|Missing Data|3|||
163917955|NCT01429285|592068754|FG000|Overall Study|Erroneously Enrolled Twice|8|||
163917956|NCT01429285|592068755|FG001|Overall Study|Erroneously Enrolled Twice|2|||
163917957|NCT00990314|592068758|FG000|Overall Study|Death|2|||
163917958|NCT00990314|592068758|FG000|Overall Study|Adverse Event|2|||
163917959|NCT00990314|592068758|FG000|Overall Study|Withdrawal by Subject|3|||
163917960|NCT00990314|592068758|FG000|Overall Study|Non-Compliance|1|||
163917961|NCT00990314|592068758|FG000|Overall Study|Physician Decision|3|||
163917962|NCT00990314|592068758|FG000|Overall Study|Lack of Efficacy|1|||
163917963|NCT02676778|592068761|FG000|Overall Study|Disease Progression|7|||
163917964|NCT02676778|592068762|FG001|Overall Study|Disease Progression|3|||
163917965|NCT02676778|592068763|FG002|Overall Study|Disease Progression|1|||
163917966|NCT02676778|592068761|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
163917967|NCT02676778|592068762|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
163917968|NCT02676778|592068763|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
163917969|NCT02676778|592068761|FG000|Overall Study|Withdrawal by Subject|3|||
163917970|NCT02676778|592068762|FG001|Overall Study|Withdrawal by Subject|2|||
163917971|NCT02676778|592068763|FG002|Overall Study|Withdrawal by Subject|0|||
163917972|NCT02676778|592068761|FG000|Overall Study|Other|4|||
163917973|NCT02676778|592068762|FG001|Overall Study|Other|3|||
163917974|NCT02676778|592068763|FG002|Overall Study|Other|0|||
163917975|NCT02676778|592068761|FG000|Overall Study|Adverse Event|2|||
163917976|NCT02676778|592068762|FG001|Overall Study|Adverse Event|3|||
164030207|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
164030208|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
164030209|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164030210|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164030211|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164030212|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
164030213|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
164030214|NCT00383721|592468894|FG000|26-Week Treatment Safety Extension|Administrative|1|||
164030215|NCT00383721|592468895|FG001|26-Week Treatment Safety Extension|Administrative|2|||
164030216|NCT00383721|592468896|FG002|26-Week Treatment Safety Extension|Administrative|3|||
164030217|NCT00383721|592468897|FG003|26-Week Treatment Safety Extension|Administrative|1|||
164030218|NCT00383721|592468898|FG004|26-Week Treatment Safety Extension|Administrative|0|||
164030219|NCT00781963|592470538|FG000|Overall Study|Death|3|||
164030220|NCT00781963|592470539|FG001|Overall Study|Death|0|||
164030221|NCT00781963|592470538|FG000|Overall Study|Lost to Follow-up|2|||
164030222|NCT00781963|592470539|FG001|Overall Study|Lost to Follow-up|1|||
164030223|NCT00781963|592470538|FG000|Overall Study|Withdrawal by Subject|3|||
164030224|NCT00781963|592470539|FG001|Overall Study|Withdrawal by Subject|1|||
164030225|NCT00781963|592470538|FG000|Overall Study|Refused follow-up|9|||
164030226|NCT00781963|592470539|FG001|Overall Study|Refused follow-up|0|||
164030227|NCT02700919|592470540|FG000|Overall Study|Physician Decision|1|||
164030228|NCT02700919|592470541|FG001|Overall Study|Physician Decision|0|||
164030229|NCT02700919|592470542|FG002|Overall Study|Physician Decision|0|||
164030230|NCT02700919|592470540|FG000|Overall Study|Protocol Violation|1|||
164030231|NCT02700919|592470541|FG001|Overall Study|Protocol Violation|0|||
164030232|NCT02700919|592470542|FG002|Overall Study|Protocol Violation|0|||
164030233|NCT02700919|592470540|FG000|Overall Study|Adverse Event|1|||
164030234|NCT02700919|592470541|FG001|Overall Study|Adverse Event|3|||
164030235|NCT02700919|592470542|FG002|Overall Study|Adverse Event|1|||
164030236|NCT02700919|592470540|FG000|Overall Study|Withdrawal by Subject|5|||
163917977|NCT02676778|592068763|FG002|Overall Study|Adverse Event|0|||
163917978|NCT00925288|592070226|FG000|Overall Study|Lost to Follow-up|9|||
163917979|NCT00925288|592070227|FG001|Overall Study|Lost to Follow-up|7|||
163917980|NCT02151643|592070228|FG000|Overall Study|Adverse Event|2|||
163917981|NCT02151643|592070229|FG001|Overall Study|Adverse Event|0|||
164030237|NCT02700919|592470541|FG001|Overall Study|Withdrawal by Subject|8|||
164030238|NCT02700919|592470542|FG002|Overall Study|Withdrawal by Subject|2|||
164030239|NCT02700919|592470540|FG000|Overall Study|Lost to Follow-up|2|||
164030240|NCT02700919|592470541|FG001|Overall Study|Lost to Follow-up|0|||
164030241|NCT02700919|592470542|FG002|Overall Study|Lost to Follow-up|0|||
164030242|NCT02700919|592470540|FG000|Overall Study|Other|2|||
164030243|NCT02700919|592470541|FG001|Overall Study|Other|1|||
164030244|NCT02700919|592470542|FG002|Overall Study|Other|1|||
164030245|NCT00132314|592470545|FG000|Overall Study|Lost to Follow-up|70|||
164030246|NCT00132314|592470546|FG001|Overall Study|Lost to Follow-up|62|||
164030247|NCT00132314|592470545|FG000|Overall Study|Lacked SSN|1|||
164030248|NCT00132314|592470546|FG001|Overall Study|Lacked SSN|3|||
164030249|NCT00132314|592470545|FG000|Overall Study|Refused intervention at baseline|2|||
164073169|NCT01347879|592632836|FG000|Overall Study|Lost to Follow-up|2|||
164073170|NCT01347879|592632837|FG001|Overall Study|Lost to Follow-up|0|||
163917982|NCT02151643|592070230|FG002|Overall Study|Adverse Event|1|||
163917983|NCT02151643|592070231|FG003|Overall Study|Adverse Event|4|||
163917984|NCT02151643|592070232|FG004|Overall Study|Adverse Event|0|||
163917985|NCT02151643|592070228|FG000|Overall Study|Withdrawal by Subject|0|||
164030250|NCT00132314|592470546|FG001|Overall Study|Refused intervention at baseline|7|||
164030251|NCT01653158|592470560|FG000|Overall Study|Death|0|||
164030252|NCT01653158|592470561|FG001|Overall Study|Death|0|||
164030253|NCT01653158|592470562|FG002|Overall Study|Death|0|||
164030254|NCT01653158|592470563|FG003|Overall Study|Death|1|||
164030255|NCT01653158|592470564|FG004|Overall Study|Death|0|||
164030256|NCT01653158|592470565|FG005|Overall Study|Death|0|||
164030257|NCT01653158|592470566|FG006|Overall Study|Death|0|||
164030258|NCT01653158|592470567|FG007|Overall Study|Death|2|||
164030259|NCT01653158|592470560|FG000|Overall Study|Adverse Event|0|||
164030260|NCT01653158|592470561|FG001|Overall Study|Adverse Event|0|||
164030261|NCT01653158|592470562|FG002|Overall Study|Adverse Event|0|||
164030262|NCT01653158|592470563|FG003|Overall Study|Adverse Event|1|||
164030263|NCT01653158|592470564|FG004|Overall Study|Adverse Event|0|||
164030264|NCT01653158|592470565|FG005|Overall Study|Adverse Event|0|||
164030265|NCT01653158|592470566|FG006|Overall Study|Adverse Event|0|||
164030266|NCT01653158|592470567|FG007|Overall Study|Adverse Event|3|||
164030267|NCT01653158|592470560|FG000|Overall Study|Other|0|||
164030268|NCT01653158|592470561|FG001|Overall Study|Other|0|||
164030269|NCT01653158|592470562|FG002|Overall Study|Other|0|||
164030270|NCT01653158|592470563|FG003|Overall Study|Other|0|||
164030271|NCT01653158|592470564|FG004|Overall Study|Other|0|||
164030272|NCT01653158|592470565|FG005|Overall Study|Other|0|||
164030273|NCT01653158|592470566|FG006|Overall Study|Other|0|||
164030274|NCT01653158|592470567|FG007|Overall Study|Other|1|||
164030275|NCT01653158|592470560|FG000|Overall Study|Progressive disease|0|||
164030276|NCT01653158|592470561|FG001|Overall Study|Progressive disease|0|||
164030277|NCT01653158|592470562|FG002|Overall Study|Progressive disease|0|||
164030278|NCT01653158|592470563|FG003|Overall Study|Progressive disease|0|||
164030279|NCT01653158|592470564|FG004|Overall Study|Progressive disease|1|||
164030280|NCT01653158|592470565|FG005|Overall Study|Progressive disease|1|||
164030281|NCT01653158|592470566|FG006|Overall Study|Progressive disease|2|||
164030282|NCT01653158|592470567|FG007|Overall Study|Progressive disease|9|||
164030283|NCT01653158|592470560|FG000|Overall Study|Withdrawal by Subject|1|||
164030284|NCT01653158|592470561|FG001|Overall Study|Withdrawal by Subject|0|||
164030285|NCT01653158|592470562|FG002|Overall Study|Withdrawal by Subject|0|||
164030286|NCT01653158|592470563|FG003|Overall Study|Withdrawal by Subject|0|||
164030287|NCT01653158|592470564|FG004|Overall Study|Withdrawal by Subject|0|||
164030288|NCT01653158|592470565|FG005|Overall Study|Withdrawal by Subject|0|||
164030289|NCT01653158|592470566|FG006|Overall Study|Withdrawal by Subject|0|||
164030290|NCT01653158|592470567|FG007|Overall Study|Withdrawal by Subject|0|||
164030291|NCT03819218|592470570|FG000|Overall Study|Protocol Violation|1|||
164030292|NCT04116073|592470574|FG000|Overall Study|Withdrawal by Subject|2|||
164030293|NCT04116073|592470574|FG000|Overall Study|failed to maintained eligibility|1|||
164030294|NCT03779334|592470578|FG000|Overall Study|Withdrawal by Subject|3|||
164030295|NCT03779334|592470579|FG001|Overall Study|Withdrawal by Subject|0|||
164030296|NCT03779334|592470580|FG002|Overall Study|Withdrawal by Subject|0|||
164030297|NCT03779334|592470578|FG000|Overall Study|Ongoing in Study|5|||
164030298|NCT03779334|592470579|FG001|Overall Study|Ongoing in Study|13|||
164030299|NCT03779334|592470580|FG002|Overall Study|Ongoing in Study|5|||
164030300|NCT01840228|592470587|FG000|Overall Study|Lost to Follow-up|1|||
164030301|NCT01840228|592470588|FG001|Overall Study|Lost to Follow-up|1|||
164030302|NCT02022033|592470591|FG000|Overall Study|Physician Decision|1|||
164030303|NCT01413542|592470592|FG000|Overall Study|Physician Decision|1|||
164030304|NCT01413542|592470593|FG001|Overall Study|Physician Decision|0|||
164030305|NCT01413542|592470594|FG002|Overall Study|Physician Decision|3|||
164030306|NCT01413542|592470595|FG003|Overall Study|Physician Decision|0|||
164030307|NCT01413542|592470592|FG000|Overall Study|Adverse Event|0|||
164030308|NCT01413542|592470593|FG001|Overall Study|Adverse Event|0|||
164030309|NCT01413542|592470594|FG002|Overall Study|Adverse Event|0|||
164030310|NCT01413542|592470595|FG003|Overall Study|Adverse Event|1|||
164030311|NCT05590767|592470600|FG000|Overall Study|Protocol Violation|1|||
164030312|NCT05590767|592470600|FG000|Overall Study|surgery canceled|1|||
164030313|NCT05590767|592470600|FG000|Overall Study|interscalene brachial block not performed|1|||
164030314|NCT02767856|592470611|FG000|Overall Study|Lost to Follow-up|9|||
164030315|NCT02767856|592470612|FG001|Overall Study|Lost to Follow-up|1|||
164030316|NCT02767856|592470611|FG000|Overall Study|Withdrawal by Subject|2|||
164030317|NCT02767856|592470612|FG001|Overall Study|Withdrawal by Subject|1|||
164030318|NCT00304915|592470615|FG000|Overall Study|Lost to Follow-up|11|||
164030319|NCT00304915|592470616|FG001|Overall Study|Lost to Follow-up|11|||
164030320|NCT00304915|592470615|FG000|Overall Study|Death|4|||
164030321|NCT00304915|592470616|FG001|Overall Study|Death|5|||
164030322|NCT00304915|592470615|FG000|Overall Study|Withdrawal by Subject|3|||
164030323|NCT00304915|592470616|FG001|Overall Study|Withdrawal by Subject|0|||
164030324|NCT02029638|592470617|FG000|Overall Study|Death|0|||
164030325|NCT02029638|592470618|FG001|Overall Study|Death|0|||
164030326|NCT02029638|592470619|FG002|Overall Study|Death|1|||
164030327|NCT02029638|592470617|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
164030328|NCT02029638|592470618|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
164030329|NCT02029638|592470619|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
164030330|NCT05489081|592470622|FG000|Overall Study|student left classroom|0|||
164030331|NCT05489081|592470623|FG001|Overall Study|student left classroom|1|||
164030332|NCT05489081|592470622|FG000|Overall Study|teacher left school|0|||
164030333|NCT05489081|592470623|FG001|Overall Study|teacher left school|2|||
164030334|NCT00973921|592470626|FG000|Overall Study|IVUS results were not available|9|||
164030335|NCT00125190|592470627|FG000|Overall Study|Subject/Parent Decision|7|||
164030336|NCT00125190|592470627|FG000|Overall Study|Non-compliance|2|||
164030337|NCT00125190|592470627|FG000|Overall Study|Adverse Event|1|||
164030338|NCT00125190|592470627|FG000|Overall Study|Other|1|||
164030339|NCT00125190|592470627|FG000|Overall Study|Lost to Follow-up|4|||
164030340|NCT00414960|592470628|FG000|Overall Study|Adverse Event|4|||
164030341|NCT00414960|592470629|FG001|Overall Study|Adverse Event|0|||
164030342|NCT00414960|592470628|FG000|Overall Study|Withdrawal by Subject|3|||
164030343|NCT00414960|592470629|FG001|Overall Study|Withdrawal by Subject|0|||
164030344|NCT00414960|592470628|FG000|Overall Study|Physician Decision|0|||
164030345|NCT00414960|592470629|FG001|Overall Study|Physician Decision|1|||
164030346|NCT01318512|592470630|FG000|Maintenance Period (6 Months)|Death|2|||
164030347|NCT01318512|592470630|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
164030348|NCT00363246|592470631|FG000|Overall Study|Death|40|||
164030349|NCT00363246|592470631|FG000|Overall Study|Withdrawal by Subject|19|||
164030350|NCT00363246|592470631|FG000|Overall Study|Lost to Follow-up|14|||
164030351|NCT00363246|592470631|FG000|Overall Study|Bad health|6|||
164030352|NCT00363246|592470631|FG000|Overall Study|Stopped using wheelchair|11|||
164030353|NCT00363246|592470631|FG000|Overall Study|Subject expressed security concerns|2|||
164030354|NCT00363246|592470631|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
164030355|NCT02756650|592470636|FG000|Overall Study|Physician Decision|1|||
164030356|NCT02756650|592470636|FG000|Overall Study|Adverse Event|1|||
164030357|NCT04348591|592470639|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
164030358|NCT04348591|592470640|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
164030359|NCT04348591|592470639|FG000|Imaging Session (120 Min)|Physician Decision|0|||
164030360|NCT04348591|592470640|FG001|Imaging Session (120 Min)|Physician Decision|1|||
164030361|NCT04348591|592470639|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
164030362|NCT04348591|592470640|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
164030363|NCT00622869|592470642|FG000|Overall Study|Subject Withdrew Consent|13|||
164030364|NCT00622869|592470643|FG001|Overall Study|Subject Withdrew Consent|17|||
164030365|NCT00622869|592470644|FG002|Overall Study|Subject Withdrew Consent|11|||
164030366|NCT00622869|592470642|FG000|Overall Study|Administrative Problems|11|||
164030367|NCT00622869|592470643|FG001|Overall Study|Administrative Problems|17|||
164030368|NCT00622869|592470644|FG002|Overall Study|Administrative Problems|13|||
164030369|NCT00622869|592470642|FG000|Overall Study|Death|12|||
164030370|NCT00622869|592470643|FG001|Overall Study|Death|15|||
164030371|NCT00622869|592470644|FG002|Overall Study|Death|10|||
164030372|NCT00622869|592470642|FG000|Overall Study|Lost to Follow-up|2|||
164030373|NCT00622869|592470643|FG001|Overall Study|Lost to Follow-up|4|||
164030374|NCT00622869|592470644|FG002|Overall Study|Lost to Follow-up|2|||
164030375|NCT00622869|592470642|FG000|Overall Study|Graft Loss|5|||
164030376|NCT00622869|592470643|FG001|Overall Study|Graft Loss|3|||
164030377|NCT00622869|592470644|FG002|Overall Study|Graft Loss|2|||
164030378|NCT00622869|592470642|FG000|Overall Study|Missing|0|||
164030379|NCT00622869|592470643|FG001|Overall Study|Missing|1|||
164030380|NCT00622869|592470644|FG002|Overall Study|Missing|1|||
164030381|NCT03722784|592470645|FG000|Overall Study|Withdrawal by Subject|1|||
164030382|NCT03722784|592470646|FG001|Overall Study|Withdrawal by Subject|0|||
164030383|NCT03722784|592470645|FG000|Overall Study|Physician Decision|1|||
164030384|NCT03722784|592470646|FG001|Overall Study|Physician Decision|1|||
164030385|NCT03722784|592470645|FG000|Overall Study|Protocol Violation|0|||
164030386|NCT03722784|592470646|FG001|Overall Study|Protocol Violation|1|||
164030387|NCT01317615|592470649|FG000|Overall Study|Disease progression|25|||
164030388|NCT01317615|592470649|FG000|Overall Study|New cancer therapy|5|||
164030389|NCT01317615|592470649|FG000|Overall Study|Death|6|||
164030390|NCT01317615|592470649|FG000|Overall Study|Withdrawal by Subject|5|||
164030391|NCT01317615|592470649|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164030392|NCT01317615|592470649|FG000|Overall Study|Adverse Event|7|||
164030393|NCT02648724|592470653|FG000|Overall Study|Withdrawal by Subject|0|||
164030394|NCT02648724|592470654|FG001|Overall Study|Withdrawal by Subject|1|||
164030395|NCT02648724|592470655|FG002|Overall Study|Withdrawal by Subject|1|||
164096894|NCT02188303|592718982|FG005|Overall Study|Dose Termination Criteria Met|0|||
163917986|NCT02151643|592070229|FG001|Overall Study|Withdrawal by Subject|1|||
163917987|NCT02151643|592070230|FG002|Overall Study|Withdrawal by Subject|1|||
163917988|NCT02151643|592070231|FG003|Overall Study|Withdrawal by Subject|1|||
163917989|NCT02151643|592070232|FG004|Overall Study|Withdrawal by Subject|1|||
163917990|NCT02151643|592070228|FG000|Overall Study|Hyperphosphataemia|1|||
163917991|NCT02151643|592070229|FG001|Overall Study|Hyperphosphataemia|0|||
163917992|NCT02151643|592070230|FG002|Overall Study|Hyperphosphataemia|0|||
163917993|NCT02151643|592070231|FG003|Overall Study|Hyperphosphataemia|0|||
163917994|NCT02151643|592070232|FG004|Overall Study|Hyperphosphataemia|1|||
163917995|NCT02151643|592070228|FG000|Overall Study|High Ferritin levels|3|||
163917996|NCT02151643|592070229|FG001|Overall Study|High Ferritin levels|3|||
163917997|NCT02151643|592070230|FG002|Overall Study|High Ferritin levels|2|||
163917998|NCT02151643|592070231|FG003|Overall Study|High Ferritin levels|2|||
163917999|NCT02151643|592070232|FG004|Overall Study|High Ferritin levels|1|||
163918000|NCT04307134|592070233|FG000|Overall Study|Lost to Follow-up|2|||
163918001|NCT04307134|592070233|FG000|Overall Study|Withdrawal by Subject|3|||
163918002|NCT04307134|592070233|FG000|Overall Study|Other|3|||
163918003|NCT04307134|592070233|FG000|Overall Study|Death|21|||
163918004|NCT04307134|592070233|FG000|Overall Study|Enrolled but not Treated|1|||
163918005|NCT01732627|592070234|FG000|Overall Study|Withdrawal by Subject|1|||
163918006|NCT01732627|592070235|FG001|Overall Study|Withdrawal by Subject|0|||
164301018|NCT03763877|593478396|FG002|Overall Study|Protocol Violation|0|||
164301019|NCT03763877|593478397|FG003|Overall Study|Protocol Violation|0|||
164301020|NCT03763877|593478394|FG000|Overall Study|Lost to Follow-up|0|||
164301021|NCT03763877|593478395|FG001|Overall Study|Lost to Follow-up|1|||
164301022|NCT03763877|593478396|FG002|Overall Study|Lost to Follow-up|1|||
164301023|NCT03763877|593478397|FG003|Overall Study|Lost to Follow-up|0|||
164301024|NCT01524796|593478406|FG000|Overall Study|Adverse Event|13|||
163918014|NCT02305797|592070237|FG000|Overall Study|Adverse Event|11|||
163918015|NCT02305797|592070238|FG001|Overall Study|Adverse Event|2|||
163918016|NCT02305797|592070237|FG000|Overall Study|Withdrawal by Subject|9|||
163918017|NCT02305797|592070238|FG001|Overall Study|Withdrawal by Subject|10|||
163918018|NCT02305797|592070237|FG000|Overall Study|Lack of Efficacy|6|||
163918019|NCT02305797|592070238|FG001|Overall Study|Lack of Efficacy|0|||
163918020|NCT02305797|592070237|FG000|Overall Study|Lost to Follow-up|5|||
163918021|NCT02305797|592070238|FG001|Overall Study|Lost to Follow-up|11|||
163918022|NCT02305797|592070237|FG000|Overall Study|Pregnancy|0|||
163918023|NCT02305797|592070238|FG001|Overall Study|Pregnancy|2|||
163918024|NCT02305797|592070237|FG000|Overall Study|Noncompliance|14|||
163918025|NCT02305797|592070238|FG001|Overall Study|Noncompliance|12|||
163918026|NCT02305797|592070237|FG000|Overall Study|Reason not collected|0|||
163918027|NCT02305797|592070238|FG001|Overall Study|Reason not collected|1|||
163918028|NCT02522299|592070239|FG000|Overall Study|Adverse Event|2|||
163918029|NCT02522299|592070240|FG001|Overall Study|Adverse Event|0|||
163918030|NCT02522299|592070239|FG000|Overall Study|Physician Decision|0|||
163918031|NCT02522299|592070240|FG001|Overall Study|Physician Decision|1|||
163918032|NCT02522299|592070239|FG000|Overall Study|Withdrawal by Subject|2|||
163918033|NCT02522299|592070240|FG001|Overall Study|Withdrawal by Subject|0|||
163918034|NCT02097056|592070241|FG000|Overall Study|Protocol Violation|2|||
163918035|NCT02097056|592070241|FG000|Overall Study|Withdrawal by Subject|15|||
163918036|NCT02097056|592070241|FG000|Overall Study|Lost to Follow-up|2|||
163918037|NCT02097056|592070241|FG000|Overall Study|Adverse Event|37|||
163918038|NCT02097056|592070241|FG000|Overall Study|Other|2|||
163918039|NCT03751280|592070244|FG000|Overall Study|Adverse Event|0|||
163918040|NCT03751280|592070245|FG001|Overall Study|Adverse Event|1|||
163918041|NCT03751280|592070244|FG000|Overall Study|Lost to Follow-up|3|||
164030396|NCT02648724|592470656|FG003|Overall Study|Withdrawal by Subject|0|||
164030397|NCT02648724|592470657|FG004|Overall Study|Withdrawal by Subject|1|||
164030398|NCT02648724|592470658|FG005|Overall Study|Withdrawal by Subject|0|||
164030399|NCT02648724|592470659|FG006|Overall Study|Withdrawal by Subject|0|||
164030400|NCT02648724|592470653|FG000|Overall Study|Progressive disease|2|||
164030401|NCT02648724|592470654|FG001|Overall Study|Progressive disease|2|||
164030402|NCT02648724|592470655|FG002|Overall Study|Progressive disease|2|||
164030403|NCT02648724|592470656|FG003|Overall Study|Progressive disease|3|||
164030404|NCT02648724|592470657|FG004|Overall Study|Progressive disease|22|||
164030405|NCT02648724|592470658|FG005|Overall Study|Progressive disease|7|||
164030406|NCT02648724|592470659|FG006|Overall Study|Progressive disease|8|||
164030407|NCT02648724|592470653|FG000|Overall Study|Other reason (unknown)|1|||
164030408|NCT02648724|592470654|FG001|Overall Study|Other reason (unknown)|0|||
163918042|NCT03751280|592070245|FG001|Overall Study|Lost to Follow-up|5|||
163918043|NCT03751280|592070244|FG000|Overall Study|Physician Decision|0|||
163918044|NCT03751280|592070245|FG001|Overall Study|Physician Decision|2|||
163918045|NCT03751280|592070244|FG000|Overall Study|Protocol Violation|0|||
163918046|NCT03751280|592070245|FG001|Overall Study|Protocol Violation|2|||
163918047|NCT03751280|592070244|FG000|Overall Study|Withdrawal by Subject|5|||
163918048|NCT03751280|592070245|FG001|Overall Study|Withdrawal by Subject|2|||
163918049|NCT00296504|592070246|FG000|Interim Analysis|Withdrawal by Subject|8|||
163918050|NCT00296504|592070247|FG001|Interim Analysis|Withdrawal by Subject|0|||
163918051|NCT00296504|592070248|FG002|Interim Analysis|Withdrawal by Subject|12|||
163918052|NCT00296504|592070249|FG003|Interim Analysis|Withdrawal by Subject|0|||
163918053|NCT00296504|592070250|FG004|Interim Analysis|Withdrawal by Subject|5|||
163918054|NCT00296504|592070251|FG005|Interim Analysis|Withdrawal by Subject|5|||
163918055|NCT00296504|592070252|FG006|Interim Analysis|Withdrawal by Subject|9|||
163918056|NCT00296504|592070253|FG007|Interim Analysis|Withdrawal by Subject|3|||
163918057|NCT00296504|592070254|FG008|Interim Analysis|Withdrawal by Subject|0|||
164096895|NCT02188303|592718983|FG006|Overall Study|Dose Termination Criteria Met|2|||
164096896|NCT02188303|592718984|FG007|Overall Study|Dose Termination Criteria Met|4|||
164096897|NCT04206332|592718986|FG000|Part A|Lost to Follow-up|0|||
164096898|NCT04206332|592718987|FG001|Part A|Lost to Follow-up|1|||
163918058|NCT00296504|592070246|FG000|Interim Analysis|Lost to Follow-up|13|||
163918059|NCT00296504|592070247|FG001|Interim Analysis|Lost to Follow-up|3|||
163918060|NCT00296504|592070248|FG002|Interim Analysis|Lost to Follow-up|26|||
163918061|NCT00296504|592070249|FG003|Interim Analysis|Lost to Follow-up|8|||
163918062|NCT00296504|592070250|FG004|Interim Analysis|Lost to Follow-up|14|||
163918063|NCT00296504|592070251|FG005|Interim Analysis|Lost to Follow-up|4|||
163918064|NCT00296504|592070252|FG006|Interim Analysis|Lost to Follow-up|11|||
163918065|NCT00296504|592070253|FG007|Interim Analysis|Lost to Follow-up|4|||
163918066|NCT00296504|592070254|FG008|Interim Analysis|Lost to Follow-up|0|||
163918067|NCT00296504|592070246|FG000|Interim Analysis|Clinical Progression|1|||
163918068|NCT00296504|592070247|FG001|Interim Analysis|Clinical Progression|0|||
163918069|NCT00296504|592070248|FG002|Interim Analysis|Clinical Progression|1|||
164030409|NCT02648724|592470655|FG002|Overall Study|Other reason (unknown)|0|||
164030410|NCT02648724|592470656|FG003|Overall Study|Other reason (unknown)|0|||
164030411|NCT02648724|592470657|FG004|Overall Study|Other reason (unknown)|0|||
164030412|NCT02648724|592470658|FG005|Overall Study|Other reason (unknown)|0|||
164030413|NCT02648724|592470659|FG006|Overall Study|Other reason (unknown)|0|||
164030414|NCT02648724|592470653|FG000|Overall Study|Protocol Violation|0|||
164030415|NCT02648724|592470654|FG001|Overall Study|Protocol Violation|0|||
164030416|NCT02648724|592470655|FG002|Overall Study|Protocol Violation|0|||
164030417|NCT02648724|592470656|FG003|Overall Study|Protocol Violation|0|||
164030418|NCT02648724|592470657|FG004|Overall Study|Protocol Violation|1|||
164030419|NCT02648724|592470658|FG005|Overall Study|Protocol Violation|0|||
164030420|NCT02648724|592470659|FG006|Overall Study|Protocol Violation|0|||
164030421|NCT02648724|592470653|FG000|Overall Study|Death|0|||
164030422|NCT02648724|592470654|FG001|Overall Study|Death|0|||
164030423|NCT02648724|592470655|FG002|Overall Study|Death|0|||
164030424|NCT02648724|592470656|FG003|Overall Study|Death|0|||
164030425|NCT02648724|592470657|FG004|Overall Study|Death|0|||
164030426|NCT02648724|592470658|FG005|Overall Study|Death|0|||
164030427|NCT02648724|592470659|FG006|Overall Study|Death|3|||
164030428|NCT02648724|592470653|FG000|Overall Study|Physician Decision|0|||
164030429|NCT02648724|592470654|FG001|Overall Study|Physician Decision|0|||
164030430|NCT02648724|592470655|FG002|Overall Study|Physician Decision|0|||
164030431|NCT02648724|592470656|FG003|Overall Study|Physician Decision|0|||
164030432|NCT02648724|592470657|FG004|Overall Study|Physician Decision|1|||
164030433|NCT02648724|592470658|FG005|Overall Study|Physician Decision|0|||
164030434|NCT02648724|592470659|FG006|Overall Study|Physician Decision|1|||
164030435|NCT02648724|592470653|FG000|Overall Study|Transferred to named patient program|0|||
164030436|NCT02648724|592470654|FG001|Overall Study|Transferred to named patient program|0|||
164030437|NCT02648724|592470655|FG002|Overall Study|Transferred to named patient program|0|||
164030438|NCT02648724|592470656|FG003|Overall Study|Transferred to named patient program|0|||
164030439|NCT02648724|592470657|FG004|Overall Study|Transferred to named patient program|0|||
164030440|NCT02648724|592470658|FG005|Overall Study|Transferred to named patient program|1|||
164030441|NCT02648724|592470659|FG006|Overall Study|Transferred to named patient program|0|||
164030442|NCT00302718|592470660|FG000|Overall Study|Participant left the hospital|1|||
164030443|NCT00302718|592470661|FG001|Overall Study|Participant left the hospital|0|||
164030444|NCT00302718|592470662|FG002|Overall Study|Participant left the hospital|0|||
164030445|NCT00302718|592470663|FG003|Overall Study|Participant left the hospital|1|||
164030446|NCT00302718|592470660|FG000|Overall Study|Withdrawal by Subject|0|||
164030447|NCT00302718|592470661|FG001|Overall Study|Withdrawal by Subject|1|||
164030448|NCT00302718|592470662|FG002|Overall Study|Withdrawal by Subject|0|||
164030449|NCT00302718|592470663|FG003|Overall Study|Withdrawal by Subject|0|||
164030450|NCT00302718|592470660|FG000|Overall Study|Participant left primary care setting|0|||
164030451|NCT00302718|592470661|FG001|Overall Study|Participant left primary care setting|0|||
164030452|NCT00302718|592470662|FG002|Overall Study|Participant left primary care setting|2|||
164030453|NCT00302718|592470663|FG003|Overall Study|Participant left primary care setting|1|||
164030454|NCT00738374|592470664|FG000|Induction Treatment Phase|Adverse Event|14|||
164030455|NCT00738374|592470665|FG001|Induction Treatment Phase|Adverse Event|0|||
164030456|NCT00738374|592470666|FG002|Induction Treatment Phase|Adverse Event|0|||
164030457|NCT00738374|592470667|FG003|Induction Treatment Phase|Adverse Event|0|||
164030458|NCT00738374|592470664|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
164030459|NCT00738374|592470665|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
164030460|NCT00738374|592470666|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
164030461|NCT00738374|592470667|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
164030462|NCT00738374|592470664|FG000|Induction Treatment Phase|Physician Decision|2|||
164030463|NCT00738374|592470665|FG001|Induction Treatment Phase|Physician Decision|0|||
164030464|NCT00738374|592470666|FG002|Induction Treatment Phase|Physician Decision|0|||
164030465|NCT00738374|592470667|FG003|Induction Treatment Phase|Physician Decision|0|||
164030466|NCT00738374|592470664|FG000|Induction Treatment Phase|Protocol Violation|2|||
164030467|NCT00738374|592470665|FG001|Induction Treatment Phase|Protocol Violation|0|||
164030468|NCT00738374|592470666|FG002|Induction Treatment Phase|Protocol Violation|0|||
164030469|NCT00738374|592470667|FG003|Induction Treatment Phase|Protocol Violation|0|||
164030470|NCT00738374|592470664|FG000|Induction Treatment Phase|Non-compliance|1|||
164030471|NCT00738374|592470665|FG001|Induction Treatment Phase|Non-compliance|0|||
164030472|NCT00738374|592470666|FG002|Induction Treatment Phase|Non-compliance|0|||
164030473|NCT00738374|592470667|FG003|Induction Treatment Phase|Non-compliance|0|||
164030474|NCT00738374|592470664|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
164030475|NCT00738374|592470665|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
164030476|NCT00738374|592470666|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
164030477|NCT00738374|592470667|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
164030478|NCT00738374|592470664|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
164030479|NCT00738374|592470665|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
164030480|NCT00738374|592470666|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
164096899|NCT04206332|592718988|FG002|Part A|Lost to Follow-up|0|||
163918070|NCT00296504|592070249|FG003|Interim Analysis|Clinical Progression|1|||
163918071|NCT00296504|592070250|FG004|Interim Analysis|Clinical Progression|0|||
164096900|NCT04206332|592718989|FG003|Part A|Lost to Follow-up|0|||
163918072|NCT00296504|592070251|FG005|Interim Analysis|Clinical Progression|2|||
163918073|NCT00296504|592070252|FG006|Interim Analysis|Clinical Progression|1|||
163918074|NCT00296504|592070253|FG007|Interim Analysis|Clinical Progression|2|||
163918075|NCT00296504|592070254|FG008|Interim Analysis|Clinical Progression|0|||
163918076|NCT00296504|592070246|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
163918077|NCT00296504|592070247|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
163918078|NCT00296504|592070248|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
163918079|NCT00296504|592070249|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
163918080|NCT00296504|592070250|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
164096901|NCT04206332|592718990|FG004|Part A|Lost to Follow-up|0|||
164096902|NCT04206332|592718991|FG005|Part A|Lost to Follow-up|0|||
164096903|NCT04206332|592718992|FG006|Part A|Lost to Follow-up|0|||
164096904|NCT04206332|592718993|FG007|Part A|Lost to Follow-up|0|||
163918081|NCT00296504|592070251|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
163918082|NCT00296504|592070252|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
164096905|NCT04206332|592718994|FG008|Part A|Lost to Follow-up|0|||
164096906|NCT04206332|592718995|FG009|Part A|Lost to Follow-up|0|||
164096907|NCT04206332|592718996|FG010|Part A|Lost to Follow-up|0|||
164030481|NCT00738374|592470667|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
164030482|NCT00738374|592470664|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
164030483|NCT00738374|592470665|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
164030484|NCT00738374|592470666|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
164030485|NCT00738374|592470667|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
164030486|NCT00738374|592470664|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
164030487|NCT00738374|592470665|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
164030488|NCT00738374|592470666|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
164030489|NCT00738374|592470667|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
164030490|NCT00738374|592470664|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
164030491|NCT00738374|592470665|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
164030492|NCT00738374|592470666|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
164030493|NCT00738374|592470667|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
164030494|NCT00738374|592470664|FG000|Maintenance Treatment/Observation Phase|Other|0|||
164030495|NCT00738374|592470665|FG001|Maintenance Treatment/Observation Phase|Other|1|||
164030496|NCT00738374|592470666|FG002|Maintenance Treatment/Observation Phase|Other|0|||
164030497|NCT00738374|592470667|FG003|Maintenance Treatment/Observation Phase|Other|0|||
164030498|NCT00632541|592470668|FG000|Overall Study|Adverse Event|7|||
164030499|NCT02927873|592470670|FG000|Overall Study|Lost to Follow-up|0|||
164030500|NCT02927873|592470671|FG001|Overall Study|Lost to Follow-up|1|||
164030501|NCT02927873|592470672|FG002|Overall Study|Lost to Follow-up|0|||
164030502|NCT02927873|592470673|FG003|Overall Study|Lost to Follow-up|0|||
164030503|NCT02927873|592470674|FG004|Overall Study|Lost to Follow-up|0|||
164030504|NCT02927873|592470675|FG005|Overall Study|Lost to Follow-up|0|||
164030505|NCT02927873|592470670|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164030506|NCT02927873|592470671|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164030507|NCT02927873|592470672|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164096908|NCT04206332|592718997|FG011|Part A|Lost to Follow-up|0|||
164096909|NCT04206332|592718998|FG012|Part A|Lost to Follow-up|0|||
164030508|NCT02927873|592470673|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164030509|NCT02927873|592470674|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164030510|NCT02927873|592470675|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164030511|NCT02927873|592470670|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164030512|NCT02927873|592470671|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164030513|NCT02927873|592470672|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164030514|NCT02927873|592470673|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164030515|NCT02927873|592470674|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164030516|NCT02927873|592470675|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164030517|NCT02927873|592470670|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164030518|NCT02927873|592470671|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
164030519|NCT02927873|592470672|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164030520|NCT02927873|592470673|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164030521|NCT02927873|592470674|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164030522|NCT02927873|592470675|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
164030523|NCT02927873|592470670|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
164030524|NCT02927873|592470671|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164030525|NCT02927873|592470672|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164030526|NCT02927873|592470673|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164030527|NCT02927873|592470674|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164030528|NCT02927873|592470675|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
164030529|NCT02927873|592470670|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
164030530|NCT02927873|592470671|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164030531|NCT02927873|592470672|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164030532|NCT02927873|592470673|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164030533|NCT02927873|592470674|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164030534|NCT02927873|592470675|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
164030535|NCT00393913|592470676|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
164096910|NCT04206332|592718999|FG013|Part A|Lost to Follow-up|0|||
164096911|NCT04206332|592719000|FG014|Part A|Lost to Follow-up|0|||
164096912|NCT04206332|592719001|FG015|Part A|Lost to Follow-up|0|||
164096913|NCT04206332|592719002|FG016|Part A|Lost to Follow-up|0|||
164096914|NCT04206332|592718986|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164030536|NCT00393913|592470676|FG000|Initial Assessment|Withdrawal by Subject|16|||
164030537|NCT00393913|592470676|FG000|CPAP|Withdrawal by Subject|3|||
164096915|NCT04206332|592718987|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
163918083|NCT00296504|592070253|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
163918084|NCT00296504|592070254|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
163918085|NCT00296504|592070246|FG000|Interim Analysis|Adverse Event|0|||
163918086|NCT00296504|592070247|FG001|Interim Analysis|Adverse Event|0|||
163918087|NCT00296504|592070248|FG002|Interim Analysis|Adverse Event|13|||
163918088|NCT00296504|592070249|FG003|Interim Analysis|Adverse Event|4|||
163918089|NCT00296504|592070250|FG004|Interim Analysis|Adverse Event|6|||
163918090|NCT00296504|592070251|FG005|Interim Analysis|Adverse Event|3|||
163918091|NCT00296504|592070252|FG006|Interim Analysis|Adverse Event|4|||
163918092|NCT00296504|592070253|FG007|Interim Analysis|Adverse Event|5|||
163918093|NCT00296504|592070254|FG008|Interim Analysis|Adverse Event|0|||
163918094|NCT00296504|592070246|FG000|Interim Analysis|Protocol Violation|0|||
163918095|NCT00296504|592070247|FG001|Interim Analysis|Protocol Violation|0|||
163918096|NCT00296504|592070248|FG002|Interim Analysis|Protocol Violation|2|||
163918097|NCT00296504|592070249|FG003|Interim Analysis|Protocol Violation|0|||
163918098|NCT00296504|592070250|FG004|Interim Analysis|Protocol Violation|1|||
163918099|NCT00296504|592070251|FG005|Interim Analysis|Protocol Violation|0|||
163918100|NCT00296504|592070252|FG006|Interim Analysis|Protocol Violation|0|||
163918101|NCT00296504|592070253|FG007|Interim Analysis|Protocol Violation|1|||
163918102|NCT00296504|592070254|FG008|Interim Analysis|Protocol Violation|0|||
163918103|NCT00296504|592070246|FG000|Interim Analysis|Insufficient CD4 Response|0|||
163918104|NCT00296504|592070247|FG001|Interim Analysis|Insufficient CD4 Response|0|||
163918105|NCT00296504|592070248|FG002|Interim Analysis|Insufficient CD4 Response|0|||
163918106|NCT00296504|592070249|FG003|Interim Analysis|Insufficient CD4 Response|0|||
163918107|NCT00296504|592070250|FG004|Interim Analysis|Insufficient CD4 Response|1|||
163918108|NCT00296504|592070251|FG005|Interim Analysis|Insufficient CD4 Response|1|||
163918109|NCT00296504|592070252|FG006|Interim Analysis|Insufficient CD4 Response|0|||
163918110|NCT00296504|592070253|FG007|Interim Analysis|Insufficient CD4 Response|0|||
163918111|NCT00296504|592070254|FG008|Interim Analysis|Insufficient CD4 Response|0|||
163918112|NCT00296504|592070246|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
163918113|NCT00296504|592070247|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
163918114|NCT00296504|592070248|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
163918115|NCT00296504|592070249|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
163918116|NCT00296504|592070250|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
163918117|NCT00296504|592070251|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
163918118|NCT00296504|592070252|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
163918119|NCT00296504|592070253|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
163918120|NCT00296504|592070254|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
163918121|NCT00296504|592070246|FG000|Interim Analysis|Pregnancy|4|||
163918122|NCT00296504|592070247|FG001|Interim Analysis|Pregnancy|1|||
163918123|NCT00296504|592070248|FG002|Interim Analysis|Pregnancy|4|||
163918124|NCT00296504|592070249|FG003|Interim Analysis|Pregnancy|2|||
163918125|NCT00296504|592070250|FG004|Interim Analysis|Pregnancy|0|||
163918126|NCT00296504|592070251|FG005|Interim Analysis|Pregnancy|1|||
163918127|NCT00296504|592070252|FG006|Interim Analysis|Pregnancy|1|||
163918128|NCT00296504|592070253|FG007|Interim Analysis|Pregnancy|1|||
163918129|NCT00296504|592070254|FG008|Interim Analysis|Pregnancy|0|||
163918130|NCT00296504|592070246|FG000|Interim Analysis|Death|1|||
163918131|NCT00296504|592070247|FG001|Interim Analysis|Death|0|||
163918132|NCT00296504|592070248|FG002|Interim Analysis|Death|3|||
163918133|NCT00296504|592070249|FG003|Interim Analysis|Death|0|||
163918134|NCT00296504|592070250|FG004|Interim Analysis|Death|0|||
163918135|NCT00296504|592070251|FG005|Interim Analysis|Death|0|||
163918136|NCT00296504|592070252|FG006|Interim Analysis|Death|0|||
163918137|NCT00296504|592070253|FG007|Interim Analysis|Death|0|||
164030538|NCT00393913|592470676|FG000|CPAP|Physician Decision|1|||
164030539|NCT00393913|592470676|FG000|CPAP|TEchnical problem with CPAP|3|||
163918138|NCT00296504|592070254|FG008|Interim Analysis|Death|0|||
164030540|NCT01518244|592470677|FG000|Overall Study|Adverse Event|3|||
163918139|NCT00296504|592070246|FG000|Interim Analysis|Participant Non-compliant|0|||
163918140|NCT00296504|592070247|FG001|Interim Analysis|Participant Non-compliant|1|||
163918141|NCT00296504|592070248|FG002|Interim Analysis|Participant Non-compliant|2|||
163918142|NCT00296504|592070249|FG003|Interim Analysis|Participant Non-compliant|1|||
164030541|NCT04900038|592470679|FG000|Overall Study|Adverse Event|1|||
164030542|NCT04900038|592470680|FG001|Overall Study|Adverse Event|0|||
164030543|NCT04900038|592470681|FG002|Overall Study|Adverse Event|1|||
164030544|NCT04900038|592470682|FG003|Overall Study|Adverse Event|1|||
164030545|NCT04900038|592470679|FG000|Overall Study|Withdrawal by Subject|0|||
164030546|NCT04900038|592470680|FG001|Overall Study|Withdrawal by Subject|1|||
164030547|NCT04900038|592470681|FG002|Overall Study|Withdrawal by Subject|0|||
164030548|NCT04900038|592470682|FG003|Overall Study|Withdrawal by Subject|0|||
164030549|NCT04900038|592470679|FG000|Overall Study|Study terminated by sponsor|18|||
164030550|NCT04900038|592470680|FG001|Overall Study|Study terminated by sponsor|15|||
164030551|NCT04900038|592470681|FG002|Overall Study|Study terminated by sponsor|17|||
164030552|NCT04900038|592470682|FG003|Overall Study|Study terminated by sponsor|14|||
164030553|NCT04900038|592470679|FG000|Overall Study|Protocol Deviation|1|||
164030554|NCT04900038|592470680|FG001|Overall Study|Protocol Deviation|1|||
164030555|NCT04900038|592470681|FG002|Overall Study|Protocol Deviation|0|||
164030556|NCT04900038|592470682|FG003|Overall Study|Protocol Deviation|0|||
164030557|NCT04900038|592470679|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
164030558|NCT04900038|592470680|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
164030559|NCT04900038|592470681|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
164030560|NCT04900038|592470682|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
164030561|NCT04900038|592470679|FG000|Overall Study|Lost to Follow-up|0|||
164030562|NCT04900038|592470680|FG001|Overall Study|Lost to Follow-up|0|||
164030563|NCT04900038|592470681|FG002|Overall Study|Lost to Follow-up|0|||
164030564|NCT04900038|592470682|FG003|Overall Study|Lost to Follow-up|1|||
164030565|NCT00077376|592470687|FG000|Overall Study|Adverse Event|8|||
164030566|NCT00077376|592470687|FG000|Overall Study|Withdrawal by Subject|2|||
164030567|NCT00077376|592470687|FG000|Overall Study|Death|1|||
164030568|NCT00077376|592470687|FG000|Overall Study|Physician Decision|1|||
164030569|NCT00077376|592470687|FG000|Overall Study|Alternative therapy|5|||
164030570|NCT00077376|592470687|FG000|Overall Study|Complicating disease|1|||
164030571|NCT00077376|592470687|FG000|Overall Study|Still on treatment|1|||
164030572|NCT00077376|592470687|FG000|Overall Study|Symptomatic deterioration|1|||
164030573|NCT00077376|592470687|FG000|Overall Study|Surgery|1|||
164030574|NCT00077376|592470687|FG000|Overall Study|Insurance ran out|1|||
164030575|NCT02017899|592472624|FG000|Overall Study|Withdrawal by Subject|0|||
164030576|NCT02017899|592472625|FG001|Overall Study|Withdrawal by Subject|0|||
164030577|NCT02017899|592472626|FG002|Overall Study|Withdrawal by Subject|0|||
164030578|NCT02017899|592472627|FG003|Overall Study|Withdrawal by Subject|1|||
164030579|NCT02017899|592472628|FG004|Overall Study|Withdrawal by Subject|1|||
164030580|NCT02017899|592472629|FG005|Overall Study|Withdrawal by Subject|0|||
164030581|NCT02843178|592472631|FG000|Overall Study|Lost to Follow-up|8|||
164030582|NCT02843178|592472632|FG001|Overall Study|Lost to Follow-up|8|||
164030583|NCT02843178|592472633|FG002|Overall Study|Lost to Follow-up|6|||
164030584|NCT02843178|592472634|FG003|Overall Study|Lost to Follow-up|3|||
164030585|NCT02843178|592472631|FG000|Overall Study|Withdrawal by Subject|0|||
164030586|NCT02843178|592472632|FG001|Overall Study|Withdrawal by Subject|0|||
164030587|NCT02843178|592472633|FG002|Overall Study|Withdrawal by Subject|1|||
164030588|NCT02843178|592472634|FG003|Overall Study|Withdrawal by Subject|1|||
164030589|NCT02420795|592472641|FG000|Overall Study|Withdrawal by Subject|1|||
164030590|NCT02420795|592472642|FG001|Overall Study|Withdrawal by Subject|0|||
164030591|NCT02420795|592472643|FG002|Overall Study|Withdrawal by Subject|0|||
164030592|NCT02420795|592472641|FG000|Overall Study|Adverse Event|1|||
164030593|NCT02420795|592472642|FG001|Overall Study|Adverse Event|0|||
164030594|NCT02420795|592472643|FG002|Overall Study|Adverse Event|0|||
164030595|NCT02420795|592472641|FG000|Overall Study|Progressive disease|2|||
164030596|NCT02420795|592472642|FG001|Overall Study|Progressive disease|2|||
164030597|NCT02420795|592472643|FG002|Overall Study|Progressive disease|4|||
164030598|NCT02420795|592472641|FG000|Overall Study|Death|0|||
164030599|NCT02420795|592472642|FG001|Overall Study|Death|0|||
164030600|NCT02420795|592472643|FG002|Overall Study|Death|1|||
164030601|NCT00949910|592472646|FG000|Overall Study|Progressive Disease|3750|||
164030602|NCT00949910|592472646|FG000|Overall Study|Symptomatic Deterioration|1088|||
164030603|NCT00949910|592472646|FG000|Overall Study|Lost to Follow-up|100|||
164030604|NCT00949910|592472646|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
164030605|NCT00949910|592472646|FG000|Overall Study|Participant Refusal|390|||
164030606|NCT00949910|592472646|FG000|Overall Study|Death Due to Malignant Disease|456|||
164030607|NCT00949910|592472646|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
163918143|NCT00296504|592070250|FG004|Interim Analysis|Participant Non-compliant|1|||
163918144|NCT00296504|592070251|FG005|Interim Analysis|Participant Non-compliant|3|||
163918145|NCT00296504|592070252|FG006|Interim Analysis|Participant Non-compliant|6|||
163918146|NCT00296504|592070253|FG007|Interim Analysis|Participant Non-compliant|2|||
163918147|NCT00296504|592070254|FG008|Interim Analysis|Participant Non-compliant|0|||
163918148|NCT00296504|592070246|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163918149|NCT00296504|592070247|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163918150|NCT00296504|592070248|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
163918151|NCT00296504|592070249|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163918152|NCT00296504|592070250|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
164030608|NCT00949910|592472646|FG000|Overall Study|Death Due to Adverse Event|115|||
164030609|NCT00949910|592472646|FG000|Overall Study|Death Due to Toxicity|3|||
164030610|NCT00949910|592472646|FG000|Overall Study|Death from Unknown Cause|5|||
164030611|NCT00949910|592472646|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
164030612|NCT00949910|592472646|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
164030613|NCT00949910|592472646|FG000|Overall Study|Switched to Commercial Treatment|4|||
164030614|NCT00949910|592472646|FG000|Overall Study|Violation of Eligibility|23|||
164030615|NCT00949910|592472646|FG000|Overall Study|Logistical Reasons|13|||
164030616|NCT00949910|592472646|FG000|Overall Study|Non-Compliance|10|||
164030617|NCT00949910|592472646|FG000|Overall Study|Prolonged Dosing Interruption|4|||
164030618|NCT00949910|592472646|FG000|Overall Study|Adverse Event|83|||
164030619|NCT00949910|592472646|FG000|Overall Study|Serious Adverse Event|6|||
164030620|NCT00949910|592472646|FG000|Overall Study|Physician/Participant Decision|7|||
164096916|NCT04206332|592718988|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096917|NCT04206332|592718989|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164030621|NCT00949910|592472646|FG000|Overall Study|Other|4|||
164030622|NCT00949910|592472646|FG000|Overall Study|No Data|9|||
164030623|NCT02034552|592472647|FG000|Overall Study|Never treated|3|||
163918153|NCT00296504|592070251|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
163918154|NCT00296504|592070252|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163918155|NCT00296504|592070253|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163918156|NCT00296504|592070254|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
163918157|NCT00296504|592070246|FG000|Interim Analysis|To Simplify Treatment|0|||
163918158|NCT00296504|592070247|FG001|Interim Analysis|To Simplify Treatment|0|||
163918159|NCT00296504|592070248|FG002|Interim Analysis|To Simplify Treatment|1|||
163918160|NCT00296504|592070249|FG003|Interim Analysis|To Simplify Treatment|0|||
163918161|NCT00296504|592070250|FG004|Interim Analysis|To Simplify Treatment|0|||
163918162|NCT00296504|592070251|FG005|Interim Analysis|To Simplify Treatment|0|||
163918163|NCT00296504|592070252|FG006|Interim Analysis|To Simplify Treatment|2|||
163918164|NCT00296504|592070253|FG007|Interim Analysis|To Simplify Treatment|0|||
163918165|NCT00296504|592070254|FG008|Interim Analysis|To Simplify Treatment|0|||
163918166|NCT00296504|592070246|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918167|NCT00296504|592070247|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918168|NCT00296504|592070248|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
163918169|NCT00296504|592070249|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918170|NCT00296504|592070250|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918171|NCT00296504|592070251|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918172|NCT00296504|592070252|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918173|NCT00296504|592070253|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918174|NCT00296504|592070254|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
163918175|NCT00296504|592070246|FG000|Interim Analysis|Participant Moved|1|||
163918176|NCT00296504|592070247|FG001|Interim Analysis|Participant Moved|0|||
163918177|NCT00296504|592070248|FG002|Interim Analysis|Participant Moved|1|||
163918178|NCT00296504|592070249|FG003|Interim Analysis|Participant Moved|0|||
163918179|NCT00296504|592070250|FG004|Interim Analysis|Participant Moved|0|||
163918180|NCT00296504|592070251|FG005|Interim Analysis|Participant Moved|1|||
163918181|NCT00296504|592070252|FG006|Interim Analysis|Participant Moved|1|||
163918182|NCT00296504|592070253|FG007|Interim Analysis|Participant Moved|0|||
163918183|NCT00296504|592070254|FG008|Interim Analysis|Participant Moved|0|||
163918184|NCT00296504|592070246|FG000|Interim Analysis|Participant Was Incarcerated|2|||
163918185|NCT00296504|592070247|FG001|Interim Analysis|Participant Was Incarcerated|0|||
163918186|NCT00296504|592070248|FG002|Interim Analysis|Participant Was Incarcerated|1|||
163918187|NCT00296504|592070249|FG003|Interim Analysis|Participant Was Incarcerated|0|||
163918188|NCT00296504|592070250|FG004|Interim Analysis|Participant Was Incarcerated|0|||
163918189|NCT00296504|592070251|FG005|Interim Analysis|Participant Was Incarcerated|0|||
163918190|NCT00296504|592070252|FG006|Interim Analysis|Participant Was Incarcerated|0|||
163918191|NCT00296504|592070253|FG007|Interim Analysis|Participant Was Incarcerated|0|||
163918192|NCT00296504|592070254|FG008|Interim Analysis|Participant Was Incarcerated|0|||
163918193|NCT00296504|592070246|FG000|Interim Analysis|Resistance to FPV|0|||
163918194|NCT00296504|592070247|FG001|Interim Analysis|Resistance to FPV|0|||
163918195|NCT00296504|592070248|FG002|Interim Analysis|Resistance to FPV|1|||
163918196|NCT00296504|592070249|FG003|Interim Analysis|Resistance to FPV|0|||
163918197|NCT00296504|592070250|FG004|Interim Analysis|Resistance to FPV|0|||
163918198|NCT00296504|592070251|FG005|Interim Analysis|Resistance to FPV|0|||
163918199|NCT00296504|592070252|FG006|Interim Analysis|Resistance to FPV|0|||
163918200|NCT00296504|592070253|FG007|Interim Analysis|Resistance to FPV|0|||
163918201|NCT00296504|592070254|FG008|Interim Analysis|Resistance to FPV|0|||
163918202|NCT00296504|592070246|FG000|Interim Analysis|Physician Decision|0|||
163918203|NCT00296504|592070247|FG001|Interim Analysis|Physician Decision|0|||
163918204|NCT00296504|592070248|FG002|Interim Analysis|Physician Decision|1|||
163918205|NCT00296504|592070249|FG003|Interim Analysis|Physician Decision|0|||
163918206|NCT00296504|592070250|FG004|Interim Analysis|Physician Decision|0|||
163918207|NCT00296504|592070251|FG005|Interim Analysis|Physician Decision|0|||
163918208|NCT00296504|592070252|FG006|Interim Analysis|Physician Decision|0|||
164030624|NCT02034552|592472648|FG001|Overall Study|Never treated|2|||
164030625|NCT02034552|592472649|FG002|Overall Study|Never treated|0|||
164030626|NCT02034552|592472647|FG000|Overall Study|Radiological progression|3|||
164030627|NCT02034552|592472648|FG001|Overall Study|Radiological progression|5|||
163918209|NCT00296504|592070253|FG007|Interim Analysis|Physician Decision|0|||
163918210|NCT00296504|592070254|FG008|Interim Analysis|Physician Decision|0|||
163918211|NCT00296504|592070246|FG000|Interim Analysis|Principle Investigator Discretion|2|||
163918212|NCT00296504|592070247|FG001|Interim Analysis|Principle Investigator Discretion|0|||
163918213|NCT00296504|592070248|FG002|Interim Analysis|Principle Investigator Discretion|1|||
163918214|NCT00296504|592070249|FG003|Interim Analysis|Principle Investigator Discretion|1|||
163918215|NCT00296504|592070250|FG004|Interim Analysis|Principle Investigator Discretion|0|||
163918216|NCT00296504|592070251|FG005|Interim Analysis|Principle Investigator Discretion|0|||
163918217|NCT00296504|592070252|FG006|Interim Analysis|Principle Investigator Discretion|0|||
163918218|NCT00296504|592070253|FG007|Interim Analysis|Principle Investigator Discretion|0|||
164030628|NCT02034552|592472649|FG002|Overall Study|Radiological progression|4|||
164146445|NCT05026177|592898060|FG002|Overall Study|Lost to Follow-up|8|||
164096918|NCT04206332|592718990|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164030629|NCT02034552|592472647|FG000|Overall Study|AE not assoc. with disease progression|1|||
164030630|NCT02034552|592472648|FG001|Overall Study|AE not assoc. with disease progression|4|||
164030631|NCT02034552|592472649|FG002|Overall Study|AE not assoc. with disease progression|2|||
164030632|NCT02034552|592472647|FG000|Overall Study|AE associated with disease progression|0|||
164030633|NCT02034552|592472648|FG001|Overall Study|AE associated with disease progression|1|||
164030634|NCT02034552|592472649|FG002|Overall Study|AE associated with disease progression|0|||
164030635|NCT02034552|592472647|FG000|Overall Study|Withdrawal by Subject|2|||
164030636|NCT02034552|592472648|FG001|Overall Study|Withdrawal by Subject|1|||
164030637|NCT02034552|592472649|FG002|Overall Study|Withdrawal by Subject|1|||
164030638|NCT02034552|592472647|FG000|Overall Study|Non-compliance with study drug|0|||
164030639|NCT02034552|592472648|FG001|Overall Study|Non-compliance with study drug|0|||
163918219|NCT00296504|592070254|FG008|Interim Analysis|Principle Investigator Discretion|0|||
163918220|NCT00296504|592070246|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
163918221|NCT00296504|592070247|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
163918222|NCT00296504|592070248|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
163918223|NCT00296504|592070249|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
163918224|NCT00296504|592070250|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
163918225|NCT00296504|592070251|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
163918226|NCT00296504|592070252|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
163918227|NCT00296504|592070253|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
163918228|NCT00296504|592070254|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
163918229|NCT00296504|592070246|FG000|Interim Analysis|Non-adherence|2|||
163918230|NCT00296504|592070247|FG001|Interim Analysis|Non-adherence|0|||
163918231|NCT00296504|592070248|FG002|Interim Analysis|Non-adherence|0|||
163918232|NCT00296504|592070249|FG003|Interim Analysis|Non-adherence|0|||
163918233|NCT00296504|592070250|FG004|Interim Analysis|Non-adherence|1|||
163918234|NCT00296504|592070251|FG005|Interim Analysis|Non-adherence|0|||
163918235|NCT00296504|592070252|FG006|Interim Analysis|Non-adherence|0|||
163918236|NCT00296504|592070253|FG007|Interim Analysis|Non-adherence|1|||
163918237|NCT00296504|592070254|FG008|Interim Analysis|Non-adherence|0|||
163918238|NCT00296504|592070246|FG000|Interim Analysis|Site Closing|1|||
163918239|NCT00296504|592070247|FG001|Interim Analysis|Site Closing|0|||
163918240|NCT00296504|592070248|FG002|Interim Analysis|Site Closing|0|||
163918241|NCT00296504|592070249|FG003|Interim Analysis|Site Closing|0|||
163918242|NCT00296504|592070250|FG004|Interim Analysis|Site Closing|0|||
163918243|NCT00296504|592070251|FG005|Interim Analysis|Site Closing|1|||
163918244|NCT00296504|592070252|FG006|Interim Analysis|Site Closing|2|||
163918245|NCT00296504|592070253|FG007|Interim Analysis|Site Closing|0|||
163918246|NCT00296504|592070254|FG008|Interim Analysis|Site Closing|0|||
163918247|NCT00296504|592070246|FG000|Interim Analysis|Lack of Personnel at Site|1|||
163918248|NCT00296504|592070247|FG001|Interim Analysis|Lack of Personnel at Site|0|||
163918249|NCT00296504|592070248|FG002|Interim Analysis|Lack of Personnel at Site|0|||
163918250|NCT00296504|592070249|FG003|Interim Analysis|Lack of Personnel at Site|0|||
163918251|NCT00296504|592070250|FG004|Interim Analysis|Lack of Personnel at Site|0|||
163918252|NCT00296504|592070251|FG005|Interim Analysis|Lack of Personnel at Site|0|||
163918253|NCT00296504|592070252|FG006|Interim Analysis|Lack of Personnel at Site|0|||
163918254|NCT00296504|592070253|FG007|Interim Analysis|Lack of Personnel at Site|0|||
163918255|NCT00296504|592070254|FG008|Interim Analysis|Lack of Personnel at Site|0|||
163918256|NCT00296504|592070246|FG000|Interim Analysis|Missed Schedule Date|1|||
163918257|NCT00296504|592070247|FG001|Interim Analysis|Missed Schedule Date|0|||
163918258|NCT00296504|592070248|FG002|Interim Analysis|Missed Schedule Date|0|||
163918259|NCT00296504|592070249|FG003|Interim Analysis|Missed Schedule Date|0|||
163918260|NCT00296504|592070250|FG004|Interim Analysis|Missed Schedule Date|0|||
163918261|NCT00296504|592070251|FG005|Interim Analysis|Missed Schedule Date|0|||
163918262|NCT00296504|592070252|FG006|Interim Analysis|Missed Schedule Date|0|||
163918263|NCT00296504|592070253|FG007|Interim Analysis|Missed Schedule Date|0|||
163918264|NCT00296504|592070254|FG008|Interim Analysis|Missed Schedule Date|0|||
163918265|NCT00296504|592070246|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
163918266|NCT00296504|592070247|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
163918267|NCT00296504|592070248|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
163918268|NCT00296504|592070249|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
163918269|NCT00296504|592070250|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
163918270|NCT00296504|592070251|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
164030640|NCT02034552|592472649|FG002|Overall Study|Non-compliance with study drug|1|||
164030641|NCT02034552|592472647|FG000|Overall Study|Clinical progression|5|||
164030642|NCT02034552|592472648|FG001|Overall Study|Clinical progression|7|||
164030643|NCT02034552|592472649|FG002|Overall Study|Clinical progression|9|||
164030644|NCT02501902|592472652|FG000|Overall Study|Subject Refused Further Follow-up|0|||
164030645|NCT02501902|592472653|FG001|Overall Study|Subject Refused Further Follow-up|0|||
164030646|NCT02501902|592472654|FG002|Overall Study|Subject Refused Further Follow-up|0|||
164030647|NCT02501902|592472655|FG003|Overall Study|Subject Refused Further Follow-up|0|||
164030648|NCT02501902|592472656|FG004|Overall Study|Subject Refused Further Follow-up|0|||
164030649|NCT02501902|592472657|FG005|Overall Study|Subject Refused Further Follow-up|0|||
164030650|NCT02501902|592472658|FG006|Overall Study|Subject Refused Further Follow-up|0|||
164030651|NCT02501902|592472659|FG007|Overall Study|Subject Refused Further Follow-up|1|||
164030652|NCT02501902|592472652|FG000|Overall Study|Study Terminated by Sponsor|0|||
164030653|NCT02501902|592472653|FG001|Overall Study|Study Terminated by Sponsor|3|||
164030654|NCT02501902|592472654|FG002|Overall Study|Study Terminated by Sponsor|0|||
164030655|NCT02501902|592472655|FG003|Overall Study|Study Terminated by Sponsor|1|||
164030656|NCT02501902|592472656|FG004|Overall Study|Study Terminated by Sponsor|1|||
164030657|NCT02501902|592472657|FG005|Overall Study|Study Terminated by Sponsor|0|||
164030658|NCT02501902|592472658|FG006|Overall Study|Study Terminated by Sponsor|2|||
164030659|NCT02501902|592472659|FG007|Overall Study|Study Terminated by Sponsor|4|||
164030660|NCT02501902|592472652|FG000|Overall Study|Death|3|||
164030661|NCT02501902|592472653|FG001|Overall Study|Death|4|||
164030662|NCT02501902|592472654|FG002|Overall Study|Death|4|||
164030663|NCT02501902|592472655|FG003|Overall Study|Death|10|||
164030664|NCT02501902|592472656|FG004|Overall Study|Death|10|||
164030665|NCT02501902|592472657|FG005|Overall Study|Death|11|||
164030666|NCT02501902|592472658|FG006|Overall Study|Death|7|||
164030667|NCT02501902|592472659|FG007|Overall Study|Death|15|||
164030668|NCT02267278|592472660|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
164030669|NCT02267278|592472660|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
164030670|NCT02267278|592472660|FG000|Overall Study|Developed new cancer diagnoses|2|||
164030671|NCT02267278|592472660|FG000|Overall Study|prescribed prohibited medication|1|||
164030672|NCT02513771|592472661|FG000|Overall Study|Lost to Follow-up|1|||
164096919|NCT04206332|592718991|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
164030673|NCT02513771|592472662|FG001|Overall Study|Lost to Follow-up|1|||
164030674|NCT02513771|592472661|FG000|Overall Study|Not being able to get to clinic|1|||
164030675|NCT02513771|592472662|FG001|Overall Study|Not being able to get to clinic|0|||
164030676|NCT00650091|592472663|FG000|Amended Study Design|Withdrawal by Subject|12|||
164030677|NCT00650091|592472664|FG001|Amended Study Design|Withdrawal by Subject|11|||
164030678|NCT00650091|592472665|FG002|Amended Study Design|Withdrawal by Subject|0|||
164030679|NCT00650091|592472663|FG000|Amended Study Design|Physician Decision|5|||
164030680|NCT00650091|592472664|FG001|Amended Study Design|Physician Decision|0|||
164030681|NCT00650091|592472665|FG002|Amended Study Design|Physician Decision|0|||
164030682|NCT00650091|592472663|FG000|Amended Study Design|Adverse Event|1|||
164030683|NCT00650091|592472664|FG001|Amended Study Design|Adverse Event|4|||
164030684|NCT00650091|592472665|FG002|Amended Study Design|Adverse Event|0|||
164030685|NCT00650091|592472663|FG000|Amended Study Design|Lung transplantation|4|||
163918271|NCT00296504|592070252|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
163918272|NCT00296504|592070253|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
163918273|NCT00296504|592070254|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
163918274|NCT00296504|592070246|FG000|Interim Analysis|Participant Stopped|0|||
163918275|NCT00296504|592070247|FG001|Interim Analysis|Participant Stopped|0|||
163918276|NCT00296504|592070248|FG002|Interim Analysis|Participant Stopped|0|||
163918277|NCT00296504|592070249|FG003|Interim Analysis|Participant Stopped|0|||
163918278|NCT00296504|592070250|FG004|Interim Analysis|Participant Stopped|1|||
163918279|NCT00296504|592070251|FG005|Interim Analysis|Participant Stopped|0|||
163918280|NCT00296504|592070252|FG006|Interim Analysis|Participant Stopped|0|||
163918281|NCT00296504|592070253|FG007|Interim Analysis|Participant Stopped|0|||
163918282|NCT00296504|592070254|FG008|Interim Analysis|Participant Stopped|0|||
163918283|NCT00296504|592070246|FG000|Interim Analysis|Physician and Participant Decision|0|||
163918284|NCT00296504|592070247|FG001|Interim Analysis|Physician and Participant Decision|0|||
163918285|NCT00296504|592070248|FG002|Interim Analysis|Physician and Participant Decision|0|||
163918286|NCT00296504|592070249|FG003|Interim Analysis|Physician and Participant Decision|0|||
163918287|NCT00296504|592070250|FG004|Interim Analysis|Physician and Participant Decision|0|||
163918288|NCT00296504|592070251|FG005|Interim Analysis|Physician and Participant Decision|1|||
163918289|NCT00296504|592070252|FG006|Interim Analysis|Physician and Participant Decision|0|||
163918290|NCT00296504|592070253|FG007|Interim Analysis|Physician and Participant Decision|0|||
163918291|NCT00296504|592070254|FG008|Interim Analysis|Physician and Participant Decision|0|||
163918292|NCT00296504|592070246|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
163918293|NCT00296504|592070247|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
163918294|NCT00296504|592070248|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
163918295|NCT00296504|592070249|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
163918296|NCT00296504|592070250|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
163918297|NCT00296504|592070251|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
163918298|NCT00296504|592070252|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
163918299|NCT00296504|592070253|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
163918300|NCT00296504|592070254|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
163918301|NCT00296504|592070246|FG000|Interim Analysis|Study Ended|0|||
163918302|NCT00296504|592070247|FG001|Interim Analysis|Study Ended|0|||
163918303|NCT00296504|592070248|FG002|Interim Analysis|Study Ended|0|||
163918304|NCT00296504|592070249|FG003|Interim Analysis|Study Ended|0|||
163918305|NCT00296504|592070250|FG004|Interim Analysis|Study Ended|0|||
163918306|NCT00296504|592070251|FG005|Interim Analysis|Study Ended|0|||
163918307|NCT00296504|592070252|FG006|Interim Analysis|Study Ended|1|||
163918308|NCT00296504|592070253|FG007|Interim Analysis|Study Ended|0|||
163918309|NCT00296504|592070254|FG008|Interim Analysis|Study Ended|0|||
163918310|NCT00296504|592070246|FG000|Interim Analysis|Participant Needed Interferon|0|||
163918311|NCT00296504|592070247|FG001|Interim Analysis|Participant Needed Interferon|0|||
163918312|NCT00296504|592070248|FG002|Interim Analysis|Participant Needed Interferon|0|||
163918313|NCT00296504|592070249|FG003|Interim Analysis|Participant Needed Interferon|0|||
163918314|NCT00296504|592070250|FG004|Interim Analysis|Participant Needed Interferon|0|||
163918315|NCT00296504|592070251|FG005|Interim Analysis|Participant Needed Interferon|0|||
163918316|NCT00296504|592070252|FG006|Interim Analysis|Participant Needed Interferon|0|||
163918317|NCT00296504|592070253|FG007|Interim Analysis|Participant Needed Interferon|1|||
163918318|NCT00296504|592070254|FG008|Interim Analysis|Participant Needed Interferon|0|||
163918319|NCT00296504|592070246|FG000|Interim Analysis|Ongoing|32|||
163918320|NCT00296504|592070247|FG001|Interim Analysis|Ongoing|12|||
164030686|NCT00650091|592472664|FG001|Amended Study Design|Lung transplantation|2|||
163918321|NCT00296504|592070248|FG002|Interim Analysis|Ongoing|16|||
164030687|NCT00650091|592472665|FG002|Amended Study Design|Lung transplantation|0|||
164030688|NCT00650091|592472663|FG000|Amended Study Design|Other|1|||
164030689|NCT00650091|592472664|FG001|Amended Study Design|Other|3|||
164030690|NCT00650091|592472665|FG002|Amended Study Design|Other|0|||
164030691|NCT04295356|592472666|FG000|Overall Study|Physician Decision|1|||
164030692|NCT04295356|592472667|FG001|Overall Study|Physician Decision|0|||
164030693|NCT04295356|592472666|FG000|Overall Study|Lost to Follow-up|0|||
164030694|NCT04295356|592472667|FG001|Overall Study|Lost to Follow-up|3|||
164030695|NCT04295356|592472666|FG000|Overall Study|Protocol Violation|0|||
164030696|NCT04295356|592472667|FG001|Overall Study|Protocol Violation|1|||
164030697|NCT01280266|592472668|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
164030698|NCT01280266|592472669|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
164030699|NCT01280266|592472668|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
164030700|NCT01280266|592472669|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
163918322|NCT00296504|592070249|FG003|Interim Analysis|Ongoing|22|||
163918323|NCT00296504|592070250|FG004|Interim Analysis|Ongoing|0|||
163918324|NCT00296504|592070251|FG005|Interim Analysis|Ongoing|0|||
163918325|NCT00296504|592070252|FG006|Interim Analysis|Ongoing|30|||
163918326|NCT00296504|592070253|FG007|Interim Analysis|Ongoing|1|||
163918327|NCT00296504|592070254|FG008|Interim Analysis|Ongoing|0|||
163918328|NCT00296504|592070246|FG000|Final Analysis|Withdrawal by Subject|0|||
163918329|NCT00296504|592070247|FG001|Final Analysis|Withdrawal by Subject|0|||
163918330|NCT00296504|592070248|FG002|Final Analysis|Withdrawal by Subject|0|||
163918331|NCT00296504|592070249|FG003|Final Analysis|Withdrawal by Subject|0|||
163918332|NCT00296504|592070250|FG004|Final Analysis|Withdrawal by Subject|0|||
163918333|NCT00296504|592070251|FG005|Final Analysis|Withdrawal by Subject|0|||
163918334|NCT00296504|592070252|FG006|Final Analysis|Withdrawal by Subject|0|||
163918335|NCT00296504|592070253|FG007|Final Analysis|Withdrawal by Subject|0|||
163918336|NCT00296504|592070254|FG008|Final Analysis|Withdrawal by Subject|1|||
163918337|NCT00296504|592070246|FG000|Final Analysis|Lost to Follow-up|0|||
163918338|NCT00296504|592070247|FG001|Final Analysis|Lost to Follow-up|0|||
163918339|NCT00296504|592070248|FG002|Final Analysis|Lost to Follow-up|0|||
163918340|NCT00296504|592070249|FG003|Final Analysis|Lost to Follow-up|0|||
163918341|NCT00296504|592070250|FG004|Final Analysis|Lost to Follow-up|0|||
163918342|NCT00296504|592070251|FG005|Final Analysis|Lost to Follow-up|0|||
163918343|NCT00296504|592070252|FG006|Final Analysis|Lost to Follow-up|0|||
163918344|NCT00296504|592070253|FG007|Final Analysis|Lost to Follow-up|0|||
163918345|NCT00296504|592070254|FG008|Final Analysis|Lost to Follow-up|5|||
163918346|NCT00296504|592070246|FG000|Final Analysis|Insufficient Viral Load Response|0|||
163918347|NCT00296504|592070247|FG001|Final Analysis|Insufficient Viral Load Response|0|||
163918348|NCT00296504|592070248|FG002|Final Analysis|Insufficient Viral Load Response|0|||
163918349|NCT00296504|592070249|FG003|Final Analysis|Insufficient Viral Load Response|0|||
163918350|NCT00296504|592070250|FG004|Final Analysis|Insufficient Viral Load Response|0|||
163918351|NCT00296504|592070251|FG005|Final Analysis|Insufficient Viral Load Response|0|||
163918352|NCT00296504|592070252|FG006|Final Analysis|Insufficient Viral Load Response|0|||
163918353|NCT00296504|592070253|FG007|Final Analysis|Insufficient Viral Load Response|0|||
163918354|NCT00296504|592070254|FG008|Final Analysis|Insufficient Viral Load Response|6|||
163918355|NCT00296504|592070246|FG000|Final Analysis|Adverse Event|0|||
163918356|NCT00296504|592070247|FG001|Final Analysis|Adverse Event|0|||
163918357|NCT00296504|592070248|FG002|Final Analysis|Adverse Event|0|||
164030701|NCT04268004|592472680|FG000|Overall Study|Excluded from analyses|0|||
163918358|NCT00296504|592070249|FG003|Final Analysis|Adverse Event|0|||
163918359|NCT00296504|592070250|FG004|Final Analysis|Adverse Event|0|||
163918360|NCT00296504|592070251|FG005|Final Analysis|Adverse Event|0|||
163918361|NCT00296504|592070252|FG006|Final Analysis|Adverse Event|0|||
163918362|NCT00296504|592070253|FG007|Final Analysis|Adverse Event|0|||
163918363|NCT00296504|592070254|FG008|Final Analysis|Adverse Event|2|||
163918364|NCT00296504|592070246|FG000|Final Analysis|Pregnancy|0|||
163918365|NCT00296504|592070247|FG001|Final Analysis|Pregnancy|0|||
163918366|NCT00296504|592070248|FG002|Final Analysis|Pregnancy|0|||
163918367|NCT00296504|592070249|FG003|Final Analysis|Pregnancy|0|||
163918368|NCT00296504|592070250|FG004|Final Analysis|Pregnancy|0|||
163918369|NCT00296504|592070251|FG005|Final Analysis|Pregnancy|0|||
163918370|NCT00296504|592070252|FG006|Final Analysis|Pregnancy|0|||
163918371|NCT00296504|592070253|FG007|Final Analysis|Pregnancy|0|||
163918372|NCT00296504|592070254|FG008|Final Analysis|Pregnancy|4|||
163918373|NCT00296504|592070246|FG000|Final Analysis|Tuberculosis|0|||
163918374|NCT00296504|592070247|FG001|Final Analysis|Tuberculosis|0|||
163918375|NCT00296504|592070248|FG002|Final Analysis|Tuberculosis|0|||
163918376|NCT00296504|592070249|FG003|Final Analysis|Tuberculosis|0|||
163918377|NCT00296504|592070250|FG004|Final Analysis|Tuberculosis|0|||
163918378|NCT00296504|592070251|FG005|Final Analysis|Tuberculosis|0|||
163918379|NCT00296504|592070252|FG006|Final Analysis|Tuberculosis|0|||
163918380|NCT00296504|592070253|FG007|Final Analysis|Tuberculosis|0|||
163918381|NCT00296504|592070254|FG008|Final Analysis|Tuberculosis|1|||
163918382|NCT00296504|592070246|FG000|Final Analysis|Participant Moved to Another Country|0|||
163918383|NCT00296504|592070247|FG001|Final Analysis|Participant Moved to Another Country|0|||
163918384|NCT00296504|592070248|FG002|Final Analysis|Participant Moved to Another Country|0|||
163918385|NCT00296504|592070249|FG003|Final Analysis|Participant Moved to Another Country|0|||
163918386|NCT00296504|592070250|FG004|Final Analysis|Participant Moved to Another Country|0|||
163918387|NCT00296504|592070251|FG005|Final Analysis|Participant Moved to Another Country|0|||
163918388|NCT00296504|592070252|FG006|Final Analysis|Participant Moved to Another Country|0|||
163918389|NCT00296504|592070253|FG007|Final Analysis|Participant Moved to Another Country|0|||
163918390|NCT00296504|592070254|FG008|Final Analysis|Participant Moved to Another Country|1|||
163918391|NCT00296504|592070246|FG000|Final Analysis|Poor Adherence|0|||
163918392|NCT00296504|592070247|FG001|Final Analysis|Poor Adherence|0|||
163918393|NCT00296504|592070248|FG002|Final Analysis|Poor Adherence|0|||
163918394|NCT00296504|592070249|FG003|Final Analysis|Poor Adherence|0|||
163918395|NCT00296504|592070250|FG004|Final Analysis|Poor Adherence|0|||
163918396|NCT00296504|592070251|FG005|Final Analysis|Poor Adherence|0|||
163918397|NCT00296504|592070252|FG006|Final Analysis|Poor Adherence|0|||
163918398|NCT00296504|592070253|FG007|Final Analysis|Poor Adherence|0|||
163918399|NCT00296504|592070254|FG008|Final Analysis|Poor Adherence|1|||
163918400|NCT01078571|592070258|FG000|Overall Study|Adverse Event|36|||
163918401|NCT01078571|592070258|FG000|Overall Study|Lack of effectiveness|36|||
163918402|NCT01078571|592070258|FG000|Overall Study|Reason not reported|21|||
164030702|NCT04268004|592472681|FG001|Overall Study|Excluded from analyses|1|||
164030703|NCT01453998|592472682|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
164030704|NCT01453998|592472683|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
164030705|NCT01453998|592472684|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
163918403|NCT01078571|592070258|FG000|Overall Study|Withdrawal by Subject|12|||
163918404|NCT01078571|592070258|FG000|Overall Study|Lost to Follow-up|8|||
163918405|NCT01078571|592070258|FG000|Overall Study|Protocol Violation|2|||
163918406|NCT01878253|592070260|FG000|Overall Study|Death|1|||
163918407|NCT01878253|592070260|FG000|Overall Study|SIdus System Removal|3|||
163918408|NCT01878253|592070260|FG000|Overall Study|Withdrawal by Subject|1|||
163918409|NCT01878253|592070260|FG000|Overall Study|Lost to Follow-up|2|||
163918410|NCT01878253|592070260|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
164030706|NCT00712933|592472691|FG000|Overall Study|Adverse Event|69|||
163918411|NCT04393779|592070263|FG000|Overall Study|Death|1|||
164030707|NCT00712933|592472691|FG000|Overall Study|Lack of Efficacy|6|||
164030708|NCT00712933|592472691|FG000|Overall Study|Lost to Follow-up|22|||
163918412|NCT04393779|592070263|FG000|Overall Study|Device reintervention or explant|4|||
163918413|NCT03802513|592070264|FG000|Overall Study|Lost to Follow-up|1|||
163918414|NCT01190228|592070268|FG000|Overall Study|Protocol Violation|4|||
163918415|NCT01190228|592070269|FG001|Overall Study|Protocol Violation|0|||
163918416|NCT01190228|592070270|FG002|Overall Study|Protocol Violation|0|||
163918417|NCT01190228|592070268|FG000|Overall Study|Withdrawal by Subject|1|||
163918418|NCT01190228|592070269|FG001|Overall Study|Withdrawal by Subject|0|||
163918419|NCT01190228|592070270|FG002|Overall Study|Withdrawal by Subject|0|||
163918420|NCT01395914|592070276|FG000|Overall Study|Unrelated to study drug AE|6|||
163918421|NCT01395914|592070277|FG001|Overall Study|Unrelated to study drug AE|1|||
163918422|NCT01395914|592070276|FG000|Overall Study|Death|23|||
164030709|NCT00712933|592472691|FG000|Overall Study|Non-compliance with study drug|13|||
164030710|NCT00712933|592472691|FG000|Overall Study|Other Pregnancy|37|||
163918423|NCT01395914|592070277|FG001|Overall Study|Death|17|||
163918424|NCT01395914|592070276|FG000|Overall Study|Other|9|||
163918425|NCT01395914|592070277|FG001|Overall Study|Other|3|||
163918426|NCT01395914|592070276|FG000|Overall Study|Withdrawal by patient|27|||
163918427|NCT01395914|592070277|FG001|Overall Study|Withdrawal by patient|14|||
163918428|NCT01395914|592070276|FG000|Overall Study|Study drug-related AE|1|||
163918429|NCT01395914|592070277|FG001|Overall Study|Study drug-related AE|0|||
163918430|NCT01395914|592070276|FG000|Overall Study|Lost to Follow-up|6|||
163918431|NCT01395914|592070277|FG001|Overall Study|Lost to Follow-up|2|||
163918432|NCT01648699|592070278|FG000|Overall Study|Death|1|||
163918433|NCT01648699|592070278|FG000|Overall Study|Lost to Follow-up|2|||
163918434|NCT01648699|592070278|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
163918435|NCT03219216|592070282|FG000|Overall Study|Lost to Follow-up|0|||
163918436|NCT03219216|592070283|FG001|Overall Study|Lost to Follow-up|1|||
163918437|NCT03305458|592070286|FG000|Overall Study|Withdrawal by Subject|50|||
163918438|NCT03305458|592070287|FG001|Overall Study|Withdrawal by Subject|46|||
163918439|NCT03305458|592070288|FG002|Overall Study|Withdrawal by Subject|93|||
163918440|NCT03305458|592070286|FG000|Overall Study|Lost to Follow-up|85|||
163918441|NCT03305458|592070287|FG001|Overall Study|Lost to Follow-up|85|||
163918442|NCT03305458|592070288|FG002|Overall Study|Lost to Follow-up|35|||
163918443|NCT05615870|592070293|FG000|Overall Study|Lost to Follow-up|10|||
163918444|NCT05615870|592070294|FG001|Overall Study|Lost to Follow-up|13|||
163918445|NCT05615870|592070293|FG000|Overall Study|Physician Decision|2|||
163918446|NCT05615870|592070294|FG001|Overall Study|Physician Decision|0|||
163918447|NCT05615870|592070293|FG000|Overall Study|Withdrawal by Subject|0|||
163918448|NCT05615870|592070294|FG001|Overall Study|Withdrawal by Subject|2|||
163918449|NCT05615870|592070293|FG000|Overall Study|Protocol Violation|0|||
163918450|NCT05615870|592070294|FG001|Overall Study|Protocol Violation|3|||
163918451|NCT05615870|592070293|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
163918452|NCT05615870|592070294|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
163918453|NCT05615870|592070293|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
163918454|NCT05615870|592070294|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
163918455|NCT05615870|592070293|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
163918456|NCT05615870|592070294|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
163918457|NCT03520036|592070297|FG000|Overall Study|Adverse Event|1|||
163918458|NCT03520036|592070298|FG001|Overall Study|Adverse Event|2|||
163918459|NCT03520036|592070299|FG002|Overall Study|Adverse Event|0|||
163918460|NCT03520036|592070297|FG000|Overall Study|Protocol Violation|1|||
163918461|NCT03520036|592070298|FG001|Overall Study|Protocol Violation|0|||
163918462|NCT03520036|592070299|FG002|Overall Study|Protocol Violation|0|||
163918463|NCT03520036|592070297|FG000|Overall Study|Withdrawal by Subject|0|||
163918464|NCT03520036|592070298|FG001|Overall Study|Withdrawal by Subject|1|||
163918465|NCT03520036|592070299|FG002|Overall Study|Withdrawal by Subject|4|||
163918466|NCT03520036|592070297|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
163918467|NCT03520036|592070298|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
163918468|NCT03520036|592070299|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
163918469|NCT01855399|592070300|FG000|6 Month|Lost to Follow-up|12|||
163918470|NCT01855399|592070301|FG001|6 Month|Lost to Follow-up|9|||
163918471|NCT01855399|592070300|FG000|6 Month|Withdrawal by Subject|8|||
163918472|NCT01855399|592070301|FG001|6 Month|Withdrawal by Subject|6|||
163918473|NCT01855399|592070300|FG000|12 Month|Lost to Follow-up|7|||
163918474|NCT01855399|592070301|FG001|12 Month|Lost to Follow-up|11|||
163918475|NCT03019289|592070302|FG000|Overall Study|Adverse Event|1|||
163918476|NCT03019289|592070303|FG001|Overall Study|Adverse Event|0|||
164030711|NCT00712933|592472691|FG000|Overall Study|Sponsor decision|14|||
164030712|NCT00712933|592472691|FG000|Overall Study|Withdrew consent|4|||
164030713|NCT00712933|592472691|FG000|Overall Study|Hip replacement surgery|1|||
164030714|NCT00712933|592472691|FG000|Overall Study|Involved in Clinical research|3|||
164030715|NCT00712933|592472691|FG000|Overall Study|Participant hospitalized|1|||
164030716|NCT00712933|592472691|FG000|Overall Study|Participant travelled overseas|2|||
164030717|NCT00712933|592472691|FG000|Overall Study|Death of patient|1|||
164030718|NCT00712933|592472691|FG000|Overall Study|Other Physician decision|1|||
164030719|NCT00712933|592472691|FG000|Overall Study|Not committed to contraception|1|||
164030720|NCT00712933|592472691|FG000|Overall Study|Participant received medication|1|||
164030721|NCT00712933|592472691|FG000|Overall Study|Physician Decision|36|||
164030722|NCT00712933|592472691|FG000|Overall Study|Protocol Violation|4|||
163918477|NCT03019289|592070304|FG002|Overall Study|Adverse Event|0|||
163918478|NCT03019289|592070305|FG003|Overall Study|Adverse Event|0|||
163918479|NCT03019289|592070306|FG004|Overall Study|Adverse Event|0|||
163918480|NCT03019289|592070307|FG005|Overall Study|Adverse Event|0|||
163918481|NCT03019289|592070308|FG006|Overall Study|Adverse Event|0|||
163918482|NCT03019289|592070309|FG007|Overall Study|Adverse Event|0|||
163918483|NCT03019289|592070310|FG008|Overall Study|Adverse Event|1|||
163918484|NCT03019289|592070302|FG000|Overall Study|Other|1|||
163918485|NCT03019289|592070303|FG001|Overall Study|Other|0|||
164030723|NCT00712933|592472691|FG000|Overall Study|Withdrawal by Subject|151|||
164030724|NCT01429077|592472695|FG000|Overall Study|Lost to Follow-up|0|||
164030725|NCT01429077|592472696|FG001|Overall Study|Lost to Follow-up|3|||
164030726|NCT01879319|592472698|FG000|Overall Study|Withdrawal by Subject|1|||
164030727|NCT01879319|592472699|FG001|Overall Study|Withdrawal by Subject|0|||
164030728|NCT01879319|592472698|FG000|Overall Study|Lost to Follow-up|1|||
164030729|NCT01879319|592472699|FG001|Overall Study|Lost to Follow-up|5|||
164030730|NCT01360762|592472700|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
164030731|NCT01360762|592472700|FG000|Main Study Period (12-month Treatment)|Death|5|||
164030732|NCT01360762|592472700|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
164030733|NCT01360762|592472700|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
164030734|NCT01360762|592472700|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
164030735|NCT01360762|592472700|FG000|Whole Study Period|Lost to Follow-up|10|||
164030736|NCT01360762|592472700|FG000|Whole Study Period|Death|7|||
164030737|NCT01360762|592472700|FG000|Whole Study Period|Patient relapsed|18|||
164030738|NCT01360762|592472700|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
163918486|NCT03019289|592070304|FG002|Overall Study|Other|0|||
163918487|NCT03019289|592070305|FG003|Overall Study|Other|0|||
163918488|NCT03019289|592070306|FG004|Overall Study|Other|0|||
163918489|NCT03019289|592070307|FG005|Overall Study|Other|0|||
163918490|NCT03019289|592070308|FG006|Overall Study|Other|0|||
163918491|NCT03019289|592070309|FG007|Overall Study|Other|0|||
163918492|NCT03019289|592070310|FG008|Overall Study|Other|0|||
163918493|NCT04743999|592070311|FG000|3-month Questionnaire|Death|1|||
163918494|NCT04743999|592070311|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
163918495|NCT04743999|592070311|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
163918496|NCT04743999|592070311|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
163918497|NCT01721759|592070312|FG000|Treatment Period|Disease Progression|85|||
163918498|NCT01721759|592070312|FG000|Treatment Period|Study drug toxicity|14|||
163918499|NCT01721759|592070312|FG000|Treatment Period|Death|1|||
163918500|NCT01721759|592070312|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
163918501|NCT01721759|592070312|FG000|Treatment Period|Participant request to withdraw|3|||
163918502|NCT01721759|592070312|FG000|Treatment Period|Other Reasons|3|||
163918503|NCT01721759|592070312|FG000|End of Study Period|Participant Withdrew Consent|5|||
163918504|NCT01721759|592070312|FG000|End of Study Period|Death|101|||
163918505|NCT01721759|592070312|FG000|End of Study Period|Lost to Follow-up|1|||
163918506|NCT01721759|592070312|FG000|End of Study Period|Other Reasons|10|||
163918507|NCT03926117|592070313|FG000|Overall Study|Unclassified|1|||
163918508|NCT03926117|592070314|FG001|Overall Study|Unclassified|4|||
163918509|NCT03926117|592070315|FG002|Overall Study|Unclassified|1|||
163918510|NCT03926117|592070316|FG003|Overall Study|Unclassified|4|||
163918511|NCT03926117|592070313|FG000|Overall Study|Withdrawal by Subject|3|||
163918512|NCT03926117|592070314|FG001|Overall Study|Withdrawal by Subject|0|||
163918513|NCT03926117|592070315|FG002|Overall Study|Withdrawal by Subject|1|||
163918514|NCT03926117|592070316|FG003|Overall Study|Withdrawal by Subject|1|||
163918515|NCT03926117|592070313|FG000|Overall Study|Lost to Follow-up|0|||
163918516|NCT03926117|592070314|FG001|Overall Study|Lost to Follow-up|2|||
163918517|NCT03926117|592070315|FG002|Overall Study|Lost to Follow-up|1|||
163918518|NCT03926117|592070316|FG003|Overall Study|Lost to Follow-up|0|||
163918519|NCT03926117|592070313|FG000|Overall Study|Adverse Event|1|||
163918520|NCT03926117|592070314|FG001|Overall Study|Adverse Event|2|||
163918521|NCT03926117|592070315|FG002|Overall Study|Adverse Event|3|||
163918522|NCT03926117|592070316|FG003|Overall Study|Adverse Event|1|||
163918523|NCT03926117|592070313|FG000|Overall Study|Randomized but not treated|1|||
163918524|NCT03926117|592070314|FG001|Overall Study|Randomized but not treated|1|||
163918525|NCT03926117|592070315|FG002|Overall Study|Randomized but not treated|0|||
163918526|NCT03926117|592070316|FG003|Overall Study|Randomized but not treated|1|||
163918527|NCT01334606|592070317|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
163918528|NCT02312245|592070318|FG000|Overall Study|Death|0|||
163918529|NCT02312245|592070319|FG001|Overall Study|Death|0|||
163918530|NCT02312245|592070320|FG002|Overall Study|Death|0|||
163918531|NCT02312245|592070321|FG003|Overall Study|Death|1|||
163918532|NCT02312245|592070318|FG000|Overall Study|Withdrawal by Subject|1|||
163918533|NCT02312245|592070319|FG001|Overall Study|Withdrawal by Subject|1|||
163918534|NCT02312245|592070320|FG002|Overall Study|Withdrawal by Subject|0|||
163918535|NCT02312245|592070321|FG003|Overall Study|Withdrawal by Subject|2|||
163918536|NCT02312245|592070318|FG000|Overall Study|Alternative Therapy|1|||
163918537|NCT02312245|592070319|FG001|Overall Study|Alternative Therapy|0|||
163918538|NCT02312245|592070320|FG002|Overall Study|Alternative Therapy|0|||
163918539|NCT02312245|592070321|FG003|Overall Study|Alternative Therapy|0|||
163918540|NCT02312245|592070318|FG000|Overall Study|Progression|0|||
163918541|NCT02312245|592070319|FG001|Overall Study|Progression|0|||
163918542|NCT02312245|592070320|FG002|Overall Study|Progression|0|||
163918543|NCT02312245|592070321|FG003|Overall Study|Progression|5|||
163918544|NCT02312245|592070318|FG000|Overall Study|Patient went to hospice|0|||
163918545|NCT02312245|592070319|FG001|Overall Study|Patient went to hospice|0|||
163918546|NCT02312245|592070320|FG002|Overall Study|Patient went to hospice|0|||
163918547|NCT02312245|592070321|FG003|Overall Study|Patient went to hospice|1|||
163918548|NCT02312245|592070318|FG000|Overall Study|Ineligible|1|||
163918549|NCT02312245|592070319|FG001|Overall Study|Ineligible|0|||
163918550|NCT02312245|592070320|FG002|Overall Study|Ineligible|0|||
163918551|NCT02312245|592070321|FG003|Overall Study|Ineligible|0|||
163918552|NCT01123200|592070322|FG000|Overall Study|Withdrawal by Subject|1|||
163918553|NCT01288729|592070327|FG000|Overall Study|Withdrawal by Subject|1|||
163918554|NCT01288729|592070328|FG001|Overall Study|Withdrawal by Subject|0|||
163918555|NCT03214198|592070329|FG000|Overall Study|Case Report Forms Uncollected|18|||
163918556|NCT03214198|592070329|FG000|Overall Study|Protocol Deviation|18|||
163918557|NCT02577315|592070332|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163918558|NCT02577315|592070333|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
163918559|NCT03686176|592070334|FG000|Overall Study|Procedure cancelled|1|||
163918560|NCT03686176|592070335|FG001|Overall Study|Procedure cancelled|0|||
163918561|NCT03686176|592070336|FG002|Overall Study|Procedure cancelled|0|||
163918562|NCT03686176|592070334|FG000|Overall Study|VR Malfunction|1|||
163918563|NCT03686176|592070335|FG001|Overall Study|VR Malfunction|0|||
163918564|NCT03686176|592070336|FG002|Overall Study|VR Malfunction|0|||
163918565|NCT03530345|592070342|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
163918566|NCT03530345|592070343|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
163918567|NCT03530345|592070342|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
163918568|NCT03530345|592070343|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
163918569|NCT03530345|592070342|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
163918570|NCT03530345|592070343|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
163918571|NCT03530345|592070342|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
163918572|NCT03530345|592070343|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
163918573|NCT02442622|592070344|FG000|Overall Study|Withdrawal by Subject|3|||
163918574|NCT02442622|592070345|FG001|Overall Study|Withdrawal by Subject|1|||
163918575|NCT02938520|592070346|FG000|Overall Study|On-going at the time of analysis|258|||
163918576|NCT02938520|592070347|FG001|Overall Study|On-going at the time of analysis|261|||
163918577|NCT02938520|592070346|FG000|Overall Study|Physician Decision|2|||
163918578|NCT02938520|592070347|FG001|Overall Study|Physician Decision|5|||
163918579|NCT02938520|592070346|FG000|Overall Study|Lost to Follow-up|2|||
163918580|NCT02938520|592070347|FG001|Overall Study|Lost to Follow-up|2|||
163918581|NCT02938520|592070346|FG000|Overall Study|Withdrawal by Subject|7|||
163918582|NCT02938520|592070347|FG001|Overall Study|Withdrawal by Subject|7|||
163918583|NCT02938520|592070346|FG000|Overall Study|Protocol Violation|0|||
163918584|NCT02938520|592070347|FG001|Overall Study|Protocol Violation|1|||
163918585|NCT02938520|592070346|FG000|Overall Study|Lack of Efficacy|5|||
163918586|NCT02938520|592070347|FG001|Overall Study|Lack of Efficacy|3|||
163918587|NCT02938520|592070346|FG000|Overall Study|Adverse Event|9|||
163918588|NCT02938520|592070347|FG001|Overall Study|Adverse Event|4|||
163918589|NCT00197106|592071279|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
163918590|NCT00197106|592071280|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
163918591|NCT00197106|592071281|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
163918592|NCT00197106|592071279|FG000|Overall Treatment Period|Lack of Efficacy|0|||
163918593|NCT00197106|592071280|FG001|Overall Treatment Period|Lack of Efficacy|1|||
163918594|NCT00197106|592071281|FG002|Overall Treatment Period|Lack of Efficacy|0|||
163918595|NCT00197106|592071279|FG000|Overall Treatment Period|Lost to Follow-up|0|||
163918596|NCT00197106|592071280|FG001|Overall Treatment Period|Lost to Follow-up|0|||
163918597|NCT00197106|592071281|FG002|Overall Treatment Period|Lost to Follow-up|2|||
163918598|NCT00197106|592071279|FG000|Overall Treatment Period|Protocol Violation|0|||
163918599|NCT00197106|592071280|FG001|Overall Treatment Period|Protocol Violation|0|||
163918600|NCT00197106|592071281|FG002|Overall Treatment Period|Protocol Violation|2|||
163918601|NCT00197106|592071279|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
163918602|NCT00197106|592071280|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
163918603|NCT00197106|592071281|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
163918604|NCT00111839|592071282|FG000|Overall Study|Disease Progression|30|||
163918605|NCT00111839|592071283|FG001|Overall Study|Disease Progression|33|||
163918606|NCT00111839|592071284|FG002|Overall Study|Disease Progression|33|||
163918607|NCT00111839|592071282|FG000|Overall Study|Adverse Event|5|||
163918608|NCT00111839|592071283|FG001|Overall Study|Adverse Event|3|||
163918609|NCT00111839|592071284|FG002|Overall Study|Adverse Event|1|||
163918610|NCT00111839|592071282|FG000|Overall Study|Protocol Violation|2|||
163918611|NCT00111839|592071283|FG001|Overall Study|Protocol Violation|4|||
163918612|NCT00111839|592071284|FG002|Overall Study|Protocol Violation|2|||
164030739|NCT04724733|592472701|FG000|Overall Study|Lost to Follow-up|1|||
164030740|NCT04724733|592472702|FG001|Overall Study|Lost to Follow-up|1|||
164030741|NCT04724733|592472703|FG002|Overall Study|Lost to Follow-up|1|||
164030742|NCT03067129|592472704|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
164030743|NCT03067129|592472705|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
164030744|NCT03067129|592472706|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
163918613|NCT00111839|592071282|FG000|Overall Study|Death|1|||
163918614|NCT00111839|592071283|FG001|Overall Study|Death|1|||
163918615|NCT00111839|592071284|FG002|Overall Study|Death|6|||
163918616|NCT00111839|592071282|FG000|Overall Study|Withdrawal by Subject|2|||
163918617|NCT00111839|592071283|FG001|Overall Study|Withdrawal by Subject|2|||
163918618|NCT00111839|592071284|FG002|Overall Study|Withdrawal by Subject|2|||
163918619|NCT00111839|592071282|FG000|Overall Study|Lost to Follow-up|1|||
163918620|NCT00111839|592071283|FG001|Overall Study|Lost to Follow-up|0|||
164030745|NCT03067129|592472707|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
164030746|NCT03067129|592472704|FG000|Overall Study|Withdrawal by Subject|0|||
164030747|NCT03067129|592472705|FG001|Overall Study|Withdrawal by Subject|0|||
164030748|NCT03067129|592472706|FG002|Overall Study|Withdrawal by Subject|1|||
164030749|NCT03067129|592472707|FG003|Overall Study|Withdrawal by Subject|2|||
164030750|NCT03067129|592472704|FG000|Overall Study|Lost to Follow-up|5|||
164030751|NCT03067129|592472705|FG001|Overall Study|Lost to Follow-up|5|||
164030752|NCT03067129|592472706|FG002|Overall Study|Lost to Follow-up|4|||
164030753|NCT03067129|592472707|FG003|Overall Study|Lost to Follow-up|3|||
164030754|NCT03372603|592472708|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
164030755|NCT03372603|592472709|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
164030756|NCT03372603|592472708|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
164030757|NCT03372603|592472709|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
164030758|NCT03341923|592472710|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
164030759|NCT03341923|592472711|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
164030760|NCT03986190|592472712|FG000|Overall Study|Withdrawal by Subject|12|||
164030761|NCT03986190|592472713|FG001|Overall Study|Withdrawal by Subject|0|||
164030762|NCT02806947|592472714|FG000|Overall Study|Withdrawal by Subject|5|||
164030763|NCT02806947|592472715|FG001|Overall Study|Withdrawal by Subject|1|||
164030764|NCT04511819|592472716|FG000|Overall Study|Non-compliance with study drug|5|||
164030765|NCT04511819|592472717|FG001|Overall Study|Non-compliance with study drug|1|||
164030766|NCT04511819|592472716|FG000|Overall Study|Withdrawal by Subject|0|||
164030767|NCT04511819|592472717|FG001|Overall Study|Withdrawal by Subject|3|||
164030768|NCT04511819|592472716|FG000|Overall Study|Adverse Event|0|||
164030769|NCT04511819|592472717|FG001|Overall Study|Adverse Event|1|||
164030770|NCT04511819|592472716|FG000|Overall Study|Protocol deviation|1|||
164030771|NCT04511819|592472717|FG001|Overall Study|Protocol deviation|0|||
164030772|NCT04929613|592472718|FG000|Overall Study|Withdrawal by Subject|12|||
164030773|NCT00084929|592472724|FG000|Overall Study|ineligible - medical contraindication|1|||
164030774|NCT00084929|592472724|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
164030775|NCT00084929|592472724|FG000|Overall Study|Ineligible - Medical history|6|||
164030776|NCT00084929|592472724|FG000|Overall Study|Withdrawal by Subject|10|||
164030777|NCT00084929|592472724|FG000|Overall Study|Missing/incomplete CTC exam|9|||
164030778|NCT00084929|592472724|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
164030779|NCT00844649|592472726|FG000|Overall Study|Progressive Disease|196|||
164030780|NCT00844649|592472727|FG001|Overall Study|Progressive Disease|245|||
164030781|NCT00844649|592472726|FG000|Overall Study|Adverse Event|128|||
164030782|NCT00844649|592472727|FG001|Overall Study|Adverse Event|73|||
164030783|NCT00844649|592472726|FG000|Overall Study|Physician Decision|25|||
164030784|NCT00844649|592472727|FG001|Overall Study|Physician Decision|18|||
164030785|NCT00844649|592472726|FG000|Overall Study|Protocol Violation|10|||
164030786|NCT00844649|592472727|FG001|Overall Study|Protocol Violation|6|||
164030787|NCT00844649|592472726|FG000|Overall Study|Withdrawal by Subject|28|||
164030788|NCT00844649|592472727|FG001|Overall Study|Withdrawal by Subject|39|||
164030789|NCT00844649|592472726|FG000|Overall Study|Other|7|||
164030790|NCT00844649|592472727|FG001|Overall Study|Other|10|||
164030791|NCT00844649|592472726|FG000|Overall Study|Withdrew prior to starting treatment|11|||
164030792|NCT00844649|592472727|FG001|Overall Study|Withdrew prior to starting treatment|27|||
164030793|NCT00664209|592472728|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
164030794|NCT00664209|592472728|FG000|Study Treatment Period|Physician Decision|4|||
164030795|NCT00664209|592472728|FG000|Study Treatment Period|Withdrawal by Subject|2|||
164030796|NCT00091026|592472729|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
164030797|NCT00091026|592472730|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
164030798|NCT00091026|592472729|FG000|Overall Study|Patient withdrew and never received trea|0|||
164030799|NCT00091026|592472730|FG001|Overall Study|Patient withdrew and never received trea|2|||
164030800|NCT00091026|592472729|FG000|Overall Study|Unknown-never received treatment|0|||
164030801|NCT00091026|592472730|FG001|Overall Study|Unknown-never received treatment|1|||
164030802|NCT00065442|592472731|FG000|Overall Study|Lost to Follow-up|1|||
164030803|NCT00065442|592472732|FG001|Overall Study|Lost to Follow-up|1|||
164030804|NCT00065442|592472731|FG000|Overall Study|Death|121|||
164030805|NCT00065442|592472732|FG001|Overall Study|Death|210|||
164030806|NCT00065442|592472731|FG000|Overall Study|Withdrawal by Subject|3|||
164030807|NCT00065442|592472732|FG001|Overall Study|Withdrawal by Subject|9|||
164030808|NCT01797965|592472733|FG000|Overall Study|Adverse Event|104|||
164030809|NCT01797965|592472734|FG001|Overall Study|Adverse Event|129|||
164030810|NCT01797965|592472735|FG002|Overall Study|Adverse Event|4|||
164030811|NCT01797965|592472736|FG003|Overall Study|Adverse Event|21|||
164030812|NCT01797965|592472733|FG000|Overall Study|Lost to Follow-up|9|||
164030813|NCT01797965|592472734|FG001|Overall Study|Lost to Follow-up|8|||
164030814|NCT01797965|592472735|FG002|Overall Study|Lost to Follow-up|1|||
164030815|NCT01797965|592472736|FG003|Overall Study|Lost to Follow-up|2|||
164030816|NCT01797965|592472733|FG000|Overall Study|Consent withdrawn|130|||
164030817|NCT01797965|592472734|FG001|Overall Study|Consent withdrawn|117|||
163918621|NCT00111839|592071284|FG002|Overall Study|Lost to Follow-up|0|||
163918622|NCT00111839|592071282|FG000|Overall Study|Logistical Constraint|1|||
164030818|NCT01797965|592472735|FG002|Overall Study|Consent withdrawn|3|||
164030819|NCT01797965|592472736|FG003|Overall Study|Consent withdrawn|35|||
164030820|NCT01797965|592472733|FG000|Overall Study|Investigator decision|21|||
164030821|NCT01797965|592472734|FG001|Overall Study|Investigator decision|15|||
164030822|NCT01797965|592472735|FG002|Overall Study|Investigator decision|0|||
164030823|NCT01797965|592472736|FG003|Overall Study|Investigator decision|0|||
164030824|NCT01797965|592472733|FG000|Overall Study|Death|2|||
164030825|NCT01797965|592472734|FG001|Overall Study|Death|4|||
164030826|NCT01797965|592472735|FG002|Overall Study|Death|0|||
164030827|NCT01797965|592472736|FG003|Overall Study|Death|0|||
164030828|NCT01797965|592472733|FG000|Overall Study|Disease progression, defined by protocol|3|||
164030829|NCT01797965|592472734|FG001|Overall Study|Disease progression, defined by protocol|1|||
164030830|NCT01797965|592472735|FG002|Overall Study|Disease progression, defined by protocol|0|||
164030831|NCT01797965|592472736|FG003|Overall Study|Disease progression, defined by protocol|0|||
164030832|NCT01797965|592472733|FG000|Overall Study|Reason Not Specified|280|||
164030833|NCT01797965|592472734|FG001|Overall Study|Reason Not Specified|295|||
164030834|NCT01797965|592472735|FG002|Overall Study|Reason Not Specified|0|||
164030835|NCT01797965|592472736|FG003|Overall Study|Reason Not Specified|15|||
164030836|NCT01764256|592472737|FG000|Received All Vaccinations|Adverse Event|1|||
164030837|NCT01764256|592472738|FG001|Received All Vaccinations|Adverse Event|1|||
164030838|NCT01764256|592472739|FG002|Received All Vaccinations|Adverse Event|0|||
164030839|NCT01764256|592472740|FG003|Received All Vaccinations|Adverse Event|0|||
164030840|NCT01764256|592472737|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
164030841|NCT01764256|592472738|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
164030842|NCT01764256|592472739|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
164030843|NCT01764256|592472740|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
164030844|NCT01764256|592472737|FG000|Received All Vaccinations|Lost to Follow-up|1|||
164030845|NCT01764256|592472738|FG001|Received All Vaccinations|Lost to Follow-up|0|||
164030846|NCT01764256|592472739|FG002|Received All Vaccinations|Lost to Follow-up|0|||
164030847|NCT01764256|592472740|FG003|Received All Vaccinations|Lost to Follow-up|0|||
164030848|NCT01764256|592472737|FG000|Completed Study|Lost to Follow-up|0|||
164030849|NCT01764256|592472738|FG001|Completed Study|Lost to Follow-up|0|||
164030850|NCT01764256|592472739|FG002|Completed Study|Lost to Follow-up|0|||
164030851|NCT01764256|592472740|FG003|Completed Study|Lost to Follow-up|1|||
164030852|NCT01153841|592472741|FG000|Overall Study|Adverse Event|1|||
164030853|NCT01153841|592472742|FG001|Overall Study|Adverse Event|0|||
164030854|NCT01153841|592472741|FG000|Overall Study|Withdrawal by Subject|1|||
164030855|NCT01153841|592472742|FG001|Overall Study|Withdrawal by Subject|0|||
164030856|NCT01153841|592472741|FG000|Overall Study|Protocol Violation|2|||
164030857|NCT01153841|592472742|FG001|Overall Study|Protocol Violation|0|||
164030858|NCT01153841|592472741|FG000|Overall Study|Lost to Follow-up|2|||
163918623|NCT00111839|592071283|FG001|Overall Study|Logistical Constraint|0|||
163918624|NCT00111839|592071284|FG002|Overall Study|Logistical Constraint|0|||
163918625|NCT00111839|592071282|FG000|Overall Study|Other|6|||
163918626|NCT00111839|592071283|FG001|Overall Study|Other|3|||
163918627|NCT00111839|592071284|FG002|Overall Study|Other|3|||
163918628|NCT00111839|592071282|FG000|Overall Study|Randomized but Not Treated|0|||
163918629|NCT00111839|592071283|FG001|Overall Study|Randomized but Not Treated|0|||
163918630|NCT00111839|592071284|FG002|Overall Study|Randomized but Not Treated|2|||
163918631|NCT00762723|592071285|FG000|Overall Study|Study Terminated slow enrollement|5|||
163918632|NCT00762723|592071286|FG001|Overall Study|Study Terminated slow enrollement|5|||
163918633|NCT00762723|592071287|FG002|Overall Study|Study Terminated slow enrollement|3|||
163918634|NCT00449033|592071297|FG000|Treatment Period|Adverse Event|117|||
163918635|NCT00449033|592071298|FG001|Treatment Period|Adverse Event|83|||
163918636|NCT00449033|592071297|FG000|Treatment Period|Death|21|||
164030859|NCT01153841|592472742|FG001|Overall Study|Lost to Follow-up|0|||
164030860|NCT00712322|592472749|FG000|Overall Study|Protocol deviation|0|||
164030861|NCT00712322|592472750|FG001|Overall Study|Protocol deviation|1|||
163918637|NCT00449033|592071298|FG001|Treatment Period|Death|12|||
163918638|NCT00449033|592071297|FG000|Treatment Period|Lost to Follow-up|0|||
163918639|NCT00449033|592071298|FG001|Treatment Period|Lost to Follow-up|2|||
164030862|NCT00712322|592472751|FG002|Overall Study|Protocol deviation|0|||
164030863|NCT04404010|592472752|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
164030864|NCT04404010|592472753|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
164030865|NCT01599754|592472757|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
164030866|NCT01599754|592472758|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
164030867|NCT01599754|592472757|FG000|Overall Study|Participant noncompliance|4|||
164030868|NCT01599754|592472758|FG001|Overall Study|Participant noncompliance|4|||
163918640|NCT00449033|592071297|FG000|Treatment Period|Physician Decision|4|||
163918641|NCT00449033|592071298|FG001|Treatment Period|Physician Decision|5|||
163918642|NCT00449033|592071297|FG000|Treatment Period|Protocol Violation|8|||
163918643|NCT00449033|592071298|FG001|Treatment Period|Protocol Violation|7|||
163918644|NCT00449033|592071297|FG000|Treatment Period|Disease Progression|231|||
164030869|NCT01599754|592472757|FG000|Overall Study|Lost to Follow-up|13|||
164030870|NCT01599754|592472758|FG001|Overall Study|Lost to Follow-up|6|||
164030871|NCT01599754|592472757|FG000|Overall Study|Death|31|||
164030872|NCT01599754|592472758|FG001|Overall Study|Death|33|||
164030873|NCT01599754|592472757|FG000|Overall Study|Adverse Event|3|||
164030874|NCT01599754|592472758|FG001|Overall Study|Adverse Event|2|||
164030875|NCT01599754|592472757|FG000|Overall Study|Investigator decision|1|||
164030876|NCT01599754|592472758|FG001|Overall Study|Investigator decision|3|||
164030877|NCT01599754|592472757|FG000|Overall Study|Withdrawal by Subject|24|||
164030878|NCT01599754|592472758|FG001|Overall Study|Withdrawal by Subject|25|||
164030879|NCT01599754|592472757|FG000|Overall Study|Study terminated by sponsor|282|||
164030880|NCT01599754|592472758|FG001|Overall Study|Study terminated by sponsor|285|||
164030881|NCT00242580|592472759|FG000|Overall Study|Adverse Event|3|||
164030882|NCT00242580|592472760|FG001|Overall Study|Adverse Event|0|||
164030883|NCT00242580|592472761|FG002|Overall Study|Adverse Event|2|||
164030884|NCT00242580|592472759|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164030885|NCT00242580|592472760|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
164030886|NCT00242580|592472761|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
164030887|NCT00242580|592472759|FG000|Overall Study|Protocol Violation|0|||
164030888|NCT00242580|592472760|FG001|Overall Study|Protocol Violation|0|||
164030889|NCT00242580|592472761|FG002|Overall Study|Protocol Violation|1|||
164030890|NCT00242580|592472759|FG000|Overall Study|Subject withdrew consent|2|||
164030891|NCT00242580|592472760|FG001|Overall Study|Subject withdrew consent|2|||
164030892|NCT00242580|592472761|FG002|Overall Study|Subject withdrew consent|5|||
164030893|NCT00242580|592472759|FG000|Overall Study|Lost to Follow-up|0|||
164030894|NCT00242580|592472760|FG001|Overall Study|Lost to Follow-up|3|||
164030895|NCT00242580|592472761|FG002|Overall Study|Lost to Follow-up|0|||
164030896|NCT00242580|592472759|FG000|Overall Study|Death|1|||
164030897|NCT00242580|592472760|FG001|Overall Study|Death|2|||
164030898|NCT00242580|592472761|FG002|Overall Study|Death|1|||
164030899|NCT03666858|592472764|FG000|Cohort 1|Adverse Event|1|||
164030900|NCT03666858|592472765|FG001|Cohort 1|Adverse Event|0|||
164030901|NCT03666858|592472764|FG000|Cohort 2|Adverse Event|0|||
164030902|NCT03666858|592472765|FG001|Cohort 2|Adverse Event|1|||
164030903|NCT03282357|592472766|FG000|Overall Study|Lost to Follow-up|3|||
164030904|NCT03282357|592472766|FG000|Overall Study|Withdrawal by Subject|4|||
164030905|NCT03282357|592472766|FG000|Overall Study|Adverse Event|1|||
164030906|NCT03282357|592472766|FG000|Overall Study|Other|9|||
164030907|NCT03550131|592472767|FG000|Overall Study|Lost to Follow-up|16|||
164030908|NCT03550131|592472768|FG001|Overall Study|Lost to Follow-up|24|||
164030909|NCT03550131|592472767|FG000|Overall Study|Withdrawal by Subject|36|||
164030910|NCT03550131|592472768|FG001|Overall Study|Withdrawal by Subject|28|||
164030911|NCT03550131|592472767|FG000|Overall Study|Illness of dyad member|10|||
164030912|NCT03550131|592472768|FG001|Overall Study|Illness of dyad member|2|||
164030913|NCT03550131|592472767|FG000|Overall Study|Death of person with dementia|4|||
164030914|NCT03550131|592472768|FG001|Overall Study|Death of person with dementia|8|||
164030915|NCT00910429|592472773|FG000|Overall Study|Death|18|||
164030916|NCT00910429|592472774|FG001|Overall Study|Death|12|||
164030917|NCT00910429|592472773|FG000|Overall Study|Withdrawal by Subject|3|||
164030918|NCT00910429|592472774|FG001|Overall Study|Withdrawal by Subject|2|||
164030919|NCT00910429|592472773|FG000|Overall Study|Protocol Violation|1|||
164030920|NCT00910429|592472774|FG001|Overall Study|Protocol Violation|0|||
164030921|NCT00910429|592472773|FG000|Overall Study|Lost to Follow-up|2|||
164030922|NCT00910429|592472774|FG001|Overall Study|Lost to Follow-up|1|||
164030923|NCT00910429|592472773|FG000|Overall Study|Adverse Event|10|||
164030924|NCT00910429|592472774|FG001|Overall Study|Adverse Event|5|||
164030925|NCT00910429|592472773|FG000|Overall Study|Drug non-compliance|1|||
164030926|NCT00910429|592472774|FG001|Overall Study|Drug non-compliance|0|||
164030927|NCT00910429|592472773|FG000|Overall Study|Lack of Efficacy|4|||
164030928|NCT00910429|592472774|FG001|Overall Study|Lack of Efficacy|1|||
164030929|NCT00594204|592472775|FG000|Overall Study|Adverse Event|15|||
164030930|NCT00594204|592472776|FG001|Overall Study|Adverse Event|3|||
164030931|NCT00594204|592472775|FG000|Overall Study|Lost to Follow-up|9|||
164030932|NCT00594204|592472776|FG001|Overall Study|Lost to Follow-up|5|||
164030933|NCT00594204|592472775|FG000|Overall Study|Withdrawal by Subject|23|||
164030934|NCT00594204|592472776|FG001|Overall Study|Withdrawal by Subject|29|||
164030935|NCT00594204|592472775|FG000|Overall Study|Other|4|||
164030936|NCT00594204|592472776|FG001|Overall Study|Other|3|||
164030937|NCT00594204|592472775|FG000|Overall Study|Lack of Efficacy|3|||
164030938|NCT00594204|592472776|FG001|Overall Study|Lack of Efficacy|4|||
164030939|NCT00594204|592472775|FG000|Overall Study|Randomized but not treated|4|||
164030940|NCT00594204|592472776|FG001|Overall Study|Randomized but not treated|1|||
164030941|NCT01740388|592472777|FG000|Overall Study|Withdrawal by Subject|1|||
164030942|NCT01740388|592472778|FG001|Overall Study|Withdrawal by Subject|2|||
164030943|NCT01740388|592472777|FG000|Overall Study|Lost to Follow-up|2|||
164030944|NCT01740388|592472778|FG001|Overall Study|Lost to Follow-up|0|||
164030945|NCT01740388|592472777|FG000|Overall Study|Physician Decision|2|||
164030946|NCT01740388|592472778|FG001|Overall Study|Physician Decision|6|||
164030947|NCT01740388|592472777|FG000|Overall Study|Subjects missing data, completed|41|||
164030948|NCT01740388|592472778|FG001|Overall Study|Subjects missing data, completed|36|||
164030949|NCT05757427|592472781|FG000|Overall Study|Adverse Event|1|||
164030950|NCT05757427|592472781|FG000|Overall Study|Device deficiency|1|||
164030951|NCT05757427|592472781|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
164030952|NCT05757427|592472781|FG000|Overall Study|MWBI scan of only 1 breast|3|||
164030953|NCT05757427|592472781|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
164030954|NCT03927911|592474660|FG000|Overall Study|problems with eDiary|0|||
164030955|NCT03927911|592474661|FG001|Overall Study|problems with eDiary|1|||
164030956|NCT03927911|592474662|FG002|Overall Study|problems with eDiary|0|||
164030957|NCT03927911|592474663|FG003|Overall Study|problems with eDiary|1|||
164030958|NCT03927911|592474664|FG004|Overall Study|problems with eDiary|0|||
164030959|NCT03927911|592474665|FG005|Overall Study|problems with eDiary|4|||
164030960|NCT03927911|592474660|FG000|Overall Study|Adverse Event|0|||
164030961|NCT03927911|592474661|FG001|Overall Study|Adverse Event|0|||
164030962|NCT03927911|592474662|FG002|Overall Study|Adverse Event|0|||
164030963|NCT03927911|592474663|FG003|Overall Study|Adverse Event|0|||
164030964|NCT03927911|592474664|FG004|Overall Study|Adverse Event|0|||
164030965|NCT03927911|592474665|FG005|Overall Study|Adverse Event|1|||
164030966|NCT03927911|592474660|FG000|Overall Study|not treated -study terminated by sponsor|0|||
164030967|NCT03927911|592474661|FG001|Overall Study|not treated -study terminated by sponsor|1|||
164030968|NCT03927911|592474662|FG002|Overall Study|not treated -study terminated by sponsor|0|||
164030969|NCT03927911|592474663|FG003|Overall Study|not treated -study terminated by sponsor|0|||
164030970|NCT03927911|592474664|FG004|Overall Study|not treated -study terminated by sponsor|0|||
164030971|NCT03927911|592474665|FG005|Overall Study|not treated -study terminated by sponsor|0|||
164030972|NCT03927911|592474660|FG000|Overall Study|Surgery cancelled|0|||
164030973|NCT03927911|592474661|FG001|Overall Study|Surgery cancelled|0|||
164030974|NCT03927911|592474662|FG002|Overall Study|Surgery cancelled|0|||
164030975|NCT03927911|592474663|FG003|Overall Study|Surgery cancelled|1|||
164030976|NCT03927911|592474664|FG004|Overall Study|Surgery cancelled|0|||
164030977|NCT03927911|592474665|FG005|Overall Study|Surgery cancelled|1|||
164030978|NCT03927911|592474660|FG000|Overall Study|Protocol Violation|0|||
164030979|NCT03927911|592474661|FG001|Overall Study|Protocol Violation|0|||
164030980|NCT03927911|592474662|FG002|Overall Study|Protocol Violation|0|||
164030981|NCT03927911|592474663|FG003|Overall Study|Protocol Violation|0|||
164030982|NCT03927911|592474664|FG004|Overall Study|Protocol Violation|0|||
164030983|NCT03927911|592474665|FG005|Overall Study|Protocol Violation|1|||
164030984|NCT02658968|592474666|FG000|Received Rituximab|Adverse Event|0|||
164030985|NCT02658968|592474667|FG001|Received Rituximab|Adverse Event|0|||
164030986|NCT02658968|592474668|FG002|Received Rituximab|Adverse Event|0|||
164030987|NCT02658968|592474669|FG003|Received Rituximab|Adverse Event|0|||
164030988|NCT02658968|592474670|FG004|Received Rituximab|Adverse Event|1|||
164030989|NCT02658968|592474666|FG000|Received Rituximab|Progressive disease|0|||
164030990|NCT02658968|592474667|FG001|Received Rituximab|Progressive disease|0|||
164030991|NCT02658968|592474668|FG002|Received Rituximab|Progressive disease|0|||
164030992|NCT02658968|592474669|FG003|Received Rituximab|Progressive disease|0|||
164030993|NCT02658968|592474670|FG004|Received Rituximab|Progressive disease|1|||
164030994|NCT02658968|592474666|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
164030995|NCT02658968|592474667|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
164030996|NCT02658968|592474668|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
164030997|NCT02658968|592474669|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
164030998|NCT02658968|592474670|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
164030999|NCT02658968|592474666|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
164031000|NCT02658968|592474667|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
164031001|NCT02658968|592474668|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
164031002|NCT02658968|592474669|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
164031003|NCT02658968|592474670|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
164031004|NCT02658968|592474666|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
164031005|NCT02658968|592474667|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
164031006|NCT02658968|592474668|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
164031007|NCT02658968|592474669|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
164031008|NCT02658968|592474670|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
164031009|NCT02658968|592474666|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164031010|NCT02658968|592474667|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
164031011|NCT02658968|592474668|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164031012|NCT02658968|592474669|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164031013|NCT02658968|592474670|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
164096920|NCT04206332|592718992|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164031014|NCT02658968|592474666|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
164031015|NCT02658968|592474667|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
164031016|NCT02658968|592474668|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
164031017|NCT02658968|592474669|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
164031018|NCT02658968|592474670|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
164031019|NCT00971425|592474671|FG000|Overall Study|Adverse Event|1|||
164031020|NCT00971425|592474672|FG001|Overall Study|Adverse Event|1|||
164031021|NCT00971425|592474671|FG000|Overall Study|Withdrawal by Subject|0|||
164031022|NCT00971425|592474672|FG001|Overall Study|Withdrawal by Subject|1|||
164031023|NCT02528253|592474675|FG000|Overall Study|Adverse Event|3|||
164031024|NCT02528253|592474676|FG001|Overall Study|Adverse Event|4|||
164031025|NCT02528253|592474677|FG002|Overall Study|Adverse Event|4|||
164031026|NCT02528253|592474678|FG003|Overall Study|Adverse Event|8|||
164031027|NCT02528253|592474679|FG004|Overall Study|Adverse Event|18|||
164031028|NCT02528253|592474675|FG000|Overall Study|Death|2|||
164031029|NCT02528253|592474676|FG001|Overall Study|Death|2|||
164031030|NCT02528253|592474677|FG002|Overall Study|Death|1|||
164031031|NCT02528253|592474678|FG003|Overall Study|Death|0|||
164031032|NCT02528253|592474679|FG004|Overall Study|Death|1|||
164031033|NCT02528253|592474675|FG000|Overall Study|Insufficient clinical response|7|||
164031034|NCT02528253|592474676|FG001|Overall Study|Insufficient clinical response|10|||
164031035|NCT02528253|592474677|FG002|Overall Study|Insufficient clinical response|13|||
164031036|NCT02528253|592474678|FG003|Overall Study|Insufficient clinical response|12|||
164031037|NCT02528253|592474679|FG004|Overall Study|Insufficient clinical response|16|||
164031038|NCT02528253|592474675|FG000|Overall Study|Lost to Follow-up|16|||
164031039|NCT02528253|592474676|FG001|Overall Study|Lost to Follow-up|9|||
164031040|NCT02528253|592474677|FG002|Overall Study|Lost to Follow-up|31|||
164031041|NCT02528253|592474678|FG003|Overall Study|Lost to Follow-up|16|||
164031042|NCT02528253|592474679|FG004|Overall Study|Lost to Follow-up|34|||
164031043|NCT02528253|592474675|FG000|Overall Study|Other|21|||
164031044|NCT02528253|592474676|FG001|Overall Study|Other|22|||
164031045|NCT02528253|592474677|FG002|Overall Study|Other|58|||
164031046|NCT02528253|592474678|FG003|Overall Study|Other|52|||
164031047|NCT02528253|592474679|FG004|Overall Study|Other|76|||
164031048|NCT02528253|592474675|FG000|Overall Study|Withdrawal by Subject|25|||
164031049|NCT02528253|592474676|FG001|Overall Study|Withdrawal by Subject|20|||
164031050|NCT02528253|592474677|FG002|Overall Study|Withdrawal by Subject|29|||
164031051|NCT02528253|592474678|FG003|Overall Study|Withdrawal by Subject|48|||
164031052|NCT02528253|592474679|FG004|Overall Study|Withdrawal by Subject|73|||
164031053|NCT02528253|592474675|FG000|Overall Study|Protocol Violation|1|||
164031054|NCT02528253|592474676|FG001|Overall Study|Protocol Violation|2|||
164031055|NCT02528253|592474677|FG002|Overall Study|Protocol Violation|4|||
164031056|NCT02528253|592474678|FG003|Overall Study|Protocol Violation|0|||
164031057|NCT02528253|592474679|FG004|Overall Study|Protocol Violation|4|||
164031058|NCT02528253|592474675|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
164031059|NCT02528253|592474676|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
164031060|NCT02528253|592474677|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
164031061|NCT02528253|592474678|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
164031062|NCT02528253|592474679|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
164031063|NCT00505752|592474680|FG000|Overall Study|Adverse Event|1|||
164031064|NCT00505752|592474681|FG001|Overall Study|Adverse Event|0|||
164031065|NCT00505752|592474682|FG002|Overall Study|Adverse Event|1|||
164031066|NCT00505752|592474683|FG003|Overall Study|Adverse Event|0|||
164031067|NCT00505752|592474680|FG000|Overall Study|Lost to Follow-up|1|||
164031068|NCT00505752|592474681|FG001|Overall Study|Lost to Follow-up|0|||
164031069|NCT00505752|592474682|FG002|Overall Study|Lost to Follow-up|0|||
164031070|NCT00505752|592474683|FG003|Overall Study|Lost to Follow-up|0|||
164031071|NCT00505752|592474680|FG000|Overall Study|Lack of ovarian response|1|||
164031072|NCT00505752|592474681|FG001|Overall Study|Lack of ovarian response|3|||
164031073|NCT00505752|592474682|FG002|Overall Study|Lack of ovarian response|0|||
164031074|NCT00505752|592474683|FG003|Overall Study|Lack of ovarian response|0|||
164031075|NCT00505752|592474680|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164031076|NCT00505752|592474681|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164031077|NCT00505752|592474682|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
164031078|NCT00505752|592474683|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164031079|NCT00505752|592474680|FG000|Overall Study|No oocytes retrieved|0|||
164031080|NCT00505752|592474681|FG001|Overall Study|No oocytes retrieved|2|||
164031081|NCT00505752|592474682|FG002|Overall Study|No oocytes retrieved|0|||
164031082|NCT00505752|592474683|FG003|Overall Study|No oocytes retrieved|1|||
164031083|NCT00505752|592474680|FG000|Overall Study|No Fertilization|1|||
164031084|NCT00505752|592474681|FG001|Overall Study|No Fertilization|1|||
164031085|NCT00505752|592474682|FG002|Overall Study|No Fertilization|2|||
164031086|NCT00505752|592474683|FG003|Overall Study|No Fertilization|1|||
164031087|NCT00505752|592474680|FG000|Overall Study|All embryos/blastocysts discarded|0|||
164031088|NCT00505752|592474681|FG001|Overall Study|All embryos/blastocysts discarded|0|||
163918645|NCT00449033|592071298|FG001|Treatment Period|Disease Progression|288|||
163918646|NCT00449033|592071297|FG000|Treatment Period|Consent Withdrawn|36|||
163918647|NCT00449033|592071298|FG001|Treatment Period|Consent Withdrawn|20|||
163918648|NCT00449033|592071297|FG000|Treatment Period|Amended Protocol Criteria|22|||
163918649|NCT00449033|592071298|FG001|Treatment Period|Amended Protocol Criteria|18|||
163918650|NCT00449033|592071297|FG000|Treatment Period|Non-compliance|7|||
163918651|NCT00449033|592071298|FG001|Treatment Period|Non-compliance|8|||
163918652|NCT00449033|592071297|FG000|Treatment Period|Second Malignancy|0|||
163918653|NCT00449033|592071298|FG001|Treatment Period|Second Malignancy|1|||
163918654|NCT00449033|592071297|FG000|Treatment Period|Reason Missing|0|||
163918655|NCT00449033|592071298|FG001|Treatment Period|Reason Missing|4|||
163918656|NCT00449033|592071297|FG000|Treatment Period|Treatment Ongoing|6|||
163918657|NCT00449033|592071298|FG001|Treatment Period|Treatment Ongoing|4|||
163918658|NCT00449033|592071297|FG000|Follow-up Period|Death|299|||
163918659|NCT00449033|592071298|FG001|Follow-up Period|Death|311|||
163918660|NCT00449033|592071297|FG000|Follow-up Period|Lost to Follow-up|6|||
163918661|NCT00449033|592071298|FG001|Follow-up Period|Lost to Follow-up|10|||
163918662|NCT00449033|592071297|FG000|Follow-up Period|Reason Missing|120|||
163918663|NCT00449033|592071298|FG001|Follow-up Period|Reason Missing|113|||
163918664|NCT04115319|592071302|FG000|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|2|||
163918665|NCT04115319|592071303|FG001|Overall Study|Randomized, but Withdrawn From Study Prior to Treatment|0|||
163918666|NCT04115319|592071302|FG000|Overall Study|Withdrawal by participant|17|||
163918667|NCT04115319|592071303|FG001|Overall Study|Withdrawal by participant|9|||
163918668|NCT04115319|592071302|FG000|Overall Study|Geopolitical Conflict Related|2|||
163918669|NCT04115319|592071303|FG001|Overall Study|Geopolitical Conflict Related|1|||
163918670|NCT04115319|592071302|FG000|Overall Study|COVID-19 Related|1|||
163918671|NCT04115319|592071303|FG001|Overall Study|COVID-19 Related|0|||
163918672|NCT04115319|592071302|FG000|Overall Study|Adverse Event|48|||
163918673|NCT04115319|592071303|FG001|Overall Study|Adverse Event|21|||
163918674|NCT04115319|592071302|FG000|Overall Study|Noncompliance with Study Drug|5|||
163918675|NCT04115319|592071303|FG001|Overall Study|Noncompliance with Study Drug|1|||
163918676|NCT04115319|592071302|FG000|Overall Study|Lack of Efficacy|6|||
163918677|NCT04115319|592071303|FG001|Overall Study|Lack of Efficacy|2|||
163918678|NCT04115319|592071302|FG000|Overall Study|Lost to Follow-up|6|||
163918679|NCT04115319|592071303|FG001|Overall Study|Lost to Follow-up|7|||
163918680|NCT04115319|592071302|FG000|Overall Study|Protocol Deviation|5|||
163918681|NCT04115319|592071303|FG001|Overall Study|Protocol Deviation|1|||
163918682|NCT04115319|592071302|FG000|Overall Study|Participant relocated|5|||
163918683|NCT04115319|592071303|FG001|Overall Study|Participant relocated|2|||
163918684|NCT04115319|592071302|FG000|Overall Study|Personal Reasons|0|||
163918685|NCT04115319|592071303|FG001|Overall Study|Personal Reasons|1|||
163918686|NCT04115319|592071302|FG000|Overall Study|Deemed Unsuitable for Participation|1|||
163918687|NCT04115319|592071303|FG001|Overall Study|Deemed Unsuitable for Participation|0|||
164301025|NCT01524796|593478406|FG000|Overall Study|Lack of Efficacy|3|||
164301026|NCT01524796|593478406|FG000|Overall Study|Lost to Follow-up|1|||
164301027|NCT01524796|593478406|FG000|Overall Study|The price|1|||
164301028|NCT01524796|593478406|FG000|Overall Study|Withdrawal by Subject|4|||
164301029|NCT01524796|593478406|FG000|Overall Study|Move|1|||
164301030|NCT01524796|593478406|FG000|Overall Study|Deterioration of pains|1|||
164301031|NCT01524796|593478406|FG000|Overall Study|Gall stone surgery|1|||
164301032|NCT01524796|593478406|FG000|Overall Study|Nervous about confidentiality|1|||
164301033|NCT01524796|593478406|FG000|Overall Study|Switch to carbamazapine|1|||
164301034|NCT01524796|593478406|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
163918698|NCT02256488|592071310|FG000|Overall Study|Lost to Follow-up|6|||
163918699|NCT02256488|592071311|FG001|Overall Study|Lost to Follow-up|6|||
163918700|NCT02256488|592071312|FG002|Overall Study|Lost to Follow-up|9|||
163918701|NCT02256488|592071313|FG003|Overall Study|Lost to Follow-up|3|||
164031089|NCT00505752|592474682|FG002|Overall Study|All embryos/blastocysts discarded|1|||
164031090|NCT00505752|592474683|FG003|Overall Study|All embryos/blastocysts discarded|1|||
164031091|NCT00505752|592474680|FG000|Overall Study|Other|1|||
164031092|NCT00505752|592474681|FG001|Overall Study|Other|2|||
164031093|NCT00505752|592474682|FG002|Overall Study|Other|1|||
164031094|NCT00505752|592474683|FG003|Overall Study|Other|2|||
163918702|NCT02256488|592071310|FG000|Overall Study|OTHER|1|||
164031095|NCT01624506|592474684|FG000|Overall Study|Lost to Follow-up|29|||
163918703|NCT02256488|592071311|FG001|Overall Study|OTHER|0|||
163918704|NCT02256488|592071312|FG002|Overall Study|OTHER|1|||
163918705|NCT02256488|592071313|FG003|Overall Study|OTHER|1|||
163918706|NCT02256488|592071310|FG000|Overall Study|Withdrawal by Subject|1|||
163918707|NCT02256488|592071311|FG001|Overall Study|Withdrawal by Subject|0|||
163918708|NCT02256488|592071312|FG002|Overall Study|Withdrawal by Subject|0|||
163918709|NCT02256488|592071313|FG003|Overall Study|Withdrawal by Subject|2|||
163918710|NCT03562117|592071314|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
163918711|NCT03562117|592071315|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
163918712|NCT03562117|592071316|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
163918713|NCT03928821|592071317|FG000|Overall Study|Death|0|||
163918714|NCT03928821|592071318|FG001|Overall Study|Death|1|||
163918715|NCT03928821|592071319|FG002|Overall Study|Death|0|||
164031096|NCT01624506|592474685|FG001|Overall Study|Lost to Follow-up|15|||
164031097|NCT01624506|592474684|FG000|Overall Study|Withdrawal by Subject|9|||
164031098|NCT01624506|592474685|FG001|Overall Study|Withdrawal by Subject|2|||
164031099|NCT01624506|592474684|FG000|Overall Study|Death|1|||
164031100|NCT01624506|592474685|FG001|Overall Study|Death|0|||
164031101|NCT01624506|592474684|FG000|Overall Study|LINX explants|23|||
164031102|NCT01624506|592474685|FG001|Overall Study|LINX explants|0|||
164031103|NCT01624506|592474684|FG000|Overall Study|Adverse Event|3|||
164031104|NCT01624506|592474685|FG001|Overall Study|Adverse Event|0|||
164031105|NCT01149343|592474686|FG000|Overall Study|Withdrawal by Subject|1|||
164031106|NCT01149343|592474687|FG001|Overall Study|Withdrawal by Subject|1|||
164031107|NCT01149343|592474688|FG002|Overall Study|Withdrawal by Subject|1|||
163918716|NCT03928821|592071320|FG003|Overall Study|Death|0|||
163918717|NCT03928821|592071317|FG000|Overall Study|Lost to Follow-up|0|||
163918718|NCT03928821|592071318|FG001|Overall Study|Lost to Follow-up|2|||
163918719|NCT03928821|592071319|FG002|Overall Study|Lost to Follow-up|3|||
163918720|NCT03928821|592071320|FG003|Overall Study|Lost to Follow-up|0|||
163918721|NCT03928821|592071317|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163918722|NCT03928821|592071318|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163918723|NCT03928821|592071319|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
163918724|NCT03928821|592071320|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
163918725|NCT03138499|592071327|FG000|Overall Study|Lost to Follow-up|1|||
163918726|NCT03138499|592071328|FG001|Overall Study|Lost to Follow-up|0|||
163918727|NCT03138499|592071327|FG000|Overall Study|Participants withdrew consent|1|||
163918728|NCT03138499|592071328|FG001|Overall Study|Participants withdrew consent|0|||
163918729|NCT03138499|592071327|FG000|Overall Study|Participant discontinued study before treatment|0|||
163918730|NCT03138499|592071328|FG001|Overall Study|Participant discontinued study before treatment|1|||
163918731|NCT03138499|592071327|FG000|Overall Study|Disease Progression|2|||
163918732|NCT03138499|592071328|FG001|Overall Study|Disease Progression|6|||
163918733|NCT03138499|592071327|FG000|Overall Study|Study drug toxicity|2|||
163918734|NCT03138499|592071328|FG001|Overall Study|Study drug toxicity|2|||
163918735|NCT03138499|592071327|FG000|Overall Study|Participant request to discontinue study treatment|1|||
163918736|NCT03138499|592071328|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163918737|NCT03138499|592071327|FG000|Overall Study|Other reasons|2|||
163918738|NCT03138499|592071328|FG001|Overall Study|Other reasons|0|||
163918739|NCT01636778|592071331|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
163918740|NCT01636778|592071332|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
163918741|NCT01636778|592071333|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
163918742|NCT01636778|592071331|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
163918743|NCT01636778|592071332|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
163918744|NCT01636778|592071333|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
163918745|NCT01636778|592071331|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
163918746|NCT01636778|592071332|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
163918747|NCT01636778|592071333|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
163918748|NCT01636778|592071331|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
163918749|NCT01636778|592071332|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
163918750|NCT01636778|592071333|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
163918751|NCT01636778|592071331|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
163918752|NCT01636778|592071332|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
163918753|NCT01636778|592071333|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
163918754|NCT01636778|592071331|FG000|Follow-up Period After Part 2|Other|0|||
163918755|NCT01636778|592071332|FG001|Follow-up Period After Part 2|Other|0|||
163918756|NCT01636778|592071333|FG002|Follow-up Period After Part 2|Other|1|||
163918757|NCT01636778|592071331|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
163918758|NCT01636778|592071332|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
163918759|NCT01636778|592071333|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
163918760|NCT01636778|592071331|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
163918761|NCT01636778|592071332|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
163918762|NCT01636778|592071333|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
163918763|NCT00990821|592071334|FG000|Overall Study|Withdrawal by Subject|0|||
163918764|NCT00990821|592071335|FG001|Overall Study|Withdrawal by Subject|2|||
163918765|NCT00990821|592071336|FG002|Overall Study|Withdrawal by Subject|0|||
163918766|NCT00990821|592071337|FG003|Overall Study|Withdrawal by Subject|0|||
163918767|NCT00990821|592071338|FG004|Overall Study|Withdrawal by Subject|3|||
163918768|NCT00990821|592071339|FG005|Overall Study|Withdrawal by Subject|3|||
163918769|NCT00990821|592071340|FG006|Overall Study|Withdrawal by Subject|1|||
163918770|NCT00990821|592071341|FG007|Overall Study|Withdrawal by Subject|0|||
164031108|NCT01149343|592474689|FG003|Overall Study|Withdrawal by Subject|5|||
164031109|NCT01149343|592474686|FG000|Overall Study|Death|10|||
164031110|NCT01149343|592474687|FG001|Overall Study|Death|13|||
164031111|NCT01149343|592474688|FG002|Overall Study|Death|18|||
164031112|NCT01149343|592474689|FG003|Overall Study|Death|18|||
164031113|NCT01149343|592474686|FG000|Overall Study|Lost to Follow-up|1|||
164031114|NCT01149343|592474687|FG001|Overall Study|Lost to Follow-up|0|||
164031115|NCT01149343|592474688|FG002|Overall Study|Lost to Follow-up|0|||
164031116|NCT01149343|592474689|FG003|Overall Study|Lost to Follow-up|1|||
164031117|NCT01149343|592474686|FG000|Overall Study|Other|8|||
164031118|NCT01149343|592474687|FG001|Overall Study|Other|10|||
164031119|NCT01149343|592474688|FG002|Overall Study|Other|2|||
164031120|NCT01149343|592474689|FG003|Overall Study|Other|14|||
164031121|NCT01149343|592474686|FG000|Overall Study|Sponsor study termination|0|||
164031122|NCT01149343|592474687|FG001|Overall Study|Sponsor study termination|0|||
164031123|NCT01149343|592474688|FG002|Overall Study|Sponsor study termination|0|||
164031124|NCT01149343|592474689|FG003|Overall Study|Sponsor study termination|2|||
164031125|NCT01149343|592474686|FG000|Overall Study|Recurrence / Progressive disease|0|||
164031126|NCT01149343|592474687|FG001|Overall Study|Recurrence / Progressive disease|0|||
164031127|NCT01149343|592474688|FG002|Overall Study|Recurrence / Progressive disease|1|||
164031128|NCT01149343|592474689|FG003|Overall Study|Recurrence / Progressive disease|0|||
164031129|NCT03472040|592474703|FG000|Overall Study|Physician Decision|0|||
164031130|NCT03472040|592474704|FG001|Overall Study|Physician Decision|3|||
164031131|NCT03472040|592474703|FG000|Overall Study|Withdrawal by Subject|10|||
164031132|NCT03472040|592474704|FG001|Overall Study|Withdrawal by Subject|23|||
164031133|NCT03472040|592474703|FG000|Overall Study|Perceived Lack of Efficacy|29|||
164031134|NCT03472040|592474704|FG001|Overall Study|Perceived Lack of Efficacy|30|||
164031135|NCT03472040|592474703|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
164031136|NCT03472040|592474704|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
164031137|NCT03472040|592474703|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
164031138|NCT03472040|592474704|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
164031139|NCT03472040|592474703|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
164031140|NCT03472040|592474704|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
164031141|NCT03472040|592474703|FG000|Overall Study|Subject Non-compliance|2|||
164031142|NCT03472040|592474704|FG001|Overall Study|Subject Non-compliance|5|||
164031143|NCT03472040|592474703|FG000|Overall Study|Discontinuation due to Rash|0|||
164031144|NCT03472040|592474704|FG001|Overall Study|Discontinuation due to Rash|1|||
164031145|NCT03472040|592474703|FG000|Overall Study|Subsequent Ineligibility|0|||
164031146|NCT03472040|592474704|FG001|Overall Study|Subsequent Ineligibility|2|||
164031147|NCT03472040|592474703|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
164031148|NCT03472040|592474704|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
164031149|NCT02769832|592474705|FG000|Overall Study|Death|30|||
164031150|NCT00225147|592474707|FG000|Open-label Phase|Lost to Follow-up|0|||
164031151|NCT00225147|592474708|FG001|Open-label Phase|Lost to Follow-up|0|||
164031152|NCT00225147|592474709|FG002|Open-label Phase|Lost to Follow-up|0|||
164031153|NCT00225147|592474710|FG003|Open-label Phase|Lost to Follow-up|4|||
164031154|NCT00225147|592474707|FG000|Open-label Phase|Withdrawal by Subject|0|||
164031155|NCT00225147|592474708|FG001|Open-label Phase|Withdrawal by Subject|0|||
164031156|NCT00225147|592474709|FG002|Open-label Phase|Withdrawal by Subject|0|||
164031157|NCT00225147|592474710|FG003|Open-label Phase|Withdrawal by Subject|6|||
164031158|NCT04019795|592474711|FG000|Overall Study|Withdrawal by Subject|1|||
164031159|NCT04019795|592474712|FG001|Overall Study|Withdrawal by Subject|2|||
164031160|NCT04019795|592474713|FG002|Overall Study|Withdrawal by Subject|2|||
164031161|NCT04019795|592474714|FG003|Overall Study|Withdrawal by Subject|1|||
164031162|NCT04019795|592474711|FG000|Overall Study|Lost to Follow-up|0|||
164031163|NCT04019795|592474712|FG001|Overall Study|Lost to Follow-up|1|||
164031164|NCT04019795|592474713|FG002|Overall Study|Lost to Follow-up|1|||
164031165|NCT04019795|592474714|FG003|Overall Study|Lost to Follow-up|2|||
164031166|NCT04019795|592474711|FG000|Overall Study|Treatment non-compliance|3|||
164031167|NCT04019795|592474712|FG001|Overall Study|Treatment non-compliance|1|||
164031168|NCT04019795|592474713|FG002|Overall Study|Treatment non-compliance|2|||
164031169|NCT04019795|592474714|FG003|Overall Study|Treatment non-compliance|0|||
164031170|NCT04019795|592474711|FG000|Overall Study|Physician Decision|0|||
164031171|NCT04019795|592474712|FG001|Overall Study|Physician Decision|0|||
164031172|NCT04019795|592474713|FG002|Overall Study|Physician Decision|1|||
164031173|NCT04019795|592474714|FG003|Overall Study|Physician Decision|0|||
164031174|NCT04019795|592474711|FG000|Overall Study|Adverse Event|1|||
164031175|NCT04019795|592474712|FG001|Overall Study|Adverse Event|0|||
164031176|NCT04019795|592474713|FG002|Overall Study|Adverse Event|0|||
164031177|NCT04019795|592474714|FG003|Overall Study|Adverse Event|0|||
164031178|NCT03625141|592474715|FG000|Overall Study|Adverse Event|0|||
164031179|NCT03625141|592474716|FG001|Overall Study|Adverse Event|2|||
163918771|NCT00990821|592071342|FG008|Overall Study|Withdrawal by Subject|0|||
163918772|NCT00990821|592071343|FG009|Overall Study|Withdrawal by Subject|1|||
163918773|NCT00990821|592071344|FG010|Overall Study|Withdrawal by Subject|3|||
163918774|NCT00990821|592071345|FG011|Overall Study|Withdrawal by Subject|5|||
163918775|NCT00990821|592071346|FG012|Overall Study|Withdrawal by Subject|2|||
163918776|NCT00990821|592071347|FG013|Overall Study|Withdrawal by Subject|1|||
163918777|NCT04150250|592071348|FG000|Overall Study|Lost to Follow-up|0|||
163918778|NCT04150250|592071349|FG001|Overall Study|Lost to Follow-up|2|||
163918779|NCT00170950|592071355|FG000|Overall Study|Death|236|||
163918780|NCT00170950|592071356|FG001|Overall Study|Death|274|||
163918781|NCT00170950|592071355|FG000|Overall Study|Withdrawal by Subject|496|||
163918782|NCT00170950|592071356|FG001|Overall Study|Withdrawal by Subject|498|||
163918783|NCT00170950|592071355|FG000|Overall Study|Lost to Follow-up|134|||
163918784|NCT00170950|592071356|FG001|Overall Study|Lost to Follow-up|115|||
163918785|NCT00170950|592071355|FG000|Overall Study|Missing|2|||
163918786|NCT00170950|592071356|FG001|Overall Study|Missing|1|||
163918787|NCT00170950|592071355|FG000|Overall Study|Termination Data Not Recorded|17|||
163918788|NCT00170950|592071356|FG001|Overall Study|Termination Data Not Recorded|22|||
163918789|NCT00748098|592071357|FG000|First Treatment Intervention Period|Adverse Event|1|||
163918790|NCT00748098|592071358|FG001|First Treatment Intervention Period|Adverse Event|1|||
163918791|NCT00748098|592071357|FG000|First Treatment Intervention Period|Protocol Violation|1|||
163918792|NCT00748098|592071358|FG001|First Treatment Intervention Period|Protocol Violation|0|||
163918793|NCT00748098|592071357|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
163918794|NCT00748098|592071358|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
163918795|NCT00748098|592071357|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
163918796|NCT00748098|592071358|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
163918797|NCT00748098|592071357|FG000|First Taper Period|Protocol Violation|1|||
163918798|NCT00748098|592071358|FG001|First Taper Period|Protocol Violation|0|||
163918799|NCT00748098|592071357|FG000|First Taper Period|Withdrawal by Subject|2|||
163918800|NCT00748098|592071358|FG001|First Taper Period|Withdrawal by Subject|0|||
163918801|NCT00748098|592071357|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
163918802|NCT00748098|592071358|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
163918803|NCT00748098|592071357|FG000|1-Week Washout Period|Adverse Event|0|||
163918804|NCT00748098|592071358|FG001|1-Week Washout Period|Adverse Event|1|||
163918805|NCT00748098|592071357|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
163918806|NCT00748098|592071358|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
163918807|NCT00748098|592071357|FG000|Second Treatment Intervention Period|Adverse Event|4|||
163918808|NCT00748098|592071358|FG001|Second Treatment Intervention Period|Adverse Event|1|||
163918809|NCT00748098|592071357|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
163918810|NCT00748098|592071358|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
163918811|NCT00748098|592071357|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
163918812|NCT00748098|592071358|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
163918813|NCT04448561|592071364|FG000|Overall Study|Noncompliance|1|||
163918814|NCT04448561|592071365|FG001|Overall Study|Noncompliance|0|||
163918815|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|10|||
163918816|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
163918817|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
163918818|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Adverse Event|0|||
163918819|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|2|||
163918820|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
163918821|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
163918822|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Disease Progression per Clinical Criteria by Investigator|0|||
163918823|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|3|||
163918824|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
163918825|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
163918826|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Risk to Patient|0|||
163918827|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|6|||
163918828|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
163918829|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
163918830|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Severe Noncompliance to Protocol|0|||
163918831|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|10|||
164096921|NCT04206332|592718993|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
163918832|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
163918833|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
163918834|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Withdrawal by Subject|0|||
163918835|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Death|10|||
163918836|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
163918837|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
164031180|NCT03625141|592474715|FG000|Overall Study|Study Terminated By Sponsor|1|||
164031181|NCT03625141|592474716|FG001|Overall Study|Study Terminated By Sponsor|13|||
164031182|NCT03625141|592474715|FG000|Overall Study|Withdrawal by Subject|3|||
164031183|NCT03625141|592474716|FG001|Overall Study|Withdrawal by Subject|0|||
164031184|NCT03625141|592474715|FG000|Overall Study|Withdrawal Of Consent|0|||
164031185|NCT03625141|592474716|FG001|Overall Study|Withdrawal Of Consent|1|||
164031186|NCT03625141|592474715|FG000|Overall Study|Death|11|||
164031187|NCT03625141|592474716|FG001|Overall Study|Death|47|||
164031188|NCT03625141|592474715|FG000|Overall Study|Progressive Disease|0|||
164031189|NCT03625141|592474716|FG001|Overall Study|Progressive Disease|2|||
164031190|NCT03250377|592474717|FG000|Overall Study|Adverse Event|2|||
164031191|NCT03250377|592474718|FG001|Overall Study|Adverse Event|4|||
164031192|NCT03250377|592474719|FG002|Overall Study|Adverse Event|0|||
164031193|NCT03250377|592474720|FG003|Overall Study|Adverse Event|4|||
164031194|NCT03250377|592474717|FG000|Overall Study|Lack of Efficacy|5|||
164031195|NCT03250377|592474718|FG001|Overall Study|Lack of Efficacy|14|||
164031196|NCT03250377|592474719|FG002|Overall Study|Lack of Efficacy|1|||
164031197|NCT03250377|592474720|FG003|Overall Study|Lack of Efficacy|3|||
164031198|NCT03250377|592474717|FG000|Overall Study|Protocol Violation|0|||
164031199|NCT03250377|592474718|FG001|Overall Study|Protocol Violation|2|||
164031200|NCT03250377|592474719|FG002|Overall Study|Protocol Violation|0|||
164031201|NCT03250377|592474720|FG003|Overall Study|Protocol Violation|1|||
164031202|NCT03250377|592474717|FG000|Overall Study|Lost to Follow-up|0|||
164031203|NCT03250377|592474718|FG001|Overall Study|Lost to Follow-up|1|||
164031204|NCT03250377|592474719|FG002|Overall Study|Lost to Follow-up|0|||
164031205|NCT03250377|592474720|FG003|Overall Study|Lost to Follow-up|0|||
164031206|NCT03250377|592474717|FG000|Overall Study|Withdrawal by Subject|7|||
164031207|NCT03250377|592474718|FG001|Overall Study|Withdrawal by Subject|7|||
164031208|NCT03250377|592474719|FG002|Overall Study|Withdrawal by Subject|0|||
164031209|NCT03250377|592474720|FG003|Overall Study|Withdrawal by Subject|4|||
164031210|NCT03250377|592474717|FG000|Overall Study|Investigator's Judgment|1|||
164031211|NCT03250377|592474718|FG001|Overall Study|Investigator's Judgment|0|||
164031212|NCT03250377|592474719|FG002|Overall Study|Investigator's Judgment|0|||
164031213|NCT03250377|592474720|FG003|Overall Study|Investigator's Judgment|0|||
164031214|NCT03250377|592474717|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
164031215|NCT03250377|592474718|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
164031216|NCT03250377|592474719|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
164031217|NCT03250377|592474720|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
164031218|NCT03250377|592474717|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
164031219|NCT03250377|592474718|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
164031220|NCT03250377|592474719|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
164031221|NCT03250377|592474720|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
164031222|NCT03250377|592474717|FG000|Overall Study|Epilepsy Surgery|0|||
164031223|NCT03250377|592474718|FG001|Overall Study|Epilepsy Surgery|1|||
164031224|NCT03250377|592474719|FG002|Overall Study|Epilepsy Surgery|2|||
164031225|NCT03250377|592474720|FG003|Overall Study|Epilepsy Surgery|0|||
164031226|NCT03250377|592474717|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
164031227|NCT03250377|592474718|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
164031228|NCT03250377|592474719|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
164031229|NCT03250377|592474720|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
164031230|NCT03250377|592474717|FG000|Overall Study|Request From The Sponsor|0|||
164031231|NCT03250377|592474718|FG001|Overall Study|Request From The Sponsor|1|||
164031232|NCT03250377|592474719|FG002|Overall Study|Request From The Sponsor|0|||
164031233|NCT03250377|592474720|FG003|Overall Study|Request From The Sponsor|0|||
164031234|NCT03250377|592474717|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
164031235|NCT03250377|592474718|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
164031236|NCT03250377|592474719|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
164031237|NCT03250377|592474720|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
164031238|NCT03250377|592474717|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
164031239|NCT03250377|592474718|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
164031240|NCT03250377|592474719|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
164031241|NCT03250377|592474720|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
164031242|NCT03250377|592474717|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
164096922|NCT04206332|592718994|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096923|NCT04206332|592718995|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164031243|NCT03250377|592474718|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
164096924|NCT04206332|592718996|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096925|NCT04206332|592718997|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096926|NCT04206332|592718998|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164031244|NCT03250377|592474719|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
164031245|NCT03250377|592474720|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
164031246|NCT03250377|592474717|FG000|Overall Study|Pregnancy Event|0|||
164031247|NCT03250377|592474718|FG001|Overall Study|Pregnancy Event|1|||
164031248|NCT03250377|592474719|FG002|Overall Study|Pregnancy Event|0|||
164031249|NCT03250377|592474720|FG003|Overall Study|Pregnancy Event|0|||
164031250|NCT03250377|592474717|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
164031251|NCT03250377|592474718|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
164031252|NCT03250377|592474719|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
164031253|NCT03250377|592474720|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
164031254|NCT03250377|592474717|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
164031255|NCT03250377|592474718|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
164031256|NCT03250377|592474719|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
164031257|NCT03250377|592474720|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
164031258|NCT03250377|592474717|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
164031259|NCT03250377|592474718|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
164031260|NCT03250377|592474719|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
164031261|NCT03250377|592474720|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
164031262|NCT03250377|592474717|FG000|Overall Study|Patient requested to change hospital|0|||
164031263|NCT03250377|592474718|FG001|Overall Study|Patient requested to change hospital|0|||
164031264|NCT03250377|592474719|FG002|Overall Study|Patient requested to change hospital|0|||
164096927|NCT04206332|592718999|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096928|NCT04206332|592719000|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164146821|NCT00352417|592898172|FG000|Overall Study|Adverse Event|1|||
163918838|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Death|0|||
163918839|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Other|27|||
163918840|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
163918841|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
163918842|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Other|0|||
163918843|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Missing|1|||
163918844|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
163918845|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
163918846|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Missing|0|||
163918847|NCT03602859|592071370|FG000|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|10|||
163918848|NCT03602859|592071371|FG001|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
163918849|NCT03602859|592071372|FG002|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
163918850|NCT03602859|592071373|FG003|Chemotherapy Run-In Period (Cycle 1)|Randomized but not treated|0|||
163918851|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|0|||
163918852|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|1|||
163918853|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|5|||
163918854|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Investigator decision|3|||
163918855|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|0|||
163918856|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|7|||
163918857|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|11|||
163918858|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Adverse Event|25|||
163918859|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|0|||
163918860|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|7|||
163918861|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|14|||
163918862|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Progression/clinical progression|15|||
163918863|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|0|||
163918864|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|2|||
163918865|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|1|||
163918866|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Risk to Patient|5|||
163918867|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|0|||
163918868|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
163918869|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|2|||
164146822|NCT00352417|592898173|FG001|Overall Study|Adverse Event|0|||
163918870|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Severe Noncompliance to Protocol|8|||
163918871|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|0|||
164031265|NCT03250377|592474720|FG003|Overall Study|Patient requested to change hospital|1|||
164031266|NCT03250377|592474717|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
164031267|NCT03250377|592474718|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
164031268|NCT03250377|592474719|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
164031269|NCT03250377|592474720|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
163918872|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|9|||
163918873|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|11|||
163918874|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Withdrawal by Subject|29|||
163918875|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
163918876|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
163918877|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|0|||
163918878|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Lost to Follow-up|1|||
163918879|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Death|0|||
163918880|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
163918881|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Death|1|||
163918882|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Death|5|||
163918883|NCT03602859|592071370|FG000|Chemo Treatment Period (Cycle 2 to 6)|Other|0|||
163918884|NCT03602859|592071371|FG001|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
163918885|NCT03602859|592071372|FG002|Chemo Treatment Period (Cycle 2 to 6)|Other|1|||
163918886|NCT03602859|592071373|FG003|Chemo Treatment Period (Cycle 2 to 6)|Other|9|||
163918887|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Ongoing|0|||
163918888|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Ongoing|3|||
163918889|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Ongoing|23|||
163918890|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Ongoing|42|||
163918891|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Adverse Event|0|||
163918892|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Adverse Event|6|||
163918893|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Adverse Event|24|||
163918894|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Adverse Event|91|||
164146823|NCT00352417|592898172|FG000|Overall Study|Protocol Violation|0|||
164096929|NCT04206332|592719001|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096930|NCT04206332|592719002|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
164096931|NCT04206332|592718986|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096932|NCT04206332|592718987|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096933|NCT04206332|592718988|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096934|NCT04206332|592718989|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096935|NCT04206332|592718990|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096936|NCT04206332|592718991|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096937|NCT04206332|592718992|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096938|NCT04206332|592718993|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
164096939|NCT04206332|592718994|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096940|NCT04206332|592718995|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096941|NCT04206332|592718996|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
164096942|NCT04206332|592718997|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096943|NCT04206332|592718998|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164146824|NCT00352417|592898173|FG001|Overall Study|Protocol Violation|2|||
163918895|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
163918896|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|0|||
163918897|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|1|||
163918898|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Thrombocytopenia Platelet Count not Returned to >=100000 cells/uL w/in|2|||
163918899|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|0|||
163918900|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|83|||
163918901|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|251|||
163918902|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Progression/clinical progression|356|||
163918903|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Risk to Patient|0|||
163918904|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
163918905|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Risk to Patient|1|||
163918906|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Risk to Patient|2|||
163918907|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|0|||
163918908|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
163918909|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|3|||
163918910|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Severe Noncompliance to Protocol|5|||
163918911|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|0|||
164031270|NCT01114373|592474721|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
164031271|NCT01114373|592474722|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
164031272|NCT01114373|592474721|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
164031273|NCT01114373|592474722|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
164031274|NCT01114373|592474721|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
164031275|NCT01114373|592474722|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
164031276|NCT01114373|592474721|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
164031277|NCT01114373|592474722|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
164031278|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164031279|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164031280|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
164031281|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
164031282|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164031283|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
164031284|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
164031285|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
164031286|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
164031287|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
164031288|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
164031289|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
164031290|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
164031291|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
164031292|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
164031293|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164031294|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164031295|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
164031296|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
164031297|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
164031298|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164031299|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164031300|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164031301|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
164031302|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
164031303|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
164031304|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164031305|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164031306|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164031307|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
164031308|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
164031309|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164031310|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164031311|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164031312|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164031313|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
164031314|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
164031315|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
164031316|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
164112596|NCT00210639|592774044|FG000|Overall Study|Withdrawal by Subject|8|||
163918912|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|7|||
164096944|NCT04206332|592718999|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164112597|NCT00210639|592774045|FG001|Overall Study|Withdrawal by Subject|1|||
163918913|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|22|||
163918914|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Withdrawal by Subject|48|||
163918915|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
163918916|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|0|||
163918917|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
163918918|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Lost to Follow-up|2|||
163918919|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Death|0|||
163918920|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Death|0|||
163918921|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Death|1|||
163918922|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Death|7|||
163918923|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
163918924|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|18|||
163918925|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
163918926|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Unblinded due to being randomized to Arm 1|0|||
163918927|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
163918928|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
163918929|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Investigator decision|0|||
163918930|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Investigator decision|1|||
163918931|NCT03602859|592071370|FG000|Maintenance Period (Cycle 7 to 89)|Other|0|||
163918932|NCT03602859|592071371|FG001|Maintenance Period (Cycle 7 to 89)|Other|2|||
163918933|NCT03602859|592071372|FG002|Maintenance Period (Cycle 7 to 89)|Other|2|||
163918934|NCT03602859|592071373|FG003|Maintenance Period (Cycle 7 to 89)|Other|12|||
163918935|NCT00506922|592072445|FG000|Overall Study|Physician Decision|0|||
163918936|NCT00506922|592072446|FG001|Overall Study|Physician Decision|0|||
163918937|NCT00506922|592072447|FG002|Overall Study|Physician Decision|0|||
163918938|NCT00506922|592072448|FG003|Overall Study|Physician Decision|2|||
163918939|NCT00506922|592072449|FG004|Overall Study|Physician Decision|0|||
163918940|NCT00506922|592072445|FG000|Overall Study|Withdrawal by Subject|0|||
163918941|NCT00506922|592072446|FG001|Overall Study|Withdrawal by Subject|0|||
163918942|NCT00506922|592072447|FG002|Overall Study|Withdrawal by Subject|0|||
163918943|NCT00506922|592072448|FG003|Overall Study|Withdrawal by Subject|0|||
164031317|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
164031318|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
164031319|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
164031320|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
164031321|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
164031322|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164031323|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164031324|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164031325|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
164031326|NCT03444870|592474723|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
164031327|NCT03444870|592474724|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164031328|NCT03444870|592474725|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164031329|NCT03444870|592474726|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164031330|NCT03444870|592474727|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164031331|NCT03444870|592474728|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
164031332|NCT03444870|592474723|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164112598|NCT00210639|592774044|FG000|Overall Study|Other|18|||
163918944|NCT00506922|592072449|FG004|Overall Study|Withdrawal by Subject|1|||
163918945|NCT04816708|592072455|FG000|Overall Study|Lost to Follow-up|10|||
163918946|NCT04816708|592072456|FG001|Overall Study|Lost to Follow-up|4|||
163918947|NCT03596905|592072457|FG000|Overall Study|Protocol Violation|0|||
163918948|NCT03596905|592072458|FG001|Overall Study|Protocol Violation|0|||
164031333|NCT03444870|592474724|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164031334|NCT03444870|592474725|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164031335|NCT03444870|592474726|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164031336|NCT03444870|592474727|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
164031337|NCT03444870|592474728|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
164031338|NCT03444870|592474723|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
164031339|NCT03444870|592474724|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
164031340|NCT03444870|592474725|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
164031341|NCT03444870|592474726|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
164031342|NCT03444870|592474727|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
164031343|NCT03444870|592474728|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
164031344|NCT03444870|592474723|FG000|Open-Label Extension (OLE) Period|Death|0|||
164031345|NCT03444870|592474724|FG001|Open-Label Extension (OLE) Period|Death|0|||
164031346|NCT03444870|592474725|FG002|Open-Label Extension (OLE) Period|Death|0|||
164031347|NCT03444870|592474726|FG003|Open-Label Extension (OLE) Period|Death|0|||
164031348|NCT03444870|592474727|FG004|Open-Label Extension (OLE) Period|Death|1|||
164031349|NCT03444870|592474728|FG005|Open-Label Extension (OLE) Period|Death|0|||
164031350|NCT02197897|592474729|FG000|Overall Study|not eligible|1|||
164031351|NCT03495453|592474740|FG000|Overall Study|Withdrawal by Subject|0|||
164031352|NCT03495453|592474741|FG001|Overall Study|Withdrawal by Subject|1|||
164031353|NCT01103778|592474744|FG000|Overall Study|Lost to Follow-up|1|||
164031354|NCT01103778|592474744|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
164096945|NCT04206332|592719000|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164031355|NCT01103778|592474744|FG000|Overall Study|Screen failure|1|||
163918949|NCT03596905|592072459|FG002|Overall Study|Protocol Violation|0|||
163918950|NCT03596905|592072460|FG003|Overall Study|Protocol Violation|0|||
163918951|NCT03596905|592072461|FG004|Overall Study|Protocol Violation|1|||
163918952|NCT03596905|592072462|FG005|Overall Study|Protocol Violation|0|||
163918953|NCT03596905|592072463|FG006|Overall Study|Protocol Violation|0|||
163918954|NCT03596905|592072457|FG000|Overall Study|Withdrawal by Subject|0|||
163918955|NCT03596905|592072458|FG001|Overall Study|Withdrawal by Subject|2|||
163918956|NCT03596905|592072459|FG002|Overall Study|Withdrawal by Subject|1|||
163918957|NCT03596905|592072460|FG003|Overall Study|Withdrawal by Subject|0|||
163918958|NCT03596905|592072461|FG004|Overall Study|Withdrawal by Subject|2|||
163918959|NCT03596905|592072462|FG005|Overall Study|Withdrawal by Subject|0|||
163918960|NCT03596905|592072463|FG006|Overall Study|Withdrawal by Subject|0|||
163918961|NCT03596905|592072457|FG000|Overall Study|Participant moved and was unable to complete study|0|||
163918962|NCT03596905|592072458|FG001|Overall Study|Participant moved and was unable to complete study|1|||
163918963|NCT03596905|592072459|FG002|Overall Study|Participant moved and was unable to complete study|0|||
163918964|NCT03596905|592072460|FG003|Overall Study|Participant moved and was unable to complete study|0|||
163918965|NCT03596905|592072461|FG004|Overall Study|Participant moved and was unable to complete study|0|||
163918966|NCT03596905|592072462|FG005|Overall Study|Participant moved and was unable to complete study|0|||
163918967|NCT03596905|592072463|FG006|Overall Study|Participant moved and was unable to complete study|0|||
163918968|NCT03596905|592072457|FG000|Overall Study|Adverse Event|0|||
163918969|NCT03596905|592072458|FG001|Overall Study|Adverse Event|0|||
163918970|NCT03596905|592072459|FG002|Overall Study|Adverse Event|0|||
163918971|NCT03596905|592072460|FG003|Overall Study|Adverse Event|0|||
163918972|NCT03596905|592072461|FG004|Overall Study|Adverse Event|0|||
163918973|NCT03596905|592072462|FG005|Overall Study|Adverse Event|0|||
163918974|NCT03596905|592072463|FG006|Overall Study|Adverse Event|1|||
163918975|NCT03596905|592072457|FG000|Overall Study|Non-Compliance with eDiary|1|||
163918976|NCT03596905|592072458|FG001|Overall Study|Non-Compliance with eDiary|0|||
163918977|NCT03596905|592072459|FG002|Overall Study|Non-Compliance with eDiary|0|||
163918978|NCT03596905|592072460|FG003|Overall Study|Non-Compliance with eDiary|0|||
163918979|NCT03596905|592072461|FG004|Overall Study|Non-Compliance with eDiary|1|||
163918980|NCT03596905|592072462|FG005|Overall Study|Non-Compliance with eDiary|0|||
163918981|NCT03596905|592072463|FG006|Overall Study|Non-Compliance with eDiary|2|||
163918982|NCT03596905|592072457|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163918983|NCT03596905|592072458|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163918984|NCT03596905|592072459|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163918985|NCT03596905|592072460|FG003|Overall Study|Non-Compliance with Study Drug|0|||
163918986|NCT03596905|592072461|FG004|Overall Study|Non-Compliance with Study Drug|1|||
163918987|NCT03596905|592072462|FG005|Overall Study|Non-Compliance with Study Drug|0|||
163918988|NCT03596905|592072463|FG006|Overall Study|Non-Compliance with Study Drug|0|||
163918989|NCT03596905|592072457|FG000|Overall Study|Lost to Follow-up|0|||
164031356|NCT03084718|592474745|FG000|Overall Study|Withdrawal by Subject|4|||
164031357|NCT03084718|592474746|FG001|Overall Study|Withdrawal by Subject|3|||
164031358|NCT03084718|592474747|FG002|Overall Study|Withdrawal by Subject|4|||
163918990|NCT03596905|592072458|FG001|Overall Study|Lost to Follow-up|0|||
163918991|NCT03596905|592072459|FG002|Overall Study|Lost to Follow-up|0|||
163918992|NCT03596905|592072460|FG003|Overall Study|Lost to Follow-up|0|||
163918993|NCT03596905|592072461|FG004|Overall Study|Lost to Follow-up|0|||
163918994|NCT03596905|592072462|FG005|Overall Study|Lost to Follow-up|1|||
163918995|NCT03596905|592072463|FG006|Overall Study|Lost to Follow-up|0|||
163918996|NCT00508274|592072464|FG000|Overall Study|Adverse Event|5|||
163918997|NCT00508274|592072464|FG000|Overall Study|Death|7|||
163918998|NCT00508274|592072464|FG000|Overall Study|Disease progression|32|||
163918999|NCT00508274|592072464|FG000|Overall Study|Withdrawal by Subject|1|||
163919000|NCT00508274|592072464|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
164031359|NCT03084718|592474748|FG003|Overall Study|Withdrawal by Subject|0|||
164031360|NCT03084718|592474749|FG004|Overall Study|Withdrawal by Subject|0|||
164031361|NCT03084718|592474745|FG000|Overall Study|Physician Decision|1|||
164031362|NCT03084718|592474746|FG001|Overall Study|Physician Decision|0|||
164031363|NCT03084718|592474747|FG002|Overall Study|Physician Decision|0|||
164031364|NCT03084718|592474748|FG003|Overall Study|Physician Decision|0|||
164031365|NCT03084718|592474749|FG004|Overall Study|Physician Decision|0|||
164031366|NCT03084718|592474745|FG000|Overall Study|Adverse Event|3|||
164031367|NCT03084718|592474746|FG001|Overall Study|Adverse Event|5|||
164031368|NCT03084718|592474747|FG002|Overall Study|Adverse Event|5|||
164031369|NCT03084718|592474748|FG003|Overall Study|Adverse Event|8|||
164031370|NCT03084718|592474749|FG004|Overall Study|Adverse Event|2|||
164031371|NCT03084718|592474745|FG000|Overall Study|Lack of Efficacy|2|||
164031372|NCT03084718|592474746|FG001|Overall Study|Lack of Efficacy|0|||
164031373|NCT03084718|592474747|FG002|Overall Study|Lack of Efficacy|1|||
164031374|NCT03084718|592474748|FG003|Overall Study|Lack of Efficacy|4|||
164031375|NCT03084718|592474749|FG004|Overall Study|Lack of Efficacy|0|||
164031376|NCT03084718|592474745|FG000|Overall Study|Lost to Follow-up|0|||
164031377|NCT03084718|592474746|FG001|Overall Study|Lost to Follow-up|1|||
164031378|NCT03084718|592474747|FG002|Overall Study|Lost to Follow-up|0|||
164031379|NCT03084718|592474748|FG003|Overall Study|Lost to Follow-up|0|||
164031380|NCT03084718|592474749|FG004|Overall Study|Lost to Follow-up|2|||
164031381|NCT03084718|592474745|FG000|Overall Study|Protocol Violation|0|||
164031382|NCT03084718|592474746|FG001|Overall Study|Protocol Violation|0|||
164031383|NCT03084718|592474747|FG002|Overall Study|Protocol Violation|1|||
164031384|NCT03084718|592474748|FG003|Overall Study|Protocol Violation|0|||
164031385|NCT03084718|592474749|FG004|Overall Study|Protocol Violation|0|||
164031386|NCT03084718|592474745|FG000|Overall Study|Death|0|||
164031387|NCT03084718|592474746|FG001|Overall Study|Death|1|||
164031388|NCT03084718|592474747|FG002|Overall Study|Death|0|||
164031389|NCT03084718|592474748|FG003|Overall Study|Death|0|||
164031390|NCT03084718|592474749|FG004|Overall Study|Death|0|||
164031391|NCT03084718|592474745|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
164031392|NCT03084718|592474746|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
164031393|NCT03084718|592474747|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
164031394|NCT03084718|592474748|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
164031395|NCT03084718|592474749|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
164031396|NCT01594333|592474754|FG000|Overall Study|Death|96|||
164031397|NCT01594333|592474755|FG001|Overall Study|Death|83|||
164031398|NCT01594333|592474754|FG000|Overall Study|Lost to Follow-up|5|||
164031399|NCT01594333|592474755|FG001|Overall Study|Lost to Follow-up|5|||
164031400|NCT01594333|592474754|FG000|Overall Study|Withdrawal by Subject|60|||
164031401|NCT01594333|592474755|FG001|Overall Study|Withdrawal by Subject|63|||
164031402|NCT00589979|592474756|FG000|Run-In Period|Adverse Event|5|||
164031403|NCT00589979|592474757|FG001|Run-In Period|Adverse Event|0|||
164031404|NCT00589979|592474758|FG002|Run-In Period|Adverse Event|0|||
164031405|NCT00589979|592474756|FG000|Run-In Period|Protocol Violation|3|||
164031406|NCT00589979|592474757|FG001|Run-In Period|Protocol Violation|0|||
164031407|NCT00589979|592474758|FG002|Run-In Period|Protocol Violation|0|||
164031408|NCT00589979|592474756|FG000|Run-In Period|Did not qualify for randomization|54|||
164031409|NCT00589979|592474757|FG001|Run-In Period|Did not qualify for randomization|0|||
164031410|NCT00589979|592474758|FG002|Run-In Period|Did not qualify for randomization|0|||
164031411|NCT00589979|592474756|FG000|Run-In Period|Withdrawal by Subject|10|||
164031412|NCT00589979|592474757|FG001|Run-In Period|Withdrawal by Subject|0|||
164031413|NCT00589979|592474758|FG002|Run-In Period|Withdrawal by Subject|0|||
164031414|NCT00589979|592474756|FG000|Run-In Period|Informed Consent Withdrawn|4|||
164031415|NCT00589979|592474757|FG001|Run-In Period|Informed Consent Withdrawn|0|||
164031416|NCT00589979|592474758|FG002|Run-In Period|Informed Consent Withdrawn|0|||
164031417|NCT00589979|592474756|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
164031418|NCT00589979|592474757|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
164031419|NCT00589979|592474758|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
164031420|NCT00589979|592474756|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
164031421|NCT00589979|592474757|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
164031422|NCT00589979|592474758|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
164031423|NCT00589979|592474756|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
164031424|NCT00589979|592474757|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
164031425|NCT00589979|592474758|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
164031426|NCT00589979|592474756|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
164031427|NCT00589979|592474757|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
164031428|NCT00589979|592474758|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
164031429|NCT00589979|592474756|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
164031430|NCT00589979|592474757|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
164031431|NCT00589979|592474758|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
164031432|NCT00589979|592474756|FG000|Double-Blind Treatment Period 2|Other|0|||
163919001|NCT00508274|592072464|FG000|Overall Study|Missing|3|||
163919002|NCT02531126|592072468|FG000|Overall Study|Non-compliance with protocol/protocol deviation|5|||
163919003|NCT02531126|592072469|FG001|Overall Study|Non-compliance with protocol/protocol deviation|0|||
163919004|NCT02531126|592072470|FG002|Overall Study|Non-compliance with protocol/protocol deviation|3|||
163919005|NCT02531126|592072471|FG003|Overall Study|Non-compliance with protocol/protocol deviation|0|||
163919006|NCT02531126|592072468|FG000|Overall Study|Adverse Event|16|||
163919007|NCT02531126|592072469|FG001|Overall Study|Adverse Event|13|||
163919008|NCT02531126|592072470|FG002|Overall Study|Adverse Event|27|||
163919009|NCT02531126|592072471|FG003|Overall Study|Adverse Event|4|||
163919010|NCT02531126|592072468|FG000|Overall Study|Lack of Efficacy|50|||
163919011|NCT02531126|592072469|FG001|Overall Study|Lack of Efficacy|32|||
163919012|NCT02531126|592072470|FG002|Overall Study|Lack of Efficacy|121|||
163919013|NCT02531126|592072471|FG003|Overall Study|Lack of Efficacy|0|||
163919014|NCT02531126|592072468|FG000|Overall Study|Withdrawal by Subject|38|||
163919015|NCT02531126|592072469|FG001|Overall Study|Withdrawal by Subject|31|||
163919016|NCT02531126|592072470|FG002|Overall Study|Withdrawal by Subject|96|||
163919017|NCT02531126|592072471|FG003|Overall Study|Withdrawal by Subject|6|||
164031433|NCT00589979|592474757|FG001|Double-Blind Treatment Period 2|Other|0|||
164031434|NCT00589979|592474758|FG002|Double-Blind Treatment Period 2|Other|1|||
164031435|NCT00589979|592474756|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
164031436|NCT00589979|592474757|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
164031437|NCT00589979|592474758|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
164031438|NCT00589979|592474756|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
163919018|NCT02531126|592072468|FG000|Overall Study|Pregnancy|2|||
163919019|NCT02531126|592072469|FG001|Overall Study|Pregnancy|3|||
163919020|NCT02531126|592072470|FG002|Overall Study|Pregnancy|2|||
163919021|NCT02531126|592072471|FG003|Overall Study|Pregnancy|0|||
163919022|NCT02531126|592072468|FG000|Overall Study|Switched to commercial drug|2|||
163919023|NCT02531126|592072469|FG001|Overall Study|Switched to commercial drug|4|||
164031439|NCT00589979|592474757|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
164031440|NCT00589979|592474758|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
164031441|NCT03428997|592474764|FG000|Overall Study|Sponsor decision.|1|||
164031442|NCT03428997|592474764|FG000|Overall Study|Withdrawal by Subject|3|||
164031443|NCT03428997|592474764|FG000|Overall Study|Lost to Follow-up|4|||
164031444|NCT00510068|592474768|FG000|Double-blind Period|Disease progression|98|||
164031445|NCT00510068|592474769|FG001|Double-blind Period|Disease progression|169|||
164031446|NCT00510068|592474768|FG000|Double-blind Period|Final primary analysis|52|||
164031447|NCT00510068|592474769|FG001|Double-blind Period|Final primary analysis|18|||
164031448|NCT00510068|592474768|FG000|Double-blind Period|Adverse Event|37|||
164031449|NCT00510068|592474769|FG001|Double-blind Period|Adverse Event|7|||
164031450|NCT00510068|592474768|FG000|Double-blind Period|Withdrawal by Subject|8|||
164031451|NCT00510068|592474769|FG001|Double-blind Period|Withdrawal by Subject|6|||
163919024|NCT02531126|592072470|FG002|Overall Study|Switched to commercial drug|4|||
163919025|NCT02531126|592072471|FG003|Overall Study|Switched to commercial drug|0|||
163919026|NCT02531126|592072468|FG000|Overall Study|Other reasons|23|||
163919027|NCT02531126|592072469|FG001|Overall Study|Other reasons|29|||
163919028|NCT02531126|592072470|FG002|Overall Study|Other reasons|27|||
163919029|NCT02531126|592072471|FG003|Overall Study|Other reasons|15|||
163919030|NCT02531126|592072468|FG000|Overall Study|Physician Decision|6|||
163919031|NCT02531126|592072469|FG001|Overall Study|Physician Decision|6|||
163919032|NCT02531126|592072470|FG002|Overall Study|Physician Decision|28|||
163919033|NCT02531126|592072471|FG003|Overall Study|Physician Decision|0|||
163919034|NCT02531126|592072468|FG000|Overall Study|Non-compliance with investigational drug|1|||
163919035|NCT02531126|592072469|FG001|Overall Study|Non-compliance with investigational drug|0|||
163919036|NCT02531126|592072470|FG002|Overall Study|Non-compliance with investigational drug|0|||
163919037|NCT02531126|592072471|FG003|Overall Study|Non-compliance with investigational drug|0|||
163919038|NCT00377312|592072472|FG000|Overall Study|Adverse Event|1|||
163919039|NCT00377312|592072473|FG001|Overall Study|Adverse Event|1|||
163919040|NCT00382408|592072476|FG000|Overall Study|Did not meet protocol requirement|3|||
163919041|NCT00382408|592072477|FG001|Overall Study|Did not meet protocol requirement|3|||
163919042|NCT00382408|592072476|FG000|Overall Study|Protocol Violation|2|||
163919043|NCT00382408|592072477|FG001|Overall Study|Protocol Violation|2|||
163919044|NCT00382408|592072476|FG000|Overall Study|Physician Decision|1|||
163919045|NCT00382408|592072477|FG001|Overall Study|Physician Decision|0|||
163919046|NCT00382408|592072476|FG000|Overall Study|Withdrawal by Subject|17|||
163919047|NCT00382408|592072477|FG001|Overall Study|Withdrawal by Subject|6|||
163919048|NCT00382408|592072476|FG000|Overall Study|Pregnancy|2|||
163919049|NCT00382408|592072477|FG001|Overall Study|Pregnancy|0|||
163919050|NCT00382408|592072476|FG000|Overall Study|Lost to Follow-up|19|||
163919051|NCT00382408|592072477|FG001|Overall Study|Lost to Follow-up|8|||
163919052|NCT00382408|592072476|FG000|Overall Study|Other|100|||
163919053|NCT00382408|592072477|FG001|Overall Study|Other|35|||
163919054|NCT01572493|592072480|FG000|Overall Study|Physician Decision|1|||
163919055|NCT01572493|592072481|FG001|Overall Study|Physician Decision|0|||
163919056|NCT01572493|592072482|FG002|Overall Study|Physician Decision|0|||
163919057|NCT01572493|592072483|FG003|Overall Study|Physician Decision|0|||
163919058|NCT01572493|592072484|FG004|Overall Study|Physician Decision|0|||
163919059|NCT01572493|592072485|FG005|Overall Study|Physician Decision|0|||
163919060|NCT01572493|592072486|FG006|Overall Study|Physician Decision|0|||
163919061|NCT01572493|592072487|FG007|Overall Study|Physician Decision|0|||
163919062|NCT01572493|592072488|FG008|Overall Study|Physician Decision|0|||
163919063|NCT01572493|592072480|FG000|Overall Study|Switched to alternative treatment|0|||
163919064|NCT01572493|592072481|FG001|Overall Study|Switched to alternative treatment|1|||
163919065|NCT01572493|592072482|FG002|Overall Study|Switched to alternative treatment|2|||
163919066|NCT01572493|592072483|FG003|Overall Study|Switched to alternative treatment|1|||
163919067|NCT01572493|592072484|FG004|Overall Study|Switched to alternative treatment|2|||
163919068|NCT01572493|592072485|FG005|Overall Study|Switched to alternative treatment|0|||
164031452|NCT00510068|592474768|FG000|Double-blind Period|Death|4|||
164031453|NCT00510068|592474769|FG001|Double-blind Period|Death|3|||
164031454|NCT00510068|592474768|FG000|Double-blind Period|Abnormal test result (s)|1|||
164031455|NCT00510068|592474769|FG001|Double-blind Period|Abnormal test result (s)|0|||
164031456|NCT00510068|592474768|FG000|Double-blind Period|Lost to Follow-up|1|||
164031457|NCT00510068|592474769|FG001|Double-blind Period|Lost to Follow-up|0|||
164031458|NCT00510068|592474768|FG000|Double-blind Period|Protocol Violation|6|||
164031459|NCT00510068|592474769|FG001|Double-blind Period|Protocol Violation|0|||
164031460|NCT00510068|592474768|FG000|Open-label Period|Disease Progression|124|||
163919069|NCT01572493|592072486|FG006|Overall Study|Switched to alternative treatment|2|||
163919070|NCT01572493|592072487|FG007|Overall Study|Switched to alternative treatment|0|||
163919071|NCT01572493|592072488|FG008|Overall Study|Switched to alternative treatment|2|||
163919072|NCT01572493|592072480|FG000|Overall Study|Death|0|||
163919073|NCT01572493|592072481|FG001|Overall Study|Death|0|||
163919074|NCT01572493|592072482|FG002|Overall Study|Death|0|||
163919075|NCT01572493|592072483|FG003|Overall Study|Death|1|||
163919076|NCT01572493|592072484|FG004|Overall Study|Death|0|||
163919077|NCT01572493|592072485|FG005|Overall Study|Death|1|||
163919078|NCT01572493|592072486|FG006|Overall Study|Death|0|||
163919079|NCT01572493|592072487|FG007|Overall Study|Death|0|||
163919080|NCT01572493|592072488|FG008|Overall Study|Death|0|||
163919081|NCT01572493|592072480|FG000|Overall Study|Adverse Event|0|||
163919082|NCT01572493|592072481|FG001|Overall Study|Adverse Event|0|||
163919083|NCT01572493|592072482|FG002|Overall Study|Adverse Event|0|||
163919084|NCT01572493|592072483|FG003|Overall Study|Adverse Event|0|||
163919085|NCT01572493|592072484|FG004|Overall Study|Adverse Event|0|||
163919086|NCT01572493|592072485|FG005|Overall Study|Adverse Event|0|||
163919087|NCT01572493|592072486|FG006|Overall Study|Adverse Event|1|||
163919088|NCT01572493|592072487|FG007|Overall Study|Adverse Event|0|||
163919089|NCT01572493|592072488|FG008|Overall Study|Adverse Event|0|||
163919090|NCT00609245|592072489|FG000|Overall Study|Adverse Event|1|||
163919091|NCT02236598|592072490|FG000|Overall Study|Adverse Event|0|||
163919092|NCT02236598|592072491|FG001|Overall Study|Adverse Event|1|||
163919093|NCT02236598|592072490|FG000|Overall Study|Withdrawal by Subject|0|||
163919094|NCT02236598|592072491|FG001|Overall Study|Withdrawal by Subject|1|||
163919095|NCT01475370|592072494|FG000|Overall Study|Exacerbation of primary disease|2|||
163919096|NCT01475370|592072495|FG001|Overall Study|Exacerbation of primary disease|2|||
163919097|NCT01475370|592072496|FG002|Overall Study|Exacerbation of primary disease|2|||
163919098|NCT01475370|592072494|FG000|Overall Study|Study drug administration difficult|0|||
163919099|NCT01475370|592072495|FG001|Overall Study|Study drug administration difficult|1|||
163919100|NCT01475370|592072496|FG002|Overall Study|Study drug administration difficult|1|||
163919101|NCT01475370|592072494|FG000|Overall Study|Other than specified|1|||
163919102|NCT01475370|592072495|FG001|Overall Study|Other than specified|0|||
163919103|NCT01475370|592072496|FG002|Overall Study|Other than specified|0|||
163919104|NCT03132753|592072497|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
163919105|NCT03132753|592072498|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
163919106|NCT03132753|592072497|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
163919107|NCT03132753|592072498|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
163919108|NCT00084747|592072499|FG000|Overall Study|Relapsed|8|||
163919109|NCT00084747|592072499|FG000|Overall Study|Death|3|||
163919110|NCT00084747|592072499|FG000|Overall Study|Withdrawal by Subject|2|||
163919111|NCT00679549|592072501|FG000|Overall Study|dropout|2|||
163919112|NCT00679549|592072502|FG001|Overall Study|dropout|4|||
163919113|NCT00679549|592072501|FG000|Overall Study|missing outcome echocardiograms|4|||
163919114|NCT00679549|592072502|FG001|Overall Study|missing outcome echocardiograms|5|||
163919115|NCT01446042|592072508|FG000|Overall Study|Withdrawal by Subject|12|||
163919116|NCT01446042|592072509|FG001|Overall Study|Withdrawal by Subject|2|||
163919117|NCT01446042|592072510|FG002|Overall Study|Withdrawal by Subject|4|||
163919118|NCT01446042|592072508|FG000|Overall Study|Adverse Event|1|||
163919119|NCT01446042|592072509|FG001|Overall Study|Adverse Event|0|||
164031461|NCT00510068|592474769|FG001|Open-label Period|Disease Progression|0|||
164031462|NCT00510068|592474768|FG000|Open-label Period|Adverse Event|46|||
164031463|NCT00510068|592474769|FG001|Open-label Period|Adverse Event|0|||
164031464|NCT00510068|592474768|FG000|Open-label Period|Withdrawal by Subject|21|||
164031465|NCT00510068|592474769|FG001|Open-label Period|Withdrawal by Subject|0|||
164031466|NCT00510068|592474768|FG000|Open-label Period|Administrative problems|17|||
163919120|NCT01446042|592072510|FG002|Overall Study|Adverse Event|4|||
163919121|NCT01446042|592072508|FG000|Overall Study|Lost to Follow-up|5|||
163919122|NCT01446042|592072509|FG001|Overall Study|Lost to Follow-up|0|||
163919123|NCT01446042|592072510|FG002|Overall Study|Lost to Follow-up|0|||
163919124|NCT01446042|592072508|FG000|Overall Study|Other reasons|2|||
163919125|NCT01446042|592072509|FG001|Overall Study|Other reasons|1|||
164031467|NCT00510068|592474769|FG001|Open-label Period|Administrative problems|0|||
164031468|NCT00510068|592474768|FG000|Open-label Period|Death|7|||
164031469|NCT00510068|592474769|FG001|Open-label Period|Death|0|||
164031470|NCT00510068|592474768|FG000|Open-label Period|New cancer therapy|7|||
164031471|NCT00510068|592474769|FG001|Open-label Period|New cancer therapy|0|||
164031472|NCT00510068|592474768|FG000|Open-label Period|Protocol Violation|2|||
164031473|NCT00510068|592474769|FG001|Open-label Period|Protocol Violation|0|||
164031474|NCT00510068|592474768|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
164031475|NCT00510068|592474769|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
164031476|NCT02120157|592474770|FG000|Overall Study|Death|8|||
164031477|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
164031478|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
164031479|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
164031480|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
164031481|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
164031482|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
164031483|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Death|1|||
164031484|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Death|3|||
164031485|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
164031486|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
164031487|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
164031488|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
164031489|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
164031490|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
164031491|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
164031492|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
164031493|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
164031494|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
164031495|NCT02553317|592474771|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
164031496|NCT02553317|592474772|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
164031497|NCT01354431|592474774|FG000|Pre-Treatment Period|Not reported|1|||
164031498|NCT01354431|592474775|FG001|Pre-Treatment Period|Not reported|0|||
164031499|NCT01354431|592474776|FG002|Pre-Treatment Period|Not reported|0|||
164031500|NCT01354431|592474774|FG000|Treatment Period|Disease Progression|50|||
164031501|NCT01354431|592474775|FG001|Treatment Period|Disease Progression|40|||
164031502|NCT01354431|592474776|FG002|Treatment Period|Disease Progression|44|||
163919126|NCT01446042|592072510|FG002|Overall Study|Other reasons|1|||
163919127|NCT05714345|592072518|FG000|Overall Study|Death|1|||
163919128|NCT05714345|592072519|FG001|Overall Study|Death|1|||
163919129|NCT04474691|592072520|FG000|Overall Study|Withdrawal by Subject|9|||
163919130|NCT01323309|592072521|FG000|Overall Study|Death|9|||
163919131|NCT01323309|592072522|FG001|Overall Study|Death|15|||
163919132|NCT01323309|592072523|FG002|Overall Study|Death|5|||
163919133|NCT01323309|592072521|FG000|Overall Study|Lost to Follow-up|11|||
163919134|NCT01323309|592072522|FG001|Overall Study|Lost to Follow-up|14|||
163919135|NCT01323309|592072523|FG002|Overall Study|Lost to Follow-up|24|||
163919136|NCT01323309|592072521|FG000|Overall Study|Withdrawal by Subject|14|||
164031503|NCT01354431|592474774|FG000|Treatment Period|Study Drug Toxicity|5|||
164031504|NCT01354431|592474775|FG001|Treatment Period|Study Drug Toxicity|8|||
164031505|NCT01354431|592474776|FG002|Treatment Period|Study Drug Toxicity|4|||
164031506|NCT01354431|592474774|FG000|Treatment Period|Death|0|||
164031507|NCT01354431|592474775|FG001|Treatment Period|Death|1|||
164031508|NCT01354431|592474776|FG002|Treatment Period|Death|0|||
164031509|NCT01354431|592474774|FG000|Treatment Period|AE unrelated to study drug|1|||
164031510|NCT01354431|592474775|FG001|Treatment Period|AE unrelated to study drug|2|||
164031511|NCT01354431|592474776|FG002|Treatment Period|AE unrelated to study drug|5|||
164031512|NCT01354431|592474774|FG000|Treatment Period|Participant request to discontinue|2|||
164031513|NCT01354431|592474775|FG001|Treatment Period|Participant request to discontinue|2|||
164031514|NCT01354431|592474776|FG002|Treatment Period|Participant request to discontinue|1|||
164031515|NCT01354431|592474774|FG000|Treatment Period|Participant withdrew consent|0|||
164031516|NCT01354431|592474775|FG001|Treatment Period|Participant withdrew consent|1|||
164031517|NCT01354431|592474776|FG002|Treatment Period|Participant withdrew consent|0|||
164031518|NCT01354431|592474774|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
164031519|NCT01354431|592474775|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
164031520|NCT01354431|592474776|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
164031521|NCT03176277|592474777|FG000|Part A Dose Escalation Study|Adverse Event|1|||
164031522|NCT03176277|592474778|FG001|Part A Dose Escalation Study|Adverse Event|0|||
164031523|NCT03176277|592474779|FG002|Part A Dose Escalation Study|Adverse Event|1|||
164031524|NCT03176277|592474780|FG003|Part A Dose Escalation Study|Adverse Event|0|||
164031525|NCT03176277|592474777|FG000|Part A Dose Escalation Study|Physician Decision|1|||
164031526|NCT03176277|592474778|FG001|Part A Dose Escalation Study|Physician Decision|1|||
164031527|NCT03176277|592474779|FG002|Part A Dose Escalation Study|Physician Decision|2|||
164031528|NCT03176277|592474780|FG003|Part A Dose Escalation Study|Physician Decision|0|||
164031529|NCT03176277|592474777|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
164031530|NCT03176277|592474778|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
164031531|NCT03176277|592474779|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
164031532|NCT03176277|592474780|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
164031533|NCT03176277|592474777|FG000|Part A Dose Escalation Study|Progressive disease|3|||
164031534|NCT03176277|592474778|FG001|Part A Dose Escalation Study|Progressive disease|1|||
164031535|NCT03176277|592474779|FG002|Part A Dose Escalation Study|Progressive disease|3|||
164031536|NCT03176277|592474780|FG003|Part A Dose Escalation Study|Progressive disease|0|||
164031537|NCT00702052|592474781|FG000|Overall Study|Adverse Event|23|||
164031538|NCT00702052|592474781|FG000|Overall Study|Disease Progression|30|||
164031539|NCT00702052|592474781|FG000|Overall Study|Withdrawal by Subject|5|||
164031540|NCT03691610|592474782|FG000|Overall Study|Adverse Event|0|||
164031541|NCT03691610|592474783|FG001|Overall Study|Adverse Event|1|||
164031542|NCT03691610|592474784|FG002|Overall Study|Adverse Event|0|||
164031543|NCT03691610|592474785|FG003|Overall Study|Adverse Event|0|||
164031544|NCT03691610|592474782|FG000|Overall Study|Protocol Deviation|15|||
164031545|NCT03691610|592474783|FG001|Overall Study|Protocol Deviation|8|||
163919137|NCT01323309|592072522|FG001|Overall Study|Withdrawal by Subject|14|||
163919138|NCT01323309|592072523|FG002|Overall Study|Withdrawal by Subject|18|||
163919139|NCT01323309|592072521|FG000|Overall Study|Disease progression|5|||
163919140|NCT01323309|592072522|FG001|Overall Study|Disease progression|11|||
163919141|NCT01323309|592072523|FG002|Overall Study|Disease progression|4|||
163919142|NCT03048058|592072530|FG000|Overall Study|Lost to Follow-up|4|||
164031546|NCT03691610|592474784|FG002|Overall Study|Protocol Deviation|1|||
164031547|NCT03691610|592474785|FG003|Overall Study|Protocol Deviation|2|||
164031548|NCT03691610|592474782|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
164031549|NCT03691610|592474783|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
164031550|NCT03691610|592474784|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
164031551|NCT03691610|592474785|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
164031552|NCT03691610|592474782|FG000|Overall Study|Lost to Follow-up|20|||
164031553|NCT03691610|592474783|FG001|Overall Study|Lost to Follow-up|11|||
164031554|NCT03691610|592474784|FG002|Overall Study|Lost to Follow-up|5|||
164031555|NCT03691610|592474785|FG003|Overall Study|Lost to Follow-up|2|||
163919143|NCT03048058|592072531|FG001|Overall Study|Lost to Follow-up|0|||
163919144|NCT03048058|592072530|FG000|Overall Study|Withdrawal by Subject|0|||
163919145|NCT03048058|592072531|FG001|Overall Study|Withdrawal by Subject|4|||
163919146|NCT01257698|592072540|FG000|Overall Study|Protocol Violation|4|||
163919147|NCT01257698|592072541|FG001|Overall Study|Protocol Violation|0|||
163919148|NCT00274846|592072544|FG000|Overall Study|Did not receive adequate NK cells|1|||
163919149|NCT04601857|592072545|FG000|Overall Study|Adverse Event/Serious Adverse Event|3|||
163919150|NCT04601857|592072546|FG001|Overall Study|Adverse Event/Serious Adverse Event|7|||
163919151|NCT04601857|592072545|FG000|Overall Study|Disease Progression|2|||
163919152|NCT04601857|592072546|FG001|Overall Study|Disease Progression|4|||
163919153|NCT04601857|592072545|FG000|Overall Study|Clinical Disease Progression|2|||
163919154|NCT04601857|592072546|FG001|Overall Study|Clinical Disease Progression|1|||
163919155|NCT04601857|592072545|FG000|Overall Study|Radiological Progression|4|||
163919156|NCT04601857|592072546|FG001|Overall Study|Radiological Progression|11|||
163919157|NCT04601857|592072545|FG000|Overall Study|Death|1|||
163919158|NCT04601857|592072546|FG001|Overall Study|Death|0|||
163919159|NCT04601857|592072545|FG000|Overall Study|Reason Not Specified|0|||
163919160|NCT04601857|592072546|FG001|Overall Study|Reason Not Specified|1|||
163919161|NCT04601857|592072545|FG000|Overall Study|At the Participant's Request|0|||
163919162|NCT04601857|592072546|FG001|Overall Study|At the Participant's Request|1|||
163919163|NCT00980954|592072547|FG000|Overall Study|Protocol Violation|9|||
163919164|NCT00980954|592072548|FG001|Overall Study|Protocol Violation|15|||
163919165|NCT04372186|592072549|FG000|Overall Study|Death|24|||
163919166|NCT04372186|592072550|FG001|Overall Study|Death|11|||
163919167|NCT04372186|592072549|FG000|Overall Study|Transferred to a different facility for care|0|||
163919168|NCT04372186|592072550|FG001|Overall Study|Transferred to a different facility for care|2|||
163919169|NCT04736472|592072551|FG000|Overall Study|Lost to Follow-up|1|||
163919170|NCT04736472|592072552|FG001|Overall Study|Lost to Follow-up|0|||
163919171|NCT04736472|592072553|FG002|Overall Study|Lost to Follow-up|0|||
163919172|NCT04736472|592072551|FG000|Overall Study|Withdrawal by Subject|2|||
163919173|NCT04736472|592072552|FG001|Overall Study|Withdrawal by Subject|0|||
163919174|NCT04736472|592072553|FG002|Overall Study|Withdrawal by Subject|0|||
163919175|NCT04736472|592072551|FG000|Overall Study|Protocol Violation|48|||
163919176|NCT04736472|592072552|FG001|Overall Study|Protocol Violation|0|||
163919177|NCT04736472|592072553|FG002|Overall Study|Protocol Violation|6|||
163919178|NCT02268526|592072554|FG000|Overall Study|Adverse Event|0|||
163919179|NCT02268526|592072555|FG001|Overall Study|Adverse Event|2|||
163919180|NCT02268526|592072556|FG002|Overall Study|Adverse Event|1|||
163919181|NCT02268526|592072554|FG000|Overall Study|Death|1|||
163919182|NCT02268526|592072555|FG001|Overall Study|Death|11|||
163919183|NCT02268526|592072556|FG002|Overall Study|Death|0|||
163919184|NCT02268526|592072554|FG000|Overall Study|protocol deviation|0|||
163919185|NCT02268526|592072555|FG001|Overall Study|protocol deviation|1|||
163919186|NCT02268526|592072556|FG002|Overall Study|protocol deviation|0|||
163919187|NCT02268526|592072554|FG000|Overall Study|Physician Decision|0|||
163919188|NCT02268526|592072555|FG001|Overall Study|Physician Decision|0|||
163919189|NCT02268526|592072556|FG002|Overall Study|Physician Decision|1|||
163919190|NCT02268526|592072554|FG000|Overall Study|Subject/guardian decision|0|||
163919191|NCT02268526|592072555|FG001|Overall Study|Subject/guardian decision|7|||
163919192|NCT02268526|592072556|FG002|Overall Study|Subject/guardian decision|3|||
163919193|NCT02332824|592072559|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
163919194|NCT02332824|592072560|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163919195|NCT02332824|592072561|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
163919196|NCT02332824|592072562|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163919197|NCT02332824|592072563|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
163919198|NCT02332824|592072564|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
163919199|NCT02332824|592072559|FG000|Overall Study|Voluntary Withdrawal|1|||
163919200|NCT02332824|592072560|FG001|Overall Study|Voluntary Withdrawal|0|||
163919201|NCT02332824|592072561|FG002|Overall Study|Voluntary Withdrawal|0|||
163919202|NCT02332824|592072562|FG003|Overall Study|Voluntary Withdrawal|0|||
163919203|NCT02332824|592072563|FG004|Overall Study|Voluntary Withdrawal|0|||
163919204|NCT02332824|592072564|FG005|Overall Study|Voluntary Withdrawal|0|||
163919205|NCT02332824|592072559|FG000|Overall Study|Inconvenient schedule|1|||
163919206|NCT02332824|592072560|FG001|Overall Study|Inconvenient schedule|1|||
163919207|NCT02332824|592072561|FG002|Overall Study|Inconvenient schedule|0|||
163919208|NCT02332824|592072562|FG003|Overall Study|Inconvenient schedule|0|||
163919209|NCT02332824|592072563|FG004|Overall Study|Inconvenient schedule|0|||
164096946|NCT04206332|592719001|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
163919210|NCT02332824|592072564|FG005|Overall Study|Inconvenient schedule|0|||
163919211|NCT02332824|592072559|FG000|Overall Study|Transfer|0|||
163919212|NCT02332824|592072560|FG001|Overall Study|Transfer|0|||
163919213|NCT02332824|592072561|FG002|Overall Study|Transfer|1|||
163919214|NCT02332824|592072562|FG003|Overall Study|Transfer|1|||
163919215|NCT02332824|592072563|FG004|Overall Study|Transfer|0|||
163919216|NCT02332824|592072564|FG005|Overall Study|Transfer|0|||
163919217|NCT00498797|592072565|FG000|Overall Study|Withdrawal by Subject|4|||
163919218|NCT00498797|592072566|FG001|Overall Study|Withdrawal by Subject|2|||
163919219|NCT00498797|592072565|FG000|Overall Study|Adverse Event|12|||
163919220|NCT00498797|592072566|FG001|Overall Study|Adverse Event|5|||
163919221|NCT00498797|592072565|FG000|Overall Study|Condition under investigation worsened|19|||
163919222|NCT00498797|592072566|FG001|Overall Study|Condition under investigation worsened|21|||
163919223|NCT00498797|592072565|FG000|Overall Study|Other|3|||
164031556|NCT02921919|592474786|FG000|Overall Study|Other|5|||
164031557|NCT02921919|592474787|FG001|Overall Study|Other|6|||
164031558|NCT02921919|592474786|FG000|Overall Study|Lost to Follow-up|0|||
164031559|NCT02921919|592474787|FG001|Overall Study|Lost to Follow-up|1|||
164031560|NCT02921919|592474786|FG000|Overall Study|Withdrawal by Subject|5|||
164031561|NCT02921919|592474787|FG001|Overall Study|Withdrawal by Subject|1|||
164031562|NCT02921919|592474786|FG000|Overall Study|Disease Progression|47|||
164031563|NCT02921919|592474787|FG001|Overall Study|Disease Progression|38|||
164031564|NCT02921919|592474786|FG000|Overall Study|Physician Decision|3|||
164031565|NCT02921919|592474787|FG001|Overall Study|Physician Decision|2|||
164031566|NCT02921919|592474786|FG000|Overall Study|Adverse Event|6|||
164031567|NCT02921919|592474787|FG001|Overall Study|Adverse Event|4|||
164031568|NCT01401465|592474790|FG000|Treatment Period 1|Adverse Event|4|||
164031569|NCT01401465|592474791|FG001|Treatment Period 1|Adverse Event|1|||
164031570|NCT01401465|592474790|FG000|Treatment Period 1|Pregnancy|0|||
164031571|NCT01401465|592474791|FG001|Treatment Period 1|Pregnancy|1|||
164096947|NCT04206332|592719002|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164112599|NCT00210639|592774045|FG001|Overall Study|Other|12|||
164031572|NCT01401465|592474790|FG000|Treatment Period 1|Protocol Violation|5|||
164031573|NCT01401465|592474791|FG001|Treatment Period 1|Protocol Violation|0|||
164031574|NCT01401465|592474790|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164031575|NCT01401465|592474791|FG001|Treatment Period 1|Withdrawal by Subject|4|||
163919224|NCT00498797|592072566|FG001|Overall Study|Other|1|||
163919225|NCT01052714|592072569|FG000|Overall Study|Adverse Event|6|||
163919226|NCT01052714|592072570|FG001|Overall Study|Adverse Event|3|||
163919227|NCT01052714|592072571|FG002|Overall Study|Adverse Event|0|||
163919228|NCT01052714|592072569|FG000|Overall Study|Death|1|||
163919229|NCT01052714|592072570|FG001|Overall Study|Death|2|||
163919230|NCT01052714|592072571|FG002|Overall Study|Death|0|||
163919231|NCT01052714|592072569|FG000|Overall Study|Lost to Follow-up|2|||
163919232|NCT01052714|592072570|FG001|Overall Study|Lost to Follow-up|3|||
163919233|NCT01052714|592072571|FG002|Overall Study|Lost to Follow-up|0|||
163919234|NCT01052714|592072569|FG000|Overall Study|Physician Decision|9|||
163919235|NCT01052714|592072570|FG001|Overall Study|Physician Decision|9|||
163919236|NCT01052714|592072571|FG002|Overall Study|Physician Decision|1|||
163919237|NCT01052714|592072569|FG000|Overall Study|Withdrawal by Subject|7|||
163919238|NCT01052714|592072570|FG001|Overall Study|Withdrawal by Subject|12|||
163919239|NCT01052714|592072571|FG002|Overall Study|Withdrawal by Subject|1|||
163919240|NCT00417989|592072575|FG000|Overall Study|Withdrawal by Subject|13|||
163919241|NCT00417989|592072576|FG001|Overall Study|Withdrawal by Subject|13|||
163919242|NCT00417989|592072575|FG000|Overall Study|Lost to Follow-up|1|||
163919243|NCT00417989|592072576|FG001|Overall Study|Lost to Follow-up|6|||
163919244|NCT00417989|592072575|FG000|Overall Study|Protocol Violation|1|||
163919245|NCT00417989|592072576|FG001|Overall Study|Protocol Violation|0|||
163919246|NCT00417989|592072575|FG000|Overall Study|Death|0|||
163919247|NCT00417989|592072576|FG001|Overall Study|Death|1|||
163919248|NCT00417989|592072575|FG000|Overall Study|Physician Decision|5|||
163919249|NCT00417989|592072576|FG001|Overall Study|Physician Decision|2|||
163919250|NCT04212299|592072580|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
163919251|NCT05379023|592072581|FG000|Overall Study|Lost to Follow-up|1|||
163919252|NCT05379023|592072582|FG001|Overall Study|Lost to Follow-up|0|||
163919253|NCT05379023|592072583|FG002|Overall Study|Lost to Follow-up|0|||
163919254|NCT05379023|592072581|FG000|Overall Study|Withdrawal by Subject|2|||
163919255|NCT05379023|592072582|FG001|Overall Study|Withdrawal by Subject|0|||
163919256|NCT05379023|592072583|FG002|Overall Study|Withdrawal by Subject|0|||
163919257|NCT01904019|592074521|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
164031576|NCT01401465|592474790|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
164031577|NCT01401465|592474791|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
163919258|NCT01904019|592074521|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
163919259|NCT01904019|592074521|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
163919260|NCT01904019|592074521|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
163919261|NCT01904019|592074521|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
163919262|NCT01904019|592074521|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
163919263|NCT00509821|592074522|FG000|Study Period 1 (Induction)|Death|0|||
163919264|NCT00509821|592074523|FG001|Study Period 1 (Induction)|Death|1|||
163919265|NCT00509821|592074522|FG000|Study Period 1 (Induction)|Adverse Event|0|||
163919266|NCT00509821|592074523|FG001|Study Period 1 (Induction)|Adverse Event|2|||
163919267|NCT00509821|592074522|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
163919268|NCT00509821|592074523|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
163919269|NCT01816685|592074524|FG000|Overall Study|Lost to Follow-up|7|||
163919270|NCT01816685|592074525|FG001|Overall Study|Lost to Follow-up|9|||
163919271|NCT01816685|592074524|FG000|Overall Study|Surgery Cancelled|3|||
163919272|NCT01816685|592074525|FG001|Overall Study|Surgery Cancelled|2|||
163919273|NCT01157351|592074526|FG000|Overall Study|Adverse Event|5|||
163919274|NCT01157351|592074527|FG001|Overall Study|Adverse Event|4|||
163919275|NCT01157351|592074526|FG000|Overall Study|Death|1|||
163919276|NCT01157351|592074527|FG001|Overall Study|Death|0|||
163919277|NCT01157351|592074526|FG000|Overall Study|Lost to Follow-up|53|||
163919278|NCT01157351|592074527|FG001|Overall Study|Lost to Follow-up|55|||
163919279|NCT01157351|592074526|FG000|Overall Study|Withdrawal by Subject|37|||
163919280|NCT01157351|592074527|FG001|Overall Study|Withdrawal by Subject|27|||
163919281|NCT01157351|592074526|FG000|Overall Study|Physician Decision|5|||
163919282|NCT01157351|592074527|FG001|Overall Study|Physician Decision|4|||
163919283|NCT01157351|592074526|FG000|Overall Study|Protocol Violation|0|||
163919284|NCT01157351|592074527|FG001|Overall Study|Protocol Violation|1|||
163919285|NCT01157351|592074526|FG000|Overall Study|Other|32|||
163919286|NCT01157351|592074527|FG001|Overall Study|Other|36|||
163919287|NCT01157351|592074526|FG000|Overall Study|Noncompliance with Study Drug|0|||
163919288|NCT01157351|592074527|FG001|Overall Study|Noncompliance with Study Drug|3|||
163919289|NCT01157351|592074526|FG000|Overall Study|Randomized but not Treated|4|||
163919290|NCT01157351|592074527|FG001|Overall Study|Randomized but not Treated|2|||
163919291|NCT02675998|592074528|FG000|8-Week Treatment Period|Adverse Event|6|||
163919292|NCT02675998|592074529|FG001|8-Week Treatment Period|Adverse Event|5|||
163919293|NCT02675998|592074530|FG002|8-Week Treatment Period|Adverse Event|6|||
163919294|NCT02675998|592074531|FG003|8-Week Treatment Period|Adverse Event|0|||
163919295|NCT02675998|592074528|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
163919296|NCT02675998|592074529|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
163919297|NCT02675998|592074530|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
163919298|NCT02675998|592074531|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
163919299|NCT02675998|592074528|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
163919300|NCT02675998|592074529|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
163919301|NCT02675998|592074530|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
163919302|NCT02675998|592074531|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
163919303|NCT02675998|592074528|FG000|8-Week Treatment Period|Physician Decision|1|||
163919304|NCT02675998|592074529|FG001|8-Week Treatment Period|Physician Decision|0|||
163919305|NCT02675998|592074530|FG002|8-Week Treatment Period|Physician Decision|2|||
163919306|NCT02675998|592074531|FG003|8-Week Treatment Period|Physician Decision|0|||
163919307|NCT02675998|592074528|FG000|8-Week Treatment Period|GI side Effects|1|||
163919308|NCT02675998|592074529|FG001|8-Week Treatment Period|GI side Effects|4|||
163919309|NCT02675998|592074530|FG002|8-Week Treatment Period|GI side Effects|2|||
163919310|NCT02675998|592074531|FG003|8-Week Treatment Period|GI side Effects|0|||
163919311|NCT02675998|592074528|FG000|8-Week Treatment Period|Protocol Violation|1|||
163919312|NCT02675998|592074529|FG001|8-Week Treatment Period|Protocol Violation|1|||
163919313|NCT02675998|592074530|FG002|8-Week Treatment Period|Protocol Violation|1|||
163919314|NCT02675998|592074531|FG003|8-Week Treatment Period|Protocol Violation|0|||
163919315|NCT02675998|592074528|FG000|8-Week Treatment Period|Other|3|||
163919316|NCT02675998|592074529|FG001|8-Week Treatment Period|Other|1|||
163919317|NCT02675998|592074530|FG002|8-Week Treatment Period|Other|2|||
163919318|NCT02675998|592074531|FG003|8-Week Treatment Period|Other|0|||
163919319|NCT02675998|592074528|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
163919320|NCT02675998|592074529|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
163919321|NCT02675998|592074530|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
163919322|NCT02675998|592074531|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
163919323|NCT02675998|592074528|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
163919324|NCT02675998|592074529|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
163919325|NCT02675998|592074530|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
163919326|NCT02675998|592074531|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
163919327|NCT02675998|592074528|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
163919328|NCT02675998|592074529|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
163919329|NCT02675998|592074530|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
163919330|NCT02675998|592074531|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
163919331|NCT02675998|592074528|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
163919332|NCT02675998|592074529|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
163919333|NCT02675998|592074530|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
163919334|NCT02675998|592074531|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
163919335|NCT02675998|592074528|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
163919336|NCT02675998|592074529|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
163919337|NCT02675998|592074530|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
163919338|NCT02675998|592074531|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
163919339|NCT02561078|592074540|FG000|Overall Study|Adverse Event|5|||
164031578|NCT01401465|592474790|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
164031579|NCT01401465|592474791|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
164031580|NCT01401465|592474790|FG000|Treatment Period 1|Scheduling Difficulties|1|||
163919340|NCT02561078|592074541|FG001|Overall Study|Adverse Event|2|||
163919341|NCT02561078|592074540|FG000|Overall Study|Death|2|||
163919342|NCT02561078|592074541|FG001|Overall Study|Death|1|||
163919343|NCT02561078|592074540|FG000|Overall Study|Lost to Follow-up|2|||
163919344|NCT02561078|592074541|FG001|Overall Study|Lost to Follow-up|6|||
163919345|NCT02561078|592074540|FG000|Overall Study|Non-Compliance with Study Drug|6|||
163919346|NCT02561078|592074541|FG001|Overall Study|Non-Compliance with Study Drug|3|||
163919347|NCT02561078|592074540|FG000|Overall Study|Physician Decision|2|||
163919348|NCT02561078|592074541|FG001|Overall Study|Physician Decision|3|||
163919349|NCT02561078|592074540|FG000|Overall Study|Withdrawal by Subject|13|||
163919350|NCT02561078|592074541|FG001|Overall Study|Withdrawal by Subject|10|||
163919351|NCT00598871|592074542|FG000|Overall Study|Adverse Event|0|||
163919352|NCT00598871|592074543|FG001|Overall Study|Adverse Event|1|||
163919353|NCT01194271|592074544|FG000|Overall Study|Withdrawal by Subject|1|||
163919354|NCT01194271|592074544|FG000|Overall Study|Ineligible, Screen Failure|1|||
163919355|NCT01194271|592074544|FG000|Overall Study|Death|1|||
163919356|NCT00443898|592074545|FG000|Overall Study|Adverse Event|0|||
163919357|NCT00443898|592074546|FG001|Overall Study|Adverse Event|0|||
163919358|NCT00443898|592074547|FG002|Overall Study|Adverse Event|1|||
163919359|NCT00443898|592074548|FG003|Overall Study|Adverse Event|1|||
163919360|NCT00443898|592074545|FG000|Overall Study|Lack of Efficacy|2|||
163919361|NCT00443898|592074546|FG001|Overall Study|Lack of Efficacy|3|||
163919362|NCT00443898|592074547|FG002|Overall Study|Lack of Efficacy|3|||
163919363|NCT00443898|592074548|FG003|Overall Study|Lack of Efficacy|1|||
163919364|NCT00443898|592074545|FG000|Overall Study|Protocol Violation|1|||
163919365|NCT00443898|592074546|FG001|Overall Study|Protocol Violation|1|||
163919366|NCT00443898|592074547|FG002|Overall Study|Protocol Violation|1|||
163919367|NCT00443898|592074548|FG003|Overall Study|Protocol Violation|0|||
163919368|NCT00443898|592074545|FG000|Overall Study|Withdrawal by Subject|11|||
163919369|NCT00443898|592074546|FG001|Overall Study|Withdrawal by Subject|10|||
163919370|NCT00443898|592074547|FG002|Overall Study|Withdrawal by Subject|10|||
163919371|NCT00443898|592074548|FG003|Overall Study|Withdrawal by Subject|6|||
163919372|NCT00443898|592074545|FG000|Overall Study|Lost to Follow-up|10|||
163919373|NCT00443898|592074546|FG001|Overall Study|Lost to Follow-up|10|||
163919374|NCT00443898|592074547|FG002|Overall Study|Lost to Follow-up|14|||
163919375|NCT00443898|592074548|FG003|Overall Study|Lost to Follow-up|10|||
163919376|NCT00443898|592074545|FG000|Overall Study|Death|0|||
163919377|NCT00443898|592074546|FG001|Overall Study|Death|1|||
163919378|NCT00443898|592074547|FG002|Overall Study|Death|0|||
163919379|NCT00443898|592074548|FG003|Overall Study|Death|0|||
163919380|NCT00043186|592074549|FG000|Overall Study|Physician Decision|0|||
163919381|NCT00043186|592074550|FG001|Overall Study|Physician Decision|0|||
163919382|NCT00043186|592074551|FG002|Overall Study|Physician Decision|3|||
163919383|NCT00043186|592074552|FG003|Overall Study|Physician Decision|0|||
163919384|NCT00043186|592074553|FG004|Overall Study|Physician Decision|1|||
163919385|NCT00043186|592074554|FG005|Overall Study|Physician Decision|0|||
163919386|NCT00043186|592074555|FG006|Overall Study|Physician Decision|0|||
163919387|NCT00043186|592074556|FG007|Overall Study|Physician Decision|1|||
163919388|NCT00043186|592074557|FG008|Overall Study|Physician Decision|1|||
163919389|NCT00043186|592074549|FG000|Overall Study|Adverse Event|2|||
163919390|NCT00043186|592074550|FG001|Overall Study|Adverse Event|2|||
163919391|NCT00043186|592074551|FG002|Overall Study|Adverse Event|2|||
163919392|NCT00043186|592074552|FG003|Overall Study|Adverse Event|3|||
163919393|NCT00043186|592074553|FG004|Overall Study|Adverse Event|2|||
163919394|NCT00043186|592074554|FG005|Overall Study|Adverse Event|1|||
163919395|NCT00043186|592074555|FG006|Overall Study|Adverse Event|2|||
163919396|NCT00043186|592074556|FG007|Overall Study|Adverse Event|1|||
163919397|NCT00043186|592074557|FG008|Overall Study|Adverse Event|3|||
163919398|NCT00043186|592074549|FG000|Overall Study|Withdrawal by Subject|11|||
163919399|NCT00043186|592074550|FG001|Overall Study|Withdrawal by Subject|8|||
163919400|NCT00043186|592074551|FG002|Overall Study|Withdrawal by Subject|11|||
163919401|NCT00043186|592074552|FG003|Overall Study|Withdrawal by Subject|13|||
163919402|NCT00043186|592074553|FG004|Overall Study|Withdrawal by Subject|14|||
163919403|NCT00043186|592074554|FG005|Overall Study|Withdrawal by Subject|6|||
163919404|NCT00043186|592074555|FG006|Overall Study|Withdrawal by Subject|12|||
163919405|NCT00043186|592074556|FG007|Overall Study|Withdrawal by Subject|9|||
163919406|NCT00043186|592074557|FG008|Overall Study|Withdrawal by Subject|10|||
163919407|NCT00043186|592074549|FG000|Overall Study|Death|0|||
163919408|NCT00043186|592074550|FG001|Overall Study|Death|0|||
163919409|NCT00043186|592074551|FG002|Overall Study|Death|1|||
163919410|NCT00043186|592074552|FG003|Overall Study|Death|0|||
163919411|NCT00043186|592074553|FG004|Overall Study|Death|0|||
163919412|NCT00043186|592074554|FG005|Overall Study|Death|0|||
163919413|NCT00043186|592074555|FG006|Overall Study|Death|2|||
163919414|NCT00043186|592074556|FG007|Overall Study|Death|0|||
163919415|NCT00043186|592074557|FG008|Overall Study|Death|0|||
163919416|NCT00043186|592074549|FG000|Overall Study|Disease progression|1|||
163919417|NCT00043186|592074550|FG001|Overall Study|Disease progression|0|||
163919418|NCT00043186|592074551|FG002|Overall Study|Disease progression|0|||
163919419|NCT00043186|592074552|FG003|Overall Study|Disease progression|3|||
163919420|NCT00043186|592074553|FG004|Overall Study|Disease progression|0|||
163919421|NCT00043186|592074554|FG005|Overall Study|Disease progression|0|||
163919422|NCT00043186|592074555|FG006|Overall Study|Disease progression|0|||
163919423|NCT00043186|592074556|FG007|Overall Study|Disease progression|4|||
163919424|NCT00043186|592074557|FG008|Overall Study|Disease progression|0|||
163919425|NCT00043186|592074549|FG000|Overall Study|Ineligibility determined|0|||
163919426|NCT00043186|592074550|FG001|Overall Study|Ineligibility determined|0|||
163919427|NCT00043186|592074551|FG002|Overall Study|Ineligibility determined|0|||
163919428|NCT00043186|592074552|FG003|Overall Study|Ineligibility determined|0|||
163919429|NCT00043186|592074553|FG004|Overall Study|Ineligibility determined|0|||
163919430|NCT00043186|592074554|FG005|Overall Study|Ineligibility determined|0|||
163919431|NCT00043186|592074555|FG006|Overall Study|Ineligibility determined|0|||
163919432|NCT00043186|592074556|FG007|Overall Study|Ineligibility determined|0|||
163919433|NCT00043186|592074557|FG008|Overall Study|Ineligibility determined|1|||
163919434|NCT00043186|592074549|FG000|Overall Study|Lost to Follow-up|3|||
163919435|NCT00043186|592074550|FG001|Overall Study|Lost to Follow-up|5|||
163919436|NCT00043186|592074551|FG002|Overall Study|Lost to Follow-up|1|||
163919437|NCT00043186|592074552|FG003|Overall Study|Lost to Follow-up|1|||
163919438|NCT00043186|592074553|FG004|Overall Study|Lost to Follow-up|1|||
163919439|NCT00043186|592074554|FG005|Overall Study|Lost to Follow-up|1|||
163919440|NCT00043186|592074555|FG006|Overall Study|Lost to Follow-up|1|||
163919441|NCT00043186|592074556|FG007|Overall Study|Lost to Follow-up|1|||
163919442|NCT00043186|592074557|FG008|Overall Study|Lost to Follow-up|2|||
163919443|NCT00043186|592074549|FG000|Overall Study|Noncompliance|0|||
163919444|NCT00043186|592074550|FG001|Overall Study|Noncompliance|0|||
163919445|NCT00043186|592074551|FG002|Overall Study|Noncompliance|1|||
163919446|NCT00043186|592074552|FG003|Overall Study|Noncompliance|1|||
163919447|NCT00043186|592074553|FG004|Overall Study|Noncompliance|0|||
163919448|NCT00043186|592074554|FG005|Overall Study|Noncompliance|0|||
163919449|NCT00043186|592074555|FG006|Overall Study|Noncompliance|0|||
163919450|NCT00043186|592074556|FG007|Overall Study|Noncompliance|0|||
163919451|NCT00043186|592074557|FG008|Overall Study|Noncompliance|0|||
163919452|NCT00043186|592074549|FG000|Overall Study|Other|0|||
163919453|NCT00043186|592074550|FG001|Overall Study|Other|0|||
163919454|NCT00043186|592074551|FG002|Overall Study|Other|1|||
164031581|NCT01401465|592474791|FG001|Treatment Period 1|Scheduling Difficulties|1|||
163919455|NCT00043186|592074552|FG003|Overall Study|Other|1|||
164031582|NCT01401465|592474790|FG000|Treatment Period 2|Lost to Follow-up|0|||
164031583|NCT01401465|592474791|FG001|Treatment Period 2|Lost to Follow-up|1|||
164031584|NCT01401465|592474790|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164031585|NCT01401465|592474791|FG001|Treatment Period 2|Withdrawal by Subject|1|||
163919456|NCT00043186|592074553|FG004|Overall Study|Other|0|||
163919457|NCT00043186|592074554|FG005|Overall Study|Other|0|||
163919458|NCT00043186|592074555|FG006|Overall Study|Other|0|||
163919459|NCT00043186|592074556|FG007|Overall Study|Other|0|||
164031586|NCT01115738|592474792|FG000|Overall Study|Death|1|||
164031587|NCT01115738|592474793|FG001|Overall Study|Death|0|||
164031588|NCT01115738|592474794|FG002|Overall Study|Death|0|||
163919460|NCT00043186|592074557|FG008|Overall Study|Other|0|||
163919461|NCT04050722|592074561|FG000|Overall Study|Withdrawal by Subject|1|||
163919462|NCT04050722|592074562|FG001|Overall Study|Withdrawal by Subject|0|||
163919463|NCT03924947|592074563|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163919464|NCT03924947|592074564|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163919465|NCT03924947|592074565|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
163919466|NCT03924947|592074566|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
164031589|NCT01115738|592474792|FG000|Overall Study|Lost to Follow-up|0|||
164031590|NCT01115738|592474793|FG001|Overall Study|Lost to Follow-up|0|||
164031591|NCT01115738|592474794|FG002|Overall Study|Lost to Follow-up|1|||
164031592|NCT01115738|592474792|FG000|Overall Study|Physician Decision|18|||
164031593|NCT01115738|592474793|FG001|Overall Study|Physician Decision|15|||
164031594|NCT01115738|592474794|FG002|Overall Study|Physician Decision|17|||
164031595|NCT01115738|592474792|FG000|Overall Study|Withdrawal by Subject|6|||
164031596|NCT01115738|592474793|FG001|Overall Study|Withdrawal by Subject|6|||
164031597|NCT01115738|592474794|FG002|Overall Study|Withdrawal by Subject|9|||
164031598|NCT02921763|592474797|FG000|Overall Study|Adverse Event|4|||
164031599|NCT02921763|592474797|FG000|Overall Study|Lost to Follow-up|4|||
164031600|NCT02921763|592474797|FG000|Overall Study|Lack of Efficacy|3|||
164031601|NCT02921763|592474797|FG000|Overall Study|Protocol Violation|2|||
164031602|NCT02921763|592474797|FG000|Overall Study|Withdrawal by Subject|2|||
164031603|NCT02921763|592474797|FG000|Overall Study|Physician Decision|1|||
164031604|NCT02921763|592474797|FG000|Overall Study|No data obtained|2|||
164031605|NCT04142216|592474798|FG000|Overall Study|Hospitalization|0|||
164031606|NCT04142216|592474799|FG001|Overall Study|Hospitalization|2|||
164031607|NCT04142216|592474798|FG000|Overall Study|Death|3|||
164031608|NCT04142216|592474799|FG001|Overall Study|Death|1|||
164031609|NCT04142216|592474798|FG000|Overall Study|Referral to another hemodialysis unit|3|||
164031610|NCT04142216|592474799|FG001|Overall Study|Referral to another hemodialysis unit|2|||
164031611|NCT04142216|592474798|FG000|Overall Study|Use of clove|0|||
164031612|NCT04142216|592474799|FG001|Overall Study|Use of clove|1|||
164031613|NCT01582971|592474800|FG000|Overall Study|Death|2|||
164031614|NCT01582971|592474801|FG001|Overall Study|Death|1|||
164031615|NCT01582971|592474800|FG000|Overall Study|Lost to Follow-up|18|||
164031616|NCT01582971|592474801|FG001|Overall Study|Lost to Follow-up|21|||
164031617|NCT01582971|592474800|FG000|Overall Study|Withdrawal by Subject|4|||
164031618|NCT01582971|592474801|FG001|Overall Study|Withdrawal by Subject|2|||
164031619|NCT01582971|592474800|FG000|Overall Study|Other|15|||
164031620|NCT01582971|592474801|FG001|Overall Study|Other|13|||
164031621|NCT01054976|592474806|FG000|Overall Study|Adverse Event|16|||
164031622|NCT01054976|592474806|FG000|Overall Study|Uncooperative participations to study|7|||
164031623|NCT01054976|592474806|FG000|Overall Study|Withdrawal by Subject|4|||
164031624|NCT01054976|592474806|FG000|Overall Study|Other|8|||
164031625|NCT01641991|592474807|FG000|Overall Study|Physician Decision|0|||
164031626|NCT01641991|592474808|FG001|Overall Study|Physician Decision|1|||
164031627|NCT01641991|592474809|FG002|Overall Study|Physician Decision|7|||
164031628|NCT01641991|592474810|FG003|Overall Study|Physician Decision|5|||
164031629|NCT01641991|592474807|FG000|Overall Study|Withdrawal by Subject|4|||
164031630|NCT01641991|592474808|FG001|Overall Study|Withdrawal by Subject|2|||
164031631|NCT01641991|592474809|FG002|Overall Study|Withdrawal by Subject|1|||
164031632|NCT01641991|592474810|FG003|Overall Study|Withdrawal by Subject|5|||
164031633|NCT01641991|592474807|FG000|Overall Study|Adverse Event|2|||
164031634|NCT01641991|592474808|FG001|Overall Study|Adverse Event|1|||
164031635|NCT01641991|592474809|FG002|Overall Study|Adverse Event|2|||
164031636|NCT01641991|592474810|FG003|Overall Study|Adverse Event|1|||
164031637|NCT01641991|592474807|FG000|Overall Study|Lost to Follow-up|0|||
164031638|NCT01641991|592474808|FG001|Overall Study|Lost to Follow-up|2|||
164031639|NCT01641991|592474809|FG002|Overall Study|Lost to Follow-up|3|||
164031640|NCT01641991|592474810|FG003|Overall Study|Lost to Follow-up|1|||
164031641|NCT01641991|592474807|FG000|Overall Study|Protocol Violation|1|||
164031642|NCT01641991|592474808|FG001|Overall Study|Protocol Violation|1|||
164031643|NCT01641991|592474809|FG002|Overall Study|Protocol Violation|3|||
164031644|NCT01641991|592474810|FG003|Overall Study|Protocol Violation|0|||
164031645|NCT01641991|592474807|FG000|Overall Study|Pregnancy|0|||
164031646|NCT01641991|592474808|FG001|Overall Study|Pregnancy|0|||
164031647|NCT01641991|592474809|FG002|Overall Study|Pregnancy|1|||
164031648|NCT01641991|592474810|FG003|Overall Study|Pregnancy|0|||
164031649|NCT01641991|592474807|FG000|Overall Study|no longer eligible|2|||
164031650|NCT01641991|592474808|FG001|Overall Study|no longer eligible|1|||
164031651|NCT01641991|592474809|FG002|Overall Study|no longer eligible|0|||
164031652|NCT01641991|592474810|FG003|Overall Study|no longer eligible|4|||
164031653|NCT00475540|592474814|FG000|36 Months|Lost to Follow-up|4|||
164031654|NCT00475540|592474815|FG001|36 Months|Lost to Follow-up|4|||
164031655|NCT00475540|592474814|FG000|36 Months|Death|1|||
164031656|NCT00475540|592474815|FG001|36 Months|Death|2|||
163919467|NCT03924947|592074567|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163919468|NCT03924947|592074568|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
163919469|NCT01145417|592074569|FG000|Overall Study|Death|1|||
163919470|NCT01145417|592074570|FG001|Overall Study|Death|0|||
163919471|NCT01145417|592074569|FG000|Overall Study|Lost to Follow-up|2|||
163919472|NCT01145417|592074570|FG001|Overall Study|Lost to Follow-up|1|||
163919473|NCT01145417|592074569|FG000|Overall Study|Withdrawal by Subject|1|||
163919474|NCT01145417|592074570|FG001|Overall Study|Withdrawal by Subject|2|||
163919475|NCT01145417|592074569|FG000|Overall Study|Pregnancy|1|||
163919476|NCT01145417|592074570|FG001|Overall Study|Pregnancy|0|||
163919477|NCT01145417|592074569|FG000|Overall Study|Adverse Event|0|||
163919478|NCT01145417|592074570|FG001|Overall Study|Adverse Event|1|||
163919479|NCT01145417|592074569|FG000|Overall Study|Study terminated by sponsor|35|||
163919480|NCT01145417|592074570|FG001|Overall Study|Study terminated by sponsor|43|||
163919481|NCT01145417|592074569|FG000|Overall Study|Other|1|||
163919482|NCT01145417|592074570|FG001|Overall Study|Other|0|||
163919483|NCT03085433|592074571|FG000|Overall Study|Withdrawal by Subject|2|||
163919484|NCT03085433|592074572|FG001|Overall Study|Withdrawal by Subject|4|||
163919485|NCT03085433|592074571|FG000|Overall Study|Physician Decision|33|||
163919486|NCT03085433|592074572|FG001|Overall Study|Physician Decision|50|||
163919487|NCT03809039|592074573|FG000|Part 1|Withdrawal by Subject|1|||
163919488|NCT03809039|592074574|FG001|Part 1|Withdrawal by Subject|0|||
163919489|NCT03809039|592074575|FG002|Part 1|Withdrawal by Subject|0|||
163919490|NCT03809039|592074576|FG003|Part 1|Withdrawal by Subject|1|||
163919491|NCT03809039|592074577|FG004|Part 1|Withdrawal by Subject|0|||
163919492|NCT03809039|592074578|FG005|Part 1|Withdrawal by Subject|0|||
163919493|NCT03809039|592074579|FG006|Part 1|Withdrawal by Subject|0|||
163919494|NCT03809039|592074580|FG007|Part 1|Withdrawal by Subject|0|||
163919495|NCT03809039|592074581|FG008|Part 1|Withdrawal by Subject|0|||
163919496|NCT03809039|592074573|FG000|Part 3|Withdrawn by study termination|0|||
163919497|NCT03809039|592074574|FG001|Part 3|Withdrawn by study termination|0|||
163919498|NCT03809039|592074575|FG002|Part 3|Withdrawn by study termination|0|||
163919499|NCT03809039|592074576|FG003|Part 3|Withdrawn by study termination|0|||
163919500|NCT03809039|592074577|FG004|Part 3|Withdrawn by study termination|0|||
163919501|NCT03809039|592074578|FG005|Part 3|Withdrawn by study termination|0|||
163919502|NCT03809039|592074579|FG006|Part 3|Withdrawn by study termination|0|||
163919503|NCT03809039|592074580|FG007|Part 3|Withdrawn by study termination|2|||
163919504|NCT03809039|592074581|FG008|Part 3|Withdrawn by study termination|6|||
163919505|NCT03451292|592074582|FG000|Overall Study|Death|44|||
163919506|NCT03451292|592074583|FG001|Overall Study|Death|59|||
163919507|NCT03451292|592074582|FG000|Overall Study|Withdrawal by Subject|18|||
163919508|NCT03451292|592074583|FG001|Overall Study|Withdrawal by Subject|13|||
163919509|NCT03451292|592074582|FG000|Overall Study|Transplantation|18|||
163919510|NCT03451292|592074583|FG001|Overall Study|Transplantation|12|||
163919511|NCT03451292|592074582|FG000|Overall Study|Lost to Follow-up|4|||
163919512|NCT03451292|592074583|FG001|Overall Study|Lost to Follow-up|12|||
163919513|NCT03451292|592074582|FG000|Overall Study|Physician Decision|4|||
163919514|NCT03451292|592074583|FG001|Overall Study|Physician Decision|3|||
163919515|NCT03451292|592074582|FG000|Overall Study|Adverse Event|3|||
163919516|NCT03451292|592074583|FG001|Overall Study|Adverse Event|3|||
163919517|NCT03451292|592074582|FG000|Overall Study|Non-compliance with Study Drug|2|||
163919518|NCT03451292|592074583|FG001|Overall Study|Non-compliance with Study Drug|0|||
163919519|NCT05271552|592074584|FG000|Overall Study|Adverse Event|4|||
163919520|NCT05271552|592074585|FG001|Overall Study|Adverse Event|6|||
163919521|NCT05271552|592074586|FG002|Overall Study|Adverse Event|3|||
163919522|NCT05271552|592074584|FG000|Overall Study|Death|1|||
163919523|NCT05271552|592074585|FG001|Overall Study|Death|1|||
163919524|NCT05271552|592074586|FG002|Overall Study|Death|1|||
163919525|NCT05271552|592074584|FG000|Overall Study|Lost to Follow-up|1|||
163919526|NCT05271552|592074585|FG001|Overall Study|Lost to Follow-up|5|||
163919527|NCT05271552|592074586|FG002|Overall Study|Lost to Follow-up|4|||
163919528|NCT05271552|592074584|FG000|Overall Study|Withdrawal by Subject|0|||
163919529|NCT05271552|592074585|FG001|Overall Study|Withdrawal by Subject|4|||
163919530|NCT05271552|592074586|FG002|Overall Study|Withdrawal by Subject|7|||
163919531|NCT05271552|592074584|FG000|Overall Study|Other medical reason.|1|||
163919532|NCT05271552|592074585|FG001|Overall Study|Other medical reason.|2|||
163919533|NCT05271552|592074586|FG002|Overall Study|Other medical reason.|0|||
163919534|NCT05271552|592074584|FG000|Overall Study|Other|3|||
163919535|NCT05271552|592074585|FG001|Overall Study|Other|3|||
163919536|NCT05271552|592074586|FG002|Overall Study|Other|6|||
163919537|NCT03840993|592074592|FG000|Overall Study|Adverse Event|1|||
163919538|NCT03840993|592074593|FG001|Overall Study|Adverse Event|0|||
163919539|NCT03840993|592074592|FG000|Overall Study|Lost to Follow-up|4|||
163919540|NCT03840993|592074593|FG001|Overall Study|Lost to Follow-up|0|||
163919541|NCT03840993|592074592|FG000|Overall Study|Physician Decision|0|||
163919542|NCT03840993|592074593|FG001|Overall Study|Physician Decision|1|||
163919543|NCT03840993|592074592|FG000|Overall Study|Pregnancy|0|||
163919544|NCT03840993|592074593|FG001|Overall Study|Pregnancy|1|||
163919545|NCT03840993|592074592|FG000|Overall Study|Withdrawal by Subject|1|||
163919546|NCT03840993|592074593|FG001|Overall Study|Withdrawal by Subject|3|||
163919547|NCT03840993|592074592|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
163919548|NCT03840993|592074593|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
163919549|NCT01090076|592074594|FG000|Overall Study|Death|1|||
163919550|NCT01090076|592074595|FG001|Overall Study|Death|1|||
163919551|NCT01090076|592074594|FG000|Overall Study|Withdrawal by Subject|0|||
163919552|NCT01090076|592074595|FG001|Overall Study|Withdrawal by Subject|1|||
163919553|NCT02176018|592074596|FG000|Overall Study|Adverse Event|0|||
163919554|NCT02176018|592074597|FG001|Overall Study|Adverse Event|2|||
163919555|NCT02176018|592074596|FG000|Overall Study|Lost to Follow-up|3|||
163919556|NCT02176018|592074597|FG001|Overall Study|Lost to Follow-up|1|||
163919557|NCT02176018|592074596|FG000|Overall Study|Protocol Violation|1|||
163919558|NCT02176018|592074597|FG001|Overall Study|Protocol Violation|1|||
163919559|NCT02176018|592074596|FG000|Overall Study|Withdrawal by Subject|1|||
163919560|NCT02176018|592074597|FG001|Overall Study|Withdrawal by Subject|2|||
163919561|NCT03022045|592074599|FG000|Overall Study|Adverse Event|0|||
163919562|NCT03022045|592074600|FG001|Overall Study|Adverse Event|1|||
163919563|NCT03022045|592074599|FG000|Overall Study|Withdrawal by Subject|1|||
163919564|NCT03022045|592074600|FG001|Overall Study|Withdrawal by Subject|1|||
163919565|NCT03275402|592074601|FG000|Overall Study|Death|17|||
163919566|NCT03275402|592074601|FG000|Overall Study|Study terminated by sponsor|21|||
163919567|NCT03275402|592074601|FG000|Overall Study|Withdrawal by Subject|1|||
163919568|NCT02986659|592074603|FG000|First Intervention Period|Adverse Event|3|||
163919569|NCT02986659|592074604|FG001|First Intervention Period|Adverse Event|1|||
163919570|NCT02986659|592074603|FG000|First Intervention Period|Lost to Follow-up|1|||
163919571|NCT02986659|592074604|FG001|First Intervention Period|Lost to Follow-up|0|||
163919572|NCT02986659|592074603|FG000|First Intervention Period|Withdrawal by Subject|0|||
163919573|NCT02986659|592074604|FG001|First Intervention Period|Withdrawal by Subject|1|||
163919574|NCT02986659|592074603|FG000|Second Intervention Period|Adverse Event|0|||
163919575|NCT02986659|592074604|FG001|Second Intervention Period|Adverse Event|6|||
163919576|NCT02253147|592074605|FG000|Overall Study|Protocol Violation|30|||
163919577|NCT02253147|592074605|FG000|Overall Study|Did not consent to study extension|9|||
163919578|NCT02253147|592074605|FG000|Overall Study|Conditional re-treatment at W52|5|||
163919579|NCT02253147|592074605|FG000|Overall Study|Lost to Follow-up|2|||
163919580|NCT02253147|592074605|FG000|Overall Study|Withdrawal by Subject|1|||
163919581|NCT02469077|592074607|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
163919582|NCT02469077|592074608|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
163919583|NCT02469077|592074607|FG000|Post Randomization/Intervention Period|Relocated|1|||
163919584|NCT02469077|592074608|FG001|Post Randomization/Intervention Period|Relocated|1|||
163919585|NCT02469077|592074607|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
163919586|NCT02469077|592074608|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
163919587|NCT02469077|592074607|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
163919588|NCT02469077|592074608|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
163919589|NCT02973477|592074609|FG000|First Intervention|Lost to Follow-up|0|||
163919590|NCT02973477|592074610|FG001|First Intervention|Lost to Follow-up|2|||
163919591|NCT02973477|592074609|FG000|Washout|Withdrawal by Subject|1|||
163919592|NCT02973477|592074610|FG001|Washout|Withdrawal by Subject|0|||
163919593|NCT02973477|592074609|FG000|Second Intervention|Lost to Follow-up|1|||
163919594|NCT02973477|592074610|FG001|Second Intervention|Lost to Follow-up|0|||
163919595|NCT02402465|592074612|FG000|Overall Study|Withdrawal by Subject|0|||
163919596|NCT02402465|592074613|FG001|Overall Study|Withdrawal by Subject|0|||
163919597|NCT02402465|592074614|FG002|Overall Study|Withdrawal by Subject|0|||
163919598|NCT02402465|592074615|FG003|Overall Study|Withdrawal by Subject|0|||
163919599|NCT02402465|592074616|FG004|Overall Study|Withdrawal by Subject|0|||
163919600|NCT02402465|592074617|FG005|Overall Study|Withdrawal by Subject|1|||
163919601|NCT02402465|592074612|FG000|Overall Study|Lost to Follow-up|0|||
163919602|NCT02402465|592074613|FG001|Overall Study|Lost to Follow-up|1|||
163919603|NCT02402465|592074614|FG002|Overall Study|Lost to Follow-up|0|||
163919604|NCT02402465|592074615|FG003|Overall Study|Lost to Follow-up|0|||
163919605|NCT02402465|592074616|FG004|Overall Study|Lost to Follow-up|1|||
163919606|NCT02402465|592074617|FG005|Overall Study|Lost to Follow-up|0|||
163919607|NCT01284634|592074618|FG000|Overall Study|Adverse Event|1|||
163919608|NCT01284634|592074619|FG001|Overall Study|Adverse Event|0|||
164096948|NCT04206332|592718986|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
163919609|NCT01284634|592074620|FG002|Overall Study|Adverse Event|2|||
163919610|NCT01284634|592074621|FG003|Overall Study|Adverse Event|1|||
163919611|NCT03807700|592074622|FG000|Overall Study|Withdrawal by Subject|2|||
163919612|NCT03807700|592074623|FG001|Overall Study|Withdrawal by Subject|1|||
163919613|NCT01059526|592074624|FG000|Overall Study|Patient enrolled but not treated|20|||
163919614|NCT01059526|592074625|FG001|Overall Study|Patient enrolled but not treated|17|||
163919615|NCT01059526|592074624|FG000|Overall Study|Adverse Event|2|||
163919616|NCT01059526|592074625|FG001|Overall Study|Adverse Event|2|||
163919617|NCT01059526|592074624|FG000|Overall Study|Protocol Violation|0|||
163919618|NCT01059526|592074625|FG001|Overall Study|Protocol Violation|1|||
163919619|NCT01059526|592074624|FG000|Overall Study|Withdrawal by Subject|3|||
163919620|NCT01059526|592074625|FG001|Overall Study|Withdrawal by Subject|1|||
163919621|NCT01059526|592074624|FG000|Overall Study|Lost to Follow-up|4|||
163919622|NCT01059526|592074625|FG001|Overall Study|Lost to Follow-up|1|||
163919623|NCT01059526|592074624|FG000|Overall Study|Patient found to be dermatographic|1|||
163919624|NCT01059526|592074625|FG001|Overall Study|Patient found to be dermatographic|0|||
163919625|NCT01732588|592074626|FG000|First Intervention (7 Days)|Adverse Event|0|||
163919626|NCT01732588|592074627|FG001|First Intervention (7 Days)|Adverse Event|1|||
163919627|NCT01732588|592074628|FG002|First Intervention (7 Days)|Adverse Event|0|||
163919628|NCT02720081|592074629|FG000|Overall Study|Adverse Event|0|||
164031657|NCT00475540|592474814|FG000|36 Months|Censored due to reoperation|3|||
163919629|NCT02720081|592074630|FG001|Overall Study|Adverse Event|3|||
163919630|NCT02720081|592074629|FG000|Overall Study|Protocol Violation|4|||
163919631|NCT02720081|592074630|FG001|Overall Study|Protocol Violation|1|||
163919632|NCT05012397|592074633|FG000|Overall Study|Death|10|||
163919633|NCT05012397|592074633|FG000|Overall Study|Physician Decision|9|||
163919634|NCT05012397|592074633|FG000|Overall Study|Withdrawal by Subject|5|||
163919635|NCT05012397|592074633|FG000|Overall Study|Lost to Follow-up|2|||
163919636|NCT03334747|592074636|FG000|Treatment Phase|Technical problems|0|||
163919637|NCT03334747|592074637|FG001|Treatment Phase|Technical problems|0|||
163919638|NCT03334747|592074638|FG002|Treatment Phase|Technical problems|0|||
163919639|NCT03334747|592074639|FG003|Treatment Phase|Technical problems|0|||
163919640|NCT03334747|592074640|FG004|Treatment Phase|Technical problems|1|||
163919641|NCT03334747|592074641|FG005|Treatment Phase|Technical problems|0|||
163919642|NCT03334747|592074642|FG006|Treatment Phase|Technical problems|0|||
163919643|NCT03334747|592074643|FG007|Treatment Phase|Technical problems|0|||
163919644|NCT03334747|592074644|FG008|Treatment Phase|Technical problems|0|||
163919645|NCT03334747|592074636|FG000|Treatment Phase|Subject/guardian decision|1|||
163919646|NCT03334747|592074637|FG001|Treatment Phase|Subject/guardian decision|0|||
163919647|NCT03334747|592074638|FG002|Treatment Phase|Subject/guardian decision|0|||
163919648|NCT03334747|592074639|FG003|Treatment Phase|Subject/guardian decision|0|||
163919649|NCT03334747|592074640|FG004|Treatment Phase|Subject/guardian decision|0|||
163919650|NCT03334747|592074641|FG005|Treatment Phase|Subject/guardian decision|1|||
163919651|NCT03334747|592074642|FG006|Treatment Phase|Subject/guardian decision|0|||
163919652|NCT03334747|592074643|FG007|Treatment Phase|Subject/guardian decision|0|||
163919653|NCT03334747|592074644|FG008|Treatment Phase|Subject/guardian decision|0|||
163919654|NCT03334747|592074636|FG000|Follow-Up Phase|Subject/guardian decision|0|||
163919655|NCT03334747|592074637|FG001|Follow-Up Phase|Subject/guardian decision|0|||
163919656|NCT03334747|592074638|FG002|Follow-Up Phase|Subject/guardian decision|0|||
163919657|NCT03334747|592074639|FG003|Follow-Up Phase|Subject/guardian decision|0|||
163919658|NCT03334747|592074640|FG004|Follow-Up Phase|Subject/guardian decision|0|||
163919659|NCT03334747|592074641|FG005|Follow-Up Phase|Subject/guardian decision|0|||
163919660|NCT03334747|592074642|FG006|Follow-Up Phase|Subject/guardian decision|1|||
163919661|NCT03334747|592074643|FG007|Follow-Up Phase|Subject/guardian decision|0|||
163919662|NCT03334747|592074644|FG008|Follow-Up Phase|Subject/guardian decision|1|||
163919663|NCT00938041|592074651|FG000|Overall Study|Lost to Follow-up|6|||
163919664|NCT00938041|592074651|FG000|Overall Study|Received Alternative Therapy|1|||
163919665|NCT00938041|592074651|FG000|Overall Study|Progressive Disease|5|||
163919666|NCT00938041|592074651|FG000|Overall Study|Death|12|||
163919667|NCT00938041|592074651|FG000|Overall Study|Adrenal Insufficiency|3|||
163919668|NCT02504502|592074652|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
163919669|NCT02504502|592074653|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
164031658|NCT00475540|592474815|FG001|36 Months|Censored due to reoperation|0|||
164031659|NCT02394795|592474818|FG000|Overall Study|Adverse Event|92|||
164031660|NCT02394795|592474819|FG001|Overall Study|Adverse Event|70|||
164031661|NCT02394795|592474818|FG000|Overall Study|Lost to Follow-up|0|||
164031662|NCT02394795|592474819|FG001|Overall Study|Lost to Follow-up|1|||
164031663|NCT02394795|592474818|FG000|Overall Study|Withdrawal by Subject|17|||
164031664|NCT02394795|592474819|FG001|Overall Study|Withdrawal by Subject|26|||
164031665|NCT02394795|592474818|FG000|Overall Study|Lack of Efficacy|181|||
164031666|NCT02394795|592474819|FG001|Overall Study|Lack of Efficacy|211|||
164031667|NCT02394795|592474818|FG000|Overall Study|Death|4|||
164031668|NCT02394795|592474819|FG001|Overall Study|Death|5|||
163919670|NCT02504502|592074652|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
163919671|NCT02504502|592074653|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
163919672|NCT03042559|592074657|FG000|Overall Study|drop out|1|||
163919673|NCT03042559|592074658|FG001|Overall Study|drop out|1|||
163919674|NCT01536535|592074662|FG000|Overall Study|Withdrawal by Subject|10|||
163919675|NCT01536535|592074663|FG001|Overall Study|Withdrawal by Subject|5|||
163919676|NCT01536535|592074662|FG000|Overall Study|Lost to Follow-up|4|||
163919677|NCT01536535|592074663|FG001|Overall Study|Lost to Follow-up|6|||
163919678|NCT01536535|592074662|FG000|Overall Study|Physician Decision|1|||
163919679|NCT01536535|592074663|FG001|Overall Study|Physician Decision|1|||
164031669|NCT02394795|592474818|FG000|Overall Study|Physician Decision|109|||
164031670|NCT02394795|592474819|FG001|Overall Study|Physician Decision|93|||
164031671|NCT03245723|592474821|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
164031672|NCT03245723|592474822|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
164031673|NCT03245723|592474821|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
164112600|NCT05740371|592774060|FG000|Overall Study|Death|1|||
164031674|NCT03245723|592474822|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
164031675|NCT03245723|592474821|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
164146983|NCT00443729|592899921|FG001|Overall Study|Lost to Follow-up|1|||
164031676|NCT03245723|592474822|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
164031677|NCT03245723|592474821|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
164031678|NCT03245723|592474822|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
164031679|NCT03784027|592474825|FG000|Period 1|Withdrawal by Subject|0|||
164031680|NCT03784027|592474826|FG001|Period 1|Withdrawal by Subject|1|||
164031681|NCT01512108|592476184|FG000|Overall Study|Adverse Event|9|||
164031682|NCT01512108|592476185|FG001|Overall Study|Adverse Event|4|||
164031683|NCT01512108|592476184|FG000|Overall Study|Protocol Violation|1|||
164031684|NCT01512108|592476185|FG001|Overall Study|Protocol Violation|2|||
164031685|NCT01512108|592476184|FG000|Overall Study|Withdrawal Criteria|1|||
164031686|NCT01512108|592476185|FG001|Overall Study|Withdrawal Criteria|0|||
164031687|NCT01512108|592476184|FG000|Overall Study|Unclassified|11|||
163919680|NCT01536535|592074662|FG000|Overall Study|Participant moved|0|||
163919681|NCT01536535|592074663|FG001|Overall Study|Participant moved|1|||
163919682|NCT00428441|592074664|FG000|Overall Study|Lost to Follow-up|1|||
163919683|NCT04203160|592074665|FG000|Overall Study|Alternative Therapy|3|||
164031688|NCT01512108|592476185|FG001|Overall Study|Unclassified|3|||
164031689|NCT03287869|592476190|FG000|Overall Study|Adverse Event|14|||
164031690|NCT03287869|592476191|FG001|Overall Study|Adverse Event|12|||
164031691|NCT03287869|592476190|FG000|Overall Study|Lack of Efficacy|1|||
164031692|NCT03287869|592476191|FG001|Overall Study|Lack of Efficacy|0|||
164031693|NCT03287869|592476190|FG000|Overall Study|Lost to Follow-up|13|||
163919684|NCT04203160|592074666|FG001|Overall Study|Alternative Therapy|0|||
163919685|NCT04203160|592074667|FG002|Overall Study|Alternative Therapy|1|||
163919686|NCT04203160|592074668|FG003|Overall Study|Alternative Therapy|0|||
163919687|NCT04203160|592074669|FG004|Overall Study|Alternative Therapy|0|||
163919688|NCT04203160|592074670|FG005|Overall Study|Alternative Therapy|2|||
163919689|NCT04203160|592074665|FG000|Overall Study|Withdrawal by Subject|4|||
163919690|NCT04203160|592074666|FG001|Overall Study|Withdrawal by Subject|5|||
163919691|NCT04203160|592074667|FG002|Overall Study|Withdrawal by Subject|0|||
163919692|NCT04203160|592074668|FG003|Overall Study|Withdrawal by Subject|0|||
163919693|NCT04203160|592074669|FG004|Overall Study|Withdrawal by Subject|0|||
163919694|NCT04203160|592074670|FG005|Overall Study|Withdrawal by Subject|4|||
163919695|NCT04203160|592074665|FG000|Overall Study|Adverse Event|7|||
164031694|NCT03287869|592476191|FG001|Overall Study|Lost to Follow-up|19|||
163919696|NCT04203160|592074666|FG001|Overall Study|Adverse Event|5|||
163919697|NCT04203160|592074667|FG002|Overall Study|Adverse Event|0|||
163919698|NCT04203160|592074668|FG003|Overall Study|Adverse Event|0|||
163919699|NCT04203160|592074669|FG004|Overall Study|Adverse Event|0|||
163919700|NCT04203160|592074670|FG005|Overall Study|Adverse Event|0|||
163919701|NCT04203160|592074665|FG000|Overall Study|Sponsor Termination|1|||
163919702|NCT04203160|592074666|FG001|Overall Study|Sponsor Termination|0|||
163919703|NCT04203160|592074667|FG002|Overall Study|Sponsor Termination|0|||
163919704|NCT04203160|592074668|FG003|Overall Study|Sponsor Termination|0|||
163919705|NCT04203160|592074669|FG004|Overall Study|Sponsor Termination|0|||
163919706|NCT04203160|592074670|FG005|Overall Study|Sponsor Termination|0|||
163919707|NCT04203160|592074665|FG000|Overall Study|Physician Decision|3|||
163919708|NCT04203160|592074666|FG001|Overall Study|Physician Decision|2|||
163919709|NCT04203160|592074667|FG002|Overall Study|Physician Decision|0|||
163919710|NCT04203160|592074668|FG003|Overall Study|Physician Decision|0|||
163919711|NCT04203160|592074669|FG004|Overall Study|Physician Decision|0|||
163919712|NCT04203160|592074670|FG005|Overall Study|Physician Decision|0|||
163919713|NCT02744898|592074671|FG000|Overall Study|Progressive Disease|2|||
163919714|NCT02744898|592074671|FG000|Overall Study|Physician Decision|1|||
163919715|NCT02744898|592074671|FG000|Overall Study|Toxicity|1|||
163919716|NCT01911819|592074676|FG000|Overall Study|Adverse Event|0|||
163919717|NCT01911819|592074677|FG001|Overall Study|Adverse Event|1|||
163919718|NCT01911819|592074678|FG002|Overall Study|Adverse Event|0|||
163919719|NCT01911819|592074676|FG000|Overall Study|Withdrawal by Subject|1|||
163919720|NCT01911819|592074677|FG001|Overall Study|Withdrawal by Subject|1|||
163919721|NCT01911819|592074678|FG002|Overall Study|Withdrawal by Subject|0|||
163919722|NCT01207453|592074679|FG000|First Intervention|Adverse Event|2|||
163919723|NCT01207453|592074680|FG001|First Intervention|Adverse Event|1|||
163919724|NCT01207453|592074679|FG000|Washout|Adverse Event|1|||
163919725|NCT01207453|592074680|FG001|Washout|Adverse Event|0|||
163919726|NCT01207453|592074679|FG000|Washout|Lost to Follow-up|1|||
163919727|NCT01207453|592074680|FG001|Washout|Lost to Follow-up|0|||
163919728|NCT01207453|592074679|FG000|2nd Intervention|Adverse Event|1|||
163919729|NCT01207453|592074680|FG001|2nd Intervention|Adverse Event|2|||
163919730|NCT01207453|592074679|FG000|2nd Intervention|Lost to Follow-up|1|||
163919731|NCT01207453|592074680|FG001|2nd Intervention|Lost to Follow-up|0|||
163919732|NCT02951052|592074683|FG000|Overall Study|Adverse Event|13|||
163919733|NCT02951052|592074684|FG001|Overall Study|Adverse Event|5|||
163919734|NCT02951052|592074683|FG000|Overall Study|Withdrawal by Subject|1|||
163919735|NCT02951052|592074684|FG001|Overall Study|Withdrawal by Subject|5|||
163919736|NCT02951052|592074683|FG000|Overall Study|Physician Decision|2|||
163919737|NCT02951052|592074684|FG001|Overall Study|Physician Decision|0|||
163919738|NCT02951052|592074683|FG000|Overall Study|Lost to Follow-up|1|||
163919739|NCT02951052|592074684|FG001|Overall Study|Lost to Follow-up|1|||
163919740|NCT02951052|592074683|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
163919741|NCT02951052|592074684|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
163919742|NCT02951052|592074683|FG000|Overall Study|Protocol Violation|5|||
163919743|NCT02951052|592074684|FG001|Overall Study|Protocol Violation|3|||
163919744|NCT02951052|592074683|FG000|Overall Study|Lack of Efficacy|3|||
163919745|NCT02951052|592074684|FG001|Overall Study|Lack of Efficacy|4|||
163919746|NCT02951052|592074683|FG000|Overall Study|Ongoing|1|||
163919747|NCT02951052|592074684|FG001|Overall Study|Ongoing|0|||
163919748|NCT01589523|592075878|FG000|Overall Study|Withdrawal by Subject|1|||
163919749|NCT00332488|592075879|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
163919750|NCT00332488|592075880|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
163919751|NCT00332488|592075881|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
163919752|NCT00332488|592075879|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
163919753|NCT00332488|592075880|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
163919754|NCT00332488|592075881|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
163919755|NCT00332488|592075879|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
163919756|NCT00332488|592075880|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
163919757|NCT00332488|592075881|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
163919758|NCT00332488|592075879|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
163919759|NCT00332488|592075880|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
163919760|NCT00332488|592075881|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
163919761|NCT00332488|592075879|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
163919762|NCT00332488|592075880|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
163919763|NCT00332488|592075881|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
163919764|NCT00332488|592075879|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
163919765|NCT00332488|592075880|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
163919766|NCT00332488|592075881|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
163919767|NCT00332488|592075879|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
163919768|NCT00332488|592075880|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
163919769|NCT00332488|592075881|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
163919770|NCT00332488|592075879|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
163919771|NCT00332488|592075880|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
163919772|NCT00332488|592075881|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
163919773|NCT00332488|592075879|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
164031695|NCT03287869|592476190|FG000|Overall Study|Non-Compliance With Study Drug|5|||
164031696|NCT03287869|592476191|FG001|Overall Study|Non-Compliance With Study Drug|9|||
164031697|NCT03287869|592476190|FG000|Overall Study|Progressive Disease|1|||
164031698|NCT03287869|592476191|FG001|Overall Study|Progressive Disease|0|||
164031699|NCT03287869|592476190|FG000|Overall Study|Protocol Deviation|2|||
164031700|NCT03287869|592476191|FG001|Overall Study|Protocol Deviation|1|||
164031701|NCT03287869|592476190|FG000|Overall Study|Withdrawal by Subject|36|||
164031702|NCT03287869|592476191|FG001|Overall Study|Withdrawal by Subject|43|||
164031703|NCT03287869|592476190|FG000|Overall Study|Early Closure of the Site|0|||
164031704|NCT03287869|592476191|FG001|Overall Study|Early Closure of the Site|1|||
163919774|NCT00332488|592075880|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
163919775|NCT00332488|592075881|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
163919776|NCT00332488|592075879|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
163919777|NCT00332488|592075880|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
163919778|NCT00332488|592075881|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
163919779|NCT00332488|592075879|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
163919780|NCT00332488|592075880|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
163919781|NCT00332488|592075881|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
163919782|NCT00332488|592075879|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
163919783|NCT00332488|592075880|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
163919784|NCT00332488|592075881|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
163919785|NCT00792259|592075882|FG000|Overall Study|Poor Quality Scans|1|||
163919786|NCT00792259|592075883|FG001|Overall Study|Poor Quality Scans|0|||
163919787|NCT00792259|592075884|FG002|Overall Study|Poor Quality Scans|0|||
163919788|NCT00371462|592075885|FG000|Overall Study|Withdrawal by Subject|1|||
163919789|NCT00371462|592075886|FG001|Overall Study|Withdrawal by Subject|0|||
163919790|NCT00371462|592075885|FG000|Overall Study|Other|7|||
163919791|NCT00371462|592075886|FG001|Overall Study|Other|8|||
163919792|NCT03721978|592075887|FG000|Overall Study|Withdrawal by Subject|6|||
163919793|NCT03721978|592075888|FG001|Overall Study|Withdrawal by Subject|1|||
163919794|NCT03721978|592075887|FG000|Overall Study|Adverse Event|1|||
163919795|NCT03721978|592075888|FG001|Overall Study|Adverse Event|1|||
163919796|NCT03721978|592075887|FG000|Overall Study|Progressive Disease|1|||
163919797|NCT03721978|592075888|FG001|Overall Study|Progressive Disease|0|||
163919798|NCT03721978|592075887|FG000|Overall Study|Lost to Follow-up|5|||
163919799|NCT03721978|592075888|FG001|Overall Study|Lost to Follow-up|1|||
163919800|NCT03721978|592075887|FG000|Overall Study|Reason not Specified|0|||
163919801|NCT03721978|592075888|FG001|Overall Study|Reason not Specified|2|||
163919802|NCT05244226|592075889|FG000|Overall Study|Adverse Event|1|||
163919803|NCT05244226|592075890|FG001|Overall Study|Adverse Event|0|||
163919804|NCT05244226|592075891|FG002|Overall Study|Adverse Event|0|||
163919805|NCT05244226|592075889|FG000|Overall Study|Lost to Follow-up|0|||
163919806|NCT05244226|592075890|FG001|Overall Study|Lost to Follow-up|0|||
163919807|NCT05244226|592075891|FG002|Overall Study|Lost to Follow-up|1|||
163919808|NCT05244226|592075889|FG000|Overall Study|Protocol Violation|0|||
163919809|NCT05244226|592075890|FG001|Overall Study|Protocol Violation|2|||
163919810|NCT05244226|592075891|FG002|Overall Study|Protocol Violation|2|||
163919811|NCT01797562|592075892|FG000|Overall Study|Protocol Violation|5|||
163919812|NCT00917462|592075893|FG000|Overall Study|Clinical Deterioration|1|||
163919813|NCT01441583|592075894|FG000|Overall Study|Withdrawal by Subject|1|||
163919814|NCT01441583|592075895|FG001|Overall Study|Withdrawal by Subject|1|||
163919815|NCT01441583|592075896|FG002|Overall Study|Withdrawal by Subject|1|||
163919816|NCT01441583|592075894|FG000|Overall Study|Death|1|||
164031705|NCT03287869|592476190|FG000|Overall Study|Physician Decision|5|||
164031706|NCT03287869|592476191|FG001|Overall Study|Physician Decision|5|||
164031707|NCT03287869|592476190|FG000|Overall Study|Reason not Specified|6|||
163919817|NCT01441583|592075895|FG001|Overall Study|Death|0|||
163919818|NCT01441583|592075896|FG002|Overall Study|Death|4|||
163919819|NCT01441583|592075894|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
163919820|NCT01441583|592075895|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
163919821|NCT01441583|592075896|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
163919822|NCT03341312|592075897|FG000|Period 1|Withdrawal by Subject|0|||
163919823|NCT03341312|592075898|FG001|Period 1|Withdrawal by Subject|1|||
163919824|NCT03341312|592075899|FG002|Period 1|Withdrawal by Subject|0|||
163919825|NCT03341312|592075900|FG003|Period 1|Withdrawal by Subject|0|||
163919826|NCT00744796|592075905|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
163919827|NCT05372913|592075909|FG000|Overall Study|Withdrawal by Subject|0|||
163919828|NCT05372913|592075910|FG001|Overall Study|Withdrawal by Subject|2|||
163919829|NCT05372913|592075909|FG000|Overall Study|Protocol Violation|2|||
163919830|NCT05372913|592075910|FG001|Overall Study|Protocol Violation|2|||
163919831|NCT05372913|592075909|FG000|Overall Study|Adverse Event|0|||
163919832|NCT05372913|592075910|FG001|Overall Study|Adverse Event|1|||
163919833|NCT03303521|592075911|FG000|Overall Study|Withdrawal by Subject|2|||
163919834|NCT03303521|592075912|FG001|Overall Study|Withdrawal by Subject|0|||
163919835|NCT03303521|592075911|FG000|Overall Study|Death|1|||
163919836|NCT03303521|592075912|FG001|Overall Study|Death|0|||
163919837|NCT03303521|592075911|FG000|Overall Study|Kidney transplantation|0|||
163919838|NCT03303521|592075912|FG001|Overall Study|Kidney transplantation|1|||
163919839|NCT03303521|592075911|FG000|Overall Study|Investigational product discontinuation|0|||
163919840|NCT03303521|592075912|FG001|Overall Study|Investigational product discontinuation|1|||
163919841|NCT03303521|592075911|FG000|Overall Study|Transferred to non-study dialysis center|1|||
163919842|NCT03303521|592075912|FG001|Overall Study|Transferred to non-study dialysis center|0|||
163919843|NCT03303521|592075911|FG000|Overall Study|Non-comliance to study protocol|0|||
163919844|NCT03303521|592075912|FG001|Overall Study|Non-comliance to study protocol|1|||
163919845|NCT03303521|592075911|FG000|Overall Study|Adverse Event|1|||
163919846|NCT03303521|592075912|FG001|Overall Study|Adverse Event|0|||
163919847|NCT00191984|592075913|FG000|Overall Study|Disease Progression|21|||
163919848|NCT00191984|592075913|FG000|Overall Study|Adverse Event|4|||
163919849|NCT00191984|592075913|FG000|Overall Study|Death|2|||
164096949|NCT04206332|592718987|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164146984|NCT00443729|592899920|FG000|Overall Study|Physician Decision|2|||
163919850|NCT00191984|592075913|FG000|Overall Study|Entry Criteria Exclusion|1|||
163919851|NCT00191984|592075913|FG000|Overall Study|Withdrawal by Subject|7|||
163919852|NCT00191984|592075913|FG000|Overall Study|Physician Decision|4|||
163919853|NCT01654289|592075914|FG000|Overall Study|Withdrawal by Subject|10|||
163919854|NCT01654289|592075915|FG001|Overall Study|Withdrawal by Subject|8|||
163919855|NCT01654289|592075916|FG002|Overall Study|Withdrawal by Subject|5|||
163919856|NCT01654289|592075914|FG000|Overall Study|Withdrew from intervention only|17|||
163919857|NCT01654289|592075915|FG001|Overall Study|Withdrew from intervention only|20|||
163919858|NCT01654289|592075916|FG002|Overall Study|Withdrew from intervention only|0|||
163919859|NCT00005908|592075918|FG000|Overall Study|Withdrawal by Subject|1|||
163919860|NCT00005908|592075919|FG001|Overall Study|Withdrawal by Subject|0|||
163919861|NCT04748445|592075922|FG000|Overall Study|No longer met eligibility criteria|12|||
163919862|NCT04748445|592075922|FG000|Overall Study|Other|36|||
163919863|NCT04748445|592075922|FG000|Overall Study|Withdrawal by Subject|553|||
163919864|NCT04748445|592075922|FG000|Overall Study|Lost to Follow-up|30|||
163919865|NCT04736602|592075923|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
163919866|NCT04736602|592075923|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
164031708|NCT03287869|592476191|FG001|Overall Study|Reason not Specified|3|||
164031709|NCT04847141|592476192|FG000|Overall Study|Adverse Event|1|||
164031710|NCT04847141|592476193|FG001|Overall Study|Adverse Event|0|||
164031711|NCT04847141|592476194|FG002|Overall Study|Adverse Event|1|||
164031712|NCT04847141|592476192|FG000|Overall Study|Withdrawal by Subject|2|||
164031713|NCT04847141|592476193|FG001|Overall Study|Withdrawal by Subject|4|||
164031714|NCT04847141|592476194|FG002|Overall Study|Withdrawal by Subject|3|||
164031715|NCT04847141|592476192|FG000|Overall Study|Lost to Follow-up|7|||
164031716|NCT04847141|592476193|FG001|Overall Study|Lost to Follow-up|5|||
164031717|NCT04847141|592476194|FG002|Overall Study|Lost to Follow-up|7|||
164031718|NCT04847141|592476192|FG000|Overall Study|Reason not Specified|0|||
164031719|NCT04847141|592476193|FG001|Overall Study|Reason not Specified|1|||
164031720|NCT04847141|592476194|FG002|Overall Study|Reason not Specified|0|||
164031721|NCT00324740|592476195|FG000|Overall Study|Withdrawal by Subject|1|||
164031722|NCT00324740|592476196|FG001|Overall Study|Withdrawal by Subject|0|||
164031723|NCT00324740|592476197|FG002|Overall Study|Withdrawal by Subject|1|||
164031724|NCT01357980|592476202|FG000|Overall Study|Lack of Efficacy|0|||
164031725|NCT01357980|592476203|FG001|Overall Study|Lack of Efficacy|1|||
164031726|NCT01357980|592476204|FG002|Overall Study|Lack of Efficacy|0|||
164031727|NCT01357980|592476205|FG003|Overall Study|Lack of Efficacy|0|||
164031728|NCT01357980|592476202|FG000|Overall Study|Consent withdrawn|0|||
164031729|NCT01357980|592476203|FG001|Overall Study|Consent withdrawn|0|||
164031730|NCT01357980|592476204|FG002|Overall Study|Consent withdrawn|1|||
164031731|NCT01357980|592476205|FG003|Overall Study|Consent withdrawn|0|||
164031732|NCT04507776|592476206|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
164031733|NCT00094835|592476210|FG000|Overall Study|Physician Decision|1|||
164031734|NCT00094835|592476211|FG001|Overall Study|Physician Decision|0|||
164031735|NCT00094835|592476212|FG002|Overall Study|Physician Decision|0|||
164031736|NCT00094835|592476213|FG003|Overall Study|Physician Decision|0|||
164031737|NCT00094835|592476214|FG004|Overall Study|Physician Decision|0|||
164031738|NCT00094835|592476215|FG005|Overall Study|Physician Decision|1|||
164031739|NCT00094835|592476216|FG006|Overall Study|Physician Decision|0|||
164031740|NCT00094835|592476210|FG000|Overall Study|Withdrawal by Subject|0|||
164031741|NCT00094835|592476211|FG001|Overall Study|Withdrawal by Subject|0|||
164031742|NCT00094835|592476212|FG002|Overall Study|Withdrawal by Subject|0|||
164031743|NCT00094835|592476213|FG003|Overall Study|Withdrawal by Subject|0|||
164031744|NCT00094835|592476214|FG004|Overall Study|Withdrawal by Subject|0|||
164031745|NCT00094835|592476215|FG005|Overall Study|Withdrawal by Subject|0|||
164031746|NCT00094835|592476216|FG006|Overall Study|Withdrawal by Subject|1|||
164031747|NCT00094835|592476210|FG000|Overall Study|Lost to Follow-up|0|||
164031748|NCT00094835|592476211|FG001|Overall Study|Lost to Follow-up|0|||
164031749|NCT00094835|592476212|FG002|Overall Study|Lost to Follow-up|0|||
164031750|NCT00094835|592476213|FG003|Overall Study|Lost to Follow-up|0|||
164031751|NCT00094835|592476214|FG004|Overall Study|Lost to Follow-up|1|||
164031752|NCT00094835|592476215|FG005|Overall Study|Lost to Follow-up|0|||
164031753|NCT00094835|592476216|FG006|Overall Study|Lost to Follow-up|0|||
164031754|NCT00094835|592476210|FG000|Overall Study|Death|1|||
164031755|NCT00094835|592476211|FG001|Overall Study|Death|0|||
163919867|NCT01485991|592075932|FG000|Overall Study|Adverse Event|0|||
163919868|NCT01485991|592075933|FG001|Overall Study|Adverse Event|4|||
163919869|NCT01485991|592075932|FG000|Overall Study|Lost to Follow-up|13|||
163919870|NCT01485991|592075933|FG001|Overall Study|Lost to Follow-up|10|||
163919871|NCT01485991|592075932|FG000|Overall Study|Withdrawal by Subject|13|||
163919872|NCT01485991|592075933|FG001|Overall Study|Withdrawal by Subject|20|||
163919873|NCT01485991|592075932|FG000|Overall Study|randomized but not treated|6|||
163919874|NCT01485991|592075933|FG001|Overall Study|randomized but not treated|2|||
163919875|NCT02538471|592075934|FG000|Overall Study|Progression of disease|2|||
163919876|NCT01713998|592075935|FG000|Overall Study|Lost to Follow-up|2|||
163919877|NCT01713998|592075936|FG001|Overall Study|Lost to Follow-up|0|||
163919878|NCT01713998|592075937|FG002|Overall Study|Lost to Follow-up|2|||
163919879|NCT01713998|592075935|FG000|Overall Study|Withdrawal by Subject|1|||
163919880|NCT01713998|592075936|FG001|Overall Study|Withdrawal by Subject|0|||
163919881|NCT01713998|592075937|FG002|Overall Study|Withdrawal by Subject|0|||
163919882|NCT02350127|592075938|FG000|4-Month Assessment|Withdrawal by Subject|10|||
163919883|NCT02350127|592075939|FG001|4-Month Assessment|Withdrawal by Subject|9|||
164096950|NCT04206332|592718988|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096951|NCT04206332|592718989|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096952|NCT04206332|592718990|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096953|NCT04206332|592718991|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096954|NCT04206332|592718992|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096955|NCT04206332|592718993|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096956|NCT04206332|592718994|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096957|NCT04206332|592718995|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096958|NCT04206332|592718996|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096959|NCT04206332|592718997|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096960|NCT04206332|592718998|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096961|NCT04206332|592718999|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096962|NCT04206332|592719000|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096963|NCT04206332|592719001|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
164096964|NCT04206332|592719002|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
164096965|NCT04206332|592718986|FG000|Part C|Withdrawal by Subject|0|||
164096966|NCT04206332|592718987|FG001|Part C|Withdrawal by Subject|0|||
164096967|NCT04206332|592718988|FG002|Part C|Withdrawal by Subject|0|||
164096968|NCT04206332|592718989|FG003|Part C|Withdrawal by Subject|0|||
164096969|NCT04206332|592718990|FG004|Part C|Withdrawal by Subject|0|||
164096970|NCT04206332|592718991|FG005|Part C|Withdrawal by Subject|0|||
164096971|NCT04206332|592718992|FG006|Part C|Withdrawal by Subject|0|||
164096972|NCT04206332|592718993|FG007|Part C|Withdrawal by Subject|0|||
164096973|NCT04206332|592718994|FG008|Part C|Withdrawal by Subject|0|||
164096974|NCT04206332|592718995|FG009|Part C|Withdrawal by Subject|0|||
163919884|NCT02350127|592075938|FG000|4-Month Assessment|Death|1|||
163919885|NCT02350127|592075939|FG001|4-Month Assessment|Death|0|||
163919886|NCT02350127|592075938|FG000|8-Month Assessment|Death|1|||
163919887|NCT02350127|592075939|FG001|8-Month Assessment|Death|1|||
163919888|NCT02350127|592075938|FG000|8-Month Assessment|Withdrawal by Subject|5|||
163919889|NCT02350127|592075939|FG001|8-Month Assessment|Withdrawal by Subject|8|||
163919890|NCT00157209|592075940|FG000|Overall Study|Ongoing at data cut-off|10|||
164031756|NCT00094835|592476212|FG002|Overall Study|Death|0|||
164031757|NCT00094835|592476213|FG003|Overall Study|Death|0|||
164031758|NCT00094835|592476214|FG004|Overall Study|Death|1|||
164031759|NCT00094835|592476215|FG005|Overall Study|Death|0|||
164031760|NCT00094835|592476216|FG006|Overall Study|Death|0|||
164031761|NCT00094835|592476210|FG000|Overall Study|Non-compliance|1|||
164031762|NCT00094835|592476211|FG001|Overall Study|Non-compliance|2|||
164031763|NCT00094835|592476212|FG002|Overall Study|Non-compliance|2|||
164031764|NCT00094835|592476213|FG003|Overall Study|Non-compliance|0|||
164031765|NCT00094835|592476214|FG004|Overall Study|Non-compliance|2|||
164031766|NCT00094835|592476215|FG005|Overall Study|Non-compliance|2|||
164031767|NCT00094835|592476216|FG006|Overall Study|Non-compliance|1|||
164031768|NCT00094835|592476210|FG000|Overall Study|Other|1|||
164031769|NCT00094835|592476211|FG001|Overall Study|Other|1|||
164031770|NCT00094835|592476212|FG002|Overall Study|Other|1|||
164031771|NCT00094835|592476213|FG003|Overall Study|Other|1|||
164031772|NCT00094835|592476214|FG004|Overall Study|Other|0|||
164031773|NCT00094835|592476215|FG005|Overall Study|Other|0|||
164031774|NCT00094835|592476216|FG006|Overall Study|Other|0|||
164031775|NCT00387348|592476217|FG000|Overall Study|Death|1|||
164031776|NCT00387348|592476218|FG001|Overall Study|Death|1|||
164031777|NCT00387348|592476219|FG002|Overall Study|Death|0|||
164031778|NCT00387348|592476217|FG000|Overall Study|Physician Decision|1|||
164031779|NCT00387348|592476218|FG001|Overall Study|Physician Decision|0|||
164031780|NCT00387348|592476219|FG002|Overall Study|Physician Decision|1|||
164031781|NCT00387348|592476217|FG000|Overall Study|Withdrawal by Subject|0|||
164031782|NCT00387348|592476218|FG001|Overall Study|Withdrawal by Subject|2|||
164031783|NCT00387348|592476219|FG002|Overall Study|Withdrawal by Subject|2|||
164031784|NCT00387348|592476217|FG000|Overall Study|Adverse Event|1|||
163919891|NCT00157209|592075941|FG001|Overall Study|Ongoing at data cut-off|0|||
163919892|NCT01348763|592075942|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
163919893|NCT01348763|592075942|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
163919894|NCT01247922|592075952|FG000|Overall Study|Disease progression|4|||
163919895|NCT01876823|592075953|FG000|Overall Study|Withdrawal by Subject|5|||
163919896|NCT01876823|592075953|FG000|Overall Study|Physician Decision|2|||
163919897|NCT01876823|592075953|FG000|Overall Study|Patients moved|2|||
163919898|NCT00577096|592075954|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
163919899|NCT00577096|592075955|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
163919900|NCT00577096|592075954|FG000|Short Term Participation|Withdrawal by Subject|3|||
163919901|NCT00577096|592075955|FG001|Short Term Participation|Withdrawal by Subject|5|||
163919902|NCT00577096|592075954|FG000|Short Term Participation|Death|1|||
163919903|NCT00577096|592075955|FG001|Short Term Participation|Death|1|||
163919904|NCT00440037|592075961|FG000|Overall Study|Withdrawal by Subject|6|||
163919905|NCT00440037|592075961|FG000|Overall Study|Administrative decision|3|||
163919906|NCT00794573|592075962|FG000|Overall Study|Death|3|||
163919907|NCT00794573|592075963|FG001|Overall Study|Death|0|||
163919908|NCT00794573|592075962|FG000|Overall Study|Withdrawal by Subject|9|||
163919909|NCT00794573|592075963|FG001|Overall Study|Withdrawal by Subject|12|||
163919910|NCT00794573|592075962|FG000|Overall Study|Lost to Follow-up|26|||
163919911|NCT00794573|592075963|FG001|Overall Study|Lost to Follow-up|33|||
163919912|NCT03740919|592075964|FG000|Lead-in Period|Lost to Follow-up|1|||
163919913|NCT03740919|592075965|FG001|Lead-in Period|Lost to Follow-up|0|||
163919914|NCT03740919|592075966|FG002|Lead-in Period|Lost to Follow-up|0|||
163919915|NCT03740919|592075967|FG003|Lead-in Period|Lost to Follow-up|0|||
163919916|NCT03740919|592075964|FG000|Lead-in Period|Physician Decision|2|||
163919917|NCT03740919|592075965|FG001|Lead-in Period|Physician Decision|0|||
163919918|NCT03740919|592075966|FG002|Lead-in Period|Physician Decision|0|||
163919919|NCT03740919|592075967|FG003|Lead-in Period|Physician Decision|0|||
163919920|NCT03740919|592075964|FG000|Lead-in Period|Protocol Violation|1|||
163919921|NCT03740919|592075965|FG001|Lead-in Period|Protocol Violation|0|||
163919922|NCT03740919|592075966|FG002|Lead-in Period|Protocol Violation|0|||
163919923|NCT03740919|592075967|FG003|Lead-in Period|Protocol Violation|0|||
163919924|NCT03740919|592075964|FG000|Lead-in Period|Withdrawal by Subject|10|||
163919925|NCT03740919|592075965|FG001|Lead-in Period|Withdrawal by Subject|0|||
163919926|NCT03740919|592075966|FG002|Lead-in Period|Withdrawal by Subject|0|||
163919927|NCT03740919|592075967|FG003|Lead-in Period|Withdrawal by Subject|0|||
163919928|NCT03740919|592075964|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
163919929|NCT03740919|592075965|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
163919930|NCT03740919|592075966|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
163919931|NCT03740919|592075967|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
163919932|NCT03740919|592075964|FG000|Lead-in Period|Study Task Too Burdensome|1|||
163919933|NCT03740919|592075965|FG001|Lead-in Period|Study Task Too Burdensome|0|||
163919934|NCT03740919|592075966|FG002|Lead-in Period|Study Task Too Burdensome|0|||
163919935|NCT03740919|592075967|FG003|Lead-in Period|Study Task Too Burdensome|0|||
163919936|NCT03740919|592075964|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
163919937|NCT03740919|592075965|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
163919938|NCT03740919|592075966|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
163919939|NCT03740919|592075967|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
163919940|NCT03740919|592075964|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
163919941|NCT03740919|592075965|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
163919942|NCT03740919|592075966|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
163919943|NCT03740919|592075967|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
163919944|NCT03740919|592075964|FG000|Treatment Period|Adverse Event|0|||
163919945|NCT03740919|592075965|FG001|Treatment Period|Adverse Event|0|||
163919946|NCT03740919|592075966|FG002|Treatment Period|Adverse Event|2|||
163919947|NCT03740919|592075967|FG003|Treatment Period|Adverse Event|0|||
163919948|NCT03740919|592075964|FG000|Treatment Period|Protocol Violation|0|||
163919949|NCT03740919|592075965|FG001|Treatment Period|Protocol Violation|1|||
163919950|NCT03740919|592075966|FG002|Treatment Period|Protocol Violation|0|||
164096975|NCT04206332|592718996|FG010|Part C|Withdrawal by Subject|0|||
163919951|NCT03740919|592075967|FG003|Treatment Period|Protocol Violation|0|||
163919952|NCT03740919|592075964|FG000|Treatment Period|Withdrawal by Subject|0|||
163919953|NCT03740919|592075965|FG001|Treatment Period|Withdrawal by Subject|7|||
163919954|NCT03740919|592075966|FG002|Treatment Period|Withdrawal by Subject|6|||
163919955|NCT03740919|592075967|FG003|Treatment Period|Withdrawal by Subject|2|||
163919956|NCT03740919|592075964|FG000|Treatment Period|Terminated by Sponsor|0|||
163919957|NCT03740919|592075965|FG001|Treatment Period|Terminated by Sponsor|1|||
163919958|NCT03740919|592075966|FG002|Treatment Period|Terminated by Sponsor|0|||
163919959|NCT03740919|592075967|FG003|Treatment Period|Terminated by Sponsor|0|||
163919960|NCT03740919|592075964|FG000|Treatment Period|Issue with Insulin Pump|0|||
163919961|NCT03740919|592075965|FG001|Treatment Period|Issue with Insulin Pump|1|||
163919962|NCT03740919|592075966|FG002|Treatment Period|Issue with Insulin Pump|0|||
163919963|NCT03740919|592075967|FG003|Treatment Period|Issue with Insulin Pump|0|||
164031785|NCT00387348|592476218|FG001|Overall Study|Adverse Event|0|||
164031786|NCT00387348|592476219|FG002|Overall Study|Adverse Event|1|||
164031787|NCT03628599|592476220|FG000|Overall Study|Adverse Event|0|||
164096976|NCT04206332|592718997|FG011|Part C|Withdrawal by Subject|0|||
164031788|NCT03628599|592476221|FG001|Overall Study|Adverse Event|1|||
164031789|NCT05905601|592476229|FG000|Overall Study|Lost to Follow-up|1|||
164031790|NCT05905601|592476230|FG001|Overall Study|Lost to Follow-up|3|||
164031791|NCT03024255|592476231|FG000|Overall Study|Adverse Event|1|||
164031792|NCT03024255|592476232|FG001|Overall Study|Adverse Event|4|||
164031793|NCT03024255|592476233|FG002|Overall Study|Adverse Event|8|||
163823735|NCT02548455|591723743|FG000|Overall Study|Withdrawal by Subject|27|||
163823736|NCT02548455|591723743|FG000|Overall Study|Death|26|||
163823737|NCT02548455|591723743|FG000|Overall Study|Lost to Follow-up|14|||
163823738|NCT02548455|591723743|FG000|Overall Study|Visit not completed|173|||
163823739|NCT02525874|591723750|FG000|Overall Study|Other|1|||
163823740|NCT02525874|591723750|FG000|Overall Study|Investigator Decision|1|||
163823741|NCT02525874|591723750|FG000|Overall Study|Consent withdrawn|22|||
163823742|NCT02525874|591723750|FG000|Overall Study|Non-compliance with study drug|3|||
163823743|NCT02525874|591723750|FG000|Overall Study|Adverse Event|17|||
163823744|NCT02525874|591723750|FG000|Overall Study|Lost to Follow-up|7|||
163823745|NCT02525874|591723750|FG000|Overall Study|Disease progression, defined by protocol|2|||
163823746|NCT02525874|591723750|FG000|Overall Study|Disease relapse|4|||
163823747|NCT02525874|591723750|FG000|Overall Study|Alternative Treatment for MS|2|||
163823748|NCT02525874|591723750|FG000|Overall Study|New lesions in Brain|1|||
163823749|NCT02794285|591723751|FG000|Overall Study|Adverse Event|11|||
163823750|NCT02794285|591723752|FG001|Overall Study|Adverse Event|4|||
163823751|NCT02794285|591723753|FG002|Overall Study|Adverse Event|5|||
163823752|NCT02794285|591723754|FG003|Overall Study|Adverse Event|8|||
163823753|NCT02794285|591723751|FG000|Overall Study|Condition Under Investigation Improved|1|||
163823754|NCT02794285|591723752|FG001|Overall Study|Condition Under Investigation Improved|0|||
163823755|NCT02794285|591723753|FG002|Overall Study|Condition Under Investigation Improved|0|||
163823756|NCT02794285|591723754|FG003|Overall Study|Condition Under Investigation Improved|0|||
163823757|NCT02794285|591723751|FG000|Overall Study|Condition Under Investigation Worsened|0|||
163823758|NCT02794285|591723752|FG001|Overall Study|Condition Under Investigation Worsened|2|||
163823759|NCT02794285|591723753|FG002|Overall Study|Condition Under Investigation Worsened|1|||
163823760|NCT02794285|591723754|FG003|Overall Study|Condition Under Investigation Worsened|0|||
163823761|NCT02794285|591723751|FG000|Overall Study|Death|2|||
163823762|NCT02794285|591723752|FG001|Overall Study|Death|1|||
163823763|NCT02794285|591723753|FG002|Overall Study|Death|2|||
163823764|NCT02794285|591723754|FG003|Overall Study|Death|0|||
163823765|NCT02794285|591723751|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
163823766|NCT02794285|591723752|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
163823767|NCT02794285|591723753|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
163823768|NCT02794285|591723754|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
163823769|NCT02794285|591723751|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
163823770|NCT02794285|591723752|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
163823771|NCT02794285|591723753|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
163823772|NCT02794285|591723754|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
163823773|NCT02794285|591723751|FG000|Overall Study|Lack of Efficacy|10|||
163823774|NCT02794285|591723752|FG001|Overall Study|Lack of Efficacy|6|||
163823775|NCT02794285|591723753|FG002|Overall Study|Lack of Efficacy|3|||
163823776|NCT02794285|591723754|FG003|Overall Study|Lack of Efficacy|3|||
163823777|NCT02794285|591723751|FG000|Overall Study|Lost to Follow-up|5|||
163823778|NCT02794285|591723752|FG001|Overall Study|Lost to Follow-up|6|||
163823779|NCT02794285|591723753|FG002|Overall Study|Lost to Follow-up|3|||
163823780|NCT02794285|591723754|FG003|Overall Study|Lost to Follow-up|1|||
163823781|NCT02794285|591723751|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
163823782|NCT02794285|591723752|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
163823783|NCT02794285|591723753|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
163823784|NCT02794285|591723754|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
163823785|NCT02794285|591723751|FG000|Overall Study|Withdrawal by Subject|38|||
163823786|NCT02794285|591723752|FG001|Overall Study|Withdrawal by Subject|29|||
163823787|NCT02794285|591723753|FG002|Overall Study|Withdrawal by Subject|20|||
163823788|NCT02794285|591723754|FG003|Overall Study|Withdrawal by Subject|12|||
163823789|NCT02794285|591723751|FG000|Overall Study|Missing|1|||
163823790|NCT02794285|591723752|FG001|Overall Study|Missing|0|||
163823791|NCT02794285|591723753|FG002|Overall Study|Missing|0|||
163823792|NCT02794285|591723754|FG003|Overall Study|Missing|0|||
163823793|NCT02794285|591723751|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
163823794|NCT02794285|591723752|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
163823795|NCT02794285|591723753|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
163823796|NCT02794285|591723754|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
163823797|NCT02794285|591723751|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
163823798|NCT02794285|591723752|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
163823799|NCT02794285|591723753|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
163823800|NCT02794285|591723754|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
163823801|NCT00423176|591723755|FG000|Overall Study|Adverse Event|4|||
163823802|NCT00423176|591723756|FG001|Overall Study|Adverse Event|6|||
163823803|NCT00423176|591723755|FG000|Overall Study|Treatment Failure|1|||
163823804|NCT00423176|591723756|FG001|Overall Study|Treatment Failure|6|||
163919964|NCT03740919|592075964|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
163823805|NCT00423176|591723755|FG000|Overall Study|Lost to Follow-up|4|||
163823806|NCT00423176|591723756|FG001|Overall Study|Lost to Follow-up|7|||
163919965|NCT03740919|592075965|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
163919966|NCT03740919|592075966|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
163919967|NCT03740919|592075967|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
163919968|NCT03740919|592075964|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
163919969|NCT03740919|592075965|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
163919970|NCT03740919|592075966|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
163919971|NCT03740919|592075967|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
163919972|NCT03740919|592075964|FG000|Treatment Period|Not Completing Diary|0|||
163919973|NCT03740919|592075965|FG001|Treatment Period|Not Completing Diary|0|||
163919974|NCT03740919|592075966|FG002|Treatment Period|Not Completing Diary|1|||
163919975|NCT03740919|592075967|FG003|Treatment Period|Not Completing Diary|0|||
163919976|NCT03740919|592075964|FG000|Treatment Period|Insulin Painful to Participant|0|||
163919977|NCT03740919|592075965|FG001|Treatment Period|Insulin Painful to Participant|0|||
163919978|NCT03740919|592075966|FG002|Treatment Period|Insulin Painful to Participant|1|||
163919979|NCT03740919|592075967|FG003|Treatment Period|Insulin Painful to Participant|0|||
163919980|NCT04374253|592075975|FG000|Overall Study|Adverse Event|0|||
163919981|NCT04374253|592075976|FG001|Overall Study|Adverse Event|26|||
163919982|NCT04374253|592075977|FG002|Overall Study|Adverse Event|2|||
163919983|NCT04374253|592075978|FG003|Overall Study|Adverse Event|12|||
163919984|NCT04374253|592075975|FG000|Overall Study|Study terminated by sponsor|13|||
163919985|NCT04374253|592075976|FG001|Overall Study|Study terminated by sponsor|593|||
163919986|NCT04374253|592075977|FG002|Overall Study|Study terminated by sponsor|21|||
163919987|NCT04374253|592075978|FG003|Overall Study|Study terminated by sponsor|567|||
163919988|NCT04374253|592075975|FG000|Overall Study|Withdrawal by Subject|0|||
163919989|NCT04374253|592075976|FG001|Overall Study|Withdrawal by Subject|55|||
163919990|NCT04374253|592075977|FG002|Overall Study|Withdrawal by Subject|3|||
163919991|NCT04374253|592075978|FG003|Overall Study|Withdrawal by Subject|40|||
163919992|NCT04374253|592075975|FG000|Overall Study|Physician Decision|1|||
163919993|NCT04374253|592075976|FG001|Overall Study|Physician Decision|10|||
163919994|NCT04374253|592075977|FG002|Overall Study|Physician Decision|1|||
163919995|NCT04374253|592075978|FG003|Overall Study|Physician Decision|10|||
163919996|NCT04374253|592075975|FG000|Overall Study|Protocol Violation|0|||
163919997|NCT04374253|592075976|FG001|Overall Study|Protocol Violation|0|||
163919998|NCT04374253|592075977|FG002|Overall Study|Protocol Violation|0|||
163919999|NCT04374253|592075978|FG003|Overall Study|Protocol Violation|2|||
163920000|NCT04374253|592075975|FG000|Overall Study|Death|0|||
163920001|NCT04374253|592075976|FG001|Overall Study|Death|3|||
163920002|NCT04374253|592075977|FG002|Overall Study|Death|1|||
163920003|NCT04374253|592075978|FG003|Overall Study|Death|1|||
163920004|NCT04374253|592075975|FG000|Overall Study|Lack of Efficacy|0|||
163920005|NCT04374253|592075976|FG001|Overall Study|Lack of Efficacy|0|||
163920006|NCT04374253|592075977|FG002|Overall Study|Lack of Efficacy|0|||
163920007|NCT04374253|592075978|FG003|Overall Study|Lack of Efficacy|1|||
163920008|NCT04374253|592075975|FG000|Overall Study|Lost to Follow-up|1|||
163920009|NCT04374253|592075976|FG001|Overall Study|Lost to Follow-up|1|||
163920010|NCT04374253|592075977|FG002|Overall Study|Lost to Follow-up|0|||
163920011|NCT04374253|592075978|FG003|Overall Study|Lost to Follow-up|2|||
163920012|NCT04374253|592075975|FG000|Overall Study|Reason Not Specified|0|||
163920013|NCT04374253|592075976|FG001|Overall Study|Reason Not Specified|8|||
163920014|NCT04374253|592075977|FG002|Overall Study|Reason Not Specified|0|||
163920015|NCT04374253|592075978|FG003|Overall Study|Reason Not Specified|8|||
163920016|NCT00448344|592075982|FG000|Overall Study|Lost to Follow-up|20|||
163920017|NCT00448344|592075983|FG001|Overall Study|Lost to Follow-up|22|||
163920018|NCT00448344|592075982|FG000|Overall Study|Withdrawal by Subject|6|||
163920019|NCT00448344|592075983|FG001|Overall Study|Withdrawal by Subject|8|||
163920020|NCT00448344|592075982|FG000|Overall Study|Death|3|||
163920021|NCT00448344|592075983|FG001|Overall Study|Death|4|||
163920022|NCT00448344|592075982|FG000|Overall Study|Physician Decision|1|||
163920023|NCT00448344|592075983|FG001|Overall Study|Physician Decision|2|||
163920024|NCT04382053|592075987|FG000|Overall Study|Death|6|||
163920025|NCT04382053|592075988|FG001|Overall Study|Death|8|||
163920026|NCT04382053|592075987|FG000|Overall Study|Lost to Follow-up|0|||
163920027|NCT04382053|592075988|FG001|Overall Study|Lost to Follow-up|2|||
163920028|NCT04382053|592075987|FG000|Overall Study|Protocol Deviation|1|||
163920029|NCT04382053|592075988|FG001|Overall Study|Protocol Deviation|2|||
163920030|NCT04382053|592075987|FG000|Overall Study|Withdrawal by Subject|2|||
163920031|NCT04382053|592075988|FG001|Overall Study|Withdrawal by Subject|1|||
163920032|NCT01399905|592075991|FG000|Overall Study|Withdrawal by Subject|1|||
163920033|NCT01399905|592075992|FG001|Overall Study|Withdrawal by Subject|1|||
163920034|NCT01945086|592075993|FG000|Overall Study|Withdrawal by Subject|1|||
163920035|NCT01945086|592075994|FG001|Overall Study|Withdrawal by Subject|0|||
163920036|NCT01945086|592075995|FG002|Overall Study|Withdrawal by Subject|1|||
163920037|NCT01945086|592075993|FG000|Overall Study|Adverse Event|0|||
163920038|NCT01945086|592075994|FG001|Overall Study|Adverse Event|0|||
163920039|NCT01945086|592075995|FG002|Overall Study|Adverse Event|1|||
163920040|NCT01524887|592075998|FG000|Overall Study|Withdrawal by Subject|6|||
163920041|NCT01524887|592075999|FG001|Overall Study|Withdrawal by Subject|2|||
163920042|NCT01524887|592076000|FG002|Overall Study|Withdrawal by Subject|3|||
163920043|NCT01524887|592075998|FG000|Overall Study|Adverse Event|5|||
163920044|NCT01524887|592075999|FG001|Overall Study|Adverse Event|1|||
163920045|NCT01524887|592076000|FG002|Overall Study|Adverse Event|1|||
163920046|NCT01524887|592075998|FG000|Overall Study|Protocol Violation|0|||
163920047|NCT01524887|592075999|FG001|Overall Study|Protocol Violation|0|||
163920048|NCT01524887|592076000|FG002|Overall Study|Protocol Violation|1|||
163920049|NCT01524887|592075998|FG000|Overall Study|Study termination|73|||
163920050|NCT01524887|592075999|FG001|Overall Study|Study termination|87|||
163920051|NCT01524887|592076000|FG002|Overall Study|Study termination|79|||
163920052|NCT01524887|592075998|FG000|Overall Study|Withdrawal by Caregiver|0|||
163920053|NCT01524887|592075999|FG001|Overall Study|Withdrawal by Caregiver|0|||
163920054|NCT01524887|592076000|FG002|Overall Study|Withdrawal by Caregiver|2|||
163920055|NCT01524887|592075998|FG000|Overall Study|Use of prohibited medication|1|||
163920056|NCT01524887|592075999|FG001|Overall Study|Use of prohibited medication|0|||
163920057|NCT01524887|592076000|FG002|Overall Study|Use of prohibited medication|0|||
163920058|NCT01808144|592076001|FG000|Overall Study|Death|1|||
163920059|NCT01808144|592076002|FG001|Overall Study|Death|0|||
163920060|NCT01808144|592076001|FG000|Overall Study|Withdrawal by Subject|16|||
163920061|NCT01808144|592076002|FG001|Overall Study|Withdrawal by Subject|23|||
163920062|NCT01808144|592076001|FG000|Overall Study|Lost to Follow-up|6|||
163920063|NCT01808144|592076002|FG001|Overall Study|Lost to Follow-up|3|||
163920064|NCT01808144|592076001|FG000|Overall Study|Protocol Violation|6|||
163920065|NCT01808144|592076002|FG001|Overall Study|Protocol Violation|6|||
163920066|NCT01808144|592076001|FG000|Overall Study|Gout flare|0|||
163920067|NCT01808144|592076002|FG001|Overall Study|Gout flare|1|||
163920068|NCT01808144|592076001|FG000|Overall Study|Adverse Event|11|||
163920069|NCT01808144|592076002|FG001|Overall Study|Adverse Event|15|||
163920070|NCT00383500|592076003|FG000|Overall Study|Withdrawal by Subject|8|||
163920071|NCT00383500|592076004|FG001|Overall Study|Withdrawal by Subject|3|||
163920072|NCT00383500|592076005|FG002|Overall Study|Withdrawal by Subject|0|||
163920073|NCT00383500|592076003|FG000|Overall Study|Lost to Follow-up|0|||
163920074|NCT00383500|592076004|FG001|Overall Study|Lost to Follow-up|0|||
163920075|NCT00383500|592076005|FG002|Overall Study|Lost to Follow-up|2|||
163823807|NCT00423176|591723755|FG000|Overall Study|Withdrawal by Subject|4|||
163823808|NCT00423176|591723756|FG001|Overall Study|Withdrawal by Subject|3|||
163823809|NCT00423176|591723755|FG000|Overall Study|Protocol Violation|1|||
163823810|NCT00423176|591723756|FG001|Overall Study|Protocol Violation|3|||
163823811|NCT00423176|591723755|FG000|Overall Study|Did not meet protocol eligibility|2|||
163823812|NCT00423176|591723756|FG001|Overall Study|Did not meet protocol eligibility|4|||
163823813|NCT04535947|591723757|FG000|Overall Study|Adverse Event|1|||
163823814|NCT04535947|591723758|FG001|Overall Study|Adverse Event|4|||
163823815|NCT04535947|591723757|FG000|Overall Study|Other reasons not specified|2|||
163823816|NCT04535947|591723758|FG001|Overall Study|Other reasons not specified|0|||
163823817|NCT04535947|591723757|FG000|Overall Study|Withdrawal by Subject|1|||
163823818|NCT04535947|591723758|FG001|Overall Study|Withdrawal by Subject|1|||
163823819|NCT04867369|591723764|FG000|Overall Study|Withdrawal by Subject|1|||
163823820|NCT04867369|591723765|FG001|Overall Study|Withdrawal by Subject|0|||
163823821|NCT03896035|591723771|FG000|Overall Study|Lost to Follow-up|2|||
163823822|NCT03896035|591723772|FG001|Overall Study|Lost to Follow-up|6|||
163823823|NCT03896035|591723771|FG000|Overall Study|Withdrawal by Subject|0|||
163823824|NCT03896035|591723772|FG001|Overall Study|Withdrawal by Subject|1|||
163823825|NCT03896035|591723771|FG000|Overall Study|Health/family health issues during COVID|0|||
163823826|NCT03896035|591723772|FG001|Overall Study|Health/family health issues during COVID|4|||
163823827|NCT00675766|591723782|FG000|Overall Study|Lost to Follow-up|6|||
163823828|NCT00675766|591723783|FG001|Overall Study|Lost to Follow-up|5|||
163823829|NCT00675766|591723784|FG002|Overall Study|Lost to Follow-up|21|||
163823830|NCT00675766|591723785|FG003|Overall Study|Lost to Follow-up|26|||
163823831|NCT01749982|591723786|FG000|Overall Study|Physician Decision|0|||
163823832|NCT01749982|591723787|FG001|Overall Study|Physician Decision|0|||
163823833|NCT01749982|591723788|FG002|Overall Study|Physician Decision|0|||
163823834|NCT01749982|591723789|FG003|Overall Study|Physician Decision|1|||
163823835|NCT01749982|591723786|FG000|Overall Study|Lost to Follow-up|0|||
163823836|NCT01749982|591723787|FG001|Overall Study|Lost to Follow-up|0|||
163823837|NCT01749982|591723788|FG002|Overall Study|Lost to Follow-up|0|||
163823838|NCT01749982|591723789|FG003|Overall Study|Lost to Follow-up|1|||
163823839|NCT01749982|591723786|FG000|Overall Study|Withdrawal by Subject|0|||
163823840|NCT01749982|591723787|FG001|Overall Study|Withdrawal by Subject|0|||
163823841|NCT01749982|591723788|FG002|Overall Study|Withdrawal by Subject|0|||
163823842|NCT01749982|591723789|FG003|Overall Study|Withdrawal by Subject|1|||
163823843|NCT02677116|591723790|FG000|Overall Study|Adverse Event|0|||
163823844|NCT02677116|591723791|FG001|Overall Study|Adverse Event|1|||
163823845|NCT02677116|591723792|FG002|Overall Study|Adverse Event|0|||
163823846|NCT02677116|591723793|FG003|Overall Study|Adverse Event|0|||
163823847|NCT02677116|591723794|FG004|Overall Study|Adverse Event|0|||
163823848|NCT02677116|591723795|FG005|Overall Study|Adverse Event|1|||
163823849|NCT02677116|591723796|FG006|Overall Study|Adverse Event|1|||
163823850|NCT02677116|591723797|FG007|Overall Study|Adverse Event|0|||
163823851|NCT02677116|591723798|FG008|Overall Study|Adverse Event|0|||
163823852|NCT02677116|591723790|FG000|Overall Study|Physician Decision|0|||
163823853|NCT02677116|591723791|FG001|Overall Study|Physician Decision|2|||
163823854|NCT02677116|591723792|FG002|Overall Study|Physician Decision|3|||
163823855|NCT02677116|591723793|FG003|Overall Study|Physician Decision|2|||
163823856|NCT02677116|591723794|FG004|Overall Study|Physician Decision|1|||
163823857|NCT02677116|591723795|FG005|Overall Study|Physician Decision|3|||
163823858|NCT02677116|591723796|FG006|Overall Study|Physician Decision|1|||
163823859|NCT02677116|591723797|FG007|Overall Study|Physician Decision|1|||
163823860|NCT02677116|591723798|FG008|Overall Study|Physician Decision|2|||
163823861|NCT02677116|591723790|FG000|Overall Study|Withdrawal by parent or guardian|2|||
163823862|NCT02677116|591723791|FG001|Overall Study|Withdrawal by parent or guardian|1|||
163823863|NCT02677116|591723792|FG002|Overall Study|Withdrawal by parent or guardian|0|||
163823864|NCT02677116|591723793|FG003|Overall Study|Withdrawal by parent or guardian|1|||
163823865|NCT02677116|591723794|FG004|Overall Study|Withdrawal by parent or guardian|0|||
163823866|NCT02677116|591723795|FG005|Overall Study|Withdrawal by parent or guardian|0|||
163823867|NCT02677116|591723796|FG006|Overall Study|Withdrawal by parent or guardian|2|||
163823868|NCT02677116|591723797|FG007|Overall Study|Withdrawal by parent or guardian|1|||
163823869|NCT02677116|591723798|FG008|Overall Study|Withdrawal by parent or guardian|0|||
163823870|NCT02677116|591723790|FG000|Overall Study|Withdrawal by Subject|1|||
163823871|NCT02677116|591723791|FG001|Overall Study|Withdrawal by Subject|0|||
163823872|NCT02677116|591723792|FG002|Overall Study|Withdrawal by Subject|0|||
163823873|NCT02677116|591723793|FG003|Overall Study|Withdrawal by Subject|0|||
163823874|NCT02677116|591723794|FG004|Overall Study|Withdrawal by Subject|0|||
163823875|NCT02677116|591723795|FG005|Overall Study|Withdrawal by Subject|0|||
163823876|NCT02677116|591723796|FG006|Overall Study|Withdrawal by Subject|0|||
163823877|NCT02677116|591723797|FG007|Overall Study|Withdrawal by Subject|0|||
163823878|NCT02677116|591723798|FG008|Overall Study|Withdrawal by Subject|0|||
163823879|NCT01207102|591723803|FG000|Overall Study|Withdrawal by Subject|5|||
163823880|NCT01207102|591723803|FG000|Overall Study|Adverse Event|2|||
163823881|NCT01207102|591723803|FG000|Overall Study|progression|2|||
163823882|NCT01207102|591723803|FG000|Overall Study|Withdrawal by Treating Physician|1|||
163823883|NCT01018394|591723804|FG000|Overall Study|Withdrawal by Subject|5|||
163823884|NCT01018394|591723805|FG001|Overall Study|Withdrawal by Subject|5|||
163823885|NCT01018394|591723804|FG000|Overall Study|Lost to Follow-up|4|||
163823886|NCT01018394|591723805|FG001|Overall Study|Lost to Follow-up|3|||
163823887|NCT03792126|591723806|FG000|Overall Study|Adverse Event|1|||
163823888|NCT03792126|591723807|FG001|Overall Study|Adverse Event|2|||
163823889|NCT03792126|591723806|FG000|Overall Study|Death|0|||
163823890|NCT03792126|591723807|FG001|Overall Study|Death|1|||
163823891|NCT03792126|591723806|FG000|Overall Study|Lost to Follow-up|1|||
163823892|NCT03792126|591723807|FG001|Overall Study|Lost to Follow-up|0|||
163823893|NCT03792126|591723806|FG000|Overall Study|Withdrawal by Subject|0|||
163823894|NCT03792126|591723807|FG001|Overall Study|Withdrawal by Subject|1|||
163823895|NCT03792126|591723806|FG000|Overall Study|COVID-19 Restrictions|1|||
163823896|NCT03792126|591723807|FG001|Overall Study|COVID-19 Restrictions|3|||
163823897|NCT03792126|591723806|FG000|Overall Study|Symptoms resolved|0|||
163823898|NCT03792126|591723807|FG001|Overall Study|Symptoms resolved|3|||
163823899|NCT04302350|591723808|FG000|Overall Study|Physician Decision|1|||
163823900|NCT04302350|591723809|FG001|Overall Study|Physician Decision|1|||
163823901|NCT04302350|591723810|FG002|Overall Study|Physician Decision|2|||
163823902|NCT04302350|591723808|FG000|Overall Study|Lack of Efficacy|1|||
163823903|NCT04302350|591723809|FG001|Overall Study|Lack of Efficacy|1|||
163823904|NCT04302350|591723810|FG002|Overall Study|Lack of Efficacy|4|||
163823905|NCT04302350|591723808|FG000|Overall Study|Adverse Event|0|||
163823906|NCT04302350|591723809|FG001|Overall Study|Adverse Event|1|||
163823907|NCT04302350|591723810|FG002|Overall Study|Adverse Event|2|||
163823908|NCT00490646|591723811|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
163823909|NCT00490646|591723812|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
163823910|NCT00490646|591723811|FG000|Overall Study|Never Treated (had an adverse event)|1|||
163823911|NCT00490646|591723812|FG001|Overall Study|Never Treated (had an adverse event)|0|||
163823912|NCT00490646|591723811|FG000|Overall Study|Never Treated (withdrew consent)|0|||
163823913|NCT00490646|591723812|FG001|Overall Study|Never Treated (withdrew consent)|1|||
163823914|NCT00983073|591723814|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
163823915|NCT00983073|591723814|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
163823916|NCT00983073|591723814|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
163823917|NCT00983073|591723814|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
163823918|NCT00983073|591723814|FG000|Titration and Optimal Dose Period|Other reason|4|||
163823919|NCT00983073|591723814|FG000|Maintenance Period|Adverse Event|5|||
163823920|NCT00983073|591723814|FG000|Maintenance Period|Withdrawal by Subject|2|||
163823921|NCT00983073|591723814|FG000|Maintenance Period|Lack of Efficacy|2|||
163823922|NCT00983073|591723814|FG000|Maintenance Period|Other Reason|7|||
163823923|NCT02962908|591723817|FG000|Overall Study|Lost to Follow-up|0|||
163823924|NCT02962908|591723818|FG001|Overall Study|Lost to Follow-up|3|||
163823925|NCT02962908|591723819|FG002|Overall Study|Lost to Follow-up|0|||
163823926|NCT02962908|591723820|FG003|Overall Study|Lost to Follow-up|1|||
163823927|NCT02962908|591723817|FG000|Overall Study|Withdrawal by Subject|0|||
163823928|NCT02962908|591723818|FG001|Overall Study|Withdrawal by Subject|3|||
163823929|NCT02962908|591723819|FG002|Overall Study|Withdrawal by Subject|0|||
163823930|NCT02962908|591723820|FG003|Overall Study|Withdrawal by Subject|2|||
163823931|NCT02962908|591723817|FG000|Overall Study|Protocol Violation|0|||
163823932|NCT02962908|591723818|FG001|Overall Study|Protocol Violation|1|||
163823933|NCT02962908|591723819|FG002|Overall Study|Protocol Violation|0|||
163823934|NCT02962908|591723820|FG003|Overall Study|Protocol Violation|0|||
163823935|NCT02962908|591723817|FG000|Overall Study|Physician Decision|0|||
163823936|NCT02962908|591723818|FG001|Overall Study|Physician Decision|1|||
163823937|NCT02962908|591723819|FG002|Overall Study|Physician Decision|0|||
163823938|NCT02962908|591723820|FG003|Overall Study|Physician Decision|0|||
163823939|NCT03543254|591723821|FG000|Overall Study|Lost to Follow-up|1|||
163823940|NCT02077166|591723822|FG000|Overall Study|Death|6|||
163823941|NCT02077166|591723823|FG001|Overall Study|Death|7|||
163823942|NCT02077166|591723824|FG002|Overall Study|Death|5|||
163823943|NCT02077166|591723825|FG003|Overall Study|Death|6|||
163823944|NCT02077166|591723826|FG004|Overall Study|Death|4|||
163823945|NCT02077166|591723827|FG005|Overall Study|Death|32|||
163823946|NCT02077166|591723828|FG006|Overall Study|Death|22|||
163823947|NCT02077166|591723822|FG000|Overall Study|Study Closure by Sponsor|3|||
163823948|NCT02077166|591723823|FG001|Overall Study|Study Closure by Sponsor|0|||
163823949|NCT02077166|591723824|FG002|Overall Study|Study Closure by Sponsor|2|||
163823950|NCT02077166|591723825|FG003|Overall Study|Study Closure by Sponsor|2|||
163823951|NCT02077166|591723826|FG004|Overall Study|Study Closure by Sponsor|2|||
163823952|NCT02077166|591723827|FG005|Overall Study|Study Closure by Sponsor|12|||
163823953|NCT02077166|591723828|FG006|Overall Study|Study Closure by Sponsor|4|||
163823954|NCT02077166|591723822|FG000|Overall Study|Lost to Follow-up|0|||
163823955|NCT02077166|591723823|FG001|Overall Study|Lost to Follow-up|0|||
163823956|NCT02077166|591723824|FG002|Overall Study|Lost to Follow-up|0|||
163823957|NCT02077166|591723825|FG003|Overall Study|Lost to Follow-up|0|||
163823958|NCT02077166|591723826|FG004|Overall Study|Lost to Follow-up|0|||
163823959|NCT02077166|591723827|FG005|Overall Study|Lost to Follow-up|1|||
163823960|NCT02077166|591723828|FG006|Overall Study|Lost to Follow-up|0|||
163920076|NCT02093897|592077693|FG000|Overall Study|Physician Decision|1|||
163823961|NCT02077166|591723822|FG000|Overall Study|Withdrawal by Subject|3|||
163823962|NCT02077166|591723823|FG001|Overall Study|Withdrawal by Subject|0|||
163823963|NCT02077166|591723824|FG002|Overall Study|Withdrawal by Subject|1|||
163823964|NCT02077166|591723825|FG003|Overall Study|Withdrawal by Subject|1|||
163823965|NCT02077166|591723826|FG004|Overall Study|Withdrawal by Subject|1|||
163823966|NCT02077166|591723827|FG005|Overall Study|Withdrawal by Subject|3|||
163823967|NCT02077166|591723828|FG006|Overall Study|Withdrawal by Subject|0|||
163823968|NCT02077166|591723822|FG000|Overall Study|Other, Not Specified|0|||
163823969|NCT02077166|591723823|FG001|Overall Study|Other, Not Specified|0|||
163823970|NCT02077166|591723824|FG002|Overall Study|Other, Not Specified|1|||
163823971|NCT02077166|591723825|FG003|Overall Study|Other, Not Specified|0|||
163823972|NCT02077166|591723826|FG004|Overall Study|Other, Not Specified|1|||
163823973|NCT02077166|591723827|FG005|Overall Study|Other, Not Specified|7|||
163823974|NCT02077166|591723828|FG006|Overall Study|Other, Not Specified|8|||
163823975|NCT02899728|591723829|FG000|Overall Study|Withdrawal by Subject|1|||
163823976|NCT02899728|591723830|FG001|Overall Study|Withdrawal by Subject|1|||
163823977|NCT01962493|591723831|FG000|Overall Study|Adverse Event|1|||
163823978|NCT01962493|591723832|FG001|Overall Study|Adverse Event|2|||
163823979|NCT01962493|591723831|FG000|Overall Study|Protocol Violation|0|||
163823980|NCT01962493|591723832|FG001|Overall Study|Protocol Violation|1|||
163823981|NCT01962493|591723831|FG000|Overall Study|Withdrawal by Subject|4|||
163823982|NCT01962493|591723832|FG001|Overall Study|Withdrawal by Subject|2|||
163823983|NCT01951625|591723833|FG000|Treatment Period|Protocol Violation|2|||
163823984|NCT01951625|591723834|FG001|Treatment Period|Protocol Violation|0|||
163823985|NCT01951625|591723835|FG002|Treatment Period|Protocol Violation|1|||
163823986|NCT01951625|591723836|FG003|Treatment Period|Protocol Violation|3|||
163823987|NCT01951625|591723837|FG004|Treatment Period|Protocol Violation|2|||
163823988|NCT01951625|591723833|FG000|Treatment Period|Physician Decision|0|||
163823989|NCT01951625|591723834|FG001|Treatment Period|Physician Decision|0|||
163823990|NCT01951625|591723835|FG002|Treatment Period|Physician Decision|0|||
163823991|NCT01951625|591723836|FG003|Treatment Period|Physician Decision|0|||
163823992|NCT01951625|591723837|FG004|Treatment Period|Physician Decision|1|||
163823993|NCT01951625|591723833|FG000|Treatment Period|Protocol driven decision point|0|||
163823994|NCT01951625|591723834|FG001|Treatment Period|Protocol driven decision point|5|||
163823995|NCT01951625|591723835|FG002|Treatment Period|Protocol driven decision point|0|||
163823996|NCT01951625|591723836|FG003|Treatment Period|Protocol driven decision point|2|||
163823997|NCT01951625|591723837|FG004|Treatment Period|Protocol driven decision point|1|||
163823998|NCT01951625|591723833|FG000|Treatment Period|Non compliance with study drug|1|||
163823999|NCT01951625|591723834|FG001|Treatment Period|Non compliance with study drug|2|||
163824000|NCT01951625|591723835|FG002|Treatment Period|Non compliance with study drug|2|||
163824001|NCT01951625|591723836|FG003|Treatment Period|Non compliance with study drug|0|||
163824002|NCT01951625|591723837|FG004|Treatment Period|Non compliance with study drug|0|||
163824003|NCT01951625|591723833|FG000|Treatment Period|Death|3|||
163824004|NCT01951625|591723834|FG001|Treatment Period|Death|2|||
163824005|NCT01951625|591723835|FG002|Treatment Period|Death|2|||
163824006|NCT01951625|591723836|FG003|Treatment Period|Death|1|||
163824007|NCT01951625|591723837|FG004|Treatment Period|Death|2|||
163824008|NCT01951625|591723833|FG000|Treatment Period|Adverse Event|7|||
163824009|NCT01951625|591723834|FG001|Treatment Period|Adverse Event|10|||
163824010|NCT01951625|591723835|FG002|Treatment Period|Adverse Event|9|||
163824011|NCT01951625|591723836|FG003|Treatment Period|Adverse Event|8|||
163824012|NCT01951625|591723837|FG004|Treatment Period|Adverse Event|8|||
163824013|NCT01951625|591723833|FG000|Treatment Period|Withdrawal by Subject|5|||
163824014|NCT01951625|591723834|FG001|Treatment Period|Withdrawal by Subject|2|||
163824015|NCT01951625|591723835|FG002|Treatment Period|Withdrawal by Subject|1|||
163824016|NCT01951625|591723836|FG003|Treatment Period|Withdrawal by Subject|7|||
163824017|NCT01951625|591723837|FG004|Treatment Period|Withdrawal by Subject|3|||
163824018|NCT01951625|591723833|FG000|Treatment Period|Lost to Follow-up|1|||
163824019|NCT01951625|591723834|FG001|Treatment Period|Lost to Follow-up|0|||
163824020|NCT01951625|591723835|FG002|Treatment Period|Lost to Follow-up|0|||
163824021|NCT01951625|591723836|FG003|Treatment Period|Lost to Follow-up|1|||
163824022|NCT01951625|591723837|FG004|Treatment Period|Lost to Follow-up|0|||
163824023|NCT01951625|591723833|FG000|Follow Up Period|Non-compliance with study drug|1|||
163920077|NCT02093897|592077693|FG000|Overall Study|Planned age group closure - no's reached|17|||
163920078|NCT02093897|592077693|FG000|Overall Study|Adverse event, non-fatal|1|||
163920079|NCT02972242|592077694|FG000|Overall Study|Withdrawal by Subject|1|||
163920080|NCT02972242|592077695|FG001|Overall Study|Withdrawal by Subject|0|||
163920081|NCT04572997|592077699|FG000|Overall Study|Adverse Event|1|||
163824024|NCT01951625|591723834|FG001|Follow Up Period|Non-compliance with study drug|0|||
163824025|NCT01951625|591723835|FG002|Follow Up Period|Non-compliance with study drug|0|||
163824026|NCT01951625|591723836|FG003|Follow Up Period|Non-compliance with study drug|0|||
163824027|NCT01951625|591723837|FG004|Follow Up Period|Non-compliance with study drug|0|||
163824028|NCT01951625|591723833|FG000|Follow Up Period|Death|1|||
163824029|NCT01951625|591723834|FG001|Follow Up Period|Death|3|||
163824030|NCT01951625|591723835|FG002|Follow Up Period|Death|2|||
163824031|NCT01951625|591723836|FG003|Follow Up Period|Death|2|||
163824032|NCT01951625|591723837|FG004|Follow Up Period|Death|1|||
163824033|NCT01951625|591723833|FG000|Follow Up Period|Logistical difficulties|1|||
163824034|NCT01951625|591723834|FG001|Follow Up Period|Logistical difficulties|2|||
163824035|NCT01951625|591723835|FG002|Follow Up Period|Logistical difficulties|0|||
163824036|NCT01951625|591723836|FG003|Follow Up Period|Logistical difficulties|0|||
163824037|NCT01951625|591723837|FG004|Follow Up Period|Logistical difficulties|0|||
163824038|NCT01951625|591723833|FG000|Follow Up Period|Adverse Event|0|||
163824039|NCT01951625|591723834|FG001|Follow Up Period|Adverse Event|3|||
163824040|NCT01951625|591723835|FG002|Follow Up Period|Adverse Event|2|||
163824041|NCT01951625|591723836|FG003|Follow Up Period|Adverse Event|3|||
163824042|NCT01951625|591723837|FG004|Follow Up Period|Adverse Event|5|||
163824043|NCT01951625|591723833|FG000|Follow Up Period|Withdrawal by Subject|4|||
163824044|NCT01951625|591723834|FG001|Follow Up Period|Withdrawal by Subject|1|||
163824045|NCT01951625|591723835|FG002|Follow Up Period|Withdrawal by Subject|0|||
163824046|NCT01951625|591723836|FG003|Follow Up Period|Withdrawal by Subject|5|||
163824047|NCT01951625|591723837|FG004|Follow Up Period|Withdrawal by Subject|3|||
163824048|NCT01951625|591723833|FG000|Follow Up Period|Lost to Follow-up|1|||
163824049|NCT01951625|591723834|FG001|Follow Up Period|Lost to Follow-up|0|||
163824050|NCT01951625|591723835|FG002|Follow Up Period|Lost to Follow-up|0|||
163824051|NCT01951625|591723836|FG003|Follow Up Period|Lost to Follow-up|1|||
163824052|NCT01951625|591723837|FG004|Follow Up Period|Lost to Follow-up|1|||
163824053|NCT03754803|591723840|FG000|Overall Study|Withdrawal by Subject|2|||
163824054|NCT05338333|591723841|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
163824055|NCT05338333|591723842|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
163824056|NCT04348604|591723845|FG000|Week 8|Withdrawal by Subject|1|||
163824057|NCT04348604|591723846|FG001|Week 8|Withdrawal by Subject|1|||
163824058|NCT04348604|591723845|FG000|Week 8|Lost to Follow-up|1|||
163824059|NCT04348604|591723846|FG001|Week 8|Lost to Follow-up|2|||
163824060|NCT04348604|591723845|FG000|Week 8|Suspended|0|||
163824061|NCT04348604|591723846|FG001|Week 8|Suspended|1|||
163824062|NCT04348604|591723845|FG000|Week 12|Lost to Follow-up|1|||
163824063|NCT04348604|591723846|FG001|Week 12|Lost to Follow-up|2|||
163824064|NCT04348604|591723845|FG000|Week 12|Withdrawal by Subject|1|||
163824065|NCT04348604|591723846|FG001|Week 12|Withdrawal by Subject|0|||
163824066|NCT04348604|591723845|FG000|Week 24|Lost to Follow-up|2|||
163824067|NCT04348604|591723846|FG001|Week 24|Lost to Follow-up|1|||
163824068|NCT02822222|591725140|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
163824069|NCT02822222|591725141|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
163824070|NCT00833560|591725142|FG000|Overall Study|Toxicity|13|||
163824071|NCT00833560|591725142|FG000|Overall Study|Adverse Event|11|||
163824072|NCT00833560|591725142|FG000|Overall Study|Protocol Violation|6|||
163824073|NCT00833560|591725142|FG000|Overall Study|Lack of Efficacy|4|||
163824074|NCT00833560|591725142|FG000|Overall Study|Death|2|||
163824075|NCT00833560|591725142|FG000|Overall Study|Pregression of other disease|1|||
163824076|NCT00833560|591725142|FG000|Overall Study|Other|5|||
163824077|NCT03382782|591725145|FG000|Cohort 1|Withdrawal by Subject|11|||
163824078|NCT03382782|591725146|FG001|Cohort 1|Withdrawal by Subject|5|||
163824079|NCT03382782|591725147|FG002|Cohort 1|Withdrawal by Subject|0|||
163824080|NCT03382782|591725145|FG000|Cohort 2|Withdrawal by Subject|1|||
163824081|NCT03382782|591725146|FG001|Cohort 2|Withdrawal by Subject|1|||
163824082|NCT03382782|591725147|FG002|Cohort 2|Withdrawal by Subject|0|||
163824083|NCT03382782|591725145|FG000|Cohort 3|Withdrawal by Subject|1|||
163824084|NCT03382782|591725146|FG001|Cohort 3|Withdrawal by Subject|2|||
163824085|NCT03382782|591725147|FG002|Cohort 3|Withdrawal by Subject|0|||
163824086|NCT01791725|591725149|FG000|Overall Study|Withdrawal by Subject|0|||
163824087|NCT01791725|591725150|FG001|Overall Study|Withdrawal by Subject|1|||
163824088|NCT01791725|591725151|FG002|Overall Study|Withdrawal by Subject|0|||
163824089|NCT02690974|591725154|FG000|Overall Study|Adverse Event|16|||
163824090|NCT02690974|591725154|FG000|Overall Study|Death|9|||
163824091|NCT02690974|591725154|FG000|Overall Study|Subject/guardian decision|4|||
163824092|NCT02690974|591725154|FG000|Overall Study|Lost to Follow-up|3|||
163824093|NCT02690974|591725154|FG000|Overall Study|Withdrawal of Informed Consent|3|||
163824094|NCT02690974|591725154|FG000|Overall Study|Physician Decision|2|||
163824095|NCT02690974|591725154|FG000|Overall Study|Non-compliance with study treatment|1|||
163824096|NCT02690974|591725154|FG000|Overall Study|Protocol-defined stopping criteria|1|||
163824097|NCT02690974|591725154|FG000|Overall Study|Protocol Deviation|1|||
163824098|NCT01666951|591725155|FG000|Overall Study|Not dosed|1|||
163824099|NCT01666951|591725156|FG001|Overall Study|Not dosed|1|||
163824100|NCT03338894|591725159|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
163824101|NCT00254982|591725168|FG000|Overall Study|Other|2|||
163824102|NCT00254982|591725169|FG001|Overall Study|Other|1|||
163824103|NCT00254982|591725168|FG000|Overall Study|Lack of Efficacy|5|||
163824104|NCT00254982|591725169|FG001|Overall Study|Lack of Efficacy|3|||
163824105|NCT00254982|591725168|FG000|Overall Study|Lost to Follow-up|5|||
163824106|NCT00254982|591725169|FG001|Overall Study|Lost to Follow-up|3|||
163824107|NCT00254982|591725168|FG000|Overall Study|Adverse Event|18|||
163824108|NCT00254982|591725169|FG001|Overall Study|Adverse Event|16|||
163824109|NCT00254982|591725168|FG000|Overall Study|Withdrawal by Subject|1|||
163824110|NCT00254982|591725169|FG001|Overall Study|Withdrawal by Subject|1|||
163824111|NCT00254982|591725168|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
163824112|NCT00254982|591725169|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
164031794|NCT03024255|592476234|FG003|Overall Study|Adverse Event|0|||
164031795|NCT03024255|592476231|FG000|Overall Study|Withdrawal by Subject|3|||
163824113|NCT00254982|591725168|FG000|Overall Study|Protocol deviation|1|||
163824114|NCT00254982|591725169|FG001|Overall Study|Protocol deviation|1|||
163824115|NCT00254982|591725168|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
163824116|NCT00254982|591725169|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
163824117|NCT00254982|591725168|FG000|Overall Study|Malignancy|0|||
163824118|NCT00254982|591725169|FG001|Overall Study|Malignancy|2|||
163824119|NCT00254982|591725168|FG000|Overall Study|Opportunistic infection|1|||
163824120|NCT00254982|591725169|FG001|Overall Study|Opportunistic infection|0|||
163824121|NCT00254982|591725168|FG000|Overall Study|Abnormal liver function tests|2|||
163824122|NCT00254982|591725169|FG001|Overall Study|Abnormal liver function tests|1|||
163824123|NCT02261493|591725170|FG000|Overall Study|Noncompliance|0|||
164031796|NCT03024255|592476232|FG001|Overall Study|Withdrawal by Subject|1|||
163824124|NCT02261493|591725171|FG001|Overall Study|Noncompliance|0|||
163824125|NCT02261493|591725172|FG002|Overall Study|Noncompliance|2|||
163824126|NCT02261493|591725170|FG000|Overall Study|Physician Decision|0|||
163824127|NCT02261493|591725171|FG001|Overall Study|Physician Decision|1|||
163824128|NCT02261493|591725172|FG002|Overall Study|Physician Decision|0|||
163824129|NCT02261493|591725170|FG000|Overall Study|Undisclosed alcohol abuse|0|||
163824130|NCT02261493|591725171|FG001|Overall Study|Undisclosed alcohol abuse|1|||
163824131|NCT02261493|591725172|FG002|Overall Study|Undisclosed alcohol abuse|0|||
163824132|NCT02261493|591725170|FG000|Overall Study|Protocol Violation|1|||
163824133|NCT02261493|591725171|FG001|Overall Study|Protocol Violation|0|||
163824134|NCT02261493|591725172|FG002|Overall Study|Protocol Violation|0|||
163824135|NCT02261493|591725170|FG000|Overall Study|Personal Reasons|14|||
163824136|NCT02261493|591725171|FG001|Overall Study|Personal Reasons|14|||
163824137|NCT02261493|591725172|FG002|Overall Study|Personal Reasons|16|||
163824138|NCT02261493|591725170|FG000|Overall Study|Lost to Follow-up|14|||
163824139|NCT02261493|591725171|FG001|Overall Study|Lost to Follow-up|27|||
163824140|NCT02261493|591725172|FG002|Overall Study|Lost to Follow-up|8|||
163824141|NCT02261493|591725170|FG000|Overall Study|Pregnancy|1|||
163824142|NCT02261493|591725171|FG001|Overall Study|Pregnancy|2|||
163824143|NCT02261493|591725172|FG002|Overall Study|Pregnancy|0|||
163824144|NCT02261493|591725170|FG000|Overall Study|Lack of Efficacy|0|||
163824145|NCT02261493|591725171|FG001|Overall Study|Lack of Efficacy|1|||
163824146|NCT02261493|591725172|FG002|Overall Study|Lack of Efficacy|0|||
163824147|NCT02261493|591725170|FG000|Overall Study|Adverse Event|0|||
163824148|NCT02261493|591725171|FG001|Overall Study|Adverse Event|1|||
163824149|NCT02261493|591725172|FG002|Overall Study|Adverse Event|0|||
163824150|NCT00558428|591725173|FG000|Overall Study|Adverse Event|6|||
163824151|NCT00558428|591725174|FG001|Overall Study|Adverse Event|22|||
163824152|NCT00558428|591725175|FG002|Overall Study|Adverse Event|3|||
163824153|NCT00558428|591725176|FG003|Overall Study|Adverse Event|4|||
163824154|NCT00558428|591725173|FG000|Overall Study|Lost to Follow-up|0|||
163824155|NCT00558428|591725174|FG001|Overall Study|Lost to Follow-up|1|||
163824156|NCT00558428|591725175|FG002|Overall Study|Lost to Follow-up|0|||
163824157|NCT00558428|591725176|FG003|Overall Study|Lost to Follow-up|0|||
163824158|NCT00558428|591725173|FG000|Overall Study|Lack of Efficacy|0|||
163824159|NCT00558428|591725174|FG001|Overall Study|Lack of Efficacy|0|||
163824160|NCT00558428|591725175|FG002|Overall Study|Lack of Efficacy|1|||
163824161|NCT00558428|591725176|FG003|Overall Study|Lack of Efficacy|2|||
163824162|NCT00558428|591725173|FG000|Overall Study|Non compliant with protocol|1|||
163824163|NCT00558428|591725174|FG001|Overall Study|Non compliant with protocol|0|||
163824164|NCT00558428|591725175|FG002|Overall Study|Non compliant with protocol|0|||
163824165|NCT00558428|591725176|FG003|Overall Study|Non compliant with protocol|3|||
163824166|NCT00558428|591725173|FG000|Overall Study|Consent withdrawn|2|||
163824167|NCT00558428|591725174|FG001|Overall Study|Consent withdrawn|1|||
163824168|NCT00558428|591725175|FG002|Overall Study|Consent withdrawn|0|||
163824169|NCT00558428|591725176|FG003|Overall Study|Consent withdrawn|1|||
163824170|NCT00558428|591725173|FG000|Overall Study|Other|3|||
163824171|NCT00558428|591725174|FG001|Overall Study|Other|0|||
163824172|NCT00558428|591725175|FG002|Overall Study|Other|0|||
163824173|NCT00558428|591725176|FG003|Overall Study|Other|1|||
163824174|NCT02570126|591725177|FG000|Overall Study|Lost to Follow-up|2|||
163824175|NCT02570126|591725178|FG001|Overall Study|Lost to Follow-up|0|||
163824176|NCT02570126|591725177|FG000|Overall Study|Unable To Arrange Visit 3|1|||
163824177|NCT02570126|591725178|FG001|Overall Study|Unable To Arrange Visit 3|0|||
163824178|NCT02570126|591725177|FG000|Overall Study|Violation Of Procedures GSK|0|||
164031797|NCT03024255|592476233|FG002|Overall Study|Withdrawal by Subject|0|||
164031798|NCT03024255|592476234|FG003|Overall Study|Withdrawal by Subject|3|||
163824179|NCT02570126|591725178|FG001|Overall Study|Violation Of Procedures GSK|1|||
163824180|NCT02570126|591725177|FG000|Overall Study|Protocol Violation|0|||
163824181|NCT02570126|591725178|FG001|Overall Study|Protocol Violation|1|||
163824182|NCT02570126|591725177|FG000|Overall Study|Withdrawal by Subject|3|||
163824183|NCT02570126|591725178|FG001|Overall Study|Withdrawal by Subject|7|||
163824184|NCT00626028|591725179|FG000|Overall Study|Adverse Event|1|||
163824185|NCT00626028|591725180|FG001|Overall Study|Adverse Event|1|||
163824186|NCT00626028|591725179|FG000|Overall Study|Device Failure|0|||
163824187|NCT00626028|591725180|FG001|Overall Study|Device Failure|1|||
163824188|NCT00626028|591725179|FG000|Overall Study|Physician Decision|2|||
163824189|NCT00626028|591725180|FG001|Overall Study|Physician Decision|1|||
163824190|NCT00626028|591725179|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
163824191|NCT00626028|591725180|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
163824192|NCT05224050|591725181|FG000|Overall Study|Withdrawal by Subject|9|||
163824193|NCT05224050|591725181|FG000|Overall Study|Lost to Follow-up|3|||
163824194|NCT01292876|591725183|FG000|Overall Study|Physician Decision|4|||
163824195|NCT00917579|591725184|FG000|Washout >= 2 Weeks|Adverse Event|1|||
163824196|NCT00917579|591725185|FG001|Washout >= 2 Weeks|Adverse Event|0|||
163824197|NCT00917579|591725184|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
163824198|NCT00917579|591725185|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
163824199|NCT01627327|591725186|FG000|Overall Study|Adverse Event|6|||
163824200|NCT01627327|591725187|FG001|Overall Study|Adverse Event|12|||
163824201|NCT01627327|591725186|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
163824202|NCT01627327|591725187|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
163824203|NCT01627327|591725186|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
163824204|NCT01627327|591725187|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
163824205|NCT01627327|591725186|FG000|Overall Study|Protocol Violation|4|||
163824206|NCT01627327|591725187|FG001|Overall Study|Protocol Violation|10|||
163824207|NCT01627327|591725186|FG000|Overall Study|Lost to Follow-up|1|||
163824208|NCT01627327|591725187|FG001|Overall Study|Lost to Follow-up|3|||
163824209|NCT01627327|591725186|FG000|Overall Study|Physician Decision|1|||
163824210|NCT01627327|591725187|FG001|Overall Study|Physician Decision|0|||
163824211|NCT01627327|591725186|FG000|Overall Study|Withdrawal by Subject|3|||
163824212|NCT01627327|591725187|FG001|Overall Study|Withdrawal by Subject|3|||
163824213|NCT05763628|591725195|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
163824214|NCT05763628|591725196|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
163824215|NCT05763628|591725195|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
163824216|NCT05763628|591725196|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
163824217|NCT05763628|591725195|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
163824218|NCT05763628|591725196|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
163824219|NCT01137474|591725197|FG000|Overall Study|Adverse Event|3|||
163824220|NCT01137474|591725198|FG001|Overall Study|Adverse Event|5|||
163824221|NCT01137474|591725199|FG002|Overall Study|Adverse Event|1|||
163824222|NCT01137474|591725200|FG003|Overall Study|Adverse Event|3|||
163824223|NCT01137474|591725197|FG000|Overall Study|Withdrawal by Subject|7|||
163824224|NCT01137474|591725198|FG001|Overall Study|Withdrawal by Subject|2|||
163824225|NCT01137474|591725199|FG002|Overall Study|Withdrawal by Subject|6|||
163824226|NCT01137474|591725200|FG003|Overall Study|Withdrawal by Subject|9|||
163824227|NCT01137474|591725197|FG000|Overall Study|No longer met study criteria|6|||
163824228|NCT01137474|591725198|FG001|Overall Study|No longer met study criteria|1|||
163824229|NCT01137474|591725199|FG002|Overall Study|No longer met study criteria|0|||
163824230|NCT01137474|591725200|FG003|Overall Study|No longer met study criteria|5|||
163824231|NCT01137474|591725197|FG000|Overall Study|Lost to Follow-up|5|||
163824232|NCT01137474|591725198|FG001|Overall Study|Lost to Follow-up|1|||
163824233|NCT01137474|591725199|FG002|Overall Study|Lost to Follow-up|0|||
163824234|NCT01137474|591725200|FG003|Overall Study|Lost to Follow-up|2|||
163920082|NCT03098797|592077700|FG000|Part 2 Open Label Extension|Adverse Event|2|||
163824235|NCT01137474|591725197|FG000|Overall Study|Lack of Efficacy|0|||
163824236|NCT01137474|591725198|FG001|Overall Study|Lack of Efficacy|0|||
163824237|NCT01137474|591725199|FG002|Overall Study|Lack of Efficacy|0|||
163824238|NCT01137474|591725200|FG003|Overall Study|Lack of Efficacy|2|||
163824239|NCT01137474|591725197|FG000|Overall Study|Other|3|||
163824240|NCT01137474|591725198|FG001|Overall Study|Other|1|||
163824241|NCT01137474|591725199|FG002|Overall Study|Other|0|||
163824242|NCT01137474|591725200|FG003|Overall Study|Other|0|||
163824243|NCT01137474|591725197|FG000|Overall Study|Pregnancy|0|||
163824244|NCT01137474|591725198|FG001|Overall Study|Pregnancy|1|||
163824245|NCT01137474|591725199|FG002|Overall Study|Pregnancy|0|||
163824246|NCT01137474|591725200|FG003|Overall Study|Pregnancy|0|||
163824247|NCT01137474|591725197|FG000|Overall Study|Administrative reason by sponsor|0|||
163824248|NCT01137474|591725198|FG001|Overall Study|Administrative reason by sponsor|1|||
163824249|NCT01137474|591725199|FG002|Overall Study|Administrative reason by sponsor|0|||
163824250|NCT01137474|591725200|FG003|Overall Study|Administrative reason by sponsor|0|||
163824251|NCT00868439|591725206|FG000|Overall Study|Adverse Event|4|||
163920083|NCT03098797|592077701|FG001|Part 2 Open Label Extension|Adverse Event|0|||
163920084|NCT02956278|592077702|FG000|Overall Study|Withdrawal by Subject|6|||
163824252|NCT00868439|591725207|FG001|Overall Study|Adverse Event|3|||
163920085|NCT02956278|592077703|FG001|Overall Study|Withdrawal by Subject|2|||
163920086|NCT02956278|592077704|FG002|Overall Study|Withdrawal by Subject|0|||
163920087|NCT01967719|592077705|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
163824253|NCT00868439|591725206|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
163824254|NCT00868439|591725207|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
163824255|NCT00868439|591725206|FG000|Overall Study|Death|0|||
163824256|NCT00868439|591725207|FG001|Overall Study|Death|1|||
163824257|NCT00868439|591725206|FG000|Overall Study|Protocol Violation|1|||
163824258|NCT00868439|591725207|FG001|Overall Study|Protocol Violation|1|||
163824259|NCT00868439|591725206|FG000|Overall Study|Physician Decision|1|||
163824260|NCT00868439|591725207|FG001|Overall Study|Physician Decision|0|||
163824261|NCT00868439|591725206|FG000|Overall Study|Withdrawal by Subject|0|||
163824262|NCT00868439|591725207|FG001|Overall Study|Withdrawal by Subject|1|||
163824263|NCT01132326|591725208|FG000|Overall Study|Lack of Efficacy|25|||
163824264|NCT01132326|591725208|FG000|Overall Study|Adverse Event|37|||
163824265|NCT01132326|591725208|FG000|Overall Study|Protocol Violation|1|||
163824266|NCT01132326|591725208|FG000|Overall Study|Lost to Follow-up|16|||
163824267|NCT01132326|591725208|FG000|Overall Study|Withdrawal by Subject|40|||
163824268|NCT01132326|591725208|FG000|Overall Study|Physician Decision|10|||
163824269|NCT01132326|591725208|FG000|Overall Study|Study Termination|80|||
163824270|NCT01132326|591725208|FG000|Overall Study|Declining Health|1|||
163824271|NCT01132326|591725208|FG000|Overall Study|Pregnancy|1|||
163824272|NCT01132326|591725208|FG000|Overall Study|Caregiver Withdrew Consent|1|||
163824273|NCT01132326|591725208|FG000|Overall Study|Death|5|||
163824274|NCT01132326|591725208|FG000|Overall Study|Subject Unable to Come To Visits|1|||
163824275|NCT00338884|591725211|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
163824276|NCT00338884|591725211|FG000|Overall Study|Adverse Event|14|||
163824277|NCT00338884|591725211|FG000|Overall Study|Death|8|||
163824278|NCT00338884|591725211|FG000|Overall Study|Other|4|||
163824279|NCT00338884|591725211|FG000|Overall Study|Global Deterioration of Health Status|3|||
163824280|NCT00338884|591725211|FG000|Overall Study|Withdrawal by Subject|3|||
163824281|NCT00338884|591725211|FG000|Overall Study|Lost to Follow-up|1|||
163824282|NCT00338884|591725211|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
163824283|NCT00911534|591725212|FG000|Overall Study|Adverse Event|4|||
163824284|NCT00911534|591725213|FG001|Overall Study|Adverse Event|4|||
163824285|NCT00911534|591725212|FG000|Overall Study|Lost to Follow-up|2|||
163824286|NCT00911534|591725213|FG001|Overall Study|Lost to Follow-up|4|||
163824287|NCT00911534|591725212|FG000|Overall Study|Withdrawal by Subject|2|||
163824288|NCT00911534|591725213|FG001|Overall Study|Withdrawal by Subject|1|||
163824289|NCT00911534|591725212|FG000|Overall Study|Lack of Efficacy|4|||
163824290|NCT00911534|591725213|FG001|Overall Study|Lack of Efficacy|1|||
163824291|NCT00911534|591725212|FG000|Overall Study|Withdrawal of consent|1|||
163824292|NCT00911534|591725213|FG001|Overall Study|Withdrawal of consent|4|||
163824293|NCT00911534|591725212|FG000|Overall Study|Other|2|||
163824294|NCT00911534|591725213|FG001|Overall Study|Other|2|||
163824295|NCT05072080|591725215|FG000|Overall Study|Death|0|||
163824296|NCT05072080|591725216|FG001|Overall Study|Death|0|||
163824297|NCT05072080|591725217|FG002|Overall Study|Death|1|||
163824298|NCT05072080|591725218|FG003|Overall Study|Death|0|||
163824299|NCT05072080|591725215|FG000|Overall Study|Lost to Follow-up|65|||
163824300|NCT05072080|591725216|FG001|Overall Study|Lost to Follow-up|70|||
163824301|NCT05072080|591725217|FG002|Overall Study|Lost to Follow-up|58|||
163824302|NCT05072080|591725218|FG003|Overall Study|Lost to Follow-up|23|||
163824303|NCT05072080|591725215|FG000|Overall Study|Physician Decision|2|||
163824304|NCT05072080|591725216|FG001|Overall Study|Physician Decision|1|||
163824305|NCT05072080|591725217|FG002|Overall Study|Physician Decision|1|||
163824306|NCT05072080|591725218|FG003|Overall Study|Physician Decision|0|||
163824307|NCT05072080|591725215|FG000|Overall Study|Withdrawal by Subject|45|||
163824308|NCT05072080|591725216|FG001|Overall Study|Withdrawal by Subject|30|||
163824309|NCT05072080|591725217|FG002|Overall Study|Withdrawal by Subject|27|||
163824310|NCT05072080|591725218|FG003|Overall Study|Withdrawal by Subject|7|||
163824311|NCT05072080|591725215|FG000|Overall Study|Sponsor Decision|0|||
163824312|NCT05072080|591725216|FG001|Overall Study|Sponsor Decision|1|||
163824313|NCT05072080|591725217|FG002|Overall Study|Sponsor Decision|0|||
163824314|NCT05072080|591725218|FG003|Overall Study|Sponsor Decision|0|||
163824315|NCT05072080|591725215|FG000|Overall Study|Subject moved|1|||
163824316|NCT05072080|591725216|FG001|Overall Study|Subject moved|3|||
163824317|NCT05072080|591725217|FG002|Overall Study|Subject moved|5|||
163824318|NCT05072080|591725218|FG003|Overall Study|Subject moved|2|||
163824319|NCT05072080|591725215|FG000|Overall Study|Withdrawal by parent|0|||
163824320|NCT05072080|591725216|FG001|Overall Study|Withdrawal by parent|0|||
163824321|NCT05072080|591725217|FG002|Overall Study|Withdrawal by parent|1|||
163824322|NCT05072080|591725218|FG003|Overall Study|Withdrawal by parent|0|||
163824323|NCT05072080|591725215|FG000|Overall Study|Subject was deployed|0|||
163824324|NCT05072080|591725216|FG001|Overall Study|Subject was deployed|1|||
163824325|NCT05072080|591725217|FG002|Overall Study|Subject was deployed|0|||
163824326|NCT05072080|591725218|FG003|Overall Study|Subject was deployed|0|||
163824327|NCT05072080|591725215|FG000|Overall Study|Subject left site without receiving dose|0|||
164096977|NCT04206332|592718998|FG012|Part C|Withdrawal by Subject|0|||
163824328|NCT05072080|591725216|FG001|Overall Study|Subject left site without receiving dose|1|||
163824329|NCT05072080|591725217|FG002|Overall Study|Subject left site without receiving dose|0|||
163824330|NCT05072080|591725218|FG003|Overall Study|Subject left site without receiving dose|0|||
163824331|NCT05072080|591725215|FG000|Overall Study|Subject incarcerated|0|||
163824332|NCT05072080|591725216|FG001|Overall Study|Subject incarcerated|1|||
163824333|NCT05072080|591725217|FG002|Overall Study|Subject incarcerated|0|||
163824334|NCT05072080|591725218|FG003|Overall Study|Subject incarcerated|1|||
163824335|NCT05072080|591725215|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
163824336|NCT05072080|591725216|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
163824337|NCT05072080|591725217|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
163824338|NCT05072080|591725218|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
163824339|NCT05072080|591725215|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
163824340|NCT05072080|591725216|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
163824341|NCT05072080|591725217|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
163824342|NCT05072080|591725218|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
163824343|NCT03492281|591725219|FG000|Overall Study|Withdrawal by Subject|21|||
163824344|NCT03492281|591725220|FG001|Overall Study|Withdrawal by Subject|14|||
163824345|NCT03492281|591725221|FG002|Overall Study|Withdrawal by Subject|13|||
163824346|NCT03492281|591725219|FG000|Overall Study|Lost to Follow-up|14|||
163824347|NCT03492281|591725220|FG001|Overall Study|Lost to Follow-up|15|||
163824348|NCT03492281|591725221|FG002|Overall Study|Lost to Follow-up|10|||
163824349|NCT03492281|591725219|FG000|Overall Study|Adverse Event|6|||
163824350|NCT03492281|591725220|FG001|Overall Study|Adverse Event|8|||
163824351|NCT03492281|591725221|FG002|Overall Study|Adverse Event|13|||
163824352|NCT03492281|591725219|FG000|Overall Study|Lack of Efficacy|3|||
163824353|NCT03492281|591725220|FG001|Overall Study|Lack of Efficacy|0|||
163824354|NCT03492281|591725221|FG002|Overall Study|Lack of Efficacy|1|||
163824355|NCT03492281|591725219|FG000|Overall Study|Physician Decision|1|||
163824356|NCT03492281|591725220|FG001|Overall Study|Physician Decision|0|||
163824357|NCT03492281|591725221|FG002|Overall Study|Physician Decision|3|||
163824358|NCT03492281|591725219|FG000|Overall Study|Protocol Violation|0|||
163824359|NCT03492281|591725220|FG001|Overall Study|Protocol Violation|2|||
163824360|NCT03492281|591725221|FG002|Overall Study|Protocol Violation|1|||
163824361|NCT03492281|591725219|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
163824362|NCT03492281|591725220|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
163824363|NCT03492281|591725221|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
163824364|NCT03492281|591725219|FG000|Overall Study|Death|0|||
163824365|NCT03492281|591725220|FG001|Overall Study|Death|0|||
163824366|NCT03492281|591725221|FG002|Overall Study|Death|1|||
163824367|NCT03492281|591725219|FG000|Overall Study|Captured as Other in Database|8|||
163824368|NCT03492281|591725220|FG001|Overall Study|Captured as Other in Database|6|||
163824369|NCT03492281|591725221|FG002|Overall Study|Captured as Other in Database|3|||
163824370|NCT03342638|591725222|FG000|Overall Study|Withdrawal by Subject|1|||
163824371|NCT03342638|591725223|FG001|Overall Study|Withdrawal by Subject|0|||
163824372|NCT03342638|591725222|FG000|Overall Study|Physician Decision|0|||
163824373|NCT03342638|591725223|FG001|Overall Study|Physician Decision|1|||
163824374|NCT00113568|591725239|FG000|Overall Study|Adverse Event|97|||
163824375|NCT00113568|591725239|FG000|Overall Study|Death|1|||
163824376|NCT00113568|591725239|FG000|Overall Study|Lack of Efficacy|30|||
163824377|NCT00113568|591725239|FG000|Overall Study|Lost to Follow-up|156|||
163824378|NCT00113568|591725239|FG000|Overall Study|Protocol Violation|32|||
163824379|NCT00113568|591725239|FG000|Overall Study|Withdrawal by Subject|117|||
163824380|NCT00113568|591725239|FG000|Overall Study|Other|112|||
163824381|NCT02191267|591725241|FG000|Overall Study|Withdrawal by Subject|1|||
163824382|NCT02191267|591725242|FG001|Overall Study|Withdrawal by Subject|0|||
163824383|NCT02191267|591725243|FG002|Overall Study|Withdrawal by Subject|0|||
163824384|NCT03213158|591725246|FG000|Overall Study|Withdrawal by Subject|1|||
163824385|NCT03213158|591725246|FG000|Overall Study|Physician Decision|2|||
163824386|NCT00587964|591725247|FG000|Overall Study|Withdrawal by Subject|1|||
163824387|NCT00587964|591725247|FG000|Overall Study|Lost to Follow-up|1|||
163824388|NCT00587964|591725247|FG000|Overall Study|Patient found to be ineligible|1|||
163824389|NCT00587964|591725247|FG000|Overall Study|Patient did not receive intervention|5|||
163824390|NCT00587964|591725247|FG000|Overall Study|Progression of Disease|4|||
163824391|NCT01569438|591725249|FG000|Overall Study|Lack of Efficacy|1|||
163824392|NCT01569438|591725250|FG001|Overall Study|Lack of Efficacy|2|||
163824393|NCT01569438|591725249|FG000|Overall Study|Withdrawal by Subject|0|||
163824394|NCT01569438|591725250|FG001|Overall Study|Withdrawal by Subject|3|||
164031799|NCT03024255|592476231|FG000|Overall Study|Protocol Violation|0|||
163824395|NCT01569438|591725249|FG000|Overall Study|Adverse Event|2|||
163824396|NCT01569438|591725250|FG001|Overall Study|Adverse Event|15|||
163824397|NCT01569438|591725249|FG000|Overall Study|Protocol Violation|2|||
163824398|NCT01569438|591725250|FG001|Overall Study|Protocol Violation|0|||
163824399|NCT01569438|591725249|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
163824400|NCT01569438|591725250|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
163824401|NCT01569438|591725249|FG000|Overall Study|Sponsor/Physician decision|1|||
163824402|NCT01569438|591725250|FG001|Overall Study|Sponsor/Physician decision|1|||
163824403|NCT01569438|591725249|FG000|Overall Study|Unable to adhere to study schedule|0|||
163824404|NCT01569438|591725250|FG001|Overall Study|Unable to adhere to study schedule|1|||
163824405|NCT03649230|591725251|FG000|Overall Study|Adverse Event|12|||
163824406|NCT03649230|591725251|FG000|Overall Study|Death|8|||
163824407|NCT03649230|591725251|FG000|Overall Study|Withdrawal by Subject|6|||
163824408|NCT03649230|591725251|FG000|Overall Study|Physician Decision|5|||
163824409|NCT03649230|591725251|FG000|Overall Study|Disease progression|5|||
163824410|NCT03649230|591725251|FG000|Overall Study|Switched to non-HEC|5|||
163824411|NCT03649230|591725251|FG000|Overall Study|Chemotherapy discontinued|4|||
163824412|NCT03649230|591725251|FG000|Overall Study|Received only 3 HEC cycles|4|||
163824413|NCT03649230|591725251|FG000|Overall Study|Screen Failure|3|||
163824414|NCT03649230|591725251|FG000|Overall Study|Patient stopped treatment|2|||
163824415|NCT03649230|591725251|FG000|Overall Study|Protocol Violation|1|||
163824416|NCT03649230|591725251|FG000|Overall Study|Non-compliance|1|||
163824417|NCT03649230|591725251|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
163824418|NCT01693068|591725256|FG000|Randomization Period|On-study|2|||
163824419|NCT01693068|591725257|FG001|Randomization Period|On-study|5|||
163824420|NCT01693068|591725258|FG002|Randomization Period|On-study|0|||
163824421|NCT01693068|591725256|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
163824422|NCT01693068|591725257|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
163824423|NCT01693068|591725258|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
163824424|NCT00617344|591725262|FG000|Overall Study|Serious adverse event|1|||
163824425|NCT00617344|591725263|FG001|Overall Study|Serious adverse event|0|||
163824426|NCT00617344|591725264|FG002|Overall Study|Serious adverse event|0|||
163824427|NCT00617344|591725262|FG000|Overall Study|Other Adverse Event|1|||
163824428|NCT00617344|591725263|FG001|Overall Study|Other Adverse Event|1|||
163824429|NCT00617344|591725264|FG002|Overall Study|Other Adverse Event|0|||
163824430|NCT00617344|591725262|FG000|Overall Study|Protocol Violation|10|||
163824431|NCT00617344|591725263|FG001|Overall Study|Protocol Violation|8|||
163824432|NCT00617344|591725264|FG002|Overall Study|Protocol Violation|5|||
163824433|NCT00617344|591725262|FG000|Overall Study|Lost to Follow-up|5|||
163824434|NCT00617344|591725263|FG001|Overall Study|Lost to Follow-up|4|||
163824435|NCT00617344|591725264|FG002|Overall Study|Lost to Follow-up|1|||
163824436|NCT00617344|591725262|FG000|Overall Study|Withdrawal by Subject|8|||
163824437|NCT00617344|591725263|FG001|Overall Study|Withdrawal by Subject|9|||
163824438|NCT00617344|591725264|FG002|Overall Study|Withdrawal by Subject|2|||
163824439|NCT02747238|591725265|FG000|Overall Study|Lack of Efficacy|0|||
163824440|NCT02747238|591725266|FG001|Overall Study|Lack of Efficacy|1|||
163824441|NCT02747238|591725265|FG000|Overall Study|Data lost|3|||
163824442|NCT02747238|591725266|FG001|Overall Study|Data lost|5|||
163824443|NCT05245864|591725271|FG000|Overall Study|Withdrawal by Subject|1|||
163824444|NCT05245864|591725272|FG001|Overall Study|Withdrawal by Subject|1|||
163824445|NCT01475136|591725273|FG000|Overall Study|Sponsor Decision|0|||
163824446|NCT01475136|591725274|FG001|Overall Study|Sponsor Decision|1|||
163824447|NCT01475136|591725275|FG002|Overall Study|Sponsor Decision|0|||
163824448|NCT01475136|591725276|FG003|Overall Study|Sponsor Decision|0|||
163824449|NCT01475136|591725273|FG000|Overall Study|Entry Criteria Not Met|0|||
163824450|NCT01475136|591725274|FG001|Overall Study|Entry Criteria Not Met|2|||
163824451|NCT01475136|591725275|FG002|Overall Study|Entry Criteria Not Met|3|||
163824452|NCT01475136|591725276|FG003|Overall Study|Entry Criteria Not Met|1|||
163824453|NCT01475136|591725273|FG000|Overall Study|Withdrawal by Subject|0|||
163824454|NCT01475136|591725274|FG001|Overall Study|Withdrawal by Subject|0|||
163824455|NCT01475136|591725275|FG002|Overall Study|Withdrawal by Subject|0|||
163824456|NCT01475136|591725276|FG003|Overall Study|Withdrawal by Subject|2|||
163824457|NCT01475136|591725273|FG000|Overall Study|Adverse Event|1|||
163824458|NCT01475136|591725274|FG001|Overall Study|Adverse Event|0|||
163824459|NCT01475136|591725275|FG002|Overall Study|Adverse Event|0|||
163824460|NCT01475136|591725276|FG003|Overall Study|Adverse Event|1|||
163824461|NCT01475136|591725273|FG000|Overall Study|Death|0|||
163824462|NCT01475136|591725274|FG001|Overall Study|Death|0|||
163824463|NCT01475136|591725275|FG002|Overall Study|Death|0|||
163824464|NCT01475136|591725276|FG003|Overall Study|Death|1|||
163824465|NCT01323530|591727561|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
163824466|NCT01323530|591727562|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163824467|NCT01323530|591727563|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163824468|NCT01323530|591727564|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163824469|NCT01323530|591727565|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163824470|NCT01323530|591727566|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
163920088|NCT01967719|592077706|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
163920089|NCT01967719|592077707|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163824471|NCT01323530|591727567|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
163824472|NCT01323530|591727561|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163824473|NCT01323530|591727562|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163824474|NCT01323530|591727563|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
163824475|NCT01323530|591727564|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163824476|NCT01323530|591727565|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
163920090|NCT01967719|592077708|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
163920091|NCT01967719|592077705|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
163824477|NCT01323530|591727566|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163824478|NCT01323530|591727567|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
163824479|NCT01323530|591727561|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163824480|NCT01323530|591727562|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
163824481|NCT01323530|591727563|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163824482|NCT01323530|591727564|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163824483|NCT01323530|591727565|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
163824484|NCT01323530|591727566|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
163824485|NCT01323530|591727567|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
163824486|NCT01323530|591727561|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163824487|NCT01323530|591727562|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163824488|NCT01323530|591727563|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163824489|NCT01323530|591727564|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163824490|NCT01323530|591727565|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163824491|NCT01323530|591727566|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
163824492|NCT01323530|591727567|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
163824493|NCT01323530|591727561|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163824494|NCT01323530|591727562|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163824495|NCT01323530|591727563|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163824496|NCT01323530|591727564|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163824497|NCT01323530|591727565|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163824498|NCT01323530|591727566|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
163824499|NCT01323530|591727567|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
163824500|NCT01323530|591727561|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163824501|NCT01323530|591727562|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163824502|NCT01323530|591727563|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163824503|NCT01323530|591727564|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163824504|NCT01323530|591727565|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163824505|NCT01323530|591727566|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
163824506|NCT01323530|591727567|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
163824507|NCT01323530|591727561|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163824508|NCT01323530|591727562|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163824509|NCT01323530|591727563|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163824510|NCT01323530|591727564|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163824511|NCT01323530|591727565|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163824512|NCT01323530|591727566|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
163824513|NCT01323530|591727567|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
163824514|NCT01323530|591727561|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163824515|NCT01323530|591727562|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163824516|NCT01323530|591727563|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163824517|NCT01323530|591727564|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163824518|NCT01323530|591727565|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163824519|NCT01323530|591727566|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
163824520|NCT01323530|591727567|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
163824521|NCT01194570|591727570|FG000|Overall Study|Adverse Event|22|||
163824522|NCT01194570|591727571|FG001|Overall Study|Adverse Event|40|||
163824523|NCT01194570|591727570|FG000|Overall Study|Death|6|||
163824524|NCT01194570|591727571|FG001|Overall Study|Death|20|||
163824525|NCT01194570|591727570|FG000|Overall Study|Lack of Efficacy|32|||
163824526|NCT01194570|591727571|FG001|Overall Study|Lack of Efficacy|33|||
163824527|NCT01194570|591727570|FG000|Overall Study|Lost to Follow-up|4|||
163824528|NCT01194570|591727571|FG001|Overall Study|Lost to Follow-up|15|||
163824529|NCT01194570|591727570|FG000|Overall Study|Non-Compliance|2|||
163824530|NCT01194570|591727571|FG001|Overall Study|Non-Compliance|2|||
163824531|NCT01194570|591727570|FG000|Overall Study|Non-Compliance With Study Drug|2|||
163824532|NCT01194570|591727571|FG001|Overall Study|Non-Compliance With Study Drug|2|||
163824533|NCT01194570|591727570|FG000|Overall Study|Other|18|||
163824534|NCT01194570|591727571|FG001|Overall Study|Other|47|||
163824535|NCT01194570|591727570|FG000|Overall Study|Physician Decision|10|||
163824536|NCT01194570|591727571|FG001|Overall Study|Physician Decision|25|||
163824537|NCT01194570|591727570|FG000|Overall Study|Protocol Violation|1|||
163824538|NCT01194570|591727571|FG001|Overall Study|Protocol Violation|2|||
163824539|NCT01194570|591727570|FG000|Overall Study|Study Terminated By Sponsor|0|||
163824540|NCT01194570|591727571|FG001|Overall Study|Study Terminated By Sponsor|1|||
163824541|NCT01194570|591727570|FG000|Overall Study|Withdrawal by Subject|57|||
163824542|NCT01194570|591727571|FG001|Overall Study|Withdrawal by Subject|82|||
163920092|NCT01967719|592077706|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
163920093|NCT01967719|592077707|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
163824543|NCT01194570|591727570|FG000|Overall Study|Pregnancy|1|||
163920094|NCT01967719|592077708|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
163824544|NCT01194570|591727571|FG001|Overall Study|Pregnancy|1|||
163824545|NCT01377480|591727578|FG000|Overall Study|Protocol Violation|0|||
163824546|NCT01377480|591727579|FG001|Overall Study|Protocol Violation|0|||
163824547|NCT01377480|591727580|FG002|Overall Study|Protocol Violation|0|||
163824548|NCT01377480|591727581|FG003|Overall Study|Protocol Violation|4|||
163824549|NCT01377480|591727578|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
163824550|NCT01377480|591727579|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
163824551|NCT01377480|591727580|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
163824552|NCT01377480|591727581|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
163824553|NCT01377480|591727578|FG000|Overall Study|Withdrawal by Subject|0|||
163824554|NCT01377480|591727579|FG001|Overall Study|Withdrawal by Subject|0|||
163824555|NCT01377480|591727580|FG002|Overall Study|Withdrawal by Subject|1|||
163824556|NCT01377480|591727581|FG003|Overall Study|Withdrawal by Subject|0|||
163824557|NCT01377480|591727578|FG000|Overall Study|Serious adverse event|0|||
163824558|NCT01377480|591727579|FG001|Overall Study|Serious adverse event|0|||
163824559|NCT01377480|591727580|FG002|Overall Study|Serious adverse event|1|||
163824560|NCT01377480|591727581|FG003|Overall Study|Serious adverse event|1|||
163824561|NCT01377480|591727578|FG000|Overall Study|Other|0|||
163824562|NCT01377480|591727579|FG001|Overall Study|Other|0|||
163824563|NCT01377480|591727580|FG002|Overall Study|Other|7|||
163824564|NCT01377480|591727581|FG003|Overall Study|Other|6|||
163824565|NCT01735201|591727588|FG000|Overall Study|Adverse Event|1|||
163824566|NCT01735201|591727589|FG001|Overall Study|Adverse Event|1|||
163824567|NCT01735201|591727590|FG002|Overall Study|Adverse Event|0|||
163824568|NCT01735201|591727591|FG003|Overall Study|Adverse Event|1|||
163824569|NCT01735201|591727592|FG004|Overall Study|Adverse Event|1|||
163824570|NCT01735201|591727593|FG005|Overall Study|Adverse Event|3|||
163824571|NCT01735201|591727594|FG006|Overall Study|Adverse Event|2|||
163824572|NCT01735201|591727595|FG007|Overall Study|Adverse Event|1|||
163824573|NCT01735201|591727588|FG000|Overall Study|Personal Reasons|1|||
163824574|NCT01735201|591727589|FG001|Overall Study|Personal Reasons|0|||
163824575|NCT01735201|591727590|FG002|Overall Study|Personal Reasons|0|||
163824576|NCT01735201|591727591|FG003|Overall Study|Personal Reasons|0|||
163824577|NCT01735201|591727592|FG004|Overall Study|Personal Reasons|0|||
163824578|NCT01735201|591727593|FG005|Overall Study|Personal Reasons|0|||
163824579|NCT01735201|591727594|FG006|Overall Study|Personal Reasons|0|||
163824580|NCT01735201|591727595|FG007|Overall Study|Personal Reasons|0|||
163824581|NCT01735201|591727588|FG000|Overall Study|Protocol Violation|1|||
163824582|NCT01735201|591727589|FG001|Overall Study|Protocol Violation|0|||
163824583|NCT01735201|591727590|FG002|Overall Study|Protocol Violation|0|||
163824584|NCT01735201|591727591|FG003|Overall Study|Protocol Violation|0|||
163824585|NCT01735201|591727592|FG004|Overall Study|Protocol Violation|0|||
163824586|NCT01735201|591727593|FG005|Overall Study|Protocol Violation|0|||
163824587|NCT01735201|591727594|FG006|Overall Study|Protocol Violation|0|||
163824588|NCT01735201|591727595|FG007|Overall Study|Protocol Violation|0|||
163824589|NCT01735201|591727588|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163824590|NCT01735201|591727589|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163824591|NCT01735201|591727590|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163824592|NCT01735201|591727591|FG003|Overall Study|Other Miscellaneous Reasons|1|||
163824593|NCT01735201|591727592|FG004|Overall Study|Other Miscellaneous Reasons|0|||
163824594|NCT01735201|591727593|FG005|Overall Study|Other Miscellaneous Reasons|2|||
163824595|NCT01735201|591727594|FG006|Overall Study|Other Miscellaneous Reasons|1|||
163824596|NCT01735201|591727595|FG007|Overall Study|Other Miscellaneous Reasons|1|||
163824597|NCT01203930|591727601|FG000|Overall Study|Disease Progression|0|||
163824598|NCT01203930|591727602|FG001|Overall Study|Disease Progression|4|||
163824599|NCT01203930|591727601|FG000|Overall Study|Death|3|||
163824600|NCT01203930|591727602|FG001|Overall Study|Death|1|||
163824601|NCT01203930|591727601|FG000|Overall Study|Withdrew Consent|1|||
163824602|NCT01203930|591727602|FG001|Overall Study|Withdrew Consent|10|||
163824603|NCT01203930|591727601|FG000|Overall Study|Investigator Request|0|||
163824604|NCT01203930|591727602|FG001|Overall Study|Investigator Request|8|||
163920095|NCT02329223|592077709|FG000|Overall Study|Withdrawal by Subject|1|||
163824605|NCT01203930|591727601|FG000|Overall Study|Study Terminated by Sponsor|0|||
163824606|NCT01203930|591727602|FG001|Overall Study|Study Terminated by Sponsor|12|||
163824607|NCT01203930|591727601|FG000|Overall Study|Poor tolerance of study drug|0|||
163824608|NCT01203930|591727602|FG001|Overall Study|Poor tolerance of study drug|1|||
163824609|NCT01203930|591727601|FG000|Overall Study|Adverse Event|17|||
163824610|NCT01203930|591727602|FG001|Overall Study|Adverse Event|5|||
163920096|NCT02329223|592077710|FG001|Overall Study|Withdrawal by Subject|2|||
163920097|NCT02329223|592077711|FG002|Overall Study|Withdrawal by Subject|5|||
163920098|NCT02329223|592077709|FG000|Overall Study|Physician Decision|0|||
163920099|NCT02329223|592077710|FG001|Overall Study|Physician Decision|0|||
163920100|NCT02329223|592077711|FG002|Overall Study|Physician Decision|1|||
163920101|NCT02329223|592077709|FG000|Overall Study|Adverse Event|0|||
163920102|NCT02329223|592077710|FG001|Overall Study|Adverse Event|1|||
163920103|NCT02329223|592077711|FG002|Overall Study|Adverse Event|0|||
163920104|NCT00651937|592077712|FG000|Overall Study|Withdrawal by Subject|4|||
163920105|NCT00651937|592077713|FG001|Overall Study|Withdrawal by Subject|1|||
164096978|NCT04206332|592718999|FG013|Part C|Withdrawal by Subject|0|||
164096979|NCT04206332|592719000|FG014|Part C|Withdrawal by Subject|2|||
164096980|NCT04206332|592719001|FG015|Part C|Withdrawal by Subject|0|||
164096981|NCT04206332|592719002|FG016|Part C|Withdrawal by Subject|0|||
163824611|NCT02178059|591727603|FG000|Washout|Physician Decision|1|||
163824612|NCT02178059|591727604|FG001|Washout|Physician Decision|0|||
163824613|NCT01266850|591727607|FG000|Overall Study|Lost to Follow-up|19|||
163824614|NCT01266850|591727608|FG001|Overall Study|Lost to Follow-up|19|||
163824615|NCT01266850|591727609|FG002|Overall Study|Lost to Follow-up|13|||
163824616|NCT01266850|591727610|FG003|Overall Study|Lost to Follow-up|13|||
163824617|NCT01266850|591727611|FG004|Overall Study|Lost to Follow-up|12|||
163824618|NCT01266850|591727607|FG000|Overall Study|Withdrawal by Subject|8|||
163824619|NCT01266850|591727608|FG001|Overall Study|Withdrawal by Subject|9|||
163824620|NCT01266850|591727609|FG002|Overall Study|Withdrawal by Subject|6|||
163824621|NCT01266850|591727610|FG003|Overall Study|Withdrawal by Subject|9|||
163824622|NCT01266850|591727611|FG004|Overall Study|Withdrawal by Subject|12|||
163824623|NCT01266850|591727607|FG000|Overall Study|Physician Decision|3|||
163824624|NCT01266850|591727608|FG001|Overall Study|Physician Decision|6|||
163824625|NCT01266850|591727609|FG002|Overall Study|Physician Decision|4|||
163824626|NCT01266850|591727610|FG003|Overall Study|Physician Decision|4|||
163824627|NCT01266850|591727611|FG004|Overall Study|Physician Decision|3|||
163824628|NCT01266850|591727607|FG000|Overall Study|Protocol Violation|0|||
163824629|NCT01266850|591727608|FG001|Overall Study|Protocol Violation|1|||
163824630|NCT01266850|591727609|FG002|Overall Study|Protocol Violation|0|||
163824631|NCT01266850|591727610|FG003|Overall Study|Protocol Violation|1|||
163824632|NCT01266850|591727611|FG004|Overall Study|Protocol Violation|2|||
163824633|NCT01266850|591727607|FG000|Overall Study|Adverse Event|0|||
163824634|NCT01266850|591727608|FG001|Overall Study|Adverse Event|0|||
163824635|NCT01266850|591727609|FG002|Overall Study|Adverse Event|0|||
163824636|NCT01266850|591727610|FG003|Overall Study|Adverse Event|0|||
163824637|NCT01266850|591727611|FG004|Overall Study|Adverse Event|1|||
163824638|NCT01266850|591727607|FG000|Overall Study|Site Closure|0|||
163824639|NCT01266850|591727608|FG001|Overall Study|Site Closure|1|||
163824640|NCT01266850|591727609|FG002|Overall Study|Site Closure|1|||
163824641|NCT01266850|591727610|FG003|Overall Study|Site Closure|1|||
163824642|NCT01266850|591727611|FG004|Overall Study|Site Closure|0|||
163824643|NCT00857207|591727615|FG000|Overall Study|Withdrawal by Subject|13|||
163824644|NCT00857207|591727616|FG001|Overall Study|Withdrawal by Subject|0|||
163824645|NCT00857207|591727615|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
163824646|NCT00857207|591727616|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
163824647|NCT00857207|591727615|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
163824648|NCT00857207|591727616|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
163824649|NCT02030015|591727617|FG000|Overall Study|Withdrawal by Subject|3|||
163824650|NCT02030015|591727617|FG000|Overall Study|Death|13|||
163824651|NCT04098406|591727618|FG000|Overall Study|Adverse Event|2|||
163824652|NCT04098406|591727619|FG001|Overall Study|Adverse Event|1|||
163824653|NCT04098406|591727618|FG000|Overall Study|Withdrawal by Subject|1|||
163824654|NCT04098406|591727619|FG001|Overall Study|Withdrawal by Subject|0|||
163824655|NCT03014674|591727620|FG000|Overall Study|Withdrawal by Subject|1|||
163824656|NCT03014674|591727621|FG001|Overall Study|Withdrawal by Subject|0|||
163824657|NCT03014674|591727622|FG002|Overall Study|Withdrawal by Subject|0|||
163824658|NCT01332227|591727623|FG000|Overall Study|Adverse Event|4|||
163824659|NCT01332227|591727624|FG001|Overall Study|Adverse Event|1|||
163824660|NCT01332227|591727623|FG000|Overall Study|Withdrawal by Subject|5|||
163824661|NCT01332227|591727624|FG001|Overall Study|Withdrawal by Subject|1|||
163824662|NCT01332227|591727623|FG000|Overall Study|Lost to Follow-up|2|||
163824663|NCT01332227|591727624|FG001|Overall Study|Lost to Follow-up|0|||
163824664|NCT01332227|591727623|FG000|Overall Study|Lack of Efficacy|3|||
163824665|NCT01332227|591727624|FG001|Overall Study|Lack of Efficacy|1|||
163824666|NCT01332227|591727623|FG000|Overall Study|Poor compliance/noncompliance|1|||
163824667|NCT01332227|591727624|FG001|Overall Study|Poor compliance/noncompliance|1|||
163824668|NCT01332227|591727623|FG000|Overall Study|Patient moved from area|1|||
163824669|NCT01332227|591727624|FG001|Overall Study|Patient moved from area|0|||
163824670|NCT01332227|591727623|FG000|Overall Study|Patient began prohibited medication|0|||
163824671|NCT01332227|591727624|FG001|Overall Study|Patient began prohibited medication|1|||
163824672|NCT00428090|591727633|FG000|Overall Study|Adverse Event|10|||
164096982|NCT05612724|592719004|FG000|Overall Study|Lost to Follow-up|4|||
164096983|NCT04000815|592719011|FG000|Overall Study|Lost to Follow-up|9|||
163920106|NCT00552513|592077719|FG000|Overall Study|Lost to Follow-up|5|||
164096984|NCT04000815|592719012|FG001|Overall Study|Lost to Follow-up|2|||
163824673|NCT00428090|591727634|FG001|Overall Study|Adverse Event|8|||
163824674|NCT00428090|591727635|FG002|Overall Study|Adverse Event|10|||
163824675|NCT00428090|591727636|FG003|Overall Study|Adverse Event|11|||
163824676|NCT00428090|591727633|FG000|Overall Study|Lost to Follow-up|3|||
163824677|NCT00428090|591727634|FG001|Overall Study|Lost to Follow-up|6|||
163824678|NCT00428090|591727635|FG002|Overall Study|Lost to Follow-up|1|||
164096985|NCT04000815|592719013|FG002|Overall Study|Lost to Follow-up|3|||
163824679|NCT00428090|591727636|FG003|Overall Study|Lost to Follow-up|4|||
163824680|NCT00428090|591727633|FG000|Overall Study|Protocol Violation|3|||
163824681|NCT00428090|591727634|FG001|Overall Study|Protocol Violation|1|||
163824682|NCT00428090|591727635|FG002|Overall Study|Protocol Violation|3|||
163824683|NCT00428090|591727636|FG003|Overall Study|Protocol Violation|3|||
163824684|NCT00428090|591727633|FG000|Overall Study|Withdrawal by Subject|10|||
163824685|NCT00428090|591727634|FG001|Overall Study|Withdrawal by Subject|12|||
163824686|NCT00428090|591727635|FG002|Overall Study|Withdrawal by Subject|15|||
163824687|NCT00428090|591727636|FG003|Overall Study|Withdrawal by Subject|5|||
163824688|NCT00428090|591727633|FG000|Overall Study|Sponsor terminated study|0|||
163824689|NCT00428090|591727634|FG001|Overall Study|Sponsor terminated study|1|||
163824690|NCT00428090|591727635|FG002|Overall Study|Sponsor terminated study|0|||
163824691|NCT00428090|591727636|FG003|Overall Study|Sponsor terminated study|0|||
163824692|NCT00428090|591727633|FG000|Overall Study|Non-compliance|4|||
163824693|NCT00428090|591727634|FG001|Overall Study|Non-compliance|0|||
163824694|NCT00428090|591727635|FG002|Overall Study|Non-compliance|1|||
163824695|NCT00428090|591727636|FG003|Overall Study|Non-compliance|3|||
163824696|NCT00428090|591727633|FG000|Overall Study|Par. did not returned to visit|1|||
163824697|NCT00428090|591727634|FG001|Overall Study|Par. did not returned to visit|0|||
163824698|NCT00428090|591727635|FG002|Overall Study|Par. did not returned to visit|0|||
163824699|NCT00428090|591727636|FG003|Overall Study|Par. did not returned to visit|1|||
163824700|NCT00428090|591727633|FG000|Overall Study|Follow-Up visit not possible|1|||
163824701|NCT00428090|591727634|FG001|Overall Study|Follow-Up visit not possible|0|||
163824702|NCT00428090|591727635|FG002|Overall Study|Follow-Up visit not possible|0|||
163824703|NCT00428090|591727636|FG003|Overall Study|Follow-Up visit not possible|0|||
163824704|NCT00428090|591727633|FG000|Overall Study|Prohibited medication used for SAE|1|||
163824705|NCT00428090|591727634|FG001|Overall Study|Prohibited medication used for SAE|0|||
163824706|NCT00428090|591727635|FG002|Overall Study|Prohibited medication used for SAE|0|||
163824707|NCT00428090|591727636|FG003|Overall Study|Prohibited medication used for SAE|0|||
163824708|NCT00428090|591727633|FG000|Overall Study|Death of par.|1|||
163824709|NCT00428090|591727634|FG001|Overall Study|Death of par.|0|||
163824710|NCT00428090|591727635|FG002|Overall Study|Death of par.|1|||
163824711|NCT00428090|591727636|FG003|Overall Study|Death of par.|0|||
163824712|NCT00428090|591727633|FG000|Overall Study|Visit 7 exceed the visit window|0|||
163824713|NCT00428090|591727634|FG001|Overall Study|Visit 7 exceed the visit window|1|||
163824714|NCT00428090|591727635|FG002|Overall Study|Visit 7 exceed the visit window|0|||
163824715|NCT00428090|591727636|FG003|Overall Study|Visit 7 exceed the visit window|0|||
163824716|NCT00428090|591727633|FG000|Overall Study|Medical monitor terminated par.|0|||
163824717|NCT00428090|591727634|FG001|Overall Study|Medical monitor terminated par.|1|||
163824718|NCT00428090|591727635|FG002|Overall Study|Medical monitor terminated par.|0|||
163824719|NCT00428090|591727636|FG003|Overall Study|Medical monitor terminated par.|0|||
163824720|NCT00428090|591727633|FG000|Overall Study|Mental status of par. was|0|||
163824721|NCT00428090|591727634|FG001|Overall Study|Mental status of par. was|1|||
163824722|NCT00428090|591727635|FG002|Overall Study|Mental status of par. was|0|||
163824723|NCT00428090|591727636|FG003|Overall Study|Mental status of par. was|0|||
163824724|NCT00428090|591727633|FG000|Overall Study|Worsening of AD|0|||
163824725|NCT00428090|591727634|FG001|Overall Study|Worsening of AD|0|||
163824726|NCT00428090|591727635|FG002|Overall Study|Worsening of AD|1|||
163824727|NCT00428090|591727636|FG003|Overall Study|Worsening of AD|0|||
163824728|NCT00428090|591727633|FG000|Overall Study|Excluded for concerning QTc value|0|||
163824729|NCT00428090|591727634|FG001|Overall Study|Excluded for concerning QTc value|0|||
163824730|NCT00428090|591727635|FG002|Overall Study|Excluded for concerning QTc value|1|||
163824731|NCT00428090|591727636|FG003|Overall Study|Excluded for concerning QTc value|0|||
163824732|NCT00428090|591727633|FG000|Overall Study|Insufficient AD documentation|0|||
163824733|NCT00428090|591727634|FG001|Overall Study|Insufficient AD documentation|0|||
163824734|NCT00428090|591727635|FG002|Overall Study|Insufficient AD documentation|1|||
163824735|NCT00428090|591727636|FG003|Overall Study|Insufficient AD documentation|0|||
163824736|NCT00428090|591727633|FG000|Overall Study|High MMSE scores|0|||
163824737|NCT00428090|591727634|FG001|Overall Study|High MMSE scores|0|||
163824738|NCT00428090|591727635|FG002|Overall Study|High MMSE scores|1|||
163824739|NCT00428090|591727636|FG003|Overall Study|High MMSE scores|0|||
163824740|NCT00428090|591727633|FG000|Overall Study|Deterioration of cognitive status|0|||
163824741|NCT00428090|591727634|FG001|Overall Study|Deterioration of cognitive status|0|||
163824742|NCT00428090|591727635|FG002|Overall Study|Deterioration of cognitive status|1|||
163824743|NCT00428090|591727636|FG003|Overall Study|Deterioration of cognitive status|0|||
163824744|NCT00428090|591727633|FG000|Overall Study|Serious adverse event|0|||
163824745|NCT00428090|591727634|FG001|Overall Study|Serious adverse event|0|||
163824746|NCT00428090|591727635|FG002|Overall Study|Serious adverse event|1|||
163824747|NCT00428090|591727636|FG003|Overall Study|Serious adverse event|0|||
163824748|NCT00428090|591727633|FG000|Overall Study|Excluded for heart insufficiency|0|||
163920107|NCT00552513|592077720|FG001|Overall Study|Lost to Follow-up|1|||
163920108|NCT02720185|592077723|FG000|Overall Study|Lost to Follow-up|1|||
163920109|NCT02507687|592077726|FG000|Overall Study|Adverse Event|3|||
163920110|NCT02507687|592077727|FG001|Overall Study|Adverse Event|2|||
163920111|NCT02507687|592077728|FG002|Overall Study|Adverse Event|2|||
163824749|NCT00428090|591727634|FG001|Overall Study|Excluded for heart insufficiency|0|||
163824750|NCT00428090|591727635|FG002|Overall Study|Excluded for heart insufficiency|1|||
163824751|NCT00428090|591727636|FG003|Overall Study|Excluded for heart insufficiency|0|||
163824752|NCT00428090|591727633|FG000|Overall Study|Raised Creatinine Value|0|||
163824753|NCT00428090|591727634|FG001|Overall Study|Raised Creatinine Value|0|||
163824754|NCT00428090|591727635|FG002|Overall Study|Raised Creatinine Value|0|||
163824755|NCT00428090|591727636|FG003|Overall Study|Raised Creatinine Value|1|||
163824756|NCT03409666|591727637|FG000|Overall Study|Physician Decision|0|||
163824757|NCT03409666|591727638|FG001|Overall Study|Physician Decision|1|||
163824758|NCT03409666|591727637|FG000|Overall Study|Protocol Violation|0|||
163824759|NCT03409666|591727638|FG001|Overall Study|Protocol Violation|3|||
163824760|NCT02366910|591727642|FG000|Overall Study|Withdrawal by Subject|2|||
163824761|NCT02366910|591727642|FG000|Overall Study|Screen Failure|3|||
163824762|NCT02623322|591727643|FG000|Overall Study|Lost to Follow-up|2|||
163824763|NCT02623322|591727644|FG001|Overall Study|Lost to Follow-up|1|||
163824764|NCT02623322|591727645|FG002|Overall Study|Lost to Follow-up|0|||
163824765|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
163824766|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
163824767|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
163824768|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
163824769|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
163824770|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
163824771|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
163824772|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
163824773|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
163824774|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
163824775|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
163824776|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
163824777|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Death|6|||
163824778|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Death|3|||
163824779|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Death|0|||
163824780|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Death|1|||
163824781|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Death|1|||
163824782|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Death|0|||
163824783|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
163824784|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
163824785|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
163824786|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
163824787|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
163824788|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
163824789|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163824790|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
163824791|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
163824792|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163824793|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163824794|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
163824795|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
163824796|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
163824797|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
163824798|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
163824799|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
163824800|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
163824801|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
163824802|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
163824803|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
163824804|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
163824805|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
163824806|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
164031800|NCT03024255|592476232|FG001|Overall Study|Protocol Violation|0|||
164031801|NCT03024255|592476233|FG002|Overall Study|Protocol Violation|2|||
164031802|NCT03024255|592476234|FG003|Overall Study|Protocol Violation|0|||
164031803|NCT03024255|592476231|FG000|Overall Study|Lost to Follow-up|1|||
163824807|NCT03104699|591727646|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
163824808|NCT03104699|591727647|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
163824809|NCT03104699|591727648|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
163824810|NCT03104699|591727649|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
163824811|NCT03104699|591727650|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
163824812|NCT03104699|591727651|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
163824813|NCT03104699|591727646|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163824814|NCT03104699|591727647|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163824815|NCT03104699|591727648|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163824816|NCT03104699|591727649|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
164031804|NCT03024255|592476232|FG001|Overall Study|Lost to Follow-up|2|||
163824817|NCT03104699|591727650|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
163824818|NCT03104699|591727651|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
163824819|NCT03104699|591727646|FG000|Phase 2: Dose Expansion|Death|0|||
163824820|NCT03104699|591727647|FG001|Phase 2: Dose Expansion|Death|0|||
163824821|NCT03104699|591727648|FG002|Phase 2: Dose Expansion|Death|0|||
163824822|NCT03104699|591727649|FG003|Phase 2: Dose Expansion|Death|0|||
163824823|NCT03104699|591727650|FG004|Phase 2: Dose Expansion|Death|0|||
163824824|NCT03104699|591727651|FG005|Phase 2: Dose Expansion|Death|107|||
163824825|NCT03104699|591727646|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163824826|NCT03104699|591727647|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163824827|NCT03104699|591727648|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163824828|NCT03104699|591727649|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163824829|NCT03104699|591727650|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
163824830|NCT03104699|591727651|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
163824831|NCT03104699|591727646|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163824832|NCT03104699|591727647|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163824833|NCT03104699|591727648|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163824834|NCT03104699|591727649|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163824835|NCT03104699|591727650|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
163824836|NCT03104699|591727651|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
163824837|NCT03104699|591727646|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163824838|NCT03104699|591727647|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163824839|NCT03104699|591727648|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163824840|NCT03104699|591727649|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163824841|NCT03104699|591727650|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
163824842|NCT03104699|591727651|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
163824843|NCT03104699|591727646|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
163920112|NCT02507687|592077729|FG003|Overall Study|Adverse Event|2|||
163920113|NCT02507687|592077726|FG000|Overall Study|Withdrawal by Subject|1|||
163824844|NCT03104699|591727647|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
163920114|NCT02507687|592077727|FG001|Overall Study|Withdrawal by Subject|4|||
163920115|NCT02507687|592077728|FG002|Overall Study|Withdrawal by Subject|6|||
163920116|NCT02507687|592077729|FG003|Overall Study|Withdrawal by Subject|6|||
163920117|NCT02507687|592077726|FG000|Overall Study|Protocol Violation|1|||
163920118|NCT02507687|592077727|FG001|Overall Study|Protocol Violation|0|||
163920119|NCT02507687|592077728|FG002|Overall Study|Protocol Violation|2|||
163920120|NCT02507687|592077729|FG003|Overall Study|Protocol Violation|0|||
163920121|NCT02507687|592077726|FG000|Overall Study|Lost to Follow-up|0|||
163920122|NCT02507687|592077727|FG001|Overall Study|Lost to Follow-up|0|||
163920123|NCT02507687|592077728|FG002|Overall Study|Lost to Follow-up|2|||
163920124|NCT02507687|592077729|FG003|Overall Study|Lost to Follow-up|1|||
163920125|NCT02507687|592077726|FG000|Overall Study|Screen Failure|0|||
163920126|NCT02507687|592077727|FG001|Overall Study|Screen Failure|0|||
163920127|NCT02507687|592077728|FG002|Overall Study|Screen Failure|1|||
163920128|NCT02507687|592077729|FG003|Overall Study|Screen Failure|0|||
163920129|NCT02507687|592077726|FG000|Overall Study|Other, Not Specified|0|||
163920130|NCT02507687|592077727|FG001|Overall Study|Other, Not Specified|0|||
164031805|NCT03024255|592476233|FG002|Overall Study|Lost to Follow-up|1|||
164031806|NCT03024255|592476234|FG003|Overall Study|Lost to Follow-up|1|||
164031807|NCT03024255|592476231|FG000|Overall Study|Lack of Efficacy|1|||
164031808|NCT03024255|592476232|FG001|Overall Study|Lack of Efficacy|0|||
164031809|NCT03024255|592476233|FG002|Overall Study|Lack of Efficacy|0|||
163824845|NCT03104699|591727648|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
163824846|NCT03104699|591727649|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
163824847|NCT03104699|591727650|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
163824848|NCT03104699|591727651|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
163824849|NCT02462876|591727652|FG000|Overall Study|Death|3|||
163824850|NCT02462876|591727652|FG000|Overall Study|Lost to Follow-up|7|||
164031810|NCT03024255|592476234|FG003|Overall Study|Lack of Efficacy|0|||
164031811|NCT03024255|592476231|FG000|Overall Study|Protocol Noncompliance|1|||
164031812|NCT03024255|592476232|FG001|Overall Study|Protocol Noncompliance|1|||
164031813|NCT03024255|592476233|FG002|Overall Study|Protocol Noncompliance|0|||
163824851|NCT02462876|591727652|FG000|Overall Study|Surgical Bypass|9|||
163824852|NCT02462876|591727652|FG000|Overall Study|Amputation Above the Metatarsals|1|||
163824853|NCT02462876|591727652|FG000|Overall Study|36 months follow-up visit missed|1|||
163824854|NCT02462876|591727652|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
163824855|NCT02462876|591727652|FG000|Overall Study|Patient did not come back to the vascular department|1|||
163920131|NCT02507687|592077728|FG002|Overall Study|Other, Not Specified|2|||
163920132|NCT02507687|592077729|FG003|Overall Study|Other, Not Specified|4|||
163920133|NCT00275301|592077730|FG000|Overall Study|Adverse Event|5|||
163920134|NCT04357964|592077731|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
163920135|NCT04357964|592077732|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
163824856|NCT02462876|591727652|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
163824857|NCT02462876|591727652|FG000|Overall Study|Patient refused to come back|1|||
163824858|NCT02462876|591727652|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
163824859|NCT02462876|591727652|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
163824860|NCT01786512|591727653|FG000|Overall Study|Lost to Follow-up|0|||
163824861|NCT01786512|591727654|FG001|Overall Study|Lost to Follow-up|0|||
163824862|NCT01786512|591727655|FG002|Overall Study|Lost to Follow-up|0|||
163824863|NCT01786512|591727656|FG003|Overall Study|Lost to Follow-up|0|||
163824864|NCT01786512|591727657|FG004|Overall Study|Lost to Follow-up|0|||
163824865|NCT01786512|591727658|FG005|Overall Study|Lost to Follow-up|0|||
163824866|NCT01786512|591727659|FG006|Overall Study|Lost to Follow-up|0|||
163824867|NCT01786512|591727660|FG007|Overall Study|Lost to Follow-up|0|||
163824868|NCT01786512|591727661|FG008|Overall Study|Lost to Follow-up|0|||
163824869|NCT01786512|591727662|FG009|Overall Study|Lost to Follow-up|1|||
163824870|NCT01786512|591727663|FG010|Overall Study|Lost to Follow-up|0|||
163824871|NCT01786512|591727653|FG000|Overall Study|Decision by sponsor|0|||
163824872|NCT01786512|591727654|FG001|Overall Study|Decision by sponsor|0|||
163824873|NCT01786512|591727655|FG002|Overall Study|Decision by sponsor|0|||
163824874|NCT01786512|591727656|FG003|Overall Study|Decision by sponsor|0|||
163824875|NCT01786512|591727657|FG004|Overall Study|Decision by sponsor|0|||
163824876|NCT01786512|591727658|FG005|Overall Study|Decision by sponsor|0|||
163824877|NCT01786512|591727659|FG006|Overall Study|Decision by sponsor|0|||
163824878|NCT01786512|591727660|FG007|Overall Study|Decision by sponsor|0|||
163824879|NCT01786512|591727661|FG008|Overall Study|Decision by sponsor|0|||
163824880|NCT01786512|591727662|FG009|Overall Study|Decision by sponsor|0|||
163824881|NCT01786512|591727663|FG010|Overall Study|Decision by sponsor|2|||
163824882|NCT01786512|591727653|FG000|Overall Study|Withdrawal by Subject|0|||
163824883|NCT01786512|591727654|FG001|Overall Study|Withdrawal by Subject|1|||
163824884|NCT01786512|591727655|FG002|Overall Study|Withdrawal by Subject|0|||
163824885|NCT01786512|591727656|FG003|Overall Study|Withdrawal by Subject|0|||
163824886|NCT01786512|591727657|FG004|Overall Study|Withdrawal by Subject|0|||
163824887|NCT01786512|591727658|FG005|Overall Study|Withdrawal by Subject|0|||
163824888|NCT01786512|591727659|FG006|Overall Study|Withdrawal by Subject|1|||
163824889|NCT01786512|591727660|FG007|Overall Study|Withdrawal by Subject|0|||
163824890|NCT01786512|591727661|FG008|Overall Study|Withdrawal by Subject|0|||
163824891|NCT01786512|591727662|FG009|Overall Study|Withdrawal by Subject|3|||
163824892|NCT01786512|591727663|FG010|Overall Study|Withdrawal by Subject|7|||
163824893|NCT01786512|591727653|FG000|Overall Study|Death|0|||
163824894|NCT01786512|591727654|FG001|Overall Study|Death|0|||
163824895|NCT01786512|591727655|FG002|Overall Study|Death|0|||
163824896|NCT01786512|591727656|FG003|Overall Study|Death|0|||
163824897|NCT01786512|591727657|FG004|Overall Study|Death|0|||
163824898|NCT01786512|591727658|FG005|Overall Study|Death|0|||
163824899|NCT01786512|591727659|FG006|Overall Study|Death|0|||
163824900|NCT01786512|591727660|FG007|Overall Study|Death|0|||
163824901|NCT01786512|591727661|FG008|Overall Study|Death|4|||
163824902|NCT01786512|591727662|FG009|Overall Study|Death|1|||
163824903|NCT01786512|591727663|FG010|Overall Study|Death|3|||
163824904|NCT02450331|591727664|FG000|Overall Study|Death|162|||
163824905|NCT02450331|591727665|FG001|Overall Study|Death|171|||
163824906|NCT02450331|591727664|FG000|Overall Study|Lost to Follow-up|14|||
163824907|NCT02450331|591727665|FG001|Overall Study|Lost to Follow-up|12|||
163824908|NCT02450331|591727664|FG000|Overall Study|Withdrawal by Subject|55|||
163824909|NCT02450331|591727665|FG001|Overall Study|Withdrawal by Subject|44|||
163824910|NCT02450331|591727664|FG000|Overall Study|Non-specified other|1|||
163824911|NCT02450331|591727665|FG001|Overall Study|Non-specified other|1|||
163824912|NCT02080871|591727666|FG000|Overall Study|Death|1|||
163824913|NCT02080871|591727666|FG000|Overall Study|Lost to Follow-up|1|||
163824914|NCT00234052|591727667|FG000|Treatment|Withdrawal by Subject|3|||
163824915|NCT00234052|591727667|FG000|Treatment|Adverse Event|5|||
163824916|NCT00234052|591727667|FG000|Treatment|Death|2|||
163824917|NCT00234052|591727667|FG000|Treatment|Progressive Disease|11|||
163824918|NCT00234052|591727667|FG000|Follow-up for 5 Years|Death|41|||
163824919|NCT00234052|591727667|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
163824920|NCT00234052|591727667|FG000|Follow-up for 5 Years|Other|7|||
163824921|NCT01410474|591727668|FG000|Overall Study|Withdrawal by Subject|0|||
163824922|NCT01410474|591727669|FG001|Overall Study|Withdrawal by Subject|1|||
163824923|NCT02428296|591727670|FG000|Overall Study|Adverse Event|7|||
163824924|NCT02428296|591727670|FG000|Overall Study|Withdrawal by Subject|2|||
163824925|NCT04493931|591727672|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
163824926|NCT04493931|591727673|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163824927|NCT04493931|591727674|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163824928|NCT04493931|591727675|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163824929|NCT04493931|591727676|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163824930|NCT04493931|591727677|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163824931|NCT04493931|591727678|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
163824932|NCT04493931|591727672|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163824933|NCT04493931|591727673|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
163824934|NCT04493931|591727674|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163824935|NCT04493931|591727675|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163824936|NCT04493931|591727676|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163824937|NCT04493931|591727677|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163824938|NCT04493931|591727678|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
163824939|NCT04493931|591727672|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163824940|NCT04493931|591727673|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
163824941|NCT04493931|591727674|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163824942|NCT04493931|591727675|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163824943|NCT04493931|591727676|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163824944|NCT04493931|591727677|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163824945|NCT04493931|591727678|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
163824946|NCT04493931|591727672|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163824947|NCT04493931|591727673|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163824948|NCT04493931|591727674|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
163824949|NCT04493931|591727675|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163824950|NCT04493931|591727676|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163824951|NCT04493931|591727677|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163824952|NCT04493931|591727678|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
163824953|NCT00420199|591727680|FG000|Overall Study|Participant no longer met study criteria|1|||
163824954|NCT00420199|591727681|FG001|Overall Study|Participant no longer met study criteria|0|||
163824955|NCT00754338|591727682|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163824956|NCT00754338|591727683|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
163824957|NCT00754338|591727684|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
163824958|NCT00754338|591727685|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163824959|NCT00754338|591727682|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163824960|NCT00754338|591727683|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
163824961|NCT00754338|591727684|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
163824962|NCT00754338|591727685|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
163824963|NCT00831779|591727686|FG000|Overall Study|Lost to Follow-up|1|||
163824964|NCT00831779|591727687|FG001|Overall Study|Lost to Follow-up|0|||
163824965|NCT00831779|591727686|FG000|Overall Study|No longer met criteria|0|||
163824966|NCT00831779|591727687|FG001|Overall Study|No longer met criteria|1|||
163824967|NCT04020341|591727688|FG000|Overall Study|Adverse Event|8|||
163824968|NCT04020341|591727689|FG001|Overall Study|Adverse Event|6|||
163824969|NCT04020341|591727688|FG000|Overall Study|Lost to Follow-up|8|||
163824970|NCT04020341|591727689|FG001|Overall Study|Lost to Follow-up|2|||
163824971|NCT04020341|591727688|FG000|Overall Study|Withdrawal by Subject|16|||
163824972|NCT04020341|591727689|FG001|Overall Study|Withdrawal by Subject|16|||
163824973|NCT04020341|591727688|FG000|Overall Study|Participant not able to swallow the tablet|1|||
163824974|NCT04020341|591727689|FG001|Overall Study|Participant not able to swallow the tablet|0|||
163824975|NCT04020341|591727688|FG000|Overall Study|Physician Decision|0|||
163824976|NCT04020341|591727689|FG001|Overall Study|Physician Decision|2|||
163824977|NCT04020341|591727688|FG000|Overall Study|Protocol Deviation|0|||
163824978|NCT04020341|591727689|FG001|Overall Study|Protocol Deviation|2|||
163824979|NCT04528069|591727690|FG000|Overall Study|Adverse Event|1|||
163824980|NCT04528069|591727690|FG000|Overall Study|Lost to Follow-up|1|||
163824981|NCT04528069|591727690|FG000|Overall Study|Patient Unable to Come|1|||
163824982|NCT04528069|591727690|FG000|Overall Study|Patient Unable to Attend|1|||
163824983|NCT01814371|591727692|FG000|Overall Study|Lost to Follow-up|30|||
163824984|NCT01814371|591727693|FG001|Overall Study|Lost to Follow-up|27|||
163824985|NCT04683926|591727694|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
163824986|NCT04683926|591727695|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
163824987|NCT04683926|591727696|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
163824988|NCT04683926|591727697|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
163824989|NCT01692782|591727699|FG000|Overall Study|Adverse Event|12|||
163824990|NCT01692782|591727700|FG001|Overall Study|Adverse Event|32|||
163824991|NCT01692782|591727701|FG002|Overall Study|Adverse Event|2|||
163824992|NCT01692782|591727699|FG000|Overall Study|Lack of Efficacy|1|||
163824993|NCT01692782|591727700|FG001|Overall Study|Lack of Efficacy|2|||
163824994|NCT01692782|591727701|FG002|Overall Study|Lack of Efficacy|0|||
163824995|NCT01692782|591727699|FG000|Overall Study|Lost to Follow-up|2|||
163824996|NCT01692782|591727700|FG001|Overall Study|Lost to Follow-up|7|||
163824997|NCT01692782|591727701|FG002|Overall Study|Lost to Follow-up|1|||
163824998|NCT01692782|591727699|FG000|Overall Study|Pregnancy|1|||
163824999|NCT01692782|591727700|FG001|Overall Study|Pregnancy|0|||
163825000|NCT01692782|591727701|FG002|Overall Study|Pregnancy|0|||
163825001|NCT01692782|591727699|FG000|Overall Study|Protocol Violation|1|||
164031814|NCT03024255|592476234|FG003|Overall Study|Protocol Noncompliance|1|||
164031815|NCT00868166|592476238|FG000|Overall Study|Death|58|||
163825002|NCT01692782|591727700|FG001|Overall Study|Protocol Violation|0|||
163825003|NCT01692782|591727701|FG002|Overall Study|Protocol Violation|2|||
163825004|NCT01692782|591727699|FG000|Overall Study|Non-complance with study drug|0|||
163825005|NCT01692782|591727700|FG001|Overall Study|Non-complance with study drug|4|||
163825006|NCT01692782|591727701|FG002|Overall Study|Non-complance with study drug|1|||
163825007|NCT01692782|591727699|FG000|Overall Study|Non-compliant with study visits|0|||
163825008|NCT01692782|591727700|FG001|Overall Study|Non-compliant with study visits|0|||
163825009|NCT01692782|591727701|FG002|Overall Study|Non-compliant with study visits|1|||
163825010|NCT01692782|591727699|FG000|Overall Study|SAE not related to study drug|0|||
163825011|NCT01692782|591727700|FG001|Overall Study|SAE not related to study drug|1|||
163825012|NCT01692782|591727701|FG002|Overall Study|SAE not related to study drug|0|||
163825013|NCT01692782|591727699|FG000|Overall Study|Withdrawal by Subject|3|||
163825014|NCT01692782|591727700|FG001|Overall Study|Withdrawal by Subject|10|||
163825015|NCT01692782|591727701|FG002|Overall Study|Withdrawal by Subject|3|||
163825016|NCT00952367|591727710|FG000|Overall Study|Withdrawal by Subject|2|||
163825017|NCT00952367|591727710|FG000|Overall Study|Noncoordination|1|||
163825018|NCT00952367|591727710|FG000|Overall Study|Protocol Violation|3|||
163825019|NCT03205371|591727717|FG000|Overall Study|Withdrawal by Subject|4|||
163825020|NCT03205371|591727718|FG001|Overall Study|Withdrawal by Subject|1|||
163825021|NCT03205371|591727719|FG002|Overall Study|Withdrawal by Subject|0|||
163825022|NCT03205371|591727720|FG003|Overall Study|Withdrawal by Subject|0|||
163825023|NCT03205371|591727721|FG004|Overall Study|Withdrawal by Subject|0|||
163825024|NCT03205371|591727722|FG005|Overall Study|Withdrawal by Subject|0|||
163825025|NCT03205371|591727723|FG006|Overall Study|Withdrawal by Subject|4|||
163825026|NCT03205371|591727724|FG007|Overall Study|Withdrawal by Subject|0|||
163825027|NCT03205371|591727725|FG008|Overall Study|Withdrawal by Subject|2|||
163825028|NCT03205371|591727726|FG009|Overall Study|Withdrawal by Subject|0|||
163825029|NCT03205371|591727727|FG010|Overall Study|Withdrawal by Subject|0|||
163825030|NCT03205371|591727728|FG011|Overall Study|Withdrawal by Subject|1|||
163825031|NCT03205371|591727717|FG000|Overall Study|Lost to Follow-up|0|||
163825032|NCT03205371|591727718|FG001|Overall Study|Lost to Follow-up|0|||
163825033|NCT03205371|591727719|FG002|Overall Study|Lost to Follow-up|0|||
163825034|NCT03205371|591727720|FG003|Overall Study|Lost to Follow-up|0|||
163825035|NCT03205371|591727721|FG004|Overall Study|Lost to Follow-up|0|||
163825036|NCT03205371|591727722|FG005|Overall Study|Lost to Follow-up|0|||
163825037|NCT03205371|591727723|FG006|Overall Study|Lost to Follow-up|5|||
163825038|NCT03205371|591727724|FG007|Overall Study|Lost to Follow-up|2|||
163825039|NCT03205371|591727725|FG008|Overall Study|Lost to Follow-up|3|||
163825040|NCT03205371|591727726|FG009|Overall Study|Lost to Follow-up|0|||
163825041|NCT03205371|591727727|FG010|Overall Study|Lost to Follow-up|0|||
163825042|NCT03205371|591727728|FG011|Overall Study|Lost to Follow-up|0|||
163825043|NCT03205371|591727717|FG000|Overall Study|Protocol Violation|0|||
163825044|NCT03205371|591727718|FG001|Overall Study|Protocol Violation|0|||
163825045|NCT03205371|591727719|FG002|Overall Study|Protocol Violation|0|||
163825046|NCT03205371|591727720|FG003|Overall Study|Protocol Violation|0|||
163825047|NCT03205371|591727721|FG004|Overall Study|Protocol Violation|0|||
163825048|NCT03205371|591727722|FG005|Overall Study|Protocol Violation|0|||
163825049|NCT03205371|591727723|FG006|Overall Study|Protocol Violation|1|||
163825050|NCT03205371|591727724|FG007|Overall Study|Protocol Violation|0|||
163825051|NCT03205371|591727725|FG008|Overall Study|Protocol Violation|0|||
163825052|NCT03205371|591727726|FG009|Overall Study|Protocol Violation|0|||
163825053|NCT03205371|591727727|FG010|Overall Study|Protocol Violation|0|||
163825054|NCT03205371|591727728|FG011|Overall Study|Protocol Violation|0|||
163825055|NCT03205371|591727717|FG000|Overall Study|Adverse Event|0|||
163825056|NCT03205371|591727718|FG001|Overall Study|Adverse Event|0|||
163825057|NCT03205371|591727719|FG002|Overall Study|Adverse Event|0|||
163825058|NCT03205371|591727720|FG003|Overall Study|Adverse Event|0|||
163825059|NCT03205371|591727721|FG004|Overall Study|Adverse Event|0|||
163825060|NCT03205371|591727722|FG005|Overall Study|Adverse Event|0|||
163825061|NCT03205371|591727723|FG006|Overall Study|Adverse Event|0|||
163825062|NCT03205371|591727724|FG007|Overall Study|Adverse Event|1|||
163825063|NCT03205371|591727725|FG008|Overall Study|Adverse Event|0|||
163825064|NCT03205371|591727726|FG009|Overall Study|Adverse Event|0|||
163825065|NCT03205371|591727727|FG010|Overall Study|Adverse Event|0|||
163825066|NCT03205371|591727728|FG011|Overall Study|Adverse Event|0|||
163825067|NCT02835339|591727729|FG000|Overall Study|Did not receive allocated intervention|13|||
163825068|NCT02835339|591727730|FG001|Overall Study|Did not receive allocated intervention|16|||
163825069|NCT00736645|591727736|FG000|Overall Study|Adverse Event|0|||
163825070|NCT00736645|591727737|FG001|Overall Study|Adverse Event|2|||
163825071|NCT00736645|591727738|FG002|Overall Study|Adverse Event|0|||
163825072|NCT00736645|591727739|FG003|Overall Study|Adverse Event|0|||
163825073|NCT02300220|591727743|FG000|Overall Study|Lost to Follow-up|1|||
163825074|NCT02300220|591727744|FG001|Overall Study|Lost to Follow-up|2|||
163825075|NCT02300220|591727743|FG000|Overall Study|Death|1|||
163825076|NCT02300220|591727744|FG001|Overall Study|Death|1|||
163825077|NCT02300220|591727743|FG000|Overall Study|Adverse Event|1|||
163825078|NCT02300220|591727744|FG001|Overall Study|Adverse Event|1|||
163825079|NCT02300220|591727743|FG000|Overall Study|Protocol Violation|1|||
163825080|NCT02300220|591727744|FG001|Overall Study|Protocol Violation|0|||
163825081|NCT02300220|591727743|FG000|Overall Study|Withdrawal by Subject|0|||
163825082|NCT02300220|591727744|FG001|Overall Study|Withdrawal by Subject|2|||
163825083|NCT02300220|591727743|FG000|Overall Study|Did not tolerate IMP|0|||
163825084|NCT02300220|591727744|FG001|Overall Study|Did not tolerate IMP|1|||
163825085|NCT04322682|591727745|FG000|Overall Study|Withdrawal by Subject|33|||
163825086|NCT04322682|591727746|FG001|Overall Study|Withdrawal by Subject|47|||
163825087|NCT04322682|591727745|FG000|Overall Study|Death|5|||
163825088|NCT04322682|591727746|FG001|Overall Study|Death|9|||
163825089|NCT04322682|591727745|FG000|Overall Study|Lost to Follow-up|4|||
163825090|NCT04322682|591727746|FG001|Overall Study|Lost to Follow-up|8|||
163825091|NCT04322682|591727745|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
163825092|NCT04322682|591727746|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
163825093|NCT02238379|591727747|FG000|Overall Study|Lost to Follow-up|1|||
163825094|NCT02238379|591727748|FG001|Overall Study|Lost to Follow-up|0|||
163825095|NCT04123067|591727749|FG000|Overall Study|Lost to Follow-up|0|||
163825096|NCT04123067|591727750|FG001|Overall Study|Lost to Follow-up|1|||
163825097|NCT03085485|591727751|FG000|Overall Study|Death|1|||
163825098|NCT03085485|591727752|FG001|Overall Study|Death|0|||
163825099|NCT03085485|591727751|FG000|Overall Study|Lost to Follow-up|1|||
163825100|NCT03085485|591727752|FG001|Overall Study|Lost to Follow-up|0|||
163825101|NCT00605280|591727753|FG000|Year 1|Protocol Violation|0|||
163825102|NCT00605280|591727754|FG001|Year 1|Protocol Violation|0|||
163825103|NCT00605280|591727755|FG002|Year 1|Protocol Violation|0|||
163825104|NCT00605280|591727756|FG003|Year 1|Protocol Violation|1|||
163825105|NCT00605280|591727753|FG000|Year 1|Adverse Event|3|||
163825106|NCT00605280|591727754|FG001|Year 1|Adverse Event|1|||
163825107|NCT00605280|591727755|FG002|Year 1|Adverse Event|1|||
163825108|NCT00605280|591727756|FG003|Year 1|Adverse Event|5|||
163825109|NCT00605280|591727753|FG000|Year 1|Physician Decision|7|||
163825110|NCT00605280|591727754|FG001|Year 1|Physician Decision|4|||
163825111|NCT00605280|591727755|FG002|Year 1|Physician Decision|0|||
163825112|NCT00605280|591727756|FG003|Year 1|Physician Decision|6|||
163825113|NCT00605280|591727753|FG000|Year 1|Withdrawal by Subject|2|||
163825114|NCT00605280|591727754|FG001|Year 1|Withdrawal by Subject|4|||
163825115|NCT00605280|591727755|FG002|Year 1|Withdrawal by Subject|0|||
163825116|NCT00605280|591727756|FG003|Year 1|Withdrawal by Subject|4|||
163825117|NCT00605280|591727753|FG000|Year 1|Other|2|||
163825118|NCT00605280|591727754|FG001|Year 1|Other|1|||
163825119|NCT00605280|591727755|FG002|Year 1|Other|0|||
163825120|NCT00605280|591727756|FG003|Year 1|Other|1|||
163825121|NCT00605280|591727753|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
163825122|NCT00605280|591727754|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
163825123|NCT00605280|591727755|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
163825124|NCT00605280|591727756|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
163825125|NCT00605280|591727753|FG000|Year 2|Adverse Event|4|||
163825126|NCT00605280|591727754|FG001|Year 2|Adverse Event|0|||
163825127|NCT00605280|591727755|FG002|Year 2|Adverse Event|2|||
163825128|NCT00605280|591727756|FG003|Year 2|Adverse Event|4|||
163825129|NCT00605280|591727753|FG000|Year 2|Physician Decision|11|||
163825130|NCT00605280|591727754|FG001|Year 2|Physician Decision|6|||
163825131|NCT00605280|591727755|FG002|Year 2|Physician Decision|4|||
163825132|NCT00605280|591727756|FG003|Year 2|Physician Decision|11|||
163825133|NCT00605280|591727753|FG000|Year 2|Withdrawal by Subject|4|||
163825134|NCT00605280|591727754|FG001|Year 2|Withdrawal by Subject|0|||
163825135|NCT00605280|591727755|FG002|Year 2|Withdrawal by Subject|0|||
163825136|NCT00605280|591727756|FG003|Year 2|Withdrawal by Subject|4|||
163825137|NCT00605280|591727753|FG000|Year 2|Other|1|||
163825138|NCT00605280|591727754|FG001|Year 2|Other|0|||
163825139|NCT00605280|591727755|FG002|Year 2|Other|0|||
163825140|NCT00605280|591727756|FG003|Year 2|Other|1|||
163825141|NCT00605280|591727753|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
163825142|NCT00605280|591727754|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
163825143|NCT00605280|591727755|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
163825144|NCT00605280|591727756|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
163825145|NCT00605280|591727753|FG000|Year 3 Extension|Adverse Event|2|||
163825146|NCT00605280|591727754|FG001|Year 3 Extension|Adverse Event|0|||
163825147|NCT00605280|591727755|FG002|Year 3 Extension|Adverse Event|0|||
163825148|NCT00605280|591727756|FG003|Year 3 Extension|Adverse Event|2|||
163825149|NCT00605280|591727753|FG000|Year 3 Extension|Physician Decision|0|||
163825150|NCT00605280|591727754|FG001|Year 3 Extension|Physician Decision|0|||
163825151|NCT00605280|591727755|FG002|Year 3 Extension|Physician Decision|0|||
163825152|NCT00605280|591727756|FG003|Year 3 Extension|Physician Decision|2|||
164031816|NCT00868166|592476239|FG001|Overall Study|Death|65|||
164031817|NCT00868166|592476238|FG000|Overall Study|Withdrawal by Subject|33|||
164031818|NCT00868166|592476239|FG001|Overall Study|Withdrawal by Subject|25|||
163825153|NCT00605280|591727753|FG000|Year 3 Extension|Withdrawal by Subject|2|||
163825154|NCT00605280|591727754|FG001|Year 3 Extension|Withdrawal by Subject|0|||
163825155|NCT00605280|591727755|FG002|Year 3 Extension|Withdrawal by Subject|0|||
163825156|NCT00605280|591727756|FG003|Year 3 Extension|Withdrawal by Subject|5|||
163825157|NCT00605280|591727753|FG000|Year 3 Extension|Other|2|||
163825158|NCT00605280|591727754|FG001|Year 3 Extension|Other|0|||
163825159|NCT00605280|591727755|FG002|Year 3 Extension|Other|0|||
163825160|NCT00605280|591727756|FG003|Year 3 Extension|Other|0|||
163825161|NCT00605280|591727753|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
163825162|NCT00605280|591727754|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
163825163|NCT00605280|591727755|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
163825164|NCT00605280|591727756|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
163825165|NCT02137369|591727762|FG000|Overall Study|Withdrawal by Subject|3|||
163825166|NCT02137369|591727763|FG001|Overall Study|Withdrawal by Subject|2|||
163825167|NCT02137369|591727762|FG000|Overall Study|Adverse Event|2|||
163825168|NCT02137369|591727763|FG001|Overall Study|Adverse Event|0|||
163825169|NCT02137369|591727762|FG000|Overall Study|Lost to Follow-up|1|||
163825170|NCT02137369|591727763|FG001|Overall Study|Lost to Follow-up|0|||
163825171|NCT02137369|591727762|FG000|Overall Study|Moved away|2|||
163825172|NCT02137369|591727763|FG001|Overall Study|Moved away|0|||
163825173|NCT01329029|591727776|FG000|Overall Study|Withdrawal by Subject|117|||
163825174|NCT01329029|591727777|FG001|Overall Study|Withdrawal by Subject|87|||
163825175|NCT01329029|591727776|FG000|Overall Study|Adverse Event|82|||
163825176|NCT01329029|591727777|FG001|Overall Study|Adverse Event|29|||
163825177|NCT01329029|591727776|FG000|Overall Study|Death|16|||
163825178|NCT01329029|591727777|FG001|Overall Study|Death|19|||
163825179|NCT01329029|591727776|FG000|Overall Study|Other|14|||
163825180|NCT01329029|591727777|FG001|Overall Study|Other|20|||
163825181|NCT01329029|591727776|FG000|Overall Study|COPD Exacerbation|11|||
163825182|NCT01329029|591727777|FG001|Overall Study|COPD Exacerbation|18|||
163825183|NCT01329029|591727776|FG000|Overall Study|Physician Decision|16|||
163825184|NCT01329029|591727777|FG001|Overall Study|Physician Decision|13|||
163825185|NCT01329029|591727776|FG000|Overall Study|Lost to Follow-up|8|||
163825186|NCT01329029|591727777|FG001|Overall Study|Lost to Follow-up|5|||
163825187|NCT01329029|591727776|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
163825188|NCT01329029|591727777|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
163825189|NCT00680407|591727790|FG000|Overall Study|Lost to Follow-up|3|||
163825190|NCT00680407|591727791|FG001|Overall Study|Lost to Follow-up|3|||
163825191|NCT00680407|591727792|FG002|Overall Study|Lost to Follow-up|1|||
163825192|NCT00680407|591727790|FG000|Overall Study|Withdrawal by Subject|5|||
163825193|NCT00680407|591727791|FG001|Overall Study|Withdrawal by Subject|2|||
163825194|NCT00680407|591727792|FG002|Overall Study|Withdrawal by Subject|2|||
163825195|NCT04128293|591730437|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163825196|NCT04128293|591730438|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163825197|NCT04128293|591730439|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163825198|NCT04128293|591730440|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
163825199|NCT00514943|591730443|FG000|Stage 1|Progressive disease|4|||
163825200|NCT00514943|591730444|FG001|Stage 1|Progressive disease|8|||
163825201|NCT00514943|591730443|FG000|Stage 1|Other Adverse Event|16|||
163825202|NCT00514943|591730444|FG001|Stage 1|Other Adverse Event|6|||
163825203|NCT00514943|591730443|FG000|Stage 1|Not treated|1|||
163825204|NCT00514943|591730444|FG001|Stage 1|Not treated|2|||
163825205|NCT00514943|591730443|FG000|Stage 1|Patient refused to continue study meds|8|||
163825206|NCT00514943|591730444|FG001|Stage 1|Patient refused to continue study meds|3|||
163825207|NCT00514943|591730443|FG000|Stage 1|Other than stated above|1|||
163825208|NCT00514943|591730444|FG001|Stage 1|Other than stated above|7|||
163825209|NCT00514943|591730443|FG000|Stage 2|Progressive disease|27|||
163825210|NCT00514943|591730444|FG001|Stage 2|Progressive disease|24|||
163825211|NCT00514943|591730443|FG000|Stage 2|Other Adverse Event|3|||
163825212|NCT00514943|591730444|FG001|Stage 2|Other Adverse Event|10|||
163825213|NCT00514943|591730443|FG000|Stage 2|Patient refused to continue study meds|2|||
163825214|NCT00514943|591730444|FG001|Stage 2|Patient refused to continue study meds|0|||
163825215|NCT00514943|591730443|FG000|Stage 2|Other than stated above|0|||
163825216|NCT00514943|591730444|FG001|Stage 2|Other than stated above|2|||
163825217|NCT00499031|591730445|FG000|Overall Study|Improper pre-protocol treatment|1|||
163825218|NCT00499031|591730445|FG000|Overall Study|Required test not done|1|||
163825219|NCT00499031|591730445|FG000|Overall Study|Never treated|1|||
163825220|NCT02001194|591730450|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
163825221|NCT02001194|591730451|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
163825222|NCT02001194|591730452|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
163825223|NCT02001194|591730453|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
163920136|NCT04357964|592077731|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
163825224|NCT02001194|591730450|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
163920137|NCT04357964|592077732|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
163920138|NCT04357964|592077731|FG000|Overall Study|Adipose sample was insufficient quality|0|||
163920139|NCT04357964|592077732|FG001|Overall Study|Adipose sample was insufficient quality|1|||
163920140|NCT00733226|592077733|FG000|Overall Study|Withdrawal by Subject|1|||
163825225|NCT02001194|591730451|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
163825226|NCT02001194|591730452|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
163825227|NCT02001194|591730453|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
164031819|NCT00868166|592476238|FG000|Overall Study|Protocol Violation|1|||
164031820|NCT00868166|592476239|FG001|Overall Study|Protocol Violation|0|||
164031821|NCT00868166|592476238|FG000|Overall Study|Lost to Follow-up|1|||
164031822|NCT00868166|592476239|FG001|Overall Study|Lost to Follow-up|3|||
164031823|NCT00868166|592476238|FG000|Overall Study|Adverse Event|9|||
164031824|NCT00868166|592476239|FG001|Overall Study|Adverse Event|10|||
164031825|NCT00868166|592476238|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
164031826|NCT00868166|592476239|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
164031827|NCT00868166|592476238|FG000|Overall Study|Non-compliance with IMP|1|||
164031828|NCT00868166|592476239|FG001|Overall Study|Non-compliance with IMP|1|||
164031829|NCT01797445|592476245|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
164031830|NCT01797445|592476246|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
164031831|NCT01797445|592476245|FG000|Double-Blind Phase|Adverse Event|3|||
164031832|NCT01797445|592476246|FG001|Double-Blind Phase|Adverse Event|0|||
164031833|NCT01797445|592476245|FG000|Double-Blind Phase|Death|5|||
164031834|NCT01797445|592476246|FG001|Double-Blind Phase|Death|4|||
164031835|NCT01797445|592476245|FG000|Double-Blind Phase|Pregnancy|0|||
164031836|NCT01797445|592476246|FG001|Double-Blind Phase|Pregnancy|1|||
164031837|NCT01797445|592476245|FG000|Double-Blind Phase|Lack of Efficacy|1|||
164031838|NCT01797445|592476246|FG001|Double-Blind Phase|Lack of Efficacy|2|||
164031839|NCT01797445|592476245|FG000|Double-Blind Phase|Investigator's Discretion|15|||
164031840|NCT01797445|592476246|FG001|Double-Blind Phase|Investigator's Discretion|17|||
164031841|NCT01797445|592476245|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
164031842|NCT01797445|592476246|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
164031843|NCT01797445|592476245|FG000|Double-Blind Phase|Protocol Violation|0|||
164031844|NCT01797445|592476246|FG001|Double-Blind Phase|Protocol Violation|1|||
164031845|NCT01797445|592476245|FG000|Double-Blind Phase|Withdrew Consent|20|||
164031846|NCT01797445|592476246|FG001|Double-Blind Phase|Withdrew Consent|35|||
164031847|NCT01797445|592476245|FG000|Double-Blind Phase|Lost to Follow-up|34|||
164031848|NCT01797445|592476246|FG001|Double-Blind Phase|Lost to Follow-up|26|||
164031849|NCT01797445|592476245|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
164031850|NCT01797445|592476246|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
164031851|NCT00168064|592476247|FG000|Overall Study|Adverse Event|26|||
164031852|NCT00168064|592476248|FG001|Overall Study|Adverse Event|22|||
164031853|NCT00168064|592476247|FG000|Overall Study|Withdrawal by Subject|3|||
164031854|NCT00168064|592476248|FG001|Overall Study|Withdrawal by Subject|4|||
164031855|NCT00168064|592476247|FG000|Overall Study|Lack of Efficacy|4|||
164031856|NCT00168064|592476248|FG001|Overall Study|Lack of Efficacy|4|||
164031857|NCT00168064|592476247|FG000|Overall Study|Lost to Follow-up|4|||
164031858|NCT00168064|592476248|FG001|Overall Study|Lost to Follow-up|3|||
164031859|NCT00168064|592476247|FG000|Overall Study|Non-compliance|2|||
164031860|NCT00168064|592476248|FG001|Overall Study|Non-compliance|3|||
164031861|NCT00168064|592476247|FG000|Overall Study|Concurrent Illness|4|||
164031862|NCT00168064|592476248|FG001|Overall Study|Concurrent Illness|3|||
164031863|NCT00168064|592476247|FG000|Overall Study|Subject's Best interest|2|||
164031864|NCT00168064|592476248|FG001|Overall Study|Subject's Best interest|2|||
164031865|NCT00168064|592476247|FG000|Overall Study|Various|4|||
164031866|NCT00168064|592476248|FG001|Overall Study|Various|3|||
164031867|NCT00776555|592476249|FG000|Overall Study|Study terminated|3|||
164031868|NCT00776555|592476250|FG001|Overall Study|Study terminated|0|||
164031869|NCT03483116|592476254|FG000|Overall Study|Adverse Event|0|||
164031870|NCT03483116|592476255|FG001|Overall Study|Adverse Event|1|||
164031871|NCT03483116|592476256|FG002|Overall Study|Adverse Event|0|||
164031872|NCT03483116|592476257|FG003|Overall Study|Adverse Event|1|||
164031873|NCT03483116|592476254|FG000|Overall Study|Protocol Violation|1|||
164031874|NCT03483116|592476255|FG001|Overall Study|Protocol Violation|0|||
164031875|NCT03483116|592476256|FG002|Overall Study|Protocol Violation|0|||
164031876|NCT03483116|592476257|FG003|Overall Study|Protocol Violation|7|||
164031877|NCT03483116|592476254|FG000|Overall Study|Lost to Follow-up|9|||
164031878|NCT03483116|592476255|FG001|Overall Study|Lost to Follow-up|4|||
164031879|NCT03483116|592476256|FG002|Overall Study|Lost to Follow-up|9|||
164031880|NCT03483116|592476257|FG003|Overall Study|Lost to Follow-up|5|||
164031881|NCT03483116|592476254|FG000|Overall Study|Death|1|||
164031882|NCT03483116|592476255|FG001|Overall Study|Death|0|||
164031883|NCT03483116|592476256|FG002|Overall Study|Death|2|||
164031884|NCT03483116|592476257|FG003|Overall Study|Death|1|||
164031885|NCT03483116|592476254|FG000|Overall Study|Withdrawal by Subject|14|||
164031886|NCT03483116|592476255|FG001|Overall Study|Withdrawal by Subject|16|||
164031887|NCT03483116|592476256|FG002|Overall Study|Withdrawal by Subject|14|||
164031888|NCT03483116|592476257|FG003|Overall Study|Withdrawal by Subject|16|||
164031889|NCT03483116|592476254|FG000|Overall Study|Unknown other reason|3|||
164031890|NCT03483116|592476255|FG001|Overall Study|Unknown other reason|2|||
164031891|NCT03483116|592476256|FG002|Overall Study|Unknown other reason|1|||
164096986|NCT04000815|592719011|FG000|Overall Study|Withdrawal by Subject|4|||
164031892|NCT03483116|592476257|FG003|Overall Study|Unknown other reason|1|||
164031893|NCT01181102|592476258|FG000|Overall Study|Adverse Event|28|||
164031894|NCT01181102|592476259|FG001|Overall Study|Adverse Event|26|||
164031895|NCT01181102|592476258|FG000|Overall Study|Lack of Efficacy|3|||
164031896|NCT01181102|592476259|FG001|Overall Study|Lack of Efficacy|1|||
163825228|NCT01699022|591730458|FG000|Overall Study|Early discontinuation from the study|3|||
164031897|NCT01181102|592476258|FG000|Overall Study|Lost to Follow-up|2|||
163825229|NCT03284788|591730459|FG000|Overall Study|Withdrawal by Subject|2|||
163825230|NCT04539821|591730460|FG000|Overall Study|Withdrawal by Subject|2|||
163825231|NCT04539821|591730460|FG000|Overall Study|continued care with their physician|20|||
163825232|NCT04539821|591730460|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
163825233|NCT00605293|591730461|FG000|Overall Study|Death|2|||
163825234|NCT00605293|591730462|FG001|Overall Study|Death|1|||
163825235|NCT00605293|591730461|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163825236|NCT00605293|591730462|FG001|Overall Study|Insufficient Therapeutic Response|0|||
163825237|NCT00605293|591730461|FG000|Overall Study|Adverse Event|1|||
163825238|NCT00605293|591730462|FG001|Overall Study|Adverse Event|0|||
163825239|NCT00605293|591730461|FG000|Overall Study|Holidays Dialysis Out|1|||
163825240|NCT00605293|591730462|FG001|Overall Study|Holidays Dialysis Out|0|||
163825241|NCT00605293|591730461|FG000|Overall Study|Blood Transfusion|7|||
163825242|NCT00605293|591730462|FG001|Overall Study|Blood Transfusion|1|||
163825243|NCT00605293|591730461|FG000|Overall Study|Renal Transplantation|3|||
163825244|NCT00605293|591730462|FG001|Overall Study|Renal Transplantation|1|||
163825245|NCT00605293|591730461|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
163825246|NCT00605293|591730462|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
163825247|NCT00605293|591730461|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
163825248|NCT00605293|591730462|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
163825249|NCT00605293|591730461|FG000|Overall Study|Principal Investigator Decision|0|||
163825250|NCT00605293|591730462|FG001|Overall Study|Principal Investigator Decision|1|||
163825251|NCT03581981|591730463|FG000|Overall Study|Withdrawal by Subject|12|||
163825252|NCT03581981|591730464|FG001|Overall Study|Withdrawal by Subject|13|||
163825253|NCT03581981|591730463|FG000|Overall Study|Physician Decision|1|||
163825254|NCT03581981|591730464|FG001|Overall Study|Physician Decision|2|||
163825255|NCT03581981|591730463|FG000|Overall Study|Lost to Follow-up|0|||
163825256|NCT03581981|591730464|FG001|Overall Study|Lost to Follow-up|4|||
163825257|NCT00781391|591730465|FG000|Overall Study|never received study drug|24|||
163825258|NCT00781391|591730466|FG001|Overall Study|never received study drug|23|||
163825259|NCT00781391|591730467|FG002|Overall Study|never received study drug|32|||
163825260|NCT00781391|591730465|FG000|Overall Study|Protocol Violation|19|||
163825261|NCT00781391|591730466|FG001|Overall Study|Protocol Violation|17|||
163825262|NCT00781391|591730467|FG002|Overall Study|Protocol Violation|20|||
163825263|NCT00781391|591730465|FG000|Overall Study|Death|789|||
163825264|NCT00781391|591730466|FG001|Overall Study|Death|730|||
163825265|NCT00781391|591730467|FG002|Overall Study|Death|706|||
163825266|NCT00781391|591730465|FG000|Overall Study|Withdrawal by Subject|47|||
163825267|NCT00781391|591730466|FG001|Overall Study|Withdrawal by Subject|37|||
163825268|NCT00781391|591730467|FG002|Overall Study|Withdrawal by Subject|25|||
163825269|NCT00781391|591730465|FG000|Overall Study|Lost to Follow-up|0|||
163825270|NCT00781391|591730466|FG001|Overall Study|Lost to Follow-up|0|||
163825271|NCT00781391|591730467|FG002|Overall Study|Lost to Follow-up|1|||
163825272|NCT01984684|591730468|FG000|Overall Study|Lost to Follow-up|25|||
163825273|NCT01984684|591730469|FG001|Overall Study|Lost to Follow-up|24|||
163825274|NCT01984684|591730468|FG000|Overall Study|Adverse Event|8|||
163825275|NCT01984684|591730469|FG001|Overall Study|Adverse Event|12|||
163825276|NCT01984684|591730468|FG000|Overall Study|Withdrawal by Subject|9|||
163825277|NCT01984684|591730469|FG001|Overall Study|Withdrawal by Subject|9|||
163825278|NCT01984684|591730468|FG000|Overall Study|Lack of Efficacy|3|||
163825279|NCT01984684|591730469|FG001|Overall Study|Lack of Efficacy|6|||
163825280|NCT01984684|591730468|FG000|Overall Study|Physician Decision|4|||
163825281|NCT01984684|591730469|FG001|Overall Study|Physician Decision|2|||
163825282|NCT01984684|591730468|FG000|Overall Study|Protocol Violation|4|||
163825283|NCT01984684|591730469|FG001|Overall Study|Protocol Violation|2|||
163825284|NCT01984684|591730468|FG000|Overall Study|Death|0|||
163825285|NCT01984684|591730469|FG001|Overall Study|Death|1|||
163825286|NCT01984684|591730468|FG000|Overall Study|Noncompliance with study drug|2|||
163825287|NCT01984684|591730469|FG001|Overall Study|Noncompliance with study drug|1|||
163825288|NCT01984684|591730468|FG000|Overall Study|Subject incarcerated|1|||
163825289|NCT01984684|591730469|FG001|Overall Study|Subject incarcerated|0|||
163825290|NCT01984684|591730468|FG000|Overall Study|Study drug not available at site|1|||
163825291|NCT01984684|591730469|FG001|Overall Study|Study drug not available at site|1|||
163825292|NCT01984684|591730468|FG000|Overall Study|Subject had inadequate IV access|0|||
163825293|NCT01984684|591730469|FG001|Overall Study|Subject had inadequate IV access|1|||
163825294|NCT01077544|591730477|FG000|Overall Study|New Cancer Therapy|3|||
164031898|NCT01181102|592476259|FG001|Overall Study|Lost to Follow-up|0|||
164031899|NCT01181102|592476258|FG000|Overall Study|Physician Decision|3|||
163825295|NCT01077544|591730478|FG001|Overall Study|New Cancer Therapy|3|||
163825296|NCT01077544|591730477|FG000|Overall Study|Adverse Event|0|||
163825297|NCT01077544|591730478|FG001|Overall Study|Adverse Event|1|||
163825298|NCT01077544|591730477|FG000|Overall Study|Disease Progression|0|||
163825299|NCT01077544|591730478|FG001|Overall Study|Disease Progression|1|||
163825300|NCT00689221|591730479|FG000|Overall Study|Ongoing at cut-off date|39|||
163825301|NCT00689221|591730480|FG001|Overall Study|Ongoing at cut-off date|36|||
163920141|NCT00733226|592077734|FG001|Overall Study|Withdrawal by Subject|0|||
163920142|NCT00733226|592077733|FG000|Overall Study|Lost to Follow-up|2|||
163920143|NCT00733226|592077734|FG001|Overall Study|Lost to Follow-up|0|||
163920144|NCT00733226|592077733|FG000|Overall Study|moved to another place|2|||
163920145|NCT00733226|592077734|FG001|Overall Study|moved to another place|0|||
163920146|NCT00349622|592077741|FG000|Overall Study|Death|168|||
163920147|NCT00349622|592077742|FG001|Overall Study|Death|86|||
163920148|NCT00349622|592077741|FG000|Overall Study|Lost to Follow-up|5|||
163920149|NCT00349622|592077742|FG001|Overall Study|Lost to Follow-up|1|||
163920150|NCT00349622|592077741|FG000|Overall Study|Withdrawal by Subject|5|||
163920151|NCT00349622|592077742|FG001|Overall Study|Withdrawal by Subject|9|||
163920152|NCT03296566|592077745|FG000|Overall Study|Lost to Follow-up|19|||
163920153|NCT03296566|592077746|FG001|Overall Study|Lost to Follow-up|46|||
163920154|NCT03296566|592077745|FG000|Overall Study|Withdrawal by Subject|0|||
163920155|NCT03296566|592077746|FG001|Overall Study|Withdrawal by Subject|3|||
163920156|NCT03511378|592077750|FG000|Overall Study|Withdrawal by Subject|2|||
163920157|NCT03511378|592077751|FG001|Overall Study|Withdrawal by Subject|2|||
163920158|NCT03511378|592077750|FG000|Overall Study|Patient not coming or schedule visit|1|||
163920159|NCT03511378|592077751|FG001|Overall Study|Patient not coming or schedule visit|0|||
163920160|NCT01503515|592077754|FG000|Overall Study|Adverse Event|4|||
163920161|NCT01503515|592077755|FG001|Overall Study|Adverse Event|5|||
163920162|NCT01503515|592077754|FG000|Overall Study|Death|0|||
163920163|NCT01503515|592077755|FG001|Overall Study|Death|1|||
163920164|NCT01503515|592077754|FG000|Overall Study|Physician Decision|14|||
163920165|NCT01503515|592077755|FG001|Overall Study|Physician Decision|23|||
163920166|NCT01503515|592077754|FG000|Overall Study|Withdrawal by Subject|0|||
163920167|NCT01503515|592077755|FG001|Overall Study|Withdrawal by Subject|1|||
163920168|NCT01503515|592077754|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
163920169|NCT01503515|592077755|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
163920170|NCT01503515|592077754|FG000|Overall Study|Ineligible|1|||
163920171|NCT01503515|592077755|FG001|Overall Study|Ineligible|1|||
163920172|NCT01350102|592077756|FG000|Overall Study|Adverse Event|0|||
163920173|NCT01350102|592077757|FG001|Overall Study|Adverse Event|0|||
163920174|NCT01350102|592077758|FG002|Overall Study|Adverse Event|1|||
163920175|NCT01350102|592077759|FG003|Overall Study|Adverse Event|0|||
163920176|NCT00550771|592077760|FG000|Overall Study|Adverse Event|11|||
163920177|NCT00550771|592077761|FG001|Overall Study|Adverse Event|3|||
163920178|NCT00550771|592077760|FG000|Overall Study|Discontinued for study-related reasons|0|||
163920179|NCT00550771|592077761|FG001|Overall Study|Discontinued for study-related reasons|1|||
163920180|NCT00550771|592077760|FG000|Overall Study|Physician Decision|2|||
164031900|NCT01181102|592476259|FG001|Overall Study|Physician Decision|1|||
164031901|NCT01181102|592476258|FG000|Overall Study|Protocol Violation|5|||
164031902|NCT01181102|592476259|FG001|Overall Study|Protocol Violation|6|||
163825302|NCT03182868|591730481|FG000|Overall Study|Protocol Violation|3|||
163825303|NCT03182868|591730482|FG001|Overall Study|Protocol Violation|0|||
163825304|NCT03182868|591730483|FG002|Overall Study|Protocol Violation|4|||
163825305|NCT03182868|591730484|FG003|Overall Study|Protocol Violation|1|||
163825306|NCT03182868|591730485|FG004|Overall Study|Protocol Violation|8|||
163825307|NCT00262821|591730486|FG000|Overall Study|Ineligible - wrong stage|0|||
163825308|NCT00262821|591730487|FG001|Overall Study|Ineligible - wrong stage|3|||
163825309|NCT00262821|591730486|FG000|Overall Study|Ineligible - wrong cell type|2|||
163825310|NCT00262821|591730487|FG001|Overall Study|Ineligible - wrong cell type|2|||
163825311|NCT00262821|591730486|FG000|Overall Study|Ineligible - wrong primary|0|||
163825312|NCT00262821|591730487|FG001|Overall Study|Ineligible - wrong primary|1|||
163825313|NCT00262821|591730486|FG000|Overall Study|Ineligible - inadequate pathology|1|||
163825314|NCT00262821|591730487|FG001|Overall Study|Ineligible - inadequate pathology|3|||
163825315|NCT00262821|591730486|FG000|Overall Study|Ineligible - elevated creatinine|0|||
163825316|NCT00262821|591730487|FG001|Overall Study|Ineligible - elevated creatinine|2|||
163825317|NCT00262821|591730486|FG000|Overall Study|Ineligible - required test not done|1|||
163825318|NCT00262821|591730487|FG001|Overall Study|Ineligible - required test not done|4|||
163825319|NCT00262821|591730486|FG000|Overall Study|Inevaluable - inadequate data|0|||
163825320|NCT00262821|591730487|FG001|Overall Study|Inevaluable - inadequate data|4|||
163825321|NCT01777854|591730488|FG000|Overall Study|Physician Decision|3|||
163825322|NCT01777854|591730489|FG001|Overall Study|Physician Decision|3|||
163825323|NCT00295022|591730490|FG000|Overall Study|Adverse Event|1|||
163920181|NCT00550771|592077761|FG001|Overall Study|Physician Decision|0|||
163920182|NCT00550771|592077760|FG000|Overall Study|Withdrawal by Subject|0|||
163920183|NCT00550771|592077761|FG001|Overall Study|Withdrawal by Subject|1|||
163920184|NCT00550771|592077760|FG000|Overall Study|Protocol Violation|4|||
163920185|NCT00550771|592077761|FG001|Overall Study|Protocol Violation|5|||
163920186|NCT03022578|592077765|FG000|Overall Study|Adverse Event|1|||
163920187|NCT03022578|592077765|FG000|Overall Study|Lack of Efficacy|2|||
163920188|NCT03022578|592077765|FG000|Overall Study|Withdrawal by Subject|1|||
163920189|NCT03681353|592077766|FG000|Overall Study|Lost to Follow-up|2|||
163920190|NCT03681353|592077766|FG000|Overall Study|Withdrawal by Subject|3|||
163920191|NCT03681353|592077766|FG000|Overall Study|withdrawn by PI|2|||
163920192|NCT00726388|592077769|FG000|Overall Study|Withdrawal by Subject|5|||
164096987|NCT04000815|592719012|FG001|Overall Study|Withdrawal by Subject|3|||
164096988|NCT04000815|592719013|FG002|Overall Study|Withdrawal by Subject|2|||
164096989|NCT04000815|592719011|FG000|Overall Study|Right ovarian cyst occured|1|||
164096990|NCT04000815|592719012|FG001|Overall Study|Right ovarian cyst occured|0|||
164096991|NCT04000815|592719013|FG002|Overall Study|Right ovarian cyst occured|0|||
164096992|NCT04000815|592719011|FG000|Overall Study|Hypertension occured on follow up|0|||
164096993|NCT04000815|592719012|FG001|Overall Study|Hypertension occured on follow up|0|||
164096994|NCT04000815|592719013|FG002|Overall Study|Hypertension occured on follow up|2|||
164096995|NCT00239577|592719014|FG000|Primary Phase|Adverse Event|0|||
164096996|NCT00239577|592719015|FG001|Primary Phase|Adverse Event|0|||
164096997|NCT00239577|592719016|FG002|Primary Phase|Adverse Event|1|||
164096998|NCT00239577|592719017|FG003|Primary Phase|Adverse Event|0|||
164096999|NCT00239577|592719014|FG000|Primary Phase|Other|5|||
164097000|NCT00239577|592719015|FG001|Primary Phase|Other|3|||
164097001|NCT00239577|592719016|FG002|Primary Phase|Other|2|||
164097002|NCT00239577|592719017|FG003|Primary Phase|Other|0|||
164097003|NCT01034358|592719020|FG000|Overall Study|Withdrawal by Subject|1|||
164097004|NCT01034358|592719020|FG000|Overall Study|Protocol Violation|1|||
164097005|NCT00377260|592719023|FG000|Overall Study|Lost to Follow-up|0|||
164097006|NCT00377260|592719024|FG001|Overall Study|Lost to Follow-up|1|||
164097007|NCT00377260|592719023|FG000|Overall Study|Withdrawal by Subject|2|||
164097008|NCT00377260|592719024|FG001|Overall Study|Withdrawal by Subject|4|||
164097009|NCT01617668|592719025|FG000|Overall Study|Adverse Event|7|||
164097010|NCT01617668|592719026|FG001|Overall Study|Adverse Event|0|||
164097011|NCT01617668|592719027|FG002|Overall Study|Adverse Event|12|||
164097012|NCT01617668|592719028|FG003|Overall Study|Adverse Event|5|||
164097013|NCT01617668|592719025|FG000|Overall Study|Physician Decision|1|||
164097014|NCT01617668|592719026|FG001|Overall Study|Physician Decision|2|||
164097015|NCT01617668|592719027|FG002|Overall Study|Physician Decision|3|||
164097016|NCT01617668|592719028|FG003|Overall Study|Physician Decision|0|||
164097017|NCT01617668|592719025|FG000|Overall Study|Progressive Disease|4|||
164097018|NCT01617668|592719026|FG001|Overall Study|Progressive Disease|4|||
164097019|NCT01617668|592719027|FG002|Overall Study|Progressive Disease|6|||
164097020|NCT01617668|592719028|FG003|Overall Study|Progressive Disease|9|||
164097021|NCT01617668|592719025|FG000|Overall Study|Subject/guardian decision|1|||
164097022|NCT01617668|592719026|FG001|Overall Study|Subject/guardian decision|3|||
164097023|NCT01617668|592719027|FG002|Overall Study|Subject/guardian decision|2|||
164097024|NCT01617668|592719028|FG003|Overall Study|Subject/guardian decision|1|||
164097025|NCT02017964|592719029|FG000|Overall Study|Patient deemed ineligible|1|||
164097026|NCT02300103|592719032|FG000|Overall Study|Lack of Efficacy|3|||
164097027|NCT02300103|592719032|FG000|Overall Study|Protocol Violation|1|||
164031903|NCT01181102|592476258|FG000|Overall Study|Withdrawal by Subject|10|||
164031904|NCT01181102|592476259|FG001|Overall Study|Withdrawal by Subject|12|||
164031905|NCT00239837|592476264|FG000|Overall Study|Lost to Follow-up|3|||
164031906|NCT00239837|592476265|FG001|Overall Study|Lost to Follow-up|7|||
164031907|NCT01838590|592476266|FG000|Overall Study|Lack of Efficacy|12|||
164031908|NCT01838590|592476267|FG001|Overall Study|Lack of Efficacy|4|||
164031909|NCT01838590|592476266|FG000|Overall Study|Lost to Follow-up|0|||
164031910|NCT01838590|592476267|FG001|Overall Study|Lost to Follow-up|1|||
164031911|NCT04685499|592476268|FG000|Overall Study|Study Terminated Early|1|||
164031912|NCT02802878|592476269|FG000|Overall Study|Withdrawal by Subject|3|||
164031913|NCT02802878|592476270|FG001|Overall Study|Withdrawal by Subject|3|||
164031914|NCT02802878|592476269|FG000|Overall Study|Protocol Violation|1|||
164031915|NCT02802878|592476270|FG001|Overall Study|Protocol Violation|0|||
164031916|NCT00101192|592476271|FG000|Overall Study|Ineligible|6|||
164031917|NCT00101192|592476271|FG000|Overall Study|Inevaluable|1|||
164031918|NCT00536978|592476272|FG000|Overall Study|Not eligible for Adback Infusion|22|||
164031919|NCT01232894|592476273|FG000|Overall Study|Lost to Follow-up|0|||
164031920|NCT01232894|592476274|FG001|Overall Study|Lost to Follow-up|1|||
164097028|NCT02300103|592719032|FG000|Overall Study|Withdrew Consent|2|||
164097029|NCT04091971|592719033|FG000|Overall Study|Withdrawal by Subject|1|||
164097030|NCT04091971|592719033|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
164097031|NCT04091971|592719033|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
164097032|NCT01391793|592719034|FG000|Overall Study|Ineligible|3|||
164097033|NCT01391793|592719035|FG001|Overall Study|Ineligible|0|||
164097034|NCT01391793|592719034|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
164097035|NCT01391793|592719035|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
164097036|NCT01391793|592719034|FG000|Overall Study|No DMSA|73|||
164097037|NCT01391793|592719035|FG001|Overall Study|No DMSA|57|||
164097038|NCT01015625|592719036|FG000|Overall Study|Lost to Follow-up|3|||
164031921|NCT01232894|592476273|FG000|Overall Study|Death|1|||
164031922|NCT01232894|592476274|FG001|Overall Study|Death|0|||
164031923|NCT01232894|592476273|FG000|Overall Study|Protocol Violation|1|||
164031924|NCT01232894|592476274|FG001|Overall Study|Protocol Violation|1|||
164031925|NCT01232894|592476273|FG000|Overall Study|Withdrawal by Subject|8|||
164031926|NCT01232894|592476274|FG001|Overall Study|Withdrawal by Subject|5|||
164097039|NCT01015625|592719037|FG001|Overall Study|Lost to Follow-up|1|||
164097040|NCT01015625|592719036|FG000|Overall Study|Withdrawal by Subject|2|||
163920193|NCT00726388|592077769|FG000|Overall Study|Adverse Event|3|||
163920194|NCT00726388|592077769|FG000|Overall Study|Lost to Follow-up|10|||
163920195|NCT00726388|592077769|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
163920196|NCT00726388|592077769|FG000|Overall Study|Other|5|||
163920197|NCT00726388|592077769|FG000|Overall Study|Enrolled, Not Treated|79|||
163920198|NCT01116440|592077777|FG000|Treatment|Withdrawal by Subject|2|||
163920199|NCT01116440|592077778|FG001|Treatment|Withdrawal by Subject|2|||
163920200|NCT01116440|592077777|FG000|Treatment|Lost to Follow-up|1|||
163920201|NCT01116440|592077778|FG001|Treatment|Lost to Follow-up|1|||
163920202|NCT01116440|592077777|FG000|Treatment|Protocol Violation|0|||
163920203|NCT01116440|592077778|FG001|Treatment|Protocol Violation|2|||
163920204|NCT01116440|592077777|FG000|Treatment|Lack of Efficacy|0|||
163920205|NCT01116440|592077778|FG001|Treatment|Lack of Efficacy|1|||
163920206|NCT01116440|592077777|FG000|Treatment|Adverse Event|0|||
163920207|NCT01116440|592077778|FG001|Treatment|Adverse Event|1|||
163920208|NCT01116440|592077777|FG000|Withdrawal|Withdrawal by Subject|0|||
163920209|NCT01116440|592077778|FG001|Withdrawal|Withdrawal by Subject|1|||
163920210|NCT01116440|592077777|FG000|Withdrawal|Lost to Follow-up|0|||
163920211|NCT01116440|592077778|FG001|Withdrawal|Lost to Follow-up|1|||
163920212|NCT01116440|592077777|FG000|Follow-up|Lost to Follow-up|0|||
163920213|NCT01116440|592077778|FG001|Follow-up|Lost to Follow-up|1|||
163920214|NCT01116440|592077777|FG000|Follow-up|Withdrawal by Subject|0|||
163920215|NCT01116440|592077778|FG001|Follow-up|Withdrawal by Subject|1|||
163920216|NCT01126879|592077779|FG000|Overall Study|Progressive Disease|3|||
163920217|NCT01126879|592077780|FG001|Overall Study|Progressive Disease|1|||
163920218|NCT01126879|592077779|FG000|Overall Study|Withdrawal by Subject|1|||
163920219|NCT01126879|592077780|FG001|Overall Study|Withdrawal by Subject|0|||
163920220|NCT01126879|592077779|FG000|Overall Study|Adverse Event|0|||
163920221|NCT01126879|592077780|FG001|Overall Study|Adverse Event|1|||
163920222|NCT01126879|592077779|FG000|Overall Study|Physician Decision|1|||
163920223|NCT01126879|592077780|FG001|Overall Study|Physician Decision|0|||
163920224|NCT01780545|592077786|FG000|Overall Study|Withdrawal by Subject|3|||
163920225|NCT01780545|592077787|FG001|Overall Study|Withdrawal by Subject|1|||
163920226|NCT01780545|592077786|FG000|Overall Study|Lost to Follow-up|1|||
163920227|NCT01780545|592077787|FG001|Overall Study|Lost to Follow-up|1|||
163920228|NCT03441789|592077788|FG000|Overall Study|Withdrawal by Subject|1|||
163920229|NCT03441789|592077789|FG001|Overall Study|Withdrawal by Subject|1|||
163920230|NCT03441789|592077788|FG000|Overall Study|Adverse Event|0|||
163920231|NCT03441789|592077789|FG001|Overall Study|Adverse Event|1|||
163920232|NCT03441789|592077788|FG000|Overall Study|Protocol Violation|0|||
163920233|NCT03441789|592077789|FG001|Overall Study|Protocol Violation|1|||
163920234|NCT03441789|592077788|FG000|Overall Study|Lost to Follow-up|0|||
163920235|NCT03441789|592077789|FG001|Overall Study|Lost to Follow-up|1|||
163920236|NCT02581189|592077791|FG000|Overall Study|Failure to return|36|||
163920237|NCT02581189|592077791|FG000|Overall Study|Withdrew consent|5|||
163920238|NCT02581189|592077791|FG000|Overall Study|Death|3|||
163920239|NCT02581189|592077791|FG000|Overall Study|Insufficient virological response|2|||
163920240|NCT02581189|592077791|FG000|Overall Study|Other, not specified|7|||
163920241|NCT01514864|592077792|FG000|Overall Study|Disease progression|7|||
164031927|NCT01232894|592476273|FG000|Overall Study|Physician Decision|2|||
163825324|NCT00295022|591730491|FG001|Overall Study|Adverse Event|1|||
163825325|NCT00295022|591730492|FG002|Overall Study|Adverse Event|2|||
163825326|NCT00295022|591730490|FG000|Overall Study|Lost to Follow-up|0|||
163825327|NCT00295022|591730491|FG001|Overall Study|Lost to Follow-up|0|||
163825328|NCT00295022|591730492|FG002|Overall Study|Lost to Follow-up|1|||
163825329|NCT00295022|591730490|FG000|Overall Study|Withdrawal by Subject|0|||
163825330|NCT00295022|591730491|FG001|Overall Study|Withdrawal by Subject|0|||
163825331|NCT00295022|591730492|FG002|Overall Study|Withdrawal by Subject|2|||
163825332|NCT00734630|591730494|FG000|Overall Study|Lack of Efficacy|4|||
163825333|NCT00734630|591730495|FG001|Overall Study|Lack of Efficacy|4|||
163825334|NCT00734630|591730494|FG000|Overall Study|Withdrawal by Subject|7|||
163825335|NCT00734630|591730495|FG001|Overall Study|Withdrawal by Subject|9|||
163825336|NCT00734630|591730494|FG000|Overall Study|Lost to Follow-up|13|||
163825337|NCT00734630|591730495|FG001|Overall Study|Lost to Follow-up|7|||
163825338|NCT00734630|591730494|FG000|Overall Study|Protocol Violation|0|||
163920242|NCT01514864|592077793|FG001|Overall Study|Disease progression|5|||
163920243|NCT01514864|592077792|FG000|Overall Study|Study drug toxicity|2|||
163920244|NCT01514864|592077793|FG001|Overall Study|Study drug toxicity|0|||
163920245|NCT05135156|592077797|FG000|Overall Study|Lost to Follow-up|0|||
163920246|NCT05135156|592077798|FG001|Overall Study|Lost to Follow-up|0|||
163920247|NCT05135156|592077799|FG002|Overall Study|Lost to Follow-up|2|||
163920248|NCT03746483|592077804|FG000|Overall Study|Adverse Event|0|||
163920249|NCT03746483|592077805|FG001|Overall Study|Adverse Event|1|||
163920250|NCT03746483|592077804|FG000|Overall Study|Lack of Efficacy|3|||
163920251|NCT03746483|592077805|FG001|Overall Study|Lack of Efficacy|2|||
163920252|NCT03746483|592077804|FG000|Overall Study|Lost to Follow-up|1|||
163920253|NCT03746483|592077805|FG001|Overall Study|Lost to Follow-up|0|||
163920254|NCT03746483|592077804|FG000|Overall Study|Protocol Violation|2|||
163825339|NCT00734630|591730495|FG001|Overall Study|Protocol Violation|3|||
163920255|NCT03746483|592077805|FG001|Overall Study|Protocol Violation|0|||
163825340|NCT00734630|591730494|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
163825341|NCT00734630|591730495|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
163825342|NCT00734630|591730494|FG000|Overall Study|Adverse Event|3|||
163825343|NCT00734630|591730495|FG001|Overall Study|Adverse Event|6|||
163825344|NCT00734630|591730494|FG000|Overall Study|Randomized in Error|0|||
163825345|NCT00734630|591730495|FG001|Overall Study|Randomized in Error|1|||
163825346|NCT00734630|591730494|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
163825347|NCT00734630|591730495|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
163825348|NCT00734630|591730494|FG000|Overall Study|Poor Compliance|1|||
163825349|NCT00734630|591730495|FG001|Overall Study|Poor Compliance|1|||
163825350|NCT01239030|591730496|FG000|Double Blind|Adverse Event|0|||
163825351|NCT01239030|591730497|FG001|Double Blind|Adverse Event|1|||
163825352|NCT01239030|591730498|FG002|Double Blind|Adverse Event|0|||
163825353|NCT01239030|591730499|FG003|Double Blind|Adverse Event|2|||
163825354|NCT01239030|591730500|FG004|Double Blind|Adverse Event|0|||
163825355|NCT01239030|591730496|FG000|Double Blind|Withdrawal by Subject|0|||
163825356|NCT01239030|591730497|FG001|Double Blind|Withdrawal by Subject|1|||
163825357|NCT01239030|591730498|FG002|Double Blind|Withdrawal by Subject|1|||
163825358|NCT01239030|591730499|FG003|Double Blind|Withdrawal by Subject|0|||
163825359|NCT01239030|591730500|FG004|Double Blind|Withdrawal by Subject|1|||
163825360|NCT01239030|591730496|FG000|Double Blind|Lost to Follow-up|1|||
163825361|NCT01239030|591730497|FG001|Double Blind|Lost to Follow-up|1|||
163825362|NCT01239030|591730498|FG002|Double Blind|Lost to Follow-up|0|||
163825363|NCT01239030|591730499|FG003|Double Blind|Lost to Follow-up|0|||
163825364|NCT01239030|591730500|FG004|Double Blind|Lost to Follow-up|0|||
163825365|NCT01239030|591730496|FG000|Double Blind|Physician Decision|0|||
163825366|NCT01239030|591730497|FG001|Double Blind|Physician Decision|1|||
163825367|NCT01239030|591730498|FG002|Double Blind|Physician Decision|0|||
163825368|NCT01239030|591730499|FG003|Double Blind|Physician Decision|0|||
163825369|NCT01239030|591730500|FG004|Double Blind|Physician Decision|0|||
163825370|NCT01239030|591730496|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
163825371|NCT01239030|591730497|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
163825372|NCT01239030|591730498|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
163825373|NCT01239030|591730499|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
163825374|NCT01239030|591730500|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
163825375|NCT01239030|591730496|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
163825376|NCT01239030|591730497|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
163825377|NCT01239030|591730498|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
163825378|NCT01239030|591730499|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
163825379|NCT01239030|591730500|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
163825380|NCT01239030|591730496|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
163825381|NCT01239030|591730497|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
163825382|NCT01239030|591730498|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
163825383|NCT01239030|591730499|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
163825384|NCT01239030|591730500|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
163825385|NCT01239030|591730496|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
163825386|NCT01239030|591730497|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
163825387|NCT01239030|591730498|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
163825388|NCT01239030|591730499|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
163825389|NCT01239030|591730500|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
163825390|NCT04403698|591730501|FG000|Overall Study|Adverse Event|1|||
163825391|NCT04403698|591730502|FG001|Overall Study|Adverse Event|1|||
163825392|NCT04403698|591730501|FG000|Overall Study|Lost to Follow-up|1|||
163825393|NCT04403698|591730502|FG001|Overall Study|Lost to Follow-up|0|||
163825394|NCT04403698|591730501|FG000|Overall Study|Protocol Violation|0|||
163825395|NCT04403698|591730502|FG001|Overall Study|Protocol Violation|1|||
163825396|NCT00977665|591730503|FG000|Overall Study|Withdrawal by Subject|1|||
163825397|NCT00977665|591730504|FG001|Overall Study|Withdrawal by Subject|3|||
163825398|NCT00977665|591730503|FG000|Overall Study|Physician Decision|2|||
163825399|NCT00977665|591730504|FG001|Overall Study|Physician Decision|1|||
163825400|NCT00977665|591730503|FG000|Overall Study|Sponsor requested withdrawal|0|||
163825401|NCT00977665|591730504|FG001|Overall Study|Sponsor requested withdrawal|1|||
163825402|NCT00977665|591730503|FG000|Overall Study|Lost to Follow-up|1|||
163825403|NCT00977665|591730504|FG001|Overall Study|Lost to Follow-up|0|||
163825404|NCT00977665|591730503|FG000|Overall Study|Death|3|||
163825405|NCT00977665|591730504|FG001|Overall Study|Death|2|||
163825406|NCT00977665|591730503|FG000|Overall Study|Adverse Event|14|||
163825407|NCT00977665|591730504|FG001|Overall Study|Adverse Event|7|||
163825408|NCT00977665|591730503|FG000|Overall Study|Treatment failure|0|||
163825409|NCT00977665|591730504|FG001|Overall Study|Treatment failure|1|||
163825410|NCT01330433|591730505|FG000|Overall Study|Death|1|||
163825411|NCT01330433|591730506|FG001|Overall Study|Death|3|||
163825412|NCT01330433|591730505|FG000|Overall Study|Lost to Follow-up|1|||
163825413|NCT01330433|591730506|FG001|Overall Study|Lost to Follow-up|0|||
163825414|NCT00441090|591730509|FG000|Overall Study|Adverse Event|0|||
163825415|NCT00441090|591730510|FG001|Overall Study|Adverse Event|1|||
163825416|NCT00441090|591730511|FG002|Overall Study|Adverse Event|1|||
163825417|NCT00441090|591730512|FG003|Overall Study|Adverse Event|0|||
163825418|NCT00441090|591730513|FG004|Overall Study|Adverse Event|0|||
163825419|NCT00441090|591730509|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163825420|NCT00441090|591730510|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163825421|NCT00441090|591730511|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163825422|NCT00441090|591730512|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
163825423|NCT00441090|591730513|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
163825424|NCT00441090|591730509|FG000|Overall Study|Withdrawal by Subject|1|||
163825425|NCT00441090|591730510|FG001|Overall Study|Withdrawal by Subject|0|||
163825426|NCT00441090|591730511|FG002|Overall Study|Withdrawal by Subject|1|||
163825427|NCT00441090|591730512|FG003|Overall Study|Withdrawal by Subject|0|||
163825428|NCT00441090|591730513|FG004|Overall Study|Withdrawal by Subject|0|||
163825429|NCT00441090|591730509|FG000|Overall Study|Lack of Efficacy|1|||
163825430|NCT00441090|591730510|FG001|Overall Study|Lack of Efficacy|0|||
163825431|NCT00441090|591730511|FG002|Overall Study|Lack of Efficacy|0|||
163825432|NCT00441090|591730512|FG003|Overall Study|Lack of Efficacy|0|||
163825433|NCT00441090|591730513|FG004|Overall Study|Lack of Efficacy|0|||
163825434|NCT01441102|591730514|FG000|Overall Study|Adverse Event|1|||
163825435|NCT01441102|591730514|FG000|Overall Study|Withdrawal by Subject|2|||
163825436|NCT00518115|591730518|FG000|Overall Study|Adverse Event|6|||
163825437|NCT00518115|591730519|FG001|Overall Study|Adverse Event|1|||
163825438|NCT00518115|591730520|FG002|Overall Study|Adverse Event|5|||
163825439|NCT00518115|591730521|FG003|Overall Study|Adverse Event|6|||
163825440|NCT00518115|591730522|FG004|Overall Study|Adverse Event|5|||
163825441|NCT00518115|591730523|FG005|Overall Study|Adverse Event|5|||
163825442|NCT00518115|591730524|FG006|Overall Study|Adverse Event|5|||
163825443|NCT00518115|591730525|FG007|Overall Study|Adverse Event|10|||
163825444|NCT00518115|591730526|FG008|Overall Study|Adverse Event|2|||
163825445|NCT00518115|591730527|FG009|Overall Study|Adverse Event|9|||
163825446|NCT00518115|591730518|FG000|Overall Study|Lost to Follow-up|0|||
163825447|NCT00518115|591730519|FG001|Overall Study|Lost to Follow-up|0|||
163825448|NCT00518115|591730520|FG002|Overall Study|Lost to Follow-up|2|||
163825449|NCT00518115|591730521|FG003|Overall Study|Lost to Follow-up|3|||
163825450|NCT00518115|591730522|FG004|Overall Study|Lost to Follow-up|1|||
163825451|NCT00518115|591730523|FG005|Overall Study|Lost to Follow-up|3|||
163825452|NCT00518115|591730524|FG006|Overall Study|Lost to Follow-up|0|||
163825453|NCT00518115|591730525|FG007|Overall Study|Lost to Follow-up|1|||
163825454|NCT00518115|591730526|FG008|Overall Study|Lost to Follow-up|1|||
163825455|NCT00518115|591730527|FG009|Overall Study|Lost to Follow-up|1|||
163825456|NCT00518115|591730518|FG000|Overall Study|Protocol Violation|1|||
163825457|NCT00518115|591730519|FG001|Overall Study|Protocol Violation|3|||
163825458|NCT00518115|591730520|FG002|Overall Study|Protocol Violation|1|||
163825459|NCT00518115|591730521|FG003|Overall Study|Protocol Violation|0|||
163825460|NCT00518115|591730522|FG004|Overall Study|Protocol Violation|0|||
163825461|NCT00518115|591730523|FG005|Overall Study|Protocol Violation|0|||
163825462|NCT00518115|591730524|FG006|Overall Study|Protocol Violation|0|||
163825463|NCT00518115|591730525|FG007|Overall Study|Protocol Violation|0|||
163825464|NCT00518115|591730526|FG008|Overall Study|Protocol Violation|0|||
163825465|NCT00518115|591730527|FG009|Overall Study|Protocol Violation|0|||
163825466|NCT00518115|591730518|FG000|Overall Study|Withdrawal by Subject|1|||
163825467|NCT00518115|591730519|FG001|Overall Study|Withdrawal by Subject|1|||
163825468|NCT00518115|591730520|FG002|Overall Study|Withdrawal by Subject|5|||
163825469|NCT00518115|591730521|FG003|Overall Study|Withdrawal by Subject|0|||
163825470|NCT00518115|591730522|FG004|Overall Study|Withdrawal by Subject|2|||
163825471|NCT00518115|591730523|FG005|Overall Study|Withdrawal by Subject|1|||
163825472|NCT00518115|591730524|FG006|Overall Study|Withdrawal by Subject|0|||
163825473|NCT00518115|591730525|FG007|Overall Study|Withdrawal by Subject|2|||
163825474|NCT00518115|591730526|FG008|Overall Study|Withdrawal by Subject|1|||
163825475|NCT00518115|591730527|FG009|Overall Study|Withdrawal by Subject|3|||
163825476|NCT00518115|591730518|FG000|Overall Study|Lack of Efficacy|1|||
163825477|NCT00518115|591730519|FG001|Overall Study|Lack of Efficacy|0|||
163825478|NCT00518115|591730520|FG002|Overall Study|Lack of Efficacy|1|||
163825479|NCT00518115|591730521|FG003|Overall Study|Lack of Efficacy|1|||
163825480|NCT00518115|591730522|FG004|Overall Study|Lack of Efficacy|0|||
163920256|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Adverse Event|3|||
164097041|NCT01015625|592719037|FG001|Overall Study|Withdrawal by Subject|3|||
163825481|NCT00518115|591730523|FG005|Overall Study|Lack of Efficacy|0|||
163825482|NCT00518115|591730524|FG006|Overall Study|Lack of Efficacy|0|||
163825483|NCT00518115|591730525|FG007|Overall Study|Lack of Efficacy|1|||
163825484|NCT00518115|591730526|FG008|Overall Study|Lack of Efficacy|0|||
163825485|NCT00518115|591730527|FG009|Overall Study|Lack of Efficacy|0|||
163825486|NCT00518115|591730518|FG000|Overall Study|Non-Compliance|1|||
163825487|NCT00518115|591730519|FG001|Overall Study|Non-Compliance|0|||
163825488|NCT00518115|591730520|FG002|Overall Study|Non-Compliance|1|||
163825489|NCT00518115|591730521|FG003|Overall Study|Non-Compliance|0|||
163825490|NCT00518115|591730522|FG004|Overall Study|Non-Compliance|1|||
163825491|NCT00518115|591730523|FG005|Overall Study|Non-Compliance|1|||
163825492|NCT00518115|591730524|FG006|Overall Study|Non-Compliance|1|||
163825493|NCT00518115|591730525|FG007|Overall Study|Non-Compliance|1|||
163825494|NCT00518115|591730526|FG008|Overall Study|Non-Compliance|0|||
163825495|NCT00518115|591730527|FG009|Overall Study|Non-Compliance|1|||
163825496|NCT00518115|591730518|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
163825497|NCT00518115|591730519|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
163825498|NCT00518115|591730520|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825499|NCT00518115|591730521|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825500|NCT00518115|591730522|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825501|NCT00518115|591730523|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
163825502|NCT00518115|591730524|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825503|NCT00518115|591730525|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825504|NCT00518115|591730526|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825505|NCT00518115|591730527|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
163825506|NCT00518115|591730518|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
163825507|NCT00518115|591730519|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825508|NCT00518115|591730520|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825509|NCT00518115|591730521|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825510|NCT00518115|591730522|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825511|NCT00518115|591730523|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825512|NCT00518115|591730524|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825513|NCT00518115|591730525|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825514|NCT00518115|591730526|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825515|NCT00518115|591730527|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
163825516|NCT00518115|591730518|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825517|NCT00518115|591730519|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825518|NCT00518115|591730520|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
163825519|NCT00518115|591730521|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825520|NCT00518115|591730522|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825521|NCT00518115|591730523|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825522|NCT00518115|591730524|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825523|NCT00518115|591730525|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825524|NCT00518115|591730526|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
163825525|NCT00518115|591730527|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
163825526|NCT00518115|591730518|FG000|Overall Study|Wrong Monotherapy Administered|0|||
163825527|NCT00518115|591730519|FG001|Overall Study|Wrong Monotherapy Administered|0|||
163825528|NCT00518115|591730520|FG002|Overall Study|Wrong Monotherapy Administered|1|||
163825529|NCT00518115|591730521|FG003|Overall Study|Wrong Monotherapy Administered|0|||
163825530|NCT00518115|591730522|FG004|Overall Study|Wrong Monotherapy Administered|0|||
163825531|NCT00518115|591730523|FG005|Overall Study|Wrong Monotherapy Administered|0|||
163825532|NCT00518115|591730524|FG006|Overall Study|Wrong Monotherapy Administered|1|||
163825533|NCT00518115|591730525|FG007|Overall Study|Wrong Monotherapy Administered|0|||
163825534|NCT00518115|591730526|FG008|Overall Study|Wrong Monotherapy Administered|0|||
163825535|NCT00518115|591730527|FG009|Overall Study|Wrong Monotherapy Administered|0|||
163825536|NCT00518115|591730518|FG000|Overall Study|Violation of Exclusion Criteria|0|||
163825537|NCT00518115|591730519|FG001|Overall Study|Violation of Exclusion Criteria|0|||
163825538|NCT00518115|591730520|FG002|Overall Study|Violation of Exclusion Criteria|0|||
163825539|NCT00518115|591730521|FG003|Overall Study|Violation of Exclusion Criteria|1|||
163825540|NCT00518115|591730522|FG004|Overall Study|Violation of Exclusion Criteria|0|||
163825541|NCT00518115|591730523|FG005|Overall Study|Violation of Exclusion Criteria|0|||
163825542|NCT00518115|591730524|FG006|Overall Study|Violation of Exclusion Criteria|1|||
163825543|NCT00518115|591730525|FG007|Overall Study|Violation of Exclusion Criteria|0|||
163825544|NCT00518115|591730526|FG008|Overall Study|Violation of Exclusion Criteria|0|||
163825545|NCT00518115|591730527|FG009|Overall Study|Violation of Exclusion Criteria|0|||
163825546|NCT00518115|591730518|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
163825547|NCT00518115|591730519|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
163825548|NCT00518115|591730520|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
163825549|NCT00518115|591730521|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
163825550|NCT00518115|591730522|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
163825551|NCT00518115|591730523|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
163825552|NCT00518115|591730524|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
163825553|NCT00518115|591730525|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
163825554|NCT00518115|591730526|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
163825555|NCT00518115|591730527|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
163825556|NCT00518115|591730518|FG000|Overall Study|Withdrew Consent|0|||
163825557|NCT00518115|591730519|FG001|Overall Study|Withdrew Consent|0|||
163825558|NCT00518115|591730520|FG002|Overall Study|Withdrew Consent|0|||
163825559|NCT00518115|591730521|FG003|Overall Study|Withdrew Consent|0|||
163825560|NCT00518115|591730522|FG004|Overall Study|Withdrew Consent|0|||
164031928|NCT01232894|592476274|FG001|Overall Study|Physician Decision|1|||
164031929|NCT03970395|592476275|FG000|Overall Study|Withdrawal by Subject|3|||
164031930|NCT03970395|592476276|FG001|Overall Study|Withdrawal by Subject|4|||
164031931|NCT03970395|592476275|FG000|Overall Study|Lost to Follow-up|4|||
164031932|NCT03970395|592476276|FG001|Overall Study|Lost to Follow-up|8|||
164031933|NCT01996904|592476277|FG000|Overall Study|Lost to Follow-up|38|||
163825561|NCT00518115|591730523|FG005|Overall Study|Withdrew Consent|1|||
163825562|NCT00518115|591730524|FG006|Overall Study|Withdrew Consent|0|||
163825563|NCT00518115|591730525|FG007|Overall Study|Withdrew Consent|0|||
163825564|NCT00518115|591730526|FG008|Overall Study|Withdrew Consent|0|||
163825565|NCT00518115|591730527|FG009|Overall Study|Withdrew Consent|0|||
163825566|NCT00518115|591730518|FG000|Overall Study|Moved Out of State|0|||
163825567|NCT00518115|591730519|FG001|Overall Study|Moved Out of State|0|||
163825568|NCT00518115|591730520|FG002|Overall Study|Moved Out of State|0|||
163825569|NCT00518115|591730521|FG003|Overall Study|Moved Out of State|0|||
163825570|NCT00518115|591730522|FG004|Overall Study|Moved Out of State|0|||
163825571|NCT00518115|591730523|FG005|Overall Study|Moved Out of State|0|||
163825572|NCT00518115|591730524|FG006|Overall Study|Moved Out of State|0|||
163825573|NCT00518115|591730525|FG007|Overall Study|Moved Out of State|0|||
163825574|NCT00518115|591730526|FG008|Overall Study|Moved Out of State|0|||
163825575|NCT00518115|591730527|FG009|Overall Study|Moved Out of State|1|||
163825576|NCT04891419|591730528|FG000|Overall Study|Withdrawal by Subject|4|||
163825577|NCT04891419|591730529|FG001|Overall Study|Withdrawal by Subject|0|||
163825578|NCT04891419|591730528|FG000|Overall Study|Lost to Follow-up|1|||
163825579|NCT04891419|591730529|FG001|Overall Study|Lost to Follow-up|3|||
163825580|NCT00827918|591730533|FG000|Overall Study|Adverse Event|4|||
163825581|NCT00827918|591730534|FG001|Overall Study|Adverse Event|0|||
163825582|NCT00827918|591730535|FG002|Overall Study|Adverse Event|0|||
163825583|NCT00827918|591730533|FG000|Overall Study|Lack of Efficacy|16|||
163825584|NCT00827918|591730534|FG001|Overall Study|Lack of Efficacy|4|||
163825585|NCT00827918|591730535|FG002|Overall Study|Lack of Efficacy|15|||
163825586|NCT00827918|591730533|FG000|Overall Study|Physician Decision|1|||
163825587|NCT00827918|591730534|FG001|Overall Study|Physician Decision|0|||
163825588|NCT00827918|591730535|FG002|Overall Study|Physician Decision|0|||
163825589|NCT00827918|591730533|FG000|Overall Study|Pregnancy|0|||
163825590|NCT00827918|591730534|FG001|Overall Study|Pregnancy|1|||
163825591|NCT00827918|591730535|FG002|Overall Study|Pregnancy|0|||
163825592|NCT00827918|591730533|FG000|Overall Study|Progressive Disease|1|||
163825593|NCT00827918|591730534|FG001|Overall Study|Progressive Disease|1|||
163825594|NCT00827918|591730535|FG002|Overall Study|Progressive Disease|0|||
163825595|NCT00827918|591730533|FG000|Overall Study|Protocol Violation|0|||
163825596|NCT00827918|591730534|FG001|Overall Study|Protocol Violation|1|||
163825597|NCT00827918|591730535|FG002|Overall Study|Protocol Violation|0|||
163825598|NCT00827918|591730533|FG000|Overall Study|Withdrawal by Subject|6|||
163825599|NCT00827918|591730534|FG001|Overall Study|Withdrawal by Subject|2|||
163825600|NCT00827918|591730535|FG002|Overall Study|Withdrawal by Subject|6|||
163825601|NCT00802074|591730536|FG000|Overall Study|Adverse Event|1|||
163825602|NCT00802074|591730537|FG001|Overall Study|Adverse Event|1|||
163825603|NCT00802074|591730538|FG002|Overall Study|Adverse Event|1|||
163825604|NCT00802074|591730539|FG003|Overall Study|Adverse Event|0|||
163825605|NCT00802074|591730540|FG004|Overall Study|Adverse Event|0|||
163825606|NCT00802074|591730541|FG005|Overall Study|Adverse Event|0|||
163825607|NCT00802074|591730536|FG000|Overall Study|Withdrawal by Subject|1|||
163825608|NCT00802074|591730537|FG001|Overall Study|Withdrawal by Subject|0|||
163825609|NCT00802074|591730538|FG002|Overall Study|Withdrawal by Subject|0|||
163825610|NCT00802074|591730539|FG003|Overall Study|Withdrawal by Subject|0|||
163825611|NCT00802074|591730540|FG004|Overall Study|Withdrawal by Subject|0|||
163825612|NCT00802074|591730541|FG005|Overall Study|Withdrawal by Subject|0|||
163825613|NCT00843167|591730544|FG000|Treatment Period|Adverse Event|1|||
163825614|NCT00843167|591730545|FG001|Treatment Period|Adverse Event|5|||
163825615|NCT00843167|591730544|FG000|Treatment Period|Withdrawal by Subject|2|||
163825616|NCT00843167|591730545|FG001|Treatment Period|Withdrawal by Subject|3|||
164031934|NCT01996904|592476278|FG001|Overall Study|Lost to Follow-up|27|||
163825617|NCT02291614|591730546|FG000|Overall Study|Lost to Follow-up|0|||
164031935|NCT00929734|592476282|FG000|Overall Study|Lost to Follow-up|2|||
163825618|NCT02291614|591730547|FG001|Overall Study|Lost to Follow-up|0|||
163825619|NCT02291614|591730548|FG002|Overall Study|Lost to Follow-up|0|||
163825620|NCT02291614|591730549|FG003|Overall Study|Lost to Follow-up|0|||
163825621|NCT02291614|591730550|FG004|Overall Study|Lost to Follow-up|0|||
163825622|NCT02291614|591730551|FG005|Overall Study|Lost to Follow-up|0|||
163825623|NCT02291614|591730552|FG006|Overall Study|Lost to Follow-up|0|||
164031936|NCT00929734|592476283|FG001|Overall Study|Lost to Follow-up|1|||
163825624|NCT02291614|591730553|FG007|Overall Study|Lost to Follow-up|1|||
163825625|NCT02291614|591730554|FG008|Overall Study|Lost to Follow-up|0|||
163825626|NCT02291614|591730555|FG009|Overall Study|Lost to Follow-up|0|||
163825627|NCT02291614|591730556|FG010|Overall Study|Lost to Follow-up|0|||
163825628|NCT02291614|591730546|FG000|Overall Study|Withdrawal by Subject|0|||
163825629|NCT02291614|591730547|FG001|Overall Study|Withdrawal by Subject|1|||
163825630|NCT02291614|591730548|FG002|Overall Study|Withdrawal by Subject|0|||
164031937|NCT00929734|592476282|FG000|Overall Study|Withdrawal by Subject|0|||
163920257|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Adverse Event|0|||
163920258|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
163920259|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
163920260|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Disease Progression|23|||
163920261|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Disease Progression|22|||
163920262|NCT01379521|592077806|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
163920263|NCT01379521|592077807|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
163825631|NCT02291614|591730549|FG003|Overall Study|Withdrawal by Subject|0|||
163825632|NCT02291614|591730550|FG004|Overall Study|Withdrawal by Subject|0|||
163825633|NCT02291614|591730551|FG005|Overall Study|Withdrawal by Subject|0|||
163825634|NCT02291614|591730552|FG006|Overall Study|Withdrawal by Subject|0|||
163825635|NCT02291614|591730553|FG007|Overall Study|Withdrawal by Subject|0|||
163825636|NCT02291614|591730554|FG008|Overall Study|Withdrawal by Subject|0|||
163825637|NCT02291614|591730555|FG009|Overall Study|Withdrawal by Subject|2|||
163920264|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
163920265|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
163920266|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
163920267|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
163920268|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
163920269|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
163920270|NCT01379521|592077806|FG000|Overall Study -Treatment Period|Death|2|||
163920271|NCT01379521|592077807|FG001|Overall Study -Treatment Period|Death|1|||
163920272|NCT01379521|592077806|FG000|Post-Treatment Evaluations|Disease Progression|22|||
163920273|NCT01379521|592077807|FG001|Post-Treatment Evaluations|Disease Progression|20|||
163920274|NCT01379521|592077806|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
163920275|NCT01379521|592077807|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
163920276|NCT01379521|592077806|FG000|Post-Treatment Evaluations|Death|1|||
163920277|NCT01379521|592077807|FG001|Post-Treatment Evaluations|Death|0|||
163920278|NCT00404547|592077808|FG000|Overall Study|Adverse Event|39|||
163920279|NCT00404547|592077809|FG001|Overall Study|Adverse Event|6|||
163920280|NCT00404547|592077808|FG000|Overall Study|Withdrawal by Subject|19|||
163920281|NCT00404547|592077809|FG001|Overall Study|Withdrawal by Subject|2|||
163920282|NCT00404547|592077808|FG000|Overall Study|Protocol Violation|0|||
163920283|NCT00404547|592077809|FG001|Overall Study|Protocol Violation|1|||
163920284|NCT00404547|592077808|FG000|Overall Study|Lost to Follow-up|20|||
163920285|NCT00404547|592077809|FG001|Overall Study|Lost to Follow-up|9|||
163920286|NCT00404547|592077808|FG000|Overall Study|Lack of compliance|5|||
163920287|NCT00404547|592077809|FG001|Overall Study|Lack of compliance|1|||
163920288|NCT00404547|592077808|FG000|Overall Study|Other|4|||
163920289|NCT00404547|592077809|FG001|Overall Study|Other|0|||
163920290|NCT00404547|592077808|FG000|Overall Study|Reason not stated|3|||
163920291|NCT00404547|592077809|FG001|Overall Study|Reason not stated|6|||
163920292|NCT00475735|592077810|FG000|Treatment Period 1|Adverse Event|2|||
163920293|NCT00475735|592077811|FG001|Treatment Period 1|Adverse Event|0|||
163920294|NCT00475735|592077812|FG002|Treatment Period 1|Adverse Event|0|||
163920295|NCT00475735|592077813|FG003|Treatment Period 1|Adverse Event|0|||
163920296|NCT00475735|592077814|FG004|Treatment Period 1|Adverse Event|0|||
163920297|NCT00475735|592077815|FG005|Treatment Period 1|Adverse Event|0|||
163920298|NCT00475735|592077810|FG000|Treatment Period 1|Lack of Efficacy|1|||
163920299|NCT00475735|592077811|FG001|Treatment Period 1|Lack of Efficacy|0|||
163920300|NCT00475735|592077812|FG002|Treatment Period 1|Lack of Efficacy|0|||
163920301|NCT00475735|592077813|FG003|Treatment Period 1|Lack of Efficacy|0|||
163920302|NCT00475735|592077814|FG004|Treatment Period 1|Lack of Efficacy|0|||
163920303|NCT00475735|592077815|FG005|Treatment Period 1|Lack of Efficacy|0|||
163920304|NCT00475735|592077810|FG000|Treatment Period 1|Lost to Follow-up|0|||
163920305|NCT00475735|592077811|FG001|Treatment Period 1|Lost to Follow-up|0|||
163920306|NCT00475735|592077812|FG002|Treatment Period 1|Lost to Follow-up|0|||
163920307|NCT00475735|592077813|FG003|Treatment Period 1|Lost to Follow-up|0|||
163920308|NCT00475735|592077814|FG004|Treatment Period 1|Lost to Follow-up|0|||
163920309|NCT00475735|592077815|FG005|Treatment Period 1|Lost to Follow-up|1|||
163920310|NCT00475735|592077810|FG000|Treatment Period 1|Protocol Violation|0|||
163920311|NCT00475735|592077811|FG001|Treatment Period 1|Protocol Violation|0|||
163825638|NCT02291614|591730556|FG010|Overall Study|Withdrawal by Subject|2|||
163920312|NCT00475735|592077812|FG002|Treatment Period 1|Protocol Violation|0|||
163920313|NCT00475735|592077813|FG003|Treatment Period 1|Protocol Violation|1|||
163920314|NCT00475735|592077814|FG004|Treatment Period 1|Protocol Violation|0|||
163825639|NCT02291614|591730546|FG000|Overall Study|Decision by sponsor|0|||
163825640|NCT02291614|591730547|FG001|Overall Study|Decision by sponsor|0|||
163920315|NCT00475735|592077815|FG005|Treatment Period 1|Protocol Violation|0|||
163920316|NCT00475735|592077810|FG000|Treatment Period 1|Withdrawal by Subject|1|||
163920317|NCT00475735|592077811|FG001|Treatment Period 1|Withdrawal by Subject|1|||
163920318|NCT00475735|592077812|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163920319|NCT00475735|592077813|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163920320|NCT00475735|592077814|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163920321|NCT00475735|592077815|FG005|Treatment Period 1|Withdrawal by Subject|0|||
163825641|NCT02291614|591730548|FG002|Overall Study|Decision by sponsor|0|||
163825642|NCT02291614|591730549|FG003|Overall Study|Decision by sponsor|1|||
163825643|NCT02291614|591730550|FG004|Overall Study|Decision by sponsor|0|||
163825644|NCT02291614|591730551|FG005|Overall Study|Decision by sponsor|0|||
163825645|NCT02291614|591730552|FG006|Overall Study|Decision by sponsor|0|||
163825646|NCT02291614|591730553|FG007|Overall Study|Decision by sponsor|0|||
163825647|NCT02291614|591730554|FG008|Overall Study|Decision by sponsor|0|||
163825648|NCT02291614|591730555|FG009|Overall Study|Decision by sponsor|0|||
163825649|NCT02291614|591730556|FG010|Overall Study|Decision by sponsor|0|||
163825650|NCT02291614|591730546|FG000|Overall Study|Death|0|||
163825651|NCT02291614|591730547|FG001|Overall Study|Death|0|||
163825652|NCT02291614|591730548|FG002|Overall Study|Death|1|||
163825653|NCT02291614|591730549|FG003|Overall Study|Death|0|||
163825654|NCT02291614|591730550|FG004|Overall Study|Death|1|||
163825655|NCT02291614|591730551|FG005|Overall Study|Death|1|||
163825656|NCT02291614|591730552|FG006|Overall Study|Death|1|||
163825657|NCT02291614|591730553|FG007|Overall Study|Death|0|||
163825658|NCT02291614|591730554|FG008|Overall Study|Death|0|||
163825659|NCT02291614|591730555|FG009|Overall Study|Death|0|||
163825660|NCT02291614|591730556|FG010|Overall Study|Death|0|||
163825661|NCT00127101|591730557|FG000|Base Protocol|Adverse Event|0|||
163825662|NCT00127101|591730558|FG001|Base Protocol|Adverse Event|2|||
163825663|NCT00127101|591730559|FG002|Base Protocol|Adverse Event|1|||
163825664|NCT00127101|591730560|FG003|Base Protocol|Adverse Event|0|||
163825665|NCT00127101|591730561|FG004|Base Protocol|Adverse Event|0|||
163825666|NCT00127101|591730562|FG005|Base Protocol|Adverse Event|0|||
163825667|NCT00127101|591730557|FG000|Base Protocol|Lack of Efficacy|1|||
163825668|NCT00127101|591730558|FG001|Base Protocol|Lack of Efficacy|0|||
163825669|NCT00127101|591730559|FG002|Base Protocol|Lack of Efficacy|0|||
163825670|NCT00127101|591730560|FG003|Base Protocol|Lack of Efficacy|0|||
163825671|NCT00127101|591730561|FG004|Base Protocol|Lack of Efficacy|2|||
163825672|NCT00127101|591730562|FG005|Base Protocol|Lack of Efficacy|0|||
163825673|NCT00127101|591730557|FG000|Base Protocol|Withdrawal by Subject|1|||
163825674|NCT00127101|591730558|FG001|Base Protocol|Withdrawal by Subject|2|||
163825675|NCT00127101|591730559|FG002|Base Protocol|Withdrawal by Subject|1|||
163825676|NCT00127101|591730560|FG003|Base Protocol|Withdrawal by Subject|0|||
163825677|NCT00127101|591730561|FG004|Base Protocol|Withdrawal by Subject|0|||
163825678|NCT00127101|591730562|FG005|Base Protocol|Withdrawal by Subject|1|||
163825679|NCT00127101|591730557|FG000|Continuation Phase|Adverse Event|0|||
163825680|NCT00127101|591730558|FG001|Continuation Phase|Adverse Event|0|||
163825681|NCT00127101|591730559|FG002|Continuation Phase|Adverse Event|0|||
163825682|NCT00127101|591730560|FG003|Continuation Phase|Adverse Event|0|||
163825683|NCT00127101|591730561|FG004|Continuation Phase|Adverse Event|1|||
163825684|NCT00127101|591730562|FG005|Continuation Phase|Adverse Event|1|||
163825685|NCT00127101|591730557|FG000|Continuation Phase|Lack of Efficacy|0|||
163825686|NCT00127101|591730558|FG001|Continuation Phase|Lack of Efficacy|0|||
163825687|NCT00127101|591730559|FG002|Continuation Phase|Lack of Efficacy|0|||
163825688|NCT00127101|591730560|FG003|Continuation Phase|Lack of Efficacy|0|||
163825689|NCT00127101|591730561|FG004|Continuation Phase|Lack of Efficacy|0|||
163825690|NCT00127101|591730562|FG005|Continuation Phase|Lack of Efficacy|1|||
163825691|NCT00127101|591730557|FG000|Continuation Phase|Withdrawal by Subject|0|||
163825692|NCT00127101|591730558|FG001|Continuation Phase|Withdrawal by Subject|0|||
163825693|NCT00127101|591730559|FG002|Continuation Phase|Withdrawal by Subject|1|||
163825694|NCT00127101|591730560|FG003|Continuation Phase|Withdrawal by Subject|0|||
163825695|NCT00127101|591730561|FG004|Continuation Phase|Withdrawal by Subject|2|||
163825696|NCT00127101|591730562|FG005|Continuation Phase|Withdrawal by Subject|1|||
163825697|NCT03743038|591730563|FG000|Overall Study|Physician Decision|1|||
164031938|NCT00929734|592476283|FG001|Overall Study|Withdrawal by Subject|2|||
164031939|NCT00980980|592476284|FG000|Overall Study|Withdrawal by Hospital|0|||
164031940|NCT00980980|592476285|FG001|Overall Study|Withdrawal by Hospital|1|||
164031941|NCT00980980|592476286|FG002|Overall Study|Withdrawal by Hospital|0|||
164031942|NCT00121992|592476287|FG000|Overall Study|Treatment not received|2|||
164031943|NCT00121992|592476288|FG001|Overall Study|Treatment not received|11|||
163825698|NCT01830127|591730565|FG000|Overall Study|Adverse Event|1|||
163825699|NCT01830127|591730566|FG001|Overall Study|Adverse Event|6|||
163825700|NCT01830127|591730565|FG000|Overall Study|Lack of Efficacy|3|||
163825701|NCT01830127|591730566|FG001|Overall Study|Lack of Efficacy|0|||
163825702|NCT01830127|591730565|FG000|Overall Study|Withdrawal by Subject|1|||
163825703|NCT01830127|591730566|FG001|Overall Study|Withdrawal by Subject|1|||
163825704|NCT01830127|591730565|FG000|Overall Study|Other reason not defined above|0|||
163825705|NCT01830127|591730566|FG001|Overall Study|Other reason not defined above|2|||
163825706|NCT01302847|591730568|FG000|Overall Study|Death|0|||
163825707|NCT01302847|591730569|FG001|Overall Study|Death|1|||
163825708|NCT01302847|591730570|FG002|Overall Study|Death|0|||
163825709|NCT01302847|591730571|FG003|Overall Study|Death|0|||
163825710|NCT01302847|591730572|FG004|Overall Study|Death|0|||
163825711|NCT01302847|591730573|FG005|Overall Study|Death|1|||
163825712|NCT01302847|591730574|FG006|Overall Study|Death|1|||
164031944|NCT04664855|592476289|FG000|Overall Study|Withdrawal by Subject|0|||
163825713|NCT01302847|591730575|FG007|Overall Study|Death|0|||
163825714|NCT01302847|591730568|FG000|Overall Study|Pregnancy|2|||
163825715|NCT01302847|591730569|FG001|Overall Study|Pregnancy|0|||
163825716|NCT01302847|591730570|FG002|Overall Study|Pregnancy|0|||
163825717|NCT01302847|591730571|FG003|Overall Study|Pregnancy|0|||
163825718|NCT01302847|591730572|FG004|Overall Study|Pregnancy|0|||
163825719|NCT01302847|591730573|FG005|Overall Study|Pregnancy|0|||
163825720|NCT01302847|591730574|FG006|Overall Study|Pregnancy|0|||
163825721|NCT01302847|591730575|FG007|Overall Study|Pregnancy|0|||
163825722|NCT01302847|591730568|FG000|Overall Study|Virologic failure|0|||
163825723|NCT01302847|591730569|FG001|Overall Study|Virologic failure|2|||
163825724|NCT01302847|591730570|FG002|Overall Study|Virologic failure|0|||
163825725|NCT01302847|591730571|FG003|Overall Study|Virologic failure|2|||
163825726|NCT01302847|591730572|FG004|Overall Study|Virologic failure|1|||
163825727|NCT01302847|591730573|FG005|Overall Study|Virologic failure|3|||
163825728|NCT01302847|591730574|FG006|Overall Study|Virologic failure|1|||
163825729|NCT01302847|591730575|FG007|Overall Study|Virologic failure|2|||
163825730|NCT01302847|591730568|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163825731|NCT01302847|591730569|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163825732|NCT01302847|591730570|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163825733|NCT01302847|591730571|FG003|Overall Study|Severe debilitation, unable to continue|0|||
163825734|NCT01302847|591730572|FG004|Overall Study|Severe debilitation, unable to continue|0|||
163825735|NCT01302847|591730573|FG005|Overall Study|Severe debilitation, unable to continue|1|||
163825736|NCT01302847|591730574|FG006|Overall Study|Severe debilitation, unable to continue|1|||
163825737|NCT01302847|591730575|FG007|Overall Study|Severe debilitation, unable to continue|0|||
163825738|NCT01302847|591730568|FG000|Overall Study|Not able to get to clinic|1|||
163825739|NCT01302847|591730569|FG001|Overall Study|Not able to get to clinic|1|||
163825740|NCT01302847|591730570|FG002|Overall Study|Not able to get to clinic|0|||
163825741|NCT01302847|591730571|FG003|Overall Study|Not able to get to clinic|0|||
163825742|NCT01302847|591730572|FG004|Overall Study|Not able to get to clinic|0|||
163825743|NCT01302847|591730573|FG005|Overall Study|Not able to get to clinic|0|||
163825744|NCT01302847|591730574|FG006|Overall Study|Not able to get to clinic|0|||
163825745|NCT01302847|591730575|FG007|Overall Study|Not able to get to clinic|0|||
163825746|NCT01302847|591730568|FG000|Overall Study|Site closing|2|||
163825747|NCT01302847|591730569|FG001|Overall Study|Site closing|2|||
163825748|NCT01302847|591730570|FG002|Overall Study|Site closing|0|||
163825749|NCT01302847|591730571|FG003|Overall Study|Site closing|0|||
163825750|NCT01302847|591730572|FG004|Overall Study|Site closing|0|||
163825751|NCT01302847|591730573|FG005|Overall Study|Site closing|0|||
163825752|NCT01302847|591730574|FG006|Overall Study|Site closing|0|||
163825753|NCT01302847|591730575|FG007|Overall Study|Site closing|0|||
163825754|NCT01302847|591730568|FG000|Overall Study|Withdrawal by Subject|1|||
163825755|NCT01302847|591730569|FG001|Overall Study|Withdrawal by Subject|0|||
163825756|NCT01302847|591730570|FG002|Overall Study|Withdrawal by Subject|0|||
163825757|NCT01302847|591730571|FG003|Overall Study|Withdrawal by Subject|0|||
163825758|NCT01302847|591730572|FG004|Overall Study|Withdrawal by Subject|1|||
163825759|NCT01302847|591730573|FG005|Overall Study|Withdrawal by Subject|0|||
163825760|NCT01302847|591730574|FG006|Overall Study|Withdrawal by Subject|0|||
163825761|NCT01302847|591730575|FG007|Overall Study|Withdrawal by Subject|1|||
163825762|NCT01302847|591730568|FG000|Overall Study|Not willing to adhere to requirements|5|||
163825763|NCT01302847|591730569|FG001|Overall Study|Not willing to adhere to requirements|0|||
163825764|NCT01302847|591730570|FG002|Overall Study|Not willing to adhere to requirements|1|||
163825765|NCT01302847|591730571|FG003|Overall Study|Not willing to adhere to requirements|0|||
163825766|NCT01302847|591730572|FG004|Overall Study|Not willing to adhere to requirements|0|||
163825767|NCT01302847|591730573|FG005|Overall Study|Not willing to adhere to requirements|0|||
163825768|NCT01302847|591730574|FG006|Overall Study|Not willing to adhere to requirements|0|||
163825769|NCT01302847|591730575|FG007|Overall Study|Not willing to adhere to requirements|2|||
163825770|NCT01302847|591730568|FG000|Overall Study|Site unable to contact participant|2|||
163825771|NCT01302847|591730569|FG001|Overall Study|Site unable to contact participant|1|||
163825772|NCT01302847|591730570|FG002|Overall Study|Site unable to contact participant|0|||
163825773|NCT01302847|591730571|FG003|Overall Study|Site unable to contact participant|0|||
163825774|NCT01302847|591730572|FG004|Overall Study|Site unable to contact participant|0|||
163825775|NCT01302847|591730573|FG005|Overall Study|Site unable to contact participant|0|||
163825776|NCT01302847|591730574|FG006|Overall Study|Site unable to contact participant|2|||
163825777|NCT01302847|591730575|FG007|Overall Study|Site unable to contact participant|0|||
163825778|NCT01565707|591730576|FG000|Overall Study|Adverse Event|1|||
163825779|NCT01565707|591730577|FG001|Overall Study|Adverse Event|6|||
163825780|NCT01565707|591730578|FG002|Overall Study|Adverse Event|2|||
163825781|NCT01565707|591730579|FG003|Overall Study|Adverse Event|1|||
163825782|NCT01565707|591730576|FG000|Overall Study|Lost to Follow-up|1|||
163825783|NCT01565707|591730577|FG001|Overall Study|Lost to Follow-up|0|||
163825784|NCT01565707|591730578|FG002|Overall Study|Lost to Follow-up|0|||
163825785|NCT01565707|591730579|FG003|Overall Study|Lost to Follow-up|0|||
163825786|NCT01565707|591730576|FG000|Overall Study|Protocol Violation|1|||
163825787|NCT01565707|591730577|FG001|Overall Study|Protocol Violation|0|||
163825788|NCT01565707|591730578|FG002|Overall Study|Protocol Violation|0|||
164097042|NCT01015625|592719036|FG000|Overall Study|Physician Decision|2|||
164097043|NCT01015625|592719037|FG001|Overall Study|Physician Decision|0|||
164097044|NCT01015625|592719036|FG000|Overall Study|Death|30|||
164097045|NCT01015625|592719037|FG001|Overall Study|Death|22|||
164097046|NCT00150462|592719040|FG000|Overall Study|Disease Progression or Relapse|3|||
163825789|NCT01565707|591730579|FG003|Overall Study|Protocol Violation|1|||
163825790|NCT01565707|591730576|FG000|Overall Study|Withdrawal by Subject|3|||
163825791|NCT01565707|591730577|FG001|Overall Study|Withdrawal by Subject|1|||
163825792|NCT01565707|591730578|FG002|Overall Study|Withdrawal by Subject|1|||
163825793|NCT01565707|591730579|FG003|Overall Study|Withdrawal by Subject|1|||
163825794|NCT01565707|591730576|FG000|Overall Study|Randomized but not evaluable|2|||
163825795|NCT01565707|591730577|FG001|Overall Study|Randomized but not evaluable|0|||
163825796|NCT01565707|591730578|FG002|Overall Study|Randomized but not evaluable|0|||
163825797|NCT01565707|591730579|FG003|Overall Study|Randomized but not evaluable|0|||
163825798|NCT01565707|591730576|FG000|Overall Study|Miscellaneous|1|||
163825799|NCT01565707|591730577|FG001|Overall Study|Miscellaneous|1|||
163825800|NCT01565707|591730578|FG002|Overall Study|Miscellaneous|0|||
163825801|NCT01565707|591730579|FG003|Overall Study|Miscellaneous|2|||
163825802|NCT01371851|591730580|FG000|Overall Study|Lost to Follow-up|5|||
163825803|NCT01371851|591730581|FG001|Overall Study|Lost to Follow-up|8|||
163825804|NCT01371851|591730580|FG000|Overall Study|was arrested and put in jail|0|||
163825805|NCT01371851|591730581|FG001|Overall Study|was arrested and put in jail|1|||
163825806|NCT01371851|591730580|FG000|Overall Study|non study related adverse event|1|||
163825807|NCT01371851|591730581|FG001|Overall Study|non study related adverse event|0|||
163825808|NCT01371851|591730580|FG000|Overall Study|Blood Pressure outside study parameters|2|||
163825809|NCT01371851|591730581|FG001|Overall Study|Blood Pressure outside study parameters|0|||
163825810|NCT00450411|591730582|FG000|Overall Study|Protocol Violation|6|||
163825811|NCT00450411|591730582|FG000|Overall Study|No protocol treatment|2|||
163825812|NCT03969719|591730593|FG000|Overall Study|Other reasons not specified|1|||
163825813|NCT03969719|591730594|FG001|Overall Study|Other reasons not specified|1|||
163825814|NCT03969719|591730595|FG002|Overall Study|Other reasons not specified|3|||
163825815|NCT03969719|591730593|FG000|Overall Study|Withdrawal by Subject|2|||
163825816|NCT03969719|591730594|FG001|Overall Study|Withdrawal by Subject|3|||
163825817|NCT03969719|591730595|FG002|Overall Study|Withdrawal by Subject|2|||
163825818|NCT03969719|591730593|FG000|Overall Study|Protocol Violation|1|||
163825819|NCT03969719|591730594|FG001|Overall Study|Protocol Violation|2|||
163825820|NCT03969719|591730595|FG002|Overall Study|Protocol Violation|0|||
163825821|NCT03969719|591730593|FG000|Overall Study|Adverse Event|0|||
163825822|NCT03969719|591730594|FG001|Overall Study|Adverse Event|2|||
163825823|NCT03969719|591730595|FG002|Overall Study|Adverse Event|0|||
163825824|NCT03969719|591730593|FG000|Overall Study|Lost to Follow-up|0|||
163825825|NCT03969719|591730594|FG001|Overall Study|Lost to Follow-up|1|||
163825826|NCT03969719|591730595|FG002|Overall Study|Lost to Follow-up|0|||
163825827|NCT05608629|591730596|FG000|Overall Study|Lost to Follow-up|2|||
163825828|NCT02130193|591730597|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
163825829|NCT02130193|591730598|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
163825830|NCT02130193|591730599|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
163825831|NCT02130193|591730597|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
163825832|NCT02130193|591730598|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
163825833|NCT02130193|591730599|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
163825834|NCT02130193|591730597|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
163825835|NCT02130193|591730598|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
163825836|NCT02130193|591730599|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
163825837|NCT02130193|591730597|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
163825838|NCT02130193|591730598|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
163825839|NCT02130193|591730599|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
163825840|NCT01212770|591730600|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
163825841|NCT01212770|591730601|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
163825842|NCT01212770|591730602|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
163825843|NCT01212770|591730603|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163825844|NCT01212770|591730604|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
164097047|NCT00150462|592719041|FG001|Overall Study|Disease Progression or Relapse|1|||
164097048|NCT00150462|592719042|FG002|Overall Study|Disease Progression or Relapse|2|||
163825845|NCT01212770|591730605|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163825846|NCT01212770|591730606|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163825847|NCT01212770|591730607|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163825848|NCT01212770|591730608|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
163825849|NCT01212770|591730600|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
163825850|NCT01212770|591730601|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
163825851|NCT01212770|591730602|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
163825852|NCT01212770|591730603|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
164097049|NCT00150462|592719043|FG003|Overall Study|Disease Progression or Relapse|1|||
163825853|NCT01212770|591730604|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163825854|NCT01212770|591730605|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163825855|NCT01212770|591730606|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163825856|NCT01212770|591730607|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163825857|NCT01212770|591730608|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
163825858|NCT01212770|591730600|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
163825859|NCT01212770|591730601|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
163825860|NCT01212770|591730602|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
163825861|NCT01212770|591730603|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163825862|NCT01212770|591730604|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163825863|NCT01212770|591730605|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163825864|NCT01212770|591730606|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163825865|NCT01212770|591730607|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163825866|NCT01212770|591730608|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
163825867|NCT01212770|591730600|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
163825868|NCT01212770|591730601|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825869|NCT01212770|591730602|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
163825870|NCT01212770|591730603|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825871|NCT01212770|591730604|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825872|NCT01212770|591730605|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825873|NCT01212770|591730606|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825874|NCT01212770|591730607|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825875|NCT01212770|591730608|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
163825876|NCT01212770|591730600|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825877|NCT01212770|591730601|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825878|NCT01212770|591730602|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
163825879|NCT01212770|591730603|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825880|NCT01212770|591730604|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825881|NCT01212770|591730605|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825882|NCT01212770|591730606|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825883|NCT01212770|591730607|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825884|NCT01212770|591730608|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
163825885|NCT01212770|591730600|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
163825886|NCT01212770|591730601|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
163825887|NCT01212770|591730602|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
163825888|NCT01212770|591730603|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163825889|NCT01212770|591730604|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163825890|NCT01212770|591730605|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163825891|NCT01212770|591730606|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163825892|NCT01212770|591730607|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163825893|NCT01212770|591730608|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
163825894|NCT01212770|591730600|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163825895|NCT01212770|591730601|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
163825896|NCT01212770|591730602|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
163825897|NCT01212770|591730603|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
163825898|NCT01212770|591730604|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163825899|NCT01212770|591730605|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163825900|NCT01212770|591730606|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
163825901|NCT01212770|591730607|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163825902|NCT01212770|591730608|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
163825903|NCT01212770|591730600|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163825904|NCT01212770|591730601|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
163825905|NCT01212770|591730602|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
163825906|NCT01212770|591730603|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
163825907|NCT01212770|591730604|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
163825908|NCT01212770|591730605|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
163825909|NCT01212770|591730606|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163825910|NCT01212770|591730607|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163825911|NCT01212770|591730608|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
163825912|NCT01212770|591730600|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
163825913|NCT01212770|591730601|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
163825914|NCT01212770|591730602|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
163825915|NCT01212770|591730603|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
163825916|NCT01212770|591730604|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
164146985|NCT00443729|592899921|FG001|Overall Study|Physician Decision|1|||
163825917|NCT01212770|591730605|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
163825918|NCT01212770|591730606|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
163825919|NCT01212770|591730607|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
163825920|NCT01212770|591730608|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
163825921|NCT01212770|591730600|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825922|NCT01212770|591730601|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825923|NCT01212770|591730602|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
163825924|NCT01212770|591730603|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825925|NCT01212770|591730604|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825926|NCT01212770|591730605|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825927|NCT01212770|591730606|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825928|NCT01212770|591730607|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825929|NCT01212770|591730608|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
163825930|NCT01212770|591730600|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825931|NCT01212770|591730601|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825932|NCT01212770|591730602|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825933|NCT01212770|591730603|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
163825934|NCT01212770|591730604|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825935|NCT01212770|591730605|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825936|NCT01212770|591730606|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825937|NCT01212770|591730607|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825938|NCT01212770|591730608|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
163825939|NCT01212770|591730600|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825940|NCT01212770|591730601|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825941|NCT01212770|591730602|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
163825942|NCT01212770|591730603|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
163825943|NCT01212770|591730604|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825944|NCT01212770|591730605|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825945|NCT01212770|591730606|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825946|NCT01212770|591730607|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825947|NCT01212770|591730608|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
163825948|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163825949|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
163825950|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
163825951|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163825952|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163825953|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163825954|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163825955|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
163825956|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
163825957|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163825958|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
163825959|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
163825960|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163825961|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163825962|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163825963|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
163825964|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
163825965|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
163825966|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825967|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
163825968|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825969|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825970|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825971|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825972|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825973|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825974|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
163825975|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163825976|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
163825977|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
163825978|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163825979|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163825980|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
164031945|NCT04664855|592476290|FG001|Overall Study|Withdrawal by Subject|2|||
163825981|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
163825982|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
163825983|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
163825984|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163825985|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
163825986|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
163825987|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163825988|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163825989|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163825990|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
163825991|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
163825992|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
163825993|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163825994|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
163825995|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163825996|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163825997|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163825998|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163825999|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163826000|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
163826001|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
163826002|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163826003|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163826004|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163826005|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163826006|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163826007|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163826008|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
163826009|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
163826010|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
163826011|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163826012|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
163826013|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
163826014|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163826015|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163826016|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163826017|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
163826018|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163826019|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
163826020|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163826021|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
163826022|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
163826023|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163826024|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163826025|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163826026|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
163826027|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163826028|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
163826029|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826030|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
163826031|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826032|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826033|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826034|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826035|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826036|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826037|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
163826038|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826039|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826040|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826041|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826042|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826043|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826044|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163920322|NCT00475735|592077810|FG000|Treatment Period 1|DC due to AE but continuing|0|||
163920323|NCT00475735|592077811|FG001|Treatment Period 1|DC due to AE but continuing|0|||
163920324|NCT00475735|592077812|FG002|Treatment Period 1|DC due to AE but continuing|0|||
163920325|NCT00475735|592077813|FG003|Treatment Period 1|DC due to AE but continuing|1|||
163920326|NCT00475735|592077814|FG004|Treatment Period 1|DC due to AE but continuing|2|||
163920327|NCT00475735|592077815|FG005|Treatment Period 1|DC due to AE but continuing|2|||
163826045|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
163826046|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
163826047|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163826048|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
163826049|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163826050|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163826051|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163826052|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163826053|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
163826054|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163826055|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
163826056|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163826057|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
163826058|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
163826059|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163826060|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163826061|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163826062|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163826063|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
163826064|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
163826065|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163826066|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
163826067|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
163826068|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163826069|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163826070|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163826071|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163826072|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
163826073|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
163826074|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163826075|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
163826076|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
163826077|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163826078|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163826079|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163826080|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163826081|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
163826082|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
163826083|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826084|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
163826085|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
163826086|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826087|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826088|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826089|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826090|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826091|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
163826092|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826093|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826094|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
163826095|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826096|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826097|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826098|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826099|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826100|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
163826101|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826102|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
163826103|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826104|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826105|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826106|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826107|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826108|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
163826109|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
163826110|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
163826111|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
163826112|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
163826113|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
163826114|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
163826115|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
163826116|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
163826117|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
163826118|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
163826119|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826120|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826121|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
163826122|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826123|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826124|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826125|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826126|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826127|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
163826128|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826129|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826130|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
163826131|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826132|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826133|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826134|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826135|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
163826136|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
163826137|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826138|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826139|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
163826140|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826141|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826142|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826143|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826144|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826145|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
163826146|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163826147|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
163826148|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163826149|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163826150|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163826151|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163826152|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163826153|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
163826154|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
163826155|NCT01212770|591730600|FG000|Long-term Safety Phase (Year 5)|Death|0|||
163826156|NCT01212770|591730601|FG001|Long-term Safety Phase (Year 5)|Death|0|||
163826157|NCT01212770|591730602|FG002|Long-term Safety Phase (Year 5)|Death|0|||
163826158|NCT01212770|591730603|FG003|Long-term Safety Phase (Year 5)|Death|0|||
163826159|NCT01212770|591730604|FG004|Long-term Safety Phase (Year 5)|Death|0|||
163826160|NCT01212770|591730605|FG005|Long-term Safety Phase (Year 5)|Death|0|||
163826161|NCT01212770|591730606|FG006|Long-term Safety Phase (Year 5)|Death|0|||
163826162|NCT01212770|591730607|FG007|Long-term Safety Phase (Year 5)|Death|1|||
163826163|NCT01212770|591730608|FG008|Long-term Safety Phase (Year 5)|Death|0|||
163826164|NCT01297959|591730609|FG000|Overall Study|Adverse Event|0|||
163826165|NCT01297959|591730610|FG001|Overall Study|Adverse Event|1|||
163826166|NCT01297959|591730609|FG000|Overall Study|Protocol Violation|2|||
163826167|NCT01297959|591730610|FG001|Overall Study|Protocol Violation|1|||
163826168|NCT01297959|591730609|FG000|Overall Study|Withdrawal by Subject|5|||
163826169|NCT01297959|591730610|FG001|Overall Study|Withdrawal by Subject|4|||
163826170|NCT01297959|591730609|FG000|Overall Study|Physician Decision|0|||
163826171|NCT01297959|591730610|FG001|Overall Study|Physician Decision|1|||
163826172|NCT01297959|591730609|FG000|Overall Study|Unrelated medical illness / complication|0|||
163826173|NCT01297959|591730610|FG001|Overall Study|Unrelated medical illness / complication|2|||
163826174|NCT01297959|591730609|FG000|Overall Study|Other|13|||
163826175|NCT01297959|591730610|FG001|Overall Study|Other|7|||
163826176|NCT03519854|591730613|FG000|Overall Study|Technical Error|0|||
163826177|NCT03519854|591730614|FG001|Overall Study|Technical Error|0|||
163826178|NCT03519854|591730615|FG002|Overall Study|Technical Error|1|||
163826179|NCT03519854|591730616|FG003|Overall Study|Technical Error|0|||
163826180|NCT03519854|591730617|FG004|Overall Study|Technical Error|0|||
163826181|NCT03519854|591730618|FG005|Overall Study|Technical Error|0|||
163826182|NCT03519854|591730619|FG006|Overall Study|Technical Error|0|||
163826183|NCT03519854|591730620|FG007|Overall Study|Technical Error|0|||
163826184|NCT03519854|591730621|FG008|Overall Study|Technical Error|0|||
163826185|NCT03519854|591730622|FG009|Overall Study|Technical Error|0|||
163920328|NCT00475735|592077810|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163920329|NCT00475735|592077811|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
163920330|NCT00475735|592077812|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163920331|NCT00475735|592077813|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163920332|NCT00475735|592077814|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163920333|NCT00475735|592077815|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
163920334|NCT00475735|592077810|FG000|Treatment Washout|Lost to Follow-up|0|||
163920335|NCT00475735|592077811|FG001|Treatment Washout|Lost to Follow-up|1|||
163920336|NCT00475735|592077812|FG002|Treatment Washout|Lost to Follow-up|0|||
163920337|NCT00475735|592077813|FG003|Treatment Washout|Lost to Follow-up|0|||
163920338|NCT00475735|592077814|FG004|Treatment Washout|Lost to Follow-up|0|||
163920339|NCT00475735|592077815|FG005|Treatment Washout|Lost to Follow-up|0|||
163920340|NCT00475735|592077810|FG000|Treatment Washout|Protocol Violation|0|||
163920341|NCT00475735|592077811|FG001|Treatment Washout|Protocol Violation|1|||
163920342|NCT00475735|592077812|FG002|Treatment Washout|Protocol Violation|0|||
163920343|NCT00475735|592077813|FG003|Treatment Washout|Protocol Violation|0|||
163920344|NCT00475735|592077814|FG004|Treatment Washout|Protocol Violation|0|||
163920345|NCT00475735|592077815|FG005|Treatment Washout|Protocol Violation|0|||
163920346|NCT00475735|592077810|FG000|Treatment Period 2|Adverse Event|0|||
163920347|NCT00475735|592077811|FG001|Treatment Period 2|Adverse Event|1|||
163920348|NCT00475735|592077812|FG002|Treatment Period 2|Adverse Event|0|||
163920349|NCT00475735|592077813|FG003|Treatment Period 2|Adverse Event|2|||
163920350|NCT00475735|592077814|FG004|Treatment Period 2|Adverse Event|0|||
163920351|NCT00475735|592077815|FG005|Treatment Period 2|Adverse Event|0|||
163920352|NCT00475735|592077810|FG000|Treatment Period 2|Lack of Efficacy|0|||
163920353|NCT00475735|592077811|FG001|Treatment Period 2|Lack of Efficacy|0|||
163920354|NCT00475735|592077812|FG002|Treatment Period 2|Lack of Efficacy|0|||
163920355|NCT00475735|592077813|FG003|Treatment Period 2|Lack of Efficacy|0|||
163920356|NCT00475735|592077814|FG004|Treatment Period 2|Lack of Efficacy|0|||
163920357|NCT00475735|592077815|FG005|Treatment Period 2|Lack of Efficacy|1|||
163920358|NCT00475735|592077810|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163920359|NCT00475735|592077811|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163920360|NCT00475735|592077812|FG002|Treatment Period 2|Withdrawal by Subject|0|||
163920361|NCT00475735|592077813|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163920362|NCT00475735|592077814|FG004|Treatment Period 2|Withdrawal by Subject|1|||
163920363|NCT00475735|592077815|FG005|Treatment Period 2|Withdrawal by Subject|0|||
163920364|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
163920365|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163920366|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163920367|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163920368|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
163920369|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
163920370|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163920371|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163920372|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163920373|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
163920374|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
163920375|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163920376|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163920377|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163920378|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
163920379|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
163920380|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163920381|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163920382|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163920383|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
163920384|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
163920385|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163920386|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163920387|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
163920388|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
164031946|NCT03076190|592476291|FG000|Overall Study|Lost to Follow-up|9|||
163920389|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
163920390|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163920391|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163920392|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163920393|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
163920394|NCT01187407|592077816|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
163920395|NCT01187407|592077817|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163920396|NCT01187407|592077818|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
164031947|NCT03076190|592476292|FG001|Overall Study|Lost to Follow-up|34|||
163826186|NCT03519854|591730623|FG010|Overall Study|Technical Error|0|||
163826187|NCT03519854|591730624|FG011|Overall Study|Technical Error|0|||
163826188|NCT03519854|591730625|FG012|Overall Study|Technical Error|0|||
163826189|NCT03519854|591730626|FG013|Overall Study|Technical Error|0|||
163826190|NCT03519854|591730627|FG014|Overall Study|Technical Error|0|||
163826191|NCT03519854|591730628|FG015|Overall Study|Technical Error|0|||
163826192|NCT03519854|591730629|FG016|Overall Study|Technical Error|0|||
163826193|NCT03519854|591730630|FG017|Overall Study|Technical Error|0|||
163826194|NCT00707031|591730631|FG000|Overall Study|Adverse Event|45|||
163826195|NCT00707031|591730632|FG001|Overall Study|Adverse Event|45|||
163826196|NCT00707031|591730631|FG000|Overall Study|Lack of Efficacy|19|||
163826197|NCT00707031|591730632|FG001|Overall Study|Lack of Efficacy|6|||
163826198|NCT00707031|591730631|FG000|Overall Study|Lost to Follow-up|2|||
163826199|NCT00707031|591730632|FG001|Overall Study|Lost to Follow-up|1|||
163826200|NCT00707031|591730631|FG000|Overall Study|Protocol Violation|1|||
163826201|NCT00707031|591730632|FG001|Overall Study|Protocol Violation|0|||
163826202|NCT00707031|591730631|FG000|Overall Study|Withdrawal by Subject|7|||
163826203|NCT00707031|591730632|FG001|Overall Study|Withdrawal by Subject|8|||
163826204|NCT00707031|591730631|FG000|Overall Study|Poor Compliance to Protocol|7|||
163826205|NCT00707031|591730632|FG001|Overall Study|Poor Compliance to Protocol|13|||
163826206|NCT00707031|591730631|FG000|Overall Study|Familial or Personal Reasons|12|||
163826207|NCT00707031|591730632|FG001|Overall Study|Familial or Personal Reasons|15|||
163826208|NCT00707031|591730631|FG000|Overall Study|Serious Noncompliance|2|||
163826209|NCT00707031|591730632|FG001|Overall Study|Serious Noncompliance|3|||
163826210|NCT00707031|591730631|FG000|Overall Study|Sponsor Decision|9|||
163826211|NCT00707031|591730632|FG001|Overall Study|Sponsor Decision|8|||
163826212|NCT00951275|591730633|FG000|Overall Study|Administrative Reason|1|||
163826213|NCT00951275|591730633|FG000|Overall Study|Adverse Event|7|||
163826214|NCT00951275|591730633|FG000|Overall Study|Withdrawal by Subject|4|||
163826215|NCT00951275|591730633|FG000|Overall Study|Protocol Violation|1|||
163826216|NCT02925676|591730637|FG000|Overall Study|Withdrawal by Subject|1|||
163826217|NCT02048072|591730638|FG000|Overall Study|Adverse Event|3|||
163826218|NCT02048072|591730638|FG000|Overall Study|Lost to Follow-up|1|||
163826219|NCT04304833|591730639|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
163826220|NCT04304833|591730640|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
163826221|NCT03776136|591730641|FG000|Overall Study|Death|85|||
163826222|NCT03776136|591730641|FG000|Overall Study|Withdrawal by Subject|3|||
163826223|NCT03776136|591730641|FG000|Overall Study|Sponsor Decision|15|||
163826224|NCT02858895|591730642|FG000|Overall Study|Disease progression|31|||
163826225|NCT02858895|591730642|FG000|Overall Study|Death|2|||
163826226|NCT02858895|591730642|FG000|Overall Study|Adverse Event|1|||
163826227|NCT02858895|591730642|FG000|Overall Study|Withdrawal by Subject|3|||
163826228|NCT02858895|591730642|FG000|Overall Study|hospice,|1|||
163826229|NCT02858895|591730642|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
163826230|NCT00251745|591730646|FG000|Overall Study|Adverse Event|7|||
163826231|NCT00251745|591730647|FG001|Overall Study|Adverse Event|9|||
163826232|NCT00251745|591730648|FG002|Overall Study|Adverse Event|11|||
163826233|NCT00251745|591730646|FG000|Overall Study|Lost to Follow-up|4|||
163826234|NCT00251745|591730647|FG001|Overall Study|Lost to Follow-up|2|||
163826235|NCT00251745|591730648|FG002|Overall Study|Lost to Follow-up|5|||
163826236|NCT00251745|591730646|FG000|Overall Study|Withdrawal by Subject|13|||
163826237|NCT00251745|591730647|FG001|Overall Study|Withdrawal by Subject|7|||
163826238|NCT00251745|591730648|FG002|Overall Study|Withdrawal by Subject|3|||
163826239|NCT00251745|591730646|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
163826240|NCT00251745|591730647|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
163826241|NCT00251745|591730648|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
163826242|NCT00251745|591730646|FG000|Overall Study|Lack of Efficacy|3|||
163826243|NCT00251745|591730647|FG001|Overall Study|Lack of Efficacy|0|||
163826244|NCT00251745|591730648|FG002|Overall Study|Lack of Efficacy|0|||
163826245|NCT00251745|591730646|FG000|Overall Study|Noncompliant|0|||
163826246|NCT00251745|591730647|FG001|Overall Study|Noncompliant|2|||
163826247|NCT00251745|591730648|FG002|Overall Study|Noncompliant|2|||
163826248|NCT00251745|591730646|FG000|Overall Study|Pregnancy|0|||
163826249|NCT00251745|591730647|FG001|Overall Study|Pregnancy|1|||
163826250|NCT00251745|591730648|FG002|Overall Study|Pregnancy|0|||
163826251|NCT00251745|591730646|FG000|Overall Study|Per Subject Request|0|||
163826252|NCT00251745|591730647|FG001|Overall Study|Per Subject Request|0|||
164031948|NCT03076190|592476291|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
163826253|NCT00251745|591730648|FG002|Overall Study|Per Subject Request|1|||
163826254|NCT00251745|591730646|FG000|Overall Study|Per Investigator Request|1|||
164031949|NCT03076190|592476292|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
163826255|NCT00251745|591730647|FG001|Overall Study|Per Investigator Request|0|||
163826256|NCT00251745|591730648|FG002|Overall Study|Per Investigator Request|0|||
163826257|NCT02543658|591732364|FG000|Overall Study|Lack of Efficacy|0|||
163826258|NCT02543658|591732365|FG001|Overall Study|Lack of Efficacy|4|||
163826259|NCT00789815|591732366|FG000|Overall Study|Protocol Violation|6|||
163826260|NCT00789815|591732367|FG001|Overall Study|Protocol Violation|1|||
163826261|NCT00789815|591732366|FG000|Overall Study|Intubation due to massive bleeding|1|||
164031950|NCT01441115|592476293|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
164031951|NCT01086150|592476299|FG000|Overall Study|Withdrawal by Subject|0|||
164031952|NCT01086150|592476300|FG001|Overall Study|Withdrawal by Subject|4|||
164031953|NCT01086150|592476301|FG002|Overall Study|Withdrawal by Subject|1|||
164031954|NCT01086150|592476299|FG000|Overall Study|Lost to Follow-up|0|||
163826262|NCT00789815|591732367|FG001|Overall Study|Intubation due to massive bleeding|0|||
163826263|NCT03255824|591732371|FG000|Overall Study|Under-sedation|2|||
163826264|NCT03255824|591732372|FG001|Overall Study|Under-sedation|1|||
163826265|NCT03432364|591732377|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
163826266|NCT00522301|591732378|FG000|Overall Study|Withdrawal by Subject|1|||
163826267|NCT00522301|591732378|FG000|Overall Study|Adverse Event|5|||
163826268|NCT03040713|591732379|FG000|Overall Study|Positive amyloid scan|3|||
163826269|NCT03813238|591732388|FG000|Overall Study|Adverse Event|0|||
163826270|NCT03813238|591732389|FG001|Overall Study|Adverse Event|6|||
163826271|NCT03813238|591732388|FG000|Overall Study|Withdrawal by parent/guardian|0|||
163826272|NCT03813238|591732389|FG001|Overall Study|Withdrawal by parent/guardian|2|||
163826273|NCT03813238|591732388|FG000|Overall Study|Lost to Follow-up|0|||
163826274|NCT03813238|591732389|FG001|Overall Study|Lost to Follow-up|1|||
163826275|NCT03813238|591732388|FG000|Overall Study|Other than specified|1|||
163826276|NCT03813238|591732389|FG001|Overall Study|Other than specified|2|||
163826277|NCT02066402|591732390|FG000|Overall Study|Adverse Event|1|||
163826278|NCT02066402|591732391|FG001|Overall Study|Adverse Event|2|||
163826279|NCT02066402|591732390|FG000|Overall Study|Lost to Follow-up|11|||
163826280|NCT02066402|591732391|FG001|Overall Study|Lost to Follow-up|8|||
163826281|NCT02066402|591732390|FG000|Overall Study|Withdrawal by Subject|14|||
163826282|NCT02066402|591732391|FG001|Overall Study|Withdrawal by Subject|11|||
163826283|NCT02066402|591732390|FG000|Overall Study|Progressive disease-clinical progression|0|||
163826284|NCT02066402|591732391|FG001|Overall Study|Progressive disease-clinical progression|1|||
163826285|NCT02066402|591732390|FG000|Overall Study|Protocol driven decision point|0|||
163826286|NCT02066402|591732391|FG001|Overall Study|Protocol driven decision point|1|||
163826287|NCT00152464|591732392|FG000|Overall Study|Adverse Event|3|||
163826288|NCT00152464|591732393|FG001|Overall Study|Adverse Event|6|||
163826289|NCT00152464|591732392|FG000|Overall Study|Lost to Follow-up|8|||
163826290|NCT00152464|591732393|FG001|Overall Study|Lost to Follow-up|4|||
163826291|NCT00152464|591732392|FG000|Overall Study|Protocol Violation|3|||
163826292|NCT00152464|591732393|FG001|Overall Study|Protocol Violation|1|||
163826293|NCT00152464|591732392|FG000|Overall Study|Withdrawal by Subject|21|||
163826294|NCT00152464|591732393|FG001|Overall Study|Withdrawal by Subject|22|||
163826295|NCT00152464|591732392|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
163826296|NCT00152464|591732393|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
163826297|NCT00152464|591732392|FG000|Overall Study|Eczema deterioration|0|||
163826298|NCT00152464|591732393|FG001|Overall Study|Eczema deterioration|1|||
163826299|NCT00152464|591732392|FG000|Overall Study|Parent decision|1|||
163826300|NCT00152464|591732393|FG001|Overall Study|Parent decision|1|||
163826301|NCT00152464|591732392|FG000|Overall Study|Investigator decision|1|||
163826302|NCT00152464|591732393|FG001|Overall Study|Investigator decision|0|||
163826303|NCT00152464|591732392|FG000|Overall Study|Lack of Efficacy|1|||
163826304|NCT00152464|591732393|FG001|Overall Study|Lack of Efficacy|0|||
163826305|NCT00152464|591732392|FG000|Overall Study|Eczema poorly controlled|1|||
163826306|NCT00152464|591732393|FG001|Overall Study|Eczema poorly controlled|0|||
163826307|NCT00152464|591732392|FG000|Overall Study|Patient relocated|1|||
163826308|NCT00152464|591732393|FG001|Overall Study|Patient relocated|0|||
163826309|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
163826310|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
163826311|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
163826312|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
163826313|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
163826314|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
163826315|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
163826316|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
163826317|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Other|18|||
164031955|NCT01086150|592476300|FG001|Overall Study|Lost to Follow-up|1|||
163826318|NCT02565914|591732394|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
163826319|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
163826320|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Other|1|||
163826321|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
163826322|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
163826323|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
163826324|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
163826325|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
164031956|NCT01086150|592476301|FG002|Overall Study|Lost to Follow-up|0|||
163826326|NCT02565914|591732394|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
163826327|NCT02565914|591732394|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
164031957|NCT01086150|592476299|FG000|Overall Study|Screen Failure|0|||
164097050|NCT00150462|592719044|FG004|Overall Study|Disease Progression or Relapse|2|||
164097051|NCT00150462|592719045|FG005|Overall Study|Disease Progression or Relapse|2|||
164097052|NCT00150462|592719046|FG006|Overall Study|Disease Progression or Relapse|3|||
164097053|NCT00150462|592719047|FG007|Overall Study|Disease Progression or Relapse|5|||
164097054|NCT00150462|592719048|FG008|Overall Study|Disease Progression or Relapse|5|||
164097055|NCT00150462|592719049|FG009|Overall Study|Disease Progression or Relapse|3|||
164097056|NCT00150462|592719050|FG010|Overall Study|Disease Progression or Relapse|2|||
164097057|NCT00150462|592719040|FG000|Overall Study|Withdrawal by Subject|0|||
164097058|NCT00150462|592719041|FG001|Overall Study|Withdrawal by Subject|1|||
164097059|NCT00150462|592719042|FG002|Overall Study|Withdrawal by Subject|1|||
164097060|NCT00150462|592719043|FG003|Overall Study|Withdrawal by Subject|0|||
164097061|NCT00150462|592719044|FG004|Overall Study|Withdrawal by Subject|1|||
164097062|NCT00150462|592719045|FG005|Overall Study|Withdrawal by Subject|2|||
164097063|NCT00150462|592719046|FG006|Overall Study|Withdrawal by Subject|0|||
164097064|NCT00150462|592719047|FG007|Overall Study|Withdrawal by Subject|1|||
164097065|NCT00150462|592719048|FG008|Overall Study|Withdrawal by Subject|0|||
164097066|NCT00150462|592719049|FG009|Overall Study|Withdrawal by Subject|1|||
164097067|NCT00150462|592719050|FG010|Overall Study|Withdrawal by Subject|0|||
164097068|NCT00150462|592719040|FG000|Overall Study|Death|0|||
164097069|NCT00150462|592719041|FG001|Overall Study|Death|1|||
164097070|NCT00150462|592719042|FG002|Overall Study|Death|0|||
164097071|NCT00150462|592719043|FG003|Overall Study|Death|0|||
164097072|NCT00150462|592719044|FG004|Overall Study|Death|0|||
164097073|NCT00150462|592719045|FG005|Overall Study|Death|0|||
164097074|NCT00150462|592719046|FG006|Overall Study|Death|0|||
164097075|NCT00150462|592719047|FG007|Overall Study|Death|0|||
164097076|NCT00150462|592719048|FG008|Overall Study|Death|1|||
164097077|NCT00150462|592719049|FG009|Overall Study|Death|0|||
164097078|NCT00150462|592719050|FG010|Overall Study|Death|0|||
164097079|NCT00150462|592719040|FG000|Overall Study|Adverse Event|0|||
164097080|NCT00150462|592719041|FG001|Overall Study|Adverse Event|0|||
164097081|NCT00150462|592719042|FG002|Overall Study|Adverse Event|0|||
164097082|NCT00150462|592719043|FG003|Overall Study|Adverse Event|1|||
164097083|NCT00150462|592719044|FG004|Overall Study|Adverse Event|0|||
164097084|NCT00150462|592719045|FG005|Overall Study|Adverse Event|0|||
164097085|NCT00150462|592719046|FG006|Overall Study|Adverse Event|0|||
164097086|NCT00150462|592719047|FG007|Overall Study|Adverse Event|2|||
164097087|NCT00150462|592719048|FG008|Overall Study|Adverse Event|0|||
164097088|NCT00150462|592719049|FG009|Overall Study|Adverse Event|1|||
164031958|NCT01086150|592476300|FG001|Overall Study|Screen Failure|1|||
164031959|NCT01086150|592476301|FG002|Overall Study|Screen Failure|0|||
164031960|NCT00870818|592476303|FG000|Overall Study|Lost to Follow-up|3|||
164031961|NCT00870818|592476304|FG001|Overall Study|Lost to Follow-up|2|||
164031962|NCT00870818|592476305|FG002|Overall Study|Lost to Follow-up|1|||
164031963|NCT00870818|592476306|FG003|Overall Study|Lost to Follow-up|0|||
164031964|NCT00870818|592476307|FG004|Overall Study|Lost to Follow-up|0|||
164031965|NCT00870818|592476303|FG000|Overall Study|Withdrawal by Subject|0|||
164031966|NCT00870818|592476304|FG001|Overall Study|Withdrawal by Subject|0|||
164031967|NCT00870818|592476305|FG002|Overall Study|Withdrawal by Subject|1|||
164097089|NCT00150462|592719050|FG010|Overall Study|Adverse Event|0|||
164097090|NCT00150462|592719040|FG000|Overall Study|Physician Decision|0|||
164097091|NCT00150462|592719041|FG001|Overall Study|Physician Decision|0|||
164097092|NCT00150462|592719042|FG002|Overall Study|Physician Decision|1|||
164097093|NCT00150462|592719043|FG003|Overall Study|Physician Decision|1|||
164097094|NCT00150462|592719044|FG004|Overall Study|Physician Decision|0|||
164031968|NCT00870818|592476306|FG003|Overall Study|Withdrawal by Subject|2|||
164097095|NCT00150462|592719045|FG005|Overall Study|Physician Decision|0|||
164097096|NCT00150462|592719046|FG006|Overall Study|Physician Decision|0|||
164097097|NCT00150462|592719047|FG007|Overall Study|Physician Decision|0|||
164097098|NCT00150462|592719048|FG008|Overall Study|Physician Decision|0|||
164097099|NCT00150462|592719049|FG009|Overall Study|Physician Decision|0|||
164097100|NCT00150462|592719050|FG010|Overall Study|Physician Decision|0|||
164097101|NCT00150462|592719040|FG000|Overall Study|Other|0|||
164097102|NCT00150462|592719041|FG001|Overall Study|Other|0|||
164097103|NCT00150462|592719042|FG002|Overall Study|Other|0|||
164097104|NCT00150462|592719043|FG003|Overall Study|Other|0|||
164097105|NCT00150462|592719044|FG004|Overall Study|Other|0|||
164097106|NCT00150462|592719045|FG005|Overall Study|Other|0|||
164097107|NCT00150462|592719046|FG006|Overall Study|Other|0|||
164097108|NCT00150462|592719047|FG007|Overall Study|Other|0|||
164097109|NCT00150462|592719048|FG008|Overall Study|Other|0|||
164097110|NCT00150462|592719049|FG009|Overall Study|Other|1|||
164097111|NCT00150462|592719050|FG010|Overall Study|Other|1|||
164097112|NCT03107091|592719053|FG000|Overall Study|Physician Decision|1|||
164031969|NCT00870818|592476307|FG004|Overall Study|Withdrawal by Subject|0|||
164031970|NCT00870818|592476303|FG000|Overall Study|Terminated by sponsor|29|||
164097113|NCT00912288|592719056|FG000|Overall Study|Death|0|||
164097114|NCT00912288|592719057|FG001|Overall Study|Death|1|||
164097115|NCT00912288|592719056|FG000|Overall Study|Adverse Event|1|||
164097116|NCT00912288|592719057|FG001|Overall Study|Adverse Event|1|||
164097117|NCT00912288|592719056|FG000|Overall Study|Lost to Follow-up|1|||
163826328|NCT02565914|591732394|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
163826329|NCT02565914|591732394|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
163826330|NCT02565914|591732394|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
163826331|NCT02565914|591732394|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
163826332|NCT02565914|591732394|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
163826333|NCT00828984|591732395|FG000|Overall Study|Adverse Event|2|||
163826334|NCT00828984|591732396|FG001|Overall Study|Adverse Event|3|||
163826335|NCT00828984|591732397|FG002|Overall Study|Adverse Event|0|||
163826336|NCT00828984|591732395|FG000|Overall Study|Lost to Follow-up|5|||
163826337|NCT00828984|591732396|FG001|Overall Study|Lost to Follow-up|3|||
163826338|NCT00828984|591732397|FG002|Overall Study|Lost to Follow-up|1|||
163826339|NCT00828984|591732395|FG000|Overall Study|Withdrawal by Subject|4|||
163826340|NCT00828984|591732396|FG001|Overall Study|Withdrawal by Subject|4|||
163826341|NCT00828984|591732397|FG002|Overall Study|Withdrawal by Subject|4|||
163826342|NCT00828984|591732395|FG000|Overall Study|Ineligable|1|||
163826343|NCT00828984|591732396|FG001|Overall Study|Ineligable|2|||
163826344|NCT00828984|591732397|FG002|Overall Study|Ineligable|0|||
163826345|NCT00828984|591732395|FG000|Overall Study|Medical Contraindication|0|||
163826346|NCT00828984|591732396|FG001|Overall Study|Medical Contraindication|1|||
163826347|NCT00828984|591732397|FG002|Overall Study|Medical Contraindication|0|||
163826348|NCT00828984|591732395|FG000|Overall Study|Noncompliant|1|||
163826349|NCT00828984|591732396|FG001|Overall Study|Noncompliant|2|||
163826350|NCT00828984|591732397|FG002|Overall Study|Noncompliant|3|||
163826351|NCT00828984|591732395|FG000|Overall Study|ConMed|1|||
163826352|NCT00828984|591732396|FG001|Overall Study|ConMed|1|||
163826353|NCT00828984|591732397|FG002|Overall Study|ConMed|1|||
163826354|NCT00863655|591732398|FG000|Overall Study|Protocol Violation|4|||
163826355|NCT00863655|591732399|FG001|Overall Study|Protocol Violation|0|||
163826356|NCT00863655|591732398|FG000|Overall Study|Adverse Event|52|||
163826357|NCT00863655|591732399|FG001|Overall Study|Adverse Event|8|||
163826358|NCT00863655|591732398|FG000|Overall Study|Withdrawal by Subject|47|||
163826359|NCT00863655|591732399|FG001|Overall Study|Withdrawal by Subject|7|||
163826360|NCT00863655|591732398|FG000|Overall Study|Administrative problems|1|||
163826361|NCT00863655|591732399|FG001|Overall Study|Administrative problems|0|||
164031971|NCT00870818|592476304|FG001|Overall Study|Terminated by sponsor|70|||
164031972|NCT00870818|592476305|FG002|Overall Study|Terminated by sponsor|36|||
164031973|NCT00870818|592476306|FG003|Overall Study|Terminated by sponsor|36|||
164031974|NCT00870818|592476307|FG004|Overall Study|Terminated by sponsor|38|||
164031975|NCT00870818|592476303|FG000|Overall Study|Other|0|||
164031976|NCT00870818|592476304|FG001|Overall Study|Other|1|||
164031977|NCT00870818|592476305|FG002|Overall Study|Other|0|||
164031978|NCT00870818|592476306|FG003|Overall Study|Other|0|||
163826362|NCT00863655|591732398|FG000|Overall Study|Death|7|||
163826363|NCT00863655|591732399|FG001|Overall Study|Death|1|||
163826364|NCT00863655|591732398|FG000|Overall Study|New cancer therapy|5|||
163826365|NCT00863655|591732399|FG001|Overall Study|New cancer therapy|1|||
163826366|NCT00863655|591732398|FG000|Overall Study|Disease progression|364|||
163826367|NCT00863655|591732399|FG001|Overall Study|Disease progression|221|||
163826368|NCT00863655|591732398|FG000|Overall Study|Treatment completed as per protocol|5|||
163826369|NCT00863655|591732399|FG001|Overall Study|Treatment completed as per protocol|1|||
163826370|NCT00716092|591732410|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
163826371|NCT00716092|591732411|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
163826372|NCT00716092|591732412|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
163826373|NCT02436330|591732413|FG000|Cohort 1|Lost to Follow-up|5|||
163826374|NCT02436330|591732414|FG001|Cohort 1|Lost to Follow-up|2|||
163826375|NCT02436330|591732413|FG000|Cohort 1|Withdrawal by Subject|0|||
163826376|NCT02436330|591732414|FG001|Cohort 1|Withdrawal by Subject|1|||
163826377|NCT02436330|591732413|FG000|Cohort 2|Lost to Follow-up|2|||
163826378|NCT02436330|591732414|FG001|Cohort 2|Lost to Follow-up|0|||
163826379|NCT02436330|591732413|FG000|Cohort 2|Withdrawal by Subject|2|||
163826380|NCT02436330|591732414|FG001|Cohort 2|Withdrawal by Subject|3|||
163826381|NCT02436330|591732413|FG000|Cohort 3|Lost to Follow-up|1|||
163826382|NCT02436330|591732414|FG001|Cohort 3|Lost to Follow-up|0|||
163826383|NCT02436330|591732413|FG000|Cohort 3|Withdrawal by Subject|4|||
163826384|NCT02436330|591732414|FG001|Cohort 3|Withdrawal by Subject|0|||
163826385|NCT02436330|591732413|FG000|Cohort 4|Lost to Follow-up|1|||
163826386|NCT02436330|591732414|FG001|Cohort 4|Lost to Follow-up|0|||
163826387|NCT02436330|591732413|FG000|Cohort 4|Withdrawal by Subject|1|||
163826388|NCT02436330|591732414|FG001|Cohort 4|Withdrawal by Subject|0|||
163826389|NCT02436330|591732413|FG000|Cohort 5|Lost to Follow-up|3|||
163826390|NCT02436330|591732414|FG001|Cohort 5|Lost to Follow-up|2|||
163826391|NCT02436330|591732413|FG000|Cohort 5|Withdrawal by Subject|3|||
163826392|NCT02436330|591732414|FG001|Cohort 5|Withdrawal by Subject|2|||
163826393|NCT02436330|591732413|FG000|Cohort 6|Lost to Follow-up|2|||
163826394|NCT02436330|591732414|FG001|Cohort 6|Lost to Follow-up|0|||
163826395|NCT02436330|591732413|FG000|Cohort 6|Withdrawal by Subject|1|||
163826396|NCT02436330|591732414|FG001|Cohort 6|Withdrawal by Subject|1|||
163826397|NCT02054806|591732415|FG000|Overall Study|Sponsor Decision|31|||
164031979|NCT00870818|592476307|FG004|Overall Study|Other|0|||
164097118|NCT00912288|592719057|FG001|Overall Study|Lost to Follow-up|0|||
164097119|NCT00912288|592719056|FG000|Overall Study|Protocol Violation|1|||
164097120|NCT00912288|592719057|FG001|Overall Study|Protocol Violation|0|||
164097121|NCT00912288|592719056|FG000|Overall Study|Withdrawal by Subject|3|||
164097122|NCT00912288|592719057|FG001|Overall Study|Withdrawal by Subject|3|||
164097123|NCT00912288|592719056|FG000|Overall Study|Study terminated by sponsor|34|||
164097124|NCT00912288|592719057|FG001|Overall Study|Study terminated by sponsor|35|||
164097125|NCT00912288|592719056|FG000|Overall Study|Other|1|||
164097126|NCT00912288|592719057|FG001|Overall Study|Other|0|||
164097127|NCT01449630|592719058|FG000|Period 1|Physician Decision|1|||
164097128|NCT01449630|592719059|FG001|Period 1|Physician Decision|0|||
164097129|NCT01449630|592719060|FG002|Period 1|Physician Decision|0|||
164097130|NCT01449630|592719061|FG003|Period 1|Physician Decision|1|||
164097131|NCT01449630|592719062|FG004|Period 1|Physician Decision|0|||
164097132|NCT01449630|592719063|FG005|Period 1|Physician Decision|0|||
164097133|NCT01449630|592719064|FG006|Period 1|Physician Decision|0|||
164097134|NCT01449630|592719065|FG007|Period 1|Physician Decision|0|||
164097135|NCT01449630|592719066|FG008|Period 1|Physician Decision|0|||
164097136|NCT01449630|592719058|FG000|Period 1|Sponsor Decision|0|||
164097137|NCT01449630|592719059|FG001|Period 1|Sponsor Decision|0|||
164097138|NCT01449630|592719060|FG002|Period 1|Sponsor Decision|0|||
164097139|NCT01449630|592719061|FG003|Period 1|Sponsor Decision|0|||
164097140|NCT01449630|592719062|FG004|Period 1|Sponsor Decision|0|||
164097141|NCT01449630|592719063|FG005|Period 1|Sponsor Decision|1|||
164097142|NCT01449630|592719064|FG006|Period 1|Sponsor Decision|0|||
164097143|NCT01449630|592719065|FG007|Period 1|Sponsor Decision|0|||
164097144|NCT01449630|592719066|FG008|Period 1|Sponsor Decision|0|||
164097145|NCT01449630|592719058|FG000|Period 2|Sponsor Decision|0|||
164097146|NCT01449630|592719059|FG001|Period 2|Sponsor Decision|0|||
164097147|NCT01449630|592719060|FG002|Period 2|Sponsor Decision|0|||
164097148|NCT01449630|592719061|FG003|Period 2|Sponsor Decision|0|||
164097149|NCT01449630|592719062|FG004|Period 2|Sponsor Decision|0|||
164097150|NCT01449630|592719063|FG005|Period 2|Sponsor Decision|0|||
164097151|NCT01449630|592719064|FG006|Period 2|Sponsor Decision|1|||
164097152|NCT01449630|592719065|FG007|Period 2|Sponsor Decision|0|||
164097153|NCT01449630|592719066|FG008|Period 2|Sponsor Decision|0|||
164097154|NCT00105196|592719067|FG000|Overall Study|Lack of Efficacy|2|||
164097155|NCT00105196|592719068|FG001|Overall Study|Lack of Efficacy|3|||
164097156|NCT00105196|592719067|FG000|Overall Study|Adverse Event|11|||
164097157|NCT00105196|592719068|FG001|Overall Study|Adverse Event|3|||
164097158|NCT00105196|592719067|FG000|Overall Study|Withdrawal by Subject|6|||
164097159|NCT00105196|592719068|FG001|Overall Study|Withdrawal by Subject|6|||
164097160|NCT00105196|592719067|FG000|Overall Study|Lost to Follow-up|3|||
164097161|NCT00105196|592719068|FG001|Overall Study|Lost to Follow-up|2|||
164097162|NCT00105196|592719067|FG000|Overall Study|Poor/noncompliance|3|||
164097163|NCT00105196|592719068|FG001|Overall Study|Poor/noncompliance|4|||
164097164|NCT00105196|592719067|FG000|Overall Study|Protocol Violation|5|||
164097165|NCT00105196|592719068|FG001|Overall Study|Protocol Violation|2|||
164097166|NCT00105196|592719067|FG000|Overall Study|pending surgery|0|||
164097167|NCT00105196|592719068|FG001|Overall Study|pending surgery|1|||
164097168|NCT00105196|592719067|FG000|Overall Study|marijuana use|0|||
164097169|NCT00105196|592719068|FG001|Overall Study|marijuana use|1|||
164097170|NCT00105196|592719067|FG000|Overall Study|Subject became unblinded|0|||
164097171|NCT00105196|592719068|FG001|Overall Study|Subject became unblinded|1|||
164097172|NCT03340727|592719069|FG000|Overall Study|Death|1|||
164097173|NCT03340727|592719070|FG001|Overall Study|Death|0|||
164097174|NCT03340727|592719069|FG000|Overall Study|Lost to Follow-up|31|||
164097175|NCT03340727|592719070|FG001|Overall Study|Lost to Follow-up|35|||
164097176|NCT03340727|592719069|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
164097177|NCT03340727|592719070|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
164097178|NCT03340727|592719069|FG000|Overall Study|Transferred to another facility|10|||
164097179|NCT03340727|592719070|FG001|Overall Study|Transferred to another facility|7|||
164097180|NCT03340727|592719069|FG000|Overall Study|Withdrawal by Subject|28|||
164097181|NCT03340727|592719070|FG001|Overall Study|Withdrawal by Subject|17|||
164097182|NCT01873586|592719071|FG000|Overall Study|Lost to Follow-up|3|||
164097183|NCT00615069|592719072|FG000|Overall Study|Death|10|||
164097184|NCT00615069|592719072|FG000|Overall Study|Physician Decision|2|||
164097185|NCT00615069|592719072|FG000|Overall Study|Withdrawal by Subject|4|||
164097186|NCT00259012|592719074|FG000|Overall Study|Adverse Event|0|||
164097187|NCT00259012|592719075|FG001|Overall Study|Adverse Event|1|||
164097188|NCT00259012|592719074|FG000|Overall Study|Withdrawal by Subject|1|||
164097189|NCT00259012|592719075|FG001|Overall Study|Withdrawal by Subject|0|||
164097190|NCT00259012|592719074|FG000|Overall Study|Physician Decision|0|||
164097191|NCT00259012|592719075|FG001|Overall Study|Physician Decision|1|||
164097192|NCT00259012|592719074|FG000|Overall Study|Lost to Follow-up|0|||
164097193|NCT00259012|592719075|FG001|Overall Study|Lost to Follow-up|1|||
164097194|NCT00259012|592719074|FG000|Overall Study|Protocol Violation|1|||
164097195|NCT00259012|592719075|FG001|Overall Study|Protocol Violation|1|||
164097196|NCT02674477|592719076|FG000|Overall Study|Protocol Violation|8|||
164097197|NCT02674477|592719077|FG001|Overall Study|Protocol Violation|2|||
164097198|NCT00834756|592719081|FG000|First Intervention|Adverse Event|1|||
164031980|NCT00178464|592476308|FG000|Overall Study|Withdrawal by Subject|1|||
164031981|NCT00178464|592476308|FG000|Overall Study|Physician Decision|1|||
164031982|NCT02260648|592476311|FG000|Overall Study|Adverse Event|3|||
164031983|NCT02260648|592476312|FG001|Overall Study|Adverse Event|0|||
164031984|NCT02260648|592476313|FG002|Overall Study|Adverse Event|1|||
163826398|NCT02054806|591732415|FG000|Overall Study|Withdrawal by Subject|43|||
163826399|NCT02054806|591732415|FG000|Overall Study|Protocol Violation|2|||
163826400|NCT02054806|591732415|FG000|Overall Study|Lost to Follow-up|10|||
163826401|NCT02054806|591732415|FG000|Overall Study|Death|391|||
163826402|NCT00677235|591732416|FG000|Overall Study|Withdrawal by Subject|1|||
163826403|NCT00677235|591732417|FG001|Overall Study|Withdrawal by Subject|1|||
163826404|NCT00677235|591732416|FG000|Overall Study|Lost to Follow-up|2|||
163826405|NCT00677235|591732417|FG001|Overall Study|Lost to Follow-up|1|||
163826406|NCT00677235|591732416|FG000|Overall Study|Death|37|||
163826407|NCT00677235|591732417|FG001|Overall Study|Death|36|||
163826408|NCT00677235|591732416|FG000|Overall Study|Adverse Experience|1|||
163826409|NCT00677235|591732417|FG001|Overall Study|Adverse Experience|0|||
163826410|NCT01040260|591732418|FG000|Overall Study|Withdrawal by Subject|12|||
163826411|NCT01040260|591732419|FG001|Overall Study|Withdrawal by Subject|6|||
163826412|NCT01040260|591732418|FG000|Overall Study|Lost to Follow-up|3|||
163826413|NCT01040260|591732419|FG001|Overall Study|Lost to Follow-up|5|||
163826414|NCT00708916|591732424|FG000|Overall Study|Subject Noncompliance|2|||
163826415|NCT00708916|591732424|FG000|Overall Study|Adverse Event|2|||
163826416|NCT03923959|591732427|FG000|Overall Study|Death|16|||
163826417|NCT03923959|591732428|FG001|Overall Study|Death|12|||
163826418|NCT03923959|591732427|FG000|Overall Study|Lost to Follow-up|56|||
163826419|NCT03923959|591732428|FG001|Overall Study|Lost to Follow-up|56|||
163826420|NCT03923959|591732427|FG000|Overall Study|Withdrawal by Subject|1|||
163826421|NCT03923959|591732428|FG001|Overall Study|Withdrawal by Subject|1|||
163826422|NCT03923959|591732427|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
163826423|NCT03923959|591732428|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
163826424|NCT04212091|591732429|FG000|Overall Study|Lost to Follow-up|0|||
163826425|NCT04212091|591732430|FG001|Overall Study|Lost to Follow-up|0|||
163826426|NCT04212091|591732431|FG002|Overall Study|Lost to Follow-up|0|||
163826427|NCT04212091|591732432|FG003|Overall Study|Lost to Follow-up|0|||
163826428|NCT04212091|591732433|FG004|Overall Study|Lost to Follow-up|1|||
163826429|NCT04212091|591732434|FG005|Overall Study|Lost to Follow-up|1|||
163826430|NCT04212091|591732429|FG000|Overall Study|Participant unable to adhere to visit|0|||
163826431|NCT04212091|591732430|FG001|Overall Study|Participant unable to adhere to visit|0|||
163826432|NCT04212091|591732431|FG002|Overall Study|Participant unable to adhere to visit|0|||
163826433|NCT04212091|591732432|FG003|Overall Study|Participant unable to adhere to visit|0|||
163826434|NCT04212091|591732433|FG004|Overall Study|Participant unable to adhere to visit|1|||
163826435|NCT04212091|591732434|FG005|Overall Study|Participant unable to adhere to visit|0|||
163826436|NCT04575051|591732435|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
163826437|NCT04575051|591732436|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
163826438|NCT04575051|591732437|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
163826439|NCT04575051|591732438|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
163826440|NCT04575051|591732439|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
163826441|NCT04575051|591732435|FG000|Time Period 1|Missing follow up|1|||
163826442|NCT04575051|591732436|FG001|Time Period 1|Missing follow up|3|||
163826443|NCT04575051|591732437|FG002|Time Period 1|Missing follow up|1|||
163826444|NCT04575051|591732438|FG003|Time Period 1|Missing follow up|3|||
163826445|NCT04575051|591732439|FG004|Time Period 1|Missing follow up|2|||
163826446|NCT04575051|591732435|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
163826447|NCT04575051|591732436|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
163826448|NCT04575051|591732437|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
163826449|NCT04575051|591732438|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
163826450|NCT04575051|591732439|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
163826451|NCT04575051|591732435|FG000|Time Period 2|Missing follow up|1|||
163826452|NCT04575051|591732436|FG001|Time Period 2|Missing follow up|8|||
163826453|NCT04575051|591732437|FG002|Time Period 2|Missing follow up|7|||
163826454|NCT04575051|591732438|FG003|Time Period 2|Missing follow up|0|||
163826455|NCT04575051|591732439|FG004|Time Period 2|Missing follow up|1|||
163826456|NCT04575051|591732435|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
163826457|NCT04575051|591732436|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
163826458|NCT04575051|591732437|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
163826459|NCT04575051|591732438|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
163826460|NCT04575051|591732439|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
163826461|NCT04575051|591732435|FG000|Time Period 3|Missing follow up|8|||
163826462|NCT04575051|591732436|FG001|Time Period 3|Missing follow up|6|||
164031985|NCT02260648|592476311|FG000|Overall Study|Withdrawal by Subject|1|||
164031986|NCT02260648|592476312|FG001|Overall Study|Withdrawal by Subject|1|||
164031987|NCT02260648|592476313|FG002|Overall Study|Withdrawal by Subject|0|||
164031988|NCT02260648|592476311|FG000|Overall Study|Protocol Violation|1|||
164031989|NCT02260648|592476312|FG001|Overall Study|Protocol Violation|0|||
164031990|NCT02260648|592476313|FG002|Overall Study|Protocol Violation|0|||
164031991|NCT02260648|592476311|FG000|Overall Study|Discontinue Due to Study Termination|13|||
164031992|NCT02260648|592476312|FG001|Overall Study|Discontinue Due to Study Termination|12|||
164031993|NCT02260648|592476313|FG002|Overall Study|Discontinue Due to Study Termination|7|||
164031994|NCT04093258|592476314|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
164031995|NCT04093258|592476315|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
164031996|NCT01890512|592476316|FG000|Overall Study|Physician Decision|1|||
164031997|NCT01890512|592476316|FG000|Overall Study|Withdrawal by Subject|1|||
164031998|NCT01890512|592476316|FG000|Overall Study|Protocol Violation|1|||
164031999|NCT01529385|592476317|FG000|Overall Study|Lost to Follow-up|2|||
164032000|NCT01529385|592476318|FG001|Overall Study|Lost to Follow-up|1|||
164032001|NCT00805545|592476319|FG000|Overall Study|Protocol Violation|3|||
164032002|NCT00805545|592476320|FG001|Overall Study|Protocol Violation|2|||
164032003|NCT00805545|592476319|FG000|Overall Study|Protocol Violation|3|||
164032004|NCT00805545|592476320|FG001|Overall Study|Protocol Violation|1|||
164032005|NCT03543358|592476321|FG000|Overall Study|Death|1|||
164032006|NCT03543358|592476322|FG001|Overall Study|Death|0|||
164032007|NCT03543358|592476321|FG000|Overall Study|Disease Progression|1|||
164032008|NCT03543358|592476322|FG001|Overall Study|Disease Progression|0|||
164032009|NCT03543358|592476321|FG000|Overall Study|Parent Study Closure|1|||
164032010|NCT03543358|592476322|FG001|Overall Study|Parent Study Closure|0|||
164032011|NCT00986427|592476323|FG000|Overall Study|Lost to Follow-up|2|||
164032012|NCT00986427|592476324|FG001|Overall Study|Lost to Follow-up|0|||
164032013|NCT00986427|592476323|FG000|Overall Study|Lack of Efficacy|1|||
164032014|NCT00986427|592476324|FG001|Overall Study|Lack of Efficacy|0|||
164032015|NCT00986427|592476323|FG000|Overall Study|Withdrawal by Subject|1|||
164032016|NCT00986427|592476324|FG001|Overall Study|Withdrawal by Subject|0|||
164032017|NCT02379390|592476327|FG000|Overall Study|Adverse Event|1|||
164032018|NCT02379390|592476328|FG001|Overall Study|Adverse Event|1|||
164032019|NCT02379390|592476327|FG000|Overall Study|Investigator's decision|1|||
164032020|NCT02379390|592476328|FG001|Overall Study|Investigator's decision|0|||
164032021|NCT02379390|592476327|FG000|Overall Study|Study Termination|0|||
164032022|NCT02379390|592476328|FG001|Overall Study|Study Termination|1|||
164032023|NCT00575094|592476329|FG000|Overall Study|Adverse Event|2|||
163826463|NCT04575051|591732437|FG002|Time Period 3|Missing follow up|4|||
163826464|NCT04575051|591732438|FG003|Time Period 3|Missing follow up|3|||
164032024|NCT00575094|592476329|FG000|Overall Study|Withdrawal by Subject|1|||
164032025|NCT00643604|592476331|FG000|Overall Study|Death|1|||
164032026|NCT02702011|592476334|FG000|Overall Study|Withdrawal by Subject|0|||
164032027|NCT02702011|592476335|FG001|Overall Study|Withdrawal by Subject|1|||
164032028|NCT02702011|592476336|FG002|Overall Study|Withdrawal by Subject|0|||
164032029|NCT02702011|592476337|FG003|Overall Study|Withdrawal by Subject|0|||
164032030|NCT02721251|592476339|FG000|Overall Study|Withdrawal by Subject|8|||
164032031|NCT02721251|592476340|FG001|Overall Study|Withdrawal by Subject|7|||
164032032|NCT02721251|592476341|FG002|Overall Study|Withdrawal by Subject|9|||
164032033|NCT02721251|592476339|FG000|Overall Study|poor adherence|2|||
164032034|NCT02721251|592476340|FG001|Overall Study|poor adherence|2|||
164032035|NCT02721251|592476341|FG002|Overall Study|poor adherence|2|||
164032036|NCT06025396|592477741|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
164032037|NCT06025396|592477742|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
164032038|NCT06025396|592477743|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
164032039|NCT06025396|592477744|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
164032040|NCT06025396|592477745|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
164032041|NCT06025396|592477741|FG000|Overall Study|Withdrawal by Subject|0|||
164032042|NCT06025396|592477742|FG001|Overall Study|Withdrawal by Subject|1|||
164032043|NCT06025396|592477743|FG002|Overall Study|Withdrawal by Subject|1|||
164032044|NCT06025396|592477744|FG003|Overall Study|Withdrawal by Subject|0|||
164032045|NCT06025396|592477745|FG004|Overall Study|Withdrawal by Subject|0|||
164032046|NCT06422377|592477746|FG000|Overall Study|Study Terminated by Sponsor|1|||
164032047|NCT00453180|592477747|FG000|Overall Study|Lost to Follow-up|2|||
164032048|NCT00453180|592477748|FG001|Overall Study|Lost to Follow-up|1|||
164032049|NCT00453180|592477747|FG000|Overall Study|Adverse Event|1|||
164097199|NCT00834756|592719082|FG001|First Intervention|Adverse Event|0|||
164097200|NCT00834756|592719081|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
163826465|NCT04575051|591732439|FG004|Time Period 3|Missing follow up|0|||
163826466|NCT04575051|591732435|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
163826467|NCT04575051|591732436|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
164032050|NCT00453180|592477748|FG001|Overall Study|Adverse Event|2|||
164032051|NCT03326869|592477750|FG000|Overall Study|Study data has been lost to natural disa|1|||
164032052|NCT03326869|592477751|FG001|Overall Study|Study data has been lost to natural disa|1|||
164032053|NCT01002742|592477754|FG000|Overall Study|Determined to be ineligible|0|||
164032054|NCT01002742|592477755|FG001|Overall Study|Determined to be ineligible|1|||
164032055|NCT00562640|592477756|FG000|Overall Study|Death|0|||
163826468|NCT04575051|591732437|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
163826469|NCT04575051|591732438|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
163826470|NCT04575051|591732439|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
163826471|NCT04575051|591732435|FG000|Time Period 4|Missing follow up|17|||
163826472|NCT04575051|591732436|FG001|Time Period 4|Missing follow up|3|||
163826473|NCT04575051|591732437|FG002|Time Period 4|Missing follow up|4|||
163826474|NCT04575051|591732438|FG003|Time Period 4|Missing follow up|2|||
163826475|NCT04575051|591732439|FG004|Time Period 4|Missing follow up|1|||
163826476|NCT04575051|591732435|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
163826477|NCT04575051|591732436|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
163826478|NCT04575051|591732437|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
163826479|NCT04575051|591732438|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
163826480|NCT04575051|591732439|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
163826481|NCT04575051|591732435|FG000|Time Period 5|Missing follow up|11|||
163826482|NCT04575051|591732436|FG001|Time Period 5|Missing follow up|8|||
163826483|NCT04575051|591732437|FG002|Time Period 5|Missing follow up|12|||
163826484|NCT04575051|591732438|FG003|Time Period 5|Missing follow up|3|||
163826485|NCT04575051|591732439|FG004|Time Period 5|Missing follow up|11|||
163826486|NCT00951483|591732440|FG000|Overall Study|Physician Decision|4|||
163826487|NCT00951483|591732441|FG001|Overall Study|Physician Decision|0|||
163826488|NCT00951483|591732440|FG000|Overall Study|Withdrawal by Subject|15|||
163826489|NCT00951483|591732441|FG001|Overall Study|Withdrawal by Subject|0|||
163826490|NCT03565887|591732442|FG000|Overall Study|Adverse Event|1|||
163826491|NCT03565887|591732443|FG001|Overall Study|Adverse Event|0|||
163826492|NCT03565887|591732442|FG000|Overall Study|Withdrawal by Subject|0|||
163826493|NCT03565887|591732443|FG001|Overall Study|Withdrawal by Subject|2|||
163826494|NCT01292239|591732444|FG000|Overall Study|Other|1|||
163826495|NCT01292239|591732445|FG001|Overall Study|Other|1|||
163826496|NCT01292239|591732444|FG000|Overall Study|Withdrawal by Subject|3|||
163826497|NCT01292239|591732445|FG001|Overall Study|Withdrawal by Subject|6|||
163826498|NCT00765388|591732446|FG000|Period 1|Lack of Efficacy|1|||
163826499|NCT00765388|591732447|FG001|Period 1|Lack of Efficacy|2|||
163826500|NCT00765388|591732446|FG000|Period 1|Lost to Follow-up|0|||
163826501|NCT00765388|591732447|FG001|Period 1|Lost to Follow-up|1|||
163826502|NCT00765388|591732446|FG000|Period 1|Herpes Zoster|0|||
163826503|NCT00765388|591732447|FG001|Period 1|Herpes Zoster|1|||
163826504|NCT00765388|591732446|FG000|Period 1|Hip operation|0|||
163826505|NCT00765388|591732447|FG001|Period 1|Hip operation|1|||
163826506|NCT03923933|591732448|FG000|Overall Study|Lost to Follow-up|1|||
163826507|NCT03923933|591732449|FG001|Overall Study|Lost to Follow-up|0|||
163826508|NCT03923933|591732448|FG000|Overall Study|Withdrawal by Subject|0|||
163826509|NCT03923933|591732449|FG001|Overall Study|Withdrawal by Subject|1|||
163826510|NCT01995461|591732450|FG000|Overall Study|Death|1|||
163826511|NCT01995461|591732450|FG000|Overall Study|Lost to Follow-up|2|||
163826512|NCT01995461|591732450|FG000|Overall Study|Withdrawal by Subject|2|||
163826513|NCT01939548|591732452|FG000|Overall Study|Non compliance|0|||
163826514|NCT01939548|591732453|FG001|Overall Study|Non compliance|2|||
163826515|NCT01939548|591732454|FG002|Overall Study|Non compliance|0|||
163826516|NCT01939548|591732452|FG000|Overall Study|Study Terminated by Sponsor|17|||
163826517|NCT01939548|591732453|FG001|Overall Study|Study Terminated by Sponsor|19|||
163826518|NCT01939548|591732454|FG002|Overall Study|Study Terminated by Sponsor|12|||
163826519|NCT01939548|591732452|FG000|Overall Study|Insufficient Clinical Response|1|||
163826520|NCT01939548|591732453|FG001|Overall Study|Insufficient Clinical Response|0|||
163826521|NCT01939548|591732454|FG002|Overall Study|Insufficient Clinical Response|0|||
163826522|NCT01939548|591732452|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
163826523|NCT01939548|591732453|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
163826524|NCT01939548|591732454|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
163826525|NCT01939548|591732452|FG000|Overall Study|Withdrawal by Subject|4|||
163826526|NCT01939548|591732453|FG001|Overall Study|Withdrawal by Subject|4|||
163826527|NCT01939548|591732454|FG002|Overall Study|Withdrawal by Subject|1|||
163826528|NCT01939548|591732452|FG000|Overall Study|Protocol Violation|7|||
163826529|NCT01939548|591732453|FG001|Overall Study|Protocol Violation|6|||
163826530|NCT01939548|591732454|FG002|Overall Study|Protocol Violation|5|||
163826531|NCT01939548|591732452|FG000|Overall Study|Lost to Follow-up|5|||
163826532|NCT01939548|591732453|FG001|Overall Study|Lost to Follow-up|5|||
163826533|NCT01939548|591732454|FG002|Overall Study|Lost to Follow-up|3|||
163826534|NCT01939548|591732452|FG000|Overall Study|Adverse Event|2|||
163826535|NCT01939548|591732453|FG001|Overall Study|Adverse Event|9|||
163826536|NCT01939548|591732454|FG002|Overall Study|Adverse Event|7|||
163826537|NCT01939548|591732452|FG000|Overall Study|Death|0|||
163826538|NCT01939548|591732453|FG001|Overall Study|Death|0|||
163826539|NCT01939548|591732454|FG002|Overall Study|Death|1|||
164146986|NCT00443729|592899920|FG000|Overall Study|Protocol Violation|1|||
163826540|NCT01939548|591732452|FG000|Overall Study|Participant dropped|0|||
163826541|NCT01939548|591732453|FG001|Overall Study|Participant dropped|0|||
163826542|NCT01939548|591732454|FG002|Overall Study|Participant dropped|1|||
163826543|NCT01939548|591732452|FG000|Overall Study|Participant unwilling to continue|0|||
163920397|NCT01187407|592077819|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163920398|NCT01187407|592077820|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
163920399|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
163920400|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
163920401|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
163920402|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
163920403|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
163920404|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
163920405|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
163920406|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
163920407|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
163920408|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
163920409|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
163920410|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
163920411|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
163920412|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
163920413|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
163920414|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163920415|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163920416|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
163920417|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
163920418|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
163920419|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
163920420|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
164032056|NCT00562640|592477757|FG001|Overall Study|Death|1|||
164032057|NCT00562640|592477758|FG002|Overall Study|Death|1|||
164032058|NCT00562640|592477759|FG003|Overall Study|Death|0|||
164032059|NCT05263921|592477760|FG000|Overall Study|Other: family emergency.|0|||
163826544|NCT01939548|591732453|FG001|Overall Study|Participant unwilling to continue|1|||
163826545|NCT01939548|591732454|FG002|Overall Study|Participant unwilling to continue|0|||
163826546|NCT01939548|591732452|FG000|Overall Study|Participant withdrew consent|0|||
163826547|NCT01939548|591732453|FG001|Overall Study|Participant withdrew consent|2|||
163826548|NCT01939548|591732454|FG002|Overall Study|Participant withdrew consent|0|||
163826549|NCT01939548|591732452|FG000|Overall Study|Did not complete follow-up|0|||
163826550|NCT01939548|591732453|FG001|Overall Study|Did not complete follow-up|1|||
163826551|NCT01939548|591732454|FG002|Overall Study|Did not complete follow-up|0|||
163826552|NCT03311373|591732455|FG000|Overall Study|Adverse Event|1|||
163826553|NCT03311373|591732455|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
163826554|NCT03311373|591732455|FG000|Overall Study|Lost to Follow-up|1|||
163826555|NCT03311373|591732455|FG000|Overall Study|Physician Decision|1|||
163826556|NCT03311373|591732455|FG000|Overall Study|Withdrawal by Subject|3|||
163826557|NCT01022762|591732458|FG000|Overall Study|Adverse Event|3|||
163826558|NCT01022762|591732459|FG001|Overall Study|Adverse Event|1|||
163826559|NCT01022762|591732458|FG000|Overall Study|Lack of Efficacy|0|||
163826560|NCT01022762|591732459|FG001|Overall Study|Lack of Efficacy|1|||
163826561|NCT01022762|591732458|FG000|Overall Study|Protocol Violation|7|||
163826562|NCT01022762|591732459|FG001|Overall Study|Protocol Violation|6|||
163826563|NCT01022762|591732458|FG000|Overall Study|Unclassified|12|||
163826564|NCT01022762|591732459|FG001|Overall Study|Unclassified|20|||
163826565|NCT01302119|591732460|FG000|Overall Study|Withdrawal by Subject|30|||
163826566|NCT01302119|591732461|FG001|Overall Study|Withdrawal by Subject|20|||
163826567|NCT01302119|591732460|FG000|Overall Study|Lost to Follow-up|10|||
163826568|NCT01302119|591732461|FG001|Overall Study|Lost to Follow-up|4|||
163826569|NCT01302119|591732460|FG000|Overall Study|Adverse Event|2|||
163826570|NCT01302119|591732461|FG001|Overall Study|Adverse Event|1|||
163826571|NCT01302119|591732460|FG000|Overall Study|Non-compliance|4|||
163826572|NCT01302119|591732461|FG001|Overall Study|Non-compliance|2|||
163826573|NCT01302119|591732460|FG000|Overall Study|Non-specific|4|||
163826574|NCT01302119|591732461|FG001|Overall Study|Non-specific|1|||
163826575|NCT01775904|591732462|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
163826576|NCT01775904|591732462|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
163826577|NCT01662310|591732465|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
163826578|NCT01662310|591732466|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
163826579|NCT01662310|591732467|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
163826580|NCT01662310|591732468|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
163826581|NCT01662310|591732469|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
163826582|NCT01662310|591732465|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
163826583|NCT01662310|591732466|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163826584|NCT01662310|591732467|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163920421|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
164032060|NCT05263921|592477761|FG001|Overall Study|Other: family emergency.|0|||
164032061|NCT05263921|592477762|FG002|Overall Study|Other: family emergency.|1|||
164032062|NCT05263921|592477763|FG003|Overall Study|Other: family emergency.|0|||
164032063|NCT01297309|592477766|FG000|Overall Study|Eligibility failure|2|||
164032064|NCT01297309|592477766|FG000|Overall Study|Screen failure|2|||
164032065|NCT01297309|592477766|FG000|Overall Study|Withdrawal by Subject|5|||
164032066|NCT01297309|592477766|FG000|Overall Study|Adverse Event|1|||
164032067|NCT01297309|592477766|FG000|Overall Study|Investigator Decision|2|||
164032068|NCT01297309|592477766|FG000|Overall Study|Death|1|||
164032069|NCT01297309|592477766|FG000|Overall Study|Participant not entering extensionperiod|1|||
164032070|NCT02591238|592477767|FG000|Overall Study|Pregnancy|1|||
164032071|NCT02591238|592477768|FG001|Overall Study|Pregnancy|0|||
164032072|NCT02591238|592477769|FG002|Overall Study|Pregnancy|0|||
164032073|NCT02591238|592477770|FG003|Overall Study|Pregnancy|0|||
164032074|NCT02591238|592477767|FG000|Overall Study|Withdrawal by Subject|0|||
164032075|NCT02591238|592477768|FG001|Overall Study|Withdrawal by Subject|0|||
164032076|NCT02591238|592477769|FG002|Overall Study|Withdrawal by Subject|0|||
164032077|NCT02591238|592477770|FG003|Overall Study|Withdrawal by Subject|1|||
164032078|NCT02591238|592477767|FG000|Overall Study|influenza|0|||
164032079|NCT02591238|592477768|FG001|Overall Study|influenza|0|||
164032080|NCT02591238|592477769|FG002|Overall Study|influenza|0|||
164032081|NCT02591238|592477770|FG003|Overall Study|influenza|1|||
164032082|NCT02591238|592477767|FG000|Overall Study|personal circumstances|0|||
164032083|NCT02591238|592477768|FG001|Overall Study|personal circumstances|0|||
164032084|NCT02591238|592477769|FG002|Overall Study|personal circumstances|0|||
164032085|NCT02591238|592477770|FG003|Overall Study|personal circumstances|1|||
164032086|NCT02591238|592477767|FG000|Overall Study|personal circumstances|0|||
164032087|NCT02591238|592477768|FG001|Overall Study|personal circumstances|1|||
164032088|NCT02591238|592477769|FG002|Overall Study|personal circumstances|0|||
164032089|NCT02591238|592477770|FG003|Overall Study|personal circumstances|0|||
164032090|NCT00640146|592477773|FG000|Overall Study|Adverse Event|2|||
164032091|NCT00640146|592477774|FG001|Overall Study|Adverse Event|0|||
164097201|NCT00834756|592719082|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
163826585|NCT01662310|591732468|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163826586|NCT01662310|591732469|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
163826587|NCT01662310|591732465|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
163826588|NCT01662310|591732466|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163826589|NCT01662310|591732467|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163826590|NCT01662310|591732468|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163826591|NCT01662310|591732469|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
163826592|NCT01662310|591732465|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
163826593|NCT01662310|591732466|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
163826594|NCT01662310|591732467|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
163826595|NCT01662310|591732468|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
163826596|NCT01662310|591732469|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
163826597|NCT01662310|591732465|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
163826598|NCT01662310|591732466|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163826599|NCT01662310|591732467|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163826600|NCT01662310|591732468|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163826601|NCT01662310|591732469|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
163826602|NCT01662310|591732465|FG000|Run-In or Stabilization Phase|Other|1|||
163826603|NCT01662310|591732466|FG001|Run-In or Stabilization Phase|Other|0|||
163826604|NCT01662310|591732467|FG002|Run-In or Stabilization Phase|Other|0|||
163826605|NCT01662310|591732468|FG003|Run-In or Stabilization Phase|Other|0|||
163826606|NCT01662310|591732469|FG004|Run-In or Stabilization Phase|Other|0|||
163826607|NCT01662310|591732465|FG000|Double-Blind Phase|Adverse Event|0|||
163826608|NCT01662310|591732466|FG001|Double-Blind Phase|Adverse Event|0|||
163826609|NCT01662310|591732467|FG002|Double-Blind Phase|Adverse Event|1|||
163826610|NCT01662310|591732468|FG003|Double-Blind Phase|Adverse Event|0|||
163826611|NCT01662310|591732469|FG004|Double-Blind Phase|Adverse Event|0|||
163826612|NCT01662310|591732465|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163826613|NCT01662310|591732466|FG001|Double-Blind Phase|Lost to Follow-up|3|||
163826614|NCT01662310|591732467|FG002|Double-Blind Phase|Lost to Follow-up|0|||
163826615|NCT01662310|591732468|FG003|Double-Blind Phase|Lost to Follow-up|0|||
163826616|NCT01662310|591732469|FG004|Double-Blind Phase|Lost to Follow-up|0|||
163826617|NCT01662310|591732465|FG000|Double-Blind Phase|Pregnancy|0|||
163826618|NCT01662310|591732466|FG001|Double-Blind Phase|Pregnancy|2|||
163826619|NCT01662310|591732467|FG002|Double-Blind Phase|Pregnancy|0|||
163826620|NCT01662310|591732468|FG003|Double-Blind Phase|Pregnancy|0|||
164032092|NCT00640146|592477773|FG000|Overall Study|Lost to Follow-up|0|||
164032093|NCT00640146|592477774|FG001|Overall Study|Lost to Follow-up|1|||
164032094|NCT00640146|592477773|FG000|Overall Study|Lack of Efficacy|0|||
164032095|NCT00640146|592477774|FG001|Overall Study|Lack of Efficacy|1|||
164032096|NCT00640146|592477773|FG000|Overall Study|Withdrawal by Subject|1|||
164032097|NCT00640146|592477774|FG001|Overall Study|Withdrawal by Subject|1|||
164032098|NCT00640146|592477773|FG000|Overall Study|Randomized but not treated|1|||
164032099|NCT00640146|592477774|FG001|Overall Study|Randomized but not treated|3|||
163920422|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
163920423|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
163920424|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
163920425|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
163920426|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
163920427|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
163920428|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
163920429|NCT01187407|592077816|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
163920430|NCT01187407|592077817|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163920431|NCT01187407|592077818|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163920432|NCT01187407|592077819|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
163920433|NCT01187407|592077820|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
163920434|NCT02382406|592077823|FG000|Study Treatment|Disease Progression|8|||
163920435|NCT02382406|592077824|FG001|Study Treatment|Disease Progression|0|||
163920436|NCT02382406|592077825|FG002|Study Treatment|Disease Progression|20|||
163920437|NCT02382406|592077823|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
163920438|NCT02382406|592077824|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
163920439|NCT02382406|592077825|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
163920440|NCT02382406|592077823|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
163920441|NCT02382406|592077824|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
163920442|NCT02382406|592077825|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
163920443|NCT02382406|592077823|FG000|Study Treatment|symptomatic deterioration|1|||
163920444|NCT02382406|592077824|FG001|Study Treatment|symptomatic deterioration|0|||
163920445|NCT02382406|592077825|FG002|Study Treatment|symptomatic deterioration|1|||
163920446|NCT02382406|592077823|FG000|Study Treatment|Death|0|||
163920447|NCT02382406|592077824|FG001|Study Treatment|Death|0|||
163920448|NCT02382406|592077825|FG002|Study Treatment|Death|2|||
163920449|NCT02382406|592077823|FG000|Follow up|Death|11|||
163920450|NCT02382406|592077824|FG001|Follow up|Death|0|||
163920451|NCT02382406|592077825|FG002|Follow up|Death|19|||
163920452|NCT02382406|592077823|FG000|Follow up|Symptomatic deterioration|1|||
163920453|NCT02382406|592077824|FG001|Follow up|Symptomatic deterioration|0|||
163920454|NCT02382406|592077825|FG002|Follow up|Symptomatic deterioration|1|||
163920455|NCT02382406|592077823|FG000|Follow up|Patient Refused Follow-up|1|||
163920456|NCT02382406|592077824|FG001|Follow up|Patient Refused Follow-up|0|||
163920457|NCT02382406|592077825|FG002|Follow up|Patient Refused Follow-up|0|||
163920458|NCT02382406|592077823|FG000|Follow up|Study Terminated|1|||
163920459|NCT02382406|592077824|FG001|Follow up|Study Terminated|0|||
163920460|NCT02382406|592077825|FG002|Follow up|Study Terminated|8|||
163920461|NCT02382406|592077823|FG000|Follow up|Withdrawal by Subject|0|||
163920462|NCT02382406|592077824|FG001|Follow up|Withdrawal by Subject|0|||
163920463|NCT02382406|592077825|FG002|Follow up|Withdrawal by Subject|2|||
163920464|NCT00125853|592077826|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
163920465|NCT00125853|592077827|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
163920466|NCT00050167|592077833|FG000|Overall Study|not eligible not invasive|1|||
163920467|NCT00050167|592077834|FG001|Overall Study|not eligible not invasive|1|||
163920468|NCT01363297|592077835|FG000|Overall Study|Other|0|||
163920469|NCT01363297|592077836|FG001|Overall Study|Other|0|||
163920470|NCT01363297|592077837|FG002|Overall Study|Other|0|||
163920471|NCT01363297|592077838|FG003|Overall Study|Other|0|||
163920472|NCT01363297|592077839|FG004|Overall Study|Other|1|||
163920473|NCT01363297|592077835|FG000|Overall Study|Death|3|||
163920474|NCT01363297|592077836|FG001|Overall Study|Death|6|||
163920475|NCT01363297|592077837|FG002|Overall Study|Death|6|||
163920476|NCT01363297|592077838|FG003|Overall Study|Death|10|||
163920477|NCT01363297|592077839|FG004|Overall Study|Death|30|||
164032100|NCT00525785|592477775|FG000|Overall Study|Withdrawal by Subject|1|||
164032101|NCT00525785|592477775|FG000|Overall Study|Lack of Efficacy|1|||
164032102|NCT00525785|592477775|FG000|Overall Study|Physician Decision|1|||
164032103|NCT01204697|592477779|FG000|Overall Study|Death|26|||
164032104|NCT01204697|592477780|FG001|Overall Study|Death|27|||
164032105|NCT01204697|592477779|FG000|Overall Study|Lost to Follow-up|3|||
163920478|NCT02038803|592077840|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
163920479|NCT02038803|592077840|FG000|Overall Study|Lost to Follow-up|1|||
163920480|NCT04754594|592077841|FG000|Blinded Period|Withdrawal by Subject|4|||
163920481|NCT04754594|592077842|FG001|Blinded Period|Withdrawal by Subject|9|||
163920482|NCT04754594|592077843|FG002|Blinded Period|Withdrawal by Subject|0|||
163920483|NCT04754594|592077844|FG003|Blinded Period|Withdrawal by Subject|0|||
163920484|NCT04754594|592077841|FG000|Blinded Period|Protocol Violation|2|||
163920485|NCT04754594|592077842|FG001|Blinded Period|Protocol Violation|2|||
163920486|NCT04754594|592077843|FG002|Blinded Period|Protocol Violation|0|||
163920487|NCT04754594|592077844|FG003|Blinded Period|Protocol Violation|0|||
163920488|NCT04754594|592077841|FG000|Blinded Period|Lost to Follow-up|1|||
163920489|NCT04754594|592077842|FG001|Blinded Period|Lost to Follow-up|1|||
163920490|NCT04754594|592077843|FG002|Blinded Period|Lost to Follow-up|0|||
164032106|NCT01204697|592477780|FG001|Overall Study|Lost to Follow-up|4|||
164097202|NCT04625114|592719094|FG000|Overall Study|Adverse Event|3|||
164097203|NCT04625114|592719095|FG001|Overall Study|Adverse Event|1|||
164097204|NCT04625114|592719094|FG000|Overall Study|Withdrawal by Subject|2|||
164097205|NCT04625114|592719095|FG001|Overall Study|Withdrawal by Subject|0|||
164097206|NCT02507375|592719098|FG000|Overall Study|Progressive Disease|4|||
164097207|NCT02507375|592719099|FG001|Overall Study|Progressive Disease|5|||
164097208|NCT02507375|592719098|FG000|Overall Study|Death|0|||
164097209|NCT02507375|592719099|FG001|Overall Study|Death|1|||
164097210|NCT02507375|592719098|FG000|Overall Study|Refused treatment|0|||
164097211|NCT02507375|592719099|FG001|Overall Study|Refused treatment|1|||
164097212|NCT02507375|592719098|FG000|Overall Study|Adverse Event|0|||
164097213|NCT02507375|592719099|FG001|Overall Study|Adverse Event|1|||
164097214|NCT01066143|592720735|FG000|Overall Study|ineligible for the study|8|||
164097215|NCT05376319|592720736|FG000|Overall Study|Funding termination|2|||
164097216|NCT05376319|592720737|FG001|Overall Study|Funding termination|4|||
164097217|NCT01340495|592720738|FG000|Overall Study|Withdrawal by Subject|1|||
164097218|NCT03478397|592720739|FG000|Overall Study|Refused to participate|31|||
164097219|NCT03478397|592720740|FG001|Overall Study|Refused to participate|7|||
164097220|NCT05327491|592720741|FG000|Periods 1 & 2|Miscellaneous|0|||
164097221|NCT05327491|592720742|FG001|Periods 1 & 2|Miscellaneous|1|||
164097222|NCT05327491|592720743|FG002|Periods 1 & 2|Miscellaneous|0|||
164097223|NCT05327491|592720744|FG003|Periods 1 & 2|Miscellaneous|0|||
164097224|NCT05327491|592720741|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
164097225|NCT05327491|592720742|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
164097226|NCT05327491|592720743|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
164097227|NCT05327491|592720744|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
164097228|NCT00096447|592720745|FG000|Overall Study|Never treated|1|||
164097229|NCT00569374|592720748|FG000|Overall Study|Withdrawal by Subject|4|||
164097230|NCT01126736|592720749|FG000|Overall Study|Death|2|||
164097231|NCT01126736|592720750|FG001|Overall Study|Death|2|||
164097232|NCT01126736|592720751|FG002|Overall Study|Death|1|||
164097233|NCT01126736|592720752|FG003|Overall Study|Death|19|||
164097234|NCT01126736|592720753|FG004|Overall Study|Death|19|||
164097235|NCT01126736|592720749|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
164097236|NCT01126736|592720750|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
164097237|NCT01126736|592720751|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
164097238|NCT01126736|592720752|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
164097239|NCT01126736|592720753|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
164097240|NCT01126736|592720749|FG000|Overall Study|Lost to Follow-up|0|||
164097241|NCT01126736|592720750|FG001|Overall Study|Lost to Follow-up|0|||
164097242|NCT01126736|592720751|FG002|Overall Study|Lost to Follow-up|0|||
164097243|NCT01126736|592720752|FG003|Overall Study|Lost to Follow-up|1|||
164097244|NCT01126736|592720753|FG004|Overall Study|Lost to Follow-up|1|||
164097245|NCT01126736|592720749|FG000|Overall Study|Administrative reasons|0|||
164097246|NCT01126736|592720750|FG001|Overall Study|Administrative reasons|0|||
164097247|NCT01126736|592720751|FG002|Overall Study|Administrative reasons|0|||
164097248|NCT01126736|592720752|FG003|Overall Study|Administrative reasons|0|||
164097249|NCT01126736|592720753|FG004|Overall Study|Administrative reasons|1|||
164097250|NCT01126736|592720749|FG000|Overall Study|Progressive disease|0|||
164097251|NCT01126736|592720750|FG001|Overall Study|Progressive disease|0|||
164097252|NCT01126736|592720751|FG002|Overall Study|Progressive disease|0|||
164097253|NCT01126736|592720752|FG003|Overall Study|Progressive disease|2|||
164097254|NCT01126736|592720753|FG004|Overall Study|Progressive disease|1|||
164097255|NCT01126736|592720749|FG000|Overall Study|Withdrawal by Subject|0|||
163826621|NCT01662310|591732469|FG004|Double-Blind Phase|Pregnancy|0|||
163826622|NCT01662310|591732465|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
163826623|NCT01662310|591732466|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
163826624|NCT01662310|591732467|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
163826625|NCT01662310|591732468|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
163826626|NCT01662310|591732469|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
163826627|NCT01662310|591732465|FG000|Double-Blind Phase|Other|0|||
163826628|NCT01662310|591732466|FG001|Double-Blind Phase|Other|0|||
163826629|NCT01662310|591732467|FG002|Double-Blind Phase|Other|1|||
163826630|NCT01662310|591732468|FG003|Double-Blind Phase|Other|0|||
163826631|NCT01662310|591732469|FG004|Double-Blind Phase|Other|0|||
163826632|NCT01662310|591732465|FG000|Double-Blind Phase|Randomized but not treated|0|||
164097256|NCT01126736|592720750|FG001|Overall Study|Withdrawal by Subject|0|||
164097257|NCT01126736|592720751|FG002|Overall Study|Withdrawal by Subject|0|||
164097258|NCT01126736|592720752|FG003|Overall Study|Withdrawal by Subject|1|||
164097259|NCT01126736|592720753|FG004|Overall Study|Withdrawal by Subject|1|||
164097260|NCT01126736|592720749|FG000|Overall Study|Other|2|||
164097261|NCT01126736|592720750|FG001|Overall Study|Other|4|||
164097262|NCT01126736|592720751|FG002|Overall Study|Other|4|||
164097263|NCT01126736|592720752|FG003|Overall Study|Other|16|||
164097264|NCT01126736|592720753|FG004|Overall Study|Other|15|||
164097265|NCT02202850|592720755|FG000|Overall Study|Other|2|||
164097266|NCT02202850|592720756|FG001|Overall Study|Other|2|||
164097267|NCT02202850|592720755|FG000|Overall Study|Enbrel treatment discontinued|15|||
164097268|NCT02202850|592720756|FG001|Overall Study|Enbrel treatment discontinued|3|||
163826633|NCT01662310|591732466|FG001|Double-Blind Phase|Randomized but not treated|1|||
163826634|NCT01662310|591732467|FG002|Double-Blind Phase|Randomized but not treated|0|||
163826635|NCT01662310|591732468|FG003|Double-Blind Phase|Randomized but not treated|0|||
163826636|NCT01662310|591732469|FG004|Double-Blind Phase|Randomized but not treated|0|||
163826637|NCT01662310|591732465|FG000|Open-Label Extension Phase|Adverse Event|0|||
163826638|NCT01662310|591732466|FG001|Open-Label Extension Phase|Adverse Event|0|||
163826639|NCT01662310|591732467|FG002|Open-Label Extension Phase|Adverse Event|0|||
163826640|NCT01662310|591732468|FG003|Open-Label Extension Phase|Adverse Event|3|||
163826641|NCT01662310|591732469|FG004|Open-Label Extension Phase|Adverse Event|0|||
163826642|NCT01662310|591732465|FG000|Open-Label Extension Phase|Death|0|||
163826643|NCT01662310|591732466|FG001|Open-Label Extension Phase|Death|0|||
163826644|NCT01662310|591732467|FG002|Open-Label Extension Phase|Death|0|||
163826645|NCT01662310|591732468|FG003|Open-Label Extension Phase|Death|1|||
163826646|NCT01662310|591732469|FG004|Open-Label Extension Phase|Death|0|||
163826647|NCT01662310|591732465|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
163826648|NCT01662310|591732466|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
163826649|NCT01662310|591732467|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
163826650|NCT01662310|591732468|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
163826651|NCT01662310|591732469|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
163826652|NCT01662310|591732465|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
163826653|NCT01662310|591732466|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
163826654|NCT01662310|591732467|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
163826655|NCT01662310|591732468|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
163826656|NCT01662310|591732469|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
163826657|NCT01662310|591732465|FG000|Open-Label Extension Phase|Pregnancy|0|||
163826658|NCT01662310|591732466|FG001|Open-Label Extension Phase|Pregnancy|0|||
163826659|NCT01662310|591732467|FG002|Open-Label Extension Phase|Pregnancy|0|||
163826660|NCT01662310|591732468|FG003|Open-Label Extension Phase|Pregnancy|1|||
163826661|NCT01662310|591732469|FG004|Open-Label Extension Phase|Pregnancy|0|||
163826662|NCT01662310|591732465|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
163826663|NCT01662310|591732466|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
163826664|NCT01662310|591732467|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
163826665|NCT01662310|591732468|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
163826666|NCT01662310|591732469|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
163826667|NCT02432105|591732473|FG000|Overall Study|Lost to Follow-up|1|||
163826668|NCT02432105|591732474|FG001|Overall Study|Lost to Follow-up|1|||
163826669|NCT02432105|591732475|FG002|Overall Study|Lost to Follow-up|0|||
163826670|NCT02432105|591732473|FG000|Overall Study|Withdrawal by Subject|1|||
163826671|NCT02432105|591732474|FG001|Overall Study|Withdrawal by Subject|0|||
163826672|NCT02432105|591732475|FG002|Overall Study|Withdrawal by Subject|1|||
163826673|NCT02432105|591732473|FG000|Overall Study|Culture positive for yeast|0|||
163826674|NCT02432105|591732474|FG001|Overall Study|Culture positive for yeast|1|||
163826675|NCT02432105|591732475|FG002|Overall Study|Culture positive for yeast|0|||
163826676|NCT02432105|591732473|FG000|Overall Study|Randomized in error|0|||
163826677|NCT02432105|591732474|FG001|Overall Study|Randomized in error|0|||
163826678|NCT02432105|591732475|FG002|Overall Study|Randomized in error|2|||
163826679|NCT00829387|591732479|FG000|Overall Study|Withdrawal by Subject|2|||
163826680|NCT00829387|591732480|FG001|Overall Study|Withdrawal by Subject|3|||
163826681|NCT00829387|591732479|FG000|Overall Study|Disqualified by PI|1|||
163826682|NCT00829387|591732480|FG001|Overall Study|Disqualified by PI|0|||
163826683|NCT02085252|591732481|FG000|Overall Study|Withdrawal of Consent|1|||
163826684|NCT02085252|591732482|FG001|Overall Study|Withdrawal of Consent|0|||
163826685|NCT02085252|591732481|FG000|Overall Study|Adverse Event|0|||
163826686|NCT02085252|591732482|FG001|Overall Study|Adverse Event|1|||
163826687|NCT02085252|591732481|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
163826688|NCT02085252|591732482|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
163826689|NCT02085252|591732481|FG000|Overall Study|Reason Not Specified|0|||
163826690|NCT02085252|591732482|FG001|Overall Study|Reason Not Specified|1|||
163826691|NCT02085252|591732481|FG000|Overall Study|Reason Unknown|0|||
163920491|NCT04754594|592077844|FG003|Blinded Period|Lost to Follow-up|0|||
163920492|NCT04754594|592077841|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
163826692|NCT02085252|591732482|FG001|Overall Study|Reason Unknown|1|||
163826693|NCT03260868|591732484|FG000|Overall Study|Poor Compliance to Protocol|0|||
163826694|NCT03260868|591732485|FG001|Overall Study|Poor Compliance to Protocol|2|||
163826695|NCT03260868|591732484|FG000|Overall Study|Study Terminated By Sponsor|2|||
163826696|NCT03260868|591732485|FG001|Overall Study|Study Terminated By Sponsor|1|||
163826697|NCT03260868|591732484|FG000|Overall Study|Other than specified above|1|||
163826698|NCT03260868|591732485|FG001|Overall Study|Other than specified above|0|||
163826699|NCT03645759|591732489|FG000|Overall Study|Lost to Follow-up|3|||
163826700|NCT03645759|591732490|FG001|Overall Study|Lost to Follow-up|2|||
163826701|NCT02693743|591732493|FG000|Overall Study|Physician Decision|1|||
163920493|NCT04754594|592077842|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
163920494|NCT04754594|592077843|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
163920495|NCT04754594|592077844|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
163920496|NCT04754594|592077841|FG000|Unblinded Period|Withdrawal by Subject|6|||
163920497|NCT04754594|592077842|FG001|Unblinded Period|Withdrawal by Subject|8|||
163920498|NCT04754594|592077843|FG002|Unblinded Period|Withdrawal by Subject|0|||
163920499|NCT04754594|592077844|FG003|Unblinded Period|Withdrawal by Subject|0|||
163920500|NCT04754594|592077841|FG000|Unblinded Period|Lost to Follow-up|5|||
163920501|NCT04754594|592077842|FG001|Unblinded Period|Lost to Follow-up|3|||
163920502|NCT04754594|592077843|FG002|Unblinded Period|Lost to Follow-up|0|||
163920503|NCT04754594|592077844|FG003|Unblinded Period|Lost to Follow-up|0|||
163920504|NCT04754594|592077841|FG000|Unblinded Period|Protocol Violation|2|||
163920505|NCT04754594|592077842|FG001|Unblinded Period|Protocol Violation|4|||
163920506|NCT04754594|592077843|FG002|Unblinded Period|Protocol Violation|0|||
163920507|NCT04754594|592077844|FG003|Unblinded Period|Protocol Violation|0|||
163920508|NCT04754594|592077841|FG000|Unblinded Period|Other|3|||
163920509|NCT04754594|592077842|FG001|Unblinded Period|Other|0|||
163920510|NCT04754594|592077843|FG002|Unblinded Period|Other|0|||
163920511|NCT04754594|592077844|FG003|Unblinded Period|Other|0|||
163920512|NCT04754594|592077841|FG000|Infant Participants|Withdrawal by Subject|0|||
163920513|NCT04754594|592077842|FG001|Infant Participants|Withdrawal by Subject|0|||
163920514|NCT04754594|592077843|FG002|Infant Participants|Withdrawal by Subject|9|||
163920515|NCT04754594|592077844|FG003|Infant Participants|Withdrawal by Subject|17|||
163920516|NCT04754594|592077841|FG000|Infant Participants|Lost to Follow-up|0|||
163920517|NCT04754594|592077842|FG001|Infant Participants|Lost to Follow-up|0|||
163920518|NCT04754594|592077843|FG002|Infant Participants|Lost to Follow-up|4|||
163920519|NCT04754594|592077844|FG003|Infant Participants|Lost to Follow-up|10|||
163920520|NCT04754594|592077841|FG000|Infant Participants|Death|0|||
163920521|NCT04754594|592077842|FG001|Infant Participants|Death|0|||
163920522|NCT04754594|592077843|FG002|Infant Participants|Death|1|||
163920523|NCT04754594|592077844|FG003|Infant Participants|Death|1|||
163920524|NCT04754594|592077841|FG000|Infant Participants|Other|0|||
163920525|NCT04754594|592077842|FG001|Infant Participants|Other|0|||
163920526|NCT04754594|592077843|FG002|Infant Participants|Other|1|||
163920527|NCT04754594|592077844|FG003|Infant Participants|Other|1|||
163920528|NCT02116582|592077845|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
163920529|NCT02116582|592077845|FG000|Overall Study|Adverse Event|22|||
163920530|NCT02116582|592077845|FG000|Overall Study|Death|9|||
163920531|NCT02116582|592077845|FG000|Overall Study|Progressive Disease|148|||
163920532|NCT02116582|592077845|FG000|Overall Study|Protocol Violation|3|||
163920533|NCT02116582|592077845|FG000|Overall Study|Withdrawal by Subject|8|||
163920534|NCT02116582|592077845|FG000|Overall Study|Other: Miscellaneous|11|||
163920535|NCT02116582|592077845|FG000|Overall Study|Lost to Follow-up|1|||
163920536|NCT02116582|592077845|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
163920537|NCT00853021|592077846|FG000|Overall Study|Adverse Event|2|||
163920538|NCT00853021|592077846|FG000|Overall Study|Withdrawal by Subject|2|||
163920539|NCT00853021|592077846|FG000|Overall Study|Death|1|||
163920540|NCT02864147|592077847|FG000|Overall Study|Withdrawal by Subject|3|||
163920541|NCT02864147|592077848|FG001|Overall Study|Withdrawal by Subject|2|||
163920542|NCT02864147|592077849|FG002|Overall Study|Withdrawal by Subject|1|||
163920543|NCT02864147|592077847|FG000|Overall Study|Lost to Follow-up|0|||
163920544|NCT02864147|592077848|FG001|Overall Study|Lost to Follow-up|4|||
163920545|NCT02864147|592077849|FG002|Overall Study|Lost to Follow-up|0|||
163920546|NCT02864147|592077847|FG000|Overall Study|Adverse Event|0|||
163920547|NCT02864147|592077848|FG001|Overall Study|Adverse Event|1|||
163920548|NCT02864147|592077849|FG002|Overall Study|Adverse Event|0|||
163920549|NCT02864147|592077847|FG000|Overall Study|Pregnancy|4|||
163920550|NCT02864147|592077848|FG001|Overall Study|Pregnancy|0|||
163920551|NCT02864147|592077849|FG002|Overall Study|Pregnancy|0|||
163920552|NCT02864147|592077847|FG000|Overall Study|Physician Decision|0|||
163920553|NCT02864147|592077848|FG001|Overall Study|Physician Decision|0|||
163920554|NCT02864147|592077849|FG002|Overall Study|Physician Decision|1|||
163920555|NCT02864147|592077847|FG000|Overall Study|Opted for excisional procedures|0|||
163920556|NCT02864147|592077848|FG001|Overall Study|Opted for excisional procedures|0|||
163920557|NCT02864147|592077849|FG002|Overall Study|Opted for excisional procedures|3|||
163920558|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
164032107|NCT01204697|592477779|FG000|Overall Study|Withdrawal by Subject|2|||
164032108|NCT01204697|592477780|FG001|Overall Study|Withdrawal by Subject|4|||
164032109|NCT01204697|592477779|FG000|Overall Study|Randomized, but not treated|0|||
164032110|NCT01204697|592477780|FG001|Overall Study|Randomized, but not treated|1|||
164032111|NCT02119026|592477781|FG000|1st-line Treatment|Adverse Event|9|||
163920559|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
163920560|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
163920561|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
163920562|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
163920563|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
163920564|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
163920565|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
163920566|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
164032112|NCT02119026|592477782|FG001|1st-line Treatment|Adverse Event|14|||
163826702|NCT02693743|591732494|FG001|Overall Study|Physician Decision|0|||
163826703|NCT02626780|591732495|FG000|Overall Study|Withdrawal by Subject|3|||
163826704|NCT05540522|591732496|FG000|Overall Study|Adverse Event|1|||
163826705|NCT05540522|591732497|FG001|Overall Study|Adverse Event|0|||
163826706|NCT05540522|591732498|FG002|Overall Study|Adverse Event|2|||
163826707|NCT05540522|591732499|FG003|Overall Study|Adverse Event|5|||
163826708|NCT05540522|591732496|FG000|Overall Study|Lost to Follow-up|487|||
163826709|NCT05540522|591732497|FG001|Overall Study|Lost to Follow-up|427|||
163826710|NCT05540522|591732498|FG002|Overall Study|Lost to Follow-up|146|||
163826711|NCT05540522|591732499|FG003|Overall Study|Lost to Follow-up|166|||
163826712|NCT05540522|591732496|FG000|Overall Study|Physician Decision|11|||
163826713|NCT05540522|591732497|FG001|Overall Study|Physician Decision|19|||
163826714|NCT05540522|591732498|FG002|Overall Study|Physician Decision|8|||
163826715|NCT05540522|591732499|FG003|Overall Study|Physician Decision|13|||
163826716|NCT05540522|591732496|FG000|Overall Study|Pregnancy|1|||
163826717|NCT05540522|591732497|FG001|Overall Study|Pregnancy|0|||
163826718|NCT05540522|591732498|FG002|Overall Study|Pregnancy|0|||
163826719|NCT05540522|591732499|FG003|Overall Study|Pregnancy|0|||
163826720|NCT05540522|591732496|FG000|Overall Study|Protocol Violation|3|||
163826721|NCT05540522|591732497|FG001|Overall Study|Protocol Violation|1|||
163826722|NCT05540522|591732498|FG002|Overall Study|Protocol Violation|9|||
163826723|NCT05540522|591732499|FG003|Overall Study|Protocol Violation|7|||
163826724|NCT05540522|591732496|FG000|Overall Study|Withdrawal by Subject|168|||
163826725|NCT05540522|591732497|FG001|Overall Study|Withdrawal by Subject|134|||
163826726|NCT05540522|591732498|FG002|Overall Study|Withdrawal by Subject|331|||
163826727|NCT05540522|591732499|FG003|Overall Study|Withdrawal by Subject|322|||
163826728|NCT05540522|591732496|FG000|Overall Study|Death|7|||
163826729|NCT05540522|591732497|FG001|Overall Study|Death|9|||
163826730|NCT05540522|591732498|FG002|Overall Study|Death|49|||
163826731|NCT05540522|591732499|FG003|Overall Study|Death|46|||
163826732|NCT05540522|591732496|FG000|Overall Study|Not vaccinated|34|||
163826733|NCT05540522|591732497|FG001|Overall Study|Not vaccinated|53|||
163826734|NCT05540522|591732498|FG002|Overall Study|Not vaccinated|57|||
163826735|NCT05540522|591732499|FG003|Overall Study|Not vaccinated|50|||
163826736|NCT05540522|591732496|FG000|Overall Study|No longer meets eligibility criteria|0|||
163826737|NCT05540522|591732497|FG001|Overall Study|No longer meets eligibility criteria|0|||
163826738|NCT05540522|591732498|FG002|Overall Study|No longer meets eligibility criteria|3|||
163826739|NCT05540522|591732499|FG003|Overall Study|No longer meets eligibility criteria|2|||
163826740|NCT05540522|591732496|FG000|Overall Study|Other (Unspecified)|8|||
163826741|NCT05540522|591732497|FG001|Overall Study|Other (Unspecified)|10|||
163826742|NCT05540522|591732498|FG002|Overall Study|Other (Unspecified)|4|||
163826743|NCT05540522|591732499|FG003|Overall Study|Other (Unspecified)|2|||
163826744|NCT02459574|591732500|FG000|Overall Study|Withdrawal by Subject|6|||
163826745|NCT02459574|591732501|FG001|Overall Study|Withdrawal by Subject|6|||
163826746|NCT02459574|591732502|FG002|Overall Study|Withdrawal by Subject|2|||
163826747|NCT02459574|591732500|FG000|Overall Study|Lost to Follow-up|1|||
163826748|NCT02459574|591732501|FG001|Overall Study|Lost to Follow-up|1|||
163826749|NCT02459574|591732502|FG002|Overall Study|Lost to Follow-up|0|||
163826750|NCT02459574|591732500|FG000|Overall Study|Death|0|||
163826751|NCT02459574|591732501|FG001|Overall Study|Death|1|||
163826752|NCT02459574|591732502|FG002|Overall Study|Death|0|||
163826753|NCT04508699|591732505|FG000|Overall Study|Lack of Efficacy|2|||
163826754|NCT04508699|591732506|FG001|Overall Study|Lack of Efficacy|15|||
163826755|NCT04508699|591732505|FG000|Overall Study|Withdrawal by Subject|0|||
163826756|NCT04508699|591732506|FG001|Overall Study|Withdrawal by Subject|2|||
163826757|NCT02586025|591734078|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
163826758|NCT02586025|591734079|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
163826759|NCT02586025|591734078|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
163826760|NCT02586025|591734079|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
163826761|NCT02586025|591734078|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
163826762|NCT02586025|591734079|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
163826763|NCT02586025|591734078|FG000|Neoadjuvant Treatment|Death|1|||
163826764|NCT02586025|591734079|FG001|Neoadjuvant Treatment|Death|0|||
163826765|NCT02586025|591734078|FG000|Neoadjuvant Treatment|Adverse Event|1|||
163826766|NCT02586025|591734079|FG001|Neoadjuvant Treatment|Adverse Event|0|||
163826767|NCT02586025|591734078|FG000|Neoadjuvant Treatment|Physician Decision|2|||
163826768|NCT02586025|591734079|FG001|Neoadjuvant Treatment|Physician Decision|1|||
163920567|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
163826769|NCT02586025|591734078|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
163826770|NCT02586025|591734079|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
163826771|NCT02586025|591734078|FG000|Adjuvant Treatment|Recurrent Disease|4|||
163826772|NCT02586025|591734079|FG001|Adjuvant Treatment|Recurrent Disease|5|||
163826773|NCT02586025|591734078|FG000|Adjuvant Treatment|Physician Decision|0|||
163826774|NCT02586025|591734079|FG001|Adjuvant Treatment|Physician Decision|1|||
163826775|NCT02586025|591734078|FG000|Adjuvant Treatment|Pregnancy|1|||
163826776|NCT02586025|591734079|FG001|Adjuvant Treatment|Pregnancy|0|||
163920568|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
163920569|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
164097269|NCT02202850|592720755|FG000|Overall Study|Lost to Follow-up|7|||
164097270|NCT02202850|592720756|FG001|Overall Study|Lost to Follow-up|1|||
164097271|NCT00669942|592720757|FG000|Parts 2 and 3|Adverse Event|0|||
164097272|NCT00669942|592720758|FG001|Parts 2 and 3|Adverse Event|0|||
164097273|NCT00669942|592720759|FG002|Parts 2 and 3|Adverse Event|0|||
163826777|NCT02586025|591734078|FG000|Treatment-Free Follow-Up|Death|11|||
163826778|NCT02586025|591734079|FG001|Treatment-Free Follow-Up|Death|11|||
163826779|NCT02586025|591734078|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
163826780|NCT02586025|591734079|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
163826781|NCT02586025|591734078|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
163826782|NCT02586025|591734079|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
163826783|NCT02586025|591734078|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
163826784|NCT02586025|591734079|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
163826785|NCT02586025|591734078|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
163826786|NCT02586025|591734079|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
163826787|NCT03822117|591734080|FG000|Overall Study|Death|18|||
163826788|NCT03822117|591734081|FG001|Overall Study|Death|17|||
163826789|NCT03822117|591734082|FG002|Overall Study|Death|12|||
163826790|NCT03822117|591734083|FG003|Overall Study|Death|4|||
163826791|NCT03822117|591734080|FG000|Overall Study|Lost to Follow-up|1|||
163826792|NCT03822117|591734081|FG001|Overall Study|Lost to Follow-up|2|||
163826793|NCT03822117|591734082|FG002|Overall Study|Lost to Follow-up|3|||
163826794|NCT03822117|591734083|FG003|Overall Study|Lost to Follow-up|0|||
163826795|NCT03822117|591734080|FG000|Overall Study|Study Terminated by Sponsor|25|||
163826796|NCT03822117|591734081|FG001|Overall Study|Study Terminated by Sponsor|11|||
163826797|NCT03822117|591734082|FG002|Overall Study|Study Terminated by Sponsor|6|||
163826798|NCT03822117|591734083|FG003|Overall Study|Study Terminated by Sponsor|0|||
163826799|NCT03822117|591734080|FG000|Overall Study|Withdrawal by Subject|4|||
163826800|NCT03822117|591734081|FG001|Overall Study|Withdrawal by Subject|0|||
163920570|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
163920571|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
163920572|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
163920573|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
163920574|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
163920575|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
163920576|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
163920577|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
163920578|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
163920579|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
163920580|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
163920581|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
163920582|NCT02269917|592077850|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
163920583|NCT02269917|592077851|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
163920584|NCT02269917|592077852|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
163920585|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
163920586|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
163920587|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
163920588|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
163920589|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
163920590|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
163920591|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
163920592|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
163920593|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
163920594|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
163920595|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
163920596|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
163920597|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
163920598|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
163920599|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
163920600|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
163920601|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
163920602|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
163920603|NCT02269917|592077850|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
163920604|NCT02269917|592077851|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
163920605|NCT02269917|592077852|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
163920606|NCT01770509|592077853|FG000|Overall Study|Injury|0|||
163920607|NCT01770509|592077854|FG001|Overall Study|Injury|1|||
163920608|NCT01770509|592077853|FG000|Overall Study|Lost to Follow-up|1|||
163920609|NCT01770509|592077854|FG001|Overall Study|Lost to Follow-up|2|||
163920610|NCT00832650|592077855|FG000|Overall Study|Randomized but not treated|0|||
163920611|NCT00832650|592077856|FG001|Overall Study|Randomized but not treated|0|||
163920612|NCT00832650|592077857|FG002|Overall Study|Randomized but not treated|1|||
163920613|NCT03356145|592077858|FG000|Overall Study|Withdrawal by Subject|2|||
163920614|NCT03356145|592077859|FG001|Overall Study|Withdrawal by Subject|1|||
163920615|NCT03356145|592077858|FG000|Overall Study|Did not meet inclusion criteria|1|||
163920616|NCT03356145|592077859|FG001|Overall Study|Did not meet inclusion criteria|0|||
163920617|NCT02418819|592077863|FG000|Overall Study|Adverse Event|0|||
163920618|NCT02418819|592077864|FG001|Overall Study|Adverse Event|0|||
163920619|NCT02418819|592077865|FG002|Overall Study|Adverse Event|1|||
163920620|NCT02418819|592077866|FG003|Overall Study|Adverse Event|0|||
163920621|NCT02418819|592077863|FG000|Overall Study|Lost to Follow-up|1|||
163920622|NCT02418819|592077864|FG001|Overall Study|Lost to Follow-up|0|||
163920623|NCT02418819|592077865|FG002|Overall Study|Lost to Follow-up|0|||
163920624|NCT02418819|592077866|FG003|Overall Study|Lost to Follow-up|0|||
163920625|NCT02418819|592077863|FG000|Overall Study|No longer meets eligibility criteria|0|||
163920626|NCT02418819|592077864|FG001|Overall Study|No longer meets eligibility criteria|0|||
163920627|NCT02418819|592077865|FG002|Overall Study|No longer meets eligibility criteria|1|||
163920628|NCT02418819|592077866|FG003|Overall Study|No longer meets eligibility criteria|0|||
163920629|NCT02418819|592077863|FG000|Overall Study|No longer willing to participate|0|||
163920630|NCT02418819|592077864|FG001|Overall Study|No longer willing to participate|0|||
163920631|NCT02418819|592077865|FG002|Overall Study|No longer willing to participate|2|||
163920632|NCT02418819|592077866|FG003|Overall Study|No longer willing to participate|1|||
163920633|NCT00714688|592077874|FG000|Overall Study|Lack of Efficacy|14|||
163920634|NCT00714688|592077875|FG001|Overall Study|Lack of Efficacy|1|||
163920635|NCT00714688|592077876|FG002|Overall Study|Lack of Efficacy|4|||
163920636|NCT00714688|592077874|FG000|Overall Study|Withdrawal by Subject|4|||
163920637|NCT00714688|592077875|FG001|Overall Study|Withdrawal by Subject|3|||
163920638|NCT00714688|592077876|FG002|Overall Study|Withdrawal by Subject|3|||
163920639|NCT00714688|592077874|FG000|Overall Study|Lost to Follow-up|5|||
163920640|NCT00714688|592077875|FG001|Overall Study|Lost to Follow-up|2|||
163920641|NCT00714688|592077876|FG002|Overall Study|Lost to Follow-up|0|||
163920642|NCT00714688|592077874|FG000|Overall Study|Adverse Event|2|||
163920643|NCT00714688|592077875|FG001|Overall Study|Adverse Event|15|||
163920644|NCT00714688|592077876|FG002|Overall Study|Adverse Event|19|||
163920645|NCT00714688|592077874|FG000|Overall Study|Subject Non-compliant|3|||
163920646|NCT00714688|592077875|FG001|Overall Study|Subject Non-compliant|5|||
163920647|NCT00714688|592077876|FG002|Overall Study|Subject Non-compliant|5|||
164032113|NCT02119026|592477781|FG000|1st-line Treatment|Physician Decision|3|||
164032114|NCT02119026|592477782|FG001|1st-line Treatment|Physician Decision|8|||
164032115|NCT02119026|592477781|FG000|1st-line Treatment|Withdrawal by Subject|4|||
164032116|NCT02119026|592477782|FG001|1st-line Treatment|Withdrawal by Subject|10|||
164032117|NCT02119026|592477781|FG000|1st-line Treatment|Patient condition or compliance|6|||
164032118|NCT02119026|592477782|FG001|1st-line Treatment|Patient condition or compliance|4|||
164032119|NCT02119026|592477781|FG000|1st-line Treatment|Surgery of metastases|2|||
164032120|NCT02119026|592477782|FG001|1st-line Treatment|Surgery of metastases|1|||
164097274|NCT00669942|592720760|FG003|Parts 2 and 3|Adverse Event|0|||
163826801|NCT03822117|591734082|FG002|Overall Study|Withdrawal by Subject|3|||
164032121|NCT02119026|592477781|FG000|1st-line Treatment|Death|2|||
164032122|NCT02119026|592477782|FG001|1st-line Treatment|Death|1|||
164032123|NCT02119026|592477781|FG000|2nd-line Treatment|Lost to Follow-up|2|||
164032124|NCT02119026|592477782|FG001|2nd-line Treatment|Lost to Follow-up|0|||
163826802|NCT03822117|591734083|FG003|Overall Study|Withdrawal by Subject|0|||
163826803|NCT03822117|591734080|FG000|Overall Study|Disease Progression|1|||
163826804|NCT03822117|591734081|FG001|Overall Study|Disease Progression|2|||
163826805|NCT03822117|591734082|FG002|Overall Study|Disease Progression|1|||
163826806|NCT03822117|591734083|FG003|Overall Study|Disease Progression|0|||
163826807|NCT03822117|591734080|FG000|Overall Study|Never Returned to Hospital|0|||
163826808|NCT03822117|591734081|FG001|Overall Study|Never Returned to Hospital|0|||
163826809|NCT03822117|591734082|FG002|Overall Study|Never Returned to Hospital|1|||
163826810|NCT03822117|591734083|FG003|Overall Study|Never Returned to Hospital|0|||
163826811|NCT00415610|591734085|FG000|Overall Study|Death|3|||
164032125|NCT02119026|592477781|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
164032126|NCT02119026|592477782|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
164097275|NCT00669942|592720761|FG004|Parts 2 and 3|Adverse Event|0|||
163826812|NCT00415610|591734086|FG001|Overall Study|Death|2|||
163826813|NCT00415610|591734087|FG002|Overall Study|Death|5|||
163920648|NCT00714688|592077874|FG000|Overall Study|Ineligible to Continue the Study|0|||
163920649|NCT00714688|592077875|FG001|Overall Study|Ineligible to Continue the Study|1|||
163920650|NCT00714688|592077876|FG002|Overall Study|Ineligible to Continue the Study|1|||
163920651|NCT00714688|592077874|FG000|Overall Study|Sponsor's Decision|0|||
163920652|NCT00714688|592077875|FG001|Overall Study|Sponsor's Decision|2|||
163920653|NCT00714688|592077876|FG002|Overall Study|Sponsor's Decision|0|||
163920654|NCT00714688|592077874|FG000|Overall Study|Other|1|||
163920655|NCT00714688|592077875|FG001|Overall Study|Other|6|||
163920656|NCT00714688|592077876|FG002|Overall Study|Other|5|||
163920657|NCT01786551|592077877|FG000|Overall Study|Participant withdrew consent|2|||
164032127|NCT02119026|592477781|FG000|2nd-line Treatment|Adverse Event|4|||
164097276|NCT00669942|592720762|FG005|Parts 2 and 3|Adverse Event|0|||
163920658|NCT03993054|592077878|FG000|Overall Study|PI Decision|1|||
163920659|NCT00961896|592079887|FG000|Overall Study|Abnormal laboratory value|0|||
163920660|NCT00961896|592079888|FG001|Overall Study|Abnormal laboratory value|0|||
163920661|NCT00961896|592079889|FG002|Overall Study|Abnormal laboratory value|1|||
163920662|NCT00848393|592079890|FG000|Overall Study|Protocol Violation|0|||
163920663|NCT00848393|592079891|FG001|Overall Study|Protocol Violation|0|||
163920664|NCT00848393|592079892|FG002|Overall Study|Protocol Violation|1|||
163920665|NCT00848393|592079890|FG000|Overall Study|surgical complications unrelated to stud|0|||
163920666|NCT00848393|592079891|FG001|Overall Study|surgical complications unrelated to stud|0|||
163920667|NCT00848393|592079892|FG002|Overall Study|surgical complications unrelated to stud|2|||
163920668|NCT00755716|592079895|FG000|Overall Study|Adverse Event|1|||
163920669|NCT00755716|592079896|FG001|Overall Study|Adverse Event|4|||
163920670|NCT00755716|592079897|FG002|Overall Study|Adverse Event|1|||
163920671|NCT00755716|592079895|FG000|Overall Study|Lack of Efficacy|2|||
163920672|NCT00755716|592079896|FG001|Overall Study|Lack of Efficacy|0|||
163920673|NCT00755716|592079897|FG002|Overall Study|Lack of Efficacy|0|||
163920674|NCT00755716|592079895|FG000|Overall Study|Lost to Follow-up|5|||
163920675|NCT00755716|592079896|FG001|Overall Study|Lost to Follow-up|3|||
163920676|NCT00755716|592079897|FG002|Overall Study|Lost to Follow-up|1|||
163920677|NCT00755716|592079895|FG000|Overall Study|work schedule issues|0|||
163920678|NCT00755716|592079896|FG001|Overall Study|work schedule issues|1|||
163920679|NCT00755716|592079897|FG002|Overall Study|work schedule issues|1|||
163920680|NCT02229396|592079898|FG000|Overall Study|Adverse Event|6|||
163920681|NCT02229396|592079899|FG001|Overall Study|Adverse Event|12|||
163920682|NCT02229396|592079900|FG002|Overall Study|Adverse Event|12|||
163920683|NCT02229396|592079898|FG000|Overall Study|Death|2|||
163920684|NCT02229396|592079899|FG001|Overall Study|Death|3|||
163920685|NCT02229396|592079900|FG002|Overall Study|Death|1|||
163920686|NCT02229396|592079898|FG000|Overall Study|Lost to Follow-up|14|||
163920687|NCT02229396|592079899|FG001|Overall Study|Lost to Follow-up|14|||
163920688|NCT02229396|592079900|FG002|Overall Study|Lost to Follow-up|21|||
163920689|NCT02229396|592079898|FG000|Overall Study|Protocol Violation|2|||
163920690|NCT02229396|592079899|FG001|Overall Study|Protocol Violation|1|||
163920691|NCT02229396|592079900|FG002|Overall Study|Protocol Violation|0|||
163920692|NCT02229396|592079898|FG000|Overall Study|Patient Incorrectly Randomized|0|||
163920693|NCT02229396|592079899|FG001|Overall Study|Patient Incorrectly Randomized|0|||
163920694|NCT02229396|592079900|FG002|Overall Study|Patient Incorrectly Randomized|1|||
163920695|NCT02229396|592079898|FG000|Overall Study|Other|10|||
163920696|NCT02229396|592079899|FG001|Overall Study|Other|18|||
163920697|NCT02229396|592079900|FG002|Overall Study|Other|15|||
163920698|NCT02229396|592079898|FG000|Overall Study|Withdrawal by Subject|42|||
163920699|NCT02229396|592079899|FG001|Overall Study|Withdrawal by Subject|28|||
163920700|NCT02229396|592079900|FG002|Overall Study|Withdrawal by Subject|41|||
163920701|NCT02229396|592079898|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
163920702|NCT02229396|592079899|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163920703|NCT02229396|592079900|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
163920704|NCT02229396|592079898|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
163920705|NCT02229396|592079899|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
163920706|NCT02229396|592079900|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
163920707|NCT02679079|592079904|FG000|Overall Study|Adverse Event|2|||
163920708|NCT02679079|592079905|FG001|Overall Study|Adverse Event|0|||
163920709|NCT02679079|592079906|FG002|Overall Study|Adverse Event|2|||
163920710|NCT02679079|592079904|FG000|Overall Study|Protocol Violation|0|||
163920711|NCT02679079|592079905|FG001|Overall Study|Protocol Violation|1|||
163920712|NCT02679079|592079906|FG002|Overall Study|Protocol Violation|0|||
163920713|NCT02679079|592079904|FG000|Overall Study|Withdrawal by Subject|2|||
163920714|NCT02679079|592079905|FG001|Overall Study|Withdrawal by Subject|1|||
163920715|NCT02679079|592079906|FG002|Overall Study|Withdrawal by Subject|0|||
163920716|NCT00520403|592079907|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
163920717|NCT00520403|592079907|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
163920718|NCT00520403|592079907|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
163920719|NCT00520403|592079907|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
163920720|NCT00520403|592079907|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
163920721|NCT00520403|592079907|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
164097277|NCT00669942|592720763|FG006|Parts 2 and 3|Adverse Event|0|||
164097278|NCT00669942|592720764|FG007|Parts 2 and 3|Adverse Event|2|||
164097279|NCT00669942|592720765|FG008|Parts 2 and 3|Adverse Event|1|||
164097280|NCT00669942|592720766|FG009|Parts 2 and 3|Adverse Event|0|||
163920722|NCT00520403|592079907|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
163920723|NCT00520403|592079907|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
163920724|NCT00805285|592079910|FG000|Overall Study|Lack of Efficacy|1|||
163920725|NCT00839306|592079914|FG000|Overall Study|Adverse Event|3|||
163920726|NCT00839306|592079915|FG001|Overall Study|Adverse Event|5|||
163920727|NCT00839306|592079914|FG000|Overall Study|Lost to Follow-up|6|||
163920728|NCT00839306|592079915|FG001|Overall Study|Lost to Follow-up|9|||
164097281|NCT00669942|592720767|FG010|Parts 2 and 3|Adverse Event|0|||
163920729|NCT00839306|592079914|FG000|Overall Study|Withdrawal by Subject|5|||
164032128|NCT02119026|592477782|FG001|2nd-line Treatment|Adverse Event|1|||
163826814|NCT01357616|591734091|FG000|Overall Study|Adverse Event|1|||
163826815|NCT01357616|591734092|FG001|Overall Study|Adverse Event|1|||
163826816|NCT01357616|591734091|FG000|Overall Study|Lost to Follow-up|4|||
163826817|NCT01357616|591734092|FG001|Overall Study|Lost to Follow-up|3|||
163826818|NCT01357616|591734091|FG000|Overall Study|Protocol Violation|0|||
163826819|NCT01357616|591734092|FG001|Overall Study|Protocol Violation|2|||
163826820|NCT01357616|591734091|FG000|Overall Study|Inadequate Control of IOP|1|||
163826821|NCT01357616|591734092|FG001|Overall Study|Inadequate Control of IOP|2|||
163826822|NCT01357616|591734091|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
163826823|NCT01357616|591734092|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
163826824|NCT01357616|591734091|FG000|Overall Study|Withdrawal by Subject|1|||
163826825|NCT01357616|591734092|FG001|Overall Study|Withdrawal by Subject|0|||
163826826|NCT04465357|591734098|FG000|Overall Study|Adverse Event|2|||
163826827|NCT04465357|591734098|FG000|Overall Study|Lack of Efficacy|1|||
163826828|NCT04465357|591734098|FG000|Overall Study|Lost to Follow-up|2|||
163826829|NCT04465357|591734098|FG000|Overall Study|Withdrawal by Subject|6|||
163826830|NCT04465357|591734098|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
163826831|NCT00430248|591734109|FG000|Overall Study|Adverse Event|49|||
163826832|NCT00430248|591734110|FG001|Overall Study|Adverse Event|61|||
163826833|NCT00430248|591734111|FG002|Overall Study|Adverse Event|64|||
163826834|NCT00430248|591734109|FG000|Overall Study|Protocol Violation|10|||
163826835|NCT00430248|591734110|FG001|Overall Study|Protocol Violation|2|||
163826836|NCT00430248|591734111|FG002|Overall Study|Protocol Violation|4|||
163826837|NCT00430248|591734109|FG000|Overall Study|Personal Reasons|12|||
163826838|NCT00430248|591734110|FG001|Overall Study|Personal Reasons|24|||
163826839|NCT00430248|591734111|FG002|Overall Study|Personal Reasons|9|||
163826840|NCT00430248|591734109|FG000|Overall Study|Lost to Follow-up|28|||
163826841|NCT00430248|591734110|FG001|Overall Study|Lost to Follow-up|33|||
163826842|NCT00430248|591734111|FG002|Overall Study|Lost to Follow-up|28|||
163826843|NCT00430248|591734109|FG000|Overall Study|Therapeutic Failure|1|||
163826844|NCT00430248|591734110|FG001|Overall Study|Therapeutic Failure|1|||
163826845|NCT00430248|591734111|FG002|Overall Study|Therapeutic Failure|1|||
163826846|NCT00430248|591734109|FG000|Overall Study|Withdrawal by Subject|14|||
163920730|NCT00839306|592079915|FG001|Overall Study|Withdrawal by Subject|7|||
163920731|NCT00839306|592079914|FG000|Overall Study|Lack of Efficacy|5|||
163920732|NCT00839306|592079915|FG001|Overall Study|Lack of Efficacy|4|||
163920733|NCT00839306|592079914|FG000|Overall Study|Other|6|||
163920734|NCT00839306|592079915|FG001|Overall Study|Other|18|||
163920735|NCT01812707|592079916|FG000|Overall Study|Adverse Event|0|||
163920736|NCT01812707|592079917|FG001|Overall Study|Adverse Event|0|||
163920737|NCT01812707|592079918|FG002|Overall Study|Adverse Event|0|||
163920738|NCT01812707|592079919|FG003|Overall Study|Adverse Event|2|||
163920739|NCT01812707|592079916|FG000|Overall Study|Poor compliance to protocol|1|||
163920740|NCT01812707|592079917|FG001|Overall Study|Poor compliance to protocol|0|||
163920741|NCT01812707|592079918|FG002|Overall Study|Poor compliance to protocol|0|||
163920742|NCT01812707|592079919|FG003|Overall Study|Poor compliance to protocol|0|||
163920743|NCT01812707|592079916|FG000|Overall Study|Consent withdrawn by participant|1|||
163920744|NCT01812707|592079917|FG001|Overall Study|Consent withdrawn by participant|0|||
163920745|NCT01812707|592079918|FG002|Overall Study|Consent withdrawn by participant|0|||
163920746|NCT01812707|592079919|FG003|Overall Study|Consent withdrawn by participant|0|||
163920747|NCT05060237|592079921|FG000|Overall Study|Withdrawal by Subject|4|||
163920748|NCT05060237|592079921|FG000|Overall Study|Screening failure|8|||
163920749|NCT01066897|592079922|FG000|Overall Study|Withdrawal by Subject|1|||
163920750|NCT01066897|592079923|FG001|Overall Study|Withdrawal by Subject|0|||
163920751|NCT01066897|592079922|FG000|Overall Study|stopped study after developing the flu.|1|||
163920752|NCT01066897|592079923|FG001|Overall Study|stopped study after developing the flu.|0|||
163920753|NCT01697592|592079926|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
163920754|NCT01697592|592079927|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163920755|NCT01697592|592079928|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163826847|NCT00430248|591734110|FG001|Overall Study|Withdrawal by Subject|20|||
163826848|NCT00430248|591734111|FG002|Overall Study|Withdrawal by Subject|16|||
163920756|NCT01697592|592079929|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163826849|NCT00430248|591734109|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163826850|NCT00430248|591734110|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
163826851|NCT00430248|591734111|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163826852|NCT00430248|591734109|FG000|Overall Study|Gout Flare|3|||
163826853|NCT00430248|591734110|FG001|Overall Study|Gout Flare|7|||
163920757|NCT01697592|592079930|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163826854|NCT00430248|591734111|FG002|Overall Study|Gout Flare|2|||
163826855|NCT00430248|591734109|FG000|Overall Study|Reason Not Specified|8|||
163826856|NCT00430248|591734110|FG001|Overall Study|Reason Not Specified|8|||
163920758|NCT01697592|592079931|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163920759|NCT01697592|592079932|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163920760|NCT01697592|592079933|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163920761|NCT01697592|592079934|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163920762|NCT01697592|592079935|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
163920763|NCT01697592|592079926|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920764|NCT01697592|592079927|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920765|NCT01697592|592079928|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920766|NCT01697592|592079929|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920767|NCT01697592|592079930|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920768|NCT01697592|592079931|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
163920769|NCT01697592|592079932|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920770|NCT01697592|592079933|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920771|NCT01697592|592079934|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920772|NCT01697592|592079935|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
163920773|NCT01697592|592079926|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
164032129|NCT01143714|592477785|FG000|Overall Study|Adverse Event|4|||
164032130|NCT01143714|592477786|FG001|Overall Study|Adverse Event|2|||
164032131|NCT01143714|592477785|FG000|Overall Study|Withdrawal by Subject|1|||
164032132|NCT01143714|592477786|FG001|Overall Study|Withdrawal by Subject|0|||
164032133|NCT01143714|592477785|FG000|Overall Study|Subject non-compliance|0|||
164032134|NCT01143714|592477786|FG001|Overall Study|Subject non-compliance|1|||
164032135|NCT01143714|592477785|FG000|Overall Study|wound closed = deemed healed|1|||
164032136|NCT01143714|592477786|FG001|Overall Study|wound closed = deemed healed|0|||
164032137|NCT01143714|592477785|FG000|Overall Study|wound size increased|1|||
164032138|NCT01143714|592477786|FG001|Overall Study|wound size increased|0|||
164032139|NCT03939637|592477790|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
164032140|NCT03939637|592477791|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
164032141|NCT03939637|592477790|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
164032142|NCT03939637|592477791|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
164032143|NCT03783442|592477792|FG000|Overall Study|Death|252|||
164032144|NCT03783442|592477793|FG001|Overall Study|Death|268|||
164032145|NCT03783442|592477792|FG000|Overall Study|Withdrawal by Subject|19|||
164032146|NCT03783442|592477793|FG001|Overall Study|Withdrawal by Subject|21|||
164032147|NCT03783442|592477792|FG000|Overall Study|Lost to Follow-up|7|||
164032148|NCT03783442|592477793|FG001|Overall Study|Lost to Follow-up|6|||
164032149|NCT03783442|592477792|FG000|Overall Study|Sponsor Ended Study|48|||
164032150|NCT03783442|592477793|FG001|Overall Study|Sponsor Ended Study|28|||
164032151|NCT04190186|592477794|FG000|Overall Study|ILR is no longer functioning|0|||
164032152|NCT04190186|592477795|FG001|Overall Study|ILR is no longer functioning|1|||
164032153|NCT04190186|592477794|FG000|Overall Study|Lost to Follow-up|0|||
164032154|NCT04190186|592477795|FG001|Overall Study|Lost to Follow-up|1|||
164032155|NCT04190186|592477794|FG000|Overall Study|Withdrawal by Subject|2|||
164032156|NCT04190186|592477795|FG001|Overall Study|Withdrawal by Subject|0|||
164032157|NCT04190186|592477794|FG000|Overall Study|Subject choice to explant|1|||
164032158|NCT04190186|592477795|FG001|Overall Study|Subject choice to explant|0|||
164032159|NCT04190186|592477794|FG000|Overall Study|Physician Decision|0|||
164032160|NCT04190186|592477795|FG001|Overall Study|Physician Decision|1|||
164032161|NCT04190186|592477794|FG000|Overall Study|Study was stopped|4|||
164032162|NCT04190186|592477795|FG001|Overall Study|Study was stopped|5|||
164032163|NCT01381718|592477796|FG000|Overall Study|Withdrawal by Subject|2|||
164032164|NCT01381718|592477797|FG001|Overall Study|Withdrawal by Subject|5|||
164032165|NCT01381718|592477796|FG000|Overall Study|Lost to Follow-up|3|||
164032166|NCT01381718|592477797|FG001|Overall Study|Lost to Follow-up|5|||
164032167|NCT01381718|592477796|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
164032168|NCT01381718|592477797|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
163920774|NCT01697592|592079927|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920775|NCT01697592|592079928|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
164032169|NCT03017846|592477800|FG000|Overall Study|Lost to Follow-up|3|||
164032170|NCT03017846|592477800|FG000|Overall Study|Adverse Event|2|||
164032171|NCT02505542|592477801|FG000|Part A: Open-Label Period|Adverse Event|31|||
164032172|NCT02505542|592477802|FG001|Part A: Open-Label Period|Adverse Event|0|||
164032173|NCT02505542|592477803|FG002|Part A: Open-Label Period|Adverse Event|0|||
164032174|NCT02505542|592477804|FG003|Part A: Open-Label Period|Adverse Event|0|||
164032175|NCT02505542|592477801|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
164032176|NCT02505542|592477802|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
164032177|NCT02505542|592477803|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
164032178|NCT02505542|592477804|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
164032179|NCT02505542|592477801|FG000|Part A: Open-Label Period|Protocol Violation|1|||
164032180|NCT02505542|592477802|FG001|Part A: Open-Label Period|Protocol Violation|0|||
164032181|NCT02505542|592477803|FG002|Part A: Open-Label Period|Protocol Violation|0|||
164032182|NCT02505542|592477804|FG003|Part A: Open-Label Period|Protocol Violation|0|||
164032183|NCT02505542|592477801|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
163920776|NCT01697592|592079929|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920777|NCT01697592|592079930|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920778|NCT01697592|592079931|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920779|NCT01697592|592079932|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920780|NCT01697592|592079933|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920781|NCT01697592|592079934|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920782|NCT01697592|592079935|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
163920783|NCT01697592|592079926|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163920784|NCT01697592|592079927|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163920785|NCT01697592|592079928|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163920786|NCT01697592|592079929|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163920787|NCT01697592|592079930|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163920788|NCT01697592|592079931|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163920789|NCT01697592|592079932|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163920790|NCT01697592|592079933|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163920791|NCT01697592|592079934|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
163920792|NCT01697592|592079935|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
163920793|NCT01697592|592079926|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163920794|NCT01697592|592079927|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
163920795|NCT01697592|592079928|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
163920796|NCT01697592|592079929|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
163920797|NCT01697592|592079930|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163920798|NCT01697592|592079931|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163920799|NCT01697592|592079932|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
163920800|NCT01697592|592079933|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163920801|NCT01697592|592079934|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
163920802|NCT01697592|592079935|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
163920803|NCT01697592|592079926|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
163920804|NCT01697592|592079927|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163920805|NCT01697592|592079928|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163920806|NCT01697592|592079929|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
163920807|NCT01697592|592079930|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163920808|NCT01697592|592079931|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164032184|NCT02505542|592477802|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
164032185|NCT02505542|592477803|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
164032186|NCT02505542|592477804|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
164032187|NCT02505542|592477801|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
163826857|NCT00430248|591734111|FG002|Overall Study|Reason Not Specified|11|||
163826858|NCT00002558|591734114|FG000|Overall Study|Withdrawal by Subject|0|||
163826859|NCT00002558|591734115|FG001|Overall Study|Withdrawal by Subject|1|||
163826860|NCT01260350|591734119|FG000|Overall Study|Lack of Efficacy|0|||
163826861|NCT01260350|591734120|FG001|Overall Study|Lack of Efficacy|0|||
163826862|NCT01260350|591734121|FG002|Overall Study|Lack of Efficacy|0|||
163826863|NCT01260350|591734122|FG003|Overall Study|Lack of Efficacy|0|||
163826864|NCT01260350|591734123|FG004|Overall Study|Lack of Efficacy|0|||
163826865|NCT01260350|591734124|FG005|Overall Study|Lack of Efficacy|0|||
164032188|NCT02505542|592477802|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
164032189|NCT02505542|592477803|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
164032190|NCT02505542|592477804|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
164032191|NCT02505542|592477801|FG000|Part A: Open-Label Period|New medical history available|1|||
164032192|NCT02505542|592477802|FG001|Part A: Open-Label Period|New medical history available|0|||
164032193|NCT02505542|592477803|FG002|Part A: Open-Label Period|New medical history available|0|||
163826866|NCT01260350|591734125|FG006|Overall Study|Lack of Efficacy|0|||
163826867|NCT01260350|591734126|FG007|Overall Study|Lack of Efficacy|0|||
163826868|NCT01260350|591734127|FG008|Overall Study|Lack of Efficacy|0|||
163826869|NCT01260350|591734128|FG009|Overall Study|Lack of Efficacy|0|||
163826870|NCT01260350|591734129|FG010|Overall Study|Lack of Efficacy|0|||
163826871|NCT01260350|591734130|FG011|Overall Study|Lack of Efficacy|0|||
163826872|NCT01260350|591734131|FG012|Overall Study|Lack of Efficacy|0|||
163826873|NCT01260350|591734132|FG013|Overall Study|Lack of Efficacy|0|||
163826874|NCT01260350|591734133|FG014|Overall Study|Lack of Efficacy|0|||
163920809|NCT01697592|592079932|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164032194|NCT02505542|592477804|FG003|Part A: Open-Label Period|New medical history available|0|||
164032195|NCT02505542|592477801|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
164032196|NCT02505542|592477802|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
164032197|NCT02505542|592477803|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
163826875|NCT01260350|591734134|FG015|Overall Study|Lack of Efficacy|0|||
163920810|NCT01697592|592079933|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
164032198|NCT02505542|592477804|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
163826876|NCT01260350|591734135|FG016|Overall Study|Lack of Efficacy|0|||
163920811|NCT01697592|592079934|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163920812|NCT01697592|592079935|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
163920813|NCT01697592|592079926|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
163920814|NCT01697592|592079927|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163826877|NCT01260350|591734136|FG017|Overall Study|Lack of Efficacy|1|||
163826878|NCT01260350|591734137|FG018|Overall Study|Lack of Efficacy|0|||
163826879|NCT01260350|591734138|FG019|Overall Study|Lack of Efficacy|0|||
163826880|NCT01260350|591734139|FG020|Overall Study|Lack of Efficacy|3|||
163826881|NCT01260350|591734140|FG021|Overall Study|Lack of Efficacy|0|||
163826882|NCT01260350|591734119|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826883|NCT01260350|591734120|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826884|NCT01260350|591734121|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826885|NCT01260350|591734122|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826886|NCT01260350|591734123|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826887|NCT01260350|591734124|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826888|NCT01260350|591734125|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826889|NCT01260350|591734126|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826890|NCT01260350|591734127|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
163826891|NCT01260350|591734128|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826892|NCT01260350|591734129|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826893|NCT01260350|591734130|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826894|NCT01260350|591734131|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826895|NCT01260350|591734132|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826896|NCT01260350|591734133|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826897|NCT01260350|591734134|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826898|NCT01260350|591734135|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826899|NCT01260350|591734136|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826900|NCT01260350|591734137|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826901|NCT01260350|591734138|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826902|NCT01260350|591734139|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826903|NCT01260350|591734140|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
163826904|NCT04385368|591734141|FG000|Overall Study|Death|5|||
163826905|NCT04385368|591734142|FG001|Overall Study|Death|5|||
163826906|NCT04385368|591734141|FG000|Overall Study|Physician Decision|3|||
163826907|NCT04385368|591734142|FG001|Overall Study|Physician Decision|0|||
163826908|NCT04385368|591734141|FG000|Overall Study|Withdrawal by Subject|4|||
163826909|NCT04385368|591734142|FG001|Overall Study|Withdrawal by Subject|3|||
163826910|NCT02123108|591734146|FG000|Overall Study|Death|2|||
163826911|NCT02123108|591734147|FG001|Overall Study|Death|3|||
163826912|NCT02219048|591734148|FG000|Overall Study|Adverse Event|2|||
163826913|NCT02219048|591734149|FG001|Overall Study|Adverse Event|5|||
163826914|NCT02219048|591734148|FG000|Overall Study|No longer meets eligibility criteria|1|||
163826915|NCT02219048|591734149|FG001|Overall Study|No longer meets eligibility criteria|0|||
163826916|NCT02219048|591734148|FG000|Overall Study|Study terminated by sponsor|16|||
163826917|NCT02219048|591734149|FG001|Overall Study|Study terminated by sponsor|15|||
163826918|NCT02219048|591734148|FG000|Overall Study|Withdrawal by Subject|2|||
163826919|NCT02219048|591734149|FG001|Overall Study|Withdrawal by Subject|0|||
163826920|NCT02219048|591734148|FG000|Overall Study|Other|0|||
163826921|NCT02219048|591734149|FG001|Overall Study|Other|1|||
163826922|NCT04721925|591734150|FG000|2-Month Assessment|Lost to Follow-up|5|||
163826923|NCT04721925|591734151|FG001|2-Month Assessment|Lost to Follow-up|3|||
163826924|NCT04721925|591734150|FG000|4-Month Assessment|Lost to Follow-up|3|||
163826925|NCT04721925|591734151|FG001|4-Month Assessment|Lost to Follow-up|6|||
163826926|NCT03802123|591734160|FG000|Overall Study|Withdrawal by Subject|3|||
163826927|NCT03802123|591734160|FG000|Overall Study|Physician Decision|1|||
163826928|NCT03802123|591734160|FG000|Overall Study|Subject moved to hospice care|1|||
163826929|NCT03802123|591734160|FG000|Overall Study|technician error|1|||
163826930|NCT03802123|591734160|FG000|Overall Study|Death|3|||
163826931|NCT01274182|591734161|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
163826932|NCT01274182|591734162|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163826933|NCT01274182|591734163|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
163826934|NCT01274182|591734161|FG000|Overall Study|Adverse Event|4|||
163826935|NCT01274182|591734162|FG001|Overall Study|Adverse Event|5|||
163826936|NCT01274182|591734163|FG002|Overall Study|Adverse Event|3|||
163826937|NCT01274182|591734161|FG000|Overall Study|Withdrawal by Subject|5|||
163826938|NCT01274182|591734162|FG001|Overall Study|Withdrawal by Subject|5|||
163826939|NCT01274182|591734163|FG002|Overall Study|Withdrawal by Subject|3|||
163826940|NCT01274182|591734161|FG000|Overall Study|Lost to Follow-up|2|||
163826941|NCT01274182|591734162|FG001|Overall Study|Lost to Follow-up|3|||
163826942|NCT01274182|591734163|FG002|Overall Study|Lost to Follow-up|1|||
163826943|NCT01274182|591734161|FG000|Overall Study|Protocol Violation|3|||
163826944|NCT01274182|591734162|FG001|Overall Study|Protocol Violation|2|||
163826945|NCT01274182|591734163|FG002|Overall Study|Protocol Violation|0|||
163826946|NCT01274182|591734161|FG000|Overall Study|Death|1|||
163920815|NCT01697592|592079928|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163920816|NCT01697592|592079929|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163826947|NCT01274182|591734162|FG001|Overall Study|Death|0|||
163826948|NCT01274182|591734163|FG002|Overall Study|Death|1|||
163826949|NCT01970982|591734164|FG000|Overall Study|Withdrawal by Subject|0|||
163826950|NCT01970982|591734165|FG001|Overall Study|Withdrawal by Subject|0|||
163920817|NCT01697592|592079930|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163920818|NCT01697592|592079931|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
163920819|NCT01697592|592079932|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163920820|NCT01697592|592079933|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
163920821|NCT01697592|592079934|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163920822|NCT01697592|592079935|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
163920823|NCT01697592|592079926|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
163920824|NCT01697592|592079927|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163920825|NCT01697592|592079928|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163920826|NCT01697592|592079929|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
163920827|NCT01697592|592079930|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
163920828|NCT01697592|592079931|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163920829|NCT01697592|592079932|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
163920830|NCT01697592|592079933|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
163920831|NCT01697592|592079934|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
163920832|NCT01697592|592079935|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
163920833|NCT02396758|592079936|FG000|Overall Study|Withdrawal by Subject|2|||
163920834|NCT02396758|592079937|FG001|Overall Study|Withdrawal by Subject|0|||
163920835|NCT02396758|592079938|FG002|Overall Study|Withdrawal by Subject|0|||
163920836|NCT02396758|592079939|FG003|Overall Study|Withdrawal by Subject|1|||
163826951|NCT01970982|591734166|FG002|Overall Study|Withdrawal by Subject|2|||
163826952|NCT04555096|591734172|FG000|Overall Study|Death|4|||
163826953|NCT04555096|591734173|FG001|Overall Study|Death|4|||
163826954|NCT04555096|591734172|FG000|Overall Study|Withdrawal by Subject|1|||
163826955|NCT04555096|591734173|FG001|Overall Study|Withdrawal by Subject|0|||
163826956|NCT04555096|591734172|FG000|Overall Study|Other|0|||
163826957|NCT04555096|591734173|FG001|Overall Study|Other|1|||
163826958|NCT04040751|591734175|FG000|Overall Study|Withdrawal by Subject|2|||
163826959|NCT04040751|591734176|FG001|Overall Study|Withdrawal by Subject|0|||
163826960|NCT04040751|591734177|FG002|Overall Study|Withdrawal by Subject|2|||
163826961|NCT04040751|591734178|FG003|Overall Study|Withdrawal by Subject|0|||
163826962|NCT02862457|591734179|FG000|Overall Study|Death|1|||
163826963|NCT02862457|591734180|FG001|Overall Study|Death|3|||
163826964|NCT02862457|591734181|FG002|Overall Study|Death|2|||
163826965|NCT02862457|591734182|FG003|Overall Study|Death|3|||
163826966|NCT02862457|591734183|FG004|Overall Study|Death|0|||
163826967|NCT02862457|591734184|FG005|Overall Study|Death|2|||
163826968|NCT02862457|591734185|FG006|Overall Study|Death|1|||
163826969|NCT02862457|591734179|FG000|Overall Study|Lost to Follow-up|1|||
163826970|NCT02862457|591734180|FG001|Overall Study|Lost to Follow-up|0|||
163826971|NCT02862457|591734181|FG002|Overall Study|Lost to Follow-up|0|||
163826972|NCT02862457|591734182|FG003|Overall Study|Lost to Follow-up|1|||
163826973|NCT02862457|591734183|FG004|Overall Study|Lost to Follow-up|0|||
163826974|NCT02862457|591734184|FG005|Overall Study|Lost to Follow-up|0|||
163826975|NCT02862457|591734185|FG006|Overall Study|Lost to Follow-up|0|||
163826976|NCT02862457|591734179|FG000|Overall Study|Withdrawal by Subject|0|||
163826977|NCT02862457|591734180|FG001|Overall Study|Withdrawal by Subject|0|||
163826978|NCT02862457|591734181|FG002|Overall Study|Withdrawal by Subject|1|||
163826979|NCT02862457|591734182|FG003|Overall Study|Withdrawal by Subject|0|||
163826980|NCT02862457|591734183|FG004|Overall Study|Withdrawal by Subject|0|||
163826981|NCT02862457|591734184|FG005|Overall Study|Withdrawal by Subject|1|||
163826982|NCT02862457|591734185|FG006|Overall Study|Withdrawal by Subject|0|||
163826983|NCT03364751|591734186|FG000|Overall Study|Withdrawal by Subject|1|||
163826984|NCT03364751|591734187|FG001|Overall Study|Withdrawal by Subject|0|||
163826985|NCT03364751|591734188|FG002|Overall Study|Withdrawal by Subject|0|||
163826986|NCT03364751|591734189|FG003|Overall Study|Withdrawal by Subject|0|||
163826987|NCT03364751|591734186|FG000|Overall Study|Lost to Follow-up|0|||
163826988|NCT03364751|591734187|FG001|Overall Study|Lost to Follow-up|1|||
163826989|NCT03364751|591734188|FG002|Overall Study|Lost to Follow-up|0|||
163920837|NCT02396758|592079936|FG000|Overall Study|Lost to Follow-up|8|||
163920838|NCT02396758|592079937|FG001|Overall Study|Lost to Follow-up|5|||
164032199|NCT02505542|592477801|FG000|Part A: Open-Label Period|Pregnancy|2|||
164032200|NCT02505542|592477802|FG001|Part A: Open-Label Period|Pregnancy|0|||
164032201|NCT02505542|592477803|FG002|Part A: Open-Label Period|Pregnancy|0|||
163826990|NCT03364751|591734189|FG003|Overall Study|Lost to Follow-up|0|||
163826991|NCT02342886|591734191|FG000|Overall Study|Treatment non-compliance|1|||
163826992|NCT02342886|591734192|FG001|Overall Study|Treatment non-compliance|0|||
163826993|NCT02342886|591734193|FG002|Overall Study|Treatment non-compliance|0|||
163826994|NCT02342886|591734194|FG003|Overall Study|Treatment non-compliance|1|||
163920839|NCT02396758|592079938|FG002|Overall Study|Lost to Follow-up|3|||
163920840|NCT02396758|592079939|FG003|Overall Study|Lost to Follow-up|3|||
163920841|NCT02396758|592079936|FG000|Overall Study|Death|1|||
163920842|NCT02396758|592079937|FG001|Overall Study|Death|1|||
163920843|NCT02396758|592079938|FG002|Overall Study|Death|0|||
163826995|NCT02342886|591734195|FG004|Overall Study|Treatment non-compliance|0|||
164032202|NCT02505542|592477804|FG003|Part A: Open-Label Period|Pregnancy|0|||
163826996|NCT02342886|591734191|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
163826997|NCT02342886|591734192|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
163826998|NCT02342886|591734193|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
163826999|NCT02342886|591734194|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
163827000|NCT02342886|591734195|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
163827001|NCT02342886|591734191|FG000|Overall Study|Adverse event/specific toxicity|4|||
163827002|NCT02342886|591734192|FG001|Overall Study|Adverse event/specific toxicity|3|||
163827003|NCT02342886|591734193|FG002|Overall Study|Adverse event/specific toxicity|11|||
163827004|NCT02342886|591734194|FG003|Overall Study|Adverse event/specific toxicity|2|||
163827005|NCT02342886|591734195|FG004|Overall Study|Adverse event/specific toxicity|1|||
163827006|NCT02342886|591734191|FG000|Overall Study|Lost to Follow-up|1|||
163827007|NCT02342886|591734192|FG001|Overall Study|Lost to Follow-up|0|||
163827008|NCT02342886|591734193|FG002|Overall Study|Lost to Follow-up|0|||
163827009|NCT02342886|591734194|FG003|Overall Study|Lost to Follow-up|0|||
163827010|NCT02342886|591734195|FG004|Overall Study|Lost to Follow-up|0|||
163827011|NCT02342886|591734191|FG000|Overall Study|Death|1|||
163827012|NCT02342886|591734192|FG001|Overall Study|Death|2|||
163827013|NCT02342886|591734193|FG002|Overall Study|Death|1|||
163827014|NCT02342886|591734194|FG003|Overall Study|Death|0|||
163827015|NCT02342886|591734195|FG004|Overall Study|Death|1|||
163827016|NCT02342886|591734191|FG000|Overall Study|Withdrawal by Subject|0|||
163827017|NCT02342886|591734192|FG001|Overall Study|Withdrawal by Subject|1|||
163827018|NCT02342886|591734193|FG002|Overall Study|Withdrawal by Subject|0|||
163827019|NCT02342886|591734194|FG003|Overall Study|Withdrawal by Subject|1|||
163827020|NCT02342886|591734195|FG004|Overall Study|Withdrawal by Subject|0|||
163827021|NCT02342886|591734191|FG000|Overall Study|Investigator/sponsor decision|0|||
163827022|NCT02342886|591734192|FG001|Overall Study|Investigator/sponsor decision|2|||
163827023|NCT02342886|591734193|FG002|Overall Study|Investigator/sponsor decision|0|||
163827024|NCT02342886|591734194|FG003|Overall Study|Investigator/sponsor decision|3|||
163827025|NCT02342886|591734195|FG004|Overall Study|Investigator/sponsor decision|1|||
163827026|NCT02342886|591734191|FG000|Overall Study|Pregnancy|0|||
163827027|NCT02342886|591734192|FG001|Overall Study|Pregnancy|0|||
163827028|NCT02342886|591734193|FG002|Overall Study|Pregnancy|2|||
163827029|NCT02342886|591734194|FG003|Overall Study|Pregnancy|0|||
163827030|NCT02342886|591734195|FG004|Overall Study|Pregnancy|0|||
163827031|NCT02342886|591734191|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163827032|NCT02342886|591734192|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163827033|NCT02342886|591734193|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
163827034|NCT02342886|591734194|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163827035|NCT02342886|591734195|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
163827036|NCT02342886|591734191|FG000|Overall Study|Protocol Violation|0|||
163827037|NCT02342886|591734192|FG001|Overall Study|Protocol Violation|0|||
163827038|NCT02342886|591734193|FG002|Overall Study|Protocol Violation|0|||
163827039|NCT02342886|591734194|FG003|Overall Study|Protocol Violation|2|||
163827040|NCT02342886|591734195|FG004|Overall Study|Protocol Violation|0|||
163827041|NCT00862134|591734196|FG000|Overall Study|Death|1|||
163827042|NCT00862134|591734197|FG001|Overall Study|Death|0|||
163827043|NCT00862134|591734196|FG000|Overall Study|Physician Decision|0|||
163827044|NCT00862134|591734197|FG001|Overall Study|Physician Decision|1|||
163827045|NCT00862134|591734196|FG000|Overall Study|Withdrawal by Subject|1|||
163827046|NCT00862134|591734197|FG001|Overall Study|Withdrawal by Subject|2|||
163827047|NCT00862134|591734196|FG000|Overall Study|Sponsor terminated study|5|||
163827048|NCT00862134|591734197|FG001|Overall Study|Sponsor terminated study|7|||
163827049|NCT00862134|591734196|FG000|Overall Study|Adverse Event|2|||
163827050|NCT00862134|591734197|FG001|Overall Study|Adverse Event|2|||
163827051|NCT00862134|591734196|FG000|Overall Study|Withdrew prior to dosing|2|||
163827052|NCT00862134|591734197|FG001|Overall Study|Withdrew prior to dosing|0|||
163827053|NCT00765674|591734198|FG000|Overall Study|Adverse Event|7|||
163827054|NCT00765674|591734199|FG001|Overall Study|Adverse Event|2|||
163827055|NCT00765674|591734200|FG002|Overall Study|Adverse Event|8|||
163827056|NCT00765674|591734201|FG003|Overall Study|Adverse Event|11|||
163827057|NCT00765674|591734198|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
163827058|NCT00765674|591734199|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
163827059|NCT00765674|591734200|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
163827060|NCT00765674|591734201|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
163827061|NCT00765674|591734198|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
163827062|NCT00765674|591734199|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
163827063|NCT00765674|591734200|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
163827064|NCT00765674|591734201|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
163827065|NCT00765674|591734198|FG000|Overall Study|Lack of Efficacy|2|||
163827066|NCT00765674|591734199|FG001|Overall Study|Lack of Efficacy|3|||
163827067|NCT00765674|591734200|FG002|Overall Study|Lack of Efficacy|1|||
163827068|NCT00765674|591734201|FG003|Overall Study|Lack of Efficacy|2|||
163827069|NCT00765674|591734198|FG000|Overall Study|Protocol Violation|2|||
163827070|NCT00765674|591734199|FG001|Overall Study|Protocol Violation|0|||
163827071|NCT00765674|591734200|FG002|Overall Study|Protocol Violation|1|||
163827072|NCT00765674|591734201|FG003|Overall Study|Protocol Violation|0|||
163827073|NCT00765674|591734198|FG000|Overall Study|Withdrawal by Subject|5|||
163827074|NCT00765674|591734199|FG001|Overall Study|Withdrawal by Subject|7|||
163827075|NCT00765674|591734200|FG002|Overall Study|Withdrawal by Subject|3|||
163827076|NCT00765674|591734201|FG003|Overall Study|Withdrawal by Subject|8|||
163827077|NCT00765674|591734198|FG000|Overall Study|Lost to Follow-up|4|||
163827078|NCT00765674|591734199|FG001|Overall Study|Lost to Follow-up|6|||
163827079|NCT00765674|591734200|FG002|Overall Study|Lost to Follow-up|2|||
163827080|NCT00765674|591734201|FG003|Overall Study|Lost to Follow-up|1|||
163827081|NCT00765674|591734198|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
163827082|NCT00765674|591734199|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
163827083|NCT00765674|591734200|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
163827084|NCT00765674|591734201|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
163827085|NCT03015402|591734202|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
163827086|NCT03015402|591734203|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
163827087|NCT03015402|591734202|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
163827088|NCT03015402|591734203|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
163827089|NCT01813474|591734209|FG000|Overall Study|Withdrawal by Subject|0|||
163827090|NCT01813474|591734210|FG001|Overall Study|Withdrawal by Subject|0|||
163827091|NCT01813474|591734211|FG002|Overall Study|Withdrawal by Subject|1|||
163827092|NCT01813474|591734209|FG000|Overall Study|Adverse Event|1|||
163827093|NCT01813474|591734210|FG001|Overall Study|Adverse Event|1|||
163827094|NCT01813474|591734211|FG002|Overall Study|Adverse Event|0|||
163827095|NCT01813474|591734209|FG000|Overall Study|Lack of Efficacy|2|||
163827096|NCT01813474|591734210|FG001|Overall Study|Lack of Efficacy|6|||
163827097|NCT01813474|591734211|FG002|Overall Study|Lack of Efficacy|9|||
163827098|NCT01813474|591734209|FG000|Overall Study|Death|0|||
163827099|NCT01813474|591734210|FG001|Overall Study|Death|0|||
163827100|NCT01813474|591734211|FG002|Overall Study|Death|1|||
163920844|NCT02396758|592079939|FG003|Overall Study|Death|1|||
163920845|NCT02396758|592079936|FG000|Overall Study|Randomized but not treated|1|||
163920846|NCT02396758|592079937|FG001|Overall Study|Randomized but not treated|0|||
163920847|NCT02396758|592079938|FG002|Overall Study|Randomized but not treated|1|||
163920848|NCT02396758|592079939|FG003|Overall Study|Randomized but not treated|0|||
163920849|NCT01631825|592079940|FG000|Overall Study|Adverse Event|42|||
163920850|NCT01631825|592079940|FG000|Overall Study|Lack of Efficacy|7|||
163920851|NCT01631825|592079940|FG000|Overall Study|Withdrawal by Subject|9|||
163920852|NCT01631825|592079940|FG000|Overall Study|Protocol Violation|4|||
163920853|NCT01631825|592079940|FG000|Overall Study|Discontinuation criteria|1|||
163920854|NCT01631825|592079940|FG000|Overall Study|Physician Decision|2|||
163920855|NCT02110225|592079941|FG000|Overall Study|Lost to Follow-up|0|||
163920856|NCT02110225|592079942|FG001|Overall Study|Lost to Follow-up|1|||
163920857|NCT02110225|592079943|FG002|Overall Study|Lost to Follow-up|0|||
163920858|NCT00265096|592079944|FG000|Overall Study|Adverse Event|14|||
163920859|NCT00265096|592079945|FG001|Overall Study|Adverse Event|18|||
163920860|NCT00265096|592079946|FG002|Overall Study|Adverse Event|18|||
163920861|NCT00265096|592079944|FG000|Overall Study|Lost to Follow-up|2|||
163920862|NCT00265096|592079945|FG001|Overall Study|Lost to Follow-up|5|||
163920863|NCT00265096|592079946|FG002|Overall Study|Lost to Follow-up|3|||
163920864|NCT00265096|592079944|FG000|Overall Study|Death|0|||
163920865|NCT00265096|592079945|FG001|Overall Study|Death|1|||
163920866|NCT00265096|592079946|FG002|Overall Study|Death|2|||
163920867|NCT00265096|592079944|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
163920868|NCT00265096|592079945|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
163920869|NCT00265096|592079946|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163920870|NCT00265096|592079944|FG000|Overall Study|Other|11|||
163920871|NCT00265096|592079945|FG001|Overall Study|Other|19|||
163920872|NCT00265096|592079946|FG002|Overall Study|Other|10|||
163920873|NCT00774306|592079947|FG000|Overall Study|Adverse Event|3|||
163920874|NCT00774306|592079948|FG001|Overall Study|Adverse Event|0|||
163920875|NCT00774306|592079949|FG002|Overall Study|Adverse Event|0|||
163920876|NCT00774306|592079950|FG003|Overall Study|Adverse Event|0|||
163827101|NCT00316082|591734212|FG000|Overall Study|Lack of Efficacy|2|||
163827102|NCT00316082|591734213|FG001|Overall Study|Lack of Efficacy|3|||
163827103|NCT00316082|591734214|FG002|Overall Study|Lack of Efficacy|3|||
163827104|NCT00316082|591734215|FG003|Overall Study|Lack of Efficacy|4|||
163827105|NCT00316082|591734216|FG004|Overall Study|Lack of Efficacy|6|||
163827106|NCT00316082|591734212|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
163920877|NCT00774306|592079947|FG000|Overall Study|Protocol Violation|2|||
163827107|NCT00316082|591734213|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
163827108|NCT00316082|591734214|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
163920878|NCT00774306|592079948|FG001|Overall Study|Protocol Violation|0|||
163920879|NCT00774306|592079949|FG002|Overall Study|Protocol Violation|3|||
163920880|NCT00774306|592079950|FG003|Overall Study|Protocol Violation|0|||
163920881|NCT00774306|592079947|FG000|Overall Study|Withdrawal by Subject|6|||
163920882|NCT00774306|592079948|FG001|Overall Study|Withdrawal by Subject|1|||
163920883|NCT00774306|592079949|FG002|Overall Study|Withdrawal by Subject|1|||
163920884|NCT00774306|592079950|FG003|Overall Study|Withdrawal by Subject|0|||
163920885|NCT00774306|592079947|FG000|Overall Study|Lost to Follow-up|6|||
163920886|NCT00774306|592079948|FG001|Overall Study|Lost to Follow-up|0|||
163920887|NCT00774306|592079949|FG002|Overall Study|Lost to Follow-up|4|||
163920888|NCT00774306|592079950|FG003|Overall Study|Lost to Follow-up|5|||
163920889|NCT00774306|592079947|FG000|Overall Study|Death|1|||
163920890|NCT00774306|592079948|FG001|Overall Study|Death|1|||
163920891|NCT00774306|592079949|FG002|Overall Study|Death|0|||
163920892|NCT00774306|592079950|FG003|Overall Study|Death|0|||
163920893|NCT03568708|592079954|FG000|Overall Study|Withdrawal by Subject|1|||
163920894|NCT03568708|592079955|FG001|Overall Study|Withdrawal by Subject|1|||
163920895|NCT03568708|592079954|FG000|Overall Study|Lost to Follow-up|0|||
163920896|NCT03568708|592079955|FG001|Overall Study|Lost to Follow-up|1|||
163920897|NCT00666835|592079956|FG000|Overall Study|Withdrawal by Subject|5|||
163920898|NCT00666835|592079957|FG001|Overall Study|Withdrawal by Subject|2|||
163920899|NCT00666835|592079956|FG000|Overall Study|Lack of Efficacy|0|||
163920900|NCT00666835|592079957|FG001|Overall Study|Lack of Efficacy|1|||
163920901|NCT00666835|592079956|FG000|Overall Study|Incl./excl. not fulfilled|7|||
163920902|NCT00666835|592079957|FG001|Overall Study|Incl./excl. not fulfilled|2|||
163920903|NCT00666835|592079956|FG000|Overall Study|Adverse Event|7|||
163920904|NCT00666835|592079957|FG001|Overall Study|Adverse Event|6|||
163920905|NCT00666835|592079956|FG000|Overall Study|Protocol Violation|2|||
163920906|NCT00666835|592079957|FG001|Overall Study|Protocol Violation|0|||
163920907|NCT00666835|592079956|FG000|Overall Study|Death|15|||
163920908|NCT00666835|592079957|FG001|Overall Study|Death|4|||
163920909|NCT00666835|592079956|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
163920910|NCT00666835|592079957|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
163920911|NCT00666835|592079956|FG000|Overall Study|Hemoglobulin concentration|4|||
163920912|NCT00666835|592079957|FG001|Overall Study|Hemoglobulin concentration|3|||
163920913|NCT00666835|592079956|FG000|Overall Study|Planned operation|2|||
163920914|NCT00666835|592079957|FG001|Overall Study|Planned operation|0|||
163920915|NCT00666835|592079956|FG000|Overall Study|Physician Decision|1|||
163920916|NCT00666835|592079957|FG001|Overall Study|Physician Decision|2|||
163920917|NCT00511147|592079958|FG000|Overall Study|Withdrawal by Subject|1|||
163920918|NCT00511147|592079958|FG000|Overall Study|Disease progression|5|||
163920919|NCT00511147|592079958|FG000|Overall Study|Required platelet transfusion|1|||
163920920|NCT00899379|592079959|FG000|Overall Study|Adverse Event|2|||
163920921|NCT00899379|592079960|FG001|Overall Study|Adverse Event|2|||
163920922|NCT00899379|592079961|FG002|Overall Study|Adverse Event|1|||
163920923|NCT00899379|592079962|FG003|Overall Study|Adverse Event|1|||
163920924|NCT00899379|592079963|FG004|Overall Study|Adverse Event|2|||
163920925|NCT00899379|592079959|FG000|Overall Study|Lack of Efficacy|0|||
163920926|NCT00899379|592079960|FG001|Overall Study|Lack of Efficacy|4|||
163920927|NCT00899379|592079961|FG002|Overall Study|Lack of Efficacy|3|||
163920928|NCT00899379|592079962|FG003|Overall Study|Lack of Efficacy|0|||
163920929|NCT00899379|592079963|FG004|Overall Study|Lack of Efficacy|1|||
163920930|NCT00899379|592079959|FG000|Overall Study|Lost to Follow-up|9|||
163920931|NCT00899379|592079960|FG001|Overall Study|Lost to Follow-up|3|||
163920932|NCT00899379|592079961|FG002|Overall Study|Lost to Follow-up|0|||
163920933|NCT00899379|592079962|FG003|Overall Study|Lost to Follow-up|6|||
164032203|NCT02505542|592477801|FG000|Part A: Open-Label Period|Sponsor directive|1|||
164032204|NCT02505542|592477802|FG001|Part A: Open-Label Period|Sponsor directive|0|||
164032205|NCT02505542|592477803|FG002|Part A: Open-Label Period|Sponsor directive|0|||
164032206|NCT02505542|592477804|FG003|Part A: Open-Label Period|Sponsor directive|0|||
164032207|NCT02505542|592477801|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
164032208|NCT02505542|592477802|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
164032209|NCT02505542|592477803|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
164032210|NCT02505542|592477804|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
164032211|NCT02505542|592477801|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
164032212|NCT02505542|592477802|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
164032213|NCT02505542|592477803|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
164032214|NCT02505542|592477804|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
164032215|NCT02505542|592477801|FG000|Part A: Open-Label Period|Non-compliance|1|||
164032216|NCT02505542|592477802|FG001|Part A: Open-Label Period|Non-compliance|0|||
163920934|NCT00899379|592079963|FG004|Overall Study|Lost to Follow-up|2|||
163920935|NCT00899379|592079959|FG000|Overall Study|Protocol Violation|0|||
163920936|NCT00899379|592079960|FG001|Overall Study|Protocol Violation|0|||
163920937|NCT00899379|592079961|FG002|Overall Study|Protocol Violation|1|||
163920938|NCT00899379|592079962|FG003|Overall Study|Protocol Violation|1|||
163920939|NCT00899379|592079963|FG004|Overall Study|Protocol Violation|0|||
163920940|NCT00899379|592079959|FG000|Overall Study|Withdrawal by Subject|2|||
163920941|NCT00899379|592079960|FG001|Overall Study|Withdrawal by Subject|4|||
163920942|NCT00899379|592079961|FG002|Overall Study|Withdrawal by Subject|2|||
163920943|NCT00899379|592079962|FG003|Overall Study|Withdrawal by Subject|3|||
163920944|NCT00899379|592079963|FG004|Overall Study|Withdrawal by Subject|6|||
163920945|NCT00899379|592079959|FG000|Overall Study|Pregnancy|0|||
163920946|NCT00899379|592079960|FG001|Overall Study|Pregnancy|0|||
163920947|NCT00899379|592079961|FG002|Overall Study|Pregnancy|1|||
163920948|NCT00899379|592079962|FG003|Overall Study|Pregnancy|0|||
163920949|NCT00899379|592079963|FG004|Overall Study|Pregnancy|1|||
163920950|NCT00899379|592079959|FG000|Overall Study|Patient Uncooperative|0|||
163920951|NCT00899379|592079960|FG001|Overall Study|Patient Uncooperative|1|||
163920952|NCT00899379|592079961|FG002|Overall Study|Patient Uncooperative|0|||
163920953|NCT00899379|592079962|FG003|Overall Study|Patient Uncooperative|1|||
163920954|NCT00899379|592079963|FG004|Overall Study|Patient Uncooperative|2|||
163920955|NCT00899379|592079959|FG000|Overall Study|Abnormal Baseline ECG|0|||
163920956|NCT00899379|592079960|FG001|Overall Study|Abnormal Baseline ECG|0|||
163920957|NCT00899379|592079961|FG002|Overall Study|Abnormal Baseline ECG|0|||
163920958|NCT00899379|592079962|FG003|Overall Study|Abnormal Baseline ECG|1|||
163920959|NCT00899379|592079963|FG004|Overall Study|Abnormal Baseline ECG|0|||
163920960|NCT00899379|592079959|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163920961|NCT00899379|592079960|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163920962|NCT00899379|592079961|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163920963|NCT00899379|592079962|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163920964|NCT00899379|592079963|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163920965|NCT00899379|592079959|FG000|Overall Study|Not Completed/Entered Extn|5|||
163920966|NCT00899379|592079960|FG001|Overall Study|Not Completed/Entered Extn|1|||
163920967|NCT00899379|592079961|FG002|Overall Study|Not Completed/Entered Extn|6|||
163920968|NCT00899379|592079962|FG003|Overall Study|Not Completed/Entered Extn|4|||
163920969|NCT00899379|592079963|FG004|Overall Study|Not Completed/Entered Extn|3|||
163920970|NCT00899379|592079959|FG000|Overall Study|Study Terminated|3|||
163920971|NCT00899379|592079960|FG001|Overall Study|Study Terminated|0|||
163920972|NCT00899379|592079961|FG002|Overall Study|Study Terminated|3|||
163920973|NCT00899379|592079962|FG003|Overall Study|Study Terminated|3|||
163920974|NCT00899379|592079963|FG004|Overall Study|Study Terminated|1|||
163920975|NCT00899379|592079959|FG000|Overall Study|Lost to Follow-up|3|||
163920976|NCT00899379|592079960|FG001|Overall Study|Lost to Follow-up|1|||
163920977|NCT00899379|592079961|FG002|Overall Study|Lost to Follow-up|0|||
163920978|NCT00899379|592079962|FG003|Overall Study|Lost to Follow-up|2|||
163920979|NCT00899379|592079963|FG004|Overall Study|Lost to Follow-up|5|||
163920980|NCT00899379|592079959|FG000|Overall Study|Withdrawal by Subject|4|||
163920981|NCT00899379|592079960|FG001|Overall Study|Withdrawal by Subject|7|||
163920982|NCT00899379|592079961|FG002|Overall Study|Withdrawal by Subject|4|||
163920983|NCT00899379|592079962|FG003|Overall Study|Withdrawal by Subject|7|||
163920984|NCT00899379|592079963|FG004|Overall Study|Withdrawal by Subject|2|||
163920985|NCT00899379|592079959|FG000|Overall Study|Pregnancy|1|||
163920986|NCT00899379|592079960|FG001|Overall Study|Pregnancy|0|||
163920987|NCT00899379|592079961|FG002|Overall Study|Pregnancy|0|||
163920988|NCT00899379|592079962|FG003|Overall Study|Pregnancy|0|||
163920989|NCT00899379|592079963|FG004|Overall Study|Pregnancy|0|||
163920990|NCT00899379|592079959|FG000|Overall Study|Patient Uncooperative|0|||
163920991|NCT00899379|592079960|FG001|Overall Study|Patient Uncooperative|0|||
163920992|NCT00899379|592079961|FG002|Overall Study|Patient Uncooperative|0|||
163920993|NCT00899379|592079962|FG003|Overall Study|Patient Uncooperative|1|||
163920994|NCT00899379|592079963|FG004|Overall Study|Patient Uncooperative|0|||
163920995|NCT00899379|592079959|FG000|Overall Study|Abnormal Prestudy Labs|0|||
163920996|NCT00899379|592079960|FG001|Overall Study|Abnormal Prestudy Labs|0|||
163920997|NCT00899379|592079961|FG002|Overall Study|Abnormal Prestudy Labs|0|||
163920998|NCT00899379|592079962|FG003|Overall Study|Abnormal Prestudy Labs|0|||
163920999|NCT00899379|592079963|FG004|Overall Study|Abnormal Prestudy Labs|2|||
163921000|NCT00899379|592079959|FG000|Overall Study|Abnormal Baseline ECG|0|||
163921001|NCT00899379|592079960|FG001|Overall Study|Abnormal Baseline ECG|0|||
163921002|NCT00899379|592079961|FG002|Overall Study|Abnormal Baseline ECG|1|||
163921003|NCT00899379|592079962|FG003|Overall Study|Abnormal Baseline ECG|1|||
163921004|NCT00899379|592079963|FG004|Overall Study|Abnormal Baseline ECG|0|||
164032217|NCT02505542|592477803|FG002|Part A: Open-Label Period|Non-compliance|0|||
164032218|NCT02505542|592477804|FG003|Part A: Open-Label Period|Non-compliance|0|||
164032219|NCT02505542|592477801|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
164032220|NCT02505542|592477802|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
164032221|NCT02505542|592477803|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
163921005|NCT00899379|592079959|FG000|Overall Study|No Attack Pretreatment|3|||
163921006|NCT00899379|592079960|FG001|Overall Study|No Attack Pretreatment|5|||
163921007|NCT00899379|592079961|FG002|Overall Study|No Attack Pretreatment|5|||
164032222|NCT02505542|592477804|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
164032223|NCT02505542|592477801|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
164032224|NCT02505542|592477802|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
163921008|NCT00899379|592079962|FG003|Overall Study|No Attack Pretreatment|6|||
163921009|NCT00899379|592079963|FG004|Overall Study|No Attack Pretreatment|4|||
164032225|NCT02505542|592477803|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
164097282|NCT00669942|592720768|FG011|Parts 2 and 3|Adverse Event|0|||
163921010|NCT00899379|592079959|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
163921011|NCT00899379|592079960|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163921012|NCT00899379|592079961|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163921013|NCT00899379|592079962|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
164097283|NCT00669942|592720757|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
164097284|NCT00669942|592720758|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
164097285|NCT00669942|592720759|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
164097286|NCT00669942|592720760|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
164097287|NCT00669942|592720761|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
164097288|NCT00669942|592720762|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
164097289|NCT00669942|592720763|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
164097290|NCT00669942|592720764|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
164097291|NCT00669942|592720765|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
164097292|NCT00669942|592720766|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
164097293|NCT00669942|592720767|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
164097294|NCT00669942|592720768|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
164097295|NCT00669942|592720757|FG000|Parts 2 and 3|Protocol Violation|0|||
164097296|NCT00669942|592720758|FG001|Parts 2 and 3|Protocol Violation|0|||
164097297|NCT00669942|592720759|FG002|Parts 2 and 3|Protocol Violation|0|||
164097298|NCT00669942|592720760|FG003|Parts 2 and 3|Protocol Violation|0|||
164097299|NCT00669942|592720761|FG004|Parts 2 and 3|Protocol Violation|0|||
164097300|NCT00669942|592720762|FG005|Parts 2 and 3|Protocol Violation|1|||
164097301|NCT00669942|592720763|FG006|Parts 2 and 3|Protocol Violation|0|||
164097302|NCT00669942|592720764|FG007|Parts 2 and 3|Protocol Violation|0|||
164097303|NCT00669942|592720765|FG008|Parts 2 and 3|Protocol Violation|0|||
164097304|NCT00669942|592720766|FG009|Parts 2 and 3|Protocol Violation|0|||
164097305|NCT00669942|592720767|FG010|Parts 2 and 3|Protocol Violation|0|||
164097306|NCT00669942|592720768|FG011|Parts 2 and 3|Protocol Violation|0|||
164097307|NCT00282048|592720769|FG000|Overall Study|Lack of Efficacy|30|||
164097308|NCT00282048|592720769|FG000|Overall Study|Adverse Event|22|||
164097309|NCT00282048|592720769|FG000|Overall Study|Withdrawal by Subject|1|||
164097310|NCT00282048|592720769|FG000|Overall Study|Other|8|||
164097311|NCT00282048|592720769|FG000|Overall Study|Ongoing|1|||
164097312|NCT03522675|592720770|FG000|Overall Study|Screen fail|1|||
164097313|NCT03522675|592720770|FG000|Overall Study|Non-reactive to histamine|1|||
164097314|NCT00707161|592720771|FG000|Overall Study|Physician Decision|6|||
164097315|NCT02336165|592720775|FG000|Overall Study|Death|3|||
164097316|NCT02336165|592720776|FG001|Overall Study|Death|0|||
164097317|NCT02336165|592720777|FG002|Overall Study|Death|0|||
164097318|NCT02336165|592720778|FG003|Overall Study|Death|0|||
164097319|NCT02336165|592720779|FG004|Overall Study|Death|1|||
164097320|NCT02336165|592720775|FG000|Overall Study|Physician Decision|2|||
164097321|NCT02336165|592720776|FG001|Overall Study|Physician Decision|2|||
164097322|NCT02336165|592720777|FG002|Overall Study|Physician Decision|1|||
164097323|NCT02336165|592720778|FG003|Overall Study|Physician Decision|1|||
164097324|NCT02336165|592720779|FG004|Overall Study|Physician Decision|0|||
164097325|NCT02336165|592720775|FG000|Overall Study|Withdrawal by Subject|0|||
164097326|NCT02336165|592720776|FG001|Overall Study|Withdrawal by Subject|0|||
163827109|NCT00316082|591734215|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
163827110|NCT00316082|591734216|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
163827111|NCT00316082|591734212|FG000|Overall Study|Lost to Follow-up|7|||
163827112|NCT00316082|591734213|FG001|Overall Study|Lost to Follow-up|6|||
163827113|NCT00316082|591734214|FG002|Overall Study|Lost to Follow-up|7|||
163827114|NCT00316082|591734215|FG003|Overall Study|Lost to Follow-up|8|||
163827115|NCT00316082|591734216|FG004|Overall Study|Lost to Follow-up|6|||
163827116|NCT00316082|591734212|FG000|Overall Study|Poor/noncompliance|6|||
163827117|NCT00316082|591734213|FG001|Overall Study|Poor/noncompliance|1|||
163827118|NCT00316082|591734214|FG002|Overall Study|Poor/noncompliance|4|||
163827119|NCT00316082|591734215|FG003|Overall Study|Poor/noncompliance|1|||
163827120|NCT00316082|591734216|FG004|Overall Study|Poor/noncompliance|4|||
163827121|NCT00316082|591734212|FG000|Overall Study|Adverse Event|4|||
163827122|NCT00316082|591734213|FG001|Overall Study|Adverse Event|2|||
163827123|NCT00316082|591734214|FG002|Overall Study|Adverse Event|5|||
163827124|NCT00316082|591734215|FG003|Overall Study|Adverse Event|1|||
163827125|NCT00316082|591734216|FG004|Overall Study|Adverse Event|3|||
163827126|NCT00316082|591734212|FG000|Overall Study|Subject no longer meets study criteria|3|||
163827127|NCT00316082|591734213|FG001|Overall Study|Subject no longer meets study criteria|1|||
163827128|NCT00316082|591734214|FG002|Overall Study|Subject no longer meets study criteria|2|||
163827129|NCT00316082|591734215|FG003|Overall Study|Subject no longer meets study criteria|2|||
164097327|NCT02336165|592720777|FG002|Overall Study|Withdrawal by Subject|1|||
164097328|NCT02336165|592720778|FG003|Overall Study|Withdrawal by Subject|0|||
164097329|NCT02336165|592720779|FG004|Overall Study|Withdrawal by Subject|1|||
164097330|NCT02336165|592720775|FG000|Overall Study|Adverse Event|4|||
163827130|NCT00316082|591734216|FG004|Overall Study|Subject no longer meets study criteria|1|||
163827131|NCT00316082|591734212|FG000|Overall Study|Physician Decision|1|||
163827132|NCT00316082|591734213|FG001|Overall Study|Physician Decision|1|||
163827133|NCT00316082|591734214|FG002|Overall Study|Physician Decision|2|||
164097331|NCT02336165|592720776|FG001|Overall Study|Adverse Event|1|||
164097332|NCT02336165|592720777|FG002|Overall Study|Adverse Event|2|||
164097333|NCT02336165|592720778|FG003|Overall Study|Adverse Event|4|||
164097334|NCT02336165|592720779|FG004|Overall Study|Adverse Event|1|||
164097335|NCT02336165|592720775|FG000|Overall Study|Progressive disease|23|||
164097336|NCT02336165|592720776|FG001|Overall Study|Progressive disease|22|||
164032226|NCT02505542|592477804|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
164032227|NCT02505542|592477801|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
164032228|NCT02505542|592477802|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
164032229|NCT02505542|592477803|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
164032230|NCT02505542|592477804|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
164032231|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Adverse Event|0|||
164032232|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Adverse Event|0|||
164032233|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Adverse Event|1|||
164032234|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Adverse Event|3|||
164032235|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
164032236|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
164032237|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
164032238|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
164032239|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
164032240|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
164032241|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
164032242|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
164032243|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
164032244|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
164032245|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
164032246|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
163921014|NCT00899379|592079963|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
163921015|NCT00899379|592079959|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
163921016|NCT00899379|592079960|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
163921017|NCT00899379|592079961|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
163921018|NCT00899379|592079962|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
163921019|NCT00899379|592079963|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
163921020|NCT00809783|592079964|FG000|Overall Study|Death|1|||
163921021|NCT00809783|592079965|FG001|Overall Study|Death|0|||
163921022|NCT00809783|592079966|FG002|Overall Study|Death|0|||
163921023|NCT00809783|592079964|FG000|Overall Study|Adverse Event|34|||
163921024|NCT00809783|592079965|FG001|Overall Study|Adverse Event|52|||
163921025|NCT00809783|592079966|FG002|Overall Study|Adverse Event|71|||
163921026|NCT00809783|592079964|FG000|Overall Study|Lack of Efficacy|39|||
163921027|NCT00809783|592079965|FG001|Overall Study|Lack of Efficacy|52|||
163921028|NCT00809783|592079966|FG002|Overall Study|Lack of Efficacy|63|||
163921029|NCT00809783|592079964|FG000|Overall Study|Lost to Follow-up|0|||
163921030|NCT00809783|592079965|FG001|Overall Study|Lost to Follow-up|3|||
163921031|NCT00809783|592079966|FG002|Overall Study|Lost to Follow-up|4|||
163921032|NCT00809783|592079964|FG000|Overall Study|Withdrawal by Subject|47|||
163921033|NCT00809783|592079965|FG001|Overall Study|Withdrawal by Subject|72|||
163921034|NCT00809783|592079966|FG002|Overall Study|Withdrawal by Subject|64|||
163921035|NCT00809783|592079964|FG000|Overall Study|Protocol Violation|2|||
163921036|NCT00809783|592079965|FG001|Overall Study|Protocol Violation|6|||
163921037|NCT00809783|592079966|FG002|Overall Study|Protocol Violation|5|||
163921038|NCT00809783|592079964|FG000|Overall Study|Randomized, but not treated|3|||
163921039|NCT00809783|592079965|FG001|Overall Study|Randomized, but not treated|0|||
163921040|NCT00809783|592079966|FG002|Overall Study|Randomized, but not treated|2|||
163921041|NCT00809783|592079964|FG000|Overall Study|Study Terminated by Sponsor|378|||
163921042|NCT00809783|592079965|FG001|Overall Study|Study Terminated by Sponsor|626|||
163921043|NCT00809783|592079966|FG002|Overall Study|Study Terminated by Sponsor|565|||
163921044|NCT00809783|592079964|FG000|Overall Study|Other|21|||
163921045|NCT00809783|592079965|FG001|Overall Study|Other|21|||
163921046|NCT00809783|592079966|FG002|Overall Study|Other|16|||
163921047|NCT00126555|592079967|FG000|Overall Study|Withdrawal by Subject|1|||
164032247|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
164032248|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
164032249|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
164032250|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
164032251|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
164097337|NCT02336165|592720777|FG002|Overall Study|Progressive disease|27|||
163921048|NCT00126555|592079967|FG000|Overall Study|Adverse Event|2|||
163921049|NCT00126555|592079967|FG000|Overall Study|Progressive Disease|3|||
163921050|NCT02254681|592079983|FG000|Overall Study|Lack of Efficacy|6|||
163921051|NCT00396097|592079984|FG000|Overall Study|Withdrawal by Subject|17|||
163921052|NCT00396097|592079985|FG001|Overall Study|Withdrawal by Subject|17|||
163921053|NCT00396097|592079984|FG000|Overall Study|Lost to Follow-up|4|||
163921054|NCT00396097|592079985|FG001|Overall Study|Lost to Follow-up|9|||
163921055|NCT00396097|592079984|FG000|Overall Study|Other|3|||
163921056|NCT00396097|592079985|FG001|Overall Study|Other|5|||
163921057|NCT00396097|592079984|FG000|Overall Study|Protocol Violation|0|||
163921058|NCT00396097|592079985|FG001|Overall Study|Protocol Violation|6|||
163921059|NCT00396097|592079984|FG000|Overall Study|Adverse Event|1|||
163921060|NCT00396097|592079985|FG001|Overall Study|Adverse Event|5|||
163921061|NCT00396097|592079984|FG000|Overall Study|Insufficient Clinical Response|1|||
163921062|NCT00396097|592079985|FG001|Overall Study|Insufficient Clinical Response|4|||
163921063|NCT03461211|592079986|FG000|Overall Study|Adverse Event|1|||
163921064|NCT03461211|592079987|FG001|Overall Study|Adverse Event|1|||
163921065|NCT03461211|592079986|FG000|Overall Study|Lack of Efficacy|0|||
163921066|NCT03461211|592079987|FG001|Overall Study|Lack of Efficacy|1|||
163921067|NCT02316847|592079989|FG000|Overall Study|Adverse Event|0|||
163921068|NCT02316847|592079990|FG001|Overall Study|Adverse Event|3|||
163921069|NCT02316847|592079989|FG000|Overall Study|Lost to Follow-up|0|||
163921070|NCT02316847|592079990|FG001|Overall Study|Lost to Follow-up|2|||
163921071|NCT02316847|592079989|FG000|Overall Study|Physician Decision|0|||
163921072|NCT02316847|592079990|FG001|Overall Study|Physician Decision|1|||
163921073|NCT02316847|592079989|FG000|Overall Study|Pregnancy|0|||
163921074|NCT02316847|592079990|FG001|Overall Study|Pregnancy|1|||
163921075|NCT02316847|592079989|FG000|Overall Study|Withdrawal by Subject|2|||
163921076|NCT02316847|592079990|FG001|Overall Study|Withdrawal by Subject|9|||
163921077|NCT02316847|592079989|FG000|Overall Study|Noncompliance with study drug|0|||
163921078|NCT02316847|592079990|FG001|Overall Study|Noncompliance with study drug|3|||
163921079|NCT02316847|592079989|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
163921080|NCT02316847|592079990|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
163921081|NCT01370018|592079991|FG000|Overall Study|Did not meet criteria for analysis|1|||
163921082|NCT01525641|592079992|FG000|Overall Study|Case report form not collected|25|||
163921083|NCT01525641|592079992|FG000|Overall Study|No visit since the first visit|16|||
163921084|NCT01525641|592079992|FG000|Overall Study|Adverse Event|73|||
163921085|NCT01525641|592079992|FG000|Overall Study|Lack of Efficacy|24|||
163921086|NCT01525641|592079992|FG000|Overall Study|Improvement|5|||
163921087|NCT01525641|592079992|FG000|Overall Study|Lost to follow-up (relocation)|1|||
163921088|NCT01525641|592079992|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
163921089|NCT01525641|592079992|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
163921090|NCT01525641|592079992|FG000|Overall Study|Other than stated above|7|||
163921091|NCT02204319|592079993|FG000|Overall Study|Pregnancy|1|||
163921092|NCT02204319|592079993|FG000|Overall Study|Withdrawal by Subject|2|||
163921093|NCT02959177|592079998|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
163921094|NCT02959177|592079999|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
163921095|NCT02959177|592080000|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
163921096|NCT02959177|592079998|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
163921097|NCT02959177|592079999|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
163921098|NCT02959177|592080000|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
163921099|NCT02959177|592079998|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
163921100|NCT02959177|592079999|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
163921101|NCT02959177|592080000|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
163921102|NCT02959177|592079998|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163921103|NCT02959177|592079999|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
163921104|NCT02959177|592080000|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
163921105|NCT02959177|592079998|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
163921106|NCT02959177|592079999|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
163921107|NCT02959177|592080000|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
163921108|NCT02959177|592079998|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
163921109|NCT02959177|592079999|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
163921110|NCT02959177|592080000|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
163921111|NCT02959177|592079998|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
163921112|NCT02959177|592079999|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
163921113|NCT02959177|592080000|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
163921114|NCT03544229|592080002|FG000|Overall Study|Adverse Event|1|||
163921115|NCT03544229|592080003|FG001|Overall Study|Adverse Event|0|||
163921116|NCT03544229|592080004|FG002|Overall Study|Adverse Event|1|||
163921117|NCT03544229|592080005|FG003|Overall Study|Adverse Event|0|||
163921118|NCT03544229|592080002|FG000|Overall Study|Protocol Deviation|0|||
163921119|NCT03544229|592080003|FG001|Overall Study|Protocol Deviation|0|||
163921120|NCT03544229|592080004|FG002|Overall Study|Protocol Deviation|1|||
164032252|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
164032253|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
164032254|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
164032255|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
164032256|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
163921121|NCT03544229|592080005|FG003|Overall Study|Protocol Deviation|0|||
163921122|NCT03544229|592080002|FG000|Overall Study|Lost to Follow-up|3|||
163921123|NCT03544229|592080003|FG001|Overall Study|Lost to Follow-up|0|||
163921124|NCT03544229|592080004|FG002|Overall Study|Lost to Follow-up|0|||
163921125|NCT03544229|592080005|FG003|Overall Study|Lost to Follow-up|2|||
163921126|NCT03544229|592080002|FG000|Overall Study|Voluntary Withdrawal|2|||
163921127|NCT03544229|592080003|FG001|Overall Study|Voluntary Withdrawal|1|||
163921128|NCT03544229|592080004|FG002|Overall Study|Voluntary Withdrawal|3|||
163921129|NCT03544229|592080005|FG003|Overall Study|Voluntary Withdrawal|0|||
164032257|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
164032258|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
164032259|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Miscalculation|0|||
164032260|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Miscalculation|1|||
164032261|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Miscalculation|0|||
164032262|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Miscalculation|0|||
164032263|NCT02505542|592477801|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
164032264|NCT02505542|592477802|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
164032265|NCT02505542|592477803|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
164032266|NCT02505542|592477804|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
164032267|NCT00992186|592477807|FG000|Overall Study|Withdrawal by Subject|2|||
164032268|NCT00992186|592477807|FG000|Overall Study|Protocol Violation|1|||
164032269|NCT00992186|592477807|FG000|Overall Study|Physician Decision|1|||
164032270|NCT00992186|592477807|FG000|Overall Study|Adverse Event|9|||
164032271|NCT00992186|592477807|FG000|Overall Study|Progressive Disease|30|||
164032272|NCT00992186|592477807|FG000|Overall Study|Refusal To Receive Study Agent|3|||
164032273|NCT00830804|592477813|FG000|Overall Study|Lost to Follow-up|4|||
164032274|NCT00830804|592477813|FG000|Overall Study|Death|1|||
164032275|NCT00830804|592477813|FG000|Overall Study|Unable to get to clinic|7|||
164032276|NCT00830804|592477813|FG000|Overall Study|Consent withdrawn|2|||
164032277|NCT00830804|592477813|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
164032278|NCT01438307|592477814|FG000|Overall Study|Death|1|||
164032279|NCT01438307|592477815|FG001|Overall Study|Death|1|||
164032280|NCT00171314|592477816|FG000|Overall Study|Adverse Event|44|||
164032281|NCT00171314|592477817|FG001|Overall Study|Adverse Event|41|||
164032282|NCT00171314|592477816|FG000|Overall Study|Lack of Efficacy|19|||
164032283|NCT00171314|592477817|FG001|Overall Study|Lack of Efficacy|14|||
164032284|NCT00171314|592477816|FG000|Overall Study|Withdrawal by Subject|9|||
164032285|NCT00171314|592477817|FG001|Overall Study|Withdrawal by Subject|6|||
164032286|NCT00171314|592477816|FG000|Overall Study|Abnormal Test Procedure Results|9|||
164032287|NCT00171314|592477817|FG001|Overall Study|Abnormal Test Procedure Results|3|||
164032288|NCT00171314|592477816|FG000|Overall Study|Protocol Violation|3|||
164032289|NCT00171314|592477817|FG001|Overall Study|Protocol Violation|7|||
164032290|NCT00171314|592477816|FG000|Overall Study|Administrative Problems|4|||
164032291|NCT00171314|592477817|FG001|Overall Study|Administrative Problems|3|||
164032292|NCT00171314|592477816|FG000|Overall Study|Lost to Follow-up|1|||
164032293|NCT00171314|592477817|FG001|Overall Study|Lost to Follow-up|3|||
164032294|NCT00171314|592477816|FG000|Overall Study|Death|2|||
164032295|NCT00171314|592477817|FG001|Overall Study|Death|1|||
164032296|NCT02378883|592477818|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
164032297|NCT02378883|592477818|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
164032298|NCT02378883|592477818|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
164032299|NCT02378883|592477818|FG000|30 Day Follow-Up|Physician Decision|2|||
164032300|NCT02378883|592477818|FG000|30 Day Follow-Up|Missed Visit|2|||
164032301|NCT02378883|592477818|FG000|30 Day Follow-Up|Death|1|||
164032302|NCT02378883|592477818|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
164032303|NCT02378883|592477818|FG000|12 Months Follow-Up|Death|2|||
164032304|NCT00318565|592477819|FG000|Overall Study|Excluded per protocol|24|||
164032305|NCT01588353|592477820|FG000|Step2|Withdrawal by Subject|0|||
164032306|NCT01588353|592477821|FG001|Step2|Withdrawal by Subject|1|||
164032307|NCT01588353|592477822|FG002|Step2|Withdrawal by Subject|0|||
164032308|NCT01588353|592477820|FG000|Step3|Adverse Event|0|||
164032309|NCT01588353|592477821|FG001|Step3|Adverse Event|0|||
164032310|NCT01588353|592477822|FG002|Step3|Adverse Event|2|||
163921130|NCT03544229|592080002|FG000|Overall Study|Lack of Efficacy|0|||
163921131|NCT03544229|592080003|FG001|Overall Study|Lack of Efficacy|1|||
163921132|NCT03544229|592080004|FG002|Overall Study|Lack of Efficacy|0|||
163921133|NCT03544229|592080005|FG003|Overall Study|Lack of Efficacy|0|||
163921134|NCT02460562|592080006|FG000|Overall Study|Lost to Follow-up|15|||
163921135|NCT02460562|592080007|FG001|Overall Study|Lost to Follow-up|16|||
163921136|NCT01061775|592080008|FG000|Overall Study|Physician Decision|2|||
163921137|NCT01061775|592080008|FG000|Overall Study|Lost to Follow-up|1|||
163921138|NCT02642159|592080009|FG000|Overall Study|Randomized but not treated|1|||
163921139|NCT02642159|592080010|FG001|Overall Study|Randomized but not treated|0|||
163921140|NCT02642159|592080009|FG000|Overall Study|Adverse Event|10|||
163921141|NCT02642159|592080010|FG001|Overall Study|Adverse Event|4|||
164032311|NCT00493467|592477823|FG000|Overall Study|Death|1|||
164032312|NCT01397448|592477827|FG000|Overall Study|Adverse Event|4|||
164032313|NCT01397448|592477828|FG001|Overall Study|Adverse Event|4|||
164032314|NCT01397448|592477829|FG002|Overall Study|Adverse Event|6|||
164032315|NCT01397448|592477827|FG000|Overall Study|Withdrawal by Subject|4|||
164032316|NCT01397448|592477828|FG001|Overall Study|Withdrawal by Subject|4|||
164032317|NCT01397448|592477829|FG002|Overall Study|Withdrawal by Subject|3|||
164032318|NCT01397448|592477827|FG000|Overall Study|Lack of Efficacy|2|||
164032319|NCT01397448|592477828|FG001|Overall Study|Lack of Efficacy|0|||
163921142|NCT02642159|592080009|FG000|Overall Study|Withdrawal by Subject|9|||
163921143|NCT02642159|592080010|FG001|Overall Study|Withdrawal by Subject|1|||
163921144|NCT02642159|592080009|FG000|Overall Study|Poor compliance to study protocol|1|||
164032320|NCT01397448|592477829|FG002|Overall Study|Lack of Efficacy|5|||
164032321|NCT01397448|592477827|FG000|Overall Study|Other|8|||
164032322|NCT01397448|592477828|FG001|Overall Study|Other|7|||
164032323|NCT01397448|592477829|FG002|Overall Study|Other|4|||
164032324|NCT01409993|592477832|FG000|Overall Study|Adverse Event|4|||
164032325|NCT01409993|592477833|FG001|Overall Study|Adverse Event|4|||
164032326|NCT01409993|592477834|FG002|Overall Study|Adverse Event|3|||
164032327|NCT01409993|592477835|FG003|Overall Study|Adverse Event|1|||
164032328|NCT01409993|592477832|FG000|Overall Study|Withdrawal by Subject|0|||
164032329|NCT01409993|592477833|FG001|Overall Study|Withdrawal by Subject|0|||
164032330|NCT01409993|592477834|FG002|Overall Study|Withdrawal by Subject|0|||
164032331|NCT01409993|592477835|FG003|Overall Study|Withdrawal by Subject|4|||
164032332|NCT01409993|592477832|FG000|Overall Study|Lost to Follow-up|0|||
164032333|NCT01409993|592477833|FG001|Overall Study|Lost to Follow-up|1|||
164032334|NCT01409993|592477834|FG002|Overall Study|Lost to Follow-up|0|||
164032335|NCT01409993|592477835|FG003|Overall Study|Lost to Follow-up|0|||
164032336|NCT00830960|592477842|FG000|Overall Study|Death|5|||
164032337|NCT00830960|592477843|FG001|Overall Study|Death|4|||
164032338|NCT00830960|592477844|FG002|Overall Study|Death|3|||
164032339|NCT00830960|592477845|FG003|Overall Study|Death|2|||
164032340|NCT00830960|592477846|FG004|Overall Study|Death|6|||
164032341|NCT00830960|592477847|FG005|Overall Study|Death|1|||
164032342|NCT00830960|592477842|FG000|Overall Study|Lost to Follow-up|1|||
164032343|NCT00830960|592477843|FG001|Overall Study|Lost to Follow-up|1|||
164032344|NCT00830960|592477844|FG002|Overall Study|Lost to Follow-up|1|||
164032345|NCT00830960|592477845|FG003|Overall Study|Lost to Follow-up|0|||
163827134|NCT00316082|591734215|FG003|Overall Study|Physician Decision|1|||
163827135|NCT00316082|591734216|FG004|Overall Study|Physician Decision|1|||
163827136|NCT00316082|591734212|FG000|Overall Study|Death|0|||
163827137|NCT00316082|591734213|FG001|Overall Study|Death|0|||
163827138|NCT00316082|591734214|FG002|Overall Study|Death|1|||
163827139|NCT00316082|591734215|FG003|Overall Study|Death|0|||
163827140|NCT00316082|591734216|FG004|Overall Study|Death|0|||
164032346|NCT00830960|592477846|FG004|Overall Study|Lost to Follow-up|0|||
164032347|NCT00830960|592477847|FG005|Overall Study|Lost to Follow-up|1|||
164032348|NCT00830960|592477842|FG000|Overall Study|Withdrawal by Subject|19|||
164032349|NCT00830960|592477843|FG001|Overall Study|Withdrawal by Subject|19|||
164032350|NCT00830960|592477844|FG002|Overall Study|Withdrawal by Subject|18|||
164032351|NCT00830960|592477845|FG003|Overall Study|Withdrawal by Subject|23|||
164032352|NCT00830960|592477846|FG004|Overall Study|Withdrawal by Subject|16|||
164032353|NCT00830960|592477847|FG005|Overall Study|Withdrawal by Subject|21|||
164032354|NCT00830960|592477842|FG000|Overall Study|Sponsor Decision|1|||
164032355|NCT00830960|592477843|FG001|Overall Study|Sponsor Decision|2|||
164032356|NCT00830960|592477844|FG002|Overall Study|Sponsor Decision|3|||
164032357|NCT00830960|592477845|FG003|Overall Study|Sponsor Decision|4|||
164032358|NCT00830960|592477846|FG004|Overall Study|Sponsor Decision|5|||
164032359|NCT00830960|592477847|FG005|Overall Study|Sponsor Decision|7|||
164032360|NCT00830960|592477842|FG000|Overall Study|No study drug received|7|||
164032361|NCT00830960|592477843|FG001|Overall Study|No study drug received|2|||
164032362|NCT00830960|592477844|FG002|Overall Study|No study drug received|4|||
164032363|NCT00830960|592477845|FG003|Overall Study|No study drug received|3|||
164032364|NCT00830960|592477846|FG004|Overall Study|No study drug received|5|||
164032365|NCT00830960|592477847|FG005|Overall Study|No study drug received|7|||
164032366|NCT02180217|592477848|FG000|Overall Study|Adverse Event|3|||
164032367|NCT02180217|592477849|FG001|Overall Study|Adverse Event|2|||
164032368|NCT02180217|592477850|FG002|Overall Study|Adverse Event|22|||
164032369|NCT02180217|592477848|FG000|Overall Study|Death|1|||
164032370|NCT02180217|592477849|FG001|Overall Study|Death|1|||
164032371|NCT02180217|592477850|FG002|Overall Study|Death|0|||
164032372|NCT02180217|592477848|FG000|Overall Study|Withdrawal by Subject|1|||
164032373|NCT02180217|592477849|FG001|Overall Study|Withdrawal by Subject|1|||
164032374|NCT02180217|592477850|FG002|Overall Study|Withdrawal by Subject|4|||
164032375|NCT02180217|592477848|FG000|Overall Study|Subject/Guardian decision|5|||
164032376|NCT02180217|592477849|FG001|Overall Study|Subject/Guardian decision|3|||
163827141|NCT00316082|591734212|FG000|Overall Study|Administrative reason by sponsor|0|||
163827142|NCT00316082|591734213|FG001|Overall Study|Administrative reason by sponsor|0|||
163827143|NCT00316082|591734214|FG002|Overall Study|Administrative reason by sponsor|1|||
163827144|NCT00316082|591734215|FG003|Overall Study|Administrative reason by sponsor|0|||
163827145|NCT00316082|591734216|FG004|Overall Study|Administrative reason by sponsor|0|||
164032377|NCT02180217|592477850|FG002|Overall Study|Subject/Guardian decision|6|||
164032378|NCT02180217|592477848|FG000|Overall Study|Physician Decision|1|||
164032379|NCT02180217|592477849|FG001|Overall Study|Physician Decision|1|||
164032380|NCT02180217|592477850|FG002|Overall Study|Physician Decision|6|||
164032381|NCT02180217|592477848|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164032382|NCT02180217|592477849|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164032383|NCT02180217|592477850|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164032384|NCT01504971|592477852|FG000|Overall Study|Physician Decision|13|||
164032385|NCT01309841|592477855|FG000|Overall Study|Other|0|||
163827146|NCT00528775|591734217|FG000|Overall Study|Other not specified|1|||
163827147|NCT02216773|591734220|FG000|Overall Study|Disease progression|4|||
164032386|NCT01309841|592477856|FG001|Overall Study|Other|1|||
164032387|NCT01309841|592477857|FG002|Overall Study|Other|1|||
164032388|NCT01309841|592477855|FG000|Overall Study|Lost to Follow-up|7|||
164032389|NCT01309841|592477856|FG001|Overall Study|Lost to Follow-up|6|||
164032390|NCT01309841|592477857|FG002|Overall Study|Lost to Follow-up|4|||
164032391|NCT01309841|592477855|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
163921145|NCT02642159|592080010|FG001|Overall Study|Poor compliance to study protocol|0|||
163921146|NCT02642159|592080009|FG000|Overall Study|Other than specified above|10|||
163921147|NCT02642159|592080010|FG001|Overall Study|Other than specified above|3|||
163921148|NCT00588341|592080011|FG000|Overall Study|Withdrawal by Subject|3|||
163921149|NCT00588341|592080011|FG000|Overall Study|Not treated due to metastatic disease|1|||
163921150|NCT00588341|592080011|FG000|Overall Study|Patient ineligible|1|||
163921151|NCT01954771|592080012|FG000|Overall Study|Missing HbA1c of end-point|1|||
163921152|NCT01954771|592080013|FG001|Overall Study|Missing HbA1c of end-point|1|||
163921153|NCT01954771|592080014|FG002|Overall Study|Missing HbA1c of end-point|0|||
163921154|NCT01954771|592080012|FG000|Overall Study|Missing CGMS of end-point|1|||
163921155|NCT01954771|592080013|FG001|Overall Study|Missing CGMS of end-point|1|||
163921156|NCT01954771|592080014|FG002|Overall Study|Missing CGMS of end-point|0|||
163921157|NCT01954771|592080012|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
163921158|NCT01954771|592080013|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
163921159|NCT01954771|592080014|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
163921160|NCT02865135|592080023|FG000|Overall Study|Death|0|||
163921161|NCT02865135|592080024|FG001|Overall Study|Death|1|||
163921162|NCT02865135|592080025|FG002|Overall Study|Death|0|||
163921163|NCT02865135|592080023|FG000|Overall Study|Progression|6|||
163921164|NCT02865135|592080024|FG001|Overall Study|Progression|2|||
163921165|NCT02865135|592080025|FG002|Overall Study|Progression|2|||
163921166|NCT00985621|592080026|FG000|Overall Study|Adverse Event|2|||
163921167|NCT00985621|592080027|FG001|Overall Study|Adverse Event|3|||
163921168|NCT00985621|592080028|FG002|Overall Study|Adverse Event|4|||
163921169|NCT00985621|592080029|FG003|Overall Study|Adverse Event|16|||
163921170|NCT00985621|592080026|FG000|Overall Study|Lack of Efficacy|10|||
163921171|NCT00985621|592080027|FG001|Overall Study|Lack of Efficacy|6|||
163921172|NCT00985621|592080028|FG002|Overall Study|Lack of Efficacy|5|||
163921173|NCT00985621|592080029|FG003|Overall Study|Lack of Efficacy|12|||
163921174|NCT00985621|592080026|FG000|Overall Study|Lost to Follow-up|2|||
163921175|NCT00985621|592080027|FG001|Overall Study|Lost to Follow-up|3|||
163921176|NCT00985621|592080028|FG002|Overall Study|Lost to Follow-up|4|||
163921177|NCT00985621|592080029|FG003|Overall Study|Lost to Follow-up|4|||
163921178|NCT00985621|592080026|FG000|Overall Study|Study Terminated by Sponsor|89|||
163921179|NCT00985621|592080027|FG001|Overall Study|Study Terminated by Sponsor|108|||
163921180|NCT00985621|592080028|FG002|Overall Study|Study Terminated by Sponsor|99|||
163921181|NCT00985621|592080029|FG003|Overall Study|Study Terminated by Sponsor|92|||
163921182|NCT00985621|592080026|FG000|Overall Study|Protocol Violation|1|||
163921183|NCT00985621|592080027|FG001|Overall Study|Protocol Violation|1|||
163921184|NCT00985621|592080028|FG002|Overall Study|Protocol Violation|1|||
163921185|NCT00985621|592080029|FG003|Overall Study|Protocol Violation|0|||
163921186|NCT00985621|592080026|FG000|Overall Study|Withdrawal by Subject|8|||
163921187|NCT00985621|592080027|FG001|Overall Study|Withdrawal by Subject|10|||
163921188|NCT00985621|592080028|FG002|Overall Study|Withdrawal by Subject|8|||
163921189|NCT00985621|592080029|FG003|Overall Study|Withdrawal by Subject|12|||
163921190|NCT00985621|592080026|FG000|Overall Study|Other|1|||
163921191|NCT00985621|592080027|FG001|Overall Study|Other|0|||
163921192|NCT00985621|592080028|FG002|Overall Study|Other|0|||
163921193|NCT00985621|592080029|FG003|Overall Study|Other|0|||
163921194|NCT00985621|592080026|FG000|Overall Study|Randomized but not Treated|1|||
163921195|NCT00985621|592080027|FG001|Overall Study|Randomized but not Treated|0|||
163921196|NCT00985621|592080028|FG002|Overall Study|Randomized but not Treated|2|||
163921197|NCT00985621|592080029|FG003|Overall Study|Randomized but not Treated|1|||
163921198|NCT04394624|592080033|FG000|Overall Study|Adverse Event|6|||
164032392|NCT01309841|592477856|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
163921199|NCT04394624|592080034|FG001|Overall Study|Adverse Event|0|||
163921200|NCT04394624|592080033|FG000|Overall Study|Progressive disease|24|||
163921201|NCT04394624|592080034|FG001|Overall Study|Progressive disease|0|||
163921202|NCT04394624|592080033|FG000|Overall Study|Not related to COVID-19|1|||
163921203|NCT04394624|592080034|FG001|Overall Study|Not related to COVID-19|0|||
163921204|NCT00905255|592080035|FG000|Overall Study|Adverse Event|7|||
163921205|NCT00905255|592080036|FG001|Overall Study|Adverse Event|5|||
163921206|NCT00905255|592080035|FG000|Overall Study|Withdrawal by Subject|5|||
163921207|NCT00905255|592080036|FG001|Overall Study|Withdrawal by Subject|4|||
163921208|NCT00905255|592080035|FG000|Overall Study|Familial and Personal Reasons|1|||
163921209|NCT00905255|592080036|FG001|Overall Study|Familial and Personal Reasons|0|||
163921210|NCT01774929|592080037|FG000|Overall Study|Adverse Event|3|||
163921211|NCT01332318|592080038|FG000|Overall Study|Adverse Event|0|||
163921212|NCT01332318|592080039|FG001|Overall Study|Adverse Event|3|||
163921213|NCT01332318|592080040|FG002|Overall Study|Adverse Event|0|||
163921214|NCT01332318|592080041|FG003|Overall Study|Adverse Event|0|||
163921215|NCT01332318|592080038|FG000|Overall Study|Withdrawal by Subject|1|||
164097338|NCT02336165|592720778|FG003|Overall Study|Progressive disease|24|||
164032393|NCT01309841|592477857|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
164032394|NCT01309841|592477855|FG000|Overall Study|Lack of Efficacy|0|||
164032395|NCT01309841|592477856|FG001|Overall Study|Lack of Efficacy|0|||
164032396|NCT01309841|592477857|FG002|Overall Study|Lack of Efficacy|2|||
164032397|NCT01309841|592477855|FG000|Overall Study|Adverse Event|9|||
164032398|NCT01309841|592477856|FG001|Overall Study|Adverse Event|22|||
164032399|NCT01309841|592477857|FG002|Overall Study|Adverse Event|11|||
164032400|NCT01309841|592477855|FG000|Overall Study|Death|1|||
164032401|NCT01309841|592477856|FG001|Overall Study|Death|0|||
164032402|NCT01309841|592477857|FG002|Overall Study|Death|0|||
164032403|NCT01309841|592477855|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164032404|NCT01309841|592477856|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164032405|NCT01309841|592477857|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
164032406|NCT01309841|592477855|FG000|Overall Study|Withdrawal by Subject|17|||
164032407|NCT01309841|592477856|FG001|Overall Study|Withdrawal by Subject|6|||
164032408|NCT01309841|592477857|FG002|Overall Study|Withdrawal by Subject|13|||
164032409|NCT01309841|592477855|FG000|Overall Study|Did Not Receive Treatment|2|||
164032410|NCT01309841|592477856|FG001|Overall Study|Did Not Receive Treatment|0|||
164032411|NCT01309841|592477857|FG002|Overall Study|Did Not Receive Treatment|1|||
164032412|NCT01309841|592477855|FG000|Overall Study|Severe non-compliance with protocol|0|||
164032413|NCT01309841|592477856|FG001|Overall Study|Severe non-compliance with protocol|5|||
164032414|NCT01309841|592477857|FG002|Overall Study|Severe non-compliance with protocol|2|||
164032415|NCT02475395|592477858|FG000|Overall Study|Protocol Violation|30|||
164032416|NCT02475395|592477859|FG001|Overall Study|Protocol Violation|3|||
164032417|NCT01681576|592477860|FG000|Period 1|Adverse Event|1|||
164032418|NCT01681576|592477861|FG001|Period 1|Adverse Event|0|||
164032419|NCT01681576|592477860|FG000|Period 1|Protocol Deviation|1|||
164032420|NCT01681576|592477861|FG001|Period 1|Protocol Deviation|0|||
164032421|NCT01681576|592477860|FG000|Period 2|subject/guardian decision|3|||
164032422|NCT01681576|592477861|FG001|Period 2|subject/guardian decision|1|||
164032423|NCT01681576|592477860|FG000|Period 2|Non-compliance with study treatment|1|||
164032424|NCT01681576|592477861|FG001|Period 2|Non-compliance with study treatment|0|||
164032425|NCT03448224|592477865|FG000|Overall Study|Provided same answer to every question|1|||
164032426|NCT03448224|592477866|FG001|Overall Study|Provided same answer to every question|0|||
164032427|NCT03103906|592477867|FG000|Overall Study|Adverse Event|2|||
164032428|NCT03103906|592477868|FG001|Overall Study|Adverse Event|3|||
164032429|NCT03103906|592477867|FG000|Overall Study|Other|2|||
164032430|NCT03103906|592477868|FG001|Overall Study|Other|0|||
164032431|NCT00764478|592477869|FG000|Overall Study|Adverse Event|1|||
164032432|NCT00764478|592477870|FG001|Overall Study|Adverse Event|1|||
164032433|NCT00764478|592477871|FG002|Overall Study|Adverse Event|1|||
164032434|NCT00764478|592477869|FG000|Overall Study|Withdrawal by Subject|7|||
164032435|NCT00764478|592477870|FG001|Overall Study|Withdrawal by Subject|12|||
164032436|NCT00764478|592477871|FG002|Overall Study|Withdrawal by Subject|1|||
164032437|NCT00764478|592477869|FG000|Overall Study|Lost to Follow-up|7|||
164032438|NCT00764478|592477870|FG001|Overall Study|Lost to Follow-up|8|||
164032439|NCT00764478|592477871|FG002|Overall Study|Lost to Follow-up|5|||
164032440|NCT00764478|592477869|FG000|Overall Study|Protocol Violation|0|||
164032441|NCT00764478|592477870|FG001|Overall Study|Protocol Violation|1|||
164032442|NCT00764478|592477871|FG002|Overall Study|Protocol Violation|1|||
164032443|NCT00862121|592477876|FG000|Overall Study|Adverse Event|1|||
164097339|NCT02336165|592720779|FG004|Overall Study|Progressive disease|19|||
164097340|NCT02336165|592720775|FG000|Overall Study|Non-compliance|1|||
164097341|NCT02336165|592720776|FG001|Overall Study|Non-compliance|0|||
164032444|NCT00862121|592477877|FG001|Overall Study|Adverse Event|2|||
164032445|NCT00862121|592477876|FG000|Overall Study|Lack of Efficacy|0|||
164032446|NCT00862121|592477877|FG001|Overall Study|Lack of Efficacy|3|||
164032447|NCT00862121|592477876|FG000|Overall Study|Protocol Violation|0|||
164032448|NCT00862121|592477877|FG001|Overall Study|Protocol Violation|1|||
164032449|NCT00862121|592477876|FG000|Overall Study|Exclusion criterion violation|0|||
164032450|NCT00862121|592477877|FG001|Overall Study|Exclusion criterion violation|1|||
164097342|NCT02336165|592720777|FG002|Overall Study|Non-compliance|0|||
164032451|NCT00862121|592477876|FG000|Overall Study|Incorrect randomisation|0|||
164032452|NCT00862121|592477877|FG001|Overall Study|Incorrect randomisation|1|||
164032453|NCT02007954|592477878|FG000|Overall Study|Received liver transplant|3|||
164032454|NCT02007954|592477878|FG000|Overall Study|Switch in treatment modality|2|||
164032455|NCT02007954|592477878|FG000|Overall Study|Disease progression and unrelated AE|1|||
164032456|NCT02007954|592477878|FG000|Overall Study|Death|1|||
164032457|NCT01195363|592477880|FG000|Overall Study|Lost to Follow-up|7|||
164032458|NCT01195363|592477881|FG001|Overall Study|Lost to Follow-up|4|||
164032459|NCT01195363|592477880|FG000|Overall Study|Adverse Event|3|||
164032460|NCT01195363|592477881|FG001|Overall Study|Adverse Event|1|||
164032461|NCT01195363|592477880|FG000|Overall Study|Lack of Efficacy|0|||
164032462|NCT01195363|592477881|FG001|Overall Study|Lack of Efficacy|4|||
164032463|NCT01195363|592477880|FG000|Overall Study|incarceration|1|||
164032464|NCT01195363|592477881|FG001|Overall Study|incarceration|0|||
164032465|NCT01164865|592477883|FG000|Overall Study|Lost to Follow-up|2|||
164097343|NCT02336165|592720778|FG003|Overall Study|Non-compliance|1|||
163921216|NCT01332318|592080039|FG001|Overall Study|Withdrawal by Subject|1|||
163921217|NCT01332318|592080040|FG002|Overall Study|Withdrawal by Subject|0|||
163921218|NCT01332318|592080041|FG003|Overall Study|Withdrawal by Subject|1|||
163921219|NCT01332318|592080038|FG000|Overall Study|Protocol Violation|1|||
163921220|NCT01332318|592080039|FG001|Overall Study|Protocol Violation|0|||
163921221|NCT01332318|592080040|FG002|Overall Study|Protocol Violation|1|||
163921222|NCT01332318|592080041|FG003|Overall Study|Protocol Violation|1|||
163921223|NCT02040532|592080042|FG000|Overall Study|Lost to Follow-up|1|||
163921224|NCT02040532|592080042|FG000|Overall Study|Physician Decision|4|||
163921225|NCT02040532|592080042|FG000|Overall Study|Adverse Event|4|||
163921226|NCT02040532|592080042|FG000|Overall Study|Withdrawal by Subject|3|||
163921227|NCT00676663|592080043|FG000|Overall Study|Death|43|||
163921228|NCT00676663|592080044|FG001|Overall Study|Death|27|||
163921229|NCT00676663|592080043|FG000|Overall Study|Withdrew Consent|1|||
163921230|NCT00676663|592080044|FG001|Overall Study|Withdrew Consent|8|||
163921231|NCT00676663|592080043|FG000|Overall Study|Lost to Follow-up|1|||
163921232|NCT00676663|592080044|FG001|Overall Study|Lost to Follow-up|3|||
163921233|NCT01772147|592081533|FG000|Overall Study|Adverse Event|13|||
163921234|NCT01772147|592081534|FG001|Overall Study|Adverse Event|10|||
163921235|NCT01772147|592081535|FG002|Overall Study|Adverse Event|6|||
163921236|NCT01772147|592081533|FG000|Overall Study|Withdrew Consent|7|||
163921237|NCT01772147|592081534|FG001|Overall Study|Withdrew Consent|8|||
163921238|NCT01772147|592081535|FG002|Overall Study|Withdrew Consent|4|||
163921239|NCT01772147|592081533|FG000|Overall Study|Lost to Follow-up|1|||
163921240|NCT01772147|592081534|FG001|Overall Study|Lost to Follow-up|0|||
163921241|NCT01772147|592081535|FG002|Overall Study|Lost to Follow-up|1|||
163921242|NCT01772147|592081533|FG000|Overall Study|Protocol Deviation|2|||
163921243|NCT01772147|592081534|FG001|Overall Study|Protocol Deviation|1|||
163921244|NCT01772147|592081535|FG002|Overall Study|Protocol Deviation|1|||
163921245|NCT01772147|592081533|FG000|Overall Study|Lack of Efficacy|8|||
163921246|NCT01772147|592081534|FG001|Overall Study|Lack of Efficacy|6|||
163921247|NCT01772147|592081535|FG002|Overall Study|Lack of Efficacy|6|||
163921248|NCT00796614|592081536|FG000|Overall Study|Adverse Event|1|||
163921249|NCT00796614|592081537|FG001|Overall Study|Adverse Event|2|||
163921250|NCT00796614|592081538|FG002|Overall Study|Adverse Event|0|||
163921251|NCT00796614|592081539|FG003|Overall Study|Adverse Event|0|||
163921252|NCT00796614|592081536|FG000|Overall Study|Protocol Violation|0|||
163921253|NCT00796614|592081537|FG001|Overall Study|Protocol Violation|0|||
163921254|NCT00796614|592081538|FG002|Overall Study|Protocol Violation|2|||
163921255|NCT00796614|592081539|FG003|Overall Study|Protocol Violation|0|||
163921256|NCT00796614|592081536|FG000|Overall Study|Lost to Follow-up|2|||
163921257|NCT00796614|592081537|FG001|Overall Study|Lost to Follow-up|2|||
163921258|NCT00796614|592081538|FG002|Overall Study|Lost to Follow-up|1|||
163921259|NCT00796614|592081539|FG003|Overall Study|Lost to Follow-up|0|||
163921260|NCT00796614|592081536|FG000|Overall Study|Withdrawal by Subject|1|||
163921261|NCT00796614|592081537|FG001|Overall Study|Withdrawal by Subject|0|||
163921262|NCT00796614|592081538|FG002|Overall Study|Withdrawal by Subject|0|||
163921263|NCT00796614|592081539|FG003|Overall Study|Withdrawal by Subject|1|||
163921264|NCT00796614|592081536|FG000|Overall Study|Other than stated|1|||
163921265|NCT00796614|592081537|FG001|Overall Study|Other than stated|0|||
163921266|NCT00796614|592081538|FG002|Overall Study|Other than stated|0|||
163921267|NCT00796614|592081539|FG003|Overall Study|Other than stated|0|||
163921268|NCT00740597|592081540|FG000|Overall Study|insurance would not cover treatment|1|||
163921269|NCT01983462|592081542|FG000|Overall Study|Adverse Event|1|||
163921270|NCT01983462|592081543|FG001|Overall Study|Adverse Event|0|||
163921271|NCT01983462|592081544|FG002|Overall Study|Adverse Event|0|||
163921272|NCT01902381|592081545|FG000|Overall Study|Withdrawal by Subject|1|||
163921273|NCT02762500|592081548|FG000|Overall Study|Lack of Efficacy|1|||
163921274|NCT02762500|592081549|FG001|Overall Study|Lack of Efficacy|0|||
163921275|NCT02762500|592081548|FG000|Overall Study|Withdrawal by Subject|1|||
163921276|NCT02762500|592081549|FG001|Overall Study|Withdrawal by Subject|1|||
163921277|NCT02762500|592081548|FG000|Overall Study|Adverse Event|0|||
163921278|NCT02762500|592081549|FG001|Overall Study|Adverse Event|2|||
163921279|NCT00730847|592081550|FG000|Overall Study|Adverse Event|1|||
163921280|NCT00730847|592081550|FG000|Overall Study|Protocol Violation|2|||
164032466|NCT01164865|592477884|FG001|Overall Study|Lost to Follow-up|1|||
164032467|NCT00377429|592477886|FG000|Overall Study|Withdrawal by Subject|5|||
164032468|NCT00377429|592477886|FG000|Overall Study|Adverse Event|8|||
164032469|NCT00377429|592477886|FG000|Overall Study|Physician Decision|1|||
163921281|NCT00730847|592081550|FG000|Overall Study|Withdrawal by Subject|16|||
163921282|NCT00730847|592081550|FG000|Overall Study|Lost to Follow-up|67|||
163921283|NCT00730847|592081550|FG000|Overall Study|Unknown completion status|21|||
163921284|NCT00730847|592081550|FG000|Overall Study|Other|24|||
163921285|NCT00280683|592081551|FG000|Overall Study|Withdrawal by Subject|1|||
163921286|NCT00280683|592081552|FG001|Overall Study|Withdrawal by Subject|2|||
163921287|NCT00280683|592081551|FG000|Overall Study|Adverse Event|1|||
163921288|NCT00280683|592081552|FG001|Overall Study|Adverse Event|1|||
163921289|NCT01243411|592081553|FG000|Overall Study|Withdrawal by Subject|18|||
163921290|NCT01243411|592081553|FG000|Overall Study|Lost to Follow-up|10|||
164032470|NCT00377429|592477886|FG000|Overall Study|Patient non-compliance|1|||
163921291|NCT01243411|592081553|FG000|Overall Study|Adverse Event|5|||
163921292|NCT01243411|592081553|FG000|Overall Study|Other|8|||
163921293|NCT00488319|592081554|FG000|Overall Study|Adverse Event|1|||
163921294|NCT00488319|592081555|FG001|Overall Study|Adverse Event|2|||
163921295|NCT00488319|592081556|FG002|Overall Study|Adverse Event|23|||
163921296|NCT00488319|592081554|FG000|Overall Study|Lack of Efficacy|6|||
163921297|NCT00488319|592081555|FG001|Overall Study|Lack of Efficacy|12|||
163921298|NCT00488319|592081556|FG002|Overall Study|Lack of Efficacy|27|||
163921299|NCT00488319|592081554|FG000|Overall Study|Lost to Follow-up|3|||
163921300|NCT00488319|592081555|FG001|Overall Study|Lost to Follow-up|5|||
163921301|NCT00488319|592081556|FG002|Overall Study|Lost to Follow-up|16|||
163921302|NCT00488319|592081554|FG000|Overall Study|Withdrawal by Subject|5|||
163921303|NCT00488319|592081555|FG001|Overall Study|Withdrawal by Subject|20|||
163921304|NCT00488319|592081556|FG002|Overall Study|Withdrawal by Subject|44|||
163921305|NCT00488319|592081554|FG000|Overall Study|Other reasons for withdrawal|0|||
163921306|NCT00488319|592081555|FG001|Overall Study|Other reasons for withdrawal|4|||
163921307|NCT00488319|592081556|FG002|Overall Study|Other reasons for withdrawal|12|||
163921308|NCT00784277|592081561|FG000|IR Treatment|Adverse Event|4|||
163921309|NCT00784277|592081562|FG001|IR Treatment|Adverse Event|8|||
163921310|NCT00784277|592081563|FG002|IR Treatment|Adverse Event|19|||
163921311|NCT00784277|592081564|FG003|IR Treatment|Adverse Event|35|||
163921312|NCT00784277|592081565|FG004|IR Treatment|Adverse Event|0|||
163921313|NCT00784277|592081566|FG005|IR Treatment|Adverse Event|0|||
163921314|NCT00784277|592081567|FG006|IR Treatment|Adverse Event|0|||
163921315|NCT00784277|592081561|FG000|IR Treatment|Lack of Efficacy|4|||
163921316|NCT00784277|592081562|FG001|IR Treatment|Lack of Efficacy|4|||
163921317|NCT00784277|592081563|FG002|IR Treatment|Lack of Efficacy|1|||
163921318|NCT00784277|592081564|FG003|IR Treatment|Lack of Efficacy|0|||
163921319|NCT00784277|592081565|FG004|IR Treatment|Lack of Efficacy|0|||
163921320|NCT00784277|592081566|FG005|IR Treatment|Lack of Efficacy|0|||
163921321|NCT00784277|592081567|FG006|IR Treatment|Lack of Efficacy|0|||
163921322|NCT00784277|592081561|FG000|IR Treatment|Lost to Follow-up|1|||
163921323|NCT00784277|592081562|FG001|IR Treatment|Lost to Follow-up|0|||
163921324|NCT00784277|592081563|FG002|IR Treatment|Lost to Follow-up|1|||
163921325|NCT00784277|592081564|FG003|IR Treatment|Lost to Follow-up|0|||
163921326|NCT00784277|592081565|FG004|IR Treatment|Lost to Follow-up|0|||
163921327|NCT00784277|592081566|FG005|IR Treatment|Lost to Follow-up|0|||
163921328|NCT00784277|592081567|FG006|IR Treatment|Lost to Follow-up|0|||
163921329|NCT00784277|592081561|FG000|IR Treatment|Withdrawal by Subject|5|||
163921330|NCT00784277|592081562|FG001|IR Treatment|Withdrawal by Subject|1|||
163921331|NCT00784277|592081563|FG002|IR Treatment|Withdrawal by Subject|4|||
163921332|NCT00784277|592081564|FG003|IR Treatment|Withdrawal by Subject|6|||
163921333|NCT00784277|592081565|FG004|IR Treatment|Withdrawal by Subject|0|||
163921334|NCT00784277|592081566|FG005|IR Treatment|Withdrawal by Subject|0|||
163921335|NCT00784277|592081567|FG006|IR Treatment|Withdrawal by Subject|0|||
163921336|NCT00784277|592081561|FG000|IR Treatment|Resolution Of Pain|0|||
163921337|NCT00784277|592081562|FG001|IR Treatment|Resolution Of Pain|1|||
163921338|NCT00784277|592081563|FG002|IR Treatment|Resolution Of Pain|0|||
163921339|NCT00784277|592081564|FG003|IR Treatment|Resolution Of Pain|0|||
163921340|NCT00784277|592081565|FG004|IR Treatment|Resolution Of Pain|0|||
163921341|NCT00784277|592081566|FG005|IR Treatment|Resolution Of Pain|0|||
163921342|NCT00784277|592081567|FG006|IR Treatment|Resolution Of Pain|0|||
163921343|NCT00784277|592081561|FG000|IR Treatment|Other|2|||
163921344|NCT00784277|592081562|FG001|IR Treatment|Other|3|||
163921345|NCT00784277|592081563|FG002|IR Treatment|Other|3|||
163921346|NCT00784277|592081564|FG003|IR Treatment|Other|2|||
163921347|NCT00784277|592081565|FG004|IR Treatment|Other|0|||
163921348|NCT00784277|592081566|FG005|IR Treatment|Other|0|||
164032471|NCT05691829|592479476|FG000|Overall Study|Physician Decision|2|||
164032472|NCT05691829|592479476|FG000|Overall Study|Eligibility criteria not met|3|||
163921349|NCT00784277|592081567|FG006|IR Treatment|Other|0|||
163921350|NCT00784277|592081561|FG000|ER Treatment|Adverse Event|0|||
163921351|NCT00784277|592081562|FG001|ER Treatment|Adverse Event|0|||
163921352|NCT00784277|592081563|FG002|ER Treatment|Adverse Event|0|||
163921353|NCT00784277|592081564|FG003|ER Treatment|Adverse Event|0|||
163921354|NCT00784277|592081565|FG004|ER Treatment|Adverse Event|1|||
163921355|NCT00784277|592081566|FG005|ER Treatment|Adverse Event|7|||
164032473|NCT00804843|592479477|FG000|Overall Study|Protocol Violation|1|||
163921356|NCT00784277|592081567|FG006|ER Treatment|Adverse Event|7|||
163921357|NCT00784277|592081561|FG000|ER Treatment|Lack of Efficacy|0|||
163921358|NCT00784277|592081562|FG001|ER Treatment|Lack of Efficacy|0|||
163921359|NCT00784277|592081563|FG002|ER Treatment|Lack of Efficacy|0|||
163921360|NCT00784277|592081564|FG003|ER Treatment|Lack of Efficacy|0|||
163921361|NCT00784277|592081565|FG004|ER Treatment|Lack of Efficacy|3|||
163921362|NCT00784277|592081566|FG005|ER Treatment|Lack of Efficacy|4|||
163921363|NCT00784277|592081567|FG006|ER Treatment|Lack of Efficacy|0|||
163921364|NCT00784277|592081561|FG000|ER Treatment|Lost to Follow-up|0|||
163921365|NCT00784277|592081562|FG001|ER Treatment|Lost to Follow-up|0|||
163921366|NCT00784277|592081563|FG002|ER Treatment|Lost to Follow-up|0|||
163921367|NCT00784277|592081564|FG003|ER Treatment|Lost to Follow-up|0|||
164097344|NCT02336165|592720779|FG004|Overall Study|Non-compliance|0|||
164097345|NCT02336165|592720775|FG000|Overall Study|Other|1|||
164097346|NCT02336165|592720776|FG001|Overall Study|Other|0|||
164097347|NCT02336165|592720777|FG002|Overall Study|Other|0|||
164097348|NCT02336165|592720778|FG003|Overall Study|Other|1|||
164097349|NCT02336165|592720779|FG004|Overall Study|Other|0|||
164097350|NCT00450190|592720780|FG000|Overall Study|Withdrawal by Subject|2|||
164097351|NCT03002077|592720783|FG000|Overall Study|Non-compliance with Study Drug|4|||
164097352|NCT03002077|592720783|FG000|Overall Study|Non-compliance w/Background ADT|1|||
164097353|NCT03002077|592720783|FG000|Overall Study|Study Terminated by Sponsor|257|||
163827148|NCT02216773|591734221|FG001|Overall Study|Disease progression|2|||
163827149|NCT02216773|591734220|FG000|Overall Study|Insufficient FLRV|4|||
163827150|NCT02216773|591734221|FG001|Overall Study|Insufficient FLRV|0|||
163827151|NCT02216773|591734220|FG000|Overall Study|Abandoned|4|||
163827152|NCT02216773|591734221|FG001|Overall Study|Abandoned|3|||
163827153|NCT00941330|591734239|FG000|Overall Study|Other|1|||
163827154|NCT00941330|591734240|FG001|Overall Study|Other|0|||
163827155|NCT00941330|591734239|FG000|Overall Study|Physician Decision|0|||
163827156|NCT00941330|591734240|FG001|Overall Study|Physician Decision|2|||
163827157|NCT00541450|591734241|FG000|Phase A|Adverse Event|3|||
163827158|NCT00541450|591734242|FG001|Phase A|Adverse Event|0|||
163827159|NCT00541450|591734241|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
163827160|NCT00541450|591734242|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
163827161|NCT00541450|591734241|FG000|Phase A|Hyperglycemia|0|||
163827162|NCT00541450|591734242|FG001|Phase A|Hyperglycemia|1|||
163827163|NCT00541450|591734241|FG000|Phase A|Lost to Follow-up|6|||
163827164|NCT00541450|591734242|FG001|Phase A|Lost to Follow-up|4|||
163827165|NCT00541450|591734241|FG000|Phase A|Physician Decision|2|||
163827166|NCT00541450|591734242|FG001|Phase A|Physician Decision|0|||
163827167|NCT00541450|591734241|FG000|Phase A|Protocol Violation|2|||
163827168|NCT00541450|591734242|FG001|Phase A|Protocol Violation|3|||
163827169|NCT00541450|591734241|FG000|Phase A|Withdrawal by Subject|7|||
163827170|NCT00541450|591734242|FG001|Phase A|Withdrawal by Subject|7|||
163827171|NCT00541450|591734241|FG000|Phase B|Adverse Event|6|||
163827172|NCT00541450|591734242|FG001|Phase B|Adverse Event|6|||
163827173|NCT00541450|591734241|FG000|Phase B|Hyperglycemia|10|||
163827174|NCT00541450|591734242|FG001|Phase B|Hyperglycemia|9|||
163827175|NCT00541450|591734241|FG000|Phase B|Lost to Follow-up|6|||
163827176|NCT00541450|591734242|FG001|Phase B|Lost to Follow-up|4|||
163827177|NCT00541450|591734241|FG000|Phase B|Physician Decision|4|||
163827178|NCT00541450|591734242|FG001|Phase B|Physician Decision|2|||
163827179|NCT00541450|591734241|FG000|Phase B|Pregnancy|0|||
163827180|NCT00541450|591734242|FG001|Phase B|Pregnancy|1|||
163827181|NCT00541450|591734241|FG000|Phase B|Protocol Violation|3|||
163827182|NCT00541450|591734242|FG001|Phase B|Protocol Violation|3|||
163827183|NCT00541450|591734241|FG000|Phase B|Withdrawal by Subject|8|||
163827184|NCT00541450|591734242|FG001|Phase B|Withdrawal by Subject|6|||
163827185|NCT00981084|591734243|FG000|Post Intervention (Data Analysis)|poor effort|1|||
163827186|NCT00981084|591734244|FG001|Post Intervention (Data Analysis)|poor effort|1|||
163827187|NCT00981084|591734243|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
163827188|NCT00981084|591734244|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
163827189|NCT01112579|591734245|FG000|Overall Study|Missed Visit|1|||
163827190|NCT01112579|591734246|FG001|Overall Study|Missed Visit|1|||
163827191|NCT01112579|591734245|FG000|Overall Study|Death|0|||
163827192|NCT01112579|591734246|FG001|Overall Study|Death|2|||
163827193|NCT01648270|591734247|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
164146987|NCT00443729|592899921|FG001|Overall Study|Protocol Violation|1|||
163921368|NCT00784277|592081565|FG004|ER Treatment|Lost to Follow-up|0|||
163827194|NCT04969263|591734248|FG000|Overall Study|Death|1|||
163827195|NCT04969263|591734248|FG000|Overall Study|Lost to Follow-up|2|||
163827196|NCT04969263|591734248|FG000|Overall Study|Withdrawal by Subject|5|||
163827197|NCT04969263|591734248|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
163827198|NCT01389973|591734249|FG000|Overall Study|Lost to Follow-up|1|||
163921369|NCT00784277|592081566|FG005|ER Treatment|Lost to Follow-up|2|||
163921370|NCT00784277|592081567|FG006|ER Treatment|Lost to Follow-up|0|||
163921371|NCT00784277|592081561|FG000|ER Treatment|Withdrawal by Subject|0|||
163921372|NCT00784277|592081562|FG001|ER Treatment|Withdrawal by Subject|0|||
163921373|NCT00784277|592081563|FG002|ER Treatment|Withdrawal by Subject|0|||
163921374|NCT00784277|592081564|FG003|ER Treatment|Withdrawal by Subject|0|||
163921375|NCT00784277|592081565|FG004|ER Treatment|Withdrawal by Subject|2|||
163921376|NCT00784277|592081566|FG005|ER Treatment|Withdrawal by Subject|5|||
163921377|NCT00784277|592081567|FG006|ER Treatment|Withdrawal by Subject|3|||
163921378|NCT00784277|592081561|FG000|ER Treatment|Study Medication Non-Compliant|0|||
163921379|NCT00784277|592081562|FG001|ER Treatment|Study Medication Non-Compliant|0|||
163921380|NCT00784277|592081563|FG002|ER Treatment|Study Medication Non-Compliant|0|||
163921381|NCT00784277|592081564|FG003|ER Treatment|Study Medication Non-Compliant|0|||
163921382|NCT00784277|592081565|FG004|ER Treatment|Study Medication Non-Compliant|2|||
163921383|NCT00784277|592081566|FG005|ER Treatment|Study Medication Non-Compliant|3|||
163921384|NCT00784277|592081567|FG006|ER Treatment|Study Medication Non-Compliant|3|||
164032474|NCT00804843|592479478|FG001|Overall Study|Protocol Violation|0|||
164032475|NCT00804843|592479477|FG000|Overall Study|Adverse Event|8|||
164032476|NCT00804843|592479478|FG001|Overall Study|Adverse Event|5|||
164032477|NCT00804843|592479477|FG000|Overall Study|Withdrawal by Subject|1|||
164032478|NCT00804843|592479478|FG001|Overall Study|Withdrawal by Subject|2|||
164032479|NCT02670928|592479485|FG000|Overall Study|Adverse Event|3|||
164032480|NCT02670928|592479486|FG001|Overall Study|Adverse Event|1|||
163827199|NCT01389973|591734249|FG000|Overall Study|Trial Stopped by Sponsor|9|||
163827200|NCT01389973|591734249|FG000|Overall Study|Other|10|||
163827201|NCT00725296|591734250|FG000|Overall Study|Adverse Event|11|||
163827202|NCT00725296|591734250|FG000|Overall Study|Lack of Efficacy|7|||
163827203|NCT00725296|591734250|FG000|Overall Study|Withdrawal by Subject|3|||
163827204|NCT00725296|591734250|FG000|Overall Study|Non-Compliance|2|||
163827205|NCT00725296|591734250|FG000|Overall Study|Lost to Follow-up|1|||
163827206|NCT00725296|591734250|FG000|Overall Study|Other|38|||
163827207|NCT03360942|591734251|FG000|Overall Study|Device explanted|2|||
163827208|NCT03360942|591734251|FG000|Overall Study|Study closure|1|||
163827209|NCT03360942|591734251|FG000|Overall Study|Withdrawal by Subject|2|||
163827210|NCT03456700|591734252|FG000|Overall Study|Withdrawal by Subject|1|||
163827211|NCT00613951|591734253|FG000|Overall Study|Adverse Event|1|||
163827212|NCT00613951|591734254|FG001|Overall Study|Adverse Event|0|||
163827213|NCT00613951|591734255|FG002|Overall Study|Adverse Event|1|||
163827214|NCT00613951|591734253|FG000|Overall Study|Lack of Efficacy|0|||
163827215|NCT00613951|591734254|FG001|Overall Study|Lack of Efficacy|1|||
163827216|NCT00613951|591734255|FG002|Overall Study|Lack of Efficacy|1|||
163827217|NCT00613951|591734253|FG000|Overall Study|Protocol Violation|1|||
163827218|NCT00613951|591734254|FG001|Overall Study|Protocol Violation|1|||
163827219|NCT00613951|591734255|FG002|Overall Study|Protocol Violation|1|||
163827220|NCT00613951|591734253|FG000|Overall Study|Unclassified|5|||
163827221|NCT00613951|591734254|FG001|Overall Study|Unclassified|3|||
163827222|NCT00613951|591734255|FG002|Overall Study|Unclassified|2|||
163827223|NCT03053050|591734256|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
163827224|NCT03053050|591734257|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
163827225|NCT03053050|591734258|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
163827226|NCT03053050|591734259|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
163827227|NCT03053050|591734256|FG000|Randomized Phase|Withdrew Consent|16|||
163827228|NCT03053050|591734257|FG001|Randomized Phase|Withdrew Consent|8|||
163827229|NCT03053050|591734258|FG002|Randomized Phase|Withdrew Consent|9|||
163827230|NCT03053050|591734259|FG003|Randomized Phase|Withdrew Consent|0|||
163827231|NCT03053050|591734256|FG000|Randomized Phase|Investigator's Discretion|6|||
163827232|NCT03053050|591734257|FG001|Randomized Phase|Investigator's Discretion|6|||
163827233|NCT03053050|591734258|FG002|Randomized Phase|Investigator's Discretion|3|||
163827234|NCT03053050|591734259|FG003|Randomized Phase|Investigator's Discretion|0|||
163827235|NCT03053050|591734256|FG000|Randomized Phase|Lost to Follow-up|5|||
163827236|NCT03053050|591734257|FG001|Randomized Phase|Lost to Follow-up|1|||
163827237|NCT03053050|591734258|FG002|Randomized Phase|Lost to Follow-up|1|||
163827238|NCT03053050|591734259|FG003|Randomized Phase|Lost to Follow-up|0|||
163827239|NCT03053050|591734256|FG000|Randomized Phase|Adverse Event|0|||
163827240|NCT03053050|591734257|FG001|Randomized Phase|Adverse Event|1|||
163827241|NCT03053050|591734258|FG002|Randomized Phase|Adverse Event|0|||
163827242|NCT03053050|591734259|FG003|Randomized Phase|Adverse Event|0|||
163827243|NCT03053050|591734256|FG000|Randomized Phase|Randomized but Never Treated|2|||
163827244|NCT03053050|591734257|FG001|Randomized Phase|Randomized but Never Treated|2|||
163827245|NCT03053050|591734258|FG002|Randomized Phase|Randomized but Never Treated|2|||
163827246|NCT03053050|591734259|FG003|Randomized Phase|Randomized but Never Treated|0|||
163827247|NCT03053050|591734256|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
163827248|NCT03053050|591734257|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
163827249|NCT03053050|591734258|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
163827250|NCT03053050|591734259|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
163827251|NCT03053050|591734256|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
163827252|NCT03053050|591734257|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
163827253|NCT03053050|591734258|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
163827254|NCT03053050|591734259|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
163827255|NCT03053050|591734256|FG000|Open-label Phase|Withdrew Consent|0|||
163827256|NCT03053050|591734257|FG001|Open-label Phase|Withdrew Consent|0|||
163827257|NCT03053050|591734258|FG002|Open-label Phase|Withdrew Consent|0|||
163827258|NCT03053050|591734259|FG003|Open-label Phase|Withdrew Consent|6|||
163827259|NCT03053050|591734256|FG000|Open-label Phase|Investigator's Discretion|0|||
163827260|NCT03053050|591734257|FG001|Open-label Phase|Investigator's Discretion|0|||
163827261|NCT03053050|591734258|FG002|Open-label Phase|Investigator's Discretion|0|||
163827262|NCT03053050|591734259|FG003|Open-label Phase|Investigator's Discretion|4|||
163827263|NCT00655980|591734260|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
163827264|NCT00655980|591734261|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
163827265|NCT00655980|591734262|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
164032481|NCT02670928|592479485|FG000|Overall Study|Withdrawal by Subject|4|||
164032482|NCT02670928|592479486|FG001|Overall Study|Withdrawal by Subject|0|||
163921385|NCT00784277|592081561|FG000|ER Treatment|Other|0|||
163921386|NCT00784277|592081562|FG001|ER Treatment|Other|0|||
163921387|NCT00784277|592081563|FG002|ER Treatment|Other|0|||
163921388|NCT00784277|592081564|FG003|ER Treatment|Other|0|||
163921389|NCT00784277|592081565|FG004|ER Treatment|Other|1|||
163921390|NCT00784277|592081566|FG005|ER Treatment|Other|3|||
163921391|NCT00784277|592081567|FG006|ER Treatment|Other|2|||
163921392|NCT01093222|592081568|FG000|Overall Study|Ineligible|6|||
163921393|NCT01093222|592081568|FG000|Overall Study|Adverse Event|7|||
163921394|NCT01093222|592081568|FG000|Overall Study|Progression/relapse|24|||
163921395|NCT01093222|592081568|FG000|Overall Study|Death|2|||
163921396|NCT01093222|592081568|FG000|Overall Study|Not protocol specified|1|||
163921397|NCT04194541|592081569|FG000|Day 1 Through 13|Lost to Follow-up|3|||
163921398|NCT04194541|592081569|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
163921399|NCT04194541|592081569|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
163921400|NCT02567227|592081570|FG000|9 Weeks|Adverse Event|5|||
163921401|NCT02567227|592081571|FG001|9 Weeks|Adverse Event|5|||
163921402|NCT02567227|592081570|FG000|9 Weeks|Withdrawal by Subject|18|||
163921403|NCT02567227|592081571|FG001|9 Weeks|Withdrawal by Subject|8|||
163921404|NCT02567227|592081570|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
163921405|NCT02567227|592081571|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
163921406|NCT02567227|592081570|FG000|6 Month|Death|2|||
163921407|NCT02567227|592081571|FG001|6 Month|Death|0|||
163921408|NCT02567227|592081570|FG000|6 Month|Lost to Follow-up|43|||
163921409|NCT02567227|592081571|FG001|6 Month|Lost to Follow-up|40|||
163921410|NCT02567227|592081570|FG000|12 Months|Lost to Follow-up|31|||
163921411|NCT02567227|592081571|FG001|12 Months|Lost to Follow-up|32|||
163921412|NCT02567227|592081570|FG000|12 Months|Death|0|||
163921413|NCT02567227|592081571|FG001|12 Months|Death|2|||
163921414|NCT00187135|592081572|FG000|Visit One|Withdrawal by Subject|1|||
163921415|NCT00187135|592081573|FG001|Visit One|Withdrawal by Subject|0|||
163921416|NCT00187135|592081574|FG002|Visit One|Withdrawal by Subject|0|||
163921417|NCT00187135|592081575|FG003|Visit One|Withdrawal by Subject|0|||
163921418|NCT00187135|592081576|FG004|Visit One|Withdrawal by Subject|0|||
163921419|NCT00187135|592081577|FG005|Visit One|Withdrawal by Subject|1|||
163921420|NCT00187135|592081572|FG000|Visit One|Physician Decision|3|||
163921421|NCT00187135|592081573|FG001|Visit One|Physician Decision|1|||
163921422|NCT00187135|592081574|FG002|Visit One|Physician Decision|0|||
163921423|NCT00187135|592081575|FG003|Visit One|Physician Decision|0|||
163921424|NCT00187135|592081576|FG004|Visit One|Physician Decision|0|||
163921425|NCT00187135|592081577|FG005|Visit One|Physician Decision|1|||
163921426|NCT00187135|592081572|FG000|Visit Two|Death|0|||
163921427|NCT00187135|592081573|FG001|Visit Two|Death|0|||
163921428|NCT00187135|592081574|FG002|Visit Two|Death|0|||
163921429|NCT00187135|592081575|FG003|Visit Two|Death|1|||
163921430|NCT00187135|592081576|FG004|Visit Two|Death|0|||
163921431|NCT00187135|592081577|FG005|Visit Two|Death|1|||
163921432|NCT00187135|592081572|FG000|Visit Two|Physician Decision|1|||
163921433|NCT00187135|592081573|FG001|Visit Two|Physician Decision|0|||
163921434|NCT00187135|592081574|FG002|Visit Two|Physician Decision|0|||
163921435|NCT00187135|592081575|FG003|Visit Two|Physician Decision|0|||
163921436|NCT00187135|592081576|FG004|Visit Two|Physician Decision|0|||
163921437|NCT00187135|592081577|FG005|Visit Two|Physician Decision|0|||
163921438|NCT00187135|592081572|FG000|Visit Two|Withdrawal by Subject|1|||
163921439|NCT00187135|592081573|FG001|Visit Two|Withdrawal by Subject|1|||
163921440|NCT00187135|592081574|FG002|Visit Two|Withdrawal by Subject|1|||
163921441|NCT00187135|592081575|FG003|Visit Two|Withdrawal by Subject|0|||
163921442|NCT00187135|592081576|FG004|Visit Two|Withdrawal by Subject|1|||
163921443|NCT00187135|592081577|FG005|Visit Two|Withdrawal by Subject|1|||
163921444|NCT00187135|592081572|FG000|Visit Two|Study Discontinued|3|||
163921445|NCT00187135|592081573|FG001|Visit Two|Study Discontinued|2|||
163921446|NCT00187135|592081574|FG002|Visit Two|Study Discontinued|1|||
163921447|NCT00187135|592081575|FG003|Visit Two|Study Discontinued|7|||
163921448|NCT00187135|592081576|FG004|Visit Two|Study Discontinued|5|||
163921449|NCT00187135|592081577|FG005|Visit Two|Study Discontinued|6|||
163921450|NCT00187135|592081572|FG000|Visit Three|Death|0|||
163921451|NCT00187135|592081573|FG001|Visit Three|Death|0|||
163921452|NCT00187135|592081574|FG002|Visit Three|Death|1|||
163921453|NCT00187135|592081575|FG003|Visit Three|Death|0|||
163921454|NCT00187135|592081576|FG004|Visit Three|Death|1|||
163921455|NCT00187135|592081577|FG005|Visit Three|Death|0|||
163921456|NCT00187135|592081572|FG000|Visit Three|Withdrawal by Subject|0|||
163921457|NCT00187135|592081573|FG001|Visit Three|Withdrawal by Subject|1|||
163921458|NCT00187135|592081574|FG002|Visit Three|Withdrawal by Subject|1|||
163921459|NCT00187135|592081575|FG003|Visit Three|Withdrawal by Subject|2|||
163921460|NCT00187135|592081576|FG004|Visit Three|Withdrawal by Subject|0|||
163921461|NCT00187135|592081577|FG005|Visit Three|Withdrawal by Subject|0|||
163921462|NCT00187135|592081572|FG000|Visit Three|Study Discontinued|7|||
163921463|NCT00187135|592081573|FG001|Visit Three|Study Discontinued|6|||
163921464|NCT00187135|592081574|FG002|Visit Three|Study Discontinued|7|||
163921465|NCT00187135|592081575|FG003|Visit Three|Study Discontinued|7|||
163921466|NCT00187135|592081576|FG004|Visit Three|Study Discontinued|7|||
163921467|NCT00187135|592081577|FG005|Visit Three|Study Discontinued|6|||
163921468|NCT01924806|592081582|FG000|Overall Study|Physician Decision|2|||
164032483|NCT02670928|592479485|FG000|Overall Study|Lost to Follow-up|1|||
164032484|NCT02670928|592479486|FG001|Overall Study|Lost to Follow-up|0|||
163827266|NCT04866017|591734269|FG000|Overall Study|Study Terminated by Sponsor|13|||
163827267|NCT04866017|591734270|FG001|Overall Study|Study Terminated by Sponsor|14|||
163827268|NCT04866017|591734271|FG002|Overall Study|Study Terminated by Sponsor|13|||
163827269|NCT04866017|591734269|FG000|Overall Study|Death|8|||
163827270|NCT04866017|591734270|FG001|Overall Study|Death|4|||
163827271|NCT04866017|591734271|FG002|Overall Study|Death|8|||
163827272|NCT04866017|591734269|FG000|Overall Study|Withdrawal by Subject|1|||
163827273|NCT04866017|591734270|FG001|Overall Study|Withdrawal by Subject|0|||
163827274|NCT04866017|591734271|FG002|Overall Study|Withdrawal by Subject|1|||
163827275|NCT04866017|591734269|FG000|Overall Study|Physician Decision|0|||
163827276|NCT04866017|591734270|FG001|Overall Study|Physician Decision|1|||
163827277|NCT04866017|591734271|FG002|Overall Study|Physician Decision|0|||
163827278|NCT01266642|591734272|FG000|Overall Study|Protocol Violation|0|||
163827279|NCT01266642|591734273|FG001|Overall Study|Protocol Violation|1|||
163827280|NCT01337674|591735530|FG000|Treatment Period 1|Adverse Event|0|||
163827281|NCT01337674|591735531|FG001|Treatment Period 1|Adverse Event|1|||
163827282|NCT01337674|591735532|FG002|Treatment Period 1|Adverse Event|0|||
163827283|NCT01337674|591735533|FG003|Treatment Period 1|Adverse Event|0|||
163827284|NCT01337674|591735530|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
163827285|NCT01337674|591735531|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
163827286|NCT01337674|591735532|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
163827287|NCT01337674|591735533|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
163827288|NCT01337674|591735530|FG000|Treatment Period 2|Withdrawal by Subject|0|||
163827289|NCT01337674|591735531|FG001|Treatment Period 2|Withdrawal by Subject|0|||
163827290|NCT01337674|591735532|FG002|Treatment Period 2|Withdrawal by Subject|1|||
163827291|NCT01337674|591735533|FG003|Treatment Period 2|Withdrawal by Subject|0|||
163827292|NCT01553318|591735536|FG000|Overall Study|Protocol Violation|3|||
163827293|NCT01553318|591735537|FG001|Overall Study|Protocol Violation|2|||
163827294|NCT00695786|591735538|FG000|Overall Study|Adverse Event|0|||
163827295|NCT00695786|591735539|FG001|Overall Study|Adverse Event|3|||
163827296|NCT00695786|591735540|FG002|Overall Study|Adverse Event|4|||
163827297|NCT00695786|591735541|FG003|Overall Study|Adverse Event|2|||
163827298|NCT00695786|591735538|FG000|Overall Study|Lost to Follow-up|0|||
163827299|NCT00695786|591735539|FG001|Overall Study|Lost to Follow-up|5|||
163827300|NCT00695786|591735540|FG002|Overall Study|Lost to Follow-up|1|||
163827301|NCT00695786|591735541|FG003|Overall Study|Lost to Follow-up|1|||
163827302|NCT00695786|591735538|FG000|Overall Study|Withdrawal by Subject|0|||
163827303|NCT00695786|591735539|FG001|Overall Study|Withdrawal by Subject|4|||
163827304|NCT00695786|591735540|FG002|Overall Study|Withdrawal by Subject|3|||
163827305|NCT00695786|591735541|FG003|Overall Study|Withdrawal by Subject|1|||
163827306|NCT00695786|591735538|FG000|Overall Study|Deemed Ineligible|1|||
163827307|NCT00695786|591735539|FG001|Overall Study|Deemed Ineligible|0|||
163827308|NCT00695786|591735540|FG002|Overall Study|Deemed Ineligible|0|||
163827309|NCT00695786|591735541|FG003|Overall Study|Deemed Ineligible|0|||
163827310|NCT00695786|591735538|FG000|Overall Study|Lack of Efficacy|0|||
163827311|NCT00695786|591735539|FG001|Overall Study|Lack of Efficacy|0|||
163827312|NCT00695786|591735540|FG002|Overall Study|Lack of Efficacy|0|||
163827313|NCT00695786|591735541|FG003|Overall Study|Lack of Efficacy|4|||
163827314|NCT04244396|591735545|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
163827315|NCT04244396|591735545|FG000|Overall Study|Withdrawal by Subject|2|||
163827316|NCT04244396|591735545|FG000|Overall Study|Study termination|37|||
163827317|NCT01787097|591735546|FG000|Overall Study|Withdrawal by Subject|1|||
163827318|NCT01787097|591735547|FG001|Overall Study|Withdrawal by Subject|0|||
163827319|NCT01787097|591735548|FG002|Overall Study|Withdrawal by Subject|0|||
163827320|NCT01787097|591735549|FG003|Overall Study|Withdrawal by Subject|0|||
163827321|NCT00245102|591735550|FG000|Overall Study|Not Treated|1|||
163827322|NCT00245102|591735551|FG001|Overall Study|Not Treated|0|||
163827323|NCT00245102|591735552|FG002|Overall Study|Not Treated|1|||
163827324|NCT00245102|591735553|FG003|Overall Study|Not Treated|0|||
163827325|NCT00245102|591735554|FG004|Overall Study|Not Treated|0|||
163827326|NCT00245102|591735555|FG005|Overall Study|Not Treated|0|||
163827327|NCT00245102|591735550|FG000|Overall Study|Protocol Violation|1|||
163827328|NCT00245102|591735551|FG001|Overall Study|Protocol Violation|0|||
163827329|NCT00245102|591735552|FG002|Overall Study|Protocol Violation|0|||
163827330|NCT00245102|591735553|FG003|Overall Study|Protocol Violation|0|||
163827331|NCT00245102|591735554|FG004|Overall Study|Protocol Violation|0|||
163827332|NCT00245102|591735555|FG005|Overall Study|Protocol Violation|0|||
163827333|NCT00245102|591735550|FG000|Overall Study|Death|0|||
163827334|NCT00245102|591735551|FG001|Overall Study|Death|0|||
163827335|NCT00245102|591735552|FG002|Overall Study|Death|0|||
163827336|NCT00245102|591735553|FG003|Overall Study|Death|1|||
163827337|NCT00245102|591735554|FG004|Overall Study|Death|0|||
163827338|NCT00245102|591735555|FG005|Overall Study|Death|0|||
163827339|NCT00245102|591735550|FG000|Overall Study|Adverse Event|4|||
163827340|NCT00245102|591735551|FG001|Overall Study|Adverse Event|2|||
163827341|NCT00245102|591735552|FG002|Overall Study|Adverse Event|5|||
163827342|NCT00245102|591735553|FG003|Overall Study|Adverse Event|1|||
164147137|NCT02466685|592899987|FG000|Overall Study|Adverse Event|5|||
163921469|NCT01924806|592081583|FG001|Overall Study|Physician Decision|1|||
163921470|NCT03635775|592081585|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
163921471|NCT03635775|592081586|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
163921472|NCT03635775|592081587|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
163921473|NCT03635775|592081588|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
163921474|NCT01026103|592081589|FG000|Overall Study|Physician Decision|1|||
163921475|NCT01026103|592081589|FG000|Overall Study|did not receive study device bc of error|1|||
163921476|NCT02498418|592081590|FG000|Overall Study|Lack of Efficacy|0|||
163921477|NCT02498418|592081591|FG001|Overall Study|Lack of Efficacy|0|||
163921478|NCT02498418|592081592|FG002|Overall Study|Lack of Efficacy|1|||
163921479|NCT02498418|592081590|FG000|Overall Study|Withdrawal by Subject|2|||
163921480|NCT02498418|592081591|FG001|Overall Study|Withdrawal by Subject|0|||
163921481|NCT02498418|592081592|FG002|Overall Study|Withdrawal by Subject|3|||
163921482|NCT02498418|592081590|FG000|Overall Study|Lost to Follow-up|0|||
163921483|NCT02498418|592081591|FG001|Overall Study|Lost to Follow-up|1|||
163921484|NCT02498418|592081592|FG002|Overall Study|Lost to Follow-up|1|||
163921485|NCT02498418|592081590|FG000|Overall Study|Participant taken prohibited medication|0|||
163921486|NCT02498418|592081591|FG001|Overall Study|Participant taken prohibited medication|1|||
163921487|NCT02498418|592081592|FG002|Overall Study|Participant taken prohibited medication|1|||
163921488|NCT00762502|592081593|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
163921489|NCT00762502|592081594|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
163921490|NCT00762502|592081595|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
163921491|NCT00762502|592081593|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
163921492|NCT00762502|592081594|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
163921493|NCT00762502|592081595|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
163921494|NCT00762502|592081593|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
163921495|NCT00762502|592081594|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
163921496|NCT00762502|592081595|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
163921497|NCT01675050|592081598|FG000|Period One Treatment|Withdrawal by Subject|1|||
163921498|NCT01675050|592081599|FG001|Period One Treatment|Withdrawal by Subject|0|||
163921499|NCT00745121|592081600|FG000|Overall Study|Death|3|||
163921500|NCT00745121|592081601|FG001|Overall Study|Death|0|||
163921501|NCT00745121|592081600|FG000|Overall Study|Adverse Event|1|||
163921502|NCT00745121|592081601|FG001|Overall Study|Adverse Event|0|||
163921503|NCT00745121|592081600|FG000|Overall Study|Lost to Follow-up|1|||
163921504|NCT00745121|592081601|FG001|Overall Study|Lost to Follow-up|0|||
163921505|NCT00745121|592081600|FG000|Overall Study|Withdrawal by Subject|4|||
163921506|NCT00745121|592081601|FG001|Overall Study|Withdrawal by Subject|2|||
163921507|NCT03280108|592081605|FG000|Overall Study|Lost to Follow-up|2|||
163921508|NCT03280108|592081606|FG001|Overall Study|Lost to Follow-up|0|||
163921509|NCT02996097|592081607|FG000|Overall Study|Lost to Follow-up|11|||
163921510|NCT02996097|592081608|FG001|Overall Study|Lost to Follow-up|11|||
163921511|NCT01820637|592081609|FG000|Overall Study|Death|2|||
163921512|NCT01820637|592081609|FG000|Overall Study|Withdrawal by Subject|1|||
163921513|NCT00264498|592081610|FG000|Randomized Treatment|Death|0|||
163921514|NCT00264498|592081611|FG001|Randomized Treatment|Death|3|||
163921515|NCT00264498|592081610|FG000|Randomized Treatment|Withdrawal by Subject|0|||
163921516|NCT00264498|592081611|FG001|Randomized Treatment|Withdrawal by Subject|1|||
163921517|NCT00264498|592081610|FG000|Randomized Treatment|Objective disease Progression|13|||
163921518|NCT00264498|592081611|FG001|Randomized Treatment|Objective disease Progression|14|||
163921519|NCT00264498|592081610|FG000|Randomized Treatment|Physician Decision|1|||
163921520|NCT00264498|592081611|FG001|Randomized Treatment|Physician Decision|0|||
163921521|NCT00264498|592081610|FG000|Randomized Treatment|Incorrectly randomized|1|||
163921522|NCT00264498|592081611|FG001|Randomized Treatment|Incorrectly randomized|0|||
164097354|NCT03002077|592720783|FG000|Overall Study|Site Terminated by Sponsor|5|||
164097355|NCT03002077|592720783|FG000|Overall Study|Miscellaneous Reasons|10|||
164097356|NCT03002077|592720783|FG000|Overall Study|Adverse Event|23|||
164097357|NCT03002077|592720783|FG000|Overall Study|Lack of Efficacy|20|||
163921523|NCT00264498|592081610|FG000|Randomized Treatment|Study Closure|1|||
163921524|NCT00264498|592081611|FG001|Randomized Treatment|Study Closure|0|||
163921525|NCT00264498|592081610|FG000|Randomized Treatment|Protocol Violation|1|||
163921526|NCT00264498|592081611|FG001|Randomized Treatment|Protocol Violation|0|||
163921527|NCT00264498|592081610|FG000|Crossover Treatment|Death|1|||
163921528|NCT00264498|592081611|FG001|Crossover Treatment|Death|3|||
164097358|NCT03002077|592720783|FG000|Overall Study|Withdrawal by Subject|72|||
164097359|NCT03002077|592720783|FG000|Overall Study|Lost to Follow-up|21|||
163921529|NCT00264498|592081610|FG000|Crossover Treatment|Objective disease progression|4|||
163921530|NCT00264498|592081611|FG001|Crossover Treatment|Objective disease progression|5|||
163921531|NCT00264498|592081610|FG000|Crossover Treatment|Study closure|0|||
163921532|NCT00264498|592081611|FG001|Crossover Treatment|Study closure|1|||
163921533|NCT00264498|592081610|FG000|Crossover Treatment|Withdrawal by Subject|1|||
163921534|NCT00264498|592081611|FG001|Crossover Treatment|Withdrawal by Subject|0|||
164097360|NCT03002077|592720783|FG000|Overall Study|Pregnancy|4|||
164097361|NCT03002077|592720783|FG000|Overall Study|Protocol Violation|21|||
164097362|NCT00986245|592720784|FG000|First Intervention|Poor compliance|8|||
164147138|NCT02466685|592899988|FG001|Overall Study|Adverse Event|2|||
163921535|NCT03794609|592081612|FG000|Overall Study|Other|10|||
163921536|NCT03794609|592081612|FG000|Overall Study|Withdrawal by Subject|66|||
163921537|NCT03794609|592081612|FG000|Overall Study|The child is enrolled in an interventional study|70|||
163921538|NCT03794609|592081612|FG000|Overall Study|Inclusion/exclusion criteria|8|||
163921539|NCT03794609|592081612|FG000|Overall Study|At sponsor's request|151|||
163921540|NCT03794609|592081612|FG000|Overall Study|Physician Decision|1|||
163921541|NCT03794609|592081612|FG000|Overall Study|Lost to Follow-up|5|||
163921542|NCT03638258|592081613|FG000|Overall Study|Adverse Event|1|||
163921543|NCT03638258|592081614|FG001|Overall Study|Adverse Event|0|||
163921544|NCT03638258|592081615|FG002|Overall Study|Adverse Event|2|||
163921545|NCT03638258|592081613|FG000|Overall Study|Lost to Follow-up|2|||
163921546|NCT03638258|592081614|FG001|Overall Study|Lost to Follow-up|4|||
163921547|NCT03638258|592081615|FG002|Overall Study|Lost to Follow-up|5|||
163921548|NCT03638258|592081613|FG000|Overall Study|Pregnancy|0|||
163921549|NCT03638258|592081614|FG001|Overall Study|Pregnancy|0|||
163921550|NCT03638258|592081615|FG002|Overall Study|Pregnancy|1|||
163921551|NCT03638258|592081613|FG000|Overall Study|Protocol Violation|0|||
163921552|NCT03638258|592081614|FG001|Overall Study|Protocol Violation|0|||
163921553|NCT03638258|592081615|FG002|Overall Study|Protocol Violation|1|||
163921554|NCT03638258|592081613|FG000|Overall Study|Withdrawal by Subject|4|||
163921555|NCT03638258|592081614|FG001|Overall Study|Withdrawal by Subject|5|||
163921556|NCT03638258|592081615|FG002|Overall Study|Withdrawal by Subject|12|||
163921557|NCT03638258|592081613|FG000|Overall Study|Lack of Efficacy|0|||
163921558|NCT03638258|592081614|FG001|Overall Study|Lack of Efficacy|0|||
163921559|NCT03638258|592081615|FG002|Overall Study|Lack of Efficacy|2|||
163921560|NCT04543942|592081616|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
163921561|NCT04543942|592081617|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
163921562|NCT04543942|592081616|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
163921563|NCT04543942|592081617|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
163921564|NCT02205476|592081618|FG000|Overall Study|Study termination by Sponsor|7|||
163921565|NCT02205476|592081619|FG001|Overall Study|Study termination by Sponsor|3|||
163921566|NCT01313299|592081630|FG000|Overall Study|Adverse Event|3|||
163921567|NCT01313299|592081631|FG001|Overall Study|Adverse Event|1|||
163921568|NCT01313299|592081632|FG002|Overall Study|Adverse Event|1|||
163921569|NCT01313299|592081630|FG000|Overall Study|Lost to Follow-up|1|||
163921570|NCT01313299|592081631|FG001|Overall Study|Lost to Follow-up|0|||
163921571|NCT01313299|592081632|FG002|Overall Study|Lost to Follow-up|0|||
163921572|NCT01313299|592081630|FG000|Overall Study|Protocol Violation|2|||
163921573|NCT01313299|592081631|FG001|Overall Study|Protocol Violation|0|||
163921574|NCT01313299|592081632|FG002|Overall Study|Protocol Violation|0|||
163921575|NCT01313299|592081630|FG000|Overall Study|Withdrawal by Subject|1|||
163921576|NCT01313299|592081631|FG001|Overall Study|Withdrawal by Subject|0|||
163921577|NCT01313299|592081632|FG002|Overall Study|Withdrawal by Subject|2|||
163921578|NCT01313299|592081630|FG000|Overall Study|Family reason and moved out of state|0|||
163921579|NCT01313299|592081631|FG001|Overall Study|Family reason and moved out of state|2|||
163921580|NCT01313299|592081632|FG002|Overall Study|Family reason and moved out of state|0|||
163921581|NCT01313299|592081630|FG000|Overall Study|Lack of subject compliance|0|||
163921582|NCT01313299|592081631|FG001|Overall Study|Lack of subject compliance|0|||
163921583|NCT01313299|592081632|FG002|Overall Study|Lack of subject compliance|1|||
163921584|NCT02506881|592081633|FG000|First Intervention (Day 1)|Protocol Violation|0|||
163921585|NCT02506881|592081634|FG001|First Intervention (Day 1)|Protocol Violation|0|||
163921586|NCT02506881|592081635|FG002|First Intervention (Day 1)|Protocol Violation|1|||
163921587|NCT02506881|592081636|FG003|First Intervention (Day 1)|Protocol Violation|0|||
163921588|NCT02506881|592081633|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
163921589|NCT02506881|592081634|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
163921590|NCT02506881|592081635|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
163921591|NCT02506881|592081636|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
163921592|NCT02506881|592081633|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
163921593|NCT02506881|592081634|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
163921594|NCT02506881|592081635|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
163921595|NCT02506881|592081636|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
163921596|NCT01919398|592081637|FG000|Overall Study|Progressive Disease|0|||
163921597|NCT01919398|592081638|FG001|Overall Study|Progressive Disease|0|||
163921598|NCT01919398|592081639|FG002|Overall Study|Progressive Disease|4|||
163921599|NCT02391545|592081645|FG000|Overall Study|Death|0|||
163921600|NCT02391545|592081646|FG001|Overall Study|Death|2|||
163921601|NCT02391545|592081645|FG000|Overall Study|Lost to Follow-up|0|||
163921602|NCT02391545|592081646|FG001|Overall Study|Lost to Follow-up|1|||
163921603|NCT02391545|592081645|FG000|Overall Study|Termination of study by sponsor|20|||
163921604|NCT02391545|592081646|FG001|Overall Study|Termination of study by sponsor|20|||
163921605|NCT02391545|592081645|FG000|Overall Study|Withdrawal by Subject|0|||
163921606|NCT02391545|592081646|FG001|Overall Study|Withdrawal by Subject|1|||
163921607|NCT02391545|592081645|FG000|Overall Study|Other Reasons|6|||
163921608|NCT02391545|592081646|FG001|Overall Study|Other Reasons|4|||
163921609|NCT02016690|592081647|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
163921610|NCT02016690|592081647|FG000|Overall Study|Excluded from SAS: Duplication|2|||
163921611|NCT02016690|592081647|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
163921612|NCT02016690|592081647|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
163921613|NCT02016690|592081647|FG000|Overall Study|Did not meet inclusion criteria|13|||
163921614|NCT02016690|592081647|FG000|Overall Study|Hospitalized for RSV at study start|3|||
164032485|NCT02670928|592479485|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
164032486|NCT02670928|592479486|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
164032487|NCT02678312|592479487|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
164032488|NCT02678312|592479488|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164032489|NCT02678312|592479489|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164032490|NCT02678312|592479490|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164032491|NCT02678312|592479491|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
164032492|NCT02678312|592479487|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
164032493|NCT02678312|592479488|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164032494|NCT02678312|592479489|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164032495|NCT02678312|592479490|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164032496|NCT02678312|592479491|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
164032497|NCT02678312|592479487|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
164032498|NCT02678312|592479488|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164032499|NCT02678312|592479489|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164032500|NCT02678312|592479490|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164032501|NCT02678312|592479491|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
164032502|NCT02678312|592479487|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
164032503|NCT02678312|592479488|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
164032504|NCT02678312|592479489|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
164032505|NCT02678312|592479490|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
163827343|NCT00245102|591735554|FG004|Overall Study|Adverse Event|0|||
163827344|NCT00245102|591735555|FG005|Overall Study|Adverse Event|2|||
163827345|NCT00245102|591735550|FG000|Overall Study|Decline in performance|0|||
163827346|NCT00245102|591735551|FG001|Overall Study|Decline in performance|2|||
163827347|NCT00245102|591735552|FG002|Overall Study|Decline in performance|0|||
163827348|NCT00245102|591735553|FG003|Overall Study|Decline in performance|1|||
163827349|NCT00245102|591735554|FG004|Overall Study|Decline in performance|0|||
163827350|NCT00245102|591735555|FG005|Overall Study|Decline in performance|2|||
163827351|NCT00245102|591735550|FG000|Overall Study|Participant needed surgery|0|||
163827352|NCT00245102|591735551|FG001|Overall Study|Participant needed surgery|0|||
163827353|NCT00245102|591735552|FG002|Overall Study|Participant needed surgery|1|||
163827354|NCT00245102|591735553|FG003|Overall Study|Participant needed surgery|0|||
163827355|NCT00245102|591735554|FG004|Overall Study|Participant needed surgery|0|||
163827356|NCT00245102|591735555|FG005|Overall Study|Participant needed surgery|0|||
163827357|NCT00245102|591735550|FG000|Overall Study|Clinical progression|1|||
163827358|NCT00245102|591735551|FG001|Overall Study|Clinical progression|0|||
163827359|NCT00245102|591735552|FG002|Overall Study|Clinical progression|0|||
163827360|NCT00245102|591735553|FG003|Overall Study|Clinical progression|0|||
163827361|NCT00245102|591735554|FG004|Overall Study|Clinical progression|0|||
163827362|NCT00245102|591735555|FG005|Overall Study|Clinical progression|0|||
163827363|NCT00289887|591735556|FG000|Overall Study|Adverse Event|3|||
163827364|NCT00289887|591735557|FG001|Overall Study|Adverse Event|3|||
163827365|NCT00289887|591735556|FG000|Overall Study|Lack of Efficacy|3|||
163827366|NCT00289887|591735557|FG001|Overall Study|Lack of Efficacy|11|||
163827367|NCT00289887|591735556|FG000|Overall Study|Lost to Follow-up|3|||
163827368|NCT00289887|591735557|FG001|Overall Study|Lost to Follow-up|3|||
163827369|NCT00289887|591735556|FG000|Overall Study|Protocol Violation|3|||
163827370|NCT00289887|591735557|FG001|Overall Study|Protocol Violation|1|||
163827371|NCT00289887|591735556|FG000|Overall Study|Withdrawal by Subject|3|||
163827372|NCT00289887|591735557|FG001|Overall Study|Withdrawal by Subject|8|||
163827373|NCT00289887|591735556|FG000|Overall Study|Other|7|||
163921615|NCT01222078|592081648|FG000|Overall Study|Early termination of the study|1|||
163921616|NCT04089332|592081649|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
164032506|NCT02678312|592479491|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
164032507|NCT02678312|592479487|FG000|Part 2 Double Blind Epoch|Death|0|||
164032508|NCT02678312|592479488|FG001|Part 2 Double Blind Epoch|Death|0|||
164032509|NCT02678312|592479489|FG002|Part 2 Double Blind Epoch|Death|0|||
163827374|NCT00289887|591735557|FG001|Overall Study|Other|3|||
164032510|NCT02678312|592479490|FG003|Part 2 Double Blind Epoch|Death|8|||
164032511|NCT02678312|592479491|FG004|Part 2 Double Blind Epoch|Death|12|||
164032512|NCT02678312|592479487|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
163827375|NCT02293395|591735560|FG000|Overall Study|Lost to Follow-up|1|||
163827376|NCT02293395|591735561|FG001|Overall Study|Lost to Follow-up|0|||
163827377|NCT02293395|591735560|FG000|Overall Study|Withdrawal by Subject|8|||
164097363|NCT00986245|592720785|FG001|First Intervention|Poor compliance|4|||
164097364|NCT00986245|592720784|FG000|First Intervention|Lack of Efficacy|1|||
164097365|NCT00986245|592720785|FG001|First Intervention|Lack of Efficacy|2|||
164097366|NCT00986245|592720784|FG000|First Intervention|Withdrawal by Subject|0|||
164097367|NCT00986245|592720785|FG001|First Intervention|Withdrawal by Subject|1|||
164097368|NCT00986245|592720784|FG000|First Intervention|Protocol Violation|0|||
164097369|NCT00986245|592720785|FG001|First Intervention|Protocol Violation|1|||
164097370|NCT00986245|592720784|FG000|First Intervention|Out of indication|1|||
164097371|NCT00986245|592720785|FG001|First Intervention|Out of indication|0|||
164097372|NCT00986245|592720784|FG000|Second Intervention|Poor compliance|1|||
164097373|NCT00986245|592720785|FG001|Second Intervention|Poor compliance|0|||
164097374|NCT00986245|592720784|FG000|Second Intervention|Lost to Follow-up|1|||
164097375|NCT00986245|592720785|FG001|Second Intervention|Lost to Follow-up|0|||
164032513|NCT02678312|592479488|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
164032514|NCT02678312|592479489|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
164032515|NCT02678312|592479490|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
164032516|NCT02678312|592479491|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
164032517|NCT02678312|592479487|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164032518|NCT02678312|592479488|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164032519|NCT02678312|592479489|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164032520|NCT02678312|592479490|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
164032521|NCT02678312|592479491|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
164032522|NCT02678312|592479487|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
164032523|NCT02678312|592479488|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
164032524|NCT02678312|592479489|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
164032525|NCT02678312|592479490|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
164032526|NCT02678312|592479491|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
164032527|NCT04624672|592479494|FG000|Overall Study|Early Study Closure|2|||
164032528|NCT04624672|592479495|FG001|Overall Study|Early Study Closure|1|||
164032529|NCT00010803|592479500|FG000|Overall Study|Withdrawal by Subject|97|||
164032530|NCT00010803|592479501|FG001|Overall Study|Withdrawal by Subject|98|||
164032531|NCT01415908|592479502|FG000|Overall Study|Withdrawal by Subject|1|||
164032532|NCT01415908|592479503|FG001|Overall Study|Withdrawal by Subject|0|||
164032533|NCT01779648|592479507|FG000|Overall Study|Protocol Violation|1|||
164032534|NCT01779648|592479508|FG001|Overall Study|Protocol Violation|0|||
164032535|NCT01878097|592479509|FG000|Baseline|Surveys not fully completed|2497|||
164032536|NCT01878097|592479510|FG001|Baseline|Surveys not fully completed|1800|||
164032537|NCT01878097|592479509|FG000|Implementation Year 1|Surveys not fully completed|3202|||
164032538|NCT01878097|592479510|FG001|Implementation Year 1|Surveys not fully completed|2549|||
164032539|NCT01878097|592479509|FG000|Implementation Year 2|Surveys not fully completed|3281|||
164032540|NCT01878097|592479510|FG001|Implementation Year 2|Surveys not fully completed|2841|||
164032541|NCT01878097|592479509|FG000|Implementation Year 3|Surveys not fully completed|3494|||
164032542|NCT01878097|592479510|FG001|Implementation Year 3|Surveys not fully completed|2980|||
164032543|NCT01878097|592479509|FG000|Implementation Year 4|Surveys not fully completed|3604|||
164032544|NCT01878097|592479510|FG001|Implementation Year 4|Surveys not fully completed|3007|||
164032545|NCT01595438|592479511|FG000|Overall Study|Lost to Follow-up|20|||
164032546|NCT01595438|592479512|FG001|Overall Study|Lost to Follow-up|20|||
164032547|NCT01595438|592479511|FG000|Overall Study|Withdrawal by Subject|12|||
164032548|NCT01595438|592479512|FG001|Overall Study|Withdrawal by Subject|12|||
164032549|NCT01595438|592479511|FG000|Overall Study|Other Eligibility criteria|11|||
164032550|NCT01595438|592479512|FG001|Overall Study|Other Eligibility criteria|9|||
164032551|NCT01373918|592479516|FG000|Overall Study|Physician Decision|0|||
164032552|NCT01373918|592479517|FG001|Overall Study|Physician Decision|1|||
164032553|NCT02786836|592479519|FG000|Overall Study|Death|1|||
164097376|NCT00986245|592720784|FG000|Second Intervention|Protocol Violation|0|||
164097377|NCT00986245|592720785|FG001|Second Intervention|Protocol Violation|1|||
164097378|NCT00854308|592720789|FG000|Overall Study|Disease progression|42|||
164097379|NCT00854308|592720790|FG001|Overall Study|Disease progression|50|||
164097380|NCT00854308|592720789|FG000|Overall Study|Adverse Event|8|||
163827378|NCT02293395|591735561|FG001|Overall Study|Withdrawal by Subject|7|||
163827379|NCT01464021|591735562|FG000|Overall Study|Withdrawal by Subject|13|||
163827380|NCT01464021|591735562|FG000|Overall Study|Lost to Follow-up|1|||
164032554|NCT02786836|592479519|FG000|Overall Study|Lack of Efficacy|2|||
164097381|NCT00854308|592720790|FG001|Overall Study|Adverse Event|3|||
164097382|NCT00854308|592720789|FG000|Overall Study|Death|2|||
164097383|NCT00854308|592720790|FG001|Overall Study|Death|5|||
164097384|NCT00854308|592720789|FG000|Overall Study|Physician Decision|6|||
164032555|NCT02786836|592479519|FG000|Overall Study|Protocol Violation|3|||
164032556|NCT02786836|592479519|FG000|Overall Study|Withdrawal by Subject|3|||
164032557|NCT02786836|592479519|FG000|Overall Study|Liver Transplantation|2|||
164032558|NCT02786836|592479519|FG000|Overall Study|Device or Pharmacy Issues|3|||
164032559|NCT02016898|592479527|FG000|Overall Study|Death|1|||
164032560|NCT02016898|592479528|FG001|Overall Study|Death|1|||
164097385|NCT00854308|592720790|FG001|Overall Study|Physician Decision|6|||
163827381|NCT01464021|591735562|FG000|Overall Study|Lack of Efficacy|1|||
163827382|NCT01464021|591735562|FG000|Overall Study|various|11|||
163827383|NCT00224770|591735568|FG000|Overall Study|Lost to Follow-up|4|||
163827384|NCT00224770|591735569|FG001|Overall Study|Lost to Follow-up|2|||
163827385|NCT00224770|591735570|FG002|Overall Study|Lost to Follow-up|0|||
163827386|NCT01106430|591735571|FG000|Overall Study|Adverse Event|8|||
163827387|NCT01106430|591735572|FG001|Overall Study|Adverse Event|10|||
163827388|NCT01106430|591735571|FG000|Overall Study|Lack of Efficacy|2|||
163827389|NCT01106430|591735572|FG001|Overall Study|Lack of Efficacy|13|||
163827390|NCT01106430|591735571|FG000|Overall Study|Lost to Follow-up|5|||
163827391|NCT01106430|591735572|FG001|Overall Study|Lost to Follow-up|1|||
163827392|NCT01106430|591735571|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
163827393|NCT01106430|591735572|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
163827394|NCT01106430|591735571|FG000|Overall Study|Moved Out Of State|0|||
163827395|NCT01106430|591735572|FG001|Overall Study|Moved Out Of State|1|||
163827396|NCT01106430|591735571|FG000|Overall Study|Refused To Take Medication|0|||
163827397|NCT01106430|591735572|FG001|Overall Study|Refused To Take Medication|1|||
163827398|NCT01106430|591735571|FG000|Overall Study|Noncompliance|0|||
163827399|NCT01106430|591735572|FG001|Overall Study|Noncompliance|1|||
163827400|NCT01106430|591735571|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
163827401|NCT01106430|591735572|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
163827402|NCT01106430|591735571|FG000|Overall Study|Previous Use Of Marijuana|1|||
163827403|NCT01106430|591735572|FG001|Overall Study|Previous Use Of Marijuana|0|||
163827404|NCT01106430|591735571|FG000|Overall Study|Protocol Violation|7|||
163827405|NCT01106430|591735572|FG001|Overall Study|Protocol Violation|2|||
163827406|NCT01106430|591735571|FG000|Overall Study|Withdrawal by Subject|8|||
163827407|NCT01106430|591735572|FG001|Overall Study|Withdrawal by Subject|4|||
163827408|NCT00437645|591735573|FG000|Overall Study|Adverse Event|15|||
163827409|NCT00437645|591735574|FG001|Overall Study|Adverse Event|84|||
163827410|NCT00437645|591735573|FG000|Overall Study|Withdrawal by Subject|10|||
163827411|NCT00437645|591735574|FG001|Overall Study|Withdrawal by Subject|22|||
163827412|NCT00437645|591735573|FG000|Overall Study|Protocol Violation|3|||
163827413|NCT00437645|591735574|FG001|Overall Study|Protocol Violation|3|||
163827414|NCT00437645|591735573|FG000|Overall Study|Lost to Follow-up|2|||
163827415|NCT00437645|591735574|FG001|Overall Study|Lost to Follow-up|3|||
163827416|NCT00437645|591735573|FG000|Overall Study|Administrative problems|2|||
163827417|NCT00437645|591735574|FG001|Overall Study|Administrative problems|1|||
163827418|NCT00437645|591735573|FG000|Overall Study|Lack of Efficacy|2|||
163827419|NCT00437645|591735574|FG001|Overall Study|Lack of Efficacy|1|||
163827420|NCT00437645|591735573|FG000|Overall Study|Condition no longer requires study drug|1|||
163827421|NCT00437645|591735574|FG001|Overall Study|Condition no longer requires study drug|1|||
163827422|NCT00175825|591735579|FG000|Overall Study|Adverse Event|3|||
163827423|NCT00175825|591735580|FG001|Overall Study|Adverse Event|2|||
163827424|NCT00175825|591735581|FG002|Overall Study|Adverse Event|1|||
163827425|NCT00175825|591735582|FG003|Overall Study|Adverse Event|1|||
163827426|NCT00175825|591735579|FG000|Overall Study|Lost to Follow-up|1|||
163827427|NCT00175825|591735580|FG001|Overall Study|Lost to Follow-up|2|||
163827428|NCT00175825|591735581|FG002|Overall Study|Lost to Follow-up|0|||
163827429|NCT00175825|591735582|FG003|Overall Study|Lost to Follow-up|0|||
163827430|NCT00175825|591735579|FG000|Overall Study|Withdrawal by Subject|1|||
163827431|NCT00175825|591735580|FG001|Overall Study|Withdrawal by Subject|0|||
163827432|NCT00175825|591735581|FG002|Overall Study|Withdrawal by Subject|0|||
163827433|NCT00175825|591735582|FG003|Overall Study|Withdrawal by Subject|0|||
163827434|NCT03704584|591735583|FG000|Overall Study|Withdrawal by Subject|1|||
163827435|NCT03704584|591735584|FG001|Overall Study|Withdrawal by Subject|0|||
163827436|NCT03412812|591735585|FG000|Level 1|Death|3|||
163827437|NCT03412812|591735586|FG001|Level 1|Death|0|||
163827438|NCT03412812|591735585|FG000|Level 1|Adverse Event|0|||
163827439|NCT03412812|591735586|FG001|Level 1|Adverse Event|1|||
163827440|NCT02127372|591735587|FG000|Overall Study|Withdrawal by Subject|1|||
163827441|NCT02127372|591735588|FG001|Overall Study|Withdrawal by Subject|0|||
163827442|NCT03548207|591735591|FG000|Overall Study|Death|10|||
163827443|NCT03548207|591735592|FG001|Overall Study|Death|23|||
163827444|NCT03548207|591735593|FG002|Overall Study|Death|3|||
163827445|NCT03548207|591735591|FG000|Overall Study|Lost to Follow-up|0|||
163827446|NCT03548207|591735592|FG001|Overall Study|Lost to Follow-up|2|||
163827447|NCT03548207|591735593|FG002|Overall Study|Lost to Follow-up|0|||
163827448|NCT03548207|591735591|FG000|Overall Study|Withdrawal by Subject|0|||
163827449|NCT03548207|591735592|FG001|Overall Study|Withdrawal by Subject|3|||
163827450|NCT03548207|591735593|FG002|Overall Study|Withdrawal by Subject|0|||
163827451|NCT03548207|591735591|FG000|Overall Study|Sponsor decision|19|||
163827452|NCT03548207|591735592|FG001|Overall Study|Sponsor decision|40|||
163827453|NCT03548207|591735593|FG002|Overall Study|Sponsor decision|6|||
163827454|NCT03548207|591735591|FG000|Overall Study|Randomized but not treated|6|||
163827455|NCT03548207|591735592|FG001|Overall Study|Randomized but not treated|10|||
163827456|NCT03548207|591735593|FG002|Overall Study|Randomized but not treated|4|||
163827457|NCT01756352|591735594|FG000|Overall Study|moved away and lost to followup|1|||
163827458|NCT02641392|591735597|FG000|Overall Study|Lost to Follow-up|0|||
163827459|NCT02641392|591735598|FG001|Overall Study|Lost to Follow-up|0|||
163827460|NCT02641392|591735599|FG002|Overall Study|Lost to Follow-up|2|||
163921617|NCT04089332|592081649|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
163921618|NCT04089332|592081649|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
163921619|NCT02588027|592081658|FG000|Overall Study|Withdrawal by Subject|1|||
163921620|NCT02588027|592081659|FG001|Overall Study|Withdrawal by Subject|3|||
163921621|NCT02588027|592081658|FG000|Overall Study|Protocol Violation|4|||
163921622|NCT02588027|592081659|FG001|Overall Study|Protocol Violation|1|||
163921623|NCT00603278|592081663|FG000|Overall Study|Lack of Efficacy|35|||
163921624|NCT00603278|592081664|FG001|Overall Study|Lack of Efficacy|10|||
163921625|NCT00603278|592081665|FG002|Overall Study|Lack of Efficacy|11|||
163921626|NCT00603278|592081666|FG003|Overall Study|Lack of Efficacy|8|||
163921627|NCT00603278|592081667|FG004|Overall Study|Lack of Efficacy|7|||
163921628|NCT00603278|592081668|FG005|Overall Study|Lack of Efficacy|14|||
163921629|NCT00603278|592081663|FG000|Overall Study|Adverse Event|0|||
163921630|NCT00603278|592081664|FG001|Overall Study|Adverse Event|3|||
163921631|NCT00603278|592081665|FG002|Overall Study|Adverse Event|1|||
163921632|NCT00603278|592081666|FG003|Overall Study|Adverse Event|0|||
163921633|NCT00603278|592081667|FG004|Overall Study|Adverse Event|2|||
163921634|NCT00603278|592081668|FG005|Overall Study|Adverse Event|1|||
163921635|NCT00603278|592081663|FG000|Overall Study|Withdrawal by Subject|2|||
163921636|NCT00603278|592081664|FG001|Overall Study|Withdrawal by Subject|3|||
163921637|NCT00603278|592081665|FG002|Overall Study|Withdrawal by Subject|1|||
163921638|NCT00603278|592081666|FG003|Overall Study|Withdrawal by Subject|2|||
163921639|NCT00603278|592081667|FG004|Overall Study|Withdrawal by Subject|1|||
163921640|NCT00603278|592081668|FG005|Overall Study|Withdrawal by Subject|2|||
163921641|NCT00603278|592081663|FG000|Overall Study|Protocol Violation|3|||
163921642|NCT00603278|592081664|FG001|Overall Study|Protocol Violation|0|||
163921643|NCT00603278|592081665|FG002|Overall Study|Protocol Violation|1|||
163921644|NCT00603278|592081666|FG003|Overall Study|Protocol Violation|1|||
163921645|NCT00603278|592081667|FG004|Overall Study|Protocol Violation|0|||
163921646|NCT00603278|592081668|FG005|Overall Study|Protocol Violation|1|||
163921647|NCT00603278|592081663|FG000|Overall Study|Physician Decision|0|||
163921648|NCT00603278|592081664|FG001|Overall Study|Physician Decision|1|||
163921649|NCT00603278|592081665|FG002|Overall Study|Physician Decision|0|||
163921650|NCT00603278|592081666|FG003|Overall Study|Physician Decision|0|||
163921651|NCT00603278|592081667|FG004|Overall Study|Physician Decision|2|||
163921652|NCT00603278|592081668|FG005|Overall Study|Physician Decision|1|||
163921653|NCT00603278|592081663|FG000|Overall Study|Lost to Follow-up|1|||
163921654|NCT00603278|592081664|FG001|Overall Study|Lost to Follow-up|0|||
163921655|NCT00603278|592081665|FG002|Overall Study|Lost to Follow-up|0|||
163921656|NCT00603278|592081666|FG003|Overall Study|Lost to Follow-up|0|||
163921657|NCT00603278|592081667|FG004|Overall Study|Lost to Follow-up|1|||
163921658|NCT00603278|592081668|FG005|Overall Study|Lost to Follow-up|0|||
163921659|NCT00500539|592081669|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
163921660|NCT00500539|592081669|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
163921661|NCT00500539|592081669|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
163921662|NCT00500539|592081669|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
163921663|NCT00500539|592081669|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
163921664|NCT00500539|592081669|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
163921665|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
163921666|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
163921667|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
163921668|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
163921669|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Death|1|||
163921670|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
163921671|NCT00500539|592081669|FG000|Follow-up Period (16 Weeks)|Missing|3|||
163921672|NCT04853394|592081670|FG000|Follow-up Interviews|Lost to Follow-up|22|||
163921673|NCT04853394|592081671|FG001|Follow-up Interviews|Lost to Follow-up|15|||
163921674|NCT01123642|592081674|FG000|Overall Study|Lost to Follow-up|23|||
163921675|NCT01123642|592081674|FG000|Overall Study|Withdrawal by Subject|9|||
163921676|NCT01123642|592081674|FG000|Overall Study|ineligible at baseline assessment|36|||
163921677|NCT04853238|592081675|FG000|Overall Study|Death|4|||
163921678|NCT04853238|592081676|FG001|Overall Study|Death|0|||
163921679|NCT04853238|592081677|FG002|Overall Study|Death|2|||
163921680|NCT04853238|592081675|FG000|Overall Study|Lost to Follow-up|16|||
163921681|NCT04853238|592081676|FG001|Overall Study|Lost to Follow-up|2|||
163921682|NCT04853238|592081677|FG002|Overall Study|Lost to Follow-up|37|||
163921683|NCT04853238|592081675|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
163921684|NCT04853238|592081676|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
163921685|NCT04853238|592081677|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
163921686|NCT04853238|592081675|FG000|Overall Study|Withdrawal by Subject|6|||
163921687|NCT04853238|592081676|FG001|Overall Study|Withdrawal by Subject|0|||
164032561|NCT02016898|592479527|FG000|Overall Study|Lost to Follow-up|4|||
163921688|NCT04853238|592081677|FG002|Overall Study|Withdrawal by Subject|21|||
163921689|NCT04853238|592081675|FG000|Overall Study|Physician Decision|0|||
163921690|NCT04853238|592081676|FG001|Overall Study|Physician Decision|0|||
163921691|NCT04853238|592081677|FG002|Overall Study|Physician Decision|2|||
164032562|NCT02016898|592479528|FG001|Overall Study|Lost to Follow-up|4|||
164032563|NCT03074149|592479531|FG000|Overall Study|Reason unknown|22|||
163827461|NCT02641392|591735597|FG000|Overall Study|Withdrawal by Subject|0|||
163827462|NCT02641392|591735598|FG001|Overall Study|Withdrawal by Subject|0|||
163827463|NCT02641392|591735599|FG002|Overall Study|Withdrawal by Subject|17|||
163827464|NCT02641392|591735597|FG000|Overall Study|Adverse Event|0|||
163827465|NCT02641392|591735598|FG001|Overall Study|Adverse Event|1|||
163827466|NCT02641392|591735599|FG002|Overall Study|Adverse Event|25|||
163827467|NCT02641392|591735597|FG000|Overall Study|Study Terminated by Sponsor|4|||
163827468|NCT02641392|591735598|FG001|Overall Study|Study Terminated by Sponsor|12|||
163827469|NCT02641392|591735599|FG002|Overall Study|Study Terminated by Sponsor|144|||
163827470|NCT02641392|591735597|FG000|Overall Study|Lack of Efficacy|0|||
163827471|NCT02641392|591735598|FG001|Overall Study|Lack of Efficacy|0|||
163827472|NCT02641392|591735599|FG002|Overall Study|Lack of Efficacy|101|||
163827473|NCT02641392|591735597|FG000|Overall Study|Miscellaneous|0|||
163827474|NCT02641392|591735598|FG001|Overall Study|Miscellaneous|0|||
163827475|NCT02641392|591735599|FG002|Overall Study|Miscellaneous|3|||
163827476|NCT02641392|591735597|FG000|Overall Study|Death|0|||
163827477|NCT02641392|591735598|FG001|Overall Study|Death|0|||
163827478|NCT02641392|591735599|FG002|Overall Study|Death|1|||
163827479|NCT03466086|591735600|FG000|Period 1|Sponsor decision due to study timeline|1|||
163827480|NCT03466086|591735601|FG001|Period 1|Sponsor decision due to study timeline|0|||
163827481|NCT03466086|591735600|FG000|Period 1|Withdrawal by Subject|1|||
163827482|NCT03466086|591735601|FG001|Period 1|Withdrawal by Subject|0|||
163827483|NCT01113502|591735602|FG000|Overall Study|Withdrawal by Subject|1|||
163827484|NCT01113502|591735603|FG001|Overall Study|Withdrawal by Subject|0|||
163827485|NCT01113502|591735604|FG002|Overall Study|Withdrawal by Subject|1|||
163827486|NCT01113502|591735605|FG003|Overall Study|Withdrawal by Subject|1|||
163827487|NCT01113502|591735606|FG004|Overall Study|Withdrawal by Subject|0|||
163827488|NCT01113502|591735602|FG000|Overall Study|Adverse Event|0|||
163827489|NCT01113502|591735603|FG001|Overall Study|Adverse Event|0|||
163827490|NCT01113502|591735604|FG002|Overall Study|Adverse Event|3|||
163827491|NCT01113502|591735605|FG003|Overall Study|Adverse Event|2|||
163827492|NCT01113502|591735606|FG004|Overall Study|Adverse Event|0|||
163827493|NCT03575325|591735612|FG000|Overall Study|Death|1|||
163827494|NCT03440372|591735613|FG000|Treatment|Adverse Event|16|||
163827495|NCT03440372|591735614|FG001|Treatment|Adverse Event|8|||
163827496|NCT03440372|591735613|FG000|Treatment|Lack of Efficacy|4|||
163827497|NCT03440372|591735614|FG001|Treatment|Lack of Efficacy|2|||
163827498|NCT03440372|591735613|FG000|Treatment|Withdrawal by Subject|12|||
163827499|NCT03440372|591735614|FG001|Treatment|Withdrawal by Subject|8|||
163827500|NCT03440372|591735613|FG000|Treatment|Lost to Follow-up|1|||
163827501|NCT03440372|591735614|FG001|Treatment|Lost to Follow-up|0|||
163827502|NCT03440372|591735613|FG000|Treatment|Pregnancy|1|||
163827503|NCT03440372|591735614|FG001|Treatment|Pregnancy|0|||
163827504|NCT03440372|591735613|FG000|Treatment|Study Terminated by Sponsor|2|||
163827505|NCT03440372|591735614|FG001|Treatment|Study Terminated by Sponsor|1|||
163827506|NCT03440372|591735613|FG000|Treatment|Other Reason|2|||
163827507|NCT03440372|591735614|FG001|Treatment|Other Reason|3|||
163827508|NCT05711641|591735615|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
163827509|NCT05711641|591735616|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
163827510|NCT05711641|591735615|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
163827511|NCT05711641|591735616|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
163827512|NCT03574597|591735617|FG000|Overall Study|Withdrawal by Subject|67|||
163827513|NCT03574597|591735618|FG001|Overall Study|Withdrawal by Subject|96|||
163827514|NCT03574597|591735617|FG000|Overall Study|Lost to Follow-up|192|||
163827515|NCT03574597|591735618|FG001|Overall Study|Lost to Follow-up|188|||
163827516|NCT03804710|591735619|FG000|Overall Study|Adverse Event|0|||
163827517|NCT03804710|591735620|FG001|Overall Study|Adverse Event|3|||
163827518|NCT03804710|591735619|FG000|Overall Study|Withdrawal by Subject|2|||
163827519|NCT03804710|591735620|FG001|Overall Study|Withdrawal by Subject|1|||
163827520|NCT03804710|591735619|FG000|Overall Study|Other|0|||
163827521|NCT03804710|591735620|FG001|Overall Study|Other|1|||
163827522|NCT04542018|591735621|FG000|Overall Study|Withdrawal by Subject|0|||
163827523|NCT04542018|591735622|FG001|Overall Study|Withdrawal by Subject|0|||
163827524|NCT04542018|591735623|FG002|Overall Study|Withdrawal by Subject|4|||
164032564|NCT03074149|592479532|FG001|Overall Study|Reason unknown|35|||
164032565|NCT03074149|592479531|FG000|Overall Study|Death|10|||
163827525|NCT04542018|591735621|FG000|Overall Study|Protocol Violation|0|||
163827526|NCT04542018|591735622|FG001|Overall Study|Protocol Violation|0|||
163827527|NCT04542018|591735623|FG002|Overall Study|Protocol Violation|2|||
163827528|NCT03583554|591735624|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
163827529|NCT03583554|591735625|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
163827530|NCT03583554|591735626|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
163827531|NCT03178266|591735627|FG000|Overall Study|Death|0|||
163827532|NCT03178266|591735628|FG001|Overall Study|Death|1|||
163827533|NCT03178266|591735627|FG000|Overall Study|Disont. Early|0|||
163827534|NCT03178266|591735628|FG001|Overall Study|Disont. Early|1|||
164032566|NCT03074149|592479532|FG001|Overall Study|Death|45|||
164097386|NCT00854308|592720789|FG000|Overall Study|Withdrawal by Subject|4|||
164097387|NCT00854308|592720790|FG001|Overall Study|Withdrawal by Subject|2|||
164097388|NCT00854308|592720789|FG000|Overall Study|Sponsor's decision to terminate study|0|||
164097389|NCT00854308|592720790|FG001|Overall Study|Sponsor's decision to terminate study|1|||
164097390|NCT01390844|592720791|FG000|Treatment Phase|Adverse Event|12|||
164097391|NCT01390844|592720792|FG001|Treatment Phase|Adverse Event|2|||
164097392|NCT01390844|592720793|FG002|Treatment Phase|Adverse Event|3|||
164097393|NCT01390844|592720794|FG003|Treatment Phase|Adverse Event|2|||
164097394|NCT01390844|592720791|FG000|Treatment Phase|Treatment Failure|23|||
164097395|NCT01390844|592720792|FG001|Treatment Phase|Treatment Failure|25|||
164097396|NCT01390844|592720793|FG002|Treatment Phase|Treatment Failure|10|||
164097397|NCT01390844|592720794|FG003|Treatment Phase|Treatment Failure|13|||
164097398|NCT01390844|592720791|FG000|Treatment Phase|Non-Medical Reasons|5|||
164097399|NCT01390844|592720792|FG001|Treatment Phase|Non-Medical Reasons|1|||
164097400|NCT01390844|592720793|FG002|Treatment Phase|Non-Medical Reasons|8|||
164097401|NCT01390844|592720794|FG003|Treatment Phase|Non-Medical Reasons|1|||
164097402|NCT01390844|592720791|FG000|Treatment Phase|Non-GCP Compliant|0|||
164097403|NCT01390844|592720792|FG001|Treatment Phase|Non-GCP Compliant|0|||
164097404|NCT01390844|592720793|FG002|Treatment Phase|Non-GCP Compliant|10|||
164097405|NCT01390844|592720794|FG003|Treatment Phase|Non-GCP Compliant|3|||
164097406|NCT01390844|592720791|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
164097407|NCT01390844|592720792|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
164097408|NCT01390844|592720793|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
164097409|NCT01390844|592720794|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
164097410|NCT00610363|592720795|FG000|Overall Study|Non-compliance with protocol|0|||
164097411|NCT00610363|592720796|FG001|Overall Study|Non-compliance with protocol|1|||
164097412|NCT00610363|592720795|FG000|Overall Study|Adverse Event|3|||
164097413|NCT00610363|592720796|FG001|Overall Study|Adverse Event|1|||
164097414|NCT00610363|592720795|FG000|Overall Study|Lack of Efficacy|2|||
164097415|NCT00610363|592720796|FG001|Overall Study|Lack of Efficacy|0|||
164097416|NCT00610363|592720795|FG000|Overall Study|Lost to Follow-up|4|||
164097417|NCT00610363|592720796|FG001|Overall Study|Lost to Follow-up|0|||
164097418|NCT00610363|592720795|FG000|Overall Study|Withdrawal by Subject|1|||
164097419|NCT00610363|592720796|FG001|Overall Study|Withdrawal by Subject|0|||
164097420|NCT00610363|592720795|FG000|Overall Study|Other than specified above|1|||
164097421|NCT00610363|592720796|FG001|Overall Study|Other than specified above|1|||
164097422|NCT03048500|592720799|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
164097423|NCT03048500|592720799|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
164097424|NCT03048500|592720799|FG000|Reached 1st Response/Continued Treatment|Death|1|||
164097425|NCT03048500|592720799|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
164097426|NCT03048500|592720799|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
164097427|NCT03048500|592720799|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
164097428|NCT03048500|592720799|FG000|Follow up for 3 Years|Death|12|||
164097429|NCT03361228|592720809|FG000|Overall Study|Other|1|||
164097430|NCT03361228|592720810|FG001|Overall Study|Other|1|||
164097431|NCT03361228|592720809|FG000|Overall Study|Death|3|||
164097432|NCT03361228|592720810|FG001|Overall Study|Death|0|||
164097433|NCT01479439|592720811|FG000|Overall Study|Adverse Event|1|||
164097434|NCT01479439|592720812|FG001|Overall Study|Adverse Event|0|||
164097435|NCT01479439|592720813|FG002|Overall Study|Adverse Event|0|||
164097436|NCT01479439|592720811|FG000|Overall Study|Lost to Follow-up|0|||
164097437|NCT01479439|592720812|FG001|Overall Study|Lost to Follow-up|1|||
164097438|NCT01479439|592720813|FG002|Overall Study|Lost to Follow-up|0|||
164097439|NCT01479439|592720811|FG000|Overall Study|Protocol Violation|0|||
164097440|NCT01479439|592720812|FG001|Overall Study|Protocol Violation|0|||
164097441|NCT01479439|592720813|FG002|Overall Study|Protocol Violation|2|||
164097442|NCT01722877|592720820|FG000|Overall Study|Death|1|||
164097443|NCT01722877|592720820|FG000|Overall Study|Lost to Follow-up|1|||
164097444|NCT03693430|592720821|FG000|Overall Study|Lost to Follow-up|3|||
164097445|NCT03693430|592720822|FG001|Overall Study|Lost to Follow-up|14|||
164097446|NCT03693430|592720821|FG000|Overall Study|Death|1|||
164097447|NCT03693430|592720822|FG001|Overall Study|Death|0|||
163827535|NCT03178266|591735627|FG000|Overall Study|Withdrawal by Subject|0|||
163827536|NCT03178266|591735628|FG001|Overall Study|Withdrawal by Subject|2|||
163827537|NCT01596582|591735640|FG000|Overall Study|Deemed ineligible after study visit|3|||
163827538|NCT01596582|591735641|FG001|Overall Study|Deemed ineligible after study visit|6|||
163827539|NCT01596582|591735640|FG000|Overall Study|Missing all outcome data|1|||
163827540|NCT01596582|591735641|FG001|Overall Study|Missing all outcome data|1|||
163827541|NCT02012491|591735646|FG000|Overall Study|Lost to Follow-up|1|||
163827542|NCT02012491|591735647|FG001|Overall Study|Lost to Follow-up|0|||
163827543|NCT02012491|591735646|FG000|Overall Study|Protocol Violation|0|||
163827544|NCT02012491|591735647|FG001|Overall Study|Protocol Violation|1|||
163827545|NCT02012491|591735646|FG000|Overall Study|Withdrawal by Subject|1|||
163827546|NCT02012491|591735647|FG001|Overall Study|Withdrawal by Subject|0|||
163827547|NCT01667432|591735648|FG000|Overall Study|Premature Study Termination|26|||
163827548|NCT01667432|591735648|FG000|Overall Study|Failure to Return|10|||
164097448|NCT03693430|592720821|FG000|Overall Study|Withdrawal by Subject|0|||
163921692|NCT04853238|592081675|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
163921693|NCT04853238|592081676|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
163921694|NCT04853238|592081677|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
163921695|NCT00632931|592083623|FG000|Part 1, Period 1|Protocol Violation|1|||
163921696|NCT00632931|592083624|FG001|Part 1, Period 1|Protocol Violation|0|||
163921697|NCT00632931|592083625|FG002|Part 1, Period 1|Protocol Violation|0|||
163921698|NCT00632931|592083623|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
163921699|NCT00632931|592083624|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
163921700|NCT00632931|592083625|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
163921701|NCT00632931|592083623|FG000|Part 2|Adverse Event|0|||
164032567|NCT02855450|592479533|FG000|Overall Study|Adverse Event|1|||
164032568|NCT02855450|592479534|FG001|Overall Study|Adverse Event|0|||
164032569|NCT02855450|592479533|FG000|Overall Study|Lost to Follow-up|4|||
164032570|NCT02855450|592479534|FG001|Overall Study|Lost to Follow-up|0|||
164032571|NCT01803711|592479535|FG000|Overall Study|Adverse Event|1|||
164032572|NCT01803711|592479536|FG001|Overall Study|Adverse Event|1|||
163921702|NCT00632931|592083624|FG001|Part 2|Adverse Event|0|||
163921703|NCT00632931|592083625|FG002|Part 2|Adverse Event|3|||
163921704|NCT00632931|592083623|FG000|Part 2|Death|0|||
163921705|NCT00632931|592083624|FG001|Part 2|Death|0|||
163921706|NCT00632931|592083625|FG002|Part 2|Death|1|||
163921707|NCT00632931|592083623|FG000|Part 2|Lack of Efficacy|0|||
163921708|NCT00632931|592083624|FG001|Part 2|Lack of Efficacy|0|||
163921709|NCT00632931|592083625|FG002|Part 2|Lack of Efficacy|17|||
163921710|NCT00632931|592083623|FG000|Part 2|Withdrawal by Subject|0|||
163921711|NCT00632931|592083624|FG001|Part 2|Withdrawal by Subject|0|||
163921712|NCT00632931|592083625|FG002|Part 2|Withdrawal by Subject|3|||
163921713|NCT02499835|592083631|FG000|Overall Study|Withdrawal by Subject|1|||
163921714|NCT02499835|592083632|FG001|Overall Study|Withdrawal by Subject|0|||
163921715|NCT02499835|592083633|FG002|Overall Study|Withdrawal by Subject|0|||
163921716|NCT02499835|592083634|FG003|Overall Study|Withdrawal by Subject|1|||
163921717|NCT02499835|592083631|FG000|Overall Study|Physician Decision|0|||
163921718|NCT02499835|592083632|FG001|Overall Study|Physician Decision|3|||
163921719|NCT02499835|592083633|FG002|Overall Study|Physician Decision|18|||
163921720|NCT02499835|592083634|FG003|Overall Study|Physician Decision|7|||
163921721|NCT02499835|592083631|FG000|Overall Study|Adverse Event|0|||
163921722|NCT02499835|592083632|FG001|Overall Study|Adverse Event|0|||
163921723|NCT02499835|592083633|FG002|Overall Study|Adverse Event|0|||
163921724|NCT02499835|592083634|FG003|Overall Study|Adverse Event|1|||
163921725|NCT02499835|592083631|FG000|Overall Study|Disease progression|2|||
163921726|NCT02499835|592083632|FG001|Overall Study|Disease progression|1|||
163921727|NCT02499835|592083633|FG002|Overall Study|Disease progression|0|||
163921728|NCT02499835|592083634|FG003|Overall Study|Disease progression|7|||
163921729|NCT03319719|592083642|FG000|Overall Study|Lost to Follow-up|1|||
163921730|NCT03193216|592083643|FG000|Overall Study|Lost to Follow-up|1|||
163921731|NCT03193216|592083644|FG001|Overall Study|Lost to Follow-up|0|||
163921732|NCT03193216|592083643|FG000|Overall Study|Withdrawal by Subject|5|||
163921733|NCT03193216|592083644|FG001|Overall Study|Withdrawal by Subject|0|||
163921734|NCT03193216|592083643|FG000|Overall Study|Physician Decision|4|||
163921735|NCT03193216|592083644|FG001|Overall Study|Physician Decision|0|||
164032573|NCT01376245|592479541|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
164032574|NCT01376245|592479542|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164032575|NCT01376245|592479543|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164032576|NCT01376245|592479544|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164032577|NCT01376245|592479545|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
164032578|NCT01376245|592479541|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
164032579|NCT01376245|592479542|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164032580|NCT01376245|592479543|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164032581|NCT01376245|592479544|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164032582|NCT01376245|592479545|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
164097449|NCT03693430|592720822|FG001|Overall Study|Withdrawal by Subject|4|||
164032583|NCT01376245|592479541|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
164097450|NCT02079766|592720823|FG000|Overall Study|Physician Decision|1|||
163921736|NCT02490878|592083645|FG000|Overall Study|deemed ineligible|0|||
163921737|NCT02490878|592083646|FG001|Overall Study|deemed ineligible|1|||
163921738|NCT02490878|592083645|FG000|Overall Study|progression prior to treatment|0|||
163921739|NCT02490878|592083646|FG001|Overall Study|progression prior to treatment|1|||
163921740|NCT02490878|592083645|FG000|Overall Study|only submitted baseline QOL|0|||
164032584|NCT01376245|592479542|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164032585|NCT01376245|592479543|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
163921741|NCT02490878|592083646|FG001|Overall Study|only submitted baseline QOL|1|||
163921742|NCT00922441|592083647|FG000|Overall Study|Protocol Violation|0|||
163921743|NCT00922441|592083648|FG001|Overall Study|Protocol Violation|0|||
163921744|NCT00922441|592083649|FG002|Overall Study|Protocol Violation|2|||
163921745|NCT00922441|592083647|FG000|Overall Study|Withdrawal by Subject|0|||
163827549|NCT01667432|591735648|FG000|Overall Study|Moved to Another Center|3|||
163827550|NCT01667432|591735648|FG000|Overall Study|Lost to Follow-up|3|||
163827551|NCT01667432|591735648|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
163827552|NCT01667432|591735648|FG000|Overall Study|Insufficient Therapeutic Response|4|||
163827553|NCT01667432|591735648|FG000|Overall Study|Adverse Event|1|||
163827554|NCT01667432|591735648|FG000|Overall Study|Protocol Deviation|2|||
163827555|NCT01667432|591735648|FG000|Overall Study|Principal Investigator Decision|1|||
163827556|NCT01667432|591735648|FG000|Overall Study|Reason Not Specified|2|||
163827557|NCT01667432|591735648|FG000|Overall Study|Missing Information|4|||
163827558|NCT00553696|591735651|FG000|Overall Study|Adverse Event|2|||
163827559|NCT00553696|591735652|FG001|Overall Study|Adverse Event|4|||
163827560|NCT00553696|591735653|FG002|Overall Study|Adverse Event|0|||
163827561|NCT00553696|591735654|FG003|Overall Study|Adverse Event|1|||
163827562|NCT00553696|591735651|FG000|Overall Study|Global deterioration of health status|0|||
163827563|NCT00553696|591735652|FG001|Overall Study|Global deterioration of health status|2|||
163827564|NCT00553696|591735653|FG002|Overall Study|Global deterioration of health status|0|||
163827565|NCT00553696|591735654|FG003|Overall Study|Global deterioration of health status|0|||
163827566|NCT00553696|591735651|FG000|Overall Study|Objective progression or relapse|2|||
163827567|NCT00553696|591735652|FG001|Overall Study|Objective progression or relapse|9|||
163827568|NCT00553696|591735653|FG002|Overall Study|Objective progression or relapse|6|||
163827569|NCT00553696|591735654|FG003|Overall Study|Objective progression or relapse|0|||
163827570|NCT00553696|591735651|FG000|Overall Study|Withdrawal by Subject|0|||
163827571|NCT00553696|591735652|FG001|Overall Study|Withdrawal by Subject|1|||
163827572|NCT00553696|591735653|FG002|Overall Study|Withdrawal by Subject|0|||
163827573|NCT00553696|591735654|FG003|Overall Study|Withdrawal by Subject|0|||
163827574|NCT00686881|591735659|FG000|Overall Study|Withdrawal by Subject|11|||
163827575|NCT00686881|591735660|FG001|Overall Study|Withdrawal by Subject|18|||
163827576|NCT00686881|591735659|FG000|Overall Study|Lost to Follow-up|0|||
163827577|NCT00686881|591735660|FG001|Overall Study|Lost to Follow-up|1|||
163827578|NCT00686881|591735659|FG000|Overall Study|Treatment-related adverse event|10|||
163827579|NCT00686881|591735660|FG001|Overall Study|Treatment-related adverse event|9|||
163827580|NCT00686881|591735659|FG000|Overall Study|Met discontinuation criteria|5|||
163827581|NCT00686881|591735660|FG001|Overall Study|Met discontinuation criteria|0|||
163827582|NCT00686881|591735659|FG000|Overall Study|Onset of malignant tumor|11|||
163827583|NCT00686881|591735660|FG001|Overall Study|Onset of malignant tumor|11|||
163827584|NCT00686881|591735659|FG000|Overall Study|Lack of Efficacy|4|||
163827585|NCT00686881|591735660|FG001|Overall Study|Lack of Efficacy|3|||
163827586|NCT00686881|591735659|FG000|Overall Study|Physician Decision|1|||
163827587|NCT00686881|591735660|FG001|Overall Study|Physician Decision|0|||
163827588|NCT00686881|591735659|FG000|Overall Study|Circumstances of site|1|||
163827589|NCT00686881|591735660|FG001|Overall Study|Circumstances of site|1|||
163827590|NCT00686881|591735659|FG000|Overall Study|Did not meet protocol eligibility|1|||
163827591|NCT00686881|591735660|FG001|Overall Study|Did not meet protocol eligibility|0|||
163827592|NCT00686881|591735659|FG000|Overall Study|Irregular visits|1|||
163827593|NCT00686881|591735660|FG001|Overall Study|Irregular visits|0|||
163827594|NCT00686881|591735659|FG000|Overall Study|Study discontinuation|35|||
163827595|NCT00686881|591735660|FG001|Overall Study|Study discontinuation|32|||
163827596|NCT00686881|591735659|FG000|Overall Study|Never received study drug|2|||
163827597|NCT00686881|591735660|FG001|Overall Study|Never received study drug|6|||
163827598|NCT00671931|591735661|FG000|Overall Study|Physician Decision|1|||
163827599|NCT00671931|591735662|FG001|Overall Study|Physician Decision|0|||
163827600|NCT00671931|591735663|FG002|Overall Study|Physician Decision|0|||
163827601|NCT00671931|591735664|FG003|Overall Study|Physician Decision|2|||
163827602|NCT00671931|591735665|FG004|Overall Study|Physician Decision|1|||
163827603|NCT01298999|591735666|FG000|Overall Study|Physician Decision|0|||
163827604|NCT01298999|591735667|FG001|Overall Study|Physician Decision|1|||
163827605|NCT01298999|591735666|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
163827606|NCT01298999|591735667|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
163827607|NCT02816138|591735668|FG000|Overall Study|Adverse Event|1|||
163827608|NCT00818753|591735669|FG000|Overall Study|Protocol Violation|1|||
163827609|NCT00818753|591735670|FG001|Overall Study|Protocol Violation|0|||
163827610|NCT00818753|591735671|FG002|Overall Study|Protocol Violation|0|||
163921746|NCT00922441|592083648|FG001|Overall Study|Withdrawal by Subject|0|||
163921747|NCT00922441|592083649|FG002|Overall Study|Withdrawal by Subject|1|||
163827611|NCT00818753|591735669|FG000|Overall Study|Other reason (not specified)|0|||
163827612|NCT00818753|591735670|FG001|Overall Study|Other reason (not specified)|0|||
163827613|NCT00818753|591735671|FG002|Overall Study|Other reason (not specified)|1|||
163827614|NCT00818753|591735669|FG000|Overall Study|Randomised and not treated|2|||
163827615|NCT00818753|591735670|FG001|Overall Study|Randomised and not treated|0|||
163921748|NCT00317603|592083650|FG000|Overall Study|Progressive Disease|3|||
163921749|NCT00523549|592083653|FG000|Overall Study|Adverse Event|6|||
163921750|NCT00523549|592083654|FG001|Overall Study|Adverse Event|3|||
163921751|NCT00523549|592083653|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163921752|NCT00523549|592083654|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163921753|NCT00523549|592083653|FG000|Overall Study|Protocol Deviation|3|||
163921754|NCT00523549|592083654|FG001|Overall Study|Protocol Deviation|1|||
163921755|NCT00523549|592083653|FG000|Overall Study|Patient withdrew consent|7|||
163921756|NCT00523549|592083654|FG001|Overall Study|Patient withdrew consent|6|||
163921757|NCT00523549|592083653|FG000|Overall Study|Lost to Follow-up|3|||
163921758|NCT00523549|592083654|FG001|Overall Study|Lost to Follow-up|5|||
163921759|NCT00439647|592083655|FG000|Overall Study|Withdrawal by Subject|25|||
163921760|NCT00439647|592083656|FG001|Overall Study|Withdrawal by Subject|22|||
163921761|NCT00439647|592083655|FG000|Overall Study|Death|15|||
163921762|NCT00439647|592083656|FG001|Overall Study|Death|18|||
163921763|NCT00439647|592083655|FG000|Overall Study|Adverse Event|11|||
163921764|NCT00439647|592083656|FG001|Overall Study|Adverse Event|11|||
163921765|NCT00439647|592083655|FG000|Overall Study|Lost to Follow-up|4|||
163921766|NCT00439647|592083656|FG001|Overall Study|Lost to Follow-up|12|||
163921767|NCT00439647|592083655|FG000|Overall Study|Protocol Violation|3|||
163921768|NCT00439647|592083656|FG001|Overall Study|Protocol Violation|4|||
163921769|NCT00439647|592083655|FG000|Overall Study|Lack of Efficacy|0|||
163921770|NCT00439647|592083656|FG001|Overall Study|Lack of Efficacy|4|||
163921771|NCT02005029|592083657|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
163921772|NCT02005029|592083658|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
163921773|NCT02621047|592083659|FG000|Overall Study|Adverse Event|0|||
163921774|NCT02621047|592083660|FG001|Overall Study|Adverse Event|0|||
163921775|NCT02621047|592083661|FG002|Overall Study|Adverse Event|1|||
163921776|NCT03371485|592083662|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
163921777|NCT03371485|592083662|FG000|2-year Follow-up|Death|5|||
163921778|NCT01264887|592083663|FG000|Overall Study|Adverse Event|5|||
163921779|NCT01264887|592083663|FG000|Overall Study|Death|7|||
163921780|NCT01264887|592083663|FG000|Overall Study|Lack of Efficacy|5|||
163921781|NCT01264887|592083663|FG000|Overall Study|Physician Decision|4|||
163921782|NCT01264887|592083663|FG000|Overall Study|Withdrawal by Subject|6|||
163921783|NCT01264887|592083663|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
163921784|NCT01264887|592083663|FG000|Overall Study|Other|2|||
163921785|NCT02853305|592083669|FG000|Overall Study|Death|287|||
163921786|NCT02853305|592083670|FG001|Overall Study|Death|249|||
163921787|NCT02853305|592083671|FG002|Overall Study|Death|300|||
163921788|NCT02853305|592083669|FG000|Overall Study|Withdrawal by Subject|2|||
163921789|NCT02853305|592083670|FG001|Overall Study|Withdrawal by Subject|8|||
163921790|NCT02853305|592083671|FG002|Overall Study|Withdrawal by Subject|3|||
163921791|NCT02853305|592083669|FG000|Overall Study|Transferred to Extension Study|46|||
163921792|NCT02853305|592083670|FG001|Overall Study|Transferred to Extension Study|30|||
163921793|NCT02853305|592083671|FG002|Overall Study|Transferred to Extension Study|25|||
163921794|NCT02853305|592083669|FG000|Overall Study|Did Not Continue on Extension Study|16|||
163921795|NCT02853305|592083670|FG001|Overall Study|Did Not Continue on Extension Study|20|||
163921796|NCT02853305|592083671|FG002|Overall Study|Did Not Continue on Extension Study|24|||
163921797|NCT00677092|592083674|FG000|Overall Study|Adverse Event|1|||
163921798|NCT00677092|592083674|FG000|Overall Study|Lost to Follow-up|1|||
163921799|NCT00677092|592083674|FG000|Overall Study|Withdrawal by Subject|3|||
163921800|NCT00677092|592083674|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
163921801|NCT02381652|592083677|FG000|Overall Study|Withdrawal by Subject|0|||
163921802|NCT02381652|592083678|FG001|Overall Study|Withdrawal by Subject|0|||
163921803|NCT02381652|592083679|FG002|Overall Study|Withdrawal by Subject|1|||
163921804|NCT04772313|592083680|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
163921805|NCT04772313|592083680|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
163921806|NCT01836198|592083681|FG000|Part A, Period 2|Protocol Violation|0|||
163921807|NCT01836198|592083682|FG001|Part A, Period 2|Protocol Violation|1|||
163921808|NCT01836198|592083683|FG002|Part A, Period 2|Protocol Violation|0|||
163921809|NCT03187353|592083684|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
163921810|NCT03187353|592083685|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
163921811|NCT03187353|592083684|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
163921812|NCT03187353|592083685|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
163921813|NCT03187353|592083684|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
163921814|NCT03187353|592083685|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
163921815|NCT03187353|592083684|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
163921816|NCT03187353|592083685|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
163921817|NCT03187353|592083684|FG000|Washout (2 Weeks)|Adverse Event|2|||
163921818|NCT03187353|592083685|FG001|Washout (2 Weeks)|Adverse Event|0|||
163921819|NCT03187353|592083684|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
163921820|NCT03187353|592083685|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
163921821|NCT02215954|592083686|FG000|Overall Study|Adverse Event|0|||
163921822|NCT02215954|592083687|FG001|Overall Study|Adverse Event|0|||
163921823|NCT02215954|592083688|FG002|Overall Study|Adverse Event|1|||
163921824|NCT02215954|592083686|FG000|Overall Study|Withdrawal by Subject|0|||
163921825|NCT02215954|592083687|FG001|Overall Study|Withdrawal by Subject|0|||
163921826|NCT02215954|592083688|FG002|Overall Study|Withdrawal by Subject|2|||
163921827|NCT02215954|592083686|FG000|Overall Study|Not exposed|1|||
163921828|NCT02215954|592083687|FG001|Overall Study|Not exposed|1|||
164097451|NCT02079766|592720824|FG001|Overall Study|Physician Decision|0|||
163827616|NCT00818753|591735671|FG002|Overall Study|Randomised and not treated|0|||
163827617|NCT00902694|591735672|FG000|Overall Study|Death|1|||
163827618|NCT00902694|591735673|FG001|Overall Study|Death|3|||
163827619|NCT00902694|591735672|FG000|Overall Study|Lost to Follow-up|1|||
163827620|NCT00902694|591735673|FG001|Overall Study|Lost to Follow-up|0|||
163827621|NCT00902694|591735672|FG000|Overall Study|Censored per protocol|3|||
163827622|NCT00902694|591735673|FG001|Overall Study|Censored per protocol|1|||
163827623|NCT00902694|591735672|FG000|Overall Study|Pregnancy|1|||
163827624|NCT00902694|591735673|FG001|Overall Study|Pregnancy|1|||
163827625|NCT00902694|591735672|FG000|Overall Study|Incarceration|1|||
163827626|NCT00902694|591735673|FG001|Overall Study|Incarceration|0|||
163827627|NCT04154787|591735674|FG000|Overall Study|Adverse Event|0|||
163827628|NCT04154787|591735675|FG001|Overall Study|Adverse Event|1|||
163827629|NCT04154787|591735676|FG002|Overall Study|Adverse Event|0|||
163827630|NCT04154787|591735674|FG000|Overall Study|Patient Requires Other Treatment|0|||
163827631|NCT04154787|591735675|FG001|Overall Study|Patient Requires Other Treatment|1|||
163827632|NCT04154787|591735676|FG002|Overall Study|Patient Requires Other Treatment|0|||
163827633|NCT04154787|591735674|FG000|Overall Study|Study Terminated By Sponsor|0|||
163827634|NCT04154787|591735675|FG001|Overall Study|Study Terminated By Sponsor|6|||
163827635|NCT04154787|591735676|FG002|Overall Study|Study Terminated By Sponsor|1|||
163827636|NCT04154787|591735674|FG000|Overall Study|Subject Decision|0|||
163827637|NCT04154787|591735675|FG001|Overall Study|Subject Decision|1|||
163827638|NCT04154787|591735676|FG002|Overall Study|Subject Decision|0|||
163827639|NCT04154787|591735674|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
163827640|NCT04154787|591735675|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
163827641|NCT04154787|591735676|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
163827642|NCT02532179|591737399|FG000|Overall Study|Lost to Follow-up|1|||
163827643|NCT02532179|591737399|FG000|Overall Study|Pregnancy|1|||
163827644|NCT02532179|591737399|FG000|Overall Study|Subject received depot steroid injection|1|||
163827645|NCT00989092|591737400|FG000|Overall Study|Physician Decision|9|||
163827646|NCT00989092|591737401|FG001|Overall Study|Physician Decision|6|||
163827647|NCT00989092|591737400|FG000|Overall Study|Adverse Event|20|||
163827648|NCT00989092|591737401|FG001|Overall Study|Adverse Event|1|||
163827649|NCT00989092|591737400|FG000|Overall Study|Chemotherapy initiated|12|||
163827650|NCT00989092|591737401|FG001|Overall Study|Chemotherapy initiated|4|||
163827651|NCT00989092|591737400|FG000|Overall Study|Withdrawal by Subject|17|||
163827652|NCT00989092|591737401|FG001|Overall Study|Withdrawal by Subject|9|||
163827653|NCT00989092|591737400|FG000|Overall Study|Death|14|||
163827654|NCT00989092|591737401|FG001|Overall Study|Death|2|||
163827655|NCT00989092|591737400|FG000|Overall Study|Ineligibility determined|3|||
163827656|NCT00989092|591737401|FG001|Overall Study|Ineligibility determined|3|||
163827657|NCT00989092|591737400|FG000|Overall Study|Lost to Follow-up|6|||
163921829|NCT02215954|592083688|FG002|Overall Study|Not exposed|3|||
163827658|NCT00989092|591737401|FG001|Overall Study|Lost to Follow-up|2|||
163827659|NCT00989092|591737400|FG000|Overall Study|Other|3|||
163827660|NCT00989092|591737401|FG001|Overall Study|Other|1|||
163827661|NCT00989092|591737400|FG000|Overall Study|Protocol deviation|2|||
163827662|NCT00989092|591737401|FG001|Overall Study|Protocol deviation|0|||
163827663|NCT00989092|591737400|FG000|Overall Study|Erythropoietin therapy initiated|2|||
163827664|NCT00989092|591737401|FG001|Overall Study|Erythropoietin therapy initiated|0|||
163827665|NCT00989092|591737400|FG000|Overall Study|Did not receive study drug|2|||
163827666|NCT00989092|591737401|FG001|Overall Study|Did not receive study drug|0|||
163827667|NCT03837509|591737406|FG000|Phase 1|Death|5|||
163827668|NCT03837509|591737407|FG001|Phase 1|Death|2|||
163827669|NCT03837509|591737408|FG002|Phase 1|Death|0|||
163827670|NCT03837509|591737409|FG003|Phase 1|Death|0|||
163827671|NCT03837509|591737410|FG004|Phase 1|Death|0|||
163827672|NCT03837509|591737406|FG000|Phase 2|Death|0|||
163827673|NCT03837509|591737407|FG001|Phase 2|Death|0|||
163827674|NCT03837509|591737408|FG002|Phase 2|Death|0|||
163827675|NCT03837509|591737409|FG003|Phase 2|Death|1|||
163827676|NCT03837509|591737410|FG004|Phase 2|Death|1|||
163827677|NCT03320018|591737417|FG000|Treatment Period|Withdrawal by Subject|1|||
163921830|NCT00139659|592083689|FG000|Overall Study|Adverse Event|12|||
163921831|NCT00139659|592083690|FG001|Overall Study|Adverse Event|1|||
163921832|NCT00139659|592083689|FG000|Overall Study|Lack of Efficacy|1|||
163921833|NCT00139659|592083690|FG001|Overall Study|Lack of Efficacy|1|||
163921834|NCT00139659|592083689|FG000|Overall Study|Lost to Follow-up|7|||
163921835|NCT00139659|592083690|FG001|Overall Study|Lost to Follow-up|3|||
163921836|NCT00139659|592083689|FG000|Overall Study|Reason not Specified|6|||
163921837|NCT00139659|592083690|FG001|Overall Study|Reason not Specified|3|||
163921838|NCT00139659|592083689|FG000|Overall Study|Withdrawal by Subject|14|||
163921839|NCT00139659|592083690|FG001|Overall Study|Withdrawal by Subject|10|||
163921840|NCT02625922|592083696|FG000|Overall Study|Non-availability of IMP|1|||
163921841|NCT02625922|592083697|FG001|Overall Study|Non-availability of IMP|1|||
163921842|NCT02625922|592083696|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
163921843|NCT02625922|592083697|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
163921844|NCT00640042|592083698|FG000|Enrollment|Did not receive study drug|83|||
163921845|NCT02359552|592083699|FG000|Overall Study|Lost to Follow-up|3|||
163921846|NCT02359552|592083700|FG001|Overall Study|Lost to Follow-up|4|||
163921847|NCT02391116|592083713|FG000|Treatment|Withdrawal by Subject|1|||
163921848|NCT02391116|592083713|FG000|Treatment|Protocol Violation|1|||
163921849|NCT02391116|592083713|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
163921850|NCT02391116|592083713|FG000|Treatment|AE with Clinical PD|3|||
163921851|NCT02391116|592083713|FG000|Safety Follow-up|Adverse Event|1|||
163921852|NCT02391116|592083713|FG000|Safety Follow-up|Withdrawal by Subject|4|||
163921853|NCT02391116|592083713|FG000|Safety Follow-up|Switching to Other Therapy|4|||
163921854|NCT02391116|592083713|FG000|Safety Follow-up|No Follow Up|1|||
163921855|NCT02391116|592083713|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
163921856|NCT02391116|592083713|FG000|Active Follow-up|Withdrawal by Subject|1|||
163921857|NCT02391116|592083713|FG000|Active Follow-up|Switching to Other Therapy|2|||
163921858|NCT02391116|592083713|FG000|Survival Follow-up|Withdrawal by Subject|3|||
163921859|NCT02391116|592083713|FG000|Survival Follow-up|Switching to Other Therapy|1|||
163921860|NCT02109107|592083714|FG000|Overall Study|Lost to Follow-up|2|||
163921861|NCT01747629|592083716|FG000|Overall Study|Adverse Event|1|||
163921862|NCT01747629|592083717|FG001|Overall Study|Adverse Event|2|||
163921863|NCT01747629|592083716|FG000|Overall Study|Withdrawal by Subject|2|||
163921864|NCT01747629|592083717|FG001|Overall Study|Withdrawal by Subject|2|||
163921865|NCT01747629|592083716|FG000|Overall Study|Noncompliance|1|||
163921866|NCT01747629|592083717|FG001|Overall Study|Noncompliance|1|||
163921867|NCT01747629|592083716|FG000|Overall Study|Inclusion criteria not met|1|||
163921868|NCT01747629|592083717|FG001|Overall Study|Inclusion criteria not met|0|||
163921869|NCT01747629|592083716|FG000|Overall Study|Not treated|1|||
163921870|NCT01747629|592083717|FG001|Overall Study|Not treated|0|||
163921871|NCT01747629|592083716|FG000|Overall Study|Other|2|||
163921872|NCT01747629|592083717|FG001|Overall Study|Other|1|||
163921873|NCT00607789|592083718|FG000|Overall Study|Adverse Event|3|||
163921874|NCT00607789|592083719|FG001|Overall Study|Adverse Event|0|||
163921875|NCT00607789|592083718|FG000|Overall Study|Lack of Efficacy|0|||
163921876|NCT00607789|592083719|FG001|Overall Study|Lack of Efficacy|1|||
163921877|NCT00607789|592083718|FG000|Overall Study|Inadequate adherence|3|||
163921878|NCT00607789|592083719|FG001|Overall Study|Inadequate adherence|0|||
163921879|NCT00607789|592083718|FG000|Overall Study|Lost to Follow-up|0|||
163921880|NCT00607789|592083719|FG001|Overall Study|Lost to Follow-up|5|||
163921881|NCT00607789|592083718|FG000|Overall Study|Withdrawal by Subject|1|||
163921882|NCT00607789|592083719|FG001|Overall Study|Withdrawal by Subject|0|||
163921883|NCT06016127|592083720|FG000|Overall Study|Withdrawal by Subject|4|||
163921884|NCT06016127|592083721|FG001|Overall Study|Withdrawal by Subject|3|||
163921885|NCT03340766|592083722|FG000|Overall Study|Withdrawal by Subject|2|||
163921886|NCT03340766|592083723|FG001|Overall Study|Withdrawal by Subject|1|||
163921887|NCT03340766|592083724|FG002|Overall Study|Withdrawal by Subject|3|||
163921888|NCT03340766|592083722|FG000|Overall Study|Lost to Follow-up|0|||
163921889|NCT03340766|592083723|FG001|Overall Study|Lost to Follow-up|0|||
163921890|NCT03340766|592083724|FG002|Overall Study|Lost to Follow-up|1|||
163921891|NCT03340766|592083722|FG000|Overall Study|Death|6|||
163921892|NCT03340766|592083723|FG001|Overall Study|Death|7|||
163921893|NCT03340766|592083724|FG002|Overall Study|Death|4|||
163921894|NCT00240097|592083725|FG000|Part I|Adverse Event|1|||
163921895|NCT00240097|592083725|FG000|Part I|Death|1|||
163921896|NCT00240097|592083725|FG000|Part I|histology|1|||
163921897|NCT00240097|592083725|FG000|Part I|unevaluable|1|||
163921898|NCT00240097|592083725|FG000|Part II|did not continue from Part I|23|||
163921899|NCT01294358|592083726|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163921900|NCT01294358|592083727|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
163921901|NCT01294358|592083728|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163921902|NCT01294358|592083729|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163921903|NCT01294358|592083730|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
163921904|NCT01294358|592083726|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
163921905|NCT01294358|592083727|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
163921906|NCT01294358|592083728|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
163921907|NCT01294358|592083729|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
164032586|NCT01376245|592479544|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164032587|NCT01376245|592479545|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
164032588|NCT01376245|592479541|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
164032589|NCT01376245|592479542|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164032590|NCT01376245|592479543|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164032591|NCT01376245|592479544|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164032592|NCT01376245|592479545|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
164032593|NCT01376245|592479541|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
164032594|NCT01376245|592479542|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164032595|NCT01376245|592479543|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164032596|NCT01376245|592479544|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164097452|NCT02079766|592720823|FG000|Overall Study|Withdrawal by Subject|1|||
163921908|NCT01294358|592083730|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
164097453|NCT02079766|592720824|FG001|Overall Study|Withdrawal by Subject|0|||
164097454|NCT02930005|592720826|FG000|Overall Study|Lost to Follow-up|1|||
164097455|NCT02930005|592720827|FG001|Overall Study|Lost to Follow-up|5|||
164097456|NCT00585689|592720828|FG000|Overall Study|Received different ABI-007 schedule|3|||
164097457|NCT00585689|592720828|FG000|Overall Study|Adverse Event|1|||
164097458|NCT00585689|592720828|FG000|Overall Study|Patient Declined Surgery|1|||
164097459|NCT00585689|592720828|FG000|Overall Study|Patient had unresectable disease|1|||
164097460|NCT00585689|592720828|FG000|Overall Study|Death|1|||
164097461|NCT02373098|592720829|FG000|Overall Study|Lost to Follow-up|1|||
164097462|NCT02373098|592720830|FG001|Overall Study|Lost to Follow-up|0|||
164097463|NCT02373098|592720829|FG000|Overall Study|Protocol Violation|3|||
164097464|NCT02373098|592720830|FG001|Overall Study|Protocol Violation|0|||
164097465|NCT02373098|592720829|FG000|Overall Study|Withdrawal by Subject|5|||
163921909|NCT01294358|592083726|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163921910|NCT01294358|592083727|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163921911|NCT01294358|592083728|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163921912|NCT01294358|592083729|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
163921913|NCT01294358|592083730|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
163921914|NCT01294358|592083726|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163921915|NCT01294358|592083727|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163921916|NCT01294358|592083728|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163921917|NCT01294358|592083729|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
163921918|NCT01294358|592083730|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
163921919|NCT03613454|592083731|FG000|Overall Study|Protocol Violation|1|||
163921920|NCT03613454|592083732|FG001|Overall Study|Protocol Violation|0|||
163921921|NCT03613454|592083731|FG000|Overall Study|Protocol Violation|0|||
163921922|NCT03613454|592083732|FG001|Overall Study|Protocol Violation|1|||
163921923|NCT02963922|592083733|FG000|Overall Study|Adverse Event|15|||
163921924|NCT02963922|592083734|FG001|Overall Study|Adverse Event|6|||
163921925|NCT02963922|592083733|FG000|Overall Study|Protocol deviation|6|||
163921926|NCT02963922|592083734|FG001|Overall Study|Protocol deviation|6|||
163921927|NCT02963922|592083733|FG000|Overall Study|Lack of Efficacy|1|||
163921928|NCT02963922|592083734|FG001|Overall Study|Lack of Efficacy|1|||
163921929|NCT02963922|592083733|FG000|Overall Study|Lost to Follow-up|2|||
163921930|NCT02963922|592083734|FG001|Overall Study|Lost to Follow-up|3|||
163921931|NCT02963922|592083733|FG000|Overall Study|Other|8|||
163921932|NCT02963922|592083734|FG001|Overall Study|Other|14|||
163921933|NCT03873038|592083743|FG000|Part 2|Withdrawal by Subject|0|||
163921934|NCT03873038|592083744|FG001|Part 2|Withdrawal by Subject|0|||
163921935|NCT03873038|592083745|FG002|Part 2|Withdrawal by Subject|0|||
163921936|NCT03873038|592083746|FG003|Part 2|Withdrawal by Subject|0|||
163921937|NCT03873038|592083747|FG004|Part 2|Withdrawal by Subject|0|||
163921938|NCT03873038|592083748|FG005|Part 2|Withdrawal by Subject|1|||
163921939|NCT03873038|592083743|FG000|Part 2|Unknon|0|||
163921940|NCT03873038|592083744|FG001|Part 2|Unknon|0|||
163921941|NCT03873038|592083745|FG002|Part 2|Unknon|0|||
163921942|NCT03873038|592083746|FG003|Part 2|Unknon|0|||
163921943|NCT03873038|592083747|FG004|Part 2|Unknon|1|||
163921944|NCT03873038|592083748|FG005|Part 2|Unknon|0|||
163921945|NCT04222088|592083749|FG000|Overall Study|Lost to Follow-up|5|||
163921946|NCT04222088|592083750|FG001|Overall Study|Lost to Follow-up|1|||
163921947|NCT04222088|592083749|FG000|Overall Study|Withdrawal by Subject|4|||
163921948|NCT04222088|592083750|FG001|Overall Study|Withdrawal by Subject|0|||
163921949|NCT00595764|592083751|FG000|Overall Study|Protocol Violation|24|||
163921950|NCT00595764|592083752|FG001|Overall Study|Protocol Violation|19|||
163921951|NCT00595764|592083751|FG000|Overall Study|Missed Medication >1 week|10|||
163921952|NCT00595764|592083752|FG001|Overall Study|Missed Medication >1 week|17|||
163921953|NCT00595764|592083751|FG000|Overall Study|Missed 3 PM visits|1|||
163921954|NCT00595764|592083752|FG001|Overall Study|Missed 3 PM visits|7|||
163921955|NCT00595764|592083751|FG000|Overall Study|Withdrawal by Subject|4|||
163921956|NCT00595764|592083752|FG001|Overall Study|Withdrawal by Subject|0|||
164097466|NCT02373098|592720830|FG001|Overall Study|Withdrawal by Subject|0|||
164097467|NCT02373098|592720829|FG000|Overall Study|Adverse Event|3|||
164097468|NCT02373098|592720830|FG001|Overall Study|Adverse Event|0|||
164097469|NCT03018249|592720837|FG000|Overall Study|Withdrawal by Subject|2|||
164097470|NCT03018249|592720838|FG001|Overall Study|Withdrawal by Subject|2|||
164097471|NCT00304083|592720840|FG000|Overall Study|Withdrawal by Subject|4|||
163921957|NCT00141271|592083753|FG000|Overall Study|Adverse Event|31|||
163921958|NCT00141271|592083754|FG001|Overall Study|Adverse Event|19|||
164097472|NCT00304083|592720841|FG001|Overall Study|Withdrawal by Subject|2|||
163921959|NCT00141271|592083755|FG002|Overall Study|Adverse Event|17|||
163921960|NCT00141271|592083753|FG000|Overall Study|Laboratory Abnormality|2|||
163921961|NCT00141271|592083754|FG001|Overall Study|Laboratory Abnormality|1|||
163921962|NCT00141271|592083755|FG002|Overall Study|Laboratory Abnormality|1|||
163921963|NCT00141271|592083753|FG000|Overall Study|Lack of Efficacy|7|||
163921964|NCT00141271|592083754|FG001|Overall Study|Lack of Efficacy|7|||
163921965|NCT00141271|592083755|FG002|Overall Study|Lack of Efficacy|3|||
163921966|NCT00141271|592083753|FG000|Overall Study|Lost to Follow-up|15|||
163921967|NCT00141271|592083754|FG001|Overall Study|Lost to Follow-up|15|||
163921968|NCT00141271|592083755|FG002|Overall Study|Lost to Follow-up|21|||
163921969|NCT00141271|592083753|FG000|Overall Study|Withdrawal by Subject|14|||
163921970|NCT00141271|592083754|FG001|Overall Study|Withdrawal by Subject|9|||
163921971|NCT00141271|592083755|FG002|Overall Study|Withdrawal by Subject|10|||
163921972|NCT00141271|592083753|FG000|Overall Study|Other|11|||
163921973|NCT00141271|592083754|FG001|Overall Study|Other|12|||
163921974|NCT00141271|592083755|FG002|Overall Study|Other|5|||
163921975|NCT01544153|592083756|FG000|Overall Study|Under 18|0|||
163921976|NCT01544153|592083757|FG001|Overall Study|Under 18|1|||
163921977|NCT01544153|592083758|FG002|Overall Study|Under 18|0|||
163921978|NCT01544153|592083759|FG003|Overall Study|Under 18|0|||
163921979|NCT01544153|592083756|FG000|Overall Study|Non-smoker|0|||
163921980|NCT01544153|592083757|FG001|Overall Study|Non-smoker|0|||
163921981|NCT01544153|592083758|FG002|Overall Study|Non-smoker|1|||
163921982|NCT01544153|592083759|FG003|Overall Study|Non-smoker|0|||
163921983|NCT00390806|592083760|FG000|Overall Study|Lost to Follow-up|7|||
163921984|NCT00390806|592083761|FG001|Overall Study|Lost to Follow-up|6|||
163921985|NCT00390806|592083760|FG000|Overall Study|Protocol Violation|2|||
163921986|NCT00390806|592083761|FG001|Overall Study|Protocol Violation|2|||
163921987|NCT00390806|592083760|FG000|Overall Study|Withdrawal by Subject|12|||
163921988|NCT00390806|592083761|FG001|Overall Study|Withdrawal by Subject|15|||
163921989|NCT00390806|592083760|FG000|Overall Study|Investigator Decision|4|||
163921990|NCT00390806|592083761|FG001|Overall Study|Investigator Decision|6|||
163921991|NCT00390806|592083760|FG000|Overall Study|Death|1|||
163921992|NCT00390806|592083761|FG001|Overall Study|Death|0|||
163921993|NCT00390806|592083760|FG000|Overall Study|Physician Decision|0|||
163921994|NCT00390806|592083761|FG001|Overall Study|Physician Decision|1|||
163921995|NCT00390806|592083760|FG000|Overall Study|Ongoing|4|||
163921996|NCT00390806|592083761|FG001|Overall Study|Ongoing|2|||
163921997|NCT00884793|592083764|FG000|Overall Study|Withdrawal by Subject|1|||
163921998|NCT04783519|592083765|FG000|Overall Study|Withdrawal by Subject|2|||
163921999|NCT04783519|592083766|FG001|Overall Study|Withdrawal by Subject|7|||
163922000|NCT04783519|592083767|FG002|Overall Study|Withdrawal by Subject|3|||
163922001|NCT04783519|592083765|FG000|Overall Study|Lost to Follow-up|9|||
163922002|NCT04783519|592083766|FG001|Overall Study|Lost to Follow-up|7|||
163922003|NCT04783519|592083767|FG002|Overall Study|Lost to Follow-up|6|||
163922004|NCT03169530|592083768|FG000|Overall Study|Study ended by NIH|15|||
163922005|NCT03169530|592083769|FG001|Overall Study|Study ended by NIH|17|||
163922006|NCT01032200|592083770|FG000|Overall Study|Death|1|||
163922007|NCT01032200|592083771|FG001|Overall Study|Death|1|||
163922008|NCT01032200|592083770|FG000|Overall Study|Withdrawal by Subject|1|||
163922009|NCT01032200|592083771|FG001|Overall Study|Withdrawal by Subject|3|||
163922010|NCT01032200|592083770|FG000|Overall Study|Toxicity|0|||
163922011|NCT01032200|592083771|FG001|Overall Study|Toxicity|2|||
163922012|NCT01032200|592083770|FG000|Overall Study|Progression|1|||
163922013|NCT01032200|592083771|FG001|Overall Study|Progression|0|||
163922014|NCT01032200|592083770|FG000|Overall Study|Multiple|1|||
163922015|NCT01032200|592083771|FG001|Overall Study|Multiple|1|||
163922016|NCT02273180|592083775|FG000|Overall Study|Adverse Event|2|||
163922017|NCT02273180|592083776|FG001|Overall Study|Adverse Event|2|||
163922018|NCT02273180|592083775|FG000|Overall Study|Lack of Efficacy|1|||
163922019|NCT02273180|592083776|FG001|Overall Study|Lack of Efficacy|0|||
163922020|NCT02273180|592083775|FG000|Overall Study|Protocol Violation|1|||
163922021|NCT02273180|592083776|FG001|Overall Study|Protocol Violation|7|||
163922022|NCT02273180|592083775|FG000|Overall Study|Randomized but not treated|1|||
163922023|NCT02273180|592083776|FG001|Overall Study|Randomized but not treated|0|||
163922024|NCT02273180|592083775|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
163922025|NCT02273180|592083776|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
163922026|NCT02273180|592083775|FG000|Overall Study|Other than specified above|21|||
163922027|NCT02273180|592083776|FG001|Overall Study|Other than specified above|10|||
163922028|NCT04531813|592083777|FG000|Overall Study|Protocol Violation|1|||
163922029|NCT04531813|592083777|FG000|Overall Study|Withdrawal by Subject|1|||
163922030|NCT04341584|592083778|FG000|Overall Study|Withdrew consent|0|||
163922031|NCT04341584|592083779|FG001|Overall Study|Withdrew consent|2|||
163922032|NCT04341584|592083780|FG002|Overall Study|Withdrew consent|2|||
163922033|NCT04341584|592083781|FG003|Overall Study|Withdrew consent|1|||
163922034|NCT00746785|592085352|FG000|Overall Study|Lost to Follow-up|29|||
163922035|NCT00746785|592085353|FG001|Overall Study|Lost to Follow-up|25|||
163922036|NCT00746785|592085354|FG002|Overall Study|Lost to Follow-up|27|||
163922037|NCT01231464|592085355|FG000|Overall Study|Adverse Event|0|||
163922038|NCT01231464|592085356|FG001|Overall Study|Adverse Event|1|||
163922039|NCT01231464|592085355|FG000|Overall Study|Protocol Violation|1|||
163922040|NCT01231464|592085356|FG001|Overall Study|Protocol Violation|2|||
163922041|NCT01231464|592085355|FG000|Overall Study|Lost to Follow-up|1|||
163922042|NCT01231464|592085356|FG001|Overall Study|Lost to Follow-up|2|||
163922043|NCT01231464|592085355|FG000|Overall Study|Withdrawal by Subject|3|||
163922044|NCT01231464|592085356|FG001|Overall Study|Withdrawal by Subject|2|||
163922045|NCT00957996|592085357|FG000|Overall Study|Death|4|||
163922046|NCT00957996|592085358|FG001|Overall Study|Death|10|||
163922047|NCT00957996|592085357|FG000|Overall Study|Lost to Follow-up|4|||
164032597|NCT01376245|592479545|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
164032598|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164032599|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
164032600|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
164032601|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
164032602|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
164032603|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
164032604|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
164032605|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
164032606|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
164032607|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
164032608|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164032609|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
164032610|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
163922048|NCT00957996|592085358|FG001|Overall Study|Lost to Follow-up|7|||
163922049|NCT00957996|592085357|FG000|Overall Study|Withdrawal by Subject|9|||
163922050|NCT00957996|592085358|FG001|Overall Study|Withdrawal by Subject|2|||
163922051|NCT00957996|592085357|FG000|Overall Study|Adverse Event|2|||
163922052|NCT00957996|592085358|FG001|Overall Study|Adverse Event|1|||
163922053|NCT00957996|592085357|FG000|Overall Study|Physician Decision|1|||
163922054|NCT00957996|592085358|FG001|Overall Study|Physician Decision|1|||
163922055|NCT00957996|592085357|FG000|Overall Study|Influenza-related complication|0|||
163922056|NCT00957996|592085358|FG001|Overall Study|Influenza-related complication|1|||
163922057|NCT00957996|592085357|FG000|Overall Study|Missing|1|||
163922058|NCT00957996|592085358|FG001|Overall Study|Missing|0|||
163922059|NCT00957996|592085357|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
163922060|NCT00957996|592085358|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
163922061|NCT00684203|592085365|FG000|Overall Study|Adverse Event|6|||
163922062|NCT00684203|592085366|FG001|Overall Study|Adverse Event|4|||
163922063|NCT00684203|592085367|FG002|Overall Study|Adverse Event|8|||
163922064|NCT00684203|592085368|FG003|Overall Study|Adverse Event|0|||
163922065|NCT00684203|592085369|FG004|Overall Study|Adverse Event|0|||
163922066|NCT00684203|592085370|FG005|Overall Study|Adverse Event|0|||
163922067|NCT00684203|592085365|FG000|Overall Study|Protocol-defined clinical event|3|||
163922068|NCT00684203|592085366|FG001|Overall Study|Protocol-defined clinical event|1|||
163922069|NCT00684203|592085367|FG002|Overall Study|Protocol-defined clinical event|0|||
163922070|NCT00684203|592085368|FG003|Overall Study|Protocol-defined clinical event|0|||
163922071|NCT00684203|592085369|FG004|Overall Study|Protocol-defined clinical event|0|||
163922072|NCT00684203|592085370|FG005|Overall Study|Protocol-defined clinical event|0|||
163922073|NCT00684203|592085365|FG000|Overall Study|Withdrawal by Subject|0|||
163922074|NCT00684203|592085366|FG001|Overall Study|Withdrawal by Subject|2|||
163922075|NCT00684203|592085367|FG002|Overall Study|Withdrawal by Subject|1|||
163922076|NCT00684203|592085368|FG003|Overall Study|Withdrawal by Subject|0|||
163922077|NCT00684203|592085369|FG004|Overall Study|Withdrawal by Subject|0|||
163922078|NCT00684203|592085370|FG005|Overall Study|Withdrawal by Subject|0|||
163922079|NCT00684203|592085365|FG000|Overall Study|Did not meet protocol eligibility|0|||
163922080|NCT00684203|592085366|FG001|Overall Study|Did not meet protocol eligibility|1|||
163922081|NCT00684203|592085367|FG002|Overall Study|Did not meet protocol eligibility|0|||
163922082|NCT00684203|592085368|FG003|Overall Study|Did not meet protocol eligibility|0|||
163922083|NCT00684203|592085369|FG004|Overall Study|Did not meet protocol eligibility|0|||
163922084|NCT00684203|592085370|FG005|Overall Study|Did not meet protocol eligibility|0|||
163922085|NCT00307164|592085373|FG000|Overall Study|Death|1|||
163922086|NCT00307164|592085374|FG001|Overall Study|Death|0|||
163922087|NCT00307164|592085373|FG000|Overall Study|Severe debilitation, unable to continue|1|||
163922088|NCT00307164|592085374|FG001|Overall Study|Severe debilitation, unable to continue|0|||
163922089|NCT00307164|592085373|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
163922090|NCT00307164|592085374|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
163922091|NCT00307164|592085373|FG000|Overall Study|Withdrawal by Subject|1|||
163922092|NCT00307164|592085374|FG001|Overall Study|Withdrawal by Subject|8|||
163922093|NCT00307164|592085373|FG000|Overall Study|Not compliant with requirements|4|||
163922094|NCT00307164|592085374|FG001|Overall Study|Not compliant with requirements|4|||
163922095|NCT00307164|592085373|FG000|Overall Study|Lost to Follow-up|6|||
163922096|NCT00307164|592085374|FG001|Overall Study|Lost to Follow-up|1|||
163922097|NCT03712449|592085376|FG000|Overall Study|Withdraw Consent|0|||
163922098|NCT03712449|592085377|FG001|Overall Study|Withdraw Consent|1|||
163922099|NCT03972137|592085381|FG000|Overall Study|Lost to Follow-up|2|||
164032611|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
163922100|NCT03972137|592085381|FG000|Overall Study|Withdrawal by Subject|4|||
163922101|NCT03226353|592085382|FG000|Overall Study|Withdrawal by Subject|1|||
163922102|NCT03226353|592085382|FG000|Overall Study|Screen Failure|5|||
163922103|NCT03168425|592085385|FG000|Overall Study|Lost to Follow-up|5|||
163922104|NCT03168425|592085386|FG001|Overall Study|Lost to Follow-up|8|||
163922105|NCT03168425|592085385|FG000|Overall Study|unable to confirm post op opioids|2|||
163922106|NCT03168425|592085386|FG001|Overall Study|unable to confirm post op opioids|3|||
163922107|NCT03029234|592085387|FG000|Overall Study|Sponsor Decision|1|||
163922108|NCT03029234|592085387|FG000|Overall Study|Withdrawal by Subject|5|||
163922109|NCT03029234|592085387|FG000|Overall Study|Death|91|||
163922110|NCT03029234|592085387|FG000|Overall Study|Lost to Follow-up|2|||
163922111|NCT00498433|592085388|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
163922112|NCT00498433|592085389|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
163922113|NCT00498433|592085390|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
163922114|NCT00498433|592085388|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
163922115|NCT00498433|592085389|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
163922116|NCT00498433|592085390|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
163922117|NCT00498433|592085388|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
163922118|NCT00498433|592085389|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
163922119|NCT00498433|592085390|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
163922120|NCT00498433|592085388|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
163922121|NCT00498433|592085389|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
163922122|NCT00498433|592085390|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
163922123|NCT00468858|592085399|FG000|Overall Study|Adverse Event|0|||
163922124|NCT00468858|592085400|FG001|Overall Study|Adverse Event|1|||
163922125|NCT00468858|592085401|FG002|Overall Study|Adverse Event|0|||
163922126|NCT00468858|592085399|FG000|Overall Study|Withdrawal by Subject|7|||
163922127|NCT00468858|592085400|FG001|Overall Study|Withdrawal by Subject|4|||
163922128|NCT00468858|592085401|FG002|Overall Study|Withdrawal by Subject|5|||
163922129|NCT00468858|592085399|FG000|Overall Study|Relocation|1|||
163922130|NCT00468858|592085400|FG001|Overall Study|Relocation|3|||
163922131|NCT00468858|592085401|FG002|Overall Study|Relocation|3|||
163922132|NCT00468858|592085399|FG000|Overall Study|Lost to Follow-up|1|||
163922133|NCT00468858|592085400|FG001|Overall Study|Lost to Follow-up|2|||
163922134|NCT00468858|592085401|FG002|Overall Study|Lost to Follow-up|5|||
163922135|NCT00468858|592085399|FG000|Overall Study|Other|0|||
163922136|NCT00468858|592085400|FG001|Overall Study|Other|0|||
163922137|NCT00468858|592085401|FG002|Overall Study|Other|1|||
163922138|NCT00797511|592085404|FG000|Overall Study|Withdrawal by Subject|1|||
163922139|NCT00843115|592085405|FG000|Overall Study|Death|4|||
163922140|NCT00843115|592085405|FG000|Overall Study|Adverse Event|30|||
163922141|NCT00843115|592085405|FG000|Overall Study|Lost to Follow-up|4|||
163922142|NCT00843115|592085405|FG000|Overall Study|Withdrawal by Subject|17|||
163922143|NCT00843115|592085405|FG000|Overall Study|Family wanted meds stopped|1|||
163922144|NCT00843115|592085405|FG000|Overall Study|Family does not want continuation|1|||
163922145|NCT00843115|592085405|FG000|Overall Study|Patient forgot to take meds|1|||
163922146|NCT00843115|592085405|FG000|Overall Study|Does not meet entrance criteria|1|||
163922147|NCT00843115|592085405|FG000|Overall Study|Physician Decision|1|||
163922148|NCT00843115|592085405|FG000|Overall Study|Family discontinued meds|1|||
163922149|NCT00843115|592085405|FG000|Overall Study|patient took for 2 days then stopped|1|||
163922150|NCT00843115|592085405|FG000|Overall Study|patient never took the medication|1|||
163922151|NCT00843115|592085405|FG000|Overall Study|hospitalized due to deterioration|1|||
163922152|NCT00843115|592085405|FG000|Overall Study|week 12 not done|1|||
163922153|NCT00843115|592085405|FG000|Overall Study|Syndrome De Glissement|1|||
163922154|NCT03772041|592085408|FG000|Overall Study|Adverse Event|8|||
163922155|NCT03772041|592085409|FG001|Overall Study|Adverse Event|3|||
163922156|NCT03772041|592085408|FG000|Overall Study|Withdrawal by Subject|0|||
163922157|NCT03772041|592085409|FG001|Overall Study|Withdrawal by Subject|2|||
163922158|NCT03772041|592085408|FG000|Overall Study|Protocol Violation|4|||
163922159|NCT03772041|592085409|FG001|Overall Study|Protocol Violation|2|||
163922160|NCT03772041|592085408|FG000|Overall Study|Physician Decision|2|||
163922161|NCT03772041|592085409|FG001|Overall Study|Physician Decision|3|||
163922162|NCT03927222|592085413|FG000|Overall Study|Progression|3|||
163922163|NCT03927222|592085413|FG000|Overall Study|CMV testing results inconclusive|1|||
163922164|NCT03927222|592085413|FG000|Overall Study|Unable to generate enough vaccines|1|||
163922165|NCT03927222|592085413|FG000|Overall Study|Early study termination|1|||
163922166|NCT02201771|592085416|FG000|Overall Study|Death|3|||
163922167|NCT02201771|592085417|FG001|Overall Study|Death|2|||
163922168|NCT02201771|592085418|FG002|Overall Study|Death|0|||
163922169|NCT02201771|592085416|FG000|Overall Study|Protocol Violation|10|||
163922170|NCT02201771|592085417|FG001|Overall Study|Protocol Violation|8|||
163922171|NCT02201771|592085418|FG002|Overall Study|Protocol Violation|10|||
163922172|NCT01287416|592085421|FG000|Pre-post Training|Withdrawal by Subject|17|||
163922173|NCT01287416|592085422|FG001|Pre-post Training|Withdrawal by Subject|24|||
163922174|NCT01287416|592085421|FG000|Pre-post Training|Lost to Follow-up|5|||
163922175|NCT01287416|592085422|FG001|Pre-post Training|Lost to Follow-up|1|||
163922176|NCT01287416|592085421|FG000|6 Month Follow-up|Lost to Follow-up|3|||
163922177|NCT01287416|592085422|FG001|6 Month Follow-up|Lost to Follow-up|2|||
163922178|NCT00495612|592085427|FG000|Overall Study|Lost to Follow-up|1|||
163922179|NCT00495612|592085428|FG001|Overall Study|Lost to Follow-up|0|||
163922180|NCT00495612|592085427|FG000|Overall Study|Subject's Decision to Withdraw|3|||
164032612|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
164032613|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164032614|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
164032615|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
164032616|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
164032617|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
164032618|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164032619|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
164032620|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164032621|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164032622|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
164032623|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164032624|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
164032625|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
164032626|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
164032627|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
164032628|NCT01376245|592479541|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164032629|NCT01376245|592479542|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
164032630|NCT01376245|592479543|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
164032631|NCT01376245|592479544|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
164032632|NCT01376245|592479545|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
164032633|NCT05159362|592479546|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
164032634|NCT05159362|592479547|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
164032635|NCT05159362|592479548|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
164032636|NCT01357889|592479549|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
164032637|NCT01357889|592479550|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
164032638|NCT01357889|592479549|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
164032639|NCT01357889|592479550|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
164032640|NCT01357889|592479549|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
164032641|NCT01357889|592479550|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
164032642|NCT01357889|592479549|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
164032643|NCT01357889|592479550|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
164032644|NCT01357889|592479549|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
164032645|NCT01357889|592479550|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
164032646|NCT01357889|592479549|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
164032647|NCT01357889|592479550|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
164032648|NCT01357889|592479549|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
164032649|NCT01357889|592479550|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
164032650|NCT01357889|592479549|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
164032651|NCT01357889|592479550|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
164032652|NCT01357889|592479549|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
164032653|NCT01357889|592479550|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
164032654|NCT01357889|592479549|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
164032655|NCT01357889|592479550|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
164032656|NCT01357889|592479549|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
164032657|NCT01357889|592479550|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
164032658|NCT01357889|592479549|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
164032659|NCT01357889|592479550|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
164032660|NCT01357889|592479549|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
164032661|NCT01357889|592479550|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
164032662|NCT01335698|592479551|FG000|Treatment Stage 1|Lack of Efficacy|3|||
164032663|NCT01335698|592479552|FG001|Treatment Stage 1|Lack of Efficacy|1|||
164032664|NCT01335698|592479553|FG002|Treatment Stage 1|Lack of Efficacy|3|||
164032665|NCT01335698|592479554|FG003|Treatment Stage 1|Lack of Efficacy|3|||
164032666|NCT01335698|592479555|FG004|Treatment Stage 1|Lack of Efficacy|1|||
164032667|NCT01335698|592479551|FG000|Treatment Stage 1|Adverse Event|1|||
164032668|NCT01335698|592479552|FG001|Treatment Stage 1|Adverse Event|2|||
164032669|NCT01335698|592479553|FG002|Treatment Stage 1|Adverse Event|2|||
164032670|NCT01335698|592479554|FG003|Treatment Stage 1|Adverse Event|1|||
164032671|NCT01335698|592479555|FG004|Treatment Stage 1|Adverse Event|1|||
164032672|NCT01335698|592479551|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
164032673|NCT01335698|592479552|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
164032674|NCT01335698|592479553|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
164032675|NCT01335698|592479554|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
164032676|NCT01335698|592479555|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
164032677|NCT01335698|592479551|FG000|Treatment Stage 1|Lost to Follow-up|1|||
164032678|NCT01335698|592479552|FG001|Treatment Stage 1|Lost to Follow-up|1|||
163827678|NCT03320018|591737418|FG001|Treatment Period|Withdrawal by Subject|0|||
163827679|NCT03320018|591737417|FG000|Day 90 Follow up|Death|0|||
163827680|NCT03320018|591737418|FG001|Day 90 Follow up|Death|1|||
163827681|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
163827682|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
163827683|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
163827684|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
163827685|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
163827686|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
163827687|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
163827688|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
163827689|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
163827690|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
163827691|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
163827692|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
163827693|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
163827694|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
163827695|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
163827696|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
163827697|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
163827698|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
163827699|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
163827700|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
163827701|NCT00549757|591737419|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
163827702|NCT00549757|591737420|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
163827703|NCT00549757|591737419|FG000|Extension Period (in Average 9 Months)|Death|143|||
163827704|NCT00549757|591737420|FG001|Extension Period (in Average 9 Months)|Death|136|||
163827705|NCT00549757|591737419|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
163827706|NCT00549757|591737420|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
163827707|NCT00549757|591737419|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
163827708|NCT00549757|591737420|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
163922181|NCT00495612|592085428|FG001|Overall Study|Subject's Decision to Withdraw|0|||
163827709|NCT00549757|591737419|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
163827710|NCT00549757|591737420|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
163827711|NCT01256411|591737430|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
163922182|NCT02383927|592085435|FG000|Overall Study|Disease Progression|8|||
163922183|NCT02383927|592085436|FG001|Overall Study|Disease Progression|8|||
163922184|NCT02383927|592085437|FG002|Overall Study|Disease Progression|15|||
163922185|NCT02383927|592085438|FG003|Overall Study|Disease Progression|4|||
163922186|NCT02383927|592085435|FG000|Overall Study|Physician Decision|0|||
163922187|NCT02383927|592085436|FG001|Overall Study|Physician Decision|0|||
163922188|NCT02383927|592085437|FG002|Overall Study|Physician Decision|2|||
163922189|NCT02383927|592085438|FG003|Overall Study|Physician Decision|0|||
163922190|NCT02383927|592085435|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
163922191|NCT02383927|592085436|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
163922192|NCT02383927|592085437|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
163922193|NCT02383927|592085438|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
163922194|NCT02383927|592085435|FG000|Overall Study|Adverse Event|4|||
163922195|NCT02383927|592085436|FG001|Overall Study|Adverse Event|1|||
163922196|NCT02383927|592085437|FG002|Overall Study|Adverse Event|3|||
163922197|NCT02383927|592085438|FG003|Overall Study|Adverse Event|5|||
163922198|NCT02383927|592085435|FG000|Overall Study|Miscellaneous|1|||
163922199|NCT02383927|592085436|FG001|Overall Study|Miscellaneous|0|||
163922200|NCT02383927|592085437|FG002|Overall Study|Miscellaneous|0|||
163922201|NCT02383927|592085438|FG003|Overall Study|Miscellaneous|1|||
163922202|NCT02383927|592085435|FG000|Overall Study|Withdrawal by Subject|0|||
163922203|NCT02383927|592085436|FG001|Overall Study|Withdrawal by Subject|1|||
163922204|NCT02383927|592085437|FG002|Overall Study|Withdrawal by Subject|4|||
163922205|NCT02383927|592085438|FG003|Overall Study|Withdrawal by Subject|0|||
163922206|NCT00734851|592085439|FG000|Overall Study|Withdrawal by Subject|2|||
163922207|NCT00734851|592085439|FG000|Overall Study|Lost to Follow-up|1|||
163922208|NCT00734851|592085439|FG000|Overall Study|Physician Decision|18|||
163922209|NCT00818519|592085440|FG000|Overall Study|Adverse Event|2|||
163922210|NCT00818519|592085441|FG001|Overall Study|Adverse Event|2|||
163922211|NCT00818519|592085440|FG000|Overall Study|Lost to Follow-up|4|||
163922212|NCT00818519|592085441|FG001|Overall Study|Lost to Follow-up|6|||
163922213|NCT00818519|592085440|FG000|Overall Study|Protocol Violation|2|||
163922214|NCT00818519|592085441|FG001|Overall Study|Protocol Violation|1|||
163922215|NCT00818519|592085440|FG000|Overall Study|Pregnancy|0|||
163922216|NCT00818519|592085441|FG001|Overall Study|Pregnancy|1|||
163922217|NCT00818519|592085440|FG000|Overall Study|Withdrawal by Subject|4|||
163827712|NCT01256411|591737431|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
163827713|NCT01256411|591737432|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
163827714|NCT01256411|591737433|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
163827715|NCT01256411|591737434|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
163827716|NCT01256411|591737435|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
163827717|NCT01256411|591737430|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
163827718|NCT01256411|591737431|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
163827719|NCT01256411|591737432|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
163827720|NCT01256411|591737433|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
163827721|NCT01256411|591737434|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
163827722|NCT01256411|591737435|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
163827723|NCT01256411|591737430|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
163827724|NCT01256411|591737431|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
163827725|NCT01256411|591737432|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
163827726|NCT01256411|591737433|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
163827727|NCT01256411|591737434|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
163827728|NCT01256411|591737435|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
163827729|NCT01256411|591737430|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
163827730|NCT01256411|591737431|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
163827731|NCT01256411|591737432|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
163827732|NCT01256411|591737433|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
163827733|NCT01256411|591737434|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
163827734|NCT01256411|591737435|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
163827735|NCT01256411|591737430|FG000|Extension by Maximum Treatment|Adverse Event|4|||
163827736|NCT01256411|591737431|FG001|Extension by Maximum Treatment|Adverse Event|2|||
163827737|NCT01256411|591737432|FG002|Extension by Maximum Treatment|Adverse Event|1|||
163827738|NCT01256411|591737433|FG003|Extension by Maximum Treatment|Adverse Event|0|||
163827739|NCT01256411|591737434|FG004|Extension by Maximum Treatment|Adverse Event|0|||
163827740|NCT01256411|591737435|FG005|Extension by Maximum Treatment|Adverse Event|0|||
163827741|NCT01256411|591737430|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
163827742|NCT01256411|591737431|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
163827743|NCT01256411|591737432|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
163827744|NCT01256411|591737433|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
163827745|NCT01256411|591737434|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
163827746|NCT01256411|591737435|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
163827747|NCT01256411|591737430|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163827748|NCT01256411|591737431|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163827749|NCT01256411|591737432|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163827750|NCT01256411|591737433|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163827751|NCT01256411|591737434|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
163827752|NCT01256411|591737435|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
163827753|NCT01256411|591737430|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163827754|NCT01256411|591737431|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163827755|NCT01256411|591737432|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163827756|NCT01256411|591737433|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163827757|NCT01256411|591737434|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
163827758|NCT01256411|591737435|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
163827759|NCT01256411|591737430|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163827760|NCT01256411|591737431|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163827761|NCT01256411|591737432|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163827762|NCT01256411|591737433|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
163827763|NCT01256411|591737434|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
163827764|NCT01256411|591737435|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
163827765|NCT01256411|591737430|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163827766|NCT01256411|591737431|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163827767|NCT01256411|591737432|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163827768|NCT01256411|591737433|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
163827769|NCT01256411|591737434|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
163827770|NCT01256411|591737435|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
163827771|NCT02274857|591737436|FG000|Overall Study|Adverse Event|1|||
163922218|NCT00818519|592085441|FG001|Overall Study|Withdrawal by Subject|9|||
163827772|NCT02274857|591737437|FG001|Overall Study|Adverse Event|0|||
163827773|NCT02274857|591737436|FG000|Overall Study|Death|1|||
163922219|NCT00818519|592085440|FG000|Overall Study|participant recovered completely|1|||
163922220|NCT00818519|592085441|FG001|Overall Study|participant recovered completely|0|||
163922221|NCT00818519|592085440|FG000|Overall Study|participant will leave for long tme|1|||
164097473|NCT00304083|592720840|FG000|Overall Study|Physician Decision|8|||
164097474|NCT00304083|592720841|FG001|Overall Study|Physician Decision|3|||
164097475|NCT00304083|592720840|FG000|Overall Study|Disease Progression|5|||
164097476|NCT00304083|592720841|FG001|Overall Study|Disease Progression|1|||
164097477|NCT00304083|592720840|FG000|Overall Study|Other|5|||
164097478|NCT00304083|592720841|FG001|Overall Study|Other|2|||
164097479|NCT03966365|592720842|FG000|Overall Study|Protocol Violation|1|||
164097480|NCT03966365|592720843|FG001|Overall Study|Protocol Violation|0|||
164097481|NCT01378975|592720844|FG000|Overall Study|Death|77|||
164097482|NCT01378975|592720845|FG001|Overall Study|Death|46|||
164097483|NCT01378975|592720844|FG000|Overall Study|Investigator Request|1|||
164097484|NCT01378975|592720845|FG001|Overall Study|Investigator Request|0|||
164097485|NCT01378975|592720844|FG000|Overall Study|Lost to Follow-up|4|||
164097486|NCT01378975|592720845|FG001|Overall Study|Lost to Follow-up|1|||
164097487|NCT01378975|592720844|FG000|Overall Study|Withdrew Consent|4|||
164097488|NCT01378975|592720845|FG001|Overall Study|Withdrew Consent|3|||
164097489|NCT00319735|592720848|FG000|Overall Study|Death|2|||
164097490|NCT03929393|592720849|FG000|Overall Study|Death|1|||
164097491|NCT03929393|592720850|FG001|Overall Study|Death|0|||
164097492|NCT03929393|592720849|FG000|Overall Study|Time Commitment|2|||
164097493|NCT03929393|592720850|FG001|Overall Study|Time Commitment|5|||
164097494|NCT03929393|592720849|FG000|Overall Study|Motor Vehicle Accident|0|||
164097495|NCT03929393|592720850|FG001|Overall Study|Motor Vehicle Accident|1|||
164097496|NCT03929393|592720849|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
164097497|NCT03929393|592720850|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
164097498|NCT03929393|592720849|FG000|Overall Study|Other|1|||
164097499|NCT03929393|592720850|FG001|Overall Study|Other|3|||
164097500|NCT00694551|592720863|FG000|Overall Study|Disease Progression|1|||
164097501|NCT00694551|592720864|FG001|Overall Study|Disease Progression|0|||
164097502|NCT00694551|592720865|FG002|Overall Study|Disease Progression|1|||
164097503|NCT01937390|592720869|FG000|Overall Study|Death|2|||
164097504|NCT01937390|592720869|FG000|Overall Study|Lost to Follow-up|7|||
164097505|NCT01937390|592720869|FG000|Overall Study|Withdrawal by Subject|5|||
164097506|NCT01937390|592720869|FG000|Overall Study|Fail to return|21|||
164097507|NCT02216071|592720872|FG000|Overall Study|Withdrawal by Subject|7|||
164097508|NCT02216071|592720873|FG001|Overall Study|Withdrawal by Subject|2|||
164097509|NCT02216071|592720872|FG000|Overall Study|Lost to Follow-up|3|||
164097510|NCT02216071|592720873|FG001|Overall Study|Lost to Follow-up|3|||
164097511|NCT02216071|592720872|FG000|Overall Study|Protocol Violation|3|||
164097512|NCT02216071|592720873|FG001|Overall Study|Protocol Violation|5|||
164097513|NCT02216071|592720872|FG000|Overall Study|Other|2|||
164097514|NCT02216071|592720873|FG001|Overall Study|Other|2|||
164097515|NCT03544138|592720874|FG000|Overall Study|Lost to Follow-up|29|||
164097516|NCT01706536|592720875|FG000|Overall Study|Withdrawal by Subject|1|||
164097517|NCT01706536|592720876|FG001|Overall Study|Withdrawal by Subject|0|||
164097518|NCT01706536|592720877|FG002|Overall Study|Withdrawal by Subject|1|||
164097519|NCT01706536|592720878|FG003|Overall Study|Withdrawal by Subject|0|||
164097520|NCT01706536|592720879|FG004|Overall Study|Withdrawal by Subject|0|||
164097521|NCT01706536|592720875|FG000|Overall Study|Adverse Event|2|||
164097522|NCT01706536|592720876|FG001|Overall Study|Adverse Event|3|||
164097523|NCT01706536|592720877|FG002|Overall Study|Adverse Event|4|||
164097524|NCT01706536|592720878|FG003|Overall Study|Adverse Event|3|||
164097525|NCT01706536|592720879|FG004|Overall Study|Adverse Event|2|||
164097526|NCT01706536|592720875|FG000|Overall Study|Lack of Efficacy|1|||
164097527|NCT01706536|592720876|FG001|Overall Study|Lack of Efficacy|0|||
164097528|NCT01706536|592720877|FG002|Overall Study|Lack of Efficacy|0|||
164097529|NCT01706536|592720878|FG003|Overall Study|Lack of Efficacy|1|||
164097530|NCT01706536|592720879|FG004|Overall Study|Lack of Efficacy|0|||
164097531|NCT01706536|592720875|FG000|Overall Study|non compliance|0|||
164097532|NCT01706536|592720876|FG001|Overall Study|non compliance|1|||
164097533|NCT01706536|592720877|FG002|Overall Study|non compliance|0|||
164097534|NCT01706536|592720878|FG003|Overall Study|non compliance|0|||
164097535|NCT01706536|592720879|FG004|Overall Study|non compliance|0|||
164097536|NCT04753437|592720882|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164097537|NCT04753437|592720883|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163922222|NCT00818519|592085441|FG001|Overall Study|participant will leave for long tme|0|||
164097538|NCT04753437|592720882|FG000|Overall Study|Liver Function Test Abnormalities|2|||
164097539|NCT04753437|592720883|FG001|Overall Study|Liver Function Test Abnormalities|4|||
164097540|NCT00385684|592720886|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
164097541|NCT00385684|592720887|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
164097542|NCT00385684|592720886|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
164097543|NCT00385684|592720887|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
164097544|NCT00385684|592720886|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
164097545|NCT00385684|592720887|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
164097546|NCT00463606|592720888|FG000|Overall Study|Adverse Event|21|||
164097547|NCT00463606|592720889|FG001|Overall Study|Adverse Event|18|||
164097548|NCT00463606|592720890|FG002|Overall Study|Adverse Event|11|||
164097549|NCT00463606|592720888|FG000|Overall Study|Withdrawal by Subject|11|||
163922223|NCT00981578|592085445|FG000|Overall Study|Death|1|||
164097550|NCT00463606|592720889|FG001|Overall Study|Withdrawal by Subject|11|||
164097551|NCT00463606|592720890|FG002|Overall Study|Withdrawal by Subject|5|||
164097552|NCT00463606|592720888|FG000|Overall Study|Lost to Follow-up|2|||
164097553|NCT00463606|592720889|FG001|Overall Study|Lost to Follow-up|2|||
164097554|NCT00463606|592720890|FG002|Overall Study|Lost to Follow-up|3|||
164097555|NCT00463606|592720888|FG000|Overall Study|Subject noncompliance|1|||
164097556|NCT00463606|592720889|FG001|Overall Study|Subject noncompliance|1|||
164097557|NCT00463606|592720890|FG002|Overall Study|Subject noncompliance|0|||
164097558|NCT00463606|592720888|FG000|Overall Study|Subject moved out of town|1|||
164097559|NCT00463606|592720889|FG001|Overall Study|Subject moved out of town|0|||
164097560|NCT00463606|592720890|FG002|Overall Study|Subject moved out of town|0|||
164097561|NCT00463606|592720888|FG000|Overall Study|Physician Decision|0|||
164097562|NCT00463606|592720889|FG001|Overall Study|Physician Decision|1|||
164097563|NCT00463606|592720890|FG002|Overall Study|Physician Decision|0|||
164097564|NCT00463606|592720888|FG000|Overall Study|Sponsor request|0|||
164097565|NCT00463606|592720889|FG001|Overall Study|Sponsor request|1|||
164097566|NCT00463606|592720890|FG002|Overall Study|Sponsor request|0|||
164097567|NCT00463606|592720888|FG000|Overall Study|Exclusion criteria violation|2|||
164097568|NCT00463606|592720889|FG001|Overall Study|Exclusion criteria violation|0|||
164097569|NCT00463606|592720890|FG002|Overall Study|Exclusion criteria violation|0|||
164097570|NCT00463606|592720888|FG000|Overall Study|Coordinator error|1|||
164097571|NCT00463606|592720889|FG001|Overall Study|Coordinator error|0|||
164097572|NCT00463606|592720890|FG002|Overall Study|Coordinator error|0|||
164032679|NCT01335698|592479553|FG002|Treatment Stage 1|Lost to Follow-up|0|||
164032680|NCT01335698|592479554|FG003|Treatment Stage 1|Lost to Follow-up|0|||
164032681|NCT01335698|592479555|FG004|Treatment Stage 1|Lost to Follow-up|0|||
164032682|NCT01335698|592479551|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
164032683|NCT01335698|592479552|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
164032684|NCT01335698|592479553|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
164032685|NCT01335698|592479554|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
164032686|NCT01335698|592479555|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
164032687|NCT01335698|592479551|FG000|Treatment Stage 1|No longer meets study criteria|1|||
164032688|NCT01335698|592479552|FG001|Treatment Stage 1|No longer meets study criteria|1|||
164032689|NCT01335698|592479553|FG002|Treatment Stage 1|No longer meets study criteria|0|||
164032690|NCT01335698|592479554|FG003|Treatment Stage 1|No longer meets study criteria|1|||
164032691|NCT01335698|592479555|FG004|Treatment Stage 1|No longer meets study criteria|0|||
164032692|NCT01335698|592479551|FG000|Treatment Stage 1|Other|1|||
164032693|NCT01335698|592479552|FG001|Treatment Stage 1|Other|0|||
164032694|NCT01335698|592479553|FG002|Treatment Stage 1|Other|0|||
164032695|NCT01335698|592479554|FG003|Treatment Stage 1|Other|1|||
164032696|NCT01335698|592479555|FG004|Treatment Stage 1|Other|0|||
164032697|NCT01335698|592479551|FG000|Treatment Stage 2|Lack of Efficacy|2|||
164032698|NCT01335698|592479552|FG001|Treatment Stage 2|Lack of Efficacy|1|||
164032699|NCT01335698|592479553|FG002|Treatment Stage 2|Lack of Efficacy|3|||
164032700|NCT01335698|592479554|FG003|Treatment Stage 2|Lack of Efficacy|1|||
164032701|NCT01335698|592479555|FG004|Treatment Stage 2|Lack of Efficacy|0|||
164032702|NCT01335698|592479551|FG000|Treatment Stage 2|Adverse Event|2|||
164032703|NCT01335698|592479552|FG001|Treatment Stage 2|Adverse Event|0|||
164032704|NCT01335698|592479553|FG002|Treatment Stage 2|Adverse Event|0|||
164032705|NCT01335698|592479554|FG003|Treatment Stage 2|Adverse Event|3|||
164032706|NCT01335698|592479555|FG004|Treatment Stage 2|Adverse Event|0|||
164032707|NCT01335698|592479551|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
164032708|NCT01335698|592479552|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
164032709|NCT01335698|592479553|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
164032710|NCT01335698|592479554|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
164032711|NCT01335698|592479555|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
164032712|NCT01335698|592479551|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
164032713|NCT01335698|592479552|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
164032714|NCT01335698|592479553|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
164032715|NCT01335698|592479554|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
164032716|NCT01335698|592479555|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
164032717|NCT01335698|592479551|FG000|Treatment Stage 2|Lost to Follow-up|1|||
164032718|NCT01335698|592479552|FG001|Treatment Stage 2|Lost to Follow-up|0|||
164097573|NCT00463606|592720888|FG000|Overall Study|Patient randomized in error|1|||
164097574|NCT00463606|592720889|FG001|Overall Study|Patient randomized in error|0|||
164097575|NCT00463606|592720890|FG002|Overall Study|Patient randomized in error|0|||
164097576|NCT00463606|592720888|FG000|Overall Study|Participation in another ABT-335 trial|1|||
164097577|NCT00463606|592720889|FG001|Overall Study|Participation in another ABT-335 trial|0|||
164097578|NCT00463606|592720890|FG002|Overall Study|Participation in another ABT-335 trial|0|||
164032719|NCT01335698|592479553|FG002|Treatment Stage 2|Lost to Follow-up|0|||
164032720|NCT01335698|592479554|FG003|Treatment Stage 2|Lost to Follow-up|0|||
164032721|NCT01335698|592479555|FG004|Treatment Stage 2|Lost to Follow-up|0|||
164097579|NCT00463606|592720888|FG000|Overall Study|Protocol Violation|0|||
164097580|NCT00463606|592720889|FG001|Overall Study|Protocol Violation|0|||
164097581|NCT00463606|592720890|FG002|Overall Study|Protocol Violation|1|||
164147139|NCT02466685|592899987|FG000|Overall Study|Lost to Follow-up|1|||
164097582|NCT02682602|592720892|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
164097583|NCT02682602|592720893|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
164097584|NCT02682602|592720892|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
164097585|NCT02682602|592720893|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
164097586|NCT03567174|592720894|FG000|Overall Study|Death|24|||
164097587|NCT03567174|592720895|FG001|Overall Study|Death|31|||
164097588|NCT03567174|592720894|FG000|Overall Study|Lost to Follow-up|165|||
164097589|NCT03567174|592720895|FG001|Overall Study|Lost to Follow-up|174|||
164097590|NCT02140060|592720896|FG000|Overall Study|Adverse Event|0|||
164097591|NCT02140060|592720897|FG001|Overall Study|Adverse Event|0|||
164097592|NCT02140060|592720898|FG002|Overall Study|Adverse Event|0|||
164097593|NCT02140060|592720899|FG003|Overall Study|Adverse Event|1|||
164097594|NCT02140060|592720900|FG004|Overall Study|Adverse Event|1|||
164097595|NCT02140060|592720901|FG005|Overall Study|Adverse Event|1|||
164097596|NCT02140060|592720896|FG000|Overall Study|Lack of Efficacy|0|||
164097597|NCT02140060|592720897|FG001|Overall Study|Lack of Efficacy|0|||
164097598|NCT02140060|592720898|FG002|Overall Study|Lack of Efficacy|0|||
164097599|NCT02140060|592720899|FG003|Overall Study|Lack of Efficacy|1|||
164097600|NCT02140060|592720900|FG004|Overall Study|Lack of Efficacy|0|||
164097601|NCT02140060|592720901|FG005|Overall Study|Lack of Efficacy|0|||
164097602|NCT00522457|592720902|FG000|Overall Study|Due to disease progression|16|||
164097603|NCT00522457|592720902|FG000|Overall Study|Adverse Event|2|||
164097604|NCT03497897|592722768|FG000|Overall Study|Adverse Event|1|||
164097605|NCT03497897|592722769|FG001|Overall Study|Adverse Event|1|||
164097606|NCT03497897|592722770|FG002|Overall Study|Adverse Event|1|||
164097607|NCT03497897|592722768|FG000|Overall Study|Lost to Follow-up|2|||
164097608|NCT03497897|592722769|FG001|Overall Study|Lost to Follow-up|0|||
164097609|NCT03497897|592722770|FG002|Overall Study|Lost to Follow-up|2|||
164097610|NCT03497897|592722768|FG000|Overall Study|Physician Decision|1|||
164097611|NCT03497897|592722769|FG001|Overall Study|Physician Decision|0|||
164097612|NCT03497897|592722770|FG002|Overall Study|Physician Decision|0|||
164097613|NCT03497897|592722768|FG000|Overall Study|Subject/Guardian Decision|2|||
164097614|NCT03497897|592722769|FG001|Overall Study|Subject/Guardian Decision|1|||
164097615|NCT03497897|592722770|FG002|Overall Study|Subject/Guardian Decision|3|||
164097616|NCT00723528|592722771|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
164097617|NCT00723528|592722772|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
164097618|NCT00723528|592722773|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
164097619|NCT00723528|592722774|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
164097620|NCT00723528|592722775|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
164097621|NCT00723528|592722776|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
164097622|NCT00723528|592722777|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
164097623|NCT00723528|592722771|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
164097624|NCT00723528|592722772|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164097625|NCT00723528|592722773|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164097626|NCT00723528|592722774|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164097627|NCT00723528|592722775|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164097628|NCT00723528|592722776|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
163827774|NCT02274857|591737437|FG001|Overall Study|Death|2|||
163827775|NCT02274857|591737436|FG000|Overall Study|Lost to Follow-up|3|||
163827776|NCT02274857|591737437|FG001|Overall Study|Lost to Follow-up|0|||
163827777|NCT02274857|591737436|FG000|Overall Study|Physician Decision|2|||
163827778|NCT02274857|591737437|FG001|Overall Study|Physician Decision|0|||
163827779|NCT02274857|591737436|FG000|Overall Study|Trial screen failure|0|||
163827780|NCT02274857|591737437|FG001|Overall Study|Trial screen failure|2|||
163827781|NCT02274857|591737436|FG000|Overall Study|Withdrawal by Subject|11|||
163827782|NCT02274857|591737437|FG001|Overall Study|Withdrawal by Subject|2|||
163827783|NCT02274857|591737436|FG000|Overall Study|Other|2|||
163827784|NCT02274857|591737437|FG001|Overall Study|Other|0|||
163827785|NCT02403180|591737438|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
163827786|NCT02403180|591737439|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
163827787|NCT02403180|591737438|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
164097629|NCT00723528|592722777|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
164097630|NCT00723528|592722771|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
164097631|NCT00723528|592722772|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
163827788|NCT02403180|591737439|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
163827789|NCT00117676|591737440|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
163827790|NCT00117676|591737441|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
163827791|NCT00117676|591737440|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
164097632|NCT00723528|592722773|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
164097633|NCT00723528|592722774|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
164097634|NCT00723528|592722775|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
164097635|NCT00723528|592722776|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
163827792|NCT00117676|591737441|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
164032722|NCT01335698|592479551|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
164032723|NCT01335698|592479552|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
164032724|NCT01335698|592479553|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
164032725|NCT01335698|592479554|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
164032726|NCT01335698|592479555|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
164097636|NCT00723528|592722777|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
164097637|NCT00723528|592722771|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164097638|NCT00723528|592722772|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164097639|NCT00723528|592722773|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
164097640|NCT00723528|592722774|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164097641|NCT00723528|592722775|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164097642|NCT00723528|592722776|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164097643|NCT00723528|592722777|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
164097644|NCT00723528|592722771|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
164097645|NCT00723528|592722772|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164097646|NCT00723528|592722773|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
164097647|NCT00723528|592722774|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164097648|NCT00723528|592722775|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164097649|NCT00723528|592722776|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164097650|NCT00723528|592722777|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
164097651|NCT00723528|592722771|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164097652|NCT00723528|592722772|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164097653|NCT00723528|592722773|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164097654|NCT00723528|592722774|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
164097655|NCT00723528|592722775|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
164032727|NCT01335698|592479551|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
164032728|NCT01335698|592479552|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
164032729|NCT01335698|592479553|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
164032730|NCT01335698|592479554|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
164032731|NCT01335698|592479555|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
164097656|NCT00723528|592722776|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
163827793|NCT00117676|591737440|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
163827794|NCT00117676|591737441|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
163827795|NCT00117676|591737440|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
163827796|NCT00117676|591737441|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
163827797|NCT00117676|591737440|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
163827798|NCT00117676|591737441|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
163827799|NCT00117676|591737440|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
163827800|NCT00117676|591737441|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
163827801|NCT00117676|591737440|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
163827802|NCT00117676|591737441|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
163827803|NCT00117676|591737440|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
163827804|NCT00117676|591737441|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
163827805|NCT00117676|591737440|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
163827806|NCT00117676|591737441|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
163827807|NCT00117676|591737440|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
163827808|NCT00117676|591737441|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
163827809|NCT00117676|591737440|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
163827810|NCT00117676|591737441|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
163827811|NCT00117676|591737440|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
163827812|NCT00117676|591737441|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
163827813|NCT00117676|591737440|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
163827814|NCT00117676|591737441|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
163827815|NCT00117676|591737440|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
163827816|NCT00117676|591737441|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
163827817|NCT00117676|591737440|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
163827818|NCT00117676|591737441|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
163827819|NCT00117676|591737440|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
163827820|NCT00117676|591737441|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
163827821|NCT00117676|591737440|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
163827822|NCT00117676|591737441|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
163827823|NCT00117676|591737440|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
163922224|NCT00981578|592085445|FG000|Overall Study|Withdrawal by Subject|2|||
163922225|NCT01180790|592085451|FG000|Overall Study|Adverse Event|1|||
163922226|NCT01180790|592085452|FG001|Overall Study|Adverse Event|1|||
163922227|NCT01180790|592085453|FG002|Overall Study|Adverse Event|2|||
163922228|NCT01180790|592085454|FG003|Overall Study|Adverse Event|0|||
163922229|NCT01180790|592085455|FG004|Overall Study|Adverse Event|1|||
163922230|NCT01180790|592085456|FG005|Overall Study|Adverse Event|3|||
163922231|NCT01180790|592085457|FG006|Overall Study|Adverse Event|0|||
163922232|NCT01180790|592085451|FG000|Overall Study|Withdrawal by Subject|3|||
163922233|NCT01180790|592085452|FG001|Overall Study|Withdrawal by Subject|0|||
163922234|NCT01180790|592085453|FG002|Overall Study|Withdrawal by Subject|5|||
163922235|NCT01180790|592085454|FG003|Overall Study|Withdrawal by Subject|0|||
163922236|NCT01180790|592085455|FG004|Overall Study|Withdrawal by Subject|2|||
163922237|NCT01180790|592085456|FG005|Overall Study|Withdrawal by Subject|1|||
163922238|NCT01180790|592085457|FG006|Overall Study|Withdrawal by Subject|0|||
163922239|NCT01180790|592085451|FG000|Overall Study|Lost to Follow-up|3|||
163922240|NCT01180790|592085452|FG001|Overall Study|Lost to Follow-up|1|||
163922241|NCT01180790|592085453|FG002|Overall Study|Lost to Follow-up|0|||
163922242|NCT01180790|592085454|FG003|Overall Study|Lost to Follow-up|2|||
163922243|NCT01180790|592085455|FG004|Overall Study|Lost to Follow-up|1|||
163922244|NCT01180790|592085456|FG005|Overall Study|Lost to Follow-up|0|||
163922245|NCT01180790|592085457|FG006|Overall Study|Lost to Follow-up|1|||
163922246|NCT01180790|592085451|FG000|Overall Study|Physician Decision|1|||
163922247|NCT01180790|592085452|FG001|Overall Study|Physician Decision|0|||
163922248|NCT01180790|592085453|FG002|Overall Study|Physician Decision|0|||
163922249|NCT01180790|592085454|FG003|Overall Study|Physician Decision|1|||
163922250|NCT01180790|592085455|FG004|Overall Study|Physician Decision|0|||
163922251|NCT01180790|592085456|FG005|Overall Study|Physician Decision|0|||
163922252|NCT01180790|592085457|FG006|Overall Study|Physician Decision|0|||
163922253|NCT01180790|592085451|FG000|Overall Study|Lack of Efficacy|1|||
163922254|NCT01180790|592085452|FG001|Overall Study|Lack of Efficacy|2|||
163922255|NCT01180790|592085453|FG002|Overall Study|Lack of Efficacy|5|||
163922256|NCT01180790|592085454|FG003|Overall Study|Lack of Efficacy|6|||
163922257|NCT01180790|592085455|FG004|Overall Study|Lack of Efficacy|1|||
163922258|NCT01180790|592085456|FG005|Overall Study|Lack of Efficacy|3|||
163922259|NCT01180790|592085457|FG006|Overall Study|Lack of Efficacy|0|||
163922260|NCT01180790|592085451|FG000|Overall Study|compliance|0|||
163922261|NCT01180790|592085452|FG001|Overall Study|compliance|1|||
163922262|NCT01180790|592085453|FG002|Overall Study|compliance|0|||
163922263|NCT01180790|592085454|FG003|Overall Study|compliance|0|||
163922264|NCT01180790|592085455|FG004|Overall Study|compliance|0|||
163922265|NCT01180790|592085456|FG005|Overall Study|compliance|0|||
163922266|NCT01180790|592085457|FG006|Overall Study|compliance|0|||
163922267|NCT01180790|592085451|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
163922268|NCT01180790|592085452|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
163922269|NCT01180790|592085453|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
163922270|NCT01180790|592085454|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
163922271|NCT01180790|592085455|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
163922272|NCT01180790|592085456|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
163922273|NCT01180790|592085457|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
163922274|NCT00655668|592085458|FG000|Overall Study|Adverse Event|6|||
163922275|NCT00655668|592085458|FG000|Overall Study|Death|5|||
163922276|NCT00655668|592085458|FG000|Overall Study|Disease Progression|27|||
163922277|NCT00655668|592085458|FG000|Overall Study|Study Terminated|9|||
163922278|NCT00655668|592085458|FG000|Overall Study|Other|1|||
163922279|NCT00655668|592085458|FG000|Overall Study|New Lymphoma Treatment Started|4|||
163922280|NCT00655668|592085458|FG000|Overall Study|Withdrawal by Subject|2|||
163922281|NCT02335242|592085459|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
163922282|NCT02335242|592085460|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
163922283|NCT02335242|592085459|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
164032732|NCT01335698|592479551|FG000|Treatment Stage 2|Switched to another formulation|1|||
164032733|NCT01335698|592479552|FG001|Treatment Stage 2|Switched to another formulation|1|||
164032734|NCT01335698|592479553|FG002|Treatment Stage 2|Switched to another formulation|0|||
163922284|NCT02335242|592085460|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
163922285|NCT02335242|592085459|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
163922286|NCT02335242|592085460|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
163922287|NCT04167085|592085461|FG000|Baseline|Withdrawal by Subject|2|||
163922288|NCT04167085|592085462|FG001|Baseline|Withdrawal by Subject|1|||
163922289|NCT04167085|592085461|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
163922290|NCT04167085|592085462|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
163922291|NCT03840148|592085463|FG000|Study Drug Disposition|Adverse Event|13|||
163922292|NCT03840148|592085464|FG001|Study Drug Disposition|Adverse Event|2|||
163922293|NCT03840148|592085463|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
163922294|NCT03840148|592085464|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
163922295|NCT03840148|592085463|FG000|Study Drug Disposition|Lack of Efficacy|3|||
163922296|NCT03840148|592085464|FG001|Study Drug Disposition|Lack of Efficacy|0|||
164032735|NCT01335698|592479554|FG003|Treatment Stage 2|Switched to another formulation|0|||
163922297|NCT03840148|592085463|FG000|Study Drug Disposition|Physician Decision|2|||
163922298|NCT03840148|592085464|FG001|Study Drug Disposition|Physician Decision|0|||
163922299|NCT03840148|592085463|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
163922300|NCT03840148|592085464|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
163922301|NCT03840148|592085463|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
163922302|NCT03840148|592085464|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
163922303|NCT03840148|592085463|FG000|Study Completion Disposition|Physician Decision|2|||
163922304|NCT03840148|592085464|FG001|Study Completion Disposition|Physician Decision|0|||
163922305|NCT03840148|592085463|FG000|Study Completion Disposition|Covid-19 related|2|||
163922306|NCT03840148|592085464|FG001|Study Completion Disposition|Covid-19 related|0|||
163922307|NCT03840148|592085463|FG000|Study Completion Disposition|Lost to Follow-up|1|||
163922308|NCT03840148|592085464|FG001|Study Completion Disposition|Lost to Follow-up|1|||
163922309|NCT03840148|592085463|FG000|Study Completion Disposition|Death|1|||
163827824|NCT00117676|591737441|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
163827825|NCT00117676|591737440|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
164032736|NCT01335698|592479555|FG004|Treatment Stage 2|Switched to another formulation|0|||
164032737|NCT01170221|592479556|FG000|Overall Study|Lost to Follow-up|22|||
164032738|NCT01170221|592479557|FG001|Overall Study|Lost to Follow-up|21|||
164032739|NCT01170221|592479556|FG000|Overall Study|Withdrawal by Subject|9|||
164032740|NCT01170221|592479557|FG001|Overall Study|Withdrawal by Subject|7|||
163922310|NCT03840148|592085464|FG001|Study Completion Disposition|Death|0|||
163922311|NCT03840148|592085463|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
163922312|NCT03840148|592085464|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
163922313|NCT03615404|592085465|FG000|Overall Study|Death|1|||
163922314|NCT03615404|592085465|FG000|Overall Study|vaccine did not pass quality assurance|1|||
163922315|NCT00257556|592085466|FG000|Overall Study|Adverse Event|1|||
163922316|NCT00257556|592085467|FG001|Overall Study|Adverse Event|4|||
163922317|NCT00257556|592085466|FG000|Overall Study|Physician Decision|6|||
163922318|NCT00257556|592085467|FG001|Overall Study|Physician Decision|0|||
164032741|NCT01170221|592479556|FG000|Overall Study|Subject completed only screening and LFU|1|||
164032742|NCT01170221|592479557|FG001|Overall Study|Subject completed only screening and LFU|0|||
164032743|NCT01170221|592479556|FG000|Overall Study|Randomized but not treated|1|||
164032744|NCT01170221|592479557|FG001|Overall Study|Randomized but not treated|0|||
164032745|NCT02693691|592479558|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
164032746|NCT02693691|592479558|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
164032747|NCT02693691|592479558|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
163827826|NCT00117676|591737441|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
163827827|NCT00117676|591737440|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
163827828|NCT00117676|591737441|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
163827829|NCT00117676|591737440|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
163827830|NCT00117676|591737441|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
163827831|NCT00117676|591737440|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
163827832|NCT00117676|591737441|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
163827833|NCT00117676|591737440|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
163827834|NCT00117676|591737441|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
163827835|NCT00117676|591737440|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
163827836|NCT00117676|591737441|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
163827837|NCT00117676|591737440|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
163827838|NCT00117676|591737441|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
163827839|NCT00117676|591737440|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
163827840|NCT00117676|591737441|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
163827841|NCT00117676|591737440|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
163827842|NCT00117676|591737441|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
163827843|NCT00117676|591737440|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
163827844|NCT00117676|591737441|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
163827845|NCT00117676|591737440|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
163827846|NCT00117676|591737441|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
163827847|NCT00117676|591737440|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
163827848|NCT00117676|591737441|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
163827849|NCT00117676|591737440|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
163827850|NCT00117676|591737441|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
163827851|NCT00117676|591737440|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
163827852|NCT00117676|591737441|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
163827853|NCT00117676|591737440|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
164032748|NCT02693691|592479558|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
164032749|NCT02693691|592479558|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
164032750|NCT02693691|592479558|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
164032751|NCT02693691|592479558|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
164032752|NCT02727660|592479559|FG000|Overall Study|Lack of Efficacy|40|||
164032753|NCT02727660|592479560|FG001|Overall Study|Lack of Efficacy|40|||
164032754|NCT02727660|592479561|FG002|Overall Study|Lack of Efficacy|70|||
164032755|NCT02727660|592479559|FG000|Overall Study|Adverse Event|28|||
164032756|NCT02727660|592479560|FG001|Overall Study|Adverse Event|21|||
164032757|NCT02727660|592479561|FG002|Overall Study|Adverse Event|32|||
164032758|NCT02727660|592479559|FG000|Overall Study|Withdrawal by Subject|26|||
164032759|NCT02727660|592479560|FG001|Overall Study|Withdrawal by Subject|25|||
164032760|NCT02727660|592479561|FG002|Overall Study|Withdrawal by Subject|30|||
164032761|NCT02727660|592479559|FG000|Overall Study|Physician Decision|3|||
164032762|NCT02727660|592479560|FG001|Overall Study|Physician Decision|8|||
164032763|NCT02727660|592479561|FG002|Overall Study|Physician Decision|14|||
164032764|NCT02727660|592479559|FG000|Overall Study|Lost to Follow-up|5|||
164032765|NCT02727660|592479560|FG001|Overall Study|Lost to Follow-up|9|||
164032766|NCT02727660|592479561|FG002|Overall Study|Lost to Follow-up|8|||
164032767|NCT02727660|592479559|FG000|Overall Study|Protocol Violation|7|||
164032768|NCT02727660|592479560|FG001|Overall Study|Protocol Violation|5|||
164032769|NCT02727660|592479561|FG002|Overall Study|Protocol Violation|5|||
164032770|NCT02727660|592479559|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
164032771|NCT02727660|592479560|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
164032772|NCT02727660|592479561|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
164032773|NCT02727660|592479559|FG000|Overall Study|Administrative Reasons|2|||
164032774|NCT02727660|592479560|FG001|Overall Study|Administrative Reasons|3|||
164032775|NCT02727660|592479561|FG002|Overall Study|Administrative Reasons|4|||
164032776|NCT00050960|592479562|FG000|Overall Study|Progressive Disease|137|||
164032777|NCT00050960|592479563|FG001|Overall Study|Progressive Disease|93|||
164032778|NCT00050960|592479562|FG000|Overall Study|Stable Disease|19|||
164032779|NCT00050960|592479563|FG001|Overall Study|Stable Disease|48|||
164032780|NCT00050960|592479562|FG000|Overall Study|Partial Response|14|||
164032781|NCT00050960|592479563|FG001|Overall Study|Partial Response|19|||
164032782|NCT00050960|592479562|FG000|Overall Study|Complete Response|0|||
164032783|NCT00050960|592479563|FG001|Overall Study|Complete Response|2|||
164032784|NCT00050960|592479562|FG000|Overall Study|Adverse Event|62|||
164032785|NCT00050960|592479563|FG001|Overall Study|Adverse Event|61|||
164032786|NCT00050960|592479562|FG000|Overall Study|Lost to Follow-up|0|||
164032787|NCT00050960|592479563|FG001|Overall Study|Lost to Follow-up|1|||
164032788|NCT00050960|592479562|FG000|Overall Study|Withdrawal by Subject|23|||
164032789|NCT00050960|592479563|FG001|Overall Study|Withdrawal by Subject|18|||
164032790|NCT00050960|592479562|FG000|Overall Study|Administrative|31|||
164032791|NCT00050960|592479563|FG001|Overall Study|Administrative|46|||
164032792|NCT00050960|592479562|FG000|Overall Study|Non-compliance|3|||
164032793|NCT00050960|592479563|FG001|Overall Study|Non-compliance|1|||
164032794|NCT00050960|592479562|FG000|Overall Study|Death|13|||
164032795|NCT00050960|592479563|FG001|Overall Study|Death|15|||
164032796|NCT00764946|592479568|FG000|Overall Study|Lack of Efficacy|1|||
164032797|NCT00764946|592479569|FG001|Overall Study|Lack of Efficacy|0|||
164032798|NCT00764946|592479570|FG002|Overall Study|Lack of Efficacy|0|||
164032799|NCT00764946|592479568|FG000|Overall Study|Lost to Follow-up|3|||
164032800|NCT00764946|592479569|FG001|Overall Study|Lost to Follow-up|4|||
164032801|NCT00764946|592479570|FG002|Overall Study|Lost to Follow-up|0|||
164032802|NCT00764946|592479568|FG000|Overall Study|Physician Decision|2|||
164032803|NCT00764946|592479569|FG001|Overall Study|Physician Decision|4|||
164032804|NCT00764946|592479570|FG002|Overall Study|Physician Decision|0|||
164032805|NCT00764946|592479568|FG000|Overall Study|Adverse Event|3|||
164032806|NCT00764946|592479569|FG001|Overall Study|Adverse Event|2|||
164032807|NCT00764946|592479570|FG002|Overall Study|Adverse Event|1|||
164032808|NCT00764946|592479568|FG000|Overall Study|Withdrawal by Subject|3|||
164032809|NCT00764946|592479569|FG001|Overall Study|Withdrawal by Subject|6|||
164032810|NCT00764946|592479570|FG002|Overall Study|Withdrawal by Subject|2|||
164032811|NCT00764946|592479568|FG000|Overall Study|Never Treated|1|||
164032812|NCT00764946|592479569|FG001|Overall Study|Never Treated|1|||
164032813|NCT00764946|592479570|FG002|Overall Study|Never Treated|1|||
164032814|NCT01162304|592479571|FG000|Overall Study|Beck scale to high|11|||
164032815|NCT01315847|592479572|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
164032816|NCT01315847|592479573|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
164032817|NCT01315847|592479572|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
164032818|NCT01315847|592479573|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
164032819|NCT02940626|592479574|FG000|Overall Study|Death|40|||
164032820|NCT02940626|592479575|FG001|Overall Study|Death|32|||
164032821|NCT02940626|592479574|FG000|Overall Study|Lost to Follow-up|5|||
164032822|NCT02940626|592479575|FG001|Overall Study|Lost to Follow-up|2|||
164032823|NCT02940626|592479574|FG000|Overall Study|Withdrawal by Subject|1|||
164032824|NCT02940626|592479575|FG001|Overall Study|Withdrawal by Subject|0|||
164032825|NCT02940626|592479574|FG000|Overall Study|Transfer to Hospice Care|1|||
163922319|NCT00257556|592085466|FG000|Overall Study|Did not meet hCG criterion|3|||
163922320|NCT00257556|592085467|FG001|Overall Study|Did not meet hCG criterion|0|||
163922321|NCT00257556|592085466|FG000|Overall Study|other reason|4|||
163922322|NCT00257556|592085467|FG001|Overall Study|other reason|6|||
163922323|NCT03849300|592085469|FG000|Overall Study|move out to different area|1|||
163922324|NCT03849300|592085470|FG001|Overall Study|move out to different area|3|||
163922325|NCT03849300|592085471|FG002|Overall Study|move out to different area|1|||
163922326|NCT03849300|592085472|FG003|Overall Study|move out to different area|4|||
163922327|NCT03849300|592085469|FG000|Overall Study|scheduling/transportation conflict|4|||
163922328|NCT03849300|592085470|FG001|Overall Study|scheduling/transportation conflict|4|||
163922329|NCT03849300|592085471|FG002|Overall Study|scheduling/transportation conflict|3|||
163922330|NCT03849300|592085472|FG003|Overall Study|scheduling/transportation conflict|2|||
163922331|NCT04839289|592085473|FG000|Overall Study|Withdrawal by Subject|1|||
163922332|NCT04839289|592085474|FG001|Overall Study|Withdrawal by Subject|0|||
163922333|NCT00464737|592085476|FG000|Overall Study|Adverse Event|12|||
163922334|NCT00464737|592085477|FG001|Overall Study|Adverse Event|17|||
163922335|NCT00464737|592085478|FG002|Overall Study|Adverse Event|33|||
163922336|NCT00464737|592085476|FG000|Overall Study|Lack of Efficacy|7|||
163922337|NCT00464737|592085477|FG001|Overall Study|Lack of Efficacy|7|||
163922338|NCT00464737|592085478|FG002|Overall Study|Lack of Efficacy|4|||
163922339|NCT00464737|592085476|FG000|Overall Study|Withdrawal by Subject|5|||
163922340|NCT00464737|592085477|FG001|Overall Study|Withdrawal by Subject|3|||
163922341|NCT00464737|592085478|FG002|Overall Study|Withdrawal by Subject|5|||
163922342|NCT00464737|592085476|FG000|Overall Study|Protocol Violation|1|||
163922343|NCT00464737|592085477|FG001|Overall Study|Protocol Violation|1|||
163922344|NCT00464737|592085478|FG002|Overall Study|Protocol Violation|5|||
163922345|NCT00464737|592085476|FG000|Overall Study|Non-compliance|0|||
163922346|NCT00464737|592085477|FG001|Overall Study|Non-compliance|1|||
163922347|NCT00464737|592085478|FG002|Overall Study|Non-compliance|1|||
163922348|NCT00464737|592085476|FG000|Overall Study|Lost to Follow-up|5|||
163922349|NCT00464737|592085477|FG001|Overall Study|Lost to Follow-up|2|||
163922350|NCT00464737|592085478|FG002|Overall Study|Lost to Follow-up|5|||
163922351|NCT00464737|592085476|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
163922352|NCT00464737|592085477|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
163922353|NCT00464737|592085478|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
163922354|NCT00464737|592085476|FG000|Overall Study|Other: Subject left town; family illness|1|||
163922355|NCT00464737|592085477|FG001|Overall Study|Other: Subject left town; family illness|0|||
163922356|NCT00464737|592085478|FG002|Overall Study|Other: Subject left town; family illness|0|||
163922357|NCT00464737|592085476|FG000|Overall Study|Other: Study demands too great|0|||
163922358|NCT00464737|592085477|FG001|Overall Study|Other: Study demands too great|1|||
163922359|NCT00464737|592085478|FG002|Overall Study|Other: Study demands too great|0|||
163922360|NCT00464737|592085476|FG000|Overall Study|Other: Personal family reasons|0|||
163922361|NCT00464737|592085477|FG001|Overall Study|Other: Personal family reasons|0|||
163922362|NCT00464737|592085478|FG002|Overall Study|Other: Personal family reasons|1|||
163922363|NCT00464737|592085476|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
163922364|NCT00464737|592085477|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
163922365|NCT00464737|592085478|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
163922366|NCT00580047|592085481|FG000|Overall Study|Lost to Follow-up|1|||
163922367|NCT00580047|592085482|FG001|Overall Study|Lost to Follow-up|1|||
164032826|NCT02940626|592479575|FG001|Overall Study|Transfer to Hospice Care|0|||
164032827|NCT02940626|592479574|FG000|Overall Study|Prohibited Concomitant Medication|0|||
164032828|NCT02940626|592479575|FG001|Overall Study|Prohibited Concomitant Medication|1|||
164032829|NCT00585923|592479577|FG000|Overall Study|Physician decided not to continue|31|||
164032830|NCT00585923|592479578|FG001|Overall Study|Physician decided not to continue|33|||
164032831|NCT01324622|592479579|FG000|Overall Study|Lost to Follow-up|7|||
164032832|NCT01324622|592479580|FG001|Overall Study|Lost to Follow-up|7|||
164032833|NCT01324622|592479579|FG000|Overall Study|Death|1|||
164032834|NCT01324622|592479580|FG001|Overall Study|Death|0|||
164032835|NCT01324622|592479579|FG000|Overall Study|Lack of Efficacy|1|||
164032836|NCT01324622|592479580|FG001|Overall Study|Lack of Efficacy|0|||
164032837|NCT00878215|592479581|FG000|Overall Study|Determined to be ineligible|0|||
164032838|NCT00878215|592479582|FG001|Overall Study|Determined to be ineligible|10|||
164032839|NCT00878215|592479583|FG002|Overall Study|Determined to be ineligible|0|||
164032840|NCT00878215|592479584|FG003|Overall Study|Determined to be ineligible|0|||
164032841|NCT00138424|592479585|FG000|Overall Study|Physician Decision|0|||
164097657|NCT00723528|592722777|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
163922368|NCT00580047|592085483|FG002|Overall Study|Lost to Follow-up|0|||
164097658|NCT00723528|592722771|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
163922369|NCT00580047|592085481|FG000|Overall Study|Withdrawal by Subject|1|||
163922370|NCT00580047|592085482|FG001|Overall Study|Withdrawal by Subject|1|||
163922371|NCT00580047|592085483|FG002|Overall Study|Withdrawal by Subject|2|||
163922372|NCT00580047|592085481|FG000|Overall Study|Withdrawal by Subject|1|||
163922373|NCT00580047|592085482|FG001|Overall Study|Withdrawal by Subject|0|||
163922374|NCT00580047|592085483|FG002|Overall Study|Withdrawal by Subject|0|||
164032842|NCT00138424|592479586|FG001|Overall Study|Physician Decision|1|||
163922375|NCT01780584|592085486|FG000|Overall Study|Death|1|||
164032843|NCT00138424|592479587|FG002|Overall Study|Physician Decision|0|||
164032844|NCT00138424|592479588|FG003|Overall Study|Physician Decision|0|||
164032845|NCT00413062|592479595|FG000|Overall Study|Adverse event/serious adverse event|289|||
164032846|NCT00413062|592479596|FG001|Overall Study|Adverse event/serious adverse event|56|||
164032847|NCT00413062|592479595|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
164032848|NCT00413062|592479596|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
164032849|NCT00413062|592479595|FG000|Overall Study|Withdrawal of informed consent|111|||
164032850|NCT00413062|592479596|FG001|Overall Study|Withdrawal of informed consent|36|||
164032851|NCT00413062|592479595|FG000|Overall Study|Pregnancy|15|||
164032852|NCT00413062|592479596|FG001|Overall Study|Pregnancy|5|||
164032853|NCT00413062|592479595|FG000|Overall Study|Pregnancy wish|17|||
164032854|NCT00413062|592479596|FG001|Overall Study|Pregnancy wish|6|||
164032855|NCT00413062|592479595|FG000|Overall Study|Lost to Follow-up|175|||
164032856|NCT00413062|592479596|FG001|Overall Study|Lost to Follow-up|73|||
164032857|NCT00413062|592479595|FG000|Overall Study|Other reason|70|||
164032858|NCT00413062|592479596|FG001|Overall Study|Other reason|34|||
164032859|NCT02176291|592479597|FG000|Overall Study|Death|1|||
164032860|NCT02176291|592479598|FG001|Overall Study|Death|0|||
164032861|NCT02176291|592479597|FG000|Overall Study|non compliance with protocol|2|||
164032862|NCT02176291|592479598|FG001|Overall Study|non compliance with protocol|0|||
164032863|NCT02176291|592479597|FG000|Overall Study|Withdrawal by Subject|2|||
164032864|NCT02176291|592479598|FG001|Overall Study|Withdrawal by Subject|0|||
164032865|NCT02815293|592479599|FG000|Overall Study|Study termination by sponsor|10|||
163922376|NCT01780584|592085487|FG001|Overall Study|Death|0|||
163922377|NCT01780584|592085488|FG002|Overall Study|Death|1|||
163922378|NCT01780584|592085486|FG000|Overall Study|Adverse Event|0|||
163922379|NCT01780584|592085487|FG001|Overall Study|Adverse Event|1|||
163922380|NCT01780584|592085488|FG002|Overall Study|Adverse Event|0|||
163922381|NCT01780584|592085486|FG000|Overall Study|Protocol Violation|0|||
163922382|NCT01780584|592085487|FG001|Overall Study|Protocol Violation|0|||
163922383|NCT01780584|592085488|FG002|Overall Study|Protocol Violation|1|||
163922384|NCT00727259|592085497|FG000|Overall Study|Not all questionnaires completed|1055|||
163922385|NCT01021683|592085498|FG000|Overall Study|Lack of Efficacy|12|||
163922386|NCT01021683|592085498|FG000|Overall Study|Recovery of neutrophil count|51|||
163922387|NCT01021683|592085498|FG000|Overall Study|Other|8|||
163922388|NCT01374971|592085499|FG000|Overall Study|Withdrawal by Subject|1|||
163922389|NCT01821729|592086888|FG000|Overall Study|Withdrawal by Subject|1|||
163922390|NCT01845649|592086889|FG000|Overall Study|Adverse Event|7|||
163922391|NCT01845649|592086890|FG001|Overall Study|Adverse Event|10|||
164032866|NCT02815293|592479600|FG001|Overall Study|Study termination by sponsor|7|||
164032867|NCT02815293|592479601|FG002|Overall Study|Study termination by sponsor|0|||
164032868|NCT02815293|592479599|FG000|Overall Study|Participants not randomized|0|||
164032869|NCT02815293|592479600|FG001|Overall Study|Participants not randomized|0|||
164032870|NCT02815293|592479601|FG002|Overall Study|Participants not randomized|18|||
164032871|NCT02815293|592479599|FG000|Overall Study|Adverse Event|0|||
164032872|NCT02815293|592479600|FG001|Overall Study|Adverse Event|1|||
164032873|NCT02815293|592479601|FG002|Overall Study|Adverse Event|0|||
164032874|NCT00006604|592479602|FG000|Overall Study|Met study objective - no further FU|1|||
164032875|NCT00006604|592479603|FG001|Overall Study|Met study objective - no further FU|0|||
164032876|NCT00006604|592479604|FG002|Overall Study|Met study objective - no further FU|0|||
164032877|NCT00006604|592479605|FG003|Overall Study|Met study objective - no further FU|0|||
164032878|NCT00006604|592479606|FG004|Overall Study|Met study objective - no further FU|0|||
164032879|NCT00006604|592479607|FG005|Overall Study|Met study objective - no further FU|0|||
164032880|NCT00006604|592479608|FG006|Overall Study|Met study objective - no further FU|0|||
164032881|NCT00006604|592479609|FG007|Overall Study|Met study objective - no further FU|0|||
164032882|NCT00006604|592479610|FG008|Overall Study|Met study objective - no further FU|0|||
164032883|NCT00006604|592479611|FG009|Overall Study|Met study objective - no further FU|0|||
164032884|NCT00006604|592479612|FG010|Overall Study|Met study objective - no further FU|0|||
164032885|NCT00006604|592479613|FG011|Overall Study|Met study objective - no further FU|0|||
164032886|NCT00006604|592479614|FG012|Overall Study|Met study objective - no further FU|0|||
164032887|NCT00006604|592479615|FG013|Overall Study|Met study objective - no further FU|0|||
164032888|NCT00006604|592479616|FG014|Overall Study|Met study objective - no further FU|1|||
163922392|NCT01845649|592086889|FG000|Overall Study|Lack of Efficacy|1|||
164032889|NCT00006604|592479617|FG015|Overall Study|Met study objective - no further FU|1|||
164032890|NCT00006604|592479618|FG016|Overall Study|Met study objective - no further FU|0|||
164032891|NCT00006604|592479602|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
164032892|NCT00006604|592479603|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
164032893|NCT00006604|592479604|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
164032894|NCT00006604|592479605|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
163922393|NCT01845649|592086890|FG001|Overall Study|Lack of Efficacy|1|||
163922394|NCT01845649|592086889|FG000|Overall Study|Lost to Follow-up|2|||
163922395|NCT01845649|592086890|FG001|Overall Study|Lost to Follow-up|2|||
163922396|NCT01845649|592086889|FG000|Overall Study|Withdrew Consent|12|||
163922397|NCT01845649|592086890|FG001|Overall Study|Withdrew Consent|4|||
163922398|NCT01845649|592086889|FG000|Overall Study|Protocol Deviation|7|||
163922399|NCT01845649|592086890|FG001|Overall Study|Protocol Deviation|4|||
163922400|NCT01845649|592086889|FG000|Overall Study|Reason not Specified|2|||
163922401|NCT01845649|592086890|FG001|Overall Study|Reason not Specified|1|||
163922402|NCT00381797|592086891|FG000|Overall Study|Withdrawal by Subject|1|||
163922403|NCT00381797|592086892|FG001|Overall Study|Withdrawal by Subject|1|||
163922404|NCT00381797|592086893|FG002|Overall Study|Withdrawal by Subject|0|||
163922405|NCT00381797|592086894|FG003|Overall Study|Withdrawal by Subject|0|||
163922406|NCT00381797|592086895|FG004|Overall Study|Withdrawal by Subject|2|||
163922407|NCT00381797|592086891|FG000|Overall Study|Ineligible|0|||
163922408|NCT00381797|592086892|FG001|Overall Study|Ineligible|0|||
163922409|NCT00381797|592086893|FG002|Overall Study|Ineligible|0|||
163922410|NCT00381797|592086894|FG003|Overall Study|Ineligible|1|||
163922411|NCT00381797|592086895|FG004|Overall Study|Ineligible|0|||
163922412|NCT03418493|592086898|FG000|Overall Study|Adverse Event|1|||
163922413|NCT03418493|592086899|FG001|Overall Study|Adverse Event|0|||
163922414|NCT03418493|592086900|FG002|Overall Study|Adverse Event|0|||
163922415|NCT03418493|592086901|FG003|Overall Study|Adverse Event|0|||
163922416|NCT03418493|592086902|FG004|Overall Study|Adverse Event|0|||
163922417|NCT03418493|592086903|FG005|Overall Study|Adverse Event|0|||
163922418|NCT03418493|592086904|FG006|Overall Study|Adverse Event|0|||
163922419|NCT03418493|592086905|FG007|Overall Study|Adverse Event|0|||
163922420|NCT03418493|592086906|FG008|Overall Study|Adverse Event|0|||
163922421|NCT03418493|592086907|FG009|Overall Study|Adverse Event|0|||
163922422|NCT03418493|592086908|FG010|Overall Study|Adverse Event|0|||
163922423|NCT03418493|592086898|FG000|Overall Study|Protocol Violation|0|||
163922424|NCT03418493|592086899|FG001|Overall Study|Protocol Violation|0|||
163922425|NCT03418493|592086900|FG002|Overall Study|Protocol Violation|0|||
163922426|NCT03418493|592086901|FG003|Overall Study|Protocol Violation|0|||
163922427|NCT03418493|592086902|FG004|Overall Study|Protocol Violation|0|||
163922428|NCT03418493|592086903|FG005|Overall Study|Protocol Violation|0|||
163922429|NCT03418493|592086904|FG006|Overall Study|Protocol Violation|0|||
163922430|NCT03418493|592086905|FG007|Overall Study|Protocol Violation|0|||
163922431|NCT03418493|592086906|FG008|Overall Study|Protocol Violation|0|||
163922432|NCT03418493|592086907|FG009|Overall Study|Protocol Violation|1|||
163922433|NCT03418493|592086908|FG010|Overall Study|Protocol Violation|0|||
163922434|NCT00526097|592086909|FG000|Overall Study|Adverse Event|6|||
163922435|NCT00526097|592086910|FG001|Overall Study|Adverse Event|44|||
163922436|NCT00526097|592086909|FG000|Overall Study|Protocol Violation|4|||
163922437|NCT00526097|592086910|FG001|Overall Study|Protocol Violation|10|||
163922438|NCT00526097|592086909|FG000|Overall Study|Withdrawal by Subject|3|||
163922439|NCT00526097|592086910|FG001|Overall Study|Withdrawal by Subject|1|||
163922440|NCT00526097|592086909|FG000|Overall Study|Other|2|||
163922441|NCT00526097|592086910|FG001|Overall Study|Other|1|||
163922442|NCT00966979|592086911|FG000|Overall Study|Death|1|||
163922443|NCT00966979|592086911|FG000|Overall Study|Lost to Follow-up|6|||
163922444|NCT00966979|592086911|FG000|Overall Study|Withdrawal by Subject|14|||
163922445|NCT00966979|592086911|FG000|Overall Study|Adverse Event|5|||
163922446|NCT00966979|592086911|FG000|Overall Study|Sponsor terminated early|49|||
163922447|NCT00966979|592086911|FG000|Overall Study|Censored because surgery not done|2|||
163922448|NCT00966979|592086911|FG000|Overall Study|Censored because study device was not implanted|14|||
163922449|NCT00966979|592086911|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
163922450|NCT01990313|592086915|FG000|Overall Study|Lost to Follow-up|1|||
163922451|NCT02412111|592086916|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
163922452|NCT02412111|592086917|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
163922453|NCT02412111|592086918|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
163922454|NCT02412111|592086916|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
163922455|NCT02412111|592086917|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
163922456|NCT02412111|592086918|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
163922457|NCT02412111|592086916|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
163922458|NCT02412111|592086917|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
163922459|NCT02412111|592086918|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
163922460|NCT02412111|592086916|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
163922461|NCT02412111|592086917|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
163922462|NCT02412111|592086918|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
163922463|NCT02412111|592086916|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
163922464|NCT02412111|592086917|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
163922465|NCT02412111|592086918|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
163922466|NCT02412111|592086916|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
163922467|NCT02412111|592086917|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
163922468|NCT02412111|592086918|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
163922469|NCT02412111|592086916|FG000|Active Comparator Period (8 Weeks)|Other|0|||
163922470|NCT02412111|592086917|FG001|Active Comparator Period (8 Weeks)|Other|0|||
163922471|NCT02412111|592086918|FG002|Active Comparator Period (8 Weeks)|Other|2|||
163922472|NCT00837096|592086920|FG000|Overall Study|Physician Decision|1|||
163922473|NCT00837096|592086921|FG001|Overall Study|Physician Decision|1|||
163922474|NCT00837096|592086920|FG000|Overall Study|Not reported|9|||
163922475|NCT00837096|592086921|FG001|Overall Study|Not reported|8|||
163922476|NCT00721214|592086922|FG000|Overall Study|Chose another center for transplant|1|||
163922477|NCT00721214|592086922|FG000|Overall Study|Death|3|||
163922478|NCT00983905|592086923|FG000|Theophylline Alone|Adverse Event|1|||
163922479|NCT00983905|592086923|FG000|Colchicine Alone|Adverse Event|2|||
163922480|NCT01169636|592086924|FG000|Overall Study|Adverse Event|0|||
163922481|NCT01169636|592086925|FG001|Overall Study|Adverse Event|0|||
163922482|NCT01169636|592086926|FG002|Overall Study|Adverse Event|1|||
163922483|NCT01169636|592086927|FG003|Overall Study|Adverse Event|1|||
163922484|NCT01169636|592086928|FG004|Overall Study|Adverse Event|0|||
163922485|NCT01169636|592086924|FG000|Overall Study|Screen failure|0|||
163922486|NCT01169636|592086925|FG001|Overall Study|Screen failure|0|||
163922487|NCT01169636|592086926|FG002|Overall Study|Screen failure|2|||
163922488|NCT01169636|592086927|FG003|Overall Study|Screen failure|0|||
163922489|NCT01169636|592086928|FG004|Overall Study|Screen failure|0|||
163922490|NCT01169636|592086924|FG000|Overall Study|Withdrawal by Subject|0|||
163922491|NCT01169636|592086925|FG001|Overall Study|Withdrawal by Subject|0|||
163922492|NCT01169636|592086926|FG002|Overall Study|Withdrawal by Subject|0|||
163922493|NCT01169636|592086927|FG003|Overall Study|Withdrawal by Subject|0|||
163922494|NCT01169636|592086928|FG004|Overall Study|Withdrawal by Subject|3|||
163922495|NCT02396953|592086929|FG000|Overall Study|Withdrawal by Subject|0|||
163922496|NCT02396953|592086930|FG001|Overall Study|Withdrawal by Subject|0|||
163922497|NCT02396953|592086931|FG002|Overall Study|Withdrawal by Subject|1|||
163922498|NCT02396953|592086929|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
163922499|NCT02396953|592086930|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
163922500|NCT02396953|592086931|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
163922501|NCT02396953|592086929|FG000|Overall Study|Personal Reasons|1|||
163922502|NCT02396953|592086930|FG001|Overall Study|Personal Reasons|1|||
163922503|NCT02396953|592086931|FG002|Overall Study|Personal Reasons|0|||
163922504|NCT00510198|592086932|FG000|Overall Study|Withdrawal by Subject|5|||
163922505|NCT00510198|592086933|FG001|Overall Study|Withdrawal by Subject|4|||
163922506|NCT00494026|592086935|FG000|Overall Study|Sponsor Decision|4|||
163922507|NCT02466243|592086936|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
163922508|NCT02466243|592086937|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
163922509|NCT02466243|592086936|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
163922510|NCT02466243|592086937|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
163922511|NCT02466243|592086936|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
163922512|NCT02466243|592086937|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
163922513|NCT02466243|592086936|FG000|Part B Open-label Treatment Period|Missing|2|||
163922514|NCT02466243|592086937|FG001|Part B Open-label Treatment Period|Missing|2|||
163922515|NCT01885936|592086943|FG000|Overall Study|Withdrawal by Subject|1|||
163922516|NCT01885936|592086944|FG001|Overall Study|Withdrawal by Subject|0|||
163922517|NCT03214250|592086945|FG000|Overall Study|Death|5|||
163922518|NCT03214250|592086946|FG001|Overall Study|Death|5|||
163922519|NCT03214250|592086947|FG002|Overall Study|Death|7|||
163922520|NCT03214250|592086948|FG003|Overall Study|Death|4|||
163922521|NCT03214250|592086949|FG004|Overall Study|Death|23|||
163922522|NCT03214250|592086950|FG005|Overall Study|Death|23|||
163922523|NCT03214250|592086951|FG006|Overall Study|Death|24|||
164032895|NCT00006604|592479606|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
164032896|NCT00006604|592479607|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
164032897|NCT00006604|592479608|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
164032898|NCT00006604|592479609|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
164032899|NCT00006604|592479610|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
164032900|NCT00006604|592479611|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
164032901|NCT00006604|592479612|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
163922524|NCT03214250|592086945|FG000|Overall Study|Lost to Follow-up|0|||
164032902|NCT00006604|592479613|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
164032903|NCT00006604|592479614|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
163922525|NCT03214250|592086946|FG001|Overall Study|Lost to Follow-up|0|||
163922526|NCT03214250|592086947|FG002|Overall Study|Lost to Follow-up|0|||
163922527|NCT03214250|592086948|FG003|Overall Study|Lost to Follow-up|1|||
163922528|NCT03214250|592086949|FG004|Overall Study|Lost to Follow-up|1|||
163922529|NCT03214250|592086950|FG005|Overall Study|Lost to Follow-up|2|||
163922530|NCT03214250|592086951|FG006|Overall Study|Lost to Follow-up|0|||
163922531|NCT03214250|592086945|FG000|Overall Study|Other|0|||
163922532|NCT03214250|592086946|FG001|Overall Study|Other|0|||
163922533|NCT03214250|592086947|FG002|Overall Study|Other|0|||
163922534|NCT03214250|592086948|FG003|Overall Study|Other|0|||
163922535|NCT03214250|592086949|FG004|Overall Study|Other|1|||
163922536|NCT03214250|592086950|FG005|Overall Study|Other|1|||
163922537|NCT03214250|592086951|FG006|Overall Study|Other|2|||
164032904|NCT00006604|592479615|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
164147140|NCT02466685|592899988|FG001|Overall Study|Lost to Follow-up|1|||
163827854|NCT00117676|591737441|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
163827855|NCT00117676|591737440|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
163827856|NCT00117676|591737441|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
163827857|NCT00117676|591737440|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
163827858|NCT00117676|591737441|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
163827859|NCT00952822|591737442|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
163827860|NCT00952822|591737443|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
163827861|NCT00952822|591737444|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
163827862|NCT00952822|591737445|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
163827863|NCT00952822|591737442|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
163827864|NCT00952822|591737443|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
163827865|NCT00952822|591737444|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
163827866|NCT00952822|591737445|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
163827867|NCT00691938|591737446|FG000|Overall Study|QTc prolongation|1|||
163827868|NCT00691938|591737447|FG001|Overall Study|QTc prolongation|0|||
163827869|NCT00691938|591737448|FG002|Overall Study|QTc prolongation|0|||
163827870|NCT00691938|591737449|FG003|Overall Study|QTc prolongation|0|||
163827871|NCT00691938|591737450|FG004|Overall Study|QTc prolongation|0|||
163827872|NCT00691938|591737451|FG005|Overall Study|QTc prolongation|0|||
163827873|NCT00691938|591737452|FG006|Overall Study|QTc prolongation|0|||
163827874|NCT00594854|591737454|FG000|Overall Study|Study terminated|7|||
163827875|NCT00594854|591737455|FG001|Overall Study|Study terminated|10|||
163827876|NCT04918147|591737466|FG000|Overall Study|Disease flare as defined in protocol|0|||
163827877|NCT04918147|591737467|FG001|Overall Study|Disease flare as defined in protocol|2|||
163827878|NCT03292146|591737468|FG000|Baseline to 12 months|Relocation|1|||
163827879|NCT03292146|591737469|FG001|Baseline to 12 months|Relocation|0|||
163827880|NCT03292146|591737468|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
163827881|NCT03292146|591737469|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
163827882|NCT03292146|591737468|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
163827883|NCT03292146|591737469|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
163827884|NCT03292146|591737468|FG000|12 months to 24 months|Planning pregnancy|2|||
163827885|NCT03292146|591737469|FG001|12 months to 24 months|Planning pregnancy|2|||
163827886|NCT03292146|591737468|FG000|12 months to 24 months|Personal reasons|1|||
163827887|NCT03292146|591737469|FG001|12 months to 24 months|Personal reasons|0|||
163827888|NCT03292146|591737468|FG000|12 months to 24 months|Lost to Follow-up|0|||
163827889|NCT03292146|591737469|FG001|12 months to 24 months|Lost to Follow-up|1|||
163827890|NCT06134180|591737470|FG000|Overall Study|Lost to Follow-up|4|||
163827891|NCT01362439|591737471|FG000|Overall Study|Adverse Event|1|||
163827892|NCT01362439|591737471|FG000|Overall Study|Lack of Efficacy|3|||
163827893|NCT01362439|591737471|FG000|Overall Study|Lost to Follow-up|2|||
163827894|NCT01362439|591737471|FG000|Overall Study|Study medication non-compliant|1|||
163827895|NCT01362439|591737471|FG000|Overall Study|Participant who withdrew consent|8|||
163827896|NCT02712905|591737474|FG000|Monotherapy|Death|2|||
163827897|NCT02712905|591737475|FG001|Monotherapy|Death|5|||
163827898|NCT02712905|591737476|FG002|Monotherapy|Death|0|||
163827899|NCT02712905|591737477|FG003|Monotherapy|Death|3|||
163827900|NCT02712905|591737478|FG004|Monotherapy|Death|15|||
163827901|NCT02712905|591737479|FG005|Monotherapy|Death|1|||
163827902|NCT02712905|591737480|FG006|Monotherapy|Death|3|||
163827903|NCT02712905|591737481|FG007|Monotherapy|Death|3|||
163827904|NCT02712905|591737482|FG008|Monotherapy|Death|0|||
163827905|NCT02712905|591737483|FG009|Monotherapy|Death|27|||
163827906|NCT02712905|591737484|FG010|Monotherapy|Death|2|||
163827907|NCT02712905|591737485|FG011|Monotherapy|Death|5|||
163827908|NCT02712905|591737486|FG012|Monotherapy|Death|0|||
163827909|NCT02712905|591737487|FG013|Monotherapy|Death|0|||
163827910|NCT02712905|591737488|FG014|Monotherapy|Death|0|||
163827911|NCT02712905|591737489|FG015|Monotherapy|Death|0|||
163827912|NCT02712905|591737490|FG016|Monotherapy|Death|0|||
163827913|NCT02712905|591737491|FG017|Monotherapy|Death|0|||
163827914|NCT02712905|591737474|FG000|Monotherapy|Lost to Follow-up|0|||
163827915|NCT02712905|591737475|FG001|Monotherapy|Lost to Follow-up|1|||
163827916|NCT02712905|591737476|FG002|Monotherapy|Lost to Follow-up|0|||
163827917|NCT02712905|591737477|FG003|Monotherapy|Lost to Follow-up|1|||
163827918|NCT02712905|591737478|FG004|Monotherapy|Lost to Follow-up|0|||
163827919|NCT02712905|591737479|FG005|Monotherapy|Lost to Follow-up|0|||
163827920|NCT02712905|591737480|FG006|Monotherapy|Lost to Follow-up|0|||
163827921|NCT02712905|591737481|FG007|Monotherapy|Lost to Follow-up|0|||
163827922|NCT02712905|591737482|FG008|Monotherapy|Lost to Follow-up|0|||
163827923|NCT02712905|591737483|FG009|Monotherapy|Lost to Follow-up|2|||
163827924|NCT02712905|591737484|FG010|Monotherapy|Lost to Follow-up|0|||
163827925|NCT02712905|591737485|FG011|Monotherapy|Lost to Follow-up|0|||
163827926|NCT02712905|591737486|FG012|Monotherapy|Lost to Follow-up|0|||
163827927|NCT02712905|591737487|FG013|Monotherapy|Lost to Follow-up|0|||
163827928|NCT02712905|591737488|FG014|Monotherapy|Lost to Follow-up|0|||
163827929|NCT02712905|591737489|FG015|Monotherapy|Lost to Follow-up|0|||
164032905|NCT00006604|592479616|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
164032906|NCT00006604|592479617|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
164032907|NCT00006604|592479618|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
163827930|NCT02712905|591737490|FG016|Monotherapy|Lost to Follow-up|0|||
163827931|NCT02712905|591737491|FG017|Monotherapy|Lost to Follow-up|0|||
163827932|NCT02712905|591737474|FG000|Monotherapy|Physician Decision|1|||
163827933|NCT02712905|591737475|FG001|Monotherapy|Physician Decision|0|||
163827934|NCT02712905|591737476|FG002|Monotherapy|Physician Decision|0|||
163827935|NCT02712905|591737477|FG003|Monotherapy|Physician Decision|1|||
163827936|NCT02712905|591737478|FG004|Monotherapy|Physician Decision|0|||
163827937|NCT02712905|591737479|FG005|Monotherapy|Physician Decision|0|||
163827938|NCT02712905|591737480|FG006|Monotherapy|Physician Decision|0|||
163827939|NCT02712905|591737481|FG007|Monotherapy|Physician Decision|0|||
163827940|NCT02712905|591737482|FG008|Monotherapy|Physician Decision|0|||
163827941|NCT02712905|591737483|FG009|Monotherapy|Physician Decision|1|||
163827942|NCT02712905|591737484|FG010|Monotherapy|Physician Decision|0|||
163827943|NCT02712905|591737485|FG011|Monotherapy|Physician Decision|0|||
163827944|NCT02712905|591737486|FG012|Monotherapy|Physician Decision|0|||
163827945|NCT02712905|591737487|FG013|Monotherapy|Physician Decision|0|||
163827946|NCT02712905|591737488|FG014|Monotherapy|Physician Decision|0|||
163827947|NCT02712905|591737489|FG015|Monotherapy|Physician Decision|0|||
163827948|NCT02712905|591737490|FG016|Monotherapy|Physician Decision|0|||
163827949|NCT02712905|591737491|FG017|Monotherapy|Physician Decision|0|||
163827950|NCT02712905|591737474|FG000|Monotherapy|Study Terminated by Sponsor|0|||
163827951|NCT02712905|591737475|FG001|Monotherapy|Study Terminated by Sponsor|0|||
163827952|NCT02712905|591737476|FG002|Monotherapy|Study Terminated by Sponsor|0|||
163827953|NCT02712905|591737477|FG003|Monotherapy|Study Terminated by Sponsor|0|||
163827954|NCT02712905|591737478|FG004|Monotherapy|Study Terminated by Sponsor|1|||
163827955|NCT02712905|591737479|FG005|Monotherapy|Study Terminated by Sponsor|0|||
163827956|NCT02712905|591737480|FG006|Monotherapy|Study Terminated by Sponsor|0|||
163827957|NCT02712905|591737481|FG007|Monotherapy|Study Terminated by Sponsor|0|||
163827958|NCT02712905|591737482|FG008|Monotherapy|Study Terminated by Sponsor|0|||
163827959|NCT02712905|591737483|FG009|Monotherapy|Study Terminated by Sponsor|2|||
163827960|NCT02712905|591737484|FG010|Monotherapy|Study Terminated by Sponsor|0|||
163827961|NCT02712905|591737485|FG011|Monotherapy|Study Terminated by Sponsor|0|||
163827962|NCT02712905|591737486|FG012|Monotherapy|Study Terminated by Sponsor|0|||
163827963|NCT02712905|591737487|FG013|Monotherapy|Study Terminated by Sponsor|0|||
163827964|NCT02712905|591737488|FG014|Monotherapy|Study Terminated by Sponsor|0|||
163827965|NCT02712905|591737489|FG015|Monotherapy|Study Terminated by Sponsor|0|||
163827966|NCT02712905|591737490|FG016|Monotherapy|Study Terminated by Sponsor|0|||
163827967|NCT02712905|591737491|FG017|Monotherapy|Study Terminated by Sponsor|0|||
163827968|NCT02712905|591737474|FG000|Monotherapy|Withdrawal by Subject|0|||
163827969|NCT02712905|591737475|FG001|Monotherapy|Withdrawal by Subject|0|||
163827970|NCT02712905|591737476|FG002|Monotherapy|Withdrawal by Subject|1|||
163827971|NCT02712905|591737477|FG003|Monotherapy|Withdrawal by Subject|0|||
163827972|NCT02712905|591737478|FG004|Monotherapy|Withdrawal by Subject|2|||
163827973|NCT02712905|591737479|FG005|Monotherapy|Withdrawal by Subject|0|||
163827974|NCT02712905|591737480|FG006|Monotherapy|Withdrawal by Subject|0|||
163827975|NCT02712905|591737481|FG007|Monotherapy|Withdrawal by Subject|0|||
163827976|NCT02712905|591737482|FG008|Monotherapy|Withdrawal by Subject|0|||
163827977|NCT02712905|591737483|FG009|Monotherapy|Withdrawal by Subject|4|||
163827978|NCT02712905|591737484|FG010|Monotherapy|Withdrawal by Subject|1|||
163827979|NCT02712905|591737485|FG011|Monotherapy|Withdrawal by Subject|2|||
163827980|NCT02712905|591737486|FG012|Monotherapy|Withdrawal by Subject|0|||
163827981|NCT02712905|591737487|FG013|Monotherapy|Withdrawal by Subject|0|||
163827982|NCT02712905|591737488|FG014|Monotherapy|Withdrawal by Subject|0|||
163827983|NCT02712905|591737489|FG015|Monotherapy|Withdrawal by Subject|0|||
163827984|NCT02712905|591737490|FG016|Monotherapy|Withdrawal by Subject|0|||
163827985|NCT02712905|591737491|FG017|Monotherapy|Withdrawal by Subject|0|||
163827986|NCT02712905|591737474|FG000|Monotherapy|Started New Cancer Drug|0|||
163827987|NCT02712905|591737475|FG001|Monotherapy|Started New Cancer Drug|0|||
163827988|NCT02712905|591737476|FG002|Monotherapy|Started New Cancer Drug|0|||
163827989|NCT02712905|591737477|FG003|Monotherapy|Started New Cancer Drug|0|||
163827990|NCT02712905|591737478|FG004|Monotherapy|Started New Cancer Drug|0|||
163827991|NCT02712905|591737479|FG005|Monotherapy|Started New Cancer Drug|1|||
163827992|NCT02712905|591737480|FG006|Monotherapy|Started New Cancer Drug|0|||
163827993|NCT02712905|591737481|FG007|Monotherapy|Started New Cancer Drug|0|||
163827994|NCT02712905|591737482|FG008|Monotherapy|Started New Cancer Drug|0|||
163827995|NCT02712905|591737483|FG009|Monotherapy|Started New Cancer Drug|0|||
163827996|NCT02712905|591737484|FG010|Monotherapy|Started New Cancer Drug|0|||
163827997|NCT02712905|591737485|FG011|Monotherapy|Started New Cancer Drug|0|||
163827998|NCT02712905|591737486|FG012|Monotherapy|Started New Cancer Drug|0|||
163827999|NCT02712905|591737487|FG013|Monotherapy|Started New Cancer Drug|0|||
163828000|NCT02712905|591737488|FG014|Monotherapy|Started New Cancer Drug|0|||
163828001|NCT02712905|591737489|FG015|Monotherapy|Started New Cancer Drug|0|||
163828002|NCT02712905|591737490|FG016|Monotherapy|Started New Cancer Drug|0|||
163828003|NCT02712905|591737491|FG017|Monotherapy|Started New Cancer Drug|0|||
163828004|NCT02712905|591737474|FG000|Monotherapy|Adverse Event|0|||
164097659|NCT00723528|592722772|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164097660|NCT00723528|592722773|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164097661|NCT00723528|592722774|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164097662|NCT00723528|592722775|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164097663|NCT00723528|592722776|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
164097664|NCT00723528|592722777|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
164097665|NCT00723528|592722771|FG000|Period 2: After Controlled Period|Other|0|||
164097666|NCT00723528|592722772|FG001|Period 2: After Controlled Period|Other|0|||
164097667|NCT00723528|592722773|FG002|Period 2: After Controlled Period|Other|0|||
164097668|NCT00723528|592722774|FG003|Period 2: After Controlled Period|Other|0|||
164097669|NCT00723528|592722775|FG004|Period 2: After Controlled Period|Other|1|||
164097670|NCT00723528|592722776|FG005|Period 2: After Controlled Period|Other|4|||
164097671|NCT00723528|592722777|FG006|Period 2: After Controlled Period|Other|0|||
164097672|NCT00723528|592722771|FG000|Period 2: After Controlled Period|Adverse Event|0|||
164097673|NCT00723528|592722772|FG001|Period 2: After Controlled Period|Adverse Event|0|||
164097674|NCT00723528|592722773|FG002|Period 2: After Controlled Period|Adverse Event|0|||
164097675|NCT00723528|592722774|FG003|Period 2: After Controlled Period|Adverse Event|0|||
164097676|NCT00723528|592722775|FG004|Period 2: After Controlled Period|Adverse Event|1|||
164097677|NCT00723528|592722776|FG005|Period 2: After Controlled Period|Adverse Event|0|||
164097678|NCT00723528|592722777|FG006|Period 2: After Controlled Period|Adverse Event|1|||
164097679|NCT00723528|592722771|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164097680|NCT00723528|592722772|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164097681|NCT00723528|592722773|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164097682|NCT00723528|592722774|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164097683|NCT00723528|592722775|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164097684|NCT00723528|592722776|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
164097685|NCT00723528|592722777|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
164097686|NCT00723528|592722771|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164097687|NCT00723528|592722772|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164097688|NCT00723528|592722773|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164097689|NCT00723528|592722774|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164097690|NCT00723528|592722775|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164097691|NCT00723528|592722776|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
164097692|NCT00723528|592722777|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
164097693|NCT00667862|592722779|FG000|Overall Study|Adverse Event|9|||
164097694|NCT00667862|592722779|FG000|Overall Study|Death|1|||
164097695|NCT00667862|592722779|FG000|Overall Study|Disease Progression|22|||
164097696|NCT00667862|592722779|FG000|Overall Study|Withdrawal by Subject|3|||
164097697|NCT00667095|592722783|FG000|Overall Study|Withdrawal by Subject|0|||
164097698|NCT00667095|592722784|FG001|Overall Study|Withdrawal by Subject|1|||
164097699|NCT01520909|592722785|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
164097700|NCT01520909|592722786|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
164097701|NCT01520909|592722787|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
164097702|NCT01520909|592722785|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
164097703|NCT01520909|592722786|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
164097704|NCT01520909|592722787|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
164097705|NCT01520909|592722785|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
164097706|NCT01520909|592722786|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
164097707|NCT01520909|592722787|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
164097708|NCT01520909|592722785|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
164097709|NCT01520909|592722786|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
164097710|NCT01520909|592722787|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
163828005|NCT02712905|591737475|FG001|Monotherapy|Adverse Event|0|||
163828006|NCT02712905|591737476|FG002|Monotherapy|Adverse Event|0|||
163828007|NCT02712905|591737477|FG003|Monotherapy|Adverse Event|0|||
163828008|NCT02712905|591737478|FG004|Monotherapy|Adverse Event|0|||
163828009|NCT02712905|591737479|FG005|Monotherapy|Adverse Event|0|||
163828010|NCT02712905|591737480|FG006|Monotherapy|Adverse Event|0|||
163828011|NCT02712905|591737481|FG007|Monotherapy|Adverse Event|0|||
163828012|NCT02712905|591737482|FG008|Monotherapy|Adverse Event|1|||
163828013|NCT02712905|591737483|FG009|Monotherapy|Adverse Event|0|||
163828014|NCT02712905|591737484|FG010|Monotherapy|Adverse Event|0|||
163828015|NCT02712905|591737485|FG011|Monotherapy|Adverse Event|0|||
163828016|NCT02712905|591737486|FG012|Monotherapy|Adverse Event|0|||
163828017|NCT02712905|591737487|FG013|Monotherapy|Adverse Event|0|||
163828018|NCT02712905|591737488|FG014|Monotherapy|Adverse Event|0|||
163828019|NCT02712905|591737489|FG015|Monotherapy|Adverse Event|0|||
163828020|NCT02712905|591737490|FG016|Monotherapy|Adverse Event|0|||
163828021|NCT02712905|591737491|FG017|Monotherapy|Adverse Event|0|||
163922538|NCT03214250|592086945|FG000|Overall Study|Remains on Study|2|||
163922539|NCT03214250|592086946|FG001|Overall Study|Remains on Study|2|||
163922540|NCT03214250|592086947|FG002|Overall Study|Remains on Study|0|||
163922541|NCT03214250|592086948|FG003|Overall Study|Remains on Study|1|||
163922542|NCT03214250|592086949|FG004|Overall Study|Remains on Study|7|||
163922543|NCT03214250|592086950|FG005|Overall Study|Remains on Study|5|||
163922544|NCT03214250|592086951|FG006|Overall Study|Remains on Study|3|||
163922545|NCT03214250|592086945|FG000|Overall Study|Withdrawal by Subject|0|||
163922546|NCT03214250|592086946|FG001|Overall Study|Withdrawal by Subject|0|||
163922547|NCT03214250|592086947|FG002|Overall Study|Withdrawal by Subject|1|||
163922548|NCT03214250|592086948|FG003|Overall Study|Withdrawal by Subject|2|||
163922549|NCT03214250|592086949|FG004|Overall Study|Withdrawal by Subject|5|||
163922550|NCT03214250|592086950|FG005|Overall Study|Withdrawal by Subject|0|||
163922551|NCT03214250|592086951|FG006|Overall Study|Withdrawal by Subject|2|||
163828022|NCT02712905|591737474|FG000|Combination Therapy|Death|0|||
163828023|NCT02712905|591737475|FG001|Combination Therapy|Death|0|||
163828024|NCT02712905|591737476|FG002|Combination Therapy|Death|0|||
163828025|NCT02712905|591737477|FG003|Combination Therapy|Death|0|||
163922552|NCT02845375|592086957|FG000|Overall Study|upper airway obstruction|1|||
163922553|NCT02845375|592086958|FG001|Overall Study|upper airway obstruction|2|||
163922554|NCT02845375|592086959|FG002|Overall Study|upper airway obstruction|1|||
163922555|NCT02171130|592086962|FG000|Overall Study|Death|1|||
163922556|NCT02171130|592086962|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
163922557|NCT02171130|592086962|FG000|Overall Study|Discontinued; Site Termination|5|||
163922558|NCT02171130|592086962|FG000|Overall Study|Withdrawal by Subject|3|||
164032908|NCT00006604|592479602|FG000|Overall Study|Death|0|||
164032909|NCT00006604|592479603|FG001|Overall Study|Death|0|||
164032910|NCT00006604|592479604|FG002|Overall Study|Death|0|||
164032911|NCT00006604|592479605|FG003|Overall Study|Death|0|||
164032912|NCT00006604|592479606|FG004|Overall Study|Death|0|||
164032913|NCT00006604|592479607|FG005|Overall Study|Death|0|||
164032914|NCT00006604|592479608|FG006|Overall Study|Death|0|||
164032915|NCT00006604|592479609|FG007|Overall Study|Death|0|||
164032916|NCT00006604|592479610|FG008|Overall Study|Death|0|||
164032917|NCT00006604|592479611|FG009|Overall Study|Death|1|||
164032918|NCT00006604|592479612|FG010|Overall Study|Death|1|||
164032919|NCT00006604|592479613|FG011|Overall Study|Death|1|||
164032920|NCT00006604|592479614|FG012|Overall Study|Death|0|||
164032921|NCT00006604|592479615|FG013|Overall Study|Death|0|||
164032922|NCT00006604|592479616|FG014|Overall Study|Death|0|||
164032923|NCT00006604|592479617|FG015|Overall Study|Death|0|||
164032924|NCT00006604|592479618|FG016|Overall Study|Death|0|||
163828026|NCT02712905|591737478|FG004|Combination Therapy|Death|0|||
163828027|NCT02712905|591737479|FG005|Combination Therapy|Death|0|||
163828028|NCT02712905|591737480|FG006|Combination Therapy|Death|0|||
163828029|NCT02712905|591737481|FG007|Combination Therapy|Death|0|||
163828030|NCT02712905|591737482|FG008|Combination Therapy|Death|0|||
163828031|NCT02712905|591737483|FG009|Combination Therapy|Death|0|||
163828032|NCT02712905|591737484|FG010|Combination Therapy|Death|0|||
163828033|NCT02712905|591737485|FG011|Combination Therapy|Death|0|||
163828034|NCT02712905|591737486|FG012|Combination Therapy|Death|5|||
163828035|NCT02712905|591737487|FG013|Combination Therapy|Death|6|||
163828036|NCT02712905|591737488|FG014|Combination Therapy|Death|1|||
163828037|NCT02712905|591737489|FG015|Combination Therapy|Death|3|||
163828038|NCT02712905|591737490|FG016|Combination Therapy|Death|1|||
163828039|NCT02712905|591737491|FG017|Combination Therapy|Death|3|||
163828040|NCT02712905|591737474|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
163828041|NCT02712905|591737475|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
163828042|NCT02712905|591737476|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
163828043|NCT02712905|591737477|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
163828044|NCT02712905|591737478|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
163828045|NCT02712905|591737479|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
163828046|NCT02712905|591737480|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
163828047|NCT02712905|591737481|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
163828048|NCT02712905|591737482|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
163922559|NCT02171130|592086962|FG000|Overall Study|Physician Decision|1|||
163922560|NCT02171130|592086962|FG000|Overall Study|Lost to Follow-up|1|||
163922561|NCT02171130|592086962|FG000|Overall Study|Met Exclusion Criteria|1|||
164032925|NCT00006604|592479602|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164032926|NCT00006604|592479603|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164032927|NCT00006604|592479604|FG002|Overall Study|Severe debilitation, unable to continue|0|||
163828049|NCT02712905|591737483|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
163828050|NCT02712905|591737484|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
163828051|NCT02712905|591737485|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
163828052|NCT02712905|591737486|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
163828053|NCT02712905|591737487|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
163922562|NCT01951261|592086963|FG000|Overall Study|Death|1|||
164032928|NCT00006604|592479605|FG003|Overall Study|Severe debilitation, unable to continue|0|||
164032929|NCT00006604|592479606|FG004|Overall Study|Severe debilitation, unable to continue|0|||
163922563|NCT01951261|592086964|FG001|Overall Study|Death|0|||
163922564|NCT01951261|592086963|FG000|Overall Study|Lost to Follow-up|4|||
163922565|NCT01951261|592086964|FG001|Overall Study|Lost to Follow-up|3|||
163922566|NCT01951261|592086963|FG000|Overall Study|Protocol Violation|4|||
163922567|NCT01951261|592086964|FG001|Overall Study|Protocol Violation|3|||
163922568|NCT03723915|592086971|FG000|Screening|Failed to meet screening requirements.|2|||
163922569|NCT03723915|592086971|FG000|On Treatment|Failed to meet treatment requirements|2|||
163922570|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
163922571|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
163922572|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
163922573|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
163922574|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
163922575|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
163922576|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
163922577|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
163922578|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
163922579|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
163922580|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
163922581|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
163922582|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
163922583|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
163922584|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
163922585|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
163922586|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
163922587|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
163922588|NCT03569475|592086972|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
163922589|NCT03569475|592086973|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
163922590|NCT03569475|592086974|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
163922591|NCT03569475|592086972|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
163922592|NCT03569475|592086973|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
163922593|NCT03569475|592086974|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
163922594|NCT03569475|592086972|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
163922595|NCT03569475|592086973|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
163922596|NCT03569475|592086974|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
163922597|NCT02630706|592086975|FG000|Overall Study|Adverse Event|2|||
163922598|NCT02630706|592086976|FG001|Overall Study|Adverse Event|1|||
163922599|NCT02630706|592086977|FG002|Overall Study|Adverse Event|1|||
163922600|NCT02630706|592086975|FG000|Overall Study|Lost to Follow-up|0|||
163922601|NCT02630706|592086976|FG001|Overall Study|Lost to Follow-up|1|||
163922602|NCT02630706|592086977|FG002|Overall Study|Lost to Follow-up|2|||
163922603|NCT02630706|592086975|FG000|Overall Study|Physician Decision|1|||
163922604|NCT02630706|592086976|FG001|Overall Study|Physician Decision|1|||
163922605|NCT02630706|592086977|FG002|Overall Study|Physician Decision|0|||
163922606|NCT02630706|592086975|FG000|Overall Study|Pregnancy|0|||
163922607|NCT02630706|592086976|FG001|Overall Study|Pregnancy|1|||
163922608|NCT02630706|592086977|FG002|Overall Study|Pregnancy|0|||
163922609|NCT02630706|592086975|FG000|Overall Study|Withdrawal by Subject|4|||
163922610|NCT02630706|592086976|FG001|Overall Study|Withdrawal by Subject|5|||
163922611|NCT02630706|592086977|FG002|Overall Study|Withdrawal by Subject|7|||
163922612|NCT02820298|592086987|FG000|Overall Study|Withdrawal by Subject|0|||
163922613|NCT02820298|592086988|FG001|Overall Study|Withdrawal by Subject|1|||
163922614|NCT02820298|592086987|FG000|Overall Study|Physician Decision|1|||
163922615|NCT02820298|592086988|FG001|Overall Study|Physician Decision|0|||
163922616|NCT02820298|592086987|FG000|Overall Study|Protocol Violation|0|||
163922617|NCT02820298|592086988|FG001|Overall Study|Protocol Violation|1|||
163922618|NCT01894256|592086989|FG000|Part A|Adverse Event|0|||
163922619|NCT01894256|592086990|FG001|Part A|Adverse Event|1|||
164097711|NCT01435265|592722789|FG000|Overall Study|Lost to Follow-up|0|||
164097712|NCT01435265|592722790|FG001|Overall Study|Lost to Follow-up|1|||
163922620|NCT01894256|592086991|FG002|Part A|Adverse Event|0|||
163922621|NCT01894256|592086989|FG000|Part B|Death|0|||
163922622|NCT01894256|592086990|FG001|Part B|Death|1|||
163922623|NCT01894256|592086991|FG002|Part B|Death|1|||
163922624|NCT01894256|592086989|FG000|Part B|Withdrawal by Subject|0|||
163922625|NCT01894256|592086990|FG001|Part B|Withdrawal by Subject|1|||
163922626|NCT01894256|592086991|FG002|Part B|Withdrawal by Subject|0|||
163922627|NCT01894256|592086989|FG000|Part B|Lack of Efficacy|15|||
163922628|NCT01894256|592086990|FG001|Part B|Lack of Efficacy|12|||
163922629|NCT01894256|592086991|FG002|Part B|Lack of Efficacy|13|||
163922630|NCT00645099|592086997|FG000|Overall Study|Lack of Efficacy|15|||
163922631|NCT00645099|592086998|FG001|Overall Study|Lack of Efficacy|6|||
163922632|NCT00645099|592086997|FG000|Overall Study|Withdrawal by Subject|30|||
163922633|NCT00645099|592086998|FG001|Overall Study|Withdrawal by Subject|22|||
164097713|NCT02128997|592722791|FG000|Overall Study|Lost to Follow-up|6|||
163922634|NCT00645099|592086997|FG000|Overall Study|Lost to Follow-up|6|||
164097714|NCT02128997|592722792|FG001|Overall Study|Lost to Follow-up|11|||
164097715|NCT00856388|592722802|FG000|Overall Study|Other|1|||
163922635|NCT00645099|592086998|FG001|Overall Study|Lost to Follow-up|4|||
163922636|NCT00645099|592086997|FG000|Overall Study|Adverse Event|11|||
163922637|NCT00645099|592086998|FG001|Overall Study|Adverse Event|5|||
163922638|NCT00645099|592086997|FG000|Overall Study|Other|9|||
163922639|NCT00645099|592086998|FG001|Overall Study|Other|5|||
163922640|NCT01201915|592086999|FG000|Overall Study|Adverse Event|2|||
163922641|NCT01201915|592087000|FG001|Overall Study|Adverse Event|1|||
163922642|NCT01201915|592087001|FG002|Overall Study|Adverse Event|1|||
163922643|NCT01201915|592086999|FG000|Overall Study|Lost to Follow-up|0|||
163922644|NCT01201915|592087000|FG001|Overall Study|Lost to Follow-up|4|||
163922645|NCT01201915|592087001|FG002|Overall Study|Lost to Follow-up|0|||
163922646|NCT01201915|592086999|FG000|Overall Study|Physician Decision|3|||
163922647|NCT01201915|592087000|FG001|Overall Study|Physician Decision|0|||
163922648|NCT01201915|592087001|FG002|Overall Study|Physician Decision|0|||
163922649|NCT01201915|592086999|FG000|Overall Study|Subject Decision|3|||
163922650|NCT01201915|592087000|FG001|Overall Study|Subject Decision|3|||
163922651|NCT01201915|592087001|FG002|Overall Study|Subject Decision|5|||
163922652|NCT01201915|592086999|FG000|Overall Study|Target Lesion Progression|0|||
163922653|NCT01201915|592087000|FG001|Overall Study|Target Lesion Progression|3|||
163922654|NCT01201915|592087001|FG002|Overall Study|Target Lesion Progression|0|||
164032930|NCT00006604|592479607|FG005|Overall Study|Severe debilitation, unable to continue|0|||
164032931|NCT00006604|592479608|FG006|Overall Study|Severe debilitation, unable to continue|3|||
164032932|NCT00006604|592479609|FG007|Overall Study|Severe debilitation, unable to continue|0|||
164032933|NCT00006604|592479610|FG008|Overall Study|Severe debilitation, unable to continue|0|||
164032934|NCT00006604|592479611|FG009|Overall Study|Severe debilitation, unable to continue|5|||
164032935|NCT00006604|592479612|FG010|Overall Study|Severe debilitation, unable to continue|0|||
164032936|NCT00006604|592479613|FG011|Overall Study|Severe debilitation, unable to continue|2|||
164032937|NCT00006604|592479614|FG012|Overall Study|Severe debilitation, unable to continue|1|||
164032938|NCT00006604|592479615|FG013|Overall Study|Severe debilitation, unable to continue|0|||
164032939|NCT00006604|592479616|FG014|Overall Study|Severe debilitation, unable to continue|2|||
164032940|NCT00006604|592479617|FG015|Overall Study|Severe debilitation, unable to continue|0|||
164032941|NCT00006604|592479618|FG016|Overall Study|Severe debilitation, unable to continue|0|||
164032942|NCT00006604|592479602|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
164032943|NCT00006604|592479603|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
164032944|NCT00006604|592479604|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
164032945|NCT00006604|592479605|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
164032946|NCT00006604|592479606|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
164032947|NCT00006604|592479607|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
164032948|NCT00006604|592479608|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
164032949|NCT00006604|592479609|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
164032950|NCT00006604|592479610|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
164032951|NCT00006604|592479611|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
164032952|NCT00006604|592479612|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
164032953|NCT00006604|592479613|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
164032954|NCT00006604|592479614|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
164032955|NCT00006604|592479615|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
164032956|NCT00006604|592479616|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
164032957|NCT00006604|592479617|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
164032958|NCT00006604|592479618|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
164032959|NCT00006604|592479602|FG000|Overall Study|Site closing|0|||
164032960|NCT00006604|592479603|FG001|Overall Study|Site closing|0|||
164032961|NCT00006604|592479604|FG002|Overall Study|Site closing|1|||
164032962|NCT00006604|592479605|FG003|Overall Study|Site closing|1|||
164032963|NCT00006604|592479606|FG004|Overall Study|Site closing|0|||
164032964|NCT00006604|592479607|FG005|Overall Study|Site closing|0|||
164032965|NCT00006604|592479608|FG006|Overall Study|Site closing|0|||
164032966|NCT00006604|592479609|FG007|Overall Study|Site closing|1|||
164032967|NCT00006604|592479610|FG008|Overall Study|Site closing|0|||
164032968|NCT00006604|592479611|FG009|Overall Study|Site closing|0|||
164032969|NCT00006604|592479612|FG010|Overall Study|Site closing|0|||
164032970|NCT00006604|592479613|FG011|Overall Study|Site closing|1|||
164032971|NCT00006604|592479614|FG012|Overall Study|Site closing|1|||
164032972|NCT00006604|592479615|FG013|Overall Study|Site closing|1|||
164032973|NCT00006604|592479616|FG014|Overall Study|Site closing|0|||
164032974|NCT00006604|592479617|FG015|Overall Study|Site closing|0|||
164032975|NCT00006604|592479618|FG016|Overall Study|Site closing|1|||
164032976|NCT00006604|592479602|FG000|Overall Study|Withdrawal by Subject|1|||
164032977|NCT00006604|592479603|FG001|Overall Study|Withdrawal by Subject|0|||
164032978|NCT00006604|592479604|FG002|Overall Study|Withdrawal by Subject|2|||
164147371|NCT05168202|592902026|FG002|Overall Study|Adverse Event|4|||
163922655|NCT02154516|592087002|FG000|Overall Study|Withdrawal by Subject|0|||
163922656|NCT02154516|592087003|FG001|Overall Study|Withdrawal by Subject|1|||
163922657|NCT02154516|592087002|FG000|Overall Study|Lost to Follow-up|1|||
163922658|NCT02154516|592087003|FG001|Overall Study|Lost to Follow-up|0|||
163922659|NCT02154516|592087002|FG000|Overall Study|Removal/revision of device|1|||
163922660|NCT02154516|592087003|FG001|Overall Study|Removal/revision of device|0|||
163922661|NCT02154516|592087002|FG000|Overall Study|Death|2|||
163922662|NCT02154516|592087003|FG001|Overall Study|Death|1|||
163922663|NCT03406507|592087004|FG000|Extension Period|Lack of Efficacy|0|||
163922664|NCT03406507|592087005|FG001|Extension Period|Lack of Efficacy|1|||
163922665|NCT00663923|592087006|FG000|Overall Study|Lost to Follow-up|2|||
163922666|NCT02316171|592087010|FG000|Overall Study|difficulties with urinary catheter|1|||
163922667|NCT02316171|592087011|FG001|Overall Study|difficulties with urinary catheter|0|||
163922668|NCT02316171|592087012|FG002|Overall Study|difficulties with urinary catheter|0|||
163922669|NCT02316171|592087013|FG003|Overall Study|difficulties with urinary catheter|0|||
163922670|NCT01804140|592087015|FG000|Overall Study|No sampling or biopsy procedures done|114|||
163922671|NCT02785900|592087018|FG000|Overall Study|Study Termination by Sponsor|64|||
163922672|NCT02785900|592087019|FG001|Overall Study|Study Termination by Sponsor|81|||
163922673|NCT02785900|592087018|FG000|Overall Study|Death|46|||
163922674|NCT02785900|592087019|FG001|Overall Study|Death|32|||
163922675|NCT02785900|592087018|FG000|Overall Study|Withdrawal by Subject|4|||
163922676|NCT02785900|592087019|FG001|Overall Study|Withdrawal by Subject|8|||
163922677|NCT02785900|592087018|FG000|Overall Study|Physician Decision|3|||
163922678|NCT02785900|592087019|FG001|Overall Study|Physician Decision|2|||
163922679|NCT00547300|592087020|FG000|Overall Study|Study was Administratively Terminated|25|||
163922680|NCT00547300|592087021|FG001|Overall Study|Study was Administratively Terminated|24|||
163922681|NCT00547300|592087020|FG000|Overall Study|Did not Meet Entry Criteria|0|||
163922682|NCT00547300|592087021|FG001|Overall Study|Did not Meet Entry Criteria|2|||
163922683|NCT04435522|592087022|FG000|Overall Study|Withdrawal by Subject|2|||
163922684|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
163922685|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
163922686|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
163922687|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
163922688|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
163922689|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
163922690|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
163922691|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
163922692|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
163922693|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
163922694|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
163922695|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
163922696|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
163922697|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
163922698|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
163922699|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
163922700|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
163922701|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
163922702|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
163922703|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
163922704|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
163922705|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
163922706|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
163922707|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
163922708|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
163922709|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
163922710|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
163922711|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
163922712|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
163922713|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
163922714|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
163922715|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
163922716|NCT00092521|592089223|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
163922717|NCT00092521|592089224|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
163922718|NCT00092521|592089225|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
163922719|NCT00092521|592089226|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
163922720|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
163922721|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
163922722|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
163922723|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
163922724|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
163922725|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
163922726|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
163922727|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
163922728|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
163922729|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
163922730|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
163922731|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
163922732|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Death|2|||
163922733|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Death|0|||
163922734|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Death|1|||
163922735|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Death|0|||
163922736|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
163922737|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
163922738|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
163922739|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
163922740|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
163922741|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
163922742|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
163922743|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
163922744|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
163922745|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
163922746|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
163922747|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
163922748|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Moved|32|||
163922749|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Moved|2|||
163922750|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Moved|28|||
163922751|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Moved|0|||
163922752|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
163922753|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
163922754|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
163922755|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
163922756|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Travel|2|||
163922757|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Travel|0|||
163922758|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Travel|0|||
163922759|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Travel|0|||
163922760|NCT00092521|592089223|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
163922761|NCT00092521|592089224|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
163922762|NCT00092521|592089225|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
163922763|NCT00092521|592089226|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
163922764|NCT00092521|592089223|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
163922765|NCT00092521|592089224|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
163922766|NCT00092521|592089225|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
163922767|NCT00092521|592089226|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
163922768|NCT00092521|592089223|FG000|Extension Study (Group 4)|Adverse Event|0|||
163922769|NCT00092521|592089224|FG001|Extension Study (Group 4)|Adverse Event|0|||
163922770|NCT00092521|592089225|FG002|Extension Study (Group 4)|Adverse Event|0|||
163922771|NCT00092521|592089226|FG003|Extension Study (Group 4)|Adverse Event|2|||
163922772|NCT00092521|592089223|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
163922773|NCT00092521|592089224|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
163922774|NCT00092521|592089225|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
163922775|NCT00092521|592089226|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
163922776|NCT00092521|592089223|FG000|Extension Study (Group 4)|Pregnancy|0|||
163922777|NCT00092521|592089224|FG001|Extension Study (Group 4)|Pregnancy|0|||
163922778|NCT00092521|592089225|FG002|Extension Study (Group 4)|Pregnancy|0|||
163922779|NCT00092521|592089226|FG003|Extension Study (Group 4)|Pregnancy|4|||
163922780|NCT00092521|592089223|FG000|Extension Study (Group 4)|Protocol Violation|0|||
163922781|NCT00092521|592089224|FG001|Extension Study (Group 4)|Protocol Violation|0|||
163922782|NCT00092521|592089225|FG002|Extension Study (Group 4)|Protocol Violation|0|||
163922783|NCT00092521|592089226|FG003|Extension Study (Group 4)|Protocol Violation|2|||
163922784|NCT00092521|592089223|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
163922785|NCT00092521|592089224|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
163922786|NCT00092521|592089225|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
163922787|NCT00092521|592089226|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
163922788|NCT00092521|592089223|FG000|Extension Study (Group 4)|Moved|0|||
163922789|NCT00092521|592089224|FG001|Extension Study (Group 4)|Moved|0|||
163922790|NCT00092521|592089225|FG002|Extension Study (Group 4)|Moved|0|||
163922791|NCT00092521|592089226|FG003|Extension Study (Group 4)|Moved|16|||
164097716|NCT05038293|592722803|FG000|Overall Study|device was not operating properly for one subject.|1|||
164097717|NCT05038293|592722804|FG001|Overall Study|device was not operating properly for one subject.|0|||
163922792|NCT00092521|592089223|FG000|Extension Study (Group 4)|Site Terminated|0|||
163922793|NCT00092521|592089224|FG001|Extension Study (Group 4)|Site Terminated|0|||
163922794|NCT00092521|592089225|FG002|Extension Study (Group 4)|Site Terminated|0|||
163922795|NCT00092521|592089226|FG003|Extension Study (Group 4)|Site Terminated|4|||
163922796|NCT00092521|592089223|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
163922797|NCT00092521|592089224|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
164032979|NCT00006604|592479605|FG003|Overall Study|Withdrawal by Subject|0|||
164032980|NCT00006604|592479606|FG004|Overall Study|Withdrawal by Subject|1|||
164032981|NCT00006604|592479607|FG005|Overall Study|Withdrawal by Subject|2|||
164032982|NCT00006604|592479608|FG006|Overall Study|Withdrawal by Subject|2|||
164032983|NCT00006604|592479609|FG007|Overall Study|Withdrawal by Subject|0|||
164032984|NCT00006604|592479610|FG008|Overall Study|Withdrawal by Subject|1|||
164032985|NCT00006604|592479611|FG009|Overall Study|Withdrawal by Subject|3|||
164032986|NCT00006604|592479612|FG010|Overall Study|Withdrawal by Subject|2|||
164032987|NCT00006604|592479613|FG011|Overall Study|Withdrawal by Subject|0|||
164032988|NCT00006604|592479614|FG012|Overall Study|Withdrawal by Subject|1|||
164032989|NCT00006604|592479615|FG013|Overall Study|Withdrawal by Subject|2|||
164032990|NCT00006604|592479616|FG014|Overall Study|Withdrawal by Subject|1|||
164032991|NCT00006604|592479617|FG015|Overall Study|Withdrawal by Subject|0|||
164032992|NCT00006604|592479618|FG016|Overall Study|Withdrawal by Subject|1|||
164032993|NCT00006604|592479602|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
164032994|NCT00006604|592479603|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
164032995|NCT00006604|592479604|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
164032996|NCT00006604|592479605|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
164032997|NCT00006604|592479606|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
164032998|NCT00006604|592479607|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
164032999|NCT00006604|592479608|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
164033000|NCT00006604|592479609|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
164033001|NCT00006604|592479610|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
164033002|NCT00006604|592479611|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
164033003|NCT00006604|592479612|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
164033004|NCT00006604|592479613|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
164033005|NCT00006604|592479614|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
164033006|NCT00006604|592479615|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
164033007|NCT00006604|592479616|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
164033008|NCT00006604|592479617|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
164033009|NCT00006604|592479618|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
164033010|NCT00006604|592479602|FG000|Overall Study|Lost to Follow-up|0|||
164033011|NCT00006604|592479603|FG001|Overall Study|Lost to Follow-up|0|||
164033012|NCT00006604|592479604|FG002|Overall Study|Lost to Follow-up|0|||
164033013|NCT00006604|592479605|FG003|Overall Study|Lost to Follow-up|0|||
164033014|NCT00006604|592479606|FG004|Overall Study|Lost to Follow-up|0|||
164033015|NCT00006604|592479607|FG005|Overall Study|Lost to Follow-up|0|||
164033016|NCT00006604|592479608|FG006|Overall Study|Lost to Follow-up|0|||
164033017|NCT00006604|592479609|FG007|Overall Study|Lost to Follow-up|1|||
164033018|NCT00006604|592479610|FG008|Overall Study|Lost to Follow-up|0|||
164033019|NCT00006604|592479611|FG009|Overall Study|Lost to Follow-up|2|||
164033020|NCT00006604|592479612|FG010|Overall Study|Lost to Follow-up|0|||
164033021|NCT00006604|592479613|FG011|Overall Study|Lost to Follow-up|0|||
164033022|NCT00006604|592479614|FG012|Overall Study|Lost to Follow-up|0|||
164033023|NCT00006604|592479615|FG013|Overall Study|Lost to Follow-up|0|||
164033024|NCT00006604|592479616|FG014|Overall Study|Lost to Follow-up|0|||
164033025|NCT00006604|592479617|FG015|Overall Study|Lost to Follow-up|1|||
164033026|NCT00006604|592479618|FG016|Overall Study|Lost to Follow-up|3|||
164033027|NCT00006604|592479602|FG000|Overall Study|Other Reason|0|||
164033028|NCT00006604|592479603|FG001|Overall Study|Other Reason|0|||
164033029|NCT00006604|592479604|FG002|Overall Study|Other Reason|0|||
164033030|NCT00006604|592479605|FG003|Overall Study|Other Reason|0|||
164033031|NCT00006604|592479606|FG004|Overall Study|Other Reason|0|||
164033032|NCT00006604|592479607|FG005|Overall Study|Other Reason|1|||
164033033|NCT00006604|592479608|FG006|Overall Study|Other Reason|0|||
164033034|NCT00006604|592479609|FG007|Overall Study|Other Reason|0|||
164033035|NCT00006604|592479610|FG008|Overall Study|Other Reason|0|||
164033036|NCT00006604|592479611|FG009|Overall Study|Other Reason|1|||
164033037|NCT00006604|592479612|FG010|Overall Study|Other Reason|0|||
164033038|NCT00006604|592479613|FG011|Overall Study|Other Reason|0|||
164033039|NCT00006604|592479614|FG012|Overall Study|Other Reason|0|||
164033040|NCT00006604|592479615|FG013|Overall Study|Other Reason|0|||
164033041|NCT00006604|592479616|FG014|Overall Study|Other Reason|0|||
164033042|NCT00006604|592479617|FG015|Overall Study|Other Reason|0|||
164033043|NCT00006604|592479618|FG016|Overall Study|Other Reason|0|||
164097718|NCT05038293|592722803|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
164033044|NCT02431468|592479619|FG000|Overall Study|Adverse Event|2|||
164033045|NCT02431468|592479620|FG001|Overall Study|Adverse Event|4|||
164033046|NCT02431468|592479621|FG002|Overall Study|Adverse Event|5|||
164033047|NCT02431468|592479619|FG000|Overall Study|Withdrawal by Subject|4|||
164033048|NCT02431468|592479620|FG001|Overall Study|Withdrawal by Subject|12|||
164033049|NCT02431468|592479621|FG002|Overall Study|Withdrawal by Subject|2|||
164033050|NCT02431468|592479619|FG000|Overall Study|noncompliance, investigator termination,|2|||
164033051|NCT02431468|592479620|FG001|Overall Study|noncompliance, investigator termination,|2|||
164097719|NCT05038293|592722804|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
163922798|NCT00092521|592089225|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
163922799|NCT00092521|592089226|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
163922800|NCT01878383|592089227|FG000|Overall Study|Lost to Follow-up|0|||
163922801|NCT01878383|592089228|FG001|Overall Study|Lost to Follow-up|1499|||
163922802|NCT03464383|592089229|FG000|Overall Study|Lost to Follow-up|1|||
163922803|NCT03464383|592089230|FG001|Overall Study|Lost to Follow-up|0|||
163922804|NCT03464383|592089231|FG002|Overall Study|Lost to Follow-up|0|||
163922805|NCT03464383|592089229|FG000|Overall Study|Withdrawal by Subject|0|||
163922806|NCT03464383|592089230|FG001|Overall Study|Withdrawal by Subject|1|||
163922807|NCT03464383|592089231|FG002|Overall Study|Withdrawal by Subject|0|||
163922808|NCT00560313|592089232|FG000|Overall Study|Adverse Events or Death|2|||
163922809|NCT00560313|592089232|FG000|Overall Study|Withdrawal by Subject|2|||
163922810|NCT00560313|592089232|FG000|Overall Study|Lost to Follow-up|1|||
163922811|NCT00560313|592089232|FG000|Overall Study|Protocol Violation|1|||
163922812|NCT00605566|592089233|FG000|Overall Study|Adverse Event|1|||
163922813|NCT00605566|592089233|FG000|Overall Study|Clinical deterioration|1|||
163922814|NCT00605566|592089233|FG000|Overall Study|Poor compliance in run-in period|1|||
163922815|NCT03449134|592089234|FG000|52-Week Treatment Period|Death|2|||
163922816|NCT03449134|592089235|FG001|52-Week Treatment Period|Death|1|||
163922817|NCT03449134|592089236|FG002|52-Week Treatment Period|Death|0|||
163922818|NCT03449134|592089234|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
163922819|NCT03449134|592089235|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
163922820|NCT03449134|592089236|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
163922821|NCT03449134|592089234|FG000|52-Week Treatment Period|Physician Decision|2|||
163922822|NCT03449134|592089235|FG001|52-Week Treatment Period|Physician Decision|3|||
163922823|NCT03449134|592089236|FG002|52-Week Treatment Period|Physician Decision|3|||
163922824|NCT03449134|592089234|FG000|52-Week Treatment Period|Screen Failure|1|||
163922825|NCT03449134|592089235|FG001|52-Week Treatment Period|Screen Failure|0|||
163922826|NCT03449134|592089236|FG002|52-Week Treatment Period|Screen Failure|1|||
163922827|NCT03449134|592089234|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
163922828|NCT03449134|592089235|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
163922829|NCT03449134|592089236|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
163922830|NCT03449134|592089234|FG000|52-Week Treatment Period|Site Closure|1|||
163922831|NCT03449134|592089235|FG001|52-Week Treatment Period|Site Closure|0|||
163922832|NCT03449134|592089236|FG002|52-Week Treatment Period|Site Closure|0|||
163922833|NCT03475056|592089237|FG000|Overall Study|Lost to Follow-up|0|||
163922834|NCT03475056|592089238|FG001|Overall Study|Lost to Follow-up|1|||
163922835|NCT03475056|592089237|FG000|Overall Study|Moved from Area|0|||
163922836|NCT03475056|592089238|FG001|Overall Study|Moved from Area|2|||
163922837|NCT00113269|592089241|FG000|Overall Study|Not transplanted, donor issues|4|||
163922838|NCT00113269|592089242|FG001|Overall Study|Not transplanted, donor issues|0|||
163922839|NCT00113269|592089243|FG002|Overall Study|Not transplanted, donor issues|2|||
163922840|NCT00113269|592089244|FG003|Overall Study|Not transplanted, donor issues|2|||
163922841|NCT00113269|592089241|FG000|Overall Study|Not transplanted, recipient issues|2|||
163922842|NCT00113269|592089242|FG001|Overall Study|Not transplanted, recipient issues|1|||
163922843|NCT00113269|592089243|FG002|Overall Study|Not transplanted, recipient issues|7|||
163922844|NCT00113269|592089244|FG003|Overall Study|Not transplanted, recipient issues|4|||
163922845|NCT00113269|592089241|FG000|Overall Study|Early graft loss, technical|0|||
163922846|NCT00113269|592089242|FG001|Overall Study|Early graft loss, technical|0|||
163922847|NCT00113269|592089243|FG002|Overall Study|Early graft loss, technical|2|||
163922848|NCT00113269|592089244|FG003|Overall Study|Early graft loss, technical|0|||
163922849|NCT00113269|592089241|FG000|Overall Study|Death in operating room|0|||
163922850|NCT00113269|592089242|FG001|Overall Study|Death in operating room|0|||
163922851|NCT00113269|592089243|FG002|Overall Study|Death in operating room|0|||
163922852|NCT00113269|592089244|FG003|Overall Study|Death in operating room|1|||
163922853|NCT00113269|592089241|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
163922854|NCT00113269|592089242|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
163922855|NCT00113269|592089243|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
163922856|NCT00113269|592089244|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
163922857|NCT00113269|592089241|FG000|Overall Study|Adverse Event|2|||
163922858|NCT00113269|592089242|FG001|Overall Study|Adverse Event|7|||
163922859|NCT00113269|592089243|FG002|Overall Study|Adverse Event|11|||
163922860|NCT00113269|592089244|FG003|Overall Study|Adverse Event|7|||
163922861|NCT00113269|592089241|FG000|Overall Study|Withdrawal by Subject|4|||
163922862|NCT00113269|592089242|FG001|Overall Study|Withdrawal by Subject|3|||
163922863|NCT00113269|592089243|FG002|Overall Study|Withdrawal by Subject|4|||
163922864|NCT00113269|592089244|FG003|Overall Study|Withdrawal by Subject|2|||
163922865|NCT00113269|592089241|FG000|Overall Study|Graft loss|6|||
163922866|NCT00113269|592089242|FG001|Overall Study|Graft loss|6|||
163922867|NCT00113269|592089243|FG002|Overall Study|Graft loss|4|||
163922868|NCT00113269|592089244|FG003|Overall Study|Graft loss|9|||
163922869|NCT00113269|592089241|FG000|Overall Study|Protocol Violation|1|||
163922870|NCT00113269|592089242|FG001|Overall Study|Protocol Violation|0|||
163922871|NCT00113269|592089243|FG002|Overall Study|Protocol Violation|4|||
163922872|NCT00113269|592089244|FG003|Overall Study|Protocol Violation|2|||
163922873|NCT00113269|592089241|FG000|Overall Study|Lost to Follow-up|2|||
163922874|NCT00113269|592089242|FG001|Overall Study|Lost to Follow-up|3|||
163922875|NCT00113269|592089243|FG002|Overall Study|Lost to Follow-up|6|||
163922876|NCT00113269|592089244|FG003|Overall Study|Lost to Follow-up|3|||
163922877|NCT00113269|592089241|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
163922878|NCT00113269|592089242|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
163922879|NCT00113269|592089243|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
163922880|NCT00113269|592089244|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
163922881|NCT00113269|592089241|FG000|Overall Study|Discontinued due to rejection|0|||
163922882|NCT00113269|592089242|FG001|Overall Study|Discontinued due to rejection|0|||
163922883|NCT00113269|592089243|FG002|Overall Study|Discontinued due to rejection|1|||
163922884|NCT00113269|592089244|FG003|Overall Study|Discontinued due to rejection|0|||
163922885|NCT00113269|592089241|FG000|Overall Study|Moved|0|||
163922886|NCT00113269|592089242|FG001|Overall Study|Moved|1|||
163922887|NCT00113269|592089243|FG002|Overall Study|Moved|0|||
163922888|NCT00113269|592089244|FG003|Overall Study|Moved|3|||
163922889|NCT00113269|592089241|FG000|Overall Study|Received pancreas transplant|0|||
163922890|NCT00113269|592089242|FG001|Overall Study|Received pancreas transplant|0|||
163922891|NCT00113269|592089243|FG002|Overall Study|Received pancreas transplant|0|||
163922892|NCT00113269|592089244|FG003|Overall Study|Received pancreas transplant|2|||
163922893|NCT00113269|592089241|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
163922894|NCT00113269|592089242|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
163922895|NCT00113269|592089243|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
163922896|NCT00113269|592089244|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
163922897|NCT00113269|592089241|FG000|Overall Study|Did not meet eligibility criteria|1|||
163922898|NCT00113269|592089242|FG001|Overall Study|Did not meet eligibility criteria|0|||
163922899|NCT00113269|592089243|FG002|Overall Study|Did not meet eligibility criteria|0|||
163922900|NCT00113269|592089244|FG003|Overall Study|Did not meet eligibility criteria|1|||
163922901|NCT00113269|592089241|FG000|Overall Study|Unable to return for follow up|2|||
163922902|NCT00113269|592089242|FG001|Overall Study|Unable to return for follow up|1|||
163922903|NCT00113269|592089243|FG002|Overall Study|Unable to return for follow up|0|||
163922904|NCT00113269|592089244|FG003|Overall Study|Unable to return for follow up|0|||
163922905|NCT03864341|592089251|FG000|Overall Study|Withdrawal by Subject|1|||
163922906|NCT01066936|592089252|FG000|Overall Study|Death|2|||
163922907|NCT01066936|592089252|FG000|Overall Study|Device revised/removed|1|||
163922908|NCT01066936|592089252|FG000|Overall Study|Lost to Follow-up|3|||
163922909|NCT01066936|592089252|FG000|Overall Study|Withdrawal by Subject|4|||
163922910|NCT01904136|592089253|FG000|Overall Study|Physician Decision|0|||
163922911|NCT01904136|592089254|FG001|Overall Study|Physician Decision|0|||
163922912|NCT01904136|592089255|FG002|Overall Study|Physician Decision|0|||
163922913|NCT01904136|592089256|FG003|Overall Study|Physician Decision|0|||
163922914|NCT01904136|592089257|FG004|Overall Study|Physician Decision|0|||
163922915|NCT01904136|592089258|FG005|Overall Study|Physician Decision|1|||
163922916|NCT01904136|592089259|FG006|Overall Study|Physician Decision|0|||
163922917|NCT01904136|592089260|FG007|Overall Study|Physician Decision|0|||
163922918|NCT01904136|592089261|FG008|Overall Study|Physician Decision|0|||
163922919|NCT01960348|592089263|FG000|Overall Study|Adverse event, not serious|2|||
163922920|NCT01960348|592089264|FG001|Overall Study|Adverse event, not serious|2|||
163922921|NCT01960348|592089263|FG000|Overall Study|Adverse event, serious fatal|6|||
164033052|NCT02431468|592479621|FG002|Overall Study|noncompliance, investigator termination,|2|||
164033053|NCT01056341|592479622|FG000|Overall Study|Treatment Intolerance|0|||
164033054|NCT01056341|592479623|FG001|Overall Study|Treatment Intolerance|2|||
164033055|NCT01056341|592479624|FG002|Overall Study|Treatment Intolerance|0|||
164033056|NCT01056341|592479625|FG003|Overall Study|Treatment Intolerance|2|||
164033057|NCT01056341|592479626|FG004|Overall Study|Treatment Intolerance|0|||
164033058|NCT01056341|592479622|FG000|Overall Study|Lack of Efficacy|32|||
164033059|NCT01056341|592479623|FG001|Overall Study|Lack of Efficacy|30|||
164033060|NCT01056341|592479624|FG002|Overall Study|Lack of Efficacy|7|||
164033061|NCT01056341|592479625|FG003|Overall Study|Lack of Efficacy|25|||
164033062|NCT01056341|592479626|FG004|Overall Study|Lack of Efficacy|9|||
164033063|NCT01056341|592479622|FG000|Overall Study|Other reasons|4|||
164033064|NCT01056341|592479623|FG001|Overall Study|Other reasons|4|||
163922922|NCT01960348|592089264|FG001|Overall Study|Adverse event, serious fatal|5|||
163922923|NCT01960348|592089263|FG000|Overall Study|Adverse event, serious non-fatal|0|||
163922924|NCT01960348|592089264|FG001|Overall Study|Adverse event, serious non-fatal|3|||
164033065|NCT01056341|592479624|FG002|Overall Study|Other reasons|8|||
164033066|NCT01056341|592479625|FG003|Overall Study|Other reasons|9|||
164097720|NCT01171989|592722806|FG000|Overall Study|Lost to Follow-up|0|||
163922925|NCT01960348|592089263|FG000|Overall Study|Withdrawal by Subject|1|||
163922926|NCT01960348|592089264|FG001|Overall Study|Withdrawal by Subject|11|||
163922927|NCT01960348|592089263|FG000|Overall Study|Physician Decision|0|||
163922928|NCT01960348|592089264|FG001|Overall Study|Physician Decision|1|||
163922929|NCT01960348|592089263|FG000|Overall Study|Protocol Violation|1|||
163922930|NCT01960348|592089264|FG001|Overall Study|Protocol Violation|0|||
164033067|NCT01056341|592479626|FG004|Overall Study|Other reasons|5|||
163828054|NCT02712905|591737488|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
163828055|NCT02712905|591737489|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
163828056|NCT02712905|591737490|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
163828057|NCT02712905|591737491|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
163828058|NCT02712905|591737474|FG000|Combination Therapy|Withdrawal by Subject|0|||
163828059|NCT02712905|591737475|FG001|Combination Therapy|Withdrawal by Subject|0|||
163828060|NCT02712905|591737476|FG002|Combination Therapy|Withdrawal by Subject|0|||
163828061|NCT02712905|591737477|FG003|Combination Therapy|Withdrawal by Subject|0|||
163828062|NCT02712905|591737478|FG004|Combination Therapy|Withdrawal by Subject|0|||
163828063|NCT02712905|591737479|FG005|Combination Therapy|Withdrawal by Subject|0|||
163828064|NCT02712905|591737480|FG006|Combination Therapy|Withdrawal by Subject|0|||
163828065|NCT02712905|591737481|FG007|Combination Therapy|Withdrawal by Subject|0|||
163828066|NCT02712905|591737482|FG008|Combination Therapy|Withdrawal by Subject|0|||
163828067|NCT02712905|591737483|FG009|Combination Therapy|Withdrawal by Subject|0|||
163828068|NCT02712905|591737484|FG010|Combination Therapy|Withdrawal by Subject|0|||
163828069|NCT02712905|591737485|FG011|Combination Therapy|Withdrawal by Subject|0|||
163828070|NCT02712905|591737486|FG012|Combination Therapy|Withdrawal by Subject|0|||
163828071|NCT02712905|591737487|FG013|Combination Therapy|Withdrawal by Subject|0|||
163828072|NCT02712905|591737488|FG014|Combination Therapy|Withdrawal by Subject|0|||
163828073|NCT02712905|591737489|FG015|Combination Therapy|Withdrawal by Subject|1|||
163828074|NCT02712905|591737490|FG016|Combination Therapy|Withdrawal by Subject|0|||
163828075|NCT02712905|591737491|FG017|Combination Therapy|Withdrawal by Subject|2|||
163828076|NCT02712905|591737474|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828077|NCT02712905|591737475|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828078|NCT02712905|591737476|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828079|NCT02712905|591737477|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828080|NCT02712905|591737478|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828081|NCT02712905|591737479|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828082|NCT02712905|591737480|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828083|NCT02712905|591737481|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828084|NCT02712905|591737482|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828085|NCT02712905|591737483|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828086|NCT02712905|591737484|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828087|NCT02712905|591737485|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828088|NCT02712905|591737486|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828089|NCT02712905|591737487|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828090|NCT02712905|591737488|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828091|NCT02712905|591737489|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
163828092|NCT02712905|591737490|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828093|NCT02712905|591737491|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
163828094|NCT03624504|591737492|FG000|Overall Study|Unsuccessful Implant|1|||
163828095|NCT02975973|591737493|FG000|Overall Study|Adverse Event|1|||
163828096|NCT02975973|591737494|FG001|Overall Study|Adverse Event|1|||
163828097|NCT02975973|591737495|FG002|Overall Study|Adverse Event|1|||
163828098|NCT02975973|591737496|FG003|Overall Study|Adverse Event|0|||
163828099|NCT01812655|591737497|FG000|Overall Study|Protocol Violation|1|||
163828100|NCT01812655|591737498|FG001|Overall Study|Protocol Violation|1|||
163828101|NCT01812655|591737499|FG002|Overall Study|Protocol Violation|0|||
163828102|NCT01428076|591737500|FG000|Overall Study|Adverse Event|0|||
163828103|NCT01428076|591737501|FG001|Overall Study|Adverse Event|1|||
163828104|NCT04435665|591737502|FG000|Overall Study|Lost to Follow-up|0|||
163828105|NCT04435665|591737503|FG001|Overall Study|Lost to Follow-up|0|||
163828106|NCT04435665|591737504|FG002|Overall Study|Lost to Follow-up|0|||
163828107|NCT04435665|591737505|FG003|Overall Study|Lost to Follow-up|1|||
163828108|NCT02454101|591737506|FG000|Overall Study|Adverse Event|2|||
163828109|NCT02454101|591737507|FG001|Overall Study|Adverse Event|3|||
163828110|NCT02454101|591737506|FG000|Overall Study|Lost to Follow-up|3|||
163828111|NCT02454101|591737507|FG001|Overall Study|Lost to Follow-up|4|||
163828112|NCT00419263|591737508|FG000|Overall Study|Lost to Follow-up|2|||
163828113|NCT00419263|591737509|FG001|Overall Study|Lost to Follow-up|1|||
163828114|NCT00419263|591737510|FG002|Overall Study|Lost to Follow-up|1|||
163828115|NCT00419263|591737508|FG000|Overall Study|Randomized in Error, Not Treated|1|||
163828116|NCT00419263|591737509|FG001|Overall Study|Randomized in Error, Not Treated|1|||
163828117|NCT00419263|591737510|FG002|Overall Study|Randomized in Error, Not Treated|0|||
163828118|NCT00419263|591737508|FG000|Overall Study|Adverse Event|0|||
163828119|NCT00419263|591737509|FG001|Overall Study|Adverse Event|0|||
163828120|NCT00419263|591737510|FG002|Overall Study|Adverse Event|1|||
164097721|NCT01171989|592722807|FG001|Overall Study|Lost to Follow-up|0|||
163828121|NCT00419263|591737508|FG000|Overall Study|Withdrawal by Subject|0|||
163828122|NCT00419263|591737509|FG001|Overall Study|Withdrawal by Subject|0|||
163828123|NCT00419263|591737510|FG002|Overall Study|Withdrawal by Subject|1|||
163828124|NCT00540124|591737514|FG000|Overall Study|Adverse Event|0|||
163828125|NCT00540124|591737515|FG001|Overall Study|Adverse Event|2|||
163828126|NCT00540124|591737516|FG002|Overall Study|Adverse Event|1|||
163828127|NCT00540124|591737514|FG000|Overall Study|Entry Criteria Not Met|2|||
163828128|NCT00540124|591737515|FG001|Overall Study|Entry Criteria Not Met|0|||
163828129|NCT00540124|591737516|FG002|Overall Study|Entry Criteria Not Met|0|||
163828130|NCT00540124|591737514|FG000|Overall Study|Lack of Efficacy|1|||
163828131|NCT00540124|591737515|FG001|Overall Study|Lack of Efficacy|0|||
163828132|NCT00540124|591737516|FG002|Overall Study|Lack of Efficacy|0|||
163828133|NCT00540124|591737514|FG000|Overall Study|Withdrawal by Subject|1|||
163828134|NCT00540124|591737515|FG001|Overall Study|Withdrawal by Subject|1|||
163828135|NCT00540124|591737516|FG002|Overall Study|Withdrawal by Subject|0|||
163828136|NCT02124265|591737517|FG000|Overall Study|Adverse Event|1|||
163828137|NCT00058123|591737518|FG000|Overall Study|Wrong histology|9|||
163828138|NCT00058123|591737518|FG000|Overall Study|Received >3 prior treatments|1|||
163828139|NCT00344461|591737521|FG000|Overall Study|Adverse Event|6|||
163828140|NCT00344461|591737521|FG000|Overall Study|Death|1|||
163828141|NCT00344461|591737521|FG000|Overall Study|Lack of Efficacy|2|||
163828142|NCT00344461|591737521|FG000|Overall Study|Lost to Follow-up|2|||
163828143|NCT00344461|591737521|FG000|Overall Study|Physician Decision|2|||
163828144|NCT00344461|591737521|FG000|Overall Study|Protocol Violation|6|||
163828145|NCT00344461|591737521|FG000|Overall Study|Withdrawal by Subject|2|||
163828146|NCT04839965|591737524|FG000|Overall Study|Death|6|||
163828147|NCT04839965|591737525|FG001|Overall Study|Death|6|||
163828148|NCT04839965|591737524|FG000|Overall Study|Lost to Follow-up|1|||
163828149|NCT04839965|591737525|FG001|Overall Study|Lost to Follow-up|0|||
163828150|NCT02291679|591737526|FG000|Overall Study|Adverse Event|2|||
163828151|NCT02291679|591737527|FG001|Overall Study|Adverse Event|12|||
163828152|NCT02291679|591737528|FG002|Overall Study|Adverse Event|19|||
163828153|NCT02291679|591737526|FG000|Overall Study|Protocol Violation|5|||
163828154|NCT02291679|591737527|FG001|Overall Study|Protocol Violation|1|||
163828155|NCT02291679|591737528|FG002|Overall Study|Protocol Violation|7|||
163828156|NCT02291679|591737526|FG000|Overall Study|Withdrew Consent|18|||
163828157|NCT02291679|591737527|FG001|Overall Study|Withdrew Consent|10|||
163828158|NCT02291679|591737528|FG002|Overall Study|Withdrew Consent|15|||
163828159|NCT02291679|591737526|FG000|Overall Study|Lost to Follow-up|12|||
163828160|NCT02291679|591737527|FG001|Overall Study|Lost to Follow-up|10|||
163828161|NCT02291679|591737528|FG002|Overall Study|Lost to Follow-up|9|||
163828162|NCT02291679|591737526|FG000|Overall Study|Insufficient Therapeutic Response|5|||
163828163|NCT02291679|591737527|FG001|Overall Study|Insufficient Therapeutic Response|5|||
163828164|NCT02291679|591737528|FG002|Overall Study|Insufficient Therapeutic Response|7|||
163828165|NCT02291679|591737526|FG000|Overall Study|Other|2|||
163828166|NCT02291679|591737527|FG001|Overall Study|Other|4|||
163828167|NCT02291679|591737528|FG002|Overall Study|Other|2|||
163828168|NCT02355028|591737529|FG000|Overall Study|Adverse Event|2|||
163828169|NCT02355028|591737530|FG001|Overall Study|Adverse Event|0|||
163828170|NCT02355028|591737529|FG000|Overall Study|Withdrawal by Subject|1|||
163828171|NCT02355028|591737530|FG001|Overall Study|Withdrawal by Subject|1|||
163828172|NCT02355028|591737529|FG000|Overall Study|Deemed ineligible after randomization|8|||
163828173|NCT02355028|591737530|FG001|Overall Study|Deemed ineligible after randomization|4|||
163828174|NCT02276222|591737531|FG000|Overall Study|Adverse Event|62|||
163828175|NCT02276222|591737532|FG001|Overall Study|Adverse Event|11|||
163828176|NCT02276222|591737531|FG000|Overall Study|Death|3|||
163828177|NCT02276222|591737532|FG001|Overall Study|Death|4|||
163828178|NCT02276222|591737531|FG000|Overall Study|Lack of Efficacy|13|||
163828179|NCT02276222|591737532|FG001|Overall Study|Lack of Efficacy|3|||
163828180|NCT02276222|591737531|FG000|Overall Study|Protocol Violation|3|||
163828181|NCT02276222|591737532|FG001|Overall Study|Protocol Violation|2|||
163828182|NCT02276222|591737531|FG000|Overall Study|Withdrawal by Subject|79|||
163828183|NCT02276222|591737532|FG001|Overall Study|Withdrawal by Subject|33|||
163828184|NCT02276222|591737531|FG000|Overall Study|non compliance with study medication|6|||
163828185|NCT02276222|591737532|FG001|Overall Study|non compliance with study medication|2|||
163828186|NCT02276222|591737531|FG000|Overall Study|sponsor decision|0|||
163828187|NCT02276222|591737532|FG001|Overall Study|sponsor decision|3|||
163828188|NCT02276222|591737531|FG000|Overall Study|Lost to Follow-up|15|||
163828189|NCT02276222|591737532|FG001|Overall Study|Lost to Follow-up|5|||
163828190|NCT02276222|591737531|FG000|Overall Study|Physician Decision|2|||
163828191|NCT02276222|591737532|FG001|Overall Study|Physician Decision|1|||
163828192|NCT02276222|591737531|FG000|Overall Study|sheduling conflict|1|||
163828193|NCT02276222|591737532|FG001|Overall Study|sheduling conflict|0|||
163828194|NCT02276222|591737531|FG000|Overall Study|subject withdrew after randomization|1|||
163828195|NCT02276222|591737532|FG001|Overall Study|subject withdrew after randomization|0|||
163828196|NCT02170025|591737533|FG000|Overall Study|Adverse Event|2|||
163828197|NCT02170025|591737534|FG001|Overall Study|Adverse Event|0|||
163828198|NCT01525602|591737535|FG000|Overall Study|Adverse Event|1|||
163922931|NCT00853372|592089265|FG000|Overall Study|Death|30|||
163922932|NCT00853372|592089266|FG001|Overall Study|Death|26|||
163922933|NCT00853372|592089265|FG000|Overall Study|Lost to Follow-up|1|||
163922934|NCT00853372|592089266|FG001|Overall Study|Lost to Follow-up|2|||
163922935|NCT00853372|592089265|FG000|Overall Study|Full Consent Withdrawn|1|||
163922936|NCT00853372|592089266|FG001|Overall Study|Full Consent Withdrawn|1|||
163922937|NCT01580995|592089267|FG000|Overall Study|Lost to Follow-up|2|||
163922938|NCT01580995|592089268|FG001|Overall Study|Lost to Follow-up|2|||
163922939|NCT02517528|592089270|FG000|Overall Study|Withdrawal by Subject|1|||
163922940|NCT02202109|592089274|FG000|Overall Study|Lost to Follow-up|88|||
163922941|NCT02202109|592089275|FG001|Overall Study|Lost to Follow-up|87|||
163922942|NCT02202109|592089274|FG000|Overall Study|Withdrawal by Subject|2|||
163922943|NCT02202109|592089275|FG001|Overall Study|Withdrawal by Subject|0|||
163922944|NCT01268098|592089278|FG000|Overall Study|Adverse Event|1|||
163922945|NCT01268098|592089279|FG001|Overall Study|Adverse Event|0|||
163922946|NCT04156399|592089287|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
163922947|NCT04156399|592089287|FG000|Overall Study|study suspension due to COVID pandemic|3|||
163922948|NCT01093599|592089290|FG000|Overall Study|Lost to Follow-up|32|||
163922949|NCT01093599|592089291|FG001|Overall Study|Lost to Follow-up|46|||
163922950|NCT01703845|592089292|FG000|Overall Study|Adverse Event|1|||
163922951|NCT01703845|592089293|FG001|Overall Study|Adverse Event|0|||
163922952|NCT01703845|592089292|FG000|Overall Study|Protocol Violation|1|||
163922953|NCT01703845|592089293|FG001|Overall Study|Protocol Violation|0|||
163922954|NCT01703845|592089292|FG000|Overall Study|other than stated above|1|||
163922955|NCT01703845|592089293|FG001|Overall Study|other than stated above|0|||
163922956|NCT01644188|592089294|FG000|Overall Study|Adverse Event|44|||
163922957|NCT01644188|592089295|FG001|Overall Study|Adverse Event|20|||
163922958|NCT01644188|592089294|FG000|Overall Study|Poor compliance to protocol|26|||
163922959|NCT01644188|592089295|FG001|Overall Study|Poor compliance to protocol|14|||
163922960|NCT01644188|592089294|FG000|Overall Study|Physician Decision|1|||
163922961|NCT01644188|592089295|FG001|Overall Study|Physician Decision|3|||
163922962|NCT01644188|592089294|FG000|Overall Study|Participant moved|7|||
163922963|NCT01644188|592089295|FG001|Overall Study|Participant moved|2|||
163922964|NCT01644188|592089294|FG000|Overall Study|Related to auto-injector administration|2|||
163922965|NCT01644188|592089295|FG001|Overall Study|Related to auto-injector administration|2|||
163922966|NCT01644188|592089294|FG000|Overall Study|Consent withdrawn by participant|14|||
163922967|NCT01644188|592089295|FG001|Overall Study|Consent withdrawn by participant|7|||
163922968|NCT01644188|592089294|FG000|Overall Study|Selection criteria finally not met|2|||
163922969|NCT01644188|592089295|FG001|Overall Study|Selection criteria finally not met|0|||
163922970|NCT01644188|592089294|FG000|Overall Study|Lost to Follow-up|1|||
163922971|NCT01644188|592089295|FG001|Overall Study|Lost to Follow-up|0|||
163922972|NCT01644188|592089294|FG000|Overall Study|Death|4|||
163922973|NCT01644188|592089295|FG001|Overall Study|Death|3|||
163922974|NCT01644188|592089294|FG000|Overall Study|Last visit outside protocol visit window|14|||
163922975|NCT01644188|592089295|FG001|Overall Study|Last visit outside protocol visit window|16|||
163922976|NCT01644188|592089294|FG000|Overall Study|Site closure|1|||
163922977|NCT01644188|592089295|FG001|Overall Study|Site closure|1|||
163922978|NCT01644188|592089294|FG000|Overall Study|Other than specified above|6|||
163922979|NCT01644188|592089295|FG001|Overall Study|Other than specified above|7|||
163922980|NCT01222533|592089302|FG000|Overall Study|Adverse Event|5|||
163922981|NCT01222533|592089302|FG000|Overall Study|Withdrawal by Subject|5|||
163922982|NCT01222533|592089302|FG000|Overall Study|Other|4|||
163922983|NCT03834623|592089303|FG000|Overall Study|Progression|0|||
163922984|NCT03834623|592089304|FG001|Overall Study|Progression|1|||
163922985|NCT01947517|592089305|FG000|Overall Study|Withdrawal by Subject|1|||
163922986|NCT01947517|592089306|FG001|Overall Study|Withdrawal by Subject|1|||
163922987|NCT00719212|592089307|FG000|Overall Study|Death|41|||
163922988|NCT00719212|592089307|FG000|Overall Study|Lost to Follow-up|2|||
163922989|NCT00719212|592089307|FG000|Overall Study|Withdrawal by Subject|1|||
163922990|NCT00460564|592089312|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
163922991|NCT00460564|592089313|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
163922992|NCT00460564|592089314|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163922993|NCT00460564|592089315|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163922994|NCT00460564|592089316|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163922995|NCT00460564|592089317|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163922996|NCT00460564|592089318|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163922997|NCT00460564|592089319|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
163922998|NCT00460564|592089312|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
163922999|NCT00460564|592089313|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163923000|NCT00460564|592089314|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163923001|NCT00460564|592089315|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163923002|NCT00460564|592089316|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163923003|NCT00460564|592089317|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163923004|NCT00460564|592089318|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
163923005|NCT00460564|592089319|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
164033068|NCT01361919|592479627|FG000|Overall Study|technical issues|10|||
164033069|NCT01361919|592479628|FG001|Overall Study|technical issues|12|||
164033070|NCT01361919|592479629|FG002|Overall Study|technical issues|10|||
164033071|NCT03454412|592479630|FG000|Baseline Assesment|Physician Decision|12|||
164033072|NCT01167582|592479633|FG000|Overall Study|Lost to Follow-up|0|||
164033073|NCT01167582|592479634|FG001|Overall Study|Lost to Follow-up|1|||
163828199|NCT01525602|591737536|FG001|Overall Study|Adverse Event|0|||
163828200|NCT01525602|591737537|FG002|Overall Study|Adverse Event|1|||
163828201|NCT01525602|591737538|FG003|Overall Study|Adverse Event|1|||
163828202|NCT01525602|591737539|FG004|Overall Study|Adverse Event|3|||
163828203|NCT01525602|591737540|FG005|Overall Study|Adverse Event|3|||
163828204|NCT01525602|591737541|FG006|Overall Study|Adverse Event|0|||
163828205|NCT01525602|591737542|FG007|Overall Study|Adverse Event|1|||
163828206|NCT01525602|591737535|FG000|Overall Study|Disease progression|6|||
163828207|NCT01525602|591737536|FG001|Overall Study|Disease progression|3|||
163828208|NCT01525602|591737537|FG002|Overall Study|Disease progression|2|||
163828209|NCT01525602|591737538|FG003|Overall Study|Disease progression|5|||
163828210|NCT01525602|591737539|FG004|Overall Study|Disease progression|22|||
163828211|NCT01525602|591737540|FG005|Overall Study|Disease progression|2|||
163828212|NCT01525602|591737541|FG006|Overall Study|Disease progression|3|||
163828213|NCT01525602|591737542|FG007|Overall Study|Disease progression|3|||
163828214|NCT01525602|591737535|FG000|Overall Study|Clinical progression|2|||
163828215|NCT01525602|591737536|FG001|Overall Study|Clinical progression|0|||
163828216|NCT01525602|591737537|FG002|Overall Study|Clinical progression|0|||
163828217|NCT01525602|591737538|FG003|Overall Study|Clinical progression|0|||
163828218|NCT01525602|591737539|FG004|Overall Study|Clinical progression|0|||
163828219|NCT01525602|591737540|FG005|Overall Study|Clinical progression|0|||
163828220|NCT01525602|591737541|FG006|Overall Study|Clinical progression|1|||
163828221|NCT01525602|591737542|FG007|Overall Study|Clinical progression|1|||
163828222|NCT01525602|591737535|FG000|Overall Study|Non-compliance|0|||
163828223|NCT01525602|591737536|FG001|Overall Study|Non-compliance|0|||
163828224|NCT01525602|591737537|FG002|Overall Study|Non-compliance|0|||
163828225|NCT01525602|591737538|FG003|Overall Study|Non-compliance|0|||
163828226|NCT01525602|591737539|FG004|Overall Study|Non-compliance|1|||
163828227|NCT01525602|591737540|FG005|Overall Study|Non-compliance|0|||
163828228|NCT01525602|591737541|FG006|Overall Study|Non-compliance|0|||
163828229|NCT01525602|591737542|FG007|Overall Study|Non-compliance|0|||
163828230|NCT01525602|591737535|FG000|Overall Study|Withdrawal by Subject|0|||
163828231|NCT01525602|591737536|FG001|Overall Study|Withdrawal by Subject|0|||
163828232|NCT01525602|591737537|FG002|Overall Study|Withdrawal by Subject|0|||
163828233|NCT01525602|591737538|FG003|Overall Study|Withdrawal by Subject|0|||
163828234|NCT01525602|591737539|FG004|Overall Study|Withdrawal by Subject|3|||
163828235|NCT01525602|591737540|FG005|Overall Study|Withdrawal by Subject|1|||
163828236|NCT01525602|591737541|FG006|Overall Study|Withdrawal by Subject|0|||
163828237|NCT01525602|591737542|FG007|Overall Study|Withdrawal by Subject|1|||
163828238|NCT01525602|591737535|FG000|Overall Study|Physician Decision|0|||
163828239|NCT01525602|591737536|FG001|Overall Study|Physician Decision|0|||
163828240|NCT01525602|591737537|FG002|Overall Study|Physician Decision|0|||
163828241|NCT01525602|591737538|FG003|Overall Study|Physician Decision|0|||
163828242|NCT01525602|591737539|FG004|Overall Study|Physician Decision|3|||
163828243|NCT01525602|591737540|FG005|Overall Study|Physician Decision|0|||
163828244|NCT01525602|591737541|FG006|Overall Study|Physician Decision|1|||
163828245|NCT01525602|591737542|FG007|Overall Study|Physician Decision|0|||
163828246|NCT01525602|591737535|FG000|Overall Study|Death|0|||
163828247|NCT01525602|591737536|FG001|Overall Study|Death|0|||
163828248|NCT01525602|591737537|FG002|Overall Study|Death|0|||
163828249|NCT01525602|591737538|FG003|Overall Study|Death|0|||
163828250|NCT01525602|591737539|FG004|Overall Study|Death|1|||
163828251|NCT01525602|591737540|FG005|Overall Study|Death|1|||
163828252|NCT01525602|591737541|FG006|Overall Study|Death|0|||
163828253|NCT01525602|591737542|FG007|Overall Study|Death|0|||
163828254|NCT01525602|591737535|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
163828255|NCT01525602|591737536|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
163828256|NCT01525602|591737537|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
163828257|NCT01525602|591737538|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
163828258|NCT01525602|591737539|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
163828259|NCT01525602|591737540|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
163828260|NCT01525602|591737541|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
163828261|NCT01525602|591737542|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
163828262|NCT03703466|591737548|FG000|Overall Study|Death|2|||
163828263|NCT03703466|591737549|FG001|Overall Study|Death|1|||
163828264|NCT03703466|591737550|FG002|Overall Study|Death|0|||
163828265|NCT03703466|591737548|FG000|Overall Study|Withdrawal by Subject|0|||
163828266|NCT03703466|591737549|FG001|Overall Study|Withdrawal by Subject|3|||
163828267|NCT03703466|591737550|FG002|Overall Study|Withdrawal by Subject|0|||
163828268|NCT03703466|591737548|FG000|Overall Study|Completed < 3 Cycles|2|||
163923006|NCT00460564|592089312|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163923007|NCT00460564|592089313|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163923008|NCT00460564|592089314|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163923009|NCT00460564|592089315|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163923010|NCT00460564|592089316|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
163923011|NCT00460564|592089317|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
163923012|NCT00460564|592089318|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
163923013|NCT00460564|592089319|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
163923014|NCT00460564|592089312|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163923015|NCT00460564|592089313|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163923016|NCT00460564|592089314|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163923017|NCT00460564|592089315|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163923018|NCT00460564|592089316|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
163923019|NCT00460564|592089317|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
163923020|NCT00460564|592089318|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163923021|NCT00460564|592089319|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
163923022|NCT00460564|592089312|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923023|NCT00460564|592089313|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923024|NCT00460564|592089314|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923025|NCT00460564|592089315|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923026|NCT00460564|592089316|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
163923027|NCT00460564|592089317|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923028|NCT00460564|592089318|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923029|NCT00460564|592089319|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
163923030|NCT04140266|592089322|FG000|Overall Study|Physician Decision|2|||
163923031|NCT04140266|592089323|FG001|Overall Study|Physician Decision|0|||
163923032|NCT04140266|592089322|FG000|Overall Study|Withdrawal by Subject|4|||
163923033|NCT04140266|592089323|FG001|Overall Study|Withdrawal by Subject|2|||
163923034|NCT00943618|592089324|FG000|Overall Study|Lost to Follow-up|38|||
163923035|NCT00943618|592089325|FG001|Overall Study|Lost to Follow-up|48|||
163923036|NCT00943618|592089326|FG002|Overall Study|Lost to Follow-up|20|||
163923037|NCT00943618|592089324|FG000|Overall Study|Discontinued Medication|17|||
163923038|NCT00943618|592089325|FG001|Overall Study|Discontinued Medication|29|||
163923039|NCT00943618|592089326|FG002|Overall Study|Discontinued Medication|11|||
163923040|NCT03713281|592089331|FG000|Overall Study|Lens handling difficuluties|2|||
163923041|NCT03713281|592089331|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
163923042|NCT02624869|592089332|FG000|Overall Study|Lost to Follow-up|0|||
163923043|NCT02624869|592089333|FG001|Overall Study|Lost to Follow-up|0|||
163923044|NCT02624869|592089334|FG002|Overall Study|Lost to Follow-up|1|||
163923045|NCT02624869|592089332|FG000|Overall Study|Withdrawal by Subject|1|||
163923046|NCT02624869|592089333|FG001|Overall Study|Withdrawal by Subject|3|||
163923047|NCT02624869|592089334|FG002|Overall Study|Withdrawal by Subject|1|||
163923048|NCT00329550|592089335|FG000|Overall Study|Adverse Event|3|||
163923049|NCT00329550|592089336|FG001|Overall Study|Adverse Event|4|||
163923050|NCT00329550|592089337|FG002|Overall Study|Adverse Event|2|||
163923051|NCT00329550|592089335|FG000|Overall Study|Withdrawal of Consent|1|||
163923052|NCT00329550|592089336|FG001|Overall Study|Withdrawal of Consent|0|||
163923053|NCT00329550|592089337|FG002|Overall Study|Withdrawal of Consent|1|||
163923054|NCT00329550|592089335|FG000|Overall Study|Due to Relocation|0|||
163923055|NCT00329550|592089336|FG001|Overall Study|Due to Relocation|0|||
163923056|NCT00329550|592089337|FG002|Overall Study|Due to Relocation|1|||
163923057|NCT02994784|592089338|FG000|6 Months Follow-up|Lost to Follow-up|3|||
163923058|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
163923059|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
163923060|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
163923061|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
163923062|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
163923063|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
163923064|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
164033074|NCT03956225|592479635|FG000|Overall Study|Lack of Efficacy|1|||
163923065|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
163923066|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
163923067|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
163923068|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
163923069|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
163923070|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
163923071|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
163923072|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
164033075|NCT03956225|592479636|FG001|Overall Study|Lack of Efficacy|1|||
163923073|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
163923074|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
164033076|NCT03956225|592479635|FG000|Overall Study|Lost to Follow-up|0|||
164033077|NCT03956225|592479636|FG001|Overall Study|Lost to Follow-up|1|||
164033078|NCT03956225|592479635|FG000|Overall Study|Withdrawal by Subject|2|||
163923075|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
163923076|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
163923077|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
163923078|NCT02637856|592089342|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
163923079|NCT02637856|592089343|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
163923080|NCT02637856|592089342|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
163923081|NCT02637856|592089343|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
163923082|NCT02637856|592089342|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
163923083|NCT02637856|592089343|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
163923084|NCT01649557|592089344|FG000|Overall Study|Lost to Follow-up|5|||
163923085|NCT01649557|592089345|FG001|Overall Study|Lost to Follow-up|0|||
163923086|NCT01649557|592089346|FG002|Overall Study|Lost to Follow-up|3|||
163923087|NCT01649557|592089344|FG000|Overall Study|Adverse Event|7|||
163923088|NCT01649557|592089345|FG001|Overall Study|Adverse Event|5|||
163923089|NCT01649557|592089346|FG002|Overall Study|Adverse Event|1|||
163923090|NCT01649557|592089344|FG000|Overall Study|Met withdrawal criteria|4|||
163923091|NCT01649557|592089345|FG001|Overall Study|Met withdrawal criteria|0|||
163923092|NCT01649557|592089346|FG002|Overall Study|Met withdrawal criteria|0|||
163923093|NCT01649557|592089344|FG000|Overall Study|Physician Decision|8|||
163923094|NCT01649557|592089345|FG001|Overall Study|Physician Decision|2|||
163923095|NCT01649557|592089346|FG002|Overall Study|Physician Decision|1|||
163923096|NCT01649557|592089344|FG000|Overall Study|Withdrawal by Subject|15|||
163923097|NCT01649557|592089345|FG001|Overall Study|Withdrawal by Subject|5|||
163923098|NCT01649557|592089346|FG002|Overall Study|Withdrawal by Subject|4|||
163923099|NCT01649557|592089344|FG000|Overall Study|Protocol deviation|0|||
163923100|NCT01649557|592089345|FG001|Overall Study|Protocol deviation|2|||
163923101|NCT01649557|592089346|FG002|Overall Study|Protocol deviation|0|||
163923102|NCT01649557|592089344|FG000|Overall Study|Lack of Efficacy|5|||
163923103|NCT01649557|592089345|FG001|Overall Study|Lack of Efficacy|0|||
163923104|NCT01649557|592089346|FG002|Overall Study|Lack of Efficacy|0|||
163923105|NCT01011049|592089347|FG000|Overall Study|Protocol Violation|0|||
163923106|NCT01011049|592089348|FG001|Overall Study|Protocol Violation|0|||
163923107|NCT01011049|592089349|FG002|Overall Study|Protocol Violation|2|||
163923108|NCT01011049|592089350|FG003|Overall Study|Protocol Violation|0|||
163923109|NCT01011049|592089347|FG000|Overall Study|Lost to Follow-up|1|||
163923110|NCT01011049|592089348|FG001|Overall Study|Lost to Follow-up|2|||
163923111|NCT01011049|592089349|FG002|Overall Study|Lost to Follow-up|1|||
163923112|NCT01011049|592089350|FG003|Overall Study|Lost to Follow-up|0|||
163923113|NCT01011049|592089347|FG000|Overall Study|Withdrawal by Subject|0|||
163923114|NCT01011049|592089348|FG001|Overall Study|Withdrawal by Subject|0|||
163923115|NCT01011049|592089349|FG002|Overall Study|Withdrawal by Subject|1|||
163923116|NCT01011049|592089350|FG003|Overall Study|Withdrawal by Subject|0|||
163923117|NCT02815735|592089351|FG000|First Intervention (4 Weeks)|Discomfort|1|||
163923118|NCT02815735|592089352|FG001|First Intervention (4 Weeks)|Discomfort|0|||
163923119|NCT02815735|592089351|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
163923120|NCT02815735|592089352|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163923121|NCT02815735|592089351|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
163923122|NCT02815735|592089352|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
163923123|NCT02815735|592089351|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
163923124|NCT02815735|592089352|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
163923125|NCT00352053|592089353|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
163923126|NCT00352053|592089354|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
163923127|NCT00352053|592089353|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
163923128|NCT00352053|592089354|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
163923129|NCT00352053|592089353|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
163923130|NCT00352053|592089354|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
163923131|NCT00352053|592089353|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
163923132|NCT00352053|592089354|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
163923133|NCT00352053|592089353|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
164033079|NCT03956225|592479636|FG001|Overall Study|Withdrawal by Subject|1|||
164033080|NCT03956225|592479635|FG000|Overall Study|Other Reasons|2|||
163923134|NCT00352053|592089354|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
163923135|NCT00352053|592089353|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
163923136|NCT00352053|592089354|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
163923137|NCT00352053|592089353|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
164033081|NCT03956225|592479636|FG001|Overall Study|Other Reasons|1|||
164033082|NCT00567541|592479637|FG000|Overall Study|Adverse Event|0|||
164033083|NCT00567541|592479638|FG001|Overall Study|Adverse Event|1|||
163923138|NCT00352053|592089354|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
163923139|NCT00352053|592089353|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
164033084|NCT02157506|592479641|FG000|Overall Study|Adverse Event|0|||
163923140|NCT00352053|592089354|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
163923141|NCT00352053|592089353|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
163923142|NCT00352053|592089354|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
163923143|NCT00352053|592089353|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
163923144|NCT00352053|592089354|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
163923145|NCT00352053|592089353|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
163923146|NCT00352053|592089354|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
163923147|NCT00352053|592089353|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
163923148|NCT00352053|592089354|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
163923149|NCT00352053|592089353|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
163923150|NCT00352053|592089354|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
163923151|NCT02435381|592089355|FG000|Overall Study|Lost to Follow-up|2|||
163923152|NCT02435381|592089356|FG001|Overall Study|Lost to Follow-up|1|||
163923153|NCT04150341|592089359|FG000|Overall Study|Physician Decision|0|||
163923154|NCT04150341|592089360|FG001|Overall Study|Physician Decision|0|||
163923155|NCT04150341|592089361|FG002|Overall Study|Physician Decision|1|||
163923156|NCT04150341|592089362|FG003|Overall Study|Physician Decision|0|||
163923157|NCT04150341|592089363|FG004|Overall Study|Physician Decision|0|||
163923158|NCT04150341|592089364|FG005|Overall Study|Physician Decision|0|||
163923159|NCT04150341|592089359|FG000|Overall Study|Adverse Event|0|||
163923160|NCT04150341|592089360|FG001|Overall Study|Adverse Event|0|||
163923161|NCT04150341|592089361|FG002|Overall Study|Adverse Event|0|||
163923162|NCT04150341|592089362|FG003|Overall Study|Adverse Event|0|||
163923163|NCT04150341|592089363|FG004|Overall Study|Adverse Event|1|||
163923164|NCT04150341|592089364|FG005|Overall Study|Adverse Event|0|||
163923165|NCT00875615|592089365|FG000|Overall Study|Withdrawal by Subject|1|||
163923166|NCT00405912|592089366|FG000|Overall Study|Withdrawal by Subject|12|||
163923167|NCT00405912|592089367|FG001|Overall Study|Withdrawal by Subject|11|||
163923168|NCT00405912|592089368|FG002|Overall Study|Withdrawal by Subject|12|||
163923169|NCT00405912|592089366|FG000|Overall Study|Lost to Follow-up|4|||
163923170|NCT00405912|592089367|FG001|Overall Study|Lost to Follow-up|8|||
163923171|NCT00405912|592089368|FG002|Overall Study|Lost to Follow-up|4|||
163923172|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
163923173|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
163923174|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
163923175|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
163923176|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
163923177|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
163923178|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
163923179|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
163923180|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Death|6|||
163923181|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Death|2|||
163923182|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Death|2|||
163923183|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Death|9|||
163923184|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
163923185|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163923186|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163923187|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
163923188|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
163923189|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
163923190|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
163923191|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
163923192|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
163923193|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
163923194|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
163923195|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
163923196|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
164033085|NCT02157506|592479642|FG001|Overall Study|Adverse Event|1|||
164033086|NCT02157506|592479643|FG002|Overall Study|Adverse Event|0|||
164033087|NCT02157506|592479644|FG003|Overall Study|Adverse Event|0|||
164033088|NCT02157506|592479645|FG004|Overall Study|Adverse Event|0|||
163923197|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
163923198|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
164033089|NCT02157506|592479641|FG000|Overall Study|Lost to Follow-up|0|||
163923199|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
163923200|NCT03730662|592089370|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
163923201|NCT03730662|592089371|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
163923202|NCT03730662|592089372|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
163923203|NCT03730662|592089373|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
163923204|NCT03730662|592089370|FG000|Variable Treatment Period|Adverse Event|1|||
163923205|NCT03730662|592089371|FG001|Variable Treatment Period|Adverse Event|2|||
163923206|NCT03730662|592089372|FG002|Variable Treatment Period|Adverse Event|0|||
163923207|NCT03730662|592089373|FG003|Variable Treatment Period|Adverse Event|7|||
164033090|NCT02157506|592479642|FG001|Overall Study|Lost to Follow-up|0|||
164033091|NCT02157506|592479643|FG002|Overall Study|Lost to Follow-up|1|||
164033092|NCT02157506|592479644|FG003|Overall Study|Lost to Follow-up|0|||
164033093|NCT02157506|592479645|FG004|Overall Study|Lost to Follow-up|0|||
164033094|NCT01182337|592479646|FG000|Overall Study|Withdrawal by Subject|3|||
164033095|NCT01182337|592479647|FG001|Overall Study|Withdrawal by Subject|1|||
164033096|NCT01182337|592479646|FG000|Overall Study|Lost to Follow-up|0|||
164033097|NCT01182337|592479647|FG001|Overall Study|Lost to Follow-up|1|||
164033098|NCT04169061|592479650|FG000|Overall Study|Adverse Event|2|||
164033099|NCT04169061|592479650|FG000|Overall Study|Death|1|||
164033100|NCT04169061|592479650|FG000|Overall Study|Withdrawal by Subject|1|||
164033101|NCT04169061|592479650|FG000|Overall Study|Protocol Violation|1|||
164033102|NCT00656084|592482113|FG000|Overall Study|Adverse Event|4|||
164033103|NCT00656084|592482113|FG000|Overall Study|Withdrawal by Subject|1|||
164033104|NCT00656084|592482113|FG000|Overall Study|Patient Request|1|||
164033105|NCT00656084|592482113|FG000|Overall Study|Investigator Request|1|||
164033106|NCT02455388|592482117|FG000|Overall Study|Protocol Violation|1|||
164033107|NCT02455388|592482118|FG001|Overall Study|Protocol Violation|0|||
164033108|NCT02455388|592482119|FG002|Overall Study|Protocol Violation|4|||
164033109|NCT02455388|592482117|FG000|Overall Study|Withdrawal by Subject|0|||
164033110|NCT02455388|592482118|FG001|Overall Study|Withdrawal by Subject|0|||
164033111|NCT02455388|592482119|FG002|Overall Study|Withdrawal by Subject|7|||
164033112|NCT01136746|592482120|FG000|Overall Study|Lost to Follow-up|0|||
164033113|NCT01136746|592482121|FG001|Overall Study|Lost to Follow-up|2|||
164033114|NCT01136746|592482120|FG000|Overall Study|Protocol Violation|2|||
164033115|NCT01136746|592482121|FG001|Overall Study|Protocol Violation|1|||
164033116|NCT01136746|592482120|FG000|Overall Study|Death|1|||
164033117|NCT01136746|592482121|FG001|Overall Study|Death|0|||
164033118|NCT00092677|592482127|FG000|Overall Study|Lost to Follow-up|0|||
164033119|NCT00092677|592482128|FG001|Overall Study|Lost to Follow-up|2|||
164033120|NCT00092677|592482127|FG000|Overall Study|Adminstrative|5|||
164033121|NCT00092677|592482128|FG001|Overall Study|Adminstrative|9|||
164033122|NCT00093470|592482141|FG000|Overall Study|Disease progression|39|||
164033123|NCT00093470|592482142|FG001|Overall Study|Disease progression|0|||
164033124|NCT00093470|592482141|FG000|Overall Study|Adverse Event|15|||
164033125|NCT00093470|592482142|FG001|Overall Study|Adverse Event|0|||
164033126|NCT00093470|592482141|FG000|Overall Study|Death|2|||
164033127|NCT00093470|592482142|FG001|Overall Study|Death|0|||
164033128|NCT00093470|592482141|FG000|Overall Study|Withdrawal by Subject|8|||
164033129|NCT00093470|592482142|FG001|Overall Study|Withdrawal by Subject|0|||
164033130|NCT00093470|592482141|FG000|Overall Study|Alternative therapy|2|||
164033131|NCT00093470|592482142|FG001|Overall Study|Alternative therapy|0|||
164033132|NCT00093470|592482141|FG000|Overall Study|Other complicating disease|3|||
164033133|NCT00093470|592482142|FG001|Overall Study|Other complicating disease|0|||
164033134|NCT00093470|592482141|FG000|Overall Study|Physician Decision|2|||
164033135|NCT00093470|592482142|FG001|Overall Study|Physician Decision|0|||
164033136|NCT00093470|592482141|FG000|Overall Study|Never started treatment|1|||
164033137|NCT00093470|592482142|FG001|Overall Study|Never started treatment|0|||
164033138|NCT00093470|592482141|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
164033139|NCT00093470|592482142|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
164033140|NCT01019252|592482143|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
164033141|NCT01019252|592482144|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
164033142|NCT01019252|592482143|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
164033143|NCT01019252|592482144|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
164033144|NCT01019252|592482143|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
164033145|NCT01019252|592482144|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
164033146|NCT01019252|592482143|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
164033147|NCT01019252|592482144|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
164033148|NCT02514772|592482145|FG000|Overall Study|Adverse Event|1|||
164033149|NCT02514772|592482146|FG001|Overall Study|Adverse Event|0|||
163923208|NCT03730662|592089370|FG000|Variable Treatment Period|Death|9|||
163923209|NCT03730662|592089371|FG001|Variable Treatment Period|Death|0|||
163923210|NCT03730662|592089372|FG002|Variable Treatment Period|Death|6|||
163923211|NCT03730662|592089373|FG003|Variable Treatment Period|Death|26|||
163923212|NCT03730662|592089370|FG000|Variable Treatment Period|Lost to Follow-up|2|||
163923213|NCT03730662|592089371|FG001|Variable Treatment Period|Lost to Follow-up|1|||
164033150|NCT02514772|592482145|FG000|Overall Study|Death|0|||
164033151|NCT02514772|592482146|FG001|Overall Study|Death|1|||
164033152|NCT02514772|592482145|FG000|Overall Study|Withdrawal by Subject|2|||
164033153|NCT02514772|592482146|FG001|Overall Study|Withdrawal by Subject|1|||
163923214|NCT03730662|592089372|FG002|Variable Treatment Period|Lost to Follow-up|4|||
164033154|NCT00877006|592482147|FG000|Treatment Period|Death|2|||
164033155|NCT00877006|592482148|FG001|Treatment Period|Death|1|||
164033156|NCT00877006|592482147|FG000|Treatment Period|Adverse Event|10|||
164033157|NCT00877006|592482148|FG001|Treatment Period|Adverse Event|3|||
164033158|NCT00877006|592482147|FG000|Treatment Period|Withdrawal by Subject|2|||
164033159|NCT00877006|592482148|FG001|Treatment Period|Withdrawal by Subject|3|||
163923215|NCT03730662|592089373|FG003|Variable Treatment Period|Lost to Follow-up|11|||
163923216|NCT03730662|592089370|FG000|Variable Treatment Period|Personal Reason|0|||
163923217|NCT03730662|592089371|FG001|Variable Treatment Period|Personal Reason|2|||
163923218|NCT03730662|592089372|FG002|Variable Treatment Period|Personal Reason|1|||
163923219|NCT03730662|592089373|FG003|Variable Treatment Period|Personal Reason|6|||
163923220|NCT03730662|592089370|FG000|Variable Treatment Period|Physician Decision|0|||
163923221|NCT03730662|592089371|FG001|Variable Treatment Period|Physician Decision|0|||
163923222|NCT03730662|592089372|FG002|Variable Treatment Period|Physician Decision|0|||
163923223|NCT03730662|592089373|FG003|Variable Treatment Period|Physician Decision|3|||
163923224|NCT03730662|592089370|FG000|Variable Treatment Period|Protocol Violation|0|||
163923225|NCT03730662|592089371|FG001|Variable Treatment Period|Protocol Violation|1|||
163923226|NCT03730662|592089372|FG002|Variable Treatment Period|Protocol Violation|1|||
163923227|NCT03730662|592089373|FG003|Variable Treatment Period|Protocol Violation|1|||
163923228|NCT03730662|592089370|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
163923229|NCT03730662|592089371|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
163923230|NCT03730662|592089372|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
163923231|NCT03730662|592089373|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
163923232|NCT00833898|592089374|FG000|Overall Study|Withdrawal by Subject|33|||
163923233|NCT00833898|592089375|FG001|Overall Study|Withdrawal by Subject|27|||
163923234|NCT00833898|592089374|FG000|Overall Study|Lost to Follow-up|7|||
163923235|NCT00833898|592089375|FG001|Overall Study|Lost to Follow-up|7|||
163923236|NCT00833898|592089374|FG000|Overall Study|Patient did not receive transplant|0|||
163923237|NCT00833898|592089375|FG001|Overall Study|Patient did not receive transplant|2|||
163923238|NCT02895360|592089384|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
163923239|NCT02895360|592089385|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163923240|NCT02895360|592089386|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163923241|NCT02895360|592089387|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163923242|NCT02895360|592089388|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163923243|NCT02895360|592089389|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
163923244|NCT02895360|592089384|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163923245|NCT02895360|592089385|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
163923246|NCT02895360|592089386|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163923247|NCT02895360|592089387|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163923248|NCT02895360|592089388|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163923249|NCT02895360|592089389|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
163923250|NCT02895360|592089384|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
164033160|NCT00877006|592482147|FG000|Treatment Period|Protocol Violation|1|||
164033161|NCT00877006|592482148|FG001|Treatment Period|Protocol Violation|0|||
164033162|NCT00877006|592482147|FG000|Treatment Period|Lost to Follow-up|0|||
164033163|NCT00877006|592482148|FG001|Treatment Period|Lost to Follow-up|1|||
164033164|NCT00877006|592482147|FG000|Treatment Period|Disease Progression|1|||
164033165|NCT00877006|592482148|FG001|Treatment Period|Disease Progression|2|||
164033166|NCT00877006|592482147|FG000|Treatment Period|Started New Treatment Regimen|2|||
164033167|NCT00877006|592482148|FG001|Treatment Period|Started New Treatment Regimen|5|||
164033168|NCT00877006|592482147|FG000|Treatment Period|Other|4|||
164033169|NCT00877006|592482148|FG001|Treatment Period|Other|4|||
164033170|NCT00877006|592482147|FG000|Treatment Period|Randomized but Not Treated|3|||
164033171|NCT00877006|592482148|FG001|Treatment Period|Randomized but Not Treated|8|||
164033172|NCT00877006|592482147|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
164033173|NCT00877006|592482148|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
164033174|NCT00877006|592482147|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
164033175|NCT00877006|592482148|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
164033176|NCT00877006|592482147|FG000|Long-Term Follow-up Period|Death|26|||
164033177|NCT00877006|592482148|FG001|Long-Term Follow-up Period|Death|18|||
164033178|NCT00877006|592482147|FG000|Long-Term Follow-up Period|Other|7|||
164033179|NCT00877006|592482148|FG001|Long-Term Follow-up Period|Other|9|||
164033180|NCT04671342|592482149|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
164033181|NCT04671342|592482149|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
164033182|NCT04671342|592482149|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
164033183|NCT04671342|592482149|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
164033184|NCT04671342|592482149|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
164033185|NCT04671342|592482149|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
164033186|NCT03583606|592482150|FG000|Overall Study|Lost to Follow-up|0|||
164033187|NCT03583606|592482151|FG001|Overall Study|Lost to Follow-up|1|||
164033188|NCT03583606|592482152|FG002|Overall Study|Lost to Follow-up|0|||
164033189|NCT03583606|592482150|FG000|Overall Study|Ineligible at baseline|1|||
164033190|NCT03583606|592482151|FG001|Overall Study|Ineligible at baseline|0|||
164033191|NCT03583606|592482152|FG002|Overall Study|Ineligible at baseline|0|||
164033192|NCT02685995|592482153|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
164033193|NCT02685995|592482154|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
164033194|NCT00817206|592482155|FG000|Overall Study|Adverse Event|10|||
164033195|NCT00817206|592482156|FG001|Overall Study|Adverse Event|3|||
164033196|NCT00817206|592482155|FG000|Overall Study|Protocol Violation|0|||
163923251|NCT02895360|592089385|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163923252|NCT02895360|592089386|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
163923253|NCT02895360|592089387|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163923254|NCT02895360|592089388|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163923255|NCT02895360|592089389|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
163923256|NCT02895360|592089384|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163923257|NCT02895360|592089385|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163923258|NCT02895360|592089386|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
163923259|NCT02895360|592089387|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163923260|NCT02895360|592089388|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163923261|NCT02895360|592089389|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
163923262|NCT02895360|592089384|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163923263|NCT02895360|592089385|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163923264|NCT02895360|592089386|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163923265|NCT02895360|592089387|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
163923266|NCT02895360|592089388|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163923267|NCT02895360|592089389|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
163923268|NCT02895360|592089384|FG000|Phase 2a|Adverse Event|0|||
163923269|NCT02895360|592089385|FG001|Phase 2a|Adverse Event|0|||
163923270|NCT02895360|592089386|FG002|Phase 2a|Adverse Event|0|||
163923271|NCT02895360|592089387|FG003|Phase 2a|Adverse Event|0|||
163923272|NCT02895360|592089388|FG004|Phase 2a|Adverse Event|0|||
163923273|NCT02895360|592089389|FG005|Phase 2a|Adverse Event|1|||
163923274|NCT02895360|592089384|FG000|Phase 2a|Progressive disease|0|||
163923275|NCT02895360|592089385|FG001|Phase 2a|Progressive disease|0|||
163923276|NCT02895360|592089386|FG002|Phase 2a|Progressive disease|0|||
163923277|NCT02895360|592089387|FG003|Phase 2a|Progressive disease|0|||
163923278|NCT02895360|592089388|FG004|Phase 2a|Progressive disease|11|||
163923279|NCT02895360|592089389|FG005|Phase 2a|Progressive disease|11|||
163923280|NCT00666198|592089390|FG000|Overall Study|Protocol Violation|10|||
163923281|NCT00666198|592089390|FG000|Overall Study|No Visit After First Day of Treatment|13|||
163923282|NCT00666198|592089390|FG000|Overall Study|Safety Not Assessable|6|||
163923283|NCT00666198|592089390|FG000|Overall Study|No Drug Administration|4|||
163923284|NCT05153499|592089391|FG000|Overall Study|Withdrawal by Subject|1|||
163923285|NCT05153499|592089392|FG001|Overall Study|Withdrawal by Subject|0|||
163923286|NCT05153499|592089391|FG000|Overall Study|Clinical Hold|1|||
163923287|NCT05153499|592089392|FG001|Overall Study|Clinical Hold|0|||
163923288|NCT05153499|592089391|FG000|Overall Study|Study Termination|6|||
163923289|NCT05153499|592089392|FG001|Overall Study|Study Termination|5|||
163923290|NCT01960114|592089394|FG000|Overall Study|Adverse Event|1|||
163923291|NCT01960114|592089395|FG001|Overall Study|Adverse Event|0|||
163923292|NCT01960114|592089394|FG000|Overall Study|Could not swallow study medication|0|||
163923293|NCT01960114|592089395|FG001|Overall Study|Could not swallow study medication|1|||
163923294|NCT00427778|592089396|FG000|First Intervention (4 Weeks)|no longer interested|1|||
163923295|NCT00427778|592089397|FG001|First Intervention (4 Weeks)|no longer interested|0|||
163923296|NCT00427778|592089396|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
163923297|NCT00427778|592089397|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
163923298|NCT00427778|592089396|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
163923299|NCT00427778|592089397|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
163923300|NCT00427778|592089396|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
163923301|NCT00427778|592089397|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
163923302|NCT00225277|592089398|FG000|Overall Study|Adverse Event|30|||
163923303|NCT00225277|592089399|FG001|Overall Study|Adverse Event|34|||
163923304|NCT00225277|592089398|FG000|Overall Study|Lack of Efficacy|4|||
163923305|NCT00225277|592089399|FG001|Overall Study|Lack of Efficacy|1|||
163923306|NCT00225277|592089398|FG000|Overall Study|Lost to Follow-up|4|||
163923307|NCT00225277|592089399|FG001|Overall Study|Lost to Follow-up|6|||
163923308|NCT00225277|592089398|FG000|Overall Study|Physician Decision|6|||
163923309|NCT00225277|592089399|FG001|Overall Study|Physician Decision|8|||
163923310|NCT00225277|592089398|FG000|Overall Study|Protocol Violation|6|||
163923311|NCT00225277|592089399|FG001|Overall Study|Protocol Violation|3|||
163923312|NCT00225277|592089398|FG000|Overall Study|Withdrawal by Subject|40|||
163923313|NCT00225277|592089399|FG001|Overall Study|Withdrawal by Subject|34|||
163923314|NCT00225277|592089398|FG000|Overall Study|Other|7|||
163923315|NCT00225277|592089399|FG001|Overall Study|Other|9|||
163923316|NCT00591409|592089405|FG000|Overall Study|Not Treated|0|||
163923317|NCT00591409|592089406|FG001|Overall Study|Not Treated|0|||
163923318|NCT00591409|592089407|FG002|Overall Study|Not Treated|0|||
164097722|NCT01171989|592722808|FG002|Overall Study|Lost to Follow-up|1|||
164097723|NCT00418184|592722809|FG000|Double-blind Phase|Withdrawal by Subject|22|||
163923319|NCT00591409|592089408|FG003|Overall Study|Not Treated|0|||
163923320|NCT00591409|592089409|FG004|Overall Study|Not Treated|1|||
163923321|NCT00591409|592089410|FG005|Overall Study|Not Treated|0|||
163923322|NCT00591409|592089411|FG006|Overall Study|Not Treated|0|||
163923323|NCT00591409|592089412|FG007|Overall Study|Not Treated|0|||
163923324|NCT00591409|592089413|FG008|Overall Study|Not Treated|0|||
163923325|NCT00591409|592089414|FG009|Overall Study|Not Treated|1|||
163923326|NCT01340300|592089415|FG000|Overall Study|Lost to Follow-up|3|||
163923327|NCT01340300|592089416|FG001|Overall Study|Lost to Follow-up|0|||
163923328|NCT01340300|592089417|FG002|Overall Study|Lost to Follow-up|5|||
163923329|NCT01340300|592089418|FG003|Overall Study|Lost to Follow-up|10|||
163923330|NCT01340300|592089415|FG000|Overall Study|Withdrawal by Subject|5|||
163923331|NCT01340300|592089416|FG001|Overall Study|Withdrawal by Subject|6|||
163923332|NCT01340300|592089417|FG002|Overall Study|Withdrawal by Subject|6|||
163923333|NCT01340300|592089418|FG003|Overall Study|Withdrawal by Subject|3|||
163923334|NCT01340300|592089415|FG000|Overall Study|Adverse Event|1|||
163923335|NCT01340300|592089416|FG001|Overall Study|Adverse Event|0|||
163923336|NCT01340300|592089417|FG002|Overall Study|Adverse Event|4|||
163923337|NCT01340300|592089418|FG003|Overall Study|Adverse Event|0|||
163923338|NCT01340300|592089415|FG000|Overall Study|Physician Decision|0|||
163923339|NCT01340300|592089416|FG001|Overall Study|Physician Decision|1|||
163923340|NCT01340300|592089417|FG002|Overall Study|Physician Decision|0|||
163923341|NCT01340300|592089418|FG003|Overall Study|Physician Decision|0|||
163923342|NCT01340300|592089415|FG000|Overall Study|Unrelated sickness|0|||
163923343|NCT01340300|592089416|FG001|Overall Study|Unrelated sickness|2|||
163923344|NCT01340300|592089417|FG002|Overall Study|Unrelated sickness|0|||
163923345|NCT01340300|592089418|FG003|Overall Study|Unrelated sickness|1|||
163923346|NCT03226106|592090920|FG000|Overall Study|Withdrawal by Subject|2|||
163923347|NCT03226106|592090921|FG001|Overall Study|Withdrawal by Subject|0|||
163923348|NCT03226106|592090920|FG000|Overall Study|Adverse Event|1|||
163923349|NCT03226106|592090921|FG001|Overall Study|Adverse Event|0|||
163923350|NCT03226106|592090920|FG000|Overall Study|Lost to Follow-up|2|||
163923351|NCT03226106|592090921|FG001|Overall Study|Lost to Follow-up|0|||
163923352|NCT04349644|592090922|FG000|Allocation/Pretest|Lost to pretest|0|||
163923353|NCT04349644|592090923|FG001|Allocation/Pretest|Lost to pretest|3|||
163923354|NCT04349644|592090922|FG000|Posttest|Lost to posttest|0|||
163923355|NCT04349644|592090923|FG001|Posttest|Lost to posttest|8|||
163923356|NCT04349644|592090922|FG000|Posttest|Discontinued intervention|6|||
163923357|NCT04349644|592090923|FG001|Posttest|Discontinued intervention|0|||
163923358|NCT04349644|592090922|FG000|Follow-up|Lost to Follow-up|0|||
163923359|NCT04349644|592090923|FG001|Follow-up|Lost to Follow-up|2|||
163923360|NCT00702650|592090924|FG000|Overall Study|Withdrawal by Subject|9|||
163923361|NCT00702650|592090924|FG000|Overall Study|Non-Compliance of Study Drug|3|||
163923362|NCT00702650|592090924|FG000|Overall Study|Lost to Follow-up|2|||
163923363|NCT00702650|592090924|FG000|Overall Study|Non-Compliance with Site Directives|1|||
163923364|NCT00702650|592090924|FG000|Overall Study|Sponsor Request|1|||
163923365|NCT00702650|592090924|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
163923366|NCT00702650|592090924|FG000|Overall Study|Adverse Event|3|||
163923367|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
163923368|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
163923369|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
163923370|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
163923371|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Death|0|||
163923372|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Death|1|||
163923373|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
163923374|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
163923375|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
163923376|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
163923377|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
163923378|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
163923379|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
163923380|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
163923381|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
163923382|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
163923383|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
163923384|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
163923385|NCT01309243|592090925|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
163923386|NCT01309243|592090926|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
163923387|NCT01309243|592090925|FG000|Extension Phase|Lost to Follow-up|6|||
163923388|NCT01309243|592090926|FG001|Extension Phase|Lost to Follow-up|0|||
163923389|NCT00943722|592090928|FG000|Base Study|Adverse Event|0|||
163923390|NCT00943722|592090929|FG001|Base Study|Adverse Event|0|||
163923391|NCT00943722|592090930|FG002|Base Study|Adverse Event|0|||
163923392|NCT00943722|592090931|FG003|Base Study|Adverse Event|1|||
163923393|NCT00943722|592090932|FG004|Base Study|Adverse Event|0|||
163923394|NCT00943722|592090933|FG005|Base Study|Adverse Event|0|||
163923395|NCT00943722|592090934|FG006|Base Study|Adverse Event|0|||
163923396|NCT00943722|592090928|FG000|Base Study|Lost to Follow-up|12|||
163923397|NCT00943722|592090929|FG001|Base Study|Lost to Follow-up|8|||
163923398|NCT00943722|592090930|FG002|Base Study|Lost to Follow-up|10|||
163923399|NCT00943722|592090931|FG003|Base Study|Lost to Follow-up|8|||
163923400|NCT00943722|592090932|FG004|Base Study|Lost to Follow-up|11|||
163923401|NCT00943722|592090933|FG005|Base Study|Lost to Follow-up|0|||
163923402|NCT00943722|592090934|FG006|Base Study|Lost to Follow-up|0|||
163923403|NCT00943722|592090928|FG000|Base Study|Physician Decision|1|||
163923404|NCT00943722|592090929|FG001|Base Study|Physician Decision|0|||
163923405|NCT00943722|592090930|FG002|Base Study|Physician Decision|0|||
163923406|NCT00943722|592090931|FG003|Base Study|Physician Decision|0|||
163923407|NCT00943722|592090932|FG004|Base Study|Physician Decision|1|||
163923408|NCT00943722|592090933|FG005|Base Study|Physician Decision|0|||
163923409|NCT00943722|592090934|FG006|Base Study|Physician Decision|0|||
163923410|NCT00943722|592090928|FG000|Base Study|Pregnancy|0|||
163923411|NCT00943722|592090929|FG001|Base Study|Pregnancy|0|||
163923412|NCT00943722|592090930|FG002|Base Study|Pregnancy|1|||
163923413|NCT00943722|592090931|FG003|Base Study|Pregnancy|0|||
163923414|NCT00943722|592090932|FG004|Base Study|Pregnancy|2|||
163923415|NCT00943722|592090933|FG005|Base Study|Pregnancy|0|||
163923416|NCT00943722|592090934|FG006|Base Study|Pregnancy|0|||
163923417|NCT00943722|592090928|FG000|Base Study|Protocol Violation|0|||
163923418|NCT00943722|592090929|FG001|Base Study|Protocol Violation|1|||
163923419|NCT00943722|592090930|FG002|Base Study|Protocol Violation|0|||
163923420|NCT00943722|592090931|FG003|Base Study|Protocol Violation|0|||
163923421|NCT00943722|592090932|FG004|Base Study|Protocol Violation|2|||
163923422|NCT00943722|592090933|FG005|Base Study|Protocol Violation|0|||
163923423|NCT00943722|592090934|FG006|Base Study|Protocol Violation|0|||
163923424|NCT00943722|592090928|FG000|Base Study|Withdrawal by Subject|12|||
163923425|NCT00943722|592090929|FG001|Base Study|Withdrawal by Subject|13|||
163923426|NCT00943722|592090930|FG002|Base Study|Withdrawal by Subject|2|||
163923427|NCT00943722|592090931|FG003|Base Study|Withdrawal by Subject|13|||
163923428|NCT00943722|592090932|FG004|Base Study|Withdrawal by Subject|8|||
163923429|NCT00943722|592090933|FG005|Base Study|Withdrawal by Subject|0|||
163923430|NCT00943722|592090934|FG006|Base Study|Withdrawal by Subject|0|||
163923431|NCT00943722|592090928|FG000|Base Study|Month 12 visit not completed|0|||
163923432|NCT00943722|592090929|FG001|Base Study|Month 12 visit not completed|0|||
163923433|NCT00943722|592090930|FG002|Base Study|Month 12 visit not completed|0|||
163923434|NCT00943722|592090931|FG003|Base Study|Month 12 visit not completed|0|||
163923435|NCT00943722|592090932|FG004|Base Study|Month 12 visit not completed|2|||
163923436|NCT00943722|592090933|FG005|Base Study|Month 12 visit not completed|0|||
163923437|NCT00943722|592090934|FG006|Base Study|Month 12 visit not completed|0|||
163923438|NCT00943722|592090928|FG000|First Extension Study: EXT 1|Adverse Event|0|||
163923439|NCT00943722|592090929|FG001|First Extension Study: EXT 1|Adverse Event|0|||
163923440|NCT00943722|592090930|FG002|First Extension Study: EXT 1|Adverse Event|0|||
163923441|NCT00943722|592090931|FG003|First Extension Study: EXT 1|Adverse Event|0|||
163923442|NCT00943722|592090932|FG004|First Extension Study: EXT 1|Adverse Event|0|||
163923443|NCT00943722|592090933|FG005|First Extension Study: EXT 1|Adverse Event|1|||
163923444|NCT00943722|592090934|FG006|First Extension Study: EXT 1|Adverse Event|0|||
163923445|NCT00943722|592090928|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
163923446|NCT00943722|592090929|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
163923447|NCT00943722|592090930|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
163923448|NCT00943722|592090931|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
163923449|NCT00943722|592090932|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
163923450|NCT00943722|592090933|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
163923451|NCT00943722|592090934|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
163923452|NCT00943722|592090928|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163923453|NCT00943722|592090929|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163923454|NCT00943722|592090930|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163923455|NCT00943722|592090931|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
164033197|NCT00817206|592482156|FG001|Overall Study|Protocol Violation|2|||
164033198|NCT00817206|592482155|FG000|Overall Study|Lost to Follow-up|0|||
164033199|NCT00817206|592482156|FG001|Overall Study|Lost to Follow-up|1|||
164033200|NCT00817206|592482155|FG000|Overall Study|Death|2|||
163923456|NCT00943722|592090932|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
163923457|NCT00943722|592090933|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
163923458|NCT00943722|592090934|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
163923459|NCT00943722|592090928|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
163923460|NCT00943722|592090929|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
163923461|NCT00943722|592090930|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
163923462|NCT00943722|592090931|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
163923463|NCT00943722|592090932|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
163923464|NCT00943722|592090933|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
163923465|NCT00943722|592090934|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
163923466|NCT00943722|592090928|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
163923467|NCT00943722|592090929|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
163923468|NCT00943722|592090930|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
163923469|NCT00943722|592090931|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
163923470|NCT00943722|592090932|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
163923471|NCT00943722|592090933|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
163923472|NCT00943722|592090934|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
163923473|NCT00943722|592090928|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163923474|NCT00943722|592090929|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163923475|NCT00943722|592090930|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163923476|NCT00943722|592090931|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163923477|NCT00943722|592090932|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
163923478|NCT00943722|592090933|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
163923479|NCT00943722|592090934|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
163923480|NCT00943722|592090928|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
163923481|NCT00943722|592090929|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
163923482|NCT00943722|592090930|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
163923483|NCT00943722|592090931|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
163923484|NCT00943722|592090932|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
163923485|NCT00943722|592090933|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
163923486|NCT00943722|592090934|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
163923487|NCT00943722|592090928|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
163923488|NCT00943722|592090929|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
163923489|NCT00943722|592090930|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
163923490|NCT00943722|592090931|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
163923491|NCT00943722|592090932|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
163923492|NCT00943722|592090933|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
163923493|NCT00943722|592090934|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
163923494|NCT00943722|592090928|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163923495|NCT00943722|592090929|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163923496|NCT00943722|592090930|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163923497|NCT00943722|592090931|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163923498|NCT00943722|592090932|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
163923499|NCT00943722|592090933|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
163923500|NCT00943722|592090934|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
163923501|NCT01772823|592090935|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
163923502|NCT01772823|592090936|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
163923503|NCT01772823|592090935|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
163923504|NCT01772823|592090936|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
163923505|NCT01772823|592090935|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
163923506|NCT01772823|592090936|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
163923507|NCT01772823|592090935|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
163923508|NCT01772823|592090936|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
163923509|NCT01772823|592090935|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
163923510|NCT01772823|592090936|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
163923511|NCT01772823|592090935|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
163923512|NCT01772823|592090936|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
163923513|NCT01772823|592090935|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
163923514|NCT01772823|592090936|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
163923515|NCT01772823|592090935|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
163923516|NCT01772823|592090936|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
163923517|NCT01772823|592090935|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
163923518|NCT01772823|592090936|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
163923519|NCT01772823|592090935|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
163923520|NCT01772823|592090936|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
163923521|NCT01772823|592090935|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
163923522|NCT01772823|592090936|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
163923523|NCT01772823|592090935|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
163923524|NCT01772823|592090936|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
163923525|NCT01772823|592090935|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
163923526|NCT01772823|592090936|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
163923527|NCT01772823|592090935|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
163923528|NCT01772823|592090936|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
163923529|NCT01772823|592090935|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
163923530|NCT01772823|592090936|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
163923531|NCT01772823|592090935|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
163923532|NCT01772823|592090936|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
163923533|NCT01402063|592090939|FG000|Overall Study|Withdrawal by Subject|3|||
163923534|NCT01402063|592090940|FG001|Overall Study|Withdrawal by Subject|3|||
163923535|NCT05109117|592090941|FG000|Overall Study|Lost to Follow-up|1|||
163923536|NCT05109117|592090941|FG000|Overall Study|Discontinued for non-compliance|1|||
163923537|NCT03220776|592090944|FG000|Overall Study|Claustrophobia|0|||
163923538|NCT03220776|592090945|FG001|Overall Study|Claustrophobia|1|||
164097724|NCT00418184|592722810|FG001|Double-blind Phase|Withdrawal by Subject|9|||
164097725|NCT00418184|592722809|FG000|Double-blind Phase|Adverse Event|2|||
164097726|NCT00418184|592722810|FG001|Double-blind Phase|Adverse Event|1|||
164097727|NCT00418184|592722809|FG000|Double-blind Phase|Poor compliance|3|||
164097728|NCT00418184|592722810|FG001|Double-blind Phase|Poor compliance|1|||
164097729|NCT00620074|592722812|FG000|Overall Study|Adverse Event|1|||
164097730|NCT04466111|592722817|FG000|Prior to Trial Phase|Physician Decision|1|||
164097731|NCT03553823|592722826|FG000|Overall Study|Physician Decision|0|||
164097732|NCT03553823|592722827|FG001|Overall Study|Physician Decision|1|||
164097733|NCT00893464|592722828|FG000|Overall Study|Did not complete therapy/experience PD|0|||
164097734|NCT00893464|592722829|FG001|Overall Study|Did not complete therapy/experience PD|0|||
164097735|NCT00893464|592722830|FG002|Overall Study|Did not complete therapy/experience PD|0|||
164097736|NCT00893464|592722831|FG003|Overall Study|Did not complete therapy/experience PD|0|||
164097737|NCT00893464|592722832|FG004|Overall Study|Did not complete therapy/experience PD|0|||
164097738|NCT00893464|592722833|FG005|Overall Study|Did not complete therapy/experience PD|0|||
164097739|NCT00893464|592722834|FG006|Overall Study|Did not complete therapy/experience PD|2|||
164097740|NCT00893464|592722835|FG007|Overall Study|Did not complete therapy/experience PD|2|||
164097741|NCT03450070|592722836|FG000|Overall Study|Withdrawal by Subject|8|||
164097742|NCT02910037|592722837|FG000|Overall Study|Withdrawal by Subject|4|||
164097743|NCT02910037|592722837|FG000|Overall Study|Lost to Follow-up|6|||
164097744|NCT00813293|592722842|FG000|Overall Study|Intercurrent illness|1|||
164097745|NCT00813293|592722843|FG001|Overall Study|Intercurrent illness|0|||
164097746|NCT00813293|592722842|FG000|Overall Study|Adverse Event|0|||
164097747|NCT00813293|592722843|FG001|Overall Study|Adverse Event|1|||
164097748|NCT02794974|592722844|FG000|Overall Study|Physician Decision|0|||
163828269|NCT03703466|591737549|FG001|Overall Study|Completed < 3 Cycles|2|||
163828270|NCT03703466|591737550|FG002|Overall Study|Completed < 3 Cycles|2|||
163828271|NCT02412137|591737551|FG000|Overall Study|Withdrawal by Subject|2|||
163828272|NCT02412137|591737552|FG001|Overall Study|Withdrawal by Subject|0|||
163828273|NCT02412137|591737551|FG000|Overall Study|Lost to Follow-up|21|||
163828274|NCT02412137|591737552|FG001|Overall Study|Lost to Follow-up|14|||
163828275|NCT02412137|591737551|FG000|Overall Study|Physician Decision|28|||
163828276|NCT02412137|591737552|FG001|Overall Study|Physician Decision|9|||
163828277|NCT00506493|591737553|FG000|Overall Study|Death|6|||
163828278|NCT00506493|591737553|FG000|Overall Study|Withdrawal by Subject|5|||
163828279|NCT02240108|591739243|FG000|Overall Study|Other than specified|8|||
163828280|NCT02240108|591739244|FG001|Overall Study|Other than specified|6|||
163828281|NCT02240108|591739243|FG000|Overall Study|Adverse Event|1|||
163828282|NCT02240108|591739244|FG001|Overall Study|Adverse Event|9|||
163828283|NCT02240108|591739243|FG000|Overall Study|Pregnancy|1|||
163828284|NCT02240108|591739244|FG001|Overall Study|Pregnancy|0|||
163828285|NCT02240108|591739243|FG000|Overall Study|Withdrawal by Subject|4|||
163828286|NCT02240108|591739244|FG001|Overall Study|Withdrawal by Subject|9|||
163828287|NCT02240108|591739243|FG000|Overall Study|StudyTerminated by Sponsor|0|||
163828288|NCT02240108|591739244|FG001|Overall Study|StudyTerminated by Sponsor|1|||
163828289|NCT00119405|591739245|FG000|Overall Study|Withdrawal by Subject|1|||
163828290|NCT00939484|591739247|FG000|Overall Study|Progression/Relapse|8|||
163828291|NCT00939484|591739248|FG001|Overall Study|Progression/Relapse|20|||
163828292|NCT00939484|591739249|FG002|Overall Study|Progression/Relapse|3|||
163828293|NCT04233372|591739250|FG000|Overall Study|Lost to Follow-up|104|||
163828294|NCT04233372|591739250|FG000|Overall Study|Adverse Event|8|||
163828295|NCT04233372|591739250|FG000|Overall Study|Withdrawal by Subject|2|||
163828296|NCT04958785|591739251|FG000|Overall Study|Study Terminated by Sponsor|4|||
163828297|NCT04958785|591739252|FG001|Overall Study|Study Terminated by Sponsor|10|||
163828298|NCT04958785|591739253|FG002|Overall Study|Study Terminated by Sponsor|7|||
163828299|NCT04958785|591739254|FG003|Overall Study|Study Terminated by Sponsor|6|||
163828300|NCT04958785|591739255|FG004|Overall Study|Study Terminated by Sponsor|34|||
163828301|NCT04958785|591739251|FG000|Overall Study|Death|2|||
163828302|NCT04958785|591739252|FG001|Overall Study|Death|3|||
163828303|NCT04958785|591739253|FG002|Overall Study|Death|4|||
163828304|NCT04958785|591739254|FG003|Overall Study|Death|5|||
163828305|NCT04958785|591739255|FG004|Overall Study|Death|5|||
163828306|NCT04958785|591739251|FG000|Overall Study|Withdrew consent|2|||
163828307|NCT04958785|591739252|FG001|Overall Study|Withdrew consent|0|||
163828308|NCT04958785|591739253|FG002|Overall Study|Withdrew consent|3|||
163828309|NCT04958785|591739254|FG003|Overall Study|Withdrew consent|1|||
163828310|NCT04958785|591739255|FG004|Overall Study|Withdrew consent|0|||
163828311|NCT04958785|591739251|FG000|Overall Study|Investigator's discretion|0|||
163828312|NCT04958785|591739252|FG001|Overall Study|Investigator's discretion|1|||
163828313|NCT04958785|591739253|FG002|Overall Study|Investigator's discretion|0|||
163828314|NCT04958785|591739254|FG003|Overall Study|Investigator's discretion|1|||
163828315|NCT04958785|591739255|FG004|Overall Study|Investigator's discretion|2|||
163828316|NCT04958785|591739251|FG000|Overall Study|Adverse Event|0|||
163828317|NCT04958785|591739252|FG001|Overall Study|Adverse Event|0|||
163828318|NCT04958785|591739253|FG002|Overall Study|Adverse Event|0|||
164097749|NCT02794974|592722845|FG001|Overall Study|Physician Decision|1|||
164097750|NCT00533273|592722848|FG000|Double-blind|Withdrew consent|0|||
164033201|NCT00817206|592482156|FG001|Overall Study|Death|0|||
163828319|NCT04958785|591739254|FG003|Overall Study|Adverse Event|0|||
163828320|NCT04958785|591739255|FG004|Overall Study|Adverse Event|1|||
163828321|NCT04958785|591739251|FG000|Overall Study|Lost to Follow-up|0|||
163828322|NCT04958785|591739252|FG001|Overall Study|Lost to Follow-up|0|||
163828323|NCT04958785|591739253|FG002|Overall Study|Lost to Follow-up|0|||
163828324|NCT04958785|591739254|FG003|Overall Study|Lost to Follow-up|0|||
163828325|NCT04958785|591739255|FG004|Overall Study|Lost to Follow-up|1|||
163828326|NCT01090310|591739256|FG000|Core Study|Adverse Event|2|||
163828327|NCT01090310|591739257|FG001|Core Study|Adverse Event|2|||
163828328|NCT01090310|591739258|FG002|Core Study|Adverse Event|1|||
163828329|NCT01090310|591739259|FG003|Core Study|Adverse Event|1|||
163828330|NCT01090310|591739256|FG000|Core Study|Subject withdrew consent|0|||
163828331|NCT01090310|591739257|FG001|Core Study|Subject withdrew consent|3|||
163828332|NCT01090310|591739258|FG002|Core Study|Subject withdrew consent|1|||
163828333|NCT01090310|591739259|FG003|Core Study|Subject withdrew consent|1|||
163828334|NCT01090310|591739256|FG000|Core Study|Abnormal test procedure result|0|||
163828335|NCT01090310|591739257|FG001|Core Study|Abnormal test procedure result|0|||
163828336|NCT01090310|591739258|FG002|Core Study|Abnormal test procedure result|1|||
163828337|NCT01090310|591739259|FG003|Core Study|Abnormal test procedure result|0|||
163828338|NCT01090310|591739256|FG000|Core Study|Administrative reasons|5|||
163828339|NCT01090310|591739257|FG001|Core Study|Administrative reasons|6|||
163828340|NCT01090310|591739258|FG002|Core Study|Administrative reasons|4|||
163828341|NCT01090310|591739259|FG003|Core Study|Administrative reasons|4|||
163828342|NCT01090310|591739256|FG000|Core Study|Protocol deviation|1|||
163828343|NCT01090310|591739257|FG001|Core Study|Protocol deviation|0|||
163828344|NCT01090310|591739258|FG002|Core Study|Protocol deviation|0|||
163828345|NCT01090310|591739259|FG003|Core Study|Protocol deviation|1|||
163828346|NCT01090310|591739256|FG000|Extension Study|Aministrative problems|13|||
163828347|NCT01090310|591739257|FG001|Extension Study|Aministrative problems|15|||
163828348|NCT01090310|591739258|FG002|Extension Study|Aministrative problems|14|||
163828349|NCT01090310|591739259|FG003|Extension Study|Aministrative problems|18|||
163828350|NCT01090310|591739256|FG000|Extension Study|Adverse Event|0|||
163828351|NCT01090310|591739257|FG001|Extension Study|Adverse Event|0|||
163828352|NCT01090310|591739258|FG002|Extension Study|Adverse Event|0|||
163828353|NCT01090310|591739259|FG003|Extension Study|Adverse Event|1|||
163828354|NCT01090310|591739256|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
163828355|NCT01090310|591739257|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
163828356|NCT01090310|591739258|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
163828357|NCT01090310|591739259|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
163828358|NCT01090310|591739256|FG000|Extension Study|Subject withdrew consent|0|||
163828359|NCT01090310|591739257|FG001|Extension Study|Subject withdrew consent|1|||
163828360|NCT01090310|591739258|FG002|Extension Study|Subject withdrew consent|0|||
163828361|NCT01090310|591739259|FG003|Extension Study|Subject withdrew consent|0|||
163828362|NCT01224925|591739260|FG000|Overall Study|Lost to Follow-up|3|||
163828363|NCT01224925|591739261|FG001|Overall Study|Lost to Follow-up|2|||
163828364|NCT02472652|591739266|FG000|Overall Study|Lost to Follow-up|1|||
163828365|NCT04586569|591739267|FG000|Overall Study|Withdrawal by Subject|0|||
163828366|NCT04586569|591739268|FG001|Overall Study|Withdrawal by Subject|2|||
163828367|NCT04586569|591739267|FG000|Overall Study|No longer eligible|2|||
163828368|NCT04586569|591739268|FG001|Overall Study|No longer eligible|3|||
163828369|NCT04586569|591739267|FG000|Overall Study|Physician Decision|1|||
163828370|NCT04586569|591739268|FG001|Overall Study|Physician Decision|0|||
163828371|NCT03185832|591739269|FG000|Overall Study|Death|9|||
163828372|NCT03185832|591739270|FG001|Overall Study|Death|14|||
163828373|NCT03185832|591739271|FG002|Overall Study|Death|9|||
163828374|NCT03185832|591739272|FG003|Overall Study|Death|7|||
163828375|NCT03185832|591739269|FG000|Overall Study|Withdrawn - vital status available|0|||
163828376|NCT03185832|591739270|FG001|Overall Study|Withdrawn - vital status available|1|||
163828377|NCT03185832|591739271|FG002|Overall Study|Withdrawn - vital status available|1|||
163828378|NCT03185832|591739272|FG003|Overall Study|Withdrawn - vital status available|4|||
163828379|NCT01083641|591739274|FG000|Overall Study|Withdrawal by Subject|2|||
163828380|NCT03439189|591739275|FG000|Overall Study|Protocol Violation|19|||
163828381|NCT03439189|591739275|FG000|Overall Study|Lack of Efficacy|63|||
163828382|NCT01777321|591739276|FG000|Overall Study|Withdrawal by Subject|0|||
163828383|NCT01777321|591739277|FG001|Overall Study|Withdrawal by Subject|1|||
163828384|NCT02173548|591739278|FG000|Overall Study|Lost to Follow-up|0|||
163828385|NCT02173548|591739279|FG001|Overall Study|Lost to Follow-up|2|||
163828386|NCT02173548|591739278|FG000|Overall Study|Withdrawal by Subject|1|||
163828387|NCT02173548|591739279|FG001|Overall Study|Withdrawal by Subject|0|||
163828388|NCT03597568|591739280|FG000|Overall Study|Withdrawal by Subject|1|||
163828389|NCT03597568|591739281|FG001|Overall Study|Withdrawal by Subject|1|||
163828390|NCT03597568|591739280|FG000|Overall Study|Unable to analyze vascular data|1|||
163828391|NCT03597568|591739281|FG001|Overall Study|Unable to analyze vascular data|1|||
163828392|NCT00999466|591739284|FG000|Main Part|Withdrawal by Subject|0|||
163828393|NCT00999466|591739285|FG001|Main Part|Withdrawal by Subject|0|||
163828394|NCT00999466|591739286|FG002|Main Part|Withdrawal by Subject|2|||
163828395|NCT00999466|591739284|FG000|Main Part|Adverse Event|0|||
163923539|NCT03220776|592090946|FG002|Overall Study|Claustrophobia|1|||
163923540|NCT03220776|592090947|FG003|Overall Study|Claustrophobia|0|||
163923541|NCT03220776|592090948|FG004|Overall Study|Claustrophobia|1|||
163923542|NCT03220776|592090949|FG005|Overall Study|Claustrophobia|0|||
163923543|NCT03220776|592090944|FG000|Overall Study|MRI Equipment Failure|1|||
163923544|NCT03220776|592090945|FG001|Overall Study|MRI Equipment Failure|0|||
163923545|NCT03220776|592090946|FG002|Overall Study|MRI Equipment Failure|0|||
163923546|NCT03220776|592090947|FG003|Overall Study|MRI Equipment Failure|0|||
163923547|NCT03220776|592090948|FG004|Overall Study|MRI Equipment Failure|0|||
163923548|NCT03220776|592090949|FG005|Overall Study|MRI Equipment Failure|0|||
163923549|NCT03220776|592090944|FG000|Overall Study|Inclimate Weather|0|||
163923550|NCT03220776|592090945|FG001|Overall Study|Inclimate Weather|0|||
163923551|NCT03220776|592090946|FG002|Overall Study|Inclimate Weather|0|||
163923552|NCT03220776|592090947|FG003|Overall Study|Inclimate Weather|0|||
163923553|NCT03220776|592090948|FG004|Overall Study|Inclimate Weather|0|||
163923554|NCT03220776|592090949|FG005|Overall Study|Inclimate Weather|1|||
163923555|NCT03220776|592090944|FG000|Overall Study|Physician Decision|0|||
163923556|NCT03220776|592090945|FG001|Overall Study|Physician Decision|0|||
163923557|NCT03220776|592090946|FG002|Overall Study|Physician Decision|0|||
163923558|NCT03220776|592090947|FG003|Overall Study|Physician Decision|1|||
163923559|NCT03220776|592090948|FG004|Overall Study|Physician Decision|0|||
163923560|NCT03220776|592090949|FG005|Overall Study|Physician Decision|0|||
163923561|NCT03220776|592090944|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163923562|NCT03220776|592090945|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163923563|NCT03220776|592090946|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163923564|NCT03220776|592090947|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
163923565|NCT03220776|592090948|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163923566|NCT03220776|592090949|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
163923567|NCT03220776|592090944|FG000|Overall Study|Protocol Violation|0|||
163923568|NCT03220776|592090945|FG001|Overall Study|Protocol Violation|0|||
163923569|NCT03220776|592090946|FG002|Overall Study|Protocol Violation|0|||
163923570|NCT03220776|592090947|FG003|Overall Study|Protocol Violation|2|||
163923571|NCT03220776|592090948|FG004|Overall Study|Protocol Violation|0|||
163923572|NCT03220776|592090949|FG005|Overall Study|Protocol Violation|1|||
163923573|NCT03220776|592090944|FG000|Overall Study|Withdrawal by Subject|1|||
163923574|NCT03220776|592090945|FG001|Overall Study|Withdrawal by Subject|0|||
163923575|NCT03220776|592090946|FG002|Overall Study|Withdrawal by Subject|0|||
163923576|NCT03220776|592090947|FG003|Overall Study|Withdrawal by Subject|0|||
163923577|NCT03220776|592090948|FG004|Overall Study|Withdrawal by Subject|0|||
163923578|NCT03220776|592090949|FG005|Overall Study|Withdrawal by Subject|0|||
163923579|NCT04491006|592090950|FG000|Overall Study|Adverse Event|0|||
163923580|NCT04491006|592090951|FG001|Overall Study|Adverse Event|3|||
163923581|NCT04491006|592090952|FG002|Overall Study|Adverse Event|5|||
163923582|NCT04491006|592090950|FG000|Overall Study|Withdrawal by Subject|1|||
163923583|NCT04491006|592090951|FG001|Overall Study|Withdrawal by Subject|0|||
163923584|NCT04491006|592090952|FG002|Overall Study|Withdrawal by Subject|2|||
163923585|NCT02166047|592090953|FG000|Overall Study|Withdrawal by Participant|0|||
163923586|NCT02166047|592090954|FG001|Overall Study|Withdrawal by Participant|1|||
163923587|NCT02166047|592090955|FG002|Overall Study|Withdrawal by Participant|2|||
163923588|NCT02166047|592090956|FG003|Overall Study|Withdrawal by Participant|0|||
163923589|NCT02166047|592090957|FG004|Overall Study|Withdrawal by Participant|0|||
163923590|NCT02166047|592090958|FG005|Overall Study|Withdrawal by Participant|0|||
163923591|NCT02166047|592090959|FG006|Overall Study|Withdrawal by Participant|1|||
163923592|NCT02166047|592090960|FG007|Overall Study|Withdrawal by Participant|0|||
163923593|NCT02166047|592090961|FG008|Overall Study|Withdrawal by Participant|0|||
163923594|NCT02166047|592090962|FG009|Overall Study|Withdrawal by Participant|0|||
163923595|NCT02166047|592090963|FG010|Overall Study|Withdrawal by Participant|0|||
163923596|NCT02166047|592090964|FG011|Overall Study|Withdrawal by Participant|0|||
163923597|NCT02166047|592090953|FG000|Overall Study|Adverse Event|0|||
163923598|NCT02166047|592090954|FG001|Overall Study|Adverse Event|0|||
163923599|NCT02166047|592090955|FG002|Overall Study|Adverse Event|0|||
163923600|NCT02166047|592090956|FG003|Overall Study|Adverse Event|0|||
163923601|NCT02166047|592090957|FG004|Overall Study|Adverse Event|1|||
163923602|NCT02166047|592090958|FG005|Overall Study|Adverse Event|0|||
163923603|NCT02166047|592090959|FG006|Overall Study|Adverse Event|1|||
163923604|NCT02166047|592090960|FG007|Overall Study|Adverse Event|0|||
163923605|NCT02166047|592090961|FG008|Overall Study|Adverse Event|0|||
163923606|NCT02166047|592090962|FG009|Overall Study|Adverse Event|0|||
163923607|NCT02166047|592090963|FG010|Overall Study|Adverse Event|2|||
163923608|NCT02166047|592090964|FG011|Overall Study|Adverse Event|0|||
163923609|NCT00451555|592090970|FG000|Overall Study|Protocol Violation|2|||
163923610|NCT00451555|592090971|FG001|Overall Study|Protocol Violation|2|||
163923611|NCT00451555|592090970|FG000|Overall Study|Adverse Event|3|||
163923612|NCT00451555|592090971|FG001|Overall Study|Adverse Event|1|||
163923613|NCT00451555|592090970|FG000|Overall Study|Withdrawal by Subject|6|||
163923614|NCT00451555|592090971|FG001|Overall Study|Withdrawal by Subject|0|||
163923615|NCT00451555|592090970|FG000|Overall Study|Physician Decision|2|||
163923616|NCT00451555|592090971|FG001|Overall Study|Physician Decision|1|||
163923617|NCT01004185|592090974|FG000|Overall Study|Adverse Event|1|||
163923618|NCT01004185|592090975|FG001|Overall Study|Adverse Event|1|||
163923619|NCT01004185|592090974|FG000|Overall Study|Lost to Follow-up|0|||
163923620|NCT01004185|592090975|FG001|Overall Study|Lost to Follow-up|1|||
163923621|NCT01004185|592090974|FG000|Overall Study|Lack of Efficacy|2|||
163923622|NCT01004185|592090975|FG001|Overall Study|Lack of Efficacy|1|||
163923623|NCT01004185|592090974|FG000|Overall Study|Sponsor Terminated Study|4|||
164033202|NCT00817206|592482155|FG000|Overall Study|Withdrawal by Subject|7|||
164033203|NCT00817206|592482156|FG001|Overall Study|Withdrawal by Subject|3|||
164033204|NCT00817206|592482155|FG000|Overall Study|Physician Decision|2|||
164033205|NCT00817206|592482156|FG001|Overall Study|Physician Decision|0|||
164033206|NCT00793182|592482157|FG000|Overall Study|Adverse Event|0|||
164033207|NCT00793182|592482158|FG001|Overall Study|Adverse Event|1|||
164033208|NCT01188096|592482159|FG000|Overall Study|progression of disease|4|||
164033209|NCT01188096|592482159|FG000|Overall Study|Withdrawal by Subject|2|||
164033210|NCT02273037|592482160|FG000|Overall Study|Lost to Follow-up|1|||
164033211|NCT02273037|592482161|FG001|Overall Study|Lost to Follow-up|0|||
164033212|NCT02273037|592482160|FG000|Overall Study|Delivered before monitoring initiated|1|||
164033213|NCT02273037|592482161|FG001|Overall Study|Delivered before monitoring initiated|3|||
164033214|NCT02273037|592482160|FG000|Overall Study|Breech delivery|2|||
164033215|NCT02273037|592482161|FG001|Overall Study|Breech delivery|3|||
164033216|NCT02273037|592482160|FG000|Overall Study|Multiple delivery|2|||
164033217|NCT02273037|592482161|FG001|Overall Study|Multiple delivery|2|||
164033218|NCT02273037|592482160|FG000|Overall Study|Other complication|2|||
164033219|NCT02273037|592482161|FG001|Overall Study|Other complication|0|||
164033220|NCT00851253|592482162|FG000|Overall Study|Disease Progression|1|||
164033221|NCT00851253|592482163|FG001|Overall Study|Disease Progression|0|||
164033222|NCT02384395|592482164|FG000|Overall Study|Physician Decision|4|||
164033223|NCT02384395|592482164|FG000|Overall Study|Withdrawal by Subject|3|||
164033224|NCT02384395|592482164|FG000|Overall Study|Lost to Follow-up|3|||
164033225|NCT03485222|592482165|FG000|Overall Study|Death|0|||
164033226|NCT03485222|592482166|FG001|Overall Study|Death|1|||
164033227|NCT03485222|592482165|FG000|Overall Study|Lost to Follow-up|2|||
164033228|NCT03485222|592482166|FG001|Overall Study|Lost to Follow-up|1|||
164033229|NCT03657810|592482167|FG000|Overall Study|Adverse Event|0|||
164033230|NCT03657810|592482168|FG001|Overall Study|Adverse Event|1|||
164033231|NCT03657810|592482169|FG002|Overall Study|Adverse Event|0|||
164033232|NCT03657810|592482167|FG000|Overall Study|Lack of Efficacy|4|||
164033233|NCT03657810|592482168|FG001|Overall Study|Lack of Efficacy|1|||
164033234|NCT03657810|592482169|FG002|Overall Study|Lack of Efficacy|3|||
164033235|NCT03657810|592482167|FG000|Overall Study|Protocol Violation|1|||
164033236|NCT03657810|592482168|FG001|Overall Study|Protocol Violation|0|||
164033237|NCT03657810|592482169|FG002|Overall Study|Protocol Violation|0|||
164033238|NCT03657810|592482167|FG000|Overall Study|Lost to Follow-up|0|||
164033239|NCT03657810|592482168|FG001|Overall Study|Lost to Follow-up|1|||
164033240|NCT03657810|592482169|FG002|Overall Study|Lost to Follow-up|0|||
164033241|NCT03657810|592482167|FG000|Overall Study|Not provided|0|||
164033242|NCT03657810|592482168|FG001|Overall Study|Not provided|1|||
164033243|NCT03657810|592482169|FG002|Overall Study|Not provided|0|||
164033244|NCT00688545|592482170|FG000|Overall Study|Lost to Follow-up|1|||
164033245|NCT00688545|592482171|FG001|Overall Study|Lost to Follow-up|4|||
164033246|NCT00688545|592482170|FG000|Overall Study|Insurance/cost of drug|0|||
164033247|NCT00688545|592482171|FG001|Overall Study|Insurance/cost of drug|1|||
164033248|NCT00688545|592482170|FG000|Overall Study|Withdrawal by Subject|2|||
164033249|NCT00688545|592482171|FG001|Overall Study|Withdrawal by Subject|3|||
164033250|NCT00688545|592482170|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
164033251|NCT00688545|592482171|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
164033252|NCT00985738|592482172|FG000|Overall Study|Study closed prematurely|8|||
164033253|NCT00985738|592482173|FG001|Overall Study|Study closed prematurely|8|||
164033254|NCT00340834|592482178|FG000|Core Phase of Study|Adverse Event|26|||
164033255|NCT00340834|592482179|FG001|Core Phase of Study|Adverse Event|9|||
164033256|NCT00340834|592482180|FG002|Core Phase of Study|Adverse Event|9|||
164033257|NCT00340834|592482181|FG003|Core Phase of Study|Adverse Event|0|||
164033258|NCT00340834|592482182|FG004|Core Phase of Study|Adverse Event|0|||
164033259|NCT00340834|592482178|FG000|Core Phase of Study|Withdrawal by Subject|11|||
164033260|NCT00340834|592482179|FG001|Core Phase of Study|Withdrawal by Subject|9|||
164033261|NCT00340834|592482180|FG002|Core Phase of Study|Withdrawal by Subject|16|||
164033262|NCT00340834|592482181|FG003|Core Phase of Study|Withdrawal by Subject|0|||
163923624|NCT01004185|592090975|FG001|Overall Study|Sponsor Terminated Study|5|||
164033263|NCT00340834|592482182|FG004|Core Phase of Study|Withdrawal by Subject|0|||
164033264|NCT00340834|592482178|FG000|Core Phase of Study|Administrative Problems|6|||
164033265|NCT00340834|592482179|FG001|Core Phase of Study|Administrative Problems|2|||
164033266|NCT00340834|592482180|FG002|Core Phase of Study|Administrative Problems|7|||
164033267|NCT00340834|592482181|FG003|Core Phase of Study|Administrative Problems|0|||
164033268|NCT00340834|592482182|FG004|Core Phase of Study|Administrative Problems|0|||
164033269|NCT00340834|592482178|FG000|Core Phase of Study|Lack of Efficacy|3|||
164033270|NCT00340834|592482179|FG001|Core Phase of Study|Lack of Efficacy|3|||
164097751|NCT00533273|592722849|FG001|Double-blind|Withdrew consent|2|||
164097752|NCT00533273|592722848|FG000|Open-label|Withdrawal by Subject|6|||
163923625|NCT01004185|592090974|FG000|Overall Study|Withdrawal by Subject|2|||
163923626|NCT01004185|592090975|FG001|Overall Study|Withdrawal by Subject|1|||
163923627|NCT01388478|592090980|FG000|Overall Study|Adverse Event|4|||
163923628|NCT01388478|592090980|FG000|Overall Study|Withdrawal by Subject|1|||
163923629|NCT01037413|592090981|FG000|Part A: Skin Testing|Adverse Event|1|||
163923630|NCT01037413|592090982|FG001|Part A: Skin Testing|Adverse Event|0|||
163923631|NCT01037413|592090981|FG000|Part A: Skin Testing|Protocol Violation|1|||
163923632|NCT01037413|592090982|FG001|Part A: Skin Testing|Protocol Violation|0|||
163923633|NCT01037413|592090981|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
163923634|NCT01037413|592090982|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
163923635|NCT01037413|592090981|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
163923636|NCT01037413|592090982|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
163923637|NCT01990664|592090983|FG000|Overall Study|Lost to Follow-up|2|||
163923638|NCT01990664|592090984|FG001|Overall Study|Lost to Follow-up|6|||
163923639|NCT01990664|592090983|FG000|Overall Study|Withdrawal by Subject|2|||
163923640|NCT01990664|592090984|FG001|Overall Study|Withdrawal by Subject|3|||
163923641|NCT01990664|592090983|FG000|Overall Study|Protocol Violation|1|||
163923642|NCT01990664|592090984|FG001|Overall Study|Protocol Violation|0|||
163923643|NCT01990664|592090983|FG000|Overall Study|Lens Discomfort|1|||
163923644|NCT01990664|592090984|FG001|Overall Study|Lens Discomfort|1|||
163923645|NCT01990664|592090983|FG000|Overall Study|Lens Handling Difficulties|1|||
163923646|NCT01990664|592090984|FG001|Overall Study|Lens Handling Difficulties|0|||
163923647|NCT01990664|592090983|FG000|Overall Study|Unsatisfactory Visual Response|0|||
163923648|NCT01990664|592090984|FG001|Overall Study|Unsatisfactory Visual Response|1|||
163923649|NCT00619983|592090985|FG000|Test Drug Alone|Withdrawal by Subject|1|||
163923650|NCT00619983|592090986|FG001|Test Drug Alone|Withdrawal by Subject|0|||
163923651|NCT00619983|592090987|FG002|Test Drug Alone|Withdrawal by Subject|0|||
163923652|NCT00619983|592090988|FG003|Test Drug Alone|Withdrawal by Subject|1|||
163923653|NCT00619983|592090985|FG000|Test Drug Alone|Failure of daily diary device|1|||
163923654|NCT00619983|592090986|FG001|Test Drug Alone|Failure of daily diary device|1|||
163923655|NCT00619983|592090987|FG002|Test Drug Alone|Failure of daily diary device|2|||
163923656|NCT00619983|592090988|FG003|Test Drug Alone|Failure of daily diary device|2|||
163923657|NCT01177137|592090990|FG000|Overall Study|Withdrawal by Subject|10|||
163923658|NCT01177137|592090991|FG001|Overall Study|Withdrawal by Subject|10|||
163923659|NCT01177137|592090992|FG002|Overall Study|Withdrawal by Subject|2|||
163923660|NCT02560389|592090997|FG000|Overall Study|Lost to Follow-up|1|||
163923661|NCT02560389|592090998|FG001|Overall Study|Lost to Follow-up|2|||
163923662|NCT02560389|592090999|FG002|Overall Study|Lost to Follow-up|2|||
163923663|NCT02560389|592090997|FG000|Overall Study|Tested positive for illicit substance|0|||
163923664|NCT02560389|592090998|FG001|Overall Study|Tested positive for illicit substance|1|||
163923665|NCT02560389|592090999|FG002|Overall Study|Tested positive for illicit substance|0|||
163923666|NCT02716298|592091000|FG000|First Intervention (1 Month)|Lens discomfort|1|||
163923667|NCT02716298|592091001|FG001|First Intervention (1 Month)|Lens discomfort|1|||
163923668|NCT00713206|592091002|FG000|Overall Study|Lost to Follow-up|4|||
163923669|NCT00713206|592091003|FG001|Overall Study|Lost to Follow-up|4|||
163923670|NCT00713206|592091002|FG000|Overall Study|Death|1|||
163923671|NCT00713206|592091003|FG001|Overall Study|Death|0|||
163923672|NCT01114672|592091006|FG000|Overall Study|Death|0|||
163923673|NCT01114672|592091007|FG001|Overall Study|Death|1|||
163923674|NCT01114672|592091006|FG000|Overall Study|Withdrawal by Subject|2|||
163923675|NCT01114672|592091007|FG001|Overall Study|Withdrawal by Subject|1|||
163923676|NCT01114672|592091006|FG000|Overall Study|Lost to Follow-up|1|||
163923677|NCT01114672|592091007|FG001|Overall Study|Lost to Follow-up|0|||
163923678|NCT01114672|592091006|FG000|Overall Study|transplanted|1|||
163923679|NCT01114672|592091007|FG001|Overall Study|transplanted|0|||
163923680|NCT00827775|592091008|FG000|Overall Study|Withdrawal by Subject|0|||
164097753|NCT00533273|592722849|FG001|Open-label|Withdrawal by Subject|0|||
164097754|NCT00454909|592722850|FG000|Overall Study|Withdrawal by Subject|1|||
164097755|NCT00454909|592722851|FG001|Overall Study|Withdrawal by Subject|0|||
163923681|NCT00827775|592091009|FG001|Overall Study|Withdrawal by Subject|5|||
163923682|NCT03041701|592091010|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
163923683|NCT03041701|592091011|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
163923684|NCT03041701|592091012|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
163923685|NCT03041701|592091010|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
163923686|NCT03041701|592091011|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
163923687|NCT03041701|592091012|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
163923688|NCT00297778|592091023|FG000|Overall Study|Adverse Event|16|||
163923689|NCT00297778|592091024|FG001|Overall Study|Adverse Event|10|||
163923690|NCT00297778|592091023|FG000|Overall Study|Withdrawal by Subject|1|||
163923691|NCT00297778|592091024|FG001|Overall Study|Withdrawal by Subject|5|||
163923692|NCT00297778|592091023|FG000|Overall Study|Lack of Efficacy|2|||
164097756|NCT00454909|592722852|FG002|Overall Study|Withdrawal by Subject|0|||
164033271|NCT00340834|592482180|FG002|Core Phase of Study|Lack of Efficacy|7|||
164033272|NCT00340834|592482181|FG003|Core Phase of Study|Lack of Efficacy|0|||
164033273|NCT00340834|592482182|FG004|Core Phase of Study|Lack of Efficacy|0|||
164033274|NCT00340834|592482178|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
164033275|NCT00340834|592482179|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
164033276|NCT00340834|592482180|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
164033277|NCT00340834|592482181|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
164033278|NCT00340834|592482182|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
164033279|NCT00340834|592482178|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
163828396|NCT00999466|591739285|FG001|Main Part|Adverse Event|4|||
163828397|NCT00999466|591739286|FG002|Main Part|Adverse Event|2|||
163828398|NCT05131165|591739287|FG000|Overall Study|Death|1|||
163828399|NCT05131165|591739288|FG001|Overall Study|Death|1|||
163828400|NCT05131165|591739289|FG002|Overall Study|Death|0|||
163828401|NCT05131165|591739287|FG000|Overall Study|Lost to Follow-up|2|||
163828402|NCT05131165|591739288|FG001|Overall Study|Lost to Follow-up|2|||
163828403|NCT05131165|591739289|FG002|Overall Study|Lost to Follow-up|5|||
163828404|NCT05131165|591739287|FG000|Overall Study|Transferred out of clinic|1|||
163828405|NCT05131165|591739288|FG001|Overall Study|Transferred out of clinic|0|||
163828406|NCT05131165|591739289|FG002|Overall Study|Transferred out of clinic|3|||
163828407|NCT05131165|591739287|FG000|Overall Study|Dropped out|1|||
163828408|NCT05131165|591739288|FG001|Overall Study|Dropped out|2|||
163828409|NCT05131165|591739289|FG002|Overall Study|Dropped out|0|||
163828410|NCT00526630|591739290|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
163828411|NCT00526630|591739291|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
163828412|NCT00526630|591739290|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
163828413|NCT00526630|591739291|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
163828414|NCT00337272|591739294|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
163828415|NCT00337272|591739295|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
163828416|NCT00337272|591739294|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
163828417|NCT00337272|591739295|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
163828418|NCT00337272|591739294|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
163828419|NCT00337272|591739295|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
163828420|NCT00337272|591739294|FG000|Treatment Period|Non-compliance|1|||
163828421|NCT00337272|591739295|FG001|Treatment Period|Non-compliance|1|||
163828422|NCT00337272|591739294|FG000|Treatment Period|Withdrawal by Subject|0|||
163828423|NCT00337272|591739295|FG001|Treatment Period|Withdrawal by Subject|1|||
163828424|NCT00337272|591739294|FG000|Withdrawal Period|Non-compliance|0|||
163828425|NCT00337272|591739295|FG001|Withdrawal Period|Non-compliance|1|||
163828426|NCT05674890|591739301|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
163828427|NCT05674890|591739302|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
163828428|NCT05674890|591739301|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
163828429|NCT05674890|591739302|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
163828430|NCT05674890|591739301|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
163828431|NCT05674890|591739302|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
163828432|NCT05906368|591739315|FG000|Overall Study|Withdrawal by Subject|1|||
163828433|NCT05906368|591739316|FG001|Overall Study|Withdrawal by Subject|1|||
163828434|NCT05906368|591739315|FG000|Overall Study|Ineligibility criteria identified|2|||
163828435|NCT05906368|591739316|FG001|Overall Study|Ineligibility criteria identified|0|||
163828436|NCT01127646|591739317|FG000|Overall Study|Entry Criteria Not Met|1|||
163828437|NCT01127646|591739318|FG001|Overall Study|Entry Criteria Not Met|0|||
163828438|NCT01127646|591739317|FG000|Overall Study|Protocol Violation|0|||
163828439|NCT01127646|591739318|FG001|Overall Study|Protocol Violation|1|||
163828440|NCT00595504|591739322|FG000|Overall Study|Withdrawal by Subject|1|||
163828441|NCT00595504|591739323|FG001|Overall Study|Withdrawal by Subject|3|||
163828442|NCT00595504|591739322|FG000|Overall Study|Physician Decision|1|||
163828443|NCT00595504|591739323|FG001|Overall Study|Physician Decision|0|||
163828444|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
163828445|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
163828446|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
163828447|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
163828448|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
163828449|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
163828450|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
163828451|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
163828452|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
163828453|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
163828454|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
163828455|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
163828456|NCT00293267|591739324|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
163828457|NCT00293267|591739325|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
163828458|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
163828459|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
163828460|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
163828461|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
163828462|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
163828463|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
163828464|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
163828465|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
163828466|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Death|3|||
163828467|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Death|0|||
163828468|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
163828469|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
163828470|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
163828471|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
163828472|NCT00293267|591739324|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
163828473|NCT00293267|591739325|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
163828474|NCT00293267|591739324|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
163828475|NCT00293267|591739325|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
163828476|NCT00293267|591739324|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
163828477|NCT00293267|591739325|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
163828478|NCT00293267|591739324|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
163828479|NCT00293267|591739325|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
163828480|NCT00293267|591739324|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
163828481|NCT00293267|591739325|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
163828482|NCT00293267|591739324|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
163828483|NCT00293267|591739325|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
163828484|NCT00293267|591739324|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
163828485|NCT00293267|591739325|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
163828486|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
163828487|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
163828488|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
163828489|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
163828490|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
163828491|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
163828492|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
163828493|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
163828494|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
163828495|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
163828496|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
163828497|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
163828498|NCT00293267|591739324|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
163828499|NCT00293267|591739325|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
163828500|NCT01804816|591739326|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
163828501|NCT01804816|591739326|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
163828502|NCT01754467|591739327|FG000|Overall Study|Lost to Follow-up|1|||
163828503|NCT01235546|591739328|FG000|Overall Study|Staff error, medication not administered|1|||
163828504|NCT01235546|591739329|FG001|Overall Study|Staff error, medication not administered|0|||
163828505|NCT01235546|591739328|FG000|Overall Study|Protocol Violation|1|||
163828506|NCT01235546|591739329|FG001|Overall Study|Protocol Violation|1|||
163828507|NCT01123382|591739330|FG000|Overall Study|Withdrawal by Subject|1|||
163828508|NCT01123382|591739331|FG001|Overall Study|Withdrawal by Subject|4|||
163828509|NCT01123382|591739330|FG000|Overall Study|Lost to Follow-up|1|||
163828510|NCT01123382|591739331|FG001|Overall Study|Lost to Follow-up|2|||
163828511|NCT00330174|591739332|FG000|Overall Study|Withdrawal by Subject|7|||
163828512|NCT00330174|591739333|FG001|Overall Study|Withdrawal by Subject|7|||
163828513|NCT00330174|591739332|FG000|Overall Study|Lost to Follow-up|4|||
163828514|NCT00330174|591739333|FG001|Overall Study|Lost to Follow-up|1|||
163828515|NCT00330174|591739332|FG000|Overall Study|Clinical deterioration|1|||
163828516|NCT00330174|591739333|FG001|Overall Study|Clinical deterioration|2|||
164033280|NCT00340834|592482179|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
164033281|NCT00340834|592482180|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
163828517|NCT00330174|591739332|FG000|Overall Study|Excessive missed visits|3|||
163828518|NCT00330174|591739333|FG001|Overall Study|Excessive missed visits|8|||
163828519|NCT00330174|591739332|FG000|Overall Study|Miscellaneous reasons|7|||
164033282|NCT00340834|592482181|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
164033283|NCT00340834|592482182|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
164033284|NCT00340834|592482178|FG000|Core Phase of Study|Lost to Follow-up|1|||
164033285|NCT00340834|592482179|FG001|Core Phase of Study|Lost to Follow-up|1|||
164033286|NCT00340834|592482180|FG002|Core Phase of Study|Lost to Follow-up|4|||
164033287|NCT00340834|592482181|FG003|Core Phase of Study|Lost to Follow-up|0|||
164033288|NCT00340834|592482182|FG004|Core Phase of Study|Lost to Follow-up|0|||
164033289|NCT00340834|592482178|FG000|Core Phase of Study|Death|2|||
164033290|NCT00340834|592482179|FG001|Core Phase of Study|Death|0|||
164033291|NCT00340834|592482180|FG002|Core Phase of Study|Death|0|||
164033292|NCT00340834|592482181|FG003|Core Phase of Study|Death|0|||
164033293|NCT00340834|592482182|FG004|Core Phase of Study|Death|0|||
164033294|NCT00340834|592482178|FG000|Core Phase of Study|Protocol Violation|0|||
164033295|NCT00340834|592482179|FG001|Core Phase of Study|Protocol Violation|0|||
164033296|NCT00340834|592482180|FG002|Core Phase of Study|Protocol Violation|2|||
164033297|NCT00340834|592482181|FG003|Core Phase of Study|Protocol Violation|0|||
164033298|NCT00340834|592482182|FG004|Core Phase of Study|Protocol Violation|0|||
164033299|NCT00340834|592482178|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
164033300|NCT00340834|592482179|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
164033301|NCT00340834|592482180|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
164033302|NCT00340834|592482181|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
164033303|NCT00340834|592482182|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
164033304|NCT00340834|592482178|FG000|Extension Phase of Study|Subject withdrew consent|26|||
164033305|NCT00340834|592482179|FG001|Extension Phase of Study|Subject withdrew consent|31|||
164033306|NCT00340834|592482180|FG002|Extension Phase of Study|Subject withdrew consent|0|||
164033307|NCT00340834|592482181|FG003|Extension Phase of Study|Subject withdrew consent|12|||
164033308|NCT00340834|592482182|FG004|Extension Phase of Study|Subject withdrew consent|15|||
164033309|NCT00340834|592482178|FG000|Extension Phase of Study|Adverse Event|21|||
164033310|NCT00340834|592482179|FG001|Extension Phase of Study|Adverse Event|22|||
164033311|NCT00340834|592482180|FG002|Extension Phase of Study|Adverse Event|0|||
164033312|NCT00340834|592482181|FG003|Extension Phase of Study|Adverse Event|19|||
164033313|NCT00340834|592482182|FG004|Extension Phase of Study|Adverse Event|7|||
164033314|NCT00340834|592482178|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
164033315|NCT00340834|592482179|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
164033316|NCT00340834|592482180|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
164033317|NCT00340834|592482181|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
164033318|NCT00340834|592482182|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
164033319|NCT00340834|592482178|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
164033320|NCT00340834|592482179|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
164033321|NCT00340834|592482180|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
164033322|NCT00340834|592482181|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
164033323|NCT00340834|592482182|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
164033324|NCT00340834|592482178|FG000|Extension Phase of Study|Lost to Follow-up|1|||
164033325|NCT00340834|592482179|FG001|Extension Phase of Study|Lost to Follow-up|1|||
164033326|NCT00340834|592482180|FG002|Extension Phase of Study|Lost to Follow-up|0|||
164033327|NCT00340834|592482181|FG003|Extension Phase of Study|Lost to Follow-up|2|||
164033328|NCT00340834|592482182|FG004|Extension Phase of Study|Lost to Follow-up|3|||
164033329|NCT00340834|592482178|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
164033330|NCT00340834|592482179|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
164033331|NCT00340834|592482180|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
164033332|NCT00340834|592482181|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
164033333|NCT00340834|592482182|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
164033334|NCT00340834|592482178|FG000|Extension Phase of Study|Administrative problems|3|||
164033335|NCT00340834|592482179|FG001|Extension Phase of Study|Administrative problems|0|||
164033336|NCT00340834|592482180|FG002|Extension Phase of Study|Administrative problems|0|||
164033337|NCT00340834|592482181|FG003|Extension Phase of Study|Administrative problems|1|||
164033338|NCT00340834|592482182|FG004|Extension Phase of Study|Administrative problems|1|||
164033339|NCT00340834|592482178|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
164033340|NCT00340834|592482179|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
164033341|NCT00340834|592482180|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
164033342|NCT00340834|592482181|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
164033343|NCT00340834|592482182|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
164033344|NCT00340834|592482178|FG000|Extension Phase of Study|Protocol Violation|3|||
164033345|NCT00340834|592482179|FG001|Extension Phase of Study|Protocol Violation|0|||
164033346|NCT00340834|592482180|FG002|Extension Phase of Study|Protocol Violation|0|||
164033347|NCT00340834|592482181|FG003|Extension Phase of Study|Protocol Violation|0|||
164033348|NCT00340834|592482182|FG004|Extension Phase of Study|Protocol Violation|0|||
164033349|NCT00340834|592482178|FG000|Extension Phase of Study|Death|0|||
164033350|NCT00340834|592482179|FG001|Extension Phase of Study|Death|0|||
163923693|NCT00297778|592091024|FG001|Overall Study|Lack of Efficacy|1|||
163923694|NCT00297778|592091023|FG000|Overall Study|Non-compliant with trial protocol|0|||
163923695|NCT00297778|592091024|FG001|Overall Study|Non-compliant with trial protocol|3|||
163923696|NCT00297778|592091023|FG000|Overall Study|Other|0|||
163923697|NCT00297778|592091024|FG001|Overall Study|Other|1|||
163923698|NCT00802438|592091027|FG000|Overall Study|Screen Failure|20|||
163923699|NCT00802438|592091027|FG000|Overall Study|Withdrawal by Subject|7|||
163923700|NCT00802438|592091027|FG000|Overall Study|Physician Decision|1|||
163923701|NCT01281917|592091028|FG000|Overall Study|Withdrawal by Subject|1|||
163923702|NCT00583115|592091029|FG000|Overall Study|Death|1|||
163923703|NCT01678898|592091033|FG000|PB-102-F01|Adverse Event|0|||
163923704|NCT01678898|592091034|FG001|PB-102-F01|Adverse Event|1|||
163923705|NCT01678898|592091035|FG002|PB-102-F01|Adverse Event|0|||
163923706|NCT01678898|592091033|FG000|PB-102-F01|Physician Decision|0|||
163923707|NCT01678898|592091034|FG001|PB-102-F01|Physician Decision|1|||
163923708|NCT01678898|592091035|FG002|PB-102-F01|Physician Decision|0|||
163923709|NCT02551692|592091041|FG000|Overall Study|Lost to Follow-up|0|||
163923710|NCT02551692|592091042|FG001|Overall Study|Lost to Follow-up|1|||
163923711|NCT02551692|592091043|FG002|Overall Study|Lost to Follow-up|4|||
163923712|NCT02551692|592091041|FG000|Overall Study|Withdrawal by Subject|1|||
163923713|NCT02551692|592091042|FG001|Overall Study|Withdrawal by Subject|0|||
163923714|NCT02551692|592091043|FG002|Overall Study|Withdrawal by Subject|1|||
163923715|NCT02965599|592091044|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
163923716|NCT02965599|592091045|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
163923717|NCT00230971|592091047|FG000|Randomization|No study drug administered|3|||
163923718|NCT00230971|592091048|FG001|Randomization|No study drug administered|3|||
163923719|NCT00230971|592091047|FG000|Baseline Participants|Lost to Follow-up|5|||
163923720|NCT00230971|592091048|FG001|Baseline Participants|Lost to Follow-up|12|||
163923721|NCT00230971|592091047|FG000|Baseline Participants|Death|6|||
163923722|NCT00230971|592091048|FG001|Baseline Participants|Death|5|||
163923723|NCT00230971|592091047|FG000|Baseline Participants|Withdrawal by Subject|7|||
163923724|NCT00230971|592091048|FG001|Baseline Participants|Withdrawal by Subject|1|||
163923725|NCT00230971|592091047|FG000|Baseline Participants|Adverse Event|1|||
163923726|NCT00230971|592091048|FG001|Baseline Participants|Adverse Event|0|||
163923727|NCT00230971|592091047|FG000|Baseline Participants|No bacteria observed|1|||
163923728|NCT00230971|592091048|FG001|Baseline Participants|No bacteria observed|0|||
163923729|NCT00230971|592091047|FG000|Baseline Participants|Failure to return|1|||
163923730|NCT00230971|592091048|FG001|Baseline Participants|Failure to return|1|||
163923731|NCT00230971|592091047|FG000|Baseline Participants|Reintervention|1|||
163923732|NCT00230971|592091048|FG001|Baseline Participants|Reintervention|0|||
164033351|NCT00340834|592482180|FG002|Extension Phase of Study|Death|0|||
164033352|NCT00340834|592482181|FG003|Extension Phase of Study|Death|0|||
163828520|NCT00330174|591739333|FG001|Overall Study|Miscellaneous reasons|1|||
163828521|NCT02230956|591739338|FG000|Overall Study|Adverse Event|1|||
163828522|NCT02230956|591739339|FG001|Overall Study|Adverse Event|1|||
163828523|NCT02230956|591739340|FG002|Overall Study|Adverse Event|0|||
163828524|NCT02230956|591739338|FG000|Overall Study|Lack of Efficacy|1|||
163828525|NCT02230956|591739339|FG001|Overall Study|Lack of Efficacy|1|||
163828526|NCT02230956|591739340|FG002|Overall Study|Lack of Efficacy|1|||
163828527|NCT02230956|591739338|FG000|Overall Study|Lost to Follow-up|1|||
163828528|NCT02230956|591739339|FG001|Overall Study|Lost to Follow-up|1|||
163828529|NCT02230956|591739340|FG002|Overall Study|Lost to Follow-up|2|||
163828530|NCT02230956|591739338|FG000|Overall Study|Personal Reasons|2|||
163828531|NCT02230956|591739339|FG001|Overall Study|Personal Reasons|1|||
163828532|NCT02230956|591739340|FG002|Overall Study|Personal Reasons|1|||
163828533|NCT02230956|591739338|FG000|Overall Study|Protocol Violation|0|||
163828534|NCT02230956|591739339|FG001|Overall Study|Protocol Violation|1|||
163828535|NCT02230956|591739340|FG002|Overall Study|Protocol Violation|1|||
163828536|NCT02230956|591739338|FG000|Overall Study|Other Miscellaneous Reason|0|||
163828537|NCT02230956|591739339|FG001|Overall Study|Other Miscellaneous Reason|1|||
163828538|NCT02230956|591739340|FG002|Overall Study|Other Miscellaneous Reason|2|||
163828539|NCT01445652|591739341|FG000|Overall Study|Not comfortable in lenses|5|||
163828540|NCT01445652|591739342|FG001|Overall Study|Not comfortable in lenses|0|||
163828541|NCT01445652|591739341|FG000|Overall Study|Failed to attend scheduled visit|2|||
163828542|NCT01445652|591739342|FG001|Overall Study|Failed to attend scheduled visit|3|||
163923733|NCT00951171|592091050|FG000|Overall Study|Adverse Event|2|||
163923734|NCT00951171|592091051|FG001|Overall Study|Adverse Event|0|||
163923735|NCT04130061|592091052|FG000|Overall Study|OR team forgot to request membrane|1|||
163923736|NCT04130061|592091053|FG001|Overall Study|OR team forgot to request membrane|0|||
164033353|NCT00340834|592482182|FG004|Extension Phase of Study|Death|1|||
164033354|NCT00291499|592482183|FG000|Overall Study|Adverse Event|3|||
163828543|NCT01445652|591739341|FG000|Overall Study|Failed teach session|2|||
163828544|NCT01445652|591739342|FG001|Overall Study|Failed teach session|0|||
163828545|NCT01445652|591739341|FG000|Overall Study|Adverse Event|1|||
163828546|NCT01445652|591739342|FG001|Overall Study|Adverse Event|0|||
163923737|NCT04267393|592091056|FG000|Randomization|Adverse Event|1|||
163923738|NCT04267393|592091057|FG001|Randomization|Adverse Event|0|||
164033355|NCT00291499|592482184|FG001|Overall Study|Adverse Event|8|||
163828547|NCT03002610|591739343|FG000|Overall Study|Withdrawal by Subject|6|||
163828548|NCT03002610|591739344|FG001|Overall Study|Withdrawal by Subject|25|||
163828549|NCT03002610|591739345|FG002|Overall Study|Withdrawal by Subject|13|||
163828550|NCT00929162|591739346|FG000|Overall Study|Adverse Event|8|||
163828551|NCT00929162|591739347|FG001|Overall Study|Adverse Event|5|||
163828552|NCT00929162|591739346|FG000|Overall Study|Withdrawal by Subject|3|||
163828553|NCT00929162|591739347|FG001|Overall Study|Withdrawal by Subject|1|||
163828554|NCT00929162|591739346|FG000|Overall Study|Protocol Violation|32|||
163828555|NCT00929162|591739347|FG001|Overall Study|Protocol Violation|30|||
163828556|NCT00929162|591739346|FG000|Overall Study|Other termination reason|5|||
163828557|NCT00929162|591739347|FG001|Overall Study|Other termination reason|6|||
163828558|NCT01822587|591739348|FG000|Overall Study|Lost to Follow-up|7|||
163828559|NCT01822587|591739349|FG001|Overall Study|Lost to Follow-up|9|||
163828560|NCT01822587|591739350|FG002|Overall Study|Lost to Follow-up|12|||
163828561|NCT01822587|591739348|FG000|Overall Study|Physician Decision|9|||
163828562|NCT01822587|591739349|FG001|Overall Study|Physician Decision|6|||
163828563|NCT01822587|591739350|FG002|Overall Study|Physician Decision|6|||
163828564|NCT00658567|591739352|FG000|Overall Study|Adverse Event|5|||
163828565|NCT00658567|591739353|FG001|Overall Study|Adverse Event|2|||
163828566|NCT00658567|591739354|FG002|Overall Study|Adverse Event|3|||
163828567|NCT00658567|591739352|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
163828568|NCT00658567|591739353|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
163828569|NCT00658567|591739354|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
163828570|NCT00658567|591739352|FG000|Overall Study|Physician Decision|0|||
163828571|NCT00658567|591739353|FG001|Overall Study|Physician Decision|1|||
163828572|NCT00658567|591739354|FG002|Overall Study|Physician Decision|0|||
163828573|NCT00658567|591739352|FG000|Overall Study|At Discretion of Sponsor|1|||
163828574|NCT00658567|591739353|FG001|Overall Study|At Discretion of Sponsor|1|||
163828575|NCT00658567|591739354|FG002|Overall Study|At Discretion of Sponsor|1|||
163828576|NCT01755702|591739355|FG000|Wash Out Period I|Other Reason|3|||
163828577|NCT01755702|591739355|FG000|Washout Period II|Other Reason|5|||
163828578|NCT04860518|591739357|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
163828579|NCT04860518|591739358|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
163828580|NCT02355743|591739361|FG000|Overall Study|Withdrawal by Subject|1|||
163828581|NCT02355743|591739361|FG000|Overall Study|Lost to Follow-up|1|||
163828582|NCT02279043|591739365|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
163828583|NCT02279043|591739366|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
163828584|NCT02279043|591739367|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
163828585|NCT02279043|591739365|FG000|Overall Study|Lost to Follow-up|46|||
163828586|NCT02279043|591739366|FG001|Overall Study|Lost to Follow-up|88|||
163828587|NCT02279043|591739367|FG002|Overall Study|Lost to Follow-up|0|||
163828588|NCT00490282|591739368|FG000|Overall Study|Withdrawal by Subject|3|||
163828589|NCT00374322|591739369|FG000|Overall Study|Lost to Follow-up|92|||
163828590|NCT00374322|591739370|FG001|Overall Study|Lost to Follow-up|90|||
163828591|NCT00374322|591739369|FG000|Overall Study|Protocol Violation|8|||
163828592|NCT00374322|591739370|FG001|Overall Study|Protocol Violation|3|||
163828593|NCT00374322|591739369|FG000|Overall Study|Withdrawal by Subject|235|||
163828594|NCT00374322|591739370|FG001|Overall Study|Withdrawal by Subject|167|||
163828595|NCT00374322|591739369|FG000|Overall Study|Sponsor Terminated Study|866|||
163828596|NCT00374322|591739370|FG001|Overall Study|Sponsor Terminated Study|990|||
163828597|NCT00374322|591739369|FG000|Overall Study|Physician Decision|36|||
163828598|NCT00374322|591739370|FG001|Overall Study|Physician Decision|32|||
163828599|NCT00374322|591739369|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
163828600|NCT00374322|591739370|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
163828601|NCT00374322|591739369|FG000|Overall Study|Sponsor Decision|2|||
163828602|NCT00374322|591739370|FG001|Overall Study|Sponsor Decision|3|||
163828603|NCT00374322|591739369|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
163828604|NCT00374322|591739370|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
163828605|NCT00374322|591739369|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
163828606|NCT00374322|591739370|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
163828607|NCT00374322|591739369|FG000|Overall Study|Severe Toxicity|1|||
163828608|NCT00374322|591739370|FG001|Overall Study|Severe Toxicity|0|||
163828609|NCT00374322|591739369|FG000|Overall Study|Site Closed|2|||
163828610|NCT00374322|591739370|FG001|Overall Study|Site Closed|2|||
163828611|NCT00374322|591739369|FG000|Overall Study|Participant Changed Physician|1|||
163828612|NCT00374322|591739370|FG001|Overall Study|Participant Changed Physician|0|||
163828613|NCT00374322|591739369|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
163828614|NCT00374322|591739370|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
163828615|NCT00374322|591739369|FG000|Overall Study|Noncompliance with Study Requirements|0|||
163828616|NCT00374322|591739370|FG001|Overall Study|Noncompliance with Study Requirements|1|||
163828617|NCT00374322|591739369|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
163828618|NCT00374322|591739370|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
163828619|NCT00374322|591739369|FG000|Overall Study|Did Not Receive Study Medication|8|||
163828620|NCT00374322|591739370|FG001|Overall Study|Did Not Receive Study Medication|6|||
163828621|NCT00636610|591739373|FG000|Overall Study|Adverse Event|4|||
163923739|NCT04267393|592091058|FG002|Randomization|Adverse Event|0|||
163923740|NCT04267393|592091056|FG000|Randomization|Administrative Reasons by Sponsor|0|||
163923741|NCT04267393|592091057|FG001|Randomization|Administrative Reasons by Sponsor|1|||
163923742|NCT04267393|592091058|FG002|Randomization|Administrative Reasons by Sponsor|0|||
163923743|NCT04267393|592091056|FG000|Treatment Period|Adverse Event|0|||
163923744|NCT04267393|592091057|FG001|Treatment Period|Adverse Event|2|||
163923745|NCT04267393|592091058|FG002|Treatment Period|Adverse Event|3|||
163923746|NCT04267393|592091056|FG000|Treatment Period|Participant Withdrew Consent|0|||
163923747|NCT04267393|592091057|FG001|Treatment Period|Participant Withdrew Consent|0|||
163923748|NCT04267393|592091058|FG002|Treatment Period|Participant Withdrew Consent|1|||
163923749|NCT04267393|592091056|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
163923750|NCT04267393|592091057|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
163923751|NCT04267393|592091058|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
163923752|NCT01932762|592092456|FG000|Overall Study|Withdrawal by Subject|1|||
163923753|NCT01932762|592092457|FG001|Overall Study|Withdrawal by Subject|2|||
163923754|NCT01932762|592092458|FG002|Overall Study|Withdrawal by Subject|0|||
163923755|NCT01932762|592092459|FG003|Overall Study|Withdrawal by Subject|0|||
163923756|NCT01932762|592092456|FG000|Overall Study|Lost to Follow-up|4|||
163923757|NCT01932762|592092457|FG001|Overall Study|Lost to Follow-up|0|||
163923758|NCT01932762|592092458|FG002|Overall Study|Lost to Follow-up|0|||
163923759|NCT01932762|592092459|FG003|Overall Study|Lost to Follow-up|1|||
163923760|NCT01932762|592092456|FG000|Overall Study|Physician Decision|1|||
163923761|NCT01932762|592092457|FG001|Overall Study|Physician Decision|0|||
163923762|NCT01932762|592092458|FG002|Overall Study|Physician Decision|0|||
163923763|NCT01932762|592092459|FG003|Overall Study|Physician Decision|0|||
163923764|NCT01726049|592092461|FG000|Overall Study|Death|1|||
163923765|NCT01726049|592092462|FG001|Overall Study|Death|1|||
163923766|NCT01726049|592092461|FG000|Overall Study|Adverse Event|4|||
163923767|NCT01726049|592092462|FG001|Overall Study|Adverse Event|1|||
163923768|NCT01726049|592092461|FG000|Overall Study|refused second HC|0|||
163923769|NCT01726049|592092462|FG001|Overall Study|refused second HC|2|||
163923770|NCT02161406|592092463|FG000|Overall Study|Death|2|||
163923771|NCT02161406|592092464|FG001|Overall Study|Death|1|||
163923772|NCT02161406|592092463|FG000|Overall Study|Lost to Follow-up|2|||
163923773|NCT02161406|592092464|FG001|Overall Study|Lost to Follow-up|1|||
163923774|NCT02161406|592092463|FG000|Overall Study|Withdrawal by Subject|2|||
163923775|NCT02161406|592092464|FG001|Overall Study|Withdrawal by Subject|4|||
163923776|NCT02161406|592092463|FG000|Overall Study|investigator withdrew subject|3|||
163923777|NCT02161406|592092464|FG001|Overall Study|investigator withdrew subject|1|||
163923778|NCT02161406|592092463|FG000|Overall Study|Lack of Efficacy|1|||
163923779|NCT02161406|592092464|FG001|Overall Study|Lack of Efficacy|1|||
163923780|NCT02161406|592092463|FG000|Overall Study|relocation|0|||
163923781|NCT02161406|592092464|FG001|Overall Study|relocation|1|||
163923782|NCT00320398|592092476|FG000|Overall Study|Adverse Event|1|||
163923783|NCT00320398|592092477|FG001|Overall Study|Adverse Event|4|||
163923784|NCT00320398|592092476|FG000|Overall Study|Other|1|||
163923785|NCT00320398|592092477|FG001|Overall Study|Other|0|||
163923786|NCT00784147|592092489|FG000|Overall Study|Lost to Follow-up|2|||
163923787|NCT00784147|592092490|FG001|Overall Study|Lost to Follow-up|4|||
163923788|NCT00784147|592092489|FG000|Overall Study|Withdrawal by Subject|1|||
163923789|NCT00784147|592092490|FG001|Overall Study|Withdrawal by Subject|3|||
163923790|NCT00784147|592092489|FG000|Overall Study|Physician Decision|2|||
163923791|NCT00784147|592092490|FG001|Overall Study|Physician Decision|1|||
163923792|NCT00784147|592092489|FG000|Overall Study|Protocol Violation|1|||
163923793|NCT00784147|592092490|FG001|Overall Study|Protocol Violation|1|||
163923794|NCT00784147|592092489|FG000|Overall Study|Death|2|||
163923795|NCT00784147|592092490|FG001|Overall Study|Death|0|||
163923796|NCT03596242|592092492|FG000|Overall Study|Lost to Follow-up|2|||
163923797|NCT03596242|592092493|FG001|Overall Study|Lost to Follow-up|2|||
163923798|NCT02973802|592092499|FG000|Overall Study|Lost to Follow-up|1|||
163923799|NCT02973802|592092499|FG000|Overall Study|Withdrawal by Subject|1|||
163923800|NCT00706914|592092500|FG000|Overall Study|Lack of Efficacy|0|||
163923801|NCT00706914|592092501|FG001|Overall Study|Lack of Efficacy|1|||
163923802|NCT00706914|592092502|FG002|Overall Study|Lack of Efficacy|0|||
163923803|NCT00706914|592092500|FG000|Overall Study|Lost to Follow-up|1|||
163923804|NCT00706914|592092501|FG001|Overall Study|Lost to Follow-up|0|||
163923805|NCT00706914|592092502|FG002|Overall Study|Lost to Follow-up|0|||
163923806|NCT00706914|592092500|FG000|Overall Study|Adverse Event|2|||
163923807|NCT00706914|592092501|FG001|Overall Study|Adverse Event|2|||
163923808|NCT00706914|592092502|FG002|Overall Study|Adverse Event|0|||
163923809|NCT00706914|592092500|FG000|Overall Study|Protocol Violation|3|||
164033356|NCT00291499|592482183|FG000|Overall Study|Change to other therapy|2|||
163923810|NCT00706914|592092501|FG001|Overall Study|Protocol Violation|1|||
163923811|NCT00706914|592092502|FG002|Overall Study|Protocol Violation|1|||
163923812|NCT01850823|592092503|FG000|Overall Study|Early Visit Window|0|||
163923813|NCT01850823|592092504|FG001|Overall Study|Early Visit Window|1|||
163923814|NCT01850823|592092505|FG002|Overall Study|Early Visit Window|4|||
163923815|NCT01850823|592092503|FG000|Overall Study|Enrolled in Error|0|||
163923816|NCT01850823|592092504|FG001|Overall Study|Enrolled in Error|1|||
163828622|NCT00636610|591739374|FG001|Overall Study|Adverse Event|4|||
163828623|NCT00636610|591739373|FG000|Overall Study|Death|6|||
163828624|NCT00636610|591739374|FG001|Overall Study|Death|3|||
163828625|NCT00636610|591739373|FG000|Overall Study|Physician decision to withdraw patient|15|||
163828626|NCT00636610|591739374|FG001|Overall Study|Physician decision to withdraw patient|9|||
163828627|NCT00636610|591739373|FG000|Overall Study|Subject decision to withdraw|15|||
163828628|NCT00636610|591739374|FG001|Overall Study|Subject decision to withdraw|11|||
163828629|NCT00636610|591739373|FG000|Overall Study|Disease progression - radiographic|41|||
163828630|NCT00636610|591739374|FG001|Overall Study|Disease progression - radiographic|51|||
163828631|NCT00636610|591739373|FG000|Overall Study|Disease progression - clinical|8|||
163828632|NCT00636610|591739374|FG001|Overall Study|Disease progression - clinical|3|||
163828633|NCT00636610|591739373|FG000|Overall Study|Reason for discontinuation not available|3|||
163828634|NCT00636610|591739374|FG001|Overall Study|Reason for discontinuation not available|2|||
163828635|NCT02495025|591739375|FG000|Overall Study|Lost to Follow-up|21|||
163828636|NCT02495025|591739376|FG001|Overall Study|Lost to Follow-up|14|||
163828637|NCT02495025|591739375|FG000|Overall Study|Withdrawal by Subject|5|||
163828638|NCT02495025|591739376|FG001|Overall Study|Withdrawal by Subject|0|||
163828639|NCT00313820|591739377|FG000|Assigned to Treatment|Other|1|||
163828640|NCT00313820|591739378|FG001|Assigned to Treatment|Other|0|||
163828641|NCT00313820|591739377|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
163828642|NCT00313820|591739378|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
163828643|NCT00313820|591739377|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
163828644|NCT00313820|591739378|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
163828645|NCT00313820|591739377|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
163828646|NCT00313820|591739378|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
163828647|NCT00313820|591739377|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
163828648|NCT00313820|591739378|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
163828649|NCT00313820|591739377|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
163828650|NCT00313820|591739378|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
163828651|NCT02151266|591739383|FG000|Overall Study|Lost to Follow-up|1|||
163828652|NCT02151266|591739384|FG001|Overall Study|Lost to Follow-up|4|||
163828653|NCT02151266|591739385|FG002|Overall Study|Lost to Follow-up|1|||
163828654|NCT02151266|591739383|FG000|Overall Study|Did NOT receive intervention|3|||
163828655|NCT02151266|591739384|FG001|Overall Study|Did NOT receive intervention|6|||
163828656|NCT02151266|591739385|FG002|Overall Study|Did NOT receive intervention|2|||
163828657|NCT02151266|591739383|FG000|Overall Study|Not able to exercise|4|||
163828658|NCT02151266|591739384|FG001|Overall Study|Not able to exercise|5|||
163828659|NCT02151266|591739385|FG002|Overall Study|Not able to exercise|4|||
163828660|NCT01169675|591739386|FG000|Overall Study|Progressive disease|13|||
163828661|NCT01169675|591739387|FG001|Overall Study|Progressive disease|2|||
163828662|NCT01169675|591739388|FG002|Overall Study|Progressive disease|5|||
163828663|NCT01169675|591739389|FG003|Overall Study|Progressive disease|15|||
163828664|NCT01169675|591739390|FG004|Overall Study|Progressive disease|1|||
163828665|NCT01169675|591739386|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
163828666|NCT01169675|591739387|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163828667|NCT01169675|591739388|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163828668|NCT01169675|591739389|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163828669|NCT01169675|591739390|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163828670|NCT01169675|591739386|FG000|Overall Study|Adverse Event|5|||
163828671|NCT01169675|591739387|FG001|Overall Study|Adverse Event|1|||
163828672|NCT01169675|591739388|FG002|Overall Study|Adverse Event|2|||
163828673|NCT01169675|591739389|FG003|Overall Study|Adverse Event|0|||
163828674|NCT01169675|591739390|FG004|Overall Study|Adverse Event|0|||
163828675|NCT01169675|591739386|FG000|Overall Study|Withdrawal by Subject|1|||
163828676|NCT01169675|591739387|FG001|Overall Study|Withdrawal by Subject|0|||
163828677|NCT01169675|591739388|FG002|Overall Study|Withdrawal by Subject|0|||
163828678|NCT01169675|591739389|FG003|Overall Study|Withdrawal by Subject|1|||
163828679|NCT01169675|591739390|FG004|Overall Study|Withdrawal by Subject|2|||
163828680|NCT01169675|591739386|FG000|Overall Study|Other Reason Not Defined Above|0|||
163828681|NCT01169675|591739387|FG001|Overall Study|Other Reason Not Defined Above|0|||
163828682|NCT01169675|591739388|FG002|Overall Study|Other Reason Not Defined Above|0|||
163828683|NCT01169675|591739389|FG003|Overall Study|Other Reason Not Defined Above|1|||
163828684|NCT01169675|591739390|FG004|Overall Study|Other Reason Not Defined Above|1|||
163828685|NCT04102579|591739393|FG000|Overall Study|Withdrawal by Subject|3|||
163828686|NCT04102579|591739394|FG001|Overall Study|Withdrawal by Subject|4|||
163828687|NCT04102579|591739393|FG000|Overall Study|Lost to Follow-up|0|||
163828688|NCT04102579|591739394|FG001|Overall Study|Lost to Follow-up|1|||
163828689|NCT04102579|591739393|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
163828690|NCT04102579|591739394|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
163828691|NCT04102579|591739393|FG000|Overall Study|Other than Specified|1|||
163923817|NCT01850823|592092505|FG002|Overall Study|Enrolled in Error|2|||
163923818|NCT01850823|592092503|FG000|Overall Study|Lack of Efficacy|1|||
163923819|NCT01850823|592092504|FG001|Overall Study|Lack of Efficacy|0|||
163923820|NCT01850823|592092505|FG002|Overall Study|Lack of Efficacy|0|||
163923821|NCT01850823|592092503|FG000|Overall Study|Lost to Follow-up|0|||
163923822|NCT01850823|592092504|FG001|Overall Study|Lost to Follow-up|0|||
163923823|NCT01850823|592092505|FG002|Overall Study|Lost to Follow-up|1|||
163923824|NCT01850823|592092503|FG000|Overall Study|Restricted Medication|0|||
163923825|NCT01850823|592092504|FG001|Overall Study|Restricted Medication|0|||
163923826|NCT01850823|592092505|FG002|Overall Study|Restricted Medication|2|||
163923827|NCT01850823|592092503|FG000|Overall Study|Significant worstening of SAR|0|||
163923828|NCT01850823|592092504|FG001|Overall Study|Significant worstening of SAR|1|||
163923829|NCT01850823|592092505|FG002|Overall Study|Significant worstening of SAR|0|||
163923830|NCT01850823|592092503|FG000|Overall Study|Withdrawal by Subject|2|||
163923831|NCT01850823|592092504|FG001|Overall Study|Withdrawal by Subject|0|||
163923832|NCT01850823|592092505|FG002|Overall Study|Withdrawal by Subject|1|||
163923833|NCT00053352|592092507|FG000|Overall Study|Lost to Follow-up|0|||
163923834|NCT00053352|592092508|FG001|Overall Study|Lost to Follow-up|1|||
163923835|NCT00053352|592092507|FG000|Overall Study|Physician Decision|11|||
163923836|NCT00053352|592092508|FG001|Overall Study|Physician Decision|1|||
163923837|NCT00053352|592092507|FG000|Overall Study|Withdrawal by Subject|1|||
163923838|NCT00053352|592092508|FG001|Overall Study|Withdrawal by Subject|0|||
163923839|NCT00053352|592092507|FG000|Overall Study|Ineligible|8|||
163923840|NCT00053352|592092508|FG001|Overall Study|Ineligible|8|||
163923841|NCT00053352|592092507|FG000|Overall Study|Disease at new site|1|||
163923842|NCT00053352|592092508|FG001|Overall Study|Disease at new site|0|||
163923843|NCT00931918|592092511|FG000|Overall Study|Adverse Event|4|||
163923844|NCT00931918|592092512|FG001|Overall Study|Adverse Event|6|||
163923845|NCT00931918|592092511|FG000|Overall Study|Progressive Disease|2|||
163923846|NCT00931918|592092512|FG001|Overall Study|Progressive Disease|1|||
163923847|NCT00931918|592092511|FG000|Overall Study|Symptomatic Deterioration|1|||
163923848|NCT00931918|592092512|FG001|Overall Study|Symptomatic Deterioration|0|||
163923849|NCT00931918|592092511|FG000|Overall Study|Withdrawal by Patient|3|||
163923850|NCT00931918|592092512|FG001|Overall Study|Withdrawal by Patient|4|||
163923851|NCT00931918|592092511|FG000|Overall Study|Other Reason not Specified|4|||
163923852|NCT00931918|592092512|FG001|Overall Study|Other Reason not Specified|4|||
163923853|NCT00931918|592092511|FG000|Overall Study|Did not receive study drug|3|||
163923854|NCT00931918|592092512|FG001|Overall Study|Did not receive study drug|2|||
163923855|NCT00809341|592092513|FG000|Overall Study|Physician Decision|0|||
163923856|NCT00809341|592092514|FG001|Overall Study|Physician Decision|1|||
163923857|NCT04081389|592092519|FG000|Overall Study|Withdrawal by Subject|0|||
163923858|NCT04081389|592092520|FG001|Overall Study|Withdrawal by Subject|0|||
163923859|NCT04081389|592092521|FG002|Overall Study|Withdrawal by Subject|1|||
163923860|NCT04081389|592092522|FG003|Overall Study|Withdrawal by Subject|0|||
163923861|NCT00866918|592092523|FG000|Overall Study|Death|1|||
163923862|NCT00866918|592092524|FG001|Overall Study|Death|5|||
163923863|NCT00866918|592092523|FG000|Overall Study|Lack of Efficacy|1|||
163923864|NCT00866918|592092524|FG001|Overall Study|Lack of Efficacy|1|||
163923865|NCT00866918|592092523|FG000|Overall Study|Physician Decision|10|||
163923866|NCT00866918|592092524|FG001|Overall Study|Physician Decision|2|||
163923867|NCT00866918|592092523|FG000|Overall Study|Ineligible|2|||
163923868|NCT00866918|592092524|FG001|Overall Study|Ineligible|4|||
163923869|NCT00866918|592092523|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
163923870|NCT00866918|592092524|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
163923871|NCT00866918|592092523|FG000|Overall Study|Secondary malignancy|1|||
163923872|NCT00866918|592092524|FG001|Overall Study|Secondary malignancy|0|||
163923873|NCT00527514|592092526|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
163923874|NCT00527514|592092526|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
163923875|NCT00527514|592092526|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
163923876|NCT00527514|592092526|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
163923877|NCT00527514|592092526|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
163923878|NCT00527514|592092526|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
163923879|NCT00527514|592092526|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
163923880|NCT00920699|592092529|FG000|Overall Study|Withdrawal by Subject|2|||
163923881|NCT00920699|592092530|FG001|Overall Study|Withdrawal by Subject|0|||
164097757|NCT00454909|592722850|FG000|Overall Study|Migrated/moved from study area|0|||
163923882|NCT00920699|592092531|FG002|Overall Study|Withdrawal by Subject|2|||
163923883|NCT00920699|592092529|FG000|Overall Study|no longer met eligibility|0|||
163923884|NCT00920699|592092530|FG001|Overall Study|no longer met eligibility|1|||
163923885|NCT00920699|592092531|FG002|Overall Study|no longer met eligibility|0|||
163923886|NCT00920699|592092529|FG000|Overall Study|Lost to Follow-up|0|||
163923887|NCT00920699|592092530|FG001|Overall Study|Lost to Follow-up|0|||
163923888|NCT00920699|592092531|FG002|Overall Study|Lost to Follow-up|2|||
163923889|NCT02287883|592092534|FG000|Overall Study|Death|8|||
163923890|NCT02287883|592092535|FG001|Overall Study|Death|7|||
163923891|NCT02287883|592092534|FG000|Overall Study|No longer eligible|222|||
163923892|NCT02287883|592092535|FG001|Overall Study|No longer eligible|182|||
164097758|NCT00454909|592722851|FG001|Overall Study|Migrated/moved from study area|0|||
164097759|NCT00454909|592722852|FG002|Overall Study|Migrated/moved from study area|1|||
164097760|NCT00454909|592722850|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
164097761|NCT00454909|592722851|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
164097762|NCT00454909|592722852|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
164097763|NCT00454909|592722850|FG000|Overall Study|Others|1|||
164097764|NCT00454909|592722851|FG001|Overall Study|Others|0|||
164097765|NCT00454909|592722852|FG002|Overall Study|Others|0|||
164097766|NCT03752528|592722853|FG000|Part A|Lost to Follow-up|1|||
164097767|NCT03752528|592722853|FG000|Part A|Protocol Violation|1|||
164097768|NCT03752528|592722853|FG000|Part B|Protocol Violation|1|||
164097769|NCT03752528|592722853|FG000|Part B|Study terminated by sponsor|3|||
164097770|NCT01981720|592722854|FG000|Overall Study|Adverse Event|1|||
164097771|NCT01981720|592722854|FG000|Overall Study|Withdrawal by Subject|3|||
164033357|NCT00291499|592482184|FG001|Overall Study|Change to other therapy|1|||
164033358|NCT00291499|592482183|FG000|Overall Study|Intercurrent illness|1|||
164033359|NCT00291499|592482184|FG001|Overall Study|Intercurrent illness|0|||
164033360|NCT00291499|592482183|FG000|Overall Study|Protocol Violation|2|||
164033361|NCT00291499|592482184|FG001|Overall Study|Protocol Violation|2|||
164033362|NCT00291499|592482183|FG000|Overall Study|Other reasons|1|||
164033363|NCT00291499|592482184|FG001|Overall Study|Other reasons|4|||
164033364|NCT01457924|592482185|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
164033365|NCT01457924|592482186|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
164033366|NCT01457924|592482187|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
164033367|NCT01457924|592482188|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
164097772|NCT01981720|592722854|FG000|Overall Study|Pregnancy|1|||
164097773|NCT02549092|592722856|FG000|Treatment Period|Adverse Event|2|||
164097774|NCT02549092|592722857|FG001|Treatment Period|Adverse Event|2|||
164097775|NCT02549092|592722856|FG000|Treatment Period|Withdrawal by Subject|1|||
164097776|NCT02549092|592722857|FG001|Treatment Period|Withdrawal by Subject|3|||
164097777|NCT02549092|592722856|FG000|Treatment Period|Lack of Efficacy|0|||
164097778|NCT02549092|592722857|FG001|Treatment Period|Lack of Efficacy|2|||
164097779|NCT02549092|592722856|FG000|Extension/Transition Period|Adverse Event|1|||
164097780|NCT02549092|592722857|FG001|Extension/Transition Period|Adverse Event|1|||
164097781|NCT02549092|592722856|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
164097782|NCT02549092|592722857|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
163923893|NCT02287883|592092534|FG000|Overall Study|Non-response to survey|229|||
164033368|NCT01457924|592482189|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
164033369|NCT01457924|592482185|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164033370|NCT01457924|592482186|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164033371|NCT01457924|592482187|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164033372|NCT01457924|592482188|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
164033373|NCT01457924|592482189|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
164033374|NCT01457924|592482185|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
164033375|NCT01457924|592482186|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164033376|NCT01457924|592482187|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164033377|NCT01457924|592482188|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164033378|NCT01457924|592482189|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
164033379|NCT01457924|592482185|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
164033380|NCT01457924|592482186|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
164033381|NCT01457924|592482187|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
164033382|NCT01457924|592482188|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
164033383|NCT01457924|592482189|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
163923894|NCT02287883|592092535|FG001|Overall Study|Non-response to survey|237|||
163923895|NCT04016805|592092540|FG000|Overall Study|Sponsor's Discretion|30|||
163923896|NCT04016805|592092541|FG001|Overall Study|Sponsor's Discretion|6|||
163923897|NCT04016805|592092542|FG002|Overall Study|Sponsor's Discretion|5|||
163923898|NCT02101268|592092545|FG000|Randomized Treatment Phase|Subject Decision|8|||
163923899|NCT02101268|592092546|FG001|Randomized Treatment Phase|Subject Decision|4|||
163923900|NCT02101268|592092547|FG002|Randomized Treatment Phase|Subject Decision|0|||
163923901|NCT02101268|592092548|FG003|Randomized Treatment Phase|Subject Decision|0|||
163923902|NCT02101268|592092545|FG000|Randomized Treatment Phase|Physician Decision|4|||
164033384|NCT01457924|592482185|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
164033385|NCT01457924|592482186|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
164033386|NCT01457924|592482187|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
164033387|NCT01457924|592482188|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
163923903|NCT02101268|592092546|FG001|Randomized Treatment Phase|Physician Decision|1|||
164033388|NCT01457924|592482189|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
164033389|NCT01457924|592482185|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
164097783|NCT02549092|592722856|FG000|Extension/Transition Period|Other, Not Specified|4|||
164097784|NCT02549092|592722857|FG001|Extension/Transition Period|Other, Not Specified|2|||
164097785|NCT00910663|592722858|FG000|Period 1|Withdrawal by Subject|0|||
164097786|NCT00910663|592722859|FG001|Period 1|Withdrawal by Subject|1|||
164033390|NCT01457924|592482186|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
164033391|NCT01457924|592482187|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
164033392|NCT01457924|592482188|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
164033393|NCT01457924|592482189|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
164033394|NCT01457924|592482185|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
164033395|NCT01457924|592482186|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
164033396|NCT01457924|592482187|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
164033397|NCT01457924|592482188|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
164033398|NCT01457924|592482189|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
164033399|NCT01457924|592482185|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
164033400|NCT01457924|592482186|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
163828692|NCT04102579|591739394|FG001|Overall Study|Other than Specified|0|||
163828693|NCT04102579|591739393|FG000|Overall Study|Not Dosed with Study Drug|0|||
163828694|NCT04102579|591739394|FG001|Overall Study|Not Dosed with Study Drug|1|||
163828695|NCT05899686|591739395|FG000|Overall Study|Protocol Violation|1|||
163828696|NCT00572195|591739396|FG000|Overall Study|Withdrawal by Subject|50|||
163828697|NCT00572195|591739396|FG000|Overall Study|Death|9|||
163828698|NCT00572195|591739396|FG000|Overall Study|Adverse Event|4|||
163828699|NCT00572195|591739396|FG000|Overall Study|Lost to Follow-up|5|||
163828700|NCT03076970|591741486|FG000|Washout Period 2|Adverse Event|0|||
163828701|NCT03076970|591741487|FG001|Washout Period 2|Adverse Event|0|||
163828702|NCT03076970|591741488|FG002|Washout Period 2|Adverse Event|0|||
163828703|NCT03076970|591741489|FG003|Washout Period 2|Adverse Event|0|||
163828704|NCT03076970|591741490|FG004|Washout Period 2|Adverse Event|1|||
163828705|NCT03076970|591741491|FG005|Washout Period 2|Adverse Event|0|||
163828706|NCT03076970|591741486|FG000|Period 3|Withdrawal by Subject|0|||
163828707|NCT03076970|591741487|FG001|Period 3|Withdrawal by Subject|0|||
163828708|NCT03076970|591741488|FG002|Period 3|Withdrawal by Subject|0|||
163828709|NCT03076970|591741489|FG003|Period 3|Withdrawal by Subject|0|||
163828710|NCT03076970|591741490|FG004|Period 3|Withdrawal by Subject|0|||
163828711|NCT03076970|591741491|FG005|Period 3|Withdrawal by Subject|1|||
163828712|NCT03076970|591741486|FG000|Period 3|Failure to meet I/E criteria|0|||
163828713|NCT03076970|591741487|FG001|Period 3|Failure to meet I/E criteria|0|||
163828714|NCT03076970|591741488|FG002|Period 3|Failure to meet I/E criteria|0|||
163828715|NCT03076970|591741489|FG003|Period 3|Failure to meet I/E criteria|0|||
163828716|NCT03076970|591741490|FG004|Period 3|Failure to meet I/E criteria|1|||
163828717|NCT03076970|591741491|FG005|Period 3|Failure to meet I/E criteria|0|||
163828718|NCT00949884|591741492|FG000|Overall Study|Adverse Event|14|||
163828719|NCT00949884|591741493|FG001|Overall Study|Adverse Event|3|||
163828720|NCT00949884|591741494|FG002|Overall Study|Adverse Event|12|||
163828721|NCT00949884|591741492|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
163828722|NCT00949884|591741493|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
163828723|NCT00949884|591741494|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
163828724|NCT00949884|591741492|FG000|Overall Study|Lost to Follow-up|7|||
163828725|NCT00949884|591741493|FG001|Overall Study|Lost to Follow-up|5|||
163828726|NCT00949884|591741494|FG002|Overall Study|Lost to Follow-up|5|||
163828727|NCT00949884|591741492|FG000|Overall Study|Physician Decision|5|||
163828728|NCT00949884|591741493|FG001|Overall Study|Physician Decision|0|||
163828729|NCT00949884|591741494|FG002|Overall Study|Physician Decision|6|||
163828730|NCT00949884|591741492|FG000|Overall Study|Treatment non-compliance|5|||
163828731|NCT00949884|591741493|FG001|Overall Study|Treatment non-compliance|0|||
163828732|NCT00949884|591741494|FG002|Overall Study|Treatment non-compliance|8|||
163828733|NCT00949884|591741492|FG000|Overall Study|Withdrawal by Subject|13|||
163828734|NCT00949884|591741493|FG001|Overall Study|Withdrawal by Subject|4|||
163828735|NCT00949884|591741494|FG002|Overall Study|Withdrawal by Subject|16|||
163828736|NCT00949884|591741492|FG000|Overall Study|Lack of Efficacy|4|||
163828737|NCT00949884|591741493|FG001|Overall Study|Lack of Efficacy|2|||
163828738|NCT00949884|591741494|FG002|Overall Study|Lack of Efficacy|7|||
163828739|NCT00949884|591741492|FG000|Overall Study|Study terminated by sponsor|0|||
163828740|NCT00949884|591741493|FG001|Overall Study|Study terminated by sponsor|0|||
163828741|NCT00949884|591741494|FG002|Overall Study|Study terminated by sponsor|1|||
163828742|NCT03391765|591741502|FG000|Overall Study|Adverse Event|2|||
163828743|NCT03391765|591741503|FG001|Overall Study|Adverse Event|0|||
163828744|NCT03391765|591741504|FG002|Overall Study|Adverse Event|0|||
163828745|NCT03391765|591741505|FG003|Overall Study|Adverse Event|2|||
163828746|NCT03391765|591741502|FG000|Overall Study|Withdrew consent|5|||
164033401|NCT01457924|592482187|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
164033402|NCT01457924|592482188|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
163828747|NCT03391765|591741503|FG001|Overall Study|Withdrew consent|7|||
163828748|NCT03391765|591741504|FG002|Overall Study|Withdrew consent|2|||
163828749|NCT03391765|591741505|FG003|Overall Study|Withdrew consent|5|||
163828750|NCT03391765|591741502|FG000|Overall Study|Other, not specified|44|||
163828751|NCT03391765|591741503|FG001|Overall Study|Other, not specified|38|||
163828752|NCT03391765|591741504|FG002|Overall Study|Other, not specified|21|||
163828753|NCT03391765|591741505|FG003|Overall Study|Other, not specified|16|||
163828754|NCT00662857|591741510|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
163828755|NCT00662857|591741511|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
163923904|NCT02101268|592092547|FG002|Randomized Treatment Phase|Physician Decision|0|||
163923905|NCT02101268|592092548|FG003|Randomized Treatment Phase|Physician Decision|0|||
163923906|NCT02101268|592092545|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
163923907|NCT02101268|592092546|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
163923908|NCT02101268|592092547|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
163923909|NCT02101268|592092548|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
163923910|NCT02101268|592092545|FG000|Randomized Treatment Phase|Adverse Event|6|||
163923911|NCT02101268|592092546|FG001|Randomized Treatment Phase|Adverse Event|0|||
163923912|NCT02101268|592092547|FG002|Randomized Treatment Phase|Adverse Event|0|||
163923913|NCT02101268|592092548|FG003|Randomized Treatment Phase|Adverse Event|0|||
163923914|NCT02101268|592092545|FG000|Randomized Treatment Phase|Death|5|||
163923915|NCT02101268|592092546|FG001|Randomized Treatment Phase|Death|4|||
163923916|NCT02101268|592092547|FG002|Randomized Treatment Phase|Death|0|||
163923917|NCT02101268|592092548|FG003|Randomized Treatment Phase|Death|0|||
163923918|NCT02101268|592092545|FG000|Randomized Treatment Phase|Disease Progression|4|||
163923919|NCT02101268|592092546|FG001|Randomized Treatment Phase|Disease Progression|1|||
163923920|NCT02101268|592092547|FG002|Randomized Treatment Phase|Disease Progression|0|||
163923921|NCT02101268|592092548|FG003|Randomized Treatment Phase|Disease Progression|0|||
163923922|NCT02101268|592092545|FG000|Extended Treatment Phase|Subject Decision|0|||
163923923|NCT02101268|592092546|FG001|Extended Treatment Phase|Subject Decision|0|||
163923924|NCT02101268|592092547|FG002|Extended Treatment Phase|Subject Decision|3|||
163923925|NCT02101268|592092548|FG003|Extended Treatment Phase|Subject Decision|2|||
163923926|NCT02101268|592092545|FG000|Extended Treatment Phase|Physician Decision|0|||
163923927|NCT02101268|592092546|FG001|Extended Treatment Phase|Physician Decision|0|||
163923928|NCT02101268|592092547|FG002|Extended Treatment Phase|Physician Decision|5|||
163923929|NCT02101268|592092548|FG003|Extended Treatment Phase|Physician Decision|2|||
163923930|NCT02101268|592092545|FG000|Extended Treatment Phase|Adverse Event|0|||
163923931|NCT02101268|592092546|FG001|Extended Treatment Phase|Adverse Event|0|||
163923932|NCT02101268|592092547|FG002|Extended Treatment Phase|Adverse Event|14|||
163923933|NCT02101268|592092548|FG003|Extended Treatment Phase|Adverse Event|18|||
163923934|NCT02101268|592092545|FG000|Extended Treatment Phase|Death|0|||
163923935|NCT02101268|592092546|FG001|Extended Treatment Phase|Death|0|||
163923936|NCT02101268|592092547|FG002|Extended Treatment Phase|Death|5|||
163923937|NCT02101268|592092548|FG003|Extended Treatment Phase|Death|1|||
163923938|NCT02101268|592092545|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
163923939|NCT02101268|592092546|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
163923940|NCT02101268|592092547|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
163923941|NCT02101268|592092548|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
163923942|NCT02101268|592092545|FG000|Extended Treatment Phase|Disease Progression|0|||
163923943|NCT02101268|592092546|FG001|Extended Treatment Phase|Disease Progression|0|||
163923944|NCT02101268|592092547|FG002|Extended Treatment Phase|Disease Progression|13|||
163923945|NCT02101268|592092548|FG003|Extended Treatment Phase|Disease Progression|6|||
163923946|NCT02101268|592092545|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
163923947|NCT02101268|592092546|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
163923948|NCT02101268|592092547|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
163923949|NCT02101268|592092548|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
163923950|NCT00740870|592092549|FG000|Overall Study|Not Catheterized|4|||
163923951|NCT00740870|592092549|FG000|Overall Study|Further testing contraindicated implant|17|||
163923952|NCT00819013|592092551|FG000|Overall Study|Not meeting continuing study eligibility|2|||
163923953|NCT00819013|592092552|FG001|Overall Study|Not meeting continuing study eligibility|1|||
163923954|NCT00819013|592092553|FG002|Overall Study|Not meeting continuing study eligibility|2|||
163923955|NCT00819013|592092554|FG003|Overall Study|Not meeting continuing study eligibility|1|||
163923956|NCT00819013|592092551|FG000|Overall Study|Adverse Event|0|||
163923957|NCT00819013|592092552|FG001|Overall Study|Adverse Event|0|||
163923958|NCT00819013|592092553|FG002|Overall Study|Adverse Event|1|||
163923959|NCT00819013|592092554|FG003|Overall Study|Adverse Event|0|||
163923960|NCT00819013|592092551|FG000|Overall Study|Withdrawal by Subject|1|||
163923961|NCT00819013|592092552|FG001|Overall Study|Withdrawal by Subject|0|||
163923962|NCT00819013|592092553|FG002|Overall Study|Withdrawal by Subject|1|||
163923963|NCT00819013|592092554|FG003|Overall Study|Withdrawal by Subject|0|||
163923964|NCT00819013|592092551|FG000|Overall Study|Lost to Follow-up|0|||
163923965|NCT00819013|592092552|FG001|Overall Study|Lost to Follow-up|0|||
163923966|NCT00819013|592092553|FG002|Overall Study|Lost to Follow-up|1|||
163923967|NCT00819013|592092554|FG003|Overall Study|Lost to Follow-up|2|||
163923968|NCT00819013|592092551|FG000|Overall Study|Death|0|||
163923969|NCT00819013|592092552|FG001|Overall Study|Death|0|||
163923970|NCT00819013|592092553|FG002|Overall Study|Death|0|||
163923971|NCT00819013|592092554|FG003|Overall Study|Death|1|||
163923972|NCT03811834|592092555|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
163923973|NCT00576823|592092556|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
163923974|NCT00576823|592092557|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
163923975|NCT00576823|592092558|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
163923976|NCT00576823|592092556|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
164147372|NCT05168202|592902027|FG003|Overall Study|Adverse Event|4|||
163923977|NCT00576823|592092557|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
163923978|NCT00576823|592092558|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
163923979|NCT00839332|592092559|FG000|Phase 1|Disease Progression|38|||
163923980|NCT00839332|592092560|FG001|Phase 1|Disease Progression|0|||
163923981|NCT00839332|592092561|FG002|Phase 1|Disease Progression|0|||
163923982|NCT00839332|592092559|FG000|Phase 1|Adverse Event|6|||
163923983|NCT00839332|592092560|FG001|Phase 1|Adverse Event|0|||
163923984|NCT00839332|592092561|FG002|Phase 1|Adverse Event|0|||
163923985|NCT00839332|592092559|FG000|Phase 1|Withdrawal by Subject|4|||
163923986|NCT00839332|592092560|FG001|Phase 1|Withdrawal by Subject|0|||
163923987|NCT00839332|592092561|FG002|Phase 1|Withdrawal by Subject|0|||
163923988|NCT00839332|592092559|FG000|Phase 1|Physician Decision|2|||
163923989|NCT00839332|592092560|FG001|Phase 1|Physician Decision|0|||
163923990|NCT00839332|592092561|FG002|Phase 1|Physician Decision|0|||
163923991|NCT00839332|592092559|FG000|Phase 2|Protocol Violation|0|||
163923992|NCT00839332|592092560|FG001|Phase 2|Protocol Violation|1|||
163923993|NCT00839332|592092561|FG002|Phase 2|Protocol Violation|0|||
163923994|NCT00839332|592092559|FG000|Phase 2|Disease Progression|0|||
163923995|NCT00839332|592092560|FG001|Phase 2|Disease Progression|46|||
163923996|NCT00839332|592092561|FG002|Phase 2|Disease Progression|21|||
163923997|NCT00839332|592092559|FG000|Phase 2|Adverse Event|0|||
163923998|NCT00839332|592092560|FG001|Phase 2|Adverse Event|8|||
163923999|NCT00839332|592092561|FG002|Phase 2|Adverse Event|6|||
163924000|NCT00839332|592092559|FG000|Phase 2|Death|0|||
163924001|NCT00839332|592092560|FG001|Phase 2|Death|4|||
163924002|NCT00839332|592092561|FG002|Phase 2|Death|2|||
163924003|NCT00839332|592092559|FG000|Phase 2|Withdrawal by Subject|0|||
163924004|NCT00839332|592092560|FG001|Phase 2|Withdrawal by Subject|5|||
163924005|NCT00839332|592092561|FG002|Phase 2|Withdrawal by Subject|8|||
163924006|NCT00839332|592092559|FG000|Phase 2|Physician Decision|0|||
163924007|NCT00839332|592092560|FG001|Phase 2|Physician Decision|4|||
163924008|NCT00839332|592092561|FG002|Phase 2|Physician Decision|1|||
163924009|NCT00839332|592092559|FG000|Phase 2|Lost to Follow-up|0|||
163924010|NCT00839332|592092560|FG001|Phase 2|Lost to Follow-up|0|||
163924011|NCT00839332|592092561|FG002|Phase 2|Lost to Follow-up|1|||
163924012|NCT01200485|592092562|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
163924013|NCT01200485|592092563|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
163924014|NCT01200485|592092564|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
163924015|NCT01200485|592092562|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
163924016|NCT01200485|592092563|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
163924017|NCT01200485|592092564|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
163924018|NCT02132117|592092566|FG000|Overall Study|Adverse Event|6|||
163924019|NCT02132117|592092567|FG001|Overall Study|Adverse Event|1|||
163924020|NCT02132117|592092566|FG000|Overall Study|Lost to Follow-up|2|||
163924021|NCT02132117|592092567|FG001|Overall Study|Lost to Follow-up|2|||
163924022|NCT02132117|592092566|FG000|Overall Study|Personal Reasons|1|||
163924023|NCT02132117|592092567|FG001|Overall Study|Personal Reasons|2|||
163924024|NCT02132117|592092566|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163924025|NCT02132117|592092567|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163924026|NCT04947436|592092569|FG000|Overall Study|Lost to Follow-up|3|||
163924027|NCT04947436|592092570|FG001|Overall Study|Lost to Follow-up|7|||
163924028|NCT04947436|592092571|FG002|Overall Study|Lost to Follow-up|5|||
163924029|NCT04947436|592092569|FG000|Overall Study|Death|1|||
163924030|NCT04947436|592092570|FG001|Overall Study|Death|1|||
163924031|NCT04947436|592092571|FG002|Overall Study|Death|1|||
164033403|NCT01457924|592482189|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
164033404|NCT01457924|592482185|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164033405|NCT01457924|592482186|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164033406|NCT01457924|592482187|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164033407|NCT01457924|592482188|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
164033408|NCT01457924|592482189|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
164033409|NCT01457924|592482185|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
164033410|NCT01457924|592482186|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
164033411|NCT01457924|592482187|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
164033412|NCT01457924|592482188|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
163924032|NCT01544309|592092575|FG000|Overall Study|Withdrawal by Subject|12|||
163924033|NCT01544309|592092576|FG001|Overall Study|Withdrawal by Subject|7|||
163924034|NCT01544309|592092575|FG000|Overall Study|Protocol Violation|2|||
163924035|NCT01544309|592092576|FG001|Overall Study|Protocol Violation|1|||
163924036|NCT01544309|592092575|FG000|Overall Study|Physician Decision|4|||
163924037|NCT01544309|592092576|FG001|Overall Study|Physician Decision|1|||
163924038|NCT01544309|592092575|FG000|Overall Study|Not performed pre-dose examination|1|||
163924039|NCT01544309|592092576|FG001|Overall Study|Not performed pre-dose examination|2|||
163924040|NCT01544309|592092575|FG000|Overall Study|Administered prohibit prior medication|1|||
164033413|NCT01457924|592482189|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
164097787|NCT01772537|592722863|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
163924041|NCT01544309|592092576|FG001|Overall Study|Administered prohibit prior medication|0|||
163924042|NCT03078751|592092577|FG000|Overall Study|Adverse Event|4|||
163924043|NCT03078751|592092578|FG001|Overall Study|Adverse Event|0|||
163924044|NCT03078751|592092577|FG000|Overall Study|Physician Decision|1|||
163924045|NCT03078751|592092578|FG001|Overall Study|Physician Decision|0|||
163924046|NCT03078751|592092577|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
163924047|NCT03078751|592092578|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
163924048|NCT03078751|592092577|FG000|Overall Study|Subject/guardian decision|8|||
163924049|NCT03078751|592092578|FG001|Overall Study|Subject/guardian decision|1|||
163924050|NCT03078751|592092577|FG000|Overall Study|Untreated|0|||
163924051|NCT03078751|592092578|FG001|Overall Study|Untreated|4|||
163924052|NCT02515097|592092583|FG000|Overall Study|Lost to Follow-up|4|||
163924053|NCT02515097|592092584|FG001|Overall Study|Lost to Follow-up|2|||
163924054|NCT02515097|592092583|FG000|Overall Study|Withdrawal by Subject|1|||
163924055|NCT02515097|592092584|FG001|Overall Study|Withdrawal by Subject|3|||
163924056|NCT02515097|592092583|FG000|Overall Study|Adverse Event|2|||
163924057|NCT02515097|592092584|FG001|Overall Study|Adverse Event|1|||
163924058|NCT01196741|592092585|FG000|Overall Study|Disease progression|34|||
163924059|NCT01196741|592092586|FG001|Overall Study|Disease progression|14|||
163924060|NCT01196741|592092585|FG000|Overall Study|Adverse Event|10|||
163924061|NCT01196741|592092586|FG001|Overall Study|Adverse Event|6|||
163924062|NCT01196741|592092585|FG000|Overall Study|Serious Adverse Event|3|||
163924063|NCT01196741|592092586|FG001|Overall Study|Serious Adverse Event|1|||
164033414|NCT01457924|592482185|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
164033415|NCT01457924|592482186|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
164033416|NCT01457924|592482187|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
164033417|NCT01457924|592482188|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
163924064|NCT01196741|592092585|FG000|Overall Study|Dose limiting Adverse Event|2|||
163924065|NCT01196741|592092586|FG001|Overall Study|Dose limiting Adverse Event|1|||
163924066|NCT01196741|592092585|FG000|Overall Study|Withdrawal by Subject|3|||
163924067|NCT01196741|592092586|FG001|Overall Study|Withdrawal by Subject|0|||
163924068|NCT01196741|592092585|FG000|Overall Study|Other reason|3|||
163924069|NCT01196741|592092586|FG001|Overall Study|Other reason|3|||
163924070|NCT01196741|592092585|FG000|Overall Study|Other|3|||
163924071|NCT01196741|592092586|FG001|Overall Study|Other|2|||
163924072|NCT01196741|592092585|FG000|Overall Study|Protocol Violation|2|||
163924073|NCT01196741|592092586|FG001|Overall Study|Protocol Violation|1|||
163924074|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
163924075|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
163924076|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
163924077|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Other|1|||
163924078|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Other|0|||
163924079|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Other|0|||
163924080|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Physician Decision|3|||
163924081|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Physician Decision|0|||
163924082|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Physician Decision|0|||
163924083|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
163924084|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
163924085|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
163924086|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
163924087|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
163924088|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
163924089|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Adverse Event|18|||
163924090|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Adverse Event|0|||
163924091|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Adverse Event|0|||
163924092|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
163924093|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
163924094|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
163924095|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
163924096|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
163924097|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
163924098|NCT03030599|592092587|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
163924099|NCT03030599|592092588|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
164033418|NCT01457924|592482189|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
163924100|NCT03030599|592092589|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
163924101|NCT03030599|592092587|FG000|Stable Dose|Protocol deviation|3|||
163924102|NCT03030599|592092588|FG001|Stable Dose|Protocol deviation|0|||
163924103|NCT03030599|592092589|FG002|Stable Dose|Protocol deviation|0|||
163924104|NCT03030599|592092587|FG000|Stable Dose|Adverse Event|1|||
163924105|NCT03030599|592092588|FG001|Stable Dose|Adverse Event|0|||
163924106|NCT03030599|592092589|FG002|Stable Dose|Adverse Event|0|||
163924107|NCT03030599|592092587|FG000|Stable Dose|Lost to Follow-up|1|||
163924108|NCT03030599|592092588|FG001|Stable Dose|Lost to Follow-up|0|||
163924109|NCT03030599|592092589|FG002|Stable Dose|Lost to Follow-up|0|||
163924110|NCT03030599|592092587|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
163828756|NCT00662857|591741510|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
163828757|NCT00662857|591741511|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
163828758|NCT00662857|591741510|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
163828759|NCT00662857|591741511|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
163828760|NCT03966053|591741512|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
163828761|NCT02832622|591741514|FG000|Overall Study|MPP not programmed|1259|||
163828762|NCT02832622|591741514|FG000|Overall Study|Withdrawal by Subject|123|||
163828763|NCT02832622|591741514|FG000|Overall Study|Death|119|||
163828764|NCT02832622|591741514|FG000|Overall Study|Unsuccessful CRT implant|93|||
163828765|NCT02832622|591741514|FG000|Overall Study|Lost to Follow-up|45|||
163828766|NCT02832622|591741514|FG000|Overall Study|Patient non-compliance|42|||
163828767|NCT02832622|591741514|FG000|Overall Study|Withdrawal by other reasons|25|||
163828768|NCT02832622|591741514|FG000|Overall Study|System explant|24|||
163828769|NCT02832622|591741514|FG000|Overall Study|Physician Decision|6|||
163828770|NCT00998400|591741515|FG000|Overall Study|Lack of interest/motivation|1|||
163828771|NCT00998400|591741516|FG001|Overall Study|Lack of interest/motivation|2|||
163828772|NCT00998400|591741515|FG000|Overall Study|Logistical problems|1|||
163828773|NCT00998400|591741516|FG001|Overall Study|Logistical problems|0|||
163828774|NCT00800202|591741518|FG000|Overall Study|Adverse Event|7|||
163828775|NCT00800202|591741519|FG001|Overall Study|Adverse Event|6|||
163828776|NCT00800202|591741518|FG000|Overall Study|Death|1|||
163828777|NCT00800202|591741519|FG001|Overall Study|Death|0|||
163828778|NCT00800202|591741518|FG000|Overall Study|Other|5|||
163828779|NCT00800202|591741519|FG001|Overall Study|Other|0|||
163828780|NCT00800202|591741518|FG000|Overall Study|Disease Progression|54|||
163828781|NCT00800202|591741519|FG001|Overall Study|Disease Progression|18|||
163828782|NCT02691182|591741520|FG000|Overall Study|Withdrawal by Subject|4|||
163828783|NCT02691182|591741521|FG001|Overall Study|Withdrawal by Subject|7|||
163828784|NCT02691182|591741522|FG002|Overall Study|Withdrawal by Subject|6|||
163828785|NCT02691182|591741523|FG003|Overall Study|Withdrawal by Subject|8|||
163828786|NCT02691182|591741520|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
163828787|NCT02691182|591741521|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
163828788|NCT02691182|591741522|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
163828789|NCT02691182|591741523|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
163828790|NCT02691182|591741520|FG000|Overall Study|Lost to Follow-up|8|||
163828791|NCT02691182|591741521|FG001|Overall Study|Lost to Follow-up|33|||
163828792|NCT02691182|591741522|FG002|Overall Study|Lost to Follow-up|19|||
163828793|NCT02691182|591741523|FG003|Overall Study|Lost to Follow-up|22|||
163828794|NCT02691182|591741520|FG000|Overall Study|Adverse Event|3|||
163828795|NCT02691182|591741521|FG001|Overall Study|Adverse Event|10|||
163828796|NCT02691182|591741522|FG002|Overall Study|Adverse Event|10|||
163828797|NCT02691182|591741523|FG003|Overall Study|Adverse Event|11|||
163828798|NCT02691182|591741520|FG000|Overall Study|Physician Decision|3|||
163828799|NCT02691182|591741521|FG001|Overall Study|Physician Decision|7|||
163828800|NCT02691182|591741522|FG002|Overall Study|Physician Decision|14|||
163828801|NCT02691182|591741523|FG003|Overall Study|Physician Decision|8|||
163828802|NCT02691182|591741520|FG000|Overall Study|Lack of Efficacy|0|||
163828803|NCT02691182|591741521|FG001|Overall Study|Lack of Efficacy|0|||
163828804|NCT02691182|591741522|FG002|Overall Study|Lack of Efficacy|0|||
163828805|NCT02691182|591741523|FG003|Overall Study|Lack of Efficacy|4|||
163828806|NCT02691182|591741520|FG000|Overall Study|Protocol Violation|2|||
163828807|NCT02691182|591741521|FG001|Overall Study|Protocol Violation|6|||
163828808|NCT02691182|591741522|FG002|Overall Study|Protocol Violation|6|||
163828809|NCT02691182|591741523|FG003|Overall Study|Protocol Violation|8|||
163828810|NCT02691182|591741520|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
163828811|NCT02691182|591741521|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
163828812|NCT02691182|591741522|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
163828813|NCT02691182|591741523|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
163828814|NCT02691182|591741520|FG000|Overall Study|Missing|0|||
163828815|NCT02691182|591741521|FG001|Overall Study|Missing|5|||
163828816|NCT02691182|591741522|FG002|Overall Study|Missing|1|||
163828817|NCT02691182|591741523|FG003|Overall Study|Missing|5|||
163828818|NCT00105235|591741524|FG000|Overall Study|Death|4|||
163828819|NCT00105235|591741524|FG000|Overall Study|Physician Decision|1|||
163828820|NCT00105235|591741524|FG000|Overall Study|Withdrawal by Subject|2|||
163828821|NCT02052310|591741525|FG000|Overall Study|Death|64|||
163828822|NCT02052310|591741526|FG001|Overall Study|Death|54|||
163828823|NCT02052310|591741525|FG000|Overall Study|Withdrawal by Subject|37|||
163828824|NCT02052310|591741526|FG001|Overall Study|Withdrawal by Subject|49|||
163828825|NCT02052310|591741525|FG000|Overall Study|Other than specified|32|||
163828826|NCT02052310|591741526|FG001|Overall Study|Other than specified|29|||
163828827|NCT02052310|591741525|FG000|Overall Study|Adverse Event|29|||
163828828|NCT02052310|591741526|FG001|Overall Study|Adverse Event|22|||
163828829|NCT02052310|591741525|FG000|Overall Study|Kidney Transplant|23|||
163828830|NCT02052310|591741526|FG001|Overall Study|Kidney Transplant|29|||
163828831|NCT02052310|591741525|FG000|Overall Study|Physician Decision|14|||
163828832|NCT02052310|591741526|FG001|Overall Study|Physician Decision|7|||
163828833|NCT02052310|591741525|FG000|Overall Study|Lack of Efficacy|6|||
163828834|NCT02052310|591741526|FG001|Overall Study|Lack of Efficacy|1|||
163828835|NCT02052310|591741525|FG000|Overall Study|Site Terminated by Sponsor|5|||
163828836|NCT02052310|591741526|FG001|Overall Study|Site Terminated by Sponsor|13|||
163828837|NCT02052310|591741525|FG000|Overall Study|Lost to Follow-up|4|||
163828838|NCT02052310|591741526|FG001|Overall Study|Lost to Follow-up|2|||
163828839|NCT02052310|591741525|FG000|Overall Study|Protocol Violation|1|||
163828840|NCT02052310|591741526|FG001|Overall Study|Protocol Violation|6|||
163828841|NCT01964326|591741527|FG000|Overall Study|Adverse Event|48|||
163828842|NCT01964326|591741527|FG000|Overall Study|Death|2|||
163828843|NCT01964326|591741527|FG000|Overall Study|Protocol Violation|4|||
163828844|NCT01964326|591741527|FG000|Overall Study|Lost to Follow-up|88|||
163828845|NCT01964326|591741527|FG000|Overall Study|Withdrawal by Subject|87|||
163828846|NCT01964326|591741527|FG000|Overall Study|Pregnancy|1|||
163828847|NCT01964326|591741527|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
163828848|NCT01964326|591741527|FG000|Overall Study|Physician Decision|55|||
163828849|NCT01964326|591741527|FG000|Overall Study|Investigator Discretion|1|||
163828850|NCT01964326|591741527|FG000|Overall Study|Other|9|||
163828851|NCT01964326|591741527|FG000|Overall Study|Did not meet eligibility criteria|1|||
163828852|NCT02563002|591741530|FG000|Overall Study|Death|72|||
163828853|NCT02563002|591741531|FG001|Overall Study|Death|87|||
163828854|NCT02563002|591741530|FG000|Overall Study|Lost to Follow-up|5|||
163828855|NCT02563002|591741531|FG001|Overall Study|Lost to Follow-up|0|||
163828856|NCT02563002|591741530|FG000|Overall Study|Physician Decision|0|||
163828857|NCT02563002|591741531|FG001|Overall Study|Physician Decision|2|||
163828858|NCT02563002|591741530|FG000|Overall Study|Withdrawal by Subject|2|||
163828859|NCT02563002|591741531|FG001|Overall Study|Withdrawal by Subject|10|||
163828860|NCT02563002|591741530|FG000|Overall Study|Sponsor decision|74|||
163828861|NCT02563002|591741531|FG001|Overall Study|Sponsor decision|55|||
163828862|NCT03518125|591741532|FG000|Overall Study|Lost to Follow-up|0|||
163828863|NCT03518125|591741533|FG001|Overall Study|Lost to Follow-up|2|||
163828864|NCT03518125|591741534|FG002|Overall Study|Lost to Follow-up|0|||
163828865|NCT03518125|591741535|FG003|Overall Study|Lost to Follow-up|0|||
163828866|NCT03518125|591741536|FG004|Overall Study|Lost to Follow-up|3|||
163828867|NCT03518125|591741537|FG005|Overall Study|Lost to Follow-up|5|||
163828868|NCT03518125|591741532|FG000|Overall Study|Physician Decision|0|||
163828869|NCT03518125|591741533|FG001|Overall Study|Physician Decision|1|||
163828870|NCT03518125|591741534|FG002|Overall Study|Physician Decision|0|||
163828871|NCT03518125|591741535|FG003|Overall Study|Physician Decision|0|||
163828872|NCT03518125|591741536|FG004|Overall Study|Physician Decision|0|||
163828873|NCT03518125|591741537|FG005|Overall Study|Physician Decision|0|||
163828874|NCT03518125|591741532|FG000|Overall Study|Withdrawal by Subject|1|||
163828875|NCT03518125|591741533|FG001|Overall Study|Withdrawal by Subject|1|||
163828876|NCT03518125|591741534|FG002|Overall Study|Withdrawal by Subject|0|||
163828877|NCT03518125|591741535|FG003|Overall Study|Withdrawal by Subject|1|||
163828878|NCT03518125|591741536|FG004|Overall Study|Withdrawal by Subject|1|||
163828879|NCT03518125|591741537|FG005|Overall Study|Withdrawal by Subject|3|||
163828880|NCT03518125|591741532|FG000|Overall Study|Missed Day 394 Visit|1|||
163828881|NCT03518125|591741533|FG001|Overall Study|Missed Day 394 Visit|0|||
163828882|NCT03518125|591741534|FG002|Overall Study|Missed Day 394 Visit|0|||
163828883|NCT03518125|591741535|FG003|Overall Study|Missed Day 394 Visit|0|||
163828884|NCT03518125|591741536|FG004|Overall Study|Missed Day 394 Visit|0|||
163828885|NCT03518125|591741537|FG005|Overall Study|Missed Day 394 Visit|0|||
163828886|NCT02093663|591741542|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
163828887|NCT02093663|591741543|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163828888|NCT02093663|591741544|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163828889|NCT02093663|591741545|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163828890|NCT02093663|591741546|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
163828891|NCT02093663|591741542|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
163828892|NCT02093663|591741543|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828893|NCT02093663|591741544|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828894|NCT02093663|591741545|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828895|NCT02093663|591741546|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828896|NCT02093663|591741542|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
163828897|NCT02093663|591741543|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
163828898|NCT02093663|591741544|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
163828899|NCT02093663|591741545|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
163828900|NCT02093663|591741546|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
163828901|NCT02093663|591741542|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163828902|NCT02093663|591741543|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163828903|NCT02093663|591741544|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
163828904|NCT02093663|591741545|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163828905|NCT02093663|591741546|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
163828906|NCT02093663|591741542|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163924111|NCT03030599|592092588|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
163924112|NCT03030599|592092589|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
163924113|NCT03030599|592092587|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
163924114|NCT03030599|592092588|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
163924115|NCT03030599|592092589|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
163924116|NCT03030599|592092587|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
163924117|NCT03030599|592092588|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
163924118|NCT03030599|592092589|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
163924119|NCT03030599|592092587|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
163924120|NCT03030599|592092588|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
163924121|NCT03030599|592092589|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
163924122|NCT03030599|592092587|FG000|Open-label Extension|Adverse Event|3|||
163924123|NCT03030599|592092588|FG001|Open-label Extension|Adverse Event|0|||
163924124|NCT03030599|592092589|FG002|Open-label Extension|Adverse Event|0|||
163924125|NCT03030599|592092587|FG000|Open-label Extension|Lost to Follow-up|2|||
163924126|NCT03030599|592092588|FG001|Open-label Extension|Lost to Follow-up|0|||
163924127|NCT03030599|592092589|FG002|Open-label Extension|Lost to Follow-up|0|||
163924128|NCT03030599|592092587|FG000|Open-label Extension|Lack of Efficacy|1|||
163924129|NCT03030599|592092588|FG001|Open-label Extension|Lack of Efficacy|0|||
163924130|NCT03030599|592092589|FG002|Open-label Extension|Lack of Efficacy|0|||
163924131|NCT03030599|592092587|FG000|Open-label Extension|Other Reason|1|||
163924132|NCT03030599|592092588|FG001|Open-label Extension|Other Reason|0|||
163924133|NCT03030599|592092589|FG002|Open-label Extension|Other Reason|0|||
163924134|NCT00356759|592092590|FG000|Overall Study|Death|5|||
163924135|NCT00356759|592092591|FG001|Overall Study|Death|2|||
163924136|NCT00356759|592092590|FG000|Overall Study|Withdrawal by Subject|2|||
163924137|NCT00356759|592092591|FG001|Overall Study|Withdrawal by Subject|2|||
163924138|NCT00356759|592092590|FG000|Overall Study|Adverse Event|1|||
163924139|NCT00356759|592092591|FG001|Overall Study|Adverse Event|3|||
163924140|NCT00356759|592092590|FG000|Overall Study|Lost to Follow-up|1|||
163924141|NCT00356759|592092591|FG001|Overall Study|Lost to Follow-up|1|||
163924142|NCT00356759|592092590|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
163924143|NCT00356759|592092591|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
163924144|NCT01592383|592092592|FG000|Overall Study|Adverse Event|1|||
163924145|NCT04582864|592092593|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
163924146|NCT04582864|592092593|FG000|Overall Study|Death|1|||
163924147|NCT01064856|592092594|FG000|Double-blind (DB) Period|Adverse Event|1|||
163924148|NCT01064856|592092595|FG001|Double-blind (DB) Period|Adverse Event|0|||
163924149|NCT01064856|592092596|FG002|Double-blind (DB) Period|Adverse Event|0|||
163924150|NCT01064856|592092597|FG003|Double-blind (DB) Period|Adverse Event|0|||
163924151|NCT01064856|592092594|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
163924152|NCT01064856|592092595|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
163924153|NCT01064856|592092596|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
163924154|NCT01064856|592092597|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
163924155|NCT01064856|592092594|FG000|Open-label (OL) Period|Adverse Event|0|||
163924156|NCT01064856|592092595|FG001|Open-label (OL) Period|Adverse Event|0|||
163924157|NCT01064856|592092596|FG002|Open-label (OL) Period|Adverse Event|12|||
163924158|NCT01064856|592092597|FG003|Open-label (OL) Period|Adverse Event|6|||
163924159|NCT01064856|592092594|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
163924160|NCT01064856|592092595|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
163924161|NCT01064856|592092596|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
163924162|NCT01064856|592092597|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
163924163|NCT01064856|592092594|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
163924164|NCT01064856|592092595|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
163924165|NCT01064856|592092596|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
163924166|NCT01064856|592092597|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
163924167|NCT01064856|592092594|FG000|Open-label (OL) Period|Other|0|||
163924168|NCT01064856|592092595|FG001|Open-label (OL) Period|Other|0|||
163924169|NCT01064856|592092596|FG002|Open-label (OL) Period|Other|7|||
163924170|NCT01064856|592092597|FG003|Open-label (OL) Period|Other|7|||
163924171|NCT02133131|592092598|FG000|Overall Study|Adverse Event|0|||
163924172|NCT02133131|592092599|FG001|Overall Study|Adverse Event|0|||
163924173|NCT02133131|592092600|FG002|Overall Study|Adverse Event|0|||
163924174|NCT02133131|592092601|FG003|Overall Study|Adverse Event|1|||
163924175|NCT02133131|592092602|FG004|Overall Study|Adverse Event|0|||
163924176|NCT02133131|592092603|FG005|Overall Study|Adverse Event|0|||
163924177|NCT02133131|592092604|FG006|Overall Study|Adverse Event|0|||
163924178|NCT02133131|592092598|FG000|Overall Study|Lost to Follow-up|1|||
163924179|NCT02133131|592092599|FG001|Overall Study|Lost to Follow-up|0|||
163924180|NCT02133131|592092600|FG002|Overall Study|Lost to Follow-up|0|||
163924181|NCT02133131|592092601|FG003|Overall Study|Lost to Follow-up|1|||
163924182|NCT02133131|592092602|FG004|Overall Study|Lost to Follow-up|0|||
163924183|NCT02133131|592092603|FG005|Overall Study|Lost to Follow-up|0|||
163924184|NCT02133131|592092604|FG006|Overall Study|Lost to Follow-up|0|||
163924185|NCT02133131|592092598|FG000|Overall Study|Status not recorded|4|||
163924186|NCT02133131|592092599|FG001|Overall Study|Status not recorded|5|||
163924187|NCT02133131|592092600|FG002|Overall Study|Status not recorded|1|||
163924188|NCT02133131|592092601|FG003|Overall Study|Status not recorded|4|||
163924189|NCT02133131|592092602|FG004|Overall Study|Status not recorded|0|||
163924190|NCT02133131|592092603|FG005|Overall Study|Status not recorded|0|||
163924191|NCT02133131|592092604|FG006|Overall Study|Status not recorded|0|||
163924192|NCT02133131|592092598|FG000|Overall Study|Ongoing in study|0|||
163924193|NCT02133131|592092599|FG001|Overall Study|Ongoing in study|0|||
163924194|NCT02133131|592092600|FG002|Overall Study|Ongoing in study|0|||
163924195|NCT02133131|592092601|FG003|Overall Study|Ongoing in study|0|||
163924196|NCT02133131|592092602|FG004|Overall Study|Ongoing in study|15|||
163924197|NCT02133131|592092603|FG005|Overall Study|Ongoing in study|14|||
163924198|NCT02133131|592092604|FG006|Overall Study|Ongoing in study|11|||
163924199|NCT02133131|592092598|FG000|Overall Study|Protocol Violation|0|||
163924200|NCT02133131|592092599|FG001|Overall Study|Protocol Violation|0|||
163924201|NCT02133131|592092600|FG002|Overall Study|Protocol Violation|0|||
163924202|NCT02133131|592092601|FG003|Overall Study|Protocol Violation|0|||
163924203|NCT02133131|592092602|FG004|Overall Study|Protocol Violation|0|||
163924204|NCT02133131|592092603|FG005|Overall Study|Protocol Violation|0|||
163924205|NCT02133131|592092604|FG006|Overall Study|Protocol Violation|1|||
163924206|NCT01679613|592092607|FG000|Overall Study|other than stated above|0|||
163924207|NCT01679613|592092608|FG001|Overall Study|other than stated above|1|||
163924208|NCT01679613|592092609|FG002|Overall Study|other than stated above|2|||
163924209|NCT01679613|592092610|FG003|Overall Study|other than stated above|2|||
163924210|NCT00509925|592092612|FG000|Overall Study|Personal reasons|0|||
163924211|NCT00509925|592092613|FG001|Overall Study|Personal reasons|1|||
163924212|NCT02799745|592092616|FG000|Overall Study|Participant moved out of state|1|||
163924213|NCT02799745|592092617|FG001|Overall Study|Participant moved out of state|0|||
163924214|NCT02799745|592092616|FG000|Overall Study|Discontinued due to planned surgery|1|||
163924215|NCT02799745|592092617|FG001|Overall Study|Discontinued due to planned surgery|0|||
163924216|NCT02799745|592092616|FG000|Overall Study|Withdrawal by Subject|16|||
163924217|NCT02799745|592092617|FG001|Overall Study|Withdrawal by Subject|25|||
163924218|NCT02799745|592092616|FG000|Overall Study|Protocol Deviation|4|||
163924219|NCT02799745|592092617|FG001|Overall Study|Protocol Deviation|5|||
163924220|NCT02799745|592092616|FG000|Overall Study|Progressive Disease|28|||
163924221|NCT02799745|592092617|FG001|Overall Study|Progressive Disease|38|||
163924222|NCT02799745|592092616|FG000|Overall Study|Lost to Follow-up|3|||
163924223|NCT02799745|592092617|FG001|Overall Study|Lost to Follow-up|2|||
163924224|NCT02799745|592092616|FG000|Overall Study|Death|3|||
163924225|NCT02799745|592092617|FG001|Overall Study|Death|0|||
163924226|NCT02799745|592092616|FG000|Overall Study|Adverse Event|0|||
163924227|NCT02799745|592092617|FG001|Overall Study|Adverse Event|1|||
163924228|NCT02210208|592094285|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
163924229|NCT02210208|592094285|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
163924230|NCT02210208|592094285|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
163924231|NCT00695136|592094286|FG000|Overall Study|Withdrawal by Subject|1|||
163924232|NCT00695136|592094286|FG000|Overall Study|unrelated adverse event|1|||
163924233|NCT01333111|592094287|FG000|Overall Study|patient undergoing major surgery|0|||
163924234|NCT01333111|592094288|FG001|Overall Study|patient undergoing major surgery|2|||
163924235|NCT01333111|592094289|FG002|Overall Study|patient undergoing major surgery|0|||
163924236|NCT01333111|592094287|FG000|Overall Study|personal reasons|0|||
163924237|NCT01333111|592094288|FG001|Overall Study|personal reasons|0|||
163924238|NCT01333111|592094289|FG002|Overall Study|personal reasons|1|||
163924239|NCT01333111|592094287|FG000|Overall Study|unclassified|1|||
164033419|NCT01457924|592482185|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
164033420|NCT01457924|592482186|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
164033421|NCT01457924|592482187|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
164033422|NCT01457924|592482188|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
164033423|NCT01457924|592482189|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
164033424|NCT01457924|592482185|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
164033425|NCT01457924|592482186|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
163924240|NCT01333111|592094288|FG001|Overall Study|unclassified|0|||
163924241|NCT01333111|592094289|FG002|Overall Study|unclassified|0|||
163924242|NCT01333111|592094287|FG000|Overall Study|withdrawal criteria|0|||
163924243|NCT01333111|592094288|FG001|Overall Study|withdrawal criteria|1|||
163924244|NCT01333111|592094289|FG002|Overall Study|withdrawal criteria|0|||
163924245|NCT01333111|592094287|FG000|Overall Study|Non-compliance|1|||
163924246|NCT01333111|592094288|FG001|Overall Study|Non-compliance|0|||
163924247|NCT01333111|592094289|FG002|Overall Study|Non-compliance|0|||
163924248|NCT01333111|592094287|FG000|Overall Study|Ineffective therapy|0|||
163924249|NCT01333111|592094288|FG001|Overall Study|Ineffective therapy|0|||
163924250|NCT01333111|592094289|FG002|Overall Study|Ineffective therapy|1|||
163924251|NCT01929876|592094290|FG000|Period 2|Non-Compliance|1|||
163924252|NCT01468077|592094291|FG000|Overall Study|Adverse Event|2|||
163924253|NCT01468077|592094292|FG001|Overall Study|Adverse Event|2|||
163924254|NCT01468077|592094291|FG000|Overall Study|Lack of Efficacy|1|||
163924255|NCT01468077|592094292|FG001|Overall Study|Lack of Efficacy|1|||
163924256|NCT01468077|592094291|FG000|Overall Study|Physician Decision|1|||
163924257|NCT01468077|592094292|FG001|Overall Study|Physician Decision|0|||
163924258|NCT05446714|592094293|FG000|Overall Study|Lost to Follow-up|1|||
163924259|NCT05446714|592094294|FG001|Overall Study|Lost to Follow-up|3|||
163924260|NCT05446714|592094295|FG002|Overall Study|Lost to Follow-up|2|||
163924261|NCT05446714|592094293|FG000|Overall Study|Protocol Violation|2|||
163924262|NCT05446714|592094294|FG001|Overall Study|Protocol Violation|0|||
163924263|NCT05446714|592094295|FG002|Overall Study|Protocol Violation|0|||
163924264|NCT03024996|592094296|FG000|Overall Study|Death|57|||
163924265|NCT03024996|592094297|FG001|Overall Study|Death|55|||
163924266|NCT03024996|592094296|FG000|Overall Study|Disease relapse|1|||
163924267|NCT03024996|592094297|FG001|Overall Study|Disease relapse|0|||
163924268|NCT03024996|592094296|FG000|Overall Study|Lost to Follow-up|5|||
163924269|NCT03024996|592094297|FG001|Overall Study|Lost to Follow-up|10|||
163924270|NCT03024996|592094296|FG000|Overall Study|Other|3|||
163924271|NCT03024996|592094297|FG001|Overall Study|Other|3|||
163924272|NCT03024996|592094296|FG000|Overall Study|Physician Decision|0|||
163924273|NCT03024996|592094297|FG001|Overall Study|Physician Decision|1|||
163924274|NCT03024996|592094296|FG000|Overall Study|Study terminated by sponsor|303|||
163924275|NCT03024996|592094297|FG001|Overall Study|Study terminated by sponsor|283|||
163924276|NCT03024996|592094296|FG000|Overall Study|Withdrawal by Subject|21|||
163924277|NCT03024996|592094297|FG001|Overall Study|Withdrawal by Subject|36|||
163924278|NCT02418845|592094300|FG000|Overall Study|Lost to Follow-up|7|||
163924279|NCT02418845|592094301|FG001|Overall Study|Lost to Follow-up|2|||
163924280|NCT02418845|592094300|FG000|Overall Study|Lack of Efficacy|0|||
163924281|NCT02418845|592094301|FG001|Overall Study|Lack of Efficacy|3|||
163924282|NCT02418845|592094300|FG000|Overall Study|Physician Decision|5|||
163924283|NCT02418845|592094301|FG001|Overall Study|Physician Decision|5|||
163924284|NCT02418845|592094300|FG000|Overall Study|Protocol Violation|1|||
163924285|NCT02418845|592094301|FG001|Overall Study|Protocol Violation|0|||
163924286|NCT02418845|592094300|FG000|Overall Study|Withdrawal by Subject|3|||
163924287|NCT02418845|592094301|FG001|Overall Study|Withdrawal by Subject|2|||
163924288|NCT00478647|592094302|FG000|Overall Study|Adverse Event|1|||
163924289|NCT00478647|592094302|FG000|Overall Study|Withdrawal by Subject|1|||
163924290|NCT04333147|592094303|FG000|Overall Study|Adverse Event|43|||
163924291|NCT04333147|592094304|FG001|Overall Study|Adverse Event|40|||
163924292|NCT04333147|592094303|FG000|Overall Study|Lack of Efficacy|49|||
163924293|NCT04333147|592094304|FG001|Overall Study|Lack of Efficacy|48|||
163924294|NCT04333147|592094303|FG000|Overall Study|Lost to Follow-up|19|||
163924295|NCT04333147|592094304|FG001|Overall Study|Lost to Follow-up|16|||
163924296|NCT04333147|592094303|FG000|Overall Study|Physician Decision|17|||
163924297|NCT04333147|592094304|FG001|Overall Study|Physician Decision|20|||
163924298|NCT04333147|592094303|FG000|Overall Study|Withdrawal by Subject|65|||
163924299|NCT04333147|592094304|FG001|Overall Study|Withdrawal by Subject|68|||
163924300|NCT04333147|592094303|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
163924301|NCT04333147|592094304|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
163924302|NCT04333147|592094303|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
163924303|NCT04333147|592094304|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
163924304|NCT04333147|592094303|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
163924305|NCT04333147|592094304|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
163924306|NCT00487552|592094305|FG000|Overall Study|Unsuccessful magnet placements|3|||
163924307|NCT00487552|592094305|FG000|Overall Study|Death due to progressive malignancy|2|||
163924308|NCT00487552|592094305|FG000|Overall Study|Stent not placed|1|||
163924309|NCT03119688|592094306|FG000|Overall Study|Adverse Event|4|||
163924310|NCT00630552|592094307|FG000|Overall Study|Adverse Event|0|||
164033426|NCT01457924|592482187|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
164033427|NCT01457924|592482188|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
164033428|NCT01457924|592482189|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
164033429|NCT00936117|592482190|FG000|Overall Study|Adverse Event|7|||
164033430|NCT00936117|592482190|FG000|Overall Study|Unable to continue oral medication|3|||
163924311|NCT00630552|592094308|FG001|Overall Study|Adverse Event|1|||
163924312|NCT00630552|592094309|FG002|Overall Study|Adverse Event|5|||
163924313|NCT00630552|592094310|FG003|Overall Study|Adverse Event|4|||
163924314|NCT00630552|592094311|FG004|Overall Study|Adverse Event|2|||
163924315|NCT00630552|592094307|FG000|Overall Study|Disease progression|5|||
163924316|NCT00630552|592094308|FG001|Overall Study|Disease progression|6|||
163924317|NCT00630552|592094309|FG002|Overall Study|Disease progression|27|||
164033431|NCT04581863|592482191|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
163924318|NCT00630552|592094310|FG003|Overall Study|Disease progression|22|||
163924319|NCT00630552|592094311|FG004|Overall Study|Disease progression|31|||
163924320|NCT00630552|592094307|FG000|Overall Study|Never received IP|0|||
163924321|NCT00630552|592094308|FG001|Overall Study|Never received IP|0|||
163924322|NCT00630552|592094309|FG002|Overall Study|Never received IP|0|||
163924323|NCT00630552|592094310|FG003|Overall Study|Never received IP|2|||
163924324|NCT00630552|592094311|FG004|Overall Study|Never received IP|2|||
163924325|NCT00630552|592094307|FG000|Overall Study|Ineligibility determined|0|||
163924326|NCT00630552|592094308|FG001|Overall Study|Ineligibility determined|0|||
163924327|NCT00630552|592094309|FG002|Overall Study|Ineligibility determined|0|||
163924328|NCT00630552|592094310|FG003|Overall Study|Ineligibility determined|0|||
163924329|NCT00630552|592094311|FG004|Overall Study|Ineligibility determined|1|||
163924330|NCT00630552|592094307|FG000|Overall Study|Protocol Violation|0|||
163924331|NCT00630552|592094308|FG001|Overall Study|Protocol Violation|0|||
163924332|NCT00630552|592094309|FG002|Overall Study|Protocol Violation|0|||
163924333|NCT00630552|592094310|FG003|Overall Study|Protocol Violation|1|||
163924334|NCT00630552|592094311|FG004|Overall Study|Protocol Violation|0|||
163924335|NCT00630552|592094307|FG000|Overall Study|Physician Decision|0|||
163924336|NCT00630552|592094308|FG001|Overall Study|Physician Decision|0|||
163924337|NCT00630552|592094309|FG002|Overall Study|Physician Decision|0|||
163924338|NCT00630552|592094310|FG003|Overall Study|Physician Decision|0|||
163924339|NCT00630552|592094311|FG004|Overall Study|Physician Decision|1|||
163924340|NCT00630552|592094307|FG000|Overall Study|Death|0|||
163924341|NCT00630552|592094308|FG001|Overall Study|Death|0|||
163924342|NCT00630552|592094309|FG002|Overall Study|Death|1|||
163924343|NCT00630552|592094310|FG003|Overall Study|Death|2|||
163924344|NCT00630552|592094311|FG004|Overall Study|Death|2|||
163924345|NCT00630552|592094307|FG000|Overall Study|Withdrawal by Subject|0|||
163924346|NCT00630552|592094308|FG001|Overall Study|Withdrawal by Subject|0|||
163924347|NCT00630552|592094309|FG002|Overall Study|Withdrawal by Subject|0|||
163924348|NCT00630552|592094310|FG003|Overall Study|Withdrawal by Subject|1|||
163924349|NCT00630552|592094311|FG004|Overall Study|Withdrawal by Subject|0|||
163924350|NCT00630552|592094307|FG000|Overall Study|Other|0|||
163924351|NCT00630552|592094308|FG001|Overall Study|Other|0|||
163924352|NCT00630552|592094309|FG002|Overall Study|Other|4|||
163924353|NCT00630552|592094310|FG003|Overall Study|Other|2|||
163924354|NCT00630552|592094311|FG004|Overall Study|Other|0|||
163924355|NCT01084239|592094312|FG000|28-Day Follow-up|Lost to Follow-up|4|||
163924356|NCT01084239|592094313|FG001|28-Day Follow-up|Lost to Follow-up|9|||
163924357|NCT05006417|592094314|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
163924358|NCT02705625|592094315|FG000|Overall Study|Protocol Violation|1|||
163924359|NCT02705625|592094316|FG001|Overall Study|Protocol Violation|0|||
163924360|NCT02705625|592094317|FG002|Overall Study|Protocol Violation|0|||
163924361|NCT02705625|592094315|FG000|Overall Study|Adverse Event|6|||
163924362|NCT02705625|592094316|FG001|Overall Study|Adverse Event|5|||
163924363|NCT02705625|592094317|FG002|Overall Study|Adverse Event|2|||
163924364|NCT02705625|592094315|FG000|Overall Study|Death|0|||
163924365|NCT02705625|592094316|FG001|Overall Study|Death|0|||
163924366|NCT02705625|592094317|FG002|Overall Study|Death|1|||
163924367|NCT02705625|592094315|FG000|Overall Study|Withdrawal by Subject|1|||
164033432|NCT04581863|592482192|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
164033433|NCT00225212|592482201|FG000|Overall Study|Disease progression|2|||
164033434|NCT00225212|592482201|FG000|Overall Study|Death|1|||
164033435|NCT00225212|592482201|FG000|Overall Study|Adverse Event|2|||
164033436|NCT00225212|592482201|FG000|Overall Study|Intercurrent illness|1|||
164033437|NCT00574496|592482204|FG000|Overall Study|Withdrawal by Subject|1|||
164033438|NCT02486952|592482205|FG000|Overall Study|Not Started Induction Therapy|3|||
164033439|NCT02486952|592482205|FG000|Overall Study|Adverse Event|1|||
164033440|NCT02486952|592482205|FG000|Overall Study|Death|15|||
164033441|NCT02486952|592482205|FG000|Overall Study|Lack of Efficacy|3|||
164033442|NCT02486952|592482205|FG000|Overall Study|Lost to Follow-up|26|||
164033443|NCT02486952|592482205|FG000|Overall Study|Other|2|||
163924368|NCT02705625|592094316|FG001|Overall Study|Withdrawal by Subject|4|||
163924369|NCT02705625|592094317|FG002|Overall Study|Withdrawal by Subject|5|||
163924370|NCT02705625|592094315|FG000|Overall Study|Lost to Follow-up|0|||
164033444|NCT03589885|592482206|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
164033445|NCT03589885|592482207|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
164033446|NCT03589885|592482208|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
164033447|NCT03589885|592482209|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
164033448|NCT03589885|592482210|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
163924371|NCT02705625|592094316|FG001|Overall Study|Lost to Follow-up|0|||
164033449|NCT03589885|592482206|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163924372|NCT02705625|592094317|FG002|Overall Study|Lost to Follow-up|1|||
163924373|NCT02705625|592094315|FG000|Overall Study|Non-compliance|0|||
163924374|NCT02705625|592094316|FG001|Overall Study|Non-compliance|1|||
163924375|NCT02705625|592094317|FG002|Overall Study|Non-compliance|1|||
163924376|NCT02705625|592094315|FG000|Overall Study|Overdosing|0|||
163924377|NCT02705625|592094316|FG001|Overall Study|Overdosing|0|||
164033450|NCT03589885|592482207|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163924378|NCT02705625|592094317|FG002|Overall Study|Overdosing|1|||
163924379|NCT00863798|592094318|FG000|Overall Study|Adverse Event|5|||
164033451|NCT03589885|592482208|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
163924380|NCT00863798|592094319|FG001|Overall Study|Adverse Event|2|||
163924381|NCT00863798|592094320|FG002|Overall Study|Adverse Event|4|||
163924382|NCT00863798|592094318|FG000|Overall Study|Participant failed to return|2|||
163924383|NCT00863798|592094319|FG001|Overall Study|Participant failed to return|1|||
163828907|NCT02093663|591741543|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828908|NCT02093663|591741544|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
163828909|NCT02093663|591741545|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828910|NCT02093663|591741546|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
163828911|NCT02093663|591741542|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
163828912|NCT02093663|591741543|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
163828913|NCT02093663|591741544|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
163828914|NCT02093663|591741545|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
163828915|NCT02093663|591741546|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
163828916|NCT02093663|591741542|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
163828917|NCT02093663|591741543|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
163828918|NCT02093663|591741544|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
163828919|NCT02093663|591741545|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
163828920|NCT02093663|591741546|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
163828921|NCT02093663|591741542|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
163828922|NCT02093663|591741543|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
163828923|NCT02093663|591741544|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
163828924|NCT02093663|591741545|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
163828925|NCT02093663|591741546|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
163828926|NCT02093663|591741542|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163828927|NCT02093663|591741543|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163828928|NCT02093663|591741544|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163828929|NCT02093663|591741545|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
163828930|NCT02093663|591741546|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
163828931|NCT00508404|591741547|FG000|Overall Study|Ongoing at Data Cut-off|12|||
163828932|NCT00508404|591741547|FG000|Overall Study|Adverse Event|2|||
163828933|NCT00508404|591741547|FG000|Overall Study|Death|16|||
163828934|NCT00508404|591741547|FG000|Overall Study|Physician Decision|2|||
163828935|NCT00508404|591741547|FG000|Overall Study|Withdrawal by Subject|3|||
163828936|NCT00508404|591741547|FG000|Overall Study|Protocol-specified Criteria|2|||
163828937|NCT00508404|591741547|FG000|Overall Study|Lost to Follow-up|2|||
163828938|NCT00508404|591741547|FG000|Overall Study|Other - Not Specified|3|||
163828939|NCT05453110|591741548|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
163828940|NCT05453110|591741549|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
163828941|NCT05453110|591741550|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
163828942|NCT01505387|591741551|FG000|Overall Study|Protocol Violation|1|||
163828943|NCT01505387|591741552|FG001|Overall Study|Protocol Violation|0|||
163828944|NCT01505387|591741551|FG000|Overall Study|Withdrawal by Subject|1|||
163828945|NCT01505387|591741552|FG001|Overall Study|Withdrawal by Subject|1|||
163828946|NCT01197508|591741553|FG000|Overall Study|Withdrawal by Subject|8|||
163828947|NCT01197508|591741554|FG001|Overall Study|Withdrawal by Subject|7|||
163828948|NCT01197508|591741555|FG002|Overall Study|Withdrawal by Subject|15|||
163828949|NCT01197508|591741556|FG003|Overall Study|Withdrawal by Subject|4|||
163828950|NCT01197508|591741553|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
163828951|NCT01197508|591741554|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
163828952|NCT01197508|591741555|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
163828953|NCT01197508|591741556|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
163828954|NCT01197508|591741553|FG000|Overall Study|Adverse Event|10|||
163828955|NCT01197508|591741554|FG001|Overall Study|Adverse Event|13|||
163828956|NCT01197508|591741555|FG002|Overall Study|Adverse Event|23|||
163828957|NCT01197508|591741556|FG003|Overall Study|Adverse Event|3|||
163828958|NCT01197508|591741553|FG000|Overall Study|Severe non-compliance to protocol|0|||
163828959|NCT01197508|591741554|FG001|Overall Study|Severe non-compliance to protocol|3|||
163828960|NCT01197508|591741555|FG002|Overall Study|Severe non-compliance to protocol|1|||
163828961|NCT01197508|591741556|FG003|Overall Study|Severe non-compliance to protocol|3|||
163828962|NCT01197508|591741553|FG000|Overall Study|Condition under investigation worsened|1|||
163828963|NCT01197508|591741554|FG001|Overall Study|Condition under investigation worsened|1|||
163828964|NCT01197508|591741555|FG002|Overall Study|Condition under investigation worsened|1|||
163828965|NCT01197508|591741556|FG003|Overall Study|Condition under investigation worsened|1|||
163828966|NCT01197508|591741553|FG000|Overall Study|Lack of Efficacy|1|||
163828967|NCT01197508|591741554|FG001|Overall Study|Lack of Efficacy|2|||
163828968|NCT01197508|591741555|FG002|Overall Study|Lack of Efficacy|2|||
163828969|NCT01197508|591741556|FG003|Overall Study|Lack of Efficacy|1|||
163828970|NCT01197508|591741553|FG000|Overall Study|Study-specific withdrawal criteria|0|||
163828971|NCT01197508|591741554|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163828972|NCT01197508|591741555|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163828973|NCT01197508|591741556|FG003|Overall Study|Study-specific withdrawal criteria|2|||
163828974|NCT01197508|591741553|FG000|Overall Study|Lost to Follow-up|1|||
163828975|NCT01197508|591741554|FG001|Overall Study|Lost to Follow-up|1|||
164033452|NCT03589885|592482209|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163924384|NCT00863798|592094320|FG002|Overall Study|Participant failed to return|0|||
163924385|NCT00863798|592094318|FG000|Overall Study|Investigator request|1|||
163924386|NCT00863798|592094319|FG001|Overall Study|Investigator request|2|||
163924387|NCT00863798|592094320|FG002|Overall Study|Investigator request|1|||
163924388|NCT00863798|592094318|FG000|Overall Study|Lack of Efficacy|4|||
163924389|NCT00863798|592094319|FG001|Overall Study|Lack of Efficacy|3|||
163924390|NCT00863798|592094320|FG002|Overall Study|Lack of Efficacy|6|||
163924391|NCT00863798|592094318|FG000|Overall Study|Lost to Follow-up|6|||
163924392|NCT00863798|592094319|FG001|Overall Study|Lost to Follow-up|9|||
163924393|NCT00863798|592094320|FG002|Overall Study|Lost to Follow-up|5|||
163924394|NCT00863798|592094318|FG000|Overall Study|Other|2|||
163924395|NCT00863798|592094319|FG001|Overall Study|Other|3|||
163924396|NCT00863798|592094320|FG002|Overall Study|Other|1|||
163924397|NCT00863798|592094318|FG000|Overall Study|Protocol Violation|0|||
163924398|NCT00863798|592094319|FG001|Overall Study|Protocol Violation|1|||
163924399|NCT00863798|592094320|FG002|Overall Study|Protocol Violation|1|||
163924400|NCT00863798|592094318|FG000|Overall Study|Withdrawal by Subject|8|||
163924401|NCT00863798|592094319|FG001|Overall Study|Withdrawal by Subject|7|||
163924402|NCT00863798|592094320|FG002|Overall Study|Withdrawal by Subject|4|||
163924403|NCT00863798|592094318|FG000|Overall Study|Randomized not treated|4|||
163924404|NCT00863798|592094319|FG001|Overall Study|Randomized not treated|2|||
163924405|NCT00863798|592094320|FG002|Overall Study|Randomized not treated|3|||
163924406|NCT04238520|592094321|FG000|Overall Study|Withdrawal by Subject|1|||
163924407|NCT04238520|592094322|FG001|Overall Study|Withdrawal by Subject|1|||
163924408|NCT04238520|592094321|FG000|Overall Study|Lost to Follow-up|1|||
163924409|NCT04238520|592094322|FG001|Overall Study|Lost to Follow-up|2|||
163924410|NCT04238520|592094321|FG000|Overall Study|Death|0|||
163924411|NCT04238520|592094322|FG001|Overall Study|Death|2|||
163924412|NCT04238520|592094321|FG000|Overall Study|Unsafe home environment for research staff|0|||
163924413|NCT04238520|592094322|FG001|Overall Study|Unsafe home environment for research staff|1|||
163924414|NCT01470599|592094323|FG000|Overall Study|Did not meet entrance criteria|1|||
163924415|NCT01470599|592094324|FG001|Overall Study|Did not meet entrance criteria|0|||
163924416|NCT01470599|592094323|FG000|Overall Study|Lost to Follow-up|2|||
163924417|NCT01470599|592094324|FG001|Overall Study|Lost to Follow-up|1|||
163924418|NCT01470599|592094323|FG000|Overall Study|Withdrawal by Subject|3|||
163924419|NCT01470599|592094324|FG001|Overall Study|Withdrawal by Subject|4|||
163924420|NCT01470599|592094323|FG000|Overall Study|Other|1|||
163924421|NCT01470599|592094324|FG001|Overall Study|Other|0|||
163924422|NCT01470599|592094323|FG000|Overall Study|Protocol Violation|3|||
163924423|NCT01470599|592094324|FG001|Overall Study|Protocol Violation|1|||
163924424|NCT01470599|592094323|FG000|Overall Study|Adverse event related to study drug|2|||
163924425|NCT01470599|592094324|FG001|Overall Study|Adverse event related to study drug|5|||
163924426|NCT01470599|592094323|FG000|Overall Study|Insufficient clinical response|6|||
163924427|NCT01470599|592094324|FG001|Overall Study|Insufficient clinical response|27|||
163924428|NCT01470599|592094323|FG000|Overall Study|Adverse event not related to study drug|1|||
163924429|NCT01470599|592094324|FG001|Overall Study|Adverse event not related to study drug|5|||
163924430|NCT00195442|592094325|FG000|Overall Study|Less than expected therapeutic effect|38|||
163924431|NCT00195442|592094325|FG000|Overall Study|Lost to Follow-up|27|||
163924432|NCT00195442|592094325|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
163924433|NCT00195442|592094325|FG000|Overall Study|Intermittent product shortage|21|||
163924434|NCT00195442|592094325|FG000|Overall Study|Death|7|||
163924435|NCT00195442|592094325|FG000|Overall Study|No reason specified|4|||
163924436|NCT00195442|592094325|FG000|Overall Study|Poor cooperation|2|||
163924437|NCT00195442|592094325|FG000|Overall Study|Other|14|||
163924438|NCT01917006|592094326|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
163924439|NCT01917006|592094327|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
163924440|NCT01917006|592094328|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
163924441|NCT01917006|592094329|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
163924442|NCT01917006|592094330|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
163924443|NCT01917006|592094331|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
163924444|NCT01917006|592094332|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
163924445|NCT01917006|592094333|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
163924446|NCT01917006|592094326|FG000|Randomized-treatment Period|Personal Reasons|0|||
163924447|NCT01917006|592094327|FG001|Randomized-treatment Period|Personal Reasons|0|||
163924448|NCT01917006|592094328|FG002|Randomized-treatment Period|Personal Reasons|0|||
163924449|NCT01917006|592094329|FG003|Randomized-treatment Period|Personal Reasons|0|||
163924450|NCT01917006|592094330|FG004|Randomized-treatment Period|Personal Reasons|0|||
163924451|NCT01917006|592094331|FG005|Randomized-treatment Period|Personal Reasons|1|||
163924452|NCT01917006|592094332|FG006|Randomized-treatment Period|Personal Reasons|0|||
163924453|NCT01917006|592094333|FG007|Randomized-treatment Period|Personal Reasons|0|||
163924454|NCT01917006|592094326|FG000|Randomized-treatment Period|Protocol Violation|1|||
163924455|NCT01917006|592094327|FG001|Randomized-treatment Period|Protocol Violation|0|||
163924456|NCT01917006|592094328|FG002|Randomized-treatment Period|Protocol Violation|0|||
163924457|NCT01917006|592094329|FG003|Randomized-treatment Period|Protocol Violation|0|||
163924458|NCT01917006|592094330|FG004|Randomized-treatment Period|Protocol Violation|0|||
163924459|NCT01917006|592094331|FG005|Randomized-treatment Period|Protocol Violation|0|||
163924460|NCT01917006|592094332|FG006|Randomized-treatment Period|Protocol Violation|0|||
163924461|NCT01917006|592094333|FG007|Randomized-treatment Period|Protocol Violation|0|||
163924462|NCT01917006|592094326|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924463|NCT01917006|592094327|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924464|NCT01917006|592094328|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924465|NCT01917006|592094329|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924466|NCT01917006|592094330|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924467|NCT01917006|592094331|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924468|NCT01917006|592094332|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
163924469|NCT01917006|592094333|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
163924470|NCT01917006|592094326|FG000|Open-label Period|Adverse Event|0|||
163924471|NCT01917006|592094327|FG001|Open-label Period|Adverse Event|0|||
163924472|NCT01917006|592094328|FG002|Open-label Period|Adverse Event|0|||
163924473|NCT01917006|592094329|FG003|Open-label Period|Adverse Event|0|||
163924474|NCT01917006|592094330|FG004|Open-label Period|Adverse Event|0|||
163924475|NCT01917006|592094331|FG005|Open-label Period|Adverse Event|0|||
163924476|NCT01917006|592094332|FG006|Open-label Period|Adverse Event|0|||
163924477|NCT01917006|592094333|FG007|Open-label Period|Adverse Event|1|||
163924478|NCT01917006|592094326|FG000|Open-label Period|Lost to Follow-up|0|||
163924479|NCT01917006|592094327|FG001|Open-label Period|Lost to Follow-up|0|||
163924480|NCT01917006|592094328|FG002|Open-label Period|Lost to Follow-up|0|||
163924481|NCT01917006|592094329|FG003|Open-label Period|Lost to Follow-up|0|||
163924482|NCT01917006|592094330|FG004|Open-label Period|Lost to Follow-up|0|||
163924483|NCT01917006|592094331|FG005|Open-label Period|Lost to Follow-up|0|||
163924484|NCT01917006|592094332|FG006|Open-label Period|Lost to Follow-up|0|||
163924485|NCT01917006|592094333|FG007|Open-label Period|Lost to Follow-up|1|||
163924486|NCT02158247|592094334|FG000|Overall Study|Invisible vocal cords|5|||
163924487|NCT01057251|592094336|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
163924488|NCT01057251|592094337|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
163924489|NCT01057251|592094336|FG000|Overall Study|Adverse Event|4|||
163924490|NCT01057251|592094337|FG001|Overall Study|Adverse Event|2|||
163924491|NCT01057251|592094336|FG000|Overall Study|Lack of Efficacy|2|||
163924492|NCT01057251|592094337|FG001|Overall Study|Lack of Efficacy|11|||
163924493|NCT01057251|592094336|FG000|Overall Study|Protocol Violation|6|||
163924494|NCT01057251|592094337|FG001|Overall Study|Protocol Violation|2|||
163924495|NCT01057251|592094336|FG000|Overall Study|Withdrawal by Subject|4|||
163924496|NCT01057251|592094337|FG001|Overall Study|Withdrawal by Subject|5|||
163924497|NCT01057251|592094336|FG000|Overall Study|Lost to Follow-up|7|||
163924498|NCT01057251|592094337|FG001|Overall Study|Lost to Follow-up|6|||
163924499|NCT01057251|592094336|FG000|Overall Study|Other Reason|1|||
163924500|NCT01057251|592094337|FG001|Overall Study|Other Reason|1|||
163924501|NCT02509312|592094338|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
163924502|NCT02509312|592094339|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
163924503|NCT02509312|592094338|FG000|Overall Study|Obstetrician refusal|0|||
163924504|NCT02509312|592094339|FG001|Overall Study|Obstetrician refusal|1|||
163924505|NCT02509312|592094338|FG000|Overall Study|Patient elected for TOLAC|1|||
163924506|NCT02509312|592094339|FG001|Overall Study|Patient elected for TOLAC|0|||
163924507|NCT02509312|592094338|FG000|Overall Study|Cesarean deemed stat|1|||
163924508|NCT02509312|592094339|FG001|Overall Study|Cesarean deemed stat|0|||
163924509|NCT02509312|592094338|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
164033453|NCT03589885|592482210|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
163924510|NCT02509312|592094339|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
163924511|NCT04544865|592094340|FG000|Overall Study|Death|0|||
163924512|NCT04544865|592094341|FG001|Overall Study|Death|2|||
163924513|NCT04544865|592094340|FG000|Overall Study|Lost to Follow-up|11|||
163924514|NCT04544865|592094341|FG001|Overall Study|Lost to Follow-up|7|||
163924515|NCT04544865|592094340|FG000|Overall Study|Withdrawal by Subject|0|||
163924516|NCT04544865|592094341|FG001|Overall Study|Withdrawal by Subject|1|||
163924517|NCT04544865|592094340|FG000|Overall Study|Other|0|||
163924518|NCT04544865|592094341|FG001|Overall Study|Other|1|||
163924519|NCT03357471|592094342|FG000|Overall Study|Adverse Event|1|||
163924520|NCT03357471|592094343|FG001|Overall Study|Adverse Event|0|||
163924521|NCT03357471|592094342|FG000|Overall Study|Lost to Follow-up|1|||
163924522|NCT03357471|592094343|FG001|Overall Study|Lost to Follow-up|0|||
163924523|NCT01202409|592094345|FG000|Overall Study|Adverse Event|1|||
163924524|NCT01202409|592094345|FG000|Overall Study|Ineligible - KRAS mutants|7|||
163924525|NCT01732926|592094348|FG000|Overall Study|Study Terminated by Sponsor|168|||
163924526|NCT01732926|592094349|FG001|Overall Study|Study Terminated by Sponsor|80|||
163924527|NCT01732926|592094348|FG000|Overall Study|Withdrawal by Subject|46|||
163924528|NCT01732926|592094349|FG001|Overall Study|Withdrawal by Subject|8|||
163924529|NCT01732926|592094348|FG000|Overall Study|Physician Decision|24|||
163924530|NCT01732926|592094349|FG001|Overall Study|Physician Decision|11|||
163924531|NCT01732926|592094348|FG000|Overall Study|Other Reason|21|||
163924532|NCT01732926|592094349|FG001|Overall Study|Other Reason|4|||
163924533|NCT01732926|592094348|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
163924534|NCT01732926|592094349|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
163924535|NCT01732926|592094348|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
163924536|NCT01732926|592094349|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
163924537|NCT00496626|592094354|FG000|Overall Study|Lost to Follow-up|0|||
163924538|NCT00496626|592094355|FG001|Overall Study|Lost to Follow-up|1|||
163924539|NCT00496626|592094354|FG000|Overall Study|Protocol Violation|1|||
163924540|NCT00496626|592094355|FG001|Overall Study|Protocol Violation|0|||
163924541|NCT00496626|592094354|FG000|Overall Study|Withdrawal by Subject|5|||
163924542|NCT00496626|592094355|FG001|Overall Study|Withdrawal by Subject|4|||
163924543|NCT00496626|592094354|FG000|Overall Study|Relocated|0|||
163924544|NCT00496626|592094355|FG001|Overall Study|Relocated|1|||
163924545|NCT02482935|592094359|FG000|Period 1|Withdrawal by Subject|1|||
163924546|NCT02482935|592094360|FG001|Period 1|Withdrawal by Subject|0|||
163924547|NCT03503162|592094361|FG000|Overall Study|did not meet eligibility|1|||
163924548|NCT02835092|592094362|FG000|Overall Study|Withdrawal by Subject|3|||
163924549|NCT02835092|592094363|FG001|Overall Study|Withdrawal by Subject|6|||
163924550|NCT02835092|592094364|FG002|Overall Study|Withdrawal by Subject|3|||
163924551|NCT02835092|592094362|FG000|Overall Study|Lost to Follow-up|0|||
163924552|NCT02835092|592094363|FG001|Overall Study|Lost to Follow-up|2|||
163924553|NCT02835092|592094364|FG002|Overall Study|Lost to Follow-up|0|||
163924554|NCT00025506|592094365|FG000|Overall Study|Ineligible: clerical error|1|||
163924555|NCT00025506|592094365|FG000|Overall Study|Ineligible: wrong cell type|5|||
163924556|NCT00025506|592094365|FG000|Overall Study|Ineligible: inadequate pathology|2|||
163924557|NCT00025506|592094365|FG000|Overall Study|Never Treated|2|||
163924558|NCT00394589|592094370|FG000|Overall Study|Adverse Event|2|||
163924559|NCT00394589|592094371|FG001|Overall Study|Adverse Event|1|||
163924560|NCT00394589|592094372|FG002|Overall Study|Adverse Event|2|||
163924561|NCT00394589|592094370|FG000|Overall Study|Lack of Efficacy|2|||
163924562|NCT00394589|592094371|FG001|Overall Study|Lack of Efficacy|2|||
163924563|NCT00394589|592094372|FG002|Overall Study|Lack of Efficacy|3|||
163924564|NCT00394589|592094370|FG000|Overall Study|Protocol Violation|4|||
163924565|NCT00394589|592094371|FG001|Overall Study|Protocol Violation|0|||
163924566|NCT00394589|592094372|FG002|Overall Study|Protocol Violation|2|||
163924567|NCT01710800|592094380|FG000|Overall Study|Withdrawal by Subject|21|||
163924568|NCT01710800|592094380|FG000|Overall Study|Protocol Violation|1|||
163924569|NCT03891641|592094384|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
163924570|NCT03891641|592094385|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
163924571|NCT01585298|592094388|FG000|Overall Study|Study completion was not documented.|1|||
163924572|NCT01585298|592094388|FG000|Overall Study|Protocol deviation|1|||
163924573|NCT01585298|592094388|FG000|Overall Study|Administrative problems|4|||
163924574|NCT01585298|592094388|FG000|Overall Study|Lost to Follow-up|2|||
163924575|NCT01585298|592094388|FG000|Overall Study|Withdrawal by Subject|4|||
163924576|NCT01585298|592094388|FG000|Overall Study|Abnormal test procedure results|1|||
163924577|NCT01585298|592094388|FG000|Overall Study|Adverse Event|24|||
163924578|NCT01670188|592094389|FG000|Overall Study|Death|0|||
163924579|NCT01670188|592094390|FG001|Overall Study|Death|1|||
163924580|NCT02212301|592094391|FG000|Period 1|Lost to Follow-up|0|||
163924581|NCT02212301|592094392|FG001|Period 1|Lost to Follow-up|1|||
163924582|NCT02427958|592094397|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
163924583|NCT02427958|592094397|FG000|Overall Study|Lost to Follow-up|6|||
163924584|NCT02427958|592094397|FG000|Overall Study|Withdrawal by Subject|14|||
163924585|NCT02427958|592094397|FG000|Overall Study|Lack of Efficacy|1|||
163924586|NCT00578318|592094398|FG000|Overall Study|Lost to Follow-up|2|||
164033454|NCT03589885|592482206|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
163924587|NCT00578318|592094399|FG001|Overall Study|Lost to Follow-up|0|||
163924588|NCT00578318|592094398|FG000|Overall Study|Physician Decision|1|||
163924589|NCT00578318|592094399|FG001|Overall Study|Physician Decision|0|||
163924590|NCT02025985|592094400|FG000|Overall Study|Consent withdrawn|0|||
163924591|NCT02025985|592094401|FG001|Overall Study|Consent withdrawn|0|||
163924592|NCT02025985|592094402|FG002|Overall Study|Consent withdrawn|1|||
163924593|NCT02025985|592094403|FG003|Overall Study|Consent withdrawn|0|||
163924594|NCT02025985|592094404|FG004|Overall Study|Consent withdrawn|0|||
163924595|NCT02025985|592094400|FG000|Overall Study|Termination of study by Sponsor|4|||
163924596|NCT02025985|592094401|FG001|Overall Study|Termination of study by Sponsor|3|||
163924597|NCT02025985|592094402|FG002|Overall Study|Termination of study by Sponsor|1|||
163924598|NCT02025985|592094403|FG003|Overall Study|Termination of study by Sponsor|1|||
163924599|NCT02025985|592094404|FG004|Overall Study|Termination of study by Sponsor|3|||
163924600|NCT02025985|592094400|FG000|Overall Study|Death|21|||
163924601|NCT02025985|592094401|FG001|Overall Study|Death|20|||
163924602|NCT02025985|592094402|FG002|Overall Study|Death|23|||
163924603|NCT02025985|592094403|FG003|Overall Study|Death|20|||
163924604|NCT02025985|592094404|FG004|Overall Study|Death|17|||
163924605|NCT00001941|592094407|FG000|Overall Study|not treated- rapidly progressing disease|0|||
163924606|NCT00001941|592094408|FG001|Overall Study|not treated- rapidly progressing disease|0|||
163924607|NCT00001941|592094409|FG002|Overall Study|not treated- rapidly progressing disease|0|||
163924608|NCT00001941|592094410|FG003|Overall Study|not treated- rapidly progressing disease|0|||
163924609|NCT00001941|592094411|FG004|Overall Study|not treated- rapidly progressing disease|1|||
163924610|NCT03175198|592094412|FG000|Overall Study|Adverse Event|480|||
163924611|NCT03175198|592094412|FG000|Overall Study|No actual visit|120|||
163924612|NCT03175198|592094412|FG000|Overall Study|Registration rule not followed|4|||
163924613|NCT03175198|592094412|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
163924614|NCT03175198|592094412|FG000|Overall Study|Other personal reason|509|||
163924615|NCT03175198|592094412|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
163924616|NCT03175198|592094412|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
163924617|NCT03175198|592094412|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
163924618|NCT03175198|592094412|FG000|Overall Study|To conduct invasive treatment of operation|53|||
163924619|NCT03175198|592094412|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
163924620|NCT00545571|592094413|FG000|Overall Study|Administrative Reasons|1|||
163924621|NCT00545571|592094413|FG000|Overall Study|Adverse Event|2|||
163924622|NCT00545571|592094413|FG000|Overall Study|Death|5|||
163924623|NCT00545571|592094413|FG000|Overall Study|Lack of Efficacy|1|||
163924624|NCT00545571|592094413|FG000|Overall Study|Protocol Violation|2|||
163924625|NCT00545571|592094413|FG000|Overall Study|Refused Treatment|1|||
163924626|NCT00545571|592094413|FG000|Overall Study|Screen Failure|16|||
163924627|NCT00545571|592094413|FG000|Overall Study|Transfusion|12|||
163924628|NCT00545571|592094413|FG000|Overall Study|Early Termination of Study|24|||
163924629|NCT00545571|592094413|FG000|Overall Study|Kidney Transplantation|3|||
163924630|NCT00874497|592094414|FG000|Overall Study|Lost to Follow-up|2|||
163924631|NCT00874497|592094415|FG001|Overall Study|Lost to Follow-up|4|||
163924632|NCT00874497|592094414|FG000|Overall Study|Adverse Event|9|||
163924633|NCT00874497|592094415|FG001|Overall Study|Adverse Event|4|||
163924634|NCT00874497|592094414|FG000|Overall Study|Sponsor Discontinued Trial|7|||
163924635|NCT00874497|592094415|FG001|Overall Study|Sponsor Discontinued Trial|3|||
163924636|NCT00874497|592094414|FG000|Overall Study|Met Withdrawal Criteria|4|||
163924637|NCT00874497|592094415|FG001|Overall Study|Met Withdrawal Criteria|2|||
163924638|NCT00874497|592094414|FG000|Overall Study|Physician Decision|1|||
163924639|NCT00874497|592094415|FG001|Overall Study|Physician Decision|1|||
163924640|NCT00874497|592094414|FG000|Overall Study|Withdrawal by Subject|5|||
163924641|NCT00874497|592094415|FG001|Overall Study|Withdrawal by Subject|4|||
163924642|NCT01013740|592094416|FG000|Overall Study|Lost to Follow-up|3|||
163924643|NCT01013740|592094417|FG001|Overall Study|Lost to Follow-up|5|||
163924644|NCT01013740|592094416|FG000|Overall Study|Physician Decision|2|||
163924645|NCT01013740|592094417|FG001|Overall Study|Physician Decision|0|||
163924646|NCT01013740|592094416|FG000|Overall Study|Withdrawal by Subject|2|||
163924647|NCT01013740|592094417|FG001|Overall Study|Withdrawal by Subject|10|||
163924648|NCT01013740|592094416|FG000|Overall Study|study close / terminated : done in error|2|||
163924649|NCT01013740|592094417|FG001|Overall Study|study close / terminated : done in error|1|||
163924650|NCT01013740|592094416|FG000|Overall Study|Missing|2|||
163924651|NCT01013740|592094417|FG001|Overall Study|Missing|1|||
163924652|NCT01013740|592094416|FG000|Overall Study|Ongoing: Study records not completed|0|||
163924653|NCT01013740|592094417|FG001|Overall Study|Ongoing: Study records not completed|2|||
163924654|NCT00607997|592094418|FG000|Overall Study|Lack of Efficacy|6|||
163924655|NCT00607997|592094419|FG001|Overall Study|Lack of Efficacy|20|||
163924656|NCT00607997|592094420|FG002|Overall Study|Lack of Efficacy|14|||
163924657|NCT00607997|592094421|FG003|Overall Study|Lack of Efficacy|10|||
163924658|NCT00607997|592094418|FG000|Overall Study|Death|8|||
163924659|NCT00607997|592094419|FG001|Overall Study|Death|5|||
163924660|NCT00607997|592094420|FG002|Overall Study|Death|2|||
163924661|NCT00607997|592094421|FG003|Overall Study|Death|5|||
163924662|NCT00607997|592094418|FG000|Overall Study|Adverse Event|3|||
163924663|NCT00607997|592094419|FG001|Overall Study|Adverse Event|1|||
163924664|NCT00607997|592094420|FG002|Overall Study|Adverse Event|2|||
163924665|NCT00607997|592094421|FG003|Overall Study|Adverse Event|0|||
164033455|NCT03589885|592482207|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
164033456|NCT03589885|592482208|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164033457|NCT03589885|592482209|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164033458|NCT03589885|592482210|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
164033459|NCT03589885|592482206|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164033460|NCT03589885|592482207|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
163924666|NCT00607997|592094418|FG000|Overall Study|Physician Decision|4|||
163924667|NCT00607997|592094419|FG001|Overall Study|Physician Decision|1|||
163924668|NCT00607997|592094420|FG002|Overall Study|Physician Decision|0|||
163924669|NCT00607997|592094421|FG003|Overall Study|Physician Decision|0|||
163924670|NCT00607997|592094418|FG000|Overall Study|Relapse, recurrent illness|4|||
163924671|NCT00607997|592094419|FG001|Overall Study|Relapse, recurrent illness|0|||
163924672|NCT00607997|592094420|FG002|Overall Study|Relapse, recurrent illness|2|||
163924673|NCT00607997|592094421|FG003|Overall Study|Relapse, recurrent illness|0|||
163924674|NCT00607997|592094418|FG000|Overall Study|Other without explanation|2|||
163924675|NCT00607997|592094419|FG001|Overall Study|Other without explanation|0|||
163924676|NCT00607997|592094420|FG002|Overall Study|Other without explanation|4|||
163924677|NCT00607997|592094421|FG003|Overall Study|Other without explanation|1|||
163924678|NCT01527500|592094423|FG000|Part A|Administrative|11|||
164033461|NCT03589885|592482208|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
164033462|NCT03589885|592482209|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164033463|NCT03589885|592482210|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
164033464|NCT03589885|592482206|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
164033465|NCT03589885|592482207|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
164033466|NCT03589885|592482208|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
164033467|NCT03589885|592482209|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
164033468|NCT03589885|592482210|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
164033469|NCT03589885|592482206|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
164033470|NCT03589885|592482207|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
164033471|NCT03589885|592482208|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
164033472|NCT03589885|592482209|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
164033473|NCT03589885|592482210|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
164033474|NCT03589885|592482206|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
164033475|NCT03589885|592482207|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
164033476|NCT03589885|592482208|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
164033477|NCT03589885|592482209|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
164033478|NCT03589885|592482210|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
164033479|NCT03589885|592482206|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164033480|NCT03589885|592482207|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
164033481|NCT03589885|592482208|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164033482|NCT03589885|592482209|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164033483|NCT03589885|592482210|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
164033484|NCT04111107|592482211|FG000|Overall Study|Withdrawal by Subject|6|||
164033485|NCT04111107|592482211|FG000|Overall Study|Declining Health|5|||
164033486|NCT01928485|592482212|FG000|Overall Study|Physician Decision|0|||
164033487|NCT01928485|592482213|FG001|Overall Study|Physician Decision|1|||
164033488|NCT00039741|592482216|FG000|Overall Study|Death|0|||
164033489|NCT00039741|592482217|FG001|Overall Study|Death|1|||
164033490|NCT00039741|592482218|FG002|Overall Study|Death|0|||
164033491|NCT00039741|592482219|FG003|Overall Study|Death|0|||
164033492|NCT00039741|592482216|FG000|Overall Study|Lost to Follow-up|3|||
164033493|NCT00039741|592482217|FG001|Overall Study|Lost to Follow-up|1|||
164033494|NCT00039741|592482218|FG002|Overall Study|Lost to Follow-up|5|||
164033495|NCT00039741|592482219|FG003|Overall Study|Lost to Follow-up|2|||
164033496|NCT00039741|592482216|FG000|Overall Study|Confounding medical condition|1|||
164033497|NCT00039741|592482217|FG001|Overall Study|Confounding medical condition|0|||
164033498|NCT00039741|592482218|FG002|Overall Study|Confounding medical condition|0|||
164033499|NCT00039741|592482219|FG003|Overall Study|Confounding medical condition|0|||
164033500|NCT00039741|592482216|FG000|Overall Study|Not able to get to clinic|5|||
164033501|NCT00039741|592482217|FG001|Overall Study|Not able to get to clinic|2|||
164033502|NCT00039741|592482218|FG002|Overall Study|Not able to get to clinic|0|||
164033503|NCT00039741|592482219|FG003|Overall Study|Not able to get to clinic|3|||
164033504|NCT00039741|592482216|FG000|Overall Study|Moved|3|||
164033505|NCT00039741|592482217|FG001|Overall Study|Moved|2|||
164033506|NCT00039741|592482218|FG002|Overall Study|Moved|3|||
164033507|NCT00039741|592482219|FG003|Overall Study|Moved|6|||
164033508|NCT00039741|592482216|FG000|Overall Study|Non-compliance with protocol|1|||
164033509|NCT00039741|592482217|FG001|Overall Study|Non-compliance with protocol|0|||
164033510|NCT00039741|592482218|FG002|Overall Study|Non-compliance with protocol|1|||
164033511|NCT00039741|592482219|FG003|Overall Study|Non-compliance with protocol|0|||
164033512|NCT00039741|592482216|FG000|Overall Study|Withdrew consent|0|||
164033513|NCT00039741|592482217|FG001|Overall Study|Withdrew consent|5|||
164033514|NCT00039741|592482218|FG002|Overall Study|Withdrew consent|0|||
164033515|NCT00039741|592482219|FG003|Overall Study|Withdrew consent|1|||
164033516|NCT00039741|592482216|FG000|Overall Study|Missed final visit|2|||
164033517|NCT00039741|592482217|FG001|Overall Study|Missed final visit|1|||
164033518|NCT00039741|592482218|FG002|Overall Study|Missed final visit|2|||
164033519|NCT00039741|592482219|FG003|Overall Study|Missed final visit|2|||
164033520|NCT00946881|592482220|FG000|First Treatment|Withdrawal by Subject|1|||
164033521|NCT00946881|592482220|FG000|First Treatment|Patient relocated to another state|1|||
164033522|NCT00946881|592482220|FG000|Retreatment|Withdrawal by Subject|1|||
164033523|NCT00293423|592482221|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
164033524|NCT00293423|592482222|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
164033525|NCT00293423|592482221|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
164033526|NCT00293423|592482222|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
164033527|NCT00293423|592482221|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
164033528|NCT00293423|592482222|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
164033529|NCT00293423|592482221|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
164033530|NCT00293423|592482222|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
164033531|NCT00293423|592482221|FG000|Surgical Resection|processing error during surgical resection|1|||
164033532|NCT00293423|592482222|FG001|Surgical Resection|processing error during surgical resection|0|||
164033533|NCT00293423|592482221|FG000|Surgical Resection|Withdrawal by Subject|4|||
164033534|NCT00293423|592482222|FG001|Surgical Resection|Withdrawal by Subject|0|||
164033535|NCT00293423|592482221|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
164033536|NCT00293423|592482222|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
164033537|NCT03571256|592482227|FG000|Overall Study|Adverse Event|3|||
164033538|NCT03571256|592482228|FG001|Overall Study|Adverse Event|0|||
164033539|NCT03571256|592482229|FG002|Overall Study|Adverse Event|1|||
164033540|NCT03571256|592482227|FG000|Overall Study|Withdrawal by Subject|3|||
164033541|NCT03571256|592482228|FG001|Overall Study|Withdrawal by Subject|1|||
164033542|NCT03571256|592482229|FG002|Overall Study|Withdrawal by Subject|1|||
164033543|NCT03571256|592482227|FG000|Overall Study|Other than specified|0|||
164033544|NCT03571256|592482228|FG001|Overall Study|Other than specified|1|||
164033545|NCT03571256|592482229|FG002|Overall Study|Other than specified|1|||
164033546|NCT03571256|592482227|FG000|Overall Study|Protocol Violation|0|||
164033547|NCT03571256|592482228|FG001|Overall Study|Protocol Violation|1|||
164033548|NCT03571256|592482229|FG002|Overall Study|Protocol Violation|1|||
164033549|NCT02270684|592482230|FG000|Overall Study|Lost to Follow-up|0|||
164033550|NCT02270684|592482231|FG001|Overall Study|Lost to Follow-up|3|||
164033551|NCT02270684|592482230|FG000|Overall Study|Study terminated|1|||
164033552|NCT02270684|592482231|FG001|Overall Study|Study terminated|0|||
164033553|NCT02247401|592482232|FG000|Overall Study|Adverse Event|1|||
164033554|NCT02247401|592482233|FG001|Overall Study|Adverse Event|0|||
164033555|NCT02247401|592482234|FG002|Overall Study|Adverse Event|0|||
164033556|NCT02247401|592482232|FG000|Overall Study|Withdrawal by Subject|4|||
164033557|NCT02247401|592482233|FG001|Overall Study|Withdrawal by Subject|1|||
164033558|NCT02247401|592482234|FG002|Overall Study|Withdrawal by Subject|1|||
164033559|NCT02247401|592482232|FG000|Overall Study|Lost to Follow-up|1|||
164033560|NCT02247401|592482233|FG001|Overall Study|Lost to Follow-up|1|||
164033561|NCT02247401|592482234|FG002|Overall Study|Lost to Follow-up|1|||
164033562|NCT03498287|592482238|FG000|Overall Study|Withdrawal by Subject|3|||
164033563|NCT03498287|592482239|FG001|Overall Study|Withdrawal by Subject|0|||
164033564|NCT03498287|592482238|FG000|Overall Study|Protocol Violation|0|||
164033565|NCT03498287|592482239|FG001|Overall Study|Protocol Violation|4|||
164033566|NCT03498287|592482238|FG000|Overall Study|Adverse Event|0|||
164033567|NCT03498287|592482239|FG001|Overall Study|Adverse Event|1|||
164033568|NCT02807363|592482242|FG000|Dosing Period|Adverse Event|0|||
164033569|NCT02807363|592482243|FG001|Dosing Period|Adverse Event|1|||
164033570|NCT02807363|592482244|FG002|Dosing Period|Adverse Event|0|||
164033571|NCT02807363|592482245|FG003|Dosing Period|Adverse Event|0|||
164033572|NCT02188719|592482246|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
164033573|NCT02188719|592482247|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
164033574|NCT02188719|592482248|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
164033575|NCT02188719|592482249|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
164033576|NCT01763866|592482251|FG000|Overall Study|Withdrawal by Subject|2|||
164033577|NCT01763866|592482252|FG001|Overall Study|Withdrawal by Subject|1|||
164033578|NCT01763866|592482253|FG002|Overall Study|Withdrawal by Subject|4|||
164033579|NCT01763866|592482254|FG003|Overall Study|Withdrawal by Subject|0|||
164033580|NCT01763866|592482255|FG004|Overall Study|Withdrawal by Subject|0|||
164033581|NCT01763866|592482256|FG005|Overall Study|Withdrawal by Subject|3|||
164033582|NCT01763866|592482257|FG006|Overall Study|Withdrawal by Subject|4|||
164033583|NCT01763866|592482258|FG007|Overall Study|Withdrawal by Subject|0|||
164033584|NCT01763866|592482259|FG008|Overall Study|Withdrawal by Subject|1|||
164033585|NCT01763866|592482260|FG009|Overall Study|Withdrawal by Subject|1|||
164033586|NCT01763866|592482261|FG010|Overall Study|Withdrawal by Subject|2|||
164033587|NCT01763866|592482262|FG011|Overall Study|Withdrawal by Subject|2|||
164033588|NCT01763866|592482263|FG012|Overall Study|Withdrawal by Subject|2|||
164033589|NCT01763866|592482264|FG013|Overall Study|Withdrawal by Subject|0|||
164033590|NCT01763866|592482265|FG014|Overall Study|Withdrawal by Subject|6|||
164033591|NCT01763866|592482266|FG015|Overall Study|Withdrawal by Subject|3|||
164033592|NCT01763866|592482267|FG016|Overall Study|Withdrawal by Subject|0|||
164033593|NCT01763866|592482268|FG017|Overall Study|Withdrawal by Subject|1|||
164033594|NCT01763866|592482269|FG018|Overall Study|Withdrawal by Subject|1|||
164033595|NCT01763866|592482270|FG019|Overall Study|Withdrawal by Subject|1|||
163828976|NCT01197508|591741555|FG002|Overall Study|Lost to Follow-up|2|||
163828977|NCT01197508|591741556|FG003|Overall Study|Lost to Follow-up|0|||
163828978|NCT01197508|591741553|FG000|Overall Study|Other|2|||
163828979|NCT01197508|591741554|FG001|Overall Study|Other|3|||
164033596|NCT01763866|592482271|FG020|Overall Study|Withdrawal by Subject|2|||
164033597|NCT01763866|592482272|FG021|Overall Study|Withdrawal by Subject|1|||
164033598|NCT01763866|592482273|FG022|Overall Study|Withdrawal by Subject|2|||
164033599|NCT01763866|592482274|FG023|Overall Study|Withdrawal by Subject|1|||
163828980|NCT01197508|591741555|FG002|Overall Study|Other|2|||
164033600|NCT01763866|592482251|FG000|Overall Study|Decision by sponsor|0|||
164033601|NCT01763866|592482252|FG001|Overall Study|Decision by sponsor|0|||
164033602|NCT01763866|592482253|FG002|Overall Study|Decision by sponsor|1|||
164033603|NCT01763866|592482254|FG003|Overall Study|Decision by sponsor|0|||
164033604|NCT01763866|592482255|FG004|Overall Study|Decision by sponsor|2|||
164033605|NCT01763866|592482256|FG005|Overall Study|Decision by sponsor|0|||
164033606|NCT01763866|592482257|FG006|Overall Study|Decision by sponsor|2|||
164033607|NCT01763866|592482258|FG007|Overall Study|Decision by sponsor|0|||
164033608|NCT01763866|592482259|FG008|Overall Study|Decision by sponsor|2|||
164033609|NCT01763866|592482260|FG009|Overall Study|Decision by sponsor|0|||
164033610|NCT01763866|592482261|FG010|Overall Study|Decision by sponsor|6|||
164033611|NCT01763866|592482262|FG011|Overall Study|Decision by sponsor|0|||
164033612|NCT01763866|592482263|FG012|Overall Study|Decision by sponsor|1|||
164033613|NCT01763866|592482264|FG013|Overall Study|Decision by sponsor|0|||
164033614|NCT01763866|592482265|FG014|Overall Study|Decision by sponsor|5|||
164033615|NCT01763866|592482266|FG015|Overall Study|Decision by sponsor|0|||
164033616|NCT01763866|592482267|FG016|Overall Study|Decision by sponsor|0|||
164033617|NCT01763866|592482268|FG017|Overall Study|Decision by sponsor|0|||
164033618|NCT01763866|592482269|FG018|Overall Study|Decision by sponsor|4|||
164033619|NCT01763866|592482270|FG019|Overall Study|Decision by sponsor|0|||
164033620|NCT01763866|592482271|FG020|Overall Study|Decision by sponsor|2|||
164033621|NCT01763866|592482272|FG021|Overall Study|Decision by sponsor|0|||
164033622|NCT01763866|592482273|FG022|Overall Study|Decision by sponsor|1|||
164033623|NCT01763866|592482274|FG023|Overall Study|Decision by sponsor|0|||
164033624|NCT01763866|592482251|FG000|Overall Study|Lost to Follow-up|0|||
164033625|NCT01763866|592482252|FG001|Overall Study|Lost to Follow-up|0|||
164033626|NCT01763866|592482253|FG002|Overall Study|Lost to Follow-up|0|||
164033627|NCT01763866|592482254|FG003|Overall Study|Lost to Follow-up|0|||
164033628|NCT01763866|592482255|FG004|Overall Study|Lost to Follow-up|0|||
164033629|NCT01763866|592482256|FG005|Overall Study|Lost to Follow-up|0|||
164033630|NCT01763866|592482257|FG006|Overall Study|Lost to Follow-up|1|||
164033631|NCT01763866|592482258|FG007|Overall Study|Lost to Follow-up|0|||
164033632|NCT01763866|592482259|FG008|Overall Study|Lost to Follow-up|0|||
164033633|NCT01763866|592482260|FG009|Overall Study|Lost to Follow-up|0|||
164033634|NCT01763866|592482261|FG010|Overall Study|Lost to Follow-up|0|||
164033635|NCT01763866|592482262|FG011|Overall Study|Lost to Follow-up|0|||
164033636|NCT01763866|592482263|FG012|Overall Study|Lost to Follow-up|1|||
164033637|NCT01763866|592482264|FG013|Overall Study|Lost to Follow-up|0|||
164033638|NCT01763866|592482265|FG014|Overall Study|Lost to Follow-up|1|||
164033639|NCT01763866|592482266|FG015|Overall Study|Lost to Follow-up|0|||
164033640|NCT01763866|592482267|FG016|Overall Study|Lost to Follow-up|0|||
164033641|NCT01763866|592482268|FG017|Overall Study|Lost to Follow-up|0|||
164033642|NCT01763866|592482269|FG018|Overall Study|Lost to Follow-up|1|||
164033643|NCT01763866|592482270|FG019|Overall Study|Lost to Follow-up|1|||
164033644|NCT01763866|592482271|FG020|Overall Study|Lost to Follow-up|0|||
164033645|NCT01763866|592482272|FG021|Overall Study|Lost to Follow-up|0|||
164033646|NCT01763866|592482273|FG022|Overall Study|Lost to Follow-up|0|||
164033647|NCT01763866|592482274|FG023|Overall Study|Lost to Follow-up|1|||
164033648|NCT01763866|592482251|FG000|Overall Study|Death|0|||
164033649|NCT01763866|592482252|FG001|Overall Study|Death|0|||
164033650|NCT01763866|592482253|FG002|Overall Study|Death|0|||
164033651|NCT01763866|592482254|FG003|Overall Study|Death|0|||
164033652|NCT01763866|592482255|FG004|Overall Study|Death|0|||
164033653|NCT01763866|592482256|FG005|Overall Study|Death|0|||
164033654|NCT01763866|592482257|FG006|Overall Study|Death|0|||
164033655|NCT01763866|592482258|FG007|Overall Study|Death|0|||
163924679|NCT01527500|592094424|FG001|Part A|Administrative|7|||
163924680|NCT01527500|592094423|FG000|Part A|Adverse Event|4|||
163924681|NCT01527500|592094424|FG001|Part A|Adverse Event|2|||
163924682|NCT01527500|592094423|FG000|Part A|Death|4|||
163924683|NCT01527500|592094424|FG001|Part A|Death|1|||
163924684|NCT01527500|592094423|FG000|Part A|Lost to Follow-up|0|||
163924685|NCT01527500|592094424|FG001|Part A|Lost to Follow-up|1|||
163924686|NCT01527500|592094423|FG000|Part A|Protocol Deviation|9|||
163924687|NCT01527500|592094424|FG001|Part A|Protocol Deviation|2|||
164033656|NCT01763866|592482259|FG008|Overall Study|Death|0|||
164033657|NCT01763866|592482260|FG009|Overall Study|Death|0|||
164033658|NCT01763866|592482261|FG010|Overall Study|Death|0|||
164033659|NCT01763866|592482262|FG011|Overall Study|Death|0|||
164033660|NCT01763866|592482263|FG012|Overall Study|Death|0|||
163924688|NCT01527500|592094423|FG000|Part A|Withdrawal by Subject|2|||
163924689|NCT01527500|592094424|FG001|Part A|Withdrawal by Subject|0|||
164033661|NCT01763866|592482264|FG013|Overall Study|Death|0|||
164033662|NCT01763866|592482265|FG014|Overall Study|Death|0|||
163924690|NCT01527500|592094423|FG000|Part B|Adverse Event|1|||
163924691|NCT01527500|592094424|FG001|Part B|Adverse Event|0|||
163924692|NCT00372255|592094425|FG000|Overall Study|Withdrawn for other reasons|2|||
163924693|NCT00372255|592094426|FG001|Overall Study|Withdrawn for other reasons|1|||
163924694|NCT00776984|592094430|FG000|Overall Study|Adverse Event|8|||
164033663|NCT01763866|592482266|FG015|Overall Study|Death|0|||
164033664|NCT01763866|592482267|FG016|Overall Study|Death|1|||
164033665|NCT01763866|592482268|FG017|Overall Study|Death|0|||
164033666|NCT01763866|592482269|FG018|Overall Study|Death|0|||
164033667|NCT01763866|592482270|FG019|Overall Study|Death|0|||
164033668|NCT01763866|592482271|FG020|Overall Study|Death|0|||
164033669|NCT01763866|592482272|FG021|Overall Study|Death|0|||
164033670|NCT01763866|592482273|FG022|Overall Study|Death|0|||
164033671|NCT01763866|592482274|FG023|Overall Study|Death|0|||
164033672|NCT00192036|592482279|FG000|Overall Study|Protocol Violation|3|||
164033673|NCT00192036|592482279|FG000|Overall Study|Adverse Event|6|||
164033674|NCT00192036|592482279|FG000|Overall Study|Patient/Physician Perception|1|||
164033675|NCT00192036|592482279|FG000|Overall Study|Objective Tumor Progression|4|||
164033676|NCT00192036|592482279|FG000|Overall Study|Clinical Disease Progression|1|||
164033677|NCT00192036|592482279|FG000|Overall Study|Death|1|||
164033678|NCT00192036|592482279|FG000|Overall Study|Unknown or Not Specified|5|||
164033679|NCT03371732|592482280|FG000|Overall Study|Withdrawal by Subject|9|||
164033680|NCT03371732|592482281|FG001|Overall Study|Withdrawal by Subject|3|||
164033681|NCT03371732|592482280|FG000|Overall Study|Refusal to continue|3|||
164033682|NCT03371732|592482281|FG001|Overall Study|Refusal to continue|4|||
164033683|NCT00599027|592482284|FG000|Overall Study|Withdrawal by Subject|1|||
164033684|NCT00599027|592482285|FG001|Overall Study|Withdrawal by Subject|1|||
164033685|NCT00599027|592482284|FG000|Overall Study|Adverse Event|0|||
164033686|NCT00599027|592482285|FG001|Overall Study|Adverse Event|1|||
164033687|NCT00599027|592482284|FG000|Overall Study|Treatment Failure|0|||
164033688|NCT00599027|592482285|FG001|Overall Study|Treatment Failure|1|||
164033689|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
164033690|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
164033691|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
164033692|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
164033693|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
164033694|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
164033695|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
164033696|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
164033697|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
164033698|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
164033699|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
164033700|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
164033701|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
164033702|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
164033703|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
164033704|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
164033705|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
164033706|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
164033707|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
164033708|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
163828981|NCT01197508|591741556|FG003|Overall Study|Other|2|||
163828982|NCT00266825|591741557|FG000|Completed Follow-Up|Lost to Follow-up|14|||
163828983|NCT00266825|591741558|FG001|Completed Follow-Up|Lost to Follow-up|19|||
163828984|NCT00266825|591741557|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
163828985|NCT00266825|591741558|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
163828986|NCT02799784|591741561|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
163828987|NCT02799784|591741562|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
163828988|NCT02799784|591741561|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
163828989|NCT02799784|591741562|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
163828990|NCT02799784|591741561|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
163828991|NCT02799784|591741562|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
163828992|NCT02799784|591741561|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
163828993|NCT02799784|591741562|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
163828994|NCT02799784|591741561|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
163828995|NCT02799784|591741562|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
163828996|NCT02799784|591741561|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
163828997|NCT02799784|591741562|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
163828998|NCT01662063|591741563|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
163828999|NCT01662063|591741564|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
163829000|NCT01662063|591741565|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
163829001|NCT01662063|591741563|FG000|Overall Study|Lack of Efficacy|1|||
163829002|NCT01662063|591741564|FG001|Overall Study|Lack of Efficacy|6|||
163829003|NCT01662063|591741565|FG002|Overall Study|Lack of Efficacy|0|||
163829004|NCT01662063|591741563|FG000|Overall Study|Lost to Follow-up|0|||
163829005|NCT01662063|591741564|FG001|Overall Study|Lost to Follow-up|4|||
163829006|NCT01662063|591741565|FG002|Overall Study|Lost to Follow-up|0|||
163829007|NCT01662063|591741563|FG000|Overall Study|Protocol Violation|1|||
163829008|NCT01662063|591741564|FG001|Overall Study|Protocol Violation|0|||
163829009|NCT01662063|591741565|FG002|Overall Study|Protocol Violation|0|||
163829010|NCT01662063|591741563|FG000|Overall Study|Withdrawal by Subject|2|||
164033709|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
164033710|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
163829011|NCT01662063|591741564|FG001|Overall Study|Withdrawal by Subject|4|||
163829012|NCT01662063|591741565|FG002|Overall Study|Withdrawal by Subject|1|||
163829013|NCT01662063|591741563|FG000|Overall Study|Physician Decision|0|||
163829014|NCT01662063|591741564|FG001|Overall Study|Physician Decision|2|||
163829015|NCT01662063|591741565|FG002|Overall Study|Physician Decision|0|||
163829016|NCT01662063|591741563|FG000|Overall Study|Other|0|||
163829017|NCT01662063|591741564|FG001|Overall Study|Other|1|||
163829018|NCT01662063|591741565|FG002|Overall Study|Other|0|||
163829019|NCT01949870|591741566|FG000|Overall Study|Lack of Efficacy|2|||
163829020|NCT01949870|591741566|FG000|Overall Study|Adverse Event|1|||
163829021|NCT01949870|591741566|FG000|Overall Study|Study termination|1|||
163829022|NCT01949870|591741566|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
163829023|NCT01477853|591741567|FG000|Phase A|Adverse Event|1|||
163829024|NCT01477853|591741568|FG001|Phase A|Adverse Event|2|||
163829025|NCT01477853|591741569|FG002|Phase A|Adverse Event|2|||
163829026|NCT01477853|591741567|FG000|Phase A|Lost to Follow-up|4|||
163829027|NCT01477853|591741568|FG001|Phase A|Lost to Follow-up|3|||
163829028|NCT01477853|591741569|FG002|Phase A|Lost to Follow-up|2|||
163829029|NCT01477853|591741567|FG000|Phase A|Physician Decision|1|||
163829030|NCT01477853|591741568|FG001|Phase A|Physician Decision|0|||
163829031|NCT01477853|591741569|FG002|Phase A|Physician Decision|1|||
163829032|NCT01477853|591741567|FG000|Phase A|Study terminated by sponsor|37|||
163829033|NCT01477853|591741568|FG001|Phase A|Study terminated by sponsor|40|||
163829034|NCT01477853|591741569|FG002|Phase A|Study terminated by sponsor|39|||
163829035|NCT01477853|591741567|FG000|Phase B|Lost to Follow-up|0|||
163829036|NCT01477853|591741568|FG001|Phase B|Lost to Follow-up|1|||
163829037|NCT01477853|591741569|FG002|Phase B|Lost to Follow-up|0|||
163829038|NCT01477853|591741567|FG000|Phase B|Study terminated by sponsor|12|||
163829039|NCT01477853|591741568|FG001|Phase B|Study terminated by sponsor|10|||
163829040|NCT01477853|591741569|FG002|Phase B|Study terminated by sponsor|11|||
163829041|NCT01050816|591741570|FG000|Overall Study|Lost to Follow-up|2|||
163829042|NCT01050816|591741570|FG000|Overall Study|patient's refusal|2|||
163829043|NCT03086330|591741571|FG000|Overall Study|Withdrawal by Subject|3|||
163829044|NCT03086330|591741572|FG001|Overall Study|Withdrawal by Subject|2|||
163829045|NCT03086330|591741571|FG000|Overall Study|Lost to Follow-up|1|||
163829046|NCT03086330|591741572|FG001|Overall Study|Lost to Follow-up|2|||
163829047|NCT01970462|591741573|FG000|Overall Study|Lost to Follow-up|0|||
163829048|NCT01970462|591741574|FG001|Overall Study|Lost to Follow-up|2|||
163829049|NCT02740049|591741575|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
163829050|NCT04570436|591741579|FG000|Overall Study|Adverse Event|0|||
163829051|NCT04570436|591741580|FG001|Overall Study|Adverse Event|0|||
163829052|NCT04570436|591741581|FG002|Overall Study|Adverse Event|1|||
163829053|NCT04570436|591741582|FG003|Overall Study|Adverse Event|0|||
163829054|NCT04570436|591741583|FG004|Overall Study|Adverse Event|0|||
163829055|NCT04570436|591741584|FG005|Overall Study|Adverse Event|0|||
163829056|NCT04570436|591741585|FG006|Overall Study|Adverse Event|0|||
163829057|NCT04570436|591741586|FG007|Overall Study|Adverse Event|0|||
163829058|NCT04570436|591741587|FG008|Overall Study|Adverse Event|0|||
163829059|NCT04570436|591741588|FG009|Overall Study|Adverse Event|0|||
163829060|NCT04570436|591741579|FG000|Overall Study|Physician Decision|1|||
163829061|NCT04570436|591741580|FG001|Overall Study|Physician Decision|0|||
163829062|NCT04570436|591741581|FG002|Overall Study|Physician Decision|0|||
163829063|NCT04570436|591741582|FG003|Overall Study|Physician Decision|0|||
163829064|NCT04570436|591741583|FG004|Overall Study|Physician Decision|0|||
163829065|NCT04570436|591741584|FG005|Overall Study|Physician Decision|0|||
163829066|NCT04570436|591741585|FG006|Overall Study|Physician Decision|0|||
163829067|NCT04570436|591741586|FG007|Overall Study|Physician Decision|0|||
163829068|NCT04570436|591741587|FG008|Overall Study|Physician Decision|0|||
163829069|NCT04570436|591741588|FG009|Overall Study|Physician Decision|0|||
163829070|NCT00645164|591741589|FG000|Overall Study|Lost to Follow-up|2|||
163829071|NCT00645164|591741589|FG000|Overall Study|Withdrawal by Subject|4|||
163829072|NCT00645164|591741589|FG000|Overall Study|Protocol Violation|1|||
163829073|NCT03172702|591741590|FG000|Overall Study|Adverse Event|9|||
163829074|NCT03172702|591741590|FG000|Overall Study|Death|2|||
163829075|NCT03172702|591741590|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
163829076|NCT03172702|591741590|FG000|Overall Study|Withdrawal by Subject|5|||
163829077|NCT03172702|591741590|FG000|Overall Study|Other|2|||
163829078|NCT04280562|591741593|FG000|Study|Adverse Event|2|||
163829079|NCT04280562|591741594|FG001|Study|Adverse Event|0|||
163829080|NCT04280562|591741593|FG000|Study|Lost to Follow-up|3|||
163829081|NCT04280562|591741594|FG001|Study|Lost to Follow-up|3|||
163829082|NCT02061202|591741595|FG000|Overall Study|Lost to Follow-up|1|||
163829083|NCT02061202|591741596|FG001|Overall Study|Lost to Follow-up|1|||
163829084|NCT00162370|591741597|FG000|Efficacy Population|Lost to Follow-up|51|||
163924695|NCT00776984|592094431|FG001|Overall Study|Adverse Event|2|||
163829085|NCT04559568|591741598|FG000|Overall Study|Physician Decision|0|||
163829086|NCT04559568|591741599|FG001|Overall Study|Physician Decision|0|||
163829087|NCT04559568|591741600|FG002|Overall Study|Physician Decision|0|||
163829088|NCT04559568|591741601|FG003|Overall Study|Physician Decision|0|||
163829089|NCT04559568|591741602|FG004|Overall Study|Physician Decision|0|||
163924696|NCT00776984|592094430|FG000|Overall Study|Protocol Violation|4|||
163829090|NCT04559568|591741603|FG005|Overall Study|Physician Decision|0|||
163924697|NCT00776984|592094431|FG001|Overall Study|Protocol Violation|2|||
163924698|NCT00776984|592094430|FG000|Overall Study|Lost to Follow-up|2|||
164147373|NCT05168202|592902028|FG004|Overall Study|Adverse Event|3|||
163829091|NCT04559568|591741604|FG006|Overall Study|Physician Decision|0|||
163829092|NCT04559568|591741605|FG007|Overall Study|Physician Decision|0|||
163829093|NCT04559568|591741606|FG008|Overall Study|Physician Decision|0|||
163829094|NCT04559568|591741607|FG009|Overall Study|Physician Decision|1|||
163829095|NCT04559568|591741608|FG010|Overall Study|Physician Decision|0|||
163829096|NCT04559568|591741598|FG000|Overall Study|Withdrawal by Subject|0|||
163829097|NCT04559568|591741599|FG001|Overall Study|Withdrawal by Subject|0|||
163829098|NCT04559568|591741600|FG002|Overall Study|Withdrawal by Subject|0|||
163829099|NCT04559568|591741601|FG003|Overall Study|Withdrawal by Subject|0|||
163829100|NCT04559568|591741602|FG004|Overall Study|Withdrawal by Subject|0|||
163829101|NCT04559568|591741603|FG005|Overall Study|Withdrawal by Subject|0|||
163829102|NCT04559568|591741604|FG006|Overall Study|Withdrawal by Subject|0|||
163829103|NCT04559568|591741605|FG007|Overall Study|Withdrawal by Subject|0|||
163829104|NCT04559568|591741606|FG008|Overall Study|Withdrawal by Subject|0|||
163829105|NCT04559568|591741607|FG009|Overall Study|Withdrawal by Subject|0|||
163829106|NCT04559568|591741608|FG010|Overall Study|Withdrawal by Subject|1|||
163829107|NCT03721965|591741613|FG000|Overall Study|Death|1|||
163829108|NCT03721965|591741613|FG000|Overall Study|Study Terminated by Sponsor|1|||
163829109|NCT01218126|591741622|FG000|Overall Study|Adverse Event|8|||
163829110|NCT01218126|591741623|FG001|Overall Study|Adverse Event|10|||
163829111|NCT01218126|591741624|FG002|Overall Study|Adverse Event|12|||
163829112|NCT01218126|591741625|FG003|Overall Study|Adverse Event|16|||
163829113|NCT01218126|591741622|FG000|Overall Study|Lack of Efficacy|7|||
163829114|NCT01218126|591741623|FG001|Overall Study|Lack of Efficacy|2|||
163829115|NCT01218126|591741624|FG002|Overall Study|Lack of Efficacy|2|||
163829116|NCT01218126|591741625|FG003|Overall Study|Lack of Efficacy|6|||
163829117|NCT01218126|591741622|FG000|Overall Study|Protocol Violation|5|||
163829118|NCT01218126|591741623|FG001|Overall Study|Protocol Violation|2|||
163829119|NCT01218126|591741624|FG002|Overall Study|Protocol Violation|2|||
163829120|NCT01218126|591741625|FG003|Overall Study|Protocol Violation|3|||
163829121|NCT01218126|591741622|FG000|Overall Study|Protocol-defined stopping criteria|1|||
163829122|NCT01218126|591741623|FG001|Overall Study|Protocol-defined stopping criteria|1|||
163829123|NCT01218126|591741624|FG002|Overall Study|Protocol-defined stopping criteria|0|||
163829124|NCT01218126|591741625|FG003|Overall Study|Protocol-defined stopping criteria|0|||
163829125|NCT01218126|591741622|FG000|Overall Study|Lost to Follow-up|0|||
163829126|NCT01218126|591741623|FG001|Overall Study|Lost to Follow-up|0|||
163829127|NCT01218126|591741624|FG002|Overall Study|Lost to Follow-up|0|||
163829128|NCT01218126|591741625|FG003|Overall Study|Lost to Follow-up|2|||
163829129|NCT01218126|591741622|FG000|Overall Study|Physician Decision|1|||
163829130|NCT01218126|591741623|FG001|Overall Study|Physician Decision|2|||
163829131|NCT01218126|591741624|FG002|Overall Study|Physician Decision|4|||
163829132|NCT01218126|591741625|FG003|Overall Study|Physician Decision|2|||
163829133|NCT01218126|591741622|FG000|Overall Study|Withdrawal by Subject|2|||
163829134|NCT01218126|591741623|FG001|Overall Study|Withdrawal by Subject|5|||
163829135|NCT01218126|591741624|FG002|Overall Study|Withdrawal by Subject|4|||
163829136|NCT01218126|591741625|FG003|Overall Study|Withdrawal by Subject|6|||
163829137|NCT05380947|591741632|FG000|Washout Period 1|Not attend visit|1|||
163829138|NCT05380947|591741633|FG001|Washout Period 1|Not attend visit|0|||
163829139|NCT05380947|591741634|FG002|Washout Period 1|Not attend visit|0|||
163829140|NCT05380947|591741635|FG003|Washout Period 1|Not attend visit|0|||
163829141|NCT05380947|591741632|FG000|Washout Period 2|Adverse Event|1|||
163829142|NCT05380947|591741633|FG001|Washout Period 2|Adverse Event|0|||
163829143|NCT05380947|591741634|FG002|Washout Period 2|Adverse Event|0|||
163829144|NCT05380947|591741635|FG003|Washout Period 2|Adverse Event|0|||
163829145|NCT05380947|591741632|FG000|Washout Period 3|Adverse Event|0|||
163829146|NCT05380947|591741633|FG001|Washout Period 3|Adverse Event|1|||
163829147|NCT05380947|591741634|FG002|Washout Period 3|Adverse Event|0|||
163829148|NCT05380947|591741635|FG003|Washout Period 3|Adverse Event|0|||
163829149|NCT05380947|591741632|FG000|Washout Period 3|Not attend visit|0|||
163829150|NCT05380947|591741633|FG001|Washout Period 3|Not attend visit|1|||
163829151|NCT05380947|591741634|FG002|Washout Period 3|Not attend visit|0|||
163829152|NCT05380947|591741635|FG003|Washout Period 3|Not attend visit|1|||
163924699|NCT00776984|592094431|FG001|Overall Study|Lost to Follow-up|0|||
163829153|NCT01563536|591741636|FG000|Overall Study|Withdrawal by Subject|0|||
163829154|NCT01563536|591741637|FG001|Overall Study|Withdrawal by Subject|2|||
163829155|NCT01563536|591741636|FG000|Overall Study|Lost to Follow-up|1|||
163829156|NCT01563536|591741637|FG001|Overall Study|Lost to Follow-up|0|||
163829157|NCT01860703|591741638|FG000|Overall Study|Adverse Event|1|||
163829158|NCT01860703|591741639|FG001|Overall Study|Adverse Event|4|||
163829159|NCT01860703|591741640|FG002|Overall Study|Adverse Event|0|||
163829160|NCT01860703|591741641|FG003|Overall Study|Adverse Event|2|||
163829161|NCT01860703|591741638|FG000|Overall Study|Withdrawal by Subject|0|||
163829162|NCT01860703|591741639|FG001|Overall Study|Withdrawal by Subject|1|||
163924700|NCT00776984|592094430|FG000|Overall Study|Withdrawal by Subject|12|||
163829163|NCT01860703|591741640|FG002|Overall Study|Withdrawal by Subject|0|||
163924701|NCT00776984|592094431|FG001|Overall Study|Withdrawal by Subject|7|||
163829164|NCT01860703|591741641|FG003|Overall Study|Withdrawal by Subject|0|||
163829165|NCT01860703|591741638|FG000|Overall Study|Personal reason|1|||
163829166|NCT01860703|591741639|FG001|Overall Study|Personal reason|0|||
163829167|NCT01860703|591741640|FG002|Overall Study|Personal reason|1|||
163829168|NCT01860703|591741641|FG003|Overall Study|Personal reason|0|||
163829169|NCT06213701|591741645|FG000|Overall Study|Withdrawal by Subject|2|||
163829170|NCT06213701|591741646|FG001|Overall Study|Withdrawal by Subject|1|||
163829171|NCT06213701|591741647|FG002|Overall Study|Withdrawal by Subject|0|||
163829172|NCT00538590|591741648|FG000|Overall Study|Death|1|||
163829173|NCT00538590|591741649|FG001|Overall Study|Death|0|||
163829174|NCT01256567|591741650|FG000|Overall Study|Withdrawal by Subject|1|||
163829175|NCT00567190|591741651|FG000|Overall Study|Death|235|||
163829176|NCT00567190|591741652|FG001|Overall Study|Death|280|||
163829177|NCT00567190|591741651|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
163829178|NCT00567190|591741652|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
163829179|NCT03184792|591741660|FG000|Overall Study|Pandemic|2|||
163829180|NCT03184792|591741661|FG001|Overall Study|Pandemic|2|||
163829181|NCT02453685|591741663|FG000|Overall Study|Adverse Event|0|||
163829182|NCT02453685|591741664|FG001|Overall Study|Adverse Event|1|||
163829183|NCT02453685|591741663|FG000|Overall Study|Protocol Violation|7|||
163829184|NCT02453685|591741664|FG001|Overall Study|Protocol Violation|4|||
163829185|NCT02453685|591741663|FG000|Overall Study|Lost to Follow-up|0|||
163829186|NCT02453685|591741664|FG001|Overall Study|Lost to Follow-up|1|||
163829187|NCT02453685|591741663|FG000|Overall Study|Withdrawal by Subject|8|||
163829188|NCT02453685|591741664|FG001|Overall Study|Withdrawal by Subject|4|||
163829189|NCT02453685|591741663|FG000|Overall Study|Unclassified|4|||
163829190|NCT02453685|591741664|FG001|Overall Study|Unclassified|2|||
163829191|NCT02778100|591741665|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
163829192|NCT02778100|591741666|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
163829193|NCT04120233|591741671|FG000|Overall Study|Adverse Event|0|||
163829194|NCT04120233|591741672|FG001|Overall Study|Adverse Event|0|||
163829195|NCT04120233|591741673|FG002|Overall Study|Adverse Event|0|||
163829196|NCT04120233|591741674|FG003|Overall Study|Adverse Event|0|||
163829197|NCT04120233|591741675|FG004|Overall Study|Adverse Event|1|||
163829198|NCT04120233|591741676|FG005|Overall Study|Adverse Event|0|||
163829199|NCT05809596|591741677|FG000|Overall Study|Death|16|||
163829200|NCT05809596|591741677|FG000|Overall Study|Withdrawal by Subject|4|||
163829201|NCT05809596|591741677|FG000|Overall Study|Physician Decision|1|||
163829202|NCT05809596|591741677|FG000|Overall Study|Missed Visit|2|||
163829203|NCT05809596|591741677|FG000|Overall Study|Other|3|||
163829204|NCT03770494|591741678|FG000|Overall Study|Lost to Follow-up|0|||
163829205|NCT03770494|591741679|FG001|Overall Study|Lost to Follow-up|0|||
163829206|NCT03770494|591741680|FG002|Overall Study|Lost to Follow-up|1|||
163829207|NCT03770494|591741681|FG003|Overall Study|Lost to Follow-up|1|||
163829208|NCT03770494|591741682|FG004|Overall Study|Lost to Follow-up|1|||
163829209|NCT03770494|591741683|FG005|Overall Study|Lost to Follow-up|0|||
163829210|NCT03770494|591741684|FG006|Overall Study|Lost to Follow-up|0|||
163829211|NCT03770494|591741685|FG007|Overall Study|Lost to Follow-up|0|||
163829212|NCT03770494|591741686|FG008|Overall Study|Lost to Follow-up|0|||
163829213|NCT03770494|591741687|FG009|Overall Study|Lost to Follow-up|0|||
163829214|NCT03770494|591741688|FG010|Overall Study|Lost to Follow-up|0|||
163829215|NCT03770494|591741689|FG011|Overall Study|Lost to Follow-up|0|||
163829216|NCT03770494|591741690|FG012|Overall Study|Lost to Follow-up|0|||
163829217|NCT03770494|591741691|FG013|Overall Study|Lost to Follow-up|0|||
163829218|NCT03770494|591741678|FG000|Overall Study|Study terminated by sponsor|1|||
163829219|NCT03770494|591741679|FG001|Overall Study|Study terminated by sponsor|2|||
163829220|NCT03770494|591741680|FG002|Overall Study|Study terminated by sponsor|1|||
163829221|NCT03770494|591741681|FG003|Overall Study|Study terminated by sponsor|1|||
163829222|NCT03770494|591741682|FG004|Overall Study|Study terminated by sponsor|1|||
163829223|NCT03770494|591741683|FG005|Overall Study|Study terminated by sponsor|2|||
163829224|NCT03770494|591741684|FG006|Overall Study|Study terminated by sponsor|1|||
163829225|NCT03770494|591741685|FG007|Overall Study|Study terminated by sponsor|2|||
163829226|NCT03770494|591741686|FG008|Overall Study|Study terminated by sponsor|1|||
163829227|NCT03770494|591741687|FG009|Overall Study|Study terminated by sponsor|2|||
163829228|NCT03770494|591741688|FG010|Overall Study|Study terminated by sponsor|1|||
163829229|NCT03770494|591741689|FG011|Overall Study|Study terminated by sponsor|2|||
163829230|NCT03770494|591741690|FG012|Overall Study|Study terminated by sponsor|0|||
163829231|NCT03770494|591741691|FG013|Overall Study|Study terminated by sponsor|0|||
163829232|NCT03770494|591741678|FG000|Overall Study|Withdrawal by Subject|1|||
163829233|NCT03770494|591741679|FG001|Overall Study|Withdrawal by Subject|1|||
163924702|NCT00776984|592094430|FG000|Overall Study|Lack of Efficacy|0|||
163829234|NCT03770494|591741680|FG002|Overall Study|Withdrawal by Subject|0|||
163829235|NCT03770494|591741681|FG003|Overall Study|Withdrawal by Subject|0|||
163829236|NCT03770494|591741682|FG004|Overall Study|Withdrawal by Subject|2|||
163829237|NCT03770494|591741683|FG005|Overall Study|Withdrawal by Subject|2|||
163924703|NCT00776984|592094431|FG001|Overall Study|Lack of Efficacy|1|||
163924704|NCT00776984|592094430|FG000|Overall Study|Other|5|||
163924705|NCT00776984|592094431|FG001|Overall Study|Other|9|||
163924706|NCT04414397|592094434|FG000|Control Period|Withdrawal by Subject|2|||
163924707|NCT04414397|592094435|FG001|Control Period|Withdrawal by Subject|2|||
163924708|NCT04414397|592094434|FG000|Control Period|Lost to Follow-up|0|||
163924709|NCT04414397|592094435|FG001|Control Period|Lost to Follow-up|4|||
163924710|NCT04414397|592094434|FG000|Control Period|Protocol deviation|0|||
163924711|NCT04414397|592094435|FG001|Control Period|Protocol deviation|1|||
163924712|NCT04414397|592094434|FG000|Post-Control Period|Withdrawal by Subject|3|||
163924713|NCT04414397|592094435|FG001|Post-Control Period|Withdrawal by Subject|6|||
163924714|NCT04414397|592094434|FG000|Post-Control Period|Lost to Follow-up|4|||
163924715|NCT04414397|592094435|FG001|Post-Control Period|Lost to Follow-up|9|||
163924716|NCT04414397|592094434|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
163924717|NCT04414397|592094435|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
163924718|NCT04414397|592094434|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
163924719|NCT04414397|592094435|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
163924720|NCT03640754|592094436|FG000|Overall Study|Withdrawal by Subject|1|||
163924721|NCT03640754|592094437|FG001|Overall Study|Withdrawal by Subject|0|||
163924722|NCT03640754|592094436|FG000|Overall Study|Lost to Follow-up|0|||
163924723|NCT03640754|592094437|FG001|Overall Study|Lost to Follow-up|1|||
163924724|NCT01204775|592094438|FG000|Overall Study|Poor/non-compliance|0|||
163924725|NCT01204775|592094439|FG001|Overall Study|Poor/non-compliance|1|||
163924726|NCT01204775|592094438|FG000|Overall Study|Withdrawal by Subject|1|||
163924727|NCT01204775|592094439|FG001|Overall Study|Withdrawal by Subject|0|||
163924728|NCT00276016|592094440|FG000|Intervention 1|Withdrawal by Subject|0|||
163924729|NCT00276016|592094441|FG001|Intervention 1|Withdrawal by Subject|1|||
163924730|NCT00276016|592094442|FG002|Intervention 1|Withdrawal by Subject|0|||
163924731|NCT00276016|592094443|FG003|Intervention 1|Withdrawal by Subject|0|||
163924732|NCT00276016|592094444|FG004|Intervention 1|Withdrawal by Subject|0|||
163924733|NCT00276016|592094445|FG005|Intervention 1|Withdrawal by Subject|0|||
163924734|NCT04380688|592094446|FG000|Overall Study|Death|2|||
163924735|NCT04380688|592094447|FG001|Overall Study|Death|2|||
163924736|NCT04380688|592094446|FG000|Overall Study|Lost to Follow-up|2|||
163924737|NCT04380688|592094447|FG001|Overall Study|Lost to Follow-up|4|||
163924738|NCT04380688|592094446|FG000|Overall Study|Withdrawal by Subject|3|||
163924739|NCT04380688|592094447|FG001|Overall Study|Withdrawal by Subject|3|||
163924740|NCT01181609|592096360|FG000|Overall Study|Adverse Event|1|||
163924741|NCT01181609|592096360|FG000|Overall Study|Withdrawal by Subject|1|||
163924742|NCT01181609|592096360|FG000|Overall Study|Lost to Follow-up|1|||
163924743|NCT01181609|592096360|FG000|Overall Study|Death|50|||
163924744|NCT00664105|592096365|FG000|Overall Study|Death|3|||
163924745|NCT00664105|592096365|FG000|Overall Study|Withdrawal by Subject|5|||
163924746|NCT00664105|592096365|FG000|Overall Study|Adverse Event|9|||
163924747|NCT00664105|592096365|FG000|Overall Study|Disease progression|7|||
163924748|NCT03991988|592096367|FG000|Overall Study|Withdrawal by Subject|2|||
163924749|NCT03991988|592096368|FG001|Overall Study|Withdrawal by Subject|2|||
163924750|NCT00847132|592096376|FG000|Overall Study|Death|1|||
163924751|NCT00847132|592096377|FG001|Overall Study|Death|1|||
163924752|NCT01751165|592096379|FG000|Overall Study|Adverse event, serious fatal|1|||
163924753|NCT01751165|592096380|FG001|Overall Study|Adverse event, serious fatal|0|||
163924754|NCT01751165|592096381|FG002|Overall Study|Adverse event, serious fatal|1|||
163924755|NCT01751165|592096379|FG000|Overall Study|Withdrawal by Subject|0|||
163924756|NCT01751165|592096380|FG001|Overall Study|Withdrawal by Subject|0|||
163924757|NCT01751165|592096381|FG002|Overall Study|Withdrawal by Subject|1|||
163924758|NCT01751165|592096379|FG000|Overall Study|Serious adverse event|0|||
163924759|NCT01751165|592096380|FG001|Overall Study|Serious adverse event|2|||
164033711|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
163924760|NCT01751165|592096381|FG002|Overall Study|Serious adverse event|0|||
163924761|NCT01751165|592096379|FG000|Overall Study|Lost to Follow-up|1|||
163924762|NCT01751165|592096380|FG001|Overall Study|Lost to Follow-up|1|||
163924763|NCT01751165|592096381|FG002|Overall Study|Lost to Follow-up|1|||
163924764|NCT00988533|592096382|FG000|Overall Study|Lost to Follow-up|3|||
163924765|NCT01036165|592096383|FG000|Overall Study|Adverse Event|6|||
163924766|NCT01036165|592096383|FG000|Overall Study|Lost to Follow-up|2|||
163924767|NCT01036165|592096383|FG000|Overall Study|Withdrawal by Subject|3|||
163924768|NCT01036165|592096383|FG000|Overall Study|Device Related Issues|3|||
163924769|NCT01036165|592096383|FG000|Overall Study|Problems finding proper area to inject|1|||
163924770|NCT00913523|592096386|FG000|Overall Study|Withdrawal by Subject|3|||
163924771|NCT00913523|592096387|FG001|Overall Study|Withdrawal by Subject|2|||
163924772|NCT00913523|592096388|FG002|Overall Study|Withdrawal by Subject|2|||
163924773|NCT00913523|592096386|FG000|Overall Study|Lost to Follow-up|1|||
163924774|NCT00913523|592096387|FG001|Overall Study|Lost to Follow-up|1|||
163924775|NCT00913523|592096388|FG002|Overall Study|Lost to Follow-up|1|||
163924776|NCT00913523|592096386|FG000|Overall Study|Adverse Event|1|||
163924777|NCT00913523|592096387|FG001|Overall Study|Adverse Event|0|||
163924778|NCT00913523|592096388|FG002|Overall Study|Adverse Event|0|||
163924779|NCT00913523|592096386|FG000|Overall Study|Protocol Violation|5|||
163924780|NCT00913523|592096387|FG001|Overall Study|Protocol Violation|8|||
163924781|NCT00913523|592096388|FG002|Overall Study|Protocol Violation|8|||
163924782|NCT00913523|592096386|FG000|Overall Study|Pregnancy|1|||
163924783|NCT00913523|592096387|FG001|Overall Study|Pregnancy|3|||
163924784|NCT00913523|592096388|FG002|Overall Study|Pregnancy|0|||
163924785|NCT00913523|592096386|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
163924786|NCT00913523|592096387|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
163924787|NCT00913523|592096388|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
163924788|NCT01649297|592096389|FG000|Overall Study|Adverse Event|5|||
163924789|NCT01649297|592096390|FG001|Overall Study|Adverse Event|5|||
163924790|NCT01649297|592096391|FG002|Overall Study|Adverse Event|4|||
163924791|NCT01649297|592096392|FG003|Overall Study|Adverse Event|13|||
163924792|NCT01649297|592096393|FG004|Overall Study|Adverse Event|1|||
163924793|NCT01649297|592096389|FG000|Overall Study|Lack of Efficacy|0|||
163924794|NCT01649297|592096390|FG001|Overall Study|Lack of Efficacy|0|||
163924795|NCT01649297|592096391|FG002|Overall Study|Lack of Efficacy|0|||
163924796|NCT01649297|592096392|FG003|Overall Study|Lack of Efficacy|0|||
163924797|NCT01649297|592096393|FG004|Overall Study|Lack of Efficacy|1|||
163924798|NCT01649297|592096389|FG000|Overall Study|Non compliant with Protocol|1|||
163924799|NCT01649297|592096390|FG001|Overall Study|Non compliant with Protocol|0|||
163924800|NCT01649297|592096391|FG002|Overall Study|Non compliant with Protocol|3|||
163924801|NCT01649297|592096392|FG003|Overall Study|Non compliant with Protocol|2|||
163924802|NCT01649297|592096393|FG004|Overall Study|Non compliant with Protocol|1|||
163924803|NCT01649297|592096389|FG000|Overall Study|Lost to Follow-up|1|||
163924804|NCT01649297|592096390|FG001|Overall Study|Lost to Follow-up|1|||
163924805|NCT01649297|592096391|FG002|Overall Study|Lost to Follow-up|4|||
163924806|NCT01649297|592096392|FG003|Overall Study|Lost to Follow-up|3|||
163924807|NCT01649297|592096393|FG004|Overall Study|Lost to Follow-up|0|||
163924808|NCT01649297|592096389|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
163924809|NCT01649297|592096390|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
163924810|NCT01649297|592096391|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
163924811|NCT01649297|592096392|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
163924812|NCT01649297|592096393|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
163924813|NCT01649297|592096389|FG000|Overall Study|For other reason|4|||
163924814|NCT01649297|592096390|FG001|Overall Study|For other reason|1|||
163924815|NCT01649297|592096391|FG002|Overall Study|For other reason|2|||
163924816|NCT01649297|592096392|FG003|Overall Study|For other reason|0|||
163924817|NCT01649297|592096393|FG004|Overall Study|For other reason|0|||
163924818|NCT01685047|592096394|FG000|Overall Study|Withdrawal by Subject|20|||
163924819|NCT01685047|592096394|FG000|Overall Study|Death|26|||
163924820|NCT01685047|592096394|FG000|Overall Study|Lost to Follow-up|8|||
163924821|NCT01685047|592096394|FG000|Overall Study|Physician Decision|25|||
163924822|NCT01685047|592096394|FG000|Overall Study|Adverse Event|5|||
163924823|NCT01685047|592096394|FG000|Overall Study|patient withdrawn by sponsor|1|||
163924824|NCT02544113|592096395|FG000|Overall Study|Death|3|||
163924825|NCT02544113|592096396|FG001|Overall Study|Death|4|||
163924826|NCT02847637|592096400|FG000|Overall Study|Withdrawal by Subject|0|||
163924827|NCT02847637|592096401|FG001|Overall Study|Withdrawal by Subject|1|||
163924828|NCT02847637|592096402|FG002|Overall Study|Withdrawal by Subject|1|||
163924829|NCT02847637|592096403|FG003|Overall Study|Withdrawal by Subject|0|||
163924830|NCT02847637|592096400|FG000|Overall Study|Lost to Follow-up|1|||
163924831|NCT02847637|592096401|FG001|Overall Study|Lost to Follow-up|1|||
163924832|NCT02847637|592096402|FG002|Overall Study|Lost to Follow-up|0|||
163924833|NCT02847637|592096403|FG003|Overall Study|Lost to Follow-up|0|||
163924834|NCT01746108|592096404|FG000|Overall Study|Migrated /moved from study area|0|||
163924835|NCT01746108|592096405|FG001|Overall Study|Migrated /moved from study area|1|||
163924836|NCT01746108|592096406|FG002|Overall Study|Migrated /moved from study area|0|||
163924837|NCT01746108|592096404|FG000|Overall Study|Adverse event, non-fatal|0|||
163924838|NCT01746108|592096405|FG001|Overall Study|Adverse event, non-fatal|1|||
163924839|NCT01746108|592096406|FG002|Overall Study|Adverse event, non-fatal|0|||
163924840|NCT01746108|592096404|FG000|Overall Study|Withdrawal by Subject|0|||
163924841|NCT01746108|592096405|FG001|Overall Study|Withdrawal by Subject|1|||
163924842|NCT01746108|592096406|FG002|Overall Study|Withdrawal by Subject|0|||
163924843|NCT01746108|592096404|FG000|Overall Study|Lost to Follow-up|0|||
163924844|NCT01746108|592096405|FG001|Overall Study|Lost to Follow-up|1|||
163924845|NCT01746108|592096406|FG002|Overall Study|Lost to Follow-up|0|||
163924846|NCT03036150|592096407|FG000|Overall Study|Withdrawal by Subject|8|||
163924847|NCT03036150|592096408|FG001|Overall Study|Withdrawal by Subject|3|||
163924848|NCT03036150|592096407|FG000|Overall Study|Lost to Follow-up|2|||
163924849|NCT03036150|592096408|FG001|Overall Study|Lost to Follow-up|2|||
163924850|NCT02741713|592096415|FG000|Overall Study|Surgery type changed intra-operatively|2|||
163924851|NCT02741713|592096416|FG001|Overall Study|Surgery type changed intra-operatively|1|||
163924852|NCT00570921|592096417|FG000|Overall Study|Protocol Violation|1|||
163924853|NCT00570921|592096417|FG000|Overall Study|Physician Decision|1|||
163924854|NCT04191148|592096418|FG000|Overall Study|Withdrawal by Subject|1|||
163924855|NCT04191148|592096419|FG001|Overall Study|Withdrawal by Subject|0|||
163924856|NCT04191148|592096418|FG000|Overall Study|Adverse Event|1|||
163924857|NCT04191148|592096419|FG001|Overall Study|Adverse Event|0|||
163924858|NCT02447432|592096420|FG000|Epoch 001|Adverse Event|1|||
163924859|NCT02447432|592096421|FG001|Epoch 001|Adverse Event|1|||
163924860|NCT02447432|592096420|FG000|Epoch 001|Withdrawal by Subject|0|||
163924861|NCT02447432|592096421|FG001|Epoch 001|Withdrawal by Subject|4|||
163924862|NCT02447432|592096420|FG000|Epoch 001|Migrated/moved from study area|3|||
163924863|NCT02447432|592096421|FG001|Epoch 001|Migrated/moved from study area|5|||
163924864|NCT02447432|592096420|FG000|Epoch 001|Lost to Follow-up|1|||
163924865|NCT02447432|592096421|FG001|Epoch 001|Lost to Follow-up|3|||
163924866|NCT02647788|592096422|FG000|Overall Study|Lost to Follow-up|13|||
163924867|NCT02647788|592096423|FG001|Overall Study|Lost to Follow-up|11|||
163924868|NCT02647788|592096422|FG000|Overall Study|Did not want opiate|0|||
163924869|NCT02647788|592096423|FG001|Overall Study|Did not want opiate|1|||
163924870|NCT02647788|592096422|FG000|Overall Study|Withdrawal by Subject|1|||
163924871|NCT02647788|592096423|FG001|Overall Study|Withdrawal by Subject|0|||
163924872|NCT02647788|592096422|FG000|Overall Study|Felt itchy with assigned medication|1|||
163924873|NCT02647788|592096423|FG001|Overall Study|Felt itchy with assigned medication|0|||
163924874|NCT02647788|592096422|FG000|Overall Study|Felt nauseous with assigned medication|1|||
163924875|NCT02647788|592096423|FG001|Overall Study|Felt nauseous with assigned medication|1|||
163924876|NCT01274559|592096426|FG000|Overall Study|Adverse Event|57|||
163924877|NCT01274559|592096427|FG001|Overall Study|Adverse Event|13|||
163924878|NCT01274559|592096426|FG000|Overall Study|Death|1|||
163924879|NCT01274559|592096427|FG001|Overall Study|Death|1|||
163924880|NCT01274559|592096426|FG000|Overall Study|Lost to Follow-up|3|||
163924881|NCT01274559|592096427|FG001|Overall Study|Lost to Follow-up|3|||
163924882|NCT01274559|592096426|FG000|Overall Study|Non-compliance with Study Drug|2|||
163924883|NCT01274559|592096427|FG001|Overall Study|Non-compliance with Study Drug|4|||
163924884|NCT01274559|592096426|FG000|Overall Study|Physician Decision|2|||
163924885|NCT01274559|592096427|FG001|Overall Study|Physician Decision|1|||
163924886|NCT01274559|592096426|FG000|Overall Study|Protocol Violation|28|||
163924887|NCT01274559|592096427|FG001|Overall Study|Protocol Violation|23|||
163924888|NCT01274559|592096426|FG000|Overall Study|Study Terminated by Sponsor|79|||
163924889|NCT01274559|592096427|FG001|Overall Study|Study Terminated by Sponsor|87|||
163924890|NCT01274559|592096426|FG000|Overall Study|Withdrawal by Subject|25|||
163924891|NCT01274559|592096427|FG001|Overall Study|Withdrawal by Subject|13|||
163924892|NCT02561806|592096438|FG000|Induction Period|Adverse Event|0|||
163924893|NCT02561806|592096439|FG001|Induction Period|Adverse Event|2|||
163924894|NCT02561806|592096438|FG000|Induction Period|Lack of Efficacy|1|||
163924895|NCT02561806|592096439|FG001|Induction Period|Lack of Efficacy|0|||
163924896|NCT02561806|592096438|FG000|Induction Period|Withdrawal by Subject|0|||
163924897|NCT02561806|592096439|FG001|Induction Period|Withdrawal by Subject|2|||
163924898|NCT02561806|592096438|FG000|Induction Period|Site staff became unblinded|1|||
163924899|NCT02561806|592096439|FG001|Induction Period|Site staff became unblinded|0|||
163924900|NCT02561806|592096438|FG000|Induction Period|Randomized but not treated|0|||
163924901|NCT02561806|592096439|FG001|Induction Period|Randomized but not treated|1|||
163924902|NCT02561806|592096438|FG000|Maintenance Period|Adverse Event|2|||
163924903|NCT02561806|592096439|FG001|Maintenance Period|Adverse Event|1|||
163924904|NCT02561806|592096438|FG000|Maintenance Period|Lack of Efficacy|3|||
163924905|NCT02561806|592096439|FG001|Maintenance Period|Lack of Efficacy|1|||
163924906|NCT02561806|592096438|FG000|Maintenance Period|Lost to Follow-up|2|||
163924907|NCT02561806|592096439|FG001|Maintenance Period|Lost to Follow-up|2|||
163924908|NCT02561806|592096438|FG000|Maintenance Period|Protocol Violation|1|||
163924909|NCT02561806|592096439|FG001|Maintenance Period|Protocol Violation|0|||
163924910|NCT02561806|592096438|FG000|Maintenance Period|Withdrawal by Subject|5|||
163924911|NCT02561806|592096439|FG001|Maintenance Period|Withdrawal by Subject|3|||
163924912|NCT02561806|592096438|FG000|Maintenance Period|Site staff became unblinded|0|||
163924913|NCT02561806|592096439|FG001|Maintenance Period|Site staff became unblinded|1|||
163924914|NCT02561806|592096438|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
163924915|NCT02561806|592096439|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
163924916|NCT02561806|592096438|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
163924917|NCT02561806|592096439|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
163924918|NCT00591591|592096443|FG000|Overall Study|Withdrawal by Subject|1|||
163924919|NCT00591591|592096444|FG001|Overall Study|Withdrawal by Subject|37|||
163924920|NCT00591591|592096443|FG000|Overall Study|Lack of Efficacy|10|||
163924921|NCT00591591|592096444|FG001|Overall Study|Lack of Efficacy|2|||
163924922|NCT00002597|592096445|FG000|Overall Study|Protocol Violation|19|||
163924923|NCT00002597|592096446|FG001|Overall Study|Protocol Violation|17|||
163924924|NCT00002597|592096445|FG000|Overall Study|Withdrawal by Subject|7|||
163924925|NCT00002597|592096446|FG001|Overall Study|Withdrawal by Subject|6|||
163924926|NCT00912223|592096447|FG000|Overall Study|Withdrawal by Subject|1|||
163924927|NCT00912223|592096447|FG000|Overall Study|Not transplanted|1|||
163924928|NCT00912223|592096447|FG000|Overall Study|Transformed disease|1|||
163924929|NCT01242371|592096451|FG000|Overall Study|Withdrawal by Subject|2|||
163924930|NCT01242371|592096452|FG001|Overall Study|Withdrawal by Subject|2|||
163924931|NCT01242371|592096451|FG000|Overall Study|Protocol Violation|0|||
163924932|NCT01242371|592096452|FG001|Overall Study|Protocol Violation|3|||
163924933|NCT00510146|592096453|FG000|Double-Blind Treatment|Adverse Event|30|||
163924934|NCT00510146|592096454|FG001|Double-Blind Treatment|Adverse Event|13|||
163924935|NCT00510146|592096453|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
163924936|NCT00510146|592096454|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
163924937|NCT00510146|592096453|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
163924938|NCT00510146|592096454|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
163924939|NCT00510146|592096453|FG000|Double-Blind Treatment|Physician Decision|6|||
163924940|NCT00510146|592096454|FG001|Double-Blind Treatment|Physician Decision|0|||
163924941|NCT00510146|592096453|FG000|Double-Blind Treatment|Protocol Violation|1|||
163924942|NCT00510146|592096454|FG001|Double-Blind Treatment|Protocol Violation|2|||
163924943|NCT00510146|592096453|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
163924944|NCT00510146|592096454|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
163924945|NCT00510146|592096453|FG000|Double-Blind Treatment|Clinical Relapse|0|||
163924946|NCT00510146|592096454|FG001|Double-Blind Treatment|Clinical Relapse|1|||
163924947|NCT00510146|592096453|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
163924948|NCT00510146|592096454|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
163924949|NCT00510146|592096453|FG000|Open-Label Treatment|Adverse Event|22|||
163924950|NCT00510146|592096454|FG001|Open-Label Treatment|Adverse Event|8|||
163924951|NCT00510146|592096453|FG000|Open-Label Treatment|Death|1|||
163924952|NCT00510146|592096454|FG001|Open-Label Treatment|Death|1|||
163924953|NCT00510146|592096453|FG000|Open-Label Treatment|Lack of Efficacy|4|||
163924954|NCT00510146|592096454|FG001|Open-Label Treatment|Lack of Efficacy|0|||
163924955|NCT00510146|592096453|FG000|Open-Label Treatment|Lost to Follow-up|10|||
163924956|NCT00510146|592096454|FG001|Open-Label Treatment|Lost to Follow-up|1|||
163924957|NCT00510146|592096453|FG000|Open-Label Treatment|Physician Decision|3|||
163924958|NCT00510146|592096454|FG001|Open-Label Treatment|Physician Decision|1|||
163924959|NCT00510146|592096453|FG000|Open-Label Treatment|Protocol Violation|4|||
163924960|NCT00510146|592096454|FG001|Open-Label Treatment|Protocol Violation|2|||
163924961|NCT00510146|592096453|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
163924962|NCT00510146|592096454|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
163924963|NCT00510146|592096453|FG000|Open-Label Treatment|Clinical Relapse|1|||
163924964|NCT00510146|592096454|FG001|Open-Label Treatment|Clinical Relapse|1|||
163924965|NCT00510146|592096453|FG000|Open-Label Treatment|Sponsor Decision|2|||
163924966|NCT00510146|592096454|FG001|Open-Label Treatment|Sponsor Decision|0|||
163924967|NCT06080438|592096457|FG000|Overall Study|Lost to Follow-up|2|||
163924968|NCT00025662|592096458|FG000|Overall Study|Withdrawal by Subject|2|||
163924969|NCT00025662|592096458|FG000|Overall Study|Technical failure of manipulation|1|||
163924970|NCT03589300|592096459|FG000|Overall Study|Adverse Event|2|||
163924971|NCT03589300|592096459|FG000|Overall Study|Death|4|||
163924972|NCT03589300|592096459|FG000|Overall Study|Lost to Follow-up|12|||
163924973|NCT03589300|592096459|FG000|Overall Study|Withdrawal by Subject|5|||
163924974|NCT02161185|592096460|FG000|Treatment Phase|Administrative/Other|7|||
163924975|NCT02573883|592096461|FG000|Six Month Follow Up|Lost to Follow-up|1|||
163924976|NCT02573883|592096462|FG001|Six Month Follow Up|Lost to Follow-up|0|||
163924977|NCT02573883|592096463|FG002|Six Month Follow Up|Lost to Follow-up|0|||
163924978|NCT02573883|592096464|FG003|Six Month Follow Up|Lost to Follow-up|0|||
163924979|NCT02573883|592096461|FG000|One Year Follow Up|Lost to Follow-up|2|||
163924980|NCT02573883|592096462|FG001|One Year Follow Up|Lost to Follow-up|1|||
163924981|NCT02573883|592096463|FG002|One Year Follow Up|Lost to Follow-up|0|||
163924982|NCT02573883|592096464|FG003|One Year Follow Up|Lost to Follow-up|0|||
163924983|NCT00582114|592096465|FG000|Overall Study|Death|4|||
163924984|NCT00582114|592096466|FG001|Overall Study|Death|4|||
163924985|NCT00582114|592096465|FG000|Overall Study|Kidney Transplant|3|||
163924986|NCT00582114|592096466|FG001|Overall Study|Kidney Transplant|1|||
163924987|NCT00582114|592096465|FG000|Overall Study|Lost to Follow-up|7|||
163924988|NCT00582114|592096466|FG001|Overall Study|Lost to Follow-up|6|||
163924989|NCT00582114|592096465|FG000|Overall Study|Withdrawal by Subject|8|||
163924990|NCT00582114|592096466|FG001|Overall Study|Withdrawal by Subject|16|||
163924991|NCT00582114|592096465|FG000|Overall Study|Adverse Event|1|||
163924992|NCT00582114|592096466|FG001|Overall Study|Adverse Event|1|||
163924993|NCT00582114|592096465|FG000|Overall Study|Physician Decision|0|||
163924994|NCT00582114|592096466|FG001|Overall Study|Physician Decision|6|||
163924995|NCT00582114|592096465|FG000|Overall Study|Stopped by data safety monitoring board|19|||
163924996|NCT00582114|592096466|FG001|Overall Study|Stopped by data safety monitoring board|20|||
163924997|NCT00130728|592096474|FG000|Overall Study|Death|258|||
163924998|NCT00130728|592096475|FG001|Overall Study|Death|258|||
163924999|NCT00130728|592096474|FG000|Overall Study|Lost to Follow-up|4|||
163925000|NCT00130728|592096475|FG001|Overall Study|Lost to Follow-up|0|||
163925001|NCT00130728|592096474|FG000|Overall Study|Withdrawal by Subject|0|||
163925002|NCT00130728|592096475|FG001|Overall Study|Withdrawal by Subject|2|||
163925003|NCT00519285|592096482|FG000|Overall Study|Adverse Event|127|||
164033712|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
163925004|NCT00519285|592096483|FG001|Overall Study|Adverse Event|266|||
163925005|NCT00519285|592096482|FG000|Overall Study|Disease progression|334|||
163925006|NCT00519285|592096483|FG001|Overall Study|Disease progression|186|||
163925007|NCT00519285|592096482|FG000|Overall Study|Physician Decision|75|||
163925008|NCT00519285|592096483|FG001|Overall Study|Physician Decision|47|||
163925009|NCT00519285|592096482|FG000|Overall Study|Participant's request|53|||
163925010|NCT00519285|592096483|FG001|Overall Study|Participant's request|84|||
163925011|NCT00519285|592096482|FG000|Overall Study|Consent withdrawn|4|||
163925012|NCT00519285|592096483|FG001|Overall Study|Consent withdrawn|5|||
164033713|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
164033714|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
163829238|NCT03770494|591741684|FG006|Overall Study|Withdrawal by Subject|2|||
163829239|NCT03770494|591741685|FG007|Overall Study|Withdrawal by Subject|0|||
163829240|NCT03770494|591741686|FG008|Overall Study|Withdrawal by Subject|2|||
163829241|NCT03770494|591741687|FG009|Overall Study|Withdrawal by Subject|3|||
163829242|NCT03770494|591741688|FG010|Overall Study|Withdrawal by Subject|1|||
163829243|NCT03770494|591741689|FG011|Overall Study|Withdrawal by Subject|0|||
163829244|NCT03770494|591741690|FG012|Overall Study|Withdrawal by Subject|0|||
163829245|NCT03770494|591741691|FG013|Overall Study|Withdrawal by Subject|0|||
163829246|NCT01984697|591743542|FG000|Overall Study|Adverse Event|0|||
163829247|NCT01984697|591743543|FG001|Overall Study|Adverse Event|0|||
163829248|NCT01984697|591743544|FG002|Overall Study|Adverse Event|2|||
163829249|NCT01984697|591743545|FG003|Overall Study|Adverse Event|0|||
163829250|NCT01984697|591743546|FG004|Overall Study|Adverse Event|0|||
163829251|NCT01984697|591743542|FG000|Overall Study|Lost to Follow-up|14|||
163829252|NCT01984697|591743543|FG001|Overall Study|Lost to Follow-up|5|||
163829253|NCT01984697|591743544|FG002|Overall Study|Lost to Follow-up|10|||
163829254|NCT01984697|591743545|FG003|Overall Study|Lost to Follow-up|6|||
163829255|NCT01984697|591743546|FG004|Overall Study|Lost to Follow-up|21|||
163829256|NCT01984697|591743542|FG000|Overall Study|Physician Decision|3|||
163829257|NCT01984697|591743543|FG001|Overall Study|Physician Decision|0|||
163829258|NCT01984697|591743544|FG002|Overall Study|Physician Decision|0|||
163829259|NCT01984697|591743545|FG003|Overall Study|Physician Decision|1|||
163829260|NCT01984697|591743546|FG004|Overall Study|Physician Decision|0|||
163829261|NCT01984697|591743542|FG000|Overall Study|Protocol Violation|8|||
163829262|NCT01984697|591743543|FG001|Overall Study|Protocol Violation|5|||
163829263|NCT01984697|591743544|FG002|Overall Study|Protocol Violation|3|||
163829264|NCT01984697|591743545|FG003|Overall Study|Protocol Violation|2|||
163829265|NCT01984697|591743546|FG004|Overall Study|Protocol Violation|0|||
163829266|NCT01984697|591743542|FG000|Overall Study|Withdrawal by Subject|15|||
163829267|NCT01984697|591743543|FG001|Overall Study|Withdrawal by Subject|21|||
163829268|NCT01984697|591743544|FG002|Overall Study|Withdrawal by Subject|13|||
163829269|NCT01984697|591743545|FG003|Overall Study|Withdrawal by Subject|11|||
163829270|NCT01984697|591743546|FG004|Overall Study|Withdrawal by Subject|13|||
163829271|NCT01984697|591743542|FG000|Overall Study|Missed last follow-up visit|1|||
163829272|NCT01984697|591743543|FG001|Overall Study|Missed last follow-up visit|0|||
163829273|NCT01984697|591743544|FG002|Overall Study|Missed last follow-up visit|0|||
163829274|NCT01984697|591743545|FG003|Overall Study|Missed last follow-up visit|0|||
163829275|NCT01984697|591743546|FG004|Overall Study|Missed last follow-up visit|0|||
163829276|NCT01984697|591743542|FG000|Overall Study|Death|0|||
163829277|NCT01984697|591743543|FG001|Overall Study|Death|0|||
163829278|NCT01984697|591743544|FG002|Overall Study|Death|0|||
163829279|NCT01984697|591743545|FG003|Overall Study|Death|1|||
163829280|NCT01984697|591743546|FG004|Overall Study|Death|0|||
163829281|NCT01984697|591743542|FG000|Overall Study|Pregnancy|2|||
163829282|NCT01984697|591743543|FG001|Overall Study|Pregnancy|0|||
163829283|NCT01984697|591743544|FG002|Overall Study|Pregnancy|1|||
163829284|NCT01984697|591743545|FG003|Overall Study|Pregnancy|0|||
163829285|NCT01984697|591743546|FG004|Overall Study|Pregnancy|1|||
163829286|NCT01345630|591743547|FG000|Overall Study|Adverse Event|22|||
163829287|NCT01345630|591743548|FG001|Overall Study|Adverse Event|23|||
163829288|NCT01345630|591743547|FG000|Overall Study|Lost to Follow-up|17|||
163829289|NCT01345630|591743548|FG001|Overall Study|Lost to Follow-up|16|||
163829290|NCT01345630|591743547|FG000|Overall Study|Protocol Violation|4|||
163829291|NCT01345630|591743548|FG001|Overall Study|Protocol Violation|1|||
163829292|NCT01345630|591743547|FG000|Overall Study|Medication error without associated AE|0|||
163829293|NCT01345630|591743548|FG001|Overall Study|Medication error without associated AE|1|||
163829294|NCT01345630|591743547|FG000|Overall Study|Study terminated by sponsor|254|||
163829295|NCT01345630|591743548|FG001|Overall Study|Study terminated by sponsor|285|||
163829296|NCT01345630|591743547|FG000|Overall Study|Other reasons|6|||
163829297|NCT01345630|591743548|FG001|Overall Study|Other reasons|8|||
163829298|NCT01345630|591743547|FG000|Overall Study|Withdrawn due to pregnancy|1|||
163829299|NCT01345630|591743548|FG001|Overall Study|Withdrawn due to pregnancy|2|||
163829300|NCT01345630|591743547|FG000|Overall Study|No longer willing to participate|9|||
163829301|NCT01345630|591743548|FG001|Overall Study|No longer willing to participate|12|||
163829302|NCT01345630|591743547|FG000|Overall Study|Insufficient clinical response|48|||
163829303|NCT01345630|591743548|FG001|Overall Study|Insufficient clinical response|11|||
163829304|NCT01364922|591743556|FG000|Open-label (OL) Period|Adverse Event|7|||
164033715|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
164033716|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
164033717|NCT00476996|592482287|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
163829305|NCT01364922|591743557|FG001|Open-label (OL) Period|Adverse Event|0|||
163829306|NCT01364922|591743558|FG002|Open-label (OL) Period|Adverse Event|0|||
163829307|NCT01364922|591743556|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
163829308|NCT01364922|591743557|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
163829309|NCT01364922|591743558|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
164033718|NCT00476996|592482288|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
164033719|NCT00476996|592482289|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
163829310|NCT01364922|591743556|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
163829311|NCT01364922|591743557|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
163925013|NCT00519285|592096482|FG000|Overall Study|Poor compliance to protocol|5|||
163925014|NCT00519285|592096483|FG001|Overall Study|Poor compliance to protocol|7|||
163925015|NCT00519285|592096482|FG000|Overall Study|Reason unspecified|5|||
163925016|NCT00519285|592096483|FG001|Overall Study|Reason unspecified|8|||
163925017|NCT00519285|592096482|FG000|Overall Study|Not treated|8|||
163925018|NCT00519285|592096483|FG001|Overall Study|Not treated|7|||
163925019|NCT00519285|592096482|FG000|Overall Study|Treatment ongoing|1|||
163925020|NCT00519285|592096483|FG001|Overall Study|Treatment ongoing|2|||
163925021|NCT02970305|592096484|FG000|Overall Study|Adverse Event|10|||
163925022|NCT02970305|592096485|FG001|Overall Study|Adverse Event|6|||
163925023|NCT02970305|592096484|FG000|Overall Study|Lack of Efficacy|1|||
163925024|NCT02970305|592096485|FG001|Overall Study|Lack of Efficacy|1|||
163925025|NCT02970305|592096484|FG000|Overall Study|Noncompliance with study drug|2|||
163925026|NCT02970305|592096485|FG001|Overall Study|Noncompliance with study drug|4|||
163925027|NCT02970305|592096484|FG000|Overall Study|Protocol Violation|2|||
163925028|NCT02970305|592096485|FG001|Overall Study|Protocol Violation|2|||
163925029|NCT02970305|592096484|FG000|Overall Study|Withdrawal by Subject|12|||
163925030|NCT02970305|592096485|FG001|Overall Study|Withdrawal by Subject|11|||
163925031|NCT02970305|592096484|FG000|Overall Study|Not further specified|1|||
163925032|NCT02970305|592096485|FG001|Overall Study|Not further specified|2|||
163925033|NCT02970305|592096484|FG000|Overall Study|Lost to Follow-up|1|||
163925034|NCT02970305|592096485|FG001|Overall Study|Lost to Follow-up|2|||
163925035|NCT02175745|592096486|FG000|Overall Study|Not Eligible|1|||
163925036|NCT00808899|592096488|FG000|Overall Study|Death|1|||
163829312|NCT01364922|591743558|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
163829313|NCT01364922|591743556|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
163829314|NCT01364922|591743557|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
163829315|NCT01364922|591743558|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
163829316|NCT01364922|591743556|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
163829317|NCT01364922|591743557|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
163829318|NCT01364922|591743558|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
163829319|NCT01364922|591743556|FG000|Open-label (OL) Period|Other, Unspecified|1|||
163829320|NCT01364922|591743557|FG001|Open-label (OL) Period|Other, Unspecified|0|||
163829321|NCT01364922|591743558|FG002|Open-label (OL) Period|Other, Unspecified|0|||
163829322|NCT01364922|591743556|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
163829323|NCT01364922|591743557|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
163829324|NCT01364922|591743558|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
163829325|NCT01364922|591743556|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
163829326|NCT01364922|591743557|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
163829327|NCT01364922|591743558|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
163829328|NCT01364922|591743556|FG000|Double-Blind (DB) Period|Adverse Event|0|||
163829329|NCT01364922|591743557|FG001|Double-Blind (DB) Period|Adverse Event|0|||
163829330|NCT01364922|591743558|FG002|Double-Blind (DB) Period|Adverse Event|1|||
163829331|NCT01364922|591743556|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
163829332|NCT01364922|591743557|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
163829333|NCT01364922|591743558|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
163829334|NCT05178121|591743559|FG000|Overall Study|Other|4|||
163829335|NCT05178121|591743559|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
163829336|NCT01953003|591743560|FG000|Overall Study|Not treated|0|||
163829337|NCT01953003|591743561|FG001|Overall Study|Not treated|1|||
163829338|NCT01953003|591743560|FG000|Overall Study|Progressive disease|35|||
163829339|NCT01953003|591743561|FG001|Overall Study|Progressive disease|45|||
163829340|NCT01953003|591743560|FG000|Overall Study|Related Adverse events|7|||
163829341|NCT01953003|591743561|FG001|Overall Study|Related Adverse events|2|||
163829342|NCT01953003|591743560|FG000|Overall Study|Non-related adverse events|0|||
163829343|NCT01953003|591743561|FG001|Overall Study|Non-related adverse events|2|||
163829344|NCT01953003|591743560|FG000|Overall Study|Protocol Violation|0|||
163829345|NCT01953003|591743561|FG001|Overall Study|Protocol Violation|1|||
163829346|NCT01953003|591743560|FG000|Overall Study|Withdrawal by Subject|14|||
163829347|NCT01953003|591743561|FG001|Overall Study|Withdrawal by Subject|4|||
163829348|NCT00553501|591743563|FG000|Overall Study|Adverse Event|2|||
163829349|NCT00553501|591743563|FG000|Overall Study|Death|1|||
163829350|NCT00553501|591743563|FG000|Overall Study|Progression|1|||
163829351|NCT00949715|591743566|FG000|Overall Study|Physician Decision|1|||
163829352|NCT00949715|591743567|FG001|Overall Study|Physician Decision|0|||
163925037|NCT00808899|592096488|FG000|Overall Study|Physician Decision|3|||
163925038|NCT04088500|592096489|FG000|Overall Study|Reason unknown|1|||
163925039|NCT04088500|592096489|FG000|Overall Study|Participant withdrew consent|1|||
163925040|NCT04088500|592096489|FG000|Overall Study|Disease progression|3|||
163925041|NCT02212197|592096490|FG000|Overall Study|Need for radiotherapy|1|||
163829353|NCT00949715|591743566|FG000|Overall Study|Lost to Follow-up|1|||
163829354|NCT00949715|591743567|FG001|Overall Study|Lost to Follow-up|0|||
163925042|NCT02212197|592096491|FG001|Overall Study|Need for radiotherapy|0|||
164033720|NCT00476996|592482290|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
164033721|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
164033722|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
164033723|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
164033724|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
164033725|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
164033726|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
164033727|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
164033728|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
164033729|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Death|0|||
164033730|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Death|0|||
164033731|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Death|0|||
164033732|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Death|7|||
164033733|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
164033734|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
164033735|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
164033736|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
164033737|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
164033738|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
164033739|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
164033740|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
164033741|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
164033742|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
164033743|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
164033744|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
164033745|NCT00476996|592482287|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
164033746|NCT00476996|592482288|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
164033747|NCT00476996|592482289|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
164033748|NCT00476996|592482290|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
164033749|NCT02939599|592482292|FG000|Overall Study|Adverse Event|1|||
164033750|NCT02939599|592482293|FG001|Overall Study|Adverse Event|0|||
164033751|NCT02939599|592482292|FG000|Overall Study|Study Terminated By Sponsor|2|||
164033752|NCT02939599|592482293|FG001|Overall Study|Study Terminated By Sponsor|2|||
164033753|NCT01669811|592482294|FG000|Overall Study|Investigator decision|0|||
164033754|NCT01669811|592482295|FG001|Overall Study|Investigator decision|1|||
164033755|NCT01669811|592482294|FG000|Overall Study|Withdrawal by Subject|1|||
164033756|NCT01669811|592482295|FG001|Overall Study|Withdrawal by Subject|2|||
164033757|NCT01669811|592482294|FG000|Overall Study|Adverse Event|2|||
164033758|NCT01669811|592482295|FG001|Overall Study|Adverse Event|6|||
164033759|NCT01669811|592482294|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
164033760|NCT01669811|592482295|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
164033761|NCT02133742|592482304|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
164033762|NCT02133742|592482304|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
164033763|NCT02133742|592482304|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
164033764|NCT02133742|592482304|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
164033765|NCT02133742|592482304|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
164033766|NCT03479216|592482305|FG000|Overall Study|Withdrawal by Subject|3|||
164033767|NCT03479216|592482306|FG001|Overall Study|Withdrawal by Subject|2|||
164033768|NCT03479216|592482305|FG000|Overall Study|Physician Decision|2|||
164033769|NCT03479216|592482306|FG001|Overall Study|Physician Decision|3|||
164033770|NCT02031432|592482307|FG000|Overall Study|Protocol Violation|1|||
164033771|NCT02031432|592482307|FG000|Overall Study|Lack of Efficacy|5|||
164033772|NCT02031432|592482307|FG000|Overall Study|Cancer Progression|2|||
164033773|NCT02031432|592482307|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
164033774|NCT02031432|592482307|FG000|Overall Study|Adverse Event|8|||
164033775|NCT02031432|592482307|FG000|Overall Study|Withdrawal by Subject|5|||
164033776|NCT02031432|592482307|FG000|Overall Study|Lost to Follow-up|1|||
164033777|NCT02031432|592482307|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
164033778|NCT02031432|592482307|FG000|Overall Study|Death|10|||
164033779|NCT02148211|592482308|FG000|Overall Study|Lost to Follow-up|352|||
164033780|NCT01617187|592482310|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
163829355|NCT00949715|591743566|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
163829356|NCT00949715|591743567|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
164033781|NCT01617187|592482311|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
164033782|NCT01617187|592482312|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
164033783|NCT01617187|592482313|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
164033784|NCT01617187|592482310|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
164033785|NCT01617187|592482311|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
164033786|NCT01617187|592482312|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
164147374|NCT05168202|592902029|FG005|Overall Study|Adverse Event|2|||
163829357|NCT01582789|591743569|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163829358|NCT01582789|591743570|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163829359|NCT02364180|591743573|FG000|Overall Study|Screen Fail|1|||
163829360|NCT01783418|591743574|FG000|Overall Study|Withdrawal by Subject|1|||
163829361|NCT01783418|591743575|FG001|Overall Study|Withdrawal by Subject|0|||
163829362|NCT00508261|591743576|FG000|Overall Study|Other|0|||
163829363|NCT00508261|591743577|FG001|Overall Study|Other|1|||
163829364|NCT00508261|591743578|FG002|Overall Study|Other|1|||
163829365|NCT00508261|591743579|FG003|Overall Study|Other|0|||
163829366|NCT00508261|591743576|FG000|Overall Study|Serious Adverse Event|0|||
163829367|NCT00508261|591743577|FG001|Overall Study|Serious Adverse Event|1|||
163829368|NCT00508261|591743578|FG002|Overall Study|Serious Adverse Event|0|||
163829369|NCT00508261|591743579|FG003|Overall Study|Serious Adverse Event|0|||
163829370|NCT00508261|591743576|FG000|Overall Study|Withdrawal by Subject|3|||
163829371|NCT00508261|591743577|FG001|Overall Study|Withdrawal by Subject|4|||
163829372|NCT00508261|591743578|FG002|Overall Study|Withdrawal by Subject|4|||
163829373|NCT00508261|591743579|FG003|Overall Study|Withdrawal by Subject|0|||
163829374|NCT00508261|591743576|FG000|Overall Study|Migrated/ moved from study area|0|||
163829375|NCT00508261|591743577|FG001|Overall Study|Migrated/ moved from study area|1|||
163829376|NCT00508261|591743578|FG002|Overall Study|Migrated/ moved from study area|0|||
163829377|NCT00508261|591743579|FG003|Overall Study|Migrated/ moved from study area|0|||
163829378|NCT00508261|591743576|FG000|Overall Study|Lost to Follow-up|0|||
163829379|NCT00508261|591743577|FG001|Overall Study|Lost to Follow-up|1|||
163829380|NCT00508261|591743578|FG002|Overall Study|Lost to Follow-up|1|||
163829381|NCT00508261|591743579|FG003|Overall Study|Lost to Follow-up|1|||
163829382|NCT00180479|591743580|FG000|Overall Study|Death|4|||
163829383|NCT00180479|591743581|FG001|Overall Study|Death|2|||
163829384|NCT00180479|591743580|FG000|Overall Study|Lost to Follow-up|9|||
163829385|NCT00180479|591743581|FG001|Overall Study|Lost to Follow-up|7|||
163829386|NCT00180479|591743580|FG000|Overall Study|Withdrawal by Subject|3|||
163829387|NCT00180479|591743581|FG001|Overall Study|Withdrawal by Subject|3|||
163829388|NCT00180479|591743580|FG000|Overall Study|Informed consent not signed|0|||
163829389|NCT00180479|591743581|FG001|Overall Study|Informed consent not signed|1|||
163829390|NCT04044456|591743589|FG000|Overall Study|Lost to Follow-up|4|||
163925043|NCT02212197|592096492|FG002|Overall Study|Need for radiotherapy|0|||
163925044|NCT01078584|592096495|FG000|Overall Study|Final Status Unknown|1073|||
163925045|NCT01078584|592096495|FG000|Overall Study|Lost to Follow-up|670|||
163925046|NCT01078584|592096495|FG000|Overall Study|Non-serious Adverse Event|577|||
163925047|NCT01078584|592096495|FG000|Overall Study|Withdrawal of Consent|244|||
163925048|NCT01078584|592096495|FG000|Overall Study|Physician Withdrew from Study|90|||
163925049|NCT01078584|592096495|FG000|Overall Study|Non-compliance|67|||
163925050|NCT01078584|592096495|FG000|Overall Study|Blood Pressure Controlled|49|||
163925051|NCT01078584|592096495|FG000|Overall Study|Physician Switched Medication|26|||
163925052|NCT01078584|592096495|FG000|Overall Study|Physician Discontinued Patient|12|||
163925053|NCT01078584|592096495|FG000|Overall Study|Lack of Efficacy|98|||
163925054|NCT01078584|592096495|FG000|Overall Study|Protocol Violation|75|||
163925055|NCT01078584|592096495|FG000|Overall Study|Serious Adverse Event|27|||
163925056|NCT01078584|592096495|FG000|Overall Study|Multiple Reasons|2|||
163925057|NCT01208870|592096496|FG000|Overall Study|Lost to Follow-up|2|||
163925058|NCT01208870|592096497|FG001|Overall Study|Lost to Follow-up|8|||
163925059|NCT02979613|592096498|FG000|Double-Blind Phase|Withdrew Consent|2|||
163925060|NCT02979613|592096499|FG001|Double-Blind Phase|Withdrew Consent|4|||
163925061|NCT02979613|592096498|FG000|Double-Blind Phase|Pregnancy|2|||
163925062|NCT02979613|592096499|FG001|Double-Blind Phase|Pregnancy|2|||
163925063|NCT02979613|592096498|FG000|Double-Blind Phase|Adverse Event|2|||
163925064|NCT02979613|592096499|FG001|Double-Blind Phase|Adverse Event|0|||
163925065|NCT02979613|592096498|FG000|Double-Blind Phase|Lost to Follow-up|1|||
163925066|NCT02979613|592096499|FG001|Double-Blind Phase|Lost to Follow-up|1|||
163925067|NCT02979613|592096498|FG000|Double-Blind Phase|Protocol Violation|1|||
163925068|NCT02979613|592096499|FG001|Double-Blind Phase|Protocol Violation|1|||
163925069|NCT02979613|592096498|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
163925070|NCT02979613|592096499|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
163925071|NCT02979613|592096498|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
163925072|NCT02979613|592096499|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
163925073|NCT02979613|592096498|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
163925074|NCT02979613|592096499|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
163925075|NCT02979613|592096498|FG000|Open-Label Extension (OLE) Phase|Death|0|||
163925076|NCT02979613|592096499|FG001|Open-Label Extension (OLE) Phase|Death|1|||
163925077|NCT02979613|592096498|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
163925078|NCT02979613|592096499|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
163925079|NCT00919061|592096502|FG000|Overall Study|Adverse Event|1|||
163925080|NCT00919061|592096502|FG000|Overall Study|Withdrawal by Subject|1|||
163925081|NCT05294328|592096503|FG000|Overall Study|Adverse Event|1|||
163925082|NCT05294328|592096504|FG001|Overall Study|Adverse Event|0|||
163925083|NCT05294328|592096505|FG002|Overall Study|Adverse Event|0|||
163925084|NCT05294328|592096503|FG000|Overall Study|Physician Decision|1|||
163925085|NCT05294328|592096504|FG001|Overall Study|Physician Decision|1|||
164033787|NCT01617187|592482313|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
164033788|NCT01617187|592482310|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
164033789|NCT01617187|592482311|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
164033790|NCT01617187|592482312|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
164033791|NCT01617187|592482313|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
164033792|NCT01617187|592482310|FG000|Treatment Through Study Completion|Adverse Event|1|||
164033793|NCT01617187|592482311|FG001|Treatment Through Study Completion|Adverse Event|1|||
164033794|NCT01617187|592482312|FG002|Treatment Through Study Completion|Adverse Event|0|||
164033795|NCT01617187|592482313|FG003|Treatment Through Study Completion|Adverse Event|1|||
164033796|NCT01617187|592482310|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
164033797|NCT01617187|592482311|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
164033798|NCT01617187|592482312|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
164033799|NCT01617187|592482313|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
164033800|NCT01617187|592482310|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
164033801|NCT01617187|592482311|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
164033802|NCT01617187|592482312|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
164033803|NCT01617187|592482313|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
164033804|NCT01617187|592482310|FG000|Treatment Through Study Completion|Protocol Violation|1|||
164033805|NCT01617187|592482311|FG001|Treatment Through Study Completion|Protocol Violation|0|||
164033806|NCT01617187|592482312|FG002|Treatment Through Study Completion|Protocol Violation|0|||
164033807|NCT01617187|592482313|FG003|Treatment Through Study Completion|Protocol Violation|1|||
164033808|NCT01265420|592482314|FG000|Overall Study|Lost to Follow-up|1|||
164033809|NCT03337139|592482318|FG000|Phase I|Withdrawal by Subject|10|||
164033810|NCT03337139|592482319|FG001|Phase I|Withdrawal by Subject|0|||
164033811|NCT02554253|592482325|FG000|Overall Study|ineligible after enrollment|1|||
164033812|NCT02554253|592482326|FG001|Overall Study|ineligible after enrollment|0|||
164033813|NCT02554253|592482325|FG000|Overall Study|converted to transcatheter procedure|0|||
163829391|NCT04044456|591743590|FG001|Overall Study|Lost to Follow-up|1|||
163829392|NCT04044456|591743589|FG000|Overall Study|Withdrawal by Subject|1|||
163829393|NCT04044456|591743590|FG001|Overall Study|Withdrawal by Subject|0|||
163829394|NCT02316769|591743598|FG000|Overall Study|Physician Decision|1|||
163829395|NCT02316769|591743599|FG001|Overall Study|Physician Decision|0|||
163829396|NCT02316769|591743598|FG000|Overall Study|Withdrawal by Subject|1|||
163829397|NCT02316769|591743599|FG001|Overall Study|Withdrawal by Subject|0|||
163829398|NCT04209725|591743603|FG000|Overall Study|Adverse Event|1|||
163829399|NCT01281644|591743606|FG000|Overall Study|Lost to Follow-up|3|||
163829400|NCT01281644|591743606|FG000|Overall Study|Withdrawal by Subject|2|||
163829401|NCT02954354|591743607|FG000|Overall Study|Adverse Event|2|||
163829402|NCT02954354|591743608|FG001|Overall Study|Adverse Event|2|||
163829403|NCT02954354|591743609|FG002|Overall Study|Adverse Event|4|||
163829404|NCT02954354|591743607|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
163829405|NCT02954354|591743608|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
163829406|NCT02954354|591743609|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
163829407|NCT02954354|591743607|FG000|Overall Study|Lack of Efficacy|0|||
163829408|NCT02954354|591743608|FG001|Overall Study|Lack of Efficacy|2|||
163829409|NCT02954354|591743609|FG002|Overall Study|Lack of Efficacy|0|||
163829410|NCT02954354|591743607|FG000|Overall Study|Withdrawal by Subject|17|||
163829411|NCT02954354|591743608|FG001|Overall Study|Withdrawal by Subject|9|||
163829412|NCT02954354|591743609|FG002|Overall Study|Withdrawal by Subject|11|||
163829413|NCT02954354|591743607|FG000|Overall Study|Lost to Follow-up|12|||
163829414|NCT02954354|591743608|FG001|Overall Study|Lost to Follow-up|5|||
163829415|NCT02954354|591743609|FG002|Overall Study|Lost to Follow-up|0|||
163829416|NCT02954354|591743607|FG000|Overall Study|Miscellaneous|2|||
163829417|NCT02954354|591743608|FG001|Overall Study|Miscellaneous|2|||
163829418|NCT02954354|591743609|FG002|Overall Study|Miscellaneous|1|||
163829419|NCT03039023|591743612|FG000|Overall Study|Withdrawal by Subject|1|||
163829420|NCT03039023|591743613|FG001|Overall Study|Withdrawal by Subject|0|||
163829421|NCT03039023|591743614|FG002|Overall Study|Withdrawal by Subject|1|||
163829422|NCT03039023|591743615|FG003|Overall Study|Withdrawal by Subject|1|||
163829423|NCT03039023|591743616|FG004|Overall Study|Withdrawal by Subject|0|||
163829424|NCT03039023|591743612|FG000|Overall Study|Physician Decision|0|||
163829425|NCT03039023|591743613|FG001|Overall Study|Physician Decision|0|||
163829426|NCT03039023|591743614|FG002|Overall Study|Physician Decision|0|||
163829427|NCT03039023|591743615|FG003|Overall Study|Physician Decision|1|||
163829428|NCT03039023|591743616|FG004|Overall Study|Physician Decision|0|||
163829429|NCT03338829|591743618|FG000|Overall Study|Lost to Follow-up|4|||
163829430|NCT03338829|591743619|FG001|Overall Study|Lost to Follow-up|2|||
163829431|NCT03338829|591743620|FG002|Overall Study|Lost to Follow-up|4|||
163829432|NCT03338829|591743618|FG000|Overall Study|Pregnancy loss|1|||
163829433|NCT03338829|591743619|FG001|Overall Study|Pregnancy loss|1|||
163829434|NCT03338829|591743620|FG002|Overall Study|Pregnancy loss|0|||
163829435|NCT03338829|591743618|FG000|Overall Study|Protocol Violation|0|||
163829436|NCT03338829|591743619|FG001|Overall Study|Protocol Violation|1|||
163925086|NCT05294328|592096505|FG002|Overall Study|Physician Decision|0|||
163925087|NCT05294328|592096503|FG000|Overall Study|Withdrawal by Subject|0|||
163925088|NCT05294328|592096504|FG001|Overall Study|Withdrawal by Subject|2|||
163925089|NCT05294328|592096505|FG002|Overall Study|Withdrawal by Subject|1|||
163925090|NCT05294328|592096503|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
163925091|NCT05294328|592096504|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
163925092|NCT05294328|592096505|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
163925093|NCT02056873|592096506|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
163925094|NCT02388347|592098553|FG000|Overall Study|Withdrawal by Subject|0|||
163925095|NCT02388347|592098554|FG001|Overall Study|Withdrawal by Subject|0|||
163925096|NCT02388347|592098555|FG002|Overall Study|Withdrawal by Subject|1|||
163925097|NCT02388347|592098556|FG003|Overall Study|Withdrawal by Subject|0|||
163925098|NCT02388347|592098557|FG004|Overall Study|Withdrawal by Subject|0|||
163925099|NCT02820597|592098558|FG000|Overall Study|Lost to Follow-up|12|||
163925100|NCT01475461|592098559|FG000|Run-in Period|Not meet eligibility criteria|16|||
163925101|NCT01475461|592098560|FG001|Run-in Period|Not meet eligibility criteria|0|||
163925102|NCT01475461|592098561|FG002|Run-in Period|Not meet eligibility criteria|0|||
163925103|NCT01475461|592098562|FG003|Run-in Period|Not meet eligibility criteria|0|||
163925104|NCT01475461|592098563|FG004|Run-in Period|Not meet eligibility criteria|0|||
163925105|NCT01475461|592098564|FG005|Run-in Period|Not meet eligibility criteria|0|||
163925106|NCT01475461|592098565|FG006|Run-in Period|Not meet eligibility criteria|0|||
163925107|NCT01475461|592098559|FG000|Run-in Period|Lost to Follow-up|7|||
163925108|NCT01475461|592098560|FG001|Run-in Period|Lost to Follow-up|0|||
163925109|NCT01475461|592098561|FG002|Run-in Period|Lost to Follow-up|0|||
163925110|NCT01475461|592098562|FG003|Run-in Period|Lost to Follow-up|0|||
163925111|NCT01475461|592098563|FG004|Run-in Period|Lost to Follow-up|0|||
163925112|NCT01475461|592098564|FG005|Run-in Period|Lost to Follow-up|0|||
163925113|NCT01475461|592098565|FG006|Run-in Period|Lost to Follow-up|0|||
163925114|NCT01475461|592098559|FG000|Run-in Period|Withdrawal by Subject|11|||
163925115|NCT01475461|592098560|FG001|Run-in Period|Withdrawal by Subject|0|||
163925116|NCT01475461|592098561|FG002|Run-in Period|Withdrawal by Subject|0|||
163925117|NCT01475461|592098562|FG003|Run-in Period|Withdrawal by Subject|0|||
163925118|NCT01475461|592098563|FG004|Run-in Period|Withdrawal by Subject|0|||
163925119|NCT01475461|592098564|FG005|Run-in Period|Withdrawal by Subject|0|||
163925120|NCT01475461|592098565|FG006|Run-in Period|Withdrawal by Subject|0|||
163925121|NCT01475461|592098559|FG000|Run-in Period|Other|3|||
163925122|NCT01475461|592098560|FG001|Run-in Period|Other|0|||
163925123|NCT01475461|592098561|FG002|Run-in Period|Other|0|||
163925124|NCT01475461|592098562|FG003|Run-in Period|Other|0|||
163925125|NCT01475461|592098563|FG004|Run-in Period|Other|0|||
163925126|NCT01475461|592098564|FG005|Run-in Period|Other|0|||
163925127|NCT01475461|592098565|FG006|Run-in Period|Other|0|||
163925128|NCT01475461|592098559|FG000|Run-in Period|Protocol Violation|4|||
163925129|NCT01475461|592098560|FG001|Run-in Period|Protocol Violation|0|||
163925130|NCT01475461|592098561|FG002|Run-in Period|Protocol Violation|0|||
163925131|NCT01475461|592098562|FG003|Run-in Period|Protocol Violation|0|||
163925132|NCT01475461|592098563|FG004|Run-in Period|Protocol Violation|0|||
163925133|NCT01475461|592098564|FG005|Run-in Period|Protocol Violation|0|||
163925134|NCT01475461|592098565|FG006|Run-in Period|Protocol Violation|0|||
163925135|NCT01475461|592098559|FG000|Treatment Period|Death|0|||
163925136|NCT01475461|592098560|FG001|Treatment Period|Death|0|||
163925137|NCT01475461|592098561|FG002|Treatment Period|Death|0|||
163925138|NCT01475461|592098562|FG003|Treatment Period|Death|1|||
163925139|NCT01475461|592098563|FG004|Treatment Period|Death|0|||
163925140|NCT01475461|592098564|FG005|Treatment Period|Death|0|||
163925141|NCT01475461|592098565|FG006|Treatment Period|Death|0|||
163925142|NCT01475461|592098559|FG000|Treatment Period|Lost to Follow-up|0|||
163925143|NCT01475461|592098560|FG001|Treatment Period|Lost to Follow-up|3|||
163925144|NCT01475461|592098561|FG002|Treatment Period|Lost to Follow-up|2|||
163925145|NCT01475461|592098562|FG003|Treatment Period|Lost to Follow-up|3|||
163925146|NCT01475461|592098563|FG004|Treatment Period|Lost to Follow-up|1|||
163925147|NCT01475461|592098564|FG005|Treatment Period|Lost to Follow-up|2|||
163925148|NCT01475461|592098565|FG006|Treatment Period|Lost to Follow-up|1|||
163925149|NCT01475461|592098559|FG000|Treatment Period|Withdrawal by Subject|0|||
163925150|NCT01475461|592098560|FG001|Treatment Period|Withdrawal by Subject|2|||
163925151|NCT01475461|592098561|FG002|Treatment Period|Withdrawal by Subject|2|||
163925152|NCT01475461|592098562|FG003|Treatment Period|Withdrawal by Subject|0|||
163925153|NCT01475461|592098563|FG004|Treatment Period|Withdrawal by Subject|2|||
163925154|NCT01475461|592098564|FG005|Treatment Period|Withdrawal by Subject|2|||
163925155|NCT01475461|592098565|FG006|Treatment Period|Withdrawal by Subject|0|||
163925156|NCT01475461|592098559|FG000|Treatment Period|Other|0|||
163925157|NCT01475461|592098560|FG001|Treatment Period|Other|1|||
163925158|NCT01475461|592098561|FG002|Treatment Period|Other|0|||
163925159|NCT01475461|592098562|FG003|Treatment Period|Other|0|||
163925160|NCT01475461|592098563|FG004|Treatment Period|Other|0|||
163925161|NCT01475461|592098564|FG005|Treatment Period|Other|0|||
163925162|NCT01475461|592098565|FG006|Treatment Period|Other|0|||
164033814|NCT02554253|592482326|FG001|Overall Study|converted to transcatheter procedure|1|||
163925163|NCT01475461|592098559|FG000|Treatment Period|Protocol Violation|0|||
163925164|NCT01475461|592098560|FG001|Treatment Period|Protocol Violation|1|||
163925165|NCT01475461|592098561|FG002|Treatment Period|Protocol Violation|0|||
163925166|NCT01475461|592098562|FG003|Treatment Period|Protocol Violation|0|||
163925167|NCT01475461|592098563|FG004|Treatment Period|Protocol Violation|0|||
163925168|NCT01475461|592098564|FG005|Treatment Period|Protocol Violation|0|||
163925169|NCT01475461|592098565|FG006|Treatment Period|Protocol Violation|1|||
163925170|NCT01475461|592098559|FG000|Treatment Period|Lack of Efficacy|0|||
163925171|NCT01475461|592098560|FG001|Treatment Period|Lack of Efficacy|2|||
163925172|NCT01475461|592098561|FG002|Treatment Period|Lack of Efficacy|0|||
163925173|NCT01475461|592098562|FG003|Treatment Period|Lack of Efficacy|2|||
163925174|NCT01475461|592098563|FG004|Treatment Period|Lack of Efficacy|1|||
163925175|NCT01475461|592098564|FG005|Treatment Period|Lack of Efficacy|1|||
163925176|NCT01475461|592098565|FG006|Treatment Period|Lack of Efficacy|0|||
163925177|NCT01475461|592098559|FG000|Treatment Period|Medication Error|0|||
163925178|NCT01475461|592098560|FG001|Treatment Period|Medication Error|0|||
163925179|NCT01475461|592098561|FG002|Treatment Period|Medication Error|0|||
163925180|NCT01475461|592098562|FG003|Treatment Period|Medication Error|1|||
163925181|NCT01475461|592098563|FG004|Treatment Period|Medication Error|0|||
163925182|NCT01475461|592098564|FG005|Treatment Period|Medication Error|0|||
163925183|NCT01475461|592098565|FG006|Treatment Period|Medication Error|0|||
163925184|NCT01475461|592098559|FG000|Treatment Period|Adverse Event|0|||
163925185|NCT01475461|592098560|FG001|Treatment Period|Adverse Event|0|||
163925186|NCT01475461|592098561|FG002|Treatment Period|Adverse Event|0|||
163925187|NCT01475461|592098562|FG003|Treatment Period|Adverse Event|1|||
163925188|NCT01475461|592098563|FG004|Treatment Period|Adverse Event|0|||
163925189|NCT01475461|592098564|FG005|Treatment Period|Adverse Event|0|||
163925190|NCT01475461|592098565|FG006|Treatment Period|Adverse Event|0|||
163925191|NCT04051242|592098566|FG000|Overall Study|Withdrawal by Subject|1|||
163925192|NCT04051242|592098566|FG000|Overall Study|Physician Decision|1|||
163925193|NCT02262364|592098567|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
163925194|NCT01049984|592098568|FG000|Overall Study|Withdrawal by Subject|1|||
163925195|NCT01049984|592098569|FG001|Overall Study|Withdrawal by Subject|5|||
163925196|NCT01049984|592098568|FG000|Overall Study|Protocol Violation|3|||
163925197|NCT01049984|592098569|FG001|Overall Study|Protocol Violation|4|||
163925198|NCT01049984|592098568|FG000|Overall Study|Lost to Follow-up|2|||
163925199|NCT01049984|592098569|FG001|Overall Study|Lost to Follow-up|1|||
163925200|NCT01049984|592098568|FG000|Overall Study|Adverse Event|13|||
163925201|NCT01049984|592098569|FG001|Overall Study|Adverse Event|7|||
163925202|NCT01049984|592098568|FG000|Overall Study|Treatment failure|0|||
163925203|NCT01049984|592098569|FG001|Overall Study|Treatment failure|2|||
163925204|NCT00337285|592098570|FG000|Overall Study|Withdrawal by Subject|42|||
163925205|NCT00337285|592098570|FG000|Overall Study|Lost to Follow-up|41|||
163925206|NCT00337285|592098570|FG000|Overall Study|Adverse Event|28|||
163925207|NCT00337285|592098570|FG000|Overall Study|Protocol Violation|27|||
163925208|NCT00337285|592098570|FG000|Overall Study|Lack of Efficacy|11|||
163925209|NCT00337285|592098570|FG000|Overall Study|Death|1|||
163925210|NCT00337285|592098570|FG000|Overall Study|Physician Decision|1|||
163925211|NCT00337285|592098570|FG000|Overall Study|Lack of protocol compliance|7|||
163925212|NCT00553605|592098571|FG000|Overall Study|Did not meet entrance criteria|1|||
163925213|NCT00553605|592098572|FG001|Overall Study|Did not meet entrance criteria|3|||
163925214|NCT00553605|592098571|FG000|Overall Study|Did not receive full dose|1|||
163925215|NCT00553605|592098572|FG001|Overall Study|Did not receive full dose|0|||
163925216|NCT00553605|592098571|FG000|Overall Study|Randomized but not treated|2|||
163925217|NCT00553605|592098572|FG001|Overall Study|Randomized but not treated|0|||
163925218|NCT01040403|592098576|FG000|Overall Study|Adverse Event|10|||
163925219|NCT01040403|592098576|FG000|Overall Study|Protocol Violation|2|||
163925220|NCT01040403|592098576|FG000|Overall Study|Lost to Follow-up|1|||
163925221|NCT01040403|592098576|FG000|Overall Study|Not treated|1|||
163925222|NCT01040403|592098576|FG000|Overall Study|Other reason not defined above|6|||
163925223|NCT01085812|592098578|FG000|Open-Label Period|Adverse Event|0|||
163925224|NCT01085812|592098579|FG001|Open-Label Period|Adverse Event|80|||
163925225|NCT01085812|592098578|FG000|Open-Label Period|Lack of Efficacy|0|||
163925226|NCT01085812|592098579|FG001|Open-Label Period|Lack of Efficacy|26|||
163925227|NCT01085812|592098578|FG000|Open-Label Period|Protocol Violation|0|||
163925228|NCT01085812|592098579|FG001|Open-Label Period|Protocol Violation|39|||
163925229|NCT01085812|592098578|FG000|Open-Label Period|Withdrawal by Subject|0|||
163925230|NCT01085812|592098579|FG001|Open-Label Period|Withdrawal by Subject|53|||
163925231|NCT01085812|592098578|FG000|Open-Label Period|Lost to Follow-up|0|||
163925232|NCT01085812|592098579|FG001|Open-Label Period|Lost to Follow-up|42|||
163925233|NCT01085812|592098578|FG000|Double-Blind Period|Adverse Event|3|||
163925234|NCT01085812|592098579|FG001|Double-Blind Period|Adverse Event|8|||
163925235|NCT01085812|592098578|FG000|Double-Blind Period|Protocol Violation|2|||
163925236|NCT01085812|592098579|FG001|Double-Blind Period|Protocol Violation|7|||
163925237|NCT01085812|592098578|FG000|Double-Blind Period|Withdrawal by Subject|11|||
163925238|NCT01085812|592098579|FG001|Double-Blind Period|Withdrawal by Subject|24|||
163925239|NCT01085812|592098578|FG000|Double-Blind Period|Lost to Follow-up|5|||
163925240|NCT01085812|592098579|FG001|Double-Blind Period|Lost to Follow-up|17|||
163925241|NCT01085812|592098578|FG000|Double-Blind Period|Other Reasons|0|||
163925242|NCT01085812|592098579|FG001|Double-Blind Period|Other Reasons|2|||
163925243|NCT01085812|592098578|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
163925244|NCT01085812|592098579|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
163925245|NCT01085812|592098578|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
163925246|NCT01085812|592098579|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
163925247|NCT01085812|592098578|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
163925248|NCT01085812|592098579|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
163925249|NCT01085812|592098578|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
163925250|NCT01085812|592098579|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
163925251|NCT01085812|592098578|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
163925252|NCT01085812|592098579|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
163925253|NCT00594178|592098580|FG000|Overall Study|Physician Decision|5|||
163925254|NCT04582669|592098587|FG000|Overall Study|Subject missed appointment(s).|1|||
163925255|NCT04582669|592098588|FG001|Overall Study|Subject missed appointment(s).|0|||
163925256|NCT04582669|592098589|FG002|Overall Study|Subject missed appointment(s).|1|||
163925257|NCT04582669|592098590|FG003|Overall Study|Subject missed appointment(s).|2|||
163925258|NCT04582669|592098587|FG000|Overall Study|Protocol Violation|0|||
163925259|NCT04582669|592098588|FG001|Overall Study|Protocol Violation|1|||
163925260|NCT04582669|592098589|FG002|Overall Study|Protocol Violation|1|||
163925261|NCT04582669|592098590|FG003|Overall Study|Protocol Violation|0|||
163925262|NCT01874665|592098591|FG000|Overall Study|Adverse Event|6|||
163925263|NCT01874665|592098592|FG001|Overall Study|Adverse Event|2|||
163925264|NCT01874665|592098591|FG000|Overall Study|Withdrawal by Subject|4|||
163925265|NCT01874665|592098592|FG001|Overall Study|Withdrawal by Subject|1|||
163925266|NCT01874665|592098591|FG000|Overall Study|Physician Decision|3|||
163925267|NCT01874665|592098592|FG001|Overall Study|Physician Decision|0|||
163925268|NCT01874665|592098591|FG000|Overall Study|Clinical Progressive Disease|4|||
163925269|NCT01874665|592098592|FG001|Overall Study|Clinical Progressive Disease|3|||
163925270|NCT01874665|592098591|FG000|Overall Study|Study Terminated by Sponsor|0|||
163925271|NCT01874665|592098592|FG001|Overall Study|Study Terminated by Sponsor|2|||
163925272|NCT01874665|592098591|FG000|Overall Study|Documented Progressive Disease|11|||
163925273|NCT01874665|592098592|FG001|Overall Study|Documented Progressive Disease|7|||
163925274|NCT01874665|592098591|FG000|Overall Study|Other|2|||
164033815|NCT02554253|592482325|FG000|Overall Study|received both drugs|0|||
164033816|NCT02554253|592482326|FG001|Overall Study|received both drugs|1|||
164033817|NCT03288493|592482328|FG000|Overall Study|Withdrawal by Subject|4|||
164033818|NCT03288493|592482329|FG001|Overall Study|Withdrawal by Subject|0|||
164033819|NCT03288493|592482330|FG002|Overall Study|Withdrawal by Subject|0|||
164033820|NCT03288493|592482331|FG003|Overall Study|Withdrawal by Subject|0|||
164033821|NCT03288493|592482332|FG004|Overall Study|Withdrawal by Subject|0|||
164033822|NCT03288493|592482333|FG005|Overall Study|Withdrawal by Subject|2|||
164033823|NCT03288493|592482334|FG006|Overall Study|Withdrawal by Subject|0|||
164033824|NCT03288493|592482328|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
164033825|NCT03288493|592482329|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
164033826|NCT03288493|592482330|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
164033827|NCT03288493|592482331|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
164033828|NCT03288493|592482332|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
164033829|NCT03288493|592482333|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
164033830|NCT03288493|592482334|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
164033831|NCT03288493|592482328|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
164033832|NCT03288493|592482329|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164033833|NCT03288493|592482330|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164033834|NCT03288493|592482331|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
164033835|NCT03288493|592482332|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164033836|NCT03288493|592482333|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
164033837|NCT03288493|592482334|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
164033838|NCT03288493|592482328|FG000|Overall Study|Death|2|||
164033839|NCT03288493|592482329|FG001|Overall Study|Death|0|||
164033840|NCT03288493|592482330|FG002|Overall Study|Death|0|||
164033841|NCT03288493|592482331|FG003|Overall Study|Death|0|||
164033842|NCT03288493|592482332|FG004|Overall Study|Death|0|||
164033843|NCT03288493|592482333|FG005|Overall Study|Death|0|||
164033844|NCT03288493|592482334|FG006|Overall Study|Death|0|||
164033845|NCT03288493|592482328|FG000|Overall Study|other reason not listed above|2|||
164033846|NCT03288493|592482329|FG001|Overall Study|other reason not listed above|0|||
164033847|NCT03288493|592482330|FG002|Overall Study|other reason not listed above|0|||
164033848|NCT03288493|592482331|FG003|Overall Study|other reason not listed above|0|||
164033849|NCT03288493|592482332|FG004|Overall Study|other reason not listed above|0|||
164033850|NCT03288493|592482333|FG005|Overall Study|other reason not listed above|0|||
164033851|NCT03288493|592482334|FG006|Overall Study|other reason not listed above|0|||
164033852|NCT02559206|592482335|FG000|Overall Study|Adverse Event|0|||
164033853|NCT02559206|592482336|FG001|Overall Study|Adverse Event|4|||
164033854|NCT02559206|592482337|FG002|Overall Study|Adverse Event|1|||
164033855|NCT02559206|592482338|FG003|Overall Study|Adverse Event|5|||
164033856|NCT02559206|592482339|FG004|Overall Study|Adverse Event|3|||
164033857|NCT02559206|592482340|FG005|Overall Study|Adverse Event|0|||
164033858|NCT02559206|592482341|FG006|Overall Study|Adverse Event|1|||
164033859|NCT02559206|592482342|FG007|Overall Study|Adverse Event|0|||
164033860|NCT02559206|592482335|FG000|Overall Study|Protocol Violation|1|||
164033861|NCT02559206|592482336|FG001|Overall Study|Protocol Violation|0|||
164033862|NCT02559206|592482337|FG002|Overall Study|Protocol Violation|1|||
164033863|NCT02559206|592482338|FG003|Overall Study|Protocol Violation|0|||
164033864|NCT02559206|592482339|FG004|Overall Study|Protocol Violation|0|||
164033865|NCT02559206|592482340|FG005|Overall Study|Protocol Violation|2|||
164033866|NCT02559206|592482341|FG006|Overall Study|Protocol Violation|0|||
164033867|NCT02559206|592482342|FG007|Overall Study|Protocol Violation|0|||
164033868|NCT02559206|592482335|FG000|Overall Study|Withdrawal by Subject|3|||
164033869|NCT02559206|592482336|FG001|Overall Study|Withdrawal by Subject|3|||
164033870|NCT02559206|592482337|FG002|Overall Study|Withdrawal by Subject|1|||
164033871|NCT02559206|592482338|FG003|Overall Study|Withdrawal by Subject|3|||
164033872|NCT02559206|592482339|FG004|Overall Study|Withdrawal by Subject|5|||
164033873|NCT02559206|592482340|FG005|Overall Study|Withdrawal by Subject|4|||
164033874|NCT02559206|592482341|FG006|Overall Study|Withdrawal by Subject|1|||
164033875|NCT02559206|592482342|FG007|Overall Study|Withdrawal by Subject|2|||
164033876|NCT02559206|592482335|FG000|Overall Study|Lost to Follow-up|3|||
164033877|NCT02559206|592482336|FG001|Overall Study|Lost to Follow-up|5|||
164033878|NCT02559206|592482337|FG002|Overall Study|Lost to Follow-up|3|||
164033879|NCT02559206|592482338|FG003|Overall Study|Lost to Follow-up|3|||
164033880|NCT02559206|592482339|FG004|Overall Study|Lost to Follow-up|2|||
164033881|NCT02559206|592482340|FG005|Overall Study|Lost to Follow-up|5|||
164033882|NCT02559206|592482341|FG006|Overall Study|Lost to Follow-up|1|||
164033883|NCT02559206|592482342|FG007|Overall Study|Lost to Follow-up|4|||
164033884|NCT02559206|592482335|FG000|Overall Study|Lack of Efficacy|1|||
164033885|NCT02559206|592482336|FG001|Overall Study|Lack of Efficacy|0|||
164033886|NCT02559206|592482337|FG002|Overall Study|Lack of Efficacy|3|||
164033887|NCT02559206|592482338|FG003|Overall Study|Lack of Efficacy|2|||
164033888|NCT02559206|592482339|FG004|Overall Study|Lack of Efficacy|2|||
164033889|NCT02559206|592482340|FG005|Overall Study|Lack of Efficacy|3|||
164033890|NCT02559206|592482341|FG006|Overall Study|Lack of Efficacy|3|||
164033891|NCT02559206|592482342|FG007|Overall Study|Lack of Efficacy|3|||
164033892|NCT02559206|592482335|FG000|Overall Study|Other Not Specified|0|||
164033893|NCT02559206|592482336|FG001|Overall Study|Other Not Specified|0|||
164033894|NCT02559206|592482337|FG002|Overall Study|Other Not Specified|0|||
164033895|NCT02559206|592482338|FG003|Overall Study|Other Not Specified|1|||
164033896|NCT02559206|592482339|FG004|Overall Study|Other Not Specified|0|||
163829437|NCT03338829|591743620|FG002|Overall Study|Protocol Violation|0|||
163829438|NCT00448448|591743624|FG000|Overall Study|Withdrawal by Subject|13|||
163829439|NCT00448448|591743625|FG001|Overall Study|Withdrawal by Subject|2|||
163829440|NCT00448448|591743624|FG000|Overall Study|On protocol when study ended|83|||
163829441|NCT00448448|591743625|FG001|Overall Study|On protocol when study ended|36|||
163829442|NCT00448448|591743624|FG000|Overall Study|Lost to Follow-up|2|||
163829443|NCT00448448|591743625|FG001|Overall Study|Lost to Follow-up|1|||
163829444|NCT00448448|591743624|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
163829445|NCT00448448|591743625|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
163829446|NCT00448448|591743624|FG000|Overall Study|Signed consent lost|0|||
163829447|NCT00448448|591743625|FG001|Overall Study|Signed consent lost|1|||
163829448|NCT02340026|591743626|FG000|Treatment Phase|Withdrawal by Subject|2|||
163829449|NCT02340026|591743627|FG001|Treatment Phase|Withdrawal by Subject|2|||
164033897|NCT02559206|592482340|FG005|Overall Study|Other Not Specified|0|||
164033898|NCT02559206|592482341|FG006|Overall Study|Other Not Specified|0|||
163829450|NCT02340026|591743626|FG000|Follow-up Phase|Lost to Follow-up|1|||
163829451|NCT02340026|591743627|FG001|Follow-up Phase|Lost to Follow-up|0|||
164033899|NCT02559206|592482342|FG007|Overall Study|Other Not Specified|0|||
164033900|NCT01561560|592482343|FG000|First Two Weeks of Wear|Time/job conflict|0|||
163829452|NCT02684006|591743628|FG000|Overall Study|Other|18|||
164033901|NCT01561560|592482344|FG001|First Two Weeks of Wear|Time/job conflict|1|||
164033902|NCT01561560|592482343|FG000|First Two Weeks of Wear|Adverse Event|0|||
164033903|NCT01561560|592482344|FG001|First Two Weeks of Wear|Adverse Event|1|||
164033904|NCT01561560|592482343|FG000|Second Two Weeks of Wear|Adverse Event|0|||
164033905|NCT01561560|592482344|FG001|Second Two Weeks of Wear|Adverse Event|1|||
163829453|NCT02684006|591743629|FG001|Overall Study|Other|6|||
164033906|NCT03862131|592482345|FG000|Overall Study|Lost to Follow-up|1|||
163829454|NCT02684006|591743628|FG000|Overall Study|Protocol Violation|2|||
163829455|NCT02684006|591743629|FG001|Overall Study|Protocol Violation|1|||
163829456|NCT02684006|591743628|FG000|Overall Study|Non-compliance with study drug|1|||
163829457|NCT02684006|591743629|FG001|Overall Study|Non-compliance with study drug|1|||
163829458|NCT02684006|591743628|FG000|Overall Study|No longer met eligibility criteria|6|||
163829459|NCT02684006|591743629|FG001|Overall Study|No longer met eligibility criteria|2|||
163829460|NCT02684006|591743628|FG000|Overall Study|Lost to Follow-up|0|||
163829461|NCT02684006|591743629|FG001|Overall Study|Lost to Follow-up|1|||
163829462|NCT02684006|591743628|FG000|Overall Study|Death|25|||
164033907|NCT03862131|592482346|FG001|Overall Study|Lost to Follow-up|0|||
164033908|NCT03862131|592482347|FG002|Overall Study|Lost to Follow-up|1|||
164033909|NCT03862131|592482345|FG000|Overall Study|Determined to be ineligible|0|||
164033910|NCT03862131|592482346|FG001|Overall Study|Determined to be ineligible|0|||
164033911|NCT03862131|592482347|FG002|Overall Study|Determined to be ineligible|5|||
164033912|NCT03862131|592482345|FG000|Overall Study|Death|4|||
164033913|NCT03862131|592482346|FG001|Overall Study|Death|4|||
164033914|NCT03862131|592482347|FG002|Overall Study|Death|0|||
164033915|NCT03862131|592482345|FG000|Overall Study|Withdrawal by Subject|5|||
164033916|NCT03862131|592482346|FG001|Overall Study|Withdrawal by Subject|3|||
164033917|NCT03862131|592482347|FG002|Overall Study|Withdrawal by Subject|0|||
164033918|NCT03862131|592482345|FG000|Overall Study|Physician Decision|0|||
164033919|NCT03862131|592482346|FG001|Overall Study|Physician Decision|1|||
164033920|NCT03862131|592482347|FG002|Overall Study|Physician Decision|0|||
164033921|NCT01871896|592482350|FG000|Overall Study|Lost to Follow-up|1|||
164033922|NCT03127852|592484279|FG000|Overall Study|Withdrawal by Subject|4|||
164033923|NCT03127852|592484280|FG001|Overall Study|Withdrawal by Subject|1|||
164033924|NCT03127852|592484279|FG000|Overall Study|Death|1|||
164033925|NCT03127852|592484280|FG001|Overall Study|Death|1|||
164033926|NCT03382262|592484281|FG000|Overall Study|Physician Decision|0|||
164033927|NCT03382262|592484282|FG001|Overall Study|Physician Decision|0|||
164033928|NCT03382262|592484283|FG002|Overall Study|Physician Decision|1|||
164033929|NCT03382262|592484284|FG003|Overall Study|Physician Decision|0|||
164033930|NCT03382262|592484281|FG000|Overall Study|Withdrawal by Subject|0|||
164033931|NCT03382262|592484282|FG001|Overall Study|Withdrawal by Subject|0|||
164033932|NCT03382262|592484283|FG002|Overall Study|Withdrawal by Subject|0|||
164033933|NCT03382262|592484284|FG003|Overall Study|Withdrawal by Subject|1|||
164033934|NCT03518034|592484285|FG000|Overall Study|Not Treated|5|||
164033935|NCT03518034|592484286|FG001|Overall Study|Not Treated|1|||
164033936|NCT03518034|592484285|FG000|Overall Study|Withdrawal by Subject|309|||
164033937|NCT03518034|592484286|FG001|Overall Study|Withdrawal by Subject|351|||
164033938|NCT03518034|592484285|FG000|Overall Study|Lost to Follow-up|446|||
164033939|NCT03518034|592484286|FG001|Overall Study|Lost to Follow-up|458|||
164033940|NCT03518034|592484285|FG000|Overall Study|Adverse Event|138|||
164033941|NCT03518034|592484286|FG001|Overall Study|Adverse Event|130|||
164033942|NCT03518034|592484285|FG000|Overall Study|Lack of Efficacy|11|||
164033943|NCT03518034|592484286|FG001|Overall Study|Lack of Efficacy|23|||
164033944|NCT03518034|592484285|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
164033945|NCT03518034|592484286|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
164033946|NCT03518034|592484285|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
164033947|NCT03518034|592484286|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
164033948|NCT03518034|592484285|FG000|Overall Study|Other, Not Specified|84|||
164033949|NCT03518034|592484286|FG001|Overall Study|Other, Not Specified|53|||
164033950|NCT03518034|592484285|FG000|Overall Study|Reason Missing|2|||
164033951|NCT03518034|592484286|FG001|Overall Study|Reason Missing|3|||
164033952|NCT00126581|592484287|FG000|Overall Study|Adverse Event|3|||
164033953|NCT00126581|592484288|FG001|Overall Study|Adverse Event|7|||
164033954|NCT00126581|592484287|FG000|Overall Study|Death|3|||
164033955|NCT00126581|592484288|FG001|Overall Study|Death|2|||
164033956|NCT00126581|592484287|FG000|Overall Study|Withdrawal by Subject|1|||
164033957|NCT00126581|592484288|FG001|Overall Study|Withdrawal by Subject|4|||
164033958|NCT00126581|592484287|FG000|Overall Study|Alternative therapy|3|||
164033959|NCT00126581|592484288|FG001|Overall Study|Alternative therapy|3|||
164033960|NCT00126581|592484287|FG000|Overall Study|Other illness/MD discretion|3|||
164033961|NCT00126581|592484288|FG001|Overall Study|Other illness/MD discretion|4|||
164033962|NCT03728140|592484289|FG000|Overall Study|Abnormal embryo transfer operation|10|||
164033963|NCT03728140|592484290|FG001|Overall Study|Abnormal embryo transfer operation|7|||
164033964|NCT02007252|592484299|FG000|Overall Study|Administrative problems|3|||
164033965|NCT02007252|592484300|FG001|Overall Study|Administrative problems|7|||
164033966|NCT02007252|592484299|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163829463|NCT02684006|591743629|FG001|Overall Study|Death|22|||
163829464|NCT02684006|591743628|FG000|Overall Study|Global deterioration of health status|18|||
164033967|NCT02007252|592484300|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164033968|NCT02007252|592484299|FG000|Overall Study|Adverse Event|7|||
164033969|NCT02007252|592484300|FG001|Overall Study|Adverse Event|4|||
164033970|NCT03325556|592484301|FG000|Open-label Period|Lack of Response in OL period|70|||
164033971|NCT03325556|592484302|FG001|Open-label Period|Lack of Response in OL period|0|||
164033972|NCT03325556|592484303|FG002|Open-label Period|Lack of Response in OL period|0|||
164033973|NCT03325556|592484301|FG000|Open-label Period|Adverse Event|27|||
163925275|NCT01874665|592098592|FG001|Overall Study|Other|0|||
163925276|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
163925277|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
163925278|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
163925279|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
163925280|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
163925281|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
163925282|NCT03201900|592098593|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
163925283|NCT03201900|592098593|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
163925284|NCT03201900|592098593|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
163925285|NCT03201900|592098593|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
163925286|NCT03201900|592098593|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
163925287|NCT03201900|592098593|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
163925288|NCT03201900|592098593|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
163925289|NCT01233999|592098594|FG000|Overall Study|Withdrawal by Subject|1|||
163925290|NCT01233999|592098594|FG000|Overall Study|Lost to Follow-up|1|||
163925291|NCT00550446|592098595|FG000|Up To Week 12|Adverse Event|2|||
163925292|NCT00550446|592098596|FG001|Up To Week 12|Adverse Event|2|||
163925293|NCT00550446|592098597|FG002|Up To Week 12|Adverse Event|0|||
163925294|NCT00550446|592098598|FG003|Up To Week 12|Adverse Event|0|||
163925295|NCT00550446|592098599|FG004|Up To Week 12|Adverse Event|2|||
163925296|NCT00550446|592098600|FG005|Up To Week 12|Adverse Event|2|||
163925297|NCT00550446|592098601|FG006|Up To Week 12|Adverse Event|1|||
163925298|NCT00550446|592098602|FG007|Up To Week 12|Adverse Event|0|||
163925299|NCT00550446|592098603|FG008|Up To Week 12|Adverse Event|0|||
163925300|NCT00550446|592098604|FG009|Up To Week 12|Adverse Event|0|||
163925301|NCT00550446|592098605|FG010|Up To Week 12|Adverse Event|0|||
163925302|NCT00550446|592098595|FG000|Up To Week 12|Lack of Efficacy|3|||
163925303|NCT00550446|592098596|FG001|Up To Week 12|Lack of Efficacy|1|||
163925304|NCT00550446|592098597|FG002|Up To Week 12|Lack of Efficacy|0|||
163925305|NCT00550446|592098598|FG003|Up To Week 12|Lack of Efficacy|1|||
163925306|NCT00550446|592098599|FG004|Up To Week 12|Lack of Efficacy|0|||
163925307|NCT00550446|592098600|FG005|Up To Week 12|Lack of Efficacy|3|||
163925308|NCT00550446|592098601|FG006|Up To Week 12|Lack of Efficacy|3|||
163925309|NCT00550446|592098602|FG007|Up To Week 12|Lack of Efficacy|0|||
163925310|NCT00550446|592098603|FG008|Up To Week 12|Lack of Efficacy|0|||
163925311|NCT00550446|592098604|FG009|Up To Week 12|Lack of Efficacy|0|||
163925312|NCT00550446|592098605|FG010|Up To Week 12|Lack of Efficacy|0|||
163925313|NCT00550446|592098595|FG000|Up To Week 12|Lost to Follow-up|0|||
163925314|NCT00550446|592098596|FG001|Up To Week 12|Lost to Follow-up|1|||
163925315|NCT00550446|592098597|FG002|Up To Week 12|Lost to Follow-up|0|||
163925316|NCT00550446|592098598|FG003|Up To Week 12|Lost to Follow-up|0|||
163925317|NCT00550446|592098599|FG004|Up To Week 12|Lost to Follow-up|1|||
163925318|NCT00550446|592098600|FG005|Up To Week 12|Lost to Follow-up|1|||
163925319|NCT00550446|592098601|FG006|Up To Week 12|Lost to Follow-up|2|||
163925320|NCT00550446|592098602|FG007|Up To Week 12|Lost to Follow-up|0|||
163925321|NCT00550446|592098603|FG008|Up To Week 12|Lost to Follow-up|0|||
163925322|NCT00550446|592098604|FG009|Up To Week 12|Lost to Follow-up|0|||
163829465|NCT02684006|591743629|FG001|Overall Study|Global deterioration of health status|20|||
163829466|NCT02684006|591743628|FG000|Overall Study|Physician Decision|15|||
163829467|NCT02684006|591743629|FG001|Overall Study|Physician Decision|8|||
163829468|NCT02684006|591743628|FG000|Overall Study|Adverse Event|86|||
163829469|NCT02684006|591743629|FG001|Overall Study|Adverse Event|65|||
163829470|NCT02684006|591743628|FG000|Overall Study|Withdrawal by Subject|29|||
163829471|NCT02684006|591743629|FG001|Overall Study|Withdrawal by Subject|43|||
163829472|NCT02684006|591743628|FG000|Overall Study|Progressive disease|236|||
163829473|NCT02684006|591743629|FG001|Overall Study|Progressive disease|266|||
163829474|NCT02684006|591743628|FG000|Overall Study|Participation terminated by sponsor|6|||
163829475|NCT02684006|591743629|FG001|Overall Study|Participation terminated by sponsor|9|||
163829476|NCT04642898|591743630|FG000|Overall Study|Withdrawal by Subject|2|||
163829477|NCT04642898|591743631|FG001|Overall Study|Withdrawal by Subject|4|||
163829478|NCT04642898|591743632|FG002|Overall Study|Withdrawal by Subject|4|||
163829479|NCT04642898|591743633|FG003|Overall Study|Withdrawal by Subject|6|||
163829480|NCT04642898|591743634|FG004|Overall Study|Withdrawal by Subject|2|||
163829481|NCT04642898|591743635|FG005|Overall Study|Withdrawal by Subject|6|||
163925323|NCT00550446|592098605|FG010|Up To Week 12|Lost to Follow-up|0|||
163925324|NCT00550446|592098595|FG000|Up To Week 12|Withdrawal by Subject|2|||
163925325|NCT00550446|592098596|FG001|Up To Week 12|Withdrawal by Subject|0|||
163925326|NCT00550446|592098597|FG002|Up To Week 12|Withdrawal by Subject|3|||
163925327|NCT00550446|592098598|FG003|Up To Week 12|Withdrawal by Subject|2|||
163925328|NCT00550446|592098599|FG004|Up To Week 12|Withdrawal by Subject|0|||
163829482|NCT04642898|591743630|FG000|Overall Study|Lost to Follow-up|0|||
163925329|NCT00550446|592098600|FG005|Up To Week 12|Withdrawal by Subject|1|||
164033974|NCT03325556|592484302|FG001|Open-label Period|Adverse Event|0|||
163925330|NCT00550446|592098601|FG006|Up To Week 12|Withdrawal by Subject|3|||
163829483|NCT04642898|591743631|FG001|Overall Study|Lost to Follow-up|0|||
164033975|NCT03325556|592484303|FG002|Open-label Period|Adverse Event|0|||
163925331|NCT00550446|592098602|FG007|Up To Week 12|Withdrawal by Subject|0|||
163925332|NCT00550446|592098603|FG008|Up To Week 12|Withdrawal by Subject|0|||
163925333|NCT00550446|592098604|FG009|Up To Week 12|Withdrawal by Subject|0|||
163925334|NCT00550446|592098605|FG010|Up To Week 12|Withdrawal by Subject|0|||
163925335|NCT00550446|592098595|FG000|Up To Week 12|Other|3|||
163925336|NCT00550446|592098596|FG001|Up To Week 12|Other|0|||
163925337|NCT00550446|592098597|FG002|Up To Week 12|Other|0|||
163925338|NCT00550446|592098598|FG003|Up To Week 12|Other|0|||
163925339|NCT00550446|592098599|FG004|Up To Week 12|Other|0|||
163925340|NCT00550446|592098600|FG005|Up To Week 12|Other|1|||
163925341|NCT00550446|592098601|FG006|Up To Week 12|Other|4|||
163925342|NCT00550446|592098602|FG007|Up To Week 12|Other|0|||
163925343|NCT00550446|592098603|FG008|Up To Week 12|Other|0|||
163925344|NCT00550446|592098604|FG009|Up To Week 12|Other|0|||
163925345|NCT00550446|592098605|FG010|Up To Week 12|Other|0|||
163925346|NCT00550446|592098595|FG000|Up To Week 12|Randomized not treated|0|||
163925347|NCT00550446|592098596|FG001|Up To Week 12|Randomized not treated|1|||
163925348|NCT00550446|592098597|FG002|Up To Week 12|Randomized not treated|1|||
163925349|NCT00550446|592098598|FG003|Up To Week 12|Randomized not treated|0|||
163925350|NCT00550446|592098599|FG004|Up To Week 12|Randomized not treated|0|||
163925351|NCT00550446|592098600|FG005|Up To Week 12|Randomized not treated|0|||
163925352|NCT00550446|592098601|FG006|Up To Week 12|Randomized not treated|0|||
163925353|NCT00550446|592098602|FG007|Up To Week 12|Randomized not treated|0|||
163925354|NCT00550446|592098603|FG008|Up To Week 12|Randomized not treated|0|||
163925355|NCT00550446|592098604|FG009|Up To Week 12|Randomized not treated|0|||
163925356|NCT00550446|592098605|FG010|Up To Week 12|Randomized not treated|0|||
163925357|NCT00550446|592098595|FG000|Post Week 12|Adverse Event|2|||
163925358|NCT00550446|592098596|FG001|Post Week 12|Adverse Event|1|||
163925359|NCT00550446|592098597|FG002|Post Week 12|Adverse Event|1|||
163925360|NCT00550446|592098598|FG003|Post Week 12|Adverse Event|1|||
163925361|NCT00550446|592098599|FG004|Post Week 12|Adverse Event|1|||
163925362|NCT00550446|592098600|FG005|Post Week 12|Adverse Event|1|||
163925363|NCT00550446|592098601|FG006|Post Week 12|Adverse Event|0|||
163925364|NCT00550446|592098602|FG007|Post Week 12|Adverse Event|0|||
163925365|NCT00550446|592098603|FG008|Post Week 12|Adverse Event|0|||
163925366|NCT00550446|592098604|FG009|Post Week 12|Adverse Event|4|||
163925367|NCT00550446|592098605|FG010|Post Week 12|Adverse Event|0|||
163925368|NCT00550446|592098595|FG000|Post Week 12|Lack of Efficacy|0|||
163925369|NCT00550446|592098596|FG001|Post Week 12|Lack of Efficacy|0|||
163925370|NCT00550446|592098597|FG002|Post Week 12|Lack of Efficacy|1|||
163925371|NCT00550446|592098598|FG003|Post Week 12|Lack of Efficacy|0|||
163925372|NCT00550446|592098599|FG004|Post Week 12|Lack of Efficacy|0|||
163925373|NCT00550446|592098600|FG005|Post Week 12|Lack of Efficacy|0|||
163925374|NCT00550446|592098601|FG006|Post Week 12|Lack of Efficacy|0|||
163925375|NCT00550446|592098602|FG007|Post Week 12|Lack of Efficacy|1|||
163925376|NCT00550446|592098603|FG008|Post Week 12|Lack of Efficacy|1|||
163925377|NCT00550446|592098604|FG009|Post Week 12|Lack of Efficacy|2|||
163925378|NCT00550446|592098605|FG010|Post Week 12|Lack of Efficacy|1|||
163925379|NCT00550446|592098595|FG000|Post Week 12|Lost to Follow-up|0|||
163925380|NCT00550446|592098596|FG001|Post Week 12|Lost to Follow-up|0|||
163925381|NCT00550446|592098597|FG002|Post Week 12|Lost to Follow-up|1|||
163925382|NCT00550446|592098598|FG003|Post Week 12|Lost to Follow-up|1|||
163925383|NCT00550446|592098599|FG004|Post Week 12|Lost to Follow-up|0|||
163925384|NCT00550446|592098600|FG005|Post Week 12|Lost to Follow-up|0|||
163925385|NCT00550446|592098601|FG006|Post Week 12|Lost to Follow-up|1|||
163925386|NCT00550446|592098602|FG007|Post Week 12|Lost to Follow-up|0|||
163925387|NCT00550446|592098603|FG008|Post Week 12|Lost to Follow-up|0|||
163925388|NCT00550446|592098604|FG009|Post Week 12|Lost to Follow-up|0|||
163925389|NCT00550446|592098605|FG010|Post Week 12|Lost to Follow-up|0|||
164033976|NCT03325556|592484301|FG000|Open-label Period|Death|1|||
164033977|NCT03325556|592484302|FG001|Open-label Period|Death|0|||
164033978|NCT03325556|592484303|FG002|Open-label Period|Death|0|||
164033979|NCT03325556|592484301|FG000|Open-label Period|Lost to Follow-up|1|||
164033980|NCT03325556|592484302|FG001|Open-label Period|Lost to Follow-up|0|||
163925390|NCT00550446|592098595|FG000|Post Week 12|Withdrawal by Subject|0|||
163925391|NCT00550446|592098596|FG001|Post Week 12|Withdrawal by Subject|0|||
163925392|NCT00550446|592098597|FG002|Post Week 12|Withdrawal by Subject|0|||
163925393|NCT00550446|592098598|FG003|Post Week 12|Withdrawal by Subject|0|||
163925394|NCT00550446|592098599|FG004|Post Week 12|Withdrawal by Subject|1|||
163925395|NCT00550446|592098600|FG005|Post Week 12|Withdrawal by Subject|0|||
163925396|NCT00550446|592098601|FG006|Post Week 12|Withdrawal by Subject|0|||
163925397|NCT00550446|592098602|FG007|Post Week 12|Withdrawal by Subject|0|||
163925398|NCT00550446|592098603|FG008|Post Week 12|Withdrawal by Subject|0|||
163925399|NCT00550446|592098604|FG009|Post Week 12|Withdrawal by Subject|0|||
163925400|NCT00550446|592098605|FG010|Post Week 12|Withdrawal by Subject|0|||
163925401|NCT00550446|592098595|FG000|Post Week 12|Other|1|||
164033981|NCT03325556|592484303|FG002|Open-label Period|Lost to Follow-up|0|||
163925402|NCT00550446|592098596|FG001|Post Week 12|Other|1|||
163925403|NCT00550446|592098597|FG002|Post Week 12|Other|0|||
164097788|NCT01772537|592722864|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
164097789|NCT01772537|592722865|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
164097790|NCT01376167|592722866|FG000|Overall Study|Lost to Follow-up|2|||
164097791|NCT01376167|592722867|FG001|Overall Study|Lost to Follow-up|4|||
164097792|NCT01376167|592722868|FG002|Overall Study|Lost to Follow-up|2|||
164097793|NCT01376167|592722866|FG000|Overall Study|Physician Decision|1|||
164097794|NCT01376167|592722867|FG001|Overall Study|Physician Decision|1|||
164097795|NCT01376167|592722868|FG002|Overall Study|Physician Decision|0|||
163925404|NCT00550446|592098598|FG003|Post Week 12|Other|1|||
163925405|NCT00550446|592098599|FG004|Post Week 12|Other|0|||
163925406|NCT00550446|592098600|FG005|Post Week 12|Other|0|||
163925407|NCT00550446|592098601|FG006|Post Week 12|Other|1|||
163925408|NCT00550446|592098602|FG007|Post Week 12|Other|0|||
163925409|NCT00550446|592098603|FG008|Post Week 12|Other|1|||
163925410|NCT00550446|592098604|FG009|Post Week 12|Other|1|||
163925411|NCT00550446|592098605|FG010|Post Week 12|Other|0|||
163925412|NCT01321723|592098606|FG000|Overall Study|Adverse Event|3|||
163925413|NCT01321723|592098607|FG001|Overall Study|Adverse Event|5|||
163925414|NCT01321723|592098608|FG002|Overall Study|Adverse Event|2|||
163925415|NCT01321723|592098606|FG000|Overall Study|Withdrawal by Subject|2|||
163925416|NCT01321723|592098607|FG001|Overall Study|Withdrawal by Subject|0|||
163925417|NCT01321723|592098608|FG002|Overall Study|Withdrawal by Subject|2|||
163925418|NCT02246218|592098609|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163925419|NCT02246218|592098610|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163925420|NCT02246218|592098609|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
163925421|NCT02246218|592098610|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
163925422|NCT02246218|592098609|FG000|Overall Study|Adverse Event|1|||
164033982|NCT03325556|592484301|FG000|Open-label Period|Non-compliance with study drug|5|||
164033983|NCT03325556|592484302|FG001|Open-label Period|Non-compliance with study drug|0|||
164033984|NCT03325556|592484303|FG002|Open-label Period|Non-compliance with study drug|0|||
164033985|NCT03325556|592484301|FG000|Open-label Period|Use of prohibited medication|1|||
164033986|NCT03325556|592484302|FG001|Open-label Period|Use of prohibited medication|0|||
164033987|NCT03325556|592484303|FG002|Open-label Period|Use of prohibited medication|0|||
164033988|NCT03325556|592484301|FG000|Open-label Period|Protocol Violation|4|||
164033989|NCT03325556|592484302|FG001|Open-label Period|Protocol Violation|0|||
164033990|NCT03325556|592484303|FG002|Open-label Period|Protocol Violation|0|||
164033991|NCT03325556|592484301|FG000|Open-label Period|Withdrawal by Subject|17|||
164033992|NCT03325556|592484302|FG001|Open-label Period|Withdrawal by Subject|0|||
164033993|NCT03325556|592484303|FG002|Open-label Period|Withdrawal by Subject|0|||
164033994|NCT03325556|592484301|FG000|Open-label Period|Not otherwise specified|8|||
164033995|NCT03325556|592484302|FG001|Open-label Period|Not otherwise specified|0|||
164033996|NCT03325556|592484303|FG002|Open-label Period|Not otherwise specified|0|||
164033997|NCT03325556|592484301|FG000|Open-label Period|Administrative discont. at study termination|41|||
164033998|NCT03325556|592484302|FG001|Open-label Period|Administrative discont. at study termination|0|||
164033999|NCT03325556|592484303|FG002|Open-label Period|Administrative discont. at study termination|0|||
164034000|NCT03325556|592484301|FG000|Double-blind Period|Relapse|0|||
164034001|NCT03325556|592484302|FG001|Double-blind Period|Relapse|15|||
164034002|NCT03325556|592484303|FG002|Double-blind Period|Relapse|34|||
164034003|NCT03325556|592484301|FG000|Double-blind Period|Adverse Event|0|||
164034004|NCT03325556|592484302|FG001|Double-blind Period|Adverse Event|3|||
164034005|NCT03325556|592484303|FG002|Double-blind Period|Adverse Event|1|||
164034006|NCT03325556|592484301|FG000|Double-blind Period|Noncompliance with study drug|0|||
164034007|NCT03325556|592484302|FG001|Double-blind Period|Noncompliance with study drug|0|||
164034008|NCT03325556|592484303|FG002|Double-blind Period|Noncompliance with study drug|1|||
164034009|NCT03325556|592484301|FG000|Double-blind Period|Use of prohibited medication|0|||
164034010|NCT03325556|592484302|FG001|Double-blind Period|Use of prohibited medication|1|||
164034011|NCT03325556|592484303|FG002|Double-blind Period|Use of prohibited medication|0|||
164034012|NCT03325556|592484301|FG000|Double-blind Period|Physician Decision|0|||
164034013|NCT03325556|592484302|FG001|Double-blind Period|Physician Decision|0|||
164034014|NCT03325556|592484303|FG002|Double-blind Period|Physician Decision|1|||
164034015|NCT03325556|592484301|FG000|Double-blind Period|Withdrawal by Subject|0|||
164097796|NCT01376167|592722866|FG000|Overall Study|Withdrawal by Subject|1|||
164097797|NCT01376167|592722867|FG001|Overall Study|Withdrawal by Subject|5|||
164097798|NCT01376167|592722868|FG002|Overall Study|Withdrawal by Subject|4|||
163925423|NCT02246218|592098610|FG001|Overall Study|Adverse Event|1|||
164097799|NCT02193165|592722871|FG000|4 Week Product Use|Lost to Follow-up|1|||
164097800|NCT02193165|592722872|FG001|4 Week Product Use|Lost to Follow-up|1|||
163925424|NCT02246218|592098609|FG000|Overall Study|Lost to Follow-up|1|||
163925425|NCT02246218|592098610|FG001|Overall Study|Lost to Follow-up|0|||
163925426|NCT00905034|592098611|FG000|Overall Study|Withdrawal by Subject|1|||
164034016|NCT03325556|592484302|FG001|Double-blind Period|Withdrawal by Subject|6|||
164034017|NCT03325556|592484303|FG002|Double-blind Period|Withdrawal by Subject|4|||
164034018|NCT03325556|592484301|FG000|Double-blind Period|Not otherwise specified|0|||
164034019|NCT03325556|592484302|FG001|Double-blind Period|Not otherwise specified|1|||
164147375|NCT05168202|592902030|FG006|Overall Study|Adverse Event|0|||
163925427|NCT03409731|592098613|FG000|Overall Study|Withdrawal by Subject|17|||
163925428|NCT03409731|592098613|FG000|Overall Study|Death|4|||
163925429|NCT00505414|592098615|FG000|Titration Phase|Adverse Event|0|||
163925430|NCT00505414|592098616|FG001|Titration Phase|Adverse Event|0|||
163925431|NCT00505414|592098617|FG002|Titration Phase|Adverse Event|0|||
163925432|NCT00505414|592098618|FG003|Titration Phase|Adverse Event|8|||
163925433|NCT00505414|592098619|FG004|Titration Phase|Adverse Event|3|||
163925434|NCT00505414|592098615|FG000|Titration Phase|Death|0|||
163925435|NCT00505414|592098616|FG001|Titration Phase|Death|0|||
163925436|NCT00505414|592098617|FG002|Titration Phase|Death|0|||
163925437|NCT00505414|592098618|FG003|Titration Phase|Death|2|||
163925438|NCT00505414|592098619|FG004|Titration Phase|Death|0|||
163925439|NCT00505414|592098615|FG000|Titration Phase|Lack of Efficacy|0|||
163925440|NCT00505414|592098616|FG001|Titration Phase|Lack of Efficacy|0|||
163925441|NCT00505414|592098617|FG002|Titration Phase|Lack of Efficacy|0|||
163925442|NCT00505414|592098618|FG003|Titration Phase|Lack of Efficacy|10|||
163925443|NCT00505414|592098619|FG004|Titration Phase|Lack of Efficacy|1|||
163925444|NCT00505414|592098615|FG000|Titration Phase|Protocol Violation|0|||
163925445|NCT00505414|592098616|FG001|Titration Phase|Protocol Violation|0|||
163925446|NCT00505414|592098617|FG002|Titration Phase|Protocol Violation|0|||
163925447|NCT00505414|592098618|FG003|Titration Phase|Protocol Violation|0|||
163925448|NCT00505414|592098619|FG004|Titration Phase|Protocol Violation|1|||
163925449|NCT00505414|592098615|FG000|Titration Phase|Withdrawal by Subject|0|||
163925450|NCT00505414|592098616|FG001|Titration Phase|Withdrawal by Subject|0|||
163925451|NCT00505414|592098617|FG002|Titration Phase|Withdrawal by Subject|0|||
163925452|NCT00505414|592098618|FG003|Titration Phase|Withdrawal by Subject|3|||
163925453|NCT00505414|592098619|FG004|Titration Phase|Withdrawal by Subject|4|||
163925454|NCT00505414|592098615|FG000|Titration Phase|Underlying disease and therapy required|0|||
163925455|NCT00505414|592098616|FG001|Titration Phase|Underlying disease and therapy required|0|||
163925456|NCT00505414|592098617|FG002|Titration Phase|Underlying disease and therapy required|0|||
163925457|NCT00505414|592098618|FG003|Titration Phase|Underlying disease and therapy required|7|||
163925458|NCT00505414|592098619|FG004|Titration Phase|Underlying disease and therapy required|3|||
163925459|NCT00505414|592098615|FG000|Maintenance Phase|Adverse Event|2|||
163925460|NCT00505414|592098616|FG001|Maintenance Phase|Adverse Event|2|||
163925461|NCT00505414|592098617|FG002|Maintenance Phase|Adverse Event|3|||
163925462|NCT00505414|592098618|FG003|Maintenance Phase|Adverse Event|0|||
163925463|NCT00505414|592098619|FG004|Maintenance Phase|Adverse Event|0|||
163925464|NCT00505414|592098615|FG000|Maintenance Phase|Death|2|||
163925465|NCT00505414|592098616|FG001|Maintenance Phase|Death|0|||
163925466|NCT00505414|592098617|FG002|Maintenance Phase|Death|1|||
163925467|NCT00505414|592098618|FG003|Maintenance Phase|Death|0|||
163925468|NCT00505414|592098619|FG004|Maintenance Phase|Death|0|||
163925469|NCT00505414|592098615|FG000|Maintenance Phase|Lack of Efficacy|2|||
163925470|NCT00505414|592098616|FG001|Maintenance Phase|Lack of Efficacy|1|||
163925471|NCT00505414|592098617|FG002|Maintenance Phase|Lack of Efficacy|1|||
163925472|NCT00505414|592098618|FG003|Maintenance Phase|Lack of Efficacy|0|||
163925473|NCT00505414|592098619|FG004|Maintenance Phase|Lack of Efficacy|0|||
163925474|NCT00505414|592098615|FG000|Maintenance Phase|Withdrawal by Subject|0|||
163925475|NCT00505414|592098616|FG001|Maintenance Phase|Withdrawal by Subject|0|||
163925476|NCT00505414|592098617|FG002|Maintenance Phase|Withdrawal by Subject|1|||
163925477|NCT00505414|592098618|FG003|Maintenance Phase|Withdrawal by Subject|0|||
163925478|NCT00505414|592098619|FG004|Maintenance Phase|Withdrawal by Subject|0|||
163925479|NCT00505414|592098615|FG000|Maintenance Phase|underlying disease and therapy required|0|||
163925480|NCT00505414|592098616|FG001|Maintenance Phase|underlying disease and therapy required|2|||
163925481|NCT00505414|592098617|FG002|Maintenance Phase|underlying disease and therapy required|2|||
163925482|NCT00505414|592098618|FG003|Maintenance Phase|underlying disease and therapy required|0|||
163925483|NCT00505414|592098619|FG004|Maintenance Phase|underlying disease and therapy required|0|||
163925484|NCT04358068|592098620|FG000|Overall Study|Did not initiate study treatment|2|||
163925485|NCT04358068|592098621|FG001|Overall Study|Did not initiate study treatment|2|||
164034020|NCT03325556|592484303|FG002|Double-blind Period|Not otherwise specified|5|||
164034021|NCT03325556|592484301|FG000|Double-blind Period|Administrative discont. at study termination|0|||
164034022|NCT03325556|592484302|FG001|Double-blind Period|Administrative discont. at study termination|35|||
164034023|NCT03325556|592484303|FG002|Double-blind Period|Administrative discont. at study termination|31|||
163925486|NCT01193218|592098622|FG000|0-12 Weeks|Adverse Event|6|||
164034024|NCT01705587|592484304|FG000|Overall Study|Withdrawal by Subject|0|||
164034025|NCT01705587|592484305|FG001|Overall Study|Withdrawal by Subject|1|||
163925487|NCT01193218|592098623|FG001|0-12 Weeks|Adverse Event|0|||
164034026|NCT00762268|592484306|FG000|Overall Study|Withdrawal by Subject|3|||
164034027|NCT00762268|592484307|FG001|Overall Study|Withdrawal by Subject|3|||
164034028|NCT03892707|592484316|FG000|Overall Study|Screen failure|6|||
163925488|NCT01193218|592098624|FG002|0-12 Weeks|Adverse Event|1|||
163925489|NCT01193218|592098625|FG003|0-12 Weeks|Adverse Event|0|||
163925490|NCT01193218|592098626|FG004|0-12 Weeks|Adverse Event|0|||
163925491|NCT01193218|592098627|FG005|0-12 Weeks|Adverse Event|2|||
163925492|NCT01193218|592098628|FG006|0-12 Weeks|Adverse Event|2|||
163925493|NCT01193218|592098629|FG007|0-12 Weeks|Adverse Event|0|||
163925494|NCT01193218|592098622|FG000|0-12 Weeks|Protocol Violation|0|||
164034029|NCT03892707|592484317|FG001|Overall Study|Screen failure|0|||
164097801|NCT02193165|592722873|FG002|4 Week Product Use|Lost to Follow-up|1|||
164097802|NCT02193165|592722871|FG000|6 Week Product Use|Lost to Follow-up|0|||
164097803|NCT02193165|592722872|FG001|6 Week Product Use|Lost to Follow-up|1|||
163925495|NCT01193218|592098623|FG001|0-12 Weeks|Protocol Violation|0|||
163925496|NCT01193218|592098624|FG002|0-12 Weeks|Protocol Violation|0|||
163925497|NCT01193218|592098625|FG003|0-12 Weeks|Protocol Violation|0|||
163925498|NCT01193218|592098626|FG004|0-12 Weeks|Protocol Violation|1|||
163925499|NCT01193218|592098627|FG005|0-12 Weeks|Protocol Violation|1|||
163925500|NCT01193218|592098628|FG006|0-12 Weeks|Protocol Violation|0|||
163925501|NCT01193218|592098629|FG007|0-12 Weeks|Protocol Violation|0|||
163925502|NCT01193218|592098622|FG000|0-12 Weeks|Withdrawal by Subject|3|||
163925503|NCT01193218|592098623|FG001|0-12 Weeks|Withdrawal by Subject|0|||
164097804|NCT02193165|592722873|FG002|6 Week Product Use|Lost to Follow-up|0|||
164097805|NCT00678639|592722876|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
164097806|NCT00678639|592722877|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
163925504|NCT01193218|592098624|FG002|0-12 Weeks|Withdrawal by Subject|2|||
163925505|NCT01193218|592098625|FG003|0-12 Weeks|Withdrawal by Subject|0|||
163925506|NCT01193218|592098626|FG004|0-12 Weeks|Withdrawal by Subject|0|||
163925507|NCT01193218|592098627|FG005|0-12 Weeks|Withdrawal by Subject|0|||
163925508|NCT01193218|592098628|FG006|0-12 Weeks|Withdrawal by Subject|1|||
163925509|NCT01193218|592098629|FG007|0-12 Weeks|Withdrawal by Subject|0|||
163925510|NCT01193218|592098622|FG000|12-52 Weeks|Adverse Event|1|||
163925511|NCT01193218|592098623|FG001|12-52 Weeks|Adverse Event|0|||
163925512|NCT01193218|592098624|FG002|12-52 Weeks|Adverse Event|1|||
163925513|NCT01193218|592098625|FG003|12-52 Weeks|Adverse Event|2|||
164097807|NCT01546545|592722879|FG000|Overall Study|Withdrawal by Subject|1|||
164097808|NCT01214850|592722880|FG000|Overall Study|Withdrawal by Subject|38|||
164097809|NCT01214850|592722881|FG001|Overall Study|Withdrawal by Subject|31|||
164097810|NCT01214850|592722882|FG002|Overall Study|Withdrawal by Subject|28|||
164097811|NCT01214850|592722880|FG000|Overall Study|Lost to Follow-up|124|||
164097812|NCT01214850|592722881|FG001|Overall Study|Lost to Follow-up|98|||
164097813|NCT01214850|592722882|FG002|Overall Study|Lost to Follow-up|123|||
164097814|NCT01214850|592722880|FG000|Overall Study|Protocol Violation|5|||
164097815|NCT01214850|592722881|FG001|Overall Study|Protocol Violation|5|||
164097816|NCT01214850|592722882|FG002|Overall Study|Protocol Violation|6|||
164097817|NCT01214850|592722880|FG000|Overall Study|Adverse event or death|11|||
164097818|NCT01214850|592722881|FG001|Overall Study|Adverse event or death|8|||
164097819|NCT01214850|592722882|FG002|Overall Study|Adverse event or death|3|||
164097820|NCT01214850|592722880|FG000|Overall Study|Inappropriate enrollment|2|||
164097821|NCT01214850|592722881|FG001|Overall Study|Inappropriate enrollment|1|||
164097822|NCT01214850|592722882|FG002|Overall Study|Inappropriate enrollment|0|||
164097823|NCT01214850|592722880|FG000|Overall Study|Administrative reason|1|||
164097824|NCT01214850|592722881|FG001|Overall Study|Administrative reason|0|||
164097825|NCT01214850|592722882|FG002|Overall Study|Administrative reason|0|||
164097826|NCT01214850|592722880|FG000|Overall Study|Unable to classify|2|||
164097827|NCT01214850|592722881|FG001|Overall Study|Unable to classify|1|||
164097828|NCT01214850|592722882|FG002|Overall Study|Unable to classify|1|||
164097829|NCT05615935|592722883|FG000|Overall Study|Lost to Follow-up|1|||
164097830|NCT05615935|592722884|FG001|Overall Study|Lost to Follow-up|1|||
164097831|NCT00735904|592722885|FG000|Overall Study|Adverse Event|3|||
164097832|NCT00735904|592722885|FG000|Overall Study|Death|20|||
164097833|NCT00735904|592722885|FG000|Overall Study|Protocol Violation|1|||
164097834|NCT00735904|592722885|FG000|Overall Study|Withdrawal by Subject|1|||
163925514|NCT01193218|592098626|FG004|12-52 Weeks|Adverse Event|3|||
163925515|NCT01193218|592098627|FG005|12-52 Weeks|Adverse Event|3|||
163925516|NCT01193218|592098628|FG006|12-52 Weeks|Adverse Event|1|||
163925517|NCT01193218|592098629|FG007|12-52 Weeks|Adverse Event|2|||
163925518|NCT01193218|592098622|FG000|12-52 Weeks|Lack of Efficacy|0|||
163925519|NCT01193218|592098623|FG001|12-52 Weeks|Lack of Efficacy|0|||
163925520|NCT01193218|592098624|FG002|12-52 Weeks|Lack of Efficacy|0|||
163925521|NCT01193218|592098625|FG003|12-52 Weeks|Lack of Efficacy|0|||
164097835|NCT00735904|592722885|FG000|Overall Study|Study Terminated by Sponsor|5|||
164097836|NCT00735904|592722885|FG000|Overall Study|Other|8|||
164097837|NCT00048581|592722892|FG000|Double-Blind Period|Adverse Event|9|||
164097838|NCT00048581|592722893|FG001|Double-Blind Period|Adverse Event|5|||
164097839|NCT00048581|592722894|FG002|Double-Blind Period|Adverse Event|0|||
164097840|NCT00048581|592722892|FG000|Double-Blind Period|Lack of Efficacy|14|||
163925522|NCT01193218|592098626|FG004|12-52 Weeks|Lack of Efficacy|0|||
163925523|NCT01193218|592098627|FG005|12-52 Weeks|Lack of Efficacy|0|||
163925524|NCT01193218|592098628|FG006|12-52 Weeks|Lack of Efficacy|1|||
163925525|NCT01193218|592098629|FG007|12-52 Weeks|Lack of Efficacy|0|||
163925526|NCT01193218|592098622|FG000|12-52 Weeks|Withdrawal by Subject|3|||
163925527|NCT01193218|592098623|FG001|12-52 Weeks|Withdrawal by Subject|0|||
163925528|NCT01193218|592098624|FG002|12-52 Weeks|Withdrawal by Subject|3|||
164097841|NCT00048581|592722893|FG001|Double-Blind Period|Lack of Efficacy|27|||
164097842|NCT00048581|592722894|FG002|Double-Blind Period|Lack of Efficacy|0|||
164097843|NCT00048581|592722892|FG000|Double-Blind Period|Lost to Follow-up|5|||
163925529|NCT01193218|592098625|FG003|12-52 Weeks|Withdrawal by Subject|0|||
163925530|NCT01193218|592098626|FG004|12-52 Weeks|Withdrawal by Subject|0|||
163925531|NCT01193218|592098627|FG005|12-52 Weeks|Withdrawal by Subject|2|||
164034030|NCT03892707|592484316|FG000|Overall Study|Pain resolution|0|||
164034031|NCT03892707|592484317|FG001|Overall Study|Pain resolution|4|||
164034032|NCT03892707|592484316|FG000|Overall Study|Withdrawal by Subject|0|||
164034033|NCT03892707|592484317|FG001|Overall Study|Withdrawal by Subject|1|||
164034034|NCT03892707|592484316|FG000|Overall Study|Other (long business trip)|0|||
163829484|NCT04642898|591743632|FG002|Overall Study|Lost to Follow-up|0|||
163829485|NCT04642898|591743633|FG003|Overall Study|Lost to Follow-up|2|||
163829486|NCT04642898|591743634|FG004|Overall Study|Lost to Follow-up|0|||
163829487|NCT04642898|591743635|FG005|Overall Study|Lost to Follow-up|1|||
163829488|NCT04642898|591743630|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
163829489|NCT04642898|591743631|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
163829490|NCT04642898|591743632|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
163829491|NCT04642898|591743633|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
163829492|NCT04642898|591743634|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
163829493|NCT04642898|591743635|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
163829494|NCT04642898|591743630|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163829495|NCT04642898|591743631|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163829496|NCT04642898|591743632|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163829497|NCT04642898|591743633|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163829498|NCT04642898|591743634|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
163829499|NCT04642898|591743635|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
163829500|NCT04495179|591743636|FG000|Overall Study|Lost to Follow-up|0|||
163829501|NCT04495179|591743637|FG001|Overall Study|Lost to Follow-up|1|||
163829502|NCT04495179|591743636|FG000|Overall Study|Withdrawal by Subject|2|||
163829503|NCT04495179|591743637|FG001|Overall Study|Withdrawal by Subject|4|||
163829504|NCT04495179|591743636|FG000|Overall Study|Study terminated by sponsor|0|||
163829505|NCT04495179|591743637|FG001|Overall Study|Study terminated by sponsor|18|||
163829506|NCT04495179|591743636|FG000|Overall Study|Death|0|||
163829507|NCT04495179|591743637|FG001|Overall Study|Death|4|||
163829508|NCT04495179|591743636|FG000|Overall Study|Adverse Event|0|||
163829509|NCT04495179|591743637|FG001|Overall Study|Adverse Event|1|||
163829510|NCT03434678|591743638|FG000|Overall Study|Withdrawal by Subject|13|||
163829511|NCT03434678|591743639|FG001|Overall Study|Withdrawal by Subject|13|||
163829512|NCT03434678|591743638|FG000|Overall Study|Found to be ineligible post randomization|2|||
163829513|NCT03434678|591743639|FG001|Overall Study|Found to be ineligible post randomization|1|||
163829514|NCT04085328|591743644|FG000|Overall Study|Witihdrew Consent|16|||
163829515|NCT04085328|591743645|FG001|Overall Study|Witihdrew Consent|16|||
163829516|NCT04085328|591743644|FG000|Overall Study|Adverse Event|8|||
163829517|NCT04085328|591743645|FG001|Overall Study|Adverse Event|7|||
163829518|NCT04085328|591743644|FG000|Overall Study|Lost to Follow-up|7|||
163829519|NCT04085328|591743645|FG001|Overall Study|Lost to Follow-up|2|||
163829520|NCT04085328|591743644|FG000|Overall Study|Physician Decision|0|||
163829521|NCT04085328|591743645|FG001|Overall Study|Physician Decision|1|||
163829522|NCT04085328|591743644|FG000|Overall Study|Pregnancy|0|||
163829523|NCT04085328|591743645|FG001|Overall Study|Pregnancy|1|||
163829524|NCT04085328|591743644|FG000|Overall Study|Reasons Related to COVID-19|5|||
163829525|NCT04085328|591743645|FG001|Overall Study|Reasons Related to COVID-19|8|||
163829526|NCT04085328|591743644|FG000|Overall Study|Did not meet inclusion criteria|1|||
163829527|NCT04085328|591743645|FG001|Overall Study|Did not meet inclusion criteria|1|||
163829528|NCT04085328|591743644|FG000|Overall Study|Early termination|1|||
163829529|NCT04085328|591743645|FG001|Overall Study|Early termination|0|||
163829530|NCT05608499|591743646|FG000|Overall Study|Lack of Efficacy|1|||
163829531|NCT05608499|591743647|FG001|Overall Study|Lack of Efficacy|0|||
163829532|NCT05608499|591743646|FG000|Overall Study|Lost to Follow-up|0|||
163829533|NCT05608499|591743647|FG001|Overall Study|Lost to Follow-up|1|||
163829534|NCT01422408|591743650|FG000|Overall Study|Adverse Event|1|||
163829535|NCT01422408|591743650|FG000|Overall Study|Withdrawal by Subject|3|||
163829536|NCT00724152|591743657|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
163829537|NCT00724152|591743658|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
163829538|NCT00724152|591743659|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
163829539|NCT00724152|591743657|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
163829540|NCT00724152|591743658|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
163829541|NCT00724152|591743659|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
164034035|NCT03892707|592484317|FG001|Overall Study|Other (long business trip)|1|||
164034036|NCT05224076|592484320|FG000|Overall Study|Lost to Follow-up|24|||
163829542|NCT01328080|591743661|FG000|Overall Study|Lost to Follow-up|5|||
163829543|NCT00045305|591743662|FG000|Overall Study|Lack of Efficacy|6|||
163829544|NCT00045305|591743662|FG000|Overall Study|Adverse Event|3|||
163829545|NCT00045305|591743662|FG000|Overall Study|Death|3|||
163829546|NCT00045305|591743662|FG000|Overall Study|site error|2|||
163829547|NCT03266770|591743663|FG000|Overall Study|Physician Decision|3|||
163829548|NCT03266770|591743663|FG000|Overall Study|Insufficient study supplies|1|||
164034037|NCT01807949|592484322|FG000|Overall Study|Adverse Event|1|||
164034038|NCT01807949|592484323|FG001|Overall Study|Adverse Event|2|||
163925532|NCT01193218|592098628|FG006|12-52 Weeks|Withdrawal by Subject|1|||
163925533|NCT01193218|592098629|FG007|12-52 Weeks|Withdrawal by Subject|2|||
163925534|NCT01193218|592098622|FG000|12-52 Weeks|Other reason than above|1|||
163925535|NCT01193218|592098623|FG001|12-52 Weeks|Other reason than above|0|||
163925536|NCT01193218|592098624|FG002|12-52 Weeks|Other reason than above|0|||
163925537|NCT01193218|592098625|FG003|12-52 Weeks|Other reason than above|1|||
163925538|NCT01193218|592098626|FG004|12-52 Weeks|Other reason than above|1|||
163925539|NCT01193218|592098627|FG005|12-52 Weeks|Other reason than above|0|||
163925540|NCT01193218|592098628|FG006|12-52 Weeks|Other reason than above|0|||
163925541|NCT01193218|592098629|FG007|12-52 Weeks|Other reason than above|0|||
163925542|NCT00665223|592098632|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
163925543|NCT00665223|592098633|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
163925544|NCT00665223|592098634|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
163925545|NCT00665223|592098632|FG000|Randomized Phase (26 Weeks)|Death|0|||
163925546|NCT00665223|592098633|FG001|Randomized Phase (26 Weeks)|Death|0|||
163925547|NCT00665223|592098634|FG002|Randomized Phase (26 Weeks)|Death|1|||
163925548|NCT00665223|592098632|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
163925549|NCT00665223|592098633|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
163925550|NCT00665223|592098634|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
163925551|NCT00665223|592098632|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
163925552|NCT00665223|592098633|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
163925553|NCT00665223|592098634|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
163925554|NCT00665223|592098632|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
163925555|NCT00665223|592098633|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
163925556|NCT00665223|592098634|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
163925557|NCT00665223|592098632|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
163925558|NCT00665223|592098633|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
163925559|NCT00665223|592098634|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
163925560|NCT00665223|592098632|FG000|Open-Label Period (26 Weeks)|Death|0|||
163925561|NCT00665223|592098633|FG001|Open-Label Period (26 Weeks)|Death|1|||
163925562|NCT00665223|592098634|FG002|Open-Label Period (26 Weeks)|Death|0|||
163925563|NCT00665223|592098632|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
163925564|NCT00665223|592098633|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
163925565|NCT00665223|592098634|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
163925566|NCT00665223|592098632|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
163925567|NCT00665223|592098633|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
163925568|NCT00665223|592098634|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
163925569|NCT00665223|592098632|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
163925570|NCT00665223|592098633|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
163925571|NCT00665223|592098634|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
163925572|NCT00665223|592098632|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
163925573|NCT00665223|592098633|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
163925574|NCT00665223|592098634|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
163925575|NCT00363649|592098635|FG000|Overall Study|Withdrawal by Subject|1|||
163925576|NCT00363649|592098636|FG001|Overall Study|Withdrawal by Subject|1|||
163925577|NCT00363649|592098635|FG000|Overall Study|Adverse Event|6|||
163925578|NCT00363649|592098636|FG001|Overall Study|Adverse Event|0|||
163925579|NCT01349036|592098637|FG000|Overall Study|Disease progression|13|||
163925580|NCT01349036|592098638|FG001|Overall Study|Disease progression|22|||
163925581|NCT01349036|592098637|FG000|Overall Study|Other|1|||
163925582|NCT01349036|592098638|FG001|Overall Study|Other|0|||
163925583|NCT01349036|592098637|FG000|Overall Study|Withdrawal by Subject|0|||
163925584|NCT01349036|592098638|FG001|Overall Study|Withdrawal by Subject|2|||
163925585|NCT03796208|592098639|FG000|Overall Study|Withdrawal by Subject|3|||
163925586|NCT03796208|592098640|FG001|Overall Study|Withdrawal by Subject|0|||
163925587|NCT03796208|592098639|FG000|Overall Study|Loss of pregnancy|1|||
163925588|NCT03796208|592098640|FG001|Overall Study|Loss of pregnancy|1|||
163925589|NCT03796208|592098639|FG000|Overall Study|Changed prenatal clinics|0|||
163925590|NCT03796208|592098640|FG001|Overall Study|Changed prenatal clinics|5|||
163925591|NCT03796208|592098639|FG000|Overall Study|Lost to Follow-up|20|||
163925592|NCT03796208|592098640|FG001|Overall Study|Lost to Follow-up|16|||
163925593|NCT01161628|592098641|FG000|Overall Study|Death|6|||
163925594|NCT01161628|592098641|FG000|Overall Study|Lack of Efficacy|2|||
163925595|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
163925596|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
163925597|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
163925598|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
163925599|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
163925600|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
163925601|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
163925602|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
163925603|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
164034039|NCT01807949|592484324|FG002|Overall Study|Adverse Event|2|||
164034040|NCT01807949|592484322|FG000|Overall Study|Withdrawal by Subject|1|||
164034041|NCT01807949|592484323|FG001|Overall Study|Withdrawal by Subject|2|||
164034042|NCT01807949|592484324|FG002|Overall Study|Withdrawal by Subject|2|||
164034043|NCT01807949|592484322|FG000|Overall Study|Non-Compliance|0|||
164034044|NCT01807949|592484323|FG001|Overall Study|Non-Compliance|0|||
164034045|NCT01807949|592484324|FG002|Overall Study|Non-Compliance|1|||
164034046|NCT01807949|592484322|FG000|Overall Study|Undefined|0|||
164034047|NCT01807949|592484323|FG001|Overall Study|Undefined|1|||
164034048|NCT01807949|592484324|FG002|Overall Study|Undefined|2|||
164034049|NCT01807949|592484322|FG000|Overall Study|Randomized But Not Treated|0|||
164034050|NCT01807949|592484323|FG001|Overall Study|Randomized But Not Treated|2|||
164034051|NCT01807949|592484324|FG002|Overall Study|Randomized But Not Treated|2|||
164034052|NCT04325906|592484327|FG000|Overall Study|Withdrawal by Subject|2|||
164034053|NCT04325906|592484328|FG001|Overall Study|Withdrawal by Subject|0|||
164034054|NCT00881361|592484329|FG000|Overall Study|Terminated prior to surgery|27|||
164034055|NCT00881361|592484330|FG001|Overall Study|Terminated prior to surgery|7|||
164034056|NCT00881361|592484331|FG002|Overall Study|Terminated prior to surgery|0|||
164034057|NCT00881361|592484329|FG000|Overall Study|Ineligible|17|||
164034058|NCT00881361|592484330|FG001|Overall Study|Ineligible|2|||
164034059|NCT00881361|592484331|FG002|Overall Study|Ineligible|2|||
164034060|NCT02141217|592484332|FG000|Overall Study|Adverse Event|1|||
164034061|NCT02141217|592484333|FG001|Overall Study|Adverse Event|2|||
164034062|NCT02141217|592484332|FG000|Overall Study|Protocol Violation|1|||
164034063|NCT02141217|592484333|FG001|Overall Study|Protocol Violation|4|||
164034064|NCT02141217|592484332|FG000|Overall Study|Withdrawal by Subject|6|||
164034065|NCT02141217|592484333|FG001|Overall Study|Withdrawal by Subject|0|||
164034066|NCT02141217|592484332|FG000|Overall Study|Lost to Follow-up|1|||
164034067|NCT02141217|592484333|FG001|Overall Study|Lost to Follow-up|1|||
164034068|NCT02141217|592484332|FG000|Overall Study|Physician Decision|1|||
164034069|NCT02141217|592484333|FG001|Overall Study|Physician Decision|0|||
164034070|NCT02141217|592484332|FG000|Overall Study|Surgical Intervention|1|||
164034071|NCT02141217|592484333|FG001|Overall Study|Surgical Intervention|1|||
164034072|NCT01628393|592484338|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
164034073|NCT01628393|592484339|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164034074|NCT01628393|592484340|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164034075|NCT01628393|592484341|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164034076|NCT01628393|592484342|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
164034077|NCT01628393|592484338|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
164034078|NCT01628393|592484339|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
164034079|NCT01628393|592484340|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
164034080|NCT01628393|592484341|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
164034081|NCT01628393|592484342|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
164034082|NCT01628393|592484338|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
164034083|NCT01628393|592484339|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
164034084|NCT01628393|592484340|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
164034085|NCT01628393|592484341|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
164034086|NCT01628393|592484342|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
164034087|NCT01628393|592484338|FG000|Blinded Active Extension Period|Adverse Event|0|||
164034088|NCT01628393|592484339|FG001|Blinded Active Extension Period|Adverse Event|1|||
164034089|NCT01628393|592484340|FG002|Blinded Active Extension Period|Adverse Event|0|||
164034090|NCT01628393|592484341|FG003|Blinded Active Extension Period|Adverse Event|2|||
164034091|NCT01628393|592484342|FG004|Blinded Active Extension Period|Adverse Event|2|||
164034092|NCT01628393|592484338|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
164034093|NCT01628393|592484339|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
164034094|NCT01628393|592484340|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
164034095|NCT01628393|592484341|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
164034096|NCT01628393|592484342|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
164034097|NCT01628393|592484338|FG000|Blinded Active Extension Period|Physician Decision|0|||
164034098|NCT01628393|592484339|FG001|Blinded Active Extension Period|Physician Decision|3|||
164034099|NCT01628393|592484340|FG002|Blinded Active Extension Period|Physician Decision|0|||
164034100|NCT01628393|592484341|FG003|Blinded Active Extension Period|Physician Decision|1|||
164034101|NCT01628393|592484342|FG004|Blinded Active Extension Period|Physician Decision|0|||
164034102|NCT01628393|592484338|FG000|Blinded Active Extension Period|Protocol Violation|0|||
164034103|NCT01628393|592484339|FG001|Blinded Active Extension Period|Protocol Violation|0|||
164034104|NCT01628393|592484340|FG002|Blinded Active Extension Period|Protocol Violation|2|||
164034105|NCT01628393|592484341|FG003|Blinded Active Extension Period|Protocol Violation|1|||
164034106|NCT01628393|592484342|FG004|Blinded Active Extension Period|Protocol Violation|0|||
164034107|NCT01628393|592484338|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
164034108|NCT01628393|592484339|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
164034109|NCT01628393|592484340|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
164097844|NCT00048581|592722893|FG001|Double-Blind Period|Lost to Follow-up|0|||
164097845|NCT00048581|592722894|FG002|Double-Blind Period|Lost to Follow-up|0|||
164097846|NCT00048581|592722892|FG000|Double-Blind Period|Withdrawal by Subject|5|||
164097847|NCT00048581|592722893|FG001|Double-Blind Period|Withdrawal by Subject|2|||
164097848|NCT00048581|592722894|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164097849|NCT00048581|592722892|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
164097850|NCT00048581|592722893|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
164097851|NCT00048581|592722894|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
164097852|NCT00048581|592722892|FG000|Double-Blind Period|Investigator Decision|1|||
164097853|NCT00048581|592722893|FG001|Double-Blind Period|Investigator Decision|0|||
164097854|NCT00048581|592722894|FG002|Double-Blind Period|Investigator Decision|0|||
164097855|NCT00048581|592722892|FG000|Open-Label Period|Death|0|||
164097856|NCT00048581|592722893|FG001|Open-Label Period|Death|0|||
164097857|NCT00048581|592722894|FG002|Open-Label Period|Death|4|||
164097858|NCT00048581|592722892|FG000|Open-Label Period|Adverse Event|0|||
164097859|NCT00048581|592722893|FG001|Open-Label Period|Adverse Event|0|||
164097860|NCT00048581|592722894|FG002|Open-Label Period|Adverse Event|37|||
164097861|NCT00048581|592722892|FG000|Open-Label Period|Lack of Efficacy|0|||
163829549|NCT03266770|591743663|FG000|Overall Study|Adverse Event|1|||
163829550|NCT04274894|591743664|FG000|Overall Study|Adverse Event|7|||
163829551|NCT04274894|591743664|FG000|Overall Study|Withdrew consent|5|||
163829552|NCT04274894|591743664|FG000|Overall Study|Lost to Follow-up|9|||
163829553|NCT04274894|591743664|FG000|Overall Study|COVID-19 infection|1|||
163829554|NCT04274894|591743664|FG000|Overall Study|Other, not specified|20|||
163829555|NCT01936857|591743665|FG000|Overall Study|Sent to prison or 06 center|11|||
163829556|NCT01936857|591743666|FG001|Overall Study|Sent to prison or 06 center|12|||
163829557|NCT01936857|591743665|FG000|Overall Study|Lost to Follow-up|10|||
163829558|NCT01936857|591743666|FG001|Overall Study|Lost to Follow-up|7|||
163829559|NCT01936857|591743665|FG000|Overall Study|Death|7|||
163829560|NCT01936857|591743666|FG001|Overall Study|Death|3|||
163829561|NCT01936857|591743665|FG000|Overall Study|Moved|2|||
163829562|NCT01936857|591743666|FG001|Overall Study|Moved|1|||
163829563|NCT01936857|591743665|FG000|Overall Study|Withdrawal by Subject|1|||
163829564|NCT01936857|591743666|FG001|Overall Study|Withdrawal by Subject|0|||
163829565|NCT01936857|591743665|FG000|Overall Study|Side effect of medication|1|||
163829566|NCT01936857|591743666|FG001|Overall Study|Side effect of medication|0|||
163829567|NCT01936857|591743665|FG000|Overall Study|Other|2|||
163829568|NCT01936857|591743666|FG001|Overall Study|Other|2|||
163829569|NCT03848403|591743667|FG000|Period 2 (Day 8)|Adverse Event|1|||
163829570|NCT03848403|591743668|FG001|Period 2 (Day 8)|Adverse Event|2|||
163829571|NCT03848403|591743669|FG002|Period 2 (Day 8)|Adverse Event|2|||
163829572|NCT03848403|591743667|FG000|Period 2 (Day 8)|Physician Decision|0|||
163829573|NCT03848403|591743668|FG001|Period 2 (Day 8)|Physician Decision|1|||
163829574|NCT03848403|591743669|FG002|Period 2 (Day 8)|Physician Decision|0|||
163829575|NCT03848403|591743667|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
163829576|NCT03848403|591743668|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
163829577|NCT03848403|591743669|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
163829578|NCT00168038|591743670|FG000|Overall Study|Adverse Event|1|||
163829579|NCT00168038|591743670|FG000|Overall Study|Therapy failure|1|||
163829580|NCT01494584|591743678|FG000|Overall Study|Study Closed/Terminated|1|||
163829581|NCT01515748|591743690|FG000|Overall Study|Withdrawal by Subject|32|||
163829582|NCT01515748|591743691|FG001|Overall Study|Withdrawal by Subject|41|||
163829583|NCT01515748|591743690|FG000|Overall Study|Lost to Follow-up|2|||
163829584|NCT01515748|591743691|FG001|Overall Study|Lost to Follow-up|4|||
163829585|NCT01515748|591743690|FG000|Overall Study|Other than specified above|5|||
163829586|NCT01515748|591743691|FG001|Overall Study|Other than specified above|10|||
163829587|NCT03221387|591743692|FG000|Overall Study|Lost to Follow-up|1|||
163829588|NCT03221387|591743692|FG000|Overall Study|Lung transplant|1|||
163829589|NCT00522626|591743693|FG000|Overall Study|Lost to Follow-up|7|||
163829590|NCT02365519|591743694|FG000|Randomized and Treated|Adverse Event|0|||
163829591|NCT02365519|591743695|FG001|Randomized and Treated|Adverse Event|1|||
163829592|NCT02365519|591743696|FG002|Randomized and Treated|Adverse Event|0|||
163829593|NCT02365519|591743694|FG000|Randomized and Treated|Withdrawal by Subject|0|||
163829594|NCT02365519|591743695|FG001|Randomized and Treated|Withdrawal by Subject|1|||
163829595|NCT02365519|591743696|FG002|Randomized and Treated|Withdrawal by Subject|1|||
163829596|NCT01971723|591743697|FG000|Overall Study|Withdrawal by Subject|1|||
163829597|NCT01971723|591743698|FG001|Overall Study|Withdrawal by Subject|1|||
163829598|NCT01971723|591743697|FG000|Overall Study|Protocol Violation|1|||
163829599|NCT01971723|591743698|FG001|Overall Study|Protocol Violation|2|||
163829600|NCT03017079|591743702|FG000|Overall Study|Physician Decision|1|||
163829601|NCT03017079|591743703|FG001|Overall Study|Physician Decision|1|||
163829602|NCT03017079|591743702|FG000|Overall Study|Death|3|||
163829603|NCT03017079|591743703|FG001|Overall Study|Death|2|||
163829604|NCT03017079|591743702|FG000|Overall Study|Lack of Efficacy|2|||
163829605|NCT03017079|591743703|FG001|Overall Study|Lack of Efficacy|2|||
163829606|NCT03017079|591743702|FG000|Overall Study|Protocol Violation|0|||
163829607|NCT03017079|591743703|FG001|Overall Study|Protocol Violation|1|||
164097862|NCT00048581|592722893|FG001|Open-Label Period|Lack of Efficacy|0|||
164097863|NCT00048581|592722894|FG002|Open-Label Period|Lack of Efficacy|69|||
163829608|NCT06223373|591743709|FG000|Overall Study|Lost to Follow-up|1|||
163829609|NCT06223373|591743710|FG001|Overall Study|Lost to Follow-up|2|||
163829610|NCT05050578|591745708|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
163829611|NCT05050578|591745709|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
163829612|NCT05050578|591745708|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
163829613|NCT05050578|591745709|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
163829614|NCT05050578|591745708|FG000|Period 2, 30 Days|Protocol Violation|0|||
163829615|NCT05050578|591745709|FG001|Period 2, 30 Days|Protocol Violation|1|||
163829616|NCT02243280|591745710|FG000|Treated|Adverse Event|1|||
163829617|NCT02243280|591745711|FG001|Treated|Adverse Event|0|||
163829618|NCT02243280|591745712|FG002|Treated|Adverse Event|0|||
163829619|NCT02243280|591745713|FG003|Treated|Adverse Event|0|||
163829620|NCT02243280|591745714|FG004|Treated|Adverse Event|0|||
163829621|NCT02243280|591745715|FG005|Treated|Adverse Event|0|||
163829622|NCT02243280|591745716|FG006|Treated|Adverse Event|0|||
163829623|NCT02243280|591745717|FG007|Treated|Adverse Event|0|||
163829624|NCT02243280|591745718|FG008|Treated|Adverse Event|0|||
163829625|NCT02243280|591745719|FG009|Treated|Adverse Event|0|||
163829626|NCT02243280|591745720|FG010|Treated|Adverse Event|1|||
163829627|NCT02243280|591745710|FG000|Treated|Lost to Follow-up|0|||
163829628|NCT02243280|591745711|FG001|Treated|Lost to Follow-up|0|||
163829629|NCT02243280|591745712|FG002|Treated|Lost to Follow-up|0|||
163829630|NCT02243280|591745713|FG003|Treated|Lost to Follow-up|0|||
163829631|NCT02243280|591745714|FG004|Treated|Lost to Follow-up|0|||
163829632|NCT02243280|591745715|FG005|Treated|Lost to Follow-up|0|||
163829633|NCT02243280|591745716|FG006|Treated|Lost to Follow-up|0|||
163829634|NCT02243280|591745717|FG007|Treated|Lost to Follow-up|0|||
163829635|NCT02243280|591745718|FG008|Treated|Lost to Follow-up|1|||
163829636|NCT02243280|591745719|FG009|Treated|Lost to Follow-up|0|||
163829637|NCT02243280|591745720|FG010|Treated|Lost to Follow-up|2|||
163829638|NCT03386032|591745729|FG000|Overall Study|Lack of Efficacy|6|||
163829639|NCT03386032|591745730|FG001|Overall Study|Lack of Efficacy|2|||
163829640|NCT03386032|591745731|FG002|Overall Study|Lack of Efficacy|0|||
163829641|NCT03386032|591745729|FG000|Overall Study|Adverse Event|2|||
163829642|NCT03386032|591745730|FG001|Overall Study|Adverse Event|2|||
163829643|NCT03386032|591745731|FG002|Overall Study|Adverse Event|0|||
163829644|NCT03386032|591745729|FG000|Overall Study|Withdrawal by Subject|1|||
163829645|NCT03386032|591745730|FG001|Overall Study|Withdrawal by Subject|0|||
163829646|NCT03386032|591745731|FG002|Overall Study|Withdrawal by Subject|0|||
163829647|NCT03386032|591745729|FG000|Overall Study|Lost to Follow-up|9|||
163829648|NCT03386032|591745730|FG001|Overall Study|Lost to Follow-up|3|||
163829649|NCT03386032|591745731|FG002|Overall Study|Lost to Follow-up|0|||
163829650|NCT04525547|591745740|FG000|Overall Study|Not treated with Ofev|2|||
163829651|NCT04525547|591745740|FG000|Overall Study|Off-label use|2|||
163829652|NCT04525547|591745740|FG000|Overall Study|Lost to Follow-up|1|||
163829653|NCT03122119|591745741|FG000|Overall Study|Did not meet eligibility critria|1|||
163829654|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
163829655|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
163829656|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
163829657|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
163829658|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
163829659|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
163829660|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
163829661|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
163829662|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
163829663|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
163829664|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
163829665|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
163829666|NCT01493687|591745751|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
163829667|NCT01493687|591745752|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
163829668|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
163829669|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
163829670|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
163829671|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
163829672|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
163829673|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
163829674|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
163829675|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
163829676|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
163829677|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
163829678|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
163829679|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
163829680|NCT01493687|591745751|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
163829681|NCT01493687|591745752|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
163829682|NCT01493687|591745751|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
163829683|NCT01493687|591745752|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
163829684|NCT00521144|591745753|FG000|Overall Study|Not Treated|0|||
163829685|NCT00521144|591745754|FG001|Overall Study|Not Treated|0|||
163829686|NCT00521144|591745755|FG002|Overall Study|Not Treated|0|||
163829687|NCT00521144|591745756|FG003|Overall Study|Not Treated|1|||
163829688|NCT00521144|591745757|FG004|Overall Study|Not Treated|0|||
163829689|NCT00521144|591745753|FG000|Overall Study|Adverse Event|0|||
163829690|NCT00521144|591745754|FG001|Overall Study|Adverse Event|1|||
163829691|NCT00521144|591745755|FG002|Overall Study|Adverse Event|0|||
163829692|NCT00521144|591745756|FG003|Overall Study|Adverse Event|0|||
163829693|NCT00521144|591745757|FG004|Overall Study|Adverse Event|1|||
163829694|NCT00521144|591745753|FG000|Overall Study|Progressive Disease|4|||
163829695|NCT00521144|591745754|FG001|Overall Study|Progressive Disease|2|||
163829696|NCT00521144|591745755|FG002|Overall Study|Progressive Disease|2|||
163829697|NCT00521144|591745756|FG003|Overall Study|Progressive Disease|0|||
163829698|NCT00521144|591745757|FG004|Overall Study|Progressive Disease|6|||
163829699|NCT00089141|591745759|FG000|Overall Study|Termination of trial|18|||
163829700|NCT00089141|591745760|FG001|Overall Study|Termination of trial|24|||
163829701|NCT03315143|591745763|FG000|Overall Study|Death|240|||
163829702|NCT03315143|591745764|FG001|Overall Study|Death|246|||
163829703|NCT03315143|591745763|FG000|Overall Study|Withdrawal by Subject|57|||
163829704|NCT03315143|591745764|FG001|Overall Study|Withdrawal by Subject|68|||
163829705|NCT03315143|591745763|FG000|Overall Study|Site Terminated by Sponsor|256|||
163829706|NCT03315143|591745764|FG001|Overall Study|Site Terminated by Sponsor|282|||
163829707|NCT03315143|591745763|FG000|Overall Study|Study Terminated by Sponsor|4723|||
163829708|NCT03315143|591745764|FG001|Overall Study|Study Terminated by Sponsor|4664|||
163829709|NCT03315143|591745763|FG000|Overall Study|Reason not Specified|16|||
163829710|NCT03315143|591745764|FG001|Overall Study|Reason not Specified|32|||
163829711|NCT01242748|591745769|FG000|Overall Study|Adverse Event|10|||
163829712|NCT01242748|591745770|FG001|Overall Study|Adverse Event|5|||
163829713|NCT01242748|591745769|FG000|Overall Study|Lost to Follow-up|6|||
163829714|NCT01242748|591745770|FG001|Overall Study|Lost to Follow-up|2|||
163829715|NCT01242748|591745769|FG000|Overall Study|Physician Decision|3|||
163829716|NCT01242748|591745770|FG001|Overall Study|Physician Decision|2|||
163829717|NCT01242748|591745769|FG000|Overall Study|Protocol Violation|1|||
163829718|NCT01242748|591745770|FG001|Overall Study|Protocol Violation|0|||
163829719|NCT01242748|591745769|FG000|Overall Study|Withdrawal by Subject|10|||
163829720|NCT01242748|591745770|FG001|Overall Study|Withdrawal by Subject|2|||
163829721|NCT01242748|591745769|FG000|Overall Study|Miscellaneous reasons|8|||
163829722|NCT01242748|591745770|FG001|Overall Study|Miscellaneous reasons|3|||
163829723|NCT00840801|591745771|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
163829724|NCT00840801|591745772|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
163829725|NCT00840801|591745773|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
163829726|NCT00840801|591745771|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
163829727|NCT00840801|591745772|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
163829728|NCT00840801|591745773|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
163829729|NCT00840801|591745771|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
163829730|NCT00840801|591745772|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
163829731|NCT00840801|591745773|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
163829732|NCT00840801|591745771|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
163829733|NCT00840801|591745772|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
163829734|NCT00840801|591745773|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
163829735|NCT00335452|591745774|FG000|Overall Study|Death|156|||
163829736|NCT00335452|591745775|FG001|Overall Study|Death|144|||
163829737|NCT00335452|591745776|FG002|Overall Study|Death|158|||
163829738|NCT00335452|591745777|FG003|Overall Study|Death|129|||
163829739|NCT00335452|591745774|FG000|Overall Study|Lost to Follow-up|2|||
163829740|NCT00335452|591745775|FG001|Overall Study|Lost to Follow-up|3|||
163829741|NCT00335452|591745776|FG002|Overall Study|Lost to Follow-up|1|||
163829742|NCT00335452|591745777|FG003|Overall Study|Lost to Follow-up|2|||
164097864|NCT00048581|592722892|FG000|Open-Label Period|Lost to Follow-up|0|||
164097865|NCT00048581|592722893|FG001|Open-Label Period|Lost to Follow-up|0|||
163829743|NCT02736825|591745778|FG000|Overall Study|Lost to Follow-up|10|||
163829744|NCT02736825|591745779|FG001|Overall Study|Lost to Follow-up|11|||
163829745|NCT02736825|591745778|FG000|Overall Study|Early Termination|0|||
163829746|NCT02736825|591745779|FG001|Overall Study|Early Termination|1|||
163829747|NCT00790452|591745780|FG000|Overall Study|Drug supply issue|1|||
163829748|NCT00790452|591745781|FG001|Overall Study|Drug supply issue|0|||
163829749|NCT02901626|591745782|FG000|Overall Study|Lost to Follow-up|1|||
163829750|NCT02901626|591745783|FG001|Overall Study|Lost to Follow-up|1|||
163829751|NCT04082884|591745784|FG000|Overall Study|Withdrawal by Subject|1|||
163829752|NCT00659490|591745789|FG000|Overall Study|Lost to Follow-up|2|||
163829753|NCT00659490|591745790|FG001|Overall Study|Lost to Follow-up|0|||
163829754|NCT00659490|591745791|FG002|Overall Study|Lost to Follow-up|1|||
163829755|NCT01649232|591745792|FG000|Overall Study|Physician Decision|2|||
163829756|NCT01649232|591745793|FG001|Overall Study|Physician Decision|0|||
163829757|NCT02421666|591745794|FG000|6-month Follow-up|Lost to Follow-up|8|||
163829758|NCT02421666|591745795|FG001|6-month Follow-up|Lost to Follow-up|7|||
163829759|NCT02421666|591745794|FG000|6-month Follow-up|Withdrawal by Subject|5|||
163829760|NCT02421666|591745795|FG001|6-month Follow-up|Withdrawal by Subject|6|||
163829761|NCT02421666|591745794|FG000|12-month Follow-up|Lost to Follow-up|5|||
163829762|NCT02421666|591745795|FG001|12-month Follow-up|Lost to Follow-up|5|||
163829763|NCT02421666|591745794|FG000|12-month Follow-up|Withdrawal by Subject|6|||
163829764|NCT02421666|591745795|FG001|12-month Follow-up|Withdrawal by Subject|11|||
163829765|NCT01078155|591745797|FG000|Overall Study|Adverse Event|7|||
163829766|NCT01078155|591745797|FG000|Overall Study|Lack of Efficacy|16|||
163829767|NCT01078155|591745797|FG000|Overall Study|Participant's Decision|6|||
163829768|NCT01078155|591745797|FG000|Overall Study|Lost to Follow-up|15|||
163829769|NCT01621880|591745798|FG000|Overall Study|Adverse Event|5|||
163829770|NCT01621880|591745799|FG001|Overall Study|Adverse Event|1|||
163829771|NCT01621880|591745798|FG000|Overall Study|Withdrawal by Subject|5|||
163829772|NCT01621880|591745799|FG001|Overall Study|Withdrawal by Subject|4|||
163829773|NCT03701399|591745806|FG000|Overall Study|Adverse Event|3|||
163829774|NCT03701399|591745807|FG001|Overall Study|Adverse Event|5|||
163829775|NCT03701399|591745806|FG000|Overall Study|Withdrawal by Subject|6|||
163829776|NCT03701399|591745807|FG001|Overall Study|Withdrawal by Subject|3|||
163829777|NCT03701399|591745806|FG000|Overall Study|Investigators decision|1|||
163829778|NCT03701399|591745807|FG001|Overall Study|Investigators decision|2|||
163829779|NCT03701399|591745806|FG000|Overall Study|Lost to Follow-up|1|||
163829780|NCT03701399|591745807|FG001|Overall Study|Lost to Follow-up|2|||
163829781|NCT03701399|591745806|FG000|Overall Study|Death|1|||
163829782|NCT03701399|591745807|FG001|Overall Study|Death|1|||
163829783|NCT03701399|591745806|FG000|Overall Study|Randomized but not treated|1|||
163829784|NCT03701399|591745807|FG001|Overall Study|Randomized but not treated|0|||
163829785|NCT04179032|591745808|FG000|Part B (Up to Week 52)|Adverse Event|1|||
163829786|NCT04179032|591745808|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
163829787|NCT04179032|591745808|FG000|Access Extension Phase|Ongoing|11|||
163829788|NCT03945292|591745809|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
163829789|NCT03945292|591745810|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163829790|NCT03945292|591745811|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
163829791|NCT03945292|591745812|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163829792|NCT03945292|591745813|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163829793|NCT03945292|591745814|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163829794|NCT03945292|591745815|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163829795|NCT03945292|591745816|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
163829796|NCT03945292|591745809|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829797|NCT03945292|591745810|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829798|NCT03945292|591745811|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
163829799|NCT03945292|591745812|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829800|NCT03945292|591745813|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829801|NCT03945292|591745814|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829802|NCT03945292|591745815|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829803|NCT03945292|591745816|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
163829804|NCT03945292|591745809|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829805|NCT03945292|591745810|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829806|NCT03945292|591745811|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829807|NCT03945292|591745812|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829808|NCT03945292|591745813|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829809|NCT03945292|591745814|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829810|NCT03945292|591745815|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
163829811|NCT03945292|591745816|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
163829812|NCT03033225|591745817|FG000|Overall Study|Withdrawal by Subject|5|||
163829813|NCT00946296|591745818|FG000|Overall Study|Physician Decision|3|||
163829814|NCT00946296|591745819|FG001|Overall Study|Physician Decision|0|||
163829815|NCT01368965|591745822|FG000|Overall Study|Lost to Follow-up|12|||
163829816|NCT02618967|591745823|FG000|Overall Study|Lost to Follow-up|0|||
163829817|NCT02618967|591745824|FG001|Overall Study|Lost to Follow-up|0|||
163829818|NCT02618967|591745825|FG002|Overall Study|Lost to Follow-up|1|||
163829819|NCT02618967|591745826|FG003|Overall Study|Lost to Follow-up|0|||
163829820|NCT02618967|591745827|FG004|Overall Study|Lost to Follow-up|2|||
163829821|NCT02618967|591745828|FG005|Overall Study|Lost to Follow-up|0|||
163829822|NCT02618967|591745829|FG006|Overall Study|Lost to Follow-up|0|||
163829823|NCT02618967|591745830|FG007|Overall Study|Lost to Follow-up|0|||
163829824|NCT02618967|591745823|FG000|Overall Study|Withdrawal by Subject|1|||
163829825|NCT02618967|591745824|FG001|Overall Study|Withdrawal by Subject|0|||
163829826|NCT02618967|591745825|FG002|Overall Study|Withdrawal by Subject|0|||
163829827|NCT02618967|591745826|FG003|Overall Study|Withdrawal by Subject|0|||
163829828|NCT02618967|591745827|FG004|Overall Study|Withdrawal by Subject|0|||
163829829|NCT02618967|591745828|FG005|Overall Study|Withdrawal by Subject|0|||
163829830|NCT02618967|591745829|FG006|Overall Study|Withdrawal by Subject|0|||
164034110|NCT01628393|592484341|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
164034111|NCT01628393|592484342|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
164034112|NCT04603391|592484347|FG000|First Intervention (4 Days)|Adverse Event|1|||
164034113|NCT04603391|592484348|FG001|First Intervention (4 Days)|Adverse Event|0|||
164034114|NCT04603391|592484347|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
164034115|NCT04603391|592484348|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
164034116|NCT02759861|592484351|FG000|Overall Study|Death|1|||
164034117|NCT02151682|592484352|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164034118|NCT02151682|592484353|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
164034119|NCT02151682|592484354|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164034120|NCT02151682|592484355|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164034121|NCT02151682|592484356|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164034122|NCT02151682|592484357|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
164034123|NCT02151682|592484352|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164034124|NCT02151682|592484353|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
164034125|NCT02151682|592484354|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164034126|NCT02151682|592484355|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164034127|NCT02151682|592484356|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164034128|NCT02151682|592484357|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
164034129|NCT02151682|592484352|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164034130|NCT02151682|592484353|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
164034131|NCT02151682|592484354|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164034132|NCT02151682|592484355|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164034133|NCT02151682|592484356|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164034134|NCT02151682|592484357|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
164034135|NCT02151682|592484352|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
164034136|NCT02151682|592484353|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
164034137|NCT02151682|592484354|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164034138|NCT02151682|592484355|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164034139|NCT02151682|592484356|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164034140|NCT02151682|592484357|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
164034141|NCT02151682|592484352|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
164034142|NCT02151682|592484353|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164034143|NCT02151682|592484354|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164034144|NCT02151682|592484355|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164034145|NCT02151682|592484356|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164034146|NCT02151682|592484357|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
164034147|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164034148|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164034149|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
164034150|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164034151|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164034152|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
164034153|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
164034154|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
164034155|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
164034156|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
164034157|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
164034158|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
164034159|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164034160|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164034161|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
164034162|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
164034163|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164034164|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
164034165|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164034166|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164034167|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
164034168|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163829831|NCT02618967|591745830|FG007|Overall Study|Withdrawal by Subject|0|||
163829832|NCT06060457|591745831|FG000|Overall Study|Adverse Event|1|||
163829833|NCT06060457|591745832|FG001|Overall Study|Adverse Event|1|||
163829834|NCT06060457|591745831|FG000|Overall Study|Death|2|||
163829835|NCT06060457|591745832|FG001|Overall Study|Death|2|||
163829836|NCT06060457|591745831|FG000|Overall Study|Lost to Follow-up|17|||
163829837|NCT06060457|591745832|FG001|Overall Study|Lost to Follow-up|19|||
163829838|NCT06060457|591745831|FG000|Overall Study|Physician Decision|0|||
163829839|NCT06060457|591745832|FG001|Overall Study|Physician Decision|1|||
163829840|NCT06060457|591745831|FG000|Overall Study|Protocol Violation|1|||
163829841|NCT06060457|591745832|FG001|Overall Study|Protocol Violation|1|||
163829842|NCT06060457|591745831|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
163829843|NCT06060457|591745832|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
163829844|NCT06060457|591745831|FG000|Overall Study|Withdrawal by Subject|12|||
163829845|NCT06060457|591745832|FG001|Overall Study|Withdrawal by Subject|15|||
164034169|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
163829846|NCT06060457|591745831|FG000|Overall Study|Other Than Specified|2|||
163829847|NCT06060457|591745832|FG001|Overall Study|Other Than Specified|1|||
163829848|NCT00569582|591745846|FG000|Overall Study|Withdrawal by Subject|5|||
163829849|NCT00569582|591745846|FG000|Overall Study|Death|2|||
163829850|NCT00569582|591745846|FG000|Overall Study|Adverse Event|7|||
163829851|NCT00569582|591745846|FG000|Overall Study|Subject was too ill to travel.|1|||
163829852|NCT00569582|591745846|FG000|Overall Study|Subject was non-compliant.|1|||
163829853|NCT05103384|591745849|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
163829854|NCT02612311|591745850|FG000|Overall Study|Adverse Event|16|||
163829855|NCT02612311|591745851|FG001|Overall Study|Adverse Event|12|||
163829856|NCT02612311|591745852|FG002|Overall Study|Adverse Event|7|||
164034170|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
164034171|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164034172|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164034173|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
164034174|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164147376|NCT05168202|592902024|FG000|Overall Study|Lack of Efficacy|0|||
163829857|NCT02612311|591745853|FG003|Overall Study|Adverse Event|13|||
163829858|NCT02612311|591745850|FG000|Overall Study|Death|29|||
163829859|NCT02612311|591745851|FG001|Overall Study|Death|10|||
163829860|NCT02612311|591745852|FG002|Overall Study|Death|11|||
163829861|NCT02612311|591745853|FG003|Overall Study|Death|11|||
163829862|NCT02612311|591745850|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
163829863|NCT02612311|591745851|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
163829864|NCT02612311|591745852|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
163829865|NCT02612311|591745853|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
163829866|NCT02612311|591745850|FG000|Overall Study|Investigator's Decision|11|||
163829867|NCT02612311|591745851|FG001|Overall Study|Investigator's Decision|15|||
163829868|NCT02612311|591745852|FG002|Overall Study|Investigator's Decision|6|||
163829869|NCT02612311|591745853|FG003|Overall Study|Investigator's Decision|6|||
163829870|NCT02612311|591745850|FG000|Overall Study|Lack of Efficacy|0|||
163829871|NCT02612311|591745851|FG001|Overall Study|Lack of Efficacy|0|||
163829872|NCT02612311|591745852|FG002|Overall Study|Lack of Efficacy|1|||
163829873|NCT02612311|591745853|FG003|Overall Study|Lack of Efficacy|1|||
163829874|NCT02612311|591745850|FG000|Overall Study|Lost to Follow-up|2|||
163829875|NCT02612311|591745851|FG001|Overall Study|Lost to Follow-up|2|||
163829876|NCT02612311|591745852|FG002|Overall Study|Lost to Follow-up|1|||
163829877|NCT02612311|591745853|FG003|Overall Study|Lost to Follow-up|2|||
163829878|NCT02612311|591745850|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
163829879|NCT02612311|591745851|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
163829880|NCT02612311|591745852|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
163829881|NCT02612311|591745853|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
163829882|NCT02612311|591745850|FG000|Overall Study|Site Terminated by Sponsor|29|||
163829883|NCT02612311|591745851|FG001|Overall Study|Site Terminated by Sponsor|12|||
163829884|NCT02612311|591745852|FG002|Overall Study|Site Terminated by Sponsor|13|||
163829885|NCT02612311|591745853|FG003|Overall Study|Site Terminated by Sponsor|5|||
163829886|NCT02612311|591745850|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
163829887|NCT02612311|591745851|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
163829888|NCT02612311|591745852|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
163829889|NCT02612311|591745853|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
163829890|NCT02612311|591745850|FG000|Overall Study|Reason Not Specified|3|||
163829891|NCT02612311|591745851|FG001|Overall Study|Reason Not Specified|7|||
163829892|NCT02612311|591745852|FG002|Overall Study|Reason Not Specified|4|||
163829893|NCT02612311|591745853|FG003|Overall Study|Reason Not Specified|5|||
163829894|NCT02612311|591745850|FG000|Overall Study|Unknown/Missing|10|||
163829895|NCT02612311|591745851|FG001|Overall Study|Unknown/Missing|13|||
163829896|NCT02612311|591745852|FG002|Overall Study|Unknown/Missing|4|||
163829897|NCT02612311|591745853|FG003|Overall Study|Unknown/Missing|0|||
163829898|NCT02612311|591745850|FG000|Overall Study|Non-Compliance with Study|1|||
163829899|NCT02612311|591745851|FG001|Overall Study|Non-Compliance with Study|0|||
163829900|NCT02612311|591745852|FG002|Overall Study|Non-Compliance with Study|0|||
163829901|NCT02612311|591745853|FG003|Overall Study|Non-Compliance with Study|0|||
163829902|NCT00514735|591745857|FG000|Overall Study|Withdrawal by Subject|13|||
163829903|NCT00514735|591745858|FG001|Overall Study|Withdrawal by Subject|5|||
163829904|NCT00514735|591745857|FG000|Overall Study|Death|1|||
163829905|NCT00514735|591745858|FG001|Overall Study|Death|0|||
164097866|NCT00048581|592722894|FG002|Open-Label Period|Lost to Follow-up|14|||
164097867|NCT00048581|592722892|FG000|Open-Label Period|Withdrawal by Subject|0|||
164097868|NCT00048581|592722893|FG001|Open-Label Period|Withdrawal by Subject|0|||
164097869|NCT00048581|592722894|FG002|Open-Label Period|Withdrawal by Subject|20|||
164097870|NCT00048581|592722892|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
164097871|NCT00048581|592722893|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
164097872|NCT00048581|592722894|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
164097873|NCT00048581|592722892|FG000|Open-Label Period|Poor/Non-compliance|0|||
164097874|NCT00048581|592722893|FG001|Open-Label Period|Poor/Non-compliance|0|||
164097875|NCT00048581|592722894|FG002|Open-Label Period|Poor/Non-compliance|5|||
164097876|NCT00048581|592722892|FG000|Open-Label Period|Pregnancy|0|||
164097877|NCT00048581|592722893|FG001|Open-Label Period|Pregnancy|0|||
164097878|NCT00048581|592722894|FG002|Open-Label Period|Pregnancy|7|||
164097879|NCT00048581|592722892|FG000|Open-Label Period|Study Site Closure|0|||
164097880|NCT00048581|592722893|FG001|Open-Label Period|Study Site Closure|0|||
164097881|NCT00048581|592722894|FG002|Open-Label Period|Study Site Closure|2|||
164097882|NCT00048581|592722892|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
164097883|NCT00048581|592722893|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
164097884|NCT00048581|592722894|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
164097885|NCT00048581|592722892|FG000|Open-Label Period|Problem With Transportation To Site|0|||
164097886|NCT00048581|592722893|FG001|Open-Label Period|Problem With Transportation To Site|0|||
164097887|NCT00048581|592722894|FG002|Open-Label Period|Problem With Transportation To Site|1|||
164097888|NCT00048581|592722892|FG000|Open-Label Period|Primary Investigator Retired|0|||
164097889|NCT00048581|592722893|FG001|Open-Label Period|Primary Investigator Retired|0|||
164097890|NCT00048581|592722894|FG002|Open-Label Period|Primary Investigator Retired|2|||
164097891|NCT00048581|592722892|FG000|Open-Label Period|Study Ended By Sponsor|0|||
164097892|NCT00048581|592722893|FG001|Open-Label Period|Study Ended By Sponsor|0|||
164097893|NCT00048581|592722894|FG002|Open-Label Period|Study Ended By Sponsor|1|||
164097894|NCT03639311|592722898|FG000|Maintenance Phase|Lost to Follow-up|1|||
164097895|NCT03639311|592722899|FG001|Maintenance Phase|Lost to Follow-up|0|||
164097896|NCT03639311|592722900|FG002|Maintenance Phase|Lost to Follow-up|0|||
164097897|NCT03639311|592722898|FG000|Maintenance Phase|Adverse Event|1|||
164097898|NCT03639311|592722899|FG001|Maintenance Phase|Adverse Event|0|||
164097899|NCT03639311|592722900|FG002|Maintenance Phase|Adverse Event|0|||
164097900|NCT03639311|592722898|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
164097901|NCT03639311|592722899|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
164097902|NCT03639311|592722900|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
164097903|NCT03639311|592722898|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
164097904|NCT03639311|592722899|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
164097905|NCT03639311|592722900|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
164097906|NCT03639311|592722898|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
164097907|NCT03639311|592722899|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
164097908|NCT03639311|592722900|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
164097909|NCT03639311|592722898|FG000|Maintenance Phase|Lack of Efficacy|1|||
164097910|NCT03639311|592722899|FG001|Maintenance Phase|Lack of Efficacy|0|||
164097911|NCT03639311|592722900|FG002|Maintenance Phase|Lack of Efficacy|0|||
164097912|NCT00855738|592722901|FG000|Overall Study|Lost to Follow-up|2|||
164097913|NCT00855738|592722901|FG000|Overall Study|Adverse Event|1|||
164097914|NCT00855738|592722901|FG000|Overall Study|Subject Defaulted|1|||
164097915|NCT00855738|592722901|FG000|Overall Study|Death|1|||
164097916|NCT00154102|592722917|FG000|Overall Study|investigational study phase ongoing|7|||
164097917|NCT00154102|592722918|FG001|Overall Study|investigational study phase ongoing|2|||
164097918|NCT02158936|592722919|FG000|Overall Study|Study closed/ terminated|57|||
164097919|NCT02158936|592722920|FG001|Overall Study|Study closed/ terminated|77|||
164097920|NCT02158936|592722919|FG000|Overall Study|Azacitidine tx discontinued|53|||
164097921|NCT02158936|592722920|FG001|Overall Study|Azacitidine tx discontinued|46|||
164097922|NCT02158936|592722919|FG000|Overall Study|Adverse Event|39|||
164097923|NCT02158936|592722920|FG001|Overall Study|Adverse Event|24|||
164097924|NCT02158936|592722919|FG000|Overall Study|Withdrawal by Subject|15|||
164097925|NCT02158936|592722920|FG001|Overall Study|Withdrawal by Subject|16|||
164097926|NCT02158936|592722919|FG000|Overall Study|Physician Decision|15|||
164097927|NCT02158936|592722920|FG001|Overall Study|Physician Decision|13|||
164097928|NCT02158936|592722919|FG000|Overall Study|Lost to Follow-up|0|||
164097929|NCT02158936|592722920|FG001|Overall Study|Lost to Follow-up|1|||
164097930|NCT01149473|592724981|FG000|First Intervention|Adverse Event|1|||
164097931|NCT01149473|592724982|FG001|First Intervention|Adverse Event|1|||
164097932|NCT01149473|592724981|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164097933|NCT01149473|592724982|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
163829906|NCT00514735|591745857|FG000|Overall Study|Lost to Follow-up|0|||
163829907|NCT00514735|591745858|FG001|Overall Study|Lost to Follow-up|1|||
164097934|NCT01247701|592724983|FG000|Overall Study|Death|2|||
164097935|NCT01247701|592724983|FG000|Overall Study|Relapsed|8|||
164097936|NCT04166630|592724984|FG000|Overall Study|Withdrawal by Subject|0|||
164097937|NCT04166630|592724985|FG001|Overall Study|Withdrawal by Subject|1|||
163829908|NCT02782169|591745859|FG000|Overall Study|Lost to Follow-up|1|||
163829909|NCT02782169|591745860|FG001|Overall Study|Lost to Follow-up|2|||
163829910|NCT04751942|591745864|FG000|Overall Study|Lost to Follow-up|9|||
163829911|NCT04751942|591745865|FG001|Overall Study|Lost to Follow-up|6|||
163829912|NCT02953938|591745866|FG000|Overall Study|Adverse Event|0|||
163829913|NCT02953938|591745867|FG001|Overall Study|Adverse Event|1|||
163829914|NCT02953938|591745866|FG000|Overall Study|Withdrawal by Subject|1|||
163925604|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
163925605|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
163925606|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
163925607|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
163925608|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
163925609|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
163925610|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
163925611|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
163925612|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
163925613|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
163925614|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
163925615|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
163925616|NCT01125566|592098643|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
163925617|NCT01125566|592098644|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
163925618|NCT01125566|592098645|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
163925619|NCT01125566|592098643|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
163925620|NCT01125566|592098644|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
163925621|NCT01125566|592098645|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
163925622|NCT01125566|592098643|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
163925623|NCT01125566|592098644|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
163925624|NCT01125566|592098645|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
163925625|NCT01125566|592098643|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
163925626|NCT01125566|592098644|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
163925627|NCT01125566|592098645|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
163925628|NCT01125566|592098643|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
163925629|NCT01125566|592098644|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
163925630|NCT01125566|592098645|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
163925631|NCT01560585|592098646|FG000|Overall Study|Physician Decision|3|||
163925632|NCT03028012|592098647|FG000|Overall Study|Lost to Follow-up|2|||
163925633|NCT03028012|592098648|FG001|Overall Study|Lost to Follow-up|3|||
164034175|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
163925634|NCT03028012|592098649|FG002|Overall Study|Lost to Follow-up|3|||
163925635|NCT01726517|592098650|FG000|Overall Study|Withdrawal by Subject|0|||
163925636|NCT01726517|592098651|FG001|Overall Study|Withdrawal by Subject|0|||
163925637|NCT01726517|592098652|FG002|Overall Study|Withdrawal by Subject|1|||
163925638|NCT01726517|592098653|FG003|Overall Study|Withdrawal by Subject|0|||
163925639|NCT01726517|592098654|FG004|Overall Study|Withdrawal by Subject|0|||
163925640|NCT00770588|592098660|FG000|Overall Study|Adverse Event|9|||
163925641|NCT00770588|592098661|FG001|Overall Study|Adverse Event|2|||
163925642|NCT00770588|592098660|FG000|Overall Study|Death caused by progression of disease|70|||
163925643|NCT00770588|592098661|FG001|Overall Study|Death caused by progression of disease|91|||
163925644|NCT00770588|592098660|FG000|Overall Study|Lost to Follow-up|1|||
163925645|NCT00770588|592098661|FG001|Overall Study|Lost to Follow-up|1|||
163925646|NCT00770588|592098660|FG000|Overall Study|Withdrawal by Subject|1|||
163925647|NCT00770588|592098661|FG001|Overall Study|Withdrawal by Subject|1|||
163925648|NCT01424189|592098662|FG000|Overall Study|Adverse Event|1|||
163925649|NCT01424189|592098663|FG001|Overall Study|Adverse Event|0|||
163925650|NCT01424189|592098662|FG000|Overall Study|Lost to Follow-up|4|||
163925651|NCT01424189|592098663|FG001|Overall Study|Lost to Follow-up|1|||
163925652|NCT01424189|592098662|FG000|Overall Study|Withdrawal by Subject|4|||
163925653|NCT01424189|592098663|FG001|Overall Study|Withdrawal by Subject|4|||
164034176|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
164034177|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164034178|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164034179|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
164034180|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164034181|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164034182|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
164097938|NCT01838941|592724986|FG000|Overall Study|Adverse Event|1|||
163829915|NCT02953938|591745867|FG001|Overall Study|Withdrawal by Subject|1|||
163829916|NCT04510675|591745872|FG000|Overall Study|Withdrawal by Subject|5|||
163925654|NCT01424189|592098662|FG000|Overall Study|Subject moved|1|||
163925655|NCT01424189|592098663|FG001|Overall Study|Subject moved|0|||
163925656|NCT01424189|592098662|FG000|Overall Study|Death|3|||
163925657|NCT01424189|592098663|FG001|Overall Study|Death|1|||
163925658|NCT01203956|592098664|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
163925659|NCT01203956|592098665|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
163925660|NCT02230306|592098668|FG000|Overall Study|Did not receive study treatment|1|||
163925661|NCT00312845|592098669|FG000|Overall Study|Adverse Event|19|||
163925662|NCT00312845|592098670|FG001|Overall Study|Adverse Event|5|||
163925663|NCT00312845|592098669|FG000|Overall Study|Death|2|||
163925664|NCT00312845|592098670|FG001|Overall Study|Death|2|||
163925665|NCT00312845|592098669|FG000|Overall Study|Withdrawal by Subject|14|||
163925666|NCT00312845|592098670|FG001|Overall Study|Withdrawal by Subject|6|||
163925667|NCT00312845|592098669|FG000|Overall Study|Disease Progression|56|||
163925668|NCT00312845|592098670|FG001|Overall Study|Disease Progression|77|||
163925669|NCT00312845|592098669|FG000|Overall Study|Lost to Follow-up|2|||
163925670|NCT00312845|592098670|FG001|Overall Study|Lost to Follow-up|0|||
163925671|NCT00312845|592098669|FG000|Overall Study|Other|6|||
163925672|NCT00312845|592098670|FG001|Overall Study|Other|5|||
163925673|NCT04206384|592098672|FG000|Overall Study|Withdrawal by Subject|8|||
164034183|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
164034184|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
164034185|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
164034186|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
164034187|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
164034188|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
164034189|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
164034190|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
164034191|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
164034192|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
164034193|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
164034194|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
164034195|NCT02151682|592484352|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164034196|NCT02151682|592484353|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164034197|NCT02151682|592484354|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
164034198|NCT02151682|592484355|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164034199|NCT02151682|592484356|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164034200|NCT02151682|592484357|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
164034201|NCT02151682|592484352|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164034202|NCT02151682|592484353|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164034203|NCT02151682|592484354|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164034204|NCT02151682|592484355|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164034205|NCT02151682|592484356|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
164034206|NCT02151682|592484357|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
164034207|NCT02151682|592484352|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164034208|NCT02151682|592484353|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164034209|NCT02151682|592484354|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164034210|NCT02151682|592484355|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164034211|NCT02151682|592484356|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
164034212|NCT02151682|592484357|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
164034213|NCT02151682|592484352|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164034214|NCT02151682|592484353|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164034215|NCT02151682|592484354|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164034216|NCT02151682|592484355|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164034217|NCT02151682|592484356|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
164034218|NCT02151682|592484357|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
164034219|NCT02151682|592484352|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164034220|NCT02151682|592484353|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164034221|NCT02151682|592484354|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164034222|NCT02151682|592484355|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164034223|NCT02151682|592484356|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
164034224|NCT02151682|592484357|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
164034225|NCT02988219|592484358|FG000|Overall Study|Lack of Efficacy|1|||
164034226|NCT02988219|592484359|FG001|Overall Study|Lack of Efficacy|1|||
164097939|NCT01838941|592724986|FG000|Overall Study|Withdrawal by Subject|1|||
164147377|NCT05168202|592902025|FG001|Overall Study|Lack of Efficacy|1|||
163925674|NCT04206384|592098672|FG000|Overall Study|Adverse Event|2|||
163925675|NCT01121185|592098673|FG000|Overall Study|Not infused|0|||
163925676|NCT01121185|592098674|FG001|Overall Study|Not infused|1|||
163925677|NCT01121185|592098673|FG000|Overall Study|Not transplanted|1|||
163925678|NCT01121185|592098674|FG001|Overall Study|Not transplanted|0|||
163925679|NCT01260142|592098676|FG000|Treatment Period 1|Study on hold|1|||
163925680|NCT01260142|592098677|FG001|Treatment Period 1|Study on hold|1|||
163925681|NCT01260142|592098678|FG002|Treatment Period 1|Study on hold|0|||
163925682|NCT01260142|592098679|FG003|Treatment Period 1|Study on hold|0|||
163925683|NCT01260142|592098680|FG004|Treatment Period 1|Study on hold|1|||
163925684|NCT01260142|592098681|FG005|Treatment Period 1|Study on hold|2|||
163925685|NCT01260142|592098676|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
163925686|NCT01260142|592098677|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
163925687|NCT01260142|592098678|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
163925688|NCT01260142|592098679|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
163925689|NCT01260142|592098680|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
163925690|NCT01260142|592098681|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
163925691|NCT01260142|592098676|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163925692|NCT01260142|592098677|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163925693|NCT01260142|592098678|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163925694|NCT01260142|592098679|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163925695|NCT01260142|592098680|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163925696|NCT01260142|592098681|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163925697|NCT00496834|592098689|FG000|Overall Study|Withdrawal by Subject|4|||
163925698|NCT00496834|592098690|FG001|Overall Study|Withdrawal by Subject|6|||
163925699|NCT00496834|592098689|FG000|Overall Study|Contraindicated medication administered|0|||
163925700|NCT00496834|592098690|FG001|Overall Study|Contraindicated medication administered|1|||
163925701|NCT00496834|592098689|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
163925702|NCT00496834|592098690|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
163925703|NCT00496834|592098689|FG000|Overall Study|Adverse Event|5|||
163925704|NCT00496834|592098690|FG001|Overall Study|Adverse Event|3|||
163925705|NCT00496834|592098689|FG000|Overall Study|IP administration violation|2|||
163925706|NCT00496834|592098690|FG001|Overall Study|IP administration violation|0|||
163925707|NCT00496834|592098689|FG000|Overall Study|Lost to Follow-up|2|||
163925708|NCT00496834|592098690|FG001|Overall Study|Lost to Follow-up|0|||
163925709|NCT00496834|592098689|FG000|Overall Study|Blood Pressure control failure|2|||
163925710|NCT00496834|592098690|FG001|Overall Study|Blood Pressure control failure|1|||
163925711|NCT01503164|592098691|FG000|Overall Study|Withdrawal by Subject|2|||
163925712|NCT01503164|592098692|FG001|Overall Study|Withdrawal by Subject|1|||
163925713|NCT01227928|592098693|FG000|Overall Study|Lost to Follow-up|4|||
163925714|NCT01227928|592098694|FG001|Overall Study|Lost to Follow-up|2|||
163925715|NCT01227928|592098693|FG000|Overall Study|Withdrawal by Subject|4|||
163925716|NCT01227928|592098694|FG001|Overall Study|Withdrawal by Subject|3|||
163925717|NCT01227928|592098693|FG000|Overall Study|Death|14|||
163925718|NCT01227928|592098694|FG001|Overall Study|Death|12|||
163925719|NCT04088136|592098697|FG000|Overall Study|Withdrawal by Subject|5|||
163925720|NCT04088136|592098698|FG001|Overall Study|Withdrawal by Subject|0|||
163925721|NCT04088136|592098697|FG000|Overall Study|Lack of Efficacy|0|||
163925722|NCT04088136|592098698|FG001|Overall Study|Lack of Efficacy|1|||
163925723|NCT01494298|592098699|FG000|Overall Study|Protocol Violation|2|||
163925724|NCT01494298|592098700|FG001|Overall Study|Protocol Violation|8|||
163925725|NCT04159805|592098701|FG000|Overall Study|Withdrawal by Subject|0|||
163925726|NCT04159805|592098702|FG001|Overall Study|Withdrawal by Subject|2|||
163925727|NCT04159805|592098703|FG002|Overall Study|Withdrawal by Subject|2|||
163925728|NCT02930837|592098704|FG000|Overall Study|Adverse Event|6|||
163925729|NCT02930837|592098704|FG000|Overall Study|Lost to Follow-up|5|||
163925730|NCT02930837|592098704|FG000|Overall Study|Withdrawal by Subject|1|||
163925731|NCT01393613|592098705|FG000|Overall Study|Adverse Event|11|||
163925732|NCT01393613|592098706|FG001|Overall Study|Adverse Event|11|||
163925733|NCT01393613|592098707|FG002|Overall Study|Adverse Event|13|||
163925734|NCT01393613|592098708|FG003|Overall Study|Adverse Event|22|||
163925735|NCT01393613|592098705|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
163925736|NCT01393613|592098706|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
163925737|NCT01393613|592098707|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
163925738|NCT01393613|592098708|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
163925739|NCT01393613|592098705|FG000|Overall Study|Physician Decision|2|||
163925740|NCT01393613|592098706|FG001|Overall Study|Physician Decision|0|||
163925741|NCT01393613|592098707|FG002|Overall Study|Physician Decision|0|||
163925742|NCT01393613|592098708|FG003|Overall Study|Physician Decision|1|||
163925743|NCT01393613|592098705|FG000|Overall Study|Withdrawal by Subject|15|||
163925744|NCT01393613|592098706|FG001|Overall Study|Withdrawal by Subject|25|||
163925745|NCT01393613|592098707|FG002|Overall Study|Withdrawal by Subject|23|||
163925746|NCT01393613|592098708|FG003|Overall Study|Withdrawal by Subject|21|||
163925747|NCT01393613|592098705|FG000|Overall Study|Protocol Deviation|2|||
163925748|NCT01393613|592098706|FG001|Overall Study|Protocol Deviation|1|||
163925749|NCT01393613|592098707|FG002|Overall Study|Protocol Deviation|0|||
163925750|NCT01393613|592098708|FG003|Overall Study|Protocol Deviation|0|||
163925751|NCT01393613|592098705|FG000|Overall Study|Lack of Efficacy|9|||
163925752|NCT01393613|592098706|FG001|Overall Study|Lack of Efficacy|20|||
163925753|NCT01393613|592098707|FG002|Overall Study|Lack of Efficacy|16|||
163925754|NCT01393613|592098708|FG003|Overall Study|Lack of Efficacy|21|||
163925755|NCT02998918|592098712|FG000|Overall Study|Withdrawal by Subject|1|||
163925756|NCT02998918|592098713|FG001|Overall Study|Withdrawal by Subject|0|||
163925757|NCT01071317|592098714|FG000|Overall Study|Lost to Follow-up|2|||
163925758|NCT01071317|592098715|FG001|Overall Study|Lost to Follow-up|2|||
163925759|NCT05041439|592098718|FG000|Overall Study|Withdrawal by Subject|1|||
163925760|NCT05041439|592098719|FG001|Overall Study|Withdrawal by Subject|1|||
163925761|NCT05041439|592098718|FG000|Overall Study|Death|1|||
163925762|NCT05041439|592098719|FG001|Overall Study|Death|0|||
163925763|NCT00497874|592100670|FG000|Overall Study|Withdrawal by Subject|48|||
163925764|NCT00497874|592100671|FG001|Overall Study|Withdrawal by Subject|17|||
163925765|NCT00497874|592100670|FG000|Overall Study|Illness|8|||
163925766|NCT00497874|592100671|FG001|Overall Study|Illness|4|||
163925767|NCT00497874|592100670|FG000|Overall Study|Death|2|||
163925768|NCT00497874|592100671|FG001|Overall Study|Death|4|||
163925769|NCT00497874|592100670|FG000|Overall Study|Unable to contact|52|||
163925770|NCT00497874|592100671|FG001|Overall Study|Unable to contact|67|||
163925771|NCT00497874|592100670|FG000|Overall Study|Unable to schedule|37|||
163925772|NCT00497874|592100671|FG001|Overall Study|Unable to schedule|24|||
163925773|NCT01101334|592100672|FG000|Overall Study|Adverse Event|9|||
163925774|NCT01101334|592100673|FG001|Overall Study|Adverse Event|4|||
163925775|NCT01101334|592100672|FG000|Overall Study|Death|7|||
163925776|NCT01101334|592100673|FG001|Overall Study|Death|1|||
163925777|NCT01101334|592100672|FG000|Overall Study|Withdrawal by Subject|4|||
163925778|NCT01101334|592100673|FG001|Overall Study|Withdrawal by Subject|3|||
163925779|NCT01101334|592100672|FG000|Overall Study|Withdrawal by Sponsor|1|||
163925780|NCT01101334|592100673|FG001|Overall Study|Withdrawal by Sponsor|1|||
163925781|NCT01101334|592100672|FG000|Overall Study|Progressive Disease|22|||
163925782|NCT01101334|592100673|FG001|Overall Study|Progressive Disease|35|||
163925783|NCT01101334|592100672|FG000|Overall Study|Other|2|||
163925784|NCT01101334|592100673|FG001|Overall Study|Other|1|||
163925785|NCT00612352|592100674|FG000|Overall Study|Adverse Event|1|||
163925786|NCT00612352|592100675|FG001|Overall Study|Adverse Event|0|||
163925787|NCT00612352|592100674|FG000|Overall Study|Withdrawal by Subject|3|||
163925788|NCT00612352|592100675|FG001|Overall Study|Withdrawal by Subject|5|||
163925789|NCT00612352|592100674|FG000|Overall Study|moved out of state|1|||
163925790|NCT00612352|592100675|FG001|Overall Study|moved out of state|0|||
163925791|NCT00612352|592100674|FG000|Overall Study|didn't return calls/show up on test date|4|||
163925792|NCT00612352|592100675|FG001|Overall Study|didn't return calls/show up on test date|1|||
163925793|NCT00263211|592100676|FG000|Overall Study|Death|1|||
163925794|NCT00263211|592100677|FG001|Overall Study|Death|0|||
163925795|NCT00263211|592100676|FG000|Overall Study|Withdrawal by Subject|3|||
163925796|NCT00263211|592100677|FG001|Overall Study|Withdrawal by Subject|0|||
163925797|NCT00263211|592100676|FG000|Overall Study|Protocol Violation|1|||
163925798|NCT00263211|592100677|FG001|Overall Study|Protocol Violation|0|||
163925799|NCT00263211|592100676|FG000|Overall Study|Disease Progression|0|||
163925800|NCT00263211|592100677|FG001|Overall Study|Disease Progression|1|||
163925801|NCT01053247|592100682|FG000|Overall Study|Withdrawal by Subject|9|||
164034227|NCT02988219|592484358|FG000|Overall Study|Withdrawal by Subject|0|||
164034228|NCT02988219|592484359|FG001|Overall Study|Withdrawal by Subject|2|||
164034229|NCT01306032|592484360|FG000|First Intervention|Adverse Event|1|||
164034230|NCT01306032|592484361|FG001|First Intervention|Adverse Event|0|||
163829917|NCT04198805|591745873|FG000|Overall Study|Death|0|||
163829918|NCT04198805|591745874|FG001|Overall Study|Death|0|||
163829919|NCT04198805|591745875|FG002|Overall Study|Death|0|||
163829920|NCT04198805|591745876|FG003|Overall Study|Death|1|||
163829921|NCT04198805|591745873|FG000|Overall Study|Early Termination|8|||
163829922|NCT04198805|591745874|FG001|Overall Study|Early Termination|4|||
163829923|NCT04198805|591745875|FG002|Overall Study|Early Termination|6|||
163925802|NCT01053247|592100683|FG001|Overall Study|Withdrawal by Subject|4|||
163925803|NCT01053247|592100684|FG002|Overall Study|Withdrawal by Subject|15|||
163925804|NCT01053247|592100682|FG000|Overall Study|Lack of Efficacy|1|||
163925805|NCT01053247|592100683|FG001|Overall Study|Lack of Efficacy|0|||
163925806|NCT01053247|592100684|FG002|Overall Study|Lack of Efficacy|1|||
163925807|NCT01053247|592100682|FG000|Overall Study|Protocol Violation|2|||
163925808|NCT01053247|592100683|FG001|Overall Study|Protocol Violation|1|||
163925809|NCT01053247|592100684|FG002|Overall Study|Protocol Violation|2|||
163925810|NCT01053247|592100682|FG000|Overall Study|Lost to Follow-up|8|||
163925811|NCT01053247|592100683|FG001|Overall Study|Lost to Follow-up|5|||
163925812|NCT01053247|592100684|FG002|Overall Study|Lost to Follow-up|7|||
164034231|NCT01306032|592484362|FG002|First Intervention|Adverse Event|1|||
164034232|NCT01306032|592484363|FG003|First Intervention|Adverse Event|0|||
164034233|NCT01306032|592484364|FG004|First Intervention|Adverse Event|0|||
163829924|NCT04198805|591745876|FG003|Overall Study|Early Termination|9|||
163829925|NCT03078816|591745877|FG000|Overall Study|Withdrawal by Subject|1|||
163925813|NCT01053247|592100682|FG000|Overall Study|Adverse Event|0|||
163925814|NCT01053247|592100683|FG001|Overall Study|Adverse Event|9|||
163925815|NCT01053247|592100684|FG002|Overall Study|Adverse Event|3|||
163925816|NCT03458728|592100685|FG000|Overall Study|Adverse Event|1|||
163925817|NCT03458728|592100686|FG001|Overall Study|Adverse Event|0|||
163925818|NCT03458728|592100685|FG000|Overall Study|Physician Decision|1|||
164034234|NCT01306032|592484365|FG005|First Intervention|Adverse Event|1|||
164034235|NCT01306032|592484360|FG000|First Intervention|Withdrawal by Subject|0|||
164034236|NCT01306032|592484361|FG001|First Intervention|Withdrawal by Subject|2|||
164034237|NCT01306032|592484362|FG002|First Intervention|Withdrawal by Subject|0|||
164034238|NCT01306032|592484363|FG003|First Intervention|Withdrawal by Subject|1|||
164034239|NCT01306032|592484364|FG004|First Intervention|Withdrawal by Subject|0|||
164034240|NCT01306032|592484365|FG005|First Intervention|Withdrawal by Subject|0|||
164034241|NCT01306032|592484360|FG000|First Intervention|Death|0|||
164034242|NCT01306032|592484361|FG001|First Intervention|Death|0|||
164034243|NCT01306032|592484362|FG002|First Intervention|Death|1|||
164034244|NCT01306032|592484363|FG003|First Intervention|Death|0|||
164097940|NCT02822235|592724987|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
164097941|NCT02822235|592724988|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
164097942|NCT02822235|592724987|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
164097943|NCT02822235|592724988|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
164097944|NCT02822235|592724987|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
164097945|NCT02822235|592724988|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
163829926|NCT02114151|591745878|FG000|Overall Study|Death|1|||
163829927|NCT02114151|591745878|FG000|Overall Study|Lost to Follow-up|1|||
163829928|NCT02114151|591745878|FG000|Overall Study|Withdrawal by Subject|5|||
163829929|NCT01499082|591745879|FG000|Overall Study|Randomized but not Treated|0|||
163829930|NCT01499082|591745880|FG001|Overall Study|Randomized but not Treated|1|||
163829931|NCT01499082|591745879|FG000|Overall Study|Adverse Event|12|||
163829932|NCT01499082|591745880|FG001|Overall Study|Adverse Event|16|||
163829933|NCT01499082|591745879|FG000|Overall Study|Lack of Efficacy|1|||
163829934|NCT01499082|591745880|FG001|Overall Study|Lack of Efficacy|1|||
163829935|NCT01499082|591745879|FG000|Overall Study|Protocol Violation|6|||
163829936|NCT01499082|591745880|FG001|Overall Study|Protocol Violation|8|||
163829937|NCT01499082|591745879|FG000|Overall Study|Diverse Reasons|18|||
163829938|NCT01499082|591745880|FG001|Overall Study|Diverse Reasons|14|||
163829939|NCT01499082|591745879|FG000|Overall Study|Site Closure for Noncompliance|5|||
163829940|NCT01499082|591745880|FG001|Overall Study|Site Closure for Noncompliance|2|||
163829941|NCT01499082|591745879|FG000|Overall Study|Hypoglycemia|2|||
163829942|NCT01499082|591745880|FG001|Overall Study|Hypoglycemia|3|||
163829943|NCT01499082|591745879|FG000|Overall Study|Lost to Follow-up|1|||
163829944|NCT01499082|591745880|FG001|Overall Study|Lost to Follow-up|3|||
163829945|NCT00500903|591745891|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
163829946|NCT00500903|591745892|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
163829947|NCT00500903|591745893|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
163829948|NCT00500903|591745891|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
163829949|NCT00500903|591745892|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
163829950|NCT00500903|591745893|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
163829951|NCT00500903|591745891|FG000|Overall Study|Progressive Disease|41|||
163829952|NCT00500903|591745892|FG001|Overall Study|Progressive Disease|2|||
163829953|NCT00500903|591745893|FG002|Overall Study|Progressive Disease|15|||
163829954|NCT00500903|591745891|FG000|Overall Study|Patient Declined Further Treatment|0|||
163829955|NCT00500903|591745892|FG001|Overall Study|Patient Declined Further Treatment|0|||
163829956|NCT00500903|591745893|FG002|Overall Study|Patient Declined Further Treatment|3|||
163829957|NCT00500903|591745891|FG000|Overall Study|Symptomatic Deterioration|2|||
163829958|NCT00500903|591745892|FG001|Overall Study|Symptomatic Deterioration|0|||
163829959|NCT00500903|591745893|FG002|Overall Study|Symptomatic Deterioration|0|||
163829960|NCT00500903|591745891|FG000|Overall Study|Reason Not Specified|10|||
163829961|NCT00500903|591745892|FG001|Overall Study|Reason Not Specified|0|||
163829962|NCT00500903|591745893|FG002|Overall Study|Reason Not Specified|2|||
163829963|NCT00803452|591745897|FG000|Overall Study|Adverse Event|0|||
163829964|NCT00803452|591745898|FG001|Overall Study|Adverse Event|2|||
163829965|NCT00803452|591745897|FG000|Overall Study|Lost to Follow-up|0|||
163829966|NCT00803452|591745898|FG001|Overall Study|Lost to Follow-up|3|||
163829967|NCT01255592|591747363|FG000|Overall Study|Adverse Event|5|||
163829968|NCT01255592|591747364|FG001|Overall Study|Adverse Event|0|||
163829969|NCT01255592|591747363|FG000|Overall Study|Withdrawal by Subject|1|||
163829970|NCT01255592|591747364|FG001|Overall Study|Withdrawal by Subject|0|||
163829971|NCT01255592|591747363|FG000|Overall Study|Other|0|||
163829972|NCT01255592|591747364|FG001|Overall Study|Other|1|||
163829973|NCT02882282|591747365|FG000|Overall Study|Adverse Event|1|||
163829974|NCT02882282|591747366|FG001|Overall Study|Adverse Event|0|||
163829975|NCT03928028|591747367|FG000|Overall Study|Physician Decision|9|||
163829976|NCT03928028|591747368|FG001|Overall Study|Physician Decision|6|||
163829977|NCT03928028|591747369|FG002|Overall Study|Physician Decision|3|||
163829978|NCT03928028|591747367|FG000|Overall Study|Withdrawal by Subject|12|||
163829979|NCT03928028|591747368|FG001|Overall Study|Withdrawal by Subject|3|||
163829980|NCT03928028|591747369|FG002|Overall Study|Withdrawal by Subject|3|||
164034245|NCT01306032|592484364|FG004|First Intervention|Death|0|||
164034246|NCT01306032|592484365|FG005|First Intervention|Death|0|||
163829981|NCT02710292|591747376|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
163829982|NCT02710292|591747377|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
163925819|NCT03458728|592100686|FG001|Overall Study|Physician Decision|0|||
163925820|NCT03458728|592100685|FG000|Overall Study|Progressive disease - clinical assessment|1|||
163925821|NCT03458728|592100686|FG001|Overall Study|Progressive disease - clinical assessment|0|||
163925822|NCT03458728|592100685|FG000|Overall Study|Progressive disease - radiological progression|21|||
163925823|NCT03458728|592100686|FG001|Overall Study|Progressive disease - radiological progression|6|||
163925824|NCT03458728|592100685|FG000|Overall Study|Withdrawal by Subject|0|||
163925825|NCT03458728|592100686|FG001|Overall Study|Withdrawal by Subject|1|||
163925826|NCT00908349|592100689|FG000|Overall Study|Adverse Event|10|||
163925827|NCT00908349|592100689|FG000|Overall Study|Withdrawal by Subject|9|||
163925828|NCT00908349|592100689|FG000|Overall Study|Physician Decision|5|||
163925829|NCT00908349|592100689|FG000|Overall Study|Lost to Follow-up|5|||
163925830|NCT00908349|592100689|FG000|Overall Study|Various|6|||
163925831|NCT04606199|592100690|FG000|Overall Study|Withdrawal by Subject|2|||
163925832|NCT00408928|592100691|FG000|Overall Study|Withdrawal by Subject|1|||
163925833|NCT00408928|592100691|FG000|Overall Study|Death|1|||
163925834|NCT00408928|592100691|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
163925835|NCT01114139|592100693|FG000|Overall Study|Adverse Event|3|||
163925836|NCT01114139|592100694|FG001|Overall Study|Adverse Event|2|||
163925837|NCT01114139|592100693|FG000|Overall Study|Lost to Follow-up|15|||
164034247|NCT01306032|592484360|FG000|First Intervention|Ineligible|0|||
164034248|NCT01306032|592484361|FG001|First Intervention|Ineligible|0|||
164034249|NCT01306032|592484362|FG002|First Intervention|Ineligible|0|||
164034250|NCT01306032|592484363|FG003|First Intervention|Ineligible|0|||
164034251|NCT01306032|592484364|FG004|First Intervention|Ineligible|0|||
163925838|NCT01114139|592100694|FG001|Overall Study|Lost to Follow-up|3|||
163925839|NCT01114139|592100693|FG000|Overall Study|Withdrawal by Subject|17|||
163925840|NCT01114139|592100694|FG001|Overall Study|Withdrawal by Subject|6|||
163925841|NCT01114139|592100693|FG000|Overall Study|Other-Missed 1 visit|1|||
163925842|NCT01114139|592100694|FG001|Overall Study|Other-Missed 1 visit|0|||
163925843|NCT01114139|592100693|FG000|Overall Study|Other-Protocol Violation|1|||
163925844|NCT01114139|592100694|FG001|Overall Study|Other-Protocol Violation|0|||
163925845|NCT01114139|592100693|FG000|Overall Study|Other-Out of window for study drug dose|1|||
163925846|NCT01114139|592100694|FG001|Overall Study|Other-Out of window for study drug dose|0|||
163925847|NCT01114139|592100693|FG000|Overall Study|Other-Participant falsified records|0|||
163925848|NCT01114139|592100694|FG001|Overall Study|Other-Participant falsified records|1|||
164034252|NCT01306032|592484365|FG005|First Intervention|Ineligible|1|||
164034253|NCT01306032|592484360|FG000|First Intervention|Progressive disease|0|||
164034254|NCT01306032|592484361|FG001|First Intervention|Progressive disease|0|||
164034255|NCT01306032|592484362|FG002|First Intervention|Progressive disease|0|||
164034256|NCT01306032|592484363|FG003|First Intervention|Progressive disease|0|||
164034257|NCT01306032|592484364|FG004|First Intervention|Progressive disease|2|||
164034258|NCT01306032|592484365|FG005|First Intervention|Progressive disease|0|||
164034259|NCT01306032|592484360|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
164034260|NCT01306032|592484361|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
164034261|NCT01306032|592484362|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
164034262|NCT01306032|592484363|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
164034263|NCT01306032|592484364|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
164034264|NCT01306032|592484365|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
164034265|NCT01306032|592484360|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
164034266|NCT01306032|592484361|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
164034267|NCT01306032|592484362|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
164034268|NCT01306032|592484363|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
164034269|NCT01306032|592484364|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
164034270|NCT01306032|592484365|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
164034271|NCT01213264|592484366|FG000|Overall Study|Adverse Event|1|||
164034272|NCT01213264|592484367|FG001|Overall Study|Adverse Event|0|||
164034273|NCT01213264|592484368|FG002|Overall Study|Adverse Event|0|||
164034274|NCT01213264|592484366|FG000|Overall Study|Lost to Follow-up|1|||
164034275|NCT01213264|592484367|FG001|Overall Study|Lost to Follow-up|2|||
164034276|NCT01213264|592484368|FG002|Overall Study|Lost to Follow-up|6|||
164034277|NCT01522443|592484371|FG000|Overall Study|No longer receiving clinical benefit|36|||
164034278|NCT01522443|592484372|FG001|Overall Study|No longer receiving clinical benefit|28|||
163925849|NCT01114139|592100693|FG000|Overall Study|Other-Participant went on hospice|0|||
163925850|NCT01114139|592100694|FG001|Overall Study|Other-Participant went on hospice|1|||
164034279|NCT01522443|592484371|FG000|Overall Study|Adverse Event|10|||
164034280|NCT01522443|592484372|FG001|Overall Study|Adverse Event|15|||
164034281|NCT01522443|592484371|FG000|Overall Study|Withdrawal by Subject|5|||
164034282|NCT01522443|592484372|FG001|Overall Study|Withdrawal by Subject|8|||
164034283|NCT01522443|592484371|FG000|Overall Study|No study treatment given|1|||
164034284|NCT01522443|592484372|FG001|Overall Study|No study treatment given|1|||
164097946|NCT02822235|592724987|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
163925851|NCT01114139|592100693|FG000|Overall Study|Other-Physician changed treatment|1|||
163925852|NCT01114139|592100694|FG001|Overall Study|Other-Physician changed treatment|0|||
163925853|NCT01114139|592100693|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
163925854|NCT01114139|592100694|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
163925855|NCT01951378|592100695|FG000|Overall Study|Study Terminated-Not completed|23|||
163925856|NCT01951378|592100696|FG001|Overall Study|Study Terminated-Not completed|17|||
163925857|NCT02512861|592100702|FG000|Overall Study|Protocol Violation|3|||
163925858|NCT02512861|592100703|FG001|Overall Study|Protocol Violation|7|||
163925859|NCT02512861|592100702|FG000|Overall Study|Physician Decision|3|||
163925860|NCT02512861|592100703|FG001|Overall Study|Physician Decision|1|||
164034285|NCT01522443|592484371|FG000|Overall Study|Other|1|||
164034286|NCT01522443|592484372|FG001|Overall Study|Other|3|||
164034287|NCT03260894|592484373|FG000|Overall Study|Death|6|||
164034288|NCT03260894|592484374|FG001|Overall Study|Death|8|||
163829983|NCT02710292|591747376|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
163829984|NCT02710292|591747377|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
163829985|NCT02323646|591747385|FG000|Treatment Course 1|Adverse Event|1|||
163829986|NCT02323646|591747386|FG001|Treatment Course 1|Adverse Event|0|||
163829987|NCT02323646|591747387|FG002|Treatment Course 1|Adverse Event|1|||
163829988|NCT02323646|591747385|FG000|Treatment Course 1|Heavy Bleeding|1|||
163829989|NCT02323646|591747386|FG001|Treatment Course 1|Heavy Bleeding|1|||
163829990|NCT02323646|591747387|FG002|Treatment Course 1|Heavy Bleeding|0|||
163829991|NCT02323646|591747385|FG000|Treatment Course 1|Lost to Follow-up|1|||
163829992|NCT02323646|591747386|FG001|Treatment Course 1|Lost to Follow-up|0|||
163829993|NCT02323646|591747387|FG002|Treatment Course 1|Lost to Follow-up|2|||
163829994|NCT02323646|591747385|FG000|Treatment Course 1|Withdrawal by Subject|0|||
163829995|NCT02323646|591747386|FG001|Treatment Course 1|Withdrawal by Subject|2|||
163829996|NCT02323646|591747387|FG002|Treatment Course 1|Withdrawal by Subject|0|||
163829997|NCT02323646|591747385|FG000|Treatment Course 2|Adverse Event|1|||
163829998|NCT02323646|591747386|FG001|Treatment Course 2|Adverse Event|0|||
163829999|NCT02323646|591747387|FG002|Treatment Course 2|Adverse Event|1|||
163830000|NCT02323646|591747385|FG000|Treatment Course 2|Lost to Follow-up|0|||
163830001|NCT02323646|591747386|FG001|Treatment Course 2|Lost to Follow-up|0|||
163830002|NCT02323646|591747387|FG002|Treatment Course 2|Lost to Follow-up|1|||
163830003|NCT02323646|591747385|FG000|Treatment Course 2|Non-compliance|0|||
163830004|NCT02323646|591747386|FG001|Treatment Course 2|Non-compliance|1|||
163830005|NCT02323646|591747387|FG002|Treatment Course 2|Non-compliance|1|||
163830006|NCT02459262|591747388|FG000|Overall Study|Withdrawal by Subject|0|||
163830007|NCT02459262|591747389|FG001|Overall Study|Withdrawal by Subject|0|||
163830008|NCT02459262|591747390|FG002|Overall Study|Withdrawal by Subject|0|||
163830009|NCT02459262|591747391|FG003|Overall Study|Withdrawal by Subject|0|||
163830010|NCT02459262|591747392|FG004|Overall Study|Withdrawal by Subject|0|||
163830011|NCT02459262|591747393|FG005|Overall Study|Withdrawal by Subject|0|||
163830012|NCT02459262|591747394|FG006|Overall Study|Withdrawal by Subject|0|||
163830013|NCT02459262|591747395|FG007|Overall Study|Withdrawal by Subject|0|||
163830014|NCT02459262|591747396|FG008|Overall Study|Withdrawal by Subject|0|||
163830015|NCT02459262|591747397|FG009|Overall Study|Withdrawal by Subject|1|||
163830016|NCT02459262|591747398|FG010|Overall Study|Withdrawal by Subject|0|||
163830017|NCT05168579|591747399|FG000|Overall Study|Lack of Consent|1|||
163830018|NCT05168579|591747400|FG001|Overall Study|Lack of Consent|0|||
163830019|NCT05168579|591747399|FG000|Overall Study|Conflicts with time|2|||
163830020|NCT05168579|591747400|FG001|Overall Study|Conflicts with time|0|||
163830021|NCT05168579|591747399|FG000|Overall Study|Time slots were full|3|||
163830022|NCT05168579|591747400|FG001|Overall Study|Time slots were full|0|||
163830023|NCT05168579|591747399|FG000|Overall Study|Lost to Follow-up|0|||
163830024|NCT05168579|591747400|FG001|Overall Study|Lost to Follow-up|15|||
163830025|NCT00387894|591747401|FG000|Overall Study|Withdrawal by Subject|1|||
163830026|NCT00827541|591747402|FG000|Overall Study|Exitus|1|||
163830027|NCT00827541|591747403|FG001|Overall Study|Exitus|8|||
163830028|NCT00827541|591747402|FG000|Overall Study|Other|1|||
163830029|NCT00827541|591747403|FG001|Overall Study|Other|3|||
163830030|NCT00827541|591747402|FG000|Overall Study|Pathogen not susceptible|1|||
163830031|NCT00827541|591747403|FG001|Overall Study|Pathogen not susceptible|0|||
163830032|NCT00827541|591747402|FG000|Overall Study|Lack of effectiveness|1|||
163830033|NCT00827541|591747403|FG001|Overall Study|Lack of effectiveness|0|||
163830034|NCT01750879|591747404|FG000|Overall Study|Adverse Event|8|||
163830035|NCT01750879|591747405|FG001|Overall Study|Adverse Event|0|||
163830036|NCT01750879|591747404|FG000|Overall Study|Lack of Efficacy|1|||
163830037|NCT01750879|591747405|FG001|Overall Study|Lack of Efficacy|0|||
163830038|NCT01750879|591747404|FG000|Overall Study|Withdrawal by Subject|1|||
163830039|NCT01750879|591747405|FG001|Overall Study|Withdrawal by Subject|0|||
163830040|NCT01750879|591747404|FG000|Overall Study|Did not complete per protocol|0|||
163830041|NCT01750879|591747405|FG001|Overall Study|Did not complete per protocol|3|||
163830042|NCT02347657|591747406|FG000|Overall Study|Physician Decision|0|||
163830043|NCT02347657|591747407|FG001|Overall Study|Physician Decision|1|||
163830044|NCT02347657|591747406|FG000|Overall Study|Adverse Event|8|||
163830045|NCT02347657|591747407|FG001|Overall Study|Adverse Event|4|||
163830046|NCT02347657|591747406|FG000|Overall Study|Withdrawal by Subject|6|||
163925861|NCT02512861|592100702|FG000|Overall Study|Withdrawal by Subject|0|||
163925862|NCT02512861|592100703|FG001|Overall Study|Withdrawal by Subject|1|||
163925863|NCT01774019|592100704|FG000|Overall Study|No longer meets protocol criteria|2|||
163925864|NCT01774019|592100705|FG001|Overall Study|No longer meets protocol criteria|0|||
163925865|NCT01774019|592100704|FG000|Overall Study|Withdrawal by Subject|1|||
163925866|NCT01774019|592100705|FG001|Overall Study|Withdrawal by Subject|0|||
163925867|NCT01774019|592100704|FG000|Overall Study|Surgery delayed > 120 days|1|||
163925868|NCT01774019|592100705|FG001|Overall Study|Surgery delayed > 120 days|0|||
163925869|NCT01774019|592100704|FG000|Overall Study|Patient refused surgery|1|||
163925870|NCT01774019|592100705|FG001|Overall Study|Patient refused surgery|1|||
163925871|NCT01774019|592100704|FG000|Overall Study|Unable to implant study device|1|||
163925872|NCT01774019|592100705|FG001|Overall Study|Unable to implant study device|0|||
163925873|NCT01774019|592100704|FG000|Overall Study|Lost to Follow-up|0|||
163925874|NCT01774019|592100705|FG001|Overall Study|Lost to Follow-up|3|||
163925875|NCT00292981|592100706|FG000|Overall Study|Adverse Event|1|||
163925876|NCT00292981|592100706|FG000|Overall Study|Lost to Follow-up|13|||
163925877|NCT00292981|592100706|FG000|Overall Study|Withdrawal by Subject|22|||
163925878|NCT00292981|592100706|FG000|Overall Study|Other|3|||
163925879|NCT03245619|592100718|FG000|Part A (Up to Day 22)|Physician Decision|4|||
163925880|NCT03245619|592100719|FG001|Part A (Up to Day 22)|Physician Decision|6|||
163925881|NCT03245619|592100720|FG002|Part A (Up to Day 22)|Physician Decision|6|||
163925882|NCT03245619|592100721|FG003|Part A (Up to Day 22)|Physician Decision|0|||
163925883|NCT03245619|592100722|FG004|Part A (Up to Day 22)|Physician Decision|0|||
163925884|NCT03245619|592100723|FG005|Part A (Up to Day 22)|Physician Decision|0|||
163925885|NCT03245619|592100724|FG006|Part A (Up to Day 22)|Physician Decision|0|||
163925886|NCT03245619|592100725|FG007|Part A (Up to Day 22)|Physician Decision|0|||
163925887|NCT03245619|592100726|FG008|Part A (Up to Day 22)|Physician Decision|0|||
163925888|NCT03245619|592100727|FG009|Part A (Up to Day 22)|Physician Decision|0|||
163925889|NCT03245619|592100728|FG010|Part A (Up to Day 22)|Physician Decision|0|||
163925890|NCT03245619|592100729|FG011|Part A (Up to Day 22)|Physician Decision|0|||
163925891|NCT03245619|592100730|FG012|Part A (Up to Day 22)|Physician Decision|0|||
163925892|NCT03245619|592100731|FG013|Part A (Up to Day 22)|Physician Decision|0|||
163925893|NCT03245619|592100732|FG014|Part A (Up to Day 22)|Physician Decision|0|||
163925894|NCT03245619|592100733|FG015|Part A (Up to Day 22)|Physician Decision|0|||
163925895|NCT03245619|592100734|FG016|Part A (Up to Day 22)|Physician Decision|0|||
163925896|NCT03470545|592100735|FG000|Overall Study|Death|0|||
163925897|NCT03470545|592100736|FG001|Overall Study|Death|1|||
163925898|NCT03470545|592100735|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
163925899|NCT03470545|592100736|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
163925900|NCT03470545|592100735|FG000|Overall Study|Adverse Event|2|||
163925901|NCT03470545|592100736|FG001|Overall Study|Adverse Event|0|||
163925902|NCT03470545|592100735|FG000|Overall Study|Withdrawal by Subject|1|||
163925903|NCT03470545|592100736|FG001|Overall Study|Withdrawal by Subject|1|||
163925904|NCT03470545|592100735|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
163925905|NCT03470545|592100736|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
163925906|NCT00776659|592100752|FG000|Overall Study|Lost to Follow-up|15|||
163925907|NCT00776659|592100752|FG000|Overall Study|Withdrawal by Subject|10|||
163925908|NCT00776659|592100752|FG000|Overall Study|Study Terminated by Sponsor|1|||
163925909|NCT02971228|592100753|FG000|Overall Study|Withdrawal by Subject|1|||
163925910|NCT02971228|592100754|FG001|Overall Study|Withdrawal by Subject|1|||
163925911|NCT02971228|592100755|FG002|Overall Study|Withdrawal by Subject|0|||
163925912|NCT02971228|592100756|FG003|Overall Study|Withdrawal by Subject|0|||
163925913|NCT02971228|592100757|FG004|Overall Study|Withdrawal by Subject|0|||
163925914|NCT02971228|592100753|FG000|Overall Study|Logistical challenges|0|||
163925915|NCT02971228|592100754|FG001|Overall Study|Logistical challenges|1|||
163925916|NCT02971228|592100755|FG002|Overall Study|Logistical challenges|0|||
163925917|NCT02971228|592100756|FG003|Overall Study|Logistical challenges|0|||
163925918|NCT02971228|592100757|FG004|Overall Study|Logistical challenges|0|||
163925919|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
163925920|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
163925921|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
163925922|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
163925923|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
163925924|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
163925925|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
163925926|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
163925927|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
163925928|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
163925929|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
163925930|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
163925931|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
163925932|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
163925933|NCT01664923|592100758|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
163925934|NCT01664923|592100759|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
163830047|NCT02347657|591747407|FG001|Overall Study|Withdrawal by Subject|7|||
163830048|NCT02347657|591747406|FG000|Overall Study|Randomized but not treated|1|||
163830049|NCT02347657|591747407|FG001|Overall Study|Randomized but not treated|0|||
163830050|NCT02347657|591747406|FG000|Overall Study|Other|3|||
164034289|NCT03260894|592484373|FG000|Overall Study|Withdrawal by Subject|4|||
164034290|NCT03260894|592484374|FG001|Overall Study|Withdrawal by Subject|11|||
164034291|NCT03260894|592484373|FG000|Overall Study|On-going at clinical cut off date|36|||
164034292|NCT03260894|592484374|FG001|Overall Study|On-going at clinical cut off date|31|||
164034293|NCT01700985|592484375|FG000|Overall Study|Incarcerated|0|||
164034294|NCT01700985|592484376|FG001|Overall Study|Incarcerated|1|||
164034295|NCT02677220|592484377|FG000|Overall Study|Adverse Event|1|||
164034296|NCT00067470|592484378|FG000|Overall Study|Withdrawal by Subject|0|||
164034297|NCT00067470|592484379|FG001|Overall Study|Withdrawal by Subject|1|||
164034298|NCT01148693|592484380|FG000|Overall Study|Attempts for cannulation were failed|13|||
164034299|NCT01148693|592484381|FG001|Overall Study|Attempts for cannulation were failed|10|||
164034300|NCT01074658|592484383|FG000|Overall Study|No implant attempted|19|||
164034301|NCT00050622|592484384|FG000|Overall Study|Adverse Event|1|||
164034302|NCT01342952|592484385|FG000|Overall Study|Adverse Event|0|||
164034303|NCT01342952|592484386|FG001|Overall Study|Adverse Event|5|||
164034304|NCT01342952|592484387|FG002|Overall Study|Adverse Event|1|||
164034305|NCT01342952|592484388|FG003|Overall Study|Adverse Event|0|||
164034306|NCT01342952|592484385|FG000|Overall Study|Lost to Follow-up|0|||
164034307|NCT01342952|592484386|FG001|Overall Study|Lost to Follow-up|2|||
164034308|NCT01342952|592484387|FG002|Overall Study|Lost to Follow-up|0|||
164034309|NCT01342952|592484388|FG003|Overall Study|Lost to Follow-up|0|||
164034310|NCT01342952|592484385|FG000|Overall Study|Withdrawal by Subject|1|||
164034311|NCT01342952|592484386|FG001|Overall Study|Withdrawal by Subject|1|||
164034312|NCT01342952|592484387|FG002|Overall Study|Withdrawal by Subject|0|||
164034313|NCT01342952|592484388|FG003|Overall Study|Withdrawal by Subject|0|||
164034314|NCT01342952|592484385|FG000|Overall Study|Physician Decision|3|||
164034315|NCT01342952|592484386|FG001|Overall Study|Physician Decision|3|||
164034316|NCT01342952|592484387|FG002|Overall Study|Physician Decision|1|||
164034317|NCT01342952|592484388|FG003|Overall Study|Physician Decision|0|||
164034318|NCT00426556|592484389|FG000|Phase I - Core Phase|Disease Progression|0|||
164034319|NCT00426556|592484390|FG001|Phase I - Core Phase|Disease Progression|6|||
164034320|NCT00426556|592484391|FG002|Phase I - Core Phase|Disease Progression|2|||
164034321|NCT00426556|592484392|FG003|Phase I - Core Phase|Disease Progression|0|||
164034322|NCT00426556|592484389|FG000|Phase I - Core Phase|Adverse Event|1|||
164034323|NCT00426556|592484390|FG001|Phase I - Core Phase|Adverse Event|3|||
164034324|NCT00426556|592484391|FG002|Phase I - Core Phase|Adverse Event|1|||
164034325|NCT00426556|592484392|FG003|Phase I - Core Phase|Adverse Event|0|||
164034326|NCT00426556|592484389|FG000|Phase I - Core Phase|Death|0|||
164034327|NCT00426556|592484390|FG001|Phase I - Core Phase|Death|1|||
164034328|NCT00426556|592484391|FG002|Phase I - Core Phase|Death|0|||
164034329|NCT00426556|592484392|FG003|Phase I - Core Phase|Death|0|||
164034330|NCT00426556|592484389|FG000|Phase I - Extension Phase|Adverse Event|0|||
164034331|NCT00426556|592484390|FG001|Phase I - Extension Phase|Adverse Event|1|||
164034332|NCT00426556|592484391|FG002|Phase I - Extension Phase|Adverse Event|1|||
164034333|NCT00426556|592484392|FG003|Phase I - Extension Phase|Adverse Event|0|||
164034334|NCT00426556|592484389|FG000|Phase I - Extension Phase|Disease Progression|5|||
164034335|NCT00426556|592484390|FG001|Phase I - Extension Phase|Disease Progression|5|||
164034336|NCT00426556|592484391|FG002|Phase I - Extension Phase|Disease Progression|6|||
164034337|NCT00426556|592484392|FG003|Phase I - Extension Phase|Disease Progression|0|||
164034338|NCT00426556|592484389|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
164034339|NCT00426556|592484390|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
164034340|NCT00426556|592484391|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
164034341|NCT00426556|592484392|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
164034342|NCT00426556|592484389|FG000|Phase II - Core Phase|Disease Progression|0|||
164034343|NCT00426556|592484390|FG001|Phase II - Core Phase|Disease Progression|0|||
163830051|NCT02347657|591747407|FG001|Overall Study|Other|3|||
163830052|NCT00677352|591747410|FG000|Treatment Phase|Adverse Event|14|||
164034344|NCT00426556|592484391|FG002|Phase II - Core Phase|Disease Progression|0|||
164034345|NCT00426556|592484392|FG003|Phase II - Core Phase|Disease Progression|16|||
164034346|NCT00426556|592484389|FG000|Phase II - Core Phase|Adverse Event|0|||
164034347|NCT00426556|592484390|FG001|Phase II - Core Phase|Adverse Event|0|||
164034348|NCT00426556|592484391|FG002|Phase II - Core Phase|Adverse Event|0|||
164034349|NCT00426556|592484392|FG003|Phase II - Core Phase|Adverse Event|8|||
164034350|NCT00426556|592484389|FG000|Phase II - Extension Phase|Disease Progression|0|||
164034351|NCT00426556|592484390|FG001|Phase II - Extension Phase|Disease Progression|0|||
164034352|NCT00426556|592484391|FG002|Phase II - Extension Phase|Disease Progression|0|||
164034353|NCT00426556|592484392|FG003|Phase II - Extension Phase|Disease Progression|21|||
164034354|NCT00426556|592484389|FG000|Phase II - Extension Phase|Adverse Event|0|||
164034355|NCT00426556|592484390|FG001|Phase II - Extension Phase|Adverse Event|0|||
164034356|NCT00426556|592484391|FG002|Phase II - Extension Phase|Adverse Event|0|||
164034357|NCT00426556|592484392|FG003|Phase II - Extension Phase|Adverse Event|2|||
164034358|NCT03970824|592484396|FG000|Overall Study|Withdrawal by Subject|1|||
163830053|NCT00677352|591747411|FG001|Treatment Phase|Adverse Event|22|||
163830054|NCT00677352|591747410|FG000|Treatment Phase|Lack of Efficacy|2|||
163830055|NCT00677352|591747411|FG001|Treatment Phase|Lack of Efficacy|3|||
163830056|NCT00677352|591747410|FG000|Treatment Phase|Lost to Follow-up|0|||
163830057|NCT00677352|591747411|FG001|Treatment Phase|Lost to Follow-up|1|||
163830058|NCT00677352|591747410|FG000|Treatment Phase|Withdrawal by Subject|7|||
163830059|NCT00677352|591747411|FG001|Treatment Phase|Withdrawal by Subject|7|||
163830060|NCT00677352|591747410|FG000|Treatment Phase|Physician Decision|1|||
163830061|NCT00677352|591747411|FG001|Treatment Phase|Physician Decision|0|||
163830062|NCT00677352|591747410|FG000|Treatment Phase|Pregnancy|0|||
163830063|NCT00677352|591747411|FG001|Treatment Phase|Pregnancy|1|||
163830064|NCT00677352|591747410|FG000|Treatment Phase|Protocol Violation|1|||
163830065|NCT00677352|591747411|FG001|Treatment Phase|Protocol Violation|1|||
163830066|NCT00677352|591747410|FG000|Treatment Phase|Transference or work related matter|0|||
163830067|NCT00677352|591747411|FG001|Treatment Phase|Transference or work related matter|5|||
163830068|NCT00677352|591747410|FG000|Treatment Phase|Not treated|0|||
163830069|NCT00677352|591747411|FG001|Treatment Phase|Not treated|2|||
163830070|NCT00677352|591747410|FG000|Tapering Phase|Adverse Event|1|||
163830071|NCT00677352|591747411|FG001|Tapering Phase|Adverse Event|5|||
163830072|NCT00677352|591747410|FG000|Tapering Phase|Withdrawal by Subject|5|||
163830073|NCT00677352|591747411|FG001|Tapering Phase|Withdrawal by Subject|3|||
163830074|NCT00677352|591747410|FG000|Tapering Phase|Pregnancy|0|||
163830075|NCT00677352|591747411|FG001|Tapering Phase|Pregnancy|1|||
163830076|NCT00677352|591747410|FG000|Tapering Phase|Job transfer|0|||
163830077|NCT00677352|591747411|FG001|Tapering Phase|Job transfer|1|||
163830078|NCT02182973|591747417|FG000|Overall Study|Withdrawal by Subject|3|||
163830079|NCT02182973|591747418|FG001|Overall Study|Withdrawal by Subject|0|||
163830080|NCT00238433|591747419|FG000|Overall Study|Screen failure|1|||
163830081|NCT00238433|591747419|FG000|Overall Study|Lost to Follow-up|1|||
163830082|NCT00238433|591747419|FG000|Overall Study|Death|1|||
163830083|NCT01814748|591747420|FG000|Overall Study|Lost to Follow-up|1|||
163830084|NCT01814748|591747421|FG001|Overall Study|Lost to Follow-up|2|||
163830085|NCT01814748|591747420|FG000|Overall Study|Study site terminated by sponsor|1|||
163830086|NCT01814748|591747421|FG001|Overall Study|Study site terminated by sponsor|1|||
163830087|NCT01814748|591747420|FG000|Overall Study|Withdrawal by Subject|6|||
163830088|NCT01814748|591747421|FG001|Overall Study|Withdrawal by Subject|4|||
163830089|NCT03641313|591747422|FG000|Overall Study|Death|1|||
163830090|NCT03641313|591747422|FG000|Overall Study|Withdrawal by Subject|2|||
163830091|NCT03641313|591747422|FG000|Overall Study|Declining health|1|||
163830092|NCT03641313|591747422|FG000|Overall Study|Adverse Event|1|||
163830093|NCT05614089|591747428|FG000|Overall Study|Pregnancy|5|||
163830094|NCT05614089|591747429|FG001|Overall Study|Pregnancy|2|||
163830095|NCT05614089|591747428|FG000|Overall Study|Lost to Follow-up|5|||
163830096|NCT05614089|591747429|FG001|Overall Study|Lost to Follow-up|1|||
163830097|NCT05614089|591747428|FG000|Overall Study|Death|0|||
163830098|NCT05614089|591747429|FG001|Overall Study|Death|1|||
163830099|NCT05614089|591747428|FG000|Overall Study|Adverse Event|1|||
163830100|NCT05614089|591747429|FG001|Overall Study|Adverse Event|0|||
163830101|NCT05163522|591747430|FG000|Overall Study|Withdrawal by Subject|0|||
163830102|NCT05163522|591747431|FG001|Overall Study|Withdrawal by Subject|0|||
163830103|NCT05163522|591747432|FG002|Overall Study|Withdrawal by Subject|1|||
163830104|NCT05163522|591747433|FG003|Overall Study|Withdrawal by Subject|0|||
163830105|NCT05163522|591747434|FG004|Overall Study|Withdrawal by Subject|0|||
163830106|NCT05163522|591747435|FG005|Overall Study|Withdrawal by Subject|0|||
163830107|NCT05163522|591747436|FG006|Overall Study|Withdrawal by Subject|0|||
163830108|NCT05163522|591747437|FG007|Overall Study|Withdrawal by Subject|0|||
163830109|NCT05163522|591747438|FG008|Overall Study|Withdrawal by Subject|0|||
163830110|NCT05163522|591747439|FG009|Overall Study|Withdrawal by Subject|0|||
163830111|NCT05163522|591747440|FG010|Overall Study|Withdrawal by Subject|0|||
163830112|NCT03937219|591747442|FG000|Overall Study|Death|223|||
163830113|NCT03937219|591747443|FG001|Overall Study|Death|211|||
163830114|NCT03937219|591747442|FG000|Overall Study|Withdrawal by Subject|17|||
163830115|NCT03937219|591747443|FG001|Overall Study|Withdrawal by Subject|25|||
163830116|NCT03937219|591747442|FG000|Overall Study|Lost to Follow-up|3|||
163830117|NCT03937219|591747443|FG001|Overall Study|Lost to Follow-up|4|||
163830118|NCT04393441|591747449|FG000|Overall Study|Adverse Event|0|||
163830119|NCT04393441|591747450|FG001|Overall Study|Adverse Event|3|||
163830120|NCT04393441|591747449|FG000|Overall Study|Withdrawal by Subject|5|||
163830121|NCT04393441|591747450|FG001|Overall Study|Withdrawal by Subject|7|||
164034359|NCT03970824|592484397|FG001|Overall Study|Withdrawal by Subject|1|||
164034360|NCT03970824|592484398|FG002|Overall Study|Withdrawal by Subject|3|||
163830122|NCT04393441|591747449|FG000|Overall Study|Lost to Follow-up|0|||
163830123|NCT04393441|591747450|FG001|Overall Study|Lost to Follow-up|2|||
163830124|NCT04393441|591747449|FG000|Overall Study|Protocol Deviation|2|||
163830125|NCT04393441|591747450|FG001|Overall Study|Protocol Deviation|1|||
163830126|NCT04393441|591747449|FG000|Overall Study|Reason not Specified|1|||
164034361|NCT03970824|592484396|FG000|Overall Study|Lost to Follow-up|0|||
163830127|NCT04393441|591747450|FG001|Overall Study|Reason not Specified|1|||
164034362|NCT03970824|592484397|FG001|Overall Study|Lost to Follow-up|2|||
164034363|NCT03970824|592484398|FG002|Overall Study|Lost to Follow-up|1|||
164034364|NCT03970824|592484396|FG000|Overall Study|Adverse Event|1|||
164034365|NCT03970824|592484397|FG001|Overall Study|Adverse Event|0|||
164034366|NCT03970824|592484398|FG002|Overall Study|Adverse Event|0|||
164034367|NCT00416312|592484399|FG000|Overall Study|tumors not visible on imaging|2|||
164034368|NCT02146248|592484401|FG000|Overall Study|Withdrawal by Subject|2|||
164034369|NCT00425100|592484402|FG000|Overall Study|Adverse Event|36|||
164034370|NCT00425100|592484402|FG000|Overall Study|Lack of Efficacy|4|||
163830128|NCT04003610|591747451|FG000|Overall Study|Lost to Follow-up|0|||
163830129|NCT04003610|591747452|FG001|Overall Study|Lost to Follow-up|1|||
163830130|NCT04003610|591747453|FG002|Overall Study|Lost to Follow-up|0|||
163830131|NCT04003610|591747451|FG000|Overall Study|Death|0|||
163830132|NCT04003610|591747452|FG001|Overall Study|Death|0|||
163830133|NCT04003610|591747453|FG002|Overall Study|Death|3|||
163830134|NCT04003610|591747451|FG000|Overall Study|Study Terminated by Sponsor|0|||
163830135|NCT04003610|591747452|FG001|Overall Study|Study Terminated by Sponsor|0|||
163830136|NCT04003610|591747453|FG002|Overall Study|Study Terminated by Sponsor|3|||
163830137|NCT00771810|591747454|FG000|Overall Study|Adverse Event|3|||
163830138|NCT00771810|591747455|FG001|Overall Study|Adverse Event|0|||
163830139|NCT00771810|591747456|FG002|Overall Study|Adverse Event|2|||
163830140|NCT00771810|591747454|FG000|Overall Study|Lost to Follow-up|0|||
163830141|NCT00771810|591747455|FG001|Overall Study|Lost to Follow-up|0|||
163830142|NCT00771810|591747456|FG002|Overall Study|Lost to Follow-up|1|||
163830143|NCT00771810|591747454|FG000|Overall Study|Physician Decision|1|||
163830144|NCT00771810|591747455|FG001|Overall Study|Physician Decision|2|||
163830145|NCT00771810|591747456|FG002|Overall Study|Physician Decision|2|||
163830146|NCT00771810|591747454|FG000|Overall Study|Protocol Violation|0|||
163830147|NCT00771810|591747455|FG001|Overall Study|Protocol Violation|1|||
163830148|NCT00771810|591747456|FG002|Overall Study|Protocol Violation|1|||
163830149|NCT00771810|591747454|FG000|Overall Study|Withdrawal by Subject|1|||
163830150|NCT00771810|591747455|FG001|Overall Study|Withdrawal by Subject|2|||
163830151|NCT00771810|591747456|FG002|Overall Study|Withdrawal by Subject|0|||
163830152|NCT00771810|591747454|FG000|Overall Study|Other|0|||
163830153|NCT00771810|591747455|FG001|Overall Study|Other|0|||
163830154|NCT00771810|591747456|FG002|Overall Study|Other|1|||
163830155|NCT02660827|591747459|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
163830156|NCT02660827|591747459|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
163830157|NCT02660827|591747459|FG000|From Study to End of Continued Access|Adverse Event|3|||
163830158|NCT02660827|591747459|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
163830159|NCT02660827|591747459|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
163830160|NCT02660827|591747459|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
163830161|NCT02660827|591747459|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
163830162|NCT02660827|591747459|FG000|Period 2: Continued Access Period|Adverse Event|3|||
163830163|NCT02657031|591747462|FG000|Overall Study|Adverse Event|1|||
163830164|NCT02657031|591747463|FG001|Overall Study|Adverse Event|2|||
163830165|NCT03599349|591747464|FG000|Overall Study|Lost to Follow-up|1|||
163830166|NCT00810264|591747467|FG000|Overall Study|Lost to Follow-up|191|||
163830167|NCT00810264|591747467|FG000|Overall Study|Withdrawal by subject or physician|721|||
163830168|NCT00810264|591747467|FG000|Overall Study|Death|641|||
163830169|NCT01648348|591747470|FG000|Overall Study|Cancel|1|||
163830170|NCT01648348|591747471|FG001|Overall Study|Cancel|0|||
163830171|NCT01648348|591747472|FG002|Overall Study|Cancel|0|||
163830172|NCT01648348|591747473|FG003|Overall Study|Cancel|0|||
163830173|NCT01648348|591747474|FG004|Overall Study|Cancel|3|||
163830174|NCT01648348|591747475|FG005|Overall Study|Cancel|6|||
163830175|NCT01648348|591747470|FG000|Overall Study|Replaced for MTD analysis|1|||
163830176|NCT01648348|591747471|FG001|Overall Study|Replaced for MTD analysis|0|||
163830177|NCT01648348|591747472|FG002|Overall Study|Replaced for MTD analysis|1|||
163830178|NCT01648348|591747473|FG003|Overall Study|Replaced for MTD analysis|0|||
163830179|NCT01648348|591747474|FG004|Overall Study|Replaced for MTD analysis|0|||
163830180|NCT01648348|591747475|FG005|Overall Study|Replaced for MTD analysis|0|||
163830181|NCT00696410|591747476|FG000|Overall Study|Lost to Follow-up|2|||
163830182|NCT00696410|591747477|FG001|Overall Study|Lost to Follow-up|0|||
163830183|NCT00696410|591747476|FG000|Overall Study|Withdrawal by Subject|8|||
163830184|NCT00696410|591747477|FG001|Overall Study|Withdrawal by Subject|0|||
163830185|NCT00696410|591747476|FG000|Overall Study|Physician Decision|3|||
163830186|NCT00696410|591747477|FG001|Overall Study|Physician Decision|0|||
163830187|NCT02134587|591747478|FG000|Overall Study|Did not completed all meetings|30|||
163830188|NCT00265889|591747479|FG000|Overall Study|Physician Decision|1|||
163830189|NCT00265889|591747479|FG000|Overall Study|Protocol Violation|1|||
163830190|NCT00265889|591747479|FG000|Overall Study|Insurance denied the request|3|||
163830191|NCT00453986|591747480|FG000|Overall Study|Lost to Follow-up|6|||
163830192|NCT00453986|591747481|FG001|Overall Study|Lost to Follow-up|5|||
163830193|NCT00453986|591747482|FG002|Overall Study|Lost to Follow-up|6|||
163830194|NCT00453986|591747483|FG003|Overall Study|Lost to Follow-up|2|||
163830195|NCT00453986|591747484|FG004|Overall Study|Lost to Follow-up|0|||
164034371|NCT00425100|592484402|FG000|Overall Study|Lost to Follow-up|2|||
164034372|NCT00425100|592484402|FG000|Overall Study|Protocol Violation|4|||
163830196|NCT03419364|591747491|FG000|Overall Study|Delivery due to maternal condition|2|||
163830197|NCT03419364|591747492|FG001|Overall Study|Delivery due to maternal condition|0|||
163830198|NCT03419364|591747493|FG002|Overall Study|Delivery due to maternal condition|0|||
163830199|NCT03355326|591747501|FG000|Overall Study|Protocol Violation|3|||
163830200|NCT03355326|591747502|FG001|Overall Study|Protocol Violation|3|||
163830201|NCT00608582|591747511|FG000|Overall Study|Lost to Follow-up|2|||
163830202|NCT00608582|591747512|FG001|Overall Study|Lost to Follow-up|0|||
163830203|NCT00608582|591747511|FG000|Overall Study|No Best Response in Phase 1 located|1|||
163830204|NCT00608582|591747512|FG001|Overall Study|No Best Response in Phase 1 located|1|||
163830205|NCT00608582|591747511|FG000|Overall Study|Illicit Drug Use|1|||
163830206|NCT00608582|591747512|FG001|Overall Study|Illicit Drug Use|0|||
163830207|NCT00608582|591747511|FG000|Overall Study|Early stage Design Change|0|||
163830208|NCT00608582|591747512|FG001|Overall Study|Early stage Design Change|3|||
163830209|NCT04922554|591747513|FG000|Overall Study|Adverse Event|4|||
163830210|NCT04922554|591747514|FG001|Overall Study|Adverse Event|0|||
163830211|NCT04922554|591747513|FG000|Overall Study|Withdrawal by Subject|1|||
163830212|NCT04922554|591747514|FG001|Overall Study|Withdrawal by Subject|0|||
163830213|NCT03308825|591749077|FG000|Overall Study|Lost to Follow-up|2|||
163830214|NCT03308825|591749078|FG001|Overall Study|Lost to Follow-up|2|||
163830215|NCT03308825|591749079|FG002|Overall Study|Lost to Follow-up|1|||
163830216|NCT03308825|591749080|FG003|Overall Study|Lost to Follow-up|0|||
163830217|NCT03308825|591749077|FG000|Overall Study|Protocol Violation|0|||
163830218|NCT03308825|591749078|FG001|Overall Study|Protocol Violation|2|||
163830219|NCT03308825|591749079|FG002|Overall Study|Protocol Violation|0|||
163830220|NCT03308825|591749080|FG003|Overall Study|Protocol Violation|0|||
163830221|NCT03559218|591749082|FG000|Overall Study|Withdrawal by Subject|1|||
163830222|NCT03559218|591749083|FG001|Overall Study|Withdrawal by Subject|0|||
163830223|NCT04277455|591749084|FG000|Overall Study|Lost to Follow-up|1|||
163830224|NCT04737109|591749094|FG000|Study Treatment|Disease Progression|5|||
163830225|NCT04737109|591749095|FG001|Study Treatment|Disease Progression|0|||
163830226|NCT04737109|591749096|FG002|Study Treatment|Disease Progression|0|||
163830227|NCT04737109|591749097|FG003|Study Treatment|Disease Progression|0|||
163830228|NCT04737109|591749094|FG000|Study Treatment|Death on study|1|||
163830229|NCT04737109|591749095|FG001|Study Treatment|Death on study|0|||
163830230|NCT04737109|591749096|FG002|Study Treatment|Death on study|0|||
163830231|NCT04737109|591749097|FG003|Study Treatment|Death on study|0|||
163830232|NCT03092375|591749098|FG000|Overall Study|Lack of Efficacy|0|||
163830233|NCT03092375|591749099|FG001|Overall Study|Lack of Efficacy|1|||
163830234|NCT03092375|591749100|FG002|Overall Study|Lack of Efficacy|1|||
163830235|NCT03092375|591749101|FG003|Overall Study|Lack of Efficacy|0|||
163830236|NCT01679301|591749102|FG000|Screening Period|screen failure|3|||
163830237|NCT01679301|591749103|FG001|Screening Period|screen failure|0|||
163830238|NCT01679301|591749104|FG002|Screening Period|screen failure|0|||
163830239|NCT02790073|591749107|FG000|Overall Study|Death|1|||
163830240|NCT02790073|591749107|FG000|Overall Study|Withdrawal from HD|1|||
163830241|NCT02790073|591749107|FG000|Overall Study|Withdrawal by Subject|1|||
163830242|NCT03328143|591749108|FG000|Overall Study|Declined|3|||
163830243|NCT03328143|591749108|FG000|Overall Study|Required increased sedation|4|||
163830244|NCT03328143|591749108|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
163830245|NCT03328143|591749108|FG000|Overall Study|Surgery cancelled|1|||
163830246|NCT00861614|591749109|FG000|Overall Study|Disease Progression|182|||
163830247|NCT00861614|591749110|FG001|Overall Study|Disease Progression|263|||
163830248|NCT00861614|591749109|FG000|Overall Study|Study Drug Toxicity|79|||
163830249|NCT00861614|591749110|FG001|Overall Study|Study Drug Toxicity|6|||
163830250|NCT00861614|591749109|FG000|Overall Study|Death|32|||
163830251|NCT00861614|591749110|FG001|Overall Study|Death|19|||
163830252|NCT00861614|591749109|FG000|Overall Study|Adverse Event|27|||
163830253|NCT00861614|591749110|FG001|Overall Study|Adverse Event|23|||
163830254|NCT00861614|591749109|FG000|Overall Study|Withdrawal by Subject|34|||
163830255|NCT00861614|591749110|FG001|Overall Study|Withdrawal by Subject|35|||
163830256|NCT00861614|591749109|FG000|Overall Study|Other|17|||
163830257|NCT00861614|591749110|FG001|Overall Study|Other|22|||
163830258|NCT00944658|591749111|FG000|Treatment 12 Weeks|Adverse Event|0|||
163830259|NCT00944658|591749112|FG001|Treatment 12 Weeks|Adverse Event|2|||
163830260|NCT02259517|591749113|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
163830261|NCT02259517|591749114|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
163830262|NCT02259517|591749115|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
163830263|NCT02259517|591749113|FG000|Overall Study|Withdrawal by Subject|0|||
163830264|NCT02259517|591749114|FG001|Overall Study|Withdrawal by Subject|0|||
163830265|NCT02259517|591749115|FG002|Overall Study|Withdrawal by Subject|3|||
163830266|NCT01289418|591749119|FG000|Day 8 Survey|email address invalid|283|||
163830267|NCT01289418|591749119|FG000|Day 8 Survey|participants did not complete the survey|1935|||
163830268|NCT01289418|591749119|FG000|Day 29 Survey|email address invalid|283|||
163830269|NCT01289418|591749119|FG000|Day 29 Survey|participants did not complete the survey|2185|||
163830270|NCT01352585|591749121|FG000|Overall Study|Adverse Event|2|||
163830271|NCT01352585|591749122|FG001|Overall Study|Adverse Event|1|||
163830272|NCT01352585|591749121|FG000|Overall Study|Lost to Follow-up|1|||
163830273|NCT01352585|591749122|FG001|Overall Study|Lost to Follow-up|0|||
164034373|NCT00425100|592484402|FG000|Overall Study|Withdrawal by Subject|7|||
164034374|NCT01969799|592484405|FG000|Overall Study|Adverse Event|0|||
164034375|NCT01969799|592484406|FG001|Overall Study|Adverse Event|1|||
164034376|NCT01969799|592484405|FG000|Overall Study|Death|16|||
164034377|NCT01969799|592484406|FG001|Overall Study|Death|11|||
164034378|NCT01969799|592484405|FG000|Overall Study|Lost to Follow-up|0|||
164034379|NCT01969799|592484406|FG001|Overall Study|Lost to Follow-up|2|||
164034380|NCT01969799|592484405|FG000|Overall Study|Physician Decision|1|||
164034381|NCT01969799|592484406|FG001|Overall Study|Physician Decision|0|||
164034382|NCT02227108|592484409|FG000|Overall Study|Did not receive treatment|2|||
164034383|NCT02227108|592484409|FG000|Overall Study|Other|3|||
164034384|NCT02227108|592484409|FG000|Overall Study|Progressive disease|17|||
164034385|NCT02227108|592484409|FG000|Overall Study|Initiation of alternative therapy|2|||
164034386|NCT02227108|592484409|FG000|Overall Study|Investigator discretion|1|||
164034387|NCT02227108|592484409|FG000|Overall Study|Adverse Event|6|||
164034388|NCT01714817|592484410|FG000|Year 1 Period|Lack of Efficacy|11|||
164034389|NCT01714817|592484411|FG001|Year 1 Period|Lack of Efficacy|9|||
164034390|NCT01714817|592484410|FG000|Year 1 Period|Adverse Event|20|||
164034391|NCT01714817|592484411|FG001|Year 1 Period|Adverse Event|17|||
164034392|NCT01714817|592484410|FG000|Year 1 Period|Withdrawal by Subject|6|||
164034393|NCT01714817|592484411|FG001|Year 1 Period|Withdrawal by Subject|7|||
164034394|NCT01714817|592484410|FG000|Year 1 Period|Death|1|||
164034395|NCT01714817|592484411|FG001|Year 1 Period|Death|1|||
164034396|NCT01714817|592484410|FG000|Year 1 Period|Lost to Follow-up|0|||
164034397|NCT01714817|592484411|FG001|Year 1 Period|Lost to Follow-up|2|||
164034398|NCT01714817|592484410|FG000|Year 1 Period|Poor / non-compliance|0|||
164034399|NCT01714817|592484411|FG001|Year 1 Period|Poor / non-compliance|1|||
164034400|NCT01714817|592484410|FG000|Year 1 Period|Pregnancy|2|||
164034401|NCT01714817|592484411|FG001|Year 1 Period|Pregnancy|0|||
164034402|NCT01714817|592484410|FG000|Year 1 Period|Participant no longer meets criteria|6|||
164034403|NCT01714817|592484411|FG001|Year 1 Period|Participant no longer meets criteria|2|||
164034404|NCT01714817|592484410|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
164034405|NCT01714817|592484411|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
164034406|NCT01714817|592484410|FG000|Year 1 Period|Change in Concomitant Medication|0|||
164034407|NCT01714817|592484411|FG001|Year 1 Period|Change in Concomitant Medication|1|||
164034408|NCT01714817|592484410|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
164034409|NCT01714817|592484411|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
164034410|NCT01714817|592484410|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
164034411|NCT01714817|592484411|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
164034412|NCT01714817|592484410|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
164034413|NCT01714817|592484411|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
164034414|NCT01714817|592484410|FG000|Year 2 Period|Lack of Efficacy|4|||
164034415|NCT01714817|592484411|FG001|Year 2 Period|Lack of Efficacy|12|||
164034416|NCT01714817|592484410|FG000|Year 2 Period|Adverse Event|7|||
164034417|NCT01714817|592484411|FG001|Year 2 Period|Adverse Event|6|||
164034418|NCT01714817|592484410|FG000|Year 2 Period|Participant request to stop treatment|4|||
164034419|NCT01714817|592484411|FG001|Year 2 Period|Participant request to stop treatment|4|||
164034420|NCT01714817|592484410|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
164034421|NCT01714817|592484411|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
164034422|NCT01714817|592484410|FG000|Year 2 Period|Participant withdrew consent|1|||
164034423|NCT01714817|592484411|FG001|Year 2 Period|Participant withdrew consent|5|||
164034424|NCT01714817|592484410|FG000|Year 2 Period|Participant no longer meets criteria|1|||
164034425|NCT01714817|592484411|FG001|Year 2 Period|Participant no longer meets criteria|4|||
164034426|NCT01714817|592484410|FG000|Year 2 Period|Lost to Follow-up|2|||
164034427|NCT01714817|592484411|FG001|Year 2 Period|Lost to Follow-up|0|||
164034428|NCT01714817|592484410|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
164034429|NCT01714817|592484411|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
164034430|NCT01714817|592484410|FG000|Year 2 Period|Pregnancy|1|||
164034431|NCT01714817|592484411|FG001|Year 2 Period|Pregnancy|1|||
164034432|NCT01714817|592484410|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
164034433|NCT01714817|592484411|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
164034434|NCT01714817|592484410|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
164034435|NCT01714817|592484411|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
164034436|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
164034437|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
164034438|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
164034439|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
164034440|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
164034441|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
164034442|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
164034443|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
164034444|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
164034445|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
164097947|NCT02822235|592724988|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
164097948|NCT02822235|592724987|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
164097949|NCT02822235|592724988|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
164097950|NCT02822235|592724987|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
163830274|NCT01352585|591749121|FG000|Overall Study|Other|5|||
164034446|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
164034447|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
164034448|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
164034449|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
164034450|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
164034451|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
164034452|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
164034453|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
164034454|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
164034455|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
164034456|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
164034457|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
164034458|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
164034459|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
164034460|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
164034461|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
164034462|NCT01714817|592484410|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
164034463|NCT01714817|592484411|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
164034464|NCT01374217|592484412|FG000|Overall Study|Lack of Efficacy|13|||
164034465|NCT02555657|592484413|FG000|Overall Study|Death|274|||
164034466|NCT02555657|592484414|FG001|Overall Study|Death|262|||
164034467|NCT02555657|592484413|FG000|Overall Study|Physician Decision|0|||
164034468|NCT02555657|592484414|FG001|Overall Study|Physician Decision|1|||
164034469|NCT02555657|592484413|FG000|Overall Study|Sponsor Decision|27|||
164034470|NCT02555657|592484414|FG001|Overall Study|Sponsor Decision|15|||
164034471|NCT02555657|592484413|FG000|Overall Study|Withdrawal by Subject|11|||
164034472|NCT02555657|592484414|FG001|Overall Study|Withdrawal by Subject|32|||
164034473|NCT01770145|592486478|FG000|Baseline|Adverse Event|20|||
164034474|NCT01770145|592486478|FG000|Baseline|Withdrawal by Subject|1|||
164034475|NCT01770145|592486478|FG000|Baseline|Lost to Follow-up|1|||
164034476|NCT01770145|592486478|FG000|Baseline|Unable to define optimal dose|4|||
164034477|NCT01770145|592486478|FG000|Treatment|Adverse Event|3|||
164034478|NCT01770145|592486478|FG000|Treatment|Withdrawal by Subject|1|||
164034479|NCT01102140|592486479|FG000|Overall Study|Lost to Follow-up|1|||
164034480|NCT01102140|592486480|FG001|Overall Study|Lost to Follow-up|0|||
164034481|NCT01102140|592486479|FG000|Overall Study|Investigator terminated study|2|||
164034482|NCT01102140|592486480|FG001|Overall Study|Investigator terminated study|2|||
164034483|NCT05406440|592486481|FG000|Overall Study|Lost to Follow-up|0|||
164097951|NCT02822235|592724988|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
163830275|NCT01352585|591749122|FG001|Overall Study|Other|2|||
163830276|NCT00838682|591749125|FG000|Overall Study|Lost to Follow-up|21|||
163830277|NCT00838682|591749126|FG001|Overall Study|Lost to Follow-up|14|||
163830278|NCT00838682|591749125|FG000|Overall Study|detection of exclusion criteria|4|||
163830279|NCT00838682|591749126|FG001|Overall Study|detection of exclusion criteria|3|||
163830280|NCT00838682|591749125|FG000|Overall Study|Protocol Violation|0|||
163830281|NCT00838682|591749126|FG001|Overall Study|Protocol Violation|1|||
163830282|NCT00838682|591749125|FG000|Overall Study|Withdrawal by Subject|0|||
163830283|NCT00838682|591749126|FG001|Overall Study|Withdrawal by Subject|1|||
163830284|NCT02305381|591749127|FG000|Overall Study|Unclassified|5|||
163830285|NCT02305381|591749128|FG001|Overall Study|Unclassified|5|||
163830286|NCT02305381|591749129|FG002|Overall Study|Unclassified|7|||
163830287|NCT02276066|591749130|FG000|Overall Study|Lost to Follow-up|21|||
163830288|NCT02276066|591749131|FG001|Overall Study|Lost to Follow-up|11|||
163830289|NCT01807156|591749132|FG000|Overall Study|Physician Decision|1|||
163830290|NCT01370525|591749133|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
163830291|NCT01370525|591749134|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
163830292|NCT01370525|591749133|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
163830293|NCT01370525|591749134|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164034484|NCT05406440|592486482|FG001|Overall Study|Lost to Follow-up|0|||
164034485|NCT05406440|592486483|FG002|Overall Study|Lost to Follow-up|0|||
164034486|NCT05406440|592486484|FG003|Overall Study|Lost to Follow-up|0|||
163830294|NCT01370525|591749133|FG000|Overall Study|Adverse Event|0|||
164034487|NCT05406440|592486485|FG004|Overall Study|Lost to Follow-up|2|||
164034488|NCT05406440|592486486|FG005|Overall Study|Lost to Follow-up|0|||
164034489|NCT05406440|592486487|FG006|Overall Study|Lost to Follow-up|0|||
164034490|NCT05406440|592486481|FG000|Overall Study|Physician Decision|0|||
164034491|NCT05406440|592486482|FG001|Overall Study|Physician Decision|0|||
164097952|NCT00829530|592724989|FG000|First Intervention|Adverse Event|0|||
164034492|NCT05406440|592486483|FG002|Overall Study|Physician Decision|0|||
164034493|NCT05406440|592486484|FG003|Overall Study|Physician Decision|0|||
164034494|NCT05406440|592486485|FG004|Overall Study|Physician Decision|1|||
164034495|NCT05406440|592486486|FG005|Overall Study|Physician Decision|0|||
164034496|NCT05406440|592486487|FG006|Overall Study|Physician Decision|0|||
164034497|NCT05406440|592486481|FG000|Overall Study|Withdrawal by Subject|0|||
164034498|NCT05406440|592486482|FG001|Overall Study|Withdrawal by Subject|0|||
164034499|NCT05406440|592486483|FG002|Overall Study|Withdrawal by Subject|0|||
164034500|NCT05406440|592486484|FG003|Overall Study|Withdrawal by Subject|0|||
164034501|NCT05406440|592486485|FG004|Overall Study|Withdrawal by Subject|0|||
163830295|NCT01370525|591749134|FG001|Overall Study|Adverse Event|1|||
163830296|NCT01370525|591749133|FG000|Overall Study|Protocol Violation|2|||
163830297|NCT01370525|591749134|FG001|Overall Study|Protocol Violation|1|||
163830298|NCT01370525|591749133|FG000|Overall Study|Lost to follow up|2|||
163830299|NCT01370525|591749134|FG001|Overall Study|Lost to follow up|6|||
163830300|NCT03642938|591749136|FG000|Overall Study|Withdrawal by Subject|0|||
163830301|NCT03642938|591749137|FG001|Overall Study|Withdrawal by Subject|0|||
163830302|NCT03642938|591749138|FG002|Overall Study|Withdrawal by Subject|0|||
163830303|NCT03642938|591749139|FG003|Overall Study|Withdrawal by Subject|1|||
163830304|NCT01424930|591749140|FG000|Overall Study|Adverse Event|0|||
163830305|NCT01424930|591749141|FG001|Overall Study|Adverse Event|1|||
163830306|NCT01424930|591749140|FG000|Overall Study|Death|1|||
163830307|NCT01424930|591749141|FG001|Overall Study|Death|0|||
163830308|NCT01424930|591749140|FG000|Overall Study|Progressive Disease|3|||
163830309|NCT01424930|591749141|FG001|Overall Study|Progressive Disease|6|||
163830310|NCT01424930|591749140|FG000|Overall Study|Screen Failure|0|||
163830311|NCT01424930|591749141|FG001|Overall Study|Screen Failure|1|||
163830312|NCT01424930|591749140|FG000|Overall Study|Reason not specified|0|||
163830313|NCT01424930|591749141|FG001|Overall Study|Reason not specified|6|||
163830314|NCT03286751|591749146|FG000|Washout Period 1|Withdrawal by Subject|0|||
163830315|NCT03286751|591749147|FG001|Washout Period 1|Withdrawal by Subject|0|||
163830316|NCT03286751|591749148|FG002|Washout Period 1|Withdrawal by Subject|0|||
163830317|NCT03286751|591749149|FG003|Washout Period 1|Withdrawal by Subject|0|||
163830318|NCT03286751|591749150|FG004|Washout Period 1|Withdrawal by Subject|1|||
163830319|NCT03286751|591749151|FG005|Washout Period 1|Withdrawal by Subject|0|||
163830320|NCT03286751|591749146|FG000|Washout Period 2|Personal Reasons|0|||
163830321|NCT03286751|591749147|FG001|Washout Period 2|Personal Reasons|1|||
163830322|NCT03286751|591749148|FG002|Washout Period 2|Personal Reasons|0|||
163830323|NCT03286751|591749149|FG003|Washout Period 2|Personal Reasons|0|||
163830324|NCT03286751|591749150|FG004|Washout Period 2|Personal Reasons|0|||
163830325|NCT03286751|591749151|FG005|Washout Period 2|Personal Reasons|0|||
163830326|NCT03286751|591749146|FG000|Washout Period 5|Adverse Event|0|||
163830327|NCT03286751|591749147|FG001|Washout Period 5|Adverse Event|0|||
163830328|NCT03286751|591749148|FG002|Washout Period 5|Adverse Event|0|||
163830329|NCT03286751|591749149|FG003|Washout Period 5|Adverse Event|0|||
163830330|NCT03286751|591749150|FG004|Washout Period 5|Adverse Event|1|||
163830331|NCT03286751|591749151|FG005|Washout Period 5|Adverse Event|0|||
163830332|NCT01119768|591749152|FG000|Treatment Period|Lack of Efficacy|18|||
163830333|NCT01119768|591749153|FG001|Treatment Period|Lack of Efficacy|25|||
163830334|NCT01301391|591749154|FG000|Overall Study|Death|13|||
163830335|NCT01301391|591749154|FG000|Overall Study|Lost to Follow-up|3|||
163830336|NCT01301391|591749154|FG000|Overall Study|Physician Decision|2|||
163830337|NCT01301391|591749154|FG000|Overall Study|Sponsor's decision|8|||
163830338|NCT01059643|591749155|FG000|Overall Study|Adverse Event|3|||
163830339|NCT01059643|591749155|FG000|Overall Study|Withdrawal by Subject|2|||
163830340|NCT01059643|591749155|FG000|Overall Study|Physician Decision|1|||
163830341|NCT00106184|591749156|FG000|Overall Study|Withdrawal by Subject|3|||
163830342|NCT00106184|591749157|FG001|Overall Study|Withdrawal by Subject|2|||
163830343|NCT05292534|591749163|FG000|Overall Study|Protocol Violation|3|||
163830344|NCT05292534|591749164|FG001|Overall Study|Protocol Violation|4|||
163830345|NCT05292534|591749163|FG000|Overall Study|Withdrawal by Subject|0|||
163830346|NCT05292534|591749164|FG001|Overall Study|Withdrawal by Subject|1|||
163830347|NCT00409682|591749170|FG000|Open-label Induction Period|Adverse Event|1|||
163830348|NCT00409682|591749171|FG001|Open-label Induction Period|Adverse Event|0|||
163830349|NCT00409682|591749172|FG002|Open-label Induction Period|Adverse Event|0|||
163830350|NCT00409682|591749170|FG000|Open-label Induction Period|Lack of Efficacy|1|||
164034502|NCT05406440|592486486|FG005|Overall Study|Withdrawal by Subject|2|||
163830351|NCT00409682|591749171|FG001|Open-label Induction Period|Lack of Efficacy|0|||
163830352|NCT00409682|591749172|FG002|Open-label Induction Period|Lack of Efficacy|0|||
163830353|NCT00409682|591749170|FG000|Open-label Induction Period|Protocol Violation|1|||
163830354|NCT00409682|591749171|FG001|Open-label Induction Period|Protocol Violation|0|||
163830355|NCT00409682|591749172|FG002|Open-label Induction Period|Protocol Violation|0|||
164034503|NCT05406440|592486487|FG006|Overall Study|Withdrawal by Subject|0|||
163830356|NCT00409682|591749170|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
163830357|NCT00409682|591749171|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
163830358|NCT00409682|591749172|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
164034504|NCT01412151|592486491|FG000|Week 0 - 306 - Treatment Period|Death|1|||
163925935|NCT01664923|592100758|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
163925936|NCT01664923|592100759|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
163925937|NCT01664923|592100758|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
163925938|NCT01664923|592100759|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
163925939|NCT01664923|592100758|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
163925940|NCT01664923|592100759|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
163925941|NCT01664923|592100758|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
163925942|NCT01664923|592100759|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
163925943|NCT01664923|592100758|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
163925944|NCT01664923|592100759|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
163925945|NCT01664923|592100758|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
163925946|NCT01664923|592100759|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
163925947|NCT01167192|592100762|FG000|Overall Study|Adverse Event|1|||
163925948|NCT01167192|592100762|FG000|Overall Study|Death|1|||
163925949|NCT01167192|592100762|FG000|Overall Study|Withdrawal by Subject|1|||
163925950|NCT01167192|592100762|FG000|Overall Study|Insurance denial|1|||
163925951|NCT01336205|592100763|FG000|Overall Study|Other|22|||
163925952|NCT01336205|592100764|FG001|Overall Study|Other|9|||
163925953|NCT01336205|592100763|FG000|Overall Study|Lost to Follow-up|40|||
163925954|NCT01336205|592100764|FG001|Overall Study|Lost to Follow-up|20|||
163925955|NCT01336205|592100763|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
163925956|NCT01336205|592100764|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
163925957|NCT01336205|592100763|FG000|Overall Study|Lack of Efficacy|4|||
163925958|NCT01336205|592100764|FG001|Overall Study|Lack of Efficacy|0|||
163925959|NCT01336205|592100763|FG000|Overall Study|Severe noncompliance with protocol|9|||
163925960|NCT01336205|592100764|FG001|Overall Study|Severe noncompliance with protocol|2|||
163925961|NCT01336205|592100763|FG000|Overall Study|Adverse Event|56|||
163925962|NCT01336205|592100764|FG001|Overall Study|Adverse Event|6|||
163925963|NCT01336205|592100763|FG000|Overall Study|Death|1|||
163925964|NCT01336205|592100764|FG001|Overall Study|Death|1|||
163925965|NCT01336205|592100763|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
163925966|NCT01336205|592100764|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
163925967|NCT01336205|592100763|FG000|Overall Study|Withdrawal by Subject|72|||
163925968|NCT01336205|592100764|FG001|Overall Study|Withdrawal by Subject|38|||
163925969|NCT01336205|592100763|FG000|Overall Study|Did not receive treatment|4|||
163925970|NCT01336205|592100764|FG001|Overall Study|Did not receive treatment|0|||
163925971|NCT00129649|592100765|FG000|Overall Study|Withdrawal by Subject|76|||
163925972|NCT00129649|592100766|FG001|Overall Study|Withdrawal by Subject|65|||
163925973|NCT04952701|592100767|FG000|Control Lens|Physician Decision|4|||
163925974|NCT04952701|592100767|FG000|Test Lens|Physician Decision|1|||
163925975|NCT02547441|592100768|FG000|Double-Blind Study Period|Adverse Event|4|||
163925976|NCT02547441|592100769|FG001|Double-Blind Study Period|Adverse Event|9|||
163925977|NCT02547441|592100768|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
163925978|NCT02547441|592100769|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
163925979|NCT02547441|592100768|FG000|Double-Blind Study Period|Physician Decision|1|||
163925980|NCT02547441|592100769|FG001|Double-Blind Study Period|Physician Decision|0|||
163925981|NCT02547441|592100768|FG000|Double-Blind Study Period|Protocol Violation|1|||
163925982|NCT02547441|592100769|FG001|Double-Blind Study Period|Protocol Violation|2|||
163925983|NCT02547441|592100768|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
163925984|NCT02547441|592100769|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
163925985|NCT02547441|592100768|FG000|Double-Blind Study Period|Sponsor Decision|1|||
163925986|NCT02547441|592100769|FG001|Double-Blind Study Period|Sponsor Decision|0|||
163925987|NCT02547441|592100768|FG000|Open-Label Study Period|Adverse Event|10|||
163925988|NCT02547441|592100769|FG001|Open-Label Study Period|Adverse Event|11|||
163925989|NCT02547441|592100768|FG000|Open-Label Study Period|Lack of Efficacy|3|||
163925990|NCT02547441|592100769|FG001|Open-Label Study Period|Lack of Efficacy|2|||
163925991|NCT02547441|592100768|FG000|Open-Label Study Period|Lost to Follow-up|7|||
163925992|NCT02547441|592100769|FG001|Open-Label Study Period|Lost to Follow-up|8|||
163925993|NCT02547441|592100768|FG000|Open-Label Study Period|Physician Decision|1|||
163925994|NCT02547441|592100769|FG001|Open-Label Study Period|Physician Decision|0|||
163925995|NCT02547441|592100768|FG000|Open-Label Study Period|Protocol Violation|2|||
163925996|NCT02547441|592100769|FG001|Open-Label Study Period|Protocol Violation|0|||
163925997|NCT02547441|592100768|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
164034505|NCT01412151|592486491|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
164034506|NCT01412151|592486491|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
164034507|NCT01412151|592486491|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
163925998|NCT02547441|592100769|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
163925999|NCT02547441|592100768|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
163926000|NCT02547441|592100769|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
164034508|NCT03621189|592486494|FG000|Overall Study|Withdrawal by Subject|0|||
164034509|NCT03621189|592486495|FG001|Overall Study|Withdrawal by Subject|3|||
163926001|NCT01322009|592100770|FG000|Overall Study|Death|0|||
163926002|NCT01322009|592100771|FG001|Overall Study|Death|1|||
164097953|NCT00829530|592724990|FG001|First Intervention|Adverse Event|1|||
164097954|NCT00829530|592724989|FG000|First Intervention|Intolerance to Venopuncture|0|||
164097955|NCT00829530|592724990|FG001|First Intervention|Intolerance to Venopuncture|1|||
164097956|NCT00829530|592724989|FG000|Second Intervention|Intolerance to Venopuncture|1|||
164097957|NCT00829530|592724990|FG001|Second Intervention|Intolerance to Venopuncture|0|||
164097958|NCT01038856|592724993|FG000|Overall Study|Adverse Event|2|||
164097959|NCT04638153|592724994|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164097960|NCT04638153|592724995|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164097961|NCT04638153|592724996|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164097962|NCT04638153|592724994|FG000|Overall Study|Study terminated by sponsor|4|||
164097963|NCT04638153|592724995|FG001|Overall Study|Study terminated by sponsor|2|||
164097964|NCT04638153|592724996|FG002|Overall Study|Study terminated by sponsor|14|||
164097965|NCT01389102|592724997|FG000|Overall Study|Adverse Event|1|||
164097966|NCT01389102|592724998|FG001|Overall Study|Adverse Event|3|||
164097967|NCT01389102|592724999|FG002|Overall Study|Adverse Event|2|||
164097968|NCT01389102|592725000|FG003|Overall Study|Adverse Event|2|||
164097969|NCT01389102|592725001|FG004|Overall Study|Adverse Event|2|||
164097970|NCT01389102|592725002|FG005|Overall Study|Adverse Event|2|||
164097971|NCT01389102|592724997|FG000|Overall Study|Hurricane Katrina|4|||
164097972|NCT01389102|592724998|FG001|Overall Study|Hurricane Katrina|2|||
164097973|NCT01389102|592724999|FG002|Overall Study|Hurricane Katrina|3|||
164097974|NCT01389102|592725000|FG003|Overall Study|Hurricane Katrina|0|||
164097975|NCT01389102|592725001|FG004|Overall Study|Hurricane Katrina|3|||
164097976|NCT01389102|592725002|FG005|Overall Study|Hurricane Katrina|1|||
164097977|NCT01389102|592724997|FG000|Overall Study|Lost to Follow-up|4|||
164097978|NCT01389102|592724998|FG001|Overall Study|Lost to Follow-up|1|||
164097979|NCT01389102|592724999|FG002|Overall Study|Lost to Follow-up|1|||
164097980|NCT01389102|592725000|FG003|Overall Study|Lost to Follow-up|2|||
164097981|NCT01389102|592725001|FG004|Overall Study|Lost to Follow-up|4|||
164097982|NCT01389102|592725002|FG005|Overall Study|Lost to Follow-up|1|||
164097983|NCT01389102|592724997|FG000|Overall Study|Protocol Violation|0|||
164097984|NCT01389102|592724998|FG001|Overall Study|Protocol Violation|0|||
163830359|NCT00409682|591749170|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
163830360|NCT00409682|591749171|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
163830361|NCT00409682|591749172|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
163830362|NCT00409682|591749170|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
163830363|NCT00409682|591749171|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
163830364|NCT00409682|591749172|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
163830365|NCT00409682|591749170|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
163830366|NCT00409682|591749171|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
163830367|NCT00409682|591749172|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
163830368|NCT00409682|591749170|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
163830369|NCT00409682|591749171|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
163830370|NCT00409682|591749172|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
163830371|NCT00409682|591749170|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
163830372|NCT00409682|591749171|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
163830373|NCT00409682|591749172|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
163830374|NCT00409682|591749170|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
164097985|NCT01389102|592724999|FG002|Overall Study|Protocol Violation|3|||
164097986|NCT01389102|592725000|FG003|Overall Study|Protocol Violation|0|||
164097987|NCT01389102|592725001|FG004|Overall Study|Protocol Violation|1|||
163830375|NCT00409682|591749171|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
163830376|NCT00409682|591749172|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
163926003|NCT01322009|592100770|FG000|Overall Study|Adverse Event|0|||
163926004|NCT01322009|592100771|FG001|Overall Study|Adverse Event|1|||
163926005|NCT01322009|592100770|FG000|Overall Study|ng tube discontinued|0|||
163926006|NCT01322009|592100771|FG001|Overall Study|ng tube discontinued|1|||
163926007|NCT01657877|592100772|FG000|Overall Study|Withdrawal by Subject|4|||
163926008|NCT01657877|592100772|FG000|Overall Study|Protocol Violation|6|||
163926009|NCT01657877|592100772|FG000|Overall Study|Adverse Event|2|||
163926010|NCT01657877|592100772|FG000|Overall Study|Other Reason|2|||
163926011|NCT04545476|592100773|FG000|Overall Study|Lost to Follow-up|1|||
163926012|NCT04545476|592100774|FG001|Overall Study|Lost to Follow-up|1|||
163926013|NCT04545476|592100775|FG002|Overall Study|Lost to Follow-up|0|||
163926014|NCT04545476|592100776|FG003|Overall Study|Lost to Follow-up|0|||
163926015|NCT00937521|592100781|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163926016|NCT00937521|592100782|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163926017|NCT00937521|592100783|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
163926018|NCT00937521|592100784|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163926019|NCT00937521|592100785|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163926020|NCT00937521|592100786|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163926021|NCT00937521|592100787|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
163926022|NCT00937521|592100788|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
163926023|NCT00937521|592100781|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
163926024|NCT00937521|592100782|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
163926025|NCT00937521|592100783|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
163926026|NCT00937521|592100784|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
163926027|NCT00937521|592100785|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
163926028|NCT00937521|592100786|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
163926029|NCT00937521|592100787|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
163926030|NCT00937521|592100788|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
163926031|NCT00937521|592100781|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163926032|NCT00937521|592100782|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163926033|NCT00937521|592100783|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
163926034|NCT00937521|592100784|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
163926035|NCT00937521|592100785|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163926036|NCT00937521|592100786|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163926037|NCT00937521|592100787|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163926038|NCT00937521|592100788|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
163926039|NCT00937521|592100781|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163926040|NCT00937521|592100782|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
163830377|NCT04710927|591749176|FG000|Overall Study|Lost to Follow-up|7|||
163830378|NCT04710927|591749177|FG001|Overall Study|Lost to Follow-up|6|||
163830379|NCT04710927|591749178|FG002|Overall Study|Lost to Follow-up|5|||
163830380|NCT03595332|591749179|FG000|Overall Study|Lost to Follow-up|16|||
163830381|NCT03595332|591749180|FG001|Overall Study|Lost to Follow-up|22|||
163830382|NCT03595332|591749179|FG000|Overall Study|Unable to retrieve ID from school|0|||
163830383|NCT03595332|591749180|FG001|Overall Study|Unable to retrieve ID from school|2|||
163830384|NCT02227875|591749181|FG000|Overall Study|Protocol Violation|10|||
163830385|NCT02227875|591749182|FG001|Overall Study|Protocol Violation|7|||
163830386|NCT02227875|591749181|FG000|Overall Study|Other|1|||
163830387|NCT02227875|591749182|FG001|Overall Study|Other|3|||
163830388|NCT02227875|591749181|FG000|Overall Study|Physician Decision|1|||
163830389|NCT02227875|591749182|FG001|Overall Study|Physician Decision|0|||
163830390|NCT02227875|591749181|FG000|Overall Study|Adverse Event|3|||
163830391|NCT02227875|591749182|FG001|Overall Study|Adverse Event|0|||
163830392|NCT02227875|591749181|FG000|Overall Study|Withdrawal by Subject|12|||
163830393|NCT02227875|591749182|FG001|Overall Study|Withdrawal by Subject|13|||
163830394|NCT02227875|591749181|FG000|Overall Study|Lost to Follow-up|10|||
163830395|NCT02227875|591749182|FG001|Overall Study|Lost to Follow-up|10|||
163830396|NCT01201811|591749183|FG000|Overall Study|Adverse Event|6|||
163830397|NCT01201811|591749183|FG000|Overall Study|Disease progression|3|||
163830398|NCT01201811|591749183|FG000|Overall Study|Withdrawal by Subject|3|||
163830399|NCT01201811|591749183|FG000|Overall Study|Death|4|||
163830400|NCT01201811|591749183|FG000|Overall Study|Treatment Failure|2|||
163830401|NCT01201811|591749183|FG000|Overall Study|Physician Decision|1|||
163830402|NCT02857426|591749184|FG000|Overall Study|Disease progression|34|||
163830403|NCT02857426|591749185|FG001|Overall Study|Disease progression|13|||
163830404|NCT02857426|591749184|FG000|Overall Study|Study drug toxicity|4|||
163830405|NCT02857426|591749185|FG001|Overall Study|Study drug toxicity|1|||
163830406|NCT02857426|591749184|FG000|Overall Study|Death|1|||
163830407|NCT02857426|591749185|FG001|Overall Study|Death|0|||
163830408|NCT02857426|591749184|FG000|Overall Study|Adverse event unrelated to study drug|6|||
163830409|NCT02857426|591749185|FG001|Overall Study|Adverse event unrelated to study drug|2|||
163830410|NCT02857426|591749184|FG000|Overall Study|Participant withdrew consent|1|||
163830411|NCT02857426|591749185|FG001|Overall Study|Participant withdrew consent|1|||
163830412|NCT02857426|591749184|FG000|Overall Study|Maximum clinical benefit|1|||
163830413|NCT02857426|591749185|FG001|Overall Study|Maximum clinical benefit|0|||
163830414|NCT02857426|591749184|FG000|Overall Study|Completed treatment|0|||
163830415|NCT02857426|591749185|FG001|Overall Study|Completed treatment|2|||
163830416|NCT01960725|591749186|FG000|Overall Study|Lost to Follow-up|4|||
164034510|NCT03621189|592486494|FG000|Overall Study|Physician Decision|0|||
163830417|NCT01960725|591749187|FG001|Overall Study|Lost to Follow-up|3|||
163830418|NCT01960725|591749186|FG000|Overall Study|Withdrawal by Subject|1|||
163830419|NCT01960725|591749187|FG001|Overall Study|Withdrawal by Subject|0|||
163830420|NCT01960725|591749186|FG000|Overall Study|unable to obtain blood sample|1|||
163926041|NCT00937521|592100783|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163830421|NCT01960725|591749187|FG001|Overall Study|unable to obtain blood sample|2|||
163830422|NCT02831257|591749188|FG000|Overall Study|Lack of Efficacy|3|||
163926042|NCT00937521|592100784|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
164034511|NCT03621189|592486495|FG001|Overall Study|Physician Decision|2|||
164034512|NCT02150213|592486496|FG000|Overall Study|Lost to Follow-up|1|||
164097988|NCT01389102|592725002|FG005|Overall Study|Protocol Violation|1|||
163830423|NCT02831257|591749188|FG000|Overall Study|Adverse Event|2|||
163830424|NCT02831257|591749188|FG000|Overall Study|Physician Decision|1|||
163830425|NCT02831257|591749188|FG000|Overall Study|Withdrawal by Subject|6|||
163830426|NCT01844284|591749189|FG000|Overall Study|Lost to Follow-up|12|||
163926043|NCT00937521|592100785|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
163926044|NCT00937521|592100786|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
163926045|NCT00937521|592100787|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
163926046|NCT00937521|592100788|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
163926047|NCT00937521|592100781|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
163926048|NCT00937521|592100782|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163926049|NCT00937521|592100783|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163926050|NCT00937521|592100784|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163926051|NCT00937521|592100785|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163926052|NCT00937521|592100786|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163926053|NCT00937521|592100787|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
163926054|NCT00937521|592100788|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
163926055|NCT00937521|592100781|FG000|Booster Phase|Adverse Event|0|||
163926056|NCT00937521|592100782|FG001|Booster Phase|Adverse Event|0|||
163926057|NCT00937521|592100783|FG002|Booster Phase|Adverse Event|0|||
163926058|NCT00937521|592100784|FG003|Booster Phase|Adverse Event|0|||
163926059|NCT00937521|592100785|FG004|Booster Phase|Adverse Event|0|||
163926060|NCT00937521|592100786|FG005|Booster Phase|Adverse Event|0|||
163926061|NCT00937521|592100787|FG006|Booster Phase|Adverse Event|1|||
163926062|NCT00937521|592100788|FG007|Booster Phase|Adverse Event|0|||
163926063|NCT00937521|592100781|FG000|Booster Phase|Withdrawal by Subject|1|||
163926064|NCT00937521|592100782|FG001|Booster Phase|Withdrawal by Subject|0|||
163926065|NCT00937521|592100783|FG002|Booster Phase|Withdrawal by Subject|0|||
163926066|NCT00937521|592100784|FG003|Booster Phase|Withdrawal by Subject|1|||
163926067|NCT00937521|592100785|FG004|Booster Phase|Withdrawal by Subject|0|||
163926068|NCT00937521|592100786|FG005|Booster Phase|Withdrawal by Subject|0|||
163926069|NCT00937521|592100787|FG006|Booster Phase|Withdrawal by Subject|0|||
163926070|NCT00937521|592100788|FG007|Booster Phase|Withdrawal by Subject|2|||
163926071|NCT00937521|592100781|FG000|Booster Phase|Lost to Follow-up|2|||
163926072|NCT00937521|592100782|FG001|Booster Phase|Lost to Follow-up|2|||
163926073|NCT00937521|592100783|FG002|Booster Phase|Lost to Follow-up|4|||
163926074|NCT00937521|592100784|FG003|Booster Phase|Lost to Follow-up|2|||
163926075|NCT00937521|592100785|FG004|Booster Phase|Lost to Follow-up|4|||
163926076|NCT00937521|592100786|FG005|Booster Phase|Lost to Follow-up|4|||
163926077|NCT00937521|592100787|FG006|Booster Phase|Lost to Follow-up|3|||
163926078|NCT00937521|592100788|FG007|Booster Phase|Lost to Follow-up|0|||
163926079|NCT00937521|592100781|FG000|Booster Phase|Administrative Reason|0|||
163926080|NCT00937521|592100782|FG001|Booster Phase|Administrative Reason|0|||
163926081|NCT00937521|592100783|FG002|Booster Phase|Administrative Reason|1|||
163926082|NCT00937521|592100784|FG003|Booster Phase|Administrative Reason|0|||
163926083|NCT00937521|592100785|FG004|Booster Phase|Administrative Reason|1|||
163926084|NCT00937521|592100786|FG005|Booster Phase|Administrative Reason|1|||
163926085|NCT00937521|592100787|FG006|Booster Phase|Administrative Reason|0|||
163926086|NCT00937521|592100788|FG007|Booster Phase|Administrative Reason|0|||
163926087|NCT00937521|592100781|FG000|Booster Phase|Protocol Deviation|0|||
163926088|NCT00937521|592100782|FG001|Booster Phase|Protocol Deviation|0|||
163926089|NCT00937521|592100783|FG002|Booster Phase|Protocol Deviation|0|||
163926090|NCT00937521|592100784|FG003|Booster Phase|Protocol Deviation|0|||
163926091|NCT00937521|592100785|FG004|Booster Phase|Protocol Deviation|0|||
163926092|NCT00937521|592100786|FG005|Booster Phase|Protocol Deviation|0|||
163926093|NCT00937521|592100787|FG006|Booster Phase|Protocol Deviation|1|||
163926094|NCT00937521|592100788|FG007|Booster Phase|Protocol Deviation|0|||
163926095|NCT01978236|592100789|FG000|Overall Study|Discontinued due to study close|2|||
163926096|NCT04035577|592100790|FG000|Overall Study|Lost to Follow-up|1|||
163926097|NCT04035577|592100790|FG000|Overall Study|Withdrawal by Subject|1|||
163926098|NCT00846768|592100792|FG000|Overall Study|Adverse Event|0|||
163926099|NCT00846768|592100793|FG001|Overall Study|Adverse Event|1|||
163926100|NCT00846768|592100794|FG002|Overall Study|Adverse Event|0|||
163926101|NCT00846768|592100795|FG003|Overall Study|Adverse Event|0|||
163926102|NCT00634920|592100797|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
163926103|NCT00634920|592100798|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
163926104|NCT00634920|592100799|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
164034513|NCT02150213|592486496|FG000|Overall Study|Withdrawal by Subject|1|||
164034514|NCT04134728|592486497|FG000|Overall Study|Adverse Event|3|||
164034515|NCT04134728|592486498|FG001|Overall Study|Adverse Event|2|||
164034516|NCT04134728|592486499|FG002|Overall Study|Adverse Event|9|||
164034517|NCT04134728|592486500|FG003|Overall Study|Adverse Event|0|||
164034518|NCT04134728|592486501|FG004|Overall Study|Adverse Event|0|||
164034519|NCT04134728|592486502|FG005|Overall Study|Adverse Event|0|||
163926105|NCT00634920|592100797|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
163926106|NCT00634920|592100798|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
164034520|NCT04134728|592486497|FG000|Overall Study|Lack of Efficacy|3|||
163926107|NCT00634920|592100799|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
163926108|NCT00634920|592100797|FG000|Period 1 - Pre-Randomization|Rejections|0|||
164034521|NCT04134728|592486498|FG001|Overall Study|Lack of Efficacy|3|||
163926109|NCT00634920|592100798|FG001|Period 1 - Pre-Randomization|Rejections|0|||
163926110|NCT00634920|592100799|FG002|Period 1 - Pre-Randomization|Rejections|55|||
163926111|NCT00634920|592100797|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
163926112|NCT00634920|592100798|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
163926113|NCT00634920|592100799|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
163926114|NCT00634920|592100797|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
163926115|NCT00634920|592100798|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
163926116|NCT00634920|592100799|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
163926117|NCT00634920|592100797|FG000|Period 1 - Pre-Randomization|Other issues|0|||
163926118|NCT00634920|592100798|FG001|Period 1 - Pre-Randomization|Other issues|0|||
163926119|NCT00634920|592100799|FG002|Period 1 - Pre-Randomization|Other issues|6|||
163926120|NCT00634920|592100797|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
163926121|NCT00634920|592100798|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
163926122|NCT00634920|592100799|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
163926123|NCT00634920|592100797|FG000|Period 2 - Post-Randomization|Rejection|11|||
163926124|NCT00634920|592100798|FG001|Period 2 - Post-Randomization|Rejection|5|||
163926125|NCT00634920|592100799|FG002|Period 2 - Post-Randomization|Rejection|0|||
163926126|NCT00634920|592100797|FG000|Period 2 - Post-Randomization|Death|2|||
163926127|NCT00634920|592100798|FG001|Period 2 - Post-Randomization|Death|5|||
163926128|NCT00634920|592100799|FG002|Period 2 - Post-Randomization|Death|0|||
163926129|NCT00634920|592100797|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
163926130|NCT00634920|592100798|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
163926131|NCT00634920|592100799|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
163926132|NCT00634920|592100797|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
163926133|NCT00634920|592100798|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
163926134|NCT00634920|592100799|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
163926135|NCT00644878|592100800|FG000|Overall Study|Adverse Event|2|||
163926136|NCT00644878|592100800|FG000|Overall Study|Abnormal laboratory value|3|||
163926137|NCT00644878|592100800|FG000|Overall Study|Protocol deviation|2|||
163926138|NCT00644878|592100800|FG000|Overall Study|Treatment duration completed as per protocol|11|||
163926139|NCT04353817|592100801|FG000|Overall Study|Adverse Event|0|||
163926140|NCT04353817|592100802|FG001|Overall Study|Adverse Event|1|||
163926141|NCT00878553|592100807|FG000|Sleep Study|Withdrawal by Subject|2|||
163926142|NCT00878553|592100808|FG001|Sleep Study|Withdrawal by Subject|0|||
163926143|NCT00878553|592100809|FG002|Sleep Study|Withdrawal by Subject|0|||
163926144|NCT00878553|592100810|FG003|Sleep Study|Withdrawal by Subject|0|||
163926145|NCT00878553|592100811|FG004|Sleep Study|Withdrawal by Subject|0|||
163926146|NCT00878553|592100807|FG000|Sleep Study|Lost to Follow-up|1|||
163926147|NCT00878553|592100808|FG001|Sleep Study|Lost to Follow-up|0|||
163926148|NCT00878553|592100809|FG002|Sleep Study|Lost to Follow-up|0|||
163926149|NCT00878553|592100810|FG003|Sleep Study|Lost to Follow-up|0|||
163926150|NCT00878553|592100811|FG004|Sleep Study|Lost to Follow-up|0|||
163926151|NCT00878553|592100807|FG000|Sleep Study|car accident|1|||
163926152|NCT00878553|592100808|FG001|Sleep Study|car accident|0|||
163926153|NCT00878553|592100809|FG002|Sleep Study|car accident|0|||
163926154|NCT00878553|592100810|FG003|Sleep Study|car accident|0|||
163926155|NCT00878553|592100811|FG004|Sleep Study|car accident|0|||
163926156|NCT00878553|592100807|FG000|Sleep Study|family emergency|1|||
163926157|NCT00878553|592100808|FG001|Sleep Study|family emergency|0|||
163926158|NCT00878553|592100809|FG002|Sleep Study|family emergency|0|||
163926159|NCT00878553|592100810|FG003|Sleep Study|family emergency|0|||
163926160|NCT00878553|592100811|FG004|Sleep Study|family emergency|0|||
163926161|NCT00878553|592100807|FG000|PK Study|Withdrawal by Subject|0|||
163926162|NCT00878553|592100808|FG001|PK Study|Withdrawal by Subject|0|||
163926163|NCT00878553|592100809|FG002|PK Study|Withdrawal by Subject|0|||
163926164|NCT00878553|592100810|FG003|PK Study|Withdrawal by Subject|1|||
163926165|NCT00878553|592100811|FG004|PK Study|Withdrawal by Subject|0|||
164034522|NCT04134728|592486499|FG002|Overall Study|Lack of Efficacy|1|||
164034523|NCT04134728|592486500|FG003|Overall Study|Lack of Efficacy|2|||
164034524|NCT04134728|592486501|FG004|Overall Study|Lack of Efficacy|0|||
164034525|NCT04134728|592486502|FG005|Overall Study|Lack of Efficacy|0|||
164034526|NCT04134728|592486497|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
163926166|NCT02143063|592100812|FG000|Overall Study|Lost to Follow-up|16|||
163926167|NCT02143063|592100813|FG001|Overall Study|Lost to Follow-up|28|||
163926168|NCT02143063|592100814|FG002|Overall Study|Lost to Follow-up|29|||
163926169|NCT02143063|592100812|FG000|Overall Study|Withdrawal by Subject|0|||
163926170|NCT02143063|592100813|FG001|Overall Study|Withdrawal by Subject|1|||
163926171|NCT02143063|592100814|FG002|Overall Study|Withdrawal by Subject|0|||
163926172|NCT02143063|592100812|FG000|Overall Study|Death|0|||
163926173|NCT02143063|592100813|FG001|Overall Study|Death|1|||
163926174|NCT02143063|592100814|FG002|Overall Study|Death|1|||
163926175|NCT03517111|592100815|FG000|Enrolled|Withdrawal by Subject|0|||
163926176|NCT03517111|592100816|FG001|Enrolled|Withdrawal by Subject|1|||
163926177|NCT03517111|592100817|FG002|Enrolled|Withdrawal by Subject|0|||
163926178|NCT03517111|592100815|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
164034527|NCT04134728|592486498|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163926179|NCT03517111|592100816|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
163926180|NCT03517111|592100817|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
163926181|NCT03517111|592100815|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
163926182|NCT03517111|592100816|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
163926183|NCT03517111|592100817|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
163926184|NCT03517111|592100815|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
163926185|NCT03517111|592100816|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
163926186|NCT03517111|592100817|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
163926187|NCT03517111|592100815|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
163926188|NCT03517111|592100816|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
163926189|NCT03517111|592100817|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
163926190|NCT00909532|592100818|FG000|Overall Study|Adverse Event|4|||
163926191|NCT00909532|592100819|FG001|Overall Study|Adverse Event|1|||
163926192|NCT00909532|592100818|FG000|Overall Study|Pregnancy|0|||
163926193|NCT00909532|592100819|FG001|Overall Study|Pregnancy|1|||
163926194|NCT00909532|592100818|FG000|Overall Study|Prohibited Medication|2|||
163926195|NCT00909532|592100819|FG001|Overall Study|Prohibited Medication|1|||
163926196|NCT00909532|592100818|FG000|Overall Study|Withdrawal of Consent|1|||
163926197|NCT00909532|592100819|FG001|Overall Study|Withdrawal of Consent|1|||
163926198|NCT00909532|592100818|FG000|Overall Study|Noncompliance with Study Requirements|0|||
163926199|NCT00909532|592100819|FG001|Overall Study|Noncompliance with Study Requirements|2|||
163926200|NCT00909532|592100818|FG000|Overall Study|Physician Decision|1|||
163926201|NCT00909532|592100819|FG001|Overall Study|Physician Decision|0|||
163926202|NCT00909532|592100818|FG000|Overall Study|Wrong Genotype|1|||
163926203|NCT00909532|592100819|FG001|Overall Study|Wrong Genotype|0|||
163926204|NCT00909532|592100818|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
163926205|NCT00909532|592100819|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
163926206|NCT03188536|592100821|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
163926207|NCT03188536|592100821|FG000|Overall Study|Not participated/met inclusion criteria|1|||
163926208|NCT02062645|592100824|FG000|Overall Study|Adverse Event|2|||
163926209|NCT02062645|592100824|FG000|Overall Study|Protocol Violation|8|||
163926210|NCT02062645|592100824|FG000|Overall Study|Lost to Follow-up|5|||
163926211|NCT02864342|592100826|FG000|Overall Study|Eligibility Criteria Deviation|2|||
163926212|NCT02864342|592100827|FG001|Overall Study|Eligibility Criteria Deviation|3|||
163926213|NCT02864342|592100826|FG000|Overall Study|Withdrawal by Subject|4|||
163926214|NCT02864342|592100827|FG001|Overall Study|Withdrawal by Subject|2|||
163926215|NCT02864342|592100826|FG000|Overall Study|Device Technology Issue|6|||
163926216|NCT02864342|592100827|FG001|Overall Study|Device Technology Issue|7|||
163926217|NCT02864342|592100826|FG000|Overall Study|Death|0|||
163926218|NCT02864342|592100827|FG001|Overall Study|Death|1|||
163926219|NCT02864342|592100826|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
163926220|NCT02864342|592100827|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
163926221|NCT02864342|592100826|FG000|Overall Study|Lost to Follow-up|1|||
163926222|NCT02864342|592100827|FG001|Overall Study|Lost to Follow-up|5|||
163926223|NCT02864342|592100826|FG000|Overall Study|Lost Device|1|||
163926224|NCT02864342|592100827|FG001|Overall Study|Lost Device|0|||
163926225|NCT02864342|592100826|FG000|Overall Study|Adverse Event|1|||
163926226|NCT02864342|592100827|FG001|Overall Study|Adverse Event|0|||
163926227|NCT00118703|592100830|FG000|Overall Study|Protocol Violation|1|||
163926228|NCT00118703|592100831|FG001|Overall Study|Protocol Violation|0|||
163926229|NCT00118703|592100830|FG000|Overall Study|Adverse Event|1|||
163926230|NCT00118703|592100831|FG001|Overall Study|Adverse Event|1|||
163926231|NCT00118703|592100830|FG000|Overall Study|Participant took two different treatment|0|||
163926232|NCT00118703|592100831|FG001|Overall Study|Participant took two different treatment|1|||
163926233|NCT00118703|592100830|FG000|Overall Study|Withdrawal by Subject|2|||
163926234|NCT00118703|592100831|FG001|Overall Study|Withdrawal by Subject|5|||
163926235|NCT00118703|592100830|FG000|Overall Study|Lost to Follow-up|1|||
164034528|NCT04134728|592486499|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
164034529|NCT04134728|592486500|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164034530|NCT04134728|592486501|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164034531|NCT04134728|592486502|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163926236|NCT00118703|592100831|FG001|Overall Study|Lost to Follow-up|2|||
163926237|NCT00461123|592100832|FG000|Overall Study|Adverse Event|1|||
164034532|NCT04134728|592486497|FG000|Overall Study|Protocol Deviation|0|||
163926238|NCT00461123|592100833|FG001|Overall Study|Adverse Event|0|||
164034533|NCT04134728|592486498|FG001|Overall Study|Protocol Deviation|0|||
164034534|NCT04134728|592486499|FG002|Overall Study|Protocol Deviation|1|||
164034535|NCT04134728|592486500|FG003|Overall Study|Protocol Deviation|0|||
163926239|NCT00461123|592100832|FG000|Overall Study|Lost to Follow-up|1|||
163926240|NCT00461123|592100833|FG001|Overall Study|Lost to Follow-up|1|||
163926241|NCT00461123|592100832|FG000|Overall Study|Protocol Violation|3|||
163926242|NCT00461123|592100833|FG001|Overall Study|Protocol Violation|2|||
163926243|NCT00461123|592100832|FG000|Overall Study|Withdrawal by Subject|1|||
163926244|NCT00461123|592100833|FG001|Overall Study|Withdrawal by Subject|3|||
164034536|NCT04134728|592486501|FG004|Overall Study|Protocol Deviation|0|||
164034537|NCT04134728|592486502|FG005|Overall Study|Protocol Deviation|0|||
164034538|NCT04134728|592486497|FG000|Overall Study|Informed Consent Withdrawn|3|||
164034539|NCT04134728|592486498|FG001|Overall Study|Informed Consent Withdrawn|6|||
164034540|NCT04134728|592486499|FG002|Overall Study|Informed Consent Withdrawn|8|||
164034541|NCT04134728|592486500|FG003|Overall Study|Informed Consent Withdrawn|1|||
163830427|NCT01844284|591749190|FG001|Overall Study|Lost to Follow-up|7|||
163830428|NCT00611858|591749191|FG000|Overall Study|Adverse Event|2|||
163830429|NCT00611858|591749191|FG000|Overall Study|Withdrawal by Subject|2|||
163830430|NCT03138733|591749193|FG000|Overall Study|Death|17|||
163830431|NCT03138733|591749194|FG001|Overall Study|Death|18|||
163830432|NCT03138733|591749193|FG000|Overall Study|Withdrawal by Subject|11|||
163830433|NCT03138733|591749194|FG001|Overall Study|Withdrawal by Subject|6|||
163830434|NCT03138733|591749193|FG000|Overall Study|Lost to Follow-up|3|||
163830435|NCT03138733|591749194|FG001|Overall Study|Lost to Follow-up|2|||
163830436|NCT03138733|591749193|FG000|Overall Study|Adverse Event|1|||
163830437|NCT03138733|591749194|FG001|Overall Study|Adverse Event|0|||
163830438|NCT03138733|591749193|FG000|Overall Study|Protocol Violation|1|||
163830439|NCT03138733|591749194|FG001|Overall Study|Protocol Violation|3|||
163830440|NCT03138733|591749193|FG000|Overall Study|Administrative or logistical reason|1|||
163830441|NCT03138733|591749194|FG001|Overall Study|Administrative or logistical reason|0|||
163830442|NCT03138733|591749193|FG000|Overall Study|The patient was transferred to another hospital|1|||
163830443|NCT03138733|591749194|FG001|Overall Study|The patient was transferred to another hospital|0|||
163830444|NCT02597036|591749199|FG000|Overall Study|Progressive Disease|0|||
163830445|NCT02597036|591749200|FG001|Overall Study|Progressive Disease|0|||
163830446|NCT02597036|591749201|FG002|Overall Study|Progressive Disease|0|||
163830447|NCT02597036|591749202|FG003|Overall Study|Progressive Disease|0|||
163830448|NCT02597036|591749203|FG004|Overall Study|Progressive Disease|1|||
163830449|NCT02597036|591749204|FG005|Overall Study|Progressive Disease|1|||
163830450|NCT02597036|591749205|FG006|Overall Study|Progressive Disease|1|||
163830451|NCT02597036|591749206|FG007|Overall Study|Progressive Disease|0|||
163830452|NCT02597036|591749207|FG008|Overall Study|Progressive Disease|0|||
163830453|NCT02597036|591749208|FG009|Overall Study|Progressive Disease|0|||
163830454|NCT02597036|591749209|FG010|Overall Study|Progressive Disease|0|||
163830455|NCT02597036|591749210|FG011|Overall Study|Progressive Disease|0|||
163830456|NCT02597036|591749199|FG000|Overall Study|Adverse Event|0|||
163830457|NCT02597036|591749200|FG001|Overall Study|Adverse Event|0|||
163830458|NCT02597036|591749201|FG002|Overall Study|Adverse Event|0|||
163830459|NCT02597036|591749202|FG003|Overall Study|Adverse Event|0|||
163830460|NCT02597036|591749203|FG004|Overall Study|Adverse Event|0|||
163830461|NCT02597036|591749204|FG005|Overall Study|Adverse Event|0|||
163830462|NCT02597036|591749205|FG006|Overall Study|Adverse Event|0|||
163830463|NCT02597036|591749206|FG007|Overall Study|Adverse Event|1|||
163830464|NCT02597036|591749207|FG008|Overall Study|Adverse Event|0|||
163830465|NCT02597036|591749208|FG009|Overall Study|Adverse Event|0|||
163830466|NCT02597036|591749209|FG010|Overall Study|Adverse Event|0|||
163830467|NCT02597036|591749210|FG011|Overall Study|Adverse Event|1|||
163830468|NCT02597036|591749199|FG000|Overall Study|Death|0|||
163830469|NCT02597036|591749200|FG001|Overall Study|Death|0|||
163830470|NCT02597036|591749201|FG002|Overall Study|Death|0|||
163830471|NCT02597036|591749202|FG003|Overall Study|Death|0|||
163830472|NCT02597036|591749203|FG004|Overall Study|Death|0|||
163830473|NCT02597036|591749204|FG005|Overall Study|Death|0|||
163830474|NCT02597036|591749205|FG006|Overall Study|Death|0|||
163830475|NCT02597036|591749206|FG007|Overall Study|Death|0|||
163830476|NCT02597036|591749207|FG008|Overall Study|Death|0|||
163830477|NCT02597036|591749208|FG009|Overall Study|Death|1|||
163830478|NCT02597036|591749209|FG010|Overall Study|Death|1|||
163830479|NCT02597036|591749210|FG011|Overall Study|Death|0|||
163830480|NCT02597036|591749199|FG000|Overall Study|Lost to Follow-up|0|||
163830481|NCT02597036|591749200|FG001|Overall Study|Lost to Follow-up|0|||
163830482|NCT02597036|591749201|FG002|Overall Study|Lost to Follow-up|0|||
163830483|NCT02597036|591749202|FG003|Overall Study|Lost to Follow-up|0|||
163830484|NCT02597036|591749203|FG004|Overall Study|Lost to Follow-up|0|||
163830485|NCT02597036|591749204|FG005|Overall Study|Lost to Follow-up|0|||
163830486|NCT02597036|591749205|FG006|Overall Study|Lost to Follow-up|0|||
163830487|NCT02597036|591749206|FG007|Overall Study|Lost to Follow-up|0|||
163830488|NCT02597036|591749207|FG008|Overall Study|Lost to Follow-up|0|||
163830489|NCT02597036|591749208|FG009|Overall Study|Lost to Follow-up|0|||
163830490|NCT02597036|591749209|FG010|Overall Study|Lost to Follow-up|1|||
163830491|NCT02597036|591749210|FG011|Overall Study|Lost to Follow-up|0|||
163830492|NCT02597036|591749199|FG000|Overall Study|Withdrawal by Subject|0|||
163830493|NCT02597036|591749200|FG001|Overall Study|Withdrawal by Subject|0|||
164034542|NCT04134728|592486501|FG004|Overall Study|Informed Consent Withdrawn|1|||
163830494|NCT02597036|591749201|FG002|Overall Study|Withdrawal by Subject|0|||
163830495|NCT02597036|591749202|FG003|Overall Study|Withdrawal by Subject|0|||
163830496|NCT02597036|591749203|FG004|Overall Study|Withdrawal by Subject|0|||
163830497|NCT02597036|591749204|FG005|Overall Study|Withdrawal by Subject|0|||
163830498|NCT02597036|591749205|FG006|Overall Study|Withdrawal by Subject|0|||
163830499|NCT02597036|591749206|FG007|Overall Study|Withdrawal by Subject|0|||
164097989|NCT01389102|592724997|FG000|Overall Study|Withdrawal by Subject|7|||
164097990|NCT01389102|592724998|FG001|Overall Study|Withdrawal by Subject|4|||
164097991|NCT01389102|592724999|FG002|Overall Study|Withdrawal by Subject|9|||
164097992|NCT01389102|592725000|FG003|Overall Study|Withdrawal by Subject|2|||
164097993|NCT01389102|592725001|FG004|Overall Study|Withdrawal by Subject|3|||
163830500|NCT02597036|591749207|FG008|Overall Study|Withdrawal by Subject|0|||
163830501|NCT02597036|591749208|FG009|Overall Study|Withdrawal by Subject|0|||
163830502|NCT02597036|591749209|FG010|Overall Study|Withdrawal by Subject|0|||
163830503|NCT02597036|591749210|FG011|Overall Study|Withdrawal by Subject|1|||
163830504|NCT02521285|591749211|FG000|Overall Study|Lost to Follow-up|1|||
164034543|NCT04134728|592486502|FG005|Overall Study|Informed Consent Withdrawn|0|||
164034544|NCT04134728|592486497|FG000|Overall Study|Physician Decision|2|||
164034545|NCT04134728|592486498|FG001|Overall Study|Physician Decision|0|||
164034546|NCT04134728|592486499|FG002|Overall Study|Physician Decision|0|||
164034547|NCT04134728|592486500|FG003|Overall Study|Physician Decision|0|||
164034548|NCT04134728|592486501|FG004|Overall Study|Physician Decision|0|||
164034549|NCT04134728|592486502|FG005|Overall Study|Physician Decision|0|||
164034550|NCT04134728|592486497|FG000|Overall Study|Lost to Follow-up|1|||
163830505|NCT02521285|591749212|FG001|Overall Study|Lost to Follow-up|1|||
163830506|NCT02521285|591749211|FG000|Overall Study|Withdrawal by Subject|1|||
163830507|NCT02521285|591749212|FG001|Overall Study|Withdrawal by Subject|1|||
163830508|NCT02521285|591749211|FG000|Overall Study|Adverse Event|0|||
163830509|NCT02521285|591749212|FG001|Overall Study|Adverse Event|1|||
163830510|NCT05701995|591749214|FG000|Pre-Treatment|Randomization Error|1|||
163830511|NCT05701995|591749215|FG001|Pre-Treatment|Randomization Error|1|||
163830512|NCT05701995|591749214|FG000|Treatment|Withdrawal by Subject|8|||
163830513|NCT05701995|591749215|FG001|Treatment|Withdrawal by Subject|4|||
163830514|NCT05701995|591749214|FG000|Treatment|Lost to Follow-up|2|||
163830515|NCT05701995|591749215|FG001|Treatment|Lost to Follow-up|3|||
163830516|NCT05701995|591749214|FG000|Treatment|Adverse Event|3|||
163830517|NCT05701995|591749215|FG001|Treatment|Adverse Event|1|||
163830518|NCT05701995|591749214|FG000|Treatment|Other Reason|1|||
163830519|NCT05701995|591749215|FG001|Treatment|Other Reason|1|||
163830520|NCT05701995|591749214|FG000|Treatment|Death|1|||
163830521|NCT05701995|591749215|FG001|Treatment|Death|0|||
163830522|NCT05701995|591749214|FG000|Treatment|Physician Decision|0|||
164034551|NCT04134728|592486498|FG001|Overall Study|Lost to Follow-up|2|||
164034552|NCT04134728|592486499|FG002|Overall Study|Lost to Follow-up|1|||
164034553|NCT04134728|592486500|FG003|Overall Study|Lost to Follow-up|0|||
164034554|NCT04134728|592486501|FG004|Overall Study|Lost to Follow-up|0|||
164034555|NCT04134728|592486502|FG005|Overall Study|Lost to Follow-up|1|||
164034556|NCT04134728|592486497|FG000|Overall Study|Investigator Site Closed|0|||
164034557|NCT04134728|592486498|FG001|Overall Study|Investigator Site Closed|1|||
164034558|NCT04134728|592486499|FG002|Overall Study|Investigator Site Closed|1|||
164034559|NCT04134728|592486500|FG003|Overall Study|Investigator Site Closed|0|||
164034560|NCT04134728|592486501|FG004|Overall Study|Investigator Site Closed|0|||
164034561|NCT04134728|592486502|FG005|Overall Study|Investigator Site Closed|0|||
164034562|NCT01175590|592486503|FG000|Overall Study|Lost to Follow-up|1|||
164034563|NCT01175590|592486504|FG001|Overall Study|Lost to Follow-up|0|||
164034564|NCT01175590|592486503|FG000|Overall Study|Withdrawal by Subject|0|||
164034565|NCT01175590|592486504|FG001|Overall Study|Withdrawal by Subject|2|||
164034566|NCT01175590|592486503|FG000|Overall Study|Adverse Event|4|||
164034567|NCT01175590|592486504|FG001|Overall Study|Adverse Event|0|||
164034568|NCT01175590|592486503|FG000|Overall Study|Physician Decision|1|||
164034569|NCT01175590|592486504|FG001|Overall Study|Physician Decision|4|||
164034570|NCT01175590|592486503|FG000|Overall Study|Lack of Efficacy|1|||
164034571|NCT01175590|592486504|FG001|Overall Study|Lack of Efficacy|1|||
164034572|NCT01175590|592486503|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
164034573|NCT01175590|592486504|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
164034574|NCT01175590|592486503|FG000|Overall Study|Treated not as randomized|3|||
164034575|NCT01175590|592486504|FG001|Overall Study|Treated not as randomized|2|||
164034576|NCT01175590|592486503|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
164034577|NCT01175590|592486504|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
163830523|NCT05701995|591749215|FG001|Treatment|Physician Decision|1|||
164034578|NCT01175590|592486503|FG000|Overall Study|Protocol Violation|0|||
164034579|NCT01175590|592486504|FG001|Overall Study|Protocol Violation|1|||
164034580|NCT01090102|592486505|FG000|First 12 Weeks|Withdrawal by Subject|1|||
164034581|NCT01090102|592486506|FG001|First 12 Weeks|Withdrawal by Subject|1|||
164034582|NCT01090102|592486505|FG000|First 12 Weeks|Adverse Event|2|||
164034583|NCT01090102|592486506|FG001|First 12 Weeks|Adverse Event|0|||
164034584|NCT01090102|592486505|FG000|First 12 Weeks|Death|1|||
164034585|NCT01090102|592486506|FG001|First 12 Weeks|Death|1|||
164034586|NCT01090102|592486505|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
164034587|NCT01090102|592486506|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
164034588|NCT02062398|592486509|FG000|Overall Study|Implant removal|1|||
164034589|NCT01527110|592486510|FG000|Overall Study|Adverse Event|1|||
164034590|NCT00367341|592486511|FG000|Overall Study|Physician Decision|1|||
164097994|NCT01389102|592725002|FG005|Overall Study|Withdrawal by Subject|3|||
164097995|NCT01389102|592724997|FG000|Overall Study|Subject Traveling Out of Country|0|||
164034591|NCT00367341|592486512|FG001|Overall Study|Physician Decision|0|||
164034592|NCT00367341|592486511|FG000|Overall Study|Protocol Violation|1|||
164034593|NCT00367341|592486512|FG001|Overall Study|Protocol Violation|0|||
164034594|NCT01387074|592486513|FG000|Overall Study|Lost to Follow-up|7|||
164034595|NCT01387074|592486513|FG000|Overall Study|Lack of Efficacy|1|||
164034596|NCT00150345|592486514|FG000|Overall Study|Death|5|||
164034597|NCT00150345|592486515|FG001|Overall Study|Death|2|||
164034598|NCT00150345|592486514|FG000|Overall Study|Adverse Event|8|||
164034599|NCT00150345|592486515|FG001|Overall Study|Adverse Event|6|||
164034600|NCT00150345|592486514|FG000|Overall Study|Lack of Efficacy|5|||
164034601|NCT00150345|592486515|FG001|Overall Study|Lack of Efficacy|4|||
164034602|NCT00150345|592486514|FG000|Overall Study|Withdrawal by Subject|3|||
164034603|NCT00150345|592486515|FG001|Overall Study|Withdrawal by Subject|4|||
164034604|NCT00150345|592486514|FG000|Overall Study|Laboratory abnormality|1|||
164034605|NCT00150345|592486515|FG001|Overall Study|Laboratory abnormality|2|||
164034606|NCT00150345|592486514|FG000|Overall Study|Other|12|||
164034607|NCT00150345|592486515|FG001|Overall Study|Other|14|||
164034608|NCT01392742|592486516|FG000|Overall Study|Premature study termination|42|||
164034609|NCT01392742|592486516|FG000|Overall Study|Failure to return|35|||
163926245|NCT00927901|592100834|FG000|Treatment Period 1|Subject withdrew consent|0|||
163926246|NCT00927901|592100835|FG001|Treatment Period 1|Subject withdrew consent|0|||
163926247|NCT00927901|592100836|FG002|Treatment Period 1|Subject withdrew consent|1|||
163926248|NCT00927901|592100837|FG003|Treatment Period 1|Subject withdrew consent|0|||
163926249|NCT00927901|592100834|FG000|Treatment Period 4|Adverse Event|0|||
163926250|NCT00927901|592100835|FG001|Treatment Period 4|Adverse Event|0|||
163926251|NCT00927901|592100836|FG002|Treatment Period 4|Adverse Event|0|||
163926252|NCT00927901|592100837|FG003|Treatment Period 4|Adverse Event|1|||
163926253|NCT00927901|592100834|FG000|Treatment Period 4|Subject withdrew consent|0|||
163926254|NCT00927901|592100835|FG001|Treatment Period 4|Subject withdrew consent|0|||
163926255|NCT00927901|592100836|FG002|Treatment Period 4|Subject withdrew consent|1|||
163926256|NCT00927901|592100837|FG003|Treatment Period 4|Subject withdrew consent|0|||
163926257|NCT02344173|592100838|FG000|Procedure|Ablation Procedure Not Performed|7|||
163926258|NCT02344173|592100838|FG000|12-month Visit|Death|8|||
163926259|NCT02344173|592100838|FG000|12-month Visit|Withdrawal by Subject|30|||
163926260|NCT02344173|592100838|FG000|12-month Visit|Lost to Follow-up|58|||
163926261|NCT00746356|592100843|FG000|Overall Study|Withdrawal by Subject|2|||
163926262|NCT00746356|592100844|FG001|Overall Study|Withdrawal by Subject|3|||
163926263|NCT00746356|592100843|FG000|Overall Study|Death|7|||
163926264|NCT00746356|592100844|FG001|Overall Study|Death|3|||
163926265|NCT00746356|592100843|FG000|Overall Study|Lost to Follow-up|1|||
163926266|NCT00746356|592100844|FG001|Overall Study|Lost to Follow-up|0|||
163926267|NCT00746356|592100843|FG000|Overall Study|Removal of Device|0|||
163926268|NCT00746356|592100844|FG001|Overall Study|Removal of Device|1|||
163926269|NCT00746356|592100843|FG000|Overall Study|Patient relocated|1|||
163926270|NCT00746356|592100844|FG001|Overall Study|Patient relocated|0|||
163926271|NCT01263925|592100845|FG000|Overall Study|Protocol Violation|1|||
163926272|NCT01263925|592100846|FG001|Overall Study|Protocol Violation|0|||
163926273|NCT01263925|592100845|FG000|Overall Study|Lack of Efficacy|0|||
163926274|NCT01263925|592100846|FG001|Overall Study|Lack of Efficacy|1|||
163926275|NCT01263925|592100845|FG000|Overall Study|Adverse Event|23|||
163926276|NCT01263925|592100846|FG001|Overall Study|Adverse Event|22|||
163926277|NCT01263925|592100845|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
163926278|NCT01263925|592100846|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
163926279|NCT01263925|592100845|FG000|Overall Study|Withdrawal by Subject|6|||
163926280|NCT01263925|592100846|FG001|Overall Study|Withdrawal by Subject|8|||
163926281|NCT01263925|592100845|FG000|Overall Study|Other|4|||
163926282|NCT01263925|592100846|FG001|Overall Study|Other|4|||
163926283|NCT01263925|592100845|FG000|Overall Study|Lost to Follow-up|3|||
163926284|NCT01263925|592100846|FG001|Overall Study|Lost to Follow-up|1|||
163926285|NCT01263925|592100845|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
163926286|NCT01263925|592100846|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
163926287|NCT01263925|592100845|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
163926288|NCT01263925|592100846|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
164034610|NCT01392742|592486516|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
164034611|NCT01392742|592486516|FG000|Overall Study|Lost to Follow-up|34|||
164034612|NCT01392742|592486516|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
164034613|NCT01392742|592486516|FG000|Overall Study|ITR and Protocol deviation|1|||
164034614|NCT01392742|592486516|FG000|Overall Study|Adverse event/intercurrent illness|17|||
164034615|NCT01392742|592486516|FG000|Overall Study|Protocol Violation|14|||
164034616|NCT01392742|592486516|FG000|Overall Study|Other|3|||
164034617|NCT01392742|592486516|FG000|Overall Study|Missing information|13|||
164034618|NCT01998958|592486517|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
163926289|NCT01263925|592100845|FG000|Overall Study|AE/ Withdrawal|1|||
163926290|NCT01263925|592100846|FG001|Overall Study|AE/ Withdrawal|4|||
163926291|NCT01263925|592100845|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
163926292|NCT01263925|592100846|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
163926293|NCT01263925|592100845|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
163926294|NCT01263925|592100846|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
163926295|NCT01263925|592100845|FG000|Overall Study|Withdrawal/ Not specified|0|||
163926296|NCT01263925|592100846|FG001|Overall Study|Withdrawal/ Not specified|1|||
163926297|NCT00477464|592102811|FG000|Overall Study|Lost to Follow-up|1|||
163926298|NCT00477464|592102811|FG000|Overall Study|Death|36|||
163926299|NCT00477464|592102811|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
163926300|NCT03568812|592102812|FG000|Overall Study|Physician Decision|0|||
163926301|NCT03568812|592102813|FG001|Overall Study|Physician Decision|1|||
163926302|NCT00639769|592102815|FG000|Overall Study|Death|2|||
163926303|NCT00639769|592102815|FG000|Overall Study|Adverse Event|7|||
163926304|NCT00639769|592102815|FG000|Overall Study|Lack of Efficacy|1|||
163926305|NCT00639769|592102815|FG000|Overall Study|Disease progression|26|||
163926306|NCT00639769|592102815|FG000|Overall Study|Withdrawal by Subject|4|||
163926307|NCT00634842|592102816|FG000|Overall Study|Adverse Event|2|||
163926308|NCT00634842|592102817|FG001|Overall Study|Adverse Event|3|||
163926309|NCT00634842|592102816|FG000|Overall Study|Protocol Violation|8|||
163926310|NCT00634842|592102817|FG001|Overall Study|Protocol Violation|4|||
163926311|NCT00634842|592102816|FG000|Overall Study|Move to another state|1|||
163926312|NCT00634842|592102817|FG001|Overall Study|Move to another state|0|||
163926313|NCT00634842|592102816|FG000|Overall Study|Inclusion criteria were not met|1|||
163926314|NCT00634842|592102817|FG001|Overall Study|Inclusion criteria were not met|0|||
163926315|NCT00634842|592102816|FG000|Overall Study|Lost to Follow-up|1|||
163926316|NCT00634842|592102817|FG001|Overall Study|Lost to Follow-up|2|||
163926317|NCT00634842|592102816|FG000|Overall Study|Physician Decision|1|||
163926318|NCT00634842|592102817|FG001|Overall Study|Physician Decision|0|||
163926319|NCT00634842|592102816|FG000|Overall Study|Withdrawal by Subject|1|||
163926320|NCT00634842|592102817|FG001|Overall Study|Withdrawal by Subject|3|||
163926321|NCT00634842|592102816|FG000|Overall Study|Lack of time and intolerance to drug|0|||
163926322|NCT00634842|592102817|FG001|Overall Study|Lack of time and intolerance to drug|1|||
163926323|NCT00634842|592102816|FG000|Overall Study|Discontinued due to injection|0|||
163926324|NCT00634842|592102817|FG001|Overall Study|Discontinued due to injection|2|||
163926325|NCT00634842|592102816|FG000|Overall Study|No need of study drug to treat diabetes|0|||
163926326|NCT00634842|592102817|FG001|Overall Study|No need of study drug to treat diabetes|1|||
163926327|NCT00634842|592102816|FG000|Overall Study|No wish to keep taking Avandia|0|||
163926328|NCT00634842|592102817|FG001|Overall Study|No wish to keep taking Avandia|1|||
163926329|NCT00634842|592102816|FG000|Overall Study|Subject off study drug for too long|0|||
163926330|NCT00634842|592102817|FG001|Overall Study|Subject off study drug for too long|1|||
163926331|NCT01316887|592102820|FG000|Overall Study|Adverse Event|13|||
163926332|NCT01316887|592102821|FG001|Overall Study|Adverse Event|21|||
163926333|NCT01316887|592102822|FG002|Overall Study|Adverse Event|17|||
163926334|NCT01316887|592102820|FG000|Overall Study|Lack of Efficacy|9|||
164034619|NCT01998958|592486518|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
164034620|NCT01998958|592486519|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034621|NCT01998958|592486520|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034622|NCT01998958|592486521|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034623|NCT01998958|592486522|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034624|NCT01998958|592486523|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034625|NCT01998958|592486524|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034626|NCT01998958|592486525|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164147378|NCT05168202|592902026|FG002|Overall Study|Lack of Efficacy|1|||
163830524|NCT00715429|591749216|FG000|Overall Study|Did not complete the study diary|0|||
163830525|NCT00715429|591749217|FG001|Overall Study|Did not complete the study diary|1|||
163830526|NCT04899245|591749222|FG000|Overall Study|Withdrawal by Subject|3|||
163830527|NCT04899245|591749223|FG001|Overall Study|Withdrawal by Subject|5|||
163830528|NCT04899245|591749224|FG002|Overall Study|Withdrawal by Subject|2|||
163830529|NCT04899245|591749222|FG000|Overall Study|No longer eligible - Left staff position|0|||
163830530|NCT04899245|591749223|FG001|Overall Study|No longer eligible - Left staff position|0|||
163830531|NCT04899245|591749224|FG002|Overall Study|No longer eligible - Left staff position|1|||
163830532|NCT04899245|591749222|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
163830533|NCT04899245|591749223|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
163830534|NCT04899245|591749224|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
163830535|NCT04899245|591749222|FG000|Overall Study|No longer eligible - Moved away from area|2|||
163830536|NCT04899245|591749223|FG001|Overall Study|No longer eligible - Moved away from area|2|||
163830537|NCT04899245|591749224|FG002|Overall Study|No longer eligible - Moved away from area|0|||
163830538|NCT00386022|591749233|FG000|Plus Estrogen|Lost to Follow-up|2|||
163830539|NCT00386022|591749234|FG001|Plus Estrogen|Lost to Follow-up|0|||
163830540|NCT00386022|591749233|FG000|Plus Estrogen|Adverse Event|0|||
163830541|NCT00386022|591749234|FG001|Plus Estrogen|Adverse Event|1|||
163830542|NCT00504426|591749237|FG000|Overall Study|Adverse Event|0|||
163830543|NCT00504426|591749238|FG001|Overall Study|Adverse Event|0|||
163830544|NCT00504426|591749239|FG002|Overall Study|Adverse Event|2|||
163926335|NCT01316887|592102821|FG001|Overall Study|Lack of Efficacy|3|||
163926336|NCT01316887|592102822|FG002|Overall Study|Lack of Efficacy|1|||
163926337|NCT01316887|592102820|FG000|Overall Study|Protocol Violation|2|||
163926338|NCT01316887|592102821|FG001|Overall Study|Protocol Violation|6|||
163926339|NCT01316887|592102822|FG002|Overall Study|Protocol Violation|6|||
163926340|NCT01316887|592102820|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
163926341|NCT01316887|592102821|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
163926342|NCT01316887|592102822|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
163926343|NCT01316887|592102820|FG000|Overall Study|Study Closed/Terminated|2|||
163926344|NCT01316887|592102821|FG001|Overall Study|Study Closed/Terminated|4|||
163926345|NCT01316887|592102822|FG002|Overall Study|Study Closed/Terminated|3|||
163926346|NCT01316887|592102820|FG000|Overall Study|Lost to Follow-up|1|||
163926347|NCT01316887|592102821|FG001|Overall Study|Lost to Follow-up|7|||
163926348|NCT01316887|592102822|FG002|Overall Study|Lost to Follow-up|5|||
163926349|NCT01316887|592102820|FG000|Overall Study|Withdrawal by Subject|8|||
163926350|NCT01316887|592102821|FG001|Overall Study|Withdrawal by Subject|16|||
163926351|NCT01316887|592102822|FG002|Overall Study|Withdrawal by Subject|15|||
163926352|NCT00832000|592102823|FG000|Overall Study|Adverse Event|2|||
163926353|NCT00832000|592102824|FG001|Overall Study|Adverse Event|0|||
163926354|NCT00832000|592102823|FG000|Overall Study|Withdrawal by Subject|1|||
163926355|NCT00832000|592102824|FG001|Overall Study|Withdrawal by Subject|0|||
163926356|NCT00832000|592102823|FG000|Overall Study|No calls to IVR in either period|1|||
163926357|NCT00832000|592102824|FG001|Overall Study|No calls to IVR in either period|1|||
163926358|NCT00832000|592102823|FG000|Overall Study|No calls to IVR in period 2|2|||
163926359|NCT00832000|592102824|FG001|Overall Study|No calls to IVR in period 2|0|||
163926360|NCT03974100|592102825|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
163926361|NCT03974100|592102826|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
163926362|NCT03974100|592102827|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
163926363|NCT03974100|592102828|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
163926364|NCT03974100|592102829|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
163926365|NCT03974100|592102825|FG000|TP1 - Day 1 to Week 52|Death|1|||
163926366|NCT03974100|592102826|FG001|TP1 - Day 1 to Week 52|Death|0|||
163926367|NCT03974100|592102827|FG002|TP1 - Day 1 to Week 52|Death|0|||
163926368|NCT03974100|592102828|FG003|TP1 - Day 1 to Week 52|Death|0|||
163926369|NCT03974100|592102829|FG004|TP1 - Day 1 to Week 52|Death|0|||
163926370|NCT03974100|592102825|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163926371|NCT03974100|592102826|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
163926372|NCT03974100|592102827|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163926373|NCT03974100|592102828|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163926374|NCT03974100|592102829|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
163926375|NCT03974100|592102825|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
163926376|NCT03974100|592102826|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
163926377|NCT03974100|592102827|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
163926378|NCT03974100|592102828|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
163926379|NCT03974100|592102829|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
163926380|NCT03974100|592102825|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
163926381|NCT03974100|592102826|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
163926382|NCT03974100|592102827|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
163926383|NCT03974100|592102828|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
163926384|NCT03974100|592102829|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
163926385|NCT03974100|592102825|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163926386|NCT03974100|592102826|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163926387|NCT03974100|592102827|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163926388|NCT03974100|592102828|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
163926389|NCT03974100|592102829|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
163926390|NCT03974100|592102825|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
163926391|NCT03974100|592102826|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
163926392|NCT03974100|592102827|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
163926393|NCT03974100|592102828|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
163926394|NCT03974100|592102829|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
163926395|NCT03318783|592102830|FG000|Overall Study|Withdrawal by Subject|0|||
163926396|NCT03318783|592102831|FG001|Overall Study|Withdrawal by Subject|1|||
163926397|NCT03318783|592102830|FG000|Overall Study|Death|0|||
163926398|NCT03318783|592102831|FG001|Overall Study|Death|1|||
163926399|NCT03856047|592102832|FG000|Overall Study|Withdrawal by Subject|0|||
163926400|NCT03856047|592102833|FG001|Overall Study|Withdrawal by Subject|1|||
163926401|NCT03856047|592102834|FG002|Overall Study|Withdrawal by Subject|1|||
163926402|NCT03856047|592102835|FG003|Overall Study|Withdrawal by Subject|0|||
163926403|NCT03856047|592102836|FG004|Overall Study|Withdrawal by Subject|3|||
163926404|NCT03856047|592102837|FG005|Overall Study|Withdrawal by Subject|0|||
163926405|NCT03856047|592102838|FG006|Overall Study|Withdrawal by Subject|2|||
163926406|NCT03856047|592102832|FG000|Overall Study|Lost to Follow-up|4|||
163926407|NCT03856047|592102833|FG001|Overall Study|Lost to Follow-up|2|||
163926408|NCT03856047|592102834|FG002|Overall Study|Lost to Follow-up|3|||
163926409|NCT03856047|592102835|FG003|Overall Study|Lost to Follow-up|1|||
164097996|NCT01389102|592724998|FG001|Overall Study|Subject Traveling Out of Country|0|||
163926410|NCT03856047|592102836|FG004|Overall Study|Lost to Follow-up|4|||
163926411|NCT03856047|592102837|FG005|Overall Study|Lost to Follow-up|4|||
163926412|NCT03856047|592102838|FG006|Overall Study|Lost to Follow-up|4|||
164034627|NCT01998958|592486526|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034628|NCT01998958|592486527|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034629|NCT01998958|592486528|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034630|NCT01998958|592486529|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034631|NCT01998958|592486530|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034632|NCT01998958|592486531|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034633|NCT01998958|592486532|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034634|NCT01998958|592486533|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034635|NCT01998958|592486534|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034636|NCT01998958|592486535|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034637|NCT01998958|592486536|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034638|NCT01998958|592486537|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034639|NCT01998958|592486538|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034640|NCT01998958|592486539|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034641|NCT01998958|592486540|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034642|NCT01998958|592486541|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034643|NCT01998958|592486542|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034644|NCT01998958|592486543|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034645|NCT01998958|592486544|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034646|NCT01998958|592486545|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034647|NCT01998958|592486546|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034648|NCT01998958|592486547|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034649|NCT01998958|592486548|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
164034650|NCT01998958|592486517|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034651|NCT01998958|592486518|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
164034652|NCT01998958|592486519|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034653|NCT01998958|592486520|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034654|NCT01998958|592486521|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034655|NCT01998958|592486522|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034656|NCT01998958|592486523|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034657|NCT01998958|592486524|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034658|NCT01998958|592486525|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034659|NCT01998958|592486526|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034660|NCT01998958|592486527|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034661|NCT01998958|592486528|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034662|NCT01998958|592486529|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034663|NCT01998958|592486530|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034664|NCT01998958|592486531|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034665|NCT01998958|592486532|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034666|NCT01998958|592486533|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034667|NCT01998958|592486534|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034668|NCT01998958|592486535|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034669|NCT01998958|592486536|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163830545|NCT00504426|591749240|FG003|Overall Study|Adverse Event|0|||
163830546|NCT00504426|591749237|FG000|Overall Study|Protocol Violation|1|||
163830547|NCT00504426|591749238|FG001|Overall Study|Protocol Violation|1|||
163830548|NCT00504426|591749239|FG002|Overall Study|Protocol Violation|2|||
163830549|NCT00504426|591749240|FG003|Overall Study|Protocol Violation|0|||
163830550|NCT00504426|591749237|FG000|Overall Study|Withdrawal by Subject|2|||
163830551|NCT00504426|591749238|FG001|Overall Study|Withdrawal by Subject|0|||
163830552|NCT00504426|591749239|FG002|Overall Study|Withdrawal by Subject|0|||
163830553|NCT00504426|591749240|FG003|Overall Study|Withdrawal by Subject|0|||
163830554|NCT03988166|591749250|FG000|Overall Study|Lost to Follow-up|2|||
163830555|NCT03988166|591749250|FG000|Overall Study|Death|1|||
163830556|NCT02286089|591749251|FG000|Overall Study|Ongoing in Study|1|||
163830557|NCT02286089|591749252|FG001|Overall Study|Ongoing in Study|1|||
163830558|NCT02286089|591749253|FG002|Overall Study|Ongoing in Study|4|||
163830559|NCT02286089|591749254|FG003|Overall Study|Ongoing in Study|10|||
163830560|NCT02286089|591749251|FG000|Overall Study|Withdrawal by Subject|0|||
163830561|NCT02286089|591749252|FG001|Overall Study|Withdrawal by Subject|0|||
163830562|NCT02286089|591749253|FG002|Overall Study|Withdrawal by Subject|2|||
163830563|NCT02286089|591749254|FG003|Overall Study|Withdrawal by Subject|2|||
163830564|NCT00045708|591751234|FG000|Phase 1|early progressive disease|0|||
164034670|NCT01998958|592486537|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034671|NCT01998958|592486538|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163830565|NCT00045708|591751235|FG001|Phase 1|early progressive disease|1|||
163830566|NCT00045708|591751236|FG002|Phase 1|early progressive disease|0|||
163830567|NCT00685945|591751237|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
164034672|NCT01998958|592486539|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034673|NCT01998958|592486540|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034674|NCT01998958|592486541|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034675|NCT01998958|592486542|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034676|NCT01998958|592486543|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
163830568|NCT00847405|591751239|FG000|First Intervention|Adverse Event|0|||
163830569|NCT00847405|591751240|FG001|First Intervention|Adverse Event|1|||
163830570|NCT00847405|591751239|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
163830571|NCT00847405|591751240|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
163830572|NCT01728792|591751241|FG000|Overall Study|Withdrawal of Consent|1|||
163830573|NCT01728792|591751242|FG001|Overall Study|Withdrawal of Consent|1|||
163830574|NCT01728792|591751243|FG002|Overall Study|Withdrawal of Consent|0|||
163830575|NCT01728792|591751244|FG003|Overall Study|Withdrawal of Consent|1|||
163830576|NCT01728792|591751245|FG004|Overall Study|Withdrawal of Consent|0|||
163830577|NCT01728792|591751241|FG000|Overall Study|Lost to Follow-up|2|||
163830578|NCT01728792|591751242|FG001|Overall Study|Lost to Follow-up|1|||
163830579|NCT01728792|591751243|FG002|Overall Study|Lost to Follow-up|4|||
163830580|NCT01728792|591751244|FG003|Overall Study|Lost to Follow-up|2|||
163830581|NCT01728792|591751245|FG004|Overall Study|Lost to Follow-up|0|||
163830582|NCT00514683|591751247|FG000|Overall Study|Not treated|2|||
163830583|NCT00514683|591751248|FG001|Overall Study|Not treated|1|||
163830584|NCT00514683|591751249|FG002|Overall Study|Not treated|0|||
163830585|NCT00514683|591751250|FG003|Overall Study|Not treated|0|||
163830586|NCT00514683|591751251|FG004|Overall Study|Not treated|1|||
163830587|NCT00514683|591751247|FG000|Overall Study|Adverse Event|21|||
163830588|NCT00514683|591751248|FG001|Overall Study|Adverse Event|20|||
163830589|NCT00514683|591751249|FG002|Overall Study|Adverse Event|15|||
163830590|NCT00514683|591751250|FG003|Overall Study|Adverse Event|13|||
163830591|NCT00514683|591751251|FG004|Overall Study|Adverse Event|27|||
163830592|NCT00514683|591751247|FG000|Overall Study|Protocol Violation|1|||
163830593|NCT00514683|591751248|FG001|Overall Study|Protocol Violation|1|||
163830594|NCT00514683|591751249|FG002|Overall Study|Protocol Violation|0|||
163830595|NCT00514683|591751250|FG003|Overall Study|Protocol Violation|1|||
163830596|NCT00514683|591751251|FG004|Overall Study|Protocol Violation|0|||
163830597|NCT00514683|591751247|FG000|Overall Study|Withdrawal by Subject|2|||
163830598|NCT00514683|591751248|FG001|Overall Study|Withdrawal by Subject|2|||
163830599|NCT00514683|591751249|FG002|Overall Study|Withdrawal by Subject|1|||
163830600|NCT00514683|591751250|FG003|Overall Study|Withdrawal by Subject|0|||
163830601|NCT00514683|591751251|FG004|Overall Study|Withdrawal by Subject|4|||
163830602|NCT00514683|591751247|FG000|Overall Study|Reason other than listed above|0|||
163830603|NCT00514683|591751248|FG001|Overall Study|Reason other than listed above|1|||
163830604|NCT00514683|591751249|FG002|Overall Study|Reason other than listed above|2|||
163830605|NCT00514683|591751250|FG003|Overall Study|Reason other than listed above|0|||
163830606|NCT00514683|591751251|FG004|Overall Study|Reason other than listed above|1|||
163830607|NCT01564368|591751252|FG000|Overall Study|Ineligible|18|||
163830608|NCT01564368|591751252|FG000|Overall Study|Not Randomized in Parent study|116|||
163830609|NCT01564368|591751252|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
163830610|NCT01564368|591751252|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
163830611|NCT01802437|591751253|FG000|Overall Study|Lost to Follow-up|1|||
163830612|NCT01802437|591751254|FG001|Overall Study|Lost to Follow-up|0|||
163830613|NCT01802437|591751253|FG000|Overall Study|Withdrawal by Subject|3|||
163830614|NCT01802437|591751254|FG001|Overall Study|Withdrawal by Subject|4|||
163830615|NCT04810221|591751255|FG000|Overall Study|Physician Decision|3|||
163830616|NCT01181726|591751256|FG000|First Intervention|Adverse Event|1|||
163830617|NCT01181726|591751257|FG001|First Intervention|Adverse Event|0|||
163830618|NCT01264380|591751258|FG000|Period C|Disease Progression|0|||
163830619|NCT01264380|591751259|FG001|Period C|Disease Progression|0|||
163830620|NCT01264380|591751260|FG002|Period C|Disease Progression|4|||
163830621|NCT01264380|591751258|FG000|Period C|Death|0|||
163830622|NCT01264380|591751259|FG001|Period C|Death|0|||
163830623|NCT01264380|591751260|FG002|Period C|Death|2|||
163830624|NCT01264380|591751258|FG000|Period C|Follow-up for survival status|0|||
163830625|NCT01264380|591751259|FG001|Period C|Follow-up for survival status|0|||
163830626|NCT01264380|591751260|FG002|Period C|Follow-up for survival status|6|||
163830627|NCT01264380|591751258|FG000|Period C|Withdrawal by Subject|0|||
163830628|NCT01264380|591751259|FG001|Period C|Withdrawal by Subject|0|||
163830629|NCT01264380|591751260|FG002|Period C|Withdrawal by Subject|1|||
163830630|NCT01264380|591751258|FG000|Period C|Adverse Event|0|||
163830631|NCT01264380|591751259|FG001|Period C|Adverse Event|0|||
163830632|NCT01264380|591751260|FG002|Period C|Adverse Event|1|||
163830633|NCT04998604|591751262|FG000|Overall Study|Adverse Event|3|||
163830634|NCT04998604|591751263|FG001|Overall Study|Adverse Event|2|||
163830635|NCT04998604|591751262|FG000|Overall Study|Withdrawal by Subject|2|||
163830636|NCT04998604|591751263|FG001|Overall Study|Withdrawal by Subject|4|||
163830637|NCT04998604|591751262|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
163830638|NCT04998604|591751263|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
163830639|NCT03953898|591751266|FG000|Overall Study|Lack of Efficacy|8|||
163830640|NCT03953898|591751266|FG000|Overall Study|Death|3|||
163830641|NCT03953898|591751266|FG000|Overall Study|Withdrawal by Subject|2|||
163830642|NCT03953898|591751266|FG000|Overall Study|Adverse Event|1|||
163830643|NCT00643123|591751269|FG000|Overall Study|Lost to Follow-up|4|||
163830644|NCT00643123|591751270|FG001|Overall Study|Lost to Follow-up|0|||
163830645|NCT00643123|591751269|FG000|Overall Study|Withdrawal by Subject|1|||
163830646|NCT00643123|591751270|FG001|Overall Study|Withdrawal by Subject|1|||
163830647|NCT01896869|591751274|FG000|Overall Study|Withdrawal by Subject|0|||
163830648|NCT01896869|591751275|FG001|Overall Study|Withdrawal by Subject|6|||
163830649|NCT01896869|591751274|FG000|Overall Study|Lost to Follow-up|1|||
163830650|NCT01896869|591751275|FG001|Overall Study|Lost to Follow-up|0|||
163830651|NCT00454571|591751282|FG000|Overall Study|Adverse Event|2|||
163830652|NCT00454571|591751283|FG001|Overall Study|Adverse Event|0|||
163830653|NCT00454571|591751282|FG000|Overall Study|Physician Decision|0|||
163830654|NCT00454571|591751283|FG001|Overall Study|Physician Decision|1|||
163830655|NCT00454571|591751282|FG000|Overall Study|Protocol Violation|1|||
163830656|NCT00454571|591751283|FG001|Overall Study|Protocol Violation|0|||
163830657|NCT00454571|591751282|FG000|Overall Study|Withdrawal by Subject|10|||
163830658|NCT00454571|591751283|FG001|Overall Study|Withdrawal by Subject|5|||
163830659|NCT01376323|591751284|FG000|Overall Study|Adverse Event|1|||
163830660|NCT01376323|591751285|FG001|Overall Study|Adverse Event|0|||
163830661|NCT01376323|591751286|FG002|Overall Study|Adverse Event|0|||
163830662|NCT01376323|591751287|FG003|Overall Study|Adverse Event|2|||
163830663|NCT01376323|591751288|FG004|Overall Study|Adverse Event|0|||
163830664|NCT01376323|591751284|FG000|Overall Study|Lost to Follow-up|0|||
163830665|NCT01376323|591751285|FG001|Overall Study|Lost to Follow-up|0|||
163830666|NCT01376323|591751286|FG002|Overall Study|Lost to Follow-up|0|||
163830667|NCT01376323|591751287|FG003|Overall Study|Lost to Follow-up|2|||
163830668|NCT01376323|591751288|FG004|Overall Study|Lost to Follow-up|0|||
163830669|NCT01376323|591751284|FG000|Overall Study|Physician Decision|1|||
163830670|NCT01376323|591751285|FG001|Overall Study|Physician Decision|0|||
163830671|NCT01376323|591751286|FG002|Overall Study|Physician Decision|2|||
163830672|NCT01376323|591751287|FG003|Overall Study|Physician Decision|1|||
163830673|NCT01376323|591751288|FG004|Overall Study|Physician Decision|1|||
163830674|NCT01376323|591751284|FG000|Overall Study|Withdrawal by Subject|0|||
163830675|NCT01376323|591751285|FG001|Overall Study|Withdrawal by Subject|1|||
163830676|NCT01376323|591751286|FG002|Overall Study|Withdrawal by Subject|1|||
163830677|NCT01376323|591751287|FG003|Overall Study|Withdrawal by Subject|0|||
163830678|NCT01376323|591751288|FG004|Overall Study|Withdrawal by Subject|0|||
163830679|NCT04681729|591751289|FG000|Overall Study|Lack of Efficacy|2|||
163830680|NCT04681729|591751290|FG001|Overall Study|Lack of Efficacy|2|||
163830681|NCT04681729|591751289|FG000|Overall Study|Withdrawal by Subject|8|||
163830682|NCT04681729|591751290|FG001|Overall Study|Withdrawal by Subject|9|||
163830683|NCT02436811|591751291|FG000|Overall Study|Lost to Follow-up|2|||
163830684|NCT02436811|591751292|FG001|Overall Study|Lost to Follow-up|9|||
163830685|NCT02436811|591751293|FG002|Overall Study|Lost to Follow-up|7|||
163830686|NCT00792103|591751294|FG000|Overall Study|Enrolled, not treated|15|||
163830687|NCT00792103|591751294|FG000|Overall Study|Lost to Follow-up|17|||
163830688|NCT00792103|591751294|FG000|Overall Study|Adverse Event|25|||
163830689|NCT00792103|591751294|FG000|Overall Study|Withdrawal by Subject|52|||
163830690|NCT00792103|591751294|FG000|Overall Study|Protocol Violation|10|||
163830691|NCT00792103|591751294|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
163830692|NCT02856113|591751295|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
163830693|NCT02856113|591751296|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
163830694|NCT02856113|591751295|FG000|Overall Study|Significant Protocol Deviation|1|||
163830695|NCT02856113|591751296|FG001|Overall Study|Significant Protocol Deviation|0|||
163830696|NCT02856113|591751295|FG000|Overall Study|Lost to Follow-up|3|||
163830697|NCT02856113|591751296|FG001|Overall Study|Lost to Follow-up|5|||
163830698|NCT02856113|591751295|FG000|Overall Study|Voluntary Withdrawal|3|||
163830699|NCT02856113|591751296|FG001|Overall Study|Voluntary Withdrawal|5|||
163830700|NCT02856113|591751295|FG000|Overall Study|Pregnancy|0|||
163830701|NCT02856113|591751296|FG001|Overall Study|Pregnancy|1|||
163830702|NCT02856113|591751295|FG000|Overall Study|Principal Investigator Discretion|2|||
163830703|NCT02856113|591751296|FG001|Overall Study|Principal Investigator Discretion|1|||
163830704|NCT02856113|591751295|FG000|Overall Study|Randomized but not Treated|1|||
163830705|NCT02856113|591751296|FG001|Overall Study|Randomized but not Treated|0|||
163830706|NCT02856113|591751295|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
163830707|NCT02856113|591751296|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
163830708|NCT03494166|591751297|FG000|Overall Study|Death|0|||
163830709|NCT03494166|591751298|FG001|Overall Study|Death|0|||
163830710|NCT03494166|591751299|FG002|Overall Study|Death|0|||
163830711|NCT03494166|591751300|FG003|Overall Study|Death|1|||
163830712|NCT03494166|591751301|FG004|Overall Study|Death|3|||
163830713|NCT03494166|591751302|FG005|Overall Study|Death|0|||
163830714|NCT03494166|591751297|FG000|Overall Study|Lost to Follow-up|2|||
163830715|NCT03494166|591751298|FG001|Overall Study|Lost to Follow-up|2|||
163830716|NCT03494166|591751299|FG002|Overall Study|Lost to Follow-up|2|||
163926413|NCT01426113|592102843|FG000|Overall Study|Study Discontinued|1|||
163830717|NCT03494166|591751300|FG003|Overall Study|Lost to Follow-up|2|||
163830718|NCT03494166|591751301|FG004|Overall Study|Lost to Follow-up|14|||
163830719|NCT03494166|591751302|FG005|Overall Study|Lost to Follow-up|0|||
163830720|NCT03494166|591751297|FG000|Overall Study|Withdrawal by Subject|10|||
163830721|NCT03494166|591751298|FG001|Overall Study|Withdrawal by Subject|7|||
163830722|NCT03494166|591751299|FG002|Overall Study|Withdrawal by Subject|0|||
163926414|NCT01426113|592102844|FG001|Overall Study|Study Discontinued|1|||
163830723|NCT03494166|591751300|FG003|Overall Study|Withdrawal by Subject|5|||
163830724|NCT03494166|591751301|FG004|Overall Study|Withdrawal by Subject|3|||
163830725|NCT03494166|591751302|FG005|Overall Study|Withdrawal by Subject|17|||
163830726|NCT03494166|591751297|FG000|Overall Study|Screen failure|1|||
163830727|NCT03494166|591751298|FG001|Overall Study|Screen failure|0|||
163830728|NCT03494166|591751299|FG002|Overall Study|Screen failure|0|||
163830729|NCT03494166|591751300|FG003|Overall Study|Screen failure|0|||
163830730|NCT03494166|591751301|FG004|Overall Study|Screen failure|1|||
163830731|NCT03494166|591751302|FG005|Overall Study|Screen failure|0|||
163830732|NCT02110901|591751307|FG000|Overall Study|Death|6|||
163830733|NCT02110901|591751308|FG001|Overall Study|Death|3|||
163830734|NCT02110901|591751307|FG000|Overall Study|Lost to Follow-up|12|||
163830735|NCT02110901|591751308|FG001|Overall Study|Lost to Follow-up|8|||
163830736|NCT02110901|591751307|FG000|Overall Study|Withdrawal by Subject|7|||
163830737|NCT02110901|591751308|FG001|Overall Study|Withdrawal by Subject|3|||
163830738|NCT02110901|591751307|FG000|Overall Study|received a kidney transplant|5|||
163830739|NCT02110901|591751308|FG001|Overall Study|received a kidney transplant|0|||
163830740|NCT00855595|591751310|FG000|Overall Study|Withdrawal by Subject|1|||
163830741|NCT00855595|591751311|FG001|Overall Study|Withdrawal by Subject|2|||
163830742|NCT00855595|591751310|FG000|Overall Study|Lost to Follow-up|3|||
163830743|NCT00855595|591751311|FG001|Overall Study|Lost to Follow-up|3|||
163830744|NCT00855595|591751310|FG000|Overall Study|Adverse Event|1|||
163830745|NCT00855595|591751311|FG001|Overall Study|Adverse Event|1|||
163830746|NCT00855595|591751310|FG000|Overall Study|patient moved out of state|1|||
163830747|NCT00855595|591751311|FG001|Overall Study|patient moved out of state|0|||
163830748|NCT00855595|591751310|FG000|Overall Study|patient left country|0|||
163830749|NCT00855595|591751311|FG001|Overall Study|patient left country|1|||
163830750|NCT01058304|591751313|FG000|Overall Study|Withdrawal by Subject|8|||
163830751|NCT01058304|591751314|FG001|Overall Study|Withdrawal by Subject|5|||
163830752|NCT01058304|591751313|FG000|Overall Study|Lost to Follow-up|13|||
163830753|NCT01058304|591751314|FG001|Overall Study|Lost to Follow-up|16|||
163830754|NCT01058304|591751313|FG000|Overall Study|Developed exclusion criterion|6|||
163830755|NCT01058304|591751314|FG001|Overall Study|Developed exclusion criterion|12|||
163830756|NCT01820559|591751315|FG000|Overall Study|Adverse Event|4|||
163830757|NCT01820559|591751316|FG001|Overall Study|Adverse Event|6|||
163830758|NCT01820559|591751317|FG002|Overall Study|Adverse Event|13|||
163830759|NCT01820559|591751315|FG000|Overall Study|Withdrawal by Subject|1|||
163830760|NCT01820559|591751316|FG001|Overall Study|Withdrawal by Subject|2|||
163830761|NCT01820559|591751317|FG002|Overall Study|Withdrawal by Subject|5|||
163830762|NCT01820559|591751315|FG000|Overall Study|Protocol Violation|2|||
163830763|NCT01820559|591751316|FG001|Overall Study|Protocol Violation|1|||
163830764|NCT01820559|591751317|FG002|Overall Study|Protocol Violation|3|||
163830765|NCT01820559|591751315|FG000|Overall Study|Subject's non-compliance|1|||
163830766|NCT01820559|591751316|FG001|Overall Study|Subject's non-compliance|0|||
163830767|NCT01820559|591751317|FG002|Overall Study|Subject's non-compliance|2|||
163830768|NCT01820559|591751315|FG000|Overall Study|Lost to Follow-up|3|||
163830769|NCT01820559|591751316|FG001|Overall Study|Lost to Follow-up|2|||
163830770|NCT01820559|591751317|FG002|Overall Study|Lost to Follow-up|2|||
163830771|NCT01820559|591751315|FG000|Overall Study|At sponsor request|0|||
163830772|NCT01820559|591751316|FG001|Overall Study|At sponsor request|0|||
163830773|NCT01820559|591751317|FG002|Overall Study|At sponsor request|1|||
163830774|NCT01820559|591751315|FG000|Overall Study|Lack of Efficacy|3|||
163830775|NCT01820559|591751316|FG001|Overall Study|Lack of Efficacy|2|||
163830776|NCT01820559|591751317|FG002|Overall Study|Lack of Efficacy|3|||
163830777|NCT02496767|591751318|FG000|Open-label Lead-in Phase|Adverse Event|176|||
163830778|NCT02496767|591751319|FG001|Open-label Lead-in Phase|Adverse Event|0|||
163830779|NCT02496767|591751320|FG002|Open-label Lead-in Phase|Adverse Event|0|||
163830780|NCT02496767|591751321|FG003|Open-label Lead-in Phase|Adverse Event|0|||
163830781|NCT02496767|591751322|FG004|Open-label Lead-in Phase|Adverse Event|0|||
163830782|NCT02496767|591751323|FG005|Open-label Lead-in Phase|Adverse Event|0|||
163830783|NCT02496767|591751324|FG006|Open-label Lead-in Phase|Adverse Event|0|||
163830784|NCT02496767|591751325|FG007|Open-label Lead-in Phase|Adverse Event|0|||
163830785|NCT02496767|591751318|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
163830786|NCT02496767|591751319|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
163830787|NCT02496767|591751320|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
163830788|NCT02496767|591751321|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
163830789|NCT02496767|591751322|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
163830790|NCT02496767|591751323|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
163926415|NCT01426113|592102843|FG000|Overall Study|Adverse Event|0|||
163926416|NCT01426113|592102844|FG001|Overall Study|Adverse Event|1|||
163926417|NCT00338949|592102845|FG000|Subject Screening|Screen failures|11|||
163926418|NCT00338949|592102846|FG001|Subject Screening|Screen failures|11|||
163926419|NCT00338949|592102845|FG000|Randomization|Withdrawal by Subject|1|||
163926420|NCT00338949|592102846|FG001|Randomization|Withdrawal by Subject|0|||
163926421|NCT00338949|592102845|FG000|Randomization|Adverse Event|0|||
163926422|NCT00338949|592102846|FG001|Randomization|Adverse Event|5|||
163926423|NCT00436956|592102849|FG000|Overall Study|Not evaluable|1|||
163926424|NCT00436956|592102850|FG001|Overall Study|Not evaluable|0|||
163926425|NCT02719743|592102856|FG000|Overall Study|Consent withdrawal|0|||
163926426|NCT02719743|592102857|FG001|Overall Study|Consent withdrawal|2|||
163926427|NCT02719743|592102858|FG002|Overall Study|Consent withdrawal|0|||
163926428|NCT02719743|592102859|FG003|Overall Study|Consent withdrawal|1|||
163926429|NCT02719743|592102860|FG004|Overall Study|Consent withdrawal|0|||
163926430|NCT02719743|592102856|FG000|Overall Study|Migrated/moved from study area|0|||
163926431|NCT02719743|592102857|FG001|Overall Study|Migrated/moved from study area|0|||
163926432|NCT02719743|592102858|FG002|Overall Study|Migrated/moved from study area|0|||
163926433|NCT02719743|592102859|FG003|Overall Study|Migrated/moved from study area|0|||
163926434|NCT02719743|592102860|FG004|Overall Study|Migrated/moved from study area|2|||
163926435|NCT02719743|592102856|FG000|Overall Study|Lost to Follow-up|1|||
163926436|NCT02719743|592102857|FG001|Overall Study|Lost to Follow-up|1|||
163926437|NCT02719743|592102858|FG002|Overall Study|Lost to Follow-up|0|||
163926438|NCT02719743|592102859|FG003|Overall Study|Lost to Follow-up|0|||
163926439|NCT02719743|592102860|FG004|Overall Study|Lost to Follow-up|0|||
163926440|NCT01930214|592102861|FG000|Overall Study|Death|4|||
163926441|NCT01930214|592102862|FG001|Overall Study|Death|4|||
163926442|NCT01930214|592102863|FG002|Overall Study|Death|11|||
163926443|NCT01930214|592102861|FG000|Overall Study|Lost to Follow-up|12|||
163926444|NCT01930214|592102862|FG001|Overall Study|Lost to Follow-up|13|||
163926445|NCT01930214|592102863|FG002|Overall Study|Lost to Follow-up|12|||
163926446|NCT01930214|592102861|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
163926447|NCT01930214|592102862|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
163926448|NCT01930214|592102863|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
163926449|NCT01930214|592102861|FG000|Overall Study|Physician Decision|2|||
163926450|NCT01930214|592102862|FG001|Overall Study|Physician Decision|0|||
163926451|NCT01930214|592102863|FG002|Overall Study|Physician Decision|0|||
163926452|NCT02601209|592102864|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
163926453|NCT02601209|592102865|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
163926454|NCT02601209|592102866|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
163926455|NCT02601209|592102867|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163926456|NCT02601209|592102868|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163926457|NCT02601209|592102869|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163926458|NCT02601209|592102870|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163926459|NCT02601209|592102871|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163926460|NCT02601209|592102872|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
163926461|NCT02601209|592102864|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163926462|NCT02601209|592102865|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163926463|NCT02601209|592102866|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163926464|NCT02601209|592102867|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163926465|NCT02601209|592102868|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
163926466|NCT02601209|592102869|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
163926467|NCT02601209|592102870|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
163926468|NCT02601209|592102871|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163926469|NCT02601209|592102872|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
163926470|NCT02024750|592102874|FG000|Overall Study|Withdrawal by Subject|2|||
163926471|NCT02024750|592102875|FG001|Overall Study|Withdrawal by Subject|1|||
163926472|NCT02261285|592102876|FG000|Overall Study|Disease progression|0|||
163926473|NCT02261285|592102877|FG001|Overall Study|Disease progression|0|||
163926474|NCT02261285|592102878|FG002|Overall Study|Disease progression|1|||
163926475|NCT01215032|592102879|FG000|Overall Study|Adverse Event|3|||
163926476|NCT01215032|592102879|FG000|Overall Study|Lack of Efficacy|17|||
163926477|NCT01020747|592102880|FG000|Overall Study|Withdrawal by Subject|1|||
163926478|NCT00983892|592102881|FG000|Overall Study|Withdrawal by Subject|10|||
163926479|NCT00983892|592102882|FG001|Overall Study|Withdrawal by Subject|12|||
163926480|NCT02484547|592102886|FG000|Placebo-Controlled Period|Adverse Event|10|||
163926481|NCT02484547|592102887|FG001|Placebo-Controlled Period|Adverse Event|13|||
163926482|NCT02484547|592102888|FG002|Placebo-Controlled Period|Adverse Event|20|||
163926483|NCT02484547|592102889|FG003|Placebo-Controlled Period|Adverse Event|0|||
163926484|NCT02484547|592102890|FG004|Placebo-Controlled Period|Adverse Event|0|||
163926485|NCT02484547|592102891|FG005|Placebo-Controlled Period|Adverse Event|0|||
163926486|NCT02484547|592102892|FG006|Placebo-Controlled Period|Adverse Event|0|||
163926487|NCT02484547|592102886|FG000|Placebo-Controlled Period|Change of Treatment|0|||
163926488|NCT02484547|592102887|FG001|Placebo-Controlled Period|Change of Treatment|0|||
163926489|NCT02484547|592102888|FG002|Placebo-Controlled Period|Change of Treatment|1|||
163926490|NCT02484547|592102889|FG003|Placebo-Controlled Period|Change of Treatment|0|||
163926491|NCT02484547|592102890|FG004|Placebo-Controlled Period|Change of Treatment|0|||
163926492|NCT02484547|592102891|FG005|Placebo-Controlled Period|Change of Treatment|0|||
163926493|NCT02484547|592102892|FG006|Placebo-Controlled Period|Change of Treatment|0|||
163926494|NCT02484547|592102886|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
163926495|NCT02484547|592102887|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
163830791|NCT02496767|591751324|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
163830792|NCT02496767|591751325|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
163830793|NCT02496767|591751318|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
163830794|NCT02496767|591751319|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830795|NCT02496767|591751320|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830796|NCT02496767|591751321|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830797|NCT02496767|591751322|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830798|NCT02496767|591751323|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830799|NCT02496767|591751324|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830800|NCT02496767|591751325|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
163830801|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163830802|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
163830803|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
163830804|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
163830805|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
163830806|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163830807|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163830808|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
163830809|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163830810|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
163830811|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
163830812|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
163830813|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
163830814|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163830815|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163830816|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
163830817|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
163830818|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
163830819|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
163830820|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
163830821|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
163830822|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
163830823|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
163830824|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
163830825|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
163830826|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
163830827|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
163830828|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
163830829|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
163830830|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
163830831|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
163830832|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
163830833|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163830834|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
163830835|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
163830836|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
163830837|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
163830838|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163830839|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163830840|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
163830841|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163830842|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
163830843|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
163830844|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163830845|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163830846|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163830847|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163830848|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
163830849|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163830850|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
163830851|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163830852|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
163830853|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
163830854|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163926496|NCT02484547|592102888|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
163926497|NCT02484547|592102889|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
163926498|NCT02484547|592102890|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
163926499|NCT02484547|592102891|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
163926500|NCT02484547|592102892|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
163926501|NCT02484547|592102886|FG000|Placebo-Controlled Period|Death|5|||
163926502|NCT02484547|592102887|FG001|Placebo-Controlled Period|Death|0|||
163926503|NCT02484547|592102888|FG002|Placebo-Controlled Period|Death|6|||
163926504|NCT02484547|592102889|FG003|Placebo-Controlled Period|Death|0|||
163926505|NCT02484547|592102890|FG004|Placebo-Controlled Period|Death|0|||
163926506|NCT02484547|592102891|FG005|Placebo-Controlled Period|Death|0|||
163926507|NCT02484547|592102892|FG006|Placebo-Controlled Period|Death|0|||
163926508|NCT02484547|592102886|FG000|Placebo-Controlled Period|Disease Progression|2|||
163926509|NCT02484547|592102887|FG001|Placebo-Controlled Period|Disease Progression|0|||
163926510|NCT02484547|592102888|FG002|Placebo-Controlled Period|Disease Progression|1|||
163926511|NCT02484547|592102889|FG003|Placebo-Controlled Period|Disease Progression|0|||
163926512|NCT02484547|592102890|FG004|Placebo-Controlled Period|Disease Progression|0|||
163926513|NCT02484547|592102891|FG005|Placebo-Controlled Period|Disease Progression|0|||
163926514|NCT02484547|592102892|FG006|Placebo-Controlled Period|Disease Progression|0|||
163926515|NCT02484547|592102886|FG000|Placebo-Controlled Period|Investigator Decision|2|||
163926516|NCT02484547|592102887|FG001|Placebo-Controlled Period|Investigator Decision|2|||
163926517|NCT02484547|592102888|FG002|Placebo-Controlled Period|Investigator Decision|5|||
163926518|NCT02484547|592102889|FG003|Placebo-Controlled Period|Investigator Decision|0|||
163926519|NCT02484547|592102890|FG004|Placebo-Controlled Period|Investigator Decision|0|||
163926520|NCT02484547|592102891|FG005|Placebo-Controlled Period|Investigator Decision|0|||
163926521|NCT02484547|592102892|FG006|Placebo-Controlled Period|Investigator Decision|0|||
163926522|NCT02484547|592102886|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
163926523|NCT02484547|592102887|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
163926524|NCT02484547|592102888|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
163926525|NCT02484547|592102889|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
163926526|NCT02484547|592102890|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
163926527|NCT02484547|592102891|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
163926528|NCT02484547|592102892|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
163926529|NCT02484547|592102886|FG000|Placebo-Controlled Period|Relocation|1|||
163926530|NCT02484547|592102887|FG001|Placebo-Controlled Period|Relocation|1|||
163926531|NCT02484547|592102888|FG002|Placebo-Controlled Period|Relocation|1|||
163926532|NCT02484547|592102889|FG003|Placebo-Controlled Period|Relocation|0|||
163926533|NCT02484547|592102890|FG004|Placebo-Controlled Period|Relocation|0|||
163926534|NCT02484547|592102891|FG005|Placebo-Controlled Period|Relocation|0|||
163926535|NCT02484547|592102892|FG006|Placebo-Controlled Period|Relocation|0|||
163926536|NCT02484547|592102886|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
163926537|NCT02484547|592102887|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
163926538|NCT02484547|592102888|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
163926539|NCT02484547|592102889|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
163926540|NCT02484547|592102890|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
163926541|NCT02484547|592102891|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
163926542|NCT02484547|592102892|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
163926543|NCT02484547|592102886|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
163926544|NCT02484547|592102887|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163926545|NCT02484547|592102888|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
163926546|NCT02484547|592102889|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163926547|NCT02484547|592102890|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163926548|NCT02484547|592102891|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163926549|NCT02484547|592102892|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
163926550|NCT02484547|592102886|FG000|Placebo-Controlled Period|Reason not Specified|216|||
163926551|NCT02484547|592102887|FG001|Placebo-Controlled Period|Reason not Specified|194|||
163926552|NCT02484547|592102888|FG002|Placebo-Controlled Period|Reason not Specified|183|||
163926553|NCT02484547|592102889|FG003|Placebo-Controlled Period|Reason not Specified|0|||
163926554|NCT02484547|592102890|FG004|Placebo-Controlled Period|Reason not Specified|0|||
163926555|NCT02484547|592102891|FG005|Placebo-Controlled Period|Reason not Specified|0|||
163926556|NCT02484547|592102892|FG006|Placebo-Controlled Period|Reason not Specified|0|||
163926557|NCT02484547|592102886|FG000|Long-Term Extension Period|Adverse Event|0|||
163926558|NCT02484547|592102887|FG001|Long-Term Extension Period|Adverse Event|0|||
163926559|NCT02484547|592102888|FG002|Long-Term Extension Period|Adverse Event|0|||
163926560|NCT02484547|592102889|FG003|Long-Term Extension Period|Adverse Event|0|||
163926561|NCT02484547|592102890|FG004|Long-Term Extension Period|Adverse Event|1|||
163926562|NCT02484547|592102891|FG005|Long-Term Extension Period|Adverse Event|3|||
163926563|NCT02484547|592102892|FG006|Long-Term Extension Period|Adverse Event|2|||
163926564|NCT02484547|592102886|FG000|Long-Term Extension Period|Death|0|||
163926565|NCT02484547|592102887|FG001|Long-Term Extension Period|Death|0|||
163926566|NCT02484547|592102888|FG002|Long-Term Extension Period|Death|0|||
163926567|NCT02484547|592102889|FG003|Long-Term Extension Period|Death|0|||
163926568|NCT02484547|592102890|FG004|Long-Term Extension Period|Death|0|||
163926569|NCT02484547|592102891|FG005|Long-Term Extension Period|Death|3|||
163926570|NCT02484547|592102892|FG006|Long-Term Extension Period|Death|0|||
163926571|NCT02484547|592102886|FG000|Long-Term Extension Period|Disease Progression|0|||
163926572|NCT02484547|592102887|FG001|Long-Term Extension Period|Disease Progression|0|||
163926573|NCT02484547|592102888|FG002|Long-Term Extension Period|Disease Progression|0|||
163926574|NCT02484547|592102889|FG003|Long-Term Extension Period|Disease Progression|0|||
163926575|NCT02484547|592102890|FG004|Long-Term Extension Period|Disease Progression|2|||
163926576|NCT02484547|592102891|FG005|Long-Term Extension Period|Disease Progression|4|||
163926577|NCT02484547|592102892|FG006|Long-Term Extension Period|Disease Progression|0|||
163926578|NCT02484547|592102886|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
163926579|NCT02484547|592102887|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
163926580|NCT02484547|592102888|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
163926581|NCT02484547|592102889|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
163926582|NCT02484547|592102890|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
163926583|NCT02484547|592102891|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
163926584|NCT02484547|592102892|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
163926585|NCT02484547|592102886|FG000|Long-Term Extension Period|Loss of Capacity|0|||
163926586|NCT02484547|592102887|FG001|Long-Term Extension Period|Loss of Capacity|0|||
163926587|NCT02484547|592102888|FG002|Long-Term Extension Period|Loss of Capacity|0|||
163926588|NCT02484547|592102889|FG003|Long-Term Extension Period|Loss of Capacity|0|||
163926589|NCT02484547|592102890|FG004|Long-Term Extension Period|Loss of Capacity|1|||
163926590|NCT02484547|592102891|FG005|Long-Term Extension Period|Loss of Capacity|0|||
163926591|NCT02484547|592102892|FG006|Long-Term Extension Period|Loss of Capacity|0|||
163926592|NCT02484547|592102886|FG000|Long-Term Extension Period|Change of Treatment|0|||
163926593|NCT02484547|592102887|FG001|Long-Term Extension Period|Change of Treatment|0|||
163926594|NCT02484547|592102888|FG002|Long-Term Extension Period|Change of Treatment|0|||
163926595|NCT02484547|592102889|FG003|Long-Term Extension Period|Change of Treatment|0|||
163926596|NCT02484547|592102890|FG004|Long-Term Extension Period|Change of Treatment|0|||
163926597|NCT02484547|592102891|FG005|Long-Term Extension Period|Change of Treatment|0|||
163926598|NCT02484547|592102892|FG006|Long-Term Extension Period|Change of Treatment|1|||
163926599|NCT02484547|592102886|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
163926600|NCT02484547|592102887|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
163926601|NCT02484547|592102888|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
163926602|NCT02484547|592102889|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
163926603|NCT02484547|592102890|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
163926604|NCT02484547|592102891|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
163926605|NCT02484547|592102892|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
163926606|NCT02484547|592102886|FG000|Long-Term Extension Period|Investigator Decision|0|||
163926607|NCT02484547|592102887|FG001|Long-Term Extension Period|Investigator Decision|0|||
163926608|NCT02484547|592102888|FG002|Long-Term Extension Period|Investigator Decision|0|||
163926609|NCT02484547|592102889|FG003|Long-Term Extension Period|Investigator Decision|2|||
163926610|NCT02484547|592102890|FG004|Long-Term Extension Period|Investigator Decision|1|||
163926611|NCT02484547|592102891|FG005|Long-Term Extension Period|Investigator Decision|0|||
163926612|NCT02484547|592102892|FG006|Long-Term Extension Period|Investigator Decision|1|||
163926613|NCT02484547|592102886|FG000|Long-Term Extension Period|Relocation|0|||
163926614|NCT02484547|592102887|FG001|Long-Term Extension Period|Relocation|0|||
163926615|NCT02484547|592102888|FG002|Long-Term Extension Period|Relocation|0|||
163926616|NCT02484547|592102889|FG003|Long-Term Extension Period|Relocation|1|||
163926617|NCT02484547|592102890|FG004|Long-Term Extension Period|Relocation|1|||
163926618|NCT02484547|592102891|FG005|Long-Term Extension Period|Relocation|0|||
163926619|NCT02484547|592102892|FG006|Long-Term Extension Period|Relocation|0|||
163926620|NCT02484547|592102886|FG000|Long-Term Extension Period|Study Visit Burden|0|||
163926621|NCT02484547|592102887|FG001|Long-Term Extension Period|Study Visit Burden|0|||
163926622|NCT02484547|592102888|FG002|Long-Term Extension Period|Study Visit Burden|0|||
163926623|NCT02484547|592102889|FG003|Long-Term Extension Period|Study Visit Burden|2|||
163926624|NCT02484547|592102890|FG004|Long-Term Extension Period|Study Visit Burden|0|||
163926625|NCT02484547|592102891|FG005|Long-Term Extension Period|Study Visit Burden|0|||
163926626|NCT02484547|592102892|FG006|Long-Term Extension Period|Study Visit Burden|3|||
163926627|NCT02484547|592102886|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
163926628|NCT02484547|592102887|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
163926629|NCT02484547|592102888|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
164034677|NCT01998958|592486544|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034678|NCT01998958|592486545|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034679|NCT01998958|592486546|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034680|NCT01998958|592486547|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034681|NCT01998958|592486548|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
164034682|NCT01998958|592486517|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
164034683|NCT01998958|592486518|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
164034684|NCT01998958|592486519|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
164034685|NCT01998958|592486520|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
163926630|NCT02484547|592102889|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
164034686|NCT01998958|592486521|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
163926631|NCT02484547|592102890|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
163926632|NCT02484547|592102891|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
163926633|NCT02484547|592102892|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
163926634|NCT02484547|592102886|FG000|Long-Term Extension Period|Reason not Specified|0|||
163926635|NCT02484547|592102887|FG001|Long-Term Extension Period|Reason not Specified|0|||
163926636|NCT02484547|592102888|FG002|Long-Term Extension Period|Reason not Specified|0|||
163926637|NCT02484547|592102889|FG003|Long-Term Extension Period|Reason not Specified|119|||
163926638|NCT02484547|592102890|FG004|Long-Term Extension Period|Reason not Specified|117|||
163926639|NCT02484547|592102891|FG005|Long-Term Extension Period|Reason not Specified|223|||
163926640|NCT02484547|592102892|FG006|Long-Term Extension Period|Reason not Specified|231|||
163926641|NCT03765164|592102893|FG000|Pre-intervention|Withdrawal by Subject|5|||
163926642|NCT03765164|592102894|FG001|Pre-intervention|Withdrawal by Subject|6|||
163926643|NCT03448536|592102895|FG000|Overall Study|Protocol Violation|2|||
163926644|NCT03448536|592102896|FG001|Overall Study|Protocol Violation|0|||
163926645|NCT03448536|592102895|FG000|Overall Study|Pregnancy|1|||
163926646|NCT03448536|592102896|FG001|Overall Study|Pregnancy|0|||
163926647|NCT03448536|592102895|FG000|Overall Study|Withdrawal by Subject|1|||
163926648|NCT03448536|592102896|FG001|Overall Study|Withdrawal by Subject|2|||
163926649|NCT03448536|592102895|FG000|Overall Study|Lost to Follow-up|3|||
163926650|NCT03448536|592102896|FG001|Overall Study|Lost to Follow-up|2|||
163926651|NCT03448536|592102895|FG000|Overall Study|Inadequate pain reporter|1|||
163926652|NCT03448536|592102896|FG001|Overall Study|Inadequate pain reporter|0|||
163926653|NCT03448536|592102895|FG000|Overall Study|Other|3|||
163926654|NCT03448536|592102896|FG001|Overall Study|Other|0|||
163926655|NCT03448536|592102895|FG000|Overall Study|Physician Decision|1|||
163926656|NCT03448536|592102896|FG001|Overall Study|Physician Decision|0|||
163926657|NCT01813305|592102897|FG000|Overall Study|Withdrawal by Subject|12|||
163926658|NCT01813305|592102898|FG001|Overall Study|Withdrawal by Subject|5|||
163926659|NCT01813305|592102897|FG000|Overall Study|Safety Concern|4|||
163926660|NCT01813305|592102898|FG001|Overall Study|Safety Concern|0|||
163926661|NCT01813305|592102897|FG000|Overall Study|Ulcer became worse|4|||
163926662|NCT01813305|592102898|FG001|Overall Study|Ulcer became worse|0|||
163926663|NCT01813305|592102897|FG000|Overall Study|Physician Decision|4|||
163926664|NCT01813305|592102898|FG001|Overall Study|Physician Decision|0|||
163926665|NCT01813305|592102897|FG000|Overall Study|Lost to Follow-up|3|||
163926666|NCT01813305|592102898|FG001|Overall Study|Lost to Follow-up|1|||
163926667|NCT01813305|592102897|FG000|Overall Study|Protocol Violation|1|||
163926668|NCT01813305|592102898|FG001|Overall Study|Protocol Violation|0|||
163926669|NCT01813305|592102897|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
163926670|NCT01813305|592102898|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
163926671|NCT01665599|592102899|FG000|Overall Study|Adverse Event|1|||
163926672|NCT01665599|592102899|FG000|Overall Study|Consent Withdrawn|1|||
163926673|NCT01665599|592102899|FG000|Overall Study|Investigator/Sponsor decision|1|||
163926674|NCT01665599|592102899|FG000|Overall Study|Death|1|||
163926675|NCT01665599|592102899|FG000|Overall Study|Lost to Follow-up|2|||
163926676|NCT01665599|592102899|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
163926677|NCT01665599|592102899|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
163926678|NCT03120949|592102900|FG000|Overall Study|randomized in error|1|||
163926679|NCT03120949|592102901|FG001|Overall Study|randomized in error|0|||
163926680|NCT03120949|592102900|FG000|Overall Study|Death|13|||
163926681|NCT03120949|592102901|FG001|Overall Study|Death|13|||
163926682|NCT03120949|592102900|FG000|Overall Study|Lost to Follow-up|23|||
163926683|NCT03120949|592102901|FG001|Overall Study|Lost to Follow-up|13|||
163926684|NCT03120949|592102900|FG000|Overall Study|Withdrawal by Subject|139|||
163926685|NCT03120949|592102901|FG001|Overall Study|Withdrawal by Subject|124|||
163926686|NCT03120949|592102900|FG000|Overall Study|Covid-19|43|||
163926687|NCT03120949|592102901|FG001|Overall Study|Covid-19|34|||
163926688|NCT03120949|592102900|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
163926689|NCT03120949|592102901|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
163926690|NCT03120949|592102900|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
163926691|NCT03120949|592102901|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
163926692|NCT03120949|592102900|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
163926693|NCT03120949|592102901|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
163926694|NCT03120949|592102900|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
163926695|NCT03120949|592102901|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
163926696|NCT03120949|592102900|FG000|Overall Study|Site was closed|2|||
163926697|NCT03120949|592102901|FG001|Overall Study|Site was closed|3|||
163926698|NCT03120949|592102900|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
163926699|NCT03120949|592102901|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
164034687|NCT01998958|592486522|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
164034688|NCT01998958|592486523|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
163926700|NCT03120949|592102900|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
163926701|NCT03120949|592102901|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
163926702|NCT03120949|592102900|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
163926703|NCT03120949|592102901|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
163926704|NCT03120949|592102900|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
163926705|NCT03120949|592102901|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
163926706|NCT03120949|592102900|FG000|Overall Study|Other: Adverse Event|0|||
163926707|NCT03120949|592102901|FG001|Overall Study|Other: Adverse Event|1|||
163926708|NCT03120949|592102900|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
163926709|NCT03120949|592102901|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
163926710|NCT03120949|592102900|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
163926711|NCT03120949|592102901|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
163926712|NCT03120949|592102900|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
163926713|NCT03120949|592102901|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
163926714|NCT03120949|592102900|FG000|Overall Study|Personal Reasons|0|||
163926715|NCT03120949|592102901|FG001|Overall Study|Personal Reasons|1|||
163926716|NCT03120949|592102900|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
163926717|NCT03120949|592102901|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
163926718|NCT03120949|592102900|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
163926719|NCT03120949|592102901|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
163926720|NCT03120949|592102900|FG000|Overall Study|Compliance With Medication|0|||
163926721|NCT03120949|592102901|FG001|Overall Study|Compliance With Medication|1|||
163926722|NCT03120949|592102900|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
163926723|NCT03120949|592102901|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
163926724|NCT03120949|592102900|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
163926725|NCT03120949|592102901|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
163926726|NCT03120949|592102900|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
163926727|NCT03120949|592102901|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
163926728|NCT01705145|592102902|FG000|Part B|Adverse Event|1|||
163926729|NCT00988117|592102903|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
163926730|NCT00988117|592102903|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
163926731|NCT03015181|592102905|FG000|Overall Study|Enrolled, but product never administered|1|||
163926732|NCT03015181|592102906|FG001|Overall Study|Enrolled, but product never administered|0|||
163926733|NCT03015181|592102907|FG002|Overall Study|Enrolled, but product never administered|0|||
163926734|NCT03015181|592102908|FG003|Overall Study|Enrolled, but product never administered|0|||
163926735|NCT03015181|592102909|FG004|Overall Study|Enrolled, but product never administered|0|||
163926736|NCT03015181|592102910|FG005|Overall Study|Enrolled, but product never administered|0|||
163926737|NCT03015181|592102911|FG006|Overall Study|Enrolled, but product never administered|0|||
163926738|NCT03015181|592102905|FG000|Overall Study|Withdrawal by Subject|0|||
163926739|NCT03015181|592102906|FG001|Overall Study|Withdrawal by Subject|0|||
163926740|NCT03015181|592102907|FG002|Overall Study|Withdrawal by Subject|0|||
163926741|NCT03015181|592102908|FG003|Overall Study|Withdrawal by Subject|0|||
163926742|NCT03015181|592102909|FG004|Overall Study|Withdrawal by Subject|0|||
163926743|NCT03015181|592102910|FG005|Overall Study|Withdrawal by Subject|1|||
163926744|NCT03015181|592102911|FG006|Overall Study|Withdrawal by Subject|0|||
163926745|NCT03015181|592102905|FG000|Overall Study|Physician Decision|0|||
163926746|NCT03015181|592102906|FG001|Overall Study|Physician Decision|0|||
163926747|NCT03015181|592102907|FG002|Overall Study|Physician Decision|0|||
163926748|NCT03015181|592102908|FG003|Overall Study|Physician Decision|0|||
163926749|NCT03015181|592102909|FG004|Overall Study|Physician Decision|0|||
163926750|NCT03015181|592102910|FG005|Overall Study|Physician Decision|0|||
163926751|NCT03015181|592102911|FG006|Overall Study|Physician Decision|1|||
163926752|NCT01077622|592102912|FG000|Overall Study|Physician Decision|2|||
163926753|NCT01077622|592102912|FG000|Overall Study|Withdrawal by Subject|1|||
163926754|NCT00424177|592102913|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
163926755|NCT00424177|592102913|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
163926756|NCT00424177|592102913|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
163926757|NCT00424177|592102913|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
163926758|NCT00424177|592102913|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
163926759|NCT00424177|592102913|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
163926760|NCT00424177|592102913|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
163926761|NCT00424177|592102913|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
163926762|NCT00424177|592102913|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
163926763|NCT00424177|592102913|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
164034689|NCT01998958|592486524|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
164034690|NCT01998958|592486525|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
164034691|NCT01998958|592486526|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
164034692|NCT01998958|592486527|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
164034693|NCT01998958|592486528|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
164034694|NCT01998958|592486529|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
164034695|NCT01998958|592486530|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
164034696|NCT01998958|592486531|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
164034697|NCT01998958|592486532|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
164034698|NCT01998958|592486533|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
164034699|NCT01998958|592486534|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
164034700|NCT01998958|592486535|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
164034701|NCT01998958|592486536|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
164034702|NCT01998958|592486537|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
164034703|NCT01998958|592486538|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
164034704|NCT01998958|592486539|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
164034705|NCT01998958|592486540|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
164034706|NCT01998958|592486541|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
164034707|NCT01998958|592486542|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
164034708|NCT01998958|592486543|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
164034709|NCT01998958|592486544|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
164034710|NCT01998958|592486545|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
164034711|NCT01998958|592486546|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
164034712|NCT01998958|592486547|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
164034713|NCT01998958|592486548|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
164034714|NCT01998958|592486517|FG000|Period 1 (Panel A and B)|Other|1|||
164034715|NCT01998958|592486518|FG001|Period 1 (Panel A and B)|Other|0|||
164034716|NCT01998958|592486519|FG002|Period 1 (Panel A and B)|Other|0|||
164034717|NCT01998958|592486520|FG003|Period 1 (Panel A and B)|Other|0|||
164034718|NCT01998958|592486521|FG004|Period 1 (Panel A and B)|Other|0|||
164034719|NCT01998958|592486522|FG005|Period 1 (Panel A and B)|Other|0|||
164034720|NCT01998958|592486523|FG006|Period 1 (Panel A and B)|Other|0|||
164034721|NCT01998958|592486524|FG007|Period 1 (Panel A and B)|Other|0|||
164034722|NCT01998958|592486525|FG008|Period 1 (Panel A and B)|Other|0|||
164034723|NCT01998958|592486526|FG009|Period 1 (Panel A and B)|Other|0|||
164034724|NCT01998958|592486527|FG010|Period 1 (Panel A and B)|Other|0|||
164034725|NCT01998958|592486528|FG011|Period 1 (Panel A and B)|Other|0|||
164034726|NCT01998958|592486529|FG012|Period 1 (Panel A and B)|Other|0|||
164034727|NCT01998958|592486530|FG013|Period 1 (Panel A and B)|Other|0|||
164034728|NCT01998958|592486531|FG014|Period 1 (Panel A and B)|Other|0|||
164034729|NCT01998958|592486532|FG015|Period 1 (Panel A and B)|Other|0|||
164034730|NCT01998958|592486533|FG016|Period 1 (Panel A and B)|Other|0|||
164034731|NCT01998958|592486534|FG017|Period 1 (Panel A and B)|Other|0|||
164034732|NCT01998958|592486535|FG018|Period 1 (Panel A and B)|Other|0|||
164034733|NCT01998958|592486536|FG019|Period 1 (Panel A and B)|Other|0|||
164034734|NCT01998958|592486537|FG020|Period 1 (Panel A and B)|Other|0|||
164034735|NCT01998958|592486538|FG021|Period 1 (Panel A and B)|Other|0|||
164034736|NCT01998958|592486539|FG022|Period 1 (Panel A and B)|Other|0|||
164034737|NCT01998958|592486540|FG023|Period 1 (Panel A and B)|Other|0|||
164034738|NCT01998958|592486541|FG024|Period 1 (Panel A and B)|Other|0|||
164034739|NCT01998958|592486542|FG025|Period 1 (Panel A and B)|Other|0|||
164034740|NCT01998958|592486543|FG026|Period 1 (Panel A and B)|Other|0|||
164034741|NCT01998958|592486544|FG027|Period 1 (Panel A and B)|Other|0|||
164034742|NCT01998958|592486545|FG028|Period 1 (Panel A and B)|Other|0|||
164034743|NCT01998958|592486546|FG029|Period 1 (Panel A and B)|Other|0|||
164034744|NCT01998958|592486547|FG030|Period 1 (Panel A and B)|Other|0|||
164034745|NCT01998958|592486548|FG031|Period 1 (Panel A and B)|Other|0|||
164034746|NCT01998958|592486517|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
164034747|NCT01998958|592486518|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
164034748|NCT01998958|592486519|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
164034749|NCT01998958|592486520|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
164034750|NCT01998958|592486521|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
163830855|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
163830856|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164034751|NCT01998958|592486522|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
164097997|NCT01389102|592724999|FG002|Overall Study|Subject Traveling Out of Country|0|||
164034752|NCT01998958|592486523|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
164034753|NCT01998958|592486524|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
164034754|NCT01998958|592486525|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
164034755|NCT01998958|592486526|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
164034756|NCT01998958|592486527|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
164034757|NCT01998958|592486528|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
164034758|NCT01998958|592486529|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
164034759|NCT01998958|592486530|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
164034760|NCT01998958|592486531|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
164034761|NCT01998958|592486532|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
164034762|NCT01998958|592486533|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
163926764|NCT01091519|592102919|FG000|Overall Study|Adverse Event|12|||
163926765|NCT01091519|592102920|FG001|Overall Study|Adverse Event|16|||
163926766|NCT01091519|592102919|FG000|Overall Study|Death|1|||
163926767|NCT01091519|592102920|FG001|Overall Study|Death|0|||
163926768|NCT01091519|592102919|FG000|Overall Study|Lack of Efficacy|16|||
163926769|NCT01091519|592102920|FG001|Overall Study|Lack of Efficacy|19|||
163926770|NCT01091519|592102919|FG000|Overall Study|Lost to Follow-up|14|||
163926771|NCT01091519|592102920|FG001|Overall Study|Lost to Follow-up|24|||
163926772|NCT01091519|592102919|FG000|Overall Study|Withdrawal by Subject|2|||
163926773|NCT01091519|592102920|FG001|Overall Study|Withdrawal by Subject|2|||
163926774|NCT01091519|592102919|FG000|Overall Study|Other|6|||
163926775|NCT01091519|592102920|FG001|Overall Study|Other|8|||
163926776|NCT01091519|592102919|FG000|Overall Study|Randomized not treated|4|||
163926777|NCT01091519|592102920|FG001|Overall Study|Randomized not treated|4|||
163926778|NCT01177228|592102925|FG000|Overall Study|Positive tuberculosis test|0|||
163926779|NCT01177228|592102926|FG001|Overall Study|Positive tuberculosis test|1|||
163926780|NCT01177228|592102927|FG002|Overall Study|Positive tuberculosis test|0|||
163926781|NCT01177228|592102928|FG003|Overall Study|Positive tuberculosis test|0|||
163926782|NCT01177228|592102925|FG000|Overall Study|Worsening disease activity|1|||
163926783|NCT01177228|592102926|FG001|Overall Study|Worsening disease activity|0|||
163926784|NCT01177228|592102927|FG002|Overall Study|Worsening disease activity|0|||
163926785|NCT01177228|592102928|FG003|Overall Study|Worsening disease activity|0|||
163926786|NCT01177228|592102925|FG000|Overall Study|Withdrawal by Subject|0|||
163926787|NCT01177228|592102926|FG001|Overall Study|Withdrawal by Subject|1|||
163926788|NCT01177228|592102927|FG002|Overall Study|Withdrawal by Subject|0|||
163926789|NCT01177228|592102928|FG003|Overall Study|Withdrawal by Subject|0|||
163926790|NCT01251887|592102929|FG000|Overall Study|Scheduling conflict|1|||
163926791|NCT01251887|592102930|FG001|Overall Study|Scheduling conflict|2|||
163926792|NCT01251887|592102931|FG002|Overall Study|Scheduling conflict|2|||
163926793|NCT01251887|592102929|FG000|Overall Study|Physician Decision|0|||
163926794|NCT01251887|592102930|FG001|Overall Study|Physician Decision|1|||
163926795|NCT01251887|592102931|FG002|Overall Study|Physician Decision|0|||
163926796|NCT00316589|592102934|FG000|Overall Study|Withdrawal by Subject|0|||
163926797|NCT00316589|592102935|FG001|Overall Study|Withdrawal by Subject|5|||
163926798|NCT00316589|592102936|FG002|Overall Study|Withdrawal by Subject|0|||
163926799|NCT00316589|592102937|FG003|Overall Study|Withdrawal by Subject|1|||
163926800|NCT00316589|592102934|FG000|Overall Study|Subject unwilling/unable to comply|0|||
163926801|NCT00316589|592102935|FG001|Overall Study|Subject unwilling/unable to comply|6|||
163926802|NCT00316589|592102936|FG002|Overall Study|Subject unwilling/unable to comply|0|||
163926803|NCT00316589|592102937|FG003|Overall Study|Subject unwilling/unable to comply|2|||
163926804|NCT00316589|592102934|FG000|Overall Study|Adverse Event|1|||
163926805|NCT00316589|592102935|FG001|Overall Study|Adverse Event|0|||
163926806|NCT00316589|592102936|FG002|Overall Study|Adverse Event|0|||
163926807|NCT00316589|592102937|FG003|Overall Study|Adverse Event|1|||
163926808|NCT00316589|592102934|FG000|Overall Study|Physician Decision|0|||
163926809|NCT00316589|592102935|FG001|Overall Study|Physician Decision|1|||
163926810|NCT00316589|592102936|FG002|Overall Study|Physician Decision|0|||
163926811|NCT00316589|592102937|FG003|Overall Study|Physician Decision|0|||
163926812|NCT00316589|592102934|FG000|Overall Study|Other reason|0|||
163926813|NCT00316589|592102935|FG001|Overall Study|Other reason|12|||
163926814|NCT00316589|592102936|FG002|Overall Study|Other reason|1|||
163926815|NCT00316589|592102937|FG003|Overall Study|Other reason|1|||
163926816|NCT01283971|592102940|FG000|Overall Study|Adverse Event|3|||
163926817|NCT01283971|592102941|FG001|Overall Study|Adverse Event|5|||
163926818|NCT01283971|592102940|FG000|Overall Study|Insufficient therapeutic responses|3|||
163926819|NCT01283971|592102941|FG001|Overall Study|Insufficient therapeutic responses|3|||
163926820|NCT01283971|592102940|FG000|Overall Study|Protocol Violation|5|||
163926821|NCT01283971|592102941|FG001|Overall Study|Protocol Violation|1|||
163926822|NCT01283971|592102940|FG000|Overall Study|Refused treatment|3|||
163926823|NCT01283971|592102941|FG001|Overall Study|Refused treatment|1|||
163926824|NCT01283971|592102940|FG000|Overall Study|Failure to return|0|||
164034763|NCT01998958|592486534|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
164034764|NCT01998958|592486535|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
164034765|NCT01998958|592486536|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
164034766|NCT01998958|592486537|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
164034767|NCT01998958|592486538|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
163926825|NCT01283971|592102941|FG001|Overall Study|Failure to return|1|||
163926826|NCT01283971|592102940|FG000|Overall Study|Administrative reasons|1|||
163926827|NCT01283971|592102941|FG001|Overall Study|Administrative reasons|1|||
163926828|NCT00562484|592102947|FG000|Overall Study|Adverse Event|6|||
163926829|NCT00562484|592102948|FG001|Overall Study|Adverse Event|1|||
163926830|NCT00562484|592102947|FG000|Overall Study|Protocol Violation|11|||
163926831|NCT00562484|592102948|FG001|Overall Study|Protocol Violation|2|||
163926832|NCT00562484|592102947|FG000|Overall Study|Withdrawal by Subject|12|||
163926833|NCT00562484|592102948|FG001|Overall Study|Withdrawal by Subject|9|||
163926834|NCT00562484|592102947|FG000|Overall Study|Moved away from the study area|20|||
163926835|NCT00562484|592102948|FG001|Overall Study|Moved away from the study area|9|||
163926836|NCT00562484|592102947|FG000|Overall Study|Lost to Follow-up|132|||
163926837|NCT00562484|592102948|FG001|Overall Study|Lost to Follow-up|71|||
163926838|NCT00562484|592102947|FG000|Overall Study|Reason not provided or not specified|25|||
163926839|NCT00562484|592102948|FG001|Overall Study|Reason not provided or not specified|12|||
163926840|NCT02598934|592102952|FG000|Overall Study|Adverse Event|11|||
163926841|NCT02598934|592102953|FG001|Overall Study|Adverse Event|13|||
163926842|NCT02598934|592102952|FG000|Overall Study|Failure to Return|3|||
163926843|NCT02598934|592102953|FG001|Overall Study|Failure to Return|3|||
163926844|NCT02598934|592102952|FG000|Overall Study|Withdrawal by Subject|2|||
163926845|NCT02598934|592102953|FG001|Overall Study|Withdrawal by Subject|3|||
163926846|NCT02598934|592102952|FG000|Overall Study|Administrative|2|||
163926847|NCT02598934|592102953|FG001|Overall Study|Administrative|1|||
163926848|NCT02598934|592102952|FG000|Overall Study|Protocol Violation|1|||
163926849|NCT02598934|592102953|FG001|Overall Study|Protocol Violation|2|||
163926850|NCT00702520|592102955|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
163926851|NCT00702520|592102956|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
163926852|NCT00702520|592102957|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
163926853|NCT00702520|592102958|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
163926854|NCT00702520|592102955|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
163926855|NCT00702520|592102956|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
163926856|NCT00702520|592102957|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
163926857|NCT00702520|592102958|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
163926858|NCT00702520|592102955|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
163926859|NCT00702520|592102956|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
163926860|NCT00702520|592102957|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
163926861|NCT00702520|592102958|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
163926862|NCT02154347|592102959|FG000|Double-blind Period|Adverse Event|1|||
163926863|NCT02154347|592102960|FG001|Double-blind Period|Adverse Event|2|||
163926864|NCT02154347|592102959|FG000|Double-blind Period|Lack of Efficacy|1|||
164034768|NCT01998958|592486539|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
164034769|NCT01998958|592486540|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
164034770|NCT01998958|592486541|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
164034771|NCT01998958|592486542|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
164034772|NCT01998958|592486543|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
164034773|NCT01998958|592486544|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
164034774|NCT01998958|592486545|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
163830857|NCT02496767|591751318|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830858|NCT02496767|591751319|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
163830859|NCT02496767|591751320|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830860|NCT02496767|591751321|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830861|NCT02496767|591751322|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830862|NCT02496767|591751323|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830863|NCT02496767|591751324|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830864|NCT02496767|591751325|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
163830865|NCT02496767|591751318|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
163830866|NCT02496767|591751319|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
163830867|NCT02496767|591751320|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
163830868|NCT02496767|591751321|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
163830869|NCT02496767|591751322|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
163830870|NCT02496767|591751323|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
163830871|NCT02496767|591751324|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
163830872|NCT02496767|591751325|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
163830873|NCT02496767|591751318|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
163830874|NCT02496767|591751319|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
163830875|NCT02496767|591751320|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
163830876|NCT02496767|591751321|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
163830877|NCT02496767|591751322|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
163830878|NCT02496767|591751323|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
163830879|NCT02496767|591751324|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
163830880|NCT02496767|591751325|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
163830881|NCT02496767|591751318|FG000|Double-blind, Withdrawal Phase|Death|0|||
163830882|NCT02496767|591751319|FG001|Double-blind, Withdrawal Phase|Death|0|||
163830883|NCT02496767|591751320|FG002|Double-blind, Withdrawal Phase|Death|0|||
163830884|NCT02496767|591751321|FG003|Double-blind, Withdrawal Phase|Death|0|||
163830885|NCT02496767|591751322|FG004|Double-blind, Withdrawal Phase|Death|0|||
163830886|NCT02496767|591751323|FG005|Double-blind, Withdrawal Phase|Death|0|||
163926865|NCT02154347|592102960|FG001|Double-blind Period|Lack of Efficacy|0|||
163926866|NCT02154347|592102959|FG000|Double-blind Period|Physician Decision|0|||
163926867|NCT02154347|592102960|FG001|Double-blind Period|Physician Decision|1|||
163926868|NCT02154347|592102959|FG000|Double-blind Period|Withdrawal by Subject|1|||
164034775|NCT01998958|592486546|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
163830887|NCT02496767|591751324|FG006|Double-blind, Withdrawal Phase|Death|1|||
163830888|NCT02496767|591751325|FG007|Double-blind, Withdrawal Phase|Death|2|||
163830889|NCT02496767|591751318|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163830890|NCT02496767|591751319|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163830891|NCT02496767|591751320|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163830892|NCT02496767|591751321|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163830893|NCT02496767|591751322|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
163830894|NCT02496767|591751323|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
163830895|NCT02496767|591751324|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
163830896|NCT02496767|591751325|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
163830897|NCT00166296|591751326|FG000|Overall Study|Withdrawal by Subject|1|||
163830898|NCT00166296|591751327|FG001|Overall Study|Withdrawal by Subject|3|||
163830899|NCT00166296|591751326|FG000|Overall Study|Adverse Event|2|||
163830900|NCT00166296|591751327|FG001|Overall Study|Adverse Event|4|||
163830901|NCT00166296|591751326|FG000|Overall Study|Lost to Follow-up|4|||
163830902|NCT00166296|591751327|FG001|Overall Study|Lost to Follow-up|2|||
163830903|NCT04035200|591751333|FG000|Overall Study|Lost to Follow-up|0|||
163830904|NCT04035200|591751334|FG001|Overall Study|Lost to Follow-up|1|||
163830905|NCT04035200|591751335|FG002|Overall Study|Lost to Follow-up|0|||
163830906|NCT04035200|591751333|FG000|Overall Study|Withdrawal by Subject|1|||
163830907|NCT04035200|591751334|FG001|Overall Study|Withdrawal by Subject|4|||
163830908|NCT04035200|591751335|FG002|Overall Study|Withdrawal by Subject|4|||
163830909|NCT04035200|591751333|FG000|Overall Study|COVID-19|1|||
163830910|NCT04035200|591751334|FG001|Overall Study|COVID-19|0|||
163830911|NCT04035200|591751335|FG002|Overall Study|COVID-19|0|||
163830912|NCT04035200|591751333|FG000|Overall Study|Early Termination|0|||
163830913|NCT04035200|591751334|FG001|Overall Study|Early Termination|1|||
163830914|NCT04035200|591751335|FG002|Overall Study|Early Termination|0|||
163830915|NCT04035200|591751333|FG000|Overall Study|Non-compliance|0|||
163830916|NCT04035200|591751334|FG001|Overall Study|Non-compliance|1|||
163830917|NCT04035200|591751335|FG002|Overall Study|Non-compliance|0|||
163830918|NCT02277990|591751336|FG000|Overall Study|Death|170|||
163830919|NCT02277990|591751337|FG001|Overall Study|Death|188|||
163830920|NCT02277990|591751336|FG000|Overall Study|Withdrawal by Subject|64|||
163830921|NCT02277990|591751337|FG001|Overall Study|Withdrawal by Subject|53|||
163830922|NCT02277990|591751336|FG000|Overall Study|Physician Decision|40|||
163830923|NCT02277990|591751337|FG001|Overall Study|Physician Decision|34|||
163830924|NCT02277990|591751336|FG000|Overall Study|Lost to Follow-up|66|||
163830925|NCT02277990|591751337|FG001|Overall Study|Lost to Follow-up|69|||
163830926|NCT02277990|591751336|FG000|Overall Study|Had other reason|26|||
163830927|NCT02277990|591751337|FG001|Overall Study|Had other reason|32|||
163830928|NCT04581200|591751338|FG000|Overall Study|Lost to Follow-up|6|||
163830929|NCT04581200|591751339|FG001|Overall Study|Lost to Follow-up|5|||
163830930|NCT04711603|591751340|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
163830931|NCT04711603|591751341|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
163830932|NCT04711603|591751342|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
163830933|NCT04711603|591751343|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
163830934|NCT04711603|591751340|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
163830935|NCT04711603|591751341|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
163830936|NCT04711603|591751342|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
163830937|NCT04711603|591751343|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
163830938|NCT04711603|591751340|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
163830939|NCT04711603|591751341|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
163830940|NCT04711603|591751342|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
163830941|NCT04711603|591751343|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
163830942|NCT04711603|591751340|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
163926869|NCT02154347|592102960|FG001|Double-blind Period|Withdrawal by Subject|1|||
163926870|NCT02154347|592102959|FG000|Open-label Period|Adverse Event|3|||
163926871|NCT02154347|592102960|FG001|Open-label Period|Adverse Event|4|||
163926872|NCT02154347|592102959|FG000|Open-label Period|Lack of Efficacy|4|||
163830943|NCT04711603|591751341|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
163830944|NCT04711603|591751342|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
163830945|NCT04711603|591751343|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
163830946|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
163830947|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
163830948|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
163830949|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
163926873|NCT02154347|592102960|FG001|Open-label Period|Lack of Efficacy|19|||
163926874|NCT02154347|592102959|FG000|Open-label Period|Protocol Violation|0|||
163926875|NCT02154347|592102960|FG001|Open-label Period|Protocol Violation|1|||
163926876|NCT02154347|592102959|FG000|Open-label Period|Withdrawal by Subject|0|||
163926877|NCT02154347|592102960|FG001|Open-label Period|Withdrawal by Subject|1|||
163926878|NCT02481934|592102961|FG000|Overall Study|Death|2|||
163926879|NCT02473913|592102962|FG000|Overall Study|Lost to Follow-up|3|||
164034776|NCT01998958|592486547|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
164034777|NCT01998958|592486548|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
164034778|NCT01998958|592486517|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034779|NCT01998958|592486518|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034780|NCT01998958|592486519|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034781|NCT01998958|592486520|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034782|NCT01998958|592486521|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034783|NCT01998958|592486522|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034784|NCT01998958|592486523|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034785|NCT01998958|592486524|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034786|NCT01998958|592486525|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034787|NCT01998958|592486526|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034788|NCT01998958|592486527|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034789|NCT01998958|592486528|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034790|NCT01998958|592486529|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034791|NCT01998958|592486530|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034792|NCT01998958|592486531|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
164034793|NCT01998958|592486532|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034794|NCT01998958|592486533|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034795|NCT01998958|592486534|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034796|NCT01998958|592486535|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
164034797|NCT01998958|592486536|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034798|NCT01998958|592486537|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034799|NCT01998958|592486538|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034800|NCT01998958|592486539|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034801|NCT01998958|592486540|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034802|NCT01998958|592486541|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034803|NCT01998958|592486542|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034804|NCT01998958|592486543|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034805|NCT01998958|592486544|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034806|NCT01998958|592486545|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034807|NCT01998958|592486546|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034808|NCT01998958|592486547|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034809|NCT01998958|592486548|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
164034810|NCT01998958|592486517|FG000|Open Label Phase (Optional)|Adverse Event|0|||
164034811|NCT01998958|592486518|FG001|Open Label Phase (Optional)|Adverse Event|0|||
164034812|NCT01998958|592486519|FG002|Open Label Phase (Optional)|Adverse Event|0|||
164034813|NCT01998958|592486520|FG003|Open Label Phase (Optional)|Adverse Event|0|||
164034814|NCT01998958|592486521|FG004|Open Label Phase (Optional)|Adverse Event|0|||
164034815|NCT01998958|592486522|FG005|Open Label Phase (Optional)|Adverse Event|0|||
164034816|NCT01998958|592486523|FG006|Open Label Phase (Optional)|Adverse Event|0|||
164034817|NCT01998958|592486524|FG007|Open Label Phase (Optional)|Adverse Event|0|||
164034818|NCT01998958|592486525|FG008|Open Label Phase (Optional)|Adverse Event|0|||
164034819|NCT01998958|592486526|FG009|Open Label Phase (Optional)|Adverse Event|0|||
164034820|NCT01998958|592486527|FG010|Open Label Phase (Optional)|Adverse Event|0|||
164034821|NCT01998958|592486528|FG011|Open Label Phase (Optional)|Adverse Event|0|||
163830950|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
163830951|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
163830952|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
163830953|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
163830954|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
163830955|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
163830956|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
163830957|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
163830958|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
163830959|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
163830960|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
163830961|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
163830962|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
163830963|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
163830964|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
163830965|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
163830966|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
163830967|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
163830968|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
163830969|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
164034822|NCT01998958|592486529|FG012|Open Label Phase (Optional)|Adverse Event|0|||
164034823|NCT01998958|592486530|FG013|Open Label Phase (Optional)|Adverse Event|0|||
163926880|NCT02473913|592102963|FG001|Overall Study|Lost to Follow-up|3|||
163926881|NCT02250183|592102971|FG000|Overall Study|Withdrawal by Subject|2|||
163926882|NCT02250183|592102971|FG000|Overall Study|Adverse Event|5|||
163926883|NCT02250183|592102971|FG000|Overall Study|Lost to Follow-up|1|||
163926884|NCT03282799|592102972|FG000|Overall Study|Pregnancy|1|||
163926885|NCT03282799|592102973|FG001|Overall Study|Pregnancy|0|||
163926886|NCT03282799|592102972|FG000|Overall Study|Physician Decision|1|||
163926887|NCT03282799|592102973|FG001|Overall Study|Physician Decision|0|||
163926888|NCT03749616|592102977|FG000|Overall Study|Lost to Follow-up|4|||
163926889|NCT03749616|592102978|FG001|Overall Study|Lost to Follow-up|7|||
163926890|NCT03749616|592102977|FG000|Overall Study|Screen Failure|1|||
163926891|NCT03749616|592102978|FG001|Overall Study|Screen Failure|1|||
163926892|NCT03749616|592102977|FG000|Overall Study|Withdrawal by Subject|2|||
163926893|NCT03749616|592102978|FG001|Overall Study|Withdrawal by Subject|0|||
163926894|NCT03302559|592102979|FG000|Overall Study|Adverse Event|2|||
163926895|NCT03302559|592102979|FG000|Overall Study|Lost to Follow-up|1|||
163926896|NCT03302559|592102979|FG000|Overall Study|Withdrew Consent|3|||
163926897|NCT02080403|592104333|FG000|Overall Study|Adverse Event|5|||
163926898|NCT02080403|592104334|FG001|Overall Study|Adverse Event|1|||
163926899|NCT02080403|592104333|FG000|Overall Study|Death|0|||
163926900|NCT02080403|592104334|FG001|Overall Study|Death|2|||
163926901|NCT02080403|592104333|FG000|Overall Study|Lost to Follow-up|2|||
163926902|NCT02080403|592104334|FG001|Overall Study|Lost to Follow-up|0|||
163926903|NCT02080403|592104333|FG000|Overall Study|Pregnancy|0|||
163926904|NCT02080403|592104334|FG001|Overall Study|Pregnancy|1|||
163926905|NCT02080403|592104333|FG000|Overall Study|Protocol Violation|3|||
163926906|NCT02080403|592104334|FG001|Overall Study|Protocol Violation|7|||
163926907|NCT02080403|592104333|FG000|Overall Study|Withdrawal by Subject|5|||
163926908|NCT02080403|592104334|FG001|Overall Study|Withdrawal by Subject|1|||
163926909|NCT01999972|592104335|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
163926910|NCT01999972|592104336|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
163926911|NCT01999972|592104337|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
163926912|NCT01999972|592104338|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
163926913|NCT01999972|592104339|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
163926914|NCT01999972|592104340|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
163926915|NCT01999972|592104335|FG000|Dose Escalation Part|Death|0|||
163926916|NCT01999972|592104336|FG001|Dose Escalation Part|Death|1|||
163926917|NCT01999972|592104337|FG002|Dose Escalation Part|Death|0|||
163926918|NCT01999972|592104338|FG003|Dose Escalation Part|Death|0|||
163926919|NCT01999972|592104339|FG004|Dose Escalation Part|Death|0|||
163926920|NCT01999972|592104340|FG005|Dose Escalation Part|Death|0|||
163926921|NCT01999972|592104335|FG000|Dose Escalation Part|Enrolled but not treated|0|||
163926922|NCT01999972|592104336|FG001|Dose Escalation Part|Enrolled but not treated|0|||
163926923|NCT01999972|592104337|FG002|Dose Escalation Part|Enrolled but not treated|1|||
163926924|NCT01999972|592104338|FG003|Dose Escalation Part|Enrolled but not treated|1|||
163926925|NCT01999972|592104339|FG004|Dose Escalation Part|Enrolled but not treated|0|||
163926926|NCT01999972|592104340|FG005|Dose Escalation Part|Enrolled but not treated|0|||
163926927|NCT01999972|592104335|FG000|Dose Escalation Part|Disease progression|3|||
163926928|NCT01999972|592104336|FG001|Dose Escalation Part|Disease progression|2|||
163926929|NCT01999972|592104337|FG002|Dose Escalation Part|Disease progression|3|||
163926930|NCT01999972|592104338|FG003|Dose Escalation Part|Disease progression|6|||
163926931|NCT01999972|592104339|FG004|Dose Escalation Part|Disease progression|0|||
163926932|NCT01999972|592104340|FG005|Dose Escalation Part|Disease progression|0|||
163926933|NCT01999972|592104335|FG000|Dose Escalation Part|Adverse Event|0|||
163926934|NCT01999972|592104336|FG001|Dose Escalation Part|Adverse Event|0|||
163926935|NCT01999972|592104337|FG002|Dose Escalation Part|Adverse Event|0|||
163926936|NCT01999972|592104338|FG003|Dose Escalation Part|Adverse Event|2|||
163926937|NCT01999972|592104339|FG004|Dose Escalation Part|Adverse Event|0|||
163926938|NCT01999972|592104340|FG005|Dose Escalation Part|Adverse Event|0|||
163926939|NCT01999972|592104335|FG000|Dose Escalation Part|Global deterioration of health status|1|||
163926940|NCT01999972|592104336|FG001|Dose Escalation Part|Global deterioration of health status|0|||
163926941|NCT01999972|592104337|FG002|Dose Escalation Part|Global deterioration of health status|0|||
163926942|NCT01999972|592104338|FG003|Dose Escalation Part|Global deterioration of health status|1|||
163926943|NCT01999972|592104339|FG004|Dose Escalation Part|Global deterioration of health status|0|||
163926944|NCT01999972|592104340|FG005|Dose Escalation Part|Global deterioration of health status|0|||
163926945|NCT01999972|592104335|FG000|Dose Expansion Part|Death|0|||
163926946|NCT01999972|592104336|FG001|Dose Expansion Part|Death|0|||
163926947|NCT01999972|592104337|FG002|Dose Expansion Part|Death|0|||
163926948|NCT01999972|592104338|FG003|Dose Expansion Part|Death|0|||
163926949|NCT01999972|592104339|FG004|Dose Expansion Part|Death|2|||
163926950|NCT01999972|592104340|FG005|Dose Expansion Part|Death|1|||
163926951|NCT01999972|592104335|FG000|Dose Expansion Part|Disease progression|0|||
163926952|NCT01999972|592104336|FG001|Dose Expansion Part|Disease progression|0|||
163926953|NCT01999972|592104337|FG002|Dose Expansion Part|Disease progression|0|||
163926954|NCT01999972|592104338|FG003|Dose Expansion Part|Disease progression|0|||
163926955|NCT01999972|592104339|FG004|Dose Expansion Part|Disease progression|9|||
164034824|NCT01998958|592486531|FG014|Open Label Phase (Optional)|Adverse Event|0|||
164034825|NCT01998958|592486532|FG015|Open Label Phase (Optional)|Adverse Event|0|||
163830970|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
163830971|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
163830972|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
163830973|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
163830974|NCT04711603|591751340|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
163830975|NCT04711603|591751341|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
163830976|NCT04711603|591751342|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
163830977|NCT04711603|591751343|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
163830978|NCT03351738|591751344|FG000|Overall Study|Withdrawal by Subject|0|||
163830979|NCT03351738|591751345|FG001|Overall Study|Withdrawal by Subject|1|||
163830980|NCT03351738|591751346|FG002|Overall Study|Withdrawal by Subject|0|||
163830981|NCT03351738|591751347|FG003|Overall Study|Withdrawal by Subject|1|||
163830982|NCT03351738|591751348|FG004|Overall Study|Withdrawal by Subject|0|||
163830983|NCT03351738|591751349|FG005|Overall Study|Withdrawal by Subject|0|||
163830984|NCT01089374|591751354|FG000|Overall Study|Lost to Follow-up|3|||
163830985|NCT01089374|591751355|FG001|Overall Study|Lost to Follow-up|0|||
163830986|NCT01089374|591751354|FG000|Overall Study|Withdrawal by Subject|1|||
163830987|NCT01089374|591751355|FG001|Overall Study|Withdrawal by Subject|0|||
163830988|NCT01089374|591751354|FG000|Overall Study|Study closed early - low accrual|6|||
163830989|NCT01089374|591751355|FG001|Overall Study|Study closed early - low accrual|0|||
163830990|NCT01533493|591751364|FG000|Overall Study|Adverse Event|2|||
163830991|NCT01533493|591751365|FG001|Overall Study|Adverse Event|1|||
163830992|NCT01533493|591751364|FG000|Overall Study|Withdrawal by Subject|1|||
163830993|NCT01533493|591751365|FG001|Overall Study|Withdrawal by Subject|2|||
163830994|NCT01533493|591751364|FG000|Overall Study|Lost to Follow-up|2|||
163830995|NCT01533493|591751365|FG001|Overall Study|Lost to Follow-up|0|||
163830996|NCT04672941|591751374|FG000|Overall Study|Investigator decision|1|||
163830997|NCT04672941|591751374|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
163830998|NCT04672941|591751374|FG000|Overall Study|COVID-19 related but no adverse event|1|||
163830999|NCT04672941|591751374|FG000|Overall Study|Adverse Event|2|||
163831000|NCT04672941|591751374|FG000|Overall Study|Lost to Follow-up|2|||
163831001|NCT03685591|591751375|FG000|Overall Study|Global Deterioration of Health Status|0|||
163831002|NCT03685591|591751376|FG001|Overall Study|Global Deterioration of Health Status|0|||
163831003|NCT03685591|591751377|FG002|Overall Study|Global Deterioration of Health Status|0|||
163831004|NCT03685591|591751378|FG003|Overall Study|Global Deterioration of Health Status|1|||
163831005|NCT03685591|591751379|FG004|Overall Study|Global Deterioration of Health Status|2|||
163831006|NCT03685591|591751380|FG005|Overall Study|Global Deterioration of Health Status|4|||
163831007|NCT03685591|591751381|FG006|Overall Study|Global Deterioration of Health Status|1|||
163831008|NCT03685591|591751382|FG007|Overall Study|Global Deterioration of Health Status|1|||
163831009|NCT03685591|591751383|FG008|Overall Study|Global Deterioration of Health Status|0|||
163831010|NCT03685591|591751375|FG000|Overall Study|Progressive Disease|1|||
163831011|NCT03685591|591751376|FG001|Overall Study|Progressive Disease|1|||
163831012|NCT03685591|591751377|FG002|Overall Study|Progressive Disease|0|||
163831013|NCT03685591|591751378|FG003|Overall Study|Progressive Disease|3|||
163831014|NCT03685591|591751379|FG004|Overall Study|Progressive Disease|5|||
163831015|NCT03685591|591751380|FG005|Overall Study|Progressive Disease|4|||
163831016|NCT03685591|591751381|FG006|Overall Study|Progressive Disease|3|||
163831017|NCT03685591|591751382|FG007|Overall Study|Progressive Disease|2|||
163831018|NCT03685591|591751383|FG008|Overall Study|Progressive Disease|1|||
163831019|NCT03685591|591751375|FG000|Overall Study|Other|0|||
163831020|NCT03685591|591751376|FG001|Overall Study|Other|0|||
163831021|NCT03685591|591751377|FG002|Overall Study|Other|1|||
163831022|NCT03685591|591751378|FG003|Overall Study|Other|0|||
163831023|NCT03685591|591751379|FG004|Overall Study|Other|2|||
163831024|NCT03685591|591751380|FG005|Overall Study|Other|3|||
163831025|NCT03685591|591751381|FG006|Overall Study|Other|0|||
163831026|NCT03685591|591751382|FG007|Overall Study|Other|0|||
163831027|NCT03685591|591751383|FG008|Overall Study|Other|0|||
163831028|NCT03685591|591751375|FG000|Overall Study|Withdrawal by Subject|0|||
163831029|NCT03685591|591751376|FG001|Overall Study|Withdrawal by Subject|0|||
163831030|NCT03685591|591751377|FG002|Overall Study|Withdrawal by Subject|0|||
163831031|NCT03685591|591751378|FG003|Overall Study|Withdrawal by Subject|0|||
163831032|NCT03685591|591751379|FG004|Overall Study|Withdrawal by Subject|3|||
163831033|NCT03685591|591751380|FG005|Overall Study|Withdrawal by Subject|2|||
163831034|NCT03685591|591751381|FG006|Overall Study|Withdrawal by Subject|0|||
163831035|NCT03685591|591751382|FG007|Overall Study|Withdrawal by Subject|0|||
163831036|NCT03685591|591751383|FG008|Overall Study|Withdrawal by Subject|1|||
163831037|NCT03685591|591751375|FG000|Overall Study|Adverse Event|0|||
163831038|NCT03685591|591751376|FG001|Overall Study|Adverse Event|0|||
163831039|NCT03685591|591751377|FG002|Overall Study|Adverse Event|0|||
163831040|NCT03685591|591751378|FG003|Overall Study|Adverse Event|1|||
164097998|NCT01389102|592725000|FG003|Overall Study|Subject Traveling Out of Country|1|||
163831041|NCT03685591|591751379|FG004|Overall Study|Adverse Event|1|||
163831042|NCT03685591|591751380|FG005|Overall Study|Adverse Event|4|||
163831043|NCT03685591|591751381|FG006|Overall Study|Adverse Event|0|||
163831044|NCT03685591|591751382|FG007|Overall Study|Adverse Event|1|||
163831045|NCT03685591|591751383|FG008|Overall Study|Adverse Event|1|||
163831046|NCT00689026|591751384|FG000|Overall Study|Withdrawal by Subject|13|||
163831047|NCT00689026|591751385|FG001|Overall Study|Withdrawal by Subject|6|||
163831048|NCT03996291|591751391|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
163831049|NCT03996291|591751392|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
163831050|NCT03996291|591751393|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
163831051|NCT03996291|591751394|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
163831052|NCT03996291|591751395|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
163831053|NCT03996291|591751396|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
163831054|NCT03996291|591751397|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
163831055|NCT03996291|591751398|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
163831056|NCT03996291|591751391|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163831057|NCT03996291|591751392|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163831058|NCT03996291|591751393|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163831059|NCT03996291|591751394|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163831060|NCT03996291|591751395|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163831061|NCT03996291|591751396|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
163831062|NCT03996291|591751397|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
163831063|NCT03996291|591751398|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
163831064|NCT03996291|591751391|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163831065|NCT03996291|591751392|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163831066|NCT03996291|591751393|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163831067|NCT03996291|591751394|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163831068|NCT03996291|591751395|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
163831069|NCT03996291|591751396|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163831070|NCT03996291|591751397|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
163831071|NCT03996291|591751398|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
163831072|NCT03996291|591751391|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
163831073|NCT03996291|591751392|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
163831074|NCT03996291|591751393|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
163831075|NCT03996291|591751394|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
163831076|NCT03996291|591751395|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
163831077|NCT03996291|591751396|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
163831078|NCT03996291|591751397|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
163831079|NCT03996291|591751398|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
163831080|NCT03996291|591751391|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831081|NCT03996291|591751392|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831082|NCT03996291|591751393|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831083|NCT03996291|591751394|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831084|NCT03996291|591751395|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
163831085|NCT03996291|591751396|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831086|NCT03996291|591751397|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831087|NCT03996291|591751398|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
163831088|NCT03933826|591751399|FG000|Overall Study|Withdrawal by Subject|8|||
163831089|NCT03933826|591751400|FG001|Overall Study|Withdrawal by Subject|1|||
163831090|NCT03933826|591751399|FG000|Overall Study|Death|19|||
163831091|NCT03933826|591751400|FG001|Overall Study|Death|11|||
163831092|NCT03933826|591751399|FG000|Overall Study|Lost to Follow-up|41|||
163831093|NCT03933826|591751400|FG001|Overall Study|Lost to Follow-up|13|||
163831094|NCT02638948|591751401|FG000|Overall Study|Withdrawal by Subject|4|||
163831095|NCT02638948|591751402|FG001|Overall Study|Withdrawal by Subject|5|||
163831096|NCT02638948|591751403|FG002|Overall Study|Withdrawal by Subject|3|||
163831097|NCT02638948|591751404|FG003|Overall Study|Withdrawal by Subject|1|||
163831098|NCT02638948|591751401|FG000|Overall Study|Administrative Reason by Sponsor|0|||
163831099|NCT02638948|591751402|FG001|Overall Study|Administrative Reason by Sponsor|1|||
163831100|NCT02638948|591751403|FG002|Overall Study|Administrative Reason by Sponsor|0|||
163831101|NCT02638948|591751404|FG003|Overall Study|Administrative Reason by Sponsor|4|||
163831102|NCT02638948|591751401|FG000|Overall Study|Adverse Event|0|||
163831103|NCT02638948|591751402|FG001|Overall Study|Adverse Event|0|||
163831104|NCT02638948|591751403|FG002|Overall Study|Adverse Event|1|||
163831105|NCT02638948|591751404|FG003|Overall Study|Adverse Event|1|||
163831106|NCT02638948|591751401|FG000|Overall Study|Lack of Efficacy|1|||
163831107|NCT02638948|591751402|FG001|Overall Study|Lack of Efficacy|1|||
163831108|NCT02638948|591751403|FG002|Overall Study|Lack of Efficacy|0|||
163831109|NCT02638948|591751404|FG003|Overall Study|Lack of Efficacy|0|||
164097999|NCT01389102|592725001|FG004|Overall Study|Subject Traveling Out of Country|0|||
164098000|NCT01389102|592725002|FG005|Overall Study|Subject Traveling Out of Country|0|||
164098001|NCT01389102|592724997|FG000|Overall Study|Subject Moved|2|||
164098002|NCT01389102|592724998|FG001|Overall Study|Subject Moved|0|||
164098003|NCT01389102|592724999|FG002|Overall Study|Subject Moved|1|||
164098004|NCT01389102|592725000|FG003|Overall Study|Subject Moved|0|||
164098005|NCT01389102|592725001|FG004|Overall Study|Subject Moved|0|||
164098006|NCT01389102|592725002|FG005|Overall Study|Subject Moved|0|||
164098007|NCT01389102|592724997|FG000|Overall Study|Unavailable due to husband's illness|0|||
164098008|NCT01389102|592724998|FG001|Overall Study|Unavailable due to husband's illness|1|||
164098009|NCT01389102|592724999|FG002|Overall Study|Unavailable due to husband's illness|0|||
164098010|NCT01389102|592725000|FG003|Overall Study|Unavailable due to husband's illness|0|||
164098011|NCT01389102|592725001|FG004|Overall Study|Unavailable due to husband's illness|0|||
164098012|NCT01389102|592725002|FG005|Overall Study|Unavailable due to husband's illness|0|||
164098013|NCT01389102|592724997|FG000|Overall Study|Investigator Judgement|0|||
164098014|NCT01389102|592724998|FG001|Overall Study|Investigator Judgement|1|||
164098015|NCT01389102|592724999|FG002|Overall Study|Investigator Judgement|0|||
163831110|NCT02638948|591751401|FG000|Overall Study|Lost to Follow-up|0|||
163831111|NCT02638948|591751402|FG001|Overall Study|Lost to Follow-up|0|||
163831112|NCT02638948|591751403|FG002|Overall Study|Lost to Follow-up|1|||
163831113|NCT02638948|591751404|FG003|Overall Study|Lost to Follow-up|1|||
163831114|NCT02638948|591751401|FG000|Overall Study|Poor/Non-Compliance|0|||
163831115|NCT02638948|591751402|FG001|Overall Study|Poor/Non-Compliance|2|||
163831116|NCT02638948|591751403|FG002|Overall Study|Poor/Non-Compliance|1|||
163831117|NCT02638948|591751404|FG003|Overall Study|Poor/Non-Compliance|0|||
163831118|NCT02638948|591751401|FG000|Overall Study|Participant no longer met study criteria|0|||
163831119|NCT02638948|591751402|FG001|Overall Study|Participant no longer met study criteria|1|||
163831120|NCT02638948|591751403|FG002|Overall Study|Participant no longer met study criteria|0|||
163831121|NCT02638948|591751404|FG003|Overall Study|Participant no longer met study criteria|0|||
163831122|NCT02638948|591751401|FG000|Overall Study|Other than specified above|4|||
163831123|NCT02638948|591751402|FG001|Overall Study|Other than specified above|1|||
163831124|NCT02638948|591751403|FG002|Overall Study|Other than specified above|1|||
163831125|NCT02638948|591751404|FG003|Overall Study|Other than specified above|1|||
163831126|NCT04992546|591751405|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
163831127|NCT04992546|591751405|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
163831128|NCT04992546|591751405|FG000|Open-Label Treatment Period|Adverse Event|3|||
163831129|NCT04992546|591751405|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
163831130|NCT05007392|591751407|FG000|Overall Study|Randomized but not treated|1|||
163831131|NCT05007392|591751408|FG001|Overall Study|Randomized but not treated|2|||
163831132|NCT05007392|591751407|FG000|Overall Study|Other|5|||
163831133|NCT05007392|591751408|FG001|Overall Study|Other|4|||
163831134|NCT05007392|591751407|FG000|Overall Study|Lost to Follow-up|1|||
163831135|NCT05007392|591751408|FG001|Overall Study|Lost to Follow-up|2|||
163831136|NCT05007392|591751407|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
163831137|NCT05007392|591751408|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
163831138|NCT05007392|591751407|FG000|Overall Study|Use of prohibited concomitant drug|1|||
163831139|NCT05007392|591751408|FG001|Overall Study|Use of prohibited concomitant drug|1|||
163831140|NCT05007392|591751407|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
163831141|NCT05007392|591751408|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
163831142|NCT05007392|591751407|FG000|Overall Study|Adverse Event|10|||
163831143|NCT05007392|591751408|FG001|Overall Study|Adverse Event|6|||
163831144|NCT05007392|591751407|FG000|Overall Study|Participant choice|5|||
163831145|NCT05007392|591751408|FG001|Overall Study|Participant choice|10|||
163831146|NCT05007392|591751407|FG000|Overall Study|Withdrawal of consent|5|||
163831147|NCT05007392|591751408|FG001|Overall Study|Withdrawal of consent|4|||
163831148|NCT02703922|591751409|FG000|Overall Study|Death|5|||
163831149|NCT02703922|591751410|FG001|Overall Study|Death|8|||
163831150|NCT02703922|591751409|FG000|Overall Study|Lost to Follow-up|10|||
163831151|NCT02703922|591751410|FG001|Overall Study|Lost to Follow-up|10|||
163831152|NCT04058353|591751414|FG000|Overall Study|Adverse Event|2|||
163831153|NCT04058353|591751415|FG001|Overall Study|Adverse Event|1|||
163831154|NCT04058353|591751414|FG000|Overall Study|Physician Decision|1|||
163831155|NCT04058353|591751415|FG001|Overall Study|Physician Decision|0|||
163831156|NCT04058353|591751414|FG000|Overall Study|Other|1|||
163831157|NCT04058353|591751415|FG001|Overall Study|Other|0|||
163831158|NCT00316173|591751419|FG000|Run-in Phase|Adverse Event|1|||
163831159|NCT00316173|591751420|FG001|Run-in Phase|Adverse Event|0|||
163831160|NCT00316173|591751419|FG000|Run-in Phase|Protocol Violation|1|||
164098016|NCT01389102|592725000|FG003|Overall Study|Investigator Judgement|0|||
164098017|NCT01389102|592725001|FG004|Overall Study|Investigator Judgement|0|||
164098018|NCT01389102|592725002|FG005|Overall Study|Investigator Judgement|0|||
164098019|NCT00050778|592725003|FG000|Overall Study|Adverse Event|13|||
164098020|NCT00050778|592725004|FG001|Overall Study|Adverse Event|3|||
164098021|NCT00050778|592725005|FG002|Overall Study|Adverse Event|2|||
163831161|NCT00316173|591751420|FG001|Run-in Phase|Protocol Violation|0|||
163831162|NCT00316173|591751419|FG000|Run-in Phase|Study Follow-up Stopped|5|||
163831163|NCT00316173|591751420|FG001|Run-in Phase|Study Follow-up Stopped|0|||
163831164|NCT00316173|591751419|FG000|Treatment Phase|Adverse Event|0|||
163831165|NCT00316173|591751420|FG001|Treatment Phase|Adverse Event|1|||
163831166|NCT00316173|591751419|FG000|Treatment Phase|Lack of Efficacy|0|||
163831167|NCT00316173|591751420|FG001|Treatment Phase|Lack of Efficacy|3|||
163831168|NCT00316173|591751419|FG000|Treatment Phase|Lost to Follow-up|0|||
163831169|NCT00316173|591751420|FG001|Treatment Phase|Lost to Follow-up|3|||
163831170|NCT00316173|591751419|FG000|Treatment Phase|Withdrawal by Subject|0|||
163831171|NCT00316173|591751420|FG001|Treatment Phase|Withdrawal by Subject|1|||
163831172|NCT00316173|591751419|FG000|Treatment Phase|Study Follow-up Stopped|0|||
163831173|NCT00316173|591751420|FG001|Treatment Phase|Study Follow-up Stopped|34|||
163831174|NCT02390531|591751421|FG000|Overall Study|Death|0|||
163831175|NCT02390531|591751422|FG001|Overall Study|Death|2|||
163831176|NCT02390531|591751423|FG002|Overall Study|Death|0|||
163831177|NCT02390531|591751424|FG003|Overall Study|Death|1|||
163831178|NCT02390531|591751425|FG004|Overall Study|Death|0|||
163831179|NCT02390531|591751426|FG005|Overall Study|Death|0|||
163831180|NCT02390531|591751427|FG006|Overall Study|Death|0|||
163831181|NCT02390531|591751428|FG007|Overall Study|Death|1|||
163831182|NCT02390531|591751421|FG000|Overall Study|Protocol Violation|0|||
163831183|NCT02390531|591751422|FG001|Overall Study|Protocol Violation|0|||
163831184|NCT02390531|591751423|FG002|Overall Study|Protocol Violation|0|||
163831185|NCT02390531|591751424|FG003|Overall Study|Protocol Violation|0|||
163831186|NCT02390531|591751425|FG004|Overall Study|Protocol Violation|1|||
163831187|NCT02390531|591751426|FG005|Overall Study|Protocol Violation|0|||
163831188|NCT02390531|591751427|FG006|Overall Study|Protocol Violation|2|||
163831189|NCT02390531|591751428|FG007|Overall Study|Protocol Violation|0|||
163831190|NCT03764072|591751432|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163831191|NCT03764072|591751433|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163831192|NCT03764072|591751434|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
163831193|NCT03764072|591751435|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163831194|NCT03764072|591751436|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163831195|NCT03764072|591751437|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
163831196|NCT03764072|591751432|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
163831197|NCT03764072|591751433|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
163831198|NCT03764072|591751434|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
163831199|NCT03764072|591751435|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
163831200|NCT03764072|591751436|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
163831201|NCT03764072|591751437|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
163831202|NCT03764072|591751432|FG000|Overall Study|Lost to Follow-up|0|||
163831203|NCT03764072|591751433|FG001|Overall Study|Lost to Follow-up|0|||
163831204|NCT03764072|591751434|FG002|Overall Study|Lost to Follow-up|0|||
163831205|NCT03764072|591751435|FG003|Overall Study|Lost to Follow-up|0|||
163831206|NCT03764072|591751436|FG004|Overall Study|Lost to Follow-up|1|||
163831207|NCT03764072|591751437|FG005|Overall Study|Lost to Follow-up|0|||
163831208|NCT03657277|591751438|FG000|Overall Study|Physician Decision|2|||
163831209|NCT03657277|591751438|FG000|Overall Study|Lost to Follow-up|1|||
163831210|NCT03657277|591751438|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
163831211|NCT01024608|591751441|FG000|Overall Study|Adverse Event|1|||
163831212|NCT01024608|591751442|FG001|Overall Study|Adverse Event|0|||
163831213|NCT01024608|591751441|FG000|Overall Study|Withdrawal by Subject|1|||
163831214|NCT01024608|591751442|FG001|Overall Study|Withdrawal by Subject|0|||
163831215|NCT01024608|591751441|FG000|Overall Study|Lost to Follow-up|0|||
163831216|NCT01024608|591751442|FG001|Overall Study|Lost to Follow-up|1|||
163831217|NCT01024608|591751441|FG000|Overall Study|Protocol Violation|0|||
163831218|NCT01024608|591751442|FG001|Overall Study|Protocol Violation|3|||
163831219|NCT01024608|591751441|FG000|Overall Study|Never received study treatment|2|||
163831220|NCT01024608|591751442|FG001|Overall Study|Never received study treatment|0|||
163831221|NCT04791761|591752668|FG000|Overall Study|Lost to Follow-up|8|||
163831222|NCT04791761|591752669|FG001|Overall Study|Lost to Follow-up|6|||
163831223|NCT04791761|591752670|FG002|Overall Study|Lost to Follow-up|10|||
163831224|NCT04791761|591752668|FG000|Overall Study|Withdrawal by Subject|0|||
163831225|NCT04791761|591752669|FG001|Overall Study|Withdrawal by Subject|1|||
163831226|NCT04791761|591752670|FG002|Overall Study|Withdrawal by Subject|1|||
163831227|NCT04791761|591752668|FG000|Overall Study|Protocol Violation|0|||
163831228|NCT04791761|591752669|FG001|Overall Study|Protocol Violation|1|||
163831229|NCT04791761|591752670|FG002|Overall Study|Protocol Violation|1|||
163831230|NCT04669600|591752671|FG000|Overall Study|Withdrawal by Subject|1|||
163831231|NCT04669600|591752671|FG000|Overall Study|Other|6|||
163831232|NCT00676130|591752678|FG000|Overall Study|Lost to Follow-up|0|||
163831233|NCT00676130|591752679|FG001|Overall Study|Lost to Follow-up|1|||
163926956|NCT01999972|592104340|FG005|Dose Expansion Part|Disease progression|3|||
163926957|NCT01999972|592104335|FG000|Dose Expansion Part|Sponsor decision|0|||
163926958|NCT01999972|592104336|FG001|Dose Expansion Part|Sponsor decision|0|||
164098022|NCT00050778|592725003|FG000|Overall Study|Death|0|||
164034826|NCT01998958|592486533|FG016|Open Label Phase (Optional)|Adverse Event|0|||
164034827|NCT01998958|592486534|FG017|Open Label Phase (Optional)|Adverse Event|0|||
164034828|NCT01998958|592486535|FG018|Open Label Phase (Optional)|Adverse Event|0|||
164034829|NCT01998958|592486536|FG019|Open Label Phase (Optional)|Adverse Event|0|||
164034830|NCT01998958|592486537|FG020|Open Label Phase (Optional)|Adverse Event|0|||
164034831|NCT01998958|592486538|FG021|Open Label Phase (Optional)|Adverse Event|0|||
164034832|NCT01998958|592486539|FG022|Open Label Phase (Optional)|Adverse Event|0|||
164034833|NCT01998958|592486540|FG023|Open Label Phase (Optional)|Adverse Event|1|||
164034834|NCT01998958|592486541|FG024|Open Label Phase (Optional)|Adverse Event|0|||
164034835|NCT01998958|592486542|FG025|Open Label Phase (Optional)|Adverse Event|0|||
164034836|NCT01998958|592486543|FG026|Open Label Phase (Optional)|Adverse Event|0|||
164034837|NCT01998958|592486544|FG027|Open Label Phase (Optional)|Adverse Event|0|||
164034838|NCT01998958|592486545|FG028|Open Label Phase (Optional)|Adverse Event|0|||
164034839|NCT01998958|592486546|FG029|Open Label Phase (Optional)|Adverse Event|0|||
164034840|NCT01998958|592486547|FG030|Open Label Phase (Optional)|Adverse Event|0|||
164034841|NCT01998958|592486548|FG031|Open Label Phase (Optional)|Adverse Event|0|||
164034842|NCT01998958|592486517|FG000|Open Label Phase (Optional)|Other|0|||
164034843|NCT01998958|592486518|FG001|Open Label Phase (Optional)|Other|0|||
164034844|NCT01998958|592486519|FG002|Open Label Phase (Optional)|Other|0|||
164034845|NCT01998958|592486520|FG003|Open Label Phase (Optional)|Other|0|||
164034846|NCT01998958|592486521|FG004|Open Label Phase (Optional)|Other|0|||
164034847|NCT01998958|592486522|FG005|Open Label Phase (Optional)|Other|0|||
164034848|NCT01998958|592486523|FG006|Open Label Phase (Optional)|Other|0|||
164034849|NCT01998958|592486524|FG007|Open Label Phase (Optional)|Other|0|||
164034850|NCT01998958|592486525|FG008|Open Label Phase (Optional)|Other|0|||
164034851|NCT01998958|592486526|FG009|Open Label Phase (Optional)|Other|0|||
164034852|NCT01998958|592486527|FG010|Open Label Phase (Optional)|Other|0|||
164034853|NCT01998958|592486528|FG011|Open Label Phase (Optional)|Other|0|||
164034854|NCT01998958|592486529|FG012|Open Label Phase (Optional)|Other|0|||
164034855|NCT01998958|592486530|FG013|Open Label Phase (Optional)|Other|0|||
164034856|NCT01998958|592486531|FG014|Open Label Phase (Optional)|Other|0|||
164034857|NCT01998958|592486532|FG015|Open Label Phase (Optional)|Other|0|||
164034858|NCT01998958|592486533|FG016|Open Label Phase (Optional)|Other|0|||
164034859|NCT01998958|592486534|FG017|Open Label Phase (Optional)|Other|0|||
164034860|NCT01998958|592486535|FG018|Open Label Phase (Optional)|Other|0|||
164034861|NCT01998958|592486536|FG019|Open Label Phase (Optional)|Other|0|||
164034862|NCT01998958|592486537|FG020|Open Label Phase (Optional)|Other|0|||
164034863|NCT01998958|592486538|FG021|Open Label Phase (Optional)|Other|0|||
164034864|NCT01998958|592486539|FG022|Open Label Phase (Optional)|Other|5|||
164034865|NCT01998958|592486540|FG023|Open Label Phase (Optional)|Other|1|||
164034866|NCT01998958|592486541|FG024|Open Label Phase (Optional)|Other|0|||
164034867|NCT01998958|592486542|FG025|Open Label Phase (Optional)|Other|0|||
164034868|NCT01998958|592486543|FG026|Open Label Phase (Optional)|Other|0|||
164034869|NCT01998958|592486544|FG027|Open Label Phase (Optional)|Other|0|||
164034870|NCT01998958|592486545|FG028|Open Label Phase (Optional)|Other|0|||
164034871|NCT01998958|592486546|FG029|Open Label Phase (Optional)|Other|0|||
163831234|NCT00676130|591752678|FG000|Overall Study|Found ineligible|3|||
163831235|NCT00676130|591752679|FG001|Overall Study|Found ineligible|2|||
163831236|NCT00676130|591752678|FG000|Overall Study|Withdrawal by Subject|0|||
163831237|NCT00676130|591752679|FG001|Overall Study|Withdrawal by Subject|1|||
163831238|NCT04857034|591752684|FG000|Placebo-Controlled Period|Request to discontinue|2|||
163831239|NCT04857034|591752685|FG001|Placebo-Controlled Period|Request to discontinue|2|||
163831240|NCT04857034|591752686|FG002|Placebo-Controlled Period|Request to discontinue|0|||
163831241|NCT04857034|591752687|FG003|Placebo-Controlled Period|Request to discontinue|0|||
163831242|NCT04857034|591752688|FG004|Placebo-Controlled Period|Request to discontinue|0|||
163831243|NCT04857034|591752684|FG000|Placebo-Controlled Period|withdrew consent|1|||
163831244|NCT04857034|591752685|FG001|Placebo-Controlled Period|withdrew consent|1|||
163831245|NCT04857034|591752686|FG002|Placebo-Controlled Period|withdrew consent|2|||
163831246|NCT04857034|591752687|FG003|Placebo-Controlled Period|withdrew consent|0|||
163831247|NCT04857034|591752688|FG004|Placebo-Controlled Period|withdrew consent|0|||
163831248|NCT04857034|591752684|FG000|Placebo-Controlled Period|Pregnancy|1|||
163831249|NCT04857034|591752685|FG001|Placebo-Controlled Period|Pregnancy|1|||
163831250|NCT04857034|591752686|FG002|Placebo-Controlled Period|Pregnancy|0|||
163831251|NCT04857034|591752687|FG003|Placebo-Controlled Period|Pregnancy|0|||
163831252|NCT04857034|591752688|FG004|Placebo-Controlled Period|Pregnancy|0|||
163831253|NCT04857034|591752684|FG000|Placebo-Controlled Period|Ongoing study period|0|||
163831254|NCT04857034|591752685|FG001|Placebo-Controlled Period|Ongoing study period|1|||
163831255|NCT04857034|591752686|FG002|Placebo-Controlled Period|Ongoing study period|0|||
163831256|NCT04857034|591752687|FG003|Placebo-Controlled Period|Ongoing study period|0|||
163831257|NCT04857034|591752688|FG004|Placebo-Controlled Period|Ongoing study period|0|||
163831258|NCT04857034|591752684|FG000|Active Treatment Period|Lack of Efficacy|1|||
163831259|NCT04857034|591752685|FG001|Active Treatment Period|Lack of Efficacy|0|||
163831260|NCT04857034|591752686|FG002|Active Treatment Period|Lack of Efficacy|0|||
163831261|NCT04857034|591752687|FG003|Active Treatment Period|Lack of Efficacy|0|||
163831262|NCT04857034|591752688|FG004|Active Treatment Period|Lack of Efficacy|0|||
163926959|NCT01999972|592104337|FG002|Dose Expansion Part|Sponsor decision|0|||
163926960|NCT01999972|592104338|FG003|Dose Expansion Part|Sponsor decision|0|||
163926961|NCT01999972|592104339|FG004|Dose Expansion Part|Sponsor decision|1|||
163926962|NCT01999972|592104340|FG005|Dose Expansion Part|Sponsor decision|0|||
163926963|NCT01999972|592104335|FG000|Dose Expansion Part|Adverse Event|0|||
163926964|NCT01999972|592104336|FG001|Dose Expansion Part|Adverse Event|0|||
163926965|NCT01999972|592104337|FG002|Dose Expansion Part|Adverse Event|0|||
163926966|NCT01999972|592104338|FG003|Dose Expansion Part|Adverse Event|0|||
163926967|NCT01999972|592104339|FG004|Dose Expansion Part|Adverse Event|4|||
163926968|NCT01999972|592104340|FG005|Dose Expansion Part|Adverse Event|2|||
163926969|NCT01999972|592104335|FG000|Dose Expansion Part|Participant's non-compliance|0|||
163926970|NCT01999972|592104336|FG001|Dose Expansion Part|Participant's non-compliance|0|||
163926971|NCT01999972|592104337|FG002|Dose Expansion Part|Participant's non-compliance|0|||
163926972|NCT01999972|592104338|FG003|Dose Expansion Part|Participant's non-compliance|0|||
163926973|NCT01999972|592104339|FG004|Dose Expansion Part|Participant's non-compliance|0|||
163926974|NCT01999972|592104340|FG005|Dose Expansion Part|Participant's non-compliance|1|||
163926975|NCT01999972|592104335|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
163926976|NCT01999972|592104336|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
163926977|NCT01999972|592104337|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
163926978|NCT01999972|592104338|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
164034872|NCT01998958|592486547|FG030|Open Label Phase (Optional)|Other|0|||
164034873|NCT01998958|592486548|FG031|Open Label Phase (Optional)|Other|0|||
164034874|NCT01998958|592486517|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034875|NCT01998958|592486518|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034876|NCT01998958|592486519|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034877|NCT01998958|592486520|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034878|NCT01998958|592486521|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034879|NCT01998958|592486522|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034880|NCT01998958|592486523|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034881|NCT01998958|592486524|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034882|NCT01998958|592486525|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034883|NCT01998958|592486526|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034884|NCT01998958|592486527|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034885|NCT01998958|592486528|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034886|NCT01998958|592486529|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034887|NCT01998958|592486530|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034888|NCT01998958|592486531|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034889|NCT01998958|592486532|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034890|NCT01998958|592486533|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034891|NCT01998958|592486534|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034892|NCT01998958|592486535|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034893|NCT01998958|592486536|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034894|NCT01998958|592486537|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034895|NCT01998958|592486538|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034896|NCT01998958|592486539|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
164034897|NCT01998958|592486540|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034898|NCT01998958|592486541|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034899|NCT01998958|592486542|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034900|NCT01998958|592486543|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034901|NCT01998958|592486544|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034902|NCT01998958|592486545|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034903|NCT01998958|592486546|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034904|NCT01998958|592486547|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034905|NCT01998958|592486548|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
164034906|NCT01998958|592486517|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034907|NCT01998958|592486518|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034908|NCT01998958|592486519|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034909|NCT01998958|592486520|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034910|NCT01998958|592486521|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034911|NCT01998958|592486522|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034912|NCT01998958|592486523|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034913|NCT01998958|592486524|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034914|NCT01998958|592486525|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034915|NCT01998958|592486526|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
163926979|NCT01999972|592104339|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
163926980|NCT01999972|592104340|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
163926981|NCT01999972|592104335|FG000|Dose Expansion Part|Changed to standard of care|0|||
163926982|NCT01999972|592104336|FG001|Dose Expansion Part|Changed to standard of care|0|||
163926983|NCT01999972|592104337|FG002|Dose Expansion Part|Changed to standard of care|0|||
163926984|NCT01999972|592104338|FG003|Dose Expansion Part|Changed to standard of care|0|||
163926985|NCT01999972|592104339|FG004|Dose Expansion Part|Changed to standard of care|1|||
163926986|NCT01999972|592104340|FG005|Dose Expansion Part|Changed to standard of care|0|||
163926987|NCT01171183|592104341|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
163926988|NCT01171183|592104342|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
163926989|NCT01171183|592104341|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
163926990|NCT01171183|592104342|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
163926991|NCT01171183|592104341|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
163926992|NCT01171183|592104342|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
163926993|NCT01171183|592104341|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
163926994|NCT01171183|592104342|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
163926995|NCT01171183|592104341|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
163926996|NCT01171183|592104342|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
163926997|NCT01171183|592104341|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
163926998|NCT01171183|592104342|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
163926999|NCT02826798|592104349|FG000|Overall Study|Withdrawal by Subject|0|||
163927000|NCT02826798|592104350|FG001|Overall Study|Withdrawal by Subject|1|||
163927001|NCT02826798|592104351|FG002|Overall Study|Withdrawal by Subject|0|||
163927002|NCT02826798|592104352|FG003|Overall Study|Withdrawal by Subject|1|||
163927003|NCT02826798|592104353|FG004|Overall Study|Withdrawal by Subject|0|||
163927004|NCT02806505|592104355|FG000|Overall Study|Adverse event/intercurrent illness|1|||
163927005|NCT02806505|592104356|FG001|Overall Study|Adverse event/intercurrent illness|3|||
163927006|NCT02806505|592104355|FG000|Overall Study|Death|4|||
163927007|NCT02806505|592104356|FG001|Overall Study|Death|0|||
163927008|NCT02806505|592104355|FG000|Overall Study|Did not cooperate/refused treatment|3|||
163927009|NCT02806505|592104356|FG001|Overall Study|Did not cooperate/refused treatment|3|||
163927010|NCT02806505|592104355|FG000|Overall Study|Failure to return|0|||
163927011|NCT02806505|592104356|FG001|Overall Study|Failure to return|1|||
163927012|NCT02806505|592104355|FG000|Overall Study|Insufficient therapeutic response|2|||
163927013|NCT02806505|592104356|FG001|Overall Study|Insufficient therapeutic response|4|||
163927014|NCT03440047|592104358|FG000|Overall Study|Withdrawal by Subject|2|||
163927015|NCT01722045|592104359|FG000|Overall Study|Adverse Event|8|||
163927016|NCT01722045|592104359|FG000|Overall Study|Death|3|||
163927017|NCT01722045|592104359|FG000|Overall Study|Withdrawal by Subject|8|||
163927018|NCT01722045|592104359|FG000|Overall Study|Lost to Follow-up|4|||
163927019|NCT01722045|592104359|FG000|Overall Study|Protocol Deviation|1|||
163927020|NCT01722045|592104359|FG000|Overall Study|Physician Decision|3|||
163927021|NCT01722045|592104359|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
163927022|NCT03898700|592104361|FG000|Overall Study|Withdrawal by Subject|2|||
163927023|NCT00701909|592104365|FG000|Overall Study|Withdrawal by Subject|0|||
163927024|NCT00701909|592104366|FG001|Overall Study|Withdrawal by Subject|1|||
163927025|NCT00971997|592104369|FG000|Overall Study|Adverse Event|2|||
163927026|NCT00971997|592104369|FG000|Overall Study|Death|1|||
163927027|NCT00971997|592104369|FG000|Overall Study|Protocol Violation|4|||
163927028|NCT00971997|592104369|FG000|Overall Study|Withdrawal by Subject|5|||
163927029|NCT00971997|592104369|FG000|Overall Study|Physician Decision|7|||
163927030|NCT04843579|592104373|FG000|Overall Study|Adverse Event|1|||
163927031|NCT04843579|592104373|FG000|Overall Study|Disease Progression|1|||
163927032|NCT04009629|592104374|FG000|Overall Study|Withdrawal by Subject|2|||
163927033|NCT04009629|592104375|FG001|Overall Study|Withdrawal by Subject|0|||
163927034|NCT00761956|592104380|FG000|Overall Study|Lost to Follow-up|6|||
163927035|NCT00761956|592104381|FG001|Overall Study|Lost to Follow-up|11|||
163927036|NCT00761956|592104380|FG000|Overall Study|Withdrawal by Subject|3|||
163927037|NCT00761956|592104381|FG001|Overall Study|Withdrawal by Subject|8|||
163927038|NCT00761956|592104380|FG000|Overall Study|Death|0|||
163927039|NCT00761956|592104381|FG001|Overall Study|Death|1|||
163927040|NCT00761956|592104380|FG000|Overall Study|Adverse Event|26|||
163927041|NCT00761956|592104381|FG001|Overall Study|Adverse Event|34|||
163927042|NCT04398368|592104384|FG000|Overall Study|Withdrawal by Subject|2|||
163927043|NCT03602586|592104385|FG000|Overall Study|Withdrawal by Subject|3|||
163927044|NCT01755546|592104388|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
164034916|NCT01998958|592486527|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034917|NCT01998958|592486528|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034918|NCT01998958|592486529|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034919|NCT01998958|592486530|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
163927045|NCT01755546|592104388|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
163927046|NCT01755546|592104388|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
163927047|NCT01755546|592104388|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
163927048|NCT01755546|592104388|FG000|Titration Phase|Adverse Event|11|||
163927049|NCT01755546|592104388|FG000|Titration Phase|Lack of Efficacy|18|||
163927050|NCT01755546|592104388|FG000|Titration Phase|Protocol Violation|9|||
164034920|NCT01998958|592486531|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034921|NCT01998958|592486532|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034922|NCT01998958|592486533|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034923|NCT01998958|592486534|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
163831263|NCT04857034|591752684|FG000|Active Treatment Period|request to discontinue|0|||
163831264|NCT04857034|591752685|FG001|Active Treatment Period|request to discontinue|1|||
163831265|NCT04857034|591752686|FG002|Active Treatment Period|request to discontinue|0|||
163831266|NCT04857034|591752687|FG003|Active Treatment Period|request to discontinue|1|||
163831267|NCT04857034|591752688|FG004|Active Treatment Period|request to discontinue|0|||
163831268|NCT04857034|591752684|FG000|Active Treatment Period|administrative reason by sponsor|1|||
163831269|NCT04857034|591752685|FG001|Active Treatment Period|administrative reason by sponsor|5|||
163831270|NCT04857034|591752686|FG002|Active Treatment Period|administrative reason by sponsor|0|||
163831271|NCT04857034|591752687|FG003|Active Treatment Period|administrative reason by sponsor|2|||
163831272|NCT04857034|591752688|FG004|Active Treatment Period|administrative reason by sponsor|2|||
163831273|NCT04857034|591752684|FG000|Active Treatment Period|other reasons|1|||
163831274|NCT04857034|591752685|FG001|Active Treatment Period|other reasons|1|||
163831275|NCT04857034|591752686|FG002|Active Treatment Period|other reasons|0|||
163831276|NCT04857034|591752687|FG003|Active Treatment Period|other reasons|0|||
163831277|NCT04857034|591752688|FG004|Active Treatment Period|other reasons|1|||
163831278|NCT04857034|591752684|FG000|Active Treatment Period|Ongoing Study Period|2|||
163831279|NCT04857034|591752685|FG001|Active Treatment Period|Ongoing Study Period|4|||
163831280|NCT04857034|591752686|FG002|Active Treatment Period|Ongoing Study Period|0|||
163831281|NCT04857034|591752687|FG003|Active Treatment Period|Ongoing Study Period|1|||
163831282|NCT04857034|591752688|FG004|Active Treatment Period|Ongoing Study Period|0|||
163831283|NCT00261495|591752693|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
163831284|NCT00261495|591752694|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
163831285|NCT00261495|591752693|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
163831286|NCT00261495|591752694|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
163831287|NCT00261495|591752693|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
163831288|NCT00261495|591752694|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
163831289|NCT00261495|591752693|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
163831290|NCT00261495|591752694|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
163831291|NCT00261495|591752693|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
163831292|NCT00261495|591752694|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
163831293|NCT00261495|591752693|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
163831294|NCT00261495|591752694|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
163831295|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
163831296|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
163831297|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
163831298|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
163831299|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
163831300|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
163831301|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
163831302|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
163831303|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
163831304|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
163831305|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
163831306|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
163831307|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
163831308|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
163831309|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
163831310|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
163831311|NCT00261495|591752693|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
163831312|NCT00261495|591752694|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
163831313|NCT00261495|591752693|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
163831314|NCT00261495|591752694|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
163831315|NCT00261495|591752693|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
163831316|NCT00261495|591752694|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
163831317|NCT00261495|591752693|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
163831318|NCT00261495|591752694|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
163831319|NCT00261495|591752693|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
163831320|NCT00261495|591752694|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
163831321|NCT00261495|591752693|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
163831322|NCT00261495|591752694|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
163831323|NCT00261495|591752693|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
163831324|NCT00261495|591752694|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
163831325|NCT01520402|591752699|FG000|Overall Study|Withdrawal by Subject|2|||
163831326|NCT01520402|591752699|FG000|Overall Study|Physician Decision|3|||
163831327|NCT02287584|591752700|FG000|the Double-blind Phase|Adverse Event|17|||
163831328|NCT02287584|591752701|FG001|the Double-blind Phase|Adverse Event|17|||
163831329|NCT02287584|591752702|FG002|the Double-blind Phase|Adverse Event|12|||
163831330|NCT02287584|591752703|FG003|the Double-blind Phase|Adverse Event|0|||
163831331|NCT02287584|591752704|FG004|the Double-blind Phase|Adverse Event|0|||
163927051|NCT01755546|592104388|FG000|Titration Phase|Lost to Follow-up|2|||
163927052|NCT01755546|592104388|FG000|Titration Phase|Other and Continuing|22|||
163927053|NCT01755546|592104388|FG000|Titration Phase|Withdrawal by Subject|8|||
163927054|NCT01755546|592104388|FG000|Long Term Treatment|Adverse Event|12|||
163927055|NCT01755546|592104388|FG000|Long Term Treatment|Lack of Efficacy|6|||
163927056|NCT01755546|592104388|FG000|Long Term Treatment|Protocol Violation|10|||
163927057|NCT01755546|592104388|FG000|Long Term Treatment|Withdrawal by Subject|35|||
163927058|NCT01755546|592104388|FG000|Long Term Treatment|Lost to Follow-up|17|||
163927059|NCT01755546|592104388|FG000|Long Term Treatment|other and ongoing|41|||
163927060|NCT04702893|592104389|FG000|Overall Study|Other reasons than listed|11|||
163927061|NCT04702893|592104389|FG000|Overall Study|Withdrawal by Subject|3|||
163927062|NCT04702893|592104389|FG000|Overall Study|Lost to Follow-up|7|||
163927063|NCT04702893|592104389|FG000|Overall Study|Death|10|||
163927064|NCT04702893|592104389|FG000|Overall Study|Not treated|6|||
163927065|NCT03294941|592104390|FG000|Overall Study|Withdrawal by Subject|0|||
163927066|NCT03294941|592104391|FG001|Overall Study|Withdrawal by Subject|2|||
163927067|NCT04629443|592104392|FG000|Overall Study|Adverse Event|2|||
163927068|NCT04629443|592104393|FG001|Overall Study|Adverse Event|1|||
163927069|NCT04629443|592104394|FG002|Overall Study|Adverse Event|2|||
163927070|NCT04629443|592104392|FG000|Overall Study|Progressive Disease|2|||
163927071|NCT04629443|592104393|FG001|Overall Study|Progressive Disease|3|||
163927072|NCT04629443|592104394|FG002|Overall Study|Progressive Disease|3|||
163927073|NCT04629443|592104392|FG000|Overall Study|Physician Decision|1|||
163927074|NCT04629443|592104393|FG001|Overall Study|Physician Decision|3|||
163927075|NCT04629443|592104394|FG002|Overall Study|Physician Decision|0|||
163927076|NCT01172639|592104398|FG000|Overall Study|Death|1|||
163927077|NCT01172639|592104399|FG001|Overall Study|Death|1|||
163927078|NCT01172639|592104400|FG002|Overall Study|Death|0|||
163927079|NCT01172639|592104401|FG003|Overall Study|Death|0|||
163927080|NCT01172639|592104402|FG004|Overall Study|Death|0|||
163927081|NCT01172639|592104398|FG000|Overall Study|Lost to Follow-up|9|||
163927082|NCT01172639|592104399|FG001|Overall Study|Lost to Follow-up|7|||
163927083|NCT01172639|592104400|FG002|Overall Study|Lost to Follow-up|11|||
163927084|NCT01172639|592104401|FG003|Overall Study|Lost to Follow-up|6|||
163927085|NCT01172639|592104402|FG004|Overall Study|Lost to Follow-up|6|||
163927086|NCT01172639|592104398|FG000|Overall Study|Withdrawal by Subject|3|||
163927087|NCT01172639|592104399|FG001|Overall Study|Withdrawal by Subject|3|||
163927088|NCT01172639|592104400|FG002|Overall Study|Withdrawal by Subject|5|||
163927089|NCT01172639|592104401|FG003|Overall Study|Withdrawal by Subject|5|||
163927090|NCT01172639|592104402|FG004|Overall Study|Withdrawal by Subject|0|||
163927091|NCT02172950|592104403|FG000|Overall Study|Physician Decision|3|||
163927092|NCT02172950|592104404|FG001|Overall Study|Physician Decision|3|||
163927093|NCT02172950|592104403|FG000|Overall Study|Lack of Efficacy|1|||
163927094|NCT02172950|592104404|FG001|Overall Study|Lack of Efficacy|0|||
163927095|NCT02172950|592104403|FG000|Overall Study|Adverse Event|4|||
163927096|NCT02172950|592104404|FG001|Overall Study|Adverse Event|1|||
163927097|NCT02172950|592104403|FG000|Overall Study|Withdrawal by Subject|10|||
163927098|NCT02172950|592104404|FG001|Overall Study|Withdrawal by Subject|0|||
163927099|NCT02172950|592104403|FG000|Overall Study|Protocol Violation|1|||
163927100|NCT02172950|592104404|FG001|Overall Study|Protocol Violation|0|||
163927101|NCT02172950|592104403|FG000|Overall Study|Lost to Follow-up|1|||
163927102|NCT02172950|592104404|FG001|Overall Study|Lost to Follow-up|0|||
163927103|NCT02172950|592104403|FG000|Overall Study|Death|1|||
163927104|NCT02172950|592104404|FG001|Overall Study|Death|0|||
163927105|NCT02172950|592104403|FG000|Overall Study|Patient traveling|1|||
163927106|NCT02172950|592104404|FG001|Overall Study|Patient traveling|0|||
163927107|NCT02172950|592104403|FG000|Overall Study|Patient went to other country|1|||
163927108|NCT02172950|592104404|FG001|Overall Study|Patient went to other country|0|||
163927109|NCT02172950|592104403|FG000|Overall Study|Patient relocated overseas|1|||
163927110|NCT02172950|592104404|FG001|Overall Study|Patient relocated overseas|1|||
163927111|NCT02172950|592104403|FG000|Overall Study|Patient moving|1|||
163927112|NCT02172950|592104404|FG001|Overall Study|Patient moving|0|||
163927113|NCT00469456|592104405|FG000|Overall Study|Adverse Event|4|||
163927114|NCT00469456|592104406|FG001|Overall Study|Adverse Event|3|||
163927115|NCT00469456|592104405|FG000|Overall Study|Protocol Violation|1|||
163927116|NCT00469456|592104406|FG001|Overall Study|Protocol Violation|0|||
163927117|NCT00469456|592104405|FG000|Overall Study|Withdrawal by Subject|4|||
163927118|NCT00469456|592104406|FG001|Overall Study|Withdrawal by Subject|1|||
163927119|NCT00704171|592104411|FG000|Overall Study|Withdrawal by Subject|1|||
163927120|NCT00704171|592104412|FG001|Overall Study|Withdrawal by Subject|0|||
163927121|NCT00813098|592104417|FG000|Overall Study|Adverse Event|2|||
163927122|NCT00813098|592104418|FG001|Overall Study|Adverse Event|4|||
163927123|NCT00813098|592104419|FG002|Overall Study|Adverse Event|1|||
163927124|NCT00813098|592104417|FG000|Overall Study|Withdrawal by Subject|0|||
163927125|NCT00813098|592104418|FG001|Overall Study|Withdrawal by Subject|1|||
164034924|NCT01998958|592486535|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034925|NCT01998958|592486536|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
163927126|NCT00813098|592104419|FG002|Overall Study|Withdrawal by Subject|0|||
163927127|NCT00813098|592104417|FG000|Overall Study|Inability to complete study procedures|1|||
163927128|NCT00813098|592104418|FG001|Overall Study|Inability to complete study procedures|0|||
163927129|NCT00813098|592104419|FG002|Overall Study|Inability to complete study procedures|0|||
163927130|NCT00813098|592104417|FG000|Overall Study|Lost to Follow-up|0|||
163927131|NCT00813098|592104418|FG001|Overall Study|Lost to Follow-up|1|||
163927132|NCT00813098|592104419|FG002|Overall Study|Lost to Follow-up|0|||
163927133|NCT00813098|592104417|FG000|Overall Study|Protocol Violation|0|||
163927134|NCT00813098|592104418|FG001|Overall Study|Protocol Violation|0|||
163927135|NCT00813098|592104419|FG002|Overall Study|Protocol Violation|1|||
163927136|NCT00813098|592104417|FG000|Overall Study|Principal Investigator decision|0|||
163927137|NCT00813098|592104418|FG001|Overall Study|Principal Investigator decision|1|||
163927138|NCT00813098|592104419|FG002|Overall Study|Principal Investigator decision|0|||
163927139|NCT00813098|592104417|FG000|Overall Study|Withdrew Consent|0|||
163927140|NCT00813098|592104418|FG001|Overall Study|Withdrew Consent|1|||
163927141|NCT00813098|592104419|FG002|Overall Study|Withdrew Consent|0|||
163927142|NCT01086384|592104424|FG000|2-week Run-in Period|Adverse Event|1|||
163927143|NCT01086384|592104425|FG001|2-week Run-in Period|Adverse Event|0|||
163927144|NCT01086384|592104426|FG002|2-week Run-in Period|Adverse Event|0|||
163927145|NCT01086384|592104424|FG000|2-week Run-in Period|Protocol Violation|1|||
163927146|NCT01086384|592104425|FG001|2-week Run-in Period|Protocol Violation|0|||
163927147|NCT01086384|592104426|FG002|2-week Run-in Period|Protocol Violation|0|||
163927148|NCT01086384|592104424|FG000|2-week Run-in Period|Lost to Follow-up|1|||
163927149|NCT01086384|592104425|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163927150|NCT01086384|592104426|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163927151|NCT01086384|592104424|FG000|2-week Run-in Period|Physician Decision|6|||
163927152|NCT01086384|592104425|FG001|2-week Run-in Period|Physician Decision|0|||
163927153|NCT01086384|592104426|FG002|2-week Run-in Period|Physician Decision|0|||
163927154|NCT01086384|592104424|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
163927155|NCT01086384|592104425|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163927156|NCT01086384|592104426|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163927157|NCT01086384|592104424|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
164034926|NCT01998958|592486537|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034927|NCT01998958|592486538|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
164034928|NCT01998958|592486539|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
164034929|NCT01998958|592486540|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034930|NCT01998958|592486541|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034931|NCT01998958|592486542|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
163831332|NCT02287584|591752705|FG005|the Double-blind Phase|Adverse Event|0|||
163831333|NCT02287584|591752700|FG000|the Double-blind Phase|Lack of Efficacy|18|||
163831334|NCT02287584|591752701|FG001|the Double-blind Phase|Lack of Efficacy|8|||
163831335|NCT02287584|591752702|FG002|the Double-blind Phase|Lack of Efficacy|8|||
163831336|NCT02287584|591752703|FG003|the Double-blind Phase|Lack of Efficacy|0|||
163831337|NCT02287584|591752704|FG004|the Double-blind Phase|Lack of Efficacy|0|||
163831338|NCT02287584|591752705|FG005|the Double-blind Phase|Lack of Efficacy|0|||
163831339|NCT02287584|591752700|FG000|the Double-blind Phase|Lost to Follow-up|0|||
163831340|NCT02287584|591752701|FG001|the Double-blind Phase|Lost to Follow-up|1|||
163831341|NCT02287584|591752702|FG002|the Double-blind Phase|Lost to Follow-up|1|||
163831342|NCT02287584|591752703|FG003|the Double-blind Phase|Lost to Follow-up|0|||
163831343|NCT02287584|591752704|FG004|the Double-blind Phase|Lost to Follow-up|0|||
163831344|NCT02287584|591752705|FG005|the Double-blind Phase|Lost to Follow-up|0|||
163831345|NCT02287584|591752700|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
163831346|NCT02287584|591752701|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
163831347|NCT02287584|591752702|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
163831348|NCT02287584|591752703|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
163831349|NCT02287584|591752704|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
163831350|NCT02287584|591752705|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
163831351|NCT02287584|591752700|FG000|the Double-blind Phase|Pregnancy|0|||
163831352|NCT02287584|591752701|FG001|the Double-blind Phase|Pregnancy|1|||
163831353|NCT02287584|591752702|FG002|the Double-blind Phase|Pregnancy|0|||
163831354|NCT02287584|591752703|FG003|the Double-blind Phase|Pregnancy|0|||
163831355|NCT02287584|591752704|FG004|the Double-blind Phase|Pregnancy|0|||
163831356|NCT02287584|591752705|FG005|the Double-blind Phase|Pregnancy|0|||
163831357|NCT02287584|591752700|FG000|the Double-blind Phase|Protocol Violation|0|||
163831358|NCT02287584|591752701|FG001|the Double-blind Phase|Protocol Violation|3|||
163831359|NCT02287584|591752702|FG002|the Double-blind Phase|Protocol Violation|0|||
163927158|NCT01086384|592104425|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
163927159|NCT01086384|592104426|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
164034932|NCT01998958|592486543|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
163831360|NCT02287584|591752703|FG003|the Double-blind Phase|Protocol Violation|0|||
163831361|NCT02287584|591752704|FG004|the Double-blind Phase|Protocol Violation|0|||
163927160|NCT01086384|592104424|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
164034933|NCT01998958|592486544|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
163831362|NCT02287584|591752705|FG005|the Double-blind Phase|Protocol Violation|0|||
163831363|NCT02287584|591752700|FG000|the Double-blind Phase|other reasons|0|||
163831364|NCT02287584|591752701|FG001|the Double-blind Phase|other reasons|0|||
163831365|NCT02287584|591752702|FG002|the Double-blind Phase|other reasons|1|||
163831366|NCT02287584|591752703|FG003|the Double-blind Phase|other reasons|0|||
163831367|NCT02287584|591752704|FG004|the Double-blind Phase|other reasons|0|||
163831368|NCT02287584|591752705|FG005|the Double-blind Phase|other reasons|0|||
163831369|NCT02287584|591752700|FG000|the Open-label Phase|Did not receive drug|0|||
163831370|NCT02287584|591752701|FG001|the Open-label Phase|Did not receive drug|0|||
163831371|NCT02287584|591752702|FG002|the Open-label Phase|Did not receive drug|0|||
163831372|NCT02287584|591752703|FG003|the Open-label Phase|Did not receive drug|7|||
163831373|NCT02287584|591752704|FG004|the Open-label Phase|Did not receive drug|6|||
163831374|NCT02287584|591752705|FG005|the Open-label Phase|Did not receive drug|4|||
163831375|NCT02287584|591752700|FG000|the Open-label Phase|Adverse Event|0|||
163831376|NCT02287584|591752701|FG001|the Open-label Phase|Adverse Event|0|||
163831377|NCT02287584|591752702|FG002|the Open-label Phase|Adverse Event|0|||
163831378|NCT02287584|591752703|FG003|the Open-label Phase|Adverse Event|15|||
163831379|NCT02287584|591752704|FG004|the Open-label Phase|Adverse Event|12|||
163831380|NCT02287584|591752705|FG005|the Open-label Phase|Adverse Event|16|||
163831381|NCT02287584|591752700|FG000|the Open-label Phase|Lack of Efficacy|0|||
163831382|NCT02287584|591752701|FG001|the Open-label Phase|Lack of Efficacy|0|||
163831383|NCT02287584|591752702|FG002|the Open-label Phase|Lack of Efficacy|0|||
163831384|NCT02287584|591752703|FG003|the Open-label Phase|Lack of Efficacy|8|||
163831385|NCT02287584|591752704|FG004|the Open-label Phase|Lack of Efficacy|3|||
163831386|NCT02287584|591752705|FG005|the Open-label Phase|Lack of Efficacy|7|||
163831387|NCT02287584|591752700|FG000|the Open-label Phase|Lost to Follow-up|0|||
163831388|NCT02287584|591752701|FG001|the Open-label Phase|Lost to Follow-up|0|||
163831389|NCT02287584|591752702|FG002|the Open-label Phase|Lost to Follow-up|0|||
163927161|NCT01086384|592104425|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
163927162|NCT01086384|592104426|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
163927163|NCT01086384|592104424|FG000|2-week Run-in Period|Randomized in Error|1|||
163927164|NCT01086384|592104425|FG001|2-week Run-in Period|Randomized in Error|0|||
163927165|NCT01086384|592104426|FG002|2-week Run-in Period|Randomized in Error|0|||
163927166|NCT01086384|592104424|FG000|Treatment Period|Withdrawal by Subject|0|||
163927167|NCT01086384|592104425|FG001|Treatment Period|Withdrawal by Subject|53|||
163927168|NCT01086384|592104426|FG002|Treatment Period|Withdrawal by Subject|55|||
163927169|NCT01086384|592104424|FG000|Treatment Period|Protocol Violation|0|||
163927170|NCT01086384|592104425|FG001|Treatment Period|Protocol Violation|26|||
163927171|NCT01086384|592104426|FG002|Treatment Period|Protocol Violation|17|||
163831390|NCT02287584|591752703|FG003|the Open-label Phase|Lost to Follow-up|4|||
163831391|NCT02287584|591752704|FG004|the Open-label Phase|Lost to Follow-up|1|||
163831392|NCT02287584|591752705|FG005|the Open-label Phase|Lost to Follow-up|2|||
163831393|NCT02287584|591752700|FG000|the Open-label Phase|Withdrawal by Subject|0|||
163831394|NCT02287584|591752701|FG001|the Open-label Phase|Withdrawal by Subject|0|||
163831395|NCT02287584|591752702|FG002|the Open-label Phase|Withdrawal by Subject|0|||
163927172|NCT01086384|592104424|FG000|Treatment Period|Lack of Efficacy|0|||
163927173|NCT01086384|592104425|FG001|Treatment Period|Lack of Efficacy|22|||
163927174|NCT01086384|592104426|FG002|Treatment Period|Lack of Efficacy|13|||
163927175|NCT01086384|592104424|FG000|Treatment Period|Adverse Event|0|||
163927176|NCT01086384|592104425|FG001|Treatment Period|Adverse Event|19|||
163927177|NCT01086384|592104426|FG002|Treatment Period|Adverse Event|15|||
163927178|NCT01086384|592104424|FG000|Treatment Period|Lost to Follow-up|0|||
163927179|NCT01086384|592104425|FG001|Treatment Period|Lost to Follow-up|11|||
163927180|NCT01086384|592104426|FG002|Treatment Period|Lost to Follow-up|9|||
163927181|NCT01086384|592104424|FG000|Treatment Period|Physician Decision|0|||
163927182|NCT01086384|592104425|FG001|Treatment Period|Physician Decision|9|||
163927183|NCT01086384|592104426|FG002|Treatment Period|Physician Decision|6|||
163927184|NCT01086384|592104424|FG000|Treatment Period|Study Closed/Terminated|0|||
163927185|NCT01086384|592104425|FG001|Treatment Period|Study Closed/Terminated|7|||
163927186|NCT01086384|592104426|FG002|Treatment Period|Study Closed/Terminated|8|||
163927187|NCT01086384|592104424|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
163927188|NCT01086384|592104425|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
164034934|NCT01998958|592486545|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034935|NCT01998958|592486546|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
164034936|NCT01998958|592486547|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
163831396|NCT02287584|591752703|FG003|the Open-label Phase|Withdrawal by Subject|18|||
163927189|NCT01086384|592104426|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
163927190|NCT01086384|592104424|FG000|Treatment Period|Received Treatment in Error|0|||
163927191|NCT01086384|592104425|FG001|Treatment Period|Received Treatment in Error|1|||
163927192|NCT01086384|592104426|FG002|Treatment Period|Received Treatment in Error|0|||
163831397|NCT02287584|591752704|FG004|the Open-label Phase|Withdrawal by Subject|29|||
163831398|NCT02287584|591752705|FG005|the Open-label Phase|Withdrawal by Subject|21|||
163831399|NCT02287584|591752700|FG000|the Open-label Phase|non-compliance|0|||
163831400|NCT02287584|591752701|FG001|the Open-label Phase|non-compliance|0|||
163831401|NCT02287584|591752702|FG002|the Open-label Phase|non-compliance|0|||
163927193|NCT02586415|592104429|FG000|Overall Study|Death|13|||
163927194|NCT02586415|592104430|FG001|Overall Study|Death|23|||
163927195|NCT02586415|592104429|FG000|Overall Study|Lost to Follow-up|1|||
163927196|NCT02586415|592104430|FG001|Overall Study|Lost to Follow-up|2|||
163927197|NCT00263575|592104436|FG000|Titration Period|Adverse Event|14|||
163927198|NCT00263575|592104436|FG000|Titration Period|Withdrawal by Subject|10|||
163927199|NCT00263575|592104436|FG000|Titration Period|Protocol Violation|9|||
163927200|NCT00263575|592104436|FG000|Titration Period|Sponsor Decision|2|||
163927201|NCT00263575|592104436|FG000|Titration Period|Other|2|||
163927202|NCT00263575|592104436|FG000|Titration Period|Lack of Efficacy|6|||
163927203|NCT00263575|592104436|FG000|Maintence Period|Adverse Event|23|||
163927204|NCT00263575|592104436|FG000|Maintence Period|Withdrawal by Subject|8|||
163927205|NCT00263575|592104436|FG000|Maintence Period|Protocol Violation|4|||
163927206|NCT00263575|592104436|FG000|Maintence Period|Lack of Efficacy|4|||
163927207|NCT00263575|592104436|FG000|Maintence Period|Physician Decision|6|||
163927208|NCT00263575|592104436|FG000|Maintence Period|Lost to Follow-up|1|||
163927209|NCT00263575|592104436|FG000|Maintence Period|Sponsor Decision|24|||
163927210|NCT00263575|592104436|FG000|Maintence Period|Other|7|||
163927211|NCT01841112|592104438|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
163927212|NCT01841112|592104439|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
163927213|NCT01841112|592104440|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
163927214|NCT01841112|592104441|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
163927215|NCT01841112|592104442|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
163927216|NCT01209286|592104447|FG000|Overall Study|Adverse Event|4|||
163927217|NCT01209286|592104448|FG001|Overall Study|Adverse Event|3|||
163927218|NCT01209286|592104449|FG002|Overall Study|Adverse Event|1|||
163927219|NCT01209286|592104447|FG000|Overall Study|Hematological Relapse After Remission|0|||
163927220|NCT01209286|592104448|FG001|Overall Study|Hematological Relapse After Remission|1|||
163927221|NCT01209286|592104449|FG002|Overall Study|Hematological Relapse After Remission|1|||
163927222|NCT01209286|592104447|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
163927223|NCT01209286|592104448|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
163927224|NCT01209286|592104449|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
163927225|NCT01209286|592104447|FG000|Overall Study|Physician Decision|0|||
163927226|NCT01209286|592104448|FG001|Overall Study|Physician Decision|2|||
163927227|NCT01209286|592104449|FG002|Overall Study|Physician Decision|0|||
163927228|NCT01209286|592104447|FG000|Overall Study|Other|0|||
163927229|NCT01209286|592104448|FG001|Overall Study|Other|1|||
163927230|NCT01209286|592104449|FG002|Overall Study|Other|0|||
163927231|NCT01891890|592104450|FG000|Overall Study|Lost to Follow-up|0|||
163927232|NCT01891890|592104451|FG001|Overall Study|Lost to Follow-up|0|||
163927233|NCT01891890|592104452|FG002|Overall Study|Lost to Follow-up|1|||
163927234|NCT01891890|592104450|FG000|Overall Study|Study ended before endpoint reached|7|||
163927235|NCT01891890|592104451|FG001|Overall Study|Study ended before endpoint reached|3|||
163927236|NCT01891890|592104452|FG002|Overall Study|Study ended before endpoint reached|6|||
163927237|NCT03029819|592104453|FG000|Overall Study|Lost to Follow-up|3|||
163831402|NCT02287584|591752703|FG003|the Open-label Phase|non-compliance|2|||
163831403|NCT02287584|591752704|FG004|the Open-label Phase|non-compliance|5|||
163831404|NCT02287584|591752705|FG005|the Open-label Phase|non-compliance|1|||
163831405|NCT02287584|591752700|FG000|the Open-label Phase|other reasons|0|||
163831406|NCT02287584|591752701|FG001|the Open-label Phase|other reasons|0|||
163831407|NCT02287584|591752702|FG002|the Open-label Phase|other reasons|0|||
163831408|NCT02287584|591752703|FG003|the Open-label Phase|other reasons|3|||
163831409|NCT02287584|591752704|FG004|the Open-label Phase|other reasons|6|||
163831410|NCT02287584|591752705|FG005|the Open-label Phase|other reasons|6|||
163831411|NCT01722162|591752711|FG000|Overall Study|Withdrawal by Subject|1|||
163927238|NCT03029819|592104454|FG001|Overall Study|Lost to Follow-up|5|||
163927239|NCT03029819|592104453|FG000|Overall Study|Removed due to disruptive behavior|0|||
163927240|NCT03029819|592104454|FG001|Overall Study|Removed due to disruptive behavior|1|||
164034937|NCT01998958|592486548|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
163831412|NCT01722162|591752712|FG001|Overall Study|Withdrawal by Subject|1|||
163831413|NCT01722162|591752711|FG000|Overall Study|Found ineligible|1|||
163831414|NCT01722162|591752712|FG001|Overall Study|Found ineligible|0|||
163831415|NCT01722162|591752711|FG000|Overall Study|Unrelated to study adverse event|2|||
163831416|NCT01722162|591752712|FG001|Overall Study|Unrelated to study adverse event|2|||
163831417|NCT01722162|591752711|FG000|Overall Study|Adverse Event|1|||
163831418|NCT01722162|591752712|FG001|Overall Study|Adverse Event|1|||
163927241|NCT03605368|592104456|FG000|Overall Study|Lost to Follow-up|2|||
163927242|NCT03605368|592104457|FG001|Overall Study|Lost to Follow-up|1|||
163927243|NCT03605368|592104458|FG002|Overall Study|Lost to Follow-up|3|||
164034938|NCT01998958|592486517|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034939|NCT01998958|592486518|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163831419|NCT01722162|591752711|FG000|Overall Study|Insurance denial post enrollment|0|||
163831420|NCT01722162|591752712|FG001|Overall Study|Insurance denial post enrollment|1|||
163831421|NCT01722162|591752711|FG000|Overall Study|Noncompliance|0|||
163927244|NCT03605368|592104459|FG003|Overall Study|Lost to Follow-up|2|||
163927245|NCT03605368|592104456|FG000|Overall Study|Withdrawal by Subject|0|||
163927246|NCT03605368|592104457|FG001|Overall Study|Withdrawal by Subject|0|||
163927247|NCT03605368|592104458|FG002|Overall Study|Withdrawal by Subject|4|||
163927248|NCT03605368|592104459|FG003|Overall Study|Withdrawal by Subject|3|||
163927249|NCT02881047|592104464|FG000|Overall Study|Adverse Event|1|||
163927250|NCT02881047|592104464|FG000|Overall Study|Withdrawal by Subject|1|||
163927251|NCT01329419|592104470|FG000|Overall Study|Protocol Violation|235|||
163927252|NCT00514813|592104475|FG000|Overall Study|Study terminated|14|||
163927253|NCT00514813|592104476|FG001|Overall Study|Study terminated|74|||
163927254|NCT00514813|592104477|FG002|Overall Study|Study terminated|40|||
163831422|NCT01722162|591752712|FG001|Overall Study|Noncompliance|1|||
163831423|NCT03086018|591752713|FG000|Final Testing for End of Trial|Adverse Event|1|||
163831424|NCT03086018|591752713|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
163831425|NCT01538472|591752714|FG000|Overall Study|Disease Progression|3|||
163831426|NCT01538472|591752714|FG000|Overall Study|Death|1|||
163831427|NCT01892345|591752715|FG000|Overall Study|Adverse Event|0|||
163831428|NCT01892345|591752716|FG001|Overall Study|Adverse Event|2|||
163831429|NCT01892345|591752715|FG000|Overall Study|Death|1|||
163831430|NCT01892345|591752716|FG001|Overall Study|Death|0|||
163831431|NCT01892345|591752715|FG000|Overall Study|Lost to Follow-up|3|||
163831432|NCT01892345|591752716|FG001|Overall Study|Lost to Follow-up|0|||
163831433|NCT01892345|591752715|FG000|Overall Study|Withdrawal by Subject|12|||
163831434|NCT01892345|591752716|FG001|Overall Study|Withdrawal by Subject|1|||
163831435|NCT00659984|591752717|FG000|Overall Study|Adverse Event|1|||
163831436|NCT02133872|591752718|FG000|Overall Study|Withdrawal by Subject|5|||
163831437|NCT02133872|591752719|FG001|Overall Study|Withdrawal by Subject|3|||
163831438|NCT02133872|591752720|FG002|Overall Study|Withdrawal by Subject|0|||
163831439|NCT02923739|591752721|FG000|Overall Study|Withdrawal by Subject|2|||
163831440|NCT02923739|591752722|FG001|Overall Study|Withdrawal by Subject|0|||
163831441|NCT02923739|591752723|FG002|Overall Study|Withdrawal by Subject|0|||
163831442|NCT02923739|591752724|FG003|Overall Study|Withdrawal by Subject|0|||
163831443|NCT02923739|591752721|FG000|Overall Study|Failed Screening|3|||
163831444|NCT02923739|591752722|FG001|Overall Study|Failed Screening|0|||
163831445|NCT02923739|591752723|FG002|Overall Study|Failed Screening|0|||
163831446|NCT02923739|591752724|FG003|Overall Study|Failed Screening|0|||
163831447|NCT00948974|591752729|FG000|Overall Study|Lost to Follow-up|23|||
163831448|NCT00948974|591752730|FG001|Overall Study|Lost to Follow-up|20|||
163831449|NCT02487810|591752731|FG000|Overall Study|Withdrawal by Subject|1|||
163831450|NCT02487810|591752732|FG001|Overall Study|Withdrawal by Subject|0|||
163831451|NCT01972529|591752733|FG000|Overall Study|Adverse Event|0|||
163831452|NCT01972529|591752734|FG001|Overall Study|Adverse Event|1|||
163831453|NCT01972529|591752735|FG002|Overall Study|Adverse Event|0|||
163831454|NCT01972529|591752736|FG003|Overall Study|Adverse Event|0|||
163831455|NCT01972529|591752733|FG000|Overall Study|Lost to Follow-up|1|||
163831456|NCT01972529|591752734|FG001|Overall Study|Lost to Follow-up|0|||
163831457|NCT01972529|591752735|FG002|Overall Study|Lost to Follow-up|0|||
163831458|NCT01972529|591752736|FG003|Overall Study|Lost to Follow-up|0|||
163831459|NCT01972529|591752733|FG000|Overall Study|Participant Choice|0|||
163831460|NCT01972529|591752734|FG001|Overall Study|Participant Choice|1|||
163831461|NCT01972529|591752735|FG002|Overall Study|Participant Choice|0|||
163831462|NCT01972529|591752736|FG003|Overall Study|Participant Choice|0|||
163831463|NCT01972529|591752733|FG000|Overall Study|Withdrawl of Consent|1|||
163831464|NCT01972529|591752734|FG001|Overall Study|Withdrawl of Consent|2|||
163831465|NCT01972529|591752735|FG002|Overall Study|Withdrawl of Consent|0|||
163831466|NCT01972529|591752736|FG003|Overall Study|Withdrawl of Consent|1|||
163831467|NCT01972529|591752733|FG000|Overall Study|Other|0|||
163831468|NCT01972529|591752734|FG001|Overall Study|Other|0|||
163831469|NCT01972529|591752735|FG002|Overall Study|Other|0|||
163831470|NCT01972529|591752736|FG003|Overall Study|Other|2|||
163831471|NCT01972529|591752733|FG000|Overall Study|Not treated|0|||
163831472|NCT01972529|591752734|FG001|Overall Study|Not treated|1|||
163831473|NCT01972529|591752735|FG002|Overall Study|Not treated|2|||
163831474|NCT01972529|591752736|FG003|Overall Study|Not treated|1|||
163831475|NCT01889186|591752737|FG000|Overall Study|Adverse event- not related to progression|18|||
163831476|NCT01889186|591752738|FG001|Overall Study|Adverse event- not related to progression|5|||
163831477|NCT01889186|591752737|FG000|Overall Study|Adverse event- related to progression|7|||
163831478|NCT01889186|591752738|FG001|Overall Study|Adverse event- related to progression|2|||
163831479|NCT01889186|591752737|FG000|Overall Study|COVID-19 logistical restrictions|1|||
163831480|NCT01889186|591752738|FG001|Overall Study|COVID-19 logistical restrictions|0|||
163831481|NCT01889186|591752737|FG000|Overall Study|Investigator request|1|||
163831482|NCT01889186|591752738|FG001|Overall Study|Investigator request|1|||
163831483|NCT01889186|591752737|FG000|Overall Study|Progressive disease- Richter's|12|||
163831484|NCT01889186|591752738|FG001|Overall Study|Progressive disease- Richter's|7|||
163831485|NCT01889186|591752737|FG000|Overall Study|Progressive disease per protocol|46|||
163831486|NCT01889186|591752738|FG001|Overall Study|Progressive disease per protocol|17|||
163831487|NCT01889186|591752737|FG000|Overall Study|Stem cell transplant|2|||
163831488|NCT01889186|591752738|FG001|Overall Study|Stem cell transplant|1|||
163831489|NCT01889186|591752737|FG000|Overall Study|Withdrew consent|2|||
163831490|NCT01889186|591752738|FG001|Overall Study|Withdrew consent|3|||
163831491|NCT01889186|591752737|FG000|Overall Study|Other, not specified|18|||
163831492|NCT01889186|591752738|FG001|Overall Study|Other, not specified|15|||
163831493|NCT00118716|591752742|FG000|Overall Study|Adverse Event|2|||
163831494|NCT00118716|591752743|FG001|Overall Study|Adverse Event|7|||
163831495|NCT00118716|591752742|FG000|Overall Study|Protocol Violation|5|||
163831496|NCT00118716|591752743|FG001|Overall Study|Protocol Violation|4|||
163831497|NCT00118716|591752742|FG000|Overall Study|Withdrawal by Subject|0|||
163831498|NCT00118716|591752743|FG001|Overall Study|Withdrawal by Subject|1|||
163831499|NCT00118716|591752742|FG000|Overall Study|Exacerbation|2|||
163831500|NCT00118716|591752743|FG001|Overall Study|Exacerbation|2|||
163831501|NCT00118716|591752742|FG000|Overall Study|Discontinued by sponsor|1|||
163831502|NCT00118716|591752743|FG001|Overall Study|Discontinued by sponsor|1|||
163831503|NCT00118716|591752742|FG000|Overall Study|Non-compliance|1|||
163831504|NCT00118716|591752743|FG001|Overall Study|Non-compliance|3|||
163831505|NCT00118716|591752742|FG000|Overall Study|misrandomized|1|||
163831506|NCT00118716|591752743|FG001|Overall Study|misrandomized|1|||
163831507|NCT00118716|591752742|FG000|Overall Study|Expired drug use|1|||
163831508|NCT00118716|591752743|FG001|Overall Study|Expired drug use|2|||
163831509|NCT00118716|591752742|FG000|Overall Study|Investigator discretion|0|||
163831510|NCT00118716|591752743|FG001|Overall Study|Investigator discretion|1|||
163831511|NCT00621543|591752744|FG000|Overall Study|Lost to Follow-up|23|||
163831512|NCT00855062|591752745|FG000|Step1|Early Study Closure|5|||
163831513|NCT00855062|591752746|FG001|Step1|Early Study Closure|7|||
163831514|NCT00855062|591752745|FG000|Step1|Adverse Event|1|||
163831515|NCT00855062|591752746|FG001|Step1|Adverse Event|1|||
163831516|NCT00855062|591752745|FG000|Step1|Protocol Violation|1|||
163831517|NCT00855062|591752746|FG001|Step1|Protocol Violation|0|||
163831518|NCT00855062|591752745|FG000|Step1|Pregnancy|1|||
163831519|NCT00855062|591752746|FG001|Step1|Pregnancy|0|||
163831520|NCT00855062|591752745|FG000|Step1|Withdrawal by Subject|2|||
163831521|NCT00855062|591752746|FG001|Step1|Withdrawal by Subject|3|||
163831522|NCT00855062|591752745|FG000|Step2|Early Study Closure|6|||
163831523|NCT00855062|591752746|FG001|Step2|Early Study Closure|2|||
163831524|NCT00855062|591752745|FG000|Step2|Adverse Event|0|||
163831525|NCT00855062|591752746|FG001|Step2|Adverse Event|3|||
163831526|NCT00855062|591752745|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
163831527|NCT00855062|591752746|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
163831528|NCT03745222|591752747|FG000|Overall Study|Withdrawal by Subject|0|||
163831529|NCT03745222|591752748|FG001|Overall Study|Withdrawal by Subject|1|||
163831530|NCT03745222|591752749|FG002|Overall Study|Withdrawal by Subject|0|||
163831531|NCT02657317|591752750|FG000|Overall Study|Withdrawal by Subject|2|||
163831532|NCT02657317|591752751|FG001|Overall Study|Withdrawal by Subject|0|||
163831533|NCT02657317|591752750|FG000|Overall Study|Lost to Follow-up|3|||
163831534|NCT02657317|591752751|FG001|Overall Study|Lost to Follow-up|3|||
163831535|NCT02755597|591752752|FG000|Overall Study|Withdrew consent|27|||
163831536|NCT02755597|591752753|FG001|Overall Study|Withdrew consent|11|||
163831537|NCT02755597|591752752|FG000|Overall Study|Lost to Follow-up|1|||
163831538|NCT02755597|591752753|FG001|Overall Study|Lost to Follow-up|0|||
163831539|NCT02755597|591752752|FG000|Overall Study|Death|78|||
163831540|NCT02755597|591752753|FG001|Overall Study|Death|36|||
163831541|NCT02755597|591752752|FG000|Overall Study|Study terminated by Sponsor|67|||
163831542|NCT02755597|591752753|FG001|Overall Study|Study terminated by Sponsor|47|||
163831543|NCT02755597|591752752|FG000|Overall Study|Other, not specified|20|||
163831544|NCT02755597|591752753|FG001|Overall Study|Other, not specified|3|||
163831545|NCT02755597|591752752|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
163831546|NCT02755597|591752753|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
163831547|NCT04252742|591752755|FG000|Overall Study|Decision by sponsor|0|||
163831548|NCT04252742|591752756|FG001|Overall Study|Decision by sponsor|2|||
163831549|NCT04252742|591752755|FG000|Overall Study|Withdrawal by Subject|15|||
163831550|NCT04252742|591752756|FG001|Overall Study|Withdrawal by Subject|9|||
163831551|NCT04252742|591752755|FG000|Overall Study|Lost to Follow-up|0|||
163831552|NCT04252742|591752756|FG001|Overall Study|Lost to Follow-up|1|||
163831553|NCT03759834|591752759|FG000|Overall Study|Withdrawal by Subject|1|||
163831554|NCT00031486|591752762|FG000|Overall Study|Adverse Event|1|||
163831555|NCT00031486|591752763|FG001|Overall Study|Adverse Event|0|||
163831556|NCT00031486|591752762|FG000|Overall Study|Lost to Follow-up|0|||
163831557|NCT00031486|591752763|FG001|Overall Study|Lost to Follow-up|1|||
163831558|NCT00031486|591752762|FG000|Overall Study|Withdrawal by Subject|3|||
163831559|NCT00031486|591752763|FG001|Overall Study|Withdrawal by Subject|2|||
163831560|NCT00031486|591752762|FG000|Overall Study|Death|0|||
163831561|NCT00031486|591752763|FG001|Overall Study|Death|3|||
163831562|NCT00031486|591752762|FG000|Overall Study|Non-compliant|0|||
163831563|NCT00031486|591752763|FG001|Overall Study|Non-compliant|4|||
163831564|NCT00031486|591752762|FG000|Overall Study|Did not meet eligibility requirement|2|||
163831565|NCT00031486|591752763|FG001|Overall Study|Did not meet eligibility requirement|1|||
163831566|NCT00031486|591752762|FG000|Overall Study|Other|1|||
163831567|NCT00031486|591752763|FG001|Overall Study|Other|1|||
163831568|NCT01685138|591752764|FG000|Overall Study|Lost to Follow-up|1|||
163831569|NCT01685138|591752764|FG000|Overall Study|Protocol Violation|1|||
163927255|NCT00514813|592104478|FG003|Overall Study|Study terminated|2|||
163927256|NCT00514813|592104475|FG000|Overall Study|Adverse Event|0|||
163927257|NCT00514813|592104476|FG001|Overall Study|Adverse Event|2|||
164098023|NCT00050778|592725004|FG001|Overall Study|Death|1|||
163831570|NCT01685138|591752764|FG000|Overall Study|No longer requires treatment|1|||
163831571|NCT01685138|591752764|FG000|Overall Study|Subject/guardian decision|2|||
163831572|NCT01685138|591752764|FG000|Overall Study|Physician Decision|6|||
163831573|NCT01685138|591752764|FG000|Overall Study|Death|10|||
163831574|NCT01685138|591752764|FG000|Overall Study|Adverse Event|18|||
163831575|NCT01685138|591752764|FG000|Overall Study|Progressive disease|53|||
163831576|NCT05805657|591752768|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
163831577|NCT05805657|591752769|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
163831578|NCT01951638|591752770|FG000|Treatment Period|Protocol Violation|0|||
163831579|NCT01951638|591752771|FG001|Treatment Period|Protocol Violation|0|||
163831580|NCT01951638|591752772|FG002|Treatment Period|Protocol Violation|0|||
163831581|NCT01951638|591752773|FG003|Treatment Period|Protocol Violation|2|||
163831582|NCT01951638|591752774|FG004|Treatment Period|Protocol Violation|0|||
163831583|NCT01951638|591752770|FG000|Treatment Period|Protocol-driven decision point|1|||
163831584|NCT01951638|591752771|FG001|Treatment Period|Protocol-driven decision point|3|||
163831585|NCT01951638|591752772|FG002|Treatment Period|Protocol-driven decision point|0|||
163831586|NCT01951638|591752773|FG003|Treatment Period|Protocol-driven decision point|0|||
163831587|NCT01951638|591752774|FG004|Treatment Period|Protocol-driven decision point|0|||
163831588|NCT01951638|591752770|FG000|Treatment Period|Logistical difficulties|0|||
163831589|NCT01951638|591752771|FG001|Treatment Period|Logistical difficulties|1|||
163831590|NCT01951638|591752772|FG002|Treatment Period|Logistical difficulties|1|||
163831591|NCT01951638|591752773|FG003|Treatment Period|Logistical difficulties|0|||
163831592|NCT01951638|591752774|FG004|Treatment Period|Logistical difficulties|0|||
163831593|NCT01951638|591752770|FG000|Treatment Period|Withdrawal by Subject|9|||
163831594|NCT01951638|591752771|FG001|Treatment Period|Withdrawal by Subject|6|||
163831595|NCT01951638|591752772|FG002|Treatment Period|Withdrawal by Subject|4|||
163831596|NCT01951638|591752773|FG003|Treatment Period|Withdrawal by Subject|5|||
163831597|NCT01951638|591752774|FG004|Treatment Period|Withdrawal by Subject|4|||
163831598|NCT01951638|591752770|FG000|Treatment Period|Death|0|||
163831599|NCT01951638|591752771|FG001|Treatment Period|Death|0|||
163831600|NCT01951638|591752772|FG002|Treatment Period|Death|0|||
163831601|NCT01951638|591752773|FG003|Treatment Period|Death|3|||
163831602|NCT01951638|591752774|FG004|Treatment Period|Death|1|||
163831603|NCT01951638|591752770|FG000|Treatment Period|Adverse Event|3|||
163831604|NCT01951638|591752771|FG001|Treatment Period|Adverse Event|4|||
163831605|NCT01951638|591752772|FG002|Treatment Period|Adverse Event|8|||
163831606|NCT01951638|591752773|FG003|Treatment Period|Adverse Event|6|||
163831607|NCT01951638|591752774|FG004|Treatment Period|Adverse Event|5|||
163831608|NCT01951638|591752770|FG000|Follow-up Period|Protocol Violation|0|||
163831609|NCT01951638|591752771|FG001|Follow-up Period|Protocol Violation|0|||
163831610|NCT01951638|591752772|FG002|Follow-up Period|Protocol Violation|0|||
163831611|NCT01951638|591752773|FG003|Follow-up Period|Protocol Violation|1|||
163831612|NCT01951638|591752774|FG004|Follow-up Period|Protocol Violation|0|||
163831613|NCT01951638|591752770|FG000|Follow-up Period|Logistical difficulties|0|||
163831614|NCT01951638|591752771|FG001|Follow-up Period|Logistical difficulties|2|||
163831615|NCT01951638|591752772|FG002|Follow-up Period|Logistical difficulties|0|||
163831616|NCT01951638|591752773|FG003|Follow-up Period|Logistical difficulties|0|||
163831617|NCT01951638|591752774|FG004|Follow-up Period|Logistical difficulties|1|||
163831618|NCT01951638|591752770|FG000|Follow-up Period|Withdrawal by Subject|1|||
163927258|NCT00514813|592104477|FG002|Overall Study|Adverse Event|2|||
163927259|NCT00514813|592104478|FG003|Overall Study|Adverse Event|0|||
163927260|NCT00514813|592104475|FG000|Overall Study|Protocol Violation|1|||
163927261|NCT00514813|592104476|FG001|Overall Study|Protocol Violation|0|||
163927262|NCT00514813|592104477|FG002|Overall Study|Protocol Violation|0|||
163927263|NCT00514813|592104478|FG003|Overall Study|Protocol Violation|0|||
163927264|NCT00514813|592104475|FG000|Overall Study|Withdrawal by Subject|0|||
163927265|NCT00514813|592104476|FG001|Overall Study|Withdrawal by Subject|1|||
163927266|NCT00514813|592104477|FG002|Overall Study|Withdrawal by Subject|0|||
163927267|NCT00514813|592104478|FG003|Overall Study|Withdrawal by Subject|0|||
163927268|NCT00514813|592104475|FG000|Overall Study|Lack of Efficacy|0|||
163927269|NCT00514813|592104476|FG001|Overall Study|Lack of Efficacy|1|||
163927270|NCT00514813|592104477|FG002|Overall Study|Lack of Efficacy|0|||
163927271|NCT00514813|592104478|FG003|Overall Study|Lack of Efficacy|0|||
163927272|NCT00514813|592104475|FG000|Overall Study|Kidney transplant|0|||
163927273|NCT00514813|592104476|FG001|Overall Study|Kidney transplant|6|||
163927274|NCT00514813|592104477|FG002|Overall Study|Kidney transplant|2|||
163927275|NCT00514813|592104478|FG003|Overall Study|Kidney transplant|0|||
163927276|NCT00514813|592104475|FG000|Overall Study|Death|0|||
163927277|NCT00514813|592104476|FG001|Overall Study|Death|2|||
163831619|NCT01951638|591752771|FG001|Follow-up Period|Withdrawal by Subject|5|||
163831620|NCT01951638|591752772|FG002|Follow-up Period|Withdrawal by Subject|2|||
163831621|NCT01951638|591752773|FG003|Follow-up Period|Withdrawal by Subject|1|||
163831622|NCT01951638|591752774|FG004|Follow-up Period|Withdrawal by Subject|2|||
163831623|NCT01951638|591752770|FG000|Follow-up Period|Lost to Follow-up|0|||
163927278|NCT00514813|592104477|FG002|Overall Study|Death|3|||
163927279|NCT00514813|592104478|FG003|Overall Study|Death|2|||
164098024|NCT00050778|592725005|FG002|Overall Study|Death|1|||
163831624|NCT01951638|591752771|FG001|Follow-up Period|Lost to Follow-up|1|||
163831625|NCT01951638|591752772|FG002|Follow-up Period|Lost to Follow-up|0|||
163831626|NCT01951638|591752773|FG003|Follow-up Period|Lost to Follow-up|1|||
163831627|NCT01951638|591752774|FG004|Follow-up Period|Lost to Follow-up|0|||
163831628|NCT01951638|591752770|FG000|Follow-up Period|Death|1|||
163831629|NCT01951638|591752771|FG001|Follow-up Period|Death|0|||
163831630|NCT01951638|591752772|FG002|Follow-up Period|Death|1|||
163831631|NCT01951638|591752773|FG003|Follow-up Period|Death|4|||
163831632|NCT01951638|591752774|FG004|Follow-up Period|Death|1|||
163831633|NCT01951638|591752770|FG000|Follow-up Period|Adverse Event|0|||
163831634|NCT01951638|591752771|FG001|Follow-up Period|Adverse Event|1|||
163831635|NCT01951638|591752772|FG002|Follow-up Period|Adverse Event|2|||
163831636|NCT01951638|591752773|FG003|Follow-up Period|Adverse Event|1|||
163831637|NCT01951638|591752774|FG004|Follow-up Period|Adverse Event|1|||
163831638|NCT00552084|591752775|FG000|Overall Study|Adverse Event|2|||
163831639|NCT00552084|591752776|FG001|Overall Study|Adverse Event|3|||
163831640|NCT00552084|591752775|FG000|Overall Study|Withdrawal by Subject|4|||
163831641|NCT00552084|591752776|FG001|Overall Study|Withdrawal by Subject|5|||
163831642|NCT00552084|591752775|FG000|Overall Study|Protocol Violation|1|||
163831643|NCT00552084|591752776|FG001|Overall Study|Protocol Violation|0|||
163831644|NCT00552084|591752775|FG000|Overall Study|change in anti-arrythmic drug|1|||
163831645|NCT00552084|591752776|FG001|Overall Study|change in anti-arrythmic drug|1|||
163831646|NCT01338025|591752777|FG000|Overall Study|Unexpected closure of study|10|||
163831647|NCT01338025|591752778|FG001|Overall Study|Unexpected closure of study|9|||
163831648|NCT01338025|591752777|FG000|Overall Study|Withdrawal by Subject|0|||
163831649|NCT01338025|591752778|FG001|Overall Study|Withdrawal by Subject|2|||
163831650|NCT01338025|591752777|FG000|Overall Study|Found ineligible after starting|1|||
163831651|NCT01338025|591752778|FG001|Overall Study|Found ineligible after starting|0|||
163831652|NCT03188055|591752779|FG000|Overall Study|Unavailable for training|0|||
163831653|NCT03188055|591752780|FG001|Overall Study|Unavailable for training|0|||
163831654|NCT03188055|591752781|FG002|Overall Study|Unavailable for training|19|||
163831655|NCT03188055|591752782|FG003|Overall Study|Unavailable for training|0|||
163831656|NCT03188055|591752783|FG004|Overall Study|Unavailable for training|0|||
163831657|NCT03188055|591752784|FG005|Overall Study|Unavailable for training|0|||
163831658|NCT03188055|591752779|FG000|Overall Study|Lost to Follow-up|0|||
163831659|NCT03188055|591752780|FG001|Overall Study|Lost to Follow-up|18|||
163831660|NCT03188055|591752781|FG002|Overall Study|Lost to Follow-up|0|||
163831661|NCT03188055|591752782|FG003|Overall Study|Lost to Follow-up|11|||
163831662|NCT03188055|591752783|FG004|Overall Study|Lost to Follow-up|0|||
163831663|NCT03188055|591752784|FG005|Overall Study|Lost to Follow-up|0|||
163831664|NCT03188055|591752779|FG000|Overall Study|Withdrawal by Subject|0|||
163831665|NCT03188055|591752780|FG001|Overall Study|Withdrawal by Subject|1|||
163831666|NCT03188055|591752781|FG002|Overall Study|Withdrawal by Subject|0|||
163831667|NCT03188055|591752782|FG003|Overall Study|Withdrawal by Subject|1|||
163831668|NCT03188055|591752783|FG004|Overall Study|Withdrawal by Subject|0|||
163831669|NCT03188055|591752784|FG005|Overall Study|Withdrawal by Subject|0|||
163831670|NCT04349280|591752785|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
163831671|NCT04349280|591752786|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
163831672|NCT04349280|591752785|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
163831673|NCT04349280|591752786|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
163831674|NCT04349280|591752785|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
163831675|NCT04349280|591752786|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
163831676|NCT00657618|591752791|FG000|Overall Study|Adverse Event|32|||
163831677|NCT00657618|591752791|FG000|Overall Study|Withdrawal by Subject|8|||
163831678|NCT00657618|591752791|FG000|Overall Study|negative for leishmaniasis|2|||
163831679|NCT00657618|591752791|FG000|Overall Study|didn't start due to schedule conflicts|1|||
163831680|NCT01659151|591752792|FG000|Overall Study|Inadequate TIL growth|1|||
163831681|NCT05774197|591752793|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
163831682|NCT05073133|591752794|FG000|Overall Study|Death|2|||
163831683|NCT04981678|591752795|FG000|Overall Study|Lost to Follow-up|0|||
163831684|NCT04981678|591752796|FG001|Overall Study|Lost to Follow-up|1|||
163831685|NCT02044848|591754669|FG000|Overall Study|Administrative Problems|2|||
163831686|NCT02044848|591754670|FG001|Overall Study|Administrative Problems|3|||
163831687|NCT00284141|591754675|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
163831688|NCT00284141|591754675|FG000|Overall Study|Adverse Event|19|||
163831689|NCT00284141|591754675|FG000|Overall Study|Participant's request|9|||
163831690|NCT00284141|591754675|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
163831691|NCT00284141|591754675|FG000|Overall Study|Clinical deterioration / death|2|||
163831692|NCT00284141|591754675|FG000|Overall Study|General decline|1|||
163831693|NCT00284141|591754675|FG000|Overall Study|Pneumonia|1|||
163831694|NCT00284141|591754675|FG000|Overall Study|Did not take study medication|2|||
163831695|NCT00284141|591754675|FG000|Overall Study|Ongoing treatment|2|||
163831696|NCT01782742|591754684|FG000|Double-blind Treatment Phase|Adverse Event|1|||
163831697|NCT01782742|591754685|FG001|Double-blind Treatment Phase|Adverse Event|0|||
163831698|NCT04170686|591754686|FG000|Screening|Physician Decision|12|||
163831699|NCT04170686|591754687|FG001|Screening|Physician Decision|13|||
163927280|NCT01075100|592104481|FG000|Overall Study|Adverse Event|15|||
163927281|NCT01075100|592104482|FG001|Overall Study|Adverse Event|18|||
163927282|NCT01075100|592104481|FG000|Overall Study|Patient Request|4|||
163927283|NCT01075100|592104482|FG001|Overall Study|Patient Request|4|||
163927284|NCT01075100|592104481|FG000|Overall Study|Investigator Request|2|||
163831700|NCT04170686|591754686|FG000|Randomization and Treatment|Lost to Follow-up|26|||
163831701|NCT04170686|591754687|FG001|Randomization and Treatment|Lost to Follow-up|15|||
163831702|NCT04425902|591754690|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
163831703|NCT01191840|591754691|FG000|Overall Study|withdrew consent|2|||
163831704|NCT01191840|591754692|FG001|Overall Study|withdrew consent|1|||
163831705|NCT01191840|591754691|FG000|Overall Study|Subject discontinued treatment|1|||
163831706|NCT01191840|591754692|FG001|Overall Study|Subject discontinued treatment|2|||
163831707|NCT01191840|591754691|FG000|Overall Study|Lost to Follow-up|4|||
163831708|NCT01191840|591754692|FG001|Overall Study|Lost to Follow-up|6|||
163927285|NCT01075100|592104482|FG001|Overall Study|Investigator Request|1|||
163927286|NCT01075100|592104481|FG000|Overall Study|Disease Progression|25|||
163927287|NCT01075100|592104482|FG001|Overall Study|Disease Progression|29|||
163927288|NCT01075100|592104481|FG000|Overall Study|Other|3|||
163927289|NCT01075100|592104482|FG001|Overall Study|Other|1|||
163927290|NCT00966264|592105562|FG000|Overall Study|Lost to Follow-up|4|||
163927291|NCT00966264|592105563|FG001|Overall Study|Lost to Follow-up|3|||
163927292|NCT03614676|592105564|FG000|Overall Study|Delivery before planned visit|2|||
163927293|NCT03614676|592105565|FG001|Overall Study|Delivery before planned visit|0|||
163927294|NCT03614676|592105564|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
163927295|NCT03614676|592105565|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
163927296|NCT03614676|592105564|FG000|Overall Study|Migrated / moved from the study area|30|||
163927297|NCT03614676|592105565|FG001|Overall Study|Migrated / moved from the study area|22|||
163927298|NCT03614676|592105564|FG000|Overall Study|Lost to Follow-up|17|||
163927299|NCT03614676|592105565|FG001|Overall Study|Lost to Follow-up|42|||
163927300|NCT03614676|592105564|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
163927301|NCT03614676|592105565|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
163927302|NCT03614676|592105564|FG000|Overall Study|Other|16|||
163927303|NCT03614676|592105565|FG001|Overall Study|Other|47|||
163927304|NCT03614676|592105564|FG000|Overall Study|Protocol Violation|0|||
163927305|NCT03614676|592105565|FG001|Overall Study|Protocol Violation|2|||
163927306|NCT03614676|592105564|FG000|Overall Study|Neonatal event of interest|0|||
163927307|NCT03614676|592105565|FG001|Overall Study|Neonatal event of interest|6|||
163927308|NCT03614676|592105564|FG000|Overall Study|Death in infant greater than 28 days old|0|||
163927309|NCT03614676|592105565|FG001|Overall Study|Death in infant greater than 28 days old|12|||
163927310|NCT03614676|592105564|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
163927311|NCT03614676|592105565|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
163927312|NCT00416598|592105568|FG000|Induction & Intensification|Adverse Event|38|||
163927313|NCT00416598|592105568|FG000|Induction & Intensification|Death|32|||
163927314|NCT00416598|592105568|FG000|Induction & Intensification|Withdrawal by Subject|46|||
163927315|NCT00416598|592105568|FG000|Induction & Intensification|Alternative Treatment|135|||
163927316|NCT00416598|592105568|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
163927317|NCT00416598|592105568|FG000|Induction & Intensification|Relapse/progression|29|||
163927318|NCT00416598|592105568|FG000|Induction & Intensification|Failed induction|87|||
163927319|NCT00416598|592105568|FG000|Decitabine Maintenance|Adverse Event|5|||
163927320|NCT00416598|592105568|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
163927321|NCT00416598|592105568|FG000|Decitabine Maintenance|Progression/relapse|38|||
163927322|NCT00416598|592105568|FG000|Decitabine Maintenance|Alternative treatment|2|||
163927323|NCT00416598|592105568|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
163927324|NCT00511836|592105569|FG000|Double-blind Period|Lost to Follow-up|1|||
163927325|NCT00511836|592105570|FG001|Double-blind Period|Lost to Follow-up|0|||
163927326|NCT00030823|592105571|FG000|Overall Study|Withdrawal by Subject|1|||
163927327|NCT00891046|592105583|FG000|Overall Study|Protocol Violation|1|||
163927328|NCT00891046|592105584|FG001|Overall Study|Protocol Violation|1|||
163927329|NCT00891046|592105585|FG002|Overall Study|Protocol Violation|0|||
163927330|NCT00891046|592105586|FG003|Overall Study|Protocol Violation|0|||
163927331|NCT00891046|592105587|FG004|Overall Study|Protocol Violation|1|||
163927332|NCT00891046|592105583|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
163927333|NCT00891046|592105584|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
163927334|NCT00891046|592105585|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
163927335|NCT00891046|592105586|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
163927336|NCT00891046|592105587|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
163927337|NCT00891046|592105583|FG000|Overall Study|Administrative problems|0|||
163927338|NCT00891046|592105584|FG001|Overall Study|Administrative problems|0|||
163927339|NCT00891046|592105585|FG002|Overall Study|Administrative problems|0|||
163927340|NCT00891046|592105586|FG003|Overall Study|Administrative problems|0|||
163831709|NCT01191840|591754691|FG000|Overall Study|Non Staph Infection|4|||
163831710|NCT01191840|591754692|FG001|Overall Study|Non Staph Infection|3|||
163927341|NCT00891046|592105587|FG004|Overall Study|Administrative problems|1|||
163927342|NCT00891046|592105583|FG000|Overall Study|Participant no longer required drug|0|||
163831711|NCT01191840|591754691|FG000|Overall Study|ineligible at enrollment|1|||
163831712|NCT01191840|591754692|FG001|Overall Study|ineligible at enrollment|0|||
163831713|NCT01191840|591754691|FG000|Overall Study|IRB approval lapse|0|||
163831714|NCT01191840|591754692|FG001|Overall Study|IRB approval lapse|2|||
163831715|NCT01191840|591754691|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
163831716|NCT01191840|591754692|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
163831717|NCT01191840|591754691|FG000|Overall Study|Withdrawal by Subject|2|||
163831718|NCT01191840|591754692|FG001|Overall Study|Withdrawal by Subject|0|||
163831719|NCT00331344|591754698|FG000|Phase I|Adverse Event|0|||
163831720|NCT00331344|591754699|FG001|Phase I|Adverse Event|0|||
163831721|NCT00331344|591754700|FG002|Phase I|Adverse Event|0|||
163831722|NCT00331344|591754701|FG003|Phase I|Adverse Event|1|||
163831723|NCT00331344|591754702|FG004|Phase I|Adverse Event|2|||
163831724|NCT00331344|591754703|FG005|Phase I|Adverse Event|2|||
163831725|NCT00331344|591754704|FG006|Phase I|Adverse Event|0|||
163831726|NCT00331344|591754705|FG007|Phase I|Adverse Event|1|||
163831727|NCT00331344|591754706|FG008|Phase I|Adverse Event|0|||
163831728|NCT00331344|591754698|FG000|Phase II|Death|0|||
163831729|NCT00331344|591754699|FG001|Phase II|Death|0|||
163831730|NCT00331344|591754700|FG002|Phase II|Death|0|||
163831731|NCT00331344|591754701|FG003|Phase II|Death|0|||
163831732|NCT00331344|591754702|FG004|Phase II|Death|0|||
163831733|NCT00331344|591754703|FG005|Phase II|Death|0|||
163831734|NCT00331344|591754704|FG006|Phase II|Death|0|||
163831735|NCT00331344|591754705|FG007|Phase II|Death|0|||
163831736|NCT00331344|591754706|FG008|Phase II|Death|4|||
163831737|NCT02940574|591754708|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
163831738|NCT02940574|591754709|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
163831739|NCT02940574|591754708|FG000|1-year Follow-up|Lost to Follow-up|3|||
163831740|NCT02940574|591754709|FG001|1-year Follow-up|Lost to Follow-up|4|||
163831741|NCT04538144|591754710|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
163831742|NCT04538144|591754711|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
163831743|NCT04538144|591754712|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
163831744|NCT04538144|591754713|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
163927343|NCT00891046|592105584|FG001|Overall Study|Participant no longer required drug|2|||
163927344|NCT00891046|592105585|FG002|Overall Study|Participant no longer required drug|0|||
163927345|NCT00891046|592105586|FG003|Overall Study|Participant no longer required drug|0|||
163927346|NCT00891046|592105587|FG004|Overall Study|Participant no longer required drug|1|||
163927347|NCT00891046|592105583|FG000|Overall Study|Adverse Event|4|||
164034940|NCT01998958|592486519|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034941|NCT01998958|592486520|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034942|NCT01998958|592486521|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034943|NCT01998958|592486522|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034944|NCT01998958|592486523|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034945|NCT01998958|592486524|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163831745|NCT00520975|591754714|FG000|Overall Study|Disease progression|31|||
163831746|NCT00520975|591754715|FG001|Overall Study|Disease progression|23|||
163831747|NCT00520975|591754714|FG000|Overall Study|Adverse Event|7|||
163831748|NCT00520975|591754715|FG001|Overall Study|Adverse Event|10|||
163831749|NCT00520975|591754714|FG000|Overall Study|Death|0|||
163831750|NCT00520975|591754715|FG001|Overall Study|Death|2|||
163831751|NCT00520975|591754714|FG000|Overall Study|Withdrawal by Subject|3|||
163831752|NCT00520975|591754715|FG001|Overall Study|Withdrawal by Subject|5|||
163831753|NCT00520975|591754714|FG000|Overall Study|Other therapy|2|||
163831754|NCT00520975|591754715|FG001|Overall Study|Other therapy|4|||
163831755|NCT00520975|591754714|FG000|Overall Study|Other reasons|4|||
163831756|NCT00520975|591754715|FG001|Overall Study|Other reasons|2|||
163831757|NCT00520975|591754714|FG000|Overall Study|Not start protocol therapy|1|||
163831758|NCT00520975|591754715|FG001|Overall Study|Not start protocol therapy|2|||
163831759|NCT01682213|591754716|FG000|Overall Study|Withdrawal by Subject|2|||
163831760|NCT04382924|591754717|FG000|Overall Study|Death|2|||
163927348|NCT00891046|592105584|FG001|Overall Study|Adverse Event|3|||
163927349|NCT00891046|592105585|FG002|Overall Study|Adverse Event|2|||
163927350|NCT00891046|592105586|FG003|Overall Study|Adverse Event|0|||
163927351|NCT00891046|592105587|FG004|Overall Study|Adverse Event|14|||
164034946|NCT01998958|592486525|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034947|NCT01998958|592486526|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163831761|NCT04382924|591754718|FG001|Overall Study|Death|5|||
163831762|NCT04382924|591754719|FG002|Overall Study|Death|4|||
163831763|NCT04382924|591754717|FG000|Overall Study|Protocol Violation|0|||
163831764|NCT04382924|591754718|FG001|Overall Study|Protocol Violation|1|||
163831765|NCT04382924|591754719|FG002|Overall Study|Protocol Violation|1|||
163831766|NCT04382924|591754717|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
163831767|NCT04382924|591754718|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
163831768|NCT04382924|591754719|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
163927352|NCT00891046|592105583|FG000|Overall Study|Withdrawal by Subject|2|||
163831769|NCT04382924|591754717|FG000|Overall Study|Withdrawal by Subject|6|||
163831770|NCT04382924|591754718|FG001|Overall Study|Withdrawal by Subject|3|||
163831771|NCT04382924|591754719|FG002|Overall Study|Withdrawal by Subject|6|||
163831772|NCT00642902|591754720|FG000|Overall Study|Adverse Event|0|||
163831773|NCT00642902|591754721|FG001|Overall Study|Adverse Event|1|||
163831774|NCT00642902|591754722|FG002|Overall Study|Adverse Event|3|||
163831775|NCT00642902|591754723|FG003|Overall Study|Adverse Event|1|||
163831776|NCT00642902|591754720|FG000|Overall Study|Lost to Follow-up|1|||
163831777|NCT00642902|591754721|FG001|Overall Study|Lost to Follow-up|1|||
163831778|NCT00642902|591754722|FG002|Overall Study|Lost to Follow-up|0|||
163831779|NCT00642902|591754723|FG003|Overall Study|Lost to Follow-up|0|||
163831780|NCT00642902|591754720|FG000|Overall Study|Lack of Efficacy|0|||
163831781|NCT00642902|591754721|FG001|Overall Study|Lack of Efficacy|3|||
163831782|NCT00642902|591754722|FG002|Overall Study|Lack of Efficacy|3|||
163831783|NCT00642902|591754723|FG003|Overall Study|Lack of Efficacy|0|||
163831784|NCT00642902|591754720|FG000|Overall Study|Death|1|||
163831785|NCT00642902|591754721|FG001|Overall Study|Death|0|||
163831786|NCT00642902|591754722|FG002|Overall Study|Death|0|||
163831787|NCT00642902|591754723|FG003|Overall Study|Death|0|||
163831788|NCT00642902|591754720|FG000|Overall Study|Premature termination of clinical trial|37|||
163831789|NCT00642902|591754721|FG001|Overall Study|Premature termination of clinical trial|32|||
163831790|NCT00642902|591754722|FG002|Overall Study|Premature termination of clinical trial|35|||
163831791|NCT00642902|591754723|FG003|Overall Study|Premature termination of clinical trial|35|||
163831792|NCT00642902|591754720|FG000|Overall Study|Randomized, but not treated|0|||
163831793|NCT00642902|591754721|FG001|Overall Study|Randomized, but not treated|0|||
163831794|NCT00642902|591754722|FG002|Overall Study|Randomized, but not treated|1|||
163831795|NCT00642902|591754723|FG003|Overall Study|Randomized, but not treated|0|||
163831796|NCT00642902|591754720|FG000|Overall Study|Other|1|||
163831797|NCT00642902|591754721|FG001|Overall Study|Other|5|||
163831798|NCT00642902|591754722|FG002|Overall Study|Other|1|||
163831799|NCT00642902|591754723|FG003|Overall Study|Other|4|||
163831800|NCT00429663|591754724|FG000|Overall Study|Lost to Follow-up|24|||
163831801|NCT00429663|591754725|FG001|Overall Study|Lost to Follow-up|31|||
163831802|NCT00429663|591754724|FG000|Overall Study|Physician Decision|6|||
163831803|NCT00429663|591754725|FG001|Overall Study|Physician Decision|3|||
163831804|NCT00429663|591754724|FG000|Overall Study|Withdrawal by Subject|2|||
163831805|NCT00429663|591754725|FG001|Overall Study|Withdrawal by Subject|5|||
163831806|NCT00429663|591754724|FG000|Overall Study|Death|4|||
163831807|NCT00429663|591754725|FG001|Overall Study|Death|0|||
163831808|NCT04207840|591754726|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
163831809|NCT04207840|591754727|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
163831810|NCT04207840|591754728|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
163831811|NCT04207840|591754726|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
163831812|NCT04207840|591754727|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
163831813|NCT04207840|591754728|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
163831814|NCT03243422|591754731|FG000|Overall Study|Death|20|||
163831815|NCT03243422|591754732|FG001|Overall Study|Death|21|||
163831816|NCT03243422|591754731|FG000|Overall Study|Lost to Follow-up|9|||
163831817|NCT03243422|591754732|FG001|Overall Study|Lost to Follow-up|21|||
163831818|NCT03243422|591754731|FG000|Overall Study|Withdrawal by Subject|22|||
163831819|NCT03243422|591754732|FG001|Overall Study|Withdrawal by Subject|8|||
163831820|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
163831821|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
163831822|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
163831823|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
163831824|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
163831825|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
163831826|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
164098025|NCT00050778|592725003|FG000|Overall Study|Lack of Efficacy|16|||
164098026|NCT00050778|592725004|FG001|Overall Study|Lack of Efficacy|2|||
164098027|NCT00050778|592725005|FG002|Overall Study|Lack of Efficacy|2|||
163831827|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
164098028|NCT00050778|592725003|FG000|Overall Study|Lost to Follow-up|0|||
164098029|NCT00050778|592725004|FG001|Overall Study|Lost to Follow-up|2|||
164098030|NCT00050778|592725005|FG002|Overall Study|Lost to Follow-up|4|||
164098031|NCT00050778|592725003|FG000|Overall Study|Physician Decision|3|||
163831828|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
163831829|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
163831830|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
163831831|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
163831832|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163831833|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163831834|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
163831835|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
164098032|NCT00050778|592725004|FG001|Overall Study|Physician Decision|0|||
164098033|NCT00050778|592725005|FG002|Overall Study|Physician Decision|2|||
164098034|NCT00050778|592725003|FG000|Overall Study|Protocol Violation|2|||
163831836|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
163831837|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163831838|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163831839|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
163831840|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Death|2|||
163831841|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Death|2|||
163831842|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Death|0|||
163831843|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Death|0|||
163831844|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Death|0|||
163831845|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
163831846|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
163831847|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
163831848|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
163831849|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
163831850|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163831851|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
163831852|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163831853|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163831854|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
163831855|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
163831856|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
163831857|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
163831858|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
163831859|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
163831860|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
163831861|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163831862|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163831863|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163831864|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
163831865|NCT03420781|591754735|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
163831866|NCT03420781|591754736|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163831867|NCT03420781|591754737|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163831868|NCT03420781|591754738|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163831869|NCT03420781|591754739|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
163831870|NCT03420781|591754735|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163831871|NCT03420781|591754736|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163831872|NCT03420781|591754737|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163831873|NCT03420781|591754738|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
163831874|NCT03420781|591754739|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
163831875|NCT03420781|591754735|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163831876|NCT03420781|591754736|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163831877|NCT03420781|591754737|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163831878|NCT03420781|591754738|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
163831879|NCT03420781|591754739|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
163831880|NCT03420781|591754735|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
163831881|NCT03420781|591754736|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
163831882|NCT03420781|591754737|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
163831883|NCT03420781|591754738|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
163831884|NCT03420781|591754739|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
163831885|NCT01226511|591754744|FG000|Acute Treatment Period|Adverse Event|7|||
163831886|NCT01226511|591754745|FG001|Acute Treatment Period|Adverse Event|6|||
163831887|NCT01226511|591754744|FG000|Acute Treatment Period|Lack of Efficacy|2|||
163831888|NCT01226511|591754745|FG001|Acute Treatment Period|Lack of Efficacy|1|||
163831889|NCT01226511|591754744|FG000|Acute Treatment Period|Lost to Follow-up|3|||
163831890|NCT01226511|591754745|FG001|Acute Treatment Period|Lost to Follow-up|6|||
163831891|NCT01226511|591754744|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
163831892|NCT01226511|591754745|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
163831893|NCT01226511|591754744|FG000|Acute Treatment Period|Protocol Violation|5|||
163831894|NCT01226511|591754745|FG001|Acute Treatment Period|Protocol Violation|5|||
163831895|NCT01226511|591754744|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
163831896|NCT01226511|591754745|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
163831897|NCT01226511|591754744|FG000|Extension Treatment Period|Adverse Event|8|||
163927353|NCT00891046|592105584|FG001|Overall Study|Withdrawal by Subject|1|||
163831898|NCT01226511|591754745|FG001|Extension Treatment Period|Adverse Event|8|||
163831899|NCT01226511|591754744|FG000|Extension Treatment Period|Lack of Efficacy|3|||
163831900|NCT01226511|591754745|FG001|Extension Treatment Period|Lack of Efficacy|2|||
163831901|NCT01226511|591754744|FG000|Extension Treatment Period|Lost to Follow-up|4|||
163831902|NCT01226511|591754745|FG001|Extension Treatment Period|Lost to Follow-up|3|||
163831903|NCT01226511|591754744|FG000|Extension Treatment Period|Protocol Violation|2|||
163831904|NCT01226511|591754745|FG001|Extension Treatment Period|Protocol Violation|2|||
163831905|NCT01226511|591754744|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
163831906|NCT01226511|591754745|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
163831907|NCT01226511|591754744|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
163831908|NCT01226511|591754745|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
163831909|NCT01226511|591754744|FG000|Extension Treatment Period|Sponsor Decision|1|||
163831910|NCT01226511|591754745|FG001|Extension Treatment Period|Sponsor Decision|1|||
163831911|NCT01226511|591754744|FG000|Taper Period|Adverse Event|1|||
163831912|NCT01226511|591754745|FG001|Taper Period|Adverse Event|0|||
163831913|NCT01226511|591754744|FG000|Taper Period|Lost to Follow-up|2|||
163831914|NCT01226511|591754745|FG001|Taper Period|Lost to Follow-up|2|||
163831915|NCT01226511|591754744|FG000|Taper Period|Protocol Violation|1|||
163831916|NCT01226511|591754745|FG001|Taper Period|Protocol Violation|0|||
163831917|NCT01226511|591754744|FG000|Taper Period|Parent/Caregiver Decision|1|||
163831918|NCT01226511|591754745|FG001|Taper Period|Parent/Caregiver Decision|1|||
163831919|NCT02696564|591754746|FG000|Overall Study|Death|1|||
163831920|NCT02696564|591754747|FG001|Overall Study|Death|2|||
163831921|NCT02696564|591754746|FG000|Overall Study|Withdrawal by Subject|3|||
163831922|NCT02696564|591754747|FG001|Overall Study|Withdrawal by Subject|2|||
163831923|NCT02696564|591754746|FG000|Overall Study|Lost to Follow-up|3|||
163831924|NCT02696564|591754747|FG001|Overall Study|Lost to Follow-up|3|||
163831925|NCT02696564|591754746|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
164034948|NCT01998958|592486527|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163831926|NCT02696564|591754747|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
163831927|NCT02696564|591754746|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
163831928|NCT02696564|591754747|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
163831929|NCT02696564|591754746|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
163831930|NCT02696564|591754747|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
163831931|NCT02696564|591754746|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
163831932|NCT02696564|591754747|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
163831933|NCT02696564|591754746|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
163831934|NCT02696564|591754747|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
163831935|NCT05267600|591754748|FG000|Overall Study|Adverse Event|1|||
163831936|NCT05267600|591754749|FG001|Overall Study|Adverse Event|4|||
163831937|NCT05267600|591754748|FG000|Overall Study|Death|1|||
163831938|NCT05267600|591754749|FG001|Overall Study|Death|2|||
163831939|NCT05267600|591754748|FG000|Overall Study|Lack of Efficacy|1|||
163831940|NCT05267600|591754749|FG001|Overall Study|Lack of Efficacy|2|||
163831941|NCT05267600|591754748|FG000|Overall Study|Lost to Follow-up|3|||
163831942|NCT05267600|591754749|FG001|Overall Study|Lost to Follow-up|0|||
163831943|NCT05267600|591754748|FG000|Overall Study|Physician Decision|4|||
163831944|NCT05267600|591754749|FG001|Overall Study|Physician Decision|0|||
163831945|NCT05267600|591754748|FG000|Overall Study|Treatment Unblinded|0|||
163831946|NCT05267600|591754749|FG001|Overall Study|Treatment Unblinded|1|||
163831947|NCT05267600|591754748|FG000|Overall Study|Withdrawal by Subject|5|||
163831948|NCT05267600|591754749|FG001|Overall Study|Withdrawal by Subject|4|||
163831949|NCT04067401|591754750|FG000|Overall Study|Withdrawal by Subject|7|||
163831950|NCT04067401|591754751|FG001|Overall Study|Withdrawal by Subject|0|||
163831951|NCT04067401|591754750|FG000|Overall Study|no data provided|1|||
163831952|NCT04067401|591754751|FG001|Overall Study|no data provided|0|||
163831953|NCT03633929|591754754|FG000|Overall Study|Lost to Follow-up|1|||
163831954|NCT03633929|591754754|FG000|Overall Study|Did not login to software. Did not participate|3|||
163831955|NCT03430063|591754756|FG000|Overall Study|Adverse Event|0|||
163831956|NCT03430063|591754757|FG001|Overall Study|Adverse Event|1|||
163831957|NCT03430063|591754758|FG002|Overall Study|Adverse Event|0|||
163831958|NCT03430063|591754756|FG000|Overall Study|Death|3|||
163831959|NCT03430063|591754757|FG001|Overall Study|Death|2|||
163831960|NCT03430063|591754758|FG002|Overall Study|Death|3|||
163831961|NCT03430063|591754756|FG000|Overall Study|Lost to Follow-up|0|||
163831962|NCT03430063|591754757|FG001|Overall Study|Lost to Follow-up|1|||
163831963|NCT03430063|591754758|FG002|Overall Study|Lost to Follow-up|0|||
163831964|NCT03430063|591754756|FG000|Overall Study|Withdrawal by Subject|0|||
163831965|NCT03430063|591754757|FG001|Overall Study|Withdrawal by Subject|0|||
163831966|NCT03430063|591754758|FG002|Overall Study|Withdrawal by Subject|1|||
163831967|NCT03430063|591754756|FG000|Overall Study|Withdrawal of consent|3|||
163831968|NCT03430063|591754757|FG001|Overall Study|Withdrawal of consent|1|||
163831969|NCT03430063|591754758|FG002|Overall Study|Withdrawal of consent|2|||
163831970|NCT03430063|591754756|FG000|Overall Study|Progressive disease|1|||
163831971|NCT03430063|591754757|FG001|Overall Study|Progressive disease|2|||
163831972|NCT03430063|591754758|FG002|Overall Study|Progressive disease|1|||
163831973|NCT03430063|591754756|FG000|Overall Study|Other un-specified|1|||
164034949|NCT01998958|592486528|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163831974|NCT03430063|591754757|FG001|Overall Study|Other un-specified|1|||
163831975|NCT03430063|591754758|FG002|Overall Study|Other un-specified|0|||
163831976|NCT03430063|591754756|FG000|Overall Study|Randomized, but never treated|0|||
163831977|NCT03430063|591754757|FG001|Overall Study|Randomized, but never treated|0|||
163831978|NCT03430063|591754758|FG002|Overall Study|Randomized, but never treated|1|||
163831979|NCT03124199|591754759|FG000|Overall Study|Lost to Follow-up|4|||
163831980|NCT02798211|591754760|FG000|Period 1|Adverse Event|1|||
163831981|NCT02798211|591754761|FG001|Period 1|Adverse Event|1|||
163831982|NCT02798211|591754762|FG002|Period 1|Adverse Event|0|||
163831983|NCT02798211|591754763|FG003|Period 1|Adverse Event|0|||
163831984|NCT02798211|591754764|FG004|Period 1|Adverse Event|0|||
163831985|NCT02798211|591754765|FG005|Period 1|Adverse Event|0|||
163831986|NCT02798211|591754760|FG000|Period 1|Lost to Follow-up|2|||
163831987|NCT02798211|591754761|FG001|Period 1|Lost to Follow-up|1|||
163831988|NCT02798211|591754762|FG002|Period 1|Lost to Follow-up|0|||
163831989|NCT02798211|591754763|FG003|Period 1|Lost to Follow-up|0|||
163831990|NCT02798211|591754764|FG004|Period 1|Lost to Follow-up|0|||
163831991|NCT02798211|591754765|FG005|Period 1|Lost to Follow-up|0|||
163831992|NCT02798211|591754760|FG000|Period 1|Protocol Violation|0|||
163831993|NCT02798211|591754761|FG001|Period 1|Protocol Violation|0|||
163831994|NCT02798211|591754762|FG002|Period 1|Protocol Violation|2|||
163831995|NCT02798211|591754763|FG003|Period 1|Protocol Violation|0|||
163831996|NCT02798211|591754764|FG004|Period 1|Protocol Violation|0|||
163831997|NCT02798211|591754765|FG005|Period 1|Protocol Violation|0|||
163831998|NCT02798211|591754760|FG000|Period 1|Withdrawal by Subject|1|||
163831999|NCT02798211|591754761|FG001|Period 1|Withdrawal by Subject|1|||
163832000|NCT02798211|591754762|FG002|Period 1|Withdrawal by Subject|0|||
163832001|NCT02798211|591754763|FG003|Period 1|Withdrawal by Subject|0|||
163832002|NCT02798211|591754764|FG004|Period 1|Withdrawal by Subject|0|||
163832003|NCT02798211|591754765|FG005|Period 1|Withdrawal by Subject|0|||
163832004|NCT02798211|591754760|FG000|Period 1|Death|0|||
163832005|NCT02798211|591754761|FG001|Period 1|Death|0|||
163832006|NCT02798211|591754762|FG002|Period 1|Death|1|||
163832007|NCT02798211|591754763|FG003|Period 1|Death|0|||
163832008|NCT02798211|591754764|FG004|Period 1|Death|0|||
163832009|NCT02798211|591754765|FG005|Period 1|Death|0|||
163832010|NCT02798211|591754760|FG000|Period 1|Withdrawal of Informed Consent|2|||
163832011|NCT02798211|591754761|FG001|Period 1|Withdrawal of Informed Consent|7|||
163832012|NCT02798211|591754762|FG002|Period 1|Withdrawal of Informed Consent|3|||
163832013|NCT02798211|591754763|FG003|Period 1|Withdrawal of Informed Consent|0|||
163832014|NCT02798211|591754764|FG004|Period 1|Withdrawal of Informed Consent|0|||
163832015|NCT02798211|591754765|FG005|Period 1|Withdrawal of Informed Consent|0|||
163832016|NCT02798211|591754760|FG000|Period 2|Withdrawal by Subject|2|||
163832017|NCT02798211|591754761|FG001|Period 2|Withdrawal by Subject|0|||
163832018|NCT02798211|591754762|FG002|Period 2|Withdrawal by Subject|0|||
163832019|NCT02798211|591754763|FG003|Period 2|Withdrawal by Subject|0|||
163832020|NCT02798211|591754764|FG004|Period 2|Withdrawal by Subject|2|||
163832021|NCT02798211|591754765|FG005|Period 2|Withdrawal by Subject|2|||
163832022|NCT02798211|591754760|FG000|Period 2|Adverse Event|5|||
163832023|NCT02798211|591754761|FG001|Period 2|Adverse Event|0|||
163832024|NCT02798211|591754762|FG002|Period 2|Adverse Event|0|||
163832025|NCT02798211|591754763|FG003|Period 2|Adverse Event|0|||
163832026|NCT02798211|591754764|FG004|Period 2|Adverse Event|1|||
163832027|NCT02798211|591754765|FG005|Period 2|Adverse Event|0|||
163832028|NCT02798211|591754760|FG000|Period 2|Lack of Efficacy|1|||
163832029|NCT02798211|591754761|FG001|Period 2|Lack of Efficacy|0|||
163832030|NCT02798211|591754762|FG002|Period 2|Lack of Efficacy|0|||
163832031|NCT02798211|591754763|FG003|Period 2|Lack of Efficacy|1|||
163832032|NCT02798211|591754764|FG004|Period 2|Lack of Efficacy|0|||
163832033|NCT02798211|591754765|FG005|Period 2|Lack of Efficacy|1|||
163832034|NCT02798211|591754760|FG000|Period 2|Lost to Follow-up|3|||
163832035|NCT02798211|591754761|FG001|Period 2|Lost to Follow-up|0|||
163832036|NCT02798211|591754762|FG002|Period 2|Lost to Follow-up|0|||
163832037|NCT02798211|591754763|FG003|Period 2|Lost to Follow-up|0|||
163832038|NCT02798211|591754764|FG004|Period 2|Lost to Follow-up|2|||
163832039|NCT02798211|591754765|FG005|Period 2|Lost to Follow-up|0|||
163832040|NCT02798211|591754760|FG000|Period 2|Physician Decision|1|||
163832041|NCT02798211|591754761|FG001|Period 2|Physician Decision|0|||
163832042|NCT02798211|591754762|FG002|Period 2|Physician Decision|0|||
163832043|NCT02798211|591754763|FG003|Period 2|Physician Decision|1|||
163832044|NCT02798211|591754764|FG004|Period 2|Physician Decision|1|||
163832045|NCT02798211|591754765|FG005|Period 2|Physician Decision|0|||
163832046|NCT02798211|591754760|FG000|Period 2|Pregnancy|0|||
163832047|NCT02798211|591754761|FG001|Period 2|Pregnancy|0|||
163832048|NCT02798211|591754762|FG002|Period 2|Pregnancy|0|||
163832049|NCT02798211|591754763|FG003|Period 2|Pregnancy|2|||
163832050|NCT02798211|591754764|FG004|Period 2|Pregnancy|0|||
163832051|NCT02798211|591754765|FG005|Period 2|Pregnancy|0|||
163832052|NCT02798211|591754760|FG000|Period 2|Technical problems|1|||
163832053|NCT02798211|591754761|FG001|Period 2|Technical problems|0|||
163832054|NCT02798211|591754762|FG002|Period 2|Technical problems|0|||
163832055|NCT02798211|591754763|FG003|Period 2|Technical problems|1|||
163832056|NCT02798211|591754764|FG004|Period 2|Technical problems|0|||
163832057|NCT02798211|591754765|FG005|Period 2|Technical problems|0|||
163832058|NCT02798211|591754760|FG000|Period 2|Withdrawal of Informed Consent|1|||
163832059|NCT02798211|591754761|FG001|Period 2|Withdrawal of Informed Consent|0|||
163832060|NCT02798211|591754762|FG002|Period 2|Withdrawal of Informed Consent|0|||
163832061|NCT02798211|591754763|FG003|Period 2|Withdrawal of Informed Consent|2|||
163832062|NCT02798211|591754764|FG004|Period 2|Withdrawal of Informed Consent|2|||
163832063|NCT02798211|591754765|FG005|Period 2|Withdrawal of Informed Consent|3|||
163832064|NCT01784068|591754766|FG000|NTCS Phase|Adverse Event|5|||
163832065|NCT01784068|591754767|FG001|NTCS Phase|Adverse Event|0|||
163832066|NCT01784068|591754766|FG000|NTCS Phase|Physician Decision|2|||
163832067|NCT01784068|591754767|FG001|NTCS Phase|Physician Decision|0|||
163832068|NCT01784068|591754766|FG000|NTCS Phase|Patient/guardian decision|3|||
163832069|NCT01784068|591754767|FG001|NTCS Phase|Patient/guardian decision|0|||
163832070|NCT01784068|591754766|FG000|NTCS Phase|Death|2|||
163832071|NCT01784068|591754767|FG001|NTCS Phase|Death|0|||
163832072|NCT01784068|591754766|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
163832073|NCT01784068|591754767|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
163832074|NCT01784068|591754766|FG000|TFR Phase|Physician Decision|0|||
163832075|NCT01784068|591754767|FG001|TFR Phase|Physician Decision|1|||
163832076|NCT01784068|591754766|FG000|TFR Phase|Patient/guardian decision|0|||
163832077|NCT01784068|591754767|FG001|TFR Phase|Patient/guardian decision|3|||
163832078|NCT01784068|591754766|FG000|TFR Phase|Death|0|||
163832079|NCT01784068|591754767|FG001|TFR Phase|Death|1|||
163832080|NCT01784068|591754766|FG000|TFR Phase|Lack of Efficacy|0|||
163832081|NCT01784068|591754767|FG001|TFR Phase|Lack of Efficacy|88|||
163832082|NCT06351371|591754768|FG000|Overall Study|Mutation Status Not Confirmed|9|||
163832083|NCT06351371|591754768|FG000|Overall Study|Ineligible|1|||
163832084|NCT06351371|591754768|FG000|Overall Study|Adverse Event|4|||
163832085|NCT06351371|591754768|FG000|Overall Study|Death|1|||
163832086|NCT06351371|591754768|FG000|Overall Study|Disease progression|14|||
163832087|NCT06351371|591754768|FG000|Overall Study|Withdrawal by Subject|3|||
163832088|NCT06351371|591754768|FG000|Overall Study|Physician Decision|3|||
163832089|NCT04359784|591754769|FG000|Overall Study|Death|2|||
163832090|NCT02063828|591754770|FG000|Overall Study|Withdrawal by Subject|4|||
163832091|NCT02063828|591754771|FG001|Overall Study|Withdrawal by Subject|6|||
163832092|NCT02063828|591754772|FG002|Overall Study|Withdrawal by Subject|3|||
163832093|NCT02063828|591754770|FG000|Overall Study|Death|0|||
163832094|NCT02063828|591754771|FG001|Overall Study|Death|0|||
163832095|NCT02063828|591754772|FG002|Overall Study|Death|1|||
163832096|NCT02753595|591754773|FG000|Overall Study|Sponsor termination|2|||
163832097|NCT02753595|591754774|FG001|Overall Study|Sponsor termination|2|||
163832098|NCT02515279|591754778|FG000|Overall Study|Adverse Event|7|||
163832099|NCT02515279|591754778|FG000|Overall Study|Lack of Efficacy|31|||
163832100|NCT02515279|591754778|FG000|Overall Study|Lost to Follow-up|9|||
163832101|NCT02515279|591754778|FG000|Overall Study|Withdrawal by Subject|18|||
163832102|NCT02515279|591754778|FG000|Overall Study|End-of-treatment visit not attended|17|||
163832103|NCT02515279|591754778|FG000|Overall Study|Other|22|||
163832104|NCT01800968|591754779|FG000|Overall Study|Death|23|||
163832105|NCT01800968|591754780|FG001|Overall Study|Death|16|||
163832106|NCT01800968|591754779|FG000|Overall Study|Lost to Follow-up|5|||
163832107|NCT01800968|591754780|FG001|Overall Study|Lost to Follow-up|7|||
164098035|NCT00050778|592725004|FG001|Overall Study|Protocol Violation|0|||
164098036|NCT00050778|592725005|FG002|Overall Study|Protocol Violation|1|||
163832108|NCT01800968|591754779|FG000|Overall Study|Withdrawal by Subject|7|||
163832109|NCT01800968|591754780|FG001|Overall Study|Withdrawal by Subject|9|||
163832110|NCT01800968|591754779|FG000|Overall Study|Physician Decision|1|||
163832111|NCT01800968|591754780|FG001|Overall Study|Physician Decision|0|||
163832112|NCT04987762|591754782|FG000|Overall Study|Study was Terminated by Sponsor|103|||
163832113|NCT02068495|591754783|FG000|Overall Study|Case Report Forms Uncollected|60|||
163832114|NCT02068495|591754783|FG000|Overall Study|Protocol Deviation|49|||
163832115|NCT01666808|591754786|FG000|Overall Study|Lost to Follow-up|9|||
163832116|NCT01666808|591754787|FG001|Overall Study|Lost to Follow-up|15|||
163832117|NCT01666808|591754786|FG000|Overall Study|Withdrawal by Subject|3|||
163832118|NCT01666808|591754787|FG001|Overall Study|Withdrawal by Subject|1|||
163832119|NCT01666808|591754786|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
163832120|NCT01666808|591754787|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
163832121|NCT02220894|591754788|FG000|Overall Study|Adverse Event|127|||
163832122|NCT02220894|591754789|FG001|Overall Study|Adverse Event|74|||
163832123|NCT02220894|591754788|FG000|Overall Study|Death|418|||
163832124|NCT02220894|591754789|FG001|Overall Study|Death|508|||
163832125|NCT02220894|591754788|FG000|Overall Study|Lost to Follow-up|0|||
163832126|NCT02220894|591754789|FG001|Overall Study|Lost to Follow-up|4|||
163832127|NCT02220894|591754788|FG000|Overall Study|Site Terminated by Sponsor|2|||
163832128|NCT02220894|591754789|FG001|Overall Study|Site Terminated by Sponsor|0|||
163832129|NCT02220894|591754788|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
163832130|NCT02220894|591754789|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
163832131|NCT02220894|591754788|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164098037|NCT00050778|592725003|FG000|Overall Study|Withdrawal by Subject|6|||
163832132|NCT02220894|591754789|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163832133|NCT02220894|591754788|FG000|Overall Study|Withdrawal by Subject|10|||
163832134|NCT02220894|591754789|FG001|Overall Study|Withdrawal by Subject|9|||
163832135|NCT03217747|591754790|FG000|Overall Study|Adverse Event|0|||
163832136|NCT03217747|591754791|FG001|Overall Study|Adverse Event|1|||
163832137|NCT03217747|591754792|FG002|Overall Study|Adverse Event|0|||
163832138|NCT03217747|591754793|FG003|Overall Study|Adverse Event|0|||
163832139|NCT03217747|591754794|FG004|Overall Study|Adverse Event|0|||
163832140|NCT03217747|591754795|FG005|Overall Study|Adverse Event|0|||
163832141|NCT03217747|591754796|FG006|Overall Study|Adverse Event|0|||
163832142|NCT03217747|591754797|FG007|Overall Study|Adverse Event|0|||
163832143|NCT03217747|591754798|FG008|Overall Study|Adverse Event|0|||
163832144|NCT03217747|591754799|FG009|Overall Study|Adverse Event|0|||
163832145|NCT03217747|591754800|FG010|Overall Study|Adverse Event|0|||
163832146|NCT03217747|591754801|FG011|Overall Study|Adverse Event|0|||
163832147|NCT03217747|591754802|FG012|Overall Study|Adverse Event|1|||
163832148|NCT03217747|591754803|FG013|Overall Study|Adverse Event|1|||
163832149|NCT03217747|591754790|FG000|Overall Study|Death|0|||
163832150|NCT03217747|591754791|FG001|Overall Study|Death|0|||
163832151|NCT03217747|591754792|FG002|Overall Study|Death|0|||
163832152|NCT03217747|591754793|FG003|Overall Study|Death|0|||
163832153|NCT03217747|591754794|FG004|Overall Study|Death|0|||
163832154|NCT03217747|591754795|FG005|Overall Study|Death|0|||
163832155|NCT03217747|591754796|FG006|Overall Study|Death|0|||
163832156|NCT03217747|591754797|FG007|Overall Study|Death|0|||
163832157|NCT03217747|591754798|FG008|Overall Study|Death|1|||
163832158|NCT03217747|591754799|FG009|Overall Study|Death|0|||
163832159|NCT03217747|591754800|FG010|Overall Study|Death|0|||
163832160|NCT03217747|591754801|FG011|Overall Study|Death|0|||
163832161|NCT03217747|591754802|FG012|Overall Study|Death|0|||
163832162|NCT03217747|591754803|FG013|Overall Study|Death|0|||
163832163|NCT03217747|591754790|FG000|Overall Study|Lack of Efficacy|12|||
163832164|NCT03217747|591754791|FG001|Overall Study|Lack of Efficacy|6|||
163832165|NCT03217747|591754792|FG002|Overall Study|Lack of Efficacy|15|||
163832166|NCT03217747|591754793|FG003|Overall Study|Lack of Efficacy|11|||
163832167|NCT03217747|591754794|FG004|Overall Study|Lack of Efficacy|3|||
163832168|NCT03217747|591754795|FG005|Overall Study|Lack of Efficacy|14|||
163832169|NCT03217747|591754796|FG006|Overall Study|Lack of Efficacy|10|||
163832170|NCT03217747|591754797|FG007|Overall Study|Lack of Efficacy|4|||
163832171|NCT03217747|591754798|FG008|Overall Study|Lack of Efficacy|2|||
163832172|NCT03217747|591754799|FG009|Overall Study|Lack of Efficacy|7|||
163832173|NCT03217747|591754800|FG010|Overall Study|Lack of Efficacy|3|||
163832174|NCT03217747|591754801|FG011|Overall Study|Lack of Efficacy|1|||
163832175|NCT03217747|591754802|FG012|Overall Study|Lack of Efficacy|3|||
163832176|NCT03217747|591754803|FG013|Overall Study|Lack of Efficacy|1|||
163832177|NCT03217747|591754790|FG000|Overall Study|Withdrawal by Subject|2|||
163832178|NCT03217747|591754791|FG001|Overall Study|Withdrawal by Subject|1|||
163832179|NCT03217747|591754792|FG002|Overall Study|Withdrawal by Subject|1|||
163832180|NCT03217747|591754793|FG003|Overall Study|Withdrawal by Subject|1|||
163832181|NCT03217747|591754794|FG004|Overall Study|Withdrawal by Subject|1|||
163832182|NCT03217747|591754795|FG005|Overall Study|Withdrawal by Subject|2|||
163832183|NCT03217747|591754796|FG006|Overall Study|Withdrawal by Subject|1|||
163832184|NCT03217747|591754797|FG007|Overall Study|Withdrawal by Subject|0|||
164034950|NCT01998958|592486529|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034951|NCT01998958|592486530|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034952|NCT01998958|592486531|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034953|NCT01998958|592486532|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034954|NCT01998958|592486533|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034955|NCT01998958|592486534|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163832185|NCT03217747|591754798|FG008|Overall Study|Withdrawal by Subject|0|||
163832186|NCT03217747|591754799|FG009|Overall Study|Withdrawal by Subject|0|||
163832187|NCT03217747|591754800|FG010|Overall Study|Withdrawal by Subject|0|||
163832188|NCT03217747|591754801|FG011|Overall Study|Withdrawal by Subject|1|||
163832189|NCT03217747|591754802|FG012|Overall Study|Withdrawal by Subject|0|||
163832190|NCT03217747|591754803|FG013|Overall Study|Withdrawal by Subject|1|||
163832191|NCT03217747|591754790|FG000|Overall Study|Toxicity and progression|1|||
163832192|NCT03217747|591754791|FG001|Overall Study|Toxicity and progression|0|||
163832193|NCT03217747|591754792|FG002|Overall Study|Toxicity and progression|0|||
163832194|NCT03217747|591754793|FG003|Overall Study|Toxicity and progression|0|||
163832195|NCT03217747|591754794|FG004|Overall Study|Toxicity and progression|0|||
163832196|NCT03217747|591754795|FG005|Overall Study|Toxicity and progression|0|||
163832197|NCT03217747|591754796|FG006|Overall Study|Toxicity and progression|0|||
163832198|NCT03217747|591754797|FG007|Overall Study|Toxicity and progression|0|||
164034956|NCT01998958|592486535|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163832199|NCT03217747|591754798|FG008|Overall Study|Toxicity and progression|0|||
163832200|NCT03217747|591754799|FG009|Overall Study|Toxicity and progression|0|||
163832201|NCT03217747|591754800|FG010|Overall Study|Toxicity and progression|0|||
163832202|NCT03217747|591754801|FG011|Overall Study|Toxicity and progression|0|||
163832203|NCT03217747|591754802|FG012|Overall Study|Toxicity and progression|0|||
163832204|NCT03217747|591754803|FG013|Overall Study|Toxicity and progression|0|||
163832205|NCT03217747|591754790|FG000|Overall Study|Removal of sole target lesion|1|||
163832206|NCT03217747|591754791|FG001|Overall Study|Removal of sole target lesion|0|||
163832207|NCT03217747|591754792|FG002|Overall Study|Removal of sole target lesion|0|||
163832208|NCT03217747|591754793|FG003|Overall Study|Removal of sole target lesion|0|||
163832209|NCT03217747|591754794|FG004|Overall Study|Removal of sole target lesion|0|||
163832210|NCT03217747|591754795|FG005|Overall Study|Removal of sole target lesion|0|||
163832211|NCT03217747|591754796|FG006|Overall Study|Removal of sole target lesion|0|||
163832212|NCT03217747|591754797|FG007|Overall Study|Removal of sole target lesion|0|||
163832213|NCT03217747|591754798|FG008|Overall Study|Removal of sole target lesion|0|||
163832214|NCT03217747|591754799|FG009|Overall Study|Removal of sole target lesion|0|||
163832215|NCT03217747|591754800|FG010|Overall Study|Removal of sole target lesion|0|||
163832216|NCT03217747|591754801|FG011|Overall Study|Removal of sole target lesion|0|||
163832217|NCT03217747|591754802|FG012|Overall Study|Removal of sole target lesion|0|||
163832218|NCT03217747|591754803|FG013|Overall Study|Removal of sole target lesion|0|||
163832219|NCT03217747|591754790|FG000|Overall Study|Stroke|0|||
163832220|NCT03217747|591754791|FG001|Overall Study|Stroke|0|||
163927354|NCT00891046|592105585|FG002|Overall Study|Withdrawal by Subject|2|||
163927355|NCT00891046|592105586|FG003|Overall Study|Withdrawal by Subject|1|||
163927356|NCT00891046|592105587|FG004|Overall Study|Withdrawal by Subject|1|||
163927357|NCT00891046|592105583|FG000|Overall Study|Lost to Follow-up|0|||
163927358|NCT00891046|592105584|FG001|Overall Study|Lost to Follow-up|0|||
163927359|NCT00891046|592105585|FG002|Overall Study|Lost to Follow-up|0|||
163927360|NCT00891046|592105586|FG003|Overall Study|Lost to Follow-up|0|||
163927361|NCT00891046|592105587|FG004|Overall Study|Lost to Follow-up|1|||
163927362|NCT02166476|592105588|FG000|Overall Study|Withdrawal by Subject|5|||
163927363|NCT02166476|592105589|FG001|Overall Study|Withdrawal by Subject|7|||
163927364|NCT02166476|592105588|FG000|Overall Study|Adverse Event|3|||
163927365|NCT02166476|592105589|FG001|Overall Study|Adverse Event|3|||
163927366|NCT02166476|592105588|FG000|Overall Study|Lost to Follow-up|5|||
163927367|NCT02166476|592105589|FG001|Overall Study|Lost to Follow-up|10|||
163927368|NCT02166476|592105588|FG000|Overall Study|Physician Decision|1|||
163927369|NCT02166476|592105589|FG001|Overall Study|Physician Decision|0|||
163927370|NCT02166476|592105588|FG000|Overall Study|Unable to Come for Visit|0|||
163927371|NCT02166476|592105589|FG001|Overall Study|Unable to Come for Visit|3|||
163927372|NCT00362375|592105592|FG000|Overall Study|Lost to Follow-up|40|||
163927373|NCT00362375|592105593|FG001|Overall Study|Lost to Follow-up|35|||
163927374|NCT02106195|592105594|FG000|Overall Study|Adverse Event|2|||
163927375|NCT02106195|592105594|FG000|Overall Study|Protocol Violation|1|||
163927376|NCT04984239|592105595|FG000|Overall Study|Lost to Follow-up|1|||
163927377|NCT04523207|592105598|FG000|Overall Study|Adverse Event|5|||
163927378|NCT04523207|592105599|FG001|Overall Study|Adverse Event|1|||
163927379|NCT04523207|592105598|FG000|Overall Study|Lost to Follow-up|2|||
163927380|NCT04523207|592105599|FG001|Overall Study|Lost to Follow-up|0|||
163927381|NCT04523207|592105598|FG000|Overall Study|Withdrawal by Subject|2|||
163927382|NCT04523207|592105599|FG001|Overall Study|Withdrawal by Subject|0|||
163927383|NCT04523207|592105598|FG000|Overall Study|Progressive Disease|2|||
163927384|NCT04523207|592105599|FG001|Overall Study|Progressive Disease|1|||
163927385|NCT04523207|592105598|FG000|Overall Study|Other|7|||
163927386|NCT04523207|592105599|FG001|Overall Study|Other|1|||
163927387|NCT03113383|592105600|FG000|Overall Study|Death|4|||
163927388|NCT03113383|592105601|FG001|Overall Study|Death|0|||
163927389|NCT02438371|592105602|FG000|Overall Study|Lost to Follow-up|3|||
163927390|NCT02438371|592105603|FG001|Overall Study|Lost to Follow-up|2|||
163927391|NCT02438371|592105602|FG000|Overall Study|Withdrawal by Subject|1|||
163927392|NCT02438371|592105603|FG001|Overall Study|Withdrawal by Subject|1|||
163927393|NCT03065933|592105604|FG000|Overall Study|study terminated|5|||
163927394|NCT01513330|592105605|FG000|SenSura Mio First,|Adverse Event|2|||
163927395|NCT01513330|592105606|FG001|SenSura Mio First,|Adverse Event|0|||
163927396|NCT01513330|592105605|FG000|SenSura Mio First,|Lack of Efficacy|0|||
163927397|NCT01513330|592105606|FG001|SenSura Mio First,|Lack of Efficacy|1|||
163927398|NCT01513330|592105605|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
163927399|NCT01513330|592105606|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
163927400|NCT01513330|592105605|FG000|SenSura Mio First,|Other|1|||
163832221|NCT03217747|591754792|FG002|Overall Study|Stroke|0|||
163927401|NCT01513330|592105606|FG001|SenSura Mio First,|Other|0|||
163927402|NCT01513330|592105605|FG000|Standard Care First,|Lack of Efficacy|2|||
163927403|NCT01513330|592105606|FG001|Standard Care First,|Lack of Efficacy|2|||
163927404|NCT01513330|592105605|FG000|Standard Care First,|Withdrawal by Subject|1|||
163927405|NCT01513330|592105606|FG001|Standard Care First,|Withdrawal by Subject|2|||
163927406|NCT01513330|592105605|FG000|Standard Care First,|Other|1|||
163927407|NCT01513330|592105606|FG001|Standard Care First,|Other|0|||
163927408|NCT00916305|592105609|FG000|Overall Study|Lost to Follow-up|21|||
163927409|NCT00916305|592105610|FG001|Overall Study|Lost to Follow-up|27|||
163927410|NCT00916305|592105609|FG000|Overall Study|Withdrawal by Subject|0|||
163927411|NCT00916305|592105610|FG001|Overall Study|Withdrawal by Subject|1|||
163927412|NCT01379703|592105611|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
164147379|NCT05168202|592902027|FG003|Overall Study|Lack of Efficacy|0|||
163832222|NCT03217747|591754793|FG003|Overall Study|Stroke|0|||
163832223|NCT03217747|591754794|FG004|Overall Study|Stroke|0|||
163832224|NCT03217747|591754795|FG005|Overall Study|Stroke|1|||
163832225|NCT03217747|591754796|FG006|Overall Study|Stroke|0|||
163832226|NCT03217747|591754797|FG007|Overall Study|Stroke|0|||
163832227|NCT03217747|591754798|FG008|Overall Study|Stroke|0|||
163832228|NCT03217747|591754799|FG009|Overall Study|Stroke|0|||
163832229|NCT03217747|591754800|FG010|Overall Study|Stroke|0|||
163832230|NCT03217747|591754801|FG011|Overall Study|Stroke|1|||
163832231|NCT03217747|591754802|FG012|Overall Study|Stroke|0|||
163832232|NCT03217747|591754803|FG013|Overall Study|Stroke|0|||
163832233|NCT03248375|591754804|FG000|Overall Study|Lost to Follow-up|5|||
163832234|NCT00394355|591754805|FG000|Overall Study|Adverse Event|10|||
163832235|NCT00394355|591754806|FG001|Overall Study|Adverse Event|6|||
163832236|NCT00394355|591754807|FG002|Overall Study|Adverse Event|7|||
163832237|NCT00394355|591754808|FG003|Overall Study|Adverse Event|8|||
163832238|NCT00394355|591754805|FG000|Overall Study|Did not meet protocol eligibility|1|||
163832239|NCT00394355|591754806|FG001|Overall Study|Did not meet protocol eligibility|5|||
163832240|NCT00394355|591754807|FG002|Overall Study|Did not meet protocol eligibility|4|||
163832241|NCT00394355|591754808|FG003|Overall Study|Did not meet protocol eligibility|2|||
163832242|NCT00394355|591754805|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
163832243|NCT00394355|591754806|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
163832244|NCT00394355|591754807|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
163832245|NCT00394355|591754808|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
163832246|NCT00394355|591754805|FG000|Overall Study|Subject withdrawal - related to drug|1|||
163832247|NCT00394355|591754806|FG001|Overall Study|Subject withdrawal - related to drug|0|||
163832248|NCT00394355|591754807|FG002|Overall Study|Subject withdrawal - related to drug|0|||
163832249|NCT00394355|591754808|FG003|Overall Study|Subject withdrawal - related to drug|0|||
163832250|NCT00394355|591754805|FG000|Overall Study|Lost to Follow-up|7|||
163832251|NCT00394355|591754806|FG001|Overall Study|Lost to Follow-up|5|||
163832252|NCT00394355|591754807|FG002|Overall Study|Lost to Follow-up|4|||
163832253|NCT00394355|591754808|FG003|Overall Study|Lost to Follow-up|3|||
163832254|NCT00394355|591754805|FG000|Overall Study|Noncompliance with protocol|4|||
163832255|NCT00394355|591754806|FG001|Overall Study|Noncompliance with protocol|3|||
163832256|NCT00394355|591754807|FG002|Overall Study|Noncompliance with protocol|10|||
163832257|NCT00394355|591754808|FG003|Overall Study|Noncompliance with protocol|8|||
163832258|NCT00394355|591754805|FG000|Overall Study|Administrative|0|||
163832259|NCT00394355|591754806|FG001|Overall Study|Administrative|1|||
163832260|NCT00394355|591754807|FG002|Overall Study|Administrative|1|||
163832261|NCT00394355|591754808|FG003|Overall Study|Administrative|1|||
163832262|NCT00394355|591754805|FG000|Overall Study|Lack of Efficacy|0|||
163832263|NCT00394355|591754806|FG001|Overall Study|Lack of Efficacy|0|||
163832264|NCT00394355|591754807|FG002|Overall Study|Lack of Efficacy|2|||
163832265|NCT00394355|591754808|FG003|Overall Study|Lack of Efficacy|3|||
163832266|NCT02618616|591754811|FG000|Overall Study|Lack of Efficacy|4|||
163832267|NCT02618616|591754812|FG001|Overall Study|Lack of Efficacy|0|||
163832268|NCT02618616|591754811|FG000|Overall Study|Pregnancy|0|||
163832269|NCT02618616|591754812|FG001|Overall Study|Pregnancy|1|||
163832270|NCT02618616|591754811|FG000|Overall Study|Adverse Event|8|||
163832271|NCT02618616|591754812|FG001|Overall Study|Adverse Event|0|||
163832272|NCT02618616|591754811|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
163832273|NCT02618616|591754812|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
163832274|NCT02618616|591754811|FG000|Overall Study|Consent withdrawn by subject|8|||
163832275|NCT02618616|591754812|FG001|Overall Study|Consent withdrawn by subject|5|||
163832276|NCT02618616|591754811|FG000|Overall Study|Lost to Follow-up|0|||
163832277|NCT02618616|591754812|FG001|Overall Study|Lost to Follow-up|1|||
163832278|NCT00459342|591754813|FG000|Overall Study|Not eligible|1|||
163832279|NCT00558064|591754814|FG000|Overall Study|Adverse Event|3|||
163832280|NCT00558064|591754815|FG001|Overall Study|Adverse Event|2|||
163832281|NCT00558064|591754814|FG000|Overall Study|Lack of Efficacy|0|||
163832282|NCT00558064|591754815|FG001|Overall Study|Lack of Efficacy|1|||
163832283|NCT00558064|591754814|FG000|Overall Study|Protocol Violation|1|||
163832284|NCT00558064|591754815|FG001|Overall Study|Protocol Violation|0|||
163832285|NCT00558064|591754814|FG000|Overall Study|Lost to Follow-up|0|||
163832286|NCT00558064|591754815|FG001|Overall Study|Lost to Follow-up|1|||
163832287|NCT00558064|591754814|FG000|Overall Study|Withdrawal by Subject|0|||
163832288|NCT00558064|591754815|FG001|Overall Study|Withdrawal by Subject|1|||
163832289|NCT00558064|591754814|FG000|Overall Study|No visit within allowance period|1|||
163832290|NCT00558064|591754815|FG001|Overall Study|No visit within allowance period|0|||
163832291|NCT02027402|591754816|FG000|Overall Study|Withdrawal by Subject|4|||
163832292|NCT02027402|591754817|FG001|Overall Study|Withdrawal by Subject|1|||
163832293|NCT04108000|591754820|FG000|Overall Study|Death of patient|1|||
163832294|NCT04108000|591754821|FG001|Overall Study|Death of patient|0|||
163832295|NCT04108000|591754822|FG002|Overall Study|Death of patient|1|||
163832296|NCT04108000|591754823|FG003|Overall Study|Death of patient|0|||
163832297|NCT04108000|591754820|FG000|Overall Study|Withdrawal by Subject|2|||
163832298|NCT04108000|591754821|FG001|Overall Study|Withdrawal by Subject|2|||
163832299|NCT04108000|591754822|FG002|Overall Study|Withdrawal by Subject|0|||
163832300|NCT04108000|591754823|FG003|Overall Study|Withdrawal by Subject|0|||
163832301|NCT04108000|591754820|FG000|Overall Study|Death of surrogate partner|0|||
163832302|NCT04108000|591754821|FG001|Overall Study|Death of surrogate partner|1|||
163832303|NCT04108000|591754822|FG002|Overall Study|Death of surrogate partner|0|||
163832304|NCT04108000|591754823|FG003|Overall Study|Death of surrogate partner|1|||
163832305|NCT03904043|591754824|FG000|Overall Study|Adverse Event|1|||
163832306|NCT03904043|591754825|FG001|Overall Study|Adverse Event|1|||
163832307|NCT03904043|591754824|FG000|Overall Study|Withdrawal by Subject|1|||
163832308|NCT03904043|591754825|FG001|Overall Study|Withdrawal by Subject|0|||
163832309|NCT03904043|591754824|FG000|Overall Study|Non-compliance|1|||
163832310|NCT03904043|591754825|FG001|Overall Study|Non-compliance|0|||
163832311|NCT03904043|591754824|FG000|Overall Study|Did not start treatment|1|||
163832312|NCT03904043|591754825|FG001|Overall Study|Did not start treatment|0|||
163832313|NCT05002218|591754833|FG000|Overall Study|Lost to Follow-up|5|||
163832314|NCT05002218|591754834|FG001|Overall Study|Lost to Follow-up|6|||
163832315|NCT03779906|591754835|FG000|Overall Study|Lost to Follow-up|7|||
163832316|NCT03779906|591754835|FG000|Overall Study|COVID pandemic|1|||
163832317|NCT03421808|591754836|FG000|Overall Study|COVID related problems|2|||
163832318|NCT03421808|591754837|FG001|Overall Study|COVID related problems|0|||
163832319|NCT03421808|591754836|FG000|Overall Study|Withdrawal by Subject|1|||
163832320|NCT03421808|591754837|FG001|Overall Study|Withdrawal by Subject|0|||
163832321|NCT03421808|591754836|FG000|Overall Study|Protocol Violation|0|||
164034957|NCT01998958|592486536|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034958|NCT01998958|592486537|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034959|NCT01998958|592486538|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
164034960|NCT01998958|592486539|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
164034961|NCT01998958|592486540|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
164034962|NCT01998958|592486541|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034963|NCT01998958|592486542|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034964|NCT01998958|592486543|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034965|NCT01998958|592486544|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034966|NCT01998958|592486545|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
163832322|NCT03421808|591754837|FG001|Overall Study|Protocol Violation|1|||
163832323|NCT03764774|591754838|FG000|Overall Study|Withdrawal by Subject|0|||
163832324|NCT03764774|591754839|FG001|Overall Study|Withdrawal by Subject|0|||
163832325|NCT03764774|591754840|FG002|Overall Study|Withdrawal by Subject|0|||
163832326|NCT03764774|591754841|FG003|Overall Study|Withdrawal by Subject|0|||
163832327|NCT03764774|591754842|FG004|Overall Study|Withdrawal by Subject|0|||
163832328|NCT03764774|591754843|FG005|Overall Study|Withdrawal by Subject|0|||
163832329|NCT03764774|591754844|FG006|Overall Study|Withdrawal by Subject|0|||
163832330|NCT03764774|591754845|FG007|Overall Study|Withdrawal by Subject|0|||
164034967|NCT01998958|592486546|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034968|NCT01998958|592486547|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034969|NCT01998958|592486548|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
164034970|NCT02432703|592486549|FG000|Overall Study|Adverse Event|1|||
164034971|NCT02432703|592486550|FG001|Overall Study|Adverse Event|4|||
164034972|NCT02432703|592486549|FG000|Overall Study|Lack of Efficacy|1|||
164034973|NCT02432703|592486550|FG001|Overall Study|Lack of Efficacy|0|||
164034974|NCT02432703|592486549|FG000|Overall Study|Lost to Follow-up|5|||
164034975|NCT02432703|592486550|FG001|Overall Study|Lost to Follow-up|3|||
164034976|NCT02432703|592486549|FG000|Overall Study|Withdrawal by Subject|9|||
164034977|NCT02432703|592486550|FG001|Overall Study|Withdrawal by Subject|6|||
164034978|NCT02432703|592486549|FG000|Overall Study|Other|6|||
164034979|NCT02432703|592486550|FG001|Overall Study|Other|5|||
164034980|NCT02137837|592486554|FG000|Overall Study|Adverse Event|0|||
164034981|NCT02137837|592486555|FG001|Overall Study|Adverse Event|2|||
164034982|NCT02137837|592486556|FG002|Overall Study|Adverse Event|1|||
163832331|NCT03764774|591754846|FG008|Overall Study|Withdrawal by Subject|0|||
163832332|NCT03764774|591754847|FG009|Overall Study|Withdrawal by Subject|0|||
163832333|NCT03764774|591754848|FG010|Overall Study|Withdrawal by Subject|1|||
163832334|NCT03764774|591754849|FG011|Overall Study|Withdrawal by Subject|0|||
163832335|NCT03764774|591754850|FG012|Overall Study|Withdrawal by Subject|0|||
163832336|NCT03764774|591754851|FG013|Overall Study|Withdrawal by Subject|0|||
163832337|NCT03764774|591754838|FG000|Overall Study|Adverse Event|0|||
163832338|NCT03764774|591754839|FG001|Overall Study|Adverse Event|0|||
163832339|NCT03764774|591754840|FG002|Overall Study|Adverse Event|0|||
163832340|NCT03764774|591754841|FG003|Overall Study|Adverse Event|0|||
164098038|NCT00050778|592725004|FG001|Overall Study|Withdrawal by Subject|8|||
163832341|NCT03764774|591754842|FG004|Overall Study|Adverse Event|0|||
163832342|NCT03764774|591754843|FG005|Overall Study|Adverse Event|0|||
164034983|NCT02137837|592486554|FG000|Overall Study|Refusal unrelated to adverse event|2|||
164034984|NCT02137837|592486555|FG001|Overall Study|Refusal unrelated to adverse event|2|||
164034985|NCT02137837|592486556|FG002|Overall Study|Refusal unrelated to adverse event|1|||
164034986|NCT02137837|592486554|FG000|Overall Study|Progression/relapse|9|||
164034987|NCT02137837|592486555|FG001|Overall Study|Progression/relapse|7|||
164034988|NCT02137837|592486556|FG002|Overall Study|Progression/relapse|7|||
163832343|NCT03764774|591754844|FG006|Overall Study|Adverse Event|0|||
163832344|NCT03764774|591754845|FG007|Overall Study|Adverse Event|0|||
163832345|NCT03764774|591754846|FG008|Overall Study|Adverse Event|0|||
163832346|NCT03764774|591754847|FG009|Overall Study|Adverse Event|0|||
163832347|NCT03764774|591754848|FG010|Overall Study|Adverse Event|0|||
163832348|NCT03764774|591754849|FG011|Overall Study|Adverse Event|0|||
163832349|NCT03764774|591754850|FG012|Overall Study|Adverse Event|2|||
163832350|NCT03764774|591754851|FG013|Overall Study|Adverse Event|0|||
164034989|NCT02137837|592486554|FG000|Overall Study|Not protocol specified|2|||
164034990|NCT02137837|592486555|FG001|Overall Study|Not protocol specified|1|||
164034991|NCT02137837|592486556|FG002|Overall Study|Not protocol specified|3|||
164034992|NCT01329341|592486557|FG000|Overall Study|Withdrawal by Subject|44|||
164034993|NCT00448760|592486558|FG000|Overall Study|Death|3|||
164034994|NCT00561340|592486559|FG000|Overall Study|refused to drink pediasure|6|||
164034995|NCT00561340|592486560|FG001|Overall Study|refused to drink pediasure|0|||
164034996|NCT00618995|592486562|FG000|Period 1|Adverse Event|0|||
164034997|NCT00618995|592486563|FG001|Period 1|Adverse Event|0|||
164034998|NCT00618995|592486564|FG002|Period 1|Adverse Event|1|||
164034999|NCT00618995|592486565|FG003|Period 1|Adverse Event|0|||
164035000|NCT00618995|592486562|FG000|Period 1|Protocol Violation|0|||
164035001|NCT00618995|592486563|FG001|Period 1|Protocol Violation|1|||
164035002|NCT00618995|592486564|FG002|Period 1|Protocol Violation|1|||
164035003|NCT00618995|592486565|FG003|Period 1|Protocol Violation|0|||
164035004|NCT00618995|592486562|FG000|Period 2|Protocol Violation|0|||
164035005|NCT00618995|592486563|FG001|Period 2|Protocol Violation|0|||
164035006|NCT00618995|592486564|FG002|Period 2|Protocol Violation|1|||
164035007|NCT00618995|592486565|FG003|Period 2|Protocol Violation|0|||
164035008|NCT00618995|592486562|FG000|Period 4|Adverse Event|1|||
164035009|NCT00618995|592486563|FG001|Period 4|Adverse Event|0|||
164035010|NCT00618995|592486564|FG002|Period 4|Adverse Event|0|||
164035011|NCT00618995|592486565|FG003|Period 4|Adverse Event|0|||
164035012|NCT00290589|592486567|FG000|Overall Study|Lost to Follow-up|2|||
164035013|NCT00290589|592486568|FG001|Overall Study|Lost to Follow-up|2|||
164035014|NCT00973622|592486569|FG000|Overall Study|did not attend MRI|14|||
164035015|NCT00973622|592486570|FG001|Overall Study|did not attend MRI|3|||
164035016|NCT00973622|592486569|FG000|Overall Study|did not pass MRI screen|6|||
164035017|NCT00973622|592486570|FG001|Overall Study|did not pass MRI screen|0|||
164035018|NCT00973622|592486569|FG000|Overall Study|did not complete rTMS sessions|11|||
164035019|NCT00973622|592486570|FG001|Overall Study|did not complete rTMS sessions|2|||
164035020|NCT00555568|592486571|FG000|Overall Study|Lost to Follow-up|26|||
164035021|NCT00555568|592486572|FG001|Overall Study|Lost to Follow-up|16|||
164035022|NCT00555568|592486573|FG002|Overall Study|Lost to Follow-up|16|||
164035023|NCT06000501|592486574|FG000|Overall Study|Screen failure|3|||
164035024|NCT06000501|592486574|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
164035025|NCT06000501|592486574|FG000|Overall Study|Physician Decision|4|||
164035026|NCT06000501|592486574|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
164035027|NCT06000501|592486574|FG000|Overall Study|Scheduling issues|2|||
164035028|NCT03814005|592486576|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
164035029|NCT03814005|592486577|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
164035030|NCT03814005|592486578|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
164035031|NCT03814005|592486576|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
164035032|NCT03814005|592486577|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
164035033|NCT03814005|592486578|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
164035034|NCT03814005|592486576|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
164035035|NCT03814005|592486577|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
163832351|NCT03764774|591754838|FG000|Overall Study|Lost to Follow-up|0|||
163832352|NCT03764774|591754839|FG001|Overall Study|Lost to Follow-up|0|||
163832353|NCT03764774|591754840|FG002|Overall Study|Lost to Follow-up|0|||
163832354|NCT03764774|591754841|FG003|Overall Study|Lost to Follow-up|0|||
164035036|NCT03814005|592486578|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
164035037|NCT03814005|592486576|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
164035038|NCT03814005|592486577|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
164035039|NCT03814005|592486578|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
164035040|NCT03814005|592486576|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
164035041|NCT03814005|592486577|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
164035042|NCT03814005|592486578|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
164035043|NCT03814005|592486576|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
164035044|NCT03814005|592486577|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
164035045|NCT03814005|592486578|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
164035046|NCT00965146|592486579|FG000|Overall Study|Death|7|||
163832355|NCT03764774|591754842|FG004|Overall Study|Lost to Follow-up|0|||
163832356|NCT03764774|591754843|FG005|Overall Study|Lost to Follow-up|0|||
164035047|NCT00965146|592486579|FG000|Overall Study|Lost to Follow-up|22|||
164035048|NCT00965146|592486579|FG000|Overall Study|Withdrawal by Subject|17|||
164035049|NCT00965146|592486579|FG000|Overall Study|Unable to return|1|||
164035050|NCT00965146|592486579|FG000|Overall Study|Unwilling to return|11|||
163832357|NCT03764774|591754844|FG006|Overall Study|Lost to Follow-up|0|||
164098039|NCT00050778|592725005|FG002|Overall Study|Withdrawal by Subject|4|||
164098040|NCT00050778|592725003|FG000|Overall Study|Randomized but not treated|4|||
164098041|NCT00050778|592725004|FG001|Overall Study|Randomized but not treated|5|||
164098042|NCT00050778|592725005|FG002|Overall Study|Randomized but not treated|2|||
164098043|NCT00050778|592725003|FG000|Overall Study|Familial and personal reasons|1|||
164098044|NCT00050778|592725004|FG001|Overall Study|Familial and personal reasons|0|||
164098045|NCT00050778|592725005|FG002|Overall Study|Familial and personal reasons|0|||
164098046|NCT01035060|592725006|FG000|Overall Study|Lost to Follow-up|0|||
164098047|NCT01035060|592725007|FG001|Overall Study|Lost to Follow-up|7|||
164098048|NCT01035060|592725006|FG000|Overall Study|Did not quality after 2nd screening|14|||
164098049|NCT01035060|592725007|FG001|Overall Study|Did not quality after 2nd screening|1|||
164098050|NCT01035060|592725006|FG000|Overall Study|Withdrawal by Subject|8|||
164098051|NCT01035060|592725007|FG001|Overall Study|Withdrawal by Subject|6|||
164098052|NCT01035060|592725006|FG000|Overall Study|Physician Decision|2|||
164098053|NCT01035060|592725007|FG001|Overall Study|Physician Decision|0|||
164098054|NCT00625443|592725009|FG000|Overall Study|Adverse Event|1|||
164098055|NCT00625443|592725010|FG001|Overall Study|Adverse Event|4|||
164098056|NCT00625443|592725011|FG002|Overall Study|Adverse Event|0|||
164098057|NCT00625443|592725009|FG000|Overall Study|Non-compliance with protocol|0|||
164098058|NCT00625443|592725010|FG001|Overall Study|Non-compliance with protocol|1|||
164098059|NCT00625443|592725011|FG002|Overall Study|Non-compliance with protocol|0|||
164098060|NCT00625443|592725009|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
164098061|NCT00625443|592725010|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
164098062|NCT00625443|592725011|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
164098063|NCT00625443|592725009|FG000|Overall Study|Withdrawal by Subject|0|||
164098064|NCT00625443|592725010|FG001|Overall Study|Withdrawal by Subject|1|||
164098065|NCT00625443|592725011|FG002|Overall Study|Withdrawal by Subject|2|||
164098066|NCT00625443|592725009|FG000|Overall Study|Physician Decision|0|||
164098067|NCT00625443|592725010|FG001|Overall Study|Physician Decision|4|||
164098068|NCT00625443|592725011|FG002|Overall Study|Physician Decision|2|||
164098069|NCT00625443|592725009|FG000|Overall Study|Other|0|||
164098070|NCT00625443|592725010|FG001|Overall Study|Other|1|||
164098071|NCT00625443|592725011|FG002|Overall Study|Other|1|||
164098072|NCT02015390|592725012|FG000|Overall Study|Lost to Follow-up|1|||
164098073|NCT02015390|592725013|FG001|Overall Study|Lost to Follow-up|0|||
164098074|NCT02015390|592725012|FG000|Overall Study|Adverse Event|0|||
164098075|NCT02015390|592725013|FG001|Overall Study|Adverse Event|3|||
164098076|NCT02015390|592725012|FG000|Overall Study|Physician Decision|0|||
164098077|NCT02015390|592725013|FG001|Overall Study|Physician Decision|1|||
164098078|NCT03136380|592725014|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164098079|NCT03136380|592725015|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
164098080|NCT03136380|592725016|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164098081|NCT03136380|592725017|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164098082|NCT03136380|592725018|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164098083|NCT01661686|592725019|FG000|Overall Study|Lost to Follow-up|2|||
164098084|NCT01661686|592725020|FG001|Overall Study|Lost to Follow-up|1|||
164098085|NCT01661686|592725019|FG000|Overall Study|did not receive allocated intervention|0|||
164098086|NCT01661686|592725020|FG001|Overall Study|did not receive allocated intervention|1|||
164098087|NCT01720264|592725025|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
164098088|NCT01720264|592725025|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
164098089|NCT01720264|592725025|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
164098090|NCT02728102|592725026|FG000|Overall Study|Death|3|||
164098091|NCT02728102|592725027|FG001|Overall Study|Death|0|||
164098092|NCT02728102|592725028|FG002|Overall Study|Death|1|||
164098093|NCT02728102|592725026|FG000|Overall Study|Withdrawal by Subject|0|||
164098094|NCT02728102|592725027|FG001|Overall Study|Withdrawal by Subject|2|||
164098095|NCT02728102|592725028|FG002|Overall Study|Withdrawal by Subject|3|||
164098096|NCT02728102|592725026|FG000|Overall Study|Physician Decision|1|||
164098097|NCT02728102|592725027|FG001|Overall Study|Physician Decision|1|||
164098098|NCT02728102|592725028|FG002|Overall Study|Physician Decision|0|||
163832358|NCT03764774|591754845|FG007|Overall Study|Lost to Follow-up|0|||
164098099|NCT02728102|592725026|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
164098100|NCT02728102|592725027|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
164098101|NCT02728102|592725028|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
164098102|NCT02728102|592725026|FG000|Overall Study|Covid|0|||
164098103|NCT02728102|592725027|FG001|Overall Study|Covid|0|||
164098104|NCT02728102|592725028|FG002|Overall Study|Covid|1|||
164098105|NCT04869787|592725029|FG000|Screening|Physician Decision|1|||
164098106|NCT04869787|592725029|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
164098107|NCT00553280|592725031|FG000|Overall Study|Adverse Event|19|||
164098108|NCT00553280|592725031|FG000|Overall Study|Lack of Efficacy|3|||
164098109|NCT00553280|592725031|FG000|Overall Study|Withdrawal by Subject|3|||
164098110|NCT00553280|592725031|FG000|Overall Study|Physician Decision|1|||
164098111|NCT01544127|592725032|FG000|Overall Study|Lost to Follow-up|4|||
164098112|NCT01544127|592725033|FG001|Overall Study|Lost to Follow-up|2|||
164098113|NCT01544127|592725034|FG002|Overall Study|Lost to Follow-up|9|||
163832359|NCT03764774|591754846|FG008|Overall Study|Lost to Follow-up|0|||
163832360|NCT03764774|591754847|FG009|Overall Study|Lost to Follow-up|0|||
163832361|NCT03764774|591754848|FG010|Overall Study|Lost to Follow-up|0|||
163832362|NCT03764774|591754849|FG011|Overall Study|Lost to Follow-up|0|||
163832363|NCT03764774|591754850|FG012|Overall Study|Lost to Follow-up|0|||
163832364|NCT03764774|591754851|FG013|Overall Study|Lost to Follow-up|1|||
163832365|NCT03764774|591754838|FG000|Overall Study|Physician Decision|0|||
163832366|NCT03764774|591754839|FG001|Overall Study|Physician Decision|0|||
163832367|NCT03764774|591754840|FG002|Overall Study|Physician Decision|0|||
163832368|NCT03764774|591754841|FG003|Overall Study|Physician Decision|0|||
163832369|NCT03764774|591754842|FG004|Overall Study|Physician Decision|0|||
163832370|NCT03764774|591754843|FG005|Overall Study|Physician Decision|0|||
163832371|NCT03764774|591754844|FG006|Overall Study|Physician Decision|0|||
163832372|NCT03764774|591754845|FG007|Overall Study|Physician Decision|0|||
163832373|NCT03764774|591754846|FG008|Overall Study|Physician Decision|0|||
163832374|NCT03764774|591754847|FG009|Overall Study|Physician Decision|4|||
163832375|NCT03764774|591754848|FG010|Overall Study|Physician Decision|1|||
163832376|NCT03764774|591754849|FG011|Overall Study|Physician Decision|4|||
163832377|NCT03764774|591754850|FG012|Overall Study|Physician Decision|9|||
163832378|NCT03764774|591754851|FG013|Overall Study|Physician Decision|0|||
163832379|NCT03764774|591754838|FG000|Overall Study|Study Termination|0|||
163832380|NCT03764774|591754839|FG001|Overall Study|Study Termination|0|||
163832381|NCT03764774|591754840|FG002|Overall Study|Study Termination|0|||
163832382|NCT03764774|591754841|FG003|Overall Study|Study Termination|0|||
163832383|NCT03764774|591754842|FG004|Overall Study|Study Termination|0|||
163832384|NCT03764774|591754843|FG005|Overall Study|Study Termination|0|||
163832385|NCT03764774|591754844|FG006|Overall Study|Study Termination|0|||
163832386|NCT03764774|591754845|FG007|Overall Study|Study Termination|0|||
163832387|NCT03764774|591754846|FG008|Overall Study|Study Termination|0|||
163832388|NCT03764774|591754847|FG009|Overall Study|Study Termination|1|||
163832389|NCT03764774|591754848|FG010|Overall Study|Study Termination|0|||
163832390|NCT03764774|591754849|FG011|Overall Study|Study Termination|0|||
163832391|NCT03764774|591754850|FG012|Overall Study|Study Termination|0|||
163832392|NCT03764774|591754851|FG013|Overall Study|Study Termination|2|||
163832393|NCT06027619|591754854|FG000|Overall Study|Adverse Event|0|||
163832394|NCT06027619|591754855|FG001|Overall Study|Adverse Event|0|||
163832395|NCT06027619|591754856|FG002|Overall Study|Adverse Event|1|||
163832396|NCT00766675|591756241|FG000|Overall Study|Adverse Event|16|||
163832397|NCT00766675|591756241|FG000|Overall Study|Lost to Follow-up|2|||
163832398|NCT00766675|591756241|FG000|Overall Study|Withdrawal by Subject|11|||
163832399|NCT00766675|591756241|FG000|Overall Study|Protocol Violation|8|||
163832400|NCT00766675|591756241|FG000|Overall Study|Participant took prohibited medication|1|||
163832401|NCT00766675|591756241|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
163832402|NCT00766675|591756241|FG000|Overall Study|Insufficient therapy|1|||
163832403|NCT03183388|591756242|FG000|Overall Study|Lost to Follow-up|3|||
163832404|NCT03183388|591756243|FG001|Overall Study|Lost to Follow-up|5|||
163832405|NCT03183388|591756242|FG000|Overall Study|Physician Decision|1|||
163832406|NCT03183388|591756243|FG001|Overall Study|Physician Decision|4|||
163832407|NCT03183388|591756242|FG000|Overall Study|Withdrawal by Subject|4|||
163832408|NCT03183388|591756243|FG001|Overall Study|Withdrawal by Subject|1|||
163832409|NCT03183388|591756242|FG000|Overall Study|Moved|1|||
163832410|NCT03183388|591756243|FG001|Overall Study|Moved|0|||
163832411|NCT03183388|591756242|FG000|Overall Study|Met Exclusion Criteria|2|||
163832412|NCT03183388|591756243|FG001|Overall Study|Met Exclusion Criteria|2|||
163832413|NCT03183388|591756242|FG000|Overall Study|COVID Pandemic Related|2|||
163832414|NCT03183388|591756243|FG001|Overall Study|COVID Pandemic Related|4|||
163832415|NCT01493960|591756246|FG000|Overall Study|Adverse Event|0|||
163832416|NCT01493960|591756247|FG001|Overall Study|Adverse Event|1|||
163832417|NCT01493960|591756246|FG000|Overall Study|Lack of Efficacy|15|||
163832418|NCT01493960|591756247|FG001|Overall Study|Lack of Efficacy|9|||
163832419|NCT01493960|591756246|FG000|Overall Study|Protocol Violation|3|||
163832420|NCT01493960|591756247|FG001|Overall Study|Protocol Violation|0|||
163832421|NCT01493960|591756246|FG000|Overall Study|Withdrawal by Subject|10|||
163832422|NCT01493960|591756247|FG001|Overall Study|Withdrawal by Subject|4|||
163832423|NCT01493960|591756246|FG000|Overall Study|Non-specified|4|||
163832424|NCT01493960|591756247|FG001|Overall Study|Non-specified|4|||
163832425|NCT01679236|591756248|FG000|Overall Study|Lost to Follow-up|15|||
163832426|NCT01679236|591756249|FG001|Overall Study|Lost to Follow-up|15|||
163832427|NCT03935217|591756250|FG000|Overall Study|Adverse Event|1|||
163832428|NCT03935217|591756251|FG001|Overall Study|Adverse Event|0|||
163832429|NCT03935217|591756250|FG000|Overall Study|Lost to Follow-up|0|||
163832430|NCT03935217|591756251|FG001|Overall Study|Lost to Follow-up|1|||
163832431|NCT03935217|591756250|FG000|Overall Study|Withdrawal by Subject|0|||
163832432|NCT03935217|591756251|FG001|Overall Study|Withdrawal by Subject|2|||
163832433|NCT01160484|591756255|FG000|Overall Study|Lack of Efficacy|9|||
163832434|NCT01160484|591756255|FG000|Overall Study|Adverse Event|6|||
163832435|NCT01160484|591756255|FG000|Overall Study|Withdrawal by Subject|2|||
163832436|NCT01160484|591756255|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
163832437|NCT00803101|591756256|FG000|Overall Study|Death / Serious Adverse Event|4|||
163832438|NCT00803101|591756257|FG001|Overall Study|Death / Serious Adverse Event|6|||
163832439|NCT00803101|591756256|FG000|Overall Study|Withdrawal by Subject|6|||
163832440|NCT00803101|591756257|FG001|Overall Study|Withdrawal by Subject|4|||
163832441|NCT00803101|591756256|FG000|Overall Study|Lost to Follow-up|2|||
163832442|NCT00803101|591756257|FG001|Overall Study|Lost to Follow-up|2|||
163832443|NCT00803101|591756256|FG000|Overall Study|Protocol Violation|1|||
163832444|NCT00803101|591756257|FG001|Overall Study|Protocol Violation|7|||
163832445|NCT00803101|591756256|FG000|Overall Study|Surgery finished outside protocol window|1|||
163832446|NCT00803101|591756257|FG001|Overall Study|Surgery finished outside protocol window|1|||
163832447|NCT00803101|591756256|FG000|Overall Study|Patient died outside SAE report period|1|||
163832448|NCT00803101|591756257|FG001|Overall Study|Patient died outside SAE report period|0|||
163832449|NCT00803101|591756256|FG000|Overall Study|Patient did not attend scheduled visit|2|||
163832450|NCT00803101|591756257|FG001|Overall Study|Patient did not attend scheduled visit|1|||
163832451|NCT00803101|591756256|FG000|Overall Study|Patient did not have surgery|1|||
163832452|NCT00803101|591756257|FG001|Overall Study|Patient did not have surgery|1|||
163832453|NCT02026232|591756260|FG000|Overall Study|incomplete visit/missing data|3|||
163832454|NCT02026232|591756261|FG001|Overall Study|incomplete visit/missing data|2|||
163832455|NCT01529008|591756262|FG000|Bone Marrow Harvesting|Physician Decision|1|||
163832456|NCT01529008|591756263|FG001|Bone Marrow Harvesting|Physician Decision|1|||
163832457|NCT01529008|591756262|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
163832458|NCT01529008|591756263|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
163832459|NCT01529008|591756262|FG000|Treatment|Adverse Event|6|||
163832460|NCT01529008|591756263|FG001|Treatment|Adverse Event|0|||
163832461|NCT01529008|591756262|FG000|Treatment|Other|3|||
163832462|NCT01529008|591756263|FG001|Treatment|Other|1|||
163832463|NCT01529008|591756262|FG000|Efficacy Analysis|Protocol Violation|2|||
163832464|NCT01529008|591756263|FG001|Efficacy Analysis|Protocol Violation|0|||
163832465|NCT01529008|591756262|FG000|Efficacy Analysis|Physician Decision|0|||
163832466|NCT01529008|591756263|FG001|Efficacy Analysis|Physician Decision|1|||
163832467|NCT01529008|591756262|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
163832468|NCT01529008|591756263|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
163832469|NCT01382602|591756264|FG000|Overall Study|Protocol Violation|0|||
163832470|NCT01382602|591756265|FG001|Overall Study|Protocol Violation|3|||
163832471|NCT01382602|591756264|FG000|Overall Study|Withdrawal by Subject|0|||
163832472|NCT01382602|591756265|FG001|Overall Study|Withdrawal by Subject|1|||
163832473|NCT01392300|591756273|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
163832474|NCT01392300|591756274|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
163832475|NCT01392300|591756275|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
163832476|NCT01392300|591756273|FG000|Main Period (MP)|Withdrawal by Subject|5|||
163832477|NCT01392300|591756274|FG001|Main Period (MP)|Withdrawal by Subject|1|||
163832478|NCT01392300|591756275|FG002|Main Period (MP)|Withdrawal by Subject|0|||
163832479|NCT01392300|591756273|FG000|Main Period (MP)|Lost to Follow-up|3|||
163832480|NCT01392300|591756274|FG001|Main Period (MP)|Lost to Follow-up|3|||
163832481|NCT01392300|591756275|FG002|Main Period (MP)|Lost to Follow-up|0|||
163832482|NCT01392300|591756273|FG000|Main Period (MP)|Non-compliance|1|||
163832483|NCT01392300|591756274|FG001|Main Period (MP)|Non-compliance|0|||
163832484|NCT01392300|591756275|FG002|Main Period (MP)|Non-compliance|0|||
163832485|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
163832486|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
163832487|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
163832488|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
163832489|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
163832490|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
163832491|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
163832492|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
163832493|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
163832494|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Death|0|||
163832495|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Death|0|||
163832496|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Death|4|||
163832497|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
163832498|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
163832499|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
163832500|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
163832501|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
163832502|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
163832503|NCT01392300|591756273|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
163832504|NCT01392300|591756274|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
163832505|NCT01392300|591756275|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
163832506|NCT02487498|591756276|FG000|Period: Period 1|Adverse Event|2|||
163832507|NCT02487498|591756277|FG001|Period: Period 1|Adverse Event|4|||
163832508|NCT02487498|591756276|FG000|Period: Period 1|Subject/guardian decision|2|||
164098114|NCT01544127|592725032|FG000|Overall Study|Withdrawal by Subject|2|||
164098115|NCT01544127|592725033|FG001|Overall Study|Withdrawal by Subject|2|||
163927413|NCT01379703|592105612|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
163927414|NCT01379703|592105613|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
163927415|NCT01379703|592105611|FG000|Study Start Through 9 Months|Adverse Event|0|||
163832509|NCT02487498|591756277|FG001|Period: Period 1|Subject/guardian decision|4|||
163832510|NCT02487498|591756276|FG000|Period: Period 1|Lost to Follow-up|0|||
163832511|NCT02487498|591756277|FG001|Period: Period 1|Lost to Follow-up|2|||
163832512|NCT02487498|591756276|FG000|Period: Period 1|Lack of Efficacy|1|||
163832513|NCT02487498|591756277|FG001|Period: Period 1|Lack of Efficacy|0|||
163832514|NCT02487498|591756276|FG000|Period: Period 1|Physician Decision|0|||
163832515|NCT02487498|591756277|FG001|Period: Period 1|Physician Decision|1|||
163832516|NCT02487498|591756276|FG000|Period: Period 1|Protocol deviation|1|||
163832517|NCT02487498|591756277|FG001|Period: Period 1|Protocol deviation|0|||
163832518|NCT02487498|591756276|FG000|Period: Washout|Subject/guardian decision|0|||
163832519|NCT02487498|591756277|FG001|Period: Washout|Subject/guardian decision|5|||
163832520|NCT02487498|591756276|FG000|Period: Washout|Lack of Efficacy|1|||
163832521|NCT02487498|591756277|FG001|Period: Washout|Lack of Efficacy|1|||
163832522|NCT02487498|591756276|FG000|Period: Washout|Physician Decision|1|||
163832523|NCT02487498|591756277|FG001|Period: Washout|Physician Decision|0|||
163832524|NCT02487498|591756276|FG000|Period: Washout|Non-compliance with study treatment|0|||
163832525|NCT02487498|591756277|FG001|Period: Washout|Non-compliance with study treatment|1|||
163832526|NCT02487498|591756276|FG000|Period: Period 2|Adverse Event|2|||
163832527|NCT02487498|591756277|FG001|Period: Period 2|Adverse Event|2|||
163832528|NCT02487498|591756276|FG000|Period: Period 2|Subject/guardian decision|2|||
163832529|NCT02487498|591756277|FG001|Period: Period 2|Subject/guardian decision|1|||
163832530|NCT02487498|591756276|FG000|Period: Period 2|Lost to Follow-up|1|||
163832531|NCT02487498|591756277|FG001|Period: Period 2|Lost to Follow-up|1|||
163832532|NCT02487498|591756276|FG000|Period: Period 2|Death|0|||
163832533|NCT02487498|591756277|FG001|Period: Period 2|Death|1|||
163832534|NCT02487498|591756276|FG000|Period: Period 2|Physician Decision|1|||
163832535|NCT02487498|591756277|FG001|Period: Period 2|Physician Decision|0|||
163832536|NCT00755222|591756278|FG000|Overall Study|Withdrawal by Subject|4|||
163832537|NCT00755222|591756279|FG001|Overall Study|Withdrawal by Subject|2|||
163832538|NCT00755222|591756278|FG000|Overall Study|Adverse Event|2|||
163832539|NCT00755222|591756279|FG001|Overall Study|Adverse Event|0|||
163832540|NCT00755222|591756278|FG000|Overall Study|Protocol Violation|2|||
163832541|NCT00755222|591756279|FG001|Overall Study|Protocol Violation|0|||
163832542|NCT02228967|591756289|FG000|Overall Study|Lost to Follow-up|146|||
163832543|NCT02228967|591756290|FG001|Overall Study|Lost to Follow-up|142|||
163832544|NCT02228967|591756289|FG000|Overall Study|Withdrawal by Subject|13|||
163832545|NCT02228967|591756290|FG001|Overall Study|Withdrawal by Subject|18|||
163832546|NCT01995539|591756293|FG000|Overall Study|Screening Failure|1|||
163832547|NCT01995539|591756293|FG000|Overall Study|Withdrawal by Investigator|15|||
163832548|NCT01995539|591756293|FG000|Overall Study|Withdrawal by Subject|11|||
163832549|NCT01995539|591756293|FG000|Overall Study|Lost to Follow-up|5|||
163832550|NCT01995539|591756293|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
163832551|NCT03261271|591756297|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
163832552|NCT03261271|591756298|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
163832553|NCT02173054|591756299|FG000|Overall Study|lack of compliance|1|||
163832554|NCT02173054|591756300|FG001|Overall Study|lack of compliance|0|||
163832555|NCT02173054|591756301|FG002|Overall Study|lack of compliance|0|||
163832556|NCT02173054|591756299|FG000|Overall Study|Withdrawal by Subject|0|||
163832557|NCT02173054|591756300|FG001|Overall Study|Withdrawal by Subject|0|||
163832558|NCT02173054|591756301|FG002|Overall Study|Withdrawal by Subject|1|||
163832559|NCT01932697|591756302|FG000|Overall Study|Received a different amount of tx|1|||
163832560|NCT01932697|591756303|FG001|Overall Study|Received a different amount of tx|0|||
163832561|NCT01932697|591756302|FG000|Overall Study|Ineligible|1|||
163832562|NCT01932697|591756303|FG001|Overall Study|Ineligible|0|||
163832563|NCT01330316|591756308|FG000|Overall Study|Adverse Event|2|||
163832564|NCT01330316|591756309|FG001|Overall Study|Adverse Event|2|||
163832565|NCT01330316|591756308|FG000|Overall Study|Lack of Efficacy|0|||
163832566|NCT01330316|591756309|FG001|Overall Study|Lack of Efficacy|10|||
163832567|NCT01330316|591756308|FG000|Overall Study|Lost to Follow-up|0|||
163832568|NCT01330316|591756309|FG001|Overall Study|Lost to Follow-up|1|||
163832569|NCT01330316|591756308|FG000|Overall Study|Withdrawal by Subject|0|||
163927416|NCT01379703|592105612|FG001|Study Start Through 9 Months|Adverse Event|14|||
163832570|NCT01330316|591756309|FG001|Overall Study|Withdrawal by Subject|1|||
163832571|NCT01330316|591756308|FG000|Overall Study|other than above|0|||
163832572|NCT01330316|591756309|FG001|Overall Study|other than above|1|||
163832573|NCT00215540|591756310|FG000|Overall Study|Withdrew from study medication|1|||
163832574|NCT00215540|591756311|FG001|Overall Study|Withdrew from study medication|0|||
163832575|NCT00215540|591756312|FG002|Overall Study|Withdrew from study medication|0|||
163832576|NCT00246337|591756315|FG000|Overall Study|Lost to Follow-up|3|||
163832577|NCT00246337|591756316|FG001|Overall Study|Lost to Follow-up|0|||
163927417|NCT01379703|592105613|FG002|Study Start Through 9 Months|Adverse Event|10|||
163927418|NCT01379703|592105611|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
163927419|NCT01379703|592105612|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
163927420|NCT01379703|592105613|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
163927421|NCT01379703|592105611|FG000|Study Start Through 9 Months|Treatment Failure|0|||
163927422|NCT01379703|592105612|FG001|Study Start Through 9 Months|Treatment Failure|2|||
163927423|NCT01379703|592105613|FG002|Study Start Through 9 Months|Treatment Failure|2|||
163927424|NCT01379703|592105611|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
163927425|NCT01379703|592105612|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
163927426|NCT01379703|592105613|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
163927427|NCT01379703|592105611|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
163927428|NCT01379703|592105612|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
163927429|NCT01379703|592105613|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
163927430|NCT01379703|592105611|FG000|Study Start Through 9 Months|Medication not available|0|||
163927431|NCT01379703|592105612|FG001|Study Start Through 9 Months|Medication not available|2|||
163927432|NCT01379703|592105613|FG002|Study Start Through 9 Months|Medication not available|1|||
163927433|NCT01379703|592105611|FG000|Study Start Through 9 Months|Poor general condition|0|||
163927434|NCT01379703|592105612|FG001|Study Start Through 9 Months|Poor general condition|1|||
163927435|NCT01379703|592105613|FG002|Study Start Through 9 Months|Poor general condition|0|||
164035051|NCT00965146|592486579|FG000|Overall Study|Intercurrent illness|1|||
164035052|NCT00965146|592486579|FG000|Overall Study|Revision / Removal of Study Implant|6|||
163927436|NCT01379703|592105611|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
163927437|NCT01379703|592105612|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
163927438|NCT01379703|592105613|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
163927439|NCT01379703|592105611|FG000|Study Start Through 9 Months|Reason unknown|2|||
163927440|NCT01379703|592105612|FG001|Study Start Through 9 Months|Reason unknown|31|||
163927441|NCT01379703|592105613|FG002|Study Start Through 9 Months|Reason unknown|24|||
163927442|NCT01379703|592105611|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
163927443|NCT01379703|592105612|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
163927444|NCT01379703|592105613|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
163927445|NCT01379703|592105611|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
163927446|NCT01379703|592105612|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
163927447|NCT01379703|592105613|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
163927448|NCT01379703|592105611|FG000|9 Months Through 18 Months|Adverse Event|0|||
163927449|NCT01379703|592105612|FG001|9 Months Through 18 Months|Adverse Event|6|||
163927450|NCT01379703|592105613|FG002|9 Months Through 18 Months|Adverse Event|0|||
163927451|NCT01379703|592105611|FG000|9 Months Through 18 Months|Treatment failure|0|||
163832578|NCT00246337|591756317|FG002|Overall Study|Lost to Follow-up|0|||
163832579|NCT00246337|591756318|FG003|Overall Study|Lost to Follow-up|0|||
163832580|NCT00246337|591756319|FG004|Overall Study|Lost to Follow-up|2|||
163832581|NCT00246337|591756320|FG005|Overall Study|Lost to Follow-up|2|||
163832582|NCT00246337|591756321|FG006|Overall Study|Lost to Follow-up|1|||
163832583|NCT00246337|591756322|FG007|Overall Study|Lost to Follow-up|2|||
163832584|NCT00246337|591756323|FG008|Overall Study|Lost to Follow-up|0|||
163927452|NCT01379703|592105612|FG001|9 Months Through 18 Months|Treatment failure|5|||
164035053|NCT00965146|592486579|FG000|Overall Study|Overall Study Termination|145|||
164035054|NCT05067452|592486580|FG000|Overall Study|Lost to Follow-up|0|||
164035055|NCT05067452|592486581|FG001|Overall Study|Lost to Follow-up|4|||
164035056|NCT01135017|592486582|FG000|Overall Study|Adverse Event|3|||
164035057|NCT01135017|592486583|FG001|Overall Study|Adverse Event|8|||
163832585|NCT00246337|591756315|FG000|Overall Study|Protocol Violation|1|||
163832586|NCT00246337|591756316|FG001|Overall Study|Protocol Violation|0|||
163832587|NCT00246337|591756317|FG002|Overall Study|Protocol Violation|0|||
163832588|NCT00246337|591756318|FG003|Overall Study|Protocol Violation|0|||
163832589|NCT00246337|591756319|FG004|Overall Study|Protocol Violation|1|||
163832590|NCT00246337|591756320|FG005|Overall Study|Protocol Violation|0|||
163832591|NCT00246337|591756321|FG006|Overall Study|Protocol Violation|1|||
163832592|NCT00246337|591756322|FG007|Overall Study|Protocol Violation|1|||
163832593|NCT00246337|591756323|FG008|Overall Study|Protocol Violation|0|||
163832594|NCT00246337|591756315|FG000|Overall Study|Withdrawal by Subject|2|||
163832595|NCT00246337|591756316|FG001|Overall Study|Withdrawal by Subject|0|||
163832596|NCT00246337|591756317|FG002|Overall Study|Withdrawal by Subject|0|||
163832597|NCT00246337|591756318|FG003|Overall Study|Withdrawal by Subject|0|||
163832598|NCT00246337|591756319|FG004|Overall Study|Withdrawal by Subject|0|||
163832599|NCT00246337|591756320|FG005|Overall Study|Withdrawal by Subject|0|||
163832600|NCT00246337|591756321|FG006|Overall Study|Withdrawal by Subject|1|||
163832601|NCT00246337|591756322|FG007|Overall Study|Withdrawal by Subject|1|||
163832602|NCT00246337|591756323|FG008|Overall Study|Withdrawal by Subject|0|||
163832603|NCT00246337|591756315|FG000|Overall Study|Lack of Qualifying Event|8|||
163927453|NCT01379703|592105613|FG002|9 Months Through 18 Months|Treatment failure|0|||
163927454|NCT01379703|592105611|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
163927455|NCT01379703|592105612|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
164035058|NCT01135017|592486582|FG000|Overall Study|Other than above|3|||
164035059|NCT01135017|592486583|FG001|Overall Study|Other than above|4|||
163832604|NCT00246337|591756316|FG001|Overall Study|Lack of Qualifying Event|2|||
163832605|NCT00246337|591756317|FG002|Overall Study|Lack of Qualifying Event|1|||
163832606|NCT00246337|591756318|FG003|Overall Study|Lack of Qualifying Event|1|||
163832607|NCT00246337|591756319|FG004|Overall Study|Lack of Qualifying Event|1|||
163832608|NCT00246337|591756320|FG005|Overall Study|Lack of Qualifying Event|3|||
163832609|NCT00246337|591756321|FG006|Overall Study|Lack of Qualifying Event|3|||
163832610|NCT00246337|591756322|FG007|Overall Study|Lack of Qualifying Event|2|||
163832611|NCT00246337|591756323|FG008|Overall Study|Lack of Qualifying Event|5|||
163832612|NCT00246337|591756315|FG000|Overall Study|Site Terminated|10|||
163927456|NCT01379703|592105613|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
163927457|NCT01379703|592105611|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
163927458|NCT01379703|592105612|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
163927459|NCT01379703|592105613|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
163927460|NCT01379703|592105611|FG000|9 Months Through 18 Months|Fatigue|0|||
163927461|NCT01379703|592105612|FG001|9 Months Through 18 Months|Fatigue|1|||
163927462|NCT01379703|592105613|FG002|9 Months Through 18 Months|Fatigue|0|||
163927463|NCT01379703|592105611|FG000|9 Months Through 18 Months|Reason Unknown|0|||
163927464|NCT01379703|592105612|FG001|9 Months Through 18 Months|Reason Unknown|23|||
163927465|NCT01379703|592105613|FG002|9 Months Through 18 Months|Reason Unknown|0|||
163927466|NCT03481556|592105614|FG000|Overall Study|Adverse Event|1|||
163927467|NCT03481556|592105615|FG001|Overall Study|Adverse Event|0|||
163927468|NCT03481556|592105616|FG002|Overall Study|Adverse Event|0|||
163927469|NCT03481556|592105617|FG003|Overall Study|Adverse Event|0|||
163927470|NCT03481556|592105614|FG000|Overall Study|Death|4|||
163927471|NCT03481556|592105615|FG001|Overall Study|Death|2|||
163927472|NCT03481556|592105616|FG002|Overall Study|Death|3|||
163927473|NCT03481556|592105617|FG003|Overall Study|Death|16|||
163927474|NCT03481556|592105614|FG000|Overall Study|Study Terminated by Sponsor|10|||
163927475|NCT03481556|592105615|FG001|Overall Study|Study Terminated by Sponsor|5|||
163927476|NCT03481556|592105616|FG002|Overall Study|Study Terminated by Sponsor|2|||
163832613|NCT00246337|591756316|FG001|Overall Study|Site Terminated|0|||
163832614|NCT00246337|591756317|FG002|Overall Study|Site Terminated|0|||
163832615|NCT00246337|591756318|FG003|Overall Study|Site Terminated|0|||
163832616|NCT00246337|591756319|FG004|Overall Study|Site Terminated|0|||
163832617|NCT00246337|591756320|FG005|Overall Study|Site Terminated|7|||
163832618|NCT00246337|591756321|FG006|Overall Study|Site Terminated|1|||
163832619|NCT00246337|591756322|FG007|Overall Study|Site Terminated|6|||
163832620|NCT00246337|591756323|FG008|Overall Study|Site Terminated|2|||
163927477|NCT03481556|592105617|FG003|Overall Study|Study Terminated by Sponsor|9|||
163927478|NCT03463577|592105618|FG000|Overall Study|Lost to Follow-up|238|||
163927479|NCT03463577|592105619|FG001|Overall Study|Lost to Follow-up|435|||
163927480|NCT03463577|592105620|FG002|Overall Study|Lost to Follow-up|0|||
163927481|NCT03463577|592105621|FG003|Overall Study|Lost to Follow-up|0|||
163927482|NCT03463577|592105622|FG004|Overall Study|Lost to Follow-up|0|||
163927483|NCT03463577|592105623|FG005|Overall Study|Lost to Follow-up|0|||
163927484|NCT03463577|592105618|FG000|Overall Study|With unknown pregnancy outcome|0|||
163927485|NCT03463577|592105619|FG001|Overall Study|With unknown pregnancy outcome|5|||
163927486|NCT03463577|592105620|FG002|Overall Study|With unknown pregnancy outcome|0|||
163927487|NCT03463577|592105621|FG003|Overall Study|With unknown pregnancy outcome|0|||
164035060|NCT00432562|592486584|FG000|Overall Study|Death|3|||
164035061|NCT00432562|592486585|FG001|Overall Study|Death|0|||
164035062|NCT01192204|592486589|FG000|Overall Study|could not keep recall appointments|1|||
164035063|NCT01192204|592486590|FG001|Overall Study|could not keep recall appointments|0|||
164035064|NCT03699631|592486592|FG000|Overall Study|Adverse Event|3|||
163832621|NCT00246337|591756315|FG000|Overall Study|Abnormal baseline lab values|7|||
163832622|NCT00246337|591756316|FG001|Overall Study|Abnormal baseline lab values|0|||
163832623|NCT00246337|591756317|FG002|Overall Study|Abnormal baseline lab values|2|||
164035065|NCT02219087|592486593|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
164035066|NCT02219087|592486594|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
164035067|NCT05127421|592486595|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
163832624|NCT00246337|591756318|FG003|Overall Study|Abnormal baseline lab values|0|||
163832625|NCT00246337|591756319|FG004|Overall Study|Abnormal baseline lab values|0|||
163927488|NCT03463577|592105622|FG004|Overall Study|With unknown pregnancy outcome|0|||
163927489|NCT03463577|592105623|FG005|Overall Study|With unknown pregnancy outcome|0|||
163927490|NCT03463577|592105618|FG000|Overall Study|Maternal death|2|||
163927491|NCT03463577|592105619|FG001|Overall Study|Maternal death|0|||
163927492|NCT03463577|592105620|FG002|Overall Study|Maternal death|0|||
163927493|NCT03463577|592105621|FG003|Overall Study|Maternal death|0|||
164035068|NCT05127421|592486596|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
164035069|NCT05127421|592486597|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
164035070|NCT05127421|592486598|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
164035071|NCT05127421|592486595|FG000|4-Week Double-Blind Period|Physician Decision|1|||
164035072|NCT05127421|592486596|FG001|4-Week Double-Blind Period|Physician Decision|0|||
164035073|NCT05127421|592486597|FG002|4-Week Double-Blind Period|Physician Decision|0|||
163927494|NCT03463577|592105622|FG004|Overall Study|Maternal death|0|||
163927495|NCT03463577|592105623|FG005|Overall Study|Maternal death|0|||
163927496|NCT03463577|592105618|FG000|Overall Study|Neonatal death|0|||
163832626|NCT00246337|591756320|FG005|Overall Study|Abnormal baseline lab values|2|||
163832627|NCT00246337|591756321|FG006|Overall Study|Abnormal baseline lab values|2|||
163832628|NCT00246337|591756322|FG007|Overall Study|Abnormal baseline lab values|0|||
163832629|NCT00246337|591756323|FG008|Overall Study|Abnormal baseline lab values|4|||
163832630|NCT00246337|591756315|FG000|Overall Study|Overwhelmed|0|||
163832631|NCT00246337|591756316|FG001|Overall Study|Overwhelmed|0|||
163832632|NCT00246337|591756317|FG002|Overall Study|Overwhelmed|0|||
163832633|NCT00246337|591756318|FG003|Overall Study|Overwhelmed|0|||
163832634|NCT00246337|591756319|FG004|Overall Study|Overwhelmed|0|||
163832635|NCT00246337|591756320|FG005|Overall Study|Overwhelmed|1|||
164098116|NCT01544127|592725034|FG002|Overall Study|Withdrawal by Subject|1|||
164098117|NCT01544127|592725032|FG000|Overall Study|Discharged out of catchment area|1|||
164098118|NCT01544127|592725033|FG001|Overall Study|Discharged out of catchment area|1|||
164098119|NCT01544127|592725034|FG002|Overall Study|Discharged out of catchment area|1|||
164098120|NCT01544127|592725032|FG000|Overall Study|Death|1|||
164098121|NCT01544127|592725033|FG001|Overall Study|Death|0|||
164098122|NCT01544127|592725034|FG002|Overall Study|Death|0|||
163832636|NCT00246337|591756321|FG006|Overall Study|Overwhelmed|0|||
163832637|NCT00246337|591756322|FG007|Overall Study|Overwhelmed|0|||
163832638|NCT00246337|591756323|FG008|Overall Study|Overwhelmed|0|||
163832639|NCT00246337|591756315|FG000|Overall Study|Protocol Violator|1|||
163832640|NCT00246337|591756316|FG001|Overall Study|Protocol Violator|0|||
163927497|NCT03463577|592105619|FG001|Overall Study|Neonatal death|0|||
163927498|NCT03463577|592105620|FG002|Overall Study|Neonatal death|0|||
163927499|NCT03463577|592105621|FG003|Overall Study|Neonatal death|15|||
163927500|NCT03463577|592105622|FG004|Overall Study|Neonatal death|17|||
163927501|NCT03463577|592105623|FG005|Overall Study|Neonatal death|0|||
163927502|NCT00236184|592105624|FG000|Overall Study|Adverse Event|5|||
163927503|NCT00236184|592105625|FG001|Overall Study|Adverse Event|2|||
163927504|NCT00236184|592105624|FG000|Overall Study|Lack of Efficacy|0|||
163927505|NCT00236184|592105625|FG001|Overall Study|Lack of Efficacy|1|||
163927506|NCT00236184|592105624|FG000|Overall Study|Lost to Follow-up|3|||
163927507|NCT00236184|592105625|FG001|Overall Study|Lost to Follow-up|4|||
163927508|NCT00236184|592105624|FG000|Overall Study|Physician Decision|1|||
163927509|NCT00236184|592105625|FG001|Overall Study|Physician Decision|1|||
163927510|NCT00236184|592105624|FG000|Overall Study|Withdrawal by Subject|3|||
163927511|NCT00236184|592105625|FG001|Overall Study|Withdrawal by Subject|0|||
163927512|NCT00236184|592105624|FG000|Overall Study|Protocol Violation|3|||
163927513|NCT00236184|592105625|FG001|Overall Study|Protocol Violation|0|||
164098123|NCT01544127|592725032|FG000|Overall Study|Jail or Prison|1|||
163832641|NCT00246337|591756317|FG002|Overall Study|Protocol Violator|0|||
163832642|NCT00246337|591756318|FG003|Overall Study|Protocol Violator|0|||
163832643|NCT00246337|591756319|FG004|Overall Study|Protocol Violator|0|||
163832644|NCT00246337|591756320|FG005|Overall Study|Protocol Violator|0|||
163832645|NCT00246337|591756321|FG006|Overall Study|Protocol Violator|0|||
163832646|NCT00246337|591756322|FG007|Overall Study|Protocol Violator|0|||
163832647|NCT00246337|591756323|FG008|Overall Study|Protocol Violator|0|||
163832648|NCT00246337|591756315|FG000|Overall Study|Reported as completing trial in error|0|||
163832649|NCT00246337|591756316|FG001|Overall Study|Reported as completing trial in error|0|||
163832650|NCT00246337|591756317|FG002|Overall Study|Reported as completing trial in error|0|||
163832651|NCT00246337|591756318|FG003|Overall Study|Reported as completing trial in error|0|||
163832652|NCT00246337|591756319|FG004|Overall Study|Reported as completing trial in error|0|||
163832653|NCT00246337|591756320|FG005|Overall Study|Reported as completing trial in error|0|||
163832654|NCT00246337|591756321|FG006|Overall Study|Reported as completing trial in error|0|||
163832655|NCT00246337|591756322|FG007|Overall Study|Reported as completing trial in error|1|||
163832656|NCT00246337|591756323|FG008|Overall Study|Reported as completing trial in error|0|||
163832657|NCT00674570|591756325|FG000|Overall Study|Withdrawal by Subject|0|||
163832658|NCT00674570|591756326|FG001|Overall Study|Withdrawal by Subject|2|||
163832659|NCT00674570|591756327|FG002|Overall Study|Withdrawal by Subject|0|||
163832660|NCT01337986|591756328|FG000|Overall Study|Adverse Event|2|||
163832661|NCT01337986|591756329|FG001|Overall Study|Adverse Event|2|||
163832662|NCT01337986|591756328|FG000|Overall Study|Lost to Follow-up|1|||
163832663|NCT01337986|591756329|FG001|Overall Study|Lost to Follow-up|0|||
163832664|NCT01337986|591756328|FG000|Overall Study|Protocol Violation|0|||
164098124|NCT01544127|592725033|FG001|Overall Study|Jail or Prison|1|||
164098125|NCT01544127|592725034|FG002|Overall Study|Jail or Prison|2|||
163832665|NCT01337986|591756329|FG001|Overall Study|Protocol Violation|3|||
163832666|NCT02313909|591756330|FG000|Overall Study|Consent withdrawn by participant|33|||
163832667|NCT02313909|591756331|FG001|Overall Study|Consent withdrawn by participant|33|||
163832668|NCT02313909|591756330|FG000|Overall Study|Lost to Follow-up|24|||
163927514|NCT00236184|592105624|FG000|Overall Study|non-compliance with study drug|2|||
163832669|NCT02313909|591756331|FG001|Overall Study|Lost to Follow-up|17|||
163832670|NCT01782872|591756333|FG000|Overall Study|Protocol Violation|0|||
163832671|NCT01782872|591756334|FG001|Overall Study|Protocol Violation|0|||
163832672|NCT01782872|591756335|FG002|Overall Study|Protocol Violation|0|||
163927515|NCT00236184|592105625|FG001|Overall Study|non-compliance with study drug|1|||
163927516|NCT00236184|592105624|FG000|Overall Study|other|1|||
164098126|NCT01544127|592725032|FG000|Overall Study|Became Psychotic|1|||
163832673|NCT01782872|591756336|FG003|Overall Study|Protocol Violation|1|||
163832674|NCT01782872|591756333|FG000|Overall Study|Withdrawal by Subject|0|||
163832675|NCT01782872|591756334|FG001|Overall Study|Withdrawal by Subject|1|||
163832676|NCT01782872|591756335|FG002|Overall Study|Withdrawal by Subject|0|||
163832677|NCT01782872|591756336|FG003|Overall Study|Withdrawal by Subject|0|||
163832678|NCT02309112|591756337|FG000|Overall Study|Withdrawal by Subject|1|||
163832679|NCT02309112|591756338|FG001|Overall Study|Withdrawal by Subject|0|||
163832680|NCT02309112|591756339|FG002|Overall Study|Withdrawal by Subject|1|||
163832681|NCT02309112|591756337|FG000|Overall Study|Lost to Follow-up|0|||
163832682|NCT02309112|591756338|FG001|Overall Study|Lost to Follow-up|1|||
163832683|NCT02309112|591756339|FG002|Overall Study|Lost to Follow-up|0|||
163832684|NCT03505476|591756341|FG000|Overall Study|Physician Decision|18|||
163832685|NCT03505476|591756341|FG000|Overall Study|Device Malfunctioned|101|||
163832686|NCT03505476|591756341|FG000|Overall Study|Data Corrupt|6|||
163832687|NCT03505476|591756341|FG000|Overall Study|Device application insufficiant|3|||
163832688|NCT04026165|591756342|FG000|Run-in Placebo Period|Enrollment Error|13|||
163832689|NCT04026165|591756343|FG001|Run-in Placebo Period|Enrollment Error|0|||
163832690|NCT04026165|591756344|FG002|Run-in Placebo Period|Enrollment Error|0|||
163832691|NCT04026165|591756345|FG003|Run-in Placebo Period|Enrollment Error|0|||
163832692|NCT04026165|591756342|FG000|Run-in Placebo Period|Run-in Failure|4|||
163832693|NCT04026165|591756343|FG001|Run-in Placebo Period|Run-in Failure|0|||
163832694|NCT04026165|591756344|FG002|Run-in Placebo Period|Run-in Failure|0|||
163832695|NCT04026165|591756345|FG003|Run-in Placebo Period|Run-in Failure|0|||
163832696|NCT04026165|591756342|FG000|Run-in Placebo Period|Protocol Violation|2|||
163832697|NCT04026165|591756343|FG001|Run-in Placebo Period|Protocol Violation|0|||
163832698|NCT04026165|591756344|FG002|Run-in Placebo Period|Protocol Violation|0|||
163832699|NCT04026165|591756345|FG003|Run-in Placebo Period|Protocol Violation|0|||
163832700|NCT04026165|591756342|FG000|Run-in Placebo Period|Withdrew Consent|2|||
163832701|NCT04026165|591756343|FG001|Run-in Placebo Period|Withdrew Consent|0|||
163832702|NCT04026165|591756344|FG002|Run-in Placebo Period|Withdrew Consent|0|||
163832703|NCT04026165|591756345|FG003|Run-in Placebo Period|Withdrew Consent|0|||
163832704|NCT04026165|591756342|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
163832705|NCT04026165|591756343|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
163832706|NCT04026165|591756344|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
163832707|NCT04026165|591756345|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
163832708|NCT04026165|591756342|FG000|Run-in SEL Period|Run-in Failure|0|||
163832709|NCT04026165|591756343|FG001|Run-in SEL Period|Run-in Failure|26|||
163832710|NCT04026165|591756344|FG002|Run-in SEL Period|Run-in Failure|0|||
163832711|NCT04026165|591756345|FG003|Run-in SEL Period|Run-in Failure|0|||
163832712|NCT04026165|591756342|FG000|Run-in SEL Period|Withdrew Consent|0|||
163832713|NCT04026165|591756343|FG001|Run-in SEL Period|Withdrew Consent|10|||
163832714|NCT04026165|591756344|FG002|Run-in SEL Period|Withdrew Consent|0|||
163832715|NCT04026165|591756345|FG003|Run-in SEL Period|Withdrew Consent|0|||
163832716|NCT04026165|591756342|FG000|Run-in SEL Period|Enrollment Error|0|||
163832717|NCT04026165|591756343|FG001|Run-in SEL Period|Enrollment Error|4|||
163832718|NCT04026165|591756344|FG002|Run-in SEL Period|Enrollment Error|0|||
163832719|NCT04026165|591756345|FG003|Run-in SEL Period|Enrollment Error|0|||
163832720|NCT04026165|591756342|FG000|Run-in SEL Period|Protocol Violation|0|||
163832721|NCT04026165|591756343|FG001|Run-in SEL Period|Protocol Violation|3|||
163832722|NCT04026165|591756344|FG002|Run-in SEL Period|Protocol Violation|0|||
163832723|NCT04026165|591756345|FG003|Run-in SEL Period|Protocol Violation|0|||
163832724|NCT04026165|591756342|FG000|Run-in SEL Period|Investigator's Discretion|0|||
163832725|NCT04026165|591756343|FG001|Run-in SEL Period|Investigator's Discretion|2|||
163832726|NCT04026165|591756344|FG002|Run-in SEL Period|Investigator's Discretion|0|||
163832727|NCT04026165|591756345|FG003|Run-in SEL Period|Investigator's Discretion|0|||
163832728|NCT04026165|591756342|FG000|Run-in SEL Period|Death|0|||
163832729|NCT04026165|591756343|FG001|Run-in SEL Period|Death|1|||
163832730|NCT04026165|591756344|FG002|Run-in SEL Period|Death|0|||
163832731|NCT04026165|591756345|FG003|Run-in SEL Period|Death|0|||
163832732|NCT04026165|591756342|FG000|Randomized Period|Withdrew Consent|0|||
163832733|NCT04026165|591756343|FG001|Randomized Period|Withdrew Consent|0|||
163832734|NCT04026165|591756344|FG002|Randomized Period|Withdrew Consent|5|||
163832735|NCT04026165|591756345|FG003|Randomized Period|Withdrew Consent|8|||
163832736|NCT04026165|591756342|FG000|Randomized Period|Death|0|||
163832737|NCT04026165|591756343|FG001|Randomized Period|Death|0|||
163832738|NCT04026165|591756344|FG002|Randomized Period|Death|5|||
163832739|NCT04026165|591756345|FG003|Randomized Period|Death|7|||
163832740|NCT04026165|591756342|FG000|Randomized Period|Investigator's Discretion|0|||
163832741|NCT04026165|591756343|FG001|Randomized Period|Investigator's Discretion|0|||
163927517|NCT00236184|592105625|FG001|Overall Study|other|2|||
163927518|NCT01101997|592105626|FG000|Overall Study|Withdrawal by Subject|2|||
163927519|NCT01841697|592105627|FG000|Overall Study|Death|0|||
163927520|NCT01841697|592105628|FG001|Overall Study|Death|1|||
163927521|NCT01841697|592105627|FG000|Overall Study|Lost to Follow-up|4|||
163927522|NCT01841697|592105628|FG001|Overall Study|Lost to Follow-up|1|||
163927523|NCT01841697|592105627|FG000|Overall Study|Withdrawal by Subject|16|||
163832742|NCT04026165|591756344|FG002|Randomized Period|Investigator's Discretion|2|||
163832743|NCT04026165|591756345|FG003|Randomized Period|Investigator's Discretion|2|||
163832744|NCT04026165|591756342|FG000|Randomized Period|Lost to Follow-up|0|||
163832745|NCT04026165|591756343|FG001|Randomized Period|Lost to Follow-up|0|||
163832746|NCT04026165|591756344|FG002|Randomized Period|Lost to Follow-up|2|||
163832747|NCT04026165|591756345|FG003|Randomized Period|Lost to Follow-up|2|||
163832748|NCT01287611|591756347|FG000|Overall Study|Lost to Follow-up|29|||
163832749|NCT01287611|591756348|FG001|Overall Study|Lost to Follow-up|16|||
163832750|NCT01287611|591756347|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
163832751|NCT01287611|591756348|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
163832752|NCT02255357|591756349|FG000|Overall Study|Physician Decision|10|||
163832753|NCT02255357|591756350|FG001|Overall Study|Physician Decision|24|||
163832754|NCT02192970|591756355|FG000|Overall Study|Lost to Follow-up|6|||
163927524|NCT01841697|592105628|FG001|Overall Study|Withdrawal by Subject|16|||
163927525|NCT01777490|592105629|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
163927526|NCT01777490|592105630|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
163927527|NCT01777490|592105631|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
163927528|NCT01777490|592105632|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
163927529|NCT01772563|592105633|FG000|Cycle 1|Dose limiting toxicity|2|||
163927530|NCT01772563|592105633|FG000|Cycle 1|Progressive disease|2|||
163927531|NCT01772563|592105633|FG000|Cycle 2 and Beyond|Progressive disease|17|||
163927532|NCT01772563|592105633|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
163927533|NCT01772563|592105633|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
163927534|NCT00255944|592105636|FG000|Overall Study|Lost to Follow-up|797|||
163927535|NCT00255944|592105637|FG001|Overall Study|Lost to Follow-up|834|||
163927536|NCT00935259|592105644|FG000|Period 1|Administrative (scheduling conflict)|1|||
163927537|NCT00935259|592105645|FG001|Period 1|Administrative (scheduling conflict)|1|||
163927538|NCT02980705|592105648|FG000|Overall Study|Adverse Event|0|||
163927539|NCT02980705|592105649|FG001|Overall Study|Adverse Event|1|||
163927540|NCT02980705|592105648|FG000|Overall Study|Withdrawal by Subject|6|||
163927541|NCT02980705|592105649|FG001|Overall Study|Withdrawal by Subject|9|||
163927542|NCT02980705|592105648|FG000|Overall Study|withdrew participation|0|||
163927543|NCT02980705|592105649|FG001|Overall Study|withdrew participation|1|||
163927544|NCT02980705|592105648|FG000|Overall Study|Lost to Follow-up|2|||
163927545|NCT02980705|592105649|FG001|Overall Study|Lost to Follow-up|0|||
163927546|NCT01721746|592105650|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
163927547|NCT01721746|592105651|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
163927548|NCT01721746|592105650|FG000|Pre-Treatment|Withdrawal by Subject|1|||
163927549|NCT01721746|592105651|FG001|Pre-Treatment|Withdrawal by Subject|16|||
163927550|NCT01721746|592105650|FG000|Pre-Treatment|Poor/Non-compliance|1|||
163927551|NCT01721746|592105651|FG001|Pre-Treatment|Poor/Non-compliance|0|||
163927552|NCT01721746|592105650|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
163927553|NCT01721746|592105651|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
163927554|NCT01721746|592105650|FG000|Treatment|Disease Progression|192|||
163927555|NCT01721746|592105651|FG001|Treatment|Disease Progression|74|||
163927556|NCT01721746|592105650|FG000|Treatment|Study Drug Toxicity|19|||
163927557|NCT01721746|592105651|FG001|Treatment|Study Drug Toxicity|11|||
163927558|NCT01721746|592105650|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
163927559|NCT01721746|592105651|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
163927560|NCT01721746|592105650|FG000|Treatment|Participant request to discontinue Study treatment|26|||
163927561|NCT01721746|592105651|FG001|Treatment|Participant request to discontinue Study treatment|7|||
163927562|NCT01721746|592105650|FG000|Treatment|Participant withdrew consent|4|||
163927563|NCT01721746|592105651|FG001|Treatment|Participant withdrew consent|2|||
163927564|NCT01721746|592105650|FG000|Treatment|Maximum Clinical Benefit|9|||
163927565|NCT01721746|592105651|FG001|Treatment|Maximum Clinical Benefit|3|||
163927566|NCT01721746|592105650|FG000|Treatment|Poor/Non-compliance|2|||
163927567|NCT01721746|592105651|FG001|Treatment|Poor/Non-compliance|0|||
163832755|NCT02192970|591756356|FG001|Overall Study|Lost to Follow-up|0|||
163832756|NCT04074590|591756359|FG000|Overall Study|Adverse Event|1|||
163927568|NCT01721746|592105650|FG000|Treatment|Participant no longer met Study criteria|4|||
163927569|NCT01721746|592105651|FG001|Treatment|Participant no longer met Study criteria|0|||
163927570|NCT01721746|592105650|FG000|Treatment|Other reasons|6|||
163927571|NCT01721746|592105651|FG001|Treatment|Other reasons|2|||
163927572|NCT01880437|592105654|FG000|Overall Study|Death|12|||
163927573|NCT01880437|592105655|FG001|Overall Study|Death|4|||
163927574|NCT01880437|592105656|FG002|Overall Study|Death|17|||
163927575|NCT01880437|592105654|FG000|Overall Study|Study terminated by Sponsor|3|||
163927576|NCT01880437|592105655|FG001|Overall Study|Study terminated by Sponsor|0|||
163927577|NCT01880437|592105656|FG002|Overall Study|Study terminated by Sponsor|2|||
163927578|NCT01209598|592105657|FG000|Overall Study|Withdrawal by Subject|1|||
163927579|NCT01209598|592105658|FG001|Overall Study|Withdrawal by Subject|0|||
163927580|NCT01438840|592105659|FG000|Core Study|Adverse Event|0|||
163832757|NCT04074590|591756360|FG001|Overall Study|Adverse Event|0|||
163832758|NCT04074590|591756359|FG000|Overall Study|Physician Decision|1|||
163832759|NCT04074590|591756360|FG001|Overall Study|Physician Decision|0|||
163927581|NCT01438840|592105660|FG001|Core Study|Adverse Event|3|||
163927582|NCT01438840|592105661|FG002|Core Study|Adverse Event|0|||
163927583|NCT01438840|592105659|FG000|Core Study|Lack of Efficacy|15|||
163927584|NCT01438840|592105660|FG001|Core Study|Lack of Efficacy|7|||
163927585|NCT01438840|592105661|FG002|Core Study|Lack of Efficacy|0|||
163927586|NCT01438840|592105659|FG000|Core Study|Withdrawal of consent|1|||
163927587|NCT01438840|592105660|FG001|Core Study|Withdrawal of consent|0|||
163927588|NCT01438840|592105661|FG002|Core Study|Withdrawal of consent|0|||
163927589|NCT01438840|592105659|FG000|Extension Phase|Adverse Event|0|||
163927590|NCT01438840|592105660|FG001|Extension Phase|Adverse Event|0|||
163927591|NCT01438840|592105661|FG002|Extension Phase|Adverse Event|3|||
163927592|NCT01438840|592105659|FG000|Extension Phase|Lost to Follow-up|0|||
163927593|NCT01438840|592105660|FG001|Extension Phase|Lost to Follow-up|0|||
163927594|NCT01438840|592105661|FG002|Extension Phase|Lost to Follow-up|1|||
163927595|NCT01438840|592105659|FG000|Extension Phase|Withdrawal by Subject|0|||
163927596|NCT01438840|592105660|FG001|Extension Phase|Withdrawal by Subject|0|||
163927597|NCT01438840|592105661|FG002|Extension Phase|Withdrawal by Subject|3|||
163927598|NCT01438840|592105659|FG000|Extension Phase|Lack of Efficacy|0|||
163927599|NCT01438840|592105660|FG001|Extension Phase|Lack of Efficacy|0|||
163927600|NCT01438840|592105661|FG002|Extension Phase|Lack of Efficacy|2|||
163927601|NCT01438840|592105659|FG000|Extension Phase|Other|0|||
163927602|NCT01438840|592105660|FG001|Extension Phase|Other|0|||
163927603|NCT01438840|592105661|FG002|Extension Phase|Other|1|||
163927604|NCT00085566|592105663|FG000|Overall Study|Adverse Event|0|||
163927605|NCT00085566|592105664|FG001|Overall Study|Adverse Event|0|||
163927606|NCT00085566|592105665|FG002|Overall Study|Adverse Event|10|||
163927607|NCT00085566|592105663|FG000|Overall Study|Patient Not treated|0|||
163927608|NCT00085566|592105664|FG001|Overall Study|Patient Not treated|0|||
163927609|NCT00085566|592105665|FG002|Overall Study|Patient Not treated|3|||
163927610|NCT00085566|592105663|FG000|Overall Study|Clinical progression|0|||
163927611|NCT00085566|592105664|FG001|Overall Study|Clinical progression|0|||
163927612|NCT00085566|592105665|FG002|Overall Study|Clinical progression|1|||
163927613|NCT02604342|592105668|FG000|Overall Study|Death|32|||
163927614|NCT02604342|592105669|FG001|Overall Study|Death|16|||
163927615|NCT02604342|592105668|FG000|Overall Study|Progression of disease|1|||
163927616|NCT02604342|592105669|FG001|Overall Study|Progression of disease|0|||
163927617|NCT02604342|592105668|FG000|Overall Study|Withdrawal by Subject|5|||
163927618|NCT02604342|592105669|FG001|Overall Study|Withdrawal by Subject|6|||
163927619|NCT02604342|592105668|FG000|Overall Study|Other|1|||
163927620|NCT02604342|592105669|FG001|Overall Study|Other|0|||
163927621|NCT02604342|592105668|FG000|Overall Study|Study Termination by Sponsor|1|||
163927622|NCT02604342|592105669|FG001|Overall Study|Study Termination by Sponsor|0|||
163927623|NCT02604342|592105668|FG000|Overall Study|Lost to Follow-up|1|||
163927624|NCT02604342|592105669|FG001|Overall Study|Lost to Follow-up|1|||
163927625|NCT02604342|592105668|FG000|Overall Study|Physician Decision|2|||
163927626|NCT02604342|592105669|FG001|Overall Study|Physician Decision|0|||
163927627|NCT01702519|592105670|FG000|Washout Period|Lost to Follow-up|1|||
163927628|NCT01702519|592105671|FG001|Washout Period|Lost to Follow-up|0|||
163927629|NCT01702519|592105670|FG000|Washout Period|Withdrawal by Subject|0|||
163927630|NCT01702519|592105671|FG001|Washout Period|Withdrawal by Subject|2|||
163927631|NCT04688086|592105674|FG000|Overall Study|Lost to Follow-up|164|||
163927632|NCT04688086|592105674|FG000|Overall Study|Imaging error;|64|||
163927633|NCT02034162|592107768|FG000|Double-blind|Lost to Follow-up|3|||
163927634|NCT02034162|592107769|FG001|Double-blind|Lost to Follow-up|0|||
163927635|NCT02034162|592107770|FG002|Double-blind|Lost to Follow-up|0|||
163927636|NCT02034162|592107768|FG000|Double-blind|Physician Decision|1|||
163927637|NCT02034162|592107769|FG001|Double-blind|Physician Decision|0|||
163927638|NCT02034162|592107770|FG002|Double-blind|Physician Decision|0|||
163927639|NCT02034162|592107768|FG000|Double-blind|Protocol Violation|0|||
163927640|NCT02034162|592107769|FG001|Double-blind|Protocol Violation|1|||
163927641|NCT02034162|592107770|FG002|Double-blind|Protocol Violation|0|||
163927642|NCT02034162|592107768|FG000|Double-blind|Withdrawal by Subject|5|||
163927643|NCT02034162|592107769|FG001|Double-blind|Withdrawal by Subject|7|||
163927644|NCT02034162|592107770|FG002|Double-blind|Withdrawal by Subject|0|||
163927645|NCT00760513|592107771|FG000|Overall Study|Withdrawal by Subject|5|||
163927646|NCT00760513|592107772|FG001|Overall Study|Withdrawal by Subject|7|||
163927647|NCT02808975|592107777|FG000|Overall Study|Adverse Event|3|||
163927648|NCT02808975|592107778|FG001|Overall Study|Adverse Event|4|||
163927649|NCT02808975|592107777|FG000|Overall Study|Withdrew consent|9|||
163927650|NCT02808975|592107778|FG001|Overall Study|Withdrew consent|8|||
163927651|NCT02808975|592107777|FG000|Overall Study|Lost to Follow-up|4|||
163927652|NCT02808975|592107778|FG001|Overall Study|Lost to Follow-up|6|||
163927653|NCT02808975|592107777|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
163927654|NCT02808975|592107778|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
163927655|NCT02808975|592107777|FG000|Overall Study|Other, not specified|5|||
163927656|NCT02808975|592107778|FG001|Overall Study|Other, not specified|1|||
163927657|NCT04469465|592107779|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
163927658|NCT04469465|592107780|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
163927659|NCT04469465|592107779|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
163927660|NCT04469465|592107780|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
163927661|NCT04469465|592107779|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
163927662|NCT04469465|592107780|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
163927663|NCT04469465|592107779|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
163832760|NCT04074590|591756359|FG000|Overall Study|Withdrawal by Subject|2|||
163832761|NCT04074590|591756360|FG001|Overall Study|Withdrawal by Subject|0|||
163832762|NCT00509236|591756363|FG000|Overall Study|Adverse Event|7|||
163832763|NCT00509236|591756364|FG001|Overall Study|Adverse Event|9|||
163832764|NCT00509236|591756363|FG000|Overall Study|Withdrawal by Subject|5|||
163832765|NCT00509236|591756364|FG001|Overall Study|Withdrawal by Subject|10|||
163832766|NCT00509236|591756363|FG000|Overall Study|Protocol Violation|3|||
163927664|NCT04469465|592107780|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
163927665|NCT04469465|592107779|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
163927666|NCT04469465|592107780|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
163927667|NCT04469465|592107779|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
163927668|NCT04469465|592107780|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
164035074|NCT05127421|592486598|FG003|4-Week Double-Blind Period|Physician Decision|0|||
164035075|NCT05127421|592486595|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
164035076|NCT05127421|592486596|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
164035077|NCT05127421|592486597|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
163927669|NCT04469465|592107779|FG000|Long-Term Extension (LTE)|Death|0|||
163927670|NCT04469465|592107780|FG001|Long-Term Extension (LTE)|Death|1|||
163927671|NCT04469465|592107779|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
163927672|NCT04469465|592107780|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
163927673|NCT02641587|592107781|FG000|Confinement Period|Adverse Event|1|||
163927674|NCT02641587|592107782|FG001|Confinement Period|Adverse Event|0|||
163927675|NCT02641587|592107781|FG000|Confinement Period|Withdrawal by Subject|2|||
163927676|NCT02641587|592107782|FG001|Confinement Period|Withdrawal by Subject|1|||
163927677|NCT02641587|592107781|FG000|Ambulatory Period|Withdrawal by Subject|1|||
163927678|NCT02641587|592107782|FG001|Ambulatory Period|Withdrawal by Subject|0|||
163927679|NCT01150045|592107786|FG000|Overall Study|Protocol Violation|0|||
163927680|NCT01150045|592107787|FG001|Overall Study|Protocol Violation|1|||
163927681|NCT01150045|592107788|FG002|Overall Study|Protocol Violation|0|||
163927682|NCT01150045|592107789|FG003|Overall Study|Protocol Violation|1|||
163927683|NCT03194867|592107790|FG000|Overall Study|Incorrect completion of end of study form|0|||
163927684|NCT03194867|592107791|FG001|Overall Study|Incorrect completion of end of study form|0|||
163927685|NCT03194867|592107792|FG002|Overall Study|Incorrect completion of end of study form|1|||
163927686|NCT03194867|592107793|FG003|Overall Study|Incorrect completion of end of study form|0|||
163927687|NCT00464945|592107794|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
163927688|NCT00464945|592107795|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
163927689|NCT00464945|592107794|FG000|Infant Series|Protocol Violation|1|||
163927690|NCT00464945|592107795|FG001|Infant Series|Protocol Violation|0|||
163927691|NCT00464945|592107794|FG000|Infant Series|Lost to Follow-up|1|||
163927692|NCT00464945|592107795|FG001|Infant Series|Lost to Follow-up|0|||
163927693|NCT00464945|592107794|FG000|After Infant Series|Withdrawal by Subject|0|||
163927694|NCT00464945|592107795|FG001|After Infant Series|Withdrawal by Subject|2|||
163927695|NCT00464945|592107794|FG000|Toddler Dose|Lost to Follow-up|0|||
163927696|NCT00464945|592107795|FG001|Toddler Dose|Lost to Follow-up|1|||
163927697|NCT02094898|592107799|FG000|Overall Study|Clinical Worsening|2|||
163927698|NCT02094898|592107799|FG000|Overall Study|Adverse Event|2|||
163927699|NCT02094898|592107799|FG000|Overall Study|Lack of Efficacy|1|||
163927700|NCT03520075|592107800|FG000|Phase 1 (Dose Escalation)|Death|2|||
163927701|NCT03520075|592107801|FG001|Phase 1 (Dose Escalation)|Death|2|||
163927702|NCT03520075|592107802|FG002|Phase 1 (Dose Escalation)|Death|3|||
163927703|NCT03520075|592107803|FG003|Phase 1 (Dose Escalation)|Death|2|||
163927704|NCT03520075|592107804|FG004|Phase 1 (Dose Escalation)|Death|6|||
163927705|NCT03520075|592107805|FG005|Phase 1 (Dose Escalation)|Death|5|||
163927706|NCT03520075|592107806|FG006|Phase 1 (Dose Escalation)|Death|3|||
163927707|NCT03520075|592107807|FG007|Phase 1 (Dose Escalation)|Death|2|||
163927708|NCT03520075|592107808|FG008|Phase 1 (Dose Escalation)|Death|3|||
163927709|NCT03520075|592107809|FG009|Phase 1 (Dose Escalation)|Death|1|||
164035078|NCT05127421|592486598|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
164035079|NCT05127421|592486595|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
163927710|NCT03520075|592107810|FG010|Phase 1 (Dose Escalation)|Death|5|||
163927711|NCT03520075|592107811|FG011|Phase 1 (Dose Escalation)|Death|7|||
163927712|NCT03520075|592107812|FG012|Phase 1 (Dose Escalation)|Death|11|||
164035080|NCT05127421|592486596|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
163927713|NCT03520075|592107813|FG013|Phase 1 (Dose Escalation)|Death|0|||
163927714|NCT03520075|592107814|FG014|Phase 1 (Dose Escalation)|Death|0|||
163832767|NCT00509236|591756364|FG001|Overall Study|Protocol Violation|0|||
163832768|NCT00509236|591756363|FG000|Overall Study|Excluded Medication|1|||
163832769|NCT00509236|591756364|FG001|Overall Study|Excluded Medication|1|||
163927715|NCT03520075|592107815|FG015|Phase 1 (Dose Escalation)|Death|0|||
163927716|NCT03520075|592107816|FG016|Phase 1 (Dose Escalation)|Death|0|||
163927717|NCT03520075|592107817|FG017|Phase 1 (Dose Escalation)|Death|0|||
163927718|NCT03520075|592107818|FG018|Phase 1 (Dose Escalation)|Death|0|||
163927719|NCT03520075|592107800|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
163927720|NCT03520075|592107801|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927721|NCT03520075|592107802|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927722|NCT03520075|592107803|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
163927723|NCT03520075|592107804|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
163927724|NCT03520075|592107805|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
163927725|NCT03520075|592107806|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927726|NCT03520075|592107807|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
163832770|NCT00509236|591756363|FG000|Overall Study|Scheduled Kidney Transplant|1|||
163832771|NCT00509236|591756364|FG001|Overall Study|Scheduled Kidney Transplant|0|||
163832772|NCT02709005|591756376|FG000|Overall Study|Lost to Follow-up|1|||
163832773|NCT02709005|591756377|FG001|Overall Study|Lost to Follow-up|1|||
163832774|NCT02709005|591756376|FG000|Overall Study|Withdrawal by Subject|3|||
163832775|NCT02709005|591756377|FG001|Overall Study|Withdrawal by Subject|0|||
163832776|NCT01572389|591756378|FG000|Overall Study|Death|1|||
163832777|NCT01572389|591756379|FG001|Overall Study|Death|3|||
163832778|NCT01572389|591756378|FG000|Overall Study|Withdrawal by Subject|14|||
163832779|NCT01572389|591756379|FG001|Overall Study|Withdrawal by Subject|2|||
163832780|NCT01572389|591756378|FG000|Overall Study|Lost to Follow-up|25|||
163832781|NCT01572389|591756379|FG001|Overall Study|Lost to Follow-up|14|||
163832782|NCT01572389|591756378|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
163832783|NCT01572389|591756379|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
163832784|NCT02634788|591756380|FG000|Overall Study|Adverse Event|0|||
163832785|NCT02634788|591756381|FG001|Overall Study|Adverse Event|8|||
163832786|NCT02634788|591756382|FG002|Overall Study|Adverse Event|3|||
163832787|NCT02634788|591756383|FG003|Overall Study|Adverse Event|1|||
163832788|NCT02634788|591756380|FG000|Overall Study|Lack of Efficacy|4|||
163832789|NCT02634788|591756381|FG001|Overall Study|Lack of Efficacy|0|||
163832790|NCT02634788|591756382|FG002|Overall Study|Lack of Efficacy|1|||
163832791|NCT02634788|591756383|FG003|Overall Study|Lack of Efficacy|4|||
163832792|NCT02634788|591756380|FG000|Overall Study|Lost to Follow-up|0|||
163832793|NCT02634788|591756381|FG001|Overall Study|Lost to Follow-up|1|||
163832794|NCT02634788|591756382|FG002|Overall Study|Lost to Follow-up|0|||
163832795|NCT02634788|591756383|FG003|Overall Study|Lost to Follow-up|0|||
163832796|NCT02634788|591756380|FG000|Overall Study|Withdrawal by Subject|0|||
163832797|NCT02634788|591756381|FG001|Overall Study|Withdrawal by Subject|1|||
163832798|NCT02634788|591756382|FG002|Overall Study|Withdrawal by Subject|1|||
163832799|NCT02634788|591756383|FG003|Overall Study|Withdrawal by Subject|0|||
163832800|NCT00758459|591756384|FG000|Overall Study|Adverse Event|3|||
163832801|NCT00758459|591756385|FG001|Overall Study|Adverse Event|2|||
163832802|NCT00758459|591756384|FG000|Overall Study|Protocol Violation|0|||
163832803|NCT00758459|591756385|FG001|Overall Study|Protocol Violation|1|||
163832804|NCT00758459|591756384|FG000|Overall Study|Withdrawal by Subject|0|||
163832805|NCT00758459|591756385|FG001|Overall Study|Withdrawal by Subject|1|||
163832806|NCT01780935|591756389|FG000|Overall Study|Admin problems due to early termination|321|||
163832807|NCT01780935|591756390|FG001|Overall Study|Admin problems due to early termination|309|||
163832808|NCT01780935|591756389|FG000|Overall Study|Adverse Event|2|||
163832809|NCT01780935|591756390|FG001|Overall Study|Adverse Event|4|||
163832810|NCT01780935|591756389|FG000|Overall Study|Death|1|||
163832811|NCT01780935|591756390|FG001|Overall Study|Death|6|||
163832812|NCT01780935|591756389|FG000|Overall Study|Lost to Follow-up|2|||
163832813|NCT01780935|591756390|FG001|Overall Study|Lost to Follow-up|6|||
163832814|NCT01780935|591756389|FG000|Overall Study|Physician Decision|1|||
163832815|NCT01780935|591756390|FG001|Overall Study|Physician Decision|1|||
163832816|NCT01780935|591756389|FG000|Overall Study|Protocol deviation|0|||
163832817|NCT01780935|591756390|FG001|Overall Study|Protocol deviation|1|||
163832818|NCT01780935|591756389|FG000|Overall Study|Patient withdrew consent|8|||
163832819|NCT01780935|591756390|FG001|Overall Study|Patient withdrew consent|9|||
163832820|NCT01281202|591756391|FG000|Overall Study|Adverse Event|2|||
163832821|NCT01281202|591756392|FG001|Overall Study|Adverse Event|0|||
163832822|NCT01281202|591756391|FG000|Overall Study|Withdrawal by Subject|2|||
163832823|NCT01281202|591756392|FG001|Overall Study|Withdrawal by Subject|2|||
163832824|NCT01281202|591756391|FG000|Overall Study|Protocol Violation|11|||
163832825|NCT01281202|591756392|FG001|Overall Study|Protocol Violation|10|||
163832826|NCT01281202|591756391|FG000|Overall Study|Administrative|2|||
163832827|NCT01281202|591756392|FG001|Overall Study|Administrative|8|||
163832828|NCT01281202|591756391|FG000|Overall Study|Lost to Follow-up|11|||
163832829|NCT01281202|591756392|FG001|Overall Study|Lost to Follow-up|13|||
163832830|NCT01281202|591756391|FG000|Overall Study|Incarceration|0|||
163832831|NCT01281202|591756392|FG001|Overall Study|Incarceration|3|||
163832832|NCT01215357|591756393|FG000|Overall Study|Withdrawal by Subject|3|||
163832833|NCT01215357|591756393|FG000|Overall Study|Protocol Violation|9|||
163832834|NCT05479604|591756394|FG000|Overall Study|Lost to Follow-up|1|||
163832835|NCT05479604|591756395|FG001|Overall Study|Lost to Follow-up|5|||
163832836|NCT01591382|591756396|FG000|Overall Study|Discharged Prior to Study Completion|2|||
163832837|NCT01591382|591756397|FG001|Overall Study|Discharged Prior to Study Completion|1|||
163927727|NCT03520075|592107808|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164035081|NCT05127421|592486597|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
164035082|NCT05127421|592486598|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
164035083|NCT05127421|592486595|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
164035084|NCT05127421|592486596|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
164035085|NCT05127421|592486597|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
164035086|NCT05127421|592486598|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
164035087|NCT05127421|592486595|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
164035088|NCT05127421|592486596|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
163832838|NCT01591382|591756396|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
163832839|NCT01591382|591756397|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
163832840|NCT00701038|591756401|FG000|Overall Study|study amended pilot group of patients|4|||
163832841|NCT00701038|591756402|FG001|Overall Study|study amended pilot group of patients|4|||
163832842|NCT05099926|591756407|FG000|Overall Study|Lost to Follow-up|1|||
163832843|NCT01059630|591757912|FG000|Overall Study|Death|100|||
163832844|NCT01059630|591757913|FG001|Overall Study|Death|84|||
163832845|NCT01059630|591757912|FG000|Overall Study|Lost to Follow-up|4|||
163832846|NCT01059630|591757913|FG001|Overall Study|Lost to Follow-up|1|||
163832847|NCT01059630|591757912|FG000|Overall Study|Physician Decision|2|||
163832848|NCT01059630|591757913|FG001|Overall Study|Physician Decision|4|||
163832849|NCT01059630|591757912|FG000|Overall Study|Withdrawal by Subject|21|||
163832850|NCT01059630|591757913|FG001|Overall Study|Withdrawal by Subject|14|||
163832851|NCT02569437|591757914|FG000|Overall Study|Lost to Follow-up|12|||
163832852|NCT02569437|591757915|FG001|Overall Study|Lost to Follow-up|14|||
163832853|NCT00441701|591757916|FG000|Overall Study|Adverse Event|3|||
163832854|NCT00441701|591757917|FG001|Overall Study|Adverse Event|2|||
163832855|NCT00441701|591757918|FG002|Overall Study|Adverse Event|1|||
163832856|NCT00441701|591757919|FG003|Overall Study|Adverse Event|0|||
163832857|NCT00441701|591757920|FG004|Overall Study|Adverse Event|2|||
163832858|NCT00441701|591757921|FG005|Overall Study|Adverse Event|2|||
163832859|NCT00441701|591757922|FG006|Overall Study|Adverse Event|0|||
163832860|NCT00441701|591757923|FG007|Overall Study|Adverse Event|0|||
163832861|NCT00441701|591757924|FG008|Overall Study|Adverse Event|0|||
163832862|NCT00441701|591757925|FG009|Overall Study|Adverse Event|0|||
163832863|NCT00441701|591757916|FG000|Overall Study|Lack of Efficacy|2|||
163832864|NCT00441701|591757917|FG001|Overall Study|Lack of Efficacy|0|||
163832865|NCT00441701|591757918|FG002|Overall Study|Lack of Efficacy|2|||
163832866|NCT00441701|591757919|FG003|Overall Study|Lack of Efficacy|2|||
163832867|NCT00441701|591757920|FG004|Overall Study|Lack of Efficacy|0|||
163832868|NCT00441701|591757921|FG005|Overall Study|Lack of Efficacy|1|||
163832869|NCT00441701|591757922|FG006|Overall Study|Lack of Efficacy|0|||
163832870|NCT00441701|591757923|FG007|Overall Study|Lack of Efficacy|0|||
163832871|NCT00441701|591757924|FG008|Overall Study|Lack of Efficacy|0|||
163832872|NCT00441701|591757925|FG009|Overall Study|Lack of Efficacy|0|||
163832873|NCT00441701|591757916|FG000|Overall Study|Withdrawal by Subject|0|||
163832874|NCT00441701|591757917|FG001|Overall Study|Withdrawal by Subject|2|||
163832875|NCT00441701|591757918|FG002|Overall Study|Withdrawal by Subject|1|||
163832876|NCT00441701|591757919|FG003|Overall Study|Withdrawal by Subject|1|||
163832877|NCT00441701|591757920|FG004|Overall Study|Withdrawal by Subject|0|||
163832878|NCT00441701|591757921|FG005|Overall Study|Withdrawal by Subject|0|||
163832879|NCT00441701|591757922|FG006|Overall Study|Withdrawal by Subject|0|||
163832880|NCT00441701|591757923|FG007|Overall Study|Withdrawal by Subject|0|||
163832881|NCT00441701|591757924|FG008|Overall Study|Withdrawal by Subject|0|||
163832882|NCT00441701|591757925|FG009|Overall Study|Withdrawal by Subject|0|||
163832883|NCT00985985|591757929|FG000|Overall Study|Adverse Event|4|||
163832884|NCT00985985|591757930|FG001|Overall Study|Adverse Event|2|||
163832885|NCT00985985|591757931|FG002|Overall Study|Adverse Event|2|||
163832886|NCT00985985|591757932|FG003|Overall Study|Adverse Event|2|||
163832887|NCT00985985|591757929|FG000|Overall Study|Lost to Follow-up|4|||
163832888|NCT00985985|591757930|FG001|Overall Study|Lost to Follow-up|11|||
163832889|NCT00985985|591757931|FG002|Overall Study|Lost to Follow-up|2|||
163832890|NCT00985985|591757932|FG003|Overall Study|Lost to Follow-up|3|||
163832891|NCT00985985|591757929|FG000|Overall Study|Protocol Violation|1|||
163832892|NCT00985985|591757930|FG001|Overall Study|Protocol Violation|2|||
163832893|NCT00985985|591757931|FG002|Overall Study|Protocol Violation|0|||
163832894|NCT00985985|591757932|FG003|Overall Study|Protocol Violation|1|||
163832895|NCT00985985|591757929|FG000|Overall Study|Lack of Efficacy|5|||
164035089|NCT05127421|592486597|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
164035090|NCT05127421|592486598|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
163832896|NCT00985985|591757930|FG001|Overall Study|Lack of Efficacy|6|||
163832897|NCT00985985|591757931|FG002|Overall Study|Lack of Efficacy|1|||
163832898|NCT00985985|591757932|FG003|Overall Study|Lack of Efficacy|3|||
163832899|NCT00985985|591757929|FG000|Overall Study|Withdrawal by Subject|4|||
163832900|NCT00985985|591757930|FG001|Overall Study|Withdrawal by Subject|2|||
163832901|NCT00985985|591757931|FG002|Overall Study|Withdrawal by Subject|2|||
163832902|NCT00985985|591757932|FG003|Overall Study|Withdrawal by Subject|2|||
163832903|NCT00985985|591757929|FG000|Overall Study|Other Reason|6|||
163832904|NCT00985985|591757930|FG001|Overall Study|Other Reason|1|||
164098127|NCT01544127|592725033|FG001|Overall Study|Became Psychotic|0|||
164098128|NCT01544127|592725034|FG002|Overall Study|Became Psychotic|0|||
164098129|NCT01544127|592725032|FG000|Overall Study|Researcher withdrew|1|||
164098130|NCT01544127|592725033|FG001|Overall Study|Researcher withdrew|0|||
163832905|NCT00985985|591757931|FG002|Overall Study|Other Reason|4|||
163832906|NCT00985985|591757932|FG003|Overall Study|Other Reason|2|||
163832907|NCT02535364|591757940|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
163832908|NCT02535364|591757940|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
164098131|NCT01544127|592725034|FG002|Overall Study|Researcher withdrew|0|||
164098132|NCT01544127|592725032|FG000|Overall Study|Went active duty|0|||
164098133|NCT01544127|592725033|FG001|Overall Study|Went active duty|0|||
164098134|NCT01544127|592725034|FG002|Overall Study|Went active duty|1|||
164098135|NCT02914600|592725037|FG000|Overall Study|Adverse Event|298|||
164098136|NCT02914600|592725038|FG001|Overall Study|Adverse Event|35|||
164098137|NCT02914600|592725039|FG002|Overall Study|Adverse Event|25|||
164098138|NCT02914600|592725037|FG000|Overall Study|Sponsors decision|287|||
164098139|NCT02914600|592725038|FG001|Overall Study|Sponsors decision|41|||
164098140|NCT02914600|592725039|FG002|Overall Study|Sponsors decision|12|||
163832909|NCT02535364|591757940|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
163832910|NCT02535364|591757940|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
163832911|NCT02535364|591757940|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
163832912|NCT02535364|591757940|FG000|Part B Screening|Death|2|||
163832913|NCT02535364|591757940|FG000|Part B Screening|Physician Decision|1|||
163832914|NCT02535364|591757940|FG000|Part B Screening|Withdrawal by Subject|1|||
163832915|NCT02535364|591757940|FG000|Part B Screening|Adverse Event|1|||
163832916|NCT02535364|591757940|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
163832917|NCT02535364|591757940|FG000|Study Treatment|Death|1|||
163832918|NCT02535364|591757940|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
163832919|NCT02535364|591757940|FG000|12-Month Follow-up Period|Disease progression|22|||
163832920|NCT02535364|591757940|FG000|12-Month Follow-up Period|Death|5|||
163832921|NCT02535364|591757940|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
163832922|NCT02535364|591757940|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
163832923|NCT02535364|591757940|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
163832924|NCT00499863|591757941|FG000|Overall Study|Lack of Efficacy|21|||
163832925|NCT00499863|591757942|FG001|Overall Study|Lack of Efficacy|27|||
163832926|NCT00499863|591757941|FG000|Overall Study|Protocol Violation|12|||
163832927|NCT00499863|591757942|FG001|Overall Study|Protocol Violation|7|||
163832928|NCT00499863|591757941|FG000|Overall Study|Withdrawal by Subject|6|||
163832929|NCT00499863|591757942|FG001|Overall Study|Withdrawal by Subject|4|||
163832930|NCT00499863|591757941|FG000|Overall Study|Adverse Event|8|||
163832931|NCT00499863|591757942|FG001|Overall Study|Adverse Event|2|||
163832932|NCT00499863|591757941|FG000|Overall Study|Sponsor decision|2|||
163832933|NCT00499863|591757942|FG001|Overall Study|Sponsor decision|2|||
163832934|NCT00499863|591757941|FG000|Overall Study|Lost to Follow-up|1|||
163832935|NCT00499863|591757942|FG001|Overall Study|Lost to Follow-up|1|||
163832936|NCT00571701|591757943|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
163832937|NCT00571701|591757944|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
163832938|NCT00571701|591757943|FG000|First Intervention 12 Months|Death|1|||
163832939|NCT00571701|591757944|FG001|First Intervention 12 Months|Death|0|||
163832940|NCT00571701|591757943|FG000|Second Intervention 12 Months|Adverse Event|0|||
163832941|NCT00571701|591757944|FG001|Second Intervention 12 Months|Adverse Event|1|||
163832942|NCT00571701|591757943|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
163832943|NCT00571701|591757944|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
163832944|NCT00691132|591757945|FG000|Overall Study|Adverse Event|2|||
163832945|NCT00691132|591757946|FG001|Overall Study|Adverse Event|3|||
163832946|NCT00691132|591757945|FG000|Overall Study|Withdrawal by Subject|10|||
163832947|NCT00691132|591757946|FG001|Overall Study|Withdrawal by Subject|10|||
163832948|NCT01959347|591757957|FG000|Overall Study|Protocol Violation|9|||
163832949|NCT01959347|591757958|FG001|Overall Study|Protocol Violation|7|||
163832950|NCT01282801|591757959|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
164098141|NCT02914600|592725037|FG000|Overall Study|Withdrawal by Subject|158|||
163832951|NCT01282801|591757960|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
163832952|NCT02889133|591757964|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
163832953|NCT02889133|591757965|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
163832954|NCT02889133|591757964|FG000|Completed Primary Outcome|Manufacturing error|3|||
163832955|NCT02889133|591757965|FG001|Completed Primary Outcome|Manufacturing error|8|||
163832956|NCT02889133|591757964|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
163832957|NCT02889133|591757965|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
163832958|NCT02889133|591757964|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
164098142|NCT02914600|592725038|FG001|Overall Study|Withdrawal by Subject|20|||
164098143|NCT02914600|592725039|FG002|Overall Study|Withdrawal by Subject|18|||
164098144|NCT02914600|592725037|FG000|Overall Study|Investigators discretion|169|||
164098145|NCT02914600|592725038|FG001|Overall Study|Investigators discretion|14|||
164098146|NCT02914600|592725039|FG002|Overall Study|Investigators discretion|13|||
163832959|NCT02889133|591757965|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
163832960|NCT02889133|591757964|FG000|Completed Primary Outcome|Protocol Violation|1|||
163832961|NCT02889133|591757965|FG001|Completed Primary Outcome|Protocol Violation|0|||
163832962|NCT02889133|591757964|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
163832963|NCT02889133|591757965|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
163832964|NCT02889133|591757964|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
163832965|NCT02889133|591757965|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
163832966|NCT02889133|591757964|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
163832967|NCT02889133|591757965|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
163832968|NCT02889133|591757964|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
163832969|NCT02889133|591757965|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
163832970|NCT02889133|591757964|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
163832971|NCT02889133|591757965|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
163832972|NCT01781390|591757967|FG000|Overall Study|Withdrawal of Consent|0|||
163832973|NCT01781390|591757968|FG001|Overall Study|Withdrawal of Consent|3|||
163832974|NCT01781390|591757969|FG002|Overall Study|Withdrawal of Consent|1|||
163832975|NCT01781390|591757967|FG000|Overall Study|Lost to Follow-up|1|||
163832976|NCT01781390|591757968|FG001|Overall Study|Lost to Follow-up|1|||
163832977|NCT01781390|591757969|FG002|Overall Study|Lost to Follow-up|1|||
163832978|NCT01781390|591757967|FG000|Overall Study|Adverse Event|1|||
163832979|NCT01781390|591757968|FG001|Overall Study|Adverse Event|2|||
163832980|NCT01781390|591757969|FG002|Overall Study|Adverse Event|1|||
163832981|NCT01781390|591757967|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
163927728|NCT03520075|592107809|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
163927729|NCT03520075|592107810|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927730|NCT03520075|592107811|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927731|NCT03520075|592107812|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
163832982|NCT01781390|591757968|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
163832983|NCT01781390|591757969|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
163832984|NCT01862796|591757970|FG000|Overall Study|Prohibited medications|0|||
163832985|NCT01862796|591757971|FG001|Overall Study|Prohibited medications|0|||
163832986|NCT01862796|591757972|FG002|Overall Study|Prohibited medications|1|||
163832987|NCT03485911|591757973|FG000|Part 1|Perceived lack of efficacy|1|||
163832988|NCT03485911|591757974|FG001|Part 1|Perceived lack of efficacy|1|||
163832989|NCT03485911|591757975|FG002|Part 1|Perceived lack of efficacy|2|||
163832990|NCT03485911|591757976|FG003|Part 1|Perceived lack of efficacy|0|||
163832991|NCT03485911|591757973|FG000|Part 1|Subject withdrew consent|0|||
163832992|NCT03485911|591757974|FG001|Part 1|Subject withdrew consent|1|||
163832993|NCT03485911|591757975|FG002|Part 1|Subject withdrew consent|0|||
163832994|NCT03485911|591757976|FG003|Part 1|Subject withdrew consent|1|||
163832995|NCT03485911|591757973|FG000|Part 1|Lab abnormalities/AEs|3|||
163832996|NCT03485911|591757974|FG001|Part 1|Lab abnormalities/AEs|1|||
163832997|NCT03485911|591757975|FG002|Part 1|Lab abnormalities/AEs|1|||
163832998|NCT03485911|591757976|FG003|Part 1|Lab abnormalities/AEs|0|||
163832999|NCT03485911|591757973|FG000|Part 1|Withdrew Consent prior to dosing|0|||
163833000|NCT03485911|591757974|FG001|Part 1|Withdrew Consent prior to dosing|0|||
163833001|NCT03485911|591757975|FG002|Part 1|Withdrew Consent prior to dosing|0|||
163833002|NCT03485911|591757976|FG003|Part 1|Withdrew Consent prior to dosing|1|||
163833003|NCT03485911|591757973|FG000|Part 1|Other NOS|0|||
163833004|NCT03485911|591757974|FG001|Part 1|Other NOS|0|||
163833005|NCT03485911|591757975|FG002|Part 1|Other NOS|0|||
163833006|NCT03485911|591757976|FG003|Part 1|Other NOS|1|||
163833007|NCT03485911|591757973|FG000|Part 2|Perceived lack of efficacy|5|||
163833008|NCT03485911|591757974|FG001|Part 2|Perceived lack of efficacy|3|||
163833009|NCT03485911|591757975|FG002|Part 2|Perceived lack of efficacy|0|||
163833010|NCT03485911|591757976|FG003|Part 2|Perceived lack of efficacy|2|||
163833011|NCT03485911|591757973|FG000|Part 2|Subject withdrew consent|1|||
163833012|NCT03485911|591757974|FG001|Part 2|Subject withdrew consent|0|||
163833013|NCT03485911|591757975|FG002|Part 2|Subject withdrew consent|2|||
163927732|NCT03520075|592107813|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163833014|NCT03485911|591757976|FG003|Part 2|Subject withdrew consent|1|||
163833015|NCT03485911|591757973|FG000|Part 2|Lab abnormalities/AEs|1|||
163833016|NCT03485911|591757974|FG001|Part 2|Lab abnormalities/AEs|2|||
163833017|NCT03485911|591757975|FG002|Part 2|Lab abnormalities/AEs|0|||
163833018|NCT03485911|591757976|FG003|Part 2|Lab abnormalities/AEs|0|||
163833019|NCT03485911|591757973|FG000|Part 2|Other NOS|0|||
163833020|NCT03485911|591757974|FG001|Part 2|Other NOS|1|||
163927733|NCT03520075|592107814|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
164098147|NCT02914600|592725037|FG000|Overall Study|Lost to Follow-up|10|||
163833021|NCT03485911|591757975|FG002|Part 2|Other NOS|0|||
163833022|NCT03485911|591757976|FG003|Part 2|Other NOS|0|||
163833023|NCT03485911|591757973|FG000|Part 2|Intercurrent illness/new medical condition|1|||
163833024|NCT03485911|591757974|FG001|Part 2|Intercurrent illness/new medical condition|0|||
163833025|NCT03485911|591757975|FG002|Part 2|Intercurrent illness/new medical condition|0|||
163833026|NCT03485911|591757976|FG003|Part 2|Intercurrent illness/new medical condition|0|||
163833027|NCT03485911|591757973|FG000|Part 2|Investigator judgement|1|||
163833028|NCT03485911|591757974|FG001|Part 2|Investigator judgement|0|||
163833029|NCT03485911|591757975|FG002|Part 2|Investigator judgement|0|||
163833030|NCT03485911|591757976|FG003|Part 2|Investigator judgement|0|||
163833031|NCT03485911|591757973|FG000|Part 3|Perceived lack of efficacy|2|||
163833032|NCT03485911|591757974|FG001|Part 3|Perceived lack of efficacy|2|||
163833033|NCT03485911|591757975|FG002|Part 3|Perceived lack of efficacy|2|||
163833034|NCT03485911|591757976|FG003|Part 3|Perceived lack of efficacy|0|||
163833035|NCT03485911|591757973|FG000|Part 3|Subject withdrew consent|1|||
163833036|NCT03485911|591757974|FG001|Part 3|Subject withdrew consent|4|||
163833037|NCT03485911|591757975|FG002|Part 3|Subject withdrew consent|0|||
163833038|NCT03485911|591757976|FG003|Part 3|Subject withdrew consent|1|||
163833039|NCT03485911|591757973|FG000|Part 3|Lab abnormalities/AEs|1|||
163833040|NCT03485911|591757974|FG001|Part 3|Lab abnormalities/AEs|1|||
163833041|NCT03485911|591757975|FG002|Part 3|Lab abnormalities/AEs|0|||
163833042|NCT03485911|591757976|FG003|Part 3|Lab abnormalities/AEs|2|||
163833043|NCT03485911|591757973|FG000|Part 3|Other NOS|1|||
163833044|NCT03485911|591757974|FG001|Part 3|Other NOS|1|||
163833045|NCT03485911|591757975|FG002|Part 3|Other NOS|0|||
163833046|NCT03485911|591757976|FG003|Part 3|Other NOS|0|||
163833047|NCT03485911|591757973|FG000|Part 3|Intercurrent illness/new medical condition|0|||
163833048|NCT03485911|591757974|FG001|Part 3|Intercurrent illness/new medical condition|1|||
163833049|NCT03485911|591757975|FG002|Part 3|Intercurrent illness/new medical condition|1|||
163833050|NCT03485911|591757976|FG003|Part 3|Intercurrent illness/new medical condition|0|||
163833051|NCT03485911|591757973|FG000|Part 3|Sponsor discontinuation|1|||
163833052|NCT03485911|591757974|FG001|Part 3|Sponsor discontinuation|0|||
163833053|NCT03485911|591757975|FG002|Part 3|Sponsor discontinuation|0|||
163833054|NCT03485911|591757976|FG003|Part 3|Sponsor discontinuation|0|||
163833055|NCT03485911|591757973|FG000|Part 3|Berotralstat provided by alternative means|13|||
163833056|NCT03485911|591757974|FG001|Part 3|Berotralstat provided by alternative means|13|||
163833057|NCT03485911|591757975|FG002|Part 3|Berotralstat provided by alternative means|7|||
163833058|NCT03485911|591757976|FG003|Part 3|Berotralstat provided by alternative means|7|||
163833059|NCT01375205|591757981|FG000|Overall Study|Lost to Follow-up|15|||
163833060|NCT01375205|591757982|FG001|Overall Study|Lost to Follow-up|12|||
163833061|NCT01375205|591757981|FG000|Overall Study|Withdrawal by Subject|6|||
163833062|NCT01375205|591757982|FG001|Overall Study|Withdrawal by Subject|1|||
163833063|NCT01859793|591757983|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
163833064|NCT01859793|591757984|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
163833065|NCT01859793|591757983|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
163833066|NCT01859793|591757984|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
163833067|NCT01859793|591757983|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
163833068|NCT01859793|591757984|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163833069|NCT01859793|591757983|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
163833070|NCT01859793|591757984|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
163833071|NCT04954586|591757989|FG000|Overall Study|Withdrawal by Subject|5|||
163833072|NCT03185481|591757996|FG000|Overall Study|Adverse Event|1|||
163927734|NCT03520075|592107815|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927735|NCT03520075|592107816|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927736|NCT03520075|592107817|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163927737|NCT03520075|592107818|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
163833073|NCT03185481|591757996|FG000|Overall Study|Study Terminated by Sponsor|4|||
163833074|NCT03371940|591757999|FG000|Overall Study|Withdrawal by Subject|8|||
163833075|NCT03371940|591758000|FG001|Overall Study|Withdrawal by Subject|1|||
163833076|NCT03371940|591758001|FG002|Overall Study|Withdrawal by Subject|3|||
163833077|NCT03371940|591758002|FG003|Overall Study|Withdrawal by Subject|4|||
163833078|NCT01064297|591758003|FG000|Overall Study|Lost to Follow-up|791|||
163833079|NCT01064297|591758004|FG001|Overall Study|Lost to Follow-up|48|||
163927738|NCT03520075|592107800|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163833080|NCT01064297|591758005|FG002|Overall Study|Lost to Follow-up|133|||
163833081|NCT00511875|591758023|FG000|Overall Study|Lost to Follow-up|4|||
163833082|NCT00511875|591758024|FG001|Overall Study|Lost to Follow-up|0|||
163833083|NCT00511875|591758023|FG000|Overall Study|Missing variables|1|||
163833084|NCT00511875|591758024|FG001|Overall Study|Missing variables|0|||
163833085|NCT02686034|591758026|FG000|Run-In Period 1|Eligibility|12|||
163833086|NCT02686034|591758027|FG001|Run-In Period 1|Eligibility|10|||
163833087|NCT02686034|591758026|FG000|Run-In Period 1|Withdrawal by Subject|4|||
163833088|NCT02686034|591758027|FG001|Run-In Period 1|Withdrawal by Subject|3|||
163833089|NCT02686034|591758026|FG000|Run-In Period 1|Lost to Follow-up|4|||
163833090|NCT02686034|591758027|FG001|Run-In Period 1|Lost to Follow-up|4|||
163927739|NCT03520075|592107801|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163927740|NCT03520075|592107802|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927741|NCT03520075|592107803|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163927742|NCT03520075|592107804|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163927743|NCT03520075|592107805|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927744|NCT03520075|592107806|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927745|NCT03520075|592107807|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927746|NCT03520075|592107808|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163833091|NCT02686034|591758026|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
163833092|NCT02686034|591758027|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
163833093|NCT02686034|591758026|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
163833094|NCT02686034|591758027|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
163833095|NCT02686034|591758026|FG000|Randomized Controlled Period 2|Adverse Event|0|||
163833096|NCT02686034|591758027|FG001|Randomized Controlled Period 2|Adverse Event|2|||
164035091|NCT05127421|592486595|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
164035092|NCT05127421|592486596|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
164035093|NCT05127421|592486597|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
164035094|NCT05127421|592486598|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
164035095|NCT05127421|592486595|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
164035096|NCT05127421|592486596|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
164035097|NCT05127421|592486597|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
164035098|NCT05127421|592486598|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
163833097|NCT02686034|591758026|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
163833098|NCT02686034|591758027|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
163833099|NCT02686034|591758026|FG000|Open Label Period 3|Lost to Follow-up|0|||
163833100|NCT02686034|591758027|FG001|Open Label Period 3|Lost to Follow-up|1|||
163833101|NCT00542880|591758028|FG000|Period 1|Eligibility criteria not fulfilled|2|||
163833102|NCT00542880|591758029|FG001|Period 1|Eligibility criteria not fulfilled|6|||
163833103|NCT00542880|591758028|FG000|Period 1|Adverse Event|2|||
163833104|NCT00542880|591758029|FG001|Period 1|Adverse Event|2|||
163833105|NCT00542880|591758028|FG000|Period 1|Development of study-specific criteria|1|||
163833106|NCT00542880|591758029|FG001|Period 1|Development of study-specific criteria|2|||
163833107|NCT00542880|591758028|FG000|Period 1|Withdrawal by Subject|1|||
163833108|NCT00542880|591758029|FG001|Period 1|Withdrawal by Subject|1|||
163833109|NCT00542880|591758028|FG000|Period 1|Protocol Violation|0|||
163833110|NCT00542880|591758029|FG001|Period 1|Protocol Violation|1|||
163833111|NCT00542880|591758028|FG000|Period 2|Adverse Event|5|||
163833112|NCT00542880|591758029|FG001|Period 2|Adverse Event|7|||
163833113|NCT00542880|591758028|FG000|Period 2|Eligibility not fulfilled|0|||
163833114|NCT00542880|591758029|FG001|Period 2|Eligibility not fulfilled|1|||
163833115|NCT00542880|591758028|FG000|Period 2|Discontinuation criteria|2|||
163833116|NCT00542880|591758029|FG001|Period 2|Discontinuation criteria|0|||
163833117|NCT00542880|591758028|FG000|Period 2|Severe non-compliance|0|||
163833118|NCT00542880|591758029|FG001|Period 2|Severe non-compliance|1|||
163833119|NCT00542880|591758028|FG000|Period 2|Other|0|||
163833120|NCT00542880|591758029|FG001|Period 2|Other|1|||
163833121|NCT00542880|591758028|FG000|Period 3|Adverse Event|0|||
163833122|NCT00542880|591758029|FG001|Period 3|Adverse Event|2|||
163833123|NCT01678131|591758030|FG000|Overall Study|Adverse Event|0|||
163833124|NCT01678131|591758031|FG001|Overall Study|Adverse Event|1|||
163833125|NCT01678131|591758032|FG002|Overall Study|Adverse Event|0|||
163833126|NCT01678131|591758030|FG000|Overall Study|Withdrawal by Subject|0|||
163833127|NCT01678131|591758031|FG001|Overall Study|Withdrawal by Subject|0|||
163833128|NCT01678131|591758032|FG002|Overall Study|Withdrawal by Subject|2|||
163833129|NCT00982930|591758036|FG000|Overall Study|Adverse Event|1|||
164035099|NCT00618449|592486599|FG000|Overall Study|Lost to Follow-up|98|||
164035100|NCT00618449|592486600|FG001|Overall Study|Lost to Follow-up|110|||
164035101|NCT00964158|592486601|FG000|Overall Study|Lost to Follow-up|0|||
163833130|NCT00982930|591758036|FG000|Overall Study|Withdrawal by Subject|1|||
163833131|NCT00982930|591758036|FG000|Overall Study|Administrative Problems|2|||
163833132|NCT00941798|591758037|FG000|Overall Study|Withdrawal by Subject|72|||
163833133|NCT00941798|591758038|FG001|Overall Study|Withdrawal by Subject|74|||
163833134|NCT00941798|591758037|FG000|Overall Study|Adverse Event|43|||
163833135|NCT00941798|591758038|FG001|Overall Study|Adverse Event|23|||
163833136|NCT00941798|591758037|FG000|Overall Study|Lost to Follow-up|29|||
163833137|NCT00941798|591758038|FG001|Overall Study|Lost to Follow-up|23|||
163833138|NCT00941798|591758037|FG000|Overall Study|Protocol Violation|17|||
163833139|NCT00941798|591758038|FG001|Overall Study|Protocol Violation|20|||
163833140|NCT00941798|591758037|FG000|Overall Study|Administrative problems|13|||
163833141|NCT00941798|591758038|FG001|Overall Study|Administrative problems|23|||
163833142|NCT00941798|591758037|FG000|Overall Study|Lack of Efficacy|10|||
163833143|NCT00941798|591758038|FG001|Overall Study|Lack of Efficacy|17|||
163833144|NCT00941798|591758037|FG000|Overall Study|Patient's inability to use device|6|||
163833145|NCT00941798|591758038|FG001|Overall Study|Patient's inability to use device|1|||
163833146|NCT00941798|591758037|FG000|Overall Study|Abnormal test procedure results|3|||
163833147|NCT00941798|591758038|FG001|Overall Study|Abnormal test procedure results|1|||
163833148|NCT00941798|591758037|FG000|Overall Study|Abnormal laboratory values|1|||
164035102|NCT00964158|592486602|FG001|Overall Study|Lost to Follow-up|1|||
164035103|NCT00964158|592486603|FG002|Overall Study|Lost to Follow-up|2|||
164035104|NCT00964158|592486601|FG000|Overall Study|Withdrawal by Subject|0|||
163833149|NCT00941798|591758038|FG001|Overall Study|Abnormal laboratory values|2|||
163833150|NCT00941798|591758037|FG000|Overall Study|Death|0|||
163833151|NCT00941798|591758038|FG001|Overall Study|Death|1|||
164035105|NCT00964158|592486602|FG001|Overall Study|Withdrawal by Subject|0|||
163833152|NCT05597722|591758039|FG000|Overall Study|Study was terminated|6|||
163833153|NCT05597722|591758040|FG001|Overall Study|Study was terminated|1|||
163833154|NCT00404495|591758041|FG000|Overall Study|Death|37|||
164035106|NCT00964158|592486603|FG002|Overall Study|Withdrawal by Subject|6|||
163833155|NCT00404495|591758042|FG001|Overall Study|Death|11|||
163833156|NCT00404495|591758041|FG000|Overall Study|Lost to Follow-up|5|||
163833157|NCT00404495|591758042|FG001|Overall Study|Lost to Follow-up|0|||
163833158|NCT00404495|591758041|FG000|Overall Study|Other|1|||
163833159|NCT00404495|591758042|FG001|Overall Study|Other|0|||
163833160|NCT00404495|591758041|FG000|Overall Study|Withdrawal by Subject|1|||
163833161|NCT00404495|591758042|FG001|Overall Study|Withdrawal by Subject|0|||
163833162|NCT03750006|591758047|FG000|Overall Study|Withdrawal by Subject|8|||
163833163|NCT03750006|591758047|FG000|Overall Study|COVID PANDEMIC|11|||
163833164|NCT03538951|591758048|FG000|Overall Study|Withdrawal by Subject|1|||
163833165|NCT03538951|591758049|FG001|Overall Study|Withdrawal by Subject|2|||
163833166|NCT01816763|591759480|FG000|Overall Study|The main reason for an incomplete survey|4|||
163833167|NCT01816763|591759481|FG001|Overall Study|The main reason for an incomplete survey|15|||
163833168|NCT01816763|591759482|FG002|Overall Study|The main reason for an incomplete survey|11|||
163833169|NCT02243202|591759487|FG000|Overall Study|Adverse Event|5|||
163833170|NCT02243202|591759488|FG001|Overall Study|Adverse Event|6|||
163833171|NCT02243202|591759489|FG002|Overall Study|Adverse Event|10|||
163833172|NCT02243202|591759490|FG003|Overall Study|Adverse Event|4|||
163833173|NCT02243202|591759487|FG000|Overall Study|Lost to Follow-up|9|||
163833174|NCT02243202|591759488|FG001|Overall Study|Lost to Follow-up|9|||
163833175|NCT02243202|591759489|FG002|Overall Study|Lost to Follow-up|14|||
163833176|NCT02243202|591759490|FG003|Overall Study|Lost to Follow-up|11|||
163833177|NCT02243202|591759487|FG000|Overall Study|Protocol Violation|3|||
163833178|NCT02243202|591759488|FG001|Overall Study|Protocol Violation|1|||
163833179|NCT02243202|591759489|FG002|Overall Study|Protocol Violation|2|||
163833180|NCT02243202|591759490|FG003|Overall Study|Protocol Violation|1|||
163833181|NCT02243202|591759487|FG000|Overall Study|Withdrawal by Subject|7|||
163833182|NCT02243202|591759488|FG001|Overall Study|Withdrawal by Subject|6|||
163833183|NCT02243202|591759489|FG002|Overall Study|Withdrawal by Subject|4|||
163833184|NCT02243202|591759490|FG003|Overall Study|Withdrawal by Subject|4|||
163833185|NCT02243202|591759487|FG000|Overall Study|Other|1|||
163833186|NCT02243202|591759488|FG001|Overall Study|Other|3|||
163833187|NCT02243202|591759489|FG002|Overall Study|Other|1|||
163833188|NCT02243202|591759490|FG003|Overall Study|Other|2|||
163833189|NCT02243202|591759487|FG000|Overall Study|Randomized but not received treatment|0|||
163833190|NCT02243202|591759488|FG001|Overall Study|Randomized but not received treatment|0|||
163833191|NCT02243202|591759489|FG002|Overall Study|Randomized but not received treatment|0|||
163833192|NCT02243202|591759490|FG003|Overall Study|Randomized but not received treatment|1|||
163833193|NCT01147822|591759491|FG000|Overall Study|Lost to Follow-up|14|||
163833194|NCT01147822|591759492|FG001|Overall Study|Lost to Follow-up|6|||
163833195|NCT01147822|591759491|FG000|Overall Study|Withdrawal by Subject|10|||
163833196|NCT01147822|591759492|FG001|Overall Study|Withdrawal by Subject|16|||
163833197|NCT01147822|591759491|FG000|Overall Study|Physician Decision|9|||
163833198|NCT01147822|591759492|FG001|Overall Study|Physician Decision|8|||
163833199|NCT01147822|591759491|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
163833200|NCT01147822|591759492|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
163833201|NCT01147822|591759491|FG000|Overall Study|Protocol Violation|1|||
163833202|NCT01147822|591759492|FG001|Overall Study|Protocol Violation|1|||
163833203|NCT03010462|591759496|FG000|Overall Study|Withdrawal by Subject|3|||
163833204|NCT03010462|591759497|FG001|Overall Study|Withdrawal by Subject|1|||
163833205|NCT01966003|591759498|FG000|Overall Study|Death|43|||
163833206|NCT01966003|591759499|FG001|Overall Study|Death|36|||
163833207|NCT01966003|591759498|FG000|Overall Study|Protocol Violation|6|||
163833208|NCT01966003|591759499|FG001|Overall Study|Protocol Violation|4|||
163833209|NCT01966003|591759498|FG000|Overall Study|Lost to Follow-up|4|||
163833210|NCT01966003|591759499|FG001|Overall Study|Lost to Follow-up|3|||
163833211|NCT01966003|591759498|FG000|Overall Study|Physician Decision|12|||
163833212|NCT01966003|591759499|FG001|Overall Study|Physician Decision|13|||
163833213|NCT01966003|591759498|FG000|Overall Study|Withdrawal by Subject|29|||
163833214|NCT01966003|591759499|FG001|Overall Study|Withdrawal by Subject|19|||
163833215|NCT01966003|591759498|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
163833216|NCT01966003|591759499|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
163833217|NCT01966003|591759498|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
164035107|NCT03695393|592486608|FG000|Overall Study|Death|3|||
163833218|NCT01966003|591759499|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
163833219|NCT01966003|591759498|FG000|Overall Study|Other|1|||
163833220|NCT01966003|591759499|FG001|Overall Study|Other|1|||
163833221|NCT00871403|591759506|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
163833222|NCT00871403|591759507|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
163833223|NCT00871403|591759508|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
163833224|NCT00871403|591759506|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
164035108|NCT03695393|592486609|FG001|Overall Study|Death|1|||
163833225|NCT00871403|591759507|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
163833226|NCT00871403|591759508|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
163833227|NCT00871403|591759506|FG000|Combination Treatment Phase|Adverse Event|0|||
163833228|NCT00871403|591759507|FG001|Combination Treatment Phase|Adverse Event|17|||
163833229|NCT00871403|591759508|FG002|Combination Treatment Phase|Adverse Event|2|||
163833230|NCT00871403|591759506|FG000|Combination Treatment Phase|Disease Progression|0|||
163833231|NCT00871403|591759507|FG001|Combination Treatment Phase|Disease Progression|8|||
163833232|NCT00871403|591759508|FG002|Combination Treatment Phase|Disease Progression|5|||
163833233|NCT00871403|591759506|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
163833234|NCT00871403|591759507|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
163833235|NCT00871403|591759508|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
163833236|NCT00871403|591759506|FG000|Combination Treatment Phase|Physician Decision|0|||
163833237|NCT00871403|591759507|FG001|Combination Treatment Phase|Physician Decision|1|||
163833238|NCT00871403|591759508|FG002|Combination Treatment Phase|Physician Decision|3|||
163833239|NCT00871403|591759506|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
163833240|NCT00871403|591759507|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
163833241|NCT00871403|591759508|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
163833242|NCT00871403|591759506|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
163833243|NCT00871403|591759507|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
163833244|NCT00871403|591759508|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
163833245|NCT02748694|591759509|FG000|Overall Study|Voluntary Withdrawal|0|||
163833246|NCT02748694|591759510|FG001|Overall Study|Voluntary Withdrawal|0|||
164098148|NCT02914600|592725038|FG001|Overall Study|Lost to Follow-up|4|||
163833247|NCT02748694|591759511|FG002|Overall Study|Voluntary Withdrawal|0|||
163833248|NCT02748694|591759512|FG003|Overall Study|Voluntary Withdrawal|0|||
163833249|NCT02748694|591759513|FG004|Overall Study|Voluntary Withdrawal|0|||
163833250|NCT02748694|591759514|FG005|Overall Study|Voluntary Withdrawal|0|||
163833251|NCT02748694|591759515|FG006|Overall Study|Voluntary Withdrawal|0|||
163833252|NCT02748694|591759516|FG007|Overall Study|Voluntary Withdrawal|0|||
163833253|NCT02748694|591759517|FG008|Overall Study|Voluntary Withdrawal|0|||
163833254|NCT02748694|591759518|FG009|Overall Study|Voluntary Withdrawal|0|||
163833255|NCT02748694|591759519|FG010|Overall Study|Voluntary Withdrawal|0|||
163833256|NCT02748694|591759520|FG011|Overall Study|Voluntary Withdrawal|0|||
163833257|NCT02748694|591759521|FG012|Overall Study|Voluntary Withdrawal|0|||
163833258|NCT02748694|591759522|FG013|Overall Study|Voluntary Withdrawal|0|||
163833259|NCT02748694|591759523|FG014|Overall Study|Voluntary Withdrawal|2|||
163833260|NCT00077064|591759526|FG000|Overall Study|Adverse Event|0|||
163833261|NCT00077064|591759527|FG001|Overall Study|Adverse Event|4|||
163833262|NCT00077064|591759526|FG000|Overall Study|Patient refusal|0|||
163833263|NCT00077064|591759527|FG001|Overall Study|Patient refusal|2|||
163833264|NCT02007434|591759528|FG000|Overall Study|Lost to Follow-up|0|||
163833265|NCT02007434|591759529|FG001|Overall Study|Lost to Follow-up|1|||
163833266|NCT02007434|591759530|FG002|Overall Study|Lost to Follow-up|0|||
163833267|NCT02007434|591759531|FG003|Overall Study|Lost to Follow-up|0|||
163833268|NCT02007434|591759532|FG004|Overall Study|Lost to Follow-up|0|||
163833269|NCT02007434|591759533|FG005|Overall Study|Lost to Follow-up|0|||
163833270|NCT02007434|591759534|FG006|Overall Study|Lost to Follow-up|0|||
163833271|NCT02007434|591759535|FG007|Overall Study|Lost to Follow-up|0|||
163833272|NCT02007434|591759528|FG000|Overall Study|Non-compliance|1|||
163833273|NCT02007434|591759529|FG001|Overall Study|Non-compliance|0|||
163833274|NCT02007434|591759530|FG002|Overall Study|Non-compliance|1|||
163833275|NCT02007434|591759531|FG003|Overall Study|Non-compliance|0|||
163833276|NCT02007434|591759532|FG004|Overall Study|Non-compliance|0|||
163833277|NCT02007434|591759533|FG005|Overall Study|Non-compliance|0|||
163833278|NCT02007434|591759534|FG006|Overall Study|Non-compliance|0|||
163833279|NCT02007434|591759535|FG007|Overall Study|Non-compliance|0|||
163833280|NCT00763958|591759536|FG000|Overall Study|did not meet final criteria|4|||
163833281|NCT00763958|591759537|FG001|Overall Study|did not meet final criteria|4|||
163833282|NCT00763958|591759536|FG000|Overall Study|Lost to Follow-up|10|||
163833283|NCT00763958|591759537|FG001|Overall Study|Lost to Follow-up|2|||
163833284|NCT00763958|591759536|FG000|Overall Study|Believed they were receiving placebo|0|||
163833285|NCT00763958|591759537|FG001|Overall Study|Believed they were receiving placebo|5|||
163833286|NCT00927355|591759538|FG000|Overall Study|Adverse Event|1|||
163833287|NCT00927355|591759539|FG001|Overall Study|Adverse Event|1|||
163833288|NCT03299686|591759540|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
164098149|NCT02914600|592725039|FG002|Overall Study|Lost to Follow-up|0|||
164098150|NCT02914600|592725037|FG000|Overall Study|Pregnancy|8|||
163833289|NCT03299686|591759541|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
163833290|NCT03299686|591759540|FG000|Treatment Epoch|Physician Decision|1|||
163833291|NCT03299686|591759541|FG001|Treatment Epoch|Physician Decision|0|||
163833292|NCT03299686|591759540|FG000|Treatment Epoch|Adverse Event|8|||
163833293|NCT03299686|591759541|FG001|Treatment Epoch|Adverse Event|4|||
163833294|NCT03299686|591759540|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
163833295|NCT03299686|591759541|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
163833296|NCT01060553|591759543|FG000|Overall Study|Lost to Follow-up|3|||
164098151|NCT02914600|592725038|FG001|Overall Study|Pregnancy|0|||
163927747|NCT03520075|592107809|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927748|NCT03520075|592107810|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163927749|NCT03520075|592107811|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927750|NCT03520075|592107812|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
163927751|NCT03520075|592107813|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927752|NCT03520075|592107814|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927753|NCT03520075|592107815|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927754|NCT03520075|592107816|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927755|NCT03520075|592107817|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927756|NCT03520075|592107818|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
163927757|NCT03520075|592107800|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927758|NCT03520075|592107801|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927759|NCT03520075|592107802|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927760|NCT03520075|592107803|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927761|NCT03520075|592107804|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927762|NCT03520075|592107805|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927763|NCT03520075|592107806|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927764|NCT03520075|592107807|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927765|NCT03520075|592107808|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927766|NCT03520075|592107809|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
163927767|NCT03520075|592107810|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927768|NCT03520075|592107811|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927769|NCT03520075|592107812|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
163927770|NCT03520075|592107813|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927771|NCT03520075|592107814|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927772|NCT03520075|592107815|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927773|NCT03520075|592107816|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927774|NCT03520075|592107817|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927775|NCT03520075|592107818|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
163927776|NCT03520075|592107800|FG000|Phase 2 (Dose Expansion)|Death|0|||
163927777|NCT03520075|592107801|FG001|Phase 2 (Dose Expansion)|Death|0|||
163927778|NCT03520075|592107802|FG002|Phase 2 (Dose Expansion)|Death|0|||
163927779|NCT03520075|592107803|FG003|Phase 2 (Dose Expansion)|Death|0|||
163927780|NCT03520075|592107804|FG004|Phase 2 (Dose Expansion)|Death|0|||
163927781|NCT03520075|592107805|FG005|Phase 2 (Dose Expansion)|Death|0|||
163927782|NCT03520075|592107806|FG006|Phase 2 (Dose Expansion)|Death|0|||
163927783|NCT03520075|592107807|FG007|Phase 2 (Dose Expansion)|Death|0|||
163927784|NCT03520075|592107808|FG008|Phase 2 (Dose Expansion)|Death|0|||
163927785|NCT03520075|592107809|FG009|Phase 2 (Dose Expansion)|Death|0|||
163927786|NCT03520075|592107810|FG010|Phase 2 (Dose Expansion)|Death|0|||
163927787|NCT03520075|592107811|FG011|Phase 2 (Dose Expansion)|Death|0|||
163927788|NCT03520075|592107812|FG012|Phase 2 (Dose Expansion)|Death|0|||
163927789|NCT03520075|592107813|FG013|Phase 2 (Dose Expansion)|Death|20|||
163927790|NCT03520075|592107814|FG014|Phase 2 (Dose Expansion)|Death|13|||
163927791|NCT03520075|592107815|FG015|Phase 2 (Dose Expansion)|Death|9|||
163927792|NCT03520075|592107816|FG016|Phase 2 (Dose Expansion)|Death|5|||
163927793|NCT03520075|592107817|FG017|Phase 2 (Dose Expansion)|Death|14|||
163927794|NCT03520075|592107818|FG018|Phase 2 (Dose Expansion)|Death|12|||
163927795|NCT03520075|592107800|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927796|NCT03520075|592107801|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927797|NCT03520075|592107802|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927798|NCT03520075|592107803|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927799|NCT03520075|592107804|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927800|NCT03520075|592107805|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927801|NCT03520075|592107806|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927802|NCT03520075|592107807|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927803|NCT03520075|592107808|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164035109|NCT03695393|592486608|FG000|Overall Study|Lost to Follow-up|0|||
164035110|NCT03695393|592486609|FG001|Overall Study|Lost to Follow-up|1|||
164035111|NCT04585451|592486610|FG000|Overall Study|Withdrawal by Subject|26|||
164035112|NCT04585451|592486611|FG001|Overall Study|Withdrawal by Subject|0|||
163927804|NCT03520075|592107809|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164035113|NCT01578785|592486614|FG000|Overall Study|Withdrawal by Subject|0|||
163927805|NCT03520075|592107810|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927806|NCT03520075|592107811|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927807|NCT03520075|592107812|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
163927808|NCT03520075|592107813|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
164035114|NCT01578785|592486615|FG001|Overall Study|Withdrawal by Subject|1|||
164035115|NCT01578785|592486614|FG000|Overall Study|Study terminated by sponsor|59|||
164035116|NCT01578785|592486615|FG001|Overall Study|Study terminated by sponsor|118|||
164035117|NCT00966693|592486616|FG000|Overall Study|Adverse Event|0|||
164035118|NCT00966693|592486617|FG001|Overall Study|Adverse Event|0|||
164035119|NCT00966693|592486618|FG002|Overall Study|Adverse Event|1|||
164035120|NCT00966693|592486619|FG003|Overall Study|Adverse Event|2|||
164035121|NCT00966693|592486616|FG000|Overall Study|Death|0|||
164035122|NCT00966693|592486617|FG001|Overall Study|Death|0|||
164035123|NCT00966693|592486618|FG002|Overall Study|Death|1|||
164035124|NCT00966693|592486619|FG003|Overall Study|Death|0|||
164035125|NCT00966693|592486616|FG000|Overall Study|Withdrawal by Subject|1|||
164035126|NCT00966693|592486617|FG001|Overall Study|Withdrawal by Subject|0|||
164035127|NCT00966693|592486618|FG002|Overall Study|Withdrawal by Subject|0|||
164035128|NCT00966693|592486619|FG003|Overall Study|Withdrawal by Subject|5|||
164035129|NCT00966693|592486616|FG000|Overall Study|Disease Progression|0|||
164035130|NCT00966693|592486617|FG001|Overall Study|Disease Progression|0|||
164035131|NCT00966693|592486618|FG002|Overall Study|Disease Progression|1|||
164035132|NCT00966693|592486619|FG003|Overall Study|Disease Progression|16|||
164035133|NCT02581982|592486620|FG000|Overall Study|Lack of Efficacy|12|||
164035134|NCT02581982|592486620|FG000|Overall Study|Adverse Event|3|||
164035135|NCT02581982|592486620|FG000|Overall Study|Physician Decision|1|||
164035136|NCT00405821|592486621|FG000|Overall Study|Death|5|||
164035137|NCT00405821|592486622|FG001|Overall Study|Death|7|||
164035138|NCT00405821|592486621|FG000|Overall Study|Lost to Follow-up|7|||
164035139|NCT00405821|592486622|FG001|Overall Study|Lost to Follow-up|7|||
164035140|NCT00405821|592486621|FG000|Overall Study|Protocol Violation|1|||
164035141|NCT00405821|592486622|FG001|Overall Study|Protocol Violation|0|||
164035142|NCT00405821|592486621|FG000|Overall Study|initiated ART|9|||
163927809|NCT03520075|592107814|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
163927810|NCT03520075|592107815|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
163927811|NCT03520075|592107816|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
163927812|NCT03520075|592107817|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
163927813|NCT03520075|592107818|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
163927814|NCT03520075|592107800|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927815|NCT03520075|592107801|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927816|NCT03520075|592107802|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927817|NCT03520075|592107803|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927818|NCT03520075|592107804|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927819|NCT03520075|592107805|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927820|NCT03520075|592107806|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927821|NCT03520075|592107807|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927822|NCT03520075|592107808|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927823|NCT03520075|592107809|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927824|NCT03520075|592107810|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927825|NCT03520075|592107811|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927826|NCT03520075|592107812|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927827|NCT03520075|592107813|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927828|NCT03520075|592107814|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163927829|NCT03520075|592107815|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163927830|NCT03520075|592107816|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927831|NCT03520075|592107817|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
163927832|NCT03520075|592107818|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
163927833|NCT03520075|592107800|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927834|NCT03520075|592107801|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927835|NCT03520075|592107802|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927836|NCT03520075|592107803|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927837|NCT03520075|592107804|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927838|NCT03520075|592107805|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927839|NCT03520075|592107806|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927840|NCT03520075|592107807|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927841|NCT03520075|592107808|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927842|NCT03520075|592107809|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927843|NCT03520075|592107810|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927844|NCT03520075|592107811|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927845|NCT03520075|592107812|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
164035143|NCT00405821|592486622|FG001|Overall Study|initiated ART|8|||
164035144|NCT01769469|592486623|FG000|Overall Study|Consent Withdrawn|5|||
164035145|NCT01769469|592486623|FG000|Overall Study|Moved Out Of Area|3|||
164035146|NCT01769469|592486623|FG000|Overall Study|Lost to Follow-up|17|||
164035147|NCT01769469|592486623|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
164035148|NCT01769469|592486623|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
164035149|NCT02713789|592486635|FG000|Overall Study|Lost to Follow-up|0|||
164035150|NCT02713789|592486636|FG001|Overall Study|Lost to Follow-up|1|||
164035151|NCT02713789|592486637|FG002|Overall Study|Lost to Follow-up|1|||
164035152|NCT00888615|592486645|FG000|Overall Study|No treatment|2|||
164035153|NCT00141037|592486646|FG000|Overall Study|Physician Decision|1|||
164035154|NCT00141037|592486647|FG001|Overall Study|Physician Decision|2|||
164098152|NCT02914600|592725039|FG002|Overall Study|Pregnancy|0|||
163833297|NCT01060553|591759544|FG001|Overall Study|Lost to Follow-up|5|||
163833298|NCT01060553|591759543|FG000|Overall Study|Withdrawal by Subject|5|||
163833299|NCT01060553|591759544|FG001|Overall Study|Withdrawal by Subject|5|||
163833300|NCT01060553|591759543|FG000|Overall Study|Lack of Efficacy|1|||
163833301|NCT01060553|591759544|FG001|Overall Study|Lack of Efficacy|0|||
163833302|NCT01446796|591759545|FG000|Overall Study|Withdrawal by Subject|1|||
163833303|NCT01446796|591759546|FG001|Overall Study|Withdrawal by Subject|0|||
163833304|NCT00954733|591759550|FG000|Overall Study|blood gas machine did not work|1|||
163833305|NCT03131960|591759551|FG000|Overall Study|Adverse Event|0|||
163833306|NCT03131960|591759552|FG001|Overall Study|Adverse Event|1|||
163833307|NCT04707196|591759553|FG000|Overall Study|Withdrawal by Subject|9|||
163833308|NCT04707196|591759554|FG001|Overall Study|Withdrawal by Subject|6|||
163833309|NCT04707196|591759553|FG000|Overall Study|Lost to Follow-up|1|||
163833310|NCT04707196|591759554|FG001|Overall Study|Lost to Follow-up|0|||
163833311|NCT04707196|591759553|FG000|Overall Study|Protocol Violation|4|||
163833312|NCT04707196|591759554|FG001|Overall Study|Protocol Violation|1|||
163833313|NCT04707196|591759553|FG000|Overall Study|Adverse Event|2|||
163833314|NCT04707196|591759554|FG001|Overall Study|Adverse Event|2|||
163833315|NCT04707196|591759553|FG000|Overall Study|Death|3|||
163833316|NCT04707196|591759554|FG001|Overall Study|Death|1|||
163833317|NCT04707196|591759553|FG000|Overall Study|Non-compliance with study drug|1|||
163833318|NCT04707196|591759554|FG001|Overall Study|Non-compliance with study drug|0|||
163833319|NCT04707196|591759553|FG000|Overall Study|Progressive disease|9|||
163833320|NCT04707196|591759554|FG001|Overall Study|Progressive disease|10|||
163833321|NCT01462162|591759558|FG000|Overall Study|Adverse Event|5|||
163833322|NCT01462162|591759558|FG000|Overall Study|Lack of Efficacy|4|||
163833323|NCT01462162|591759558|FG000|Overall Study|Abnormal laboratory parameters|1|||
163833324|NCT01462162|591759558|FG000|Overall Study|Other|2|||
163833325|NCT03333928|591759559|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
163833326|NCT03333928|591759560|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
163833327|NCT03333928|591759561|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
163833328|NCT03333928|591759559|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
163833329|NCT03333928|591759560|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
163833330|NCT03333928|591759561|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
163833331|NCT03333928|591759559|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
163833332|NCT03333928|591759560|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
163833333|NCT03333928|591759561|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
163833334|NCT03333928|591759559|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
163833335|NCT03333928|591759560|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
163833336|NCT03333928|591759561|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
163833337|NCT03333928|591759559|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
163833338|NCT03333928|591759560|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
163833339|NCT03333928|591759561|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
163833340|NCT03333928|591759559|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
163833341|NCT03333928|591759560|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
163833342|NCT03333928|591759561|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
163833343|NCT03333928|591759559|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
163833344|NCT03333928|591759560|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
163833345|NCT03333928|591759561|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
163833346|NCT03333928|591759559|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
163833347|NCT03333928|591759560|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
163833348|NCT03333928|591759561|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
163833349|NCT00728962|591759564|FG000|Implant Placement Surgery|Adverse Event|8|||
163833350|NCT00728962|591759564|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
163833351|NCT00728962|591759564|FG000|Implant Placement Surgery|Protocol Violation|1|||
163833352|NCT00728962|591759564|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
163833353|NCT00728962|591759564|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
163833354|NCT01987817|591759568|FG000|Overall Study|Adverse Event|4|||
163833355|NCT01987817|591759569|FG001|Overall Study|Adverse Event|0|||
163833356|NCT01987817|591759568|FG000|Overall Study|Withdrawal by Subject|1|||
163833357|NCT01987817|591759569|FG001|Overall Study|Withdrawal by Subject|1|||
163833358|NCT01987817|591759568|FG000|Overall Study|Physician Decision|1|||
163833359|NCT01987817|591759569|FG001|Overall Study|Physician Decision|0|||
163833360|NCT05918978|591759574|FG000|Overall Study|Study Terminated by Sponsor|17|||
163833361|NCT05918978|591759575|FG001|Overall Study|Study Terminated by Sponsor|11|||
163833362|NCT05918978|591759574|FG000|Overall Study|Withdrawal by Subject|1|||
163833363|NCT05918978|591759575|FG001|Overall Study|Withdrawal by Subject|1|||
163833364|NCT05918978|591759574|FG000|Overall Study|Adverse Event|1|||
163833365|NCT05918978|591759575|FG001|Overall Study|Adverse Event|0|||
163833366|NCT05918978|591759574|FG000|Overall Study|Other|0|||
163833367|NCT05918978|591759575|FG001|Overall Study|Other|1|||
164035155|NCT00141037|592486646|FG000|Overall Study|Lost to Follow-up|3|||
164035156|NCT00141037|592486647|FG001|Overall Study|Lost to Follow-up|1|||
164035157|NCT00141037|592486646|FG000|Overall Study|Protocol Violation|0|||
164035158|NCT00141037|592486647|FG001|Overall Study|Protocol Violation|2|||
164035159|NCT00141037|592486646|FG000|Overall Study|Withdrawal by Subject|2|||
164035160|NCT00141037|592486647|FG001|Overall Study|Withdrawal by Subject|1|||
164035161|NCT00141037|592486646|FG000|Overall Study|Other|0|||
164035162|NCT00141037|592486647|FG001|Overall Study|Other|1|||
164035163|NCT00141037|592486646|FG000|Overall Study|Moved from area|1|||
164035164|NCT00141037|592486647|FG001|Overall Study|Moved from area|7|||
164035165|NCT00141037|592486646|FG000|Overall Study|Graft Failure|3|||
164035166|NCT00141037|592486647|FG001|Overall Study|Graft Failure|4|||
164035167|NCT00861380|592486648|FG000|Overall Study|Withdrawal Information not recorded|8427|||
164098153|NCT02914600|592725037|FG000|Overall Study|Protocol Violation|5|||
164098154|NCT02914600|592725038|FG001|Overall Study|Protocol Violation|3|||
164098155|NCT02914600|592725039|FG002|Overall Study|Protocol Violation|0|||
164098156|NCT02914600|592725037|FG000|Overall Study|Non-compliance with study drug|6|||
164098157|NCT02914600|592725038|FG001|Overall Study|Non-compliance with study drug|1|||
164098158|NCT02914600|592725039|FG002|Overall Study|Non-compliance with study drug|0|||
164098159|NCT02914600|592725037|FG000|Overall Study|Death|3|||
163833368|NCT00622180|591759576|FG000|Overall Study|Lost to Follow-up|1|||
163833369|NCT00622180|591759577|FG001|Overall Study|Lost to Follow-up|2|||
163833370|NCT00698646|591759580|FG000|Overall Study|Adverse Event|8|||
163833371|NCT00698646|591759581|FG001|Overall Study|Adverse Event|7|||
163833372|NCT00698646|591759582|FG002|Overall Study|Adverse Event|8|||
163833373|NCT00698646|591759580|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
163833374|NCT00698646|591759581|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
163833375|NCT00698646|591759582|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
163833376|NCT00698646|591759580|FG000|Overall Study|Protocol Deviation|6|||
163833377|NCT00698646|591759581|FG001|Overall Study|Protocol Deviation|2|||
163833378|NCT00698646|591759582|FG002|Overall Study|Protocol Deviation|3|||
163833379|NCT00698646|591759580|FG000|Overall Study|Withdrawal by Subject|10|||
163833380|NCT00698646|591759581|FG001|Overall Study|Withdrawal by Subject|11|||
163833381|NCT00698646|591759582|FG002|Overall Study|Withdrawal by Subject|8|||
163833382|NCT00698646|591759580|FG000|Overall Study|Lost to Follow-up|0|||
163833383|NCT00698646|591759581|FG001|Overall Study|Lost to Follow-up|0|||
163833384|NCT00698646|591759582|FG002|Overall Study|Lost to Follow-up|2|||
163833385|NCT00698646|591759580|FG000|Overall Study|Administrative problems|1|||
163833386|NCT00698646|591759581|FG001|Overall Study|Administrative problems|0|||
163833387|NCT00698646|591759582|FG002|Overall Study|Administrative problems|1|||
163833388|NCT00279201|591759585|FG000|Initiation|Death|1|||
163833389|NCT00279201|591759586|FG001|Initiation|Death|5|||
163833390|NCT00279201|591759587|FG002|Initiation|Death|0|||
163833391|NCT00279201|591759588|FG003|Initiation|Death|0|||
163833392|NCT00279201|591759589|FG004|Initiation|Death|0|||
163833393|NCT00279201|591759590|FG005|Initiation|Death|0|||
163833394|NCT00279201|591759585|FG000|Initiation|Adverse Event|6|||
163833395|NCT00279201|591759586|FG001|Initiation|Adverse Event|15|||
163833396|NCT00279201|591759587|FG002|Initiation|Adverse Event|0|||
163833397|NCT00279201|591759588|FG003|Initiation|Adverse Event|0|||
163833398|NCT00279201|591759589|FG004|Initiation|Adverse Event|0|||
163833399|NCT00279201|591759590|FG005|Initiation|Adverse Event|0|||
163833400|NCT00279201|591759585|FG000|Initiation|Lost to Follow-up|42|||
163833401|NCT00279201|591759586|FG001|Initiation|Lost to Follow-up|41|||
163833402|NCT00279201|591759587|FG002|Initiation|Lost to Follow-up|0|||
163833403|NCT00279201|591759588|FG003|Initiation|Lost to Follow-up|0|||
163833404|NCT00279201|591759589|FG004|Initiation|Lost to Follow-up|0|||
163833405|NCT00279201|591759590|FG005|Initiation|Lost to Follow-up|0|||
163833406|NCT00279201|591759585|FG000|Initiation|Entry Criteria Exclusion|7|||
163833407|NCT00279201|591759586|FG001|Initiation|Entry Criteria Exclusion|9|||
163833408|NCT00279201|591759587|FG002|Initiation|Entry Criteria Exclusion|0|||
163833409|NCT00279201|591759588|FG003|Initiation|Entry Criteria Exclusion|0|||
163833410|NCT00279201|591759589|FG004|Initiation|Entry Criteria Exclusion|0|||
163833411|NCT00279201|591759590|FG005|Initiation|Entry Criteria Exclusion|0|||
163833412|NCT00279201|591759585|FG000|Initiation|Protocol Violation|9|||
163833413|NCT00279201|591759586|FG001|Initiation|Protocol Violation|10|||
163833414|NCT00279201|591759587|FG002|Initiation|Protocol Violation|0|||
163833415|NCT00279201|591759588|FG003|Initiation|Protocol Violation|0|||
163833416|NCT00279201|591759589|FG004|Initiation|Protocol Violation|0|||
163833417|NCT00279201|591759590|FG005|Initiation|Protocol Violation|0|||
163833418|NCT00279201|591759585|FG000|Initiation|Withdrawal by Subject|35|||
163833419|NCT00279201|591759586|FG001|Initiation|Withdrawal by Subject|41|||
163833420|NCT00279201|591759587|FG002|Initiation|Withdrawal by Subject|0|||
163833421|NCT00279201|591759588|FG003|Initiation|Withdrawal by Subject|0|||
163833422|NCT00279201|591759589|FG004|Initiation|Withdrawal by Subject|0|||
163833423|NCT00279201|591759590|FG005|Initiation|Withdrawal by Subject|0|||
164035168|NCT00861380|592486649|FG001|Overall Study|Withdrawal Information not recorded|9112|||
163833424|NCT00279201|591759585|FG000|Initiation|Physician Decision|15|||
163833425|NCT00279201|591759586|FG001|Initiation|Physician Decision|18|||
163833426|NCT00279201|591759587|FG002|Initiation|Physician Decision|0|||
164098160|NCT02914600|592725038|FG001|Overall Study|Death|1|||
163927846|NCT03520075|592107813|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
163927847|NCT03520075|592107814|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927848|NCT03520075|592107815|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927849|NCT03520075|592107816|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
163927850|NCT03520075|592107817|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
163927851|NCT03520075|592107818|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
163927852|NCT01432626|592107821|FG000|Overall Study|LV function recovered|2|||
163927853|NCT01432626|592107821|FG000|Overall Study|Withdrawal by Subject|2|||
163927854|NCT01432626|592107821|FG000|Overall Study|Only 1 image competed|2|||
163927855|NCT01432626|592107821|FG000|Overall Study|Imaging agent not available|1|||
163927856|NCT03305809|592107822|FG000|Overall Study|Adverse Event|2|||
163927857|NCT03305809|592107823|FG001|Overall Study|Adverse Event|2|||
163927858|NCT03305809|592107824|FG002|Overall Study|Adverse Event|6|||
163927859|NCT03305809|592107825|FG003|Overall Study|Adverse Event|6|||
163927860|NCT03305809|592107822|FG000|Overall Study|Death|0|||
163927861|NCT03305809|592107823|FG001|Overall Study|Death|0|||
163927862|NCT03305809|592107824|FG002|Overall Study|Death|1|||
163927863|NCT03305809|592107825|FG003|Overall Study|Death|1|||
163927864|NCT03305809|592107822|FG000|Overall Study|Lost to Follow-up|1|||
163927865|NCT03305809|592107823|FG001|Overall Study|Lost to Follow-up|2|||
163927866|NCT03305809|592107824|FG002|Overall Study|Lost to Follow-up|0|||
163927867|NCT03305809|592107825|FG003|Overall Study|Lost to Follow-up|0|||
163927868|NCT03305809|592107822|FG000|Overall Study|Sponsor Decision|1|||
163927869|NCT03305809|592107823|FG001|Overall Study|Sponsor Decision|0|||
163927870|NCT03305809|592107824|FG002|Overall Study|Sponsor Decision|1|||
163927871|NCT03305809|592107825|FG003|Overall Study|Sponsor Decision|8|||
163927872|NCT03305809|592107822|FG000|Overall Study|Physician Decision|0|||
163927873|NCT03305809|592107823|FG001|Overall Study|Physician Decision|0|||
163833427|NCT00279201|591759588|FG003|Initiation|Physician Decision|0|||
163833428|NCT00279201|591759589|FG004|Initiation|Physician Decision|0|||
163833429|NCT00279201|591759590|FG005|Initiation|Physician Decision|0|||
163833430|NCT00279201|591759585|FG000|Initiation|Sponsor Decision|13|||
163833431|NCT00279201|591759586|FG001|Initiation|Sponsor Decision|5|||
163833432|NCT00279201|591759587|FG002|Initiation|Sponsor Decision|0|||
163833433|NCT00279201|591759588|FG003|Initiation|Sponsor Decision|0|||
163833434|NCT00279201|591759589|FG004|Initiation|Sponsor Decision|0|||
163833435|NCT00279201|591759590|FG005|Initiation|Sponsor Decision|0|||
163833436|NCT00279201|591759585|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163833437|NCT00279201|591759586|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
163833438|NCT00279201|591759587|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163833439|NCT00279201|591759588|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163833440|NCT00279201|591759589|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163833441|NCT00279201|591759590|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
163833442|NCT00279201|591759585|FG000|Maintenance|Lack of Efficacy|32|||
163833443|NCT00279201|591759586|FG001|Maintenance|Lack of Efficacy|30|||
163833444|NCT00279201|591759587|FG002|Maintenance|Lack of Efficacy|0|||
163833445|NCT00279201|591759588|FG003|Maintenance|Lack of Efficacy|0|||
163833446|NCT00279201|591759589|FG004|Maintenance|Lack of Efficacy|0|||
163833447|NCT00279201|591759590|FG005|Maintenance|Lack of Efficacy|0|||
163833448|NCT00279201|591759585|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
163833449|NCT00279201|591759586|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
163833450|NCT00279201|591759587|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163833451|NCT00279201|591759588|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163833452|NCT00279201|591759589|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163833453|NCT00279201|591759590|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
163833454|NCT00279201|591759585|FG000|Maintenance|Adverse Event|4|||
163833455|NCT00279201|591759586|FG001|Maintenance|Adverse Event|4|||
163833456|NCT00279201|591759587|FG002|Maintenance|Adverse Event|0|||
163833457|NCT00279201|591759588|FG003|Maintenance|Adverse Event|0|||
163833458|NCT00279201|591759589|FG004|Maintenance|Adverse Event|0|||
163833459|NCT00279201|591759590|FG005|Maintenance|Adverse Event|0|||
164035169|NCT00861380|592486650|FG002|Overall Study|Withdrawal Information not recorded|8872|||
164035170|NCT00861380|592486651|FG003|Overall Study|Withdrawal Information not recorded|3689|||
164035171|NCT00861380|592486652|FG004|Overall Study|Withdrawal Information not recorded|1812|||
163927874|NCT03305809|592107824|FG002|Overall Study|Physician Decision|2|||
163927875|NCT03305809|592107825|FG003|Overall Study|Physician Decision|4|||
163927876|NCT03305809|592107822|FG000|Overall Study|Progressive Disease|0|||
163927877|NCT03305809|592107823|FG001|Overall Study|Progressive Disease|0|||
163927878|NCT03305809|592107824|FG002|Overall Study|Progressive Disease|1|||
163927879|NCT03305809|592107825|FG003|Overall Study|Progressive Disease|0|||
163833460|NCT00279201|591759585|FG000|Maintenance|Death|4|||
163833461|NCT00279201|591759586|FG001|Maintenance|Death|4|||
163833462|NCT00279201|591759587|FG002|Maintenance|Death|0|||
163833463|NCT00279201|591759588|FG003|Maintenance|Death|0|||
163833464|NCT00279201|591759589|FG004|Maintenance|Death|0|||
163833465|NCT00279201|591759590|FG005|Maintenance|Death|0|||
163833466|NCT00279201|591759585|FG000|Maintenance|Lost to Follow-up|17|||
163927880|NCT03305809|592107822|FG000|Overall Study|Protocol Violation|1|||
163927881|NCT03305809|592107823|FG001|Overall Study|Protocol Violation|0|||
163927882|NCT03305809|592107824|FG002|Overall Study|Protocol Violation|2|||
163927883|NCT03305809|592107825|FG003|Overall Study|Protocol Violation|3|||
163927884|NCT03305809|592107822|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
163927885|NCT03305809|592107823|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
163927886|NCT03305809|592107824|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
163927887|NCT03305809|592107825|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
163927888|NCT03305809|592107822|FG000|Overall Study|Withdrawal by Subject|2|||
163927889|NCT03305809|592107823|FG001|Overall Study|Withdrawal by Subject|4|||
163927890|NCT03305809|592107824|FG002|Overall Study|Withdrawal by Subject|5|||
163927891|NCT03305809|592107825|FG003|Overall Study|Withdrawal by Subject|2|||
163927892|NCT03305809|592107822|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
163927893|NCT03305809|592107823|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
163927894|NCT03305809|592107824|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
163927895|NCT03305809|592107825|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
163927896|NCT00816556|592107828|FG000|Overall Study|Adverse Event|1|||
163927897|NCT00816556|592107829|FG001|Overall Study|Adverse Event|1|||
163927898|NCT00816556|592107830|FG002|Overall Study|Adverse Event|1|||
163927899|NCT00816556|592107828|FG000|Overall Study|Withdrawal by Subject|1|||
163927900|NCT00816556|592107829|FG001|Overall Study|Withdrawal by Subject|1|||
163927901|NCT00816556|592107830|FG002|Overall Study|Withdrawal by Subject|1|||
163927902|NCT00816556|592107828|FG000|Overall Study|Lost to Follow-up|0|||
163927903|NCT00816556|592107829|FG001|Overall Study|Lost to Follow-up|0|||
163927904|NCT00816556|592107830|FG002|Overall Study|Lost to Follow-up|1|||
163927905|NCT02536742|592107834|FG000|Overall Study|Did not start protocol therapy|1|||
163927906|NCT02536742|592107834|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
163927907|NCT01010204|592107835|FG000|Overall Study|Lost to Follow-up|2|||
163927908|NCT01010204|592107836|FG001|Overall Study|Lost to Follow-up|2|||
163927909|NCT01010204|592107835|FG000|Overall Study|Adverse Event|1|||
163927910|NCT01010204|592107836|FG001|Overall Study|Adverse Event|3|||
163927911|NCT01010204|592107835|FG000|Overall Study|Withdrawal by Subject|2|||
163927912|NCT01010204|592107836|FG001|Overall Study|Withdrawal by Subject|3|||
163927913|NCT01010204|592107835|FG000|Overall Study|psychiatric hospitalization|2|||
163927914|NCT01010204|592107836|FG001|Overall Study|psychiatric hospitalization|1|||
163927915|NCT01519778|592107837|FG000|Overall Study|Withdrawal by Subject|3|||
163927916|NCT01519778|592107837|FG000|Overall Study|Lost to Follow-up|10|||
163927917|NCT01519778|592107837|FG000|Overall Study|Physician Decision|1|||
163927918|NCT01547117|592107843|FG000|Overall Study|Physician Decision|0|||
163927919|NCT01547117|592107844|FG001|Overall Study|Physician Decision|1|||
163927920|NCT01547117|592107845|FG002|Overall Study|Physician Decision|1|||
163927921|NCT01547117|592107846|FG003|Overall Study|Physician Decision|3|||
163927922|NCT01547117|592107843|FG000|Overall Study|Withdrawal by Subject|1|||
163927923|NCT01547117|592107844|FG001|Overall Study|Withdrawal by Subject|2|||
163927924|NCT01547117|592107845|FG002|Overall Study|Withdrawal by Subject|1|||
163927925|NCT01547117|592107846|FG003|Overall Study|Withdrawal by Subject|2|||
163927926|NCT01844726|592107847|FG000|Overall Study|Withdrawal by Subject|0|||
163927927|NCT01844726|592107848|FG001|Overall Study|Withdrawal by Subject|1|||
163927928|NCT01844726|592107847|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
163927929|NCT01844726|592107848|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
163927930|NCT02229578|592107849|FG000|Overall Study|Withdrawal by Subject|1|||
163927931|NCT02229578|592107850|FG001|Overall Study|Withdrawal by Subject|3|||
163927932|NCT02229578|592107849|FG000|Overall Study|Protocol Violation|2|||
163927933|NCT02229578|592107850|FG001|Overall Study|Protocol Violation|0|||
163927934|NCT01288209|592107851|FG000|Overall Study|Withdrawal by Subject|1|||
163927935|NCT01288209|592107852|FG001|Overall Study|Withdrawal by Subject|3|||
163927936|NCT01288209|592107851|FG000|Overall Study|Other|1|||
163927937|NCT01288209|592107852|FG001|Overall Study|Other|0|||
163927938|NCT01496365|592107853|FG000|Overall Study|Adverse Event|2|||
163927939|NCT01496365|592107854|FG001|Overall Study|Adverse Event|3|||
163927940|NCT01496365|592107855|FG002|Overall Study|Adverse Event|3|||
163927941|NCT01496365|592107856|FG003|Overall Study|Adverse Event|2|||
163927942|NCT01496365|592107857|FG004|Overall Study|Adverse Event|5|||
163927943|NCT01496365|592107858|FG005|Overall Study|Adverse Event|6|||
163927944|NCT01496365|592107859|FG006|Overall Study|Adverse Event|4|||
163927945|NCT01496365|592107853|FG000|Overall Study|Withdrawal by Subject|6|||
164035172|NCT00861380|592486653|FG005|Overall Study|Withdrawal Information not recorded|6249|||
164035173|NCT00861380|592486654|FG006|Overall Study|Withdrawal Information not recorded|3020|||
164035174|NCT04186663|592486655|FG000|Overall Study|Lost to Follow-up|1|||
164035175|NCT04186663|592486655|FG000|Overall Study|Unable to complete blood draw|3|||
163927946|NCT01496365|592107854|FG001|Overall Study|Withdrawal by Subject|6|||
163927947|NCT01496365|592107855|FG002|Overall Study|Withdrawal by Subject|0|||
163927948|NCT01496365|592107856|FG003|Overall Study|Withdrawal by Subject|1|||
163927949|NCT01496365|592107857|FG004|Overall Study|Withdrawal by Subject|3|||
164035176|NCT01375647|592488044|FG000|Overall Study|Lost to Follow-up|3|||
163927950|NCT01496365|592107858|FG005|Overall Study|Withdrawal by Subject|2|||
163927951|NCT01496365|592107859|FG006|Overall Study|Withdrawal by Subject|1|||
163927952|NCT01496365|592107853|FG000|Overall Study|Protocol Violation|2|||
163927953|NCT01496365|592107854|FG001|Overall Study|Protocol Violation|1|||
163927954|NCT01496365|592107855|FG002|Overall Study|Protocol Violation|1|||
163927955|NCT01496365|592107856|FG003|Overall Study|Protocol Violation|0|||
163927956|NCT01496365|592107857|FG004|Overall Study|Protocol Violation|0|||
163927957|NCT01496365|592107858|FG005|Overall Study|Protocol Violation|1|||
163927958|NCT01496365|592107859|FG006|Overall Study|Protocol Violation|0|||
163927959|NCT01496365|592107853|FG000|Overall Study|Lack of Efficacy|1|||
163927960|NCT01496365|592107854|FG001|Overall Study|Lack of Efficacy|0|||
163927961|NCT01496365|592107855|FG002|Overall Study|Lack of Efficacy|0|||
163927962|NCT01496365|592107856|FG003|Overall Study|Lack of Efficacy|0|||
163927963|NCT01496365|592107857|FG004|Overall Study|Lack of Efficacy|0|||
163927964|NCT01496365|592107858|FG005|Overall Study|Lack of Efficacy|1|||
163927965|NCT01496365|592107859|FG006|Overall Study|Lack of Efficacy|0|||
163927966|NCT01496365|592107853|FG000|Overall Study|Lost to Follow-up|0|||
163927967|NCT01496365|592107854|FG001|Overall Study|Lost to Follow-up|1|||
163927968|NCT01496365|592107855|FG002|Overall Study|Lost to Follow-up|0|||
163927969|NCT01496365|592107856|FG003|Overall Study|Lost to Follow-up|0|||
163927970|NCT01496365|592107857|FG004|Overall Study|Lost to Follow-up|2|||
163927971|NCT01496365|592107858|FG005|Overall Study|Lost to Follow-up|0|||
163927972|NCT01496365|592107859|FG006|Overall Study|Lost to Follow-up|0|||
163927973|NCT01496365|592107853|FG000|Overall Study|Other|4|||
163927974|NCT01496365|592107854|FG001|Overall Study|Other|4|||
163927975|NCT01496365|592107855|FG002|Overall Study|Other|2|||
163927976|NCT01496365|592107856|FG003|Overall Study|Other|1|||
163927977|NCT01496365|592107857|FG004|Overall Study|Other|3|||
163927978|NCT01496365|592107858|FG005|Overall Study|Other|0|||
163927979|NCT01496365|592107859|FG006|Overall Study|Other|1|||
163927980|NCT01015677|592107860|FG000|Overall Study|Adverse Event|0|||
163927981|NCT01015677|592107861|FG001|Overall Study|Adverse Event|1|||
163927982|NCT01015677|592107862|FG002|Overall Study|Adverse Event|0|||
163927983|NCT01015677|592107860|FG000|Overall Study|Lack of Efficacy|0|||
163927984|NCT01015677|592107861|FG001|Overall Study|Lack of Efficacy|1|||
163927985|NCT01015677|592107862|FG002|Overall Study|Lack of Efficacy|0|||
163927986|NCT01015677|592107860|FG000|Overall Study|Protocol Violation|0|||
163927987|NCT01015677|592107861|FG001|Overall Study|Protocol Violation|1|||
163927988|NCT01015677|592107862|FG002|Overall Study|Protocol Violation|0|||
163927989|NCT01015677|592107860|FG000|Overall Study|Withdrawal by Subject|1|||
163927990|NCT01015677|592107861|FG001|Overall Study|Withdrawal by Subject|1|||
163927991|NCT01015677|592107862|FG002|Overall Study|Withdrawal by Subject|0|||
163927992|NCT01660256|592107863|FG000|Overall Study|Adverse Event|4|||
163927993|NCT01660256|592107864|FG001|Overall Study|Adverse Event|0|||
163927994|NCT01660256|592107865|FG002|Overall Study|Adverse Event|2|||
163927995|NCT01660256|592107863|FG000|Overall Study|Withdrawal by Subject|1|||
163927996|NCT01660256|592107864|FG001|Overall Study|Withdrawal by Subject|0|||
163927997|NCT01660256|592107865|FG002|Overall Study|Withdrawal by Subject|2|||
163927998|NCT01646385|592107867|FG000|Overall Study|Death|202|||
163927999|NCT01646385|592107868|FG001|Overall Study|Death|222|||
163928000|NCT01646385|592107867|FG000|Overall Study|Switched to alternate biologic|636|||
163928001|NCT01646385|592107868|FG001|Overall Study|Switched to alternate biologic|649|||
163928002|NCT03603639|592107872|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163928003|NCT03603639|592107873|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163928004|NCT03603639|592107874|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163928005|NCT03603639|592107875|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
163928006|NCT03603639|592107876|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163928007|NCT03603639|592107877|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
163928008|NCT03603639|592107872|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
163928009|NCT03603639|592107873|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
163928010|NCT03603639|592107874|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
163928011|NCT03603639|592107875|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
163928012|NCT03603639|592107876|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
163928013|NCT03603639|592107877|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
163928014|NCT00858247|592107881|FG000|Baseline Assessment|Withdrawal by Subject|1|||
163928015|NCT00858247|592107882|FG001|Baseline Assessment|Withdrawal by Subject|1|||
163928016|NCT00858247|592107881|FG000|Baseline Assessment|Poor IV access|1|||
163928017|NCT00858247|592107882|FG001|Baseline Assessment|Poor IV access|0|||
163928018|NCT00858247|592107881|FG000|Baseline Assessment|Protocol Violation|0|||
163928019|NCT00858247|592107882|FG001|Baseline Assessment|Protocol Violation|1|||
163928020|NCT00858247|592107881|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
163928021|NCT00858247|592107882|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
163928022|NCT02165397|592107885|FG000|Overall Study|Death|7|||
163928023|NCT02165397|592107886|FG001|Overall Study|Death|10|||
163928024|NCT02165397|592107887|FG002|Overall Study|Death|8|||
163928025|NCT02165397|592107885|FG000|Overall Study|Lost to Follow-up|1|||
163928026|NCT02165397|592107886|FG001|Overall Study|Lost to Follow-up|3|||
163928027|NCT02165397|592107887|FG002|Overall Study|Lost to Follow-up|0|||
163928028|NCT02165397|592107885|FG000|Overall Study|Withdrawal by Subject|6|||
163928029|NCT02165397|592107886|FG001|Overall Study|Withdrawal by Subject|6|||
163928030|NCT02165397|592107887|FG002|Overall Study|Withdrawal by Subject|1|||
163928031|NCT02165397|592107885|FG000|Overall Study|Other, Not Specified|0|||
163928032|NCT02165397|592107886|FG001|Overall Study|Other, Not Specified|0|||
163928033|NCT02165397|592107887|FG002|Overall Study|Other, Not Specified|1|||
163928034|NCT03898960|592107888|FG000|Overall Study|Death|10|||
163928035|NCT01898442|592107891|FG000|Overall Study|Hemolysis/technical problems|1|||
163928036|NCT01898442|592107892|FG001|Overall Study|Hemolysis/technical problems|2|||
163928037|NCT01898442|592107893|FG002|Overall Study|Hemolysis/technical problems|2|||
163928038|NCT01898442|592107891|FG000|Overall Study|Patient vomited pills|0|||
163928039|NCT01898442|592107892|FG001|Overall Study|Patient vomited pills|0|||
163928040|NCT01898442|592107893|FG002|Overall Study|Patient vomited pills|1|||
163928041|NCT02725008|592107897|FG000|Overall Study|Lost to Follow-up|7|||
163928042|NCT02725008|592107898|FG001|Overall Study|Lost to Follow-up|9|||
163928043|NCT02725008|592107897|FG000|Overall Study|Withdrawal by Subject|2|||
163928044|NCT02725008|592107898|FG001|Overall Study|Withdrawal by Subject|2|||
163928045|NCT02725008|592107897|FG000|Overall Study|Admitted to hospital|0|||
163928046|NCT02725008|592107898|FG001|Overall Study|Admitted to hospital|1|||
163928047|NCT01837797|592107901|FG000|Period 1|Adverse Event|9|||
163928048|NCT01837797|592107902|FG001|Period 1|Adverse Event|0|||
163928049|NCT01837797|592107903|FG002|Period 1|Adverse Event|0|||
163928050|NCT01837797|592107904|FG003|Period 1|Adverse Event|0|||
163928051|NCT01837797|592107905|FG004|Period 1|Adverse Event|0|||
163928052|NCT01837797|592107901|FG000|Period 1|Withdrawal by Subject|6|||
163928053|NCT01837797|592107902|FG001|Period 1|Withdrawal by Subject|0|||
163928054|NCT01837797|592107903|FG002|Period 1|Withdrawal by Subject|0|||
163928055|NCT01837797|592107904|FG003|Period 1|Withdrawal by Subject|0|||
163928056|NCT01837797|592107905|FG004|Period 1|Withdrawal by Subject|0|||
163928057|NCT01837797|592107901|FG000|Period 1|Administrative reasons|76|||
163928058|NCT01837797|592107902|FG001|Period 1|Administrative reasons|0|||
163928059|NCT01837797|592107903|FG002|Period 1|Administrative reasons|0|||
163928060|NCT01837797|592107904|FG003|Period 1|Administrative reasons|0|||
163928061|NCT01837797|592107905|FG004|Period 1|Administrative reasons|0|||
163928062|NCT01837797|592107901|FG000|Period 1|Withdrawal of consent before treatment|1|||
163928063|NCT01837797|592107902|FG001|Period 1|Withdrawal of consent before treatment|0|||
163928064|NCT01837797|592107903|FG002|Period 1|Withdrawal of consent before treatment|0|||
163928065|NCT01837797|592107904|FG003|Period 1|Withdrawal of consent before treatment|0|||
163928066|NCT01837797|592107905|FG004|Period 1|Withdrawal of consent before treatment|0|||
163928067|NCT01837797|592107901|FG000|Period 1|Other|10|||
163928068|NCT01837797|592107902|FG001|Period 1|Other|0|||
163928069|NCT01837797|592107903|FG002|Period 1|Other|0|||
163928070|NCT01837797|592107904|FG003|Period 1|Other|0|||
163928071|NCT01837797|592107905|FG004|Period 1|Other|0|||
163928072|NCT01837797|592107901|FG000|Period 2|Administrative or other reasons|0|||
163928073|NCT01837797|592107902|FG001|Period 2|Administrative or other reasons|5|||
163928074|NCT01837797|592107903|FG002|Period 2|Administrative or other reasons|2|||
163928075|NCT01837797|592107904|FG003|Period 2|Administrative or other reasons|4|||
163928076|NCT01837797|592107905|FG004|Period 2|Administrative or other reasons|0|||
163928077|NCT01837797|592107901|FG000|Period 2|Adverse Event|0|||
163928078|NCT01837797|592107902|FG001|Period 2|Adverse Event|0|||
163928079|NCT01837797|592107903|FG002|Period 2|Adverse Event|0|||
163928080|NCT01837797|592107904|FG003|Period 2|Adverse Event|1|||
163928081|NCT01837797|592107905|FG004|Period 2|Adverse Event|0|||
163928082|NCT01837797|592107901|FG000|Period 3|Adverse Event|0|||
163928083|NCT01837797|592107902|FG001|Period 3|Adverse Event|0|||
163928084|NCT01837797|592107903|FG002|Period 3|Adverse Event|0|||
163928085|NCT01837797|592107904|FG003|Period 3|Adverse Event|0|||
163928086|NCT01837797|592107905|FG004|Period 3|Adverse Event|1|||
163928087|NCT01837797|592107901|FG000|Period 3|Administrative reasons|0|||
163928088|NCT01837797|592107902|FG001|Period 3|Administrative reasons|0|||
163928089|NCT01837797|592107903|FG002|Period 3|Administrative reasons|0|||
163928090|NCT01837797|592107904|FG003|Period 3|Administrative reasons|0|||
163928091|NCT01837797|592107905|FG004|Period 3|Administrative reasons|20|||
163928092|NCT01837797|592107901|FG000|Period 3|Other|0|||
163928093|NCT01837797|592107902|FG001|Period 3|Other|0|||
163928094|NCT01837797|592107903|FG002|Period 3|Other|0|||
164035177|NCT01375647|592488045|FG001|Overall Study|Lost to Follow-up|3|||
163928095|NCT01837797|592107904|FG003|Period 3|Other|0|||
163928096|NCT01837797|592107905|FG004|Period 3|Other|2|||
163928097|NCT03797989|592107926|FG000|VAC069A|Withdrawal by Subject|0|||
163928098|NCT03797989|592107927|FG001|VAC069A|Withdrawal by Subject|0|||
163928099|NCT03797989|592107928|FG002|VAC069A|Withdrawal by Subject|1|||
163928100|NCT03797989|592107929|FG003|VAC069A|Withdrawal by Subject|0|||
163928101|NCT03797989|592107930|FG004|VAC069A|Withdrawal by Subject|0|||
163928102|NCT03797989|592107931|FG005|VAC069A|Withdrawal by Subject|0|||
163928103|NCT03797989|592107932|FG006|VAC069A|Withdrawal by Subject|0|||
163928104|NCT03797989|592107933|FG007|VAC069A|Withdrawal by Subject|0|||
163928105|NCT03797989|592107934|FG008|VAC069A|Withdrawal by Subject|0|||
163928106|NCT03797989|592107935|FG009|VAC069A|Withdrawal by Subject|0|||
163928107|NCT03797989|592107936|FG010|VAC069A|Withdrawal by Subject|0|||
163928108|NCT03797989|592107937|FG011|VAC069A|Withdrawal by Subject|0|||
163928109|NCT04052997|592107939|FG000|Overall Study|Withdrawal by Subject|17|||
163928110|NCT04052997|592107939|FG000|Overall Study|Physician Decision|50|||
163928111|NCT04052997|592107939|FG000|Overall Study|Death|43|||
163928112|NCT04052997|592107939|FG000|Overall Study|Lost to Follow-up|5|||
163928113|NCT04052997|592107939|FG000|Overall Study|Progression of Disease|1|||
163928114|NCT04522778|592107940|FG000|Overall Study|Patient did not want to wear the device|1|||
163928115|NCT04522778|592107941|FG001|Overall Study|Patient did not want to wear the device|0|||
163928116|NCT04522778|592107940|FG000|Overall Study|Lost to Follow-up|0|||
163928117|NCT04522778|592107941|FG001|Overall Study|Lost to Follow-up|1|||
163928118|NCT00069277|592107942|FG000|Overall Study|Adverse Event|3|||
163928119|NCT00069277|592107942|FG000|Overall Study|Withdrawal by Subject|1|||
163928120|NCT00069277|592107942|FG000|Overall Study|Progressive Disease|15|||
163928121|NCT00069277|592107942|FG000|Overall Study|Physician Decision|2|||
163928122|NCT04594733|592107943|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
163928123|NCT04594733|592107944|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
163928124|NCT04594733|592107943|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
163928125|NCT04594733|592107944|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
163928126|NCT04594733|592107943|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
163928127|NCT04594733|592107944|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
163928128|NCT01024036|592107953|FG000|Blinded Treatment|Adverse Event|1|||
163928129|NCT01024036|592107954|FG001|Blinded Treatment|Adverse Event|1|||
163928130|NCT01024036|592107953|FG000|Blinded Treatment|Lack of Efficacy|16|||
163928131|NCT01024036|592107954|FG001|Blinded Treatment|Lack of Efficacy|14|||
163928132|NCT01024036|592107953|FG000|Blinded Treatment|Physician Decision|1|||
163928133|NCT01024036|592107954|FG001|Blinded Treatment|Physician Decision|0|||
163928134|NCT01024036|592107953|FG000|Blinded Treatment|Death|0|||
163928135|NCT01024036|592107954|FG001|Blinded Treatment|Death|2|||
163928136|NCT01024036|592107953|FG000|Blinded Treatment|Withdrawal by Subject|4|||
163928137|NCT01024036|592107954|FG001|Blinded Treatment|Withdrawal by Subject|3|||
163928138|NCT01024036|592107953|FG000|Unblinded Treatment|Adverse Event|0|||
163928139|NCT01024036|592107954|FG001|Unblinded Treatment|Adverse Event|1|||
163928140|NCT01024036|592107953|FG000|Unblinded Treatment|Lack of Efficacy|0|||
163928141|NCT01024036|592107954|FG001|Unblinded Treatment|Lack of Efficacy|2|||
163928142|NCT01024036|592107953|FG000|Follow-Up Period|Lost to Follow-up|1|||
163928143|NCT01024036|592107954|FG001|Follow-Up Period|Lost to Follow-up|1|||
163928144|NCT01024036|592107953|FG000|Follow-Up Period|Withdrawal by Subject|0|||
163928145|NCT01024036|592107954|FG001|Follow-Up Period|Withdrawal by Subject|1|||
163928146|NCT01024036|592107953|FG000|Follow-Up Period|Adverse Event|4|||
163928147|NCT01024036|592107954|FG001|Follow-Up Period|Adverse Event|1|||
163928148|NCT00361842|592107955|FG000|Overall Study|Withdrawal by Subject|2|||
163928149|NCT00361842|592107956|FG001|Overall Study|Withdrawal by Subject|3|||
163928150|NCT00361842|592107955|FG000|Overall Study|Death|2|||
163928151|NCT00361842|592107956|FG001|Overall Study|Death|1|||
163928152|NCT00361842|592107955|FG000|Overall Study|Disease progression|19|||
163928153|NCT00361842|592107956|FG001|Overall Study|Disease progression|20|||
163928154|NCT00361842|592107955|FG000|Overall Study|Adverse Event|2|||
163928155|NCT00361842|592107956|FG001|Overall Study|Adverse Event|3|||
163928156|NCT00361842|592107955|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
163928157|NCT00361842|592107956|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
163928158|NCT00361842|592107955|FG000|Overall Study|Other|1|||
163928159|NCT00361842|592107956|FG001|Overall Study|Other|0|||
163928160|NCT00361842|592107955|FG000|Overall Study|Other|0|||
163928161|NCT00361842|592107956|FG001|Overall Study|Other|2|||
163928162|NCT03512288|592107957|FG000|Overall Study|Adverse Event|1|||
163928163|NCT03512288|592107958|FG001|Overall Study|Adverse Event|0|||
163928164|NCT03512288|592107957|FG000|Overall Study|Lost to Follow-up|12|||
163928165|NCT03512288|592107958|FG001|Overall Study|Lost to Follow-up|15|||
163928166|NCT03512288|592107957|FG000|Overall Study|Physician Decision|0|||
164035178|NCT01375647|592488046|FG002|Overall Study|Lost to Follow-up|7|||
164035179|NCT01375647|592488047|FG003|Overall Study|Lost to Follow-up|10|||
164035180|NCT01375647|592488044|FG000|Overall Study|Death|1|||
164035181|NCT01375647|592488045|FG001|Overall Study|Death|2|||
164035182|NCT01375647|592488046|FG002|Overall Study|Death|1|||
164035183|NCT01375647|592488047|FG003|Overall Study|Death|0|||
164035184|NCT01375647|592488044|FG000|Overall Study|Withdrawal by Subject|17|||
164035185|NCT01375647|592488045|FG001|Overall Study|Withdrawal by Subject|20|||
163928167|NCT03512288|592107958|FG001|Overall Study|Physician Decision|2|||
163928168|NCT03512288|592107957|FG000|Overall Study|Protocol Violation|6|||
163928169|NCT03512288|592107958|FG001|Overall Study|Protocol Violation|4|||
163928170|NCT03512288|592107957|FG000|Overall Study|Medication error without associated adverse event|1|||
163928171|NCT03512288|592107958|FG001|Overall Study|Medication error without associated adverse event|0|||
163928172|NCT03512288|592107957|FG000|Overall Study|No longer met eligibility criteria|5|||
163928173|NCT03512288|592107958|FG001|Overall Study|No longer met eligibility criteria|2|||
163928174|NCT03512288|592107957|FG000|Overall Study|Withdrawal by parent/guardian|14|||
163928175|NCT03512288|592107958|FG001|Overall Study|Withdrawal by parent/guardian|18|||
163928176|NCT03512288|592107957|FG000|Overall Study|Other|1|||
163928177|NCT03512288|592107958|FG001|Overall Study|Other|1|||
164035186|NCT01375647|592488046|FG002|Overall Study|Withdrawal by Subject|26|||
163928178|NCT03512288|592107957|FG000|Overall Study|Randomized but not treated|1|||
163928179|NCT03512288|592107958|FG001|Overall Study|Randomized but not treated|1|||
163928180|NCT00934700|592107961|FG000|Overall Study|missing scan|5|||
163928181|NCT00934700|592107962|FG001|Overall Study|missing scan|9|||
163928182|NCT00934700|592107961|FG000|Overall Study|Death|8|||
163928183|NCT00934700|592107962|FG001|Overall Study|Death|3|||
163928184|NCT01831726|592107963|FG000|Overall Study|Adverse Event|16|||
163928185|NCT01831726|592107963|FG000|Overall Study|Death|7|||
163928186|NCT01831726|592107963|FG000|Overall Study|Disease Progression|49|||
163928187|NCT01831726|592107963|FG000|Overall Study|Physician Decision|1|||
163928188|NCT01831726|592107963|FG000|Overall Study|Subject/guardian decision|7|||
163928189|NCT03821064|592107964|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
163928190|NCT00474383|592107966|FG000|Main Study|Adverse Event|11|||
163928191|NCT00474383|592107967|FG001|Main Study|Adverse Event|0|||
163928192|NCT00474383|592107966|FG000|Main Study|Symptomatic Deterioration|1|||
163928193|NCT00474383|592107967|FG001|Main Study|Symptomatic Deterioration|0|||
163928194|NCT00474383|592107966|FG000|Main Study|Progressive Disease|23|||
163928195|NCT00474383|592107967|FG001|Main Study|Progressive Disease|0|||
163928196|NCT00474383|592107966|FG000|Main Study|Other|1|||
163928197|NCT00474383|592107967|FG001|Main Study|Other|0|||
163928198|NCT00474383|592107966|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
163928199|NCT00474383|592107967|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
163928200|NCT00474383|592107966|FG000|Extension|Progressive Disease|0|||
163928201|NCT00474383|592107967|FG001|Extension|Progressive Disease|5|||
163928202|NCT01482819|592107968|FG000|Overall Study|Lost to Follow-up|2|||
163928203|NCT00942188|592107973|FG000|Overall Study|Adverse Event|0|||
163928204|NCT00942188|592107974|FG001|Overall Study|Adverse Event|3|||
163928205|NCT00942188|592107975|FG002|Overall Study|Adverse Event|2|||
163928206|NCT00942188|592107976|FG003|Overall Study|Adverse Event|0|||
163928207|NCT00942188|592107973|FG000|Overall Study|Lack of Efficacy|0|||
163928208|NCT00942188|592107974|FG001|Overall Study|Lack of Efficacy|0|||
163928209|NCT00942188|592107975|FG002|Overall Study|Lack of Efficacy|0|||
163928210|NCT00942188|592107976|FG003|Overall Study|Lack of Efficacy|1|||
163928211|NCT00942188|592107973|FG000|Overall Study|Protocol Violation|1|||
163928212|NCT00942188|592107974|FG001|Overall Study|Protocol Violation|1|||
163928213|NCT00942188|592107975|FG002|Overall Study|Protocol Violation|0|||
163928214|NCT00942188|592107976|FG003|Overall Study|Protocol Violation|0|||
163928215|NCT00942188|592107973|FG000|Overall Study|Lost to Follow-up|2|||
163928216|NCT00942188|592107974|FG001|Overall Study|Lost to Follow-up|1|||
163928217|NCT00942188|592107975|FG002|Overall Study|Lost to Follow-up|2|||
163928218|NCT00942188|592107976|FG003|Overall Study|Lost to Follow-up|0|||
163928219|NCT00942188|592107973|FG000|Overall Study|Withdrawal by Subject|1|||
163928220|NCT00942188|592107974|FG001|Overall Study|Withdrawal by Subject|3|||
163928221|NCT00942188|592107975|FG002|Overall Study|Withdrawal by Subject|4|||
163928222|NCT00942188|592107976|FG003|Overall Study|Withdrawal by Subject|2|||
163928223|NCT00942188|592107973|FG000|Overall Study|Physician Decision|0|||
163928224|NCT00942188|592107974|FG001|Overall Study|Physician Decision|0|||
163928225|NCT00942188|592107975|FG002|Overall Study|Physician Decision|1|||
163928226|NCT00942188|592107976|FG003|Overall Study|Physician Decision|0|||
163928227|NCT00942188|592107973|FG000|Overall Study|Sponsor Decision|0|||
163928228|NCT00942188|592107974|FG001|Overall Study|Sponsor Decision|2|||
163928229|NCT00942188|592107975|FG002|Overall Study|Sponsor Decision|0|||
163928230|NCT00942188|592107976|FG003|Overall Study|Sponsor Decision|1|||
163928231|NCT04811339|592107978|FG000|Overall Study|lack of transportation not wanting to return|4|||
163928232|NCT04811339|592107979|FG001|Overall Study|lack of transportation not wanting to return|8|||
163928233|NCT04811339|592107980|FG002|Overall Study|lack of transportation not wanting to return|0|||
163928234|NCT04811339|592107978|FG000|Overall Study|Adverse Event|3|||
163928235|NCT04811339|592107979|FG001|Overall Study|Adverse Event|0|||
163928236|NCT04811339|592107980|FG002|Overall Study|Adverse Event|0|||
163928237|NCT04811339|592107978|FG000|Overall Study|Lost to Follow-up|1|||
163928238|NCT04811339|592107979|FG001|Overall Study|Lost to Follow-up|0|||
163928239|NCT04811339|592107980|FG002|Overall Study|Lost to Follow-up|0|||
163928240|NCT04811339|592107978|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
163928241|NCT04811339|592107979|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
163928242|NCT04811339|592107980|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
163928243|NCT04811339|592107978|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
163928244|NCT04811339|592107979|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
163928245|NCT04811339|592107980|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
163928246|NCT04811339|592107978|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
163928247|NCT04811339|592107979|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
164035187|NCT01375647|592488047|FG003|Overall Study|Withdrawal by Subject|14|||
164035188|NCT01375647|592488044|FG000|Overall Study|Physician Decision|1|||
163928248|NCT04811339|592107980|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
163928249|NCT04811339|592107978|FG000|Overall Study|Withdrawal by Subject|0|||
163928250|NCT04811339|592107979|FG001|Overall Study|Withdrawal by Subject|3|||
163928251|NCT04811339|592107980|FG002|Overall Study|Withdrawal by Subject|0|||
163928252|NCT04811339|592107978|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
163928253|NCT04811339|592107979|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
163928254|NCT04811339|592107980|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
163928255|NCT04811339|592107978|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
163928256|NCT04811339|592107979|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
163928257|NCT04811339|592107980|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
163928258|NCT00143598|592107981|FG000|Overall Study|Lost to Follow-up|23|||
163928259|NCT00143598|592107982|FG001|Overall Study|Lost to Follow-up|21|||
163928260|NCT00143598|592107981|FG000|Overall Study|Withdrawal by Subject|33|||
163928261|NCT00143598|592107982|FG001|Overall Study|Withdrawal by Subject|37|||
163928262|NCT00143598|592107981|FG000|Overall Study|Death|36|||
163928263|NCT00143598|592107982|FG001|Overall Study|Death|36|||
163928264|NCT04944784|592107983|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
163928265|NCT04944784|592107984|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
163928266|NCT04944784|592107985|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
163928267|NCT04944784|592107986|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
163928268|NCT04944784|592107983|FG000|Double-blind Period|Adverse Event|20|||
163928269|NCT04944784|592107984|FG001|Double-blind Period|Adverse Event|4|||
163928270|NCT04944784|592107985|FG002|Double-blind Period|Adverse Event|0|||
163928271|NCT04944784|592107986|FG003|Double-blind Period|Adverse Event|0|||
163928272|NCT04944784|592107983|FG000|Double-blind Period|Withdrawal by Subject|15|||
163928273|NCT04944784|592107984|FG001|Double-blind Period|Withdrawal by Subject|4|||
163928274|NCT04944784|592107985|FG002|Double-blind Period|Withdrawal by Subject|0|||
163928275|NCT04944784|592107986|FG003|Double-blind Period|Withdrawal by Subject|0|||
163928276|NCT04944784|592107983|FG000|Double-blind Period|Death|7|||
163928277|NCT04944784|592107984|FG001|Double-blind Period|Death|2|||
163928278|NCT04944784|592107985|FG002|Double-blind Period|Death|0|||
163928279|NCT04944784|592107986|FG003|Double-blind Period|Death|0|||
163928280|NCT04944784|592107983|FG000|Double-blind Period|Physician Decision|2|||
163928281|NCT04944784|592107984|FG001|Double-blind Period|Physician Decision|1|||
163928282|NCT04944784|592107985|FG002|Double-blind Period|Physician Decision|0|||
163928283|NCT04944784|592107986|FG003|Double-blind Period|Physician Decision|0|||
163928284|NCT04944784|592107983|FG000|Double-blind Period|Lack of Efficacy|0|||
163928285|NCT04944784|592107984|FG001|Double-blind Period|Lack of Efficacy|1|||
163928286|NCT04944784|592107985|FG002|Double-blind Period|Lack of Efficacy|0|||
163928287|NCT04944784|592107986|FG003|Double-blind Period|Lack of Efficacy|0|||
163928288|NCT04944784|592107983|FG000|Double-blind Period|Sponsor Request|2|||
163928289|NCT04944784|592107984|FG001|Double-blind Period|Sponsor Request|1|||
163928290|NCT04944784|592107985|FG002|Double-blind Period|Sponsor Request|0|||
163928291|NCT04944784|592107986|FG003|Double-blind Period|Sponsor Request|0|||
163928292|NCT04944784|592107983|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
163928293|NCT04944784|592107984|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
163928294|NCT04944784|592107985|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
163928295|NCT04944784|592107986|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
163928296|NCT04944784|592107983|FG000|Double-blind Period|Participant Choice|1|||
163928297|NCT04944784|592107984|FG001|Double-blind Period|Participant Choice|1|||
163928298|NCT04944784|592107985|FG002|Double-blind Period|Participant Choice|0|||
163928299|NCT04944784|592107986|FG003|Double-blind Period|Participant Choice|0|||
163928300|NCT04944784|592107983|FG000|Double-blind Period|Progressive Disease|2|||
163928301|NCT04944784|592107984|FG001|Double-blind Period|Progressive Disease|2|||
163928302|NCT04944784|592107985|FG002|Double-blind Period|Progressive Disease|0|||
163928303|NCT04944784|592107986|FG003|Double-blind Period|Progressive Disease|0|||
163928304|NCT04944784|592107983|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
163928305|NCT04944784|592107984|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
163928306|NCT04944784|592107985|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
163928307|NCT04944784|592107986|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
163928308|NCT04944784|592107983|FG000|Active Drug Period|Adverse Event|0|||
163928309|NCT04944784|592107984|FG001|Active Drug Period|Adverse Event|0|||
163928310|NCT04944784|592107985|FG002|Active Drug Period|Adverse Event|3|||
163928311|NCT04944784|592107986|FG003|Active Drug Period|Adverse Event|6|||
163928312|NCT04944784|592107983|FG000|Active Drug Period|Withdrawal by Subject|0|||
163928313|NCT04944784|592107984|FG001|Active Drug Period|Withdrawal by Subject|0|||
163928314|NCT04944784|592107985|FG002|Active Drug Period|Withdrawal by Subject|4|||
163928315|NCT04944784|592107986|FG003|Active Drug Period|Withdrawal by Subject|7|||
163928316|NCT04944784|592107983|FG000|Active Drug Period|Death|0|||
164035189|NCT01375647|592488045|FG001|Overall Study|Physician Decision|0|||
164035190|NCT01375647|592488046|FG002|Overall Study|Physician Decision|0|||
163928317|NCT04944784|592107984|FG001|Active Drug Period|Death|0|||
163928318|NCT04944784|592107985|FG002|Active Drug Period|Death|3|||
163928319|NCT04944784|592107986|FG003|Active Drug Period|Death|4|||
163928320|NCT04944784|592107983|FG000|Active Drug Period|Lack of Efficacy|0|||
163928321|NCT04944784|592107984|FG001|Active Drug Period|Lack of Efficacy|0|||
163928322|NCT04944784|592107985|FG002|Active Drug Period|Lack of Efficacy|2|||
163928323|NCT04944784|592107986|FG003|Active Drug Period|Lack of Efficacy|2|||
163928324|NCT04944784|592107983|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
163928325|NCT04944784|592107984|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
163928326|NCT04944784|592107985|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
163928327|NCT04944784|592107986|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
163928328|NCT04944784|592107983|FG000|Active Drug Period|Participant Choice|0|||
163928329|NCT04944784|592107984|FG001|Active Drug Period|Participant Choice|0|||
163928330|NCT04944784|592107985|FG002|Active Drug Period|Participant Choice|0|||
163928331|NCT04944784|592107986|FG003|Active Drug Period|Participant Choice|1|||
163928332|NCT04944784|592107983|FG000|Active Drug Period|Progressive Disease|0|||
163928333|NCT04944784|592107984|FG001|Active Drug Period|Progressive Disease|0|||
163928334|NCT04944784|592107985|FG002|Active Drug Period|Progressive Disease|4|||
163928335|NCT04944784|592107986|FG003|Active Drug Period|Progressive Disease|4|||
163928336|NCT04944784|592107983|FG000|Active Drug Period|Lost to Follow-up|0|||
163928337|NCT04944784|592107984|FG001|Active Drug Period|Lost to Follow-up|0|||
163928338|NCT04944784|592107985|FG002|Active Drug Period|Lost to Follow-up|0|||
163928339|NCT04944784|592107986|FG003|Active Drug Period|Lost to Follow-up|1|||
163928340|NCT03900715|592107987|FG000|Overall Study|Protocol Deviation|1|||
163928341|NCT03900715|592107987|FG000|Overall Study|Lack of Efficacy|1|||
163928342|NCT03900715|592107987|FG000|Overall Study|Progressive Disease|6|||
163928343|NCT03900715|592107987|FG000|Overall Study|Adverse Event|2|||
163928344|NCT03900715|592107987|FG000|Overall Study|Other reasons|11|||
163928345|NCT04367480|592109729|FG000|Overall Study|Adverse Event|1|||
163928346|NCT04367480|592109730|FG001|Overall Study|Adverse Event|1|||
163928347|NCT04367480|592109729|FG000|Overall Study|Death|1|||
163928348|NCT04367480|592109730|FG001|Overall Study|Death|0|||
163928349|NCT04367480|592109729|FG000|Overall Study|Lost to Follow-up|1|||
163928350|NCT04367480|592109730|FG001|Overall Study|Lost to Follow-up|1|||
163928351|NCT04367480|592109729|FG000|Overall Study|Withdrawal by Subject|0|||
163928352|NCT04367480|592109730|FG001|Overall Study|Withdrawal by Subject|3|||
163928353|NCT04367480|592109729|FG000|Overall Study|App glitch during the study|1|||
163928354|NCT04367480|592109730|FG001|Overall Study|App glitch during the study|0|||
163928355|NCT04367480|592109729|FG000|Overall Study|Device Distribution Error|0|||
163928356|NCT04367480|592109730|FG001|Overall Study|Device Distribution Error|2|||
163928357|NCT04367480|592109729|FG000|Overall Study|Ineligible after Randomization|0|||
163928358|NCT04367480|592109730|FG001|Overall Study|Ineligible after Randomization|1|||
163928359|NCT04367480|592109729|FG000|Overall Study|Other Medical Reasons|0|||
163928360|NCT04367480|592109730|FG001|Overall Study|Other Medical Reasons|2|||
163928361|NCT03382561|592109731|FG000|Overall Study|Disease progression|47|||
163928362|NCT03382561|592109732|FG001|Overall Study|Disease progression|6|||
163928363|NCT03382561|592109731|FG000|Overall Study|Adverse Event|10|||
163928364|NCT03382561|592109732|FG001|Overall Study|Adverse Event|2|||
163928365|NCT03382561|592109731|FG000|Overall Study|Death|8|||
163928366|NCT03382561|592109732|FG001|Overall Study|Death|3|||
163928367|NCT03382561|592109731|FG000|Overall Study|Withdrawal by Subject|6|||
163928368|NCT03382561|592109732|FG001|Overall Study|Withdrawal by Subject|5|||
163928369|NCT03382561|592109731|FG000|Overall Study|Alternative therapy|2|||
163928370|NCT03382561|592109732|FG001|Overall Study|Alternative therapy|8|||
163928371|NCT03382561|592109731|FG000|Overall Study|Never started treatment|3|||
163928372|NCT03382561|592109732|FG001|Overall Study|Never started treatment|6|||
163928373|NCT03382561|592109731|FG000|Overall Study|Lack of Efficacy|0|||
163928374|NCT03382561|592109732|FG001|Overall Study|Lack of Efficacy|1|||
163928375|NCT03382561|592109731|FG000|Overall Study|Physician Decision|0|||
163928376|NCT03382561|592109732|FG001|Overall Study|Physician Decision|1|||
163928377|NCT03382561|592109731|FG000|Overall Study|Other complicating disease|0|||
163928378|NCT03382561|592109732|FG001|Overall Study|Other complicating disease|1|||
163928379|NCT01131104|592109733|FG000|Overall Study|Withdrawal by Subject|3|||
163928380|NCT01131104|592109733|FG000|Overall Study|Physician Decision|4|||
163928381|NCT01131104|592109733|FG000|Overall Study|Information Not Available|5|||
164035191|NCT01375647|592488047|FG003|Overall Study|Physician Decision|0|||
164035192|NCT03788967|592488050|FG000|Overall Study|Lost to Follow-up|14|||
164035193|NCT03788967|592488051|FG001|Overall Study|Lost to Follow-up|10|||
164035194|NCT03788967|592488050|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
164035195|NCT03788967|592488051|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
164035196|NCT03788967|592488050|FG000|Overall Study|Participant Withdrawal of Consent|13|||
164035197|NCT03788967|592488051|FG001|Overall Study|Participant Withdrawal of Consent|5|||
163928382|NCT01131104|592109733|FG000|Overall Study|No Information on Index Date of Onset|1|||
163928383|NCT02370251|592109735|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
163928384|NCT02370251|592109735|FG000|Overall Study|Death|4|||
163928385|NCT04120376|592109736|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
163928386|NCT04120376|592109737|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
163928387|NCT01165177|592109738|FG000|Overall Study|Serious Adverse Event|227|||
163928388|NCT01165177|592109739|FG001|Overall Study|Serious Adverse Event|235|||
163928389|NCT01165177|592109738|FG000|Overall Study|Withdrawal by Subject|368|||
163928390|NCT01165177|592109739|FG001|Overall Study|Withdrawal by Subject|354|||
164035198|NCT03788967|592488050|FG000|Overall Study|Adverse Event|1|||
164035199|NCT03788967|592488051|FG001|Overall Study|Adverse Event|1|||
164035200|NCT03788967|592488050|FG000|Overall Study|COVID-19|1|||
164035201|NCT03788967|592488051|FG001|Overall Study|COVID-19|2|||
164035202|NCT01824693|592488052|FG000|Overall Study|Death|0|||
164035203|NCT01824693|592488053|FG001|Overall Study|Death|1|||
164035204|NCT01824693|592488054|FG002|Overall Study|Death|0|||
164035205|NCT01824693|592488052|FG000|Overall Study|Physician Decision|1|||
163833467|NCT00279201|591759586|FG001|Maintenance|Lost to Follow-up|13|||
163833468|NCT00279201|591759587|FG002|Maintenance|Lost to Follow-up|0|||
163833469|NCT00279201|591759588|FG003|Maintenance|Lost to Follow-up|0|||
163833470|NCT00279201|591759589|FG004|Maintenance|Lost to Follow-up|0|||
163833471|NCT00279201|591759590|FG005|Maintenance|Lost to Follow-up|0|||
163833472|NCT00279201|591759585|FG000|Maintenance|Entry Criteria Exclusion|1|||
163833473|NCT00279201|591759586|FG001|Maintenance|Entry Criteria Exclusion|4|||
163833474|NCT00279201|591759587|FG002|Maintenance|Entry Criteria Exclusion|0|||
163833475|NCT00279201|591759588|FG003|Maintenance|Entry Criteria Exclusion|0|||
163833476|NCT00279201|591759589|FG004|Maintenance|Entry Criteria Exclusion|0|||
163833477|NCT00279201|591759590|FG005|Maintenance|Entry Criteria Exclusion|0|||
163833478|NCT00279201|591759585|FG000|Maintenance|Protocol Violation|16|||
163833479|NCT00279201|591759586|FG001|Maintenance|Protocol Violation|24|||
163833480|NCT00279201|591759587|FG002|Maintenance|Protocol Violation|0|||
163833481|NCT00279201|591759588|FG003|Maintenance|Protocol Violation|0|||
163833482|NCT00279201|591759589|FG004|Maintenance|Protocol Violation|0|||
163833483|NCT00279201|591759590|FG005|Maintenance|Protocol Violation|0|||
163833484|NCT00279201|591759585|FG000|Maintenance|Withdrawal by Subject|18|||
163833485|NCT00279201|591759586|FG001|Maintenance|Withdrawal by Subject|18|||
163833486|NCT00279201|591759587|FG002|Maintenance|Withdrawal by Subject|0|||
163833487|NCT00279201|591759588|FG003|Maintenance|Withdrawal by Subject|0|||
163833488|NCT00279201|591759589|FG004|Maintenance|Withdrawal by Subject|0|||
163833489|NCT00279201|591759590|FG005|Maintenance|Withdrawal by Subject|0|||
163833490|NCT00279201|591759585|FG000|Maintenance|Physician Decision|9|||
163833491|NCT00279201|591759586|FG001|Maintenance|Physician Decision|9|||
163833492|NCT00279201|591759587|FG002|Maintenance|Physician Decision|0|||
163833493|NCT00279201|591759588|FG003|Maintenance|Physician Decision|0|||
163833494|NCT00279201|591759589|FG004|Maintenance|Physician Decision|0|||
163833495|NCT00279201|591759590|FG005|Maintenance|Physician Decision|0|||
163833496|NCT00279201|591759585|FG000|Maintenance|Sponsor Decision|4|||
163833497|NCT00279201|591759586|FG001|Maintenance|Sponsor Decision|0|||
163833498|NCT00279201|591759587|FG002|Maintenance|Sponsor Decision|0|||
163833499|NCT00279201|591759588|FG003|Maintenance|Sponsor Decision|0|||
163833500|NCT00279201|591759589|FG004|Maintenance|Sponsor Decision|0|||
163833501|NCT00279201|591759590|FG005|Maintenance|Sponsor Decision|0|||
163833502|NCT00279201|591759585|FG000|Maintenance|HbA1c>7.5%|123|||
163833503|NCT00279201|591759586|FG001|Maintenance|HbA1c>7.5%|126|||
163833504|NCT00279201|591759587|FG002|Maintenance|HbA1c>7.5%|0|||
163833505|NCT00279201|591759588|FG003|Maintenance|HbA1c>7.5%|0|||
163833506|NCT00279201|591759589|FG004|Maintenance|HbA1c>7.5%|0|||
163833507|NCT00279201|591759590|FG005|Maintenance|HbA1c>7.5%|0|||
163833508|NCT00279201|591759585|FG000|Intensification Addendum|Withdrawal by Subject|0|||
163833509|NCT00279201|591759586|FG001|Intensification Addendum|Withdrawal by Subject|0|||
163833510|NCT00279201|591759587|FG002|Intensification Addendum|Withdrawal by Subject|12|||
163833511|NCT00279201|591759588|FG003|Intensification Addendum|Withdrawal by Subject|14|||
163833512|NCT00279201|591759589|FG004|Intensification Addendum|Withdrawal by Subject|9|||
163833513|NCT00279201|591759590|FG005|Intensification Addendum|Withdrawal by Subject|18|||
163833514|NCT00279201|591759585|FG000|Intensification Addendum|Lost to Follow-up|0|||
163833515|NCT00279201|591759586|FG001|Intensification Addendum|Lost to Follow-up|0|||
163833516|NCT00279201|591759587|FG002|Intensification Addendum|Lost to Follow-up|4|||
163833517|NCT00279201|591759588|FG003|Intensification Addendum|Lost to Follow-up|6|||
163833518|NCT00279201|591759589|FG004|Intensification Addendum|Lost to Follow-up|7|||
163833519|NCT00279201|591759590|FG005|Intensification Addendum|Lost to Follow-up|7|||
163833520|NCT00279201|591759585|FG000|Intensification Addendum|Protocol Violation|0|||
163833521|NCT00279201|591759586|FG001|Intensification Addendum|Protocol Violation|0|||
163833522|NCT00279201|591759587|FG002|Intensification Addendum|Protocol Violation|2|||
163833523|NCT00279201|591759588|FG003|Intensification Addendum|Protocol Violation|2|||
163833524|NCT00279201|591759589|FG004|Intensification Addendum|Protocol Violation|6|||
163833525|NCT00279201|591759590|FG005|Intensification Addendum|Protocol Violation|6|||
163833526|NCT00279201|591759585|FG000|Intensification Addendum|Adverse Event|0|||
163833527|NCT00279201|591759586|FG001|Intensification Addendum|Adverse Event|0|||
163833528|NCT00279201|591759587|FG002|Intensification Addendum|Adverse Event|0|||
163833529|NCT00279201|591759588|FG003|Intensification Addendum|Adverse Event|4|||
163833530|NCT00279201|591759589|FG004|Intensification Addendum|Adverse Event|1|||
163833531|NCT00279201|591759590|FG005|Intensification Addendum|Adverse Event|3|||
163833532|NCT00279201|591759585|FG000|Intensification Addendum|Physician Decision|0|||
163833533|NCT00279201|591759586|FG001|Intensification Addendum|Physician Decision|0|||
163928391|NCT01165177|592109738|FG000|Overall Study|Protocol Violation|19|||
163928392|NCT01165177|592109739|FG001|Overall Study|Protocol Violation|21|||
163928393|NCT01165177|592109738|FG000|Overall Study|Non-serious adverse event|30|||
163928394|NCT01165177|592109739|FG001|Overall Study|Non-serious adverse event|18|||
163928395|NCT01165177|592109738|FG000|Overall Study|Other unspecified reasons|47|||
163928396|NCT01165177|592109739|FG001|Overall Study|Other unspecified reasons|35|||
163928397|NCT01165177|592109738|FG000|Overall Study|Suspected HZ episode|0|||
163928398|NCT01165177|592109739|FG001|Overall Study|Suspected HZ episode|2|||
163928399|NCT01165177|592109738|FG000|Overall Study|Lost to Follow-up|183|||
163928400|NCT01165177|592109739|FG001|Overall Study|Lost to Follow-up|194|||
163928401|NCT01165177|592109738|FG000|Overall Study|Migrated/ moved from study area|48|||
163928402|NCT01165177|592109739|FG001|Overall Study|Migrated/ moved from study area|43|||
163928403|NCT05499130|592109740|FG000|Overall Study|Adverse Event|2|||
163928404|NCT05499130|592109741|FG001|Overall Study|Adverse Event|0|||
163928405|NCT05499130|592109742|FG002|Overall Study|Adverse Event|1|||
163928406|NCT05499130|592109743|FG003|Overall Study|Adverse Event|0|||
163928407|NCT05499130|592109744|FG004|Overall Study|Adverse Event|1|||
163928408|NCT05499130|592109745|FG005|Overall Study|Adverse Event|4|||
163928409|NCT05499130|592109746|FG006|Overall Study|Adverse Event|1|||
163928410|NCT05499130|592109747|FG007|Overall Study|Adverse Event|0|||
163928411|NCT05499130|592109740|FG000|Overall Study|Lack of Efficacy|1|||
163928412|NCT05499130|592109741|FG001|Overall Study|Lack of Efficacy|0|||
163928413|NCT05499130|592109742|FG002|Overall Study|Lack of Efficacy|0|||
163928414|NCT05499130|592109743|FG003|Overall Study|Lack of Efficacy|0|||
163928415|NCT05499130|592109744|FG004|Overall Study|Lack of Efficacy|5|||
163928416|NCT05499130|592109745|FG005|Overall Study|Lack of Efficacy|0|||
163928417|NCT05499130|592109746|FG006|Overall Study|Lack of Efficacy|1|||
163928418|NCT05499130|592109747|FG007|Overall Study|Lack of Efficacy|0|||
163928419|NCT05499130|592109740|FG000|Overall Study|Withdrawal by Subject|2|||
163928420|NCT05499130|592109741|FG001|Overall Study|Withdrawal by Subject|0|||
163928421|NCT05499130|592109742|FG002|Overall Study|Withdrawal by Subject|0|||
163928422|NCT05499130|592109743|FG003|Overall Study|Withdrawal by Subject|0|||
163928423|NCT05499130|592109744|FG004|Overall Study|Withdrawal by Subject|1|||
163928424|NCT05499130|592109745|FG005|Overall Study|Withdrawal by Subject|2|||
163928425|NCT05499130|592109746|FG006|Overall Study|Withdrawal by Subject|0|||
163928426|NCT05499130|592109747|FG007|Overall Study|Withdrawal by Subject|0|||
163928427|NCT05499130|592109740|FG000|Overall Study|Lost to Follow-up|0|||
163928428|NCT05499130|592109741|FG001|Overall Study|Lost to Follow-up|0|||
163928429|NCT05499130|592109742|FG002|Overall Study|Lost to Follow-up|0|||
163928430|NCT05499130|592109743|FG003|Overall Study|Lost to Follow-up|0|||
163928431|NCT05499130|592109744|FG004|Overall Study|Lost to Follow-up|0|||
163928432|NCT05499130|592109745|FG005|Overall Study|Lost to Follow-up|2|||
163928433|NCT05499130|592109746|FG006|Overall Study|Lost to Follow-up|0|||
163928434|NCT05499130|592109747|FG007|Overall Study|Lost to Follow-up|0|||
163928435|NCT05499130|592109740|FG000|Overall Study|Other Than Specified|0|||
163928436|NCT05499130|592109741|FG001|Overall Study|Other Than Specified|0|||
163928437|NCT05499130|592109742|FG002|Overall Study|Other Than Specified|0|||
163928438|NCT05499130|592109743|FG003|Overall Study|Other Than Specified|0|||
163928439|NCT05499130|592109744|FG004|Overall Study|Other Than Specified|1|||
163928440|NCT05499130|592109745|FG005|Overall Study|Other Than Specified|1|||
163928441|NCT05499130|592109746|FG006|Overall Study|Other Than Specified|2|||
163928442|NCT05499130|592109747|FG007|Overall Study|Other Than Specified|0|||
163928443|NCT05499130|592109740|FG000|Overall Study|Protocol Violation|0|||
163928444|NCT05499130|592109741|FG001|Overall Study|Protocol Violation|0|||
163928445|NCT05499130|592109742|FG002|Overall Study|Protocol Violation|0|||
163928446|NCT05499130|592109743|FG003|Overall Study|Protocol Violation|0|||
163928447|NCT05499130|592109744|FG004|Overall Study|Protocol Violation|1|||
163928448|NCT05499130|592109745|FG005|Overall Study|Protocol Violation|0|||
163928449|NCT05499130|592109746|FG006|Overall Study|Protocol Violation|0|||
163928450|NCT05499130|592109747|FG007|Overall Study|Protocol Violation|0|||
163928451|NCT00781937|592109749|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
164035206|NCT01824693|592488053|FG001|Overall Study|Physician Decision|1|||
164035207|NCT01824693|592488054|FG002|Overall Study|Physician Decision|1|||
163928452|NCT00781937|592109750|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
163928453|NCT00781937|592109749|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
163928454|NCT00781937|592109750|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
163928455|NCT00781937|592109749|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
163928456|NCT00781937|592109750|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
163928457|NCT00781937|592109749|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
163928458|NCT00781937|592109750|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
163928459|NCT00781937|592109749|FG000|Main Trial Period Through Week 56|Unclassified|10|||
163928460|NCT00781937|592109750|FG001|Main Trial Period Through Week 56|Unclassified|15|||
163928461|NCT00781937|592109749|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
163928462|NCT00781937|592109750|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
163928463|NCT00781937|592109749|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
163928464|NCT00781937|592109750|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
163928465|NCT00013611|592109751|FG000|Overall Study|Lost to Follow-up|91|||
163928466|NCT00013611|592109752|FG001|Overall Study|Lost to Follow-up|100|||
163928467|NCT01663506|592109753|FG000|Overall Study|Lack of Efficacy|3|||
163928468|NCT01663506|592109753|FG000|Overall Study|Consent Withdrawal by Subject|1|||
163928469|NCT01663506|592109753|FG000|Overall Study|Lost to Follow-up|1|||
163928470|NCT01663506|592109753|FG000|Overall Study|Adverse Event|1|||
163928471|NCT01663506|592109753|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
163928472|NCT00810342|592109754|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
163928473|NCT00810342|592109755|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
163928474|NCT00810342|592109754|FG000|Month 1 Follow-up|Pregnancy|1|||
163928475|NCT00810342|592109755|FG001|Month 1 Follow-up|Pregnancy|0|||
163928476|NCT00810342|592109754|FG000|6-month Follow-up|Lost to Follow-up|18|||
163928477|NCT00810342|592109755|FG001|6-month Follow-up|Lost to Follow-up|6|||
163928478|NCT00810342|592109754|FG000|6-month Follow-up|Pregnancy|6|||
163928479|NCT00810342|592109755|FG001|6-month Follow-up|Pregnancy|2|||
163928480|NCT00810342|592109754|FG000|12-month Followup|Pregnancy|9|||
163928481|NCT00810342|592109755|FG001|12-month Followup|Pregnancy|10|||
163928482|NCT00810342|592109754|FG000|12-month Followup|Lost to Follow-up|3|||
163928483|NCT00810342|592109755|FG001|12-month Followup|Lost to Follow-up|1|||
163928484|NCT02330562|592109756|FG000|Overall Study|Adverse Event|0|||
163928485|NCT02330562|592109757|FG001|Overall Study|Adverse Event|0|||
163928486|NCT02330562|592109758|FG002|Overall Study|Adverse Event|3|||
163928487|NCT02330562|592109759|FG003|Overall Study|Adverse Event|0|||
163928488|NCT02330562|592109760|FG004|Overall Study|Adverse Event|3|||
163928489|NCT02330562|592109761|FG005|Overall Study|Adverse Event|1|||
163928490|NCT02330562|592109762|FG006|Overall Study|Adverse Event|0|||
163928491|NCT02330562|592109763|FG007|Overall Study|Adverse Event|0|||
163928492|NCT02330562|592109764|FG008|Overall Study|Adverse Event|0|||
163928493|NCT02330562|592109765|FG009|Overall Study|Adverse Event|1|||
163928494|NCT02330562|592109766|FG010|Overall Study|Adverse Event|1|||
163928495|NCT02330562|592109756|FG000|Overall Study|Participant decision|1|||
163928496|NCT02330562|592109757|FG001|Overall Study|Participant decision|0|||
163928497|NCT02330562|592109758|FG002|Overall Study|Participant decision|4|||
163928498|NCT02330562|592109759|FG003|Overall Study|Participant decision|1|||
163928499|NCT02330562|592109760|FG004|Overall Study|Participant decision|5|||
163928500|NCT02330562|592109761|FG005|Overall Study|Participant decision|2|||
163928501|NCT02330562|592109762|FG006|Overall Study|Participant decision|0|||
163928502|NCT02330562|592109763|FG007|Overall Study|Participant decision|0|||
163928503|NCT02330562|592109764|FG008|Overall Study|Participant decision|0|||
163928504|NCT02330562|592109765|FG009|Overall Study|Participant decision|3|||
163928505|NCT02330562|592109766|FG010|Overall Study|Participant decision|0|||
163928506|NCT02330562|592109756|FG000|Overall Study|Disease progression|5|||
163928507|NCT02330562|592109757|FG001|Overall Study|Disease progression|3|||
163928508|NCT02330562|592109758|FG002|Overall Study|Disease progression|20|||
163928509|NCT02330562|592109759|FG003|Overall Study|Disease progression|28|||
163928510|NCT02330562|592109760|FG004|Overall Study|Disease progression|23|||
163928511|NCT02330562|592109761|FG005|Overall Study|Disease progression|7|||
163928512|NCT02330562|592109762|FG006|Overall Study|Disease progression|1|||
163928513|NCT02330562|592109763|FG007|Overall Study|Disease progression|1|||
164035208|NCT01824693|592488052|FG000|Overall Study|Withdrawal by Subject|0|||
164035209|NCT01824693|592488053|FG001|Overall Study|Withdrawal by Subject|0|||
163928514|NCT02330562|592109764|FG008|Overall Study|Disease progression|1|||
164035210|NCT01824693|592488054|FG002|Overall Study|Withdrawal by Subject|1|||
164035211|NCT01824693|592488052|FG000|Overall Study|Progressive Disease|0|||
164035212|NCT01824693|592488053|FG001|Overall Study|Progressive Disease|5|||
164035213|NCT01824693|592488054|FG002|Overall Study|Progressive Disease|0|||
164035214|NCT01824693|592488052|FG000|Overall Study|Ineligible|0|||
164035215|NCT01824693|592488053|FG001|Overall Study|Ineligible|0|||
164035216|NCT01824693|592488054|FG002|Overall Study|Ineligible|3|||
164035217|NCT01824693|592488052|FG000|Overall Study|No Transplant Planned|0|||
164035218|NCT01824693|592488053|FG001|Overall Study|No Transplant Planned|0|||
164035219|NCT01824693|592488054|FG002|Overall Study|No Transplant Planned|10|||
164035220|NCT03488238|592488055|FG000|Overall Study|Equipment malfunction|1|||
164035221|NCT03488238|592488055|FG000|Overall Study|Adverse Event|1|||
164035222|NCT01316939|592488058|FG000|Overall Study|Study closed/terminated|26|||
164035223|NCT01316939|592488059|FG001|Overall Study|Study closed/terminated|25|||
164035224|NCT01316939|592488060|FG002|Overall Study|Study closed/terminated|23|||
163928515|NCT02330562|592109765|FG009|Overall Study|Disease progression|0|||
163928516|NCT02330562|592109766|FG010|Overall Study|Disease progression|5|||
163928517|NCT02330562|592109756|FG000|Overall Study|Other reasons|0|||
163928518|NCT02330562|592109757|FG001|Overall Study|Other reasons|0|||
163928519|NCT02330562|592109758|FG002|Overall Study|Other reasons|0|||
163928520|NCT02330562|592109759|FG003|Overall Study|Other reasons|1|||
163928521|NCT02330562|592109760|FG004|Overall Study|Other reasons|0|||
163928522|NCT02330562|592109761|FG005|Overall Study|Other reasons|0|||
163928523|NCT02330562|592109762|FG006|Overall Study|Other reasons|0|||
163928524|NCT02330562|592109763|FG007|Overall Study|Other reasons|0|||
163928525|NCT02330562|592109764|FG008|Overall Study|Other reasons|0|||
163928526|NCT02330562|592109765|FG009|Overall Study|Other reasons|0|||
164035225|NCT01316939|592488058|FG000|Overall Study|Lack of Efficacy|24|||
164035226|NCT01316939|592488059|FG001|Overall Study|Lack of Efficacy|25|||
164035227|NCT01316939|592488060|FG002|Overall Study|Lack of Efficacy|25|||
163928527|NCT02330562|592109766|FG010|Overall Study|Other reasons|0|||
163928528|NCT02330562|592109756|FG000|Overall Study|Withdrawal by Subject|0|||
163928529|NCT02330562|592109757|FG001|Overall Study|Withdrawal by Subject|0|||
163928530|NCT02330562|592109758|FG002|Overall Study|Withdrawal by Subject|0|||
163928531|NCT02330562|592109759|FG003|Overall Study|Withdrawal by Subject|0|||
163928532|NCT02330562|592109760|FG004|Overall Study|Withdrawal by Subject|0|||
163928533|NCT02330562|592109761|FG005|Overall Study|Withdrawal by Subject|0|||
163928534|NCT02330562|592109762|FG006|Overall Study|Withdrawal by Subject|0|||
163928535|NCT02330562|592109763|FG007|Overall Study|Withdrawal by Subject|0|||
163928536|NCT02330562|592109764|FG008|Overall Study|Withdrawal by Subject|0|||
163928537|NCT02330562|592109765|FG009|Overall Study|Withdrawal by Subject|1|||
163928538|NCT02330562|592109766|FG010|Overall Study|Withdrawal by Subject|0|||
163928539|NCT01657799|592109768|FG000|Overall Study|Adverse Event Related to progression|6|||
163928540|NCT01657799|592109769|FG001|Overall Study|Adverse Event Related to progression|8|||
163928541|NCT01657799|592109770|FG002|Overall Study|Adverse Event Related to progression|12|||
163928542|NCT01657799|592109768|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
163928543|NCT01657799|592109769|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
163928544|NCT01657799|592109770|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
163928545|NCT01657799|592109768|FG000|Overall Study|Withdrawal by Subject|13|||
163928546|NCT01657799|592109769|FG001|Overall Study|Withdrawal by Subject|10|||
163928547|NCT01657799|592109770|FG002|Overall Study|Withdrawal by Subject|10|||
163928548|NCT01657799|592109768|FG000|Overall Study|Lost to Follow-up|1|||
163928549|NCT01657799|592109769|FG001|Overall Study|Lost to Follow-up|0|||
163928550|NCT01657799|592109770|FG002|Overall Study|Lost to Follow-up|1|||
163928551|NCT01657799|592109768|FG000|Overall Study|Disease Progression|2|||
163928552|NCT01657799|592109769|FG001|Overall Study|Disease Progression|4|||
163928553|NCT01657799|592109770|FG002|Overall Study|Disease Progression|4|||
163928554|NCT01657799|592109768|FG000|Overall Study|Progressive Disease Clinical|7|||
163928555|NCT01657799|592109769|FG001|Overall Study|Progressive Disease Clinical|4|||
163928556|NCT01657799|592109770|FG002|Overall Study|Progressive Disease Clinical|7|||
163928557|NCT01657799|592109768|FG000|Overall Study|Radiographic & Clinical Progression|16|||
163928558|NCT01657799|592109769|FG001|Overall Study|Radiographic & Clinical Progression|11|||
163928559|NCT01657799|592109770|FG002|Overall Study|Radiographic & Clinical Progression|15|||
163928560|NCT01657799|592109768|FG000|Overall Study|Other|52|||
163928561|NCT01657799|592109769|FG001|Overall Study|Other|62|||
163928562|NCT01657799|592109770|FG002|Overall Study|Other|49|||
163928563|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
163928564|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
163928565|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
163928566|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
163928567|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
163928568|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
163928569|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
163928570|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
163928571|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
163928572|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
163928573|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
163928574|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
163928575|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
163928576|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
163928577|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
163928578|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
163928579|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
163928580|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
163928581|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
163928582|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
163928583|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
164035228|NCT01316939|592488058|FG000|Overall Study|Adverse Event|9|||
164035229|NCT01316939|592488059|FG001|Overall Study|Adverse Event|12|||
164035230|NCT01316939|592488060|FG002|Overall Study|Adverse Event|11|||
164035231|NCT01316939|592488058|FG000|Overall Study|Withdrawal by Subject|1|||
164035232|NCT01316939|592488059|FG001|Overall Study|Withdrawal by Subject|3|||
164035233|NCT01316939|592488060|FG002|Overall Study|Withdrawal by Subject|6|||
163928584|NCT04599855|592109775|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
163928585|NCT04599855|592109776|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
163928586|NCT04599855|592109777|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
163928587|NCT04599855|592109775|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
163928588|NCT04599855|592109776|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
164035234|NCT01316939|592488058|FG000|Overall Study|Physician Decision|2|||
164035235|NCT01316939|592488059|FG001|Overall Study|Physician Decision|2|||
164035236|NCT01316939|592488060|FG002|Overall Study|Physician Decision|1|||
164035237|NCT01316939|592488058|FG000|Overall Study|Lost to Follow-up|0|||
164035238|NCT01316939|592488059|FG001|Overall Study|Lost to Follow-up|0|||
164035239|NCT01316939|592488060|FG002|Overall Study|Lost to Follow-up|2|||
164035240|NCT01316939|592488058|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
164035241|NCT01316939|592488059|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
163833534|NCT00279201|591759587|FG002|Intensification Addendum|Physician Decision|4|||
163833535|NCT00279201|591759588|FG003|Intensification Addendum|Physician Decision|1|||
163833536|NCT00279201|591759589|FG004|Intensification Addendum|Physician Decision|3|||
163833537|NCT00279201|591759590|FG005|Intensification Addendum|Physician Decision|2|||
163833538|NCT00279201|591759585|FG000|Intensification Addendum|Sponsor Decision|0|||
163833539|NCT00279201|591759586|FG001|Intensification Addendum|Sponsor Decision|0|||
163833540|NCT00279201|591759587|FG002|Intensification Addendum|Sponsor Decision|0|||
163833541|NCT00279201|591759588|FG003|Intensification Addendum|Sponsor Decision|0|||
163833542|NCT00279201|591759589|FG004|Intensification Addendum|Sponsor Decision|1|||
163833543|NCT00279201|591759590|FG005|Intensification Addendum|Sponsor Decision|1|||
163833544|NCT00279201|591759585|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
163833545|NCT00279201|591759586|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
163833546|NCT00279201|591759587|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
163833547|NCT00279201|591759588|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
163833548|NCT00279201|591759589|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
163833549|NCT00279201|591759590|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
163833550|NCT00279201|591759585|FG000|Intensification Addendum|Lack of Efficacy|0|||
163833551|NCT00279201|591759586|FG001|Intensification Addendum|Lack of Efficacy|0|||
163833552|NCT00279201|591759587|FG002|Intensification Addendum|Lack of Efficacy|0|||
163833553|NCT00279201|591759588|FG003|Intensification Addendum|Lack of Efficacy|1|||
163833554|NCT00279201|591759589|FG004|Intensification Addendum|Lack of Efficacy|1|||
163833555|NCT00279201|591759590|FG005|Intensification Addendum|Lack of Efficacy|0|||
163833556|NCT00279201|591759585|FG000|Intensification Addendum|Death|0|||
163833557|NCT00279201|591759586|FG001|Intensification Addendum|Death|0|||
163833558|NCT00279201|591759587|FG002|Intensification Addendum|Death|0|||
163833559|NCT00279201|591759588|FG003|Intensification Addendum|Death|0|||
163833560|NCT00279201|591759589|FG004|Intensification Addendum|Death|1|||
163833561|NCT00279201|591759590|FG005|Intensification Addendum|Death|0|||
163833562|NCT04179721|591759606|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
163833563|NCT04179721|591759607|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
163833564|NCT04179721|591759606|FG000|Overall Study|Lost to Follow-up|0|||
163833565|NCT04179721|591759607|FG001|Overall Study|Lost to Follow-up|1|||
163833566|NCT01489189|591759608|FG000|Overall Study|Withdrawal by Subject|20|||
163833567|NCT01489189|591759609|FG001|Overall Study|Withdrawal by Subject|23|||
163833568|NCT01489189|591759608|FG000|Overall Study|Death|10|||
163833569|NCT01489189|591759609|FG001|Overall Study|Death|8|||
163833570|NCT01489189|591759608|FG000|Overall Study|Missed Visit|1|||
163833571|NCT01489189|591759609|FG001|Overall Study|Missed Visit|4|||
163833572|NCT00112580|591759610|FG000|Overall Study|Adverse Event|1|||
163833573|NCT00112580|591759611|FG001|Overall Study|Adverse Event|2|||
163833574|NCT00112580|591759610|FG000|Overall Study|Disease progression|5|||
163833575|NCT00112580|591759611|FG001|Overall Study|Disease progression|16|||
163833576|NCT00112580|591759610|FG000|Overall Study|Participant withdrew consent|2|||
163833577|NCT00112580|591759611|FG001|Overall Study|Participant withdrew consent|1|||
163833578|NCT05559866|591759612|FG000|Overall Study|Withdrawal by Subject|1|||
163833579|NCT05559866|591759613|FG001|Overall Study|Withdrawal by Subject|0|||
163833580|NCT03444376|591759616|FG000|Part A|Disease relapse or Progression|1|||
163833581|NCT03444376|591759616|FG000|Part A|Withdrawal by Subject|2|||
163833582|NCT03444376|591759616|FG000|Part A|Adverse Event|1|||
163833583|NCT03444376|591759616|FG000|Part B|Disease relapse or Progression|18|||
163833584|NCT03444376|591759616|FG000|Part B|Withdrawal by Subject|2|||
163833585|NCT03444376|591759616|FG000|Part B|Adverse Event|2|||
163833586|NCT03444376|591759616|FG000|Part B|Physician Decision|1|||
163833587|NCT03444376|591759616|FG000|Part C|Disease relapse or Progression|43|||
163833588|NCT03444376|591759616|FG000|Part C|Withdrawal by Subject|5|||
163833589|NCT03444376|591759616|FG000|Part C|Adverse Event|2|||
163833590|NCT03444376|591759616|FG000|Part C|Physician Decision|2|||
163833591|NCT03444376|591759616|FG000|Part C|Death|1|||
163833592|NCT03881696|591759620|FG000|Overall Study|Adverse Event|2|||
163833593|NCT03881696|591759621|FG001|Overall Study|Adverse Event|0|||
163833594|NCT03881696|591759620|FG000|Overall Study|Withdrawal by Subject|2|||
163833595|NCT03881696|591759621|FG001|Overall Study|Withdrawal by Subject|0|||
163833596|NCT03881696|591759620|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
163833597|NCT03881696|591759621|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
163833598|NCT03881696|591759620|FG000|Overall Study|Failure to meet continuation criteria|1|||
163833599|NCT03881696|591759621|FG001|Overall Study|Failure to meet continuation criteria|0|||
163833600|NCT00856167|591759624|FG000|Period 1|Withdrawal by Subject|1|||
163833601|NCT00856167|591759625|FG001|Period 1|Withdrawal by Subject|4|||
164098161|NCT02914600|592725039|FG002|Overall Study|Death|1|||
163928589|NCT04599855|592109777|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
163928590|NCT04599855|592109775|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
163928591|NCT04599855|592109776|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
163928592|NCT04599855|592109777|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
163928593|NCT04599855|592109775|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
163928594|NCT04599855|592109776|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
163928595|NCT04599855|592109777|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
163928596|NCT04599855|592109775|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
163928597|NCT04599855|592109776|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
163928598|NCT04599855|592109777|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
163928599|NCT04599855|592109775|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
163928600|NCT04599855|592109776|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
163928601|NCT04599855|592109777|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
163928602|NCT04599855|592109775|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
163928603|NCT04599855|592109776|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
163928604|NCT04599855|592109777|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
163928605|NCT01588366|592109780|FG000|Overall Study|Adverse Event|0|||
163928606|NCT01588366|592109781|FG001|Overall Study|Adverse Event|1|||
163928607|NCT01588366|592109782|FG002|Overall Study|Adverse Event|0|||
163928608|NCT01588366|592109783|FG003|Overall Study|Adverse Event|1|||
163928609|NCT01588366|592109784|FG004|Overall Study|Adverse Event|0|||
163928610|NCT01588366|592109785|FG005|Overall Study|Adverse Event|2|||
163928611|NCT04962698|592109786|FG000|Motor Imagery|Technical difficulty|1|||
163928612|NCT04962698|592109787|FG001|Motor Imagery|Technical difficulty|0|||
163928613|NCT04962698|592109786|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
163928614|NCT04962698|592109787|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
163928615|NCT04962698|592109786|FG000|Kinesthetic MI|Technical difficulty|1|||
163928616|NCT04962698|592109787|FG001|Kinesthetic MI|Technical difficulty|0|||
163928617|NCT04962698|592109786|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
163928618|NCT04962698|592109787|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
163928619|NCT04962698|592109786|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
163928620|NCT04962698|592109787|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
163928621|NCT04962698|592109786|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
163928622|NCT04962698|592109787|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
163928623|NCT04962698|592109786|FG000|Virtual-hand Interaction|Technical difficulty|1|||
163928624|NCT04962698|592109787|FG001|Virtual-hand Interaction|Technical difficulty|0|||
163928625|NCT04962698|592109786|FG000|Robotic Action Observation|Technical difficulty|1|||
163928626|NCT04962698|592109787|FG001|Robotic Action Observation|Technical difficulty|0|||
163928627|NCT04962698|592109786|FG000|Rest|Technical difficulty|1|||
163928628|NCT04962698|592109787|FG001|Rest|Technical difficulty|0|||
163928629|NCT04962698|592109786|FG000|Rest|Exclusion criteria met after enrollment|0|||
163928630|NCT04962698|592109787|FG001|Rest|Exclusion criteria met after enrollment|2|||
163928631|NCT00853229|592109788|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
163928632|NCT00853229|592109789|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
163928633|NCT00585975|592109793|FG000|Overall Study|Withdrawal by Subject|3|||
163928634|NCT00585975|592109794|FG001|Overall Study|Withdrawal by Subject|3|||
163928635|NCT00585975|592109793|FG000|Overall Study|Lost to Follow-up|2|||
163928636|NCT00585975|592109794|FG001|Overall Study|Lost to Follow-up|1|||
163928637|NCT00585975|592109793|FG000|Overall Study|Enrollment met/over-enrolled|10|||
163928638|NCT00585975|592109794|FG001|Overall Study|Enrollment met/over-enrolled|9|||
163928639|NCT03414047|592109801|FG000|Overall Study|Adverse Event|0|||
163928640|NCT03414047|592109802|FG001|Overall Study|Adverse Event|0|||
164035242|NCT01316939|592488060|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
164035243|NCT01316939|592488058|FG000|Overall Study|Protocol Violation|0|||
164035244|NCT01316939|592488059|FG001|Overall Study|Protocol Violation|1|||
164035245|NCT01316939|592488060|FG002|Overall Study|Protocol Violation|0|||
164035246|NCT01432457|592488061|FG000|Overall Study|Adverse Event|7|||
164035247|NCT01432457|592488062|FG001|Overall Study|Adverse Event|10|||
163928641|NCT03414047|592109803|FG002|Overall Study|Adverse Event|1|||
163928642|NCT03414047|592109804|FG003|Overall Study|Adverse Event|1|||
163928643|NCT03414047|592109801|FG000|Overall Study|Physician Decision|1|||
163928644|NCT03414047|592109802|FG001|Overall Study|Physician Decision|0|||
163928645|NCT03414047|592109803|FG002|Overall Study|Physician Decision|0|||
164035248|NCT01432457|592488063|FG002|Overall Study|Adverse Event|16|||
164035249|NCT01432457|592488061|FG000|Overall Study|Lack of Efficacy|2|||
164035250|NCT01432457|592488062|FG001|Overall Study|Lack of Efficacy|1|||
163928646|NCT03414047|592109804|FG003|Overall Study|Physician Decision|1|||
163928647|NCT03414047|592109801|FG000|Overall Study|Withdrawal by Subject|1|||
163928648|NCT03414047|592109802|FG001|Overall Study|Withdrawal by Subject|0|||
163928649|NCT03414047|592109803|FG002|Overall Study|Withdrawal by Subject|2|||
163928650|NCT03414047|592109804|FG003|Overall Study|Withdrawal by Subject|0|||
163928651|NCT01129115|592109809|FG000|Overall Study|Adverse Event|1|||
164098162|NCT02914600|592725037|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
164098163|NCT02914600|592725038|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
164098164|NCT02914600|592725039|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
164098165|NCT02914600|592725037|FG000|Overall Study|Enrolled but not treated|1|||
164098166|NCT02914600|592725038|FG001|Overall Study|Enrolled but not treated|0|||
164098167|NCT02914600|592725039|FG002|Overall Study|Enrolled but not treated|0|||
164098168|NCT02996682|592725041|FG000|Overall Study|Death|0|||
164098169|NCT02996682|592725042|FG001|Overall Study|Death|3|||
164098170|NCT02457520|592725043|FG000|Active Treatment Phase|Adverse Event|10|||
164098171|NCT02457520|592725043|FG000|Active Treatment Phase|Lost to Follow-up|8|||
163928652|NCT01129115|592109810|FG001|Overall Study|Adverse Event|2|||
163928653|NCT01129115|592109811|FG002|Overall Study|Adverse Event|3|||
163928654|NCT01129115|592109812|FG003|Overall Study|Adverse Event|3|||
163928655|NCT01129115|592109809|FG000|Overall Study|Withdrawal by Subject|1|||
163928656|NCT01129115|592109810|FG001|Overall Study|Withdrawal by Subject|3|||
163928657|NCT01129115|592109811|FG002|Overall Study|Withdrawal by Subject|1|||
163928658|NCT01129115|592109812|FG003|Overall Study|Withdrawal by Subject|4|||
163928659|NCT01129115|592109809|FG000|Overall Study|Protocol Violation|0|||
163928660|NCT01129115|592109810|FG001|Overall Study|Protocol Violation|2|||
163928661|NCT01129115|592109811|FG002|Overall Study|Protocol Violation|2|||
163928662|NCT01129115|592109812|FG003|Overall Study|Protocol Violation|2|||
164035251|NCT01432457|592488063|FG002|Overall Study|Lack of Efficacy|1|||
164035252|NCT01432457|592488061|FG000|Overall Study|Lost to Follow-up|11|||
164035253|NCT01432457|592488062|FG001|Overall Study|Lost to Follow-up|15|||
164035254|NCT01432457|592488063|FG002|Overall Study|Lost to Follow-up|20|||
164035255|NCT01432457|592488061|FG000|Overall Study|Protocol Violation|3|||
164035256|NCT01432457|592488062|FG001|Overall Study|Protocol Violation|2|||
164035257|NCT01432457|592488063|FG002|Overall Study|Protocol Violation|6|||
164035258|NCT01432457|592488061|FG000|Overall Study|Withdrawal by Subject|6|||
164035259|NCT01432457|592488062|FG001|Overall Study|Withdrawal by Subject|11|||
164035260|NCT01432457|592488063|FG002|Overall Study|Withdrawal by Subject|9|||
164035261|NCT01432457|592488061|FG000|Overall Study|Reasons not defined|2|||
164035262|NCT01432457|592488062|FG001|Overall Study|Reasons not defined|3|||
164035263|NCT01432457|592488063|FG002|Overall Study|Reasons not defined|4|||
164035264|NCT01432457|592488061|FG000|Overall Study|Did not take study drug|6|||
164035265|NCT01432457|592488062|FG001|Overall Study|Did not take study drug|6|||
164035266|NCT01432457|592488063|FG002|Overall Study|Did not take study drug|3|||
164035267|NCT02715804|592488064|FG000|Overall Study|Death|222|||
164035268|NCT02715804|592488065|FG001|Overall Study|Death|106|||
164035269|NCT02715804|592488064|FG000|Overall Study|Withdrawal by Subject|5|||
164035270|NCT02715804|592488065|FG001|Overall Study|Withdrawal by Subject|4|||
164035271|NCT02715804|592488064|FG000|Overall Study|Other than specified|2|||
164035272|NCT02715804|592488065|FG001|Overall Study|Other than specified|3|||
164035273|NCT00801892|592488072|FG000|Main Study Period|Withdrawal by Subject|0|||
164035274|NCT00801892|592488073|FG001|Main Study Period|Withdrawal by Subject|1|||
164035275|NCT00801892|592488072|FG000|Sham Crossover Period|Lost to Follow-up|0|||
164035276|NCT00801892|592488073|FG001|Sham Crossover Period|Lost to Follow-up|2|||
164035277|NCT01281189|592488078|FG000|Overall Study|Adverse Event|7|||
164035278|NCT01281189|592488079|FG001|Overall Study|Adverse Event|9|||
164035279|NCT01281189|592488078|FG000|Overall Study|Lost to Follow-up|6|||
164035280|NCT01281189|592488079|FG001|Overall Study|Lost to Follow-up|4|||
164035281|NCT01281189|592488078|FG000|Overall Study|Withdrawal by Subject|21|||
164035282|NCT01281189|592488079|FG001|Overall Study|Withdrawal by Subject|24|||
164035283|NCT01281189|592488078|FG000|Overall Study|Physician Decision|2|||
164035284|NCT01281189|592488079|FG001|Overall Study|Physician Decision|3|||
164035285|NCT01281189|592488078|FG000|Overall Study|Death|103|||
164035286|NCT01281189|592488079|FG001|Overall Study|Death|91|||
164035287|NCT01281189|592488078|FG000|Overall Study|Other|8|||
164035288|NCT01281189|592488079|FG001|Overall Study|Other|12|||
164035289|NCT02966353|592488081|FG000|Overall Study|Withdrawal by Subject|7|||
164035290|NCT02966353|592488081|FG000|Overall Study|Adverse Event|4|||
164098172|NCT02457520|592725043|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
164035291|NCT02966353|592488081|FG000|Overall Study|Death|4|||
164035292|NCT02966353|592488081|FG000|Overall Study|Physician Decision|3|||
164035293|NCT02966353|592488081|FG000|Overall Study|Progressive disease|2|||
164098173|NCT02457520|592725043|FG000|Active Treatment Phase|other|4|||
163928663|NCT01747837|592109814|FG000|Overall Study|Lost to Follow-up|5|||
164035294|NCT02966353|592488081|FG000|Overall Study|Protocol deviation|2|||
164035295|NCT03351478|592488082|FG000|Overall Study|At the subject's own request|11|||
164035296|NCT03351478|592488083|FG001|Overall Study|At the subject's own request|12|||
164147380|NCT05168202|592902028|FG004|Overall Study|Lack of Efficacy|1|||
163928664|NCT01747837|592109815|FG001|Overall Study|Lost to Follow-up|2|||
163928665|NCT01747837|592109814|FG000|Overall Study|Death|4|||
164035297|NCT03351478|592488084|FG002|Overall Study|At the subject's own request|5|||
164035298|NCT03351478|592488082|FG000|Overall Study|Adverse Event|1|||
164035299|NCT03351478|592488083|FG001|Overall Study|Adverse Event|2|||
164035300|NCT03351478|592488084|FG002|Overall Study|Adverse Event|1|||
164035301|NCT03351478|592488082|FG000|Overall Study|Poor compliance to protocol|1|||
164035302|NCT03351478|592488083|FG001|Overall Study|Poor compliance to protocol|0|||
164035303|NCT03351478|592488084|FG002|Overall Study|Poor compliance to protocol|0|||
164035304|NCT03351478|592488082|FG000|Overall Study|Reason not Specified|1|||
164035305|NCT03351478|592488083|FG001|Overall Study|Reason not Specified|3|||
164035306|NCT03351478|592488084|FG002|Overall Study|Reason not Specified|0|||
164035307|NCT03351478|592488082|FG000|Overall Study|Lost to Follow-up|0|||
164035308|NCT03351478|592488083|FG001|Overall Study|Lost to Follow-up|0|||
164035309|NCT03351478|592488084|FG002|Overall Study|Lost to Follow-up|1|||
164035310|NCT03911869|592488087|FG000|Safety Lead-in Phase|Death|7|||
164035311|NCT03911869|592488088|FG001|Safety Lead-in Phase|Death|0|||
164035312|NCT03911869|592488089|FG002|Safety Lead-in Phase|Death|0|||
164035313|NCT03911869|592488087|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
164035314|NCT03911869|592488088|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
164035315|NCT03911869|592488089|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
163833602|NCT00856167|591759626|FG002|Period 1|Withdrawal by Subject|0|||
163833603|NCT00856167|591759627|FG003|Period 1|Withdrawal by Subject|0|||
163833604|NCT00856167|591759624|FG000|Period 1|Lost to Follow-up|2|||
163833605|NCT00856167|591759625|FG001|Period 1|Lost to Follow-up|1|||
163833606|NCT00856167|591759626|FG002|Period 1|Lost to Follow-up|0|||
163833607|NCT00856167|591759627|FG003|Period 1|Lost to Follow-up|0|||
163833608|NCT00856167|591759624|FG000|Period 2|Lost to Follow-up|0|||
163833609|NCT00856167|591759625|FG001|Period 2|Lost to Follow-up|0|||
163833610|NCT00856167|591759626|FG002|Period 2|Lost to Follow-up|3|||
163833611|NCT00856167|591759627|FG003|Period 2|Lost to Follow-up|1|||
163833612|NCT00856167|591759624|FG000|Period 2|Withdrawal by Subject|0|||
163833613|NCT00856167|591759625|FG001|Period 2|Withdrawal by Subject|0|||
163833614|NCT00856167|591759626|FG002|Period 2|Withdrawal by Subject|2|||
163833615|NCT00856167|591759627|FG003|Period 2|Withdrawal by Subject|4|||
163833616|NCT01061333|591759630|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
163833617|NCT01061333|591759631|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
163833618|NCT02764775|591761400|FG000|Overall Study|Death|1|||
163833619|NCT02764775|591761400|FG000|Overall Study|Lost to Follow-up|2|||
163833620|NCT02764775|591761400|FG000|Overall Study|Withdrawal by Subject|3|||
163833621|NCT00975221|591761401|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
163833622|NCT00975221|591761402|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
163833623|NCT00975221|591761401|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
163833624|NCT00975221|591761402|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
163833625|NCT00975221|591761401|FG000|Titration Phase (Weeks 1-12)|Other|0|||
163833626|NCT00975221|591761402|FG001|Titration Phase (Weeks 1-12)|Other|1|||
163833627|NCT00975221|591761401|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
163833628|NCT00975221|591761402|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
163833629|NCT00975221|591761401|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
163833630|NCT00975221|591761402|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
163833631|NCT00975221|591761401|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
163833632|NCT00975221|591761402|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
163833633|NCT04022889|591761403|FG000|Stage 1: Period 1|Adverse Event|1|||
163833634|NCT04022889|591761404|FG001|Stage 1: Period 1|Adverse Event|0|||
163833635|NCT04022889|591761405|FG002|Stage 1: Period 1|Adverse Event|0|||
163833636|NCT04022889|591761403|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
163833637|NCT04022889|591761404|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
163833638|NCT04022889|591761405|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
163833639|NCT04022889|591761403|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
163833640|NCT04022889|591761404|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
163833641|NCT04022889|591761405|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
163833642|NCT04022889|591761403|FG000|Stage 2|Screen Failure|0|||
163833643|NCT04022889|591761404|FG001|Stage 2|Screen Failure|0|||
163833644|NCT04022889|591761405|FG002|Stage 2|Screen Failure|3|||
163833645|NCT04022889|591761403|FG000|Stage 2|Ineligible for apheresis donation|0|||
163833646|NCT04022889|591761404|FG001|Stage 2|Ineligible for apheresis donation|0|||
163833647|NCT04022889|591761405|FG002|Stage 2|Ineligible for apheresis donation|2|||
163833648|NCT04022889|591761403|FG000|Stage 2|Adverse Event|0|||
163833649|NCT04022889|591761404|FG001|Stage 2|Adverse Event|0|||
163833650|NCT04022889|591761405|FG002|Stage 2|Adverse Event|2|||
163833651|NCT04022889|591761403|FG000|Stage 2|Protocol Violation|0|||
163833652|NCT04022889|591761404|FG001|Stage 2|Protocol Violation|0|||
163833653|NCT04022889|591761405|FG002|Stage 2|Protocol Violation|1|||
164035316|NCT03911869|592488087|FG000|Safety Lead-in Phase|Other|1|||
164035317|NCT03911869|592488088|FG001|Safety Lead-in Phase|Other|0|||
164035318|NCT03911869|592488089|FG002|Safety Lead-in Phase|Other|0|||
163833654|NCT04022889|591761403|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
163833655|NCT04022889|591761404|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
163833656|NCT04022889|591761405|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
163833657|NCT01186328|591761410|FG000|Overall Study|Death|1|||
163833658|NCT01186328|591761411|FG001|Overall Study|Death|0|||
163833659|NCT01186328|591761412|FG002|Overall Study|Death|0|||
163928666|NCT01747837|592109815|FG001|Overall Study|Death|4|||
163928667|NCT01121913|592109816|FG000|First Intervention Period|Adverse Event|0|||
163928668|NCT01121913|592109817|FG001|First Intervention Period|Adverse Event|0|||
163928669|NCT01121913|592109818|FG002|First Intervention Period|Adverse Event|1|||
163928670|NCT01121913|592109819|FG003|First Intervention Period|Adverse Event|0|||
163928671|NCT01121913|592109816|FG000|First Washout Period|Withdrawal by Subject|1|||
163928672|NCT01121913|592109817|FG001|First Washout Period|Withdrawal by Subject|0|||
163928673|NCT01121913|592109818|FG002|First Washout Period|Withdrawal by Subject|0|||
163928674|NCT01121913|592109819|FG003|First Washout Period|Withdrawal by Subject|0|||
163928675|NCT01121913|592109816|FG000|Second Intervention Period|Adverse Event|0|||
163928676|NCT01121913|592109817|FG001|Second Intervention Period|Adverse Event|0|||
163928677|NCT01121913|592109818|FG002|Second Intervention Period|Adverse Event|1|||
163928678|NCT01121913|592109819|FG003|Second Intervention Period|Adverse Event|0|||
163928679|NCT01121913|592109816|FG000|Second Washout Period|Withdrawal by Subject|0|||
163928680|NCT01121913|592109817|FG001|Second Washout Period|Withdrawal by Subject|0|||
163928681|NCT01121913|592109818|FG002|Second Washout Period|Withdrawal by Subject|1|||
163928682|NCT01121913|592109819|FG003|Second Washout Period|Withdrawal by Subject|0|||
163928683|NCT01121913|592109816|FG000|Third Washout Period|Adverse Event|1|||
163928684|NCT01121913|592109817|FG001|Third Washout Period|Adverse Event|0|||
163928685|NCT01121913|592109818|FG002|Third Washout Period|Adverse Event|0|||
163928686|NCT01121913|592109819|FG003|Third Washout Period|Adverse Event|0|||
163928687|NCT00690378|592109820|FG000|Overall Study|Adverse Event|1|||
163928688|NCT00690378|592109821|FG001|Overall Study|Adverse Event|0|||
163928689|NCT00690378|592109820|FG000|Overall Study|Withdrawal by Subject|2|||
163928690|NCT00690378|592109821|FG001|Overall Study|Withdrawal by Subject|0|||
163928691|NCT00690378|592109820|FG000|Overall Study|Protocol Violation|1|||
163928692|NCT00690378|592109821|FG001|Overall Study|Protocol Violation|0|||
163928693|NCT00690378|592109820|FG000|Overall Study|Lost to Follow-up|2|||
163928694|NCT00690378|592109821|FG001|Overall Study|Lost to Follow-up|3|||
163928695|NCT00690378|592109820|FG000|Overall Study|Did not meet inc/exc criteria|13|||
163928696|NCT00690378|592109821|FG001|Overall Study|Did not meet inc/exc criteria|11|||
163928697|NCT00690378|592109820|FG000|Overall Study|Social problem|1|||
163928698|NCT00690378|592109821|FG001|Overall Study|Social problem|0|||
163928699|NCT02019641|592109825|FG000|10-Week Follow up|Withdrawal by investigator|2|||
163928700|NCT02019641|592109826|FG001|10-Week Follow up|Withdrawal by investigator|0|||
163928701|NCT02019641|592109827|FG002|10-Week Follow up|Withdrawal by investigator|0|||
163928702|NCT02019641|592109825|FG000|10-Week Follow up|Withdrawal by Subject|1|||
163928703|NCT02019641|592109826|FG001|10-Week Follow up|Withdrawal by Subject|1|||
163928704|NCT02019641|592109827|FG002|10-Week Follow up|Withdrawal by Subject|0|||
163928705|NCT02019641|592109825|FG000|20-Week Follow up|Withdrawal by investigator|0|||
163928706|NCT02019641|592109826|FG001|20-Week Follow up|Withdrawal by investigator|0|||
163928707|NCT02019641|592109827|FG002|20-Week Follow up|Withdrawal by investigator|1|||
163928708|NCT03269695|592109831|FG000|Overall Study|Adverse Event|2|||
163928709|NCT03269695|592109832|FG001|Overall Study|Adverse Event|1|||
163928710|NCT03269695|592109831|FG000|Overall Study|Lack of Efficacy|0|||
163928711|NCT03269695|592109832|FG001|Overall Study|Lack of Efficacy|1|||
163928712|NCT03269695|592109831|FG000|Overall Study|Withdrawal by Subject|0|||
163928713|NCT03269695|592109832|FG001|Overall Study|Withdrawal by Subject|1|||
163928714|NCT01017263|592109833|FG000|Overall Study|not eligible|12|||
163928715|NCT05043883|592109834|FG000|Overall Study|Minimum required measurements could not be taken|4|||
163928716|NCT02447718|592109837|FG000|Overall Study|Lost to Follow-up|8|||
163928717|NCT02447718|592109838|FG001|Overall Study|Lost to Follow-up|0|||
163928718|NCT02447718|592109837|FG000|Overall Study|Withdrawal by Subject|3|||
163928719|NCT02447718|592109838|FG001|Overall Study|Withdrawal by Subject|0|||
163928720|NCT02447718|592109837|FG000|Overall Study|Screen Failure|1|||
163928721|NCT02447718|592109838|FG001|Overall Study|Screen Failure|0|||
163928722|NCT00239681|592109839|FG000|Overall Study|Adverse Event|100|||
163928723|NCT00239681|592109840|FG001|Overall Study|Adverse Event|99|||
163928724|NCT00239681|592109839|FG000|Overall Study|Withdrawal by Subject|458|||
163928725|NCT00239681|592109840|FG001|Overall Study|Withdrawal by Subject|489|||
163928726|NCT00239681|592109839|FG000|Overall Study|Lost to Follow-up|28|||
163928727|NCT00239681|592109840|FG001|Overall Study|Lost to Follow-up|22|||
163928728|NCT00239681|592109839|FG000|Overall Study|Protocol Violation|4|||
163928729|NCT00239681|592109840|FG001|Overall Study|Protocol Violation|4|||
163928730|NCT00239681|592109839|FG000|Overall Study|Physician Decision|13|||
163928731|NCT00239681|592109840|FG001|Overall Study|Physician Decision|17|||
163928732|NCT00239681|592109839|FG000|Overall Study|No information chacked on CaseReportForm|90|||
163928733|NCT00239681|592109840|FG001|Overall Study|No information chacked on CaseReportForm|84|||
163928734|NCT03599622|592109843|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
163928735|NCT03599622|592109844|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
163928736|NCT03599622|592109845|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
163928737|NCT03599622|592109846|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
163928738|NCT03599622|592109843|FG000|Pre-Treatment Period|Other reasons|1|||
163928739|NCT03599622|592109844|FG001|Pre-Treatment Period|Other reasons|1|||
163928740|NCT03599622|592109845|FG002|Pre-Treatment Period|Other reasons|1|||
164035319|NCT03911869|592488087|FG000|Phase 2|Death|0|||
164035320|NCT03911869|592488088|FG001|Phase 2|Death|3|||
164035321|NCT03911869|592488089|FG002|Phase 2|Death|0|||
164035322|NCT00527072|592488090|FG000|Overall Study|Adverse Event|13|||
164035323|NCT00527072|592488090|FG000|Overall Study|Lack of Efficacy|11|||
164035324|NCT00527072|592488090|FG000|Overall Study|Lost to Follow-up|3|||
164035325|NCT00527072|592488090|FG000|Overall Study|Protocol Violation|2|||
164035326|NCT00527072|592488090|FG000|Overall Study|Withdrawal by Subject|7|||
164035327|NCT02657434|592488091|FG000|Overall Study|Study Terminated By Sponsor|64|||
164035328|NCT02657434|592488092|FG001|Overall Study|Study Terminated By Sponsor|82|||
163833660|NCT02202434|591761413|FG000|Overall Study|Death|70|||
163833661|NCT02202434|591761414|FG001|Overall Study|Death|39|||
163833662|NCT02202434|591761415|FG002|Overall Study|Death|13|||
163833663|NCT02202434|591761416|FG003|Overall Study|Death|27|||
163833664|NCT02202434|591761413|FG000|Overall Study|Lost to Follow-up|1|||
163833665|NCT02202434|591761414|FG001|Overall Study|Lost to Follow-up|1|||
163833666|NCT02202434|591761415|FG002|Overall Study|Lost to Follow-up|1|||
163833667|NCT02202434|591761416|FG003|Overall Study|Lost to Follow-up|0|||
163833668|NCT02202434|591761413|FG000|Overall Study|Physician Decision|2|||
163833669|NCT02202434|591761414|FG001|Overall Study|Physician Decision|3|||
163833670|NCT02202434|591761415|FG002|Overall Study|Physician Decision|0|||
163833671|NCT02202434|591761416|FG003|Overall Study|Physician Decision|0|||
163833672|NCT02202434|591761413|FG000|Overall Study|Withdrawal by Subject|13|||
163833673|NCT02202434|591761414|FG001|Overall Study|Withdrawal by Subject|14|||
163833674|NCT02202434|591761415|FG002|Overall Study|Withdrawal by Subject|1|||
163833675|NCT02202434|591761416|FG003|Overall Study|Withdrawal by Subject|4|||
163833676|NCT02202434|591761413|FG000|Overall Study|Completed Study|1|||
163833677|NCT02202434|591761414|FG001|Overall Study|Completed Study|0|||
163833678|NCT02202434|591761415|FG002|Overall Study|Completed Study|0|||
163833679|NCT02202434|591761416|FG003|Overall Study|Completed Study|0|||
163833680|NCT02202434|591761413|FG000|Overall Study|Visit Missed|21|||
163833681|NCT02202434|591761414|FG001|Overall Study|Visit Missed|12|||
163833682|NCT02202434|591761415|FG002|Overall Study|Visit Missed|0|||
163833683|NCT02202434|591761416|FG003|Overall Study|Visit Missed|5|||
163833684|NCT02202434|591761413|FG000|Overall Study|Other|1|||
163833685|NCT02202434|591761414|FG001|Overall Study|Other|0|||
163833686|NCT02202434|591761415|FG002|Overall Study|Other|0|||
163833687|NCT02202434|591761416|FG003|Overall Study|Other|1|||
163833688|NCT03237858|591761417|FG000|Overall Study|Death|19|||
163833689|NCT03237858|591761417|FG000|Overall Study|Withdrawal by Subject|37|||
163833690|NCT02207725|591761421|FG000|Overall Study|Did Not Receive Treatment|0|||
163833691|NCT02207725|591761422|FG001|Overall Study|Did Not Receive Treatment|1|||
163833692|NCT02207725|591761423|FG002|Overall Study|Did Not Receive Treatment|1|||
163833693|NCT02207725|591761424|FG003|Overall Study|Did Not Receive Treatment|1|||
163833694|NCT00185640|591761428|FG000|Overall Study|Not Eligible|4|||
163833695|NCT00185640|591761428|FG000|Overall Study|Withdrawal by Subject|3|||
163833696|NCT00185640|591761428|FG000|Overall Study|Death|138|||
163833697|NCT00058422|591761429|FG000|Overall Study|Not treated|2|||
163833698|NCT03170375|591761430|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
163833699|NCT03170375|591761431|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
163833700|NCT03170375|591761432|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
163833701|NCT03170375|591761430|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
163833702|NCT03170375|591761431|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
163833703|NCT03170375|591761432|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
163833704|NCT01691521|591761433|FG000|Overall Study|Adverse Event|4|||
163833705|NCT01691521|591761434|FG001|Overall Study|Adverse Event|0|||
163833706|NCT01691521|591761435|FG002|Overall Study|Adverse Event|1|||
163833707|NCT01691521|591761433|FG000|Overall Study|Lack of Efficacy|1|||
163833708|NCT01691521|591761434|FG001|Overall Study|Lack of Efficacy|1|||
163833709|NCT01691521|591761435|FG002|Overall Study|Lack of Efficacy|2|||
163833710|NCT01691521|591761433|FG000|Overall Study|Protocol Violation|0|||
163833711|NCT01691521|591761434|FG001|Overall Study|Protocol Violation|3|||
163833712|NCT01691521|591761435|FG002|Overall Study|Protocol Violation|0|||
163833713|NCT01691521|591761433|FG000|Overall Study|Lost to Follow-up|0|||
163833714|NCT01691521|591761434|FG001|Overall Study|Lost to Follow-up|2|||
163833715|NCT01691521|591761435|FG002|Overall Study|Lost to Follow-up|2|||
163833716|NCT01691521|591761433|FG000|Overall Study|Physician Decision|2|||
163833717|NCT01691521|591761434|FG001|Overall Study|Physician Decision|1|||
163833718|NCT01691521|591761435|FG002|Overall Study|Physician Decision|0|||
163833719|NCT01691521|591761433|FG000|Overall Study|Withdrawal by Subject|5|||
164035329|NCT02657434|592488091|FG000|Overall Study|Death|189|||
163833720|NCT01691521|591761434|FG001|Overall Study|Withdrawal by Subject|9|||
163833721|NCT01691521|591761435|FG002|Overall Study|Withdrawal by Subject|4|||
163833722|NCT02343003|591761436|FG000|Overall Study|Withdrawal by Subject|9|||
164035330|NCT02657434|592488092|FG001|Overall Study|Death|190|||
164035331|NCT02657434|592488091|FG000|Overall Study|Lost to Follow-up|2|||
163833723|NCT02343003|591761437|FG001|Overall Study|Withdrawal by Subject|4|||
163833724|NCT02343003|591761436|FG000|Overall Study|Lost to Follow-up|5|||
163833725|NCT02343003|591761437|FG001|Overall Study|Lost to Follow-up|1|||
163833726|NCT02343003|591761436|FG000|Overall Study|Protocol Violation|1|||
164035332|NCT02657434|592488092|FG001|Overall Study|Lost to Follow-up|2|||
163928741|NCT03599622|592109846|FG003|Pre-Treatment Period|Other reasons|0|||
163928742|NCT03599622|592109843|FG000|Treatment Period|Adverse Event|11|||
163928743|NCT03599622|592109844|FG001|Treatment Period|Adverse Event|20|||
163928744|NCT03599622|592109845|FG002|Treatment Period|Adverse Event|18|||
163928745|NCT03599622|592109846|FG003|Treatment Period|Adverse Event|2|||
163928746|NCT03599622|592109843|FG000|Treatment Period|Lack of Efficacy|18|||
163928747|NCT03599622|592109844|FG001|Treatment Period|Lack of Efficacy|12|||
163928748|NCT03599622|592109845|FG002|Treatment Period|Lack of Efficacy|13|||
163928749|NCT03599622|592109846|FG003|Treatment Period|Lack of Efficacy|2|||
163928750|NCT03599622|592109843|FG000|Treatment Period|Withdrawal by Subject|5|||
163928751|NCT03599622|592109844|FG001|Treatment Period|Withdrawal by Subject|11|||
163928752|NCT03599622|592109845|FG002|Treatment Period|Withdrawal by Subject|16|||
163928753|NCT03599622|592109846|FG003|Treatment Period|Withdrawal by Subject|1|||
163928754|NCT03599622|592109843|FG000|Treatment Period|Other reasons|4|||
163928755|NCT03599622|592109844|FG001|Treatment Period|Other reasons|6|||
163928756|NCT03599622|592109845|FG002|Treatment Period|Other reasons|7|||
163928757|NCT03599622|592109846|FG003|Treatment Period|Other reasons|0|||
163928758|NCT03599622|592109843|FG000|Treatment Period|Lost to Follow-up|1|||
163928759|NCT03599622|592109844|FG001|Treatment Period|Lost to Follow-up|0|||
163928760|NCT03599622|592109845|FG002|Treatment Period|Lost to Follow-up|0|||
163928761|NCT03599622|592109846|FG003|Treatment Period|Lost to Follow-up|0|||
163928762|NCT03599622|592109843|FG000|Treatment Period|Study terminated by sponsor|7|||
163928763|NCT03599622|592109844|FG001|Treatment Period|Study terminated by sponsor|20|||
163928764|NCT03599622|592109845|FG002|Treatment Period|Study terminated by sponsor|15|||
163928765|NCT03599622|592109846|FG003|Treatment Period|Study terminated by sponsor|0|||
163928766|NCT03599622|592109843|FG000|Treatment Period|Site terminated by sponsor|0|||
163833727|NCT02343003|591761437|FG001|Overall Study|Protocol Violation|0|||
163928767|NCT03599622|592109844|FG001|Treatment Period|Site terminated by sponsor|1|||
163928768|NCT03599622|592109845|FG002|Treatment Period|Site terminated by sponsor|0|||
163928769|NCT03599622|592109846|FG003|Treatment Period|Site terminated by sponsor|0|||
163833728|NCT02343003|591761436|FG000|Overall Study|Death|0|||
163833729|NCT02343003|591761437|FG001|Overall Study|Death|1|||
163833730|NCT02343003|591761436|FG000|Overall Study|exclusion criteria met|1|||
163833731|NCT02343003|591761437|FG001|Overall Study|exclusion criteria met|1|||
163833732|NCT02343003|591761436|FG000|Overall Study|terminated by sponsor|2|||
163833733|NCT02343003|591761437|FG001|Overall Study|terminated by sponsor|0|||
163833734|NCT00622713|591761442|FG000|Overall Study|Adverse Event|35|||
163833735|NCT00622713|591761442|FG000|Overall Study|Administrative problems|4|||
163833736|NCT00622713|591761442|FG000|Overall Study|Withdrawal by Subject|11|||
163833737|NCT00622713|591761442|FG000|Overall Study|Lost to Follow-up|5|||
163833738|NCT00622713|591761442|FG000|Overall Study|Death|2|||
163833739|NCT00622713|591761442|FG000|Overall Study|Subject no longer required study drug|1|||
163833740|NCT00622713|591761442|FG000|Overall Study|Did not meet eligibility criteria|1|||
163833741|NCT04404478|591761443|FG000|Overall Study|Withdrawal by Subject|1|||
163833742|NCT04404478|591761444|FG001|Overall Study|Withdrawal by Subject|3|||
163833743|NCT00879996|591761454|FG000|Overall Study|Lost to Follow-up|7|||
163833744|NCT00879996|591761455|FG001|Overall Study|Lost to Follow-up|6|||
163833745|NCT00879996|591761454|FG000|Overall Study|non-compliance|6|||
163833746|NCT00879996|591761455|FG001|Overall Study|non-compliance|4|||
163833747|NCT00879996|591761454|FG000|Overall Study|Physician Decision|1|||
163833748|NCT00879996|591761455|FG001|Overall Study|Physician Decision|2|||
163833749|NCT00879996|591761454|FG000|Overall Study|psychiatric problem|0|||
163833750|NCT00879996|591761455|FG001|Overall Study|psychiatric problem|1|||
163833751|NCT00879996|591761454|FG000|Overall Study|put on parole|1|||
163833752|NCT00879996|591761455|FG001|Overall Study|put on parole|0|||
163833753|NCT01148862|591761460|FG000|Second Intervention|Withdrawal by Subject|0|||
163833754|NCT01148862|591761461|FG001|Second Intervention|Withdrawal by Subject|2|||
163833755|NCT03056534|591761462|FG000|Overall Study|Participant withdrew consent|8|||
163833756|NCT03056534|591761462|FG000|Overall Study|Participant not able to return|6|||
163833757|NCT03056534|591761462|FG000|Overall Study|Lost to Follow-up|37|||
163833758|NCT03056534|591761462|FG000|Overall Study|Investigator judgment|1|||
163833759|NCT03056534|591761462|FG000|Overall Study|Death|4|||
163833760|NCT03056534|591761462|FG000|Overall Study|Adverse Event|1|||
163928770|NCT00905359|592109849|FG000|Overall Study|Lost to Follow-up|17|||
163928771|NCT00905359|592109850|FG001|Overall Study|Lost to Follow-up|10|||
163928772|NCT00905359|592109849|FG000|Overall Study|Death|2|||
163928773|NCT00905359|592109850|FG001|Overall Study|Death|0|||
163928774|NCT00905359|592109849|FG000|Overall Study|Withdrawal consent|5|||
163928775|NCT00905359|592109850|FG001|Overall Study|Withdrawal consent|6|||
163928776|NCT00468130|592109851|FG000|Overall Study|Adverse Event|2|||
163928777|NCT00468130|592109852|FG001|Overall Study|Adverse Event|1|||
163928778|NCT00468130|592109851|FG000|Overall Study|Withdrawal by Subject|0|||
163928779|NCT00468130|592109852|FG001|Overall Study|Withdrawal by Subject|1|||
163928780|NCT02485899|592109853|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
163928781|NCT02485899|592109854|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
163928782|NCT02485899|592109853|FG000|Overall Study|Withdrawal by Subject|1|||
164035333|NCT02657434|592488091|FG000|Overall Study|Randomization by Error|2|||
164035334|NCT02657434|592488092|FG001|Overall Study|Randomization by Error|0|||
164035335|NCT02657434|592488091|FG000|Overall Study|Withdrawal by Subject|28|||
163833761|NCT03056534|591761462|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
163833762|NCT04543188|591761463|FG000|Phase 1a|Adverse Event|0|||
163833763|NCT04543188|591761464|FG001|Phase 1a|Adverse Event|0|||
163833764|NCT04543188|591761465|FG002|Phase 1a|Adverse Event|0|||
163833765|NCT04543188|591761466|FG003|Phase 1a|Adverse Event|1|||
163833766|NCT04543188|591761467|FG004|Phase 1a|Adverse Event|0|||
163833767|NCT04543188|591761468|FG005|Phase 1a|Adverse Event|0|||
163833768|NCT04543188|591761469|FG006|Phase 1a|Adverse Event|1|||
163833769|NCT04543188|591761470|FG007|Phase 1a|Adverse Event|0|||
163833770|NCT04543188|591761471|FG008|Phase 1a|Adverse Event|0|||
163833771|NCT04543188|591761472|FG009|Phase 1a|Adverse Event|0|||
163833772|NCT04543188|591761473|FG010|Phase 1a|Adverse Event|0|||
163833773|NCT04543188|591761474|FG011|Phase 1a|Adverse Event|0|||
163833774|NCT04543188|591761475|FG012|Phase 1a|Adverse Event|0|||
163833775|NCT04543188|591761476|FG013|Phase 1a|Adverse Event|0|||
163833776|NCT04543188|591761477|FG014|Phase 1a|Adverse Event|0|||
163833777|NCT04543188|591761463|FG000|Phase 1a|Other (Death)|0|||
163833778|NCT04543188|591761464|FG001|Phase 1a|Other (Death)|1|||
163833779|NCT04543188|591761465|FG002|Phase 1a|Other (Death)|0|||
163833780|NCT04543188|591761466|FG003|Phase 1a|Other (Death)|0|||
163833781|NCT04543188|591761467|FG004|Phase 1a|Other (Death)|1|||
163833782|NCT04543188|591761468|FG005|Phase 1a|Other (Death)|0|||
163833783|NCT04543188|591761469|FG006|Phase 1a|Other (Death)|0|||
163833784|NCT04543188|591761470|FG007|Phase 1a|Other (Death)|0|||
163833785|NCT04543188|591761471|FG008|Phase 1a|Other (Death)|0|||
163833786|NCT04543188|591761472|FG009|Phase 1a|Other (Death)|1|||
163833787|NCT04543188|591761473|FG010|Phase 1a|Other (Death)|0|||
163833788|NCT04543188|591761474|FG011|Phase 1a|Other (Death)|0|||
163833789|NCT04543188|591761475|FG012|Phase 1a|Other (Death)|0|||
163833790|NCT04543188|591761476|FG013|Phase 1a|Other (Death)|0|||
163833791|NCT04543188|591761477|FG014|Phase 1a|Other (Death)|0|||
163833792|NCT04543188|591761463|FG000|Phase 1a|Lost to Follow-up|0|||
163833793|NCT04543188|591761464|FG001|Phase 1a|Lost to Follow-up|0|||
163833794|NCT04543188|591761465|FG002|Phase 1a|Lost to Follow-up|0|||
163833795|NCT04543188|591761466|FG003|Phase 1a|Lost to Follow-up|0|||
163833796|NCT04543188|591761467|FG004|Phase 1a|Lost to Follow-up|0|||
163833797|NCT04543188|591761468|FG005|Phase 1a|Lost to Follow-up|0|||
163833798|NCT04543188|591761469|FG006|Phase 1a|Lost to Follow-up|0|||
163833799|NCT04543188|591761470|FG007|Phase 1a|Lost to Follow-up|0|||
163833800|NCT04543188|591761471|FG008|Phase 1a|Lost to Follow-up|0|||
163833801|NCT04543188|591761472|FG009|Phase 1a|Lost to Follow-up|0|||
163833802|NCT04543188|591761473|FG010|Phase 1a|Lost to Follow-up|1|||
163833803|NCT04543188|591761474|FG011|Phase 1a|Lost to Follow-up|0|||
163833804|NCT04543188|591761475|FG012|Phase 1a|Lost to Follow-up|0|||
163833805|NCT04543188|591761476|FG013|Phase 1a|Lost to Follow-up|0|||
163833806|NCT04543188|591761477|FG014|Phase 1a|Lost to Follow-up|0|||
163833807|NCT04543188|591761463|FG000|Phase 1a|Progressive Disease|2|||
163833808|NCT04543188|591761464|FG001|Phase 1a|Progressive Disease|2|||
163833809|NCT04543188|591761465|FG002|Phase 1a|Progressive Disease|3|||
163833810|NCT04543188|591761466|FG003|Phase 1a|Progressive Disease|1|||
163833811|NCT04543188|591761467|FG004|Phase 1a|Progressive Disease|4|||
163833812|NCT04543188|591761468|FG005|Phase 1a|Progressive Disease|2|||
163833813|NCT04543188|591761469|FG006|Phase 1a|Progressive Disease|3|||
163833814|NCT04543188|591761470|FG007|Phase 1a|Progressive Disease|4|||
163833815|NCT04543188|591761471|FG008|Phase 1a|Progressive Disease|1|||
163833816|NCT04543188|591761472|FG009|Phase 1a|Progressive Disease|0|||
163833817|NCT04543188|591761473|FG010|Phase 1a|Progressive Disease|4|||
163833818|NCT04543188|591761474|FG011|Phase 1a|Progressive Disease|0|||
163833819|NCT04543188|591761475|FG012|Phase 1a|Progressive Disease|0|||
163833820|NCT04543188|591761476|FG013|Phase 1a|Progressive Disease|0|||
163833821|NCT04543188|591761477|FG014|Phase 1a|Progressive Disease|0|||
163833822|NCT04543188|591761463|FG000|Phase 1a|Study terminated by sponsor|0|||
163833823|NCT04543188|591761464|FG001|Phase 1a|Study terminated by sponsor|0|||
163833824|NCT04543188|591761465|FG002|Phase 1a|Study terminated by sponsor|0|||
163833825|NCT04543188|591761466|FG003|Phase 1a|Study terminated by sponsor|0|||
164035336|NCT02657434|592488092|FG001|Overall Study|Withdrawal by Subject|17|||
163833826|NCT04543188|591761467|FG004|Phase 1a|Study terminated by sponsor|1|||
163833827|NCT04543188|591761468|FG005|Phase 1a|Study terminated by sponsor|0|||
163833828|NCT04543188|591761469|FG006|Phase 1a|Study terminated by sponsor|0|||
163833829|NCT04543188|591761470|FG007|Phase 1a|Study terminated by sponsor|0|||
163833830|NCT04543188|591761471|FG008|Phase 1a|Study terminated by sponsor|0|||
163833831|NCT04543188|591761472|FG009|Phase 1a|Study terminated by sponsor|0|||
163833832|NCT04543188|591761473|FG010|Phase 1a|Study terminated by sponsor|1|||
163833833|NCT04543188|591761474|FG011|Phase 1a|Study terminated by sponsor|0|||
163833834|NCT04543188|591761475|FG012|Phase 1a|Study terminated by sponsor|0|||
163833835|NCT04543188|591761476|FG013|Phase 1a|Study terminated by sponsor|0|||
163833836|NCT04543188|591761477|FG014|Phase 1a|Study terminated by sponsor|0|||
164035337|NCT02657434|592488091|FG000|Overall Study|Protocol Violation|1|||
164035338|NCT02657434|592488092|FG001|Overall Study|Protocol Violation|0|||
164098174|NCT02457520|592725043|FG000|Active Treatment Phase|Physician Decision|1|||
163833837|NCT04543188|591761463|FG000|Phase 1a|Withdrawal by Subject|0|||
163833838|NCT04543188|591761464|FG001|Phase 1a|Withdrawal by Subject|0|||
163833839|NCT04543188|591761465|FG002|Phase 1a|Withdrawal by Subject|0|||
163833840|NCT04543188|591761466|FG003|Phase 1a|Withdrawal by Subject|0|||
163833841|NCT04543188|591761467|FG004|Phase 1a|Withdrawal by Subject|3|||
163833842|NCT04543188|591761468|FG005|Phase 1a|Withdrawal by Subject|0|||
163833843|NCT04543188|591761469|FG006|Phase 1a|Withdrawal by Subject|0|||
163833844|NCT04543188|591761470|FG007|Phase 1a|Withdrawal by Subject|0|||
163833845|NCT04543188|591761471|FG008|Phase 1a|Withdrawal by Subject|1|||
163833846|NCT04543188|591761472|FG009|Phase 1a|Withdrawal by Subject|1|||
163833847|NCT04543188|591761473|FG010|Phase 1a|Withdrawal by Subject|2|||
163833848|NCT04543188|591761474|FG011|Phase 1a|Withdrawal by Subject|0|||
163833849|NCT04543188|591761475|FG012|Phase 1a|Withdrawal by Subject|0|||
163833850|NCT04543188|591761476|FG013|Phase 1a|Withdrawal by Subject|0|||
163833851|NCT04543188|591761477|FG014|Phase 1a|Withdrawal by Subject|0|||
163833852|NCT04543188|591761463|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
163833853|NCT04543188|591761464|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
163833854|NCT04543188|591761465|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
163833855|NCT04543188|591761466|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
163833856|NCT04543188|591761467|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
163833857|NCT04543188|591761468|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
163833858|NCT04543188|591761469|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
163833859|NCT04543188|591761470|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
163833860|NCT04543188|591761471|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
163833861|NCT04543188|591761472|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
163833862|NCT04543188|591761473|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
163833863|NCT04543188|591761474|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
163833864|NCT04543188|591761475|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
163833865|NCT04543188|591761476|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
163833866|NCT04543188|591761477|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
163833867|NCT04543188|591761463|FG000|Phase 1a|Other|0|||
163833868|NCT04543188|591761464|FG001|Phase 1a|Other|0|||
163833869|NCT04543188|591761465|FG002|Phase 1a|Other|0|||
163833870|NCT04543188|591761466|FG003|Phase 1a|Other|0|||
163833871|NCT04543188|591761467|FG004|Phase 1a|Other|0|||
163833872|NCT04543188|591761468|FG005|Phase 1a|Other|0|||
163833873|NCT04543188|591761469|FG006|Phase 1a|Other|0|||
163833874|NCT04543188|591761470|FG007|Phase 1a|Other|0|||
163833875|NCT04543188|591761471|FG008|Phase 1a|Other|0|||
163833876|NCT04543188|591761472|FG009|Phase 1a|Other|1|||
163833877|NCT04543188|591761473|FG010|Phase 1a|Other|0|||
163833878|NCT04543188|591761474|FG011|Phase 1a|Other|0|||
163833879|NCT04543188|591761475|FG012|Phase 1a|Other|0|||
163833880|NCT04543188|591761476|FG013|Phase 1a|Other|0|||
163833881|NCT04543188|591761477|FG014|Phase 1a|Other|0|||
163833882|NCT04543188|591761463|FG000|Phase 1b|Adverse Event|0|||
163833883|NCT04543188|591761464|FG001|Phase 1b|Adverse Event|0|||
163833884|NCT04543188|591761465|FG002|Phase 1b|Adverse Event|0|||
163833885|NCT04543188|591761466|FG003|Phase 1b|Adverse Event|0|||
163833886|NCT04543188|591761467|FG004|Phase 1b|Adverse Event|0|||
163833887|NCT04543188|591761468|FG005|Phase 1b|Adverse Event|0|||
163833888|NCT04543188|591761469|FG006|Phase 1b|Adverse Event|0|||
163833889|NCT04543188|591761470|FG007|Phase 1b|Adverse Event|0|||
163833890|NCT04543188|591761471|FG008|Phase 1b|Adverse Event|0|||
163833891|NCT04543188|591761472|FG009|Phase 1b|Adverse Event|0|||
163833892|NCT04543188|591761473|FG010|Phase 1b|Adverse Event|0|||
163833893|NCT04543188|591761474|FG011|Phase 1b|Adverse Event|0|||
163833894|NCT04543188|591761475|FG012|Phase 1b|Adverse Event|0|||
163833895|NCT04543188|591761476|FG013|Phase 1b|Adverse Event|0|||
163833896|NCT04543188|591761477|FG014|Phase 1b|Adverse Event|2|||
163833897|NCT04543188|591761463|FG000|Phase 1b|Other (Death)|0|||
163833898|NCT04543188|591761464|FG001|Phase 1b|Other (Death)|0|||
163833899|NCT04543188|591761465|FG002|Phase 1b|Other (Death)|0|||
163833900|NCT04543188|591761466|FG003|Phase 1b|Other (Death)|0|||
163833901|NCT04543188|591761467|FG004|Phase 1b|Other (Death)|0|||
163833902|NCT04543188|591761468|FG005|Phase 1b|Other (Death)|0|||
163833903|NCT04543188|591761469|FG006|Phase 1b|Other (Death)|0|||
163833904|NCT04543188|591761470|FG007|Phase 1b|Other (Death)|0|||
163833905|NCT04543188|591761471|FG008|Phase 1b|Other (Death)|0|||
163833906|NCT04543188|591761472|FG009|Phase 1b|Other (Death)|0|||
163833907|NCT04543188|591761473|FG010|Phase 1b|Other (Death)|0|||
163833908|NCT04543188|591761474|FG011|Phase 1b|Other (Death)|0|||
163833909|NCT04543188|591761475|FG012|Phase 1b|Other (Death)|1|||
163833910|NCT04543188|591761476|FG013|Phase 1b|Other (Death)|0|||
163833911|NCT04543188|591761477|FG014|Phase 1b|Other (Death)|1|||
163833912|NCT04543188|591761463|FG000|Phase 1b|Progressive Disease|0|||
163833913|NCT04543188|591761464|FG001|Phase 1b|Progressive Disease|0|||
163833914|NCT04543188|591761465|FG002|Phase 1b|Progressive Disease|0|||
163833915|NCT04543188|591761466|FG003|Phase 1b|Progressive Disease|0|||
163833916|NCT04543188|591761467|FG004|Phase 1b|Progressive Disease|0|||
164035339|NCT02657434|592488091|FG000|Overall Study|Physician Decision|0|||
164035340|NCT02657434|592488092|FG001|Overall Study|Physician Decision|1|||
164035341|NCT00608881|592488093|FG000|Overall Study|Death|22|||
164035342|NCT00608881|592488094|FG001|Overall Study|Death|13|||
164035343|NCT00608881|592488093|FG000|Overall Study|Adverse Event|5|||
164035344|NCT00608881|592488094|FG001|Overall Study|Adverse Event|3|||
164035345|NCT00608881|592488093|FG000|Overall Study|Lost to Follow-up|28|||
164035346|NCT00608881|592488094|FG001|Overall Study|Lost to Follow-up|14|||
164035347|NCT00608881|592488093|FG000|Overall Study|Withdrawal by Subject|18|||
164035348|NCT00608881|592488094|FG001|Overall Study|Withdrawal by Subject|29|||
164035349|NCT00608881|592488093|FG000|Overall Study|Physician Decision|5|||
164035350|NCT00608881|592488094|FG001|Overall Study|Physician Decision|5|||
164035351|NCT00608881|592488093|FG000|Overall Study|Institutionalized|1|||
164035352|NCT00608881|592488094|FG001|Overall Study|Institutionalized|2|||
163928783|NCT02485899|592109854|FG001|Overall Study|Withdrawal by Subject|0|||
163928784|NCT02485899|592109853|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
163928785|NCT02485899|592109854|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
163928786|NCT03713320|592109855|FG000|Randomized Period|Adverse Event|1|||
163928787|NCT03713320|592109856|FG001|Randomized Period|Adverse Event|5|||
163928788|NCT03713320|592109857|FG002|Randomized Period|Adverse Event|0|||
163928789|NCT03713320|592109855|FG000|Randomized Period|Physician Decision|1|||
163928790|NCT03713320|592109856|FG001|Randomized Period|Physician Decision|1|||
163928791|NCT03713320|592109857|FG002|Randomized Period|Physician Decision|0|||
163928792|NCT03713320|592109855|FG000|Randomized Period|Withdrawal by Subject|4|||
163928793|NCT03713320|592109856|FG001|Randomized Period|Withdrawal by Subject|0|||
163928794|NCT03713320|592109857|FG002|Randomized Period|Withdrawal by Subject|0|||
163928795|NCT03713320|592109855|FG000|Randomized Period|Participant decision|3|||
163928796|NCT03713320|592109856|FG001|Randomized Period|Participant decision|1|||
163928797|NCT03713320|592109857|FG002|Randomized Period|Participant decision|0|||
163928798|NCT03713320|592109855|FG000|Randomized Period|Study terminated by sponsor|6|||
163928799|NCT03713320|592109856|FG001|Randomized Period|Study terminated by sponsor|3|||
163928800|NCT03713320|592109857|FG002|Randomized Period|Study terminated by sponsor|0|||
163928801|NCT03713320|592109855|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
163928802|NCT03713320|592109856|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
163928803|NCT03713320|592109857|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
163928804|NCT03713320|592109855|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
163928805|NCT03713320|592109856|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
163928806|NCT03713320|592109857|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
163928807|NCT02725528|592109858|FG000|Overall Study|Lost to Follow-up|1|||
163928808|NCT02725528|592109859|FG001|Overall Study|Lost to Follow-up|4|||
163928809|NCT02725528|592109858|FG000|Overall Study|Withdrawal by Subject|0|||
163928810|NCT02725528|592109859|FG001|Overall Study|Withdrawal by Subject|1|||
163928811|NCT02706847|592109860|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
163928812|NCT02706847|592109861|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
163928813|NCT02706847|592109862|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
163928814|NCT02706847|592109863|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
163928815|NCT02706847|592109860|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
163928816|NCT02706847|592109861|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
163928817|NCT02706847|592109862|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
163928818|NCT02706847|592109863|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
163928819|NCT02706847|592109860|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
163928820|NCT02706847|592109861|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
163928821|NCT02706847|592109862|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
163928822|NCT02706847|592109863|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
163928823|NCT02706847|592109860|FG000|Period 1: Day 1 to Week 12|Other|4|||
163928824|NCT02706847|592109861|FG001|Period 1: Day 1 to Week 12|Other|4|||
164035353|NCT00510484|592488096|FG000|Wash-out Period|Adverse Event|0|||
164035354|NCT00510484|592488097|FG001|Wash-out Period|Adverse Event|1|||
164035355|NCT01590212|592488098|FG000|Overall Study|Withdrawal by Subject|2|||
163928825|NCT02706847|592109862|FG002|Period 1: Day 1 to Week 12|Other|2|||
164035356|NCT01590212|592488099|FG001|Overall Study|Withdrawal by Subject|2|||
164035357|NCT01590212|592488100|FG002|Overall Study|Withdrawal by Subject|2|||
164035358|NCT01590212|592488098|FG000|Overall Study|Lost to Follow-up|1|||
164035359|NCT01590212|592488099|FG001|Overall Study|Lost to Follow-up|2|||
164035360|NCT01590212|592488100|FG002|Overall Study|Lost to Follow-up|3|||
163928826|NCT02706847|592109863|FG003|Period 1: Day 1 to Week 12|Other|2|||
163928827|NCT02706847|592109860|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
164035361|NCT02533401|592488101|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
164035362|NCT02533401|592488101|FG000|Overall Study|Death|5|||
164035363|NCT02533401|592488101|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
164035364|NCT02533401|592488101|FG000|Overall Study|Lost to Follow-up|1|||
163928828|NCT02706847|592109861|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
163928829|NCT02706847|592109862|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
163928830|NCT02706847|592109863|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
164035365|NCT02533401|592488101|FG000|Overall Study|Violation of Selection Criteria|1|||
163928831|NCT02706847|592109860|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
163928832|NCT02706847|592109861|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
163928833|NCT02706847|592109862|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
163928834|NCT02706847|592109863|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
163928835|NCT02706847|592109860|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
163928836|NCT02706847|592109861|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
163928837|NCT02706847|592109862|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
163928838|NCT02706847|592109863|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
163928839|NCT02706847|592109860|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
163928840|NCT02706847|592109861|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
163928841|NCT02706847|592109862|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
163928842|NCT02706847|592109863|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
163928843|NCT02706847|592109860|FG000|Period 1: Week 12 to Week 24|Other|1|||
163928844|NCT02706847|592109861|FG001|Period 1: Week 12 to Week 24|Other|0|||
163928845|NCT02706847|592109862|FG002|Period 1: Week 12 to Week 24|Other|1|||
163928846|NCT02706847|592109863|FG003|Period 1: Week 12 to Week 24|Other|4|||
163928847|NCT02706847|592109860|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
163928848|NCT02706847|592109861|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
163928849|NCT02706847|592109862|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
163928850|NCT02706847|592109863|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
163928851|NCT02706847|592109860|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
163928852|NCT02706847|592109861|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
163928853|NCT02706847|592109862|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
163928854|NCT02706847|592109863|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
163928855|NCT02706847|592109860|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
163928856|NCT02706847|592109861|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
163928857|NCT02706847|592109862|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
163928858|NCT02706847|592109863|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
163928859|NCT02706847|592109860|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
163928860|NCT02706847|592109861|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
163928861|NCT02706847|592109862|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
163928862|NCT02706847|592109863|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
163928863|NCT02706847|592109860|FG000|Period 2: Week 24 to Week 260|Other|8|||
163928864|NCT02706847|592109861|FG001|Period 2: Week 24 to Week 260|Other|5|||
163928865|NCT02706847|592109862|FG002|Period 2: Week 24 to Week 260|Other|15|||
163928866|NCT02706847|592109863|FG003|Period 2: Week 24 to Week 260|Other|15|||
163928867|NCT01174264|592109864|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
163928868|NCT01174264|592109865|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
163928869|NCT01174264|592109866|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
163928870|NCT01174264|592109864|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
163928871|NCT01174264|592109865|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
163928872|NCT01174264|592109866|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
163928873|NCT01174264|592109864|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
163928874|NCT01174264|592109865|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
163928875|NCT01174264|592109866|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
163928876|NCT03432390|592109867|FG000|Apnea Period|Protocol Violation|2|||
163928877|NCT03432390|592109868|FG001|Apnea Period|Protocol Violation|2|||
163928878|NCT01774305|592109871|FG000|Overall Study|Physician Decision|1|||
163928879|NCT01774305|592109872|FG001|Overall Study|Physician Decision|0|||
163928880|NCT03772613|592109879|FG000|Overall Study|Lost to Follow-up|0|||
163928881|NCT03772613|592109880|FG001|Overall Study|Lost to Follow-up|1|||
163928882|NCT03772613|592109881|FG002|Overall Study|Lost to Follow-up|1|||
163928883|NCT01185171|592109884|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
163928884|NCT01185171|592109884|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
163928885|NCT01185171|592109884|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
163928886|NCT01185171|592109884|FG000|Maintenance|Elevated liver transaminases|3|||
163928887|NCT01185171|592109884|FG000|Maintenance|Rush|2|||
163928888|NCT01185171|592109884|FG000|Maintenance|Diarrhea|1|||
164035366|NCT01106391|592488104|FG000|Overall Study|Death|12|||
164035367|NCT01106391|592488104|FG000|Overall Study|Withdrawal by Subject|7|||
164035368|NCT04897594|592488107|FG000|Overall Study|Lost to Follow-up|0|||
164035369|NCT04897594|592488108|FG001|Overall Study|Lost to Follow-up|1|||
164035370|NCT04897594|592488109|FG002|Overall Study|Lost to Follow-up|1|||
163928889|NCT01185171|592109884|FG000|Maintenance|Xerostomia|1|||
163928890|NCT01185171|592109884|FG000|Maintenance|Nausea|1|||
163928891|NCT01185171|592109884|FG000|Maintenance|Comorbid Illness|2|||
163928892|NCT01185171|592109884|FG000|Maintenance|Withdrawal by Subject|1|||
163928893|NCT01185171|592109884|FG000|Maintenance|Disease Recurrence|1|||
163928894|NCT01482429|592109886|FG000|Care Usual|Protocol Violation|0|||
163928895|NCT01482429|592109887|FG001|Care Usual|Protocol Violation|172|||
163928896|NCT01482429|592109886|FG000|Care Usual|Lost to Follow-up|0|||
163928897|NCT01482429|592109887|FG001|Care Usual|Lost to Follow-up|1|||
163928898|NCT01482429|592109886|FG000|Protocol|Protocol Violation|275|||
164035371|NCT04897594|592488107|FG000|Overall Study|Sponsor Decision|0|||
164035372|NCT04897594|592488108|FG001|Overall Study|Sponsor Decision|0|||
164035373|NCT04897594|592488109|FG002|Overall Study|Sponsor Decision|1|||
164035374|NCT04897594|592488107|FG000|Overall Study|Withdrawal by Subject|1|||
164035375|NCT04897594|592488108|FG001|Overall Study|Withdrawal by Subject|0|||
164035376|NCT04897594|592488109|FG002|Overall Study|Withdrawal by Subject|1|||
164035377|NCT02147691|592488112|FG000|Overall Study|Withdrawal by Subject|2|||
163833917|NCT04543188|591761468|FG005|Phase 1b|Progressive Disease|0|||
163833918|NCT04543188|591761469|FG006|Phase 1b|Progressive Disease|0|||
163833919|NCT04543188|591761470|FG007|Phase 1b|Progressive Disease|0|||
163833920|NCT04543188|591761471|FG008|Phase 1b|Progressive Disease|0|||
163833921|NCT04543188|591761472|FG009|Phase 1b|Progressive Disease|0|||
163833922|NCT04543188|591761473|FG010|Phase 1b|Progressive Disease|0|||
164035378|NCT02147691|592488113|FG001|Overall Study|Withdrawal by Subject|0|||
164035379|NCT02147691|592488112|FG000|Overall Study|Adverse Event|2|||
163833923|NCT04543188|591761474|FG011|Phase 1b|Progressive Disease|0|||
163833924|NCT04543188|591761475|FG012|Phase 1b|Progressive Disease|2|||
163833925|NCT04543188|591761476|FG013|Phase 1b|Progressive Disease|1|||
163833926|NCT04543188|591761477|FG014|Phase 1b|Progressive Disease|5|||
163833927|NCT04543188|591761463|FG000|Phase 1b|Study Terminated By Sponsor|0|||
163833928|NCT04543188|591761464|FG001|Phase 1b|Study Terminated By Sponsor|0|||
163833929|NCT04543188|591761465|FG002|Phase 1b|Study Terminated By Sponsor|0|||
163833930|NCT04543188|591761466|FG003|Phase 1b|Study Terminated By Sponsor|0|||
163833931|NCT04543188|591761467|FG004|Phase 1b|Study Terminated By Sponsor|0|||
163833932|NCT04543188|591761468|FG005|Phase 1b|Study Terminated By Sponsor|0|||
163833933|NCT04543188|591761469|FG006|Phase 1b|Study Terminated By Sponsor|0|||
163833934|NCT04543188|591761470|FG007|Phase 1b|Study Terminated By Sponsor|0|||
163833935|NCT04543188|591761471|FG008|Phase 1b|Study Terminated By Sponsor|0|||
163833936|NCT04543188|591761472|FG009|Phase 1b|Study Terminated By Sponsor|0|||
163833937|NCT04543188|591761473|FG010|Phase 1b|Study Terminated By Sponsor|0|||
163833938|NCT04543188|591761474|FG011|Phase 1b|Study Terminated By Sponsor|1|||
163833939|NCT04543188|591761475|FG012|Phase 1b|Study Terminated By Sponsor|1|||
163833940|NCT04543188|591761476|FG013|Phase 1b|Study Terminated By Sponsor|0|||
163833941|NCT04543188|591761477|FG014|Phase 1b|Study Terminated By Sponsor|1|||
163833942|NCT04543188|591761463|FG000|Phase 1b|Withdrawal by Subject|0|||
163833943|NCT04543188|591761464|FG001|Phase 1b|Withdrawal by Subject|0|||
163833944|NCT04543188|591761465|FG002|Phase 1b|Withdrawal by Subject|0|||
163833945|NCT04543188|591761466|FG003|Phase 1b|Withdrawal by Subject|0|||
163833946|NCT04543188|591761467|FG004|Phase 1b|Withdrawal by Subject|0|||
163833947|NCT04543188|591761468|FG005|Phase 1b|Withdrawal by Subject|0|||
163833948|NCT04543188|591761469|FG006|Phase 1b|Withdrawal by Subject|0|||
163833949|NCT04543188|591761470|FG007|Phase 1b|Withdrawal by Subject|0|||
163833950|NCT04543188|591761471|FG008|Phase 1b|Withdrawal by Subject|0|||
163833951|NCT04543188|591761472|FG009|Phase 1b|Withdrawal by Subject|0|||
163833952|NCT04543188|591761473|FG010|Phase 1b|Withdrawal by Subject|0|||
163833953|NCT04543188|591761474|FG011|Phase 1b|Withdrawal by Subject|0|||
163833954|NCT04543188|591761475|FG012|Phase 1b|Withdrawal by Subject|0|||
163833955|NCT04543188|591761476|FG013|Phase 1b|Withdrawal by Subject|0|||
163833956|NCT04543188|591761477|FG014|Phase 1b|Withdrawal by Subject|2|||
163833957|NCT03815019|591761478|FG000|Overall Study|Withdrawal by Subject|6|||
163833958|NCT03815019|591761479|FG001|Overall Study|Withdrawal by Subject|8|||
163833959|NCT05398796|591761480|FG000|Overall Study|Participant moved from the area|0|||
163833960|NCT05398796|591761481|FG001|Overall Study|Participant moved from the area|1|||
163833961|NCT05398796|591761482|FG002|Overall Study|Participant moved from the area|0|||
163833962|NCT05398796|591761483|FG003|Overall Study|Participant moved from the area|0|||
163833963|NCT04270747|591761485|FG000|Through Week 16|Adverse Event|1|||
163833964|NCT04270747|591761486|FG001|Through Week 16|Adverse Event|2|||
163833965|NCT04270747|591761487|FG002|Through Week 16|Adverse Event|0|||
163833966|NCT04270747|591761485|FG000|Through Week 16|Death|0|||
163833967|NCT04270747|591761486|FG001|Through Week 16|Death|2|||
163833968|NCT04270747|591761487|FG002|Through Week 16|Death|0|||
163833969|NCT04270747|591761485|FG000|Through Week 16|Consent Withdrawn|3|||
163833970|NCT04270747|591761486|FG001|Through Week 16|Consent Withdrawn|3|||
163833971|NCT04270747|591761487|FG002|Through Week 16|Consent Withdrawn|0|||
163833972|NCT04270747|591761485|FG000|Through Week 16|Physician Decision|1|||
163833973|NCT04270747|591761486|FG001|Through Week 16|Physician Decision|1|||
163833974|NCT04270747|591761487|FG002|Through Week 16|Physician Decision|0|||
163833975|NCT04270747|591761485|FG000|Through Week 16|Lost to Follow-up|2|||
163833976|NCT04270747|591761486|FG001|Through Week 16|Lost to Follow-up|0|||
163833977|NCT04270747|591761487|FG002|Through Week 16|Lost to Follow-up|0|||
163833978|NCT04270747|591761485|FG000|Through Week 16|Protocol Violation|1|||
163833979|NCT04270747|591761486|FG001|Through Week 16|Protocol Violation|2|||
164035380|NCT02147691|592488113|FG001|Overall Study|Adverse Event|0|||
163833980|NCT04270747|591761487|FG002|Through Week 16|Protocol Violation|0|||
163833981|NCT04270747|591761485|FG000|Through Week 16|Protocol Specified Criteria|6|||
163833982|NCT04270747|591761486|FG001|Through Week 16|Protocol Specified Criteria|7|||
163833983|NCT04270747|591761487|FG002|Through Week 16|Protocol Specified Criteria|0|||
163833984|NCT04270747|591761485|FG000|Through Week 16|Miscellaneous|1|||
163928899|NCT01482429|592109887|FG001|Protocol|Protocol Violation|0|||
163928900|NCT01502371|592109895|FG000|Overall Study|Withdrawal by Subject|1|||
163928901|NCT01502371|592109896|FG001|Overall Study|Withdrawal by Subject|2|||
163928902|NCT01502371|592109897|FG002|Overall Study|Withdrawal by Subject|1|||
163928903|NCT01502371|592109898|FG003|Overall Study|Withdrawal by Subject|1|||
163928904|NCT01502371|592109899|FG004|Overall Study|Withdrawal by Subject|1|||
163928905|NCT01502371|592109895|FG000|Overall Study|Adverse Event|2|||
163928906|NCT01502371|592109896|FG001|Overall Study|Adverse Event|1|||
163928907|NCT01502371|592109897|FG002|Overall Study|Adverse Event|0|||
163928908|NCT01502371|592109898|FG003|Overall Study|Adverse Event|4|||
163928909|NCT01502371|592109899|FG004|Overall Study|Adverse Event|3|||
163928910|NCT01502371|592109895|FG000|Overall Study|Treatment Failure|22|||
163928911|NCT01502371|592109896|FG001|Overall Study|Treatment Failure|20|||
163928912|NCT01502371|592109897|FG002|Overall Study|Treatment Failure|12|||
163928913|NCT01502371|592109898|FG003|Overall Study|Treatment Failure|19|||
163928914|NCT01502371|592109899|FG004|Overall Study|Treatment Failure|30|||
163928915|NCT01502371|592109895|FG000|Overall Study|Lack of Efficacy|3|||
163928916|NCT01502371|592109896|FG001|Overall Study|Lack of Efficacy|3|||
163928917|NCT01502371|592109897|FG002|Overall Study|Lack of Efficacy|2|||
163928918|NCT01502371|592109898|FG003|Overall Study|Lack of Efficacy|2|||
163928919|NCT01502371|592109899|FG004|Overall Study|Lack of Efficacy|4|||
163928920|NCT01502371|592109895|FG000|Overall Study|Physician Decision|3|||
163928921|NCT01502371|592109896|FG001|Overall Study|Physician Decision|0|||
163928922|NCT01502371|592109897|FG002|Overall Study|Physician Decision|0|||
163928923|NCT01502371|592109898|FG003|Overall Study|Physician Decision|0|||
163928924|NCT01502371|592109899|FG004|Overall Study|Physician Decision|1|||
163928925|NCT01502371|592109895|FG000|Overall Study|Noncompliance with Study Drug|0|||
163928926|NCT01502371|592109896|FG001|Overall Study|Noncompliance with Study Drug|0|||
163928927|NCT01502371|592109897|FG002|Overall Study|Noncompliance with Study Drug|1|||
163928928|NCT01502371|592109898|FG003|Overall Study|Noncompliance with Study Drug|2|||
163928929|NCT01502371|592109899|FG004|Overall Study|Noncompliance with Study Drug|1|||
163928930|NCT01502371|592109895|FG000|Overall Study|Technical Problems|1|||
163928931|NCT01502371|592109896|FG001|Overall Study|Technical Problems|0|||
163928932|NCT01502371|592109897|FG002|Overall Study|Technical Problems|2|||
163928933|NCT01502371|592109898|FG003|Overall Study|Technical Problems|4|||
163928934|NCT01502371|592109899|FG004|Overall Study|Technical Problems|1|||
163928935|NCT01502371|592109895|FG000|Overall Study|Protocol Violation|9|||
163928936|NCT01502371|592109896|FG001|Overall Study|Protocol Violation|5|||
163928937|NCT01502371|592109897|FG002|Overall Study|Protocol Violation|6|||
163928938|NCT01502371|592109898|FG003|Overall Study|Protocol Violation|5|||
163928939|NCT01502371|592109899|FG004|Overall Study|Protocol Violation|10|||
163928940|NCT01502371|592109895|FG000|Overall Study|Excluded Medication|0|||
163928941|NCT01502371|592109896|FG001|Overall Study|Excluded Medication|1|||
163928942|NCT01502371|592109897|FG002|Overall Study|Excluded Medication|1|||
163928943|NCT01502371|592109898|FG003|Overall Study|Excluded Medication|0|||
163928944|NCT01502371|592109899|FG004|Overall Study|Excluded Medication|1|||
163928945|NCT03325608|592109900|FG000|Overall Study|Lost to Follow-up|23|||
163928946|NCT03325608|592109901|FG001|Overall Study|Lost to Follow-up|23|||
163928947|NCT03325608|592109902|FG002|Overall Study|Lost to Follow-up|30|||
163928948|NCT03325608|592109903|FG003|Overall Study|Lost to Follow-up|30|||
163928949|NCT03325608|592109900|FG000|Overall Study|Death of Caregiver|0|||
163928950|NCT03325608|592109901|FG001|Overall Study|Death of Caregiver|0|||
163928951|NCT03325608|592109902|FG002|Overall Study|Death of Caregiver|2|||
163928952|NCT03325608|592109903|FG003|Overall Study|Death of Caregiver|2|||
163928953|NCT03325608|592109900|FG000|Overall Study|Death of Care Recipient|34|||
163928954|NCT03325608|592109901|FG001|Overall Study|Death of Care Recipient|34|||
163928955|NCT03325608|592109902|FG002|Overall Study|Death of Care Recipient|28|||
163928956|NCT03325608|592109903|FG003|Overall Study|Death of Care Recipient|28|||
163928957|NCT03325608|592109900|FG000|Overall Study|Withdrawal by Subject|49|||
163928958|NCT03325608|592109901|FG001|Overall Study|Withdrawal by Subject|49|||
163928959|NCT03325608|592109902|FG002|Overall Study|Withdrawal by Subject|35|||
163928960|NCT03325608|592109903|FG003|Overall Study|Withdrawal by Subject|35|||
163928961|NCT03325608|592109900|FG000|Overall Study|Ineligible|7|||
163928962|NCT03325608|592109901|FG001|Overall Study|Ineligible|7|||
163928963|NCT03325608|592109902|FG002|Overall Study|Ineligible|5|||
163928964|NCT03325608|592109903|FG003|Overall Study|Ineligible|5|||
163928965|NCT01639742|592111858|FG000|Overall Study|Study Ongoing|17|||
163928966|NCT01639742|592111858|FG000|Overall Study|Lost to Follow-up|1|||
163928967|NCT01986114|592111859|FG000|Overall Study|Adverse Event|59|||
163928968|NCT01986114|592111859|FG000|Overall Study|Lack of Efficacy|23|||
163928969|NCT01986114|592111859|FG000|Overall Study|Withdrawal by Subject|58|||
163928970|NCT01986114|592111859|FG000|Overall Study|Noncompliance|3|||
163928971|NCT01986114|592111859|FG000|Overall Study|Protocol Violation|1|||
163928972|NCT01986114|592111859|FG000|Overall Study|Lost to Follow-up|5|||
163928973|NCT01986114|592111859|FG000|Overall Study|Other reason|7|||
163928974|NCT04411186|592111860|FG000|Overall Study|Withdrawn due to protocol violation|0|||
163928975|NCT04411186|592111861|FG001|Overall Study|Withdrawn due to protocol violation|1|||
163928976|NCT02172911|592111862|FG000|Overall Study|Serious Adverse Event|0|||
163928977|NCT02172911|592111863|FG001|Overall Study|Serious Adverse Event|1|||
163928978|NCT02172911|592111862|FG000|Overall Study|Progression of Disease|0|||
163928979|NCT02172911|592111863|FG001|Overall Study|Progression of Disease|1|||
163928980|NCT02172911|592111862|FG000|Overall Study|Loss of insurance coverage|1|||
163928981|NCT02172911|592111863|FG001|Overall Study|Loss of insurance coverage|0|||
163928982|NCT00575042|592111866|FG000|Overall Study|Adverse Event|2|||
163928983|NCT00575042|592111866|FG000|Overall Study|Lost to Follow-up|1|||
163928984|NCT04795336|592111869|FG000|Overall Study|Withdrawal by Subject|3|||
163928985|NCT04795336|592111870|FG001|Overall Study|Withdrawal by Subject|4|||
163928986|NCT04795336|592111871|FG002|Overall Study|Withdrawal by Subject|3|||
163928987|NCT04795336|592111872|FG003|Overall Study|Withdrawal by Subject|12|||
163928988|NCT04795336|592111869|FG000|Overall Study|Lost study logs|0|||
163928989|NCT04795336|592111870|FG001|Overall Study|Lost study logs|1|||
163928990|NCT04795336|592111871|FG002|Overall Study|Lost study logs|0|||
163928991|NCT04795336|592111872|FG003|Overall Study|Lost study logs|2|||
163928992|NCT04795336|592111869|FG000|Overall Study|Did not take study medication|2|||
163928993|NCT04795336|592111870|FG001|Overall Study|Did not take study medication|0|||
163928994|NCT04795336|592111871|FG002|Overall Study|Did not take study medication|0|||
163928995|NCT04795336|592111872|FG003|Overall Study|Did not take study medication|0|||
163928996|NCT01266018|592111873|FG000|Overall Study|Physician Decision|1|||
163928997|NCT01266018|592111874|FG001|Overall Study|Physician Decision|0|||
163928998|NCT01266018|592111873|FG000|Overall Study|Progressive disease|0|||
163928999|NCT01266018|592111874|FG001|Overall Study|Progressive disease|1|||
163929000|NCT03167151|592111875|FG000|Overall Study|Withdrawal by Subject|1|||
163929001|NCT03167151|592111876|FG001|Overall Study|Withdrawal by Subject|0|||
163929002|NCT03167151|592111877|FG002|Overall Study|Withdrawal by Subject|0|||
163929003|NCT03167151|592111875|FG000|Overall Study|No evidence of tumour at surgery|0|||
163929004|NCT03167151|592111876|FG001|Overall Study|No evidence of tumour at surgery|1|||
163929005|NCT03167151|592111877|FG002|Overall Study|No evidence of tumour at surgery|1|||
163929006|NCT01458522|592111878|FG000|Overall Study|Withdrawal by Subject|2|||
163929007|NCT01458522|592111879|FG001|Overall Study|Withdrawal by Subject|2|||
163929008|NCT01458522|592111878|FG000|Overall Study|Physician Decision|1|||
163929009|NCT01458522|592111879|FG001|Overall Study|Physician Decision|9|||
163929010|NCT00516139|592111880|FG000|Overall Study|Adverse Event|27|||
163929011|NCT00516139|592111880|FG000|Overall Study|Lost to Follow-up|1|||
163929012|NCT00516139|592111880|FG000|Overall Study|Protocol Violation|1|||
163929013|NCT00516139|592111880|FG000|Overall Study|Withdrawal by Subject|8|||
163929014|NCT00516139|592111880|FG000|Overall Study|Lack of Efficacy|1|||
163929015|NCT00589303|592111881|FG000|Overall Study|Withdrawal by Subject|2|||
163929016|NCT00589303|592111882|FG001|Overall Study|Withdrawal by Subject|1|||
163929017|NCT00730015|592111883|FG000|Overall Study|Adverse Event|11|||
163929018|NCT00730015|592111884|FG001|Overall Study|Adverse Event|10|||
163929019|NCT00730015|592111885|FG002|Overall Study|Adverse Event|8|||
163929020|NCT00730015|592111883|FG000|Overall Study|Protocol Violation|2|||
163929021|NCT00730015|592111884|FG001|Overall Study|Protocol Violation|6|||
163929022|NCT00730015|592111885|FG002|Overall Study|Protocol Violation|4|||
163929023|NCT00730015|592111883|FG000|Overall Study|Withdrawal by Subject|12|||
163929024|NCT00730015|592111884|FG001|Overall Study|Withdrawal by Subject|12|||
163929025|NCT00730015|592111885|FG002|Overall Study|Withdrawal by Subject|8|||
163929026|NCT00730015|592111883|FG000|Overall Study|Lost to Follow-up|4|||
163929027|NCT00730015|592111884|FG001|Overall Study|Lost to Follow-up|10|||
163929028|NCT00730015|592111885|FG002|Overall Study|Lost to Follow-up|3|||
163929029|NCT00730015|592111883|FG000|Overall Study|Lack of Efficacy|1|||
163929030|NCT00730015|592111884|FG001|Overall Study|Lack of Efficacy|2|||
163929031|NCT00730015|592111885|FG002|Overall Study|Lack of Efficacy|8|||
163929032|NCT00730015|592111883|FG000|Overall Study|Other Reason|1|||
163929033|NCT00730015|592111884|FG001|Overall Study|Other Reason|0|||
163929034|NCT00730015|592111885|FG002|Overall Study|Other Reason|1|||
163929035|NCT03062449|592111887|FG000|Overall Study|Withdrawal by Subject|7|||
163929036|NCT03062449|592111888|FG001|Overall Study|Withdrawal by Subject|1|||
163929037|NCT02053610|592111890|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
163929038|NCT02053610|592111891|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
163929039|NCT02053610|592111890|FG000|Overall Study|Withdrew Consent|2|||
164035381|NCT02147691|592488112|FG000|Overall Study|Lost to Follow-up|0|||
164035382|NCT02147691|592488113|FG001|Overall Study|Lost to Follow-up|1|||
164035383|NCT01181141|592488116|FG000|Overall Study|Adverse Event|2|||
164035384|NCT01181141|592488117|FG001|Overall Study|Adverse Event|1|||
163929040|NCT02053610|592111891|FG001|Overall Study|Withdrew Consent|9|||
163929041|NCT02053610|592111890|FG000|Overall Study|Death|5|||
163929042|NCT02053610|592111891|FG001|Overall Study|Death|5|||
163929043|NCT02053610|592111890|FG000|Overall Study|Administrative/Other|1|||
163929044|NCT02053610|592111891|FG001|Overall Study|Administrative/Other|1|||
163929045|NCT02053610|592111890|FG000|Overall Study|Disease Progression|2|||
164035385|NCT01181141|592488116|FG000|Overall Study|Lack of Efficacy|1|||
164035386|NCT01181141|592488117|FG001|Overall Study|Lack of Efficacy|0|||
163929046|NCT02053610|592111891|FG001|Overall Study|Disease Progression|3|||
163929047|NCT02053610|592111890|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
163929048|NCT02053610|592111891|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
163929049|NCT02053610|592111890|FG000|Overall Study|Did not Receive Treatment|4|||
163929050|NCT02053610|592111891|FG001|Overall Study|Did not Receive Treatment|2|||
163929051|NCT02053610|592111890|FG000|Overall Study|Insufficient Therapeutic Response|1|||
163929052|NCT02053610|592111891|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163929053|NCT02053610|592111890|FG000|Overall Study|Violation of Selection Criteria|1|||
163929054|NCT02053610|592111891|FG001|Overall Study|Violation of Selection Criteria|0|||
163929055|NCT00543062|592111892|FG000|Overall Study|Withdrawal by Subject|1|||
163929056|NCT00543062|592111893|FG001|Overall Study|Withdrawal by Subject|0|||
163929057|NCT00543062|592111894|FG002|Overall Study|Withdrawal by Subject|2|||
163929058|NCT00543062|592111895|FG003|Overall Study|Withdrawal by Subject|0|||
163929059|NCT00543062|592111892|FG000|Overall Study|Adverse Event|0|||
163929060|NCT00543062|592111893|FG001|Overall Study|Adverse Event|1|||
163929061|NCT00543062|592111894|FG002|Overall Study|Adverse Event|1|||
163929062|NCT00543062|592111895|FG003|Overall Study|Adverse Event|1|||
163929063|NCT00543062|592111892|FG000|Overall Study|Protocol Violation|1|||
163929064|NCT00543062|592111893|FG001|Overall Study|Protocol Violation|0|||
163929065|NCT00543062|592111894|FG002|Overall Study|Protocol Violation|0|||
163929066|NCT00543062|592111895|FG003|Overall Study|Protocol Violation|0|||
163929067|NCT00328562|592111901|FG000|Overall Study|Disease progression|1|||
163929068|NCT04014790|592111902|FG000|Overall Study|Death|4|||
163929069|NCT04014790|592111902|FG000|Overall Study|Adverse Event|1|||
163929070|NCT04014790|592111902|FG000|Overall Study|Withdrawal by Subject|1|||
163929071|NCT03546816|592111903|FG000|Overall Study|Adverse Event|5|||
163929072|NCT03546816|592111904|FG001|Overall Study|Adverse Event|3|||
163929073|NCT03546816|592111903|FG000|Overall Study|Lack of Efficacy|2|||
163929074|NCT03546816|592111904|FG001|Overall Study|Lack of Efficacy|4|||
163929075|NCT03546816|592111903|FG000|Overall Study|Pregnancy|1|||
163929076|NCT03546816|592111904|FG001|Overall Study|Pregnancy|0|||
163929077|NCT03546816|592111903|FG000|Overall Study|Physician Decision|2|||
163929078|NCT03546816|592111904|FG001|Overall Study|Physician Decision|0|||
163929079|NCT03546816|592111903|FG000|Overall Study|Withdrawal by Subject|8|||
163929080|NCT03546816|592111904|FG001|Overall Study|Withdrawal by Subject|10|||
163929081|NCT03546816|592111903|FG000|Overall Study|Lost to Follow-up|3|||
163929082|NCT03546816|592111904|FG001|Overall Study|Lost to Follow-up|2|||
163929083|NCT01161446|592111905|FG000|Overall Study|Lost to Follow-up|18|||
163929084|NCT01161446|592111906|FG001|Overall Study|Lost to Follow-up|14|||
163929085|NCT01161446|592111905|FG000|Overall Study|Withdrawal by Subject|0|||
163929086|NCT01161446|592111906|FG001|Overall Study|Withdrawal by Subject|1|||
163929087|NCT02270671|592111907|FG000|Overall Study|Withdrawal by Subject|1|||
163929088|NCT02270671|592111908|FG001|Overall Study|Withdrawal by Subject|1|||
163929089|NCT02270671|592111907|FG000|Overall Study|Protocol Violation|0|||
163929090|NCT02270671|592111908|FG001|Overall Study|Protocol Violation|1|||
163929091|NCT02270671|592111907|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
163929092|NCT02270671|592111908|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
163929093|NCT02270671|592111907|FG000|Overall Study|Lost to Follow-up|2|||
163929094|NCT02270671|592111908|FG001|Overall Study|Lost to Follow-up|1|||
163929095|NCT03927690|592111913|FG000|Overall Study|Withdrawal by Subject|3|||
163929096|NCT03927690|592111914|FG001|Overall Study|Withdrawal by Subject|1|||
163929097|NCT03927690|592111915|FG002|Overall Study|Withdrawal by Subject|1|||
163929098|NCT03927690|592111913|FG000|Overall Study|Adverse Event|1|||
163929099|NCT03927690|592111914|FG001|Overall Study|Adverse Event|0|||
163929100|NCT03927690|592111915|FG002|Overall Study|Adverse Event|0|||
163929101|NCT03927690|592111913|FG000|Overall Study|Death|1|||
163929102|NCT03927690|592111914|FG001|Overall Study|Death|0|||
163929103|NCT03927690|592111915|FG002|Overall Study|Death|0|||
163929104|NCT03927690|592111913|FG000|Overall Study|Lost to Follow-up|2|||
163929105|NCT03927690|592111914|FG001|Overall Study|Lost to Follow-up|2|||
163929106|NCT03927690|592111915|FG002|Overall Study|Lost to Follow-up|1|||
163929107|NCT00126659|592111918|FG000|Overall Study|Adverse Event|0|||
163929108|NCT00126659|592111919|FG001|Overall Study|Adverse Event|0|||
163929109|NCT00126659|592111920|FG002|Overall Study|Adverse Event|2|||
163929110|NCT00174447|592111923|FG000|Overall Study|Adverse Event|19|||
163929111|NCT00174447|592111923|FG000|Overall Study|Withdrawal by Subject|15|||
163929112|NCT00174447|592111923|FG000|Overall Study|Protocol Violation|1|||
163929113|NCT00174447|592111923|FG000|Overall Study|Lack of Efficacy|1|||
163929114|NCT00174447|592111923|FG000|Overall Study|Administrative reason/Other|2|||
163929115|NCT00551135|592111943|FG000|Overall Study|Adverse Event|1|||
163929116|NCT00551135|592111944|FG001|Overall Study|Adverse Event|0|||
163929117|NCT00551135|592111945|FG002|Overall Study|Adverse Event|1|||
163929118|NCT00551135|592111946|FG003|Overall Study|Adverse Event|1|||
163929119|NCT00551135|592111943|FG000|Overall Study|Lost to Follow-up|0|||
163929120|NCT00551135|592111944|FG001|Overall Study|Lost to Follow-up|0|||
163929121|NCT00551135|592111945|FG002|Overall Study|Lost to Follow-up|0|||
163929122|NCT00551135|592111946|FG003|Overall Study|Lost to Follow-up|1|||
163929123|NCT00551135|592111943|FG000|Overall Study|Other|3|||
163929124|NCT00551135|592111944|FG001|Overall Study|Other|2|||
163929125|NCT00551135|592111945|FG002|Overall Study|Other|1|||
163929126|NCT00551135|592111946|FG003|Overall Study|Other|2|||
163929127|NCT00551135|592111943|FG000|Overall Study|Withdrawal by Subject|1|||
163929128|NCT00551135|592111944|FG001|Overall Study|Withdrawal by Subject|0|||
164035387|NCT01181141|592488116|FG000|Overall Study|Lost to Follow-up|1|||
164035388|NCT01181141|592488117|FG001|Overall Study|Lost to Follow-up|1|||
163833985|NCT04270747|591761486|FG001|Through Week 16|Miscellaneous|1|||
163833986|NCT04270747|591761487|FG002|Through Week 16|Miscellaneous|0|||
163833987|NCT04270747|591761485|FG000|Post Week 16|Adverse Event|7|||
163833988|NCT04270747|591761486|FG001|Post Week 16|Adverse Event|5|||
163833989|NCT04270747|591761487|FG002|Post Week 16|Adverse Event|1|||
163833990|NCT04270747|591761485|FG000|Post Week 16|Death|2|||
163833991|NCT04270747|591761486|FG001|Post Week 16|Death|0|||
163833992|NCT04270747|591761487|FG002|Post Week 16|Death|2|||
163833993|NCT04270747|591761485|FG000|Post Week 16|Consent Withdrawn|4|||
163833994|NCT04270747|591761486|FG001|Post Week 16|Consent Withdrawn|3|||
163833995|NCT04270747|591761487|FG002|Post Week 16|Consent Withdrawn|6|||
163833996|NCT04270747|591761485|FG000|Post Week 16|Physician Decision|3|||
163833997|NCT04270747|591761486|FG001|Post Week 16|Physician Decision|1|||
163833998|NCT04270747|591761487|FG002|Post Week 16|Physician Decision|1|||
163833999|NCT04270747|591761485|FG000|Post Week 16|Lost to Follow-up|2|||
163834000|NCT04270747|591761486|FG001|Post Week 16|Lost to Follow-up|1|||
163834001|NCT04270747|591761487|FG002|Post Week 16|Lost to Follow-up|0|||
163834002|NCT04270747|591761485|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
163834003|NCT04270747|591761486|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
163834004|NCT04270747|591761487|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
163834005|NCT04270747|591761485|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
163834006|NCT04270747|591761486|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
163834007|NCT04270747|591761487|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
163834008|NCT04270747|591761485|FG000|Post Week 16|Miscellaneous|1|||
163834009|NCT04270747|591761486|FG001|Post Week 16|Miscellaneous|0|||
163834010|NCT04270747|591761487|FG002|Post Week 16|Miscellaneous|1|||
163834011|NCT05004688|591761488|FG000|Overall Study|Protocol Violation|7|||
163834012|NCT05004688|591761488|FG000|Overall Study|Physician Decision|2|||
163834013|NCT05004688|591761488|FG000|Overall Study|Withdrawal by Subject|2|||
163834014|NCT05960097|591761489|FG000|Overall Study|Lost to Follow-up|3|||
163834015|NCT05960097|591761490|FG001|Overall Study|Lost to Follow-up|1|||
163834016|NCT05960097|591761491|FG002|Overall Study|Lost to Follow-up|1|||
163834017|NCT05960097|591761492|FG003|Overall Study|Lost to Follow-up|2|||
163834018|NCT05960097|591761493|FG004|Overall Study|Lost to Follow-up|1|||
163834019|NCT05960097|591761494|FG005|Overall Study|Lost to Follow-up|1|||
163834020|NCT05960097|591761495|FG006|Overall Study|Lost to Follow-up|2|||
163834021|NCT05960097|591761496|FG007|Overall Study|Lost to Follow-up|3|||
163834022|NCT05960097|591761489|FG000|Overall Study|Physician Decision|0|||
163834023|NCT05960097|591761490|FG001|Overall Study|Physician Decision|0|||
163834024|NCT05960097|591761491|FG002|Overall Study|Physician Decision|0|||
163834025|NCT05960097|591761492|FG003|Overall Study|Physician Decision|0|||
163834026|NCT05960097|591761493|FG004|Overall Study|Physician Decision|0|||
163834027|NCT05960097|591761494|FG005|Overall Study|Physician Decision|0|||
163834028|NCT05960097|591761495|FG006|Overall Study|Physician Decision|1|||
163834029|NCT05960097|591761496|FG007|Overall Study|Physician Decision|0|||
163834030|NCT05960097|591761489|FG000|Overall Study|Withdrawal by Subject|1|||
163834031|NCT05960097|591761490|FG001|Overall Study|Withdrawal by Subject|0|||
163834032|NCT05960097|591761491|FG002|Overall Study|Withdrawal by Subject|0|||
163834033|NCT05960097|591761492|FG003|Overall Study|Withdrawal by Subject|1|||
163834034|NCT05960097|591761493|FG004|Overall Study|Withdrawal by Subject|1|||
163834035|NCT05960097|591761494|FG005|Overall Study|Withdrawal by Subject|0|||
163834036|NCT05960097|591761495|FG006|Overall Study|Withdrawal by Subject|0|||
163834037|NCT05960097|591761496|FG007|Overall Study|Withdrawal by Subject|0|||
163834038|NCT05960097|591761489|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834039|NCT05960097|591761490|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834040|NCT05960097|591761491|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
163834041|NCT05960097|591761492|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834042|NCT05960097|591761493|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834043|NCT05960097|591761494|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834044|NCT05960097|591761495|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834045|NCT05960097|591761496|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
163834046|NCT02134925|591761497|FG000|Overall Study|Withdrawal by Subject|1|||
164035389|NCT01181141|592488116|FG000|Overall Study|Physician Decision|2|||
164035390|NCT01181141|592488117|FG001|Overall Study|Physician Decision|0|||
164035391|NCT01181141|592488116|FG000|Overall Study|Protocol Violation|3|||
164035392|NCT01181141|592488117|FG001|Overall Study|Protocol Violation|1|||
163834047|NCT02134925|591761498|FG001|Overall Study|Withdrawal by Subject|0|||
163834048|NCT02134925|591761497|FG000|Overall Study|Cancel|1|||
163834049|NCT02134925|591761498|FG001|Overall Study|Cancel|6|||
163834050|NCT02158884|591761499|FG000|Baseline Assessment|Missed performance assessment|3|||
163834051|NCT02158884|591761499|FG000|Baseline Assessment|Missed SMFA|1|||
164035393|NCT01181141|592488116|FG000|Overall Study|Withdrawal by Subject|3|||
164035394|NCT01181141|592488117|FG001|Overall Study|Withdrawal by Subject|1|||
163929129|NCT00551135|592111945|FG002|Overall Study|Withdrawal by Subject|3|||
163929130|NCT00551135|592111946|FG003|Overall Study|Withdrawal by Subject|1|||
163929131|NCT04294667|592111947|FG000|Overall Study|Lack of Efficacy|4|||
163929132|NCT04294667|592111948|FG001|Overall Study|Lack of Efficacy|4|||
163929133|NCT04294667|592111947|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
163929134|NCT04294667|592111948|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
163929135|NCT04294667|592111947|FG000|Overall Study|Patient has a Renal Flare|1|||
163929136|NCT04294667|592111948|FG001|Overall Study|Patient has a Renal Flare|0|||
163929137|NCT04294667|592111947|FG000|Overall Study|SLE Worsening|0|||
163929138|NCT04294667|592111948|FG001|Overall Study|SLE Worsening|1|||
163929139|NCT04294667|592111947|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
163929140|NCT04294667|592111948|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
163929141|NCT04294667|592111947|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
163929142|NCT04294667|592111948|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
163929143|NCT04294667|592111947|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
163929144|NCT04294667|592111948|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
163929145|NCT04294667|592111947|FG000|Overall Study|Subject Moved to Another State|0|||
163929146|NCT04294667|592111948|FG001|Overall Study|Subject Moved to Another State|1|||
163929147|NCT04294667|592111947|FG000|Overall Study|Adverse event, serious fatal|0|||
163929148|NCT04294667|592111948|FG001|Overall Study|Adverse event, serious fatal|1|||
163929149|NCT04294667|592111947|FG000|Overall Study|Adverse event, non-fatal|3|||
163929150|NCT04294667|592111948|FG001|Overall Study|Adverse event, non-fatal|4|||
163929151|NCT00548847|592111949|FG000|Overall Study|Disease progression|7|||
163929152|NCT00727415|592111950|FG000|Phase I|Dose Limiting Toxicity|2|||
163929153|NCT03634839|592111951|FG000|First Intervention (2 Hours)|Adverse Event|0|||
163929154|NCT03634839|592111952|FG001|First Intervention (2 Hours)|Adverse Event|2|||
163929155|NCT00302159|592111955|FG000|Overall Study|pt declined before treatment started|1|||
163929156|NCT00302159|592111955|FG000|Overall Study|pt started Avastin|1|||
163929157|NCT02312206|592111961|FG000|Overall Study|Adverse Event|3|||
163929158|NCT02312206|592111962|FG001|Overall Study|Adverse Event|6|||
163834052|NCT02158884|591761499|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
163834053|NCT02158884|591761499|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
163834054|NCT02158884|591761499|FG000|6 Month Assessment|Missed SMFA|20|||
163834055|NCT02158884|591761499|FG000|12 Month Assessment|Missed SMFA|17|||
163834056|NCT05158296|591761500|FG000|Overall Study|Sponsor Decision|2|||
163834057|NCT05158296|591761501|FG001|Overall Study|Sponsor Decision|3|||
163834058|NCT05158296|591761502|FG002|Overall Study|Sponsor Decision|2|||
163834059|NCT01521884|591761505|FG000|Overall Study|Non Responders|10|||
163834060|NCT01521884|591761505|FG000|Overall Study|Adverse Event|5|||
163834061|NCT01521884|591761505|FG000|Overall Study|Pregnancy|1|||
163834062|NCT01521884|591761505|FG000|Overall Study|Withdrawal by Subject|1|||
163834063|NCT01521884|591761505|FG000|Overall Study|Physician Decision|2|||
164035395|NCT00118911|592488118|FG000|Overall Study|Withdrawal by Subject|2|||
163834064|NCT01521884|591761505|FG000|Overall Study|Protocol Violation|3|||
163834065|NCT01521884|591761505|FG000|Overall Study|Participant non-eligible|1|||
163834066|NCT01521884|591761505|FG000|Overall Study|Lost to Follow-up|4|||
163834067|NCT04098250|591761506|FG000|Overall Study|Withdrawal by Subject|1|||
163834068|NCT04098250|591761507|FG001|Overall Study|Withdrawal by Subject|0|||
163834069|NCT04098250|591761506|FG000|Overall Study|Lost to Follow-up|0|||
163834070|NCT04098250|591761507|FG001|Overall Study|Lost to Follow-up|1|||
163834071|NCT00633464|591761512|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
163834072|NCT00633464|591761513|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
163929159|NCT02312206|592111961|FG000|Overall Study|Withdrawal by Subject|6|||
163929160|NCT02312206|592111962|FG001|Overall Study|Withdrawal by Subject|6|||
163929161|NCT02312206|592111961|FG000|Overall Study|Physician Decision|7|||
163929162|NCT02312206|592111962|FG001|Overall Study|Physician Decision|6|||
163929163|NCT02312206|592111961|FG000|Overall Study|Death|31|||
163929164|NCT02312206|592111962|FG001|Overall Study|Death|36|||
163929165|NCT02312206|592111961|FG000|Overall Study|Study Terminated by Sponsor|81|||
163929166|NCT02312206|592111962|FG001|Overall Study|Study Terminated by Sponsor|74|||
163929167|NCT02312206|592111961|FG000|Overall Study|Patient transferred to hospice|0|||
163929168|NCT02312206|592111962|FG001|Overall Study|Patient transferred to hospice|1|||
163929169|NCT02312206|592111961|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
163929170|NCT02312206|592111962|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
163929171|NCT02312206|592111961|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
163929172|NCT02312206|592111962|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
163929173|NCT02312206|592111961|FG000|Overall Study|Disease Progression|1|||
163929174|NCT02312206|592111962|FG001|Overall Study|Disease Progression|0|||
164035396|NCT00118911|592488119|FG001|Overall Study|Withdrawal by Subject|5|||
164147381|NCT05168202|592902029|FG005|Overall Study|Lack of Efficacy|2|||
163929175|NCT03082612|592111963|FG000|Overall Study|Lost to Follow-up|2|||
163929176|NCT03082612|592111964|FG001|Overall Study|Lost to Follow-up|0|||
163834073|NCT00633464|591761512|FG000|Overall Study|Never Treated (Randomized in error)|0|||
163834074|NCT00633464|591761513|FG001|Overall Study|Never Treated (Randomized in error)|1|||
163929177|NCT01006616|592111965|FG000|Period 1 (6 Months)|Adverse Event|10|||
163929178|NCT01006616|592111966|FG001|Period 1 (6 Months)|Adverse Event|31|||
163929179|NCT01006616|592111967|FG002|Period 1 (6 Months)|Adverse Event|37|||
163929180|NCT01006616|592111968|FG003|Period 1 (6 Months)|Adverse Event|9|||
163929181|NCT01006616|592111965|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
163929182|NCT01006616|592111966|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
163929183|NCT01006616|592111967|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
163929184|NCT01006616|592111968|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
163929185|NCT01006616|592111965|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
163929186|NCT01006616|592111966|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
163929187|NCT01006616|592111967|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
163929188|NCT01006616|592111968|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
163929189|NCT01006616|592111965|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
163929190|NCT01006616|592111966|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
163929191|NCT01006616|592111967|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
163929192|NCT01006616|592111968|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
163929193|NCT01006616|592111965|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
163929194|NCT01006616|592111966|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
163929195|NCT01006616|592111967|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
163929196|NCT01006616|592111968|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
163929197|NCT01006616|592111965|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
163929198|NCT01006616|592111966|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
163929199|NCT01006616|592111967|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
163929200|NCT01006616|592111968|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
163929201|NCT01006616|592111965|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
163929202|NCT01006616|592111966|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
163929203|NCT01006616|592111967|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
163929204|NCT01006616|592111968|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
163929205|NCT01006616|592111965|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
163929206|NCT01006616|592111966|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
163929207|NCT01006616|592111967|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
163929208|NCT01006616|592111968|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
163929209|NCT01006616|592111965|FG000|Period 1 (6 Months)|Not Treated|0|||
163929210|NCT01006616|592111966|FG001|Period 1 (6 Months)|Not Treated|0|||
163929211|NCT01006616|592111967|FG002|Period 1 (6 Months)|Not Treated|1|||
163929212|NCT01006616|592111968|FG003|Period 1 (6 Months)|Not Treated|1|||
163929213|NCT01006616|592111965|FG000|Period 2 (18 Months)|Adverse Event|6|||
163929214|NCT01006616|592111966|FG001|Period 2 (18 Months)|Adverse Event|6|||
163929215|NCT01006616|592111967|FG002|Period 2 (18 Months)|Adverse Event|6|||
163929216|NCT01006616|592111968|FG003|Period 2 (18 Months)|Adverse Event|4|||
163929217|NCT01006616|592111965|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
163929218|NCT01006616|592111966|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
163929219|NCT01006616|592111967|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
163929220|NCT01006616|592111968|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
163929221|NCT01006616|592111965|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
163929222|NCT01006616|592111966|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
163929223|NCT01006616|592111967|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
163929224|NCT01006616|592111968|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
163929225|NCT01006616|592111965|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
163929226|NCT01006616|592111966|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
163929227|NCT01006616|592111967|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
163929228|NCT01006616|592111968|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
163929229|NCT01006616|592111965|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
163929230|NCT01006616|592111966|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
163929231|NCT01006616|592111967|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
163929232|NCT01006616|592111968|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
163929233|NCT01006616|592111965|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
163929234|NCT01006616|592111966|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
163929235|NCT01006616|592111967|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
163929236|NCT01006616|592111968|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
163929237|NCT01006616|592111965|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
163929238|NCT01006616|592111966|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
163929239|NCT01006616|592111967|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
163929240|NCT01006616|592111968|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
163929241|NCT01006616|592111965|FG000|Period 2 (18 Months)|Study Terminated|63|||
163929242|NCT01006616|592111966|FG001|Period 2 (18 Months)|Study Terminated|46|||
163929243|NCT01006616|592111967|FG002|Period 2 (18 Months)|Study Terminated|44|||
163929244|NCT01006616|592111968|FG003|Period 2 (18 Months)|Study Terminated|70|||
163929245|NCT03672175|592111969|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
163929246|NCT03672175|592111970|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
164147382|NCT05168202|592902030|FG006|Overall Study|Lack of Efficacy|2|||
163929247|NCT03672175|592111971|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
163929248|NCT03672175|592111969|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
163929249|NCT03672175|592111970|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
163929250|NCT03672175|592111971|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
163929251|NCT03672175|592111969|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
163929252|NCT03672175|592111970|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
163929253|NCT03672175|592111971|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
163929254|NCT03672175|592111969|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
163929255|NCT03672175|592111970|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
163929256|NCT03672175|592111971|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
163929257|NCT03672175|592111969|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
163929258|NCT03672175|592111970|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
163929259|NCT03672175|592111971|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
163929260|NCT03672175|592111969|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
163929261|NCT03672175|592111970|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
163929262|NCT03672175|592111971|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
163929263|NCT03672175|592111969|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
163929264|NCT03672175|592111970|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
163929265|NCT03672175|592111971|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
163929266|NCT03672175|592111969|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
163929267|NCT03672175|592111970|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
163929268|NCT03672175|592111971|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
163929269|NCT03672175|592111969|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
163929270|NCT03672175|592111970|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
163929271|NCT03672175|592111971|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
163929272|NCT03672175|592111969|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
163929273|NCT03672175|592111970|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
163929274|NCT03672175|592111971|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
163929275|NCT03672175|592111969|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
163929276|NCT03672175|592111970|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
163929277|NCT03672175|592111971|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
163929278|NCT03672175|592111969|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
163929279|NCT03672175|592111970|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
163929280|NCT03672175|592111971|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
163929281|NCT03410108|592111972|FG000|Overall Study|Ongoing|41|||
163929282|NCT03410108|592111972|FG000|Overall Study|Adverse Event|4|||
163929283|NCT03410108|592111972|FG000|Overall Study|Progressive Disease|58|||
163929284|NCT03410108|592111972|FG000|Overall Study|Withdrawal by Subject|1|||
163929285|NCT01313624|592111973|FG000|Double-Blind Phase|Adverse Event|27|||
163929286|NCT01313624|592111974|FG001|Double-Blind Phase|Adverse Event|4|||
163929287|NCT01313624|592111973|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
163929288|NCT01313624|592111974|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
163929289|NCT01313624|592111973|FG000|Double-Blind Phase|Lost to Follow-up|0|||
163929290|NCT01313624|592111974|FG001|Double-Blind Phase|Lost to Follow-up|2|||
163929291|NCT01313624|592111973|FG000|Double-Blind Phase|Physician Decision|1|||
163929292|NCT01313624|592111974|FG001|Double-Blind Phase|Physician Decision|0|||
163929293|NCT01313624|592111973|FG000|Double-Blind Phase|Lack of Efficacy|1|||
163929294|NCT01313624|592111974|FG001|Double-Blind Phase|Lack of Efficacy|0|||
163929295|NCT01313624|592111973|FG000|Open-Label Phase|Adverse Event|1|||
163929296|NCT01313624|592111974|FG001|Open-Label Phase|Adverse Event|10|||
163929297|NCT01313624|592111973|FG000|Open-Label Phase|Withdrawal by Subject|2|||
163929298|NCT01313624|592111974|FG001|Open-Label Phase|Withdrawal by Subject|2|||
163929299|NCT01313624|592111973|FG000|Open-Label Phase|Lost to Follow-up|1|||
163929300|NCT01313624|592111974|FG001|Open-Label Phase|Lost to Follow-up|1|||
163929301|NCT02654132|592111975|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
163929302|NCT02654132|592111976|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
163929303|NCT02654132|592111975|FG000|Treatment Period|Disease progression|43|||
163929304|NCT02654132|592111976|FG001|Treatment Period|Disease progression|38|||
163929305|NCT02654132|592111975|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
163929306|NCT02654132|592111976|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
163929307|NCT02654132|592111975|FG000|Treatment Period|Other reasons|4|||
163929308|NCT02654132|592111976|FG001|Treatment Period|Other reasons|2|||
163929309|NCT02654132|592111975|FG000|Treatment Period|Study drug toxicity|2|||
164035397|NCT05014542|592488120|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
163929310|NCT02654132|592111976|FG001|Treatment Period|Study drug toxicity|2|||
163929311|NCT02654132|592111975|FG000|Treatment Period|Withdrawal by Subject|2|||
163929312|NCT02654132|592111976|FG001|Treatment Period|Withdrawal by Subject|1|||
164035398|NCT05014542|592488121|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
164035399|NCT05014542|592488120|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
164035400|NCT05014542|592488121|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
164147611|NCT03685344|592902084|FG000|Overall Study|Death|1|||
163834075|NCT04241094|591761514|FG000|Overall Study|Dropped out of treatment|4|||
163834076|NCT04241094|591761514|FG000|Overall Study|Ineligible after clinical assessment|2|||
163834077|NCT04241094|591761514|FG000|Overall Study|Lost to Follow-up|2|||
163834078|NCT02612064|591761516|FG000|Overall Study|Withdrawal by Subject|1|||
163834079|NCT02612064|591761517|FG001|Overall Study|Withdrawal by Subject|1|||
163834080|NCT02612064|591761516|FG000|Overall Study|Other|0|||
163834081|NCT02612064|591761517|FG001|Overall Study|Other|2|||
163834082|NCT06387472|591761518|FG000|Overall Study|Withdrawal by Subject|1|||
163834083|NCT06387472|591761518|FG000|Overall Study|Lost to Follow-up|2|||
163834084|NCT06387472|591761518|FG000|Overall Study|Physician Decision|1|||
163834085|NCT04182880|591761519|FG000|Overall Study|Pregnancy|1|||
163834086|NCT04182880|591761520|FG001|Overall Study|Pregnancy|0|||
163834087|NCT02036645|591761521|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834088|NCT02036645|591761522|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834089|NCT02036645|591761523|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834090|NCT02036645|591761524|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834091|NCT02036645|591761525|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834092|NCT02036645|591761526|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834093|NCT02036645|591761527|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
163834094|NCT02036645|591761528|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834095|NCT02036645|591761529|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834096|NCT02036645|591761530|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834097|NCT02036645|591761531|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834098|NCT02036645|591761532|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
163834099|NCT02036645|591761521|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834100|NCT02036645|591761522|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834101|NCT02036645|591761523|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834102|NCT02036645|591761524|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
163834103|NCT02036645|591761525|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834104|NCT02036645|591761526|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834105|NCT02036645|591761527|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834106|NCT02036645|591761528|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834107|NCT02036645|591761529|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834108|NCT02036645|591761530|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834109|NCT02036645|591761531|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834110|NCT02036645|591761532|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
163834111|NCT00717860|591761537|FG000|Overall Study|Clinical adverse experience|5|||
163834112|NCT00717860|591761538|FG001|Overall Study|Clinical adverse experience|9|||
163834113|NCT00717860|591761537|FG000|Overall Study|Laboratory adverse experience|2|||
163834114|NCT00717860|591761538|FG001|Overall Study|Laboratory adverse experience|2|||
163834115|NCT00717860|591761537|FG000|Overall Study|Lack of Efficacy|7|||
163834116|NCT00717860|591761538|FG001|Overall Study|Lack of Efficacy|13|||
163834117|NCT00717860|591761537|FG000|Overall Study|Discontinued for other reason|6|||
163834118|NCT00717860|591761538|FG001|Overall Study|Discontinued for other reason|1|||
163834119|NCT00717860|591761537|FG000|Overall Study|Withdrew consent|7|||
163834120|NCT00717860|591761538|FG001|Overall Study|Withdrew consent|3|||
163834121|NCT00696384|591761539|FG000|Open Label Phase|Adverse Event|27|||
163834122|NCT00696384|591761540|FG001|Open Label Phase|Adverse Event|0|||
163834123|NCT00696384|591761541|FG002|Open Label Phase|Adverse Event|0|||
163834124|NCT00696384|591761539|FG000|Open Label Phase|Protocol Violation|18|||
163834125|NCT00696384|591761540|FG001|Open Label Phase|Protocol Violation|0|||
163834126|NCT00696384|591761541|FG002|Open Label Phase|Protocol Violation|0|||
163834127|NCT00696384|591761539|FG000|Open Label Phase|Lost to Follow-up|24|||
163834128|NCT00696384|591761540|FG001|Open Label Phase|Lost to Follow-up|0|||
163834129|NCT00696384|591761541|FG002|Open Label Phase|Lost to Follow-up|0|||
163834130|NCT00696384|591761539|FG000|Open Label Phase|Withdrawal by Subject|37|||
163834131|NCT00696384|591761540|FG001|Open Label Phase|Withdrawal by Subject|0|||
163834132|NCT00696384|591761541|FG002|Open Label Phase|Withdrawal by Subject|0|||
163834133|NCT00696384|591761539|FG000|Open Label Phase|Other|6|||
163834134|NCT00696384|591761540|FG001|Open Label Phase|Other|0|||
163834135|NCT00696384|591761541|FG002|Open Label Phase|Other|0|||
163834136|NCT00696384|591761539|FG000|Open Label Phase|Lack of Efficacy|3|||
163834137|NCT00696384|591761540|FG001|Open Label Phase|Lack of Efficacy|0|||
163834138|NCT00696384|591761541|FG002|Open Label Phase|Lack of Efficacy|0|||
163834139|NCT00696384|591761539|FG000|Open Label Phase|Physician Decision|4|||
163834140|NCT00696384|591761540|FG001|Open Label Phase|Physician Decision|0|||
163834141|NCT00696384|591761541|FG002|Open Label Phase|Physician Decision|0|||
163834142|NCT00696384|591761539|FG000|Double Blind Phase|Adverse Event|0|||
163834143|NCT00696384|591761540|FG001|Double Blind Phase|Adverse Event|2|||
163834144|NCT00696384|591761541|FG002|Double Blind Phase|Adverse Event|2|||
163834145|NCT00696384|591761539|FG000|Double Blind Phase|Lost to Follow-up|0|||
163834146|NCT00696384|591761540|FG001|Double Blind Phase|Lost to Follow-up|2|||
163834147|NCT00696384|591761541|FG002|Double Blind Phase|Lost to Follow-up|1|||
163834148|NCT00696384|591761539|FG000|Double Blind Phase|Withdrawal by Subject|0|||
163834149|NCT00696384|591761540|FG001|Double Blind Phase|Withdrawal by Subject|4|||
163834150|NCT00696384|591761541|FG002|Double Blind Phase|Withdrawal by Subject|3|||
163834151|NCT00696384|591761539|FG000|Double Blind Phase|Lack of Efficacy|0|||
163834152|NCT00696384|591761540|FG001|Double Blind Phase|Lack of Efficacy|1|||
163834153|NCT00696384|591761541|FG002|Double Blind Phase|Lack of Efficacy|0|||
163834154|NCT00696384|591761539|FG000|Double Blind Phase|Physician Decision|0|||
163834155|NCT00696384|591761540|FG001|Double Blind Phase|Physician Decision|2|||
163834156|NCT00696384|591761541|FG002|Double Blind Phase|Physician Decision|0|||
163834157|NCT03995784|591761542|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
163834158|NCT03015116|591762996|FG000|Overall Study|Lost to Follow-up|3|||
163834159|NCT03015116|591762997|FG001|Overall Study|Lost to Follow-up|0|||
163834160|NCT03015116|591762998|FG002|Overall Study|Lost to Follow-up|2|||
163834161|NCT03015116|591762996|FG000|Overall Study|Withdrawal by Subject|3|||
163834162|NCT03015116|591762997|FG001|Overall Study|Withdrawal by Subject|1|||
163834163|NCT03015116|591762998|FG002|Overall Study|Withdrawal by Subject|0|||
163834164|NCT03015116|591762996|FG000|Overall Study|Subject has New Medical Status|1|||
163834165|NCT03015116|591762997|FG001|Overall Study|Subject has New Medical Status|0|||
163834166|NCT03015116|591762998|FG002|Overall Study|Subject has New Medical Status|0|||
163834167|NCT03015116|591762996|FG000|Overall Study|Physician Decision|0|||
163834168|NCT03015116|591762997|FG001|Overall Study|Physician Decision|1|||
163834169|NCT03015116|591762998|FG002|Overall Study|Physician Decision|0|||
163834170|NCT01862991|591762999|FG000|Overall Study|Lost to Follow-up|2|||
163834171|NCT01862991|591763000|FG001|Overall Study|Lost to Follow-up|1|||
163834172|NCT01862991|591763001|FG002|Overall Study|Lost to Follow-up|1|||
163834173|NCT01862991|591762999|FG000|Overall Study|Protocol Violation|1|||
163834174|NCT01862991|591763000|FG001|Overall Study|Protocol Violation|0|||
163834175|NCT01862991|591763001|FG002|Overall Study|Protocol Violation|0|||
163834176|NCT04858802|591763002|FG000|Overall Study|Lost to Follow-up|1|||
163834177|NCT04858802|591763003|FG001|Overall Study|Lost to Follow-up|1|||
163834178|NCT04858802|591763002|FG000|Overall Study|Withdrawal by Subject|1|||
163834179|NCT04858802|591763003|FG001|Overall Study|Withdrawal by Subject|1|||
163834180|NCT00332332|591763004|FG000|Overall Study|Adverse Event|13|||
163834181|NCT00332332|591763004|FG000|Overall Study|Death|1|||
163834182|NCT00332332|591763004|FG000|Overall Study|Withdrawal by Subject|8|||
163834183|NCT00332332|591763004|FG000|Overall Study|Physician Decision|1|||
163834184|NCT00332332|591763004|FG000|Overall Study|Lost to Follow-up|3|||
163834185|NCT00332332|591763004|FG000|Overall Study|Protocol deviation|4|||
163834186|NCT00332332|591763004|FG000|Overall Study|Noncompliance|2|||
163834187|NCT00332332|591763004|FG000|Overall Study|Disease progression|2|||
163834188|NCT00332332|591763004|FG000|Overall Study|Other|18|||
163834189|NCT00332332|591763004|FG000|Overall Study|Did not receive study treatment|16|||
163834190|NCT01108458|591763005|FG000|Overall Study|Withdrawal by Subject|1|||
163834191|NCT03075501|591763006|FG000|Overall Study|Scheduling difficulties|15|||
163834192|NCT03075501|591763007|FG001|Overall Study|Scheduling difficulties|9|||
163834193|NCT00857805|591763008|FG000|Overall Study|Withdrawal by Subject|1|||
163834194|NCT00857805|591763009|FG001|Overall Study|Withdrawal by Subject|1|||
163834195|NCT00710606|591763016|FG000|Overall Study|Adverse Event|0|||
163834196|NCT00710606|591763017|FG001|Overall Study|Adverse Event|2|||
163834197|NCT02670538|591763018|FG000|Overall Study|Withdrawal of Consent|8|||
163834198|NCT02670538|591763019|FG001|Overall Study|Withdrawal of Consent|6|||
163834199|NCT02670538|591763020|FG002|Overall Study|Withdrawal of Consent|5|||
163834200|NCT02670538|591763018|FG000|Overall Study|Lost to Follow-up|8|||
163834201|NCT02670538|591763019|FG001|Overall Study|Lost to Follow-up|12|||
163834202|NCT02670538|591763020|FG002|Overall Study|Lost to Follow-up|7|||
163834203|NCT02670538|591763018|FG000|Overall Study|Adverse Event|5|||
163834204|NCT02670538|591763019|FG001|Overall Study|Adverse Event|5|||
163834205|NCT02670538|591763020|FG002|Overall Study|Adverse Event|11|||
163834206|NCT02670538|591763018|FG000|Overall Study|Lack of Efficacy|7|||
163834207|NCT02670538|591763019|FG001|Overall Study|Lack of Efficacy|1|||
163834208|NCT02670538|591763020|FG002|Overall Study|Lack of Efficacy|2|||
163834209|NCT02670538|591763018|FG000|Overall Study|Protocol Violation|3|||
163834210|NCT02670538|591763019|FG001|Overall Study|Protocol Violation|4|||
163834211|NCT02670538|591763020|FG002|Overall Study|Protocol Violation|1|||
163834212|NCT02670538|591763018|FG000|Overall Study|Noncompliance with Study Drug|1|||
163834213|NCT02670538|591763019|FG001|Overall Study|Noncompliance with Study Drug|3|||
163834214|NCT02670538|591763020|FG002|Overall Study|Noncompliance with Study Drug|2|||
163834215|NCT02670538|591763018|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163834216|NCT02670538|591763019|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163834217|NCT02670538|591763020|FG002|Overall Study|Other Miscellaneous Reasons|2|||
163834218|NCT00708435|591763023|FG000|Overall Study|Death / Serious Adverse Event|10|||
163834219|NCT00708435|591763024|FG001|Overall Study|Death / Serious Adverse Event|5|||
163834220|NCT00708435|591763023|FG000|Overall Study|Lost to Follow-up|9|||
163834221|NCT00708435|591763024|FG001|Overall Study|Lost to Follow-up|4|||
163834222|NCT00708435|591763023|FG000|Overall Study|Withdrawal by Subject|3|||
163834223|NCT00708435|591763024|FG001|Overall Study|Withdrawal by Subject|7|||
163834224|NCT00708435|591763023|FG000|Overall Study|Adverse Event|1|||
163834225|NCT00708435|591763024|FG001|Overall Study|Adverse Event|0|||
163834226|NCT00708435|591763023|FG000|Overall Study|Protocol Violation|0|||
163834227|NCT00708435|591763024|FG001|Overall Study|Protocol Violation|1|||
163834228|NCT00708435|591763023|FG000|Overall Study|Intervention by primary care physician|1|||
163834229|NCT00708435|591763024|FG001|Overall Study|Intervention by primary care physician|0|||
163834230|NCT00708435|591763023|FG000|Overall Study|Refused hospitalization|1|||
163834231|NCT00708435|591763024|FG001|Overall Study|Refused hospitalization|0|||
163834232|NCT04766086|591763027|FG000|Overall Study|Lost to Follow-up|3|||
163834233|NCT04766086|591763028|FG001|Overall Study|Lost to Follow-up|5|||
163834234|NCT04766086|591763029|FG002|Overall Study|Lost to Follow-up|3|||
163834235|NCT04766086|591763027|FG000|Overall Study|Withdrawal by Subject|1|||
163834236|NCT04766086|591763028|FG001|Overall Study|Withdrawal by Subject|1|||
163834237|NCT04766086|591763029|FG002|Overall Study|Withdrawal by Subject|2|||
163834238|NCT04766086|591763027|FG000|Overall Study|Other|0|||
163834239|NCT04766086|591763028|FG001|Overall Study|Other|0|||
163834240|NCT04766086|591763029|FG002|Overall Study|Other|1|||
163834241|NCT02281760|591763030|FG000|Overall Study|Withdrawal by Subject|1|||
163834242|NCT02635724|591763031|FG000|Overall Study|Withdrawal by Subject|0|||
163834243|NCT02635724|591763032|FG001|Overall Study|Withdrawal by Subject|1|||
163834244|NCT02635724|591763033|FG002|Overall Study|Withdrawal by Subject|0|||
163834245|NCT00100932|591763034|FG000|Overall Study|Adverse Event|11|||
163834246|NCT00100932|591763035|FG001|Overall Study|Adverse Event|2|||
163834247|NCT00100932|591763034|FG000|Overall Study|Withdrawal by Subject|6|||
163834248|NCT00100932|591763035|FG001|Overall Study|Withdrawal by Subject|0|||
163834249|NCT00100932|591763034|FG000|Overall Study|Progressive Disease|44|||
163834250|NCT00100932|591763035|FG001|Overall Study|Progressive Disease|18|||
163834251|NCT00100932|591763034|FG000|Overall Study|Physician Decision|7|||
163834252|NCT00100932|591763035|FG001|Overall Study|Physician Decision|5|||
163834253|NCT00100932|591763034|FG000|Overall Study|Other|5|||
163834254|NCT00100932|591763035|FG001|Overall Study|Other|2|||
163834255|NCT01453348|591763036|FG000|Overall Study|Death|0|||
163834256|NCT01453348|591763037|FG001|Overall Study|Death|0|||
163834257|NCT01453348|591763038|FG002|Overall Study|Death|1|||
163834258|NCT01453348|591763036|FG000|Overall Study|Withdrawal by Subject|0|||
163834259|NCT01453348|591763037|FG001|Overall Study|Withdrawal by Subject|1|||
163834260|NCT01453348|591763038|FG002|Overall Study|Withdrawal by Subject|0|||
163834261|NCT01453348|591763036|FG000|Overall Study|Protocol Violation|1|||
163834262|NCT01453348|591763037|FG001|Overall Study|Protocol Violation|0|||
163834263|NCT01453348|591763038|FG002|Overall Study|Protocol Violation|0|||
163834264|NCT02756832|591763039|FG000|Overall Study|Lost for Observation after Baseline|6|||
163834265|NCT02756832|591763039|FG000|Overall Study|Lost for Observation|13|||
163834266|NCT02756832|591763039|FG000|Overall Study|Patient's Unwillingness|12|||
163834267|NCT02756832|591763039|FG000|Overall Study|Insufficient Efficacy|2|||
163834268|NCT02756832|591763039|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
163834269|NCT02756832|591763039|FG000|Overall Study|Reason not Specified|9|||
163834270|NCT02756832|591763039|FG000|Overall Study|Protocol Deviation|10|||
163834271|NCT03579290|591763041|FG000|Overall Study|Lost to Follow-up|9|||
163834272|NCT01674621|591763048|FG000|Overall Study|Adverse Event|3|||
163834273|NCT01674621|591763049|FG001|Overall Study|Adverse Event|2|||
163834274|NCT01674621|591763050|FG002|Overall Study|Adverse Event|5|||
163834275|NCT01674621|591763051|FG003|Overall Study|Adverse Event|5|||
163834276|NCT01674621|591763052|FG004|Overall Study|Adverse Event|1|||
163834277|NCT01674621|591763048|FG000|Overall Study|Inability to Complete Study Procedures|0|||
163834278|NCT01674621|591763049|FG001|Overall Study|Inability to Complete Study Procedures|0|||
163834279|NCT01674621|591763050|FG002|Overall Study|Inability to Complete Study Procedures|0|||
163834280|NCT01674621|591763051|FG003|Overall Study|Inability to Complete Study Procedures|0|||
163834281|NCT01674621|591763052|FG004|Overall Study|Inability to Complete Study Procedures|2|||
163834282|NCT01674621|591763048|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163834283|NCT01674621|591763049|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163834284|NCT01674621|591763050|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163834285|NCT01674621|591763051|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
163834286|NCT01674621|591763052|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
163834287|NCT01674621|591763048|FG000|Overall Study|Withdrawal by Subject|2|||
163834288|NCT01674621|591763049|FG001|Overall Study|Withdrawal by Subject|5|||
163834289|NCT01674621|591763050|FG002|Overall Study|Withdrawal by Subject|2|||
163834290|NCT01674621|591763051|FG003|Overall Study|Withdrawal by Subject|0|||
163834291|NCT01674621|591763052|FG004|Overall Study|Withdrawal by Subject|1|||
163834292|NCT01674621|591763048|FG000|Overall Study|Other than specified|0|||
163834293|NCT01674621|591763049|FG001|Overall Study|Other than specified|1|||
163834294|NCT01674621|591763050|FG002|Overall Study|Other than specified|0|||
163834295|NCT01674621|591763051|FG003|Overall Study|Other than specified|0|||
163834296|NCT01674621|591763052|FG004|Overall Study|Other than specified|2|||
163834297|NCT01725386|591763053|FG000|Overall Study|Death|84|||
163834298|NCT01725386|591763054|FG001|Overall Study|Death|40|||
163834299|NCT01725386|591763053|FG000|Overall Study|Lost to Follow-up|81|||
163834300|NCT01725386|591763054|FG001|Overall Study|Lost to Follow-up|6|||
163834301|NCT01725386|591763053|FG000|Overall Study|Withdrawal by Subject|10|||
163834302|NCT01725386|591763054|FG001|Overall Study|Withdrawal by Subject|0|||
163929313|NCT02654132|592111975|FG000|Treatment Period|Maximum Clinical Benefit|0|||
163929314|NCT02654132|592111976|FG001|Treatment Period|Maximum Clinical Benefit|2|||
163929315|NCT02654132|592111975|FG000|Treatment Period|Participant request to discontinue|2|||
163929316|NCT02654132|592111976|FG001|Treatment Period|Participant request to discontinue|0|||
163929317|NCT02654132|592111975|FG000|Treatment Period|Administrative reasons by sponsor|0|||
163929318|NCT02654132|592111976|FG001|Treatment Period|Administrative reasons by sponsor|1|||
163929319|NCT02654132|592111975|FG000|Treatment Period|Death|1|||
163929320|NCT02654132|592111976|FG001|Treatment Period|Death|0|||
163929321|NCT01006889|592111977|FG000|Overall Study|Withdrawal by Subject|3|||
163929322|NCT00623363|592111978|FG000|Overall Study|Adverse Event|2|||
163929323|NCT00623363|592111979|FG001|Overall Study|Adverse Event|2|||
163929324|NCT04706793|592111980|FG000|Treatment|Disease worsening|10|||
163929325|NCT04706793|592111981|FG001|Treatment|Disease worsening|10|||
163929326|NCT04706793|592111980|FG000|Follow-up|Lack of Efficacy|1|||
163929327|NCT04706793|592111981|FG001|Follow-up|Lack of Efficacy|0|||
163929328|NCT04706793|592111980|FG000|Follow-up|Disease worsening|8|||
163929329|NCT04706793|592111981|FG001|Follow-up|Disease worsening|10|||
163929330|NCT04706793|592111980|FG000|Follow-up|Adverse Event|1|||
163929331|NCT04706793|592111981|FG001|Follow-up|Adverse Event|0|||
163929332|NCT00823836|592111982|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
163929333|NCT00823836|592111983|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
163929334|NCT00823836|592111982|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
163929335|NCT00823836|592111983|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
163929336|NCT00823836|592111982|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
163929337|NCT00823836|592111983|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
163929338|NCT00823836|592111982|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
163929339|NCT00823836|592111983|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
163929340|NCT00823836|592111982|FG000|Long-term Phase|Adverse Event|3|||
163929341|NCT00823836|592111983|FG001|Long-term Phase|Adverse Event|2|||
163929342|NCT00823836|592111982|FG000|Long-term Phase|Physician Decision|1|||
163929343|NCT00823836|592111983|FG001|Long-term Phase|Physician Decision|2|||
163929344|NCT00823836|592111982|FG000|Long-term Phase|Withdrawal by Subject|1|||
163929345|NCT00823836|592111983|FG001|Long-term Phase|Withdrawal by Subject|1|||
163929346|NCT01130168|592111984|FG000|Period 1|Withdrawal by Subject|0|||
163929347|NCT01130168|592111985|FG001|Period 1|Withdrawal by Subject|1|||
163929348|NCT01130168|592111986|FG002|Period 1|Withdrawal by Subject|0|||
163929349|NCT01130168|592111987|FG003|Period 1|Withdrawal by Subject|1|||
163929350|NCT01130168|592111988|FG004|Period 1|Withdrawal by Subject|0|||
163929351|NCT01130168|592111989|FG005|Period 1|Withdrawal by Subject|0|||
163929352|NCT01130168|592111984|FG000|Period 1|Discontinued For Other Reason|0|||
163929353|NCT01130168|592111985|FG001|Period 1|Discontinued For Other Reason|0|||
163929354|NCT01130168|592111986|FG002|Period 1|Discontinued For Other Reason|1|||
163929355|NCT01130168|592111987|FG003|Period 1|Discontinued For Other Reason|1|||
163929356|NCT01130168|592111988|FG004|Period 1|Discontinued For Other Reason|0|||
163929357|NCT01130168|592111989|FG005|Period 1|Discontinued For Other Reason|0|||
163929358|NCT01130168|592111984|FG000|Period 1|Adverse Event|0|||
163929359|NCT01130168|592111985|FG001|Period 1|Adverse Event|0|||
163929360|NCT01130168|592111986|FG002|Period 1|Adverse Event|0|||
163929361|NCT01130168|592111987|FG003|Period 1|Adverse Event|1|||
163929362|NCT01130168|592111988|FG004|Period 1|Adverse Event|0|||
163929363|NCT01130168|592111989|FG005|Period 1|Adverse Event|0|||
163929364|NCT04354168|592111990|FG000|Overall Study|Lost to Follow-up|22|||
163929365|NCT01781832|592111991|FG000|Overall Study|Withdrawal by Subject|1|||
163929366|NCT02287233|592111992|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
163929367|NCT02287233|592111993|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
163929368|NCT02287233|592111994|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
163929369|NCT02287233|592111992|FG000|Overall Study|Adverse Event Related to Progression|0|||
163929370|NCT02287233|592111993|FG001|Overall Study|Adverse Event Related to Progression|2|||
163929371|NCT02287233|592111994|FG002|Overall Study|Adverse Event Related to Progression|8|||
163929372|NCT02287233|592111992|FG000|Overall Study|Physician Decision|1|||
163929373|NCT02287233|592111993|FG001|Overall Study|Physician Decision|2|||
163929374|NCT02287233|592111994|FG002|Overall Study|Physician Decision|4|||
163929375|NCT02287233|592111992|FG000|Overall Study|Progressive Disease with Death|0|||
163929376|NCT02287233|592111993|FG001|Overall Study|Progressive Disease with Death|0|||
164035401|NCT05014542|592488120|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
164035402|NCT05014542|592488121|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
163929377|NCT02287233|592111994|FG002|Overall Study|Progressive Disease with Death|10|||
164035403|NCT05014542|592488120|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
163929378|NCT02287233|592111992|FG000|Overall Study|Progressive Disease Without Death|2|||
163929379|NCT02287233|592111993|FG001|Overall Study|Progressive Disease Without Death|3|||
163929380|NCT02287233|592111994|FG002|Overall Study|Progressive Disease Without Death|20|||
163929381|NCT02287233|592111992|FG000|Overall Study|Withdrawal by Subject|1|||
163929382|NCT02287233|592111993|FG001|Overall Study|Withdrawal by Subject|1|||
163929383|NCT02287233|592111994|FG002|Overall Study|Withdrawal by Subject|7|||
163929384|NCT02287233|592111992|FG000|Overall Study|Other|3|||
163929385|NCT02287233|592111993|FG001|Overall Study|Other|0|||
163929386|NCT02287233|592111994|FG002|Overall Study|Other|15|||
163929387|NCT02287233|592111992|FG000|Overall Study|Did Not Receive Treatment|0|||
163929388|NCT02287233|592111993|FG001|Overall Study|Did Not Receive Treatment|0|||
163929389|NCT02287233|592111994|FG002|Overall Study|Did Not Receive Treatment|2|||
163929390|NCT02804399|592111997|FG000|Period 2|Adverse Event|0|||
163929391|NCT02804399|592111998|FG001|Period 2|Adverse Event|1|||
163929392|NCT02058836|592111999|FG000|Overall Study|Withdrawal by Subject|1|||
163929393|NCT02058836|592112000|FG001|Overall Study|Withdrawal by Subject|1|||
163929394|NCT00573651|592112002|FG000|Overall Study|Lost to Follow-up|3|||
163929395|NCT00573651|592112002|FG000|Overall Study|Withdrawal by Subject|1|||
163929396|NCT01225159|592112003|FG000|Overall Study|Change operation|1|||
163929397|NCT01225159|592112004|FG001|Overall Study|Change operation|0|||
163929398|NCT01220856|592112009|FG000|Overall Study|graft loss|3|||
163929399|NCT01220856|592112010|FG001|Overall Study|graft loss|3|||
163929400|NCT01220856|592112009|FG000|Overall Study|Lost to Follow-up|1|||
163929401|NCT01220856|592112010|FG001|Overall Study|Lost to Follow-up|0|||
163929402|NCT04814992|592112011|FG000|Overall Study|Withdrawal by Subject|6|||
163929403|NCT04814992|592112012|FG001|Overall Study|Withdrawal by Subject|3|||
163929404|NCT04814992|592112011|FG000|Overall Study|Lost to Follow-up|1|||
163929405|NCT04814992|592112012|FG001|Overall Study|Lost to Follow-up|4|||
163929406|NCT00691678|592112013|FG000|Overall Study|Adverse Event|5|||
163929407|NCT00691678|592112013|FG000|Overall Study|life events, pain|11|||
163929408|NCT02188784|592112015|FG000|Overall Study|Death|3|||
163929409|NCT02188784|592112016|FG001|Overall Study|Death|1|||
163929410|NCT02188784|592112015|FG000|Overall Study|Lost to Follow-up|1|||
163929411|NCT02188784|592112016|FG001|Overall Study|Lost to Follow-up|0|||
163929412|NCT02188784|592112015|FG000|Overall Study|Withdrawal by Subject|3|||
163929413|NCT02188784|592112016|FG001|Overall Study|Withdrawal by Subject|9|||
163929414|NCT02188784|592112015|FG000|Overall Study|Physician Decision|2|||
163929415|NCT02188784|592112016|FG001|Overall Study|Physician Decision|3|||
163929416|NCT01568112|592112019|FG000|Overall Study|Randomized But Not Treated|0|||
163929417|NCT01568112|592112020|FG001|Overall Study|Randomized But Not Treated|1|||
163929418|NCT01568112|592112021|FG002|Overall Study|Randomized But Not Treated|0|||
163929419|NCT01568112|592112022|FG003|Overall Study|Randomized But Not Treated|0|||
163929420|NCT01568112|592112019|FG000|Overall Study|Withdrew due to Adverse Event|2|||
163929421|NCT01568112|592112020|FG001|Overall Study|Withdrew due to Adverse Event|4|||
163929422|NCT01568112|592112021|FG002|Overall Study|Withdrew due to Adverse Event|6|||
163929423|NCT01568112|592112022|FG003|Overall Study|Withdrew due to Adverse Event|3|||
163929424|NCT01568112|592112019|FG000|Overall Study|Lost to Follow-up|0|||
163929425|NCT01568112|592112020|FG001|Overall Study|Lost to Follow-up|0|||
163929426|NCT01568112|592112021|FG002|Overall Study|Lost to Follow-up|0|||
163929427|NCT01568112|592112022|FG003|Overall Study|Lost to Follow-up|1|||
163929428|NCT01568112|592112019|FG000|Overall Study|Withdrawal by Subject|2|||
163929429|NCT01568112|592112020|FG001|Overall Study|Withdrawal by Subject|3|||
163929430|NCT01568112|592112021|FG002|Overall Study|Withdrawal by Subject|0|||
163929431|NCT01568112|592112022|FG003|Overall Study|Withdrawal by Subject|7|||
163929432|NCT01568112|592112019|FG000|Overall Study|Withdrawal by Physician|1|||
163929433|NCT01568112|592112020|FG001|Overall Study|Withdrawal by Physician|0|||
163929434|NCT01568112|592112021|FG002|Overall Study|Withdrawal by Physician|1|||
163929435|NCT01568112|592112022|FG003|Overall Study|Withdrawal by Physician|1|||
163929436|NCT00903760|592114122|FG000|Overall Study|Disease Progression/Death|8|||
163929437|NCT00903760|592114123|FG001|Overall Study|Disease Progression/Death|6|||
163929438|NCT00903760|592114122|FG000|Overall Study|Stem Cell Transplant|8|||
163929439|NCT00903760|592114123|FG001|Overall Study|Stem Cell Transplant|4|||
163929440|NCT00903760|592114122|FG000|Overall Study|Physician Decision|1|||
163929441|NCT00903760|592114123|FG001|Overall Study|Physician Decision|2|||
163929442|NCT00903760|592114122|FG000|Overall Study|Death|0|||
163929443|NCT00903760|592114123|FG001|Overall Study|Death|1|||
163929444|NCT00903760|592114122|FG000|Overall Study|Lost to Follow-up|1|||
163929445|NCT00903760|592114123|FG001|Overall Study|Lost to Follow-up|0|||
163929446|NCT00903760|592114122|FG000|Overall Study|Withdrawal by Subject|1|||
163929447|NCT00903760|592114123|FG001|Overall Study|Withdrawal by Subject|2|||
163929448|NCT00903760|592114122|FG000|Overall Study|Off treatment for long period|0|||
163929449|NCT00903760|592114123|FG001|Overall Study|Off treatment for long period|1|||
163929450|NCT00487825|592114124|FG000|Overall Study|Adverse Event|2|||
163929451|NCT00487825|592114125|FG001|Overall Study|Adverse Event|2|||
163929452|NCT00487825|592114124|FG000|Overall Study|Lack of Efficacy|1|||
163929453|NCT00487825|592114125|FG001|Overall Study|Lack of Efficacy|1|||
163929454|NCT00487825|592114124|FG000|Overall Study|Other|3|||
163929455|NCT00487825|592114125|FG001|Overall Study|Other|2|||
163929456|NCT01256671|592114126|FG000|Overall Study|Adverse Event|29|||
163929457|NCT01256671|592114126|FG000|Overall Study|Lost to Follow-up|16|||
163929458|NCT01256671|592114126|FG000|Overall Study|Withdrawal by Subject|31|||
163929459|NCT01256671|592114126|FG000|Overall Study|Physician Decision|3|||
163929460|NCT01256671|592114126|FG000|Overall Study|Lack of Efficacy|4|||
163929461|NCT01256671|592114126|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
163929462|NCT01190644|592114127|FG000|Overall Study|Death|2|||
163929463|NCT01190644|592114127|FG000|Overall Study|Disease progression|1|||
164035404|NCT05014542|592488121|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
164035405|NCT03496662|592488122|FG000|Overall Study|Adverse Event|0|||
164035406|NCT03496662|592488123|FG001|Overall Study|Adverse Event|0|||
164035407|NCT03496662|592488124|FG002|Overall Study|Adverse Event|4|||
164035408|NCT03496662|592488122|FG000|Overall Study|Withdrawal by Subject|1|||
164035409|NCT03496662|592488123|FG001|Overall Study|Withdrawal by Subject|0|||
164035410|NCT03496662|592488124|FG002|Overall Study|Withdrawal by Subject|2|||
164035411|NCT03496662|592488122|FG000|Overall Study|Death|0|||
164035412|NCT03496662|592488123|FG001|Overall Study|Death|0|||
164035413|NCT03496662|592488124|FG002|Overall Study|Death|2|||
164035414|NCT03496662|592488122|FG000|Overall Study|Noncompliance|0|||
164035415|NCT03496662|592488123|FG001|Overall Study|Noncompliance|0|||
164035416|NCT03496662|592488124|FG002|Overall Study|Noncompliance|1|||
164035417|NCT01467661|592488125|FG000|Overall Study|Adverse Event|16|||
164035418|NCT01467661|592488125|FG000|Overall Study|Withdrawal by Subject|1|||
164035419|NCT01467661|592488125|FG000|Overall Study|Lack of Efficacy|3|||
164035420|NCT01467661|592488125|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
164035421|NCT00691093|592488127|FG000|Overall Study|Adverse Event|1|||
164035422|NCT00691093|592488127|FG000|Overall Study|Lost to Follow-up|1|||
164035423|NCT00691093|592488127|FG000|Overall Study|Lack of Efficacy|1|||
164035424|NCT00691093|592488127|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
164035425|NCT03395223|592488129|FG000|Overall Study|Lost to Follow-up|3|||
164035426|NCT03395223|592488129|FG000|Overall Study|Other|1|||
164035427|NCT00810810|592488130|FG000|Overall Study|Withdrawal by Subject|0|||
164035428|NCT00810810|592488131|FG001|Overall Study|Withdrawal by Subject|8|||
164035429|NCT00810810|592488132|FG002|Overall Study|Withdrawal by Subject|10|||
164035430|NCT00810810|592488133|FG003|Overall Study|Withdrawal by Subject|8|||
164035431|NCT00810810|592488130|FG000|Overall Study|Physician Decision|0|||
164035432|NCT00810810|592488131|FG001|Overall Study|Physician Decision|3|||
163834303|NCT01216163|591763059|FG000|Overall Study|Withdrawal by Subject|1|||
163834304|NCT01216163|591763060|FG001|Overall Study|Withdrawal by Subject|1|||
163834305|NCT01216163|591763061|FG002|Overall Study|Withdrawal by Subject|0|||
163834306|NCT02914314|591763062|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
163834307|NCT02914314|591763063|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
163834308|NCT02914314|591763064|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
163834309|NCT02914314|591763065|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
163834310|NCT02914314|591763062|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
163834311|NCT02914314|591763063|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
163834312|NCT02914314|591763064|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
163834313|NCT02914314|591763065|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
163834314|NCT02914314|591763062|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
163834315|NCT02914314|591763063|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
163834316|NCT02914314|591763064|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
163834317|NCT02914314|591763065|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
163834318|NCT02914314|591763062|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
163834319|NCT02914314|591763063|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
163834320|NCT02914314|591763064|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
163834321|NCT02914314|591763065|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
163834322|NCT02914314|591763062|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
163834323|NCT02914314|591763063|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
163834324|NCT02914314|591763064|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
163834325|NCT02914314|591763065|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
163834326|NCT00532155|591763066|FG000|Overall Study|Adverse Event|66|||
163834327|NCT00532155|591763067|FG001|Overall Study|Adverse Event|123|||
163834328|NCT00532155|591763066|FG000|Overall Study|Lack of Efficacy|332|||
163834329|NCT00532155|591763067|FG001|Overall Study|Lack of Efficacy|255|||
163834330|NCT00532155|591763066|FG000|Overall Study|Protocol Violation|1|||
163834331|NCT00532155|591763067|FG001|Overall Study|Protocol Violation|3|||
163834332|NCT00532155|591763066|FG000|Overall Study|Lost to Follow-up|2|||
163834333|NCT00532155|591763067|FG001|Overall Study|Lost to Follow-up|0|||
163834334|NCT00532155|591763066|FG000|Overall Study|Physician Decision|16|||
163834335|NCT00532155|591763067|FG001|Overall Study|Physician Decision|15|||
163834336|NCT00532155|591763066|FG000|Overall Study|Withdrawal by Subject|23|||
163834337|NCT00532155|591763067|FG001|Overall Study|Withdrawal by Subject|44|||
163834338|NCT00532155|591763066|FG000|Overall Study|Consent withdrawn|5|||
163834339|NCT00532155|591763067|FG001|Overall Study|Consent withdrawn|7|||
163834340|NCT00532155|591763066|FG000|Overall Study|Moved|1|||
163834341|NCT00532155|591763067|FG001|Overall Study|Moved|0|||
164035433|NCT00810810|592488132|FG002|Overall Study|Physician Decision|1|||
164035434|NCT00810810|592488133|FG003|Overall Study|Physician Decision|5|||
164035435|NCT01896856|592488134|FG000|Overall Study|Transportation issues / Non-compliance|0|||
164035436|NCT01896856|592488135|FG001|Overall Study|Transportation issues / Non-compliance|0|||
164035437|NCT01896856|592488136|FG002|Overall Study|Transportation issues / Non-compliance|1|||
164035438|NCT01896856|592488137|FG003|Overall Study|Transportation issues / Non-compliance|0|||
164035439|NCT01896856|592488138|FG004|Overall Study|Transportation issues / Non-compliance|0|||
164035440|NCT01896856|592488139|FG005|Overall Study|Transportation issues / Non-compliance|0|||
164035441|NCT01156532|592488140|FG000|Overall Study|Family Reasons|1|||
164035442|NCT01156532|592488140|FG000|Overall Study|Lost to Follow-up|1|||
164035443|NCT02563925|592488143|FG000|Overall Study|Withdrawal by Subject|2|||
164035444|NCT00282867|592488147|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
163929464|NCT02366143|592114128|FG000|Overall Study|Death|307|||
163929465|NCT02366143|592114129|FG001|Overall Study|Death|278|||
163929466|NCT02366143|592114130|FG002|Overall Study|Death|280|||
163929467|NCT02366143|592114128|FG000|Overall Study|Lost to Follow-up|2|||
163929468|NCT02366143|592114129|FG001|Overall Study|Lost to Follow-up|4|||
163929469|NCT02366143|592114130|FG002|Overall Study|Lost to Follow-up|2|||
163929470|NCT02366143|592114128|FG000|Overall Study|Physician Decision|1|||
163929471|NCT02366143|592114129|FG001|Overall Study|Physician Decision|2|||
163929472|NCT02366143|592114130|FG002|Overall Study|Physician Decision|1|||
163929473|NCT02366143|592114128|FG000|Overall Study|Protocol Violation|0|||
163929474|NCT02366143|592114129|FG001|Overall Study|Protocol Violation|0|||
163929475|NCT02366143|592114130|FG002|Overall Study|Protocol Violation|2|||
163929476|NCT02366143|592114128|FG000|Overall Study|Withdrawal by Subject|16|||
163929477|NCT02366143|592114129|FG001|Overall Study|Withdrawal by Subject|17|||
164035445|NCT00282867|592488148|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
163929478|NCT02366143|592114130|FG002|Overall Study|Withdrawal by Subject|22|||
163929479|NCT02366143|592114128|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
163929480|NCT02366143|592114129|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
163929481|NCT02366143|592114130|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
163929482|NCT02366143|592114128|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
163929483|NCT02366143|592114129|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
163929484|NCT02366143|592114130|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
163929485|NCT02366143|592114128|FG000|Overall Study|Randomization Error|1|||
163929486|NCT02366143|592114129|FG001|Overall Study|Randomization Error|0|||
163929487|NCT02366143|592114130|FG002|Overall Study|Randomization Error|0|||
163929488|NCT02366143|592114128|FG000|Overall Study|PI Move and Site Closure|1|||
163929489|NCT02366143|592114129|FG001|Overall Study|PI Move and Site Closure|0|||
163929490|NCT02366143|592114130|FG002|Overall Study|PI Move and Site Closure|1|||
163929491|NCT02366143|592114128|FG000|Overall Study|Study Terminated By Sponsor|0|||
163929492|NCT02366143|592114129|FG001|Overall Study|Study Terminated By Sponsor|0|||
163929493|NCT02366143|592114130|FG002|Overall Study|Study Terminated By Sponsor|2|||
163929494|NCT02366143|592114128|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
163929495|NCT02366143|592114129|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
163929496|NCT02366143|592114130|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
163929497|NCT02366143|592114128|FG000|Overall Study|Patient moved to roll-over study|1|||
163929498|NCT02366143|592114129|FG001|Overall Study|Patient moved to roll-over study|19|||
163929499|NCT02366143|592114130|FG002|Overall Study|Patient moved to roll-over study|28|||
163929500|NCT02366143|592114128|FG000|Overall Study|Patient moved to commercial stock|0|||
163929501|NCT02366143|592114129|FG001|Overall Study|Patient moved to commercial stock|0|||
163929502|NCT02366143|592114130|FG002|Overall Study|Patient moved to commercial stock|1|||
163929503|NCT02366143|592114128|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
163929504|NCT02366143|592114129|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
163929505|NCT02366143|592114130|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
163929506|NCT02366143|592114128|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
163929507|NCT02366143|592114129|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
163929508|NCT02366143|592114130|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
163929509|NCT02366143|592114128|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
163929510|NCT02366143|592114129|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
163929511|NCT02366143|592114130|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
163929512|NCT02366143|592114128|FG000|Overall Study|Requester's instructions|1|||
163929513|NCT02366143|592114129|FG001|Overall Study|Requester's instructions|1|||
163929514|NCT02366143|592114130|FG002|Overall Study|Requester's instructions|1|||
163929515|NCT02366143|592114128|FG000|Overall Study|Uneligible|0|||
163929516|NCT02366143|592114129|FG001|Overall Study|Uneligible|1|||
163929517|NCT02366143|592114130|FG002|Overall Study|Uneligible|0|||
164035446|NCT00282867|592488149|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
164035447|NCT04311177|592488157|FG000|Overall Study|Adverse Event|3|||
164035448|NCT04311177|592488158|FG001|Overall Study|Adverse Event|1|||
164035449|NCT04311177|592488157|FG000|Overall Study|Physician Decision|4|||
164035450|NCT04311177|592488158|FG001|Overall Study|Physician Decision|3|||
164035451|NCT04311177|592488157|FG000|Overall Study|Withdrawal by Subject|1|||
163929518|NCT02366143|592114128|FG000|Overall Study|Post Trial Migration|0|||
164035452|NCT04311177|592488158|FG001|Overall Study|Withdrawal by Subject|0|||
164035453|NCT00507416|592488159|FG000|Overall Study|Adverse Event|58|||
164035454|NCT00507416|592488160|FG001|Overall Study|Adverse Event|67|||
163929519|NCT02366143|592114129|FG001|Overall Study|Post Trial Migration|1|||
163929520|NCT02366143|592114130|FG002|Overall Study|Post Trial Migration|0|||
163929521|NCT02366143|592114128|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
163929522|NCT02366143|592114129|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
163929523|NCT02366143|592114130|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
163929524|NCT02366143|592114128|FG000|Overall Study|Patient switched to PTAP|0|||
163929525|NCT02366143|592114129|FG001|Overall Study|Patient switched to PTAP|1|||
163929526|NCT02366143|592114130|FG002|Overall Study|Patient switched to PTAP|0|||
163929527|NCT02366143|592114128|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
163929528|NCT02366143|592114129|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
163929529|NCT02366143|592114130|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
163929530|NCT01638390|592114131|FG000|Overall Study|screening failures|21|||
163929531|NCT01536587|592114134|FG000|Overall Study|Adverse Event|2|||
164035455|NCT00507416|592488161|FG002|Overall Study|Adverse Event|65|||
164035456|NCT00507416|592488159|FG000|Overall Study|Protocol Violation|1|||
164035457|NCT00507416|592488160|FG001|Overall Study|Protocol Violation|2|||
164035458|NCT00507416|592488161|FG002|Overall Study|Protocol Violation|0|||
164035459|NCT00507416|592488159|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
164035460|NCT00507416|592488160|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
164035461|NCT00507416|592488161|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
164035462|NCT00507416|592488159|FG000|Overall Study|Progressive Disease|20|||
164098175|NCT02457520|592725043|FG000|Active Treatment Phase|Protocol Violation|1|||
164098176|NCT02457520|592725043|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
164098177|NCT02457520|592725043|FG000|Post-treatment Period|Other: Retreatment Required|7|||
163929532|NCT02666664|592114135|FG000|Overall Study|Physician Decision|0|||
163929533|NCT02666664|592114136|FG001|Overall Study|Physician Decision|1|||
163929534|NCT02666664|592114135|FG000|Overall Study|Protocol Violation|0|||
163929535|NCT02666664|592114136|FG001|Overall Study|Protocol Violation|2|||
163929536|NCT02666664|592114135|FG000|Overall Study|Other|0|||
163929537|NCT02666664|592114136|FG001|Overall Study|Other|1|||
163929538|NCT02666664|592114135|FG000|Overall Study|Adverse Event|12|||
163929539|NCT02666664|592114136|FG001|Overall Study|Adverse Event|37|||
163929540|NCT02666664|592114135|FG000|Overall Study|Withdrawal by participant|23|||
163929541|NCT02666664|592114136|FG001|Overall Study|Withdrawal by participant|40|||
163929542|NCT02666664|592114135|FG000|Overall Study|Sponsor decision|0|||
163929543|NCT02666664|592114136|FG001|Overall Study|Sponsor decision|1|||
163929544|NCT02666664|592114135|FG000|Overall Study|Lost to Follow-up|1|||
163929545|NCT02666664|592114136|FG001|Overall Study|Lost to Follow-up|2|||
163929546|NCT05923112|592114137|FG000|Overall Study|Protocol Violation|4|||
163929547|NCT05923112|592114137|FG000|Overall Study|No informed consent on publication of study results|243|||
163929548|NCT03210519|592114138|FG000|Overall Study|Adverse Event|2|||
163929549|NCT03210519|592114139|FG001|Overall Study|Adverse Event|0|||
163929550|NCT03865953|592114142|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
163929551|NCT03865953|592114143|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163929552|NCT03865953|592114142|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
163929553|NCT03865953|592114143|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
163929554|NCT03865953|592114142|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
163929555|NCT03865953|592114143|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
163929556|NCT03021551|592114144|FG000|Overall Study|Equipment Issues|2|||
163929557|NCT03021551|592114144|FG000|Overall Study|Protocol Violation|1|||
163929558|NCT00490945|592114147|FG000|Overall Study|Adverse Event|0|||
163929559|NCT00490945|592114148|FG001|Overall Study|Adverse Event|1|||
163929560|NCT00490945|592114149|FG002|Overall Study|Adverse Event|0|||
163929561|NCT00490945|592114150|FG003|Overall Study|Adverse Event|0|||
163929562|NCT00490945|592114151|FG004|Overall Study|Adverse Event|0|||
164035463|NCT00507416|592488160|FG001|Overall Study|Progressive Disease|10|||
164035464|NCT00507416|592488161|FG002|Overall Study|Progressive Disease|13|||
164035465|NCT00507416|592488159|FG000|Overall Study|Patient declined further treatment|18|||
164035466|NCT00507416|592488160|FG001|Overall Study|Patient declined further treatment|14|||
164035467|NCT00507416|592488161|FG002|Overall Study|Patient declined further treatment|11|||
164098178|NCT02457520|592725043|FG000|Post-treatment Period|Lost to Follow-up|23|||
164098179|NCT02457520|592725043|FG000|Post-treatment Period|Other|3|||
164098180|NCT02457520|592725043|FG000|Post-treatment Period|Physician Decision|1|||
164035468|NCT00507416|592488159|FG000|Overall Study|Other|11|||
164035469|NCT00507416|592488160|FG001|Overall Study|Other|16|||
164035470|NCT00507416|592488161|FG002|Overall Study|Other|13|||
163929563|NCT00412880|592114152|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
163929564|NCT00412880|592114152|FG000|Overall Study|Consent withdrawn|1|||
163929565|NCT00412880|592114152|FG000|Overall Study|Adverse Event|1|||
163929566|NCT00412880|592114152|FG000|Overall Study|Progressive disease|20|||
163929567|NCT02232399|592114153|FG000|Overall Study|Adverse Event|1|||
163929568|NCT02232399|592114154|FG001|Overall Study|Adverse Event|0|||
163929569|NCT02232399|592114153|FG000|Overall Study|Withdrawal by Subject|0|||
163929570|NCT02232399|592114154|FG001|Overall Study|Withdrawal by Subject|1|||
164035471|NCT00507416|592488159|FG000|Overall Study|Did not Receive Study Treatment|3|||
164035472|NCT00507416|592488160|FG001|Overall Study|Did not Receive Study Treatment|9|||
164035473|NCT00507416|592488161|FG002|Overall Study|Did not Receive Study Treatment|4|||
164035474|NCT03101514|592488162|FG000|Overall Study|Withdrawal by Subject|4|||
164035475|NCT03101514|592488162|FG000|Overall Study|Protocol Violation|2|||
164035476|NCT03101514|592488162|FG000|Overall Study|patient's information was incomplete|1|||
163834342|NCT00532155|591763066|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
163834343|NCT00532155|591763067|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
163834344|NCT00532155|591763066|FG000|Overall Study|Occurence of a second cancer|0|||
163834345|NCT00532155|591763067|FG001|Overall Study|Occurence of a second cancer|1|||
163834346|NCT00532155|591763066|FG000|Overall Study|Occurence of a secondary cancer|0|||
163834347|NCT00532155|591763067|FG001|Overall Study|Occurence of a secondary cancer|1|||
163834348|NCT00532155|591763066|FG000|Overall Study|Promotor ended study|1|||
163834349|NCT00532155|591763067|FG001|Overall Study|Promotor ended study|0|||
163834350|NCT00532155|591763066|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
163834351|NCT00532155|591763067|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
163834352|NCT00532155|591763066|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
163834353|NCT00532155|591763067|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
163834354|NCT00532155|591763066|FG000|Overall Study|Study stopped|1|||
163834355|NCT00532155|591763067|FG001|Overall Study|Study stopped|0|||
163834356|NCT00532155|591763066|FG000|Overall Study|Study terminated by sponsor|1|||
163834357|NCT00532155|591763067|FG001|Overall Study|Study terminated by sponsor|0|||
163834358|NCT00532155|591763066|FG000|Overall Study|Study termination stop further treatment|4|||
163834359|NCT00532155|591763067|FG001|Overall Study|Study termination stop further treatment|0|||
163834360|NCT00532155|591763066|FG000|Overall Study|Did not receive study medication|2|||
163834361|NCT00532155|591763067|FG001|Overall Study|Did not receive study medication|6|||
163834362|NCT03483038|591763068|FG000|Overall Study|Subjects still in follow-up|18|||
163834363|NCT03635489|591763069|FG000|Overall Study|Death|19|||
163834364|NCT03635489|591763070|FG001|Overall Study|Death|13|||
163834365|NCT03635489|591763069|FG000|Overall Study|Lost to Follow-up|1|||
163834366|NCT03635489|591763070|FG001|Overall Study|Lost to Follow-up|2|||
163834367|NCT03635489|591763069|FG000|Overall Study|Withdrawal by Subject|1|||
163834368|NCT03635489|591763070|FG001|Overall Study|Withdrawal by Subject|2|||
163834369|NCT03635489|591763069|FG000|Overall Study|Study Ended by Sponsor|28|||
163834370|NCT03635489|591763070|FG001|Overall Study|Study Ended by Sponsor|34|||
163834371|NCT01368900|591763071|FG000|Overall Study|Lost to Follow-up|7|||
163834372|NCT04027348|591763076|FG000|Overall Study|Adverse Event|2|||
163834373|NCT02487472|591763077|FG000|Overall Study|Did not complete telephonic interviews|9|||
163834374|NCT02487472|591763077|FG000|Overall Study|Other|2|||
163834375|NCT01313286|591763078|FG000|Period 1|Withdrawal by Subject|2|||
163834376|NCT01313286|591763079|FG001|Period 1|Withdrawal by Subject|0|||
163834377|NCT00654901|591763080|FG000|Overall Study|Lost to Follow-up|1|||
163834378|NCT00654901|591763081|FG001|Overall Study|Lost to Follow-up|0|||
163834379|NCT00654901|591763082|FG002|Overall Study|Lost to Follow-up|1|||
163834380|NCT00654901|591763083|FG003|Overall Study|Lost to Follow-up|0|||
163834381|NCT00654901|591763080|FG000|Overall Study|Withdrawal by Subject|3|||
163834382|NCT00654901|591763081|FG001|Overall Study|Withdrawal by Subject|0|||
163834383|NCT00654901|591763082|FG002|Overall Study|Withdrawal by Subject|1|||
163834384|NCT00654901|591763083|FG003|Overall Study|Withdrawal by Subject|0|||
163834385|NCT04843930|591763085|FG000|Randomization|Withdrawal by Subject|6|||
163834386|NCT04843930|591763086|FG001|Randomization|Withdrawal by Subject|6|||
163834387|NCT04843930|591763087|FG002|Randomization|Withdrawal by Subject|0|||
163834388|NCT04843930|591763088|FG003|Randomization|Withdrawal by Subject|0|||
163834389|NCT04843930|591763085|FG000|Week 6 Assessment|Adverse Event|3|||
163834390|NCT04843930|591763086|FG001|Week 6 Assessment|Adverse Event|0|||
163834391|NCT04843930|591763087|FG002|Week 6 Assessment|Adverse Event|0|||
163834392|NCT04843930|591763088|FG003|Week 6 Assessment|Adverse Event|0|||
163834393|NCT04843930|591763085|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
163834394|NCT04843930|591763086|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
163834395|NCT04843930|591763087|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
163834396|NCT04843930|591763088|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
163834397|NCT04843930|591763085|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
163834398|NCT04843930|591763086|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
163834399|NCT04843930|591763087|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
163834400|NCT04843930|591763088|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
163834401|NCT02552238|591763089|FG000|Overall Study|Withdrawal by Subject|2|||
163834402|NCT02552238|591763089|FG000|Overall Study|Adverse Event|2|||
163834403|NCT02010632|591763090|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
163834404|NCT02010632|591763091|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
163834405|NCT02404389|591763092|FG000|Overall Study|Adverse Event|1|||
163834406|NCT02404389|591763093|FG001|Overall Study|Adverse Event|0|||
163834407|NCT02404389|591763094|FG002|Overall Study|Adverse Event|1|||
163834408|NCT02404389|591763095|FG003|Overall Study|Adverse Event|0|||
163834409|NCT02404389|591763096|FG004|Overall Study|Adverse Event|2|||
163834410|NCT02404389|591763092|FG000|Overall Study|Subject/guardian decision|1|||
164035477|NCT00673894|592488170|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
164035478|NCT00673894|592488171|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
163834411|NCT02404389|591763093|FG001|Overall Study|Subject/guardian decision|0|||
163834412|NCT02404389|591763094|FG002|Overall Study|Subject/guardian decision|0|||
163834413|NCT02404389|591763095|FG003|Overall Study|Subject/guardian decision|1|||
163834414|NCT02404389|591763096|FG004|Overall Study|Subject/guardian decision|1|||
163834415|NCT01576718|591763097|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
163834416|NCT01576718|591763098|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163834417|NCT01576718|591763099|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163834418|NCT01576718|591763100|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163834419|NCT01576718|591763101|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163834420|NCT01576718|591763102|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163834421|NCT01576718|591763103|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
163834422|NCT01576718|591763097|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
163834423|NCT01576718|591763098|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163834424|NCT01576718|591763099|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163834425|NCT01576718|591763100|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163834426|NCT01576718|591763101|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163834427|NCT01576718|591763102|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163834428|NCT01576718|591763103|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
163834429|NCT01576718|591763097|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
163834430|NCT01576718|591763098|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163834431|NCT01576718|591763099|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163834432|NCT01576718|591763100|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163834433|NCT01576718|591763101|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163834434|NCT01576718|591763102|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163834435|NCT01576718|591763103|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
163834436|NCT01576718|591763097|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
163834437|NCT01576718|591763098|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163834438|NCT01576718|591763099|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163834439|NCT01576718|591763100|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163834440|NCT01576718|591763101|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163834441|NCT01576718|591763102|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163834442|NCT01576718|591763103|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
163834443|NCT01576718|591763097|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
163834444|NCT01576718|591763098|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163834445|NCT01576718|591763099|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163834446|NCT01576718|591763100|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163834447|NCT01576718|591763101|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163834448|NCT01576718|591763102|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163834449|NCT01576718|591763103|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
163834450|NCT01576718|591763097|FG000|Treatment Period|Adverse Event|0|||
163834451|NCT01576718|591763098|FG001|Treatment Period|Adverse Event|1|||
163834452|NCT01576718|591763099|FG002|Treatment Period|Adverse Event|1|||
163834453|NCT01576718|591763100|FG003|Treatment Period|Adverse Event|1|||
163834454|NCT01576718|591763101|FG004|Treatment Period|Adverse Event|1|||
163834455|NCT01576718|591763102|FG005|Treatment Period|Adverse Event|1|||
163834456|NCT01576718|591763103|FG006|Treatment Period|Adverse Event|0|||
163834457|NCT01576718|591763097|FG000|Treatment Period|Withdrawal by Subject|0|||
163834458|NCT01576718|591763098|FG001|Treatment Period|Withdrawal by Subject|1|||
163834459|NCT01576718|591763099|FG002|Treatment Period|Withdrawal by Subject|1|||
163834460|NCT01576718|591763100|FG003|Treatment Period|Withdrawal by Subject|0|||
163834461|NCT01576718|591763101|FG004|Treatment Period|Withdrawal by Subject|2|||
163834462|NCT01576718|591763102|FG005|Treatment Period|Withdrawal by Subject|4|||
163834463|NCT01576718|591763103|FG006|Treatment Period|Withdrawal by Subject|2|||
163834464|NCT01576718|591763097|FG000|Treatment Period|Physician Decision|0|||
163834465|NCT01576718|591763098|FG001|Treatment Period|Physician Decision|1|||
163834466|NCT01576718|591763099|FG002|Treatment Period|Physician Decision|1|||
163834467|NCT01576718|591763100|FG003|Treatment Period|Physician Decision|1|||
163834468|NCT01576718|591763101|FG004|Treatment Period|Physician Decision|1|||
163834469|NCT01576718|591763102|FG005|Treatment Period|Physician Decision|0|||
163834470|NCT01576718|591763103|FG006|Treatment Period|Physician Decision|0|||
163834471|NCT01576718|591763097|FG000|Treatment Period|Protocol Violation|0|||
163834472|NCT01576718|591763098|FG001|Treatment Period|Protocol Violation|5|||
163834473|NCT01576718|591763099|FG002|Treatment Period|Protocol Violation|4|||
163834474|NCT01576718|591763100|FG003|Treatment Period|Protocol Violation|10|||
163834475|NCT01576718|591763101|FG004|Treatment Period|Protocol Violation|6|||
163834476|NCT01576718|591763102|FG005|Treatment Period|Protocol Violation|8|||
163834477|NCT01576718|591763103|FG006|Treatment Period|Protocol Violation|12|||
163834478|NCT01576718|591763097|FG000|Treatment Period|Sponsor request|0|||
163834479|NCT01576718|591763098|FG001|Treatment Period|Sponsor request|1|||
163929571|NCT02706951|592114161|FG000|Period 1|Adverse Event|1|||
163929572|NCT02706951|592114162|FG001|Period 1|Adverse Event|5|||
163929573|NCT02706951|592114163|FG002|Period 1|Adverse Event|3|||
163929574|NCT02706951|592114164|FG003|Period 1|Adverse Event|0|||
163929575|NCT02706951|592114165|FG004|Period 1|Adverse Event|0|||
163929576|NCT02706951|592114161|FG000|Period 1|Withdrawal by Subject|10|||
163929577|NCT02706951|592114162|FG001|Period 1|Withdrawal by Subject|6|||
163929578|NCT02706951|592114163|FG002|Period 1|Withdrawal by Subject|6|||
163929579|NCT02706951|592114164|FG003|Period 1|Withdrawal by Subject|0|||
163929580|NCT02706951|592114165|FG004|Period 1|Withdrawal by Subject|0|||
163929581|NCT02706951|592114161|FG000|Period 1|Lost to Follow-up|0|||
163929582|NCT02706951|592114162|FG001|Period 1|Lost to Follow-up|4|||
163929583|NCT02706951|592114163|FG002|Period 1|Lost to Follow-up|1|||
163929584|NCT02706951|592114164|FG003|Period 1|Lost to Follow-up|0|||
163929585|NCT02706951|592114165|FG004|Period 1|Lost to Follow-up|0|||
163929586|NCT02706951|592114161|FG000|Period 1|Other|2|||
163929587|NCT02706951|592114162|FG001|Period 1|Other|1|||
163929588|NCT02706951|592114163|FG002|Period 1|Other|0|||
163929589|NCT02706951|592114164|FG003|Period 1|Other|0|||
163929590|NCT02706951|592114165|FG004|Period 1|Other|0|||
163929591|NCT02706951|592114161|FG000|Period 2|Adverse Event|0|||
163929592|NCT02706951|592114162|FG001|Period 2|Adverse Event|0|||
163929593|NCT02706951|592114163|FG002|Period 2|Adverse Event|0|||
163929594|NCT02706951|592114164|FG003|Period 2|Adverse Event|25|||
163929595|NCT02706951|592114165|FG004|Period 2|Adverse Event|34|||
163929596|NCT02706951|592114161|FG000|Period 2|Withdrawal by Subject|0|||
163929597|NCT02706951|592114162|FG001|Period 2|Withdrawal by Subject|0|||
163929598|NCT02706951|592114163|FG002|Period 2|Withdrawal by Subject|0|||
163929599|NCT02706951|592114164|FG003|Period 2|Withdrawal by Subject|38|||
163929600|NCT02706951|592114165|FG004|Period 2|Withdrawal by Subject|44|||
163929601|NCT02706951|592114161|FG000|Period 2|Lost to Follow-up|0|||
163929602|NCT02706951|592114162|FG001|Period 2|Lost to Follow-up|0|||
163929603|NCT02706951|592114163|FG002|Period 2|Lost to Follow-up|0|||
163929604|NCT02706951|592114164|FG003|Period 2|Lost to Follow-up|17|||
163929605|NCT02706951|592114165|FG004|Period 2|Lost to Follow-up|9|||
163929606|NCT02706951|592114161|FG000|Period 2|COVID-19 Related|0|||
163929607|NCT02706951|592114162|FG001|Period 2|COVID-19 Related|0|||
163929608|NCT02706951|592114163|FG002|Period 2|COVID-19 Related|0|||
163929609|NCT02706951|592114164|FG003|Period 2|COVID-19 Related|1|||
163929610|NCT02706951|592114165|FG004|Period 2|COVID-19 Related|2|||
163929611|NCT02706951|592114161|FG000|Period 2|Other|0|||
163929612|NCT02706951|592114162|FG001|Period 2|Other|0|||
163929613|NCT02706951|592114163|FG002|Period 2|Other|0|||
164035479|NCT00673894|592488170|FG000|First Intervention 4 Weeks|Adverse Event|1|||
164035480|NCT00673894|592488171|FG001|First Intervention 4 Weeks|Adverse Event|0|||
164035481|NCT02726113|592488180|FG000|Total Enrollment|Physician Decision|0|||
164035482|NCT02726113|592488181|FG001|Total Enrollment|Physician Decision|1|||
164035483|NCT02726113|592488180|FG000|Total Enrollment|Protocol Violation|1|||
164035484|NCT02726113|592488181|FG001|Total Enrollment|Protocol Violation|0|||
164035485|NCT02726113|592488180|FG000|Total Enrollment|Withdrawal by Subject|2|||
164035486|NCT02726113|592488181|FG001|Total Enrollment|Withdrawal by Subject|1|||
164035487|NCT02726113|592488180|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
164035488|NCT02726113|592488181|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
164035489|NCT02726113|592488180|FG000|Genomic Analysis|Protocol Violation|1|||
164035490|NCT02726113|592488181|FG001|Genomic Analysis|Protocol Violation|0|||
164035491|NCT02726113|592488180|FG000|Genomic Analysis|Withdrawal by Subject|2|||
164035492|NCT02726113|592488181|FG001|Genomic Analysis|Withdrawal by Subject|1|||
164035493|NCT02726113|592488180|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
164035494|NCT02726113|592488181|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
164035495|NCT03549117|592488182|FG000|Overall Study|Withdrawal by Subject|1|||
164035496|NCT03549117|592488183|FG001|Overall Study|Withdrawal by Subject|0|||
164035497|NCT00637377|592488184|FG000|Overall Study|Adverse Event|2|||
164035498|NCT00637377|592488185|FG001|Overall Study|Adverse Event|6|||
164035499|NCT00637377|592488186|FG002|Overall Study|Adverse Event|8|||
164035500|NCT00637377|592488187|FG003|Overall Study|Adverse Event|9|||
164035501|NCT00637377|592488184|FG000|Overall Study|Death|1|||
163929614|NCT02706951|592114164|FG003|Period 2|Other|37|||
163929615|NCT02706951|592114165|FG004|Period 2|Other|31|||
163929616|NCT03491215|592114166|FG000|Overall Study|Death|6|||
163929617|NCT03491215|592114167|FG001|Overall Study|Death|2|||
163929618|NCT03491215|592114168|FG002|Overall Study|Death|1|||
163929619|NCT03491215|592114169|FG003|Overall Study|Death|0|||
163929620|NCT03491215|592114166|FG000|Overall Study|Physician Decision|1|||
163929621|NCT03491215|592114167|FG001|Overall Study|Physician Decision|0|||
163929622|NCT03491215|592114168|FG002|Overall Study|Physician Decision|0|||
164035502|NCT00637377|592488185|FG001|Overall Study|Death|3|||
164035503|NCT00637377|592488186|FG002|Overall Study|Death|2|||
164035504|NCT00637377|592488187|FG003|Overall Study|Death|1|||
163929623|NCT03491215|592114169|FG003|Overall Study|Physician Decision|0|||
163929624|NCT04799418|592114184|FG000|Overall Study|Death|1|||
163929625|NCT04799418|592114185|FG001|Overall Study|Death|1|||
163929626|NCT04799418|592114184|FG000|Overall Study|Lack of Efficacy|14|||
164035505|NCT00637377|592488184|FG000|Overall Study|Lack of Efficacy|0|||
163929627|NCT04799418|592114185|FG001|Overall Study|Lack of Efficacy|14|||
163929628|NCT04799418|592114184|FG000|Overall Study|Withdrawal by Subject|10|||
163929629|NCT04799418|592114185|FG001|Overall Study|Withdrawal by Subject|7|||
163929630|NCT04799418|592114184|FG000|Overall Study|Adverse Event|3|||
163929631|NCT04799418|592114185|FG001|Overall Study|Adverse Event|2|||
164035506|NCT00637377|592488185|FG001|Overall Study|Lack of Efficacy|0|||
164035507|NCT00637377|592488186|FG002|Overall Study|Lack of Efficacy|1|||
164035508|NCT00637377|592488187|FG003|Overall Study|Lack of Efficacy|1|||
164035509|NCT00637377|592488184|FG000|Overall Study|Lost to Follow-up|4|||
164035510|NCT00637377|592488185|FG001|Overall Study|Lost to Follow-up|1|||
164035511|NCT00637377|592488186|FG002|Overall Study|Lost to Follow-up|2|||
164035512|NCT00637377|592488187|FG003|Overall Study|Lost to Follow-up|2|||
164035513|NCT00637377|592488184|FG000|Overall Study|Protocol Violation|2|||
164035514|NCT00637377|592488185|FG001|Overall Study|Protocol Violation|1|||
164035515|NCT00637377|592488186|FG002|Overall Study|Protocol Violation|1|||
164035516|NCT00637377|592488187|FG003|Overall Study|Protocol Violation|0|||
164035517|NCT00637377|592488184|FG000|Overall Study|Withdrawal by Subject|11|||
164035518|NCT00637377|592488185|FG001|Overall Study|Withdrawal by Subject|15|||
164035519|NCT00637377|592488186|FG002|Overall Study|Withdrawal by Subject|13|||
164035520|NCT00637377|592488187|FG003|Overall Study|Withdrawal by Subject|11|||
163834480|NCT01576718|591763099|FG002|Treatment Period|Sponsor request|0|||
163834481|NCT01576718|591763100|FG003|Treatment Period|Sponsor request|0|||
163834482|NCT01576718|591763101|FG004|Treatment Period|Sponsor request|0|||
163834483|NCT01576718|591763102|FG005|Treatment Period|Sponsor request|1|||
163834484|NCT01576718|591763103|FG006|Treatment Period|Sponsor request|0|||
163834485|NCT01576718|591763097|FG000|Treatment Period|Met stopping criteria|0|||
163834486|NCT01576718|591763098|FG001|Treatment Period|Met stopping criteria|16|||
163834487|NCT01576718|591763099|FG002|Treatment Period|Met stopping criteria|13|||
163834488|NCT01576718|591763100|FG003|Treatment Period|Met stopping criteria|19|||
163834489|NCT01576718|591763101|FG004|Treatment Period|Met stopping criteria|16|||
163834490|NCT01576718|591763102|FG005|Treatment Period|Met stopping criteria|33|||
163834491|NCT01576718|591763103|FG006|Treatment Period|Met stopping criteria|15|||
163929632|NCT03297398|592114186|FG000|Overall Study|Sponsor's decision|6|||
163929633|NCT03297398|592114187|FG001|Overall Study|Sponsor's decision|9|||
163929634|NCT03297398|592114188|FG002|Overall Study|Sponsor's decision|7|||
164035521|NCT00637377|592488184|FG000|Overall Study|Other (no further information available)|7|||
164035522|NCT00637377|592488185|FG001|Overall Study|Other (no further information available)|6|||
164035523|NCT00637377|592488186|FG002|Overall Study|Other (no further information available)|10|||
164035524|NCT00637377|592488187|FG003|Overall Study|Other (no further information available)|5|||
164035525|NCT01293084|592488189|FG000|Overall Study|Physician Decision|3|||
164035526|NCT01293084|592488189|FG000|Overall Study|Withdrawal by Subject|2|||
164035527|NCT00107172|592490231|FG000|Overall Study|Withdrawal by Subject|1|||
164035528|NCT00107172|592490232|FG001|Overall Study|Withdrawal by Subject|0|||
164035529|NCT00107172|592490231|FG000|Overall Study|Death|0|||
164035530|NCT00107172|592490232|FG001|Overall Study|Death|2|||
164035531|NCT00107172|592490231|FG000|Overall Study|Other Reason|4|||
164035532|NCT00107172|592490232|FG001|Overall Study|Other Reason|3|||
164035533|NCT04268303|592490233|FG000|Overall Study|Lost to Follow-up|1|||
164035534|NCT04268303|592490234|FG001|Overall Study|Lost to Follow-up|1|||
164035535|NCT04268303|592490235|FG002|Overall Study|Lost to Follow-up|2|||
164035536|NCT04268303|592490233|FG000|Overall Study|Withdrawal by Subject|0|||
164035537|NCT04268303|592490234|FG001|Overall Study|Withdrawal by Subject|1|||
164035538|NCT04268303|592490235|FG002|Overall Study|Withdrawal by Subject|1|||
164035539|NCT04268303|592490233|FG000|Overall Study|Adverse Event|2|||
164035540|NCT04268303|592490234|FG001|Overall Study|Adverse Event|0|||
164035541|NCT04268303|592490235|FG002|Overall Study|Adverse Event|0|||
164035542|NCT00355134|592490236|FG000|Core Phase|Withdrawal by Subject|35|||
164035543|NCT00355134|592490237|FG001|Core Phase|Withdrawal by Subject|24|||
164035544|NCT00355134|592490238|FG002|Core Phase|Withdrawal by Subject|35|||
164035545|NCT00355134|592490239|FG003|Core Phase|Withdrawal by Subject|0|||
164035546|NCT00355134|592490240|FG004|Core Phase|Withdrawal by Subject|0|||
164035547|NCT00355134|592490236|FG000|Core Phase|Adverse Event|28|||
164035548|NCT00355134|592490237|FG001|Core Phase|Adverse Event|22|||
164035549|NCT00355134|592490238|FG002|Core Phase|Adverse Event|16|||
164147612|NCT03685344|592902085|FG001|Overall Study|Death|1|||
163834492|NCT01576718|591763097|FG000|Treatment Period|Lost to Follow-up|0|||
163834493|NCT01576718|591763098|FG001|Treatment Period|Lost to Follow-up|0|||
163929635|NCT03297398|592114186|FG000|Overall Study|Adverse Event|1|||
164035550|NCT00355134|592490239|FG003|Core Phase|Adverse Event|0|||
164035551|NCT00355134|592490240|FG004|Core Phase|Adverse Event|0|||
164035552|NCT00355134|592490236|FG000|Core Phase|Lost to Follow-up|17|||
164035553|NCT00355134|592490237|FG001|Core Phase|Lost to Follow-up|13|||
164035554|NCT00355134|592490238|FG002|Core Phase|Lost to Follow-up|21|||
164035555|NCT00355134|592490239|FG003|Core Phase|Lost to Follow-up|0|||
164035556|NCT00355134|592490240|FG004|Core Phase|Lost to Follow-up|0|||
164035557|NCT00355134|592490236|FG000|Core Phase|Abnormal laboratory value(s)|19|||
164035558|NCT00355134|592490237|FG001|Core Phase|Abnormal laboratory value(s)|14|||
164035559|NCT00355134|592490238|FG002|Core Phase|Abnormal laboratory value(s)|2|||
164035560|NCT00355134|592490239|FG003|Core Phase|Abnormal laboratory value(s)|0|||
163929636|NCT03297398|592114187|FG001|Overall Study|Adverse Event|4|||
163929637|NCT03297398|592114188|FG002|Overall Study|Adverse Event|4|||
163929638|NCT03297398|592114186|FG000|Overall Study|Withdrawal by Subject|1|||
163929639|NCT03297398|592114187|FG001|Overall Study|Withdrawal by Subject|2|||
163929640|NCT03297398|592114188|FG002|Overall Study|Withdrawal by Subject|2|||
163929641|NCT03297398|592114186|FG000|Overall Study|Protocol Violation|0|||
163929642|NCT03297398|592114187|FG001|Overall Study|Protocol Violation|2|||
163929643|NCT03297398|592114188|FG002|Overall Study|Protocol Violation|0|||
163929644|NCT03297398|592114186|FG000|Overall Study|Physician Decision|0|||
163929645|NCT03297398|592114187|FG001|Overall Study|Physician Decision|0|||
163929646|NCT03297398|592114188|FG002|Overall Study|Physician Decision|1|||
163929647|NCT03297398|592114186|FG000|Overall Study|Lost to Follow-up|0|||
163929648|NCT03297398|592114187|FG001|Overall Study|Lost to Follow-up|0|||
163929649|NCT03297398|592114188|FG002|Overall Study|Lost to Follow-up|1|||
163929650|NCT00611715|592114193|FG000|Overall Study|Disease Progression|24|||
163929651|NCT00611715|592114194|FG001|Overall Study|Disease Progression|4|||
163929652|NCT00611715|592114193|FG000|Overall Study|Withdrawal by Subject|5|||
163929653|NCT00611715|592114194|FG001|Overall Study|Withdrawal by Subject|1|||
163929654|NCT00611715|592114193|FG000|Overall Study|Adverse Event|9|||
163929655|NCT00611715|592114194|FG001|Overall Study|Adverse Event|1|||
163929656|NCT00611715|592114193|FG000|Overall Study|Death|1|||
163929657|NCT00611715|592114194|FG001|Overall Study|Death|0|||
163929658|NCT00611715|592114193|FG000|Overall Study|two patients are still on treatment|2|||
163929659|NCT00611715|592114194|FG001|Overall Study|two patients are still on treatment|0|||
163929660|NCT00107978|592114195|FG000|Overall Study|Adverse Event|1|||
163929661|NCT00107978|592114196|FG001|Overall Study|Adverse Event|5|||
163929662|NCT00107978|592114195|FG000|Overall Study|Death|3|||
163929663|NCT00107978|592114196|FG001|Overall Study|Death|3|||
163929664|NCT00107978|592114195|FG000|Overall Study|Lost to Follow-up|20|||
163929665|NCT00107978|592114196|FG001|Overall Study|Lost to Follow-up|28|||
163929666|NCT00107978|592114195|FG000|Overall Study|Withdrawal by Subject|4|||
163929667|NCT00107978|592114196|FG001|Overall Study|Withdrawal by Subject|9|||
163929668|NCT00107978|592114195|FG000|Overall Study|Protocol Violation|0|||
163929669|NCT00107978|592114196|FG001|Overall Study|Protocol Violation|1|||
163929670|NCT00107978|592114195|FG000|Overall Study|Other|5|||
163929671|NCT00107978|592114196|FG001|Overall Study|Other|4|||
163929672|NCT02669407|592114197|FG000|Overall Study|Physician Decision|3|||
163929673|NCT00350298|592114200|FG000|Overall Study|Death|7|||
163929674|NCT00350298|592114201|FG001|Overall Study|Death|8|||
163929675|NCT00350298|592114200|FG000|Overall Study|Lost to Follow-up|1|||
163929676|NCT00350298|592114201|FG001|Overall Study|Lost to Follow-up|2|||
163929677|NCT00350298|592114200|FG000|Overall Study|Withdrawal by Subject|1|||
163929678|NCT00350298|592114201|FG001|Overall Study|Withdrawal by Subject|3|||
163929679|NCT00233389|592114202|FG000|Overall Study|Adverse Event|5|||
163929680|NCT00233389|592114203|FG001|Overall Study|Adverse Event|5|||
163929681|NCT00233389|592114202|FG000|Overall Study|Lack of Efficacy|11|||
163929682|NCT00233389|592114203|FG001|Overall Study|Lack of Efficacy|8|||
163929683|NCT00233389|592114202|FG000|Overall Study|Lost to Follow-up|1|||
163929684|NCT00233389|592114203|FG001|Overall Study|Lost to Follow-up|1|||
163929685|NCT00233389|592114202|FG000|Overall Study|Physician Decision|1|||
163929686|NCT00233389|592114203|FG001|Overall Study|Physician Decision|0|||
163929687|NCT00233389|592114202|FG000|Overall Study|Protocol Violation|0|||
163929688|NCT00233389|592114203|FG001|Overall Study|Protocol Violation|1|||
163929689|NCT00233389|592114202|FG000|Overall Study|Withdrawal by Subject|0|||
163929690|NCT00233389|592114203|FG001|Overall Study|Withdrawal by Subject|1|||
163929691|NCT00719043|592114209|FG000|Overall Study|Adverse Event|5|||
163929692|NCT00719043|592114210|FG001|Overall Study|Adverse Event|1|||
163929693|NCT00719043|592114211|FG002|Overall Study|Adverse Event|2|||
163929694|NCT00719043|592114212|FG003|Overall Study|Adverse Event|2|||
163929695|NCT00719043|592114213|FG004|Overall Study|Adverse Event|1|||
163929696|NCT00719043|592114214|FG005|Overall Study|Adverse Event|4|||
163929697|NCT00719043|592114215|FG006|Overall Study|Adverse Event|4|||
163929698|NCT00719043|592114209|FG000|Overall Study|Lost to Follow-up|14|||
163929699|NCT00719043|592114210|FG001|Overall Study|Lost to Follow-up|10|||
163929700|NCT00719043|592114211|FG002|Overall Study|Lost to Follow-up|8|||
163929701|NCT00719043|592114212|FG003|Overall Study|Lost to Follow-up|9|||
163929702|NCT00719043|592114213|FG004|Overall Study|Lost to Follow-up|10|||
163929703|NCT00719043|592114214|FG005|Overall Study|Lost to Follow-up|9|||
163929704|NCT00719043|592114215|FG006|Overall Study|Lost to Follow-up|9|||
163929705|NCT00719043|592114209|FG000|Overall Study|Protocol Violation|0|||
163929706|NCT00719043|592114210|FG001|Overall Study|Protocol Violation|0|||
163929707|NCT00719043|592114211|FG002|Overall Study|Protocol Violation|0|||
163929708|NCT00719043|592114212|FG003|Overall Study|Protocol Violation|0|||
163929709|NCT00719043|592114213|FG004|Overall Study|Protocol Violation|0|||
163929710|NCT00719043|592114214|FG005|Overall Study|Protocol Violation|1|||
163929711|NCT00719043|592114215|FG006|Overall Study|Protocol Violation|0|||
163929712|NCT00719043|592114209|FG000|Overall Study|Other|1|||
163929713|NCT00719043|592114210|FG001|Overall Study|Other|0|||
163929714|NCT00719043|592114211|FG002|Overall Study|Other|1|||
163929715|NCT00719043|592114212|FG003|Overall Study|Other|2|||
163929716|NCT00719043|592114213|FG004|Overall Study|Other|0|||
163929717|NCT00719043|592114214|FG005|Overall Study|Other|2|||
163929718|NCT00719043|592114215|FG006|Overall Study|Other|1|||
163929719|NCT00719043|592114209|FG000|Overall Study|Withdrawal by Subject|12|||
163929720|NCT00719043|592114210|FG001|Overall Study|Withdrawal by Subject|14|||
163929721|NCT00719043|592114211|FG002|Overall Study|Withdrawal by Subject|9|||
163929722|NCT00719043|592114212|FG003|Overall Study|Withdrawal by Subject|10|||
163929723|NCT00719043|592114213|FG004|Overall Study|Withdrawal by Subject|16|||
163929724|NCT00719043|592114214|FG005|Overall Study|Withdrawal by Subject|18|||
163929725|NCT00719043|592114215|FG006|Overall Study|Withdrawal by Subject|14|||
163929726|NCT00822770|592114216|FG000|Overall Study|Not treated|1|||
163929727|NCT00822770|592114217|FG001|Overall Study|Not treated|0|||
163929728|NCT00822770|592114216|FG000|Overall Study|Complication/Incomplete treatment|1|||
163929729|NCT00822770|592114217|FG001|Overall Study|Complication/Incomplete treatment|0|||
163929730|NCT00822770|592114216|FG000|Overall Study|Death|1|||
163929731|NCT00822770|592114217|FG001|Overall Study|Death|1|||
163929732|NCT04593823|592114218|FG000|Overall Study|Withdrawal by Subject|1|||
163929733|NCT04593823|592114219|FG001|Overall Study|Withdrawal by Subject|1|||
163929734|NCT04593823|592114218|FG000|Overall Study|Lost to Follow-up|0|||
163929735|NCT04593823|592114219|FG001|Overall Study|Lost to Follow-up|1|||
163929736|NCT00952848|592114226|FG000|Overall Study|Withdrawal by Subject|4|||
163929737|NCT00217022|592114228|FG000|Overall Study|Withdrawal by Subject|1|||
163929738|NCT00217022|592114229|FG001|Overall Study|Withdrawal by Subject|1|||
163929739|NCT00458393|592114230|FG000|Overall Study|Withdrawal by Subject|67|||
163929740|NCT00458393|592114231|FG001|Overall Study|Withdrawal by Subject|80|||
163929741|NCT00458393|592114230|FG000|Overall Study|Physician Decision|31|||
163929742|NCT00458393|592114231|FG001|Overall Study|Physician Decision|22|||
163929743|NCT00458393|592114230|FG000|Overall Study|Relocated|77|||
163929744|NCT00458393|592114231|FG001|Overall Study|Relocated|81|||
163929745|NCT00458393|592114230|FG000|Overall Study|Lost to Follow-up|115|||
163929746|NCT00458393|592114231|FG001|Overall Study|Lost to Follow-up|92|||
163929747|NCT00458393|592114230|FG000|Overall Study|Sites marked other on the form.|19|||
163929748|NCT00458393|592114231|FG001|Overall Study|Sites marked other on the form.|20|||
163929749|NCT02725567|592114232|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
163929750|NCT02725567|592114233|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
163929751|NCT02725567|592114232|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
163929752|NCT02725567|592114233|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
163929753|NCT02725567|592114232|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
163929754|NCT02725567|592114233|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
163929755|NCT02777242|592114235|FG000|Overall Study|Other|2|||
163929756|NCT02777242|592114235|FG000|Overall Study|Lost to Follow-up|1|||
163929757|NCT02777242|592114235|FG000|Overall Study|Multiple|1|||
163929758|NCT02777242|592114235|FG000|Overall Study|Sponsor's request|1|||
163929759|NCT02777242|592114235|FG000|Overall Study|Withdrawal by Subject|1|||
163929760|NCT05178979|592114236|FG000|Overall Study|Death|0|||
163929761|NCT05178979|592114237|FG001|Overall Study|Death|5|||
163929762|NCT05178979|592114238|FG002|Overall Study|Death|0|||
163929763|NCT05178979|592114239|FG003|Overall Study|Death|3|||
163929764|NCT05178979|592114236|FG000|Overall Study|Adverse Event|0|||
164035561|NCT00355134|592490240|FG004|Core Phase|Abnormal laboratory value(s)|0|||
164035562|NCT00355134|592490236|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
164035563|NCT00355134|592490237|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
164035564|NCT00355134|592490238|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
164035565|NCT00355134|592490239|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
164035566|NCT00355134|592490240|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
164035567|NCT00355134|592490236|FG000|Core Phase|Administrative problems|5|||
164035568|NCT00355134|592490237|FG001|Core Phase|Administrative problems|3|||
164035569|NCT00355134|592490238|FG002|Core Phase|Administrative problems|5|||
164035570|NCT00355134|592490239|FG003|Core Phase|Administrative problems|0|||
164035571|NCT00355134|592490240|FG004|Core Phase|Administrative problems|0|||
164035572|NCT00355134|592490236|FG000|Core Phase|Protocol Violation|3|||
164035573|NCT00355134|592490237|FG001|Core Phase|Protocol Violation|2|||
164035574|NCT00355134|592490238|FG002|Core Phase|Protocol Violation|2|||
164035575|NCT00355134|592490239|FG003|Core Phase|Protocol Violation|0|||
163929765|NCT05178979|592114237|FG001|Overall Study|Adverse Event|1|||
163929766|NCT05178979|592114238|FG002|Overall Study|Adverse Event|0|||
163929767|NCT05178979|592114239|FG003|Overall Study|Adverse Event|0|||
163929768|NCT05178979|592114236|FG000|Overall Study|Lost to Follow-up|1|||
163929769|NCT05178979|592114237|FG001|Overall Study|Lost to Follow-up|8|||
163929770|NCT05178979|592114238|FG002|Overall Study|Lost to Follow-up|3|||
163929771|NCT05178979|592114239|FG003|Overall Study|Lost to Follow-up|8|||
163929772|NCT00817336|592114240|FG000|Overall Study|Withdrawal by Subject|1|||
163929773|NCT00817336|592114241|FG001|Overall Study|Withdrawal by Subject|1|||
163929774|NCT01704547|592114249|FG000|Overall Study|Physician Decision|4|||
163929775|NCT01704547|592114249|FG000|Overall Study|Withdrawal by Subject|1|||
163929776|NCT02413593|592114250|FG000|Overall Study|Lost to Follow-up|3|||
164035576|NCT00355134|592490240|FG004|Core Phase|Protocol Violation|0|||
164035577|NCT00355134|592490236|FG000|Core Phase|Abnormal test procedure result(s)|1|||
163929777|NCT02413593|592114250|FG000|Overall Study|Adverse Event|1|||
163929778|NCT03845075|592114251|FG000|Part 1 - DB|Withdrawal by Subject|1|||
163929779|NCT03845075|592114252|FG001|Part 1 - DB|Withdrawal by Subject|1|||
163929780|NCT03845075|592114253|FG002|Part 1 - DB|Withdrawal by Subject|0|||
163929781|NCT03845075|592114254|FG003|Part 1 - DB|Withdrawal by Subject|0|||
163929782|NCT03845075|592114251|FG000|Part 1 - DB|Adverse Event|0|||
163929783|NCT03845075|592114252|FG001|Part 1 - DB|Adverse Event|1|||
163929784|NCT03845075|592114253|FG002|Part 1 - DB|Adverse Event|0|||
163929785|NCT03845075|592114254|FG003|Part 1 - DB|Adverse Event|0|||
163929786|NCT03845075|592114251|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
163929787|NCT03845075|592114252|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
163929788|NCT03845075|592114253|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
163929789|NCT03845075|592114254|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
163929790|NCT02564718|592114255|FG000|Overall Study|Withdrew from treatment|0|||
163929791|NCT02564718|592114256|FG001|Overall Study|Withdrew from treatment|1|||
163929792|NCT00104637|592114257|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
163929793|NCT00104637|592114258|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
163929794|NCT00409409|592114259|FG000|Overall Study|Adverse Event|7|||
163929795|NCT00409409|592114260|FG001|Overall Study|Adverse Event|2|||
163929796|NCT00409409|592114259|FG000|Overall Study|Withdrawal by Subject|1|||
163929797|NCT00409409|592114260|FG001|Overall Study|Withdrawal by Subject|1|||
163929798|NCT00409409|592114259|FG000|Overall Study|Any other reason not above-mentioned|0|||
163929799|NCT00409409|592114260|FG001|Overall Study|Any other reason not above-mentioned|1|||
163929800|NCT01918371|592114264|FG000|Overall Study|Missing Data|1|||
163929801|NCT01918371|592114265|FG001|Overall Study|Missing Data|1|||
163929802|NCT03802617|592114270|FG000|Overall Study|Adverse Event|0|||
163929803|NCT03802617|592114271|FG001|Overall Study|Adverse Event|4|||
163929804|NCT03802617|592114272|FG002|Overall Study|Adverse Event|5|||
163929805|NCT03802617|592114273|FG003|Overall Study|Adverse Event|1|||
163929806|NCT03802617|592114270|FG000|Overall Study|Lack of Efficacy|0|||
163929807|NCT03802617|592114271|FG001|Overall Study|Lack of Efficacy|1|||
163929808|NCT03802617|592114272|FG002|Overall Study|Lack of Efficacy|0|||
163929809|NCT03802617|592114273|FG003|Overall Study|Lack of Efficacy|2|||
163929810|NCT03802617|592114270|FG000|Overall Study|Protocol Violation|1|||
163929811|NCT03802617|592114271|FG001|Overall Study|Protocol Violation|1|||
163929812|NCT03802617|592114272|FG002|Overall Study|Protocol Violation|1|||
163929813|NCT03802617|592114273|FG003|Overall Study|Protocol Violation|0|||
163929814|NCT03802617|592114270|FG000|Overall Study|Withdrawal by Subject|1|||
163929815|NCT03802617|592114271|FG001|Overall Study|Withdrawal by Subject|1|||
163929816|NCT03802617|592114272|FG002|Overall Study|Withdrawal by Subject|1|||
163929817|NCT03802617|592114273|FG003|Overall Study|Withdrawal by Subject|0|||
163929818|NCT03802617|592114270|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
163929819|NCT03802617|592114271|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
163929820|NCT03802617|592114272|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
163929821|NCT03802617|592114273|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
163929822|NCT00621192|592114274|FG000|Overall Study|Withdrawal by Subject|0|||
163929823|NCT00621192|592114275|FG001|Overall Study|Withdrawal by Subject|0|||
163929824|NCT00621192|592114276|FG002|Overall Study|Withdrawal by Subject|2|||
163929825|NCT00621192|592114277|FG003|Overall Study|Withdrawal by Subject|0|||
163929826|NCT00621192|592114274|FG000|Overall Study|Physician Decision|1|||
163929827|NCT00621192|592114275|FG001|Overall Study|Physician Decision|3|||
163929828|NCT00621192|592114276|FG002|Overall Study|Physician Decision|0|||
163929829|NCT00621192|592114277|FG003|Overall Study|Physician Decision|0|||
163929830|NCT00621192|592114274|FG000|Overall Study|Protocol Violation|1|||
163929831|NCT00621192|592114275|FG001|Overall Study|Protocol Violation|0|||
163929832|NCT00621192|592114276|FG002|Overall Study|Protocol Violation|0|||
163929833|NCT00621192|592114277|FG003|Overall Study|Protocol Violation|1|||
163929834|NCT00621192|592114274|FG000|Overall Study|Adverse Event|0|||
163929835|NCT00621192|592114275|FG001|Overall Study|Adverse Event|1|||
163929836|NCT00621192|592114276|FG002|Overall Study|Adverse Event|0|||
163929837|NCT00621192|592114277|FG003|Overall Study|Adverse Event|1|||
163929838|NCT00621192|592114274|FG000|Overall Study|Death|2|||
163929839|NCT00621192|592114275|FG001|Overall Study|Death|5|||
163929840|NCT00621192|592114276|FG002|Overall Study|Death|0|||
163929841|NCT00621192|592114277|FG003|Overall Study|Death|0|||
164035578|NCT00355134|592490237|FG001|Core Phase|Abnormal test procedure result(s)|2|||
164035579|NCT00355134|592490238|FG002|Core Phase|Abnormal test procedure result(s)|1|||
164035580|NCT00355134|592490239|FG003|Core Phase|Abnormal test procedure result(s)|0|||
163929842|NCT00621192|592114274|FG000|Overall Study|Final Assessments not Completed|0|||
163929843|NCT00621192|592114275|FG001|Overall Study|Final Assessments not Completed|0|||
163929844|NCT00621192|592114276|FG002|Overall Study|Final Assessments not Completed|3|||
163929845|NCT00621192|592114277|FG003|Overall Study|Final Assessments not Completed|1|||
163929846|NCT02635386|592114280|FG000|Overall Study|Pregnancy|2|||
163929847|NCT02635386|592114281|FG001|Overall Study|Pregnancy|0|||
163929848|NCT02635386|592114282|FG002|Overall Study|Pregnancy|0|||
164035581|NCT00355134|592490240|FG004|Core Phase|Abnormal test procedure result(s)|0|||
163929849|NCT02635386|592114283|FG003|Overall Study|Pregnancy|0|||
163929850|NCT02635386|592114284|FG004|Overall Study|Pregnancy|2|||
163929851|NCT02635386|592114280|FG000|Overall Study|Withdrawal by Subject|1|||
163929852|NCT02635386|592114281|FG001|Overall Study|Withdrawal by Subject|1|||
163929853|NCT02635386|592114282|FG002|Overall Study|Withdrawal by Subject|0|||
163929854|NCT02635386|592114283|FG003|Overall Study|Withdrawal by Subject|1|||
163929855|NCT02635386|592114284|FG004|Overall Study|Withdrawal by Subject|0|||
163929856|NCT02635386|592114280|FG000|Overall Study|Physician Decision|0|||
163929857|NCT02635386|592114281|FG001|Overall Study|Physician Decision|1|||
163929858|NCT02635386|592114282|FG002|Overall Study|Physician Decision|0|||
163929859|NCT02635386|592114283|FG003|Overall Study|Physician Decision|0|||
163929860|NCT02635386|592114284|FG004|Overall Study|Physician Decision|0|||
163929861|NCT02635386|592114280|FG000|Overall Study|Moved Out of State|0|||
163929862|NCT02635386|592114281|FG001|Overall Study|Moved Out of State|1|||
163929863|NCT02635386|592114282|FG002|Overall Study|Moved Out of State|0|||
163929864|NCT02635386|592114283|FG003|Overall Study|Moved Out of State|0|||
163929865|NCT02635386|592114284|FG004|Overall Study|Moved Out of State|0|||
163929866|NCT02635386|592114280|FG000|Overall Study|Noncompliant|0|||
163929867|NCT02635386|592114281|FG001|Overall Study|Noncompliant|2|||
163929868|NCT02635386|592114282|FG002|Overall Study|Noncompliant|1|||
163929869|NCT02635386|592114283|FG003|Overall Study|Noncompliant|1|||
163929870|NCT02635386|592114284|FG004|Overall Study|Noncompliant|1|||
163929871|NCT02635386|592114280|FG000|Overall Study|side effects|0|||
163929872|NCT02635386|592114281|FG001|Overall Study|side effects|0|||
163929873|NCT02635386|592114282|FG002|Overall Study|side effects|1|||
163929874|NCT02635386|592114283|FG003|Overall Study|side effects|4|||
163929875|NCT02635386|592114284|FG004|Overall Study|side effects|6|||
163929876|NCT02635386|592114280|FG000|Overall Study|needed other major surgery|0|||
163929877|NCT02635386|592114281|FG001|Overall Study|needed other major surgery|1|||
163929878|NCT02635386|592114282|FG002|Overall Study|needed other major surgery|0|||
163929879|NCT02635386|592114283|FG003|Overall Study|needed other major surgery|0|||
163929880|NCT02635386|592114284|FG004|Overall Study|needed other major surgery|0|||
163929881|NCT02635386|592114280|FG000|Overall Study|Other medical problems not drug related|0|||
163929882|NCT02635386|592114281|FG001|Overall Study|Other medical problems not drug related|0|||
163929883|NCT02635386|592114282|FG002|Overall Study|Other medical problems not drug related|0|||
163929884|NCT02635386|592114283|FG003|Overall Study|Other medical problems not drug related|1|||
163929885|NCT02635386|592114284|FG004|Overall Study|Other medical problems not drug related|0|||
163929886|NCT00745498|592114285|FG000|Overall Study|Lost to Follow-up|1|||
163929887|NCT00745498|592114286|FG001|Overall Study|Lost to Follow-up|1|||
163929888|NCT00745498|592114287|FG002|Overall Study|Lost to Follow-up|3|||
163929889|NCT00745498|592114285|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
163929890|NCT00745498|592114286|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
163929891|NCT00745498|592114287|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
163929892|NCT00745498|592114285|FG000|Overall Study|Non-PDR related VH|0|||
163929893|NCT00745498|592114286|FG001|Overall Study|Non-PDR related VH|1|||
163929894|NCT00745498|592114287|FG002|Overall Study|Non-PDR related VH|1|||
163929895|NCT00745498|592114285|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
163929896|NCT00745498|592114286|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
163929897|NCT00745498|592114287|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
163929898|NCT00267098|592114289|FG000|Overall Study|Death|0|||
163929899|NCT00267098|592114290|FG001|Overall Study|Death|0|||
163929900|NCT00267098|592114291|FG002|Overall Study|Death|57|||
163929901|NCT00267098|592114292|FG003|Overall Study|Death|66|||
163929902|NCT00267098|592114293|FG004|Overall Study|Death|14|||
163929903|NCT00267098|592114294|FG005|Overall Study|Death|23|||
163929904|NCT00267098|592114295|FG006|Overall Study|Death|28|||
163929905|NCT00267098|592114296|FG007|Overall Study|Death|9|||
163929906|NCT00267098|592114289|FG000|Overall Study|Lost to Follow-up|0|||
163929907|NCT00267098|592114290|FG001|Overall Study|Lost to Follow-up|0|||
163929908|NCT00267098|592114291|FG002|Overall Study|Lost to Follow-up|6|||
163929909|NCT00267098|592114292|FG003|Overall Study|Lost to Follow-up|5|||
163929910|NCT00267098|592114293|FG004|Overall Study|Lost to Follow-up|2|||
163929911|NCT00267098|592114294|FG005|Overall Study|Lost to Follow-up|3|||
163929912|NCT00267098|592114295|FG006|Overall Study|Lost to Follow-up|1|||
163929913|NCT00267098|592114296|FG007|Overall Study|Lost to Follow-up|1|||
163929914|NCT00267098|592114289|FG000|Overall Study|Withdrawal by Subject|8|||
163929915|NCT00267098|592114290|FG001|Overall Study|Withdrawal by Subject|0|||
163929916|NCT00267098|592114291|FG002|Overall Study|Withdrawal by Subject|24|||
163929917|NCT00267098|592114292|FG003|Overall Study|Withdrawal by Subject|21|||
163929918|NCT00267098|592114293|FG004|Overall Study|Withdrawal by Subject|12|||
163929919|NCT00267098|592114294|FG005|Overall Study|Withdrawal by Subject|9|||
163929920|NCT00267098|592114295|FG006|Overall Study|Withdrawal by Subject|12|||
164035582|NCT00355134|592490236|FG000|Core Phase|Condition no longer requires study drug|1|||
163929921|NCT00267098|592114296|FG007|Overall Study|Withdrawal by Subject|5|||
163929922|NCT00267098|592114289|FG000|Overall Study|Physician Decision|5|||
163929923|NCT00267098|592114290|FG001|Overall Study|Physician Decision|0|||
163929924|NCT00267098|592114291|FG002|Overall Study|Physician Decision|7|||
163929925|NCT00267098|592114292|FG003|Overall Study|Physician Decision|11|||
164098181|NCT02457520|592725043|FG000|Post-treatment Period|Withdrawal by Subject|14|||
164098182|NCT00696020|592725048|FG000|Overall Study|Adverse Event|3|||
163929926|NCT00267098|592114293|FG004|Overall Study|Physician Decision|5|||
163929927|NCT00267098|592114294|FG005|Overall Study|Physician Decision|4|||
163929928|NCT00267098|592114295|FG006|Overall Study|Physician Decision|3|||
163929929|NCT00267098|592114296|FG007|Overall Study|Physician Decision|0|||
163929930|NCT00267098|592114289|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
163929931|NCT00267098|592114290|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163929932|NCT00267098|592114291|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163929933|NCT00267098|592114292|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163929934|NCT00267098|592114293|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
163929935|NCT00267098|592114294|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163929936|NCT00267098|592114295|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163929937|NCT00267098|592114296|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
163929938|NCT00267098|592114289|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929939|NCT00267098|592114290|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
163929940|NCT00267098|592114291|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929941|NCT00267098|592114292|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929942|NCT00267098|592114293|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929943|NCT00267098|592114294|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929944|NCT00267098|592114295|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929945|NCT00267098|592114296|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
163929946|NCT00267098|592114289|FG000|Overall Study|Site closure|0|||
163929947|NCT00267098|592114290|FG001|Overall Study|Site closure|0|||
163929948|NCT00267098|592114291|FG002|Overall Study|Site closure|0|||
163929949|NCT00267098|592114292|FG003|Overall Study|Site closure|1|||
163929950|NCT00267098|592114293|FG004|Overall Study|Site closure|0|||
163929951|NCT00267098|592114294|FG005|Overall Study|Site closure|1|||
163929952|NCT00267098|592114295|FG006|Overall Study|Site closure|1|||
163929953|NCT00267098|592114296|FG007|Overall Study|Site closure|0|||
163929954|NCT00267098|592114289|FG000|Overall Study|Explanted Medtronic device|0|||
163929955|NCT00267098|592114290|FG001|Overall Study|Explanted Medtronic device|0|||
163929956|NCT00267098|592114291|FG002|Overall Study|Explanted Medtronic device|0|||
163929957|NCT00267098|592114292|FG003|Overall Study|Explanted Medtronic device|1|||
163929958|NCT00267098|592114293|FG004|Overall Study|Explanted Medtronic device|0|||
163929959|NCT00267098|592114294|FG005|Overall Study|Explanted Medtronic device|0|||
163929960|NCT00267098|592114295|FG006|Overall Study|Explanted Medtronic device|0|||
163929961|NCT00267098|592114296|FG007|Overall Study|Explanted Medtronic device|0|||
163929962|NCT00267098|592114289|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929963|NCT00267098|592114290|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929964|NCT00267098|592114291|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929965|NCT00267098|592114292|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929966|NCT00267098|592114293|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
163929967|NCT00267098|592114294|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929968|NCT00267098|592114295|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929969|NCT00267098|592114296|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
163929970|NCT00267098|592114289|FG000|Overall Study|Subject listed for heart transplant|0|||
163929971|NCT00267098|592114290|FG001|Overall Study|Subject listed for heart transplant|0|||
163929972|NCT00267098|592114291|FG002|Overall Study|Subject listed for heart transplant|0|||
163929973|NCT00267098|592114292|FG003|Overall Study|Subject listed for heart transplant|0|||
163929974|NCT00267098|592114293|FG004|Overall Study|Subject listed for heart transplant|0|||
163929975|NCT00267098|592114294|FG005|Overall Study|Subject listed for heart transplant|0|||
163929976|NCT00267098|592114295|FG006|Overall Study|Subject listed for heart transplant|1|||
163929977|NCT00267098|592114296|FG007|Overall Study|Subject listed for heart transplant|0|||
163929978|NCT00267098|592114289|FG000|Overall Study|Sponsor withdrew subject|0|||
163929979|NCT00267098|592114290|FG001|Overall Study|Sponsor withdrew subject|0|||
163929980|NCT00267098|592114291|FG002|Overall Study|Sponsor withdrew subject|0|||
163929981|NCT00267098|592114292|FG003|Overall Study|Sponsor withdrew subject|1|||
163929982|NCT00267098|592114293|FG004|Overall Study|Sponsor withdrew subject|0|||
163929983|NCT00267098|592114294|FG005|Overall Study|Sponsor withdrew subject|0|||
163929984|NCT00267098|592114295|FG006|Overall Study|Sponsor withdrew subject|0|||
163929985|NCT00267098|592114296|FG007|Overall Study|Sponsor withdrew subject|0|||
163929986|NCT00547534|592114297|FG000|Overall Study|Adverse Event|7|||
163929987|NCT00547534|592114297|FG000|Overall Study|Disease Progression|4|||
163929988|NCT01157377|592114298|FG000|Overall Study|Lost to Follow-up|0|||
163929989|NCT01157377|592114299|FG001|Overall Study|Lost to Follow-up|0|||
163929990|NCT01157377|592114300|FG002|Overall Study|Lost to Follow-up|1|||
163929991|NCT01157377|592114301|FG003|Overall Study|Lost to Follow-up|0|||
163929992|NCT01157377|592114302|FG004|Overall Study|Lost to Follow-up|1|||
163929993|NCT01157377|592114303|FG005|Overall Study|Lost to Follow-up|1|||
163929994|NCT01157377|592114304|FG006|Overall Study|Lost to Follow-up|0|||
163929995|NCT01157377|592114298|FG000|Overall Study|Personal Reasons|2|||
163929996|NCT01157377|592114299|FG001|Overall Study|Personal Reasons|1|||
164035583|NCT00355134|592490237|FG001|Core Phase|Condition no longer requires study drug|0|||
164035584|NCT00355134|592490238|FG002|Core Phase|Condition no longer requires study drug|1|||
164035585|NCT00355134|592490239|FG003|Core Phase|Condition no longer requires study drug|0|||
164035586|NCT00355134|592490240|FG004|Core Phase|Condition no longer requires study drug|0|||
164035587|NCT00355134|592490236|FG000|Extension Phase|Withdrawal by Subject|7|||
164035588|NCT00355134|592490237|FG001|Extension Phase|Withdrawal by Subject|11|||
164035589|NCT00355134|592490238|FG002|Extension Phase|Withdrawal by Subject|0|||
164035590|NCT00355134|592490239|FG003|Extension Phase|Withdrawal by Subject|7|||
164098183|NCT00696020|592725049|FG001|Overall Study|Adverse Event|1|||
163834494|NCT01576718|591763099|FG002|Treatment Period|Lost to Follow-up|0|||
163834495|NCT01576718|591763100|FG003|Treatment Period|Lost to Follow-up|0|||
163834496|NCT01576718|591763101|FG004|Treatment Period|Lost to Follow-up|1|||
163834497|NCT01576718|591763102|FG005|Treatment Period|Lost to Follow-up|0|||
163834498|NCT01576718|591763103|FG006|Treatment Period|Lost to Follow-up|0|||
163834499|NCT01576718|591763097|FG000|Treatment Period|Noncompliance to study medication|0|||
163834500|NCT01576718|591763098|FG001|Treatment Period|Noncompliance to study medication|0|||
163834501|NCT01576718|591763099|FG002|Treatment Period|Noncompliance to study medication|0|||
163834502|NCT01576718|591763100|FG003|Treatment Period|Noncompliance to study medication|0|||
163834503|NCT01576718|591763101|FG004|Treatment Period|Noncompliance to study medication|0|||
163834504|NCT01576718|591763102|FG005|Treatment Period|Noncompliance to study medication|1|||
163834505|NCT01576718|591763103|FG006|Treatment Period|Noncompliance to study medication|1|||
163834506|NCT04631705|591763104|FG000|Overall Study|Withdrawal by Subject|0|||
163834507|NCT04631705|591763105|FG001|Overall Study|Withdrawal by Subject|0|||
163834508|NCT04631705|591763106|FG002|Overall Study|Withdrawal by Subject|0|||
163834509|NCT04631705|591763107|FG003|Overall Study|Withdrawal by Subject|0|||
163834510|NCT04631705|591763108|FG004|Overall Study|Withdrawal by Subject|0|||
163834511|NCT04631705|591763109|FG005|Overall Study|Withdrawal by Subject|0|||
163834512|NCT04631705|591763110|FG006|Overall Study|Withdrawal by Subject|1|||
163834513|NCT04631705|591763111|FG007|Overall Study|Withdrawal by Subject|0|||
163834514|NCT04631705|591763112|FG008|Overall Study|Withdrawal by Subject|0|||
163834515|NCT02070484|591763114|FG000|Overall Study|Withdrawal by Subject|1|||
163834516|NCT02070484|591763115|FG001|Overall Study|Withdrawal by Subject|0|||
163834517|NCT02821819|591763120|FG000|Overall Study|Protocol Violation|1|||
163834518|NCT02332590|591763121|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
163834519|NCT02332590|591763122|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
163834520|NCT02332590|591763121|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
163834521|NCT02332590|591763122|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
163834522|NCT02332590|591763121|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
163834523|NCT02332590|591763122|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
163834524|NCT02332590|591763121|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
163834525|NCT02332590|591763122|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
163834526|NCT02332590|591763121|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
163834527|NCT02332590|591763122|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
163834528|NCT02332590|591763121|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
163834529|NCT02332590|591763122|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
163834530|NCT02332590|591763121|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
163834531|NCT02332590|591763122|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
163834532|NCT02332590|591763121|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
163834533|NCT02332590|591763122|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
163834534|NCT02332590|591763121|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
163834535|NCT02332590|591763122|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
163834536|NCT04225988|591763124|FG000|Overall Study|Withdrawal by Subject|2|||
163834537|NCT04225988|591763125|FG001|Overall Study|Withdrawal by Subject|0|||
163834538|NCT05619003|591763127|FG000|Overall Study|Adverse Event|1|||
163834539|NCT02272725|591763132|FG000|Overall Study|equipment malfunction|2|||
163834540|NCT02272725|591763133|FG001|Overall Study|equipment malfunction|0|||
163834541|NCT07018999|591763134|FG000|Overall Study|Protocol Violation|0|||
163834542|NCT07018999|591763135|FG001|Overall Study|Protocol Violation|1|||
163834543|NCT07018999|591763134|FG000|Overall Study|Incomplete data entry|4|||
163834544|NCT07018999|591763135|FG001|Overall Study|Incomplete data entry|7|||
163834545|NCT04739761|591763138|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
163834546|NCT04739761|591763139|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
163834547|NCT04739761|591763138|FG000|Overall Study|By complete response from the participant|1|||
163834548|NCT04739761|591763139|FG001|Overall Study|By complete response from the participant|0|||
163834549|NCT04739761|591763138|FG000|Overall Study|Lost to Follow-up|3|||
163834550|NCT04739761|591763139|FG001|Overall Study|Lost to Follow-up|3|||
163834551|NCT04739761|591763138|FG000|Overall Study|Death|13|||
163834552|NCT04739761|591763139|FG001|Overall Study|Death|13|||
163834553|NCT04739761|591763138|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
164035591|NCT00355134|592490240|FG004|Extension Phase|Withdrawal by Subject|5|||
164035592|NCT00355134|592490236|FG000|Extension Phase|Adverse Event|13|||
163929997|NCT01157377|592114300|FG002|Overall Study|Personal Reasons|0|||
163929998|NCT01157377|592114301|FG003|Overall Study|Personal Reasons|1|||
163929999|NCT01157377|592114302|FG004|Overall Study|Personal Reasons|0|||
163930000|NCT01157377|592114303|FG005|Overall Study|Personal Reasons|0|||
163930001|NCT01157377|592114304|FG006|Overall Study|Personal Reasons|0|||
163930002|NCT01157377|592114298|FG000|Overall Study|Protocol Violation|0|||
163930003|NCT01157377|592114299|FG001|Overall Study|Protocol Violation|0|||
163930004|NCT01157377|592114300|FG002|Overall Study|Protocol Violation|0|||
163930005|NCT01157377|592114301|FG003|Overall Study|Protocol Violation|0|||
163930006|NCT01157377|592114302|FG004|Overall Study|Protocol Violation|0|||
163930007|NCT01157377|592114303|FG005|Overall Study|Protocol Violation|1|||
163930008|NCT01157377|592114304|FG006|Overall Study|Protocol Violation|0|||
163930009|NCT01157377|592114298|FG000|Overall Study|Lack of Efficacy|0|||
163930010|NCT01157377|592114299|FG001|Overall Study|Lack of Efficacy|0|||
163930011|NCT01157377|592114300|FG002|Overall Study|Lack of Efficacy|0|||
163930012|NCT01157377|592114301|FG003|Overall Study|Lack of Efficacy|0|||
163930013|NCT01157377|592114302|FG004|Overall Study|Lack of Efficacy|0|||
163930014|NCT01157377|592114303|FG005|Overall Study|Lack of Efficacy|0|||
163930015|NCT01157377|592114304|FG006|Overall Study|Lack of Efficacy|1|||
163930016|NCT01157377|592114298|FG000|Overall Study|Other Miscellaneous Reasons|0|||
163930017|NCT01157377|592114299|FG001|Overall Study|Other Miscellaneous Reasons|2|||
163930018|NCT01157377|592114300|FG002|Overall Study|Other Miscellaneous Reasons|0|||
163930019|NCT01157377|592114301|FG003|Overall Study|Other Miscellaneous Reasons|0|||
163930020|NCT01157377|592114302|FG004|Overall Study|Other Miscellaneous Reasons|1|||
163930021|NCT01157377|592114303|FG005|Overall Study|Other Miscellaneous Reasons|1|||
163930022|NCT01157377|592114304|FG006|Overall Study|Other Miscellaneous Reasons|1|||
163930023|NCT00904722|592114305|FG000|Overall Study|Physician Decision|1|||
163930024|NCT03561597|592114306|FG000|Overall Study|Lost to Follow-up|20|||
163930025|NCT05347485|592114309|FG000|Overall Study|Death|14|||
163930026|NCT05347485|592114309|FG000|Overall Study|Lost to Follow-up|2|||
163930027|NCT05347485|592114309|FG000|Overall Study|Withdrawal by Subject|13|||
163930028|NCT05347485|592114309|FG000|Overall Study|Progressive Disease|1|||
163930029|NCT05347485|592114309|FG000|Overall Study|Study Terminated by Sponsor|49|||
163930030|NCT05347485|592114309|FG000|Overall Study|Other|1|||
163930031|NCT05347485|592114309|FG000|Overall Study|Enrolled (consented) but not treated|4|||
163930032|NCT05347485|592114309|FG000|Overall Study|Disease Relapse|2|||
163930033|NCT05896696|592114310|FG000|Overall Study|Screening Failure|7|||
163930034|NCT05896696|592114310|FG000|Overall Study|Withdrawal by Subject|2|||
163930035|NCT00129935|592116090|FG000|Overall Study|Adverse Event|18|||
163930036|NCT00129935|592116091|FG001|Overall Study|Adverse Event|56|||
163930037|NCT00129935|592116090|FG000|Overall Study|Death|1|||
163930038|NCT00129935|592116091|FG001|Overall Study|Death|1|||
163930039|NCT00129935|592116090|FG000|Overall Study|Withdrawal by Subject|7|||
163930040|NCT00129935|592116091|FG001|Overall Study|Withdrawal by Subject|20|||
163930041|NCT00129935|592116090|FG000|Overall Study|Protocol Violation|0|||
163930042|NCT00129935|592116091|FG001|Overall Study|Protocol Violation|4|||
163930043|NCT00129935|592116090|FG000|Overall Study|Physician Decision|3|||
163930044|NCT00129935|592116091|FG001|Overall Study|Physician Decision|4|||
163930045|NCT00129935|592116090|FG000|Overall Study|Recurrence|1|||
163930046|NCT00129935|592116091|FG001|Overall Study|Recurrence|3|||
163930047|NCT00129935|592116090|FG000|Overall Study|Second primary|0|||
163930048|NCT00129935|592116091|FG001|Overall Study|Second primary|1|||
163930049|NCT00129935|592116090|FG000|Overall Study|Other|3|||
163930050|NCT00129935|592116091|FG001|Overall Study|Other|2|||
163930051|NCT00129935|592116090|FG000|Overall Study|Crossed to the other arm|2|||
163930052|NCT00129935|592116091|FG001|Overall Study|Crossed to the other arm|1|||
163930053|NCT00129935|592116090|FG000|Overall Study|Incorrect study treatment|1|||
163930054|NCT00129935|592116091|FG001|Overall Study|Incorrect study treatment|0|||
163930055|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
163930056|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
163930057|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
163930058|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Death|4|||
163930059|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Death|2|||
163930060|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Death|3|||
163930061|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163930062|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
163930063|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
163930064|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
163930065|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
163930066|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
163930067|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
163930068|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
163930069|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
163930070|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
163930071|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
164035593|NCT00355134|592490237|FG001|Extension Phase|Adverse Event|9|||
164035594|NCT00355134|592490238|FG002|Extension Phase|Adverse Event|0|||
163930072|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
163930073|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
163930074|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
163930075|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
163930076|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
163930077|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
163930078|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
163930079|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
163930080|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
163930081|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
163930082|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
163930083|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
163930084|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
163930085|NCT02783573|592116093|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
163930086|NCT02783573|592116094|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
163930087|NCT02783573|592116095|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
163930088|NCT02783573|592116093|FG000|Delayed-Start Period|Sponsor Decision|0|||
163930089|NCT02783573|592116094|FG001|Delayed-Start Period|Sponsor Decision|17|||
163930090|NCT02783573|592116095|FG002|Delayed-Start Period|Sponsor Decision|12|||
163930091|NCT00590564|592116096|FG000|Overall Study|Withdrawal by Subject|4|||
163930092|NCT00590564|592116096|FG000|Overall Study|Lost to Follow-up|6|||
163930093|NCT00590564|592116096|FG000|Overall Study|Protocol Violation|1|||
163930094|NCT00590564|592116096|FG000|Overall Study|Patient Found to be Ineligible|1|||
163930095|NCT00590564|592116096|FG000|Overall Study|Patient Non-compliance|6|||
163930096|NCT01434680|592116099|FG000|Overall Study|Withdrawal by Subject|1|||
163930097|NCT01434680|592116100|FG001|Overall Study|Withdrawal by Subject|0|||
163930098|NCT01434680|592116101|FG002|Overall Study|Withdrawal by Subject|2|||
163930099|NCT01434680|592116102|FG003|Overall Study|Withdrawal by Subject|0|||
163930100|NCT01434680|592116099|FG000|Overall Study|Lost to Follow-up|1|||
163930101|NCT01434680|592116100|FG001|Overall Study|Lost to Follow-up|1|||
163930102|NCT01434680|592116101|FG002|Overall Study|Lost to Follow-up|0|||
163930103|NCT01434680|592116102|FG003|Overall Study|Lost to Follow-up|0|||
163930104|NCT01434680|592116099|FG000|Overall Study|Protocol Violation|1|||
163930105|NCT01434680|592116100|FG001|Overall Study|Protocol Violation|1|||
163930106|NCT01434680|592116101|FG002|Overall Study|Protocol Violation|0|||
163930107|NCT01434680|592116102|FG003|Overall Study|Protocol Violation|0|||
163930108|NCT01367847|592116104|FG000|Overall Study|Withdrawal by Subject|2|||
163930109|NCT01367847|592116105|FG001|Overall Study|Withdrawal by Subject|2|||
163930110|NCT04978350|592116108|FG000|Overall Study|Lost to Follow-up|6|||
163930111|NCT04991766|592116109|FG000|Overall Study|Withdrawal by Subject|2|||
163930112|NCT04991766|592116110|FG001|Overall Study|Withdrawal by Subject|0|||
163930113|NCT01162135|592116118|FG000|Overall Study|Withdrawal by Subject|1|||
163930114|NCT01162135|592116118|FG000|Overall Study|Severe back pain|1|||
163930115|NCT01162135|592116118|FG000|Overall Study|Ineligible|1|||
163930116|NCT01777334|592116119|FG000|Overall Study|Adverse Event|18|||
163930117|NCT01777334|592116120|FG001|Overall Study|Adverse Event|14|||
163930118|NCT01777334|592116119|FG000|Overall Study|Lack of Efficacy|15|||
163930119|NCT01777334|592116120|FG001|Overall Study|Lack of Efficacy|29|||
163930120|NCT01777334|592116119|FG000|Overall Study|Protocol Violation|3|||
163930121|NCT01777334|592116120|FG001|Overall Study|Protocol Violation|7|||
163930122|NCT01777334|592116119|FG000|Overall Study|Lost to Follow-up|3|||
163930123|NCT01777334|592116120|FG001|Overall Study|Lost to Follow-up|2|||
163930124|NCT01777334|592116119|FG000|Overall Study|Withdrawal by Subject|14|||
163930125|NCT01777334|592116120|FG001|Overall Study|Withdrawal by Subject|11|||
163930126|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
163930127|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
163930128|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
163930129|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
163930130|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
163930131|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
163930132|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
163930133|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
163930134|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
163930135|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
163930136|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
163930137|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
163930138|NCT01216072|592116121|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
163930139|NCT01216072|592116122|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
164035595|NCT00355134|592490239|FG003|Extension Phase|Adverse Event|3|||
163930140|NCT01216072|592116121|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
164035596|NCT00355134|592490240|FG004|Extension Phase|Adverse Event|5|||
164035597|NCT00355134|592490236|FG000|Extension Phase|Lost to Follow-up|2|||
163930141|NCT01216072|592116122|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
163930142|NCT01216072|592116121|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
163930143|NCT01216072|592116122|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
163930144|NCT01216072|592116121|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
163930145|NCT01216072|592116122|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
163930146|NCT06136897|592116123|FG000|Overall Study|Ineligible|3|||
163930147|NCT06136897|592116123|FG000|Overall Study|Mutation status not confirmed|7|||
163930148|NCT06136897|592116123|FG000|Overall Study|Adverse Event|2|||
163930149|NCT06136897|592116123|FG000|Overall Study|Death|1|||
163930150|NCT06136897|592116123|FG000|Overall Study|Disease progression|18|||
163930151|NCT06136897|592116123|FG000|Overall Study|Other complicating disease|1|||
163930152|NCT06136897|592116123|FG000|Overall Study|Withdrawal by Subject|1|||
163930153|NCT06136897|592116123|FG000|Overall Study|Still on treatment|1|||
163930154|NCT06136897|592116123|FG000|Overall Study|Lost to Follow-up|1|||
163930155|NCT01296555|592116124|FG000|Overall Study|Adverse Event|0|||
163930156|NCT01296555|592116125|FG001|Overall Study|Adverse Event|0|||
163930157|NCT01296555|592116126|FG002|Overall Study|Adverse Event|1|||
163930158|NCT01296555|592116127|FG003|Overall Study|Adverse Event|1|||
163930159|NCT01296555|592116128|FG004|Overall Study|Adverse Event|2|||
163930160|NCT01296555|592116129|FG005|Overall Study|Adverse Event|4|||
163930161|NCT01296555|592116130|FG006|Overall Study|Adverse Event|1|||
163930162|NCT01296555|592116131|FG007|Overall Study|Adverse Event|4|||
163930163|NCT01296555|592116132|FG008|Overall Study|Adverse Event|3|||
163930164|NCT01296555|592116133|FG009|Overall Study|Adverse Event|1|||
163930165|NCT01296555|592116134|FG010|Overall Study|Adverse Event|0|||
163930166|NCT01296555|592116135|FG011|Overall Study|Adverse Event|4|||
163930167|NCT01296555|592116136|FG012|Overall Study|Adverse Event|1|||
163930168|NCT01296555|592116137|FG013|Overall Study|Adverse Event|4|||
163930169|NCT01296555|592116138|FG014|Overall Study|Adverse Event|0|||
163930170|NCT01296555|592116139|FG015|Overall Study|Adverse Event|0|||
163930171|NCT01296555|592116140|FG016|Overall Study|Adverse Event|0|||
163930172|NCT01296555|592116141|FG017|Overall Study|Adverse Event|0|||
163930173|NCT01296555|592116142|FG018|Overall Study|Adverse Event|0|||
163930174|NCT01296555|592116143|FG019|Overall Study|Adverse Event|1|||
163930175|NCT01296555|592116144|FG020|Overall Study|Adverse Event|0|||
163930176|NCT01296555|592116145|FG021|Overall Study|Adverse Event|0|||
163930177|NCT01296555|592116146|FG022|Overall Study|Adverse Event|0|||
163930178|NCT01296555|592116147|FG023|Overall Study|Adverse Event|0|||
163930179|NCT01296555|592116148|FG024|Overall Study|Adverse Event|0|||
163930180|NCT01296555|592116149|FG025|Overall Study|Adverse Event|0|||
163930181|NCT01296555|592116150|FG026|Overall Study|Adverse Event|0|||
163930182|NCT01296555|592116151|FG027|Overall Study|Adverse Event|0|||
163930183|NCT01296555|592116152|FG028|Overall Study|Adverse Event|0|||
163930184|NCT01296555|592116124|FG000|Overall Study|Reason Not Specified|0|||
163930185|NCT01296555|592116125|FG001|Overall Study|Reason Not Specified|0|||
163930186|NCT01296555|592116126|FG002|Overall Study|Reason Not Specified|0|||
163930187|NCT01296555|592116127|FG003|Overall Study|Reason Not Specified|0|||
163930188|NCT01296555|592116128|FG004|Overall Study|Reason Not Specified|0|||
163930189|NCT01296555|592116129|FG005|Overall Study|Reason Not Specified|0|||
163930190|NCT01296555|592116130|FG006|Overall Study|Reason Not Specified|0|||
163930191|NCT01296555|592116131|FG007|Overall Study|Reason Not Specified|0|||
163930192|NCT01296555|592116132|FG008|Overall Study|Reason Not Specified|0|||
163930193|NCT01296555|592116133|FG009|Overall Study|Reason Not Specified|0|||
163930194|NCT01296555|592116134|FG010|Overall Study|Reason Not Specified|0|||
163930195|NCT01296555|592116135|FG011|Overall Study|Reason Not Specified|0|||
163930196|NCT01296555|592116136|FG012|Overall Study|Reason Not Specified|0|||
163930197|NCT01296555|592116137|FG013|Overall Study|Reason Not Specified|1|||
163930198|NCT01296555|592116138|FG014|Overall Study|Reason Not Specified|2|||
163930199|NCT01296555|592116139|FG015|Overall Study|Reason Not Specified|3|||
163930200|NCT01296555|592116140|FG016|Overall Study|Reason Not Specified|7|||
163930201|NCT01296555|592116141|FG017|Overall Study|Reason Not Specified|4|||
163930202|NCT01296555|592116142|FG018|Overall Study|Reason Not Specified|3|||
163930203|NCT01296555|592116143|FG019|Overall Study|Reason Not Specified|7|||
163930204|NCT01296555|592116144|FG020|Overall Study|Reason Not Specified|11|||
163930205|NCT01296555|592116145|FG021|Overall Study|Reason Not Specified|5|||
163930206|NCT01296555|592116146|FG022|Overall Study|Reason Not Specified|5|||
163930207|NCT01296555|592116147|FG023|Overall Study|Reason Not Specified|7|||
163930208|NCT01296555|592116148|FG024|Overall Study|Reason Not Specified|2|||
163930209|NCT01296555|592116149|FG025|Overall Study|Reason Not Specified|2|||
163930210|NCT01296555|592116150|FG026|Overall Study|Reason Not Specified|19|||
163930211|NCT01296555|592116151|FG027|Overall Study|Reason Not Specified|11|||
163930212|NCT01296555|592116152|FG028|Overall Study|Reason Not Specified|9|||
163930213|NCT01296555|592116124|FG000|Overall Study|Physician Decision|0|||
163930214|NCT01296555|592116125|FG001|Overall Study|Physician Decision|0|||
163930215|NCT01296555|592116126|FG002|Overall Study|Physician Decision|0|||
163930216|NCT01296555|592116127|FG003|Overall Study|Physician Decision|0|||
164035598|NCT00355134|592490237|FG001|Extension Phase|Lost to Follow-up|6|||
164035599|NCT00355134|592490238|FG002|Extension Phase|Lost to Follow-up|0|||
163930217|NCT01296555|592116128|FG004|Overall Study|Physician Decision|1|||
163930218|NCT01296555|592116129|FG005|Overall Study|Physician Decision|0|||
163930219|NCT01296555|592116130|FG006|Overall Study|Physician Decision|0|||
163930220|NCT01296555|592116131|FG007|Overall Study|Physician Decision|0|||
163930221|NCT01296555|592116132|FG008|Overall Study|Physician Decision|0|||
163930222|NCT01296555|592116133|FG009|Overall Study|Physician Decision|0|||
163930223|NCT01296555|592116134|FG010|Overall Study|Physician Decision|0|||
163930224|NCT01296555|592116135|FG011|Overall Study|Physician Decision|0|||
163930225|NCT01296555|592116136|FG012|Overall Study|Physician Decision|0|||
163930226|NCT01296555|592116137|FG013|Overall Study|Physician Decision|1|||
163930227|NCT01296555|592116138|FG014|Overall Study|Physician Decision|0|||
163930228|NCT01296555|592116139|FG015|Overall Study|Physician Decision|0|||
163930229|NCT01296555|592116140|FG016|Overall Study|Physician Decision|0|||
163930230|NCT01296555|592116141|FG017|Overall Study|Physician Decision|0|||
163930231|NCT01296555|592116142|FG018|Overall Study|Physician Decision|0|||
163930232|NCT01296555|592116143|FG019|Overall Study|Physician Decision|1|||
163930233|NCT01296555|592116144|FG020|Overall Study|Physician Decision|0|||
163930234|NCT01296555|592116145|FG021|Overall Study|Physician Decision|0|||
163930235|NCT01296555|592116146|FG022|Overall Study|Physician Decision|0|||
163930236|NCT01296555|592116147|FG023|Overall Study|Physician Decision|0|||
163930237|NCT01296555|592116148|FG024|Overall Study|Physician Decision|0|||
163930238|NCT01296555|592116149|FG025|Overall Study|Physician Decision|0|||
163930239|NCT01296555|592116150|FG026|Overall Study|Physician Decision|0|||
163930240|NCT01296555|592116151|FG027|Overall Study|Physician Decision|0|||
163930241|NCT01296555|592116152|FG028|Overall Study|Physician Decision|0|||
163930242|NCT01296555|592116124|FG000|Overall Study|Progressive Disease|6|||
163930243|NCT01296555|592116125|FG001|Overall Study|Progressive Disease|3|||
163930244|NCT01296555|592116126|FG002|Overall Study|Progressive Disease|3|||
163930245|NCT01296555|592116127|FG003|Overall Study|Progressive Disease|7|||
163930246|NCT01296555|592116128|FG004|Overall Study|Progressive Disease|6|||
163930247|NCT01296555|592116129|FG005|Overall Study|Progressive Disease|16|||
163930248|NCT01296555|592116130|FG006|Overall Study|Progressive Disease|16|||
163930249|NCT01296555|592116131|FG007|Overall Study|Progressive Disease|8|||
163930250|NCT01296555|592116132|FG008|Overall Study|Progressive Disease|7|||
163930251|NCT01296555|592116133|FG009|Overall Study|Progressive Disease|18|||
163930252|NCT01296555|592116134|FG010|Overall Study|Progressive Disease|7|||
163930253|NCT01296555|592116135|FG011|Overall Study|Progressive Disease|14|||
163930254|NCT01296555|592116136|FG012|Overall Study|Progressive Disease|5|||
163930255|NCT01296555|592116137|FG013|Overall Study|Progressive Disease|12|||
163930256|NCT01296555|592116138|FG014|Overall Study|Progressive Disease|1|||
163930257|NCT01296555|592116139|FG015|Overall Study|Progressive Disease|1|||
163930258|NCT01296555|592116140|FG016|Overall Study|Progressive Disease|0|||
163930259|NCT01296555|592116141|FG017|Overall Study|Progressive Disease|0|||
163930260|NCT01296555|592116142|FG018|Overall Study|Progressive Disease|0|||
163930261|NCT01296555|592116143|FG019|Overall Study|Progressive Disease|1|||
163930262|NCT01296555|592116144|FG020|Overall Study|Progressive Disease|0|||
163930263|NCT01296555|592116145|FG021|Overall Study|Progressive Disease|0|||
163930264|NCT01296555|592116146|FG022|Overall Study|Progressive Disease|0|||
163930265|NCT01296555|592116147|FG023|Overall Study|Progressive Disease|0|||
163930266|NCT01296555|592116148|FG024|Overall Study|Progressive Disease|1|||
163930267|NCT01296555|592116149|FG025|Overall Study|Progressive Disease|0|||
163930268|NCT01296555|592116150|FG026|Overall Study|Progressive Disease|5|||
163930269|NCT01296555|592116151|FG027|Overall Study|Progressive Disease|1|||
163930270|NCT01296555|592116152|FG028|Overall Study|Progressive Disease|0|||
163930271|NCT01296555|592116124|FG000|Overall Study|Protocol Violation|0|||
163930272|NCT01296555|592116125|FG001|Overall Study|Protocol Violation|0|||
163930273|NCT01296555|592116126|FG002|Overall Study|Protocol Violation|0|||
163930274|NCT01296555|592116127|FG003|Overall Study|Protocol Violation|0|||
163930275|NCT01296555|592116128|FG004|Overall Study|Protocol Violation|0|||
163930276|NCT01296555|592116129|FG005|Overall Study|Protocol Violation|0|||
163930277|NCT01296555|592116130|FG006|Overall Study|Protocol Violation|0|||
163930278|NCT01296555|592116131|FG007|Overall Study|Protocol Violation|0|||
163930279|NCT01296555|592116132|FG008|Overall Study|Protocol Violation|0|||
163930280|NCT01296555|592116133|FG009|Overall Study|Protocol Violation|0|||
163930281|NCT01296555|592116134|FG010|Overall Study|Protocol Violation|0|||
163930282|NCT01296555|592116135|FG011|Overall Study|Protocol Violation|0|||
163930283|NCT01296555|592116136|FG012|Overall Study|Protocol Violation|0|||
163930284|NCT01296555|592116137|FG013|Overall Study|Protocol Violation|1|||
163930285|NCT01296555|592116138|FG014|Overall Study|Protocol Violation|0|||
163930286|NCT01296555|592116139|FG015|Overall Study|Protocol Violation|0|||
163930287|NCT01296555|592116140|FG016|Overall Study|Protocol Violation|0|||
163930288|NCT01296555|592116141|FG017|Overall Study|Protocol Violation|0|||
163930289|NCT01296555|592116142|FG018|Overall Study|Protocol Violation|0|||
163930290|NCT01296555|592116143|FG019|Overall Study|Protocol Violation|0|||
163930291|NCT01296555|592116144|FG020|Overall Study|Protocol Violation|0|||
163930292|NCT01296555|592116145|FG021|Overall Study|Protocol Violation|0|||
163930293|NCT01296555|592116146|FG022|Overall Study|Protocol Violation|0|||
163930294|NCT01296555|592116147|FG023|Overall Study|Protocol Violation|0|||
163930295|NCT01296555|592116148|FG024|Overall Study|Protocol Violation|0|||
163930296|NCT01296555|592116149|FG025|Overall Study|Protocol Violation|0|||
163930297|NCT01296555|592116150|FG026|Overall Study|Protocol Violation|0|||
163930298|NCT01296555|592116151|FG027|Overall Study|Protocol Violation|0|||
163930299|NCT01296555|592116152|FG028|Overall Study|Protocol Violation|0|||
163930300|NCT01296555|592116124|FG000|Overall Study|Study Terminated By Sponsor|0|||
163930301|NCT01296555|592116125|FG001|Overall Study|Study Terminated By Sponsor|0|||
163930302|NCT01296555|592116126|FG002|Overall Study|Study Terminated By Sponsor|0|||
163930303|NCT01296555|592116127|FG003|Overall Study|Study Terminated By Sponsor|0|||
163930304|NCT01296555|592116128|FG004|Overall Study|Study Terminated By Sponsor|0|||
163930305|NCT01296555|592116129|FG005|Overall Study|Study Terminated By Sponsor|0|||
163930306|NCT01296555|592116130|FG006|Overall Study|Study Terminated By Sponsor|0|||
163930307|NCT01296555|592116131|FG007|Overall Study|Study Terminated By Sponsor|0|||
163930308|NCT01296555|592116132|FG008|Overall Study|Study Terminated By Sponsor|0|||
163930309|NCT01296555|592116133|FG009|Overall Study|Study Terminated By Sponsor|0|||
163930310|NCT01296555|592116134|FG010|Overall Study|Study Terminated By Sponsor|0|||
163930311|NCT01296555|592116135|FG011|Overall Study|Study Terminated By Sponsor|0|||
163930312|NCT01296555|592116136|FG012|Overall Study|Study Terminated By Sponsor|0|||
163930313|NCT01296555|592116137|FG013|Overall Study|Study Terminated By Sponsor|0|||
163930314|NCT01296555|592116138|FG014|Overall Study|Study Terminated By Sponsor|0|||
163930315|NCT01296555|592116139|FG015|Overall Study|Study Terminated By Sponsor|0|||
163930316|NCT01296555|592116140|FG016|Overall Study|Study Terminated By Sponsor|0|||
163930317|NCT01296555|592116141|FG017|Overall Study|Study Terminated By Sponsor|0|||
163930318|NCT01296555|592116142|FG018|Overall Study|Study Terminated By Sponsor|0|||
163930319|NCT01296555|592116143|FG019|Overall Study|Study Terminated By Sponsor|0|||
163930320|NCT01296555|592116144|FG020|Overall Study|Study Terminated By Sponsor|0|||
163930321|NCT01296555|592116145|FG021|Overall Study|Study Terminated By Sponsor|0|||
163930322|NCT01296555|592116146|FG022|Overall Study|Study Terminated By Sponsor|0|||
163930323|NCT01296555|592116147|FG023|Overall Study|Study Terminated By Sponsor|0|||
163930324|NCT01296555|592116148|FG024|Overall Study|Study Terminated By Sponsor|0|||
163930325|NCT01296555|592116149|FG025|Overall Study|Study Terminated By Sponsor|1|||
164035600|NCT00355134|592490239|FG003|Extension Phase|Lost to Follow-up|2|||
164035601|NCT00355134|592490240|FG004|Extension Phase|Lost to Follow-up|4|||
164035602|NCT00355134|592490236|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
164035603|NCT00355134|592490237|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
164035604|NCT00355134|592490238|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
164035605|NCT00355134|592490239|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
164035606|NCT00355134|592490240|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
164035607|NCT00355134|592490236|FG000|Extension Phase|Administrative problems|2|||
164035608|NCT00355134|592490237|FG001|Extension Phase|Administrative problems|4|||
164035609|NCT00355134|592490238|FG002|Extension Phase|Administrative problems|0|||
164035610|NCT00355134|592490239|FG003|Extension Phase|Administrative problems|1|||
164035611|NCT00355134|592490240|FG004|Extension Phase|Administrative problems|1|||
164035612|NCT00355134|592490236|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
164035613|NCT00355134|592490237|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
164035614|NCT00355134|592490238|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
164035615|NCT00355134|592490239|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
164035616|NCT00355134|592490240|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
164035617|NCT00355134|592490236|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
164035618|NCT00355134|592490237|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
164035619|NCT00355134|592490238|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
164035620|NCT00355134|592490239|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
164035621|NCT00355134|592490240|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
164035622|NCT00355134|592490236|FG000|Extension Phase|Protocol Violation|0|||
164035623|NCT00355134|592490237|FG001|Extension Phase|Protocol Violation|0|||
164035624|NCT00355134|592490238|FG002|Extension Phase|Protocol Violation|0|||
164035625|NCT00355134|592490239|FG003|Extension Phase|Protocol Violation|1|||
164035626|NCT00355134|592490240|FG004|Extension Phase|Protocol Violation|0|||
164035627|NCT04432376|592490241|FG000|Double-blind Treatment Period|Adverse Event|2|||
164035628|NCT04432376|592490242|FG001|Double-blind Treatment Period|Adverse Event|6|||
164035629|NCT04432376|592490243|FG002|Double-blind Treatment Period|Adverse Event|0|||
164035630|NCT04432376|592490241|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
164035631|NCT04432376|592490242|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164035632|NCT04432376|592490243|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164035633|NCT04432376|592490241|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164035634|NCT04432376|592490242|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
163930326|NCT01296555|592116150|FG026|Overall Study|Study Terminated By Sponsor|0|||
163930327|NCT01296555|592116151|FG027|Overall Study|Study Terminated By Sponsor|0|||
163930328|NCT01296555|592116152|FG028|Overall Study|Study Terminated By Sponsor|0|||
163930329|NCT01296555|592116124|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930330|NCT01296555|592116125|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930331|NCT01296555|592116126|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
164035635|NCT04432376|592490243|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164035636|NCT04432376|592490241|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163930332|NCT01296555|592116127|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930333|NCT01296555|592116128|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930334|NCT01296555|592116129|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930335|NCT01296555|592116130|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930336|NCT01296555|592116131|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930337|NCT01296555|592116132|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930338|NCT01296555|592116133|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930339|NCT01296555|592116134|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930340|NCT01296555|592116135|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930341|NCT01296555|592116136|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930342|NCT01296555|592116137|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930343|NCT01296555|592116138|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930344|NCT01296555|592116139|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930345|NCT01296555|592116140|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930346|NCT01296555|592116141|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930347|NCT01296555|592116142|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930348|NCT01296555|592116143|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
163930349|NCT01296555|592116144|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930350|NCT01296555|592116145|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930351|NCT01296555|592116146|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930352|NCT01296555|592116147|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930353|NCT01296555|592116148|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930354|NCT01296555|592116149|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930355|NCT01296555|592116150|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930356|NCT01296555|592116151|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930357|NCT01296555|592116152|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
163930358|NCT01296555|592116124|FG000|Overall Study|Death|0|||
163930359|NCT01296555|592116125|FG001|Overall Study|Death|0|||
163930360|NCT01296555|592116126|FG002|Overall Study|Death|0|||
163930361|NCT01296555|592116127|FG003|Overall Study|Death|2|||
163930362|NCT01296555|592116128|FG004|Overall Study|Death|1|||
163930363|NCT01296555|592116129|FG005|Overall Study|Death|0|||
163930364|NCT01296555|592116130|FG006|Overall Study|Death|2|||
163930365|NCT01296555|592116131|FG007|Overall Study|Death|0|||
163930366|NCT01296555|592116132|FG008|Overall Study|Death|0|||
163930367|NCT01296555|592116133|FG009|Overall Study|Death|1|||
163930368|NCT01296555|592116134|FG010|Overall Study|Death|0|||
163930369|NCT01296555|592116135|FG011|Overall Study|Death|1|||
163930370|NCT01296555|592116136|FG012|Overall Study|Death|0|||
163930371|NCT01296555|592116137|FG013|Overall Study|Death|2|||
163930372|NCT01296555|592116138|FG014|Overall Study|Death|27|||
163930373|NCT01296555|592116139|FG015|Overall Study|Death|15|||
163930374|NCT01296555|592116140|FG016|Overall Study|Death|11|||
163930375|NCT01296555|592116141|FG017|Overall Study|Death|11|||
163930376|NCT01296555|592116142|FG018|Overall Study|Death|17|||
163930377|NCT01296555|592116143|FG019|Overall Study|Death|12|||
163930378|NCT01296555|592116144|FG020|Overall Study|Death|13|||
163930379|NCT01296555|592116145|FG021|Overall Study|Death|12|||
163930380|NCT01296555|592116146|FG022|Overall Study|Death|12|||
163930381|NCT01296555|592116147|FG023|Overall Study|Death|13|||
163930382|NCT01296555|592116148|FG024|Overall Study|Death|7|||
163930383|NCT01296555|592116149|FG025|Overall Study|Death|7|||
163930384|NCT01296555|592116150|FG026|Overall Study|Death|35|||
163930385|NCT01296555|592116151|FG027|Overall Study|Death|92|||
163930386|NCT01296555|592116152|FG028|Overall Study|Death|44|||
163930387|NCT01296555|592116124|FG000|Overall Study|Lost to Follow-up|0|||
163930388|NCT01296555|592116125|FG001|Overall Study|Lost to Follow-up|0|||
163930389|NCT01296555|592116126|FG002|Overall Study|Lost to Follow-up|0|||
163930390|NCT01296555|592116127|FG003|Overall Study|Lost to Follow-up|0|||
163930391|NCT01296555|592116128|FG004|Overall Study|Lost to Follow-up|0|||
163930392|NCT01296555|592116129|FG005|Overall Study|Lost to Follow-up|0|||
163930393|NCT01296555|592116130|FG006|Overall Study|Lost to Follow-up|0|||
163930394|NCT01296555|592116131|FG007|Overall Study|Lost to Follow-up|0|||
163930395|NCT01296555|592116132|FG008|Overall Study|Lost to Follow-up|0|||
163930396|NCT01296555|592116133|FG009|Overall Study|Lost to Follow-up|0|||
163930397|NCT01296555|592116134|FG010|Overall Study|Lost to Follow-up|0|||
163930398|NCT01296555|592116135|FG011|Overall Study|Lost to Follow-up|0|||
163930399|NCT01296555|592116136|FG012|Overall Study|Lost to Follow-up|0|||
163930400|NCT01296555|592116137|FG013|Overall Study|Lost to Follow-up|0|||
163930401|NCT01296555|592116138|FG014|Overall Study|Lost to Follow-up|2|||
163930402|NCT01296555|592116139|FG015|Overall Study|Lost to Follow-up|1|||
163930403|NCT01296555|592116140|FG016|Overall Study|Lost to Follow-up|0|||
163930404|NCT01296555|592116141|FG017|Overall Study|Lost to Follow-up|2|||
163930405|NCT01296555|592116142|FG018|Overall Study|Lost to Follow-up|0|||
163930406|NCT01296555|592116143|FG019|Overall Study|Lost to Follow-up|2|||
163930407|NCT01296555|592116144|FG020|Overall Study|Lost to Follow-up|3|||
163930408|NCT01296555|592116145|FG021|Overall Study|Lost to Follow-up|2|||
163930409|NCT01296555|592116146|FG022|Overall Study|Lost to Follow-up|0|||
163930410|NCT01296555|592116147|FG023|Overall Study|Lost to Follow-up|0|||
163930411|NCT01296555|592116148|FG024|Overall Study|Lost to Follow-up|0|||
163930412|NCT01296555|592116149|FG025|Overall Study|Lost to Follow-up|0|||
163930413|NCT01296555|592116150|FG026|Overall Study|Lost to Follow-up|3|||
163930414|NCT01296555|592116151|FG027|Overall Study|Lost to Follow-up|13|||
163930415|NCT01296555|592116152|FG028|Overall Study|Lost to Follow-up|5|||
163930416|NCT01296555|592116124|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163930417|NCT01296555|592116125|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163930418|NCT01296555|592116126|FG002|Overall Study|Non-Compliance With Study Drug|0|||
163930419|NCT01296555|592116127|FG003|Overall Study|Non-Compliance With Study Drug|0|||
163930420|NCT01296555|592116128|FG004|Overall Study|Non-Compliance With Study Drug|0|||
163930421|NCT01296555|592116129|FG005|Overall Study|Non-Compliance With Study Drug|0|||
163930422|NCT01296555|592116130|FG006|Overall Study|Non-Compliance With Study Drug|0|||
163930423|NCT01296555|592116131|FG007|Overall Study|Non-Compliance With Study Drug|1|||
163930424|NCT01296555|592116132|FG008|Overall Study|Non-Compliance With Study Drug|0|||
163930425|NCT01296555|592116133|FG009|Overall Study|Non-Compliance With Study Drug|0|||
163930426|NCT01296555|592116134|FG010|Overall Study|Non-Compliance With Study Drug|0|||
163930427|NCT01296555|592116135|FG011|Overall Study|Non-Compliance With Study Drug|0|||
163930428|NCT01296555|592116136|FG012|Overall Study|Non-Compliance With Study Drug|0|||
163930429|NCT01296555|592116137|FG013|Overall Study|Non-Compliance With Study Drug|0|||
163930430|NCT01296555|592116138|FG014|Overall Study|Non-Compliance With Study Drug|0|||
163930431|NCT01296555|592116139|FG015|Overall Study|Non-Compliance With Study Drug|0|||
164035637|NCT04432376|592490242|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164035638|NCT04432376|592490243|FG002|Double-blind Treatment Period|Protocol Violation|0|||
164035639|NCT04432376|592490241|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
164098184|NCT00696020|592725050|FG002|Overall Study|Adverse Event|2|||
164098185|NCT00696020|592725051|FG003|Overall Study|Adverse Event|1|||
164098186|NCT00696020|592725048|FG000|Overall Study|Lack of Efficacy|1|||
164098187|NCT00696020|592725049|FG001|Overall Study|Lack of Efficacy|0|||
164098188|NCT00696020|592725050|FG002|Overall Study|Lack of Efficacy|0|||
164098189|NCT00696020|592725051|FG003|Overall Study|Lack of Efficacy|0|||
164098190|NCT00696020|592725048|FG000|Overall Study|Protocol Violation|0|||
164098191|NCT00696020|592725049|FG001|Overall Study|Protocol Violation|0|||
164098192|NCT00696020|592725050|FG002|Overall Study|Protocol Violation|0|||
164098193|NCT00696020|592725051|FG003|Overall Study|Protocol Violation|1|||
164098194|NCT00696020|592725048|FG000|Overall Study|Withdrawal by Subject|0|||
164098195|NCT00696020|592725049|FG001|Overall Study|Withdrawal by Subject|1|||
164035640|NCT04432376|592490242|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
164098196|NCT00696020|592725050|FG002|Overall Study|Withdrawal by Subject|0|||
164098197|NCT00696020|592725051|FG003|Overall Study|Withdrawal by Subject|1|||
164098198|NCT00696020|592725048|FG000|Overall Study|Other not stated above|0|||
164098199|NCT00696020|592725049|FG001|Overall Study|Other not stated above|0|||
164035641|NCT04432376|592490243|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
164035642|NCT03706040|592490244|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
164035643|NCT03706040|592490245|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
164035644|NCT03706040|592490246|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
164035645|NCT03706040|592490247|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
164035646|NCT03706040|592490248|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
164035647|NCT03706040|592490249|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
164035648|NCT03706040|592490250|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
164035649|NCT03706040|592490244|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
164035650|NCT03706040|592490245|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
164035651|NCT03706040|592490246|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
164035652|NCT03706040|592490247|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164035653|NCT03706040|592490248|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164035654|NCT03706040|592490249|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164035655|NCT03706040|592490250|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
164035656|NCT03706040|592490244|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
164035657|NCT03706040|592490245|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
164035658|NCT03706040|592490246|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
164035659|NCT03706040|592490247|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164035660|NCT03706040|592490248|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164098200|NCT00696020|592725050|FG002|Overall Study|Other not stated above|1|||
164098201|NCT00696020|592725051|FG003|Overall Study|Other not stated above|1|||
163930432|NCT01296555|592116140|FG016|Overall Study|Non-Compliance With Study Drug|0|||
164035661|NCT03706040|592490249|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
164098202|NCT03687736|592725054|FG000|Overall Study|Lost to Follow-up|7|||
164098203|NCT03687736|592725054|FG000|Overall Study|Withdrawal by Subject|3|||
164098204|NCT02511782|592725055|FG000|Overall Study|Withdrawal by Subject|1|||
164098205|NCT02511782|592725056|FG001|Overall Study|Withdrawal by Subject|0|||
164098206|NCT02511782|592725057|FG002|Overall Study|Withdrawal by Subject|0|||
163930433|NCT01296555|592116141|FG017|Overall Study|Non-Compliance With Study Drug|0|||
163930434|NCT01296555|592116142|FG018|Overall Study|Non-Compliance With Study Drug|0|||
163930435|NCT01296555|592116143|FG019|Overall Study|Non-Compliance With Study Drug|0|||
163930436|NCT01296555|592116144|FG020|Overall Study|Non-Compliance With Study Drug|0|||
163930437|NCT01296555|592116145|FG021|Overall Study|Non-Compliance With Study Drug|0|||
163930438|NCT01296555|592116146|FG022|Overall Study|Non-Compliance With Study Drug|0|||
163930439|NCT01296555|592116147|FG023|Overall Study|Non-Compliance With Study Drug|0|||
163930440|NCT01296555|592116148|FG024|Overall Study|Non-Compliance With Study Drug|0|||
163930441|NCT01296555|592116149|FG025|Overall Study|Non-Compliance With Study Drug|0|||
163930442|NCT01296555|592116150|FG026|Overall Study|Non-Compliance With Study Drug|0|||
163930443|NCT01296555|592116151|FG027|Overall Study|Non-Compliance With Study Drug|0|||
163930444|NCT01296555|592116152|FG028|Overall Study|Non-Compliance With Study Drug|0|||
163930445|NCT01296555|592116124|FG000|Overall Study|Withdrawal by Subject|0|||
163930446|NCT01296555|592116125|FG001|Overall Study|Withdrawal by Subject|0|||
163930447|NCT01296555|592116126|FG002|Overall Study|Withdrawal by Subject|0|||
163930448|NCT01296555|592116127|FG003|Overall Study|Withdrawal by Subject|0|||
163930449|NCT01296555|592116128|FG004|Overall Study|Withdrawal by Subject|1|||
163930450|NCT01296555|592116129|FG005|Overall Study|Withdrawal by Subject|0|||
163930451|NCT01296555|592116130|FG006|Overall Study|Withdrawal by Subject|1|||
163930452|NCT01296555|592116131|FG007|Overall Study|Withdrawal by Subject|0|||
163930453|NCT01296555|592116132|FG008|Overall Study|Withdrawal by Subject|0|||
163930454|NCT01296555|592116133|FG009|Overall Study|Withdrawal by Subject|0|||
163930455|NCT01296555|592116134|FG010|Overall Study|Withdrawal by Subject|1|||
163930456|NCT01296555|592116135|FG011|Overall Study|Withdrawal by Subject|1|||
163930457|NCT01296555|592116136|FG012|Overall Study|Withdrawal by Subject|0|||
163930458|NCT01296555|592116137|FG013|Overall Study|Withdrawal by Subject|0|||
163930459|NCT01296555|592116138|FG014|Overall Study|Withdrawal by Subject|3|||
163930460|NCT01296555|592116139|FG015|Overall Study|Withdrawal by Subject|0|||
163930461|NCT01296555|592116140|FG016|Overall Study|Withdrawal by Subject|2|||
163930462|NCT01296555|592116141|FG017|Overall Study|Withdrawal by Subject|1|||
163930463|NCT01296555|592116142|FG018|Overall Study|Withdrawal by Subject|0|||
163930464|NCT01296555|592116143|FG019|Overall Study|Withdrawal by Subject|1|||
163930465|NCT01296555|592116144|FG020|Overall Study|Withdrawal by Subject|1|||
163930466|NCT01296555|592116145|FG021|Overall Study|Withdrawal by Subject|1|||
163930467|NCT01296555|592116146|FG022|Overall Study|Withdrawal by Subject|3|||
163930468|NCT01296555|592116147|FG023|Overall Study|Withdrawal by Subject|0|||
163930469|NCT01296555|592116148|FG024|Overall Study|Withdrawal by Subject|0|||
163930470|NCT01296555|592116149|FG025|Overall Study|Withdrawal by Subject|0|||
163930471|NCT01296555|592116150|FG026|Overall Study|Withdrawal by Subject|8|||
163930472|NCT01296555|592116151|FG027|Overall Study|Withdrawal by Subject|4|||
163930473|NCT01296555|592116152|FG028|Overall Study|Withdrawal by Subject|2|||
163930474|NCT00992992|592116153|FG000|Overall Study|Lost to Follow-up|3|||
163930475|NCT00992992|592116153|FG000|Overall Study|Death|16|||
163930476|NCT00992992|592116153|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
163930477|NCT00992992|592116153|FG000|Overall Study|Sponsor Closed the Study|4|||
163930478|NCT01253447|592116154|FG000|Overall Study|Adverse Event|2|||
163930479|NCT02299427|592116155|FG000|Overall Study|Withdrawal by Subject|1|||
163930480|NCT02299427|592116156|FG001|Overall Study|Withdrawal by Subject|0|||
163930481|NCT02299427|592116155|FG000|Overall Study|Lost to Follow-up|1|||
163930482|NCT02299427|592116156|FG001|Overall Study|Lost to Follow-up|3|||
163930483|NCT02299427|592116155|FG000|Overall Study|not adherent to dog website use|21|||
163930484|NCT02299427|592116156|FG001|Overall Study|not adherent to dog website use|0|||
163930485|NCT02108652|592116157|FG000|Overall Study|Death|253|||
163930486|NCT02108652|592116157|FG000|Overall Study|Lost to Follow-up|2|||
163930487|NCT02108652|592116157|FG000|Overall Study|Withdrawal by Subject|16|||
163930488|NCT02108652|592116157|FG000|Overall Study|Study Terminated By Sponsor|31|||
163930489|NCT02108652|592116157|FG000|Overall Study|Non-Compliance|1|||
163930490|NCT02108652|592116157|FG000|Overall Study|Physician Decision|6|||
163930491|NCT02108652|592116157|FG000|Overall Study|Progression Of Disease|1|||
163930492|NCT01182181|592116158|FG000|First Intervention|Adverse Event|1|||
163930493|NCT01182181|592116159|FG001|First Intervention|Adverse Event|0|||
163930494|NCT01182181|592116158|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
163930495|NCT01182181|592116159|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
163930496|NCT00511797|592116160|FG000|Overall Study|Adverse Event|1|||
164035662|NCT03706040|592490250|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
163930497|NCT00511797|592116161|FG001|Overall Study|Adverse Event|2|||
163930498|NCT00511797|592116162|FG002|Overall Study|Adverse Event|2|||
163930499|NCT00511797|592116163|FG003|Overall Study|Adverse Event|2|||
163930500|NCT00511797|592116160|FG000|Overall Study|Lost to Follow-up|1|||
163930501|NCT00511797|592116161|FG001|Overall Study|Lost to Follow-up|0|||
163930502|NCT00511797|592116162|FG002|Overall Study|Lost to Follow-up|0|||
163930503|NCT00511797|592116163|FG003|Overall Study|Lost to Follow-up|1|||
163930504|NCT00511797|592116160|FG000|Overall Study|Pregnancy|0|||
163930505|NCT00511797|592116161|FG001|Overall Study|Pregnancy|0|||
163930506|NCT00511797|592116162|FG002|Overall Study|Pregnancy|0|||
163930507|NCT00511797|592116163|FG003|Overall Study|Pregnancy|1|||
163930508|NCT00511797|592116160|FG000|Overall Study|Protocol Violation|0|||
163930509|NCT00511797|592116161|FG001|Overall Study|Protocol Violation|2|||
163930510|NCT00511797|592116162|FG002|Overall Study|Protocol Violation|2|||
163930511|NCT00511797|592116163|FG003|Overall Study|Protocol Violation|3|||
163930512|NCT00511797|592116160|FG000|Overall Study|Withdrawal by Subject|3|||
163930513|NCT00511797|592116161|FG001|Overall Study|Withdrawal by Subject|3|||
163930514|NCT00511797|592116162|FG002|Overall Study|Withdrawal by Subject|4|||
163930515|NCT00511797|592116163|FG003|Overall Study|Withdrawal by Subject|2|||
163930516|NCT00511797|592116160|FG000|Overall Study|Never dispensed|1|||
163930517|NCT00511797|592116161|FG001|Overall Study|Never dispensed|0|||
163930518|NCT00511797|592116162|FG002|Overall Study|Never dispensed|1|||
163930519|NCT00511797|592116163|FG003|Overall Study|Never dispensed|3|||
163930520|NCT00511797|592116160|FG000|Overall Study|Study drug not taken|0|||
163930521|NCT00511797|592116161|FG001|Overall Study|Study drug not taken|1|||
163930522|NCT00511797|592116162|FG002|Overall Study|Study drug not taken|0|||
163930523|NCT00511797|592116163|FG003|Overall Study|Study drug not taken|1|||
163930524|NCT00511797|592116160|FG000|Overall Study|Partially missing diary|0|||
163930525|NCT00511797|592116161|FG001|Overall Study|Partially missing diary|0|||
163930526|NCT00511797|592116162|FG002|Overall Study|Partially missing diary|1|||
163930527|NCT00511797|592116163|FG003|Overall Study|Partially missing diary|0|||
163930528|NCT00511797|592116160|FG000|Overall Study|Other (moving etc)|1|||
163930529|NCT00511797|592116161|FG001|Overall Study|Other (moving etc)|0|||
163930530|NCT00511797|592116162|FG002|Overall Study|Other (moving etc)|1|||
163930531|NCT00511797|592116163|FG003|Overall Study|Other (moving etc)|2|||
163930532|NCT01278615|592116164|FG000|Overall Study|Withdrawal by Subject|2|||
163930533|NCT02138253|592116165|FG000|Overall Study|Adverse Event|3|||
163930534|NCT02138253|592116166|FG001|Overall Study|Adverse Event|3|||
163930535|NCT02138253|592116165|FG000|Overall Study|Lost to Follow-up|2|||
163930536|NCT02138253|592116166|FG001|Overall Study|Lost to Follow-up|1|||
163930537|NCT02138253|592116165|FG000|Overall Study|Physician Decision|2|||
163930538|NCT02138253|592116166|FG001|Overall Study|Physician Decision|0|||
163930539|NCT02138253|592116165|FG000|Overall Study|Non compliance|1|||
163930540|NCT02138253|592116166|FG001|Overall Study|Non compliance|0|||
163930541|NCT02138253|592116165|FG000|Overall Study|Withdrawal by Subject|1|||
163930542|NCT02138253|592116166|FG001|Overall Study|Withdrawal by Subject|0|||
163930543|NCT01390441|592116167|FG000|Treatment Period|Protocol Violation|0|||
163930544|NCT01390441|592116168|FG001|Treatment Period|Protocol Violation|1|||
163930545|NCT01390441|592116169|FG002|Treatment Period|Protocol Violation|0|||
163930546|NCT01390441|592116170|FG003|Treatment Period|Protocol Violation|0|||
163930547|NCT01390441|592116171|FG004|Treatment Period|Protocol Violation|0|||
163930548|NCT01390441|592116167|FG000|Treatment Period|Physician Decision|0|||
163930549|NCT01390441|592116168|FG001|Treatment Period|Physician Decision|0|||
163930550|NCT01390441|592116169|FG002|Treatment Period|Physician Decision|0|||
163930551|NCT01390441|592116170|FG003|Treatment Period|Physician Decision|1|||
163930552|NCT01390441|592116171|FG004|Treatment Period|Physician Decision|0|||
163930553|NCT01390441|592116167|FG000|Treatment Period|Lack of Efficacy|0|||
163930554|NCT01390441|592116168|FG001|Treatment Period|Lack of Efficacy|0|||
163930555|NCT01390441|592116169|FG002|Treatment Period|Lack of Efficacy|0|||
163930556|NCT01390441|592116170|FG003|Treatment Period|Lack of Efficacy|0|||
163930557|NCT01390441|592116171|FG004|Treatment Period|Lack of Efficacy|1|||
163930558|NCT01390441|592116167|FG000|Treatment Period|Unknown due to early stopping of study|0|||
163930559|NCT01390441|592116168|FG001|Treatment Period|Unknown due to early stopping of study|0|||
163930560|NCT01390441|592116169|FG002|Treatment Period|Unknown due to early stopping of study|8|||
163930561|NCT01390441|592116170|FG003|Treatment Period|Unknown due to early stopping of study|11|||
163930562|NCT01390441|592116171|FG004|Treatment Period|Unknown due to early stopping of study|7|||
163930563|NCT01390441|592116167|FG000|Treatment Period|Adverse Event|0|||
163930564|NCT01390441|592116168|FG001|Treatment Period|Adverse Event|0|||
163930565|NCT01390441|592116169|FG002|Treatment Period|Adverse Event|1|||
163930566|NCT01390441|592116170|FG003|Treatment Period|Adverse Event|1|||
163930567|NCT01390441|592116171|FG004|Treatment Period|Adverse Event|2|||
164098207|NCT01536574|592725058|FG000|Overall Study|Adverse Event|4|||
164098208|NCT01536574|592725059|FG001|Overall Study|Adverse Event|5|||
163834554|NCT04739761|591763139|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
163834555|NCT04739761|591763138|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
163834556|NCT04739761|591763139|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
163834557|NCT04739761|591763138|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
163834558|NCT04739761|591763139|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
163834559|NCT04739761|591763138|FG000|Overall Study|Adverse Event|0|||
163834560|NCT04739761|591763139|FG001|Overall Study|Adverse Event|3|||
163834561|NCT04739761|591763138|FG000|Overall Study|Participant decision|1|||
163834562|NCT04739761|591763139|FG001|Overall Study|Participant decision|0|||
163834563|NCT04739761|591763138|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
163834564|NCT04739761|591763139|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
163834565|NCT04739761|591763138|FG000|Overall Study|Participant immediately started next line of treatment|1|||
163930568|NCT01390441|592116167|FG000|Treatment Period|Withdrawal by Subject|0|||
163930569|NCT01390441|592116168|FG001|Treatment Period|Withdrawal by Subject|0|||
163930570|NCT01390441|592116169|FG002|Treatment Period|Withdrawal by Subject|1|||
163930571|NCT01390441|592116170|FG003|Treatment Period|Withdrawal by Subject|0|||
163930572|NCT01390441|592116171|FG004|Treatment Period|Withdrawal by Subject|1|||
164098209|NCT01536574|592725058|FG000|Overall Study|Withdrawal by Subject|1|||
164098210|NCT01536574|592725059|FG001|Overall Study|Withdrawal by Subject|2|||
164098211|NCT01536574|592725058|FG000|Overall Study|Lack of Efficacy|1|||
164098212|NCT01536574|592725059|FG001|Overall Study|Lack of Efficacy|0|||
164098213|NCT02514122|592725060|FG000|Overall Study|Withdrawal by Subject|2|||
164098214|NCT02514122|592725061|FG001|Overall Study|Withdrawal by Subject|0|||
164098215|NCT01472341|592725065|FG000|Overall Study|Started insulin therapy|55|||
164098216|NCT01472341|592725065|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
163930573|NCT01390441|592116167|FG000|Treatment Period|Lost to Follow-up|1|||
163930574|NCT01390441|592116168|FG001|Treatment Period|Lost to Follow-up|0|||
163930575|NCT01390441|592116169|FG002|Treatment Period|Lost to Follow-up|0|||
163930576|NCT01390441|592116170|FG003|Treatment Period|Lost to Follow-up|0|||
163930577|NCT01390441|592116171|FG004|Treatment Period|Lost to Follow-up|0|||
163930578|NCT01390441|592116167|FG000|Extension Period|Protocol Violation|3|||
163930579|NCT01390441|592116168|FG001|Extension Period|Protocol Violation|1|||
163930580|NCT01390441|592116169|FG002|Extension Period|Protocol Violation|0|||
163930581|NCT01390441|592116170|FG003|Extension Period|Protocol Violation|1|||
163930582|NCT01390441|592116171|FG004|Extension Period|Protocol Violation|0|||
163930583|NCT04788511|592116174|FG000|Overall Study|Withdrawal by Subject|2|||
163930584|NCT04788511|592116175|FG001|Overall Study|Withdrawal by Subject|1|||
163930585|NCT04788511|592116174|FG000|Overall Study|Lost to Follow-up|2|||
163930586|NCT04788511|592116175|FG001|Overall Study|Lost to Follow-up|7|||
163930587|NCT04788511|592116174|FG000|Overall Study|Death|3|||
163930588|NCT04788511|592116175|FG001|Overall Study|Death|4|||
163930589|NCT03174782|592116176|FG000|Overall Study|Protocol Violation|1|||
163930590|NCT03174782|592116177|FG001|Overall Study|Protocol Violation|0|||
163930591|NCT03174782|592116176|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
163930592|NCT03174782|592116177|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
163930593|NCT00778921|592116178|FG000|Overall Study|Adverse Event|9|||
163930594|NCT00778921|592116179|FG001|Overall Study|Adverse Event|10|||
164098217|NCT01472341|592725065|FG000|Overall Study|Withdrawal by Subject|39|||
164098218|NCT01472341|592725065|FG000|Overall Study|Lost to Follow-up|52|||
164098219|NCT01472341|592725065|FG000|Overall Study|Laboratory parameters unavailable|25|||
164098220|NCT01472341|592725065|FG000|Overall Study|Death|9|||
164098221|NCT00579670|592725066|FG000|Overall Study|Death|1|||
163834566|NCT04739761|591763139|FG001|Overall Study|Participant immediately started next line of treatment|0|||
163834567|NCT04739761|591763138|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
163834568|NCT04739761|591763139|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
163834569|NCT04739761|591763138|FG000|Overall Study|Lack of clinical benefit|1|||
163834570|NCT04739761|591763139|FG001|Overall Study|Lack of clinical benefit|0|||
163834571|NCT04739761|591763138|FG000|Overall Study|Disease progression|5|||
163834572|NCT04739761|591763139|FG001|Overall Study|Disease progression|5|||
163834573|NCT04739761|591763138|FG000|Overall Study|Withdrawal by Subject|14|||
163834574|NCT04739761|591763139|FG001|Overall Study|Withdrawal by Subject|13|||
163834575|NCT04739761|591763138|FG000|Overall Study|Protocol Violation|1|||
163834576|NCT04739761|591763139|FG001|Overall Study|Protocol Violation|0|||
163834577|NCT04739761|591763138|FG000|Overall Study|Physician Decision|2|||
163834578|NCT04739761|591763139|FG001|Overall Study|Physician Decision|0|||
163834579|NCT00429494|591765029|FG000|Overall Study|Withdrawal by Subject|9|||
163834580|NCT00429494|591765029|FG000|Overall Study|Death|6|||
163834581|NCT00976703|591765032|FG000|Overall Study|Physician Decision|1|||
163834582|NCT00976703|591765033|FG001|Overall Study|Physician Decision|1|||
163834583|NCT00976703|591765032|FG000|Overall Study|ineligible for study|2|||
163834584|NCT00976703|591765033|FG001|Overall Study|ineligible for study|2|||
163834585|NCT01289041|591765037|FG000|Overall Study|Adverse Event|24|||
163834586|NCT01289041|591765037|FG000|Overall Study|Physician Decision|1|||
163834587|NCT01289041|591765037|FG000|Overall Study|Progressive Disease|41|||
163834588|NCT01289041|591765037|FG000|Overall Study|Withdrawal by Subject|3|||
163834589|NCT01289041|591765037|FG000|Overall Study|Death|1|||
163834590|NCT03610737|591765040|FG000|Overall Study|Withdrawal by Subject|1|||
163834591|NCT03610737|591765041|FG001|Overall Study|Withdrawal by Subject|5|||
163834592|NCT03610737|591765040|FG000|Overall Study|Death|1|||
163834593|NCT03610737|591765041|FG001|Overall Study|Death|0|||
163834594|NCT03610737|591765040|FG000|Overall Study|Not treated|5|||
163834595|NCT03610737|591765041|FG001|Overall Study|Not treated|2|||
163834596|NCT03610737|591765040|FG000|Overall Study|Missed Visit|1|||
163834597|NCT03610737|591765041|FG001|Overall Study|Missed Visit|2|||
163834598|NCT02714868|591765046|FG000|Overall Study|Withdrawal by Subject|3|||
163834599|NCT02714868|591765047|FG001|Overall Study|Withdrawal by Subject|0|||
163930595|NCT00778921|592116180|FG002|Overall Study|Adverse Event|14|||
163930596|NCT00778921|592116178|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
163834600|NCT02714868|591765046|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
163834601|NCT02714868|591765047|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
163834602|NCT02714868|591765046|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
163834603|NCT02714868|591765047|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
163834604|NCT05056870|591765052|FG000|Period 1|Site COVID-19 Related|3|||
163834605|NCT05056870|591765053|FG001|Period 1|Site COVID-19 Related|3|||
163834606|NCT05056870|591765052|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
163834607|NCT05056870|591765053|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
163834608|NCT05056870|591765052|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
163834609|NCT05056870|591765053|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
163834610|NCT05056870|591765052|FG000|Period 2|COVID-19 Related|1|||
163834611|NCT05056870|591765053|FG001|Period 2|COVID-19 Related|0|||
163834612|NCT05056870|591765052|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
163834613|NCT05056870|591765053|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
163834614|NCT05044325|591765056|FG000|Part A:Treatment Period 1|Adverse Event|0|||
163834615|NCT05044325|591765057|FG001|Part A:Treatment Period 1|Adverse Event|0|||
163834616|NCT05044325|591765058|FG002|Part A:Treatment Period 1|Adverse Event|0|||
163834617|NCT05044325|591765059|FG003|Part A:Treatment Period 1|Adverse Event|0|||
163834618|NCT05044325|591765060|FG004|Part A:Treatment Period 1|Adverse Event|0|||
163834619|NCT05044325|591765061|FG005|Part A:Treatment Period 1|Adverse Event|1|||
163834620|NCT05044325|591765062|FG006|Part A:Treatment Period 1|Adverse Event|0|||
163834621|NCT05044325|591765063|FG007|Part A:Treatment Period 1|Adverse Event|1|||
163834622|NCT05044325|591765064|FG008|Part A:Treatment Period 1|Adverse Event|0|||
163834623|NCT05044325|591765065|FG009|Part A:Treatment Period 1|Adverse Event|0|||
163834624|NCT05044325|591765056|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834625|NCT05044325|591765057|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834626|NCT05044325|591765058|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834627|NCT05044325|591765059|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
163834628|NCT05044325|591765060|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
163834629|NCT05044325|591765061|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
163834630|NCT05044325|591765062|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834631|NCT05044325|591765063|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834632|NCT05044325|591765064|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834633|NCT05044325|591765065|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
163834634|NCT05044325|591765056|FG000|Part A:Treatment Period 1|Physician Decision|0|||
163834635|NCT05044325|591765057|FG001|Part A:Treatment Period 1|Physician Decision|0|||
163834636|NCT05044325|591765058|FG002|Part A:Treatment Period 1|Physician Decision|0|||
163834637|NCT05044325|591765059|FG003|Part A:Treatment Period 1|Physician Decision|0|||
163834638|NCT05044325|591765060|FG004|Part A:Treatment Period 1|Physician Decision|0|||
163834639|NCT05044325|591765061|FG005|Part A:Treatment Period 1|Physician Decision|0|||
163834640|NCT05044325|591765062|FG006|Part A:Treatment Period 1|Physician Decision|1|||
163834641|NCT05044325|591765063|FG007|Part A:Treatment Period 1|Physician Decision|0|||
163834642|NCT05044325|591765064|FG008|Part A:Treatment Period 1|Physician Decision|0|||
163834643|NCT05044325|591765065|FG009|Part A:Treatment Period 1|Physician Decision|0|||
163834644|NCT05044325|591765056|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834645|NCT05044325|591765057|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834646|NCT05044325|591765058|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
163834647|NCT05044325|591765059|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834648|NCT05044325|591765060|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834649|NCT05044325|591765061|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834650|NCT05044325|591765062|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834651|NCT05044325|591765063|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834652|NCT05044325|591765064|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834653|NCT05044325|591765065|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
163834654|NCT05044325|591765056|FG000|Part A:Treatment Period 2|Adverse Event|0|||
163834655|NCT05044325|591765057|FG001|Part A:Treatment Period 2|Adverse Event|1|||
163834656|NCT05044325|591765058|FG002|Part A:Treatment Period 2|Adverse Event|0|||
163834657|NCT05044325|591765059|FG003|Part A:Treatment Period 2|Adverse Event|0|||
163834658|NCT05044325|591765060|FG004|Part A:Treatment Period 2|Adverse Event|1|||
163834659|NCT05044325|591765061|FG005|Part A:Treatment Period 2|Adverse Event|1|||
163834660|NCT05044325|591765062|FG006|Part A:Treatment Period 2|Adverse Event|0|||
163834661|NCT05044325|591765063|FG007|Part A:Treatment Period 2|Adverse Event|0|||
163834662|NCT05044325|591765064|FG008|Part A:Treatment Period 2|Adverse Event|0|||
163834663|NCT05044325|591765065|FG009|Part A:Treatment Period 2|Adverse Event|0|||
163834664|NCT05044325|591765056|FG000|Part A:Treatment Period 2|Physician Decision|0|||
163834665|NCT05044325|591765057|FG001|Part A:Treatment Period 2|Physician Decision|0|||
163834666|NCT05044325|591765058|FG002|Part A:Treatment Period 2|Physician Decision|0|||
163834667|NCT05044325|591765059|FG003|Part A:Treatment Period 2|Physician Decision|0|||
163834668|NCT05044325|591765060|FG004|Part A:Treatment Period 2|Physician Decision|0|||
163834669|NCT05044325|591765061|FG005|Part A:Treatment Period 2|Physician Decision|1|||
163834670|NCT05044325|591765062|FG006|Part A:Treatment Period 2|Physician Decision|0|||
164035663|NCT03706040|592490244|FG000|Period A (Week 0 to Week 16)|Other|2|||
164035664|NCT03706040|592490245|FG001|Period A (Week 0 to Week 16)|Other|0|||
164035665|NCT03706040|592490246|FG002|Period A (Week 0 to Week 16)|Other|2|||
164035666|NCT03706040|592490247|FG003|Period A (Week 0 to Week 16)|Other|0|||
164035667|NCT03706040|592490248|FG004|Period A (Week 0 to Week 16)|Other|0|||
164035668|NCT03706040|592490249|FG005|Period A (Week 0 to Week 16)|Other|0|||
164035669|NCT03706040|592490250|FG006|Period A (Week 0 to Week 16)|Other|0|||
163834671|NCT05044325|591765063|FG007|Part A:Treatment Period 2|Physician Decision|0|||
163834672|NCT05044325|591765064|FG008|Part A:Treatment Period 2|Physician Decision|0|||
163834673|NCT05044325|591765065|FG009|Part A:Treatment Period 2|Physician Decision|0|||
163834674|NCT05044325|591765056|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834675|NCT05044325|591765057|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834676|NCT05044325|591765058|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834677|NCT05044325|591765059|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
163834678|NCT05044325|591765060|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
163834679|NCT05044325|591765061|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834680|NCT05044325|591765062|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834681|NCT05044325|591765063|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834682|NCT05044325|591765064|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834683|NCT05044325|591765065|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
163834684|NCT01373931|591765068|FG000|Lead-in Period|Adverse Event|2|||
163834685|NCT01373931|591765069|FG001|Lead-in Period|Adverse Event|0|||
163834686|NCT01373931|591765068|FG000|Period 1|Adverse Event|2|||
163834687|NCT01373931|591765069|FG001|Period 1|Adverse Event|0|||
163834688|NCT01373931|591765068|FG000|Period 1|Withdrawal by Subject|0|||
163834689|NCT01373931|591765069|FG001|Period 1|Withdrawal by Subject|2|||
163834690|NCT00674323|591765070|FG000|Overall Study|Adverse Event|0|||
163834691|NCT00674323|591765071|FG001|Overall Study|Adverse Event|1|||
163834692|NCT00674323|591765072|FG002|Overall Study|Adverse Event|0|||
163834693|NCT00674323|591765070|FG000|Overall Study|Protocol Violation|1|||
163834694|NCT00674323|591765071|FG001|Overall Study|Protocol Violation|0|||
163834695|NCT00674323|591765072|FG002|Overall Study|Protocol Violation|0|||
163834696|NCT00742079|591765073|FG000|Overall Study|Lost to Follow-up|0|||
163834697|NCT00742079|591765074|FG001|Overall Study|Lost to Follow-up|1|||
163834698|NCT02013388|591765080|FG000|Overall Study|work emergency|1|||
163834699|NCT02013388|591765081|FG001|Overall Study|work emergency|0|||
163834700|NCT02013388|591765082|FG002|Overall Study|work emergency|0|||
163834701|NCT02013388|591765083|FG003|Overall Study|work emergency|0|||
163834702|NCT02013388|591765084|FG004|Overall Study|work emergency|1|||
163834703|NCT02013388|591765085|FG005|Overall Study|work emergency|0|||
163834704|NCT02013388|591765086|FG006|Overall Study|work emergency|0|||
163834705|NCT02013388|591765087|FG007|Overall Study|work emergency|0|||
163834706|NCT01559454|591765091|FG000|Overall Study|Lost to Follow-up|3|||
163834707|NCT01559454|591765092|FG001|Overall Study|Lost to Follow-up|2|||
163834708|NCT01559454|591765091|FG000|Overall Study|Withdrawal by Subject|0|||
163834709|NCT01559454|591765092|FG001|Overall Study|Withdrawal by Subject|1|||
163834710|NCT01559454|591765091|FG000|Overall Study|Physician Decision|0|||
163834711|NCT01559454|591765092|FG001|Overall Study|Physician Decision|1|||
163834712|NCT01559454|591765091|FG000|Overall Study|Protocol Violation|0|||
163834713|NCT01559454|591765092|FG001|Overall Study|Protocol Violation|1|||
163834714|NCT01559454|591765091|FG000|Overall Study|Lack of Efficacy|0|||
163834715|NCT01559454|591765092|FG001|Overall Study|Lack of Efficacy|1|||
163834716|NCT01114204|591765093|FG000|Overall Study|Adverse Event|3|||
163834717|NCT01114204|591765094|FG001|Overall Study|Adverse Event|2|||
163834718|NCT01114204|591765093|FG000|Overall Study|Lost to Follow-up|1|||
163834719|NCT01114204|591765094|FG001|Overall Study|Lost to Follow-up|0|||
163834720|NCT01114204|591765093|FG000|Overall Study|Withdrawal by Subject|10|||
163834721|NCT01114204|591765094|FG001|Overall Study|Withdrawal by Subject|6|||
163834722|NCT01114204|591765093|FG000|Overall Study|Death|1|||
163834723|NCT01114204|591765094|FG001|Overall Study|Death|0|||
163834724|NCT01114204|591765093|FG000|Overall Study|Other-Personal reasons|2|||
163834725|NCT01114204|591765094|FG001|Overall Study|Other-Personal reasons|0|||
163834726|NCT01114204|591765093|FG000|Overall Study|Other-Medical monitor request|1|||
163834727|NCT01114204|591765094|FG001|Overall Study|Other-Medical monitor request|0|||
163834728|NCT01114204|591765093|FG000|Overall Study|Other-Participant request|2|||
163834729|NCT01114204|591765094|FG001|Overall Study|Other-Participant request|0|||
164035670|NCT03706040|592490244|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
163834730|NCT01114204|591765093|FG000|Overall Study|Other-Protocol Violation|1|||
163834731|NCT01114204|591765094|FG001|Overall Study|Other-Protocol Violation|0|||
163834732|NCT00991341|591765099|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
163834733|NCT00991341|591765100|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
163834734|NCT00991341|591765099|FG000|Overall Study|Death|3|||
163834735|NCT00991341|591765100|FG001|Overall Study|Death|0|||
163834736|NCT00991341|591765099|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
163834737|NCT00991341|591765100|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
163834738|NCT00991341|591765099|FG000|Overall Study|Physician Decision|1|||
163930597|NCT00778921|592116179|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
163930598|NCT00778921|592116180|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
163930599|NCT00778921|592116178|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
163930600|NCT00778921|592116179|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
163930601|NCT00778921|592116180|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
163930602|NCT00778921|592116178|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
163930603|NCT00778921|592116179|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
163930604|NCT00778921|592116180|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
163930605|NCT00778921|592116178|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
163930606|NCT00778921|592116179|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
163930607|NCT00778921|592116180|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
163930608|NCT00778921|592116178|FG000|Overall Study|Patient withdrew request|3|||
163930609|NCT00778921|592116179|FG001|Overall Study|Patient withdrew request|1|||
163930610|NCT00778921|592116180|FG002|Overall Study|Patient withdrew request|6|||
163930611|NCT00778921|592116178|FG000|Overall Study|Lost to Follow-up|0|||
163930612|NCT00778921|592116179|FG001|Overall Study|Lost to Follow-up|2|||
163930613|NCT00778921|592116180|FG002|Overall Study|Lost to Follow-up|1|||
163930614|NCT00778921|592116178|FG000|Overall Study|Administrative Problems|1|||
163930615|NCT00778921|592116179|FG001|Overall Study|Administrative Problems|2|||
163930616|NCT00778921|592116180|FG002|Overall Study|Administrative Problems|0|||
163930617|NCT00778921|592116178|FG000|Overall Study|Protocol Violation|3|||
163930618|NCT00778921|592116179|FG001|Overall Study|Protocol Violation|0|||
163930619|NCT00778921|592116180|FG002|Overall Study|Protocol Violation|2|||
163930620|NCT00778921|592116178|FG000|Overall Study|Not treated|0|||
163930621|NCT00778921|592116179|FG001|Overall Study|Not treated|2|||
163930622|NCT00778921|592116180|FG002|Overall Study|Not treated|2|||
163930623|NCT03178045|592116181|FG000|Overall Study|Withdrawal by Subject|5|||
163930624|NCT03178045|592116182|FG001|Overall Study|Withdrawal by Subject|7|||
163930625|NCT03178045|592116181|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
163930626|NCT03178045|592116182|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
163930627|NCT03178045|592116181|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
163930628|NCT03178045|592116182|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
163930629|NCT01078922|592116183|FG000|Overall Study|Adverse Event|1|||
163930630|NCT02353468|592116184|FG000|Overall Study|Study terminated|3|||
163930631|NCT00798304|592116186|FG000|Overall Study|Adverse Event|0|||
163930632|NCT00798304|592116187|FG001|Overall Study|Adverse Event|1|||
163930633|NCT00798304|592116188|FG002|Overall Study|Adverse Event|1|||
163930634|NCT00798304|592116186|FG000|Overall Study|Discontinuation by Sponsor|14|||
163930635|NCT00798304|592116187|FG001|Overall Study|Discontinuation by Sponsor|21|||
163930636|NCT00798304|592116188|FG002|Overall Study|Discontinuation by Sponsor|9|||
163930637|NCT02031536|592116189|FG000|Overall Study|ineligible|1|||
163930638|NCT02031536|592116190|FG001|Overall Study|ineligible|0|||
163930639|NCT04211389|592116192|FG000|Overall Study|Adverse Event|1|||
163930640|NCT04211389|592116193|FG001|Overall Study|Adverse Event|2|||
163930641|NCT04211389|592116192|FG000|Overall Study|Lost to Follow-up|15|||
163930642|NCT04211389|592116193|FG001|Overall Study|Lost to Follow-up|7|||
163930643|NCT04211389|592116192|FG000|Overall Study|Protocol Violation|0|||
163930644|NCT04211389|592116193|FG001|Overall Study|Protocol Violation|1|||
163930645|NCT04211389|592116192|FG000|Overall Study|Withdrawal by Subject|10|||
163930646|NCT04211389|592116193|FG001|Overall Study|Withdrawal by Subject|11|||
163930647|NCT01182207|592116202|FG000|First Intervention|Positive Hepatitis Results|0|||
163930648|NCT01182207|592116203|FG001|First Intervention|Positive Hepatitis Results|1|||
163930649|NCT01182207|592116202|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
163930650|NCT01182207|592116203|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
163930651|NCT01427738|592116204|FG000|Overall Study|Death|12|||
163930652|NCT01427738|592116205|FG001|Overall Study|Death|9|||
163930653|NCT01427738|592116204|FG000|Overall Study|Severe debilitation, unable to continue|0|||
163930654|NCT01427738|592116205|FG001|Overall Study|Severe debilitation, unable to continue|1|||
163930655|NCT01427738|592116204|FG000|Overall Study|Subject unable to get to clinic|5|||
163930656|NCT01427738|592116205|FG001|Overall Study|Subject unable to get to clinic|2|||
163930657|NCT01427738|592116204|FG000|Overall Study|Withdrawal by Subject|0|||
163930658|NCT01427738|592116205|FG001|Overall Study|Withdrawal by Subject|2|||
163930659|NCT01427738|592116204|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
163930660|NCT01427738|592116205|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
163930661|NCT01427738|592116204|FG000|Overall Study|Lost to Follow-up|1|||
163930662|NCT01427738|592116205|FG001|Overall Study|Lost to Follow-up|5|||
163930663|NCT01801982|592116208|FG000|Overall Study|Lost to Follow-up|1|||
163930664|NCT00727506|592116209|FG000|Overall Study|Adverse Event|0|||
163930665|NCT00727506|592116210|FG001|Overall Study|Adverse Event|0|||
163930666|NCT00727506|592116211|FG002|Overall Study|Adverse Event|4|||
163930667|NCT00727506|592116212|FG003|Overall Study|Adverse Event|4|||
163930668|NCT00727506|592116213|FG004|Overall Study|Adverse Event|1|||
163930669|NCT00727506|592116214|FG005|Overall Study|Adverse Event|8|||
163930670|NCT00727506|592116209|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163930671|NCT00727506|592116210|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164035671|NCT03706040|592490245|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
164035672|NCT03706040|592490246|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
164035673|NCT03706040|592490247|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
164035674|NCT03706040|592490248|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
164035675|NCT03706040|592490249|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
164035676|NCT03706040|592490250|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
163834739|NCT00991341|591765100|FG001|Overall Study|Physician Decision|2|||
163834740|NCT00991341|591765099|FG000|Overall Study|Withdrawal by Subject|3|||
163834741|NCT00991341|591765100|FG001|Overall Study|Withdrawal by Subject|4|||
163834742|NCT03145766|591765111|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
163834743|NCT03145766|591765112|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
163834744|NCT03145766|591765113|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
163834745|NCT03145766|591765114|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
163834746|NCT03145766|591765115|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
163834747|NCT03145766|591765111|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
163834748|NCT03145766|591765112|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
163834749|NCT03145766|591765113|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
163834750|NCT03145766|591765114|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
163834751|NCT03145766|591765115|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
163834752|NCT03145766|591765111|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
163834753|NCT03145766|591765112|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
163834754|NCT03145766|591765113|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
163834755|NCT03145766|591765114|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
163834756|NCT03145766|591765115|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
163834757|NCT03145766|591765111|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
163834758|NCT03145766|591765112|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
163834759|NCT03145766|591765113|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
163834760|NCT03145766|591765114|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
163834761|NCT03145766|591765115|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
163834762|NCT03145766|591765111|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
163834763|NCT03145766|591765112|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
163834764|NCT03145766|591765113|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
163834765|NCT03145766|591765114|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
163834766|NCT03145766|591765115|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
163834767|NCT03145766|591765111|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
163834768|NCT03145766|591765112|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
163834769|NCT03145766|591765113|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
163834770|NCT03145766|591765114|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
163834771|NCT03145766|591765115|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
163834772|NCT03145766|591765111|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
163834773|NCT03145766|591765112|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
163834774|NCT03145766|591765113|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
163834775|NCT03145766|591765114|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
163834776|NCT03145766|591765115|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
163834777|NCT02799472|591765118|FG000|Overall Study|Withdrawal by Subject|2|||
163834778|NCT02799472|591765119|FG001|Overall Study|Withdrawal by Subject|4|||
163834779|NCT02799472|591765118|FG000|Overall Study|Lack of Efficacy|2|||
163834780|NCT02799472|591765119|FG001|Overall Study|Lack of Efficacy|0|||
163834781|NCT02799472|591765118|FG000|Overall Study|Lost to Follow-up|0|||
163834782|NCT02799472|591765119|FG001|Overall Study|Lost to Follow-up|1|||
163834783|NCT02801669|591765120|FG000|Overall Study|Death|66|||
163834784|NCT02801669|591765121|FG001|Overall Study|Death|69|||
163834785|NCT02801669|591765120|FG000|Overall Study|Withdrawal by Subject|81|||
163834786|NCT02801669|591765121|FG001|Overall Study|Withdrawal by Subject|77|||
163834787|NCT02801669|591765120|FG000|Overall Study|Other|4|||
163834788|NCT02801669|591765121|FG001|Overall Study|Other|6|||
163834789|NCT00462670|591765123|FG000|Overall Study|Adverse Event|3|||
163834790|NCT00462670|591765124|FG001|Overall Study|Adverse Event|5|||
163834791|NCT00462670|591765123|FG000|Overall Study|Lack of Efficacy|1|||
163834792|NCT00462670|591765124|FG001|Overall Study|Lack of Efficacy|0|||
163834793|NCT00462670|591765123|FG000|Overall Study|Protocol Violation|1|||
163834794|NCT00462670|591765124|FG001|Overall Study|Protocol Violation|0|||
163834795|NCT00462670|591765123|FG000|Overall Study|Resolution of signs and symptoms|0|||
163834796|NCT00462670|591765124|FG001|Overall Study|Resolution of signs and symptoms|2|||
163834797|NCT04461795|591765125|FG000|Overall Study|Lost to Follow-up|2|||
164035677|NCT03706040|592490244|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
164035678|NCT03706040|592490245|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
163930672|NCT00727506|592116211|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
163930673|NCT00727506|592116212|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163930674|NCT00727506|592116213|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163930675|NCT00727506|592116214|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
163930676|NCT00727506|592116209|FG000|Overall Study|Progressive disease|4|||
163930677|NCT00727506|592116210|FG001|Overall Study|Progressive disease|7|||
163930678|NCT00727506|592116211|FG002|Overall Study|Progressive disease|9|||
163930679|NCT00727506|592116212|FG003|Overall Study|Progressive disease|28|||
163930680|NCT00727506|592116213|FG004|Overall Study|Progressive disease|38|||
163930681|NCT00727506|592116214|FG005|Overall Study|Progressive disease|28|||
163930682|NCT00727506|592116209|FG000|Overall Study|Refused to continue medication|0|||
163930683|NCT00727506|592116210|FG001|Overall Study|Refused to continue medication|1|||
163930684|NCT00727506|592116211|FG002|Overall Study|Refused to continue medication|2|||
163930685|NCT00727506|592116212|FG003|Overall Study|Refused to continue medication|3|||
163930686|NCT00727506|592116213|FG004|Overall Study|Refused to continue medication|1|||
163930687|NCT00727506|592116214|FG005|Overall Study|Refused to continue medication|2|||
163930688|NCT00727506|592116209|FG000|Overall Study|Other reason not described above|0|||
163930689|NCT00727506|592116210|FG001|Overall Study|Other reason not described above|0|||
163930690|NCT00727506|592116211|FG002|Overall Study|Other reason not described above|1|||
163930691|NCT00727506|592116212|FG003|Overall Study|Other reason not described above|4|||
163930692|NCT00727506|592116213|FG004|Overall Study|Other reason not described above|1|||
163930693|NCT00727506|592116214|FG005|Overall Study|Other reason not described above|1|||
163930694|NCT02650466|592116216|FG000|Overall Study|Physician Decision|1|||
163930695|NCT02650466|592116216|FG000|Overall Study|Withdrawal by Subject|5|||
163930696|NCT02650466|592116216|FG000|Overall Study|Lost to Follow-up|1|||
163930697|NCT01214421|592116220|FG000|Overall Study|Lost to Follow-up|7|||
163930698|NCT01214421|592116221|FG001|Overall Study|Lost to Follow-up|3|||
163930699|NCT01214421|592116222|FG002|Overall Study|Lost to Follow-up|7|||
163930700|NCT01214421|592116223|FG003|Overall Study|Lost to Follow-up|3|||
163930701|NCT01214421|592116220|FG000|Overall Study|Adverse Event|16|||
163930702|NCT01214421|592116221|FG001|Overall Study|Adverse Event|35|||
163930703|NCT01214421|592116222|FG002|Overall Study|Adverse Event|14|||
163930704|NCT01214421|592116223|FG003|Overall Study|Adverse Event|3|||
163930705|NCT01214421|592116220|FG000|Overall Study|Sponsor Discontinued Site|1|||
163930706|NCT01214421|592116221|FG001|Overall Study|Sponsor Discontinued Site|2|||
163930707|NCT01214421|592116222|FG002|Overall Study|Sponsor Discontinued Site|0|||
163930708|NCT01214421|592116223|FG003|Overall Study|Sponsor Discontinued Site|0|||
163930709|NCT01214421|592116220|FG000|Overall Study|Withdrawal Criteria Met|3|||
163930710|NCT01214421|592116221|FG001|Overall Study|Withdrawal Criteria Met|0|||
163930711|NCT01214421|592116222|FG002|Overall Study|Withdrawal Criteria Met|2|||
163930712|NCT01214421|592116223|FG003|Overall Study|Withdrawal Criteria Met|1|||
163930713|NCT01214421|592116220|FG000|Overall Study|Physician Decision|2|||
163930714|NCT01214421|592116221|FG001|Overall Study|Physician Decision|0|||
163930715|NCT01214421|592116222|FG002|Overall Study|Physician Decision|4|||
163930716|NCT01214421|592116223|FG003|Overall Study|Physician Decision|0|||
163930717|NCT01214421|592116220|FG000|Overall Study|Withdrawal by Subject|21|||
163930718|NCT01214421|592116221|FG001|Overall Study|Withdrawal by Subject|18|||
163930719|NCT01214421|592116222|FG002|Overall Study|Withdrawal by Subject|11|||
163930720|NCT01214421|592116223|FG003|Overall Study|Withdrawal by Subject|2|||
163930721|NCT02392104|592116225|FG000|Overall Study|discontinuation of warfarin|3|||
163930722|NCT02392104|592116225|FG000|Overall Study|bleeding event|1|||
163930723|NCT02392104|592116225|FG000|Overall Study|transferred care to another doctor|2|||
163930724|NCT02392104|592116225|FG000|Overall Study|INR goal range changed|1|||
163930725|NCT02392104|592116225|FG000|Overall Study|admitted to skilled nursing facility|3|||
163930726|NCT02392104|592116225|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
163930727|NCT04590404|592116226|FG000|Overall Study|Death|16|||
163930728|NCT04590404|592116227|FG001|Overall Study|Death|17|||
163930729|NCT04590404|592116226|FG000|Overall Study|Withdrawal by Subject|7|||
163930730|NCT04590404|592116227|FG001|Overall Study|Withdrawal by Subject|2|||
163930731|NCT03912532|592116228|FG000|Overall Study|Adverse Event|3|||
163930732|NCT03912532|592116229|FG001|Overall Study|Adverse Event|3|||
164098222|NCT00579670|592725067|FG001|Overall Study|Death|0|||
163930733|NCT03912532|592116230|FG002|Overall Study|Adverse Event|2|||
163930734|NCT03912532|592116231|FG003|Overall Study|Adverse Event|2|||
163930735|NCT03912532|592116228|FG000|Overall Study|Lost to Follow-up|3|||
164098223|NCT00579670|592725068|FG002|Overall Study|Death|0|||
163930736|NCT03912532|592116229|FG001|Overall Study|Lost to Follow-up|2|||
163930737|NCT03912532|592116230|FG002|Overall Study|Lost to Follow-up|1|||
163930738|NCT03912532|592116231|FG003|Overall Study|Lost to Follow-up|2|||
163930739|NCT03912532|592116228|FG000|Overall Study|Withdrawal by Subject|1|||
163930740|NCT03912532|592116229|FG001|Overall Study|Withdrawal by Subject|1|||
163930741|NCT03912532|592116230|FG002|Overall Study|Withdrawal by Subject|2|||
164098224|NCT00579670|592725069|FG003|Overall Study|Death|0|||
163930742|NCT03912532|592116231|FG003|Overall Study|Withdrawal by Subject|0|||
163930743|NCT03912532|592116228|FG000|Overall Study|Physician Decision|1|||
163930744|NCT03912532|592116229|FG001|Overall Study|Physician Decision|0|||
164098225|NCT00579670|592725070|FG004|Overall Study|Death|0|||
164098226|NCT00579670|592725066|FG000|Overall Study|Adverse Event|1|||
164098227|NCT00579670|592725067|FG001|Overall Study|Adverse Event|0|||
164098228|NCT00579670|592725068|FG002|Overall Study|Adverse Event|1|||
164098229|NCT00579670|592725069|FG003|Overall Study|Adverse Event|2|||
164098230|NCT00579670|592725070|FG004|Overall Study|Adverse Event|0|||
164098231|NCT00579670|592725066|FG000|Overall Study|Lack of Efficacy|0|||
164098232|NCT00579670|592725067|FG001|Overall Study|Lack of Efficacy|0|||
164098233|NCT00579670|592725068|FG002|Overall Study|Lack of Efficacy|1|||
164098234|NCT00579670|592725069|FG003|Overall Study|Lack of Efficacy|14|||
164098235|NCT00579670|592725070|FG004|Overall Study|Lack of Efficacy|0|||
164098236|NCT00579670|592725066|FG000|Overall Study|Lost to Follow-up|0|||
164098237|NCT00579670|592725067|FG001|Overall Study|Lost to Follow-up|1|||
164098238|NCT00579670|592725068|FG002|Overall Study|Lost to Follow-up|0|||
164098239|NCT00579670|592725069|FG003|Overall Study|Lost to Follow-up|4|||
163834798|NCT04461795|591765125|FG000|Overall Study|Withdrawal by Subject|2|||
163834799|NCT04461795|591765125|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
163834800|NCT00615264|591765126|FG000|Overall Study|Withdrawal by Subject|17|||
163834801|NCT00615264|591765127|FG001|Overall Study|Withdrawal by Subject|19|||
163834802|NCT00615264|591765126|FG000|Overall Study|Lost to Follow-up|6|||
163834803|NCT00615264|591765127|FG001|Overall Study|Lost to Follow-up|13|||
163834804|NCT00615264|591765126|FG000|Overall Study|Adverse Event|8|||
163834805|NCT00615264|591765127|FG001|Overall Study|Adverse Event|5|||
163834806|NCT00615264|591765126|FG000|Overall Study|Death|1|||
163834807|NCT00615264|591765127|FG001|Overall Study|Death|1|||
163834808|NCT00615264|591765126|FG000|Overall Study|Protocol Violation|11|||
163834809|NCT00615264|591765127|FG001|Overall Study|Protocol Violation|7|||
163834810|NCT00615264|591765126|FG000|Overall Study|Not defined|7|||
163834811|NCT00615264|591765127|FG001|Overall Study|Not defined|4|||
163834812|NCT00615264|591765126|FG000|Overall Study|Dermal Hypersensitivity|0|||
163834813|NCT00615264|591765127|FG001|Overall Study|Dermal Hypersensitivity|3|||
163834814|NCT00633932|591765132|FG000|Overall Study|Adverse Event|1|||
163834815|NCT00633932|591765133|FG001|Overall Study|Adverse Event|3|||
163834816|NCT00633932|591765134|FG002|Overall Study|Adverse Event|4|||
163834817|NCT00633932|591765132|FG000|Overall Study|Withdrawal by Subject|3|||
163834818|NCT00633932|591765133|FG001|Overall Study|Withdrawal by Subject|9|||
163834819|NCT00633932|591765134|FG002|Overall Study|Withdrawal by Subject|1|||
163834820|NCT00633932|591765132|FG000|Overall Study|Lost to Follow-up|1|||
163834821|NCT00633932|591765133|FG001|Overall Study|Lost to Follow-up|0|||
163834822|NCT00633932|591765134|FG002|Overall Study|Lost to Follow-up|2|||
163834823|NCT00633932|591765132|FG000|Overall Study|Protocol Violation|5|||
163834824|NCT00633932|591765133|FG001|Overall Study|Protocol Violation|2|||
163834825|NCT00633932|591765134|FG002|Overall Study|Protocol Violation|3|||
163834826|NCT00633932|591765132|FG000|Overall Study|Physician Decision|0|||
163834827|NCT00633932|591765133|FG001|Overall Study|Physician Decision|0|||
163834828|NCT00633932|591765134|FG002|Overall Study|Physician Decision|1|||
163834829|NCT00633932|591765132|FG000|Overall Study|Doctor's judgement|1|||
163834830|NCT00633932|591765133|FG001|Overall Study|Doctor's judgement|0|||
163834831|NCT00633932|591765134|FG002|Overall Study|Doctor's judgement|0|||
163834832|NCT00633932|591765132|FG000|Overall Study|Moved Away|1|||
163834833|NCT00633932|591765133|FG001|Overall Study|Moved Away|0|||
163834834|NCT00633932|591765134|FG002|Overall Study|Moved Away|0|||
163834835|NCT00482274|591765135|FG000|Overall Study|Adverse Event|1|||
163834836|NCT04836858|591765136|FG000|Overall Study|Adverse Event|0|||
163834837|NCT04836858|591765137|FG001|Overall Study|Adverse Event|0|||
163834838|NCT04836858|591765138|FG002|Overall Study|Adverse Event|0|||
163834839|NCT04836858|591765139|FG003|Overall Study|Adverse Event|1|||
163834840|NCT04836858|591765136|FG000|Overall Study|Lost to Follow-up|1|||
163834841|NCT04836858|591765137|FG001|Overall Study|Lost to Follow-up|0|||
163834842|NCT04836858|591765138|FG002|Overall Study|Lost to Follow-up|0|||
163834843|NCT04836858|591765139|FG003|Overall Study|Lost to Follow-up|0|||
163834844|NCT04836858|591765136|FG000|Overall Study|Subject/Guardian decision|3|||
163834845|NCT04836858|591765137|FG001|Overall Study|Subject/Guardian decision|0|||
163834846|NCT04836858|591765138|FG002|Overall Study|Subject/Guardian decision|0|||
163834847|NCT04836858|591765139|FG003|Overall Study|Subject/Guardian decision|1|||
163834848|NCT04836858|591765136|FG000|Overall Study|Randomized but not treated|4|||
163834849|NCT04836858|591765137|FG001|Overall Study|Randomized but not treated|0|||
163834850|NCT04836858|591765138|FG002|Overall Study|Randomized but not treated|0|||
163834851|NCT04836858|591765139|FG003|Overall Study|Randomized but not treated|0|||
163834852|NCT02396537|591765141|FG000|Overall Study|Protocol Violation|0|||
163834853|NCT02396537|591765142|FG001|Overall Study|Protocol Violation|1|||
163834854|NCT01982435|591765143|FG000|Overall Study|Adverse Event|1|||
163834855|NCT01982435|591765144|FG001|Overall Study|Adverse Event|0|||
163834856|NCT00787319|591765148|FG000|Overall Study|Lost to Follow-up|2|||
163834857|NCT00787319|591765148|FG000|Overall Study|Withdrawal by Subject|15|||
163834858|NCT00787319|591765148|FG000|Overall Study|Adverse Event|3|||
164098240|NCT00579670|592725070|FG004|Overall Study|Lost to Follow-up|0|||
163834859|NCT00787319|591765148|FG000|Overall Study|Objective progression or relapse|30|||
163834860|NCT00787319|591765148|FG000|Overall Study|Lack of Efficacy|1|||
163834861|NCT00787319|591765148|FG000|Overall Study|Budget exhausted/exceeded|1|||
164098241|NCT00579670|592725066|FG000|Overall Study|Other|0|||
163930745|NCT03912532|592116230|FG002|Overall Study|Physician Decision|0|||
163930746|NCT03912532|592116231|FG003|Overall Study|Physician Decision|3|||
163930747|NCT03912532|592116228|FG000|Overall Study|Other|0|||
163930748|NCT03912532|592116229|FG001|Overall Study|Other|1|||
163930749|NCT03912532|592116230|FG002|Overall Study|Other|1|||
163930750|NCT03912532|592116231|FG003|Overall Study|Other|0|||
163930751|NCT03783871|592116234|FG000|Overall Study|Withdrawal by Subject|15|||
163930752|NCT03783871|592116234|FG000|Overall Study|Death|13|||
163930753|NCT03783871|592116234|FG000|Overall Study|Lost to Follow-up|2|||
163930754|NCT05990387|592116235|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
163930755|NCT05990387|592116236|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
163930756|NCT00815919|592116237|FG000|Overall Study|Unrelated Fungal Infection|1|||
163930757|NCT00815919|592116237|FG000|Overall Study|AML Relapse|1|||
163930758|NCT00815919|592116237|FG000|Overall Study|Lack of Efficacy|2|||
163930759|NCT03522389|592116238|FG000|Overall Study|Lost to Follow-up|1|||
163930760|NCT03522389|592116239|FG001|Overall Study|Lost to Follow-up|1|||
163930761|NCT03522389|592116240|FG002|Overall Study|Lost to Follow-up|2|||
163930762|NCT03522389|592116238|FG000|Overall Study|had herniated nucleus pulposus|0|||
163930763|NCT03522389|592116239|FG001|Overall Study|had herniated nucleus pulposus|1|||
163930764|NCT03522389|592116240|FG002|Overall Study|had herniated nucleus pulposus|0|||
163930765|NCT03522389|592116238|FG000|Overall Study|go to work in other province|1|||
163930766|NCT03522389|592116239|FG001|Overall Study|go to work in other province|0|||
163930767|NCT03522389|592116240|FG002|Overall Study|go to work in other province|0|||
163930768|NCT04750577|592116241|FG000|Overall Study|Adverse Event|2|||
163930769|NCT04750577|592116242|FG001|Overall Study|Adverse Event|10|||
163930770|NCT04750577|592116243|FG002|Overall Study|Adverse Event|8|||
163930771|NCT04750577|592116244|FG003|Overall Study|Adverse Event|1|||
163930772|NCT04750577|592116241|FG000|Overall Study|Change of residence|0|||
163930773|NCT04750577|592116242|FG001|Overall Study|Change of residence|0|||
163930774|NCT04750577|592116243|FG002|Overall Study|Change of residence|1|||
163930775|NCT04750577|592116244|FG003|Overall Study|Change of residence|0|||
163930776|NCT04750577|592116241|FG000|Overall Study|Burden of study procedures|0|||
163930777|NCT04750577|592116242|FG001|Overall Study|Burden of study procedures|2|||
163930778|NCT04750577|592116243|FG002|Overall Study|Burden of study procedures|2|||
163930779|NCT04750577|592116244|FG003|Overall Study|Burden of study procedures|0|||
163930780|NCT04750577|592116241|FG000|Overall Study|Prematurely discontinued|0|||
163930781|NCT04750577|592116242|FG001|Overall Study|Prematurely discontinued|0|||
163930782|NCT04750577|592116243|FG002|Overall Study|Prematurely discontinued|0|||
163930783|NCT04750577|592116244|FG003|Overall Study|Prematurely discontinued|2|||
163930784|NCT04750577|592116241|FG000|Overall Study|Protocol deviation|1|||
163930785|NCT04750577|592116242|FG001|Overall Study|Protocol deviation|1|||
163930786|NCT04750577|592116243|FG002|Overall Study|Protocol deviation|1|||
163930787|NCT04750577|592116244|FG003|Overall Study|Protocol deviation|1|||
163930788|NCT04750577|592116241|FG000|Overall Study|Other than listed|3|||
163930789|NCT04750577|592116242|FG001|Overall Study|Other than listed|2|||
163930790|NCT04750577|592116243|FG002|Overall Study|Other than listed|2|||
163930791|NCT04750577|592116244|FG003|Overall Study|Other than listed|1|||
163930792|NCT04750577|592116241|FG000|Overall Study|Not treated|0|||
163930793|NCT04750577|592116242|FG001|Overall Study|Not treated|0|||
163930794|NCT04750577|592116243|FG002|Overall Study|Not treated|0|||
163930795|NCT04750577|592116244|FG003|Overall Study|Not treated|2|||
163930796|NCT02473042|592116250|FG000|Overall Study|Withdrawal by Subject|1|||
163930797|NCT02473042|592116251|FG001|Overall Study|Withdrawal by Subject|0|||
163930798|NCT02473042|592116250|FG000|Overall Study|Patient became ineligible after enrollment|2|||
163930799|NCT02473042|592116251|FG001|Overall Study|Patient became ineligible after enrollment|5|||
163930800|NCT02473042|592116250|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
163930801|NCT02473042|592116251|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
164035679|NCT03706040|592490246|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
164035680|NCT03706040|592490247|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
164035681|NCT03706040|592490248|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
164035682|NCT03706040|592490249|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
163930802|NCT02473042|592116250|FG000|Overall Study|PACU data unable to be collected|3|||
164035683|NCT03706040|592490250|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
164035684|NCT03706040|592490244|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164035685|NCT03706040|592490245|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
163930803|NCT02473042|592116251|FG001|Overall Study|PACU data unable to be collected|0|||
163930804|NCT00604188|592116254|FG000|Overall Study|Adverse Event|1|||
163930805|NCT00604188|592116255|FG001|Overall Study|Adverse Event|4|||
163930806|NCT00604188|592116254|FG000|Overall Study|Lost to Follow-up|17|||
163930807|NCT00604188|592116255|FG001|Overall Study|Lost to Follow-up|15|||
163930808|NCT00604188|592116254|FG000|Overall Study|Withdrawal by Subject|5|||
163930809|NCT00604188|592116255|FG001|Overall Study|Withdrawal by Subject|1|||
163930810|NCT00604188|592116254|FG000|Overall Study|Non-compliance with protocol|4|||
163930811|NCT00604188|592116255|FG001|Overall Study|Non-compliance with protocol|4|||
163930812|NCT00604188|592116254|FG000|Overall Study|Did not receive study drug|0|||
163930813|NCT00604188|592116255|FG001|Overall Study|Did not receive study drug|1|||
163834862|NCT00787319|591765148|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
163834863|NCT00787319|591765148|FG000|Overall Study|No health insurance reimbursement|2|||
163834864|NCT00787319|591765148|FG000|Overall Study|Stabilized disease findings|3|||
163834865|NCT00787319|591765148|FG000|Overall Study|Inactive disease|5|||
163834866|NCT03954743|591765149|FG000|Overall Study|Adverse Event|1|||
163834867|NCT03954743|591765150|FG001|Overall Study|Adverse Event|0|||
163834868|NCT03954743|591765149|FG000|Overall Study|Lost to Follow-up|6|||
163834869|NCT03954743|591765150|FG001|Overall Study|Lost to Follow-up|4|||
163834870|NCT03954743|591765149|FG000|Overall Study|Protocol Violation|1|||
163834871|NCT03954743|591765150|FG001|Overall Study|Protocol Violation|0|||
163834872|NCT03954743|591765149|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
163834873|NCT03954743|591765150|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
163834874|NCT03954743|591765149|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
163834875|NCT03954743|591765150|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
163834876|NCT01153269|591765161|FG000|Overall Study|Withdrawal by Subject|1|||
163834877|NCT01153269|591765161|FG000|Overall Study|Antiretroviral therapy break|1|||
163834878|NCT03541044|591765162|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
163834879|NCT03541044|591765163|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
163834880|NCT03541044|591765162|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
163834881|NCT03541044|591765163|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
163834882|NCT00860067|591765164|FG000|Overall Study|Lost to Follow-up|46|||
163834883|NCT00860067|591765165|FG001|Overall Study|Lost to Follow-up|9|||
163834884|NCT00860067|591765166|FG002|Overall Study|Lost to Follow-up|9|||
163834885|NCT00860067|591765164|FG000|Overall Study|Withdrawal by Subject|4|||
163834886|NCT00860067|591765165|FG001|Overall Study|Withdrawal by Subject|0|||
163834887|NCT00860067|591765166|FG002|Overall Study|Withdrawal by Subject|0|||
163834888|NCT00860067|591765164|FG000|Overall Study|Pregnancy|1|||
163834889|NCT00860067|591765165|FG001|Overall Study|Pregnancy|0|||
163834890|NCT00860067|591765166|FG002|Overall Study|Pregnancy|0|||
163834891|NCT02387996|591765173|FG000|Overall Study|Disease Progression|167|||
163834892|NCT02387996|591765173|FG000|Overall Study|Study Drug Toxicity|31|||
163834893|NCT02387996|591765173|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
163834894|NCT02387996|591765173|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
163834895|NCT02387996|591765173|FG000|Overall Study|Subject Withdrew Consent|5|||
163834896|NCT02387996|591765173|FG000|Overall Study|Lost to Follow-up|1|||
163834897|NCT02387996|591765173|FG000|Overall Study|Poor/Non-Compliance|1|||
163834898|NCT02387996|591765173|FG000|Overall Study|Other Reasons|5|||
163834899|NCT02387996|591765173|FG000|Overall Study|Death|1|||
163834900|NCT00770432|591765174|FG000|Overall Study|Other|4|||
163834901|NCT00770432|591765175|FG001|Overall Study|Other|6|||
163834902|NCT00770432|591765174|FG000|Overall Study|Non-compliance|0|||
163834903|NCT00770432|591765175|FG001|Overall Study|Non-compliance|1|||
163834904|NCT00312702|591765176|FG000|Immunization Phase|Lost to Follow-up|0|||
163834905|NCT00312702|591765177|FG001|Immunization Phase|Lost to Follow-up|1|||
163834906|NCT00312702|591765178|FG002|Immunization Phase|Lost to Follow-up|0|||
163834907|NCT01498822|591765179|FG000|Overall Study|Protocol Violation|8|||
163834908|NCT01498822|591765180|FG001|Overall Study|Protocol Violation|4|||
163834909|NCT01498822|591765179|FG000|Overall Study|Other Reason|5|||
163834910|NCT01498822|591765180|FG001|Overall Study|Other Reason|2|||
163834911|NCT01498822|591765179|FG000|Overall Study|Lack of Efficacy|7|||
163834912|NCT01498822|591765180|FG001|Overall Study|Lack of Efficacy|2|||
163834913|NCT01498822|591765179|FG000|Overall Study|AE, non-serious non-fatal|8|||
163834914|NCT01498822|591765180|FG001|Overall Study|AE, non-serious non-fatal|17|||
163834915|NCT01498822|591765179|FG000|Overall Study|SAE, non-fatal|2|||
163834916|NCT01498822|591765180|FG001|Overall Study|SAE, non-fatal|2|||
163834917|NCT01498822|591765179|FG000|Overall Study|Adverse Event, serious fatal|1|||
163930814|NCT04680637|592116256|FG000|Overall Study|Lost to Follow-up|0|||
163930815|NCT04680637|592116257|FG001|Overall Study|Lost to Follow-up|1|||
163930816|NCT04680637|592116258|FG002|Overall Study|Lost to Follow-up|0|||
163930817|NCT04680637|592116259|FG003|Overall Study|Lost to Follow-up|1|||
163930818|NCT04680637|592116256|FG000|Overall Study|Death|1|||
163930819|NCT04680637|592116257|FG001|Overall Study|Death|0|||
163930820|NCT04680637|592116258|FG002|Overall Study|Death|0|||
163930821|NCT04680637|592116259|FG003|Overall Study|Death|0|||
163930822|NCT04680637|592116256|FG000|Overall Study|Withdrawal by Subject|7|||
163930823|NCT04680637|592116257|FG001|Overall Study|Withdrawal by Subject|10|||
163930824|NCT04680637|592116258|FG002|Overall Study|Withdrawal by Subject|17|||
163930825|NCT04680637|592116259|FG003|Overall Study|Withdrawal by Subject|15|||
163930826|NCT04680637|592116256|FG000|Overall Study|Decision by Sponsor|21|||
163930827|NCT04680637|592116257|FG001|Overall Study|Decision by Sponsor|15|||
163930828|NCT04680637|592116258|FG002|Overall Study|Decision by Sponsor|7|||
163930829|NCT04680637|592116259|FG003|Overall Study|Decision by Sponsor|32|||
163930830|NCT02242643|592116264|FG000|Overall Study|Protocol Violation|1|||
163930831|NCT02242643|592116265|FG001|Overall Study|Protocol Violation|2|||
163930832|NCT02242643|592116264|FG000|Overall Study|Withdrawal by Subject|15|||
163930833|NCT02242643|592116265|FG001|Overall Study|Withdrawal by Subject|10|||
163930834|NCT02242643|592116264|FG000|Overall Study|Migrated/moved from study area|1|||
164098242|NCT00579670|592725067|FG001|Overall Study|Other|0|||
164098243|NCT00579670|592725068|FG002|Overall Study|Other|1|||
164098244|NCT00579670|592725069|FG003|Overall Study|Other|2|||
164098245|NCT00579670|592725070|FG004|Overall Study|Other|0|||
164098246|NCT00579670|592725066|FG000|Overall Study|Withdrawal by Subject|0|||
164098247|NCT00579670|592725067|FG001|Overall Study|Withdrawal by Subject|0|||
164098248|NCT00579670|592725068|FG002|Overall Study|Withdrawal by Subject|1|||
164098249|NCT00579670|592725069|FG003|Overall Study|Withdrawal by Subject|0|||
164098250|NCT00579670|592725070|FG004|Overall Study|Withdrawal by Subject|0|||
164098251|NCT00112463|592725071|FG000|Overall Study|Physician Decision|1|||
164098252|NCT00112463|592725071|FG000|Overall Study|Progression|30|||
164098253|NCT00112463|592725071|FG000|Overall Study|Second Primary|1|||
164098254|NCT00112463|592725071|FG000|Overall Study|Toxicity|3|||
164098255|NCT00112463|592725071|FG000|Overall Study|Withdrawal by Subject|2|||
164098256|NCT00112463|592725071|FG000|Overall Study|Never started treatment|2|||
164098257|NCT00296647|592725073|FG000|Overall Study|Death|4|||
164098258|NCT00296647|592725074|FG001|Overall Study|Death|1|||
164098259|NCT00296647|592725075|FG002|Overall Study|Death|2|||
164098260|NCT00296647|592725076|FG003|Overall Study|Death|1|||
164098261|NCT00296647|592725077|FG004|Overall Study|Death|1|||
164098262|NCT00296647|592725073|FG000|Overall Study|Withdrawal by Subject|28|||
164098263|NCT00296647|592725074|FG001|Overall Study|Withdrawal by Subject|27|||
164098264|NCT00296647|592725075|FG002|Overall Study|Withdrawal by Subject|32|||
164098265|NCT00296647|592725076|FG003|Overall Study|Withdrawal by Subject|16|||
164098266|NCT00296647|592725077|FG004|Overall Study|Withdrawal by Subject|19|||
164098267|NCT01863745|592725078|FG000|Overall Study|Disease Progression|9|||
164098268|NCT01863745|592725078|FG000|Overall Study|Adverse Event|2|||
164098269|NCT01863745|592725078|FG000|Overall Study|Death|1|||
164098270|NCT01863745|592725078|FG000|Overall Study|Withdrawal by Subject|1|||
164098271|NCT01171963|592725081|FG000|Overall Study|Adverse Event|10|||
164098272|NCT01171963|592725082|FG001|Overall Study|Adverse Event|15|||
164098273|NCT01171963|592725081|FG000|Overall Study|Lost to Follow-up|23|||
164098274|NCT01171963|592725082|FG001|Overall Study|Lost to Follow-up|24|||
164098275|NCT01171963|592725081|FG000|Overall Study|Other - diarrhoea|1|||
164098276|NCT01171963|592725082|FG001|Overall Study|Other - diarrhoea|0|||
164098277|NCT01171963|592725081|FG000|Overall Study|Withdrawal by Subject|114|||
164098278|NCT01171963|592725082|FG001|Overall Study|Withdrawal by Subject|129|||
164098279|NCT05093205|592725083|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
164098280|NCT05093205|592725084|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
164098281|NCT05093205|592725085|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
164098282|NCT05093205|592725086|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
164098283|NCT05093205|592725087|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
164098284|NCT05093205|592725088|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
164098285|NCT05093205|592725089|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
164098286|NCT05093205|592725090|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
164098287|NCT05093205|592725091|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
164098288|NCT05093205|592725092|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
164098289|NCT05093205|592725093|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
164098290|NCT05093205|592725094|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
164098291|NCT05093205|592725095|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
164098292|NCT05093205|592725083|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098293|NCT05093205|592725084|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098294|NCT05093205|592725085|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
164098295|NCT05093205|592725086|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098296|NCT05093205|592725087|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098297|NCT05093205|592725088|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098298|NCT05093205|592725089|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098299|NCT05093205|592725090|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098300|NCT05093205|592725091|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098301|NCT05093205|592725092|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098302|NCT05093205|592725093|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098303|NCT05093205|592725094|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098304|NCT05093205|592725095|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
164098305|NCT05093205|592725083|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
164098306|NCT05093205|592725084|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
164098307|NCT05093205|592725085|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
164098308|NCT05093205|592725086|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
164098309|NCT05093205|592725087|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
164098310|NCT05093205|592725088|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
164098311|NCT05093205|592725089|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
164098312|NCT05093205|592725090|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
164098313|NCT05093205|592725091|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
164098314|NCT05093205|592725092|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
164098315|NCT05093205|592725093|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
164098316|NCT05093205|592725094|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
164098317|NCT05093205|592725095|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
163930835|NCT02242643|592116265|FG001|Overall Study|Migrated/moved from study area|3|||
163930836|NCT02242643|592116264|FG000|Overall Study|Lost to Follow-up|54|||
163930837|NCT02242643|592116265|FG001|Overall Study|Lost to Follow-up|61|||
163930838|NCT02242643|592116264|FG000|Overall Study|Child placed in foster care by family|0|||
163930839|NCT02242643|592116265|FG001|Overall Study|Child placed in foster care by family|1|||
163930840|NCT02242643|592116264|FG000|Overall Study|Non-compliance|1|||
163930841|NCT02242643|592116265|FG001|Overall Study|Non-compliance|0|||
163930842|NCT02242643|592116264|FG000|Overall Study|Consent withdrawal by parent|1|||
163930843|NCT02242643|592116265|FG001|Overall Study|Consent withdrawal by parent|0|||
163930844|NCT02242643|592116264|FG000|Overall Study|Protocol requirements not followed|1|||
163930845|NCT02242643|592116265|FG001|Overall Study|Protocol requirements not followed|0|||
163930846|NCT02242643|592116264|FG000|Overall Study|Language barrier|1|||
163930847|NCT02242643|592116265|FG001|Overall Study|Language barrier|0|||
163930848|NCT02242643|592116264|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
163930849|NCT02242643|592116265|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
163930850|NCT01103232|592116269|FG000|Overall Study|Withdrawal by Subject|1|||
163930851|NCT01103232|592116270|FG001|Overall Study|Withdrawal by Subject|1|||
163930852|NCT01103232|592116269|FG000|Overall Study|Protocol Violation|0|||
163930853|NCT01103232|592116270|FG001|Overall Study|Protocol Violation|1|||
163930854|NCT00443599|592116274|FG000|Overall Study|Physician Decision|2|||
163930855|NCT00443599|592116275|FG001|Overall Study|Physician Decision|1|||
163930856|NCT00443599|592116274|FG000|Overall Study|Death|1|||
163930857|NCT00443599|592116275|FG001|Overall Study|Death|1|||
163930858|NCT00443599|592116274|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
163930859|NCT00443599|592116275|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
164035686|NCT03706040|592490246|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164035687|NCT03706040|592490247|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164035688|NCT03706040|592490248|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164035689|NCT03706040|592490249|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
164035690|NCT03706040|592490250|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
164035691|NCT03706040|592490244|FG000|Period B (Week 16 to Week 52)|Other|0|||
164035692|NCT03706040|592490245|FG001|Period B (Week 16 to Week 52)|Other|0|||
164035693|NCT03706040|592490246|FG002|Period B (Week 16 to Week 52)|Other|0|||
164035694|NCT03706040|592490247|FG003|Period B (Week 16 to Week 52)|Other|4|||
164035695|NCT03706040|592490248|FG004|Period B (Week 16 to Week 52)|Other|5|||
164035696|NCT03706040|592490249|FG005|Period B (Week 16 to Week 52)|Other|23|||
164035697|NCT03706040|592490250|FG006|Period B (Week 16 to Week 52)|Other|17|||
164035698|NCT00927758|592490251|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164035699|NCT00927758|592490252|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164035700|NCT00927758|592490253|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164035701|NCT00927758|592490254|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
164035702|NCT00927758|592490255|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
164035703|NCT00927758|592490256|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
164035704|NCT00927758|592490251|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
164035705|NCT00927758|592490252|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
164035706|NCT00927758|592490253|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
164035707|NCT00927758|592490254|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
164035708|NCT00927758|592490255|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
164035709|NCT00927758|592490256|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
164035710|NCT00439725|592490257|FG000|Treatment Period|Withdrawal by Subject|22|||
164035711|NCT00439725|592490258|FG001|Treatment Period|Withdrawal by Subject|19|||
164035712|NCT00439725|592490257|FG000|Treatment Period|Study terminated by sponsor|156|||
164035713|NCT00439725|592490258|FG001|Treatment Period|Study terminated by sponsor|148|||
164035714|NCT00439725|592490257|FG000|Treatment Period|Site closed by investigator|1|||
164035715|NCT00439725|592490258|FG001|Treatment Period|Site closed by investigator|2|||
164035716|NCT00439725|592490257|FG000|Treatment Period|Adverse Event|39|||
164035717|NCT00439725|592490258|FG001|Treatment Period|Adverse Event|18|||
164035718|NCT00439725|592490257|FG000|Treatment Period|Physician Decision|1|||
164035719|NCT00439725|592490258|FG001|Treatment Period|Physician Decision|1|||
163930860|NCT03049306|592116276|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
163930861|NCT03049306|592116277|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
163930862|NCT05093504|592116278|FG000|Overall Study|Death|0|||
163930863|NCT05093504|592116279|FG001|Overall Study|Death|1|||
163930864|NCT03151551|592116280|FG000|Open-Label Treatment Period|Adverse Event|0|||
163930865|NCT03151551|592116281|FG001|Open-Label Treatment Period|Adverse Event|2|||
163930866|NCT03151551|592116280|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
163930867|NCT03151551|592116281|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
164035720|NCT00439725|592490257|FG000|Treatment Period|Protocol Violation|2|||
164035721|NCT00439725|592490258|FG001|Treatment Period|Protocol Violation|1|||
164035722|NCT00439725|592490257|FG000|Treatment Period|Clinical endpoint reached|6|||
164035723|NCT00439725|592490258|FG001|Treatment Period|Clinical endpoint reached|50|||
163930868|NCT03151551|592116280|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
163930869|NCT03151551|592116281|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
163930870|NCT03151551|592116280|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
163930871|NCT03151551|592116281|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
163930872|NCT03151551|592116280|FG000|Open-Label Treatment Period|Physician Decision|3|||
163930873|NCT03151551|592116281|FG001|Open-Label Treatment Period|Physician Decision|0|||
163930874|NCT03151551|592116280|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
163930875|NCT03151551|592116281|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
163930876|NCT03151551|592116280|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
163930877|NCT03151551|592116281|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
163930878|NCT03151551|592116280|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
163930879|NCT03151551|592116281|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
163930880|NCT03151551|592116280|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
163930881|NCT03151551|592116281|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
163930882|NCT03151551|592116280|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
163930883|NCT03151551|592116281|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
163930884|NCT01190449|592116282|FG000|Overall Study|Ineligible|0|||
163930885|NCT01190449|592116283|FG001|Overall Study|Ineligible|4|||
163930886|NCT02056626|592117680|FG000|Overall Study|patient did not follow directions|3|||
163930887|NCT02056626|592117681|FG001|Overall Study|patient did not follow directions|1|||
163930888|NCT02056626|592117682|FG002|Overall Study|patient did not follow directions|0|||
163930889|NCT02056626|592117683|FG003|Overall Study|patient did not follow directions|0|||
163930890|NCT04916002|592117685|FG000|Overall Study|Adverse Event|0|||
163930891|NCT04916002|592117686|FG001|Overall Study|Adverse Event|1|||
163930892|NCT04916002|592117687|FG002|Overall Study|Adverse Event|0|||
163930893|NCT04916002|592117688|FG003|Overall Study|Adverse Event|1|||
163930894|NCT04916002|592117689|FG004|Overall Study|Adverse Event|0|||
163930895|NCT04916002|592117685|FG000|Overall Study|Withdrawal by Subject|3|||
163930896|NCT04916002|592117686|FG001|Overall Study|Withdrawal by Subject|1|||
163930897|NCT04916002|592117687|FG002|Overall Study|Withdrawal by Subject|0|||
163930898|NCT04916002|592117688|FG003|Overall Study|Withdrawal by Subject|1|||
163930899|NCT04916002|592117689|FG004|Overall Study|Withdrawal by Subject|0|||
163930900|NCT04916002|592117685|FG000|Overall Study|Death|8|||
163930901|NCT04916002|592117686|FG001|Overall Study|Death|7|||
163930902|NCT04916002|592117687|FG002|Overall Study|Death|4|||
163930903|NCT04916002|592117688|FG003|Overall Study|Death|9|||
163930904|NCT04916002|592117689|FG004|Overall Study|Death|0|||
163930905|NCT04916002|592117685|FG000|Overall Study|Study Terminated by Sponsor|11|||
163930906|NCT04916002|592117686|FG001|Overall Study|Study Terminated by Sponsor|10|||
163930907|NCT04916002|592117687|FG002|Overall Study|Study Terminated by Sponsor|8|||
163930908|NCT04916002|592117688|FG003|Overall Study|Study Terminated by Sponsor|5|||
163930909|NCT04916002|592117689|FG004|Overall Study|Study Terminated by Sponsor|4|||
163930910|NCT04916002|592117685|FG000|Overall Study|End of trial|1|||
163930911|NCT04916002|592117686|FG001|Overall Study|End of trial|0|||
163930912|NCT04916002|592117687|FG002|Overall Study|End of trial|0|||
163930913|NCT04916002|592117688|FG003|Overall Study|End of trial|0|||
163930914|NCT04916002|592117689|FG004|Overall Study|End of trial|0|||
163930915|NCT04916002|592117685|FG000|Overall Study|Progressive disease|0|||
163930916|NCT04916002|592117686|FG001|Overall Study|Progressive disease|0|||
163930917|NCT04916002|592117687|FG002|Overall Study|Progressive disease|1|||
163930918|NCT04916002|592117688|FG003|Overall Study|Progressive disease|0|||
163930919|NCT04916002|592117689|FG004|Overall Study|Progressive disease|0|||
163930920|NCT04916002|592117685|FG000|Overall Study|Participant non-compliance|2|||
163930921|NCT04916002|592117686|FG001|Overall Study|Participant non-compliance|0|||
163930922|NCT04916002|592117687|FG002|Overall Study|Participant non-compliance|0|||
163930923|NCT04916002|592117688|FG003|Overall Study|Participant non-compliance|0|||
163930924|NCT04916002|592117689|FG004|Overall Study|Participant non-compliance|0|||
163930925|NCT04836559|592117690|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163930926|NCT04836559|592117691|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
163930927|NCT04836559|592117692|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
163930928|NCT04836559|592117693|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
163930929|NCT04836559|592117694|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163930930|NCT04836559|592117695|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163930931|NCT04836559|592117696|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163930932|NCT04836559|592117697|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
163930933|NCT04836559|592117690|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163930934|NCT04836559|592117691|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
163930935|NCT04836559|592117692|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
163930936|NCT04836559|592117693|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
163930937|NCT04836559|592117694|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163930938|NCT04836559|592117695|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163930939|NCT04836559|592117696|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
163930940|NCT04836559|592117697|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
164147613|NCT03685344|592902086|FG002|Overall Study|Death|0|||
163834918|NCT01498822|591765180|FG001|Overall Study|Adverse Event, serious fatal|1|||
163834919|NCT01498822|591765179|FG000|Overall Study|Withdrawal by Subject|15|||
163834920|NCT01498822|591765180|FG001|Overall Study|Withdrawal by Subject|25|||
163834921|NCT01498822|591765179|FG000|Overall Study|Lost to Follow-up|8|||
163834922|NCT01498822|591765180|FG001|Overall Study|Lost to Follow-up|3|||
163834923|NCT03592277|591765181|FG000|Overall Study|Withdrawal by Subject|6|||
163834924|NCT03592277|591765182|FG001|Overall Study|Withdrawal by Subject|8|||
163834925|NCT02917265|591765185|FG000|Overall Study|Physician Decision|1|||
163834926|NCT02917265|591765186|FG001|Overall Study|Physician Decision|0|||
163834927|NCT02917265|591765185|FG000|Overall Study|Withdrawal by Subject|1|||
163834928|NCT02917265|591765186|FG001|Overall Study|Withdrawal by Subject|0|||
163834929|NCT00979602|591765199|FG000|Overall Study|Serious Adverse Event|5|||
163834930|NCT00979602|591765200|FG001|Overall Study|Serious Adverse Event|3|||
163834931|NCT00979602|591765199|FG000|Overall Study|Protocol Violation|3|||
163834932|NCT00979602|591765200|FG001|Overall Study|Protocol Violation|0|||
163834933|NCT00979602|591765199|FG000|Overall Study|Withdrawal by Subject|31|||
163834934|NCT00979602|591765200|FG001|Overall Study|Withdrawal by Subject|25|||
163834935|NCT00979602|591765199|FG000|Overall Study|Lost to Follow-up|100|||
163834936|NCT00979602|591765200|FG001|Overall Study|Lost to Follow-up|96|||
163834937|NCT00979602|591765199|FG000|Overall Study|Migrated/moved from study area|3|||
163834938|NCT00979602|591765200|FG001|Overall Study|Migrated/moved from study area|6|||
163834939|NCT00979602|591765199|FG000|Overall Study|Others|3|||
163834940|NCT00979602|591765200|FG001|Overall Study|Others|3|||
163834941|NCT02002182|591765203|FG000|Overall Study|Withdraw from study|3|||
163834942|NCT02002182|591765204|FG001|Overall Study|Withdraw from study|1|||
163834943|NCT02002182|591765203|FG000|Overall Study|Health Reasons|1|||
163834944|NCT02002182|591765204|FG001|Overall Study|Health Reasons|0|||
163834945|NCT02002182|591765203|FG000|Overall Study|Death|1|||
163834946|NCT02002182|591765204|FG001|Overall Study|Death|0|||
163834947|NCT01320943|591765212|FG000|Overall Study|Lost to Follow-up|1|||
163834948|NCT01320943|591765213|FG001|Overall Study|Lost to Follow-up|0|||
163834949|NCT01320943|591765212|FG000|Overall Study|Physician Decision|0|||
163834950|NCT01320943|591765213|FG001|Overall Study|Physician Decision|1|||
163834951|NCT01320943|591765212|FG000|Overall Study|Randomized but not Treated|0|||
163834952|NCT01320943|591765213|FG001|Overall Study|Randomized but not Treated|1|||
163834953|NCT01669798|591765221|FG000|Overall Study|Physician Decision|5|||
163834954|NCT01806584|591765225|FG000|Overall Study|Adverse Event|2|||
163834955|NCT01806584|591765226|FG001|Overall Study|Adverse Event|1|||
163834956|NCT01806584|591765225|FG000|Overall Study|Death|1|||
163834957|NCT01806584|591765226|FG001|Overall Study|Death|0|||
163834958|NCT01806584|591765225|FG000|Overall Study|Lost to Follow-up|0|||
163834959|NCT01806584|591765226|FG001|Overall Study|Lost to Follow-up|2|||
163834960|NCT01806584|591765225|FG000|Overall Study|Study terminated by sponsor|9|||
163834961|NCT01806584|591765226|FG001|Overall Study|Study terminated by sponsor|14|||
163834962|NCT01806584|591765225|FG000|Overall Study|Withdrawal by Subject|1|||
163834963|NCT01806584|591765226|FG001|Overall Study|Withdrawal by Subject|1|||
163834964|NCT01806584|591765225|FG000|Overall Study|Other unspecified|1|||
163834965|NCT01806584|591765226|FG001|Overall Study|Other unspecified|0|||
163834966|NCT00311155|591767155|FG000|Overall Study|Adverse Event|21|||
163834967|NCT00311155|591767155|FG000|Overall Study|Withdrawal by Subject|17|||
163834968|NCT00311155|591767155|FG000|Overall Study|Did not meet entry criteria|55|||
163834969|NCT02243631|591767164|FG000|Overall Study|no synovial fluid on second aspirate|0|||
163834970|NCT02243631|591767165|FG001|Overall Study|no synovial fluid on second aspirate|1|||
163834971|NCT01992549|591767172|FG000|Overall Study|Lost to Follow-up|2|||
163834972|NCT01992549|591767172|FG000|Overall Study|Serious Adverse Event|1|||
163834973|NCT01992549|591767172|FG000|Overall Study|Product Switch to Extend Half Life|1|||
163834974|NCT01590771|591767173|FG000|Overall Study|Other Protocol Specified Criteria|5|||
163834975|NCT01590771|591767174|FG001|Overall Study|Other Protocol Specified Criteria|14|||
163834976|NCT01590771|591767173|FG000|Overall Study|Withdrawal by Subject|8|||
163834977|NCT01590771|591767174|FG001|Overall Study|Withdrawal by Subject|15|||
163834978|NCT01590771|591767173|FG000|Overall Study|Protocol Violation|1|||
163834979|NCT01590771|591767174|FG001|Overall Study|Protocol Violation|2|||
163834980|NCT01590771|591767173|FG000|Overall Study|Lost to Follow-up|1|||
163834981|NCT01590771|591767174|FG001|Overall Study|Lost to Follow-up|1|||
164035724|NCT00439725|592490257|FG000|Treatment Period|Technical problems|1|||
164035725|NCT00439725|592490258|FG001|Treatment Period|Technical problems|0|||
164035726|NCT00439725|592490257|FG000|Treatment Period|Lost to Follow-up|1|||
164035727|NCT00439725|592490258|FG001|Treatment Period|Lost to Follow-up|1|||
164035728|NCT00439725|592490257|FG000|Treatment Period|Participant convenience|1|||
163834982|NCT01590771|591767173|FG000|Overall Study|Lack of Efficacy|1|||
163834983|NCT01590771|591767174|FG001|Overall Study|Lack of Efficacy|0|||
163834984|NCT01590771|591767173|FG000|Overall Study|Adverse Event|3|||
163834985|NCT01590771|591767174|FG001|Overall Study|Adverse Event|7|||
163834986|NCT01785628|591767175|FG000|Overall Study|Lost to Follow-up|2|||
163834987|NCT01785628|591767176|FG001|Overall Study|Lost to Follow-up|3|||
163834988|NCT00369681|591767177|FG000|Overall Study|Death|1|||
163834989|NCT01250119|591767185|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
163834990|NCT01250119|591767186|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
163930941|NCT04836559|592117690|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
163930942|NCT04836559|592117691|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163930943|NCT04836559|592117692|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163930944|NCT04836559|592117693|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163930945|NCT04836559|592117694|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163930946|NCT04836559|592117695|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163930947|NCT04836559|592117696|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
164035729|NCT00439725|592490258|FG001|Treatment Period|Participant convenience|0|||
164035730|NCT00439725|592490257|FG000|Treatment Period|Protocol driven decision point|1|||
164035731|NCT00439725|592490258|FG001|Treatment Period|Protocol driven decision point|1|||
164035732|NCT00439725|592490257|FG000|Treatment Period|Death|1|||
164035733|NCT00439725|592490258|FG001|Treatment Period|Death|1|||
164035734|NCT00439725|592490257|FG000|Treatment Period|Participant did not receive treatment|4|||
164035735|NCT00439725|592490258|FG001|Treatment Period|Participant did not receive treatment|4|||
164035736|NCT00439725|592490257|FG000|Observational Period|Withdrawal by Subject|2|||
164035737|NCT00439725|592490258|FG001|Observational Period|Withdrawal by Subject|2|||
164035738|NCT00439725|592490257|FG000|Observational Period|Lost to Follow-up|0|||
164035739|NCT00439725|592490258|FG001|Observational Period|Lost to Follow-up|1|||
164035740|NCT00439725|592490257|FG000|Observational Period|Death|0|||
164035741|NCT00439725|592490258|FG001|Observational Period|Death|2|||
163930948|NCT04836559|592117697|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
163930949|NCT04836559|592117690|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
163930950|NCT04836559|592117691|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930951|NCT04836559|592117692|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930952|NCT04836559|592117693|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930953|NCT04836559|592117694|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930954|NCT04836559|592117695|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930955|NCT04836559|592117696|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930956|NCT04836559|592117697|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
163930957|NCT04836559|592117690|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930958|NCT04836559|592117691|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930959|NCT04836559|592117692|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930960|NCT04836559|592117693|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
163930961|NCT04836559|592117694|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930962|NCT04836559|592117695|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930963|NCT04836559|592117696|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930964|NCT04836559|592117697|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
163930965|NCT04836559|592117690|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163930966|NCT04836559|592117691|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163930967|NCT04836559|592117692|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163930968|NCT04836559|592117693|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
163930969|NCT04836559|592117694|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
163930970|NCT04836559|592117695|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
163930971|NCT04836559|592117696|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
163930972|NCT04836559|592117697|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
163930973|NCT04836559|592117690|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163930974|NCT04836559|592117691|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163930975|NCT04836559|592117692|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163930976|NCT04836559|592117693|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
163930977|NCT04836559|592117694|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
163930978|NCT04836559|592117695|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
163930979|NCT04836559|592117696|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
163930980|NCT04836559|592117697|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
163930981|NCT04836559|592117690|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163930982|NCT04836559|592117691|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
164035742|NCT00439725|592490257|FG000|Observational Period|Study termination by sponsor|1|||
164035743|NCT00439725|592490258|FG001|Observational Period|Study termination by sponsor|1|||
164035744|NCT00439725|592490257|FG000|Observational Period|Clinical endpoint reached|3|||
164035745|NCT00439725|592490258|FG001|Observational Period|Clinical endpoint reached|1|||
164035746|NCT00439725|592490257|FG000|Observational Period|Technical problems|1|||
164035747|NCT00439725|592490258|FG001|Observational Period|Technical problems|0|||
164035748|NCT00439725|592490257|FG000|Observational Period|Participant convenience|1|||
164035749|NCT00439725|592490258|FG001|Observational Period|Participant convenience|0|||
164035750|NCT03510910|592490259|FG000|Overall Study|Incomplete Survey|2|||
164035751|NCT03510910|592490260|FG001|Overall Study|Incomplete Survey|3|||
163930983|NCT04836559|592117692|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163930984|NCT04836559|592117693|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163930985|NCT04836559|592117694|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
163930986|NCT04836559|592117695|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
163930987|NCT04836559|592117696|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
163930988|NCT04836559|592117697|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
163930989|NCT04836559|592117690|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930990|NCT04836559|592117691|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930991|NCT04836559|592117692|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930992|NCT04836559|592117693|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930993|NCT04836559|592117694|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930994|NCT04836559|592117695|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930995|NCT04836559|592117696|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
163930996|NCT04836559|592117697|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
163930997|NCT02786004|592117700|FG000|Overall Study|Withdrawal by Subject|0|||
163930998|NCT02786004|592117701|FG001|Overall Study|Withdrawal by Subject|1|||
163930999|NCT05147350|592117702|FG000|Overall Study|Death|2|||
163931000|NCT05147350|592117703|FG001|Overall Study|Death|3|||
163931001|NCT05147350|592117704|FG002|Overall Study|Death|3|||
163931002|NCT05147350|592117705|FG003|Overall Study|Death|2|||
163931003|NCT05147350|592117706|FG004|Overall Study|Death|2|||
163931004|NCT05147350|592117707|FG005|Overall Study|Death|1|||
163931005|NCT05147350|592117708|FG006|Overall Study|Death|1|||
163931006|NCT05147350|592117709|FG007|Overall Study|Death|3|||
163931007|NCT05147350|592117702|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
163931008|NCT05147350|592117703|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
163931009|NCT05147350|592117704|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
163931010|NCT05147350|592117705|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
163931011|NCT05147350|592117706|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
163931012|NCT05147350|592117707|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
163931013|NCT05147350|592117708|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
163931014|NCT05147350|592117709|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
163931015|NCT05147350|592117702|FG000|Overall Study|Withdrawal by Subject|0|||
163931016|NCT05147350|592117703|FG001|Overall Study|Withdrawal by Subject|0|||
163931017|NCT05147350|592117704|FG002|Overall Study|Withdrawal by Subject|3|||
163931018|NCT05147350|592117705|FG003|Overall Study|Withdrawal by Subject|1|||
163931019|NCT05147350|592117706|FG004|Overall Study|Withdrawal by Subject|1|||
163931020|NCT05147350|592117707|FG005|Overall Study|Withdrawal by Subject|0|||
163931021|NCT05147350|592117708|FG006|Overall Study|Withdrawal by Subject|1|||
163931022|NCT05147350|592117709|FG007|Overall Study|Withdrawal by Subject|0|||
163931023|NCT05147350|592117702|FG000|Overall Study|Other Reasons|0|||
163931024|NCT05147350|592117703|FG001|Overall Study|Other Reasons|0|||
163931025|NCT05147350|592117704|FG002|Overall Study|Other Reasons|2|||
163931026|NCT05147350|592117705|FG003|Overall Study|Other Reasons|0|||
163931027|NCT05147350|592117706|FG004|Overall Study|Other Reasons|0|||
163931028|NCT05147350|592117707|FG005|Overall Study|Other Reasons|2|||
163931029|NCT05147350|592117708|FG006|Overall Study|Other Reasons|1|||
163931030|NCT05147350|592117709|FG007|Overall Study|Other Reasons|1|||
163931031|NCT00756457|592117712|FG000|Overall Study|Lost to Follow-up|1|||
163931032|NCT00756457|592117713|FG001|Overall Study|Lost to Follow-up|2|||
163931033|NCT02947100|592117714|FG000|Overall Study|study terminated early|3|||
163931034|NCT02947100|592117714|FG000|Overall Study|did not meet inclusion criteria|1|||
163931035|NCT02472145|592117718|FG000|Overall Study|Death|10|||
163931036|NCT02472145|592117719|FG001|Overall Study|Death|101|||
163931037|NCT02472145|592117720|FG002|Overall Study|Death|99|||
163931038|NCT02472145|592117718|FG000|Overall Study|Lost to Follow-up|0|||
163931039|NCT02472145|592117719|FG001|Overall Study|Lost to Follow-up|1|||
163931040|NCT02472145|592117720|FG002|Overall Study|Lost to Follow-up|0|||
164035752|NCT01673490|592490261|FG000|Overall Study|Lost to Follow-up|1|||
164035753|NCT01673490|592490261|FG000|Overall Study|Adverse Event|3|||
164035754|NCT01673490|592490261|FG000|Overall Study|Withdrawal by Subject|3|||
163931041|NCT02472145|592117718|FG000|Overall Study|Withdrawal by Subject|0|||
163931042|NCT02472145|592117719|FG001|Overall Study|Withdrawal by Subject|9|||
163931043|NCT02472145|592117720|FG002|Overall Study|Withdrawal by Subject|13|||
163931044|NCT02472145|592117718|FG000|Overall Study|Sponsor decision|0|||
163931045|NCT02472145|592117719|FG001|Overall Study|Sponsor decision|3|||
163931046|NCT02472145|592117720|FG002|Overall Study|Sponsor decision|2|||
163931047|NCT02472145|592117718|FG000|Overall Study|Other|0|||
163931048|NCT02472145|592117719|FG001|Overall Study|Other|45|||
163931049|NCT02472145|592117720|FG002|Overall Study|Other|43|||
164035755|NCT00379236|592490262|FG000|Double-blind|Adverse Event|11|||
163931050|NCT01080326|592117721|FG000|Overall Study|Patient deterioration prior to procedure|3|||
163931051|NCT01080326|592117721|FG000|Overall Study|Surgeon decision|1|||
163931052|NCT00632021|592117723|FG000|Overall Study|Withdrawal/death|4|||
163931053|NCT00632021|592117724|FG001|Overall Study|Withdrawal/death|7|||
163931054|NCT01318876|592117725|FG000|Day 8 Survey|email address invalid|96|||
163931055|NCT01318876|592117725|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
163931056|NCT01318876|592117725|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
163931057|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
163931058|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
163931059|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
163931060|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
163931061|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
163931062|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
163931063|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
163931064|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
163931065|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
163931066|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
163931067|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
163931068|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
163931069|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
163931070|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
163931071|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
163931072|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
163931073|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
163931074|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
163931075|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Missing|2|||
163931076|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Missing|1|||
163931077|NCT00443209|592117726|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
163931078|NCT00443209|592117727|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
163931079|NCT00443209|592117726|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
163931080|NCT00443209|592117727|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
163931081|NCT00443209|592117726|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
163931082|NCT00443209|592117727|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
163931083|NCT00443209|592117726|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
163931084|NCT00443209|592117727|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
163931085|NCT00443209|592117726|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
163931086|NCT00443209|592117727|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
163931087|NCT00443209|592117726|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
163931088|NCT00443209|592117727|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
163931089|NCT00443209|592117726|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
163931090|NCT00443209|592117727|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
163931091|NCT02250534|592117730|FG000|Overall Study|Lost to Follow-up|18|||
163931092|NCT02250534|592117731|FG001|Overall Study|Lost to Follow-up|28|||
163931093|NCT02250534|592117732|FG002|Overall Study|Lost to Follow-up|33|||
163931094|NCT02250534|592117730|FG000|Overall Study|Personal reasons|7|||
163931095|NCT02250534|592117731|FG001|Overall Study|Personal reasons|8|||
163931096|NCT02250534|592117732|FG002|Overall Study|Personal reasons|14|||
163931097|NCT02250534|592117730|FG000|Overall Study|Adverse Event|6|||
163931098|NCT02250534|592117731|FG001|Overall Study|Adverse Event|3|||
163931099|NCT02250534|592117732|FG002|Overall Study|Adverse Event|8|||
163931100|NCT02250534|592117730|FG000|Overall Study|incarcerated|2|||
163931101|NCT02250534|592117731|FG001|Overall Study|incarcerated|1|||
163931102|NCT02250534|592117732|FG002|Overall Study|incarcerated|2|||
163931103|NCT02250534|592117730|FG000|Overall Study|Withdrawal by Subject|0|||
163931104|NCT02250534|592117731|FG001|Overall Study|Withdrawal by Subject|1|||
163931105|NCT02250534|592117732|FG002|Overall Study|Withdrawal by Subject|2|||
163931106|NCT02250534|592117730|FG000|Overall Study|Death|0|||
163931107|NCT02250534|592117731|FG001|Overall Study|Death|1|||
163931108|NCT02250534|592117732|FG002|Overall Study|Death|1|||
163931109|NCT02250534|592117730|FG000|Overall Study|Physician Decision|1|||
163931110|NCT02250534|592117731|FG001|Overall Study|Physician Decision|3|||
163931111|NCT02250534|592117732|FG002|Overall Study|Physician Decision|1|||
163931112|NCT02250534|592117730|FG000|Overall Study|Protocol Violation|1|||
163931113|NCT02250534|592117731|FG001|Overall Study|Protocol Violation|0|||
163931114|NCT02250534|592117732|FG002|Overall Study|Protocol Violation|1|||
163931115|NCT02250534|592117730|FG000|Overall Study|Reason unknown|1|||
163931116|NCT02250534|592117731|FG001|Overall Study|Reason unknown|0|||
163931117|NCT02250534|592117732|FG002|Overall Study|Reason unknown|0|||
163931118|NCT01628692|592117735|FG000|Overall Study|Lack of Efficacy|4|||
163931119|NCT01628692|592117736|FG001|Overall Study|Lack of Efficacy|4|||
163931120|NCT01628692|592117737|FG002|Overall Study|Lack of Efficacy|5|||
163931121|NCT01628692|592117738|FG003|Overall Study|Lack of Efficacy|1|||
163931122|NCT01628692|592117739|FG004|Overall Study|Lack of Efficacy|4|||
163931123|NCT01628692|592117740|FG005|Overall Study|Lack of Efficacy|7|||
163931124|NCT01628692|592117735|FG000|Overall Study|Adverse Event|2|||
163931125|NCT01628692|592117736|FG001|Overall Study|Adverse Event|0|||
163931126|NCT01628692|592117737|FG002|Overall Study|Adverse Event|2|||
164035756|NCT00379236|592490263|FG001|Double-blind|Adverse Event|6|||
164035757|NCT00379236|592490264|FG002|Double-blind|Adverse Event|0|||
164035758|NCT00379236|592490262|FG000|Double-blind|Protocol Violation|3|||
163931127|NCT01628692|592117738|FG003|Overall Study|Adverse Event|0|||
163931128|NCT01628692|592117739|FG004|Overall Study|Adverse Event|0|||
163931129|NCT01628692|592117740|FG005|Overall Study|Adverse Event|0|||
163931130|NCT01628692|592117735|FG000|Overall Study|Withdrawal by Subject|0|||
163931131|NCT01628692|592117736|FG001|Overall Study|Withdrawal by Subject|1|||
163931132|NCT01628692|592117737|FG002|Overall Study|Withdrawal by Subject|1|||
163931133|NCT01628692|592117738|FG003|Overall Study|Withdrawal by Subject|0|||
163931134|NCT01628692|592117739|FG004|Overall Study|Withdrawal by Subject|0|||
163931135|NCT01628692|592117740|FG005|Overall Study|Withdrawal by Subject|0|||
163931136|NCT01628692|592117735|FG000|Overall Study|Death|0|||
163931137|NCT01628692|592117736|FG001|Overall Study|Death|1|||
163931138|NCT01628692|592117737|FG002|Overall Study|Death|0|||
163931139|NCT01628692|592117738|FG003|Overall Study|Death|0|||
163931140|NCT01628692|592117739|FG004|Overall Study|Death|0|||
163931141|NCT01628692|592117740|FG005|Overall Study|Death|0|||
163931142|NCT01628692|592117735|FG000|Overall Study|Poor compliance/noncompliance|1|||
163931143|NCT01628692|592117736|FG001|Overall Study|Poor compliance/noncompliance|0|||
163931144|NCT01628692|592117737|FG002|Overall Study|Poor compliance/noncompliance|0|||
163931145|NCT01628692|592117738|FG003|Overall Study|Poor compliance/noncompliance|0|||
163931146|NCT01628692|592117739|FG004|Overall Study|Poor compliance/noncompliance|0|||
163931147|NCT01628692|592117740|FG005|Overall Study|Poor compliance/noncompliance|0|||
163931148|NCT01628692|592117735|FG000|Overall Study|Administrative reason by sponsor|0|||
163931149|NCT01628692|592117736|FG001|Overall Study|Administrative reason by sponsor|0|||
163931150|NCT01628692|592117737|FG002|Overall Study|Administrative reason by sponsor|0|||
163931151|NCT01628692|592117738|FG003|Overall Study|Administrative reason by sponsor|0|||
163931152|NCT01628692|592117739|FG004|Overall Study|Administrative reason by sponsor|0|||
163931153|NCT01628692|592117740|FG005|Overall Study|Administrative reason by sponsor|1|||
163834991|NCT01250119|591767185|FG000|Diagnostic Phase|Participants Not Tested|44|||
163834992|NCT01250119|591767186|FG001|Diagnostic Phase|Participants Not Tested|0|||
163834993|NCT01250119|591767185|FG000|Treatment Phase|Progressive Disease|0|||
163834994|NCT01250119|591767186|FG001|Treatment Phase|Progressive Disease|32|||
163834995|NCT01250119|591767185|FG000|Treatment Phase|Death|0|||
163834996|NCT01250119|591767186|FG001|Treatment Phase|Death|2|||
163834997|NCT01250119|591767185|FG000|Treatment Phase|Withdrawal by Subject|0|||
163834998|NCT01250119|591767186|FG001|Treatment Phase|Withdrawal by Subject|1|||
163834999|NCT01250119|591767185|FG000|Treatment Phase|Adverse Event|0|||
163835000|NCT01250119|591767186|FG001|Treatment Phase|Adverse Event|2|||
163835001|NCT01250119|591767185|FG000|Treatment Phase|Unknown reason|0|||
163835002|NCT01250119|591767186|FG001|Treatment Phase|Unknown reason|4|||
163835003|NCT01932294|591767187|FG000|Overall Study|Death|43|||
163835004|NCT01932294|591767187|FG000|Overall Study|Lost to Follow-up|8|||
163835005|NCT01932294|591767187|FG000|Overall Study|VAD Implantation|20|||
163835006|NCT01932294|591767187|FG000|Overall Study|Heart Transplantation|16|||
163835007|NCT01932294|591767187|FG000|Overall Study|Transferred to other hospitals|12|||
163835008|NCT00409786|591767190|FG000|Overall Study|Withdrawal by Subject|3|||
163835009|NCT03075904|591767197|FG000|Overall Study|Physician Decision|3|||
163835010|NCT03075904|591767197|FG000|Overall Study|Need for Medication not Permitted|1|||
163835011|NCT00597714|591767198|FG000|Overall Study|Death|56|||
163835012|NCT00597714|591767199|FG001|Overall Study|Death|46|||
163835013|NCT00597714|591767200|FG002|Overall Study|Death|0|||
163835014|NCT00597714|591767198|FG000|Overall Study|Recipient death|0|||
163835015|NCT00597714|591767199|FG001|Overall Study|Recipient death|0|||
163835016|NCT00597714|591767200|FG002|Overall Study|Recipient death|10|||
163835017|NCT02228395|591767201|FG000|First Intervention Period|No longer willing to participate|1|||
163835018|NCT02228395|591767202|FG001|First Intervention Period|No longer willing to participate|0|||
163835019|NCT02228395|591767203|FG002|First Intervention Period|No longer willing to participate|0|||
163835020|NCT02228395|591767201|FG000|First Intervention Period|Unable to comply with study dates|0|||
163835021|NCT02228395|591767202|FG001|First Intervention Period|Unable to comply with study dates|1|||
163835022|NCT02228395|591767203|FG002|First Intervention Period|Unable to comply with study dates|1|||
163835023|NCT02424591|591767208|FG000|Overall Study|Protocol Violation|2|||
163835024|NCT02424591|591767209|FG001|Overall Study|Protocol Violation|3|||
163835025|NCT00988221|591767212|FG000|Part I|Adverse Event|0|||
163931154|NCT01628692|592117735|FG000|Overall Study|Completed 12 Week only|0|||
163931155|NCT01628692|592117736|FG001|Overall Study|Completed 12 Week only|0|||
163931156|NCT01628692|592117737|FG002|Overall Study|Completed 12 Week only|0|||
163931157|NCT01628692|592117738|FG003|Overall Study|Completed 12 Week only|0|||
163931158|NCT01628692|592117739|FG004|Overall Study|Completed 12 Week only|0|||
163931159|NCT01628692|592117740|FG005|Overall Study|Completed 12 Week only|1|||
163931160|NCT00857233|592117741|FG000|Overall Study|Adverse Event|24|||
163931161|NCT00857233|592117741|FG000|Overall Study|Lack of Efficacy|1|||
163931162|NCT00857233|592117741|FG000|Overall Study|Non-compliance|1|||
163931163|NCT00857233|592117741|FG000|Overall Study|Withdrawal of Consent|9|||
164035759|NCT00379236|592490263|FG001|Double-blind|Protocol Violation|3|||
163835026|NCT00988221|591767213|FG001|Part I|Adverse Event|1|||
163835027|NCT00988221|591767214|FG002|Part I|Adverse Event|2|||
163835028|NCT00988221|591767215|FG003|Part I|Adverse Event|0|||
163835029|NCT00988221|591767212|FG000|Part I|Insufficient Therapeutic Response|4|||
163931164|NCT00857233|592117741|FG000|Overall Study|Lost to Follow-up|4|||
163931165|NCT00857233|592117741|FG000|Overall Study|Nursing Home Placement|14|||
163931166|NCT00857233|592117741|FG000|Overall Study|Other Reasons|2|||
163931167|NCT01560871|592117742|FG000|Overall Study|transportation issues|2|||
163931168|NCT01560871|592117743|FG001|Overall Study|transportation issues|1|||
163931169|NCT01560871|592117742|FG000|Overall Study|relocation|1|||
163931170|NCT01560871|592117743|FG001|Overall Study|relocation|0|||
163931171|NCT01560871|592117742|FG000|Overall Study|readmission to a hospital|2|||
163931172|NCT01560871|592117743|FG001|Overall Study|readmission to a hospital|1|||
163931173|NCT01560871|592117742|FG000|Overall Study|Lost to Follow-up|1|||
163931174|NCT01560871|592117743|FG001|Overall Study|Lost to Follow-up|0|||
163931175|NCT00572533|592117746|FG000|Overall Study|Death|4|||
163931176|NCT00572533|592117747|FG001|Overall Study|Death|1|||
163931177|NCT00572533|592117746|FG000|Overall Study|Received Kidney Transplant|2|||
163931178|NCT00572533|592117747|FG001|Overall Study|Received Kidney Transplant|1|||
163931179|NCT00572533|592117746|FG000|Overall Study|Social Issues|1|||
163931180|NCT00572533|592117747|FG001|Overall Study|Social Issues|0|||
163931181|NCT00572533|592117746|FG000|Overall Study|Transfer out of Facility|0|||
163931182|NCT00572533|592117747|FG001|Overall Study|Transfer out of Facility|1|||
163931183|NCT00003477|592117750|FG000|Overall Study|Not evalauable|4|||
163931184|NCT04206085|592117756|FG000|Overall Study|Lost to Follow-up|0|||
163931185|NCT04206085|592117757|FG001|Overall Study|Lost to Follow-up|1|||
163931186|NCT04206085|592117758|FG002|Overall Study|Lost to Follow-up|0|||
163931187|NCT04206085|592117756|FG000|Overall Study|Lost to Follow-up|0|||
163931188|NCT04206085|592117757|FG001|Overall Study|Lost to Follow-up|0|||
163931189|NCT04206085|592117758|FG002|Overall Study|Lost to Follow-up|1|||
163931190|NCT00725543|592117762|FG000|Overall Study|Adverse Event|10|||
163931191|NCT00725543|592117762|FG000|Overall Study|Lack of Efficacy|3|||
163931192|NCT00725543|592117762|FG000|Overall Study|Withdrawal by Subject|10|||
163931193|NCT00725543|592117762|FG000|Overall Study|Physician Decision|5|||
163931194|NCT00725543|592117762|FG000|Overall Study|Lost to Follow-up|4|||
163931195|NCT00725543|592117762|FG000|Overall Study|Non-compliance|2|||
163931196|NCT00725543|592117762|FG000|Overall Study|Other|119|||
163931197|NCT02168478|592117769|FG000|Overall Study|Withdrawal by Subject|1|||
163931198|NCT02168478|592117769|FG000|Overall Study|Did Not Consent to Participation|2|||
163931199|NCT02168478|592117769|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
163931200|NCT00087555|592117770|FG000|Overall Study|Adverse Event|3|||
163931201|NCT00087555|592117771|FG001|Overall Study|Adverse Event|6|||
163931202|NCT00087555|592117772|FG002|Overall Study|Adverse Event|14|||
163931203|NCT00087555|592117770|FG000|Overall Study|Lost to Follow-up|0|||
163931204|NCT00087555|592117771|FG001|Overall Study|Lost to Follow-up|1|||
163931205|NCT00087555|592117772|FG002|Overall Study|Lost to Follow-up|1|||
163931206|NCT00087555|592117770|FG000|Overall Study|Non - Compliance|1|||
163931207|NCT00087555|592117771|FG001|Overall Study|Non - Compliance|0|||
163931208|NCT00087555|592117772|FG002|Overall Study|Non - Compliance|0|||
163931209|NCT00087555|592117770|FG000|Overall Study|Protocol Violation|0|||
163931210|NCT00087555|592117771|FG001|Overall Study|Protocol Violation|0|||
163931211|NCT00087555|592117772|FG002|Overall Study|Protocol Violation|2|||
163931212|NCT00087555|592117770|FG000|Overall Study|Screen Failure|1|||
163931213|NCT00087555|592117771|FG001|Overall Study|Screen Failure|1|||
163931214|NCT00087555|592117772|FG002|Overall Study|Screen Failure|0|||
163931215|NCT00087555|592117770|FG000|Overall Study|Pregnancy|0|||
163931216|NCT00087555|592117771|FG001|Overall Study|Pregnancy|1|||
163931217|NCT00087555|592117772|FG002|Overall Study|Pregnancy|1|||
163931218|NCT00087555|592117770|FG000|Overall Study|Withdrawal by Subject|3|||
163931219|NCT00087555|592117771|FG001|Overall Study|Withdrawal by Subject|2|||
164035760|NCT00379236|592490264|FG002|Double-blind|Protocol Violation|0|||
163931220|NCT00087555|592117772|FG002|Overall Study|Withdrawal by Subject|1|||
163931221|NCT00087555|592117770|FG000|Overall Study|Lack of Efficacy|2|||
163931222|NCT00087555|592117771|FG001|Overall Study|Lack of Efficacy|0|||
163931223|NCT00087555|592117772|FG002|Overall Study|Lack of Efficacy|1|||
163931224|NCT00087555|592117770|FG000|Overall Study|Non Compliance|0|||
163931225|NCT00087555|592117771|FG001|Overall Study|Non Compliance|0|||
163931226|NCT00087555|592117772|FG002|Overall Study|Non Compliance|1|||
163931227|NCT00087555|592117770|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
163931228|NCT00087555|592117771|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
163931229|NCT00087555|592117772|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
163931230|NCT00087555|592117770|FG000|Overall Study|Patient wanted to go back on Med|1|||
163931231|NCT00087555|592117771|FG001|Overall Study|Patient wanted to go back on Med|0|||
163931232|NCT00087555|592117772|FG002|Overall Study|Patient wanted to go back on Med|0|||
163931233|NCT01062971|592117773|FG000|Overall Study|Protocol Violation|1|||
163931234|NCT01062971|592117774|FG001|Overall Study|Protocol Violation|3|||
163931235|NCT01062971|592117773|FG000|Overall Study|Lost to Follow-up|3|||
163931236|NCT01062971|592117774|FG001|Overall Study|Lost to Follow-up|4|||
163931237|NCT01530087|592117775|FG000|Overall Study|Physician Decision|2|||
163931238|NCT05523219|592117776|FG000|Overall Study|Wrong inclusion|1|||
163931239|NCT05523219|592117776|FG000|Overall Study|Lost to Follow-up|7|||
163931240|NCT02760485|592117777|FG000|Phase 1|Death|3|||
163931241|NCT02760485|592117778|FG001|Phase 1|Death|6|||
163931242|NCT02760485|592117779|FG002|Phase 1|Death|0|||
163835030|NCT00988221|591767213|FG001|Part I|Insufficient Therapeutic Response|6|||
163835031|NCT00988221|591767214|FG002|Part I|Insufficient Therapeutic Response|5|||
163835032|NCT00988221|591767215|FG003|Part I|Insufficient Therapeutic Response|0|||
163835033|NCT00988221|591767212|FG000|Part I|Refused Treatment|0|||
163835034|NCT00988221|591767213|FG001|Part I|Refused Treatment|2|||
163835035|NCT00988221|591767214|FG002|Part I|Refused Treatment|1|||
163835036|NCT00988221|591767215|FG003|Part I|Refused Treatment|0|||
163835037|NCT00988221|591767212|FG000|Part I|Lost to Follow-up|0|||
163835038|NCT00988221|591767213|FG001|Part I|Lost to Follow-up|1|||
163835039|NCT00988221|591767214|FG002|Part I|Lost to Follow-up|0|||
163835040|NCT00988221|591767215|FG003|Part I|Lost to Follow-up|0|||
163835041|NCT00988221|591767212|FG000|Part II|Adverse Event|1|||
163835042|NCT00988221|591767213|FG001|Part II|Adverse Event|0|||
163835043|NCT00988221|591767214|FG002|Part II|Adverse Event|0|||
163835044|NCT00988221|591767215|FG003|Part II|Adverse Event|1|||
163835045|NCT00988221|591767212|FG000|Part II|Withdrawal by Subject|0|||
163835046|NCT00988221|591767213|FG001|Part II|Withdrawal by Subject|0|||
163835047|NCT00988221|591767214|FG002|Part II|Withdrawal by Subject|2|||
163835048|NCT00988221|591767215|FG003|Part II|Withdrawal by Subject|2|||
163835049|NCT00988221|591767212|FG000|Part II|Reason not Specified|0|||
163835050|NCT00988221|591767213|FG001|Part II|Reason not Specified|0|||
163835051|NCT00988221|591767214|FG002|Part II|Reason not Specified|1|||
163835052|NCT00988221|591767215|FG003|Part II|Reason not Specified|0|||
163835053|NCT00988221|591767212|FG000|Part III|Adverse Event|1|||
163835054|NCT00988221|591767213|FG001|Part III|Adverse Event|0|||
163835055|NCT00988221|591767214|FG002|Part III|Adverse Event|1|||
163835056|NCT00988221|591767215|FG003|Part III|Adverse Event|0|||
163835057|NCT00988221|591767212|FG000|Part III|Insufficient Therapeutic Response|0|||
163835058|NCT00988221|591767213|FG001|Part III|Insufficient Therapeutic Response|1|||
163835059|NCT00988221|591767214|FG002|Part III|Insufficient Therapeutic Response|1|||
163835060|NCT00988221|591767215|FG003|Part III|Insufficient Therapeutic Response|0|||
163835061|NCT00988221|591767212|FG000|Part III|Refused Treatment|0|||
163835062|NCT00988221|591767213|FG001|Part III|Refused Treatment|0|||
163835063|NCT00988221|591767214|FG002|Part III|Refused Treatment|1|||
163835064|NCT00988221|591767215|FG003|Part III|Refused Treatment|0|||
163835065|NCT02904902|591767222|FG000|Overall Study|Withdrawal by Subject|1|||
163835066|NCT02712398|591767226|FG000|Overall Study|Withdrawal by Subject|6|||
163835067|NCT02712398|591767226|FG000|Overall Study|Lost to Follow-up|6|||
163835068|NCT02712398|591767226|FG000|Overall Study|Sponsor Decision|1|||
163835069|NCT02712398|591767226|FG000|Overall Study|Physician Decision|1|||
163835070|NCT02712398|591767226|FG000|Overall Study|Death|2|||
163835071|NCT02712398|591767226|FG000|Overall Study|Re-operation|21|||
163835072|NCT01719237|591767227|FG000|Overall Study|Physician Decision|0|||
163835073|NCT01719237|591767228|FG001|Overall Study|Physician Decision|1|||
163835074|NCT04772053|591767239|FG000|Overall Study|Physician Decision|2|||
163835075|NCT04772053|591767239|FG000|Overall Study|Withdrawal by Subject|3|||
163835076|NCT04772053|591767239|FG000|Overall Study|Study Terminated by Sponsor|1|||
163835077|NCT04146896|591767244|FG000|Overall Study|Adverse Event|5|||
163835078|NCT04146896|591767245|FG001|Overall Study|Adverse Event|8|||
163835079|NCT04146896|591767244|FG000|Overall Study|Lack of Efficacy|3|||
163835080|NCT04146896|591767245|FG001|Overall Study|Lack of Efficacy|2|||
163835081|NCT04146896|591767244|FG000|Overall Study|Lost to Follow-up|0|||
163835082|NCT04146896|591767245|FG001|Overall Study|Lost to Follow-up|1|||
163835083|NCT04146896|591767244|FG000|Overall Study|Non-compliance|5|||
163835084|NCT04146896|591767245|FG001|Overall Study|Non-compliance|4|||
163835085|NCT04146896|591767244|FG000|Overall Study|Withdrawal by Subject|3|||
163835086|NCT04146896|591767245|FG001|Overall Study|Withdrawal by Subject|5|||
163835087|NCT04146896|591767244|FG000|Overall Study|Randomized in error|1|||
163835088|NCT04146896|591767245|FG001|Overall Study|Randomized in error|2|||
163835089|NCT03107377|591767246|FG000|Overall Study|Adverse Event|3|||
163835090|NCT03107377|591767247|FG001|Overall Study|Adverse Event|3|||
163835091|NCT03107377|591767246|FG000|Overall Study|Protocol Violation|9|||
163835092|NCT03107377|591767247|FG001|Overall Study|Protocol Violation|12|||
163835093|NCT03107377|591767246|FG000|Overall Study|Physician Decision|3|||
163835094|NCT03107377|591767247|FG001|Overall Study|Physician Decision|6|||
163835095|NCT03107377|591767246|FG000|Overall Study|Pregnancy|7|||
163835096|NCT03107377|591767247|FG001|Overall Study|Pregnancy|7|||
163835097|NCT03107377|591767246|FG000|Overall Study|Withdrawal by Subject|16|||
163835098|NCT03107377|591767247|FG001|Overall Study|Withdrawal by Subject|22|||
163835099|NCT03107377|591767246|FG000|Overall Study|Lost to Follow-up|37|||
163835100|NCT03107377|591767247|FG001|Overall Study|Lost to Follow-up|34|||
163835101|NCT03107377|591767246|FG000|Overall Study|Other reason not specified|16|||
163835102|NCT03107377|591767247|FG001|Overall Study|Other reason not specified|15|||
163835103|NCT01597505|591767248|FG000|Overall Study|Physician Decision|5|||
163835104|NCT01597505|591767249|FG001|Overall Study|Physician Decision|0|||
163835105|NCT01597505|591767248|FG000|Overall Study|Adverse Event|19|||
163835106|NCT01597505|591767249|FG001|Overall Study|Adverse Event|7|||
163835107|NCT01597505|591767248|FG000|Overall Study|Lost to Follow-up|4|||
163835108|NCT01597505|591767249|FG001|Overall Study|Lost to Follow-up|2|||
163835109|NCT01597505|591767248|FG000|Overall Study|Withdrawal by Subject|10|||
163835110|NCT01597505|591767249|FG001|Overall Study|Withdrawal by Subject|18|||
163931243|NCT02760485|592117777|FG000|Phase 1|Withdrawal by Subject|2|||
163931244|NCT02760485|592117778|FG001|Phase 1|Withdrawal by Subject|0|||
163931245|NCT02760485|592117779|FG002|Phase 1|Withdrawal by Subject|0|||
163931246|NCT02760485|592117777|FG000|Phase 1|Progressive Disease|1|||
163931247|NCT02760485|592117778|FG001|Phase 1|Progressive Disease|0|||
163931248|NCT02760485|592117779|FG002|Phase 1|Progressive Disease|0|||
163931249|NCT02760485|592117777|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
163931250|NCT02760485|592117778|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
163931251|NCT02760485|592117779|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
163931252|NCT02760485|592117777|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
163931253|NCT02760485|592117778|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
163931254|NCT02760485|592117779|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
163931255|NCT02760485|592117777|FG000|Phase 2|Death|0|||
163931256|NCT02760485|592117778|FG001|Phase 2|Death|0|||
163931257|NCT02760485|592117779|FG002|Phase 2|Death|12|||
163931258|NCT02760485|592117777|FG000|Phase 2|Withdrawal by Subject|0|||
163931259|NCT02760485|592117778|FG001|Phase 2|Withdrawal by Subject|0|||
163931260|NCT02760485|592117779|FG002|Phase 2|Withdrawal by Subject|3|||
163931261|NCT02760485|592117777|FG000|Phase 2|Progressive Disease|0|||
163931262|NCT02760485|592117778|FG001|Phase 2|Progressive Disease|0|||
163931263|NCT02760485|592117779|FG002|Phase 2|Progressive Disease|1|||
163931264|NCT02760485|592117777|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
163931265|NCT02760485|592117778|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
163931266|NCT02760485|592117779|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
163931267|NCT03845023|592117780|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
163931268|NCT03845023|592117781|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
163931269|NCT03845023|592117782|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
163931270|NCT03845023|592117783|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
163931271|NCT03845023|592117780|FG000|Follow-Up (14 Days)|Adverse Event|0|||
163931272|NCT03845023|592117781|FG001|Follow-Up (14 Days)|Adverse Event|0|||
163931273|NCT03845023|592117782|FG002|Follow-Up (14 Days)|Adverse Event|1|||
163931274|NCT03845023|592117783|FG003|Follow-Up (14 Days)|Adverse Event|1|||
163931275|NCT03738397|592117784|FG000|Overall Study|Adverse Event|3|||
163931276|NCT03738397|592117785|FG001|Overall Study|Adverse Event|7|||
163931277|NCT03738397|592117784|FG000|Overall Study|Withdrawal by Subject|8|||
163931278|NCT03738397|592117785|FG001|Overall Study|Withdrawal by Subject|11|||
163931279|NCT03738397|592117784|FG000|Overall Study|Lost to Follow-up|7|||
163931280|NCT03738397|592117785|FG001|Overall Study|Lost to Follow-up|5|||
163931281|NCT03738397|592117784|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
163931282|NCT03738397|592117785|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
163931283|NCT03738397|592117784|FG000|Overall Study|Other|4|||
163931284|NCT03738397|592117785|FG001|Overall Study|Other|6|||
163931285|NCT01087814|592117788|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
163931286|NCT01087814|592117789|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
164035761|NCT00379236|592490262|FG000|Double-blind|Withdrawal by Subject|12|||
164035762|NCT00379236|592490263|FG001|Double-blind|Withdrawal by Subject|13|||
164035763|NCT00379236|592490264|FG002|Double-blind|Withdrawal by Subject|0|||
164035764|NCT00379236|592490262|FG000|Double-blind|Lost to Follow-up|4|||
164035765|NCT00379236|592490263|FG001|Double-blind|Lost to Follow-up|3|||
164035766|NCT00379236|592490264|FG002|Double-blind|Lost to Follow-up|0|||
164035767|NCT00379236|592490262|FG000|Double-blind|Use of exclusionary medication|1|||
164035768|NCT00379236|592490263|FG001|Double-blind|Use of exclusionary medication|2|||
164035769|NCT00379236|592490264|FG002|Double-blind|Use of exclusionary medication|0|||
164035770|NCT00379236|592490262|FG000|Double-blind|Other|3|||
164035771|NCT00379236|592490263|FG001|Double-blind|Other|7|||
164035772|NCT00379236|592490264|FG002|Double-blind|Other|0|||
164035773|NCT00379236|592490262|FG000|Double-blind|Data could not be retrieved|2|||
164035774|NCT00379236|592490263|FG001|Double-blind|Data could not be retrieved|2|||
164035775|NCT00379236|592490264|FG002|Double-blind|Data could not be retrieved|0|||
164035776|NCT00379236|592490262|FG000|Open-label Extension|Adverse Event|0|||
164035777|NCT00379236|592490263|FG001|Open-label Extension|Adverse Event|0|||
164035778|NCT00379236|592490264|FG002|Open-label Extension|Adverse Event|13|||
164035779|NCT00379236|592490262|FG000|Open-label Extension|Protocol Violation|0|||
164035780|NCT00379236|592490263|FG001|Open-label Extension|Protocol Violation|0|||
164035781|NCT00379236|592490264|FG002|Open-label Extension|Protocol Violation|7|||
163931287|NCT01087814|592117788|FG000|Second Intervention (5 Days)|Physician Decision|1|||
163931288|NCT01087814|592117789|FG001|Second Intervention (5 Days)|Physician Decision|0|||
163931289|NCT00661713|592117790|FG000|Overall Study|Death|1|||
164035782|NCT00379236|592490262|FG000|Open-label Extension|Withdrawal by Subject|0|||
163931290|NCT00661713|592117791|FG001|Overall Study|Death|0|||
163931291|NCT00661713|592117792|FG002|Overall Study|Death|0|||
163931292|NCT00661713|592117793|FG003|Overall Study|Death|0|||
163931293|NCT00661713|592117794|FG004|Overall Study|Death|1|||
163931294|NCT00661713|592117795|FG005|Overall Study|Death|0|||
163931295|NCT00661713|592117796|FG006|Overall Study|Death|0|||
164035783|NCT00379236|592490263|FG001|Open-label Extension|Withdrawal by Subject|0|||
164147614|NCT03685344|592902087|FG003|Overall Study|Death|0|||
163931296|NCT00661713|592117797|FG007|Overall Study|Death|0|||
163931297|NCT00661713|592117790|FG000|Overall Study|Unable to Classify|1|||
163931298|NCT00661713|592117791|FG001|Overall Study|Unable to Classify|0|||
163931299|NCT00661713|592117792|FG002|Overall Study|Unable to Classify|0|||
163931300|NCT00661713|592117793|FG003|Overall Study|Unable to Classify|0|||
163931301|NCT00661713|592117794|FG004|Overall Study|Unable to Classify|0|||
163931302|NCT00661713|592117795|FG005|Overall Study|Unable to Classify|0|||
163931303|NCT00661713|592117796|FG006|Overall Study|Unable to Classify|0|||
163931304|NCT00661713|592117797|FG007|Overall Study|Unable to Classify|0|||
163931305|NCT00661713|592117790|FG000|Overall Study|Protocol Violation|1|||
163931306|NCT00661713|592117791|FG001|Overall Study|Protocol Violation|6|||
163931307|NCT00661713|592117792|FG002|Overall Study|Protocol Violation|3|||
163931308|NCT00661713|592117793|FG003|Overall Study|Protocol Violation|3|||
163931309|NCT00661713|592117794|FG004|Overall Study|Protocol Violation|0|||
163931310|NCT00661713|592117795|FG005|Overall Study|Protocol Violation|2|||
163931311|NCT00661713|592117796|FG006|Overall Study|Protocol Violation|2|||
163931312|NCT00661713|592117797|FG007|Overall Study|Protocol Violation|1|||
163931313|NCT00661713|592117790|FG000|Overall Study|Withdrawal by Subject|11|||
163931314|NCT00661713|592117791|FG001|Overall Study|Withdrawal by Subject|25|||
163931315|NCT00661713|592117792|FG002|Overall Study|Withdrawal by Subject|12|||
163931316|NCT00661713|592117793|FG003|Overall Study|Withdrawal by Subject|21|||
163931317|NCT00661713|592117794|FG004|Overall Study|Withdrawal by Subject|12|||
163931318|NCT00661713|592117795|FG005|Overall Study|Withdrawal by Subject|26|||
163931319|NCT00661713|592117796|FG006|Overall Study|Withdrawal by Subject|45|||
163931320|NCT00661713|592117797|FG007|Overall Study|Withdrawal by Subject|9|||
163931321|NCT00661713|592117790|FG000|Overall Study|Lost to Follow-up|2|||
163931322|NCT00661713|592117791|FG001|Overall Study|Lost to Follow-up|7|||
163931323|NCT00661713|592117792|FG002|Overall Study|Lost to Follow-up|2|||
163931324|NCT00661713|592117793|FG003|Overall Study|Lost to Follow-up|2|||
163931325|NCT00661713|592117794|FG004|Overall Study|Lost to Follow-up|5|||
163931326|NCT00661713|592117795|FG005|Overall Study|Lost to Follow-up|7|||
163931327|NCT00661713|592117796|FG006|Overall Study|Lost to Follow-up|14|||
163931328|NCT00661713|592117797|FG007|Overall Study|Lost to Follow-up|1|||
163931329|NCT00661713|592117790|FG000|Overall Study|Administrative Reason|0|||
163931330|NCT00661713|592117791|FG001|Overall Study|Administrative Reason|1|||
163931331|NCT00661713|592117792|FG002|Overall Study|Administrative Reason|0|||
163931332|NCT00661713|592117793|FG003|Overall Study|Administrative Reason|2|||
163931333|NCT00661713|592117794|FG004|Overall Study|Administrative Reason|2|||
163931334|NCT00661713|592117795|FG005|Overall Study|Administrative Reason|2|||
163931335|NCT00661713|592117796|FG006|Overall Study|Administrative Reason|1|||
163931336|NCT00661713|592117797|FG007|Overall Study|Administrative Reason|0|||
163931337|NCT00661713|592117790|FG000|Overall Study|Adverse Event|0|||
163931338|NCT00661713|592117791|FG001|Overall Study|Adverse Event|0|||
163931339|NCT00661713|592117792|FG002|Overall Study|Adverse Event|0|||
163931340|NCT00661713|592117793|FG003|Overall Study|Adverse Event|0|||
163931341|NCT00661713|592117794|FG004|Overall Study|Adverse Event|0|||
163931342|NCT00661713|592117795|FG005|Overall Study|Adverse Event|0|||
163931343|NCT00661713|592117796|FG006|Overall Study|Adverse Event|1|||
163931344|NCT00661713|592117797|FG007|Overall Study|Adverse Event|0|||
163931345|NCT00661713|592117790|FG000|Overall Study|Inappropriate Enrollment|0|||
163931346|NCT00661713|592117791|FG001|Overall Study|Inappropriate Enrollment|0|||
163931347|NCT00661713|592117792|FG002|Overall Study|Inappropriate Enrollment|0|||
163931348|NCT00661713|592117793|FG003|Overall Study|Inappropriate Enrollment|0|||
163931349|NCT00661713|592117794|FG004|Overall Study|Inappropriate Enrollment|0|||
163931350|NCT00661713|592117795|FG005|Overall Study|Inappropriate Enrollment|0|||
163931351|NCT00661713|592117796|FG006|Overall Study|Inappropriate Enrollment|1|||
163931352|NCT00661713|592117797|FG007|Overall Study|Inappropriate Enrollment|0|||
163931353|NCT02353871|592117798|FG000|Overall Study|Protocol deviation|0|||
163931354|NCT02353871|592117799|FG001|Overall Study|Protocol deviation|1|||
163931355|NCT02353871|592117798|FG000|Overall Study|Consent withdrawn|1|||
163931356|NCT02353871|592117799|FG001|Overall Study|Consent withdrawn|8|||
163931357|NCT02353871|592117798|FG000|Overall Study|Lost to Follow-up|2|||
163931358|NCT02353871|592117799|FG001|Overall Study|Lost to Follow-up|0|||
163931359|NCT05314374|592117800|FG000|Overall Study|Adverse Event|2|||
163931360|NCT05314374|592117801|FG001|Overall Study|Adverse Event|2|||
163931361|NCT02658175|592117802|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
163931362|NCT02658175|592117803|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
163931363|NCT02658175|592117804|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
163931364|NCT02658175|592117802|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
163931365|NCT02658175|592117803|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
163931366|NCT02658175|592117804|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
163931367|NCT02658175|592117802|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
163931368|NCT02658175|592117803|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
163931369|NCT02658175|592117804|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
163931370|NCT02658175|592117802|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
163931371|NCT02658175|592117803|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
164147693|NCT03910673|592902127|FG003|Overall Study|Adverse Event|2|||
164035784|NCT00379236|592490264|FG002|Open-label Extension|Withdrawal by Subject|13|||
164035785|NCT00379236|592490262|FG000|Open-label Extension|Lost to Follow-up|0|||
164035786|NCT00379236|592490263|FG001|Open-label Extension|Lost to Follow-up|0|||
164035787|NCT00379236|592490264|FG002|Open-label Extension|Lost to Follow-up|12|||
164035788|NCT00379236|592490262|FG000|Open-label Extension|Use of exclusionary medication|0|||
164035789|NCT00379236|592490263|FG001|Open-label Extension|Use of exclusionary medication|0|||
164035790|NCT00379236|592490264|FG002|Open-label Extension|Use of exclusionary medication|3|||
164035791|NCT00379236|592490262|FG000|Open-label Extension|Other|0|||
164035792|NCT00379236|592490263|FG001|Open-label Extension|Other|0|||
164035793|NCT00379236|592490264|FG002|Open-label Extension|Other|7|||
164035794|NCT02940860|592490270|FG000|Overall Study|Non-serious AE|1|||
164035795|NCT02940860|592490271|FG001|Overall Study|Non-serious AE|2|||
164035796|NCT02940860|592490270|FG000|Overall Study|Serious AE|7|||
164035797|NCT02940860|592490271|FG001|Overall Study|Serious AE|3|||
164035798|NCT02940860|592490270|FG000|Overall Study|Withdrawal by Subject|19|||
164035799|NCT02940860|592490271|FG001|Overall Study|Withdrawal by Subject|9|||
164035800|NCT02940860|592490270|FG000|Overall Study|Lost to Follow-up|13|||
164035801|NCT02940860|592490271|FG001|Overall Study|Lost to Follow-up|7|||
164035802|NCT02940860|592490270|FG000|Overall Study|Physician Decision|5|||
164035803|NCT02940860|592490271|FG001|Overall Study|Physician Decision|3|||
163931372|NCT02658175|592117804|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
163931373|NCT02658175|592117802|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
163931374|NCT02658175|592117803|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
163931375|NCT02658175|592117804|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
163931376|NCT02658175|592117802|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
163931377|NCT02658175|592117803|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
163931378|NCT02658175|592117804|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
163931379|NCT02658175|592117802|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
163931380|NCT02658175|592117803|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
163931381|NCT02658175|592117804|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
163931382|NCT02658175|592117802|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
163931383|NCT02658175|592117803|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
163931384|NCT02658175|592117804|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
163931385|NCT02658175|592117802|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
163931386|NCT02658175|592117803|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
163931387|NCT02658175|592117804|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
163931388|NCT02658175|592117802|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
163931389|NCT02658175|592117803|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
163931390|NCT02658175|592117804|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
163931391|NCT02554383|592117810|FG000|Overall Study|Ineligible|3|||
163931392|NCT02554383|592117811|FG001|Overall Study|Ineligible|2|||
163931393|NCT02554383|592117810|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
163931394|NCT02554383|592117811|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
163931395|NCT02554383|592117810|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
163931396|NCT02554383|592117811|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
163931397|NCT02554383|592117810|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
163931398|NCT02554383|592117811|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
163931399|NCT02918292|592117814|FG000|Study Enrollment Prior to Transplant|Death|1|||
163931400|NCT02918292|592117814|FG000|Study Follow up After Transplant|Death|6|||
163931401|NCT03783689|592117815|FG000|Overall Study|Adverse Event|2|||
163931402|NCT03783689|592117816|FG001|Overall Study|Adverse Event|0|||
163931403|NCT03783689|592117815|FG000|Overall Study|Lost to Follow-up|2|||
163931404|NCT03783689|592117816|FG001|Overall Study|Lost to Follow-up|1|||
163931405|NCT03783689|592117815|FG000|Overall Study|Physician Decision|2|||
163931406|NCT03783689|592117816|FG001|Overall Study|Physician Decision|1|||
164035804|NCT02940860|592490270|FG000|Overall Study|Sponsor Decision|0|||
164035805|NCT02940860|592490271|FG001|Overall Study|Sponsor Decision|1|||
164035806|NCT02940860|592490270|FG000|Overall Study|Protocol Violation|0|||
164035807|NCT02940860|592490271|FG001|Overall Study|Protocol Violation|2|||
164035808|NCT02940860|592490270|FG000|Overall Study|Death|3|||
164035809|NCT02940860|592490271|FG001|Overall Study|Death|2|||
164035810|NCT02940860|592490270|FG000|Overall Study|Moved, poor venous access, transport|6|||
164035811|NCT02940860|592490271|FG001|Overall Study|Moved, poor venous access, transport|4|||
164035812|NCT02940860|592490270|FG000|Overall Study|Not treated|2|||
164035813|NCT02940860|592490271|FG001|Overall Study|Not treated|2|||
164098318|NCT05093205|592725083|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
164098319|NCT05093205|592725084|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
164035814|NCT04914819|592490272|FG000|Overall Study|Pregnancy|3|||
164035815|NCT04914819|592490273|FG001|Overall Study|Pregnancy|1|||
164035816|NCT04914819|592490272|FG000|Overall Study|Discontinued study|4|||
163931407|NCT03783689|592117815|FG000|Overall Study|Withdrawal by Subject|3|||
163931408|NCT03783689|592117816|FG001|Overall Study|Withdrawal by Subject|3|||
163931409|NCT02165826|592117818|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
163931410|NCT02165826|592117819|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
163931411|NCT02165826|592117820|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
163931412|NCT02165826|592117818|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
163931413|NCT02165826|592117819|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
163931414|NCT02165826|592117820|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
163931415|NCT02165826|592117818|FG000|Main Treatment Period|Lost to Follow-up|4|||
163931416|NCT02165826|592117819|FG001|Main Treatment Period|Lost to Follow-up|2|||
163931417|NCT02165826|592117820|FG002|Main Treatment Period|Lost to Follow-up|1|||
163931418|NCT02165826|592117818|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
163931419|NCT02165826|592117819|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
163931420|NCT02165826|592117820|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
163931421|NCT02165826|592117818|FG000|Main Treatment Period|Lack of Efficacy|2|||
163931422|NCT02165826|592117819|FG001|Main Treatment Period|Lack of Efficacy|0|||
163931423|NCT02165826|592117820|FG002|Main Treatment Period|Lack of Efficacy|0|||
163931424|NCT02165826|592117818|FG000|Main Treatment Period|Reason Not Specified|8|||
163931425|NCT02165826|592117819|FG001|Main Treatment Period|Reason Not Specified|5|||
163931426|NCT02165826|592117820|FG002|Main Treatment Period|Reason Not Specified|16|||
163931427|NCT02165826|592117818|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
163931428|NCT02165826|592117819|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
163931429|NCT02165826|592117820|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
163931430|NCT02165826|592117818|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
163931431|NCT02165826|592117819|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
163931432|NCT02165826|592117820|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
163931433|NCT02165826|592117818|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
163931434|NCT02165826|592117819|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
163931435|NCT02165826|592117820|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
163931436|NCT02165826|592117818|FG000|Down-Titration Period|Reason Not Specified|1|||
163931437|NCT02165826|592117819|FG001|Down-Titration Period|Reason Not Specified|0|||
163931438|NCT02165826|592117820|FG002|Down-Titration Period|Reason Not Specified|2|||
163931439|NCT02581059|592117821|FG000|Study Treatment|Disease Progression|1|||
163931440|NCT02581059|592117822|FG001|Study Treatment|Disease Progression|1|||
163931441|NCT02581059|592117821|FG000|Study Treatment|Adverse Event|2|||
163931442|NCT02581059|592117822|FG001|Study Treatment|Adverse Event|1|||
163931443|NCT02581059|592117821|FG000|Study Treatment|Death|1|||
163931444|NCT02581059|592117822|FG001|Study Treatment|Death|1|||
163931445|NCT02581059|592117821|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
163931446|NCT02581059|592117822|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
163931447|NCT02581059|592117821|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
163931448|NCT02581059|592117822|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
163931449|NCT02581059|592117821|FG000|Follow up|Death|1|||
163931450|NCT02581059|592117822|FG001|Follow up|Death|3|||
163931451|NCT02581059|592117821|FG000|Follow up|study terminated|1|||
163931452|NCT02581059|592117822|FG001|Follow up|study terminated|1|||
163931453|NCT02581059|592117821|FG000|Follow up|screen failure|0|||
163931454|NCT02581059|592117822|FG001|Follow up|screen failure|1|||
163931455|NCT02581059|592117821|FG000|Follow up|Patient started new clinical trial|1|||
163931456|NCT02581059|592117822|FG001|Follow up|Patient started new clinical trial|0|||
163931457|NCT04887506|592117823|FG000|Overall Study|Death|1|||
163931458|NCT04887506|592117824|FG001|Overall Study|Death|1|||
163931459|NCT04887506|592117823|FG000|Overall Study|Withdrawal by Subject|0|||
163931460|NCT04887506|592117824|FG001|Overall Study|Withdrawal by Subject|3|||
163931461|NCT04887506|592117823|FG000|Overall Study|Adverse Event|4|||
163931462|NCT04887506|592117824|FG001|Overall Study|Adverse Event|3|||
163931463|NCT04887506|592117823|FG000|Overall Study|Other - Not Reported|1|||
163931464|NCT04887506|592117824|FG001|Overall Study|Other - Not Reported|1|||
163931465|NCT02636608|592117828|FG000|Overall Study|Failure to Return|4|||
163931466|NCT02636608|592117828|FG000|Overall Study|Insufficient Virological Response|1|||
163931467|NCT02636608|592117828|FG000|Overall Study|Death|3|||
163931468|NCT02636608|592117828|FG000|Overall Study|Other|2|||
163931469|NCT02636608|592117828|FG000|Overall Study|Did Not Receive Treatment|1|||
163931470|NCT04913948|592117830|FG000|Overall Study|Withdrawal by Subject|2|||
163931471|NCT04913948|592117830|FG000|Overall Study|Sample processing issues|1|||
163931472|NCT04913948|592117830|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
163931473|NCT05739994|592117834|FG000|Overall Study|Withdrawal by Subject|2|||
163931474|NCT05739994|592117835|FG001|Overall Study|Withdrawal by Subject|2|||
164035817|NCT04914819|592490273|FG001|Overall Study|Discontinued study|1|||
164035818|NCT04914819|592490272|FG000|Overall Study|Lost to Follow-up|7|||
164035819|NCT04914819|592490273|FG001|Overall Study|Lost to Follow-up|0|||
164035820|NCT01625611|592490277|FG000|Overall Study|No adlib drinks Lab 1|3|||
163931475|NCT05739994|592117836|FG002|Overall Study|Withdrawal by Subject|4|||
163835111|NCT01597505|591767248|FG000|Overall Study|Other|5|||
163835112|NCT01597505|591767249|FG001|Overall Study|Other|6|||
163835113|NCT01597505|591767248|FG000|Overall Study|Missing|1|||
163835114|NCT01597505|591767249|FG001|Overall Study|Missing|0|||
163835115|NCT02675465|591767251|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
163835116|NCT02675465|591767252|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
163835117|NCT02675465|591767253|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
163835118|NCT02675465|591767254|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
163835119|NCT02675465|591767255|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
163835120|NCT02675465|591767256|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
163835121|NCT02675465|591767251|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163835122|NCT02675465|591767252|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163835123|NCT02675465|591767253|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
163835124|NCT02675465|591767254|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163835125|NCT02675465|591767255|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163835126|NCT02675465|591767256|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
163835127|NCT02675465|591767251|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
163835128|NCT02675465|591767252|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
163835129|NCT02675465|591767253|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
163835130|NCT02675465|591767254|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
163835131|NCT02675465|591767255|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
163835132|NCT02675465|591767256|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
163835133|NCT02675465|591767251|FG000|Stage 4: Long Term Extension|Death|0|||
163835134|NCT02675465|591767252|FG001|Stage 4: Long Term Extension|Death|0|||
163835135|NCT02675465|591767253|FG002|Stage 4: Long Term Extension|Death|0|||
163835136|NCT02675465|591767254|FG003|Stage 4: Long Term Extension|Death|1|||
163835137|NCT02675465|591767255|FG004|Stage 4: Long Term Extension|Death|0|||
163835138|NCT02675465|591767256|FG005|Stage 4: Long Term Extension|Death|0|||
163835139|NCT00453102|591767257|FG000|Overall Study|Withdrawal by Subject|2|||
163835140|NCT05031078|591767258|FG000|Overall Study|Withdrawal by Subject|0|||
163835141|NCT05031078|591767259|FG001|Overall Study|Withdrawal by Subject|1|||
163835142|NCT05031078|591767260|FG002|Overall Study|Withdrawal by Subject|0|||
163835143|NCT03728972|591767261|FG000|Overall Study|Death|1|||
163835144|NCT03728972|591767262|FG001|Overall Study|Death|0|||
163835145|NCT03728972|591767261|FG000|Overall Study|Lack of Efficacy|1|||
163835146|NCT03728972|591767262|FG001|Overall Study|Lack of Efficacy|0|||
163835147|NCT03728972|591767261|FG000|Overall Study|Physician Decision|3|||
163835148|NCT03728972|591767262|FG001|Overall Study|Physician Decision|0|||
163835149|NCT03728972|591767261|FG000|Overall Study|Disease progression|4|||
163835150|NCT03728972|591767262|FG001|Overall Study|Disease progression|3|||
163835151|NCT03787680|591767267|FG000|Overall Study|Physician Decision|2|||
163835152|NCT03787680|591767268|FG001|Overall Study|Physician Decision|3|||
163835153|NCT03787680|591767267|FG000|Overall Study|Adverse Event|7|||
163835154|NCT03787680|591767268|FG001|Overall Study|Adverse Event|3|||
163835155|NCT03787680|591767267|FG000|Overall Study|Withdrawal by Subject|2|||
163835156|NCT03787680|591767268|FG001|Overall Study|Withdrawal by Subject|1|||
163835157|NCT05454410|591767271|FG000|Overall Study|Withdrawal by Subject|0|||
163835158|NCT05454410|591767272|FG001|Overall Study|Withdrawal by Subject|0|||
163835159|NCT05454410|591767273|FG002|Overall Study|Withdrawal by Subject|1|||
163835160|NCT05454410|591767274|FG003|Overall Study|Withdrawal by Subject|1|||
163835161|NCT00895622|591767275|FG000|Overall Study|Protocol Violation|5|||
163835162|NCT00895622|591767276|FG001|Overall Study|Protocol Violation|4|||
163835163|NCT00895622|591767277|FG002|Overall Study|Protocol Violation|4|||
163835164|NCT01490125|591767278|FG000|Period I|Adverse Event|4|||
163835165|NCT01490125|591767279|FG001|Period I|Adverse Event|1|||
163835166|NCT01490125|591767280|FG002|Period I|Adverse Event|1|||
163835167|NCT01490125|591767281|FG003|Period I|Adverse Event|3|||
163835168|NCT01490125|591767282|FG004|Period I|Adverse Event|2|||
163835169|NCT01490125|591767283|FG005|Period I|Adverse Event|4|||
163835170|NCT01490125|591767278|FG000|Period I|Protocol Violation|1|||
163835171|NCT01490125|591767279|FG001|Period I|Protocol Violation|1|||
163835172|NCT01490125|591767280|FG002|Period I|Protocol Violation|1|||
163835173|NCT01490125|591767281|FG003|Period I|Protocol Violation|1|||
163835174|NCT01490125|591767282|FG004|Period I|Protocol Violation|0|||
163835175|NCT01490125|591767283|FG005|Period I|Protocol Violation|0|||
163835176|NCT01490125|591767278|FG000|Period I|Withdrawal by Subject|1|||
163835177|NCT01490125|591767279|FG001|Period I|Withdrawal by Subject|3|||
163835178|NCT01490125|591767280|FG002|Period I|Withdrawal by Subject|2|||
163835179|NCT01490125|591767281|FG003|Period I|Withdrawal by Subject|1|||
163835180|NCT01490125|591767282|FG004|Period I|Withdrawal by Subject|2|||
163835181|NCT01490125|591767283|FG005|Period I|Withdrawal by Subject|1|||
163835182|NCT01490125|591767278|FG000|Period II|Adverse Event|2|||
163835183|NCT01490125|591767279|FG001|Period II|Adverse Event|3|||
163835184|NCT01490125|591767280|FG002|Period II|Adverse Event|2|||
163835185|NCT01490125|591767281|FG003|Period II|Adverse Event|2|||
163835186|NCT01490125|591767282|FG004|Period II|Adverse Event|4|||
163835187|NCT01490125|591767283|FG005|Period II|Adverse Event|2|||
163835188|NCT01490125|591767278|FG000|Period II|Protocol Violation|0|||
163835189|NCT01490125|591767279|FG001|Period II|Protocol Violation|0|||
163931476|NCT04021043|592119793|FG000|Overall Study|Adverse Event|3|||
163931477|NCT04021043|592119794|FG001|Overall Study|Adverse Event|1|||
163931478|NCT04021043|592119795|FG002|Overall Study|Adverse Event|1|||
163931479|NCT04021043|592119796|FG003|Overall Study|Adverse Event|0|||
163931480|NCT04021043|592119793|FG000|Overall Study|Death|2|||
163931481|NCT04021043|592119794|FG001|Overall Study|Death|3|||
164035821|NCT01625611|592490278|FG001|Overall Study|No adlib drinks Lab 1|0|||
164035822|NCT01625611|592490277|FG000|Overall Study|Technical issues with PET|1|||
164035823|NCT01625611|592490278|FG001|Overall Study|Technical issues with PET|0|||
164035824|NCT01625611|592490277|FG000|Overall Study|Unable to complete study procedures|1|||
164035825|NCT01625611|592490278|FG001|Overall Study|Unable to complete study procedures|0|||
164035826|NCT01625611|592490277|FG000|Overall Study|Withdrawal by Subject|3|||
164035827|NCT01625611|592490278|FG001|Overall Study|Withdrawal by Subject|0|||
164035828|NCT02431793|592490279|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
164035829|NCT02431793|592490280|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
164035830|NCT02431793|592490281|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
164035831|NCT02431793|592490279|FG000|Overall Study|Withdrawal by Subject|7|||
164035832|NCT02431793|592490280|FG001|Overall Study|Withdrawal by Subject|5|||
164035833|NCT02431793|592490281|FG002|Overall Study|Withdrawal by Subject|5|||
164035834|NCT02431793|592490279|FG000|Overall Study|Lost to Follow-up|101|||
164035835|NCT02431793|592490280|FG001|Overall Study|Lost to Follow-up|122|||
164035836|NCT02431793|592490281|FG002|Overall Study|Lost to Follow-up|104|||
164035837|NCT00233324|592490282|FG000|Main Study|Death|68|||
164035838|NCT00233324|592490283|FG001|Main Study|Death|60|||
164035839|NCT00233324|592490284|FG002|Main Study|Death|62|||
164035840|NCT00233324|592490285|FG003|Main Study|Death|47|||
164035841|NCT00233324|592490282|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
164035842|NCT00233324|592490283|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
164035843|NCT00233324|592490284|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
164035844|NCT00233324|592490285|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
164035845|NCT00233324|592490282|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
164035846|NCT00233324|592490283|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
164035847|NCT00233324|592490284|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
164035848|NCT00233324|592490285|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
164035849|NCT01711541|592490292|FG000|Overall Study|Cancel prior to treatment|0|||
164035850|NCT01711541|592490293|FG001|Overall Study|Cancel prior to treatment|0|||
164035851|NCT01711541|592490294|FG002|Overall Study|Cancel prior to treatment|0|||
164098320|NCT05093205|592725085|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
164098321|NCT05093205|592725086|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
164098322|NCT05093205|592725087|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
163931482|NCT04021043|592119795|FG002|Overall Study|Death|1|||
163931483|NCT04021043|592119796|FG003|Overall Study|Death|3|||
163931484|NCT04021043|592119793|FG000|Overall Study|Withdrawal by Subject|1|||
163931485|NCT04021043|592119794|FG001|Overall Study|Withdrawal by Subject|1|||
163931486|NCT04021043|592119795|FG002|Overall Study|Withdrawal by Subject|1|||
163931487|NCT04021043|592119796|FG003|Overall Study|Withdrawal by Subject|6|||
163931488|NCT04021043|592119793|FG000|Overall Study|Discontinued due to disease progression|4|||
163931489|NCT04021043|592119794|FG001|Overall Study|Discontinued due to disease progression|5|||
163931490|NCT04021043|592119795|FG002|Overall Study|Discontinued due to disease progression|7|||
163931491|NCT04021043|592119796|FG003|Overall Study|Discontinued due to disease progression|10|||
163931492|NCT00826228|592119797|FG000|Overall Study|Withdrawal by Subject|1|||
163931493|NCT03526679|592119798|FG000|Overall Study|still under treatment|2|||
163931494|NCT01246999|592119799|FG000|Overall Study|Lost to Follow-up|0|||
163931495|NCT01246999|592119800|FG001|Overall Study|Lost to Follow-up|1|||
163931496|NCT01246999|592119801|FG002|Overall Study|Lost to Follow-up|0|||
163931497|NCT01246999|592119802|FG003|Overall Study|Lost to Follow-up|0|||
163931498|NCT01246999|592119799|FG000|Overall Study|Withdrawal by Subject|0|||
163931499|NCT01246999|592119800|FG001|Overall Study|Withdrawal by Subject|0|||
163931500|NCT01246999|592119801|FG002|Overall Study|Withdrawal by Subject|0|||
163931501|NCT01246999|592119802|FG003|Overall Study|Withdrawal by Subject|2|||
164035852|NCT01711541|592490295|FG003|Overall Study|Cancel prior to treatment|1|||
164035853|NCT01711541|592490296|FG004|Overall Study|Cancel prior to treatment|0|||
164035854|NCT01711541|592490292|FG000|Overall Study|Ineligible|0|||
164035855|NCT01711541|592490293|FG001|Overall Study|Ineligible|1|||
164035856|NCT01711541|592490294|FG002|Overall Study|Ineligible|0|||
164098323|NCT05093205|592725088|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
164035857|NCT01711541|592490295|FG003|Overall Study|Ineligible|0|||
164098324|NCT05093205|592725089|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
164098325|NCT05093205|592725090|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
163931502|NCT01867047|592119803|FG000|Overall Study|Lost to Follow-up|3|||
163931503|NCT01867047|592119804|FG001|Overall Study|Lost to Follow-up|3|||
163931504|NCT01867047|592119803|FG000|Overall Study|Withdrawal by Subject|2|||
164035858|NCT01711541|592490296|FG004|Overall Study|Ineligible|0|||
164035859|NCT02707601|592490299|FG000|Overall Study|Death|0|||
164035860|NCT02707601|592490300|FG001|Overall Study|Death|1|||
164098326|NCT05093205|592725091|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
164035861|NCT02707601|592490299|FG000|Overall Study|Lack of Efficacy|0|||
164035862|NCT02707601|592490300|FG001|Overall Study|Lack of Efficacy|1|||
164035863|NCT02707601|592490299|FG000|Overall Study|Investigator's Discretion|1|||
164035864|NCT02707601|592490300|FG001|Overall Study|Investigator's Discretion|0|||
164035865|NCT02707601|592490299|FG000|Overall Study|Withdrew Consent|0|||
164035866|NCT02707601|592490300|FG001|Overall Study|Withdrew Consent|1|||
164035867|NCT02707601|592490299|FG000|Overall Study|Lost to Follow-up|1|||
163835190|NCT01490125|591767280|FG002|Period II|Protocol Violation|1|||
163835191|NCT01490125|591767281|FG003|Period II|Protocol Violation|1|||
163835192|NCT01490125|591767282|FG004|Period II|Protocol Violation|0|||
163835193|NCT01490125|591767283|FG005|Period II|Protocol Violation|0|||
163835194|NCT01490125|591767278|FG000|Period II|Lost to Follow-up|0|||
163835195|NCT01490125|591767279|FG001|Period II|Lost to Follow-up|1|||
163835196|NCT01490125|591767280|FG002|Period II|Lost to Follow-up|0|||
163835197|NCT01490125|591767281|FG003|Period II|Lost to Follow-up|0|||
163835198|NCT01490125|591767282|FG004|Period II|Lost to Follow-up|0|||
163835199|NCT01490125|591767283|FG005|Period II|Lost to Follow-up|0|||
163835200|NCT01490125|591767278|FG000|Period II|Withdrawal by Subject|1|||
163835201|NCT01490125|591767279|FG001|Period II|Withdrawal by Subject|0|||
163835202|NCT01490125|591767280|FG002|Period II|Withdrawal by Subject|0|||
163835203|NCT01490125|591767281|FG003|Period II|Withdrawal by Subject|0|||
163835204|NCT01490125|591767282|FG004|Period II|Withdrawal by Subject|0|||
163835205|NCT01490125|591767283|FG005|Period II|Withdrawal by Subject|0|||
163835206|NCT01490125|591767278|FG000|Period III|Adverse Event|3|||
163835207|NCT01490125|591767279|FG001|Period III|Adverse Event|1|||
163835208|NCT01490125|591767280|FG002|Period III|Adverse Event|0|||
163835209|NCT01490125|591767281|FG003|Period III|Adverse Event|1|||
163835210|NCT01490125|591767282|FG004|Period III|Adverse Event|0|||
163835211|NCT01490125|591767283|FG005|Period III|Adverse Event|0|||
163835212|NCT01490125|591767278|FG000|Period III|Death|0|||
163835213|NCT01490125|591767279|FG001|Period III|Death|0|||
163835214|NCT01490125|591767280|FG002|Period III|Death|0|||
163835215|NCT01490125|591767281|FG003|Period III|Death|1|||
163835216|NCT01490125|591767282|FG004|Period III|Death|0|||
163835217|NCT01490125|591767283|FG005|Period III|Death|0|||
163835218|NCT01490125|591767278|FG000|Period III|Lack of Efficacy|0|||
163835219|NCT01490125|591767279|FG001|Period III|Lack of Efficacy|0|||
163835220|NCT01490125|591767280|FG002|Period III|Lack of Efficacy|0|||
163835221|NCT01490125|591767281|FG003|Period III|Lack of Efficacy|0|||
163835222|NCT01490125|591767282|FG004|Period III|Lack of Efficacy|1|||
163835223|NCT01490125|591767283|FG005|Period III|Lack of Efficacy|0|||
163835224|NCT01224158|591767284|FG000|Overall Study|Withdrawal by Subject|1|||
163835225|NCT01224158|591767285|FG001|Overall Study|Withdrawal by Subject|0|||
163835226|NCT01412801|591767291|FG000|Overall Study|Death|0|||
163835227|NCT01412801|591767292|FG001|Overall Study|Death|1|||
163835228|NCT01412801|591767293|FG002|Overall Study|Death|0|||
163835229|NCT01412801|591767294|FG003|Overall Study|Death|4|||
163835230|NCT01412801|591767295|FG004|Overall Study|Death|2|||
163835231|NCT01412801|591767296|FG005|Overall Study|Death|2|||
163835232|NCT01412801|591767291|FG000|Overall Study|Lost to Follow-up|1|||
163835233|NCT01412801|591767292|FG001|Overall Study|Lost to Follow-up|2|||
163835234|NCT01412801|591767293|FG002|Overall Study|Lost to Follow-up|4|||
163835235|NCT01412801|591767294|FG003|Overall Study|Lost to Follow-up|0|||
163835236|NCT01412801|591767295|FG004|Overall Study|Lost to Follow-up|1|||
163835237|NCT01412801|591767296|FG005|Overall Study|Lost to Follow-up|1|||
163835238|NCT01412801|591767291|FG000|Overall Study|Withdrawal by Subject|3|||
163835239|NCT01412801|591767292|FG001|Overall Study|Withdrawal by Subject|2|||
163835240|NCT01412801|591767293|FG002|Overall Study|Withdrawal by Subject|1|||
163835241|NCT01412801|591767294|FG003|Overall Study|Withdrawal by Subject|0|||
163835242|NCT01412801|591767295|FG004|Overall Study|Withdrawal by Subject|0|||
163835243|NCT01412801|591767296|FG005|Overall Study|Withdrawal by Subject|0|||
163835244|NCT01412801|591767291|FG000|Overall Study|Relocated to another area|0|||
163835245|NCT01412801|591767292|FG001|Overall Study|Relocated to another area|0|||
163835246|NCT01412801|591767293|FG002|Overall Study|Relocated to another area|2|||
163835247|NCT01412801|591767294|FG003|Overall Study|Relocated to another area|0|||
163835248|NCT01412801|591767295|FG004|Overall Study|Relocated to another area|0|||
163835249|NCT01412801|591767296|FG005|Overall Study|Relocated to another area|0|||
163835250|NCT01919970|591767297|FG000|Overall Study|Withdrawal by Subject|3|||
163835251|NCT01919970|591767298|FG001|Overall Study|Withdrawal by Subject|0|||
163835252|NCT00990340|591767299|FG000|First 14-day Treatment|Not Compliant|2|||
163835253|NCT00990340|591767300|FG001|First 14-day Treatment|Not Compliant|1|||
163835254|NCT00990340|591767299|FG000|First 14-day Treatment|Lost to Follow-up|2|||
163835255|NCT00990340|591767300|FG001|First 14-day Treatment|Lost to Follow-up|1|||
163835256|NCT00990340|591767299|FG000|First 14-day Treatment|Protocol Violation|2|||
163835257|NCT00990340|591767300|FG001|First 14-day Treatment|Protocol Violation|2|||
163835258|NCT04615182|591767301|FG000|Overall Study|Re-transplanted|2|||
164035868|NCT02707601|592490300|FG001|Overall Study|Lost to Follow-up|1|||
163835259|NCT04615182|591767301|FG000|Overall Study|Protocol Violation|6|||
163835260|NCT04615182|591767301|FG000|Overall Study|Death|6|||
163835261|NCT04615182|591767301|FG000|Overall Study|Death and protocol violation|1|||
163835262|NCT01126060|591767302|FG000|Overall Study|Protocol Violation|0|||
163931505|NCT01867047|592119804|FG001|Overall Study|Withdrawal by Subject|0|||
163931506|NCT01867047|592119803|FG000|Overall Study|Physician Decision|2|||
163931507|NCT01867047|592119804|FG001|Overall Study|Physician Decision|0|||
163931508|NCT01867047|592119803|FG000|Overall Study|surgery not indicated in protocol|1|||
163931509|NCT01867047|592119804|FG001|Overall Study|surgery not indicated in protocol|2|||
163931510|NCT00307047|592119805|FG000|Overall Study|Lost to Follow-up|35|||
163931511|NCT00307047|592119806|FG001|Overall Study|Lost to Follow-up|24|||
163931512|NCT00307047|592119805|FG000|Overall Study|Withdrawal by Subject|6|||
163931513|NCT00307047|592119806|FG001|Overall Study|Withdrawal by Subject|6|||
163931514|NCT00307047|592119805|FG000|Overall Study|Physician Decision|1|||
163931515|NCT00307047|592119806|FG001|Overall Study|Physician Decision|2|||
163931516|NCT00307047|592119805|FG000|Overall Study|Lost to follow-up for other reasons|0|||
163931517|NCT00307047|592119806|FG001|Overall Study|Lost to follow-up for other reasons|1|||
163931518|NCT00307047|592119805|FG000|Overall Study|All death, all MI, all Revascularization|27|||
163931519|NCT00307047|592119806|FG001|Overall Study|All death, all MI, all Revascularization|16|||
163931520|NCT02825251|592119809|FG000|Overall Study|Adverse Event|0|||
163931521|NCT02825251|592119810|FG001|Overall Study|Adverse Event|1|||
163931522|NCT02825251|592119809|FG000|Overall Study|Lost to Follow-up|0|||
163931523|NCT02825251|592119810|FG001|Overall Study|Lost to Follow-up|1|||
163931524|NCT02825251|592119809|FG000|Overall Study|Withdrawal by Subject|1|||
163931525|NCT02825251|592119810|FG001|Overall Study|Withdrawal by Subject|4|||
163931526|NCT02825251|592119809|FG000|Overall Study|Unclassified|2|||
163931527|NCT02825251|592119810|FG001|Overall Study|Unclassified|0|||
163931528|NCT01689363|592119813|FG000|Overall Study|Protocol Violation|0|||
163931529|NCT01689363|592119814|FG001|Overall Study|Protocol Violation|1|||
163931530|NCT01689363|592119815|FG002|Overall Study|Protocol Violation|0|||
163931531|NCT01689363|592119816|FG003|Overall Study|Protocol Violation|0|||
163931532|NCT01689363|592119817|FG004|Overall Study|Protocol Violation|0|||
163931533|NCT01689363|592119818|FG005|Overall Study|Protocol Violation|0|||
163931534|NCT01689363|592119819|FG006|Overall Study|Protocol Violation|0|||
163931535|NCT01689363|592119820|FG007|Overall Study|Protocol Violation|0|||
163931536|NCT00321685|592119821|FG000|Overall Study|Adverse Event|18|||
163931537|NCT00321685|592119821|FG000|Overall Study|Death|2|||
163931538|NCT00321685|592119821|FG000|Overall Study|Withdrawal by Subject|8|||
163931539|NCT00321685|592119821|FG000|Overall Study|Alternative therapy|1|||
163931540|NCT00321685|592119821|FG000|Overall Study|Complicating disese|1|||
163931541|NCT00321685|592119821|FG000|Overall Study|Other|5|||
163931542|NCT00321685|592119821|FG000|Overall Study|Not start protocol therapy|2|||
163931543|NCT00321685|592119821|FG000|Overall Study|Ineligible|2|||
163931544|NCT05064488|592119825|FG000|Overall Study|Withdrawal by Subject|2|||
163931545|NCT05064488|592119826|FG001|Overall Study|Withdrawal by Subject|0|||
163931546|NCT03023722|592119827|FG000|Overall Study|No follow-up assessment|4|||
163931547|NCT03616964|592119828|FG000|Overall Study|Adverse Event|15|||
163931548|NCT03616964|592119829|FG001|Overall Study|Adverse Event|10|||
163931549|NCT03616964|592119830|FG002|Overall Study|Adverse Event|16|||
163931550|NCT03616964|592119828|FG000|Overall Study|Death|3|||
163931551|NCT03616964|592119829|FG001|Overall Study|Death|0|||
163931552|NCT03616964|592119830|FG002|Overall Study|Death|4|||
163931553|NCT03616964|592119828|FG000|Overall Study|Lack of Efficacy|4|||
163931554|NCT03616964|592119829|FG001|Overall Study|Lack of Efficacy|8|||
163931555|NCT03616964|592119830|FG002|Overall Study|Lack of Efficacy|8|||
163931556|NCT03616964|592119828|FG000|Overall Study|Lost to Follow-up|2|||
163931557|NCT03616964|592119829|FG001|Overall Study|Lost to Follow-up|1|||
163931558|NCT03616964|592119830|FG002|Overall Study|Lost to Follow-up|3|||
163931559|NCT03616964|592119828|FG000|Overall Study|Withdrawal by Subject|18|||
163931560|NCT03616964|592119829|FG001|Overall Study|Withdrawal by Subject|14|||
163931561|NCT03616964|592119830|FG002|Overall Study|Withdrawal by Subject|21|||
163931562|NCT03616964|592119828|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
163931563|NCT03616964|592119829|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
163931564|NCT03616964|592119830|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
163931565|NCT03616964|592119828|FG000|Overall Study|Sponsor's Decision|1|||
164035869|NCT02707601|592490299|FG000|Overall Study|Participants Randomized but Not Treated|2|||
163931566|NCT03616964|592119829|FG001|Overall Study|Sponsor's Decision|0|||
163931567|NCT03616964|592119830|FG002|Overall Study|Sponsor's Decision|0|||
163931568|NCT03616964|592119828|FG000|Overall Study|Physician Decision|0|||
163931569|NCT03616964|592119829|FG001|Overall Study|Physician Decision|2|||
163931570|NCT03616964|592119830|FG002|Overall Study|Physician Decision|0|||
163931571|NCT03616964|592119828|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
163931572|NCT03616964|592119829|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
164035870|NCT02707601|592490300|FG001|Overall Study|Participants Randomized but Not Treated|0|||
163931573|NCT03616964|592119830|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
163931574|NCT03616964|592119828|FG000|Overall Study|Protocol Violation|0|||
163931575|NCT03616964|592119829|FG001|Overall Study|Protocol Violation|1|||
163931576|NCT03616964|592119830|FG002|Overall Study|Protocol Violation|0|||
164035871|NCT03004976|592490306|FG000|Overall Study|Lost to Follow-up|7|||
163931577|NCT03616964|592119828|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
163931578|NCT03616964|592119829|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
163835263|NCT01126060|591767303|FG001|Overall Study|Protocol Violation|2|||
163835264|NCT01874145|591767304|FG000|Core Period|Non-compliance|1|||
163835265|NCT01874145|591767305|FG001|Core Period|Non-compliance|0|||
163835266|NCT01874145|591767304|FG000|Core Period|Protocol Violation|1|||
163835267|NCT01874145|591767305|FG001|Core Period|Protocol Violation|1|||
163835268|NCT01874145|591767304|FG000|Core Period|Physician Decision|1|||
163835269|NCT01874145|591767305|FG001|Core Period|Physician Decision|1|||
163835270|NCT01874145|591767304|FG000|Core Period|Adverse Event|0|||
163835271|NCT01874145|591767305|FG001|Core Period|Adverse Event|1|||
163835272|NCT01874145|591767304|FG000|Core Period|Withdrawal by Subject|0|||
163835273|NCT01874145|591767305|FG001|Core Period|Withdrawal by Subject|4|||
163835274|NCT01874145|591767304|FG000|Extension Period|Adverse Event|3|||
163835275|NCT01874145|591767305|FG001|Extension Period|Adverse Event|2|||
163835276|NCT01874145|591767304|FG000|Extension Period|Withdrawal by Subject|2|||
163835277|NCT01874145|591767305|FG001|Extension Period|Withdrawal by Subject|1|||
163835278|NCT01874145|591767304|FG000|Extension Period|Lost to Follow-up|1|||
163835279|NCT01874145|591767305|FG001|Extension Period|Lost to Follow-up|1|||
163835280|NCT00402337|591767306|FG000|Overall Study|Adverse Event|0|||
163835281|NCT00402337|591767307|FG001|Overall Study|Adverse Event|2|||
163835282|NCT00402337|591767308|FG002|Overall Study|Adverse Event|2|||
163835283|NCT00402337|591767309|FG003|Overall Study|Adverse Event|3|||
163835284|NCT00402337|591767310|FG004|Overall Study|Adverse Event|2|||
163835285|NCT00402337|591767306|FG000|Overall Study|Noncompliance|0|||
163835286|NCT00402337|591767307|FG001|Overall Study|Noncompliance|0|||
163835287|NCT00402337|591767308|FG002|Overall Study|Noncompliance|0|||
163835288|NCT00402337|591767309|FG003|Overall Study|Noncompliance|0|||
163835289|NCT00402337|591767310|FG004|Overall Study|Noncompliance|2|||
163835290|NCT00402337|591767306|FG000|Overall Study|Withdrawal by Subject|5|||
163835291|NCT00402337|591767307|FG001|Overall Study|Withdrawal by Subject|3|||
163835292|NCT00402337|591767308|FG002|Overall Study|Withdrawal by Subject|1|||
163835293|NCT00402337|591767309|FG003|Overall Study|Withdrawal by Subject|6|||
163835294|NCT00402337|591767310|FG004|Overall Study|Withdrawal by Subject|4|||
163835295|NCT00402337|591767306|FG000|Overall Study|Lost to Follow-up|0|||
163835296|NCT00402337|591767307|FG001|Overall Study|Lost to Follow-up|0|||
163835297|NCT00402337|591767308|FG002|Overall Study|Lost to Follow-up|1|||
163835298|NCT00402337|591767309|FG003|Overall Study|Lost to Follow-up|2|||
163835299|NCT00402337|591767310|FG004|Overall Study|Lost to Follow-up|0|||
163835300|NCT00402337|591767306|FG000|Overall Study|Physician Decision|0|||
163835301|NCT00402337|591767307|FG001|Overall Study|Physician Decision|0|||
163835302|NCT00402337|591767308|FG002|Overall Study|Physician Decision|0|||
163835303|NCT00402337|591767309|FG003|Overall Study|Physician Decision|1|||
163835304|NCT00402337|591767310|FG004|Overall Study|Physician Decision|0|||
163835305|NCT00402337|591767306|FG000|Overall Study|Other Reason|0|||
163835306|NCT00402337|591767307|FG001|Overall Study|Other Reason|1|||
163835307|NCT00402337|591767308|FG002|Overall Study|Other Reason|0|||
163835308|NCT00402337|591767309|FG003|Overall Study|Other Reason|0|||
163835309|NCT00402337|591767310|FG004|Overall Study|Other Reason|0|||
163835310|NCT03565068|591767311|FG000|Overall Study|Protocol Violation|0|||
163835311|NCT03565068|591767312|FG001|Overall Study|Protocol Violation|0|||
163835312|NCT03565068|591767313|FG002|Overall Study|Protocol Violation|0|||
163835313|NCT03565068|591767314|FG003|Overall Study|Protocol Violation|0|||
163835314|NCT03565068|591767315|FG004|Overall Study|Protocol Violation|1|||
163835315|NCT03565068|591767316|FG005|Overall Study|Protocol Violation|0|||
163835316|NCT03565068|591767317|FG006|Overall Study|Protocol Violation|0|||
163835317|NCT03565068|591767318|FG007|Overall Study|Protocol Violation|1|||
163835318|NCT03565068|591767319|FG008|Overall Study|Protocol Violation|0|||
163835319|NCT03565068|591767311|FG000|Overall Study|Sponsor decision|0|||
163835320|NCT03565068|591767312|FG001|Overall Study|Sponsor decision|0|||
163835321|NCT03565068|591767313|FG002|Overall Study|Sponsor decision|0|||
163835322|NCT03565068|591767314|FG003|Overall Study|Sponsor decision|0|||
163835323|NCT03565068|591767315|FG004|Overall Study|Sponsor decision|1|||
163835324|NCT03565068|591767316|FG005|Overall Study|Sponsor decision|1|||
163835325|NCT03565068|591767317|FG006|Overall Study|Sponsor decision|0|||
163835326|NCT03565068|591767318|FG007|Overall Study|Sponsor decision|0|||
163835327|NCT03565068|591767319|FG008|Overall Study|Sponsor decision|0|||
163835328|NCT03565068|591767311|FG000|Overall Study|Withdrawal by Subject|0|||
163835329|NCT03565068|591767312|FG001|Overall Study|Withdrawal by Subject|0|||
163835330|NCT03565068|591767313|FG002|Overall Study|Withdrawal by Subject|1|||
163835331|NCT03565068|591767314|FG003|Overall Study|Withdrawal by Subject|0|||
163835332|NCT03565068|591767315|FG004|Overall Study|Withdrawal by Subject|2|||
163835333|NCT03565068|591767316|FG005|Overall Study|Withdrawal by Subject|0|||
163835334|NCT03565068|591767317|FG006|Overall Study|Withdrawal by Subject|1|||
163835335|NCT03565068|591767318|FG007|Overall Study|Withdrawal by Subject|5|||
163835336|NCT03565068|591767319|FG008|Overall Study|Withdrawal by Subject|1|||
163835337|NCT03565068|591767311|FG000|Overall Study|Physician Decision|0|||
163835338|NCT03565068|591767312|FG001|Overall Study|Physician Decision|0|||
163835339|NCT03565068|591767313|FG002|Overall Study|Physician Decision|0|||
163835340|NCT03565068|591767314|FG003|Overall Study|Physician Decision|0|||
163835341|NCT03565068|591767315|FG004|Overall Study|Physician Decision|0|||
163835342|NCT03565068|591767316|FG005|Overall Study|Physician Decision|0|||
164035872|NCT03004976|592490307|FG001|Overall Study|Lost to Follow-up|5|||
163931579|NCT03616964|592119830|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
163931580|NCT03616964|592119828|FG000|Overall Study|Randomized but Never Treated|1|||
163931581|NCT03616964|592119829|FG001|Overall Study|Randomized but Never Treated|1|||
163931582|NCT03616964|592119830|FG002|Overall Study|Randomized but Never Treated|1|||
163931583|NCT04596995|592119831|FG000|Overall Study|Lack of Efficacy|8|||
163931584|NCT04596995|592119831|FG000|Overall Study|Lost to Follow-up|3|||
163931585|NCT04596995|592119831|FG000|Overall Study|Withdrawal by Subject|12|||
163931586|NCT04596995|592119831|FG000|Overall Study|Sponsor decision|3|||
163931587|NCT04596995|592119831|FG000|Overall Study|Enrolled in managed access program|3|||
163931588|NCT02037477|592119834|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
163931589|NCT02037477|592119835|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
163931590|NCT02037477|592119836|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
163931591|NCT02037477|592119837|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
163931592|NCT01245140|592119838|FG000|Overall Study|Adverse Event|1|||
163931593|NCT01245140|592119839|FG001|Overall Study|Adverse Event|3|||
163931594|NCT01245140|592119838|FG000|Overall Study|Lack of Efficacy|2|||
163931595|NCT01245140|592119839|FG001|Overall Study|Lack of Efficacy|4|||
163931596|NCT01245140|592119838|FG000|Overall Study|Protocol Violation|0|||
163931597|NCT01245140|592119839|FG001|Overall Study|Protocol Violation|1|||
163931598|NCT01245140|592119838|FG000|Overall Study|Withdrawal by Subject|0|||
163931599|NCT01245140|592119839|FG001|Overall Study|Withdrawal by Subject|1|||
163931600|NCT01245140|592119838|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
163931601|NCT01245140|592119839|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
163931602|NCT02635360|592119840|FG000|Overall Study|Adverse Event|0|||
163931603|NCT02635360|592119841|FG001|Overall Study|Adverse Event|3|||
163931604|NCT02635360|592119840|FG000|Overall Study|Withdrawal by Subject|2|||
163931605|NCT02635360|592119841|FG001|Overall Study|Withdrawal by Subject|0|||
163931606|NCT02635360|592119840|FG000|Overall Study|Non-Compliance|3|||
163931607|NCT02635360|592119841|FG001|Overall Study|Non-Compliance|1|||
163931608|NCT02635360|592119840|FG000|Overall Study|Disease Progression|0|||
163931609|NCT02635360|592119841|FG001|Overall Study|Disease Progression|2|||
163931610|NCT02635360|592119840|FG000|Overall Study|Lost to Follow-up|1|||
163931611|NCT02635360|592119841|FG001|Overall Study|Lost to Follow-up|1|||
163931612|NCT04082429|592119842|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
163931613|NCT04082429|592119843|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163931614|NCT04082429|592119844|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
163931615|NCT04082429|592119845|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
163931616|NCT04082429|592119846|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
163931617|NCT04082429|592119847|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163931618|NCT04082429|592119848|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163931619|NCT04082429|592119849|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163931620|NCT04082429|592119850|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
163931621|NCT04082429|592119842|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931622|NCT04082429|592119843|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931623|NCT04082429|592119844|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931624|NCT04082429|592119845|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931625|NCT04082429|592119846|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
163931626|NCT04082429|592119847|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931627|NCT04082429|592119848|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931628|NCT04082429|592119849|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931629|NCT04082429|592119850|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
163931630|NCT04082429|592119842|FG000|Main Part (After the Treatment Pause)|Death|0|||
164035873|NCT03004976|592490306|FG000|Overall Study|Physician Decision|1|||
164035874|NCT03004976|592490307|FG001|Overall Study|Physician Decision|0|||
164035875|NCT03004976|592490306|FG000|Overall Study|Withdrawal by Subject|1|||
164035876|NCT03004976|592490307|FG001|Overall Study|Withdrawal by Subject|0|||
164035877|NCT03004976|592490306|FG000|Overall Study|Death|4|||
164035878|NCT03004976|592490307|FG001|Overall Study|Death|1|||
164035879|NCT01665768|592490308|FG000|Overall Study|Adverse Event|3|||
163931631|NCT04082429|592119843|FG001|Main Part (After the Treatment Pause)|Death|0|||
163931632|NCT04082429|592119844|FG002|Main Part (After the Treatment Pause)|Death|0|||
163931633|NCT04082429|592119845|FG003|Main Part (After the Treatment Pause)|Death|0|||
163931634|NCT04082429|592119846|FG004|Main Part (After the Treatment Pause)|Death|1|||
163931635|NCT04082429|592119847|FG005|Main Part (After the Treatment Pause)|Death|0|||
163931636|NCT04082429|592119848|FG006|Main Part (After the Treatment Pause)|Death|0|||
163931637|NCT04082429|592119849|FG007|Main Part (After the Treatment Pause)|Death|0|||
164035880|NCT01665768|592490308|FG000|Overall Study|Lack of Efficacy|19|||
164035881|NCT01665768|592490308|FG000|Overall Study|Withdrawal by Subject|1|||
164035882|NCT01117012|592490311|FG000|Overall Study|Adverse Event|0|||
163931638|NCT04082429|592119850|FG008|Main Part (After the Treatment Pause)|Death|0|||
164035883|NCT01117012|592490312|FG001|Overall Study|Adverse Event|1|||
164035884|NCT01117012|592490311|FG000|Overall Study|Death|1|||
164035885|NCT01117012|592490312|FG001|Overall Study|Death|1|||
164035886|NCT01117012|592490311|FG000|Overall Study|Withdrawal by Subject|3|||
164035887|NCT01117012|592490312|FG001|Overall Study|Withdrawal by Subject|0|||
164035888|NCT01117012|592490311|FG000|Overall Study|Undefined|4|||
164035889|NCT01117012|592490312|FG001|Overall Study|Undefined|3|||
164035890|NCT00493974|592490316|FG000|Overall Study|Death|1|||
164035891|NCT00493974|592490317|FG001|Overall Study|Death|2|||
164035892|NCT00493974|592490316|FG000|Overall Study|Withdrawal by Subject|8|||
164035893|NCT00493974|592490317|FG001|Overall Study|Withdrawal by Subject|6|||
164035894|NCT00493974|592490316|FG000|Overall Study|Lost to Follow-up|4|||
164035895|NCT00493974|592490317|FG001|Overall Study|Lost to Follow-up|6|||
164035896|NCT00326417|592490318|FG000|Overall Study|Withdrawal by Subject|0|||
164035897|NCT00326417|592490319|FG001|Overall Study|Withdrawal by Subject|0|||
164035898|NCT00326417|592490320|FG002|Overall Study|Withdrawal by Subject|1|||
164035899|NCT00326417|592490321|FG003|Overall Study|Withdrawal by Subject|0|||
164035900|NCT00326417|592490318|FG000|Overall Study|Arm Closed|7|||
164035901|NCT00326417|592490319|FG001|Overall Study|Arm Closed|0|||
164035902|NCT00326417|592490320|FG002|Overall Study|Arm Closed|0|||
164035903|NCT00326417|592490321|FG003|Overall Study|Arm Closed|3|||
164035904|NCT00326417|592490318|FG000|Overall Study|Death|7|||
164035905|NCT00326417|592490319|FG001|Overall Study|Death|0|||
164035906|NCT00326417|592490320|FG002|Overall Study|Death|0|||
164035907|NCT00326417|592490321|FG003|Overall Study|Death|0|||
164035908|NCT00844285|592490322|FG000|Overall Study|Other|0|||
164035909|NCT00844285|592490323|FG001|Overall Study|Other|1|||
164035910|NCT00844285|592490324|FG002|Overall Study|Other|0|||
164035911|NCT00844285|592490322|FG000|Overall Study|Other than specified|95|||
164035912|NCT00844285|592490323|FG001|Overall Study|Other than specified|129|||
164035913|NCT00844285|592490324|FG002|Overall Study|Other than specified|12|||
164035914|NCT00844285|592490322|FG000|Overall Study|Site closure|256|||
164035915|NCT00844285|592490323|FG001|Overall Study|Site closure|450|||
164035916|NCT00844285|592490324|FG002|Overall Study|Site closure|50|||
164035917|NCT00844285|592490322|FG000|Overall Study|Follow-up < 8 years|16|||
164035918|NCT00844285|592490323|FG001|Overall Study|Follow-up < 8 years|23|||
164035919|NCT00844285|592490324|FG002|Overall Study|Follow-up < 8 years|4|||
164035920|NCT00844285|592490322|FG000|Overall Study|Protocol Violation|26|||
164035921|NCT00844285|592490323|FG001|Overall Study|Protocol Violation|28|||
164035922|NCT00844285|592490324|FG002|Overall Study|Protocol Violation|54|||
164035923|NCT00844285|592490322|FG000|Overall Study|Death|22|||
164035924|NCT00844285|592490323|FG001|Overall Study|Death|21|||
164098327|NCT05093205|592725092|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
163931639|NCT04082429|592119842|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931640|NCT04082429|592119843|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931641|NCT04082429|592119844|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931642|NCT04082429|592119845|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
163931643|NCT04082429|592119846|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931644|NCT04082429|592119847|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
163931645|NCT04082429|592119848|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931646|NCT04082429|592119849|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931647|NCT04082429|592119850|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
163931648|NCT04082429|592119842|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163931649|NCT04082429|592119843|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163931650|NCT04082429|592119844|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
163931651|NCT04082429|592119845|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
163931652|NCT04082429|592119846|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163931653|NCT04082429|592119847|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163931654|NCT04082429|592119848|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
163931655|NCT04082429|592119849|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
163931656|NCT04082429|592119850|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
164035925|NCT00844285|592490324|FG002|Overall Study|Death|8|||
164035926|NCT00844285|592490322|FG000|Overall Study|Withdrew Consent|344|||
164035927|NCT00844285|592490323|FG001|Overall Study|Withdrew Consent|466|||
164035928|NCT00844285|592490324|FG002|Overall Study|Withdrew Consent|70|||
164035929|NCT00844285|592490322|FG000|Overall Study|Lost to Follow-up|330|||
164035930|NCT00844285|592490323|FG001|Overall Study|Lost to Follow-up|486|||
164035931|NCT00844285|592490324|FG002|Overall Study|Lost to Follow-up|74|||
164035932|NCT04682353|592490329|FG000|Overall Study|Lost to Follow-up|0|||
164035933|NCT04682353|592490330|FG001|Overall Study|Lost to Follow-up|1|||
164035934|NCT04682353|592490331|FG002|Overall Study|Lost to Follow-up|0|||
164035935|NCT04682353|592490332|FG003|Overall Study|Lost to Follow-up|1|||
164035936|NCT04682353|592490329|FG000|Overall Study|Personal reasons|0|||
164035937|NCT04682353|592490330|FG001|Overall Study|Personal reasons|1|||
164035938|NCT04682353|592490331|FG002|Overall Study|Personal reasons|0|||
164035939|NCT04682353|592490332|FG003|Overall Study|Personal reasons|0|||
164035940|NCT01586806|592490333|FG000|Overall Study|Protocol Violation|0|||
164035941|NCT01586806|592490334|FG001|Overall Study|Protocol Violation|1|||
164035942|NCT01586806|592490335|FG002|Overall Study|Protocol Violation|0|||
164035943|NCT01586806|592490333|FG000|Overall Study|Withdrawal by Subject|1|||
164035944|NCT01586806|592490334|FG001|Overall Study|Withdrawal by Subject|0|||
164035945|NCT01586806|592490335|FG002|Overall Study|Withdrawal by Subject|0|||
164035946|NCT01586806|592490333|FG000|Overall Study|Lost to Follow-up|2|||
164035947|NCT01586806|592490334|FG001|Overall Study|Lost to Follow-up|3|||
164035948|NCT01586806|592490335|FG002|Overall Study|Lost to Follow-up|2|||
164035949|NCT00555906|592490336|FG000|Phase 1|Objective Progression or Relapse|3|||
164035950|NCT00555906|592490337|FG001|Phase 1|Objective Progression or Relapse|5|||
163835343|NCT03565068|591767317|FG006|Overall Study|Physician Decision|0|||
163835344|NCT03565068|591767318|FG007|Overall Study|Physician Decision|1|||
163835345|NCT03565068|591767319|FG008|Overall Study|Physician Decision|0|||
163835346|NCT03565068|591767311|FG000|Overall Study|Lost to Follow-up|0|||
163835347|NCT03565068|591767312|FG001|Overall Study|Lost to Follow-up|0|||
163835348|NCT03565068|591767313|FG002|Overall Study|Lost to Follow-up|0|||
163835349|NCT03565068|591767314|FG003|Overall Study|Lost to Follow-up|0|||
163835350|NCT03565068|591767315|FG004|Overall Study|Lost to Follow-up|0|||
163835351|NCT03565068|591767316|FG005|Overall Study|Lost to Follow-up|0|||
163835352|NCT03565068|591767317|FG006|Overall Study|Lost to Follow-up|0|||
163835353|NCT03565068|591767318|FG007|Overall Study|Lost to Follow-up|1|||
163835354|NCT03565068|591767319|FG008|Overall Study|Lost to Follow-up|0|||
163835355|NCT00767104|591769591|FG000|Overall Study|Lost to Follow-up|1|||
163835356|NCT00767104|591769592|FG001|Overall Study|Lost to Follow-up|2|||
163835357|NCT00840996|591769593|FG000|Overall Study|Withdrawal by Subject|1|||
163835358|NCT00840996|591769594|FG001|Overall Study|Withdrawal by Subject|0|||
163835359|NCT02200939|591769602|FG000|Overall Study|Participant withdrew consent|0|||
163835360|NCT02200939|591769603|FG001|Overall Study|Participant withdrew consent|1|||
163835361|NCT02200939|591769602|FG000|Overall Study|Lost to Follow-up|2|||
163835362|NCT02200939|591769603|FG001|Overall Study|Lost to Follow-up|9|||
163835363|NCT02200939|591769602|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
163835364|NCT02200939|591769603|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
163835365|NCT04567693|591769604|FG000|Overall Study|Death|0|||
163835366|NCT04567693|591769605|FG001|Overall Study|Death|0|||
163835367|NCT04567693|591769606|FG002|Overall Study|Death|2|||
163835368|NCT04567693|591769604|FG000|Overall Study|Lost to Follow-up|1|||
163835369|NCT04567693|591769605|FG001|Overall Study|Lost to Follow-up|0|||
163835370|NCT04567693|591769606|FG002|Overall Study|Lost to Follow-up|2|||
163835371|NCT04567693|591769604|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
163835372|NCT04567693|591769605|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
163835373|NCT04567693|591769606|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
163835374|NCT03722264|591769612|FG000|Overall Study|Physician Decision|3|||
163835375|NCT00957931|591769613|FG000|Overall Study|Death|4|||
163835376|NCT01486758|591769614|FG000|Overall Study|Lost to Follow-up|0|||
163835377|NCT01486758|591769615|FG001|Overall Study|Lost to Follow-up|1|||
163835378|NCT02392611|591769622|FG000|Overall Study|Adverse Event|0|||
163835379|NCT02392611|591769623|FG001|Overall Study|Adverse Event|0|||
163835380|NCT02392611|591769624|FG002|Overall Study|Adverse Event|0|||
163835381|NCT02392611|591769625|FG003|Overall Study|Adverse Event|1|||
163835382|NCT02392611|591769626|FG004|Overall Study|Adverse Event|0|||
163835383|NCT02392611|591769627|FG005|Overall Study|Adverse Event|0|||
163835384|NCT02392611|591769628|FG006|Overall Study|Adverse Event|0|||
163835385|NCT02392611|591769629|FG007|Overall Study|Adverse Event|0|||
163835386|NCT02392611|591769630|FG008|Overall Study|Adverse Event|0|||
163835387|NCT02392611|591769622|FG000|Overall Study|Progressive disease|0|||
163835388|NCT02392611|591769623|FG001|Overall Study|Progressive disease|0|||
163835389|NCT02392611|591769624|FG002|Overall Study|Progressive disease|0|||
163835390|NCT02392611|591769625|FG003|Overall Study|Progressive disease|2|||
163835391|NCT02392611|591769626|FG004|Overall Study|Progressive disease|1|||
163835392|NCT02392611|591769627|FG005|Overall Study|Progressive disease|0|||
163835393|NCT02392611|591769628|FG006|Overall Study|Progressive disease|0|||
163835394|NCT02392611|591769629|FG007|Overall Study|Progressive disease|0|||
163835395|NCT02392611|591769630|FG008|Overall Study|Progressive disease|0|||
163835396|NCT02392611|591769622|FG000|Overall Study|Death|1|||
163835397|NCT02392611|591769623|FG001|Overall Study|Death|0|||
163835398|NCT02392611|591769624|FG002|Overall Study|Death|0|||
163835399|NCT02392611|591769625|FG003|Overall Study|Death|0|||
163835400|NCT02392611|591769626|FG004|Overall Study|Death|0|||
163835401|NCT02392611|591769627|FG005|Overall Study|Death|1|||
163835402|NCT02392611|591769628|FG006|Overall Study|Death|0|||
163835403|NCT02392611|591769629|FG007|Overall Study|Death|0|||
163835404|NCT02392611|591769630|FG008|Overall Study|Death|0|||
163835405|NCT02392611|591769622|FG000|Overall Study|Withdrawal by Subject|0|||
163835406|NCT02392611|591769623|FG001|Overall Study|Withdrawal by Subject|0|||
163835407|NCT02392611|591769624|FG002|Overall Study|Withdrawal by Subject|0|||
163835408|NCT02392611|591769625|FG003|Overall Study|Withdrawal by Subject|1|||
163835409|NCT02392611|591769626|FG004|Overall Study|Withdrawal by Subject|0|||
163835410|NCT02392611|591769627|FG005|Overall Study|Withdrawal by Subject|0|||
163835411|NCT02392611|591769628|FG006|Overall Study|Withdrawal by Subject|0|||
163835412|NCT02392611|591769629|FG007|Overall Study|Withdrawal by Subject|0|||
163835413|NCT02392611|591769630|FG008|Overall Study|Withdrawal by Subject|0|||
163835414|NCT02392611|591769622|FG000|Overall Study|Lost to Follow-up|0|||
163835415|NCT02392611|591769623|FG001|Overall Study|Lost to Follow-up|0|||
163835416|NCT02392611|591769624|FG002|Overall Study|Lost to Follow-up|0|||
163835417|NCT02392611|591769625|FG003|Overall Study|Lost to Follow-up|0|||
163835418|NCT02392611|591769626|FG004|Overall Study|Lost to Follow-up|0|||
163835419|NCT02392611|591769627|FG005|Overall Study|Lost to Follow-up|0|||
163835420|NCT02392611|591769628|FG006|Overall Study|Lost to Follow-up|1|||
163835421|NCT02392611|591769629|FG007|Overall Study|Lost to Follow-up|0|||
163835422|NCT02392611|591769630|FG008|Overall Study|Lost to Follow-up|0|||
163835423|NCT02392611|591769622|FG000|Overall Study|Enrolled, not treated|0|||
163835424|NCT02392611|591769623|FG001|Overall Study|Enrolled, not treated|0|||
163835425|NCT02392611|591769624|FG002|Overall Study|Enrolled, not treated|0|||
163835426|NCT02392611|591769625|FG003|Overall Study|Enrolled, not treated|2|||
163835427|NCT02392611|591769626|FG004|Overall Study|Enrolled, not treated|0|||
163835428|NCT02392611|591769627|FG005|Overall Study|Enrolled, not treated|0|||
163835429|NCT02392611|591769628|FG006|Overall Study|Enrolled, not treated|0|||
163835430|NCT02392611|591769629|FG007|Overall Study|Enrolled, not treated|0|||
163835431|NCT02392611|591769630|FG008|Overall Study|Enrolled, not treated|0|||
163835432|NCT00553202|591769637|FG000|Overall Study|Death|16|||
163835433|NCT00553202|591769637|FG000|Overall Study|Lost to Follow-up|1|||
163835434|NCT00553202|591769637|FG000|Overall Study|Physician Decision|28|||
163835435|NCT00553202|591769637|FG000|Overall Study|Withdrawal by Subject|1|||
163835436|NCT00553202|591769637|FG000|Overall Study|No donor identified|16|||
163835437|NCT00553202|591769637|FG000|Overall Study|Fails to meet organ function|6|||
163835438|NCT03239873|591769638|FG000|Overall Study|Lost to Follow-up|15|||
163835439|NCT03239873|591769639|FG001|Overall Study|Lost to Follow-up|16|||
163835440|NCT03239873|591769638|FG000|Overall Study|Physician Decision|1|||
163835441|NCT03239873|591769639|FG001|Overall Study|Physician Decision|0|||
163835442|NCT03239873|591769638|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
163835443|NCT03239873|591769639|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
163835444|NCT03239873|591769638|FG000|Overall Study|Withdrawal by Subject|2|||
163835445|NCT03239873|591769639|FG001|Overall Study|Withdrawal by Subject|0|||
163835446|NCT03239873|591769638|FG000|Overall Study|Contraindication to study medication|1|||
163835447|NCT03239873|591769639|FG001|Overall Study|Contraindication to study medication|0|||
163835448|NCT03239873|591769638|FG000|Overall Study|Protocol Violation|1|||
163835449|NCT03239873|591769639|FG001|Overall Study|Protocol Violation|0|||
163835450|NCT02045433|591769646|FG000|Overall Study|Withdrawal by Subject|1|||
163835451|NCT03585296|591769647|FG000|Overall Study|Adverse Event|1|||
163835452|NCT03585296|591769647|FG000|Overall Study|Lost to Follow-up|2|||
163931657|NCT04082429|592119842|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
163931658|NCT04082429|592119843|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931659|NCT04082429|592119844|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931660|NCT04082429|592119845|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931661|NCT04082429|592119846|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931662|NCT04082429|592119847|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
163931663|NCT04082429|592119848|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931664|NCT04082429|592119849|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931665|NCT04082429|592119850|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
163931666|NCT04082429|592119842|FG000|Extension Part|Ongoing|0|||
163931667|NCT04082429|592119843|FG001|Extension Part|Ongoing|7|||
163931668|NCT04082429|592119844|FG002|Extension Part|Ongoing|17|||
163931669|NCT04082429|592119845|FG003|Extension Part|Ongoing|6|||
163931670|NCT04082429|592119846|FG004|Extension Part|Ongoing|45|||
163931671|NCT04082429|592119847|FG005|Extension Part|Ongoing|0|||
163931672|NCT04082429|592119848|FG006|Extension Part|Ongoing|10|||
163931673|NCT04082429|592119849|FG007|Extension Part|Ongoing|23|||
163931674|NCT04082429|592119850|FG008|Extension Part|Ongoing|25|||
163931675|NCT00334542|592119851|FG000|Overall Study|Adverse Event|3|||
163931676|NCT00334542|592119851|FG000|Overall Study|Withdrawal by Subject|1|||
163931677|NCT00334542|592119851|FG000|Overall Study|New cancer diagnosis|1|||
163931678|NCT03118050|592119852|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
163931679|NCT03118050|592119853|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
163931680|NCT03118050|592119854|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
163931681|NCT03118050|592119855|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
163931682|NCT03118050|592119856|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
163931683|NCT03118050|592119857|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
163931684|NCT03118050|592119858|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
163931685|NCT01454739|592119860|FG000|Overall Study|Protocol Violation|2|||
163931686|NCT01454739|592119861|FG001|Overall Study|Protocol Violation|3|||
163931687|NCT01454739|592119860|FG000|Overall Study|Withdrawal by Subject|2|||
164035951|NCT00555906|592490338|FG002|Phase 1|Objective Progression or Relapse|3|||
164035952|NCT00555906|592490339|FG003|Phase 1|Objective Progression or Relapse|1|||
164035953|NCT00555906|592490340|FG004|Phase 1|Objective Progression or Relapse|0|||
164035954|NCT00555906|592490336|FG000|Phase 1|Global Deterioration of Health Status|0|||
164035955|NCT00555906|592490337|FG001|Phase 1|Global Deterioration of Health Status|1|||
163835453|NCT03585296|591769647|FG000|Overall Study|Withdrawal by Subject|2|||
163835454|NCT00041756|591769648|FG000|Overall Study|Adverse Event|4|||
163835455|NCT00041756|591769649|FG001|Overall Study|Adverse Event|10|||
163835456|NCT00041756|591769650|FG002|Overall Study|Adverse Event|6|||
163835457|NCT00041756|591769651|FG003|Overall Study|Adverse Event|11|||
163835458|NCT00041756|591769652|FG004|Overall Study|Adverse Event|34|||
163835459|NCT00041756|591769648|FG000|Overall Study|Protocol Violation|1|||
163835460|NCT00041756|591769649|FG001|Overall Study|Protocol Violation|1|||
163835461|NCT00041756|591769650|FG002|Overall Study|Protocol Violation|2|||
163835462|NCT00041756|591769651|FG003|Overall Study|Protocol Violation|2|||
163835463|NCT00041756|591769652|FG004|Overall Study|Protocol Violation|1|||
163835464|NCT00041756|591769648|FG000|Overall Study|Withdrawal by Subject|3|||
163835465|NCT00041756|591769649|FG001|Overall Study|Withdrawal by Subject|3|||
163835466|NCT00041756|591769650|FG002|Overall Study|Withdrawal by Subject|4|||
163835467|NCT00041756|591769651|FG003|Overall Study|Withdrawal by Subject|2|||
163835468|NCT00041756|591769652|FG004|Overall Study|Withdrawal by Subject|3|||
163835469|NCT00041756|591769648|FG000|Overall Study|Lost to Follow-up|0|||
163835470|NCT00041756|591769649|FG001|Overall Study|Lost to Follow-up|1|||
163835471|NCT00041756|591769650|FG002|Overall Study|Lost to Follow-up|0|||
163835472|NCT00041756|591769651|FG003|Overall Study|Lost to Follow-up|1|||
163835473|NCT00041756|591769652|FG004|Overall Study|Lost to Follow-up|0|||
163835474|NCT00041756|591769648|FG000|Overall Study|Unable to meet protocol criteria|0|||
163835475|NCT00041756|591769649|FG001|Overall Study|Unable to meet protocol criteria|0|||
163835476|NCT00041756|591769650|FG002|Overall Study|Unable to meet protocol criteria|1|||
163835477|NCT00041756|591769651|FG003|Overall Study|Unable to meet protocol criteria|0|||
163835478|NCT00041756|591769652|FG004|Overall Study|Unable to meet protocol criteria|1|||
163835479|NCT00041756|591769648|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
163835480|NCT00041756|591769649|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
163835481|NCT00041756|591769650|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
163835482|NCT00041756|591769651|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
163835483|NCT00041756|591769652|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
163835484|NCT02002884|591769655|FG000|Main Period (MP)|Other|0|||
163835485|NCT02002884|591769656|FG001|Main Period (MP)|Other|3|||
163835486|NCT02002884|591769657|FG002|Main Period (MP)|Other|3|||
163835487|NCT02002884|591769658|FG003|Main Period (MP)|Other|0|||
163835488|NCT02002884|591769655|FG000|Main Period (MP)|Adverse Event|0|||
163835489|NCT02002884|591769656|FG001|Main Period (MP)|Adverse Event|1|||
163835490|NCT02002884|591769657|FG002|Main Period (MP)|Adverse Event|1|||
163835491|NCT02002884|591769658|FG003|Main Period (MP)|Adverse Event|0|||
163835492|NCT02002884|591769655|FG000|Main Period (MP)|Withdrawal by Subject|6|||
163835493|NCT02002884|591769656|FG001|Main Period (MP)|Withdrawal by Subject|2|||
163835494|NCT02002884|591769657|FG002|Main Period (MP)|Withdrawal by Subject|2|||
163835495|NCT02002884|591769658|FG003|Main Period (MP)|Withdrawal by Subject|0|||
163835496|NCT02002884|591769655|FG000|Main Period (MP)|Lost to Follow-up|0|||
163835497|NCT02002884|591769656|FG001|Main Period (MP)|Lost to Follow-up|0|||
163835498|NCT02002884|591769657|FG002|Main Period (MP)|Lost to Follow-up|2|||
163835499|NCT02002884|591769658|FG003|Main Period (MP)|Lost to Follow-up|0|||
163835500|NCT02002884|591769655|FG000|Open-Label Extension Period (OLEX)|Other|0|||
163835501|NCT02002884|591769656|FG001|Open-Label Extension Period (OLEX)|Other|0|||
163835502|NCT02002884|591769657|FG002|Open-Label Extension Period (OLEX)|Other|0|||
163835503|NCT02002884|591769658|FG003|Open-Label Extension Period (OLEX)|Other|24|||
163835504|NCT02002884|591769655|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
163835505|NCT02002884|591769656|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
163835506|NCT02002884|591769657|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
163835507|NCT02002884|591769658|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
163835508|NCT02002884|591769655|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
163835509|NCT02002884|591769656|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
163835510|NCT02002884|591769657|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
163835511|NCT02002884|591769658|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
163835512|NCT02002884|591769655|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
163835513|NCT02002884|591769656|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
163835514|NCT02002884|591769657|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
163835515|NCT02002884|591769658|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
163835516|NCT02002884|591769655|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
163835517|NCT02002884|591769656|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
163835518|NCT02002884|591769657|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
163835519|NCT02002884|591769658|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
163835520|NCT02110732|591769659|FG000|Overall Study|Physician Decision|5|||
163835521|NCT02110732|591769660|FG001|Overall Study|Physician Decision|2|||
163931688|NCT01454739|592119861|FG001|Overall Study|Withdrawal by Subject|6|||
163931689|NCT01454739|592119860|FG000|Overall Study|Other|3|||
163931690|NCT01454739|592119861|FG001|Overall Study|Other|5|||
164098328|NCT05093205|592725093|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
164098329|NCT05093205|592725094|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
163931691|NCT01454739|592119860|FG000|Overall Study|Physician Decision|0|||
163931692|NCT01454739|592119861|FG001|Overall Study|Physician Decision|5|||
163931693|NCT01454739|592119860|FG000|Overall Study|Lost to Follow-up|0|||
163931694|NCT01454739|592119861|FG001|Overall Study|Lost to Follow-up|1|||
163931695|NCT01454739|592119860|FG000|Overall Study|Adverse Event|0|||
163931696|NCT01454739|592119861|FG001|Overall Study|Adverse Event|1|||
163835522|NCT02110732|591769659|FG000|Overall Study|Lost to Follow-up|1|||
163835523|NCT02110732|591769660|FG001|Overall Study|Lost to Follow-up|1|||
163835524|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
163835525|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
164098330|NCT05093205|592725095|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
164098331|NCT05093205|592725083|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
164098332|NCT05093205|592725084|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
163835526|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Adverse Event|2|||
163835527|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Adverse Event|5|||
163835528|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
163835529|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
163835530|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
163835531|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
163835532|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Randomized by error|0|||
163835533|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Randomized by error|5|||
163835534|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
163835535|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
163835536|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
163835537|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
163835538|NCT02948959|591769661|FG000|52 Weeks Treatment Period|Change of residence location|0|||
163835539|NCT02948959|591769662|FG001|52 Weeks Treatment Period|Change of residence location|1|||
163835540|NCT02948959|591769661|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
163835541|NCT02948959|591769662|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
163835542|NCT02948959|591769661|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
163835543|NCT02948959|591769662|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
163835544|NCT02948959|591769661|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
163835545|NCT02948959|591769662|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
163835546|NCT02948959|591769661|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
163835547|NCT02948959|591769662|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
163835548|NCT02948959|591769661|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
163835549|NCT02948959|591769662|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
163835550|NCT02948959|591769661|FG000|12 Weeks Follow-up Period|Study site closure|1|||
163835551|NCT02948959|591769662|FG001|12 Weeks Follow-up Period|Study site closure|0|||
163835552|NCT01800201|591769666|FG000|Overall Study|Withdrawal by Subject|2|||
163835553|NCT01800201|591769667|FG001|Overall Study|Withdrawal by Subject|0|||
163835554|NCT01800201|591769666|FG000|Overall Study|patient privacy concerns|1|||
163835555|NCT01800201|591769667|FG001|Overall Study|patient privacy concerns|1|||
163835556|NCT01800201|591769666|FG000|Overall Study|did not want to use device|0|||
163835557|NCT01800201|591769667|FG001|Overall Study|did not want to use device|1|||
163835558|NCT01800201|591769666|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
163835559|NCT01800201|591769667|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
163835560|NCT01480596|591769668|FG000|Overall Study|Adverse Event|3|||
163835561|NCT01480596|591769669|FG001|Overall Study|Adverse Event|0|||
163835562|NCT01480596|591769668|FG000|Overall Study|MG exacerbation or change in medication|2|||
163835563|NCT01480596|591769669|FG001|Overall Study|MG exacerbation or change in medication|2|||
163835564|NCT03812536|591769673|FG000|Overall Study|Protocol Violation|2|||
163835565|NCT03812536|591769674|FG001|Overall Study|Protocol Violation|0|||
163835566|NCT03812536|591769673|FG000|Overall Study|Withdrawal by Subject|1|||
163835567|NCT03812536|591769674|FG001|Overall Study|Withdrawal by Subject|1|||
163835568|NCT00152009|591769675|FG000|Overall Study|Adverse Event|9|||
163835569|NCT00152009|591769676|FG001|Overall Study|Adverse Event|13|||
163835570|NCT00152009|591769677|FG002|Overall Study|Adverse Event|20|||
163835571|NCT00152009|591769678|FG003|Overall Study|Adverse Event|1|||
163835572|NCT00152009|591769675|FG000|Overall Study|Protocol Violation|3|||
163835573|NCT00152009|591769676|FG001|Overall Study|Protocol Violation|0|||
163835574|NCT00152009|591769677|FG002|Overall Study|Protocol Violation|0|||
163931697|NCT01952847|592119862|FG000|Overall Study|Ineligible|1|||
163835575|NCT00152009|591769678|FG003|Overall Study|Protocol Violation|1|||
163835576|NCT00152009|591769675|FG000|Overall Study|Withdrawal by Subject|2|||
163835577|NCT00152009|591769676|FG001|Overall Study|Withdrawal by Subject|3|||
163835578|NCT00152009|591769677|FG002|Overall Study|Withdrawal by Subject|4|||
163835579|NCT00152009|591769678|FG003|Overall Study|Withdrawal by Subject|9|||
164035956|NCT00555906|592490338|FG002|Phase 1|Global Deterioration of Health Status|1|||
164035957|NCT00555906|592490339|FG003|Phase 1|Global Deterioration of Health Status|1|||
163835580|NCT00152009|591769675|FG000|Overall Study|Lost to Follow-up|2|||
163835581|NCT00152009|591769676|FG001|Overall Study|Lost to Follow-up|4|||
163835582|NCT00152009|591769677|FG002|Overall Study|Lost to Follow-up|3|||
163835583|NCT00152009|591769678|FG003|Overall Study|Lost to Follow-up|3|||
163835584|NCT00152009|591769675|FG000|Overall Study|Lack of Efficacy|8|||
163835585|NCT00152009|591769676|FG001|Overall Study|Lack of Efficacy|6|||
163835586|NCT00152009|591769677|FG002|Overall Study|Lack of Efficacy|7|||
163835587|NCT00152009|591769678|FG003|Overall Study|Lack of Efficacy|15|||
163835588|NCT00152009|591769675|FG000|Overall Study|ECG abnormalities|2|||
163835589|NCT00152009|591769676|FG001|Overall Study|ECG abnormalities|2|||
163835590|NCT00152009|591769677|FG002|Overall Study|ECG abnormalities|2|||
163835591|NCT00152009|591769678|FG003|Overall Study|ECG abnormalities|1|||
163835592|NCT00152009|591769675|FG000|Overall Study|Sponsor's decision|3|||
163835593|NCT00152009|591769676|FG001|Overall Study|Sponsor's decision|3|||
163835594|NCT00152009|591769677|FG002|Overall Study|Sponsor's decision|1|||
163835595|NCT00152009|591769678|FG003|Overall Study|Sponsor's decision|3|||
163835596|NCT01306201|591769679|FG000|Overall Study|Arrhythmia|4|||
163835597|NCT01306201|591769679|FG000|Overall Study|Files could not be processed|3|||
163835598|NCT01306201|591769679|FG000|Overall Study|Files unreadable|3|||
163835599|NCT00980005|591769682|FG000|Overall Study|Withdrawal by Subject|6|||
163835600|NCT00980005|591769683|FG001|Overall Study|Withdrawal by Subject|17|||
163835601|NCT00980005|591769682|FG000|Overall Study|Lost to Follow-up|37|||
163835602|NCT00980005|591769683|FG001|Overall Study|Lost to Follow-up|43|||
163835603|NCT00980005|591769682|FG000|Overall Study|Other|4|||
163835604|NCT00980005|591769683|FG001|Overall Study|Other|3|||
163835605|NCT00572624|591769684|FG000|Overall Study|Lost to Follow-up|10|||
163835606|NCT00572624|591769685|FG001|Overall Study|Lost to Follow-up|4|||
163835607|NCT00572624|591769684|FG000|Overall Study|Wanted to do a different diet program|1|||
163835608|NCT00572624|591769685|FG001|Overall Study|Wanted to do a different diet program|0|||
163835609|NCT00572624|591769684|FG000|Overall Study|Medication change|1|||
163835610|NCT00572624|591769685|FG001|Overall Study|Medication change|0|||
163835611|NCT00572624|591769684|FG000|Overall Study|Started a new job-- no time for study|1|||
163835612|NCT00572624|591769685|FG001|Overall Study|Started a new job-- no time for study|0|||
163835613|NCT00572624|591769684|FG000|Overall Study|Admitted to being a smoker|1|||
163835614|NCT00572624|591769685|FG001|Overall Study|Admitted to being a smoker|0|||
163835615|NCT00572624|591769684|FG000|Overall Study|Refused to do the stress test|1|||
163835616|NCT00572624|591769685|FG001|Overall Study|Refused to do the stress test|0|||
163835617|NCT00572624|591769684|FG000|Overall Study|Problem with vascular access|1|||
163835618|NCT00572624|591769685|FG001|Overall Study|Problem with vascular access|0|||
163835619|NCT00572624|591769684|FG000|Overall Study|Health issues unrelated to the study|1|||
163835620|NCT00572624|591769685|FG001|Overall Study|Health issues unrelated to the study|0|||
163835621|NCT05400746|591769690|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
163835622|NCT05400746|591769691|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
163835623|NCT05400746|591769692|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
163835624|NCT05375955|591769693|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
163835625|NCT05375955|591769694|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
163835626|NCT05375955|591769695|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
163835627|NCT05375955|591769696|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
163835628|NCT05375955|591769697|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
163835629|NCT05375955|591769698|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
163835630|NCT05375955|591769699|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
163835631|NCT05375955|591769693|FG000|Treatment (12 Weeks)|Physician Decision|4|||
163835632|NCT05375955|591769694|FG001|Treatment (12 Weeks)|Physician Decision|1|||
163835633|NCT05375955|591769695|FG002|Treatment (12 Weeks)|Physician Decision|3|||
163835634|NCT05375955|591769696|FG003|Treatment (12 Weeks)|Physician Decision|0|||
163835635|NCT05375955|591769697|FG004|Treatment (12 Weeks)|Physician Decision|0|||
163835636|NCT05375955|591769698|FG005|Treatment (12 Weeks)|Physician Decision|1|||
163835637|NCT05375955|591769699|FG006|Treatment (12 Weeks)|Physician Decision|0|||
163835638|NCT05375955|591769693|FG000|Treatment (12 Weeks)|Other|0|||
163835639|NCT05375955|591769694|FG001|Treatment (12 Weeks)|Other|1|||
163835640|NCT05375955|591769695|FG002|Treatment (12 Weeks)|Other|0|||
163835641|NCT05375955|591769696|FG003|Treatment (12 Weeks)|Other|0|||
163835642|NCT05375955|591769697|FG004|Treatment (12 Weeks)|Other|0|||
163835643|NCT05375955|591769698|FG005|Treatment (12 Weeks)|Other|0|||
163835644|NCT05375955|591769699|FG006|Treatment (12 Weeks)|Other|0|||
163835645|NCT05375955|591769693|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163835646|NCT05375955|591769694|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163835647|NCT05375955|591769695|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163835648|NCT05375955|591769696|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163835649|NCT05375955|591769697|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163835650|NCT05375955|591769698|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
163835651|NCT05375955|591769699|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
164035958|NCT00555906|592490340|FG004|Phase 1|Global Deterioration of Health Status|0|||
164035959|NCT00555906|592490336|FG000|Phase 1|Adverse Event|0|||
164035960|NCT00555906|592490337|FG001|Phase 1|Adverse Event|0|||
164035961|NCT00555906|592490338|FG002|Phase 1|Adverse Event|3|||
164035962|NCT00555906|592490339|FG003|Phase 1|Adverse Event|2|||
164035963|NCT00555906|592490340|FG004|Phase 1|Adverse Event|0|||
164035964|NCT00555906|592490336|FG000|Phase 1|Withdrawal by Subject|0|||
164035965|NCT00555906|592490337|FG001|Phase 1|Withdrawal by Subject|0|||
164035966|NCT00555906|592490338|FG002|Phase 1|Withdrawal by Subject|0|||
164035967|NCT00555906|592490339|FG003|Phase 1|Withdrawal by Subject|1|||
164035968|NCT00555906|592490340|FG004|Phase 1|Withdrawal by Subject|0|||
164035969|NCT00555906|592490336|FG000|Phase 2|Adverse Event|0|||
164035970|NCT00555906|592490337|FG001|Phase 2|Adverse Event|0|||
164035971|NCT00555906|592490338|FG002|Phase 2|Adverse Event|0|||
164035972|NCT00555906|592490339|FG003|Phase 2|Adverse Event|0|||
164035973|NCT00555906|592490340|FG004|Phase 2|Adverse Event|4|||
164035974|NCT00555906|592490336|FG000|Phase 2|Global Deterioration of Health Status|0|||
164035975|NCT00555906|592490337|FG001|Phase 2|Global Deterioration of Health Status|0|||
164035976|NCT00555906|592490338|FG002|Phase 2|Global Deterioration of Health Status|0|||
164035977|NCT00555906|592490339|FG003|Phase 2|Global Deterioration of Health Status|0|||
164035978|NCT00555906|592490340|FG004|Phase 2|Global Deterioration of Health Status|2|||
164035979|NCT00555906|592490336|FG000|Phase 2|Objective Progression or Relapse|0|||
164035980|NCT00555906|592490337|FG001|Phase 2|Objective Progression or Relapse|0|||
164035981|NCT00555906|592490338|FG002|Phase 2|Objective Progression or Relapse|0|||
164035982|NCT00555906|592490339|FG003|Phase 2|Objective Progression or Relapse|0|||
164035983|NCT00555906|592490340|FG004|Phase 2|Objective Progression or Relapse|16|||
164035984|NCT00555906|592490336|FG000|Phase 2|Withdrawal by Subject|0|||
164035985|NCT00555906|592490337|FG001|Phase 2|Withdrawal by Subject|0|||
163835652|NCT05375955|591769693|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
163835653|NCT05375955|591769694|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
163835654|NCT05375955|591769695|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
163835655|NCT05375955|591769696|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
163835656|NCT05375955|591769697|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
163835657|NCT05375955|591769698|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
163835658|NCT05375955|591769699|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
163835659|NCT05375955|591769693|FG000|Treatment (12 Weeks)|Pregnancy|0|||
163835660|NCT05375955|591769694|FG001|Treatment (12 Weeks)|Pregnancy|0|||
163835661|NCT05375955|591769695|FG002|Treatment (12 Weeks)|Pregnancy|1|||
163835662|NCT05375955|591769696|FG003|Treatment (12 Weeks)|Pregnancy|0|||
163835663|NCT05375955|591769697|FG004|Treatment (12 Weeks)|Pregnancy|0|||
163835664|NCT05375955|591769698|FG005|Treatment (12 Weeks)|Pregnancy|0|||
163835665|NCT05375955|591769699|FG006|Treatment (12 Weeks)|Pregnancy|0|||
163835666|NCT05375955|591769693|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163835667|NCT05375955|591769694|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163835668|NCT05375955|591769695|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
163835669|NCT05375955|591769696|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163835670|NCT05375955|591769697|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163835671|NCT05375955|591769698|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163835672|NCT05375955|591769699|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
163835673|NCT05375955|591769693|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
163835674|NCT05375955|591769694|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163835675|NCT05375955|591769695|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
163835676|NCT05375955|591769696|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163835677|NCT05375955|591769697|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163835678|NCT05375955|591769698|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
163835679|NCT05375955|591769699|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
163835680|NCT05375955|591769693|FG000|Follow-up (up to 5 Weeks)|Other|0|||
163835681|NCT05375955|591769694|FG001|Follow-up (up to 5 Weeks)|Other|1|||
163835682|NCT05375955|591769695|FG002|Follow-up (up to 5 Weeks)|Other|0|||
163835683|NCT05375955|591769696|FG003|Follow-up (up to 5 Weeks)|Other|0|||
163835684|NCT05375955|591769697|FG004|Follow-up (up to 5 Weeks)|Other|0|||
163835685|NCT05375955|591769698|FG005|Follow-up (up to 5 Weeks)|Other|0|||
163835686|NCT05375955|591769699|FG006|Follow-up (up to 5 Weeks)|Other|0|||
163835687|NCT05375955|591769693|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
163835688|NCT05375955|591769694|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163835689|NCT05375955|591769695|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
163835690|NCT05375955|591769696|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163835691|NCT05375955|591769697|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163835692|NCT05375955|591769698|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163835693|NCT05375955|591769699|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
163835694|NCT05375955|591769693|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
164035986|NCT00555906|592490338|FG002|Phase 2|Withdrawal by Subject|0|||
164035987|NCT00555906|592490339|FG003|Phase 2|Withdrawal by Subject|0|||
164035988|NCT00555906|592490340|FG004|Phase 2|Withdrawal by Subject|2|||
164035989|NCT00555906|592490336|FG000|Phase 2|Other|0|||
164035990|NCT00555906|592490337|FG001|Phase 2|Other|0|||
164035991|NCT00555906|592490338|FG002|Phase 2|Other|0|||
164035992|NCT00555906|592490339|FG003|Phase 2|Other|0|||
164035993|NCT00555906|592490340|FG004|Phase 2|Other|6|||
164035994|NCT00555906|592490336|FG000|Phase 2|Randomized but not Treated|0|||
164035995|NCT00555906|592490337|FG001|Phase 2|Randomized but not Treated|0|||
164035996|NCT00555906|592490338|FG002|Phase 2|Randomized but not Treated|0|||
164035997|NCT00555906|592490339|FG003|Phase 2|Randomized but not Treated|0|||
164035998|NCT00555906|592490340|FG004|Phase 2|Randomized but not Treated|2|||
164035999|NCT02193828|592490341|FG000|Overall Study|Withdrawal by Subject|0|||
164036000|NCT02193828|592490342|FG001|Overall Study|Withdrawal by Subject|0|||
164036001|NCT02193828|592490343|FG002|Overall Study|Withdrawal by Subject|1|||
164036002|NCT02193828|592490344|FG003|Overall Study|Withdrawal by Subject|1|||
164036003|NCT01313208|592490345|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
164036004|NCT01313208|592490346|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
164036005|NCT01313208|592490345|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
164036006|NCT01313208|592490346|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
164036007|NCT01313208|592490345|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
164036008|NCT01313208|592490346|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
164036009|NCT01313208|592490345|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
164036010|NCT01313208|592490346|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
164036011|NCT01313208|592490345|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
164036012|NCT01313208|592490346|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
164036013|NCT01313208|592490345|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
164036014|NCT01313208|592490346|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
164036015|NCT01313208|592490345|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
164036016|NCT01313208|592490346|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
164036017|NCT01313208|592490345|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
164036018|NCT01313208|592490346|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
164036019|NCT01313208|592490345|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
164036020|NCT01313208|592490346|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
164036021|NCT01412060|592490348|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
164036022|NCT01412060|592490349|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
164036023|NCT01412060|592490350|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
163835695|NCT05375955|591769694|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
163835696|NCT05375955|591769695|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163835697|NCT05375955|591769696|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
163835698|NCT05375955|591769697|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163835699|NCT05375955|591769698|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
163835700|NCT05375955|591769699|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
163835701|NCT03879408|591769709|FG000|Overall Study|Lost to Follow-up|0|||
163835702|NCT03879408|591769710|FG001|Overall Study|Lost to Follow-up|3|||
163835703|NCT03879408|591769711|FG002|Overall Study|Lost to Follow-up|2|||
163835704|NCT03879408|591769712|FG003|Overall Study|Lost to Follow-up|1|||
163835705|NCT03879408|591769713|FG004|Overall Study|Lost to Follow-up|0|||
163835706|NCT03879408|591769709|FG000|Overall Study|Withdrawal by Subject|2|||
163835707|NCT03879408|591769710|FG001|Overall Study|Withdrawal by Subject|1|||
163835708|NCT03879408|591769711|FG002|Overall Study|Withdrawal by Subject|1|||
163835709|NCT03879408|591769712|FG003|Overall Study|Withdrawal by Subject|0|||
163835710|NCT03879408|591769713|FG004|Overall Study|Withdrawal by Subject|1|||
163835711|NCT04522180|591769714|FG000|Overall Study|Investigator judgement|3|||
163835712|NCT04522180|591769715|FG001|Overall Study|Investigator judgement|4|||
163835713|NCT04522180|591769714|FG000|Overall Study|Voluntary withdrawal|1|||
163835714|NCT04522180|591769715|FG001|Overall Study|Voluntary withdrawal|0|||
163835715|NCT04522180|591769714|FG000|Overall Study|Pregnancy|0|||
163835716|NCT04522180|591769715|FG001|Overall Study|Pregnancy|1|||
163835717|NCT04522180|591769714|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
163835718|NCT04522180|591769715|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
163835719|NCT04522180|591769714|FG000|Overall Study|Reason not specified|8|||
163835720|NCT04522180|591769715|FG001|Overall Study|Reason not specified|5|||
163835721|NCT02055157|591769722|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
163835722|NCT02055157|591769723|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
163835723|NCT02055157|591769724|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
163835724|NCT02055157|591769725|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
163835725|NCT02055157|591769722|FG000|Initial 6 Months|Adverse Event|0|||
163835726|NCT02055157|591769723|FG001|Initial 6 Months|Adverse Event|0|||
163835727|NCT02055157|591769724|FG002|Initial 6 Months|Adverse Event|0|||
163835728|NCT02055157|591769725|FG003|Initial 6 Months|Adverse Event|1|||
163835729|NCT02055157|591769722|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
163835730|NCT02055157|591769723|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
163835731|NCT02055157|591769724|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
163835732|NCT02055157|591769725|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
163835733|NCT02055157|591769722|FG000|18-month Extension|Investigator decision|0|||
164036024|NCT01412060|592490348|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
164036025|NCT01412060|592490349|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
164098333|NCT05093205|592725085|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
164098334|NCT05093205|592725086|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
164098335|NCT05093205|592725087|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
164098336|NCT05093205|592725088|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
164098337|NCT05093205|592725089|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
164098338|NCT05093205|592725090|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
164098339|NCT05093205|592725091|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
164098340|NCT05093205|592725092|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
164098341|NCT05093205|592725093|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
164098342|NCT05093205|592725094|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
164098343|NCT05093205|592725095|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
164098344|NCT05093205|592725083|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
164098345|NCT05093205|592725084|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
164098346|NCT05093205|592725085|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
164098347|NCT05093205|592725086|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
164098348|NCT05093205|592725087|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
164098349|NCT05093205|592725088|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
164098350|NCT05093205|592725089|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
164098351|NCT05093205|592725090|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
164098352|NCT05093205|592725091|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
164098353|NCT05093205|592725092|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
164098354|NCT05093205|592725093|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
164098355|NCT05093205|592725094|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
164098356|NCT05093205|592725095|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
164098357|NCT05093205|592725083|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
163835734|NCT02055157|591769723|FG001|18-month Extension|Investigator decision|1|||
163835735|NCT02055157|591769724|FG002|18-month Extension|Investigator decision|0|||
163835736|NCT02055157|591769725|FG003|18-month Extension|Investigator decision|0|||
163835737|NCT02055157|591769722|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
163835738|NCT02055157|591769723|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
163835739|NCT02055157|591769724|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
163835740|NCT02055157|591769725|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
163835741|NCT03976466|591769726|FG000|Overall Study|Lost to Follow-up|1|||
163835742|NCT03976466|591769727|FG001|Overall Study|Lost to Follow-up|3|||
164098358|NCT05093205|592725084|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
164098359|NCT05093205|592725085|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
164098360|NCT05093205|592725086|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
164098361|NCT05093205|592725087|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
163835743|NCT02034708|591769728|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
163835744|NCT02034708|591769729|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
163835745|NCT02034708|591769728|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
163835746|NCT02034708|591769729|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
163835747|NCT02034708|591769728|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
163835748|NCT02034708|591769729|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
163835749|NCT02034708|591769728|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
163835750|NCT02034708|591769729|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
163835751|NCT00733499|591769732|FG000|Pre-operative|Protocol Violation|0|||
163835752|NCT00733499|591769733|FG001|Pre-operative|Protocol Violation|1|||
163835753|NCT00733499|591769732|FG000|3 Months Follow-up|Death|1|||
163835754|NCT00733499|591769733|FG001|3 Months Follow-up|Death|2|||
163835755|NCT00733499|591769732|FG000|6 Months Follow-up|Death|0|||
163835756|NCT00733499|591769733|FG001|6 Months Follow-up|Death|2|||
163835757|NCT00733499|591769732|FG000|6 Months Follow-up|Adverse Event|0|||
163835758|NCT00733499|591769733|FG001|6 Months Follow-up|Adverse Event|1|||
163835759|NCT00733499|591769732|FG000|12 Months Follow-up|Death|2|||
163835760|NCT00733499|591769733|FG001|12 Months Follow-up|Death|1|||
163835761|NCT00733499|591769732|FG000|24 Months Follow-up|Death|0|||
163835762|NCT00733499|591769733|FG001|24 Months Follow-up|Death|1|||
163835763|NCT00733499|591769732|FG000|5 Year Followup|Adverse Event|2|||
163835764|NCT00733499|591769733|FG001|5 Year Followup|Adverse Event|2|||
163835765|NCT00733499|591769732|FG000|5 Year Followup|Non device related AE|0|||
163835766|NCT00733499|591769733|FG001|5 Year Followup|Non device related AE|1|||
163835767|NCT00733499|591769732|FG000|5 Year Followup|Revision of Study Implant|0|||
163835768|NCT00733499|591769733|FG001|5 Year Followup|Revision of Study Implant|1|||
163835769|NCT00733499|591769732|FG000|5 Year Followup|Lost to Follow-up|2|||
163835770|NCT00733499|591769733|FG001|5 Year Followup|Lost to Follow-up|0|||
163835771|NCT00733499|591769732|FG000|5 Year Followup|Death|13|||
163835772|NCT00733499|591769733|FG001|5 Year Followup|Death|19|||
163835773|NCT00733499|591769732|FG000|5 Year Followup|missing, unable to locate|0|||
163835774|NCT00733499|591769733|FG001|5 Year Followup|missing, unable to locate|1|||
163835775|NCT00733499|591769732|FG000|5 Year Followup|Withdrawal by Subject|4|||
163835776|NCT00733499|591769733|FG001|5 Year Followup|Withdrawal by Subject|1|||
163835777|NCT00733499|591769732|FG000|10 Year Followup|Death|9|||
163835778|NCT00733499|591769733|FG001|10 Year Followup|Death|7|||
163835779|NCT00733499|591769732|FG000|10 Year Followup|Adverse Event|3|||
163835780|NCT00733499|591769733|FG001|10 Year Followup|Adverse Event|3|||
163835781|NCT00733499|591769732|FG000|10 Year Followup|Lost to Follow-up|3|||
163835782|NCT00733499|591769733|FG001|10 Year Followup|Lost to Follow-up|2|||
163835783|NCT00733499|591769732|FG000|10 Year Followup|Withdrawal by Subject|5|||
163835784|NCT00733499|591769733|FG001|10 Year Followup|Withdrawal by Subject|5|||
163835785|NCT00733499|591769732|FG000|10 Year Followup|missing, unable to locate|0|||
163835786|NCT00733499|591769733|FG001|10 Year Followup|missing, unable to locate|2|||
163835787|NCT00733980|591769734|FG000|Overall Study|Adverse Event|5|||
163931698|NCT01952847|592119863|FG001|Overall Study|Ineligible|0|||
163931699|NCT01952847|592119864|FG002|Overall Study|Ineligible|0|||
163835788|NCT00733980|591769735|FG001|Overall Study|Adverse Event|2|||
163835789|NCT00733980|591769734|FG000|Overall Study|Lack of Efficacy|0|||
163835790|NCT00733980|591769735|FG001|Overall Study|Lack of Efficacy|1|||
163835791|NCT00733980|591769734|FG000|Overall Study|Protocol Violation|2|||
163835792|NCT00733980|591769735|FG001|Overall Study|Protocol Violation|1|||
163835793|NCT00733980|591769734|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
163835794|NCT00733980|591769735|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
163835795|NCT00733980|591769734|FG000|Overall Study|Lost to Follow-up|6|||
163931700|NCT01952847|592119865|FG003|Overall Study|Ineligible|0|||
163835796|NCT00733980|591769735|FG001|Overall Study|Lost to Follow-up|11|||
163835797|NCT00733980|591769734|FG000|Overall Study|Physician Decision|2|||
163835798|NCT00733980|591769735|FG001|Overall Study|Physician Decision|3|||
163835799|NCT00733980|591769734|FG000|Overall Study|Withdrawal by Subject|6|||
163835800|NCT00733980|591769735|FG001|Overall Study|Withdrawal by Subject|2|||
163835801|NCT01931735|591769736|FG000|Randomized Phase|Lost to Follow-up|2|||
163931701|NCT01952847|592119862|FG000|Overall Study|Lack of Insurance Coverage|0|||
163931702|NCT01952847|592119863|FG001|Overall Study|Lack of Insurance Coverage|1|||
163931703|NCT01952847|592119864|FG002|Overall Study|Lack of Insurance Coverage|0|||
163931704|NCT01952847|592119865|FG003|Overall Study|Lack of Insurance Coverage|0|||
163931705|NCT01952847|592119862|FG000|Overall Study|Withdrawal by Subject|1|||
163931706|NCT01952847|592119863|FG001|Overall Study|Withdrawal by Subject|1|||
163931707|NCT01952847|592119864|FG002|Overall Study|Withdrawal by Subject|0|||
163931708|NCT01952847|592119865|FG003|Overall Study|Withdrawal by Subject|1|||
163931709|NCT05382039|592119866|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
163931710|NCT05382039|592119867|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
163931711|NCT05382039|592119868|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
163931712|NCT05382039|592119866|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
163931713|NCT05382039|592119867|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
163931714|NCT05382039|592119868|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
163931715|NCT05382039|592119866|FG000|Overall Study|waiting for confirmation|0|||
163931716|NCT05382039|592119867|FG001|Overall Study|waiting for confirmation|0|||
163931717|NCT05382039|592119868|FG002|Overall Study|waiting for confirmation|1|||
163931718|NCT04464421|592119869|FG000|Overall Study|Lost to Follow-up|2|||
163835802|NCT01931735|591769737|FG001|Randomized Phase|Lost to Follow-up|2|||
163835803|NCT01931735|591769738|FG002|Randomized Phase|Lost to Follow-up|5|||
163835804|NCT01931735|591769739|FG003|Randomized Phase|Lost to Follow-up|0|||
163835805|NCT01931735|591769736|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
163931719|NCT04464421|592119870|FG001|Overall Study|Lost to Follow-up|2|||
163931720|NCT02577003|592119871|FG000|Overall Study|Adverse Event|2|||
163931721|NCT02577003|592119872|FG001|Overall Study|Adverse Event|4|||
164036026|NCT01412060|592490350|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
163835806|NCT01931735|591769737|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
163835807|NCT01931735|591769738|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
163835808|NCT01931735|591769739|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
163835809|NCT01931735|591769736|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
163835810|NCT01931735|591769737|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
163835811|NCT01931735|591769738|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
163835812|NCT01931735|591769739|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
163835813|NCT02719990|591769743|FG000|Overall Study|Physician Decision|2|||
163835814|NCT02719990|591769743|FG000|Overall Study|Withdrawal by Subject|2|||
163835815|NCT02719990|591769743|FG000|Overall Study|Study Terminated By Sponsor|32|||
163835816|NCT00652938|591769747|FG000|Overall Study|Adverse Event|1|||
163835817|NCT00652938|591769748|FG001|Overall Study|Adverse Event|0|||
164036027|NCT01412060|592490348|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
164036028|NCT01412060|592490349|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
164036029|NCT01412060|592490350|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
163835818|NCT00652938|591769749|FG002|Overall Study|Adverse Event|2|||
163835819|NCT00652938|591769747|FG000|Overall Study|Withdrawal by Subject|0|||
164036030|NCT01412060|592490348|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
163835820|NCT00652938|591769748|FG001|Overall Study|Withdrawal by Subject|6|||
163835821|NCT00652938|591769749|FG002|Overall Study|Withdrawal by Subject|1|||
163835822|NCT00652938|591769747|FG000|Overall Study|Lost to Follow-up|0|||
163835823|NCT00652938|591769748|FG001|Overall Study|Lost to Follow-up|0|||
163835824|NCT00652938|591769749|FG002|Overall Study|Lost to Follow-up|2|||
163835825|NCT00652938|591769747|FG000|Overall Study|fear of blood sampling|0|||
163835826|NCT00652938|591769748|FG001|Overall Study|fear of blood sampling|1|||
163835827|NCT00652938|591769749|FG002|Overall Study|fear of blood sampling|0|||
163835828|NCT03324880|591769750|FG000|Overall Study|Adverse Event|0|||
163835829|NCT03324880|591769751|FG001|Overall Study|Adverse Event|2|||
163835830|NCT03324880|591769750|FG000|Overall Study|Withdrawal by Subject|2|||
163835831|NCT03324880|591769751|FG001|Overall Study|Withdrawal by Subject|2|||
163835832|NCT03324880|591769750|FG000|Overall Study|Lost to Follow-up|0|||
163835833|NCT03324880|591769751|FG001|Overall Study|Lost to Follow-up|1|||
163835834|NCT03324880|591769750|FG000|Overall Study|Product Recall|0|||
163835835|NCT03324880|591769751|FG001|Overall Study|Product Recall|1|||
163835836|NCT01547299|591769754|FG000|Overall Study|Withdrawal by Subject|2|||
163835837|NCT01547299|591769755|FG001|Overall Study|Withdrawal by Subject|2|||
163835838|NCT05076149|591769756|FG000|Overall Study|Adverse Event|3|||
163835839|NCT05076149|591769757|FG001|Overall Study|Adverse Event|9|||
163835840|NCT05076149|591769756|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
163835841|NCT05076149|591769757|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
163835842|NCT05076149|591769756|FG000|Overall Study|Lost to Follow-up|0|||
163835843|NCT05076149|591769757|FG001|Overall Study|Lost to Follow-up|1|||
163835844|NCT05076149|591769756|FG000|Overall Study|Commercial drug is available for participant|0|||
163835845|NCT05076149|591769757|FG001|Overall Study|Commercial drug is available for participant|1|||
163835846|NCT05076149|591769756|FG000|Overall Study|Other non compliance|1|||
163835847|NCT05076149|591769757|FG001|Overall Study|Other non compliance|1|||
163835848|NCT05076149|591769756|FG000|Overall Study|Physician Decision|0|||
163835849|NCT05076149|591769757|FG001|Overall Study|Physician Decision|1|||
163835850|NCT05076149|591769756|FG000|Overall Study|Other|5|||
163835851|NCT05076149|591769757|FG001|Overall Study|Other|4|||
163835852|NCT02087501|591769758|FG000|Overall Study|Death|7|||
163835853|NCT02087501|591769758|FG000|Overall Study|Open repair of aneurysm|1|||
163835854|NCT02087501|591769758|FG000|Overall Study|Lost to Follow-up|2|||
163835855|NCT03682705|591769761|FG000|Overall Study|Adverse Event|1|||
163835856|NCT03682705|591769762|FG001|Overall Study|Adverse Event|1|||
163835857|NCT03682705|591769763|FG002|Overall Study|Adverse Event|1|||
163835858|NCT03682705|591769764|FG003|Overall Study|Adverse Event|0|||
163835859|NCT03682705|591769765|FG004|Overall Study|Adverse Event|1|||
163835860|NCT03682705|591769766|FG005|Overall Study|Adverse Event|1|||
163835861|NCT03682705|591769761|FG000|Overall Study|Withdrawal by Subject|1|||
163835862|NCT03682705|591769762|FG001|Overall Study|Withdrawal by Subject|3|||
163835863|NCT03682705|591769763|FG002|Overall Study|Withdrawal by Subject|2|||
163835864|NCT03682705|591769764|FG003|Overall Study|Withdrawal by Subject|4|||
163835865|NCT03682705|591769765|FG004|Overall Study|Withdrawal by Subject|0|||
163835866|NCT03682705|591769766|FG005|Overall Study|Withdrawal by Subject|1|||
163835867|NCT03682705|591769761|FG000|Overall Study|Other, not specified|0|||
163835868|NCT03682705|591769762|FG001|Overall Study|Other, not specified|0|||
163835869|NCT03682705|591769763|FG002|Overall Study|Other, not specified|0|||
163835870|NCT03682705|591769764|FG003|Overall Study|Other, not specified|1|||
163835871|NCT03682705|591769765|FG004|Overall Study|Other, not specified|2|||
163835872|NCT03682705|591769766|FG005|Overall Study|Other, not specified|0|||
163835873|NCT03682705|591769761|FG000|Overall Study|Lost to Follow-up|0|||
163835874|NCT03682705|591769762|FG001|Overall Study|Lost to Follow-up|0|||
163835875|NCT03682705|591769763|FG002|Overall Study|Lost to Follow-up|0|||
163835876|NCT03682705|591769764|FG003|Overall Study|Lost to Follow-up|0|||
163835877|NCT03682705|591769765|FG004|Overall Study|Lost to Follow-up|3|||
163835878|NCT03682705|591769766|FG005|Overall Study|Lost to Follow-up|0|||
163835879|NCT00094328|591769767|FG000|Overall Study|Lost to Follow-up|1|||
163835880|NCT00117156|591769768|FG000|Overall Study|Adverse Event|9|||
163835881|NCT00117156|591769768|FG000|Overall Study|Physician Decision|1|||
163835882|NCT00117156|591769768|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
163835883|NCT02213328|591769769|FG000|Overall Study|Withdrawal by Subject|10|||
163835884|NCT02213328|591769769|FG000|Overall Study|Physician Decision|2|||
163835885|NCT02213328|591769769|FG000|Overall Study|Lost to Follow-up|16|||
163835886|NCT04043962|591769770|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
163835887|NCT04043962|591769770|FG000|Post-Treatment|Withdrawal by Subject|5|||
163835888|NCT04043962|591769770|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
163835889|NCT01654601|591769771|FG000|1st Administration|Withdrawal by Subject|2|||
163835890|NCT01654601|591769772|FG001|1st Administration|Withdrawal by Subject|0|||
163835891|NCT01654601|591769771|FG000|1st Administration|Protocol Violation|0|||
163835892|NCT01654601|591769772|FG001|1st Administration|Protocol Violation|2|||
164098362|NCT05093205|592725088|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
163835893|NCT01654601|591769771|FG000|2nd Administration|Adverse Event|1|||
163835894|NCT01654601|591769772|FG001|2nd Administration|Adverse Event|0|||
163835895|NCT01654601|591769771|FG000|2nd Administration|Protocol Violation|0|||
163835896|NCT01654601|591769772|FG001|2nd Administration|Protocol Violation|1|||
163835897|NCT02636270|591769773|FG000|Overall Study|Adverse Event|1|||
163835898|NCT02636270|591769774|FG001|Overall Study|Adverse Event|0|||
164036031|NCT01412060|592490349|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
164036032|NCT01412060|592490350|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
164036033|NCT01412060|592490348|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
164036034|NCT01412060|592490349|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
164036035|NCT01412060|592490350|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
164036036|NCT01412060|592490348|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
164036037|NCT01412060|592490349|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
164036038|NCT01412060|592490350|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
164036039|NCT01412060|592490348|FG000|Period Between RIP and SP|Adverse Event|4|||
164036040|NCT01412060|592490349|FG001|Period Between RIP and SP|Adverse Event|0|||
164036041|NCT01412060|592490350|FG002|Period Between RIP and SP|Adverse Event|0|||
164036042|NCT01412060|592490348|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
164036043|NCT01412060|592490349|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
164036044|NCT01412060|592490350|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
164036045|NCT01412060|592490348|FG000|Period Between RIP and SP|Protocol Violation|2|||
164036046|NCT01412060|592490349|FG001|Period Between RIP and SP|Protocol Violation|0|||
164036047|NCT01412060|592490350|FG002|Period Between RIP and SP|Protocol Violation|0|||
164036048|NCT01412060|592490348|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
164036049|NCT01412060|592490349|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
164036050|NCT01412060|592490350|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
164036051|NCT01412060|592490348|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
164036052|NCT01412060|592490349|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
164036053|NCT01412060|592490350|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
164036054|NCT01412060|592490348|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
164036055|NCT01412060|592490349|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
164036056|NCT01412060|592490350|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
164036057|NCT01412060|592490348|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
164036058|NCT01412060|592490349|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
164036059|NCT01412060|592490350|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
164036060|NCT01412060|592490348|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
164036061|NCT01412060|592490349|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
163835899|NCT02636270|591769775|FG002|Overall Study|Adverse Event|0|||
163835900|NCT02636270|591769773|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
163835901|NCT02636270|591769774|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
163835902|NCT02636270|591769775|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
163835903|NCT03285295|591772129|FG000|Alinity s HBsAg|Protocol Violation|11|||
163835904|NCT03285295|591772130|FG001|Alinity s HBsAg|Protocol Violation|0|||
163835905|NCT03285295|591772131|FG002|Alinity s HBsAg|Protocol Violation|0|||
163835906|NCT03285295|591772132|FG003|Alinity s HBsAg|Protocol Violation|0|||
163835907|NCT03285295|591772133|FG004|Alinity s HBsAg|Protocol Violation|0|||
163835908|NCT03285295|591772129|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
163835909|NCT03285295|591772130|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
163835910|NCT03285295|591772131|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
163835911|NCT03285295|591772132|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
163835912|NCT03285295|591772133|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
163835913|NCT03285295|591772129|FG000|Alinity s HBsAg|No Results Generated|74|||
163835914|NCT03285295|591772130|FG001|Alinity s HBsAg|No Results Generated|6|||
163835915|NCT03285295|591772131|FG002|Alinity s HBsAg|No Results Generated|0|||
163835916|NCT03285295|591772132|FG003|Alinity s HBsAg|No Results Generated|0|||
163835917|NCT03285295|591772133|FG004|Alinity s HBsAg|No Results Generated|0|||
163835918|NCT03285295|591772129|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
163835919|NCT03285295|591772130|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
163835920|NCT03285295|591772131|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
163835921|NCT03285295|591772132|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
163835922|NCT03285295|591772133|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
163835923|NCT03285295|591772129|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
163835924|NCT03285295|591772130|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163835925|NCT03285295|591772131|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163835926|NCT03285295|591772132|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163835927|NCT03285295|591772133|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
163835928|NCT03285295|591772129|FG000|Alinity s HTLV I/II|No Results Generated|70|||
163835929|NCT03285295|591772130|FG001|Alinity s HTLV I/II|No Results Generated|0|||
163835930|NCT03285295|591772131|FG002|Alinity s HTLV I/II|No Results Generated|0|||
163835931|NCT03285295|591772132|FG003|Alinity s HTLV I/II|No Results Generated|0|||
163835932|NCT03285295|591772133|FG004|Alinity s HTLV I/II|No Results Generated|0|||
163835933|NCT03285295|591772129|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
163835934|NCT03285295|591772130|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163835935|NCT03285295|591772131|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163931722|NCT02577003|592119871|FG000|Overall Study|Withdrawal by Subject|0|||
163931723|NCT02577003|592119872|FG001|Overall Study|Withdrawal by Subject|1|||
163931724|NCT01234883|592119873|FG000|Overall Study|Early treatment release|8|||
163931725|NCT01234883|592119874|FG001|Overall Study|Early treatment release|10|||
163931726|NCT01234883|592119873|FG000|Overall Study|Parent/guardian withdrew consent|1|||
163931727|NCT01234883|592119874|FG001|Overall Study|Parent/guardian withdrew consent|2|||
163931728|NCT01234883|592119873|FG000|Overall Study|Technical difficulties with IV infusion|0|||
164036062|NCT01412060|592490350|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
163835936|NCT03285295|591772132|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163835937|NCT03285295|591772133|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
163835938|NCT03285295|591772129|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
163835939|NCT03285295|591772130|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
163835940|NCT03285295|591772131|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
163835941|NCT03285295|591772132|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
163835942|NCT03285295|591772133|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
163835943|NCT03285295|591772129|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
163835944|NCT03285295|591772130|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163835945|NCT03285295|591772131|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163835946|NCT03285295|591772132|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163835947|NCT03285295|591772133|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
163835948|NCT03285295|591772129|FG000|Alinity s Anti-HCV|No Results Generated|71|||
163835949|NCT03285295|591772130|FG001|Alinity s Anti-HCV|No Results Generated|0|||
163835950|NCT03285295|591772131|FG002|Alinity s Anti-HCV|No Results Generated|0|||
163835951|NCT03285295|591772132|FG003|Alinity s Anti-HCV|No Results Generated|0|||
163835952|NCT03285295|591772133|FG004|Alinity s Anti-HCV|No Results Generated|0|||
163835953|NCT03285295|591772129|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
163835954|NCT03285295|591772130|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163835955|NCT03285295|591772131|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163835956|NCT03285295|591772132|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163835957|NCT03285295|591772133|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
163835958|NCT03285295|591772129|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
163835959|NCT03285295|591772130|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163835960|NCT03285295|591772131|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163835961|NCT03285295|591772132|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163835962|NCT03285295|591772133|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
163835963|NCT03285295|591772129|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
164036063|NCT01412060|592490348|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
164036064|NCT01412060|592490349|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
164036065|NCT01412060|592490350|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
164036066|NCT01412060|592490348|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
164036067|NCT01412060|592490349|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
164036068|NCT01412060|592490350|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
164036069|NCT01412060|592490348|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
164036070|NCT01412060|592490349|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
164036071|NCT01412060|592490350|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
164036072|NCT01412060|592490348|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
164036073|NCT01412060|592490349|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
164036074|NCT01412060|592490350|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
164036075|NCT01412060|592490348|FG000|Period Between SP and DBP|Protocol Violation|2|||
164036076|NCT01412060|592490349|FG001|Period Between SP and DBP|Protocol Violation|0|||
164036077|NCT01412060|592490350|FG002|Period Between SP and DBP|Protocol Violation|0|||
163835964|NCT03285295|591772130|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163835965|NCT03285295|591772131|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163835966|NCT03285295|591772132|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163835967|NCT03285295|591772133|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
163835968|NCT03285295|591772129|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
163835969|NCT03285295|591772130|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163835970|NCT03285295|591772131|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163835971|NCT03285295|591772132|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163835972|NCT03285295|591772133|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
163835973|NCT03285295|591772129|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
163835974|NCT03285295|591772130|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
164036078|NCT01412060|592490348|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
164036079|NCT01412060|592490349|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
164036080|NCT01412060|592490350|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
164036081|NCT01412060|592490348|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
164036082|NCT01412060|592490349|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
164036083|NCT01412060|592490350|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
163835975|NCT03285295|591772131|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163835976|NCT03285295|591772132|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163835977|NCT03285295|591772133|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
163835978|NCT03285295|591772129|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
163835979|NCT03285295|591772130|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
163835980|NCT03285295|591772131|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
163835981|NCT03285295|591772132|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
163835982|NCT03285295|591772133|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
163835983|NCT03285295|591772129|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
163835984|NCT03285295|591772130|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
163835985|NCT03285295|591772131|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
163835986|NCT03285295|591772132|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
163835987|NCT03285295|591772133|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
163835988|NCT03285295|591772129|FG000|Alinity s Anti-HBc|No Results Generated|70|||
163835989|NCT03285295|591772130|FG001|Alinity s Anti-HBc|No Results Generated|0|||
163835990|NCT03285295|591772131|FG002|Alinity s Anti-HBc|No Results Generated|0|||
163835991|NCT03285295|591772132|FG003|Alinity s Anti-HBc|No Results Generated|0|||
163835992|NCT03285295|591772133|FG004|Alinity s Anti-HBc|No Results Generated|0|||
163835993|NCT03285295|591772129|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
163835994|NCT03285295|591772130|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163835995|NCT03285295|591772131|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163835996|NCT03285295|591772132|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163835997|NCT03285295|591772133|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
163931729|NCT01234883|592119874|FG001|Overall Study|Technical difficulties with IV infusion|1|||
163931730|NCT01234883|592119873|FG000|Overall Study|Inclusion/exclusion failure|1|||
163931731|NCT01234883|592119874|FG001|Overall Study|Inclusion/exclusion failure|0|||
163931732|NCT01013961|592119875|FG000|Overall Study|Adverse Event|2|||
163931733|NCT01013961|592119876|FG001|Overall Study|Adverse Event|2|||
163931734|NCT01013961|592119875|FG000|Overall Study|Withdrawal by Subject|1|||
163931735|NCT01013961|592119876|FG001|Overall Study|Withdrawal by Subject|0|||
163931736|NCT01013961|592119875|FG000|Overall Study|Physician Decision|0|||
163931737|NCT01013961|592119876|FG001|Overall Study|Physician Decision|1|||
163931738|NCT01271504|592119877|FG000|Overall Study|Death|7|||
163835998|NCT03285295|591772129|FG000|Alinity s Chagas|Protocol Violation|76|||
163835999|NCT03285295|591772130|FG001|Alinity s Chagas|Protocol Violation|0|||
163836000|NCT03285295|591772131|FG002|Alinity s Chagas|Protocol Violation|0|||
163836001|NCT03285295|591772132|FG003|Alinity s Chagas|Protocol Violation|0|||
163836002|NCT03285295|591772133|FG004|Alinity s Chagas|Protocol Violation|0|||
163836003|NCT03285295|591772129|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
163836004|NCT03285295|591772130|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
163836005|NCT03285295|591772131|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
163836006|NCT03285295|591772132|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
163836007|NCT03285295|591772133|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
163836008|NCT03285295|591772129|FG000|Alinity s Chagas|No Results Generated|105|||
163836009|NCT03285295|591772130|FG001|Alinity s Chagas|No Results Generated|0|||
163836010|NCT03285295|591772131|FG002|Alinity s Chagas|No Results Generated|0|||
163836011|NCT03285295|591772132|FG003|Alinity s Chagas|No Results Generated|0|||
163836012|NCT03285295|591772133|FG004|Alinity s Chagas|No Results Generated|0|||
163836013|NCT03285295|591772129|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
163836014|NCT03285295|591772130|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163836015|NCT03285295|591772131|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163836016|NCT03285295|591772132|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
164036084|NCT01412060|592490348|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
163836017|NCT03285295|591772133|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
163836018|NCT02762981|591772134|FG000|Overall Study|Adverse Event|2|||
163836019|NCT02762981|591772135|FG001|Overall Study|Adverse Event|3|||
163836020|NCT02762981|591772136|FG002|Overall Study|Adverse Event|1|||
163836021|NCT02762981|591772137|FG003|Overall Study|Adverse Event|1|||
163931739|NCT01271504|592119878|FG001|Overall Study|Death|6|||
163931740|NCT01271504|592119879|FG002|Overall Study|Death|32|||
163931741|NCT01271504|592119880|FG003|Overall Study|Death|32|||
164036085|NCT01412060|592490349|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
163931742|NCT01271504|592119877|FG000|Overall Study|Lost to Follow-up|0|||
163931743|NCT01271504|592119878|FG001|Overall Study|Lost to Follow-up|1|||
163931744|NCT01271504|592119879|FG002|Overall Study|Lost to Follow-up|3|||
163931745|NCT01271504|592119880|FG003|Overall Study|Lost to Follow-up|1|||
163931746|NCT01271504|592119877|FG000|Overall Study|Protocol Violation|0|||
163931747|NCT01271504|592119878|FG001|Overall Study|Protocol Violation|0|||
163931748|NCT01271504|592119879|FG002|Overall Study|Protocol Violation|0|||
163931749|NCT01271504|592119880|FG003|Overall Study|Protocol Violation|2|||
164147694|NCT03910673|592902128|FG004|Overall Study|Adverse Event|0|||
163836022|NCT02762981|591772138|FG004|Overall Study|Adverse Event|3|||
163836023|NCT02762981|591772134|FG000|Overall Study|Physician Decision|0|||
163836024|NCT02762981|591772135|FG001|Overall Study|Physician Decision|1|||
163836025|NCT02762981|591772136|FG002|Overall Study|Physician Decision|0|||
163836026|NCT02762981|591772137|FG003|Overall Study|Physician Decision|0|||
163836027|NCT02762981|591772138|FG004|Overall Study|Physician Decision|1|||
163836028|NCT02762981|591772134|FG000|Overall Study|Disease progression|11|||
163836029|NCT02762981|591772135|FG001|Overall Study|Disease progression|23|||
163836030|NCT02762981|591772136|FG002|Overall Study|Disease progression|4|||
163836031|NCT02762981|591772137|FG003|Overall Study|Disease progression|10|||
163931750|NCT01271504|592119877|FG000|Overall Study|Administrative Reasons|0|||
163931751|NCT01271504|592119878|FG001|Overall Study|Administrative Reasons|0|||
163836032|NCT02762981|591772138|FG004|Overall Study|Disease progression|1|||
163836033|NCT02762981|591772134|FG000|Overall Study|Enrolled not treated|1|||
163836034|NCT02762981|591772135|FG001|Overall Study|Enrolled not treated|5|||
163836035|NCT02762981|591772136|FG002|Overall Study|Enrolled not treated|0|||
163836036|NCT02762981|591772137|FG003|Overall Study|Enrolled not treated|2|||
163836037|NCT02762981|591772138|FG004|Overall Study|Enrolled not treated|0|||
163836038|NCT02762981|591772134|FG000|Overall Study|Other|2|||
163836039|NCT02762981|591772135|FG001|Overall Study|Other|3|||
163836040|NCT02762981|591772136|FG002|Overall Study|Other|1|||
163836041|NCT02762981|591772137|FG003|Overall Study|Other|0|||
163836042|NCT02762981|591772138|FG004|Overall Study|Other|0|||
163836043|NCT02762981|591772134|FG000|Overall Study|Missing|1|||
163836044|NCT02762981|591772135|FG001|Overall Study|Missing|0|||
163836045|NCT02762981|591772136|FG002|Overall Study|Missing|0|||
163836046|NCT02762981|591772137|FG003|Overall Study|Missing|0|||
163836047|NCT02762981|591772138|FG004|Overall Study|Missing|0|||
163836048|NCT02762981|591772134|FG000|Overall Study|Withdrawal by Subject|0|||
163836049|NCT02762981|591772135|FG001|Overall Study|Withdrawal by Subject|5|||
163836050|NCT02762981|591772136|FG002|Overall Study|Withdrawal by Subject|1|||
163836051|NCT02762981|591772137|FG003|Overall Study|Withdrawal by Subject|3|||
163836052|NCT02762981|591772138|FG004|Overall Study|Withdrawal by Subject|0|||
163836053|NCT00976482|591772139|FG000|Overall Study|Death|208|||
163836054|NCT00976482|591772139|FG000|Overall Study|Withdrawal by Subject|45|||
163836055|NCT00976482|591772139|FG000|Overall Study|Center terminated|1|||
163836056|NCT00976482|591772139|FG000|Overall Study|Protocol Violation|5|||
163836057|NCT04867785|591772141|FG000|Overall Study|Adverse Event|1|||
163836058|NCT04867785|591772142|FG001|Overall Study|Adverse Event|0|||
163836059|NCT04867785|591772143|FG002|Overall Study|Adverse Event|1|||
163836060|NCT04867785|591772144|FG003|Overall Study|Adverse Event|0|||
163836061|NCT04867785|591772145|FG004|Overall Study|Adverse Event|0|||
163836062|NCT04867785|591772146|FG005|Overall Study|Adverse Event|0|||
163836063|NCT04867785|591772147|FG006|Overall Study|Adverse Event|0|||
163836064|NCT04867785|591772148|FG007|Overall Study|Adverse Event|2|||
163836065|NCT04867785|591772141|FG000|Overall Study|Lost to Follow-up|4|||
163836066|NCT04867785|591772142|FG001|Overall Study|Lost to Follow-up|4|||
163836067|NCT04867785|591772143|FG002|Overall Study|Lost to Follow-up|3|||
163836068|NCT04867785|591772144|FG003|Overall Study|Lost to Follow-up|2|||
163836069|NCT04867785|591772145|FG004|Overall Study|Lost to Follow-up|0|||
163836070|NCT04867785|591772146|FG005|Overall Study|Lost to Follow-up|1|||
163836071|NCT04867785|591772147|FG006|Overall Study|Lost to Follow-up|0|||
163836072|NCT04867785|591772148|FG007|Overall Study|Lost to Follow-up|1|||
163836073|NCT04867785|591772141|FG000|Overall Study|Withdrawal by Subject|6|||
163836074|NCT04867785|591772142|FG001|Overall Study|Withdrawal by Subject|2|||
163836075|NCT04867785|591772143|FG002|Overall Study|Withdrawal by Subject|2|||
163836076|NCT04867785|591772144|FG003|Overall Study|Withdrawal by Subject|1|||
163836077|NCT04867785|591772145|FG004|Overall Study|Withdrawal by Subject|2|||
163836078|NCT04867785|591772146|FG005|Overall Study|Withdrawal by Subject|0|||
163836079|NCT04867785|591772147|FG006|Overall Study|Withdrawal by Subject|2|||
163836080|NCT04867785|591772148|FG007|Overall Study|Withdrawal by Subject|5|||
163836081|NCT04867785|591772141|FG000|Overall Study|Physician Decision|0|||
163836082|NCT04867785|591772142|FG001|Overall Study|Physician Decision|0|||
163836083|NCT04867785|591772143|FG002|Overall Study|Physician Decision|0|||
163836084|NCT04867785|591772144|FG003|Overall Study|Physician Decision|0|||
163836085|NCT04867785|591772145|FG004|Overall Study|Physician Decision|0|||
163836086|NCT04867785|591772146|FG005|Overall Study|Physician Decision|0|||
163836087|NCT04867785|591772147|FG006|Overall Study|Physician Decision|0|||
163836088|NCT04867785|591772148|FG007|Overall Study|Physician Decision|1|||
163836089|NCT04867785|591772141|FG000|Overall Study|Inadvertent Enrollment|0|||
163836090|NCT04867785|591772142|FG001|Overall Study|Inadvertent Enrollment|0|||
163836091|NCT04867785|591772143|FG002|Overall Study|Inadvertent Enrollment|0|||
163836092|NCT04867785|591772144|FG003|Overall Study|Inadvertent Enrollment|1|||
163836093|NCT04867785|591772145|FG004|Overall Study|Inadvertent Enrollment|1|||
163836094|NCT04867785|591772146|FG005|Overall Study|Inadvertent Enrollment|0|||
163836095|NCT04867785|591772147|FG006|Overall Study|Inadvertent Enrollment|0|||
163836096|NCT04867785|591772148|FG007|Overall Study|Inadvertent Enrollment|1|||
163931752|NCT01271504|592119879|FG002|Overall Study|Administrative Reasons|6|||
163931753|NCT01271504|592119880|FG003|Overall Study|Administrative Reasons|5|||
163931754|NCT01271504|592119877|FG000|Overall Study|Withdrawal by Subject|0|||
163931755|NCT01271504|592119878|FG001|Overall Study|Withdrawal by Subject|0|||
163931756|NCT01271504|592119879|FG002|Overall Study|Withdrawal by Subject|1|||
163931757|NCT01271504|592119880|FG003|Overall Study|Withdrawal by Subject|3|||
163836097|NCT04867785|591772141|FG000|Overall Study|Eligibility Criteria Not Met|0|||
163836098|NCT04867785|591772142|FG001|Overall Study|Eligibility Criteria Not Met|0|||
163836099|NCT04867785|591772143|FG002|Overall Study|Eligibility Criteria Not Met|0|||
163836100|NCT04867785|591772144|FG003|Overall Study|Eligibility Criteria Not Met|0|||
163836101|NCT04867785|591772145|FG004|Overall Study|Eligibility Criteria Not Met|0|||
163836102|NCT04867785|591772146|FG005|Overall Study|Eligibility Criteria Not Met|0|||
163836103|NCT04867785|591772147|FG006|Overall Study|Eligibility Criteria Not Met|0|||
163836104|NCT04867785|591772148|FG007|Overall Study|Eligibility Criteria Not Met|1|||
163836105|NCT02959671|591772149|FG000|Overall Study|Adverse Event|2|||
163836106|NCT02959671|591772149|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
163836107|NCT01062763|591772150|FG000|Overall Study|Adverse Event|3|||
163836108|NCT01062763|591772151|FG001|Overall Study|Adverse Event|4|||
163836109|NCT02494921|591772152|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
163836110|NCT02494921|591772153|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
163836111|NCT02494921|591772154|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
163836112|NCT02494921|591772155|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
163836113|NCT02494921|591772156|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
163836114|NCT02494921|591772152|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
163836115|NCT02494921|591772153|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
163836116|NCT02494921|591772154|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
163836117|NCT02494921|591772155|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
163836118|NCT02494921|591772156|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
163836119|NCT02494921|591772152|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
163836120|NCT02494921|591772153|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
163836121|NCT02494921|591772154|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
163836122|NCT02494921|591772155|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
163836123|NCT02494921|591772156|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
163836124|NCT00605319|591772161|FG000|Overall Study|Adverse Event|6|||
163836125|NCT02991482|591772162|FG000|Overall Study|Disease progression|56|||
163836126|NCT02991482|591772163|FG001|Overall Study|Disease progression|47|||
163836127|NCT02991482|591772162|FG000|Overall Study|Death|4|||
163836128|NCT02991482|591772163|FG001|Overall Study|Death|4|||
163836129|NCT02991482|591772162|FG000|Overall Study|Adverse Event|1|||
163836130|NCT02991482|591772163|FG001|Overall Study|Adverse Event|6|||
163836131|NCT02991482|591772162|FG000|Overall Study|Patient decision|1|||
163836132|NCT02991482|591772163|FG001|Overall Study|Patient decision|1|||
163836133|NCT02991482|591772162|FG000|Overall Study|Physician Decision|0|||
163836134|NCT02991482|591772163|FG001|Overall Study|Physician Decision|6|||
163836135|NCT02991482|591772162|FG000|Overall Study|Clinical deterioration|1|||
163836136|NCT02991482|591772163|FG001|Overall Study|Clinical deterioration|0|||
163836137|NCT02991482|591772162|FG000|Overall Study|Patient feeling too unwell|1|||
163836138|NCT02991482|591772163|FG001|Overall Study|Patient feeling too unwell|0|||
163836139|NCT02991482|591772162|FG000|Overall Study|Worsening of performance status|0|||
163836140|NCT02991482|591772163|FG001|Overall Study|Worsening of performance status|1|||
163836141|NCT02991482|591772162|FG000|Overall Study|Death prior to study drug initiation|1|||
163836142|NCT02991482|591772163|FG001|Overall Study|Death prior to study drug initiation|0|||
163836143|NCT02991482|591772162|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
163836144|NCT02991482|591772163|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
163836145|NCT02887989|591772172|FG000|Overall Study|Withdrawal by Subject|8|||
163836146|NCT02887989|591772173|FG001|Overall Study|Withdrawal by Subject|11|||
163836147|NCT02887989|591772172|FG000|Overall Study|Death|1|||
163836148|NCT02887989|591772173|FG001|Overall Study|Death|0|||
163836149|NCT05648357|591772174|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
163836150|NCT00768430|591772175|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
163836151|NCT00768430|591772176|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
163836152|NCT04887948|591772182|FG000|Overall Study|Death|1|||
163836153|NCT04887948|591772183|FG001|Overall Study|Death|0|||
163836154|NCT04887948|591772184|FG002|Overall Study|Death|0|||
163836155|NCT04887948|591772182|FG000|Overall Study|Lost to Follow-up|1|||
163836156|NCT04887948|591772183|FG001|Overall Study|Lost to Follow-up|0|||
163836157|NCT04887948|591772184|FG002|Overall Study|Lost to Follow-up|3|||
163836158|NCT04887948|591772182|FG000|Overall Study|Physician Decision|0|||
163836159|NCT04887948|591772183|FG001|Overall Study|Physician Decision|4|||
163836160|NCT04887948|591772184|FG002|Overall Study|Physician Decision|1|||
164036086|NCT01412060|592490350|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
164147695|NCT02006732|592902129|FG000|Overall Study|Adverse Event|10|||
163836161|NCT04887948|591772182|FG000|Overall Study|Protocol Violation|1|||
163836162|NCT04887948|591772183|FG001|Overall Study|Protocol Violation|1|||
163836163|NCT04887948|591772184|FG002|Overall Study|Protocol Violation|0|||
163836164|NCT04887948|591772182|FG000|Overall Study|Withdrawal by Subject|0|||
163836165|NCT04887948|591772183|FG001|Overall Study|Withdrawal by Subject|6|||
163836166|NCT04887948|591772184|FG002|Overall Study|Withdrawal by Subject|1|||
163836167|NCT04887948|591772182|FG000|Overall Study|No longer met eligibility criteria|1|||
163836168|NCT04887948|591772183|FG001|Overall Study|No longer met eligibility criteria|2|||
163836169|NCT04887948|591772184|FG002|Overall Study|No longer met eligibility criteria|1|||
163836170|NCT04887948|591772182|FG000|Overall Study|Other|2|||
163836171|NCT04887948|591772183|FG001|Overall Study|Other|1|||
163836172|NCT04887948|591772184|FG002|Overall Study|Other|1|||
163836173|NCT02312856|591772185|FG000|Overall Study|Death|1|||
163836174|NCT02312856|591772185|FG000|Overall Study|Lost to Follow-up|3|||
163836175|NCT04415151|591772186|FG000|Overall Study|Death|1|||
163836176|NCT04415151|591772187|FG001|Overall Study|Death|1|||
163836177|NCT04415151|591772186|FG000|Overall Study|Withdrawal by Subject|1|||
163836178|NCT04415151|591772187|FG001|Overall Study|Withdrawal by Subject|0|||
163836179|NCT00638235|591772188|FG000|Overall Study|Lost to Follow-up|31|||
163836180|NCT00638235|591772189|FG001|Overall Study|Lost to Follow-up|3|||
163836181|NCT00638235|591772190|FG002|Overall Study|Lost to Follow-up|18|||
163836182|NCT00638235|591772191|FG003|Overall Study|Lost to Follow-up|10|||
163836183|NCT00638235|591772192|FG004|Overall Study|Lost to Follow-up|13|||
163836184|NCT00638235|591772193|FG005|Overall Study|Lost to Follow-up|26|||
163836185|NCT00638235|591772194|FG006|Overall Study|Lost to Follow-up|0|||
163836186|NCT00638235|591772195|FG007|Overall Study|Lost to Follow-up|1|||
163836187|NCT00638235|591772196|FG008|Overall Study|Lost to Follow-up|18|||
163836188|NCT01588990|591772199|FG000|Phase A|Withdrawal by Subject|5|||
163836189|NCT01588990|591772199|FG000|Phase A|Physician Decision|11|||
163836190|NCT01588990|591772199|FG000|Phase A|Other|14|||
163836191|NCT01588990|591772199|FG000|Phase A|Lost to Follow-up|1|||
163836192|NCT01588990|591772199|FG000|Phase A|Death|5|||
163836193|NCT01588990|591772199|FG000|Phase A|Adverse Event|28|||
163836194|NCT01588990|591772199|FG000|Phase A|Still on therapy at end of study|6|||
163836195|NCT01588990|591772199|FG000|Phase B|Adverse Event|2|||
163836196|NCT01588990|591772199|FG000|Phase B|Still on therapy at end of study|5|||
163836197|NCT01588990|591772199|FG000|Phase B|Withdrawal by Subject|3|||
163836198|NCT01588990|591772199|FG000|Phase B|Physician Decision|4|||
163836199|NCT01588990|591772199|FG000|Phase B|Other|2|||
163836200|NCT02367716|591772200|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
163836201|NCT01473381|591772201|FG000|Overall Study|Adverse Event|8|||
163836202|NCT01473381|591772202|FG001|Overall Study|Adverse Event|20|||
163836203|NCT01473381|591772203|FG002|Overall Study|Adverse Event|25|||
163836204|NCT01473381|591772204|FG003|Overall Study|Adverse Event|17|||
163836205|NCT01473381|591772201|FG000|Overall Study|Insufficient Therapeutic Response|10|||
163836206|NCT01473381|591772202|FG001|Overall Study|Insufficient Therapeutic Response|1|||
163836207|NCT01473381|591772203|FG002|Overall Study|Insufficient Therapeutic Response|2|||
163836208|NCT01473381|591772204|FG003|Overall Study|Insufficient Therapeutic Response|3|||
163836209|NCT01473381|591772201|FG000|Overall Study|Protocol Violation|17|||
163836210|NCT01473381|591772202|FG001|Overall Study|Protocol Violation|23|||
163836211|NCT01473381|591772203|FG002|Overall Study|Protocol Violation|19|||
163836212|NCT01473381|591772204|FG003|Overall Study|Protocol Violation|17|||
163836213|NCT01473381|591772201|FG000|Overall Study|Withdrawal of Consent|20|||
163836214|NCT01473381|591772202|FG001|Overall Study|Withdrawal of Consent|21|||
163836215|NCT01473381|591772203|FG002|Overall Study|Withdrawal of Consent|20|||
163836216|NCT01473381|591772204|FG003|Overall Study|Withdrawal of Consent|26|||
163836217|NCT01473381|591772201|FG000|Overall Study|Lost to Follow-up|25|||
164098363|NCT05093205|592725089|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
164098364|NCT05093205|592725090|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
163836218|NCT01473381|591772202|FG001|Overall Study|Lost to Follow-up|28|||
163836219|NCT01473381|591772203|FG002|Overall Study|Lost to Follow-up|35|||
163836220|NCT01473381|591772204|FG003|Overall Study|Lost to Follow-up|23|||
163836221|NCT01473381|591772201|FG000|Overall Study|Other Reasons|0|||
163836222|NCT01473381|591772202|FG001|Overall Study|Other Reasons|0|||
163836223|NCT01473381|591772203|FG002|Overall Study|Other Reasons|1|||
163836224|NCT01473381|591772204|FG003|Overall Study|Other Reasons|3|||
163836225|NCT00539643|591772205|FG000|Overall Study|Adverse Event|1|||
163836226|NCT00539643|591772206|FG001|Overall Study|Adverse Event|0|||
163836227|NCT00539643|591772205|FG000|Overall Study|Death|2|||
163836228|NCT00539643|591772206|FG001|Overall Study|Death|1|||
163836229|NCT00539643|591772205|FG000|Overall Study|Physician Decision|3|||
163836230|NCT00539643|591772206|FG001|Overall Study|Physician Decision|1|||
163931758|NCT01271504|592119877|FG000|Overall Study|Other|0|||
163931759|NCT01271504|592119878|FG001|Overall Study|Other|1|||
163931760|NCT01271504|592119879|FG002|Overall Study|Other|2|||
163931761|NCT01271504|592119880|FG003|Overall Study|Other|0|||
163931762|NCT01850589|592119887|FG000|Overall Study|Withdrawal by Subject|8|||
163931763|NCT01850589|592119888|FG001|Overall Study|Withdrawal by Subject|0|||
163931764|NCT03912662|592119889|FG000|Overall Study|Adverse Event|3|||
163931765|NCT03912662|592119889|FG000|Overall Study|Adverse Event and Death|1|||
163931766|NCT03912662|592119889|FG000|Overall Study|Death|1|||
163931767|NCT03912662|592119889|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
163931768|NCT03912662|592119889|FG000|Overall Study|Mesh Removal|1|||
163931769|NCT03912662|592119889|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
163931770|NCT03912662|592119889|FG000|Overall Study|Early study termination|20|||
163931771|NCT03845140|592119890|FG000|Overall Study|Participant travelled outside study area|0|||
163931772|NCT03845140|592119891|FG001|Overall Study|Participant travelled outside study area|1|||
163836231|NCT00539643|591772205|FG000|Overall Study|Withdrawal by Subject|0|||
163836232|NCT00539643|591772206|FG001|Overall Study|Withdrawal by Subject|1|||
163836233|NCT02508532|591772207|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836234|NCT02508532|591772208|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836235|NCT02508532|591772209|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836236|NCT02508532|591772210|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836237|NCT02508532|591772211|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836238|NCT02508532|591772212|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836239|NCT02508532|591772213|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
163836240|NCT02508532|591772214|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836241|NCT02508532|591772215|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
163836242|NCT02508532|591772207|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836243|NCT02508532|591772208|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836244|NCT02508532|591772209|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836245|NCT02508532|591772210|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836246|NCT02508532|591772211|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836247|NCT02508532|591772212|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836248|NCT02508532|591772213|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836249|NCT02508532|591772214|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
163836250|NCT02508532|591772215|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
163836251|NCT02508532|591772207|FG000|Part 2 - Treatment|Disease Progression|0|||
163836252|NCT02508532|591772208|FG001|Part 2 - Treatment|Disease Progression|0|||
163836253|NCT02508532|591772209|FG002|Part 2 - Treatment|Disease Progression|0|||
163836254|NCT02508532|591772210|FG003|Part 2 - Treatment|Disease Progression|0|||
163836255|NCT02508532|591772211|FG004|Part 2 - Treatment|Disease Progression|0|||
163836256|NCT02508532|591772212|FG005|Part 2 - Treatment|Disease Progression|0|||
163836257|NCT02508532|591772213|FG006|Part 2 - Treatment|Disease Progression|0|||
163836258|NCT02508532|591772214|FG007|Part 2 - Treatment|Disease Progression|0|||
163836259|NCT02508532|591772215|FG008|Part 2 - Treatment|Disease Progression|118|||
163836260|NCT02508532|591772207|FG000|Part 2 - Treatment|Adverse Event|0|||
163836261|NCT02508532|591772208|FG001|Part 2 - Treatment|Adverse Event|0|||
163836262|NCT02508532|591772209|FG002|Part 2 - Treatment|Adverse Event|0|||
163836263|NCT02508532|591772210|FG003|Part 2 - Treatment|Adverse Event|0|||
163836264|NCT02508532|591772211|FG004|Part 2 - Treatment|Adverse Event|0|||
163836265|NCT02508532|591772212|FG005|Part 2 - Treatment|Adverse Event|0|||
163836266|NCT02508532|591772213|FG006|Part 2 - Treatment|Adverse Event|0|||
163836267|NCT02508532|591772214|FG007|Part 2 - Treatment|Adverse Event|0|||
163836268|NCT02508532|591772215|FG008|Part 2 - Treatment|Adverse Event|49|||
163836269|NCT02508532|591772207|FG000|Part 2 - Treatment|Physician Decision|0|||
163836270|NCT02508532|591772208|FG001|Part 2 - Treatment|Physician Decision|0|||
163836271|NCT02508532|591772209|FG002|Part 2 - Treatment|Physician Decision|0|||
163836272|NCT02508532|591772210|FG003|Part 2 - Treatment|Physician Decision|0|||
163836273|NCT02508532|591772211|FG004|Part 2 - Treatment|Physician Decision|0|||
163836274|NCT02508532|591772212|FG005|Part 2 - Treatment|Physician Decision|0|||
163836275|NCT02508532|591772213|FG006|Part 2 - Treatment|Physician Decision|0|||
163836276|NCT02508532|591772214|FG007|Part 2 - Treatment|Physician Decision|0|||
163836277|NCT02508532|591772215|FG008|Part 2 - Treatment|Physician Decision|12|||
163836278|NCT02508532|591772207|FG000|Part 2 - Treatment|Administrative|0|||
163836279|NCT02508532|591772208|FG001|Part 2 - Treatment|Administrative|0|||
163836280|NCT02508532|591772209|FG002|Part 2 - Treatment|Administrative|0|||
163836281|NCT02508532|591772210|FG003|Part 2 - Treatment|Administrative|0|||
163836282|NCT02508532|591772211|FG004|Part 2 - Treatment|Administrative|0|||
163836283|NCT02508532|591772212|FG005|Part 2 - Treatment|Administrative|0|||
163836284|NCT02508532|591772213|FG006|Part 2 - Treatment|Administrative|0|||
163836285|NCT02508532|591772214|FG007|Part 2 - Treatment|Administrative|0|||
163836286|NCT02508532|591772215|FG008|Part 2 - Treatment|Administrative|3|||
163836287|NCT02508532|591772207|FG000|Part 2 - Treatment|Sponsor Decision|0|||
163836288|NCT02508532|591772208|FG001|Part 2 - Treatment|Sponsor Decision|0|||
163836289|NCT02508532|591772209|FG002|Part 2 - Treatment|Sponsor Decision|0|||
163836290|NCT02508532|591772210|FG003|Part 2 - Treatment|Sponsor Decision|0|||
163836291|NCT02508532|591772211|FG004|Part 2 - Treatment|Sponsor Decision|0|||
163836292|NCT02508532|591772212|FG005|Part 2 - Treatment|Sponsor Decision|0|||
163836293|NCT02508532|591772213|FG006|Part 2 - Treatment|Sponsor Decision|0|||
163836294|NCT02508532|591772214|FG007|Part 2 - Treatment|Sponsor Decision|0|||
163836295|NCT02508532|591772215|FG008|Part 2 - Treatment|Sponsor Decision|28|||
163836296|NCT02508532|591772207|FG000|Part 2 - Treatment|Death|0|||
163836297|NCT02508532|591772208|FG001|Part 2 - Treatment|Death|0|||
163836298|NCT02508532|591772209|FG002|Part 2 - Treatment|Death|0|||
163836299|NCT02508532|591772210|FG003|Part 2 - Treatment|Death|0|||
163836300|NCT02508532|591772211|FG004|Part 2 - Treatment|Death|0|||
163836301|NCT02508532|591772212|FG005|Part 2 - Treatment|Death|0|||
163836302|NCT02508532|591772213|FG006|Part 2 - Treatment|Death|0|||
163836303|NCT02508532|591772214|FG007|Part 2 - Treatment|Death|0|||
163836304|NCT02508532|591772215|FG008|Part 2 - Treatment|Death|1|||
164147696|NCT02006732|592902130|FG001|Overall Study|Adverse Event|7|||
163836305|NCT02508532|591772207|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
163836306|NCT02508532|591772208|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
163836307|NCT02508532|591772209|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
163836308|NCT02508532|591772210|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
163836309|NCT02508532|591772211|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
163836310|NCT02508532|591772212|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
163836311|NCT02508532|591772213|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
163836312|NCT02508532|591772214|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
163836313|NCT02508532|591772215|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
163836314|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
163836315|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
163836316|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
163836317|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
163836318|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
163836319|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
163836320|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
163836321|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
163836322|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
163836323|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
163836324|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
163836325|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
163836326|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
163836327|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
163836328|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
163836329|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
163836330|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
163836331|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
163836332|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Death|0|||
163836333|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Death|4|||
163836334|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Death|2|||
163836335|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Death|4|||
163836336|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Death|3|||
163836337|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Death|0|||
163836338|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Death|0|||
163836339|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Death|1|||
163836340|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Death|111|||
163836341|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
163836342|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
163836343|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
163836344|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163836345|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163836346|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163836347|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163836348|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
163836349|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
163836350|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836351|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836352|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836353|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836354|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
164036087|NCT01412060|592490348|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
164036088|NCT01412060|592490349|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
164036089|NCT01412060|592490350|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
164036090|NCT01412060|592490348|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
164036091|NCT01412060|592490349|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
164036092|NCT01412060|592490350|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
164036093|NCT01412060|592490348|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
163836355|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836356|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836357|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
163836358|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
163836359|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
163836360|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
163836361|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
163836362|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
163836363|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
163836364|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
163836365|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
163836366|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
163836367|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
164098365|NCT05093205|592725091|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
163836368|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836369|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836370|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836371|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836372|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836373|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836374|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836375|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
163836376|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
163836377|NCT02508532|591772207|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
163836378|NCT02508532|591772208|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
163836379|NCT02508532|591772209|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
163836380|NCT02508532|591772210|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
163836381|NCT02508532|591772211|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
163836382|NCT02508532|591772212|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
163836383|NCT02508532|591772213|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
163836384|NCT02508532|591772214|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
163836385|NCT02508532|591772215|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
163836386|NCT01641926|591772216|FG000|Overall Study|Adverse Event|5|||
163836387|NCT01641926|591772217|FG001|Overall Study|Adverse Event|2|||
163836388|NCT01641926|591772218|FG002|Overall Study|Adverse Event|3|||
163836389|NCT01641926|591772219|FG003|Overall Study|Adverse Event|1|||
163836390|NCT01641926|591772216|FG000|Overall Study|Lost to Follow-up|2|||
163836391|NCT01641926|591772217|FG001|Overall Study|Lost to Follow-up|2|||
163836392|NCT01641926|591772218|FG002|Overall Study|Lost to Follow-up|1|||
163836393|NCT01641926|591772219|FG003|Overall Study|Lost to Follow-up|0|||
163836394|NCT01641926|591772216|FG000|Overall Study|Physician Decision|6|||
163836395|NCT01641926|591772217|FG001|Overall Study|Physician Decision|5|||
163836396|NCT01641926|591772218|FG002|Overall Study|Physician Decision|0|||
163836397|NCT01641926|591772219|FG003|Overall Study|Physician Decision|1|||
163836398|NCT01641926|591772216|FG000|Overall Study|Protocol Violation|1|||
163836399|NCT01641926|591772217|FG001|Overall Study|Protocol Violation|0|||
163836400|NCT01641926|591772218|FG002|Overall Study|Protocol Violation|0|||
163836401|NCT01641926|591772219|FG003|Overall Study|Protocol Violation|1|||
163836402|NCT01641926|591772216|FG000|Overall Study|Withdrawal by Subject|13|||
163836403|NCT01641926|591772217|FG001|Overall Study|Withdrawal by Subject|5|||
163836404|NCT01641926|591772218|FG002|Overall Study|Withdrawal by Subject|6|||
163836405|NCT01641926|591772219|FG003|Overall Study|Withdrawal by Subject|1|||
163836406|NCT01641926|591772216|FG000|Overall Study|Not Treated|1|||
163836407|NCT01641926|591772217|FG001|Overall Study|Not Treated|1|||
163836408|NCT01641926|591772218|FG002|Overall Study|Not Treated|1|||
163836409|NCT01641926|591772219|FG003|Overall Study|Not Treated|0|||
163836410|NCT01111838|591772220|FG000|Overall Study|Patient Ineligible|2|||
163836411|NCT01111838|591772220|FG000|Overall Study|Not Treated|3|||
163836412|NCT01111838|591772220|FG000|Overall Study|Clinical deterioration|1|||
163836413|NCT01111838|591772220|FG000|Overall Study|Other Complicating Disease|1|||
163836414|NCT04399356|591772221|FG000|Overall Study|Lost to Follow-up|1|||
163836415|NCT04399356|591772222|FG001|Overall Study|Lost to Follow-up|1|||
163836416|NCT04399356|591772221|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
163836417|NCT04399356|591772222|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
163836418|NCT04399356|591772221|FG000|Overall Study|Withdrawal by Subject|1|||
163836419|NCT04399356|591772222|FG001|Overall Study|Withdrawal by Subject|0|||
163836420|NCT00098254|591772225|FG000|Overall Study|Adverse Event|2|||
163836421|NCT00098254|591772225|FG000|Overall Study|Death|1|||
163836422|NCT02118337|591772226|FG000|Overall Study|Other|1|||
163836423|NCT02118337|591772227|FG001|Overall Study|Other|0|||
163836424|NCT02118337|591772228|FG002|Overall Study|Other|0|||
163836425|NCT02118337|591772229|FG003|Overall Study|Other|0|||
163836426|NCT02118337|591772230|FG004|Overall Study|Other|2|||
163836427|NCT02118337|591772231|FG005|Overall Study|Other|3|||
163836428|NCT02118337|591772232|FG006|Overall Study|Other|1|||
163836429|NCT02118337|591772233|FG007|Overall Study|Other|28|||
163836430|NCT02118337|591772234|FG008|Overall Study|Other|15|||
163836431|NCT02118337|591772226|FG000|Overall Study|Lost to Follow-up|0|||
163931773|NCT03845140|592119892|FG002|Overall Study|Participant travelled outside study area|0|||
163931774|NCT03845140|592119893|FG003|Overall Study|Participant travelled outside study area|0|||
163931775|NCT03845140|592119894|FG004|Overall Study|Participant travelled outside study area|0|||
163931776|NCT03845140|592119895|FG005|Overall Study|Participant travelled outside study area|0|||
163931777|NCT01592045|592119896|FG000|Overall Study|Disease Progression|1|||
163931778|NCT01592045|592119897|FG001|Overall Study|Disease Progression|1|||
163931779|NCT01592045|592119896|FG000|Overall Study|Adverse Event|1|||
163931780|NCT01592045|592119897|FG001|Overall Study|Adverse Event|1|||
163931781|NCT01592045|592119896|FG000|Overall Study|Withdrawal by Subject|1|||
163931782|NCT01592045|592119897|FG001|Overall Study|Withdrawal by Subject|0|||
164036094|NCT01412060|592490349|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
164036095|NCT01412060|592490350|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
164036096|NCT01412060|592490348|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
164036097|NCT01412060|592490349|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
164036098|NCT01412060|592490350|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
164036099|NCT01412060|592490348|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
164036100|NCT01412060|592490349|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
164036101|NCT01412060|592490350|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
163836432|NCT02118337|591772227|FG001|Overall Study|Lost to Follow-up|0|||
163836433|NCT02118337|591772228|FG002|Overall Study|Lost to Follow-up|0|||
163836434|NCT02118337|591772229|FG003|Overall Study|Lost to Follow-up|0|||
163836435|NCT02118337|591772230|FG004|Overall Study|Lost to Follow-up|0|||
163836436|NCT02118337|591772231|FG005|Overall Study|Lost to Follow-up|0|||
163836437|NCT02118337|591772232|FG006|Overall Study|Lost to Follow-up|0|||
163836438|NCT02118337|591772233|FG007|Overall Study|Lost to Follow-up|1|||
163836439|NCT02118337|591772234|FG008|Overall Study|Lost to Follow-up|0|||
163836440|NCT02118337|591772226|FG000|Overall Study|Withdrawal by Subject|1|||
163836441|NCT02118337|591772227|FG001|Overall Study|Withdrawal by Subject|3|||
163836442|NCT02118337|591772228|FG002|Overall Study|Withdrawal by Subject|2|||
163836443|NCT02118337|591772229|FG003|Overall Study|Withdrawal by Subject|1|||
163836444|NCT02118337|591772230|FG004|Overall Study|Withdrawal by Subject|2|||
163836445|NCT02118337|591772231|FG005|Overall Study|Withdrawal by Subject|2|||
163836446|NCT02118337|591772232|FG006|Overall Study|Withdrawal by Subject|1|||
163836447|NCT02118337|591772233|FG007|Overall Study|Withdrawal by Subject|4|||
163836448|NCT02118337|591772234|FG008|Overall Study|Withdrawal by Subject|2|||
163836449|NCT02118337|591772226|FG000|Overall Study|Death|2|||
163836450|NCT02118337|591772227|FG001|Overall Study|Death|2|||
163836451|NCT02118337|591772228|FG002|Overall Study|Death|1|||
163836452|NCT02118337|591772229|FG003|Overall Study|Death|2|||
163836453|NCT02118337|591772230|FG004|Overall Study|Death|5|||
163836454|NCT02118337|591772231|FG005|Overall Study|Death|1|||
163836455|NCT02118337|591772232|FG006|Overall Study|Death|2|||
163836456|NCT02118337|591772233|FG007|Overall Study|Death|9|||
163836457|NCT02118337|591772234|FG008|Overall Study|Death|4|||
163836458|NCT00130793|591772236|FG000|Overall Study|Lost to Follow-up|1|||
163836459|NCT00130793|591772237|FG001|Overall Study|Lost to Follow-up|4|||
163836460|NCT00130793|591772236|FG000|Overall Study|Withdrew consent|2|||
163836461|NCT00130793|591772237|FG001|Overall Study|Withdrew consent|0|||
163836462|NCT00211237|591772238|FG000|Baseline|Withdrew|1|||
163836463|NCT00211237|591772239|FG001|Baseline|Withdrew|3|||
163836464|NCT00211237|591772240|FG002|Baseline|Withdrew|0|||
163836465|NCT00211237|591772238|FG000|Baseline|Refused random assignment|1|||
163836466|NCT00211237|591772239|FG001|Baseline|Refused random assignment|0|||
163836467|NCT00211237|591772240|FG002|Baseline|Refused random assignment|0|||
163836468|NCT00211237|591772238|FG000|1 Month|Death|2|||
163836469|NCT00211237|591772239|FG001|1 Month|Death|1|||
163836470|NCT00211237|591772240|FG002|1 Month|Death|0|||
163836471|NCT00211237|591772238|FG000|1 Month|Lost to Follow-up|0|||
163836472|NCT00211237|591772239|FG001|1 Month|Lost to Follow-up|2|||
163836473|NCT00211237|591772240|FG002|1 Month|Lost to Follow-up|0|||
163836474|NCT00211237|591772238|FG000|1 Month|Withdrew|0|||
163836475|NCT00211237|591772239|FG001|1 Month|Withdrew|4|||
163836476|NCT00211237|591772240|FG002|1 Month|Withdrew|0|||
163836477|NCT00211237|591772238|FG000|1 Month|Additional surgery needed|1|||
163836478|NCT00211237|591772239|FG001|1 Month|Additional surgery needed|0|||
163836479|NCT00211237|591772240|FG002|1 Month|Additional surgery needed|0|||
163836480|NCT00211237|591772238|FG000|1 Month|Non-medical problem|0|||
163836481|NCT00211237|591772239|FG001|1 Month|Non-medical problem|2|||
163836482|NCT00211237|591772240|FG002|1 Month|Non-medical problem|0|||
163836483|NCT00211237|591772238|FG000|3 Months|Death|7|||
163836484|NCT00211237|591772239|FG001|3 Months|Death|3|||
163836485|NCT00211237|591772240|FG002|3 Months|Death|0|||
163836486|NCT00211237|591772238|FG000|3 Months|Could not comply with protocol|1|||
163836487|NCT00211237|591772239|FG001|3 Months|Could not comply with protocol|0|||
163836488|NCT00211237|591772240|FG002|3 Months|Could not comply with protocol|0|||
164036102|NCT01412060|592490348|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
164036103|NCT01412060|592490349|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
164036104|NCT01412060|592490350|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
164036105|NCT01412060|592490348|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
164036106|NCT01412060|592490349|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
164036107|NCT01412060|592490350|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
164036108|NCT02661464|592490353|FG000|Overall Study|Lost to Follow-up|28|||
164036109|NCT02661464|592490354|FG001|Overall Study|Lost to Follow-up|0|||
164036110|NCT02661464|592490355|FG002|Overall Study|Lost to Follow-up|0|||
164036111|NCT02661464|592490356|FG003|Overall Study|Lost to Follow-up|0|||
164036112|NCT02661464|592490353|FG000|Overall Study|Withdrawal by Subject|3|||
164036113|NCT02661464|592490354|FG001|Overall Study|Withdrawal by Subject|1|||
164036114|NCT02661464|592490355|FG002|Overall Study|Withdrawal by Subject|0|||
164036115|NCT02661464|592490356|FG003|Overall Study|Withdrawal by Subject|0|||
163836489|NCT00211237|591772238|FG000|3 Months|Withdrew|0|||
163836490|NCT00211237|591772239|FG001|3 Months|Withdrew|1|||
163836491|NCT00211237|591772240|FG002|3 Months|Withdrew|0|||
163836492|NCT00211237|591772238|FG000|3 Months|Non-medical problem|0|||
163836493|NCT00211237|591772239|FG001|3 Months|Non-medical problem|0|||
163836494|NCT00211237|591772240|FG002|3 Months|Non-medical problem|1|||
163836495|NCT00211237|591772238|FG000|6 Months|Death|6|||
163836496|NCT00211237|591772239|FG001|6 Months|Death|0|||
163836497|NCT00211237|591772240|FG002|6 Months|Death|3|||
163931783|NCT01592045|592119896|FG000|Overall Study|Moved out of country|2|||
163931784|NCT01592045|592119897|FG001|Overall Study|Moved out of country|0|||
163931785|NCT01790295|592119900|FG000|Overall Study|Adverse Event|1|||
163931786|NCT01790295|592119900|FG000|Overall Study|Death|4|||
163931787|NCT01790295|592119900|FG000|Overall Study|Lack of Efficacy|2|||
163931788|NCT01790295|592119900|FG000|Overall Study|Study closure|4|||
163931789|NCT03721705|592119901|FG000|Overall Study|Adverse Event|2|||
163931790|NCT03721705|592119902|FG001|Overall Study|Adverse Event|0|||
163931791|NCT03721705|592119901|FG000|Overall Study|Withdrawal by Subject|4|||
163931792|NCT03721705|592119902|FG001|Overall Study|Withdrawal by Subject|10|||
163931793|NCT03721705|592119901|FG000|Overall Study|No Suitable Study Partner|1|||
163931794|NCT03721705|592119902|FG001|Overall Study|No Suitable Study Partner|0|||
163931795|NCT03721705|592119901|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
163931796|NCT03721705|592119902|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
163931797|NCT03721705|592119901|FG000|Overall Study|Death|0|||
163931798|NCT03721705|592119902|FG001|Overall Study|Death|1|||
163931799|NCT01843777|592119903|FG000|Overall Study|Withdrawal by Subject|1|||
163931800|NCT01843777|592119904|FG001|Overall Study|Withdrawal by Subject|0|||
163931801|NCT00420784|592119910|FG000|Overall Study|Adverse Event|11|||
163931802|NCT00420784|592119911|FG001|Overall Study|Adverse Event|29|||
163931803|NCT00420784|592119912|FG002|Overall Study|Adverse Event|10|||
163931804|NCT00420784|592119913|FG003|Overall Study|Adverse Event|5|||
163931805|NCT00420784|592119910|FG000|Overall Study|Withdrawal by Subject|0|||
163931806|NCT00420784|592119911|FG001|Overall Study|Withdrawal by Subject|1|||
163931807|NCT00420784|592119912|FG002|Overall Study|Withdrawal by Subject|0|||
163931808|NCT00420784|592119913|FG003|Overall Study|Withdrawal by Subject|0|||
163931809|NCT00420784|592119910|FG000|Overall Study|Lost to Follow-up|0|||
163931810|NCT00420784|592119911|FG001|Overall Study|Lost to Follow-up|0|||
163931811|NCT00420784|592119912|FG002|Overall Study|Lost to Follow-up|2|||
163931812|NCT00420784|592119913|FG003|Overall Study|Lost to Follow-up|1|||
163931813|NCT00420784|592119910|FG000|Overall Study|Virologic Stopping Rule|17|||
163931814|NCT00420784|592119911|FG001|Overall Study|Virologic Stopping Rule|26|||
163931815|NCT00420784|592119912|FG002|Overall Study|Virologic Stopping Rule|41|||
163931816|NCT00420784|592119913|FG003|Overall Study|Virologic Stopping Rule|67|||
163931817|NCT00420784|592119910|FG000|Overall Study|Other|1|||
163931818|NCT00420784|592119911|FG001|Overall Study|Other|2|||
163931819|NCT00420784|592119912|FG002|Overall Study|Other|0|||
163931820|NCT00420784|592119913|FG003|Overall Study|Other|5|||
163931821|NCT02599688|592119916|FG000|Overall Study|Lack of Efficacy|1|||
163931822|NCT02599688|592119916|FG000|Overall Study|Withdrawal by Subject|1|||
163931823|NCT02599688|592119916|FG000|Overall Study|Termination by Sponsor|2|||
163931824|NCT02402322|592119922|FG000|Pretreatment|Withdrawal by Subject|3|||
163931825|NCT02402322|592119923|FG001|Pretreatment|Withdrawal by Subject|1|||
163931826|NCT02402322|592119924|FG002|Pretreatment|Withdrawal by Subject|1|||
163931827|NCT02402322|592119922|FG000|Follow-up|Withdrawal by Subject|6|||
163931828|NCT02402322|592119923|FG001|Follow-up|Withdrawal by Subject|3|||
163931829|NCT02402322|592119924|FG002|Follow-up|Withdrawal by Subject|24|||
163931830|NCT02818998|592119925|FG000|Overall Study|Adverse Event|3|||
163931831|NCT02818998|592119926|FG001|Overall Study|Adverse Event|2|||
163931832|NCT02818998|592119927|FG002|Overall Study|Adverse Event|1|||
163931833|NCT02818998|592119925|FG000|Overall Study|Lost to Follow-up|4|||
163931834|NCT02818998|592119926|FG001|Overall Study|Lost to Follow-up|1|||
163931835|NCT02818998|592119927|FG002|Overall Study|Lost to Follow-up|2|||
163931836|NCT02818998|592119925|FG000|Overall Study|Withdrawal by sponsor|0|||
163931837|NCT02818998|592119926|FG001|Overall Study|Withdrawal by sponsor|1|||
163931838|NCT02818998|592119927|FG002|Overall Study|Withdrawal by sponsor|1|||
163931839|NCT02818998|592119925|FG000|Overall Study|Death|3|||
163931840|NCT02818998|592119926|FG001|Overall Study|Death|6|||
163931841|NCT02818998|592119927|FG002|Overall Study|Death|8|||
163931842|NCT02818998|592119925|FG000|Overall Study|Withdrawal by Subject|7|||
163931843|NCT02818998|592119926|FG001|Overall Study|Withdrawal by Subject|6|||
163931844|NCT02818998|592119927|FG002|Overall Study|Withdrawal by Subject|6|||
163931845|NCT02818998|592119925|FG000|Overall Study|Physician Decision|1|||
163931846|NCT02818998|592119926|FG001|Overall Study|Physician Decision|0|||
163931847|NCT02818998|592119927|FG002|Overall Study|Physician Decision|0|||
163931848|NCT02437071|592119928|FG000|Overall Study|Withdrawal by Subject|1|||
163931849|NCT02437071|592119929|FG001|Overall Study|Withdrawal by Subject|0|||
163931850|NCT01587118|592119932|FG000|Overall Study|Adverse Event|3|||
163931851|NCT01587118|592119932|FG000|Overall Study|Lost to Follow-up|2|||
163931852|NCT01587118|592119932|FG000|Overall Study|Relocation|1|||
163931853|NCT01587118|592119932|FG000|Overall Study|nonresponse|1|||
163836498|NCT00211237|591772238|FG000|6 Months|Lost to Follow-up|2|||
163836499|NCT00211237|591772239|FG001|6 Months|Lost to Follow-up|0|||
163836500|NCT00211237|591772240|FG002|6 Months|Lost to Follow-up|0|||
163931854|NCT00537329|592119933|FG000|Overall Study|Death|10|||
163836501|NCT00211237|591772238|FG000|6 Months|Could not comply with protocol|0|||
163836502|NCT00211237|591772239|FG001|6 Months|Could not comply with protocol|2|||
163836503|NCT00211237|591772240|FG002|6 Months|Could not comply with protocol|0|||
163836504|NCT00211237|591772238|FG000|12 Months|Death|8|||
163836505|NCT00211237|591772239|FG001|12 Months|Death|2|||
163836506|NCT00211237|591772240|FG002|12 Months|Death|3|||
163836507|NCT00211237|591772238|FG000|12 Months|Lost to Follow-up|1|||
163836508|NCT00211237|591772239|FG001|12 Months|Lost to Follow-up|0|||
163836509|NCT00211237|591772240|FG002|12 Months|Lost to Follow-up|1|||
163836510|NCT00211237|591772238|FG000|12 Months|Withdrew|0|||
163836511|NCT00211237|591772239|FG001|12 Months|Withdrew|0|||
163836512|NCT00211237|591772240|FG002|12 Months|Withdrew|1|||
163836513|NCT00211237|591772238|FG000|12 Months|unrelated medical problem|0|||
163836514|NCT00211237|591772239|FG001|12 Months|unrelated medical problem|0|||
163836515|NCT00211237|591772240|FG002|12 Months|unrelated medical problem|1|||
163836516|NCT01003639|591772243|FG000|Overall Study|Lost to Follow-up|6|||
163836517|NCT01003639|591772244|FG001|Overall Study|Lost to Follow-up|9|||
163836518|NCT01003639|591772243|FG000|Overall Study|Withdrawal by Subject|9|||
163836519|NCT01003639|591772244|FG001|Overall Study|Withdrawal by Subject|5|||
163836520|NCT01003639|591772243|FG000|Overall Study|Lack of Efficacy|1|||
163836521|NCT01003639|591772244|FG001|Overall Study|Lack of Efficacy|6|||
163836522|NCT01003639|591772243|FG000|Overall Study|Adverse Event|0|||
163836523|NCT01003639|591772244|FG001|Overall Study|Adverse Event|1|||
163836524|NCT01003639|591772243|FG000|Overall Study|Protocol Violation|0|||
163836525|NCT01003639|591772244|FG001|Overall Study|Protocol Violation|1|||
163836526|NCT01003639|591772243|FG000|Overall Study|Physician Decision|1|||
163836527|NCT01003639|591772244|FG001|Overall Study|Physician Decision|0|||
163836528|NCT02237508|591772245|FG000|Overall Study|Withdrawal by Subject|0|||
163836529|NCT02237508|591772246|FG001|Overall Study|Withdrawal by Subject|2|||
163836530|NCT02237508|591772247|FG002|Overall Study|Withdrawal by Subject|0|||
163836531|NCT02237508|591772248|FG003|Overall Study|Withdrawal by Subject|1|||
163836532|NCT02237508|591772249|FG004|Overall Study|Withdrawal by Subject|0|||
163836533|NCT02237508|591772250|FG005|Overall Study|Withdrawal by Subject|1|||
163836534|NCT02237508|591772251|FG006|Overall Study|Withdrawal by Subject|1|||
163836535|NCT02237508|591772252|FG007|Overall Study|Withdrawal by Subject|0|||
163836536|NCT02237508|591772253|FG008|Overall Study|Withdrawal by Subject|1|||
163836537|NCT02237508|591772254|FG009|Overall Study|Withdrawal by Subject|0|||
163836538|NCT02237508|591772245|FG000|Overall Study|Physician Decision|0|||
163836539|NCT02237508|591772246|FG001|Overall Study|Physician Decision|1|||
163836540|NCT02237508|591772247|FG002|Overall Study|Physician Decision|0|||
163836541|NCT02237508|591772248|FG003|Overall Study|Physician Decision|0|||
163836542|NCT02237508|591772249|FG004|Overall Study|Physician Decision|0|||
163836543|NCT02237508|591772250|FG005|Overall Study|Physician Decision|0|||
163836544|NCT02237508|591772251|FG006|Overall Study|Physician Decision|0|||
163836545|NCT02237508|591772252|FG007|Overall Study|Physician Decision|0|||
163836546|NCT02237508|591772253|FG008|Overall Study|Physician Decision|0|||
163836547|NCT02237508|591772254|FG009|Overall Study|Physician Decision|0|||
163836548|NCT02237508|591772245|FG000|Overall Study|Protocol Violation|0|||
163836549|NCT02237508|591772246|FG001|Overall Study|Protocol Violation|0|||
163836550|NCT02237508|591772247|FG002|Overall Study|Protocol Violation|1|||
163836551|NCT02237508|591772248|FG003|Overall Study|Protocol Violation|0|||
163836552|NCT02237508|591772249|FG004|Overall Study|Protocol Violation|0|||
163836553|NCT02237508|591772250|FG005|Overall Study|Protocol Violation|0|||
163836554|NCT02237508|591772251|FG006|Overall Study|Protocol Violation|0|||
163836555|NCT02237508|591772252|FG007|Overall Study|Protocol Violation|0|||
163836556|NCT02237508|591772253|FG008|Overall Study|Protocol Violation|0|||
163836557|NCT02237508|591772254|FG009|Overall Study|Protocol Violation|0|||
163836558|NCT01650519|591772255|FG000|Overall Study|Withdrawal by Subject|1|||
163836559|NCT01650519|591772256|FG001|Overall Study|Withdrawal by Subject|0|||
163836560|NCT05458024|591772257|FG000|Overall Study|Withdrawal by Subject|1|||
163836561|NCT05458024|591772258|FG001|Overall Study|Withdrawal by Subject|1|||
163836562|NCT04000594|591772260|FG000|Overall Study|Withdrawal by Subject|1|||
163836563|NCT04000594|591772261|FG001|Overall Study|Withdrawal by Subject|0|||
163836564|NCT04000594|591772262|FG002|Overall Study|Withdrawal by Subject|0|||
163836565|NCT05807919|591772263|FG000|Overall Study|Received antibiotics - excluded|0|||
163836566|NCT05807919|591772264|FG001|Overall Study|Received antibiotics - excluded|1|||
163836567|NCT05807919|591772263|FG000|Overall Study|Withdrawal by Subject|0|||
163836568|NCT05807919|591772264|FG001|Overall Study|Withdrawal by Subject|3|||
163836569|NCT05807919|591772263|FG000|Overall Study|Adverse Event|1|||
163836570|NCT05807919|591772264|FG001|Overall Study|Adverse Event|1|||
163836571|NCT00747123|591772265|FG000|Overall Study|Investigator's request|0|||
163836572|NCT00747123|591772266|FG001|Overall Study|Investigator's request|0|||
163836573|NCT00747123|591772267|FG002|Overall Study|Investigator's request|1|||
163931855|NCT00537329|592119933|FG000|Overall Study|Adverse Event|3|||
163931856|NCT00537329|592119933|FG000|Overall Study|Lack of Efficacy|2|||
163931857|NCT00537329|592119933|FG000|Overall Study|Lost to Follow-up|6|||
163931858|NCT00537329|592119933|FG000|Overall Study|Withdrawal by Subject|4|||
163931859|NCT00537329|592119933|FG000|Overall Study|Other|1|||
163931860|NCT02049515|592119934|FG000|Overall Study|Adverse Event|46|||
163931861|NCT02049515|592119935|FG001|Overall Study|Adverse Event|2|||
163931862|NCT02049515|592119934|FG000|Overall Study|Protocol-specified Disease Progression|23|||
163931863|NCT02049515|592119935|FG001|Overall Study|Protocol-specified Disease Progression|2|||
163931864|NCT02049515|592119934|FG000|Overall Study|Death|6|||
163931865|NCT02049515|592119935|FG001|Overall Study|Death|0|||
163931866|NCT02049515|592119934|FG000|Overall Study|Physician Decision|5|||
163931867|NCT02049515|592119935|FG001|Overall Study|Physician Decision|1|||
163931868|NCT02049515|592119934|FG000|Overall Study|Withdrawal by Subject|3|||
163931869|NCT02049515|592119935|FG001|Overall Study|Withdrawal by Subject|0|||
163931870|NCT02049515|592119934|FG000|Overall Study|Termination of the Study by Sponsor|2|||
163931871|NCT02049515|592119935|FG001|Overall Study|Termination of the Study by Sponsor|0|||
163931872|NCT02049515|592119934|FG000|Overall Study|Protocol Violation|1|||
163931873|NCT02049515|592119935|FG001|Overall Study|Protocol Violation|1|||
163931874|NCT02049515|592119934|FG000|Overall Study|Clinical Deterioration|1|||
163931875|NCT02049515|592119935|FG001|Overall Study|Clinical Deterioration|0|||
163931876|NCT02049515|592119934|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
163931877|NCT02049515|592119935|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
163931878|NCT02049515|592119934|FG000|Overall Study|Treatment Interruption >42 Days|1|||
163931879|NCT02049515|592119935|FG001|Overall Study|Treatment Interruption >42 Days|0|||
163931880|NCT02049515|592119934|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
163931881|NCT02049515|592119935|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
163931882|NCT00224029|592119939|FG000|Overall Study|Lost to Follow-up|1|||
163931883|NCT00224029|592119939|FG000|Overall Study|Withdrawal by Subject|4|||
163931884|NCT00224029|592119939|FG000|Overall Study|Other|1|||
163931885|NCT00243022|592119940|FG000|Overall Study|Withdrawal by Subject|1|||
163931886|NCT00243022|592119941|FG001|Overall Study|Withdrawal by Subject|0|||
163931887|NCT00243022|592119940|FG000|Overall Study|Death|1|||
163931888|NCT00243022|592119941|FG001|Overall Study|Death|0|||
163931889|NCT00243022|592119940|FG000|Overall Study|Difficult Travel Distance|0|||
163931890|NCT00243022|592119941|FG001|Overall Study|Difficult Travel Distance|1|||
163931891|NCT01099579|592119942|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
163931892|NCT01099579|592119943|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
163931893|NCT01099579|592119944|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
163931894|NCT01099579|592119942|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
163931895|NCT01099579|592119943|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
163931896|NCT01099579|592119944|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
163931897|NCT01099579|592119942|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
163931898|NCT01099579|592119943|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
163931899|NCT01099579|592119944|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
163931900|NCT01099579|592119942|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
163931901|NCT01099579|592119943|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
163931902|NCT01099579|592119944|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
163931903|NCT01099579|592119942|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
163931904|NCT01099579|592119943|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
163931905|NCT01099579|592119944|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
163931906|NCT01099579|592119942|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
163931907|NCT01099579|592119943|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
163931908|NCT01099579|592119944|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
163931909|NCT01099579|592119942|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
163931910|NCT01099579|592119943|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
163931911|NCT01099579|592119944|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
163931912|NCT01099579|592119942|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
163931913|NCT01099579|592119943|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
163931914|NCT01099579|592119944|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
163931915|NCT01099579|592119942|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
163931916|NCT01099579|592119943|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
163931917|NCT01099579|592119944|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
163931918|NCT01099579|592119942|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
163931919|NCT01099579|592119943|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
163931920|NCT01099579|592119944|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
163931921|NCT02569957|592119945|FG000|Overall Study|Withdrawal by Subject|0|||
163931922|NCT02569957|592119946|FG001|Overall Study|Withdrawal by Subject|1|||
163931923|NCT03513068|592119947|FG000|Overall Study|Death|1|||
163931924|NCT03513068|592119948|FG001|Overall Study|Death|0|||
163931925|NCT03513068|592119947|FG000|Overall Study|Withdrawal by Subject|4|||
163931926|NCT03513068|592119948|FG001|Overall Study|Withdrawal by Subject|6|||
163931927|NCT03636373|592119950|FG000|Overall Study|Study closure due to Covid-19|1|||
164147697|NCT02006732|592902131|FG002|Overall Study|Adverse Event|4|||
164036116|NCT02661464|592490353|FG000|Overall Study|Participants terminated prematurely|288|||
164036117|NCT02661464|592490354|FG001|Overall Study|Participants terminated prematurely|52|||
164036118|NCT02661464|592490355|FG002|Overall Study|Participants terminated prematurely|1|||
164036119|NCT02661464|592490356|FG003|Overall Study|Participants terminated prematurely|1|||
164036120|NCT02661464|592490353|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
164036121|NCT02661464|592490354|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
164036122|NCT02661464|592490355|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
164036123|NCT02661464|592490356|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
164036124|NCT03148756|592490358|FG000|Overall Study|Study Terminated|0|||
164036125|NCT03148756|592490359|FG001|Overall Study|Study Terminated|1|||
164036126|NCT05567393|592490360|FG000|Overall Study|Voluntary Withdrawal|0|||
164036127|NCT05567393|592490361|FG001|Overall Study|Voluntary Withdrawal|0|||
164036128|NCT05567393|592490362|FG002|Overall Study|Voluntary Withdrawal|0|||
164036129|NCT05567393|592490363|FG003|Overall Study|Voluntary Withdrawal|0|||
164036130|NCT05567393|592490364|FG004|Overall Study|Voluntary Withdrawal|0|||
164036131|NCT05567393|592490365|FG005|Overall Study|Voluntary Withdrawal|0|||
164036132|NCT05567393|592490366|FG006|Overall Study|Voluntary Withdrawal|0|||
164036133|NCT05567393|592490367|FG007|Overall Study|Voluntary Withdrawal|0|||
164036134|NCT05567393|592490368|FG008|Overall Study|Voluntary Withdrawal|0|||
164036135|NCT05567393|592490369|FG009|Overall Study|Voluntary Withdrawal|0|||
164036136|NCT05567393|592490370|FG010|Overall Study|Voluntary Withdrawal|0|||
164036137|NCT05567393|592490371|FG011|Overall Study|Voluntary Withdrawal|0|||
164036138|NCT05567393|592490372|FG012|Overall Study|Voluntary Withdrawal|0|||
164036139|NCT05567393|592490373|FG013|Overall Study|Voluntary Withdrawal|1|||
164036140|NCT05567393|592490374|FG014|Overall Study|Voluntary Withdrawal|0|||
164036141|NCT05567393|592490375|FG015|Overall Study|Voluntary Withdrawal|0|||
164036142|NCT05567393|592490376|FG016|Overall Study|Voluntary Withdrawal|0|||
164036143|NCT05567393|592490377|FG017|Overall Study|Voluntary Withdrawal|0|||
164036144|NCT02177175|592490381|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
164036145|NCT02177175|592490382|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
164036146|NCT01924299|592490383|FG000|Period 2|Withdrawal by Subject|1|||
164036147|NCT01924299|592490384|FG001|Period 2|Withdrawal by Subject|0|||
164036148|NCT01924299|592490383|FG000|Period 2|Adverse Event|0|||
164036149|NCT01924299|592490384|FG001|Period 2|Adverse Event|1|||
164036150|NCT04199793|592490385|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
164036151|NCT04199793|592490386|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
164036152|NCT04199793|592490385|FG000|Overall Study|Withdrawal by Subject|1|||
164036153|NCT04199793|592490386|FG001|Overall Study|Withdrawal by Subject|1|||
164036154|NCT03820726|592490387|FG000|Overall Study|Other than listed|23|||
164036155|NCT03820726|592490387|FG000|Overall Study|Withdrawal by Subject|37|||
164036156|NCT03820726|592490387|FG000|Overall Study|Lost to Follow-up|3|||
164036157|NCT03820726|592490387|FG000|Overall Study|Protocol deviation|1|||
164036158|NCT03820726|592490387|FG000|Overall Study|Adverse Event|146|||
164036159|NCT03820726|592490387|FG000|Overall Study|Not treated|1|||
164036160|NCT00628758|592490391|FG000|Overall Study|Adverse Event|2|||
163836574|NCT00747123|591772268|FG003|Overall Study|Investigator's request|0|||
163836575|NCT00747123|591772265|FG000|Overall Study|Withdrew consent|0|||
164036161|NCT00628758|592490392|FG001|Overall Study|Adverse Event|3|||
164036162|NCT00628758|592490391|FG000|Overall Study|Withdrawal by Subject|6|||
164036163|NCT00628758|592490392|FG001|Overall Study|Withdrawal by Subject|3|||
164036164|NCT00628758|592490391|FG000|Overall Study|Death|1|||
164036165|NCT00628758|592490392|FG001|Overall Study|Death|0|||
164036166|NCT00628758|592490391|FG000|Overall Study|Protocol Violation|5|||
164036167|NCT00628758|592490392|FG001|Overall Study|Protocol Violation|1|||
164036168|NCT00628758|592490391|FG000|Overall Study|Lost to Follow-up|25|||
164036169|NCT00628758|592490392|FG001|Overall Study|Lost to Follow-up|31|||
164036170|NCT00628758|592490391|FG000|Overall Study|Pregnancy|2|||
164036171|NCT00628758|592490392|FG001|Overall Study|Pregnancy|2|||
164036172|NCT00628758|592490391|FG000|Overall Study|Investigator Moved|3|||
164036173|NCT00628758|592490392|FG001|Overall Study|Investigator Moved|0|||
164036174|NCT00628758|592490391|FG000|Overall Study|Treatment Failure|0|||
164036175|NCT00628758|592490392|FG001|Overall Study|Treatment Failure|2|||
163836576|NCT00747123|591772266|FG001|Overall Study|Withdrew consent|1|||
163836577|NCT00747123|591772267|FG002|Overall Study|Withdrew consent|0|||
163836578|NCT00747123|591772268|FG003|Overall Study|Withdrew consent|0|||
163836579|NCT00747123|591772265|FG000|Overall Study|Adverse Event|0|||
163836580|NCT00747123|591772266|FG001|Overall Study|Adverse Event|1|||
163836581|NCT00747123|591772267|FG002|Overall Study|Adverse Event|0|||
163836582|NCT00747123|591772268|FG003|Overall Study|Adverse Event|1|||
163836583|NCT03489057|591772269|FG000|Overall Study|Lost to Follow-up|16|||
163836584|NCT03489057|591772270|FG001|Overall Study|Lost to Follow-up|16|||
163836585|NCT03489057|591772271|FG002|Overall Study|Lost to Follow-up|14|||
163836586|NCT03489057|591772272|FG003|Overall Study|Lost to Follow-up|14|||
164036176|NCT02983799|592490397|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
164036177|NCT02983799|592490398|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
164036178|NCT02983799|592490399|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
163931928|NCT03636373|592119951|FG001|Overall Study|Study closure due to Covid-19|0|||
163931929|NCT01575873|592119952|FG000|Overall Study|Withdrawal by Subject|15|||
163931930|NCT01575873|592119953|FG001|Overall Study|Withdrawal by Subject|20|||
163931931|NCT01575873|592119954|FG002|Overall Study|Withdrawal by Subject|34|||
163931932|NCT01575873|592119955|FG003|Overall Study|Withdrawal by Subject|34|||
163931933|NCT01575873|592119952|FG000|Overall Study|Adverse Event|7|||
163931934|NCT01575873|592119953|FG001|Overall Study|Adverse Event|7|||
163931935|NCT01575873|592119954|FG002|Overall Study|Adverse Event|9|||
163931936|NCT01575873|592119955|FG003|Overall Study|Adverse Event|12|||
163931937|NCT01575873|592119952|FG000|Overall Study|Lost to Follow-up|1|||
163931938|NCT01575873|592119953|FG001|Overall Study|Lost to Follow-up|3|||
163931939|NCT01575873|592119954|FG002|Overall Study|Lost to Follow-up|13|||
163931940|NCT01575873|592119955|FG003|Overall Study|Lost to Follow-up|5|||
163931941|NCT01575873|592119952|FG000|Overall Study|Death|3|||
163931942|NCT01575873|592119953|FG001|Overall Study|Death|2|||
163931943|NCT01575873|592119954|FG002|Overall Study|Death|8|||
163931944|NCT01575873|592119955|FG003|Overall Study|Death|9|||
163931945|NCT01575873|592119952|FG000|Overall Study|Noncompliance|1|||
163931946|NCT01575873|592119953|FG001|Overall Study|Noncompliance|2|||
163931947|NCT01575873|592119954|FG002|Overall Study|Noncompliance|4|||
163931948|NCT01575873|592119955|FG003|Overall Study|Noncompliance|3|||
163931949|NCT01575873|592119952|FG000|Overall Study|Administrative decision|1|||
163931950|NCT01575873|592119953|FG001|Overall Study|Administrative decision|1|||
163931951|NCT01575873|592119954|FG002|Overall Study|Administrative decision|1|||
163931952|NCT01575873|592119955|FG003|Overall Study|Administrative decision|0|||
163931953|NCT01575873|592119952|FG000|Overall Study|Protocol deviation|0|||
163931954|NCT01575873|592119953|FG001|Overall Study|Protocol deviation|1|||
163931955|NCT01575873|592119954|FG002|Overall Study|Protocol deviation|0|||
163836587|NCT03489057|591772269|FG000|Overall Study|Withdrawal by Subject|12|||
163836588|NCT03489057|591772270|FG001|Overall Study|Withdrawal by Subject|12|||
163836589|NCT03489057|591772271|FG002|Overall Study|Withdrawal by Subject|8|||
163836590|NCT03489057|591772272|FG003|Overall Study|Withdrawal by Subject|8|||
163836591|NCT03489057|591772269|FG000|Overall Study|Protocol Violation|7|||
163836592|NCT03489057|591772270|FG001|Overall Study|Protocol Violation|7|||
163836593|NCT03489057|591772271|FG002|Overall Study|Protocol Violation|2|||
163836594|NCT03489057|591772272|FG003|Overall Study|Protocol Violation|2|||
163836595|NCT02277743|591772278|FG000|Overall Study|Protocol Violation|1|||
163836596|NCT02277743|591772279|FG001|Overall Study|Protocol Violation|1|||
163836597|NCT02277743|591772280|FG002|Overall Study|Protocol Violation|1|||
163836598|NCT02277743|591772278|FG000|Overall Study|Adverse Event|10|||
163836599|NCT02277743|591772279|FG001|Overall Study|Adverse Event|6|||
163836600|NCT02277743|591772280|FG002|Overall Study|Adverse Event|6|||
163836601|NCT02277743|591772278|FG000|Overall Study|Lack of Efficacy|11|||
163836602|NCT02277743|591772279|FG001|Overall Study|Lack of Efficacy|4|||
163836603|NCT02277743|591772280|FG002|Overall Study|Lack of Efficacy|3|||
163836604|NCT02277743|591772278|FG000|Overall Study|Other than specified above|18|||
163836605|NCT02277743|591772279|FG001|Overall Study|Other than specified above|5|||
163931956|NCT01575873|592119955|FG003|Overall Study|Protocol deviation|1|||
163931957|NCT01575873|592119952|FG000|Overall Study|Requirement for Alternative Therapy|0|||
163931958|NCT01575873|592119953|FG001|Overall Study|Requirement for Alternative Therapy|0|||
163931959|NCT01575873|592119954|FG002|Overall Study|Requirement for Alternative Therapy|1|||
163931960|NCT01575873|592119955|FG003|Overall Study|Requirement for Alternative Therapy|1|||
164036179|NCT02983799|592490400|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
164036180|NCT02983799|592490401|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
164036181|NCT02983799|592490397|FG000|Overall Study|Death|20|||
164036182|NCT02983799|592490398|FG001|Overall Study|Death|5|||
164036183|NCT02983799|592490399|FG002|Overall Study|Death|23|||
164036184|NCT02983799|592490400|FG003|Overall Study|Death|47|||
164036185|NCT02983799|592490401|FG004|Overall Study|Death|7|||
164036186|NCT02983799|592490397|FG000|Overall Study|Withdrawal by Subject|1|||
163836606|NCT02277743|591772280|FG002|Overall Study|Other than specified above|16|||
163836607|NCT00943306|591772283|FG000|Overall Study|Physician Decision|1|||
163836608|NCT00943306|591772283|FG000|Overall Study|Death|1|||
163836609|NCT00943306|591772283|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
163836610|NCT02739347|591772284|FG000|Overall Study|Adverse Event|3|||
163836611|NCT02739347|591772285|FG001|Overall Study|Adverse Event|0|||
163836612|NCT02739347|591772284|FG000|Overall Study|Protocol Violation|0|||
163836613|NCT02739347|591772285|FG001|Overall Study|Protocol Violation|1|||
163836614|NCT02739347|591772284|FG000|Overall Study|Lost to Follow-up|0|||
163931961|NCT01575873|592119952|FG000|Overall Study|Other|0|||
163931962|NCT01575873|592119953|FG001|Overall Study|Other|0|||
163931963|NCT01575873|592119954|FG002|Overall Study|Other|4|||
163931964|NCT01575873|592119955|FG003|Overall Study|Other|2|||
163931965|NCT01850030|592119956|FG000|Overall Study|Adverse Event|64|||
163931966|NCT01850030|592119957|FG001|Overall Study|Adverse Event|82|||
163931967|NCT01850030|592119956|FG000|Overall Study|Lack of Efficacy|3|||
163931968|NCT01850030|592119957|FG001|Overall Study|Lack of Efficacy|1|||
163931969|NCT01850030|592119956|FG000|Overall Study|Lost to Follow-up|5|||
164036187|NCT02983799|592490398|FG001|Overall Study|Withdrawal by Subject|0|||
164098366|NCT05093205|592725092|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
163836615|NCT02739347|591772285|FG001|Overall Study|Lost to Follow-up|2|||
163836616|NCT01552954|591772286|FG000|Overall Study|Adverse Event|1|||
163836617|NCT01552954|591772287|FG001|Overall Study|Adverse Event|2|||
163836618|NCT01552954|591772286|FG000|Overall Study|Lost to Follow-up|1|||
163836619|NCT01552954|591772287|FG001|Overall Study|Lost to Follow-up|1|||
163836620|NCT01552954|591772286|FG000|Overall Study|Withdrawal by Subject|1|||
163836621|NCT01552954|591772287|FG001|Overall Study|Withdrawal by Subject|1|||
163836622|NCT01552954|591772286|FG000|Overall Study|Protocol Violation|1|||
163836623|NCT01552954|591772287|FG001|Overall Study|Protocol Violation|2|||
163836624|NCT01552954|591772286|FG000|Overall Study|diagnosed DM|1|||
163836625|NCT01552954|591772287|FG001|Overall Study|diagnosed DM|0|||
163836626|NCT00779779|591772288|FG000|Overall Study|Adverse Event|1|||
163836627|NCT00779779|591772288|FG000|Overall Study|Protocol Violation|14|||
163836628|NCT00779779|591772288|FG000|Overall Study|Withdrawal by Subject|4|||
163836629|NCT00779779|591772288|FG000|Overall Study|Lost to Follow-up|5|||
163836630|NCT01395823|591772289|FG000|Overall Study|Death|4|||
163836631|NCT01395823|591772290|FG001|Overall Study|Death|4|||
163836632|NCT01395823|591772289|FG000|Overall Study|Physician Decision|3|||
163836633|NCT01395823|591772290|FG001|Overall Study|Physician Decision|1|||
163836634|NCT01395823|591772289|FG000|Overall Study|Lost to Follow-up|1|||
163836635|NCT01395823|591772290|FG001|Overall Study|Lost to Follow-up|0|||
163836636|NCT01395823|591772289|FG000|Overall Study|Transplant|1|||
163836637|NCT01395823|591772290|FG001|Overall Study|Transplant|0|||
163836638|NCT01395823|591772289|FG000|Overall Study|GI symptoms|1|||
163836639|NCT01395823|591772290|FG001|Overall Study|GI symptoms|0|||
163836640|NCT01395823|591772289|FG000|Overall Study|Withdrawal by Subject|5|||
163836641|NCT01395823|591772290|FG001|Overall Study|Withdrawal by Subject|4|||
163836642|NCT03300570|591772292|FG000|Overall Study|Adverse Event|0|||
163836643|NCT03300570|591772293|FG001|Overall Study|Adverse Event|1|||
163836644|NCT03300570|591772292|FG000|Overall Study|Withdrawal by Subject|1|||
163931970|NCT01850030|592119957|FG001|Overall Study|Lost to Follow-up|5|||
163931971|NCT01850030|592119956|FG000|Overall Study|Withdrawal by Subject|3|||
163931972|NCT01850030|592119957|FG001|Overall Study|Withdrawal by Subject|4|||
163931973|NCT01850030|592119956|FG000|Overall Study|Protocol Violation|24|||
163931974|NCT01850030|592119957|FG001|Overall Study|Protocol Violation|28|||
163931975|NCT01850030|592119956|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
163931976|NCT01850030|592119957|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
163931977|NCT02688530|592119961|FG000|Overall Study|Withdrawal by Subject|0|||
163931978|NCT02688530|592119962|FG001|Overall Study|Withdrawal by Subject|1|||
163931979|NCT02688530|592119963|FG002|Overall Study|Withdrawal by Subject|0|||
163931980|NCT02688530|592119964|FG003|Overall Study|Withdrawal by Subject|0|||
163931981|NCT02688530|592119961|FG000|Overall Study|Lost to Follow-up|0|||
163931982|NCT02688530|592119962|FG001|Overall Study|Lost to Follow-up|0|||
163931983|NCT02688530|592119963|FG002|Overall Study|Lost to Follow-up|2|||
163931984|NCT02688530|592119964|FG003|Overall Study|Lost to Follow-up|0|||
163931985|NCT01658020|592119965|FG000|Overall Study|Adverse Event|3|||
163931986|NCT01658020|592119966|FG001|Overall Study|Adverse Event|3|||
163931987|NCT01658020|592119965|FG000|Overall Study|Lost to Follow-up|1|||
163931988|NCT01658020|592119966|FG001|Overall Study|Lost to Follow-up|0|||
163931989|NCT01658020|592119965|FG000|Overall Study|Withdrawal by Subject|4|||
163931990|NCT01658020|592119966|FG001|Overall Study|Withdrawal by Subject|5|||
163931991|NCT01658020|592119965|FG000|Overall Study|Protocol Violation|0|||
163931992|NCT01658020|592119966|FG001|Overall Study|Protocol Violation|1|||
163931993|NCT03698019|592119969|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
163931994|NCT03698019|592119970|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
163931995|NCT03698019|592119969|FG000|Step 1: Registration|Withdrawal by Subject|7|||
163931996|NCT03698019|592119970|FG001|Step 1: Registration|Withdrawal by Subject|2|||
163931997|NCT03698019|592119969|FG000|Step 1: Registration|Toxicity|0|||
163931998|NCT03698019|592119970|FG001|Step 1: Registration|Toxicity|1|||
163931999|NCT03698019|592119969|FG000|Step 1: Registration|Disease Progression|0|||
163932000|NCT03698019|592119970|FG001|Step 1: Registration|Disease Progression|12|||
163932001|NCT03698019|592119969|FG000|Step 1: Registration|Co-morbidities|0|||
163932002|NCT03698019|592119970|FG001|Step 1: Registration|Co-morbidities|1|||
163932003|NCT03698019|592119969|FG000|Step 1: Registration|Scheduling Issues|1|||
163932004|NCT03698019|592119970|FG001|Step 1: Registration|Scheduling Issues|0|||
163836645|NCT03300570|591772293|FG001|Overall Study|Withdrawal by Subject|0|||
163836646|NCT03300570|591772292|FG000|Overall Study|Inadequate bowel prep|1|||
163836647|NCT03300570|591772293|FG001|Overall Study|Inadequate bowel prep|0|||
163836648|NCT00116272|591772294|FG000|Overall Study|Lost to Follow-up|11|||
163836649|NCT00116272|591772295|FG001|Overall Study|Lost to Follow-up|6|||
163836650|NCT03188120|591772296|FG000|Overall Study|Adverse Event|4|||
163836651|NCT03188120|591772296|FG000|Overall Study|Insufficient Effectiveness|8|||
163932005|NCT03698019|592119969|FG000|Step 1: Registration|Participant Refusal|0|||
163932006|NCT03698019|592119970|FG001|Step 1: Registration|Participant Refusal|1|||
163932007|NCT03698019|592119969|FG000|Step 2: Surgery|Participant Refusal|2|||
163932008|NCT03698019|592119970|FG001|Step 2: Surgery|Participant Refusal|1|||
163932009|NCT03698019|592119969|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
164036188|NCT02983799|592490399|FG002|Overall Study|Withdrawal by Subject|3|||
164036189|NCT02983799|592490400|FG003|Overall Study|Withdrawal by Subject|4|||
164036190|NCT02983799|592490401|FG004|Overall Study|Withdrawal by Subject|1|||
164036191|NCT02983799|592490397|FG000|Overall Study|Protocol Violation|0|||
164036192|NCT02983799|592490398|FG001|Overall Study|Protocol Violation|1|||
164036193|NCT02983799|592490399|FG002|Overall Study|Protocol Violation|0|||
164036194|NCT02983799|592490400|FG003|Overall Study|Protocol Violation|0|||
164036195|NCT02983799|592490401|FG004|Overall Study|Protocol Violation|1|||
164036196|NCT02983799|592490397|FG000|Overall Study|Lost to Follow-up|1|||
164036197|NCT02983799|592490398|FG001|Overall Study|Lost to Follow-up|0|||
164036198|NCT02983799|592490399|FG002|Overall Study|Lost to Follow-up|1|||
164036199|NCT02983799|592490400|FG003|Overall Study|Lost to Follow-up|0|||
164036200|NCT02983799|592490401|FG004|Overall Study|Lost to Follow-up|0|||
164036201|NCT00719862|592490411|FG000|Overall Study|Adverse Event|1|||
164036202|NCT00719862|592490412|FG001|Overall Study|Adverse Event|2|||
164036203|NCT00719862|592490411|FG000|Overall Study|Lack of Efficacy|3|||
164036204|NCT00719862|592490412|FG001|Overall Study|Lack of Efficacy|0|||
164036205|NCT00719862|592490411|FG000|Overall Study|Non-Compliance|1|||
164036206|NCT00719862|592490412|FG001|Overall Study|Non-Compliance|0|||
164036207|NCT00719862|592490411|FG000|Overall Study|Withdrawal by Subject|1|||
164036208|NCT00719862|592490412|FG001|Overall Study|Withdrawal by Subject|0|||
164036209|NCT00719862|592490411|FG000|Overall Study|Lost to Follow-up|0|||
164036210|NCT00719862|592490412|FG001|Overall Study|Lost to Follow-up|1|||
164036211|NCT00719862|592490411|FG000|Overall Study|Other|2|||
164036212|NCT00719862|592490412|FG001|Overall Study|Other|3|||
164036213|NCT01184846|592490413|FG000|Overall Study|Adverse Event|2|||
164036214|NCT01184846|592490413|FG000|Overall Study|Insufficient response|1|||
164036215|NCT01736254|592490415|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
164036216|NCT01736254|592490415|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
164036217|NCT02293902|592490424|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
164036218|NCT02293902|592490425|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
164036219|NCT02293902|592490426|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
164036220|NCT02293902|592490427|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
164036221|NCT02293902|592490428|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
164036222|NCT02293902|592490424|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
164036223|NCT02293902|592490425|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
164036224|NCT02293902|592490426|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
164036225|NCT02293902|592490427|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
164036226|NCT02293902|592490428|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
164036227|NCT02293902|592490424|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
164036228|NCT02293902|592490425|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164036229|NCT02293902|592490426|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164036230|NCT02293902|592490427|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164036231|NCT02293902|592490428|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
164036232|NCT02293902|592490424|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
164036233|NCT02293902|592490425|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
164036234|NCT02293902|592490426|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
164036235|NCT02293902|592490427|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
164036236|NCT02293902|592490428|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
164036237|NCT02293902|592490424|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
164036238|NCT02293902|592490425|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
164036239|NCT02293902|592490426|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
164036240|NCT02293902|592490427|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
164036241|NCT02293902|592490428|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
164036242|NCT00859573|592491949|FG000|Overall Study|Withdrawal by Subject|4|||
164036243|NCT00859573|592491950|FG001|Overall Study|Withdrawal by Subject|1|||
164036244|NCT00859573|592491949|FG000|Overall Study|Physician Decision|1|||
164036245|NCT00859573|592491950|FG001|Overall Study|Physician Decision|1|||
164036246|NCT01135394|592491951|FG000|Screening|Lost to Follow-up|2|||
164036247|NCT01135394|592491951|FG000|Screening|Withdrawal by Subject|10|||
164036248|NCT01135394|592491951|FG000|Screening|Screening failure|16|||
164098367|NCT05093205|592725093|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
164036249|NCT01135394|592491951|FG000|Screening|Physician Decision|5|||
164036250|NCT01135394|592491951|FG000|Baseline Assessment|Withdrawal by Subject|9|||
164036251|NCT01135394|592491951|FG000|Baseline Assessment|Physician Decision|3|||
164036252|NCT01135394|592491951|FG000|Baseline Assessment|Lost to Follow-up|2|||
164036253|NCT01135394|592491951|FG000|Baseline Assessment|Adverse Event|1|||
164036254|NCT01135394|592491951|FG000|Study Treatment|Withdrawal by Subject|1|||
164036255|NCT01135394|592491951|FG000|Study Treatment|Physician Decision|1|||
164036256|NCT01135394|592491951|FG000|Study Treatment|Adverse Event|2|||
164036257|NCT00462488|592491952|FG000|Overall Study|Protocol Violation|1|||
164036258|NCT00462488|592491953|FG001|Overall Study|Protocol Violation|0|||
164036259|NCT00462488|592491952|FG000|Overall Study|Lack of Efficacy|19|||
164036260|NCT00462488|592491953|FG001|Overall Study|Lack of Efficacy|17|||
164036261|NCT03984812|592491954|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036262|NCT03984812|592491955|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036263|NCT03984812|592491956|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
164036264|NCT03984812|592491957|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036265|NCT03984812|592491958|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036266|NCT03984812|592491959|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036267|NCT03984812|592491960|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036268|NCT03984812|592491961|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036269|NCT03984812|592491962|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036270|NCT03984812|592491963|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036271|NCT03984812|592491964|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
164036272|NCT00948194|592491965|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
164036273|NCT00948194|592491966|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
164036274|NCT00438464|592491967|FG000|Overall Study|Terminated Early|14|||
164036275|NCT00438464|592491968|FG001|Overall Study|Terminated Early|5|||
164036276|NCT00438464|592491967|FG000|Overall Study|Incomplete data submission|0|||
164036277|NCT00438464|592491968|FG001|Overall Study|Incomplete data submission|2|||
164036278|NCT00728936|592491969|FG000|Overall Study|Withdrawal by Subject|0|||
164036279|NCT00728936|592491970|FG001|Overall Study|Withdrawal by Subject|0|||
164036280|NCT00728936|592491971|FG002|Overall Study|Withdrawal by Subject|0|||
164036281|NCT00728936|592491972|FG003|Overall Study|Withdrawal by Subject|0|||
164036282|NCT00728936|592491973|FG004|Overall Study|Withdrawal by Subject|0|||
164036283|NCT00728936|592491974|FG005|Overall Study|Withdrawal by Subject|1|||
164036284|NCT00728936|592491975|FG006|Overall Study|Withdrawal by Subject|0|||
164036285|NCT03943446|592491976|FG000|Overall Study|Lost to Follow-up|0|||
164036286|NCT03943446|592491977|FG001|Overall Study|Lost to Follow-up|0|||
164036287|NCT03943446|592491978|FG002|Overall Study|Lost to Follow-up|1|||
164036288|NCT03943446|592491976|FG000|Overall Study|Withdrawal by Subject|1|||
164036289|NCT03943446|592491977|FG001|Overall Study|Withdrawal by Subject|1|||
164036290|NCT03943446|592491978|FG002|Overall Study|Withdrawal by Subject|2|||
164036291|NCT03943446|592491976|FG000|Overall Study|Study Terminated by Sponsor|1|||
164036292|NCT03943446|592491977|FG001|Overall Study|Study Terminated by Sponsor|2|||
164036293|NCT03943446|592491978|FG002|Overall Study|Study Terminated by Sponsor|1|||
164036294|NCT03943446|592491976|FG000|Overall Study|Reason not Specified|5|||
164036295|NCT03943446|592491977|FG001|Overall Study|Reason not Specified|1|||
164098368|NCT05093205|592725094|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
164098369|NCT05093205|592725095|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
164098370|NCT05093205|592725083|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
164098371|NCT05093205|592725084|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
164098372|NCT05093205|592725085|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
164098373|NCT05093205|592725086|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
164098374|NCT05093205|592725087|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
164098375|NCT05093205|592725088|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
164098376|NCT05093205|592725089|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
164098377|NCT05093205|592725090|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
164098378|NCT05093205|592725091|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
164098379|NCT05093205|592725092|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
164098380|NCT05093205|592725093|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
164098381|NCT05093205|592725094|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
164098382|NCT05093205|592725095|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
164098383|NCT05093205|592725083|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098384|NCT05093205|592725084|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098385|NCT05093205|592725085|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098386|NCT05093205|592725086|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098387|NCT05093205|592725087|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098388|NCT05093205|592725088|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098389|NCT05093205|592725089|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098390|NCT05093205|592725090|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098391|NCT05093205|592725091|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098392|NCT05093205|592725092|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
164098393|NCT05093205|592725093|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098394|NCT05093205|592725094|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098395|NCT05093205|592725095|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
164098396|NCT05093205|592725083|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
164098397|NCT05093205|592725084|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
164098398|NCT05093205|592725085|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
164098399|NCT05093205|592725086|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
164098400|NCT05093205|592725087|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
164098401|NCT05093205|592725088|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
164098402|NCT05093205|592725089|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
164098403|NCT05093205|592725090|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
164098404|NCT05093205|592725091|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
164036296|NCT03943446|592491978|FG002|Overall Study|Reason not Specified|3|||
164036297|NCT02905825|592491979|FG000|Overall Study|Protocol Violation|11|||
164036298|NCT02905825|592491979|FG000|Overall Study|Device Malfunction|1|||
164036299|NCT05355818|592491980|FG000|Overall Study|Adverse Event|1|||
164036300|NCT05355818|592491981|FG001|Overall Study|Adverse Event|1|||
164036301|NCT05355818|592491980|FG000|Overall Study|Lack of Efficacy|2|||
164036302|NCT05355818|592491981|FG001|Overall Study|Lack of Efficacy|1|||
164036303|NCT05355818|592491980|FG000|Overall Study|Lost to Follow-up|0|||
164036304|NCT05355818|592491981|FG001|Overall Study|Lost to Follow-up|1|||
164036305|NCT01563107|592491982|FG000|Overall Study|Physician Decision|0|||
164036306|NCT01563107|592491983|FG001|Overall Study|Physician Decision|1|||
164036307|NCT01563107|592491984|FG002|Overall Study|Physician Decision|1|||
164036308|NCT01563107|592491985|FG003|Overall Study|Physician Decision|3|||
164036309|NCT01563107|592491982|FG000|Overall Study|Withdrawal by Subject|1|||
164036310|NCT01563107|592491983|FG001|Overall Study|Withdrawal by Subject|2|||
164036311|NCT01563107|592491984|FG002|Overall Study|Withdrawal by Subject|1|||
164036312|NCT01563107|592491985|FG003|Overall Study|Withdrawal by Subject|2|||
164036313|NCT00247273|592491987|FG000|Overall Study|Adverse Event|85|||
164036314|NCT00247273|592491988|FG001|Overall Study|Adverse Event|80|||
164036315|NCT00247273|592491987|FG000|Overall Study|Physician Decision|6|||
164036316|NCT00247273|592491988|FG001|Overall Study|Physician Decision|3|||
164036317|NCT00247273|592491987|FG000|Overall Study|Lost to Follow-up|7|||
164036318|NCT00247273|592491988|FG001|Overall Study|Lost to Follow-up|7|||
164036319|NCT00247273|592491987|FG000|Overall Study|Withdrawal by Subject|46|||
164036320|NCT00247273|592491988|FG001|Overall Study|Withdrawal by Subject|47|||
164036321|NCT00247273|592491987|FG000|Overall Study|Did not take any study drug|2|||
164036322|NCT00247273|592491988|FG001|Overall Study|Did not take any study drug|0|||
164036323|NCT01709708|592492001|FG000|Overall Study|Protocol Violation|1|||
164036324|NCT01709708|592492002|FG001|Overall Study|Protocol Violation|2|||
164036325|NCT00511108|592492005|FG000|Overall Study|Adverse Event|2|||
164036326|NCT00511108|592492006|FG001|Overall Study|Adverse Event|0|||
164036327|NCT00511108|592492007|FG002|Overall Study|Adverse Event|1|||
164036328|NCT00511108|592492008|FG003|Overall Study|Adverse Event|2|||
164036329|NCT00511108|592492005|FG000|Overall Study|Lost to Follow-up|0|||
164036330|NCT00511108|592492006|FG001|Overall Study|Lost to Follow-up|2|||
164036331|NCT00511108|592492007|FG002|Overall Study|Lost to Follow-up|1|||
164036332|NCT00511108|592492008|FG003|Overall Study|Lost to Follow-up|0|||
164036333|NCT00511108|592492005|FG000|Overall Study|Physician Decision|0|||
164036334|NCT00511108|592492006|FG001|Overall Study|Physician Decision|0|||
164036335|NCT00511108|592492007|FG002|Overall Study|Physician Decision|0|||
164036336|NCT00511108|592492008|FG003|Overall Study|Physician Decision|1|||
164036337|NCT00511108|592492005|FG000|Overall Study|Withdrawal by Subject|4|||
164036338|NCT00511108|592492006|FG001|Overall Study|Withdrawal by Subject|0|||
164036339|NCT00511108|592492007|FG002|Overall Study|Withdrawal by Subject|3|||
164036340|NCT00511108|592492008|FG003|Overall Study|Withdrawal by Subject|2|||
164036341|NCT02954952|592492009|FG000|Overall Study|Withdrawal by Subject|1|||
164036342|NCT02954952|592492010|FG001|Overall Study|Withdrawal by Subject|0|||
164036343|NCT02954952|592492011|FG002|Overall Study|Withdrawal by Subject|0|||
164036344|NCT02954952|592492009|FG000|Overall Study|No data collected|0|||
164036345|NCT02954952|592492010|FG001|Overall Study|No data collected|1|||
164036346|NCT02954952|592492011|FG002|Overall Study|No data collected|0|||
164036347|NCT02911519|592492012|FG000|Overall Study|Lost to Follow-up|2|||
164036348|NCT02911519|592492013|FG001|Overall Study|Lost to Follow-up|2|||
164036349|NCT02911519|592492012|FG000|Overall Study|Death|0|||
164036350|NCT02911519|592492013|FG001|Overall Study|Death|2|||
164036351|NCT00810043|592492014|FG000|Overall Study|Withdrawal by Subject|1|||
164036352|NCT00810043|592492015|FG001|Overall Study|Withdrawal by Subject|0|||
164036353|NCT00810043|592492016|FG002|Overall Study|Withdrawal by Subject|2|||
164036354|NCT00810043|592492014|FG000|Overall Study|Lost to Follow-up|1|||
164036355|NCT00810043|592492015|FG001|Overall Study|Lost to Follow-up|0|||
164036356|NCT00810043|592492016|FG002|Overall Study|Lost to Follow-up|0|||
164036357|NCT00810043|592492014|FG000|Overall Study|Physician Decision|0|||
164036358|NCT00810043|592492015|FG001|Overall Study|Physician Decision|0|||
164036359|NCT00810043|592492016|FG002|Overall Study|Physician Decision|2|||
164036360|NCT00810043|592492014|FG000|Overall Study|Death|2|||
164036361|NCT00810043|592492015|FG001|Overall Study|Death|0|||
164036362|NCT00810043|592492016|FG002|Overall Study|Death|0|||
164036363|NCT00810043|592492014|FG000|Overall Study|Unrelated medical problem|0|||
164036364|NCT00810043|592492015|FG001|Overall Study|Unrelated medical problem|1|||
164036365|NCT00810043|592492016|FG002|Overall Study|Unrelated medical problem|0|||
164036366|NCT00810043|592492014|FG000|Overall Study|Non-medical problem|0|||
164036367|NCT00810043|592492015|FG001|Overall Study|Non-medical problem|0|||
164036368|NCT00810043|592492016|FG002|Overall Study|Non-medical problem|1|||
164036369|NCT00810043|592492014|FG000|Overall Study|No longer met enrollment criteria|0|||
164036370|NCT00810043|592492015|FG001|Overall Study|No longer met enrollment criteria|0|||
164036371|NCT00810043|592492016|FG002|Overall Study|No longer met enrollment criteria|3|||
164036372|NCT02001688|592492017|FG000|Overall Study|Withdrawal by Subject|0|||
164036373|NCT02001688|592492018|FG001|Overall Study|Withdrawal by Subject|0|||
164036374|NCT02001688|592492019|FG002|Overall Study|Withdrawal by Subject|1|||
164036375|NCT02001688|592492017|FG000|Overall Study|Adverse Event|0|||
163836652|NCT03188120|591772296|FG000|Overall Study|Improved|12|||
163836653|NCT03188120|591772296|FG000|Overall Study|Lost to Follow-up|7|||
163836654|NCT03188120|591772296|FG000|Overall Study|Other than specified|3|||
163836655|NCT03188120|591772296|FG000|Overall Study|No visit after the first visit|13|||
163836656|NCT01235403|591772298|FG000|Overall Study|Adverse Event|14|||
163836657|NCT01235403|591772298|FG000|Overall Study|Lost to Follow-up|2|||
163836658|NCT01235403|591772298|FG000|Overall Study|Withdrawal by Subject|4|||
163836659|NCT01235403|591772298|FG000|Overall Study|Lack of Efficacy|2|||
163836660|NCT01235403|591772298|FG000|Overall Study|Other reasons for premature termination|4|||
163836661|NCT02296190|591772299|FG000|Overall Study|Lost to Follow-up|0|||
163836662|NCT02296190|591772300|FG001|Overall Study|Lost to Follow-up|0|||
163836663|NCT02296190|591772301|FG002|Overall Study|Lost to Follow-up|0|||
163836664|NCT02296190|591772302|FG003|Overall Study|Lost to Follow-up|0|||
163836665|NCT02296190|591772303|FG004|Overall Study|Lost to Follow-up|1|||
163836666|NCT02296190|591772304|FG005|Overall Study|Lost to Follow-up|0|||
163836667|NCT02296190|591772299|FG000|Overall Study|Failure to induce PSVT|6|||
163836668|NCT02296190|591772300|FG001|Overall Study|Failure to induce PSVT|10|||
163836669|NCT02296190|591772301|FG002|Overall Study|Failure to induce PSVT|5|||
163836670|NCT02296190|591772302|FG003|Overall Study|Failure to induce PSVT|13|||
163836671|NCT02296190|591772303|FG004|Overall Study|Failure to induce PSVT|8|||
163836672|NCT02296190|591772304|FG005|Overall Study|Failure to induce PSVT|0|||
163836673|NCT02296190|591772299|FG000|Overall Study|Physician Decision|1|||
163836674|NCT02296190|591772300|FG001|Overall Study|Physician Decision|1|||
163836675|NCT02296190|591772301|FG002|Overall Study|Physician Decision|0|||
163836676|NCT02296190|591772302|FG003|Overall Study|Physician Decision|1|||
163836677|NCT02296190|591772303|FG004|Overall Study|Physician Decision|2|||
163836678|NCT02296190|591772304|FG005|Overall Study|Physician Decision|0|||
163836679|NCT02296190|591772299|FG000|Overall Study|Withdrawal by Subject|0|||
163836680|NCT02296190|591772300|FG001|Overall Study|Withdrawal by Subject|1|||
163836681|NCT02296190|591772301|FG002|Overall Study|Withdrawal by Subject|0|||
163836682|NCT02296190|591772302|FG003|Overall Study|Withdrawal by Subject|0|||
163836683|NCT02296190|591772303|FG004|Overall Study|Withdrawal by Subject|0|||
163836684|NCT02296190|591772304|FG005|Overall Study|Withdrawal by Subject|0|||
163836685|NCT02296190|591772299|FG000|Overall Study|PSVT < 5 minutes|5|||
163836686|NCT02296190|591772300|FG001|Overall Study|PSVT < 5 minutes|6|||
163836687|NCT02296190|591772301|FG002|Overall Study|PSVT < 5 minutes|6|||
163836688|NCT02296190|591772302|FG003|Overall Study|PSVT < 5 minutes|6|||
163836689|NCT02296190|591772303|FG004|Overall Study|PSVT < 5 minutes|5|||
163836690|NCT02296190|591772304|FG005|Overall Study|PSVT < 5 minutes|0|||
163836691|NCT02296190|591772299|FG000|Overall Study|Patient was given Propofol|0|||
163836692|NCT02296190|591772300|FG001|Overall Study|Patient was given Propofol|1|||
163836693|NCT02296190|591772301|FG002|Overall Study|Patient was given Propofol|0|||
163836694|NCT02296190|591772302|FG003|Overall Study|Patient was given Propofol|1|||
163836695|NCT02296190|591772303|FG004|Overall Study|Patient was given Propofol|0|||
163836696|NCT02296190|591772304|FG005|Overall Study|Patient was given Propofol|0|||
163836697|NCT02296190|591772299|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
163836698|NCT02296190|591772300|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
163836699|NCT02296190|591772301|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
163836700|NCT02296190|591772302|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
163836701|NCT02296190|591772303|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
163836702|NCT02296190|591772304|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
163836703|NCT02296190|591772299|FG000|Overall Study|Blood pressure <100 after sedation|0|||
163836704|NCT02296190|591772300|FG001|Overall Study|Blood pressure <100 after sedation|0|||
163836705|NCT02296190|591772301|FG002|Overall Study|Blood pressure <100 after sedation|0|||
163836706|NCT02296190|591772302|FG003|Overall Study|Blood pressure <100 after sedation|1|||
163836707|NCT02296190|591772303|FG004|Overall Study|Blood pressure <100 after sedation|0|||
163836708|NCT02296190|591772304|FG005|Overall Study|Blood pressure <100 after sedation|0|||
163836709|NCT02296190|591772299|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163836710|NCT02296190|591772300|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
163836711|NCT02296190|591772301|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
163836712|NCT02296190|591772302|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163836713|NCT02296190|591772303|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163836714|NCT02296190|591772304|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
163836715|NCT02296190|591772299|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
163836716|NCT02296190|591772300|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
163836717|NCT02296190|591772301|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
163836718|NCT02296190|591772302|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
163836719|NCT02296190|591772303|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
163836720|NCT02296190|591772304|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
163836721|NCT02296190|591772299|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163836722|NCT02296190|591772300|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
163836723|NCT02296190|591772301|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163836724|NCT02296190|591772302|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163836725|NCT02296190|591772303|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163836726|NCT02296190|591772304|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
163836727|NCT02296190|591772299|FG000|Overall Study|Lab result not available in time|1|||
163836728|NCT02296190|591772300|FG001|Overall Study|Lab result not available in time|0|||
163836729|NCT02296190|591772301|FG002|Overall Study|Lab result not available in time|0|||
163836730|NCT02296190|591772302|FG003|Overall Study|Lab result not available in time|0|||
163836731|NCT02296190|591772303|FG004|Overall Study|Lab result not available in time|0|||
163836732|NCT02296190|591772304|FG005|Overall Study|Lab result not available in time|0|||
163836733|NCT00717314|591772306|FG000|Overall Study|Adverse Event|3|||
163836734|NCT00717314|591772307|FG001|Overall Study|Adverse Event|2|||
163836735|NCT00717314|591772306|FG000|Overall Study|Protocol Violation|1|||
163836736|NCT00717314|591772307|FG001|Overall Study|Protocol Violation|0|||
163836737|NCT00717314|591772306|FG000|Overall Study|Lost to Follow-up|1|||
163836738|NCT00717314|591772307|FG001|Overall Study|Lost to Follow-up|5|||
163836739|NCT00717314|591772306|FG000|Overall Study|Withdrawal by Subject|1|||
163836740|NCT00717314|591772307|FG001|Overall Study|Withdrawal by Subject|3|||
163836741|NCT05096208|591772308|FG000|Overall Study|Lost to Follow-up|3|||
163932010|NCT03698019|592119970|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
163932011|NCT03698019|592119969|FG000|Step 2: Surgery|Metastatic Disease|16|||
163932012|NCT03698019|592119970|FG001|Step 2: Surgery|Metastatic Disease|9|||
163932013|NCT03698019|592119969|FG000|Step 2: Surgery|Residual Disease|2|||
163932014|NCT03698019|592119970|FG001|Step 2: Surgery|Residual Disease|1|||
163932015|NCT03698019|592119969|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
163932016|NCT03698019|592119970|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
163932017|NCT03698019|592119969|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
163932018|NCT03698019|592119970|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
163932019|NCT03698019|592119969|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
163932020|NCT03698019|592119970|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
163932021|NCT03698019|592119969|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
163932022|NCT03698019|592119970|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
163932023|NCT03698019|592119969|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
163932024|NCT03698019|592119970|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
163932025|NCT03698019|592119969|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
163932026|NCT03698019|592119970|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
163932027|NCT03698019|592119969|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
163932028|NCT03698019|592119970|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
163932029|NCT03698019|592119969|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
164036376|NCT02001688|592492018|FG001|Overall Study|Adverse Event|1|||
164036377|NCT02001688|592492019|FG002|Overall Study|Adverse Event|0|||
163836742|NCT05096208|591772309|FG001|Overall Study|Lost to Follow-up|5|||
163836743|NCT05096208|591772310|FG002|Overall Study|Lost to Follow-up|5|||
163836744|NCT05096208|591772311|FG003|Overall Study|Lost to Follow-up|2|||
163836745|NCT05096208|591772308|FG000|Overall Study|Withdrawal by Subject|0|||
163836746|NCT05096208|591772309|FG001|Overall Study|Withdrawal by Subject|1|||
163836747|NCT05096208|591772310|FG002|Overall Study|Withdrawal by Subject|2|||
163836748|NCT05096208|591772311|FG003|Overall Study|Withdrawal by Subject|3|||
163836749|NCT05096208|591772308|FG000|Overall Study|No longer met eligibility criteria|1|||
163836750|NCT05096208|591772309|FG001|Overall Study|No longer met eligibility criteria|0|||
163836751|NCT05096208|591772310|FG002|Overall Study|No longer met eligibility criteria|0|||
163836752|NCT05096208|591772311|FG003|Overall Study|No longer met eligibility criteria|0|||
163836753|NCT05096208|591772308|FG000|Overall Study|Other|0|||
163836754|NCT05096208|591772309|FG001|Overall Study|Other|0|||
164036378|NCT01675141|592492023|FG000|Overall Study|Lenalidomide outside NIH|3|||
164036379|NCT01675141|592492023|FG000|Overall Study|Withdrawal by Subject|3|||
163836755|NCT05096208|591772310|FG002|Overall Study|Other|1|||
163836756|NCT05096208|591772311|FG003|Overall Study|Other|0|||
163836757|NCT00782496|591772312|FG000|Overall Study|Lost to Follow-up|14|||
163836758|NCT00782496|591772313|FG001|Overall Study|Lost to Follow-up|15|||
163836759|NCT01483937|591772315|FG000|Overall Study|Withdrawal by Subject|4|||
163836760|NCT01483937|591772316|FG001|Overall Study|Withdrawal by Subject|3|||
163836761|NCT00399763|591772317|FG000|Overall Study|Lost to Follow-up|2|||
163836762|NCT00399763|591772318|FG001|Overall Study|Lost to Follow-up|3|||
163836763|NCT01833143|591772321|FG000|Overall Study|Not Treated|1|||
163836764|NCT00116844|591772322|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
163836765|NCT00116844|591772323|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
163836766|NCT00116844|591772322|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
163836767|NCT00116844|591772323|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
163836768|NCT00116844|591772322|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
163836769|NCT00116844|591772323|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
163836770|NCT00116844|591772322|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
163836771|NCT00116844|591772323|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
163836772|NCT00116844|591772322|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
163932030|NCT03698019|592119970|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
164036380|NCT01675141|592492023|FG000|Overall Study|Physician Decision|4|||
163836773|NCT00116844|591772323|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
163836774|NCT00116844|591772322|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
163836775|NCT00116844|591772323|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
163836776|NCT00116844|591772322|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
163836777|NCT00116844|591772323|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
163836778|NCT00116844|591772322|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
163836779|NCT00116844|591772323|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
163836780|NCT00116844|591772322|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
163836781|NCT00116844|591772323|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
163836782|NCT00926003|591772324|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
163836783|NCT00926003|591772325|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
163836784|NCT00926003|591772326|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
163836785|NCT00926003|591772324|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
163836786|NCT00926003|591772325|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
163836787|NCT00926003|591772326|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
163836788|NCT00386308|591774292|FG000|Overall Study|Adverse Event|3|||
163836789|NCT00386308|591774293|FG001|Overall Study|Adverse Event|3|||
163836790|NCT00386308|591774292|FG000|Overall Study|Protocol Violation|2|||
163932031|NCT03668223|592119971|FG000|Overall Study|Death|10|||
163932032|NCT03668223|592119972|FG001|Overall Study|Death|5|||
163932033|NCT03668223|592119971|FG000|Overall Study|Lost to Follow-up|12|||
163932034|NCT03668223|592119972|FG001|Overall Study|Lost to Follow-up|12|||
163932035|NCT03668223|592119971|FG000|Overall Study|Withdrawal by Subject|8|||
163932036|NCT03668223|592119972|FG001|Overall Study|Withdrawal by Subject|3|||
163932037|NCT05502783|592119973|FG000|Overall Study|Lack of Efficacy|1|||
163932038|NCT02035696|592121620|FG000|Overall Study|Lost to Follow-up|0|||
163932039|NCT02035696|592121621|FG001|Overall Study|Lost to Follow-up|3|||
163836791|NCT00386308|591774293|FG001|Overall Study|Protocol Violation|5|||
163836792|NCT00386308|591774292|FG000|Overall Study|Lack of Efficacy|0|||
163836793|NCT00386308|591774293|FG001|Overall Study|Lack of Efficacy|2|||
163836794|NCT00386308|591774292|FG000|Overall Study|Lost to Follow-up|10|||
163836795|NCT00386308|591774293|FG001|Overall Study|Lost to Follow-up|6|||
163836796|NCT00386308|591774292|FG000|Overall Study|Withdrawal by Subject|6|||
163836797|NCT00386308|591774293|FG001|Overall Study|Withdrawal by Subject|2|||
163836798|NCT00386308|591774292|FG000|Overall Study|Other Event|8|||
163836799|NCT00386308|591774293|FG001|Overall Study|Other Event|1|||
163836800|NCT01167179|591774294|FG000|Overall Study|disease recurrence|4|||
163836801|NCT01167179|591774295|FG001|Overall Study|disease recurrence|4|||
163836802|NCT01167179|591774294|FG000|Overall Study|Death|4|||
163836803|NCT01167179|591774295|FG001|Overall Study|Death|10|||
163836804|NCT01167179|591774294|FG000|Overall Study|Withdrawal by Subject|1|||
163836805|NCT01167179|591774295|FG001|Overall Study|Withdrawal by Subject|2|||
163836806|NCT01167179|591774294|FG000|Overall Study|diverse|6|||
163836807|NCT01167179|591774295|FG001|Overall Study|diverse|5|||
163836808|NCT02769065|591774296|FG000|Overall Study|Voluntary Withdrawal|1|||
163836809|NCT02769065|591774297|FG001|Overall Study|Voluntary Withdrawal|0|||
163836810|NCT02769065|591774298|FG002|Overall Study|Voluntary Withdrawal|0|||
163836811|NCT02769065|591774299|FG003|Overall Study|Voluntary Withdrawal|0|||
163836812|NCT02769065|591774300|FG004|Overall Study|Voluntary Withdrawal|0|||
163836813|NCT02769065|591774301|FG005|Overall Study|Voluntary Withdrawal|0|||
163836814|NCT02769065|591774302|FG006|Overall Study|Voluntary Withdrawal|0|||
163836815|NCT02769065|591774303|FG007|Overall Study|Voluntary Withdrawal|0|||
163836816|NCT02769065|591774304|FG008|Overall Study|Voluntary Withdrawal|0|||
163836817|NCT02769065|591774305|FG009|Overall Study|Voluntary Withdrawal|0|||
163836818|NCT02769065|591774306|FG010|Overall Study|Voluntary Withdrawal|0|||
163836819|NCT02769065|591774307|FG011|Overall Study|Voluntary Withdrawal|0|||
163836820|NCT02769065|591774308|FG012|Overall Study|Voluntary Withdrawal|0|||
163836821|NCT02769065|591774309|FG013|Overall Study|Voluntary Withdrawal|0|||
163836822|NCT02769065|591774310|FG014|Overall Study|Voluntary Withdrawal|0|||
163836823|NCT02769065|591774311|FG015|Overall Study|Voluntary Withdrawal|0|||
163836824|NCT02769065|591774312|FG016|Overall Study|Voluntary Withdrawal|0|||
163836825|NCT02769065|591774313|FG017|Overall Study|Voluntary Withdrawal|0|||
163932040|NCT02035696|592121622|FG002|Overall Study|Lost to Follow-up|1|||
163932041|NCT02035696|592121623|FG003|Overall Study|Lost to Follow-up|2|||
163932042|NCT02035696|592121620|FG000|Overall Study|Withdrawal by Subject|3|||
163932043|NCT02035696|592121621|FG001|Overall Study|Withdrawal by Subject|0|||
163932044|NCT02035696|592121622|FG002|Overall Study|Withdrawal by Subject|2|||
163932045|NCT02035696|592121623|FG003|Overall Study|Withdrawal by Subject|1|||
163932046|NCT00379769|592121624|FG000|Main Study|Death|57|||
163932047|NCT00379769|592121625|FG001|Main Study|Death|67|||
163932048|NCT00379769|592121626|FG002|Main Study|Death|54|||
163932049|NCT00379769|592121627|FG003|Main Study|Death|72|||
163932050|NCT00379769|592121628|FG004|Main Study|Death|0|||
163932051|NCT00379769|592121629|FG005|Main Study|Death|0|||
163932052|NCT00379769|592121624|FG000|Main Study|Adverse Event|5|||
163932053|NCT00379769|592121625|FG001|Main Study|Adverse Event|8|||
163932054|NCT00379769|592121626|FG002|Main Study|Adverse Event|10|||
164036381|NCT01675141|592492023|FG000|Overall Study|No treatment, per protocol|1|||
164036382|NCT02443805|592492034|FG000|Overall Study|Adverse Event|100|||
164036383|NCT02443805|592492035|FG001|Overall Study|Adverse Event|18|||
164036384|NCT02443805|592492034|FG000|Overall Study|Withdrawal by Subject|73|||
164036385|NCT02443805|592492035|FG001|Overall Study|Withdrawal by Subject|74|||
164036386|NCT02443805|592492034|FG000|Overall Study|Lost to Follow-up|19|||
164036387|NCT02443805|592492035|FG001|Overall Study|Lost to Follow-up|14|||
164036388|NCT02443805|592492034|FG000|Overall Study|Pregnancy|6|||
164036389|NCT02443805|592492035|FG001|Overall Study|Pregnancy|5|||
164036390|NCT02443805|592492034|FG000|Overall Study|Protocol Violation|2|||
164036391|NCT02443805|592492035|FG001|Overall Study|Protocol Violation|4|||
164036392|NCT02443805|592492034|FG000|Overall Study|Lack of Efficacy|1|||
164036393|NCT02443805|592492035|FG001|Overall Study|Lack of Efficacy|1|||
164036394|NCT02443805|592492034|FG000|Overall Study|Non-compliance with study drug|6|||
164036395|NCT02443805|592492035|FG001|Overall Study|Non-compliance with study drug|4|||
164036396|NCT02443805|592492034|FG000|Overall Study|Withdrawal by parent/guardian|3|||
164036397|NCT02443805|592492035|FG001|Overall Study|Withdrawal by parent/guardian|5|||
164036398|NCT02443805|592492034|FG000|Overall Study|Any other reason not above-mentioned|3|||
164036399|NCT02443805|592492035|FG001|Overall Study|Any other reason not above-mentioned|2|||
164036400|NCT00961116|592492036|FG000|Washout Period of 7 Days|Adverse Event|1|||
164036401|NCT00961116|592492037|FG001|Washout Period of 7 Days|Adverse Event|1|||
164036402|NCT00961116|592492036|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164036403|NCT00961116|592492037|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164036404|NCT00961116|592492036|FG000|Washout Period of 7 Days|Protocol Violation|0|||
164036405|NCT00961116|592492037|FG001|Washout Period of 7 Days|Protocol Violation|1|||
164036406|NCT00968708|592492038|FG000|Overall Study|Adverse Event|169|||
164036407|NCT00968708|592492039|FG001|Overall Study|Adverse Event|150|||
164036408|NCT00968708|592492038|FG000|Overall Study|Major Protocol Deviation|0|||
164036409|NCT00968708|592492039|FG001|Overall Study|Major Protocol Deviation|1|||
164036410|NCT00968708|592492038|FG000|Overall Study|Lost to Follow-up|19|||
164036411|NCT00968708|592492039|FG001|Overall Study|Lost to Follow-up|11|||
164036412|NCT00968708|592492038|FG000|Overall Study|Voluntary Withdrawal|104|||
164036413|NCT00968708|592492039|FG001|Overall Study|Voluntary Withdrawal|101|||
164036414|NCT00968708|592492038|FG000|Overall Study|Investigator Discretion|0|||
164036415|NCT00968708|592492039|FG001|Overall Study|Investigator Discretion|1|||
164036416|NCT00968708|592492038|FG000|Overall Study|Other|26|||
164036417|NCT00968708|592492039|FG001|Overall Study|Other|34|||
164036418|NCT02708966|592492040|FG000|Overall Study|Lost to Follow-up|2|||
164036419|NCT02708966|592492041|FG001|Overall Study|Lost to Follow-up|2|||
164036420|NCT00389441|592492042|FG000|Overall Study|Adverse Event|7|||
164036421|NCT00389441|592492042|FG000|Overall Study|Death|4|||
164036422|NCT00389441|592492042|FG000|Overall Study|Lost to Follow-up|2|||
164036423|NCT00389441|592492042|FG000|Overall Study|Withdrawal by Subject|4|||
164036424|NCT00389441|592492042|FG000|Overall Study|Physician Decision|1|||
164036425|NCT00389441|592492042|FG000|Overall Study|Protocol Violation|1|||
164036426|NCT00389441|592492042|FG000|Overall Study|Global deterioration of health status|4|||
164036427|NCT00389441|592492042|FG000|Overall Study|Objective progression or relapse|26|||
164036428|NCT00389441|592492042|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
164036429|NCT00389441|592492042|FG000|Overall Study|Clinical progression|1|||
164036430|NCT03407170|592492043|FG000|Overall Study|Adverse Event|1|||
164036431|NCT00105560|592492045|FG000|Overall Study|Lost to Follow-up|1|||
164036432|NCT00636441|592492046|FG000|Overall Study|Adverse Event|0|||
164036433|NCT00636441|592492047|FG001|Overall Study|Adverse Event|1|||
164036434|NCT00636441|592492048|FG002|Overall Study|Adverse Event|1|||
164036435|NCT00636441|592492049|FG003|Overall Study|Adverse Event|0|||
164036436|NCT00636441|592492050|FG004|Overall Study|Adverse Event|0|||
164036437|NCT00636441|592492051|FG005|Overall Study|Adverse Event|1|||
164036438|NCT00636441|592492052|FG006|Overall Study|Adverse Event|0|||
164036439|NCT00636441|592492046|FG000|Overall Study|Late, ineligible|0|||
164036440|NCT00636441|592492047|FG001|Overall Study|Late, ineligible|0|||
164036441|NCT00636441|592492048|FG002|Overall Study|Late, ineligible|0|||
164036442|NCT00636441|592492049|FG003|Overall Study|Late, ineligible|0|||
164036443|NCT00636441|592492050|FG004|Overall Study|Late, ineligible|0|||
164036444|NCT00636441|592492051|FG005|Overall Study|Late, ineligible|0|||
164036445|NCT00636441|592492052|FG006|Overall Study|Late, ineligible|1|||
164036446|NCT00636441|592492046|FG000|Overall Study|Screen Failure|0|||
164036447|NCT00636441|592492047|FG001|Overall Study|Screen Failure|0|||
164036448|NCT00636441|592492048|FG002|Overall Study|Screen Failure|0|||
164036449|NCT00636441|592492049|FG003|Overall Study|Screen Failure|0|||
164036450|NCT00636441|592492050|FG004|Overall Study|Screen Failure|0|||
164036451|NCT00636441|592492051|FG005|Overall Study|Screen Failure|0|||
164036452|NCT00636441|592492052|FG006|Overall Study|Screen Failure|17|||
164036453|NCT00305604|592492054|FG000|Overall Study|Adverse Event|6|||
164036454|NCT00305604|592492055|FG001|Overall Study|Adverse Event|3|||
164036455|NCT00305604|592492054|FG000|Overall Study|Lack of Efficacy|11|||
164036456|NCT00305604|592492055|FG001|Overall Study|Lack of Efficacy|18|||
164036457|NCT00305604|592492054|FG000|Overall Study|Lost to Follow-up|0|||
164036458|NCT00305604|592492055|FG001|Overall Study|Lost to Follow-up|4|||
164036459|NCT00305604|592492054|FG000|Overall Study|Protocol Violation|2|||
164036460|NCT00305604|592492055|FG001|Overall Study|Protocol Violation|1|||
164036461|NCT00305604|592492054|FG000|Overall Study|Withdrawal by Subject|12|||
164036462|NCT00305604|592492055|FG001|Overall Study|Withdrawal by Subject|21|||
164036463|NCT00305604|592492054|FG000|Overall Study|Patient moved|1|||
164036464|NCT00305604|592492055|FG001|Overall Study|Patient moved|0|||
164036465|NCT02559713|592492059|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
164036466|NCT01021813|592492061|FG000|DB Treatment Phase|Adverse Event|60|||
164036467|NCT01021813|592492062|FG001|DB Treatment Phase|Adverse Event|22|||
164036468|NCT01021813|592492063|FG002|DB Treatment Phase|Adverse Event|0|||
164036469|NCT01021813|592492064|FG003|DB Treatment Phase|Adverse Event|0|||
164036470|NCT01021813|592492065|FG004|DB Treatment Phase|Adverse Event|0|||
164036471|NCT01021813|592492061|FG000|DB Treatment Phase|Lack of Efficacy|44|||
164036472|NCT01021813|592492062|FG001|DB Treatment Phase|Lack of Efficacy|28|||
164036473|NCT01021813|592492063|FG002|DB Treatment Phase|Lack of Efficacy|0|||
164036474|NCT01021813|592492064|FG003|DB Treatment Phase|Lack of Efficacy|0|||
164036475|NCT01021813|592492065|FG004|DB Treatment Phase|Lack of Efficacy|0|||
164036476|NCT01021813|592492061|FG000|DB Treatment Phase|Lost to Follow-up|14|||
164036477|NCT01021813|592492062|FG001|DB Treatment Phase|Lost to Follow-up|12|||
164036478|NCT01021813|592492063|FG002|DB Treatment Phase|Lost to Follow-up|0|||
164036479|NCT01021813|592492064|FG003|DB Treatment Phase|Lost to Follow-up|0|||
164036480|NCT01021813|592492065|FG004|DB Treatment Phase|Lost to Follow-up|0|||
164036481|NCT01021813|592492061|FG000|DB Treatment Phase|Physician Decision|17|||
164036482|NCT01021813|592492062|FG001|DB Treatment Phase|Physician Decision|8|||
164036483|NCT01021813|592492063|FG002|DB Treatment Phase|Physician Decision|0|||
164036484|NCT01021813|592492064|FG003|DB Treatment Phase|Physician Decision|0|||
164036485|NCT01021813|592492065|FG004|DB Treatment Phase|Physician Decision|0|||
164036486|NCT01021813|592492061|FG000|DB Treatment Phase|Pregnancy|1|||
164036487|NCT01021813|592492062|FG001|DB Treatment Phase|Pregnancy|0|||
164036488|NCT01021813|592492063|FG002|DB Treatment Phase|Pregnancy|0|||
164036489|NCT01021813|592492064|FG003|DB Treatment Phase|Pregnancy|0|||
164036490|NCT01021813|592492065|FG004|DB Treatment Phase|Pregnancy|0|||
164036491|NCT01021813|592492061|FG000|DB Treatment Phase|Protocol Violation|4|||
164036492|NCT01021813|592492062|FG001|DB Treatment Phase|Protocol Violation|3|||
164036493|NCT01021813|592492063|FG002|DB Treatment Phase|Protocol Violation|0|||
164036494|NCT01021813|592492064|FG003|DB Treatment Phase|Protocol Violation|0|||
164036495|NCT01021813|592492065|FG004|DB Treatment Phase|Protocol Violation|0|||
164036496|NCT01021813|592492061|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
164036497|NCT01021813|592492062|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
164036498|NCT01021813|592492063|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
164036499|NCT01021813|592492064|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
164036500|NCT01021813|592492065|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
164036501|NCT01021813|592492061|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
164036502|NCT01021813|592492062|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
164036503|NCT01021813|592492063|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
164036504|NCT01021813|592492064|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
164036505|NCT01021813|592492065|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
164036506|NCT01021813|592492061|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164036507|NCT01021813|592492062|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164036508|NCT01021813|592492063|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164036509|NCT01021813|592492064|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
164036510|NCT01021813|592492065|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
164036511|NCT01021813|592492061|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164036512|NCT01021813|592492062|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164036513|NCT01021813|592492063|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164036514|NCT01021813|592492064|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
164036515|NCT01021813|592492065|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
164036516|NCT01021813|592492061|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164036517|NCT01021813|592492062|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164036518|NCT01021813|592492063|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
164036519|NCT01021813|592492064|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164036520|NCT01021813|592492065|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
164036521|NCT01021813|592492061|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
164036522|NCT01021813|592492062|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
164036523|NCT01021813|592492063|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
164036524|NCT01021813|592492064|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
164036525|NCT01021813|592492065|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
164036526|NCT00862654|592492066|FG000|Overall Study|Lack of Efficacy|1|||
164036527|NCT00862654|592492067|FG001|Overall Study|Lack of Efficacy|0|||
164036528|NCT00862654|592492068|FG002|Overall Study|Lack of Efficacy|1|||
164036529|NCT00862654|592492069|FG003|Overall Study|Lack of Efficacy|0|||
164036530|NCT00862654|592492066|FG000|Overall Study|Lost to Follow-up|1|||
164036531|NCT00862654|592492067|FG001|Overall Study|Lost to Follow-up|2|||
163836826|NCT02769065|591774314|FG018|Overall Study|Voluntary Withdrawal|0|||
163836827|NCT02769065|591774315|FG019|Overall Study|Voluntary Withdrawal|0|||
163836828|NCT02769065|591774316|FG020|Overall Study|Voluntary Withdrawal|0|||
163836829|NCT02769065|591774317|FG021|Overall Study|Voluntary Withdrawal|0|||
163836830|NCT02769065|591774318|FG022|Overall Study|Voluntary Withdrawal|0|||
163836831|NCT02769065|591774319|FG023|Overall Study|Voluntary Withdrawal|0|||
163836832|NCT02769065|591774320|FG024|Overall Study|Voluntary Withdrawal|0|||
163836833|NCT02769065|591774321|FG025|Overall Study|Voluntary Withdrawal|0|||
163836834|NCT02769065|591774322|FG026|Overall Study|Voluntary Withdrawal|0|||
163836835|NCT02769065|591774323|FG027|Overall Study|Voluntary Withdrawal|0|||
163836836|NCT02769065|591774324|FG028|Overall Study|Voluntary Withdrawal|0|||
163836837|NCT02769065|591774325|FG029|Overall Study|Voluntary Withdrawal|0|||
163836838|NCT02769065|591774296|FG000|Overall Study|Reason Not Specified|0|||
163836839|NCT02769065|591774297|FG001|Overall Study|Reason Not Specified|0|||
163836840|NCT02769065|591774298|FG002|Overall Study|Reason Not Specified|0|||
163836841|NCT02769065|591774299|FG003|Overall Study|Reason Not Specified|0|||
163836842|NCT02769065|591774300|FG004|Overall Study|Reason Not Specified|0|||
163836843|NCT02769065|591774301|FG005|Overall Study|Reason Not Specified|0|||
163836844|NCT02769065|591774302|FG006|Overall Study|Reason Not Specified|1|||
163836845|NCT02769065|591774303|FG007|Overall Study|Reason Not Specified|0|||
163836846|NCT02769065|591774304|FG008|Overall Study|Reason Not Specified|0|||
163836847|NCT02769065|591774305|FG009|Overall Study|Reason Not Specified|0|||
163836848|NCT02769065|591774306|FG010|Overall Study|Reason Not Specified|0|||
163836849|NCT02769065|591774307|FG011|Overall Study|Reason Not Specified|0|||
163836850|NCT02769065|591774308|FG012|Overall Study|Reason Not Specified|0|||
163836851|NCT02769065|591774309|FG013|Overall Study|Reason Not Specified|0|||
163836852|NCT02769065|591774310|FG014|Overall Study|Reason Not Specified|0|||
163836853|NCT02769065|591774311|FG015|Overall Study|Reason Not Specified|0|||
163836854|NCT02769065|591774312|FG016|Overall Study|Reason Not Specified|0|||
163836855|NCT02769065|591774313|FG017|Overall Study|Reason Not Specified|0|||
163836856|NCT02769065|591774314|FG018|Overall Study|Reason Not Specified|0|||
163836857|NCT02769065|591774315|FG019|Overall Study|Reason Not Specified|0|||
163836858|NCT02769065|591774316|FG020|Overall Study|Reason Not Specified|0|||
163836859|NCT02769065|591774317|FG021|Overall Study|Reason Not Specified|0|||
163836860|NCT02769065|591774318|FG022|Overall Study|Reason Not Specified|0|||
163836861|NCT02769065|591774319|FG023|Overall Study|Reason Not Specified|0|||
163836862|NCT02769065|591774320|FG024|Overall Study|Reason Not Specified|0|||
163836863|NCT02769065|591774321|FG025|Overall Study|Reason Not Specified|0|||
163836864|NCT02769065|591774322|FG026|Overall Study|Reason Not Specified|0|||
163836865|NCT02769065|591774323|FG027|Overall Study|Reason Not Specified|0|||
163836866|NCT02769065|591774324|FG028|Overall Study|Reason Not Specified|0|||
163836867|NCT02769065|591774325|FG029|Overall Study|Reason Not Specified|0|||
163836868|NCT02769065|591774296|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836869|NCT02769065|591774297|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836870|NCT02769065|591774298|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836871|NCT02769065|591774299|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836872|NCT02769065|591774300|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836873|NCT02769065|591774301|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836874|NCT02769065|591774302|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836875|NCT02769065|591774303|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836876|NCT02769065|591774304|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836877|NCT02769065|591774305|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836878|NCT02769065|591774306|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
163836879|NCT02769065|591774307|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836880|NCT02769065|591774308|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836881|NCT02769065|591774309|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836882|NCT02769065|591774310|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836883|NCT02769065|591774311|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836884|NCT02769065|591774312|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836885|NCT02769065|591774313|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836886|NCT02769065|591774314|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836887|NCT02769065|591774315|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836888|NCT02769065|591774316|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
163932055|NCT00379769|592121627|FG003|Main Study|Adverse Event|11|||
163932056|NCT00379769|592121628|FG004|Main Study|Adverse Event|0|||
163932057|NCT00379769|592121629|FG005|Main Study|Adverse Event|0|||
163932058|NCT00379769|592121624|FG000|Main Study|Lost to Follow-up|29|||
163932059|NCT00379769|592121625|FG001|Main Study|Lost to Follow-up|29|||
163932060|NCT00379769|592121626|FG002|Main Study|Lost to Follow-up|25|||
163932061|NCT00379769|592121627|FG003|Main Study|Lost to Follow-up|26|||
163932062|NCT00379769|592121628|FG004|Main Study|Lost to Follow-up|0|||
163932063|NCT00379769|592121629|FG005|Main Study|Lost to Follow-up|0|||
163932064|NCT00379769|592121624|FG000|Main Study|Withdrawal by Subject|46|||
163932065|NCT00379769|592121625|FG001|Main Study|Withdrawal by Subject|56|||
164036532|NCT00862654|592492068|FG002|Overall Study|Lost to Follow-up|1|||
164036533|NCT00862654|592492069|FG003|Overall Study|Lost to Follow-up|3|||
164036534|NCT00862654|592492066|FG000|Overall Study|Adverse Event|0|||
164036535|NCT00862654|592492067|FG001|Overall Study|Adverse Event|1|||
164036536|NCT00862654|592492068|FG002|Overall Study|Adverse Event|1|||
164036537|NCT00862654|592492069|FG003|Overall Study|Adverse Event|0|||
164036538|NCT00862654|592492066|FG000|Overall Study|Pregnancy|1|||
164036539|NCT00862654|592492067|FG001|Overall Study|Pregnancy|1|||
164036540|NCT00862654|592492068|FG002|Overall Study|Pregnancy|0|||
164036541|NCT00862654|592492069|FG003|Overall Study|Pregnancy|0|||
164036542|NCT00862654|592492066|FG000|Overall Study|Withdrawal by Subject|2|||
164036543|NCT00862654|592492067|FG001|Overall Study|Withdrawal by Subject|2|||
164036544|NCT00862654|592492068|FG002|Overall Study|Withdrawal by Subject|2|||
164036545|NCT00862654|592492069|FG003|Overall Study|Withdrawal by Subject|3|||
164036546|NCT00862654|592492066|FG000|Overall Study|Subject mistake|0|||
164036547|NCT00862654|592492067|FG001|Overall Study|Subject mistake|1|||
164036548|NCT00862654|592492068|FG002|Overall Study|Subject mistake|0|||
164036549|NCT00862654|592492069|FG003|Overall Study|Subject mistake|0|||
164036550|NCT00862654|592492066|FG000|Overall Study|Familly constraint|0|||
164036551|NCT00862654|592492067|FG001|Overall Study|Familly constraint|1|||
164036552|NCT00862654|592492068|FG002|Overall Study|Familly constraint|0|||
164036553|NCT00862654|592492069|FG003|Overall Study|Familly constraint|0|||
164036554|NCT00862654|592492066|FG000|Overall Study|Never used study drugs|1|||
164036555|NCT00862654|592492067|FG001|Overall Study|Never used study drugs|0|||
164036556|NCT00862654|592492068|FG002|Overall Study|Never used study drugs|0|||
164036557|NCT00862654|592492069|FG003|Overall Study|Never used study drugs|0|||
164036558|NCT00862654|592492066|FG000|Overall Study|Included after end of inclusions|0|||
164036559|NCT00862654|592492067|FG001|Overall Study|Included after end of inclusions|0|||
164036560|NCT00862654|592492068|FG002|Overall Study|Included after end of inclusions|1|||
164036561|NCT00862654|592492069|FG003|Overall Study|Included after end of inclusions|0|||
164036562|NCT03219567|592492070|FG000|Overall Study|Withdrawal by Subject|0|||
164036563|NCT03219567|592492071|FG001|Overall Study|Withdrawal by Subject|1|||
164036564|NCT01151540|592492072|FG000|Overall Study|Other|2|||
164036565|NCT01151540|592492072|FG000|Overall Study|Adverse event, non-fatal|4|||
164036566|NCT01151540|592492072|FG000|Overall Study|Withdrawal by Subject|7|||
164036567|NCT02261883|592492076|FG000|Overall Study|Death|3|||
164036568|NCT02261883|592492077|FG001|Overall Study|Death|2|||
164036569|NCT02261883|592492076|FG000|Overall Study|Physician Decision|1|||
164036570|NCT02261883|592492077|FG001|Overall Study|Physician Decision|0|||
164036571|NCT02261883|592492076|FG000|Overall Study|Protocol Violation|1|||
164036572|NCT02261883|592492077|FG001|Overall Study|Protocol Violation|0|||
164036573|NCT02261883|592492076|FG000|Overall Study|Withdrawal by Subject|0|||
164036574|NCT02261883|592492077|FG001|Overall Study|Withdrawal by Subject|1|||
164036575|NCT02261883|592492076|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
164036576|NCT02261883|592492077|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
164036577|NCT00004732|592492078|FG000|Overall Study|Withdrawal by Subject|36|||
164036578|NCT00004732|592492079|FG001|Overall Study|Withdrawal by Subject|64|||
164036579|NCT00004732|592492078|FG000|Overall Study|Lost to Follow-up|33|||
164036580|NCT00004732|592492079|FG001|Overall Study|Lost to Follow-up|47|||
164036581|NCT01688635|592492080|FG000|Washout 1|Withdrawal by Subject|1|||
164036582|NCT01688635|592492081|FG001|Washout 1|Withdrawal by Subject|0|||
164036583|NCT01688635|592492080|FG000|Washout 1|Adverse Event|0|||
164036584|NCT01688635|592492081|FG001|Washout 1|Adverse Event|1|||
164036585|NCT01688635|592492080|FG000|Washout 1|Physician Decision|0|||
164036586|NCT01688635|592492081|FG001|Washout 1|Physician Decision|1|||
164036587|NCT01688635|592492080|FG000|Washout 2|Physician Decision|1|||
164036588|NCT01688635|592492081|FG001|Washout 2|Physician Decision|0|||
164036589|NCT01688635|592492080|FG000|Washout 2|Withdrawal by Subject|1|||
164036590|NCT01688635|592492081|FG001|Washout 2|Withdrawal by Subject|0|||
164036591|NCT01688635|592492080|FG000|Washout 2|Sponsor Decision|1|||
164036592|NCT01688635|592492081|FG001|Washout 2|Sponsor Decision|2|||
164036593|NCT01688635|592492080|FG000|Washout 3|Withdrawal by Subject|1|||
164036594|NCT01688635|592492081|FG001|Washout 3|Withdrawal by Subject|0|||
164036595|NCT02674685|592492082|FG000|Overall Study|Withdrawal by Subject|4|||
164036596|NCT01181778|592492083|FG000|Overall Study|Physician Decision|48|||
164036597|NCT01626989|592492091|FG000|Screening Period|Screen Failure|15|||
164036598|NCT01626989|592492092|FG001|Screening Period|Screen Failure|0|||
164036599|NCT01626989|592492093|FG002|Screening Period|Screen Failure|0|||
164036600|NCT01626989|592492091|FG000|Screening Period|Withdrawal by Subject|2|||
164036601|NCT01626989|592492092|FG001|Screening Period|Withdrawal by Subject|0|||
164036602|NCT01626989|592492093|FG002|Screening Period|Withdrawal by Subject|0|||
164036603|NCT04021706|592494370|FG000|Overall Study|Adverse Event|2|||
164036604|NCT04021706|592494371|FG001|Overall Study|Adverse Event|0|||
164036605|NCT04021706|592494370|FG000|Overall Study|Withdrawal by Subject|1|||
164036606|NCT04021706|592494371|FG001|Overall Study|Withdrawal by Subject|2|||
164036607|NCT04021706|592494370|FG000|Overall Study|Physician Decision|1|||
164036608|NCT04021706|592494371|FG001|Overall Study|Physician Decision|0|||
164036609|NCT03366844|592494372|FG000|Overall Study|Physician Decision|1|||
164073171|NCT01347879|592632836|FG000|Overall Study|Withdrawal by Subject|3|||
163932066|NCT00379769|592121626|FG002|Main Study|Withdrawal by Subject|72|||
163932067|NCT00379769|592121627|FG003|Main Study|Withdrawal by Subject|70|||
163932068|NCT00379769|592121628|FG004|Main Study|Withdrawal by Subject|0|||
163932069|NCT00379769|592121629|FG005|Main Study|Withdrawal by Subject|0|||
163932070|NCT00379769|592121624|FG000|Main Study|Moved to survival status follow-up only|27|||
163932071|NCT00379769|592121625|FG001|Main Study|Moved to survival status follow-up only|25|||
163932072|NCT00379769|592121626|FG002|Main Study|Moved to survival status follow-up only|32|||
163932073|NCT00379769|592121627|FG003|Main Study|Moved to survival status follow-up only|36|||
163932074|NCT00379769|592121628|FG004|Main Study|Moved to survival status follow-up only|0|||
163932075|NCT00379769|592121629|FG005|Main Study|Moved to survival status follow-up only|0|||
163932076|NCT00379769|592121624|FG000|Main Study|Participant moved|3|||
163932077|NCT00379769|592121625|FG001|Main Study|Participant moved|2|||
163932078|NCT00379769|592121626|FG002|Main Study|Participant moved|3|||
163932079|NCT00379769|592121627|FG003|Main Study|Participant moved|3|||
163932080|NCT00379769|592121628|FG004|Main Study|Participant moved|0|||
163932081|NCT00379769|592121629|FG005|Main Study|Participant moved|0|||
163932082|NCT00379769|592121624|FG000|Main Study|Poor compliance|3|||
163932083|NCT00379769|592121625|FG001|Main Study|Poor compliance|2|||
163932084|NCT00379769|592121626|FG002|Main Study|Poor compliance|2|||
163932085|NCT00379769|592121627|FG003|Main Study|Poor compliance|1|||
163932086|NCT00379769|592121628|FG004|Main Study|Poor compliance|0|||
163932087|NCT00379769|592121629|FG005|Main Study|Poor compliance|0|||
163932088|NCT00379769|592121624|FG000|Main Study|Prohibited glucose lowering medication|0|||
163932089|NCT00379769|592121625|FG001|Main Study|Prohibited glucose lowering medication|3|||
163932090|NCT00379769|592121626|FG002|Main Study|Prohibited glucose lowering medication|0|||
163932091|NCT00379769|592121627|FG003|Main Study|Prohibited glucose lowering medication|1|||
163932092|NCT00379769|592121628|FG004|Main Study|Prohibited glucose lowering medication|0|||
163932093|NCT00379769|592121629|FG005|Main Study|Prohibited glucose lowering medication|0|||
163932094|NCT00379769|592121624|FG000|Main Study|Site closed|4|||
163932095|NCT00379769|592121625|FG001|Main Study|Site closed|4|||
163932096|NCT00379769|592121626|FG002|Main Study|Site closed|4|||
163932097|NCT00379769|592121627|FG003|Main Study|Site closed|8|||
163932098|NCT00379769|592121628|FG004|Main Study|Site closed|0|||
163932099|NCT00379769|592121629|FG005|Main Study|Site closed|0|||
163932100|NCT00379769|592121624|FG000|Main Study|Entry criteria violation|0|||
163932101|NCT00379769|592121625|FG001|Main Study|Entry criteria violation|0|||
163932102|NCT00379769|592121626|FG002|Main Study|Entry criteria violation|1|||
163932103|NCT00379769|592121627|FG003|Main Study|Entry criteria violation|1|||
163932104|NCT00379769|592121628|FG004|Main Study|Entry criteria violation|0|||
163932105|NCT00379769|592121629|FG005|Main Study|Entry criteria violation|0|||
163932106|NCT00379769|592121624|FG000|Main Study|Participant did not take study drug|0|||
163932107|NCT00379769|592121625|FG001|Main Study|Participant did not take study drug|0|||
163932108|NCT00379769|592121626|FG002|Main Study|Participant did not take study drug|1|||
163932109|NCT00379769|592121627|FG003|Main Study|Participant did not take study drug|0|||
163932110|NCT00379769|592121628|FG004|Main Study|Participant did not take study drug|0|||
163932111|NCT00379769|592121629|FG005|Main Study|Participant did not take study drug|0|||
163932112|NCT00379769|592121624|FG000|Main Study|Physician Decision|2|||
163932113|NCT00379769|592121625|FG001|Main Study|Physician Decision|2|||
163932114|NCT00379769|592121626|FG002|Main Study|Physician Decision|1|||
163932115|NCT00379769|592121627|FG003|Main Study|Physician Decision|1|||
163932116|NCT00379769|592121628|FG004|Main Study|Physician Decision|0|||
163932117|NCT00379769|592121629|FG005|Main Study|Physician Decision|0|||
163932118|NCT00379769|592121624|FG000|Main Study|Participant completed study at visit 27|1|||
163932119|NCT00379769|592121625|FG001|Main Study|Participant completed study at visit 27|0|||
163932120|NCT00379769|592121626|FG002|Main Study|Participant completed study at visit 27|0|||
163932121|NCT00379769|592121627|FG003|Main Study|Participant completed study at visit 27|0|||
163932122|NCT00379769|592121628|FG004|Main Study|Participant completed study at visit 27|0|||
163932123|NCT00379769|592121629|FG005|Main Study|Participant completed study at visit 27|0|||
163932124|NCT00379769|592121624|FG000|Main Study|Personal reasons|1|||
163932125|NCT00379769|592121625|FG001|Main Study|Personal reasons|0|||
163932126|NCT00379769|592121626|FG002|Main Study|Personal reasons|0|||
163932127|NCT00379769|592121627|FG003|Main Study|Personal reasons|0|||
163932128|NCT00379769|592121628|FG004|Main Study|Personal reasons|0|||
163932129|NCT00379769|592121629|FG005|Main Study|Personal reasons|0|||
163932130|NCT00379769|592121624|FG000|Main Study|Risk of heart failure|0|||
163932131|NCT00379769|592121625|FG001|Main Study|Risk of heart failure|1|||
163932132|NCT00379769|592121626|FG002|Main Study|Risk of heart failure|0|||
163932133|NCT00379769|592121627|FG003|Main Study|Risk of heart failure|0|||
163932134|NCT00379769|592121628|FG004|Main Study|Risk of heart failure|0|||
163932135|NCT00379769|592121629|FG005|Main Study|Risk of heart failure|0|||
163932136|NCT00379769|592121624|FG000|Main Study|Investigator refused to log temperature|0|||
163932137|NCT00379769|592121625|FG001|Main Study|Investigator refused to log temperature|0|||
163932138|NCT00379769|592121626|FG002|Main Study|Investigator refused to log temperature|1|||
163932139|NCT00379769|592121627|FG003|Main Study|Investigator refused to log temperature|0|||
163932140|NCT00379769|592121628|FG004|Main Study|Investigator refused to log temperature|0|||
164036610|NCT03366844|592494372|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
164036611|NCT02332798|592494375|FG000|Overall Study|Unwilling to Participate in Study|0|||
164036612|NCT02332798|592494376|FG001|Overall Study|Unwilling to Participate in Study|1|||
164036613|NCT02332798|592494377|FG002|Overall Study|Unwilling to Participate in Study|1|||
164036614|NCT02332798|592494375|FG000|Overall Study|Positive Urine Drug Test|0|||
164036615|NCT02332798|592494376|FG001|Overall Study|Positive Urine Drug Test|1|||
164036616|NCT02332798|592494377|FG002|Overall Study|Positive Urine Drug Test|0|||
164036617|NCT02332798|592494375|FG000|Overall Study|Abnormal Laboratory Findings|1|||
164036618|NCT02332798|592494376|FG001|Overall Study|Abnormal Laboratory Findings|0|||
164036619|NCT02332798|592494377|FG002|Overall Study|Abnormal Laboratory Findings|0|||
164036620|NCT00595868|592494378|FG000|Overall Study|Lost to Follow-up|45|||
164036621|NCT00595868|592494379|FG001|Overall Study|Lost to Follow-up|50|||
164036622|NCT02688153|592494380|FG000|Overall Study|Death|7|||
164036623|NCT02688153|592494381|FG001|Overall Study|Death|5|||
164036624|NCT02688153|592494380|FG000|Overall Study|Withdrawal by Subject|4|||
164036625|NCT02688153|592494381|FG001|Overall Study|Withdrawal by Subject|2|||
164036626|NCT02688153|592494380|FG000|Overall Study|Valve Explant|1|||
164036627|NCT02688153|592494381|FG001|Overall Study|Valve Explant|0|||
164036628|NCT02688153|592494380|FG000|Overall Study|Conversion to Commercial Valve|3|||
164036629|NCT02688153|592494381|FG001|Overall Study|Conversion to Commercial Valve|0|||
164036630|NCT02687711|592494393|FG000|Overall Study|Adverse Event|89|||
164036631|NCT02687711|592494393|FG000|Overall Study|Lack of Efficacy|70|||
164036632|NCT02687711|592494393|FG000|Overall Study|Lost to Follow-up|20|||
164036633|NCT02687711|592494393|FG000|Overall Study|Consent withdrawn|15|||
164036634|NCT02687711|592494393|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
164036635|NCT02687711|592494393|FG000|Overall Study|Too expensive|4|||
164036636|NCT02687711|592494393|FG000|Overall Study|Participant moved abroad|1|||
164036637|NCT02687711|592494393|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
164036638|NCT02687711|592494393|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
164036639|NCT02687711|592494393|FG000|Overall Study|Disliked taste|1|||
164036640|NCT02687711|592494393|FG000|Overall Study|Low mood|1|||
164036641|NCT02687711|592494393|FG000|Overall Study|Side effects|1|||
164036642|NCT02687711|592494393|FG000|Overall Study|Change of Hospital|1|||
164036643|NCT02687711|592494393|FG000|Overall Study|Liver Encephalopathy|1|||
164036644|NCT02687711|592494393|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
164036645|NCT02687711|592494393|FG000|Overall Study|Withdrawn due to intake interruption|1|||
164036646|NCT02687711|592494393|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
164036647|NCT02687711|592494393|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
164036648|NCT02687711|592494393|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
164036649|NCT01742091|592494398|FG000|Overall Study|Adverse Event|0|||
164036650|NCT01742091|592494399|FG001|Overall Study|Adverse Event|0|||
164036651|NCT01742091|592494400|FG002|Overall Study|Adverse Event|0|||
164036652|NCT01742091|592494401|FG003|Overall Study|Adverse Event|0|||
164036653|NCT01742091|592494402|FG004|Overall Study|Adverse Event|1|||
164036654|NCT01742091|592494403|FG005|Overall Study|Adverse Event|0|||
164036655|NCT01742091|592494398|FG000|Overall Study|Physician Decision|0|||
164036656|NCT01742091|592494399|FG001|Overall Study|Physician Decision|0|||
164036657|NCT01742091|592494400|FG002|Overall Study|Physician Decision|0|||
164036658|NCT01742091|592494401|FG003|Overall Study|Physician Decision|0|||
164036659|NCT01742091|592494402|FG004|Overall Study|Physician Decision|0|||
164036660|NCT01742091|592494403|FG005|Overall Study|Physician Decision|1|||
164036661|NCT01742091|592494398|FG000|Overall Study|Withdrawal by Subject|0|||
164036662|NCT01742091|592494399|FG001|Overall Study|Withdrawal by Subject|0|||
164036663|NCT01742091|592494400|FG002|Overall Study|Withdrawal by Subject|0|||
164036664|NCT01742091|592494401|FG003|Overall Study|Withdrawal by Subject|1|||
164036665|NCT01742091|592494402|FG004|Overall Study|Withdrawal by Subject|0|||
164036666|NCT01742091|592494403|FG005|Overall Study|Withdrawal by Subject|0|||
164036667|NCT01742091|592494398|FG000|Overall Study|Lost to Follow-up|0|||
164036668|NCT01742091|592494399|FG001|Overall Study|Lost to Follow-up|0|||
164036669|NCT01742091|592494400|FG002|Overall Study|Lost to Follow-up|0|||
164036670|NCT01742091|592494401|FG003|Overall Study|Lost to Follow-up|0|||
164036671|NCT01742091|592494402|FG004|Overall Study|Lost to Follow-up|0|||
164036672|NCT01742091|592494403|FG005|Overall Study|Lost to Follow-up|1|||
164036673|NCT05742841|592494404|FG000|Overall Study|Withdrawal by Subject|1|||
164036674|NCT05742841|592494404|FG000|Overall Study|Lost to Follow-up|1|||
164036675|NCT02088541|592494405|FG000|Overall Study|Adverse Event|3|||
164036676|NCT02088541|592494406|FG001|Overall Study|Adverse Event|0|||
164036677|NCT02088541|592494407|FG002|Overall Study|Adverse Event|3|||
164036678|NCT02088541|592494408|FG003|Overall Study|Adverse Event|3|||
164036679|NCT02088541|592494409|FG004|Overall Study|Adverse Event|0|||
164036680|NCT02088541|592494405|FG000|Overall Study|Death|51|||
164036681|NCT02088541|592494406|FG001|Overall Study|Death|21|||
164036682|NCT02088541|592494407|FG002|Overall Study|Death|85|||
164036683|NCT02088541|592494408|FG003|Overall Study|Death|28|||
164036684|NCT02088541|592494409|FG004|Overall Study|Death|38|||
164036685|NCT02088541|592494405|FG000|Overall Study|Lost to Follow-up|2|||
164036686|NCT02088541|592494406|FG001|Overall Study|Lost to Follow-up|0|||
164036687|NCT02088541|592494407|FG002|Overall Study|Lost to Follow-up|1|||
164036688|NCT02088541|592494408|FG003|Overall Study|Lost to Follow-up|0|||
164036689|NCT02088541|592494409|FG004|Overall Study|Lost to Follow-up|0|||
164036690|NCT02088541|592494405|FG000|Overall Study|Physician Decision|2|||
164036691|NCT02088541|592494406|FG001|Overall Study|Physician Decision|1|||
164036692|NCT02088541|592494407|FG002|Overall Study|Physician Decision|2|||
164036693|NCT02088541|592494408|FG003|Overall Study|Physician Decision|0|||
164036694|NCT02088541|592494409|FG004|Overall Study|Physician Decision|2|||
164036695|NCT02088541|592494405|FG000|Overall Study|Disease progression|7|||
164036696|NCT02088541|592494406|FG001|Overall Study|Disease progression|1|||
164036697|NCT02088541|592494407|FG002|Overall Study|Disease progression|2|||
164036698|NCT02088541|592494408|FG003|Overall Study|Disease progression|3|||
164036699|NCT02088541|592494409|FG004|Overall Study|Disease progression|1|||
164036700|NCT02088541|592494405|FG000|Overall Study|Study terminated by sponsor|1|||
164036701|NCT02088541|592494406|FG001|Overall Study|Study terminated by sponsor|1|||
164036702|NCT02088541|592494407|FG002|Overall Study|Study terminated by sponsor|12|||
164036703|NCT02088541|592494408|FG003|Overall Study|Study terminated by sponsor|2|||
164036704|NCT02088541|592494409|FG004|Overall Study|Study terminated by sponsor|6|||
164098405|NCT05093205|592725092|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
164098406|NCT05093205|592725093|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
164098407|NCT05093205|592725094|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
164098408|NCT05093205|592725095|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
164098409|NCT05093205|592725083|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098410|NCT05093205|592725084|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098411|NCT05093205|592725085|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098412|NCT05093205|592725086|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098413|NCT05093205|592725087|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098414|NCT05093205|592725088|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098415|NCT05093205|592725089|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098416|NCT05093205|592725090|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098417|NCT05093205|592725091|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098418|NCT05093205|592725092|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098419|NCT05093205|592725093|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
164098420|NCT05093205|592725094|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098421|NCT05093205|592725095|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
164098422|NCT05093205|592725083|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098423|NCT05093205|592725084|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098424|NCT05093205|592725085|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098425|NCT05093205|592725086|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098426|NCT05093205|592725087|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098427|NCT05093205|592725088|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098428|NCT05093205|592725089|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098429|NCT05093205|592725090|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098430|NCT05093205|592725091|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098431|NCT05093205|592725092|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098432|NCT05093205|592725093|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098433|NCT05093205|592725094|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
164098434|NCT05093205|592725095|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
164098435|NCT05093205|592725083|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
164098436|NCT05093205|592725084|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
164098437|NCT05093205|592725085|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
164098438|NCT05093205|592725086|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
164098439|NCT05093205|592725087|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
164098440|NCT05093205|592725088|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
164098441|NCT05093205|592725089|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
164098442|NCT05093205|592725090|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
164098443|NCT05093205|592725091|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
164098444|NCT05093205|592725092|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
164098445|NCT05093205|592725093|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
164098446|NCT05093205|592725094|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
164098447|NCT05093205|592725095|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
164098448|NCT05093205|592725083|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164036705|NCT02088541|592494405|FG000|Overall Study|Withdrawal by Subject|3|||
164036706|NCT02088541|592494406|FG001|Overall Study|Withdrawal by Subject|2|||
164036707|NCT02088541|592494407|FG002|Overall Study|Withdrawal by Subject|9|||
164036708|NCT02088541|592494408|FG003|Overall Study|Withdrawal by Subject|7|||
164036709|NCT02088541|592494409|FG004|Overall Study|Withdrawal by Subject|10|||
164036710|NCT02088541|592494405|FG000|Overall Study|Other|2|||
164036711|NCT02088541|592494406|FG001|Overall Study|Other|1|||
164036712|NCT02088541|592494407|FG002|Overall Study|Other|3|||
164036713|NCT02088541|592494408|FG003|Overall Study|Other|1|||
164036714|NCT02088541|592494409|FG004|Overall Study|Other|1|||
164036715|NCT03750240|592494411|FG000|Overall Study|Technical Difficulties|2|||
164036716|NCT02848313|592494412|FG000|Overall Study|Adverse Event|1|||
164036717|NCT02848313|592494413|FG001|Overall Study|Adverse Event|2|||
164036718|NCT02848313|592494412|FG000|Overall Study|Lack of Efficacy|0|||
164036719|NCT02848313|592494413|FG001|Overall Study|Lack of Efficacy|1|||
164098449|NCT05093205|592725084|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098450|NCT05093205|592725085|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098451|NCT05093205|592725086|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098452|NCT05093205|592725087|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098453|NCT05093205|592725088|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098454|NCT05093205|592725089|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098455|NCT05093205|592725090|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098456|NCT05093205|592725091|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098457|NCT05093205|592725092|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098458|NCT05093205|592725093|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098459|NCT05093205|592725094|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
164098460|NCT05093205|592725095|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
164098461|NCT00268905|592725103|FG000|Overall Study|Adverse Event|3|||
164098462|NCT00268905|592725104|FG001|Overall Study|Adverse Event|0|||
164098463|NCT00268905|592725105|FG002|Overall Study|Adverse Event|4|||
164098464|NCT00268905|592725103|FG000|Overall Study|Lost to Follow-up|0|||
164098465|NCT00268905|592725104|FG001|Overall Study|Lost to Follow-up|1|||
164098466|NCT00268905|592725105|FG002|Overall Study|Lost to Follow-up|0|||
164098467|NCT00268905|592725103|FG000|Overall Study|Withdrawal by Subject|0|||
164098468|NCT00268905|592725104|FG001|Overall Study|Withdrawal by Subject|0|||
164098469|NCT00268905|592725105|FG002|Overall Study|Withdrawal by Subject|3|||
164098470|NCT00268905|592725103|FG000|Overall Study|Progressive Disease|28|||
164098471|NCT00268905|592725104|FG001|Overall Study|Progressive Disease|4|||
164098472|NCT00268905|592725105|FG002|Overall Study|Progressive Disease|3|||
164098473|NCT00268905|592725103|FG000|Overall Study|Physician Decision|3|||
164098474|NCT00268905|592725104|FG001|Overall Study|Physician Decision|0|||
164098475|NCT00268905|592725105|FG002|Overall Study|Physician Decision|1|||
164098476|NCT00268905|592725103|FG000|Overall Study|Clinical Progression|9|||
164098477|NCT00268905|592725104|FG001|Overall Study|Clinical Progression|4|||
164098478|NCT00268905|592725105|FG002|Overall Study|Clinical Progression|1|||
164098479|NCT04510285|592725106|FG000|Overall Study|Death|1|||
164098480|NCT00870870|592725107|FG000|Overall Study|Withdrawal by Subject|0|||
164036720|NCT02848313|592494412|FG000|Overall Study|Withdrawal by Subject|1|||
164036721|NCT02848313|592494413|FG001|Overall Study|Withdrawal by Subject|1|||
164036722|NCT02848313|592494412|FG000|Overall Study|Lost to follow up|1|||
164036723|NCT02848313|592494413|FG001|Overall Study|Lost to follow up|0|||
164036724|NCT02971007|592494417|FG000|Overall Study|Adverse Event|1|||
164036725|NCT02971007|592494418|FG001|Overall Study|Adverse Event|0|||
164036726|NCT02971007|592494419|FG002|Overall Study|Adverse Event|0|||
164036727|NCT02971007|592494417|FG000|Overall Study|Lost to Follow-up|0|||
164036728|NCT02971007|592494418|FG001|Overall Study|Lost to Follow-up|1|||
164036729|NCT02971007|592494419|FG002|Overall Study|Lost to Follow-up|1|||
164036730|NCT02971007|592494417|FG000|Overall Study|Withdrawal by Subject|0|||
164036731|NCT02971007|592494418|FG001|Overall Study|Withdrawal by Subject|1|||
164036732|NCT02971007|592494419|FG002|Overall Study|Withdrawal by Subject|0|||
164036733|NCT02971007|592494417|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
164036734|NCT02971007|592494418|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
164036735|NCT02971007|592494419|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
164036736|NCT02971007|592494417|FG000|Overall Study|Patient discontinued study drug|0|||
164036737|NCT02971007|592494418|FG001|Overall Study|Patient discontinued study drug|1|||
164036738|NCT02971007|592494419|FG002|Overall Study|Patient discontinued study drug|0|||
164036739|NCT00063986|592494426|FG000|Overall Study|Withdrawal by Subject|1|||
164036740|NCT00063986|592494426|FG000|Overall Study|Ineligible|1|||
164036741|NCT00063986|592494426|FG000|Overall Study|Intra-operatively ineligible|4|||
164036742|NCT02471586|592494427|FG000|Overall Study|Lost to Follow-up|3|||
164036743|NCT02471586|592494428|FG001|Overall Study|Lost to Follow-up|8|||
164036744|NCT02471586|592494429|FG002|Overall Study|Lost to Follow-up|4|||
164036745|NCT02471586|592494427|FG000|Overall Study|Death|2|||
164036746|NCT02471586|592494428|FG001|Overall Study|Death|2|||
164036747|NCT02471586|592494429|FG002|Overall Study|Death|0|||
164036748|NCT01601704|592494430|FG000|Overall Study|Randomized but not dispensed study med|1|||
164036749|NCT01601704|592494431|FG001|Overall Study|Randomized but not dispensed study med|4|||
164036750|NCT03276572|592494434|FG000|Overall Study|In follow-up|0|||
164036751|NCT03276572|592494435|FG001|Overall Study|In follow-up|0|||
164036752|NCT03276572|592494436|FG002|Overall Study|In follow-up|0|||
164036753|NCT03276572|592494437|FG003|Overall Study|In follow-up|0|||
164036754|NCT03276572|592494438|FG004|Overall Study|In follow-up|0|||
164098481|NCT00870870|592725108|FG001|Overall Study|Withdrawal by Subject|1|||
164098482|NCT00870870|592725109|FG002|Overall Study|Withdrawal by Subject|1|||
164036755|NCT03276572|592494439|FG005|Overall Study|In follow-up|1|||
164036756|NCT03276572|592494440|FG006|Overall Study|In follow-up|1|||
164036757|NCT03276572|592494434|FG000|Overall Study|Lost to Follow-up|0|||
163836889|NCT02769065|591774317|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836890|NCT02769065|591774318|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836891|NCT02769065|591774319|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836892|NCT02769065|591774320|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836893|NCT02769065|591774321|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836894|NCT02769065|591774322|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836895|NCT02769065|591774323|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836896|NCT02769065|591774324|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836897|NCT02769065|591774325|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
163836898|NCT03017235|591774326|FG000|Overall Study|Withdrawal by Subject|4|||
163836899|NCT03017235|591774327|FG001|Overall Study|Withdrawal by Subject|3|||
163836900|NCT03017235|591774326|FG000|Overall Study|Lost to Follow-up|2|||
163836901|NCT03017235|591774327|FG001|Overall Study|Lost to Follow-up|7|||
163836902|NCT03017235|591774326|FG000|Overall Study|Adverse Event|0|||
163836903|NCT03017235|591774327|FG001|Overall Study|Adverse Event|1|||
163836904|NCT03017235|591774326|FG000|Overall Study|Protocol Violation|2|||
163836905|NCT03017235|591774327|FG001|Overall Study|Protocol Violation|1|||
163836906|NCT03017235|591774326|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
163836907|NCT03017235|591774327|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
163836908|NCT03518658|591774328|FG000|Overall Study|Other|51|||
163836909|NCT03518658|591774329|FG001|Overall Study|Other|0|||
163836910|NCT00649389|591774330|FG000|Overall Study|Adverse Event|22|||
163836911|NCT00649389|591774331|FG001|Overall Study|Adverse Event|46|||
163836912|NCT00649389|591774332|FG002|Overall Study|Adverse Event|38|||
163836913|NCT00649389|591774333|FG003|Overall Study|Adverse Event|48|||
163836914|NCT00649389|591774330|FG000|Overall Study|Lost to Follow-up|15|||
163836915|NCT00649389|591774331|FG001|Overall Study|Lost to Follow-up|17|||
163836916|NCT00649389|591774332|FG002|Overall Study|Lost to Follow-up|21|||
163836917|NCT00649389|591774333|FG003|Overall Study|Lost to Follow-up|26|||
163836918|NCT00649389|591774330|FG000|Overall Study|Protocol Violation|11|||
163836919|NCT00649389|591774331|FG001|Overall Study|Protocol Violation|13|||
163836920|NCT00649389|591774332|FG002|Overall Study|Protocol Violation|9|||
163836921|NCT00649389|591774333|FG003|Overall Study|Protocol Violation|8|||
163836922|NCT00649389|591774330|FG000|Overall Study|Withdrawal by Subject|20|||
163836923|NCT00649389|591774331|FG001|Overall Study|Withdrawal by Subject|21|||
163836924|NCT00649389|591774332|FG002|Overall Study|Withdrawal by Subject|19|||
163836925|NCT00649389|591774333|FG003|Overall Study|Withdrawal by Subject|23|||
163836926|NCT00649389|591774330|FG000|Overall Study|Other|3|||
163836927|NCT00649389|591774331|FG001|Overall Study|Other|9|||
163836928|NCT00649389|591774332|FG002|Overall Study|Other|1|||
163836929|NCT00649389|591774333|FG003|Overall Study|Other|6|||
163836930|NCT02746575|591774336|FG000|Overall Study|Surgery cancelled or time chaned|13|||
163836931|NCT02746575|591774336|FG000|Overall Study|Received epidural|10|||
163836932|NCT02746575|591774336|FG000|Overall Study|Withdrawal by Subject|3|||
163836933|NCT02746575|591774336|FG000|Overall Study|Bradycardia/hypotension|9|||
163836934|NCT02746575|591774336|FG000|Overall Study|Study paused|8|||
163836935|NCT02746575|591774336|FG000|Overall Study|put on beta-blocker|3|||
163836936|NCT02746575|591774336|FG000|Overall Study|type of surgery|1|||
163836937|NCT02746575|591774336|FG000|Overall Study|typ of surgery|1|||
163836938|NCT02746575|591774336|FG000|Overall Study|PI unavailable|1|||
163836939|NCT02746575|591774336|FG000|Overall Study|Unknown history of CVA|1|||
163836940|NCT00432835|591774342|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
163836941|NCT00432835|591774343|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
163836942|NCT02341456|591774350|FG000|Overall Study|Disease progression|2|||
163836943|NCT02341456|591774351|FG001|Overall Study|Disease progression|3|||
163836944|NCT02341456|591774352|FG002|Overall Study|Disease progression|1|||
163836945|NCT02341456|591774350|FG000|Overall Study|Death|1|||
163836946|NCT02341456|591774351|FG001|Overall Study|Death|1|||
163836947|NCT02341456|591774352|FG002|Overall Study|Death|1|||
163836948|NCT02341456|591774350|FG000|Overall Study|Withdrawal by Subject|0|||
163836949|NCT02341456|591774351|FG001|Overall Study|Withdrawal by Subject|1|||
163836950|NCT02341456|591774352|FG002|Overall Study|Withdrawal by Subject|1|||
163932141|NCT00379769|592121629|FG005|Main Study|Investigator refused to log temperature|0|||
163932142|NCT00379769|592121624|FG000|Main Study|Reason unspecified|0|||
163932143|NCT00379769|592121625|FG001|Main Study|Reason unspecified|0|||
163932144|NCT00379769|592121626|FG002|Main Study|Reason unspecified|1|||
163932145|NCT00379769|592121627|FG003|Main Study|Reason unspecified|0|||
163932146|NCT00379769|592121628|FG004|Main Study|Reason unspecified|0|||
163932147|NCT00379769|592121629|FG005|Main Study|Reason unspecified|0|||
164036758|NCT03276572|592494435|FG001|Overall Study|Lost to Follow-up|0|||
163836951|NCT02341456|591774350|FG000|Overall Study|Moved to local access programme.|0|||
163836952|NCT02341456|591774351|FG001|Overall Study|Moved to local access programme.|1|||
163836953|NCT02341456|591774352|FG002|Overall Study|Moved to local access programme.|1|||
163836954|NCT02341456|591774350|FG000|Overall Study|Physician Decision|1|||
163836955|NCT02341456|591774351|FG001|Overall Study|Physician Decision|0|||
163836956|NCT02341456|591774352|FG002|Overall Study|Physician Decision|0|||
163836957|NCT01077362|591774353|FG000|Overall Study|Lack of Efficacy|13|||
163932148|NCT00379769|592121624|FG000|Observational Follow-up|Death|0|||
164036759|NCT03276572|592494436|FG002|Overall Study|Lost to Follow-up|0|||
164036760|NCT03276572|592494437|FG003|Overall Study|Lost to Follow-up|0|||
164036761|NCT03276572|592494438|FG004|Overall Study|Lost to Follow-up|0|||
164036762|NCT03276572|592494439|FG005|Overall Study|Lost to Follow-up|0|||
164036763|NCT03276572|592494440|FG006|Overall Study|Lost to Follow-up|1|||
164036764|NCT02580240|592494441|FG000|Overall Study|Physician Decision|2|||
164036765|NCT02580240|592494442|FG001|Overall Study|Physician Decision|0|||
164036766|NCT00607919|592494443|FG000|Acute Phase|Adverse Event|9|||
164036767|NCT00607919|592494444|FG001|Acute Phase|Adverse Event|2|||
164036768|NCT00607919|592494443|FG000|Acute Phase|Entry Criteria Not Met|1|||
164036769|NCT00607919|592494444|FG001|Acute Phase|Entry Criteria Not Met|1|||
164036770|NCT00607919|592494443|FG000|Acute Phase|Lack of Efficacy|1|||
164036771|NCT00607919|592494444|FG001|Acute Phase|Lack of Efficacy|2|||
164036772|NCT00607919|592494443|FG000|Acute Phase|Lost to Follow-up|9|||
164036773|NCT00607919|592494444|FG001|Acute Phase|Lost to Follow-up|3|||
164036774|NCT00607919|592494443|FG000|Acute Phase|Parent/Caregiver Decision|6|||
164036775|NCT00607919|592494444|FG001|Acute Phase|Parent/Caregiver Decision|4|||
164036776|NCT00607919|592494443|FG000|Acute Phase|Protocol Violation|5|||
164036777|NCT00607919|592494444|FG001|Acute Phase|Protocol Violation|1|||
164036778|NCT00607919|592494443|FG000|Acute Phase|Withdrawal by Subject|3|||
164036779|NCT00607919|592494444|FG001|Acute Phase|Withdrawal by Subject|3|||
164036780|NCT00607919|592494443|FG000|Open-Label Phase|Adverse Event|1|||
164036781|NCT00607919|592494444|FG001|Open-Label Phase|Adverse Event|5|||
164036782|NCT00607919|592494443|FG000|Open-Label Phase|Lost to Follow-up|4|||
164036783|NCT00607919|592494444|FG001|Open-Label Phase|Lost to Follow-up|1|||
164036784|NCT00607919|592494443|FG000|Open-Label Phase|Protocol Violation|2|||
164036785|NCT00607919|592494444|FG001|Open-Label Phase|Protocol Violation|2|||
164036786|NCT00607919|592494443|FG000|Open-Label Phase|Withdrawal by Subject|2|||
164036787|NCT00607919|592494444|FG001|Open-Label Phase|Withdrawal by Subject|2|||
164036788|NCT00607919|592494443|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
164036789|NCT00607919|592494444|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
164036790|NCT00239356|592494450|FG000|Overall Study|Lack of Efficacy|1|||
164036791|NCT00239356|592494451|FG001|Overall Study|Lack of Efficacy|0|||
164036792|NCT00239356|592494450|FG000|Overall Study|Adverse Event|6|||
164036793|NCT00239356|592494451|FG001|Overall Study|Adverse Event|0|||
164036794|NCT00239356|592494450|FG000|Overall Study|Withdrawal by Subject|15|||
164036795|NCT00239356|592494451|FG001|Overall Study|Withdrawal by Subject|6|||
164036796|NCT00239356|592494450|FG000|Overall Study|Lost to Follow-up|3|||
164036797|NCT00239356|592494451|FG001|Overall Study|Lost to Follow-up|0|||
164036798|NCT00239356|592494450|FG000|Overall Study|poor/non-compliance|2|||
164036799|NCT00239356|592494451|FG001|Overall Study|poor/non-compliance|0|||
164036800|NCT00239356|592494450|FG000|Overall Study|Pregnancy|1|||
164036801|NCT00239356|592494451|FG001|Overall Study|Pregnancy|0|||
164036802|NCT00239356|592494450|FG000|Overall Study|Administrative reason|0|||
164036803|NCT00239356|592494451|FG001|Overall Study|Administrative reason|1|||
164036804|NCT00239356|592494450|FG000|Overall Study|Drug available on market|11|||
164036805|NCT00239356|592494451|FG001|Overall Study|Drug available on market|2|||
164036806|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
164036807|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
164036808|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
164036809|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
164036810|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
164036811|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
164036812|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
164036813|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
164036814|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
164036815|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
164036816|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
164036817|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
164036818|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
164036819|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
164036820|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
164036821|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
164036822|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
164036823|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
164036824|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
164036825|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
164036826|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
164036827|NCT01001572|592494452|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
164036828|NCT01001572|592494453|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
164036829|NCT01001572|592494454|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
164036830|NCT01001572|592494452|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164036831|NCT01001572|592494453|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
164036832|NCT01001572|592494454|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
164036833|NCT01001572|592494452|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164036834|NCT01001572|592494453|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
164036835|NCT01001572|592494454|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
164036836|NCT01001572|592494452|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
164036837|NCT01001572|592494453|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
164036838|NCT01001572|592494454|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
164036839|NCT01001572|592494452|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
164036840|NCT01001572|592494453|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
164036841|NCT01001572|592494454|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
164036842|NCT01001572|592494452|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
164036843|NCT01001572|592494453|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
164036844|NCT01001572|592494454|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
164036845|NCT01001572|592494452|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164036846|NCT01001572|592494453|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164036847|NCT01001572|592494454|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164036848|NCT01237223|592494457|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
164036849|NCT01237223|592494458|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164036850|NCT01237223|592494459|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164036851|NCT01237223|592494460|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164036852|NCT01237223|592494461|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164036853|NCT01237223|592494462|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
164036854|NCT01237223|592494457|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
164036855|NCT01237223|592494458|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164036856|NCT01237223|592494459|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164036857|NCT01237223|592494460|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164036858|NCT01237223|592494461|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164036859|NCT01237223|592494462|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
164036860|NCT01237223|592494457|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
164036861|NCT01237223|592494458|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164036862|NCT01237223|592494459|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164036863|NCT01237223|592494460|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164036864|NCT01237223|592494461|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164036865|NCT01237223|592494462|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
164036866|NCT01237223|592494457|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
164036867|NCT01237223|592494458|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164036868|NCT01237223|592494459|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164036869|NCT01237223|592494460|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164036870|NCT01237223|592494461|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164036871|NCT01237223|592494462|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
164036872|NCT01237223|592494457|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
164036873|NCT01237223|592494458|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164036874|NCT01237223|592494459|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164036875|NCT01237223|592494460|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164036876|NCT01237223|592494461|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164036877|NCT01237223|592494462|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
164036878|NCT01237223|592494457|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
164036879|NCT01237223|592494458|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
164036880|NCT01237223|592494459|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
164036881|NCT01237223|592494460|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
164036882|NCT01237223|592494461|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
164036883|NCT01237223|592494462|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
164036884|NCT01237223|592494457|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
164036885|NCT01237223|592494458|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
164036886|NCT01237223|592494459|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
164036887|NCT01237223|592494460|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
164036888|NCT01237223|592494461|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
164036889|NCT01237223|592494462|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
164036890|NCT01237223|592494457|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
164036891|NCT01237223|592494458|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
164036892|NCT01237223|592494459|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
164098483|NCT00870870|592725110|FG003|Overall Study|Withdrawal by Subject|3|||
163836958|NCT01077362|591774354|FG001|Overall Study|Lack of Efficacy|8|||
163836959|NCT01077362|591774355|FG002|Overall Study|Lack of Efficacy|10|||
163836960|NCT01077362|591774353|FG000|Overall Study|Lost to Follow-up|1|||
163836961|NCT01077362|591774354|FG001|Overall Study|Lost to Follow-up|0|||
163836962|NCT01077362|591774355|FG002|Overall Study|Lost to Follow-up|3|||
163836963|NCT01077362|591774353|FG000|Overall Study|Adverse Event|12|||
163836964|NCT01077362|591774354|FG001|Overall Study|Adverse Event|7|||
163836965|NCT01077362|591774355|FG002|Overall Study|Adverse Event|4|||
163836966|NCT01077362|591774353|FG000|Overall Study|Withdrawal by Subject|5|||
163836967|NCT01077362|591774354|FG001|Overall Study|Withdrawal by Subject|3|||
163836968|NCT01077362|591774355|FG002|Overall Study|Withdrawal by Subject|5|||
163836969|NCT01077362|591774353|FG000|Overall Study|Other|0|||
163836970|NCT01077362|591774354|FG001|Overall Study|Other|1|||
163836971|NCT01077362|591774355|FG002|Overall Study|Other|2|||
163836972|NCT00301080|591774360|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
163836973|NCT00301080|591774361|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163836974|NCT00301080|591774362|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163836975|NCT00301080|591774363|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163836976|NCT00301080|591774364|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
163836977|NCT01287520|591774365|FG000|Overall Study|Adverse Event|2|||
163836978|NCT01287520|591774366|FG001|Overall Study|Adverse Event|2|||
163836979|NCT01287520|591774367|FG002|Overall Study|Adverse Event|2|||
163836980|NCT01287520|591774368|FG003|Overall Study|Adverse Event|1|||
163836981|NCT01287520|591774369|FG004|Overall Study|Adverse Event|1|||
163836982|NCT01287520|591774370|FG005|Overall Study|Adverse Event|2|||
163836983|NCT01287520|591774371|FG006|Overall Study|Adverse Event|0|||
163836984|NCT01287520|591774372|FG007|Overall Study|Adverse Event|2|||
164036893|NCT01237223|592494460|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
163836985|NCT01287520|591774373|FG008|Overall Study|Adverse Event|0|||
163836986|NCT01287520|591774365|FG000|Overall Study|Physician Decision|1|||
163836987|NCT01287520|591774366|FG001|Overall Study|Physician Decision|1|||
163836988|NCT01287520|591774367|FG002|Overall Study|Physician Decision|2|||
163836989|NCT01287520|591774368|FG003|Overall Study|Physician Decision|0|||
163836990|NCT01287520|591774369|FG004|Overall Study|Physician Decision|1|||
163836991|NCT01287520|591774370|FG005|Overall Study|Physician Decision|1|||
163836992|NCT01287520|591774371|FG006|Overall Study|Physician Decision|0|||
163836993|NCT01287520|591774372|FG007|Overall Study|Physician Decision|1|||
163836994|NCT01287520|591774373|FG008|Overall Study|Physician Decision|0|||
163836995|NCT01287520|591774365|FG000|Overall Study|Progressive disease|0|||
163836996|NCT01287520|591774366|FG001|Overall Study|Progressive disease|4|||
163836997|NCT01287520|591774367|FG002|Overall Study|Progressive disease|1|||
163836998|NCT01287520|591774368|FG003|Overall Study|Progressive disease|6|||
163836999|NCT01287520|591774369|FG004|Overall Study|Progressive disease|1|||
163837000|NCT01287520|591774370|FG005|Overall Study|Progressive disease|0|||
163837001|NCT01287520|591774371|FG006|Overall Study|Progressive disease|2|||
163837002|NCT01287520|591774372|FG007|Overall Study|Progressive disease|2|||
163837003|NCT01287520|591774373|FG008|Overall Study|Progressive disease|4|||
163837004|NCT01287520|591774365|FG000|Overall Study|Withdrawal by Subject|0|||
163837005|NCT01287520|591774366|FG001|Overall Study|Withdrawal by Subject|0|||
163837006|NCT01287520|591774367|FG002|Overall Study|Withdrawal by Subject|0|||
163837007|NCT01287520|591774368|FG003|Overall Study|Withdrawal by Subject|0|||
163837008|NCT01287520|591774369|FG004|Overall Study|Withdrawal by Subject|0|||
163837009|NCT01287520|591774370|FG005|Overall Study|Withdrawal by Subject|1|||
163837010|NCT01287520|591774371|FG006|Overall Study|Withdrawal by Subject|0|||
163837011|NCT01287520|591774372|FG007|Overall Study|Withdrawal by Subject|0|||
163837012|NCT01287520|591774373|FG008|Overall Study|Withdrawal by Subject|1|||
163837013|NCT03587142|591774374|FG000|Overall Study|Lost to Follow-up|5|||
163837014|NCT03587142|591774375|FG001|Overall Study|Lost to Follow-up|3|||
163837015|NCT03587142|591774374|FG000|Overall Study|Did not complete the f4 visit|3|||
163837016|NCT03587142|591774375|FG001|Overall Study|Did not complete the f4 visit|7|||
163837017|NCT03673462|591774376|FG000|Overall Study|Adverse Event|11|||
164036894|NCT01237223|592494461|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
164036895|NCT01237223|592494462|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
163837018|NCT03673462|591774377|FG001|Overall Study|Adverse Event|1|||
163837019|NCT03673462|591774376|FG000|Overall Study|Protocol Violation|25|||
164036896|NCT01237223|592494457|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164036897|NCT01237223|592494458|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
163837020|NCT03673462|591774377|FG001|Overall Study|Protocol Violation|11|||
164098484|NCT00870870|592725107|FG000|Overall Study|Adverse Event|0|||
163837021|NCT03673462|591774376|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
163837022|NCT03673462|591774377|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
163837023|NCT03673462|591774376|FG000|Overall Study|Lost to Follow-up|102|||
163837024|NCT03673462|591774377|FG001|Overall Study|Lost to Follow-up|19|||
163837025|NCT01616771|591774380|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
163837026|NCT04359771|591774385|FG000|Overall Study|Lack of Efficacy|2|||
163837027|NCT04359771|591774386|FG001|Overall Study|Lack of Efficacy|2|||
163837028|NCT04041440|591774388|FG000|Overall Study|Withdrawal by Subject|0|||
163837029|NCT04041440|591774389|FG001|Overall Study|Withdrawal by Subject|1|||
163837030|NCT04041440|591774388|FG000|Overall Study|Lost to Follow-up|0|||
163837031|NCT04041440|591774389|FG001|Overall Study|Lost to Follow-up|1|||
163837032|NCT02306265|591774390|FG000|Overall Study|Withdrawal by Subject|1|||
163837033|NCT02247804|591774395|FG000|Treatment Period 1|Adverse Event|9|||
163837034|NCT02247804|591774396|FG001|Treatment Period 1|Adverse Event|2|||
163837035|NCT02247804|591774397|FG002|Treatment Period 1|Adverse Event|0|||
163837036|NCT02247804|591774395|FG000|Treatment Period 1|Lack of Efficacy|0|||
163837037|NCT02247804|591774396|FG001|Treatment Period 1|Lack of Efficacy|0|||
163837038|NCT02247804|591774397|FG002|Treatment Period 1|Lack of Efficacy|2|||
163837039|NCT02247804|591774395|FG000|Treatment Period 1|Lost to Follow-up|1|||
163837040|NCT02247804|591774396|FG001|Treatment Period 1|Lost to Follow-up|0|||
163837041|NCT02247804|591774397|FG002|Treatment Period 1|Lost to Follow-up|2|||
163837042|NCT02247804|591774395|FG000|Treatment Period 1|Personal Reasons|7|||
163837043|NCT02247804|591774396|FG001|Treatment Period 1|Personal Reasons|1|||
163837044|NCT02247804|591774397|FG002|Treatment Period 1|Personal Reasons|2|||
163837045|NCT02247804|591774395|FG000|Treatment Period 1|Protocol Deviation|0|||
163837046|NCT02247804|591774396|FG001|Treatment Period 1|Protocol Deviation|0|||
163837047|NCT02247804|591774397|FG002|Treatment Period 1|Protocol Deviation|1|||
163837048|NCT02247804|591774395|FG000|Treatment Period 1|Randomized but not Treated|5|||
163837049|NCT02247804|591774396|FG001|Treatment Period 1|Randomized but not Treated|1|||
163837050|NCT02247804|591774397|FG002|Treatment Period 1|Randomized but not Treated|1|||
163837051|NCT02247804|591774395|FG000|Treatment Period 2|Adverse Event|6|||
163837052|NCT02247804|591774396|FG001|Treatment Period 2|Adverse Event|3|||
163837053|NCT02247804|591774397|FG002|Treatment Period 2|Adverse Event|3|||
163837054|NCT02247804|591774395|FG000|Treatment Period 2|Lack of Efficacy|0|||
163837055|NCT02247804|591774396|FG001|Treatment Period 2|Lack of Efficacy|0|||
163837056|NCT02247804|591774397|FG002|Treatment Period 2|Lack of Efficacy|1|||
163837057|NCT02247804|591774395|FG000|Treatment Period 2|Lost to Follow-up|0|||
163837058|NCT02247804|591774396|FG001|Treatment Period 2|Lost to Follow-up|1|||
163837059|NCT02247804|591774397|FG002|Treatment Period 2|Lost to Follow-up|1|||
163837060|NCT02247804|591774395|FG000|Treatment Period 2|Personal Reasons|2|||
163837061|NCT02247804|591774396|FG001|Treatment Period 2|Personal Reasons|1|||
163837062|NCT02247804|591774397|FG002|Treatment Period 2|Personal Reasons|1|||
163837063|NCT02247804|591774395|FG000|Treatment Period 2|Reason not Specified|0|||
163837064|NCT02247804|591774396|FG001|Treatment Period 2|Reason not Specified|0|||
163837065|NCT02247804|591774397|FG002|Treatment Period 2|Reason not Specified|2|||
163837066|NCT02247804|591774395|FG000|Treatment Period 3|Adverse Event|4|||
163837067|NCT02247804|591774396|FG001|Treatment Period 3|Adverse Event|3|||
163837068|NCT02247804|591774397|FG002|Treatment Period 3|Adverse Event|3|||
163837069|NCT02247804|591774395|FG000|Treatment Period 3|Lack of Efficacy|0|||
163837070|NCT02247804|591774396|FG001|Treatment Period 3|Lack of Efficacy|1|||
163837071|NCT02247804|591774397|FG002|Treatment Period 3|Lack of Efficacy|0|||
163837072|NCT02247804|591774395|FG000|Treatment Period 3|Lost to Follow-up|1|||
163837073|NCT02247804|591774396|FG001|Treatment Period 3|Lost to Follow-up|2|||
163837074|NCT02247804|591774397|FG002|Treatment Period 3|Lost to Follow-up|2|||
163837075|NCT02247804|591774395|FG000|Treatment Period 3|Personal Reasons|4|||
163837076|NCT02247804|591774396|FG001|Treatment Period 3|Personal Reasons|3|||
163837077|NCT02247804|591774397|FG002|Treatment Period 3|Personal Reasons|2|||
163837078|NCT02247804|591774395|FG000|Treatment Period 3|Reason not Specified|2|||
163837079|NCT02247804|591774396|FG001|Treatment Period 3|Reason not Specified|1|||
163837080|NCT02247804|591774397|FG002|Treatment Period 3|Reason not Specified|3|||
163837081|NCT01346514|591774400|FG000|Overall Study|Lost to Follow-up|19|||
163837082|NCT01346514|591774401|FG001|Overall Study|Lost to Follow-up|30|||
163837083|NCT01346514|591774400|FG000|Overall Study|Withdrawal by Subject|7|||
163837084|NCT01346514|591774401|FG001|Overall Study|Withdrawal by Subject|3|||
163837085|NCT01346514|591774400|FG000|Overall Study|Death|3|||
163837086|NCT01346514|591774401|FG001|Overall Study|Death|4|||
163837087|NCT00909480|591774402|FG000|Overall Study|Adverse Event|5|||
163837088|NCT00909480|591774403|FG001|Overall Study|Adverse Event|3|||
163837089|NCT00909480|591774402|FG000|Overall Study|Protocol Violation|6|||
163837090|NCT00909480|591774403|FG001|Overall Study|Protocol Violation|8|||
163837091|NCT00909480|591774402|FG000|Overall Study|Withdrawal criteria|9|||
163837092|NCT00909480|591774403|FG001|Overall Study|Withdrawal criteria|11|||
163837093|NCT00909480|591774402|FG000|Overall Study|Unclassified|18|||
163837094|NCT00909480|591774403|FG001|Overall Study|Unclassified|19|||
163837095|NCT03002038|591774407|FG000|Overall Study|Adverse Event|3|||
163837096|NCT03002038|591774408|FG001|Overall Study|Adverse Event|1|||
163837097|NCT03002038|591774407|FG000|Overall Study|Withdrawal by Subject|8|||
163837098|NCT03002038|591774408|FG001|Overall Study|Withdrawal by Subject|4|||
163837099|NCT03002038|591774407|FG000|Overall Study|Immigration to another region|0|||
163837100|NCT03002038|591774408|FG001|Overall Study|Immigration to another region|2|||
163837101|NCT01054573|591774409|FG000|Overall Study|Adverse Event|1|||
163837102|NCT01054573|591774410|FG001|Overall Study|Adverse Event|0|||
163837103|NCT01054573|591774411|FG002|Overall Study|Adverse Event|1|||
163837104|NCT01054573|591774412|FG003|Overall Study|Adverse Event|1|||
163837105|NCT01054573|591774409|FG000|Overall Study|Lost to Follow-up|0|||
164036898|NCT01237223|592494459|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164036899|NCT01237223|592494460|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164036900|NCT01237223|592494461|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
164036901|NCT01237223|592494462|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
164036902|NCT01237223|592494457|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
164036903|NCT01237223|592494458|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164036904|NCT01237223|592494459|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164036905|NCT01237223|592494460|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
164036906|NCT01237223|592494461|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164036907|NCT01237223|592494462|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
164036908|NCT00724815|592494465|FG000|Overall Study|Randomized, not treated|31|||
164036909|NCT00724815|592494466|FG001|Overall Study|Randomized, not treated|30|||
164036910|NCT00724815|592494465|FG000|Overall Study|Adverse Event|5|||
164036911|NCT00724815|592494466|FG001|Overall Study|Adverse Event|3|||
164036912|NCT00724815|592494465|FG000|Overall Study|Lost to Follow-up|4|||
164036913|NCT00724815|592494466|FG001|Overall Study|Lost to Follow-up|1|||
164036914|NCT00724815|592494465|FG000|Overall Study|Other Various|3|||
164036915|NCT00724815|592494466|FG001|Overall Study|Other Various|5|||
164036916|NCT00445341|592494470|FG000|Overall Study|refused further treatment|1|||
164036917|NCT00445341|592494470|FG000|Overall Study|taken off treatment too early|1|||
164036918|NCT00641706|592494471|FG000|Overall Study|Adverse Event|2|||
164036919|NCT00641706|592494472|FG001|Overall Study|Adverse Event|1|||
164036920|NCT00641706|592494471|FG000|Overall Study|Withdrawal by Subject|6|||
164036921|NCT00641706|592494472|FG001|Overall Study|Withdrawal by Subject|1|||
164036922|NCT00641706|592494471|FG000|Overall Study|Clinical Decline|1|||
164036923|NCT00641706|592494472|FG001|Overall Study|Clinical Decline|0|||
164036924|NCT00641706|592494471|FG000|Overall Study|Lead Investigator Decision|0|||
164036925|NCT00641706|592494472|FG001|Overall Study|Lead Investigator Decision|1|||
164036926|NCT00813917|592494473|FG000|Overall Study|Adverse Event|0|||
164036927|NCT00813917|592494474|FG001|Overall Study|Adverse Event|1|||
164036928|NCT00813917|592494473|FG000|Overall Study|Withdrawal by Subject|3|||
164036929|NCT00813917|592494474|FG001|Overall Study|Withdrawal by Subject|4|||
164036930|NCT00813917|592494473|FG000|Overall Study|Lost to Follow-up|3|||
164036931|NCT00813917|592494474|FG001|Overall Study|Lost to Follow-up|1|||
164036932|NCT05441540|592494475|FG000|Overall Study|Withdrawal by Subject|2|||
164036933|NCT01359046|592494476|FG000|Overall Study|Did not receive allocated intervention|6|||
164036934|NCT01359046|592494477|FG001|Overall Study|Did not receive allocated intervention|6|||
164036935|NCT01359046|592494476|FG000|Overall Study|Physician Decision|1|||
164036936|NCT01359046|592494477|FG001|Overall Study|Physician Decision|11|||
164036937|NCT00105183|592494481|FG000|Overall Study|Death|19|||
164036938|NCT00105183|592494482|FG001|Overall Study|Death|13|||
164036939|NCT00105183|592494483|FG002|Overall Study|Death|15|||
164036940|NCT00105183|592494481|FG000|Overall Study|Withdrawal by Subject|1|||
164036941|NCT00105183|592494482|FG001|Overall Study|Withdrawal by Subject|1|||
164036942|NCT00105183|592494483|FG002|Overall Study|Withdrawal by Subject|4|||
164036943|NCT00105183|592494481|FG000|Overall Study|Physician Decision|1|||
164036944|NCT00105183|592494482|FG001|Overall Study|Physician Decision|2|||
164036945|NCT00105183|592494483|FG002|Overall Study|Physician Decision|3|||
164036946|NCT00105183|592494481|FG000|Overall Study|Lost to Follow-up|0|||
164036947|NCT00105183|592494482|FG001|Overall Study|Lost to Follow-up|1|||
164036948|NCT00105183|592494483|FG002|Overall Study|Lost to Follow-up|1|||
164036949|NCT00105183|592494481|FG000|Overall Study|Other reason|1|||
164036950|NCT00105183|592494482|FG001|Overall Study|Other reason|2|||
163837106|NCT01054573|591774410|FG001|Overall Study|Lost to Follow-up|2|||
163837107|NCT01054573|591774411|FG002|Overall Study|Lost to Follow-up|0|||
163837108|NCT01054573|591774412|FG003|Overall Study|Lost to Follow-up|0|||
163837109|NCT01054573|591774409|FG000|Overall Study|Withdrawal by Subject|0|||
163837110|NCT01054573|591774410|FG001|Overall Study|Withdrawal by Subject|2|||
163837111|NCT01054573|591774411|FG002|Overall Study|Withdrawal by Subject|2|||
164036951|NCT00105183|592494483|FG002|Overall Study|Other reason|0|||
164036952|NCT00615914|592494485|FG000|Overall Study|Adverse Event|274|||
164036953|NCT00615914|592494485|FG000|Overall Study|Death|20|||
164036954|NCT00615914|592494485|FG000|Overall Study|Lack of Efficacy|59|||
163837112|NCT01054573|591774412|FG003|Overall Study|Withdrawal by Subject|1|||
164036955|NCT00615914|592494485|FG000|Overall Study|Lost to Follow-up|187|||
164036956|NCT00615914|592494485|FG000|Overall Study|Withdrawal by Subject|16|||
164036957|NCT00615914|592494485|FG000|Overall Study|Physician Decision|4|||
164036958|NCT00615914|592494485|FG000|Overall Study|No data was collected.|65|||
164036959|NCT00615914|592494485|FG000|Overall Study|No treatment|2|||
164036960|NCT00615914|592494485|FG000|Overall Study|Irregularly enrolled patients|10|||
164036961|NCT00270998|592494486|FG000|3 Month Follow-up|Adverse Event|1|||
164036962|NCT00270998|592494487|FG001|3 Month Follow-up|Adverse Event|0|||
164036963|NCT00270998|592494488|FG002|3 Month Follow-up|Adverse Event|0|||
164036964|NCT00270998|592494486|FG000|3 Month Follow-up|Lack of Efficacy|1|||
164036965|NCT00270998|592494487|FG001|3 Month Follow-up|Lack of Efficacy|2|||
164036966|NCT00270998|592494488|FG002|3 Month Follow-up|Lack of Efficacy|1|||
163837113|NCT00393523|591774413|FG000|Overall Study|Lost to Follow-up|0|||
163837114|NCT00393523|591774414|FG001|Overall Study|Lost to Follow-up|0|||
163837115|NCT00393523|591774415|FG002|Overall Study|Lost to Follow-up|0|||
163837116|NCT00393523|591774416|FG003|Overall Study|Lost to Follow-up|2|||
163837117|NCT00393523|591774417|FG004|Overall Study|Lost to Follow-up|1|||
163837118|NCT00393523|591774413|FG000|Overall Study|Protocol Violation|6|||
163837119|NCT00393523|591774414|FG001|Overall Study|Protocol Violation|2|||
163837120|NCT00393523|591774415|FG002|Overall Study|Protocol Violation|0|||
163837121|NCT00393523|591774416|FG003|Overall Study|Protocol Violation|1|||
163837122|NCT00393523|591774417|FG004|Overall Study|Protocol Violation|0|||
163837123|NCT00393523|591774413|FG000|Overall Study|Withdrawal by Subject|6|||
163837124|NCT00393523|591774414|FG001|Overall Study|Withdrawal by Subject|7|||
163837125|NCT00393523|591774415|FG002|Overall Study|Withdrawal by Subject|2|||
163837126|NCT00393523|591774416|FG003|Overall Study|Withdrawal by Subject|3|||
163837127|NCT00393523|591774417|FG004|Overall Study|Withdrawal by Subject|0|||
163837128|NCT00393523|591774413|FG000|Overall Study|Difficulties in specimen collection|0|||
163837129|NCT00393523|591774414|FG001|Overall Study|Difficulties in specimen collection|0|||
163837130|NCT00393523|591774415|FG002|Overall Study|Difficulties in specimen collection|1|||
163837131|NCT00393523|591774416|FG003|Overall Study|Difficulties in specimen collection|0|||
163837132|NCT00393523|591774417|FG004|Overall Study|Difficulties in specimen collection|0|||
163837133|NCT00393523|591774413|FG000|Overall Study|Vaccine supply issue|0|||
163837134|NCT00393523|591774414|FG001|Overall Study|Vaccine supply issue|0|||
163837135|NCT00393523|591774415|FG002|Overall Study|Vaccine supply issue|1|||
163837136|NCT00393523|591774416|FG003|Overall Study|Vaccine supply issue|0|||
163837137|NCT00393523|591774417|FG004|Overall Study|Vaccine supply issue|0|||
163837138|NCT01735396|591774421|FG000|Overall Study|not evaluable|1|||
163837139|NCT03724396|591774424|FG000|Overall Study|Lost to Follow-up|1|||
163837140|NCT03724396|591774425|FG001|Overall Study|Lost to Follow-up|1|||
163837141|NCT03724396|591774424|FG000|Overall Study|Withdrawal by Subject|1|||
163837142|NCT03724396|591774425|FG001|Overall Study|Withdrawal by Subject|0|||
163837143|NCT00682643|591774428|FG000|Overall Study|Adverse Event|12|||
163837144|NCT00682643|591774429|FG001|Overall Study|Adverse Event|23|||
163837145|NCT00682643|591774428|FG000|Overall Study|Lack of Efficacy|2|||
163837146|NCT00682643|591774429|FG001|Overall Study|Lack of Efficacy|0|||
163837147|NCT00682643|591774428|FG000|Overall Study|Protocol Violation|38|||
163837148|NCT00682643|591774429|FG001|Overall Study|Protocol Violation|76|||
163837149|NCT00682643|591774428|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
163837150|NCT00682643|591774429|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
163837151|NCT00682643|591774428|FG000|Overall Study|Lost to Follow-up|1|||
163837152|NCT00682643|591774429|FG001|Overall Study|Lost to Follow-up|6|||
163837153|NCT00682643|591774428|FG000|Overall Study|Physician Decision|2|||
163837154|NCT00682643|591774429|FG001|Overall Study|Physician Decision|6|||
163837155|NCT00682643|591774428|FG000|Overall Study|Withdrawal by Subject|19|||
163837156|NCT00682643|591774429|FG001|Overall Study|Withdrawal by Subject|53|||
163837157|NCT00682643|591774428|FG000|Overall Study|Did Not Receive Study Drug|1|||
163837158|NCT00682643|591774429|FG001|Overall Study|Did Not Receive Study Drug|1|||
163837159|NCT01875185|591774430|FG000|Overall Study|study was terminated|52|||
163837160|NCT01875185|591774431|FG001|Overall Study|study was terminated|48|||
163837161|NCT03238300|591774432|FG000|Baseline (Before Intervention)|Physician Decision|0|||
163837162|NCT03238300|591774433|FG001|Baseline (Before Intervention)|Physician Decision|1|||
163837163|NCT03238300|591774432|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
163837164|NCT03238300|591774433|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
163837165|NCT03238300|591774432|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
163837166|NCT03238300|591774433|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
163837167|NCT03238300|591774432|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
163837168|NCT03238300|591774433|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
163837169|NCT03389477|591774444|FG000|Step 1|Withdrawal by Subject|1|||
163837170|NCT03389477|591774445|FG001|Step 1|Withdrawal by Subject|0|||
163837171|NCT03389477|591774444|FG000|Step 2|Withdrawal by Subject|1|||
163837172|NCT03389477|591774445|FG001|Step 2|Withdrawal by Subject|2|||
163837173|NCT03389477|591774444|FG000|Step 2|Disease progression|1|||
163837174|NCT03389477|591774445|FG001|Step 2|Disease progression|0|||
163837175|NCT03389477|591774444|FG000|Step 2|Death|0|||
163837176|NCT03389477|591774445|FG001|Step 2|Death|1|||
163837177|NCT03389477|591774444|FG000|Step 2|Poor performance status and nutrition|0|||
163837178|NCT03389477|591774445|FG001|Step 2|Poor performance status and nutrition|1|||
163837179|NCT03389477|591774444|FG000|Step 3|Withdrawal after 3 cycles|0|||
163837180|NCT03389477|591774445|FG001|Step 3|Withdrawal after 3 cycles|1|||
163837181|NCT03389477|591774444|FG000|Step 3|Still receiving active treatment|4|||
163837182|NCT03389477|591774445|FG001|Step 3|Still receiving active treatment|0|||
163837183|NCT03389477|591774444|FG000|Step 3|Progressive disease after 2 cycles|1|||
163837184|NCT03389477|591774445|FG001|Step 3|Progressive disease after 2 cycles|0|||
163837185|NCT04512066|591774446|FG000|Double-blind Treatment Period|Adverse Event|6|||
163837186|NCT04512066|591774447|FG001|Double-blind Treatment Period|Adverse Event|4|||
163837187|NCT04512066|591774448|FG002|Double-blind Treatment Period|Adverse Event|5|||
163837188|NCT04512066|591774449|FG003|Double-blind Treatment Period|Adverse Event|1|||
163837189|NCT04512066|591774450|FG004|Double-blind Treatment Period|Adverse Event|0|||
163837190|NCT04512066|591774451|FG005|Double-blind Treatment Period|Adverse Event|0|||
163837191|NCT04512066|591774446|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
163837192|NCT04512066|591774447|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
163837193|NCT04512066|591774448|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
163837194|NCT04512066|591774449|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
164036967|NCT00270998|592494486|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
164036968|NCT00270998|592494487|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
164036969|NCT00270998|592494488|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
164036970|NCT00270998|592494486|FG000|3 Month Follow-up|Pessary did not fit|12|||
164036971|NCT00270998|592494487|FG001|3 Month Follow-up|Pessary did not fit|0|||
164036972|NCT00270998|592494488|FG002|3 Month Follow-up|Pessary did not fit|0|||
164036973|NCT00270998|592494486|FG000|3 Month Follow-up|Personal/family health|1|||
164036974|NCT00270998|592494487|FG001|3 Month Follow-up|Personal/family health|1|||
164036975|NCT00270998|592494488|FG002|3 Month Follow-up|Personal/family health|0|||
164036976|NCT00270998|592494486|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
164036977|NCT00270998|592494487|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
164036978|NCT00270998|592494488|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
164036979|NCT00270998|592494486|FG000|12 Month Follow-up|Lack of Efficacy|5|||
164036980|NCT00270998|592494487|FG001|12 Month Follow-up|Lack of Efficacy|4|||
164036981|NCT00270998|592494488|FG002|12 Month Follow-up|Lack of Efficacy|3|||
164036982|NCT00270998|592494486|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
164036983|NCT00270998|592494487|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
164036984|NCT00270998|592494488|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
164036985|NCT00270998|592494486|FG000|12 Month Follow-up|Pessary did not fit|1|||
164036986|NCT00270998|592494487|FG001|12 Month Follow-up|Pessary did not fit|0|||
164036987|NCT00270998|592494488|FG002|12 Month Follow-up|Pessary did not fit|0|||
164036988|NCT00270998|592494486|FG000|12 Month Follow-up|Personal/family health|0|||
164036989|NCT00270998|592494487|FG001|12 Month Follow-up|Personal/family health|5|||
164036990|NCT00270998|592494488|FG002|12 Month Follow-up|Personal/family health|1|||
164036991|NCT00270998|592494486|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
164036992|NCT00270998|592494487|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
164036993|NCT00270998|592494488|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
164036994|NCT04075396|592494489|FG000|Overall Study|Death|11|||
164036995|NCT04075396|592494490|FG001|Overall Study|Death|9|||
164036996|NCT04075396|592494489|FG000|Overall Study|Withdrawal by Subject|1|||
164036997|NCT04075396|592494490|FG001|Overall Study|Withdrawal by Subject|2|||
164036998|NCT04075396|592494489|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
164036999|NCT04075396|592494490|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
164037000|NCT04075396|592494489|FG000|Overall Study|Enrolled but not-treated|0|||
164037001|NCT04075396|592494490|FG001|Overall Study|Enrolled but not-treated|1|||
164037002|NCT04737759|592494491|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
164037003|NCT04737759|592494492|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
164037004|NCT04737759|592494491|FG000|Overall Study|Death|2|||
164037005|NCT04737759|592494492|FG001|Overall Study|Death|0|||
164037006|NCT04737759|592494491|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
164037007|NCT04737759|592494492|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
164037008|NCT04737759|592494491|FG000|Overall Study|Lost to Follow-up|4|||
164037009|NCT04737759|592494492|FG001|Overall Study|Lost to Follow-up|12|||
164037010|NCT00294684|592494493|FG000|Overall Study|Lost to Follow-up|5|||
164037011|NCT00294684|592494494|FG001|Overall Study|Lost to Follow-up|8|||
164037012|NCT01981109|592494497|FG000|Overall Study|Death|36|||
164037013|NCT01981109|592494497|FG000|Overall Study|Withdrawal by Subject|40|||
164037014|NCT01981109|592494497|FG000|Overall Study|Lost to Follow-up|9|||
164037015|NCT01981109|592494497|FG000|Overall Study|No Discontinuation Documentation|37|||
164037016|NCT01981109|592494497|FG000|Overall Study|Study Termination|100|||
164037017|NCT01981109|592494497|FG000|Overall Study|No data available|2|||
164037018|NCT01248364|592494498|FG000|Overall Study|Adverse Event|0|||
164037019|NCT01248364|592494499|FG001|Overall Study|Adverse Event|1|||
164037020|NCT01248364|592494500|FG002|Overall Study|Adverse Event|0|||
164037021|NCT01248364|592494501|FG003|Overall Study|Adverse Event|0|||
164037022|NCT01767519|592494502|FG000|Overall Study|Other Reasons|4|||
164037023|NCT01767519|592494503|FG001|Overall Study|Other Reasons|4|||
164037024|NCT01767519|592494504|FG002|Overall Study|Other Reasons|2|||
164037025|NCT01767519|592494502|FG000|Overall Study|Protocol Violation|0|||
164037026|NCT01767519|592494503|FG001|Overall Study|Protocol Violation|3|||
164037027|NCT01767519|592494504|FG002|Overall Study|Protocol Violation|0|||
164037028|NCT01767519|592494502|FG000|Overall Study|Personal Reasons|1|||
164037029|NCT01767519|592494503|FG001|Overall Study|Personal Reasons|0|||
164037030|NCT01767519|592494504|FG002|Overall Study|Personal Reasons|0|||
164037031|NCT01767519|592494502|FG000|Overall Study|Lost to Follow-up|3|||
164037032|NCT01767519|592494503|FG001|Overall Study|Lost to Follow-up|1|||
164037033|NCT01767519|592494504|FG002|Overall Study|Lost to Follow-up|2|||
163837195|NCT04512066|591774450|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
163837196|NCT04512066|591774451|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
163837197|NCT04512066|591774446|FG000|Double-blind Treatment Period|Physician Decision|1|||
163837198|NCT04512066|591774447|FG001|Double-blind Treatment Period|Physician Decision|0|||
163837199|NCT04512066|591774448|FG002|Double-blind Treatment Period|Physician Decision|1|||
163837200|NCT04512066|591774449|FG003|Double-blind Treatment Period|Physician Decision|0|||
163837201|NCT04512066|591774450|FG004|Double-blind Treatment Period|Physician Decision|0|||
163837202|NCT04512066|591774451|FG005|Double-blind Treatment Period|Physician Decision|0|||
163837203|NCT04512066|591774446|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
163837204|NCT04512066|591774447|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
163837205|NCT04512066|591774448|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
163837206|NCT04512066|591774449|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
163837207|NCT04512066|591774450|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
163837208|NCT04512066|591774451|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
163837209|NCT04512066|591774446|FG000|Extension Period|Adverse Event|0|||
163837210|NCT04512066|591774447|FG001|Extension Period|Adverse Event|1|||
163837211|NCT04512066|591774448|FG002|Extension Period|Adverse Event|4|||
163837212|NCT04512066|591774449|FG003|Extension Period|Adverse Event|3|||
163837213|NCT04512066|591774450|FG004|Extension Period|Adverse Event|1|||
163837214|NCT04512066|591774451|FG005|Extension Period|Adverse Event|3|||
163837215|NCT04512066|591774446|FG000|Extension Period|Death|0|||
163837216|NCT04512066|591774447|FG001|Extension Period|Death|0|||
163837217|NCT04512066|591774448|FG002|Extension Period|Death|0|||
163837218|NCT04512066|591774449|FG003|Extension Period|Death|0|||
163837219|NCT04512066|591774450|FG004|Extension Period|Death|0|||
163837220|NCT04512066|591774451|FG005|Extension Period|Death|1|||
163837221|NCT04512066|591774446|FG000|Extension Period|Lack of Efficacy|0|||
163837222|NCT04512066|591774447|FG001|Extension Period|Lack of Efficacy|4|||
163837223|NCT04512066|591774448|FG002|Extension Period|Lack of Efficacy|4|||
163837224|NCT04512066|591774449|FG003|Extension Period|Lack of Efficacy|1|||
163837225|NCT04512066|591774450|FG004|Extension Period|Lack of Efficacy|3|||
163837226|NCT04512066|591774451|FG005|Extension Period|Lack of Efficacy|3|||
163837227|NCT04512066|591774446|FG000|Extension Period|Lost to Follow-up|0|||
163837228|NCT04512066|591774447|FG001|Extension Period|Lost to Follow-up|1|||
163837229|NCT04512066|591774448|FG002|Extension Period|Lost to Follow-up|5|||
163837230|NCT04512066|591774449|FG003|Extension Period|Lost to Follow-up|2|||
163837231|NCT04512066|591774450|FG004|Extension Period|Lost to Follow-up|3|||
163837232|NCT04512066|591774451|FG005|Extension Period|Lost to Follow-up|2|||
163837233|NCT04512066|591774446|FG000|Extension Period|Non-compliance with study drug|0|||
163837234|NCT04512066|591774447|FG001|Extension Period|Non-compliance with study drug|1|||
163837235|NCT04512066|591774448|FG002|Extension Period|Non-compliance with study drug|0|||
163837236|NCT04512066|591774449|FG003|Extension Period|Non-compliance with study drug|0|||
163837237|NCT04512066|591774450|FG004|Extension Period|Non-compliance with study drug|0|||
163837238|NCT04512066|591774451|FG005|Extension Period|Non-compliance with study drug|1|||
163837239|NCT04512066|591774446|FG000|Extension Period|Other|0|||
163837240|NCT04512066|591774447|FG001|Extension Period|Other|2|||
163837241|NCT04512066|591774448|FG002|Extension Period|Other|0|||
163837242|NCT04512066|591774449|FG003|Extension Period|Other|0|||
163837243|NCT04512066|591774450|FG004|Extension Period|Other|0|||
163837244|NCT04512066|591774451|FG005|Extension Period|Other|0|||
163837245|NCT04512066|591774446|FG000|Extension Period|Physician Decision|0|||
163837246|NCT04512066|591774447|FG001|Extension Period|Physician Decision|2|||
163837247|NCT04512066|591774448|FG002|Extension Period|Physician Decision|0|||
163837248|NCT04512066|591774449|FG003|Extension Period|Physician Decision|1|||
163837249|NCT04512066|591774450|FG004|Extension Period|Physician Decision|1|||
163837250|NCT04512066|591774451|FG005|Extension Period|Physician Decision|0|||
163837251|NCT04512066|591774446|FG000|Extension Period|Withdrawal by Subject|0|||
163837252|NCT04512066|591774447|FG001|Extension Period|Withdrawal by Subject|3|||
163837253|NCT04512066|591774448|FG002|Extension Period|Withdrawal by Subject|7|||
163837254|NCT04512066|591774449|FG003|Extension Period|Withdrawal by Subject|11|||
164037034|NCT01767519|592494502|FG000|Overall Study|Lack of Efficacy|1|||
164037035|NCT01767519|592494503|FG001|Overall Study|Lack of Efficacy|0|||
164037036|NCT01767519|592494504|FG002|Overall Study|Lack of Efficacy|0|||
164037037|NCT01767519|592494502|FG000|Overall Study|Adverse Event|5|||
164037038|NCT01767519|592494503|FG001|Overall Study|Adverse Event|5|||
163837255|NCT04512066|591774450|FG004|Extension Period|Withdrawal by Subject|8|||
163837256|NCT04512066|591774451|FG005|Extension Period|Withdrawal by Subject|4|||
163837257|NCT03403426|591774452|FG000|Overall Study|Death|1|||
163837258|NCT03403426|591774452|FG000|Overall Study|Lost to Follow-up|2|||
163837259|NCT01657266|591774457|FG000|Overall Study|Lost to Follow-up|2|||
163837260|NCT01657266|591774458|FG001|Overall Study|Lost to Follow-up|2|||
163837261|NCT01657266|591774457|FG000|Overall Study|Adverse Event|2|||
163837262|NCT01657266|591774458|FG001|Overall Study|Adverse Event|3|||
163837263|NCT03520400|591774459|FG000|Overall Study|Physician Decision|15|||
164037039|NCT01767519|592494504|FG002|Overall Study|Adverse Event|1|||
163837264|NCT03520400|591774460|FG001|Overall Study|Physician Decision|7|||
163837265|NCT00445679|591774461|FG000|Overall Study|Adverse Event|22|||
163837266|NCT00445679|591774462|FG001|Overall Study|Adverse Event|12|||
163837267|NCT00445679|591774463|FG002|Overall Study|Adverse Event|30|||
163837268|NCT00445679|591774464|FG003|Overall Study|Adverse Event|19|||
163837269|NCT00445679|591774461|FG000|Overall Study|Failed to return|1|||
163837270|NCT00445679|591774462|FG001|Overall Study|Failed to return|3|||
163837271|NCT00445679|591774463|FG002|Overall Study|Failed to return|2|||
163837272|NCT00445679|591774464|FG003|Overall Study|Failed to return|2|||
163837273|NCT00445679|591774461|FG000|Overall Study|Physician Decision|0|||
163837274|NCT00445679|591774462|FG001|Overall Study|Physician Decision|0|||
163837275|NCT00445679|591774463|FG002|Overall Study|Physician Decision|1|||
163837276|NCT00445679|591774464|FG003|Overall Study|Physician Decision|0|||
163837277|NCT00445679|591774461|FG000|Overall Study|Lost to Follow-up|10|||
163837278|NCT00445679|591774462|FG001|Overall Study|Lost to Follow-up|6|||
163837279|NCT00445679|591774463|FG002|Overall Study|Lost to Follow-up|6|||
163837280|NCT00445679|591774464|FG003|Overall Study|Lost to Follow-up|5|||
163837281|NCT00445679|591774461|FG000|Overall Study|Compliance|3|||
163837282|NCT00445679|591774462|FG001|Overall Study|Compliance|2|||
163837283|NCT00445679|591774463|FG002|Overall Study|Compliance|1|||
163837284|NCT00445679|591774464|FG003|Overall Study|Compliance|2|||
163837285|NCT00445679|591774461|FG000|Overall Study|Withdrawal of Informed Consent|0|||
163837286|NCT00445679|591774462|FG001|Overall Study|Withdrawal of Informed Consent|0|||
163837287|NCT00445679|591774463|FG002|Overall Study|Withdrawal of Informed Consent|1|||
163837288|NCT00445679|591774464|FG003|Overall Study|Withdrawal of Informed Consent|0|||
163837289|NCT00445679|591774461|FG000|Overall Study|Protocol Violation|2|||
163837290|NCT00445679|591774462|FG001|Overall Study|Protocol Violation|3|||
163837291|NCT00445679|591774463|FG002|Overall Study|Protocol Violation|3|||
163837292|NCT00445679|591774464|FG003|Overall Study|Protocol Violation|1|||
163837293|NCT00445679|591774461|FG000|Overall Study|Withdrawal by Subject|8|||
163837294|NCT00445679|591774462|FG001|Overall Study|Withdrawal by Subject|14|||
163837295|NCT00445679|591774463|FG002|Overall Study|Withdrawal by Subject|20|||
163837296|NCT00445679|591774464|FG003|Overall Study|Withdrawal by Subject|18|||
163837297|NCT00445679|591774461|FG000|Overall Study|Lack of Efficacy|2|||
163837298|NCT00445679|591774462|FG001|Overall Study|Lack of Efficacy|6|||
163837299|NCT00445679|591774463|FG002|Overall Study|Lack of Efficacy|2|||
163837300|NCT00445679|591774464|FG003|Overall Study|Lack of Efficacy|0|||
163837301|NCT00909428|591774468|FG000|Overall Study|Lost to Follow-up|13|||
163837302|NCT00909428|591774469|FG001|Overall Study|Lost to Follow-up|10|||
163837303|NCT00909428|591774470|FG002|Overall Study|Lost to Follow-up|9|||
163837304|NCT01933880|591774473|FG000|Overall Study|Withdrawal by Subject|5|||
163837305|NCT01933880|591774474|FG001|Overall Study|Withdrawal by Subject|0|||
163837306|NCT01933880|591774473|FG000|Overall Study|Lack of Efficacy|1|||
163837307|NCT01933880|591774474|FG001|Overall Study|Lack of Efficacy|0|||
163837308|NCT01933880|591774473|FG000|Overall Study|Concomitant medication Interference|0|||
163837309|NCT01933880|591774474|FG001|Overall Study|Concomitant medication Interference|1|||
163837310|NCT01933880|591774473|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
163837311|NCT01933880|591774474|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
163837312|NCT01933880|591774473|FG000|Overall Study|Other|4|||
163837313|NCT01933880|591774474|FG001|Overall Study|Other|0|||
163837314|NCT01933880|591774473|FG000|Overall Study|Protocol Violation|1|||
163837315|NCT01933880|591774474|FG001|Overall Study|Protocol Violation|0|||
163837316|NCT01125722|591774475|FG000|Overall Study|Withdrawal by Subject|2|||
163837317|NCT01125722|591774476|FG001|Overall Study|Withdrawal by Subject|1|||
163837318|NCT01125722|591774475|FG000|Overall Study|Lost to Follow-up|1|||
163837319|NCT01125722|591774476|FG001|Overall Study|Lost to Follow-up|0|||
163837320|NCT03474549|591774477|FG000|Overall Study|Death|31|||
163837321|NCT03474549|591774477|FG000|Overall Study|Lost to Follow-up|4|||
163837322|NCT03474549|591774477|FG000|Overall Study|Withdrawal by Subject|2|||
163837323|NCT00069784|591774478|FG000|Overall Study|Adverse Event|105|||
163837324|NCT00069784|591774479|FG001|Overall Study|Adverse Event|0|||
163837325|NCT00069784|591774478|FG000|Overall Study|Withdrawal by Subject|1090|||
163837326|NCT00069784|591774479|FG001|Overall Study|Withdrawal by Subject|0|||
163837327|NCT00069784|591774478|FG000|Overall Study|Other|17|||
163837328|NCT00069784|591774479|FG001|Overall Study|Other|0|||
163837329|NCT00709059|591774484|FG000|Overall Study|Lost to Follow-up|34|||
163837330|NCT00709059|591774484|FG000|Overall Study|Withdrawal by Subject|19|||
163837331|NCT00709059|591774484|FG000|Overall Study|Physician Decision|7|||
163837332|NCT00709059|591774484|FG000|Overall Study|Disease complication|3|||
163932149|NCT00379769|592121625|FG001|Observational Follow-up|Death|0|||
163932150|NCT00379769|592121626|FG002|Observational Follow-up|Death|0|||
163837333|NCT00709059|591774484|FG000|Overall Study|Side effects|20|||
163837334|NCT00709059|591774484|FG000|Overall Study|Serious side effects|11|||
163837335|NCT01786330|591774485|FG000|Overall Study|Withdrawal by Subject|0|||
163837336|NCT01786330|591774486|FG001|Overall Study|Withdrawal by Subject|1|||
163837337|NCT01786330|591774485|FG000|Overall Study|Lost to Follow-up|0|||
163932151|NCT00379769|592121627|FG003|Observational Follow-up|Death|0|||
163932152|NCT00379769|592121628|FG004|Observational Follow-up|Death|78|||
163837338|NCT01786330|591774486|FG001|Overall Study|Lost to Follow-up|1|||
163837339|NCT01786330|591774485|FG000|Overall Study|Excluded intraoperatively|0|||
163932153|NCT00379769|592121629|FG005|Observational Follow-up|Death|70|||
163837340|NCT01786330|591774486|FG001|Overall Study|Excluded intraoperatively|1|||
163837341|NCT01786330|591774485|FG000|Overall Study|Protocol Violation|1|||
163837342|NCT01786330|591774486|FG001|Overall Study|Protocol Violation|0|||
163837343|NCT00720902|591776207|FG000|Overall Study|Withdrawal by Subject|1|||
163837344|NCT00720902|591776208|FG001|Overall Study|Withdrawal by Subject|0|||
163837345|NCT00720902|591776207|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
163837346|NCT00720902|591776208|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
163837347|NCT01478113|591776211|FG000|Overall Study|Withdrawal by Subject|0|||
163837348|NCT01478113|591776212|FG001|Overall Study|Withdrawal by Subject|1|||
163837349|NCT01478113|591776211|FG000|Overall Study|Physician Decision|1|||
163837350|NCT01478113|591776212|FG001|Overall Study|Physician Decision|0|||
163837351|NCT00289770|591776213|FG000|Year 15|Withdrawal by Subject|1|||
163837352|NCT02966002|591776220|FG000|Overall Study|Withdrawal by Subject|2|||
163837353|NCT02966002|591776220|FG000|Overall Study|Adverse Event|1|||
163837354|NCT02966002|591776220|FG000|Overall Study|Lost to Follow-up|1|||
163837355|NCT00067990|591776221|FG000|Overall Study|Death|5|||
163837356|NCT00067990|591776222|FG001|Overall Study|Death|7|||
163837357|NCT00067990|591776221|FG000|Overall Study|ESRD, Non IF/TA|1|||
163837358|NCT00067990|591776222|FG001|Overall Study|ESRD, Non IF/TA|3|||
163837359|NCT00067990|591776221|FG000|Overall Study|Withdrawal by Subject|4|||
163837360|NCT00067990|591776222|FG001|Overall Study|Withdrawal by Subject|12|||
163837361|NCT02291432|591776223|FG000|Overall Study|Withdrawal by Subject|2|||
163837362|NCT02145078|591776224|FG000|Overall Study|Death|1|||
163837363|NCT02145078|591776224|FG000|Overall Study|Reason not given|3|||
163837364|NCT01350141|591776225|FG000|Overall Study|Lost to Follow-up|1|||
163837365|NCT01350141|591776226|FG001|Overall Study|Lost to Follow-up|0|||
163837366|NCT01350141|591776227|FG002|Overall Study|Lost to Follow-up|1|||
163837367|NCT01350141|591776225|FG000|Overall Study|Withdrawal by Subject|1|||
163837368|NCT01350141|591776226|FG001|Overall Study|Withdrawal by Subject|0|||
163837369|NCT01350141|591776227|FG002|Overall Study|Withdrawal by Subject|0|||
163837370|NCT01350141|591776225|FG000|Overall Study|Randomized but not treated|1|||
163837371|NCT01350141|591776226|FG001|Overall Study|Randomized but not treated|0|||
163837372|NCT01350141|591776227|FG002|Overall Study|Randomized but not treated|0|||
163837373|NCT00810082|591776228|FG000|Overall Study|Lost to Follow-up|0|||
163837374|NCT00810082|591776229|FG001|Overall Study|Lost to Follow-up|4|||
163837375|NCT03327402|591776230|FG000|Overall Study|Withdrawal by Subject|1|||
163837376|NCT03327402|591776230|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
163837377|NCT01454830|591776233|FG000|Overall Study|Withdrawal by Subject|4|||
163837378|NCT01454830|591776234|FG001|Overall Study|Withdrawal by Subject|4|||
163837379|NCT01454830|591776233|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
163837380|NCT01454830|591776234|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
163837381|NCT01454830|591776233|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
163837382|NCT01454830|591776234|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
163837383|NCT01454830|591776233|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
163837384|NCT01454830|591776234|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
163837385|NCT01454830|591776233|FG000|Overall Study|Withdrawal - no polysomnography|3|||
163837386|NCT01454830|591776234|FG001|Overall Study|Withdrawal - no polysomnography|2|||
163837387|NCT03810313|591776235|FG000|Overall Study|Study terminated by sponsor|164|||
163837388|NCT03810313|591776236|FG001|Overall Study|Study terminated by sponsor|159|||
163837389|NCT03810313|591776235|FG000|Overall Study|Subject decision|10|||
163837390|NCT03810313|591776236|FG001|Overall Study|Subject decision|11|||
163837391|NCT03810313|591776235|FG000|Overall Study|Lost to Follow-up|3|||
163837392|NCT03810313|591776236|FG001|Overall Study|Lost to Follow-up|3|||
163837393|NCT03810313|591776235|FG000|Overall Study|Adverse Event|2|||
163837394|NCT03810313|591776236|FG001|Overall Study|Adverse Event|1|||
163837395|NCT03810313|591776235|FG000|Overall Study|Death|2|||
163837396|NCT03810313|591776236|FG001|Overall Study|Death|1|||
163837397|NCT03810313|591776235|FG000|Overall Study|Physician Decision|0|||
163837398|NCT03810313|591776236|FG001|Overall Study|Physician Decision|1|||
163837399|NCT00584805|591776237|FG000|Overall Study|No longer at risk of exposure|39|||
163837400|NCT00584805|591776237|FG000|Overall Study|Relocation|36|||
163932154|NCT00379769|592121624|FG000|Observational Follow-up|Adverse Event|0|||
163932155|NCT00379769|592121625|FG001|Observational Follow-up|Adverse Event|0|||
163932156|NCT00379769|592121626|FG002|Observational Follow-up|Adverse Event|0|||
163837401|NCT00584805|591776237|FG000|Overall Study|Withdrawal by Subject|18|||
163837402|NCT00584805|591776237|FG000|Overall Study|Non-compliance|1|||
163837403|NCT00584805|591776237|FG000|Overall Study|Lost to follow up|3|||
163837404|NCT00584805|591776237|FG000|Overall Study|Screen failures|2|||
163837405|NCT02768662|591776247|FG000|Overall Study|Adverse Event|1|||
163837406|NCT02768662|591776247|FG000|Overall Study|Lost to Follow-up|4|||
163837407|NCT02768662|591776247|FG000|Overall Study|Withdrawal by Subject|3|||
163837408|NCT02768662|591776247|FG000|Overall Study|Study terminated by Sponsor|78|||
163837409|NCT02567825|591776254|FG000|Overall Study|No follow-up post-randomization|5|||
163932157|NCT00379769|592121627|FG003|Observational Follow-up|Adverse Event|0|||
163932158|NCT00379769|592121628|FG004|Observational Follow-up|Adverse Event|1|||
163932159|NCT00379769|592121629|FG005|Observational Follow-up|Adverse Event|0|||
164037040|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
164037041|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
164037042|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
164037043|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
164037044|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
164037045|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
164037046|NCT00996593|592494507|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
164037047|NCT00996593|592494507|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
164037048|NCT00996593|592494507|FG000|Long-Term Follow-Up|Site Closed|1|||
164037049|NCT01033487|592494508|FG000|Fourth Intervention Period|Adverse Event|0|||
164037050|NCT01033487|592494509|FG001|Fourth Intervention Period|Adverse Event|0|||
164037051|NCT01033487|592494510|FG002|Fourth Intervention Period|Adverse Event|0|||
164037052|NCT01033487|592494511|FG003|Fourth Intervention Period|Adverse Event|0|||
164037053|NCT01033487|592494512|FG004|Fourth Intervention Period|Adverse Event|0|||
164037054|NCT01033487|592494513|FG005|Fourth Intervention Period|Adverse Event|0|||
164037055|NCT01033487|592494514|FG006|Fourth Intervention Period|Adverse Event|0|||
164037056|NCT01033487|592494515|FG007|Fourth Intervention Period|Adverse Event|0|||
164037057|NCT01033487|592494516|FG008|Fourth Intervention Period|Adverse Event|1|||
164037058|NCT01033487|592494517|FG009|Fourth Intervention Period|Adverse Event|0|||
164037059|NCT02849626|592494518|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
164037060|NCT02849626|592494519|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
164037061|NCT02849626|592494520|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
164037062|NCT02849626|592494521|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
164037063|NCT02849626|592494518|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
164037064|NCT02849626|592494519|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
164037065|NCT02849626|592494520|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
164037066|NCT02849626|592494521|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
164037067|NCT02849626|592494518|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
164037068|NCT02849626|592494519|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
164037069|NCT02849626|592494520|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
164037070|NCT02849626|592494521|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
164037071|NCT02849626|592494518|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
163837410|NCT02567825|591776255|FG001|Overall Study|No follow-up post-randomization|1|||
163837411|NCT02567825|591776254|FG000|Overall Study|Follow-up less than 23 months|16|||
163837412|NCT02567825|591776255|FG001|Overall Study|Follow-up less than 23 months|20|||
163837413|NCT03097861|591776260|FG000|Overall Study|Adverse Event|3|||
163837414|NCT03097861|591776261|FG001|Overall Study|Adverse Event|8|||
163837415|NCT03097861|591776262|FG002|Overall Study|Adverse Event|4|||
163837416|NCT03097861|591776260|FG000|Overall Study|Investigator Decision|0|||
163837417|NCT03097861|591776261|FG001|Overall Study|Investigator Decision|1|||
163837418|NCT03097861|591776262|FG002|Overall Study|Investigator Decision|0|||
163837419|NCT03097861|591776260|FG000|Overall Study|Lost to Follow-up|0|||
163837420|NCT03097861|591776261|FG001|Overall Study|Lost to Follow-up|7|||
163837421|NCT03097861|591776262|FG002|Overall Study|Lost to Follow-up|1|||
163837422|NCT03097861|591776260|FG000|Overall Study|Withdrawal by Subject|1|||
163837423|NCT03097861|591776261|FG001|Overall Study|Withdrawal by Subject|5|||
163837424|NCT03097861|591776262|FG002|Overall Study|Withdrawal by Subject|3|||
163837425|NCT03097861|591776260|FG000|Overall Study|Reason not provided|3|||
163837426|NCT03097861|591776261|FG001|Overall Study|Reason not provided|1|||
163837427|NCT03097861|591776262|FG002|Overall Study|Reason not provided|1|||
163837428|NCT05061537|591776263|FG000|Treatment Phase|Progressive disease|0|||
163837429|NCT05061537|591776264|FG001|Treatment Phase|Progressive disease|1|||
163837430|NCT05061537|591776265|FG002|Treatment Phase|Progressive disease|2|||
163837431|NCT05061537|591776266|FG003|Treatment Phase|Progressive disease|0|||
163837432|NCT05061537|591776267|FG004|Treatment Phase|Progressive disease|0|||
163837433|NCT05061537|591776263|FG000|Treatment Phase|Adverse Event|0|||
163837434|NCT05061537|591776264|FG001|Treatment Phase|Adverse Event|0|||
163837435|NCT05061537|591776265|FG002|Treatment Phase|Adverse Event|2|||
163837436|NCT05061537|591776266|FG003|Treatment Phase|Adverse Event|0|||
163837437|NCT05061537|591776267|FG004|Treatment Phase|Adverse Event|0|||
163837438|NCT05061537|591776263|FG000|Treatment Phase|Global deterioration of health status|0|||
163837439|NCT05061537|591776264|FG001|Treatment Phase|Global deterioration of health status|1|||
163837440|NCT05061537|591776265|FG002|Treatment Phase|Global deterioration of health status|0|||
164037072|NCT02849626|592494519|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
164037073|NCT02849626|592494520|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
164037074|NCT02849626|592494521|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
163837441|NCT05061537|591776266|FG003|Treatment Phase|Global deterioration of health status|0|||
164037075|NCT02849626|592494518|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
163837442|NCT05061537|591776267|FG004|Treatment Phase|Global deterioration of health status|0|||
163837443|NCT05061537|591776263|FG000|Follow up|Other|2|||
163837444|NCT05061537|591776264|FG001|Follow up|Other|0|||
163837445|NCT05061537|591776265|FG002|Follow up|Other|2|||
163837446|NCT05061537|591776266|FG003|Follow up|Other|0|||
163837447|NCT05061537|591776267|FG004|Follow up|Other|0|||
163837448|NCT05061537|591776263|FG000|Follow up|Study terminated by sponsor|0|||
163837449|NCT05061537|591776264|FG001|Follow up|Study terminated by sponsor|0|||
163837450|NCT05061537|591776265|FG002|Follow up|Study terminated by sponsor|2|||
163837451|NCT05061537|591776266|FG003|Follow up|Study terminated by sponsor|0|||
163837452|NCT05061537|591776267|FG004|Follow up|Study terminated by sponsor|0|||
163837453|NCT05061537|591776263|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
163837454|NCT05061537|591776264|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
163837455|NCT05061537|591776265|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
163837456|NCT05061537|591776266|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
163837457|NCT05061537|591776267|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
163837458|NCT05061537|591776263|FG000|Long-term Follow-up|Death|0|||
163837459|NCT05061537|591776264|FG001|Long-term Follow-up|Death|1|||
163837460|NCT05061537|591776265|FG002|Long-term Follow-up|Death|0|||
163837461|NCT05061537|591776266|FG003|Long-term Follow-up|Death|0|||
163837462|NCT05061537|591776267|FG004|Long-term Follow-up|Death|0|||
163837463|NCT03502616|591776269|FG000|Up to Week 16|Withdrawal by Subject|1|||
163837464|NCT03502616|591776270|FG001|Up to Week 16|Withdrawal by Subject|2|||
163837465|NCT03502616|591776269|FG000|Up to Week 16|Lost to Follow-up|0|||
163837466|NCT03502616|591776270|FG001|Up to Week 16|Lost to Follow-up|1|||
163837467|NCT03502616|591776269|FG000|Up to Week 16|Randomized, but not treated|1|||
163837468|NCT03502616|591776270|FG001|Up to Week 16|Randomized, but not treated|0|||
163837469|NCT03502616|591776269|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
163837470|NCT03502616|591776270|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
163837471|NCT03502616|591776269|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
163837472|NCT03502616|591776270|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
163837473|NCT04503096|591776271|FG000|Overall Study|Withdrawal by Subject|3|||
164037076|NCT02849626|592494519|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
164037077|NCT02849626|592494520|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
164037078|NCT02849626|592494521|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
164037079|NCT02849626|592494518|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
164037080|NCT02849626|592494519|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
164037081|NCT02849626|592494520|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
164037082|NCT02849626|592494521|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
164037083|NCT02849626|592494518|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
164037084|NCT02849626|592494519|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
164037085|NCT02849626|592494520|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
164037086|NCT02849626|592494521|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
164037087|NCT02849626|592494518|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
164037088|NCT02849626|592494519|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
164037089|NCT02849626|592494520|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
164037090|NCT02849626|592494521|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
164037091|NCT02849626|592494518|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
164037092|NCT02849626|592494519|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
164037093|NCT02849626|592494520|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
164037094|NCT02849626|592494521|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
164037095|NCT02849626|592494518|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
164037096|NCT02849626|592494519|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
164037097|NCT02849626|592494520|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
164037098|NCT02849626|592494521|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
164037099|NCT02849626|592494518|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
164037100|NCT02849626|592494519|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
164037101|NCT02849626|592494520|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
164037102|NCT02849626|592494521|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
164037103|NCT04046341|592494526|FG000|Overall Study|Lost to Follow-up|2|||
164037104|NCT04046341|592494526|FG000|Overall Study|Withdrawal by Subject|1|||
164037105|NCT04377672|592494527|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
164037106|NCT02447458|592494528|FG000|Overall Study|Other|0|||
164037107|NCT02447458|592494529|FG001|Overall Study|Other|0|||
164037108|NCT02447458|592494530|FG002|Overall Study|Other|1|||
164037109|NCT02447458|592494531|FG003|Overall Study|Other|0|||
164037110|NCT02447458|592494532|FG004|Overall Study|Other|0|||
164037111|NCT02447458|592494533|FG005|Overall Study|Other|0|||
164037112|NCT00405652|592494534|FG000|Overall Study|Adverse Event|4|||
164037113|NCT00435994|592494536|FG000|Overall Study|Lost to Follow-up|7|||
164037114|NCT00435994|592494537|FG001|Overall Study|Lost to Follow-up|0|||
164037115|NCT00435994|592494538|FG002|Overall Study|Lost to Follow-up|0|||
164037116|NCT03505749|592494540|FG000|Overall Study|Lost to Follow-up|7|||
164037117|NCT03505749|592494541|FG001|Overall Study|Lost to Follow-up|11|||
163837474|NCT01785563|591776272|FG000|Overall Study|Physician Decision|10|||
163837475|NCT01785563|591776272|FG000|Overall Study|Withdrawal by Subject|1|||
163837476|NCT01785563|591776272|FG000|Overall Study|Protocol Violation|2|||
163837477|NCT01872910|591776273|FG000|Overall Study|Lost to Follow-up|2|||
164037118|NCT03505749|592494540|FG000|Overall Study|Withdrawal by Subject|6|||
163837478|NCT01872910|591776274|FG001|Overall Study|Lost to Follow-up|0|||
163837479|NCT01872910|591776275|FG002|Overall Study|Lost to Follow-up|2|||
163837480|NCT01872910|591776276|FG003|Overall Study|Lost to Follow-up|0|||
163837481|NCT01872910|591776277|FG004|Overall Study|Lost to Follow-up|0|||
163837482|NCT01872910|591776278|FG005|Overall Study|Lost to Follow-up|0|||
163837483|NCT00744328|591776281|FG000|Overall Study|Lost to Follow-up|2|||
163837484|NCT00744328|591776282|FG001|Overall Study|Lost to Follow-up|5|||
163837485|NCT00744328|591776283|FG002|Overall Study|Lost to Follow-up|3|||
163837486|NCT00744328|591776281|FG000|Overall Study|Withdrawal by Subject|5|||
163837487|NCT00744328|591776282|FG001|Overall Study|Withdrawal by Subject|3|||
163837488|NCT00744328|591776283|FG002|Overall Study|Withdrawal by Subject|4|||
163837489|NCT00744328|591776281|FG000|Overall Study|Found ineligible after randomization|0|||
163837490|NCT00744328|591776282|FG001|Overall Study|Found ineligible after randomization|0|||
163837491|NCT00744328|591776283|FG002|Overall Study|Found ineligible after randomization|1|||
163837492|NCT01576367|591776284|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163837493|NCT01576367|591776284|FG000|Overall Study|Moved to commercial use after 6 months|1|||
163837494|NCT02387216|591776288|FG000|Overall Study|Progressive disease|2|||
163837495|NCT02387216|591776289|FG001|Overall Study|Progressive disease|0|||
163837496|NCT02387216|591776288|FG000|Overall Study|Withdrawal by Subject|3|||
163837497|NCT02387216|591776289|FG001|Overall Study|Withdrawal by Subject|5|||
163837498|NCT02387216|591776288|FG000|Overall Study|Physician Decision|2|||
163837499|NCT02387216|591776289|FG001|Overall Study|Physician Decision|0|||
163837500|NCT02387216|591776288|FG000|Overall Study|Sponsor Decision|28|||
163837501|NCT02387216|591776289|FG001|Overall Study|Sponsor Decision|12|||
163837502|NCT02387216|591776288|FG000|Overall Study|Death|60|||
163837503|NCT02387216|591776289|FG001|Overall Study|Death|23|||
163837504|NCT02387216|591776288|FG000|Overall Study|Other|5|||
163837505|NCT02387216|591776289|FG001|Overall Study|Other|4|||
163837506|NCT02387216|591776288|FG000|Overall Study|Lost to Follow-up|0|||
163837507|NCT02387216|591776289|FG001|Overall Study|Lost to Follow-up|3|||
163837508|NCT02091739|591776290|FG000|MP: 16 Weeks|Adverse Event|1|||
163837509|NCT02091739|591776291|FG001|MP: 16 Weeks|Adverse Event|1|||
163837510|NCT02091739|591776292|FG002|MP: 16 Weeks|Adverse Event|1|||
163837511|NCT02091739|591776293|FG003|MP: 16 Weeks|Adverse Event|0|||
163837512|NCT02091739|591776294|FG004|MP: 16 Weeks|Adverse Event|0|||
163837513|NCT02091739|591776290|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
163837514|NCT02091739|591776291|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
163837515|NCT02091739|591776292|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
163837516|NCT02091739|591776293|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
163837517|NCT02091739|591776294|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
163837518|NCT02091739|591776290|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
163837519|NCT02091739|591776291|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
163837520|NCT02091739|591776292|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
163837521|NCT02091739|591776293|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
163837522|NCT02091739|591776294|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
163837523|NCT02091739|591776290|FG000|EP: 48 Weeks|Other|0|||
163837524|NCT02091739|591776291|FG001|EP: 48 Weeks|Other|0|||
163837525|NCT02091739|591776292|FG002|EP: 48 Weeks|Other|0|||
163837526|NCT02091739|591776293|FG003|EP: 48 Weeks|Other|1|||
163837527|NCT02091739|591776294|FG004|EP: 48 Weeks|Other|0|||
163837528|NCT02091739|591776290|FG000|EP: 48 Weeks|Death|0|||
163837529|NCT02091739|591776291|FG001|EP: 48 Weeks|Death|0|||
163837530|NCT02091739|591776292|FG002|EP: 48 Weeks|Death|0|||
163837531|NCT02091739|591776293|FG003|EP: 48 Weeks|Death|3|||
163837532|NCT02091739|591776294|FG004|EP: 48 Weeks|Death|2|||
163837533|NCT02091739|591776290|FG000|EP: 48 Weeks|Adverse Event|0|||
163837534|NCT02091739|591776291|FG001|EP: 48 Weeks|Adverse Event|0|||
163837535|NCT02091739|591776292|FG002|EP: 48 Weeks|Adverse Event|0|||
163837536|NCT02091739|591776293|FG003|EP: 48 Weeks|Adverse Event|2|||
163837537|NCT02091739|591776294|FG004|EP: 48 Weeks|Adverse Event|6|||
163837538|NCT02091739|591776290|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
163837539|NCT02091739|591776291|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
163837540|NCT02091739|591776292|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
163837541|NCT02091739|591776293|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
163837542|NCT02091739|591776294|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
163837543|NCT03469349|591776295|FG000|Overall Study|Withdrawal by Subject|1|||
163837544|NCT03469349|591776296|FG001|Overall Study|Withdrawal by Subject|3|||
163837545|NCT03469349|591776295|FG000|Overall Study|Progressive Disease|0|||
163837546|NCT03469349|591776296|FG001|Overall Study|Progressive Disease|1|||
163932160|NCT00379769|592121624|FG000|Observational Follow-up|Lost to Follow-up|0|||
163932161|NCT00379769|592121625|FG001|Observational Follow-up|Lost to Follow-up|0|||
163932162|NCT00379769|592121626|FG002|Observational Follow-up|Lost to Follow-up|0|||
163837547|NCT03469349|591776295|FG000|Overall Study|Lost to Follow-up|2|||
163837548|NCT03469349|591776296|FG001|Overall Study|Lost to Follow-up|2|||
163932163|NCT00379769|592121627|FG003|Observational Follow-up|Lost to Follow-up|0|||
163932164|NCT00379769|592121628|FG004|Observational Follow-up|Lost to Follow-up|25|||
163837549|NCT03469349|591776295|FG000|Overall Study|Adverse Event|2|||
163837550|NCT03469349|591776296|FG001|Overall Study|Adverse Event|4|||
163837551|NCT03528174|591776297|FG000|Overall Study|Adverse Event|1|||
163837552|NCT03528174|591776297|FG000|Overall Study|sensors dislodged|1|||
163837553|NCT04251065|591776301|FG000|Overall Study|Death|2|||
163837554|NCT04251065|591776301|FG000|Overall Study|Lack of Efficacy|3|||
163837555|NCT04251065|591776301|FG000|Overall Study|Death|1|||
163837556|NCT00525265|591776310|FG000|Overall Study|Protocol Violation|1|||
163837557|NCT00525265|591776311|FG001|Overall Study|Protocol Violation|0|||
163837558|NCT01778556|591776312|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
163837559|NCT01778556|591776313|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
163837560|NCT01778556|591776312|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
163837561|NCT01778556|591776313|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
163837562|NCT01778556|591776312|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
163837563|NCT01778556|591776313|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
163837564|NCT01778556|591776312|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
163837565|NCT01778556|591776313|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
163837566|NCT00576732|591776314|FG000|DOUBLE BLIND|Adverse Event|0|||
163837567|NCT00576732|591776315|FG001|DOUBLE BLIND|Adverse Event|0|||
163837568|NCT00576732|591776316|FG002|DOUBLE BLIND|Adverse Event|1|||
163837569|NCT00576732|591776317|FG003|DOUBLE BLIND|Adverse Event|0|||
163837570|NCT00576732|591776318|FG004|DOUBLE BLIND|Adverse Event|0|||
163837571|NCT00576732|591776319|FG005|DOUBLE BLIND|Adverse Event|0|||
163837572|NCT00576732|591776314|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
163837573|NCT00576732|591776315|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
163837574|NCT00576732|591776316|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
163837575|NCT00576732|591776317|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
163837576|NCT00576732|591776318|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
163837577|NCT00576732|591776319|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
163837578|NCT00576732|591776314|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
163837579|NCT00576732|591776315|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
163837580|NCT00576732|591776316|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
163837581|NCT00576732|591776317|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
163837582|NCT00576732|591776318|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
163837583|NCT00576732|591776319|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
163837584|NCT00576732|591776314|FG000|DOUBLE BLIND|OTHER|0|||
163837585|NCT00576732|591776315|FG001|DOUBLE BLIND|OTHER|2|||
163837586|NCT00576732|591776316|FG002|DOUBLE BLIND|OTHER|1|||
163837587|NCT00576732|591776317|FG003|DOUBLE BLIND|OTHER|0|||
163837588|NCT00576732|591776318|FG004|DOUBLE BLIND|OTHER|0|||
163837589|NCT00576732|591776319|FG005|DOUBLE BLIND|OTHER|0|||
163837590|NCT00576732|591776314|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
163837591|NCT00576732|591776315|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
163837592|NCT00576732|591776316|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
163837593|NCT00576732|591776317|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
163837594|NCT00576732|591776318|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
163837595|NCT00576732|591776319|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
163837596|NCT00576732|591776314|FG000|DOUBLE BLIND|Protocol Violation|1|||
163837597|NCT00576732|591776315|FG001|DOUBLE BLIND|Protocol Violation|0|||
163837598|NCT00576732|591776316|FG002|DOUBLE BLIND|Protocol Violation|0|||
163837599|NCT00576732|591776317|FG003|DOUBLE BLIND|Protocol Violation|0|||
163837600|NCT00576732|591776318|FG004|DOUBLE BLIND|Protocol Violation|0|||
163837601|NCT00576732|591776319|FG005|DOUBLE BLIND|Protocol Violation|0|||
163837602|NCT00576732|591776314|FG000|OPEN LABEL|Adverse Event|0|||
163837603|NCT00576732|591776315|FG001|OPEN LABEL|Adverse Event|0|||
163837604|NCT00576732|591776316|FG002|OPEN LABEL|Adverse Event|0|||
163837605|NCT00576732|591776317|FG003|OPEN LABEL|Adverse Event|4|||
163837606|NCT00576732|591776318|FG004|OPEN LABEL|Adverse Event|0|||
163837607|NCT00576732|591776319|FG005|OPEN LABEL|Adverse Event|1|||
163837608|NCT00576732|591776314|FG000|OPEN LABEL|Lost to Follow-up|0|||
163837609|NCT00576732|591776315|FG001|OPEN LABEL|Lost to Follow-up|0|||
163837610|NCT00576732|591776316|FG002|OPEN LABEL|Lost to Follow-up|0|||
163837611|NCT00576732|591776317|FG003|OPEN LABEL|Lost to Follow-up|2|||
163837612|NCT00576732|591776318|FG004|OPEN LABEL|Lost to Follow-up|1|||
163837613|NCT00576732|591776319|FG005|OPEN LABEL|Lost to Follow-up|1|||
163837614|NCT00576732|591776314|FG000|OPEN LABEL|Withdrawal by Subject|0|||
163837615|NCT00576732|591776315|FG001|OPEN LABEL|Withdrawal by Subject|0|||
163837616|NCT00576732|591776316|FG002|OPEN LABEL|Withdrawal by Subject|0|||
164098485|NCT00870870|592725108|FG001|Overall Study|Adverse Event|0|||
164098486|NCT00870870|592725109|FG002|Overall Study|Adverse Event|2|||
163837617|NCT00576732|591776317|FG003|OPEN LABEL|Withdrawal by Subject|1|||
163837618|NCT00576732|591776318|FG004|OPEN LABEL|Withdrawal by Subject|0|||
163837619|NCT00576732|591776319|FG005|OPEN LABEL|Withdrawal by Subject|1|||
163837620|NCT00576732|591776314|FG000|OPEN LABEL|OTHER|0|||
163837621|NCT00576732|591776315|FG001|OPEN LABEL|OTHER|0|||
163837622|NCT00576732|591776316|FG002|OPEN LABEL|OTHER|0|||
163837623|NCT00576732|591776317|FG003|OPEN LABEL|OTHER|0|||
163837624|NCT00576732|591776318|FG004|OPEN LABEL|OTHER|0|||
163837625|NCT00576732|591776319|FG005|OPEN LABEL|OTHER|2|||
163837626|NCT00576732|591776314|FG000|OPEN LABEL|Lack of Efficacy|0|||
163837627|NCT00576732|591776315|FG001|OPEN LABEL|Lack of Efficacy|0|||
163837628|NCT00576732|591776316|FG002|OPEN LABEL|Lack of Efficacy|0|||
163837629|NCT00576732|591776317|FG003|OPEN LABEL|Lack of Efficacy|2|||
163837630|NCT00576732|591776318|FG004|OPEN LABEL|Lack of Efficacy|2|||
163837631|NCT00576732|591776319|FG005|OPEN LABEL|Lack of Efficacy|3|||
163837632|NCT00576732|591776314|FG000|OPEN LABEL|Protocol Violation|0|||
163837633|NCT00576732|591776315|FG001|OPEN LABEL|Protocol Violation|0|||
163837634|NCT00576732|591776316|FG002|OPEN LABEL|Protocol Violation|0|||
163837635|NCT00576732|591776317|FG003|OPEN LABEL|Protocol Violation|2|||
163837636|NCT00576732|591776318|FG004|OPEN LABEL|Protocol Violation|1|||
163837637|NCT00576732|591776319|FG005|OPEN LABEL|Protocol Violation|0|||
163837638|NCT00265330|591776320|FG000|Overall Study|Adverse Event|41|||
163837639|NCT00265330|591776320|FG000|Overall Study|Lost to Follow-up|8|||
163837640|NCT00265330|591776320|FG000|Overall Study|Withdrawal by Subject|34|||
163837641|NCT00265330|591776320|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
163837642|NCT00265330|591776320|FG000|Overall Study|Lack of Efficacy|4|||
163837643|NCT00265330|591776320|FG000|Overall Study|Family Scheduling Conflicts|1|||
163837644|NCT00265330|591776320|FG000|Overall Study|Began Taking Formulary Geodon|1|||
163837645|NCT00265330|591776320|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
163837646|NCT00265330|591776320|FG000|Overall Study|Site Closed by Sponsor|1|||
163837647|NCT00265330|591776320|FG000|Overall Study|Principal Investigators Request|1|||
163837648|NCT00265330|591776320|FG000|Overall Study|Withdrew Consent|1|||
163837649|NCT00265330|591776320|FG000|Overall Study|Protocol Violation|1|||
163837650|NCT02178566|591776328|FG000|Overall Study|patient did not complete due to noncompliance|0|||
163837651|NCT02178566|591776329|FG001|Overall Study|patient did not complete due to noncompliance|1|||
163837652|NCT02658630|591776330|FG000|Overall Study|Withdrawal by Subject|4|||
163837653|NCT00085202|591776331|FG000|Overall Study|Still on therapy|2|||
163837654|NCT00085202|591776332|FG001|Overall Study|Still on therapy|0|||
163837655|NCT00085202|591776331|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
163837656|NCT00085202|591776332|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
163837657|NCT00085202|591776331|FG000|Overall Study|Excessive toxicity|6|||
163837658|NCT00085202|591776332|FG001|Overall Study|Excessive toxicity|5|||
163837659|NCT00085202|591776331|FG000|Overall Study|Non-specified|3|||
163837660|NCT00085202|591776332|FG001|Overall Study|Non-specified|5|||
163837661|NCT00085202|591776331|FG000|Overall Study|Withdrawal by Subject|2|||
163837662|NCT00085202|591776332|FG001|Overall Study|Withdrawal by Subject|1|||
163837663|NCT00085202|591776331|FG000|Overall Study|Physician Decision|4|||
163837664|NCT00085202|591776332|FG001|Overall Study|Physician Decision|1|||
163837665|NCT00085202|591776331|FG000|Overall Study|Progressive disease|1|||
163837666|NCT00085202|591776332|FG001|Overall Study|Progressive disease|11|||
163837667|NCT01436201|591776334|FG000|Overall Study|Adverse Event|2|||
163837668|NCT01436201|591776334|FG000|Overall Study|Withdrawal by Subject|1|||
163837669|NCT01436201|591776334|FG000|Overall Study|Protocol Violation|1|||
163837670|NCT00110890|591776335|FG000|Overall Study|Adverse Event|30|||
163837671|NCT00110890|591776336|FG001|Overall Study|Adverse Event|7|||
163837672|NCT00110890|591776335|FG000|Overall Study|Death|16|||
163837673|NCT00110890|591776336|FG001|Overall Study|Death|9|||
163837674|NCT00110890|591776335|FG000|Overall Study|Lost to Follow-up|3|||
163837675|NCT00110890|591776336|FG001|Overall Study|Lost to Follow-up|1|||
163837676|NCT00110890|591776335|FG000|Overall Study|Physician Decision|4|||
163837677|NCT00110890|591776336|FG001|Overall Study|Physician Decision|5|||
163837678|NCT00110890|591776335|FG000|Overall Study|Withdrawal by Subject|17|||
163837679|NCT00110890|591776336|FG001|Overall Study|Withdrawal by Subject|5|||
163837680|NCT00110890|591776335|FG000|Overall Study|Protocol Deviation|1|||
163837681|NCT00110890|591776336|FG001|Overall Study|Protocol Deviation|0|||
163837682|NCT00110890|591776335|FG000|Overall Study|Noncompliance|10|||
163837683|NCT00110890|591776336|FG001|Overall Study|Noncompliance|0|||
163837684|NCT00110890|591776335|FG000|Overall Study|Kidney Transplant|16|||
163837685|NCT00110890|591776336|FG001|Overall Study|Kidney Transplant|12|||
163837686|NCT00110890|591776335|FG000|Overall Study|Invest. Product Commercially Available|217|||
163837687|NCT00110890|591776336|FG001|Overall Study|Invest. Product Commercially Available|110|||
163837688|NCT00110890|591776335|FG000|Overall Study|Other|34|||
163837689|NCT00110890|591776336|FG001|Overall Study|Other|23|||
164037119|NCT03505749|592494541|FG001|Overall Study|Withdrawal by Subject|0|||
164037120|NCT03505749|592494540|FG000|Overall Study|Discharged from treatment|3|||
164037121|NCT03505749|592494541|FG001|Overall Study|Discharged from treatment|6|||
164037122|NCT03846219|592494542|FG000|Overall Study|Withdrawal by Subject|3|||
164037123|NCT03846219|592494543|FG001|Overall Study|Withdrawal by Subject|2|||
164037124|NCT03846219|592494544|FG002|Overall Study|Withdrawal by Subject|2|||
164037125|NCT03846219|592494542|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
164037126|NCT03846219|592494543|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
164037127|NCT03846219|592494544|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
164037128|NCT03846219|592494542|FG000|Overall Study|Physician Decision|0|||
163837690|NCT00110890|591776335|FG000|Overall Study|Ineligibility determined|3|||
163837691|NCT00110890|591776336|FG001|Overall Study|Ineligibility determined|0|||
163837692|NCT00110890|591776335|FG000|Overall Study|Requirement for alternative therapy|0|||
164037129|NCT03846219|592494543|FG001|Overall Study|Physician Decision|0|||
164037130|NCT03846219|592494544|FG002|Overall Study|Physician Decision|2|||
163837693|NCT00110890|591776336|FG001|Overall Study|Requirement for alternative therapy|1|||
163837694|NCT00110890|591776335|FG000|Overall Study|Disease progression|0|||
163837695|NCT00110890|591776336|FG001|Overall Study|Disease progression|1|||
163837696|NCT00110890|591776335|FG000|Overall Study|Parathyroidectomy|0|||
163837697|NCT00110890|591776336|FG001|Overall Study|Parathyroidectomy|1|||
163837698|NCT00110890|591776335|FG000|Overall Study|Did not enter follow-up phase|10|||
163837699|NCT00110890|591776336|FG001|Overall Study|Did not enter follow-up phase|4|||
163837700|NCT01686581|591776337|FG000|Overall Study|Side-effects or Health Problems|15|||
163837701|NCT01686581|591776337|FG000|Overall Study|Lack of Efficacy|90|||
163837702|NCT01686581|591776337|FG000|Overall Study|Participant Concerned about Risks|6|||
163837703|NCT01686581|591776337|FG000|Overall Study|Thinks Injections Too Painful|8|||
163837704|NCT01686581|591776337|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
163837705|NCT01686581|591776337|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
163837706|NCT01686581|591776337|FG000|Overall Study|Thinks it is Inconvenient|17|||
163837707|NCT01686581|591776337|FG000|Overall Study|Other Miscellaneous Reasons|36|||
163837708|NCT01686581|591776337|FG000|Overall Study|Reason Missing|1|||
163837709|NCT01975220|591776338|FG000|Test Period 1|Not treated|0|||
163837710|NCT01975220|591776339|FG001|Test Period 1|Not treated|1|||
163837711|NCT01975220|591776340|FG002|Test Period 1|Not treated|0|||
163837712|NCT01975220|591776341|FG003|Test Period 1|Not treated|0|||
163837713|NCT01975220|591776342|FG004|Test Period 1|Not treated|0|||
163837714|NCT01975220|591776343|FG005|Test Period 1|Not treated|0|||
163837715|NCT00263328|591776346|FG000|Overall Study|Death|0|||
163837716|NCT00263328|591776347|FG001|Overall Study|Death|0|||
163837717|NCT00263328|591776348|FG002|Overall Study|Death|1|||
163837718|NCT00263328|591776346|FG000|Overall Study|Lost to Follow-up|1|||
163837719|NCT00263328|591776347|FG001|Overall Study|Lost to Follow-up|1|||
163837720|NCT00263328|591776348|FG002|Overall Study|Lost to Follow-up|0|||
163837721|NCT00263328|591776346|FG000|Overall Study|Withdrawal by Subject|3|||
163837722|NCT00263328|591776347|FG001|Overall Study|Withdrawal by Subject|0|||
163837723|NCT00263328|591776348|FG002|Overall Study|Withdrawal by Subject|1|||
163837724|NCT00263328|591776346|FG000|Overall Study|Other|3|||
163837725|NCT00263328|591776347|FG001|Overall Study|Other|0|||
163837726|NCT00263328|591776348|FG002|Overall Study|Other|1|||
163837727|NCT00263328|591776346|FG000|Overall Study|Adverse Event|1|||
163837728|NCT00263328|591776347|FG001|Overall Study|Adverse Event|1|||
163837729|NCT00263328|591776348|FG002|Overall Study|Adverse Event|4|||
163837730|NCT01008475|591776353|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
163837731|NCT01008475|591776354|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
163837732|NCT01008475|591776355|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
163837733|NCT01008475|591776356|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
163837734|NCT01008475|591776357|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
163837735|NCT01008475|591776358|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
163837736|NCT01008475|591776359|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
163837737|NCT01301274|591776360|FG000|Overall Study|Physician Decision|2|||
163837738|NCT01301274|591776361|FG001|Overall Study|Physician Decision|1|||
163837739|NCT00661661|591776362|FG000|Overall Study|Adverse Event|99|||
163837740|NCT00661661|591776363|FG001|Overall Study|Adverse Event|24|||
163837741|NCT00661661|591776362|FG000|Overall Study|Lack of Efficacy|3|||
163837742|NCT00661661|591776363|FG001|Overall Study|Lack of Efficacy|2|||
163837743|NCT00661661|591776362|FG000|Overall Study|Lost to Follow-up|0|||
163837744|NCT00661661|591776363|FG001|Overall Study|Lost to Follow-up|1|||
163837745|NCT00661661|591776362|FG000|Overall Study|Withdrawal by Subject|15|||
163837746|NCT00661661|591776363|FG001|Overall Study|Withdrawal by Subject|5|||
163837747|NCT00661661|591776362|FG000|Overall Study|Other|22|||
163837748|NCT00661661|591776363|FG001|Overall Study|Other|7|||
163837749|NCT00661661|591776362|FG000|Overall Study|Not assigned treatment|1|||
163837750|NCT00661661|591776363|FG001|Overall Study|Not assigned treatment|0|||
163837751|NCT02917941|591776364|FG000|Treatment Period|Adverse Event|11|||
163837752|NCT02917941|591776364|FG000|Treatment Period|Progressive Disease|11|||
163837753|NCT02917941|591776364|FG000|Treatment Period|Reason not Specified|2|||
163932165|NCT00379769|592121629|FG005|Observational Follow-up|Lost to Follow-up|27|||
163932166|NCT00379769|592121624|FG000|Observational Follow-up|Withdrawal by Subject|0|||
163932167|NCT00379769|592121625|FG001|Observational Follow-up|Withdrawal by Subject|0|||
163837754|NCT02917941|591776364|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
163837755|NCT02917941|591776364|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
163837756|NCT01893827|591776365|FG000|Overall Study|Lost to Follow-up|19|||
163837757|NCT01893827|591776366|FG001|Overall Study|Lost to Follow-up|26|||
163837758|NCT03021668|591776369|FG000|Overall Study|Physician Decision|0|||
163837759|NCT03021668|591776370|FG001|Overall Study|Physician Decision|1|||
163837760|NCT01382940|591777656|FG000|Overall Study|Adverse Event|19|||
163837761|NCT01382940|591777656|FG000|Overall Study|Lost to Follow-up|4|||
163932168|NCT00379769|592121626|FG002|Observational Follow-up|Withdrawal by Subject|0|||
163837762|NCT01382940|591777656|FG000|Overall Study|Physician Decision|7|||
163837763|NCT01382940|591777656|FG000|Overall Study|Withdrawal by Subject|23|||
163837764|NCT01382940|591777656|FG000|Overall Study|Protocol Violation|20|||
163837765|NCT02105636|591777657|FG000|Pre-Treatment|Disease Progression|1|||
163837766|NCT02105636|591777658|FG001|Pre-Treatment|Disease Progression|0|||
163837767|NCT02105636|591777657|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
163837768|NCT02105636|591777658|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
163837769|NCT02105636|591777657|FG000|Pre-Treatment|Participant withdrew consent|0|||
163837770|NCT02105636|591777658|FG001|Pre-Treatment|Participant withdrew consent|6|||
163837771|NCT02105636|591777657|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
163837772|NCT02105636|591777658|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
163837773|NCT02105636|591777657|FG000|Treatment|Study Drug Toxicity|14|||
163837774|NCT02105636|591777658|FG001|Treatment|Study Drug Toxicity|10|||
163837775|NCT02105636|591777657|FG000|Treatment|Adverse event unrelated to study drug|19|||
163837776|NCT02105636|591777658|FG001|Treatment|Adverse event unrelated to study drug|3|||
163837777|NCT02105636|591777657|FG000|Treatment|Participant request to discontinue study treatment|8|||
163837778|NCT02105636|591777658|FG001|Treatment|Participant request to discontinue study treatment|6|||
163837779|NCT02105636|591777657|FG000|Treatment|Participant withdrew consent|5|||
163837780|NCT02105636|591777658|FG001|Treatment|Participant withdrew consent|1|||
163837781|NCT02105636|591777657|FG000|Treatment|Lost to Follow-up|1|||
163837782|NCT02105636|591777658|FG001|Treatment|Lost to Follow-up|0|||
163837783|NCT02105636|591777657|FG000|Treatment|Maximum Clinical Benefit|1|||
163837784|NCT02105636|591777658|FG001|Treatment|Maximum Clinical Benefit|3|||
163837785|NCT02105636|591777657|FG000|Treatment|Poor/Non-compliance|0|||
163837786|NCT02105636|591777658|FG001|Treatment|Poor/Non-compliance|1|||
163932169|NCT00379769|592121627|FG003|Observational Follow-up|Withdrawal by Subject|0|||
163932170|NCT00379769|592121628|FG004|Observational Follow-up|Withdrawal by Subject|12|||
163932171|NCT00379769|592121629|FG005|Observational Follow-up|Withdrawal by Subject|12|||
163932172|NCT00379769|592121624|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
163932173|NCT00379769|592121625|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
163932174|NCT00379769|592121626|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
163932175|NCT00379769|592121627|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
163932176|NCT00379769|592121628|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
163932177|NCT00379769|592121629|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
163932178|NCT00379769|592121624|FG000|Observational Follow-up|Physician Decision|0|||
163932179|NCT00379769|592121625|FG001|Observational Follow-up|Physician Decision|0|||
163932180|NCT00379769|592121626|FG002|Observational Follow-up|Physician Decision|0|||
163932181|NCT00379769|592121627|FG003|Observational Follow-up|Physician Decision|0|||
163932182|NCT00379769|592121628|FG004|Observational Follow-up|Physician Decision|8|||
163932183|NCT00379769|592121629|FG005|Observational Follow-up|Physician Decision|8|||
163932184|NCT00379769|592121624|FG000|Observational Follow-up|Site Closed Early|0|||
163932185|NCT00379769|592121625|FG001|Observational Follow-up|Site Closed Early|0|||
163932186|NCT00379769|592121626|FG002|Observational Follow-up|Site Closed Early|0|||
163932187|NCT00379769|592121627|FG003|Observational Follow-up|Site Closed Early|0|||
163932188|NCT00379769|592121628|FG004|Observational Follow-up|Site Closed Early|6|||
163932189|NCT00379769|592121629|FG005|Observational Follow-up|Site Closed Early|7|||
163932190|NCT00379769|592121624|FG000|Observational Follow-up|Participant Moved|0|||
163932191|NCT00379769|592121625|FG001|Observational Follow-up|Participant Moved|0|||
163932192|NCT00379769|592121626|FG002|Observational Follow-up|Participant Moved|0|||
163932193|NCT00379769|592121627|FG003|Observational Follow-up|Participant Moved|0|||
163932194|NCT00379769|592121628|FG004|Observational Follow-up|Participant Moved|0|||
163932195|NCT00379769|592121629|FG005|Observational Follow-up|Participant Moved|1|||
163932196|NCT00379769|592121624|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
163932197|NCT00379769|592121625|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
163932198|NCT00379769|592121626|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
163932199|NCT00379769|592121627|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
163932200|NCT00379769|592121628|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
163932201|NCT00379769|592121629|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
163932202|NCT00667459|592121637|FG000|Overall Study|Death|0|||
163932203|NCT00667459|592121638|FG001|Overall Study|Death|2|||
163932204|NCT00667459|592121637|FG000|Overall Study|Lost to Follow-up|8|||
163932205|NCT00667459|592121638|FG001|Overall Study|Lost to Follow-up|43|||
163932206|NCT04546217|592121641|FG000|Overall Study|Withdrawal by Subject|2|||
163932207|NCT04546217|592121642|FG001|Overall Study|Withdrawal by Subject|0|||
163932208|NCT04546217|592121641|FG000|Overall Study|Uncontrolled hypertension|1|||
163932209|NCT04546217|592121642|FG001|Overall Study|Uncontrolled hypertension|0|||
164098487|NCT00870870|592725110|FG003|Overall Study|Adverse Event|2|||
164098488|NCT01406795|592725111|FG000|Overall Study|Withdrawal by Subject|1|||
164098489|NCT00822926|592725114|FG000|Second Injection Visit|Lost to Follow-up|1|||
164098490|NCT00822926|592725115|FG001|Second Injection Visit|Lost to Follow-up|0|||
163837787|NCT02105636|591777657|FG000|Treatment|Participant no longer meets study criteria|1|||
163837788|NCT02105636|591777658|FG001|Treatment|Participant no longer meets study criteria|0|||
163837789|NCT02105636|591777657|FG000|Treatment|Other reasons|1|||
163932210|NCT02550938|592121643|FG000|Overall Study|Lost to Follow-up|8|||
163932211|NCT02550938|592121644|FG001|Overall Study|Lost to Follow-up|7|||
163932212|NCT02550938|592121645|FG002|Overall Study|Lost to Follow-up|12|||
163932213|NCT02550938|592121646|FG003|Overall Study|Lost to Follow-up|11|||
163932214|NCT05765435|592121651|FG000|Overall Study|Lost to Follow-up|0|||
163932215|NCT05765435|592121652|FG001|Overall Study|Lost to Follow-up|1|||
163932216|NCT05765435|592121653|FG002|Overall Study|Lost to Follow-up|0|||
163932217|NCT05765435|592121651|FG000|Overall Study|Withdrawal by Subject|0|||
163932218|NCT05765435|592121652|FG001|Overall Study|Withdrawal by Subject|0|||
163932219|NCT05765435|592121653|FG002|Overall Study|Withdrawal by Subject|1|||
163932220|NCT04328623|592121654|FG000|Overall Study|Protocol Violation|0|||
164037131|NCT05109702|592494545|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
164037132|NCT05109702|592494546|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
163837790|NCT02105636|591777658|FG001|Treatment|Other reasons|0|||
163837791|NCT02105636|591777657|FG000|Treatment|Disease Progression|185|||
163837792|NCT02105636|591777658|FG001|Treatment|Disease Progression|87|||
163837793|NCT02254408|591777664|FG000|Overall Study|Randomized But Not Treated|1|||
163837794|NCT02254408|591777665|FG001|Overall Study|Randomized But Not Treated|3|||
163837795|NCT02254408|591777664|FG000|Overall Study|Adverse Event|1|||
163837796|NCT02254408|591777665|FG001|Overall Study|Adverse Event|0|||
163837797|NCT02254408|591777664|FG000|Overall Study|Death|2|||
163837798|NCT02254408|591777665|FG001|Overall Study|Death|3|||
163837799|NCT02254408|591777664|FG000|Overall Study|Investigator's Discretion|0|||
163837800|NCT02254408|591777665|FG001|Overall Study|Investigator's Discretion|1|||
163837801|NCT02254408|591777664|FG000|Overall Study|Withdrawal by Subject|3|||
163837802|NCT02254408|591777665|FG001|Overall Study|Withdrawal by Subject|3|||
163837803|NCT02254408|591777664|FG000|Overall Study|Lost to Follow-up|1|||
163837804|NCT02254408|591777665|FG001|Overall Study|Lost to Follow-up|0|||
163837805|NCT01993017|591777666|FG000|Overall Study|Death|23|||
163837806|NCT01993017|591777667|FG001|Overall Study|Death|26|||
163837807|NCT01993017|591777668|FG002|Overall Study|Death|18|||
163837808|NCT01993017|591777666|FG000|Overall Study|Could not be contacted|43|||
163837809|NCT01993017|591777667|FG001|Overall Study|Could not be contacted|42|||
163837810|NCT01993017|591777668|FG002|Overall Study|Could not be contacted|38|||
163837811|NCT01993017|591777666|FG000|Overall Study|Dropped out|19|||
163837812|NCT01993017|591777667|FG001|Overall Study|Dropped out|6|||
163837813|NCT01993017|591777668|FG002|Overall Study|Dropped out|11|||
163837814|NCT01993017|591777666|FG000|Overall Study|Other reasons|17|||
163837815|NCT01993017|591777667|FG001|Overall Study|Other reasons|11|||
163837816|NCT01993017|591777668|FG002|Overall Study|Other reasons|7|||
163837817|NCT01993017|591777666|FG000|Overall Study|Ineligible after randomization|4|||
163837818|NCT01993017|591777667|FG001|Overall Study|Ineligible after randomization|5|||
163837819|NCT01993017|591777668|FG002|Overall Study|Ineligible after randomization|5|||
163837820|NCT00003511|591777669|FG000|Overall Study|Not evaluable|4|||
163837821|NCT00917267|591777670|FG000|Overall Study|Adverse Event|15|||
163837822|NCT00917267|591777671|FG001|Overall Study|Adverse Event|36|||
163837823|NCT00917267|591777670|FG000|Overall Study|Physician Decision|2|||
163837824|NCT00917267|591777671|FG001|Overall Study|Physician Decision|4|||
163837825|NCT00917267|591777670|FG000|Overall Study|Protocol Violation|9|||
163837826|NCT00917267|591777671|FG001|Overall Study|Protocol Violation|18|||
163837827|NCT00917267|591777670|FG000|Overall Study|Withdrawal by Subject|5|||
163837828|NCT00917267|591777671|FG001|Overall Study|Withdrawal by Subject|12|||
163837829|NCT00917267|591777670|FG000|Overall Study|Lost to follow up|0|||
163837830|NCT00917267|591777671|FG001|Overall Study|Lost to follow up|2|||
163837831|NCT00917267|591777670|FG000|Overall Study|Entry Criteria Not Met|1|||
163837832|NCT00917267|591777671|FG001|Overall Study|Entry Criteria Not Met|0|||
163837833|NCT00917267|591777670|FG000|Overall Study|Sponsor Decision|5|||
163837834|NCT00917267|591777671|FG001|Overall Study|Sponsor Decision|5|||
163837835|NCT00917267|591777670|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
163837836|NCT00917267|591777671|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
163837837|NCT03638635|591777672|FG000|Initial Hospitalization|Study terminated prematurely|0|||
163837838|NCT03638635|591777673|FG001|Initial Hospitalization|Study terminated prematurely|1|||
163837839|NCT03638635|591777672|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
163837840|NCT03638635|591777673|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
163837841|NCT03638635|591777672|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
163837842|NCT03638635|591777673|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
163837843|NCT00423293|591777674|FG000|Overall Study|Ineligible / No protocol treatment|11|||
163837844|NCT00519896|591777681|FG000|Overall Study|Protocol Violation|1|||
163837845|NCT00519896|591777681|FG000|Overall Study|Adverse Event|1|||
163837846|NCT01129336|591777682|FG000|Overall Study|Protocol Violation|1|||
163837847|NCT01129336|591777683|FG001|Overall Study|Protocol Violation|0|||
163837848|NCT01129336|591777682|FG000|Overall Study|Disease Progression|1|||
163837849|NCT01129336|591777683|FG001|Overall Study|Disease Progression|4|||
163837850|NCT01129336|591777682|FG000|Overall Study|Lost to Follow-up|1|||
163837851|NCT01129336|591777683|FG001|Overall Study|Lost to Follow-up|0|||
163837852|NCT01129336|591777682|FG000|Overall Study|Withdrawal by Subject|7|||
163837853|NCT01129336|591777683|FG001|Overall Study|Withdrawal by Subject|4|||
163837854|NCT01129336|591777682|FG000|Overall Study|Adverse Event|0|||
163837855|NCT01129336|591777683|FG001|Overall Study|Adverse Event|1|||
163837856|NCT01129336|591777682|FG000|Overall Study|Missing Study Completion Status|2|||
163932221|NCT04328623|592121655|FG001|Overall Study|Protocol Violation|1|||
163932222|NCT02312557|592121656|FG000|Overall Study|Survival follow-up|4|||
163932223|NCT04351269|592121657|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
163932224|NCT04351269|592121658|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
163932225|NCT04351269|592121659|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
163932226|NCT04351269|592121657|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
163932227|NCT04351269|592121658|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
163932228|NCT04351269|592121659|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
163932229|NCT04351269|592121657|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
163932230|NCT04351269|592121658|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
163932231|NCT04351269|592121659|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
163932232|NCT04351269|592121657|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
163932233|NCT04351269|592121658|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
163932234|NCT04351269|592121659|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
163932235|NCT04351269|592121657|FG000|Overall Study|Lost to Follow-up|1|||
163932236|NCT04351269|592121658|FG001|Overall Study|Lost to Follow-up|3|||
163932237|NCT04351269|592121659|FG002|Overall Study|Lost to Follow-up|0|||
163932238|NCT04486313|592121664|FG000|Overall Study|Lost to Follow-up|7|||
163932239|NCT04486313|592121665|FG001|Overall Study|Lost to Follow-up|9|||
163932240|NCT04486313|592121664|FG000|Overall Study|Withdrawal by Subject|8|||
163932241|NCT04486313|592121665|FG001|Overall Study|Withdrawal by Subject|6|||
163932242|NCT04486313|592121664|FG000|Overall Study|Physician Decision|1|||
163932243|NCT04486313|592121665|FG001|Overall Study|Physician Decision|1|||
163932244|NCT04486313|592121664|FG000|Overall Study|Death|2|||
163932245|NCT04486313|592121665|FG001|Overall Study|Death|0|||
163932246|NCT04486313|592121664|FG000|Overall Study|Protocol Violation|1|||
163932247|NCT04486313|592121665|FG001|Overall Study|Protocol Violation|1|||
163932248|NCT02980523|592121671|FG000|Overall Study|Lost to Follow-up|1|||
163932249|NCT02980523|592121672|FG001|Overall Study|Lost to Follow-up|4|||
163932250|NCT02980523|592121673|FG002|Overall Study|Lost to Follow-up|1|||
163932251|NCT02980523|592121674|FG003|Overall Study|Lost to Follow-up|2|||
163932252|NCT02980523|592121675|FG004|Overall Study|Lost to Follow-up|1|||
163932253|NCT02980523|592121671|FG000|Overall Study|Excluded from analysis|1|||
163932254|NCT02980523|592121672|FG001|Overall Study|Excluded from analysis|3|||
163932255|NCT02980523|592121673|FG002|Overall Study|Excluded from analysis|1|||
163932256|NCT02980523|592121674|FG003|Overall Study|Excluded from analysis|1|||
163932257|NCT02980523|592121675|FG004|Overall Study|Excluded from analysis|1|||
163932258|NCT02980523|592121671|FG000|Overall Study|Lack of Efficacy|1|||
163932259|NCT02980523|592121672|FG001|Overall Study|Lack of Efficacy|4|||
163932260|NCT02980523|592121673|FG002|Overall Study|Lack of Efficacy|4|||
163932261|NCT02980523|592121674|FG003|Overall Study|Lack of Efficacy|5|||
163932262|NCT02980523|592121675|FG004|Overall Study|Lack of Efficacy|8|||
163932263|NCT02980523|592121671|FG000|Overall Study|Did not receive intervention|0|||
163932264|NCT02980523|592121672|FG001|Overall Study|Did not receive intervention|0|||
163932265|NCT02980523|592121673|FG002|Overall Study|Did not receive intervention|0|||
163932266|NCT02980523|592121674|FG003|Overall Study|Did not receive intervention|1|||
163932267|NCT02980523|592121675|FG004|Overall Study|Did not receive intervention|0|||
163932268|NCT01236352|592121691|FG000|Overall Study|Death|0|||
163932269|NCT01236352|592121692|FG001|Overall Study|Death|0|||
163932270|NCT01236352|592121693|FG002|Overall Study|Death|0|||
163932271|NCT01236352|592121694|FG003|Overall Study|Death|0|||
163932272|NCT01236352|592121695|FG004|Overall Study|Death|0|||
163932273|NCT01236352|592121696|FG005|Overall Study|Death|0|||
163932274|NCT01236352|592121697|FG006|Overall Study|Death|0|||
163932275|NCT01236352|592121698|FG007|Overall Study|Death|1|||
163932276|NCT01236352|592121699|FG008|Overall Study|Death|0|||
163932277|NCT01236352|592121700|FG009|Overall Study|Death|0|||
163932278|NCT01236352|592121701|FG010|Overall Study|Death|0|||
163932279|NCT01236352|592121691|FG000|Overall Study|Withdrawal by Subject|0|||
163932280|NCT01236352|592121692|FG001|Overall Study|Withdrawal by Subject|0|||
163932281|NCT01236352|592121693|FG002|Overall Study|Withdrawal by Subject|0|||
163932282|NCT01236352|592121694|FG003|Overall Study|Withdrawal by Subject|0|||
163932283|NCT01236352|592121695|FG004|Overall Study|Withdrawal by Subject|0|||
163932284|NCT01236352|592121696|FG005|Overall Study|Withdrawal by Subject|0|||
164037133|NCT05109702|592494547|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
164037134|NCT05109702|592494545|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
163932285|NCT01236352|592121697|FG006|Overall Study|Withdrawal by Subject|0|||
163932286|NCT01236352|592121698|FG007|Overall Study|Withdrawal by Subject|0|||
163932287|NCT01236352|592121699|FG008|Overall Study|Withdrawal by Subject|0|||
163932288|NCT01236352|592121700|FG009|Overall Study|Withdrawal by Subject|2|||
163932289|NCT01236352|592121701|FG010|Overall Study|Withdrawal by Subject|1|||
164037135|NCT05109702|592494546|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
163932290|NCT01236352|592121691|FG000|Overall Study|Adverse Event|0|||
163932291|NCT01236352|592121692|FG001|Overall Study|Adverse Event|0|||
163932292|NCT01236352|592121693|FG002|Overall Study|Adverse Event|0|||
163932293|NCT01236352|592121694|FG003|Overall Study|Adverse Event|0|||
164037136|NCT05109702|592494547|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
163837857|NCT01129336|591777683|FG001|Overall Study|Missing Study Completion Status|3|||
163837858|NCT01129336|591777682|FG000|Overall Study|Death|0|||
163837859|NCT01129336|591777683|FG001|Overall Study|Death|4|||
163837860|NCT00791921|591777686|FG000|Overall Study|Protocol planed|24|||
163837861|NCT00791921|591777687|FG001|Overall Study|Protocol planed|88|||
163837862|NCT00791921|591777686|FG000|Overall Study|Withdrawal by Subject|1|||
163837863|NCT00791921|591777687|FG001|Overall Study|Withdrawal by Subject|2|||
163837864|NCT00791921|591777686|FG000|Overall Study|Adverse Event|8|||
163837865|NCT00791921|591777687|FG001|Overall Study|Adverse Event|2|||
163837866|NCT00791921|591777686|FG000|Overall Study|Lack of Efficacy|0|||
163837867|NCT00791921|591777687|FG001|Overall Study|Lack of Efficacy|2|||
163837868|NCT00791921|591777686|FG000|Overall Study|Lack of study drug administration|1|||
163837869|NCT00791921|591777687|FG001|Overall Study|Lack of study drug administration|1|||
163837870|NCT00791921|591777686|FG000|Overall Study|Reason other than those above|0|||
163837871|NCT00791921|591777687|FG001|Overall Study|Reason other than those above|1|||
163837872|NCT01540565|591777691|FG000|Overall Study|Ineligible|2|||
163837873|NCT01827254|591777692|FG000|Overall Study|Death|10|||
163837874|NCT01827254|591777692|FG000|Overall Study|Case report form not completed|4|||
163837875|NCT01827254|591777692|FG000|Overall Study|Invalidated centre|3|||
163837876|NCT01827254|591777692|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
163837877|NCT01827254|591777692|FG000|Overall Study|Did not complete re-challenge|1|||
163837878|NCT01827254|591777692|FG000|Overall Study|Disease progression|36|||
163837879|NCT01827254|591777692|FG000|Overall Study|Intolerance to treatment|4|||
163837880|NCT04145037|591777693|FG000|Overall Study|Study terminated|2|||
163837881|NCT04145037|591777694|FG001|Overall Study|Study terminated|0|||
163837882|NCT04145037|591777693|FG000|Overall Study|Withdrawal by Subject|1|||
163837883|NCT04145037|591777694|FG001|Overall Study|Withdrawal by Subject|0|||
163837884|NCT04145037|591777693|FG000|Overall Study|Lost to Follow-up|1|||
163837885|NCT04145037|591777694|FG001|Overall Study|Lost to Follow-up|0|||
163837886|NCT02307513|591777697|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
163837887|NCT02307513|591777698|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
163837888|NCT02307513|591777697|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
163837889|NCT02307513|591777698|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
163837890|NCT02307513|591777697|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
163837891|NCT02307513|591777698|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
163837892|NCT02307513|591777697|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
163837893|NCT02307513|591777698|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
163837894|NCT02307513|591777697|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
163837895|NCT02307513|591777698|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
163837896|NCT02307513|591777697|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
163837897|NCT02307513|591777698|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
163837898|NCT02307513|591777697|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
163837899|NCT02307513|591777698|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
163837900|NCT02307513|591777697|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
163837901|NCT02307513|591777698|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
163837902|NCT02307513|591777697|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
163837903|NCT02307513|591777698|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
163837904|NCT02307513|591777697|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
163837905|NCT02307513|591777698|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
163837906|NCT02307513|591777697|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
163837907|NCT02307513|591777698|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
163837908|NCT02307513|591777697|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
163837909|NCT02307513|591777698|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
163837910|NCT02307513|591777697|FG000|Long-term Extension|Physician Decision|1|||
163837911|NCT02307513|591777698|FG001|Long-term Extension|Physician Decision|0|||
163837912|NCT01107743|591777700|FG000|Overall Study|Protocol Violation|46|||
163837913|NCT00744263|591777703|FG000|Overall Study|Death|3006|||
163837914|NCT00744263|591777704|FG001|Overall Study|Death|3005|||
163837915|NCT00744263|591777703|FG000|Overall Study|Lost to Follow-up|2038|||
163837916|NCT00744263|591777704|FG001|Overall Study|Lost to Follow-up|2135|||
163837917|NCT00744263|591777703|FG000|Overall Study|Withdrawal by Subject|166|||
163837918|NCT00744263|591777704|FG001|Overall Study|Withdrawal by Subject|150|||
163837919|NCT00744263|591777703|FG000|Overall Study|Physician Decision|20|||
163837920|NCT00744263|591777704|FG001|Overall Study|Physician Decision|23|||
163837921|NCT00744263|591777703|FG000|Overall Study|Protocol Violation|3|||
163837922|NCT00744263|591777704|FG001|Overall Study|Protocol Violation|5|||
163837923|NCT00744263|591777703|FG000|Overall Study|Adverse Event|1|||
163837924|NCT00744263|591777704|FG001|Overall Study|Adverse Event|0|||
163837925|NCT00744263|591777703|FG000|Overall Study|Other|2|||
163837926|NCT00744263|591777704|FG001|Overall Study|Other|2|||
163837927|NCT01913639|591777705|FG000|Overall Study|Not Eligible|3|||
164037137|NCT05109702|592494545|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
163932294|NCT01236352|592121695|FG004|Overall Study|Adverse Event|0|||
163932295|NCT01236352|592121696|FG005|Overall Study|Adverse Event|0|||
163932296|NCT01236352|592121697|FG006|Overall Study|Adverse Event|2|||
163932297|NCT01236352|592121698|FG007|Overall Study|Adverse Event|0|||
163932298|NCT01236352|592121699|FG008|Overall Study|Adverse Event|0|||
163932299|NCT01236352|592121700|FG009|Overall Study|Adverse Event|4|||
163932300|NCT01236352|592121701|FG010|Overall Study|Adverse Event|1|||
163932301|NCT01236352|592121691|FG000|Overall Study|Study drug toxicity|0|||
163932302|NCT01236352|592121692|FG001|Overall Study|Study drug toxicity|0|||
163932303|NCT01236352|592121693|FG002|Overall Study|Study drug toxicity|0|||
163932304|NCT01236352|592121694|FG003|Overall Study|Study drug toxicity|0|||
163932305|NCT01236352|592121695|FG004|Overall Study|Study drug toxicity|0|||
163932306|NCT01236352|592121696|FG005|Overall Study|Study drug toxicity|1|||
163932307|NCT01236352|592121697|FG006|Overall Study|Study drug toxicity|1|||
163932308|NCT01236352|592121698|FG007|Overall Study|Study drug toxicity|0|||
163932309|NCT01236352|592121699|FG008|Overall Study|Study drug toxicity|0|||
163932310|NCT01236352|592121700|FG009|Overall Study|Study drug toxicity|2|||
163932311|NCT01236352|592121701|FG010|Overall Study|Study drug toxicity|2|||
163932312|NCT01236352|592121691|FG000|Overall Study|Disease progression|1|||
163932313|NCT01236352|592121692|FG001|Overall Study|Disease progression|2|||
163932314|NCT01236352|592121693|FG002|Overall Study|Disease progression|1|||
163932315|NCT01236352|592121694|FG003|Overall Study|Disease progression|2|||
163932316|NCT01236352|592121695|FG004|Overall Study|Disease progression|2|||
163932317|NCT01236352|592121696|FG005|Overall Study|Disease progression|2|||
163932318|NCT01236352|592121697|FG006|Overall Study|Disease progression|1|||
163932319|NCT01236352|592121698|FG007|Overall Study|Disease progression|3|||
163932320|NCT01236352|592121699|FG008|Overall Study|Disease progression|2|||
163932321|NCT01236352|592121700|FG009|Overall Study|Disease progression|2|||
163932322|NCT01236352|592121701|FG010|Overall Study|Disease progression|2|||
163932323|NCT01236352|592121691|FG000|Overall Study|Poor/Non-compliance|1|||
163932324|NCT01236352|592121692|FG001|Overall Study|Poor/Non-compliance|0|||
163932325|NCT01236352|592121693|FG002|Overall Study|Poor/Non-compliance|0|||
163932326|NCT01236352|592121694|FG003|Overall Study|Poor/Non-compliance|0|||
163932327|NCT01236352|592121695|FG004|Overall Study|Poor/Non-compliance|0|||
163932328|NCT01236352|592121696|FG005|Overall Study|Poor/Non-compliance|0|||
163932329|NCT01236352|592121697|FG006|Overall Study|Poor/Non-compliance|0|||
163932330|NCT01236352|592121698|FG007|Overall Study|Poor/Non-compliance|0|||
163932331|NCT01236352|592121699|FG008|Overall Study|Poor/Non-compliance|0|||
163932332|NCT01236352|592121700|FG009|Overall Study|Poor/Non-compliance|0|||
163932333|NCT01236352|592121701|FG010|Overall Study|Poor/Non-compliance|0|||
163932334|NCT01236352|592121691|FG000|Overall Study|Maximum clinical benefit|1|||
163932335|NCT01236352|592121692|FG001|Overall Study|Maximum clinical benefit|1|||
163932336|NCT01236352|592121693|FG002|Overall Study|Maximum clinical benefit|1|||
163932337|NCT01236352|592121694|FG003|Overall Study|Maximum clinical benefit|0|||
163932338|NCT01236352|592121695|FG004|Overall Study|Maximum clinical benefit|2|||
163932339|NCT01236352|592121696|FG005|Overall Study|Maximum clinical benefit|0|||
163932340|NCT01236352|592121697|FG006|Overall Study|Maximum clinical benefit|3|||
163932341|NCT01236352|592121698|FG007|Overall Study|Maximum clinical benefit|1|||
163932342|NCT01236352|592121699|FG008|Overall Study|Maximum clinical benefit|1|||
163932343|NCT01236352|592121700|FG009|Overall Study|Maximum clinical benefit|4|||
163932344|NCT01236352|592121701|FG010|Overall Study|Maximum clinical benefit|2|||
163932345|NCT01236352|592121691|FG000|Overall Study|Subject request to discontinue treatment|0|||
163932346|NCT01236352|592121692|FG001|Overall Study|Subject request to discontinue treatment|0|||
163932347|NCT01236352|592121693|FG002|Overall Study|Subject request to discontinue treatment|1|||
163932348|NCT01236352|592121694|FG003|Overall Study|Subject request to discontinue treatment|1|||
163932349|NCT01236352|592121695|FG004|Overall Study|Subject request to discontinue treatment|0|||
163932350|NCT01236352|592121696|FG005|Overall Study|Subject request to discontinue treatment|1|||
163932351|NCT01236352|592121697|FG006|Overall Study|Subject request to discontinue treatment|0|||
163932352|NCT01236352|592121698|FG007|Overall Study|Subject request to discontinue treatment|0|||
163932353|NCT01236352|592121699|FG008|Overall Study|Subject request to discontinue treatment|0|||
163932354|NCT01236352|592121700|FG009|Overall Study|Subject request to discontinue treatment|1|||
163932355|NCT01236352|592121701|FG010|Overall Study|Subject request to discontinue treatment|4|||
163932356|NCT01236352|592121691|FG000|Overall Study|Subject to receive drug via EAP|1|||
163932357|NCT01236352|592121692|FG001|Overall Study|Subject to receive drug via EAP|1|||
163932358|NCT01236352|592121693|FG002|Overall Study|Subject to receive drug via EAP|1|||
163932359|NCT01236352|592121694|FG003|Overall Study|Subject to receive drug via EAP|0|||
163932360|NCT01236352|592121695|FG004|Overall Study|Subject to receive drug via EAP|0|||
163932361|NCT01236352|592121696|FG005|Overall Study|Subject to receive drug via EAP|0|||
163932362|NCT01236352|592121697|FG006|Overall Study|Subject to receive drug via EAP|0|||
163932363|NCT01236352|592121698|FG007|Overall Study|Subject to receive drug via EAP|2|||
163932364|NCT01236352|592121699|FG008|Overall Study|Subject to receive drug via EAP|0|||
163932365|NCT01236352|592121700|FG009|Overall Study|Subject to receive drug via EAP|4|||
163932366|NCT01236352|592121701|FG010|Overall Study|Subject to receive drug via EAP|0|||
163932367|NCT01236352|592121691|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
163932368|NCT01236352|592121692|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
164037138|NCT05109702|592494546|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
164037139|NCT05109702|592494547|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
163837928|NCT01290822|591777708|FG000|Overall Study|Withdrawal by Subject|1|||
163837929|NCT01290822|591777708|FG000|Overall Study|Physician Decision|10|||
163837930|NCT04078035|591777709|FG000|Session 2|Lost to Follow-up|3|||
163837931|NCT04078035|591777710|FG001|Session 2|Lost to Follow-up|1|||
163837932|NCT04078035|591777709|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
163837933|NCT04078035|591777710|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
163837934|NCT04296890|591777713|FG000|Overall Study|Withdrawal by Subject|1|||
163837935|NCT04296890|591777713|FG000|Overall Study|Death|62|||
163837936|NCT04296890|591777713|FG000|Overall Study|Lost to Follow-up|3|||
163837937|NCT04296890|591777713|FG000|Overall Study|Other than specified|2|||
163837938|NCT02100722|591777714|FG000|Overall Study|Withdrawal pre-procedure|4|||
163837939|NCT02100722|591777715|FG001|Overall Study|Withdrawal pre-procedure|9|||
163837940|NCT02100722|591777714|FG000|Overall Study|Withdrawal post-procedure|0|||
163837941|NCT02100722|591777715|FG001|Overall Study|Withdrawal post-procedure|3|||
163837942|NCT02100722|591777714|FG000|Overall Study|Lost to Follow-up|2|||
163837943|NCT02100722|591777715|FG001|Overall Study|Lost to Follow-up|2|||
163837944|NCT02100722|591777714|FG000|Overall Study|Continuing on study|751|||
163837945|NCT02100722|591777715|FG001|Overall Study|Continuing on study|729|||
163837946|NCT04986982|591777717|FG000|Overall Study|Withdrawal by Subject|3|||
163837947|NCT04986982|591777718|FG001|Overall Study|Withdrawal by Subject|1|||
163837948|NCT04986982|591777717|FG000|Overall Study|Lack of Efficacy|0|||
163837949|NCT04986982|591777718|FG001|Overall Study|Lack of Efficacy|2|||
163837950|NCT04986982|591777717|FG000|Overall Study|Ineligibility|3|||
163837951|NCT04986982|591777718|FG001|Overall Study|Ineligibility|0|||
163837952|NCT04986982|591777717|FG000|Overall Study|Adverse Event|4|||
163837953|NCT04986982|591777718|FG001|Overall Study|Adverse Event|4|||
163837954|NCT04986982|591777717|FG000|Overall Study|Lost to Follow-up|0|||
163837955|NCT04986982|591777718|FG001|Overall Study|Lost to Follow-up|1|||
163837956|NCT04986982|591777717|FG000|Overall Study|Sponsor's discretion|1|||
163837957|NCT04986982|591777718|FG001|Overall Study|Sponsor's discretion|0|||
163837958|NCT03500640|591777719|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
163837959|NCT03500640|591777720|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
163837960|NCT03500640|591777721|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
163837961|NCT03500640|591777719|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
163837962|NCT03500640|591777720|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
163837963|NCT03500640|591777721|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
163837964|NCT03500640|591777719|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
163837965|NCT03500640|591777720|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
163837966|NCT03500640|591777721|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
163837967|NCT03500640|591777719|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
163837968|NCT03500640|591777720|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
163837969|NCT03500640|591777721|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
163837970|NCT03500640|591777719|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
163837971|NCT03500640|591777720|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
163837972|NCT03500640|591777721|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
163837973|NCT03500640|591777719|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
163837974|NCT03500640|591777720|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
163837975|NCT03500640|591777721|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
163837976|NCT03500640|591777719|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
163837977|NCT03500640|591777720|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
163837978|NCT03500640|591777721|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
163837979|NCT03500640|591777719|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
163837980|NCT03500640|591777720|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
163837981|NCT03500640|591777721|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
163837982|NCT03500640|591777719|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
163837983|NCT03500640|591777720|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
163837984|NCT03500640|591777721|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
163837985|NCT03500640|591777719|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
163837986|NCT03500640|591777720|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
163837987|NCT03500640|591777721|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
163837988|NCT02613221|591777722|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
163837989|NCT02613221|591777722|FG000|Overall Study|Adverse Event|2|||
163837990|NCT02613221|591777722|FG000|Overall Study|Voluntary Discontinuation|1|||
163837991|NCT02613221|591777722|FG000|Overall Study|Delayed Treatment|1|||
163837992|NCT02613221|591777722|FG000|Overall Study|Enrolled but Not Treated|1|||
163837993|NCT01353222|591777723|FG000|Overall Study|Death|30|||
163837994|NCT01353222|591777724|FG001|Overall Study|Death|30|||
163837995|NCT01353222|591777723|FG000|Overall Study|Withdrawal by Subject|8|||
163837996|NCT01353222|591777724|FG001|Overall Study|Withdrawal by Subject|5|||
164037140|NCT05109702|592494545|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
163932369|NCT01236352|592121693|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
163932370|NCT01236352|592121694|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
163932371|NCT01236352|592121695|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
163932372|NCT01236352|592121696|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
163932373|NCT01236352|592121697|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
163932374|NCT01236352|592121698|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
163932375|NCT01236352|592121699|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
163932376|NCT01236352|592121700|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
163932377|NCT01236352|592121701|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
163932378|NCT01236352|592121691|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932379|NCT01236352|592121692|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932380|NCT01236352|592121693|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932381|NCT01236352|592121694|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932382|NCT01236352|592121695|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932383|NCT01236352|592121696|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932384|NCT01236352|592121697|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932385|NCT01236352|592121698|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932386|NCT01236352|592121699|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932387|NCT01236352|592121700|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
163932388|NCT01236352|592121701|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
163932389|NCT01236352|592121691|FG000|Overall Study|Lack of response to drug|0|||
163932390|NCT01236352|592121692|FG001|Overall Study|Lack of response to drug|0|||
163932391|NCT01236352|592121693|FG002|Overall Study|Lack of response to drug|0|||
163932392|NCT01236352|592121694|FG003|Overall Study|Lack of response to drug|0|||
163932393|NCT01236352|592121695|FG004|Overall Study|Lack of response to drug|0|||
163932394|NCT01236352|592121696|FG005|Overall Study|Lack of response to drug|0|||
163932395|NCT01236352|592121697|FG006|Overall Study|Lack of response to drug|0|||
163932396|NCT01236352|592121698|FG007|Overall Study|Lack of response to drug|0|||
163932397|NCT01236352|592121699|FG008|Overall Study|Lack of response to drug|0|||
163837997|NCT01353222|591777723|FG000|Overall Study|Study Terminated|31|||
163837998|NCT01353222|591777724|FG001|Overall Study|Study Terminated|37|||
163837999|NCT01353222|591777723|FG000|Overall Study|Site closed research department|1|||
163838000|NCT01353222|591777724|FG001|Overall Study|Site closed research department|0|||
163838001|NCT01119898|591777725|FG000|Overall Study|Adverse Event|4|||
163838002|NCT01119898|591777726|FG001|Overall Study|Adverse Event|5|||
163838003|NCT01119898|591777725|FG000|Overall Study|Withdrawal by Subject|1|||
163838004|NCT01119898|591777726|FG001|Overall Study|Withdrawal by Subject|4|||
163838005|NCT01119898|591777725|FG000|Overall Study|Lack of Efficacy|0|||
163838006|NCT01119898|591777726|FG001|Overall Study|Lack of Efficacy|2|||
163838007|NCT01119898|591777725|FG000|Overall Study|Protocol Violation|1|||
163838008|NCT01119898|591777726|FG001|Overall Study|Protocol Violation|1|||
163838009|NCT01119898|591777725|FG000|Overall Study|Medical procedure|1|||
163838010|NCT01119898|591777726|FG001|Overall Study|Medical procedure|0|||
163838011|NCT01119898|591777725|FG000|Overall Study|Randomized in error did not participate|1|||
163838012|NCT01119898|591777726|FG001|Overall Study|Randomized in error did not participate|0|||
163838013|NCT01807650|591777727|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
163838014|NCT01807650|591777727|FG000|Overall Study|Adverse Event|5|||
163838015|NCT01807650|591777727|FG000|Overall Study|Other|2|||
163838016|NCT01122381|591777730|FG000|Overall Study|study terminated early|0|||
163838017|NCT01122381|591777731|FG001|Overall Study|study terminated early|1|||
163838018|NCT02217280|591777732|FG000|Overall Study|Withdrawal by Subject|2|||
163838019|NCT02217280|591777732|FG000|Overall Study|Post-consent sceen fail|2|||
163838020|NCT00736489|591777733|FG000|Period 1|Lost to Follow-up|1|||
163838021|NCT00736489|591777734|FG001|Period 1|Lost to Follow-up|0|||
163838022|NCT00736489|591777735|FG002|Period 1|Lost to Follow-up|0|||
163838023|NCT00736489|591777736|FG003|Period 1|Lost to Follow-up|0|||
163838024|NCT00736489|591777737|FG004|Period 1|Lost to Follow-up|0|||
163838025|NCT00736489|591777738|FG005|Period 1|Lost to Follow-up|0|||
163838026|NCT00736489|591777733|FG000|Period 1|Withdrawal by Subject|0|||
163838027|NCT00736489|591777734|FG001|Period 1|Withdrawal by Subject|0|||
163838028|NCT00736489|591777735|FG002|Period 1|Withdrawal by Subject|0|||
163838029|NCT00736489|591777736|FG003|Period 1|Withdrawal by Subject|0|||
163838030|NCT00736489|591777737|FG004|Period 1|Withdrawal by Subject|0|||
163838031|NCT00736489|591777738|FG005|Period 1|Withdrawal by Subject|1|||
163838032|NCT02395133|591777739|FG000|Overall Study|Adverse Event|4|||
163838033|NCT02395133|591777740|FG001|Overall Study|Adverse Event|1|||
163838034|NCT02395133|591777741|FG002|Overall Study|Adverse Event|3|||
163838035|NCT02395133|591777742|FG003|Overall Study|Adverse Event|0|||
163838036|NCT02395133|591777739|FG000|Overall Study|Lack of Efficacy|1|||
163838037|NCT02395133|591777740|FG001|Overall Study|Lack of Efficacy|0|||
163838038|NCT02395133|591777741|FG002|Overall Study|Lack of Efficacy|1|||
163838039|NCT02395133|591777742|FG003|Overall Study|Lack of Efficacy|1|||
163838040|NCT02395133|591777739|FG000|Overall Study|Protocol Violation|1|||
163838041|NCT02395133|591777740|FG001|Overall Study|Protocol Violation|1|||
163932398|NCT01236352|592121700|FG009|Overall Study|Lack of response to drug|1|||
163932399|NCT01236352|592121701|FG010|Overall Study|Lack of response to drug|1|||
163932400|NCT01236352|592121691|FG000|Overall Study|Patient transferred to IST|0|||
163932401|NCT01236352|592121692|FG001|Overall Study|Patient transferred to IST|0|||
163932402|NCT01236352|592121693|FG002|Overall Study|Patient transferred to IST|0|||
163932403|NCT01236352|592121694|FG003|Overall Study|Patient transferred to IST|0|||
163932404|NCT01236352|592121695|FG004|Overall Study|Patient transferred to IST|0|||
163932405|NCT01236352|592121696|FG005|Overall Study|Patient transferred to IST|0|||
163932406|NCT01236352|592121697|FG006|Overall Study|Patient transferred to IST|0|||
163932407|NCT01236352|592121698|FG007|Overall Study|Patient transferred to IST|0|||
163932408|NCT01236352|592121699|FG008|Overall Study|Patient transferred to IST|0|||
163932409|NCT01236352|592121700|FG009|Overall Study|Patient transferred to IST|2|||
163932410|NCT01236352|592121701|FG010|Overall Study|Patient transferred to IST|6|||
163932411|NCT05903183|592121706|FG000|Main Trial Part (365 Days)|Death|1|||
163932412|NCT05903183|592121707|FG001|Main Trial Part (365 Days)|Death|0|||
163932413|NCT05903183|592121708|FG002|Main Trial Part (365 Days)|Death|0|||
163932414|NCT05903183|592121709|FG003|Main Trial Part (365 Days)|Death|0|||
163932415|NCT05903183|592121710|FG004|Main Trial Part (365 Days)|Death|0|||
163932416|NCT05903183|592121706|FG000|Main Trial Part (365 Days)|Other|1|||
163932417|NCT05903183|592121707|FG001|Main Trial Part (365 Days)|Other|2|||
163932418|NCT05903183|592121708|FG002|Main Trial Part (365 Days)|Other|1|||
163932419|NCT05903183|592121709|FG003|Main Trial Part (365 Days)|Other|0|||
163932420|NCT05903183|592121710|FG004|Main Trial Part (365 Days)|Other|0|||
163932421|NCT05903183|592121706|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163932422|NCT05903183|592121707|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163932423|NCT05903183|592121708|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
163932424|NCT05903183|592121709|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163932425|NCT05903183|592121710|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
163932426|NCT05903183|592121706|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
163932427|NCT05903183|592121707|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163932428|NCT05903183|592121708|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163932429|NCT05903183|592121709|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163932430|NCT05903183|592121710|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
163932431|NCT05903183|592121706|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
163932432|NCT05903183|592121707|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
163932433|NCT05903183|592121708|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
163932434|NCT05903183|592121709|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
163932435|NCT05903183|592121710|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
163932436|NCT03149029|592121711|FG000|Overall Study|Adverse Event|2|||
163932437|NCT03149029|592121712|FG001|Overall Study|Adverse Event|0|||
163932438|NCT03735121|592121713|FG000|Overall Study|Death|3|||
163932439|NCT03735121|592121714|FG001|Overall Study|Death|6|||
163932440|NCT03735121|592121715|FG002|Overall Study|Death|19|||
163932441|NCT03735121|592121716|FG003|Overall Study|Death|97|||
163932442|NCT03735121|592121717|FG004|Overall Study|Death|205|||
163932443|NCT03735121|592121713|FG000|Overall Study|Lost to Follow-up|0|||
163932444|NCT03735121|592121714|FG001|Overall Study|Lost to Follow-up|0|||
163932445|NCT03735121|592121715|FG002|Overall Study|Lost to Follow-up|0|||
163932446|NCT03735121|592121716|FG003|Overall Study|Lost to Follow-up|2|||
163932447|NCT03735121|592121717|FG004|Overall Study|Lost to Follow-up|3|||
163932448|NCT03735121|592121713|FG000|Overall Study|New Therapy|0|||
163932449|NCT03735121|592121714|FG001|Overall Study|New Therapy|1|||
163932450|NCT03735121|592121715|FG002|Overall Study|New Therapy|0|||
163932451|NCT03735121|592121716|FG003|Overall Study|New Therapy|0|||
163932452|NCT03735121|592121717|FG004|Overall Study|New Therapy|0|||
164098491|NCT00822926|592725114|FG000|Second Injection Visit|Withdrawal by Subject|0|||
164098492|NCT00822926|592725115|FG001|Second Injection Visit|Withdrawal by Subject|1|||
163932453|NCT03735121|592121713|FG000|Overall Study|Study Ended by Sponsor|1|||
163932454|NCT03735121|592121714|FG001|Overall Study|Study Ended by Sponsor|0|||
163932455|NCT03735121|592121715|FG002|Overall Study|Study Ended by Sponsor|1|||
163932456|NCT03735121|592121716|FG003|Overall Study|Study Ended by Sponsor|17|||
163932457|NCT03735121|592121717|FG004|Overall Study|Study Ended by Sponsor|28|||
163932458|NCT03735121|592121713|FG000|Overall Study|Withdrawal by Subject|1|||
163932459|NCT03735121|592121714|FG001|Overall Study|Withdrawal by Subject|1|||
163932460|NCT03735121|592121715|FG002|Overall Study|Withdrawal by Subject|6|||
163932461|NCT03735121|592121716|FG003|Overall Study|Withdrawal by Subject|8|||
163932462|NCT03735121|592121717|FG004|Overall Study|Withdrawal by Subject|11|||
163932463|NCT02176863|592121718|FG000|Overall Study|Physician Decision|1|||
163932464|NCT02176863|592121719|FG001|Overall Study|Physician Decision|0|||
163932465|NCT02176863|592121720|FG002|Overall Study|Physician Decision|0|||
163932466|NCT02176863|592121721|FG003|Overall Study|Physician Decision|0|||
164098493|NCT03897088|592725116|FG000|Overall Study|Withdrawal by Subject|12|||
163932467|NCT02176863|592121722|FG004|Overall Study|Physician Decision|0|||
163932468|NCT02176863|592121718|FG000|Overall Study|Adverse Event|10|||
163932469|NCT02176863|592121719|FG001|Overall Study|Adverse Event|4|||
163932470|NCT02176863|592121720|FG002|Overall Study|Adverse Event|4|||
163932471|NCT02176863|592121721|FG003|Overall Study|Adverse Event|1|||
163932472|NCT02176863|592121722|FG004|Overall Study|Adverse Event|1|||
163932473|NCT02176863|592121718|FG000|Overall Study|Protocol Violation|2|||
163932474|NCT02176863|592121719|FG001|Overall Study|Protocol Violation|0|||
163932475|NCT02176863|592121720|FG002|Overall Study|Protocol Violation|1|||
163932476|NCT02176863|592121721|FG003|Overall Study|Protocol Violation|1|||
163932477|NCT02176863|592121722|FG004|Overall Study|Protocol Violation|0|||
163932478|NCT02176863|592121718|FG000|Overall Study|Withdrawal by Subject|4|||
163932479|NCT02176863|592121719|FG001|Overall Study|Withdrawal by Subject|2|||
163932480|NCT02176863|592121720|FG002|Overall Study|Withdrawal by Subject|2|||
163932481|NCT02176863|592121721|FG003|Overall Study|Withdrawal by Subject|3|||
163932482|NCT02176863|592121722|FG004|Overall Study|Withdrawal by Subject|4|||
163932483|NCT02176863|592121718|FG000|Overall Study|Reason not specified|0|||
163932484|NCT02176863|592121719|FG001|Overall Study|Reason not specified|1|||
163932485|NCT02176863|592121720|FG002|Overall Study|Reason not specified|1|||
163932486|NCT02176863|592121721|FG003|Overall Study|Reason not specified|2|||
163932487|NCT02176863|592121722|FG004|Overall Study|Reason not specified|1|||
163932488|NCT02176863|592121718|FG000|Overall Study|Lost to Follow-up|0|||
163932489|NCT02176863|592121719|FG001|Overall Study|Lost to Follow-up|1|||
163932490|NCT02176863|592121720|FG002|Overall Study|Lost to Follow-up|1|||
163932491|NCT02176863|592121721|FG003|Overall Study|Lost to Follow-up|0|||
163932492|NCT02176863|592121722|FG004|Overall Study|Lost to Follow-up|0|||
163932493|NCT02647645|592121723|FG000|Overall Study|Lost to Follow-up|2|||
163932494|NCT02647645|592121724|FG001|Overall Study|Lost to Follow-up|1|||
163932495|NCT02037256|592121725|FG000|Overall Study|Protocol Violation|0|||
163932496|NCT02037256|592121726|FG001|Overall Study|Protocol Violation|1|||
163932497|NCT02037256|592121725|FG000|Overall Study|Withdrawn prior to Velcade|0|||
163932498|NCT02037256|592121726|FG001|Overall Study|Withdrawn prior to Velcade|2|||
163932499|NCT04599907|592121731|FG000|Overall Study|Withdrawal by Subject|1|||
163932500|NCT04599907|592121732|FG001|Overall Study|Withdrawal by Subject|7|||
163932501|NCT04599907|592121733|FG002|Overall Study|Withdrawal by Subject|6|||
163932502|NCT04599907|592121731|FG000|Overall Study|Lost to Follow-up|0|||
163932503|NCT04599907|592121732|FG001|Overall Study|Lost to Follow-up|1|||
163932504|NCT04599907|592121733|FG002|Overall Study|Lost to Follow-up|0|||
163932505|NCT03007732|592121734|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
163932506|NCT03007732|592121735|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
163932507|NCT03007732|592121736|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
163932508|NCT03007732|592121737|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
163932509|NCT03371823|592121738|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
163932510|NCT03371823|592121739|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
163932511|NCT01466790|592121741|FG000|Overall Study|Adverse Event|1|||
163932512|NCT01466790|592121742|FG001|Overall Study|Adverse Event|0|||
163932513|NCT01466790|592121743|FG002|Overall Study|Adverse Event|0|||
163932514|NCT01466790|592121744|FG003|Overall Study|Adverse Event|0|||
163932515|NCT01466790|592121745|FG004|Overall Study|Adverse Event|2|||
163932516|NCT01466790|592121746|FG005|Overall Study|Adverse Event|0|||
163932517|NCT01466790|592121747|FG006|Overall Study|Adverse Event|0|||
163932518|NCT01466790|592121748|FG007|Overall Study|Adverse Event|0|||
163932519|NCT01466790|592121741|FG000|Overall Study|Lost to Follow-up|2|||
163932520|NCT01466790|592121742|FG001|Overall Study|Lost to Follow-up|0|||
163932521|NCT01466790|592121743|FG002|Overall Study|Lost to Follow-up|0|||
163932522|NCT01466790|592121744|FG003|Overall Study|Lost to Follow-up|0|||
163932523|NCT01466790|592121745|FG004|Overall Study|Lost to Follow-up|0|||
163932524|NCT01466790|592121746|FG005|Overall Study|Lost to Follow-up|0|||
163932525|NCT01466790|592121747|FG006|Overall Study|Lost to Follow-up|0|||
163932526|NCT01466790|592121748|FG007|Overall Study|Lost to Follow-up|0|||
163932527|NCT01466790|592121741|FG000|Overall Study|Withdrawal by Subject|1|||
163932528|NCT01466790|592121742|FG001|Overall Study|Withdrawal by Subject|1|||
163932529|NCT01466790|592121743|FG002|Overall Study|Withdrawal by Subject|0|||
163932530|NCT01466790|592121744|FG003|Overall Study|Withdrawal by Subject|0|||
163932531|NCT01466790|592121745|FG004|Overall Study|Withdrawal by Subject|1|||
163932532|NCT01466790|592121746|FG005|Overall Study|Withdrawal by Subject|0|||
163932533|NCT01466790|592121747|FG006|Overall Study|Withdrawal by Subject|1|||
163932534|NCT01466790|592121748|FG007|Overall Study|Withdrawal by Subject|1|||
163932535|NCT01310699|592121749|FG000|Overall Study|Patients did not complete tandem.|4|||
163932536|NCT01310699|592121750|FG001|Overall Study|Patients did not complete tandem.|6|||
163932537|NCT02386839|592121751|FG000|Overall Study|Death|1|||
163932538|NCT02386839|592121752|FG001|Overall Study|Death|0|||
163932539|NCT02386839|592121751|FG000|Overall Study|Withdrawal by Subject|9|||
164037141|NCT05109702|592494546|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
163932540|NCT02386839|592121752|FG001|Overall Study|Withdrawal by Subject|10|||
163932541|NCT02386839|592121751|FG000|Overall Study|Lost to Follow-up|4|||
163932542|NCT02386839|592121752|FG001|Overall Study|Lost to Follow-up|4|||
163932543|NCT02386839|592121751|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
163932544|NCT02386839|592121752|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
163932545|NCT02386839|592121751|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
163932546|NCT02386839|592121752|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
163932547|NCT02386839|592121751|FG000|Overall Study|Other (unspecified)|1|||
163932548|NCT02386839|592121752|FG001|Overall Study|Other (unspecified)|0|||
163932549|NCT00926575|592121753|FG000|Overall Study|Adverse Event|1|||
163932550|NCT00926575|592121754|FG001|Overall Study|Adverse Event|1|||
163932551|NCT00926575|592121753|FG000|Overall Study|Death|4|||
163932552|NCT00926575|592121754|FG001|Overall Study|Death|4|||
163932553|NCT00926575|592121753|FG000|Overall Study|Lost to Follow-up|1|||
163932554|NCT00926575|592121754|FG001|Overall Study|Lost to Follow-up|1|||
163932555|NCT00926575|592121753|FG000|Overall Study|Physician Decision|1|||
163932556|NCT00926575|592121754|FG001|Overall Study|Physician Decision|2|||
163932557|NCT00926575|592121753|FG000|Overall Study|Protocol Violation|1|||
163932558|NCT00926575|592121754|FG001|Overall Study|Protocol Violation|0|||
163932559|NCT00926575|592121753|FG000|Overall Study|Withdrawal by Subject|8|||
163932560|NCT00926575|592121754|FG001|Overall Study|Withdrawal by Subject|9|||
163932561|NCT00490698|592121755|FG000|Overall Study|Withdrawal by Subject|1|||
163932562|NCT00490698|592121755|FG000|Overall Study|Disease Progression|7|||
163932563|NCT00490698|592121755|FG000|Overall Study|Physician Decision|2|||
163932564|NCT02101983|592121760|FG000|Overall Study|Physician Decision|1|||
163932565|NCT02101983|592121761|FG001|Overall Study|Physician Decision|0|||
163932566|NCT04124471|592121762|FG000|Overall Study|screen failure|1|||
163932567|NCT04870957|592121763|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163932568|NCT04870957|592121764|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163932569|NCT04870957|592121765|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163932570|NCT04870957|592121766|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163932571|NCT04870957|592121767|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
163932572|NCT04870957|592121768|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
163932573|NCT04870957|592121763|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163932574|NCT04870957|592121764|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163932575|NCT04870957|592121765|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163932576|NCT04870957|592121766|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163932577|NCT04870957|592121767|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
163932578|NCT04870957|592121768|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
163932579|NCT04870957|592121763|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163932580|NCT04870957|592121764|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163932581|NCT04870957|592121765|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163932582|NCT04870957|592121766|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163932583|NCT04870957|592121767|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
163932584|NCT04870957|592121768|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
163932585|NCT04870957|592121763|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163932586|NCT04870957|592121764|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163932587|NCT04870957|592121765|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163932588|NCT04870957|592121766|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163932589|NCT04870957|592121767|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
163932590|NCT04870957|592121768|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
163932591|NCT04870957|592121763|FG000|T2 (Randomization) - T3|Adverse Event|1|||
163932592|NCT04870957|592121764|FG001|T2 (Randomization) - T3|Adverse Event|1|||
163932593|NCT04870957|592121765|FG002|T2 (Randomization) - T3|Adverse Event|0|||
163932594|NCT04870957|592121766|FG003|T2 (Randomization) - T3|Adverse Event|0|||
163932595|NCT04870957|592121767|FG004|T2 (Randomization) - T3|Adverse Event|0|||
163932596|NCT04870957|592121768|FG005|T2 (Randomization) - T3|Adverse Event|0|||
163932597|NCT04870957|592121763|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
163932598|NCT04870957|592121764|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
163932599|NCT04870957|592121765|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
163932600|NCT04870957|592121766|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
163932601|NCT04870957|592121767|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
163932602|NCT04870957|592121768|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
163932603|NCT04870957|592121763|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
163932604|NCT04870957|592121764|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
163932605|NCT04870957|592121765|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
163932606|NCT04870957|592121766|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
163932607|NCT04870957|592121767|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
163932608|NCT04870957|592121768|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
164098494|NCT03897088|592725117|FG001|Overall Study|Withdrawal by Subject|12|||
164098495|NCT03897088|592725116|FG000|Overall Study|Lost to Follow-up|7|||
164098496|NCT03897088|592725117|FG001|Overall Study|Lost to Follow-up|15|||
164098497|NCT03897088|592725116|FG000|Overall Study|Sponsor Decision|1|||
163932609|NCT04870957|592121763|FG000|T2 (Randomization) - T3|Physician Decision|0|||
163932610|NCT04870957|592121764|FG001|T2 (Randomization) - T3|Physician Decision|0|||
163932611|NCT04870957|592121765|FG002|T2 (Randomization) - T3|Physician Decision|2|||
163932612|NCT04870957|592121766|FG003|T2 (Randomization) - T3|Physician Decision|1|||
163838042|NCT02395133|591777741|FG002|Overall Study|Protocol Violation|0|||
163838043|NCT02395133|591777742|FG003|Overall Study|Protocol Violation|3|||
163838044|NCT02395133|591777739|FG000|Overall Study|Lost to Follow-up|0|||
163838045|NCT02395133|591777740|FG001|Overall Study|Lost to Follow-up|1|||
163838046|NCT02395133|591777741|FG002|Overall Study|Lost to Follow-up|1|||
163838047|NCT02395133|591777742|FG003|Overall Study|Lost to Follow-up|0|||
163838048|NCT02395133|591777739|FG000|Overall Study|Pregnancy|0|||
163838049|NCT02395133|591777740|FG001|Overall Study|Pregnancy|0|||
163838050|NCT02395133|591777741|FG002|Overall Study|Pregnancy|3|||
163838051|NCT02395133|591777742|FG003|Overall Study|Pregnancy|0|||
163838052|NCT02395133|591777739|FG000|Overall Study|Consent withdrawn with no reason given|1|||
163838053|NCT02395133|591777740|FG001|Overall Study|Consent withdrawn with no reason given|3|||
163838054|NCT02395133|591777741|FG002|Overall Study|Consent withdrawn with no reason given|0|||
163838055|NCT02395133|591777742|FG003|Overall Study|Consent withdrawn with no reason given|2|||
163838056|NCT02395133|591777739|FG000|Overall Study|Consent withdrawn with personal reason|0|||
163838057|NCT02395133|591777740|FG001|Overall Study|Consent withdrawn with personal reason|1|||
163838058|NCT02395133|591777741|FG002|Overall Study|Consent withdrawn with personal reason|0|||
163838059|NCT02395133|591777742|FG003|Overall Study|Consent withdrawn with personal reason|3|||
163838060|NCT02395133|591777739|FG000|Overall Study|Sponsor decision|2|||
163838061|NCT02395133|591777740|FG001|Overall Study|Sponsor decision|0|||
163838062|NCT02395133|591777741|FG002|Overall Study|Sponsor decision|0|||
163838063|NCT02395133|591777742|FG003|Overall Study|Sponsor decision|1|||
163838064|NCT02395133|591777739|FG000|Overall Study|Other than specified above|5|||
163838065|NCT02395133|591777740|FG001|Overall Study|Other than specified above|2|||
163838066|NCT02395133|591777741|FG002|Overall Study|Other than specified above|2|||
163838067|NCT02395133|591777742|FG003|Overall Study|Other than specified above|4|||
163838068|NCT03573908|591777750|FG000|Treatment Period|Adverse Event|4|||
163838069|NCT03573908|591777751|FG001|Treatment Period|Adverse Event|9|||
163838070|NCT03573908|591777752|FG002|Treatment Period|Adverse Event|0|||
163838071|NCT03573908|591777753|FG003|Treatment Period|Adverse Event|0|||
163838072|NCT03573908|591777754|FG004|Treatment Period|Adverse Event|0|||
163838073|NCT03573908|591777750|FG000|Treatment Period|Protocol Violation|1|||
163838074|NCT03573908|591777751|FG001|Treatment Period|Protocol Violation|0|||
163838075|NCT03573908|591777752|FG002|Treatment Period|Protocol Violation|0|||
163838076|NCT03573908|591777753|FG003|Treatment Period|Protocol Violation|0|||
163838077|NCT03573908|591777754|FG004|Treatment Period|Protocol Violation|0|||
163838078|NCT03573908|591777750|FG000|Treatment Period|Withdrawal by Subject|7|||
163838079|NCT03573908|591777751|FG001|Treatment Period|Withdrawal by Subject|5|||
163838080|NCT03573908|591777752|FG002|Treatment Period|Withdrawal by Subject|0|||
163838081|NCT03573908|591777753|FG003|Treatment Period|Withdrawal by Subject|0|||
163838082|NCT03573908|591777754|FG004|Treatment Period|Withdrawal by Subject|0|||
163838083|NCT03573908|591777750|FG000|Treatment Period|Lost to Follow-up|7|||
163838084|NCT03573908|591777751|FG001|Treatment Period|Lost to Follow-up|6|||
163838085|NCT03573908|591777752|FG002|Treatment Period|Lost to Follow-up|0|||
163838086|NCT03573908|591777753|FG003|Treatment Period|Lost to Follow-up|0|||
163838087|NCT03573908|591777754|FG004|Treatment Period|Lost to Follow-up|0|||
163838088|NCT03573908|591777750|FG000|Treatment Period|Pregnancy|1|||
163838089|NCT03573908|591777751|FG001|Treatment Period|Pregnancy|0|||
163838090|NCT03573908|591777752|FG002|Treatment Period|Pregnancy|0|||
163838091|NCT03573908|591777753|FG003|Treatment Period|Pregnancy|0|||
163838092|NCT03573908|591777754|FG004|Treatment Period|Pregnancy|0|||
163838093|NCT03573908|591777750|FG000|Treatment Period|Other, Not Specified|4|||
163838094|NCT03573908|591777751|FG001|Treatment Period|Other, Not Specified|6|||
163838095|NCT03573908|591777752|FG002|Treatment Period|Other, Not Specified|0|||
163838096|NCT03573908|591777753|FG003|Treatment Period|Other, Not Specified|0|||
163838097|NCT03573908|591777754|FG004|Treatment Period|Other, Not Specified|0|||
163838098|NCT03573908|591777750|FG000|Randomized Withdrawal Period|Adverse Event|0|||
163838099|NCT03573908|591777751|FG001|Randomized Withdrawal Period|Adverse Event|0|||
163838100|NCT03573908|591777752|FG002|Randomized Withdrawal Period|Adverse Event|3|||
163838101|NCT03573908|591777753|FG003|Randomized Withdrawal Period|Adverse Event|0|||
163838102|NCT03573908|591777754|FG004|Randomized Withdrawal Period|Adverse Event|0|||
163838103|NCT03573908|591777750|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163838104|NCT03573908|591777751|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163838105|NCT03573908|591777752|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163838106|NCT03573908|591777753|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
163838107|NCT03573908|591777754|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
163838108|NCT03573908|591777750|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
163838109|NCT03573908|591777751|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
163838110|NCT03573908|591777752|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
163838111|NCT03573908|591777753|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
163838112|NCT03573908|591777754|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
163838113|NCT03573908|591777750|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
163838114|NCT03573908|591777751|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
163838115|NCT03573908|591777752|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
163932613|NCT04870957|592121767|FG004|T2 (Randomization) - T3|Physician Decision|0|||
163932614|NCT04870957|592121768|FG005|T2 (Randomization) - T3|Physician Decision|0|||
163932615|NCT04870957|592121763|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
163932616|NCT04870957|592121764|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
163932617|NCT04870957|592121765|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
163932618|NCT04870957|592121766|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
163932619|NCT04870957|592121767|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
163932620|NCT04870957|592121768|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
163932621|NCT04870957|592121763|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
163932622|NCT04870957|592121764|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
163932623|NCT04870957|592121765|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
163932624|NCT04870957|592121766|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
163932625|NCT04870957|592121767|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
163932626|NCT04870957|592121768|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
163932627|NCT04870957|592121763|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
163932628|NCT04870957|592121764|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
163932629|NCT04870957|592121765|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
163932630|NCT04870957|592121766|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
163932631|NCT04870957|592121767|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
163932632|NCT04870957|592121768|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
163932633|NCT04870957|592121763|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
163932634|NCT04870957|592121764|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
163932635|NCT04870957|592121765|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
163932636|NCT04870957|592121766|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
163932637|NCT04870957|592121767|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
163932638|NCT04870957|592121768|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
163932639|NCT04870957|592121763|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
164037142|NCT05109702|592494547|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
163838116|NCT03573908|591777753|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
163838117|NCT03573908|591777754|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
163838118|NCT04006925|591777755|FG000|Overall Study|Side effects|2|||
163838119|NCT04006925|591777756|FG001|Overall Study|Side effects|0|||
163838120|NCT02669095|591777757|FG000|Overall Study|Adverse Event|1|||
163838121|NCT02669095|591777758|FG001|Overall Study|Adverse Event|0|||
163838122|NCT02669095|591777757|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
163838123|NCT02669095|591777758|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
163838124|NCT02669095|591777757|FG000|Overall Study|Torn Lens|0|||
163838125|NCT02669095|591777758|FG001|Overall Study|Torn Lens|1|||
163838126|NCT02669095|591777757|FG000|Overall Study|Visit 5 assessments not completed|0|||
163838127|NCT02669095|591777758|FG001|Overall Study|Visit 5 assessments not completed|1|||
163838128|NCT00738101|591777760|FG000|Overall Study|Physician Decision|5|||
163838129|NCT00738101|591777760|FG000|Overall Study|Death|1|||
163838130|NCT00738101|591777760|FG000|Overall Study|Repeat enrollment|1|||
163838131|NCT01396317|591777762|FG000|Overall Study|Adverse Event|1|||
163838132|NCT01396317|591777763|FG001|Overall Study|Adverse Event|0|||
163838133|NCT02906683|591779580|FG000|Overall Study|Adverse Event|0|||
163838134|NCT02906683|591779581|FG001|Overall Study|Adverse Event|1|||
163838135|NCT02906683|591779582|FG002|Overall Study|Adverse Event|0|||
163838136|NCT02906683|591779580|FG000|Overall Study|Physician Decision|0|||
163838137|NCT02906683|591779581|FG001|Overall Study|Physician Decision|1|||
163838138|NCT02906683|591779582|FG002|Overall Study|Physician Decision|1|||
163838139|NCT02906683|591779580|FG000|Overall Study|Withdrawal by Subject|0|||
163838140|NCT02906683|591779581|FG001|Overall Study|Withdrawal by Subject|2|||
163838141|NCT02906683|591779582|FG002|Overall Study|Withdrawal by Subject|1|||
163838142|NCT02906683|591779580|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
163838143|NCT02906683|591779581|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
163838144|NCT02906683|591779582|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
163838145|NCT02906683|591779580|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
163932640|NCT04870957|592121764|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
163932641|NCT04870957|592121765|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
163932642|NCT04870957|592121766|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
163932643|NCT04870957|592121767|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
163932644|NCT04870957|592121768|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
163932645|NCT04870957|592121763|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
163932646|NCT04870957|592121764|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
163932647|NCT04870957|592121765|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
163932648|NCT04870957|592121766|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
163838146|NCT02906683|591779581|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
163838147|NCT02906683|591779582|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
163838148|NCT01158378|591779583|FG000|Overall Study|Death|4|||
163838149|NCT01158378|591779584|FG001|Overall Study|Death|5|||
163838150|NCT01158378|591779583|FG000|Overall Study|Lost to Follow-up|2|||
163838151|NCT01158378|591779584|FG001|Overall Study|Lost to Follow-up|4|||
163838152|NCT01158378|591779583|FG000|Overall Study|Withdrawal by Subject|4|||
163838153|NCT01158378|591779584|FG001|Overall Study|Withdrawal by Subject|0|||
163838154|NCT02531295|591779589|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
163838155|NCT02531295|591779590|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
163838156|NCT02531295|591779591|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
163838157|NCT02531295|591779592|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
163838158|NCT02531295|591779593|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
163838159|NCT02531295|591779594|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
163838160|NCT00453310|591779595|FG000|Overall Study|Progression of Disease|10|||
163838161|NCT01806740|591779596|FG000|Overall Study|Withdrawal by Subject|4|||
163838162|NCT01806740|591779596|FG000|Overall Study|Physician Decision|1|||
163838163|NCT01806740|591779596|FG000|Overall Study|Patient's refusal of treatment|1|||
163838164|NCT04666922|591779597|FG000|Overall Study|Withdrawal by Subject|1|||
163838165|NCT04666922|591779598|FG001|Overall Study|Withdrawal by Subject|0|||
163838166|NCT04666922|591779599|FG002|Overall Study|Withdrawal by Subject|0|||
163838167|NCT04666922|591779600|FG003|Overall Study|Withdrawal by Subject|0|||
163838168|NCT04666922|591779601|FG004|Overall Study|Withdrawal by Subject|0|||
163838169|NCT04666922|591779602|FG005|Overall Study|Withdrawal by Subject|0|||
163838170|NCT04666922|591779603|FG006|Overall Study|Withdrawal by Subject|0|||
163838171|NCT04651114|591779604|FG000|Overall Study|Withdrawal by Subject|8|||
163838172|NCT03661996|591779605|FG000|Overall Study|Adverse Event|0|||
163838173|NCT03661996|591779606|FG001|Overall Study|Adverse Event|0|||
163838174|NCT03661996|591779607|FG002|Overall Study|Adverse Event|1|||
163838175|NCT03661996|591779608|FG003|Overall Study|Adverse Event|1|||
163838176|NCT03661996|591779609|FG004|Overall Study|Adverse Event|0|||
163838177|NCT03661996|591779605|FG000|Overall Study|Lost to Follow-up|5|||
163838178|NCT03661996|591779606|FG001|Overall Study|Lost to Follow-up|1|||
163838179|NCT03661996|591779607|FG002|Overall Study|Lost to Follow-up|2|||
163838180|NCT03661996|591779608|FG003|Overall Study|Lost to Follow-up|2|||
163838181|NCT03661996|591779609|FG004|Overall Study|Lost to Follow-up|6|||
163838182|NCT03661996|591779605|FG000|Overall Study|Physician Decision|1|||
163838183|NCT03661996|591779606|FG001|Overall Study|Physician Decision|1|||
163838184|NCT03661996|591779607|FG002|Overall Study|Physician Decision|1|||
163838185|NCT03661996|591779608|FG003|Overall Study|Physician Decision|2|||
163838186|NCT03661996|591779609|FG004|Overall Study|Physician Decision|0|||
163838187|NCT03661996|591779605|FG000|Overall Study|Protocol Violation|0|||
163838188|NCT03661996|591779606|FG001|Overall Study|Protocol Violation|0|||
163838189|NCT03661996|591779607|FG002|Overall Study|Protocol Violation|0|||
163838190|NCT03661996|591779608|FG003|Overall Study|Protocol Violation|0|||
163838191|NCT03661996|591779609|FG004|Overall Study|Protocol Violation|1|||
163838192|NCT03661996|591779605|FG000|Overall Study|Withdrawal by Subject|3|||
163838193|NCT03661996|591779606|FG001|Overall Study|Withdrawal by Subject|5|||
163838194|NCT03661996|591779607|FG002|Overall Study|Withdrawal by Subject|1|||
163838195|NCT03661996|591779608|FG003|Overall Study|Withdrawal by Subject|7|||
163838196|NCT03661996|591779609|FG004|Overall Study|Withdrawal by Subject|7|||
163838197|NCT03661996|591779605|FG000|Overall Study|Sponsors Decision|2|||
163838198|NCT03661996|591779606|FG001|Overall Study|Sponsors Decision|0|||
163838199|NCT03661996|591779607|FG002|Overall Study|Sponsors Decision|0|||
163838200|NCT03661996|591779608|FG003|Overall Study|Sponsors Decision|0|||
163838201|NCT03661996|591779609|FG004|Overall Study|Sponsors Decision|0|||
163838202|NCT03661996|591779605|FG000|Overall Study|Other|1|||
163838203|NCT03661996|591779606|FG001|Overall Study|Other|1|||
163838204|NCT03661996|591779607|FG002|Overall Study|Other|1|||
163838205|NCT03661996|591779608|FG003|Overall Study|Other|1|||
163838206|NCT03661996|591779609|FG004|Overall Study|Other|0|||
163838207|NCT01161472|591779610|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
163838208|NCT01161472|591779611|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
163838209|NCT01161472|591779612|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
163838210|NCT01161472|591779613|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
163838211|NCT03980184|591779616|FG000|Overall Study|Dropped out before treatment|2|||
163838212|NCT03980184|591779617|FG001|Overall Study|Dropped out before treatment|2|||
163838213|NCT03980184|591779616|FG000|Overall Study|Lost to Follow-up|11|||
163838214|NCT03980184|591779617|FG001|Overall Study|Lost to Follow-up|13|||
163838215|NCT02176421|591779618|FG000|Overall Study|Lost to Follow-up|4|||
163838216|NCT02176421|591779618|FG000|Overall Study|Adverse Event|1|||
163838217|NCT01965158|591779622|FG000|Overall Study|Adverse Event|14|||
163838218|NCT01965158|591779623|FG001|Overall Study|Adverse Event|5|||
163838219|NCT01965158|591779622|FG000|Overall Study|Withdrawal by Subject|16|||
163838220|NCT01965158|591779623|FG001|Overall Study|Withdrawal by Subject|24|||
163838221|NCT01965158|591779622|FG000|Overall Study|Lost to Follow-up|7|||
163838222|NCT01965158|591779623|FG001|Overall Study|Lost to Follow-up|5|||
163838223|NCT01965158|591779622|FG000|Overall Study|Protocol Violation|1|||
163838224|NCT01965158|591779623|FG001|Overall Study|Protocol Violation|1|||
163838225|NCT01965158|591779622|FG000|Overall Study|Other - Miscellaneous|3|||
163838226|NCT01965158|591779623|FG001|Overall Study|Other - Miscellaneous|0|||
163932649|NCT04870957|592121767|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
163932650|NCT04870957|592121768|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
163932651|NCT04870957|592121763|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163932652|NCT04870957|592121764|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163932653|NCT04870957|592121765|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163932654|NCT04870957|592121766|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163932655|NCT04870957|592121767|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
163932656|NCT04870957|592121768|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
163932657|NCT04870957|592121763|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163932658|NCT04870957|592121764|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163932659|NCT04870957|592121765|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163932660|NCT04870957|592121766|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163932661|NCT04870957|592121767|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
163932662|NCT04870957|592121768|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
163932663|NCT04870957|592121763|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
163932664|NCT04870957|592121764|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
163932665|NCT04870957|592121765|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
163932666|NCT04870957|592121766|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
163932667|NCT04870957|592121767|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
163932668|NCT04870957|592121768|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
163932669|NCT05970640|592121769|FG000|Overall Study|Adverse Event|1|||
163932670|NCT05970640|592121770|FG001|Overall Study|Adverse Event|3|||
163932671|NCT05970640|592121771|FG002|Overall Study|Adverse Event|1|||
163932672|NCT05970640|592121772|FG003|Overall Study|Adverse Event|0|||
163932673|NCT05970640|592121769|FG000|Overall Study|Withdrawal by Subject|0|||
163932674|NCT05970640|592121770|FG001|Overall Study|Withdrawal by Subject|0|||
163932675|NCT05970640|592121771|FG002|Overall Study|Withdrawal by Subject|1|||
163932676|NCT05970640|592121772|FG003|Overall Study|Withdrawal by Subject|1|||
163932677|NCT05970640|592121769|FG000|Overall Study|Sponsor decision|0|||
163932678|NCT05970640|592121770|FG001|Overall Study|Sponsor decision|0|||
163932679|NCT05970640|592121771|FG002|Overall Study|Sponsor decision|1|||
163932680|NCT05970640|592121772|FG003|Overall Study|Sponsor decision|1|||
163932681|NCT02394925|592121773|FG000|Overall Study|Adverse Event|1|||
163932682|NCT02394925|592121773|FG000|Overall Study|Lens Discomfort|3|||
163932683|NCT02394925|592121773|FG000|Overall Study|Lens handling difficulities|5|||
163932684|NCT02394925|592121773|FG000|Overall Study|Lost to Follow-up|9|||
164037143|NCT05109702|592494545|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
164037144|NCT05109702|592494546|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
164037145|NCT05109702|592494547|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
164037146|NCT00788697|592494548|FG000|Overall Study|No study drug administered|12|||
164037147|NCT00788697|592494548|FG000|Overall Study|Training Patients|74|||
164037148|NCT00788697|592494548|FG000|Overall Study|no truth standard procedure available|5|||
164037149|NCT00788697|592494548|FG000|Overall Study|Technically inadequate truth standard|1|||
164037150|NCT00788697|592494548|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
164037151|NCT00903370|592494551|FG000|Overall Study|Death|13|||
164037152|NCT00903370|592494552|FG001|Overall Study|Death|10|||
164037153|NCT00903370|592494551|FG000|Overall Study|Withdrawal by Subject|9|||
164037154|NCT00903370|592494552|FG001|Overall Study|Withdrawal by Subject|6|||
164037155|NCT00903370|592494551|FG000|Overall Study|Lost to Follow-up|6|||
164037156|NCT00903370|592494552|FG001|Overall Study|Lost to Follow-up|8|||
164037157|NCT00367432|592494553|FG000|First Period (16 Weeks)|Adverse Event|6|||
164037158|NCT00367432|592494554|FG001|First Period (16 Weeks)|Adverse Event|0|||
164037159|NCT00367432|592494553|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
164037160|NCT00367432|592494554|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
164037161|NCT00367432|592494553|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
164037162|NCT00367432|592494554|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
164037163|NCT00367432|592494553|FG000|First Period (16 Weeks)|Other Reason|2|||
164037164|NCT00367432|592494554|FG001|First Period (16 Weeks)|Other Reason|0|||
163932685|NCT02394925|592121773|FG000|Overall Study|Protocol Violation|5|||
163932686|NCT02394925|592121773|FG000|Overall Study|No longer meet eligibility criteria|1|||
163932687|NCT02394925|592121773|FG000|Overall Study|Unsatisfactory Visual Response|5|||
163932688|NCT04340843|592121779|FG000|Overall Study|Adverse Event|0|||
163932689|NCT04340843|592121780|FG001|Overall Study|Adverse Event|2|||
163932690|NCT04340843|592121779|FG000|Overall Study|Withdrawal by Subject|0|||
163932691|NCT04340843|592121780|FG001|Overall Study|Withdrawal by Subject|2|||
163932692|NCT03733899|592121783|FG000|Period 1|Protocol Violation|0|||
163932693|NCT03733899|592121784|FG001|Period 1|Protocol Violation|0|||
163932694|NCT03733899|592121785|FG002|Period 1|Protocol Violation|0|||
163932695|NCT03733899|592121786|FG003|Period 1|Protocol Violation|0|||
163932696|NCT03733899|592121787|FG004|Period 1|Protocol Violation|0|||
163932697|NCT03733899|592121788|FG005|Period 1|Protocol Violation|1|||
163932698|NCT03733899|592121783|FG000|Period 2|Unscuccessful Treatment|0|||
163932699|NCT03733899|592121784|FG001|Period 2|Unscuccessful Treatment|1|||
163932700|NCT03733899|592121785|FG002|Period 2|Unscuccessful Treatment|0|||
164037165|NCT00367432|592494553|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
164037166|NCT00367432|592494554|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
163932701|NCT03733899|592121786|FG003|Period 2|Unscuccessful Treatment|0|||
163932702|NCT03733899|592121787|FG004|Period 2|Unscuccessful Treatment|0|||
163932703|NCT03733899|592121788|FG005|Period 2|Unscuccessful Treatment|0|||
163932704|NCT03733899|592121783|FG000|Period 3|Withdrawal by Subject|1|||
163932705|NCT03733899|592121784|FG001|Period 3|Withdrawal by Subject|0|||
163932706|NCT03733899|592121785|FG002|Period 3|Withdrawal by Subject|0|||
163932707|NCT03733899|592121786|FG003|Period 3|Withdrawal by Subject|0|||
163932708|NCT03733899|592121787|FG004|Period 3|Withdrawal by Subject|0|||
163932709|NCT03733899|592121788|FG005|Period 3|Withdrawal by Subject|0|||
163932710|NCT04650698|592123416|FG000|Overall Study|Protocol Violation|2|||
163932711|NCT04650698|592123417|FG001|Overall Study|Protocol Violation|1|||
163932712|NCT04650698|592123416|FG000|Overall Study|Withdrawal by Subject|0|||
163932713|NCT04650698|592123417|FG001|Overall Study|Withdrawal by Subject|1|||
163932714|NCT02358668|592123418|FG000|Overall Study|Adverse Event|2|||
163932715|NCT02358668|592123419|FG001|Overall Study|Adverse Event|0|||
163932716|NCT02358668|592123420|FG002|Overall Study|Adverse Event|0|||
163932717|NCT02358668|592123418|FG000|Overall Study|Withdrawal by Subject|0|||
163932718|NCT02358668|592123419|FG001|Overall Study|Withdrawal by Subject|1|||
163932719|NCT02358668|592123420|FG002|Overall Study|Withdrawal by Subject|0|||
163932720|NCT02104505|592123421|FG000|First Intervention (14 Days)|Adverse Event|2|||
163932721|NCT02104505|592123422|FG001|First Intervention (14 Days)|Adverse Event|0|||
163932722|NCT02104505|592123421|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
163932723|NCT02104505|592123422|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
163932724|NCT02104505|592123421|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
163932725|NCT02104505|592123422|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
163932726|NCT02104505|592123421|FG000|First Intervention (14 Days)|exclusionary condition|0|||
163932727|NCT02104505|592123422|FG001|First Intervention (14 Days)|exclusionary condition|1|||
163932728|NCT02104505|592123421|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
163932729|NCT02104505|592123422|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
163932730|NCT02104505|592123421|FG000|Second Intervention (14 Days)|Adverse Event|2|||
163932731|NCT02104505|592123422|FG001|Second Intervention (14 Days)|Adverse Event|0|||
163932732|NCT02859064|592123423|FG000|Overall Study|Progressive Disease|3|||
163932733|NCT02859064|592123423|FG000|Overall Study|Physician Decision|1|||
163932734|NCT02859064|592123423|FG000|Overall Study|Withdrawal by Subject|1|||
163932735|NCT02859064|592123423|FG000|Overall Study|Death|1|||
163932736|NCT01730950|592123426|FG000|Overall Study|Protocol Violation|6|||
163932737|NCT01730950|592123427|FG001|Overall Study|Protocol Violation|6|||
163932738|NCT02737826|592123428|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
163932739|NCT02737826|592123429|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
163932740|NCT02737826|592123430|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
163932741|NCT02568397|592123431|FG000|Period 2|Withdrawal by Subject|0|||
163932742|NCT02568397|592123432|FG001|Period 2|Withdrawal by Subject|1|||
163932743|NCT02568397|592123431|FG000|Period 2|Physician Decision|0|||
163932744|NCT02568397|592123432|FG001|Period 2|Physician Decision|1|||
163932745|NCT00078377|592123433|FG000|Overall Study|Adverse Event|2|||
163932746|NCT00078377|592123434|FG001|Overall Study|Adverse Event|5|||
163932747|NCT00078377|592123435|FG002|Overall Study|Adverse Event|1|||
163932748|NCT00078377|592123433|FG000|Overall Study|Lack of Efficacy|2|||
163932749|NCT00078377|592123434|FG001|Overall Study|Lack of Efficacy|0|||
163932750|NCT00078377|592123435|FG002|Overall Study|Lack of Efficacy|2|||
163932751|NCT00078377|592123433|FG000|Overall Study|Lost to Follow-up|0|||
163932752|NCT00078377|592123434|FG001|Overall Study|Lost to Follow-up|1|||
164037167|NCT00367432|592494553|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
164037168|NCT00367432|592494554|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
164037169|NCT00367432|592494553|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
164037170|NCT00367432|592494554|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
164037171|NCT00367432|592494553|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
164037172|NCT00367432|592494554|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
163932753|NCT00078377|592123435|FG002|Overall Study|Lost to Follow-up|1|||
163932754|NCT00078377|592123433|FG000|Overall Study|Physician Decision|2|||
163932755|NCT00078377|592123434|FG001|Overall Study|Physician Decision|0|||
163932756|NCT00078377|592123435|FG002|Overall Study|Physician Decision|0|||
164037173|NCT00367432|592494553|FG000|Second Period (up to 54 Months)|Other Reason|6|||
164037174|NCT00367432|592494554|FG001|Second Period (up to 54 Months)|Other Reason|2|||
163932757|NCT00078377|592123433|FG000|Overall Study|Withdrawal by Subject|3|||
163932758|NCT00078377|592123434|FG001|Overall Study|Withdrawal by Subject|4|||
163932759|NCT00078377|592123435|FG002|Overall Study|Withdrawal by Subject|4|||
163932760|NCT00078377|592123433|FG000|Overall Study|Miscellaneous|2|||
163932761|NCT00078377|592123434|FG001|Overall Study|Miscellaneous|6|||
163932762|NCT00078377|592123435|FG002|Overall Study|Miscellaneous|1|||
163932763|NCT02354651|592123436|FG000|Overall Study|Withdrawal by Subject|2|||
163932764|NCT02354651|592123436|FG000|Overall Study|Physician Decision|1|||
163932765|NCT01317875|592123437|FG000|Overall Study|Other|0|||
163932766|NCT01317875|592123438|FG001|Overall Study|Other|0|||
163932767|NCT01317875|592123439|FG002|Overall Study|Other|1|||
163932768|NCT01317875|592123440|FG003|Overall Study|Other|0|||
163932769|NCT01317875|592123441|FG004|Overall Study|Other|0|||
163932770|NCT01317875|592123442|FG005|Overall Study|Other|0|||
163932771|NCT01317875|592123443|FG006|Overall Study|Other|0|||
163932772|NCT01317875|592123444|FG007|Overall Study|Other|0|||
163932773|NCT01317875|592123445|FG008|Overall Study|Other|0|||
163932774|NCT01317875|592123446|FG009|Overall Study|Other|0|||
163932775|NCT01317875|592123437|FG000|Overall Study|Noncompliance with study drug|0|||
163932776|NCT01317875|592123438|FG001|Overall Study|Noncompliance with study drug|0|||
163932777|NCT01317875|592123439|FG002|Overall Study|Noncompliance with study drug|1|||
163932778|NCT01317875|592123440|FG003|Overall Study|Noncompliance with study drug|0|||
163932779|NCT01317875|592123441|FG004|Overall Study|Noncompliance with study drug|0|||
163932780|NCT01317875|592123442|FG005|Overall Study|Noncompliance with study drug|0|||
163932781|NCT01317875|592123443|FG006|Overall Study|Noncompliance with study drug|0|||
163932782|NCT01317875|592123444|FG007|Overall Study|Noncompliance with study drug|0|||
163932783|NCT01317875|592123445|FG008|Overall Study|Noncompliance with study drug|0|||
163932784|NCT01317875|592123446|FG009|Overall Study|Noncompliance with study drug|0|||
163932785|NCT01317875|592123437|FG000|Overall Study|Progressive Disease|1|||
163932786|NCT01317875|592123438|FG001|Overall Study|Progressive Disease|0|||
163932787|NCT01317875|592123439|FG002|Overall Study|Progressive Disease|2|||
163932788|NCT01317875|592123440|FG003|Overall Study|Progressive Disease|0|||
163932789|NCT01317875|592123441|FG004|Overall Study|Progressive Disease|1|||
163932790|NCT01317875|592123442|FG005|Overall Study|Progressive Disease|0|||
163932791|NCT01317875|592123443|FG006|Overall Study|Progressive Disease|0|||
163932792|NCT01317875|592123444|FG007|Overall Study|Progressive Disease|1|||
163932793|NCT01317875|592123445|FG008|Overall Study|Progressive Disease|0|||
163932794|NCT01317875|592123446|FG009|Overall Study|Progressive Disease|0|||
163932795|NCT01317875|592123437|FG000|Overall Study|Withdrawal by Subject|0|||
163932796|NCT01317875|592123438|FG001|Overall Study|Withdrawal by Subject|0|||
163932797|NCT01317875|592123439|FG002|Overall Study|Withdrawal by Subject|0|||
163932798|NCT01317875|592123440|FG003|Overall Study|Withdrawal by Subject|0|||
163932799|NCT01317875|592123441|FG004|Overall Study|Withdrawal by Subject|1|||
163932800|NCT01317875|592123442|FG005|Overall Study|Withdrawal by Subject|0|||
163932801|NCT01317875|592123443|FG006|Overall Study|Withdrawal by Subject|0|||
163932802|NCT01317875|592123444|FG007|Overall Study|Withdrawal by Subject|3|||
163932803|NCT01317875|592123445|FG008|Overall Study|Withdrawal by Subject|0|||
163932804|NCT01317875|592123446|FG009|Overall Study|Withdrawal by Subject|0|||
163932805|NCT01317875|592123437|FG000|Overall Study|Physician Decision|0|||
163932806|NCT01317875|592123438|FG001|Overall Study|Physician Decision|1|||
163932807|NCT01317875|592123439|FG002|Overall Study|Physician Decision|1|||
163932808|NCT01317875|592123440|FG003|Overall Study|Physician Decision|0|||
163932809|NCT01317875|592123441|FG004|Overall Study|Physician Decision|2|||
163932810|NCT01317875|592123442|FG005|Overall Study|Physician Decision|0|||
163932811|NCT01317875|592123443|FG006|Overall Study|Physician Decision|0|||
163932812|NCT01317875|592123444|FG007|Overall Study|Physician Decision|2|||
163932813|NCT01317875|592123445|FG008|Overall Study|Physician Decision|0|||
163932814|NCT01317875|592123446|FG009|Overall Study|Physician Decision|0|||
163932815|NCT01317875|592123437|FG000|Overall Study|Death|0|||
163932816|NCT01317875|592123438|FG001|Overall Study|Death|0|||
163932817|NCT01317875|592123439|FG002|Overall Study|Death|2|||
163932818|NCT01317875|592123440|FG003|Overall Study|Death|1|||
163932819|NCT01317875|592123441|FG004|Overall Study|Death|0|||
163932820|NCT01317875|592123442|FG005|Overall Study|Death|1|||
163932821|NCT01317875|592123443|FG006|Overall Study|Death|0|||
163932822|NCT01317875|592123444|FG007|Overall Study|Death|4|||
163932823|NCT01317875|592123445|FG008|Overall Study|Death|0|||
163932824|NCT01317875|592123446|FG009|Overall Study|Death|0|||
163932825|NCT01317875|592123437|FG000|Overall Study|Adverse Event|2|||
163932826|NCT01317875|592123438|FG001|Overall Study|Adverse Event|1|||
163932827|NCT01317875|592123439|FG002|Overall Study|Adverse Event|2|||
163932828|NCT01317875|592123440|FG003|Overall Study|Adverse Event|1|||
163932829|NCT01317875|592123441|FG004|Overall Study|Adverse Event|5|||
163932830|NCT01317875|592123442|FG005|Overall Study|Adverse Event|1|||
163932831|NCT01317875|592123443|FG006|Overall Study|Adverse Event|2|||
163932832|NCT01317875|592123444|FG007|Overall Study|Adverse Event|5|||
164037175|NCT00014911|592494555|FG000|Overall Study|Adverse Event|1|||
164037176|NCT00014911|592494555|FG000|Overall Study|Lost to Follow-up|1|||
164037177|NCT00014911|592494555|FG000|Overall Study|Withdrawal by Subject|6|||
164037178|NCT00014911|592494555|FG000|Overall Study|Unknown Reasons|2|||
164037179|NCT00014911|592494555|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
164073172|NCT01347879|592632837|FG001|Overall Study|Withdrawal by Subject|2|||
163932833|NCT01317875|592123445|FG008|Overall Study|Adverse Event|0|||
163932834|NCT01317875|592123446|FG009|Overall Study|Adverse Event|0|||
163932835|NCT00581893|592123447|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
163932836|NCT00581893|592123448|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
163932837|NCT01381575|592123449|FG000|Overall Study|Serious Adverse Event|1|||
163932838|NCT01381575|592123450|FG001|Overall Study|Serious Adverse Event|0|||
163932839|NCT01381575|592123451|FG002|Overall Study|Serious Adverse Event|0|||
163932840|NCT01381575|592123449|FG000|Overall Study|Non-Serious Adverse Event|0|||
163932841|NCT01381575|592123450|FG001|Overall Study|Non-Serious Adverse Event|0|||
163932842|NCT01381575|592123451|FG002|Overall Study|Non-Serious Adverse Event|1|||
163932843|NCT01381575|592123449|FG000|Overall Study|Protocol Violation|0|||
163932844|NCT01381575|592123450|FG001|Overall Study|Protocol Violation|1|||
163932845|NCT01381575|592123451|FG002|Overall Study|Protocol Violation|1|||
163932846|NCT01381575|592123449|FG000|Overall Study|Withdrawal by Subject|15|||
163932847|NCT01381575|592123450|FG001|Overall Study|Withdrawal by Subject|9|||
163932848|NCT01381575|592123451|FG002|Overall Study|Withdrawal by Subject|7|||
163932849|NCT01381575|592123449|FG000|Overall Study|Migrated/moved from study area|2|||
163932850|NCT01381575|592123450|FG001|Overall Study|Migrated/moved from study area|12|||
163932851|NCT01381575|592123451|FG002|Overall Study|Migrated/moved from study area|2|||
163932852|NCT01381575|592123449|FG000|Overall Study|Lost to Follow-up|8|||
163932853|NCT01381575|592123450|FG001|Overall Study|Lost to Follow-up|17|||
163932854|NCT01381575|592123451|FG002|Overall Study|Lost to Follow-up|9|||
163932855|NCT01377389|592123452|FG000|Overall Study|Withdrawal by Subject|1|||
163932856|NCT01377389|592123452|FG000|Overall Study|Screen failure|2|||
163932857|NCT04090528|592123453|FG000|Overall Study|participants still on study|9|||
163932858|NCT04090528|592123454|FG001|Overall Study|participants still on study|13|||
163932859|NCT03020069|592123455|FG000|Overall Study|Lost to Follow-up|0|||
163932860|NCT03020069|592123456|FG001|Overall Study|Lost to Follow-up|1|||
163932861|NCT02684123|592123459|FG000|Phase 1|Lack of Efficacy|5|||
163932862|NCT02684123|592123460|FG001|Phase 1|Lack of Efficacy|0|||
163932863|NCT02684123|592123459|FG000|Phase 1|Adverse Event|3|||
163932864|NCT02684123|592123460|FG001|Phase 1|Adverse Event|0|||
163932865|NCT02684123|592123459|FG000|Phase 1|Lost to Follow-up|0|||
163932866|NCT02684123|592123460|FG001|Phase 1|Lost to Follow-up|1|||
163932867|NCT02684123|592123459|FG000|Phase 2|Lack of Efficacy|1|||
163932868|NCT02684123|592123460|FG001|Phase 2|Lack of Efficacy|8|||
163932869|NCT01920932|592123462|FG000|Overall Study|Death|1|||
163932870|NCT01920932|592123462|FG000|Overall Study|Withdrawal of consent|1|||
163932871|NCT05274750|592123464|FG000|Overall Study|Adverse Event|0|||
163932872|NCT05274750|592123465|FG001|Overall Study|Adverse Event|1|||
163932873|NCT05274750|592123464|FG000|Overall Study|Lost to Follow-up|2|||
163932874|NCT05274750|592123465|FG001|Overall Study|Lost to Follow-up|3|||
163932875|NCT05274750|592123464|FG000|Overall Study|Physician Decision|3|||
163932876|NCT05274750|592123465|FG001|Overall Study|Physician Decision|0|||
163932877|NCT05274750|592123464|FG000|Overall Study|Withdrawal by Subject|10|||
163932878|NCT05274750|592123465|FG001|Overall Study|Withdrawal by Subject|9|||
163932879|NCT05274750|592123464|FG000|Overall Study|GCP Violation|0|||
163932880|NCT05274750|592123465|FG001|Overall Study|GCP Violation|4|||
163932881|NCT05274750|592123464|FG000|Overall Study|Randomized, not treated|0|||
163932882|NCT05274750|592123465|FG001|Overall Study|Randomized, not treated|1|||
163932883|NCT04340947|592123470|FG000|7-day Washout Period|Lost to Follow-up|5|||
163932884|NCT04340947|592123471|FG001|7-day Washout Period|Lost to Follow-up|4|||
163932885|NCT01437423|592123477|FG000|Overall Study|Lost to Follow-up|12|||
163932886|NCT01437423|592123477|FG000|Overall Study|Off label usage|3|||
163932887|NCT01375751|592123478|FG000|Overall Study|Other|0|||
163932888|NCT01375751|592123479|FG001|Overall Study|Other|1|||
163932889|NCT01375751|592123480|FG002|Overall Study|Other|0|||
163932890|NCT00633945|592123481|FG000|Overall Study|Physician Decision|2|||
163932891|NCT00882115|592123482|FG000|Overall Study|Withdrawal by Subject|3|||
163932892|NCT00882115|592123482|FG000|Overall Study|did not respond to DEP challe|6|||
163932893|NCT02552147|592123483|FG000|First Intervention (7 Days)|Protocol Violation|1|||
163932894|NCT02552147|592123484|FG001|First Intervention (7 Days)|Protocol Violation|0|||
163932895|NCT02552147|592123483|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
163932896|NCT02552147|592123484|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
163932897|NCT00940875|592123485|FG000|Treatment Phase|Adverse Event|9|||
163932898|NCT00940875|592123486|FG001|Treatment Phase|Adverse Event|3|||
163932899|NCT00940875|592123485|FG000|Treatment Phase|Death|3|||
163932900|NCT00940875|592123486|FG001|Treatment Phase|Death|5|||
163932901|NCT00940875|592123485|FG000|Treatment Phase|Lack of Efficacy|1|||
163932902|NCT00940875|592123486|FG001|Treatment Phase|Lack of Efficacy|0|||
163932903|NCT00940875|592123485|FG000|Treatment Phase|Withdrawal by Subject|3|||
163932904|NCT00940875|592123486|FG001|Treatment Phase|Withdrawal by Subject|0|||
163932905|NCT00940875|592123485|FG000|Treatment Phase|Disease progression|9|||
163932906|NCT00940875|592123486|FG001|Treatment Phase|Disease progression|11|||
163932907|NCT00940875|592123485|FG000|Treatment Phase|Physician Decision|1|||
164037180|NCT04209530|592496644|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
164037181|NCT04209530|592496645|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
164037182|NCT04209530|592496644|FG000|Overall Study|Withdrawal by Subject|0|||
164037183|NCT04209530|592496645|FG001|Overall Study|Withdrawal by Subject|1|||
164037184|NCT01100658|592496646|FG000|Overall Study|Withdrawal by Subject|1|||
164037185|NCT01094808|592496647|FG000|Overall Study|Withdrawal by Subject|1|||
163932908|NCT00940875|592123486|FG001|Treatment Phase|Physician Decision|0|||
163932909|NCT00940875|592123485|FG000|Post-Study Treatment|Death|0|||
163932910|NCT00940875|592123486|FG001|Post-Study Treatment|Death|1|||
163932911|NCT00940875|592123485|FG000|Post-Study Treatment|Disease Progression|0|||
163932912|NCT00940875|592123486|FG001|Post-Study Treatment|Disease Progression|2|||
163932913|NCT00943787|592123487|FG000|Overall Study|Physician Decision|4|||
163932914|NCT00943787|592123487|FG000|Overall Study|Withdrawal by Subject|3|||
163932915|NCT01547598|592123488|FG000|Overall Study|Withdrew consent|1|||
163932916|NCT01547598|592123489|FG001|Overall Study|Withdrew consent|1|||
163932917|NCT01547598|592123488|FG000|Overall Study|Lost to Follow-up|1|||
163932918|NCT01547598|592123489|FG001|Overall Study|Lost to Follow-up|1|||
163932919|NCT01547598|592123488|FG000|Overall Study|Adverse Event|1|||
163932920|NCT01547598|592123489|FG001|Overall Study|Adverse Event|1|||
163932921|NCT01547598|592123488|FG000|Overall Study|Protocol Violation|1|||
163932922|NCT01547598|592123489|FG001|Overall Study|Protocol Violation|1|||
163932923|NCT01547598|592123488|FG000|Overall Study|Other Miscellaneous Reasons|2|||
163932924|NCT01547598|592123489|FG001|Overall Study|Other Miscellaneous Reasons|1|||
163932925|NCT00872001|592123493|FG000|Overall Study|Adverse Event|34|||
163932926|NCT00872001|592123494|FG001|Overall Study|Adverse Event|23|||
163932927|NCT00872001|592123493|FG000|Overall Study|Protocol Defined Clinical Event|5|||
163932928|NCT00872001|592123494|FG001|Overall Study|Protocol Defined Clinical Event|7|||
163932929|NCT00872001|592123493|FG000|Overall Study|Lost to Follow-up|13|||
163932930|NCT00872001|592123494|FG001|Overall Study|Lost to Follow-up|12|||
163932931|NCT00872001|592123493|FG000|Overall Study|Withdrawal by Subject|18|||
163932932|NCT00872001|592123494|FG001|Overall Study|Withdrawal by Subject|30|||
163932933|NCT00872001|592123493|FG000|Overall Study|Protocol Violation|5|||
163932934|NCT00872001|592123494|FG001|Overall Study|Protocol Violation|8|||
163932935|NCT00872001|592123493|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
163932936|NCT00872001|592123494|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
163932937|NCT00872001|592123493|FG000|Overall Study|Administrative|23|||
163932938|NCT00872001|592123494|FG001|Overall Study|Administrative|15|||
163932939|NCT04071301|592123495|FG000|Overall Study|Withdrawal by Subject|6|||
163932940|NCT04071301|592123495|FG000|Overall Study|Death|1|||
163932941|NCT05186311|592123496|FG000|Part A: Serum|Withdrawal by Subject|1|||
163932942|NCT02879383|592123497|FG000|First 24 Weeks|Physician Decision|0|||
163932943|NCT02879383|592123498|FG001|First 24 Weeks|Physician Decision|1|||
163932944|NCT02879383|592123499|FG002|First 24 Weeks|Physician Decision|0|||
163932945|NCT02879383|592123500|FG003|First 24 Weeks|Physician Decision|0|||
163932946|NCT02125279|592123501|FG000|Overall Study|Lack of Efficacy|2|||
163932947|NCT02125279|592123501|FG000|Overall Study|Withdrawal by Subject|6|||
163932948|NCT02125279|592123501|FG000|Overall Study|Protocol Violation|1|||
163932949|NCT02125279|592123501|FG000|Overall Study|Lost to Follow-up|4|||
163932950|NCT01607879|592123506|FG000|Overall Study|Death|1|||
163932951|NCT01607879|592123507|FG001|Overall Study|Death|0|||
163932952|NCT03721172|592123510|FG000|Placebo-controlled Phase|Adverse Event|7|||
163932953|NCT03721172|592123511|FG001|Placebo-controlled Phase|Adverse Event|7|||
163932954|NCT03721172|592123512|FG002|Placebo-controlled Phase|Adverse Event|0|||
163932955|NCT03721172|592123510|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
163932956|NCT03721172|592123511|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
163932957|NCT03721172|592123512|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
163932958|NCT03721172|592123510|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
163932959|NCT03721172|592123511|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
163932960|NCT03721172|592123512|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
163932961|NCT03721172|592123510|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
163932962|NCT03721172|592123511|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
163932963|NCT03721172|592123512|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
163932964|NCT03721172|592123510|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
163932965|NCT03721172|592123511|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
163932966|NCT03721172|592123512|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
163932967|NCT03721172|592123510|FG000|Placebo-controlled Phase|Other|3|||
163932968|NCT03721172|592123511|FG001|Placebo-controlled Phase|Other|0|||
163932969|NCT03721172|592123512|FG002|Placebo-controlled Phase|Other|0|||
163932970|NCT03721172|592123510|FG000|Apremilast Extension Phase|Adverse Event|0|||
163932971|NCT03721172|592123511|FG001|Apremilast Extension Phase|Adverse Event|0|||
163932972|NCT03721172|592123512|FG002|Apremilast Extension Phase|Adverse Event|10|||
163932973|NCT03721172|592123510|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
163932974|NCT03721172|592123511|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
163932975|NCT03721172|592123512|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
163932976|NCT03721172|592123510|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
163932977|NCT03721172|592123511|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
163932978|NCT03721172|592123512|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
163932979|NCT03721172|592123510|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
163932980|NCT03721172|592123511|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
163932981|NCT03721172|592123512|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
163932982|NCT03721172|592123510|FG000|Apremilast Extension Phase|Protocol Violation|0|||
163932983|NCT03721172|592123511|FG001|Apremilast Extension Phase|Protocol Violation|0|||
163932984|NCT03721172|592123512|FG002|Apremilast Extension Phase|Protocol Violation|1|||
163932985|NCT03721172|592123510|FG000|Apremilast Extension Phase|Physician Decision|0|||
163932986|NCT03721172|592123511|FG001|Apremilast Extension Phase|Physician Decision|0|||
163932987|NCT03721172|592123512|FG002|Apremilast Extension Phase|Physician Decision|1|||
163932988|NCT03721172|592123510|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
163932989|NCT03721172|592123511|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
163932990|NCT03721172|592123512|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
163932991|NCT03721172|592123510|FG000|Apremilast Extension Phase|Other|0|||
163932992|NCT03721172|592123511|FG001|Apremilast Extension Phase|Other|0|||
163932993|NCT03721172|592123512|FG002|Apremilast Extension Phase|Other|3|||
163932994|NCT03721172|592123510|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
163932995|NCT03721172|592123511|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
163932996|NCT03721172|592123512|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
163932997|NCT02417441|592123513|FG000|Overall Study|Inconclusive due to missing data|52|||
163932998|NCT02417441|592123514|FG001|Overall Study|Inconclusive due to missing data|19|||
163932999|NCT05628285|592123515|FG000|Overall Study|Lost to Follow-up|1|||
163933000|NCT00983853|592123516|FG000|Overall Study|Lost to Follow-up|1|||
163933001|NCT00983853|592123517|FG001|Overall Study|Lost to Follow-up|1|||
163933002|NCT00983853|592123518|FG002|Overall Study|Lost to Follow-up|2|||
163933003|NCT00983853|592123519|FG003|Overall Study|Lost to Follow-up|2|||
163933004|NCT00983853|592123520|FG004|Overall Study|Lost to Follow-up|2|||
163933005|NCT00983853|592123521|FG005|Overall Study|Lost to Follow-up|1|||
163933006|NCT00983853|592123516|FG000|Overall Study|Withdrawal by Subject|0|||
163933007|NCT00983853|592123517|FG001|Overall Study|Withdrawal by Subject|0|||
163933008|NCT00983853|592123518|FG002|Overall Study|Withdrawal by Subject|1|||
163933009|NCT00983853|592123519|FG003|Overall Study|Withdrawal by Subject|0|||
163933010|NCT00983853|592123520|FG004|Overall Study|Withdrawal by Subject|1|||
163933011|NCT00983853|592123521|FG005|Overall Study|Withdrawal by Subject|0|||
163933012|NCT00983853|592123516|FG000|Overall Study|Unable to come to study follow-up visits|0|||
163933013|NCT00983853|592123517|FG001|Overall Study|Unable to come to study follow-up visits|1|||
163933014|NCT00983853|592123518|FG002|Overall Study|Unable to come to study follow-up visits|0|||
163933015|NCT00983853|592123519|FG003|Overall Study|Unable to come to study follow-up visits|0|||
163933016|NCT00983853|592123520|FG004|Overall Study|Unable to come to study follow-up visits|0|||
163933017|NCT00983853|592123521|FG005|Overall Study|Unable to come to study follow-up visits|0|||
163933018|NCT02339506|592123522|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
163933019|NCT02339506|592123523|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
163933020|NCT02339506|592123522|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
163933021|NCT02339506|592123523|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
163933022|NCT03016598|592123527|FG000|Overall Study|Lost to Follow-up|0|||
163933023|NCT03016598|592123528|FG001|Overall Study|Lost to Follow-up|2|||
163933024|NCT01101061|592123531|FG000|Overall Study|Adverse Event|0|||
163933025|NCT01101061|592123532|FG001|Overall Study|Adverse Event|0|||
163933026|NCT01101061|592123533|FG002|Overall Study|Adverse Event|1|||
163933027|NCT01101061|592123534|FG003|Overall Study|Adverse Event|0|||
163933028|NCT01101061|592123535|FG004|Overall Study|Adverse Event|0|||
163933029|NCT01101061|592123536|FG005|Overall Study|Adverse Event|0|||
163933030|NCT00478205|592123538|FG000|Overall Study|Adverse Event|182|||
163933031|NCT00478205|592123539|FG001|Overall Study|Adverse Event|39|||
163933032|NCT00478205|592123538|FG000|Overall Study|Medication Non-compliance|9|||
163933033|NCT00478205|592123539|FG001|Overall Study|Medication Non-compliance|4|||
163933034|NCT00478205|592123538|FG000|Overall Study|Protocol Violation|15|||
163933035|NCT00478205|592123539|FG001|Overall Study|Protocol Violation|5|||
163933036|NCT00478205|592123538|FG000|Overall Study|Request of Investigator or Sponsor|4|||
163933037|NCT00478205|592123539|FG001|Overall Study|Request of Investigator or Sponsor|5|||
163933038|NCT00478205|592123538|FG000|Overall Study|Withdrawal by Subject|61|||
163933039|NCT00478205|592123539|FG001|Overall Study|Withdrawal by Subject|22|||
163933040|NCT00478205|592123538|FG000|Overall Study|Lack of Efficacy|1|||
163933041|NCT00478205|592123539|FG001|Overall Study|Lack of Efficacy|0|||
163933042|NCT00478205|592123538|FG000|Overall Study|Other|24|||
163933043|NCT00478205|592123539|FG001|Overall Study|Other|12|||
163933044|NCT01791413|592123540|FG000|Overall Study|Lost to Follow-up|5|||
163933045|NCT01791413|592123541|FG001|Overall Study|Lost to Follow-up|1|||
163933046|NCT00825305|592123549|FG000|Overall Study|Adverse Event|1|||
163933047|NCT00825305|592123550|FG001|Overall Study|Adverse Event|1|||
163933048|NCT00825305|592123549|FG000|Overall Study|Withdrawal by Subject|6|||
163933049|NCT00825305|592123550|FG001|Overall Study|Withdrawal by Subject|12|||
163933050|NCT00825305|592123549|FG000|Overall Study|Inappropriate inclusion|1|||
163933051|NCT00825305|592123550|FG001|Overall Study|Inappropriate inclusion|0|||
163933052|NCT00825305|592123549|FG000|Overall Study|Protocol Violation|9|||
163933053|NCT00825305|592123550|FG001|Overall Study|Protocol Violation|9|||
164098498|NCT03897088|592725117|FG001|Overall Study|Sponsor Decision|2|||
163933054|NCT00825305|592123549|FG000|Overall Study|Can not be classified|0|||
163933055|NCT00825305|592123550|FG001|Overall Study|Can not be classified|1|||
163933056|NCT04016272|592123551|FG000|Overall Study|Withdrawal by Subject|1|||
163933057|NCT04016272|592123552|FG001|Overall Study|Withdrawal by Subject|2|||
163933058|NCT02282917|592123562|FG000|Overall Study|Withdrawal by Subject|1|||
163933059|NCT02282917|592123562|FG000|Overall Study|Screen Failure/Not Eligible|1|||
163933060|NCT00115336|592123563|FG000|Overall Study|Hospital discharge before study drug|0|||
163933061|NCT00115336|592123564|FG001|Overall Study|Hospital discharge before study drug|1|||
163933062|NCT00715117|592123573|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
163933063|NCT00715117|592123574|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
163933064|NCT01018732|592123578|FG000|Overall Study|Lost to Follow-up|0|||
163933065|NCT01018732|592123579|FG001|Overall Study|Lost to Follow-up|0|||
163933066|NCT01018732|592123580|FG002|Overall Study|Lost to Follow-up|3|||
163933067|NCT01018732|592123578|FG000|Overall Study|Protocol Violation|1|||
163933068|NCT01018732|592123579|FG001|Overall Study|Protocol Violation|1|||
163933069|NCT01018732|592123580|FG002|Overall Study|Protocol Violation|0|||
163933070|NCT01018732|592123578|FG000|Overall Study|Inappropriate Enrollment|0|||
163933071|NCT01018732|592123579|FG001|Overall Study|Inappropriate Enrollment|1|||
163933072|NCT01018732|592123580|FG002|Overall Study|Inappropriate Enrollment|0|||
163933073|NCT01018732|592123578|FG000|Overall Study|Unable to Classify|0|||
163933074|NCT01018732|592123579|FG001|Overall Study|Unable to Classify|0|||
163933075|NCT01018732|592123580|FG002|Overall Study|Unable to Classify|1|||
163933076|NCT01536171|592123581|FG000|Overall Study|Withdrawal by Subject|1|||
163933077|NCT03566979|592123582|FG000|Overall Study|Withdrawal by Subject|2|||
163933078|NCT03566979|592123583|FG001|Overall Study|Withdrawal by Subject|0|||
163933079|NCT03566979|592123584|FG002|Overall Study|Withdrawal by Subject|1|||
163933080|NCT03566979|592123585|FG003|Overall Study|Withdrawal by Subject|1|||
163933081|NCT03566979|592123582|FG000|Overall Study|Lost to Follow-up|2|||
163933082|NCT03566979|592123583|FG001|Overall Study|Lost to Follow-up|7|||
163933083|NCT03566979|592123584|FG002|Overall Study|Lost to Follow-up|9|||
163933084|NCT03566979|592123585|FG003|Overall Study|Lost to Follow-up|5|||
163933085|NCT03566979|592123582|FG000|Overall Study|Adverse Event|1|||
163933086|NCT03566979|592123583|FG001|Overall Study|Adverse Event|0|||
163933087|NCT03566979|592123584|FG002|Overall Study|Adverse Event|0|||
163933088|NCT03566979|592123585|FG003|Overall Study|Adverse Event|0|||
163933089|NCT03725605|592123586|FG000|Overall Study|Unsuccessful TIL expansion|2|||
163933090|NCT01503086|592123587|FG000|Overall Study|Lost to Follow-up|0|||
163933091|NCT01503086|592123588|FG001|Overall Study|Lost to Follow-up|1|||
163933092|NCT01503086|592123589|FG002|Overall Study|Lost to Follow-up|0|||
163933093|NCT01503086|592123587|FG000|Overall Study|Did Not Start Treatment|4|||
163933094|NCT01503086|592123588|FG001|Overall Study|Did Not Start Treatment|3|||
163933095|NCT01503086|592123589|FG002|Overall Study|Did Not Start Treatment|3|||
163933096|NCT01503086|592123587|FG000|Overall Study|Progressive disease|3|||
163933097|NCT01503086|592123588|FG001|Overall Study|Progressive disease|1|||
163933098|NCT01503086|592123589|FG002|Overall Study|Progressive disease|0|||
163933099|NCT01503086|592123587|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
163933100|NCT01503086|592123588|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
163933101|NCT01503086|592123589|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
163933102|NCT01503086|592123587|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
163933103|NCT01503086|592123588|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
163933104|NCT01503086|592123589|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
163933105|NCT02419417|592125395|FG000|Overall Study|Disease progression|5|||
163933106|NCT02419417|592125396|FG001|Overall Study|Disease progression|4|||
163933107|NCT02419417|592125397|FG002|Overall Study|Disease progression|13|||
163933108|NCT02419417|592125398|FG003|Overall Study|Disease progression|10|||
163933109|NCT02419417|592125399|FG004|Overall Study|Disease progression|10|||
163933110|NCT02419417|592125400|FG005|Overall Study|Disease progression|3|||
163933111|NCT02419417|592125401|FG006|Overall Study|Disease progression|4|||
163933112|NCT02419417|592125402|FG007|Overall Study|Disease progression|5|||
163933113|NCT02419417|592125403|FG008|Overall Study|Disease progression|13|||
163933114|NCT02419417|592125404|FG009|Overall Study|Disease progression|9|||
163933115|NCT02419417|592125405|FG010|Overall Study|Disease progression|0|||
163933116|NCT02419417|592125395|FG000|Overall Study|Study drug toxicity|0|||
163933117|NCT02419417|592125396|FG001|Overall Study|Study drug toxicity|0|||
163933118|NCT02419417|592125397|FG002|Overall Study|Study drug toxicity|0|||
163933119|NCT02419417|592125398|FG003|Overall Study|Study drug toxicity|0|||
163933120|NCT02419417|592125399|FG004|Overall Study|Study drug toxicity|1|||
164037186|NCT01094808|592496648|FG001|Overall Study|Withdrawal by Subject|1|||
164037187|NCT01094808|592496649|FG002|Overall Study|Withdrawal by Subject|0|||
163933121|NCT02419417|592125400|FG005|Overall Study|Study drug toxicity|0|||
163933122|NCT02419417|592125401|FG006|Overall Study|Study drug toxicity|0|||
163933123|NCT02419417|592125402|FG007|Overall Study|Study drug toxicity|0|||
163933124|NCT02419417|592125403|FG008|Overall Study|Study drug toxicity|0|||
163933125|NCT02419417|592125404|FG009|Overall Study|Study drug toxicity|0|||
163933126|NCT02419417|592125405|FG010|Overall Study|Study drug toxicity|0|||
163933127|NCT02419417|592125395|FG000|Overall Study|Adverse event unrelated to study drug|0|||
163933128|NCT02419417|592125396|FG001|Overall Study|Adverse event unrelated to study drug|0|||
163933129|NCT02419417|592125397|FG002|Overall Study|Adverse event unrelated to study drug|0|||
163933130|NCT02419417|592125398|FG003|Overall Study|Adverse event unrelated to study drug|0|||
163933131|NCT02419417|592125399|FG004|Overall Study|Adverse event unrelated to study drug|2|||
163933132|NCT02419417|592125400|FG005|Overall Study|Adverse event unrelated to study drug|1|||
163933133|NCT02419417|592125401|FG006|Overall Study|Adverse event unrelated to study drug|0|||
163933134|NCT02419417|592125402|FG007|Overall Study|Adverse event unrelated to study drug|1|||
164098499|NCT03897088|592725116|FG000|Overall Study|COVID-19|2|||
164098500|NCT03897088|592725117|FG001|Overall Study|COVID-19|0|||
163838227|NCT00467142|591779624|FG000|Overall Study|Withdrawal by Subject|1|||
163838228|NCT00467142|591779624|FG000|Overall Study|Adverse Event|1|||
163838229|NCT00467142|591779624|FG000|Overall Study|Protocol Violation|1|||
163838230|NCT00154310|591779625|FG000|Overall Study|Adverse Event|19|||
163838231|NCT00154310|591779626|FG001|Overall Study|Adverse Event|9|||
163838232|NCT00154310|591779625|FG000|Overall Study|Lack of Efficacy|5|||
163838233|NCT00154310|591779626|FG001|Overall Study|Lack of Efficacy|4|||
163838234|NCT00154310|591779625|FG000|Overall Study|Protocol Violation|4|||
163838235|NCT00154310|591779626|FG001|Overall Study|Protocol Violation|2|||
163838236|NCT00154310|591779625|FG000|Overall Study|Withdrawal by Subject|9|||
163838237|NCT00154310|591779626|FG001|Overall Study|Withdrawal by Subject|3|||
163838238|NCT00154310|591779625|FG000|Overall Study|Lost to Follow-up|0|||
163838239|NCT00154310|591779626|FG001|Overall Study|Lost to Follow-up|8|||
163838240|NCT00154310|591779625|FG000|Overall Study|Administrative problems|0|||
163838241|NCT00154310|591779626|FG001|Overall Study|Administrative problems|1|||
163838242|NCT00154310|591779625|FG000|Overall Study|Death|0|||
163838243|NCT00154310|591779626|FG001|Overall Study|Death|1|||
163838244|NCT03447730|591779628|FG000|Overall Study|Adverse Event|0|||
163838245|NCT03447730|591779629|FG001|Overall Study|Adverse Event|2|||
163838246|NCT03447730|591779630|FG002|Overall Study|Adverse Event|0|||
163838247|NCT02086162|591779631|FG000|Overall Study|Withdrawal by Subject|4|||
163838248|NCT02086162|591779632|FG001|Overall Study|Withdrawal by Subject|4|||
163838249|NCT02086162|591779631|FG000|Overall Study|moved|1|||
163838250|NCT02086162|591779632|FG001|Overall Study|moved|1|||
163838251|NCT02086162|591779631|FG000|Overall Study|Lost to Follow-up|4|||
163838252|NCT02086162|591779632|FG001|Overall Study|Lost to Follow-up|2|||
163838253|NCT02086162|591779631|FG000|Overall Study|Death|1|||
163838254|NCT02086162|591779632|FG001|Overall Study|Death|0|||
163838255|NCT01248962|591779636|FG000|Overall Study|Withdrawal by Subject|1|||
163838256|NCT01248962|591779637|FG001|Overall Study|Withdrawal by Subject|1|||
163838257|NCT01248962|591779636|FG000|Overall Study|Adverse Event|2|||
163838258|NCT01248962|591779637|FG001|Overall Study|Adverse Event|1|||
163838259|NCT01248962|591779636|FG000|Overall Study|Complete Response after 4 Cycles|1|||
163838260|NCT01248962|591779637|FG001|Overall Study|Complete Response after 4 Cycles|0|||
163838261|NCT01248962|591779636|FG000|Overall Study|Complete Response after 3 Cycles|0|||
163838262|NCT01248962|591779637|FG001|Overall Study|Complete Response after 3 Cycles|1|||
163838263|NCT01248962|591779636|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
163838264|NCT01248962|591779637|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
163838265|NCT04848662|591779639|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
163838266|NCT04848662|591779640|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
163838267|NCT01350505|591779641|FG000|Overall Study|Lost to Follow-up|4|||
163838268|NCT01834222|591779642|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
163838269|NCT04702568|591779643|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
163838270|NCT04702568|591779644|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
163838271|NCT04702568|591779643|FG000|Overall Study|Pregnancy|1|||
163838272|NCT04702568|591779644|FG001|Overall Study|Pregnancy|0|||
163838273|NCT04702568|591779643|FG000|Overall Study|Bone marrow transplant|1|||
163838274|NCT04702568|591779644|FG001|Overall Study|Bone marrow transplant|0|||
163838275|NCT04702568|591779643|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
163838276|NCT04702568|591779644|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
163838277|NCT04702568|591779643|FG000|Overall Study|Withdrawal by Subject|0|||
163838278|NCT04702568|591779644|FG001|Overall Study|Withdrawal by Subject|2|||
163838279|NCT00423852|591779647|FG000|Overall Study|Removed pior to the high-dose portion|3|||
163838280|NCT00308737|591779650|FG000|Overall Study|Adverse Event|104|||
163838281|NCT00308737|591779651|FG001|Overall Study|Adverse Event|9|||
163838282|NCT00308737|591779652|FG002|Overall Study|Adverse Event|0|||
163838283|NCT00308737|591779650|FG000|Overall Study|Death|4|||
163838284|NCT00308737|591779651|FG001|Overall Study|Death|3|||
163838285|NCT00308737|591779652|FG002|Overall Study|Death|0|||
163838286|NCT00308737|591779650|FG000|Overall Study|Lost to Follow-up|56|||
163838287|NCT00308737|591779651|FG001|Overall Study|Lost to Follow-up|80|||
163838288|NCT00308737|591779652|FG002|Overall Study|Lost to Follow-up|5|||
163838289|NCT00308737|591779650|FG000|Overall Study|Physician Decision|15|||
164098501|NCT03897088|592725116|FG000|Overall Study|Other|3|||
164098502|NCT03897088|592725117|FG001|Overall Study|Other|0|||
163838290|NCT00308737|591779651|FG001|Overall Study|Physician Decision|2|||
163838291|NCT00308737|591779652|FG002|Overall Study|Physician Decision|1|||
163838292|NCT00308737|591779650|FG000|Overall Study|Protocol Violation|34|||
163838293|NCT00308737|591779651|FG001|Overall Study|Protocol Violation|9|||
163838294|NCT00308737|591779652|FG002|Overall Study|Protocol Violation|5|||
163838295|NCT00308737|591779650|FG000|Overall Study|Withdrawal by Subject|218|||
163838296|NCT00308737|591779651|FG001|Overall Study|Withdrawal by Subject|166|||
163838297|NCT00308737|591779652|FG002|Overall Study|Withdrawal by Subject|18|||
163838298|NCT00308737|591779650|FG000|Overall Study|Various|32|||
163838299|NCT00308737|591779651|FG001|Overall Study|Various|20|||
164098503|NCT03897088|592725116|FG000|Overall Study|Non-compliance with Study Drug|1|||
163933135|NCT02419417|592125403|FG008|Overall Study|Adverse event unrelated to study drug|0|||
163933136|NCT02419417|592125404|FG009|Overall Study|Adverse event unrelated to study drug|0|||
163838300|NCT00308737|591779652|FG002|Overall Study|Various|8|||
163838301|NCT01225822|591779662|FG000|Overall Study|Adverse Event|13|||
163838302|NCT01225822|591779663|FG001|Overall Study|Adverse Event|31|||
163838303|NCT01225822|591779664|FG002|Overall Study|Adverse Event|18|||
163838304|NCT01225822|591779665|FG003|Overall Study|Adverse Event|23|||
163838305|NCT01225822|591779666|FG004|Overall Study|Adverse Event|14|||
163838306|NCT01225822|591779662|FG000|Overall Study|Protocol Violation|6|||
163838307|NCT01225822|591779663|FG001|Overall Study|Protocol Violation|8|||
163838308|NCT01225822|591779664|FG002|Overall Study|Protocol Violation|6|||
163838309|NCT01225822|591779665|FG003|Overall Study|Protocol Violation|7|||
163838310|NCT01225822|591779666|FG004|Overall Study|Protocol Violation|4|||
163838311|NCT01225822|591779662|FG000|Overall Study|Lost to Follow-up|0|||
163838312|NCT01225822|591779663|FG001|Overall Study|Lost to Follow-up|0|||
163838313|NCT01225822|591779664|FG002|Overall Study|Lost to Follow-up|0|||
163838314|NCT01225822|591779665|FG003|Overall Study|Lost to Follow-up|1|||
163838315|NCT01225822|591779666|FG004|Overall Study|Lost to Follow-up|0|||
163838316|NCT01225822|591779662|FG000|Overall Study|Withdrawal by Subject|6|||
163838317|NCT01225822|591779663|FG001|Overall Study|Withdrawal by Subject|7|||
163838318|NCT01225822|591779664|FG002|Overall Study|Withdrawal by Subject|7|||
163838319|NCT01225822|591779665|FG003|Overall Study|Withdrawal by Subject|11|||
163838320|NCT01225822|591779666|FG004|Overall Study|Withdrawal by Subject|6|||
163838321|NCT01225822|591779662|FG000|Overall Study|Other|13|||
163838322|NCT01225822|591779663|FG001|Overall Study|Other|10|||
163838323|NCT01225822|591779664|FG002|Overall Study|Other|7|||
163838324|NCT01225822|591779665|FG003|Overall Study|Other|10|||
163838325|NCT01225822|591779666|FG004|Overall Study|Other|7|||
163838326|NCT00089895|591779667|FG000|Overall Study|Consent Withdrawn|11|||
163838327|NCT00089895|591779668|FG001|Overall Study|Consent Withdrawn|14|||
163838328|NCT00089895|591779667|FG000|Overall Study|Technical reason|7|||
163838329|NCT00089895|591779668|FG001|Overall Study|Technical reason|2|||
163838330|NCT00089895|591779667|FG000|Overall Study|Surgery|0|||
163838331|NCT00089895|591779668|FG001|Overall Study|Surgery|1|||
163838332|NCT00089895|591779667|FG000|Overall Study|Bleeding|0|||
163838333|NCT00089895|591779668|FG001|Overall Study|Bleeding|2|||
163838334|NCT00089895|591779667|FG000|Overall Study|Physician Decision|3|||
163838335|NCT00089895|591779668|FG001|Overall Study|Physician Decision|7|||
163838336|NCT00089895|591779667|FG000|Overall Study|Exclusion criteria met|6|||
163838337|NCT00089895|591779668|FG001|Overall Study|Exclusion criteria met|6|||
163838338|NCT00089895|591779667|FG000|Overall Study|Not otherwise specified|4|||
163838339|NCT00089895|591779668|FG001|Overall Study|Not otherwise specified|8|||
163838340|NCT00089895|591779667|FG000|Overall Study|Missing|4|||
163838341|NCT00089895|591779668|FG001|Overall Study|Missing|2|||
163838342|NCT05644353|591779669|FG000|Overall Study|Physician Decision|1|||
163838343|NCT05644353|591779670|FG001|Overall Study|Physician Decision|0|||
163838344|NCT05644353|591779671|FG002|Overall Study|Physician Decision|0|||
163838345|NCT05644353|591779672|FG003|Overall Study|Physician Decision|0|||
163838346|NCT05644353|591779673|FG004|Overall Study|Physician Decision|0|||
163838347|NCT05644353|591779674|FG005|Overall Study|Physician Decision|0|||
163838348|NCT05644353|591779669|FG000|Overall Study|Protocol Violation|1|||
163838349|NCT05644353|591779670|FG001|Overall Study|Protocol Violation|0|||
163838350|NCT05644353|591779671|FG002|Overall Study|Protocol Violation|0|||
163838351|NCT05644353|591779672|FG003|Overall Study|Protocol Violation|0|||
163838352|NCT05644353|591779673|FG004|Overall Study|Protocol Violation|0|||
163838353|NCT05644353|591779674|FG005|Overall Study|Protocol Violation|0|||
163838354|NCT05644353|591779669|FG000|Overall Study|Withdrawal by Subject|0|||
163838355|NCT05644353|591779670|FG001|Overall Study|Withdrawal by Subject|2|||
163838356|NCT05644353|591779671|FG002|Overall Study|Withdrawal by Subject|0|||
163838357|NCT05644353|591779672|FG003|Overall Study|Withdrawal by Subject|0|||
163838358|NCT05644353|591779673|FG004|Overall Study|Withdrawal by Subject|1|||
163838359|NCT05644353|591779674|FG005|Overall Study|Withdrawal by Subject|0|||
163838360|NCT05644353|591779669|FG000|Overall Study|Lost to Follow-up|0|||
163838361|NCT05644353|591779670|FG001|Overall Study|Lost to Follow-up|0|||
163838362|NCT05644353|591779671|FG002|Overall Study|Lost to Follow-up|1|||
163838363|NCT05644353|591779672|FG003|Overall Study|Lost to Follow-up|0|||
163838364|NCT05644353|591779673|FG004|Overall Study|Lost to Follow-up|0|||
163838365|NCT05644353|591779674|FG005|Overall Study|Lost to Follow-up|0|||
163838366|NCT01535274|591779675|FG000|Overall Study|Determined to be ineligible|0|||
163838367|NCT01535274|591779676|FG001|Overall Study|Determined to be ineligible|1|||
163838368|NCT01535274|591779675|FG000|Overall Study|Misallocated to propofol intervention|0|||
163838369|NCT01535274|591779676|FG001|Overall Study|Misallocated to propofol intervention|1|||
163838370|NCT02954458|591779679|FG000|Overall Study|Adverse Event|0|||
163838371|NCT02954458|591779680|FG001|Overall Study|Adverse Event|0|||
163838372|NCT02954458|591779681|FG002|Overall Study|Adverse Event|0|||
163933137|NCT02419417|592125405|FG010|Overall Study|Adverse event unrelated to study drug|0|||
163933138|NCT02419417|592125395|FG000|Overall Study|Participant request to discontinue|0|||
163838373|NCT02954458|591779682|FG003|Overall Study|Adverse Event|1|||
163838374|NCT02954458|591779679|FG000|Overall Study|Withdrawal by Subject|0|||
163933139|NCT02419417|592125396|FG001|Overall Study|Participant request to discontinue|0|||
163933140|NCT02419417|592125397|FG002|Overall Study|Participant request to discontinue|0|||
163933141|NCT02419417|592125398|FG003|Overall Study|Participant request to discontinue|0|||
163933142|NCT02419417|592125399|FG004|Overall Study|Participant request to discontinue|0|||
163933143|NCT02419417|592125400|FG005|Overall Study|Participant request to discontinue|0|||
163933144|NCT02419417|592125401|FG006|Overall Study|Participant request to discontinue|0|||
163933145|NCT02419417|592125402|FG007|Overall Study|Participant request to discontinue|0|||
163933146|NCT02419417|592125403|FG008|Overall Study|Participant request to discontinue|0|||
163933147|NCT02419417|592125404|FG009|Overall Study|Participant request to discontinue|1|||
163933148|NCT02419417|592125405|FG010|Overall Study|Participant request to discontinue|0|||
163933149|NCT02419417|592125395|FG000|Overall Study|Withdrawal by Subject|0|||
163933150|NCT02419417|592125396|FG001|Overall Study|Withdrawal by Subject|0|||
163933151|NCT02419417|592125397|FG002|Overall Study|Withdrawal by Subject|0|||
163933152|NCT02419417|592125398|FG003|Overall Study|Withdrawal by Subject|0|||
163933153|NCT02419417|592125399|FG004|Overall Study|Withdrawal by Subject|0|||
163933154|NCT02419417|592125400|FG005|Overall Study|Withdrawal by Subject|0|||
163933155|NCT02419417|592125401|FG006|Overall Study|Withdrawal by Subject|0|||
163933156|NCT02419417|592125402|FG007|Overall Study|Withdrawal by Subject|0|||
163933157|NCT02419417|592125403|FG008|Overall Study|Withdrawal by Subject|0|||
163933158|NCT02419417|592125404|FG009|Overall Study|Withdrawal by Subject|0|||
163933159|NCT02419417|592125405|FG010|Overall Study|Withdrawal by Subject|1|||
163933160|NCT01240551|592125406|FG000|Overall Study|Refused further treatment|3|||
163933161|NCT01240551|592125407|FG001|Overall Study|Refused further treatment|2|||
163933162|NCT01240551|592125406|FG000|Overall Study|Lost to Follow-up|1|||
163933163|NCT01240551|592125407|FG001|Overall Study|Lost to Follow-up|1|||
163933164|NCT01385748|592125408|FG000|Overall Study|Withdrawal by Subject|7|||
163933165|NCT01385748|592125409|FG001|Overall Study|Withdrawal by Subject|4|||
163933166|NCT01385748|592125410|FG002|Overall Study|Withdrawal by Subject|5|||
163933167|NCT01385748|592125408|FG000|Overall Study|Noncompliance|3|||
163933168|NCT01385748|592125409|FG001|Overall Study|Noncompliance|1|||
163933169|NCT01385748|592125410|FG002|Overall Study|Noncompliance|6|||
163933170|NCT01385748|592125408|FG000|Overall Study|Other|1|||
163933171|NCT01385748|592125409|FG001|Overall Study|Other|7|||
163933172|NCT01385748|592125410|FG002|Overall Study|Other|1|||
163933173|NCT01385748|592125408|FG000|Overall Study|Adverse Event|4|||
163933174|NCT01385748|592125409|FG001|Overall Study|Adverse Event|2|||
163933175|NCT01385748|592125410|FG002|Overall Study|Adverse Event|1|||
163933176|NCT01200342|592125417|FG000|Overall Study|Disease Progression|1|||
163933177|NCT01012947|592125425|FG000|Overall Study|Lost to Follow-up|131|||
163933178|NCT01012947|592125426|FG001|Overall Study|Lost to Follow-up|135|||
163933179|NCT01012947|592125427|FG002|Overall Study|Lost to Follow-up|130|||
163933180|NCT01012947|592125428|FG003|Overall Study|Lost to Follow-up|118|||
163933181|NCT01012947|592125429|FG004|Overall Study|Lost to Follow-up|142|||
163933182|NCT00246090|592125430|FG000|Overall Study|Adverse Event|25|||
163933183|NCT00246090|592125430|FG000|Overall Study|Withdrawal by Subject|7|||
163933184|NCT00246090|592125430|FG000|Overall Study|Progressive Disease|212|||
163933185|NCT00246090|592125430|FG000|Overall Study|Clinical Progression|30|||
163933186|NCT00246090|592125430|FG000|Overall Study|Physician Decision|11|||
163933187|NCT00246090|592125430|FG000|Overall Study|Not Otherwise Specified|10|||
163933188|NCT03332784|592125433|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933189|NCT03332784|592125434|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
163933190|NCT03332784|592125435|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164037188|NCT00369278|592496650|FG000|Overall Study|Adverse Event|14|||
164037189|NCT00369278|592496651|FG001|Overall Study|Adverse Event|11|||
164037190|NCT00369278|592496650|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164037191|NCT00369278|592496651|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
164037192|NCT00369278|592496650|FG000|Overall Study|Protocol Violation|2|||
164037193|NCT00369278|592496651|FG001|Overall Study|Protocol Violation|1|||
163933191|NCT03332784|592125436|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933192|NCT03332784|592125437|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933193|NCT03332784|592125438|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933194|NCT03332784|592125439|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933195|NCT03332784|592125440|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933196|NCT03332784|592125441|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933197|NCT03332784|592125442|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933198|NCT03332784|592125443|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933199|NCT03332784|592125444|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933200|NCT03332784|592125445|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933201|NCT03332784|592125446|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933202|NCT03332784|592125447|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
163933203|NCT03332784|592125448|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933204|NCT03332784|592125449|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933205|NCT03332784|592125450|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
164037194|NCT00369278|592496650|FG000|Overall Study|Withdrawal by Subject|2|||
164037195|NCT00369278|592496651|FG001|Overall Study|Withdrawal by Subject|2|||
163933206|NCT03332784|592125451|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933207|NCT03332784|592125452|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
163933208|NCT00763451|592125458|FG000|Overall Study|Adverse Event|4|||
163933209|NCT00763451|592125459|FG001|Overall Study|Adverse Event|6|||
163933210|NCT00763451|592125460|FG002|Overall Study|Adverse Event|19|||
163933211|NCT00763451|592125461|FG003|Overall Study|Adverse Event|14|||
163933212|NCT00763451|592125458|FG000|Overall Study|Lack of Efficacy|1|||
163933213|NCT00763451|592125459|FG001|Overall Study|Lack of Efficacy|4|||
163933214|NCT00763451|592125460|FG002|Overall Study|Lack of Efficacy|3|||
163838375|NCT02954458|591779680|FG001|Overall Study|Withdrawal by Subject|0|||
163838376|NCT02954458|591779681|FG002|Overall Study|Withdrawal by Subject|0|||
163838377|NCT02954458|591779682|FG003|Overall Study|Withdrawal by Subject|1|||
163838378|NCT02954458|591779679|FG000|Overall Study|Physician Decision|0|||
163838379|NCT02954458|591779680|FG001|Overall Study|Physician Decision|0|||
163838380|NCT02954458|591779681|FG002|Overall Study|Physician Decision|1|||
163838381|NCT02954458|591779682|FG003|Overall Study|Physician Decision|1|||
163838382|NCT02954458|591779679|FG000|Overall Study|Lost to Follow-up|1|||
163838383|NCT02954458|591779680|FG001|Overall Study|Lost to Follow-up|0|||
163838384|NCT02954458|591779681|FG002|Overall Study|Lost to Follow-up|0|||
163838385|NCT02954458|591779682|FG003|Overall Study|Lost to Follow-up|1|||
163838386|NCT02954458|591779679|FG000|Overall Study|Death|0|||
163838387|NCT02954458|591779680|FG001|Overall Study|Death|0|||
163838388|NCT02954458|591779681|FG002|Overall Study|Death|0|||
163838389|NCT02954458|591779682|FG003|Overall Study|Death|1|||
163838390|NCT02954458|591779679|FG000|Overall Study|Other|0|||
163838391|NCT02954458|591779680|FG001|Overall Study|Other|0|||
163838392|NCT02954458|591779681|FG002|Overall Study|Other|0|||
163933215|NCT00763451|592125461|FG003|Overall Study|Lack of Efficacy|2|||
163933216|NCT00763451|592125458|FG000|Overall Study|Withdrawal by Subject|1|||
163933217|NCT00763451|592125459|FG001|Overall Study|Withdrawal by Subject|6|||
163933218|NCT00763451|592125460|FG002|Overall Study|Withdrawal by Subject|9|||
163933219|NCT00763451|592125461|FG003|Overall Study|Withdrawal by Subject|7|||
163933220|NCT00763451|592125458|FG000|Overall Study|Protocol Violation|0|||
163933221|NCT00763451|592125459|FG001|Overall Study|Protocol Violation|0|||
163933222|NCT00763451|592125460|FG002|Overall Study|Protocol Violation|1|||
163933223|NCT00763451|592125461|FG003|Overall Study|Protocol Violation|0|||
163933224|NCT00763451|592125458|FG000|Overall Study|Poor Compliance to Protocol|1|||
163933225|NCT00763451|592125459|FG001|Overall Study|Poor Compliance to Protocol|1|||
163933226|NCT00763451|592125460|FG002|Overall Study|Poor Compliance to Protocol|2|||
163933227|NCT00763451|592125461|FG003|Overall Study|Poor Compliance to Protocol|2|||
163933228|NCT00763451|592125458|FG000|Overall Study|Familial and Personal Reasons|5|||
163933229|NCT00763451|592125459|FG001|Overall Study|Familial and Personal Reasons|3|||
163933230|NCT00763451|592125460|FG002|Overall Study|Familial and Personal Reasons|5|||
163933231|NCT00763451|592125461|FG003|Overall Study|Familial and Personal Reasons|4|||
163933232|NCT00763451|592125458|FG000|Overall Study|Randomized but not Treated|1|||
163933233|NCT00763451|592125459|FG001|Overall Study|Randomized but not Treated|1|||
163933234|NCT00763451|592125460|FG002|Overall Study|Randomized but not Treated|0|||
163933235|NCT00763451|592125461|FG003|Overall Study|Randomized but not Treated|0|||
163933236|NCT00763451|592125458|FG000|Overall Study|Study Site Reason|0|||
163933237|NCT00763451|592125459|FG001|Overall Study|Study Site Reason|1|||
163933238|NCT00763451|592125460|FG002|Overall Study|Study Site Reason|1|||
163933239|NCT00763451|592125461|FG003|Overall Study|Study Site Reason|1|||
163933240|NCT01827046|592125462|FG000|Overall Study|Lost to Follow-up|1|||
164098504|NCT03897088|592725117|FG001|Overall Study|Non-compliance with Study Drug|1|||
164098505|NCT03897088|592725116|FG000|Overall Study|Pregnancy|0|||
164098506|NCT03897088|592725117|FG001|Overall Study|Pregnancy|1|||
163838393|NCT02954458|591779682|FG003|Overall Study|Other|7|||
163838394|NCT02690077|591779685|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
163933241|NCT01827046|592125463|FG001|Overall Study|Lost to Follow-up|5|||
163933242|NCT01827046|592125462|FG000|Overall Study|Withdrawal by Subject|0|||
163933243|NCT01827046|592125463|FG001|Overall Study|Withdrawal by Subject|4|||
163933244|NCT05594589|592125468|FG000|Overall Study|Other|0|||
163933245|NCT05594589|592125469|FG001|Overall Study|Other|1|||
163933246|NCT05594589|592125470|FG002|Overall Study|Other|0|||
163933247|NCT02498236|592125471|FG000|Overall Study|Did not show for testing|1|||
163933248|NCT02498236|592125472|FG001|Overall Study|Did not show for testing|0|||
163933249|NCT02498236|592125473|FG002|Overall Study|Did not show for testing|0|||
163933250|NCT02498236|592125474|FG003|Overall Study|Did not show for testing|0|||
163933251|NCT02498236|592125475|FG004|Overall Study|Did not show for testing|0|||
163933252|NCT02498236|592125476|FG005|Overall Study|Did not show for testing|0|||
163933253|NCT02498236|592125477|FG006|Overall Study|Did not show for testing|0|||
163933254|NCT02498236|592125478|FG007|Overall Study|Did not show for testing|1|||
164098507|NCT04320849|592725126|FG000|Overall Study|Withdrawal by Subject|4|||
163838395|NCT02690077|591779686|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
163838396|NCT02690077|591779685|FG000|Overall Study|Withdrawal by Subject|0|||
163838397|NCT02690077|591779686|FG001|Overall Study|Withdrawal by Subject|5|||
163838398|NCT02690077|591779685|FG000|Overall Study|Excluded by IRB|0|||
163838399|NCT02690077|591779686|FG001|Overall Study|Excluded by IRB|2|||
163838400|NCT01845974|591779687|FG000|Overall Study|screen failure|1|||
163838401|NCT01845974|591779688|FG001|Overall Study|screen failure|0|||
163838402|NCT02667886|591779689|FG000|Dose Escalation (Part A)|Adverse Event|1|||
163838403|NCT02667886|591779690|FG001|Dose Escalation (Part A)|Adverse Event|3|||
163838404|NCT02667886|591779691|FG002|Dose Escalation (Part A)|Adverse Event|1|||
163838405|NCT02667886|591779692|FG003|Dose Escalation (Part A)|Adverse Event|0|||
163838406|NCT02667886|591779693|FG004|Dose Escalation (Part A)|Adverse Event|0|||
163838407|NCT02667886|591779689|FG000|Dose Escalation (Part A)|Disease Progression|1|||
163838408|NCT02667886|591779690|FG001|Dose Escalation (Part A)|Disease Progression|4|||
163838409|NCT02667886|591779691|FG002|Dose Escalation (Part A)|Disease Progression|3|||
163838410|NCT02667886|591779692|FG003|Dose Escalation (Part A)|Disease Progression|0|||
163838411|NCT02667886|591779693|FG004|Dose Escalation (Part A)|Disease Progression|0|||
163838412|NCT02667886|591779689|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163838413|NCT02667886|591779690|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163838414|NCT02667886|591779691|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
163838415|NCT02667886|591779692|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163838416|NCT02667886|591779693|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
163838417|NCT02667886|591779689|FG000|Dose Expansion (Part B)|Adverse Event|0|||
163838418|NCT02667886|591779690|FG001|Dose Expansion (Part B)|Adverse Event|0|||
163838419|NCT02667886|591779691|FG002|Dose Expansion (Part B)|Adverse Event|0|||
163838420|NCT02667886|591779692|FG003|Dose Expansion (Part B)|Adverse Event|9|||
163838421|NCT02667886|591779693|FG004|Dose Expansion (Part B)|Adverse Event|0|||
163838422|NCT02667886|591779689|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
163838423|NCT02667886|591779690|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
163838424|NCT02667886|591779691|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
163838425|NCT02667886|591779692|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
163838426|NCT02667886|591779693|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
163838427|NCT02667886|591779689|FG000|Dose Expansion (Part B)|Disease Progression|0|||
163838428|NCT02667886|591779690|FG001|Dose Expansion (Part B)|Disease Progression|0|||
163838429|NCT02667886|591779691|FG002|Dose Expansion (Part B)|Disease Progression|0|||
163838430|NCT02667886|591779692|FG003|Dose Expansion (Part B)|Disease Progression|38|||
163838431|NCT02667886|591779693|FG004|Dose Expansion (Part B)|Disease Progression|0|||
163838432|NCT02667886|591779689|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163838433|NCT02667886|591779690|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163838434|NCT02667886|591779691|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163838435|NCT02667886|591779692|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
163838436|NCT02667886|591779693|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
163838437|NCT02667886|591779689|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163838438|NCT02667886|591779690|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163838439|NCT02667886|591779691|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163838440|NCT02667886|591779692|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
163838441|NCT02667886|591779693|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
163838442|NCT02667886|591779689|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
163838443|NCT02667886|591779690|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
163838444|NCT02667886|591779691|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
163838445|NCT02667886|591779692|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
163838446|NCT02667886|591779693|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
163838447|NCT01905046|591779694|FG000|Months 13-24|Withdrawal by Subject|10|||
163838448|NCT01905046|591779695|FG001|Months 13-24|Withdrawal by Subject|10|||
163838449|NCT01905046|591779694|FG000|Months 13-24|Adverse Event|3|||
163838450|NCT01905046|591779695|FG001|Months 13-24|Adverse Event|2|||
163838451|NCT01905046|591779694|FG000|Months 13-24|Protocol Violation|3|||
163838452|NCT01905046|591779695|FG001|Months 13-24|Protocol Violation|3|||
163838453|NCT01905046|591779694|FG000|Months 13-24|Physician Decision|1|||
163838454|NCT01905046|591779695|FG001|Months 13-24|Physician Decision|0|||
163838455|NCT05672680|591779696|FG000|Overall Study|Patient Did Not Complete the Form|5|||
163838456|NCT05672680|591779697|FG001|Overall Study|Patient Did Not Complete the Form|4|||
163838457|NCT05672680|591779696|FG000|Overall Study|Procedure Aborted|1|||
163838458|NCT05672680|591779697|FG001|Overall Study|Procedure Aborted|0|||
163838459|NCT03929562|591779698|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
163838460|NCT03929562|591779699|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
163838461|NCT03929562|591779698|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
163838462|NCT03929562|591779699|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
163838463|NCT03929562|591779698|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
163838464|NCT03929562|591779699|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
163838465|NCT02778399|591779708|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
163838466|NCT02778399|591779709|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
163838467|NCT02778399|591779710|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
163838468|NCT02778399|591779711|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
163838469|NCT02778399|591779712|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
163838470|NCT02778399|591779713|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
163933255|NCT02498236|592125471|FG000|Overall Study|Equipment failure|0|||
163933256|NCT02498236|592125472|FG001|Overall Study|Equipment failure|0|||
163933257|NCT02498236|592125473|FG002|Overall Study|Equipment failure|0|||
163933258|NCT02498236|592125474|FG003|Overall Study|Equipment failure|0|||
163933259|NCT02498236|592125475|FG004|Overall Study|Equipment failure|0|||
163933260|NCT02498236|592125476|FG005|Overall Study|Equipment failure|0|||
163933261|NCT02498236|592125477|FG006|Overall Study|Equipment failure|1|||
163933262|NCT02498236|592125478|FG007|Overall Study|Equipment failure|0|||
163933263|NCT02498236|592125471|FG000|Overall Study|Withdrawal by Subject|0|||
163933264|NCT02498236|592125472|FG001|Overall Study|Withdrawal by Subject|0|||
163933265|NCT02498236|592125473|FG002|Overall Study|Withdrawal by Subject|0|||
163933266|NCT02498236|592125474|FG003|Overall Study|Withdrawal by Subject|0|||
163933267|NCT02498236|592125475|FG004|Overall Study|Withdrawal by Subject|1|||
163933268|NCT02498236|592125476|FG005|Overall Study|Withdrawal by Subject|0|||
163933269|NCT02498236|592125477|FG006|Overall Study|Withdrawal by Subject|0|||
163933270|NCT02498236|592125478|FG007|Overall Study|Withdrawal by Subject|0|||
163933271|NCT01262092|592125480|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
163933272|NCT01262092|592125481|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
163933273|NCT01262092|592125480|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
163933274|NCT01262092|592125481|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
163933275|NCT01262092|592125480|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
163933276|NCT01262092|592125481|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
163933277|NCT01262092|592125480|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
163933278|NCT01262092|592125481|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
163933279|NCT03784820|592125482|FG000|Overall Study|Lost to Follow-up|5|||
163933280|NCT03784820|592125483|FG001|Overall Study|Lost to Follow-up|5|||
163933281|NCT03784820|592125484|FG002|Overall Study|Lost to Follow-up|3|||
163933282|NCT03784820|592125485|FG003|Overall Study|Lost to Follow-up|3|||
163933283|NCT02336425|592125486|FG000|Overall Study|Study terminated.|2|||
163933284|NCT02336425|592125487|FG001|Overall Study|Study terminated.|2|||
163933285|NCT02336425|592125488|FG002|Overall Study|Study terminated.|3|||
163933286|NCT02336425|592125489|FG003|Overall Study|Study terminated.|3|||
163933287|NCT00658606|592125490|FG000|Overall Study|Adverse Event|2|||
163933288|NCT00658606|592125491|FG001|Overall Study|Adverse Event|1|||
163933289|NCT00658606|592125490|FG000|Overall Study|Lack of Efficacy|6|||
163933290|NCT00658606|592125491|FG001|Overall Study|Lack of Efficacy|3|||
163933291|NCT00658606|592125490|FG000|Overall Study|Lost to Follow-up|1|||
163933292|NCT00658606|592125491|FG001|Overall Study|Lost to Follow-up|0|||
163933293|NCT00658606|592125490|FG000|Overall Study|Withdrawal by Subject|7|||
163933294|NCT00658606|592125491|FG001|Overall Study|Withdrawal by Subject|16|||
163933295|NCT00658606|592125490|FG000|Overall Study|Lack of Compliance|0|||
163933296|NCT00658606|592125491|FG001|Overall Study|Lack of Compliance|3|||
163933297|NCT01191008|592125492|FG000|Overall Study|Protocol Violation|7|||
163933298|NCT01191008|592125492|FG000|Overall Study|Lost to Follow-up|8|||
163933299|NCT00978562|592125493|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
163933300|NCT02394665|592125496|FG000|Overall Study|Physician Decision|1|||
163933301|NCT02394665|592125497|FG001|Overall Study|Physician Decision|0|||
163933302|NCT02394665|592125498|FG002|Overall Study|Physician Decision|0|||
163933303|NCT00569127|592125499|FG000|Overall Study|Adverse Event|57|||
163933304|NCT00569127|592125500|FG001|Overall Study|Adverse Event|47|||
163933305|NCT00569127|592125499|FG000|Overall Study|Withdrawal by Subject|13|||
163933306|NCT00569127|592125500|FG001|Overall Study|Withdrawal by Subject|27|||
163933307|NCT00569127|592125499|FG000|Overall Study|Progression|99|||
163933308|NCT00569127|592125500|FG001|Overall Study|Progression|100|||
163933309|NCT00569127|592125499|FG000|Overall Study|Death|4|||
163933310|NCT00569127|592125500|FG001|Overall Study|Death|3|||
163933311|NCT00569127|592125499|FG000|Overall Study|Other|20|||
163933312|NCT00569127|592125500|FG001|Overall Study|Other|19|||
163933313|NCT00569127|592125499|FG000|Overall Study|Lost to Follow-up|0|||
163933314|NCT00569127|592125500|FG001|Overall Study|Lost to Follow-up|3|||
163933315|NCT00569127|592125499|FG000|Overall Study|Not Eligible|14|||
163933316|NCT00569127|592125500|FG001|Overall Study|Not Eligible|11|||
163933317|NCT00569127|592125499|FG000|Overall Study|Still on Treatment|7|||
163933318|NCT00569127|592125500|FG001|Overall Study|Still on Treatment|3|||
163933319|NCT03348631|592125515|FG000|Overall Study|Not Eligible, No treatment|0|||
163933320|NCT03348631|592125516|FG001|Overall Study|Not Eligible, No treatment|1|||
163933321|NCT03348631|592125515|FG000|Overall Study|Not Eligible, Treated|2|||
163933322|NCT03348631|592125516|FG001|Overall Study|Not Eligible, Treated|0|||
163933323|NCT03348631|592125515|FG000|Overall Study|Eligible, No Treatment|1|||
163933324|NCT03348631|592125516|FG001|Overall Study|Eligible, No Treatment|0|||
163933325|NCT01068210|592125517|FG000|Overall Study|Lost to Follow-up|1|||
163933326|NCT01068210|592125518|FG001|Overall Study|Lost to Follow-up|2|||
163933327|NCT01068210|592125519|FG002|Overall Study|Lost to Follow-up|2|||
163933328|NCT01068210|592125520|FG003|Overall Study|Lost to Follow-up|1|||
163933329|NCT01068210|592125517|FG000|Overall Study|Second cancer|0|||
163933330|NCT01068210|592125518|FG001|Overall Study|Second cancer|1|||
163933331|NCT01068210|592125519|FG002|Overall Study|Second cancer|0|||
163933332|NCT01068210|592125520|FG003|Overall Study|Second cancer|0|||
163933333|NCT01068210|592125517|FG000|Overall Study|Disease progression|0|||
163933334|NCT01068210|592125518|FG001|Overall Study|Disease progression|0|||
163933335|NCT01068210|592125519|FG002|Overall Study|Disease progression|0|||
163933336|NCT01068210|592125520|FG003|Overall Study|Disease progression|2|||
163933337|NCT03569891|592125521|FG000|Lead-in|Ineligible during lead-in|8|||
163933338|NCT03569891|592125521|FG000|Lead-in|Withdrawal by Subject|3|||
163933339|NCT03569891|592125521|FG000|Lead-in|Risks related to COVID-19|2|||
163933340|NCT03569891|592125521|FG000|AMT-061|Adverse Event|1|||
163933341|NCT03299959|592125524|FG000|Overall Study|Lost to Follow-up|7|||
163933342|NCT03299959|592125525|FG001|Overall Study|Lost to Follow-up|9|||
163933343|NCT03299959|592125524|FG000|Overall Study|Death|1|||
163933344|NCT03299959|592125525|FG001|Overall Study|Death|0|||
163933345|NCT03299959|592125524|FG000|Overall Study|Withdrawal by Subject|13|||
163933346|NCT03299959|592125525|FG001|Overall Study|Withdrawal by Subject|9|||
163933347|NCT03299959|592125524|FG000|Overall Study|Changes in study team and government regulations|1|||
163933348|NCT03299959|592125525|FG001|Overall Study|Changes in study team and government regulations|1|||
163933349|NCT03299959|592125524|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
163933350|NCT03299959|592125525|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
163933351|NCT03170518|592125526|FG000|Overall Study|Lost to Follow-up|4|||
163933352|NCT03170518|592125527|FG001|Overall Study|Lost to Follow-up|1|||
163933353|NCT03170518|592125528|FG002|Overall Study|Lost to Follow-up|0|||
163933354|NCT03170518|592125526|FG000|Overall Study|Physician Decision|1|||
163933355|NCT03170518|592125527|FG001|Overall Study|Physician Decision|0|||
163933356|NCT03170518|592125528|FG002|Overall Study|Physician Decision|0|||
163933357|NCT03170518|592125526|FG000|Overall Study|Withdrawal by Subject|4|||
163933358|NCT03170518|592125527|FG001|Overall Study|Withdrawal by Subject|5|||
163933359|NCT03170518|592125528|FG002|Overall Study|Withdrawal by Subject|2|||
163933360|NCT03170518|592125526|FG000|Overall Study|Site terminated by sponsor|0|||
163933361|NCT03170518|592125527|FG001|Overall Study|Site terminated by sponsor|1|||
163933362|NCT03170518|592125528|FG002|Overall Study|Site terminated by sponsor|0|||
163933363|NCT03170518|592125526|FG000|Overall Study|Non-compliance with study drug|1|||
163933364|NCT03170518|592125527|FG001|Overall Study|Non-compliance with study drug|0|||
163933365|NCT03170518|592125528|FG002|Overall Study|Non-compliance with study drug|1|||
163933366|NCT03170518|592125526|FG000|Overall Study|Withdrawal by parent/guardian|2|||
163933367|NCT03170518|592125527|FG001|Overall Study|Withdrawal by parent/guardian|0|||
163933368|NCT03170518|592125528|FG002|Overall Study|Withdrawal by parent/guardian|0|||
163933369|NCT03842436|592125529|FG000|Overall Study|Lost to Follow-up|1|||
163933370|NCT01948076|592125530|FG000|Overall Study|Withdrawal by Subject|0|||
163933371|NCT01948076|592125531|FG001|Overall Study|Withdrawal by Subject|1|||
163933372|NCT00356811|592125532|FG000|Overall Study|Death|35|||
163933373|NCT00356811|592125532|FG000|Overall Study|Lost to Follow-up|2|||
163933374|NCT00356811|592125532|FG000|Overall Study|Withdrawal by Subject|6|||
163933375|NCT00356811|592125532|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
163933376|NCT00356811|592125532|FG000|Overall Study|Study Is Terminating|3|||
163933377|NCT00356811|592125532|FG000|Overall Study|Site Closed during Follow-up|2|||
163933378|NCT02201901|592125537|FG000|Overall Study|Randomized but never treated|0|||
163933379|NCT02201901|592125538|FG001|Overall Study|Randomized but never treated|1|||
163933380|NCT02201901|592125539|FG002|Overall Study|Randomized but never treated|0|||
163933381|NCT02201901|592125537|FG000|Overall Study|Lack of Efficacy|7|||
163933382|NCT02201901|592125538|FG001|Overall Study|Lack of Efficacy|1|||
163933383|NCT02201901|592125539|FG002|Overall Study|Lack of Efficacy|6|||
163933384|NCT02201901|592125537|FG000|Overall Study|Death|3|||
163933385|NCT02201901|592125538|FG001|Overall Study|Death|3|||
164037196|NCT00369278|592496650|FG000|Overall Study|Lost to Follow-up|1|||
164037197|NCT00369278|592496651|FG001|Overall Study|Lost to Follow-up|0|||
164037198|NCT00369278|592496650|FG000|Overall Study|Graft loss|1|||
164037199|NCT00369278|592496651|FG001|Overall Study|Graft loss|2|||
164037200|NCT02044822|592496652|FG000|Overall Study|Study Terminated by Sponsor|77|||
164037201|NCT02044822|592496652|FG000|Overall Study|Investigator's Discretion|10|||
164037202|NCT02044822|592496652|FG000|Overall Study|Withdrew Consent|3|||
164037203|NCT02044822|592496652|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
164037204|NCT02044822|592496652|FG000|Overall Study|Lost to Follow-up|1|||
163933386|NCT02201901|592125539|FG002|Overall Study|Death|3|||
163933387|NCT02201901|592125537|FG000|Overall Study|Lost to Follow-up|2|||
163933388|NCT02201901|592125538|FG001|Overall Study|Lost to Follow-up|3|||
163933389|NCT02201901|592125539|FG002|Overall Study|Lost to Follow-up|2|||
163933390|NCT02201901|592125537|FG000|Overall Study|Withdrew Consent|2|||
163933391|NCT02201901|592125538|FG001|Overall Study|Withdrew Consent|0|||
163933392|NCT02201901|592125539|FG002|Overall Study|Withdrew Consent|2|||
163933393|NCT02201901|592125537|FG000|Overall Study|Adverse Event|1|||
163933394|NCT02201901|592125538|FG001|Overall Study|Adverse Event|1|||
163933395|NCT02201901|592125539|FG002|Overall Study|Adverse Event|0|||
163933396|NCT01431950|592125540|FG000|Overall Study|Study Site Closed/Terminated|7|||
164037205|NCT02025530|592496655|FG000|Overall Study|No longer met elligibility criteria|5|||
164037206|NCT02025530|592496656|FG001|Overall Study|No longer met elligibility criteria|1|||
164037207|NCT03551626|592496661|FG000|Overall Study|Adverse Event|88|||
164037208|NCT03551626|592496661|FG000|Overall Study|Disease relapse|18|||
163933397|NCT01431950|592125541|FG001|Overall Study|Study Site Closed/Terminated|3|||
163933398|NCT01431950|592125540|FG000|Overall Study|Withdrawal by Subject|4|||
163933399|NCT01431950|592125541|FG001|Overall Study|Withdrawal by Subject|3|||
163933400|NCT01431950|592125540|FG000|Overall Study|Protocol Violation|2|||
163933401|NCT01431950|592125541|FG001|Overall Study|Protocol Violation|3|||
163933402|NCT01431950|592125540|FG000|Overall Study|Adverse Event|2|||
163933403|NCT01431950|592125541|FG001|Overall Study|Adverse Event|2|||
163933404|NCT01431950|592125540|FG000|Overall Study|Physician Decision|2|||
163933405|NCT01431950|592125541|FG001|Overall Study|Physician Decision|1|||
163933406|NCT01431950|592125540|FG000|Overall Study|Lack of Efficacy|2|||
163933407|NCT01431950|592125541|FG001|Overall Study|Lack of Efficacy|1|||
163933408|NCT01431950|592125540|FG000|Overall Study|Lost to Follow-up|0|||
163933409|NCT01431950|592125541|FG001|Overall Study|Lost to Follow-up|1|||
163933410|NCT01431950|592125540|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
163933411|NCT01431950|592125541|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
163933412|NCT00738283|592125542|FG000|Overall Study|Death|1|||
163933413|NCT00738283|592125542|FG000|Overall Study|Transfer to another facility|2|||
163933414|NCT00738283|592125542|FG000|Overall Study|Discharge home prior to end of study|1|||
163933415|NCT00469859|592125543|FG000|Overall Study|Inevaluable|0|||
163933416|NCT00469859|592125544|FG001|Overall Study|Inevaluable|2|||
163933417|NCT03494985|592125545|FG000|Overall Study|Adverse Event|3|||
163933418|NCT03494985|592125546|FG001|Overall Study|Adverse Event|2|||
163933419|NCT03494985|592125547|FG002|Overall Study|Adverse Event|3|||
163933420|NCT03494985|592125548|FG003|Overall Study|Adverse Event|0|||
163933421|NCT03494985|592125545|FG000|Overall Study|Other (Withdrawal of consent)|2|||
163933422|NCT03494985|592125546|FG001|Overall Study|Other (Withdrawal of consent)|3|||
163933423|NCT03494985|592125547|FG002|Overall Study|Other (Withdrawal of consent)|2|||
163933424|NCT03494985|592125548|FG003|Overall Study|Other (Withdrawal of consent)|5|||
163933425|NCT03494985|592125545|FG000|Overall Study|Other (Not specified)|0|||
163933426|NCT03494985|592125546|FG001|Overall Study|Other (Not specified)|1|||
163933427|NCT03494985|592125547|FG002|Overall Study|Other (Not specified)|1|||
163933428|NCT03494985|592125548|FG003|Overall Study|Other (Not specified)|0|||
163933429|NCT02282059|592125549|FG000|Overall Study|Other|15|||
163933430|NCT02282059|592125550|FG001|Overall Study|Other|3|||
163933431|NCT02282059|592125549|FG000|Overall Study|Participant refused further follow-up|8|||
163933432|NCT02282059|592125550|FG001|Overall Study|Participant refused further follow-up|4|||
163933433|NCT02282059|592125549|FG000|Overall Study|Lost to Follow-up|19|||
163933434|NCT02282059|592125550|FG001|Overall Study|Lost to Follow-up|3|||
163933435|NCT02282059|592125549|FG000|Overall Study|Death|40|||
163933436|NCT02282059|592125550|FG001|Overall Study|Death|8|||
163933437|NCT03459846|592125551|FG000|Overall Study|Death|52|||
163933438|NCT03459846|592125552|FG001|Overall Study|Death|46|||
163933439|NCT03459846|592125551|FG000|Overall Study|Study terminated by sponsor|24|||
163933440|NCT03459846|592125552|FG001|Overall Study|Study terminated by sponsor|28|||
163933441|NCT03459846|592125551|FG000|Overall Study|Withdrawal by Subject|2|||
163933442|NCT03459846|592125552|FG001|Overall Study|Withdrawal by Subject|2|||
163933443|NCT04886518|592125559|FG000|Overall Study|Noncompliance with study drug|1|||
163933444|NCT04886518|592125560|FG001|Overall Study|Noncompliance with study drug|0|||
163933445|NCT04886518|592125561|FG002|Overall Study|Noncompliance with study drug|0|||
163933446|NCT04886518|592125559|FG000|Overall Study|Adverse Event|0|||
163933447|NCT04886518|592125560|FG001|Overall Study|Adverse Event|1|||
163933448|NCT04886518|592125561|FG002|Overall Study|Adverse Event|0|||
163933449|NCT04886518|592125559|FG000|Overall Study|Withdrawal by Subject|1|||
163933450|NCT04886518|592125560|FG001|Overall Study|Withdrawal by Subject|0|||
163933451|NCT04886518|592125561|FG002|Overall Study|Withdrawal by Subject|0|||
163933452|NCT01443403|592127766|FG000|Overall Study|Adverse Event|1|||
163933453|NCT01443403|592127767|FG001|Overall Study|Adverse Event|1|||
163933454|NCT01443403|592127768|FG002|Overall Study|Adverse Event|4|||
163933455|NCT01443403|592127769|FG003|Overall Study|Adverse Event|5|||
163933456|NCT01443403|592127766|FG000|Overall Study|Withdrawal by Subject|0|||
163933457|NCT01443403|592127767|FG001|Overall Study|Withdrawal by Subject|1|||
163933458|NCT01443403|592127768|FG002|Overall Study|Withdrawal by Subject|2|||
163933459|NCT01443403|592127769|FG003|Overall Study|Withdrawal by Subject|1|||
163933460|NCT01443403|592127766|FG000|Overall Study|Lost to Follow-up|0|||
164037209|NCT03551626|592496661|FG000|Overall Study|Withdrawal of informed consent|6|||
164037210|NCT03551626|592496661|FG000|Overall Study|Patient decision|5|||
163933461|NCT01443403|592127767|FG001|Overall Study|Lost to Follow-up|0|||
163933462|NCT01443403|592127768|FG002|Overall Study|Lost to Follow-up|0|||
163933463|NCT01443403|592127769|FG003|Overall Study|Lost to Follow-up|1|||
163933464|NCT01443403|592127766|FG000|Overall Study|Protocol Violation|2|||
163933465|NCT01443403|592127767|FG001|Overall Study|Protocol Violation|1|||
163933466|NCT01443403|592127768|FG002|Overall Study|Protocol Violation|1|||
163933467|NCT01443403|592127769|FG003|Overall Study|Protocol Violation|1|||
163933468|NCT01443403|592127766|FG000|Overall Study|Use of Prohibited Treatment|2|||
163933469|NCT01443403|592127767|FG001|Overall Study|Use of Prohibited Treatment|3|||
163933470|NCT01443403|592127768|FG002|Overall Study|Use of Prohibited Treatment|0|||
163933471|NCT01443403|592127769|FG003|Overall Study|Use of Prohibited Treatment|0|||
163933472|NCT01443403|592127766|FG000|Overall Study|Other - Miscellaneous|1|||
163933473|NCT01443403|592127767|FG001|Overall Study|Other - Miscellaneous|0|||
163933474|NCT01443403|592127768|FG002|Overall Study|Other - Miscellaneous|0|||
163933475|NCT01443403|592127769|FG003|Overall Study|Other - Miscellaneous|1|||
163933476|NCT00725712|592127772|FG000|Overall Study|Withdrawal by Subject|2|||
163933477|NCT00725712|592127773|FG001|Overall Study|Withdrawal by Subject|1|||
163933478|NCT00725712|592127772|FG000|Overall Study|Protocol Violation|1|||
163933479|NCT00725712|592127773|FG001|Overall Study|Protocol Violation|0|||
163933480|NCT00725712|592127772|FG000|Overall Study|Progressive disease|37|||
163933481|NCT00725712|592127773|FG001|Overall Study|Progressive disease|16|||
163933482|NCT00725712|592127772|FG000|Overall Study|Clinical progression not based on RECIST|0|||
163933483|NCT00725712|592127773|FG001|Overall Study|Clinical progression not based on RECIST|3|||
163933484|NCT00725712|592127772|FG000|Overall Study|Adverse Event|5|||
163933485|NCT00725712|592127773|FG001|Overall Study|Adverse Event|5|||
163933486|NCT00725712|592127772|FG000|Overall Study|Death|2|||
163933487|NCT00725712|592127773|FG001|Overall Study|Death|0|||
163933488|NCT00725712|592127772|FG000|Overall Study|Other: Death|1|||
163933489|NCT00725712|592127773|FG001|Overall Study|Other: Death|0|||
163933490|NCT00725712|592127772|FG000|Overall Study|Hospitalized, unable to continue|0|||
163933491|NCT00725712|592127773|FG001|Overall Study|Hospitalized, unable to continue|1|||
163933492|NCT03607422|592127776|FG000|Overall Study|Adverse Event|7|||
163933493|NCT03607422|592127777|FG001|Overall Study|Adverse Event|3|||
163933494|NCT03607422|592127778|FG002|Overall Study|Adverse Event|2|||
163933495|NCT03607422|592127779|FG003|Overall Study|Adverse Event|0|||
163933496|NCT03607422|592127780|FG004|Overall Study|Adverse Event|2|||
163933497|NCT03607422|592127781|FG005|Overall Study|Adverse Event|0|||
163933498|NCT03607422|592127776|FG000|Overall Study|Withdrawal by Subject|11|||
163933499|NCT03607422|592127777|FG001|Overall Study|Withdrawal by Subject|3|||
163933500|NCT03607422|592127778|FG002|Overall Study|Withdrawal by Subject|6|||
163933501|NCT03607422|592127779|FG003|Overall Study|Withdrawal by Subject|2|||
163933502|NCT03607422|592127780|FG004|Overall Study|Withdrawal by Subject|0|||
163933503|NCT03607422|592127781|FG005|Overall Study|Withdrawal by Subject|0|||
163933504|NCT03607422|592127776|FG000|Overall Study|Lost to Follow-up|0|||
163933505|NCT03607422|592127777|FG001|Overall Study|Lost to Follow-up|0|||
163933506|NCT03607422|592127778|FG002|Overall Study|Lost to Follow-up|1|||
163933507|NCT03607422|592127779|FG003|Overall Study|Lost to Follow-up|0|||
163933508|NCT03607422|592127780|FG004|Overall Study|Lost to Follow-up|0|||
163933509|NCT03607422|592127781|FG005|Overall Study|Lost to Follow-up|0|||
163933510|NCT03607422|592127776|FG000|Overall Study|Other|12|||
163933511|NCT03607422|592127777|FG001|Overall Study|Other|4|||
163933512|NCT03607422|592127778|FG002|Overall Study|Other|1|||
163933513|NCT03607422|592127779|FG003|Overall Study|Other|2|||
163933514|NCT03607422|592127780|FG004|Overall Study|Other|0|||
163933515|NCT03607422|592127781|FG005|Overall Study|Other|2|||
163933516|NCT03607422|592127776|FG000|Overall Study|Ongoing at Time of Analysis|8|||
163933517|NCT03607422|592127777|FG001|Overall Study|Ongoing at Time of Analysis|0|||
163933518|NCT03607422|592127778|FG002|Overall Study|Ongoing at Time of Analysis|2|||
163933519|NCT03607422|592127779|FG003|Overall Study|Ongoing at Time of Analysis|1|||
163933520|NCT03607422|592127780|FG004|Overall Study|Ongoing at Time of Analysis|1|||
163933521|NCT03607422|592127781|FG005|Overall Study|Ongoing at Time of Analysis|1|||
163933522|NCT00863512|592127782|FG000|Overall Study|Adverse Event|2|||
163933523|NCT00863512|592127783|FG001|Overall Study|Adverse Event|0|||
163933524|NCT00863512|592127782|FG000|Overall Study|Withdrawal by Subject|11|||
163933525|NCT00863512|592127783|FG001|Overall Study|Withdrawal by Subject|0|||
163933526|NCT00863512|592127782|FG000|Overall Study|Physician Decision|1|||
163933527|NCT00863512|592127783|FG001|Overall Study|Physician Decision|0|||
163933528|NCT03258723|592127786|FG000|Overall Study|COVID Interruption of study|54|||
163933529|NCT03258723|592127786|FG000|Overall Study|Lost to Follow-up|8|||
164098508|NCT04320849|592725126|FG000|Overall Study|Imaging data unavailable|2|||
163933530|NCT04832971|592127787|FG000|Double-Blind (DB) Treatment Period|Death|1|||
163933531|NCT04832971|592127788|FG001|Double-Blind (DB) Treatment Period|Death|0|||
163933532|NCT04832971|592127789|FG002|Double-Blind (DB) Treatment Period|Death|0|||
163933533|NCT04832971|592127790|FG003|Double-Blind (DB) Treatment Period|Death|0|||
163933534|NCT04832971|592127791|FG004|Double-Blind (DB) Treatment Period|Death|0|||
163933535|NCT04832971|592127792|FG005|Double-Blind (DB) Treatment Period|Death|0|||
163933536|NCT04832971|592127793|FG006|Double-Blind (DB) Treatment Period|Death|0|||
163933537|NCT04832971|592127794|FG007|Double-Blind (DB) Treatment Period|Death|0|||
163933538|NCT04832971|592127795|FG008|Double-Blind (DB) Treatment Period|Death|0|||
163933539|NCT04832971|592127796|FG009|Double-Blind (DB) Treatment Period|Death|0|||
164098509|NCT04320849|592725126|FG000|Overall Study|Incomplete imaging|2|||
163933540|NCT04832971|592127787|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163933541|NCT04832971|592127788|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163933542|NCT04832971|592127789|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
163933543|NCT04832971|592127790|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933544|NCT04832971|592127791|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933545|NCT04832971|592127792|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933546|NCT04832971|592127793|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933547|NCT04832971|592127794|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933548|NCT04832971|592127795|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933549|NCT04832971|592127796|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
163933550|NCT04832971|592127787|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
163933551|NCT04832971|592127788|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
163933552|NCT04832971|592127789|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
163933553|NCT04832971|592127790|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
163933554|NCT04832971|592127791|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163933555|NCT04832971|592127792|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163933556|NCT04832971|592127793|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163933557|NCT04832971|592127794|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163933558|NCT04832971|592127795|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163933559|NCT04832971|592127796|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
163933560|NCT04832971|592127787|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933561|NCT04832971|592127788|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
163933562|NCT04832971|592127789|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933563|NCT04832971|592127790|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933564|NCT04832971|592127791|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933565|NCT04832971|592127792|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933566|NCT04832971|592127793|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933567|NCT04832971|592127794|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933568|NCT04832971|592127795|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933569|NCT04832971|592127796|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
163933570|NCT04832971|592127787|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
163933571|NCT04832971|592127788|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
163933572|NCT04832971|592127789|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
163933573|NCT04832971|592127790|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
163933574|NCT04832971|592127791|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
163933575|NCT04832971|592127792|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
163933576|NCT04832971|592127793|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
163933577|NCT04832971|592127794|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
163933578|NCT04832971|592127795|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
163933579|NCT04832971|592127796|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
163933580|NCT04832971|592127787|FG000|Open-Label Extension (OLE) Period|Death|0|||
163933581|NCT04832971|592127788|FG001|Open-Label Extension (OLE) Period|Death|0|||
163933582|NCT04832971|592127789|FG002|Open-Label Extension (OLE) Period|Death|0|||
163933583|NCT04832971|592127790|FG003|Open-Label Extension (OLE) Period|Death|0|||
163933584|NCT04832971|592127791|FG004|Open-Label Extension (OLE) Period|Death|0|||
163933585|NCT04832971|592127792|FG005|Open-Label Extension (OLE) Period|Death|0|||
163933586|NCT04832971|592127793|FG006|Open-Label Extension (OLE) Period|Death|0|||
163933587|NCT04832971|592127794|FG007|Open-Label Extension (OLE) Period|Death|1|||
163933588|NCT04832971|592127795|FG008|Open-Label Extension (OLE) Period|Death|0|||
163933589|NCT04832971|592127796|FG009|Open-Label Extension (OLE) Period|Death|0|||
163933590|NCT04832971|592127787|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933591|NCT04832971|592127788|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933592|NCT04832971|592127789|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933593|NCT04832971|592127790|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933594|NCT04832971|592127791|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933595|NCT04832971|592127792|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933596|NCT04832971|592127793|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
163933597|NCT04832971|592127794|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
163933598|NCT04832971|592127795|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933599|NCT04832971|592127796|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
163933600|NCT04832971|592127787|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163933601|NCT04832971|592127788|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163933602|NCT04832971|592127789|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163933603|NCT04832971|592127790|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
163933604|NCT04832971|592127791|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
163933605|NCT04832971|592127792|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
163933606|NCT04832971|592127793|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
163933607|NCT04832971|592127794|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
163933608|NCT04832971|592127795|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
164037211|NCT03551626|592496661|FG000|Overall Study|Physician Decision|4|||
164037212|NCT03551626|592496661|FG000|Overall Study|Lost to Follow-up|3|||
164037213|NCT03551626|592496661|FG000|Overall Study|Pregnancy|1|||
163933609|NCT04832971|592127796|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
163933610|NCT04832971|592127787|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
164037214|NCT03551626|592496661|FG000|Overall Study|Protocol deviation|1|||
164098510|NCT03135834|592725133|FG000|Stage 1|Adverse Event|1|||
163838471|NCT02778399|591779708|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
163838472|NCT02778399|591779709|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
163838473|NCT02778399|591779710|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
163838474|NCT02778399|591779711|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
163838475|NCT02778399|591779712|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
163838476|NCT02778399|591779713|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
163838477|NCT02778399|591779708|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
163838478|NCT02778399|591779709|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
163838479|NCT02778399|591779710|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
163838480|NCT02778399|591779711|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
163838481|NCT02778399|591779712|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
163838482|NCT02778399|591779713|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
163838483|NCT02778399|591779708|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
163838484|NCT02778399|591779709|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163838485|NCT02778399|591779710|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163838486|NCT02778399|591779711|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163838487|NCT02778399|591779712|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
163838488|NCT02778399|591779713|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
163838489|NCT02778399|591779708|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
163838490|NCT02778399|591779709|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
163838491|NCT02778399|591779710|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
163838492|NCT02778399|591779711|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
163838493|NCT02778399|591779712|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
163838494|NCT02778399|591779713|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
163838495|NCT02778399|591779708|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
163838496|NCT02778399|591779709|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
163838497|NCT02778399|591779710|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
163838498|NCT02778399|591779711|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
163838499|NCT02778399|591779712|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
163838500|NCT02778399|591779713|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
163838501|NCT02778399|591779708|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
163838502|NCT02778399|591779709|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
163838503|NCT02778399|591779710|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
163838504|NCT02778399|591779711|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
163838505|NCT02778399|591779712|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
163838506|NCT02778399|591779713|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
163838507|NCT02778399|591779708|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163838508|NCT02778399|591779709|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
163838509|NCT02778399|591779710|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163838510|NCT02778399|591779711|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163838511|NCT02778399|591779712|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163838512|NCT02778399|591779713|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
163838513|NCT02778399|591779708|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
163838514|NCT02778399|591779709|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
163838515|NCT02778399|591779710|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
163838516|NCT02778399|591779711|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
163838517|NCT02778399|591779712|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
163838518|NCT02778399|591779713|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
163838519|NCT02778399|591779708|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
163838520|NCT02778399|591779709|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163838521|NCT02778399|591779710|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
163838522|NCT02778399|591779711|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163838523|NCT02778399|591779712|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163838524|NCT02778399|591779713|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
163838525|NCT02778399|591779708|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
163838526|NCT02778399|591779709|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
163838527|NCT02778399|591779710|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
163838528|NCT02778399|591779711|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
163838529|NCT02778399|591779712|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
163838530|NCT02778399|591779713|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
163838531|NCT02978443|591779715|FG000|Overall Study|Withdrawal by Subject|1|||
163838532|NCT02978443|591779715|FG000|Overall Study|Adverse Event|3|||
163838533|NCT02978443|591779715|FG000|Overall Study|Disease Progression on study|6|||
163838534|NCT02978443|591779715|FG000|Overall Study|Death|1|||
163838535|NCT02978443|591779715|FG000|Overall Study|Physician Decision|1|||
163838536|NCT02978443|591779715|FG000|Overall Study|Switch to alternative therapy|1|||
163838537|NCT02978443|591779715|FG000|Overall Study|Refused further treatment|1|||
163933611|NCT04832971|592127788|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163933612|NCT04832971|592127789|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163933613|NCT04832971|592127790|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163933614|NCT04832971|592127791|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
163933615|NCT04832971|592127792|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
163933616|NCT04832971|592127793|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163933617|NCT04832971|592127794|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163933618|NCT04832971|592127795|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163838538|NCT00405639|591779716|FG000|Overall Study|Withdrawal by Subject|1|||
163838539|NCT00405639|591779717|FG001|Overall Study|Withdrawal by Subject|0|||
163838540|NCT00405639|591779716|FG000|Overall Study|Adverse Event|1|||
163838541|NCT00405639|591779717|FG001|Overall Study|Adverse Event|0|||
163838542|NCT00405639|591779716|FG000|Overall Study|Seizure prior to receiving BNP|1|||
163838543|NCT00405639|591779717|FG001|Overall Study|Seizure prior to receiving BNP|0|||
163838544|NCT00612534|591779721|FG000|Overall Study|Adverse Event|0|||
163838545|NCT00612534|591779722|FG001|Overall Study|Adverse Event|4|||
163838546|NCT00612534|591779723|FG002|Overall Study|Adverse Event|2|||
163838547|NCT00612534|591779724|FG003|Overall Study|Adverse Event|1|||
163838548|NCT00612534|591779721|FG000|Overall Study|Lack of Efficacy|13|||
163838549|NCT00612534|591779722|FG001|Overall Study|Lack of Efficacy|12|||
163838550|NCT00612534|591779723|FG002|Overall Study|Lack of Efficacy|5|||
163838551|NCT00612534|591779724|FG003|Overall Study|Lack of Efficacy|16|||
163838552|NCT00612534|591779721|FG000|Overall Study|Other Reason|0|||
163838553|NCT00612534|591779722|FG001|Overall Study|Other Reason|1|||
163838554|NCT00612534|591779723|FG002|Overall Study|Other Reason|0|||
163838555|NCT00612534|591779724|FG003|Overall Study|Other Reason|0|||
163838556|NCT02130284|591779731|FG000|Overall Study|Withdrawal by Subject|3|||
163838557|NCT02130284|591779731|FG000|Overall Study|Subject Withdrew Consent|1|||
163838558|NCT02130284|591779731|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
163838559|NCT02130284|591779731|FG000|Overall Study|Subject was screened as backup for study|3|||
163838560|NCT02130284|591779731|FG000|Overall Study|Screen Failure|1|||
163838561|NCT01852058|591779733|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
163838562|NCT01852058|591779734|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838563|NCT01852058|591779735|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838564|NCT01852058|591779736|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838565|NCT01852058|591779737|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838566|NCT01852058|591779738|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838567|NCT01852058|591779739|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838568|NCT01852058|591779740|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838569|NCT01852058|591779741|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838570|NCT01852058|591779742|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838571|NCT01852058|591779743|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838572|NCT01852058|591779744|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
163838573|NCT01852058|591779733|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838574|NCT01852058|591779734|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838575|NCT01852058|591779735|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838576|NCT01852058|591779736|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838577|NCT01852058|591779737|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
163838578|NCT01852058|591779738|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838579|NCT01852058|591779739|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838580|NCT01852058|591779740|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838581|NCT01852058|591779741|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838582|NCT01852058|591779742|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838583|NCT01852058|591779743|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838584|NCT01852058|591779744|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
163838585|NCT01852058|591779733|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838586|NCT01852058|591779734|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838587|NCT01852058|591779735|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838588|NCT01852058|591779736|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838589|NCT01852058|591779737|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
163838590|NCT01852058|591779738|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
163838591|NCT01852058|591779739|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838592|NCT01852058|591779740|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838593|NCT01852058|591779741|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838594|NCT01852058|591779742|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838595|NCT01852058|591779743|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838596|NCT01852058|591779744|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
163838597|NCT01852058|591779733|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163933619|NCT04832971|592127796|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
163933620|NCT04832971|592127787|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933621|NCT04832971|592127788|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933622|NCT04832971|592127789|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933623|NCT04832971|592127790|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933624|NCT04832971|592127791|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933625|NCT04832971|592127792|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933626|NCT04832971|592127793|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
163933627|NCT04832971|592127794|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
163933628|NCT04832971|592127795|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
163933629|NCT04832971|592127796|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
163933630|NCT01107899|592127797|FG000|Overall Study|Physician Decision|5|||
163933631|NCT01107899|592127798|FG001|Overall Study|Physician Decision|0|||
163933632|NCT01107899|592127799|FG002|Overall Study|Physician Decision|3|||
163933633|NCT01107899|592127797|FG000|Overall Study|Withdrawal by Subject|0|||
163933634|NCT01107899|592127798|FG001|Overall Study|Withdrawal by Subject|0|||
163933635|NCT01107899|592127799|FG002|Overall Study|Withdrawal by Subject|1|||
163933636|NCT03584152|592127800|FG000|Overall Study|Discontinued intervention|7|||
163933637|NCT03584152|592127801|FG001|Overall Study|Discontinued intervention|4|||
163933638|NCT04024462|592127802|FG000|Overall Study|Withdrawal by Subject|6|||
163933639|NCT04024462|592127803|FG001|Overall Study|Withdrawal by Subject|7|||
163933640|NCT04024462|592127802|FG000|Overall Study|Progressive Disease|0|||
163933641|NCT04024462|592127803|FG001|Overall Study|Progressive Disease|1|||
163933642|NCT04024462|592127802|FG000|Overall Study|Adverse Event|0|||
163933643|NCT04024462|592127803|FG001|Overall Study|Adverse Event|1|||
163933644|NCT04024462|592127802|FG000|Overall Study|Death|0|||
163933645|NCT04024462|592127803|FG001|Overall Study|Death|1|||
163933646|NCT04024462|592127802|FG000|Overall Study|Lost to Follow-up|1|||
163933647|NCT04024462|592127803|FG001|Overall Study|Lost to Follow-up|0|||
163933648|NCT04024462|592127802|FG000|Overall Study|Ongoing in the Study|94|||
163933649|NCT04024462|592127803|FG001|Overall Study|Ongoing in the Study|89|||
163933650|NCT00983749|592127808|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
163933651|NCT00983749|592127809|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
163933652|NCT04292470|592127810|FG000|Overall Study|Withdrawal by Subject|0|||
163933653|NCT04292470|592127811|FG001|Overall Study|Withdrawal by Subject|1|||
163933654|NCT02906020|592127825|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
163933655|NCT02906020|592127826|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
163933656|NCT02906020|592127827|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
163933657|NCT02906020|592127828|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
163933658|NCT02906020|592127829|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
163933659|NCT02906020|592127830|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
163933660|NCT02906020|592127831|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
163933661|NCT02906020|592127832|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
163933662|NCT02906020|592127833|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
163933663|NCT02906020|592127834|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
163933664|NCT02906020|592127835|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
163933665|NCT02906020|592127836|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
163933666|NCT02906020|592127837|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
163933667|NCT02906020|592127838|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
163933668|NCT02906020|592127839|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
163933669|NCT02906020|592127840|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
163933670|NCT02906020|592127825|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933671|NCT02906020|592127826|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933672|NCT02906020|592127827|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933673|NCT02906020|592127828|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933674|NCT02906020|592127829|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933675|NCT02906020|592127830|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933676|NCT02906020|592127831|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933677|NCT02906020|592127832|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933678|NCT02906020|592127833|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
163933679|NCT02906020|592127834|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
163933680|NCT02906020|592127835|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933681|NCT02906020|592127836|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933682|NCT02906020|592127837|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933683|NCT02906020|592127838|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933684|NCT02906020|592127839|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933685|NCT02906020|592127840|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
163933686|NCT02906020|592127825|FG000|Part 2: Double-blind Treatment Period|Other|0|||
163933687|NCT02906020|592127826|FG001|Part 2: Double-blind Treatment Period|Other|0|||
163933688|NCT02906020|592127827|FG002|Part 2: Double-blind Treatment Period|Other|0|||
163933689|NCT02906020|592127828|FG003|Part 2: Double-blind Treatment Period|Other|0|||
163933690|NCT02906020|592127829|FG004|Part 2: Double-blind Treatment Period|Other|0|||
163933691|NCT02906020|592127830|FG005|Part 2: Double-blind Treatment Period|Other|0|||
163933692|NCT02906020|592127831|FG006|Part 2: Double-blind Treatment Period|Other|0|||
163933693|NCT02906020|592127832|FG007|Part 2: Double-blind Treatment Period|Other|0|||
163933694|NCT02906020|592127833|FG008|Part 2: Double-blind Treatment Period|Other|6|||
163933695|NCT02906020|592127834|FG009|Part 2: Double-blind Treatment Period|Other|10|||
163933696|NCT02906020|592127835|FG010|Part 2: Double-blind Treatment Period|Other|0|||
163933697|NCT02906020|592127836|FG011|Part 2: Double-blind Treatment Period|Other|0|||
163933698|NCT02906020|592127837|FG012|Part 2: Double-blind Treatment Period|Other|0|||
163933699|NCT02906020|592127838|FG013|Part 2: Double-blind Treatment Period|Other|0|||
163933700|NCT02906020|592127839|FG014|Part 2: Double-blind Treatment Period|Other|0|||
163933701|NCT02906020|592127840|FG015|Part 2: Double-blind Treatment Period|Other|0|||
163933702|NCT02906020|592127825|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933703|NCT02906020|592127826|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933704|NCT02906020|592127827|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933705|NCT02906020|592127828|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933706|NCT02906020|592127829|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933707|NCT02906020|592127830|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933708|NCT02906020|592127831|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933709|NCT02906020|592127832|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933710|NCT02906020|592127833|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933711|NCT02906020|592127834|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933712|NCT02906020|592127835|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933713|NCT02906020|592127836|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933714|NCT02906020|592127837|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
163933715|NCT02906020|592127838|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
163933716|NCT02906020|592127839|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933717|NCT02906020|592127840|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
163933718|NCT02906020|592127825|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933719|NCT02906020|592127826|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933720|NCT02906020|592127827|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933721|NCT02906020|592127828|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933722|NCT02906020|592127829|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933723|NCT02906020|592127830|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933724|NCT02906020|592127831|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933725|NCT02906020|592127832|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933726|NCT02906020|592127833|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933727|NCT02906020|592127834|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933728|NCT02906020|592127835|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933729|NCT02906020|592127836|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933730|NCT02906020|592127837|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
163933731|NCT02906020|592127838|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
163933732|NCT02906020|592127839|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
163933733|NCT02906020|592127840|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
163933734|NCT02906020|592127825|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933735|NCT02906020|592127826|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933736|NCT02906020|592127827|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933737|NCT02906020|592127828|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933738|NCT02906020|592127829|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933739|NCT02906020|592127830|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933740|NCT02906020|592127831|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933741|NCT02906020|592127832|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933742|NCT02906020|592127833|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933743|NCT02906020|592127834|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933744|NCT02906020|592127835|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933745|NCT02906020|592127836|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933746|NCT02906020|592127837|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
164037215|NCT03551626|592496661|FG000|Overall Study|Technical problems|1|||
164037216|NCT00653328|592496662|FG000|Overall Study|Withdrawal by Subject|1|||
164037217|NCT00653328|592496662|FG000|Overall Study|Adverse Event|2|||
164037218|NCT00653328|592496662|FG000|Overall Study|Disease progression|10|||
164037219|NCT00653328|592496662|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
163933747|NCT02906020|592127838|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
163933748|NCT02906020|592127839|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933749|NCT02906020|592127840|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
163933750|NCT02906020|592127825|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
164037220|NCT00443846|592496670|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
163933751|NCT02906020|592127826|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933752|NCT02906020|592127827|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933753|NCT02906020|592127828|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933754|NCT02906020|592127829|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933755|NCT02906020|592127830|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933756|NCT02906020|592127831|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933757|NCT02906020|592127832|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933758|NCT02906020|592127833|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933759|NCT02906020|592127834|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933760|NCT02906020|592127835|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933761|NCT02906020|592127836|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933762|NCT02906020|592127837|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
163933763|NCT02906020|592127838|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
163933764|NCT02906020|592127839|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933765|NCT02906020|592127840|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
163933766|NCT02906020|592127825|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933767|NCT02906020|592127826|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933768|NCT02906020|592127827|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933769|NCT02906020|592127828|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933770|NCT02906020|592127829|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933771|NCT02906020|592127830|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933772|NCT02906020|592127831|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933773|NCT02906020|592127832|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933774|NCT02906020|592127833|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933775|NCT02906020|592127834|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933776|NCT02906020|592127835|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933777|NCT02906020|592127836|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
163933778|NCT02906020|592127837|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
163933779|NCT02906020|592127838|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
163933780|NCT02906020|592127839|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
163933781|NCT02906020|592127840|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
163933782|NCT02906020|592127825|FG000|Part 2: Long-term Follow-up Period|Other|0|||
163933783|NCT02906020|592127826|FG001|Part 2: Long-term Follow-up Period|Other|0|||
163933784|NCT02906020|592127827|FG002|Part 2: Long-term Follow-up Period|Other|0|||
163933785|NCT02906020|592127828|FG003|Part 2: Long-term Follow-up Period|Other|0|||
163933786|NCT02906020|592127829|FG004|Part 2: Long-term Follow-up Period|Other|0|||
163933787|NCT02906020|592127830|FG005|Part 2: Long-term Follow-up Period|Other|0|||
163933788|NCT02906020|592127831|FG006|Part 2: Long-term Follow-up Period|Other|0|||
163933789|NCT02906020|592127832|FG007|Part 2: Long-term Follow-up Period|Other|0|||
163933790|NCT02906020|592127833|FG008|Part 2: Long-term Follow-up Period|Other|0|||
163933791|NCT02906020|592127834|FG009|Part 2: Long-term Follow-up Period|Other|0|||
163933792|NCT02906020|592127835|FG010|Part 2: Long-term Follow-up Period|Other|0|||
163933793|NCT02906020|592127836|FG011|Part 2: Long-term Follow-up Period|Other|0|||
163933794|NCT02906020|592127837|FG012|Part 2: Long-term Follow-up Period|Other|13|||
164037221|NCT00443846|592496671|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
164037222|NCT00443846|592496670|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
164037223|NCT00443846|592496671|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
164037224|NCT00443846|592496670|FG000|Overall Study|Adverse Event|0|||
164037225|NCT00443846|592496671|FG001|Overall Study|Adverse Event|1|||
164037226|NCT00443846|592496670|FG000|Overall Study|Personal reason|8|||
164037227|NCT00443846|592496671|FG001|Overall Study|Personal reason|3|||
163838598|NCT01852058|591779734|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838599|NCT01852058|591779735|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838600|NCT01852058|591779736|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838601|NCT01852058|591779737|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
163838602|NCT01852058|591779738|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838603|NCT01852058|591779739|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838604|NCT01852058|591779740|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838605|NCT01852058|591779741|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838606|NCT01852058|591779742|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838607|NCT01852058|591779743|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838608|NCT01852058|591779744|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
163838609|NCT01852058|591779733|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838610|NCT01852058|591779734|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838611|NCT01852058|591779735|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163933795|NCT02906020|592127838|FG013|Part 2: Long-term Follow-up Period|Other|8|||
163933796|NCT02906020|592127839|FG014|Part 2: Long-term Follow-up Period|Other|3|||
163933797|NCT02906020|592127840|FG015|Part 2: Long-term Follow-up Period|Other|2|||
163933798|NCT01907906|592127846|FG000|Overall Study|Withdrawal by Subject|1|||
163933799|NCT01907906|592127847|FG001|Overall Study|Withdrawal by Subject|0|||
163933800|NCT01907906|592127846|FG000|Overall Study|Physician Decision|3|||
163933801|NCT01907906|592127847|FG001|Overall Study|Physician Decision|1|||
163933802|NCT00979953|592127848|FG000|Overall Study|Adverse Event|5|||
163933803|NCT00979953|592127849|FG001|Overall Study|Adverse Event|2|||
163933804|NCT00979953|592127850|FG002|Overall Study|Adverse Event|17|||
163933805|NCT00979953|592127851|FG003|Overall Study|Adverse Event|4|||
163933806|NCT00979953|592127848|FG000|Overall Study|Lack of Efficacy|1|||
163933807|NCT00979953|592127849|FG001|Overall Study|Lack of Efficacy|2|||
163933808|NCT00979953|592127850|FG002|Overall Study|Lack of Efficacy|0|||
163933809|NCT00979953|592127851|FG003|Overall Study|Lack of Efficacy|0|||
163933810|NCT00979953|592127848|FG000|Overall Study|Lost to Follow-up|1|||
163933811|NCT00979953|592127849|FG001|Overall Study|Lost to Follow-up|1|||
163933812|NCT00979953|592127850|FG002|Overall Study|Lost to Follow-up|1|||
163933813|NCT00979953|592127851|FG003|Overall Study|Lost to Follow-up|0|||
163933814|NCT00979953|592127848|FG000|Overall Study|Withdrawal by Subject|0|||
163933815|NCT00979953|592127849|FG001|Overall Study|Withdrawal by Subject|0|||
163933816|NCT00979953|592127850|FG002|Overall Study|Withdrawal by Subject|2|||
163933817|NCT00979953|592127851|FG003|Overall Study|Withdrawal by Subject|1|||
163933818|NCT00979953|592127848|FG000|Overall Study|Protocol Violation|1|||
163933819|NCT00979953|592127849|FG001|Overall Study|Protocol Violation|0|||
163933820|NCT00979953|592127850|FG002|Overall Study|Protocol Violation|2|||
163933821|NCT00979953|592127851|FG003|Overall Study|Protocol Violation|2|||
163933822|NCT01124097|592127852|FG000|Overall Study|Withdrawal by Subject|4|||
163933823|NCT01124097|592127853|FG001|Overall Study|Withdrawal by Subject|3|||
163933824|NCT01124097|592127854|FG002|Overall Study|Withdrawal by Subject|2|||
163933825|NCT01124097|592127855|FG003|Overall Study|Withdrawal by Subject|3|||
163933826|NCT01124097|592127852|FG000|Overall Study|Lack of Efficacy|2|||
163933827|NCT01124097|592127853|FG001|Overall Study|Lack of Efficacy|3|||
163933828|NCT01124097|592127854|FG002|Overall Study|Lack of Efficacy|1|||
163933829|NCT01124097|592127855|FG003|Overall Study|Lack of Efficacy|3|||
163933830|NCT01124097|592127852|FG000|Overall Study|Adverse Event|24|||
163933831|NCT01124097|592127853|FG001|Overall Study|Adverse Event|15|||
163933832|NCT01124097|592127854|FG002|Overall Study|Adverse Event|15|||
163933833|NCT01124097|592127855|FG003|Overall Study|Adverse Event|7|||
163933834|NCT01124097|592127852|FG000|Overall Study|Protocol Violation|2|||
163933835|NCT01124097|592127853|FG001|Overall Study|Protocol Violation|0|||
163933836|NCT01124097|592127854|FG002|Overall Study|Protocol Violation|2|||
163933837|NCT01124097|592127855|FG003|Overall Study|Protocol Violation|1|||
163933838|NCT01124097|592127852|FG000|Overall Study|Physician Decision|2|||
163933839|NCT01124097|592127853|FG001|Overall Study|Physician Decision|1|||
163933840|NCT01124097|592127854|FG002|Overall Study|Physician Decision|0|||
163933841|NCT01124097|592127855|FG003|Overall Study|Physician Decision|0|||
163933842|NCT00559377|592127865|FG000|Overall Study|Withdrawal by Subject|9|||
163933843|NCT00203047|592127870|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
163933844|NCT00203047|592127871|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
163933845|NCT00203047|592127870|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
163933846|NCT00203047|592127871|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
164037228|NCT00443846|592496670|FG000|Overall Study|Lost to Follow-up|1|||
164037229|NCT00443846|592496671|FG001|Overall Study|Lost to Follow-up|2|||
164037230|NCT03051217|592496675|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
164037231|NCT03051217|592496676|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164037232|NCT03051217|592496677|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
164037233|NCT03051217|592496678|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164037234|NCT03051217|592496679|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164037235|NCT03051217|592496680|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164037236|NCT03051217|592496681|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164037237|NCT03051217|592496675|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164037238|NCT03051217|592496676|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
163933847|NCT00203047|592127870|FG000|Overall Study|Withdrawal by Subject|13|||
163933848|NCT00203047|592127871|FG001|Overall Study|Withdrawal by Subject|47|||
163933849|NCT00203047|592127870|FG000|Overall Study|Teva requested participant withdrawal|1|||
164037239|NCT03051217|592496677|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
163933850|NCT00203047|592127871|FG001|Overall Study|Teva requested participant withdrawal|1|||
163933851|NCT00203047|592127870|FG000|Overall Study|Physician Decision|8|||
163933852|NCT00203047|592127871|FG001|Overall Study|Physician Decision|7|||
163933853|NCT00203047|592127870|FG000|Overall Study|Non-compliance|4|||
163933854|NCT00203047|592127871|FG001|Overall Study|Non-compliance|8|||
163933855|NCT00203047|592127870|FG000|Overall Study|Protocol Violation|1|||
163933856|NCT00203047|592127871|FG001|Overall Study|Protocol Violation|0|||
163933857|NCT00203047|592127870|FG000|Overall Study|Lost to Follow-up|11|||
163933858|NCT00203047|592127871|FG001|Overall Study|Lost to Follow-up|5|||
163933859|NCT00203047|592127870|FG000|Overall Study|Adverse Event|8|||
163933860|NCT00203047|592127871|FG001|Overall Study|Adverse Event|18|||
163933861|NCT00203047|592127870|FG000|Overall Study|Death|1|||
163933862|NCT00203047|592127871|FG001|Overall Study|Death|2|||
163933863|NCT00203047|592127870|FG000|Overall Study|Pregnancy|3|||
163933864|NCT00203047|592127871|FG001|Overall Study|Pregnancy|0|||
163933865|NCT00203047|592127870|FG000|Overall Study|Other|5|||
163933866|NCT00203047|592127871|FG001|Overall Study|Other|5|||
163933867|NCT02229227|592127872|FG000|Overall Study|Adverse Event|14|||
163933868|NCT02229227|592127873|FG001|Overall Study|Adverse Event|9|||
163933869|NCT02229227|592127872|FG000|Overall Study|Lack of Efficacy|3|||
163933870|NCT02229227|592127873|FG001|Overall Study|Lack of Efficacy|3|||
163933871|NCT02229227|592127872|FG000|Overall Study|Protocol Violation|6|||
163933872|NCT02229227|592127873|FG001|Overall Study|Protocol Violation|8|||
163933873|NCT02229227|592127872|FG000|Overall Study|Protocol defined stopping criteria|1|||
163933874|NCT02229227|592127873|FG001|Overall Study|Protocol defined stopping criteria|3|||
163933875|NCT02229227|592127872|FG000|Overall Study|Lost to Follow-up|3|||
163933876|NCT02229227|592127873|FG001|Overall Study|Lost to Follow-up|3|||
163933877|NCT02229227|592127872|FG000|Overall Study|Study terminated by sponsor|11|||
163933878|NCT02229227|592127873|FG001|Overall Study|Study terminated by sponsor|11|||
163933879|NCT02229227|592127872|FG000|Overall Study|Withdrawal by Subject|8|||
163933880|NCT02229227|592127873|FG001|Overall Study|Withdrawal by Subject|12|||
163933881|NCT02229227|592127872|FG000|Overall Study|Other|0|||
163933882|NCT02229227|592127873|FG001|Overall Study|Other|1|||
163933883|NCT02229227|592127872|FG000|Overall Study|Physician Decision|5|||
163933884|NCT02229227|592127873|FG001|Overall Study|Physician Decision|12|||
163933885|NCT01453023|592127874|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
163933886|NCT01453023|592127875|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
163933887|NCT01453023|592127874|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
163933888|NCT01453023|592127875|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
163933889|NCT01453023|592127874|FG000|Treatment Period 2|Protocol Violation|0|||
163933890|NCT01453023|592127875|FG001|Treatment Period 2|Protocol Violation|1|||
163933891|NCT03934099|592127878|FG000|Overall Study|Adverse Event|0|||
163933892|NCT03934099|592127879|FG001|Overall Study|Adverse Event|3|||
163933893|NCT03934099|592127880|FG002|Overall Study|Adverse Event|1|||
163933894|NCT03934099|592127881|FG003|Overall Study|Adverse Event|0|||
163933895|NCT03934099|592127878|FG000|Overall Study|Lost to Follow-up|1|||
163933896|NCT03934099|592127879|FG001|Overall Study|Lost to Follow-up|2|||
163933897|NCT03934099|592127880|FG002|Overall Study|Lost to Follow-up|1|||
163933898|NCT03934099|592127881|FG003|Overall Study|Lost to Follow-up|1|||
163933899|NCT03934099|592127878|FG000|Overall Study|Protocol Violation|1|||
163933900|NCT03934099|592127879|FG001|Overall Study|Protocol Violation|0|||
163933901|NCT03934099|592127880|FG002|Overall Study|Protocol Violation|0|||
163933902|NCT03934099|592127881|FG003|Overall Study|Protocol Violation|0|||
163933903|NCT03934099|592127878|FG000|Overall Study|Withdrawal by Subject|2|||
163933904|NCT03934099|592127879|FG001|Overall Study|Withdrawal by Subject|0|||
163933905|NCT03934099|592127880|FG002|Overall Study|Withdrawal by Subject|1|||
163933906|NCT03934099|592127881|FG003|Overall Study|Withdrawal by Subject|1|||
163933907|NCT03934099|592127878|FG000|Overall Study|Other reasons|0|||
163933908|NCT03934099|592127879|FG001|Overall Study|Other reasons|1|||
163933909|NCT03934099|592127880|FG002|Overall Study|Other reasons|0|||
163933910|NCT03934099|592127881|FG003|Overall Study|Other reasons|0|||
163933911|NCT02869867|592127882|FG000|Overall Study|Protocol Violation|1|||
163933912|NCT02869867|592127883|FG001|Overall Study|Protocol Violation|0|||
163933913|NCT02869867|592127882|FG000|Overall Study|Lost to Follow-up|5|||
163933914|NCT02869867|592127883|FG001|Overall Study|Lost to Follow-up|5|||
163933915|NCT05555615|592127885|FG000|Overall Study|Adverse Event|7|||
163933916|NCT05555615|592127885|FG000|Overall Study|Lack of Efficacy|12|||
163933917|NCT05555615|592127885|FG000|Overall Study|Lost to Follow-up|10|||
163933918|NCT05555615|592127885|FG000|Overall Study|Noncompliance with study drug|5|||
163933919|NCT05555615|592127885|FG000|Overall Study|Physician Decision|2|||
163933920|NCT05555615|592127885|FG000|Overall Study|Study terminated by sponsor|80|||
164037240|NCT03051217|592496678|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164037241|NCT03051217|592496679|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164037242|NCT03051217|592496680|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164037243|NCT03051217|592496681|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
164037244|NCT03051217|592496675|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
164037245|NCT03051217|592496676|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163933921|NCT05555615|592127885|FG000|Overall Study|Prohibited medication use|2|||
163933922|NCT05555615|592127885|FG000|Overall Study|Withdrawal by Subject|20|||
163933923|NCT05555615|592127885|FG000|Overall Study|Not further specified|4|||
163933924|NCT02872012|592127890|FG000|Overall Study|Withdrawal by Subject|1|||
163933925|NCT02872012|592127891|FG001|Overall Study|Withdrawal by Subject|0|||
163933926|NCT02872012|592127892|FG002|Overall Study|Withdrawal by Subject|0|||
163933927|NCT02872012|592127893|FG003|Overall Study|Withdrawal by Subject|0|||
164037246|NCT03051217|592496677|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
163933928|NCT02872012|592127894|FG004|Overall Study|Withdrawal by Subject|0|||
163933929|NCT01728623|592127895|FG000|Overall Study|Disease progression|26|||
163933930|NCT01728623|592127895|FG000|Overall Study|Adverse Event|1|||
163933931|NCT01728623|592127895|FG000|Overall Study|Withdrawal by Subject|1|||
163933932|NCT03000348|592127896|FG000|Overall Study|Adverse Event|1|||
163933933|NCT03000348|592127897|FG001|Overall Study|Adverse Event|1|||
163933934|NCT03000348|592127898|FG002|Overall Study|Adverse Event|1|||
163933935|NCT03000348|592127899|FG003|Overall Study|Adverse Event|1|||
163933936|NCT03000348|592127900|FG004|Overall Study|Adverse Event|1|||
163933937|NCT03000348|592127901|FG005|Overall Study|Adverse Event|1|||
163933938|NCT03000348|592127896|FG000|Overall Study|Lost to Follow-up|0|||
163933939|NCT03000348|592127897|FG001|Overall Study|Lost to Follow-up|0|||
163933940|NCT03000348|592127898|FG002|Overall Study|Lost to Follow-up|1|||
163933941|NCT03000348|592127899|FG003|Overall Study|Lost to Follow-up|0|||
163933942|NCT03000348|592127900|FG004|Overall Study|Lost to Follow-up|0|||
163933943|NCT03000348|592127901|FG005|Overall Study|Lost to Follow-up|0|||
163933944|NCT03000348|592127896|FG000|Overall Study|Withdrawal by Subject|0|||
163933945|NCT03000348|592127897|FG001|Overall Study|Withdrawal by Subject|1|||
163933946|NCT03000348|592127898|FG002|Overall Study|Withdrawal by Subject|0|||
163933947|NCT03000348|592127899|FG003|Overall Study|Withdrawal by Subject|0|||
163933948|NCT03000348|592127900|FG004|Overall Study|Withdrawal by Subject|0|||
163933949|NCT03000348|592127901|FG005|Overall Study|Withdrawal by Subject|0|||
163933950|NCT03000348|592127896|FG000|Overall Study|Consent|0|||
163933951|NCT03000348|592127897|FG001|Overall Study|Consent|0|||
163933952|NCT03000348|592127898|FG002|Overall Study|Consent|0|||
163933953|NCT03000348|592127899|FG003|Overall Study|Consent|0|||
163933954|NCT03000348|592127900|FG004|Overall Study|Consent|1|||
163933955|NCT03000348|592127901|FG005|Overall Study|Consent|0|||
163933956|NCT03000348|592127896|FG000|Overall Study|Failure to expectorate sputum|1|||
163933957|NCT03000348|592127897|FG001|Overall Study|Failure to expectorate sputum|0|||
163933958|NCT03000348|592127898|FG002|Overall Study|Failure to expectorate sputum|1|||
163933959|NCT03000348|592127899|FG003|Overall Study|Failure to expectorate sputum|0|||
163933960|NCT03000348|592127900|FG004|Overall Study|Failure to expectorate sputum|1|||
163933961|NCT03000348|592127901|FG005|Overall Study|Failure to expectorate sputum|0|||
163933962|NCT03000348|592127896|FG000|Overall Study|No gram negative|1|||
163933963|NCT03000348|592127897|FG001|Overall Study|No gram negative|2|||
163933964|NCT03000348|592127898|FG002|Overall Study|No gram negative|1|||
163933965|NCT03000348|592127899|FG003|Overall Study|No gram negative|1|||
163933966|NCT03000348|592127900|FG004|Overall Study|No gram negative|1|||
163933967|NCT03000348|592127901|FG005|Overall Study|No gram negative|1|||
163933968|NCT03000348|592127896|FG000|Overall Study|Patient had no transport|0|||
163933969|NCT03000348|592127897|FG001|Overall Study|Patient had no transport|0|||
163933970|NCT03000348|592127898|FG002|Overall Study|Patient had no transport|0|||
163933971|NCT03000348|592127899|FG003|Overall Study|Patient had no transport|1|||
163933972|NCT03000348|592127900|FG004|Overall Study|Patient had no transport|0|||
163933973|NCT03000348|592127901|FG005|Overall Study|Patient had no transport|0|||
163933974|NCT03000348|592127896|FG000|Overall Study|Dosing|0|||
163933975|NCT03000348|592127897|FG001|Overall Study|Dosing|0|||
163933976|NCT03000348|592127898|FG002|Overall Study|Dosing|0|||
163933977|NCT03000348|592127899|FG003|Overall Study|Dosing|0|||
163933978|NCT03000348|592127900|FG004|Overall Study|Dosing|1|||
163933979|NCT03000348|592127901|FG005|Overall Study|Dosing|0|||
163933980|NCT00723125|592127902|FG000|Overall Study|Met Dx|1|||
163933981|NCT00723125|592127903|FG001|Overall Study|Met Dx|0|||
163933982|NCT00723125|592127902|FG000|Overall Study|Withdrawal by Subject|15|||
163933983|NCT00723125|592127903|FG001|Overall Study|Withdrawal by Subject|6|||
163933984|NCT00723125|592127902|FG000|Overall Study|Adverse Event|2|||
163933985|NCT00723125|592127903|FG001|Overall Study|Adverse Event|0|||
163933986|NCT01667549|592127906|FG000|Overall Study|Withdrawal by Subject|3|||
163933987|NCT01667549|592127907|FG001|Overall Study|Withdrawal by Subject|5|||
163933988|NCT01667549|592127908|FG002|Overall Study|Withdrawal by Subject|7|||
163933989|NCT01667549|592127909|FG003|Overall Study|Withdrawal by Subject|6|||
163933990|NCT01667549|592127910|FG004|Overall Study|Withdrawal by Subject|1|||
163933991|NCT01407276|592127911|FG000|Overall Study|Withdrawal by Subject|0|||
164037247|NCT03051217|592496678|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
163933992|NCT01407276|592127912|FG001|Overall Study|Withdrawal by Subject|0|||
163933993|NCT01407276|592127913|FG002|Overall Study|Withdrawal by Subject|0|||
163933994|NCT01407276|592127914|FG003|Overall Study|Withdrawal by Subject|0|||
163933995|NCT01407276|592127915|FG004|Overall Study|Withdrawal by Subject|0|||
163933996|NCT01407276|592127916|FG005|Overall Study|Withdrawal by Subject|0|||
163933997|NCT01407276|592127917|FG006|Overall Study|Withdrawal by Subject|0|||
163933998|NCT01407276|592127918|FG007|Overall Study|Withdrawal by Subject|1|||
163933999|NCT03482752|592127922|FG000|Overall Study|Withdrawal by Subject|2|||
163934000|NCT03482752|592127922|FG000|Overall Study|Lost to Follow-up|1|||
163934001|NCT03482752|592127922|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
163934002|NCT01807182|592127924|FG000|Overall Study|Death|1|||
163934003|NCT01807182|592127924|FG000|Overall Study|New therapy|1|||
163934004|NCT01807182|592127924|FG000|Overall Study|Moved to hospice care|1|||
163934005|NCT02844777|592127925|FG000|Overall Study|Withdrawal by Subject|2|||
163934006|NCT02844777|592127926|FG001|Overall Study|Withdrawal by Subject|0|||
163934007|NCT02844777|592127927|FG002|Overall Study|Withdrawal by Subject|0|||
163934008|NCT01776008|592127928|FG000|Overall Study|ineligible|2|||
163934009|NCT00150618|592127929|FG000|Overall Study|Adverse Event|2|||
163934010|NCT00150618|592127930|FG001|Overall Study|Adverse Event|2|||
163934011|NCT00150618|592127931|FG002|Overall Study|Adverse Event|6|||
163934012|NCT00150618|592127932|FG003|Overall Study|Adverse Event|9|||
163934013|NCT00150618|592127933|FG004|Overall Study|Adverse Event|5|||
163934014|NCT00150618|592127929|FG000|Overall Study|Withdrawal by Subject|6|||
163934015|NCT00150618|592127930|FG001|Overall Study|Withdrawal by Subject|8|||
163934016|NCT00150618|592127931|FG002|Overall Study|Withdrawal by Subject|8|||
163934017|NCT00150618|592127932|FG003|Overall Study|Withdrawal by Subject|4|||
163934018|NCT00150618|592127933|FG004|Overall Study|Withdrawal by Subject|5|||
163934019|NCT00150618|592127929|FG000|Overall Study|Lost to Follow-up|4|||
163934020|NCT00150618|592127930|FG001|Overall Study|Lost to Follow-up|1|||
163934021|NCT00150618|592127931|FG002|Overall Study|Lost to Follow-up|5|||
163934022|NCT00150618|592127932|FG003|Overall Study|Lost to Follow-up|8|||
163934023|NCT00150618|592127933|FG004|Overall Study|Lost to Follow-up|4|||
163934024|NCT00150618|592127929|FG000|Overall Study|Protocol Violation|1|||
163934025|NCT00150618|592127930|FG001|Overall Study|Protocol Violation|0|||
163934026|NCT00150618|592127931|FG002|Overall Study|Protocol Violation|0|||
163934027|NCT00150618|592127932|FG003|Overall Study|Protocol Violation|0|||
163934028|NCT00150618|592127933|FG004|Overall Study|Protocol Violation|1|||
163934029|NCT00150618|592127929|FG000|Overall Study|Lack of Efficacy|1|||
163934030|NCT00150618|592127930|FG001|Overall Study|Lack of Efficacy|4|||
163934031|NCT00150618|592127931|FG002|Overall Study|Lack of Efficacy|7|||
163934032|NCT00150618|592127932|FG003|Overall Study|Lack of Efficacy|4|||
163934033|NCT00150618|592127933|FG004|Overall Study|Lack of Efficacy|6|||
163934034|NCT00150618|592127929|FG000|Overall Study|No study meds|0|||
164098511|NCT03135834|592725134|FG001|Stage 1|Adverse Event|2|||
164098512|NCT03135834|592725135|FG002|Stage 1|Adverse Event|2|||
164098513|NCT03135834|592725136|FG003|Stage 1|Adverse Event|1|||
164098514|NCT03135834|592725133|FG000|Stage 1|Death|1|||
164098515|NCT03135834|592725134|FG001|Stage 1|Death|0|||
164098516|NCT03135834|592725135|FG002|Stage 1|Death|0|||
164098517|NCT03135834|592725136|FG003|Stage 1|Death|0|||
164098518|NCT03135834|592725133|FG000|Stage 1|Lost to Follow-up|17|||
164098519|NCT03135834|592725134|FG001|Stage 1|Lost to Follow-up|24|||
163838612|NCT01852058|591779736|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838613|NCT01852058|591779737|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
163838614|NCT01852058|591779738|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
163838615|NCT01852058|591779739|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838616|NCT01852058|591779740|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838617|NCT01852058|591779741|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838618|NCT01852058|591779742|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838619|NCT01852058|591779743|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838620|NCT01852058|591779744|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
163838621|NCT01852058|591779733|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838622|NCT01852058|591779734|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838623|NCT01852058|591779735|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838624|NCT01852058|591779736|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
163838625|NCT01852058|591779737|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838626|NCT01852058|591779738|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838627|NCT01852058|591779739|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838628|NCT01852058|591779740|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838629|NCT01852058|591779741|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838630|NCT01852058|591779742|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838631|NCT01852058|591779743|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838632|NCT01852058|591779744|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
163838633|NCT01852058|591779733|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838634|NCT01852058|591779734|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838635|NCT01852058|591779735|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838636|NCT01852058|591779736|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838637|NCT01852058|591779737|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
163838638|NCT01852058|591779738|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
163838639|NCT01852058|591779739|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163934035|NCT00150618|592127930|FG001|Overall Study|No study meds|0|||
163934036|NCT00150618|592127931|FG002|Overall Study|No study meds|0|||
163934037|NCT00150618|592127932|FG003|Overall Study|No study meds|0|||
163934038|NCT00150618|592127933|FG004|Overall Study|No study meds|2|||
164098520|NCT03135834|592725135|FG002|Stage 1|Lost to Follow-up|21|||
164098521|NCT03135834|592725136|FG003|Stage 1|Lost to Follow-up|38|||
164098522|NCT03135834|592725133|FG000|Stage 1|No longer met eligibility criteria|1|||
164098523|NCT03135834|592725134|FG001|Stage 1|No longer met eligibility criteria|6|||
163934039|NCT00150618|592127929|FG000|Overall Study|Physician Decision|0|||
163934040|NCT00150618|592127930|FG001|Overall Study|Physician Decision|2|||
163934041|NCT00150618|592127931|FG002|Overall Study|Physician Decision|0|||
163934042|NCT00150618|592127932|FG003|Overall Study|Physician Decision|0|||
163934043|NCT00150618|592127933|FG004|Overall Study|Physician Decision|1|||
163934044|NCT00150618|592127929|FG000|Overall Study|Lack of compliance|2|||
163934045|NCT00150618|592127930|FG001|Overall Study|Lack of compliance|1|||
163934046|NCT00150618|592127931|FG002|Overall Study|Lack of compliance|1|||
163934047|NCT00150618|592127932|FG003|Overall Study|Lack of compliance|0|||
163934048|NCT00150618|592127933|FG004|Overall Study|Lack of compliance|1|||
163934049|NCT00150618|592127929|FG000|Overall Study|Abnormal ECG|1|||
163934050|NCT00150618|592127930|FG001|Overall Study|Abnormal ECG|0|||
163934051|NCT00150618|592127931|FG002|Overall Study|Abnormal ECG|0|||
163934052|NCT00150618|592127932|FG003|Overall Study|Abnormal ECG|0|||
163934053|NCT00150618|592127933|FG004|Overall Study|Abnormal ECG|0|||
163934054|NCT00150618|592127929|FG000|Overall Study|Sponsor's decision|0|||
163934055|NCT00150618|592127930|FG001|Overall Study|Sponsor's decision|0|||
163934056|NCT00150618|592127931|FG002|Overall Study|Sponsor's decision|0|||
163934057|NCT00150618|592127932|FG003|Overall Study|Sponsor's decision|1|||
163934058|NCT00150618|592127933|FG004|Overall Study|Sponsor's decision|0|||
163934059|NCT04092452|592127934|FG000|Overall Study|Adverse Event|1|||
163934060|NCT04092452|592127935|FG001|Overall Study|Adverse Event|3|||
163934061|NCT04092452|592127936|FG002|Overall Study|Adverse Event|3|||
163934062|NCT04092452|592127937|FG003|Overall Study|Adverse Event|7|||
163934063|NCT04092452|592127934|FG000|Overall Study|Lack of Efficacy|1|||
163934064|NCT04092452|592127935|FG001|Overall Study|Lack of Efficacy|1|||
163934065|NCT04092452|592127936|FG002|Overall Study|Lack of Efficacy|1|||
163934066|NCT04092452|592127937|FG003|Overall Study|Lack of Efficacy|0|||
163934067|NCT04092452|592127934|FG000|Overall Study|Lost to Follow-up|4|||
163934068|NCT04092452|592127935|FG001|Overall Study|Lost to Follow-up|3|||
163934069|NCT04092452|592127936|FG002|Overall Study|Lost to Follow-up|5|||
163934070|NCT04092452|592127937|FG003|Overall Study|Lost to Follow-up|1|||
163934071|NCT04092452|592127934|FG000|Overall Study|Non-Compliance With Study Drug|0|||
163934072|NCT04092452|592127935|FG001|Overall Study|Non-Compliance With Study Drug|0|||
163934073|NCT04092452|592127936|FG002|Overall Study|Non-Compliance With Study Drug|1|||
163934074|NCT04092452|592127937|FG003|Overall Study|Non-Compliance With Study Drug|1|||
163934075|NCT04092452|592127934|FG000|Overall Study|Physician Decision|1|||
163934076|NCT04092452|592127935|FG001|Overall Study|Physician Decision|0|||
163934077|NCT04092452|592127936|FG002|Overall Study|Physician Decision|1|||
163934078|NCT04092452|592127937|FG003|Overall Study|Physician Decision|0|||
163934079|NCT04092452|592127934|FG000|Overall Study|Pregnancy|2|||
163934080|NCT04092452|592127935|FG001|Overall Study|Pregnancy|0|||
163934081|NCT04092452|592127936|FG002|Overall Study|Pregnancy|0|||
163934082|NCT04092452|592127937|FG003|Overall Study|Pregnancy|0|||
163934083|NCT04092452|592127934|FG000|Overall Study|Protocol Deviation|1|||
163934084|NCT04092452|592127935|FG001|Overall Study|Protocol Deviation|0|||
163934085|NCT04092452|592127936|FG002|Overall Study|Protocol Deviation|0|||
163934086|NCT04092452|592127937|FG003|Overall Study|Protocol Deviation|0|||
163934087|NCT04092452|592127934|FG000|Overall Study|Withdrawal by Subject|3|||
163934088|NCT04092452|592127935|FG001|Overall Study|Withdrawal by Subject|10|||
163934089|NCT04092452|592127936|FG002|Overall Study|Withdrawal by Subject|3|||
163934090|NCT04092452|592127937|FG003|Overall Study|Withdrawal by Subject|5|||
163934091|NCT04092452|592127934|FG000|Overall Study|Other|0|||
163934092|NCT04092452|592127935|FG001|Overall Study|Other|0|||
163934093|NCT04092452|592127936|FG002|Overall Study|Other|1|||
163934094|NCT04092452|592127937|FG003|Overall Study|Other|2|||
163934095|NCT02127125|592127939|FG000|Overall Study|Lost to Follow-up|0|||
163934096|NCT02127125|592127940|FG001|Overall Study|Lost to Follow-up|0|||
163934097|NCT02127125|592127941|FG002|Overall Study|Lost to Follow-up|0|||
163934098|NCT02127125|592127942|FG003|Overall Study|Lost to Follow-up|0|||
163934099|NCT02127125|592127943|FG004|Overall Study|Lost to Follow-up|2|||
163934100|NCT02127125|592127944|FG005|Overall Study|Lost to Follow-up|1|||
163934101|NCT02127125|592127945|FG006|Overall Study|Lost to Follow-up|0|||
163934102|NCT02127125|592127946|FG007|Overall Study|Lost to Follow-up|0|||
163934103|NCT02127125|592127947|FG008|Overall Study|Lost to Follow-up|0|||
163934104|NCT02127125|592127939|FG000|Overall Study|Withdrawal by Subject|0|||
163934105|NCT02127125|592127940|FG001|Overall Study|Withdrawal by Subject|0|||
163934106|NCT02127125|592127941|FG002|Overall Study|Withdrawal by Subject|0|||
163934107|NCT02127125|592127942|FG003|Overall Study|Withdrawal by Subject|1|||
163934108|NCT02127125|592127943|FG004|Overall Study|Withdrawal by Subject|0|||
163934109|NCT02127125|592127944|FG005|Overall Study|Withdrawal by Subject|0|||
163934110|NCT02127125|592127945|FG006|Overall Study|Withdrawal by Subject|0|||
163934111|NCT02127125|592127946|FG007|Overall Study|Withdrawal by Subject|0|||
163934112|NCT02127125|592127947|FG008|Overall Study|Withdrawal by Subject|0|||
163934113|NCT02127125|592127939|FG000|Overall Study|Physician Decision|0|||
163934114|NCT02127125|592127940|FG001|Overall Study|Physician Decision|0|||
163934115|NCT02127125|592127941|FG002|Overall Study|Physician Decision|1|||
163934116|NCT02127125|592127942|FG003|Overall Study|Physician Decision|0|||
163934117|NCT02127125|592127943|FG004|Overall Study|Physician Decision|1|||
163934118|NCT02127125|592127944|FG005|Overall Study|Physician Decision|2|||
164037248|NCT03051217|592496679|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164037249|NCT03051217|592496680|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164037250|NCT03051217|592496681|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164037251|NCT03051217|592496675|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
164037252|NCT03051217|592496676|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
164037253|NCT03051217|592496677|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
164037254|NCT03051217|592496678|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
163838640|NCT01852058|591779740|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838641|NCT01852058|591779741|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838642|NCT01852058|591779742|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838643|NCT01852058|591779743|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838644|NCT01852058|591779744|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
163838645|NCT01852058|591779733|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838646|NCT01852058|591779734|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838647|NCT01852058|591779735|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838648|NCT01852058|591779736|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838649|NCT01852058|591779737|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838650|NCT01852058|591779738|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838651|NCT01852058|591779739|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838652|NCT01852058|591779740|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
163838653|NCT01852058|591779741|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838654|NCT01852058|591779742|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838655|NCT01852058|591779743|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838656|NCT01852058|591779744|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
163838657|NCT01852058|591779733|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838658|NCT01852058|591779734|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838659|NCT01852058|591779735|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838660|NCT01852058|591779736|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838661|NCT01852058|591779737|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838662|NCT01852058|591779738|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838663|NCT01852058|591779739|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838664|NCT01852058|591779740|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838665|NCT01852058|591779741|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
163838666|NCT01852058|591779742|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838667|NCT01852058|591779743|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838668|NCT01852058|591779744|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
163838669|NCT01279343|591779745|FG000|Overall Study|Did not receive treatment|2|||
163838670|NCT01279343|591779746|FG001|Overall Study|Did not receive treatment|6|||
163838671|NCT03287414|591779747|FG000|Treatment Epoch|Adverse Event|0|||
163838672|NCT03287414|591779748|FG001|Treatment Epoch|Adverse Event|1|||
163838673|NCT03287414|591779747|FG000|Treatment Epoch|Study terminated by sponsor|2|||
163838674|NCT03287414|591779748|FG001|Treatment Epoch|Study terminated by sponsor|2|||
163838675|NCT03287414|591779747|FG000|Treatment Epoch|Subject/Guardian decision|4|||
163838676|NCT03287414|591779748|FG001|Treatment Epoch|Subject/Guardian decision|0|||
163838677|NCT03287414|591779747|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
163838678|NCT03287414|591779748|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
163838679|NCT03287414|591779747|FG000|Treatment Epoch|Withdrawal by Subject|1|||
163838680|NCT03287414|591779748|FG001|Treatment Epoch|Withdrawal by Subject|0|||
163838681|NCT03287414|591779747|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
163838682|NCT03287414|591779748|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
163838683|NCT03287414|591779747|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
163838684|NCT03287414|591779748|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
163838685|NCT02569710|591779753|FG000|Overall Study|Adverse Event|1|||
163838686|NCT02569710|591779754|FG001|Overall Study|Adverse Event|0|||
163838687|NCT02569710|591779755|FG002|Overall Study|Adverse Event|0|||
163838688|NCT02569710|591779756|FG003|Overall Study|Adverse Event|0|||
163838689|NCT02569710|591779757|FG004|Overall Study|Adverse Event|0|||
163838690|NCT02569710|591779758|FG005|Overall Study|Adverse Event|0|||
163838691|NCT02569710|591779759|FG006|Overall Study|Adverse Event|0|||
163838692|NCT02569710|591779760|FG007|Overall Study|Adverse Event|0|||
163838693|NCT02569710|591779761|FG008|Overall Study|Adverse Event|0|||
163838694|NCT02569710|591779762|FG009|Overall Study|Adverse Event|0|||
163838695|NCT02569710|591779753|FG000|Overall Study|Lost to Follow-up|0|||
163838696|NCT02569710|591779754|FG001|Overall Study|Lost to Follow-up|0|||
163838697|NCT02569710|591779755|FG002|Overall Study|Lost to Follow-up|0|||
163838698|NCT02569710|591779756|FG003|Overall Study|Lost to Follow-up|0|||
163838699|NCT02569710|591779757|FG004|Overall Study|Lost to Follow-up|0|||
163838700|NCT02569710|591779758|FG005|Overall Study|Lost to Follow-up|0|||
163838701|NCT02569710|591779759|FG006|Overall Study|Lost to Follow-up|1|||
163838702|NCT02569710|591779760|FG007|Overall Study|Lost to Follow-up|0|||
163838703|NCT02569710|591779761|FG008|Overall Study|Lost to Follow-up|1|||
163838704|NCT02569710|591779762|FG009|Overall Study|Lost to Follow-up|0|||
163838705|NCT02569710|591779753|FG000|Overall Study|Virologic failure|0|||
163838706|NCT02569710|591779754|FG001|Overall Study|Virologic failure|0|||
163838707|NCT02569710|591779755|FG002|Overall Study|Virologic failure|0|||
163838708|NCT02569710|591779756|FG003|Overall Study|Virologic failure|0|||
163838709|NCT02569710|591779757|FG004|Overall Study|Virologic failure|1|||
163838710|NCT02569710|591779758|FG005|Overall Study|Virologic failure|0|||
163838711|NCT02569710|591779759|FG006|Overall Study|Virologic failure|1|||
163838712|NCT02569710|591779760|FG007|Overall Study|Virologic failure|0|||
163838713|NCT02569710|591779761|FG008|Overall Study|Virologic failure|0|||
163838714|NCT02569710|591779762|FG009|Overall Study|Virologic failure|0|||
163838715|NCT02569710|591779753|FG000|Overall Study|Withdrawal by Subject|0|||
163838716|NCT02569710|591779754|FG001|Overall Study|Withdrawal by Subject|0|||
163838717|NCT02569710|591779755|FG002|Overall Study|Withdrawal by Subject|0|||
163838718|NCT02569710|591779756|FG003|Overall Study|Withdrawal by Subject|0|||
163838719|NCT02569710|591779757|FG004|Overall Study|Withdrawal by Subject|0|||
163838720|NCT02569710|591779758|FG005|Overall Study|Withdrawal by Subject|1|||
163838721|NCT02569710|591779759|FG006|Overall Study|Withdrawal by Subject|0|||
163838722|NCT02569710|591779760|FG007|Overall Study|Withdrawal by Subject|0|||
163838723|NCT02569710|591779761|FG008|Overall Study|Withdrawal by Subject|0|||
163838724|NCT02569710|591779762|FG009|Overall Study|Withdrawal by Subject|0|||
163838725|NCT02946918|591779763|FG000|Overall Study|Patient unblinded himself|1|||
163838726|NCT02946918|591779764|FG001|Overall Study|Patient unblinded himself|0|||
163838727|NCT02946918|591779763|FG000|Overall Study|Physician Decision|0|||
163838728|NCT02946918|591779764|FG001|Overall Study|Physician Decision|2|||
163838729|NCT02946918|591779763|FG000|Overall Study|Ran out of study medication|0|||
163838730|NCT02946918|591779764|FG001|Overall Study|Ran out of study medication|1|||
163838731|NCT03203694|591779771|FG000|Overall Study|Withdrawal by Subject|2|||
163838732|NCT03203694|591779772|FG001|Overall Study|Withdrawal by Subject|0|||
163838733|NCT03203694|591779773|FG002|Overall Study|Withdrawal by Subject|0|||
163838734|NCT03203694|591779774|FG003|Overall Study|Withdrawal by Subject|0|||
163838735|NCT03203694|591779775|FG004|Overall Study|Withdrawal by Subject|0|||
163838736|NCT03203694|591779776|FG005|Overall Study|Withdrawal by Subject|0|||
163838737|NCT00663117|591781545|FG000|Overall Study|Lack of Efficacy|1|||
163838738|NCT00663117|591781546|FG001|Overall Study|Lack of Efficacy|0|||
163838739|NCT02781506|591781547|FG000|Overall Study|Adverse Event|5|||
163838740|NCT02593539|591781548|FG000|Overall Study|Adverse Event|1|||
163838741|NCT00437125|591781551|FG000|Overall Study|Adverse Event|12|||
163838742|NCT00437125|591781551|FG000|Overall Study|Death|1|||
163838743|NCT00437125|591781551|FG000|Overall Study|Clinical Relapse|1|||
163838744|NCT00437125|591781551|FG000|Overall Study|Lack of Efficacy|1|||
163838745|NCT00437125|591781551|FG000|Overall Study|Lost to Follow-up|1|||
163838746|NCT00437125|591781551|FG000|Overall Study|Withdrawal by Subject|13|||
163838747|NCT00437125|591781551|FG000|Overall Study|Withdrawal by Caregiver|2|||
163838748|NCT00437125|591781551|FG000|Overall Study|Physician Decision|1|||
163838749|NCT02248961|591781552|FG000|Overall Study|Adverse Event|1|||
163838750|NCT02248961|591781553|FG001|Overall Study|Adverse Event|0|||
163838751|NCT02248961|591781552|FG000|Overall Study|Withdrawal by Subject|1|||
163838752|NCT02248961|591781553|FG001|Overall Study|Withdrawal by Subject|2|||
163838753|NCT02248961|591781552|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
163838754|NCT02248961|591781553|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
163838755|NCT00244374|591781560|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
163838756|NCT00244374|591781561|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163838757|NCT00244374|591781562|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163838758|NCT00244374|591781563|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163838759|NCT00244374|591781564|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
163838760|NCT00244374|591781560|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
163838761|NCT00244374|591781561|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163838762|NCT00244374|591781562|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163838763|NCT00244374|591781563|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163838764|NCT00244374|591781564|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
163838765|NCT00244374|591781560|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
163838766|NCT00244374|591781561|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163838767|NCT00244374|591781562|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163838768|NCT00244374|591781563|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163838769|NCT00244374|591781564|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
163934119|NCT02127125|592127945|FG006|Overall Study|Physician Decision|0|||
163838770|NCT00244374|591781560|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
163934120|NCT02127125|592127946|FG007|Overall Study|Physician Decision|0|||
163934121|NCT02127125|592127947|FG008|Overall Study|Physician Decision|0|||
163934122|NCT01255761|592127948|FG000|Overall Study|Adverse Event|29|||
163934123|NCT01255761|592127949|FG001|Overall Study|Adverse Event|43|||
163934124|NCT01255761|592127948|FG000|Overall Study|Lack of Efficacy|86|||
163934125|NCT01255761|592127949|FG001|Overall Study|Lack of Efficacy|74|||
163934126|NCT01255761|592127948|FG000|Overall Study|Protocol Violation|9|||
163934127|NCT01255761|592127949|FG001|Overall Study|Protocol Violation|5|||
163934128|NCT01255761|592127948|FG000|Overall Study|Lost to Follow-up|10|||
163934129|NCT01255761|592127949|FG001|Overall Study|Lost to Follow-up|8|||
163934130|NCT01255761|592127948|FG000|Overall Study|Withdrawal by Subject|11|||
163934131|NCT01255761|592127949|FG001|Overall Study|Withdrawal by Subject|27|||
163934132|NCT01255761|592127948|FG000|Overall Study|Other Reasons|37|||
163934133|NCT01255761|592127949|FG001|Overall Study|Other Reasons|18|||
163934134|NCT00936598|592127950|FG000|Overall Study|Withdrawal by Subject|1|||
163934135|NCT00936598|592127951|FG001|Overall Study|Withdrawal by Subject|0|||
163934136|NCT00936598|592127950|FG000|Overall Study|Ineligible after consent|1|||
163934137|NCT00936598|592127951|FG001|Overall Study|Ineligible after consent|0|||
163934138|NCT00486252|592127954|FG000|Overall Study|Adverse Event|7|||
163934139|NCT00486252|592127954|FG000|Overall Study|Lack of Efficacy|9|||
163934140|NCT00486252|592127954|FG000|Overall Study|Lost to Follow-up|24|||
163934141|NCT00486252|592127954|FG000|Overall Study|Other|18|||
163934142|NCT01210651|592127955|FG000|Overall Study|Lost to Follow-up|1|||
163934143|NCT01210651|592127956|FG001|Overall Study|Lost to Follow-up|1|||
163934144|NCT01210651|592127955|FG000|Overall Study|schedule conflicts|1|||
163934145|NCT01210651|592127956|FG001|Overall Study|schedule conflicts|5|||
163934146|NCT01210651|592127955|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
163934147|NCT01210651|592127956|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
163934148|NCT01210651|592127955|FG000|Overall Study|Withdrawal by Subject|1|||
163934149|NCT01210651|592127956|FG001|Overall Study|Withdrawal by Subject|1|||
163934150|NCT01210651|592127955|FG000|Overall Study|Injury outside study|2|||
163934151|NCT01210651|592127956|FG001|Overall Study|Injury outside study|0|||
163934152|NCT02559310|592127957|FG000|Overall Study|Death|4|||
163934153|NCT02559310|592127958|FG001|Overall Study|Death|3|||
163934154|NCT02559310|592127957|FG000|Overall Study|Lost to Follow-up|5|||
163934155|NCT02559310|592127958|FG001|Overall Study|Lost to Follow-up|3|||
163934156|NCT02559310|592127957|FG000|Overall Study|Physician Decision|2|||
163934157|NCT02559310|592127958|FG001|Overall Study|Physician Decision|1|||
163934158|NCT02559310|592127957|FG000|Overall Study|Withdrawal by Subject|13|||
163934159|NCT02559310|592127958|FG001|Overall Study|Withdrawal by Subject|9|||
163934160|NCT02559310|592127957|FG000|Overall Study|Sponsor Decision|0|||
163934161|NCT02559310|592127958|FG001|Overall Study|Sponsor Decision|1|||
163934162|NCT02559310|592127957|FG000|Overall Study|Randomized but not treated|3|||
163934163|NCT02559310|592127958|FG001|Overall Study|Randomized but not treated|2|||
163934164|NCT04596540|592127959|FG000|Overall Study|Withdrawal by Subject|9|||
163934165|NCT04596540|592127960|FG001|Overall Study|Withdrawal by Subject|8|||
163934166|NCT04596540|592127961|FG002|Overall Study|Withdrawal by Subject|5|||
163934167|NCT04596540|592127959|FG000|Overall Study|Lost to Follow-up|1|||
163934168|NCT04596540|592127960|FG001|Overall Study|Lost to Follow-up|2|||
163934169|NCT04596540|592127961|FG002|Overall Study|Lost to Follow-up|1|||
163934170|NCT04596540|592127959|FG000|Overall Study|Sponsor Decision|2|||
163934171|NCT04596540|592127960|FG001|Overall Study|Sponsor Decision|0|||
163934172|NCT04596540|592127961|FG002|Overall Study|Sponsor Decision|0|||
163934173|NCT04596540|592127959|FG000|Overall Study|Physician Decision|0|||
163934174|NCT04596540|592127960|FG001|Overall Study|Physician Decision|1|||
163934175|NCT04596540|592127961|FG002|Overall Study|Physician Decision|1|||
163934176|NCT04596540|592127959|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
163934177|NCT04596540|592127960|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163934178|NCT04596540|592127961|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
163934179|NCT04596540|592127959|FG000|Overall Study|Other Than Specified|5|||
163934180|NCT04596540|592127960|FG001|Overall Study|Other Than Specified|5|||
163934181|NCT04596540|592127961|FG002|Overall Study|Other Than Specified|2|||
163934182|NCT01090011|592129744|FG000|Overall Study|Progressive disease|128|||
163934183|NCT01090011|592129744|FG000|Overall Study|Adverse Event|32|||
163934184|NCT01090011|592129744|FG000|Overall Study|Protocol Violation|1|||
163934185|NCT01090011|592129744|FG000|Overall Study|Refusal to start/continue medication|5|||
163934186|NCT01090011|592129744|FG000|Overall Study|Other reason not defined above|5|||
163934187|NCT00433511|592129745|FG000|Step 1|Adverse Event|50|||
163934188|NCT00433511|592129746|FG001|Step 1|Adverse Event|157|||
163934189|NCT00433511|592129747|FG002|Step 1|Adverse Event|153|||
163934190|NCT00433511|592129745|FG000|Step 1|Withdrawal by Subject|45|||
163934191|NCT00433511|592129746|FG001|Step 1|Withdrawal by Subject|143|||
163934192|NCT00433511|592129747|FG002|Step 1|Withdrawal by Subject|154|||
163934193|NCT00433511|592129745|FG000|Step 1|Death|3|||
163934194|NCT00433511|592129746|FG001|Step 1|Death|1|||
163934195|NCT00433511|592129747|FG002|Step 1|Death|1|||
163934196|NCT00433511|592129745|FG000|Step 1|Physician Decision|1|||
163934197|NCT00433511|592129746|FG001|Step 1|Physician Decision|4|||
163934198|NCT00433511|592129747|FG002|Step 1|Physician Decision|3|||
163934199|NCT00433511|592129745|FG000|Step 1|Never started protocol therapy|28|||
164098524|NCT03135834|592725135|FG002|Stage 1|No longer met eligibility criteria|2|||
163838771|NCT00244374|591781561|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163838772|NCT00244374|591781562|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163838773|NCT00244374|591781563|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163838774|NCT00244374|591781564|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
163838775|NCT00244374|591781560|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
163838776|NCT00244374|591781561|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163838777|NCT00244374|591781562|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163838778|NCT00244374|591781563|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163838779|NCT00244374|591781564|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
163838780|NCT00244374|591781560|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
163838781|NCT00244374|591781561|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163838782|NCT00244374|591781562|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163838783|NCT00244374|591781563|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163838784|NCT00244374|591781564|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
163838785|NCT00244374|591781560|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
163838786|NCT00244374|591781561|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163838787|NCT00244374|591781562|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163838788|NCT00244374|591781563|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163838789|NCT00244374|591781564|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
163838790|NCT00244374|591781560|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
163838791|NCT00244374|591781561|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163838792|NCT00244374|591781562|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163838793|NCT00244374|591781563|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163838794|NCT00244374|591781564|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
163838795|NCT00244374|591781560|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
163838796|NCT00244374|591781561|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163838797|NCT00244374|591781562|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163838798|NCT00244374|591781563|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163838799|NCT00244374|591781564|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
163838800|NCT03462706|591781566|FG000|Overall Study|Polyp was pedunculated|1|||
163838801|NCT03462706|591781567|FG001|Overall Study|Polyp was pedunculated|0|||
163838802|NCT03462706|591781568|FG002|Overall Study|Polyp was pedunculated|1|||
163838803|NCT03462706|591781569|FG003|Overall Study|Polyp was pedunculated|0|||
163838804|NCT03462706|591781566|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
163838805|NCT03462706|591781567|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
163838806|NCT03462706|591781568|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
163838807|NCT03462706|591781569|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
163838808|NCT04105972|591781580|FG000|Overall Study|Adverse Event|2|||
163838809|NCT04105972|591781581|FG001|Overall Study|Adverse Event|1|||
163838810|NCT02802319|591781582|FG000|Overall Study|Physician Decision|2|||
163838811|NCT02802319|591781583|FG001|Overall Study|Physician Decision|1|||
163838812|NCT02802319|591781582|FG000|Overall Study|Lost to Follow-up|0|||
163838813|NCT02802319|591781583|FG001|Overall Study|Lost to Follow-up|4|||
163838814|NCT01923896|591781588|FG000|Overall Study|Adverse Event|1|||
163838815|NCT01923896|591781589|FG001|Overall Study|Adverse Event|0|||
163838816|NCT03545113|591781592|FG000|Overall Study|Surgery Cancelled|1|||
163838817|NCT03545113|591781593|FG001|Overall Study|Surgery Cancelled|0|||
163838818|NCT03545113|591781592|FG000|Overall Study|Death|1|||
163838819|NCT03545113|591781593|FG001|Overall Study|Death|0|||
163838820|NCT03545113|591781592|FG000|Overall Study|Adverse Event|2|||
163838821|NCT03545113|591781593|FG001|Overall Study|Adverse Event|0|||
163838822|NCT03545113|591781592|FG000|Overall Study|Received different surgery|1|||
163838823|NCT03545113|591781593|FG001|Overall Study|Received different surgery|0|||
163838824|NCT00235443|591781594|FG000|Overall Study|Adverse Event|4|||
163838825|NCT00235443|591781595|FG001|Overall Study|Adverse Event|12|||
163838826|NCT00235443|591781596|FG002|Overall Study|Adverse Event|17|||
163838827|NCT00235443|591781597|FG003|Overall Study|Adverse Event|44|||
163838828|NCT00235443|591781598|FG004|Overall Study|Adverse Event|10|||
163838829|NCT00235443|591781599|FG005|Overall Study|Adverse Event|15|||
163838830|NCT00235443|591781594|FG000|Overall Study|Lack of Efficacy|0|||
163838831|NCT00235443|591781595|FG001|Overall Study|Lack of Efficacy|1|||
163838832|NCT00235443|591781596|FG002|Overall Study|Lack of Efficacy|5|||
163838833|NCT00235443|591781597|FG003|Overall Study|Lack of Efficacy|12|||
163934200|NCT00433511|592129746|FG001|Step 1|Never started protocol therapy|64|||
164098525|NCT03135834|592725136|FG003|Stage 1|No longer met eligibility criteria|5|||
163934201|NCT00433511|592129747|FG002|Step 1|Never started protocol therapy|66|||
163934202|NCT00433511|592129745|FG000|Step 1|Alternative therapy|2|||
163934203|NCT00433511|592129746|FG001|Step 1|Alternative therapy|1|||
163934204|NCT00433511|592129747|FG002|Step 1|Alternative therapy|3|||
163934205|NCT00433511|592129745|FG000|Step 1|Disease progression, relapse|5|||
163934206|NCT00433511|592129746|FG001|Step 1|Disease progression, relapse|3|||
163934207|NCT00433511|592129747|FG002|Step 1|Disease progression, relapse|3|||
163934208|NCT00433511|592129745|FG000|Step 1|Other complicating disease|2|||
163934209|NCT00433511|592129746|FG001|Step 1|Other complicating disease|6|||
163934210|NCT00433511|592129747|FG002|Step 1|Other complicating disease|3|||
163934211|NCT00433511|592129745|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
163934212|NCT00433511|592129746|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
163934213|NCT00433511|592129747|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
163934214|NCT00433511|592129745|FG000|Step 1|Suspected recurrence|0|||
163934215|NCT00433511|592129746|FG001|Step 1|Suspected recurrence|1|||
163934216|NCT00433511|592129747|FG002|Step 1|Suspected recurrence|0|||
163934217|NCT00433511|592129745|FG000|Step 1|Insurance/drug distribution issues|0|||
163934218|NCT00433511|592129746|FG001|Step 1|Insurance/drug distribution issues|1|||
163934219|NCT00433511|592129747|FG002|Step 1|Insurance/drug distribution issues|2|||
163934220|NCT00433511|592129745|FG000|Step 1|Patient moved|0|||
163934221|NCT00433511|592129746|FG001|Step 1|Patient moved|0|||
163934222|NCT00433511|592129747|FG002|Step 1|Patient moved|1|||
163934223|NCT00433511|592129745|FG000|Step 2 (Arm D)|Adverse Event|0|||
163934224|NCT00433511|592129746|FG001|Step 2 (Arm D)|Adverse Event|0|||
163934225|NCT00433511|592129747|FG002|Step 2 (Arm D)|Adverse Event|135|||
163934226|NCT00433511|592129745|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
163934227|NCT00433511|592129746|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
163934228|NCT00433511|592129747|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
163934229|NCT00433511|592129745|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
163934230|NCT00433511|592129746|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
163934231|NCT00433511|592129747|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
163934232|NCT00433511|592129745|FG000|Step 2 (Arm D)|Physician Decision|0|||
163934233|NCT00433511|592129746|FG001|Step 2 (Arm D)|Physician Decision|0|||
163934234|NCT00433511|592129747|FG002|Step 2 (Arm D)|Physician Decision|9|||
163934235|NCT00433511|592129745|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
163934236|NCT00433511|592129746|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
163934237|NCT00433511|592129747|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
163934238|NCT00433511|592129745|FG000|Step 2 (Arm D)|Other complicating disease|0|||
163934239|NCT00433511|592129746|FG001|Step 2 (Arm D)|Other complicating disease|0|||
163934240|NCT00433511|592129747|FG002|Step 2 (Arm D)|Other complicating disease|3|||
163934241|NCT00433511|592129745|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
163934242|NCT00433511|592129746|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
163934243|NCT00433511|592129747|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
163934244|NCT00433511|592129745|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
163934245|NCT00433511|592129746|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
163934246|NCT00433511|592129747|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
163934247|NCT00433511|592129745|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
163934248|NCT00433511|592129746|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
163934249|NCT00433511|592129747|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
163934250|NCT00433511|592129745|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
163934251|NCT00433511|592129746|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
163934252|NCT00433511|592129747|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
163934253|NCT01375673|592129748|FG000|Overall Study|Withdrawal by Subject|0|||
163934254|NCT01375673|592129749|FG001|Overall Study|Withdrawal by Subject|1|||
163934255|NCT04698915|592129754|FG000|Overall Study|Adverse Event|2|||
163934256|NCT04698915|592129755|FG001|Overall Study|Adverse Event|0|||
163934257|NCT04698915|592129754|FG000|Overall Study|Death|23|||
163934258|NCT04698915|592129755|FG001|Overall Study|Death|20|||
163934259|NCT04698915|592129754|FG000|Overall Study|Physician Decision|1|||
163934260|NCT04698915|592129755|FG001|Overall Study|Physician Decision|1|||
163934261|NCT04698915|592129754|FG000|Overall Study|Lost to Follow-up|1|||
163934262|NCT04698915|592129755|FG001|Overall Study|Lost to Follow-up|0|||
163934263|NCT04698915|592129754|FG000|Overall Study|Study Terminated by Sponsor|55|||
163934264|NCT04698915|592129755|FG001|Overall Study|Study Terminated by Sponsor|60|||
163934265|NCT04698915|592129754|FG000|Overall Study|Withdrawal by Subject|2|||
163934266|NCT04698915|592129755|FG001|Overall Study|Withdrawal by Subject|3|||
163934267|NCT05687032|592129760|FG000|Treatment Phase|Adverse Event|13|||
163934268|NCT05687032|592129760|FG000|Treatment Phase|Death|1|||
163934269|NCT05687032|592129760|FG000|Treatment Phase|Physician Decision|3|||
163934270|NCT05687032|592129760|FG000|Treatment Phase|Progressive disease|9|||
163934271|NCT05687032|592129760|FG000|Treatment Phase|Withdrawal by Subject|5|||
163934272|NCT05687032|592129760|FG000|Follow-Up Phase|Death|16|||
163934273|NCT05687032|592129760|FG000|Follow-Up Phase|Ongoing|26|||
163934274|NCT04829747|592129761|FG000|Overall Study|Protocol Violation|1|||
163934275|NCT02367352|592129764|FG000|Overall Study|Progressive disease|7|||
163934276|NCT02367352|592129765|FG001|Overall Study|Progressive disease|0|||
163934277|NCT02367352|592129766|FG002|Overall Study|Progressive disease|0|||
163934278|NCT02367352|592129764|FG000|Overall Study|Participant Received Alternative Therapy|1|||
163934279|NCT02367352|592129765|FG001|Overall Study|Participant Received Alternative Therapy|0|||
163934280|NCT02367352|592129766|FG002|Overall Study|Participant Received Alternative Therapy|0|||
163934281|NCT02367352|592129764|FG000|Overall Study|Adverse Event|1|||
163934282|NCT02367352|592129765|FG001|Overall Study|Adverse Event|0|||
163934283|NCT02367352|592129766|FG002|Overall Study|Adverse Event|0|||
163934284|NCT05878873|592129771|FG000|Overall Study|Lost to Follow-up|2|||
163934285|NCT05878873|592129772|FG001|Overall Study|Lost to Follow-up|0|||
163934286|NCT02375347|592129774|FG000|Overall Study|Protocol Violation|1|||
163934287|NCT00193479|592129775|FG000|Induction Chemotherapy|Adverse Event|2|||
163934288|NCT00193479|592129775|FG000|Induction Chemotherapy|Disease Progression|1|||
163934289|NCT00193479|592129775|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
163934290|NCT00193479|592129775|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
163934291|NCT00425607|592129776|FG000|Overall Study|Death|1|||
163934292|NCT00425607|592129776|FG000|Overall Study|Withdrawal by Subject|1|||
163934293|NCT00079339|592129777|FG000|Overall Study|Adverse Event|1|||
163934294|NCT00079339|592129778|FG001|Overall Study|Adverse Event|7|||
163934295|NCT00079339|592129779|FG002|Overall Study|Adverse Event|2|||
163934296|NCT00079339|592129777|FG000|Overall Study|Death|1|||
163934297|NCT00079339|592129778|FG001|Overall Study|Death|0|||
163934298|NCT00079339|592129779|FG002|Overall Study|Death|0|||
163934299|NCT00079339|592129777|FG000|Overall Study|Non-compliance|0|||
163934300|NCT00079339|592129778|FG001|Overall Study|Non-compliance|0|||
163934301|NCT00079339|592129779|FG002|Overall Study|Non-compliance|1|||
163934302|NCT00079339|592129777|FG000|Overall Study|Withdrawal by Subject|0|||
163934303|NCT00079339|592129778|FG001|Overall Study|Withdrawal by Subject|4|||
163934304|NCT00079339|592129779|FG002|Overall Study|Withdrawal by Subject|1|||
163934305|NCT00079339|592129777|FG000|Overall Study|Disease progression|3|||
163934306|NCT00079339|592129778|FG001|Overall Study|Disease progression|28|||
163934307|NCT00079339|592129779|FG002|Overall Study|Disease progression|2|||
163934308|NCT02563548|592129780|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
163934309|NCT02563548|592129781|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163934310|NCT02563548|592129782|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163934311|NCT02563548|592129783|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
163934312|NCT02563548|592129784|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163934313|NCT02563548|592129785|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
163934314|NCT02563548|592129780|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
163934315|NCT02563548|592129781|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
163934316|NCT02563548|592129782|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
163934317|NCT02563548|592129783|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
163934318|NCT02563548|592129784|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
163934319|NCT02563548|592129785|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
163934320|NCT02563548|592129780|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163934321|NCT02563548|592129781|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163934322|NCT02563548|592129782|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
163934323|NCT02563548|592129783|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163934324|NCT02563548|592129784|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163934325|NCT02563548|592129785|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
163934326|NCT02563548|592129780|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163934327|NCT02563548|592129781|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163934328|NCT02563548|592129782|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
163934329|NCT02563548|592129783|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
163934330|NCT02563548|592129784|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163934331|NCT02563548|592129785|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
163934332|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163934333|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163934334|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163934335|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
163934336|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
163934337|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
163934338|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
163934339|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
163934340|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
164037255|NCT03051217|592496679|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
164037256|NCT03051217|592496680|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
163934341|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
164037257|NCT03051217|592496681|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
163934342|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
163934343|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
163934344|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163838834|NCT00235443|591781598|FG004|Overall Study|Lack of Efficacy|2|||
163838835|NCT00235443|591781599|FG005|Overall Study|Lack of Efficacy|9|||
163838836|NCT00235443|591781594|FG000|Overall Study|Withdrawal by Subject|3|||
163838837|NCT00235443|591781595|FG001|Overall Study|Withdrawal by Subject|9|||
163838838|NCT00235443|591781596|FG002|Overall Study|Withdrawal by Subject|25|||
163838839|NCT00235443|591781597|FG003|Overall Study|Withdrawal by Subject|24|||
163838840|NCT00235443|591781598|FG004|Overall Study|Withdrawal by Subject|10|||
163838841|NCT00235443|591781599|FG005|Overall Study|Withdrawal by Subject|12|||
163838842|NCT00235443|591781594|FG000|Overall Study|Lost to Follow-up|0|||
163838843|NCT00235443|591781595|FG001|Overall Study|Lost to Follow-up|8|||
163838844|NCT00235443|591781596|FG002|Overall Study|Lost to Follow-up|6|||
163838845|NCT00235443|591781597|FG003|Overall Study|Lost to Follow-up|6|||
163838846|NCT00235443|591781598|FG004|Overall Study|Lost to Follow-up|4|||
163838847|NCT00235443|591781599|FG005|Overall Study|Lost to Follow-up|3|||
163838848|NCT00235443|591781594|FG000|Overall Study|Unsatisfactory compliance|0|||
163838849|NCT00235443|591781595|FG001|Overall Study|Unsatisfactory compliance|2|||
163838850|NCT00235443|591781596|FG002|Overall Study|Unsatisfactory compliance|3|||
163838851|NCT00235443|591781597|FG003|Overall Study|Unsatisfactory compliance|4|||
163838852|NCT00235443|591781598|FG004|Overall Study|Unsatisfactory compliance|1|||
163838853|NCT00235443|591781599|FG005|Overall Study|Unsatisfactory compliance|0|||
163838854|NCT00235443|591781594|FG000|Overall Study|Other reasons for premature termination|1|||
163838855|NCT00235443|591781595|FG001|Overall Study|Other reasons for premature termination|6|||
163838856|NCT00235443|591781596|FG002|Overall Study|Other reasons for premature termination|6|||
163838857|NCT00235443|591781597|FG003|Overall Study|Other reasons for premature termination|7|||
163838858|NCT00235443|591781598|FG004|Overall Study|Other reasons for premature termination|3|||
163838859|NCT00235443|591781599|FG005|Overall Study|Other reasons for premature termination|6|||
163838860|NCT00474929|591781603|FG000|Overall Study|Withdrawal by Subject|0|||
163838861|NCT00474929|591781604|FG001|Overall Study|Withdrawal by Subject|1|||
163838862|NCT00474929|591781605|FG002|Overall Study|Withdrawal by Subject|0|||
163838863|NCT00474929|591781606|FG003|Overall Study|Withdrawal by Subject|0|||
163838864|NCT00474929|591781607|FG004|Overall Study|Withdrawal by Subject|0|||
163838865|NCT00474929|591781603|FG000|Overall Study|Unrelated medical condition|0|||
163838866|NCT00474929|591781604|FG001|Overall Study|Unrelated medical condition|0|||
163838867|NCT00474929|591781605|FG002|Overall Study|Unrelated medical condition|1|||
163838868|NCT00474929|591781606|FG003|Overall Study|Unrelated medical condition|0|||
163838869|NCT00474929|591781607|FG004|Overall Study|Unrelated medical condition|0|||
163838870|NCT00474929|591781603|FG000|Overall Study|Physician Decision|0|||
163838871|NCT00474929|591781604|FG001|Overall Study|Physician Decision|0|||
163838872|NCT00474929|591781605|FG002|Overall Study|Physician Decision|1|||
163838873|NCT00474929|591781606|FG003|Overall Study|Physician Decision|2|||
163838874|NCT00474929|591781607|FG004|Overall Study|Physician Decision|0|||
163838875|NCT03321513|591781610|FG000|Overall Study|Death|11|||
163838876|NCT03321513|591781611|FG001|Overall Study|Death|5|||
163838877|NCT03321513|591781610|FG000|Overall Study|Withdrawal by Subject|5|||
163838878|NCT03321513|591781611|FG001|Overall Study|Withdrawal by Subject|10|||
163838879|NCT03321513|591781610|FG000|Overall Study|Lost to Follow-up|10|||
163838880|NCT03321513|591781611|FG001|Overall Study|Lost to Follow-up|11|||
163838881|NCT03029247|591781612|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
163838882|NCT03029247|591781613|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
163838883|NCT03029247|591781612|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
163838884|NCT03029247|591781613|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
163838885|NCT03029247|591781612|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
163838886|NCT03029247|591781613|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
163838887|NCT03029247|591781612|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
163838888|NCT03029247|591781613|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
163838889|NCT02593305|591781614|FG000|Post 1|Comparison only group. No intervention.|0|||
163838890|NCT02593305|591781615|FG001|Post 1|Comparison only group. No intervention.|0|||
163838891|NCT02593305|591781616|FG002|Post 1|Comparison only group. No intervention.|10|||
163838892|NCT02757521|591781617|FG000|Overall Study|Adverse Event|1|||
163838893|NCT02757521|591781618|FG001|Overall Study|Adverse Event|0|||
163838894|NCT00798174|591781622|FG000|Overall Study|inability to implant azygos coil|3|||
163838895|NCT00798174|591781623|FG001|Overall Study|inability to implant azygos coil|3|||
163838896|NCT00798174|591781622|FG000|Overall Study|Inability to sedate for DFT testing|1|||
163838897|NCT00798174|591781623|FG001|Overall Study|Inability to sedate for DFT testing|0|||
163838898|NCT01683994|591781642|FG000|Overall Study|Withdrawal by Subject|1|||
163838899|NCT01683994|591781643|FG001|Overall Study|Withdrawal by Subject|0|||
163838900|NCT01683994|591781644|FG002|Overall Study|Withdrawal by Subject|0|||
163838901|NCT01683994|591781645|FG003|Overall Study|Withdrawal by Subject|1|||
163838902|NCT01683994|591781646|FG004|Overall Study|Withdrawal by Subject|0|||
163838903|NCT01683994|591781642|FG000|Overall Study|Intercurrent illness|0|||
163838904|NCT01683994|591781643|FG001|Overall Study|Intercurrent illness|0|||
163838905|NCT01683994|591781644|FG002|Overall Study|Intercurrent illness|0|||
163838906|NCT01683994|591781645|FG003|Overall Study|Intercurrent illness|2|||
163838907|NCT01683994|591781646|FG004|Overall Study|Intercurrent illness|1|||
163934345|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163934346|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163934347|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163934348|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
163934349|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
163934350|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163934351|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163934352|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163934353|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
163934354|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
163934355|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
163934356|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163934357|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163934358|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163934359|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163934360|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
163934361|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
163934362|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163934363|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164037258|NCT03051217|592496675|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164037259|NCT03051217|592496676|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164037260|NCT03051217|592496677|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164037261|NCT03051217|592496678|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
164037262|NCT03051217|592496679|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164037263|NCT03051217|592496680|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164037264|NCT03051217|592496681|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
164037265|NCT03051217|592496675|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164037266|NCT03051217|592496676|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164037267|NCT03051217|592496677|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
163838908|NCT00999661|591781647|FG000|Overall Study|Lost to Follow-up|59|||
163838909|NCT00999661|591781647|FG000|Overall Study|Adverse Event|1|||
163838910|NCT00999661|591781647|FG000|Overall Study|Withdrawal by Subject|1|||
163838911|NCT00999661|591781647|FG000|Overall Study|Not meeting eligibility criteria|9|||
163838912|NCT00312858|591781651|FG000|Overall Study|Adverse Event|0|||
163838913|NCT00312858|591781652|FG001|Overall Study|Adverse Event|1|||
163838914|NCT00312858|591781651|FG000|Overall Study|Lost to Follow-up|25|||
163838915|NCT00312858|591781652|FG001|Overall Study|Lost to Follow-up|42|||
163838916|NCT00312858|591781651|FG000|Overall Study|Protocol Violation|3|||
163838917|NCT00312858|591781652|FG001|Overall Study|Protocol Violation|8|||
163838918|NCT00312858|591781651|FG000|Overall Study|Withdraw by Participant|20|||
163838919|NCT00312858|591781652|FG001|Overall Study|Withdraw by Participant|20|||
163838920|NCT00312858|591781651|FG000|Overall Study|Participant Moved|11|||
163838921|NCT00312858|591781652|FG001|Overall Study|Participant Moved|10|||
163838922|NCT00312858|591781651|FG000|Overall Study|Other|9|||
163838923|NCT00312858|591781652|FG001|Overall Study|Other|12|||
163838924|NCT02318719|591781655|FG000|Double-blind Phase|Adverse Event|7|||
163838925|NCT02318719|591781656|FG001|Double-blind Phase|Adverse Event|6|||
163838926|NCT02318719|591781657|FG002|Double-blind Phase|Adverse Event|12|||
163838927|NCT02318719|591781658|FG003|Double-blind Phase|Adverse Event|4|||
163838928|NCT02318719|591781659|FG004|Double-blind Phase|Adverse Event|0|||
163838929|NCT02318719|591781655|FG000|Double-blind Phase|Lack of Efficacy|5|||
163838930|NCT02318719|591781656|FG001|Double-blind Phase|Lack of Efficacy|0|||
163838931|NCT02318719|591781657|FG002|Double-blind Phase|Lack of Efficacy|1|||
163838932|NCT02318719|591781658|FG003|Double-blind Phase|Lack of Efficacy|1|||
163838933|NCT02318719|591781659|FG004|Double-blind Phase|Lack of Efficacy|0|||
163838934|NCT02318719|591781655|FG000|Double-blind Phase|Protocol Violation|0|||
163838935|NCT02318719|591781656|FG001|Double-blind Phase|Protocol Violation|1|||
163838936|NCT02318719|591781657|FG002|Double-blind Phase|Protocol Violation|3|||
163838937|NCT02318719|591781658|FG003|Double-blind Phase|Protocol Violation|0|||
163838938|NCT02318719|591781659|FG004|Double-blind Phase|Protocol Violation|0|||
163838939|NCT02318719|591781655|FG000|Double-blind Phase|Withdrawal by Subject|25|||
163838940|NCT02318719|591781656|FG001|Double-blind Phase|Withdrawal by Subject|7|||
163838941|NCT02318719|591781657|FG002|Double-blind Phase|Withdrawal by Subject|9|||
163838942|NCT02318719|591781658|FG003|Double-blind Phase|Withdrawal by Subject|10|||
163838943|NCT02318719|591781659|FG004|Double-blind Phase|Withdrawal by Subject|0|||
163838944|NCT02318719|591781655|FG000|Double-blind Phase|Other|1|||
163838945|NCT02318719|591781656|FG001|Double-blind Phase|Other|2|||
163934364|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
164037268|NCT03051217|592496678|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
163838946|NCT02318719|591781657|FG002|Double-blind Phase|Other|0|||
164073173|NCT01347879|592632836|FG000|Overall Study|Other|2|||
163838947|NCT02318719|591781658|FG003|Double-blind Phase|Other|0|||
164098526|NCT03135834|592725133|FG000|Stage 1|Other|0|||
164098527|NCT03135834|592725134|FG001|Stage 1|Other|2|||
164098528|NCT03135834|592725135|FG002|Stage 1|Other|1|||
164098529|NCT03135834|592725136|FG003|Stage 1|Other|0|||
164098530|NCT03135834|592725133|FG000|Stage 1|Physician Decision|0|||
164098531|NCT03135834|592725134|FG001|Stage 1|Physician Decision|1|||
164098532|NCT03135834|592725135|FG002|Stage 1|Physician Decision|0|||
164098533|NCT03135834|592725136|FG003|Stage 1|Physician Decision|0|||
164098534|NCT03135834|592725133|FG000|Stage 1|Pregnancy|0|||
164098535|NCT03135834|592725134|FG001|Stage 1|Pregnancy|4|||
164098536|NCT03135834|592725135|FG002|Stage 1|Pregnancy|2|||
164098537|NCT03135834|592725136|FG003|Stage 1|Pregnancy|4|||
164098538|NCT03135834|592725133|FG000|Stage 1|Protocol Violation|1|||
164098539|NCT03135834|592725134|FG001|Stage 1|Protocol Violation|1|||
164098540|NCT03135834|592725135|FG002|Stage 1|Protocol Violation|2|||
164098541|NCT03135834|592725136|FG003|Stage 1|Protocol Violation|1|||
164037269|NCT03051217|592496679|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164037270|NCT03051217|592496680|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164037271|NCT03051217|592496681|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
164037272|NCT03051217|592496675|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164037273|NCT03051217|592496676|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164037274|NCT03051217|592496677|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164037275|NCT03051217|592496678|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164037276|NCT03051217|592496679|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
164037277|NCT03051217|592496680|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164037278|NCT03051217|592496681|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
164037279|NCT03051217|592496675|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164037280|NCT03051217|592496676|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164037281|NCT03051217|592496677|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164037282|NCT03051217|592496678|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164037283|NCT03051217|592496679|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164037284|NCT03051217|592496680|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
164037285|NCT03051217|592496681|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
164037286|NCT00109772|592496682|FG000|Double-blind Treatment|Adverse Event|14|||
164037287|NCT00109772|592496683|FG001|Double-blind Treatment|Adverse Event|5|||
164037288|NCT00109772|592496682|FG000|Double-blind Treatment|Lack of Efficacy|1|||
164037289|NCT00109772|592496683|FG001|Double-blind Treatment|Lack of Efficacy|0|||
164037290|NCT00109772|592496682|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
164037291|NCT00109772|592496683|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
164037292|NCT00109772|592496682|FG000|Double-blind Treatment|Lost to Follow-up|2|||
164037293|NCT00109772|592496683|FG001|Double-blind Treatment|Lost to Follow-up|3|||
164037294|NCT00109772|592496682|FG000|Double-blind Treatment|Protocol Violation|0|||
164037295|NCT00109772|592496683|FG001|Double-blind Treatment|Protocol Violation|1|||
164037296|NCT00109772|592496682|FG000|Double-blind Treatment|Other|0|||
164037297|NCT00109772|592496683|FG001|Double-blind Treatment|Other|4|||
164037298|NCT00109772|592496682|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
164037299|NCT00109772|592496683|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
164037300|NCT00109772|592496682|FG000|Open-label Extension|Adverse Event|10|||
164037301|NCT00109772|592496683|FG001|Open-label Extension|Adverse Event|19|||
164037302|NCT00109772|592496682|FG000|Open-label Extension|Lack of Efficacy|19|||
164037303|NCT00109772|592496683|FG001|Open-label Extension|Lack of Efficacy|11|||
164037304|NCT00109772|592496682|FG000|Open-label Extension|Withdrawal by Subject|9|||
164037305|NCT00109772|592496683|FG001|Open-label Extension|Withdrawal by Subject|6|||
164037306|NCT00109772|592496682|FG000|Open-label Extension|Lost to Follow-up|1|||
164037307|NCT00109772|592496683|FG001|Open-label Extension|Lost to Follow-up|0|||
164037308|NCT00109772|592496682|FG000|Open-label Extension|Death|0|||
164037309|NCT00109772|592496683|FG001|Open-label Extension|Death|1|||
164037310|NCT00109772|592496682|FG000|Open-label Extension|Protocol Violation|2|||
164037311|NCT00109772|592496683|FG001|Open-label Extension|Protocol Violation|2|||
164037312|NCT00109772|592496682|FG000|Open-label Extension|Other|4|||
164037313|NCT00109772|592496683|FG001|Open-label Extension|Other|10|||
164037314|NCT01989754|592496684|FG000|Overall Study|Withdrawal by Subject|10|||
164037315|NCT01989754|592496685|FG001|Overall Study|Withdrawal by Subject|14|||
164037316|NCT01989754|592496684|FG000|Overall Study|Lost to Follow-up|28|||
164037317|NCT01989754|592496685|FG001|Overall Study|Lost to Follow-up|20|||
164098542|NCT03135834|592725133|FG000|Stage 1|Withdrawal by parent/guardian|2|||
164098543|NCT03135834|592725134|FG001|Stage 1|Withdrawal by parent/guardian|10|||
164037318|NCT01989754|592496684|FG000|Overall Study|Closed Site|1|||
164037319|NCT01989754|592496685|FG001|Overall Study|Closed Site|1|||
164098544|NCT03135834|592725135|FG002|Stage 1|Withdrawal by parent/guardian|2|||
164098545|NCT03135834|592725136|FG003|Stage 1|Withdrawal by parent/guardian|1|||
164098546|NCT03135834|592725133|FG000|Stage 1|Withdrawal by Subject|16|||
164098547|NCT03135834|592725134|FG001|Stage 1|Withdrawal by Subject|22|||
164098548|NCT03135834|592725135|FG002|Stage 1|Withdrawal by Subject|7|||
164037320|NCT00391807|592496691|FG000|Overall Study|Did not receive study medication|23|||
164037321|NCT00391807|592496691|FG000|Overall Study|Adverse Event|177|||
164037322|NCT00391807|592496691|FG000|Overall Study|Pregnancy|25|||
164037323|NCT00391807|592496691|FG000|Overall Study|Lost to Follow-up|227|||
164037324|NCT00391807|592496691|FG000|Overall Study|Withdrawal by Subject|147|||
164037325|NCT00391807|592496691|FG000|Overall Study|Protocol Violation|20|||
164037326|NCT00391807|592496691|FG000|Overall Study|Various|96|||
164037327|NCT01369225|592496694|FG000|Overall Study|Withdrawal by Subject|1|||
164037328|NCT01369225|592496695|FG001|Overall Study|Withdrawal by Subject|0|||
164037329|NCT01369225|592496696|FG002|Overall Study|Withdrawal by Subject|2|||
164037330|NCT01369225|592496697|FG003|Overall Study|Withdrawal by Subject|1|||
164037331|NCT01369225|592496698|FG004|Overall Study|Withdrawal by Subject|0|||
164037332|NCT01369225|592496699|FG005|Overall Study|Withdrawal by Subject|0|||
164037333|NCT01369225|592496694|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
164037334|NCT01369225|592496695|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
164037335|NCT01369225|592496696|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
164037336|NCT01369225|592496697|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
164037337|NCT01369225|592496698|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
164037338|NCT01369225|592496699|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
164037339|NCT01369225|592496694|FG000|Overall Study|Other|1|||
164037340|NCT01369225|592496695|FG001|Overall Study|Other|0|||
164037341|NCT01369225|592496696|FG002|Overall Study|Other|0|||
164037342|NCT01369225|592496697|FG003|Overall Study|Other|0|||
164037343|NCT01369225|592496698|FG004|Overall Study|Other|1|||
164037344|NCT01369225|592496699|FG005|Overall Study|Other|0|||
164037345|NCT01369225|592496694|FG000|Overall Study|Adverse Event|0|||
164037346|NCT01369225|592496695|FG001|Overall Study|Adverse Event|0|||
164037347|NCT01369225|592496696|FG002|Overall Study|Adverse Event|0|||
164037348|NCT01369225|592496697|FG003|Overall Study|Adverse Event|1|||
164037349|NCT01369225|592496698|FG004|Overall Study|Adverse Event|1|||
164037350|NCT01369225|592496699|FG005|Overall Study|Adverse Event|0|||
164037351|NCT04539262|592496703|FG000|Overall Study|Adverse Event|0|||
164037352|NCT04539262|592496704|FG001|Overall Study|Adverse Event|0|||
164037353|NCT04539262|592496705|FG002|Overall Study|Adverse Event|1|||
164037354|NCT04539262|592496706|FG003|Overall Study|Adverse Event|0|||
164037355|NCT04539262|592496707|FG004|Overall Study|Adverse Event|0|||
164037356|NCT04539262|592496708|FG005|Overall Study|Adverse Event|0|||
164037357|NCT04539262|592496709|FG006|Overall Study|Adverse Event|0|||
164037358|NCT04539262|592496710|FG007|Overall Study|Adverse Event|0|||
164037359|NCT04539262|592496703|FG000|Overall Study|Withdrew Consent|0|||
164037360|NCT04539262|592496704|FG001|Overall Study|Withdrew Consent|0|||
164037361|NCT04539262|592496705|FG002|Overall Study|Withdrew Consent|0|||
164037362|NCT04539262|592496706|FG003|Overall Study|Withdrew Consent|1|||
164037363|NCT04539262|592496707|FG004|Overall Study|Withdrew Consent|0|||
164037364|NCT04539262|592496708|FG005|Overall Study|Withdrew Consent|0|||
164037365|NCT04539262|592496709|FG006|Overall Study|Withdrew Consent|0|||
164037366|NCT04539262|592496710|FG007|Overall Study|Withdrew Consent|0|||
164037367|NCT04539262|592496703|FG000|Overall Study|Randomized, Not treated|0|||
164037368|NCT04539262|592496704|FG001|Overall Study|Randomized, Not treated|1|||
164037369|NCT04539262|592496705|FG002|Overall Study|Randomized, Not treated|0|||
164037370|NCT04539262|592496706|FG003|Overall Study|Randomized, Not treated|0|||
164037371|NCT04539262|592496707|FG004|Overall Study|Randomized, Not treated|0|||
164037372|NCT04539262|592496708|FG005|Overall Study|Randomized, Not treated|0|||
164037373|NCT04539262|592496709|FG006|Overall Study|Randomized, Not treated|1|||
164037374|NCT04539262|592496710|FG007|Overall Study|Randomized, Not treated|0|||
164037375|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
164037376|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
164037377|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
164037378|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
163838948|NCT02318719|591781659|FG004|Double-blind Phase|Other|0|||
163838949|NCT02318719|591781655|FG000|Open-label Extension Phase|Adverse Event|0|||
163838950|NCT02318719|591781656|FG001|Open-label Extension Phase|Adverse Event|0|||
164037379|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
164037380|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
164037381|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
163838951|NCT02318719|591781657|FG002|Open-label Extension Phase|Adverse Event|0|||
164037382|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
164037383|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
164037384|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
164037385|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164037386|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164037387|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164037388|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
164037389|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
164037390|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
164037391|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
164037392|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
164037393|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
164037394|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
164037395|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
164037396|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
164037397|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
164037398|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
164037399|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
164037400|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Other|1|||
164037401|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Other|0|||
164037402|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Other|0|||
164037403|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Other|0|||
164037404|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Other|1|||
164037405|NCT02980692|592496713|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
164037406|NCT02980692|592496714|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
164037407|NCT02980692|592496715|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
164037408|NCT02980692|592496716|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
164037409|NCT02980692|592496717|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
164037410|NCT02980692|592496713|FG000|Double-blind Follow-up Period|Adverse Event|0|||
164037411|NCT02980692|592496714|FG001|Double-blind Follow-up Period|Adverse Event|0|||
164037412|NCT02980692|592496715|FG002|Double-blind Follow-up Period|Adverse Event|0|||
164037413|NCT02980692|592496716|FG003|Double-blind Follow-up Period|Adverse Event|1|||
164037414|NCT02980692|592496717|FG004|Double-blind Follow-up Period|Adverse Event|1|||
164037415|NCT02980692|592496713|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
164037416|NCT02980692|592496714|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
164037417|NCT02980692|592496715|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
164037418|NCT02980692|592496716|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
164037419|NCT02980692|592496717|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
164037420|NCT02980692|592496713|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
164037421|NCT02980692|592496714|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
164037422|NCT02980692|592496715|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
164037423|NCT02980692|592496716|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
164037424|NCT02980692|592496717|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
164037425|NCT02980692|592496713|FG000|Double-blind Follow-up Period|Pregnancy|0|||
164037426|NCT02980692|592496714|FG001|Double-blind Follow-up Period|Pregnancy|0|||
164037427|NCT02980692|592496715|FG002|Double-blind Follow-up Period|Pregnancy|1|||
163838952|NCT02318719|591781658|FG003|Open-label Extension Phase|Adverse Event|0|||
163838953|NCT02318719|591781659|FG004|Open-label Extension Phase|Adverse Event|15|||
163838954|NCT02318719|591781655|FG000|Open-label Extension Phase|Death|0|||
163838955|NCT02318719|591781656|FG001|Open-label Extension Phase|Death|0|||
163838956|NCT02318719|591781657|FG002|Open-label Extension Phase|Death|0|||
163838957|NCT02318719|591781658|FG003|Open-label Extension Phase|Death|0|||
163838958|NCT02318719|591781659|FG004|Open-label Extension Phase|Death|1|||
163838959|NCT02318719|591781655|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
163838960|NCT02318719|591781656|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
163838961|NCT02318719|591781657|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
163838962|NCT02318719|591781658|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
163838963|NCT02318719|591781659|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
163838964|NCT02318719|591781655|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
163838965|NCT02318719|591781656|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
163838966|NCT02318719|591781657|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
163838967|NCT02318719|591781658|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
163838968|NCT02318719|591781659|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
163838969|NCT02318719|591781655|FG000|Open-label Extension Phase|Other|0|||
163838970|NCT02318719|591781656|FG001|Open-label Extension Phase|Other|0|||
163838971|NCT02318719|591781657|FG002|Open-label Extension Phase|Other|0|||
163838972|NCT02318719|591781658|FG003|Open-label Extension Phase|Other|0|||
163838973|NCT02318719|591781659|FG004|Open-label Extension Phase|Other|7|||
163838974|NCT00854295|591781663|FG000|Overall Study|Death|7|||
163838975|NCT00854295|591781664|FG001|Overall Study|Death|0|||
163838976|NCT00854295|591781665|FG002|Overall Study|Death|1|||
163838977|NCT00854295|591781666|FG003|Overall Study|Death|1|||
163838978|NCT00854295|591781663|FG000|Overall Study|Adverse Event|6|||
163838979|NCT00854295|591781664|FG001|Overall Study|Adverse Event|1|||
163838980|NCT00854295|591781665|FG002|Overall Study|Adverse Event|1|||
163838981|NCT00854295|591781666|FG003|Overall Study|Adverse Event|3|||
163838982|NCT00854295|591781663|FG000|Overall Study|Lost to Follow-up|18|||
164098549|NCT03135834|592725136|FG003|Stage 1|Withdrawal by Subject|10|||
164098550|NCT03135834|592725133|FG000|Stage 1|Randomized but not Vaccinated|0|||
164098551|NCT03135834|592725134|FG001|Stage 1|Randomized but not Vaccinated|3|||
164098552|NCT03135834|592725135|FG002|Stage 1|Randomized but not Vaccinated|1|||
164098553|NCT03135834|592725136|FG003|Stage 1|Randomized but not Vaccinated|6|||
164098554|NCT03135834|592725133|FG000|Stage 2|Lost to Follow-up|0|||
164098555|NCT03135834|592725134|FG001|Stage 2|Lost to Follow-up|1|||
164098556|NCT03135834|592725135|FG002|Stage 2|Lost to Follow-up|0|||
164098557|NCT03135834|592725136|FG003|Stage 2|Lost to Follow-up|0|||
163838983|NCT00854295|591781664|FG001|Overall Study|Lost to Follow-up|5|||
163838984|NCT00854295|591781665|FG002|Overall Study|Lost to Follow-up|21|||
163838985|NCT00854295|591781666|FG003|Overall Study|Lost to Follow-up|21|||
163838986|NCT00854295|591781663|FG000|Overall Study|Physician Decision|10|||
163838987|NCT00854295|591781664|FG001|Overall Study|Physician Decision|0|||
163838988|NCT00854295|591781665|FG002|Overall Study|Physician Decision|0|||
163838989|NCT00854295|591781666|FG003|Overall Study|Physician Decision|0|||
163838990|NCT02440594|591781667|FG000|Overall Study|Lost to Follow-up|34|||
163838991|NCT02440594|591781668|FG001|Overall Study|Lost to Follow-up|33|||
163838992|NCT02440594|591781669|FG002|Overall Study|Lost to Follow-up|54|||
163838993|NCT02440594|591781670|FG003|Overall Study|Lost to Follow-up|47|||
163838994|NCT02440594|591781671|FG004|Overall Study|Lost to Follow-up|5|||
163838995|NCT02440594|591781672|FG005|Overall Study|Lost to Follow-up|4|||
163838996|NCT02440594|591781673|FG006|Overall Study|Lost to Follow-up|28|||
163838997|NCT02440594|591781674|FG007|Overall Study|Lost to Follow-up|48|||
163838998|NCT02440594|591781667|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
163838999|NCT02440594|591781668|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
163839000|NCT02440594|591781669|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
163839001|NCT02440594|591781670|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
163839002|NCT02440594|591781671|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
163839003|NCT02440594|591781672|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
163839004|NCT02440594|591781673|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
163839005|NCT02440594|591781674|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
163839006|NCT02440594|591781667|FG000|Overall Study|Withdrawal by Subject|81|||
163839007|NCT02440594|591781668|FG001|Overall Study|Withdrawal by Subject|67|||
163839008|NCT02440594|591781669|FG002|Overall Study|Withdrawal by Subject|59|||
163839009|NCT02440594|591781670|FG003|Overall Study|Withdrawal by Subject|38|||
163839010|NCT02440594|591781671|FG004|Overall Study|Withdrawal by Subject|2|||
163839011|NCT02440594|591781672|FG005|Overall Study|Withdrawal by Subject|2|||
163839012|NCT02440594|591781673|FG006|Overall Study|Withdrawal by Subject|7|||
163839013|NCT02440594|591781674|FG007|Overall Study|Withdrawal by Subject|7|||
163839014|NCT02440594|591781667|FG000|Overall Study|Administratively w/drawn|3|||
163934365|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163934366|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
163934367|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
163934368|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163934369|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163934370|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163934371|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163934372|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
163934373|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
163934374|NCT02563548|592129780|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163934375|NCT02563548|592129781|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163934376|NCT02563548|592129782|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163934377|NCT02563548|592129783|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163934378|NCT02563548|592129784|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
163934379|NCT02563548|592129785|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
163934380|NCT00340704|592129791|FG000|PK Study|Adverse Event|0|||
163934381|NCT00340704|592129792|FG001|PK Study|Adverse Event|1|||
163934382|NCT00340704|592129793|FG002|PK Study|Adverse Event|0|||
163934383|NCT00340704|592129794|FG003|PK Study|Adverse Event|0|||
163934384|NCT00340704|592129795|FG004|PK Study|Adverse Event|0|||
163934385|NCT00340704|592129796|FG005|PK Study|Adverse Event|0|||
163934386|NCT00340704|592129797|FG006|PK Study|Adverse Event|0|||
163934387|NCT00340704|592129798|FG007|PK Study|Adverse Event|0|||
163934388|NCT00340704|592129799|FG008|PK Study|Adverse Event|0|||
163934389|NCT00340704|592129791|FG000|PK Study|Not treated|0|||
163934390|NCT00340704|592129792|FG001|PK Study|Not treated|0|||
163934391|NCT00340704|592129793|FG002|PK Study|Not treated|1|||
163934392|NCT00340704|592129794|FG003|PK Study|Not treated|0|||
163934393|NCT00340704|592129795|FG004|PK Study|Not treated|0|||
163934394|NCT00340704|592129796|FG005|PK Study|Not treated|0|||
163934395|NCT00340704|592129797|FG006|PK Study|Not treated|0|||
163934396|NCT00340704|592129798|FG007|PK Study|Not treated|0|||
163934397|NCT00340704|592129799|FG008|PK Study|Not treated|0|||
163934398|NCT00340704|592129791|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
164098558|NCT03135834|592725133|FG000|Stage 2|Withdrawal by Subject|0|||
163934399|NCT00340704|592129792|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163934400|NCT00340704|592129793|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163934401|NCT00340704|592129794|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
163934402|NCT00340704|592129795|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
163934403|NCT00340704|592129796|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163934404|NCT00340704|592129797|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
163934405|NCT00340704|592129798|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
163934406|NCT00340704|592129799|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
163934407|NCT00340704|592129791|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934408|NCT00340704|592129792|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934409|NCT00340704|592129793|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934410|NCT00340704|592129794|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934411|NCT00340704|592129795|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934412|NCT00340704|592129796|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
163934413|NCT00340704|592129797|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934414|NCT00340704|592129798|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934415|NCT00340704|592129799|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
163934416|NCT00340704|592129791|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934417|NCT00340704|592129792|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934418|NCT00340704|592129793|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934419|NCT00340704|592129794|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934420|NCT00340704|592129795|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
163934421|NCT00340704|592129796|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
163934422|NCT00340704|592129797|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934423|NCT00340704|592129798|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934424|NCT00340704|592129799|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
163934425|NCT00340704|592129791|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163934426|NCT00340704|592129792|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163934427|NCT00340704|592129793|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163934428|NCT00340704|592129794|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163934429|NCT00340704|592129795|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
163934430|NCT00340704|592129796|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
163934431|NCT00340704|592129797|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
163934432|NCT00340704|592129798|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
163934433|NCT00340704|592129799|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
163934434|NCT01732549|592129800|FG000|Overall Study|Adverse Event|13|||
163934435|NCT01732549|592129801|FG001|Overall Study|Adverse Event|3|||
163934436|NCT01732549|592129800|FG000|Overall Study|Consent withdrawn|13|||
163934437|NCT01732549|592129801|FG001|Overall Study|Consent withdrawn|6|||
163934438|NCT01732549|592129800|FG000|Overall Study|Disease progression|37|||
163934439|NCT01732549|592129801|FG001|Overall Study|Disease progression|50|||
163934440|NCT01732549|592129800|FG000|Overall Study|Other|8|||
163934441|NCT01732549|592129801|FG001|Overall Study|Other|14|||
163934442|NCT00121667|592129802|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
163934443|NCT00121667|592129803|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
163934444|NCT00121667|592129804|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
163934445|NCT00121667|592129805|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
163934446|NCT00121667|592129802|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
163934447|NCT00121667|592129803|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
163934448|NCT00121667|592129804|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
163934449|NCT00121667|592129805|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
163934450|NCT00121667|592129802|FG000|Short Term (ST) Period|Adverse Event|5|||
163934451|NCT00121667|592129803|FG001|Short Term (ST) Period|Adverse Event|6|||
163934452|NCT00121667|592129804|FG002|Short Term (ST) Period|Adverse Event|5|||
163934453|NCT00121667|592129805|FG003|Short Term (ST) Period|Adverse Event|3|||
163934454|NCT00121667|592129802|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
163934455|NCT00121667|592129803|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
163934456|NCT00121667|592129804|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
163934457|NCT00121667|592129805|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
163934458|NCT00121667|592129802|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
163934459|NCT00121667|592129803|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
163934460|NCT00121667|592129804|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
163934461|NCT00121667|592129805|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
163934462|NCT00121667|592129802|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
163934463|NCT00121667|592129803|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
163934464|NCT00121667|592129804|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
164098559|NCT03135834|592725134|FG001|Stage 2|Withdrawal by Subject|1|||
163934465|NCT00121667|592129805|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
163934466|NCT00121667|592129802|FG000|Short Term (ST) Period|Other Reason|3|||
163934467|NCT00121667|592129803|FG001|Short Term (ST) Period|Other Reason|0|||
163934468|NCT00121667|592129804|FG002|Short Term (ST) Period|Other Reason|0|||
163934469|NCT00121667|592129805|FG003|Short Term (ST) Period|Other Reason|0|||
163934470|NCT00121667|592129802|FG000|Short Term (ST) Period|Death|0|||
163934471|NCT00121667|592129803|FG001|Short Term (ST) Period|Death|0|||
163934472|NCT00121667|592129804|FG002|Short Term (ST) Period|Death|0|||
163934473|NCT00121667|592129805|FG003|Short Term (ST) Period|Death|1|||
163934474|NCT00121667|592129802|FG000|Short Term (ST) Period|Pregnancy|0|||
163934475|NCT00121667|592129803|FG001|Short Term (ST) Period|Pregnancy|0|||
163934476|NCT00121667|592129804|FG002|Short Term (ST) Period|Pregnancy|0|||
163934477|NCT00121667|592129805|FG003|Short Term (ST) Period|Pregnancy|1|||
163934478|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
163934479|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
163934480|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
163934481|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
163934482|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
163934483|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
163934484|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
163934485|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
163934486|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
163934487|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
163934488|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
163934489|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
163934490|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
163934491|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
163934492|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
163934493|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
163934494|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
163934495|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
163934496|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
163934497|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
163934498|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
163934499|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
163934500|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
163934501|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
163934502|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
163934503|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
163934504|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
163934505|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
163934506|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
163934507|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
163934508|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
163934509|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
163934510|NCT00121667|592129802|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
163934511|NCT00121667|592129803|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
163934512|NCT00121667|592129804|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
163934513|NCT00121667|592129805|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
163934514|NCT04468230|592129811|FG000|Overall Study|Adverse Event|2|||
163934515|NCT03994731|592129816|FG000|Pegloticase + IMM Period|Death|2|||
163934516|NCT03994731|592129817|FG001|Pegloticase + IMM Period|Death|0|||
163934517|NCT03994731|592129816|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
163934518|NCT03994731|592129817|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
163934519|NCT03994731|592129816|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
163934520|NCT03994731|592129817|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
163934521|NCT03377361|592129823|FG000|Pre-Treatment|Subject withdrew consent|0|||
163934522|NCT03377361|592129824|FG001|Pre-Treatment|Subject withdrew consent|0|||
163934523|NCT03377361|592129825|FG002|Pre-Treatment|Subject withdrew consent|0|||
163934524|NCT03377361|592129826|FG003|Pre-Treatment|Subject withdrew consent|0|||
163934525|NCT03377361|592129827|FG004|Pre-Treatment|Subject withdrew consent|0|||
163934526|NCT03377361|592129828|FG005|Pre-Treatment|Subject withdrew consent|0|||
164098560|NCT03135834|592725135|FG002|Stage 2|Withdrawal by Subject|0|||
163934527|NCT03377361|592129829|FG006|Pre-Treatment|Subject withdrew consent|0|||
163934528|NCT03377361|592129830|FG007|Pre-Treatment|Subject withdrew consent|3|||
163934529|NCT03377361|592129831|FG008|Pre-Treatment|Subject withdrew consent|1|||
163934530|NCT03377361|592129832|FG009|Pre-Treatment|Subject withdrew consent|0|||
163934531|NCT03377361|592129823|FG000|Pre-Treatment|Not Reported|0|||
163934532|NCT03377361|592129824|FG001|Pre-Treatment|Not Reported|0|||
163934533|NCT03377361|592129825|FG002|Pre-Treatment|Not Reported|0|||
163934534|NCT03377361|592129826|FG003|Pre-Treatment|Not Reported|0|||
163934535|NCT03377361|592129827|FG004|Pre-Treatment|Not Reported|0|||
163934536|NCT03377361|592129828|FG005|Pre-Treatment|Not Reported|0|||
163934537|NCT03377361|592129829|FG006|Pre-Treatment|Not Reported|0|||
163934538|NCT03377361|592129830|FG007|Pre-Treatment|Not Reported|0|||
163934539|NCT03377361|592129831|FG008|Pre-Treatment|Not Reported|3|||
163934540|NCT03377361|592129832|FG009|Pre-Treatment|Not Reported|0|||
163934541|NCT03377361|592129823|FG000|Treatment Period|Disease Progression|3|||
163934542|NCT03377361|592129824|FG001|Treatment Period|Disease Progression|2|||
163934543|NCT03377361|592129825|FG002|Treatment Period|Disease Progression|5|||
163934544|NCT03377361|592129826|FG003|Treatment Period|Disease Progression|3|||
163934545|NCT03377361|592129827|FG004|Treatment Period|Disease Progression|3|||
163934546|NCT03377361|592129828|FG005|Treatment Period|Disease Progression|3|||
163934547|NCT03377361|592129829|FG006|Treatment Period|Disease Progression|6|||
163934548|NCT03377361|592129830|FG007|Treatment Period|Disease Progression|106|||
163934549|NCT03377361|592129831|FG008|Treatment Period|Disease Progression|48|||
163934550|NCT03377361|592129832|FG009|Treatment Period|Disease Progression|59|||
163934551|NCT03377361|592129823|FG000|Treatment Period|Study Drug Toxicity|0|||
163934552|NCT03377361|592129824|FG001|Treatment Period|Study Drug Toxicity|0|||
163934553|NCT03377361|592129825|FG002|Treatment Period|Study Drug Toxicity|0|||
163934554|NCT03377361|592129826|FG003|Treatment Period|Study Drug Toxicity|1|||
163934555|NCT03377361|592129827|FG004|Treatment Period|Study Drug Toxicity|0|||
163934556|NCT03377361|592129828|FG005|Treatment Period|Study Drug Toxicity|0|||
163934557|NCT03377361|592129829|FG006|Treatment Period|Study Drug Toxicity|0|||
163934558|NCT03377361|592129830|FG007|Treatment Period|Study Drug Toxicity|7|||
163934559|NCT03377361|592129831|FG008|Treatment Period|Study Drug Toxicity|2|||
163934560|NCT03377361|592129832|FG009|Treatment Period|Study Drug Toxicity|16|||
163934561|NCT03377361|592129823|FG000|Treatment Period|Death|0|||
163934562|NCT03377361|592129824|FG001|Treatment Period|Death|0|||
163934563|NCT03377361|592129825|FG002|Treatment Period|Death|1|||
163934564|NCT03377361|592129826|FG003|Treatment Period|Death|0|||
163934565|NCT03377361|592129827|FG004|Treatment Period|Death|0|||
163934566|NCT03377361|592129828|FG005|Treatment Period|Death|0|||
163934567|NCT03377361|592129829|FG006|Treatment Period|Death|0|||
163934568|NCT03377361|592129830|FG007|Treatment Period|Death|2|||
163934569|NCT03377361|592129831|FG008|Treatment Period|Death|1|||
163934570|NCT03377361|592129832|FG009|Treatment Period|Death|3|||
163934571|NCT03377361|592129823|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163934572|NCT03377361|592129824|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163934573|NCT03377361|592129825|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163934574|NCT03377361|592129826|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163934575|NCT03377361|592129827|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163934576|NCT03377361|592129828|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
164098561|NCT03135834|592725136|FG003|Stage 2|Withdrawal by Subject|0|||
164098562|NCT03135834|592725133|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
164098563|NCT03135834|592725134|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
164098564|NCT03135834|592725135|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
163839015|NCT02440594|591781668|FG001|Overall Study|Administratively w/drawn|2|||
163839016|NCT02440594|591781669|FG002|Overall Study|Administratively w/drawn|0|||
163839017|NCT02440594|591781670|FG003|Overall Study|Administratively w/drawn|0|||
163839018|NCT02440594|591781671|FG004|Overall Study|Administratively w/drawn|0|||
163839019|NCT02440594|591781672|FG005|Overall Study|Administratively w/drawn|0|||
163839020|NCT02440594|591781673|FG006|Overall Study|Administratively w/drawn|2|||
163839021|NCT02440594|591781674|FG007|Overall Study|Administratively w/drawn|1|||
163839022|NCT00152763|591781675|FG000|Overall Study|Death|4|||
163839023|NCT00152763|591781676|FG001|Overall Study|Death|1|||
163839024|NCT00152763|591781677|FG002|Overall Study|Death|2|||
163839025|NCT00152763|591781678|FG003|Overall Study|Death|1|||
163839026|NCT00152763|591781675|FG000|Overall Study|Lost to Follow-up|6|||
163839027|NCT00152763|591781676|FG001|Overall Study|Lost to Follow-up|4|||
163839028|NCT00152763|591781677|FG002|Overall Study|Lost to Follow-up|2|||
163839029|NCT00152763|591781678|FG003|Overall Study|Lost to Follow-up|13|||
163839030|NCT02912468|591781679|FG000|Overall Study|Adverse Event|3|||
163839031|NCT02912468|591781680|FG001|Overall Study|Adverse Event|2|||
163839032|NCT02912468|591781679|FG000|Overall Study|Withdrawal by Subject|6|||
163839033|NCT02912468|591781680|FG001|Overall Study|Withdrawal by Subject|2|||
163839034|NCT02912468|591781679|FG000|Overall Study|Randomized and not treated|0|||
163839035|NCT02912468|591781680|FG001|Overall Study|Randomized and not treated|1|||
163839036|NCT01515189|591781681|FG000|Induction|Disease Progression|109|||
163934577|NCT03377361|592129829|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
163934578|NCT03377361|592129830|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
163839037|NCT01515189|591781682|FG001|Induction|Disease Progression|155|||
163839038|NCT01515189|591781681|FG000|Induction|Study drug toxicity|86|||
163934579|NCT03377361|592129831|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
163934580|NCT03377361|592129832|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
163934581|NCT03377361|592129823|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
164037428|NCT02980692|592496716|FG003|Double-blind Follow-up Period|Pregnancy|1|||
164037429|NCT02980692|592496717|FG004|Double-blind Follow-up Period|Pregnancy|0|||
164037430|NCT02980692|592496713|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
164037431|NCT02980692|592496714|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
164037432|NCT02980692|592496715|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
164037433|NCT02980692|592496716|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
164037434|NCT02980692|592496717|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
164037435|NCT02980692|592496713|FG000|Double-blind Follow-up Period|Other|0|||
164037436|NCT02980692|592496714|FG001|Double-blind Follow-up Period|Other|0|||
164037437|NCT02980692|592496715|FG002|Double-blind Follow-up Period|Other|1|||
164037438|NCT02980692|592496716|FG003|Double-blind Follow-up Period|Other|1|||
164037439|NCT02980692|592496717|FG004|Double-blind Follow-up Period|Other|3|||
164037440|NCT00792701|592496718|FG000|Overall Study|Adverse Event|0|||
164037441|NCT00792701|592496719|FG001|Overall Study|Adverse Event|22|||
164037442|NCT00792701|592496718|FG000|Overall Study|Ineligible|1|||
164037443|NCT00792701|592496719|FG001|Overall Study|Ineligible|3|||
164037444|NCT00792701|592496718|FG000|Overall Study|Withdrawal by Subject|1|||
164098565|NCT03135834|592725136|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
164098566|NCT03135834|592725133|FG000|Stage 2|Did not receive Booster Vaccination|1|||
164098567|NCT03135834|592725134|FG001|Stage 2|Did not receive Booster Vaccination|1|||
164098568|NCT03135834|592725135|FG002|Stage 2|Did not receive Booster Vaccination|0|||
164098569|NCT03135834|592725136|FG003|Stage 2|Did not receive Booster Vaccination|0|||
164098570|NCT00119379|592725139|FG000|Overall Study|Adverse Event|4|||
164098571|NCT00119379|592725140|FG001|Overall Study|Adverse Event|1|||
164098572|NCT03262012|592725144|FG000|Overall Study|Withdrawal by Subject|15|||
164098573|NCT03262012|592725145|FG001|Overall Study|Withdrawal by Subject|13|||
164098574|NCT03262012|592725146|FG002|Overall Study|Withdrawal by Subject|8|||
164098575|NCT03262012|592725147|FG003|Overall Study|Withdrawal by Subject|7|||
164098576|NCT03262012|592725144|FG000|Overall Study|Adverse Event|10|||
164098577|NCT03262012|592725145|FG001|Overall Study|Adverse Event|12|||
164098578|NCT03262012|592725146|FG002|Overall Study|Adverse Event|4|||
164098579|NCT03262012|592725147|FG003|Overall Study|Adverse Event|6|||
164098580|NCT03262012|592725144|FG000|Overall Study|Physician Decision|2|||
164098581|NCT03262012|592725145|FG001|Overall Study|Physician Decision|5|||
164098582|NCT03262012|592725146|FG002|Overall Study|Physician Decision|1|||
164098583|NCT03262012|592725147|FG003|Overall Study|Physician Decision|0|||
164098584|NCT03262012|592725144|FG000|Overall Study|Lack of Efficacy|0|||
164098585|NCT03262012|592725145|FG001|Overall Study|Lack of Efficacy|5|||
164098586|NCT03262012|592725146|FG002|Overall Study|Lack of Efficacy|1|||
164098587|NCT03262012|592725147|FG003|Overall Study|Lack of Efficacy|2|||
164098588|NCT03262012|592725144|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
164098589|NCT03262012|592725145|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
164098590|NCT03262012|592725146|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
164098591|NCT03262012|592725147|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
164098592|NCT01469546|592725148|FG000|Received 5 mg Dose|Adverse Event|13|||
164098593|NCT01469546|592725148|FG000|Received 5 mg Dose|Death|2|||
164098594|NCT01469546|592725148|FG000|Received 5 mg Dose|Protocol Violation|2|||
163839039|NCT01515189|591781682|FG001|Induction|Study drug toxicity|36|||
163839040|NCT01515189|591781681|FG000|Induction|Death|24|||
163839041|NCT01515189|591781682|FG001|Induction|Death|17|||
163839042|NCT01515189|591781681|FG000|Induction|Adverse Event|14|||
163839043|NCT01515189|591781682|FG001|Induction|Adverse Event|9|||
163839044|NCT01515189|591781681|FG000|Induction|Withdrawal by Subject|3|||
163839045|NCT01515189|591781682|FG001|Induction|Withdrawal by Subject|9|||
163839046|NCT01515189|591781681|FG000|Induction|No longer meets study criteria|0|||
163839047|NCT01515189|591781682|FG001|Induction|No longer meets study criteria|2|||
163839048|NCT01515189|591781681|FG000|Induction|Lost to Follow-up|1|||
163839049|NCT01515189|591781682|FG001|Induction|Lost to Follow-up|0|||
163839050|NCT01515189|591781681|FG000|Induction|Other|0|||
163839051|NCT01515189|591781682|FG001|Induction|Other|4|||
163839052|NCT01515189|591781681|FG000|First Re-Induction Phase|Disease progression|6|||
163839053|NCT01515189|591781682|FG001|First Re-Induction Phase|Disease progression|14|||
163839054|NCT01515189|591781681|FG000|First Re-Induction Phase|Study drug toxicity|5|||
163839055|NCT01515189|591781682|FG001|First Re-Induction Phase|Study drug toxicity|0|||
163839056|NCT01515189|591781681|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
163839057|NCT01515189|591781682|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
163839058|NCT01515189|591781681|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
163839059|NCT01515189|591781682|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
163839060|NCT01515189|591781681|FG000|First Re-Induction Phase|Other|1|||
163839061|NCT01515189|591781682|FG001|First Re-Induction Phase|Other|0|||
163839062|NCT00284089|591781683|FG000|Multiple Dose Phase|Adverse Event|1|||
163839063|NCT00284089|591781684|FG001|Multiple Dose Phase|Adverse Event|0|||
163839064|NCT00284089|591781685|FG002|Multiple Dose Phase|Adverse Event|1|||
163839065|NCT00284089|591781686|FG003|Multiple Dose Phase|Adverse Event|1|||
163839066|NCT00284089|591781683|FG000|Multiple Dose Phase|Protocol Violation|0|||
163839067|NCT00284089|591781684|FG001|Multiple Dose Phase|Protocol Violation|0|||
164098595|NCT01469546|592725148|FG000|Received 5 mg Dose|Progressive Disease|3|||
164037445|NCT00792701|592496719|FG001|Overall Study|Withdrawal by Subject|19|||
164037446|NCT00792701|592496718|FG000|Overall Study|Not protocol specified|17|||
164037447|NCT00792701|592496719|FG001|Overall Study|Not protocol specified|0|||
164037448|NCT05507580|592496722|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
164037449|NCT05507580|592496723|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
164037450|NCT05507580|592496724|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
164037451|NCT05507580|592496725|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
164037452|NCT05507580|592496726|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
164037453|NCT05507580|592496727|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
164037454|NCT05507580|592496722|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
164037455|NCT05507580|592496723|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164037456|NCT05507580|592496724|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164037457|NCT05507580|592496725|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164037458|NCT05507580|592496726|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164037459|NCT05507580|592496727|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164037460|NCT05507580|592496722|FG000|Double-Blind Treatment Period|Other, not specified|5|||
164037461|NCT05507580|592496723|FG001|Double-Blind Treatment Period|Other, not specified|4|||
164037462|NCT05507580|592496724|FG002|Double-Blind Treatment Period|Other, not specified|0|||
164037463|NCT05507580|592496725|FG003|Double-Blind Treatment Period|Other, not specified|0|||
164037464|NCT05507580|592496726|FG004|Double-Blind Treatment Period|Other, not specified|0|||
164037465|NCT05507580|592496727|FG005|Double-Blind Treatment Period|Other, not specified|0|||
164037466|NCT05507580|592496722|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
164037467|NCT05507580|592496723|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
164037468|NCT05507580|592496724|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
164098596|NCT01469546|592725148|FG000|Received 5 mg Dose|Physician Decision|3|||
164098597|NCT02801877|592725149|FG000|Overall Study|Lost to Follow-up|1|||
164098598|NCT02801877|592725150|FG001|Overall Study|Lost to Follow-up|1|||
164098599|NCT02801877|592725151|FG002|Overall Study|Lost to Follow-up|2|||
164098600|NCT02801877|592725152|FG003|Overall Study|Lost to Follow-up|0|||
164098601|NCT02801877|592725149|FG000|Overall Study|Never Started Treatment|2|||
164098602|NCT02801877|592725150|FG001|Overall Study|Never Started Treatment|0|||
164098603|NCT02801877|592725151|FG002|Overall Study|Never Started Treatment|4|||
164098604|NCT02801877|592725152|FG003|Overall Study|Never Started Treatment|0|||
164098605|NCT02865122|592725153|FG000|Overall Study|Adverse Event|1|||
164098606|NCT02865122|592725154|FG001|Overall Study|Adverse Event|0|||
164098607|NCT02865122|592725155|FG002|Overall Study|Adverse Event|0|||
164098608|NCT04934722|592726833|FG000|Overall Study|Death|4|||
164098609|NCT04934722|592726834|FG001|Overall Study|Death|3|||
164098610|NCT04934722|592726833|FG000|Overall Study|Participants Ongoing|88|||
164098611|NCT04934722|592726834|FG001|Overall Study|Participants Ongoing|91|||
164098612|NCT06358820|592726835|FG000|Overall Study|Adverse Event|11|||
164098613|NCT06358820|592726835|FG000|Overall Study|kidney transplantation|3|||
164098614|NCT06358820|592726835|FG000|Overall Study|patient voluntary withdrawal|6|||
164098615|NCT06358820|592726835|FG000|Overall Study|Physician Decision|1|||
164098616|NCT01294787|592726836|FG000|Period 1|Adverse Event|0|||
164098617|NCT01294787|592726837|FG001|Period 1|Adverse Event|0|||
164098618|NCT01294787|592726838|FG002|Period 1|Adverse Event|0|||
164098619|NCT01294787|592726839|FG003|Period 1|Adverse Event|0|||
164098620|NCT01294787|592726840|FG004|Period 1|Adverse Event|1|||
164098621|NCT01294787|592726841|FG005|Period 1|Adverse Event|0|||
164098622|NCT01294787|592726836|FG000|Period 1|Withdrawal by Subject|0|||
164098623|NCT01294787|592726837|FG001|Period 1|Withdrawal by Subject|0|||
164098624|NCT01294787|592726838|FG002|Period 1|Withdrawal by Subject|0|||
164098625|NCT01294787|592726839|FG003|Period 1|Withdrawal by Subject|1|||
164098626|NCT01294787|592726840|FG004|Period 1|Withdrawal by Subject|1|||
164098627|NCT01294787|592726841|FG005|Period 1|Withdrawal by Subject|1|||
164098628|NCT01294787|592726836|FG000|Period 1|Administrative problem|0|||
164098629|NCT01294787|592726837|FG001|Period 1|Administrative problem|0|||
164098630|NCT01294787|592726838|FG002|Period 1|Administrative problem|1|||
164098631|NCT01294787|592726839|FG003|Period 1|Administrative problem|0|||
163839068|NCT00284089|591781685|FG002|Multiple Dose Phase|Protocol Violation|1|||
164037469|NCT05507580|592496725|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
164037470|NCT05507580|592496726|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
164037471|NCT05507580|592496727|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
164037472|NCT05507580|592496722|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
164037473|NCT05507580|592496723|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
164037474|NCT05507580|592496724|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
164037475|NCT05507580|592496725|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
164098632|NCT01294787|592726840|FG004|Period 1|Administrative problem|0|||
164098633|NCT01294787|592726841|FG005|Period 1|Administrative problem|1|||
164098634|NCT01294787|592726836|FG000|Period 2|Adverse Event|0|||
164098635|NCT01294787|592726837|FG001|Period 2|Adverse Event|3|||
164098636|NCT01294787|592726838|FG002|Period 2|Adverse Event|0|||
164098637|NCT01294787|592726839|FG003|Period 2|Adverse Event|1|||
164098638|NCT01294787|592726840|FG004|Period 2|Adverse Event|0|||
164037476|NCT05507580|592496726|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
164037477|NCT05507580|592496727|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
164037478|NCT05507580|592496722|FG000|Single-Blind Treatment Period|Other, not specified|0|||
164037479|NCT05507580|592496723|FG001|Single-Blind Treatment Period|Other, not specified|0|||
164037480|NCT05507580|592496724|FG002|Single-Blind Treatment Period|Other, not specified|2|||
164037481|NCT05507580|592496725|FG003|Single-Blind Treatment Period|Other, not specified|7|||
164037482|NCT05507580|592496726|FG004|Single-Blind Treatment Period|Other, not specified|3|||
164037483|NCT05507580|592496727|FG005|Single-Blind Treatment Period|Other, not specified|5|||
164037484|NCT04702984|592496728|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
164037485|NCT03862495|592496731|FG000|Overall Study|Lost to Follow-up|37|||
164037486|NCT03862495|592496732|FG001|Overall Study|Lost to Follow-up|35|||
164037487|NCT00064077|592496733|FG000|Overall Study|Improper prior treatment|1|||
164037488|NCT00064077|592496734|FG001|Overall Study|Improper prior treatment|0|||
164037489|NCT00064077|592496735|FG002|Overall Study|Improper prior treatment|0|||
164037490|NCT00064077|592496736|FG003|Overall Study|Improper prior treatment|0|||
164037491|NCT00064077|592496733|FG000|Overall Study|Poor risk|2|||
164037492|NCT00064077|592496734|FG001|Overall Study|Poor risk|0|||
164037493|NCT00064077|592496735|FG002|Overall Study|Poor risk|1|||
164037494|NCT00064077|592496736|FG003|Overall Study|Poor risk|1|||
164037495|NCT00064077|592496733|FG000|Overall Study|Pathology|10|||
164037496|NCT00064077|592496734|FG001|Overall Study|Pathology|7|||
164037497|NCT00064077|592496735|FG002|Overall Study|Pathology|3|||
164037498|NCT00064077|592496736|FG003|Overall Study|Pathology|4|||
164037499|NCT00064077|592496733|FG000|Overall Study|No surgery|0|||
164037500|NCT00064077|592496734|FG001|Overall Study|No surgery|0|||
164037501|NCT00064077|592496735|FG002|Overall Study|No surgery|1|||
164037502|NCT00064077|592496736|FG003|Overall Study|No surgery|0|||
164037503|NCT00064077|592496733|FG000|Overall Study|No tumor|0|||
164037504|NCT00064077|592496734|FG001|Overall Study|No tumor|0|||
164037505|NCT00064077|592496735|FG002|Overall Study|No tumor|1|||
164037506|NCT00064077|592496736|FG003|Overall Study|No tumor|0|||
164037507|NCT00064077|592496733|FG000|Overall Study|Other reasons|2|||
164037508|NCT00064077|592496734|FG001|Overall Study|Other reasons|2|||
164037509|NCT00064077|592496735|FG002|Overall Study|Other reasons|1|||
164037510|NCT00064077|592496736|FG003|Overall Study|Other reasons|2|||
164037511|NCT04397796|592496737|FG000|Overall Study|Death|3|||
164037512|NCT04397796|592496738|FG001|Overall Study|Death|1|||
164037513|NCT03037307|592496741|FG000|Period 1|Did Not Meet Study Criteria|0|||
164037514|NCT03037307|592496742|FG001|Period 1|Did Not Meet Study Criteria|0|||
164037515|NCT03037307|592496743|FG002|Period 1|Did Not Meet Study Criteria|0|||
164037516|NCT03037307|592496744|FG003|Period 1|Did Not Meet Study Criteria|1|||
164037517|NCT03037307|592496745|FG004|Period 1|Did Not Meet Study Criteria|0|||
164037518|NCT03037307|592496746|FG005|Period 1|Did Not Meet Study Criteria|0|||
164037519|NCT00802867|592496747|FG000|Overall Study|Lost to Follow-up|6|||
164037520|NCT00802867|592496747|FG000|Overall Study|Protocol Violation|6|||
164037521|NCT00802867|592496747|FG000|Overall Study|Withdrawal by Subject|1|||
164037522|NCT03363165|592496750|FG000|3-month Follow-up|Death|0|||
164037523|NCT03363165|592496751|FG001|3-month Follow-up|Death|1|||
164037524|NCT03363165|592496750|FG000|6-month Follow-up|Death|0|||
164037525|NCT03363165|592496751|FG001|6-month Follow-up|Death|1|||
164037526|NCT03363165|592496750|FG000|6-month Follow-up|Withdrawal by Subject|1|||
164037527|NCT03363165|592496751|FG001|6-month Follow-up|Withdrawal by Subject|1|||
164037528|NCT03363165|592496750|FG000|12-month Follow-up|Death|1|||
164037529|NCT03363165|592496751|FG001|12-month Follow-up|Death|1|||
164037530|NCT03363165|592496750|FG000|12-month Follow-up|Withdrawal by Subject|1|||
164037531|NCT03363165|592496751|FG001|12-month Follow-up|Withdrawal by Subject|1|||
164037532|NCT01809197|592496752|FG000|Overall Study|Lost to Follow-up|4|||
164037533|NCT01809197|592496753|FG001|Overall Study|Lost to Follow-up|2|||
164037534|NCT01809197|592496752|FG000|Overall Study|Adverse Event|2|||
164037535|NCT01809197|592496753|FG001|Overall Study|Adverse Event|3|||
164037536|NCT01809197|592496752|FG000|Overall Study|Failed slit lamp exam|1|||
164037537|NCT01809197|592496753|FG001|Overall Study|Failed slit lamp exam|0|||
164037538|NCT01809197|592496752|FG000|Overall Study|Non-Compliance|1|||
164037539|NCT01809197|592496753|FG001|Overall Study|Non-Compliance|1|||
164037540|NCT01809197|592496752|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
164037541|NCT01809197|592496753|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
164037542|NCT01809197|592496752|FG000|Overall Study|Withdrawal by Subject|1|||
164037543|NCT01809197|592496753|FG001|Overall Study|Withdrawal by Subject|1|||
164037544|NCT01809197|592496752|FG000|Overall Study|Product not available|0|||
164037545|NCT01809197|592496753|FG001|Overall Study|Product not available|1|||
164037546|NCT02156804|592496758|FG000|Overall Study|Withdrawal by Subject|1|||
164037547|NCT03000686|592496759|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
164037548|NCT03000686|592496760|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
164037549|NCT03000686|592496761|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
164037550|NCT03000686|592496762|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
164037551|NCT01484561|592496763|FG000|Overall Study|Lack of Efficacy|3|||
164037552|NCT01484561|592496764|FG001|Overall Study|Lack of Efficacy|1|||
164037553|NCT01484561|592496763|FG000|Overall Study|Lost to Follow-up|1|||
164037554|NCT01484561|592496764|FG001|Overall Study|Lost to Follow-up|0|||
164037555|NCT01484561|592496763|FG000|Overall Study|Withdrawal by Subject|3|||
164037556|NCT01484561|592496764|FG001|Overall Study|Withdrawal by Subject|0|||
164037557|NCT01484561|592496763|FG000|Overall Study|Other|1|||
164037558|NCT01484561|592496764|FG001|Overall Study|Other|1|||
164037559|NCT01484561|592496763|FG000|Overall Study|Adverse Event|1|||
164037560|NCT01484561|592496764|FG001|Overall Study|Adverse Event|4|||
164037561|NCT01112982|592496765|FG000|Overall Study|Withdrawal by Subject|1|||
164037562|NCT01112982|592496765|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
164037563|NCT03371251|592496766|FG000|Overall Study|Withdrawal by Subject|1|||
163839069|NCT00284089|591781686|FG003|Multiple Dose Phase|Protocol Violation|0|||
163839070|NCT00284089|591781683|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
163839071|NCT00284089|591781684|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
164037564|NCT03371251|592496767|FG001|Overall Study|Withdrawal by Subject|0|||
164037565|NCT03371251|592496768|FG002|Overall Study|Withdrawal by Subject|1|||
164037566|NCT03371251|592496769|FG003|Overall Study|Withdrawal by Subject|0|||
164037567|NCT03371251|592496770|FG004|Overall Study|Withdrawal by Subject|2|||
164037568|NCT03371251|592496771|FG005|Overall Study|Withdrawal by Subject|2|||
164037569|NCT03371251|592496766|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
164037570|NCT03371251|592496767|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
164037571|NCT03371251|592496768|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
164037572|NCT03371251|592496769|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
164037573|NCT03371251|592496770|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
164037574|NCT03371251|592496771|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
164037575|NCT03371251|592496766|FG000|Overall Study|Adverse Event|0|||
164037576|NCT03371251|592496767|FG001|Overall Study|Adverse Event|0|||
164037577|NCT03371251|592496768|FG002|Overall Study|Adverse Event|0|||
164037578|NCT03371251|592496769|FG003|Overall Study|Adverse Event|0|||
164037579|NCT03371251|592496770|FG004|Overall Study|Adverse Event|1|||
164037580|NCT03371251|592496771|FG005|Overall Study|Adverse Event|0|||
164037581|NCT03371251|592496766|FG000|Overall Study|Decision by Sponsor|0|||
164037582|NCT03371251|592496767|FG001|Overall Study|Decision by Sponsor|0|||
164037583|NCT03371251|592496768|FG002|Overall Study|Decision by Sponsor|0|||
164037584|NCT03371251|592496769|FG003|Overall Study|Decision by Sponsor|0|||
164037585|NCT03371251|592496770|FG004|Overall Study|Decision by Sponsor|2|||
164037586|NCT03371251|592496771|FG005|Overall Study|Decision by Sponsor|0|||
164037587|NCT01851863|592496772|FG000|Overall Study|Did not receive study medication|2|||
164037588|NCT01851863|592496773|FG001|Overall Study|Did not receive study medication|5|||
164037589|NCT01851863|592496774|FG002|Overall Study|Did not receive study medication|3|||
164037590|NCT01851863|592496775|FG003|Overall Study|Did not receive study medication|0|||
164037591|NCT01851863|592496772|FG000|Overall Study|Lost to Follow-up|3|||
164037592|NCT01851863|592496773|FG001|Overall Study|Lost to Follow-up|4|||
164037593|NCT01851863|592496774|FG002|Overall Study|Lost to Follow-up|2|||
164037594|NCT01851863|592496775|FG003|Overall Study|Lost to Follow-up|3|||
164037595|NCT05425719|592496776|FG000|Overall Study|Lost to Follow-up|4|||
164037596|NCT05425719|592496777|FG001|Overall Study|Lost to Follow-up|0|||
164037597|NCT05425719|592496776|FG000|Overall Study|Withdrew consent|1|||
164037598|NCT05425719|592496777|FG001|Overall Study|Withdrew consent|1|||
164037599|NCT00889681|592496778|FG000|Overall Study|Not meeting qualification Criteria|2|||
164037600|NCT00889681|592496778|FG000|Overall Study|Insurance disapproval|1|||
164037601|NCT01185704|592496779|FG000|Overall Study|Randomized but not treated|3|||
164037602|NCT01185704|592496780|FG001|Overall Study|Randomized but not treated|3|||
164037603|NCT01185704|592496779|FG000|Overall Study|Lack of ovarian response|5|||
164037604|NCT01185704|592496780|FG001|Overall Study|Lack of ovarian response|1|||
164037605|NCT01185704|592496779|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
164037606|NCT01185704|592496780|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
164037607|NCT01185704|592496779|FG000|Overall Study|Ectopic pregnancy|0|||
164037608|NCT01185704|592496780|FG001|Overall Study|Ectopic pregnancy|1|||
164037609|NCT00871572|592496781|FG000|Overall Study|Adverse Event|0|||
164037610|NCT00871572|592496782|FG001|Overall Study|Adverse Event|2|||
164037611|NCT00871572|592496783|FG002|Overall Study|Adverse Event|0|||
164037612|NCT00871572|592496784|FG003|Overall Study|Adverse Event|3|||
164037613|NCT00871572|592496781|FG000|Overall Study|Investigator Decision|0|||
164037614|NCT00871572|592496782|FG001|Overall Study|Investigator Decision|1|||
164037615|NCT00871572|592496783|FG002|Overall Study|Investigator Decision|0|||
164037616|NCT00871572|592496784|FG003|Overall Study|Investigator Decision|1|||
164037617|NCT00871572|592496781|FG000|Overall Study|Lost to Follow-up|0|||
164037618|NCT00871572|592496782|FG001|Overall Study|Lost to Follow-up|1|||
164037619|NCT00871572|592496783|FG002|Overall Study|Lost to Follow-up|0|||
164037620|NCT00871572|592496784|FG003|Overall Study|Lost to Follow-up|1|||
164037621|NCT00871572|592496781|FG000|Overall Study|Protocol Violation|0|||
164037622|NCT00871572|592496782|FG001|Overall Study|Protocol Violation|0|||
164037623|NCT00871572|592496783|FG002|Overall Study|Protocol Violation|1|||
164037624|NCT00871572|592496784|FG003|Overall Study|Protocol Violation|1|||
164037625|NCT00871572|592496781|FG000|Overall Study|Sponsor Decision|1|||
163934582|NCT03377361|592129824|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
163934583|NCT03377361|592129825|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
163934584|NCT03377361|592129826|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
163934585|NCT03377361|592129827|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
163934586|NCT03377361|592129828|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
163934587|NCT03377361|592129829|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
163934588|NCT03377361|592129830|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
163934589|NCT03377361|592129831|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
163934590|NCT03377361|592129832|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
163934591|NCT03377361|592129823|FG000|Treatment Period|Subject Withdrew Consent|0|||
163934592|NCT03377361|592129824|FG001|Treatment Period|Subject Withdrew Consent|0|||
163934593|NCT03377361|592129825|FG002|Treatment Period|Subject Withdrew Consent|0|||
163934594|NCT03377361|592129826|FG003|Treatment Period|Subject Withdrew Consent|0|||
163934595|NCT03377361|592129827|FG004|Treatment Period|Subject Withdrew Consent|0|||
163934596|NCT03377361|592129828|FG005|Treatment Period|Subject Withdrew Consent|0|||
163934597|NCT03377361|592129829|FG006|Treatment Period|Subject Withdrew Consent|0|||
163934598|NCT03377361|592129830|FG007|Treatment Period|Subject Withdrew Consent|0|||
163934599|NCT03377361|592129831|FG008|Treatment Period|Subject Withdrew Consent|2|||
163934600|NCT03377361|592129832|FG009|Treatment Period|Subject Withdrew Consent|1|||
163934601|NCT03377361|592129823|FG000|Treatment Period|No longer meets study criteria|0|||
163934602|NCT03377361|592129824|FG001|Treatment Period|No longer meets study criteria|1|||
163934603|NCT03377361|592129825|FG002|Treatment Period|No longer meets study criteria|0|||
163934604|NCT03377361|592129826|FG003|Treatment Period|No longer meets study criteria|0|||
163934605|NCT03377361|592129827|FG004|Treatment Period|No longer meets study criteria|0|||
163934606|NCT03377361|592129828|FG005|Treatment Period|No longer meets study criteria|0|||
163934607|NCT03377361|592129829|FG006|Treatment Period|No longer meets study criteria|0|||
163934608|NCT03377361|592129830|FG007|Treatment Period|No longer meets study criteria|1|||
163934609|NCT03377361|592129831|FG008|Treatment Period|No longer meets study criteria|0|||
163934610|NCT03377361|592129832|FG009|Treatment Period|No longer meets study criteria|0|||
163934611|NCT03377361|592129823|FG000|Treatment Period|Other Reasons|0|||
163934612|NCT03377361|592129824|FG001|Treatment Period|Other Reasons|0|||
163934613|NCT03377361|592129825|FG002|Treatment Period|Other Reasons|0|||
163934614|NCT03377361|592129826|FG003|Treatment Period|Other Reasons|3|||
163934615|NCT03377361|592129827|FG004|Treatment Period|Other Reasons|0|||
163934616|NCT03377361|592129828|FG005|Treatment Period|Other Reasons|0|||
163934617|NCT03377361|592129829|FG006|Treatment Period|Other Reasons|0|||
163934618|NCT03377361|592129830|FG007|Treatment Period|Other Reasons|2|||
163934619|NCT03377361|592129831|FG008|Treatment Period|Other Reasons|0|||
163934620|NCT03377361|592129832|FG009|Treatment Period|Other Reasons|1|||
163934621|NCT00742326|592129833|FG000|Overall Study|Physician Decision|0|||
163934622|NCT00742326|592129834|FG001|Overall Study|Physician Decision|1|||
163934623|NCT03698994|592129845|FG000|Overall Study|Adverse Event|2|||
163934624|NCT03698994|592129845|FG000|Overall Study|Death|1|||
163934625|NCT03698994|592129845|FG000|Overall Study|Physician Decision|1|||
163934626|NCT03698994|592129845|FG000|Overall Study|Withdrawal by Subject|3|||
163934627|NCT03698994|592129845|FG000|Overall Study|Progressive Disease|12|||
163934628|NCT03635086|592129848|FG000|Overall Study|Withdrawal of consent|0|||
163934629|NCT03635086|592129849|FG001|Overall Study|Withdrawal of consent|0|||
163934630|NCT03635086|592129850|FG002|Overall Study|Withdrawal of consent|1|||
163934631|NCT03635086|592129851|FG003|Overall Study|Withdrawal of consent|0|||
163934632|NCT03635086|592129852|FG004|Overall Study|Withdrawal of consent|0|||
163934633|NCT03635086|592129848|FG000|Overall Study|Adverse Event|0|||
163934634|NCT03635086|592129849|FG001|Overall Study|Adverse Event|1|||
163934635|NCT03635086|592129850|FG002|Overall Study|Adverse Event|0|||
163934636|NCT03635086|592129851|FG003|Overall Study|Adverse Event|0|||
163934637|NCT03635086|592129852|FG004|Overall Study|Adverse Event|0|||
163934638|NCT03635086|592129848|FG000|Overall Study|Lost to Follow-up|1|||
163934639|NCT03635086|592129849|FG001|Overall Study|Lost to Follow-up|0|||
163934640|NCT03635086|592129850|FG002|Overall Study|Lost to Follow-up|0|||
163934641|NCT03635086|592129851|FG003|Overall Study|Lost to Follow-up|0|||
164037626|NCT00871572|592496782|FG001|Overall Study|Sponsor Decision|0|||
164037627|NCT00871572|592496783|FG002|Overall Study|Sponsor Decision|0|||
164037628|NCT00871572|592496784|FG003|Overall Study|Sponsor Decision|0|||
164037629|NCT00871572|592496781|FG000|Overall Study|Withdrawal by Subject|1|||
163934642|NCT03635086|592129852|FG004|Overall Study|Lost to Follow-up|0|||
163934643|NCT01162486|592129855|FG000|Overall Study|low ANC|1|||
163934644|NCT01162486|592129856|FG001|Overall Study|low ANC|0|||
163934645|NCT01162486|592129857|FG002|Overall Study|low ANC|0|||
163934646|NCT01162486|592129858|FG003|Overall Study|low ANC|0|||
163934647|NCT01162486|592129859|FG004|Overall Study|low ANC|0|||
164037630|NCT00871572|592496782|FG001|Overall Study|Withdrawal by Subject|2|||
164037631|NCT00871572|592496783|FG002|Overall Study|Withdrawal by Subject|3|||
164037632|NCT00871572|592496784|FG003|Overall Study|Withdrawal by Subject|1|||
163934648|NCT01162486|592129855|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
163934649|NCT01162486|592129856|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
164037633|NCT04176445|592496785|FG000|Overall Study|Adverse Event|0|||
164037634|NCT04176445|592496786|FG001|Overall Study|Adverse Event|1|||
164037635|NCT04176445|592496785|FG000|Overall Study|change plans weaning after first intervention|0|||
164037636|NCT04176445|592496786|FG001|Overall Study|change plans weaning after first intervention|1|||
164037637|NCT00187889|592496787|FG000|Overall Study|Withdrawal by Subject|6|||
164037638|NCT00187889|592496788|FG001|Overall Study|Withdrawal by Subject|4|||
164037639|NCT03954444|592496789|FG000|Overall Study|Withdrawal by Subject|5|||
164037640|NCT03954444|592496790|FG001|Overall Study|Withdrawal by Subject|5|||
164037641|NCT03954444|592496791|FG002|Overall Study|Withdrawal by Subject|5|||
164037642|NCT03954444|592496789|FG000|Overall Study|Adverse Event|1|||
164037643|NCT03954444|592496790|FG001|Overall Study|Adverse Event|3|||
164037644|NCT03954444|592496791|FG002|Overall Study|Adverse Event|2|||
164037645|NCT03954444|592496789|FG000|Overall Study|Protocol Violation|0|||
164037646|NCT03954444|592496790|FG001|Overall Study|Protocol Violation|3|||
164037647|NCT03954444|592496791|FG002|Overall Study|Protocol Violation|5|||
164037648|NCT03954444|592496789|FG000|Overall Study|Use of prohibited therapy|1|||
164037649|NCT03954444|592496790|FG001|Overall Study|Use of prohibited therapy|1|||
164037650|NCT03954444|592496791|FG002|Overall Study|Use of prohibited therapy|2|||
164037651|NCT03954444|592496789|FG000|Overall Study|Lost to Follow-up|1|||
164037652|NCT03954444|592496790|FG001|Overall Study|Lost to Follow-up|0|||
164037653|NCT03954444|592496791|FG002|Overall Study|Lost to Follow-up|1|||
164037654|NCT03954444|592496789|FG000|Overall Study|Non-compliant with study drug application|2|||
164037655|NCT03954444|592496790|FG001|Overall Study|Non-compliant with study drug application|2|||
164037656|NCT03954444|592496791|FG002|Overall Study|Non-compliant with study drug application|0|||
164037657|NCT03954444|592496789|FG000|Overall Study|Administrative reasons|0|||
164037658|NCT03954444|592496790|FG001|Overall Study|Administrative reasons|0|||
164037659|NCT03954444|592496791|FG002|Overall Study|Administrative reasons|1|||
164037660|NCT03954444|592496789|FG000|Overall Study|Miscellaneous|3|||
164037661|NCT03954444|592496790|FG001|Overall Study|Miscellaneous|2|||
164037662|NCT03954444|592496791|FG002|Overall Study|Miscellaneous|1|||
164037663|NCT03094832|592496797|FG000|Overall Study|Lost to Follow-up|0|||
164037664|NCT03094832|592496798|FG001|Overall Study|Lost to Follow-up|0|||
164037665|NCT03094832|592496799|FG002|Overall Study|Lost to Follow-up|0|||
164037666|NCT03094832|592496800|FG003|Overall Study|Lost to Follow-up|1|||
164037667|NCT03094832|592496801|FG004|Overall Study|Lost to Follow-up|1|||
164037668|NCT03094832|592496797|FG000|Overall Study|Death|1|||
164037669|NCT03094832|592496798|FG001|Overall Study|Death|0|||
164037670|NCT03094832|592496799|FG002|Overall Study|Death|0|||
164037671|NCT03094832|592496800|FG003|Overall Study|Death|0|||
164037672|NCT03094832|592496801|FG004|Overall Study|Death|0|||
164037673|NCT03094832|592496797|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164037674|NCT03094832|592496798|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164037675|NCT03094832|592496799|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
164037676|NCT03094832|592496800|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164037677|NCT03094832|592496801|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164037678|NCT03094832|592496797|FG000|Overall Study|Other|13|||
164037679|NCT03094832|592496798|FG001|Overall Study|Other|20|||
164037680|NCT03094832|592496799|FG002|Overall Study|Other|1|||
164037681|NCT03094832|592496800|FG003|Overall Study|Other|7|||
164037682|NCT03094832|592496801|FG004|Overall Study|Other|1|||
164037683|NCT02322411|592496804|FG000|Overall Study|Lost to Follow-up|4|||
164037684|NCT02322411|592496805|FG001|Overall Study|Lost to Follow-up|7|||
164037685|NCT02322411|592496804|FG000|Overall Study|Withdrawal by Subject|1|||
164037686|NCT02322411|592496805|FG001|Overall Study|Withdrawal by Subject|0|||
164037687|NCT01392378|592496806|FG000|Infant Series|Adverse Event|0|||
164037688|NCT01392378|592496807|FG001|Infant Series|Adverse Event|0|||
164037689|NCT01392378|592496808|FG002|Infant Series|Adverse Event|0|||
164037690|NCT01392378|592496809|FG003|Infant Series|Adverse Event|1|||
164037691|NCT01392378|592496810|FG004|Infant Series|Adverse Event|0|||
164037692|NCT01392378|592496806|FG000|Infant Series|Lost to Follow-up|0|||
164037693|NCT01392378|592496807|FG001|Infant Series|Lost to Follow-up|0|||
164037694|NCT01392378|592496808|FG002|Infant Series|Lost to Follow-up|0|||
164037695|NCT01392378|592496809|FG003|Infant Series|Lost to Follow-up|1|||
164037696|NCT01392378|592496810|FG004|Infant Series|Lost to Follow-up|0|||
164037697|NCT01392378|592496806|FG000|Infant Series|Protocol Violation|0|||
164037698|NCT01392378|592496807|FG001|Infant Series|Protocol Violation|1|||
164037699|NCT01392378|592496808|FG002|Infant Series|Protocol Violation|0|||
164037700|NCT01392378|592496809|FG003|Infant Series|Protocol Violation|0|||
164037701|NCT01392378|592496810|FG004|Infant Series|Protocol Violation|0|||
164037702|NCT01392378|592496806|FG000|Infant Series|Withdrawal by Parent|4|||
164037703|NCT01392378|592496807|FG001|Infant Series|Withdrawal by Parent|1|||
164037704|NCT01392378|592496808|FG002|Infant Series|Withdrawal by Parent|0|||
164037705|NCT01392378|592496809|FG003|Infant Series|Withdrawal by Parent|0|||
164037706|NCT01392378|592496810|FG004|Infant Series|Withdrawal by Parent|0|||
164037707|NCT01392378|592496806|FG000|After Infant Series|Lost to Follow-up|0|||
164037708|NCT01392378|592496807|FG001|After Infant Series|Lost to Follow-up|0|||
164037709|NCT01392378|592496808|FG002|After Infant Series|Lost to Follow-up|1|||
163839072|NCT00284089|591781685|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
163934650|NCT01162486|592129857|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163934651|NCT01162486|592129858|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163934652|NCT01162486|592129859|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
163934653|NCT01162486|592129855|FG000|Overall Study|elevated LFTs|0|||
163934654|NCT01162486|592129856|FG001|Overall Study|elevated LFTs|0|||
163934655|NCT01162486|592129857|FG002|Overall Study|elevated LFTs|1|||
163934656|NCT01162486|592129858|FG003|Overall Study|elevated LFTs|0|||
163934657|NCT01162486|592129859|FG004|Overall Study|elevated LFTs|0|||
163934658|NCT01162486|592129855|FG000|Overall Study|Pregnancy|0|||
163934659|NCT01162486|592129856|FG001|Overall Study|Pregnancy|0|||
163934660|NCT01162486|592129857|FG002|Overall Study|Pregnancy|0|||
163934661|NCT01162486|592129858|FG003|Overall Study|Pregnancy|1|||
163934662|NCT01162486|592129859|FG004|Overall Study|Pregnancy|0|||
163934663|NCT02296892|592129864|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
163934664|NCT02296892|592129865|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
163934665|NCT02296892|592129866|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
163934666|NCT02296892|592129864|FG000|Overall Study|Lost to Follow-up|5|||
163934667|NCT02296892|592129865|FG001|Overall Study|Lost to Follow-up|0|||
163934668|NCT02296892|592129866|FG002|Overall Study|Lost to Follow-up|1|||
163934669|NCT01056263|592129871|FG000|Overall Study|Adverse Event|12|||
163934670|NCT01056263|592129871|FG000|Overall Study|Death|1|||
163934671|NCT01056263|592129871|FG000|Overall Study|Withdrawal by Subject|1|||
163934672|NCT01056263|592129871|FG000|Overall Study|Lack of Efficacy|29|||
163934673|NCT01056263|592129871|FG000|Overall Study|Progressive disease|2|||
163934674|NCT01056263|592129871|FG000|Overall Study|Neoplasm progression|1|||
163934675|NCT01056263|592129871|FG000|Overall Study|Objective progression or relapse|1|||
163934676|NCT01056263|592129871|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
163934677|NCT03375320|592129876|FG000|Overall Study|Adverse Event|34|||
163934678|NCT03375320|592129877|FG001|Overall Study|Adverse Event|9|||
163934679|NCT03375320|592129878|FG002|Overall Study|Adverse Event|10|||
163934680|NCT03375320|592129879|FG003|Overall Study|Adverse Event|0|||
163934681|NCT03375320|592129876|FG000|Overall Study|Death|6|||
163934682|NCT03375320|592129877|FG001|Overall Study|Death|3|||
163934683|NCT03375320|592129878|FG002|Overall Study|Death|0|||
163934684|NCT03375320|592129879|FG003|Overall Study|Death|0|||
163934685|NCT03375320|592129876|FG000|Overall Study|Withdrawal by Subject|7|||
163934686|NCT03375320|592129877|FG001|Overall Study|Withdrawal by Subject|4|||
163934687|NCT03375320|592129878|FG002|Overall Study|Withdrawal by Subject|5|||
163934688|NCT03375320|592129879|FG003|Overall Study|Withdrawal by Subject|4|||
163934689|NCT03375320|592129876|FG000|Overall Study|Progressive disease|55|||
163934690|NCT03375320|592129877|FG001|Overall Study|Progressive disease|41|||
163934691|NCT03375320|592129878|FG002|Overall Study|Progressive disease|29|||
163934692|NCT03375320|592129879|FG003|Overall Study|Progressive disease|24|||
163934693|NCT03375320|592129876|FG000|Overall Study|Alternative treatment|6|||
163934694|NCT03375320|592129877|FG001|Overall Study|Alternative treatment|1|||
163934695|NCT03375320|592129878|FG002|Overall Study|Alternative treatment|1|||
163934696|NCT03375320|592129879|FG003|Overall Study|Alternative treatment|0|||
163934697|NCT03375320|592129876|FG000|Overall Study|Other disease|1|||
163934698|NCT03375320|592129877|FG001|Overall Study|Other disease|1|||
163934699|NCT03375320|592129878|FG002|Overall Study|Other disease|3|||
163934700|NCT03375320|592129879|FG003|Overall Study|Other disease|0|||
163934701|NCT03375320|592129876|FG000|Overall Study|Withdrawal prior to initiation|2|||
163934702|NCT03375320|592129877|FG001|Overall Study|Withdrawal prior to initiation|2|||
163934703|NCT03375320|592129878|FG002|Overall Study|Withdrawal prior to initiation|1|||
163934704|NCT03375320|592129879|FG003|Overall Study|Withdrawal prior to initiation|0|||
163934705|NCT03375320|592129876|FG000|Overall Study|Physician Decision|1|||
163934706|NCT03375320|592129877|FG001|Overall Study|Physician Decision|1|||
163934707|NCT03375320|592129878|FG002|Overall Study|Physician Decision|1|||
163934708|NCT03375320|592129879|FG003|Overall Study|Physician Decision|1|||
163934709|NCT03375320|592129876|FG000|Overall Study|Non-compliance|1|||
163934710|NCT03375320|592129877|FG001|Overall Study|Non-compliance|0|||
163934711|NCT03375320|592129878|FG002|Overall Study|Non-compliance|0|||
164037710|NCT01392378|592496809|FG003|After Infant Series|Lost to Follow-up|0|||
164037711|NCT01392378|592496810|FG004|After Infant Series|Lost to Follow-up|0|||
164037712|NCT01392378|592496806|FG000|After Infant Series|Withdrawal by Parent|0|||
164037713|NCT01392378|592496807|FG001|After Infant Series|Withdrawal by Parent|1|||
164037714|NCT01392378|592496808|FG002|After Infant Series|Withdrawal by Parent|1|||
163934712|NCT03375320|592129879|FG003|Overall Study|Non-compliance|0|||
163934713|NCT04907357|592129888|FG000|Overall Study|Death|0|||
163934714|NCT04907357|592129889|FG001|Overall Study|Death|1|||
163934715|NCT04907357|592129888|FG000|Overall Study|Lost to Follow-up|9|||
164037715|NCT01392378|592496809|FG003|After Infant Series|Withdrawal by Parent|0|||
164037716|NCT01392378|592496810|FG004|After Infant Series|Withdrawal by Parent|1|||
163934716|NCT04907357|592129889|FG001|Overall Study|Lost to Follow-up|18|||
163934717|NCT04907357|592129888|FG000|Overall Study|Physician Decision|1|||
163934718|NCT04907357|592129889|FG001|Overall Study|Physician Decision|0|||
163934719|NCT04907357|592129888|FG000|Overall Study|Withdrawal by Subject|0|||
163934720|NCT04907357|592129889|FG001|Overall Study|Withdrawal by Subject|1|||
164098639|NCT01294787|592726841|FG005|Period 2|Adverse Event|0|||
164098640|NCT01294787|592726836|FG000|Period 2|No longer needs study drug|0|||
164098641|NCT01294787|592726837|FG001|Period 2|No longer needs study drug|0|||
164098642|NCT01294787|592726838|FG002|Period 2|No longer needs study drug|0|||
164098643|NCT01294787|592726839|FG003|Period 2|No longer needs study drug|1|||
164098644|NCT01294787|592726840|FG004|Period 2|No longer needs study drug|0|||
164098645|NCT01294787|592726841|FG005|Period 2|No longer needs study drug|0|||
164098646|NCT01294787|592726836|FG000|Period 3|Adverse Event|0|||
164098647|NCT01294787|592726837|FG001|Period 3|Adverse Event|0|||
164098648|NCT01294787|592726838|FG002|Period 3|Adverse Event|0|||
164098649|NCT01294787|592726839|FG003|Period 3|Adverse Event|0|||
164098650|NCT01294787|592726840|FG004|Period 3|Adverse Event|1|||
164098651|NCT01294787|592726841|FG005|Period 3|Adverse Event|0|||
164098652|NCT01124175|592726842|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164098653|NCT01124175|592726843|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
164098654|NCT00942968|592726844|FG000|Overall Study|Adverse Event|60|||
164098655|NCT00942968|592726844|FG000|Overall Study|Death|76|||
164098656|NCT00942968|592726844|FG000|Overall Study|Protocol Violation|9|||
164098657|NCT00942968|592726844|FG000|Overall Study|Lost to Follow-up|4|||
164098658|NCT00942968|592726844|FG000|Overall Study|Withdrawal by Subject|44|||
164098659|NCT00942968|592726844|FG000|Overall Study|Sponsor request|5|||
163839073|NCT00284089|591781686|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
164037717|NCT01392378|592496806|FG000|Toddler Dose|Lost to Follow-up|0|||
164037718|NCT01392378|592496807|FG001|Toddler Dose|Lost to Follow-up|0|||
164037719|NCT01392378|592496808|FG002|Toddler Dose|Lost to Follow-up|0|||
164037720|NCT01392378|592496809|FG003|Toddler Dose|Lost to Follow-up|1|||
164037721|NCT01392378|592496810|FG004|Toddler Dose|Lost to Follow-up|0|||
164037722|NCT01392378|592496806|FG000|Toddler Dose|Withdrawal by Parent|0|||
164037723|NCT01392378|592496807|FG001|Toddler Dose|Withdrawal by Parent|1|||
164037724|NCT01392378|592496808|FG002|Toddler Dose|Withdrawal by Parent|0|||
164037725|NCT01392378|592496809|FG003|Toddler Dose|Withdrawal by Parent|1|||
164037726|NCT01392378|592496810|FG004|Toddler Dose|Withdrawal by Parent|1|||
164037727|NCT01998880|592496813|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
164037728|NCT01998880|592496814|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
164037729|NCT01998880|592496813|FG000|Overall Study|Disease Progression|1|||
164098660|NCT00942968|592726844|FG000|Overall Study|Physician Decision|11|||
164098661|NCT00942968|592726844|FG000|Overall Study|Progression of disease|12|||
163839074|NCT00284089|591781683|FG000|Multiple Dose Phase|Death|0|||
163839075|NCT00284089|591781684|FG001|Multiple Dose Phase|Death|0|||
163839076|NCT00284089|591781685|FG002|Multiple Dose Phase|Death|1|||
163839077|NCT00284089|591781686|FG003|Multiple Dose Phase|Death|1|||
163839078|NCT00284089|591781683|FG000|Extension Phase|Adverse Event|0|||
163839079|NCT00284089|591781684|FG001|Extension Phase|Adverse Event|0|||
163839080|NCT00284089|591781685|FG002|Extension Phase|Adverse Event|2|||
163839081|NCT00284089|591781686|FG003|Extension Phase|Adverse Event|2|||
163839082|NCT00284089|591781683|FG000|Extension Phase|condition no longer requires study drug|2|||
163839083|NCT00284089|591781684|FG001|Extension Phase|condition no longer requires study drug|0|||
163839084|NCT00284089|591781685|FG002|Extension Phase|condition no longer requires study drug|2|||
163839085|NCT00284089|591781686|FG003|Extension Phase|condition no longer requires study drug|7|||
163839086|NCT00284089|591781683|FG000|Extension Phase|Protocol Violation|0|||
163839087|NCT00284089|591781684|FG001|Extension Phase|Protocol Violation|0|||
163839088|NCT00284089|591781685|FG002|Extension Phase|Protocol Violation|1|||
163839089|NCT00284089|591781686|FG003|Extension Phase|Protocol Violation|0|||
163839090|NCT00284089|591781683|FG000|Extension Phase|Withdrawal by Subject|0|||
163839091|NCT00284089|591781684|FG001|Extension Phase|Withdrawal by Subject|0|||
163839092|NCT00284089|591781685|FG002|Extension Phase|Withdrawal by Subject|1|||
163839093|NCT00284089|591781686|FG003|Extension Phase|Withdrawal by Subject|3|||
163839094|NCT02541383|591781687|FG000|Overall Study|Death|50|||
163839095|NCT02541383|591781688|FG001|Overall Study|Death|37|||
163839096|NCT02541383|591781689|FG002|Overall Study|Death|48|||
163839097|NCT02541383|591781690|FG003|Overall Study|Death|41|||
163839098|NCT02541383|591781691|FG004|Overall Study|Death|21|||
163839099|NCT02541383|591781692|FG005|Overall Study|Death|25|||
163839100|NCT02541383|591781687|FG000|Overall Study|Lost to Follow-up|5|||
163839101|NCT02541383|591781688|FG001|Overall Study|Lost to Follow-up|3|||
163839102|NCT02541383|591781689|FG002|Overall Study|Lost to Follow-up|1|||
163839103|NCT02541383|591781690|FG003|Overall Study|Lost to Follow-up|1|||
163839104|NCT02541383|591781691|FG004|Overall Study|Lost to Follow-up|3|||
163839105|NCT02541383|591781692|FG005|Overall Study|Lost to Follow-up|0|||
164037730|NCT01998880|592496814|FG001|Overall Study|Disease Progression|8|||
164098662|NCT00942968|592726844|FG000|Overall Study|Inferior vena cava filter placement|4|||
163839106|NCT02541383|591781687|FG000|Overall Study|Consent withdrawn|5|||
163839107|NCT02541383|591781688|FG001|Overall Study|Consent withdrawn|6|||
164098663|NCT00942968|592726844|FG000|Overall Study|Pulmonary embolism (PE)|1|||
164098664|NCT00942968|592726844|FG000|Overall Study|Participant required pancreatic biopsy|1|||
164098665|NCT00942968|592726844|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
164098666|NCT01948258|592726845|FG000|Overall Study|Pregnancy|41|||
164098667|NCT01948258|592726845|FG000|Overall Study|Did not complete by cut-off date|35|||
164098668|NCT01948258|592726845|FG000|Overall Study|Lost to Follow-up|27|||
163934721|NCT04907357|592129888|FG000|Overall Study|Unable to attend visits|1|||
163934722|NCT04907357|592129889|FG001|Overall Study|Unable to attend visits|0|||
163934723|NCT04907357|592129888|FG000|Overall Study|Incarcerated|1|||
163934724|NCT04907357|592129889|FG001|Overall Study|Incarcerated|1|||
163934725|NCT00365547|592129890|FG000|Overall Study|Insurance did not cover Avastin|1|||
163934726|NCT00365547|592129890|FG000|Overall Study|Screen failure|1|||
163934727|NCT00365547|592129890|FG000|Overall Study|Withdrawal by Subject|1|||
163934728|NCT00546078|592129891|FG000|Overall Study|Lost to Follow-up|1|||
163934729|NCT00546078|592129892|FG001|Overall Study|Lost to Follow-up|3|||
163934730|NCT00546078|592129891|FG000|Overall Study|Withdrawal by Subject|2|||
163934731|NCT00546078|592129892|FG001|Overall Study|Withdrawal by Subject|3|||
163934732|NCT00546078|592129891|FG000|Overall Study|Other reason|1|||
163934733|NCT00546078|592129892|FG001|Overall Study|Other reason|1|||
163934734|NCT03512197|592129893|FG000|Overall Study|Guardian decision|1|||
163934735|NCT03512197|592129894|FG001|Overall Study|Guardian decision|1|||
163934736|NCT03512197|592129893|FG000|Overall Study|Lack of Efficacy|19|||
163934737|NCT03512197|592129894|FG001|Overall Study|Lack of Efficacy|11|||
163934738|NCT03512197|592129893|FG000|Overall Study|New Therapy for Study Indication|16|||
163934739|NCT03512197|592129894|FG001|Overall Study|New Therapy for Study Indication|16|||
163934740|NCT03512197|592129893|FG000|Overall Study|Physician Decision|60|||
163934741|NCT03512197|592129894|FG001|Overall Study|Physician Decision|60|||
163934742|NCT03512197|592129893|FG000|Overall Study|Protocol Violation|0|||
163934743|NCT03512197|592129894|FG001|Overall Study|Protocol Violation|2|||
163934744|NCT03512197|592129893|FG000|Overall Study|Terminated by Sponsored|46|||
163934745|NCT03512197|592129894|FG001|Overall Study|Terminated by Sponsored|50|||
163934746|NCT03512197|592129893|FG000|Overall Study|Subject Decision|15|||
163934747|NCT03512197|592129894|FG001|Overall Study|Subject Decision|12|||
163934748|NCT03512197|592129893|FG000|Overall Study|Withdrawal of informed consent|20|||
163934749|NCT03512197|592129894|FG001|Overall Study|Withdrawal of informed consent|14|||
163934750|NCT03512197|592129893|FG000|Overall Study|Adverse Event|30|||
163934751|NCT03512197|592129894|FG001|Overall Study|Adverse Event|34|||
163934752|NCT03512197|592129893|FG000|Overall Study|Death|14|||
163934753|NCT03512197|592129894|FG001|Overall Study|Death|9|||
163934754|NCT03512197|592129893|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
163934755|NCT03512197|592129894|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
163934756|NCT03512197|592129893|FG000|Overall Study|Missing|3|||
163934757|NCT03512197|592129894|FG001|Overall Study|Missing|13|||
163934758|NCT01806389|592129895|FG000|Overall Study|Withdrawal by Subject|4|||
163934759|NCT03358238|592129900|FG000|Overall Study|Withdrawal by Subject|0|||
163934760|NCT03358238|592129901|FG001|Overall Study|Withdrawal by Subject|1|||
163934761|NCT02633397|592129902|FG000|Overall Study|Adverse Event|8|||
163934762|NCT02633397|592129903|FG001|Overall Study|Adverse Event|8|||
163934763|NCT02633397|592129902|FG000|Overall Study|Study Burden|4|||
163934764|NCT02633397|592129903|FG001|Overall Study|Study Burden|1|||
163934765|NCT02633397|592129902|FG000|Overall Study|Treatment interruption|2|||
163934766|NCT02633397|592129903|FG001|Overall Study|Treatment interruption|5|||
163934767|NCT02633397|592129902|FG000|Overall Study|Death|2|||
163934768|NCT02633397|592129903|FG001|Overall Study|Death|2|||
163934769|NCT02633397|592129902|FG000|Overall Study|Physician Decision|0|||
163934770|NCT02633397|592129903|FG001|Overall Study|Physician Decision|1|||
163934771|NCT03595878|592129904|FG000|Overall Study|Death|2|||
163934772|NCT03595878|592129905|FG001|Overall Study|Death|1|||
163934773|NCT03595878|592129906|FG002|Overall Study|Death|0|||
163934774|NCT03595878|592129904|FG000|Overall Study|Disease progression|2|||
163934775|NCT03595878|592129905|FG001|Overall Study|Disease progression|1|||
163934776|NCT03595878|592129906|FG002|Overall Study|Disease progression|2|||
163934777|NCT03036124|592129907|FG000|Overall Study|Lost to Follow-up|0|||
163934778|NCT03036124|592129908|FG001|Overall Study|Lost to Follow-up|2|||
163934779|NCT03036124|592129907|FG000|Overall Study|Withdrawal by Subject|5|||
163934780|NCT03036124|592129908|FG001|Overall Study|Withdrawal by Subject|4|||
163934781|NCT04949802|592131357|FG000|Overall Study|Lost to Follow-up|3|||
163934782|NCT03778294|592131358|FG000|Overall Study|Death|1|||
163934783|NCT03778294|592131358|FG000|Overall Study|Issues with insurance|1|||
163934784|NCT03778294|592131358|FG000|Overall Study|disease progression before treatment|2|||
163934785|NCT01845805|592131359|FG000|Overall Study|Withdrawal by Subject|1|||
163934786|NCT01845805|592131360|FG001|Overall Study|Withdrawal by Subject|2|||
163934787|NCT01845805|592131359|FG000|Overall Study|Disease Progression|13|||
163934788|NCT01845805|592131360|FG001|Overall Study|Disease Progression|14|||
163934789|NCT01845805|592131359|FG000|Overall Study|Drug-related Toxicity|4|||
163934790|NCT01845805|592131360|FG001|Overall Study|Drug-related Toxicity|0|||
163934791|NCT00127842|592131361|FG000|Overall Study|Adverse Event|15|||
163934792|NCT00127842|592131361|FG000|Overall Study|Withdrawal by Subject|3|||
163934793|NCT00127842|592131361|FG000|Overall Study|Lost to Follow-up|1|||
163934794|NCT00127842|592131361|FG000|Overall Study|Lack of Efficacy|12|||
163934795|NCT00127842|592131361|FG000|Overall Study|Noncompliance|2|||
163934796|NCT00127842|592131361|FG000|Overall Study|Protocol Violation|1|||
163934797|NCT00127842|592131361|FG000|Overall Study|Other|5|||
163934798|NCT03595124|592131365|FG000|Overall Study|Physician Decision|1|||
164098669|NCT01948258|592726845|FG000|Overall Study|Withdrawal by SPD|8|||
164098670|NCT01948258|592726845|FG000|Overall Study|Withdrawal by Subject|6|||
164098671|NCT01948258|592726845|FG000|Overall Study|Health Care Professional|43|||
163839108|NCT02541383|591781689|FG002|Overall Study|Consent withdrawn|1|||
163839109|NCT02541383|591781690|FG003|Overall Study|Consent withdrawn|1|||
163839110|NCT02541383|591781691|FG004|Overall Study|Consent withdrawn|0|||
163839111|NCT02541383|591781692|FG005|Overall Study|Consent withdrawn|0|||
163839112|NCT02541383|591781687|FG000|Overall Study|Sponsor's decision|1|||
163839113|NCT02541383|591781688|FG001|Overall Study|Sponsor's decision|1|||
163839114|NCT02541383|591781689|FG002|Overall Study|Sponsor's decision|0|||
163839115|NCT02541383|591781690|FG003|Overall Study|Sponsor's decision|0|||
163839116|NCT02541383|591781691|FG004|Overall Study|Sponsor's decision|0|||
163839117|NCT02541383|591781692|FG005|Overall Study|Sponsor's decision|0|||
163839118|NCT05796518|591781693|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
163839119|NCT00594217|591781694|FG000|Overall Study|Withdrawal by Subject|1|||
163839120|NCT00594217|591781695|FG001|Overall Study|Withdrawal by Subject|3|||
163839121|NCT05778526|591781698|FG000|Overall Study|Lost to Follow-up|0|||
163839122|NCT05778526|591781699|FG001|Overall Study|Lost to Follow-up|1|||
163839123|NCT05778526|591781700|FG002|Overall Study|Lost to Follow-up|3|||
163839124|NCT05778526|591781698|FG000|Overall Study|Protocol Violation|0|||
163839125|NCT05778526|591781699|FG001|Overall Study|Protocol Violation|0|||
163839126|NCT05778526|591781700|FG002|Overall Study|Protocol Violation|8|||
163839127|NCT03108157|591781703|FG000|Overall Study|Protocol Violation|15|||
163839128|NCT03108157|591781704|FG001|Overall Study|Protocol Violation|4|||
163839129|NCT01435655|591781705|FG000|Overall Study|Death|2|||
163839130|NCT01435655|591781705|FG000|Overall Study|Other|1|||
163839131|NCT02839343|591781708|FG000|Overall Study|Withdrawal by Subject|3|||
163839132|NCT02839343|591781709|FG001|Overall Study|Withdrawal by Subject|1|||
163839133|NCT02839343|591781708|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
163839134|NCT02839343|591781709|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
163839135|NCT02839343|591781708|FG000|Overall Study|Adverse Event|1|||
163839136|NCT02839343|591781709|FG001|Overall Study|Adverse Event|0|||
163839137|NCT02223754|591781710|FG000|Period 1|Adverse Event|1|||
163839138|NCT02223754|591781711|FG001|Period 1|Adverse Event|0|||
163839139|NCT02223754|591781710|FG000|Period 1|Lost to Follow-up|0|||
163839140|NCT02223754|591781711|FG001|Period 1|Lost to Follow-up|1|||
163839141|NCT02223754|591781710|FG000|Period 1|Protocol Violation|2|||
163839142|NCT02223754|591781711|FG001|Period 1|Protocol Violation|4|||
163839143|NCT02223754|591781710|FG000|Period 1|Withdrawal by Subject|0|||
163839144|NCT02223754|591781711|FG001|Period 1|Withdrawal by Subject|4|||
163839145|NCT02223754|591781710|FG000|Period 1|Test Article No Longer Available|1|||
163839146|NCT02223754|591781711|FG001|Period 1|Test Article No Longer Available|5|||
163839147|NCT02223754|591781710|FG000|Period 1|Unsatisfactory Visual Response|0|||
163839148|NCT02223754|591781711|FG001|Period 1|Unsatisfactory Visual Response|1|||
163839149|NCT02223754|591781710|FG000|Period 2|Adverse Event|0|||
163839150|NCT02223754|591781711|FG001|Period 2|Adverse Event|1|||
163839151|NCT02223754|591781710|FG000|Period 2|Protocol Violation|1|||
163839152|NCT02223754|591781711|FG001|Period 2|Protocol Violation|0|||
163839153|NCT02223754|591781710|FG000|Period 2|Lens Discomfort|1|||
163839154|NCT02223754|591781711|FG001|Period 2|Lens Discomfort|1|||
163839155|NCT02223754|591781710|FG000|Period 2|Lost to Follow-up|1|||
163839156|NCT02223754|591781711|FG001|Period 2|Lost to Follow-up|0|||
163839157|NCT02223754|591781710|FG000|Period 2|Test Article No Longer Available|0|||
163839158|NCT02223754|591781711|FG001|Period 2|Test Article No Longer Available|1|||
163839159|NCT04395183|591781713|FG000|Overall Study|Withdrawal by Subject|1|||
163839160|NCT04395183|591781714|FG001|Overall Study|Withdrawal by Subject|0|||
163839161|NCT04395183|591781715|FG002|Overall Study|Withdrawal by Subject|2|||
163839162|NCT04395183|591781716|FG003|Overall Study|Withdrawal by Subject|2|||
163839163|NCT02668016|591781717|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
163839164|NCT02668016|591781717|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
163839165|NCT02668016|591781717|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
163839166|NCT02668016|591781717|FG000|Month 4|Withdrawal due to severe symptoms|1|||
163839167|NCT02668016|591781717|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
163839168|NCT02668016|591781717|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
163839169|NCT02668016|591781717|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
163839170|NCT02668016|591781717|FG000|Month 6|Withdrawal due to severe symptoms|2|||
163839171|NCT02668016|591781717|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
163839172|NCT02668016|591781717|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
163839173|NCT02668016|591781717|FG000|Month 8|Withdrawal due to severe symptoms|1|||
163839174|NCT02668016|591781717|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
163839175|NCT02668016|591781717|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
163934799|NCT03595124|592131366|FG001|Overall Study|Physician Decision|1|||
163934800|NCT03595124|592131367|FG002|Overall Study|Physician Decision|1|||
163934801|NCT03595124|592131365|FG000|Overall Study|Ineligible|1|||
164147698|NCT02006732|592902132|FG003|Overall Study|Adverse Event|2|||
164037731|NCT01998880|592496813|FG000|Overall Study|Withdrew Consent|2|||
164037732|NCT01998880|592496814|FG001|Overall Study|Withdrew Consent|1|||
164037733|NCT01998880|592496813|FG000|Overall Study|Death|3|||
164037734|NCT01998880|592496814|FG001|Overall Study|Death|6|||
164037735|NCT01998880|592496813|FG000|Overall Study|Insufficient Therapeutic Response|1|||
164037736|NCT01998880|592496814|FG001|Overall Study|Insufficient Therapeutic Response|5|||
164037737|NCT01998880|592496813|FG000|Overall Study|Administrative/Other|1|||
164037738|NCT01998880|592496814|FG001|Overall Study|Administrative/Other|1|||
164037739|NCT01998880|592496813|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
164037740|NCT01998880|592496814|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
164037741|NCT01998880|592496813|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
164037742|NCT01998880|592496814|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
164037743|NCT01998880|592496813|FG000|Overall Study|Did Not Receive Treatment|3|||
164037744|NCT01998880|592496814|FG001|Overall Study|Did Not Receive Treatment|2|||
164037745|NCT02248857|592496815|FG000|3 Month|Withdrawal by Subject|9|||
164037746|NCT02248857|592496816|FG001|3 Month|Withdrawal by Subject|3|||
164037747|NCT02248857|592496817|FG002|3 Month|Withdrawal by Subject|4|||
164037748|NCT02248857|592496815|FG000|3 Month|Unable to reach for 3 month|35|||
164037749|NCT02248857|592496816|FG001|3 Month|Unable to reach for 3 month|29|||
164037750|NCT02248857|592496817|FG002|3 Month|Unable to reach for 3 month|26|||
164037751|NCT02248857|592496815|FG000|3 Month|Partially completed, unable to finish|2|||
164037752|NCT02248857|592496816|FG001|3 Month|Partially completed, unable to finish|2|||
164037753|NCT02248857|592496817|FG002|3 Month|Partially completed, unable to finish|1|||
164037754|NCT02248857|592496815|FG000|6 Month|Lost to Follow-up|27|||
164037755|NCT02248857|592496816|FG001|6 Month|Lost to Follow-up|26|||
164037756|NCT02248857|592496817|FG002|6 Month|Lost to Follow-up|15|||
164037757|NCT02248857|592496815|FG000|6 Month|Partially completed, unable to finish|0|||
164037758|NCT02248857|592496816|FG001|6 Month|Partially completed, unable to finish|1|||
164037759|NCT02248857|592496817|FG002|6 Month|Partially completed, unable to finish|0|||
164037760|NCT02248857|592496815|FG000|6 Month|Withdrawal by Subject|0|||
164037761|NCT02248857|592496816|FG001|6 Month|Withdrawal by Subject|2|||
164037762|NCT02248857|592496817|FG002|6 Month|Withdrawal by Subject|2|||
164037763|NCT02248857|592496815|FG000|6 Month|Death|1|||
163934802|NCT03595124|592131366|FG001|Overall Study|Ineligible|1|||
163934803|NCT03595124|592131367|FG002|Overall Study|Ineligible|0|||
163934804|NCT03595124|592131365|FG000|Overall Study|Disease Progression|4|||
163934805|NCT03595124|592131366|FG001|Overall Study|Disease Progression|1|||
163934806|NCT03595124|592131367|FG002|Overall Study|Disease Progression|4|||
163934807|NCT02113124|592131368|FG000|Overall Study|Unable to retrieve blood sample|1|||
163934808|NCT02113124|592131369|FG001|Overall Study|Unable to retrieve blood sample|1|||
163934809|NCT01439867|592131370|FG000|Overall Study|Non-compliance|0|||
163934810|NCT01439867|592131371|FG001|Overall Study|Non-compliance|1|||
163934811|NCT01439867|592131370|FG000|Overall Study|Withdrawal by Subject|1|||
163934812|NCT01439867|592131371|FG001|Overall Study|Withdrawal by Subject|2|||
163934813|NCT01439867|592131370|FG000|Overall Study|Administrative Decision|4|||
163934814|NCT01439867|592131371|FG001|Overall Study|Administrative Decision|5|||
163934815|NCT01439867|592131370|FG000|Overall Study|Protocol-specified Criteria|1|||
163934816|NCT01439867|592131371|FG001|Overall Study|Protocol-specified Criteria|0|||
163934817|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
163934818|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
163934819|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
163934820|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
163934821|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
163934822|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
163934823|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
163934824|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
164037764|NCT02248857|592496816|FG001|6 Month|Death|0|||
164037765|NCT02248857|592496817|FG002|6 Month|Death|0|||
164037766|NCT02671461|592496818|FG000|Treatment|Adverse Event|0|||
164037767|NCT02671461|592496819|FG001|Treatment|Adverse Event|0|||
164037768|NCT02671461|592496820|FG002|Treatment|Adverse Event|1|||
164037769|NCT02671461|592496818|FG000|Treatment|Administrative Reason by Sponsor|1|||
163934825|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
163934826|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
163934827|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
164037770|NCT02671461|592496819|FG001|Treatment|Administrative Reason by Sponsor|3|||
164037771|NCT02671461|592496820|FG002|Treatment|Administrative Reason by Sponsor|4|||
164037772|NCT02671461|592496818|FG000|Treatment|Randomized, not treated|1|||
164037773|NCT02671461|592496819|FG001|Treatment|Randomized, not treated|0|||
163934828|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
164037774|NCT02671461|592496820|FG002|Treatment|Randomized, not treated|0|||
164037775|NCT02671461|592496818|FG000|Follow-up|Withdrawal by Subject|1|||
164037776|NCT02671461|592496819|FG001|Follow-up|Withdrawal by Subject|0|||
164037777|NCT02671461|592496820|FG002|Follow-up|Withdrawal by Subject|0|||
164037778|NCT02671461|592496818|FG000|Follow-up|Lost to Follow-up|0|||
164037779|NCT02671461|592496819|FG001|Follow-up|Lost to Follow-up|0|||
163934829|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
163934830|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
163934831|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163934832|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163934833|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163934834|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163934835|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163934836|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
163934837|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
163934838|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
163934839|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
163934840|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
163934841|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
163934842|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
163934843|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
163934844|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
163934845|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163934846|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163934847|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163934848|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163934849|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
163934850|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163934851|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
163934852|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163934853|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
163934854|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163934855|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163934856|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163934857|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163934858|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
163934859|NCT01888874|592131372|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163934860|NCT01888874|592131373|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
163934861|NCT01888874|592131374|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163934862|NCT01888874|592131375|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163934863|NCT01888874|592131376|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163934864|NCT01888874|592131377|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
163934865|NCT01888874|592131378|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
163934866|NCT01888874|592131372|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
163934867|NCT01888874|592131373|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
163934868|NCT01888874|592131374|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
163934869|NCT01888874|592131375|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163934870|NCT01888874|592131376|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
163934871|NCT01888874|592131377|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163934872|NCT01888874|592131378|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
163934873|NCT01888874|592131372|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163934874|NCT01888874|592131373|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163934875|NCT01888874|592131374|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163934876|NCT01888874|592131375|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163934877|NCT01888874|592131376|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
163934878|NCT01888874|592131377|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163934879|NCT01888874|592131378|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
163934880|NCT01888874|592131372|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163934881|NCT01888874|592131373|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163934882|NCT01888874|592131374|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
163934883|NCT01888874|592131375|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163934884|NCT01888874|592131376|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163934885|NCT01888874|592131377|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
163934886|NCT01888874|592131378|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
163934887|NCT01888874|592131372|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163934888|NCT01888874|592131373|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
164037780|NCT02671461|592496820|FG002|Follow-up|Lost to Follow-up|1|||
164037781|NCT02671461|592496818|FG000|Follow-up|Administrative Reason by Sponsor|0|||
164037782|NCT02671461|592496819|FG001|Follow-up|Administrative Reason by Sponsor|1|||
164037783|NCT02671461|592496820|FG002|Follow-up|Administrative Reason by Sponsor|0|||
164037784|NCT00345540|592496821|FG000|Overall Study|Withdrawal by Subject|1|||
164037785|NCT04179786|592496822|FG000|Overall Study|Withdrawal by Subject|8|||
164037786|NCT01938001|592496823|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
164037787|NCT01938001|592496824|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
164037788|NCT01938001|592496823|FG000|Pre-Treatment|Death|1|||
164037789|NCT01938001|592496824|FG001|Pre-Treatment|Death|0|||
164037790|NCT01938001|592496823|FG000|Treatment|Death|2|||
164037791|NCT01938001|592496824|FG001|Treatment|Death|0|||
164037792|NCT01938001|592496823|FG000|Treatment|Adverse Event|14|||
164037793|NCT01938001|592496824|FG001|Treatment|Adverse Event|8|||
164037794|NCT01938001|592496823|FG000|Treatment|Progressive Disease|21|||
164037795|NCT01938001|592496824|FG001|Treatment|Progressive Disease|54|||
164037796|NCT01938001|592496823|FG000|Treatment|Withdrawal by Subject|13|||
164037797|NCT01938001|592496824|FG001|Treatment|Withdrawal by Subject|7|||
164037798|NCT01938001|592496823|FG000|Treatment|Other reasons|2|||
164037799|NCT01938001|592496824|FG001|Treatment|Other reasons|1|||
164037800|NCT03310580|592496825|FG000|Overall Study|Adverse Event|0|||
164037801|NCT03310580|592496826|FG001|Overall Study|Adverse Event|1|||
164037802|NCT03310580|592496827|FG002|Overall Study|Adverse Event|0|||
164037803|NCT03205982|592496828|FG000|Overall Study|Lost to Follow-up|20|||
164037804|NCT03205982|592496829|FG001|Overall Study|Lost to Follow-up|19|||
164037805|NCT03205982|592496828|FG000|Overall Study|Withdrawal by Subject|4|||
164037806|NCT03205982|592496829|FG001|Overall Study|Withdrawal by Subject|3|||
163839176|NCT02668016|591781717|FG000|Month 10|Withdrawal due to severe symptoms|1|||
163839177|NCT02668016|591781717|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
163839178|NCT02234063|591781726|FG000|Overall Study|Lost to Follow-up|235|||
163839179|NCT02234063|591781727|FG001|Overall Study|Lost to Follow-up|42|||
163839180|NCT02234063|591781726|FG000|Overall Study|Withdrawal by Subject|20|||
163839181|NCT02234063|591781727|FG001|Overall Study|Withdrawal by Subject|1|||
163839182|NCT00510458|591781728|FG000|Overall Study|5 year not evaluable/missed|21|||
163839183|NCT00510458|591781728|FG000|Overall Study|Death|1|||
163839184|NCT00510458|591781728|FG000|Overall Study|Terminated|14|||
163839185|NCT00510458|591781728|FG000|Overall Study|Lost to Follow-up|6|||
163839186|NCT00510458|591781728|FG000|Overall Study|Withdrawal by Subject|3|||
163839187|NCT00510458|591781728|FG000|Overall Study|Revision|2|||
163839188|NCT03535337|591781731|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
163839189|NCT03535337|591781732|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
163839190|NCT03535337|591781733|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
163839191|NCT03535337|591781734|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
163839192|NCT03535337|591781735|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
163839193|NCT03535337|591781736|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
163839194|NCT03535337|591781737|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
163839195|NCT03535337|591781738|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
163839196|NCT03535337|591781739|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
163839197|NCT03535337|591781740|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
163839198|NCT05879198|591781741|FG000|Overall Study|Lost to Follow-up|1|||
163839199|NCT01598298|591781742|FG000|Overall Study|Not eligible|5|||
163839200|NCT01598298|591781743|FG001|Overall Study|Not eligible|5|||
163839201|NCT01598298|591781742|FG000|Overall Study|Adverse Event|21|||
163839202|NCT01598298|591781743|FG001|Overall Study|Adverse Event|19|||
163839203|NCT01598298|591781742|FG000|Overall Study|Progression/relapse|0|||
163839204|NCT01598298|591781743|FG001|Overall Study|Progression/relapse|2|||
163839205|NCT01598298|591781742|FG000|Overall Study|Withdrawal by Subject|10|||
163839206|NCT01598298|591781743|FG001|Overall Study|Withdrawal by Subject|15|||
163839207|NCT01598298|591781742|FG000|Overall Study|Other reason (not protocol specified)|4|||
163839208|NCT01598298|591781743|FG001|Overall Study|Other reason (not protocol specified)|0|||
163839209|NCT04668989|591783520|FG000|First Intervention|Covid-19 related self-isolation|0|||
163839210|NCT04668989|591783521|FG001|First Intervention|Covid-19 related self-isolation|1|||
163839211|NCT04668989|591783520|FG000|Second Intervention|Adverse Event|0|||
163839212|NCT04668989|591783521|FG001|Second Intervention|Adverse Event|1|||
163839213|NCT01622348|591783525|FG000|Overall Study|Withdrawal by Subject|1|||
163839214|NCT01622348|591783526|FG001|Overall Study|Withdrawal by Subject|0|||
163839215|NCT01622348|591783527|FG002|Overall Study|Withdrawal by Subject|1|||
163839216|NCT00474175|591783530|FG000|Overall Study|Lack of Efficacy|0|||
163839217|NCT00474175|591783531|FG001|Overall Study|Lack of Efficacy|0|||
163839218|NCT00474175|591783532|FG002|Overall Study|Lack of Efficacy|1|||
163839219|NCT00474175|591783530|FG000|Overall Study|Withdrawal by Subject|0|||
163839220|NCT00474175|591783531|FG001|Overall Study|Withdrawal by Subject|1|||
163839221|NCT00474175|591783532|FG002|Overall Study|Withdrawal by Subject|1|||
163839222|NCT00474175|591783530|FG000|Overall Study|Ineligible|1|||
163839223|NCT00474175|591783531|FG001|Overall Study|Ineligible|3|||
163839224|NCT00474175|591783532|FG002|Overall Study|Ineligible|1|||
163839225|NCT00474175|591783530|FG000|Overall Study|Protocol Violation|0|||
163839226|NCT00474175|591783531|FG001|Overall Study|Protocol Violation|2|||
163839227|NCT00474175|591783532|FG002|Overall Study|Protocol Violation|1|||
163839228|NCT00474175|591783530|FG000|Overall Study|Administrative|0|||
163839229|NCT00474175|591783531|FG001|Overall Study|Administrative|1|||
163839230|NCT00474175|591783532|FG002|Overall Study|Administrative|0|||
163839231|NCT01619787|591783533|FG000|Overall Study|Lost to Follow-up|5|||
163839232|NCT04537897|591783534|FG000|Overall Study|Other than listed|0|||
163839233|NCT04537897|591783535|FG001|Overall Study|Other than listed|0|||
163839234|NCT04537897|591783536|FG002|Overall Study|Other than listed|0|||
163839235|NCT04537897|591783537|FG003|Overall Study|Other than listed|0|||
163839236|NCT04537897|591783538|FG004|Overall Study|Other than listed|0|||
163839237|NCT04537897|591783539|FG005|Overall Study|Other than listed|0|||
163839238|NCT04537897|591783540|FG006|Overall Study|Other than listed|1|||
163839239|NCT04537897|591783541|FG007|Overall Study|Other than listed|0|||
163839240|NCT04537897|591783542|FG008|Overall Study|Other than listed|0|||
163839241|NCT04537897|591783534|FG000|Overall Study|Adverse Event|0|||
163839242|NCT04537897|591783535|FG001|Overall Study|Adverse Event|0|||
163839243|NCT04537897|591783536|FG002|Overall Study|Adverse Event|0|||
163839244|NCT04537897|591783537|FG003|Overall Study|Adverse Event|1|||
163839245|NCT04537897|591783538|FG004|Overall Study|Adverse Event|0|||
163839246|NCT04537897|591783539|FG005|Overall Study|Adverse Event|0|||
163839247|NCT04537897|591783540|FG006|Overall Study|Adverse Event|0|||
163839248|NCT04537897|591783541|FG007|Overall Study|Adverse Event|0|||
163839249|NCT04537897|591783542|FG008|Overall Study|Adverse Event|0|||
163839250|NCT04537897|591783534|FG000|Overall Study|Withdrawal by Subject|0|||
163839251|NCT04537897|591783535|FG001|Overall Study|Withdrawal by Subject|1|||
163839252|NCT04537897|591783536|FG002|Overall Study|Withdrawal by Subject|0|||
163839253|NCT04537897|591783537|FG003|Overall Study|Withdrawal by Subject|0|||
163839254|NCT04537897|591783538|FG004|Overall Study|Withdrawal by Subject|0|||
163839255|NCT04537897|591783539|FG005|Overall Study|Withdrawal by Subject|0|||
163839256|NCT04537897|591783540|FG006|Overall Study|Withdrawal by Subject|0|||
163839257|NCT04537897|591783541|FG007|Overall Study|Withdrawal by Subject|0|||
163839258|NCT04537897|591783542|FG008|Overall Study|Withdrawal by Subject|0|||
163839259|NCT00197028|591783546|FG000|Overall Study|Adverse Event|2|||
163839260|NCT00197028|591783547|FG001|Overall Study|Adverse Event|2|||
163839261|NCT00197028|591783546|FG000|Overall Study|Protocol Violation|2|||
163839262|NCT00197028|591783547|FG001|Overall Study|Protocol Violation|1|||
163839263|NCT00197028|591783546|FG000|Overall Study|Withdrawal by Subject|8|||
163839264|NCT00197028|591783547|FG001|Overall Study|Withdrawal by Subject|12|||
163839265|NCT00197028|591783546|FG000|Overall Study|Lost to Follow-up|1|||
163839266|NCT00197028|591783547|FG001|Overall Study|Lost to Follow-up|0|||
163839267|NCT00197028|591783546|FG000|Overall Study|Other|3|||
163839268|NCT00197028|591783547|FG001|Overall Study|Other|6|||
163839269|NCT03893825|591783548|FG000|Overall Study|Death|2|||
163839270|NCT03893825|591783549|FG001|Overall Study|Death|1|||
163839271|NCT03893825|591783548|FG000|Overall Study|Adverse Event|0|||
163839272|NCT03893825|591783549|FG001|Overall Study|Adverse Event|2|||
163839273|NCT03893825|591783548|FG000|Overall Study|Withdrawal by Subject|19|||
163839274|NCT03893825|591783549|FG001|Overall Study|Withdrawal by Subject|21|||
163839275|NCT03893825|591783548|FG000|Overall Study|Protocol deviation|1|||
163839276|NCT03893825|591783549|FG001|Overall Study|Protocol deviation|0|||
163839277|NCT03893825|591783548|FG000|Overall Study|Lost to Follow-up|10|||
163839278|NCT03893825|591783549|FG001|Overall Study|Lost to Follow-up|10|||
163839279|NCT03893825|591783548|FG000|Overall Study|Other than specified|7|||
163839280|NCT03893825|591783549|FG001|Overall Study|Other than specified|6|||
163839281|NCT04488003|591783552|FG000|Assessed for Eligibility|Screen Failure|24|||
163839282|NCT04488003|591783553|FG001|Assessed for Eligibility|Screen Failure|0|||
163839283|NCT04488003|591783554|FG002|Assessed for Eligibility|Screen Failure|0|||
163839284|NCT04488003|591783552|FG000|Assessed for Eligibility|Adverse Event|1|||
163839285|NCT04488003|591783553|FG001|Assessed for Eligibility|Adverse Event|0|||
163839286|NCT04488003|591783554|FG002|Assessed for Eligibility|Adverse Event|0|||
163839287|NCT04488003|591783552|FG000|Assessed for Eligibility|Death|1|||
163839288|NCT04488003|591783553|FG001|Assessed for Eligibility|Death|0|||
163839289|NCT04488003|591783554|FG002|Assessed for Eligibility|Death|0|||
163839290|NCT04488003|591783552|FG000|Assessed for Eligibility|Physician Decision|1|||
163839291|NCT04488003|591783553|FG001|Assessed for Eligibility|Physician Decision|0|||
163839292|NCT04488003|591783554|FG002|Assessed for Eligibility|Physician Decision|0|||
163839293|NCT04488003|591783552|FG000|Allocated to Treatment|Progressive Disease|51|||
164037807|NCT03205982|592496828|FG000|Overall Study|Withdrawal by PI|0|||
163839294|NCT04488003|591783553|FG001|Allocated to Treatment|Progressive Disease|0|||
163839295|NCT04488003|591783554|FG002|Allocated to Treatment|Progressive Disease|0|||
163839296|NCT04488003|591783552|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
163839297|NCT04488003|591783553|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
163839298|NCT04488003|591783554|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
163839299|NCT04488003|591783552|FG000|Allocated to Treatment|Adverse Event|6|||
163839300|NCT04488003|591783553|FG001|Allocated to Treatment|Adverse Event|0|||
163839301|NCT04488003|591783554|FG002|Allocated to Treatment|Adverse Event|0|||
163839302|NCT04488003|591783552|FG000|Allocated to Treatment|Other|5|||
163839303|NCT04488003|591783553|FG001|Allocated to Treatment|Other|0|||
163839304|NCT04488003|591783554|FG002|Allocated to Treatment|Other|0|||
163839305|NCT04488003|591783552|FG000|Allocated to Treatment|Physician Decision|4|||
163934889|NCT01888874|592131374|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
163934890|NCT01888874|592131375|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163934891|NCT01888874|592131376|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163934892|NCT01888874|592131377|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163934893|NCT01888874|592131378|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
163934894|NCT01888874|592131372|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
163934895|NCT01888874|592131373|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
164037808|NCT03205982|592496829|FG001|Overall Study|Withdrawal by PI|1|||
164037809|NCT01468701|592496832|FG000|Overall Study|Not eligible|91|||
164037810|NCT01468701|592496833|FG001|Overall Study|Not eligible|140|||
164037811|NCT01468701|592496834|FG002|Overall Study|Not eligible|29|||
164037812|NCT01468701|592496835|FG003|Overall Study|Not eligible|12|||
164037813|NCT01468701|592496836|FG004|Overall Study|Not eligible|22|||
164037814|NCT01468701|592496837|FG005|Overall Study|Not eligible|2|||
164037815|NCT01468701|592496838|FG006|Overall Study|Not eligible|39|||
164037816|NCT01468701|592496839|FG007|Overall Study|Not eligible|1|||
164037817|NCT01468701|592496840|FG008|Overall Study|Not eligible|40|||
164037818|NCT01468701|592496841|FG009|Overall Study|Not eligible|126|||
164037819|NCT01468701|592496842|FG010|Overall Study|Not eligible|39|||
164037820|NCT01468701|592496843|FG011|Overall Study|Not eligible|33|||
164037821|NCT01468701|592496844|FG012|Overall Study|Not eligible|1|||
164037822|NCT01468701|592496845|FG013|Overall Study|Not eligible|19|||
164037823|NCT01468701|592496846|FG014|Overall Study|Not eligible|1|||
164037824|NCT01468701|592496847|FG015|Overall Study|Not eligible|32|||
164037825|NCT01468701|592496848|FG016|Overall Study|Not eligible|0|||
164037826|NCT01468701|592496832|FG000|Overall Study|Lost to Follow-up|306|||
164037827|NCT01468701|592496833|FG001|Overall Study|Lost to Follow-up|0|||
164037828|NCT01468701|592496834|FG002|Overall Study|Lost to Follow-up|0|||
164037829|NCT01468701|592496835|FG003|Overall Study|Lost to Follow-up|0|||
164037830|NCT01468701|592496836|FG004|Overall Study|Lost to Follow-up|0|||
164037831|NCT01468701|592496837|FG005|Overall Study|Lost to Follow-up|0|||
164037832|NCT01468701|592496838|FG006|Overall Study|Lost to Follow-up|0|||
164037833|NCT01468701|592496839|FG007|Overall Study|Lost to Follow-up|0|||
164037834|NCT01468701|592496840|FG008|Overall Study|Lost to Follow-up|215|||
164037835|NCT01468701|592496841|FG009|Overall Study|Lost to Follow-up|309|||
164037836|NCT01468701|592496842|FG010|Overall Study|Lost to Follow-up|224|||
164037837|NCT01468701|592496843|FG011|Overall Study|Lost to Follow-up|212|||
164037838|NCT01468701|592496844|FG012|Overall Study|Lost to Follow-up|11|||
164037839|NCT01468701|592496845|FG013|Overall Study|Lost to Follow-up|164|||
164037840|NCT01468701|592496846|FG014|Overall Study|Lost to Follow-up|17|||
164037841|NCT01468701|592496847|FG015|Overall Study|Lost to Follow-up|127|||
164037842|NCT01468701|592496848|FG016|Overall Study|Lost to Follow-up|1|||
164037843|NCT01468701|592496832|FG000|Overall Study|Withdrawal by Subject|165|||
164037844|NCT01468701|592496833|FG001|Overall Study|Withdrawal by Subject|0|||
164037845|NCT01468701|592496834|FG002|Overall Study|Withdrawal by Subject|0|||
164037846|NCT01468701|592496835|FG003|Overall Study|Withdrawal by Subject|0|||
164037847|NCT01468701|592496836|FG004|Overall Study|Withdrawal by Subject|0|||
164037848|NCT01468701|592496837|FG005|Overall Study|Withdrawal by Subject|0|||
164037849|NCT01468701|592496838|FG006|Overall Study|Withdrawal by Subject|0|||
164037850|NCT01468701|592496839|FG007|Overall Study|Withdrawal by Subject|0|||
164037851|NCT01468701|592496840|FG008|Overall Study|Withdrawal by Subject|83|||
164037852|NCT01468701|592496841|FG009|Overall Study|Withdrawal by Subject|88|||
164037853|NCT01468701|592496842|FG010|Overall Study|Withdrawal by Subject|100|||
164037854|NCT01468701|592496843|FG011|Overall Study|Withdrawal by Subject|114|||
164037855|NCT01468701|592496844|FG012|Overall Study|Withdrawal by Subject|9|||
164037856|NCT01468701|592496845|FG013|Overall Study|Withdrawal by Subject|47|||
163934896|NCT01888874|592131374|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
163934897|NCT01888874|592131375|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
163934898|NCT01888874|592131376|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
163934899|NCT01888874|592131377|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
163934900|NCT01888874|592131378|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
163934901|NCT01888874|592131372|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163934902|NCT01888874|592131373|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
164037857|NCT01468701|592496846|FG014|Overall Study|Withdrawal by Subject|6|||
164037858|NCT01468701|592496847|FG015|Overall Study|Withdrawal by Subject|31|||
164037859|NCT01468701|592496848|FG016|Overall Study|Withdrawal by Subject|0|||
164037860|NCT01468701|592496832|FG000|Overall Study|Other reasons than listed|437|||
164037861|NCT01468701|592496833|FG001|Overall Study|Other reasons than listed|0|||
163934903|NCT01888874|592131374|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
164037862|NCT01468701|592496834|FG002|Overall Study|Other reasons than listed|0|||
164037863|NCT01468701|592496835|FG003|Overall Study|Other reasons than listed|0|||
164037864|NCT01468701|592496836|FG004|Overall Study|Other reasons than listed|0|||
164037865|NCT01468701|592496837|FG005|Overall Study|Other reasons than listed|0|||
164037866|NCT01468701|592496838|FG006|Overall Study|Other reasons than listed|0|||
164037867|NCT01468701|592496839|FG007|Overall Study|Other reasons than listed|0|||
164037868|NCT01468701|592496840|FG008|Overall Study|Other reasons than listed|318|||
164037869|NCT01468701|592496841|FG009|Overall Study|Other reasons than listed|658|||
163934904|NCT01888874|592131375|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163934905|NCT01888874|592131376|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163934906|NCT01888874|592131377|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
163934907|NCT01888874|592131378|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
163934908|NCT02763215|592131379|FG000|Overall Study|Participants withdrew from study|3|||
163934909|NCT02763215|592131379|FG000|Overall Study|Missed visit|1|||
163934910|NCT02763215|592131379|FG000|Overall Study|Visit outside visit-window|1|||
163934911|NCT02763215|592131379|FG000|Overall Study|Death|1|||
163934912|NCT02763215|592131379|FG000|Overall Study|Lost to Follow-up|1|||
163934913|NCT01020877|592131382|FG000|Second Intervention|Withdrawal by Subject|1|||
163934914|NCT01020877|592131383|FG001|Second Intervention|Withdrawal by Subject|0|||
163934915|NCT02963090|592131385|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
163934916|NCT02963090|592131386|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
163934917|NCT01784523|592131387|FG000|Overall Study|Study closed early|7|||
163934918|NCT01784523|592131388|FG001|Overall Study|Study closed early|4|||
163934919|NCT00709228|592131389|FG000|Overall Study|Not treated|14|||
163934920|NCT00709228|592131389|FG000|Overall Study|Eligibility criteria not met|281|||
163934921|NCT00709228|592131389|FG000|Overall Study|Adverse events|2|||
163934922|NCT00709228|592131389|FG000|Overall Study|Discontinued treatment|14|||
163934923|NCT00709228|592131389|FG000|Overall Study|Did not enter follow-up|4|||
163934924|NCT00709228|592131389|FG000|Overall Study|Discontinued follow-up|5|||
163934925|NCT00709228|592131389|FG000|Overall Study|Disease progression|1|||
163934926|NCT00709228|592131389|FG000|Overall Study|Lost to Follow-up|6|||
163934927|NCT00709228|592131389|FG000|Overall Study|Non-compliance|5|||
163934928|NCT02179177|592131390|FG000|Overall Study|Lost to Follow-up|1|||
163934929|NCT02179177|592131391|FG001|Overall Study|Lost to Follow-up|1|||
163934930|NCT02179177|592131390|FG000|Overall Study|Withdrawal by Subject|1|||
163934931|NCT02179177|592131391|FG001|Overall Study|Withdrawal by Subject|1|||
163934932|NCT00022659|592131392|FG000|Overall Study|Ineligible: wrong primary|1|||
163934933|NCT00022659|592131392|FG000|Overall Study|Never treated|1|||
163934934|NCT00884650|592131393|FG000|Overall Study|Did not return complete pain diaries|7|||
163934935|NCT00884650|592131394|FG001|Overall Study|Did not return complete pain diaries|7|||
163934936|NCT00884650|592131393|FG000|Overall Study|Admitted Post-Op|1|||
163934937|NCT00884650|592131394|FG001|Overall Study|Admitted Post-Op|0|||
163934938|NCT00884650|592131393|FG000|Overall Study|Femoral Stress Fracture|1|||
163934939|NCT00884650|592131394|FG001|Overall Study|Femoral Stress Fracture|0|||
163934940|NCT00884650|592131393|FG000|Overall Study|Pain Pump Complication|0|||
163934941|NCT00884650|592131394|FG001|Overall Study|Pain Pump Complication|1|||
163934942|NCT04334278|592131395|FG000|Overall Study|Lost to Follow-up|0|||
163934943|NCT04334278|592131396|FG001|Overall Study|Lost to Follow-up|3|||
163934944|NCT04334278|592131395|FG000|Overall Study|Withdrawal by Subject|4|||
163934945|NCT04334278|592131396|FG001|Overall Study|Withdrawal by Subject|2|||
163934946|NCT01516749|592131397|FG000|Active Therapy|Lost to Follow-up|1|||
163934947|NCT01516749|592131397|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
163934948|NCT02196077|592131407|FG000|Overall Study|Adverse Event|4|||
163934949|NCT02196077|592131407|FG000|Overall Study|Lack of Efficacy|1|||
163934950|NCT02196077|592131407|FG000|Overall Study|Withdrawal by Subject|14|||
163934951|NCT02196077|592131407|FG000|Overall Study|Physician Decision|1|||
163934952|NCT02196077|592131407|FG000|Overall Study|Lost to Follow-up|3|||
163934953|NCT02196077|592131407|FG000|Overall Study|Protocol Violation|24|||
163934954|NCT00732992|592131408|FG000|Overall Study|Adverse Event|1|||
163934955|NCT00732992|592131409|FG001|Overall Study|Adverse Event|1|||
163934956|NCT00732992|592131408|FG000|Overall Study|Objective Progression or Relapse|3|||
163934957|NCT00732992|592131409|FG001|Overall Study|Objective Progression or Relapse|5|||
163934958|NCT00732992|592131408|FG000|Overall Study|Global Deterioration of Health Status|1|||
163934959|NCT00732992|592131409|FG001|Overall Study|Global Deterioration of Health Status|0|||
163934960|NCT00732992|592131408|FG000|Overall Study|Withdrawal by Subject|1|||
163934961|NCT00732992|592131409|FG001|Overall Study|Withdrawal by Subject|0|||
163934962|NCT04042077|592131412|FG000|Overall Study|Adverse Event|0|||
163934963|NCT04042077|592131413|FG001|Overall Study|Adverse Event|1|||
163934964|NCT04042077|592131412|FG000|Overall Study|Death|2|||
163934965|NCT04042077|592131413|FG001|Overall Study|Death|1|||
163934966|NCT04042077|592131412|FG000|Overall Study|Physician Decision|2|||
163934967|NCT04042077|592131413|FG001|Overall Study|Physician Decision|0|||
163934968|NCT04042077|592131412|FG000|Overall Study|Withdrawal by Subject|3|||
163934969|NCT04042077|592131413|FG001|Overall Study|Withdrawal by Subject|2|||
163934970|NCT04042077|592131412|FG000|Overall Study|Lack of Efficacy|0|||
163934971|NCT04042077|592131413|FG001|Overall Study|Lack of Efficacy|1|||
163934972|NCT01163474|592131417|FG000|Overall Study|Withdrawal by Subject|1|||
163934973|NCT01163474|592131417|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
163934974|NCT01163474|592131417|FG000|Overall Study|Lost to Follow-up|3|||
163934975|NCT02493946|592131418|FG000|DB Period|Withdrawal by Subject|8|||
163934976|NCT02493946|592131419|FG001|DB Period|Withdrawal by Subject|5|||
163934977|NCT02493946|592131420|FG002|DB Period|Withdrawal by Subject|0|||
163934978|NCT02493946|592131418|FG000|Open Label Period|Withdrawal by Subject|0|||
163934979|NCT02493946|592131419|FG001|Open Label Period|Withdrawal by Subject|0|||
164037870|NCT01468701|592496842|FG010|Overall Study|Other reasons than listed|433|||
164037871|NCT01468701|592496843|FG011|Overall Study|Other reasons than listed|504|||
164037872|NCT01468701|592496844|FG012|Overall Study|Other reasons than listed|28|||
164037873|NCT01468701|592496845|FG013|Overall Study|Other reasons than listed|239|||
164037874|NCT01468701|592496846|FG014|Overall Study|Other reasons than listed|39|||
164037875|NCT01468701|592496847|FG015|Overall Study|Other reasons than listed|172|||
164037876|NCT01468701|592496848|FG016|Overall Study|Other reasons than listed|0|||
164037877|NCT01468701|592496832|FG000|Overall Study|No end of study case report form|0|||
164037878|NCT01468701|592496833|FG001|Overall Study|No end of study case report form|0|||
164037879|NCT01468701|592496834|FG002|Overall Study|No end of study case report form|0|||
164037880|NCT01468701|592496835|FG003|Overall Study|No end of study case report form|0|||
164037881|NCT01468701|592496836|FG004|Overall Study|No end of study case report form|0|||
164037882|NCT01468701|592496837|FG005|Overall Study|No end of study case report form|0|||
164037883|NCT01468701|592496838|FG006|Overall Study|No end of study case report form|0|||
164037884|NCT01468701|592496839|FG007|Overall Study|No end of study case report form|0|||
164037885|NCT01468701|592496840|FG008|Overall Study|No end of study case report form|4|||
164037886|NCT01468701|592496841|FG009|Overall Study|No end of study case report form|1|||
164037887|NCT01468701|592496842|FG010|Overall Study|No end of study case report form|2|||
164037888|NCT01468701|592496843|FG011|Overall Study|No end of study case report form|3|||
164037889|NCT01468701|592496844|FG012|Overall Study|No end of study case report form|0|||
164037890|NCT01468701|592496845|FG013|Overall Study|No end of study case report form|1|||
164037891|NCT01468701|592496846|FG014|Overall Study|No end of study case report form|0|||
164037892|NCT01468701|592496847|FG015|Overall Study|No end of study case report form|0|||
164037893|NCT01468701|592496848|FG016|Overall Study|No end of study case report form|0|||
164037894|NCT01468701|592496832|FG000|Overall Study|Not being followed up|0|||
164037895|NCT01468701|592496833|FG001|Overall Study|Not being followed up|4963|||
164037896|NCT01468701|592496834|FG002|Overall Study|Not being followed up|1755|||
164037897|NCT01468701|592496835|FG003|Overall Study|Not being followed up|703|||
164098672|NCT01948258|592726845|FG000|Overall Study|Removed from statistical analysis|2|||
164098673|NCT00520130|592726854|FG000|Overall Study|Disease progression on study|4|||
164098674|NCT00520130|592726855|FG001|Overall Study|Disease progression on study|0|||
164098675|NCT00520130|592726854|FG000|Overall Study|Physician Decision|1|||
164098676|NCT00520130|592726855|FG001|Overall Study|Physician Decision|1|||
164098677|NCT01045096|592726856|FG000|Overall Study|Withdrawal by Subject|2|||
164098678|NCT01045096|592726857|FG001|Overall Study|Withdrawal by Subject|0|||
164098679|NCT01045096|592726858|FG002|Overall Study|Withdrawal by Subject|0|||
164098680|NCT01045096|592726856|FG000|Overall Study|Other|1|||
164098681|NCT01045096|592726857|FG001|Overall Study|Other|0|||
164098682|NCT01045096|592726858|FG002|Overall Study|Other|0|||
164098683|NCT01900691|592726859|FG000|Overall Study|Death|7|||
164098684|NCT01900691|592726859|FG000|Overall Study|Lost to Follow-up|4|||
164098685|NCT01900691|592726859|FG000|Overall Study|Study Device Not Placed|3|||
164098686|NCT01900691|592726859|FG000|Overall Study|Non study stent placed|2|||
164098687|NCT01900691|592726859|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
164098688|NCT01900691|592726859|FG000|Overall Study|Complete stent migration through digestive tract|1|||
164098689|NCT01954394|592726860|FG000|Overall Study|Enrolled but not treated|1|||
164098690|NCT01954394|592726861|FG001|Overall Study|Enrolled but not treated|0|||
164098691|NCT01954394|592726860|FG000|Overall Study|Adverse Event|10|||
164098692|NCT01954394|592726861|FG001|Overall Study|Adverse Event|23|||
164098693|NCT01954394|592726860|FG000|Overall Study|Poor compliance to protocol|7|||
164098694|NCT01954394|592726861|FG001|Overall Study|Poor compliance to protocol|7|||
164098695|NCT01954394|592726860|FG000|Overall Study|Participant Moved|0|||
164098696|NCT01954394|592726861|FG001|Overall Study|Participant Moved|4|||
164098697|NCT01954394|592726860|FG000|Overall Study|Related to Study Drug administration|2|||
164098698|NCT01954394|592726861|FG001|Overall Study|Related to Study Drug administration|2|||
164098699|NCT01954394|592726860|FG000|Overall Study|Other than specified above|10|||
164098700|NCT01954394|592726861|FG001|Overall Study|Other than specified above|21|||
164098701|NCT00909610|592726862|FG000|Period: First Intervention|Adverse Event|0|||
164098702|NCT00909610|592726863|FG001|Period: First Intervention|Adverse Event|1|||
164098703|NCT00909610|592726862|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
163839306|NCT04488003|591783553|FG001|Allocated to Treatment|Physician Decision|0|||
164037898|NCT01468701|592496836|FG004|Overall Study|Not being followed up|1714|||
164037899|NCT01468701|592496837|FG005|Overall Study|Not being followed up|126|||
164098704|NCT00909610|592726863|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
164098705|NCT00909610|592726862|FG000|Period: Second Intervention|Adverse Event|1|||
164098706|NCT00909610|592726863|FG001|Period: Second Intervention|Adverse Event|0|||
164098707|NCT02422264|592726867|FG000|Overall Study|Serious Adverse Event|1|||
164037900|NCT01468701|592496838|FG006|Overall Study|Not being followed up|1170|||
164098708|NCT02422264|592726868|FG001|Overall Study|Serious Adverse Event|0|||
164098709|NCT02422264|592726867|FG000|Overall Study|Withdrawal by Subject|1|||
164098710|NCT02422264|592726868|FG001|Overall Study|Withdrawal by Subject|2|||
164098711|NCT02422264|592726867|FG000|Overall Study|Migrated/moved from study area|3|||
163839307|NCT04488003|591783554|FG002|Allocated to Treatment|Physician Decision|0|||
164098712|NCT02422264|592726868|FG001|Overall Study|Migrated/moved from study area|1|||
164037901|NCT01468701|592496839|FG007|Overall Study|Not being followed up|4|||
164037902|NCT01468701|592496840|FG008|Overall Study|Not being followed up|0|||
164037903|NCT01468701|592496841|FG009|Overall Study|Not being followed up|0|||
164037904|NCT01468701|592496842|FG010|Overall Study|Not being followed up|0|||
164037905|NCT01468701|592496843|FG011|Overall Study|Not being followed up|0|||
164037906|NCT01468701|592496844|FG012|Overall Study|Not being followed up|0|||
164037907|NCT01468701|592496845|FG013|Overall Study|Not being followed up|0|||
164037908|NCT01468701|592496846|FG014|Overall Study|Not being followed up|0|||
164037909|NCT01468701|592496847|FG015|Overall Study|Not being followed up|0|||
164037910|NCT01468701|592496848|FG016|Overall Study|Not being followed up|0|||
164037911|NCT01079195|592496856|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
164037912|NCT01079195|592496856|FG000|Overall Study|No Documentation Available|437|||
164037913|NCT01079195|592496856|FG000|Overall Study|Adverse Event|157|||
164037914|NCT01079195|592496856|FG000|Overall Study|Reason Unknown|39|||
164037915|NCT01079195|592496856|FG000|Overall Study|Withdrawal by Subject|18|||
164037916|NCT01079195|592496856|FG000|Overall Study|Financial Reasons|15|||
164037917|NCT01079195|592496856|FG000|Overall Study|Lack of Effectiveness|12|||
164037918|NCT01079195|592496856|FG000|Overall Study|Physician Decision|4|||
164037919|NCT01079195|592496856|FG000|Overall Study|Improved Status of Participant|4|||
164037920|NCT01079195|592496856|FG000|Overall Study|No Follow-up Documentation Available|4|||
164037921|NCT01079195|592496856|FG000|Overall Study|Non-compliance|2|||
164037922|NCT03170258|592498260|FG000|Overall Study|Physician Decision|4|||
164037923|NCT03170258|592498261|FG001|Overall Study|Physician Decision|0|||
164037924|NCT03170258|592498260|FG000|Overall Study|Equipment issues|1|||
164037925|NCT03170258|592498261|FG001|Overall Study|Equipment issues|0|||
164037926|NCT03170258|592498260|FG000|Overall Study|Medication|1|||
164037927|NCT03170258|592498261|FG001|Overall Study|Medication|0|||
164037928|NCT03170258|592498260|FG000|Overall Study|Sleep issues|1|||
164037929|NCT03170258|592498261|FG001|Overall Study|Sleep issues|0|||
164037930|NCT00666536|592498262|FG000|Overall Study|Adverse Event|9|||
164037931|NCT00666536|592498263|FG001|Overall Study|Adverse Event|19|||
164037932|NCT00666536|592498262|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164037933|NCT00666536|592498263|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164037934|NCT00666536|592498262|FG000|Overall Study|Protocol deviation(s)|8|||
164037935|NCT00666536|592498263|FG001|Overall Study|Protocol deviation(s)|6|||
164037936|NCT00666536|592498262|FG000|Overall Study|Withdrawal by Subject|10|||
164037937|NCT00666536|592498263|FG001|Overall Study|Withdrawal by Subject|9|||
164037938|NCT00666536|592498262|FG000|Overall Study|Lost to Follow-up|4|||
164037939|NCT00666536|592498263|FG001|Overall Study|Lost to Follow-up|3|||
164037940|NCT02853123|592498267|FG000|Treatment Period 1|Adverse Event|0|||
164037941|NCT02853123|592498268|FG001|Treatment Period 1|Adverse Event|3|||
164037942|NCT02853123|592498267|FG000|Washout Period|Worsening of COPD|0|||
164037943|NCT02853123|592498268|FG001|Washout Period|Worsening of COPD|3|||
163934980|NCT02493946|592131420|FG002|Open Label Period|Withdrawal by Subject|74|||
163934981|NCT02493946|592131418|FG000|Open Label Period|Adverse Event|0|||
163934982|NCT02493946|592131419|FG001|Open Label Period|Adverse Event|0|||
163934983|NCT02493946|592131420|FG002|Open Label Period|Adverse Event|4|||
163934984|NCT02493946|592131418|FG000|Open Label Period|Lost to Follow-up|0|||
163934985|NCT02493946|592131419|FG001|Open Label Period|Lost to Follow-up|0|||
163934986|NCT02493946|592131420|FG002|Open Label Period|Lost to Follow-up|1|||
163934987|NCT02493946|592131418|FG000|Open Label Period|Investigator decision, non-compliance|0|||
163934988|NCT02493946|592131419|FG001|Open Label Period|Investigator decision, non-compliance|0|||
163934989|NCT02493946|592131420|FG002|Open Label Period|Investigator decision, non-compliance|2|||
163934990|NCT02493946|592131418|FG000|Open Label Period|Investigator decision, non-availability|0|||
163934991|NCT02493946|592131419|FG001|Open Label Period|Investigator decision, non-availability|0|||
163934992|NCT02493946|592131420|FG002|Open Label Period|Investigator decision, non-availability|1|||
163934993|NCT02493946|592131418|FG000|Open Label Period|Pregnancy|0|||
163934994|NCT02493946|592131419|FG001|Open Label Period|Pregnancy|0|||
163934995|NCT02493946|592131420|FG002|Open Label Period|Pregnancy|3|||
163934996|NCT02493946|592131418|FG000|Open Label Period|Site error|0|||
163934997|NCT02493946|592131419|FG001|Open Label Period|Site error|0|||
164037944|NCT02853123|592498267|FG000|Washout Period|Adverse Event|1|||
164037945|NCT02853123|592498268|FG001|Washout Period|Adverse Event|0|||
164037946|NCT04839393|592498281|FG000|Overall Study|Adverse Event|0|||
164037947|NCT04839393|592498282|FG001|Overall Study|Adverse Event|0|||
164037948|NCT04839393|592498283|FG002|Overall Study|Adverse Event|2|||
164037949|NCT04839393|592498281|FG000|Overall Study|Withdrawal by participant|0|||
164037950|NCT04839393|592498282|FG001|Overall Study|Withdrawal by participant|0|||
164037951|NCT04839393|592498283|FG002|Overall Study|Withdrawal by participant|1|||
164037952|NCT01510028|592498286|FG000|Overall Study|Lack of Efficacy|1|||
163934998|NCT02493946|592131420|FG002|Open Label Period|Site error|1|||
163934999|NCT00965497|592131422|FG000|Overall Study|Physician Decision|1|||
164037953|NCT01510028|592498287|FG001|Overall Study|Lack of Efficacy|0|||
164037954|NCT01510028|592498288|FG002|Overall Study|Lack of Efficacy|0|||
164037955|NCT01510028|592498289|FG003|Overall Study|Lack of Efficacy|0|||
164037956|NCT00633893|592498290|FG000|Overall Study|Death|1|||
164037957|NCT00633893|592498291|FG001|Overall Study|Death|3|||
163839308|NCT04488003|591783552|FG000|Allocated to Treatment|Death|4|||
163839309|NCT04488003|591783553|FG001|Allocated to Treatment|Death|0|||
163839310|NCT04488003|591783554|FG002|Allocated to Treatment|Death|0|||
163839311|NCT01468922|591783560|FG000|Overall Study|Screening failure|0|||
163839312|NCT01468922|591783561|FG001|Overall Study|Screening failure|0|||
163839313|NCT01468922|591783562|FG002|Overall Study|Screening failure|0|||
163839314|NCT01468922|591783563|FG003|Overall Study|Screening failure|0|||
163839315|NCT01468922|591783564|FG004|Overall Study|Screening failure|0|||
163839316|NCT01468922|591783565|FG005|Overall Study|Screening failure|0|||
163839317|NCT01468922|591783566|FG006|Overall Study|Screening failure|0|||
163839318|NCT01468922|591783567|FG007|Overall Study|Screening failure|0|||
163839319|NCT01468922|591783568|FG008|Overall Study|Screening failure|1|||
163839320|NCT01468922|591783560|FG000|Overall Study|Per patient choice|1|||
163839321|NCT01468922|591783561|FG001|Overall Study|Per patient choice|0|||
163839322|NCT01468922|591783562|FG002|Overall Study|Per patient choice|0|||
163839323|NCT01468922|591783563|FG003|Overall Study|Per patient choice|0|||
163839324|NCT01468922|591783564|FG004|Overall Study|Per patient choice|0|||
163839325|NCT01468922|591783565|FG005|Overall Study|Per patient choice|0|||
163839326|NCT01468922|591783566|FG006|Overall Study|Per patient choice|0|||
163839327|NCT01468922|591783567|FG007|Overall Study|Per patient choice|0|||
163839328|NCT01468922|591783568|FG008|Overall Study|Per patient choice|0|||
163839329|NCT01468922|591783560|FG000|Overall Study|Switched to alternative treatment|1|||
163839330|NCT01468922|591783561|FG001|Overall Study|Switched to alternative treatment|0|||
163839331|NCT01468922|591783562|FG002|Overall Study|Switched to alternative treatment|0|||
163839332|NCT01468922|591783563|FG003|Overall Study|Switched to alternative treatment|0|||
163839333|NCT01468922|591783564|FG004|Overall Study|Switched to alternative treatment|1|||
163839334|NCT01468922|591783565|FG005|Overall Study|Switched to alternative treatment|0|||
163839335|NCT01468922|591783566|FG006|Overall Study|Switched to alternative treatment|0|||
163839336|NCT01468922|591783567|FG007|Overall Study|Switched to alternative treatment|0|||
163839337|NCT01468922|591783568|FG008|Overall Study|Switched to alternative treatment|0|||
163839338|NCT01468922|591783560|FG000|Overall Study|Enrolled on new protocol|0|||
163839339|NCT01468922|591783561|FG001|Overall Study|Enrolled on new protocol|0|||
163839340|NCT01468922|591783562|FG002|Overall Study|Enrolled on new protocol|0|||
163839341|NCT01468922|591783563|FG003|Overall Study|Enrolled on new protocol|0|||
163839342|NCT01468922|591783564|FG004|Overall Study|Enrolled on new protocol|1|||
163839343|NCT01468922|591783565|FG005|Overall Study|Enrolled on new protocol|0|||
163839344|NCT01468922|591783566|FG006|Overall Study|Enrolled on new protocol|0|||
163839345|NCT01468922|591783567|FG007|Overall Study|Enrolled on new protocol|0|||
163839346|NCT01468922|591783568|FG008|Overall Study|Enrolled on new protocol|0|||
163839347|NCT01468922|591783560|FG000|Overall Study|Adverse Event|0|||
163839348|NCT01468922|591783561|FG001|Overall Study|Adverse Event|0|||
163839349|NCT01468922|591783562|FG002|Overall Study|Adverse Event|0|||
163839350|NCT01468922|591783563|FG003|Overall Study|Adverse Event|0|||
163839351|NCT01468922|591783564|FG004|Overall Study|Adverse Event|0|||
163839352|NCT01468922|591783565|FG005|Overall Study|Adverse Event|0|||
163839353|NCT01468922|591783566|FG006|Overall Study|Adverse Event|0|||
163839354|NCT01468922|591783567|FG007|Overall Study|Adverse Event|1|||
163839355|NCT01468922|591783568|FG008|Overall Study|Adverse Event|0|||
163839356|NCT01468922|591783560|FG000|Overall Study|Infection of blood|0|||
163839357|NCT01468922|591783561|FG001|Overall Study|Infection of blood|0|||
163839358|NCT01468922|591783562|FG002|Overall Study|Infection of blood|0|||
163839359|NCT01468922|591783563|FG003|Overall Study|Infection of blood|0|||
163839360|NCT01468922|591783564|FG004|Overall Study|Infection of blood|0|||
163839361|NCT01468922|591783565|FG005|Overall Study|Infection of blood|0|||
163839362|NCT01468922|591783566|FG006|Overall Study|Infection of blood|0|||
163839363|NCT01468922|591783567|FG007|Overall Study|Infection of blood|1|||
163839364|NCT01468922|591783568|FG008|Overall Study|Infection of blood|0|||
163839365|NCT01468922|591783560|FG000|Overall Study|Patient choice - surgery|0|||
163839366|NCT01468922|591783561|FG001|Overall Study|Patient choice - surgery|0|||
163839367|NCT01468922|591783562|FG002|Overall Study|Patient choice - surgery|0|||
163839368|NCT01468922|591783563|FG003|Overall Study|Patient choice - surgery|0|||
163839369|NCT01468922|591783564|FG004|Overall Study|Patient choice - surgery|0|||
163839370|NCT01468922|591783565|FG005|Overall Study|Patient choice - surgery|0|||
163839371|NCT01468922|591783566|FG006|Overall Study|Patient choice - surgery|0|||
163839372|NCT01468922|591783567|FG007|Overall Study|Patient choice - surgery|1|||
163839373|NCT01468922|591783568|FG008|Overall Study|Patient choice - surgery|0|||
163839374|NCT01468922|591783560|FG000|Overall Study|Refused further treatment|0|||
163839375|NCT01468922|591783561|FG001|Overall Study|Refused further treatment|0|||
163839376|NCT01468922|591783562|FG002|Overall Study|Refused further treatment|0|||
163839377|NCT01468922|591783563|FG003|Overall Study|Refused further treatment|0|||
163839378|NCT01468922|591783564|FG004|Overall Study|Refused further treatment|0|||
163839379|NCT01468922|591783565|FG005|Overall Study|Refused further treatment|0|||
163839380|NCT01468922|591783566|FG006|Overall Study|Refused further treatment|0|||
163839381|NCT01468922|591783567|FG007|Overall Study|Refused further treatment|1|||
163839382|NCT01468922|591783568|FG008|Overall Study|Refused further treatment|0|||
164098713|NCT02422264|592726867|FG000|Overall Study|Subject vaccinated outside of the study|0|||
163935000|NCT00794924|592131423|FG000|Overall Study|Lost to Follow-up|6|||
163935001|NCT00794924|592131424|FG001|Overall Study|Lost to Follow-up|8|||
163935002|NCT00794924|592131423|FG000|Overall Study|Withdrawal by Subject|48|||
163935003|NCT00794924|592131424|FG001|Overall Study|Withdrawal by Subject|60|||
163935004|NCT00794924|592131423|FG000|Overall Study|Adverse Event|6|||
163935005|NCT00794924|592131424|FG001|Overall Study|Adverse Event|2|||
163935006|NCT01294436|592131429|FG000|Overall Study|Adverse Event|10|||
163935007|NCT01294436|592131430|FG001|Overall Study|Adverse Event|17|||
163935008|NCT01294436|592131429|FG000|Overall Study|Withdrawal by Subject|11|||
163935009|NCT01294436|592131430|FG001|Overall Study|Withdrawal by Subject|28|||
163935010|NCT01294436|592131429|FG000|Overall Study|subject no longer meets study criteria|5|||
163935011|NCT01294436|592131430|FG001|Overall Study|subject no longer meets study criteria|20|||
163935012|NCT01294436|592131429|FG000|Overall Study|poor/non-compliance|2|||
163935013|NCT01294436|592131430|FG001|Overall Study|poor/non-compliance|5|||
163935014|NCT02389764|592131431|FG000|Overall Study|Lack of Efficacy|9|||
163935015|NCT00585078|592131434|FG000|Overall Study|Withdrawal by Subject|4|||
163935016|NCT00585078|592131434|FG000|Overall Study|Poor performance status|1|||
163935017|NCT00585078|592131434|FG000|Overall Study|Disease Progression|24|||
163935018|NCT00585078|592131434|FG000|Overall Study|Adverse Event|10|||
163935019|NCT00585078|592131434|FG000|Overall Study|Death|1|||
163935020|NCT01814072|592131437|FG000|Overall Study|Lost to Follow-up|2|||
163935021|NCT01814072|592131438|FG001|Overall Study|Lost to Follow-up|2|||
163935022|NCT01814072|592131439|FG002|Overall Study|Lost to Follow-up|2|||
163935023|NCT01814072|592131440|FG003|Overall Study|Lost to Follow-up|0|||
163935024|NCT01814072|592131441|FG004|Overall Study|Lost to Follow-up|2|||
163935025|NCT01814072|592131442|FG005|Overall Study|Lost to Follow-up|3|||
163935026|NCT01814072|592131443|FG006|Overall Study|Lost to Follow-up|3|||
163935027|NCT01814072|592131444|FG007|Overall Study|Lost to Follow-up|1|||
163935028|NCT01814072|592131445|FG008|Overall Study|Lost to Follow-up|2|||
163935029|NCT01814072|592131446|FG009|Overall Study|Lost to Follow-up|3|||
163935030|NCT01814072|592131447|FG010|Overall Study|Lost to Follow-up|1|||
163935031|NCT01814072|592131448|FG011|Overall Study|Lost to Follow-up|2|||
163935032|NCT01814072|592131449|FG012|Overall Study|Lost to Follow-up|2|||
163935033|NCT01814072|592131450|FG013|Overall Study|Lost to Follow-up|1|||
163935034|NCT01814072|592131451|FG014|Overall Study|Lost to Follow-up|2|||
163935035|NCT01814072|592131452|FG015|Overall Study|Lost to Follow-up|1|||
163935036|NCT01814072|592131453|FG016|Overall Study|Lost to Follow-up|3|||
163935037|NCT01814072|592131454|FG017|Overall Study|Lost to Follow-up|1|||
163935038|NCT01814072|592131455|FG018|Overall Study|Lost to Follow-up|3|||
163935039|NCT01814072|592131456|FG019|Overall Study|Lost to Follow-up|3|||
163935040|NCT01814072|592131457|FG020|Overall Study|Lost to Follow-up|2|||
163935041|NCT01814072|592131458|FG021|Overall Study|Lost to Follow-up|1|||
163935042|NCT01814072|592131459|FG022|Overall Study|Lost to Follow-up|3|||
163935043|NCT01814072|592131460|FG023|Overall Study|Lost to Follow-up|1|||
163935044|NCT01814072|592131461|FG024|Overall Study|Lost to Follow-up|4|||
163935045|NCT01814072|592131462|FG025|Overall Study|Lost to Follow-up|1|||
163935046|NCT01814072|592131463|FG026|Overall Study|Lost to Follow-up|1|||
163935047|NCT01814072|592131464|FG027|Overall Study|Lost to Follow-up|2|||
163935048|NCT01814072|592131465|FG028|Overall Study|Lost to Follow-up|3|||
163935049|NCT01814072|592131466|FG029|Overall Study|Lost to Follow-up|3|||
163935050|NCT01814072|592131467|FG030|Overall Study|Lost to Follow-up|2|||
163935051|NCT01814072|592131468|FG031|Overall Study|Lost to Follow-up|0|||
163935052|NCT01814072|592131437|FG000|Overall Study|Withdrawal by Subject|2|||
163935053|NCT01814072|592131438|FG001|Overall Study|Withdrawal by Subject|0|||
163935054|NCT01814072|592131439|FG002|Overall Study|Withdrawal by Subject|1|||
163935055|NCT01814072|592131440|FG003|Overall Study|Withdrawal by Subject|0|||
163935056|NCT01814072|592131441|FG004|Overall Study|Withdrawal by Subject|2|||
163935057|NCT01814072|592131442|FG005|Overall Study|Withdrawal by Subject|3|||
163935058|NCT01814072|592131443|FG006|Overall Study|Withdrawal by Subject|1|||
163935059|NCT01814072|592131444|FG007|Overall Study|Withdrawal by Subject|0|||
163935060|NCT01814072|592131445|FG008|Overall Study|Withdrawal by Subject|1|||
163935061|NCT01814072|592131446|FG009|Overall Study|Withdrawal by Subject|2|||
163935062|NCT01814072|592131447|FG010|Overall Study|Withdrawal by Subject|0|||
163935063|NCT01814072|592131448|FG011|Overall Study|Withdrawal by Subject|0|||
163935064|NCT01814072|592131449|FG012|Overall Study|Withdrawal by Subject|1|||
163935065|NCT01814072|592131450|FG013|Overall Study|Withdrawal by Subject|1|||
163935066|NCT01814072|592131451|FG014|Overall Study|Withdrawal by Subject|1|||
163935067|NCT01814072|592131452|FG015|Overall Study|Withdrawal by Subject|1|||
163935068|NCT01814072|592131453|FG016|Overall Study|Withdrawal by Subject|0|||
163935069|NCT01814072|592131454|FG017|Overall Study|Withdrawal by Subject|0|||
163935070|NCT01814072|592131455|FG018|Overall Study|Withdrawal by Subject|0|||
163935071|NCT01814072|592131456|FG019|Overall Study|Withdrawal by Subject|2|||
163935072|NCT01814072|592131457|FG020|Overall Study|Withdrawal by Subject|0|||
163935073|NCT01814072|592131458|FG021|Overall Study|Withdrawal by Subject|0|||
163935074|NCT01814072|592131459|FG022|Overall Study|Withdrawal by Subject|1|||
163935075|NCT01814072|592131460|FG023|Overall Study|Withdrawal by Subject|0|||
163935076|NCT01814072|592131461|FG024|Overall Study|Withdrawal by Subject|2|||
164037958|NCT00633893|592498292|FG002|Overall Study|Death|9|||
164037959|NCT00633893|592498290|FG000|Overall Study|Adverse Event|65|||
164037960|NCT00633893|592498291|FG001|Overall Study|Adverse Event|58|||
164037961|NCT00633893|592498292|FG002|Overall Study|Adverse Event|126|||
164037962|NCT00633893|592498290|FG000|Overall Study|Withdrawal by Subject|7|||
164037963|NCT00633893|592498291|FG001|Overall Study|Withdrawal by Subject|12|||
164037964|NCT00633893|592498292|FG002|Overall Study|Withdrawal by Subject|6|||
164037965|NCT00633893|592498290|FG000|Overall Study|Lost to Follow-up|2|||
164037966|NCT00633893|592498291|FG001|Overall Study|Lost to Follow-up|4|||
164037967|NCT00633893|592498292|FG002|Overall Study|Lost to Follow-up|8|||
164037968|NCT00633893|592498290|FG000|Overall Study|Poor/non-compliance|5|||
164037969|NCT00633893|592498291|FG001|Overall Study|Poor/non-compliance|12|||
164037970|NCT00633893|592498292|FG002|Overall Study|Poor/non-compliance|3|||
164037971|NCT00633893|592498290|FG000|Overall Study|Pregnancy|2|||
164037972|NCT00633893|592498291|FG001|Overall Study|Pregnancy|1|||
164037973|NCT00633893|592498292|FG002|Overall Study|Pregnancy|1|||
164037974|NCT00633893|592498290|FG000|Overall Study|Not meet/no longer meets criteria|4|||
164037975|NCT00633893|592498291|FG001|Overall Study|Not meet/no longer meets criteria|6|||
164037976|NCT00633893|592498292|FG002|Overall Study|Not meet/no longer meets criteria|4|||
164037977|NCT00633893|592498290|FG000|Overall Study|Other|28|||
164037978|NCT00633893|592498291|FG001|Overall Study|Other|33|||
164037979|NCT00633893|592498292|FG002|Overall Study|Other|31|||
164037980|NCT02741310|592498293|FG000|Overall Study|Sponsor Decision|2|||
164037981|NCT02741310|592498294|FG001|Overall Study|Sponsor Decision|2|||
164037982|NCT05091918|592498295|FG000|Overall Study|Adverse Event|1|||
164037983|NCT05091918|592498295|FG000|Overall Study|Withdrawal by Subject|81|||
164037984|NCT01784211|592498297|FG000|Part A (Days 1-15)|Adverse Event|1|||
164037985|NCT01784211|592498298|FG001|Part A (Days 1-15)|Adverse Event|1|||
164037986|NCT01784211|592498299|FG002|Part A (Days 1-15)|Adverse Event|0|||
164037987|NCT01784211|592498300|FG003|Part A (Days 1-15)|Adverse Event|0|||
164037988|NCT01784211|592498301|FG004|Part A (Days 1-15)|Adverse Event|0|||
164037989|NCT01784211|592498302|FG005|Part A (Days 1-15)|Adverse Event|0|||
164037990|NCT01784211|592498297|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
164037991|NCT01784211|592498298|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
164037992|NCT01784211|592498299|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
164037993|NCT01784211|592498300|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
164037994|NCT01784211|592498301|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
164037995|NCT01784211|592498302|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
164037996|NCT01017549|592498305|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
164037997|NCT01017549|592498305|FG000|One-year Follow-up|Lost to Follow-up|2|||
164037998|NCT01017549|592498305|FG000|One-year Follow-up|Withdrawal by Subject|5|||
164037999|NCT01017549|592498305|FG000|5 Year Follow-up|Lost to Follow-up|9|||
164038000|NCT01017549|592498305|FG000|5 Year Follow-up|Mastectomy|3|||
164038001|NCT02143141|592498315|FG000|Overall Study|pain scores at 24 hours not collected|1|||
164038002|NCT02143141|592498316|FG001|Overall Study|pain scores at 24 hours not collected|0|||
164038003|NCT03673956|592498317|FG000|Overall Study|Lost to Follow-up|1|||
164038004|NCT03673956|592498318|FG001|Overall Study|Lost to Follow-up|0|||
164038005|NCT03673956|592498319|FG002|Overall Study|Lost to Follow-up|0|||
164038006|NCT03673956|592498320|FG003|Overall Study|Lost to Follow-up|0|||
164038007|NCT03673956|592498317|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
164038008|NCT03673956|592498318|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
164038009|NCT03673956|592498319|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
164038010|NCT03673956|592498320|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
164038011|NCT01057862|592498321|FG000|Overall Study|Withdrawal by Subject|1|||
164038012|NCT01057862|592498322|FG001|Overall Study|Withdrawal by Subject|2|||
164038013|NCT02255760|592498323|FG000|Overall Study|Lost to Follow-up|0|||
164038014|NCT02255760|592498324|FG001|Overall Study|Lost to Follow-up|1|||
164038015|NCT02255760|592498325|FG002|Overall Study|Lost to Follow-up|0|||
164038016|NCT02255760|592498326|FG003|Overall Study|Lost to Follow-up|0|||
164038017|NCT02255760|592498327|FG004|Overall Study|Lost to Follow-up|0|||
164038018|NCT00003838|592498328|FG000|Overall Study|Death|0|||
164038019|NCT00003838|592498329|FG001|Overall Study|Death|12|||
164038020|NCT00003838|592498330|FG002|Overall Study|Death|7|||
164038021|NCT00003838|592498328|FG000|Overall Study|Lost to Follow-up|0|||
164038022|NCT00003838|592498329|FG001|Overall Study|Lost to Follow-up|1|||
164038023|NCT00003838|592498330|FG002|Overall Study|Lost to Follow-up|1|||
164038024|NCT00003838|592498328|FG000|Overall Study|Disease Progression|0|||
164038025|NCT00003838|592498329|FG001|Overall Study|Disease Progression|12|||
164038026|NCT00003838|592498330|FG002|Overall Study|Disease Progression|0|||
164038027|NCT00618813|592498331|FG000|Overall Study|Lack of Efficacy|1|||
164038028|NCT00618813|592498331|FG000|Overall Study|Physician Decision|2|||
164038029|NCT00618813|592498331|FG000|Overall Study|Withdrawal by Subject|1|||
164038030|NCT01855945|592498332|FG000|Overall Study|Adverse Event|0|||
164038031|NCT01855945|592498333|FG001|Overall Study|Adverse Event|0|||
164038032|NCT01855945|592498334|FG002|Overall Study|Adverse Event|0|||
164038033|NCT01855945|592498335|FG003|Overall Study|Adverse Event|0|||
164038034|NCT01855945|592498336|FG004|Overall Study|Adverse Event|0|||
164038035|NCT01855945|592498337|FG005|Overall Study|Adverse Event|0|||
164038036|NCT01855945|592498338|FG006|Overall Study|Adverse Event|1|||
164038037|NCT01855945|592498339|FG007|Overall Study|Adverse Event|0|||
164038038|NCT01855945|592498340|FG008|Overall Study|Adverse Event|0|||
164038039|NCT01855945|592498341|FG009|Overall Study|Adverse Event|0|||
164038040|NCT01855945|592498342|FG010|Overall Study|Adverse Event|0|||
164038041|NCT01855945|592498343|FG011|Overall Study|Adverse Event|0|||
164038042|NCT01855945|592498332|FG000|Overall Study|Death|0|||
164038043|NCT01855945|592498333|FG001|Overall Study|Death|0|||
164038044|NCT01855945|592498334|FG002|Overall Study|Death|0|||
164038045|NCT01855945|592498335|FG003|Overall Study|Death|0|||
164038046|NCT01855945|592498336|FG004|Overall Study|Death|0|||
164038047|NCT01855945|592498337|FG005|Overall Study|Death|0|||
164098714|NCT02422264|592726868|FG001|Overall Study|Subject vaccinated outside of the study|1|||
164098715|NCT03021018|592726869|FG000|Overall Study|Adverse Event|1|||
163935077|NCT01814072|592131462|FG025|Overall Study|Withdrawal by Subject|1|||
163935078|NCT01814072|592131463|FG026|Overall Study|Withdrawal by Subject|1|||
163935079|NCT01814072|592131464|FG027|Overall Study|Withdrawal by Subject|2|||
163935080|NCT01814072|592131465|FG028|Overall Study|Withdrawal by Subject|1|||
163935081|NCT01814072|592131466|FG029|Overall Study|Withdrawal by Subject|0|||
163935082|NCT01814072|592131467|FG030|Overall Study|Withdrawal by Subject|0|||
163935083|NCT01814072|592131468|FG031|Overall Study|Withdrawal by Subject|0|||
163935084|NCT00383123|592131469|FG000|Overall Study|Adverse Event|1|||
163935085|NCT00383123|592131470|FG001|Overall Study|Adverse Event|0|||
163935086|NCT00383123|592131469|FG000|Overall Study|Lost to Follow-up|68|||
163935087|NCT00383123|592131470|FG001|Overall Study|Lost to Follow-up|61|||
163935088|NCT00383123|592131469|FG000|Overall Study|Protocol Violation|5|||
163935089|NCT00383123|592131470|FG001|Overall Study|Protocol Violation|1|||
163935090|NCT00383123|592131469|FG000|Overall Study|Withdrawal by Subject|27|||
163935091|NCT00383123|592131470|FG001|Overall Study|Withdrawal by Subject|18|||
163935092|NCT00383123|592131469|FG000|Overall Study|Other reason|10|||
163935093|NCT00383123|592131470|FG001|Overall Study|Other reason|6|||
163935094|NCT02781311|592131471|FG000|Overall Study|Adverse Event|2|||
163935095|NCT02781311|592131472|FG001|Overall Study|Adverse Event|6|||
163935096|NCT02781311|592131473|FG002|Overall Study|Adverse Event|1|||
163935097|NCT02781311|592131471|FG000|Overall Study|Withdrawal of Consent|11|||
163935098|NCT02781311|592131472|FG001|Overall Study|Withdrawal of Consent|12|||
163935099|NCT02781311|592131473|FG002|Overall Study|Withdrawal of Consent|2|||
163935100|NCT02781311|592131471|FG000|Overall Study|Lost to Follow-up|11|||
163935101|NCT02781311|592131472|FG001|Overall Study|Lost to Follow-up|8|||
163935102|NCT02781311|592131473|FG002|Overall Study|Lost to Follow-up|1|||
163935103|NCT02781311|592131471|FG000|Overall Study|Non-Compliance with Study Drug|2|||
163935104|NCT02781311|592131472|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163935105|NCT02781311|592131473|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163935106|NCT00250432|592131480|FG000|Overall Study|Adverse Event|25|||
163935107|NCT00250432|592131481|FG001|Overall Study|Adverse Event|29|||
163935108|NCT00250432|592131480|FG000|Overall Study|Lack of Efficacy|2|||
163935109|NCT00250432|592131481|FG001|Overall Study|Lack of Efficacy|1|||
163935110|NCT00250432|592131480|FG000|Overall Study|Lost to Follow-up|6|||
163935111|NCT00250432|592131481|FG001|Overall Study|Lost to Follow-up|5|||
163935112|NCT00250432|592131480|FG000|Overall Study|Patient Moved|0|||
163935113|NCT00250432|592131481|FG001|Overall Study|Patient Moved|1|||
163935114|NCT00250432|592131480|FG000|Overall Study|Protocol Violation|0|||
163935115|NCT00250432|592131481|FG001|Overall Study|Protocol Violation|3|||
163935116|NCT00250432|592131480|FG000|Overall Study|Withdrawal by Subject|6|||
163935117|NCT00250432|592131481|FG001|Overall Study|Withdrawal by Subject|2|||
163935118|NCT00250432|592131480|FG000|Overall Study|Pt died out of posttherapy report period|6|||
163935119|NCT00250432|592131481|FG001|Overall Study|Pt died out of posttherapy report period|5|||
163935120|NCT00250432|592131480|FG000|Overall Study|Pt was considered untreatable|0|||
163935121|NCT00250432|592131481|FG001|Overall Study|Pt was considered untreatable|1|||
163935122|NCT01011868|592131482|FG000|After Week 18 Follow-up|Adverse Event|8|||
163935123|NCT01011868|592131483|FG001|After Week 18 Follow-up|Adverse Event|6|||
163935124|NCT01011868|592131484|FG002|After Week 18 Follow-up|Adverse Event|13|||
163935125|NCT01011868|592131482|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
163935126|NCT01011868|592131483|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
163935127|NCT01011868|592131484|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
163935128|NCT01011868|592131482|FG000|After Week 18 Follow-up|Protocol Violation|1|||
163935129|NCT01011868|592131483|FG001|After Week 18 Follow-up|Protocol Violation|1|||
163935130|NCT01011868|592131484|FG002|After Week 18 Follow-up|Protocol Violation|1|||
163935131|NCT01011868|592131482|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
163935132|NCT01011868|592131483|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
163935133|NCT01011868|592131484|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
163935134|NCT01011868|592131482|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
163935135|NCT01011868|592131483|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
163935136|NCT01011868|592131484|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
164038048|NCT01855945|592498338|FG006|Overall Study|Death|2|||
164038049|NCT01855945|592498339|FG007|Overall Study|Death|0|||
164038050|NCT01855945|592498340|FG008|Overall Study|Death|0|||
164038051|NCT01855945|592498341|FG009|Overall Study|Death|0|||
163935137|NCT01011868|592131482|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
163935138|NCT01011868|592131483|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
163935139|NCT01011868|592131484|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
163935140|NCT01011868|592131482|FG000|After Week 78 Follow-up|Adverse Event|14|||
163935141|NCT01011868|592131483|FG001|After Week 78 Follow-up|Adverse Event|18|||
163935142|NCT01011868|592131484|FG002|After Week 78 Follow-up|Adverse Event|21|||
163935143|NCT01011868|592131482|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
163935144|NCT01011868|592131483|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
163935145|NCT01011868|592131484|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
163935146|NCT01011868|592131482|FG000|After Week 78 Follow-up|Protocol Violation|9|||
163935147|NCT01011868|592131483|FG001|After Week 78 Follow-up|Protocol Violation|1|||
163935148|NCT01011868|592131484|FG002|After Week 78 Follow-up|Protocol Violation|2|||
163935149|NCT01011868|592131482|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
163935150|NCT01011868|592131483|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
163935151|NCT01011868|592131484|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
163935152|NCT01011868|592131482|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
163935153|NCT01011868|592131483|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
163935154|NCT01011868|592131484|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
163935155|NCT01011868|592131482|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
163935156|NCT01011868|592131483|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
163935157|NCT01011868|592131484|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
163935158|NCT04147858|592131485|FG000|Overall Study|Adverse Event|6|||
163935159|NCT04147858|592131486|FG001|Overall Study|Adverse Event|6|||
163935160|NCT04147858|592131487|FG002|Overall Study|Adverse Event|6|||
163935161|NCT04147858|592131485|FG000|Overall Study|Lack of Efficacy|3|||
163935162|NCT04147858|592131486|FG001|Overall Study|Lack of Efficacy|3|||
163935163|NCT04147858|592131487|FG002|Overall Study|Lack of Efficacy|1|||
163935164|NCT04147858|592131485|FG000|Overall Study|Lost to Follow-up|1|||
163935165|NCT04147858|592131486|FG001|Overall Study|Lost to Follow-up|6|||
163935166|NCT04147858|592131487|FG002|Overall Study|Lost to Follow-up|2|||
163935167|NCT04147858|592131485|FG000|Overall Study|Withdrawal by Subject|3|||
163935168|NCT04147858|592131486|FG001|Overall Study|Withdrawal by Subject|4|||
163935169|NCT04147858|592131487|FG002|Overall Study|Withdrawal by Subject|10|||
163935170|NCT04147858|592131485|FG000|Overall Study|Subject Noncompliance, Other|4|||
163935171|NCT04147858|592131486|FG001|Overall Study|Subject Noncompliance, Other|3|||
163935172|NCT04147858|592131487|FG002|Overall Study|Subject Noncompliance, Other|1|||
163935173|NCT02615938|592131488|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
163935174|NCT02615938|592131489|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
163935175|NCT02615938|592131490|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163935176|NCT02615938|592131491|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163935177|NCT02615938|592131488|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
163935178|NCT02615938|592131489|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
163935179|NCT02615938|592131490|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
163935180|NCT02615938|592131491|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
163935181|NCT02615938|592131488|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163935182|NCT02615938|592131489|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163935183|NCT02615938|592131490|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
163935184|NCT02615938|592131491|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
163935185|NCT04905849|592131493|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
163935186|NCT04905849|592131494|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
163935187|NCT00838929|592131500|FG000|Overall Study|Protocol Violation|0|||
163935188|NCT00838929|592131501|FG001|Overall Study|Protocol Violation|1|||
163935189|NCT00838929|592131502|FG002|Overall Study|Protocol Violation|0|||
163935190|NCT00838929|592131500|FG000|Overall Study|Disease progression|0|||
163935191|NCT00838929|592131501|FG001|Overall Study|Disease progression|2|||
163935192|NCT00838929|592131502|FG002|Overall Study|Disease progression|1|||
163935193|NCT01340014|592131510|FG000|Period 1, First 7 Days|Adverse Event|1|||
163935194|NCT01340014|592131511|FG001|Period 1, First 7 Days|Adverse Event|0|||
163935195|NCT01340014|592131510|FG000|Period 1, First 7 Days|Personal Reasons|1|||
163935196|NCT01340014|592131511|FG001|Period 1, First 7 Days|Personal Reasons|0|||
163935197|NCT01340014|592131510|FG000|Period 2, Second 7 Days|Adverse Event|0|||
163935198|NCT01340014|592131511|FG001|Period 2, Second 7 Days|Adverse Event|1|||
163935199|NCT05101993|592131516|FG000|Overall Study|Withdrawal by Subject|1|||
163935200|NCT04577573|592131517|FG000|Overall Study|Technical - invalid protocol|0|||
163935201|NCT04577573|592131518|FG001|Overall Study|Technical - invalid protocol|2|||
163935202|NCT04577573|592131519|FG002|Overall Study|Technical - invalid protocol|0|||
163935203|NCT01667926|592132972|FG000|Overall Study|Withdrawal by Subject|1|||
163935204|NCT01667926|592132973|FG001|Overall Study|Withdrawal by Subject|2|||
163935205|NCT01667926|592132974|FG002|Overall Study|Withdrawal by Subject|2|||
163935206|NCT01667926|592132972|FG000|Overall Study|Physician Decision|0|||
163935207|NCT01667926|592132973|FG001|Overall Study|Physician Decision|0|||
164038052|NCT01855945|592498342|FG010|Overall Study|Death|0|||
164038053|NCT01855945|592498343|FG011|Overall Study|Death|0|||
164038054|NCT01855945|592498332|FG000|Overall Study|Lost to Follow-up|11|||
164038055|NCT01855945|592498333|FG001|Overall Study|Lost to Follow-up|10|||
164038056|NCT01855945|592498334|FG002|Overall Study|Lost to Follow-up|7|||
164038057|NCT01855945|592498335|FG003|Overall Study|Lost to Follow-up|3|||
164038058|NCT01855945|592498336|FG004|Overall Study|Lost to Follow-up|0|||
164038059|NCT01855945|592498337|FG005|Overall Study|Lost to Follow-up|3|||
164038060|NCT01855945|592498338|FG006|Overall Study|Lost to Follow-up|4|||
164038061|NCT01855945|592498339|FG007|Overall Study|Lost to Follow-up|7|||
164038062|NCT01855945|592498340|FG008|Overall Study|Lost to Follow-up|2|||
164038063|NCT01855945|592498341|FG009|Overall Study|Lost to Follow-up|0|||
164038064|NCT01855945|592498342|FG010|Overall Study|Lost to Follow-up|0|||
164038065|NCT01855945|592498343|FG011|Overall Study|Lost to Follow-up|2|||
164038066|NCT01855945|592498332|FG000|Overall Study|Other - Unclassified|1|||
164038067|NCT01855945|592498333|FG001|Overall Study|Other - Unclassified|1|||
164038068|NCT01855945|592498334|FG002|Overall Study|Other - Unclassified|1|||
164038069|NCT01855945|592498335|FG003|Overall Study|Other - Unclassified|0|||
164038070|NCT01855945|592498336|FG004|Overall Study|Other - Unclassified|0|||
164038071|NCT01855945|592498337|FG005|Overall Study|Other - Unclassified|0|||
164038072|NCT01855945|592498338|FG006|Overall Study|Other - Unclassified|2|||
164038073|NCT01855945|592498339|FG007|Overall Study|Other - Unclassified|1|||
164038074|NCT01855945|592498340|FG008|Overall Study|Other - Unclassified|0|||
164038075|NCT01855945|592498341|FG009|Overall Study|Other - Unclassified|0|||
164038076|NCT01855945|592498342|FG010|Overall Study|Other - Unclassified|1|||
164038077|NCT01855945|592498343|FG011|Overall Study|Other - Unclassified|0|||
164038078|NCT01855945|592498332|FG000|Overall Study|Withdrawal by Subject|4|||
164038079|NCT01855945|592498333|FG001|Overall Study|Withdrawal by Subject|0|||
164038080|NCT01855945|592498334|FG002|Overall Study|Withdrawal by Subject|4|||
164038081|NCT01855945|592498335|FG003|Overall Study|Withdrawal by Subject|1|||
164038082|NCT01855945|592498336|FG004|Overall Study|Withdrawal by Subject|1|||
164038083|NCT01855945|592498337|FG005|Overall Study|Withdrawal by Subject|0|||
164038084|NCT01855945|592498338|FG006|Overall Study|Withdrawal by Subject|1|||
164038085|NCT01855945|592498339|FG007|Overall Study|Withdrawal by Subject|0|||
164038086|NCT01855945|592498340|FG008|Overall Study|Withdrawal by Subject|0|||
164038087|NCT01855945|592498341|FG009|Overall Study|Withdrawal by Subject|2|||
164038088|NCT01855945|592498342|FG010|Overall Study|Withdrawal by Subject|4|||
164038089|NCT01855945|592498343|FG011|Overall Study|Withdrawal by Subject|1|||
164038090|NCT00770224|592498347|FG000|Step 1: Induction|Adverse Event|3|||
164038091|NCT00770224|592498348|FG001|Step 1: Induction|Adverse Event|0|||
164038092|NCT00770224|592498347|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
164038093|NCT00770224|592498348|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
164038094|NCT00770224|592498347|FG000|Step 1: Induction|Other reason not protocol specified|2|||
164038095|NCT00770224|592498348|FG001|Step 1: Induction|Other reason not protocol specified|0|||
164038096|NCT00770224|592498347|FG000|Step 1: Induction|Ineligible|2|||
164038097|NCT00770224|592498348|FG001|Step 1: Induction|Ineligible|0|||
164038098|NCT00770224|592498347|FG000|Step 1: Induction|No protocol treatment given|1|||
164038099|NCT00770224|592498348|FG001|Step 1: Induction|No protocol treatment given|0|||
164038100|NCT00770224|592498347|FG000|Step 2: Maintenance|Adverse Event|0|||
164038101|NCT00770224|592498348|FG001|Step 2: Maintenance|Adverse Event|10|||
164038102|NCT00770224|592498347|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
164038103|NCT00770224|592498348|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
164038104|NCT00770224|592498347|FG000|Step 2: Maintenance|Progression/relapse|0|||
164038105|NCT00770224|592498348|FG001|Step 2: Maintenance|Progression/relapse|1|||
164038106|NCT00770224|592498347|FG000|Step 2: Maintenance|Death|0|||
164038107|NCT00770224|592498348|FG001|Step 2: Maintenance|Death|2|||
164038108|NCT00770224|592498347|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
164038109|NCT00770224|592498348|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
164038110|NCT00770224|592498347|FG000|Step 2: Maintenance|Ineligible|0|||
164038111|NCT00770224|592498348|FG001|Step 2: Maintenance|Ineligible|2|||
164038112|NCT02260388|592498351|FG000|Overall Study|Lost to Follow-up|2|||
163839383|NCT00007475|591783571|FG000|Overall Study|Withdrawal by Subject|1|||
163839384|NCT00007475|591783572|FG001|Overall Study|Withdrawal by Subject|0|||
163839385|NCT00007475|591783573|FG002|Overall Study|Withdrawal by Subject|0|||
163839386|NCT00007475|591783574|FG003|Overall Study|Withdrawal by Subject|0|||
163839387|NCT00007475|591783571|FG000|Overall Study|Adverse Event|3|||
164038113|NCT02260388|592498352|FG001|Overall Study|Lost to Follow-up|8|||
164038114|NCT02260388|592498353|FG002|Overall Study|Lost to Follow-up|3|||
164038115|NCT02260388|592498354|FG003|Overall Study|Lost to Follow-up|4|||
164038116|NCT00126672|592498355|FG000|Overall Study|Adverse Event|4|||
164098716|NCT03021018|592726870|FG001|Overall Study|Adverse Event|0|||
163839388|NCT00007475|591783572|FG001|Overall Study|Adverse Event|0|||
164038117|NCT00126672|592498355|FG000|Overall Study|Lost to Follow-up|4|||
164038118|NCT00753623|592498357|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
164038119|NCT00753623|592498358|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
164038120|NCT00753623|592498357|FG000|Phase I (14 Days)|Physician Decision|1|||
164098717|NCT03021018|592726871|FG002|Overall Study|Adverse Event|0|||
164073174|NCT01347879|592632837|FG001|Overall Study|Other|3|||
163839389|NCT00007475|591783573|FG002|Overall Study|Adverse Event|0|||
163839390|NCT00007475|591783574|FG003|Overall Study|Adverse Event|0|||
163839391|NCT01719224|591783575|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
163839392|NCT01719224|591783576|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
163839393|NCT00258440|591783577|FG000|Overall Study|Withdrawal by Subject|0|||
163839394|NCT00258440|591783578|FG001|Overall Study|Withdrawal by Subject|0|||
163839395|NCT00258440|591783579|FG002|Overall Study|Withdrawal by Subject|1|||
163839396|NCT00737061|591783580|FG000|Waiting Period|Lost to Follow-up|6|||
163839397|NCT00737061|591783580|FG000|Waiting Period|Withdrawal by Subject|1|||
163839398|NCT00737061|591783580|FG000|Waiting Period|Bilateral placement failure|34|||
163839399|NCT00737061|591783580|FG000|Waiting Period|Deemed patent following HSG|26|||
163839400|NCT00737061|591783580|FG000|Waiting Period|Alternative contraception failure|3|||
163839401|NCT00737061|591783580|FG000|Waiting Period|Elected surgical tubal ligation|5|||
163839402|NCT00737061|591783580|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
163839403|NCT00737061|591783580|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
163839404|NCT00737061|591783580|FG000|1 Year Wearing Period|Discontinued reilance|3|||
163839405|NCT00737061|591783580|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
163839406|NCT03000673|591783581|FG000|Overall Study|Withdrawal by Subject|1|||
163839407|NCT03000673|591783582|FG001|Overall Study|Withdrawal by Subject|0|||
163839408|NCT03000673|591783583|FG002|Overall Study|Withdrawal by Subject|0|||
163839409|NCT03000673|591783584|FG003|Overall Study|Withdrawal by Subject|0|||
163839410|NCT00692406|591783585|FG000|Overall Study|PI dropped, bad data|57|||
163839411|NCT04186403|591783590|FG000|Overall Study|Adverse Event|1|||
163839412|NCT04186403|591783591|FG001|Overall Study|Adverse Event|8|||
163839413|NCT04186403|591783590|FG000|Overall Study|Lost to Follow-up|7|||
163839414|NCT04186403|591783591|FG001|Overall Study|Lost to Follow-up|3|||
163839415|NCT04186403|591783590|FG000|Overall Study|Physician Decision|1|||
163839416|NCT04186403|591783591|FG001|Overall Study|Physician Decision|0|||
163839417|NCT04186403|591783590|FG000|Overall Study|Withdrawal by Subject|7|||
163839418|NCT04186403|591783591|FG001|Overall Study|Withdrawal by Subject|8|||
163839419|NCT04186403|591783590|FG000|Overall Study|Other: Not Related to Covid-19|3|||
163839420|NCT04186403|591783591|FG001|Overall Study|Other: Not Related to Covid-19|0|||
163839421|NCT01407354|591783596|FG000|First Intervention|Withdrawal by Subject|0|||
163839422|NCT01407354|591783597|FG001|First Intervention|Withdrawal by Subject|2|||
163839423|NCT01407354|591783596|FG000|First Intervention|Adverse Event|1|||
163839424|NCT01407354|591783597|FG001|First Intervention|Adverse Event|0|||
163839425|NCT01407354|591783596|FG000|First Intervention|Physician Decision|1|||
163839426|NCT01407354|591783597|FG001|First Intervention|Physician Decision|0|||
163839427|NCT01036022|591783598|FG000|Overall Study|Adverse Event|1|||
163839428|NCT01036022|591783599|FG001|Overall Study|Adverse Event|3|||
163839429|NCT01036022|591783600|FG002|Overall Study|Adverse Event|2|||
163839430|NCT01036022|591783601|FG003|Overall Study|Adverse Event|1|||
163839431|NCT01036022|591783602|FG004|Overall Study|Adverse Event|0|||
163839432|NCT01036022|591783603|FG005|Overall Study|Adverse Event|2|||
163839433|NCT01036022|591783598|FG000|Overall Study|Lack of Efficacy|1|||
163839434|NCT01036022|591783599|FG001|Overall Study|Lack of Efficacy|1|||
163839435|NCT01036022|591783600|FG002|Overall Study|Lack of Efficacy|1|||
163839436|NCT01036022|591783601|FG003|Overall Study|Lack of Efficacy|0|||
163839437|NCT01036022|591783602|FG004|Overall Study|Lack of Efficacy|1|||
163839438|NCT01036022|591783603|FG005|Overall Study|Lack of Efficacy|1|||
163839439|NCT01036022|591783598|FG000|Overall Study|Physician Decision|0|||
163839440|NCT01036022|591783599|FG001|Overall Study|Physician Decision|0|||
163839441|NCT01036022|591783600|FG002|Overall Study|Physician Decision|1|||
163839442|NCT01036022|591783601|FG003|Overall Study|Physician Decision|0|||
163839443|NCT01036022|591783602|FG004|Overall Study|Physician Decision|0|||
163839444|NCT01036022|591783603|FG005|Overall Study|Physician Decision|0|||
163839445|NCT01036022|591783598|FG000|Overall Study|Withdrawal by Subject|0|||
163839446|NCT01036022|591783599|FG001|Overall Study|Withdrawal by Subject|0|||
163839447|NCT01036022|591783600|FG002|Overall Study|Withdrawal by Subject|0|||
163839448|NCT01036022|591783601|FG003|Overall Study|Withdrawal by Subject|1|||
163839449|NCT01036022|591783602|FG004|Overall Study|Withdrawal by Subject|2|||
163839450|NCT01036022|591783603|FG005|Overall Study|Withdrawal by Subject|0|||
163839451|NCT02487095|591783605|FG000|Dose Expansion|Unable to scan/restage participant|0|||
163839452|NCT02487095|591783606|FG001|Dose Expansion|Unable to scan/restage participant|0|||
163839453|NCT02487095|591783607|FG002|Dose Expansion|Unable to scan/restage participant|0|||
163839454|NCT02487095|591783608|FG003|Dose Expansion|Unable to scan/restage participant|0|||
163839455|NCT02487095|591783609|FG004|Dose Expansion|Unable to scan/restage participant|1|||
163839456|NCT01065350|591783610|FG000|Overall Study|Received incorrect drug allocation|0|||
163839457|NCT01065350|591783611|FG001|Overall Study|Received incorrect drug allocation|1|||
163839458|NCT00962247|591783616|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
163935208|NCT01667926|592132974|FG002|Overall Study|Physician Decision|1|||
163935209|NCT01667926|592132972|FG000|Overall Study|Time committment|0|||
163935210|NCT01667926|592132973|FG001|Overall Study|Time committment|0|||
163935211|NCT01667926|592132974|FG002|Overall Study|Time committment|2|||
163935212|NCT01667926|592132972|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
164038121|NCT00753623|592498358|FG001|Phase I (14 Days)|Physician Decision|2|||
163839459|NCT00962247|591783616|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
163839460|NCT01555164|591783620|FG000|Overall Study|Adverse Event|5|||
163839461|NCT01555164|591783621|FG001|Overall Study|Adverse Event|7|||
163839462|NCT01555164|591783620|FG000|Overall Study|Hyperglycemia|0|||
163839463|NCT01555164|591783621|FG001|Overall Study|Hyperglycemia|1|||
163839464|NCT01555164|591783620|FG000|Overall Study|Investigator's Discretion|2|||
163839465|NCT01555164|591783621|FG001|Overall Study|Investigator's Discretion|2|||
163839466|NCT01555164|591783620|FG000|Overall Study|Lost to Follow-up|4|||
163839467|NCT01555164|591783621|FG001|Overall Study|Lost to Follow-up|3|||
163839468|NCT01555164|591783620|FG000|Overall Study|Protocol Violation|9|||
163839469|NCT01555164|591783621|FG001|Overall Study|Protocol Violation|5|||
163839470|NCT01555164|591783620|FG000|Overall Study|Subject Non-compliance|14|||
163839471|NCT01555164|591783621|FG001|Overall Study|Subject Non-compliance|6|||
163839472|NCT01555164|591783620|FG000|Overall Study|Subject Withdrew Consent|6|||
163839473|NCT01555164|591783621|FG001|Overall Study|Subject Withdrew Consent|11|||
163839474|NCT00886639|591783624|FG000|Overall Study|acute exacerbation|14|||
163839475|NCT00886639|591783624|FG000|Overall Study|non-compliance|2|||
163839476|NCT01871558|591783625|FG000|Overall Study|Other reason|0|||
163839477|NCT01871558|591783626|FG001|Overall Study|Other reason|1|||
163839478|NCT01871558|591783625|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
163839479|NCT01871558|591783626|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
163839480|NCT01871558|591783625|FG000|Overall Study|Withdrawal by Subject|2|||
163839481|NCT01871558|591783626|FG001|Overall Study|Withdrawal by Subject|0|||
163839482|NCT01709305|591783627|FG000|Phase 1|Clinical Adverse Event|80|||
163839483|NCT01709305|591783628|FG001|Phase 1|Clinical Adverse Event|0|||
163839484|NCT01709305|591783629|FG002|Phase 1|Clinical Adverse Event|0|||
163839485|NCT01709305|591783630|FG003|Phase 1|Clinical Adverse Event|0|||
163839486|NCT01709305|591783631|FG004|Phase 1|Clinical Adverse Event|0|||
163839487|NCT01709305|591783627|FG000|Phase 1|Death|2|||
163839488|NCT01709305|591783628|FG001|Phase 1|Death|0|||
163839489|NCT01709305|591783629|FG002|Phase 1|Death|0|||
163839490|NCT01709305|591783630|FG003|Phase 1|Death|0|||
163839491|NCT01709305|591783631|FG004|Phase 1|Death|0|||
163839492|NCT01709305|591783627|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
163839493|NCT01709305|591783628|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163839494|NCT01709305|591783629|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163839495|NCT01709305|591783630|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163839496|NCT01709305|591783631|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
163839497|NCT01709305|591783627|FG000|Phase 1|Laboratory Adverse Event|16|||
163839498|NCT01709305|591783628|FG001|Phase 1|Laboratory Adverse Event|0|||
163839499|NCT01709305|591783629|FG002|Phase 1|Laboratory Adverse Event|0|||
163839500|NCT01709305|591783630|FG003|Phase 1|Laboratory Adverse Event|0|||
163839501|NCT01709305|591783631|FG004|Phase 1|Laboratory Adverse Event|0|||
163839502|NCT01709305|591783627|FG000|Phase 1|Lost to Follow-up|147|||
163839503|NCT01709305|591783628|FG001|Phase 1|Lost to Follow-up|0|||
163839504|NCT01709305|591783629|FG002|Phase 1|Lost to Follow-up|0|||
163839505|NCT01709305|591783630|FG003|Phase 1|Lost to Follow-up|0|||
163839506|NCT01709305|591783631|FG004|Phase 1|Lost to Follow-up|0|||
163839507|NCT01709305|591783627|FG000|Phase 1|Travel, moving, etc.|30|||
163839508|NCT01709305|591783628|FG001|Phase 1|Travel, moving, etc.|0|||
163839509|NCT01709305|591783629|FG002|Phase 1|Travel, moving, etc.|0|||
163839510|NCT01709305|591783630|FG003|Phase 1|Travel, moving, etc.|0|||
163839511|NCT01709305|591783631|FG004|Phase 1|Travel, moving, etc.|0|||
163839512|NCT01709305|591783627|FG000|Phase 1|Physician Decision|13|||
163839513|NCT01709305|591783628|FG001|Phase 1|Physician Decision|0|||
163839514|NCT01709305|591783629|FG002|Phase 1|Physician Decision|0|||
163839515|NCT01709305|591783630|FG003|Phase 1|Physician Decision|0|||
163839516|NCT01709305|591783631|FG004|Phase 1|Physician Decision|0|||
163839517|NCT01709305|591783627|FG000|Phase 1|Protocol Violation|118|||
164038122|NCT00753623|592498357|FG000|Phase I (14 Days)|Adverse Event|0|||
163839518|NCT01709305|591783628|FG001|Phase 1|Protocol Violation|0|||
163839519|NCT01709305|591783629|FG002|Phase 1|Protocol Violation|0|||
163839520|NCT01709305|591783630|FG003|Phase 1|Protocol Violation|0|||
163839521|NCT01709305|591783631|FG004|Phase 1|Protocol Violation|0|||
163839522|NCT01709305|591783627|FG000|Phase 1|Withdrawal by Subject|218|||
163839523|NCT01709305|591783628|FG001|Phase 1|Withdrawal by Subject|0|||
163839524|NCT01709305|591783629|FG002|Phase 1|Withdrawal by Subject|0|||
163839525|NCT01709305|591783630|FG003|Phase 1|Withdrawal by Subject|0|||
163839526|NCT01709305|591783631|FG004|Phase 1|Withdrawal by Subject|0|||
163839527|NCT01709305|591783627|FG000|Phase 2|Clinical Adverse Event|0|||
163839528|NCT01709305|591783628|FG001|Phase 2|Clinical Adverse Event|10|||
163839529|NCT01709305|591783629|FG002|Phase 2|Clinical Adverse Event|10|||
163839530|NCT01709305|591783630|FG003|Phase 2|Clinical Adverse Event|6|||
163839531|NCT01709305|591783631|FG004|Phase 2|Clinical Adverse Event|11|||
163839532|NCT01709305|591783627|FG000|Phase 2|Death|0|||
163839533|NCT01709305|591783628|FG001|Phase 2|Death|0|||
163839534|NCT01709305|591783629|FG002|Phase 2|Death|1|||
163839535|NCT01709305|591783630|FG003|Phase 2|Death|0|||
163839536|NCT01709305|591783631|FG004|Phase 2|Death|0|||
163839537|NCT01709305|591783627|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
164038123|NCT00753623|592498358|FG001|Phase I (14 Days)|Adverse Event|1|||
164038124|NCT00753623|592498357|FG000|Washout (7 Days)|Physician Decision|1|||
164038125|NCT00753623|592498358|FG001|Washout (7 Days)|Physician Decision|0|||
164038126|NCT00753623|592498357|FG000|Phase II (14 Days)|Physician Decision|0|||
164038127|NCT00753623|592498358|FG001|Phase II (14 Days)|Physician Decision|1|||
164038128|NCT03332303|592498359|FG000|Overall Study|Participant did not dose|1|||
164038129|NCT03332303|592498360|FG001|Overall Study|Participant did not dose|2|||
164038130|NCT03332303|592498361|FG002|Overall Study|Participant did not dose|0|||
164038131|NCT03332303|592498359|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
164038132|NCT03332303|592498360|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
164038133|NCT03332303|592498361|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
164098718|NCT03021018|592726869|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
164147699|NCT02006732|592902129|FG000|Overall Study|Lack of Efficacy|6|||
163839538|NCT01709305|591783628|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163839539|NCT01709305|591783629|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163839540|NCT01709305|591783630|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
163839541|NCT01709305|591783631|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
163839542|NCT01709305|591783627|FG000|Phase 2|Laboratory Adverse Event|0|||
163839543|NCT01709305|591783628|FG001|Phase 2|Laboratory Adverse Event|1|||
163839544|NCT01709305|591783629|FG002|Phase 2|Laboratory Adverse Event|0|||
163839545|NCT01709305|591783630|FG003|Phase 2|Laboratory Adverse Event|1|||
163839546|NCT01709305|591783631|FG004|Phase 2|Laboratory Adverse Event|1|||
163839547|NCT01709305|591783627|FG000|Phase 2|Lost to Follow-up|0|||
163839548|NCT01709305|591783628|FG001|Phase 2|Lost to Follow-up|10|||
163839549|NCT01709305|591783629|FG002|Phase 2|Lost to Follow-up|6|||
163839550|NCT01709305|591783630|FG003|Phase 2|Lost to Follow-up|9|||
163839551|NCT01709305|591783631|FG004|Phase 2|Lost to Follow-up|5|||
163839552|NCT01709305|591783627|FG000|Phase 2|Travel, moving, etc.|0|||
163839553|NCT01709305|591783628|FG001|Phase 2|Travel, moving, etc.|2|||
163839554|NCT01709305|591783629|FG002|Phase 2|Travel, moving, etc.|3|||
163839555|NCT01709305|591783630|FG003|Phase 2|Travel, moving, etc.|3|||
163935213|NCT01667926|592132973|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
163935214|NCT01667926|592132974|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
163935215|NCT01667926|592132972|FG000|Overall Study|Lost to Follow-up|1|||
163935216|NCT01667926|592132973|FG001|Overall Study|Lost to Follow-up|2|||
163935217|NCT01667926|592132974|FG002|Overall Study|Lost to Follow-up|1|||
163935218|NCT01667926|592132972|FG000|Overall Study|Side effects|3|||
163935219|NCT01667926|592132973|FG001|Overall Study|Side effects|0|||
163935220|NCT01667926|592132974|FG002|Overall Study|Side effects|0|||
163935221|NCT02870972|592132976|FG000|Overall Study|Adverse Event|1|||
163935222|NCT02870972|592132977|FG001|Overall Study|Adverse Event|0|||
163935223|NCT02870972|592132978|FG002|Overall Study|Adverse Event|0|||
163935224|NCT02870972|592132979|FG003|Overall Study|Adverse Event|0|||
163935225|NCT02870972|592132980|FG004|Overall Study|Adverse Event|0|||
163935226|NCT02878603|592132981|FG000|Overall Study|Lost to Follow-up|4|||
163935227|NCT02878603|592132982|FG001|Overall Study|Lost to Follow-up|1|||
163935228|NCT02878603|592132981|FG000|Overall Study|Withdrawal by Subject|1|||
163935229|NCT02878603|592132982|FG001|Overall Study|Withdrawal by Subject|1|||
163935230|NCT02878603|592132981|FG000|Overall Study|Death|1|||
163935231|NCT02878603|592132982|FG001|Overall Study|Death|0|||
163935232|NCT02878603|592132981|FG000|Overall Study|Physician Decision|0|||
163935233|NCT02878603|592132982|FG001|Overall Study|Physician Decision|3|||
163935234|NCT02689453|592132983|FG000|Overall Study|Progressive disease|0|||
163935235|NCT02689453|592132984|FG001|Overall Study|Progressive disease|1|||
163935236|NCT02689453|592132985|FG002|Overall Study|Progressive disease|1|||
163935237|NCT00953615|592132986|FG000|Overall Study|Adverse Event|1|||
163935238|NCT03274895|592132987|FG000|Overall Study|Lack of Efficacy|1|||
163935239|NCT03274895|592132988|FG001|Overall Study|Lack of Efficacy|0|||
163935240|NCT03274895|592132987|FG000|Overall Study|Adverse Event|8|||
163935241|NCT03274895|592132988|FG001|Overall Study|Adverse Event|7|||
163935242|NCT03274895|592132987|FG000|Overall Study|Lost to Follow-up|1|||
163935243|NCT03274895|592132988|FG001|Overall Study|Lost to Follow-up|0|||
163935244|NCT03274895|592132987|FG000|Overall Study|Diagnosis not confirmed|3|||
163935245|NCT03274895|592132988|FG001|Overall Study|Diagnosis not confirmed|4|||
163935246|NCT01969851|592132989|FG000|Overall Study|Adverse Event|0|||
163935247|NCT01969851|592132990|FG001|Overall Study|Adverse Event|0|||
163935248|NCT01969851|592132991|FG002|Overall Study|Adverse Event|3|||
163935249|NCT01969851|592132989|FG000|Overall Study|Lack of Efficacy|0|||
163935250|NCT01969851|592132990|FG001|Overall Study|Lack of Efficacy|3|||
163935251|NCT01969851|592132991|FG002|Overall Study|Lack of Efficacy|1|||
163935252|NCT01969851|592132989|FG000|Overall Study|Withdrawal by Subject|1|||
163839556|NCT01709305|591783631|FG004|Phase 2|Travel, moving, etc.|5|||
163935253|NCT01969851|592132990|FG001|Overall Study|Withdrawal by Subject|0|||
163935254|NCT01969851|592132991|FG002|Overall Study|Withdrawal by Subject|1|||
163935255|NCT01969851|592132989|FG000|Overall Study|No effective dose in Titration period|0|||
163935256|NCT01969851|592132990|FG001|Overall Study|No effective dose in Titration period|0|||
163935257|NCT01969851|592132991|FG002|Overall Study|No effective dose in Titration period|1|||
163935258|NCT01969851|592132989|FG000|Overall Study|Sponsor decision|0|||
164038134|NCT03332303|592498359|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
164038135|NCT03332303|592498360|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
164038136|NCT03332303|592498361|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
164038137|NCT03332303|592498359|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
164038138|NCT03332303|592498360|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
164038139|NCT03332303|592498361|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
164038140|NCT03332303|592498359|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
164038141|NCT03332303|592498360|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
164038142|NCT03332303|592498361|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
164038143|NCT03332303|592498359|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
164038144|NCT03332303|592498360|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
164038145|NCT03332303|592498361|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
164038146|NCT03332303|592498359|FG000|Overall Study|Participant had a significant protocol deviation|0|||
164038147|NCT03332303|592498360|FG001|Overall Study|Participant had a significant protocol deviation|1|||
164038148|NCT03332303|592498361|FG002|Overall Study|Participant had a significant protocol deviation|0|||
164038149|NCT01296698|592498362|FG000|Overall Study|Adverse Event|1|||
164038150|NCT01296698|592498363|FG001|Overall Study|Adverse Event|0|||
164038151|NCT01296698|592498362|FG000|Overall Study|Death|1|||
164038152|NCT01296698|592498363|FG001|Overall Study|Death|0|||
164038153|NCT01296698|592498362|FG000|Overall Study|Lost to Follow-up|19|||
164038154|NCT01296698|592498363|FG001|Overall Study|Lost to Follow-up|1|||
164038155|NCT01296698|592498362|FG000|Overall Study|Withdrawal by Subject|12|||
164038156|NCT01296698|592498363|FG001|Overall Study|Withdrawal by Subject|0|||
164038157|NCT01296698|592498362|FG000|Overall Study|Difficulty Contacting Subject|2|||
164038158|NCT01296698|592498363|FG001|Overall Study|Difficulty Contacting Subject|0|||
164038159|NCT01296698|592498362|FG000|Overall Study|Study Terminated by Sponsor|209|||
164038160|NCT01296698|592498363|FG001|Overall Study|Study Terminated by Sponsor|12|||
164038161|NCT03495817|592498365|FG000|26 Week Open Label|Adverse Event|3|||
164038162|NCT03495817|592498365|FG000|26 Week Open Label|Withdrawal by Subject|4|||
164038163|NCT03495817|592498365|FG000|26 Week Open Label|Lost to Follow-up|1|||
164038164|NCT03495817|592498365|FG000|26 Week Extension|Lost to Follow-up|2|||
164038165|NCT01957787|592498366|FG000|Overall Study|Death|18|||
164038166|NCT01957787|592498366|FG000|Overall Study|Lost to Follow-up|3|||
164038167|NCT01957787|592498366|FG000|Overall Study|Withdrawal by Subject|3|||
164038168|NCT01957787|592498366|FG000|Overall Study|Entered Hospice or Similar Program|2|||
164038169|NCT01957787|592498366|FG000|Overall Study|Index Tumor(s) Resected|2|||
164038170|NCT01957787|592498366|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
164038171|NCT01957787|592498366|FG000|Overall Study|Local therapy, not cryoablation|6|||
164038172|NCT04294095|592498373|FG000|Overall Study|Adverse Event|1|||
164038173|NCT04294095|592498374|FG001|Overall Study|Adverse Event|0|||
164038174|NCT00260429|592498379|FG000|Overall Study|failure to follow appointments|1|||
164098719|NCT03021018|592726870|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
164098720|NCT03021018|592726871|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
163839557|NCT01709305|591783627|FG000|Phase 2|Physician Decision|0|||
163839558|NCT01709305|591783628|FG001|Phase 2|Physician Decision|2|||
163839559|NCT01709305|591783629|FG002|Phase 2|Physician Decision|0|||
163839560|NCT01709305|591783630|FG003|Phase 2|Physician Decision|1|||
163839561|NCT01709305|591783631|FG004|Phase 2|Physician Decision|2|||
163839562|NCT01709305|591783627|FG000|Phase 2|Protocol Violation|0|||
163839563|NCT01709305|591783628|FG001|Phase 2|Protocol Violation|19|||
163839564|NCT01709305|591783629|FG002|Phase 2|Protocol Violation|19|||
163839565|NCT01709305|591783630|FG003|Phase 2|Protocol Violation|13|||
163839566|NCT01709305|591783631|FG004|Phase 2|Protocol Violation|9|||
163839567|NCT01709305|591783627|FG000|Phase 2|Withdrawal by Subject|0|||
163839568|NCT01709305|591783628|FG001|Phase 2|Withdrawal by Subject|8|||
163839569|NCT01709305|591783629|FG002|Phase 2|Withdrawal by Subject|6|||
163839570|NCT01709305|591783630|FG003|Phase 2|Withdrawal by Subject|15|||
163839571|NCT01709305|591783631|FG004|Phase 2|Withdrawal by Subject|12|||
163839572|NCT02875834|591783634|FG000|Open-label Phase|Withdrawal by Subject|3|||
163839573|NCT02875834|591783635|FG001|Open-label Phase|Withdrawal by Subject|0|||
163839574|NCT02875834|591783636|FG002|Open-label Phase|Withdrawal by Subject|0|||
163839575|NCT02875834|591783637|FG003|Open-label Phase|Withdrawal by Subject|0|||
163839576|NCT02875834|591783634|FG000|Open-label Phase|(Not collected)|4|||
163839577|NCT02875834|591783635|FG001|Open-label Phase|(Not collected)|0|||
163839578|NCT02875834|591783636|FG002|Open-label Phase|(Not collected)|0|||
163839579|NCT02875834|591783637|FG003|Open-label Phase|(Not collected)|0|||
163839580|NCT02875834|591783634|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
163839581|NCT02875834|591783635|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
163839582|NCT02875834|591783636|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
163839583|NCT02875834|591783637|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
163839584|NCT02875834|591783634|FG000|Randomized Treatment Phase|Protocol Violation|0|||
163839585|NCT02875834|591783635|FG001|Randomized Treatment Phase|Protocol Violation|2|||
164038175|NCT00260429|592498380|FG001|Overall Study|failure to follow appointments|0|||
164038176|NCT00260429|592498379|FG000|Overall Study|scheduled hand surgery|1|||
164038177|NCT00260429|592498380|FG001|Overall Study|scheduled hand surgery|0|||
164038178|NCT00659126|592498381|FG000|Overall Study|Adverse Event|2|||
164038179|NCT00659126|592498382|FG001|Overall Study|Adverse Event|2|||
164038180|NCT00659126|592498381|FG000|Overall Study|Screen failure|1|||
164038181|NCT00659126|592498382|FG001|Overall Study|Screen failure|1|||
164038182|NCT00659126|592498381|FG000|Overall Study|Technical problems with MRI|0|||
164038183|NCT00659126|592498382|FG001|Overall Study|Technical problems with MRI|1|||
164038184|NCT02762708|592498386|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
164038185|NCT02762708|592498387|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
164038186|NCT02762708|592498388|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
164038187|NCT02762708|592498389|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
164038188|NCT00631540|592498390|FG000|Overall Study|Withdrawal by Subject|5|||
164098721|NCT00328926|592726874|FG000|Overall Study|Pregnancy|2|||
163839586|NCT02875834|591783636|FG002|Randomized Treatment Phase|Protocol Violation|0|||
163839587|NCT02875834|591783637|FG003|Randomized Treatment Phase|Protocol Violation|0|||
163839588|NCT02875834|591783634|FG000|Randomized Treatment Phase|(Not collected)|0|||
163935259|NCT01969851|592132990|FG001|Overall Study|Sponsor decision|0|||
163935260|NCT01969851|592132991|FG002|Overall Study|Sponsor decision|1|||
163935261|NCT01754753|592132992|FG000|Overall Study|Study close|43|||
163935262|NCT01754753|592132993|FG001|Overall Study|Study close|44|||
163935263|NCT01754753|592132992|FG000|Overall Study|Lost to Follow-up|9|||
163935264|NCT01754753|592132993|FG001|Overall Study|Lost to Follow-up|5|||
163935265|NCT03229486|592132994|FG000|Overall Study|Protocol Violation|0|||
163935266|NCT03229486|592132995|FG001|Overall Study|Protocol Violation|1|||
163935267|NCT00856245|592132996|FG000|Overall Study|Was not transplanted|5|||
163935268|NCT01782690|592133000|FG000|Overall Study|Not reported|7|||
163935269|NCT01782690|592133000|FG000|Overall Study|Toxicity of gemcitabine|1|||
163935270|NCT01782690|592133000|FG000|Overall Study|Toxicity of erlotinib|1|||
163935271|NCT01782690|592133000|FG000|Overall Study|Lost to Follow-up|31|||
163935272|NCT01782690|592133000|FG000|Overall Study|Withdrawal of informed consent|2|||
163935273|NCT01782690|592133000|FG000|Overall Study|Absent rash|9|||
163935274|NCT01782690|592133000|FG000|Overall Study|Physician Decision|13|||
163935275|NCT01782690|592133000|FG000|Overall Study|Patient's wish|21|||
163935276|NCT01782690|592133000|FG000|Overall Study|Tumor progression|74|||
163935277|NCT01782690|592133000|FG000|Overall Study|Death|133|||
163935278|NCT01782690|592133000|FG000|Overall Study|Study completion unknown|7|||
163935279|NCT01637077|592133006|FG000|Overall Study|Cancel|1|||
163935280|NCT01637077|592133007|FG001|Overall Study|Cancel|1|||
163935281|NCT01637077|592133006|FG000|Overall Study|Withdrawal by Subject|1|||
163935282|NCT01637077|592133007|FG001|Overall Study|Withdrawal by Subject|0|||
163935283|NCT01637077|592133006|FG000|Overall Study|No cycle 1 questionnaire data|2|||
163935284|NCT01637077|592133007|FG001|Overall Study|No cycle 1 questionnaire data|0|||
163935285|NCT02638103|592133008|FG000|Overall Study|Adverse Event|13|||
163935286|NCT02638103|592133009|FG001|Overall Study|Adverse Event|12|||
163935287|NCT02638103|592133010|FG002|Overall Study|Adverse Event|19|||
163935288|NCT02638103|592133011|FG003|Overall Study|Adverse Event|12|||
163935289|NCT02638103|592133008|FG000|Overall Study|Withdrawal by Subject|43|||
163935290|NCT02638103|592133009|FG001|Overall Study|Withdrawal by Subject|53|||
163935291|NCT02638103|592133010|FG002|Overall Study|Withdrawal by Subject|30|||
163935292|NCT02638103|592133011|FG003|Overall Study|Withdrawal by Subject|61|||
163935293|NCT02638103|592133008|FG000|Overall Study|Protocol Violation|1|||
163935294|NCT02638103|592133009|FG001|Overall Study|Protocol Violation|2|||
163935295|NCT02638103|592133010|FG002|Overall Study|Protocol Violation|1|||
163935296|NCT02638103|592133011|FG003|Overall Study|Protocol Violation|4|||
164038189|NCT00631540|592498390|FG000|Overall Study|Death|4|||
164038190|NCT00631540|592498390|FG000|Overall Study|Lost to Follow-up|2|||
163839589|NCT02875834|591783635|FG001|Randomized Treatment Phase|(Not collected)|9|||
163839590|NCT02875834|591783636|FG002|Randomized Treatment Phase|(Not collected)|10|||
163839591|NCT02875834|591783637|FG003|Randomized Treatment Phase|(Not collected)|9|||
163839592|NCT01302938|591783638|FG000|Overall Study|Withdrawal by Subject|1|||
163839593|NCT01302938|591783639|FG001|Overall Study|Withdrawal by Subject|0|||
163839594|NCT01302938|591783638|FG000|Overall Study|Adverse Event|1|||
163839595|NCT01302938|591783639|FG001|Overall Study|Adverse Event|0|||
163839596|NCT03443713|591783641|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
163839597|NCT03443713|591783642|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
163839598|NCT03443713|591783643|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
164038191|NCT00631540|592498390|FG000|Overall Study|Core Lab Data Unavailable|3|||
164038192|NCT00970268|592498391|FG000|Overall Study|Withdrawal by Subject|12|||
164098722|NCT00328926|592726875|FG001|Overall Study|Pregnancy|1|||
163935297|NCT02638103|592133008|FG000|Overall Study|Pregnancy|2|||
163935298|NCT02638103|592133009|FG001|Overall Study|Pregnancy|3|||
163935299|NCT02638103|592133010|FG002|Overall Study|Pregnancy|0|||
163935300|NCT02638103|592133011|FG003|Overall Study|Pregnancy|1|||
163935301|NCT02638103|592133008|FG000|Overall Study|Non-compliance to Study Procedures|2|||
163935302|NCT02638103|592133009|FG001|Overall Study|Non-compliance to Study Procedures|1|||
164038193|NCT00970268|592498392|FG001|Overall Study|Withdrawal by Subject|19|||
164038194|NCT00970268|592498391|FG000|Overall Study|Adverse Event|15|||
164038195|NCT00970268|592498392|FG001|Overall Study|Adverse Event|12|||
164038196|NCT00970268|592498391|FG000|Overall Study|Lack of Efficacy|3|||
164038197|NCT00970268|592498392|FG001|Overall Study|Lack of Efficacy|6|||
164038198|NCT00970268|592498391|FG000|Overall Study|Protocol Violation|4|||
164038199|NCT00970268|592498392|FG001|Overall Study|Protocol Violation|7|||
164038200|NCT00970268|592498391|FG000|Overall Study|Other Reason|3|||
164038201|NCT00970268|592498392|FG001|Overall Study|Other Reason|1|||
164038202|NCT00970268|592498391|FG000|Overall Study|COPD Exacerbation|4|||
164038203|NCT00970268|592498392|FG001|Overall Study|COPD Exacerbation|2|||
164038204|NCT00970268|592498391|FG000|Overall Study|Lost to Follow-up|1|||
164038205|NCT00970268|592498392|FG001|Overall Study|Lost to Follow-up|2|||
164038206|NCT00970268|592498391|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
164038207|NCT00970268|592498392|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
164038208|NCT01999946|592498393|FG000|Overall Study|Participant not released from jail|2|||
164038209|NCT01999946|592498394|FG001|Overall Study|Participant not released from jail|2|||
164038210|NCT01999946|592498395|FG002|Overall Study|Participant not released from jail|0|||
164038211|NCT01999946|592498393|FG000|Overall Study|Not included in primary outcome analysis|0|||
164038212|NCT01999946|592498394|FG001|Overall Study|Not included in primary outcome analysis|0|||
164038213|NCT01999946|592498395|FG002|Overall Study|Not included in primary outcome analysis|79|||
164038214|NCT00719953|592498396|FG000|Overall Study|Adverse Event|4|||
164038215|NCT03726333|592498402|FG000|Overall Study|Progressive Disease|0|||
164038216|NCT03726333|592498403|FG001|Overall Study|Progressive Disease|0|||
164038217|NCT03726333|592498404|FG002|Overall Study|Progressive Disease|1|||
164038218|NCT03726333|592498405|FG003|Overall Study|Progressive Disease|0|||
164038219|NCT03726333|592498406|FG004|Overall Study|Progressive Disease|0|||
164038220|NCT03906136|592500908|FG000|Overall Study|Adverse Event|1|||
164038221|NCT03906136|592500909|FG001|Overall Study|Adverse Event|0|||
164038222|NCT03906136|592500908|FG000|Overall Study|Lost to Follow-up|7|||
164038223|NCT03906136|592500909|FG001|Overall Study|Lost to Follow-up|4|||
164038224|NCT03906136|592500908|FG000|Overall Study|Physician Decision|1|||
164038225|NCT03906136|592500909|FG001|Overall Study|Physician Decision|0|||
164038226|NCT03906136|592500908|FG000|Overall Study|Withdrawal by Subject|3|||
164038227|NCT03906136|592500909|FG001|Overall Study|Withdrawal by Subject|7|||
164038228|NCT01696396|592500912|FG000|Overall Study|Withdrawal by Subject|19|||
164038229|NCT01696396|592500913|FG001|Overall Study|Withdrawal by Subject|5|||
164038230|NCT01696396|592500914|FG002|Overall Study|Withdrawal by Subject|19|||
164038231|NCT01696396|592500915|FG003|Overall Study|Withdrawal by Subject|11|||
164038232|NCT01696396|592500912|FG000|Overall Study|Decision by Sponsor|3|||
164038233|NCT01696396|592500913|FG001|Overall Study|Decision by Sponsor|1|||
164038234|NCT01696396|592500914|FG002|Overall Study|Decision by Sponsor|2|||
164038235|NCT01696396|592500915|FG003|Overall Study|Decision by Sponsor|2|||
164038236|NCT01696396|592500912|FG000|Overall Study|Lost to Follow-up|9|||
164038237|NCT01696396|592500913|FG001|Overall Study|Lost to Follow-up|1|||
164038238|NCT01696396|592500914|FG002|Overall Study|Lost to Follow-up|4|||
164038239|NCT01696396|592500915|FG003|Overall Study|Lost to Follow-up|1|||
164038240|NCT01696396|592500912|FG000|Overall Study|Death|0|||
164038241|NCT01696396|592500913|FG001|Overall Study|Death|0|||
164038242|NCT01696396|592500914|FG002|Overall Study|Death|1|||
164038243|NCT01696396|592500915|FG003|Overall Study|Death|0|||
164038244|NCT02371980|592500921|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
164038245|NCT02371980|592500922|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
164038246|NCT02371980|592500923|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
164038247|NCT02371980|592500924|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
164038248|NCT02371980|592500925|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
164038249|NCT02371980|592500921|FG000|Open-label Period|Significant Protocol Deviation|19|||
164038250|NCT02371980|592500922|FG001|Open-label Period|Significant Protocol Deviation|0|||
164038251|NCT02371980|592500923|FG002|Open-label Period|Significant Protocol Deviation|0|||
164038252|NCT02371980|592500924|FG003|Open-label Period|Significant Protocol Deviation|0|||
164038253|NCT02371980|592500925|FG004|Open-label Period|Significant Protocol Deviation|0|||
164038254|NCT02371980|592500921|FG000|Open-label Period|Noncompliance with Study Drug|10|||
164038255|NCT02371980|592500922|FG001|Open-label Period|Noncompliance with Study Drug|0|||
164038256|NCT02371980|592500923|FG002|Open-label Period|Noncompliance with Study Drug|0|||
164038257|NCT02371980|592500924|FG003|Open-label Period|Noncompliance with Study Drug|0|||
164038258|NCT02371980|592500925|FG004|Open-label Period|Noncompliance with Study Drug|0|||
164038259|NCT02371980|592500921|FG000|Open-label Period|Lost to Follow-up|55|||
164038260|NCT02371980|592500922|FG001|Open-label Period|Lost to Follow-up|0|||
164038261|NCT02371980|592500923|FG002|Open-label Period|Lost to Follow-up|0|||
164038262|NCT02371980|592500924|FG003|Open-label Period|Lost to Follow-up|0|||
164038263|NCT02371980|592500925|FG004|Open-label Period|Lost to Follow-up|0|||
164038264|NCT02371980|592500921|FG000|Open-label Period|Voluntary Withdrawal|91|||
164038265|NCT02371980|592500922|FG001|Open-label Period|Voluntary Withdrawal|0|||
164038266|NCT02371980|592500923|FG002|Open-label Period|Voluntary Withdrawal|0|||
164038267|NCT02371980|592500924|FG003|Open-label Period|Voluntary Withdrawal|0|||
164038268|NCT02371980|592500925|FG004|Open-label Period|Voluntary Withdrawal|0|||
163839599|NCT01672853|591783644|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
163839600|NCT01672853|591783645|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
163839601|NCT01672853|591783646|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
163839602|NCT01672853|591783644|FG000|Overall Study|Pregnancy|0|||
163839603|NCT01672853|591783645|FG001|Overall Study|Pregnancy|1|||
163839604|NCT01672853|591783646|FG002|Overall Study|Pregnancy|0|||
163839605|NCT01672853|591783644|FG000|Overall Study|Investigator's Discretion|1|||
163839606|NCT01672853|591783645|FG001|Overall Study|Investigator's Discretion|0|||
163839607|NCT01672853|591783646|FG002|Overall Study|Investigator's Discretion|0|||
163839608|NCT01672853|591783644|FG000|Overall Study|Withdrew Consent|5|||
163839609|NCT01672853|591783645|FG001|Overall Study|Withdrew Consent|5|||
163839610|NCT01672853|591783646|FG002|Overall Study|Withdrew Consent|5|||
163839611|NCT01672853|591783644|FG000|Overall Study|Adverse Event|4|||
163839612|NCT01672853|591783645|FG001|Overall Study|Adverse Event|6|||
163839613|NCT01672853|591783646|FG002|Overall Study|Adverse Event|8|||
163839614|NCT01672853|591783644|FG000|Overall Study|Lost to Follow-up|0|||
163839615|NCT01672853|591783645|FG001|Overall Study|Lost to Follow-up|1|||
163839616|NCT01672853|591783646|FG002|Overall Study|Lost to Follow-up|0|||
163839617|NCT01672853|591783644|FG000|Overall Study|Randomized but Never Treated|0|||
163839618|NCT01672853|591783645|FG001|Overall Study|Randomized but Never Treated|0|||
163839619|NCT01672853|591783646|FG002|Overall Study|Randomized but Never Treated|1|||
163839620|NCT02969525|591783647|FG000|Double-Blind Period|Adverse Event|0|||
163839621|NCT02969525|591783648|FG001|Double-Blind Period|Adverse Event|0|||
163839622|NCT02969525|591783649|FG002|Double-Blind Period|Adverse Event|1|||
163839623|NCT02969525|591783650|FG003|Double-Blind Period|Adverse Event|1|||
163839624|NCT02969525|591783651|FG004|Double-Blind Period|Adverse Event|0|||
163839625|NCT02969525|591783652|FG005|Double-Blind Period|Adverse Event|0|||
163839626|NCT02969525|591783653|FG006|Double-Blind Period|Adverse Event|0|||
163839627|NCT02969525|591783654|FG007|Double-Blind Period|Adverse Event|0|||
163935303|NCT02638103|592133010|FG002|Overall Study|Non-compliance to Study Procedures|1|||
163935304|NCT02638103|592133011|FG003|Overall Study|Non-compliance to Study Procedures|1|||
163935305|NCT02638103|592133008|FG000|Overall Study|Lost to Follow-up|26|||
163935306|NCT02638103|592133009|FG001|Overall Study|Lost to Follow-up|33|||
163935307|NCT02638103|592133010|FG002|Overall Study|Lost to Follow-up|20|||
163935308|NCT02638103|592133011|FG003|Overall Study|Lost to Follow-up|37|||
163935309|NCT02638103|592133008|FG000|Overall Study|Lack of Efficacy|14|||
163935310|NCT02638103|592133009|FG001|Overall Study|Lack of Efficacy|10|||
163935311|NCT02638103|592133010|FG002|Overall Study|Lack of Efficacy|12|||
163935312|NCT02638103|592133011|FG003|Overall Study|Lack of Efficacy|22|||
163935313|NCT02638103|592133008|FG000|Overall Study|Other than specified|5|||
163935314|NCT02638103|592133009|FG001|Overall Study|Other than specified|4|||
163935315|NCT02638103|592133010|FG002|Overall Study|Other than specified|2|||
163935316|NCT02638103|592133011|FG003|Overall Study|Other than specified|4|||
163935317|NCT04199052|592133014|FG000|Overall Study|Lost to Follow-up|11|||
163935318|NCT04199052|592133015|FG001|Overall Study|Lost to Follow-up|18|||
163935319|NCT00699842|592133016|FG000|Overall Study|Death|0|||
163935320|NCT00699842|592133017|FG001|Overall Study|Death|1|||
163935321|NCT00699842|592133018|FG002|Overall Study|Death|0|||
163935322|NCT01358331|592133019|FG000|Overall Study|Lost to Follow-up|0|||
163935323|NCT01358331|592133020|FG001|Overall Study|Lost to Follow-up|0|||
163935324|NCT01358331|592133021|FG002|Overall Study|Lost to Follow-up|0|||
163935325|NCT01358331|592133022|FG003|Overall Study|Lost to Follow-up|1|||
163935326|NCT01358331|592133023|FG004|Overall Study|Lost to Follow-up|0|||
163935327|NCT01358331|592133024|FG005|Overall Study|Lost to Follow-up|0|||
163935328|NCT01358331|592133019|FG000|Overall Study|Withdrawal by Subject|0|||
163935329|NCT01358331|592133020|FG001|Overall Study|Withdrawal by Subject|0|||
163935330|NCT01358331|592133021|FG002|Overall Study|Withdrawal by Subject|0|||
163935331|NCT01358331|592133022|FG003|Overall Study|Withdrawal by Subject|1|||
163935332|NCT01358331|592133023|FG004|Overall Study|Withdrawal by Subject|1|||
163935333|NCT01358331|592133024|FG005|Overall Study|Withdrawal by Subject|1|||
163935334|NCT01358331|592133019|FG000|Overall Study|Adverse Events|1|||
163935335|NCT01358331|592133020|FG001|Overall Study|Adverse Events|1|||
163935336|NCT01358331|592133021|FG002|Overall Study|Adverse Events|1|||
163935337|NCT01358331|592133022|FG003|Overall Study|Adverse Events|0|||
163935338|NCT01358331|592133023|FG004|Overall Study|Adverse Events|1|||
163935339|NCT01358331|592133024|FG005|Overall Study|Adverse Events|5|||
163935340|NCT01358331|592133019|FG000|Overall Study|Symptomatic Deterioration|0|||
163935341|NCT01358331|592133020|FG001|Overall Study|Symptomatic Deterioration|0|||
163935342|NCT01358331|592133021|FG002|Overall Study|Symptomatic Deterioration|0|||
163935343|NCT01358331|592133022|FG003|Overall Study|Symptomatic Deterioration|0|||
163935344|NCT01358331|592133023|FG004|Overall Study|Symptomatic Deterioration|1|||
163935345|NCT01358331|592133024|FG005|Overall Study|Symptomatic Deterioration|0|||
163935346|NCT01358331|592133019|FG000|Overall Study|Participants did not wish to continue|0|||
163935347|NCT01358331|592133020|FG001|Overall Study|Participants did not wish to continue|0|||
163935348|NCT01358331|592133021|FG002|Overall Study|Participants did not wish to continue|0|||
163935349|NCT01358331|592133022|FG003|Overall Study|Participants did not wish to continue|0|||
163935350|NCT01358331|592133023|FG004|Overall Study|Participants did not wish to continue|1|||
164038269|NCT02371980|592500921|FG000|Open-label Period|Pregnancy|1|||
164038270|NCT02371980|592500922|FG001|Open-label Period|Pregnancy|0|||
164038271|NCT02371980|592500923|FG002|Open-label Period|Pregnancy|0|||
164038272|NCT02371980|592500924|FG003|Open-label Period|Pregnancy|0|||
164038273|NCT02371980|592500925|FG004|Open-label Period|Pregnancy|0|||
164038274|NCT02371980|592500921|FG000|Open-label Period|Lack of Efficacy|116|||
164038275|NCT02371980|592500922|FG001|Open-label Period|Lack of Efficacy|0|||
164038276|NCT02371980|592500923|FG002|Open-label Period|Lack of Efficacy|0|||
164038277|NCT02371980|592500924|FG003|Open-label Period|Lack of Efficacy|0|||
163839628|NCT02969525|591783655|FG008|Double-Blind Period|Adverse Event|0|||
163839629|NCT02969525|591783656|FG009|Double-Blind Period|Adverse Event|0|||
163839630|NCT02969525|591783657|FG010|Double-Blind Period|Adverse Event|0|||
163839631|NCT02969525|591783658|FG011|Double-Blind Period|Adverse Event|0|||
163839632|NCT02969525|591783647|FG000|Double-Blind Period|LOW EGFR|0|||
163839633|NCT02969525|591783648|FG001|Double-Blind Period|LOW EGFR|0|||
163839634|NCT02969525|591783649|FG002|Double-Blind Period|LOW EGFR|0|||
163839635|NCT02969525|591783650|FG003|Double-Blind Period|LOW EGFR|1|||
163839636|NCT02969525|591783651|FG004|Double-Blind Period|LOW EGFR|0|||
163839637|NCT02969525|591783652|FG005|Double-Blind Period|LOW EGFR|0|||
163839638|NCT02969525|591783653|FG006|Double-Blind Period|LOW EGFR|0|||
163839639|NCT02969525|591783654|FG007|Double-Blind Period|LOW EGFR|0|||
163839640|NCT02969525|591783655|FG008|Double-Blind Period|LOW EGFR|0|||
163839641|NCT02969525|591783656|FG009|Double-Blind Period|LOW EGFR|0|||
163839642|NCT02969525|591783657|FG010|Double-Blind Period|LOW EGFR|0|||
163839643|NCT02969525|591783658|FG011|Double-Blind Period|LOW EGFR|0|||
163839644|NCT02969525|591783647|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
163839645|NCT02969525|591783648|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839646|NCT02969525|591783649|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839647|NCT02969525|591783650|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
163839648|NCT02969525|591783651|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839649|NCT02969525|591783652|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839650|NCT02969525|591783653|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839651|NCT02969525|591783654|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839652|NCT02969525|591783655|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839653|NCT02969525|591783656|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839654|NCT02969525|591783657|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839655|NCT02969525|591783658|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
163839656|NCT02969525|591783647|FG000|Dose-Blind Period|Adverse Event|0|||
163839657|NCT02969525|591783648|FG001|Dose-Blind Period|Adverse Event|0|||
163839658|NCT02969525|591783649|FG002|Dose-Blind Period|Adverse Event|0|||
163839659|NCT02969525|591783650|FG003|Dose-Blind Period|Adverse Event|0|||
163839660|NCT02969525|591783651|FG004|Dose-Blind Period|Adverse Event|0|||
163839661|NCT02969525|591783652|FG005|Dose-Blind Period|Adverse Event|0|||
163839662|NCT02969525|591783653|FG006|Dose-Blind Period|Adverse Event|0|||
163839663|NCT02969525|591783654|FG007|Dose-Blind Period|Adverse Event|0|||
163839664|NCT02969525|591783655|FG008|Dose-Blind Period|Adverse Event|0|||
163839665|NCT02969525|591783656|FG009|Dose-Blind Period|Adverse Event|1|||
163839666|NCT02969525|591783657|FG010|Dose-Blind Period|Adverse Event|1|||
163839667|NCT02969525|591783658|FG011|Dose-Blind Period|Adverse Event|1|||
163839668|NCT02969525|591783647|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
163839669|NCT02969525|591783648|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
163839670|NCT02969525|591783649|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
163839671|NCT02969525|591783650|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
163839672|NCT02969525|591783651|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
163839673|NCT02969525|591783652|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
163839674|NCT02969525|591783653|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
163839675|NCT02969525|591783654|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
163839676|NCT02969525|591783655|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
163839677|NCT02969525|591783656|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
163839678|NCT02969525|591783657|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
163839679|NCT02969525|591783658|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
163839680|NCT02969525|591783647|FG000|Dose-Blind Period|Non-cooperating patient|0|||
163839681|NCT02969525|591783648|FG001|Dose-Blind Period|Non-cooperating patient|0|||
163839682|NCT02969525|591783649|FG002|Dose-Blind Period|Non-cooperating patient|0|||
163839683|NCT02969525|591783650|FG003|Dose-Blind Period|Non-cooperating patient|0|||
163839684|NCT02969525|591783651|FG004|Dose-Blind Period|Non-cooperating patient|0|||
163839685|NCT02969525|591783652|FG005|Dose-Blind Period|Non-cooperating patient|0|||
164038278|NCT02371980|592500925|FG004|Open-label Period|Lack of Efficacy|0|||
163839686|NCT02969525|591783653|FG006|Dose-Blind Period|Non-cooperating patient|0|||
163839687|NCT02969525|591783654|FG007|Dose-Blind Period|Non-cooperating patient|0|||
163839688|NCT02969525|591783655|FG008|Dose-Blind Period|Non-cooperating patient|0|||
163839689|NCT02969525|591783656|FG009|Dose-Blind Period|Non-cooperating patient|0|||
163839690|NCT02969525|591783657|FG010|Dose-Blind Period|Non-cooperating patient|0|||
163839691|NCT02969525|591783658|FG011|Dose-Blind Period|Non-cooperating patient|1|||
163839692|NCT02969525|591783647|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164098723|NCT00328926|592726876|FG002|Overall Study|Pregnancy|0|||
164098724|NCT00328926|592726874|FG000|Overall Study|Lost to Follow-up|0|||
164098725|NCT00328926|592726875|FG001|Overall Study|Lost to Follow-up|1|||
164098726|NCT00328926|592726876|FG002|Overall Study|Lost to Follow-up|0|||
164098727|NCT00328926|592726874|FG000|Overall Study|Death|0|||
163935351|NCT01358331|592133024|FG005|Overall Study|Participants did not wish to continue|0|||
163935352|NCT01358331|592133019|FG000|Overall Study|Progress of disease under investigation|1|||
163935353|NCT01358331|592133020|FG001|Overall Study|Progress of disease under investigation|2|||
163935354|NCT01358331|592133021|FG002|Overall Study|Progress of disease under investigation|3|||
163935355|NCT01358331|592133022|FG003|Overall Study|Progress of disease under investigation|1|||
163935356|NCT01358331|592133023|FG004|Overall Study|Progress of disease under investigation|3|||
163935357|NCT01358331|592133024|FG005|Overall Study|Progress of disease under investigation|0|||
163935358|NCT04946942|592133025|FG000|Overall Study|Lost to Follow-up|6|||
163935359|NCT04946942|592133026|FG001|Overall Study|Lost to Follow-up|2|||
163935360|NCT04946942|592133027|FG002|Overall Study|Lost to Follow-up|0|||
163935361|NCT03342196|592133028|FG000|Overall Study|Physician Decision|1|||
163935362|NCT02257918|592133029|FG000|Overall Study|Lost to Follow-up|4|||
163935363|NCT02257918|592133030|FG001|Overall Study|Lost to Follow-up|1|||
163935364|NCT02257918|592133031|FG002|Overall Study|Lost to Follow-up|0|||
163935365|NCT02257918|592133029|FG000|Overall Study|Withdrawal by Subject|0|||
163935366|NCT02257918|592133030|FG001|Overall Study|Withdrawal by Subject|0|||
163935367|NCT02257918|592133031|FG002|Overall Study|Withdrawal by Subject|1|||
163935368|NCT02257918|592133029|FG000|Overall Study|Pregnancy|0|||
163935369|NCT02257918|592133030|FG001|Overall Study|Pregnancy|0|||
163935370|NCT02257918|592133031|FG002|Overall Study|Pregnancy|1|||
163935371|NCT03023423|592133034|FG000|Overall Study|Death|5|||
163935372|NCT03023423|592133035|FG001|Overall Study|Death|12|||
163935373|NCT03023423|592133036|FG002|Overall Study|Death|20|||
163935374|NCT03023423|592133034|FG000|Overall Study|Other|0|||
163935375|NCT03023423|592133035|FG001|Overall Study|Other|2|||
163935376|NCT03023423|592133036|FG002|Overall Study|Other|2|||
163935377|NCT03023423|592133034|FG000|Overall Study|Ongoing|2|||
163935378|NCT03023423|592133035|FG001|Overall Study|Ongoing|32|||
163935379|NCT03023423|592133036|FG002|Overall Study|Ongoing|24|||
163935380|NCT01151423|592133037|FG000|Overall Study|Study terminated by Sponsor|9|||
163935381|NCT01151423|592133038|FG001|Overall Study|Study terminated by Sponsor|10|||
163935382|NCT01151423|592133037|FG000|Overall Study|Protocol Violation|0|||
163935383|NCT01151423|592133038|FG001|Overall Study|Protocol Violation|1|||
163935384|NCT01151423|592133037|FG000|Overall Study|Physician Decision|1|||
163935385|NCT01151423|592133038|FG001|Overall Study|Physician Decision|1|||
163935386|NCT01151423|592133037|FG000|Overall Study|Pregnancy|0|||
163935387|NCT01151423|592133038|FG001|Overall Study|Pregnancy|1|||
163935388|NCT01151423|592133037|FG000|Overall Study|Death|0|||
163935389|NCT01151423|592133038|FG001|Overall Study|Death|1|||
163935390|NCT01151423|592133037|FG000|Overall Study|Adverse Event|3|||
163935391|NCT01151423|592133038|FG001|Overall Study|Adverse Event|0|||
163935392|NCT01151423|592133037|FG000|Overall Study|Withdrawal by Subject|1|||
163935393|NCT01151423|592133038|FG001|Overall Study|Withdrawal by Subject|3|||
163935394|NCT01151423|592133037|FG000|Overall Study|Lost to Follow-up|1|||
163935395|NCT01151423|592133038|FG001|Overall Study|Lost to Follow-up|0|||
163935396|NCT01151423|592133037|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
163935397|NCT01151423|592133038|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
163935398|NCT01151423|592133037|FG000|Overall Study|Participated in other clinical trial|1|||
163935399|NCT01151423|592133038|FG001|Overall Study|Participated in other clinical trial|0|||
163935400|NCT01263054|592133039|FG000|Overall Study|Death|1|||
163935401|NCT01263054|592133040|FG001|Overall Study|Death|0|||
163935402|NCT01263054|592133039|FG000|Overall Study|Lost to Follow-up|2|||
163935403|NCT01263054|592133040|FG001|Overall Study|Lost to Follow-up|2|||
163935404|NCT01263054|592133039|FG000|Overall Study|Withdrawal by Subject|1|||
163935405|NCT01263054|592133040|FG001|Overall Study|Withdrawal by Subject|3|||
163935406|NCT01263054|592133039|FG000|Overall Study|Qualification Violation|1|||
163935407|NCT01263054|592133040|FG001|Overall Study|Qualification Violation|0|||
163935408|NCT01263054|592133039|FG000|Overall Study|Other|0|||
163935409|NCT01263054|592133040|FG001|Overall Study|Other|1|||
163935410|NCT00681668|592133041|FG000|Overall Study|Protocol Violation|1|||
163935411|NCT00681668|592133041|FG000|Overall Study|Withdrawal by Subject|1|||
163935412|NCT04277507|592133045|FG000|Overall Study|Lost to Follow-up|17|||
163935413|NCT04277507|592133045|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
163935414|NCT04277507|592133045|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
163935415|NCT04277507|592133045|FG000|Overall Study|Withdrawal by Subject|3|||
163935416|NCT04277507|592133045|FG000|Overall Study|Death due to COVID-19|1|||
163935417|NCT04277507|592133045|FG000|Overall Study|Data missing for full evaluation|5|||
163935418|NCT00583947|592133055|FG000|Cross-over Period|Adverse Event|2|||
163935419|NCT00583947|592133056|FG001|Cross-over Period|Adverse Event|0|||
163935420|NCT00583947|592133055|FG000|Cross-over Period|Withdrawal by Subject|2|||
163935421|NCT00583947|592133056|FG001|Cross-over Period|Withdrawal by Subject|0|||
163935422|NCT00583947|592133055|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
164098728|NCT00328926|592726875|FG001|Overall Study|Death|0|||
164038279|NCT02371980|592500921|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
164038280|NCT02371980|592500922|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
164038281|NCT02371980|592500923|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
164038282|NCT02371980|592500924|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
164038283|NCT02371980|592500925|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
164038284|NCT02371980|592500921|FG000|Open-label Period|Reason not Specified|9|||
164038285|NCT02371980|592500922|FG001|Open-label Period|Reason not Specified|0|||
164038286|NCT02371980|592500923|FG002|Open-label Period|Reason not Specified|0|||
164038287|NCT02371980|592500924|FG003|Open-label Period|Reason not Specified|0|||
164038288|NCT02371980|592500925|FG004|Open-label Period|Reason not Specified|0|||
164038289|NCT02371980|592500921|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
164038290|NCT02371980|592500922|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
164038291|NCT02371980|592500923|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
164038292|NCT02371980|592500924|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
164038293|NCT02371980|592500925|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
164038294|NCT02371980|592500921|FG000|Double-blind Period|Significant Protocol Deviation|0|||
164038295|NCT02371980|592500922|FG001|Double-blind Period|Significant Protocol Deviation|2|||
164038296|NCT02371980|592500923|FG002|Double-blind Period|Significant Protocol Deviation|7|||
164038297|NCT02371980|592500924|FG003|Double-blind Period|Significant Protocol Deviation|3|||
164038298|NCT02371980|592500925|FG004|Double-blind Period|Significant Protocol Deviation|3|||
164038299|NCT02371980|592500921|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
164038300|NCT02371980|592500922|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
164038301|NCT02371980|592500923|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
164038302|NCT02371980|592500924|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
164038303|NCT02371980|592500925|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
164038304|NCT02371980|592500921|FG000|Double-blind Period|Lost to Follow-up|0|||
164038305|NCT02371980|592500922|FG001|Double-blind Period|Lost to Follow-up|8|||
164038306|NCT02371980|592500923|FG002|Double-blind Period|Lost to Follow-up|8|||
164038307|NCT02371980|592500924|FG003|Double-blind Period|Lost to Follow-up|6|||
164038308|NCT02371980|592500925|FG004|Double-blind Period|Lost to Follow-up|5|||
164038309|NCT02371980|592500921|FG000|Double-blind Period|Voluntary Withdrawal|0|||
164038310|NCT02371980|592500922|FG001|Double-blind Period|Voluntary Withdrawal|12|||
164038311|NCT02371980|592500923|FG002|Double-blind Period|Voluntary Withdrawal|8|||
164038312|NCT02371980|592500924|FG003|Double-blind Period|Voluntary Withdrawal|9|||
164038313|NCT02371980|592500925|FG004|Double-blind Period|Voluntary Withdrawal|11|||
164038314|NCT02371980|592500921|FG000|Double-blind Period|Relapse|0|||
164038315|NCT02371980|592500922|FG001|Double-blind Period|Relapse|50|||
164038316|NCT02371980|592500923|FG002|Double-blind Period|Relapse|25|||
164038317|NCT02371980|592500924|FG003|Double-blind Period|Relapse|25|||
164038318|NCT02371980|592500925|FG004|Double-blind Period|Relapse|26|||
164038319|NCT02371980|592500921|FG000|Double-blind Period|Reason not Specified|0|||
164038320|NCT02371980|592500922|FG001|Double-blind Period|Reason not Specified|3|||
164038321|NCT02371980|592500923|FG002|Double-blind Period|Reason not Specified|3|||
164038322|NCT02371980|592500924|FG003|Double-blind Period|Reason not Specified|2|||
164038323|NCT02371980|592500925|FG004|Double-blind Period|Reason not Specified|1|||
164038324|NCT02371980|592500921|FG000|Double-blind Period|Missing|0|||
164038325|NCT02371980|592500922|FG001|Double-blind Period|Missing|1|||
164038326|NCT02371980|592500923|FG002|Double-blind Period|Missing|0|||
164038327|NCT02371980|592500924|FG003|Double-blind Period|Missing|0|||
164038328|NCT02371980|592500925|FG004|Double-blind Period|Missing|0|||
164038329|NCT01280812|592500927|FG000|Overall Study|Withdrawal by Subject|2|||
164038330|NCT01280812|592500928|FG001|Overall Study|Withdrawal by Subject|1|||
164038331|NCT01280812|592500929|FG002|Overall Study|Withdrawal by Subject|0|||
164038332|NCT01280812|592500927|FG000|Overall Study|Lost to Follow-up|1|||
164038333|NCT01280812|592500928|FG001|Overall Study|Lost to Follow-up|1|||
164038334|NCT01280812|592500929|FG002|Overall Study|Lost to Follow-up|1|||
164038335|NCT01594749|592500935|FG000|Overall Study|Adverse Event|2|||
164038336|NCT01594749|592500936|FG001|Overall Study|Adverse Event|1|||
164038337|NCT01594749|592500935|FG000|Overall Study|Withdrawal by Subject|2|||
164038338|NCT01594749|592500936|FG001|Overall Study|Withdrawal by Subject|2|||
164038339|NCT01594749|592500935|FG000|Overall Study|Protocol Violation|2|||
164038340|NCT01594749|592500936|FG001|Overall Study|Protocol Violation|0|||
164038341|NCT01594749|592500935|FG000|Overall Study|Physician Decision|1|||
164038342|NCT01594749|592500936|FG001|Overall Study|Physician Decision|1|||
164038343|NCT01594749|592500935|FG000|Overall Study|Non-compliance with Protocol|0|||
164038344|NCT01594749|592500936|FG001|Overall Study|Non-compliance with Protocol|1|||
164038345|NCT01594749|592500935|FG000|Overall Study|Lost to Follow-up|1|||
164038346|NCT01594749|592500936|FG001|Overall Study|Lost to Follow-up|0|||
164038347|NCT01594749|592500935|FG000|Overall Study|Death|9|||
164038348|NCT01594749|592500936|FG001|Overall Study|Death|3|||
164038349|NCT01594749|592500935|FG000|Overall Study|Not Treated|4|||
164038350|NCT01594749|592500936|FG001|Overall Study|Not Treated|10|||
164038351|NCT01594749|592500935|FG000|Overall Study|Lost Source Documentation|1|||
164038352|NCT01594749|592500936|FG001|Overall Study|Lost Source Documentation|0|||
164038353|NCT00959894|592500937|FG000|Overall Study|Lost to Follow-up|10|||
163935423|NCT00583947|592133056|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
163935424|NCT00583947|592133055|FG000|Cross-over Period|Other|1|||
163935425|NCT00583947|592133056|FG001|Cross-over Period|Other|1|||
163935426|NCT01740154|592133058|FG000|Overall Study|Adverse Event|1|||
163935427|NCT03358472|592133062|FG000|Overall Study|Death|6|||
163935428|NCT03358472|592133063|FG001|Overall Study|Death|3|||
163935429|NCT03358472|592133064|FG002|Overall Study|Death|10|||
163935430|NCT03358472|592133062|FG000|Overall Study|Physician Decision|0|||
163935431|NCT03358472|592133063|FG001|Overall Study|Physician Decision|1|||
163935432|NCT03358472|592133064|FG002|Overall Study|Physician Decision|0|||
163935433|NCT03358472|592133062|FG000|Overall Study|Withdrawal by Subject|0|||
163935434|NCT03358472|592133063|FG001|Overall Study|Withdrawal by Subject|0|||
163935435|NCT03358472|592133064|FG002|Overall Study|Withdrawal by Subject|1|||
163935436|NCT03358472|592133062|FG000|Overall Study|On-going at clinical cut off date|9|||
163935437|NCT03358472|592133063|FG001|Overall Study|On-going at clinical cut off date|6|||
163935438|NCT03358472|592133064|FG002|Overall Study|On-going at clinical cut off date|5|||
163935439|NCT02520310|592133069|FG000|At 6 Months Clinical Follow-up|Death|1|||
163935440|NCT02520310|592133069|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
163935441|NCT02520310|592133069|FG000|AT 3 Year Clinical Follow-up|Death|2|||
163935442|NCT02520310|592133069|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
163935443|NCT02520310|592133069|FG000|AT 4 Year Clinical Follow-up|Death|1|||
163935444|NCT02520310|592133069|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
163935445|NCT05032066|592133070|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
163935446|NCT05032066|592133071|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
163935447|NCT05032066|592133072|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
163935448|NCT05032066|592133070|FG000|Part 1: Core Phase|Physician Decision|0|||
163935449|NCT05032066|592133071|FG001|Part 1: Core Phase|Physician Decision|1|||
163935450|NCT05032066|592133072|FG002|Part 1: Core Phase|Physician Decision|1|||
163935451|NCT05032066|592133070|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
163935452|NCT05032066|592133071|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
163935453|NCT05032066|592133072|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
163935454|NCT05032066|592133070|FG000|Part 1: Core Phase|Death|3|||
163935455|NCT05032066|592133071|FG001|Part 1: Core Phase|Death|4|||
163935456|NCT05032066|592133072|FG002|Part 1: Core Phase|Death|2|||
163935457|NCT05032066|592133070|FG000|Part 1: Core Phase|Adverse Event|2|||
163935458|NCT05032066|592133071|FG001|Part 1: Core Phase|Adverse Event|3|||
163935459|NCT05032066|592133072|FG002|Part 1: Core Phase|Adverse Event|0|||
163935460|NCT05032066|592133070|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
163935461|NCT05032066|592133071|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
163935462|NCT05032066|592133072|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
163935463|NCT05032066|592133070|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
163935464|NCT05032066|592133071|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
163935465|NCT05032066|592133072|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
163935466|NCT05032066|592133070|FG000|Part 2: Extension Phase|Physician Decision|1|||
163935467|NCT05032066|592133071|FG001|Part 2: Extension Phase|Physician Decision|2|||
163935468|NCT05032066|592133072|FG002|Part 2: Extension Phase|Physician Decision|0|||
163935469|NCT05032066|592133070|FG000|Part 2: Extension Phase|Death|2|||
163935470|NCT05032066|592133071|FG001|Part 2: Extension Phase|Death|4|||
163935471|NCT05032066|592133072|FG002|Part 2: Extension Phase|Death|5|||
163935472|NCT01124838|592133075|FG000|Overall Study|Miscellaneous|4|||
163935473|NCT01124838|592133076|FG001|Overall Study|Miscellaneous|2|||
163935474|NCT01124838|592133075|FG000|Overall Study|Adverse Event|7|||
163935475|NCT01124838|592133076|FG001|Overall Study|Adverse Event|11|||
163935476|NCT01124838|592133075|FG000|Overall Study|Lack of Efficacy|2|||
163935477|NCT01124838|592133076|FG001|Overall Study|Lack of Efficacy|0|||
163935478|NCT01124838|592133075|FG000|Overall Study|Withdrawal by Subject|3|||
163935479|NCT01124838|592133076|FG001|Overall Study|Withdrawal by Subject|2|||
163935480|NCT01124838|592133075|FG000|Overall Study|Lost to Follow-up|2|||
163935481|NCT01124838|592133076|FG001|Overall Study|Lost to Follow-up|0|||
163935482|NCT02065882|592133077|FG000|Part I: PK/PD|Screening failure|5|||
163935483|NCT02065882|592133077|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
163935484|NCT02065882|592133077|FG000|Part I: PK/PD|Adverse Event|1|||
163935485|NCT02065882|592133077|FG000|Part II: Clinical Efficacy|Screening failure|7|||
163935486|NCT02065882|592133077|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
163935487|NCT02065882|592133077|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
163935488|NCT02065882|592133077|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
163935489|NCT02065882|592133077|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
163935490|NCT02065882|592133077|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
163935491|NCT06719986|592133078|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
163935492|NCT06719986|592133079|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
163935493|NCT06719986|592133080|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
163935494|NCT06719986|592133078|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
163935495|NCT06719986|592133079|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
163935496|NCT06719986|592133080|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
163935497|NCT03213704|592133082|FG000|Overall Study|Physician Decision|3|||
163935498|NCT03213704|592133082|FG000|Overall Study|Protocol Violation|1|||
163935499|NCT03213704|592133082|FG000|Overall Study|Progressive disease|4|||
163935500|NCT01183390|592134918|FG000|First Intervention|Adverse Event|0|||
163935501|NCT01183390|592134919|FG001|First Intervention|Adverse Event|1|||
163935502|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Adverse Event|2|||
163935503|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Adverse Event|0|||
163935504|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Adverse Event|0|||
163935505|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Adverse Event|0|||
163935506|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
163935507|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
163935508|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
163935509|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
163935510|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
163935511|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
163935512|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
163935513|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
163935514|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Physician Decision|1|||
163935515|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Physician Decision|0|||
163935516|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Physician Decision|0|||
163935517|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Physician Decision|0|||
163935518|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Pregnancy|1|||
163935519|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Pregnancy|0|||
163935520|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Pregnancy|0|||
163935521|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Pregnancy|0|||
163935522|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
163935523|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
163935524|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163935525|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
163935526|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
163935527|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
163935528|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
163935529|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
163935530|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
163935531|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
163935532|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
163935533|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
163935534|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
163935535|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
163935536|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
163935537|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
163935538|NCT04057573|592134922|FG000|24-Week Double-Blind Period|Not Treated|1|||
163935539|NCT04057573|592134923|FG001|24-Week Double-Blind Period|Not Treated|0|||
163935540|NCT04057573|592134924|FG002|24-Week Double-Blind Period|Not Treated|0|||
163935541|NCT04057573|592134925|FG003|24-Week Double-Blind Period|Not Treated|0|||
163935542|NCT04057573|592134922|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
163935543|NCT04057573|592134923|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
163935544|NCT04057573|592134924|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
163935545|NCT04057573|592134925|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
163935546|NCT04057573|592134922|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
163935547|NCT04057573|592134923|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
163935548|NCT04057573|592134924|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
163935549|NCT04057573|592134925|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
163935550|NCT04057573|592134922|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
163935551|NCT04057573|592134923|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
163935552|NCT04057573|592134924|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
163935553|NCT04057573|592134925|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
163935554|NCT04057573|592134922|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
163935555|NCT04057573|592134923|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
163935556|NCT04057573|592134924|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
163935557|NCT04057573|592134925|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
163935558|NCT04057573|592134922|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
163935559|NCT04057573|592134923|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
163935560|NCT04057573|592134924|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
163935561|NCT04057573|592134925|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
163935562|NCT04991753|592134926|FG000|Overall Study|Withdrawal by Subject|0|||
163935563|NCT04991753|592134927|FG001|Overall Study|Withdrawal by Subject|1|||
163935564|NCT00233480|592134930|FG000|Overall Study|Underwent status II heart transplant|0|||
164038354|NCT00959894|592500937|FG000|Overall Study|Adverse Event|3|||
164038355|NCT00959894|592500937|FG000|Overall Study|Withdrawal by Subject|1|||
164038356|NCT00959894|592500937|FG000|Overall Study|Need for contraindicated medication|1|||
164038357|NCT00959894|592500937|FG000|Overall Study|Subject moved out of town|1|||
164038358|NCT00922974|592500938|FG000|Phase II Component|Protocol Violation|2|||
164038359|NCT00922974|592500939|FG001|Phase II Component|Protocol Violation|0|||
164038360|NCT00922974|592500938|FG000|Phase II Component|Not evaluable for treatment review|5|||
164038361|NCT00922974|592500939|FG001|Phase II Component|Not evaluable for treatment review|0|||
164038362|NCT00922974|592500938|FG000|Phase III Component|Protocol Violation|8|||
164038363|NCT00922974|592500939|FG001|Phase III Component|Protocol Violation|6|||
164038364|NCT01826448|592500940|FG000|Overall Study|Adverse Event|1|||
164038365|NCT01826448|592500941|FG001|Overall Study|Adverse Event|3|||
164038366|NCT01826448|592500940|FG000|Overall Study|Disease progression|2|||
164038367|NCT01826448|592500941|FG001|Overall Study|Disease progression|4|||
164038368|NCT01826448|592500940|FG000|Overall Study|Withdrawal by Subject|1|||
164038369|NCT01826448|592500941|FG001|Overall Study|Withdrawal by Subject|0|||
164038370|NCT01826448|592500940|FG000|Overall Study|Physician Decision|0|||
164038371|NCT01826448|592500941|FG001|Overall Study|Physician Decision|1|||
164038372|NCT01826448|592500940|FG000|Overall Study|2 active cancers|0|||
164038373|NCT01826448|592500941|FG001|Overall Study|2 active cancers|1|||
164038374|NCT02578992|592500943|FG000|Overall Study|equipment not available or malfunction|3|||
164038375|NCT02578992|592500944|FG001|Overall Study|equipment not available or malfunction|3|||
164038376|NCT00880100|592500946|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
164038377|NCT00880100|592500946|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
164038378|NCT00880100|592500946|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
164038379|NCT02038790|592500949|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
164038380|NCT02038790|592500950|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
164038381|NCT02431702|592500952|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
164038382|NCT02431702|592500953|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164038383|NCT02431702|592500954|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164038384|NCT02431702|592500955|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164038385|NCT02431702|592500956|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164038386|NCT02431702|592500957|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164038387|NCT02431702|592500958|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
164038388|NCT02431702|592500952|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
164038389|NCT02431702|592500953|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164038390|NCT02431702|592500954|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164038391|NCT02431702|592500955|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164038392|NCT02431702|592500956|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164038393|NCT02431702|592500957|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
164038394|NCT02431702|592500958|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
164038395|NCT02431702|592500952|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
164038396|NCT02431702|592500953|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164038397|NCT02431702|592500954|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164038398|NCT02431702|592500955|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164038399|NCT02431702|592500956|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164038400|NCT02431702|592500957|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
164038401|NCT02431702|592500958|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
164038402|NCT02431702|592500952|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
164038403|NCT02431702|592500953|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164038404|NCT02431702|592500954|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164038405|NCT02431702|592500955|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164038406|NCT02431702|592500956|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164038407|NCT02431702|592500957|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
164038408|NCT02431702|592500958|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
164038409|NCT02431702|592500952|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
164038410|NCT02431702|592500953|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164038411|NCT02431702|592500954|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164038412|NCT02431702|592500955|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164038413|NCT02431702|592500956|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164038414|NCT02431702|592500957|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164038415|NCT02431702|592500958|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
164038416|NCT02431702|592500952|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164038417|NCT02431702|592500953|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
164038418|NCT02431702|592500954|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
164038419|NCT02431702|592500955|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164038420|NCT02431702|592500956|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164038421|NCT02431702|592500957|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164038422|NCT02431702|592500958|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
164038423|NCT02431702|592500952|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164038424|NCT02431702|592500953|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
164038425|NCT02431702|592500954|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
164038426|NCT02431702|592500955|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164038427|NCT02431702|592500956|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164038428|NCT02431702|592500957|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164038429|NCT02431702|592500958|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
164038430|NCT02431702|592500952|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164038431|NCT02431702|592500953|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
164038432|NCT02431702|592500954|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
164038433|NCT02431702|592500955|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164038434|NCT02431702|592500956|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164038435|NCT02431702|592500957|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164038436|NCT02431702|592500958|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
164038437|NCT02431702|592500952|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164038438|NCT02431702|592500953|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
164038439|NCT02431702|592500954|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164038440|NCT02431702|592500955|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164038441|NCT02431702|592500956|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164038442|NCT02431702|592500957|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164038443|NCT02431702|592500958|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
164038444|NCT02431702|592500952|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
164038445|NCT02431702|592500953|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
164038446|NCT02431702|592500954|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
164038447|NCT02431702|592500955|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
164038448|NCT02431702|592500956|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
164038449|NCT02431702|592500957|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
164038450|NCT02431702|592500958|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
164038451|NCT02431702|592500952|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164038452|NCT02431702|592500953|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164038453|NCT02431702|592500954|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
164038454|NCT02431702|592500955|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164038455|NCT02431702|592500956|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164038456|NCT02431702|592500957|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164038457|NCT02431702|592500958|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
164038458|NCT02431702|592500952|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164038459|NCT02431702|592500953|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164038460|NCT02431702|592500954|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164038461|NCT02431702|592500955|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
164038462|NCT02431702|592500956|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
164038463|NCT02431702|592500957|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164038464|NCT02431702|592500958|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
164038465|NCT02431702|592500952|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164038466|NCT02431702|592500953|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164038467|NCT02431702|592500954|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164038468|NCT02431702|592500955|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
164038469|NCT02431702|592500956|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164038470|NCT02431702|592500957|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
164038471|NCT02431702|592500958|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
164038472|NCT02431702|592500952|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164038473|NCT02431702|592500953|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164038474|NCT02431702|592500954|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164038475|NCT02431702|592500955|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
164038476|NCT02431702|592500956|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
164038477|NCT02431702|592500957|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
164038478|NCT02431702|592500958|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
164038479|NCT02431702|592500952|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
164038480|NCT02431702|592500953|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
164038481|NCT02431702|592500954|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
164038482|NCT02431702|592500955|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
164038483|NCT02431702|592500956|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
164038484|NCT02431702|592500957|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
164038485|NCT02431702|592500958|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
164038486|NCT01376388|592500968|FG000|Overall Study|Adverse Event|13|||
164038487|NCT01376388|592500968|FG000|Overall Study|Lack of Efficacy|2|||
164038488|NCT01376388|592500968|FG000|Overall Study|Withdrawal by Subject|3|||
164038489|NCT02009930|592500969|FG000|Overall Study|withdrawn|5|||
164038490|NCT03907969|592500973|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
164038491|NCT03907969|592500974|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
164038492|NCT03907969|592500975|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
164038493|NCT03907969|592500976|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
164038494|NCT03907969|592500977|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
164038495|NCT03907969|592500978|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
164038496|NCT03907969|592500979|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
164038497|NCT03907969|592500980|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
164038498|NCT03907969|592500981|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
164038499|NCT03907969|592500982|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
164038500|NCT03907969|592500983|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
164038501|NCT03907969|592500973|FG000|Monotherapy Part A|Progressive Disease|0|||
164038502|NCT03907969|592500974|FG001|Monotherapy Part A|Progressive Disease|1|||
164038503|NCT03907969|592500975|FG002|Monotherapy Part A|Progressive Disease|0|||
164038504|NCT03907969|592500976|FG003|Monotherapy Part A|Progressive Disease|0|||
164038505|NCT03907969|592500977|FG004|Monotherapy Part A|Progressive Disease|0|||
164038506|NCT03907969|592500978|FG005|Monotherapy Part A|Progressive Disease|1|||
164038507|NCT03907969|592500979|FG006|Monotherapy Part A|Progressive Disease|2|||
164038508|NCT03907969|592500980|FG007|Monotherapy Part A|Progressive Disease|0|||
164038509|NCT03907969|592500981|FG008|Monotherapy Part A|Progressive Disease|0|||
164038510|NCT03907969|592500982|FG009|Monotherapy Part A|Progressive Disease|0|||
164038511|NCT03907969|592500983|FG010|Monotherapy Part A|Progressive Disease|0|||
164038512|NCT03907969|592500973|FG000|Monotherapy Part A|Death|0|||
164038513|NCT03907969|592500974|FG001|Monotherapy Part A|Death|0|||
164038514|NCT03907969|592500975|FG002|Monotherapy Part A|Death|1|||
164038515|NCT03907969|592500976|FG003|Monotherapy Part A|Death|1|||
164038516|NCT03907969|592500977|FG004|Monotherapy Part A|Death|0|||
164038517|NCT03907969|592500978|FG005|Monotherapy Part A|Death|1|||
164038518|NCT03907969|592500979|FG006|Monotherapy Part A|Death|0|||
164038519|NCT03907969|592500980|FG007|Monotherapy Part A|Death|0|||
164038520|NCT03907969|592500981|FG008|Monotherapy Part A|Death|0|||
164038521|NCT03907969|592500982|FG009|Monotherapy Part A|Death|0|||
164038522|NCT03907969|592500983|FG010|Monotherapy Part A|Death|0|||
164038523|NCT03907969|592500973|FG000|Combination Therapy Part A|Adverse Event|0|||
164038524|NCT03907969|592500974|FG001|Combination Therapy Part A|Adverse Event|0|||
164038525|NCT03907969|592500975|FG002|Combination Therapy Part A|Adverse Event|0|||
164038526|NCT03907969|592500976|FG003|Combination Therapy Part A|Adverse Event|0|||
164038527|NCT03907969|592500977|FG004|Combination Therapy Part A|Adverse Event|0|||
164038528|NCT03907969|592500978|FG005|Combination Therapy Part A|Adverse Event|0|||
164038529|NCT03907969|592500979|FG006|Combination Therapy Part A|Adverse Event|0|||
164038530|NCT03907969|592500980|FG007|Combination Therapy Part A|Adverse Event|0|||
164038531|NCT03907969|592500981|FG008|Combination Therapy Part A|Adverse Event|0|||
164038532|NCT03907969|592500982|FG009|Combination Therapy Part A|Adverse Event|1|||
164038533|NCT03907969|592500983|FG010|Combination Therapy Part A|Adverse Event|1|||
164038534|NCT03907969|592500973|FG000|Combination Therapy Part A|Progressive disease|0|||
164038535|NCT03907969|592500974|FG001|Combination Therapy Part A|Progressive disease|0|||
164038536|NCT03907969|592500975|FG002|Combination Therapy Part A|Progressive disease|0|||
164038537|NCT03907969|592500976|FG003|Combination Therapy Part A|Progressive disease|0|||
164038538|NCT03907969|592500977|FG004|Combination Therapy Part A|Progressive disease|0|||
164098729|NCT00328926|592726876|FG002|Overall Study|Death|1|||
164038539|NCT03907969|592500978|FG005|Combination Therapy Part A|Progressive disease|0|||
164038540|NCT03907969|592500979|FG006|Combination Therapy Part A|Progressive disease|0|||
164038541|NCT03907969|592500980|FG007|Combination Therapy Part A|Progressive disease|1|||
164038542|NCT03907969|592500981|FG008|Combination Therapy Part A|Progressive disease|0|||
164038543|NCT03907969|592500982|FG009|Combination Therapy Part A|Progressive disease|2|||
164038544|NCT03907969|592500983|FG010|Combination Therapy Part A|Progressive disease|3|||
164038545|NCT03907969|592500973|FG000|Combination Therapy Part A|Death|0|||
164038546|NCT03907969|592500974|FG001|Combination Therapy Part A|Death|0|||
164038547|NCT03907969|592500975|FG002|Combination Therapy Part A|Death|0|||
164038548|NCT03907969|592500976|FG003|Combination Therapy Part A|Death|0|||
164038549|NCT03907969|592500977|FG004|Combination Therapy Part A|Death|0|||
164038550|NCT03907969|592500978|FG005|Combination Therapy Part A|Death|0|||
164038551|NCT03907969|592500979|FG006|Combination Therapy Part A|Death|0|||
164038552|NCT03907969|592500980|FG007|Combination Therapy Part A|Death|0|||
164038553|NCT03907969|592500981|FG008|Combination Therapy Part A|Death|1|||
164038554|NCT03907969|592500982|FG009|Combination Therapy Part A|Death|0|||
164038555|NCT03907969|592500983|FG010|Combination Therapy Part A|Death|1|||
164038556|NCT03907969|592500973|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
164038557|NCT03907969|592500974|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
164038558|NCT03907969|592500975|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
164038559|NCT03907969|592500976|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
164038560|NCT03907969|592500977|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
164038561|NCT03907969|592500978|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
164038562|NCT03907969|592500979|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
164038563|NCT03907969|592500980|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
164038564|NCT03907969|592500981|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
164038565|NCT03907969|592500982|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
164038566|NCT03907969|592500983|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
164038567|NCT03907969|592500973|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
164038568|NCT03907969|592500974|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
164038569|NCT03907969|592500975|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
164038570|NCT03907969|592500976|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
164038571|NCT03907969|592500977|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
164038572|NCT03907969|592500978|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
164038573|NCT03907969|592500979|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
164038574|NCT03907969|592500980|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
164038575|NCT03907969|592500981|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
164038576|NCT03907969|592500982|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
164038577|NCT03907969|592500983|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
164038578|NCT03907969|592500973|FG000|Combination Therapy Part A|Physician Decision|0|||
164038579|NCT03907969|592500974|FG001|Combination Therapy Part A|Physician Decision|0|||
164038580|NCT03907969|592500975|FG002|Combination Therapy Part A|Physician Decision|0|||
164038581|NCT03907969|592500976|FG003|Combination Therapy Part A|Physician Decision|0|||
164038582|NCT03907969|592500977|FG004|Combination Therapy Part A|Physician Decision|0|||
164038583|NCT03907969|592500978|FG005|Combination Therapy Part A|Physician Decision|0|||
164038584|NCT03907969|592500979|FG006|Combination Therapy Part A|Physician Decision|0|||
164038585|NCT03907969|592500980|FG007|Combination Therapy Part A|Physician Decision|1|||
164038586|NCT03907969|592500981|FG008|Combination Therapy Part A|Physician Decision|0|||
164038587|NCT03907969|592500982|FG009|Combination Therapy Part A|Physician Decision|0|||
164038588|NCT03907969|592500983|FG010|Combination Therapy Part A|Physician Decision|1|||
164038589|NCT01419015|592500984|FG000|Overall Study|Death|2|||
164038590|NCT03725293|592500989|FG000|Overall Study|Physician Decision|9|||
164038591|NCT03725293|592500990|FG001|Overall Study|Physician Decision|6|||
164038592|NCT03725293|592500989|FG000|Overall Study|alternative vascular access needs|1|||
164038593|NCT03725293|592500990|FG001|Overall Study|alternative vascular access needs|2|||
164038594|NCT03725293|592500989|FG000|Overall Study|venous anatomy screen failures|2|||
164038595|NCT03725293|592500990|FG001|Overall Study|venous anatomy screen failures|1|||
164038596|NCT03228394|592500991|FG000|Overall Study|Lost to Follow-up|0|||
164038597|NCT03228394|592500992|FG001|Overall Study|Lost to Follow-up|0|||
164038598|NCT03228394|592500993|FG002|Overall Study|Lost to Follow-up|1|||
164038599|NCT03228394|592500994|FG003|Overall Study|Lost to Follow-up|1|||
164038600|NCT03228394|592500995|FG004|Overall Study|Lost to Follow-up|0|||
164038601|NCT03228394|592500996|FG005|Overall Study|Lost to Follow-up|0|||
164038602|NCT03228394|592500997|FG006|Overall Study|Lost to Follow-up|2|||
164038603|NCT03228394|592500998|FG007|Overall Study|Lost to Follow-up|0|||
164038604|NCT03228394|592500991|FG000|Overall Study|Withdrawal by Subject|0|||
164038605|NCT03228394|592500992|FG001|Overall Study|Withdrawal by Subject|0|||
164038606|NCT03228394|592500993|FG002|Overall Study|Withdrawal by Subject|1|||
164038607|NCT03228394|592500994|FG003|Overall Study|Withdrawal by Subject|0|||
164038608|NCT03228394|592500995|FG004|Overall Study|Withdrawal by Subject|0|||
164038609|NCT03228394|592500996|FG005|Overall Study|Withdrawal by Subject|0|||
164038610|NCT03228394|592500997|FG006|Overall Study|Withdrawal by Subject|1|||
164038611|NCT03228394|592500998|FG007|Overall Study|Withdrawal by Subject|3|||
164038612|NCT03228394|592500991|FG000|Overall Study|Protocol Violation|0|||
164038613|NCT03228394|592500992|FG001|Overall Study|Protocol Violation|0|||
164038614|NCT03228394|592500993|FG002|Overall Study|Protocol Violation|0|||
164038615|NCT03228394|592500994|FG003|Overall Study|Protocol Violation|1|||
164038616|NCT03228394|592500995|FG004|Overall Study|Protocol Violation|0|||
164038617|NCT03228394|592500996|FG005|Overall Study|Protocol Violation|0|||
164038618|NCT03228394|592500997|FG006|Overall Study|Protocol Violation|0|||
164038619|NCT03228394|592500998|FG007|Overall Study|Protocol Violation|0|||
164038620|NCT03228394|592500991|FG000|Overall Study|Physician Decision|0|||
164038621|NCT03228394|592500992|FG001|Overall Study|Physician Decision|0|||
164038622|NCT03228394|592500993|FG002|Overall Study|Physician Decision|0|||
163935565|NCT00233480|592134931|FG001|Overall Study|Underwent status II heart transplant|1|||
163935566|NCT01484431|592134936|FG000|Period 1: High Dose|Physician Decision|0|||
163935567|NCT01484431|592134937|FG001|Period 1: High Dose|Physician Decision|1|||
163935568|NCT01484431|592134938|FG002|Period 1: High Dose|Physician Decision|0|||
163935569|NCT01484431|592134936|FG000|Period 2|Death|0|||
163935570|NCT01484431|592134937|FG001|Period 2|Death|1|||
163935571|NCT01484431|592134938|FG002|Period 2|Death|1|||
163935572|NCT01484431|592134936|FG000|Period 2|Physician Decision|0|||
163935573|NCT01484431|592134937|FG001|Period 2|Physician Decision|0|||
163935574|NCT01484431|592134938|FG002|Period 2|Physician Decision|1|||
163935575|NCT01484431|592134936|FG000|Period 2|Non-Compliance with Study Drug|1|||
163935576|NCT01484431|592134937|FG001|Period 2|Non-Compliance with Study Drug|0|||
163935577|NCT01484431|592134938|FG002|Period 2|Non-Compliance with Study Drug|0|||
163935578|NCT01251770|592134940|FG000|Overall Study|Protocol Violation|13|||
163935579|NCT01251770|592134941|FG001|Overall Study|Protocol Violation|7|||
163935580|NCT02514239|592134942|FG000|Overall Study|Refused to continue trial medication|0|||
163935581|NCT02514239|592134943|FG001|Overall Study|Refused to continue trial medication|0|||
163935582|NCT02514239|592134944|FG002|Overall Study|Refused to continue trial medication|0|||
163935583|NCT02514239|592134945|FG003|Overall Study|Refused to continue trial medication|0|||
163935584|NCT02514239|592134946|FG004|Overall Study|Refused to continue trial medication|0|||
163935585|NCT02514239|592134947|FG005|Overall Study|Refused to continue trial medication|0|||
163935586|NCT02514239|592134948|FG006|Overall Study|Refused to continue trial medication|0|||
163935587|NCT02514239|592134949|FG007|Overall Study|Refused to continue trial medication|0|||
163935588|NCT02514239|592134950|FG008|Overall Study|Refused to continue trial medication|0|||
163935589|NCT02514239|592134951|FG009|Overall Study|Refused to continue trial medication|1|||
163935590|NCT02514239|592134942|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935591|NCT02514239|592134943|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935592|NCT02514239|592134944|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935593|NCT02514239|592134945|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935594|NCT02514239|592134946|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935595|NCT02514239|592134947|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935596|NCT02514239|592134948|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935597|NCT02514239|592134949|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
163935598|NCT02514239|592134950|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
163935599|NCT02514239|592134951|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
163935600|NCT02514239|592134942|FG000|Overall Study|Not treated|0|||
163935601|NCT02514239|592134943|FG001|Overall Study|Not treated|1|||
163935602|NCT02514239|592134944|FG002|Overall Study|Not treated|0|||
163935603|NCT02514239|592134945|FG003|Overall Study|Not treated|0|||
163935604|NCT02514239|592134946|FG004|Overall Study|Not treated|0|||
163935605|NCT02514239|592134947|FG005|Overall Study|Not treated|0|||
163935606|NCT02514239|592134948|FG006|Overall Study|Not treated|0|||
163935607|NCT02514239|592134949|FG007|Overall Study|Not treated|0|||
163935608|NCT02514239|592134950|FG008|Overall Study|Not treated|0|||
163935609|NCT02514239|592134951|FG009|Overall Study|Not treated|0|||
163935610|NCT02514239|592134942|FG000|Overall Study|Other Adverse Events|2|||
163935611|NCT02514239|592134943|FG001|Overall Study|Other Adverse Events|0|||
163935612|NCT02514239|592134944|FG002|Overall Study|Other Adverse Events|0|||
163935613|NCT02514239|592134945|FG003|Overall Study|Other Adverse Events|1|||
163935614|NCT02514239|592134946|FG004|Overall Study|Other Adverse Events|0|||
163935615|NCT02514239|592134947|FG005|Overall Study|Other Adverse Events|1|||
163935616|NCT02514239|592134948|FG006|Overall Study|Other Adverse Events|0|||
163935617|NCT02514239|592134949|FG007|Overall Study|Other Adverse Events|1|||
163935618|NCT02514239|592134950|FG008|Overall Study|Other Adverse Events|2|||
163935619|NCT02514239|592134951|FG009|Overall Study|Other Adverse Events|0|||
163935620|NCT02514239|592134942|FG000|Overall Study|Progressive disease|3|||
163935621|NCT02514239|592134943|FG001|Overall Study|Progressive disease|3|||
163935622|NCT02514239|592134944|FG002|Overall Study|Progressive disease|2|||
163935623|NCT02514239|592134945|FG003|Overall Study|Progressive disease|2|||
163935624|NCT02514239|592134946|FG004|Overall Study|Progressive disease|3|||
163935625|NCT02514239|592134947|FG005|Overall Study|Progressive disease|3|||
163935626|NCT02514239|592134948|FG006|Overall Study|Progressive disease|4|||
163935627|NCT02514239|592134949|FG007|Overall Study|Progressive disease|2|||
163935628|NCT02514239|592134950|FG008|Overall Study|Progressive disease|5|||
163935629|NCT02514239|592134951|FG009|Overall Study|Progressive disease|0|||
163935630|NCT03299049|592134952|FG000|Overall Study|On-going|486|||
163935631|NCT03299049|592134953|FG001|Overall Study|On-going|481|||
163935632|NCT03299049|592134952|FG000|Overall Study|Withdrawal by Subject|6|||
163935633|NCT03299049|592134953|FG001|Overall Study|Withdrawal by Subject|21|||
163935634|NCT03299049|592134952|FG000|Overall Study|Physician Decision|5|||
163935635|NCT03299049|592134953|FG001|Overall Study|Physician Decision|1|||
163935636|NCT03299049|592134952|FG000|Overall Study|Lost to Follow-up|2|||
163935637|NCT03299049|592134953|FG001|Overall Study|Lost to Follow-up|0|||
163935638|NCT03299049|592134952|FG000|Overall Study|Pregnancy|1|||
163935639|NCT03299049|592134953|FG001|Overall Study|Pregnancy|3|||
163935640|NCT03299049|592134952|FG000|Overall Study|Protocol Violation|1|||
163935641|NCT03299049|592134953|FG001|Overall Study|Protocol Violation|1|||
163935642|NCT03299049|592134952|FG000|Overall Study|Lack of Efficacy|9|||
163935643|NCT03299049|592134953|FG001|Overall Study|Lack of Efficacy|3|||
163935644|NCT03299049|592134952|FG000|Overall Study|Adverse Event|12|||
163935645|NCT03299049|592134953|FG001|Overall Study|Adverse Event|13|||
163935646|NCT01901419|592134954|FG000|Overall Study|Protocol Violation|2|||
163935647|NCT01901419|592134955|FG001|Overall Study|Protocol Violation|6|||
163935648|NCT01901419|592134954|FG000|Overall Study|unavailable researchers|6|||
163935649|NCT01901419|592134955|FG001|Overall Study|unavailable researchers|3|||
163935650|NCT01411241|592134958|FG000|Overall Study|Protocol Violation|0|||
163935651|NCT01411241|592134959|FG001|Overall Study|Protocol Violation|5|||
163935652|NCT01411241|592134958|FG000|Overall Study|Withdrawal by Subject|9|||
163935653|NCT01411241|592134959|FG001|Overall Study|Withdrawal by Subject|10|||
163935654|NCT01411241|592134958|FG000|Overall Study|Serious Adverse Event|0|||
164038623|NCT03228394|592500994|FG003|Overall Study|Physician Decision|0|||
164038624|NCT03228394|592500995|FG004|Overall Study|Physician Decision|0|||
164038625|NCT03228394|592500996|FG005|Overall Study|Physician Decision|0|||
164038626|NCT03228394|592500997|FG006|Overall Study|Physician Decision|1|||
164038627|NCT03228394|592500998|FG007|Overall Study|Physician Decision|0|||
164038628|NCT03228394|592500991|FG000|Overall Study|Noncompliance|0|||
164038629|NCT03228394|592500992|FG001|Overall Study|Noncompliance|0|||
164038630|NCT03228394|592500993|FG002|Overall Study|Noncompliance|0|||
164038631|NCT03228394|592500994|FG003|Overall Study|Noncompliance|0|||
164038632|NCT03228394|592500995|FG004|Overall Study|Noncompliance|0|||
164038633|NCT03228394|592500996|FG005|Overall Study|Noncompliance|0|||
164038634|NCT03228394|592500997|FG006|Overall Study|Noncompliance|1|||
164038635|NCT03228394|592500998|FG007|Overall Study|Noncompliance|0|||
164038636|NCT00291187|592501002|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
164038637|NCT00291187|592501003|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
164038638|NCT00291187|592501004|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
164038639|NCT00291187|592501005|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
164038640|NCT02023268|592501006|FG000|Overall Study|Lack of Efficacy|0|||
164038641|NCT02023268|592501007|FG001|Overall Study|Lack of Efficacy|1|||
164038642|NCT02023268|592501006|FG000|Overall Study|Adverse Event|0|||
164038643|NCT02023268|592501007|FG001|Overall Study|Adverse Event|2|||
164038644|NCT02023268|592501006|FG000|Overall Study|Withdrawal by Subject|0|||
164038645|NCT02023268|592501007|FG001|Overall Study|Withdrawal by Subject|1|||
164038646|NCT01001234|592501010|FG000|Overall Study|Withdrawal by Subject|2|||
164038647|NCT01001234|592501011|FG001|Overall Study|Withdrawal by Subject|0|||
164038648|NCT01001234|592501012|FG002|Overall Study|Withdrawal by Subject|3|||
164038649|NCT01001234|592501013|FG003|Overall Study|Withdrawal by Subject|0|||
164038650|NCT01001234|592501014|FG004|Overall Study|Withdrawal by Subject|0|||
164038651|NCT01001234|592501010|FG000|Overall Study|Protocol Violation|34|||
164038652|NCT01001234|592501011|FG001|Overall Study|Protocol Violation|3|||
164038653|NCT01001234|592501012|FG002|Overall Study|Protocol Violation|19|||
164038654|NCT01001234|592501013|FG003|Overall Study|Protocol Violation|18|||
164038655|NCT01001234|592501014|FG004|Overall Study|Protocol Violation|0|||
164038656|NCT01001234|592501010|FG000|Overall Study|Lost to Follow-up|0|||
164038657|NCT01001234|592501011|FG001|Overall Study|Lost to Follow-up|0|||
164038658|NCT01001234|592501012|FG002|Overall Study|Lost to Follow-up|1|||
164038659|NCT01001234|592501013|FG003|Overall Study|Lost to Follow-up|2|||
164038660|NCT01001234|592501014|FG004|Overall Study|Lost to Follow-up|0|||
164038661|NCT01001234|592501010|FG000|Overall Study|Physician Decision|1|||
164038662|NCT01001234|592501011|FG001|Overall Study|Physician Decision|0|||
164038663|NCT01001234|592501012|FG002|Overall Study|Physician Decision|0|||
164038664|NCT01001234|592501013|FG003|Overall Study|Physician Decision|0|||
164038665|NCT01001234|592501014|FG004|Overall Study|Physician Decision|0|||
164038666|NCT01001234|592501010|FG000|Overall Study|Not Treated: Adverse Event|1|||
164038667|NCT01001234|592501011|FG001|Overall Study|Not Treated: Adverse Event|0|||
164038668|NCT01001234|592501012|FG002|Overall Study|Not Treated: Adverse Event|0|||
164038669|NCT01001234|592501013|FG003|Overall Study|Not Treated: Adverse Event|0|||
164038670|NCT01001234|592501014|FG004|Overall Study|Not Treated: Adverse Event|0|||
164038671|NCT01001234|592501010|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
164038672|NCT01001234|592501011|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
164038673|NCT01001234|592501012|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
164038674|NCT01001234|592501013|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
164038675|NCT01001234|592501014|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
163839693|NCT02969525|591783648|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839694|NCT02969525|591783649|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839695|NCT02969525|591783650|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839696|NCT02969525|591783651|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839697|NCT02969525|591783652|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839698|NCT02969525|591783653|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164038676|NCT01001234|592501010|FG000|Overall Study|Not Treated: Protocol Violation|3|||
164038677|NCT01001234|592501011|FG001|Overall Study|Not Treated: Protocol Violation|0|||
164038678|NCT01001234|592501012|FG002|Overall Study|Not Treated: Protocol Violation|0|||
164038679|NCT01001234|592501013|FG003|Overall Study|Not Treated: Protocol Violation|0|||
164098730|NCT00328926|592726874|FG000|Overall Study|In vitro fertilization treatment|0|||
164038680|NCT01001234|592501014|FG004|Overall Study|Not Treated: Protocol Violation|0|||
164098731|NCT00328926|592726875|FG001|Overall Study|In vitro fertilization treatment|0|||
164098732|NCT00328926|592726876|FG002|Overall Study|In vitro fertilization treatment|1|||
163839699|NCT02969525|591783654|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164038681|NCT01001234|592501010|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
164038682|NCT01001234|592501011|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
164038683|NCT01001234|592501012|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
164038684|NCT01001234|592501013|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
164038685|NCT01001234|592501014|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
164038686|NCT01001234|592501010|FG000|Overall Study|Not Treated: Pregnancy|3|||
164038687|NCT01001234|592501011|FG001|Overall Study|Not Treated: Pregnancy|0|||
163935655|NCT01411241|592134959|FG001|Overall Study|Serious Adverse Event|3|||
163935656|NCT01411241|592134958|FG000|Overall Study|Lost to Follow-up|2|||
163935657|NCT01411241|592134959|FG001|Overall Study|Lost to Follow-up|4|||
163935658|NCT02980042|592134960|FG000|Overall Study|Lost to Follow-up|5|||
163935659|NCT02980042|592134961|FG001|Overall Study|Lost to Follow-up|0|||
163935660|NCT02980042|592134960|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
163935661|NCT02980042|592134961|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
163935662|NCT02521363|592134964|FG000|Overall Study|Withdrawal by Subject|1|||
163935663|NCT02521363|592134965|FG001|Overall Study|Withdrawal by Subject|2|||
163935664|NCT00953771|592134966|FG000|Overall Study|Death|1|||
163935665|NCT00953771|592134967|FG001|Overall Study|Death|0|||
163935666|NCT00974259|592134968|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
163935667|NCT00974259|592134969|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
163935668|NCT00592293|592134973|FG000|Overall Study|Withdrawal by Subject|1|||
163935669|NCT01270828|592134976|FG000|Pregabalin CR SB|Reason Unspecified|0|||
163935670|NCT01270828|592134977|FG001|Pregabalin CR SB|Reason Unspecified|0|||
163935671|NCT01270828|592134978|FG002|Pregabalin CR SB|Reason Unspecified|8|||
163935672|NCT01270828|592134976|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
163935673|NCT01270828|592134977|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
163935674|NCT01270828|592134978|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
163935675|NCT01270828|592134976|FG000|Pregabalin CR SB|Related adverse event|0|||
163935676|NCT01270828|592134977|FG001|Pregabalin CR SB|Related adverse event|0|||
163935677|NCT01270828|592134978|FG002|Pregabalin CR SB|Related adverse event|46|||
163935678|NCT01270828|592134976|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
163935679|NCT01270828|592134977|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
163935680|NCT01270828|592134978|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
163935681|NCT01270828|592134976|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
163935682|NCT01270828|592134977|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
163935683|NCT01270828|592134978|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
163935684|NCT01270828|592134976|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
163935685|NCT01270828|592134977|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
163935686|NCT01270828|592134978|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
163935687|NCT01270828|592134976|FG000|Pregabalin CR SB|Unrelated AE|0|||
163935688|NCT01270828|592134977|FG001|Pregabalin CR SB|Unrelated AE|0|||
163935689|NCT01270828|592134978|FG002|Pregabalin CR SB|Unrelated AE|8|||
163935690|NCT01270828|592134976|FG000|Pregabalin CR SB|Protocol Violation|0|||
163935691|NCT01270828|592134977|FG001|Pregabalin CR SB|Protocol Violation|0|||
163935692|NCT01270828|592134978|FG002|Pregabalin CR SB|Protocol Violation|8|||
163935693|NCT01270828|592134976|FG000|Double Blind Phase|Death|0|||
163935694|NCT01270828|592134977|FG001|Double Blind Phase|Death|1|||
163935695|NCT01270828|592134978|FG002|Double Blind Phase|Death|0|||
163935696|NCT01270828|592134976|FG000|Double Blind Phase|Protocol Violation|0|||
163935697|NCT01270828|592134977|FG001|Double Blind Phase|Protocol Violation|1|||
163935698|NCT01270828|592134978|FG002|Double Blind Phase|Protocol Violation|0|||
163935699|NCT01270828|592134976|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
163935700|NCT01270828|592134977|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
163935701|NCT01270828|592134978|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
163935702|NCT01270828|592134976|FG000|Double Blind Phase|Reason Unspecified|7|||
163935703|NCT01270828|592134977|FG001|Double Blind Phase|Reason Unspecified|4|||
163935704|NCT01270828|592134978|FG002|Double Blind Phase|Reason Unspecified|0|||
163935705|NCT01270828|592134976|FG000|Double Blind Phase|Withdrawal by Subject|6|||
163935706|NCT01270828|592134977|FG001|Double Blind Phase|Withdrawal by Subject|15|||
163935707|NCT01270828|592134978|FG002|Double Blind Phase|Withdrawal by Subject|0|||
163935708|NCT01270828|592134976|FG000|Double Blind Phase|Lost to Follow-up|1|||
164038688|NCT01001234|592501012|FG002|Overall Study|Not Treated: Pregnancy|0|||
164038689|NCT01001234|592501013|FG003|Overall Study|Not Treated: Pregnancy|0|||
164038690|NCT01001234|592501014|FG004|Overall Study|Not Treated: Pregnancy|0|||
164038691|NCT01001234|592501010|FG000|Overall Study|Not Treated: Physician Decision|37|||
164038692|NCT01001234|592501011|FG001|Overall Study|Not Treated: Physician Decision|4|||
164038693|NCT01001234|592501012|FG002|Overall Study|Not Treated: Physician Decision|0|||
164038694|NCT01001234|592501013|FG003|Overall Study|Not Treated: Physician Decision|0|||
164038695|NCT01001234|592501014|FG004|Overall Study|Not Treated: Physician Decision|0|||
164038696|NCT01001234|592501010|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
164038697|NCT01001234|592501011|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
164038698|NCT01001234|592501012|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
164038699|NCT01001234|592501013|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
164038700|NCT01001234|592501014|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
163935709|NCT01270828|592134977|FG001|Double Blind Phase|Lost to Follow-up|2|||
163935710|NCT01270828|592134978|FG002|Double Blind Phase|Lost to Follow-up|0|||
163935711|NCT01270828|592134976|FG000|Double Blind Phase|Lack of Efficacy|2|||
163935712|NCT01270828|592134977|FG001|Double Blind Phase|Lack of Efficacy|11|||
163935713|NCT01270828|592134978|FG002|Double Blind Phase|Lack of Efficacy|0|||
163935714|NCT01270828|592134976|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
163935715|NCT01270828|592134977|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
163839700|NCT02969525|591783655|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839701|NCT02969525|591783656|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
164038701|NCT01611298|592501017|FG000|Overall Study|Relapsed|2|||
164038702|NCT03238352|592501018|FG000|Overall Study|Lost to Follow-up|0|||
164038703|NCT03238352|592501019|FG001|Overall Study|Lost to Follow-up|2|||
164038704|NCT03238352|592501020|FG002|Overall Study|Lost to Follow-up|1|||
164038705|NCT03238352|592501018|FG000|Overall Study|Withdrawal by Subject|0|||
164038706|NCT03238352|592501019|FG001|Overall Study|Withdrawal by Subject|1|||
164038707|NCT03238352|592501020|FG002|Overall Study|Withdrawal by Subject|0|||
164038708|NCT00928512|592501021|FG000|Overall Study|Adverse Event|4|||
164038709|NCT00928512|592501022|FG001|Overall Study|Adverse Event|3|||
164038710|NCT00928512|592501023|FG002|Overall Study|Adverse Event|2|||
164038711|NCT00928512|592501024|FG003|Overall Study|Adverse Event|8|||
164038712|NCT00928512|592501025|FG004|Overall Study|Adverse Event|6|||
164038713|NCT00928512|592501021|FG000|Overall Study|Lack of Efficacy|2|||
164038714|NCT00928512|592501022|FG001|Overall Study|Lack of Efficacy|0|||
164038715|NCT00928512|592501023|FG002|Overall Study|Lack of Efficacy|4|||
164038716|NCT00928512|592501024|FG003|Overall Study|Lack of Efficacy|7|||
164038717|NCT00928512|592501025|FG004|Overall Study|Lack of Efficacy|3|||
164038718|NCT00928512|592501021|FG000|Overall Study|Protocol Violation|0|||
164038719|NCT00928512|592501022|FG001|Overall Study|Protocol Violation|1|||
164038720|NCT00928512|592501023|FG002|Overall Study|Protocol Violation|0|||
164038721|NCT00928512|592501024|FG003|Overall Study|Protocol Violation|1|||
164038722|NCT00928512|592501025|FG004|Overall Study|Protocol Violation|3|||
164038723|NCT00928512|592501021|FG000|Overall Study|Withdrawal by Subject|3|||
164038724|NCT00928512|592501022|FG001|Overall Study|Withdrawal by Subject|0|||
164038725|NCT00928512|592501023|FG002|Overall Study|Withdrawal by Subject|3|||
164038726|NCT00928512|592501024|FG003|Overall Study|Withdrawal by Subject|4|||
164038727|NCT00928512|592501025|FG004|Overall Study|Withdrawal by Subject|0|||
164038728|NCT00928512|592501021|FG000|Overall Study|Lost to Follow-up|1|||
164038729|NCT00928512|592501022|FG001|Overall Study|Lost to Follow-up|1|||
164038730|NCT00928512|592501023|FG002|Overall Study|Lost to Follow-up|2|||
164038731|NCT00928512|592501024|FG003|Overall Study|Lost to Follow-up|1|||
164038732|NCT00928512|592501025|FG004|Overall Study|Lost to Follow-up|3|||
164038733|NCT00928512|592501021|FG000|Overall Study|Administrative Problems|0|||
164038734|NCT00928512|592501022|FG001|Overall Study|Administrative Problems|1|||
164038735|NCT00928512|592501023|FG002|Overall Study|Administrative Problems|0|||
164038736|NCT00928512|592501024|FG003|Overall Study|Administrative Problems|0|||
163839702|NCT02969525|591783657|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
163839703|NCT02969525|591783658|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
163839704|NCT03445065|591783659|FG000|Overall Study|Withdrawal by Subject|3|||
163839705|NCT03445065|591783660|FG001|Overall Study|Withdrawal by Subject|6|||
163839706|NCT03445065|591783661|FG002|Overall Study|Withdrawal by Subject|2|||
163839707|NCT03445065|591783662|FG003|Overall Study|Withdrawal by Subject|2|||
163839708|NCT03445065|591783659|FG000|Overall Study|Other|4|||
163839709|NCT03445065|591783660|FG001|Overall Study|Other|3|||
163839710|NCT03445065|591783661|FG002|Overall Study|Other|3|||
163839711|NCT03445065|591783662|FG003|Overall Study|Other|1|||
163839712|NCT02172625|591783663|FG000|Overall Study|Adverse Event|0|||
163839713|NCT02172625|591783664|FG001|Overall Study|Adverse Event|1|||
163839714|NCT02172625|591783663|FG000|Overall Study|Pregnancy|0|||
163839715|NCT02172625|591783664|FG001|Overall Study|Pregnancy|1|||
163839716|NCT02172625|591783663|FG000|Overall Study|car accident|0|||
163839717|NCT02172625|591783664|FG001|Overall Study|car accident|1|||
163839718|NCT03315130|591783665|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
163839719|NCT03315130|591783666|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
163839720|NCT03315130|591783667|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
164038737|NCT00928512|592501025|FG004|Overall Study|Administrative Problems|0|||
164038738|NCT04153929|592501026|FG000|Overall Study|Other than listed|2|||
164038739|NCT04153929|592501027|FG001|Overall Study|Other than listed|2|||
164038740|NCT04153929|592501028|FG002|Overall Study|Other than listed|0|||
164038741|NCT04153929|592501029|FG003|Overall Study|Other than listed|1|||
164038742|NCT04153929|592501030|FG004|Overall Study|Other than listed|0|||
164038743|NCT04153929|592501031|FG005|Overall Study|Other than listed|2|||
164038744|NCT04153929|592501032|FG006|Overall Study|Other than listed|2|||
164038745|NCT04153929|592501033|FG007|Overall Study|Other than listed|1|||
164038746|NCT04153929|592501026|FG000|Overall Study|Lost to Follow-up|2|||
164038747|NCT04153929|592501027|FG001|Overall Study|Lost to Follow-up|1|||
163839721|NCT03315130|591783668|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
163839722|NCT03315130|591783665|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
163839723|NCT03315130|591783666|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
164038748|NCT04153929|592501028|FG002|Overall Study|Lost to Follow-up|0|||
164038749|NCT04153929|592501029|FG003|Overall Study|Lost to Follow-up|1|||
164038750|NCT04153929|592501030|FG004|Overall Study|Lost to Follow-up|1|||
164038751|NCT04153929|592501031|FG005|Overall Study|Lost to Follow-up|0|||
164038752|NCT04153929|592501032|FG006|Overall Study|Lost to Follow-up|0|||
164038753|NCT04153929|592501033|FG007|Overall Study|Lost to Follow-up|0|||
164038754|NCT04153929|592501026|FG000|Overall Study|Withdrawal by Subject|3|||
164147700|NCT02006732|592902130|FG001|Overall Study|Lack of Efficacy|3|||
164098733|NCT00328926|592726874|FG000|Overall Study|Lack of ovarian response|0|||
164098734|NCT00328926|592726875|FG001|Overall Study|Lack of ovarian response|1|||
164098735|NCT00328926|592726876|FG002|Overall Study|Lack of ovarian response|0|||
164098736|NCT02269657|592726877|FG000|Overall Study|Protocol Violation|3|||
164098737|NCT00834249|592726884|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164098738|NCT00834249|592726885|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
164098739|NCT00834249|592726884|FG000|Second Intervention|Adverse Event|1|||
163839724|NCT03315130|591783667|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
163839725|NCT03315130|591783668|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
163839726|NCT03315130|591783665|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
163839727|NCT03315130|591783666|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
163839728|NCT03315130|591783667|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
163839729|NCT03315130|591783668|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
163839730|NCT03315130|591783665|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
163839731|NCT03315130|591783666|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
163839732|NCT03315130|591783667|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
163839733|NCT03315130|591783668|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
163839734|NCT03315130|591783665|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
163839735|NCT03315130|591783666|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
163839736|NCT03315130|591783667|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
163839737|NCT03315130|591783668|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
163839738|NCT03315130|591783665|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
163839739|NCT03315130|591783666|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
163839740|NCT03315130|591783667|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
163839741|NCT03315130|591783668|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
163839742|NCT00524030|591783669|FG000|Overall Study|Lack of Efficacy|10|||
163839743|NCT00524030|591783670|FG001|Overall Study|Lack of Efficacy|24|||
163839744|NCT00524030|591783669|FG000|Overall Study|Lost to Follow-up|0|||
163839745|NCT00524030|591783670|FG001|Overall Study|Lost to Follow-up|2|||
163839746|NCT00524030|591783669|FG000|Overall Study|Withdrawal by Subject|3|||
163839747|NCT00524030|591783670|FG001|Overall Study|Withdrawal by Subject|8|||
163839748|NCT00524030|591783669|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
163839749|NCT00524030|591783670|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
163839750|NCT00524030|591783669|FG000|Overall Study|Protocol Violation|0|||
163839751|NCT00524030|591783670|FG001|Overall Study|Protocol Violation|1|||
163839752|NCT00524030|591783669|FG000|Overall Study|Pregnancy|1|||
163839753|NCT00524030|591783670|FG001|Overall Study|Pregnancy|0|||
163839754|NCT00524030|591783669|FG000|Overall Study|Adverse Event|3|||
163839755|NCT00524030|591783670|FG001|Overall Study|Adverse Event|21|||
163839756|NCT00524030|591783669|FG000|Overall Study|Death|0|||
163839757|NCT00524030|591783670|FG001|Overall Study|Death|1|||
163839758|NCT02944656|591783671|FG000|Overall Study|No longer eligible|3|||
163839759|NCT02944656|591783672|FG001|Overall Study|No longer eligible|0|||
163839760|NCT02944656|591783671|FG000|Overall Study|Lost to Follow-up|7|||
163839761|NCT02944656|591783672|FG001|Overall Study|Lost to Follow-up|10|||
163839762|NCT04398537|591783673|FG000|Overall Study|Physician Decision|10|||
163839763|NCT04398537|591783674|FG001|Overall Study|Physician Decision|15|||
163839764|NCT00118898|591783675|FG000|Overall Study|Death|6|||
163839765|NCT00118898|591783676|FG001|Overall Study|Death|11|||
163839766|NCT00118898|591783677|FG002|Overall Study|Death|6|||
163839767|NCT00118898|591783678|FG003|Overall Study|Death|8|||
163839768|NCT00118898|591783675|FG000|Overall Study|Lost to Follow-up|26|||
163839769|NCT00118898|591783676|FG001|Overall Study|Lost to Follow-up|34|||
163839770|NCT00118898|591783677|FG002|Overall Study|Lost to Follow-up|33|||
163839771|NCT00118898|591783678|FG003|Overall Study|Lost to Follow-up|33|||
163839772|NCT00118898|591783675|FG000|Overall Study|Withdrawal by Subject|10|||
163839773|NCT00118898|591783676|FG001|Overall Study|Withdrawal by Subject|5|||
163839774|NCT00118898|591783677|FG002|Overall Study|Withdrawal by Subject|8|||
163839775|NCT00118898|591783678|FG003|Overall Study|Withdrawal by Subject|8|||
163839776|NCT00118898|591783675|FG000|Overall Study|Site Closure|33|||
163839777|NCT00118898|591783676|FG001|Overall Study|Site Closure|31|||
163839778|NCT00118898|591783677|FG002|Overall Study|Site Closure|28|||
163839779|NCT00118898|591783678|FG003|Overall Study|Site Closure|37|||
163839780|NCT00118898|591783675|FG000|Overall Study|Severe debilitation|1|||
163839781|NCT00118898|591783676|FG001|Overall Study|Severe debilitation|4|||
163839782|NCT00118898|591783677|FG002|Overall Study|Severe debilitation|6|||
163839783|NCT00118898|591783678|FG003|Overall Study|Severe debilitation|4|||
163839784|NCT00118898|591783675|FG000|Overall Study|Not compliant with requirements|11|||
163839785|NCT00118898|591783676|FG001|Overall Study|Not compliant with requirements|13|||
163935716|NCT01270828|592134978|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
163935717|NCT01270828|592134976|FG000|Double Blind Phase|Adverse event related to study drug|5|||
163839786|NCT00118898|591783677|FG002|Overall Study|Not compliant with requirements|11|||
163839787|NCT00118898|591783678|FG003|Overall Study|Not compliant with requirements|11|||
163839788|NCT00118898|591783675|FG000|Overall Study|Not able to get to clinic|34|||
164098740|NCT00834249|592726885|FG001|Second Intervention|Adverse Event|0|||
164038755|NCT04153929|592501027|FG001|Overall Study|Withdrawal by Subject|1|||
164038756|NCT04153929|592501028|FG002|Overall Study|Withdrawal by Subject|0|||
164038757|NCT04153929|592501029|FG003|Overall Study|Withdrawal by Subject|3|||
164038758|NCT04153929|592501030|FG004|Overall Study|Withdrawal by Subject|1|||
164038759|NCT04153929|592501031|FG005|Overall Study|Withdrawal by Subject|0|||
164038760|NCT04153929|592501032|FG006|Overall Study|Withdrawal by Subject|1|||
164038761|NCT04153929|592501033|FG007|Overall Study|Withdrawal by Subject|0|||
164038762|NCT04153929|592501026|FG000|Overall Study|Protocol Violation|0|||
164038763|NCT04153929|592501027|FG001|Overall Study|Protocol Violation|0|||
164038764|NCT04153929|592501028|FG002|Overall Study|Protocol Violation|0|||
164038765|NCT04153929|592501029|FG003|Overall Study|Protocol Violation|0|||
164038766|NCT04153929|592501030|FG004|Overall Study|Protocol Violation|0|||
164038767|NCT04153929|592501031|FG005|Overall Study|Protocol Violation|0|||
164038768|NCT04153929|592501032|FG006|Overall Study|Protocol Violation|1|||
164038769|NCT04153929|592501033|FG007|Overall Study|Protocol Violation|2|||
164038770|NCT04153929|592501026|FG000|Overall Study|Adverse Event|3|||
164038771|NCT04153929|592501027|FG001|Overall Study|Adverse Event|5|||
164038772|NCT04153929|592501028|FG002|Overall Study|Adverse Event|5|||
164038773|NCT04153929|592501029|FG003|Overall Study|Adverse Event|11|||
164038774|NCT04153929|592501030|FG004|Overall Study|Adverse Event|15|||
164038775|NCT04153929|592501031|FG005|Overall Study|Adverse Event|4|||
164038776|NCT04153929|592501032|FG006|Overall Study|Adverse Event|8|||
164038777|NCT04153929|592501033|FG007|Overall Study|Adverse Event|2|||
164038778|NCT04153929|592501026|FG000|Overall Study|Not treated|1|||
164038779|NCT04153929|592501027|FG001|Overall Study|Not treated|0|||
164038780|NCT04153929|592501028|FG002|Overall Study|Not treated|0|||
164038781|NCT04153929|592501029|FG003|Overall Study|Not treated|0|||
164038782|NCT04153929|592501030|FG004|Overall Study|Not treated|0|||
164038783|NCT04153929|592501031|FG005|Overall Study|Not treated|0|||
164038784|NCT04153929|592501032|FG006|Overall Study|Not treated|1|||
164038785|NCT04153929|592501033|FG007|Overall Study|Not treated|0|||
164038786|NCT03383614|592501034|FG000|Overall Study|Withdrawal by Subject|0|||
164038787|NCT03383614|592501035|FG001|Overall Study|Withdrawal by Subject|1|||
164038788|NCT03383614|592501036|FG002|Overall Study|Withdrawal by Subject|0|||
164038789|NCT03383614|592501037|FG003|Overall Study|Withdrawal by Subject|0|||
164038790|NCT01686958|592501040|FG000|Overall Study|Withdrawal by Subject|1|||
164038791|NCT03199638|592501045|FG000|Overall Study|inability to drink glutamine during regularly|0|||
164038792|NCT03199638|592501046|FG001|Overall Study|inability to drink glutamine during regularly|2|||
164038793|NCT02807844|592501047|FG000|Overall Study|Physician Decision|0|||
164038794|NCT02807844|592501048|FG001|Overall Study|Physician Decision|0|||
164038795|NCT02807844|592501049|FG002|Overall Study|Physician Decision|0|||
164038796|NCT02807844|592501050|FG003|Overall Study|Physician Decision|0|||
164038797|NCT02807844|592501051|FG004|Overall Study|Physician Decision|0|||
164038798|NCT02807844|592501052|FG005|Overall Study|Physician Decision|0|||
164038799|NCT02807844|592501053|FG006|Overall Study|Physician Decision|3|||
164038800|NCT02807844|592501054|FG007|Overall Study|Physician Decision|0|||
164038801|NCT02807844|592501055|FG008|Overall Study|Physician Decision|1|||
164038802|NCT02807844|592501056|FG009|Overall Study|Physician Decision|2|||
164038803|NCT02807844|592501047|FG000|Overall Study|Death|0|||
164038804|NCT02807844|592501048|FG001|Overall Study|Death|0|||
164038805|NCT02807844|592501049|FG002|Overall Study|Death|2|||
164038806|NCT02807844|592501050|FG003|Overall Study|Death|4|||
164038807|NCT02807844|592501051|FG004|Overall Study|Death|1|||
164038808|NCT02807844|592501052|FG005|Overall Study|Death|2|||
164038809|NCT02807844|592501053|FG006|Overall Study|Death|1|||
164038810|NCT02807844|592501054|FG007|Overall Study|Death|2|||
164038811|NCT02807844|592501055|FG008|Overall Study|Death|0|||
164038812|NCT02807844|592501056|FG009|Overall Study|Death|1|||
164038813|NCT02807844|592501047|FG000|Overall Study|Withdrawal by Subject|0|||
164038814|NCT02807844|592501048|FG001|Overall Study|Withdrawal by Subject|0|||
164038815|NCT02807844|592501049|FG002|Overall Study|Withdrawal by Subject|2|||
164038816|NCT02807844|592501050|FG003|Overall Study|Withdrawal by Subject|1|||
164038817|NCT02807844|592501051|FG004|Overall Study|Withdrawal by Subject|1|||
164038818|NCT02807844|592501052|FG005|Overall Study|Withdrawal by Subject|0|||
164038819|NCT02807844|592501053|FG006|Overall Study|Withdrawal by Subject|1|||
164038820|NCT02807844|592501054|FG007|Overall Study|Withdrawal by Subject|0|||
164038821|NCT02807844|592501055|FG008|Overall Study|Withdrawal by Subject|0|||
164038822|NCT02807844|592501056|FG009|Overall Study|Withdrawal by Subject|0|||
164038823|NCT02807844|592501047|FG000|Overall Study|Progressive disease|5|||
164038824|NCT02807844|592501048|FG001|Overall Study|Progressive disease|12|||
164038825|NCT02807844|592501049|FG002|Overall Study|Progressive disease|8|||
164038826|NCT02807844|592501050|FG003|Overall Study|Progressive disease|8|||
164038827|NCT02807844|592501051|FG004|Overall Study|Progressive disease|3|||
164038828|NCT02807844|592501052|FG005|Overall Study|Progressive disease|8|||
164038829|NCT02807844|592501053|FG006|Overall Study|Progressive disease|14|||
164038830|NCT02807844|592501054|FG007|Overall Study|Progressive disease|17|||
164038831|NCT02807844|592501055|FG008|Overall Study|Progressive disease|19|||
164038832|NCT02807844|592501056|FG009|Overall Study|Progressive disease|15|||
164038833|NCT02807844|592501047|FG000|Overall Study|Adverse Event|1|||
164038834|NCT02807844|592501048|FG001|Overall Study|Adverse Event|0|||
163935718|NCT01270828|592134977|FG001|Double Blind Phase|Adverse event related to study drug|7|||
163935719|NCT01270828|592134978|FG002|Double Blind Phase|Adverse event related to study drug|0|||
163935720|NCT04052425|592134987|FG000|24-Week Double-blind Period|Adverse Event|0|||
163935721|NCT04052425|592134988|FG001|24-Week Double-blind Period|Adverse Event|1|||
163935722|NCT04052425|592134989|FG002|24-Week Double-blind Period|Adverse Event|0|||
163935723|NCT04052425|592134990|FG003|24-Week Double-blind Period|Adverse Event|0|||
163935724|NCT04052425|592134987|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
163935725|NCT04052425|592134988|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
163935726|NCT04052425|592134989|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
163935727|NCT04052425|592134990|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
163935728|NCT04052425|592134987|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
163935729|NCT04052425|592134988|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
163935730|NCT04052425|592134989|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
163935731|NCT04052425|592134990|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
163935732|NCT04052425|592134987|FG000|24-Week Double-blind Period|Physician Decision|1|||
163935733|NCT04052425|592134988|FG001|24-Week Double-blind Period|Physician Decision|0|||
163935734|NCT04052425|592134989|FG002|24-Week Double-blind Period|Physician Decision|0|||
163935735|NCT04052425|592134990|FG003|24-Week Double-blind Period|Physician Decision|0|||
163935736|NCT04052425|592134987|FG000|24-Week Double-blind Period|Protocol Violation|1|||
163935737|NCT04052425|592134988|FG001|24-Week Double-blind Period|Protocol Violation|0|||
163935738|NCT04052425|592134989|FG002|24-Week Double-blind Period|Protocol Violation|0|||
163935739|NCT04052425|592134990|FG003|24-Week Double-blind Period|Protocol Violation|0|||
163935740|NCT04052425|592134987|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
163935741|NCT04052425|592134988|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
163935742|NCT04052425|592134989|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
163935743|NCT04052425|592134990|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
163935744|NCT04052425|592134987|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
163935745|NCT04052425|592134988|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
163935746|NCT04052425|592134989|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
163935747|NCT04052425|592134990|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
163935748|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
163935749|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
163935750|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
163935751|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
163935752|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
163935753|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
163935754|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
163935755|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
163935756|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163935757|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
163935758|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
163935759|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
163935760|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
163935761|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
163935762|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
163935763|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
163935764|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163935765|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
163935766|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
163935767|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
163935768|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
163935769|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
163935770|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
163935771|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
163935772|NCT04052425|592134987|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
163935773|NCT04052425|592134988|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
163935774|NCT04052425|592134989|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
163935775|NCT04052425|592134990|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
163935776|NCT00945672|592134993|FG000|Overall Study|Withdrawal by Subject|0|||
163935777|NCT00945672|592134994|FG001|Overall Study|Withdrawal by Subject|0|||
163935778|NCT00945672|592134995|FG002|Overall Study|Withdrawal by Subject|0|||
163935779|NCT00945672|592134996|FG003|Overall Study|Withdrawal by Subject|1|||
163935780|NCT01681992|592134999|FG000|Overall Study|Adverse Event|3|||
163935781|NCT01681992|592135000|FG001|Overall Study|Adverse Event|2|||
163935782|NCT01681992|592135001|FG002|Overall Study|Adverse Event|3|||
163935783|NCT01681992|592134999|FG000|Overall Study|Lost to Follow-up|36|||
164038835|NCT02807844|592501049|FG002|Overall Study|Adverse Event|0|||
164038836|NCT02807844|592501050|FG003|Overall Study|Adverse Event|0|||
164038837|NCT02807844|592501051|FG004|Overall Study|Adverse Event|1|||
164038838|NCT02807844|592501052|FG005|Overall Study|Adverse Event|1|||
164038839|NCT02807844|592501053|FG006|Overall Study|Adverse Event|1|||
164038840|NCT02807844|592501054|FG007|Overall Study|Adverse Event|1|||
164038841|NCT02807844|592501055|FG008|Overall Study|Adverse Event|1|||
164038842|NCT02807844|592501056|FG009|Overall Study|Adverse Event|2|||
164038843|NCT00108953|592501063|FG000|Follow-up|Death|18|||
164038844|NCT00108953|592501064|FG001|Follow-up|Death|26|||
164038845|NCT00108953|592501063|FG000|Follow-up|Lost to Follow-up|1|||
164038846|NCT00108953|592501064|FG001|Follow-up|Lost to Follow-up|1|||
164038847|NCT00108953|592501063|FG000|Follow-up|Study terminated by sponsor|10|||
164038848|NCT00108953|592501064|FG001|Follow-up|Study terminated by sponsor|6|||
164038849|NCT03595384|592501066|FG000|Overall Study|Other time commitments|8|||
164038850|NCT03595384|592501066|FG000|Overall Study|Changes to session time|7|||
164038851|NCT03595384|592501066|FG000|Overall Study|Relocation out of country|1|||
164038852|NCT03803202|592501067|FG000|Overall Study|Other|0|||
164038853|NCT03803202|592501068|FG001|Overall Study|Other|1|||
164038854|NCT03803202|592501069|FG002|Overall Study|Other|0|||
164038855|NCT03803202|592501070|FG003|Overall Study|Other|0|||
164038856|NCT03803202|592501071|FG004|Overall Study|Other|0|||
164038857|NCT03803202|592501072|FG005|Overall Study|Other|0|||
164038858|NCT03803202|592501073|FG006|Overall Study|Other|0|||
164038859|NCT03803202|592501074|FG007|Overall Study|Other|0|||
164038860|NCT03803202|592501075|FG008|Overall Study|Other|0|||
164038861|NCT03803202|592501067|FG000|Overall Study|Death|0|||
164038862|NCT03803202|592501068|FG001|Overall Study|Death|0|||
164038863|NCT03803202|592501069|FG002|Overall Study|Death|0|||
164038864|NCT03803202|592501070|FG003|Overall Study|Death|0|||
163935784|NCT01681992|592135000|FG001|Overall Study|Lost to Follow-up|38|||
163935785|NCT01681992|592135001|FG002|Overall Study|Lost to Follow-up|53|||
163935786|NCT01681992|592134999|FG000|Overall Study|As Per Sponsor Decision|0|||
163935787|NCT01681992|592135000|FG001|Overall Study|As Per Sponsor Decision|0|||
163935788|NCT01681992|592135001|FG002|Overall Study|As Per Sponsor Decision|1|||
163935789|NCT01681992|592134999|FG000|Overall Study|Protocol Violation|0|||
163935790|NCT01681992|592135000|FG001|Overall Study|Protocol Violation|0|||
163935791|NCT01681992|592135001|FG002|Overall Study|Protocol Violation|1|||
163935792|NCT01681992|592134999|FG000|Overall Study|Withdrawal by Subject|27|||
163935793|NCT01681992|592135000|FG001|Overall Study|Withdrawal by Subject|30|||
163935794|NCT01681992|592135001|FG002|Overall Study|Withdrawal by Subject|25|||
163935795|NCT00447590|592135002|FG000|Overall Study|Withdrawal by Subject|26|||
163935796|NCT00447590|592135002|FG000|Overall Study|Lost to Follow-up|24|||
163935797|NCT00447590|592135002|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
163935798|NCT03880019|592135003|FG000|Overall Study|Competing disease|1|||
163935799|NCT03812029|592135008|FG000|Overall Study|Protocol Violation|1|||
163935800|NCT03812029|592135009|FG001|Overall Study|Protocol Violation|0|||
163935801|NCT03812029|592135010|FG002|Overall Study|Protocol Violation|0|||
163935802|NCT03812029|592135011|FG003|Overall Study|Protocol Violation|1|||
163935803|NCT03812029|592135012|FG004|Overall Study|Protocol Violation|0|||
163935804|NCT03812029|592135008|FG000|Overall Study|Withdrawal by Subject|1|||
163935805|NCT03812029|592135009|FG001|Overall Study|Withdrawal by Subject|0|||
163935806|NCT03812029|592135010|FG002|Overall Study|Withdrawal by Subject|0|||
163935807|NCT03812029|592135011|FG003|Overall Study|Withdrawal by Subject|2|||
163935808|NCT03812029|592135012|FG004|Overall Study|Withdrawal by Subject|2|||
163935809|NCT03812029|592135008|FG000|Overall Study|Stopping rules|0|||
163935810|NCT03812029|592135009|FG001|Overall Study|Stopping rules|1|||
163935811|NCT03812029|592135010|FG002|Overall Study|Stopping rules|0|||
163935812|NCT03812029|592135011|FG003|Overall Study|Stopping rules|0|||
163935813|NCT03812029|592135012|FG004|Overall Study|Stopping rules|0|||
163935814|NCT03812029|592135008|FG000|Overall Study|Adverse Event|0|||
163935815|NCT03812029|592135009|FG001|Overall Study|Adverse Event|9|||
163935816|NCT03812029|592135010|FG002|Overall Study|Adverse Event|0|||
163935817|NCT03812029|592135011|FG003|Overall Study|Adverse Event|3|||
163935818|NCT03812029|592135012|FG004|Overall Study|Adverse Event|5|||
163935819|NCT03812029|592135008|FG000|Overall Study|Lost to Follow-up|0|||
163935820|NCT03812029|592135009|FG001|Overall Study|Lost to Follow-up|0|||
163935821|NCT03812029|592135010|FG002|Overall Study|Lost to Follow-up|0|||
163935822|NCT03812029|592135011|FG003|Overall Study|Lost to Follow-up|0|||
163935823|NCT03812029|592135012|FG004|Overall Study|Lost to Follow-up|3|||
163935824|NCT01080300|592135013|FG000|Overall Study|Adverse Event|49|||
163935825|NCT01080300|592135014|FG001|Overall Study|Adverse Event|35|||
163935826|NCT01080300|592135013|FG000|Overall Study|Lack of Efficacy|12|||
163935827|NCT01080300|592135014|FG001|Overall Study|Lack of Efficacy|15|||
163935828|NCT01080300|592135013|FG000|Overall Study|Protocol Violation|7|||
163935829|NCT01080300|592135014|FG001|Overall Study|Protocol Violation|13|||
163935830|NCT01080300|592135013|FG000|Overall Study|Lost to Follow-up|10|||
163935831|NCT01080300|592135014|FG001|Overall Study|Lost to Follow-up|6|||
163935832|NCT01080300|592135013|FG000|Overall Study|Death|0|||
163935833|NCT01080300|592135014|FG001|Overall Study|Death|1|||
164038865|NCT03803202|592501071|FG004|Overall Study|Death|0|||
164038866|NCT03803202|592501072|FG005|Overall Study|Death|1|||
164038867|NCT03803202|592501073|FG006|Overall Study|Death|0|||
163935834|NCT01080300|592135013|FG000|Overall Study|Withdrawal by Subject|12|||
163935835|NCT01080300|592135014|FG001|Overall Study|Withdrawal by Subject|28|||
163935836|NCT01080300|592135013|FG000|Overall Study|Reasons not specified|4|||
163935837|NCT01080300|592135014|FG001|Overall Study|Reasons not specified|6|||
163935838|NCT02269423|592135022|FG000|Overall Study|Discontinued due to change in residence|0|||
163935839|NCT02269423|592135023|FG001|Overall Study|Discontinued due to change in residence|1|||
163935840|NCT02269423|592135024|FG002|Overall Study|Discontinued due to change in residence|0|||
163935841|NCT02269423|592135025|FG003|Overall Study|Discontinued due to change in residence|1|||
163935842|NCT01281839|592135026|FG000|Overall Study|Lost to Follow-up|6|||
163935843|NCT01281839|592135027|FG001|Overall Study|Lost to Follow-up|3|||
163935844|NCT01281839|592135026|FG000|Overall Study|Withdrawal by Subject|4|||
163935845|NCT01281839|592135027|FG001|Overall Study|Withdrawal by Subject|10|||
163935846|NCT01281839|592135026|FG000|Overall Study|Reason not specified|0|||
163935847|NCT01281839|592135027|FG001|Overall Study|Reason not specified|1|||
163935848|NCT01305239|592135028|FG000|Overall Study|Adverse Event|22|||
163935849|NCT01305239|592135028|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
163935850|NCT04674189|592135030|FG000|Overall Study|Adverse Event|0|||
163935851|NCT04674189|592135031|FG001|Overall Study|Adverse Event|0|||
163935852|NCT04674189|592135032|FG002|Overall Study|Adverse Event|1|||
163935853|NCT04674189|592135030|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
163935854|NCT04674189|592135031|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
163935855|NCT04674189|592135032|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
163935856|NCT04674189|592135030|FG000|Overall Study|Physician Decision|1|||
163935857|NCT04674189|592135031|FG001|Overall Study|Physician Decision|0|||
163935858|NCT04674189|592135032|FG002|Overall Study|Physician Decision|0|||
163935859|NCT04674189|592135030|FG000|Overall Study|Withdrawal by Participant|83|||
163935860|NCT04674189|592135031|FG001|Overall Study|Withdrawal by Participant|71|||
163935861|NCT04674189|592135032|FG002|Overall Study|Withdrawal by Participant|142|||
163935862|NCT04674189|592135030|FG000|Overall Study|Lost to Follow-up|55|||
163935863|NCT04674189|592135031|FG001|Overall Study|Lost to Follow-up|53|||
163935864|NCT04674189|592135032|FG002|Overall Study|Lost to Follow-up|44|||
163935865|NCT04674189|592135030|FG000|Overall Study|Miscellaneous|27|||
163935866|NCT04674189|592135031|FG001|Overall Study|Miscellaneous|23|||
163935867|NCT04674189|592135032|FG002|Overall Study|Miscellaneous|207|||
163935868|NCT04674189|592135030|FG000|Overall Study|Did Not Receive Treatment|3|||
163935869|NCT04674189|592135031|FG001|Overall Study|Did Not Receive Treatment|1|||
163935870|NCT04674189|592135032|FG002|Overall Study|Did Not Receive Treatment|2|||
163935871|NCT01261247|592135033|FG000|Overall Study|Ineligible|2|||
163935872|NCT05226130|592135034|FG000|Overall Study|Lost to Follow-up|0|||
163935873|NCT05226130|592135035|FG001|Overall Study|Lost to Follow-up|1|||
163935874|NCT05226130|592135034|FG000|Overall Study|Not treatment adherent|0|||
163935875|NCT05226130|592135035|FG001|Overall Study|Not treatment adherent|2|||
163935876|NCT03974022|592135036|FG000|Overall Study|Death|0|||
163935877|NCT03974022|592135037|FG001|Overall Study|Death|1|||
163935878|NCT03974022|592135038|FG002|Overall Study|Death|0|||
163935879|NCT03974022|592135039|FG003|Overall Study|Death|2|||
163935880|NCT03974022|592135040|FG004|Overall Study|Death|0|||
163935881|NCT03974022|592135041|FG005|Overall Study|Death|1|||
163935882|NCT03974022|592135042|FG006|Overall Study|Death|0|||
163935883|NCT03974022|592135043|FG007|Overall Study|Death|2|||
163935884|NCT03974022|592135044|FG008|Overall Study|Death|1|||
163935885|NCT03974022|592135045|FG009|Overall Study|Death|4|||
163935886|NCT03974022|592135046|FG010|Overall Study|Death|0|||
163935887|NCT03974022|592135047|FG011|Overall Study|Death|0|||
163935888|NCT03974022|592135048|FG012|Overall Study|Death|0|||
163935889|NCT03974022|592135049|FG013|Overall Study|Death|33|||
163935890|NCT03974022|592135050|FG014|Overall Study|Death|40|||
163935891|NCT03974022|592135036|FG000|Overall Study|Withdrawal by Subject|0|||
163935892|NCT03974022|592135037|FG001|Overall Study|Withdrawal by Subject|0|||
163935893|NCT03974022|592135038|FG002|Overall Study|Withdrawal by Subject|0|||
164038868|NCT03803202|592501074|FG007|Overall Study|Death|0|||
164038869|NCT03803202|592501075|FG008|Overall Study|Death|0|||
164038870|NCT03803202|592501067|FG000|Overall Study|Withdrawal by Subject|0|||
164038871|NCT03803202|592501068|FG001|Overall Study|Withdrawal by Subject|0|||
164038872|NCT03803202|592501069|FG002|Overall Study|Withdrawal by Subject|1|||
164038873|NCT03803202|592501070|FG003|Overall Study|Withdrawal by Subject|0|||
164038874|NCT03803202|592501071|FG004|Overall Study|Withdrawal by Subject|0|||
163935894|NCT03974022|592135039|FG003|Overall Study|Withdrawal by Subject|0|||
163935895|NCT03974022|592135040|FG004|Overall Study|Withdrawal by Subject|0|||
163935896|NCT03974022|592135041|FG005|Overall Study|Withdrawal by Subject|4|||
163935897|NCT03974022|592135042|FG006|Overall Study|Withdrawal by Subject|4|||
163935898|NCT03974022|592135043|FG007|Overall Study|Withdrawal by Subject|2|||
163935899|NCT03974022|592135044|FG008|Overall Study|Withdrawal by Subject|2|||
163935900|NCT03974022|592135045|FG009|Overall Study|Withdrawal by Subject|3|||
163935901|NCT03974022|592135046|FG010|Overall Study|Withdrawal by Subject|0|||
163935902|NCT03974022|592135047|FG011|Overall Study|Withdrawal by Subject|1|||
163935903|NCT03974022|592135048|FG012|Overall Study|Withdrawal by Subject|0|||
164038875|NCT03803202|592501072|FG005|Overall Study|Withdrawal by Subject|0|||
164038876|NCT03803202|592501073|FG006|Overall Study|Withdrawal by Subject|0|||
164038877|NCT03803202|592501074|FG007|Overall Study|Withdrawal by Subject|1|||
164038878|NCT03803202|592501075|FG008|Overall Study|Withdrawal by Subject|0|||
164038879|NCT03803202|592501067|FG000|Overall Study|Lost to Follow-up|0|||
164038880|NCT03803202|592501068|FG001|Overall Study|Lost to Follow-up|0|||
164038881|NCT03803202|592501069|FG002|Overall Study|Lost to Follow-up|0|||
164038882|NCT03803202|592501070|FG003|Overall Study|Lost to Follow-up|1|||
164038883|NCT03803202|592501071|FG004|Overall Study|Lost to Follow-up|1|||
164038884|NCT03803202|592501072|FG005|Overall Study|Lost to Follow-up|0|||
164038885|NCT03803202|592501073|FG006|Overall Study|Lost to Follow-up|1|||
164038886|NCT03803202|592501074|FG007|Overall Study|Lost to Follow-up|0|||
164038887|NCT03803202|592501075|FG008|Overall Study|Lost to Follow-up|0|||
164038888|NCT00293241|592501076|FG000|Overall Study|Lost to Follow-up|9|||
164038889|NCT00293241|592501077|FG001|Overall Study|Lost to Follow-up|16|||
164038890|NCT00293241|592501076|FG000|Overall Study|Physician Decision|23|||
164038891|NCT00293241|592501077|FG001|Overall Study|Physician Decision|17|||
164038892|NCT00293241|592501076|FG000|Overall Study|Withdrawal by Subject|4|||
164038893|NCT00293241|592501077|FG001|Overall Study|Withdrawal by Subject|8|||
164038894|NCT01125293|592501078|FG000|Overall Study|Disease Progression|1|||
164038895|NCT01125293|592501079|FG001|Overall Study|Disease Progression|3|||
164038896|NCT01125293|592501080|FG002|Overall Study|Disease Progression|4|||
164038897|NCT01125293|592501081|FG003|Overall Study|Disease Progression|3|||
164038898|NCT01125293|592501082|FG004|Overall Study|Disease Progression|5|||
164038899|NCT01125293|592501083|FG005|Overall Study|Disease Progression|12|||
164038900|NCT01125293|592501078|FG000|Overall Study|Adverse Event|1|||
164038901|NCT01125293|592501079|FG001|Overall Study|Adverse Event|0|||
164038902|NCT01125293|592501080|FG002|Overall Study|Adverse Event|0|||
164038903|NCT01125293|592501081|FG003|Overall Study|Adverse Event|0|||
164038904|NCT01125293|592501082|FG004|Overall Study|Adverse Event|2|||
164038905|NCT01125293|592501083|FG005|Overall Study|Adverse Event|8|||
164038906|NCT01125293|592501078|FG000|Overall Study|Symptomatic Deterioration|1|||
164038907|NCT01125293|592501079|FG001|Overall Study|Symptomatic Deterioration|0|||
164038908|NCT01125293|592501080|FG002|Overall Study|Symptomatic Deterioration|0|||
164038909|NCT01125293|592501081|FG003|Overall Study|Symptomatic Deterioration|0|||
164038910|NCT01125293|592501082|FG004|Overall Study|Symptomatic Deterioration|0|||
164038911|NCT01125293|592501083|FG005|Overall Study|Symptomatic Deterioration|0|||
164038912|NCT01125293|592501078|FG000|Overall Study|Death|0|||
164038913|NCT01125293|592501079|FG001|Overall Study|Death|0|||
164038914|NCT01125293|592501080|FG002|Overall Study|Death|0|||
164038915|NCT01125293|592501081|FG003|Overall Study|Death|0|||
164038916|NCT01125293|592501082|FG004|Overall Study|Death|1|||
164038917|NCT01125293|592501083|FG005|Overall Study|Death|0|||
164038918|NCT01125293|592501078|FG000|Overall Study|Withdrawal by Subject|0|||
164038919|NCT01125293|592501079|FG001|Overall Study|Withdrawal by Subject|0|||
164038920|NCT01125293|592501080|FG002|Overall Study|Withdrawal by Subject|0|||
164038921|NCT01125293|592501081|FG003|Overall Study|Withdrawal by Subject|0|||
164038922|NCT01125293|592501082|FG004|Overall Study|Withdrawal by Subject|2|||
164038923|NCT01125293|592501083|FG005|Overall Study|Withdrawal by Subject|1|||
164038924|NCT01125293|592501078|FG000|Overall Study|Physician Decision|0|||
164038925|NCT01125293|592501079|FG001|Overall Study|Physician Decision|0|||
164038926|NCT01125293|592501080|FG002|Overall Study|Physician Decision|0|||
164038927|NCT01125293|592501081|FG003|Overall Study|Physician Decision|0|||
164038928|NCT01125293|592501082|FG004|Overall Study|Physician Decision|0|||
164038929|NCT01125293|592501083|FG005|Overall Study|Physician Decision|2|||
164038930|NCT02224638|592501084|FG000|Overall Study|Adverse Event|1|||
164038931|NCT02224638|592501085|FG001|Overall Study|Adverse Event|1|||
164038932|NCT01270958|592501086|FG000|Overall Study|Lost to Follow-up|2|||
164038933|NCT01270958|592501086|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
164038934|NCT01406652|592501087|FG000|Overall Study|Lost-to-follow-up|3|||
164038935|NCT01406652|592501088|FG001|Overall Study|Lost-to-follow-up|4|||
164038936|NCT01406652|592501087|FG000|Overall Study|Withdrawal by Subject|2|||
164038937|NCT01406652|592501088|FG001|Overall Study|Withdrawal by Subject|2|||
164098741|NCT00834743|592726886|FG000|Second Intervention|Withdrawal by Subject|1|||
164038938|NCT01406652|592501087|FG000|Overall Study|Insufficient follow-up|5|||
164038939|NCT01406652|592501088|FG001|Overall Study|Insufficient follow-up|4|||
164038940|NCT01406652|592501087|FG000|Overall Study|Infection not sure|10|||
164038941|NCT01406652|592501088|FG001|Overall Study|Infection not sure|10|||
164038942|NCT02228564|592501091|FG000|Overall Study|Withdrawal by Subject|10|||
164038943|NCT02228564|592501091|FG000|Overall Study|Death|11|||
164038944|NCT02228564|592501091|FG000|Overall Study|Physician Decision|5|||
164038945|NCT02228564|592501091|FG000|Overall Study|Lost to Follow-up|17|||
164038946|NCT02228564|592501091|FG000|Overall Study|Other|6|||
164038947|NCT02633046|592501093|FG000|Overall Study|Adverse Event|8|||
164038948|NCT02633046|592501093|FG000|Overall Study|Physician Decision|7|||
164038949|NCT02633046|592501093|FG000|Overall Study|Withdrawal by Subject|8|||
164038950|NCT02633046|592501093|FG000|Overall Study|Increased proteinuria|2|||
164038951|NCT02633046|592501093|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
164038952|NCT02633046|592501093|FG000|Overall Study|Mutual decision patient and physician|1|||
164038953|NCT02142504|592501094|FG000|Overall Study|Protocol Violation|2|||
163935904|NCT03974022|592135049|FG013|Overall Study|Withdrawal by Subject|3|||
163935905|NCT03974022|592135050|FG014|Overall Study|Withdrawal by Subject|9|||
163935906|NCT03974022|592135036|FG000|Overall Study|Lost to Follow-up|0|||
163935907|NCT03974022|592135037|FG001|Overall Study|Lost to Follow-up|0|||
163935908|NCT03974022|592135038|FG002|Overall Study|Lost to Follow-up|0|||
163935909|NCT03974022|592135039|FG003|Overall Study|Lost to Follow-up|0|||
163935910|NCT03974022|592135040|FG004|Overall Study|Lost to Follow-up|0|||
163935911|NCT03974022|592135041|FG005|Overall Study|Lost to Follow-up|0|||
163935912|NCT03974022|592135042|FG006|Overall Study|Lost to Follow-up|1|||
163935913|NCT03974022|592135043|FG007|Overall Study|Lost to Follow-up|0|||
163935914|NCT03974022|592135044|FG008|Overall Study|Lost to Follow-up|0|||
163935915|NCT03974022|592135045|FG009|Overall Study|Lost to Follow-up|0|||
163935916|NCT03974022|592135046|FG010|Overall Study|Lost to Follow-up|0|||
163935917|NCT03974022|592135047|FG011|Overall Study|Lost to Follow-up|0|||
163935918|NCT03974022|592135048|FG012|Overall Study|Lost to Follow-up|0|||
163935919|NCT03974022|592135049|FG013|Overall Study|Lost to Follow-up|1|||
163935920|NCT03974022|592135050|FG014|Overall Study|Lost to Follow-up|1|||
163935921|NCT03974022|592135036|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
163935922|NCT03974022|592135037|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
163935923|NCT03974022|592135038|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
163935924|NCT03974022|592135039|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
163935925|NCT03974022|592135040|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
163935926|NCT03974022|592135041|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
163935927|NCT03974022|592135042|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
163935928|NCT03974022|592135043|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
163935929|NCT03974022|592135044|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
163935930|NCT03974022|592135045|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
163935931|NCT03974022|592135046|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
163935932|NCT03974022|592135047|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
163935933|NCT03974022|592135048|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
163935934|NCT03974022|592135049|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
163935935|NCT03974022|592135050|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
163935936|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
163935937|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
163935938|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
163935939|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
163935940|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
163935941|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
163935942|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
163935943|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
163935944|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
163935945|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
163935946|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
163935947|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
163935948|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
163935949|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
163935950|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
163935951|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
163935952|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
163935953|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
163935954|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
163935955|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
163935956|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
163935957|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
163935958|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
163935959|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
163935960|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
163935961|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
163935962|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
163935963|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
163935964|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
164098742|NCT00834743|592726887|FG001|Second Intervention|Withdrawal by Subject|0|||
164098743|NCT01534663|592726888|FG000|Overall Study|Lost to Follow-up|0|||
163935965|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
163935966|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
164098744|NCT01534663|592726889|FG001|Overall Study|Lost to Follow-up|2|||
164098745|NCT01534663|592726888|FG000|Overall Study|Adverse Event|2|||
164038954|NCT02142504|592501095|FG001|Overall Study|Protocol Violation|1|||
164038955|NCT02142504|592501096|FG002|Overall Study|Protocol Violation|2|||
164038956|NCT02142504|592501094|FG000|Overall Study|Adverse Event|2|||
164038957|NCT02142504|592501095|FG001|Overall Study|Adverse Event|3|||
164038958|NCT02142504|592501096|FG002|Overall Study|Adverse Event|4|||
164038959|NCT02142504|592501094|FG000|Overall Study|Lost to Follow-up|12|||
164038960|NCT02142504|592501095|FG001|Overall Study|Lost to Follow-up|19|||
164038961|NCT02142504|592501096|FG002|Overall Study|Lost to Follow-up|17|||
164038962|NCT02142504|592501094|FG000|Overall Study|Withdrawal by Subject|7|||
164038963|NCT02142504|592501095|FG001|Overall Study|Withdrawal by Subject|9|||
164038964|NCT02142504|592501096|FG002|Overall Study|Withdrawal by Subject|11|||
164038965|NCT02142504|592501094|FG000|Overall Study|Pregnancy|4|||
164038966|NCT02142504|592501095|FG001|Overall Study|Pregnancy|4|||
164038967|NCT02142504|592501096|FG002|Overall Study|Pregnancy|2|||
164038968|NCT02142504|592501094|FG000|Overall Study|Physician Decision|0|||
164038969|NCT02142504|592501095|FG001|Overall Study|Physician Decision|1|||
164038970|NCT02142504|592501096|FG002|Overall Study|Physician Decision|3|||
164038971|NCT02142504|592501094|FG000|Overall Study|Reason Not Specified|4|||
164038972|NCT02142504|592501095|FG001|Overall Study|Reason Not Specified|5|||
164038973|NCT02142504|592501096|FG002|Overall Study|Reason Not Specified|4|||
164038974|NCT02925312|592501097|FG000|Overall Study|Lost to Follow-up|25|||
164038975|NCT02925312|592501098|FG001|Overall Study|Lost to Follow-up|0|||
164038976|NCT02925312|592501097|FG000|Overall Study|Adverse Event|2|||
164038977|NCT02925312|592501098|FG001|Overall Study|Adverse Event|0|||
164038978|NCT04114539|592501107|FG000|Overall Study|Adverse Event|14|||
164038979|NCT04114539|592501107|FG000|Overall Study|Lost to Follow-up|2|||
164038980|NCT04114539|592501107|FG000|Overall Study|Non-compliance with Protocol|2|||
164038981|NCT04114539|592501107|FG000|Overall Study|Non-compliance with Study Drug|1|||
164038982|NCT04114539|592501107|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
164038983|NCT04114539|592501107|FG000|Overall Study|Withdrew consent|10|||
164038984|NCT04114539|592501107|FG000|Overall Study|Others not specified|5|||
164038985|NCT04114539|592501107|FG000|Overall Study|Investigator Decision|2|||
164038986|NCT00418717|592501115|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
164038987|NCT00418717|592501115|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
164038988|NCT01400139|592501116|FG000|HYD Core Study|Adverse Event|210|||
164038989|NCT01400139|592501116|FG000|HYD Core Study|Lack of Efficacy|59|||
164038990|NCT01400139|592501116|FG000|HYD Core Study|Withdrawal by Subject|114|||
164038991|NCT01400139|592501116|FG000|HYD Core Study|Lost to Follow-up|39|||
164038992|NCT01400139|592501116|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
164038993|NCT01400139|592501116|FG000|HYD Core Study|Administrative|56|||
164038994|NCT01400139|592501116|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
164038995|NCT01400139|592501116|FG000|HYD Extension Period|Adverse Event|8|||
164038996|NCT01400139|592501116|FG000|HYD Extension Period|Withdrawal by Subject|5|||
164038997|NCT01400139|592501116|FG000|HYD Extension Period|Administrative|10|||
164038998|NCT00795509|592501124|FG000|Overall Study|Protocol Violation|31|||
164038999|NCT03136367|592501126|FG000|T1 Consultation|discontinued mistakenly included|2|||
164039000|NCT03136367|592501127|FG001|T1 Consultation|discontinued mistakenly included|6|||
164039001|NCT03136367|592501128|FG002|T1 Consultation|discontinued mistakenly included|1|||
164039002|NCT03136367|592501126|FG000|T1 Consultation|Discontinued other|0|||
164039003|NCT03136367|592501127|FG001|T1 Consultation|Discontinued other|1|||
164039004|NCT03136367|592501128|FG002|T1 Consultation|Discontinued other|0|||
164039005|NCT03136367|592501126|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
164039006|NCT03136367|592501127|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
164039007|NCT03136367|592501128|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
164039008|NCT03136367|592501126|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
164039009|NCT03136367|592501127|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
164039010|NCT03136367|592501128|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
164039011|NCT03136367|592501126|FG000|T2 Post-consultation|Discontinued other|0|||
164039012|NCT03136367|592501127|FG001|T2 Post-consultation|Discontinued other|2|||
164039013|NCT03136367|592501128|FG002|T2 Post-consultation|Discontinued other|6|||
164039014|NCT03136367|592501126|FG000|T2 Post-consultation|Discontinued transferred care|0|||
164039015|NCT03136367|592501127|FG001|T2 Post-consultation|Discontinued transferred care|0|||
164039016|NCT03136367|592501128|FG002|T2 Post-consultation|Discontinued transferred care|3|||
164039017|NCT03136367|592501126|FG000|T2 Post-consultation|Discontinued lost contact|0|||
164039018|NCT03136367|592501127|FG001|T2 Post-consultation|Discontinued lost contact|1|||
164039019|NCT03136367|592501128|FG002|T2 Post-consultation|Discontinued lost contact|0|||
164039020|NCT03136367|592501126|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
164039021|NCT03136367|592501127|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
164039022|NCT03136367|592501128|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
164039023|NCT03136367|592501126|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
164039024|NCT03136367|592501127|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
164039025|NCT03136367|592501128|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
164039026|NCT03136367|592501126|FG000|T3 1 Week After Surgery|other discontinued|2|||
163839789|NCT00118898|591783676|FG001|Overall Study|Not able to get to clinic|43|||
163935967|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
163935968|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
163935969|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
164039027|NCT03136367|592501127|FG001|T3 1 Week After Surgery|other discontinued|4|||
164039028|NCT03136367|592501128|FG002|T3 1 Week After Surgery|other discontinued|3|||
164039029|NCT03136367|592501126|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
164039030|NCT03136367|592501127|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
164039031|NCT03136367|592501128|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
164039032|NCT03136367|592501126|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
164039033|NCT03136367|592501127|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
164039034|NCT03136367|592501128|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
164039035|NCT03136367|592501126|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
164039036|NCT03136367|592501127|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
164039037|NCT03136367|592501128|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
164039038|NCT03136367|592501126|FG000|T4 12 Weeks After Surgery|Death|0|||
164039039|NCT03136367|592501127|FG001|T4 12 Weeks After Surgery|Death|1|||
164039040|NCT03136367|592501128|FG002|T4 12 Weeks After Surgery|Death|3|||
164039041|NCT03136367|592501126|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
164039042|NCT03136367|592501127|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
164039043|NCT03136367|592501128|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
164039044|NCT03136367|592501126|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
164039045|NCT03136367|592501127|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
164039046|NCT03136367|592501128|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
164039047|NCT03136367|592501126|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
164039048|NCT03136367|592501127|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
164039049|NCT03136367|592501128|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
164039050|NCT03136367|592501126|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
164039051|NCT03136367|592501127|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
164039052|NCT03136367|592501128|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
164039053|NCT03136367|592501126|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
164039054|NCT03136367|592501127|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
164039055|NCT03136367|592501128|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
164039056|NCT03136367|592501126|FG000|T5 1 Year After Surgery|Death|0|||
164039057|NCT03136367|592501127|FG001|T5 1 Year After Surgery|Death|0|||
164039058|NCT03136367|592501128|FG002|T5 1 Year After Surgery|Death|1|||
164039059|NCT03136367|592501126|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
164039060|NCT03136367|592501127|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
164039061|NCT03136367|592501128|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
164039062|NCT03136367|592501126|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
164039063|NCT03136367|592501127|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
164039064|NCT03136367|592501128|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
164039065|NCT03136367|592501126|FG000|T5 1 Year After Surgery|study ended before due|31|||
164039066|NCT03136367|592501127|FG001|T5 1 Year After Surgery|study ended before due|103|||
164039067|NCT03136367|592501128|FG002|T5 1 Year After Surgery|study ended before due|110|||
164039068|NCT03136367|592501126|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
164039069|NCT03136367|592501127|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
163935970|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
163935971|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
163935972|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
163935973|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
163935974|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
163935975|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
163935976|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
163935977|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
163935978|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
163935979|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
163935980|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
163935981|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
163935982|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
163935983|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
163935984|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
163935985|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
163935986|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
163935987|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
163935988|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
164039070|NCT03136367|592501128|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
164039071|NCT02947022|592501131|FG000|Overall Study|Study Stopped|1|||
164039072|NCT01230749|592501132|FG000|Overall Study|Adverse Event|0|||
163935989|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
163935990|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
163935991|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
163935992|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
163935993|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
163935994|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
163935995|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
163935996|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
163935997|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
163935998|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
163935999|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
163936000|NCT00217737|592135053|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
163936001|NCT00217737|592135054|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
163936002|NCT00217737|592135055|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
163936003|NCT00217737|592135056|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
163936004|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
163936005|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
163936006|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
163936007|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
163936008|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
163936009|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
163936010|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
163936011|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
163936012|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Study suspension|0|||
163936013|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Study suspension|45|||
163936014|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Study suspension|0|||
163936015|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Study suspension|0|||
163936016|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
163936017|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
163936018|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
163936019|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
163936020|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Death|2|||
163936021|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Death|3|||
163936022|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Death|0|||
163936023|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Death|0|||
163936024|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
163936025|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
163936026|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
163936027|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
163936028|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
163936029|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
163936030|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
163936031|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
163936032|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
163936033|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
163936034|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
163936035|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
163936036|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
163936037|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
163936038|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
163936039|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
163936040|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
164039073|NCT01230749|592501133|FG001|Overall Study|Adverse Event|0|||
164039074|NCT01230749|592501134|FG002|Overall Study|Adverse Event|0|||
164039075|NCT01230749|592501135|FG003|Overall Study|Adverse Event|1|||
164039076|NCT01230749|592501132|FG000|Overall Study|Physician Decision|0|||
164039077|NCT01230749|592501133|FG001|Overall Study|Physician Decision|0|||
164039078|NCT01230749|592501134|FG002|Overall Study|Physician Decision|1|||
164039079|NCT01230749|592501135|FG003|Overall Study|Physician Decision|0|||
164039080|NCT01230749|592501132|FG000|Overall Study|Withdrawal by Subject|0|||
164039081|NCT01230749|592501133|FG001|Overall Study|Withdrawal by Subject|1|||
164098746|NCT01534663|592726889|FG001|Overall Study|Adverse Event|1|||
163936041|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
163936042|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
163936043|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
163936044|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
164039082|NCT01230749|592501134|FG002|Overall Study|Withdrawal by Subject|0|||
163839790|NCT00118898|591783677|FG002|Overall Study|Not able to get to clinic|31|||
163839791|NCT00118898|591783678|FG003|Overall Study|Not able to get to clinic|40|||
163839792|NCT02714205|591783684|FG000|Overall Study|Cannot tolerate medication|1|||
163839793|NCT02714205|591783685|FG001|Overall Study|Cannot tolerate medication|0|||
163839794|NCT02714205|591783684|FG000|Overall Study|Adverse Event|2|||
163839795|NCT02714205|591783685|FG001|Overall Study|Adverse Event|0|||
163839796|NCT02714205|591783684|FG000|Overall Study|Too busy|1|||
163839797|NCT02714205|591783685|FG001|Overall Study|Too busy|0|||
163839798|NCT02714205|591783684|FG000|Overall Study|Incomplete outcome data|0|||
163839799|NCT02714205|591783685|FG001|Overall Study|Incomplete outcome data|1|||
163839800|NCT02073097|591783686|FG000|Overall Study|Adverse Event|0|||
163839801|NCT02073097|591783687|FG001|Overall Study|Adverse Event|0|||
163839802|NCT02073097|591783688|FG002|Overall Study|Adverse Event|0|||
163839803|NCT02073097|591783689|FG003|Overall Study|Adverse Event|0|||
163839804|NCT02073097|591783690|FG004|Overall Study|Adverse Event|0|||
163839805|NCT02073097|591783691|FG005|Overall Study|Adverse Event|0|||
163839806|NCT02073097|591783692|FG006|Overall Study|Adverse Event|0|||
163839807|NCT02073097|591783693|FG007|Overall Study|Adverse Event|2|||
163839808|NCT02073097|591783686|FG000|Overall Study|Withdrawal by Subject|0|||
163839809|NCT02073097|591783687|FG001|Overall Study|Withdrawal by Subject|0|||
163839810|NCT02073097|591783688|FG002|Overall Study|Withdrawal by Subject|0|||
163839811|NCT02073097|591783689|FG003|Overall Study|Withdrawal by Subject|0|||
163839812|NCT02073097|591783690|FG004|Overall Study|Withdrawal by Subject|0|||
163839813|NCT02073097|591783691|FG005|Overall Study|Withdrawal by Subject|0|||
163839814|NCT02073097|591783692|FG006|Overall Study|Withdrawal by Subject|0|||
163839815|NCT02073097|591783693|FG007|Overall Study|Withdrawal by Subject|2|||
163839816|NCT02073097|591783686|FG000|Overall Study|Death|0|||
163839817|NCT02073097|591783687|FG001|Overall Study|Death|0|||
163839818|NCT02073097|591783688|FG002|Overall Study|Death|0|||
163839819|NCT02073097|591783689|FG003|Overall Study|Death|0|||
163839820|NCT02073097|591783690|FG004|Overall Study|Death|0|||
163839821|NCT02073097|591783691|FG005|Overall Study|Death|0|||
163839822|NCT02073097|591783692|FG006|Overall Study|Death|0|||
163839823|NCT02073097|591783693|FG007|Overall Study|Death|1|||
163839824|NCT02073097|591783686|FG000|Overall Study|Physician Decision|0|||
163839825|NCT02073097|591783687|FG001|Overall Study|Physician Decision|0|||
163839826|NCT02073097|591783688|FG002|Overall Study|Physician Decision|0|||
163839827|NCT02073097|591783689|FG003|Overall Study|Physician Decision|0|||
163839828|NCT02073097|591783690|FG004|Overall Study|Physician Decision|0|||
163839829|NCT02073097|591783691|FG005|Overall Study|Physician Decision|0|||
163839830|NCT02073097|591783692|FG006|Overall Study|Physician Decision|0|||
163839831|NCT02073097|591783693|FG007|Overall Study|Physician Decision|1|||
163839832|NCT03813147|591783696|FG000|Overall Study|Lack of Efficacy|4|||
163839833|NCT03813147|591783697|FG001|Overall Study|Lack of Efficacy|4|||
163839834|NCT03813147|591783696|FG000|Overall Study|Physician Decision|2|||
163839835|NCT03813147|591783697|FG001|Overall Study|Physician Decision|1|||
163839836|NCT01693692|591783698|FG000|Overall Study|Withdrawal by Subject|12|||
163839837|NCT01693692|591783699|FG001|Overall Study|Withdrawal by Subject|10|||
163839838|NCT01693692|591783700|FG002|Overall Study|Withdrawal by Subject|11|||
163839839|NCT01693692|591783698|FG000|Overall Study|Adverse Event|7|||
163839840|NCT01693692|591783699|FG001|Overall Study|Adverse Event|14|||
163839841|NCT01693692|591783700|FG002|Overall Study|Adverse Event|9|||
163839842|NCT01693692|591783698|FG000|Overall Study|Physician Decision|0|||
163839843|NCT01693692|591783699|FG001|Overall Study|Physician Decision|0|||
163839844|NCT01693692|591783700|FG002|Overall Study|Physician Decision|1|||
163839845|NCT01693692|591783698|FG000|Overall Study|Protocol Violation|5|||
163839846|NCT01693692|591783699|FG001|Overall Study|Protocol Violation|4|||
163839847|NCT01693692|591783700|FG002|Overall Study|Protocol Violation|6|||
163839848|NCT01693692|591783698|FG000|Overall Study|Lost to Follow-up|2|||
163839849|NCT01693692|591783699|FG001|Overall Study|Lost to Follow-up|2|||
163839850|NCT01693692|591783700|FG002|Overall Study|Lost to Follow-up|3|||
163839851|NCT01693692|591783698|FG000|Overall Study|Other|4|||
163839852|NCT01693692|591783699|FG001|Overall Study|Other|4|||
163839853|NCT01693692|591783700|FG002|Overall Study|Other|6|||
163839854|NCT01811563|591785670|FG000|Overall Study|Lost to Follow-up|5|||
163839855|NCT01811563|591785671|FG001|Overall Study|Lost to Follow-up|2|||
163839856|NCT01811563|591785670|FG000|Overall Study|Incorrect Randomization procedure|0|||
163839857|NCT01811563|591785671|FG001|Overall Study|Incorrect Randomization procedure|1|||
163839858|NCT04424290|591785672|FG000|Overall Study|Not treated|0|||
163839859|NCT04424290|591785673|FG001|Overall Study|Not treated|0|||
163839860|NCT04424290|591785674|FG002|Overall Study|Not treated|1|||
163839861|NCT04424290|591785675|FG003|Overall Study|Not treated|0|||
163839862|NCT04424290|591785676|FG004|Overall Study|Not treated|1|||
163839863|NCT04424290|591785672|FG000|Overall Study|Adverse Event|0|||
163839864|NCT04424290|591785673|FG001|Overall Study|Adverse Event|0|||
163839865|NCT04424290|591785674|FG002|Overall Study|Adverse Event|0|||
163839866|NCT04424290|591785675|FG003|Overall Study|Adverse Event|2|||
163839867|NCT04424290|591785676|FG004|Overall Study|Adverse Event|0|||
163839868|NCT04424290|591785672|FG000|Overall Study|Withdrawal by Subject|0|||
163839869|NCT04424290|591785673|FG001|Overall Study|Withdrawal by Subject|0|||
164039083|NCT01230749|592501135|FG003|Overall Study|Withdrawal by Subject|0|||
164039084|NCT01230749|592501132|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
164039085|NCT01230749|592501133|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
164039086|NCT01230749|592501134|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
164039087|NCT01230749|592501135|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
164039088|NCT03682055|592503362|FG000|Overall Study|Lack of Efficacy|1|||
164039089|NCT03682055|592503363|FG001|Overall Study|Lack of Efficacy|2|||
164039090|NCT03682055|592503364|FG002|Overall Study|Lack of Efficacy|1|||
164039091|NCT03682055|592503365|FG003|Overall Study|Lack of Efficacy|2|||
164039092|NCT03682055|592503366|FG004|Overall Study|Lack of Efficacy|1|||
164039093|NCT03682055|592503367|FG005|Overall Study|Lack of Efficacy|3|||
164039094|NCT03682055|592503362|FG000|Overall Study|Withdrawal by Subject|0|||
164039095|NCT03682055|592503363|FG001|Overall Study|Withdrawal by Subject|0|||
164039096|NCT03682055|592503364|FG002|Overall Study|Withdrawal by Subject|0|||
164039097|NCT03682055|592503365|FG003|Overall Study|Withdrawal by Subject|0|||
164039098|NCT03682055|592503366|FG004|Overall Study|Withdrawal by Subject|0|||
164039099|NCT03682055|592503367|FG005|Overall Study|Withdrawal by Subject|1|||
164039100|NCT03682055|592503362|FG000|Overall Study|Termination of Study by Sponsor|0|||
164039101|NCT03682055|592503363|FG001|Overall Study|Termination of Study by Sponsor|0|||
164039102|NCT03682055|592503364|FG002|Overall Study|Termination of Study by Sponsor|0|||
164039103|NCT03682055|592503365|FG003|Overall Study|Termination of Study by Sponsor|0|||
164039104|NCT03682055|592503366|FG004|Overall Study|Termination of Study by Sponsor|0|||
164039105|NCT03682055|592503367|FG005|Overall Study|Termination of Study by Sponsor|3|||
164039106|NCT00191386|592503368|FG000|Overall Study|Adverse Event|16|||
164039107|NCT00191386|592503368|FG000|Overall Study|Lost to Follow-up|1|||
164039108|NCT00191386|592503368|FG000|Overall Study|Entry Criteria Exclusion|3|||
164039109|NCT00191386|592503368|FG000|Overall Study|Protocol Violation|18|||
164039110|NCT00191386|592503368|FG000|Overall Study|Withdrawal by Subject|96|||
164039111|NCT00191386|592503368|FG000|Overall Study|Physician Decision|11|||
164039112|NCT00191386|592503368|FG000|Overall Study|Lack of Efficacy|15|||
164039113|NCT03077243|592503370|FG000|Overall Study|Death|1|||
164039114|NCT03077243|592503371|FG001|Overall Study|Death|2|||
164039115|NCT03077243|592503372|FG002|Overall Study|Death|0|||
164039116|NCT03077243|592503373|FG003|Overall Study|Death|0|||
164039117|NCT03077243|592503370|FG000|Overall Study|Withdrawal by Subject|1|||
164039118|NCT03077243|592503371|FG001|Overall Study|Withdrawal by Subject|3|||
164039119|NCT03077243|592503372|FG002|Overall Study|Withdrawal by Subject|0|||
164039120|NCT03077243|592503373|FG003|Overall Study|Withdrawal by Subject|0|||
164039121|NCT03077243|592503370|FG000|Overall Study|Physician Decision|1|||
164039122|NCT03077243|592503371|FG001|Overall Study|Physician Decision|0|||
164039123|NCT03077243|592503372|FG002|Overall Study|Physician Decision|0|||
164039124|NCT03077243|592503373|FG003|Overall Study|Physician Decision|0|||
164039125|NCT03077243|592503370|FG000|Overall Study|Research at two study sites terminated early|0|||
164039126|NCT03077243|592503371|FG001|Overall Study|Research at two study sites terminated early|0|||
164039127|NCT03077243|592503372|FG002|Overall Study|Research at two study sites terminated early|0|||
164039128|NCT03077243|592503373|FG003|Overall Study|Research at two study sites terminated early|69|||
164039129|NCT01544478|592503374|FG000|Overall Study|Adverse Event|1|||
164039130|NCT01544478|592503374|FG000|Overall Study|Death|1|||
164039131|NCT01544478|592503374|FG000|Overall Study|Lost to Follow-up|48|||
164039132|NCT01544478|592503374|FG000|Overall Study|Physician Decision|15|||
164039133|NCT01544478|592503374|FG000|Overall Study|Pregnancy|1|||
164039134|NCT01544478|592503374|FG000|Overall Study|Withdrawal by Subject|52|||
164039135|NCT00212758|592503375|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
164039136|NCT00212758|592503376|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
164039137|NCT00212758|592503375|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
164039138|NCT00212758|592503376|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
164039139|NCT02574481|592503377|FG000|Overall Study|Withdrawal by Subject|29|||
164039140|NCT02574481|592503378|FG001|Overall Study|Withdrawal by Subject|15|||
164039141|NCT02574481|592503379|FG002|Overall Study|Withdrawal by Subject|4|||
164039142|NCT02574481|592503380|FG003|Overall Study|Withdrawal by Subject|1|||
164039143|NCT02574481|592503377|FG000|Overall Study|Adverse Event|5|||
164039144|NCT02574481|592503378|FG001|Overall Study|Adverse Event|1|||
164039145|NCT02574481|592503379|FG002|Overall Study|Adverse Event|1|||
164039146|NCT02574481|592503380|FG003|Overall Study|Adverse Event|0|||
164039147|NCT02574481|592503377|FG000|Overall Study|Visit Missed|15|||
164039148|NCT02574481|592503378|FG001|Overall Study|Visit Missed|7|||
164039149|NCT02574481|592503379|FG002|Overall Study|Visit Missed|5|||
164039150|NCT02574481|592503380|FG003|Overall Study|Visit Missed|0|||
164039151|NCT02574481|592503377|FG000|Overall Study|Other|7|||
164039152|NCT02574481|592503378|FG001|Overall Study|Other|2|||
164039153|NCT02574481|592503379|FG002|Overall Study|Other|0|||
164039154|NCT02574481|592503380|FG003|Overall Study|Other|0|||
164039155|NCT02574481|592503377|FG000|Overall Study|Death|48|||
164039156|NCT02574481|592503378|FG001|Overall Study|Death|26|||
164039157|NCT02574481|592503379|FG002|Overall Study|Death|12|||
164039158|NCT02574481|592503380|FG003|Overall Study|Death|4|||
164039159|NCT02574481|592503377|FG000|Overall Study|Physician Decision|5|||
164039160|NCT02574481|592503378|FG001|Overall Study|Physician Decision|2|||
164039161|NCT02574481|592503379|FG002|Overall Study|Physician Decision|0|||
164039162|NCT02574481|592503380|FG003|Overall Study|Physician Decision|0|||
164039163|NCT02574481|592503377|FG000|Overall Study|Lost to Follow-up|5|||
164039164|NCT02574481|592503378|FG001|Overall Study|Lost to Follow-up|1|||
163839870|NCT04424290|591785674|FG002|Overall Study|Withdrawal by Subject|0|||
163839871|NCT04424290|591785675|FG003|Overall Study|Withdrawal by Subject|0|||
163839872|NCT04424290|591785676|FG004|Overall Study|Withdrawal by Subject|1|||
163839873|NCT04424290|591785672|FG000|Overall Study|Other than listed|0|||
163839874|NCT04424290|591785673|FG001|Overall Study|Other than listed|0|||
163839875|NCT04424290|591785674|FG002|Overall Study|Other than listed|0|||
163839876|NCT04424290|591785675|FG003|Overall Study|Other than listed|1|||
163839877|NCT04424290|591785676|FG004|Overall Study|Other than listed|0|||
163839878|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
163839879|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
163839880|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
163839881|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
163839882|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
163839883|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
163839884|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Death|0|||
163839885|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Death|1|||
163839886|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Adverse Event|11|||
163839887|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Adverse Event|11|||
163839888|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
163839889|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
163839890|NCT02936037|591785677|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163839891|NCT02936037|591785678|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163839892|NCT02936037|591785677|FG000|Open Label Extension|Adverse Event|0|||
163839893|NCT02936037|591785678|FG001|Open Label Extension|Adverse Event|3|||
163839894|NCT02936037|591785677|FG000|Open Label Extension|Other|0|||
163839895|NCT02936037|591785678|FG001|Open Label Extension|Other|3|||
163839896|NCT02936037|591785677|FG000|Open Label Extension|Withdrawal by Subject|0|||
163839897|NCT02936037|591785678|FG001|Open Label Extension|Withdrawal by Subject|4|||
163839898|NCT01267825|591785679|FG000|Overall Study|study terminated. no data collected.|1|||
163839899|NCT01267825|591785680|FG001|Overall Study|study terminated. no data collected.|0|||
163839900|NCT04249336|591785681|FG000|Overall Study|Lost to Follow-up|3|||
163839901|NCT04249336|591785682|FG001|Overall Study|Lost to Follow-up|3|||
163839902|NCT04249336|591785683|FG002|Overall Study|Lost to Follow-up|3|||
163839903|NCT04249336|591785684|FG003|Overall Study|Lost to Follow-up|3|||
163839904|NCT01189890|591785688|FG000|Overall Study|Adverse Event|3|||
163839905|NCT01189890|591785689|FG001|Overall Study|Adverse Event|4|||
163839906|NCT01189890|591785688|FG000|Overall Study|Lack of Efficacy|7|||
163839907|NCT01189890|591785689|FG001|Overall Study|Lack of Efficacy|2|||
163839908|NCT01189890|591785688|FG000|Overall Study|Lost to Follow-up|1|||
163839909|NCT01189890|591785689|FG001|Overall Study|Lost to Follow-up|7|||
163839910|NCT01189890|591785688|FG000|Overall Study|Protocol Violation|1|||
163839911|NCT01189890|591785689|FG001|Overall Study|Protocol Violation|5|||
163839912|NCT01189890|591785688|FG000|Overall Study|Withdrawal by Subject|15|||
163839913|NCT01189890|591785689|FG001|Overall Study|Withdrawal by Subject|11|||
163839914|NCT01189890|591785688|FG000|Overall Study|Non Compliance|0|||
163839915|NCT01189890|591785689|FG001|Overall Study|Non Compliance|1|||
163839916|NCT01189890|591785688|FG000|Overall Study|Physician Decision|5|||
163839917|NCT01189890|591785689|FG001|Overall Study|Physician Decision|4|||
163839918|NCT01189890|591785688|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
163839919|NCT01189890|591785689|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
163839920|NCT00077636|591785690|FG000|Overall Study|Refused Treatment|9|||
163839921|NCT00077636|591785691|FG001|Overall Study|Refused Treatment|31|||
163839922|NCT00077636|591785690|FG000|Overall Study|Admin|3|||
163839923|NCT00077636|591785691|FG001|Overall Study|Admin|3|||
163839924|NCT00077636|591785690|FG000|Overall Study|Withdrawal by Subject|2|||
163839925|NCT00077636|591785691|FG001|Overall Study|Withdrawal by Subject|2|||
163839926|NCT00077636|591785690|FG000|Overall Study|Adverse Event|17|||
163839927|NCT00077636|591785691|FG001|Overall Study|Adverse Event|34|||
163936045|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
163936046|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
163936047|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
163936048|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
163936049|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
163936050|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
163936051|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
163936052|NCT00217737|592135053|FG000|Step 2 Randomization/Registration|Other|1|||
163936053|NCT00217737|592135054|FG001|Step 2 Randomization/Registration|Other|2|||
163936054|NCT00217737|592135055|FG002|Step 2 Randomization/Registration|Other|0|||
163936055|NCT00217737|592135056|FG003|Step 2 Randomization/Registration|Other|0|||
164039165|NCT02574481|592503379|FG002|Overall Study|Lost to Follow-up|3|||
163839928|NCT00077636|591785690|FG000|Overall Study|Protocol Violation|0|||
163839929|NCT00077636|591785691|FG001|Overall Study|Protocol Violation|2|||
163839930|NCT00077636|591785690|FG000|Overall Study|Lost to Follow-up|10|||
163839931|NCT00077636|591785691|FG001|Overall Study|Lost to Follow-up|18|||
163839932|NCT00077636|591785690|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
163839933|NCT00077636|591785691|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
163839934|NCT00068380|591785694|FG000|Overall Study|Withdrawal by Subject|3|||
163839935|NCT00068380|591785694|FG000|Overall Study|Adverse Event|2|||
163839936|NCT01976364|591785695|FG000|Main Study (36 Months)|Adverse Event|63|||
163839937|NCT01976364|591785696|FG001|Main Study (36 Months)|Adverse Event|0|||
163839938|NCT01976364|591785697|FG002|Main Study (36 Months)|Adverse Event|0|||
163839939|NCT01976364|591785695|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
163839940|NCT01976364|591785696|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
163839941|NCT01976364|591785697|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
163839942|NCT01976364|591785695|FG000|Main Study (36 Months)|Other|13|||
163839943|NCT01976364|591785696|FG001|Main Study (36 Months)|Other|0|||
163839944|NCT01976364|591785697|FG002|Main Study (36 Months)|Other|0|||
163839945|NCT01976364|591785695|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
163839946|NCT01976364|591785696|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
163839947|NCT01976364|591785697|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
163839948|NCT01976364|591785695|FG000|Main Study (36 Months)|Medication error|1|||
163839949|NCT01976364|591785696|FG001|Main Study (36 Months)|Medication error|0|||
163839950|NCT01976364|591785697|FG002|Main Study (36 Months)|Medication error|0|||
163839951|NCT01976364|591785695|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
163839952|NCT01976364|591785696|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
163839953|NCT01976364|591785697|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
163839954|NCT01976364|591785695|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
163839955|NCT01976364|591785696|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
163839956|NCT01976364|591785697|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
163839957|NCT01976364|591785695|FG000|Main Study (36 Months)|Protocol Violation|13|||
163839958|NCT01976364|591785696|FG001|Main Study (36 Months)|Protocol Violation|0|||
163839959|NCT01976364|591785697|FG002|Main Study (36 Months)|Protocol Violation|0|||
163839960|NCT01976364|591785695|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
163839961|NCT01976364|591785696|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
163839962|NCT01976364|591785697|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
163839963|NCT01976364|591785695|FG000|Main Study (36 Months)|Death|5|||
163839964|NCT01976364|591785696|FG001|Main Study (36 Months)|Death|0|||
163839965|NCT01976364|591785697|FG002|Main Study (36 Months)|Death|0|||
163839966|NCT01976364|591785695|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
163839967|NCT01976364|591785696|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
163839968|NCT01976364|591785697|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
163839969|NCT01976364|591785695|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
163839970|NCT01976364|591785696|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
163839971|NCT01976364|591785697|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
163839972|NCT01976364|591785695|FG000|Sub-study (12 Months)|Protocol Violation|0|||
163839973|NCT01976364|591785696|FG001|Sub-study (12 Months)|Protocol Violation|1|||
163839974|NCT01976364|591785697|FG002|Sub-study (12 Months)|Protocol Violation|1|||
163839975|NCT01976364|591785695|FG000|Sub-study (12 Months)|Adverse Event|0|||
163839976|NCT01976364|591785696|FG001|Sub-study (12 Months)|Adverse Event|4|||
163839977|NCT01976364|591785697|FG002|Sub-study (12 Months)|Adverse Event|3|||
163839978|NCT01190215|591785698|FG000|Up to Month 6|Lost to Follow-up|2|||
163839979|NCT01190215|591785699|FG001|Up to Month 6|Lost to Follow-up|0|||
163839980|NCT02914184|591785701|FG000|Overall Study|Lost to Follow-up|7|||
163839981|NCT02914184|591785702|FG001|Overall Study|Lost to Follow-up|10|||
163839982|NCT02914184|591785703|FG002|Overall Study|Lost to Follow-up|8|||
163839983|NCT02914184|591785704|FG003|Overall Study|Lost to Follow-up|7|||
163839984|NCT02914184|591785701|FG000|Overall Study|Withdrawal by Subject|4|||
163839985|NCT02914184|591785702|FG001|Overall Study|Withdrawal by Subject|2|||
163839986|NCT02914184|591785703|FG002|Overall Study|Withdrawal by Subject|7|||
163839987|NCT02914184|591785704|FG003|Overall Study|Withdrawal by Subject|3|||
163839988|NCT02914184|591785701|FG000|Overall Study|Other|1|||
163839989|NCT02914184|591785702|FG001|Overall Study|Other|0|||
163839990|NCT02914184|591785703|FG002|Overall Study|Other|0|||
163839991|NCT02914184|591785704|FG003|Overall Study|Other|0|||
163839992|NCT02914184|591785701|FG000|Overall Study|Migrated/moved from the study area|2|||
163839993|NCT02914184|591785702|FG001|Overall Study|Migrated/moved from the study area|1|||
163839994|NCT02914184|591785703|FG002|Overall Study|Migrated/moved from the study area|2|||
163839995|NCT02914184|591785704|FG003|Overall Study|Migrated/moved from the study area|1|||
163839996|NCT00802659|591785705|FG000|Overall Study|Physician Decision|0|||
163839997|NCT00802659|591785706|FG001|Overall Study|Physician Decision|1|||
163839998|NCT00802659|591785707|FG002|Overall Study|Physician Decision|0|||
163839999|NCT00802659|591785708|FG003|Overall Study|Physician Decision|0|||
163936056|NCT04680533|592135060|FG000|Overall Study|Screen failure|1|||
163840000|NCT00806624|591785709|FG000|Overall Study|Adverse Event|2|||
163840001|NCT00806624|591785710|FG001|Overall Study|Adverse Event|8|||
163840002|NCT00806624|591785711|FG002|Overall Study|Adverse Event|0|||
164039166|NCT02574481|592503380|FG003|Overall Study|Lost to Follow-up|0|||
164039167|NCT01105936|592503384|FG000|Period 1|Adverse Event|0|||
164039168|NCT01105936|592503385|FG001|Period 1|Adverse Event|0|||
164039169|NCT01105936|592503386|FG002|Period 1|Adverse Event|0|||
164039170|NCT01105936|592503387|FG003|Period 1|Adverse Event|1|||
164039171|NCT01105936|592503384|FG000|Period 2|Adverse Event|1|||
164039172|NCT01105936|592503385|FG001|Period 2|Adverse Event|0|||
163840003|NCT00806624|591785709|FG000|Overall Study|Death|0|||
163840004|NCT00806624|591785710|FG001|Overall Study|Death|1|||
163840005|NCT00806624|591785711|FG002|Overall Study|Death|1|||
163840006|NCT00806624|591785709|FG000|Overall Study|Lost to Follow-up|1|||
163840007|NCT00806624|591785710|FG001|Overall Study|Lost to Follow-up|0|||
163840008|NCT00806624|591785711|FG002|Overall Study|Lost to Follow-up|1|||
163840009|NCT00806624|591785709|FG000|Overall Study|Withdrawal by Subject|6|||
163840010|NCT00806624|591785710|FG001|Overall Study|Withdrawal by Subject|3|||
163840011|NCT00806624|591785711|FG002|Overall Study|Withdrawal by Subject|3|||
163840012|NCT00806624|591785709|FG000|Overall Study|discontinued before start of treatment|0|||
163840013|NCT00806624|591785710|FG001|Overall Study|discontinued before start of treatment|0|||
163840014|NCT00806624|591785711|FG002|Overall Study|discontinued before start of treatment|1|||
163840015|NCT03093428|591785712|FG000|Overall Study|Not eligible for treatment|2|||
163840016|NCT03093428|591785713|FG001|Overall Study|Not eligible for treatment|1|||
163840017|NCT03093428|591785712|FG000|Overall Study|Progression|14|||
163840018|NCT03093428|591785713|FG001|Overall Study|Progression|4|||
163840019|NCT03093428|591785712|FG000|Overall Study|Death|1|||
163840020|NCT03093428|591785713|FG001|Overall Study|Death|0|||
163840021|NCT03093428|591785712|FG000|Overall Study|Adverse Event|1|||
163840022|NCT03093428|591785713|FG001|Overall Study|Adverse Event|0|||
163840023|NCT03093428|591785712|FG000|Overall Study|Withdrawal by Subject|1|||
163840024|NCT03093428|591785713|FG001|Overall Study|Withdrawal by Subject|1|||
163840025|NCT01336634|591785717|FG000|Overall Study|Study closed/terminated|5|||
163840026|NCT01336634|591785718|FG001|Overall Study|Study closed/terminated|6|||
163840027|NCT01336634|591785719|FG002|Overall Study|Study closed/terminated|6|||
163840028|NCT01336634|591785717|FG000|Overall Study|Lost to Follow-up|2|||
163840029|NCT01336634|591785718|FG001|Overall Study|Lost to Follow-up|1|||
163840030|NCT01336634|591785719|FG002|Overall Study|Lost to Follow-up|1|||
163840031|NCT01336634|591785717|FG000|Overall Study|Physician Decision|1|||
163840032|NCT01336634|591785718|FG001|Overall Study|Physician Decision|1|||
163840033|NCT01336634|591785719|FG002|Overall Study|Physician Decision|0|||
163840034|NCT01336634|591785717|FG000|Overall Study|Withdrawal by Subject|6|||
163840035|NCT01336634|591785718|FG001|Overall Study|Withdrawal by Subject|0|||
163840036|NCT01336634|591785719|FG002|Overall Study|Withdrawal by Subject|2|||
163840037|NCT01973491|591785720|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
163840038|NCT01973491|591785720|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
163840039|NCT01973491|591785720|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
163840040|NCT01863043|591785724|FG000|Overall Study|Death|6|||
163840041|NCT01863043|591785725|FG001|Overall Study|Death|1|||
163936057|NCT00475644|592136588|FG000|Overall Study|Protocol Violation|13|||
163936058|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
163936059|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
163936060|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
163936061|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
163936062|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
163936063|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
163936064|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
163936065|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
163936066|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
163936067|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
163936068|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
163936069|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
163936070|NCT00790400|592136592|FG000|Double-blind Period (Core Phase)|Death|1|||
163936071|NCT00790400|592136593|FG001|Double-blind Period (Core Phase)|Death|0|||
163936072|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
163936073|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
163936074|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
163936075|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
163936076|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
163936077|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
164039173|NCT01105936|592503386|FG002|Period 2|Adverse Event|0|||
164039174|NCT01105936|592503387|FG003|Period 2|Adverse Event|0|||
164039175|NCT01105936|592503384|FG000|Period 3|Protocol Violation|0|||
164039176|NCT01105936|592503385|FG001|Period 3|Protocol Violation|2|||
164039177|NCT01105936|592503386|FG002|Period 3|Protocol Violation|0|||
164039178|NCT01105936|592503387|FG003|Period 3|Protocol Violation|0|||
164039179|NCT00446641|592503388|FG000|Overall Study|Withdrawal by Subject|8|||
164039180|NCT00446641|592503389|FG001|Overall Study|Withdrawal by Subject|3|||
164039181|NCT00446641|592503388|FG000|Overall Study|poor compliance|8|||
164039182|NCT00446641|592503389|FG001|Overall Study|poor compliance|6|||
164039183|NCT00446641|592503388|FG000|Overall Study|Lost to Follow-up|1|||
164039184|NCT00446641|592503389|FG001|Overall Study|Lost to Follow-up|1|||
164039185|NCT00086385|592503393|FG000|Overall Study|Death|2|||
164039186|NCT00086385|592503394|FG001|Overall Study|Death|2|||
164039187|NCT00086385|592503395|FG002|Overall Study|Death|1|||
164039188|NCT00086385|592503396|FG003|Overall Study|Death|1|||
164039189|NCT04038385|592503397|FG000|Overall Study|Completed baseline assessment only|7|||
164039190|NCT04038385|592503398|FG001|Overall Study|Completed baseline assessment only|4|||
164039191|NCT04038385|592503397|FG000|Overall Study|Moved out of area|4|||
164039192|NCT04038385|592503398|FG001|Overall Study|Moved out of area|2|||
164039193|NCT04038385|592503397|FG000|Overall Study|Discontinued study involvement|6|||
164039194|NCT04038385|592503398|FG001|Overall Study|Discontinued study involvement|1|||
164039195|NCT00402285|592503405|FG000|Overall Study|insufficient RNA quality|7|||
164039196|NCT00402285|592503406|FG001|Overall Study|insufficient RNA quality|6|||
164039197|NCT00402285|592503407|FG002|Overall Study|insufficient RNA quality|2|||
164039198|NCT00784459|592503410|FG000|Overall Study|Adverse Event|0|||
164039199|NCT00784459|592503411|FG001|Overall Study|Adverse Event|2|||
164039200|NCT00405275|592503412|FG000|Overall Study|Death|1|||
164039201|NCT00405275|592503413|FG001|Overall Study|Death|0|||
164039202|NCT00405275|592503412|FG000|Overall Study|Lost to Follow-up|5|||
164039203|NCT00405275|592503413|FG001|Overall Study|Lost to Follow-up|1|||
164039204|NCT00405275|592503412|FG000|Overall Study|Withdrawal by Subject|7|||
164039205|NCT00405275|592503413|FG001|Overall Study|Withdrawal by Subject|9|||
164039206|NCT00405275|592503412|FG000|Overall Study|Unwilling to continue|10|||
164039207|NCT00405275|592503413|FG001|Overall Study|Unwilling to continue|9|||
164039208|NCT00088595|592503414|FG000|Overall Study|Adverse Event|11|||
164039209|NCT00088595|592503414|FG000|Overall Study|Withdrawal by Subject|8|||
164039210|NCT00088595|592503414|FG000|Overall Study|Ongoing (After Core)|7|||
164039211|NCT00088595|592503414|FG000|Overall Study|New Cancer Therapy|2|||
164039212|NCT02959970|592503429|FG000|Overall Study|Adverse Event|1|||
164039213|NCT02959970|592503430|FG001|Overall Study|Adverse Event|0|||
164039214|NCT02959970|592503429|FG000|Overall Study|Withdrawal by Subject|0|||
164039215|NCT02959970|592503430|FG001|Overall Study|Withdrawal by Subject|2|||
164039216|NCT02959970|592503429|FG000|Overall Study|Lost to Follow-up|1|||
164039217|NCT02959970|592503430|FG001|Overall Study|Lost to Follow-up|5|||
164039218|NCT01473355|592503435|FG000|Overall Study|Protocol Violation|2|||
164039219|NCT01473355|592503435|FG000|Overall Study|Adverse Event|2|||
164039220|NCT01473355|592503435|FG000|Overall Study|Lost to Follow-up|2|||
164039221|NCT02603172|592503444|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039222|NCT02603172|592503445|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039223|NCT02603172|592503446|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
164039224|NCT02603172|592503447|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039225|NCT02603172|592503448|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039226|NCT02603172|592503449|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039227|NCT02603172|592503450|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039228|NCT02603172|592503451|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
164039229|NCT00863317|592503452|FG000|Overall Study|Lost to Follow-up|8|||
164039230|NCT00863317|592503453|FG001|Overall Study|Lost to Follow-up|9|||
164039231|NCT00441727|592503454|FG000|Overall Study|Protocol Violation|19|||
164039232|NCT00441727|592503455|FG001|Overall Study|Protocol Violation|28|||
164039233|NCT00441727|592503456|FG002|Overall Study|Protocol Violation|32|||
164039234|NCT00441727|592503454|FG000|Overall Study|Adverse Event|26|||
164039235|NCT00441727|592503455|FG001|Overall Study|Adverse Event|33|||
164039236|NCT00441727|592503456|FG002|Overall Study|Adverse Event|28|||
164039237|NCT00441727|592503454|FG000|Overall Study|Lack of Efficacy|7|||
164039238|NCT00441727|592503455|FG001|Overall Study|Lack of Efficacy|8|||
164039239|NCT00441727|592503456|FG002|Overall Study|Lack of Efficacy|48|||
164098747|NCT04112823|592726892|FG000|Overall Study|Lost to Follow-up|2|||
164098748|NCT04112823|592726893|FG001|Overall Study|Lost to Follow-up|3|||
164098749|NCT01693523|592726894|FG000|Overall Study|Adverse Event|2|||
164098750|NCT01693523|592726895|FG001|Overall Study|Adverse Event|1|||
164098751|NCT01693523|592726896|FG002|Overall Study|Adverse Event|0|||
164039240|NCT00441727|592503454|FG000|Overall Study|Withdrawal by Subject|40|||
164039241|NCT00441727|592503455|FG001|Overall Study|Withdrawal by Subject|34|||
164039242|NCT00441727|592503456|FG002|Overall Study|Withdrawal by Subject|47|||
164039243|NCT00441727|592503454|FG000|Overall Study|Lost to Follow-up|5|||
164039244|NCT00441727|592503455|FG001|Overall Study|Lost to Follow-up|6|||
164039245|NCT00441727|592503456|FG002|Overall Study|Lost to Follow-up|5|||
164098752|NCT01693523|592726894|FG000|Overall Study|Death|0|||
164098753|NCT01693523|592726895|FG001|Overall Study|Death|1|||
164039246|NCT00441727|592503454|FG000|Overall Study|Safety Reasons|3|||
164039247|NCT00441727|592503455|FG001|Overall Study|Safety Reasons|1|||
164039248|NCT00441727|592503456|FG002|Overall Study|Safety Reasons|3|||
164039249|NCT00441727|592503454|FG000|Overall Study|Various reason specified|6|||
164039250|NCT00441727|592503455|FG001|Overall Study|Various reason specified|8|||
164039251|NCT00441727|592503456|FG002|Overall Study|Various reason specified|5|||
164098754|NCT01693523|592726896|FG002|Overall Study|Death|1|||
164039252|NCT03417505|592503459|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
164039253|NCT03417505|592503460|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
164039254|NCT02133001|592503461|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
164039255|NCT02133001|592503462|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
164039256|NCT02133001|592503461|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
164039257|NCT02133001|592503462|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
164039258|NCT02133001|592503461|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
164039259|NCT02133001|592503462|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
164039260|NCT02133001|592503461|FG000|Double Blind (Day 1-25)|Other|2|||
164039261|NCT02133001|592503462|FG001|Double Blind (Day 1-25)|Other|2|||
164039262|NCT02133001|592503461|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
164039263|NCT02133001|592503462|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
164039264|NCT02133001|592503461|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
164039265|NCT02133001|592503462|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
164039266|NCT02133001|592503461|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
164039267|NCT02133001|592503462|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
164039268|NCT02133001|592503461|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
164039269|NCT02133001|592503462|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
164039270|NCT04211961|592503463|FG000|Overall Study|Death|0|||
164039271|NCT04211961|592503464|FG001|Overall Study|Death|1|||
164039272|NCT04211961|592503463|FG000|Overall Study|Lost to Follow-up|0|||
164039273|NCT04211961|592503464|FG001|Overall Study|Lost to Follow-up|1|||
164039274|NCT04211961|592503463|FG000|Overall Study|Withdrawal by Subject|0|||
164039275|NCT04211961|592503464|FG001|Overall Study|Withdrawal by Subject|1|||
164039276|NCT03235726|592503469|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039277|NCT03235726|592503470|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039278|NCT03235726|592503471|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039279|NCT03235726|592503472|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039280|NCT03235726|592503473|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
164039281|NCT03235726|592503474|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039282|NCT03235726|592503475|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039283|NCT03235726|592503476|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039284|NCT03235726|592503477|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039285|NCT03235726|592503478|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
164039286|NCT03235726|592503469|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039287|NCT03235726|592503470|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039288|NCT03235726|592503471|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039289|NCT03235726|592503472|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039290|NCT03235726|592503473|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
164039291|NCT03235726|592503474|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039292|NCT03235726|592503475|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039293|NCT03235726|592503476|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039294|NCT03235726|592503477|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039295|NCT03235726|592503478|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
164039296|NCT00425113|592503479|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
164039297|NCT00425113|592503480|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
164039298|NCT00425113|592503479|FG000|Overall Study|diagnosis of abdominal TB|0|||
164039299|NCT00425113|592503480|FG001|Overall Study|diagnosis of abdominal TB|1|||
164039300|NCT00425113|592503479|FG000|Overall Study|missing study drug more than 14 days|0|||
164039301|NCT00425113|592503480|FG001|Overall Study|missing study drug more than 14 days|1|||
164039302|NCT00425113|592503479|FG000|Overall Study|Withdrawal by Subject|1|||
164039303|NCT00425113|592503480|FG001|Overall Study|Withdrawal by Subject|0|||
164039304|NCT00879437|592503481|FG000|Overall Study|Protocol Violation|0|||
164039305|NCT00879437|592503482|FG001|Overall Study|Protocol Violation|1|||
164039306|NCT00879437|592503481|FG000|Overall Study|Death|1|||
164039307|NCT00879437|592503482|FG001|Overall Study|Death|0|||
164039308|NCT00268463|592503483|FG000|Overall Study|study terminated due to low accrual|10|||
164039309|NCT00268463|592503484|FG001|Overall Study|study terminated due to low accrual|12|||
164039310|NCT04685538|592503485|FG000|Overall Study|Adverse Event|0|||
164039311|NCT04685538|592503486|FG001|Overall Study|Adverse Event|1|||
164039312|NCT04685538|592503485|FG000|Overall Study|Lost to Follow-up|0|||
164039313|NCT04685538|592503486|FG001|Overall Study|Lost to Follow-up|2|||
164039314|NCT02920450|592503487|FG000|Overall Study|Death|1|||
164039315|NCT02920450|592503488|FG001|Overall Study|Death|0|||
164039316|NCT02920450|592503489|FG002|Overall Study|Death|0|||
164039317|NCT02920450|592503490|FG003|Overall Study|Death|0|||
164039318|NCT02920450|592503487|FG000|Overall Study|Withdrawal by Subject|1|||
164039319|NCT02920450|592503488|FG001|Overall Study|Withdrawal by Subject|0|||
164039320|NCT02920450|592503489|FG002|Overall Study|Withdrawal by Subject|0|||
164039321|NCT02920450|592503490|FG003|Overall Study|Withdrawal by Subject|0|||
164039322|NCT01040845|592503491|FG000|Overall Study|Withdrawal by Subject|1|||
164039323|NCT01040845|592503492|FG001|Overall Study|Withdrawal by Subject|1|||
164039324|NCT01040845|592503491|FG000|Overall Study|Physician Decision|1|||
164039325|NCT01040845|592503492|FG001|Overall Study|Physician Decision|0|||
164039326|NCT04362813|592503493|FG000|Overall Study|Death|12|||
164039327|NCT04362813|592503494|FG001|Overall Study|Death|16|||
164039328|NCT04362813|592503493|FG000|Overall Study|Withdrawal by Subject|3|||
164039329|NCT04362813|592503494|FG001|Overall Study|Withdrawal by Subject|1|||
164039330|NCT04362813|592503493|FG000|Overall Study|Protocol Violation|0|||
164039331|NCT04362813|592503494|FG001|Overall Study|Protocol Violation|3|||
164039332|NCT04362813|592503493|FG000|Overall Study|Lost to Follow-up|1|||
164039333|NCT04362813|592503494|FG001|Overall Study|Lost to Follow-up|1|||
164039334|NCT04362813|592503493|FG000|Overall Study|Enrolled but did not receive treatment|2|||
164039335|NCT04362813|592503494|FG001|Overall Study|Enrolled but did not receive treatment|4|||
164039336|NCT01732107|592503499|FG000|Overall Study|Adverse Event|2|||
164039337|NCT01732107|592503499|FG000|Overall Study|Disease Progression|8|||
164039338|NCT01732107|592503499|FG000|Overall Study|Physician Decision|1|||
164039339|NCT01732107|592503499|FG000|Overall Study|Withdrawal by Subject|2|||
164039340|NCT04445688|592503500|FG000|Washout (One Week)|Adverse Event|2|||
164039341|NCT04445688|592503500|FG000|Washout (One Week)|Withdrawal by Subject|1|||
164039342|NCT00918346|592503504|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
164039343|NCT00918346|592503505|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
164039344|NCT03379376|592503506|FG000|Overall Study|Lost to Follow-up|2|||
164039345|NCT03379376|592503506|FG000|Overall Study|Did not wish to complete follow up|1|||
164039346|NCT03379376|592503506|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
164039347|NCT03379376|592503506|FG000|Overall Study|Death|1|||
164039348|NCT02475629|592503507|FG000|Overall Study|Adverse Event|1|||
164039349|NCT02475629|592503507|FG000|Overall Study|Death|4|||
164039350|NCT02475629|592503507|FG000|Overall Study|Physician Decision|1|||
164039351|NCT02475629|592503507|FG000|Overall Study|Withdrawal by Subject|1|||
164039352|NCT02475629|592503507|FG000|Overall Study|Lost to Follow-up|1|||
164039353|NCT02475629|592503507|FG000|Overall Study|Subject non-compliance|1|||
164039354|NCT04083794|592503508|FG000|Overall Study|Lost to Follow-up|9|||
164039355|NCT00224003|592503515|FG000|Overall Study|Adverse Event|1|||
164039356|NCT00224003|592503515|FG000|Overall Study|Protocol Violation|2|||
164039357|NCT00224003|592503515|FG000|Overall Study|Withdrawal by Subject|1|||
164039358|NCT00224003|592503515|FG000|Overall Study|unk|3|||
164039359|NCT03549429|592503516|FG000|Overall Study|Protocol Violation|5|||
163840042|NCT01863043|591785724|FG000|Overall Study|Withdrawal by Subject|0|||
163840043|NCT01863043|591785725|FG001|Overall Study|Withdrawal by Subject|2|||
163840044|NCT01863043|591785724|FG000|Overall Study|Adverse Event|7|||
163840045|NCT01863043|591785725|FG001|Overall Study|Adverse Event|8|||
163840046|NCT01863043|591785724|FG000|Overall Study|exclusion criteria found after enrollment|0|||
163840047|NCT01863043|591785725|FG001|Overall Study|exclusion criteria found after enrollment|1|||
163840048|NCT00313911|591785726|FG000|Overall Study|Serious adverse event|6|||
163840049|NCT00313911|591785727|FG001|Overall Study|Serious adverse event|1|||
163840050|NCT00313911|591785726|FG000|Overall Study|Adverse Event|2|||
163840051|NCT00313911|591785727|FG001|Overall Study|Adverse Event|3|||
163840052|NCT00313911|591785726|FG000|Overall Study|Protocol Violation|19|||
163840053|NCT00313911|591785727|FG001|Overall Study|Protocol Violation|10|||
163840054|NCT00313911|591785726|FG000|Overall Study|Lost to Follow-up|27|||
163840055|NCT00313911|591785727|FG001|Overall Study|Lost to Follow-up|14|||
163840056|NCT00313911|591785726|FG000|Overall Study|Withdrawal by Subject|39|||
163840057|NCT00313911|591785727|FG001|Overall Study|Withdrawal by Subject|12|||
163840058|NCT00313911|591785726|FG000|Overall Study|Did not meet age criteria|1|||
163840059|NCT00313911|591785727|FG001|Overall Study|Did not meet age criteria|1|||
163840060|NCT01987596|591785728|FG000|Overall Study|Physician Decision|1|||
163840061|NCT01987596|591785729|FG001|Overall Study|Physician Decision|0|||
163840062|NCT01987596|591785728|FG000|Overall Study|Progressive Disease; missing all period|0|||
163840063|NCT01987596|591785729|FG001|Overall Study|Progressive Disease; missing all period|1|||
163840064|NCT02632786|591785732|FG000|Overall Study|Adverse Event|2|||
163840065|NCT02632786|591785733|FG001|Overall Study|Adverse Event|1|||
163840066|NCT02632786|591785732|FG000|Overall Study|Death|3|||
163840067|NCT02632786|591785733|FG001|Overall Study|Death|2|||
163840068|NCT02632786|591785732|FG000|Overall Study|Physician Decision|5|||
163840069|NCT02632786|591785733|FG001|Overall Study|Physician Decision|4|||
163840070|NCT02632786|591785732|FG000|Overall Study|Withdrawal by Subject|1|||
163840071|NCT02632786|591785733|FG001|Overall Study|Withdrawal by Subject|0|||
163840072|NCT00709592|591785734|FG000|Overall Study|Unable to proceed to transplant|0|||
164039360|NCT03549429|592503517|FG001|Overall Study|Protocol Violation|3|||
164039361|NCT00729326|592503527|FG000|Overall Study|Lost to Follow-up|2|||
164039362|NCT00729326|592503528|FG001|Overall Study|Lost to Follow-up|0|||
164039363|NCT00729326|592503527|FG000|Overall Study|Physician Decision|0|||
164039364|NCT00729326|592503528|FG001|Overall Study|Physician Decision|1|||
164039365|NCT00729326|592503527|FG000|Overall Study|Protocol Violation|3|||
164039366|NCT00729326|592503528|FG001|Overall Study|Protocol Violation|2|||
164039367|NCT00729326|592503527|FG000|Overall Study|Subject Decision|4|||
164039368|NCT00729326|592503528|FG001|Overall Study|Subject Decision|4|||
164039369|NCT00729326|592503527|FG000|Overall Study|Sponsor Decision|1|||
163936078|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
164039370|NCT00729326|592503528|FG001|Overall Study|Sponsor Decision|2|||
164039371|NCT01235728|592503529|FG000|Overall Study|Protocol Violation|0|||
164039372|NCT01235728|592503530|FG001|Overall Study|Protocol Violation|0|||
164039373|NCT01235728|592503531|FG002|Overall Study|Protocol Violation|0|||
164039374|NCT01235728|592503532|FG003|Overall Study|Protocol Violation|1|||
164039375|NCT01235728|592503533|FG004|Overall Study|Protocol Violation|0|||
164039376|NCT01235728|592503534|FG005|Overall Study|Protocol Violation|0|||
164039377|NCT01235728|592503535|FG006|Overall Study|Protocol Violation|0|||
164039378|NCT01235728|592503536|FG007|Overall Study|Protocol Violation|0|||
164039379|NCT01000025|592503537|FG000|Overall Study|Adverse Event|43|||
164039380|NCT01000025|592503538|FG001|Overall Study|Adverse Event|2|||
164039381|NCT01000025|592503537|FG000|Overall Study|Withdrawal by Subject|13|||
164039382|NCT01000025|592503538|FG001|Overall Study|Withdrawal by Subject|8|||
164039383|NCT01000025|592503537|FG000|Overall Study|Death|23|||
164039384|NCT01000025|592503538|FG001|Overall Study|Death|13|||
164039385|NCT01000025|592503537|FG000|Overall Study|Lack of Efficacy|363|||
164039386|NCT01000025|592503538|FG001|Overall Study|Lack of Efficacy|208|||
164039387|NCT01000025|592503537|FG000|Overall Study|Intercurrent Illness|26|||
163936079|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
163936080|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
163936081|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
163936082|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Death|1|||
163936083|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Death|0|||
163936084|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
163936085|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
163936086|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
163936087|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
163936088|NCT00790400|592136592|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
163936089|NCT00790400|592136593|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
163936090|NCT00699153|592136594|FG000|Overall Study|Lost to Follow-up|1|||
163936091|NCT00699153|592136595|FG001|Overall Study|Lost to Follow-up|0|||
163936092|NCT00699153|592136594|FG000|Overall Study|Adverse Event|0|||
163936093|NCT00699153|592136595|FG001|Overall Study|Adverse Event|2|||
163936094|NCT00699153|592136594|FG000|Overall Study|Protocol Violation|1|||
163936095|NCT00699153|592136595|FG001|Overall Study|Protocol Violation|0|||
163936096|NCT00699153|592136594|FG000|Overall Study|Travel Problem|1|||
163936097|NCT00699153|592136595|FG001|Overall Study|Travel Problem|0|||
163936098|NCT00078338|592136599|FG000|Overall Study|Adverse Event|31|||
163936099|NCT00078338|592136600|FG001|Overall Study|Adverse Event|24|||
163936100|NCT00078338|592136599|FG000|Overall Study|Lost to Follow-up|17|||
163936101|NCT00078338|592136600|FG001|Overall Study|Lost to Follow-up|2|||
163936102|NCT00078338|592136599|FG000|Overall Study|Protocol Violation|2|||
163936103|NCT00078338|592136600|FG001|Overall Study|Protocol Violation|2|||
163936104|NCT00078338|592136599|FG000|Overall Study|Disease Progression|4|||
163936105|NCT00078338|592136600|FG001|Overall Study|Disease Progression|7|||
163936106|NCT00078338|592136599|FG000|Overall Study|Other|28|||
163936107|NCT00078338|592136600|FG001|Overall Study|Other|16|||
163936108|NCT00078338|592136599|FG000|Overall Study|Subjects randomized, but not treated|3|||
163936109|NCT00078338|592136600|FG001|Overall Study|Subjects randomized, but not treated|3|||
163936110|NCT02124811|592136601|FG000|Overall Study|Early termination|2|||
163936111|NCT02124811|592136602|FG001|Overall Study|Early termination|2|||
163936112|NCT02124811|592136601|FG000|Overall Study|Withdrawal by Subject|1|||
163936113|NCT02124811|592136602|FG001|Overall Study|Withdrawal by Subject|0|||
163936114|NCT04201288|592136610|FG000|Overall Study|Death|1|||
163936115|NCT04201288|592136611|FG001|Overall Study|Death|1|||
163936116|NCT04201288|592136610|FG000|Overall Study|Lost to Follow-up|5|||
163936117|NCT04201288|592136611|FG001|Overall Study|Lost to Follow-up|3|||
163936118|NCT04201288|592136610|FG000|Overall Study|Withdrawal by Subject|1|||
163936119|NCT04201288|592136611|FG001|Overall Study|Withdrawal by Subject|0|||
163936120|NCT01606319|592136612|FG000|Overall Study|Lost to Follow-up|17|||
163936121|NCT01606319|592136613|FG001|Overall Study|Lost to Follow-up|14|||
163936122|NCT01606319|592136612|FG000|Overall Study|Withdrawal by Subject|9|||
163936123|NCT01606319|592136613|FG001|Overall Study|Withdrawal by Subject|12|||
163936124|NCT01606319|592136612|FG000|Overall Study|Physician Decision|1|||
163936125|NCT01606319|592136613|FG001|Overall Study|Physician Decision|2|||
163936126|NCT01606319|592136612|FG000|Overall Study|Lack of Efficacy|6|||
163936127|NCT01606319|592136613|FG001|Overall Study|Lack of Efficacy|8|||
163936128|NCT01606319|592136612|FG000|Overall Study|Adverse Event|1|||
163936129|NCT01606319|592136613|FG001|Overall Study|Adverse Event|4|||
164039388|NCT01000025|592503538|FG001|Overall Study|Intercurrent Illness|7|||
163936130|NCT01821937|592136615|FG000|Overall Study|Adverse Event|0|||
164039389|NCT04423757|592503539|FG000|Overall Study|Adverse Event|2|||
164039390|NCT04423757|592503540|FG001|Overall Study|Adverse Event|0|||
164039391|NCT04423757|592503539|FG000|Overall Study|Not treated|1|||
164039392|NCT04423757|592503540|FG001|Overall Study|Not treated|1|||
164039393|NCT01202760|592503541|FG000|Overall Study|Entry Criteria Not Met|0|||
164039394|NCT01202760|592503542|FG001|Overall Study|Entry Criteria Not Met|3|||
163936131|NCT01821937|592136616|FG001|Overall Study|Adverse Event|3|||
163936132|NCT02615509|592136617|FG000|Overall Study|Lost to Follow-up|134|||
163936133|NCT02615509|592136617|FG000|Overall Study|Death|4|||
163936134|NCT02615509|592136617|FG000|Overall Study|Withdrawal by Subject|8|||
163936135|NCT02030002|592136621|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
163936136|NCT02030002|592136621|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
163936137|NCT02030002|592136621|FG000|Follow-up|Lost to Follow-up|2|||
163936138|NCT01294397|592136622|FG000|Overall Study|Withdrawal by Subject|1|||
163936139|NCT01294397|592136622|FG000|Overall Study|Administrative Decision|1|||
163936140|NCT00504075|592136623|FG000|Overall Study|Adverse Event|1|||
163936141|NCT00504075|592136623|FG000|Overall Study|Lost to Follow-up|5|||
163936142|NCT00504075|592136623|FG000|Overall Study|Withdrawal by Subject|1|||
163936143|NCT00504075|592136623|FG000|Overall Study|Required other therapeutic intervention|1|||
163936144|NCT02406248|592136624|FG000|Overall Study|Death|7|||
163936145|NCT02406248|592136624|FG000|Overall Study|Withdrawal by Subject|2|||
163936146|NCT01689857|592136626|FG000|Overall Study|Lost to Follow-up|5|||
163936147|NCT01689857|592136627|FG001|Overall Study|Lost to Follow-up|2|||
163936148|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
163936149|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
163936150|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
163936151|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
163936152|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
163936153|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
163936154|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
163936155|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
163936156|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
163936157|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
163936158|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
163936159|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
163936160|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
163936161|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
163936162|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
163936163|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
163936164|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
163936165|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
163936166|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
163936167|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
163936168|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
163936169|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
163936170|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
163936171|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
163936172|NCT00479882|592136630|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
163936173|NCT00479882|592136631|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
163936174|NCT00479882|592136632|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
163936175|NCT00479882|592136633|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
163936176|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
163936177|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
163936178|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
163936179|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
163936180|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
163936181|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
163936182|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
163936183|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
163936184|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
163936185|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
163936186|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
163936187|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
163936188|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
163936189|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
163936190|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
163936191|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
163936192|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
163936193|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
163936194|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
163936195|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
163936196|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
164098755|NCT01693523|592726894|FG000|Overall Study|Lost to Follow-up|0|||
164039395|NCT01202760|592503543|FG002|Overall Study|Entry Criteria Not Met|1|||
164039396|NCT01202760|592503541|FG000|Overall Study|Adverse Event|11|||
164039397|NCT01202760|592503542|FG001|Overall Study|Adverse Event|9|||
164039398|NCT01202760|592503543|FG002|Overall Study|Adverse Event|10|||
164039399|NCT01202760|592503541|FG000|Overall Study|Death|2|||
164039400|NCT01202760|592503542|FG001|Overall Study|Death|1|||
164039401|NCT01202760|592503543|FG002|Overall Study|Death|0|||
164039402|NCT01202760|592503541|FG000|Overall Study|Lack of Efficacy|6|||
164039403|NCT01202760|592503542|FG001|Overall Study|Lack of Efficacy|8|||
164039404|NCT01202760|592503543|FG002|Overall Study|Lack of Efficacy|7|||
164039405|NCT01202760|592503541|FG000|Overall Study|Lost to Follow-up|0|||
164039406|NCT01202760|592503542|FG001|Overall Study|Lost to Follow-up|2|||
164039407|NCT01202760|592503543|FG002|Overall Study|Lost to Follow-up|1|||
164039408|NCT01202760|592503541|FG000|Overall Study|Parent / Caregiver Decision|0|||
164039409|NCT01202760|592503542|FG001|Overall Study|Parent / Caregiver Decision|1|||
164039410|NCT01202760|592503543|FG002|Overall Study|Parent / Caregiver Decision|0|||
164039411|NCT01202760|592503541|FG000|Overall Study|Withdrawal by Subject|17|||
164039412|NCT01202760|592503542|FG001|Overall Study|Withdrawal by Subject|18|||
164039413|NCT01202760|592503543|FG002|Overall Study|Withdrawal by Subject|14|||
164039414|NCT01202760|592503541|FG000|Overall Study|Physician Decision|0|||
164039415|NCT01202760|592503542|FG001|Overall Study|Physician Decision|1|||
164039416|NCT01202760|592503543|FG002|Overall Study|Physician Decision|0|||
164039417|NCT01202760|592503541|FG000|Overall Study|Protocol Violation|7|||
164039418|NCT01202760|592503542|FG001|Overall Study|Protocol Violation|5|||
164039419|NCT01202760|592503543|FG002|Overall Study|Protocol Violation|2|||
164039420|NCT01202760|592503541|FG000|Overall Study|Sponsor Decision|4|||
164039421|NCT01202760|592503542|FG001|Overall Study|Sponsor Decision|4|||
164039422|NCT01202760|592503543|FG002|Overall Study|Sponsor Decision|0|||
164039423|NCT01654523|592503544|FG000|Overall Study|Withdrawal by Subject|1|||
164039424|NCT02810951|592503545|FG000|Overall Study|Adverse Event|1|||
164039425|NCT01575899|592503546|FG000|Overall Study|Lost to Follow-up|3|||
164039426|NCT01575899|592503547|FG001|Overall Study|Lost to Follow-up|4|||
164039427|NCT01575899|592503548|FG002|Overall Study|Lost to Follow-up|2|||
164039428|NCT01575899|592503546|FG000|Overall Study|Protocol Violation|2|||
164039429|NCT01575899|592503547|FG001|Overall Study|Protocol Violation|1|||
164039430|NCT01575899|592503548|FG002|Overall Study|Protocol Violation|0|||
164039431|NCT03097029|592503549|FG000|Overall Study|Withdrawal by Subject|1|||
164039432|NCT00709124|592503550|FG000|Overall Study|Death|3|||
164039433|NCT00709124|592503551|FG001|Overall Study|Death|1|||
164039434|NCT00709124|592503550|FG000|Overall Study|encephalopathy; can't do assessment|1|||
164039435|NCT00709124|592503551|FG001|Overall Study|encephalopathy; can't do assessment|0|||
164039436|NCT00373490|592503552|FG000|Overall Study|Adverse Event|0|||
164039437|NCT00373490|592503553|FG001|Overall Study|Adverse Event|1|||
164039438|NCT00373490|592503552|FG000|Overall Study|Lack of Efficacy|9|||
164039439|NCT00373490|592503553|FG001|Overall Study|Lack of Efficacy|4|||
164039440|NCT00373490|592503552|FG000|Overall Study|Withdrawal by Subject|0|||
164039441|NCT00373490|592503553|FG001|Overall Study|Withdrawal by Subject|1|||
164039442|NCT00753688|592503554|FG000|Overall Study|Death|102|||
164039443|NCT00753688|592503555|FG001|Overall Study|Death|203|||
164039444|NCT00753688|592503554|FG000|Overall Study|Missing|4|||
164039445|NCT00753688|592503555|FG001|Overall Study|Missing|9|||
164039446|NCT00753688|592503554|FG000|Overall Study|Participant Withdrew Consent|2|||
164039447|NCT00753688|592503555|FG001|Overall Study|Participant Withdrew Consent|2|||
164039448|NCT00753688|592503554|FG000|Overall Study|Ongoing - in Follow-up|15|||
164039449|NCT00753688|592503555|FG001|Overall Study|Ongoing - in Follow-up|31|||
164039450|NCT00753688|592503554|FG000|Overall Study|Adverse Event|0|||
164039451|NCT00753688|592503555|FG001|Overall Study|Adverse Event|1|||
164039452|NCT01250756|592503556|FG000|Infant Series|Withdrawal by Subject|4|||
164039453|NCT01250756|592503557|FG001|Infant Series|Withdrawal by Subject|5|||
164039454|NCT01250756|592503556|FG000|Infant Series|Randomized, Not Vaccinated|2|||
164039455|NCT01250756|592503557|FG001|Infant Series|Randomized, Not Vaccinated|2|||
164039456|NCT01250756|592503556|FG000|Infant Series|Other|22|||
164098756|NCT01693523|592726895|FG001|Overall Study|Lost to Follow-up|0|||
164098757|NCT01693523|592726896|FG002|Overall Study|Lost to Follow-up|4|||
164039457|NCT01250756|592503557|FG001|Infant Series|Other|0|||
164039458|NCT01250756|592503556|FG000|After Infant Series|Adverse Event|5|||
164039459|NCT01250756|592503557|FG001|After Infant Series|Adverse Event|2|||
164039460|NCT01250756|592503556|FG000|After Infant Series|Withdrawal by Subject|4|||
164039461|NCT01250756|592503557|FG001|After Infant Series|Withdrawal by Subject|1|||
164039462|NCT01250756|592503556|FG000|After Infant Series|Other|2|||
164039463|NCT01250756|592503557|FG001|After Infant Series|Other|1|||
164039464|NCT01250756|592503556|FG000|Toddler Dose|Adverse Event|0|||
164039465|NCT01250756|592503557|FG001|Toddler Dose|Adverse Event|1|||
164039466|NCT01250756|592503556|FG000|After Toddler Dose|Adverse Event|0|||
164039467|NCT01250756|592503557|FG001|After Toddler Dose|Adverse Event|1|||
164039468|NCT02999100|592503560|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
164039469|NCT02999100|592503561|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
164039470|NCT02999100|592503562|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
164039471|NCT02999100|592503563|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
164039472|NCT02999100|592503564|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
164098758|NCT01693523|592726894|FG000|Overall Study|Physician Decision|0|||
164098759|NCT01693523|592726895|FG001|Overall Study|Physician Decision|0|||
163840073|NCT00709592|591785735|FG001|Overall Study|Unable to proceed to transplant|1|||
163840074|NCT00451217|591785738|FG000|Overall Study|Lost to Follow-up|0|||
163840075|NCT00451217|591785739|FG001|Overall Study|Lost to Follow-up|1|||
163840076|NCT00451217|591785740|FG002|Overall Study|Lost to Follow-up|1|||
163936197|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
163936198|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
163840077|NCT00451217|591785741|FG003|Overall Study|Lost to Follow-up|1|||
163840078|NCT00451217|591785738|FG000|Overall Study|Withdrawal by Subject|1|||
163840079|NCT00451217|591785739|FG001|Overall Study|Withdrawal by Subject|0|||
163840080|NCT00451217|591785740|FG002|Overall Study|Withdrawal by Subject|0|||
163840081|NCT00451217|591785741|FG003|Overall Study|Withdrawal by Subject|0|||
163840082|NCT00451217|591785738|FG000|Overall Study|Not Treated|1|||
163840083|NCT00451217|591785739|FG001|Overall Study|Not Treated|1|||
163840084|NCT00451217|591785740|FG002|Overall Study|Not Treated|3|||
163840085|NCT00451217|591785741|FG003|Overall Study|Not Treated|4|||
163840086|NCT03154359|591785744|FG000|Overall Study|Adverse Event|1|||
163840087|NCT03154359|591785744|FG000|Overall Study|Lack of Efficacy|2|||
163840088|NCT03154359|591785744|FG000|Overall Study|Lost to Follow-up|3|||
163840089|NCT03154359|591785744|FG000|Overall Study|Physician Decision|3|||
163936199|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
163936200|NCT00479882|592136630|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
163936201|NCT00479882|592136631|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
163936202|NCT00479882|592136632|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
163936203|NCT00479882|592136633|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
163936204|NCT03106753|592136634|FG000|Overall Study|Withdrawal by Subject|0|||
163936205|NCT03106753|592136635|FG001|Overall Study|Withdrawal by Subject|1|||
163936206|NCT01643044|592136639|FG000|Overall Study|Lost to Follow-up|1|||
163936207|NCT01643044|592136640|FG001|Overall Study|Lost to Follow-up|1|||
163936208|NCT01643044|592136639|FG000|Overall Study|Miscarried baby|2|||
163936209|NCT01643044|592136640|FG001|Overall Study|Miscarried baby|2|||
163936210|NCT01643044|592136639|FG000|Overall Study|Delivered outside of hospital|1|||
163936211|NCT01643044|592136640|FG001|Overall Study|Delivered outside of hospital|2|||
163936212|NCT03149042|592136641|FG000|Overall Study|Invasive FFR not performed|21|||
163936213|NCT03149042|592136641|FG000|Overall Study|Poor CT Image Quality|1|||
163936214|NCT03149042|592136641|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
163936215|NCT01023958|592136646|FG000|Overall Study|Progressive disease|48|||
163936216|NCT01023958|592136646|FG000|Overall Study|Other adverse event|1|||
163936217|NCT01023958|592136646|FG000|Overall Study|Refused to continue medication|1|||
163936218|NCT01031628|592136647|FG000|Overall Study|Study terminated early|0|||
163936219|NCT01031628|592136648|FG001|Overall Study|Study terminated early|1|||
163936220|NCT01031628|592136649|FG002|Overall Study|Study terminated early|3|||
163936221|NCT01031628|592136650|FG003|Overall Study|Study terminated early|0|||
163936222|NCT02362503|592136651|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
163936223|NCT02362503|592136652|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
163936224|NCT02362503|592136653|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
163936225|NCT02362503|592136651|FG000|Double-blind Period-Up to 8 Days|Death|1|||
163936226|NCT02362503|592136652|FG001|Double-blind Period-Up to 8 Days|Death|0|||
163936227|NCT02362503|592136653|FG002|Double-blind Period-Up to 8 Days|Death|0|||
163936228|NCT02362503|592136651|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
163936229|NCT02362503|592136652|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
163936230|NCT02362503|592136653|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
163936231|NCT02362503|592136651|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
163936232|NCT02362503|592136652|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
163936233|NCT02362503|592136653|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
163936234|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
163936235|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
163936236|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
163936237|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
163936238|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
163936239|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
163936240|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
163936241|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
163936242|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
163936243|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
163936244|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
163936245|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
163936246|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
163936247|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
163936248|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
163936249|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
164039473|NCT02999100|592503565|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
164039474|NCT02999100|592503560|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164039475|NCT02999100|592503561|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164039476|NCT02999100|592503562|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164039477|NCT02999100|592503563|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164039478|NCT02999100|592503564|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
164039479|NCT02999100|592503565|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
164039480|NCT02999100|592503560|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164039481|NCT02999100|592503561|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164039482|NCT02999100|592503562|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
164039483|NCT02999100|592503563|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164039484|NCT02999100|592503564|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164039485|NCT02999100|592503565|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
164039486|NCT01455415|592503568|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
164039487|NCT01455415|592503569|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
164039488|NCT01455415|592503568|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
164039489|NCT01455415|592503569|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
164039490|NCT01455415|592503568|FG000|Period 1|Drug Error not Associated to AE|0|||
164039491|NCT01455415|592503569|FG001|Period 1|Drug Error not Associated to AE|1|||
164039492|NCT01455415|592503568|FG000|Period 1|AE Not Related to Study Drug|2|||
164039493|NCT01455415|592503569|FG001|Period 1|AE Not Related to Study Drug|6|||
164039494|NCT01455415|592503568|FG000|Period 1|Withdrawal by Subject|4|||
164039495|NCT01455415|592503569|FG001|Period 1|Withdrawal by Subject|5|||
164039496|NCT01455415|592503568|FG000|Period 1|Unspecified Reason|1|||
164039497|NCT01455415|592503569|FG001|Period 1|Unspecified Reason|1|||
164039498|NCT01455415|592503568|FG000|Period 1|Protocol Violation|0|||
164039499|NCT01455415|592503569|FG001|Period 1|Protocol Violation|2|||
164039500|NCT01455415|592503568|FG000|Washout|AE Related to Study Drug|2|||
164039501|NCT01455415|592503569|FG001|Washout|AE Related to Study Drug|0|||
164039502|NCT01455415|592503568|FG000|Washout|Lost to Follow-up|1|||
164039503|NCT01455415|592503569|FG001|Washout|Lost to Follow-up|0|||
164039504|NCT01455415|592503568|FG000|Washout|Drug Error not Associated to AE|2|||
164039505|NCT01455415|592503569|FG001|Washout|Drug Error not Associated to AE|1|||
164039506|NCT01455415|592503568|FG000|Washout|AE Not Related to Study Drug|2|||
164039507|NCT01455415|592503569|FG001|Washout|AE Not Related to Study Drug|3|||
164039508|NCT01455415|592503568|FG000|Washout|Unspecified Reason|1|||
164039509|NCT01455415|592503569|FG001|Washout|Unspecified Reason|2|||
164039510|NCT01455415|592503568|FG000|Washout|Protocol Violation|0|||
164039511|NCT01455415|592503569|FG001|Washout|Protocol Violation|1|||
164039512|NCT01455415|592503568|FG000|Period 2|AE Related to Study Drug|1|||
164039513|NCT01455415|592503569|FG001|Period 2|AE Related to Study Drug|2|||
164039514|NCT01455415|592503568|FG000|Period 2|Lost to Follow-up|2|||
164039515|NCT01455415|592503569|FG001|Period 2|Lost to Follow-up|1|||
164039516|NCT01455415|592503568|FG000|Period 2|AE Not Related to Study Drug|2|||
164039517|NCT01455415|592503569|FG001|Period 2|AE Not Related to Study Drug|1|||
164039518|NCT01455415|592503568|FG000|Period 2|Lack of Efficacy|2|||
164039519|NCT01455415|592503569|FG001|Period 2|Lack of Efficacy|0|||
164039520|NCT01455415|592503568|FG000|Period 2|Withdrawal by Subject|2|||
164039521|NCT01455415|592503569|FG001|Period 2|Withdrawal by Subject|3|||
164039522|NCT01455415|592503568|FG000|Period 2|Unspecified Reason|2|||
164039523|NCT01455415|592503569|FG001|Period 2|Unspecified Reason|3|||
164039524|NCT01455415|592503568|FG000|Period 2|Protocol Violation|2|||
164039525|NCT01455415|592503569|FG001|Period 2|Protocol Violation|0|||
164039526|NCT01455415|592503568|FG000|Follow-up|AE Related to Study Drug|0|||
164039527|NCT01455415|592503569|FG001|Follow-up|AE Related to Study Drug|1|||
164039528|NCT01455415|592503568|FG000|Follow-up|Lack of Efficacy|0|||
164039529|NCT01455415|592503569|FG001|Follow-up|Lack of Efficacy|1|||
164039530|NCT01455415|592503568|FG000|Follow-up|Withdrawal by Subject|2|||
164039531|NCT01455415|592503569|FG001|Follow-up|Withdrawal by Subject|0|||
164039532|NCT01455415|592503568|FG000|Follow-up|Unspecified Reason|1|||
164039533|NCT01455415|592503569|FG001|Follow-up|Unspecified Reason|0|||
164039534|NCT00587301|592503570|FG000|Overall Study|Screen Failure|9|||
164039535|NCT00587301|592503570|FG000|Overall Study|Lost to Follow-up|22|||
164039536|NCT00587301|592503570|FG000|Overall Study|Withdrawal by Subject|7|||
164039537|NCT00587301|592503570|FG000|Overall Study|Protocol Violation|7|||
164039538|NCT01731990|592504954|FG000|Overall Study|Adverse Event|1|||
163840090|NCT03154359|591785744|FG000|Overall Study|Protocol Violation|4|||
163840091|NCT03154359|591785744|FG000|Overall Study|Withdrawal by Subject|5|||
164039539|NCT01731990|592504955|FG001|Overall Study|Adverse Event|5|||
164039540|NCT01731990|592504954|FG000|Overall Study|Withdrawal by Subject|1|||
164039541|NCT01731990|592504955|FG001|Overall Study|Withdrawal by Subject|1|||
164039542|NCT01731990|592504954|FG000|Overall Study|Protocol deviation|1|||
164039543|NCT01731990|592504955|FG001|Overall Study|Protocol deviation|2|||
164039544|NCT01731990|592504954|FG000|Overall Study|Death|1|||
164039545|NCT01731990|592504955|FG001|Overall Study|Death|0|||
164039546|NCT01183104|592504956|FG000|Overall Study|Adverse Event|8|||
164098760|NCT01693523|592726896|FG002|Overall Study|Physician Decision|1|||
164039547|NCT01183104|592504957|FG001|Overall Study|Adverse Event|6|||
164039548|NCT01183104|592504956|FG000|Overall Study|Death|0|||
164039549|NCT01183104|592504957|FG001|Overall Study|Death|1|||
164039550|NCT01183104|592504956|FG000|Overall Study|Lost to Follow-up|14|||
164039551|NCT01183104|592504957|FG001|Overall Study|Lost to Follow-up|7|||
164039552|NCT01183104|592504956|FG000|Overall Study|Physician Decision|5|||
164039553|NCT01183104|592504957|FG001|Overall Study|Physician Decision|8|||
164039554|NCT01183104|592504956|FG000|Overall Study|Withdrawal by Subject|6|||
164039555|NCT01183104|592504957|FG001|Overall Study|Withdrawal by Subject|11|||
164039556|NCT01183104|592504956|FG000|Overall Study|Nonparticipation in Extension Study|39|||
164039557|NCT01183104|592504957|FG001|Overall Study|Nonparticipation in Extension Study|50|||
164039558|NCT01183104|592504956|FG000|Overall Study|Did not receive study drug|5|||
164039559|NCT01183104|592504957|FG001|Overall Study|Did not receive study drug|9|||
164039560|NCT00323310|592504958|FG000|Overall Study|Withdrawal by Subject|1|||
164039561|NCT00323310|592504958|FG000|Overall Study|a parent refused blood draw|1|||
164039562|NCT00323310|592504958|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
164039563|NCT02944513|592504959|FG000|Overall Study|Withdrawal by Subject|4|||
164039564|NCT02944513|592504960|FG001|Overall Study|Withdrawal by Subject|1|||
164039565|NCT00937326|592504961|FG000|Overall Study|Adverse Event|0|||
164039566|NCT00937326|592504962|FG001|Overall Study|Adverse Event|3|||
164039567|NCT00937326|592504963|FG002|Overall Study|Adverse Event|1|||
164039568|NCT00937326|592504964|FG003|Overall Study|Adverse Event|1|||
164039569|NCT00937326|592504965|FG004|Overall Study|Adverse Event|2|||
164039570|NCT00937326|592504961|FG000|Overall Study|Death|0|||
164039571|NCT00937326|592504962|FG001|Overall Study|Death|0|||
164039572|NCT00937326|592504963|FG002|Overall Study|Death|1|||
164039573|NCT00937326|592504964|FG003|Overall Study|Death|0|||
164039574|NCT00937326|592504965|FG004|Overall Study|Death|0|||
164039575|NCT00937326|592504961|FG000|Overall Study|Withdrawal by Subject|3|||
164039576|NCT00937326|592504962|FG001|Overall Study|Withdrawal by Subject|4|||
164039577|NCT00937326|592504963|FG002|Overall Study|Withdrawal by Subject|1|||
164039578|NCT00937326|592504964|FG003|Overall Study|Withdrawal by Subject|4|||
164039579|NCT00937326|592504965|FG004|Overall Study|Withdrawal by Subject|3|||
164039580|NCT00937326|592504961|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164039581|NCT00937326|592504962|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164039582|NCT00937326|592504963|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
164039583|NCT00937326|592504964|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164039584|NCT00937326|592504965|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
164039585|NCT00790218|592504966|FG000|Overall Study|Death|1|||
164039586|NCT00790218|592504967|FG001|Overall Study|Death|0|||
164039587|NCT00790218|592504968|FG002|Overall Study|Death|0|||
164039588|NCT03424044|592504974|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039589|NCT03424044|592504975|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039590|NCT03424044|592504976|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
164039591|NCT03424044|592504977|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039592|NCT03424044|592504978|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039593|NCT03424044|592504979|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039594|NCT03424044|592504980|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039595|NCT03424044|592504981|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039596|NCT03424044|592504982|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
164039597|NCT03424044|592504974|FG000|First Intervention (76 Hours)|Adverse Event|0|||
164039598|NCT03424044|592504975|FG001|First Intervention (76 Hours)|Adverse Event|0|||
164039599|NCT03424044|592504976|FG002|First Intervention (76 Hours)|Adverse Event|0|||
164039600|NCT03424044|592504977|FG003|First Intervention (76 Hours)|Adverse Event|0|||
164039601|NCT03424044|592504978|FG004|First Intervention (76 Hours)|Adverse Event|1|||
164039602|NCT03424044|592504979|FG005|First Intervention (76 Hours)|Adverse Event|0|||
164039603|NCT03424044|592504980|FG006|First Intervention (76 Hours)|Adverse Event|0|||
164039604|NCT03424044|592504981|FG007|First Intervention (76 Hours)|Adverse Event|0|||
164039605|NCT03424044|592504982|FG008|First Intervention (76 Hours)|Adverse Event|0|||
164039606|NCT03424044|592504974|FG000|First Intervention (76 Hours)|device issues|0|||
164039607|NCT03424044|592504975|FG001|First Intervention (76 Hours)|device issues|0|||
164039608|NCT03424044|592504976|FG002|First Intervention (76 Hours)|device issues|0|||
164039609|NCT03424044|592504977|FG003|First Intervention (76 Hours)|device issues|0|||
164039610|NCT03424044|592504978|FG004|First Intervention (76 Hours)|device issues|0|||
164039611|NCT03424044|592504979|FG005|First Intervention (76 Hours)|device issues|0|||
164039612|NCT03424044|592504980|FG006|First Intervention (76 Hours)|device issues|1|||
164039613|NCT03424044|592504981|FG007|First Intervention (76 Hours)|device issues|1|||
163840092|NCT03154359|591785744|FG000|Overall Study|Disruption of study due to COVID-19|4|||
163840093|NCT04250337|591785745|FG000|Overall Study|Adverse Event|0|||
163840094|NCT04250337|591785746|FG001|Overall Study|Adverse Event|3|||
163840095|NCT04250337|591785745|FG000|Overall Study|Lack of Efficacy|1|||
163840096|NCT04250337|591785746|FG001|Overall Study|Lack of Efficacy|3|||
163840097|NCT04250337|591785745|FG000|Overall Study|Physician Decision|1|||
163840098|NCT04250337|591785746|FG001|Overall Study|Physician Decision|0|||
163936250|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
163936251|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
163936252|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
163936253|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
163936254|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
163936255|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
163936256|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
163936257|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
163936258|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
163936259|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
163936260|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
163936261|NCT02362503|592136651|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
163936262|NCT02362503|592136652|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
163936263|NCT02362503|592136653|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
163936264|NCT03017742|592136656|FG000|Overall Study|Protocol Violation|36|||
163936265|NCT03017742|592136656|FG000|Overall Study|Withdrawal by Subject|37|||
163936266|NCT04148651|592136657|FG000|Overall Study|Lost to Follow-up|2|||
163936267|NCT01001390|592136658|FG000|Overall Study|Failure to wear AFO device|2|||
163936268|NCT01001390|592136659|FG001|Overall Study|Failure to wear AFO device|0|||
163936269|NCT03690427|592136660|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
163936270|NCT03690427|592136661|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
163936271|NCT03519204|592136662|FG000|Overall Study|Lost to Follow-up|3|||
163936272|NCT03519204|592136663|FG001|Overall Study|Lost to Follow-up|8|||
163936273|NCT03519204|592136662|FG000|Overall Study|Withdrawal by Subject|9|||
163936274|NCT03519204|592136663|FG001|Overall Study|Withdrawal by Subject|7|||
163936275|NCT03519204|592136662|FG000|Overall Study|Other Miscellaneous Reasons|1|||
163936276|NCT03519204|592136663|FG001|Overall Study|Other Miscellaneous Reasons|0|||
163936277|NCT02609672|592136667|FG000|Overall Study|Lost to Follow-up|3|||
163936278|NCT02609672|592136668|FG001|Overall Study|Lost to Follow-up|1|||
163936279|NCT03392168|592136669|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
163936280|NCT03392168|592136670|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
163936281|NCT03392168|592136671|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
163936282|NCT03392168|592136672|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
163936283|NCT03392168|592136669|FG000|Period 2: Cohort 2|Other|0|||
163936284|NCT03392168|592136670|FG001|Period 2: Cohort 2|Other|1|||
163936285|NCT03392168|592136671|FG002|Period 2: Cohort 2|Other|0|||
163936286|NCT03392168|592136672|FG003|Period 2: Cohort 2|Other|0|||
163936287|NCT00762476|592136673|FG000|Overall Study|Adverse Event|7|||
163936288|NCT00762476|592136674|FG001|Overall Study|Adverse Event|1|||
163936289|NCT00762476|592136673|FG000|Overall Study|Lost to Follow-up|2|||
163936290|NCT00762476|592136674|FG001|Overall Study|Lost to Follow-up|0|||
163936291|NCT00762476|592136673|FG000|Overall Study|Protocol Violation|5|||
163936292|NCT00762476|592136674|FG001|Overall Study|Protocol Violation|6|||
163936293|NCT00762476|592136673|FG000|Overall Study|Physician Decision|2|||
163936294|NCT00762476|592136674|FG001|Overall Study|Physician Decision|14|||
163936295|NCT00762476|592136673|FG000|Overall Study|Withdrawal by Subject|6|||
163936296|NCT00762476|592136674|FG001|Overall Study|Withdrawal by Subject|12|||
163936297|NCT00762476|592136673|FG000|Overall Study|antibiotic use|0|||
163936298|NCT00762476|592136674|FG001|Overall Study|antibiotic use|1|||
163936299|NCT00762476|592136673|FG000|Overall Study|non-compliance with study visits|0|||
163936300|NCT00762476|592136674|FG001|Overall Study|non-compliance with study visits|2|||
163936301|NCT00762476|592136673|FG000|Overall Study|Seasonal allergies|1|||
163936302|NCT00762476|592136674|FG001|Overall Study|Seasonal allergies|0|||
163936303|NCT01441635|592136675|FG000|Overall Study|Adverse Event|4|||
163936304|NCT01441635|592136676|FG001|Overall Study|Adverse Event|3|||
163936305|NCT01441635|592136677|FG002|Overall Study|Adverse Event|1|||
163936306|NCT01441635|592136678|FG003|Overall Study|Adverse Event|5|||
163936307|NCT01441635|592136679|FG004|Overall Study|Adverse Event|1|||
163936308|NCT01441635|592136680|FG005|Overall Study|Adverse Event|2|||
163936309|NCT01441635|592136681|FG006|Overall Study|Adverse Event|2|||
163936310|NCT01441635|592136682|FG007|Overall Study|Adverse Event|2|||
163936311|NCT01441635|592136683|FG008|Overall Study|Adverse Event|1|||
163936312|NCT01441635|592136684|FG009|Overall Study|Adverse Event|0|||
163936313|NCT01441635|592136675|FG000|Overall Study|Withdrawal by Subject|1|||
163936314|NCT01441635|592136676|FG001|Overall Study|Withdrawal by Subject|1|||
163936315|NCT01441635|592136677|FG002|Overall Study|Withdrawal by Subject|0|||
163936316|NCT01441635|592136678|FG003|Overall Study|Withdrawal by Subject|1|||
163936317|NCT01441635|592136679|FG004|Overall Study|Withdrawal by Subject|0|||
163936318|NCT01441635|592136680|FG005|Overall Study|Withdrawal by Subject|0|||
163936319|NCT01441635|592136681|FG006|Overall Study|Withdrawal by Subject|2|||
163936320|NCT01441635|592136682|FG007|Overall Study|Withdrawal by Subject|0|||
163936321|NCT01441635|592136683|FG008|Overall Study|Withdrawal by Subject|1|||
163936322|NCT01441635|592136684|FG009|Overall Study|Withdrawal by Subject|1|||
163936323|NCT01441635|592136675|FG000|Overall Study|Lost to Follow-up|0|||
163936324|NCT01441635|592136676|FG001|Overall Study|Lost to Follow-up|1|||
163936325|NCT01441635|592136677|FG002|Overall Study|Lost to Follow-up|1|||
164039614|NCT03424044|592504982|FG008|First Intervention (76 Hours)|device issues|1|||
164039615|NCT03424044|592504974|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
164039616|NCT03424044|592504975|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
164039617|NCT03424044|592504976|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
164039618|NCT03424044|592504977|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
164039619|NCT03424044|592504978|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
164039620|NCT03424044|592504979|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
164039621|NCT03424044|592504980|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
164039622|NCT03424044|592504981|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
164039623|NCT03424044|592504982|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
164039624|NCT03424044|592504974|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039625|NCT03424044|592504975|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039626|NCT03424044|592504976|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039627|NCT03424044|592504977|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
164039628|NCT03424044|592504978|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039629|NCT03424044|592504979|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039630|NCT03424044|592504980|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039631|NCT03424044|592504981|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039632|NCT03424044|592504982|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
164039633|NCT04402385|592504984|FG000|Overall Study|Withdrawal by Subject|4|||
164039634|NCT04402385|592504985|FG001|Overall Study|Withdrawal by Subject|4|||
164039635|NCT04402385|592504984|FG000|Overall Study|Lost to Follow-up|1|||
164039636|NCT04402385|592504985|FG001|Overall Study|Lost to Follow-up|1|||
164098761|NCT01693523|592726894|FG000|Overall Study|Withdrawal by Subject|1|||
163936326|NCT01441635|592136678|FG003|Overall Study|Lost to Follow-up|1|||
163936327|NCT01441635|592136679|FG004|Overall Study|Lost to Follow-up|1|||
163936328|NCT01441635|592136680|FG005|Overall Study|Lost to Follow-up|3|||
163936329|NCT01441635|592136681|FG006|Overall Study|Lost to Follow-up|1|||
163936330|NCT01441635|592136682|FG007|Overall Study|Lost to Follow-up|1|||
163936331|NCT01441635|592136683|FG008|Overall Study|Lost to Follow-up|0|||
163936332|NCT01441635|592136684|FG009|Overall Study|Lost to Follow-up|1|||
163936333|NCT01441635|592136675|FG000|Overall Study|Noncompliance|0|||
163936334|NCT01441635|592136676|FG001|Overall Study|Noncompliance|1|||
163936335|NCT01441635|592136677|FG002|Overall Study|Noncompliance|0|||
163936336|NCT01441635|592136678|FG003|Overall Study|Noncompliance|0|||
163936337|NCT01441635|592136679|FG004|Overall Study|Noncompliance|0|||
163936338|NCT01441635|592136680|FG005|Overall Study|Noncompliance|0|||
163936339|NCT01441635|592136681|FG006|Overall Study|Noncompliance|1|||
163936340|NCT01441635|592136682|FG007|Overall Study|Noncompliance|0|||
163936341|NCT01441635|592136683|FG008|Overall Study|Noncompliance|0|||
163936342|NCT01441635|592136684|FG009|Overall Study|Noncompliance|0|||
163936343|NCT01441635|592136675|FG000|Overall Study|Surgery or Invasive Intervention|0|||
163936344|NCT01441635|592136676|FG001|Overall Study|Surgery or Invasive Intervention|0|||
163936345|NCT01441635|592136677|FG002|Overall Study|Surgery or Invasive Intervention|1|||
163936346|NCT01441635|592136678|FG003|Overall Study|Surgery or Invasive Intervention|0|||
163936347|NCT01441635|592136679|FG004|Overall Study|Surgery or Invasive Intervention|0|||
163936348|NCT01441635|592136680|FG005|Overall Study|Surgery or Invasive Intervention|0|||
163936349|NCT01441635|592136681|FG006|Overall Study|Surgery or Invasive Intervention|0|||
163936350|NCT01441635|592136682|FG007|Overall Study|Surgery or Invasive Intervention|0|||
163936351|NCT01441635|592136683|FG008|Overall Study|Surgery or Invasive Intervention|0|||
163936352|NCT01441635|592136684|FG009|Overall Study|Surgery or Invasive Intervention|0|||
163936353|NCT01441635|592136675|FG000|Overall Study|Received Exclusionary Medication|1|||
163936354|NCT01441635|592136676|FG001|Overall Study|Received Exclusionary Medication|0|||
163936355|NCT01441635|592136677|FG002|Overall Study|Received Exclusionary Medication|0|||
163936356|NCT01441635|592136678|FG003|Overall Study|Received Exclusionary Medication|0|||
163936357|NCT01441635|592136679|FG004|Overall Study|Received Exclusionary Medication|0|||
163936358|NCT01441635|592136680|FG005|Overall Study|Received Exclusionary Medication|0|||
163936359|NCT01441635|592136681|FG006|Overall Study|Received Exclusionary Medication|0|||
163936360|NCT01441635|592136682|FG007|Overall Study|Received Exclusionary Medication|0|||
163936361|NCT01441635|592136683|FG008|Overall Study|Received Exclusionary Medication|0|||
163936362|NCT01441635|592136684|FG009|Overall Study|Received Exclusionary Medication|0|||
163936363|NCT01441635|592136675|FG000|Overall Study|Other|0|||
164039637|NCT04402385|592504984|FG000|Overall Study|Physician Decision|0|||
163936364|NCT01441635|592136676|FG001|Overall Study|Other|0|||
163936365|NCT01441635|592136677|FG002|Overall Study|Other|0|||
163936366|NCT01441635|592136678|FG003|Overall Study|Other|0|||
163936367|NCT01441635|592136679|FG004|Overall Study|Other|0|||
164039638|NCT04402385|592504985|FG001|Overall Study|Physician Decision|1|||
164039639|NCT00731666|592504986|FG000|Overall Study|Adverse Event|2|||
164098762|NCT01693523|592726895|FG001|Overall Study|Withdrawal by Subject|2|||
163936368|NCT01441635|592136680|FG005|Overall Study|Other|0|||
163936369|NCT01441635|592136681|FG006|Overall Study|Other|0|||
163936370|NCT01441635|592136682|FG007|Overall Study|Other|1|||
163936371|NCT01441635|592136683|FG008|Overall Study|Other|0|||
163936372|NCT01441635|592136684|FG009|Overall Study|Other|0|||
164098763|NCT01693523|592726896|FG002|Overall Study|Withdrawal by Subject|2|||
164098764|NCT01693523|592726894|FG000|Overall Study|Lack of compliance study medication|1|||
164098765|NCT01693523|592726895|FG001|Overall Study|Lack of compliance study medication|2|||
163936373|NCT02637323|592136686|FG000|Overall Study|Lost to Follow-up|2|||
163936374|NCT02637323|592136687|FG001|Overall Study|Lost to Follow-up|0|||
163936375|NCT02637323|592136686|FG000|Overall Study|Protocol Violation|0|||
163936376|NCT02637323|592136687|FG001|Overall Study|Protocol Violation|1|||
163936377|NCT02838134|592136688|FG000|Overall Study|Lost to Follow-up|1|||
163936378|NCT02838134|592136689|FG001|Overall Study|Lost to Follow-up|2|||
163936379|NCT02838134|592136688|FG000|Overall Study|logistic problems|1|||
163936380|NCT02838134|592136689|FG001|Overall Study|logistic problems|1|||
163936381|NCT01912404|592136690|FG000|Overall Study|Due to personal reasons|1|||
163936382|NCT01912404|592136691|FG001|Overall Study|Due to personal reasons|0|||
163936383|NCT01430468|592136692|FG000|Overall Study|Physician Decision|2|||
163936384|NCT01430468|592136693|FG001|Overall Study|Physician Decision|1|||
163936385|NCT01430468|592136692|FG000|Overall Study|Withdrawal by Subject|5|||
163936386|NCT01430468|592136693|FG001|Overall Study|Withdrawal by Subject|5|||
163936387|NCT01443923|592136694|FG000|Overall Study|Adverse Event|1|||
163936388|NCT01443923|592136695|FG001|Overall Study|Adverse Event|0|||
163936389|NCT04547023|592136698|FG000|Overall Study|Did Not Receive Intervention|3|||
163936390|NCT04547023|592136699|FG001|Overall Study|Did Not Receive Intervention|2|||
163936391|NCT04547023|592136698|FG000|Overall Study|Lost to Follow-up|1|||
163936392|NCT04547023|592136699|FG001|Overall Study|Lost to Follow-up|1|||
163936393|NCT01245374|592136700|FG000|Overall Study|Protocol Violation|1|||
163936394|NCT01245374|592136700|FG000|Overall Study|Withdrawal by Subject|3|||
163936395|NCT04013971|592136705|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
163936396|NCT04013971|592136706|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
163936397|NCT04013971|592136705|FG000|Overall Study|Missing biomechanical data|0|||
163936398|NCT04013971|592136706|FG001|Overall Study|Missing biomechanical data|1|||
163936399|NCT04297618|592136707|FG000|Overall Study|Adverse Event|1|||
163936400|NCT04297618|592136707|FG000|Overall Study|Withdrawal by Subject|1|||
163936401|NCT04704219|592136708|FG000|Overall Study|Screen Failure|1|||
163936402|NCT04704219|592136708|FG000|Overall Study|Withdrawal by Subject|1|||
163936403|NCT04704219|592136708|FG000|Overall Study|Death|78|||
163936404|NCT04704219|592136708|FG000|Overall Study|Participants Ongoing|80|||
163936405|NCT02600897|592136709|FG000|Overall Study|Death|1|||
163936406|NCT02600897|592136710|FG001|Overall Study|Death|2|||
163936407|NCT02600897|592136711|FG002|Overall Study|Death|1|||
163936408|NCT02600897|592136712|FG003|Overall Study|Death|2|||
163936409|NCT02600897|592136713|FG004|Overall Study|Death|3|||
163936410|NCT02600897|592136714|FG005|Overall Study|Death|2|||
163936411|NCT02600897|592136715|FG006|Overall Study|Death|10|||
163936412|NCT02600897|592136716|FG007|Overall Study|Death|7|||
163936413|NCT02600897|592136717|FG008|Overall Study|Death|20|||
163936414|NCT02600897|592136709|FG000|Overall Study|Lost to Follow-up|1|||
163936415|NCT02600897|592136710|FG001|Overall Study|Lost to Follow-up|0|||
163936416|NCT02600897|592136711|FG002|Overall Study|Lost to Follow-up|0|||
163936417|NCT02600897|592136712|FG003|Overall Study|Lost to Follow-up|0|||
163936418|NCT02600897|592136713|FG004|Overall Study|Lost to Follow-up|0|||
163936419|NCT02600897|592136714|FG005|Overall Study|Lost to Follow-up|0|||
163936420|NCT02600897|592136715|FG006|Overall Study|Lost to Follow-up|0|||
163936421|NCT02600897|592136716|FG007|Overall Study|Lost to Follow-up|1|||
163936422|NCT02600897|592136717|FG008|Overall Study|Lost to Follow-up|0|||
163936423|NCT02600897|592136709|FG000|Overall Study|Withdrawal by Subject|0|||
163936424|NCT02600897|592136710|FG001|Overall Study|Withdrawal by Subject|0|||
163936425|NCT02600897|592136711|FG002|Overall Study|Withdrawal by Subject|0|||
163936426|NCT02600897|592136712|FG003|Overall Study|Withdrawal by Subject|0|||
163936427|NCT02600897|592136713|FG004|Overall Study|Withdrawal by Subject|0|||
163936428|NCT02600897|592136714|FG005|Overall Study|Withdrawal by Subject|0|||
163936429|NCT02600897|592136715|FG006|Overall Study|Withdrawal by Subject|0|||
163936430|NCT02600897|592136716|FG007|Overall Study|Withdrawal by Subject|4|||
163936431|NCT02600897|592136717|FG008|Overall Study|Withdrawal by Subject|2|||
163936432|NCT02600897|592136709|FG000|Overall Study|Reason Not Specified|0|||
163936433|NCT02600897|592136710|FG001|Overall Study|Reason Not Specified|0|||
163936434|NCT02600897|592136711|FG002|Overall Study|Reason Not Specified|0|||
163936435|NCT02600897|592136712|FG003|Overall Study|Reason Not Specified|0|||
163936436|NCT02600897|592136713|FG004|Overall Study|Reason Not Specified|0|||
163936437|NCT02600897|592136714|FG005|Overall Study|Reason Not Specified|0|||
163936438|NCT02600897|592136715|FG006|Overall Study|Reason Not Specified|0|||
163936439|NCT02600897|592136716|FG007|Overall Study|Reason Not Specified|0|||
163936440|NCT02600897|592136717|FG008|Overall Study|Reason Not Specified|1|||
163936441|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Adverse Event|10|||
163936442|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Adverse Event|9|||
163936443|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Adverse Event|7|||
163936444|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
163936445|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
163936446|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
164039640|NCT00731666|592504986|FG000|Overall Study|Lost to Follow-up|8|||
164039641|NCT00731666|592504986|FG000|Overall Study|Withdrawal by Subject|2|||
164039642|NCT01308853|592504987|FG000|Overall Study|Adverse Event|1|||
164039643|NCT01308853|592504987|FG000|Overall Study|Lost to Follow-up|2|||
164039644|NCT01308853|592504987|FG000|Overall Study|Insertion of permanent implants|1|||
164039645|NCT03250624|592504989|FG000|Overall Study|Lack of Efficacy|1|||
164039646|NCT03250624|592504990|FG001|Overall Study|Lack of Efficacy|4|||
164039647|NCT03250624|592504989|FG000|Overall Study|Adverse Event|0|||
164039648|NCT03250624|592504990|FG001|Overall Study|Adverse Event|1|||
164039649|NCT03250624|592504989|FG000|Overall Study|Other|1|||
164039650|NCT03250624|592504990|FG001|Overall Study|Other|2|||
164039651|NCT00606177|592504991|FG000|Overall Study|Adverse Event|9|||
164039652|NCT00606177|592504992|FG001|Overall Study|Adverse Event|5|||
164039653|NCT00606177|592504991|FG000|Overall Study|Lack of Efficacy|3|||
164039654|NCT00606177|592504992|FG001|Overall Study|Lack of Efficacy|7|||
164039655|NCT00606177|592504991|FG000|Overall Study|Physician Decision|1|||
164039656|NCT00606177|592504992|FG001|Overall Study|Physician Decision|0|||
164039657|NCT00606177|592504991|FG000|Overall Study|Protocol Violation|1|||
164039658|NCT00606177|592504992|FG001|Overall Study|Protocol Violation|4|||
164039659|NCT00606177|592504991|FG000|Overall Study|Withdrawal by Subject|5|||
164039660|NCT00606177|592504992|FG001|Overall Study|Withdrawal by Subject|6|||
164039661|NCT00606177|592504991|FG000|Overall Study|Progression to depressive phase|6|||
164039662|NCT00606177|592504992|FG001|Overall Study|Progression to depressive phase|1|||
164039663|NCT00606177|592504991|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
164039664|NCT00606177|592504992|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
164039665|NCT00606177|592504991|FG000|Overall Study|Change of residence or other commitments|1|||
164039666|NCT00606177|592504992|FG001|Overall Study|Change of residence or other commitments|1|||
164039667|NCT00136357|592504993|FG000|Overall Study|Withdrawal by Subject|3|||
164039668|NCT00136357|592504994|FG001|Overall Study|Withdrawal by Subject|2|||
164039669|NCT01819506|592504997|FG000|Overall Study|Physician Decision|5|||
164039670|NCT01819506|592504998|FG001|Overall Study|Physician Decision|2|||
164039671|NCT01819506|592504997|FG000|Overall Study|Withdrawal by Subject|3|||
164039672|NCT01819506|592504998|FG001|Overall Study|Withdrawal by Subject|3|||
164039673|NCT01505114|592504999|FG000|Overall Study|Withdrawal by Subject|5|||
164039674|NCT01505114|592505000|FG001|Overall Study|Withdrawal by Subject|4|||
164039675|NCT01505114|592505001|FG002|Overall Study|Withdrawal by Subject|4|||
164039676|NCT01505114|592505002|FG003|Overall Study|Withdrawal by Subject|7|||
164039677|NCT01505114|592504999|FG000|Overall Study|Death|1|||
164039678|NCT01505114|592505000|FG001|Overall Study|Death|0|||
164039679|NCT01505114|592505001|FG002|Overall Study|Death|0|||
164039680|NCT01505114|592505002|FG003|Overall Study|Death|1|||
164039681|NCT01505114|592504999|FG000|Overall Study|unable to adhere to visit schedule|3|||
164039682|NCT01505114|592505000|FG001|Overall Study|unable to adhere to visit schedule|2|||
164039683|NCT01505114|592505001|FG002|Overall Study|unable to adhere to visit schedule|3|||
164039684|NCT01505114|592505002|FG003|Overall Study|unable to adhere to visit schedule|3|||
164039685|NCT01505114|592504999|FG000|Overall Study|Lost to Follow-up|11|||
164039686|NCT01505114|592505000|FG001|Overall Study|Lost to Follow-up|5|||
164039687|NCT01505114|592505001|FG002|Overall Study|Lost to Follow-up|8|||
164039688|NCT01505114|592505002|FG003|Overall Study|Lost to Follow-up|7|||
164039689|NCT01505114|592504999|FG000|Overall Study|relocated|4|||
164039690|NCT01505114|592505000|FG001|Overall Study|relocated|2|||
164039691|NCT01505114|592505001|FG002|Overall Study|relocated|2|||
164039692|NCT01505114|592505002|FG003|Overall Study|relocated|3|||
164039693|NCT01505114|592504999|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
164039694|NCT01505114|592505000|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
164039695|NCT01505114|592505001|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
164039696|NCT01505114|592505002|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
164039697|NCT01505114|592504999|FG000|Overall Study|staff safety concerns|0|||
164039698|NCT01505114|592505000|FG001|Overall Study|staff safety concerns|0|||
164039699|NCT01505114|592505001|FG002|Overall Study|staff safety concerns|0|||
164039700|NCT01505114|592505002|FG003|Overall Study|staff safety concerns|1|||
164039701|NCT01505114|592504999|FG000|Overall Study|investigator decision|1|||
164039702|NCT01505114|592505000|FG001|Overall Study|investigator decision|0|||
164039703|NCT01505114|592505001|FG002|Overall Study|investigator decision|1|||
164039704|NCT01505114|592505002|FG003|Overall Study|investigator decision|0|||
164039705|NCT02017704|592505009|FG000|Overall Study|Withdrawal by Subject|2|||
164039706|NCT02017704|592505010|FG001|Overall Study|Withdrawal by Subject|0|||
164039707|NCT02076334|592505011|FG000|Overall Study|Protocol Violation|1|||
164039708|NCT02076334|592505012|FG001|Overall Study|Protocol Violation|0|||
164039709|NCT02076334|592505013|FG002|Overall Study|Protocol Violation|0|||
164039710|NCT02076334|592505014|FG003|Overall Study|Protocol Violation|0|||
164039711|NCT02076334|592505011|FG000|Overall Study|Lost to Follow-up|0|||
164039712|NCT02076334|592505012|FG001|Overall Study|Lost to Follow-up|1|||
164039713|NCT02076334|592505013|FG002|Overall Study|Lost to Follow-up|1|||
164039714|NCT02076334|592505014|FG003|Overall Study|Lost to Follow-up|0|||
164039715|NCT02076334|592505011|FG000|Overall Study|muscle soreness|0|||
164039716|NCT02076334|592505012|FG001|Overall Study|muscle soreness|0|||
163936447|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
163936448|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
163936449|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
163936450|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Physician Decision|7|||
163936451|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Physician Decision|3|||
163936452|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Physician Decision|2|||
163936453|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Pregnancy|2|||
163936454|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Pregnancy|1|||
163936455|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Pregnancy|3|||
163936456|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
163936457|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
163936458|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
163936459|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
163936460|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
163936461|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
163936462|NCT02614183|592136718|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
163936463|NCT02614183|592136719|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
163936464|NCT02614183|592136720|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
163936465|NCT02614183|592136718|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
163936466|NCT02614183|592136719|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
163936467|NCT02614183|592136720|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
163936468|NCT02614183|592136718|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
163936469|NCT02614183|592136719|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
163936470|NCT02614183|592136720|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
163936471|NCT02614183|592136718|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
163936472|NCT02614183|592136719|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
163936473|NCT02614183|592136720|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
163936474|NCT02614183|592136718|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
163936475|NCT02614183|592136719|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
163936476|NCT02614183|592136720|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
163936477|NCT03816761|592138885|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163936478|NCT03816761|592138886|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163936479|NCT03816761|592138887|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163936480|NCT03816761|592138888|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163936481|NCT03816761|592138889|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
163936482|NCT03816761|592138890|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
163936483|NCT03816761|592138885|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
163936484|NCT03816761|592138886|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
163936485|NCT03816761|592138887|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
163936486|NCT03816761|592138888|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
163936487|NCT03816761|592138889|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
163936488|NCT03816761|592138890|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
163936489|NCT00474526|592138899|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
163936490|NCT00474526|592138900|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
163936491|NCT00474526|592138901|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
163936492|NCT00474526|592138902|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
163936493|NCT00474526|592138903|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
163936494|NCT00474526|592138904|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
163936495|NCT00474526|592138905|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
163936496|NCT00474526|592138906|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
163936497|NCT00474526|592138907|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
163936498|NCT00474526|592138908|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
163936499|NCT00474526|592138909|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
163936500|NCT00474526|592138910|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
163936501|NCT00474526|592138911|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
163936502|NCT00474526|592138912|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
163936503|NCT00474526|592138913|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
163936504|NCT00474526|592138914|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
164039717|NCT02076334|592505013|FG002|Overall Study|muscle soreness|0|||
164039718|NCT02076334|592505014|FG003|Overall Study|muscle soreness|1|||
164039719|NCT01963780|592505015|FG000|Overall Study|Death|7|||
164039720|NCT01749800|592505016|FG000|Overall Study|not meeting inclusion criteria|3|||
163936505|NCT00474526|592138915|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
163936506|NCT00474526|592138899|FG000|Overall Study|Adverse Event|2|||
163936507|NCT00474526|592138900|FG001|Overall Study|Adverse Event|0|||
163936508|NCT00474526|592138901|FG002|Overall Study|Adverse Event|2|||
164039721|NCT01749800|592505017|FG001|Overall Study|not meeting inclusion criteria|0|||
164039722|NCT01749800|592505018|FG002|Overall Study|not meeting inclusion criteria|0|||
164039723|NCT01749800|592505016|FG000|Overall Study|Withdrawal by Subject|0|||
164039724|NCT01749800|592505017|FG001|Overall Study|Withdrawal by Subject|1|||
164039725|NCT01749800|592505018|FG002|Overall Study|Withdrawal by Subject|0|||
164039726|NCT01975675|592505019|FG000|Overall Study|Death|0|||
164098766|NCT01693523|592726896|FG002|Overall Study|Lack of compliance study medication|0|||
164098767|NCT01693523|592726894|FG000|Overall Study|Chemotherapy was held|1|||
164098768|NCT01693523|592726895|FG001|Overall Study|Chemotherapy was held|2|||
163936509|NCT00474526|592138902|FG003|Overall Study|Adverse Event|4|||
163936510|NCT00474526|592138903|FG004|Overall Study|Adverse Event|2|||
163936511|NCT00474526|592138904|FG005|Overall Study|Adverse Event|1|||
163936512|NCT00474526|592138905|FG006|Overall Study|Adverse Event|1|||
163936513|NCT00474526|592138906|FG007|Overall Study|Adverse Event|0|||
163936514|NCT00474526|592138907|FG008|Overall Study|Adverse Event|0|||
163936515|NCT00474526|592138908|FG009|Overall Study|Adverse Event|0|||
163936516|NCT00474526|592138909|FG010|Overall Study|Adverse Event|0|||
163936517|NCT00474526|592138910|FG011|Overall Study|Adverse Event|0|||
163936518|NCT00474526|592138911|FG012|Overall Study|Adverse Event|0|||
163936519|NCT00474526|592138912|FG013|Overall Study|Adverse Event|0|||
163936520|NCT00474526|592138913|FG014|Overall Study|Adverse Event|1|||
163936521|NCT00474526|592138914|FG015|Overall Study|Adverse Event|1|||
163936522|NCT00474526|592138915|FG016|Overall Study|Adverse Event|0|||
163936523|NCT00474526|592138899|FG000|Overall Study|Death|0|||
163936524|NCT00474526|592138900|FG001|Overall Study|Death|0|||
163936525|NCT00474526|592138901|FG002|Overall Study|Death|0|||
163936526|NCT00474526|592138902|FG003|Overall Study|Death|0|||
163936527|NCT00474526|592138903|FG004|Overall Study|Death|0|||
163936528|NCT00474526|592138904|FG005|Overall Study|Death|0|||
163936529|NCT00474526|592138905|FG006|Overall Study|Death|0|||
163936530|NCT00474526|592138906|FG007|Overall Study|Death|0|||
163936531|NCT00474526|592138907|FG008|Overall Study|Death|0|||
163936532|NCT00474526|592138908|FG009|Overall Study|Death|0|||
163936533|NCT00474526|592138909|FG010|Overall Study|Death|0|||
163936534|NCT00474526|592138910|FG011|Overall Study|Death|0|||
163936535|NCT00474526|592138911|FG012|Overall Study|Death|0|||
163936536|NCT00474526|592138912|FG013|Overall Study|Death|3|||
163936537|NCT00474526|592138913|FG014|Overall Study|Death|0|||
163936538|NCT00474526|592138914|FG015|Overall Study|Death|0|||
163936539|NCT00474526|592138915|FG016|Overall Study|Death|0|||
163936540|NCT00474526|592138899|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936541|NCT00474526|592138900|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
163936542|NCT00474526|592138901|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936543|NCT00474526|592138902|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
163936544|NCT00474526|592138903|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
163936545|NCT00474526|592138904|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936546|NCT00474526|592138905|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936547|NCT00474526|592138906|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936548|NCT00474526|592138907|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936549|NCT00474526|592138908|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936550|NCT00474526|592138909|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936551|NCT00474526|592138910|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936552|NCT00474526|592138911|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936553|NCT00474526|592138912|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
163936554|NCT00474526|592138913|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
163936555|NCT00474526|592138914|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936556|NCT00474526|592138915|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
163936557|NCT00474526|592138899|FG000|Overall Study|Lost to Follow-up|8|||
163936558|NCT00474526|592138900|FG001|Overall Study|Lost to Follow-up|6|||
163936559|NCT00474526|592138901|FG002|Overall Study|Lost to Follow-up|13|||
163936560|NCT00474526|592138902|FG003|Overall Study|Lost to Follow-up|29|||
163936561|NCT00474526|592138903|FG004|Overall Study|Lost to Follow-up|11|||
163936562|NCT00474526|592138904|FG005|Overall Study|Lost to Follow-up|5|||
163936563|NCT00474526|592138905|FG006|Overall Study|Lost to Follow-up|8|||
163936564|NCT00474526|592138906|FG007|Overall Study|Lost to Follow-up|1|||
163936565|NCT00474526|592138907|FG008|Overall Study|Lost to Follow-up|0|||
163936566|NCT00474526|592138908|FG009|Overall Study|Lost to Follow-up|6|||
163936567|NCT00474526|592138909|FG010|Overall Study|Lost to Follow-up|2|||
163936568|NCT00474526|592138910|FG011|Overall Study|Lost to Follow-up|4|||
163936569|NCT00474526|592138911|FG012|Overall Study|Lost to Follow-up|6|||
163936570|NCT00474526|592138912|FG013|Overall Study|Lost to Follow-up|74|||
163936571|NCT00474526|592138913|FG014|Overall Study|Lost to Follow-up|29|||
163936572|NCT00474526|592138914|FG015|Overall Study|Lost to Follow-up|4|||
163936573|NCT00474526|592138915|FG016|Overall Study|Lost to Follow-up|5|||
163936574|NCT00474526|592138899|FG000|Overall Study|Protocol Violation|2|||
163936575|NCT00474526|592138900|FG001|Overall Study|Protocol Violation|6|||
163936576|NCT00474526|592138901|FG002|Overall Study|Protocol Violation|4|||
163936577|NCT00474526|592138902|FG003|Overall Study|Protocol Violation|12|||
163936578|NCT00474526|592138903|FG004|Overall Study|Protocol Violation|3|||
163936579|NCT00474526|592138904|FG005|Overall Study|Protocol Violation|1|||
163936580|NCT00474526|592138905|FG006|Overall Study|Protocol Violation|3|||
163936581|NCT00474526|592138906|FG007|Overall Study|Protocol Violation|0|||
163936582|NCT00474526|592138907|FG008|Overall Study|Protocol Violation|0|||
163936583|NCT00474526|592138908|FG009|Overall Study|Protocol Violation|4|||
163936584|NCT00474526|592138909|FG010|Overall Study|Protocol Violation|2|||
163936585|NCT00474526|592138910|FG011|Overall Study|Protocol Violation|2|||
163936586|NCT00474526|592138911|FG012|Overall Study|Protocol Violation|4|||
163936587|NCT00474526|592138912|FG013|Overall Study|Protocol Violation|19|||
163936588|NCT00474526|592138913|FG014|Overall Study|Protocol Violation|9|||
163936589|NCT00474526|592138914|FG015|Overall Study|Protocol Violation|6|||
163936590|NCT00474526|592138915|FG016|Overall Study|Protocol Violation|2|||
163936591|NCT00474526|592138899|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
163936592|NCT00474526|592138900|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
163936593|NCT00474526|592138901|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
163936594|NCT00474526|592138902|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
163936595|NCT00474526|592138903|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
163936596|NCT00474526|592138904|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
163936597|NCT00474526|592138905|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
163936598|NCT00474526|592138906|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
163936599|NCT00474526|592138907|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
163936600|NCT00474526|592138908|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
163936601|NCT00474526|592138909|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
163936602|NCT00474526|592138910|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
163936603|NCT00474526|592138911|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
163936604|NCT00474526|592138912|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
163936605|NCT00474526|592138913|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
163936606|NCT00474526|592138914|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
163936607|NCT00474526|592138915|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
163936608|NCT00474526|592138899|FG000|Overall Study|Withdrawal by Subject|9|||
163936609|NCT00474526|592138900|FG001|Overall Study|Withdrawal by Subject|24|||
163936610|NCT00474526|592138901|FG002|Overall Study|Withdrawal by Subject|21|||
163936611|NCT00474526|592138902|FG003|Overall Study|Withdrawal by Subject|52|||
163936612|NCT00474526|592138903|FG004|Overall Study|Withdrawal by Subject|38|||
163936613|NCT00474526|592138904|FG005|Overall Study|Withdrawal by Subject|6|||
163936614|NCT00474526|592138905|FG006|Overall Study|Withdrawal by Subject|12|||
163936615|NCT00474526|592138906|FG007|Overall Study|Withdrawal by Subject|4|||
163936616|NCT00474526|592138907|FG008|Overall Study|Withdrawal by Subject|4|||
163936617|NCT00474526|592138908|FG009|Overall Study|Withdrawal by Subject|13|||
163936618|NCT00474526|592138909|FG010|Overall Study|Withdrawal by Subject|5|||
163936619|NCT00474526|592138910|FG011|Overall Study|Withdrawal by Subject|4|||
163936620|NCT00474526|592138911|FG012|Overall Study|Withdrawal by Subject|4|||
163936621|NCT00474526|592138912|FG013|Overall Study|Withdrawal by Subject|37|||
163936622|NCT00474526|592138913|FG014|Overall Study|Withdrawal by Subject|22|||
163936623|NCT00474526|592138914|FG015|Overall Study|Withdrawal by Subject|1|||
163936624|NCT00474526|592138915|FG016|Overall Study|Withdrawal by Subject|1|||
163936625|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
163936626|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
163936627|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
163936628|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
163936629|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
163936630|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
163936631|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
163936632|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
163936633|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
163936634|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
163936635|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
163936636|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
163936637|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
163936638|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
163936639|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
163936640|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
163936641|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
163936642|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
164039727|NCT01975675|592505020|FG001|Overall Study|Death|1|||
164039728|NCT01975675|592505021|FG002|Overall Study|Death|0|||
163936643|NCT00132678|592138916|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
163936644|NCT00132678|592138917|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
163936645|NCT00132678|592138918|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
163936646|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Death|2|||
163936647|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Death|0|||
163936648|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Death|0|||
163936649|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
164039729|NCT01975675|592505022|FG003|Overall Study|Death|0|||
164039730|NCT03639987|592505023|FG000|Overall Study|Study terminated by sponsor|26|||
164039731|NCT03639987|592505024|FG001|Overall Study|Study terminated by sponsor|25|||
164039732|NCT03639987|592505023|FG000|Overall Study|Lost to Follow-up|0|||
163936650|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
163936651|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
163936652|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
164039733|NCT03639987|592505024|FG001|Overall Study|Lost to Follow-up|1|||
164039734|NCT04354155|592505025|FG000|Overall Study|Withdrawal by Subject|1|||
164039735|NCT04354155|592505025|FG000|Overall Study|Did not meet criteria for study intervention|1|||
164039736|NCT01015820|592505028|FG000|Overall Study|Suboptimal measurements|1|||
164039737|NCT01015820|592505029|FG001|Overall Study|Suboptimal measurements|0|||
164039738|NCT01998399|592505030|FG000|Overall Study|Lost to Follow-up|1|||
164039739|NCT01998399|592505031|FG001|Overall Study|Lost to Follow-up|3|||
164039740|NCT01998399|592505030|FG000|Overall Study|Death|4|||
164039741|NCT01998399|592505031|FG001|Overall Study|Death|2|||
164039742|NCT01998399|592505030|FG000|Overall Study|Study stopped before dosing completed|3|||
164039743|NCT01998399|592505031|FG001|Overall Study|Study stopped before dosing completed|3|||
164039744|NCT01998399|592505030|FG000|Overall Study|Withdrawal by Subject|0|||
164039745|NCT01998399|592505031|FG001|Overall Study|Withdrawal by Subject|1|||
164039746|NCT00376246|592505032|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
164039747|NCT00376246|592505033|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
164039748|NCT00376246|592505032|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164039749|NCT00376246|592505033|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
164039750|NCT00376246|592505032|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
164039751|NCT00376246|592505033|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
164039752|NCT00351819|592505036|FG000|Overall Study|Lost to Follow-up|4|||
164039753|NCT00351819|592505037|FG001|Overall Study|Lost to Follow-up|4|||
164039754|NCT00351819|592505036|FG000|Overall Study|Withdrawal by Subject|0|||
164039755|NCT00351819|592505037|FG001|Overall Study|Withdrawal by Subject|4|||
164039756|NCT00351819|592505036|FG000|Overall Study|Elevated PSA|1|||
164039757|NCT00351819|592505037|FG001|Overall Study|Elevated PSA|1|||
164039758|NCT00351819|592505036|FG000|Overall Study|Traumatic ankle fracture|1|||
164039759|NCT00351819|592505037|FG001|Overall Study|Traumatic ankle fracture|0|||
164039760|NCT00351819|592505036|FG000|Overall Study|Unprofessional behavior|1|||
164039761|NCT00351819|592505037|FG001|Overall Study|Unprofessional behavior|0|||
164039762|NCT00351819|592505036|FG000|Overall Study|Non-compliance|0|||
164039763|NCT00351819|592505037|FG001|Overall Study|Non-compliance|1|||
164039764|NCT00351819|592505036|FG000|Overall Study|Incarcerated|0|||
164039765|NCT00351819|592505037|FG001|Overall Study|Incarcerated|1|||
164039766|NCT00351819|592505036|FG000|Overall Study|Enrolled in another trial|0|||
164039767|NCT00351819|592505037|FG001|Overall Study|Enrolled in another trial|1|||
164039768|NCT00719537|592505039|FG000|Overall Study|Withdrawal by Subject|1|||
164039769|NCT00719537|592505040|FG001|Overall Study|Withdrawal by Subject|0|||
164039770|NCT00719537|592505039|FG000|Overall Study|Lost to Follow-up|0|||
164039771|NCT00719537|592505040|FG001|Overall Study|Lost to Follow-up|1|||
164039772|NCT02460978|592505041|FG000|Overall Study|Adverse Event|17|||
164039773|NCT02460978|592505042|FG001|Overall Study|Adverse Event|11|||
164039774|NCT02460978|592505043|FG002|Overall Study|Adverse Event|11|||
164039775|NCT02460978|592505041|FG000|Overall Study|Withdrawal by Subject|5|||
164039776|NCT02460978|592505042|FG001|Overall Study|Withdrawal by Subject|5|||
164039777|NCT02460978|592505043|FG002|Overall Study|Withdrawal by Subject|14|||
164039778|NCT02460978|592505041|FG000|Overall Study|Lost to Follow-up|2|||
164039779|NCT02460978|592505042|FG001|Overall Study|Lost to Follow-up|3|||
164039780|NCT02460978|592505043|FG002|Overall Study|Lost to Follow-up|1|||
164039781|NCT02460978|592505041|FG000|Overall Study|Protocol Violation|1|||
164039782|NCT02460978|592505042|FG001|Overall Study|Protocol Violation|1|||
164039783|NCT02460978|592505043|FG002|Overall Study|Protocol Violation|1|||
164039784|NCT02460978|592505041|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
164039785|NCT02460978|592505042|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
164039786|NCT02460978|592505043|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
164039787|NCT02460978|592505041|FG000|Overall Study|Pregnancy|0|||
164039788|NCT02460978|592505042|FG001|Overall Study|Pregnancy|0|||
164039789|NCT02460978|592505043|FG002|Overall Study|Pregnancy|2|||
164039790|NCT01142193|592505044|FG000|Overall Study|Adverse Event|12|||
164039791|NCT01142193|592505045|FG001|Overall Study|Adverse Event|4|||
164039792|NCT01142193|592505044|FG000|Overall Study|Lack of Efficacy|2|||
164039793|NCT01142193|592505045|FG001|Overall Study|Lack of Efficacy|1|||
164039794|NCT01142193|592505044|FG000|Overall Study|Physician Decision|1|||
164039795|NCT01142193|592505045|FG001|Overall Study|Physician Decision|1|||
164039796|NCT01142193|592505044|FG000|Overall Study|Withdrawal by Subject|4|||
164039797|NCT01142193|592505045|FG001|Overall Study|Withdrawal by Subject|3|||
164039798|NCT01142193|592505044|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
164039799|NCT01142193|592505045|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
164039800|NCT01142193|592505044|FG000|Overall Study|Other|1|||
164039801|NCT01142193|592505045|FG001|Overall Study|Other|2|||
164039802|NCT00994162|592505046|FG000|Overall Study|Withdrawal by Subject|1|||
164039803|NCT00994162|592505046|FG000|Overall Study|Lost to Follow-up|2|||
164039804|NCT00994162|592505046|FG000|Overall Study|Product Complaint|1|||
164039805|NCT00994162|592505046|FG000|Overall Study|Poor Compliance|5|||
164039806|NCT00994162|592505046|FG000|Overall Study|Lack of Response|3|||
164039807|NCT00994162|592505046|FG000|Overall Study|Discharged from Hospital|4|||
164039808|NCT00994162|592505046|FG000|Overall Study|Death|2|||
164039809|NCT00994162|592505046|FG000|Overall Study|Care Transferred to Another Physician|2|||
164147701|NCT02006732|592902131|FG002|Overall Study|Lack of Efficacy|1|||
164039810|NCT00994162|592505046|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
164039811|NCT00994162|592505046|FG000|Overall Study|Physician Decision|2|||
164039812|NCT00994162|592505046|FG000|Overall Study|Surrounding Wound Erythematous|1|||
164039813|NCT00994162|592505046|FG000|Overall Study|Machine Losing Vaccum|1|||
164039814|NCT00994162|592505046|FG000|Overall Study|Patient Lived Too Far Away|1|||
164039815|NCT00994162|592505046|FG000|Overall Study|Above Knee Amputation|1|||
164039816|NCT00994162|592505046|FG000|Overall Study|Reason Not Reported By Site|1|||
164039817|NCT01459068|592505049|FG000|Overall Study|Withdrawal by Subject|8|||
164039818|NCT01459068|592505050|FG001|Overall Study|Withdrawal by Subject|18|||
164039819|NCT01459068|592505049|FG000|Overall Study|Lost to Follow-up|31|||
164039820|NCT01459068|592505050|FG001|Overall Study|Lost to Follow-up|15|||
164039821|NCT01459068|592505049|FG000|Overall Study|Death|0|||
164039822|NCT01459068|592505050|FG001|Overall Study|Death|1|||
164039823|NCT02023112|592505051|FG000|Overall Study|Withdrawal by Subject|2|||
164039824|NCT02023112|592505052|FG001|Overall Study|Withdrawal by Subject|1|||
163936653|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
163936654|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
163936655|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
163936656|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
163936657|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
163936658|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
163936659|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
163936660|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
163936661|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
163936662|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
163936663|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
163936664|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
163936665|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
163936666|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
163936667|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
163936668|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
163936669|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
163936670|NCT00132678|592138916|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
163936671|NCT00132678|592138917|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
163936672|NCT00132678|592138918|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
163936673|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
163936674|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
163936675|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
163936676|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
163936677|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
163936678|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
163936679|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
163936680|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
163936681|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
163936682|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
163936683|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
163936684|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
163936685|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
163936686|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
163936687|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
163936688|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
163936689|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
163936690|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
163936691|NCT00132678|592138916|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
163936692|NCT00132678|592138917|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
163936693|NCT00132678|592138918|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
164039825|NCT00910728|592505053|FG000|Overall Study|Lack of Efficacy|2|||
164039826|NCT00910728|592505054|FG001|Overall Study|Lack of Efficacy|3|||
164039827|NCT00910728|592505055|FG002|Overall Study|Lack of Efficacy|1|||
164039828|NCT00910728|592505056|FG003|Overall Study|Lack of Efficacy|2|||
163936694|NCT00953147|592138919|FG000|Overall Study|Adverse Event|8|||
163936695|NCT00953147|592138920|FG001|Overall Study|Adverse Event|16|||
163936696|NCT00953147|592138921|FG002|Overall Study|Adverse Event|6|||
164039829|NCT00910728|592505057|FG004|Overall Study|Lack of Efficacy|1|||
164039830|NCT00910728|592505058|FG005|Overall Study|Lack of Efficacy|0|||
164039831|NCT00910728|592505059|FG006|Overall Study|Lack of Efficacy|2|||
164039832|NCT00910728|592505060|FG007|Overall Study|Lack of Efficacy|2|||
164039833|NCT00910728|592505061|FG008|Overall Study|Lack of Efficacy|2|||
164039834|NCT00910728|592505053|FG000|Overall Study|Withdrawal by Subject|0|||
164039835|NCT00910728|592505054|FG001|Overall Study|Withdrawal by Subject|0|||
164039836|NCT00910728|592505055|FG002|Overall Study|Withdrawal by Subject|0|||
164039837|NCT00910728|592505056|FG003|Overall Study|Withdrawal by Subject|0|||
164039838|NCT00910728|592505057|FG004|Overall Study|Withdrawal by Subject|3|||
164039839|NCT00910728|592505058|FG005|Overall Study|Withdrawal by Subject|1|||
164039840|NCT00910728|592505059|FG006|Overall Study|Withdrawal by Subject|2|||
164039841|NCT00910728|592505060|FG007|Overall Study|Withdrawal by Subject|0|||
164039842|NCT00910728|592505061|FG008|Overall Study|Withdrawal by Subject|0|||
164039843|NCT00910728|592505053|FG000|Overall Study|(not specified)|2|||
164039844|NCT00910728|592505054|FG001|Overall Study|(not specified)|0|||
164039845|NCT00910728|592505055|FG002|Overall Study|(not specified)|1|||
164039846|NCT00910728|592505056|FG003|Overall Study|(not specified)|0|||
164039847|NCT00910728|592505057|FG004|Overall Study|(not specified)|1|||
164039848|NCT00910728|592505058|FG005|Overall Study|(not specified)|0|||
164039849|NCT00910728|592505059|FG006|Overall Study|(not specified)|0|||
164039850|NCT00910728|592505060|FG007|Overall Study|(not specified)|0|||
164039851|NCT00910728|592505061|FG008|Overall Study|(not specified)|0|||
164039852|NCT00910728|592505053|FG000|Overall Study|Adverse Event|2|||
164039853|NCT00910728|592505054|FG001|Overall Study|Adverse Event|0|||
164039854|NCT00910728|592505055|FG002|Overall Study|Adverse Event|1|||
164039855|NCT00910728|592505056|FG003|Overall Study|Adverse Event|1|||
164039856|NCT00910728|592505057|FG004|Overall Study|Adverse Event|0|||
164039857|NCT00910728|592505058|FG005|Overall Study|Adverse Event|0|||
164039858|NCT00910728|592505059|FG006|Overall Study|Adverse Event|2|||
164039859|NCT00910728|592505060|FG007|Overall Study|Adverse Event|1|||
164039860|NCT00910728|592505061|FG008|Overall Study|Adverse Event|1|||
164039861|NCT01225172|592505063|FG000|Overall Study|Subject decision to stop|1|||
164039862|NCT01225172|592505064|FG001|Overall Study|Subject decision to stop|0|||
164039863|NCT01225172|592505063|FG000|Overall Study|Subject request to discontinue treatment|3|||
164039864|NCT01225172|592505064|FG001|Overall Study|Subject request to discontinue treatment|1|||
164039865|NCT01225172|592505063|FG000|Overall Study|Subject no longer meets study criteria|1|||
164039866|NCT01225172|592505064|FG001|Overall Study|Subject no longer meets study criteria|0|||
164039867|NCT01225172|592505063|FG000|Overall Study|Withdrawal by Subject|1|||
164039868|NCT01225172|592505064|FG001|Overall Study|Withdrawal by Subject|0|||
164039869|NCT03404518|592505076|FG000|Overall Study|Lost to Follow-up|28|||
164039870|NCT03404518|592505077|FG001|Overall Study|Lost to Follow-up|30|||
164039871|NCT03404518|592505076|FG000|Overall Study|Protocol Violation|13|||
164039872|NCT03404518|592505077|FG001|Overall Study|Protocol Violation|6|||
164039873|NCT03693404|592505080|FG000|Overall Study|Withdrawal by Subject|1|||
164039874|NCT03693404|592505081|FG001|Overall Study|Withdrawal by Subject|0|||
164039875|NCT03693404|592505080|FG000|Overall Study|Lost to Follow-up|0|||
164039876|NCT03693404|592505081|FG001|Overall Study|Lost to Follow-up|5|||
164039877|NCT03693404|592505080|FG000|Overall Study|Excluded from Analysis|0|||
164039878|NCT03693404|592505081|FG001|Overall Study|Excluded from Analysis|1|||
164039879|NCT01176240|592505082|FG000|Study 306A|Lack of Efficacy|2|||
164039880|NCT01176240|592505083|FG001|Study 306A|Lack of Efficacy|1|||
164039881|NCT01176240|592505082|FG000|Study 306A|Protocol Violation|0|||
164039882|NCT01176240|592505083|FG001|Study 306A|Protocol Violation|1|||
164039883|NCT01176240|592505082|FG000|Study 306A|Withdrawal by Subject|0|||
164039884|NCT01176240|592505083|FG001|Study 306A|Withdrawal by Subject|1|||
164039885|NCT01176240|592505082|FG000|Study 306A|Stop due to diverse problems|1|||
164039886|NCT01176240|592505083|FG001|Study 306A|Stop due to diverse problems|0|||
164039887|NCT01176240|592505082|FG000|Study 306B|Lack of Efficacy|5|||
164039888|NCT01176240|592505083|FG001|Study 306B|Lack of Efficacy|3|||
164039889|NCT01176240|592505082|FG000|Study 306B|Adverse Event|10|||
164039890|NCT01176240|592505083|FG001|Study 306B|Adverse Event|5|||
164039891|NCT01176240|592505082|FG000|Study 306B|Protocol Violation|2|||
164039892|NCT01176240|592505083|FG001|Study 306B|Protocol Violation|3|||
164039893|NCT01176240|592505082|FG000|Study 306B|Withdrawal by Subject|4|||
164039894|NCT01176240|592505083|FG001|Study 306B|Withdrawal by Subject|1|||
164039895|NCT01176240|592505082|FG000|Study 306B|Physician Decision|2|||
164039896|NCT01176240|592505083|FG001|Study 306B|Physician Decision|1|||
164039897|NCT01176240|592505082|FG000|Study 306B|Supine Hypertension|1|||
164039898|NCT01176240|592505083|FG001|Study 306B|Supine Hypertension|2|||
164039899|NCT01176240|592505082|FG000|Study 306B|Lost to Follow-up|0|||
164039900|NCT01176240|592505083|FG001|Study 306B|Lost to Follow-up|1|||
164039901|NCT01176240|592505082|FG000|Study 306B|withdrew prior to dosing|2|||
164039902|NCT01176240|592505083|FG001|Study 306B|withdrew prior to dosing|1|||
164039903|NCT00807014|592505086|FG000|Overall Study|Participant Considered Disease Cured|13|||
164039904|NCT00807014|592505087|FG001|Overall Study|Participant Considered Disease Cured|2|||
164039905|NCT00807014|592505086|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
164039906|NCT00807014|592505087|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
164039907|NCT00807014|592505086|FG000|Overall Study|Protocol Violation|2|||
164039908|NCT00807014|592505087|FG001|Overall Study|Protocol Violation|8|||
164039909|NCT00807014|592505086|FG000|Overall Study|Adverse Event|0|||
164039910|NCT00807014|592505087|FG001|Overall Study|Adverse Event|2|||
164039911|NCT00807014|592505086|FG000|Overall Study|Lost to Follow-up|9|||
164039912|NCT00807014|592505087|FG001|Overall Study|Lost to Follow-up|7|||
164039913|NCT00807014|592505086|FG000|Overall Study|Recovery|1|||
164039914|NCT00807014|592505087|FG001|Overall Study|Recovery|0|||
164039915|NCT00807014|592505086|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
164039916|NCT00807014|592505087|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
164039917|NCT03175562|592505089|FG000|Overall Study|Adverse Event|1|||
164039918|NCT03175562|592505089|FG000|Overall Study|Lost to Follow-up|3|||
164039919|NCT03175562|592505089|FG000|Overall Study|Withdrawal by Subject|7|||
164039920|NCT03175562|592505089|FG000|Overall Study|Other (Not Specified)|5|||
164039921|NCT01946412|592505090|FG000|Overall Study|Adverse Event|1|||
164039922|NCT01946412|592505090|FG000|Overall Study|Non-Compliance|1|||
164039923|NCT01946412|592505090|FG000|Overall Study|Continued with commercial Kalydeco|2|||
164039924|NCT01946412|592505090|FG000|Overall Study|Difficulty in swallowing|1|||
164039925|NCT03565991|592507006|FG000|Overall Study|Other|11|||
164039926|NCT03565991|592507007|FG001|Overall Study|Other|0|||
164039927|NCT03565991|592507006|FG000|Overall Study|Global deterioration of health status|14|||
164039928|NCT03565991|592507007|FG001|Overall Study|Global deterioration of health status|4|||
164039929|NCT03565991|592507006|FG000|Overall Study|Withdrawal by Subject|2|||
164039930|NCT03565991|592507007|FG001|Overall Study|Withdrawal by Subject|6|||
164039931|NCT03565991|592507006|FG000|Overall Study|Progressive disease|121|||
164039932|NCT03565991|592507007|FG001|Overall Study|Progressive disease|29|||
164039933|NCT03565991|592507006|FG000|Overall Study|Death|3|||
164039934|NCT03565991|592507007|FG001|Overall Study|Death|0|||
164039935|NCT03565991|592507006|FG000|Overall Study|Adverse Event|7|||
164039936|NCT03565991|592507007|FG001|Overall Study|Adverse Event|2|||
164039937|NCT00106249|592507010|FG000|Overall Study|Lost to Follow-up|3|||
164039938|NCT00106249|592507011|FG001|Overall Study|Lost to Follow-up|2|||
164039939|NCT00948428|592507012|FG000|Overall Study|Withdrawal by Subject|6|||
164039940|NCT00948428|592507013|FG001|Overall Study|Withdrawal by Subject|12|||
164039941|NCT00948428|592507014|FG002|Overall Study|Withdrawal by Subject|7|||
164039942|NCT00948428|592507012|FG000|Overall Study|Adverse Event|6|||
164039943|NCT00948428|592507013|FG001|Overall Study|Adverse Event|3|||
164039944|NCT00948428|592507014|FG002|Overall Study|Adverse Event|0|||
164039945|NCT00948428|592507012|FG000|Overall Study|Lost to Follow-up|2|||
164039946|NCT00948428|592507013|FG001|Overall Study|Lost to Follow-up|1|||
164039947|NCT00948428|592507014|FG002|Overall Study|Lost to Follow-up|1|||
164039948|NCT00948428|592507012|FG000|Overall Study|Death|2|||
164039949|NCT00948428|592507013|FG001|Overall Study|Death|0|||
164039950|NCT00948428|592507014|FG002|Overall Study|Death|0|||
164039951|NCT00948428|592507012|FG000|Overall Study|Intercurrent Illness|1|||
164039952|NCT00948428|592507013|FG001|Overall Study|Intercurrent Illness|0|||
164039953|NCT00948428|592507014|FG002|Overall Study|Intercurrent Illness|0|||
164039954|NCT00948428|592507012|FG000|Overall Study|Non-compliance|1|||
164039955|NCT00948428|592507013|FG001|Overall Study|Non-compliance|2|||
164039956|NCT00948428|592507014|FG002|Overall Study|Non-compliance|0|||
164039957|NCT01495689|592507018|FG000|Overall Study|Death|0|||
164039958|NCT01495689|592507019|FG001|Overall Study|Death|1|||
164039959|NCT01495689|592507018|FG000|Overall Study|Withdrawal by Subject|3|||
164039960|NCT01495689|592507019|FG001|Overall Study|Withdrawal by Subject|0|||
164039961|NCT01495689|592507018|FG000|Overall Study|Lost to Follow-up|7|||
164039962|NCT01495689|592507019|FG001|Overall Study|Lost to Follow-up|6|||
164039963|NCT05516134|592507026|FG000|Overall Study|Lost to Follow-up|1|||
164039964|NCT05516134|592507027|FG001|Overall Study|Lost to Follow-up|0|||
164039965|NCT05516134|592507028|FG002|Overall Study|Lost to Follow-up|0|||
164039966|NCT01843205|592507039|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
164039967|NCT01843205|592507040|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
164039968|NCT01518309|592507041|FG000|Overall Study|Adverse Event|6|||
164039969|NCT01518309|592507041|FG000|Overall Study|Death|6|||
164039970|NCT01518309|592507041|FG000|Overall Study|Lack of Efficacy|7|||
164039971|NCT01518309|592507041|FG000|Overall Study|Withdrawal by Subject|6|||
164039972|NCT01518309|592507041|FG000|Overall Study|Physician Decision|3|||
164039973|NCT01518309|592507041|FG000|Overall Study|Sponsor Decision|2|||
164039974|NCT01518309|592507041|FG000|Overall Study|Not in Predefined Categories|9|||
164039975|NCT00839436|592507048|FG000|Overall Study|Developed exclusionary condition|1|||
164039976|NCT00839436|592507049|FG001|Overall Study|Developed exclusionary condition|0|||
164039977|NCT00839436|592507050|FG002|Overall Study|Developed exclusionary condition|0|||
164039978|NCT00839436|592507048|FG000|Overall Study|Withdrawal by Subject|0|||
164039979|NCT00839436|592507049|FG001|Overall Study|Withdrawal by Subject|1|||
164039980|NCT00839436|592507050|FG002|Overall Study|Withdrawal by Subject|0|||
164039981|NCT00839436|592507048|FG000|Overall Study|Study drug no longer available|0|||
164039982|NCT00839436|592507049|FG001|Overall Study|Study drug no longer available|0|||
164039983|NCT00839436|592507050|FG002|Overall Study|Study drug no longer available|1|||
164039984|NCT01440972|592507051|FG000|Overall Study|Withdrawal by Subject|3|||
164039985|NCT01440972|592507052|FG001|Overall Study|Withdrawal by Subject|2|||
164039986|NCT04072575|592507053|FG000|Overall Study|Physician Decision|1|||
164039987|NCT04072575|592507053|FG000|Overall Study|Adverse Event|7|||
164039988|NCT04072575|592507053|FG000|Overall Study|Withdrawal by Subject|14|||
164039989|NCT04072575|592507053|FG000|Overall Study|Other|2|||
164039990|NCT01599806|592507054|FG000|Overall Study|Lost to Follow-up|20|||
164039991|NCT01599806|592507055|FG001|Overall Study|Lost to Follow-up|20|||
163936697|NCT00953147|592138919|FG000|Overall Study|Protocol Violation|2|||
163936698|NCT00953147|592138920|FG001|Overall Study|Protocol Violation|8|||
163936699|NCT00953147|592138921|FG002|Overall Study|Protocol Violation|4|||
163936700|NCT00953147|592138919|FG000|Overall Study|Withdrawal by Subject|13|||
163936701|NCT00953147|592138920|FG001|Overall Study|Withdrawal by Subject|15|||
163936702|NCT00953147|592138921|FG002|Overall Study|Withdrawal by Subject|12|||
163936703|NCT00953147|592138919|FG000|Overall Study|Lost to Follow-up|8|||
163936704|NCT00953147|592138920|FG001|Overall Study|Lost to Follow-up|9|||
163936705|NCT00953147|592138921|FG002|Overall Study|Lost to Follow-up|4|||
163936706|NCT00953147|592138919|FG000|Overall Study|Physician Decision|2|||
163936707|NCT00953147|592138920|FG001|Overall Study|Physician Decision|7|||
163936708|NCT00953147|592138921|FG002|Overall Study|Physician Decision|3|||
163936709|NCT00953147|592138919|FG000|Overall Study|Other|4|||
163936710|NCT00953147|592138920|FG001|Overall Study|Other|11|||
163936711|NCT00953147|592138921|FG002|Overall Study|Other|13|||
163936712|NCT03838731|592138926|FG000|Overall Study|Pregnancy|0|||
163936713|NCT03838731|592138927|FG001|Overall Study|Pregnancy|1|||
163936714|NCT03838731|592138926|FG000|Overall Study|Withdrawal of consent|1|||
163936715|NCT03838731|592138927|FG001|Overall Study|Withdrawal of consent|0|||
163936716|NCT02412735|592138931|FG000|Overall Study|Adverse Event|0|||
163936717|NCT02412735|592138932|FG001|Overall Study|Adverse Event|1|||
163936718|NCT02412735|592138933|FG002|Overall Study|Adverse Event|2|||
163936719|NCT02412735|592138931|FG000|Overall Study|Withdrawal by Subject|23|||
163936720|NCT02412735|592138932|FG001|Overall Study|Withdrawal by Subject|27|||
163936721|NCT02412735|592138933|FG002|Overall Study|Withdrawal by Subject|22|||
163936722|NCT02412735|592138931|FG000|Overall Study|Investigator Decision|3|||
163936723|NCT02412735|592138932|FG001|Overall Study|Investigator Decision|3|||
163936724|NCT02412735|592138933|FG002|Overall Study|Investigator Decision|2|||
163936725|NCT02412735|592138931|FG000|Overall Study|Lost to Follow-up|17|||
163936726|NCT02412735|592138932|FG001|Overall Study|Lost to Follow-up|11|||
163936727|NCT02412735|592138933|FG002|Overall Study|Lost to Follow-up|18|||
163936728|NCT02412735|592138931|FG000|Overall Study|Reason not Specified|3|||
163936729|NCT02412735|592138932|FG001|Overall Study|Reason not Specified|2|||
163936730|NCT02412735|592138933|FG002|Overall Study|Reason not Specified|2|||
163936731|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
163936732|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
163936733|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
163936734|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
163936735|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Death|13|||
163936736|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Death|12|||
163936737|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Progression|257|||
163936738|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Progression|218|||
163936739|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
163936740|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
163936741|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
163936742|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
163936743|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
163936744|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
163936745|NCT01006980|592138934|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
163936746|NCT01006980|592138935|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
163936747|NCT01006980|592138934|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
163936748|NCT01006980|592138935|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
163936749|NCT01006980|592138934|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
163936750|NCT01006980|592138935|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
163936751|NCT01006980|592138934|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
163936752|NCT01006980|592138935|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
163936753|NCT01006980|592138934|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
163936754|NCT01006980|592138935|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
163936755|NCT01006980|592138934|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
163936756|NCT01006980|592138935|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
163936757|NCT04043143|592138936|FG000|Overall Study|Lost to Follow-up|5|||
163936758|NCT04043143|592138937|FG001|Overall Study|Lost to Follow-up|5|||
163936759|NCT04043143|592138936|FG000|Overall Study|screen failure|1|||
163936760|NCT04043143|592138937|FG001|Overall Study|screen failure|0|||
163936761|NCT04307940|592138938|FG000|Overall Study|Adverse Event|1|||
163936762|NCT04307940|592138939|FG001|Overall Study|Adverse Event|0|||
163936763|NCT04307940|592138940|FG002|Overall Study|Adverse Event|0|||
163936764|NCT04307940|592138938|FG000|Overall Study|Withdrawal by Subject|2|||
163936765|NCT04307940|592138939|FG001|Overall Study|Withdrawal by Subject|3|||
163936766|NCT04307940|592138940|FG002|Overall Study|Withdrawal by Subject|1|||
163936767|NCT04307940|592138938|FG000|Overall Study|Lost to Follow-up|2|||
163936768|NCT04307940|592138939|FG001|Overall Study|Lost to Follow-up|0|||
163936769|NCT04307940|592138940|FG002|Overall Study|Lost to Follow-up|1|||
163936770|NCT04996004|592138944|FG000|Phase I|Death|1|||
163936771|NCT04996004|592138945|FG001|Phase I|Death|2|||
163936772|NCT04996004|592138946|FG002|Phase I|Death|1|||
163936773|NCT04996004|592138947|FG003|Phase I|Death|0|||
163936774|NCT04996004|592138948|FG004|Phase I|Death|0|||
163936775|NCT04996004|592138949|FG005|Phase I|Death|0|||
163936776|NCT04996004|592138944|FG000|Phase I|Study terminated by sponsor|2|||
163936777|NCT04996004|592138945|FG001|Phase I|Study terminated by sponsor|1|||
163936778|NCT04996004|592138946|FG002|Phase I|Study terminated by sponsor|2|||
163936779|NCT04996004|592138947|FG003|Phase I|Study terminated by sponsor|0|||
163936780|NCT04996004|592138948|FG004|Phase I|Study terminated by sponsor|0|||
163936781|NCT04996004|592138949|FG005|Phase I|Study terminated by sponsor|0|||
163936782|NCT04996004|592138944|FG000|Phase II|Study terminated by sponsor|0|||
163936783|NCT04996004|592138945|FG001|Phase II|Study terminated by sponsor|0|||
163936784|NCT04996004|592138946|FG002|Phase II|Study terminated by sponsor|0|||
163936785|NCT04996004|592138947|FG003|Phase II|Study terminated by sponsor|20|||
163936786|NCT04996004|592138948|FG004|Phase II|Study terminated by sponsor|10|||
163936787|NCT04996004|592138949|FG005|Phase II|Study terminated by sponsor|10|||
163936788|NCT04996004|592138944|FG000|Phase II|Withdrawal by Subject|0|||
163936789|NCT04996004|592138945|FG001|Phase II|Withdrawal by Subject|0|||
163936790|NCT04996004|592138946|FG002|Phase II|Withdrawal by Subject|0|||
163936791|NCT04996004|592138947|FG003|Phase II|Withdrawal by Subject|0|||
163936792|NCT04996004|592138948|FG004|Phase II|Withdrawal by Subject|1|||
163936793|NCT04996004|592138949|FG005|Phase II|Withdrawal by Subject|2|||
163936794|NCT04996004|592138944|FG000|Phase II|Death|0|||
163936795|NCT04996004|592138945|FG001|Phase II|Death|0|||
163936796|NCT04996004|592138946|FG002|Phase II|Death|0|||
163936797|NCT04996004|592138947|FG003|Phase II|Death|12|||
163936798|NCT04996004|592138948|FG004|Phase II|Death|2|||
163936799|NCT04996004|592138949|FG005|Phase II|Death|9|||
163936800|NCT04996004|592138944|FG000|Phase II|Other|0|||
163936801|NCT04996004|592138945|FG001|Phase II|Other|0|||
163936802|NCT04996004|592138946|FG002|Phase II|Other|0|||
163936803|NCT04996004|592138947|FG003|Phase II|Other|0|||
163936804|NCT04996004|592138948|FG004|Phase II|Other|0|||
163936805|NCT04996004|592138949|FG005|Phase II|Other|1|||
163936806|NCT05543174|592138950|FG000|Overall Study|Ongoing|7|||
163936807|NCT04896008|592138951|FG000|Overall Study|Ongoing|70|||
163936808|NCT04896008|592138952|FG001|Overall Study|Ongoing|38|||
163936809|NCT04896008|592138951|FG000|Overall Study|Adverse Event|0|||
163936810|NCT04896008|592138952|FG001|Overall Study|Adverse Event|2|||
163936811|NCT04896008|592138951|FG000|Overall Study|Death|5|||
163936812|NCT04896008|592138952|FG001|Overall Study|Death|10|||
163936813|NCT04896008|592138951|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
163936814|NCT04896008|592138952|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
163936815|NCT04896008|592138951|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
163936816|NCT04896008|592138952|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
163936817|NCT04896008|592138951|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
163936818|NCT04896008|592138952|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
163936819|NCT04896008|592138951|FG000|Overall Study|Withdrawal by Subject|1|||
163936820|NCT04896008|592138952|FG001|Overall Study|Withdrawal by Subject|4|||
163936821|NCT04896008|592138951|FG000|Overall Study|Investigator Decision|2|||
163936822|NCT04896008|592138952|FG001|Overall Study|Investigator Decision|0|||
163936823|NCT04896008|592138951|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
163936824|NCT04896008|592138952|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
163936825|NCT03322540|592138955|FG000|Overall Study|Death|21|||
163936826|NCT03322540|592138956|FG001|Overall Study|Death|28|||
163936827|NCT03322540|592138955|FG000|Overall Study|Lost to Follow-up|0|||
163936828|NCT03322540|592138956|FG001|Overall Study|Lost to Follow-up|1|||
163936829|NCT03322540|592138955|FG000|Overall Study|Physician Decision|7|||
163936830|NCT03322540|592138956|FG001|Overall Study|Physician Decision|6|||
163936831|NCT03322540|592138955|FG000|Overall Study|Withdrawal by Subject|3|||
163936832|NCT03322540|592138956|FG001|Overall Study|Withdrawal by Subject|1|||
163936833|NCT03322540|592138955|FG000|Overall Study|Study terminated by sponsor|0|||
163936834|NCT03322540|592138956|FG001|Overall Study|Study terminated by sponsor|1|||
163936835|NCT01594827|592138957|FG000|Overall Study|Adverse Event|1|||
163936836|NCT01594827|592138958|FG001|Overall Study|Adverse Event|0|||
163936837|NCT01594827|592138957|FG000|Overall Study|Physician Decision|3|||
163936838|NCT01594827|592138958|FG001|Overall Study|Physician Decision|0|||
163936839|NCT03445533|592138959|FG000|Overall Study|Progressive Disease|48|||
163936840|NCT03445533|592138960|FG001|Overall Study|Progressive Disease|81|||
163936841|NCT03445533|592138959|FG000|Overall Study|Adverse Event|60|||
163936842|NCT03445533|592138960|FG001|Overall Study|Adverse Event|64|||
163936843|NCT03445533|592138959|FG000|Overall Study|Death|9|||
163936844|NCT03445533|592138960|FG001|Overall Study|Death|19|||
163936845|NCT03445533|592138959|FG000|Overall Study|Miscellaneous|0|||
163936846|NCT03445533|592138960|FG001|Overall Study|Miscellaneous|16|||
163936847|NCT03445533|592138959|FG000|Overall Study|Withdrawal by Subject|3|||
163936848|NCT03445533|592138960|FG001|Overall Study|Withdrawal by Subject|4|||
163936849|NCT03445533|592138959|FG000|Overall Study|Physician Decision|1|||
163936850|NCT03445533|592138960|FG001|Overall Study|Physician Decision|3|||
163936851|NCT03445533|592138959|FG000|Overall Study|Sponsor Decision|0|||
163936852|NCT03445533|592138960|FG001|Overall Study|Sponsor Decision|1|||
163840099|NCT04250337|591785745|FG000|Overall Study|Protocol Deviation|2|||
163840100|NCT04250337|591785746|FG001|Overall Study|Protocol Deviation|2|||
163840101|NCT04250337|591785745|FG000|Overall Study|Withdrawal by Subject|4|||
163840102|NCT04250337|591785746|FG001|Overall Study|Withdrawal by Subject|3|||
163840103|NCT00569803|591785749|FG000|Overall Study|Lost to Follow-up|1|||
163840104|NCT00569803|591785750|FG001|Overall Study|Lost to Follow-up|0|||
163840105|NCT00569803|591785751|FG002|Overall Study|Lost to Follow-up|0|||
163840106|NCT00569803|591785752|FG003|Overall Study|Lost to Follow-up|0|||
163840107|NCT00569803|591785753|FG004|Overall Study|Lost to Follow-up|0|||
163840108|NCT00569803|591785754|FG005|Overall Study|Lost to Follow-up|0|||
163840109|NCT00569803|591785755|FG006|Overall Study|Lost to Follow-up|0|||
163840110|NCT00569803|591785756|FG007|Overall Study|Lost to Follow-up|0|||
163840111|NCT00569803|591785749|FG000|Overall Study|injection syringe leaked during dosing|0|||
163840112|NCT00569803|591785750|FG001|Overall Study|injection syringe leaked during dosing|0|||
163840113|NCT00569803|591785751|FG002|Overall Study|injection syringe leaked during dosing|0|||
163840114|NCT00569803|591785752|FG003|Overall Study|injection syringe leaked during dosing|1|||
163840115|NCT00569803|591785753|FG004|Overall Study|injection syringe leaked during dosing|0|||
163840116|NCT00569803|591785754|FG005|Overall Study|injection syringe leaked during dosing|0|||
163840117|NCT00569803|591785755|FG006|Overall Study|injection syringe leaked during dosing|0|||
163840118|NCT00569803|591785756|FG007|Overall Study|injection syringe leaked during dosing|0|||
163840119|NCT00569803|591785749|FG000|Overall Study|Withdrawal by Subject|0|||
163840120|NCT00569803|591785750|FG001|Overall Study|Withdrawal by Subject|0|||
163840121|NCT00569803|591785751|FG002|Overall Study|Withdrawal by Subject|0|||
163840122|NCT00569803|591785752|FG003|Overall Study|Withdrawal by Subject|0|||
163840123|NCT00569803|591785753|FG004|Overall Study|Withdrawal by Subject|0|||
163840124|NCT00569803|591785754|FG005|Overall Study|Withdrawal by Subject|0|||
163840125|NCT00569803|591785755|FG006|Overall Study|Withdrawal by Subject|0|||
163840126|NCT00569803|591785756|FG007|Overall Study|Withdrawal by Subject|1|||
163840127|NCT01993823|591785757|FG000|Overall Study|Requested by the patient|6|||
163840128|NCT01993823|591785758|FG001|Overall Study|Requested by the patient|11|||
163840129|NCT01993823|591785757|FG000|Overall Study|Protocol Violation|0|||
163840130|NCT01993823|591785758|FG001|Overall Study|Protocol Violation|1|||
163840131|NCT01993823|591785757|FG000|Overall Study|Lost to Follow-up|1|||
163840132|NCT01993823|591785758|FG001|Overall Study|Lost to Follow-up|4|||
163840133|NCT01592695|591785764|FG000|Overall Study|Lost to Follow-up|8|||
163840134|NCT01592695|591785765|FG001|Overall Study|Lost to Follow-up|4|||
163840135|NCT00422799|591785766|FG000|Overall Study|Withdrawal by Subject|6|||
163840136|NCT00422799|591785766|FG000|Overall Study|Adverse Event|7|||
163840137|NCT03029780|591785770|FG000|Overall Study|Disease Progression|20|||
163840138|NCT03029780|591785771|FG001|Overall Study|Disease Progression|22|||
163840139|NCT03029780|591785770|FG000|Overall Study|Study Drug Toxicity|15|||
163840140|NCT03029780|591785771|FG001|Overall Study|Study Drug Toxicity|11|||
163840141|NCT03029780|591785770|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
163840142|NCT03029780|591785771|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
163840143|NCT03029780|591785770|FG000|Overall Study|Participant request to discontinue study treatment|4|||
163840144|NCT03029780|591785771|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163840145|NCT03029780|591785770|FG000|Overall Study|Maximum clinical benefit|1|||
163840146|NCT03029780|591785771|FG001|Overall Study|Maximum clinical benefit|0|||
163840147|NCT03029780|591785770|FG000|Overall Study|Participant no longer meets study criteria|0|||
163840148|NCT03029780|591785771|FG001|Overall Study|Participant no longer meets study criteria|1|||
163840149|NCT03029780|591785770|FG000|Overall Study|Other reasons|6|||
163840150|NCT03029780|591785771|FG001|Overall Study|Other reasons|6|||
163840151|NCT03029780|591785770|FG000|Overall Study|Not reported|1|||
163840152|NCT03029780|591785771|FG001|Overall Study|Not reported|1|||
163840153|NCT03029780|591785770|FG000|Overall Study|Death|2|||
163840154|NCT03029780|591785771|FG001|Overall Study|Death|6|||
163840155|NCT00178256|591785772|FG000|Overall Study|Adverse Event|2|||
163840156|NCT00178256|591785773|FG001|Overall Study|Adverse Event|0|||
164147702|NCT02006732|592902132|FG003|Overall Study|Lack of Efficacy|1|||
163840157|NCT00178256|591785774|FG002|Overall Study|Adverse Event|0|||
163840158|NCT00178256|591785775|FG003|Overall Study|Adverse Event|0|||
163840159|NCT00178256|591785772|FG000|Overall Study|Death|0|||
163840160|NCT00178256|591785773|FG001|Overall Study|Death|1|||
163840161|NCT00178256|591785774|FG002|Overall Study|Death|0|||
163840162|NCT00178256|591785775|FG003|Overall Study|Death|1|||
163840163|NCT00178256|591785772|FG000|Overall Study|Cancer progression|2|||
163840164|NCT00178256|591785773|FG001|Overall Study|Cancer progression|0|||
163840165|NCT00178256|591785774|FG002|Overall Study|Cancer progression|0|||
163840166|NCT00178256|591785775|FG003|Overall Study|Cancer progression|1|||
163840167|NCT03066622|591785776|FG000|Overall Study|Lost to Follow-up|24|||
163840168|NCT03066622|591785777|FG001|Overall Study|Lost to Follow-up|25|||
163840169|NCT03066622|591785776|FG000|Overall Study|Withdrawal by Subject|2|||
163840170|NCT03066622|591785777|FG001|Overall Study|Withdrawal by Subject|1|||
163840171|NCT01763788|591785778|FG000|Overall Study|Lost to Follow-up|0|||
163840172|NCT01763788|591785779|FG001|Overall Study|Lost to Follow-up|0|||
163840173|NCT01763788|591785780|FG002|Overall Study|Lost to Follow-up|1|||
163840174|NCT01763788|591785781|FG003|Overall Study|Lost to Follow-up|0|||
164039992|NCT01599806|592507054|FG000|Overall Study|Withdrawal by Subject|12|||
164039993|NCT01599806|592507055|FG001|Overall Study|Withdrawal by Subject|12|||
164039994|NCT01599806|592507054|FG000|Overall Study|Other Eligibility criteria|11|||
164039995|NCT01599806|592507055|FG001|Overall Study|Other Eligibility criteria|9|||
164039996|NCT02873208|592507056|FG000|Overall Study|Withdrawal by Subject|36|||
164039997|NCT02873208|592507056|FG000|Overall Study|Lost to Follow-up|22|||
164039998|NCT02873208|592507056|FG000|Overall Study|Adverse Event|15|||
164039999|NCT02873208|592507056|FG000|Overall Study|Non-compliance with study drug|12|||
164040000|NCT02873208|592507056|FG000|Overall Study|Protocol Violation|8|||
164040001|NCT02873208|592507056|FG000|Overall Study|Pregnancy|2|||
164040002|NCT02873208|592507056|FG000|Overall Study|Incarceration|1|||
164040003|NCT02873208|592507056|FG000|Overall Study|Lack of Efficacy|1|||
164040004|NCT02873208|592507056|FG000|Overall Study|Physician Decision|1|||
164040005|NCT00415584|592507057|FG000|Overall Study|Withdrawal by Subject|1|||
164040006|NCT00563368|592507058|FG000|Overall Study|Lost to Follow-up|14|||
164040007|NCT00563368|592507059|FG001|Overall Study|Lost to Follow-up|14|||
164040008|NCT00563368|592507060|FG002|Overall Study|Lost to Follow-up|12|||
164040009|NCT00563368|592507061|FG003|Overall Study|Lost to Follow-up|6|||
164040010|NCT00563368|592507062|FG004|Overall Study|Lost to Follow-up|9|||
164040011|NCT00563368|592507063|FG005|Overall Study|Lost to Follow-up|8|||
164040012|NCT00563368|592507064|FG006|Overall Study|Lost to Follow-up|9|||
164040013|NCT00563368|592507058|FG000|Overall Study|Adverse Event|3|||
164040014|NCT00563368|592507059|FG001|Overall Study|Adverse Event|4|||
164040015|NCT00563368|592507060|FG002|Overall Study|Adverse Event|5|||
164040016|NCT00563368|592507061|FG003|Overall Study|Adverse Event|9|||
164040017|NCT00563368|592507062|FG004|Overall Study|Adverse Event|6|||
164040018|NCT00563368|592507063|FG005|Overall Study|Adverse Event|10|||
164040019|NCT00563368|592507064|FG006|Overall Study|Adverse Event|17|||
164040020|NCT00563368|592507058|FG000|Overall Study|Withdrawal by Subject|11|||
164040021|NCT00563368|592507059|FG001|Overall Study|Withdrawal by Subject|6|||
164040022|NCT00563368|592507060|FG002|Overall Study|Withdrawal by Subject|5|||
164040023|NCT00563368|592507061|FG003|Overall Study|Withdrawal by Subject|7|||
164040024|NCT00563368|592507062|FG004|Overall Study|Withdrawal by Subject|8|||
164040025|NCT00563368|592507063|FG005|Overall Study|Withdrawal by Subject|5|||
164040026|NCT00563368|592507064|FG006|Overall Study|Withdrawal by Subject|4|||
164040027|NCT00563368|592507058|FG000|Overall Study|protocol non-compliance|1|||
164040028|NCT00563368|592507059|FG001|Overall Study|protocol non-compliance|1|||
164040029|NCT00563368|592507060|FG002|Overall Study|protocol non-compliance|2|||
164040030|NCT00563368|592507061|FG003|Overall Study|protocol non-compliance|1|||
164040031|NCT00563368|592507062|FG004|Overall Study|protocol non-compliance|0|||
164040032|NCT00563368|592507063|FG005|Overall Study|protocol non-compliance|1|||
164040033|NCT00563368|592507064|FG006|Overall Study|protocol non-compliance|3|||
164040034|NCT00563368|592507058|FG000|Overall Study|Pregnancy|1|||
164040035|NCT00563368|592507059|FG001|Overall Study|Pregnancy|0|||
164098769|NCT01693523|592726896|FG002|Overall Study|Chemotherapy was held|0|||
164098770|NCT01440283|592726899|FG000|Overall Study|Death|3|||
164098771|NCT01440283|592726899|FG000|Overall Study|Withdrawal by Subject|4|||
164098772|NCT01440283|592726899|FG000|Overall Study|Physician Decision|3|||
164098773|NCT01196052|592726900|FG000|Overall Study|Adverse Event|9|||
164098774|NCT01196052|592726900|FG000|Overall Study|Lost to Follow-up|1|||
164098775|NCT01196052|592726900|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
164098776|NCT01196052|592726900|FG000|Overall Study|Reason not Specified|5|||
164098777|NCT01196052|592726900|FG000|Overall Study|Withdrawal by Subject|6|||
164098778|NCT03603314|592726901|FG000|Overall Study|Lost to Follow-up|0|||
164098779|NCT03603314|592726902|FG001|Overall Study|Lost to Follow-up|3|||
164098780|NCT03603314|592726903|FG002|Overall Study|Lost to Follow-up|0|||
164098781|NCT03603314|592726901|FG000|Overall Study|Protocol Violation|0|||
164098782|NCT03603314|592726902|FG001|Overall Study|Protocol Violation|1|||
164098783|NCT03603314|592726903|FG002|Overall Study|Protocol Violation|0|||
164098784|NCT03603314|592726901|FG000|Overall Study|Adverse Event|2|||
164098785|NCT03603314|592726902|FG001|Overall Study|Adverse Event|0|||
164098786|NCT03603314|592726903|FG002|Overall Study|Adverse Event|0|||
164098787|NCT03603314|592726901|FG000|Overall Study|Physician Decision|1|||
164098788|NCT03603314|592726902|FG001|Overall Study|Physician Decision|1|||
164098789|NCT03603314|592726903|FG002|Overall Study|Physician Decision|0|||
164098790|NCT03603314|592726901|FG000|Overall Study|Withdrawal by Subject|4|||
164098791|NCT03603314|592726902|FG001|Overall Study|Withdrawal by Subject|5|||
164098792|NCT03603314|592726903|FG002|Overall Study|Withdrawal by Subject|3|||
164098793|NCT03603314|592726901|FG000|Overall Study|Other|0|||
164098794|NCT03603314|592726902|FG001|Overall Study|Other|1|||
164098795|NCT03603314|592726903|FG002|Overall Study|Other|0|||
164098796|NCT00436553|592726904|FG000|Overall Study|Adverse Event|4|||
164098797|NCT00436553|592726905|FG001|Overall Study|Adverse Event|3|||
164098798|NCT00436553|592726906|FG002|Overall Study|Adverse Event|4|||
164098799|NCT00436553|592726904|FG000|Overall Study|Death|3|||
164098800|NCT00436553|592726905|FG001|Overall Study|Death|1|||
164098801|NCT00436553|592726906|FG002|Overall Study|Death|3|||
164098802|NCT00436553|592726904|FG000|Overall Study|Lost to Follow-up|0|||
164098803|NCT00436553|592726905|FG001|Overall Study|Lost to Follow-up|2|||
164040036|NCT00563368|592507060|FG002|Overall Study|Pregnancy|1|||
164040037|NCT00563368|592507061|FG003|Overall Study|Pregnancy|2|||
164040038|NCT00563368|592507062|FG004|Overall Study|Pregnancy|1|||
164040039|NCT00563368|592507063|FG005|Overall Study|Pregnancy|2|||
164040040|NCT00563368|592507064|FG006|Overall Study|Pregnancy|0|||
164040041|NCT00563368|592507058|FG000|Overall Study|requirement for restricted medication|0|||
164040042|NCT00563368|592507059|FG001|Overall Study|requirement for restricted medication|0|||
164040043|NCT00563368|592507060|FG002|Overall Study|requirement for restricted medication|2|||
164040044|NCT00563368|592507061|FG003|Overall Study|requirement for restricted medication|0|||
164040045|NCT00563368|592507062|FG004|Overall Study|requirement for restricted medication|0|||
164040046|NCT00563368|592507063|FG005|Overall Study|requirement for restricted medication|0|||
164040047|NCT00563368|592507064|FG006|Overall Study|requirement for restricted medication|0|||
164040048|NCT00563368|592507058|FG000|Overall Study|Other|5|||
164040049|NCT00563368|592507059|FG001|Overall Study|Other|5|||
164040050|NCT00563368|592507060|FG002|Overall Study|Other|3|||
164040051|NCT00563368|592507061|FG003|Overall Study|Other|4|||
164040052|NCT00563368|592507062|FG004|Overall Study|Other|4|||
164040053|NCT00563368|592507063|FG005|Overall Study|Other|4|||
164040054|NCT00563368|592507064|FG006|Overall Study|Other|0|||
164040055|NCT01061567|592507065|FG000|Overall Study|Adverse Event|32|||
164040056|NCT01061567|592507065|FG000|Overall Study|Death|2|||
164040057|NCT01061567|592507065|FG000|Overall Study|Lack of Efficacy|3|||
164040058|NCT01061567|592507065|FG000|Overall Study|Lost to Follow-up|24|||
164098804|NCT00436553|592726906|FG002|Overall Study|Lost to Follow-up|0|||
164098805|NCT00436553|592726904|FG000|Overall Study|Protocol Violation|1|||
164098806|NCT00436553|592726905|FG001|Overall Study|Protocol Violation|0|||
164098807|NCT00436553|592726906|FG002|Overall Study|Protocol Violation|0|||
164098808|NCT00436553|592726904|FG000|Overall Study|Withdrawal by Subject|5|||
164040059|NCT01061567|592507065|FG000|Overall Study|Protocol Violation|1|||
164040060|NCT01061567|592507065|FG000|Overall Study|Withdrawal by Subject|11|||
164040061|NCT01061567|592507065|FG000|Overall Study|Other reason than stated above|3|||
164040062|NCT01831804|592507066|FG000|Overall Study|Adverse Event|0|||
164040063|NCT01831804|592507067|FG001|Overall Study|Adverse Event|0|||
164040064|NCT01831804|592507068|FG002|Overall Study|Adverse Event|0|||
164040065|NCT01831804|592507069|FG003|Overall Study|Adverse Event|0|||
164040066|NCT01831804|592507070|FG004|Overall Study|Adverse Event|0|||
164040067|NCT01831804|592507071|FG005|Overall Study|Adverse Event|0|||
164040068|NCT01831804|592507072|FG006|Overall Study|Adverse Event|1|||
164040069|NCT01831804|592507073|FG007|Overall Study|Adverse Event|0|||
164040070|NCT01831804|592507074|FG008|Overall Study|Adverse Event|1|||
164040071|NCT01831804|592507066|FG000|Overall Study|Protocol Violation|0|||
164040072|NCT01831804|592507067|FG001|Overall Study|Protocol Violation|0|||
164040073|NCT01831804|592507068|FG002|Overall Study|Protocol Violation|2|||
164098809|NCT00436553|592726905|FG001|Overall Study|Withdrawal by Subject|6|||
163840175|NCT03321006|591785782|FG000|Overall Study|Death|1|||
163840176|NCT03321006|591785783|FG001|Overall Study|Death|0|||
163840177|NCT03321006|591785782|FG000|Overall Study|Lack of Efficacy|1|||
163840178|NCT03321006|591785783|FG001|Overall Study|Lack of Efficacy|0|||
163840179|NCT02006121|591785786|FG000|Double Blind Phase|Adverse Event|6|||
163840180|NCT02006121|591785787|FG001|Double Blind Phase|Adverse Event|0|||
163840181|NCT02006121|591785786|FG000|Double Blind Phase|Lack of Efficacy|1|||
163840182|NCT02006121|591785787|FG001|Double Blind Phase|Lack of Efficacy|16|||
163840183|NCT02006121|591785786|FG000|Double Blind Phase|Withdrawal by Subject|3|||
163840184|NCT02006121|591785787|FG001|Double Blind Phase|Withdrawal by Subject|4|||
163840185|NCT02006121|591785786|FG000|Double Blind Phase|Non-compliance with study drug|1|||
163840186|NCT02006121|591785787|FG001|Double Blind Phase|Non-compliance with study drug|3|||
163840187|NCT02006121|591785786|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
163840188|NCT02006121|591785787|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
163840189|NCT02006121|591785786|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
163840190|NCT02006121|591785787|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
163840191|NCT02006121|591785786|FG000|Open Label Phase|Adverse Event|15|||
163840192|NCT02006121|591785787|FG001|Open Label Phase|Adverse Event|0|||
163840193|NCT02006121|591785786|FG000|Open Label Phase|Lack of Efficacy|2|||
163840194|NCT02006121|591785787|FG001|Open Label Phase|Lack of Efficacy|0|||
163840195|NCT02006121|591785786|FG000|Open Label Phase|Protocol Violation|2|||
163840196|NCT02006121|591785787|FG001|Open Label Phase|Protocol Violation|0|||
163840197|NCT02006121|591785786|FG000|Open Label Phase|Withdrawal by Subject|3|||
164040074|NCT01831804|592507069|FG003|Overall Study|Protocol Violation|0|||
164040075|NCT01831804|592507070|FG004|Overall Study|Protocol Violation|0|||
164040076|NCT01831804|592507071|FG005|Overall Study|Protocol Violation|0|||
164040077|NCT01831804|592507072|FG006|Overall Study|Protocol Violation|0|||
164040078|NCT01831804|592507073|FG007|Overall Study|Protocol Violation|0|||
164098810|NCT00436553|592726906|FG002|Overall Study|Withdrawal by Subject|3|||
164098811|NCT00064753|592726915|FG000|Overall Study|Death|251|||
163840198|NCT02006121|591785787|FG001|Open Label Phase|Withdrawal by Subject|0|||
163840199|NCT02006121|591785786|FG000|Open Label Phase|Non-compliance with study drug|3|||
163840200|NCT02006121|591785787|FG001|Open Label Phase|Non-compliance with study drug|0|||
164098812|NCT00064753|592726916|FG001|Overall Study|Death|242|||
164040079|NCT01831804|592507074|FG008|Overall Study|Protocol Violation|0|||
164040080|NCT01831804|592507066|FG000|Overall Study|Protocol defined stopping criteria|1|||
164040081|NCT01831804|592507067|FG001|Overall Study|Protocol defined stopping criteria|1|||
164040082|NCT01831804|592507068|FG002|Overall Study|Protocol defined stopping criteria|3|||
164040083|NCT01831804|592507069|FG003|Overall Study|Protocol defined stopping criteria|0|||
164040084|NCT01831804|592507070|FG004|Overall Study|Protocol defined stopping criteria|1|||
164040085|NCT01831804|592507071|FG005|Overall Study|Protocol defined stopping criteria|0|||
164040086|NCT01831804|592507072|FG006|Overall Study|Protocol defined stopping criteria|0|||
164040087|NCT01831804|592507073|FG007|Overall Study|Protocol defined stopping criteria|0|||
163936853|NCT03445533|592138959|FG000|Overall Study|Lost to Follow-up|0|||
163936854|NCT03445533|592138960|FG001|Overall Study|Lost to Follow-up|1|||
164040088|NCT01831804|592507074|FG008|Overall Study|Protocol defined stopping criteria|0|||
164040089|NCT01831804|592507066|FG000|Overall Study|Lost to Follow-up|0|||
164040090|NCT01831804|592507067|FG001|Overall Study|Lost to Follow-up|0|||
164040091|NCT01831804|592507068|FG002|Overall Study|Lost to Follow-up|1|||
164040092|NCT01831804|592507069|FG003|Overall Study|Lost to Follow-up|0|||
164040093|NCT01831804|592507070|FG004|Overall Study|Lost to Follow-up|0|||
164040094|NCT01831804|592507071|FG005|Overall Study|Lost to Follow-up|0|||
164040095|NCT01831804|592507072|FG006|Overall Study|Lost to Follow-up|0|||
164040096|NCT01831804|592507073|FG007|Overall Study|Lost to Follow-up|0|||
164040097|NCT01831804|592507074|FG008|Overall Study|Lost to Follow-up|1|||
163936855|NCT03445533|592138959|FG000|Overall Study|Never Received any Study Treatment|7|||
163936856|NCT03445533|592138960|FG001|Overall Study|Never Received any Study Treatment|4|||
163936857|NCT02153905|592138961|FG000|Overall Study|Death|1|||
163936858|NCT02153905|592138962|FG001|Overall Study|Death|0|||
163936859|NCT03334253|592138963|FG000|Overall Study|Withdrawal by Subject|1|||
163936860|NCT03334253|592138964|FG001|Overall Study|Withdrawal by Subject|0|||
163936861|NCT03334253|592138963|FG000|Overall Study|Lost to Follow-up|4|||
163936862|NCT03334253|592138964|FG001|Overall Study|Lost to Follow-up|3|||
163936863|NCT03334253|592138963|FG000|Overall Study|Moved residence|2|||
163936864|NCT03334253|592138964|FG001|Overall Study|Moved residence|2|||
163936865|NCT03274453|592138965|FG000|Overall Study|Lost to Follow-up|2|||
163936866|NCT03274453|592138966|FG001|Overall Study|Lost to Follow-up|5|||
163936867|NCT03274453|592138967|FG002|Overall Study|Lost to Follow-up|4|||
163936868|NCT03274453|592138968|FG003|Overall Study|Lost to Follow-up|1|||
163936869|NCT03274453|592138965|FG000|Overall Study|Physician Decision|2|||
163936870|NCT03274453|592138966|FG001|Overall Study|Physician Decision|0|||
163936871|NCT03274453|592138967|FG002|Overall Study|Physician Decision|0|||
163936872|NCT03274453|592138968|FG003|Overall Study|Physician Decision|3|||
163936873|NCT03274453|592138965|FG000|Overall Study|Surgery Cancelled|0|||
163936874|NCT03274453|592138966|FG001|Overall Study|Surgery Cancelled|1|||
163936875|NCT03274453|592138967|FG002|Overall Study|Surgery Cancelled|0|||
163936876|NCT03274453|592138968|FG003|Overall Study|Surgery Cancelled|0|||
163936877|NCT00968526|592138969|FG000|Overall Study|Adverse Event|2|||
163936878|NCT00968526|592138970|FG001|Overall Study|Adverse Event|0|||
163936879|NCT00968526|592138969|FG000|Overall Study|Migrated/moved from study area|1|||
163936880|NCT00968526|592138970|FG001|Overall Study|Migrated/moved from study area|0|||
163936881|NCT02493062|592138971|FG000|Overall Study|Physician Decision|12|||
163936882|NCT03926195|592138972|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
163936883|NCT03926195|592138973|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
163936884|NCT03926195|592138972|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
163936885|NCT03926195|592138973|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
163936886|NCT03926195|592138972|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
164040098|NCT01831804|592507066|FG000|Overall Study|Investigator discretion|0|||
164040099|NCT01831804|592507067|FG001|Overall Study|Investigator discretion|0|||
164040100|NCT01831804|592507068|FG002|Overall Study|Investigator discretion|0|||
164040101|NCT01831804|592507069|FG003|Overall Study|Investigator discretion|0|||
164040102|NCT01831804|592507070|FG004|Overall Study|Investigator discretion|1|||
164040103|NCT01831804|592507071|FG005|Overall Study|Investigator discretion|0|||
163936887|NCT03926195|592138973|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
164040104|NCT01831804|592507072|FG006|Overall Study|Investigator discretion|0|||
164040105|NCT01831804|592507073|FG007|Overall Study|Investigator discretion|1|||
163936888|NCT03926195|592138972|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
163936889|NCT03926195|592138973|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
163936890|NCT03926195|592138972|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
163936891|NCT03926195|592138973|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
163936892|NCT03926195|592138972|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
163936893|NCT03926195|592138973|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
163936894|NCT03054337|592138974|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
163936895|NCT03054337|592138975|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
163936896|NCT03054337|592138976|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
164040106|NCT01831804|592507074|FG008|Overall Study|Investigator discretion|0|||
164040107|NCT01831804|592507066|FG000|Overall Study|Withdrew Consent|0|||
164040108|NCT01831804|592507067|FG001|Overall Study|Withdrew Consent|1|||
164040109|NCT01831804|592507068|FG002|Overall Study|Withdrew Consent|0|||
164040110|NCT01831804|592507069|FG003|Overall Study|Withdrew Consent|0|||
164040111|NCT01831804|592507070|FG004|Overall Study|Withdrew Consent|0|||
164040112|NCT01831804|592507071|FG005|Overall Study|Withdrew Consent|0|||
164040113|NCT01831804|592507072|FG006|Overall Study|Withdrew Consent|0|||
164040114|NCT01831804|592507073|FG007|Overall Study|Withdrew Consent|2|||
164040115|NCT01831804|592507074|FG008|Overall Study|Withdrew Consent|0|||
164040116|NCT00114218|592507088|FG000|Overall Study|Wrong Cell Type|2|||
164040117|NCT00114218|592507088|FG000|Overall Study|Wrong Primary|1|||
164040118|NCT00114218|592507088|FG000|Overall Study|Never Treated|1|||
164040119|NCT03168555|592507089|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
164040120|NCT03168555|592507089|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
164040121|NCT03168555|592507089|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
164040122|NCT03168555|592507089|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
164040123|NCT02959190|592507091|FG000|Open Label|Adverse Event|5|||
164040124|NCT02959190|592507092|FG001|Open Label|Adverse Event|7|||
164040125|NCT02959190|592507093|FG002|Open Label|Adverse Event|3|||
164040126|NCT02959190|592507094|FG003|Open Label|Adverse Event|4|||
164040127|NCT02959190|592507091|FG000|Open Label|Pregnancy|0|||
164040128|NCT02959190|592507092|FG001|Open Label|Pregnancy|1|||
164040129|NCT02959190|592507093|FG002|Open Label|Pregnancy|0|||
164040130|NCT02959190|592507094|FG003|Open Label|Pregnancy|0|||
164040131|NCT02959190|592507091|FG000|Open Label|Withdrawal by Subject|2|||
164040132|NCT02959190|592507092|FG001|Open Label|Withdrawal by Subject|8|||
164040133|NCT02959190|592507093|FG002|Open Label|Withdrawal by Subject|0|||
164040134|NCT02959190|592507094|FG003|Open Label|Withdrawal by Subject|0|||
164040135|NCT02959190|592507091|FG000|Open Label|Physician Decision|0|||
164040136|NCT02959190|592507092|FG001|Open Label|Physician Decision|0|||
164040137|NCT02959190|592507093|FG002|Open Label|Physician Decision|1|||
164040138|NCT02959190|592507094|FG003|Open Label|Physician Decision|0|||
164040139|NCT02959190|592507091|FG000|Open Label|Protocol Violation|0|||
164040140|NCT02959190|592507092|FG001|Open Label|Protocol Violation|0|||
164040141|NCT02959190|592507093|FG002|Open Label|Protocol Violation|0|||
164040142|NCT02959190|592507094|FG003|Open Label|Protocol Violation|2|||
164040143|NCT02959190|592507091|FG000|Post Treatment Follow Up|Adverse Event|1|||
164040144|NCT02959190|592507092|FG001|Post Treatment Follow Up|Adverse Event|1|||
164040145|NCT02959190|592507093|FG002|Post Treatment Follow Up|Adverse Event|0|||
164040146|NCT02959190|592507094|FG003|Post Treatment Follow Up|Adverse Event|0|||
164040147|NCT02959190|592507091|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
164040148|NCT02959190|592507092|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
164040149|NCT02959190|592507093|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
164040150|NCT02959190|592507094|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
164040151|NCT00615459|592507096|FG000|Period I|Adverse Event|2|||
164040152|NCT00615459|592507097|FG001|Period I|Adverse Event|0|||
164040153|NCT00615459|592507098|FG002|Period I|Adverse Event|1|||
164040154|NCT00615459|592507099|FG003|Period I|Adverse Event|0|||
164040155|NCT00615459|592507096|FG000|Period I|Subject withdrew consent|1|||
164040156|NCT00615459|592507097|FG001|Period I|Subject withdrew consent|0|||
164040157|NCT00615459|592507098|FG002|Period I|Subject withdrew consent|0|||
164040158|NCT00615459|592507099|FG003|Period I|Subject withdrew consent|1|||
164040159|NCT00615459|592507096|FG000|Period I|Abnormal test procedure results|1|||
164040160|NCT00615459|592507097|FG001|Period I|Abnormal test procedure results|1|||
164040161|NCT00615459|592507098|FG002|Period I|Abnormal test procedure results|1|||
164040162|NCT00615459|592507099|FG003|Period I|Abnormal test procedure results|0|||
164040163|NCT00615459|592507096|FG000|Period II|Adverse Event|1|||
164040164|NCT00615459|592507097|FG001|Period II|Adverse Event|0|||
164040165|NCT00615459|592507098|FG002|Period II|Adverse Event|0|||
164040166|NCT00615459|592507099|FG003|Period II|Adverse Event|0|||
164040167|NCT00615459|592507096|FG000|Period II|Lost to Follow-up|0|||
164040168|NCT00615459|592507097|FG001|Period II|Lost to Follow-up|0|||
164040169|NCT00615459|592507098|FG002|Period II|Lost to Follow-up|0|||
164040170|NCT00615459|592507099|FG003|Period II|Lost to Follow-up|1|||
164040171|NCT00615459|592507096|FG000|Period III|Adverse Event|0|||
163840201|NCT04498247|591785791|FG000|Overall Study|Lost to Follow-up|0|||
164040172|NCT00615459|592507097|FG001|Period III|Adverse Event|1|||
164040173|NCT00615459|592507098|FG002|Period III|Adverse Event|0|||
164040174|NCT00615459|592507099|FG003|Period III|Adverse Event|0|||
164040175|NCT00615459|592507096|FG000|Period III|Administrative problems|0|||
164040176|NCT00615459|592507097|FG001|Period III|Administrative problems|1|||
164040177|NCT00615459|592507098|FG002|Period III|Administrative problems|1|||
164040178|NCT00615459|592507099|FG003|Period III|Administrative problems|0|||
164040179|NCT00615459|592507096|FG000|Period III|Unsatisfactory therapeutic effect|0|||
164040180|NCT00615459|592507097|FG001|Period III|Unsatisfactory therapeutic effect|1|||
164040181|NCT00615459|592507098|FG002|Period III|Unsatisfactory therapeutic effect|0|||
164040182|NCT00615459|592507099|FG003|Period III|Unsatisfactory therapeutic effect|0|||
164040183|NCT01235507|592507100|FG000|Overall Study|Adverse Event|1|||
164040184|NCT01235507|592507100|FG000|Overall Study|Withdrawal by Subject|1|||
164040185|NCT02738580|592507103|FG000|Overall Study|Adverse Event|1|||
164040186|NCT02738580|592507104|FG001|Overall Study|Adverse Event|0|||
164040187|NCT02738580|592507103|FG000|Overall Study|Lack of Efficacy|3|||
164040188|NCT02738580|592507104|FG001|Overall Study|Lack of Efficacy|2|||
164040189|NCT02738580|592507103|FG000|Overall Study|Withdrawal by Subject|0|||
164040190|NCT02738580|592507104|FG001|Overall Study|Withdrawal by Subject|1|||
164040191|NCT02738580|592507103|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
164040192|NCT02738580|592507104|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
164040193|NCT00617591|592507108|FG000|Overall Study|Withdrew consent during Induction|4|||
164040194|NCT00617591|592507108|FG000|Overall Study|Withdrew consent during Maintenance|6|||
164040195|NCT00588523|592507111|FG000|Overall Study|Not treated|3|||
164040196|NCT02910219|592507114|FG000|Overall Study|Withdrawal by Subject|1|||
164040197|NCT02910219|592507115|FG001|Overall Study|Withdrawal by Subject|1|||
164040198|NCT01425749|592507116|FG000|Overall Study|progression of melanoma|0|||
164040199|NCT01425749|592507117|FG001|Overall Study|progression of melanoma|1|||
164040200|NCT02096042|592507120|FG000|Overall Study|Disease Progression|1|||
164040201|NCT02096042|592507121|FG001|Overall Study|Disease Progression|0|||
164040202|NCT02096042|592507122|FG002|Overall Study|Disease Progression|0|||
164040203|NCT00701441|592507126|FG000|Overall Study|failure in cpap compliance|0|||
164040204|NCT00701441|592507127|FG001|Overall Study|failure in cpap compliance|4|||
164040205|NCT03034057|592507128|FG000|Overall Study|Withdrawal by Subject|10|||
164040206|NCT03034057|592507128|FG000|Overall Study|Protocol Violation|1|||
164040207|NCT03034057|592507128|FG000|Overall Study|Not defined|2|||
164040208|NCT03034057|592507128|FG000|Overall Study|Lost to Follow-up|19|||
164040209|NCT03034057|592507128|FG000|Overall Study|Adverse Event|22|||
164040210|NCT03034057|592507128|FG000|Overall Study|Medication error without associated AE|1|||
163936897|NCT03054337|592138977|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
163936898|NCT03054337|592138978|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
163936899|NCT03054337|592138979|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
163936900|NCT01327612|592138980|FG000|Overall Study|Withdrawal by Subject|0|||
163936901|NCT01327612|592138981|FG001|Overall Study|Withdrawal by Subject|0|||
163936902|NCT01327612|592138982|FG002|Overall Study|Withdrawal by Subject|0|||
163936903|NCT01327612|592138983|FG003|Overall Study|Withdrawal by Subject|0|||
163936904|NCT01327612|592138984|FG004|Overall Study|Withdrawal by Subject|0|||
163936905|NCT01327612|592138985|FG005|Overall Study|Withdrawal by Subject|1|||
163936906|NCT01327612|592138986|FG006|Overall Study|Withdrawal by Subject|0|||
163936907|NCT01327612|592138980|FG000|Overall Study|Disease Progression|1|||
163936908|NCT01327612|592138981|FG001|Overall Study|Disease Progression|1|||
163936909|NCT01327612|592138982|FG002|Overall Study|Disease Progression|1|||
163936910|NCT01327612|592138983|FG003|Overall Study|Disease Progression|0|||
163936911|NCT01327612|592138984|FG004|Overall Study|Disease Progression|1|||
163936912|NCT01327612|592138985|FG005|Overall Study|Disease Progression|2|||
163936913|NCT01327612|592138986|FG006|Overall Study|Disease Progression|2|||
163936914|NCT01327612|592138980|FG000|Overall Study|Administrative Decision|0|||
163936915|NCT01327612|592138981|FG001|Overall Study|Administrative Decision|0|||
163936916|NCT01327612|592138982|FG002|Overall Study|Administrative Decision|0|||
163936917|NCT01327612|592138983|FG003|Overall Study|Administrative Decision|1|||
163936918|NCT01327612|592138984|FG004|Overall Study|Administrative Decision|0|||
163936919|NCT01327612|592138985|FG005|Overall Study|Administrative Decision|0|||
163936920|NCT01327612|592138986|FG006|Overall Study|Administrative Decision|0|||
163936921|NCT01327612|592138980|FG000|Overall Study|Death|0|||
163936922|NCT01327612|592138981|FG001|Overall Study|Death|0|||
163936923|NCT01327612|592138982|FG002|Overall Study|Death|0|||
163936924|NCT01327612|592138983|FG003|Overall Study|Death|0|||
163936925|NCT01327612|592138984|FG004|Overall Study|Death|1|||
163936926|NCT01327612|592138985|FG005|Overall Study|Death|0|||
163936927|NCT01327612|592138986|FG006|Overall Study|Death|0|||
163936928|NCT01967069|592138990|FG000|Overall Study|Adverse Event|2|||
163936929|NCT01967069|592138991|FG001|Overall Study|Adverse Event|2|||
163936930|NCT01967069|592138990|FG000|Overall Study|Lost to Follow-up|5|||
163936931|NCT01967069|592138991|FG001|Overall Study|Lost to Follow-up|2|||
163936932|NCT01967069|592138990|FG000|Overall Study|Withdrawal by Subject|1|||
163936933|NCT01967069|592138991|FG001|Overall Study|Withdrawal by Subject|3|||
163936934|NCT01967069|592138990|FG000|Overall Study|Lack of Efficacy|0|||
164040211|NCT03339401|592507129|FG000|Overall Study|Death|2|||
163936935|NCT01967069|592138991|FG001|Overall Study|Lack of Efficacy|1|||
164040212|NCT03339401|592507130|FG001|Overall Study|Death|1|||
164040213|NCT03339401|592507129|FG000|Overall Study|Withdrawal by Subject|2|||
164040214|NCT03339401|592507130|FG001|Overall Study|Withdrawal by Subject|0|||
164040215|NCT03339401|592507129|FG000|Overall Study|Study terminated|4|||
164040216|NCT03339401|592507130|FG001|Overall Study|Study terminated|3|||
164040217|NCT03339401|592507129|FG000|Overall Study|Investigator Decision|1|||
164040218|NCT03339401|592507130|FG001|Overall Study|Investigator Decision|0|||
163936936|NCT00609947|592138992|FG000|Overall Study|Death|1|||
163936937|NCT05569421|592138994|FG000|Overall Study|Withdrawal by Subject|1|||
163936938|NCT05569421|592138995|FG001|Overall Study|Withdrawal by Subject|0|||
163936939|NCT05569421|592138996|FG002|Overall Study|Withdrawal by Subject|0|||
163936940|NCT00874731|592138998|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
163936941|NCT00874731|592138999|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
163936942|NCT00874731|592139000|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
163936943|NCT00874731|592138998|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
164040219|NCT00718523|592507131|FG000|Overall Study|Withdrawal by Subject|5|||
164040220|NCT00718523|592507132|FG001|Overall Study|Withdrawal by Subject|7|||
164040221|NCT00718523|592507131|FG000|Overall Study|Death|13|||
164040222|NCT00718523|592507132|FG001|Overall Study|Death|17|||
164040223|NCT01313078|592507133|FG000|Overall Study|Death|1|||
164040224|NCT01313078|592507133|FG000|Overall Study|Discontinued study drug|1|||
164040225|NCT01313078|592507133|FG000|Overall Study|Withdrawal by Subject|1|||
164040226|NCT01068717|592507137|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
164040227|NCT01068717|592507138|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
164040228|NCT01068717|592507139|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
164040229|NCT01068717|592507140|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
164040230|NCT01822223|592507141|FG000|Overall Study|Death|0|||
164040231|NCT01822223|592507142|FG001|Overall Study|Death|1|||
164040232|NCT04209400|592507145|FG000|Overall Study|Withdrawal by Subject|0|||
164040233|NCT04209400|592507146|FG001|Overall Study|Withdrawal by Subject|1|||
164040234|NCT01449955|592507150|FG000|Overall Study|Withdrawal by Subject|1|||
164040235|NCT01449955|592507151|FG001|Overall Study|Withdrawal by Subject|2|||
164040236|NCT05041062|592507153|FG000|Overall Study|Adverse Event|2|||
164040237|NCT04968353|592507154|FG000|Overall Study|Non-compliance|1|||
164040238|NCT04968353|592507155|FG001|Overall Study|Non-compliance|0|||
164040239|NCT04968353|592507156|FG002|Overall Study|Non-compliance|2|||
164040240|NCT04968353|592507157|FG003|Overall Study|Non-compliance|0|||
164040241|NCT00318370|592507158|FG000|Period 1|Lack of Efficacy|5|||
164040242|NCT00318370|592507159|FG001|Period 1|Lack of Efficacy|0|||
164040243|NCT00318370|592507160|FG002|Period 1|Lack of Efficacy|0|||
164040244|NCT00318370|592507158|FG000|Period 1|Physician Decision|1|||
164040245|NCT00318370|592507159|FG001|Period 1|Physician Decision|0|||
164040246|NCT00318370|592507160|FG002|Period 1|Physician Decision|0|||
164040247|NCT00318370|592507158|FG000|Period 1|Withdrawal by Subject|1|||
164040248|NCT00318370|592507159|FG001|Period 1|Withdrawal by Subject|0|||
164040249|NCT00318370|592507160|FG002|Period 1|Withdrawal by Subject|0|||
164040250|NCT00318370|592507158|FG000|Period 2|Adverse Event|0|||
164040251|NCT00318370|592507159|FG001|Period 2|Adverse Event|3|||
164040252|NCT00318370|592507160|FG002|Period 2|Adverse Event|0|||
164040253|NCT00318370|592507158|FG000|Period 2|Lack of Efficacy|0|||
164040254|NCT00318370|592507159|FG001|Period 2|Lack of Efficacy|5|||
164040255|NCT00318370|592507160|FG002|Period 2|Lack of Efficacy|0|||
164040256|NCT00318370|592507158|FG000|Period 2|Physician Decision|0|||
164040257|NCT00318370|592507159|FG001|Period 2|Physician Decision|1|||
164040258|NCT00318370|592507160|FG002|Period 2|Physician Decision|0|||
164040259|NCT00318370|592507158|FG000|Period 2|Withdrawal by Subject|0|||
164040260|NCT00318370|592507159|FG001|Period 2|Withdrawal by Subject|1|||
164040261|NCT00318370|592507160|FG002|Period 2|Withdrawal by Subject|0|||
164040262|NCT00318370|592507158|FG000|Period 2|Other|0|||
164040263|NCT00318370|592507159|FG001|Period 2|Other|1|||
164040264|NCT00318370|592507160|FG002|Period 2|Other|0|||
164040265|NCT00318370|592507158|FG000|Period 3|Adverse Event|0|||
164040266|NCT00318370|592507159|FG001|Period 3|Adverse Event|0|||
164040267|NCT00318370|592507160|FG002|Period 3|Adverse Event|1|||
164040268|NCT00318370|592507158|FG000|Period 3|Lack of Efficacy|0|||
164040269|NCT00318370|592507159|FG001|Period 3|Lack of Efficacy|0|||
164040270|NCT00318370|592507160|FG002|Period 3|Lack of Efficacy|24|||
164040271|NCT00318370|592507158|FG000|Period 3|Death|0|||
164040272|NCT00318370|592507159|FG001|Period 3|Death|0|||
164040273|NCT00318370|592507160|FG002|Period 3|Death|1|||
164040274|NCT00318370|592507158|FG000|Period 3|Physician Decision|0|||
164040275|NCT00318370|592507159|FG001|Period 3|Physician Decision|0|||
164040276|NCT00318370|592507160|FG002|Period 3|Physician Decision|1|||
164040277|NCT00318370|592507158|FG000|Period 3|Withdrawal by Subject|0|||
164040278|NCT00318370|592507159|FG001|Period 3|Withdrawal by Subject|0|||
164040279|NCT00318370|592507160|FG002|Period 3|Withdrawal by Subject|3|||
164040280|NCT00318370|592507158|FG000|Period 3|Other|0|||
164040281|NCT00318370|592507159|FG001|Period 3|Other|0|||
164040282|NCT00318370|592507160|FG002|Period 3|Other|3|||
164040283|NCT00651313|592507161|FG000|Overall Study|Adverse Event|0|||
164040284|NCT00651313|592507162|FG001|Overall Study|Adverse Event|1|||
164040285|NCT00651313|592507161|FG000|Overall Study|Withdrawal by Subject|3|||
164040286|NCT00651313|592507162|FG001|Overall Study|Withdrawal by Subject|1|||
164040287|NCT00651313|592507161|FG000|Overall Study|Lost to Follow-up|1|||
164040288|NCT00651313|592507162|FG001|Overall Study|Lost to Follow-up|1|||
164040289|NCT00651313|592507161|FG000|Overall Study|Adminstrative Discontinuation|2|||
164040290|NCT00651313|592507162|FG001|Overall Study|Adminstrative Discontinuation|3|||
164040291|NCT03307629|592507168|FG000|Overall Study|Withdrawal by Subject|0|||
164040292|NCT03307629|592507169|FG001|Overall Study|Withdrawal by Subject|0|||
164040293|NCT03307629|592507170|FG002|Overall Study|Withdrawal by Subject|0|||
164040294|NCT03307629|592507171|FG003|Overall Study|Withdrawal by Subject|2|||
164040295|NCT03307629|592507168|FG000|Overall Study|Disease Progression|0|||
164040296|NCT03307629|592507169|FG001|Overall Study|Disease Progression|0|||
164040297|NCT03307629|592507170|FG002|Overall Study|Disease Progression|0|||
164040298|NCT03307629|592507171|FG003|Overall Study|Disease Progression|3|||
164040299|NCT03307629|592507168|FG000|Overall Study|Death|0|||
164040300|NCT03307629|592507169|FG001|Overall Study|Death|3|||
164040301|NCT03307629|592507170|FG002|Overall Study|Death|0|||
164040302|NCT03307629|592507171|FG003|Overall Study|Death|1|||
164040303|NCT02853032|592507176|FG000|Overall Study|Adverse Event|4|||
164040304|NCT02853032|592507177|FG001|Overall Study|Adverse Event|0|||
164040305|NCT02853032|592507176|FG000|Overall Study|Withdrawal by Subject|3|||
164040306|NCT02853032|592507177|FG001|Overall Study|Withdrawal by Subject|1|||
164040307|NCT02853032|592507176|FG000|Overall Study|Requested to withdraw from all treatment|2|||
164040308|NCT02853032|592507177|FG001|Overall Study|Requested to withdraw from all treatment|2|||
164040309|NCT02146833|592507178|FG000|Overall Study|Death|10|||
164040310|NCT02146833|592507178|FG000|Overall Study|No longer consented to study treatment|1|||
164040311|NCT00676208|592507181|FG000|Overall Study|Lost to Follow-up|0|||
164040312|NCT00676208|592507182|FG001|Overall Study|Lost to Follow-up|2|||
164040313|NCT00676208|592507181|FG000|Overall Study|Incomplete data|2|||
164040314|NCT00676208|592507182|FG001|Overall Study|Incomplete data|4|||
164040315|NCT03700736|592507185|FG000|Overall Study|Pregnancy|1|||
164040316|NCT03700736|592507186|FG001|Overall Study|Pregnancy|1|||
164040317|NCT03700736|592507185|FG000|Overall Study|Withdrawal by Subject|2|||
164040318|NCT03700736|592507186|FG001|Overall Study|Withdrawal by Subject|6|||
164040319|NCT00642018|592507187|FG000|Overall Study|Adverse Event|11|||
164040320|NCT00642018|592507188|FG001|Overall Study|Adverse Event|36|||
164040321|NCT00642018|592507187|FG000|Overall Study|Withdrawal by Subject|4|||
164040322|NCT00642018|592507188|FG001|Overall Study|Withdrawal by Subject|10|||
164040323|NCT00642018|592507187|FG000|Overall Study|Progressive Disease|13|||
164040324|NCT00642018|592507188|FG001|Overall Study|Progressive Disease|18|||
164040325|NCT00642018|592507187|FG000|Overall Study|Physician Decision|0|||
164040326|NCT00642018|592507188|FG001|Overall Study|Physician Decision|10|||
164040327|NCT00642018|592507187|FG000|Overall Study|Protocol Violation|0|||
164040328|NCT00642018|592507188|FG001|Overall Study|Protocol Violation|1|||
164040329|NCT00642018|592507187|FG000|Overall Study|Death|0|||
164040330|NCT00642018|592507188|FG001|Overall Study|Death|3|||
164040331|NCT00642018|592507187|FG000|Overall Study|Entry Criteria Not Met|0|||
164040332|NCT00642018|592507188|FG001|Overall Study|Entry Criteria Not Met|1|||
164040333|NCT01410799|592507189|FG000|Overall Study|PI decision|13|||
164040334|NCT00617656|592507190|FG000|Overall Study|Inclusion error|4|||
164040335|NCT00617656|592507191|FG001|Overall Study|Inclusion error|4|||
164040336|NCT00617656|592507192|FG002|Overall Study|Inclusion error|0|||
164040337|NCT00617656|592507193|FG003|Overall Study|Inclusion error|0|||
164040338|NCT00617656|592507190|FG000|Overall Study|Missing data|44|||
164040339|NCT00617656|592507191|FG001|Overall Study|Missing data|30|||
164040340|NCT00617656|592507192|FG002|Overall Study|Missing data|13|||
164040341|NCT00617656|592507193|FG003|Overall Study|Missing data|6|||
164040342|NCT00617656|592507190|FG000|Overall Study|Withdrawal by Subject|0|||
164040343|NCT00617656|592507191|FG001|Overall Study|Withdrawal by Subject|2|||
164040344|NCT00617656|592507192|FG002|Overall Study|Withdrawal by Subject|0|||
164040345|NCT00617656|592507193|FG003|Overall Study|Withdrawal by Subject|0|||
164040346|NCT00254163|592508754|FG000|Overall Study|Adverse Event|29|||
164040347|NCT00254163|592508755|FG001|Overall Study|Adverse Event|26|||
164040348|NCT00254163|592508754|FG000|Overall Study|Patient request/withdrew consent|6|||
164040349|NCT00254163|592508755|FG001|Overall Study|Patient request/withdrew consent|4|||
164040350|NCT00254163|592508754|FG000|Overall Study|Investigator request|1|||
164040351|NCT00254163|592508755|FG001|Overall Study|Investigator request|3|||
164040352|NCT00254163|592508754|FG000|Overall Study|Failed entry|1|||
164040353|NCT00254163|592508755|FG001|Overall Study|Failed entry|3|||
164040354|NCT00254163|592508754|FG000|Overall Study|Progressive disease|0|||
164040355|NCT00254163|592508755|FG001|Overall Study|Progressive disease|1|||
164040356|NCT00254163|592508754|FG000|Overall Study|Death|0|||
164040357|NCT00254163|592508755|FG001|Overall Study|Death|1|||
164040358|NCT00254163|592508754|FG000|Overall Study|Other|8|||
164040359|NCT00254163|592508755|FG001|Overall Study|Other|8|||
164040360|NCT01119963|592508756|FG000|Overall Study|Lost to Follow-up|1|||
164040361|NCT01119963|592508757|FG001|Overall Study|Lost to Follow-up|1|||
164040362|NCT01355497|592508758|FG000|Overall Study|Death|19|||
164040363|NCT01355497|592508759|FG001|Overall Study|Death|18|||
164040364|NCT01355497|592508758|FG000|Overall Study|Lost to Follow-up|3|||
164040365|NCT01355497|592508759|FG001|Overall Study|Lost to Follow-up|0|||
164040366|NCT01355497|592508758|FG000|Overall Study|Protocol Violation|0|||
163840202|NCT04498247|591785792|FG001|Overall Study|Lost to Follow-up|0|||
163840203|NCT04498247|591785793|FG002|Overall Study|Lost to Follow-up|0|||
163840204|NCT04498247|591785794|FG003|Overall Study|Lost to Follow-up|1|||
163840205|NCT04498247|591785795|FG004|Overall Study|Lost to Follow-up|0|||
163840206|NCT04498247|591785796|FG005|Overall Study|Lost to Follow-up|0|||
163840207|NCT04498247|591785797|FG006|Overall Study|Lost to Follow-up|0|||
164040367|NCT01355497|592508759|FG001|Overall Study|Protocol Violation|1|||
164040368|NCT01355497|592508758|FG000|Overall Study|other-not provided|9|||
164040369|NCT01355497|592508759|FG001|Overall Study|other-not provided|4|||
164040370|NCT01355497|592508758|FG000|Overall Study|Withdrawal by Subject|12|||
164040371|NCT01355497|592508759|FG001|Overall Study|Withdrawal by Subject|20|||
164040372|NCT01355497|592508758|FG000|Overall Study|noncompliance|1|||
164040373|NCT01355497|592508759|FG001|Overall Study|noncompliance|2|||
163936944|NCT00874731|592138999|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
163936945|NCT00874731|592139000|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
163936946|NCT00874731|592138998|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
163936947|NCT00874731|592138999|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
163936948|NCT00874731|592139000|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
163936949|NCT01736540|592139001|FG000|Overall Study|Did not complete scan within 45 days|2|||
163936950|NCT01736540|592139001|FG000|Overall Study|Death|1|||
163936951|NCT01736540|592139001|FG000|Overall Study|Abnormal test procedure|1|||
163936952|NCT01736540|592139001|FG000|Overall Study|Withdrawal by Subject|5|||
163936953|NCT01736540|592139001|FG000|Overall Study|Protocol Violation|1|||
163936954|NCT01736540|592139001|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
163936955|NCT01736540|592139001|FG000|Overall Study|No show for MRI appointment|1|||
163936956|NCT01736540|592139001|FG000|Overall Study|Unable to make MRI appointment|3|||
163936957|NCT00581477|592139002|FG000|Overall Study|Physician Decision|2|||
163936958|NCT00790205|592139008|FG000|Overall Study|Lost to Follow-up|61|||
163936959|NCT00790205|592139009|FG001|Overall Study|Lost to Follow-up|71|||
163936960|NCT00790205|592139008|FG000|Overall Study|Withdrawal by Subject|299|||
163936961|NCT00790205|592139009|FG001|Overall Study|Withdrawal by Subject|363|||
163936962|NCT02643628|592139012|FG000|Overall Study|Lost to Follow-up|1|||
163936963|NCT02643628|592139013|FG001|Overall Study|Lost to Follow-up|4|||
163936964|NCT02643628|592139012|FG000|Overall Study|Withdrawal by Subject|0|||
163936965|NCT02643628|592139013|FG001|Overall Study|Withdrawal by Subject|1|||
163936966|NCT02643628|592139012|FG000|Overall Study|Relocated out of state|0|||
163936967|NCT02643628|592139013|FG001|Overall Study|Relocated out of state|1|||
163936968|NCT05143138|592139014|FG000|Overall Study|Death|5|||
163936969|NCT05143138|592139015|FG001|Overall Study|Death|35|||
163936970|NCT05143138|592139016|FG002|Overall Study|Death|1|||
163936971|NCT05143138|592139014|FG000|Overall Study|Lost to Follow-up|2|||
163936972|NCT05143138|592139015|FG001|Overall Study|Lost to Follow-up|4|||
163936973|NCT05143138|592139016|FG002|Overall Study|Lost to Follow-up|0|||
163936974|NCT05143138|592139014|FG000|Overall Study|withdrawal|1|||
163936975|NCT05143138|592139015|FG001|Overall Study|withdrawal|1|||
163936976|NCT05143138|592139016|FG002|Overall Study|withdrawal|0|||
163936977|NCT04245345|592139019|FG000|Overall Study|Death|1|||
163936978|NCT04245345|592139019|FG000|Overall Study|Exited prior to implant|5|||
163936979|NCT04245345|592139019|FG000|Overall Study|Exited prior to 1-month|9|||
163936980|NCT04245345|592139019|FG000|Overall Study|Missed 1-month visit|3|||
163936981|NCT04245345|592139019|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
163936982|NCT04245345|592139019|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
163936983|NCT04805073|592139027|FG000|Overall Study|study personnel not available|2|||
163936984|NCT04805073|592139028|FG001|Overall Study|study personnel not available|0|||
163936985|NCT04805073|592139027|FG000|Overall Study|spinal anesthesia failure|0|||
163936986|NCT04805073|592139028|FG001|Overall Study|spinal anesthesia failure|1|||
163936987|NCT04805073|592139027|FG000|Overall Study|Lost to Follow-up|0|||
163936988|NCT04805073|592139028|FG001|Overall Study|Lost to Follow-up|2|||
163936989|NCT00422734|592139032|FG000|Overall Study|Physician Decision|1|||
163936990|NCT00422734|592139033|FG001|Overall Study|Physician Decision|1|||
163936991|NCT00422734|592139032|FG000|Overall Study|Protocol Violation|1|||
163936992|NCT00422734|592139033|FG001|Overall Study|Protocol Violation|6|||
163936993|NCT00422734|592139032|FG000|Overall Study|Withdrawal by Subject|12|||
163936994|NCT00422734|592139033|FG001|Overall Study|Withdrawal by Subject|8|||
163936995|NCT00422734|592139032|FG000|Overall Study|Adverse Event|0|||
163936996|NCT00422734|592139033|FG001|Overall Study|Adverse Event|3|||
163936997|NCT00422734|592139032|FG000|Overall Study|Partner Decision|0|||
163936998|NCT00422734|592139033|FG001|Overall Study|Partner Decision|3|||
163936999|NCT00848484|592139034|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
163937000|NCT00848484|592139035|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
163937001|NCT00848484|592139034|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
163937002|NCT00848484|592139035|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
163937003|NCT00848484|592139034|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
163937004|NCT00848484|592139035|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
163937005|NCT00848484|592139034|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
163937006|NCT00848484|592139035|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
163937007|NCT00848484|592139034|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
163937008|NCT00848484|592139035|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
163937009|NCT01081886|592139037|FG000|Overall Study|Study termination|11|||
163937010|NCT01081886|592139038|FG001|Overall Study|Study termination|13|||
163937011|NCT02567708|592139039|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
163937012|NCT02567708|592139040|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
163937013|NCT02567708|592139039|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
163937014|NCT02567708|592139040|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
163937015|NCT02567708|592139039|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
164040374|NCT01355497|592508758|FG000|Overall Study|progressive disease|11|||
164040375|NCT01355497|592508759|FG001|Overall Study|progressive disease|8|||
164040376|NCT01355497|592508758|FG000|Overall Study|Adverse Event|11|||
163840208|NCT04498247|591785798|FG007|Overall Study|Lost to Follow-up|0|||
163840209|NCT04498247|591785791|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
163840210|NCT04498247|591785792|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
163840211|NCT04498247|591785793|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
163840212|NCT04498247|591785794|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
163840213|NCT04498247|591785795|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
163840214|NCT04498247|591785796|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
163840215|NCT04498247|591785797|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
163840216|NCT04498247|591785798|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
163937016|NCT02567708|592139040|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
163937017|NCT02567708|592139039|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
163937018|NCT02567708|592139040|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
163937019|NCT00706654|592139041|FG000|Conversion Phase|Lost to Follow-up|4|||
163937020|NCT00706654|592139042|FG001|Conversion Phase|Lost to Follow-up|0|||
163937021|NCT00706654|592139043|FG002|Conversion Phase|Lost to Follow-up|0|||
163937022|NCT00706654|592139044|FG003|Conversion Phase|Lost to Follow-up|0|||
163937023|NCT00706654|592139041|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
163937024|NCT00706654|592139042|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
163937025|NCT00706654|592139043|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
163937026|NCT00706654|592139044|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
163937027|NCT00706654|592139041|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
163937028|NCT00706654|592139042|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
163937029|NCT00706654|592139043|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
163937030|NCT00706654|592139044|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
163937031|NCT00706654|592139041|FG000|Conversion Phase|Withdrawn by Investigator|14|||
163937032|NCT00706654|592139042|FG001|Conversion Phase|Withdrawn by Investigator|0|||
163937033|NCT00706654|592139043|FG002|Conversion Phase|Withdrawn by Investigator|0|||
163937034|NCT00706654|592139044|FG003|Conversion Phase|Withdrawn by Investigator|0|||
163937035|NCT00706654|592139041|FG000|Conversion Phase|Withdrew Consent|38|||
163937036|NCT00706654|592139042|FG001|Conversion Phase|Withdrew Consent|0|||
163937037|NCT00706654|592139043|FG002|Conversion Phase|Withdrew Consent|0|||
163937038|NCT00706654|592139044|FG003|Conversion Phase|Withdrew Consent|0|||
163937039|NCT00706654|592139041|FG000|Conversion Phase|Adverse Event|18|||
163937040|NCT00706654|592139042|FG001|Conversion Phase|Adverse Event|0|||
163937041|NCT00706654|592139043|FG002|Conversion Phase|Adverse Event|0|||
163937042|NCT00706654|592139044|FG003|Conversion Phase|Adverse Event|0|||
163937043|NCT00706654|592139041|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
163937044|NCT00706654|592139042|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163937045|NCT00706654|592139043|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163937046|NCT00706654|592139044|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
163937047|NCT00706654|592139041|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
163937048|NCT00706654|592139042|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163937049|NCT00706654|592139043|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163937050|NCT00706654|592139044|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
163937051|NCT00706654|592139041|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
163937052|NCT00706654|592139042|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
163937053|NCT00706654|592139043|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
163937054|NCT00706654|592139044|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
163937055|NCT00706654|592139041|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
163937056|NCT00706654|592139042|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
163937057|NCT00706654|592139043|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
163937058|NCT00706654|592139044|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
163937059|NCT00706654|592139041|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
163937060|NCT00706654|592139042|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163937061|NCT00706654|592139043|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163937062|NCT00706654|592139044|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
163937063|NCT00706654|592139041|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
163937064|NCT00706654|592139042|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163937065|NCT00706654|592139043|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163937066|NCT00706654|592139044|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
163937067|NCT00706654|592139041|FG000|Oral Stabilization Phase|Withdrew consent|55|||
163937068|NCT00706654|592139042|FG001|Oral Stabilization Phase|Withdrew consent|0|||
163937069|NCT00706654|592139043|FG002|Oral Stabilization Phase|Withdrew consent|0|||
163937070|NCT00706654|592139044|FG003|Oral Stabilization Phase|Withdrew consent|0|||
163937071|NCT00706654|592139041|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
163937072|NCT00706654|592139042|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
163937073|NCT00706654|592139043|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
163937074|NCT00706654|592139044|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
163937075|NCT00706654|592139041|FG000|Oral Stabilization Phase|Adverse Event|21|||
163937076|NCT00706654|592139042|FG001|Oral Stabilization Phase|Adverse Event|0|||
164040377|NCT01355497|592508759|FG001|Overall Study|Adverse Event|10|||
163937077|NCT00706654|592139043|FG002|Oral Stabilization Phase|Adverse Event|0|||
163937078|NCT00706654|592139044|FG003|Oral Stabilization Phase|Adverse Event|0|||
163937079|NCT00706654|592139041|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
163937080|NCT00706654|592139042|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163937081|NCT00706654|592139043|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163937082|NCT00706654|592139044|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
163937083|NCT00706654|592139041|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
163937084|NCT00706654|592139042|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163937085|NCT00706654|592139043|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163937086|NCT00706654|592139044|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
163937087|NCT00706654|592139041|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
163937088|NCT00706654|592139042|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
163937089|NCT00706654|592139043|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
163937090|NCT00706654|592139044|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
163937091|NCT00706654|592139041|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
163937092|NCT00706654|592139042|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
163937093|NCT00706654|592139043|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
163937094|NCT00706654|592139044|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
163937095|NCT00706654|592139041|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
163937096|NCT00706654|592139042|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
163937097|NCT00706654|592139043|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
163937098|NCT00706654|592139044|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
163937099|NCT00706654|592139041|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
163937100|NCT00706654|592139042|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
163937101|NCT00706654|592139043|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
163937102|NCT00706654|592139044|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
163937103|NCT00706654|592139041|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
163937104|NCT00706654|592139042|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
163937105|NCT00706654|592139043|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
163937106|NCT00706654|592139044|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
163937107|NCT00706654|592139041|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
163937108|NCT00706654|592139042|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
163937109|NCT00706654|592139043|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
163937110|NCT00706654|592139044|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
163937111|NCT00706654|592139041|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
163937112|NCT00706654|592139042|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
163937113|NCT00706654|592139043|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
163937114|NCT00706654|592139044|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
163937115|NCT00706654|592139041|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
163937116|NCT00706654|592139042|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
163937117|NCT00706654|592139043|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
163937118|NCT00706654|592139044|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
163937119|NCT02975102|592139048|FG000|Overall Study|Adverse Event|2|||
163937120|NCT02975102|592139049|FG001|Overall Study|Adverse Event|1|||
163937121|NCT05262751|592139052|FG000|Washout Period 2|Adverse Event|1|||
163937122|NCT05262751|592139053|FG001|Washout Period 2|Adverse Event|0|||
163937123|NCT05262751|592139054|FG002|Washout Period 2|Adverse Event|0|||
163937124|NCT05262751|592139055|FG003|Washout Period 2|Adverse Event|0|||
163937125|NCT05262751|592139056|FG004|Washout Period 2|Adverse Event|0|||
163937126|NCT05262751|592139057|FG005|Washout Period 2|Adverse Event|0|||
163937127|NCT05262751|592139052|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
163937128|NCT05262751|592139053|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
163937129|NCT05262751|592139054|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
164040378|NCT02579863|592508761|FG000|Overall Study|Final Disposition Unknown|2|||
164040379|NCT02579863|592508762|FG001|Overall Study|Final Disposition Unknown|1|||
164040380|NCT02579863|592508761|FG000|Overall Study|Adverse Event|18|||
164040381|NCT02579863|592508762|FG001|Overall Study|Adverse Event|11|||
164040382|NCT02579863|592508761|FG000|Overall Study|Death|31|||
164040383|NCT02579863|592508762|FG001|Overall Study|Death|29|||
164040384|NCT02579863|592508761|FG000|Overall Study|Lost to Follow-up|2|||
164040385|NCT02579863|592508762|FG001|Overall Study|Lost to Follow-up|1|||
164040386|NCT02579863|592508761|FG000|Overall Study|Physician Decision|1|||
164040387|NCT02579863|592508762|FG001|Overall Study|Physician Decision|2|||
163937130|NCT05262751|592139055|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
163937131|NCT05262751|592139056|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
163937132|NCT05262751|592139057|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
163937133|NCT02956837|592139060|FG000|Overall Study|Serious Adverse Events|0|||
163937134|NCT02956837|592139061|FG001|Overall Study|Serious Adverse Events|1|||
164040388|NCT02579863|592508761|FG000|Overall Study|Screen Failure|0|||
164040389|NCT02579863|592508762|FG001|Overall Study|Screen Failure|2|||
163937135|NCT02956837|592139062|FG002|Overall Study|Serious Adverse Events|0|||
163937136|NCT02956837|592139063|FG003|Overall Study|Serious Adverse Events|0|||
163937137|NCT02956837|592139060|FG000|Overall Study|Withdrawal by Subject|0|||
163937138|NCT02956837|592139061|FG001|Overall Study|Withdrawal by Subject|1|||
163937139|NCT02956837|592139062|FG002|Overall Study|Withdrawal by Subject|0|||
163937140|NCT02956837|592139063|FG003|Overall Study|Withdrawal by Subject|3|||
163937141|NCT02956837|592139060|FG000|Overall Study|Lost to Follow-up|0|||
163937142|NCT02956837|592139061|FG001|Overall Study|Lost to Follow-up|1|||
163937143|NCT02956837|592139062|FG002|Overall Study|Lost to Follow-up|2|||
163937144|NCT02956837|592139063|FG003|Overall Study|Lost to Follow-up|0|||
163937145|NCT01727505|592139071|FG000|First 24 Hours|Adverse Event|0|||
163937146|NCT01727505|592139072|FG001|First 24 Hours|Adverse Event|1|||
163937147|NCT01727505|592139071|FG000|Second 24 Hours|Missing data|0|||
163937148|NCT01727505|592139072|FG001|Second 24 Hours|Missing data|1|||
163937149|NCT01154140|592139073|FG000|Overall Study|Death|71|||
163937150|NCT01154140|592139074|FG001|Overall Study|Death|81|||
163937151|NCT01154140|592139073|FG000|Overall Study|Lost to Follow-up|4|||
163937152|NCT01154140|592139074|FG001|Overall Study|Lost to Follow-up|5|||
163937153|NCT01154140|592139073|FG000|Overall Study|Withdrawal by Subject|12|||
163937154|NCT01154140|592139074|FG001|Overall Study|Withdrawal by Subject|13|||
163937155|NCT01154140|592139073|FG000|Overall Study|Other|3|||
163937156|NCT01154140|592139074|FG001|Overall Study|Other|1|||
163937157|NCT01154140|592139073|FG000|Overall Study|Randomized but not treated|1|||
163937158|NCT01154140|592139074|FG001|Overall Study|Randomized but not treated|2|||
163937159|NCT00358644|592139075|FG000|Overall Study|Progressive Disease|21|||
163937160|NCT00358644|592139075|FG000|Overall Study|Adverse Event|7|||
163937161|NCT00358644|592139075|FG000|Overall Study|Death|11|||
163937162|NCT00358644|592139075|FG000|Overall Study|Withdrawal by Subject|4|||
163937163|NCT00358644|592139075|FG000|Overall Study|Physician Decision|6|||
163937164|NCT00358644|592139075|FG000|Overall Study|Patient not eligible for study|1|||
163937165|NCT00368875|592139076|FG000|Overall Study|Adverse Event|0|||
163937166|NCT00368875|592139077|FG001|Overall Study|Adverse Event|12|||
163937167|NCT00368875|592139076|FG000|Overall Study|Progressive disease|3|||
163937168|NCT00368875|592139077|FG001|Overall Study|Progressive disease|27|||
163937169|NCT00368875|592139076|FG000|Overall Study|Withdrawal by Subject|2|||
163937170|NCT00368875|592139077|FG001|Overall Study|Withdrawal by Subject|6|||
163937171|NCT00368875|592139076|FG000|Overall Study|Other Reason|0|||
163937172|NCT00368875|592139077|FG001|Overall Study|Other Reason|2|||
163937173|NCT00368875|592139076|FG000|Overall Study|Alternative Therapy|1|||
163937174|NCT00368875|592139077|FG001|Overall Study|Alternative Therapy|1|||
163937175|NCT03327831|592139078|FG000|Overall Study|Lost to Follow-up|2|||
163937176|NCT02595372|592139079|FG000|Overall Study|Adverse Event|6|||
163937177|NCT02595372|592139079|FG000|Overall Study|Physician Decision|2|||
163937178|NCT02595372|592139079|FG000|Overall Study|Disease Progression|1|||
163937179|NCT00401258|592139082|FG000|Overall Study|Adverse Event|7|||
163937180|NCT02706405|592140706|FG000|Overall Study|Death|3|||
163937181|NCT02706405|592140707|FG001|Overall Study|Death|2|||
163937182|NCT02706405|592140708|FG002|Overall Study|Death|0|||
163937183|NCT02706405|592140709|FG003|Overall Study|Death|1|||
163937184|NCT02706405|592140710|FG004|Overall Study|Death|0|||
163937185|NCT02706405|592140711|FG005|Overall Study|Death|0|||
163937186|NCT02706405|592140712|FG006|Overall Study|Death|3|||
163937187|NCT02706405|592140713|FG007|Overall Study|Death|4|||
163937188|NCT02706405|592140706|FG000|Overall Study|Disease progression|0|||
163937189|NCT02706405|592140707|FG001|Overall Study|Disease progression|0|||
163937190|NCT02706405|592140708|FG002|Overall Study|Disease progression|0|||
163937191|NCT02706405|592140709|FG003|Overall Study|Disease progression|0|||
163937192|NCT02706405|592140710|FG004|Overall Study|Disease progression|0|||
163937193|NCT02706405|592140711|FG005|Overall Study|Disease progression|0|||
163937194|NCT02706405|592140712|FG006|Overall Study|Disease progression|0|||
163937195|NCT02706405|592140713|FG007|Overall Study|Disease progression|1|||
163937196|NCT02706405|592140706|FG000|Overall Study|Pt moved to new therapy|0|||
164040390|NCT02579863|592508761|FG000|Overall Study|Study Terminated at Selected Sites|82|||
164040391|NCT02579863|592508762|FG001|Overall Study|Study Terminated at Selected Sites|88|||
163937197|NCT02706405|592140707|FG001|Overall Study|Pt moved to new therapy|0|||
163937198|NCT02706405|592140708|FG002|Overall Study|Pt moved to new therapy|0|||
163937199|NCT02706405|592140709|FG003|Overall Study|Pt moved to new therapy|0|||
163937200|NCT02706405|592140710|FG004|Overall Study|Pt moved to new therapy|0|||
163937201|NCT02706405|592140711|FG005|Overall Study|Pt moved to new therapy|1|||
163937202|NCT02706405|592140712|FG006|Overall Study|Pt moved to new therapy|0|||
163937203|NCT02706405|592140713|FG007|Overall Study|Pt moved to new therapy|1|||
163937204|NCT02706405|592140706|FG000|Overall Study|Physician Decision|1|||
163937205|NCT02706405|592140707|FG001|Overall Study|Physician Decision|0|||
163937206|NCT02706405|592140708|FG002|Overall Study|Physician Decision|0|||
163937207|NCT02706405|592140709|FG003|Overall Study|Physician Decision|0|||
163937208|NCT02706405|592140710|FG004|Overall Study|Physician Decision|0|||
163937209|NCT02706405|592140711|FG005|Overall Study|Physician Decision|0|||
163937210|NCT02706405|592140712|FG006|Overall Study|Physician Decision|0|||
163937211|NCT02706405|592140713|FG007|Overall Study|Physician Decision|0|||
163937212|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
164040392|NCT02579863|592508761|FG000|Overall Study|Withdrawal by Subject|20|||
164040393|NCT02579863|592508762|FG001|Overall Study|Withdrawal by Subject|20|||
164040394|NCT00038142|592508767|FG000|Overall Study|Ineligible|1|||
164040395|NCT00038142|592508768|FG001|Overall Study|Ineligible|0|||
164040396|NCT00038142|592508767|FG000|Overall Study|Progressive Disease|11|||
164040397|NCT00038142|592508768|FG001|Overall Study|Progressive Disease|7|||
164040398|NCT00038142|592508767|FG000|Overall Study|Death|1|||
164040399|NCT00038142|592508768|FG001|Overall Study|Death|0|||
164040400|NCT00038142|592508767|FG000|Overall Study|Adverse Event|1|||
164040401|NCT00038142|592508768|FG001|Overall Study|Adverse Event|0|||
164040402|NCT00038142|592508767|FG000|Overall Study|Unknown Reason|8|||
164040403|NCT00038142|592508768|FG001|Overall Study|Unknown Reason|0|||
164040404|NCT00809614|592508769|FG000|Overall Study|Lack of Efficacy|2|||
164040405|NCT00809614|592508770|FG001|Overall Study|Lack of Efficacy|3|||
164040406|NCT00809614|592508769|FG000|Overall Study|Withdrawal by Subject|1|||
164040407|NCT00809614|592508770|FG001|Overall Study|Withdrawal by Subject|1|||
164040408|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Death|3|||
164040409|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Death|0|||
164040410|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Death|0|||
164040411|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Death|0|||
164040412|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Death|0|||
164040413|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
164040414|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
164040415|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
164040416|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
164040417|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
164040418|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164040419|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
164040420|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
164040421|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164040422|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
164040423|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Other|0|||
164040424|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Other|0|||
164040425|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Other|1|||
164040426|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Other|0|||
164040427|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Other|0|||
164040428|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
164040429|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
164040430|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
164040431|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
164040432|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
164040433|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
164040434|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
164040435|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
164040436|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
164040437|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
164040438|NCT01224106|592508771|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164040439|NCT01224106|592508772|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164040440|NCT01224106|592508773|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164040441|NCT01224106|592508774|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164040442|NCT01224106|592508775|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164040443|NCT01224106|592508771|FG000|Open-Label Extension (OLE) Phase|Death|0|||
163937213|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
163937214|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
163937215|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
163937216|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163937217|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
163937218|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
163937219|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
163937220|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
163937221|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
163937222|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
163937223|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
163937224|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
163937225|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
163937226|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
163937227|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
163937228|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
163937229|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
163937230|NCT00603525|592140718|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
163937231|NCT00603525|592140719|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
163937232|NCT00603525|592140720|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
163937233|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
163937234|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
163937235|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
163937236|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
163937237|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
163937238|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
163937239|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
163937240|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
163937241|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
163937242|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
163937243|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
163937244|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
163937245|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
163937246|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
163937247|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
163937248|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
163937249|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
163937250|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
163937251|NCT00603525|592140718|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
163937252|NCT00603525|592140719|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
163937253|NCT00603525|592140720|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
163937254|NCT00603525|592140718|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
163937255|NCT00603525|592140719|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
163937256|NCT00603525|592140720|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
163937257|NCT01483144|592140721|FG000|Overall Study|Adverse Event|9|||
163937258|NCT01483144|592140722|FG001|Overall Study|Adverse Event|4|||
163937259|NCT01483144|592140723|FG002|Overall Study|Adverse Event|6|||
163937260|NCT01483144|592140721|FG000|Overall Study|Withdrawal by Subject|0|||
163937261|NCT01483144|592140722|FG001|Overall Study|Withdrawal by Subject|2|||
163937262|NCT01483144|592140723|FG002|Overall Study|Withdrawal by Subject|5|||
163937263|NCT01483144|592140721|FG000|Overall Study|Physician Decision|1|||
163937264|NCT01483144|592140722|FG001|Overall Study|Physician Decision|0|||
163937265|NCT01483144|592140723|FG002|Overall Study|Physician Decision|0|||
163937266|NCT01483144|592140721|FG000|Overall Study|Lost to Follow-up|2|||
163937267|NCT01483144|592140722|FG001|Overall Study|Lost to Follow-up|4|||
163937268|NCT01483144|592140723|FG002|Overall Study|Lost to Follow-up|1|||
163937269|NCT01483144|592140721|FG000|Overall Study|Protocol Violation|3|||
163937270|NCT01483144|592140722|FG001|Overall Study|Protocol Violation|3|||
163937271|NCT01483144|592140723|FG002|Overall Study|Protocol Violation|3|||
163937272|NCT02460575|592140724|FG000|Overall Study|Lost to Follow-up|1|||
163937273|NCT02460575|592140725|FG001|Overall Study|Lost to Follow-up|0|||
163937274|NCT04624243|592140726|FG000|Overall Study|Death|0|||
163937275|NCT04624243|592140727|FG001|Overall Study|Death|1|||
163937276|NCT04624243|592140728|FG002|Overall Study|Death|0|||
163937277|NCT04624243|592140729|FG003|Overall Study|Death|0|||
163937278|NCT04624243|592140730|FG004|Overall Study|Death|0|||
163937279|NCT04624243|592140726|FG000|Overall Study|Lost to Follow-up|2|||
163937280|NCT04624243|592140727|FG001|Overall Study|Lost to Follow-up|3|||
163937281|NCT04624243|592140728|FG002|Overall Study|Lost to Follow-up|7|||
163937282|NCT04624243|592140729|FG003|Overall Study|Lost to Follow-up|1|||
163937283|NCT04624243|592140730|FG004|Overall Study|Lost to Follow-up|3|||
163937284|NCT04624243|592140726|FG000|Overall Study|Physician Decision|3|||
163937285|NCT04624243|592140727|FG001|Overall Study|Physician Decision|8|||
163937286|NCT04624243|592140728|FG002|Overall Study|Physician Decision|15|||
163937287|NCT04624243|592140729|FG003|Overall Study|Physician Decision|2|||
163937288|NCT04624243|592140730|FG004|Overall Study|Physician Decision|11|||
163937289|NCT04624243|592140726|FG000|Overall Study|Withdrawal by Subject|19|||
163937290|NCT04624243|592140727|FG001|Overall Study|Withdrawal by Subject|44|||
163937291|NCT04624243|592140728|FG002|Overall Study|Withdrawal by Subject|40|||
163937292|NCT04624243|592140729|FG003|Overall Study|Withdrawal by Subject|21|||
163937293|NCT04624243|592140730|FG004|Overall Study|Withdrawal by Subject|39|||
163937294|NCT04624243|592140726|FG000|Overall Study|Miscellaneous|3|||
163937295|NCT04624243|592140727|FG001|Overall Study|Miscellaneous|12|||
163937296|NCT04624243|592140728|FG002|Overall Study|Miscellaneous|9|||
163937297|NCT04624243|592140729|FG003|Overall Study|Miscellaneous|4|||
163937298|NCT04624243|592140730|FG004|Overall Study|Miscellaneous|6|||
163937299|NCT03374488|592140731|FG000|Overall Study|Death|13|||
163937300|NCT03374488|592140732|FG001|Overall Study|Death|13|||
163937301|NCT03374488|592140731|FG000|Overall Study|Withdrawal by Subject|3|||
163937302|NCT03374488|592140732|FG001|Overall Study|Withdrawal by Subject|1|||
163937303|NCT03374488|592140731|FG000|Overall Study|Physician Decision|3|||
163937304|NCT03374488|592140732|FG001|Overall Study|Physician Decision|0|||
163937305|NCT03104075|592140733|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
163937306|NCT03104075|592140734|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
163937307|NCT00944229|592140735|FG000|Overall Study|Withdrawal by Subject|11|||
163937308|NCT00944229|592140735|FG000|Overall Study|Physician Decision|14|||
163937309|NCT01810939|592140738|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
163937310|NCT01810939|592140739|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
163937311|NCT01810939|592140740|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
163937312|NCT01810939|592140738|FG000|Part A Treatment Period|Protocol Violation|2|||
163937313|NCT01810939|592140739|FG001|Part A Treatment Period|Protocol Violation|0|||
163937314|NCT01810939|592140740|FG002|Part A Treatment Period|Protocol Violation|0|||
163937315|NCT01810939|592140738|FG000|Part A Treatment Period|Adverse Event|10|||
163937316|NCT01810939|592140739|FG001|Part A Treatment Period|Adverse Event|0|||
163937317|NCT01810939|592140740|FG002|Part A Treatment Period|Adverse Event|0|||
163937318|NCT01810939|592140738|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
163937319|NCT01810939|592140739|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
163937320|NCT01810939|592140740|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
163937321|NCT01810939|592140738|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
163937322|NCT01810939|592140739|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
163937323|NCT01810939|592140740|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
163937324|NCT01810939|592140738|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
163937325|NCT01810939|592140739|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
163937326|NCT01810939|592140740|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
163937327|NCT01810939|592140738|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
163937328|NCT01810939|592140739|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
163937329|NCT01810939|592140740|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
163937330|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
163937331|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
163937332|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
163937333|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
163937334|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
163937335|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
163937336|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
163937337|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
163937338|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
163937339|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
163937340|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
163937341|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
163937342|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
163937343|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
163937344|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
163937345|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
163937346|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
163937347|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
163937348|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
163937349|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
163937350|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
163937351|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
163937352|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
163937353|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
163937354|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
163937355|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
163937356|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
163937357|NCT01810939|592140738|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
163937358|NCT01810939|592140739|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
163937359|NCT01810939|592140740|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
163937360|NCT04497389|592140743|FG000|Overall Study|Withdrawal by Subject|1|||
163937361|NCT04497389|592140744|FG001|Overall Study|Withdrawal by Subject|0|||
163937362|NCT00789360|592140747|FG000|Overall Study|Protocol Violation|3|||
163937363|NCT00789360|592140748|FG001|Overall Study|Protocol Violation|1|||
163937364|NCT04400487|592140749|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
163937365|NCT04400487|592140749|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
163937366|NCT04400487|592140749|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
163937367|NCT03559062|592140750|FG000|Overall Study|Other|0|||
163937368|NCT03559062|592140751|FG001|Overall Study|Other|1|||
163937369|NCT03559062|592140752|FG002|Overall Study|Other|0|||
163937370|NCT01757197|592140753|FG000|Overall Study|Death|2|||
163937371|NCT01677299|592140761|FG000|Overall Study|Adverse Event|0|||
164040444|NCT01224106|592508772|FG001|Open-Label Extension (OLE) Phase|Death|0|||
164040445|NCT01224106|592508773|FG002|Open-Label Extension (OLE) Phase|Death|0|||
164040446|NCT01224106|592508774|FG003|Open-Label Extension (OLE) Phase|Death|1|||
164040447|NCT01224106|592508775|FG004|Open-Label Extension (OLE) Phase|Death|3|||
164040448|NCT01224106|592508771|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164040449|NCT01224106|592508772|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164040450|NCT01224106|592508773|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
164040451|NCT01224106|592508774|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
164040452|NCT01224106|592508775|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
164040453|NCT01224106|592508771|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
164040454|NCT01224106|592508772|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
164040455|NCT01224106|592508773|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
164040456|NCT01224106|592508774|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
164040457|NCT01224106|592508775|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
164040458|NCT01224106|592508771|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
164040459|NCT01224106|592508772|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
164040460|NCT01224106|592508773|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
164040461|NCT01224106|592508774|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
164040462|NCT01224106|592508775|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
164040463|NCT01224106|592508771|FG000|Open-Label Extension (OLE) Phase|Other|0|||
164040464|NCT01224106|592508772|FG001|Open-Label Extension (OLE) Phase|Other|0|||
164040465|NCT01224106|592508773|FG002|Open-Label Extension (OLE) Phase|Other|0|||
164040466|NCT01224106|592508774|FG003|Open-Label Extension (OLE) Phase|Other|5|||
164040467|NCT01224106|592508775|FG004|Open-Label Extension (OLE) Phase|Other|3|||
164040468|NCT00446797|592508776|FG000|Overall Study|Lack of Efficacy|0|||
164040469|NCT00446797|592508777|FG001|Overall Study|Lack of Efficacy|2|||
164040470|NCT00446797|592508776|FG000|Overall Study|Lost to Follow-up|5|||
164040471|NCT00446797|592508777|FG001|Overall Study|Lost to Follow-up|3|||
164040472|NCT00446797|592508776|FG000|Overall Study|Withdrawal by Subject|2|||
164040473|NCT00446797|592508777|FG001|Overall Study|Withdrawal by Subject|2|||
164040474|NCT00446797|592508776|FG000|Overall Study|Protocol Violation|1|||
164040475|NCT00446797|592508777|FG001|Overall Study|Protocol Violation|3|||
164040476|NCT00446797|592508776|FG000|Overall Study|subject entered at another site|0|||
164040477|NCT00446797|592508777|FG001|Overall Study|subject entered at another site|1|||
164040478|NCT00446797|592508776|FG000|Overall Study|did not meet entrance criteria|0|||
164040479|NCT00446797|592508777|FG001|Overall Study|did not meet entrance criteria|1|||
164040480|NCT03210220|592508778|FG000|Overall Study|Physician Decision|1|||
164040481|NCT03210220|592508779|FG001|Overall Study|Physician Decision|0|||
164040482|NCT00420342|592508780|FG000|Overall Study|Lost to Follow-up|1|||
164040483|NCT00420342|592508781|FG001|Overall Study|Lost to Follow-up|0|||
164040484|NCT00420342|592508782|FG002|Overall Study|Lost to Follow-up|1|||
163937372|NCT01677299|592140762|FG001|Overall Study|Adverse Event|2|||
163937373|NCT01677299|592140763|FG002|Overall Study|Adverse Event|1|||
163937374|NCT01677299|592140764|FG003|Overall Study|Adverse Event|0|||
163937375|NCT01677299|592140761|FG000|Overall Study|Withdrawal by Subject|0|||
163937376|NCT01677299|592140762|FG001|Overall Study|Withdrawal by Subject|1|||
163937377|NCT01677299|592140763|FG002|Overall Study|Withdrawal by Subject|0|||
163937378|NCT01677299|592140764|FG003|Overall Study|Withdrawal by Subject|1|||
163937379|NCT00520845|592140765|FG000|Overall Study|Death|3|||
163937380|NCT00520845|592140765|FG000|Overall Study|Adverse Event|4|||
163937381|NCT00520845|592140765|FG000|Overall Study|Disease Progression, relapse|13|||
163937382|NCT00520845|592140765|FG000|Overall Study|Withdrawal by Subject|1|||
163937383|NCT00520845|592140765|FG000|Overall Study|Alternative Therapy|1|||
163937384|NCT03057847|592140766|FG000|Overall Study|Lost to Follow-up|16|||
163937385|NCT00351377|592140768|FG000|Overall Study|Adverse Event|5|||
163937386|NCT00351377|592140768|FG000|Overall Study|Death|1|||
163937387|NCT00351377|592140768|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163937388|NCT02088957|592140770|FG000|Overall Study|Lack of Efficacy|1|||
163937389|NCT02088957|592140771|FG001|Overall Study|Lack of Efficacy|0|||
163937390|NCT05105087|592140772|FG000|Overall Study|Withdrawal by Subject|2|||
163937391|NCT05105087|592140772|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
163937392|NCT00755417|592140775|FG000|Overall Study|Adverse Event|28|||
163937393|NCT00755417|592140776|FG001|Overall Study|Adverse Event|20|||
163937394|NCT00755417|592140777|FG002|Overall Study|Adverse Event|7|||
163937395|NCT00755417|592140775|FG000|Overall Study|Lack of Efficacy|8|||
164040485|NCT00420342|592508780|FG000|Overall Study|Withdrawal by Subject|0|||
164040486|NCT00420342|592508781|FG001|Overall Study|Withdrawal by Subject|2|||
164040487|NCT00420342|592508782|FG002|Overall Study|Withdrawal by Subject|0|||
163937396|NCT00755417|592140776|FG001|Overall Study|Lack of Efficacy|4|||
163937397|NCT00755417|592140777|FG002|Overall Study|Lack of Efficacy|9|||
163937398|NCT00755417|592140775|FG000|Overall Study|Protocol Violation|2|||
163937399|NCT00755417|592140776|FG001|Overall Study|Protocol Violation|1|||
163937400|NCT00755417|592140777|FG002|Overall Study|Protocol Violation|1|||
163937401|NCT00755417|592140775|FG000|Overall Study|Lost to Follow-up|3|||
163937402|NCT00755417|592140776|FG001|Overall Study|Lost to Follow-up|0|||
164040488|NCT03933215|592508785|FG000|Overall Study|Other|6|||
163937403|NCT00755417|592140777|FG002|Overall Study|Lost to Follow-up|1|||
163937404|NCT00755417|592140775|FG000|Overall Study|Withdrawal by Subject|12|||
163937405|NCT00755417|592140776|FG001|Overall Study|Withdrawal by Subject|12|||
163937406|NCT00755417|592140777|FG002|Overall Study|Withdrawal by Subject|12|||
163937407|NCT00755417|592140775|FG000|Overall Study|Not specified or missing data|9|||
163937408|NCT00755417|592140776|FG001|Overall Study|Not specified or missing data|18|||
163937409|NCT00755417|592140777|FG002|Overall Study|Not specified or missing data|12|||
163937410|NCT02803593|592140778|FG000|Overall Study|Lost to Follow-up|17|||
163937411|NCT02803593|592140779|FG001|Overall Study|Lost to Follow-up|35|||
163937412|NCT03443414|592140780|FG000|Overall Study|Adverse Event|6|||
163937413|NCT03443414|592140781|FG001|Overall Study|Adverse Event|0|||
163937414|NCT03443414|592140782|FG002|Overall Study|Adverse Event|4|||
163937415|NCT03443414|592140783|FG003|Overall Study|Adverse Event|2|||
163937416|NCT03443414|592140784|FG004|Overall Study|Adverse Event|3|||
163937417|NCT03443414|592140780|FG000|Overall Study|Withdrawal by Subject|3|||
163937418|NCT03443414|592140781|FG001|Overall Study|Withdrawal by Subject|2|||
163937419|NCT03443414|592140782|FG002|Overall Study|Withdrawal by Subject|2|||
163937420|NCT03443414|592140783|FG003|Overall Study|Withdrawal by Subject|2|||
163937421|NCT03443414|592140784|FG004|Overall Study|Withdrawal by Subject|1|||
163937422|NCT03443414|592140780|FG000|Overall Study|Death|0|||
163937423|NCT03443414|592140781|FG001|Overall Study|Death|1|||
163937424|NCT03443414|592140782|FG002|Overall Study|Death|0|||
163937425|NCT03443414|592140783|FG003|Overall Study|Death|1|||
163937426|NCT03443414|592140784|FG004|Overall Study|Death|0|||
163937427|NCT03443414|592140780|FG000|Overall Study|Reason not specified|2|||
163937428|NCT03443414|592140781|FG001|Overall Study|Reason not specified|0|||
163937429|NCT03443414|592140782|FG002|Overall Study|Reason not specified|0|||
163937430|NCT03443414|592140783|FG003|Overall Study|Reason not specified|0|||
163937431|NCT03443414|592140784|FG004|Overall Study|Reason not specified|1|||
163937432|NCT03933462|592140785|FG000|Overall Study|Adverse Event|2|||
163937433|NCT03933462|592140786|FG001|Overall Study|Adverse Event|0|||
163937434|NCT02522728|592140787|FG000|Overall Study|Withdrawal by Subject|6|||
163937435|NCT02522728|592140788|FG001|Overall Study|Withdrawal by Subject|6|||
163937436|NCT02522728|592140787|FG000|Overall Study|Death|4|||
163937437|NCT02522728|592140788|FG001|Overall Study|Death|3|||
163937438|NCT02522728|592140787|FG000|Overall Study|Adverse Event|2|||
163937439|NCT02522728|592140788|FG001|Overall Study|Adverse Event|1|||
163937440|NCT02522728|592140787|FG000|Overall Study|Did not receive randomized study device|0|||
163937441|NCT02522728|592140788|FG001|Overall Study|Did not receive randomized study device|1|||
163937442|NCT01436305|592140789|FG000|Overall Study|Death|1|||
163937443|NCT01436305|592140790|FG001|Overall Study|Death|0|||
163937444|NCT01436305|592140791|FG002|Overall Study|Death|0|||
163937445|NCT01436305|592140789|FG000|Overall Study|Lost to Follow-up|0|||
163937446|NCT01436305|592140790|FG001|Overall Study|Lost to Follow-up|1|||
163937447|NCT01436305|592140791|FG002|Overall Study|Lost to Follow-up|0|||
163937448|NCT01436305|592140789|FG000|Overall Study|Withdrawal by Subject|1|||
163937449|NCT01436305|592140790|FG001|Overall Study|Withdrawal by Subject|3|||
163937450|NCT01436305|592140791|FG002|Overall Study|Withdrawal by Subject|0|||
163937451|NCT01485120|592140792|FG000|Overall Study|Withdrawal by Subject|2|||
163937452|NCT02344342|592140793|FG000|Overall Study|Industry partner dropped out|11|||
163937453|NCT02344342|592140794|FG001|Overall Study|Industry partner dropped out|9|||
163937454|NCT02344342|592140795|FG002|Overall Study|Industry partner dropped out|14|||
163937455|NCT02344342|592140796|FG003|Overall Study|Industry partner dropped out|10|||
163937456|NCT03355209|592140797|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
163937457|NCT03355209|592140798|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
163937458|NCT03355209|592140799|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
163937459|NCT03355209|592140800|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
163937460|NCT03355209|592140801|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
163937461|NCT03355209|592140802|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
163937462|NCT03355209|592140797|FG000|Part 1: Double-Blind Period|Death|0|||
163937463|NCT03355209|592140798|FG001|Part 1: Double-Blind Period|Death|0|||
163937464|NCT03355209|592140799|FG002|Part 1: Double-Blind Period|Death|1|||
163937465|NCT03355209|592140800|FG003|Part 1: Double-Blind Period|Death|0|||
163937466|NCT03355209|592140801|FG004|Part 1: Double-Blind Period|Death|0|||
163937467|NCT03355209|592140802|FG005|Part 1: Double-Blind Period|Death|0|||
163937468|NCT03355209|592140797|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
163937469|NCT03355209|592140798|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
163937470|NCT03355209|592140799|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
163937471|NCT03355209|592140800|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
163937472|NCT03355209|592140801|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
164098813|NCT00064753|592726915|FG000|Overall Study|Withdrawal by Subject|198|||
164098814|NCT00064753|592726916|FG001|Overall Study|Withdrawal by Subject|171|||
163937473|NCT03355209|592140802|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
163937474|NCT03355209|592140797|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
163937475|NCT03355209|592140798|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
163937476|NCT03355209|592140799|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
163937477|NCT03355209|592140800|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
164040489|NCT03933215|592508785|FG000|Overall Study|Sponsor decision|5|||
164040490|NCT03933215|592508785|FG000|Overall Study|Protocol Violation|5|||
164040491|NCT03933215|592508785|FG000|Overall Study|Withdrawal by Subject|6|||
164040492|NCT03933215|592508785|FG000|Overall Study|Lost to Follow-up|6|||
164040493|NCT03933215|592508785|FG000|Overall Study|Enrolled but not treated|38|||
164040494|NCT05784129|592508788|FG000|Overall Study|Study terminated by sponsor|2|||
164040495|NCT05784129|592508789|FG001|Overall Study|Study terminated by sponsor|2|||
164040496|NCT00407550|592508790|FG000|Overall Study|Adverse Event|0|||
164040497|NCT00407550|592508791|FG001|Overall Study|Adverse Event|1|||
164040498|NCT00407550|592508790|FG000|Overall Study|Withdrawal by Subject|0|||
164040499|NCT00407550|592508791|FG001|Overall Study|Withdrawal by Subject|2|||
164040500|NCT00407550|592508790|FG000|Overall Study|Death|1|||
164040501|NCT00407550|592508791|FG001|Overall Study|Death|0|||
164040502|NCT00407550|592508790|FG000|Overall Study|Insurance or Other medical condition|2|||
164040503|NCT00407550|592508791|FG001|Overall Study|Insurance or Other medical condition|1|||
164040504|NCT01444898|592508792|FG000|Overall Study|Withdrawal by Subject|1|||
164040505|NCT02580591|592508794|FG000|Overall Study|Adverse Event|0|||
164040506|NCT02580591|592508795|FG001|Overall Study|Adverse Event|1|||
164040507|NCT02580591|592508796|FG002|Overall Study|Adverse Event|2|||
164040508|NCT02580591|592508797|FG003|Overall Study|Adverse Event|5|||
164040509|NCT02580591|592508794|FG000|Overall Study|Protocol Violation|3|||
164040510|NCT02580591|592508795|FG001|Overall Study|Protocol Violation|2|||
164040511|NCT02580591|592508796|FG002|Overall Study|Protocol Violation|1|||
164040512|NCT02580591|592508797|FG003|Overall Study|Protocol Violation|1|||
164040513|NCT02580591|592508794|FG000|Overall Study|Lost to Follow-up|5|||
164040514|NCT02580591|592508795|FG001|Overall Study|Lost to Follow-up|3|||
164040515|NCT02580591|592508796|FG002|Overall Study|Lost to Follow-up|3|||
164040516|NCT02580591|592508797|FG003|Overall Study|Lost to Follow-up|1|||
164040517|NCT02580591|592508794|FG000|Overall Study|Withdrawal by Subject|6|||
164040518|NCT02580591|592508795|FG001|Overall Study|Withdrawal by Subject|1|||
164040519|NCT02580591|592508796|FG002|Overall Study|Withdrawal by Subject|2|||
164040520|NCT02580591|592508797|FG003|Overall Study|Withdrawal by Subject|3|||
164040521|NCT02580591|592508794|FG000|Overall Study|Not treated|1|||
164040522|NCT02580591|592508795|FG001|Overall Study|Not treated|1|||
164040523|NCT02580591|592508796|FG002|Overall Study|Not treated|0|||
164040524|NCT02580591|592508797|FG003|Overall Study|Not treated|0|||
164040525|NCT02580591|592508794|FG000|Overall Study|Other than specified|3|||
164040526|NCT02580591|592508795|FG001|Overall Study|Other than specified|2|||
164040527|NCT02580591|592508796|FG002|Overall Study|Other than specified|5|||
164040528|NCT02580591|592508797|FG003|Overall Study|Other than specified|2|||
164040529|NCT01366534|592508802|FG000|Overall Study|Lost to Follow-up|1|||
164040530|NCT01366534|592508803|FG001|Overall Study|Lost to Follow-up|0|||
164040531|NCT01366534|592508804|FG002|Overall Study|Lost to Follow-up|0|||
164040532|NCT01366534|592508802|FG000|Overall Study|Migrated|1|||
164040533|NCT01366534|592508803|FG001|Overall Study|Migrated|1|||
164040534|NCT01366534|592508804|FG002|Overall Study|Migrated|0|||
164040535|NCT01366534|592508802|FG000|Overall Study|Declined challenged|0|||
164040536|NCT01366534|592508803|FG001|Overall Study|Declined challenged|1|||
164040537|NCT01366534|592508804|FG002|Overall Study|Declined challenged|0|||
164040538|NCT03006926|592508805|FG000|Overall Study|Adverse Event|0|||
164040539|NCT03006926|592508806|FG001|Overall Study|Adverse Event|27|||
164040540|NCT03006926|592508805|FG000|Overall Study|Withdrawal by Subject|0|||
164040541|NCT03006926|592508806|FG001|Overall Study|Withdrawal by Subject|1|||
164040542|NCT03006926|592508805|FG000|Overall Study|Radiological Disease Progression|0|||
164040543|NCT03006926|592508806|FG001|Overall Study|Radiological Disease Progression|52|||
164040544|NCT03006926|592508805|FG000|Overall Study|Clinical Disease Progression|0|||
164040545|NCT03006926|592508806|FG001|Overall Study|Clinical Disease Progression|10|||
164040546|NCT03006926|592508805|FG000|Overall Study|Other|0|||
164040547|NCT03006926|592508806|FG001|Overall Study|Other|8|||
164040548|NCT02918318|592508811|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
164040549|NCT02918318|592508812|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
164040550|NCT02918318|592508813|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
164040551|NCT02918318|592508814|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
164040552|NCT02918318|592508815|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
164040553|NCT02918318|592508811|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164040554|NCT02918318|592508812|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164040555|NCT02918318|592508813|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164040556|NCT02918318|592508814|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
164040557|NCT02918318|592508815|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
164040558|NCT02918318|592508811|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164040559|NCT02918318|592508812|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164040560|NCT02918318|592508813|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164040561|NCT02918318|592508814|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
164040562|NCT02918318|592508815|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
164040563|NCT02918318|592508811|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
164098815|NCT00064753|592726915|FG000|Overall Study|Lost to Follow-up|225|||
164040564|NCT02918318|592508812|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
164040565|NCT02918318|592508813|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
164040566|NCT02918318|592508814|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
164040567|NCT02918318|592508815|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
164040568|NCT02918318|592508811|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164040569|NCT02918318|592508812|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164040570|NCT02918318|592508813|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164040571|NCT02918318|592508814|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
164040572|NCT02918318|592508815|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
164040573|NCT02918318|592508811|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
164040574|NCT02918318|592508812|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
163937478|NCT03355209|592140801|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163937479|NCT03355209|592140802|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
163937480|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
163937481|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
163937482|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
163937483|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
163937484|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
163937485|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
163937486|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163937487|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
163937488|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163937489|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163937490|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163937491|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
163937492|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
163937493|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
163937494|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
163937495|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
163937496|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
163937497|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
163937498|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
163937499|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
163937500|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
163937501|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
163937502|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
163937503|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
163937504|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
163937505|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
163937506|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
163937507|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163937508|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
163937509|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
163937510|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163937511|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163937512|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163937513|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
163937514|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
163937515|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
163937516|NCT03355209|592140797|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
163937517|NCT03355209|592140798|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163937518|NCT03355209|592140799|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
163937519|NCT03355209|592140800|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163937520|NCT03355209|592140801|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
163937521|NCT03355209|592140802|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
164040575|NCT02918318|592508813|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
163937522|NCT01151215|592140806|FG000|Overall Study|Worsening of condition under study|1|||
163937523|NCT01151215|592140807|FG001|Overall Study|Worsening of condition under study|1|||
164040576|NCT02918318|592508814|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
164040577|NCT02918318|592508815|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
164040578|NCT02918318|592508811|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164040579|NCT02918318|592508812|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164040580|NCT02918318|592508813|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164098816|NCT00064753|592726916|FG001|Overall Study|Lost to Follow-up|235|||
163937524|NCT01151215|592140808|FG002|Overall Study|Worsening of condition under study|1|||
163937525|NCT01151215|592140806|FG000|Overall Study|Death|16|||
163937526|NCT01151215|592140807|FG001|Overall Study|Death|20|||
163937527|NCT01151215|592140808|FG002|Overall Study|Death|11|||
163937528|NCT01151215|592140806|FG000|Overall Study|Lost to Follow-up|0|||
163937529|NCT01151215|592140807|FG001|Overall Study|Lost to Follow-up|0|||
163937530|NCT01151215|592140808|FG002|Overall Study|Lost to Follow-up|3|||
163937531|NCT01151215|592140806|FG000|Overall Study|Withdrawal by Subject|3|||
163937532|NCT01151215|592140807|FG001|Overall Study|Withdrawal by Subject|1|||
163937533|NCT01151215|592140808|FG002|Overall Study|Withdrawal by Subject|2|||
163937534|NCT01151215|592140806|FG000|Overall Study|Disease progression|0|||
163937535|NCT01151215|592140807|FG001|Overall Study|Disease progression|1|||
163937536|NCT01151215|592140808|FG002|Overall Study|Disease progression|1|||
163937537|NCT01151215|592140806|FG000|Overall Study|Safety as judged by the investigator|0|||
163937538|NCT01151215|592140807|FG001|Overall Study|Safety as judged by the investigator|0|||
163937539|NCT01151215|592140808|FG002|Overall Study|Safety as judged by the investigator|1|||
163937540|NCT02597712|592140809|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
163937541|NCT02597712|592140810|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
163937542|NCT02597712|592140809|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
163937543|NCT02597712|592140810|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
163937544|NCT02597712|592140809|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
163937545|NCT02597712|592140810|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
163937546|NCT00513708|592140811|FG000|Overall Study|Lost to Follow-up|4|||
163937547|NCT00513708|592140812|FG001|Overall Study|Lost to Follow-up|4|||
163937548|NCT00513708|592140813|FG002|Overall Study|Lost to Follow-up|4|||
163937549|NCT01564277|592140814|FG000|Overall Study|Protocol Violation|0|||
163937550|NCT01564277|592140815|FG001|Overall Study|Protocol Violation|1|||
163937551|NCT01564277|592140814|FG000|Overall Study|Physician Decision|1|||
163937552|NCT01564277|592140815|FG001|Overall Study|Physician Decision|0|||
163937553|NCT01594970|592140816|FG000|Overall Study|Non-Adverse Event Related|4|||
163937554|NCT01594970|592140817|FG001|Overall Study|Non-Adverse Event Related|5|||
163937555|NCT01594970|592140818|FG002|Overall Study|Non-Adverse Event Related|6|||
163937556|NCT01594970|592140816|FG000|Overall Study|Adverse Event|17|||
163937557|NCT01594970|592140817|FG001|Overall Study|Adverse Event|23|||
163937558|NCT01594970|592140818|FG002|Overall Study|Adverse Event|23|||
163937559|NCT01594970|592140816|FG000|Overall Study|Lost to Follow-up|54|||
163937560|NCT01594970|592140817|FG001|Overall Study|Lost to Follow-up|54|||
163937561|NCT01594970|592140818|FG002|Overall Study|Lost to Follow-up|37|||
163937562|NCT04276051|592140821|FG000|Overall Study|Lost to Follow-up|0|||
163937563|NCT04276051|592140822|FG001|Overall Study|Lost to Follow-up|1|||
163937564|NCT04276051|592140821|FG000|Overall Study|Physician Decision|0|||
163937565|NCT04276051|592140822|FG001|Overall Study|Physician Decision|1|||
163937566|NCT04276051|592140821|FG000|Overall Study|Withdrawal by Subject|1|||
163937567|NCT04276051|592140822|FG001|Overall Study|Withdrawal by Subject|1|||
163937568|NCT01299480|592140823|FG000|Overall Study|No longer willing to participate|19|||
163937569|NCT01299480|592140824|FG001|Overall Study|No longer willing to participate|17|||
163937570|NCT01299480|592140825|FG002|Overall Study|No longer willing to participate|14|||
163937571|NCT01299480|592140826|FG003|Overall Study|No longer willing to participate|13|||
163937572|NCT01299480|592140827|FG004|Overall Study|No longer willing to participate|10|||
163937573|NCT01299480|592140823|FG000|Overall Study|Protocol Violation|7|||
163937574|NCT01299480|592140824|FG001|Overall Study|Protocol Violation|5|||
163937575|NCT01299480|592140825|FG002|Overall Study|Protocol Violation|8|||
163937576|NCT01299480|592140826|FG003|Overall Study|Protocol Violation|1|||
163937577|NCT01299480|592140827|FG004|Overall Study|Protocol Violation|1|||
163937578|NCT01299480|592140823|FG000|Overall Study|Withdrawal by Subject|3|||
163937579|NCT01299480|592140824|FG001|Overall Study|Withdrawal by Subject|4|||
163937580|NCT01299480|592140825|FG002|Overall Study|Withdrawal by Subject|7|||
163937581|NCT01299480|592140826|FG003|Overall Study|Withdrawal by Subject|3|||
163937582|NCT01299480|592140827|FG004|Overall Study|Withdrawal by Subject|4|||
163937583|NCT01299480|592140823|FG000|Overall Study|Adverse Event|6|||
163937584|NCT01299480|592140824|FG001|Overall Study|Adverse Event|4|||
163937585|NCT01299480|592140825|FG002|Overall Study|Adverse Event|5|||
163937586|NCT01299480|592140826|FG003|Overall Study|Adverse Event|4|||
163937587|NCT01299480|592140827|FG004|Overall Study|Adverse Event|0|||
163937588|NCT01299480|592140823|FG000|Overall Study|Withdrawal due to pregnancy|0|||
163937589|NCT01299480|592140824|FG001|Overall Study|Withdrawal due to pregnancy|1|||
163937590|NCT01299480|592140825|FG002|Overall Study|Withdrawal due to pregnancy|1|||
163937591|NCT01299480|592140826|FG003|Overall Study|Withdrawal due to pregnancy|0|||
163937592|NCT01299480|592140827|FG004|Overall Study|Withdrawal due to pregnancy|0|||
163937593|NCT01299480|592140823|FG000|Overall Study|Physician Decision|1|||
163937594|NCT01299480|592140824|FG001|Overall Study|Physician Decision|1|||
163937595|NCT01299480|592140825|FG002|Overall Study|Physician Decision|0|||
163937596|NCT01299480|592140826|FG003|Overall Study|Physician Decision|2|||
164040581|NCT02918318|592508814|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
163937597|NCT01299480|592140827|FG004|Overall Study|Physician Decision|0|||
163937598|NCT01299480|592140823|FG000|Overall Study|Lost to Follow-up|3|||
164040582|NCT02918318|592508815|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
164040583|NCT02918318|592508811|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
164040584|NCT02918318|592508812|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
164040585|NCT02918318|592508813|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
164040586|NCT02918318|592508814|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
164040587|NCT02918318|592508815|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
164040588|NCT02918318|592508811|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
164040589|NCT02918318|592508812|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
164040590|NCT02918318|592508813|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
164040591|NCT02918318|592508814|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
164040592|NCT02918318|592508815|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
164040593|NCT02918318|592508811|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
164040594|NCT02918318|592508812|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
164040595|NCT02918318|592508813|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
164040596|NCT02918318|592508814|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
164040597|NCT02918318|592508815|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
164040598|NCT02918318|592508811|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164040599|NCT02918318|592508812|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164040600|NCT02918318|592508813|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164040601|NCT02918318|592508814|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
164040602|NCT02918318|592508815|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
164040603|NCT02918318|592508811|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164040604|NCT02918318|592508812|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164040605|NCT02918318|592508813|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164040606|NCT02918318|592508814|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
164040607|NCT02918318|592508815|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
164040608|NCT00990249|592508816|FG000|Overall Study|Disease Progression|8|||
164040609|NCT00990249|592508816|FG000|Overall Study|Non-Compliance|1|||
163937599|NCT01299480|592140824|FG001|Overall Study|Lost to Follow-up|1|||
163937600|NCT01299480|592140825|FG002|Overall Study|Lost to Follow-up|2|||
163937601|NCT01299480|592140826|FG003|Overall Study|Lost to Follow-up|1|||
163937602|NCT01299480|592140827|FG004|Overall Study|Lost to Follow-up|2|||
163937603|NCT01299480|592140823|FG000|Overall Study|Other|3|||
163937604|NCT01299480|592140824|FG001|Overall Study|Other|2|||
163937605|NCT01299480|592140825|FG002|Overall Study|Other|3|||
163937606|NCT01299480|592140826|FG003|Overall Study|Other|0|||
163937607|NCT01299480|592140827|FG004|Overall Study|Other|3|||
163937608|NCT01299480|592140823|FG000|Overall Study|Started, but not vaccinated|0|||
163937609|NCT01299480|592140824|FG001|Overall Study|Started, but not vaccinated|0|||
163937610|NCT01299480|592140825|FG002|Overall Study|Started, but not vaccinated|1|||
163937611|NCT01299480|592140826|FG003|Overall Study|Started, but not vaccinated|1|||
163937612|NCT01299480|592140827|FG004|Overall Study|Started, but not vaccinated|0|||
163937613|NCT00604708|592140833|FG000|Overall Study|Withdrawal by Subject|9|||
163937614|NCT00604708|592140834|FG001|Overall Study|Withdrawal by Subject|10|||
163937615|NCT00604708|592140833|FG000|Overall Study|Protocol Violation|2|||
163937616|NCT00604708|592140834|FG001|Overall Study|Protocol Violation|8|||
163937617|NCT00604708|592140833|FG000|Overall Study|Lost to Follow-up|5|||
163937618|NCT00604708|592140834|FG001|Overall Study|Lost to Follow-up|5|||
163937619|NCT00604708|592140833|FG000|Overall Study|administrative reasons|9|||
163937620|NCT00604708|592140834|FG001|Overall Study|administrative reasons|11|||
163937621|NCT00604708|592140833|FG000|Overall Study|Adverse Event|6|||
163937622|NCT00604708|592140834|FG001|Overall Study|Adverse Event|6|||
163937623|NCT04916730|592140835|FG000|Overall Study|Withdrawal by Subject|4|||
163937624|NCT04916730|592140836|FG001|Overall Study|Withdrawal by Subject|2|||
163937625|NCT04916730|592140835|FG000|Overall Study|Lost to Follow-up|0|||
163937626|NCT04916730|592140836|FG001|Overall Study|Lost to Follow-up|2|||
163937627|NCT04916730|592140835|FG000|Overall Study|Physician Decision|1|||
163937628|NCT04916730|592140836|FG001|Overall Study|Physician Decision|0|||
163937629|NCT00617929|592140837|FG000|Overall Study|Physician Decision|1|||
163937630|NCT00760747|592140841|FG000|Study Period II|Adverse Event|3|||
163937631|NCT00760747|592140842|FG001|Study Period II|Adverse Event|4|||
163937632|NCT00760747|592140841|FG000|Study Period II|Lack of Efficacy|0|||
163937633|NCT00760747|592140842|FG001|Study Period II|Lack of Efficacy|6|||
163937634|NCT00760747|592140841|FG000|Study Period II|Parent/Caregiver Decision|3|||
163937635|NCT00760747|592140842|FG001|Study Period II|Parent/Caregiver Decision|0|||
163937636|NCT00760747|592140841|FG000|Study Period II|Protocol Violation|6|||
164040610|NCT00990249|592508816|FG000|Overall Study|Death|2|||
164040611|NCT00990249|592508816|FG000|Overall Study|Not treated|2|||
163937637|NCT00760747|592140842|FG001|Study Period II|Protocol Violation|3|||
163937638|NCT00760747|592140841|FG000|Study Period II|Withdrawal by Subject|1|||
163937639|NCT00760747|592140842|FG001|Study Period II|Withdrawal by Subject|0|||
163937640|NCT00760747|592140841|FG000|Study Period II|No drug administered|0|||
163937641|NCT00760747|592140842|FG001|Study Period II|No drug administered|1|||
163937642|NCT00760747|592140841|FG000|Study Period III|Adverse Event|1|||
163937643|NCT00760747|592140842|FG001|Study Period III|Adverse Event|0|||
163840217|NCT04498247|591785791|FG000|Overall Study|Withdrawal by Subject|0|||
163840218|NCT04498247|591785792|FG001|Overall Study|Withdrawal by Subject|8|||
163840219|NCT04498247|591785793|FG002|Overall Study|Withdrawal by Subject|0|||
163840220|NCT04498247|591785794|FG003|Overall Study|Withdrawal by Subject|7|||
163840221|NCT04498247|591785795|FG004|Overall Study|Withdrawal by Subject|0|||
163840222|NCT04498247|591785796|FG005|Overall Study|Withdrawal by Subject|0|||
163840223|NCT04498247|591785797|FG006|Overall Study|Withdrawal by Subject|1|||
163840224|NCT04498247|591785798|FG007|Overall Study|Withdrawal by Subject|0|||
163840225|NCT04498247|591785791|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163840226|NCT04498247|591785792|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
163840227|NCT04498247|591785793|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163840228|NCT04498247|591785794|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
163840229|NCT04498247|591785795|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163840230|NCT04498247|591785796|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163840231|NCT04498247|591785797|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
163840232|NCT04498247|591785798|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
163840233|NCT01737996|591785799|FG000|Overall Study|Adverse Event|0|||
163840234|NCT01737996|591785800|FG001|Overall Study|Adverse Event|1|||
163840235|NCT01737996|591785801|FG002|Overall Study|Adverse Event|1|||
163840236|NCT01737996|591785799|FG000|Overall Study|Withdrawal by Subject|0|||
163840237|NCT01737996|591785800|FG001|Overall Study|Withdrawal by Subject|0|||
163840238|NCT01737996|591785801|FG002|Overall Study|Withdrawal by Subject|1|||
163840239|NCT01003184|591785802|FG000|Overall Study|Adverse Event|12|||
163840240|NCT01003184|591785803|FG001|Overall Study|Adverse Event|5|||
163840241|NCT01003184|591785802|FG000|Overall Study|Lost to Follow-up|1|||
163840242|NCT01003184|591785803|FG001|Overall Study|Lost to Follow-up|0|||
163840243|NCT01003184|591785802|FG000|Overall Study|Loss of glucose control|1|||
163840244|NCT01003184|591785803|FG001|Overall Study|Loss of glucose control|1|||
163840245|NCT01003184|591785802|FG000|Overall Study|Protocol Violation|3|||
163840246|NCT01003184|591785803|FG001|Overall Study|Protocol Violation|0|||
163840247|NCT01003184|591785802|FG000|Overall Study|Withdrawal by Subject|1|||
163840248|NCT01003184|591785803|FG001|Overall Study|Withdrawal by Subject|6|||
163840249|NCT01003184|591785802|FG000|Overall Study|Physician Decision|1|||
163840250|NCT01003184|591785803|FG001|Overall Study|Physician Decision|0|||
163840251|NCT00557622|591785804|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
163840252|NCT00557622|591785805|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
163840253|NCT00557622|591785804|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
163840254|NCT00557622|591785805|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
163840255|NCT00557622|591785804|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
163840256|NCT00557622|591785805|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
163840257|NCT02765490|591785806|FG000|Overall Study|Lost to Follow-up|1|||
163840258|NCT02765490|591785807|FG001|Overall Study|Lost to Follow-up|1|||
163840259|NCT02765490|591785806|FG000|Overall Study|Other|0|||
163840260|NCT02765490|591785807|FG001|Overall Study|Other|1|||
163840261|NCT02765490|591785806|FG000|Overall Study|Death|0|||
163840262|NCT02765490|591785807|FG001|Overall Study|Death|1|||
163840263|NCT01923389|591785808|FG000|Overall Study|Protocol Violation|1|||
163840264|NCT01923389|591785809|FG001|Overall Study|Protocol Violation|0|||
163840265|NCT03237013|591785810|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
163840266|NCT03237013|591785811|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
163840267|NCT03237013|591785812|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
163840268|NCT05266963|591785813|FG000|Drug Period A|Withdrawal by Subject|0|||
163840269|NCT05266963|591785814|FG001|Drug Period A|Withdrawal by Subject|1|||
163840270|NCT00152971|591785815|FG000|Overall Study|Adverse Event|12|||
163840271|NCT00152971|591785816|FG001|Overall Study|Adverse Event|10|||
163840272|NCT00152971|591785817|FG002|Overall Study|Adverse Event|9|||
163840273|NCT00152971|591785815|FG000|Overall Study|Protocol Violation|10|||
163840274|NCT00152971|591785816|FG001|Overall Study|Protocol Violation|11|||
163840275|NCT00152971|591785817|FG002|Overall Study|Protocol Violation|8|||
163840276|NCT00152971|591785815|FG000|Overall Study|Lost to Follow-up|17|||
163840277|NCT00152971|591785816|FG001|Overall Study|Lost to Follow-up|14|||
163840278|NCT00152971|591785817|FG002|Overall Study|Lost to Follow-up|13|||
163840279|NCT00152971|591785815|FG000|Overall Study|Withdrawal by Subject|9|||
163840280|NCT00152971|591785816|FG001|Overall Study|Withdrawal by Subject|8|||
163840281|NCT00152971|591785817|FG002|Overall Study|Withdrawal by Subject|14|||
163840282|NCT00152971|591785815|FG000|Overall Study|Other|3|||
163840283|NCT00152971|591785816|FG001|Overall Study|Other|5|||
163840284|NCT00152971|591785817|FG002|Overall Study|Other|5|||
163840285|NCT00152971|591785815|FG000|Treatment|Adverse Event|49|||
163840286|NCT00152971|591785816|FG001|Treatment|Adverse Event|40|||
163840287|NCT00152971|591785817|FG002|Treatment|Adverse Event|54|||
163840288|NCT00152971|591785815|FG000|Treatment|Protocol Violation|8|||
163840289|NCT00152971|591785816|FG001|Treatment|Protocol Violation|6|||
163840290|NCT00152971|591785817|FG002|Treatment|Protocol Violation|10|||
163840291|NCT00152971|591785815|FG000|Treatment|Lost to Follow-up|1|||
163840292|NCT00152971|591785816|FG001|Treatment|Lost to Follow-up|2|||
163840293|NCT00152971|591785817|FG002|Treatment|Lost to Follow-up|1|||
163937644|NCT00760747|592140841|FG000|Study Period III|Lack of Efficacy|1|||
163937645|NCT00760747|592140842|FG001|Study Period III|Lack of Efficacy|0|||
163937646|NCT00760747|592140841|FG000|Study Period III|Parent/Caregiver Decision|0|||
163937647|NCT00760747|592140842|FG001|Study Period III|Parent/Caregiver Decision|1|||
163937648|NCT00760747|592140841|FG000|Study Period III|Protocol Violation|1|||
163937649|NCT00760747|592140842|FG001|Study Period III|Protocol Violation|1|||
163937650|NCT00760747|592140841|FG000|Study Period III|Physician Decision|0|||
163937651|NCT00760747|592140842|FG001|Study Period III|Physician Decision|1|||
163937652|NCT01228175|592140843|FG000|Overall Study|Lost to Follow-up|64|||
163937653|NCT01228175|592140844|FG001|Overall Study|Lost to Follow-up|50|||
163937654|NCT01228175|592140843|FG000|Overall Study|Withdrawal by Subject|1|||
163937655|NCT01228175|592140844|FG001|Overall Study|Withdrawal by Subject|2|||
163937656|NCT01228175|592140843|FG000|Overall Study|Physician Decision|1|||
163937657|NCT01228175|592140844|FG001|Overall Study|Physician Decision|1|||
163937658|NCT00402051|592140847|FG000|Overall Study|Progressive Disease|13|||
163937659|NCT00402051|592140848|FG001|Overall Study|Progressive Disease|20|||
163937660|NCT00402051|592140847|FG000|Overall Study|Adverse Event|11|||
163937661|NCT00402051|592140848|FG001|Overall Study|Adverse Event|4|||
163937662|NCT00402051|592140847|FG000|Overall Study|Physician Decision|7|||
163937663|NCT00402051|592140848|FG001|Overall Study|Physician Decision|3|||
163937664|NCT00402051|592140847|FG000|Overall Study|Withdrawal by Subject|3|||
163937665|NCT00402051|592140848|FG001|Overall Study|Withdrawal by Subject|3|||
163937666|NCT00402051|592140847|FG000|Overall Study|Death - Related to Study Drug|1|||
163937667|NCT00402051|592140848|FG001|Overall Study|Death - Related to Study Drug|2|||
163937668|NCT00402051|592140847|FG000|Overall Study|Death Due to Study Disease|2|||
163937669|NCT00402051|592140848|FG001|Overall Study|Death Due to Study Disease|1|||
163937670|NCT00402051|592140847|FG000|Overall Study|Death Due to Adverse Event|0|||
163937671|NCT00402051|592140848|FG001|Overall Study|Death Due to Adverse Event|2|||
163937672|NCT00402051|592140847|FG000|Overall Study|Lost to Follow-up|1|||
163937673|NCT00402051|592140848|FG001|Overall Study|Lost to Follow-up|0|||
163937674|NCT02194829|592140854|FG000|Overall Study|Adverse Event|2|||
163937675|NCT02194829|592140855|FG001|Overall Study|Adverse Event|2|||
163937676|NCT02194829|592140854|FG000|Overall Study|Death|0|||
163937677|NCT02194829|592140855|FG001|Overall Study|Death|1|||
163937678|NCT02194829|592140854|FG000|Overall Study|Disease progression|0|||
163937679|NCT02194829|592140855|FG001|Overall Study|Disease progression|1|||
163937680|NCT02194829|592140854|FG000|Overall Study|Withdrawal by Subject|0|||
163937681|NCT02194829|592140855|FG001|Overall Study|Withdrawal by Subject|1|||
163937682|NCT02194829|592140854|FG000|Overall Study|Never started protocol therapy|0|||
163937683|NCT02194829|592140855|FG001|Overall Study|Never started protocol therapy|1|||
163937684|NCT04427280|592142678|FG000|Overall Study|Withdrawal by Subject|0|||
163937685|NCT04427280|592142679|FG001|Overall Study|Withdrawal by Subject|2|||
163937686|NCT02473965|592142681|FG000|Overall Study|Adverse Event|6|||
163937687|NCT02473965|592142682|FG001|Overall Study|Adverse Event|4|||
163937688|NCT02473965|592142681|FG000|Overall Study|MG worsening|4|||
163937689|NCT02473965|592142682|FG001|Overall Study|MG worsening|1|||
163937690|NCT02473965|592142681|FG000|Overall Study|Withdrawal by Subject|2|||
163937691|NCT02473965|592142682|FG001|Overall Study|Withdrawal by Subject|3|||
163937692|NCT02473965|592142681|FG000|Overall Study|Physician Decision|0|||
163937693|NCT02473965|592142682|FG001|Overall Study|Physician Decision|2|||
163937694|NCT01681277|592142685|FG000|Overall Study|Adverse Event|1|||
163937695|NCT01681277|592142686|FG001|Overall Study|Adverse Event|0|||
163937696|NCT01681277|592142687|FG002|Overall Study|Adverse Event|0|||
163937697|NCT01681277|592142688|FG003|Overall Study|Adverse Event|0|||
163937698|NCT01681277|592142689|FG004|Overall Study|Adverse Event|0|||
163937699|NCT02271984|592142692|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937700|NCT02271984|592142693|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937701|NCT02271984|592142694|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937702|NCT02271984|592142695|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937703|NCT02271984|592142696|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937704|NCT02271984|592142697|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
163937705|NCT02271984|592142698|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937706|NCT02271984|592142699|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
163937707|NCT02271984|592142700|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937708|NCT02271984|592142701|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937709|NCT02271984|592142702|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164040612|NCT04080752|592508817|FG000|Overall Study|Adverse Event|2|||
163937710|NCT02271984|592142703|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
163937711|NCT01088984|592142704|FG000|Phase 1|Death|2|||
163937712|NCT01088984|592142705|FG001|Phase 1|Death|1|||
163937713|NCT01088984|592142704|FG000|Phase 1|Disease Progression|2|||
163937714|NCT01088984|592142705|FG001|Phase 1|Disease Progression|4|||
163937715|NCT01088984|592142704|FG000|Phase 1|Other|1|||
163937716|NCT01088984|592142705|FG001|Phase 1|Other|1|||
163937717|NCT01088984|592142704|FG000|Phase 2|Death|0|||
163937718|NCT01088984|592142705|FG001|Phase 2|Death|5|||
163937719|NCT01088984|592142704|FG000|Phase 2|Withdrawal by Subject|0|||
163937720|NCT01088984|592142705|FG001|Phase 2|Withdrawal by Subject|1|||
163937721|NCT01088984|592142704|FG000|Phase 2|DIsease Progression|0|||
163937722|NCT01088984|592142705|FG001|Phase 2|DIsease Progression|25|||
163937723|NCT01088984|592142704|FG000|Phase 2|Other|0|||
163937724|NCT01088984|592142705|FG001|Phase 2|Other|1|||
163937725|NCT02304705|592142706|FG000|Overall Study|Withdrawal by Subject|2|||
163937726|NCT02304705|592142707|FG001|Overall Study|Withdrawal by Subject|0|||
163937727|NCT02304705|592142706|FG000|Overall Study|Physician Decision|2|||
163937728|NCT02304705|592142707|FG001|Overall Study|Physician Decision|4|||
163937729|NCT02304705|592142706|FG000|Overall Study|Death|0|||
163937730|NCT02304705|592142707|FG001|Overall Study|Death|1|||
163937731|NCT02304705|592142706|FG000|Overall Study|Lost to Follow-up|0|||
163937732|NCT02304705|592142707|FG001|Overall Study|Lost to Follow-up|2|||
163937733|NCT00770029|592142708|FG000|Overall Study|Lost to Follow-up|2|||
163937734|NCT00770029|592142709|FG001|Overall Study|Lost to Follow-up|0|||
163937735|NCT00770029|592142708|FG000|Overall Study|Withdrawal by Subject|3|||
163937736|NCT00770029|592142709|FG001|Overall Study|Withdrawal by Subject|3|||
163937737|NCT00770029|592142708|FG000|Overall Study|Adverse Event|1|||
163937738|NCT00770029|592142709|FG001|Overall Study|Adverse Event|0|||
163937739|NCT05620108|592142712|FG000|Overall Study|Physician Decision|1|||
163937740|NCT05620108|592142713|FG001|Overall Study|Physician Decision|2|||
163937741|NCT05602727|592142714|FG000|Overall Study|Physician Decision|0|||
163937742|NCT05602727|592142715|FG001|Overall Study|Physician Decision|1|||
163937743|NCT05602727|592142716|FG002|Overall Study|Physician Decision|0|||
163937744|NCT05602727|592142714|FG000|Overall Study|Randomized by mistake without study medication|1|||
163937745|NCT05602727|592142715|FG001|Overall Study|Randomized by mistake without study medication|0|||
163937746|NCT05602727|592142716|FG002|Overall Study|Randomized by mistake without study medication|0|||
163937747|NCT05602727|592142714|FG000|Overall Study|Study termination by Sponsor|18|||
163937748|NCT05602727|592142715|FG001|Overall Study|Study termination by Sponsor|15|||
163937749|NCT05602727|592142716|FG002|Overall Study|Study termination by Sponsor|19|||
163937750|NCT05602727|592142714|FG000|Overall Study|Withdrawal by Subject|2|||
163937751|NCT05602727|592142715|FG001|Overall Study|Withdrawal by Subject|1|||
163937752|NCT05602727|592142716|FG002|Overall Study|Withdrawal by Subject|1|||
163937753|NCT05602727|592142714|FG000|Overall Study|Various reasons|1|||
163937754|NCT05602727|592142715|FG001|Overall Study|Various reasons|6|||
163937755|NCT05602727|592142716|FG002|Overall Study|Various reasons|1|||
163937756|NCT02038842|592142718|FG000|Overall Study|Withdrawal by Subject|2|||
163937757|NCT02038842|592142719|FG001|Overall Study|Withdrawal by Subject|2|||
163937758|NCT02038842|592142720|FG002|Overall Study|Withdrawal by Subject|0|||
163937759|NCT02038842|592142721|FG003|Overall Study|Withdrawal by Subject|0|||
163937760|NCT02038842|592142718|FG000|Overall Study|Participant decision|0|||
163937761|NCT02038842|592142719|FG001|Overall Study|Participant decision|0|||
163937762|NCT02038842|592142720|FG002|Overall Study|Participant decision|2|||
163937763|NCT02038842|592142721|FG003|Overall Study|Participant decision|1|||
163937764|NCT02038842|592142718|FG000|Overall Study|Adverse Event|0|||
163937765|NCT02038842|592142719|FG001|Overall Study|Adverse Event|0|||
163937766|NCT02038842|592142720|FG002|Overall Study|Adverse Event|3|||
163937767|NCT02038842|592142721|FG003|Overall Study|Adverse Event|1|||
163937768|NCT02038842|592142718|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
163937769|NCT02038842|592142719|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
163937770|NCT02038842|592142720|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
163937771|NCT02038842|592142721|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
163937772|NCT01661205|592142722|FG000|Overall Study|Physician Decision|2|||
163937773|NCT00426127|592142723|FG000|Overall Study|Adverse Event|1|||
163937774|NCT00426127|592142723|FG000|Overall Study|Removed due to disease progression|1|||
164098817|NCT02193880|592726919|FG000|Overall Study|patients did not collect enough HPC|3|||
163937775|NCT03111095|592142724|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
163937776|NCT03111095|592142725|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
163937777|NCT03111095|592142724|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
163937778|NCT03111095|592142725|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
163937779|NCT00955708|592142726|FG000|Overall Study|Death|269|||
163937780|NCT00955708|592142726|FG000|Overall Study|Lost to Follow-up|72|||
163937781|NCT00955708|592142726|FG000|Overall Study|Physician Decision|36|||
164098818|NCT02419937|592726926|FG000|Overall Study|Lost to Follow-up|1|||
164098819|NCT02419937|592726927|FG001|Overall Study|Lost to Follow-up|0|||
164098820|NCT01182415|592726928|FG000|Overall Study|Lost to Follow-up|1|||
163937782|NCT00955708|592142726|FG000|Overall Study|Protocol Violation|134|||
163937783|NCT00955708|592142726|FG000|Overall Study|Registry Conclusion|186|||
163937784|NCT00955708|592142726|FG000|Overall Study|Product removed from service|94|||
163937785|NCT00955708|592142726|FG000|Overall Study|Patient Refused to participate further|116|||
163937786|NCT00955708|592142726|FG000|Overall Study|Closure of study location|60|||
163937787|NCT00955708|592142726|FG000|Overall Study|Patient changed care provider/moved|91|||
163937788|NCT01735175|592142736|FG000|Overall Study|Withdrawal by Subject|9|||
163937789|NCT01735175|592142737|FG001|Overall Study|Withdrawal by Subject|2|||
163937790|NCT01735175|592142736|FG000|Overall Study|Lost to Follow-up|4|||
163937791|NCT01735175|592142737|FG001|Overall Study|Lost to Follow-up|2|||
163937792|NCT01735175|592142736|FG000|Overall Study|Death|3|||
163937793|NCT01735175|592142737|FG001|Overall Study|Death|2|||
163937794|NCT01735175|592142736|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
163937795|NCT01735175|592142737|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
163937796|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
163937797|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
163937798|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
163937799|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
163937800|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
163937801|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
163937802|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
163937803|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
163937804|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
163937805|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
163937806|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
163937807|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
163937808|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
163937809|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
163937810|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
163937811|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
163937812|NCT04210843|592142740|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
163937813|NCT04210843|592142741|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
163937814|NCT04210843|592142740|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
163937815|NCT04210843|592142741|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
163937816|NCT04210843|592142740|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
163937817|NCT04210843|592142741|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
163937818|NCT04210843|592142740|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
163937819|NCT04210843|592142741|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
163937820|NCT04210843|592142740|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
163937821|NCT04210843|592142741|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
163937822|NCT04210843|592142740|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
163937823|NCT04210843|592142741|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
163937824|NCT04210843|592142740|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
163937825|NCT04210843|592142741|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
163937826|NCT04210843|592142740|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
163937827|NCT04210843|592142741|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
163937828|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
163937829|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
163937830|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
163937831|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
163937832|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
163937833|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
163937834|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
163937835|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
163937836|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
163937837|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
163937838|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
163937839|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
163937840|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
163937841|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
163937842|NCT04210843|592142740|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
163937843|NCT04210843|592142741|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
163937844|NCT01266161|592142742|FG000|Overall Study|Ineligible|1|||
163937845|NCT01266161|592142743|FG001|Overall Study|Ineligible|0|||
163937846|NCT01266161|592142742|FG000|Overall Study|Lack of Efficacy|0|||
163937847|NCT01266161|592142743|FG001|Overall Study|Lack of Efficacy|1|||
163937848|NCT01266161|592142742|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
163937849|NCT01266161|592142743|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
163937850|NCT01427725|592142748|FG000|Overall Study|Lost to Follow-up|17|||
163937851|NCT01427725|592142748|FG000|Overall Study|Protocol Violation|1|||
163937852|NCT01427725|592142748|FG000|Overall Study|Drug not administered|1|||
163937853|NCT01427725|592142748|FG000|Overall Study|Failure to visit|7|||
163937854|NCT01427725|592142748|FG000|Overall Study|Adverse Event|46|||
163937855|NCT01427725|592142748|FG000|Overall Study|Failure to visit after administration|40|||
164040613|NCT04080752|592508818|FG001|Overall Study|Adverse Event|3|||
164040614|NCT04080752|592508817|FG000|Overall Study|Lack of Efficacy|1|||
164040615|NCT04080752|592508818|FG001|Overall Study|Lack of Efficacy|0|||
163937856|NCT01427725|592142748|FG000|Overall Study|Patient's rejection|27|||
163937857|NCT01427725|592142748|FG000|Overall Study|Transfer to a different hospital|17|||
163937858|NCT01427725|592142748|FG000|Overall Study|Lack of Efficacy|8|||
163937859|NCT01427725|592142748|FG000|Overall Study|Death|7|||
163937860|NCT01427725|592142748|FG000|Overall Study|Symptom improvement|6|||
163937861|NCT01427725|592142748|FG000|Overall Study|AE and Patient's rejection|5|||
163937862|NCT01427725|592142748|FG000|Overall Study|Physician Decision|5|||
163937863|NCT01427725|592142748|FG000|Overall Study|Exacerbation of underlying disease|5|||
163937864|NCT01427725|592142748|FG000|Overall Study|Oral feeding difficulty|5|||
163937865|NCT01427725|592142748|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
163937866|NCT01427725|592142748|FG000|Overall Study|Forgetting prescription|1|||
163937867|NCT01427725|592142748|FG000|Overall Study|Other|2|||
163937868|NCT01374568|592142749|FG000|Overall Study|Lab unable to analyze BTM|0|||
163937869|NCT01374568|592142750|FG001|Overall Study|Lab unable to analyze BTM|2|||
163937870|NCT01277887|592142752|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
163937871|NCT01277887|592142753|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
163937872|NCT01277887|592142752|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
163937873|NCT01277887|592142753|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
163937874|NCT01277887|592142752|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
163937875|NCT01277887|592142753|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
163937876|NCT00415051|592142754|FG000|Overall Study|Protocol Violation|1|||
163937877|NCT04160988|592142763|FG000|Overall Study|poor image quality|28|||
163937878|NCT00844597|592142764|FG000|Overall Study|Adverse Event|0|||
163937879|NCT00844597|592142765|FG001|Overall Study|Adverse Event|0|||
163937880|NCT00844597|592142766|FG002|Overall Study|Adverse Event|0|||
163937881|NCT00844597|592142767|FG003|Overall Study|Adverse Event|1|||
163937882|NCT00844597|592142768|FG004|Overall Study|Adverse Event|0|||
163937883|NCT00844597|592142769|FG005|Overall Study|Adverse Event|0|||
163937884|NCT01250509|592142770|FG000|Overall Study|Lost to Follow-up|5|||
163937885|NCT01250509|592142771|FG001|Overall Study|Lost to Follow-up|2|||
163937886|NCT00243074|592142778|FG000|Overall Study|Ineligible|6|||
163937887|NCT00243074|592142778|FG000|Overall Study|Adverse Event|6|||
163937888|NCT00243074|592142778|FG000|Overall Study|Withdrawal by Subject|2|||
163937889|NCT00243074|592142778|FG000|Overall Study|Lack of Efficacy|36|||
163937890|NCT00243074|592142778|FG000|Overall Study|Death|2|||
163937891|NCT00243074|592142778|FG000|Overall Study|not protocol specified|1|||
163937892|NCT00243074|592142778|FG000|Overall Study|Did not receive any treatment|1|||
163937893|NCT00570908|592142781|FG000|Overall Study|Adverse Event|5|||
163937894|NCT00570908|592142781|FG000|Overall Study|Withdrawal by Subject|2|||
163937895|NCT01213524|592142782|FG000|Baseline|Withdrawal by Subject|5|||
163937896|NCT01213524|592142782|FG000|Baseline|high breath alcohol levels|1|||
163937897|NCT01213524|592142782|FG000|Baseline|Physician Decision|1|||
163937898|NCT01213524|592142782|FG000|Session 2|Withdrawal by Subject|5|||
163937899|NCT01213524|592142782|FG000|Session 3|Withdrawal by Subject|4|||
163937900|NCT01213524|592142782|FG000|Session 4|Physician Decision|1|||
163937901|NCT01213524|592142782|FG000|Session 4|Withdrawal by Subject|2|||
163937902|NCT05415748|592142783|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
163937903|NCT05415748|592142784|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
163937904|NCT05415748|592142785|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
163937905|NCT05415748|592142786|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
163937906|NCT05415748|592142783|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
163937907|NCT05415748|592142784|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
163937908|NCT05415748|592142785|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
163937909|NCT05415748|592142786|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
163937910|NCT01447576|592142787|FG000|Overall Study|Lost to Follow-up|52|||
163937911|NCT01447576|592142787|FG000|Overall Study|Adverse Event|127|||
163937912|NCT01447576|592142787|FG000|Overall Study|Participant met withdrawal criteria|40|||
163937913|NCT01447576|592142787|FG000|Overall Study|Withdrawal by Subject|100|||
163937914|NCT01447576|592142787|FG000|Overall Study|Protocol deviation|83|||
163937915|NCT01447576|592142787|FG000|Overall Study|Lack of Efficacy|68|||
163937916|NCT01447576|592142787|FG000|Overall Study|Physician Decision|6|||
163937917|NCT00975676|592142788|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
163937918|NCT00975676|592142789|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
164098821|NCT01256684|592726929|FG000|Overall Study|Adverse Event|1|||
164098822|NCT01256684|592726930|FG001|Overall Study|Adverse Event|4|||
163937919|NCT02209181|592142790|FG000|Overall Study|Adverse Event|1|||
163937920|NCT02209181|592142791|FG001|Overall Study|Adverse Event|0|||
163937921|NCT02209181|592142792|FG002|Overall Study|Adverse Event|1|||
163937922|NCT02209181|592142793|FG003|Overall Study|Adverse Event|0|||
163937923|NCT02209181|592142790|FG000|Overall Study|Withdrawal by Subject|0|||
163937924|NCT02209181|592142791|FG001|Overall Study|Withdrawal by Subject|1|||
163937925|NCT02209181|592142792|FG002|Overall Study|Withdrawal by Subject|0|||
163937926|NCT02209181|592142793|FG003|Overall Study|Withdrawal by Subject|0|||
163937927|NCT02579772|592142794|FG000|Overall Study|Withdrawal by Subject|0|||
163937928|NCT02579772|592142795|FG001|Overall Study|Withdrawal by Subject|1|||
164098823|NCT01256684|592726931|FG002|Overall Study|Adverse Event|2|||
164098824|NCT01256684|592726929|FG000|Overall Study|Withdrawal by Subject|4|||
163937929|NCT02579772|592142794|FG000|Overall Study|Usage of additional antioxidants|1|||
163937930|NCT02579772|592142795|FG001|Overall Study|Usage of additional antioxidants|0|||
163937931|NCT02579772|592142794|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
163937932|NCT02579772|592142795|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
163937933|NCT03128671|592142796|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
163937934|NCT03128671|592142797|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
163937935|NCT03128671|592142796|FG000|Allocation|Death|1|||
163937936|NCT03128671|592142797|FG001|Allocation|Death|0|||
163937937|NCT03128671|592142796|FG000|Allocation|Withdrawal by Subject|4|||
163937938|NCT03128671|592142797|FG001|Allocation|Withdrawal by Subject|0|||
163937939|NCT03128671|592142796|FG000|Intervention|Withdrawal by Subject|11|||
163937940|NCT03128671|592142797|FG001|Intervention|Withdrawal by Subject|10|||
163937941|NCT03128671|592142796|FG000|Intervention|Palliative/hospice care initiated|9|||
163937942|NCT03128671|592142797|FG001|Intervention|Palliative/hospice care initiated|10|||
163937943|NCT03128671|592142796|FG000|Intervention|Death|13|||
163937944|NCT03128671|592142797|FG001|Intervention|Death|11|||
163937945|NCT03128671|592142796|FG000|Intervention|Interrupted by hurricane|1|||
163937946|NCT03128671|592142797|FG001|Intervention|Interrupted by hurricane|0|||
163937947|NCT03128671|592142796|FG000|Intervention|Physician Decision|2|||
163937948|NCT03128671|592142797|FG001|Intervention|Physician Decision|3|||
163937949|NCT04641962|592142799|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
163937950|NCT04641962|592142800|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
163937951|NCT04641962|592142801|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
163937952|NCT04641962|592142802|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
163937953|NCT04641962|592142803|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
163937954|NCT04641962|592142799|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163937955|NCT04641962|592142800|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163937956|NCT04641962|592142801|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163937957|NCT04641962|592142802|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
163937958|NCT04641962|592142803|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
163937959|NCT04641962|592142799|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
163937960|NCT04641962|592142800|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
163937961|NCT04641962|592142801|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
163937962|NCT04641962|592142802|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
163937963|NCT04641962|592142803|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
163937964|NCT04641962|592142799|FG000|DBT Period: Up to 52 Weeks|Death|1|||
163937965|NCT04641962|592142800|FG001|DBT Period: Up to 52 Weeks|Death|0|||
163937966|NCT04641962|592142801|FG002|DBT Period: Up to 52 Weeks|Death|0|||
163937967|NCT04641962|592142802|FG003|DBT Period: Up to 52 Weeks|Death|0|||
163937968|NCT04641962|592142803|FG004|DBT Period: Up to 52 Weeks|Death|0|||
163937969|NCT04641962|592142799|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
163937970|NCT04641962|592142800|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
163937971|NCT04641962|592142801|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
163937972|NCT04641962|592142802|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
163937973|NCT04641962|592142803|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
163937974|NCT04641962|592142799|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
163937975|NCT04641962|592142800|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
163937976|NCT04641962|592142801|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
163937977|NCT04641962|592142802|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
163937978|NCT04641962|592142803|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
163937979|NCT04641962|592142799|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163937980|NCT04641962|592142800|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163937981|NCT04641962|592142801|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
163937982|NCT04641962|592142802|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163937983|NCT04641962|592142803|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
163937984|NCT00862836|592142804|FG000|Overall Study|Withdrawal by Subject|1|||
163937985|NCT04463680|592142805|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
163937986|NCT04463680|592142805|FG000|Overall Study|Not eligible due to implant duration of use|1|||
163937987|NCT04463680|592142805|FG000|Overall Study|Withdrawal by Subject|3|||
163937988|NCT02998476|592142810|FG000|Overall Study|Lost to Follow-up|1|||
163937989|NCT02998476|592142811|FG001|Overall Study|Lost to Follow-up|0|||
163937990|NCT02998476|592142810|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
163937991|NCT02998476|592142811|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
163937992|NCT02998476|592142810|FG000|Overall Study|Withdrawal by Subject|1|||
163937993|NCT02998476|592142811|FG001|Overall Study|Withdrawal by Subject|2|||
163937994|NCT02998476|592142810|FG000|Overall Study|Death|45|||
163937995|NCT02998476|592142811|FG001|Overall Study|Death|2|||
163937996|NCT02998476|592142810|FG000|Overall Study|Other|6|||
163937997|NCT02998476|592142811|FG001|Overall Study|Other|1|||
163937998|NCT00344032|592142813|FG000|Overall Study|Adverse Event|0|||
163937999|NCT00344032|592142814|FG001|Overall Study|Adverse Event|1|||
163938000|NCT00344032|592142813|FG000|Overall Study|Withdrawal by Subject|6|||
163938001|NCT00344032|592142814|FG001|Overall Study|Withdrawal by Subject|2|||
164040616|NCT04080752|592508817|FG000|Overall Study|Lost to Follow-up|1|||
163840294|NCT00152971|591785815|FG000|Treatment|Withdrawal by Subject|4|||
163840295|NCT00152971|591785816|FG001|Treatment|Withdrawal by Subject|4|||
163840296|NCT00152971|591785817|FG002|Treatment|Withdrawal by Subject|5|||
163840297|NCT00152971|591785815|FG000|Treatment|Other|9|||
163840298|NCT00152971|591785816|FG001|Treatment|Other|11|||
163840299|NCT00152971|591785817|FG002|Treatment|Other|10|||
163840300|NCT04091360|591785818|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840301|NCT04091360|591785819|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840302|NCT04091360|591785820|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840303|NCT04091360|591785821|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840304|NCT04091360|591785822|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840305|NCT04091360|591785823|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840306|NCT04091360|591785824|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840307|NCT04091360|591785825|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
163840308|NCT04091360|591785826|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
163840309|NCT04091360|591785827|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
163840310|NCT04091360|591785818|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840311|NCT04091360|591785819|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840312|NCT04091360|591785820|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840313|NCT04091360|591785821|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840314|NCT04091360|591785822|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840315|NCT04091360|591785823|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840316|NCT04091360|591785824|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
163840317|NCT04091360|591785825|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
163840318|NCT04091360|591785826|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840319|NCT04091360|591785827|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
163840320|NCT04091360|591785818|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840321|NCT04091360|591785819|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840322|NCT04091360|591785820|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840323|NCT04091360|591785821|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840324|NCT04091360|591785822|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840325|NCT04091360|591785823|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840326|NCT04091360|591785824|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
163840327|NCT04091360|591785825|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840328|NCT04091360|591785826|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
163840329|NCT04091360|591785827|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
163840330|NCT02597933|591785828|FG000|Overall Study|Withdrawal by Subject|7|||
163840331|NCT02597933|591785829|FG001|Overall Study|Withdrawal by Subject|5|||
163840332|NCT02597933|591785828|FG000|Overall Study|Protocol Violation|2|||
163840333|NCT02597933|591785829|FG001|Overall Study|Protocol Violation|2|||
163840334|NCT02597933|591785828|FG000|Overall Study|Adverse Event|20|||
163840335|NCT02597933|591785829|FG001|Overall Study|Adverse Event|28|||
163840336|NCT02597933|591785828|FG000|Overall Study|Not treated|2|||
163840337|NCT02597933|591785829|FG001|Overall Study|Not treated|2|||
163840338|NCT02597933|591785828|FG000|Overall Study|Other than stated above|7|||
163840339|NCT02597933|591785829|FG001|Overall Study|Other than stated above|14|||
163840340|NCT01617005|591785830|FG000|Overall Study|Pregnancy|1|||
163840341|NCT01617005|591785830|FG000|Overall Study|Lack of motivation for treatment|1|||
163840342|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
163840343|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
163840344|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
163840345|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
163840346|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
163840347|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
163840348|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
163840349|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
163840350|NCT01336621|591785835|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
163840351|NCT01336621|591785835|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
163840352|NCT01336621|591785835|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
163840353|NCT01336621|591785835|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
163840354|NCT01336621|591785835|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
163840355|NCT01336621|591785835|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
163840356|NCT04534114|591785836|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
163840357|NCT04534114|591785837|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
163840358|NCT04534114|591785838|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
163840359|NCT04534114|591785839|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
163938002|NCT00344032|592142813|FG000|Overall Study|Lost to Follow-up|4|||
163938003|NCT00344032|592142814|FG001|Overall Study|Lost to Follow-up|6|||
163938004|NCT00344032|592142813|FG000|Overall Study|Physician Decision|4|||
163938005|NCT00344032|592142814|FG001|Overall Study|Physician Decision|1|||
163938006|NCT05131477|592142815|FG000|PART 1|Withdrawal by Subject|2|||
163938007|NCT05131477|592142816|FG001|PART 1|Withdrawal by Subject|9|||
163938008|NCT05131477|592142817|FG002|PART 1|Withdrawal by Subject|6|||
163938009|NCT05131477|592142818|FG003|PART 1|Withdrawal by Subject|2|||
163938010|NCT05131477|592142819|FG004|PART 1|Withdrawal by Subject|8|||
163938011|NCT05131477|592142820|FG005|PART 1|Withdrawal by Subject|0|||
163938012|NCT05131477|592142821|FG006|PART 1|Withdrawal by Subject|0|||
163938013|NCT05131477|592142822|FG007|PART 1|Withdrawal by Subject|0|||
163938014|NCT05131477|592142823|FG008|PART 1|Withdrawal by Subject|0|||
163938015|NCT05131477|592142824|FG009|PART 1|Withdrawal by Subject|0|||
163938016|NCT05131477|592142825|FG010|PART 1|Withdrawal by Subject|0|||
163938017|NCT05131477|592142826|FG011|PART 1|Withdrawal by Subject|0|||
163938018|NCT05131477|592142827|FG012|PART 1|Withdrawal by Subject|0|||
163938019|NCT05131477|592142828|FG013|PART 1|Withdrawal by Subject|0|||
163938020|NCT05131477|592142815|FG000|PART 1|Physician Decision|1|||
163938021|NCT05131477|592142816|FG001|PART 1|Physician Decision|0|||
163938022|NCT05131477|592142817|FG002|PART 1|Physician Decision|0|||
163938023|NCT05131477|592142818|FG003|PART 1|Physician Decision|0|||
163938024|NCT05131477|592142819|FG004|PART 1|Physician Decision|0|||
163938025|NCT05131477|592142820|FG005|PART 1|Physician Decision|0|||
163938026|NCT05131477|592142821|FG006|PART 1|Physician Decision|0|||
163938027|NCT05131477|592142822|FG007|PART 1|Physician Decision|0|||
163938028|NCT05131477|592142823|FG008|PART 1|Physician Decision|0|||
163938029|NCT05131477|592142824|FG009|PART 1|Physician Decision|0|||
163938030|NCT05131477|592142825|FG010|PART 1|Physician Decision|0|||
163938031|NCT05131477|592142826|FG011|PART 1|Physician Decision|0|||
163938032|NCT05131477|592142827|FG012|PART 1|Physician Decision|0|||
163938033|NCT05131477|592142828|FG013|PART 1|Physician Decision|0|||
163938034|NCT05131477|592142815|FG000|PART 1|Adverse Event|3|||
163938035|NCT05131477|592142816|FG001|PART 1|Adverse Event|5|||
163938036|NCT05131477|592142817|FG002|PART 1|Adverse Event|1|||
163938037|NCT05131477|592142818|FG003|PART 1|Adverse Event|6|||
163938038|NCT05131477|592142819|FG004|PART 1|Adverse Event|4|||
163938039|NCT05131477|592142820|FG005|PART 1|Adverse Event|0|||
164040617|NCT04080752|592508818|FG001|Overall Study|Lost to Follow-up|0|||
164040618|NCT04080752|592508817|FG000|Overall Study|Pregnancy|0|||
164040619|NCT04080752|592508818|FG001|Overall Study|Pregnancy|1|||
164040620|NCT04080752|592508817|FG000|Overall Study|Withdrawal by Subject|7|||
164040621|NCT04080752|592508818|FG001|Overall Study|Withdrawal by Subject|0|||
164040622|NCT04080752|592508817|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164040623|NCT04080752|592508818|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164040624|NCT04080752|592508817|FG000|Overall Study|Other|2|||
164040625|NCT04080752|592508818|FG001|Overall Study|Other|1|||
164040626|NCT01641081|592508821|FG000|Period 1|Sponsor request (potential unblinding)|0|||
164040627|NCT01641081|592508822|FG001|Period 1|Sponsor request (potential unblinding)|0|||
164040628|NCT01641081|592508823|FG002|Period 1|Sponsor request (potential unblinding)|0|||
164040629|NCT01641081|592508824|FG003|Period 1|Sponsor request (potential unblinding)|0|||
164040630|NCT01641081|592508825|FG004|Period 1|Sponsor request (potential unblinding)|0|||
164040631|NCT01641081|592508826|FG005|Period 1|Sponsor request (potential unblinding)|0|||
164040632|NCT01641081|592508827|FG006|Period 1|Sponsor request (potential unblinding)|1|||
164040633|NCT01641081|592508828|FG007|Period 1|Sponsor request (potential unblinding)|0|||
164040634|NCT01641081|592508829|FG008|Period 1|Sponsor request (potential unblinding)|0|||
164040635|NCT01641081|592508830|FG009|Period 1|Sponsor request (potential unblinding)|0|||
164040636|NCT01641081|592508821|FG000|Period 1|Protocol Violation|0|||
164040637|NCT01641081|592508822|FG001|Period 1|Protocol Violation|0|||
164040638|NCT01641081|592508823|FG002|Period 1|Protocol Violation|0|||
164040639|NCT01641081|592508824|FG003|Period 1|Protocol Violation|0|||
164098825|NCT01256684|592726930|FG001|Overall Study|Withdrawal by Subject|0|||
164098826|NCT01256684|592726931|FG002|Overall Study|Withdrawal by Subject|2|||
164040640|NCT01641081|592508825|FG004|Period 1|Protocol Violation|1|||
164040641|NCT01641081|592508826|FG005|Period 1|Protocol Violation|0|||
164040642|NCT01641081|592508827|FG006|Period 1|Protocol Violation|0|||
164040643|NCT01641081|592508828|FG007|Period 1|Protocol Violation|1|||
164040644|NCT01641081|592508829|FG008|Period 1|Protocol Violation|0|||
164040645|NCT01641081|592508830|FG009|Period 1|Protocol Violation|0|||
164040646|NCT01641081|592508821|FG000|Period 1|Adverse Event|1|||
164040647|NCT01641081|592508822|FG001|Period 1|Adverse Event|0|||
164040648|NCT01641081|592508823|FG002|Period 1|Adverse Event|0|||
164098827|NCT01256684|592726929|FG000|Overall Study|Physician Decision|0|||
164098828|NCT01256684|592726930|FG001|Overall Study|Physician Decision|1|||
163938040|NCT05131477|592142821|FG006|PART 1|Adverse Event|0|||
163938041|NCT05131477|592142822|FG007|PART 1|Adverse Event|0|||
163938042|NCT05131477|592142823|FG008|PART 1|Adverse Event|0|||
164040649|NCT01641081|592508824|FG003|Period 1|Adverse Event|0|||
163938043|NCT05131477|592142824|FG009|PART 1|Adverse Event|0|||
163938044|NCT05131477|592142825|FG010|PART 1|Adverse Event|0|||
163938045|NCT05131477|592142826|FG011|PART 1|Adverse Event|0|||
164040650|NCT01641081|592508825|FG004|Period 1|Adverse Event|0|||
164040651|NCT01641081|592508826|FG005|Period 1|Adverse Event|0|||
164098829|NCT01256684|592726931|FG002|Overall Study|Physician Decision|0|||
163938046|NCT05131477|592142827|FG012|PART 1|Adverse Event|0|||
163938047|NCT05131477|592142828|FG013|PART 1|Adverse Event|0|||
163938048|NCT05131477|592142815|FG000|PART 1|unclassified|1|||
163938049|NCT05131477|592142816|FG001|PART 1|unclassified|1|||
163938050|NCT05131477|592142817|FG002|PART 1|unclassified|0|||
163938051|NCT05131477|592142818|FG003|PART 1|unclassified|0|||
163938052|NCT05131477|592142819|FG004|PART 1|unclassified|4|||
163938053|NCT05131477|592142820|FG005|PART 1|unclassified|0|||
163938054|NCT05131477|592142821|FG006|PART 1|unclassified|0|||
163938055|NCT05131477|592142822|FG007|PART 1|unclassified|0|||
163938056|NCT05131477|592142823|FG008|PART 1|unclassified|0|||
163938057|NCT05131477|592142824|FG009|PART 1|unclassified|0|||
163938058|NCT05131477|592142825|FG010|PART 1|unclassified|0|||
163938059|NCT05131477|592142826|FG011|PART 1|unclassified|0|||
163938060|NCT05131477|592142827|FG012|PART 1|unclassified|0|||
163938061|NCT05131477|592142828|FG013|PART 1|unclassified|0|||
163938062|NCT05131477|592142815|FG000|PART 1|Randomized and not treated|0|||
163938063|NCT05131477|592142816|FG001|PART 1|Randomized and not treated|0|||
163938064|NCT05131477|592142817|FG002|PART 1|Randomized and not treated|0|||
163938065|NCT05131477|592142818|FG003|PART 1|Randomized and not treated|1|||
163938066|NCT05131477|592142819|FG004|PART 1|Randomized and not treated|1|||
163938067|NCT05131477|592142820|FG005|PART 1|Randomized and not treated|0|||
163938068|NCT05131477|592142821|FG006|PART 1|Randomized and not treated|0|||
163938069|NCT05131477|592142822|FG007|PART 1|Randomized and not treated|0|||
163938070|NCT05131477|592142823|FG008|PART 1|Randomized and not treated|0|||
163938071|NCT05131477|592142824|FG009|PART 1|Randomized and not treated|0|||
163938072|NCT05131477|592142825|FG010|PART 1|Randomized and not treated|0|||
163938073|NCT05131477|592142826|FG011|PART 1|Randomized and not treated|0|||
163938074|NCT05131477|592142827|FG012|PART 1|Randomized and not treated|0|||
163938075|NCT05131477|592142828|FG013|PART 1|Randomized and not treated|0|||
163938076|NCT05131477|592142815|FG000|PART 1|Protocol Violation|2|||
163938077|NCT05131477|592142816|FG001|PART 1|Protocol Violation|0|||
163938078|NCT05131477|592142817|FG002|PART 1|Protocol Violation|0|||
163938079|NCT05131477|592142818|FG003|PART 1|Protocol Violation|1|||
163938080|NCT05131477|592142819|FG004|PART 1|Protocol Violation|0|||
163938081|NCT05131477|592142820|FG005|PART 1|Protocol Violation|0|||
163938082|NCT05131477|592142821|FG006|PART 1|Protocol Violation|0|||
163938083|NCT05131477|592142822|FG007|PART 1|Protocol Violation|0|||
163938084|NCT05131477|592142823|FG008|PART 1|Protocol Violation|0|||
163938085|NCT05131477|592142824|FG009|PART 1|Protocol Violation|0|||
163938086|NCT05131477|592142825|FG010|PART 1|Protocol Violation|0|||
163938087|NCT05131477|592142826|FG011|PART 1|Protocol Violation|0|||
163938088|NCT05131477|592142827|FG012|PART 1|Protocol Violation|0|||
163938089|NCT05131477|592142828|FG013|PART 1|Protocol Violation|0|||
163938090|NCT05131477|592142815|FG000|PART 1|Lack of Efficacy|0|||
163938091|NCT05131477|592142816|FG001|PART 1|Lack of Efficacy|1|||
163938092|NCT05131477|592142817|FG002|PART 1|Lack of Efficacy|1|||
163938093|NCT05131477|592142818|FG003|PART 1|Lack of Efficacy|2|||
163938094|NCT05131477|592142819|FG004|PART 1|Lack of Efficacy|5|||
163938095|NCT05131477|592142820|FG005|PART 1|Lack of Efficacy|0|||
163938096|NCT05131477|592142821|FG006|PART 1|Lack of Efficacy|0|||
163938097|NCT05131477|592142822|FG007|PART 1|Lack of Efficacy|0|||
163938098|NCT05131477|592142823|FG008|PART 1|Lack of Efficacy|0|||
163938099|NCT05131477|592142824|FG009|PART 1|Lack of Efficacy|0|||
163938100|NCT05131477|592142825|FG010|PART 1|Lack of Efficacy|0|||
163938101|NCT05131477|592142826|FG011|PART 1|Lack of Efficacy|0|||
163938102|NCT05131477|592142827|FG012|PART 1|Lack of Efficacy|0|||
163938103|NCT05131477|592142828|FG013|PART 1|Lack of Efficacy|0|||
163938104|NCT05131477|592142815|FG000|PART 2|Withdrawal by Subject|0|||
163938105|NCT05131477|592142816|FG001|PART 2|Withdrawal by Subject|0|||
163938106|NCT05131477|592142817|FG002|PART 2|Withdrawal by Subject|0|||
163938107|NCT05131477|592142818|FG003|PART 2|Withdrawal by Subject|0|||
163938108|NCT05131477|592142819|FG004|PART 2|Withdrawal by Subject|0|||
163938109|NCT05131477|592142820|FG005|PART 2|Withdrawal by Subject|0|||
163938110|NCT05131477|592142821|FG006|PART 2|Withdrawal by Subject|2|||
163938111|NCT05131477|592142822|FG007|PART 2|Withdrawal by Subject|0|||
163938112|NCT05131477|592142823|FG008|PART 2|Withdrawal by Subject|0|||
163938113|NCT05131477|592142824|FG009|PART 2|Withdrawal by Subject|0|||
164098830|NCT01256684|592726929|FG000|Overall Study|Lack of Efficacy|0|||
163938114|NCT05131477|592142825|FG010|PART 2|Withdrawal by Subject|2|||
164098831|NCT01256684|592726930|FG001|Overall Study|Lack of Efficacy|1|||
164098832|NCT01256684|592726931|FG002|Overall Study|Lack of Efficacy|1|||
163938115|NCT05131477|592142826|FG011|PART 2|Withdrawal by Subject|0|||
163938116|NCT05131477|592142827|FG012|PART 2|Withdrawal by Subject|2|||
163938117|NCT05131477|592142828|FG013|PART 2|Withdrawal by Subject|2|||
163938118|NCT05131477|592142815|FG000|PART 2|Other|0|||
163938119|NCT05131477|592142816|FG001|PART 2|Other|0|||
163938120|NCT05131477|592142817|FG002|PART 2|Other|0|||
163938121|NCT05131477|592142818|FG003|PART 2|Other|0|||
163938122|NCT05131477|592142819|FG004|PART 2|Other|0|||
163938123|NCT05131477|592142820|FG005|PART 2|Other|0|||
163938124|NCT05131477|592142821|FG006|PART 2|Other|0|||
163938125|NCT05131477|592142822|FG007|PART 2|Other|0|||
163938126|NCT05131477|592142823|FG008|PART 2|Other|1|||
163938127|NCT05131477|592142824|FG009|PART 2|Other|1|||
163938128|NCT05131477|592142825|FG010|PART 2|Other|0|||
163938129|NCT05131477|592142826|FG011|PART 2|Other|0|||
163938130|NCT05131477|592142827|FG012|PART 2|Other|1|||
163938131|NCT05131477|592142828|FG013|PART 2|Other|0|||
163938132|NCT05131477|592142815|FG000|PART 2|Lack of Efficacy|0|||
163938133|NCT05131477|592142816|FG001|PART 2|Lack of Efficacy|0|||
163938134|NCT05131477|592142817|FG002|PART 2|Lack of Efficacy|0|||
163938135|NCT05131477|592142818|FG003|PART 2|Lack of Efficacy|0|||
163938136|NCT05131477|592142819|FG004|PART 2|Lack of Efficacy|0|||
163938137|NCT05131477|592142820|FG005|PART 2|Lack of Efficacy|1|||
163938138|NCT05131477|592142821|FG006|PART 2|Lack of Efficacy|1|||
163938139|NCT05131477|592142822|FG007|PART 2|Lack of Efficacy|0|||
163938140|NCT05131477|592142823|FG008|PART 2|Lack of Efficacy|3|||
163938141|NCT05131477|592142824|FG009|PART 2|Lack of Efficacy|0|||
163938142|NCT05131477|592142825|FG010|PART 2|Lack of Efficacy|1|||
163938143|NCT05131477|592142826|FG011|PART 2|Lack of Efficacy|0|||
163938144|NCT05131477|592142827|FG012|PART 2|Lack of Efficacy|2|||
163938145|NCT05131477|592142828|FG013|PART 2|Lack of Efficacy|0|||
163938146|NCT05131477|592142815|FG000|PART 2|Unclassified|0|||
163938147|NCT05131477|592142816|FG001|PART 2|Unclassified|0|||
163938148|NCT05131477|592142817|FG002|PART 2|Unclassified|0|||
163938149|NCT05131477|592142818|FG003|PART 2|Unclassified|0|||
163938150|NCT05131477|592142819|FG004|PART 2|Unclassified|0|||
163938151|NCT05131477|592142820|FG005|PART 2|Unclassified|0|||
163938152|NCT05131477|592142821|FG006|PART 2|Unclassified|0|||
163938153|NCT05131477|592142822|FG007|PART 2|Unclassified|0|||
163938154|NCT05131477|592142823|FG008|PART 2|Unclassified|0|||
163938155|NCT05131477|592142824|FG009|PART 2|Unclassified|0|||
163938156|NCT05131477|592142825|FG010|PART 2|Unclassified|1|||
163938157|NCT05131477|592142826|FG011|PART 2|Unclassified|0|||
163938158|NCT05131477|592142827|FG012|PART 2|Unclassified|0|||
163938159|NCT05131477|592142828|FG013|PART 2|Unclassified|0|||
163938160|NCT05131477|592142815|FG000|PART 2|Re-randomized and not treated|0|||
163938161|NCT05131477|592142816|FG001|PART 2|Re-randomized and not treated|0|||
163938162|NCT05131477|592142817|FG002|PART 2|Re-randomized and not treated|0|||
163938163|NCT05131477|592142818|FG003|PART 2|Re-randomized and not treated|0|||
163938164|NCT05131477|592142819|FG004|PART 2|Re-randomized and not treated|0|||
163938165|NCT05131477|592142820|FG005|PART 2|Re-randomized and not treated|0|||
163938166|NCT05131477|592142821|FG006|PART 2|Re-randomized and not treated|0|||
163938167|NCT05131477|592142822|FG007|PART 2|Re-randomized and not treated|1|||
163938168|NCT05131477|592142823|FG008|PART 2|Re-randomized and not treated|0|||
163938169|NCT05131477|592142824|FG009|PART 2|Re-randomized and not treated|0|||
163938170|NCT05131477|592142825|FG010|PART 2|Re-randomized and not treated|1|||
163938171|NCT05131477|592142826|FG011|PART 2|Re-randomized and not treated|0|||
163938172|NCT05131477|592142827|FG012|PART 2|Re-randomized and not treated|1|||
163938173|NCT05131477|592142828|FG013|PART 2|Re-randomized and not treated|1|||
163938174|NCT06840769|592142830|FG000|Overall Study|Withdrawal by Subject|1|||
163938175|NCT06840769|592142831|FG001|Overall Study|Withdrawal by Subject|0|||
163938176|NCT06840769|592142832|FG002|Overall Study|Withdrawal by Subject|0|||
163938177|NCT06840769|592142833|FG003|Overall Study|Withdrawal by Subject|0|||
163938178|NCT06840769|592142834|FG004|Overall Study|Withdrawal by Subject|0|||
163938179|NCT02726945|592142835|FG000|Overall Study|Withdrawal by Subject|0|||
163938180|NCT02726945|592142836|FG001|Overall Study|Withdrawal by Subject|0|||
163938181|NCT02726945|592142837|FG002|Overall Study|Withdrawal by Subject|1|||
163938182|NCT02726945|592142835|FG000|Overall Study|Elected to have total knee replacement|0|||
163938183|NCT02726945|592142836|FG001|Overall Study|Elected to have total knee replacement|1|||
163938184|NCT02726945|592142837|FG002|Overall Study|Elected to have total knee replacement|0|||
163938185|NCT05992922|592142838|FG000|Overall Study|Adverse Event|6|||
163938186|NCT05992922|592142839|FG001|Overall Study|Adverse Event|0|||
163938187|NCT05992922|592142838|FG000|Overall Study|Sponsor Termination of Study|14|||
163938188|NCT05992922|592142839|FG001|Overall Study|Sponsor Termination of Study|20|||
163938189|NCT03939689|592144415|FG000|Overall Study|Radiographic progression|14|||
163938190|NCT03939689|592144416|FG001|Overall Study|Radiographic progression|17|||
163938191|NCT03939689|592144415|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
163938192|NCT03939689|592144416|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
163938193|NCT03939689|592144415|FG000|Overall Study|Adverse Event|1|||
163938194|NCT03939689|592144416|FG001|Overall Study|Adverse Event|8|||
163938195|NCT03939689|592144415|FG000|Overall Study|Unequivocal clinical progression|2|||
163938196|NCT03939689|592144416|FG001|Overall Study|Unequivocal clinical progression|5|||
163938197|NCT03939689|592144415|FG000|Overall Study|Other|1|||
163938198|NCT03939689|592144416|FG001|Overall Study|Other|4|||
163938199|NCT03939689|592144415|FG000|Overall Study|Death|0|||
163938200|NCT03939689|592144416|FG001|Overall Study|Death|3|||
163938201|NCT03939689|592144415|FG000|Overall Study|Participant decision|0|||
163938202|NCT03939689|592144416|FG001|Overall Study|Participant decision|3|||
163938203|NCT03939689|592144415|FG000|Overall Study|Withdrawal of consent|2|||
163938204|NCT03939689|592144416|FG001|Overall Study|Withdrawal of consent|1|||
163938205|NCT03939689|592144415|FG000|Overall Study|Investigator decision|1|||
163938206|NCT03939689|592144416|FG001|Overall Study|Investigator decision|0|||
163938207|NCT01920477|592144417|FG000|Overall Study|Adverse Event|0|||
163938208|NCT01920477|592144418|FG001|Overall Study|Adverse Event|1|||
163938209|NCT01920477|592144417|FG000|Overall Study|Lack of Efficacy|1|||
163938210|NCT01920477|592144418|FG001|Overall Study|Lack of Efficacy|0|||
163938211|NCT01920477|592144417|FG000|Overall Study|Study closed/terminated|14|||
163938212|NCT01920477|592144418|FG001|Overall Study|Study closed/terminated|15|||
163938213|NCT01920477|592144417|FG000|Overall Study|Withdrawal by Subject|0|||
163938214|NCT01920477|592144418|FG001|Overall Study|Withdrawal by Subject|1|||
163938215|NCT03554629|592144419|FG000|Overall Study|Inadequate data|6|||
163938216|NCT01228318|592144420|FG000|Overall Study|Clinic no show to receive intervention|1|||
163938217|NCT01228318|592144421|FG001|Overall Study|Clinic no show to receive intervention|0|||
163938218|NCT01228318|592144420|FG000|Overall Study|Unable to contact|2|||
163938219|NCT01228318|592144421|FG001|Overall Study|Unable to contact|5|||
163938220|NCT01228318|592144420|FG000|Overall Study|Moved|0|||
163938221|NCT01228318|592144421|FG001|Overall Study|Moved|2|||
163938222|NCT01228318|592144420|FG000|Overall Study|Incarcerated|1|||
163938223|NCT01228318|592144421|FG001|Overall Study|Incarcerated|0|||
163938224|NCT03140280|592144422|FG000|Overall Study|Physician Decision|5|||
163938225|NCT03412773|592144425|FG000|Overall Study|Lost to Follow-up|0|||
163938226|NCT03412773|592144426|FG001|Overall Study|Lost to Follow-up|7|||
163938227|NCT03412773|592144427|FG002|Overall Study|Lost to Follow-up|6|||
163938228|NCT03412773|592144425|FG000|Overall Study|Withdrawal by Subject|0|||
163938229|NCT03412773|592144426|FG001|Overall Study|Withdrawal by Subject|15|||
163938230|NCT03412773|592144427|FG002|Overall Study|Withdrawal by Subject|19|||
163938231|NCT03412773|592144425|FG000|Overall Study|Study Closed By Sponsor|3|||
163938232|NCT03412773|592144426|FG001|Overall Study|Study Closed By Sponsor|46|||
163938233|NCT03412773|592144427|FG002|Overall Study|Study Closed By Sponsor|33|||
163938234|NCT03412773|592144425|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
163938235|NCT03412773|592144426|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
163938236|NCT03412773|592144427|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
163938237|NCT03412773|592144425|FG000|Overall Study|Death|7|||
163938238|NCT03412773|592144426|FG001|Overall Study|Death|259|||
163938239|NCT03412773|592144427|FG002|Overall Study|Death|273|||
163938240|NCT03412773|592144425|FG000|Overall Study|Physician Decision|0|||
163938241|NCT03412773|592144426|FG001|Overall Study|Physician Decision|0|||
163938242|NCT03412773|592144427|FG002|Overall Study|Physician Decision|1|||
163938243|NCT02643303|592144430|FG000|Overall Study|Progressive Disease|4|||
163938244|NCT02643303|592144431|FG001|Overall Study|Progressive Disease|4|||
163938245|NCT02643303|592144432|FG002|Overall Study|Progressive Disease|1|||
163938246|NCT02643303|592144433|FG003|Overall Study|Progressive Disease|12|||
163938247|NCT02643303|592144434|FG004|Overall Study|Progressive Disease|6|||
163938248|NCT02643303|592144435|FG005|Overall Study|Progressive Disease|4|||
163938249|NCT02643303|592144436|FG006|Overall Study|Progressive Disease|8|||
163938250|NCT02643303|592144437|FG007|Overall Study|Progressive Disease|2|||
163938251|NCT02643303|592144438|FG008|Overall Study|Progressive Disease|6|||
163938252|NCT02643303|592144430|FG000|Overall Study|Adverse Event|0|||
163938253|NCT02643303|592144431|FG001|Overall Study|Adverse Event|1|||
163938254|NCT02643303|592144432|FG002|Overall Study|Adverse Event|0|||
163938255|NCT02643303|592144433|FG003|Overall Study|Adverse Event|0|||
163938256|NCT02643303|592144434|FG004|Overall Study|Adverse Event|1|||
163938257|NCT02643303|592144435|FG005|Overall Study|Adverse Event|0|||
163938258|NCT02643303|592144436|FG006|Overall Study|Adverse Event|0|||
163938259|NCT02643303|592144437|FG007|Overall Study|Adverse Event|0|||
163938260|NCT02643303|592144438|FG008|Overall Study|Adverse Event|0|||
163938261|NCT02643303|592144430|FG000|Overall Study|Withdrawal by Subject|0|||
163938262|NCT02643303|592144431|FG001|Overall Study|Withdrawal by Subject|0|||
163938263|NCT02643303|592144432|FG002|Overall Study|Withdrawal by Subject|0|||
163938264|NCT02643303|592144433|FG003|Overall Study|Withdrawal by Subject|1|||
163938265|NCT02643303|592144434|FG004|Overall Study|Withdrawal by Subject|0|||
163938266|NCT02643303|592144435|FG005|Overall Study|Withdrawal by Subject|0|||
163938267|NCT02643303|592144436|FG006|Overall Study|Withdrawal by Subject|1|||
163938268|NCT02643303|592144437|FG007|Overall Study|Withdrawal by Subject|1|||
163938269|NCT02643303|592144438|FG008|Overall Study|Withdrawal by Subject|1|||
163938270|NCT05282121|592144441|FG000|Overall Study|Adverse Event|1|||
163938271|NCT05282121|592144442|FG001|Overall Study|Adverse Event|1|||
163938272|NCT05282121|592144443|FG002|Overall Study|Adverse Event|4|||
163938273|NCT05282121|592144444|FG003|Overall Study|Adverse Event|1|||
163938274|NCT05282121|592144441|FG000|Overall Study|Study Terminated by Sponsor|1|||
163938275|NCT05282121|592144442|FG001|Overall Study|Study Terminated by Sponsor|2|||
163938276|NCT05282121|592144443|FG002|Overall Study|Study Terminated by Sponsor|2|||
164098833|NCT01256684|592726929|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
163938277|NCT05282121|592144444|FG003|Overall Study|Study Terminated by Sponsor|2|||
163938278|NCT05282121|592144441|FG000|Overall Study|Other than listed|0|||
163938279|NCT05282121|592144442|FG001|Overall Study|Other than listed|0|||
163938280|NCT05282121|592144443|FG002|Overall Study|Other than listed|1|||
163938281|NCT05282121|592144444|FG003|Overall Study|Other than listed|0|||
163938282|NCT05282121|592144441|FG000|Overall Study|No reason available|0|||
163938283|NCT05282121|592144442|FG001|Overall Study|No reason available|0|||
163938284|NCT05282121|592144443|FG002|Overall Study|No reason available|1|||
163938285|NCT05282121|592144444|FG003|Overall Study|No reason available|0|||
163938286|NCT01250925|592144446|FG000|Overall Study|Lost to Follow-up|1|||
163938287|NCT01250925|592144447|FG001|Overall Study|Lost to Follow-up|1|||
163938288|NCT01250925|592144448|FG002|Overall Study|Lost to Follow-up|0|||
163938289|NCT01250925|592144446|FG000|Overall Study|Withdrawal by Subject|2|||
163938290|NCT01250925|592144447|FG001|Overall Study|Withdrawal by Subject|0|||
163938291|NCT01250925|592144448|FG002|Overall Study|Withdrawal by Subject|0|||
163938292|NCT01250925|592144446|FG000|Overall Study|Protocol Violation|2|||
163938293|NCT01250925|592144447|FG001|Overall Study|Protocol Violation|0|||
163938294|NCT01250925|592144448|FG002|Overall Study|Protocol Violation|0|||
163938295|NCT01250925|592144446|FG000|Overall Study|Physician Decision|0|||
163938296|NCT01250925|592144447|FG001|Overall Study|Physician Decision|2|||
163938297|NCT01250925|592144448|FG002|Overall Study|Physician Decision|1|||
163938298|NCT01250925|592144446|FG000|Overall Study|Adverse Event|0|||
163938299|NCT01250925|592144447|FG001|Overall Study|Adverse Event|0|||
163938300|NCT01250925|592144448|FG002|Overall Study|Adverse Event|1|||
163938301|NCT00678301|592144452|FG000|Overall Study|Non-compliance with study procedures|0|||
163938302|NCT00678301|592144453|FG001|Overall Study|Non-compliance with study procedures|1|||
163938303|NCT00678301|592144452|FG000|Overall Study|Adverse Event|1|||
163938304|NCT00678301|592144453|FG001|Overall Study|Adverse Event|0|||
163938305|NCT00678301|592144452|FG000|Overall Study|Withdrawal by Subject|4|||
163938306|NCT00678301|592144453|FG001|Overall Study|Withdrawal by Subject|0|||
163938307|NCT00678301|592144452|FG000|Overall Study|Lost to Follow-up|3|||
163938308|NCT00678301|592144453|FG001|Overall Study|Lost to Follow-up|1|||
163938309|NCT02476175|592144456|FG000|Overall Study|Adverse Event|2|||
163938310|NCT01016262|592144462|FG000|Double-blind Phase|Adverse Event|0|||
163938311|NCT01016262|592144463|FG001|Double-blind Phase|Adverse Event|0|||
163938312|NCT01016262|592144464|FG002|Double-blind Phase|Adverse Event|1|||
163938313|NCT01016262|592144465|FG003|Double-blind Phase|Adverse Event|0|||
163938314|NCT01016262|592144466|FG004|Double-blind Phase|Adverse Event|0|||
163938315|NCT01016262|592144467|FG005|Double-blind Phase|Adverse Event|0|||
163938316|NCT01016262|592144462|FG000|Double-blind Phase|Lack of Efficacy|1|||
163938317|NCT01016262|592144463|FG001|Double-blind Phase|Lack of Efficacy|0|||
163938318|NCT01016262|592144464|FG002|Double-blind Phase|Lack of Efficacy|5|||
163938319|NCT01016262|592144465|FG003|Double-blind Phase|Lack of Efficacy|0|||
163938320|NCT01016262|592144466|FG004|Double-blind Phase|Lack of Efficacy|0|||
163938321|NCT01016262|592144467|FG005|Double-blind Phase|Lack of Efficacy|0|||
163938322|NCT01016262|592144462|FG000|Double-blind Phase|Disease Progression|0|||
163938323|NCT01016262|592144463|FG001|Double-blind Phase|Disease Progression|1|||
163938324|NCT01016262|592144464|FG002|Double-blind Phase|Disease Progression|2|||
163938325|NCT01016262|592144465|FG003|Double-blind Phase|Disease Progression|0|||
163938326|NCT01016262|592144466|FG004|Double-blind Phase|Disease Progression|0|||
163938327|NCT01016262|592144467|FG005|Double-blind Phase|Disease Progression|0|||
163938328|NCT01016262|592144462|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
163938329|NCT01016262|592144463|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
163938330|NCT01016262|592144464|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
163938331|NCT01016262|592144465|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
163938332|NCT01016262|592144466|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
163938333|NCT01016262|592144467|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
163938334|NCT01016262|592144462|FG000|Open-Label Phase|Adverse Event|0|||
163938335|NCT01016262|592144463|FG001|Open-Label Phase|Adverse Event|0|||
163938336|NCT01016262|592144464|FG002|Open-Label Phase|Adverse Event|0|||
163938337|NCT01016262|592144465|FG003|Open-Label Phase|Adverse Event|1|||
163938338|NCT01016262|592144466|FG004|Open-Label Phase|Adverse Event|0|||
163938339|NCT01016262|592144467|FG005|Open-Label Phase|Adverse Event|0|||
163938340|NCT01016262|592144462|FG000|Open-Label Phase|Lost to Follow-up|0|||
163938341|NCT01016262|592144463|FG001|Open-Label Phase|Lost to Follow-up|0|||
163938342|NCT01016262|592144464|FG002|Open-Label Phase|Lost to Follow-up|0|||
163938343|NCT01016262|592144465|FG003|Open-Label Phase|Lost to Follow-up|0|||
163938344|NCT01016262|592144466|FG004|Open-Label Phase|Lost to Follow-up|1|||
163938345|NCT01016262|592144467|FG005|Open-Label Phase|Lost to Follow-up|0|||
163938346|NCT01016262|592144462|FG000|Open-Label Phase|Lack of Efficacy|0|||
164040652|NCT01641081|592508827|FG006|Period 1|Adverse Event|0|||
164040653|NCT01641081|592508828|FG007|Period 1|Adverse Event|2|||
163938347|NCT01016262|592144463|FG001|Open-Label Phase|Lack of Efficacy|0|||
163938348|NCT01016262|592144464|FG002|Open-Label Phase|Lack of Efficacy|0|||
163938349|NCT01016262|592144465|FG003|Open-Label Phase|Lack of Efficacy|1|||
163938350|NCT01016262|592144466|FG004|Open-Label Phase|Lack of Efficacy|0|||
163938351|NCT01016262|592144467|FG005|Open-Label Phase|Lack of Efficacy|0|||
163938352|NCT01016262|592144462|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
163938353|NCT01016262|592144463|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
163938354|NCT01016262|592144464|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
163938355|NCT01016262|592144465|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
163938356|NCT01016262|592144466|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
164040654|NCT01641081|592508829|FG008|Period 1|Adverse Event|0|||
164040655|NCT01641081|592508830|FG009|Period 1|Adverse Event|0|||
163938357|NCT01016262|592144467|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
163938358|NCT03738475|592144469|FG000|Overall Study|Participant Non-Compliance|1|||
163938359|NCT03738475|592144470|FG001|Overall Study|Participant Non-Compliance|0|||
163938360|NCT00677534|592144471|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
163938361|NCT00677534|592144471|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
163938362|NCT00677534|592144471|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
163938363|NCT00667394|592144472|FG000|Overall Study|Adverse Event|3|||
163938364|NCT00667394|592144473|FG001|Overall Study|Adverse Event|0|||
163938365|NCT00667394|592144472|FG000|Overall Study|Progressive disease|1|||
163938366|NCT00667394|592144473|FG001|Overall Study|Progressive disease|0|||
163938367|NCT04638660|592144474|FG000|Overall Study|Withdrawal by Subject|2|||
163938368|NCT04638660|592144475|FG001|Overall Study|Withdrawal by Subject|0|||
163938369|NCT04638660|592144474|FG000|Overall Study|Lost to Follow-up|1|||
163938370|NCT04638660|592144475|FG001|Overall Study|Lost to Follow-up|0|||
163938371|NCT04076943|592144476|FG000|Overall Study|Withdrawal by Subject|12|||
163938372|NCT04076943|592144476|FG000|Overall Study|Adverse Event|1|||
163938373|NCT04076943|592144476|FG000|Overall Study|Progressive Disease|2|||
163938374|NCT04076943|592144476|FG000|Overall Study|Death|13|||
163938375|NCT04076943|592144476|FG000|Overall Study|Other than specified|6|||
163938376|NCT03080493|592144478|FG000|Overall Study|Did not provide NRS pain results|1|||
163938377|NCT03080493|592144479|FG001|Overall Study|Did not provide NRS pain results|0|||
163938378|NCT03080493|592144478|FG000|Overall Study|Adverse Event|0|||
163938379|NCT03080493|592144479|FG001|Overall Study|Adverse Event|1|||
163938380|NCT03080493|592144478|FG000|Overall Study|Randomization error (parity group)|0|||
163938381|NCT03080493|592144479|FG001|Overall Study|Randomization error (parity group)|1|||
163938382|NCT01304498|592144480|FG000|Overall Study|Adverse Event|1|||
163938383|NCT01304498|592144481|FG001|Overall Study|Adverse Event|1|||
163938384|NCT01304498|592144480|FG000|Overall Study|Withdrawal by Subject|2|||
163938385|NCT01304498|592144481|FG001|Overall Study|Withdrawal by Subject|3|||
163938386|NCT01304498|592144480|FG000|Overall Study|Protocol Violation|1|||
163938387|NCT01304498|592144481|FG001|Overall Study|Protocol Violation|0|||
163938388|NCT01304498|592144480|FG000|Overall Study|Lost to Follow-up|2|||
163938389|NCT01304498|592144481|FG001|Overall Study|Lost to Follow-up|1|||
163938390|NCT03325777|592144482|FG000|Overall Study|Lost to Follow-up|9|||
163938391|NCT03325777|592144483|FG001|Overall Study|Lost to Follow-up|12|||
163938392|NCT03004404|592144485|FG000|Period 2|Adverse Event|0|||
163938393|NCT03004404|592144486|FG001|Period 2|Adverse Event|0|||
163938394|NCT03004404|592144487|FG002|Period 2|Adverse Event|0|||
163938395|NCT03004404|592144488|FG003|Period 2|Adverse Event|0|||
163938396|NCT03004404|592144489|FG004|Period 2|Adverse Event|0|||
163938397|NCT03004404|592144490|FG005|Period 2|Adverse Event|0|||
163938398|NCT03004404|592144491|FG006|Period 2|Adverse Event|0|||
163938399|NCT03004404|592144492|FG007|Period 2|Adverse Event|0|||
163938400|NCT03004404|592144493|FG008|Period 2|Adverse Event|1|||
163938401|NCT03004404|592144494|FG009|Period 2|Adverse Event|0|||
163938402|NCT03004404|592144495|FG010|Period 2|Adverse Event|0|||
163938403|NCT03004404|592144496|FG011|Period 2|Adverse Event|0|||
163938404|NCT03004404|592144497|FG012|Period 2|Adverse Event|0|||
163938405|NCT03004404|592144498|FG013|Period 2|Adverse Event|0|||
163938406|NCT03004404|592144499|FG014|Period 2|Adverse Event|0|||
163938407|NCT03004404|592144500|FG015|Period 2|Adverse Event|1|||
163938408|NCT01099917|592144505|FG000|Overall Study|Adverse Event|3|||
163938409|NCT01099917|592144505|FG000|Overall Study|Not Treated|24|||
163938410|NCT02990468|592144506|FG000|Phase 2: MTD|Change in treatment|0|||
163938411|NCT02990468|592144507|FG001|Phase 2: MTD|Change in treatment|0|||
163938412|NCT02990468|592144508|FG002|Phase 2: MTD|Change in treatment|1|||
163938413|NCT01602510|592144513|FG000|Open Label Phase|Adverse Event|46|||
163938414|NCT01602510|592144514|FG001|Open Label Phase|Adverse Event|0|||
163938415|NCT01602510|592144515|FG002|Open Label Phase|Adverse Event|0|||
163938416|NCT01602510|592144513|FG000|Open Label Phase|Lack of Efficacy|22|||
163938417|NCT01602510|592144514|FG001|Open Label Phase|Lack of Efficacy|0|||
163938418|NCT01602510|592144515|FG002|Open Label Phase|Lack of Efficacy|0|||
163938419|NCT01602510|592144513|FG000|Open Label Phase|Protocol Violation|15|||
163938420|NCT01602510|592144514|FG001|Open Label Phase|Protocol Violation|0|||
163938421|NCT01602510|592144515|FG002|Open Label Phase|Protocol Violation|0|||
163938422|NCT01602510|592144513|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
163938423|NCT01602510|592144514|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
163938424|NCT01602510|592144515|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
163938425|NCT01602510|592144513|FG000|Open Label Phase|Lost to Follow-up|22|||
163938426|NCT01602510|592144514|FG001|Open Label Phase|Lost to Follow-up|0|||
163938427|NCT01602510|592144515|FG002|Open Label Phase|Lost to Follow-up|0|||
163938428|NCT01602510|592144513|FG000|Open Label Phase|Physician Decision|19|||
163938429|NCT01602510|592144514|FG001|Open Label Phase|Physician Decision|0|||
163938430|NCT01602510|592144515|FG002|Open Label Phase|Physician Decision|0|||
163938431|NCT01602510|592144513|FG000|Open Label Phase|Withdrawal by Subject|57|||
163938432|NCT01602510|592144514|FG001|Open Label Phase|Withdrawal by Subject|0|||
163938433|NCT01602510|592144515|FG002|Open Label Phase|Withdrawal by Subject|0|||
163938434|NCT01602510|592144513|FG000|Randomized Phase|Adverse Event|0|||
163938435|NCT01602510|592144514|FG001|Randomized Phase|Adverse Event|2|||
163938436|NCT01602510|592144515|FG002|Randomized Phase|Adverse Event|6|||
163938437|NCT01602510|592144513|FG000|Randomized Phase|Lack of Efficacy|0|||
163938438|NCT01602510|592144514|FG001|Randomized Phase|Lack of Efficacy|4|||
163938439|NCT01602510|592144515|FG002|Randomized Phase|Lack of Efficacy|4|||
163938440|NCT01602510|592144513|FG000|Randomized Phase|Protocol Violation|0|||
163938441|NCT01602510|592144514|FG001|Randomized Phase|Protocol Violation|3|||
163938442|NCT01602510|592144515|FG002|Randomized Phase|Protocol Violation|3|||
163938443|NCT01602510|592144513|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
163938444|NCT01602510|592144514|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
163938445|NCT01602510|592144515|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
163938446|NCT01602510|592144513|FG000|Randomized Phase|Lost to Follow-up|0|||
163938447|NCT01602510|592144514|FG001|Randomized Phase|Lost to Follow-up|1|||
163938448|NCT01602510|592144515|FG002|Randomized Phase|Lost to Follow-up|3|||
163938449|NCT01602510|592144513|FG000|Randomized Phase|Physician Decision|0|||
163938450|NCT01602510|592144514|FG001|Randomized Phase|Physician Decision|0|||
163938451|NCT01602510|592144515|FG002|Randomized Phase|Physician Decision|2|||
163938452|NCT01602510|592144513|FG000|Randomized Phase|Withdrawal by Subject|0|||
163938453|NCT01602510|592144514|FG001|Randomized Phase|Withdrawal by Subject|6|||
163938454|NCT01602510|592144515|FG002|Randomized Phase|Withdrawal by Subject|7|||
163938455|NCT01825577|592144516|FG000|Overall Study|Physician Decision|2|||
163938456|NCT01825577|592144516|FG000|Overall Study|Withdrawal by Subject|1|||
163938457|NCT01825577|592144516|FG000|Overall Study|Withdrawn by family members|2|||
163938458|NCT01825577|592144516|FG000|Overall Study|Lack of Efficacy|3|||
163938459|NCT04191616|592144519|FG000|Pre-assignment Period|Did not receive study treatment|2|||
163938460|NCT04191616|592144519|FG000|Treatment Period|Death|37|||
163938461|NCT04191616|592144519|FG000|Treatment Period|Sponsor decision|11|||
163938462|NCT04191616|592144519|FG000|Treatment Period|Withdrawal by Subject|4|||
163938463|NCT04230122|592144520|FG000|Overall Study|Lost to Follow-up|1|||
163938464|NCT04230122|592144521|FG001|Overall Study|Lost to Follow-up|0|||
163938465|NCT01361594|592144523|FG000|Overall Study|Withdrawal by Subject|1|||
163938466|NCT01361594|592144524|FG001|Overall Study|Withdrawal by Subject|2|||
163938467|NCT02670122|592144529|FG000|Overall Study|Lost to Follow-up|4|||
163938468|NCT02762903|592144530|FG000|Overall Study|Lost to Follow-up|0|||
163938469|NCT02762903|592144531|FG001|Overall Study|Lost to Follow-up|1|||
163938470|NCT00108745|592144532|FG000|Overall Study|Withdrawal by Subject|19|||
163938471|NCT00108745|592144533|FG001|Overall Study|Withdrawal by Subject|12|||
163938472|NCT00108745|592144534|FG002|Overall Study|Withdrawal by Subject|12|||
163938473|NCT00108745|592144532|FG000|Overall Study|Never Treated|8|||
163938474|NCT00108745|592144533|FG001|Overall Study|Never Treated|10|||
163938475|NCT00108745|592144534|FG002|Overall Study|Never Treated|12|||
163938476|NCT00108745|592144532|FG000|Overall Study|Ineligible|7|||
163938477|NCT00108745|592144533|FG001|Overall Study|Ineligible|13|||
163938478|NCT00108745|592144534|FG002|Overall Study|Ineligible|13|||
163938479|NCT04978090|592144536|FG000|Overall Study|unable to adequately fit device|2|||
163938480|NCT00632502|592144541|FG000|Overall Study|Adverse Event|0|||
163938481|NCT00632502|592144542|FG001|Overall Study|Adverse Event|1|||
163938482|NCT00632502|592144541|FG000|Overall Study|Randomized not treated|3|||
163938483|NCT00632502|592144542|FG001|Overall Study|Randomized not treated|0|||
163938484|NCT00277095|592144543|FG000|Overall Study|Death|2|||
163938485|NCT00277095|592144543|FG000|Overall Study|Explanted|7|||
163938486|NCT00277095|592144543|FG000|Overall Study|Lost to Follow-up|2|||
163938487|NCT00277095|592144543|FG000|Overall Study|Missed Follow-up|9|||
163938488|NCT00277095|592144543|FG000|Overall Study|Physician Decision|1|||
163938489|NCT02548078|592144550|FG000|Overall Study|Serious adverse event/Adverse event|1|||
163938490|NCT02548078|592144551|FG001|Overall Study|Serious adverse event/Adverse event|0|||
163938491|NCT02548078|592144550|FG000|Overall Study|Moved from study area|3|||
163938492|NCT02548078|592144551|FG001|Overall Study|Moved from study area|3|||
163938493|NCT02548078|592144550|FG000|Overall Study|Lost to Follow-up|1|||
163938494|NCT02548078|592144551|FG001|Overall Study|Lost to Follow-up|3|||
163938495|NCT01040169|592144552|FG000|Overall Study|Lost to Follow-up|3|||
163938496|NCT01040169|592144553|FG001|Overall Study|Lost to Follow-up|8|||
163938497|NCT05239598|592144556|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
163938498|NCT05239598|592144557|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
163938499|NCT05239598|592144556|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
163938500|NCT05239598|592144557|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
163938501|NCT02592707|592144558|FG000|Overall Study|Consent Withdrawn|0|||
163938502|NCT02592707|592144559|FG001|Overall Study|Consent Withdrawn|1|||
163938503|NCT02592707|592144560|FG002|Overall Study|Consent Withdrawn|2|||
163938504|NCT02592707|592144561|FG003|Overall Study|Consent Withdrawn|0|||
163938505|NCT02592707|592144558|FG000|Overall Study|Death|1|||
163938506|NCT02592707|592144559|FG001|Overall Study|Death|0|||
163938507|NCT02592707|592144560|FG002|Overall Study|Death|0|||
163938508|NCT02592707|592144561|FG003|Overall Study|Death|0|||
163938509|NCT02592707|592144558|FG000|Overall Study|Progressive Disease|4|||
163938510|NCT02592707|592144559|FG001|Overall Study|Progressive Disease|4|||
163938511|NCT02592707|592144560|FG002|Overall Study|Progressive Disease|3|||
163938512|NCT02592707|592144561|FG003|Overall Study|Progressive Disease|3|||
163938513|NCT02592707|592144558|FG000|Overall Study|Other|0|||
163938514|NCT02592707|592144559|FG001|Overall Study|Other|0|||
163938515|NCT02592707|592144560|FG002|Overall Study|Other|1|||
163840360|NCT04534114|591785836|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
163840361|NCT04534114|591785837|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
163840362|NCT04534114|591785838|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
163840363|NCT04534114|591785839|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
163840364|NCT04534114|591785836|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
163840365|NCT04534114|591785837|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
163840366|NCT04534114|591785838|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
163840367|NCT04534114|591785839|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
163840368|NCT04534114|591785836|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
163840369|NCT04534114|591785837|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
163840370|NCT04534114|591785838|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
163840371|NCT04534114|591785839|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
163840372|NCT04534114|591785836|FG000|Main Treatment Period|Physician Decision|0|||
163840373|NCT04534114|591785837|FG001|Main Treatment Period|Physician Decision|0|||
163840374|NCT04534114|591785838|FG002|Main Treatment Period|Physician Decision|0|||
163840375|NCT04534114|591785839|FG003|Main Treatment Period|Physician Decision|1|||
163840376|NCT04534114|591785836|FG000|Main Treatment Period|Death|1|||
163840377|NCT04534114|591785837|FG001|Main Treatment Period|Death|0|||
163840378|NCT04534114|591785838|FG002|Main Treatment Period|Death|0|||
163840379|NCT04534114|591785839|FG003|Main Treatment Period|Death|1|||
163840380|NCT04534114|591785836|FG000|Main Treatment Period|Other reason|1|||
163840381|NCT04534114|591785837|FG001|Main Treatment Period|Other reason|1|||
163840382|NCT04534114|591785838|FG002|Main Treatment Period|Other reason|0|||
163840383|NCT04534114|591785839|FG003|Main Treatment Period|Other reason|0|||
163840384|NCT04534114|591785836|FG000|Main Treatment Period|Participant decision|1|||
163840385|NCT04534114|591785837|FG001|Main Treatment Period|Participant decision|3|||
163840386|NCT04534114|591785838|FG002|Main Treatment Period|Participant decision|3|||
163840387|NCT04534114|591785839|FG003|Main Treatment Period|Participant decision|1|||
163840388|NCT04534114|591785836|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
163840389|NCT04534114|591785837|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
163840390|NCT04534114|591785838|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
163840391|NCT04534114|591785839|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
163840392|NCT04534114|591785836|FG000|Main Treatment Period|Adverse Event|4|||
163840393|NCT04534114|591785837|FG001|Main Treatment Period|Adverse Event|2|||
163840394|NCT04534114|591785838|FG002|Main Treatment Period|Adverse Event|1|||
163840395|NCT04534114|591785839|FG003|Main Treatment Period|Adverse Event|2|||
163840396|NCT04534114|591785836|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
163840397|NCT04534114|591785837|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
163840398|NCT04534114|591785838|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
163840399|NCT04534114|591785839|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
163840400|NCT04534114|591785836|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
163840401|NCT04534114|591785837|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
163840402|NCT04534114|591785838|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
163840403|NCT04534114|591785839|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
163840404|NCT04534114|591785836|FG000|Extension Treatment Period|Other reason|0|||
163840405|NCT04534114|591785837|FG001|Extension Treatment Period|Other reason|1|||
163840406|NCT04534114|591785838|FG002|Extension Treatment Period|Other reason|0|||
163840407|NCT04534114|591785839|FG003|Extension Treatment Period|Other reason|0|||
163840408|NCT04534114|591785836|FG000|Extension Treatment Period|Death|0|||
163840409|NCT04534114|591785837|FG001|Extension Treatment Period|Death|0|||
163840410|NCT04534114|591785838|FG002|Extension Treatment Period|Death|1|||
163840411|NCT04534114|591785839|FG003|Extension Treatment Period|Death|2|||
163840412|NCT04534114|591785836|FG000|Extension Treatment Period|Adverse Event|0|||
163840413|NCT04534114|591785837|FG001|Extension Treatment Period|Adverse Event|1|||
163840414|NCT04534114|591785838|FG002|Extension Treatment Period|Adverse Event|0|||
163840415|NCT04534114|591785839|FG003|Extension Treatment Period|Adverse Event|1|||
163840416|NCT04534114|591785836|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
163840417|NCT04534114|591785837|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
163840418|NCT04534114|591785838|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
163840419|NCT04534114|591785839|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
163840420|NCT02759185|591785840|FG000|Stage 1|Adverse Event|0|||
163840421|NCT02759185|591785841|FG001|Stage 1|Adverse Event|1|||
163840422|NCT02759185|591785842|FG002|Stage 1|Adverse Event|3|||
163840423|NCT02759185|591785843|FG003|Stage 1|Adverse Event|0|||
163840424|NCT02759185|591785844|FG004|Stage 1|Adverse Event|0|||
163840425|NCT02759185|591785845|FG005|Stage 1|Adverse Event|0|||
163840426|NCT02759185|591785846|FG006|Stage 1|Adverse Event|0|||
163840427|NCT02759185|591785840|FG000|Stage 1|Withdrawal by Subject|1|||
163840428|NCT02759185|591785841|FG001|Stage 1|Withdrawal by Subject|0|||
163938516|NCT02592707|592144561|FG003|Overall Study|Other|2|||
163938517|NCT02592707|592144558|FG000|Overall Study|Never entered LTFU period|1|||
163938518|NCT02592707|592144559|FG001|Overall Study|Never entered LTFU period|0|||
163938519|NCT02592707|592144560|FG002|Overall Study|Never entered LTFU period|0|||
163938520|NCT02592707|592144561|FG003|Overall Study|Never entered LTFU period|2|||
163938521|NCT04855734|592144564|FG000|Overall Study|Lost to Follow-up|2|||
163938522|NCT04855734|592144565|FG001|Overall Study|Lost to Follow-up|2|||
163938523|NCT03832595|592144566|FG000|Overall Study|Death|142|||
163938524|NCT03832595|592144567|FG001|Overall Study|Death|130|||
163938525|NCT03832595|592144566|FG000|Overall Study|Medical management without dialysis|37|||
163938526|NCT03832595|592144567|FG001|Overall Study|Medical management without dialysis|1|||
163938527|NCT03277352|592144568|FG000|Overall Study|Study Terminated By Sponsor|2|||
163938528|NCT03277352|592144568|FG000|Overall Study|Withdrawal by Subject|4|||
163938529|NCT03277352|592144568|FG000|Overall Study|Death|4|||
163938530|NCT05577715|592146567|FG000|Overall Study|Withdrawal by Subject|1|||
163938531|NCT05577715|592146567|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
163938532|NCT05577715|592146567|FG000|Overall Study|Lost to Follow-up|1|||
163938533|NCT05577715|592146567|FG000|Overall Study|Death|6|||
163938534|NCT00626197|592146572|FG000|Overall Study|Did not cooperate|2|||
163938535|NCT00626197|592146573|FG001|Overall Study|Did not cooperate|6|||
163938536|NCT00626197|592146574|FG002|Overall Study|Did not cooperate|1|||
163938537|NCT00626197|592146572|FG000|Overall Study|Failure to return|6|||
163938538|NCT00626197|592146573|FG001|Overall Study|Failure to return|5|||
163938539|NCT00626197|592146574|FG002|Overall Study|Failure to return|6|||
163938540|NCT00626197|592146572|FG000|Overall Study|Adverse event, serious fatal|3|||
163938541|NCT00626197|592146573|FG001|Overall Study|Adverse event, serious fatal|6|||
163938542|NCT00626197|592146574|FG002|Overall Study|Adverse event, serious fatal|6|||
163938543|NCT00626197|592146572|FG000|Overall Study|Adverse Event|1|||
163938544|NCT00626197|592146573|FG001|Overall Study|Adverse Event|1|||
163938545|NCT00626197|592146574|FG002|Overall Study|Adverse Event|2|||
163938546|NCT00626197|592146572|FG000|Overall Study|Withdrawal by Subject|17|||
163938547|NCT00626197|592146573|FG001|Overall Study|Withdrawal by Subject|17|||
163938548|NCT00626197|592146574|FG002|Overall Study|Withdrawal by Subject|7|||
163938549|NCT00626197|592146572|FG000|Overall Study|Administrative reasons|15|||
163938550|NCT00626197|592146573|FG001|Overall Study|Administrative reasons|19|||
163938551|NCT00626197|592146574|FG002|Overall Study|Administrative reasons|55|||
163938552|NCT05332912|592146579|FG000|Overall Study|Withdrawal by Subject|0|||
163938553|NCT05332912|592146580|FG001|Overall Study|Withdrawal by Subject|1|||
163938554|NCT05332912|592146581|FG002|Overall Study|Withdrawal by Subject|2|||
163938555|NCT05332912|592146582|FG003|Overall Study|Withdrawal by Subject|0|||
163938556|NCT05332912|592146579|FG000|Overall Study|Lost to Follow-up|0|||
163938557|NCT05332912|592146580|FG001|Overall Study|Lost to Follow-up|0|||
163938558|NCT05332912|592146581|FG002|Overall Study|Lost to Follow-up|1|||
163938559|NCT05332912|592146582|FG003|Overall Study|Lost to Follow-up|0|||
163938560|NCT01174446|592146585|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
163938561|NCT01174446|592146586|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
163938562|NCT01174446|592146587|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
163938563|NCT01174446|592146588|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
163938564|NCT01174446|592146585|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
163938565|NCT01174446|592146586|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
163938566|NCT01174446|592146587|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
163938567|NCT01174446|592146588|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
163938568|NCT01174446|592146585|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
163938569|NCT01174446|592146586|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
163938570|NCT01174446|592146587|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
163938571|NCT01174446|592146588|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
163938572|NCT01174446|592146585|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
163938573|NCT01174446|592146586|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
163938574|NCT01174446|592146587|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
163938575|NCT01174446|592146588|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
163938576|NCT00847626|592146591|FG000|Overall Study|Adverse Event|10|||
163938577|NCT00847626|592146592|FG001|Overall Study|Adverse Event|10|||
163938578|NCT00847626|592146593|FG002|Overall Study|Adverse Event|6|||
163938579|NCT00847626|592146594|FG003|Overall Study|Adverse Event|19|||
163938580|NCT00847626|592146595|FG004|Overall Study|Adverse Event|11|||
163938581|NCT00847626|592146596|FG005|Overall Study|Adverse Event|22|||
163938582|NCT00847626|592146597|FG006|Overall Study|Adverse Event|4|||
163938583|NCT00847626|592146598|FG007|Overall Study|Adverse Event|6|||
163938584|NCT00847626|592146599|FG008|Overall Study|Adverse Event|3|||
163938585|NCT00847626|592146600|FG009|Overall Study|Adverse Event|6|||
163938586|NCT00847626|592146601|FG010|Overall Study|Adverse Event|6|||
163938587|NCT00847626|592146591|FG000|Overall Study|Protocol Violation|2|||
163938588|NCT00847626|592146592|FG001|Overall Study|Protocol Violation|1|||
163938589|NCT00847626|592146593|FG002|Overall Study|Protocol Violation|2|||
163938590|NCT00847626|592146594|FG003|Overall Study|Protocol Violation|1|||
163938591|NCT00847626|592146595|FG004|Overall Study|Protocol Violation|1|||
163938592|NCT00847626|592146596|FG005|Overall Study|Protocol Violation|1|||
163938593|NCT00847626|592146597|FG006|Overall Study|Protocol Violation|1|||
163938594|NCT00847626|592146598|FG007|Overall Study|Protocol Violation|1|||
163938595|NCT00847626|592146599|FG008|Overall Study|Protocol Violation|0|||
163938596|NCT00847626|592146600|FG009|Overall Study|Protocol Violation|1|||
163938597|NCT00847626|592146601|FG010|Overall Study|Protocol Violation|1|||
163938598|NCT00847626|592146591|FG000|Overall Study|Lost to Follow-up|0|||
163938599|NCT00847626|592146592|FG001|Overall Study|Lost to Follow-up|1|||
163938600|NCT00847626|592146593|FG002|Overall Study|Lost to Follow-up|1|||
163938601|NCT00847626|592146594|FG003|Overall Study|Lost to Follow-up|1|||
163938602|NCT00847626|592146595|FG004|Overall Study|Lost to Follow-up|0|||
163938603|NCT00847626|592146596|FG005|Overall Study|Lost to Follow-up|3|||
163938604|NCT00847626|592146597|FG006|Overall Study|Lost to Follow-up|1|||
163938605|NCT00847626|592146598|FG007|Overall Study|Lost to Follow-up|3|||
163938606|NCT00847626|592146599|FG008|Overall Study|Lost to Follow-up|1|||
163938607|NCT00847626|592146600|FG009|Overall Study|Lost to Follow-up|0|||
163938608|NCT00847626|592146601|FG010|Overall Study|Lost to Follow-up|1|||
163938609|NCT00847626|592146591|FG000|Overall Study|Withdrawal by Subject|5|||
163938610|NCT00847626|592146592|FG001|Overall Study|Withdrawal by Subject|5|||
163938611|NCT00847626|592146593|FG002|Overall Study|Withdrawal by Subject|3|||
163938612|NCT00847626|592146594|FG003|Overall Study|Withdrawal by Subject|8|||
163938613|NCT00847626|592146595|FG004|Overall Study|Withdrawal by Subject|12|||
163938614|NCT00847626|592146596|FG005|Overall Study|Withdrawal by Subject|9|||
163938615|NCT00847626|592146597|FG006|Overall Study|Withdrawal by Subject|8|||
163938616|NCT00847626|592146598|FG007|Overall Study|Withdrawal by Subject|4|||
163938617|NCT00847626|592146599|FG008|Overall Study|Withdrawal by Subject|4|||
163938618|NCT00847626|592146600|FG009|Overall Study|Withdrawal by Subject|5|||
163938619|NCT00847626|592146601|FG010|Overall Study|Withdrawal by Subject|2|||
163938620|NCT00847626|592146591|FG000|Overall Study|Lack of Efficacy|3|||
163938621|NCT00847626|592146592|FG001|Overall Study|Lack of Efficacy|1|||
163938622|NCT00847626|592146593|FG002|Overall Study|Lack of Efficacy|0|||
163938623|NCT00847626|592146594|FG003|Overall Study|Lack of Efficacy|1|||
163938624|NCT00847626|592146595|FG004|Overall Study|Lack of Efficacy|2|||
163938625|NCT00847626|592146596|FG005|Overall Study|Lack of Efficacy|0|||
163938626|NCT00847626|592146597|FG006|Overall Study|Lack of Efficacy|6|||
163938627|NCT00847626|592146598|FG007|Overall Study|Lack of Efficacy|2|||
163938628|NCT00847626|592146599|FG008|Overall Study|Lack of Efficacy|5|||
163938629|NCT00847626|592146600|FG009|Overall Study|Lack of Efficacy|1|||
163938630|NCT00847626|592146601|FG010|Overall Study|Lack of Efficacy|7|||
163938631|NCT00847626|592146591|FG000|Overall Study|Other|1|||
163938632|NCT00847626|592146592|FG001|Overall Study|Other|5|||
163938633|NCT00847626|592146593|FG002|Overall Study|Other|4|||
163938634|NCT00847626|592146594|FG003|Overall Study|Other|1|||
163938635|NCT00847626|592146595|FG004|Overall Study|Other|2|||
163938636|NCT00847626|592146596|FG005|Overall Study|Other|2|||
163938637|NCT00847626|592146597|FG006|Overall Study|Other|2|||
163938638|NCT00847626|592146598|FG007|Overall Study|Other|3|||
163938639|NCT00847626|592146599|FG008|Overall Study|Other|1|||
163938640|NCT00847626|592146600|FG009|Overall Study|Other|1|||
163938641|NCT00847626|592146601|FG010|Overall Study|Other|3|||
163938642|NCT03301155|592146602|FG000|Overall Study|Сompliance with exclusion criteria|8|||
163938643|NCT03301155|592146603|FG001|Overall Study|Сompliance with exclusion criteria|7|||
163938644|NCT03510455|592146606|FG000|Overall Study|Physician Decision|1|||
163938645|NCT00384189|592146610|FG000|Overall Study|Reason Not Specified|50|||
163938646|NCT00384189|592146611|FG001|Overall Study|Reason Not Specified|57|||
163938647|NCT00384189|592146612|FG002|Overall Study|Reason Not Specified|58|||
163938648|NCT00384189|592146613|FG003|Overall Study|Reason Not Specified|40|||
163938649|NCT04958642|592146614|FG000|Overall Study|Transferred to OLEX program|3|||
163938650|NCT04958642|592146615|FG001|Overall Study|Transferred to OLEX program|0|||
163938651|NCT04958642|592146616|FG002|Overall Study|Transferred to OLEX program|5|||
163938652|NCT04958642|592146614|FG000|Overall Study|Death|0|||
163938653|NCT04958642|592146615|FG001|Overall Study|Death|0|||
163938654|NCT04958642|592146616|FG002|Overall Study|Death|1|||
163938655|NCT04958642|592146614|FG000|Overall Study|Withdrawal by Subject|4|||
163938656|NCT04958642|592146615|FG001|Overall Study|Withdrawal by Subject|9|||
163938657|NCT04958642|592146616|FG002|Overall Study|Withdrawal by Subject|13|||
163938658|NCT04958642|592146614|FG000|Overall Study|Investigator's Decision|0|||
163938659|NCT04958642|592146615|FG001|Overall Study|Investigator's Decision|0|||
163938660|NCT04958642|592146616|FG002|Overall Study|Investigator's Decision|1|||
163938661|NCT04958642|592146614|FG000|Overall Study|Adverse Event|1|||
163938662|NCT04958642|592146615|FG001|Overall Study|Adverse Event|0|||
163938663|NCT04958642|592146616|FG002|Overall Study|Adverse Event|1|||
163938664|NCT04958642|592146614|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
163938665|NCT04958642|592146615|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
163938666|NCT04958642|592146616|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
163938667|NCT04958642|592146614|FG000|Overall Study|Lost to Follow-up|1|||
163938668|NCT04958642|592146615|FG001|Overall Study|Lost to Follow-up|0|||
163938669|NCT04958642|592146616|FG002|Overall Study|Lost to Follow-up|0|||
163938670|NCT04958642|592146614|FG000|Overall Study|Transferred to EAP following study termination|0|||
163938671|NCT04958642|592146615|FG001|Overall Study|Transferred to EAP following study termination|0|||
163938672|NCT04958642|592146616|FG002|Overall Study|Transferred to EAP following study termination|1|||
163938673|NCT04958642|592146614|FG000|Overall Study|Transferred to Expanded Access Program|1|||
163938674|NCT04958642|592146615|FG001|Overall Study|Transferred to Expanded Access Program|0|||
163938675|NCT04958642|592146616|FG002|Overall Study|Transferred to Expanded Access Program|0|||
163938676|NCT02942004|592146617|FG000|Overall Study|Withdrawal by Subject|0|||
163938677|NCT02942004|592146618|FG001|Overall Study|Withdrawal by Subject|2|||
163938678|NCT02942004|592146619|FG002|Overall Study|Withdrawal by Subject|3|||
163938679|NCT02942004|592146617|FG000|Overall Study|Lost to Follow-up|1|||
163938680|NCT02942004|592146618|FG001|Overall Study|Lost to Follow-up|1|||
163938681|NCT02942004|592146619|FG002|Overall Study|Lost to Follow-up|2|||
163938682|NCT02942004|592146617|FG000|Overall Study|Randomized but not dosed|3|||
163938683|NCT02942004|592146618|FG001|Overall Study|Randomized but not dosed|9|||
163938684|NCT02942004|592146619|FG002|Overall Study|Randomized but not dosed|4|||
164098834|NCT01256684|592726930|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
164098835|NCT01256684|592726931|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
163938685|NCT05627258|592146620|FG000|Overall Study|Lost to Follow-up|1|||
163938686|NCT05627258|592146621|FG001|Overall Study|Lost to Follow-up|0|||
163938687|NCT05627258|592146622|FG002|Overall Study|Lost to Follow-up|0|||
163938688|NCT05627258|592146623|FG003|Overall Study|Lost to Follow-up|0|||
163938689|NCT05627258|592146624|FG004|Overall Study|Lost to Follow-up|0|||
163938690|NCT05627258|592146625|FG005|Overall Study|Lost to Follow-up|0|||
163938691|NCT05627258|592146620|FG000|Overall Study|Withdrawal by Subject|0|||
163938692|NCT05627258|592146621|FG001|Overall Study|Withdrawal by Subject|0|||
163938693|NCT05627258|592146622|FG002|Overall Study|Withdrawal by Subject|0|||
163938694|NCT05627258|592146623|FG003|Overall Study|Withdrawal by Subject|0|||
163938695|NCT05627258|592146624|FG004|Overall Study|Withdrawal by Subject|2|||
163938696|NCT05627258|592146625|FG005|Overall Study|Withdrawal by Subject|0|||
163938697|NCT05627258|592146620|FG000|Overall Study|Enrolled, but product not administered|1|||
163938698|NCT05627258|592146621|FG001|Overall Study|Enrolled, but product not administered|0|||
163938699|NCT05627258|592146622|FG002|Overall Study|Enrolled, but product not administered|0|||
163938700|NCT05627258|592146623|FG003|Overall Study|Enrolled, but product not administered|0|||
163938701|NCT05627258|592146624|FG004|Overall Study|Enrolled, but product not administered|0|||
163938702|NCT05627258|592146625|FG005|Overall Study|Enrolled, but product not administered|0|||
163938703|NCT05627258|592146620|FG000|Overall Study|Other subject illness/injury|1|||
163938704|NCT05627258|592146621|FG001|Overall Study|Other subject illness/injury|0|||
163938705|NCT05627258|592146622|FG002|Overall Study|Other subject illness/injury|0|||
163938706|NCT05627258|592146623|FG003|Overall Study|Other subject illness/injury|0|||
163938707|NCT05627258|592146624|FG004|Overall Study|Other subject illness/injury|0|||
163938708|NCT05627258|592146625|FG005|Overall Study|Other subject illness/injury|0|||
163938709|NCT05627258|592146620|FG000|Overall Study|Subject moved from area|0|||
163938710|NCT05627258|592146621|FG001|Overall Study|Subject moved from area|0|||
163938711|NCT05627258|592146622|FG002|Overall Study|Subject moved from area|1|||
163938712|NCT05627258|592146623|FG003|Overall Study|Subject moved from area|0|||
163938713|NCT05627258|592146624|FG004|Overall Study|Subject moved from area|0|||
163938714|NCT05627258|592146625|FG005|Overall Study|Subject moved from area|0|||
163938715|NCT04517669|592146626|FG000|Overall Study|Lost to Follow-up|2|||
163938716|NCT04517669|592146626|FG000|Overall Study|Withdrawal by Subject|3|||
163938717|NCT04517669|592146626|FG000|Overall Study|Drug withdrawn|44|||
163938718|NCT04517669|592146626|FG000|Overall Study|Other|1|||
163938719|NCT04517669|592146626|FG000|Overall Study|Eligibility criteria not met|4|||
163938720|NCT04517669|592146626|FG000|Overall Study|Did not receive treatment|3|||
163938721|NCT02138786|592146627|FG000|Overall Study|Adverse Event|0|||
163938722|NCT02138786|592146628|FG001|Overall Study|Adverse Event|2|||
163938723|NCT02138786|592146629|FG002|Overall Study|Adverse Event|1|||
163938724|NCT02138786|592146627|FG000|Overall Study|Death|1|||
163938725|NCT02138786|592146628|FG001|Overall Study|Death|7|||
163938726|NCT02138786|592146629|FG002|Overall Study|Death|2|||
163938727|NCT02138786|592146627|FG000|Overall Study|Disease Progression|1|||
163938728|NCT02138786|592146628|FG001|Overall Study|Disease Progression|1|||
163938729|NCT02138786|592146629|FG002|Overall Study|Disease Progression|3|||
163938730|NCT02138786|592146627|FG000|Overall Study|Withdrawal by Subject|1|||
163938731|NCT02138786|592146628|FG001|Overall Study|Withdrawal by Subject|2|||
163938732|NCT02138786|592146629|FG002|Overall Study|Withdrawal by Subject|0|||
163938733|NCT02138786|592146627|FG000|Overall Study|Patient's Wish|0|||
163938734|NCT02138786|592146628|FG001|Overall Study|Patient's Wish|2|||
163938735|NCT02138786|592146629|FG002|Overall Study|Patient's Wish|0|||
163938736|NCT02138786|592146627|FG000|Overall Study|Sponsor Terminated Study|0|||
163938737|NCT02138786|592146628|FG001|Overall Study|Sponsor Terminated Study|1|||
163938738|NCT02138786|592146629|FG002|Overall Study|Sponsor Terminated Study|1|||
163938739|NCT02138786|592146627|FG000|Overall Study|Non-Compliance|0|||
163938740|NCT02138786|592146628|FG001|Overall Study|Non-Compliance|0|||
163938741|NCT02138786|592146629|FG002|Overall Study|Non-Compliance|1|||
163938742|NCT01923662|592146630|FG000|Overall Study|Withdrawal by Subject|1|||
163938743|NCT01199068|592146631|FG000|Overall Study|Unacceptable toxicity|0|||
163938744|NCT01199068|592146632|FG001|Overall Study|Unacceptable toxicity|0|||
163938745|NCT01199068|592146633|FG002|Overall Study|Unacceptable toxicity|2|||
163938746|NCT01199068|592146631|FG000|Overall Study|Progressive disease|3|||
163938747|NCT01199068|592146632|FG001|Overall Study|Progressive disease|3|||
163938748|NCT01199068|592146633|FG002|Overall Study|Progressive disease|6|||
163938749|NCT01199068|592146631|FG000|Overall Study|Withdrawal by Subject|0|||
163938750|NCT01199068|592146632|FG001|Overall Study|Withdrawal by Subject|0|||
163938751|NCT01199068|592146633|FG002|Overall Study|Withdrawal by Subject|1|||
163938752|NCT05048238|592146634|FG000|Overall Study|Withdrawal by Subject|1|||
163938753|NCT01370655|592146637|FG000|Period 1|Adverse Event|2|||
163938754|NCT01370655|592146638|FG001|Period 1|Adverse Event|0|||
163938755|NCT01370655|592146639|FG002|Period 1|Adverse Event|0|||
163938756|NCT01370655|592146640|FG003|Period 1|Adverse Event|0|||
163938757|NCT01370655|592146641|FG004|Period 1|Adverse Event|0|||
163938758|NCT01370655|592146642|FG005|Period 1|Adverse Event|0|||
163938759|NCT01370655|592146643|FG006|Period 1|Adverse Event|1|||
163938760|NCT01370655|592146644|FG007|Period 1|Adverse Event|0|||
163938761|NCT01370655|592146645|FG008|Period 1|Adverse Event|0|||
163938762|NCT01370655|592146646|FG009|Period 1|Adverse Event|0|||
163938763|NCT01370655|592146647|FG010|Period 1|Adverse Event|0|||
163938764|NCT01370655|592146648|FG011|Period 1|Adverse Event|0|||
163938765|NCT01370655|592146637|FG000|Period 2|Adverse Event|0|||
163938766|NCT01370655|592146638|FG001|Period 2|Adverse Event|0|||
163938767|NCT01370655|592146639|FG002|Period 2|Adverse Event|1|||
163938768|NCT01370655|592146640|FG003|Period 2|Adverse Event|0|||
163938769|NCT01370655|592146641|FG004|Period 2|Adverse Event|1|||
163938770|NCT01370655|592146642|FG005|Period 2|Adverse Event|0|||
163938771|NCT01370655|592146643|FG006|Period 2|Adverse Event|0|||
163938772|NCT01370655|592146644|FG007|Period 2|Adverse Event|1|||
163938773|NCT01370655|592146645|FG008|Period 2|Adverse Event|0|||
163938774|NCT01370655|592146646|FG009|Period 2|Adverse Event|0|||
163938775|NCT01370655|592146647|FG010|Period 2|Adverse Event|0|||
163938776|NCT01370655|592146648|FG011|Period 2|Adverse Event|0|||
163938777|NCT01370655|592146637|FG000|Period 2|met protocol specified stopping criteria|0|||
163938778|NCT01370655|592146638|FG001|Period 2|met protocol specified stopping criteria|0|||
163938779|NCT01370655|592146639|FG002|Period 2|met protocol specified stopping criteria|1|||
163938780|NCT01370655|592146640|FG003|Period 2|met protocol specified stopping criteria|0|||
163938781|NCT01370655|592146641|FG004|Period 2|met protocol specified stopping criteria|0|||
163938782|NCT01370655|592146642|FG005|Period 2|met protocol specified stopping criteria|0|||
163938783|NCT01370655|592146643|FG006|Period 2|met protocol specified stopping criteria|1|||
163938784|NCT01370655|592146644|FG007|Period 2|met protocol specified stopping criteria|0|||
163938785|NCT01370655|592146645|FG008|Period 2|met protocol specified stopping criteria|1|||
163938786|NCT01370655|592146646|FG009|Period 2|met protocol specified stopping criteria|0|||
163938787|NCT01370655|592146647|FG010|Period 2|met protocol specified stopping criteria|1|||
163938788|NCT01370655|592146648|FG011|Period 2|met protocol specified stopping criteria|0|||
163938789|NCT01370655|592146637|FG000|Period 2|Withdrawal by Subject|0|||
163938790|NCT01370655|592146638|FG001|Period 2|Withdrawal by Subject|0|||
163938791|NCT01370655|592146639|FG002|Period 2|Withdrawal by Subject|0|||
163938792|NCT01370655|592146640|FG003|Period 2|Withdrawal by Subject|0|||
163938793|NCT01370655|592146641|FG004|Period 2|Withdrawal by Subject|0|||
163938794|NCT01370655|592146642|FG005|Period 2|Withdrawal by Subject|0|||
163938795|NCT01370655|592146643|FG006|Period 2|Withdrawal by Subject|0|||
163938796|NCT01370655|592146644|FG007|Period 2|Withdrawal by Subject|0|||
163938797|NCT01370655|592146645|FG008|Period 2|Withdrawal by Subject|1|||
163938798|NCT01370655|592146646|FG009|Period 2|Withdrawal by Subject|0|||
163938799|NCT01370655|592146647|FG010|Period 2|Withdrawal by Subject|0|||
163938800|NCT01370655|592146648|FG011|Period 2|Withdrawal by Subject|0|||
163938801|NCT02224703|592146655|FG000|Overall Study|Adverse Event|0|||
163938802|NCT02224703|592146656|FG001|Overall Study|Adverse Event|5|||
163938803|NCT02224703|592146657|FG002|Overall Study|Adverse Event|0|||
163938804|NCT02224703|592146655|FG000|Overall Study|Withdrawn by investigator|1|||
163938805|NCT02224703|592146656|FG001|Overall Study|Withdrawn by investigator|0|||
163938806|NCT02224703|592146657|FG002|Overall Study|Withdrawn by investigator|0|||
163938807|NCT02224703|592146655|FG000|Overall Study|Advised by medical monitor|1|||
163938808|NCT02224703|592146656|FG001|Overall Study|Advised by medical monitor|0|||
163938809|NCT02224703|592146657|FG002|Overall Study|Advised by medical monitor|0|||
164040656|NCT01641081|592508821|FG000|Period 2|Adverse Event|0|||
163938810|NCT02224703|592146655|FG000|Overall Study|Withdrawn by parent/guardian|0|||
163938811|NCT02224703|592146656|FG001|Overall Study|Withdrawn by parent/guardian|1|||
163938812|NCT02224703|592146657|FG002|Overall Study|Withdrawn by parent/guardian|0|||
163938813|NCT02224703|592146655|FG000|Overall Study|Lack of Efficacy|1|||
163938814|NCT02224703|592146656|FG001|Overall Study|Lack of Efficacy|0|||
163938815|NCT02224703|592146657|FG002|Overall Study|Lack of Efficacy|0|||
163938816|NCT02057575|592146658|FG000|Overall Study|Adverse Event|0|||
163938817|NCT02057575|592146659|FG001|Overall Study|Adverse Event|2|||
163938818|NCT02057575|592146660|FG002|Overall Study|Adverse Event|0|||
164040657|NCT01641081|592508822|FG001|Period 2|Adverse Event|0|||
163938819|NCT02057575|592146661|FG003|Overall Study|Adverse Event|1|||
164040658|NCT01641081|592508823|FG002|Period 2|Adverse Event|0|||
163938820|NCT02057575|592146658|FG000|Overall Study|Withdrawal by Subject|1|||
163938821|NCT02057575|592146659|FG001|Overall Study|Withdrawal by Subject|0|||
163938822|NCT02057575|592146660|FG002|Overall Study|Withdrawal by Subject|0|||
163938823|NCT02057575|592146661|FG003|Overall Study|Withdrawal by Subject|0|||
163938824|NCT02057575|592146658|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
163938825|NCT02057575|592146659|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
163938826|NCT02057575|592146660|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
163938827|NCT02057575|592146661|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
163938828|NCT02057575|592146658|FG000|Overall Study|Protocol Violation|0|||
163938829|NCT02057575|592146659|FG001|Overall Study|Protocol Violation|1|||
163938830|NCT02057575|592146660|FG002|Overall Study|Protocol Violation|0|||
163938831|NCT02057575|592146661|FG003|Overall Study|Protocol Violation|0|||
163938832|NCT00332462|592146662|FG000|Overall Study|Adverse Event|5|||
163938833|NCT00332462|592146662|FG000|Overall Study|Abnormal Lab Value|1|||
163938834|NCT00332462|592146662|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
163938835|NCT00332462|592146662|FG000|Overall Study|no longer requires study drug|1|||
163938836|NCT00332462|592146662|FG000|Overall Study|Death|3|||
163938837|NCT00332462|592146662|FG000|Overall Study|Graft Loss|2|||
163938838|NCT00863681|592146667|FG000|Overall Study|Other|2|||
163938839|NCT00863681|592146668|FG001|Overall Study|Other|0|||
163938840|NCT00863681|592146669|FG002|Overall Study|Other|0|||
163938841|NCT00863681|592146667|FG000|Overall Study|Missing|1|||
163938842|NCT00863681|592146668|FG001|Overall Study|Missing|0|||
163938843|NCT00863681|592146669|FG002|Overall Study|Missing|0|||
163938844|NCT00863681|592146667|FG000|Overall Study|Death|40|||
163938845|NCT00863681|592146668|FG001|Overall Study|Death|23|||
163938846|NCT00863681|592146669|FG002|Overall Study|Death|6|||
163938847|NCT00863681|592146667|FG000|Overall Study|Withdrawal by Subject|12|||
163938848|NCT00863681|592146668|FG001|Overall Study|Withdrawal by Subject|5|||
163938849|NCT00863681|592146669|FG002|Overall Study|Withdrawal by Subject|2|||
163938850|NCT00863681|592146667|FG000|Overall Study|Protocol Violation|2|||
163938851|NCT00863681|592146668|FG001|Overall Study|Protocol Violation|0|||
163938852|NCT00863681|592146669|FG002|Overall Study|Protocol Violation|0|||
163938853|NCT00863681|592146667|FG000|Overall Study|Lost to Follow-up|3|||
163938854|NCT00863681|592146668|FG001|Overall Study|Lost to Follow-up|0|||
163938855|NCT00863681|592146669|FG002|Overall Study|Lost to Follow-up|3|||
163938856|NCT00863681|592146667|FG000|Overall Study|Adverse Event|28|||
163938857|NCT00863681|592146668|FG001|Overall Study|Adverse Event|10|||
163938858|NCT00863681|592146669|FG002|Overall Study|Adverse Event|6|||
163938859|NCT00863681|592146667|FG000|Overall Study|Lack of Efficacy|2|||
163938860|NCT00863681|592146668|FG001|Overall Study|Lack of Efficacy|2|||
163938861|NCT00863681|592146669|FG002|Overall Study|Lack of Efficacy|1|||
163938862|NCT00863681|592146667|FG000|Overall Study|Non-compliance with study drug|1|||
163938863|NCT00863681|592146668|FG001|Overall Study|Non-compliance with study drug|3|||
163938864|NCT00863681|592146669|FG002|Overall Study|Non-compliance with study drug|0|||
163938865|NCT02922023|592146670|FG000|Overall Study|Lost to Follow-up|2|||
163938866|NCT02922023|592146671|FG001|Overall Study|Lost to Follow-up|0|||
163938867|NCT02979249|592146672|FG000|Overall Study|Lost to Follow-up|2|||
163938868|NCT02979249|592146672|FG000|Overall Study|Withdrawal by Subject|4|||
163938869|NCT01125046|592146673|FG000|First 6 Months of Treatment|Death|1|||
163938870|NCT01125046|592146673|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
163938871|NCT01125046|592146673|FG000|First 6 Months of Treatment|Non-compliance|1|||
163938872|NCT01125046|592146673|FG000|First 6 Months of Treatment|Surgery|1|||
163938873|NCT01125046|592146673|FG000|First 6 Months of Treatment|Progressive Disease|7|||
163938874|NCT01125046|592146673|FG000|First 6 Months of Treatment|Adverse Event|2|||
163938875|NCT01125046|592146673|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
163938876|NCT01125046|592146673|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
163938877|NCT01125046|592146673|FG000|Follow-up/Data Cut Off Point|Death|29|||
163938878|NCT01125046|592146673|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
163938879|NCT02159040|592146674|FG000|Overall Study|Death|1|||
164098836|NCT02587962|592726934|FG000|Overall Study|Adverse Event|0|||
163938880|NCT02766777|592146678|FG000|Overall Study|Adverse Event|12|||
163938881|NCT02766777|592146678|FG000|Overall Study|Lost to Follow-up|16|||
164098837|NCT02587962|592726935|FG001|Overall Study|Adverse Event|0|||
164098838|NCT02587962|592726936|FG002|Overall Study|Adverse Event|1|||
163938882|NCT02766777|592146678|FG000|Overall Study|Non-Compliance With Study Drug|1|||
163938883|NCT02766777|592146678|FG000|Overall Study|Protocol Violation|1|||
163938884|NCT02766777|592146678|FG000|Overall Study|Withdrawal by Subject|4|||
163938885|NCT01886287|592146679|FG000|Overall Study|Radiographic disease progression|1|||
163938886|NCT01886287|592146679|FG000|Overall Study|Clinical progression due to disease|1|||
163938887|NCT01371825|592146683|FG000|Overall Study|Death|4|||
163938888|NCT00895895|592146684|FG000|Period 1|Adverse Event|7|||
163938889|NCT00895895|592146685|FG001|Period 1|Adverse Event|6|||
163938890|NCT00895895|592146686|FG002|Period 1|Adverse Event|4|||
163938891|NCT00895895|592146687|FG003|Period 1|Adverse Event|6|||
163938892|NCT00895895|592146688|FG004|Period 1|Adverse Event|7|||
163938893|NCT00895895|592146684|FG000|Period 1|Death|0|||
163938894|NCT00895895|592146685|FG001|Period 1|Death|0|||
163938895|NCT00895895|592146686|FG002|Period 1|Death|0|||
163938896|NCT00895895|592146687|FG003|Period 1|Death|0|||
163938897|NCT00895895|592146688|FG004|Period 1|Death|1|||
163938898|NCT00895895|592146684|FG000|Period 1|discontinued by sponsor|2|||
163938899|NCT00895895|592146685|FG001|Period 1|discontinued by sponsor|1|||
163938900|NCT00895895|592146686|FG002|Period 1|discontinued by sponsor|2|||
163938901|NCT00895895|592146687|FG003|Period 1|discontinued by sponsor|1|||
163938902|NCT00895895|592146688|FG004|Period 1|discontinued by sponsor|1|||
163938903|NCT00895895|592146684|FG000|Period 1|failed to return|0|||
163938904|NCT00895895|592146685|FG001|Period 1|failed to return|0|||
163938905|NCT00895895|592146686|FG002|Period 1|failed to return|1|||
163938906|NCT00895895|592146687|FG003|Period 1|failed to return|0|||
163938907|NCT00895895|592146688|FG004|Period 1|failed to return|1|||
163938908|NCT00895895|592146684|FG000|Period 1|investigator request|0|||
163938909|NCT00895895|592146685|FG001|Period 1|investigator request|1|||
163938910|NCT00895895|592146686|FG002|Period 1|investigator request|0|||
163938911|NCT00895895|592146687|FG003|Period 1|investigator request|0|||
163938912|NCT00895895|592146688|FG004|Period 1|investigator request|0|||
163938913|NCT00895895|592146684|FG000|Period 1|Lost to Follow-up|2|||
163938914|NCT00895895|592146685|FG001|Period 1|Lost to Follow-up|1|||
163938915|NCT00895895|592146686|FG002|Period 1|Lost to Follow-up|3|||
163938916|NCT00895895|592146687|FG003|Period 1|Lost to Follow-up|2|||
163938917|NCT00895895|592146688|FG004|Period 1|Lost to Follow-up|3|||
163938918|NCT00895895|592146684|FG000|Period 1|Other|1|||
163938919|NCT00895895|592146685|FG001|Period 1|Other|2|||
163938920|NCT00895895|592146686|FG002|Period 1|Other|1|||
163938921|NCT00895895|592146687|FG003|Period 1|Other|1|||
163938922|NCT00895895|592146688|FG004|Period 1|Other|1|||
163938923|NCT00895895|592146684|FG000|Period 1|Protocol Violation|0|||
163938924|NCT00895895|592146685|FG001|Period 1|Protocol Violation|1|||
163938925|NCT00895895|592146686|FG002|Period 1|Protocol Violation|0|||
163938926|NCT00895895|592146687|FG003|Period 1|Protocol Violation|0|||
163938927|NCT00895895|592146688|FG004|Period 1|Protocol Violation|0|||
163938928|NCT00895895|592146684|FG000|Period 1|Withdrawal by Subject|6|||
163938929|NCT00895895|592146685|FG001|Period 1|Withdrawal by Subject|6|||
163938930|NCT00895895|592146686|FG002|Period 1|Withdrawal by Subject|8|||
163938931|NCT00895895|592146687|FG003|Period 1|Withdrawal by Subject|2|||
163938932|NCT00895895|592146688|FG004|Period 1|Withdrawal by Subject|4|||
163938933|NCT00895895|592146684|FG000|Period 1|unsatisfactory response-efficacy|2|||
163938934|NCT00895895|592146685|FG001|Period 1|unsatisfactory response-efficacy|0|||
163938935|NCT00895895|592146686|FG002|Period 1|unsatisfactory response-efficacy|0|||
163938936|NCT00895895|592146687|FG003|Period 1|unsatisfactory response-efficacy|0|||
163938937|NCT00895895|592146688|FG004|Period 1|unsatisfactory response-efficacy|0|||
163938938|NCT00895895|592146684|FG000|Period 1|randomized and not treated|1|||
163938939|NCT00895895|592146685|FG001|Period 1|randomized and not treated|3|||
163938940|NCT00895895|592146686|FG002|Period 1|randomized and not treated|1|||
163938941|NCT00895895|592146687|FG003|Period 1|randomized and not treated|1|||
163938942|NCT00895895|592146688|FG004|Period 1|randomized and not treated|2|||
163938943|NCT00895895|592146684|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
163938944|NCT00895895|592146685|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
163938945|NCT00895895|592146686|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
163938946|NCT00895895|592146687|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
163938947|NCT00895895|592146688|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
163938948|NCT00895895|592146684|FG000|After Period 1, Prior to Period 2|Other|0|||
163938949|NCT00895895|592146685|FG001|After Period 1, Prior to Period 2|Other|0|||
163938950|NCT00895895|592146686|FG002|After Period 1, Prior to Period 2|Other|1|||
163938951|NCT00895895|592146687|FG003|After Period 1, Prior to Period 2|Other|0|||
163938952|NCT00895895|592146688|FG004|After Period 1, Prior to Period 2|Other|0|||
163938953|NCT00895895|592146684|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
163938954|NCT00895895|592146685|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
163938955|NCT00895895|592146686|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
163938956|NCT00895895|592146687|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
163938957|NCT00895895|592146688|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
163938958|NCT00895895|592146684|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163938959|NCT00895895|592146685|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163938960|NCT00895895|592146686|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163938961|NCT00895895|592146687|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
163938962|NCT00895895|592146688|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
163938963|NCT00895895|592146684|FG000|Period 2|Adverse Event|3|||
163938964|NCT00895895|592146685|FG001|Period 2|Adverse Event|3|||
163938965|NCT00895895|592146686|FG002|Period 2|Adverse Event|5|||
163938966|NCT00895895|592146687|FG003|Period 2|Adverse Event|2|||
163938967|NCT00895895|592146688|FG004|Period 2|Adverse Event|5|||
163938968|NCT00895895|592146684|FG000|Period 2|Death|0|||
163938969|NCT00895895|592146685|FG001|Period 2|Death|0|||
163938970|NCT00895895|592146686|FG002|Period 2|Death|1|||
163938971|NCT00895895|592146687|FG003|Period 2|Death|0|||
163938972|NCT00895895|592146688|FG004|Period 2|Death|0|||
163938973|NCT00895895|592146684|FG000|Period 2|discontinued by sponsor|44|||
163938974|NCT00895895|592146685|FG001|Period 2|discontinued by sponsor|44|||
163938975|NCT00895895|592146686|FG002|Period 2|discontinued by sponsor|38|||
163938976|NCT00895895|592146687|FG003|Period 2|discontinued by sponsor|46|||
163938977|NCT00895895|592146688|FG004|Period 2|discontinued by sponsor|37|||
163938978|NCT00895895|592146684|FG000|Period 2|failed to return|2|||
163938979|NCT00895895|592146685|FG001|Period 2|failed to return|0|||
163938980|NCT00895895|592146686|FG002|Period 2|failed to return|0|||
163938981|NCT00895895|592146687|FG003|Period 2|failed to return|0|||
163938982|NCT00895895|592146688|FG004|Period 2|failed to return|0|||
163938983|NCT00895895|592146684|FG000|Period 2|investigator request|2|||
163938984|NCT00895895|592146685|FG001|Period 2|investigator request|0|||
163938985|NCT00895895|592146686|FG002|Period 2|investigator request|0|||
163938986|NCT00895895|592146687|FG003|Period 2|investigator request|0|||
163938987|NCT00895895|592146688|FG004|Period 2|investigator request|0|||
163938988|NCT00895895|592146684|FG000|Period 2|Lost to Follow-up|1|||
163938989|NCT00895895|592146685|FG001|Period 2|Lost to Follow-up|2|||
163938990|NCT00895895|592146686|FG002|Period 2|Lost to Follow-up|1|||
163938991|NCT00895895|592146687|FG003|Period 2|Lost to Follow-up|1|||
163938992|NCT00895895|592146688|FG004|Period 2|Lost to Follow-up|0|||
163938993|NCT00895895|592146684|FG000|Period 2|Other|1|||
163938994|NCT00895895|592146685|FG001|Period 2|Other|1|||
163938995|NCT00895895|592146686|FG002|Period 2|Other|3|||
163938996|NCT00895895|592146687|FG003|Period 2|Other|1|||
163938997|NCT00895895|592146688|FG004|Period 2|Other|1|||
163938998|NCT00895895|592146684|FG000|Period 2|Protocol Violation|1|||
163938999|NCT00895895|592146685|FG001|Period 2|Protocol Violation|0|||
163939000|NCT00895895|592146686|FG002|Period 2|Protocol Violation|1|||
163939001|NCT00895895|592146687|FG003|Period 2|Protocol Violation|1|||
163939002|NCT00895895|592146688|FG004|Period 2|Protocol Violation|1|||
163939003|NCT00895895|592146684|FG000|Period 2|Withdrawal by Subject|0|||
163939004|NCT00895895|592146685|FG001|Period 2|Withdrawal by Subject|2|||
163939005|NCT00895895|592146686|FG002|Period 2|Withdrawal by Subject|0|||
163939006|NCT00895895|592146687|FG003|Period 2|Withdrawal by Subject|3|||
163939007|NCT00895895|592146688|FG004|Period 2|Withdrawal by Subject|5|||
163939008|NCT00895895|592146684|FG000|Period 2|unsatisfactory response-efficacy|2|||
163939009|NCT00895895|592146685|FG001|Period 2|unsatisfactory response-efficacy|1|||
163939010|NCT00895895|592146686|FG002|Period 2|unsatisfactory response-efficacy|0|||
163939011|NCT00895895|592146687|FG003|Period 2|unsatisfactory response-efficacy|0|||
163939012|NCT00895895|592146688|FG004|Period 2|unsatisfactory response-efficacy|0|||
163939013|NCT01261000|592146689|FG000|Overall Study|Screen failure|1|||
163939014|NCT03019640|592146690|FG000|Overall Study|Screen Failures|4|||
163939015|NCT03019640|592146690|FG000|Overall Study|Adverse Event|3|||
163939016|NCT03019640|592146690|FG000|Overall Study|Participant Relapsed|1|||
163939017|NCT01721954|592146691|FG000|Overall Study|Death|58|||
163939018|NCT01721954|592146692|FG001|Overall Study|Death|64|||
163939019|NCT01721954|592146691|FG000|Overall Study|Withdrawal by Subject|8|||
163939020|NCT01721954|592146692|FG001|Overall Study|Withdrawal by Subject|4|||
163939021|NCT01721954|592146691|FG000|Overall Study|Adverse Event|2|||
163939022|NCT01721954|592146692|FG001|Overall Study|Adverse Event|0|||
163939023|NCT01721954|592146691|FG000|Overall Study|Lost to Follow-up|2|||
163939024|NCT01721954|592146692|FG001|Overall Study|Lost to Follow-up|1|||
163939025|NCT01195623|592146693|FG000|Overall Study|Lost to Follow-up|35|||
163939026|NCT01195623|592146694|FG001|Overall Study|Lost to Follow-up|37|||
163939027|NCT00534495|592146695|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
163939028|NCT00534495|592146696|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
163939029|NCT00534495|592146697|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
163939030|NCT00534495|592146695|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
163939031|NCT00534495|592146696|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
163939032|NCT00534495|592146697|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
163939033|NCT00534495|592146695|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
163939034|NCT00534495|592146696|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
163939035|NCT00534495|592146697|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
163939036|NCT00534495|592146695|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
163939037|NCT00534495|592146696|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
163939038|NCT00534495|592146697|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
163939039|NCT00534495|592146695|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
163939040|NCT00534495|592146696|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
163939041|NCT00534495|592146697|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
163939042|NCT00534495|592146695|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
163939043|NCT00534495|592146696|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
163939044|NCT00534495|592146697|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
163939045|NCT00534495|592146695|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
163939046|NCT00534495|592146696|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
163939047|NCT00534495|592146697|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
163939048|NCT00534495|592146695|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
163939049|NCT00534495|592146696|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
163939050|NCT00534495|592146697|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
164040659|NCT01641081|592508824|FG003|Period 2|Adverse Event|0|||
163939051|NCT00534495|592146695|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
163939052|NCT00534495|592146696|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
163939053|NCT00534495|592146697|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
163939054|NCT02920970|592146701|FG000|First Intervention|Protocol Violation|0|||
163939055|NCT02920970|592146702|FG001|First Intervention|Protocol Violation|1|||
163939056|NCT02920970|592146701|FG000|First Intervention|Adverse Event|0|||
163939057|NCT02920970|592146702|FG001|First Intervention|Adverse Event|1|||
163939058|NCT02920970|592146701|FG000|Second Intervention|Poor Lens Fit|1|||
163939059|NCT02920970|592146702|FG001|Second Intervention|Poor Lens Fit|0|||
163939060|NCT01711853|592146703|FG000|Overall Study|Not treated|3|||
163939061|NCT01889069|592146704|FG000|Overall Study|Death|18|||
163939062|NCT01889069|592146704|FG000|Overall Study|Progression of Disease|14|||
163939063|NCT01889069|592146704|FG000|Overall Study|Lost to Follow-up|6|||
163939064|NCT01889069|592146704|FG000|Overall Study|Other|4|||
163939065|NCT01889069|592146704|FG000|Overall Study|Consent Withdrawal|3|||
163939066|NCT01509547|592146705|FG000|Overall Study|Lost to Follow-up|24|||
163939067|NCT01509547|592146706|FG001|Overall Study|Lost to Follow-up|14|||
163939068|NCT01509547|592146705|FG000|Overall Study|Withdrawal by Subject|11|||
163939069|NCT01509547|592146706|FG001|Overall Study|Withdrawal by Subject|24|||
163939070|NCT01509547|592146705|FG000|Overall Study|Physician Decision|0|||
163939071|NCT01509547|592146706|FG001|Overall Study|Physician Decision|1|||
163939072|NCT02227992|592146709|FG000|Overall Study|Lost to Follow-up|1|||
163939073|NCT02227992|592146710|FG001|Overall Study|Lost to Follow-up|1|||
163939074|NCT01371708|592146713|FG000|Overall Study|Insufficient clinical response|3|||
163939075|NCT01371708|592146714|FG001|Overall Study|Insufficient clinical response|2|||
163939076|NCT01371708|592146715|FG002|Overall Study|Insufficient clinical response|0|||
163939077|NCT01371708|592146713|FG000|Overall Study|Lost to Follow-up|5|||
163939078|NCT01371708|592146714|FG001|Overall Study|Lost to Follow-up|9|||
163939079|NCT01371708|592146715|FG002|Overall Study|Lost to Follow-up|7|||
163939080|NCT01371708|592146713|FG000|Overall Study|Protocol Violation|2|||
163939081|NCT01371708|592146714|FG001|Overall Study|Protocol Violation|1|||
163939082|NCT01371708|592146715|FG002|Overall Study|Protocol Violation|2|||
163939083|NCT01371708|592146713|FG000|Overall Study|No longer willing to participate|7|||
163939084|NCT01371708|592146714|FG001|Overall Study|No longer willing to participate|7|||
163939085|NCT01371708|592146715|FG002|Overall Study|No longer willing to participate|13|||
163939086|NCT01371708|592146713|FG000|Overall Study|Medication error/not related to AE|0|||
163939087|NCT01371708|592146714|FG001|Overall Study|Medication error/not related to AE|1|||
163939088|NCT01371708|592146715|FG002|Overall Study|Medication error/not related to AE|0|||
163939089|NCT01371708|592146713|FG000|Overall Study|Other|3|||
163939090|NCT01371708|592146714|FG001|Overall Study|Other|2|||
163939091|NCT01371708|592146715|FG002|Overall Study|Other|4|||
163939092|NCT01371708|592146713|FG000|Overall Study|Adverse Event|5|||
163939093|NCT01371708|592146714|FG001|Overall Study|Adverse Event|8|||
163939094|NCT01371708|592146715|FG002|Overall Study|Adverse Event|12|||
163939095|NCT01371708|592146713|FG000|Overall Study|Started but did not receive treatment|1|||
163939096|NCT01371708|592146714|FG001|Overall Study|Started but did not receive treatment|0|||
163939097|NCT01371708|592146715|FG002|Overall Study|Started but did not receive treatment|1|||
163939098|NCT02514551|592146716|FG000|Overall Study|Lost to Follow-up|0|||
163939099|NCT02514551|592146717|FG001|Overall Study|Lost to Follow-up|1|||
163939100|NCT02514551|592146716|FG000|Overall Study|Participant Never Treated|0|||
163939101|NCT02514551|592146717|FG001|Overall Study|Participant Never Treated|2|||
163939102|NCT00996606|592146728|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
163939103|NCT00996606|592146728|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163939104|NCT00996606|592146728|FG000|Overall Study|Protocol Violation|1|||
163939105|NCT00996606|592146728|FG000|Overall Study|Withdrawal by Subject|3|||
163939106|NCT03197766|592146729|FG000|Overall Study|Withdrawal by Subject|2|||
163939107|NCT03197766|592146730|FG001|Overall Study|Withdrawal by Subject|0|||
163939108|NCT00350727|592146735|FG000|Phase I: Dose Escalation|Adverse Event|4|||
163939109|NCT00350727|592146736|FG001|Phase I: Dose Escalation|Adverse Event|0|||
163939110|NCT00350727|592146737|FG002|Phase I: Dose Escalation|Adverse Event|0|||
163939111|NCT00350727|592146735|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
163939112|NCT00350727|592146736|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
163939113|NCT00350727|592146737|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
163939114|NCT00350727|592146735|FG000|Phase I: Dose Escalation|Death|1|||
163939115|NCT00350727|592146736|FG001|Phase I: Dose Escalation|Death|0|||
163939116|NCT00350727|592146737|FG002|Phase I: Dose Escalation|Death|0|||
163939117|NCT00350727|592146735|FG000|Phase I: Dose Escalation|Physician Decision|1|||
163939118|NCT00350727|592146736|FG001|Phase I: Dose Escalation|Physician Decision|0|||
163939119|NCT00350727|592146737|FG002|Phase I: Dose Escalation|Physician Decision|0|||
163939120|NCT00350727|592146735|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
163939121|NCT00350727|592146736|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
163939122|NCT00350727|592146737|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
163939123|NCT00350727|592146735|FG000|Phase II|Disease Progression|0|||
163939124|NCT00350727|592146736|FG001|Phase II|Disease Progression|15|||
163939125|NCT00350727|592146737|FG002|Phase II|Disease Progression|16|||
163939126|NCT00350727|592146735|FG000|Phase II|Clinical Deterioration|0|||
163939127|NCT00350727|592146736|FG001|Phase II|Clinical Deterioration|1|||
163939128|NCT00350727|592146737|FG002|Phase II|Clinical Deterioration|0|||
163939129|NCT00350727|592146735|FG000|Phase II|Withdrawal by Subject|0|||
163939130|NCT00350727|592146736|FG001|Phase II|Withdrawal by Subject|2|||
163939131|NCT00350727|592146737|FG002|Phase II|Withdrawal by Subject|1|||
163939132|NCT00350727|592146735|FG000|Phase II|Adverse Event|0|||
163939133|NCT00350727|592146736|FG001|Phase II|Adverse Event|1|||
163939134|NCT00350727|592146737|FG002|Phase II|Adverse Event|1|||
163939135|NCT00350727|592146735|FG000|Phase II|Death|0|||
163939136|NCT00350727|592146736|FG001|Phase II|Death|0|||
163939137|NCT00350727|592146737|FG002|Phase II|Death|2|||
163939138|NCT00350727|592146735|FG000|Phase II|Sponsor Terminated Study|0|||
163939139|NCT00350727|592146736|FG001|Phase II|Sponsor Terminated Study|0|||
163939140|NCT00350727|592146737|FG002|Phase II|Sponsor Terminated Study|1|||
163939141|NCT00350727|592146735|FG000|Phase II|Enrolled in Rollover Study|0|||
163939142|NCT00350727|592146736|FG001|Phase II|Enrolled in Rollover Study|0|||
163939143|NCT00350727|592146737|FG002|Phase II|Enrolled in Rollover Study|1|||
163939144|NCT04535544|592146738|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
163939145|NCT04535544|592146739|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
163939146|NCT04535544|592146740|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
163939147|NCT04535544|592146741|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
163939148|NCT04535544|592146738|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
163939149|NCT04535544|592146739|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
163939150|NCT04535544|592146740|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
163939151|NCT04535544|592146741|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
163939152|NCT04535544|592146738|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
163939153|NCT04535544|592146739|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
163939154|NCT04535544|592146740|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
163939155|NCT04535544|592146741|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
163939156|NCT04535544|592146738|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
163939157|NCT04535544|592146739|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
163939158|NCT04535544|592146740|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
164098839|NCT02587962|592726937|FG003|Overall Study|Adverse Event|0|||
164098840|NCT02587962|592726938|FG004|Overall Study|Adverse Event|0|||
164098841|NCT02587962|592726934|FG000|Overall Study|Withdrawal by Subject|0|||
164098842|NCT02587962|592726935|FG001|Overall Study|Withdrawal by Subject|0|||
164098843|NCT02587962|592726936|FG002|Overall Study|Withdrawal by Subject|1|||
164098844|NCT02587962|592726937|FG003|Overall Study|Withdrawal by Subject|1|||
164098845|NCT02587962|592726938|FG004|Overall Study|Withdrawal by Subject|4|||
164098846|NCT02587962|592726934|FG000|Overall Study|Radiological progression|2|||
164098847|NCT02587962|592726935|FG001|Overall Study|Radiological progression|2|||
164098848|NCT02587962|592726936|FG002|Overall Study|Radiological progression|2|||
164098849|NCT02587962|592726937|FG003|Overall Study|Radiological progression|5|||
164098850|NCT02587962|592726938|FG004|Overall Study|Radiological progression|10|||
164098851|NCT02587962|592726934|FG000|Overall Study|Clinical progression|0|||
163939159|NCT04535544|592146741|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
164040660|NCT01641081|592508825|FG004|Period 2|Adverse Event|0|||
164040661|NCT01641081|592508826|FG005|Period 2|Adverse Event|1|||
163939160|NCT04535544|592146738|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
163939161|NCT04535544|592146739|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
163939162|NCT04535544|592146740|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
163939163|NCT04535544|592146741|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
163939164|NCT04535544|592146738|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
163939165|NCT04535544|592146739|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
164040662|NCT01641081|592508827|FG006|Period 2|Adverse Event|0|||
164040663|NCT01641081|592508828|FG007|Period 2|Adverse Event|0|||
164040664|NCT01641081|592508829|FG008|Period 2|Adverse Event|0|||
164040665|NCT01641081|592508830|FG009|Period 2|Adverse Event|0|||
164040666|NCT01641081|592508821|FG000|Period 2|Withdrawal by Subject|0|||
164040667|NCT01641081|592508822|FG001|Period 2|Withdrawal by Subject|0|||
164040668|NCT01641081|592508823|FG002|Period 2|Withdrawal by Subject|0|||
164040669|NCT01641081|592508824|FG003|Period 2|Withdrawal by Subject|1|||
164040670|NCT01641081|592508825|FG004|Period 2|Withdrawal by Subject|0|||
164040671|NCT01641081|592508826|FG005|Period 2|Withdrawal by Subject|0|||
164040672|NCT01641081|592508827|FG006|Period 2|Withdrawal by Subject|2|||
164040673|NCT01641081|592508828|FG007|Period 2|Withdrawal by Subject|0|||
164040674|NCT01641081|592508829|FG008|Period 2|Withdrawal by Subject|0|||
164040675|NCT01641081|592508830|FG009|Period 2|Withdrawal by Subject|0|||
164040676|NCT01641081|592508821|FG000|Period 2|Protocol Violation|1|||
164040677|NCT01641081|592508822|FG001|Period 2|Protocol Violation|0|||
164040678|NCT01641081|592508823|FG002|Period 2|Protocol Violation|0|||
164040679|NCT01641081|592508824|FG003|Period 2|Protocol Violation|0|||
164040680|NCT01641081|592508825|FG004|Period 2|Protocol Violation|0|||
164040681|NCT01641081|592508826|FG005|Period 2|Protocol Violation|0|||
164040682|NCT01641081|592508827|FG006|Period 2|Protocol Violation|0|||
164098852|NCT02587962|592726935|FG001|Overall Study|Clinical progression|1|||
164040683|NCT01641081|592508828|FG007|Period 2|Protocol Violation|0|||
164040684|NCT01641081|592508829|FG008|Period 2|Protocol Violation|0|||
164040685|NCT01641081|592508830|FG009|Period 2|Protocol Violation|0|||
164040686|NCT01641081|592508821|FG000|Period 3|Adverse Event|0|||
164040687|NCT01641081|592508822|FG001|Period 3|Adverse Event|0|||
164040688|NCT01641081|592508823|FG002|Period 3|Adverse Event|1|||
164040689|NCT01641081|592508824|FG003|Period 3|Adverse Event|0|||
164040690|NCT01641081|592508825|FG004|Period 3|Adverse Event|0|||
164040691|NCT01641081|592508826|FG005|Period 3|Adverse Event|0|||
164040692|NCT01641081|592508827|FG006|Period 3|Adverse Event|0|||
164040693|NCT01641081|592508828|FG007|Period 3|Adverse Event|0|||
164040694|NCT01641081|592508829|FG008|Period 3|Adverse Event|0|||
164040695|NCT01641081|592508830|FG009|Period 3|Adverse Event|0|||
164040696|NCT01641081|592508821|FG000|Period 3|Withdrawal by Subject|0|||
164040697|NCT01641081|592508822|FG001|Period 3|Withdrawal by Subject|0|||
164040698|NCT01641081|592508823|FG002|Period 3|Withdrawal by Subject|0|||
164040699|NCT01641081|592508824|FG003|Period 3|Withdrawal by Subject|0|||
164040700|NCT01641081|592508825|FG004|Period 3|Withdrawal by Subject|0|||
164040701|NCT01641081|592508826|FG005|Period 3|Withdrawal by Subject|0|||
164040702|NCT01641081|592508827|FG006|Period 3|Withdrawal by Subject|0|||
164040703|NCT01641081|592508828|FG007|Period 3|Withdrawal by Subject|0|||
164040704|NCT01641081|592508829|FG008|Period 3|Withdrawal by Subject|1|||
164040705|NCT01641081|592508830|FG009|Period 3|Withdrawal by Subject|0|||
164040706|NCT01641081|592508821|FG000|Period 4|Adverse Event|0|||
164040707|NCT01641081|592508822|FG001|Period 4|Adverse Event|1|||
164040708|NCT01641081|592508823|FG002|Period 4|Adverse Event|0|||
164040709|NCT01641081|592508824|FG003|Period 4|Adverse Event|1|||
164040710|NCT01641081|592508825|FG004|Period 4|Adverse Event|0|||
164040711|NCT01641081|592508826|FG005|Period 4|Adverse Event|0|||
163939166|NCT04535544|592146740|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
163939167|NCT04535544|592146741|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
163939168|NCT04535544|592146738|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
163939169|NCT04535544|592146739|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
163939170|NCT04535544|592146740|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
163939171|NCT04535544|592146741|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
163939172|NCT04535544|592146738|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
163939173|NCT04535544|592146739|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
163939174|NCT04535544|592146740|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
163939175|NCT04535544|592146741|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
163939176|NCT03829501|592149357|FG000|Overall Study|Withdrawal of Consent|2|||
163939177|NCT03829501|592149358|FG001|Overall Study|Withdrawal of Consent|0|||
163939178|NCT03829501|592149359|FG002|Overall Study|Withdrawal of Consent|3|||
163939179|NCT03829501|592149360|FG003|Overall Study|Withdrawal of Consent|0|||
163939180|NCT03829501|592149361|FG004|Overall Study|Withdrawal of Consent|1|||
163939181|NCT03829501|592149362|FG005|Overall Study|Withdrawal of Consent|1|||
163939182|NCT03829501|592149363|FG006|Overall Study|Withdrawal of Consent|0|||
163939183|NCT03829501|592149364|FG007|Overall Study|Withdrawal of Consent|10|||
163939184|NCT03829501|592149365|FG008|Overall Study|Withdrawal of Consent|10|||
163939185|NCT03829501|592149366|FG009|Overall Study|Withdrawal of Consent|3|||
163939186|NCT03829501|592149367|FG010|Overall Study|Withdrawal of Consent|4|||
163939187|NCT03829501|592149368|FG011|Overall Study|Withdrawal of Consent|4|||
163939188|NCT03829501|592149369|FG012|Overall Study|Withdrawal of Consent|4|||
163939189|NCT03829501|592149370|FG013|Overall Study|Withdrawal of Consent|0|||
163939190|NCT03829501|592149371|FG014|Overall Study|Withdrawal of Consent|3|||
163939191|NCT03829501|592149372|FG015|Overall Study|Withdrawal of Consent|0|||
163939192|NCT03829501|592149373|FG016|Overall Study|Withdrawal of Consent|1|||
163939193|NCT03829501|592149374|FG017|Overall Study|Withdrawal of Consent|1|||
163939194|NCT03829501|592149375|FG018|Overall Study|Withdrawal of Consent|0|||
163939195|NCT03829501|592149376|FG019|Overall Study|Withdrawal of Consent|0|||
163939196|NCT03829501|592149377|FG020|Overall Study|Withdrawal of Consent|3|||
163939197|NCT03829501|592149378|FG021|Overall Study|Withdrawal of Consent|0|||
163939198|NCT03829501|592149379|FG022|Overall Study|Withdrawal of Consent|1|||
163939199|NCT03829501|592149357|FG000|Overall Study|PD|0|||
163939200|NCT03829501|592149358|FG001|Overall Study|PD|0|||
164040712|NCT01641081|592508827|FG006|Period 4|Adverse Event|0|||
164040713|NCT01641081|592508828|FG007|Period 4|Adverse Event|0|||
164040714|NCT01641081|592508829|FG008|Period 4|Adverse Event|0|||
164040715|NCT01641081|592508830|FG009|Period 4|Adverse Event|0|||
164040716|NCT01641081|592508821|FG000|Period 5|Adverse Event|0|||
164040717|NCT01641081|592508822|FG001|Period 5|Adverse Event|0|||
164040718|NCT01641081|592508823|FG002|Period 5|Adverse Event|2|||
164040719|NCT01641081|592508824|FG003|Period 5|Adverse Event|0|||
164040720|NCT01641081|592508825|FG004|Period 5|Adverse Event|0|||
164040721|NCT01641081|592508826|FG005|Period 5|Adverse Event|0|||
164040722|NCT01641081|592508827|FG006|Period 5|Adverse Event|0|||
164040723|NCT01641081|592508828|FG007|Period 5|Adverse Event|0|||
164040724|NCT01641081|592508829|FG008|Period 5|Adverse Event|0|||
163939201|NCT03829501|592149359|FG002|Overall Study|PD|0|||
163939202|NCT03829501|592149360|FG003|Overall Study|PD|2|||
164040725|NCT01641081|592508830|FG009|Period 5|Adverse Event|0|||
164040726|NCT01095666|592508831|FG000|Overall Study|Lack of Efficacy|0|||
163939203|NCT03829501|592149361|FG004|Overall Study|PD|0|||
163939204|NCT03829501|592149362|FG005|Overall Study|PD|0|||
163939205|NCT03829501|592149363|FG006|Overall Study|PD|0|||
163939206|NCT03829501|592149364|FG007|Overall Study|PD|0|||
163939207|NCT03829501|592149365|FG008|Overall Study|PD|0|||
163939208|NCT03829501|592149366|FG009|Overall Study|PD|0|||
163939209|NCT03829501|592149367|FG010|Overall Study|PD|0|||
163939210|NCT03829501|592149368|FG011|Overall Study|PD|0|||
163939211|NCT03829501|592149369|FG012|Overall Study|PD|0|||
163939212|NCT03829501|592149370|FG013|Overall Study|PD|0|||
163939213|NCT03829501|592149371|FG014|Overall Study|PD|0|||
163939214|NCT03829501|592149372|FG015|Overall Study|PD|1|||
163939215|NCT03829501|592149373|FG016|Overall Study|PD|0|||
163939216|NCT03829501|592149374|FG017|Overall Study|PD|0|||
163939217|NCT03829501|592149375|FG018|Overall Study|PD|0|||
163939218|NCT03829501|592149376|FG019|Overall Study|PD|0|||
163939219|NCT03829501|592149377|FG020|Overall Study|PD|1|||
163939220|NCT03829501|592149378|FG021|Overall Study|PD|0|||
163939221|NCT03829501|592149379|FG022|Overall Study|PD|0|||
163939222|NCT03829501|592149357|FG000|Overall Study|Study Terminated by Sponsor|0|||
163939223|NCT03829501|592149358|FG001|Overall Study|Study Terminated by Sponsor|0|||
163939224|NCT03829501|592149359|FG002|Overall Study|Study Terminated by Sponsor|0|||
163939225|NCT03829501|592149360|FG003|Overall Study|Study Terminated by Sponsor|0|||
163939226|NCT03829501|592149361|FG004|Overall Study|Study Terminated by Sponsor|0|||
163939227|NCT03829501|592149362|FG005|Overall Study|Study Terminated by Sponsor|0|||
163939228|NCT03829501|592149363|FG006|Overall Study|Study Terminated by Sponsor|0|||
163939229|NCT03829501|592149364|FG007|Overall Study|Study Terminated by Sponsor|3|||
163939230|NCT03829501|592149365|FG008|Overall Study|Study Terminated by Sponsor|1|||
163939231|NCT03829501|592149366|FG009|Overall Study|Study Terminated by Sponsor|0|||
163939232|NCT03829501|592149367|FG010|Overall Study|Study Terminated by Sponsor|0|||
163939233|NCT03829501|592149368|FG011|Overall Study|Study Terminated by Sponsor|0|||
163939234|NCT03829501|592149369|FG012|Overall Study|Study Terminated by Sponsor|0|||
163939235|NCT03829501|592149370|FG013|Overall Study|Study Terminated by Sponsor|0|||
163939236|NCT03829501|592149371|FG014|Overall Study|Study Terminated by Sponsor|3|||
163939237|NCT03829501|592149372|FG015|Overall Study|Study Terminated by Sponsor|2|||
163939238|NCT03829501|592149373|FG016|Overall Study|Study Terminated by Sponsor|2|||
163939239|NCT03829501|592149374|FG017|Overall Study|Study Terminated by Sponsor|0|||
163939240|NCT03829501|592149375|FG018|Overall Study|Study Terminated by Sponsor|0|||
163939241|NCT03829501|592149376|FG019|Overall Study|Study Terminated by Sponsor|0|||
163939242|NCT03829501|592149377|FG020|Overall Study|Study Terminated by Sponsor|1|||
163939243|NCT03829501|592149378|FG021|Overall Study|Study Terminated by Sponsor|0|||
163939244|NCT03829501|592149379|FG022|Overall Study|Study Terminated by Sponsor|3|||
163939245|NCT03829501|592149357|FG000|Overall Study|Lost to Follow Up|0|||
163939246|NCT03829501|592149358|FG001|Overall Study|Lost to Follow Up|0|||
163939247|NCT03829501|592149359|FG002|Overall Study|Lost to Follow Up|0|||
163939248|NCT03829501|592149360|FG003|Overall Study|Lost to Follow Up|0|||
163939249|NCT03829501|592149361|FG004|Overall Study|Lost to Follow Up|1|||
163939250|NCT03829501|592149362|FG005|Overall Study|Lost to Follow Up|0|||
163939251|NCT03829501|592149363|FG006|Overall Study|Lost to Follow Up|0|||
163939252|NCT03829501|592149364|FG007|Overall Study|Lost to Follow Up|2|||
163939253|NCT03829501|592149365|FG008|Overall Study|Lost to Follow Up|2|||
163939254|NCT03829501|592149366|FG009|Overall Study|Lost to Follow Up|0|||
163939255|NCT03829501|592149367|FG010|Overall Study|Lost to Follow Up|2|||
163939256|NCT03829501|592149368|FG011|Overall Study|Lost to Follow Up|1|||
163939257|NCT03829501|592149369|FG012|Overall Study|Lost to Follow Up|0|||
163939258|NCT03829501|592149370|FG013|Overall Study|Lost to Follow Up|1|||
163939259|NCT03829501|592149371|FG014|Overall Study|Lost to Follow Up|1|||
163939260|NCT03829501|592149372|FG015|Overall Study|Lost to Follow Up|0|||
163939261|NCT03829501|592149373|FG016|Overall Study|Lost to Follow Up|0|||
163939262|NCT03829501|592149374|FG017|Overall Study|Lost to Follow Up|0|||
163939263|NCT03829501|592149375|FG018|Overall Study|Lost to Follow Up|0|||
163939264|NCT03829501|592149376|FG019|Overall Study|Lost to Follow Up|0|||
163939265|NCT03829501|592149377|FG020|Overall Study|Lost to Follow Up|0|||
163939266|NCT03829501|592149378|FG021|Overall Study|Lost to Follow Up|0|||
163939267|NCT03829501|592149379|FG022|Overall Study|Lost to Follow Up|1|||
163939268|NCT03829501|592149357|FG000|Overall Study|Death|2|||
163939269|NCT03829501|592149358|FG001|Overall Study|Death|4|||
163939270|NCT03829501|592149359|FG002|Overall Study|Death|5|||
163939271|NCT03829501|592149360|FG003|Overall Study|Death|6|||
163939272|NCT03829501|592149361|FG004|Overall Study|Death|5|||
163939273|NCT03829501|592149362|FG005|Overall Study|Death|4|||
163939274|NCT03829501|592149363|FG006|Overall Study|Death|5|||
163939275|NCT03829501|592149364|FG007|Overall Study|Death|24|||
163939276|NCT03829501|592149365|FG008|Overall Study|Death|22|||
163939277|NCT03829501|592149366|FG009|Overall Study|Death|6|||
163939278|NCT03829501|592149367|FG010|Overall Study|Death|3|||
163939279|NCT03829501|592149368|FG011|Overall Study|Death|10|||
163939280|NCT03829501|592149369|FG012|Overall Study|Death|10|||
163939281|NCT03829501|592149370|FG013|Overall Study|Death|5|||
163939282|NCT03829501|592149371|FG014|Overall Study|Death|7|||
163939283|NCT03829501|592149372|FG015|Overall Study|Death|2|||
163939284|NCT03829501|592149373|FG016|Overall Study|Death|2|||
163939285|NCT03829501|592149374|FG017|Overall Study|Death|1|||
163939286|NCT03829501|592149375|FG018|Overall Study|Death|1|||
163939287|NCT03829501|592149376|FG019|Overall Study|Death|1|||
163939288|NCT03829501|592149377|FG020|Overall Study|Death|1|||
163939289|NCT03829501|592149378|FG021|Overall Study|Death|2|||
163939290|NCT03829501|592149379|FG022|Overall Study|Death|3|||
163939291|NCT03829501|592149357|FG000|Overall Study|Miscellaneous|0|||
163939292|NCT03829501|592149358|FG001|Overall Study|Miscellaneous|0|||
163939293|NCT03829501|592149359|FG002|Overall Study|Miscellaneous|1|||
163939294|NCT03829501|592149360|FG003|Overall Study|Miscellaneous|0|||
163939295|NCT03829501|592149361|FG004|Overall Study|Miscellaneous|0|||
163939296|NCT03829501|592149362|FG005|Overall Study|Miscellaneous|0|||
163939297|NCT03829501|592149363|FG006|Overall Study|Miscellaneous|0|||
163939298|NCT03829501|592149364|FG007|Overall Study|Miscellaneous|1|||
163939299|NCT03829501|592149365|FG008|Overall Study|Miscellaneous|0|||
163939300|NCT03829501|592149366|FG009|Overall Study|Miscellaneous|0|||
163939301|NCT03829501|592149367|FG010|Overall Study|Miscellaneous|0|||
163939302|NCT03829501|592149368|FG011|Overall Study|Miscellaneous|0|||
163939303|NCT03829501|592149369|FG012|Overall Study|Miscellaneous|0|||
163939304|NCT03829501|592149370|FG013|Overall Study|Miscellaneous|0|||
163939305|NCT03829501|592149371|FG014|Overall Study|Miscellaneous|0|||
163939306|NCT03829501|592149372|FG015|Overall Study|Miscellaneous|0|||
163939307|NCT03829501|592149373|FG016|Overall Study|Miscellaneous|0|||
163939308|NCT03829501|592149374|FG017|Overall Study|Miscellaneous|0|||
163939309|NCT03829501|592149375|FG018|Overall Study|Miscellaneous|0|||
163939310|NCT03829501|592149376|FG019|Overall Study|Miscellaneous|0|||
163939311|NCT03829501|592149377|FG020|Overall Study|Miscellaneous|0|||
163939312|NCT03829501|592149378|FG021|Overall Study|Miscellaneous|0|||
163939313|NCT03829501|592149379|FG022|Overall Study|Miscellaneous|1|||
163939314|NCT02964013|592149380|FG000|Overall Study|Death|58|||
163939315|NCT02964013|592149381|FG001|Overall Study|Death|239|||
163939316|NCT02964013|592149382|FG002|Overall Study|Death|38|||
163939317|NCT02964013|592149383|FG003|Overall Study|Death|10|||
163939318|NCT02964013|592149384|FG004|Overall Study|Death|33|||
163939319|NCT02964013|592149380|FG000|Overall Study|Lost to Follow-up|1|||
163939320|NCT02964013|592149381|FG001|Overall Study|Lost to Follow-up|4|||
163939321|NCT02964013|592149382|FG002|Overall Study|Lost to Follow-up|2|||
163939322|NCT02964013|592149383|FG003|Overall Study|Lost to Follow-up|0|||
163939323|NCT02964013|592149384|FG004|Overall Study|Lost to Follow-up|0|||
163939324|NCT02964013|592149380|FG000|Overall Study|Physician Decision|0|||
163939325|NCT02964013|592149381|FG001|Overall Study|Physician Decision|1|||
163939326|NCT02964013|592149382|FG002|Overall Study|Physician Decision|0|||
163939327|NCT02964013|592149383|FG003|Overall Study|Physician Decision|0|||
163939328|NCT02964013|592149384|FG004|Overall Study|Physician Decision|0|||
163939329|NCT02964013|592149380|FG000|Overall Study|Sponsor Decision|3|||
163939330|NCT02964013|592149381|FG001|Overall Study|Sponsor Decision|22|||
163939331|NCT02964013|592149382|FG002|Overall Study|Sponsor Decision|11|||
163939332|NCT02964013|592149383|FG003|Overall Study|Sponsor Decision|0|||
163939333|NCT02964013|592149384|FG004|Overall Study|Sponsor Decision|7|||
163939334|NCT02964013|592149380|FG000|Overall Study|Withdrawal by Subject|6|||
163939335|NCT02964013|592149381|FG001|Overall Study|Withdrawal by Subject|27|||
163939336|NCT02964013|592149382|FG002|Overall Study|Withdrawal by Subject|9|||
163939337|NCT02964013|592149383|FG003|Overall Study|Withdrawal by Subject|0|||
163939338|NCT02964013|592149384|FG004|Overall Study|Withdrawal by Subject|0|||
163939339|NCT02964013|592149380|FG000|Overall Study|Not Treated|0|||
163939340|NCT02964013|592149381|FG001|Overall Study|Not Treated|2|||
163939341|NCT02964013|592149382|FG002|Overall Study|Not Treated|0|||
163939342|NCT02964013|592149383|FG003|Overall Study|Not Treated|1|||
163939343|NCT02964013|592149384|FG004|Overall Study|Not Treated|0|||
163939344|NCT01123070|592149385|FG000|Part B Double Blind Period|Protocol Violation|0|||
163939345|NCT01123070|592149386|FG001|Part B Double Blind Period|Protocol Violation|0|||
163939346|NCT01123070|592149387|FG002|Part B Double Blind Period|Protocol Violation|0|||
163939347|NCT01123070|592149388|FG003|Part B Double Blind Period|Protocol Violation|1|||
163939348|NCT01123070|592149385|FG000|Part B Double Blind Period|Adverse Event|0|||
163939349|NCT01123070|592149386|FG001|Part B Double Blind Period|Adverse Event|0|||
163939350|NCT01123070|592149387|FG002|Part B Double Blind Period|Adverse Event|2|||
163939351|NCT01123070|592149388|FG003|Part B Double Blind Period|Adverse Event|0|||
163939352|NCT01123070|592149385|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
163939353|NCT01123070|592149386|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
163939354|NCT01123070|592149387|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
163939355|NCT01123070|592149388|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
163939356|NCT04942366|592149389|FG000|Overall Study|Withdrawal by Subject|5|||
163939357|NCT04942366|592149390|FG001|Overall Study|Withdrawal by Subject|5|||
163939358|NCT00747227|592149397|FG000|Overall Study|Death|3|||
163939359|NCT00747227|592149398|FG001|Overall Study|Death|1|||
163939360|NCT00747227|592149397|FG000|Overall Study|Withdrawal by Subject|1|||
163939361|NCT00747227|592149398|FG001|Overall Study|Withdrawal by Subject|0|||
163939362|NCT00747227|592149397|FG000|Overall Study|Lost to Follow-up|1|||
163939363|NCT00747227|592149398|FG001|Overall Study|Lost to Follow-up|2|||
163939364|NCT00747227|592149397|FG000|Overall Study|Illness|1|||
163939365|NCT00747227|592149398|FG001|Overall Study|Illness|1|||
163939366|NCT03284229|592149399|FG000|Overall Study|Lost to Follow-up|3|||
163939367|NCT00918879|592149401|FG000|Overall Study|Withdrawal by Subject|4|||
163939368|NCT00918879|592149402|FG001|Overall Study|Withdrawal by Subject|4|||
163939369|NCT00918879|592149401|FG000|Overall Study|Lost to Follow-up|1|||
163939370|NCT00918879|592149402|FG001|Overall Study|Lost to Follow-up|1|||
163939371|NCT00918879|592149401|FG000|Overall Study|Severe non-compliance to protocol|1|||
163939372|NCT00918879|592149402|FG001|Overall Study|Severe non-compliance to protocol|1|||
163939373|NCT04707664|592149403|FG000|Overall Study|Adverse Event|2|||
163939374|NCT04707664|592149404|FG001|Overall Study|Adverse Event|0|||
163939375|NCT04707664|592149403|FG000|Overall Study|Death|1|||
163939376|NCT04707664|592149404|FG001|Overall Study|Death|2|||
163939377|NCT04707664|592149403|FG000|Overall Study|Withdrawal by Subject|13|||
163939378|NCT04707664|592149404|FG001|Overall Study|Withdrawal by Subject|21|||
163939379|NCT04707664|592149403|FG000|Overall Study|Lost to Follow-up|11|||
163939380|NCT04707664|592149404|FG001|Overall Study|Lost to Follow-up|13|||
163939381|NCT04707664|592149403|FG000|Overall Study|Not treated|2|||
163939382|NCT04707664|592149404|FG001|Overall Study|Not treated|0|||
163939383|NCT00357110|592149405|FG000|Overall Study|Early study termination|5|||
163939384|NCT00357110|592149406|FG001|Overall Study|Early study termination|5|||
163939385|NCT03339245|592149416|FG000|Overall Study|Adverse Event|1|||
163939386|NCT03339245|592149417|FG001|Overall Study|Adverse Event|1|||
163939387|NCT03339245|592149416|FG000|Overall Study|Withdrawal by Subject|1|||
163939388|NCT03339245|592149417|FG001|Overall Study|Withdrawal by Subject|0|||
163939389|NCT01182441|592149418|FG000|Overall Study|Patient Still in Follow-up|152|||
163939390|NCT01182441|592149419|FG001|Overall Study|Patient Still in Follow-up|72|||
163939391|NCT01182441|592149418|FG000|Overall Study|Death|37|||
163939392|NCT01182441|592149419|FG001|Overall Study|Death|25|||
163939393|NCT01182441|592149418|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
163939394|NCT01182441|592149419|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
163939395|NCT01182441|592149418|FG000|Overall Study|Lost to Follow-up|5|||
163939396|NCT01182441|592149419|FG001|Overall Study|Lost to Follow-up|8|||
163939397|NCT01182441|592149418|FG000|Overall Study|Withdrawal by Subject|6|||
163939398|NCT01182441|592149419|FG001|Overall Study|Withdrawal by Subject|13|||
163939399|NCT01182441|592149418|FG000|Overall Study|Implant Not Attempted|4|||
163939400|NCT01182441|592149419|FG001|Overall Study|Implant Not Attempted|0|||
163939401|NCT01182441|592149418|FG000|Overall Study|Adverse Event|2|||
163939402|NCT01182441|592149419|FG001|Overall Study|Adverse Event|0|||
163939403|NCT01182441|592149418|FG000|Overall Study|Physician Decision|1|||
163939404|NCT01182441|592149419|FG001|Overall Study|Physician Decision|1|||
163939405|NCT00288639|592149427|FG000|Overall Study|Adverse Event|5|||
163939406|NCT00288639|592149427|FG000|Overall Study|Lack of Efficacy|4|||
163939407|NCT00288639|592149427|FG000|Overall Study|Withdrawal by Subject|2|||
163939408|NCT00288639|592149427|FG000|Overall Study|Other|1|||
163939409|NCT03480932|592149436|FG000|Overall Study|Death|1|||
163939410|NCT03480932|592149437|FG001|Overall Study|Death|1|||
163939411|NCT03480932|592149438|FG002|Overall Study|Death|0|||
163939412|NCT03480932|592149436|FG000|Overall Study|Lost to Follow-up|0|||
163939413|NCT03480932|592149437|FG001|Overall Study|Lost to Follow-up|2|||
163939414|NCT03480932|592149438|FG002|Overall Study|Lost to Follow-up|3|||
163939415|NCT03480932|592149436|FG000|Overall Study|Incarcerated|2|||
163939416|NCT03480932|592149437|FG001|Overall Study|Incarcerated|2|||
163939417|NCT03480932|592149438|FG002|Overall Study|Incarcerated|2|||
163939418|NCT00663702|592149439|FG000|Overall Study|Adverse Event|8|||
163939419|NCT00663702|592149440|FG001|Overall Study|Adverse Event|4|||
163939420|NCT00663702|592149439|FG000|Overall Study|Withdrawal by Subject|3|||
163939421|NCT00663702|592149440|FG001|Overall Study|Withdrawal by Subject|1|||
163939422|NCT00663702|592149439|FG000|Overall Study|Pregnancy|0|||
163939423|NCT00663702|592149440|FG001|Overall Study|Pregnancy|1|||
163939424|NCT00663702|592149439|FG000|Overall Study|Lost to Follow-up|3|||
163939425|NCT00663702|592149440|FG001|Overall Study|Lost to Follow-up|0|||
163939426|NCT00663702|592149439|FG000|Overall Study|Death|1|||
163939427|NCT00663702|592149440|FG001|Overall Study|Death|1|||
163939428|NCT00663702|592149439|FG000|Overall Study|Lack of Efficacy|3|||
163939429|NCT00663702|592149440|FG001|Overall Study|Lack of Efficacy|3|||
163939430|NCT03056300|592149441|FG000|Overall Study|Surgical reason per study protocol|3|||
163939431|NCT05262517|592149442|FG000|Overall Study|Randomized but not treated|5|||
163939432|NCT05262517|592149443|FG001|Overall Study|Randomized but not treated|11|||
163939433|NCT01730378|592149449|FG000|Overall Study|Lost to Follow-up|1|||
163939434|NCT01730378|592149450|FG001|Overall Study|Lost to Follow-up|0|||
163939435|NCT04481373|592149454|FG000|Overall Study|Protocol Violation|1|||
163939436|NCT04481373|592149455|FG001|Overall Study|Protocol Violation|0|||
163939437|NCT04481373|592149454|FG000|Overall Study|Viral load in hospital not over 1000|2|||
163939438|NCT04481373|592149455|FG001|Overall Study|Viral load in hospital not over 1000|1|||
163939439|NCT04481373|592149454|FG000|Overall Study|Death before hospital discharge|1|||
163939440|NCT04481373|592149455|FG001|Overall Study|Death before hospital discharge|0|||
163939441|NCT01685229|592149458|FG000|Overall Study|Subjects missing Study Exit form|3|||
163939442|NCT01685229|592149459|FG001|Overall Study|Subjects missing Study Exit form|1|||
163939443|NCT01685229|592149458|FG000|Overall Study|Lost to Follow-up|16|||
163939444|NCT01685229|592149459|FG001|Overall Study|Lost to Follow-up|10|||
163939445|NCT01685229|592149458|FG000|Overall Study|Withdrawal by Subject|6|||
164040727|NCT01095666|592508832|FG001|Overall Study|Lack of Efficacy|0|||
164040728|NCT01095666|592508833|FG002|Overall Study|Lack of Efficacy|1|||
164040729|NCT01095666|592508831|FG000|Overall Study|Adverse Event|2|||
164040730|NCT01095666|592508832|FG001|Overall Study|Adverse Event|1|||
164040731|NCT01095666|592508833|FG002|Overall Study|Adverse Event|3|||
164040732|NCT01095666|592508831|FG000|Overall Study|Lost to Follow-up|2|||
164040733|NCT01095666|592508832|FG001|Overall Study|Lost to Follow-up|2|||
164040734|NCT01095666|592508833|FG002|Overall Study|Lost to Follow-up|0|||
164040735|NCT01095666|592508831|FG000|Overall Study|Withdrawal by Subject|6|||
164040736|NCT01095666|592508832|FG001|Overall Study|Withdrawal by Subject|6|||
164040737|NCT01095666|592508833|FG002|Overall Study|Withdrawal by Subject|1|||
164040738|NCT01095666|592508831|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
164040739|NCT01095666|592508832|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
164040740|NCT01095666|592508833|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
164040741|NCT02758613|592508838|FG000|Treatment|Physician and Sponsor Decision|1|||
164040742|NCT02758613|592508839|FG001|Treatment|Physician and Sponsor Decision|0|||
164040743|NCT02758613|592508840|FG002|Treatment|Physician and Sponsor Decision|0|||
164040744|NCT02758613|592508841|FG003|Treatment|Physician and Sponsor Decision|0|||
164040745|NCT02758613|592508838|FG000|Treatment|Withdrawal by Subject|1|||
164040746|NCT02758613|592508839|FG001|Treatment|Withdrawal by Subject|0|||
164040747|NCT02758613|592508840|FG002|Treatment|Withdrawal by Subject|1|||
164040748|NCT02758613|592508841|FG003|Treatment|Withdrawal by Subject|0|||
164040749|NCT02679781|592508846|FG000|Overall Study|Lost to Follow-up|1|||
164040750|NCT02679781|592508847|FG001|Overall Study|Lost to Follow-up|2|||
164040751|NCT02679781|592508846|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
164040752|NCT02679781|592508847|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
164040753|NCT01496274|592508848|FG000|Overall Study|Protocol Violation|0|||
164040754|NCT01496274|592508849|FG001|Overall Study|Protocol Violation|1|||
164040755|NCT01496274|592508848|FG000|Overall Study|Adverse Event|1|||
164040756|NCT01496274|592508849|FG001|Overall Study|Adverse Event|1|||
164040757|NCT01496274|592508848|FG000|Overall Study|Withdrawal by Subject|2|||
164040758|NCT01496274|592508849|FG001|Overall Study|Withdrawal by Subject|0|||
163840429|NCT02759185|591785842|FG002|Stage 1|Withdrawal by Subject|0|||
163840430|NCT02759185|591785843|FG003|Stage 1|Withdrawal by Subject|0|||
163840431|NCT02759185|591785844|FG004|Stage 1|Withdrawal by Subject|0|||
163840432|NCT02759185|591785845|FG005|Stage 1|Withdrawal by Subject|0|||
163840433|NCT02759185|591785846|FG006|Stage 1|Withdrawal by Subject|0|||
163840434|NCT02759185|591785840|FG000|Stage 2|Adverse Event|0|||
163840435|NCT02759185|591785841|FG001|Stage 2|Adverse Event|0|||
163840436|NCT02759185|591785842|FG002|Stage 2|Adverse Event|0|||
163840437|NCT02759185|591785843|FG003|Stage 2|Adverse Event|0|||
163840438|NCT02759185|591785844|FG004|Stage 2|Adverse Event|1|||
163840439|NCT02759185|591785845|FG005|Stage 2|Adverse Event|2|||
163840440|NCT02759185|591785846|FG006|Stage 2|Adverse Event|0|||
163840441|NCT02759185|591785840|FG000|Stage 2|Withdrawal by Subject|0|||
163840442|NCT02759185|591785841|FG001|Stage 2|Withdrawal by Subject|0|||
163840443|NCT02759185|591785842|FG002|Stage 2|Withdrawal by Subject|0|||
163840444|NCT02759185|591785843|FG003|Stage 2|Withdrawal by Subject|0|||
163840445|NCT02759185|591785844|FG004|Stage 2|Withdrawal by Subject|1|||
163840446|NCT02759185|591785845|FG005|Stage 2|Withdrawal by Subject|1|||
163840447|NCT02759185|591785846|FG006|Stage 2|Withdrawal by Subject|1|||
163840448|NCT00539279|591785851|FG000|Treatment|Withdrawal by Subject|10|||
163840449|NCT00539279|591785852|FG001|Treatment|Withdrawal by Subject|8|||
163840450|NCT00539279|591785851|FG000|Treatment|Death|1|||
163840451|NCT00539279|591785852|FG001|Treatment|Death|0|||
163840452|NCT00539279|591785851|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
163840453|NCT00539279|591785852|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
163840454|NCT00539279|591785851|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
163840455|NCT00539279|591785852|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
163840456|NCT02791490|591787351|FG000|Overall Study|Lost to Follow-up|1|||
163840457|NCT02791490|591787352|FG001|Overall Study|Lost to Follow-up|2|||
163840458|NCT02791490|591787351|FG000|Overall Study|Withdrawal by Subject|2|||
163840459|NCT02791490|591787352|FG001|Overall Study|Withdrawal by Subject|6|||
163840460|NCT02960763|591787353|FG000|Step 1|Withdrawal by Subject|10|||
163840461|NCT02960763|591787354|FG001|Step 1|Withdrawal by Subject|8|||
163840462|NCT02960763|591787355|FG002|Step 1|Withdrawal by Subject|13|||
163840463|NCT02960763|591787356|FG003|Step 1|Withdrawal by Subject|0|||
163840464|NCT02960763|591787357|FG004|Step 1|Withdrawal by Subject|0|||
163840465|NCT02960763|591787353|FG000|Step 1|Lost to Follow-up|7|||
163840466|NCT02960763|591787354|FG001|Step 1|Lost to Follow-up|9|||
163840467|NCT02960763|591787355|FG002|Step 1|Lost to Follow-up|12|||
163840468|NCT02960763|591787356|FG003|Step 1|Lost to Follow-up|0|||
164040759|NCT01496274|592508848|FG000|Overall Study|Lost to Follow-up|0|||
164040760|NCT01496274|592508849|FG001|Overall Study|Lost to Follow-up|3|||
164040761|NCT04018612|592508850|FG000|Overall Study|Withdrawal by Subject|1|||
163840469|NCT02960763|591787357|FG004|Step 1|Lost to Follow-up|0|||
163840470|NCT02960763|591787353|FG000|Step 1|Death|1|||
163840471|NCT02960763|591787354|FG001|Step 1|Death|1|||
163840472|NCT02960763|591787355|FG002|Step 1|Death|1|||
164040762|NCT04018612|592508851|FG001|Overall Study|Withdrawal by Subject|0|||
164040763|NCT04018612|592508852|FG002|Overall Study|Withdrawal by Subject|1|||
164040764|NCT00361218|592508853|FG000|Overall Study|Lost to Follow-up|11|||
164040765|NCT00361218|592508853|FG000|Overall Study|Personal Reasons|7|||
164040766|NCT00361218|592508853|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
164040767|NCT01041404|592508857|FG000|Overall Study|Adverse Event|45|||
164040768|NCT01041404|592508858|FG001|Overall Study|Adverse Event|35|||
164040769|NCT01041404|592508857|FG000|Overall Study|Lack of Efficacy|200|||
164040770|NCT01041404|592508858|FG001|Overall Study|Lack of Efficacy|210|||
164040771|NCT01041404|592508857|FG000|Overall Study|Violation of Selection Criteria|0|||
164040772|NCT01041404|592508858|FG001|Overall Study|Violation of Selection Criteria|1|||
164040773|NCT01041404|592508857|FG000|Overall Study|Protocol Violation|4|||
164040774|NCT01041404|592508858|FG001|Overall Study|Protocol Violation|0|||
164040775|NCT01041404|592508857|FG000|Overall Study|Withdrawal by Subject|29|||
164040776|NCT01041404|592508858|FG001|Overall Study|Withdrawal by Subject|23|||
164040777|NCT01041404|592508857|FG000|Overall Study|Failure to Return|1|||
164040778|NCT01041404|592508858|FG001|Overall Study|Failure to Return|2|||
164040779|NCT01041404|592508857|FG000|Overall Study|Other|11|||
164040780|NCT01041404|592508858|FG001|Overall Study|Other|23|||
164040781|NCT01750840|592508863|FG000|Overall Study|Lost to Follow-up|4|||
164040782|NCT05200455|592508866|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
164040783|NCT00892957|592508868|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
164040784|NCT00892957|592508869|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
164040785|NCT00892957|592508868|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
164040786|NCT00892957|592508869|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
164040787|NCT02091921|592508870|FG000|Overall Study|Adverse Event|3|||
164040788|NCT02483078|592508871|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
164040789|NCT02483078|592508872|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
164040790|NCT02483078|592508871|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
164040791|NCT02483078|592508872|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
164040792|NCT02483078|592508871|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
164040793|NCT02483078|592508872|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
164040794|NCT02483078|592508871|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
164040795|NCT02483078|592508872|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
164040796|NCT02483078|592508871|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
164040797|NCT02483078|592508872|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
164040798|NCT02483078|592508871|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
164040799|NCT02483078|592508872|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
164040800|NCT04876599|592508873|FG000|Overall Study|Missed|2|||
164040801|NCT04876599|592508874|FG001|Overall Study|Missed|0|||
164040802|NCT04876599|592508873|FG000|Overall Study|Declined|2|||
164040803|NCT04876599|592508874|FG001|Overall Study|Declined|3|||
164040804|NCT00669032|592508879|FG000|Overall Study|Lost to Follow-up|6|||
164040805|NCT00669032|592508880|FG001|Overall Study|Lost to Follow-up|5|||
164040806|NCT00669032|592508879|FG000|Overall Study|Lack of Efficacy|8|||
164040807|NCT00669032|592508880|FG001|Overall Study|Lack of Efficacy|19|||
164040808|NCT00669032|592508879|FG000|Overall Study|Withdrawal by Subject|12|||
164040809|NCT00669032|592508880|FG001|Overall Study|Withdrawal by Subject|13|||
164040810|NCT00669032|592508879|FG000|Overall Study|Adverse Event|12|||
164040811|NCT00669032|592508880|FG001|Overall Study|Adverse Event|16|||
164040812|NCT00669032|592508879|FG000|Overall Study|Physician Decision|1|||
164040813|NCT00669032|592508880|FG001|Overall Study|Physician Decision|1|||
164040814|NCT00669032|592508879|FG000|Overall Study|No fulfilment of the selection criteria|5|||
164040815|NCT00669032|592508880|FG001|Overall Study|No fulfilment of the selection criteria|5|||
164040816|NCT01607073|592508881|FG000|Overall Study|Adverse Event|1|||
164040817|NCT04126031|592508883|FG000|Part A|Withdrawal by Subject|0|||
164040818|NCT04126031|592508884|FG001|Part A|Withdrawal by Subject|0|||
164040819|NCT04126031|592508885|FG002|Part A|Withdrawal by Subject|1|||
164040820|NCT04126031|592508886|FG003|Part A|Withdrawal by Subject|0|||
164040821|NCT04126031|592508887|FG004|Part A|Withdrawal by Subject|0|||
164040822|NCT04126031|592508888|FG005|Part A|Withdrawal by Subject|0|||
164098853|NCT02587962|592726936|FG002|Overall Study|Clinical progression|2|||
164098854|NCT02587962|592726937|FG003|Overall Study|Clinical progression|0|||
164098855|NCT02587962|592726938|FG004|Overall Study|Clinical progression|1|||
164040823|NCT04126031|592508883|FG000|Part A|Other|1|||
164040824|NCT04126031|592508884|FG001|Part A|Other|0|||
164040825|NCT04126031|592508885|FG002|Part A|Other|0|||
164040826|NCT04126031|592508886|FG003|Part A|Other|0|||
164040827|NCT04126031|592508887|FG004|Part A|Other|0|||
164040828|NCT04126031|592508888|FG005|Part A|Other|0|||
164040829|NCT04126031|592508883|FG000|Part B|Adverse Event|0|||
164040830|NCT04126031|592508884|FG001|Part B|Adverse Event|0|||
164040831|NCT04126031|592508885|FG002|Part B|Adverse Event|0|||
164040832|NCT04126031|592508886|FG003|Part B|Adverse Event|0|||
164040833|NCT04126031|592508887|FG004|Part B|Adverse Event|0|||
164040834|NCT04126031|592508888|FG005|Part B|Adverse Event|2|||
164040835|NCT04126031|592508883|FG000|Part B|Pre-existing hypertransaminasemia|0|||
164040836|NCT04126031|592508884|FG001|Part B|Pre-existing hypertransaminasemia|0|||
164040837|NCT04126031|592508885|FG002|Part B|Pre-existing hypertransaminasemia|0|||
164040838|NCT04126031|592508886|FG003|Part B|Pre-existing hypertransaminasemia|0|||
164040839|NCT04126031|592508887|FG004|Part B|Pre-existing hypertransaminasemia|1|||
164040840|NCT04126031|592508888|FG005|Part B|Pre-existing hypertransaminasemia|0|||
164040841|NCT00131664|592508889|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
164040842|NCT00131664|592508890|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
164040843|NCT00131664|592508891|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
164040844|NCT00131664|592508892|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
164040845|NCT00131664|592508893|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
164040846|NCT00131664|592508894|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
164040847|NCT00131664|592508889|FG000|First Period (First 6 Months)|Death|0|||
164040848|NCT00131664|592508890|FG001|First Period (First 6 Months)|Death|1|||
164040849|NCT00131664|592508891|FG002|First Period (First 6 Months)|Death|0|||
164040850|NCT00131664|592508892|FG003|First Period (First 6 Months)|Death|0|||
164040851|NCT00131664|592508893|FG004|First Period (First 6 Months)|Death|0|||
164040852|NCT00131664|592508894|FG005|First Period (First 6 Months)|Death|0|||
164040853|NCT00131664|592508889|FG000|First Period (First 6 Months)|Protocol Violation|2|||
164040854|NCT00131664|592508890|FG001|First Period (First 6 Months)|Protocol Violation|2|||
164040855|NCT00131664|592508891|FG002|First Period (First 6 Months)|Protocol Violation|1|||
164040856|NCT00131664|592508892|FG003|First Period (First 6 Months)|Protocol Violation|0|||
164040857|NCT00131664|592508893|FG004|First Period (First 6 Months)|Protocol Violation|0|||
164040858|NCT00131664|592508894|FG005|First Period (First 6 Months)|Protocol Violation|0|||
164040859|NCT00131664|592508889|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
164040860|NCT00131664|592508890|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
164040861|NCT00131664|592508891|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
164040862|NCT00131664|592508892|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
164040863|NCT00131664|592508893|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
164040864|NCT00131664|592508894|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
164040865|NCT00131664|592508889|FG000|First Period (First 6 Months)|Adverse Event|9|||
164040866|NCT00131664|592508890|FG001|First Period (First 6 Months)|Adverse Event|4|||
164040867|NCT00131664|592508891|FG002|First Period (First 6 Months)|Adverse Event|5|||
164040868|NCT00131664|592508892|FG003|First Period (First 6 Months)|Adverse Event|0|||
164040869|NCT00131664|592508893|FG004|First Period (First 6 Months)|Adverse Event|0|||
164040870|NCT00131664|592508894|FG005|First Period (First 6 Months)|Adverse Event|0|||
164040871|NCT00131664|592508889|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
164040872|NCT00131664|592508890|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
164040873|NCT00131664|592508891|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164040874|NCT00131664|592508892|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164040875|NCT00131664|592508893|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164040876|NCT00131664|592508894|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
164040877|NCT00131664|592508889|FG000|First Period (First 6 Months)|Administrative reasons|2|||
164040878|NCT00131664|592508890|FG001|First Period (First 6 Months)|Administrative reasons|0|||
164040879|NCT00131664|592508891|FG002|First Period (First 6 Months)|Administrative reasons|5|||
164040880|NCT00131664|592508892|FG003|First Period (First 6 Months)|Administrative reasons|0|||
164040881|NCT00131664|592508893|FG004|First Period (First 6 Months)|Administrative reasons|0|||
164040882|NCT00131664|592508894|FG005|First Period (First 6 Months)|Administrative reasons|0|||
164040883|NCT00131664|592508889|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
164040884|NCT00131664|592508890|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
164040885|NCT00131664|592508891|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
164040886|NCT00131664|592508892|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
164040887|NCT00131664|592508893|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
164040888|NCT00131664|592508894|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
164040889|NCT00131664|592508889|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
164040890|NCT00131664|592508890|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
164040891|NCT00131664|592508891|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
164040892|NCT00131664|592508892|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
164040893|NCT00131664|592508893|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
164040894|NCT00131664|592508894|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
164040895|NCT00131664|592508889|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
164040896|NCT00131664|592508890|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164040897|NCT00131664|592508891|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164098856|NCT00184600|592726939|FG000|Overall Study|Adverse Event|9|||
164098857|NCT00184600|592726940|FG001|Overall Study|Adverse Event|0|||
164098858|NCT00184600|592726941|FG002|Overall Study|Adverse Event|5|||
164098859|NCT00184600|592726939|FG000|Overall Study|Death|3|||
164098860|NCT00184600|592726940|FG001|Overall Study|Death|9|||
164098861|NCT00184600|592726941|FG002|Overall Study|Death|7|||
163840473|NCT02960763|591787356|FG003|Step 1|Death|0|||
164098862|NCT00184600|592726939|FG000|Overall Study|Lack of Efficacy|3|||
164040898|NCT00131664|592508892|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164040899|NCT00131664|592508893|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164040900|NCT00131664|592508894|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
164040901|NCT00131664|592508889|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
164040902|NCT00131664|592508890|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
164040903|NCT00131664|592508891|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
163939446|NCT01685229|592149459|FG001|Overall Study|Withdrawal by Subject|5|||
163939447|NCT01685229|592149458|FG000|Overall Study|Death|1|||
163939448|NCT01685229|592149459|FG001|Overall Study|Death|0|||
163939449|NCT00659880|592149474|FG000|Overall Study|Lost to Follow-up|5|||
163939450|NCT01853475|592149475|FG000|Overall Study|Withdrawal by Subject|0|||
163939451|NCT01853475|592149476|FG001|Overall Study|Withdrawal by Subject|1|||
163939452|NCT01853475|592149477|FG002|Overall Study|Withdrawal by Subject|0|||
163939453|NCT02964325|592149478|FG000|Overall Study|Lost to Follow-up|3|||
163939454|NCT02964325|592149479|FG001|Overall Study|Lost to Follow-up|3|||
163939455|NCT02964325|592149478|FG000|Overall Study|Physician Decision|5|||
163939456|NCT02964325|592149479|FG001|Overall Study|Physician Decision|4|||
163939457|NCT02964325|592149478|FG000|Overall Study|Death|1|||
163939458|NCT02964325|592149479|FG001|Overall Study|Death|3|||
163939459|NCT02964325|592149478|FG000|Overall Study|Withdrawal by Subject|2|||
163939460|NCT02964325|592149479|FG001|Overall Study|Withdrawal by Subject|1|||
163939461|NCT02964325|592149478|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
163939462|NCT02964325|592149479|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
163939463|NCT02510040|592149480|FG000|Overall Study|Deemed no longer eligible|18|||
163939464|NCT02510040|592149481|FG001|Overall Study|Deemed no longer eligible|3|||
163939465|NCT02510040|592149482|FG002|Overall Study|Deemed no longer eligible|1|||
163939466|NCT03596762|592149483|FG000|Overall Study|Protocol Violation|0|||
163939467|NCT03596762|592149484|FG001|Overall Study|Protocol Violation|0|||
163939468|NCT03596762|592149485|FG002|Overall Study|Protocol Violation|0|||
163939469|NCT03596762|592149486|FG003|Overall Study|Protocol Violation|0|||
163939470|NCT03596762|592149487|FG004|Overall Study|Protocol Violation|1|||
163939471|NCT03596762|592149483|FG000|Overall Study|Adverse Event|2|||
163939472|NCT03596762|592149484|FG001|Overall Study|Adverse Event|0|||
163939473|NCT03596762|592149485|FG002|Overall Study|Adverse Event|1|||
163939474|NCT03596762|592149486|FG003|Overall Study|Adverse Event|0|||
163939475|NCT03596762|592149487|FG004|Overall Study|Adverse Event|5|||
163939476|NCT03596762|592149483|FG000|Overall Study|Withdrawal by Subject|2|||
163939477|NCT03596762|592149484|FG001|Overall Study|Withdrawal by Subject|1|||
163939478|NCT03596762|592149485|FG002|Overall Study|Withdrawal by Subject|0|||
163939479|NCT03596762|592149486|FG003|Overall Study|Withdrawal by Subject|1|||
163939480|NCT03596762|592149487|FG004|Overall Study|Withdrawal by Subject|1|||
163939481|NCT03842228|592149488|FG000|Overall Study|Adverse Event|1|||
163939482|NCT03842228|592149489|FG001|Overall Study|Adverse Event|1|||
163939483|NCT03842228|592149490|FG002|Overall Study|Adverse Event|1|||
163939484|NCT03842228|592149491|FG003|Overall Study|Adverse Event|0|||
163939485|NCT03842228|592149492|FG004|Overall Study|Adverse Event|0|||
163939486|NCT03842228|592149493|FG005|Overall Study|Adverse Event|0|||
163939487|NCT03842228|592149494|FG006|Overall Study|Adverse Event|0|||
163939488|NCT03842228|592149488|FG000|Overall Study|Death|0|||
163939489|NCT03842228|592149489|FG001|Overall Study|Death|1|||
163939490|NCT03842228|592149490|FG002|Overall Study|Death|0|||
163939491|NCT03842228|592149491|FG003|Overall Study|Death|0|||
163939492|NCT03842228|592149492|FG004|Overall Study|Death|0|||
163939493|NCT03842228|592149493|FG005|Overall Study|Death|0|||
163939494|NCT03842228|592149494|FG006|Overall Study|Death|0|||
163939495|NCT03842228|592149488|FG000|Overall Study|Withdrawal by Subject|0|||
163939496|NCT03842228|592149489|FG001|Overall Study|Withdrawal by Subject|0|||
163939497|NCT03842228|592149490|FG002|Overall Study|Withdrawal by Subject|2|||
163939498|NCT03842228|592149491|FG003|Overall Study|Withdrawal by Subject|1|||
163939499|NCT03842228|592149492|FG004|Overall Study|Withdrawal by Subject|0|||
163939500|NCT03842228|592149493|FG005|Overall Study|Withdrawal by Subject|0|||
163939501|NCT03842228|592149494|FG006|Overall Study|Withdrawal by Subject|2|||
163939502|NCT03842228|592149488|FG000|Overall Study|Progression|8|||
163939503|NCT03842228|592149489|FG001|Overall Study|Progression|1|||
163939504|NCT03842228|592149490|FG002|Overall Study|Progression|7|||
163939505|NCT03842228|592149491|FG003|Overall Study|Progression|5|||
163939506|NCT03842228|592149492|FG004|Overall Study|Progression|4|||
163939507|NCT03842228|592149493|FG005|Overall Study|Progression|2|||
163939508|NCT03842228|592149494|FG006|Overall Study|Progression|3|||
163939509|NCT02195479|592149507|FG000|Overall Study|Lost to Follow-up|18|||
163939510|NCT02195479|592149508|FG001|Overall Study|Lost to Follow-up|15|||
163939511|NCT02195479|592149507|FG000|Overall Study|Death|217|||
163939512|NCT02195479|592149508|FG001|Overall Study|Death|171|||
163939513|NCT02195479|592149507|FG000|Overall Study|Physician Decision|1|||
163939514|NCT02195479|592149508|FG001|Overall Study|Physician Decision|0|||
163939515|NCT02195479|592149507|FG000|Overall Study|Withdrawal by Subject|30|||
163939516|NCT02195479|592149508|FG001|Overall Study|Withdrawal by Subject|30|||
163939517|NCT02195479|592149507|FG000|Overall Study|Other|3|||
164098863|NCT00184600|592726940|FG001|Overall Study|Lack of Efficacy|1|||
164040904|NCT00131664|592508892|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
164040905|NCT00131664|592508893|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
164040906|NCT00131664|592508894|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
164040907|NCT00131664|592508889|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164040908|NCT00131664|592508890|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164040909|NCT00131664|592508891|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164040910|NCT00131664|592508892|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
164040911|NCT00131664|592508893|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164040912|NCT00131664|592508894|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
164040913|NCT00131664|592508889|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
164040914|NCT00131664|592508890|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
164040915|NCT00131664|592508891|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
164040916|NCT00131664|592508892|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
164040917|NCT00131664|592508893|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
164040918|NCT00131664|592508894|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
164040919|NCT01432756|592510398|FG000|Overall Study|Lost to Follow-up|1|||
164040920|NCT01432756|592510399|FG001|Overall Study|Lost to Follow-up|0|||
164040921|NCT01432756|592510400|FG002|Overall Study|Lost to Follow-up|2|||
164040922|NCT01432756|592510401|FG003|Overall Study|Lost to Follow-up|1|||
164040923|NCT02712008|592510402|FG000|Baseline (Day 1) up to Week 12|Death|3|||
164040924|NCT02712008|592510403|FG001|Baseline (Day 1) up to Week 12|Death|0|||
164040925|NCT02712008|592510404|FG002|Baseline (Day 1) up to Week 12|Death|0|||
164040926|NCT02712008|592510405|FG003|Baseline (Day 1) up to Week 12|Death|0|||
164040927|NCT02712008|592510406|FG004|Baseline (Day 1) up to Week 12|Death|0|||
164040928|NCT02712008|592510407|FG005|Baseline (Day 1) up to Week 12|Death|0|||
164040929|NCT02712008|592510408|FG006|Baseline (Day 1) up to Week 12|Death|0|||
164040930|NCT02712008|592510409|FG007|Baseline (Day 1) up to Week 12|Death|0|||
164040931|NCT02712008|592510402|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164040932|NCT02712008|592510403|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
164040933|NCT02712008|592510404|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
164040934|NCT02712008|592510405|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164040935|NCT02712008|592510406|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164040936|NCT02712008|592510407|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164040937|NCT02712008|592510408|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164040938|NCT02712008|592510409|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
164040939|NCT02712008|592510402|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
164040940|NCT02712008|592510403|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164040941|NCT02712008|592510404|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
164040942|NCT02712008|592510405|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164040943|NCT02712008|592510406|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164040944|NCT02712008|592510407|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164040945|NCT02712008|592510408|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164040946|NCT02712008|592510409|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
164040947|NCT02712008|592510402|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040948|NCT02712008|592510403|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040949|NCT02712008|592510404|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
164040950|NCT02712008|592510405|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040951|NCT02712008|592510406|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040952|NCT02712008|592510407|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040953|NCT02712008|592510408|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040954|NCT02712008|592510409|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
164040955|NCT02712008|592510402|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040956|NCT02712008|592510403|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
164040957|NCT02712008|592510404|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040958|NCT02712008|592510405|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040959|NCT02712008|592510406|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040960|NCT02712008|592510407|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040961|NCT02712008|592510408|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040962|NCT02712008|592510409|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
164040963|NCT02712008|592510402|FG000|From Week 12 up to Week 36|Adverse Event|0|||
164040964|NCT02712008|592510403|FG001|From Week 12 up to Week 36|Adverse Event|0|||
164040965|NCT02712008|592510404|FG002|From Week 12 up to Week 36|Adverse Event|0|||
164040966|NCT02712008|592510405|FG003|From Week 12 up to Week 36|Adverse Event|0|||
164040967|NCT02712008|592510406|FG004|From Week 12 up to Week 36|Adverse Event|1|||
164040968|NCT02712008|592510407|FG005|From Week 12 up to Week 36|Adverse Event|0|||
164040969|NCT02712008|592510408|FG006|From Week 12 up to Week 36|Adverse Event|0|||
164040970|NCT02712008|592510409|FG007|From Week 12 up to Week 36|Adverse Event|2|||
164040971|NCT02712008|592510402|FG000|From Week 12 up to Week 36|Death|1|||
164040972|NCT02712008|592510403|FG001|From Week 12 up to Week 36|Death|0|||
164040973|NCT02712008|592510404|FG002|From Week 12 up to Week 36|Death|0|||
163840474|NCT02960763|591787357|FG004|Step 1|Death|0|||
163840475|NCT02960763|591787353|FG000|Step 1|Investigator discretion|1|||
163840476|NCT02960763|591787354|FG001|Step 1|Investigator discretion|0|||
163840477|NCT02960763|591787355|FG002|Step 1|Investigator discretion|1|||
163840478|NCT02960763|591787356|FG003|Step 1|Investigator discretion|0|||
163840479|NCT02960763|591787357|FG004|Step 1|Investigator discretion|0|||
163840480|NCT02960763|591787353|FG000|Step 1|Other|0|||
163840481|NCT02960763|591787354|FG001|Step 1|Other|0|||
163840482|NCT02960763|591787355|FG002|Step 1|Other|1|||
163840483|NCT02960763|591787356|FG003|Step 1|Other|0|||
163840484|NCT02960763|591787357|FG004|Step 1|Other|0|||
163840485|NCT02960763|591787353|FG000|Step 2|Withdrawal by Subject|0|||
163840486|NCT02960763|591787354|FG001|Step 2|Withdrawal by Subject|0|||
163840487|NCT02960763|591787355|FG002|Step 2|Withdrawal by Subject|0|||
163840488|NCT02960763|591787356|FG003|Step 2|Withdrawal by Subject|7|||
163840489|NCT02960763|591787357|FG004|Step 2|Withdrawal by Subject|3|||
163840490|NCT02960763|591787353|FG000|Step 2|Lost to Follow-up|0|||
163840491|NCT02960763|591787354|FG001|Step 2|Lost to Follow-up|0|||
163840492|NCT02960763|591787355|FG002|Step 2|Lost to Follow-up|0|||
163840493|NCT02960763|591787356|FG003|Step 2|Lost to Follow-up|4|||
163840494|NCT02960763|591787357|FG004|Step 2|Lost to Follow-up|1|||
163840495|NCT02960763|591787353|FG000|Step 2|Investigator discretion|0|||
163840496|NCT02960763|591787354|FG001|Step 2|Investigator discretion|0|||
163840497|NCT02960763|591787355|FG002|Step 2|Investigator discretion|0|||
163840498|NCT02960763|591787356|FG003|Step 2|Investigator discretion|0|||
163840499|NCT02960763|591787357|FG004|Step 2|Investigator discretion|1|||
163840500|NCT01017120|591787358|FG000|Overall Study|Adverse Event|9|||
163840501|NCT01017120|591787359|FG001|Overall Study|Adverse Event|0|||
163840502|NCT01017120|591787358|FG000|Overall Study|Lost to Follow-up|13|||
163840503|NCT01017120|591787359|FG001|Overall Study|Lost to Follow-up|11|||
163840504|NCT01017120|591787358|FG000|Overall Study|Lack of Efficacy|1|||
163840505|NCT01017120|591787359|FG001|Overall Study|Lack of Efficacy|0|||
163840506|NCT01017120|591787358|FG000|Overall Study|Withdrawal by Subject|39|||
163840507|NCT01017120|591787359|FG001|Overall Study|Withdrawal by Subject|21|||
163840508|NCT01017120|591787358|FG000|Overall Study|Pregnancy|1|||
163840509|NCT01017120|591787359|FG001|Overall Study|Pregnancy|1|||
163840510|NCT01017120|591787358|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
163840511|NCT01017120|591787359|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
163840512|NCT01017120|591787358|FG000|Overall Study|Relocated Out of Town|0|||
163840513|NCT01017120|591787359|FG001|Overall Study|Relocated Out of Town|2|||
163840514|NCT01017120|591787358|FG000|Overall Study|Protocol Violation|1|||
163840515|NCT01017120|591787359|FG001|Overall Study|Protocol Violation|0|||
163840516|NCT01017120|591787358|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
163840517|NCT01017120|591787359|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
163840518|NCT05340751|591787360|FG000|Overall Study|Physician Decision|3|||
163840519|NCT01014975|591787373|FG000|Overall Study|Withdrawal by Subject|1|||
163840520|NCT01014975|591787374|FG001|Overall Study|Withdrawal by Subject|0|||
163840521|NCT01014975|591787375|FG002|Overall Study|Withdrawal by Subject|1|||
163840522|NCT01014975|591787373|FG000|Overall Study|Death|3|||
163840523|NCT01014975|591787374|FG001|Overall Study|Death|3|||
163840524|NCT01014975|591787375|FG002|Overall Study|Death|4|||
163840525|NCT01014975|591787373|FG000|Overall Study|Lost to Follow-up|0|||
163840526|NCT01014975|591787374|FG001|Overall Study|Lost to Follow-up|0|||
163840527|NCT01014975|591787375|FG002|Overall Study|Lost to Follow-up|1|||
163840528|NCT01642602|591787376|FG000|Overall Study|Adverse Event|2|||
163840529|NCT01112514|591787377|FG000|Overall Study|Lost to Follow-up|1|||
163840530|NCT01024959|591787378|FG000|Overall Study|ineligible|12|||
163840531|NCT01024959|591787378|FG000|Overall Study|results not evaluable|12|||
163840532|NCT01024959|591787378|FG000|Overall Study|missing results required for analysis|17|||
163840533|NCT02961881|591787379|FG000|Overall Study|Adverse Event|1|||
163840534|NCT02961881|591787380|FG001|Overall Study|Adverse Event|2|||
163840535|NCT02961881|591787381|FG002|Overall Study|Adverse Event|2|||
163840536|NCT02961881|591787382|FG003|Overall Study|Adverse Event|0|||
163840537|NCT02961881|591787383|FG004|Overall Study|Adverse Event|1|||
163840538|NCT02961881|591787379|FG000|Overall Study|Participant request|0|||
163840539|NCT02961881|591787380|FG001|Overall Study|Participant request|2|||
163840540|NCT02961881|591787381|FG002|Overall Study|Participant request|0|||
163840541|NCT02961881|591787382|FG003|Overall Study|Participant request|0|||
163840542|NCT02961881|591787383|FG004|Overall Study|Participant request|0|||
163840543|NCT02961881|591787379|FG000|Overall Study|Disease progression|1|||
163840544|NCT02961881|591787380|FG001|Overall Study|Disease progression|0|||
163840545|NCT02961881|591787381|FG002|Overall Study|Disease progression|1|||
163840546|NCT02961881|591787382|FG003|Overall Study|Disease progression|0|||
163840547|NCT02961881|591787383|FG004|Overall Study|Disease progression|0|||
163840548|NCT00636792|591787388|FG000|Overall Study|Adverse Event|16|||
163840549|NCT00636792|591787388|FG000|Overall Study|Physician Decision|7|||
163840550|NCT00636792|591787388|FG000|Overall Study|Progressive Disease|4|||
164040974|NCT02712008|592510405|FG003|From Week 12 up to Week 36|Death|0|||
164040975|NCT02712008|592510406|FG004|From Week 12 up to Week 36|Death|0|||
164040976|NCT02712008|592510407|FG005|From Week 12 up to Week 36|Death|0|||
164040977|NCT02712008|592510408|FG006|From Week 12 up to Week 36|Death|1|||
164040978|NCT02712008|592510409|FG007|From Week 12 up to Week 36|Death|0|||
164040979|NCT02712008|592510402|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
164040980|NCT02712008|592510403|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
164040981|NCT02712008|592510404|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
164040982|NCT02712008|592510405|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
164040983|NCT02712008|592510406|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
164040984|NCT02712008|592510407|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
164040985|NCT02712008|592510408|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
164040986|NCT02712008|592510409|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
164040987|NCT02712008|592510402|FG000|From Week 12 up to Week 36|Physician Decision|0|||
164040988|NCT02712008|592510403|FG001|From Week 12 up to Week 36|Physician Decision|0|||
164040989|NCT02712008|592510404|FG002|From Week 12 up to Week 36|Physician Decision|0|||
163939518|NCT02195479|592149508|FG001|Overall Study|Other|4|||
163939519|NCT02195479|592149507|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
163939520|NCT02195479|592149508|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
163939521|NCT01834586|592149509|FG000|Overall Study|Adverse Event|1|||
163939522|NCT01263509|592149512|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
163939523|NCT01263509|592149513|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
163939524|NCT01263509|592149514|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
163939525|NCT01263509|592149515|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
163939526|NCT01263509|592149512|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163939527|NCT01263509|592149513|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
163939528|NCT01263509|592149514|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
163939529|NCT01263509|592149515|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
163939530|NCT01263509|592149512|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
163939531|NCT01263509|592149513|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
163939532|NCT01263509|592149514|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163939533|NCT01263509|592149515|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
163939534|NCT01263509|592149512|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
163939535|NCT01263509|592149513|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
163939536|NCT01263509|592149514|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163939537|NCT01263509|592149515|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
163939538|NCT01263509|592149512|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
163939539|NCT01263509|592149513|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
163939540|NCT01263509|592149514|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
163939541|NCT01263509|592149515|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
163939542|NCT01818531|592149525|FG000|Overall Study|Withdrawn for case delay after block|1|||
163939543|NCT01818531|592149526|FG001|Overall Study|Withdrawn for case delay after block|0|||
163939544|NCT01818531|592149525|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
163939545|NCT01818531|592149526|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
163939546|NCT01818531|592149525|FG000|Overall Study|Withdrawn for failure to place block|0|||
163939547|NCT01818531|592149526|FG001|Overall Study|Withdrawn for failure to place block|1|||
163939548|NCT00214019|592149527|FG000|Overall Study|Lost to Follow-up|11|||
163939549|NCT00214019|592149527|FG000|Overall Study|Withdrawal by Subject|2|||
163939550|NCT00214019|592149527|FG000|Overall Study|Screen Failed prior to randomization|17|||
163939551|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
163939552|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
163939553|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
163939554|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
163939555|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
163939556|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
163939557|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
163939558|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
163939559|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
164040990|NCT02712008|592510405|FG003|From Week 12 up to Week 36|Physician Decision|1|||
164040991|NCT02712008|592510406|FG004|From Week 12 up to Week 36|Physician Decision|1|||
164040992|NCT02712008|592510407|FG005|From Week 12 up to Week 36|Physician Decision|0|||
164098864|NCT00184600|592726941|FG002|Overall Study|Lack of Efficacy|3|||
163939560|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
164040993|NCT02712008|592510408|FG006|From Week 12 up to Week 36|Physician Decision|0|||
164040994|NCT02712008|592510409|FG007|From Week 12 up to Week 36|Physician Decision|0|||
164040995|NCT02712008|592510402|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164040996|NCT02712008|592510403|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164040997|NCT02712008|592510404|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164040998|NCT02712008|592510405|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164040999|NCT02712008|592510406|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164041000|NCT02712008|592510407|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
164041001|NCT02712008|592510408|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
164041002|NCT02712008|592510409|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
164041003|NCT00364351|592510410|FG000|Overall Study|Adverse Event|90|||
164041004|NCT00364351|592510411|FG001|Overall Study|Adverse Event|44|||
164041005|NCT00364351|592510410|FG000|Overall Study|Condition under investigation worsened|469|||
164041006|NCT00364351|592510411|FG001|Overall Study|Condition under investigation worsened|497|||
164041007|NCT00364351|592510410|FG000|Overall Study|Prohibited concomitant medication|0|||
164041008|NCT00364351|592510411|FG001|Overall Study|Prohibited concomitant medication|2|||
164041009|NCT00364351|592510410|FG000|Overall Study|Lost to Follow-up|1|||
164041010|NCT00364351|592510411|FG001|Overall Study|Lost to Follow-up|1|||
164041011|NCT00364351|592510410|FG000|Overall Study|Withdrawal by Subject|30|||
164041012|NCT00364351|592510411|FG001|Overall Study|Withdrawal by Subject|29|||
164041013|NCT00364351|592510410|FG000|Overall Study|Incorrect enrollment|1|||
164041014|NCT00364351|592510411|FG001|Overall Study|Incorrect enrollment|1|||
164041015|NCT00364351|592510410|FG000|Overall Study|Sponsor decision|1|||
164041016|NCT00364351|592510411|FG001|Overall Study|Sponsor decision|0|||
164041017|NCT00364351|592510410|FG000|Overall Study|Poor treatment compliance|0|||
164041018|NCT00364351|592510411|FG001|Overall Study|Poor treatment compliance|3|||
164041019|NCT00364351|592510410|FG000|Overall Study|Investigator error|0|||
164041020|NCT00364351|592510411|FG001|Overall Study|Investigator error|2|||
164041021|NCT00364351|592510410|FG000|Overall Study|Patient could not travel to site|0|||
164041022|NCT00364351|592510411|FG001|Overall Study|Patient could not travel to site|1|||
164041023|NCT00364351|592510410|FG000|Overall Study|Randomised treatment not started|0|||
164041024|NCT00364351|592510411|FG001|Overall Study|Randomised treatment not started|3|||
164041025|NCT00509028|592510420|FG000|Overall Study|Adverse Event|2|||
164041026|NCT00509028|592510421|FG001|Overall Study|Adverse Event|0|||
164041027|NCT00509028|592510420|FG000|Overall Study|Withdrawal by Subject|4|||
164041028|NCT00509028|592510421|FG001|Overall Study|Withdrawal by Subject|3|||
164041029|NCT00509028|592510420|FG000|Overall Study|Lost to Follow-up|0|||
164041030|NCT00509028|592510421|FG001|Overall Study|Lost to Follow-up|1|||
164041031|NCT00509028|592510420|FG000|Overall Study|Protocol Violation|4|||
164041032|NCT00509028|592510421|FG001|Overall Study|Protocol Violation|2|||
164041033|NCT00509028|592510420|FG000|Overall Study|Non-compliance|2|||
164041034|NCT00509028|592510421|FG001|Overall Study|Non-compliance|1|||
164041035|NCT02996110|592510422|FG000|Pre-Treatment|Other Reasons|0|||
164041036|NCT02996110|592510423|FG001|Pre-Treatment|Other Reasons|1|||
164041037|NCT02996110|592510424|FG002|Pre-Treatment|Other Reasons|0|||
164041038|NCT02996110|592510425|FG003|Pre-Treatment|Other Reasons|0|||
164041039|NCT02996110|592510426|FG004|Pre-Treatment|Other Reasons|1|||
164041040|NCT02996110|592510422|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
164041041|NCT02996110|592510423|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
164041042|NCT02996110|592510424|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
164041043|NCT02996110|592510425|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
164041044|NCT02996110|592510426|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
164041045|NCT02996110|592510422|FG000|Track 1|Disease Progression|15|||
164041046|NCT02996110|592510423|FG001|Track 1|Disease Progression|17|||
164041047|NCT02996110|592510424|FG002|Track 1|Disease Progression|0|||
164041048|NCT02996110|592510425|FG003|Track 1|Disease Progression|0|||
164041049|NCT02996110|592510426|FG004|Track 1|Disease Progression|0|||
164041050|NCT02996110|592510422|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
164041051|NCT02996110|592510423|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
164041052|NCT02996110|592510424|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
164041053|NCT02996110|592510425|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
164041054|NCT02996110|592510426|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
164041055|NCT02996110|592510422|FG000|Track 1|Study Drug Toxicity|5|||
164041056|NCT02996110|592510423|FG001|Track 1|Study Drug Toxicity|3|||
164041057|NCT02996110|592510424|FG002|Track 1|Study Drug Toxicity|0|||
164041058|NCT02996110|592510425|FG003|Track 1|Study Drug Toxicity|0|||
164041059|NCT02996110|592510426|FG004|Track 1|Study Drug Toxicity|0|||
164041060|NCT02996110|592510422|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
164041061|NCT02996110|592510423|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164041062|NCT02996110|592510424|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164041063|NCT02996110|592510425|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164041064|NCT02996110|592510426|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
164041065|NCT02996110|592510422|FG000|Track 1|Administrative Reason by Sponsor|0|||
164041066|NCT02996110|592510423|FG001|Track 1|Administrative Reason by Sponsor|1|||
164041067|NCT02996110|592510424|FG002|Track 1|Administrative Reason by Sponsor|0|||
164041068|NCT02996110|592510425|FG003|Track 1|Administrative Reason by Sponsor|0|||
164041069|NCT02996110|592510426|FG004|Track 1|Administrative Reason by Sponsor|0|||
164041070|NCT02996110|592510422|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
164041071|NCT02996110|592510423|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
164041072|NCT02996110|592510424|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
164041073|NCT02996110|592510425|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
164041074|NCT02996110|592510426|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
164041075|NCT02996110|592510422|FG000|Track 2|Disease Progression|33|||
164041076|NCT02996110|592510423|FG001|Track 2|Disease Progression|26|||
163939561|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163939562|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163939563|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
163939564|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
163939565|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163939566|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163939567|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163939568|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
163939569|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
163939570|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939571|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939572|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939573|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
163939574|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939575|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939576|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939577|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
163939578|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
163939579|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
163939580|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
163939581|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
163939582|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
163939583|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163939584|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163939585|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163939586|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
163939587|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
163939588|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
163939589|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
163939590|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
163939591|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
163939592|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163939593|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163939594|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163939595|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
163939596|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
163939597|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
163939598|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
163939599|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
163939600|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
163939601|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
163939602|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
163939603|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
163939604|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
163939605|NCT00477490|592149530|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
163939606|NCT00477490|592149531|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
163939607|NCT00477490|592149532|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
163939608|NCT00477490|592149533|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
163939609|NCT00477490|592149534|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
163939610|NCT00477490|592149535|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
163939611|NCT00477490|592149536|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
163939612|NCT00477490|592149537|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
163939613|NCT00477490|592149538|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
164041077|NCT02996110|592510424|FG002|Track 2|Disease Progression|19|||
164041078|NCT02996110|592510425|FG003|Track 2|Disease Progression|16|||
164041079|NCT02996110|592510426|FG004|Track 2|Disease Progression|15|||
163939614|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
163939615|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
163939616|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
163939617|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
163939618|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
163939619|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
163939620|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
163939621|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
163939622|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
164041080|NCT02996110|592510422|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
164041081|NCT02996110|592510423|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
163939623|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
163939624|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
163939625|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
163939626|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163939627|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163939628|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163939629|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163939630|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
163939631|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
163939632|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163939633|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
163939634|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
163939635|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163939636|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
163939637|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163939638|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
163939639|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163939640|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
163939641|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163939642|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163939643|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163939644|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163939645|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
163939646|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163939647|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
163939648|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
163939649|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
163939650|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939651|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
163939652|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939653|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939654|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939655|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939656|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939657|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939658|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
163939659|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
163939660|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
163939661|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
163939662|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
163939663|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
163939664|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
163939665|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
163939666|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
163939667|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
163939668|NCT00477490|592149530|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163939669|NCT00477490|592149531|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
163939670|NCT00477490|592149532|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
163939671|NCT00477490|592149533|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163939672|NCT00477490|592149534|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
163939673|NCT00477490|592149535|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163939674|NCT00477490|592149536|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163939675|NCT00477490|592149537|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163939676|NCT00477490|592149538|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
163939677|NCT01465763|592149539|FG000|Overall Study|Withdrawal by Subject|4|||
163939678|NCT01465763|592149540|FG001|Overall Study|Withdrawal by Subject|0|||
163939679|NCT01465763|592149541|FG002|Overall Study|Withdrawal by Subject|1|||
163939680|NCT01465763|592149539|FG000|Overall Study|Insufficient Clinical Response|11|||
163939681|NCT01465763|592149540|FG001|Overall Study|Insufficient Clinical Response|0|||
163939682|NCT01465763|592149541|FG002|Overall Study|Insufficient Clinical Response|1|||
164041082|NCT02996110|592510424|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
164041083|NCT02996110|592510425|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
164041084|NCT02996110|592510426|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
163939683|NCT01465763|592149539|FG000|Overall Study|Adverse Event|9|||
164041085|NCT02996110|592510422|FG000|Track 2|Death|0|||
164041086|NCT02996110|592510423|FG001|Track 2|Death|0|||
163840551|NCT00636792|591787388|FG000|Overall Study|Withdrawal by Subject|3|||
163840552|NCT00636792|591787388|FG000|Overall Study|Other|3|||
163840553|NCT01928225|591787389|FG000|Overall Study|Pregnancy|1|||
163840554|NCT01928225|591787390|FG001|Overall Study|Pregnancy|0|||
163840555|NCT01928225|591787389|FG000|Overall Study|basaloid cervical cancer|1|||
163840556|NCT01928225|591787390|FG001|Overall Study|basaloid cervical cancer|0|||
163840557|NCT01928225|591787389|FG000|Overall Study|Lost to Follow-up|1|||
163840558|NCT01928225|591787390|FG001|Overall Study|Lost to Follow-up|3|||
163840559|NCT01235975|591787395|FG000|Overall Study|Serious Adverse Event|0|||
163840560|NCT01235975|591787396|FG001|Overall Study|Serious Adverse Event|1|||
163840561|NCT01235975|591787395|FG000|Overall Study|Withdrawal by Subject|8|||
163840562|NCT01235975|591787396|FG001|Overall Study|Withdrawal by Subject|2|||
163840563|NCT01235975|591787395|FG000|Overall Study|Migrated/moved from study area|2|||
163840564|NCT01235975|591787396|FG001|Overall Study|Migrated/moved from study area|1|||
163840565|NCT01235975|591787395|FG000|Overall Study|Lost to Follow-up|7|||
163840566|NCT01235975|591787396|FG001|Overall Study|Lost to Follow-up|3|||
163840567|NCT00641719|591787397|FG000|Overall Study|Lack of Efficacy|1|||
163840568|NCT00641719|591787398|FG001|Overall Study|Lack of Efficacy|2|||
163840569|NCT00641719|591787397|FG000|Overall Study|Adverse Event|24|||
163840570|NCT00641719|591787398|FG001|Overall Study|Adverse Event|29|||
163840571|NCT00641719|591787397|FG000|Overall Study|Withdrawal by Subject|4|||
163840572|NCT00641719|591787398|FG001|Overall Study|Withdrawal by Subject|4|||
163840573|NCT00641719|591787397|FG000|Overall Study|Reason Not Specified|1|||
163840574|NCT00641719|591787398|FG001|Overall Study|Reason Not Specified|2|||
163840575|NCT03303469|591787399|FG000|Overall Study|Lost to Follow-up|2|||
163840576|NCT00885352|591787400|FG000|Overall Study|Adverse Event|2|||
163840577|NCT00885352|591787401|FG001|Overall Study|Adverse Event|3|||
163840578|NCT00885352|591787400|FG000|Overall Study|Lost to Follow-up|2|||
163840579|NCT00885352|591787401|FG001|Overall Study|Lost to Follow-up|2|||
163840580|NCT00885352|591787400|FG000|Overall Study|Physician Decision|0|||
163840581|NCT00885352|591787401|FG001|Overall Study|Physician Decision|3|||
163840582|NCT00885352|591787400|FG000|Overall Study|Protocol Violation|0|||
163840583|NCT00885352|591787401|FG001|Overall Study|Protocol Violation|2|||
163840584|NCT00885352|591787400|FG000|Overall Study|Withdrawal by Subject|1|||
163840585|NCT00885352|591787401|FG001|Overall Study|Withdrawal by Subject|5|||
163840586|NCT00885352|591787400|FG000|Overall Study|Contradiction to study medication|0|||
163840587|NCT00885352|591787401|FG001|Overall Study|Contradiction to study medication|2|||
163840588|NCT00885352|591787400|FG000|Overall Study|Excluded medication|2|||
163840589|NCT00885352|591787401|FG001|Overall Study|Excluded medication|2|||
163840590|NCT00885352|591787400|FG000|Overall Study|Lab abnormalities|1|||
163840591|NCT00885352|591787401|FG001|Overall Study|Lab abnormalities|1|||
163840592|NCT03560258|591787402|FG000|Overall Study|Lost to Follow-up|3|||
163840593|NCT03560258|591787403|FG001|Overall Study|Lost to Follow-up|0|||
163840594|NCT03560258|591787404|FG002|Overall Study|Lost to Follow-up|0|||
163840595|NCT03560258|591787402|FG000|Overall Study|Protocol Violation|0|||
163840596|NCT03560258|591787403|FG001|Overall Study|Protocol Violation|1|||
163840597|NCT03560258|591787404|FG002|Overall Study|Protocol Violation|0|||
163840598|NCT03560258|591787402|FG000|Overall Study|Withdrawal by Subject|0|||
163840599|NCT03560258|591787403|FG001|Overall Study|Withdrawal by Subject|0|||
163840600|NCT03560258|591787404|FG002|Overall Study|Withdrawal by Subject|1|||
163840601|NCT01460160|591787405|FG000|Treatment Phase|Lack of Efficacy|3|||
163840602|NCT01460160|591787405|FG000|Treatment Phase|Study Drug Toxicity|2|||
163840603|NCT01460160|591787405|FG000|Treatment Phase|Adverse Event|8|||
163840604|NCT01460160|591787405|FG000|Treatment Phase|Withdrawal by Subject|4|||
163840605|NCT01460160|591787405|FG000|Treatment Phase|Death|2|||
163840606|NCT01460160|591787405|FG000|Treatment Phase|Other reasons|9|||
163840607|NCT01460160|591787405|FG000|Follow-up Phase|Withdrawal by Subject|4|||
163840608|NCT01460160|591787405|FG000|Follow-up Phase|Death|14|||
163840609|NCT01460160|591787405|FG000|Follow-up Phase|Lost to Follow-up|7|||
163840610|NCT01460160|591787405|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
163840611|NCT01460160|591787405|FG000|Follow-up Phase|Other and not reported reasons|5|||
163840612|NCT03101241|591787406|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
163840613|NCT03101241|591787407|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
163840614|NCT03101241|591787406|FG000|Overall Study|Participant withdrew consent|3|||
163840615|NCT03101241|591787407|FG001|Overall Study|Participant withdrew consent|1|||
163840616|NCT03101241|591787406|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
163840617|NCT03101241|591787407|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
163840618|NCT03101241|591787406|FG000|Overall Study|Lost to Follow-up|2|||
163840619|NCT03101241|591787407|FG001|Overall Study|Lost to Follow-up|0|||
163840620|NCT03101241|591787406|FG000|Overall Study|Lack of Efficacy|0|||
163840621|NCT03101241|591787407|FG001|Overall Study|Lack of Efficacy|1|||
163840622|NCT03101241|591787406|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
163840623|NCT03101241|591787407|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
163840624|NCT00669903|591787408|FG000|Overall Study|Adverse Event|0|||
163840625|NCT00669903|591787409|FG001|Overall Study|Adverse Event|1|||
163840626|NCT00669903|591787410|FG002|Overall Study|Adverse Event|3|||
163939684|NCT01465763|592149540|FG001|Overall Study|Adverse Event|0|||
163939685|NCT01465763|592149541|FG002|Overall Study|Adverse Event|1|||
163939686|NCT01465763|592149539|FG000|Overall Study|Other|2|||
163939687|NCT01465763|592149540|FG001|Overall Study|Other|0|||
163939688|NCT01465763|592149541|FG002|Overall Study|Other|0|||
163939689|NCT01465763|592149539|FG000|Overall Study|Protocol Violation|4|||
163939690|NCT01465763|592149540|FG001|Overall Study|Protocol Violation|1|||
163939691|NCT01465763|592149541|FG002|Overall Study|Protocol Violation|1|||
163939692|NCT01465763|592149539|FG000|Overall Study|Death|1|||
163939693|NCT01465763|592149540|FG001|Overall Study|Death|0|||
163939694|NCT01465763|592149541|FG002|Overall Study|Death|0|||
163939695|NCT01646177|592149542|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
163939696|NCT01646177|592149543|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
163939697|NCT01646177|592149544|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
163939698|NCT01646177|592149545|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
163939699|NCT01646177|592149546|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939700|NCT01646177|592149547|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939701|NCT01646177|592149548|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939702|NCT01646177|592149549|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939703|NCT01646177|592149550|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939704|NCT01646177|592149551|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939705|NCT01646177|592149552|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939706|NCT01646177|592149553|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
163939707|NCT01646177|592149542|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
163939708|NCT01646177|592149543|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
163939709|NCT01646177|592149544|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
163939710|NCT01646177|592149545|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
163939711|NCT01646177|592149546|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939712|NCT01646177|592149547|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939713|NCT01646177|592149548|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939714|NCT01646177|592149549|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939715|NCT01646177|592149550|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939716|NCT01646177|592149551|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939717|NCT01646177|592149552|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939718|NCT01646177|592149553|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
163939719|NCT01646177|592149542|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
163939720|NCT01646177|592149543|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
163939721|NCT01646177|592149544|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
163939722|NCT01646177|592149545|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
163939723|NCT01646177|592149546|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939724|NCT01646177|592149547|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939725|NCT01646177|592149548|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939726|NCT01646177|592149549|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939727|NCT01646177|592149550|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939728|NCT01646177|592149551|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939729|NCT01646177|592149552|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939730|NCT01646177|592149553|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
163939731|NCT01646177|592149542|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
163939732|NCT01646177|592149543|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
163939733|NCT01646177|592149544|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
163939734|NCT01646177|592149545|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
163939735|NCT01646177|592149546|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163939736|NCT01646177|592149547|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163939737|NCT01646177|592149548|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163939738|NCT01646177|592149549|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163939739|NCT01646177|592149550|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164041087|NCT02996110|592510424|FG002|Track 2|Death|1|||
164041088|NCT02996110|592510425|FG003|Track 2|Death|0|||
164041089|NCT02996110|592510426|FG004|Track 2|Death|1|||
164041090|NCT02996110|592510422|FG000|Track 2|Study Drug Toxicity|4|||
164041091|NCT02996110|592510423|FG001|Track 2|Study Drug Toxicity|1|||
164041092|NCT02996110|592510424|FG002|Track 2|Study Drug Toxicity|4|||
164098865|NCT00184600|592726939|FG000|Overall Study|Lost to Follow-up|4|||
163939740|NCT01646177|592149551|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163939741|NCT01646177|592149552|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
163939742|NCT01646177|592149553|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
164041093|NCT02996110|592510425|FG003|Track 2|Study Drug Toxicity|1|||
164041094|NCT02996110|592510426|FG004|Track 2|Study Drug Toxicity|0|||
164041095|NCT02996110|592510422|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
163939743|NCT01646177|592149542|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939744|NCT01646177|592149543|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939745|NCT01646177|592149544|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
163939746|NCT01646177|592149545|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
163939747|NCT01646177|592149546|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939748|NCT01646177|592149547|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939749|NCT01646177|592149548|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939750|NCT01646177|592149549|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939751|NCT01646177|592149550|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939752|NCT01646177|592149551|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939753|NCT01646177|592149552|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939754|NCT01646177|592149553|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
163939755|NCT01646177|592149542|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
163939756|NCT01646177|592149543|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
163939757|NCT01646177|592149544|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
163939758|NCT01646177|592149545|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939759|NCT01646177|592149546|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939760|NCT01646177|592149547|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939761|NCT01646177|592149548|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939762|NCT01646177|592149549|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939763|NCT01646177|592149550|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939764|NCT01646177|592149551|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939765|NCT01646177|592149552|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939766|NCT01646177|592149553|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
163939767|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939768|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939769|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939770|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939771|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
163939772|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
163939773|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
163939774|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
163939775|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939776|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939777|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939778|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
163939779|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939780|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939781|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939782|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939783|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
163939784|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
163939785|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
163939786|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
163939787|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939788|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939789|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939790|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
163939791|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939792|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939793|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939794|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939795|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
163939796|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
163939797|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
163939798|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
163939799|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939800|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939801|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
164041096|NCT02996110|592510423|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
164041097|NCT02996110|592510424|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
164041098|NCT02996110|592510425|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
164041099|NCT02996110|592510426|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
164041100|NCT02996110|592510422|FG000|Track 2|Participant Withdrew Consent|1|||
163939802|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
163939803|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939804|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939805|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939806|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939807|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
163939808|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
163939809|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
163939810|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
163939811|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939812|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939813|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939814|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
163939815|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939816|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939817|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939818|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939819|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
163939820|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
163939821|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
163939822|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
163939823|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939824|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939825|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939826|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
163939827|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939828|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939829|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939830|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939831|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
163939832|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
163939833|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939834|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
163939835|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939836|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939837|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939838|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
163939839|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939840|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939841|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939842|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939843|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
163939844|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
163939845|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
163939846|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
163939847|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939848|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939849|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939850|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
163939851|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
163939852|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
163939853|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
163939854|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
163939855|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
163939856|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
163939857|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
163939858|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
163939859|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
163939860|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
163939861|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
163939862|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
163939863|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939864|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939865|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
164098866|NCT00184600|592726940|FG001|Overall Study|Lost to Follow-up|6|||
163939866|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939867|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
163939868|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
163939869|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
163939870|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
163939871|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939872|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939873|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939874|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
163939875|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939876|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939877|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939878|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939879|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939880|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939881|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939882|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
163939883|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939884|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939885|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939886|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
163939887|NCT01646177|592149542|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939888|NCT01646177|592149543|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939889|NCT01646177|592149544|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939890|NCT01646177|592149545|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939891|NCT01646177|592149546|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939892|NCT01646177|592149547|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
163939893|NCT01646177|592149548|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
163939894|NCT01646177|592149549|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
163939895|NCT01646177|592149550|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939896|NCT01646177|592149551|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939897|NCT01646177|592149552|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
164041101|NCT02996110|592510423|FG001|Track 2|Participant Withdrew Consent|2|||
164041102|NCT02996110|592510424|FG002|Track 2|Participant Withdrew Consent|3|||
164041103|NCT02996110|592510425|FG003|Track 2|Participant Withdrew Consent|1|||
164041104|NCT02996110|592510426|FG004|Track 2|Participant Withdrew Consent|1|||
164041105|NCT02996110|592510422|FG000|Track 2|Other Reasons|0|||
164041106|NCT02996110|592510423|FG001|Track 2|Other Reasons|0|||
164041107|NCT02996110|592510424|FG002|Track 2|Other Reasons|1|||
164041108|NCT02996110|592510425|FG003|Track 2|Other Reasons|0|||
164041109|NCT02996110|592510426|FG004|Track 2|Other Reasons|1|||
164041110|NCT02436915|592510427|FG000|Overall Study|Withdrawal by Subject|0|||
164041111|NCT02436915|592510428|FG001|Overall Study|Withdrawal by Subject|1|||
164041112|NCT03805971|592510429|FG000|Overall Study|Withdrawal by Subject|1|||
164041113|NCT03805971|592510429|FG000|Overall Study|Protocol Violation|2|||
164041114|NCT00364832|592510434|FG000|Core Period|Early Withdrawals|2|||
164041115|NCT00364832|592510435|FG001|Core Period|Early Withdrawals|2|||
164041116|NCT00364832|592510436|FG002|Core Period|Early Withdrawals|1|||
164041117|NCT00364832|592510437|FG003|Core Period|Early Withdrawals|1|||
164041118|NCT00364832|592510438|FG004|Core Period|Early Withdrawals|0|||
164041119|NCT00364832|592510439|FG005|Core Period|Early Withdrawals|0|||
164041120|NCT00364832|592510440|FG006|Core Period|Early Withdrawals|4|||
164041121|NCT00364832|592510441|FG007|Core Period|Early Withdrawals|1|||
164041122|NCT00364832|592510442|FG008|Core Period|Early Withdrawals|0|||
164041123|NCT00364832|592510443|FG009|Core Period|Early Withdrawals|0|||
164098867|NCT00184600|592726941|FG002|Overall Study|Lost to Follow-up|1|||
164098868|NCT00184600|592726939|FG000|Overall Study|Protocol Violation|2|||
163939898|NCT01646177|592149553|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
163939899|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
164041124|NCT00364832|592510444|FG010|Core Period|Early Withdrawals|0|||
164041125|NCT00364832|592510445|FG011|Core Period|Early Withdrawals|0|||
164041126|NCT00364832|592510434|FG000|Extension Year 1|Early Withdrawals|0|||
164041127|NCT00364832|592510435|FG001|Extension Year 1|Early Withdrawals|0|||
164098869|NCT00184600|592726940|FG001|Overall Study|Protocol Violation|2|||
164098870|NCT00184600|592726941|FG002|Overall Study|Protocol Violation|3|||
164098871|NCT00184600|592726939|FG000|Overall Study|Withdrawal by Subject|20|||
164041128|NCT00364832|592510436|FG002|Extension Year 1|Early Withdrawals|0|||
164041129|NCT00364832|592510437|FG003|Extension Year 1|Early Withdrawals|0|||
164041130|NCT00364832|592510438|FG004|Extension Year 1|Early Withdrawals|0|||
164147703|NCT02006732|592902129|FG000|Overall Study|Protocol Violation|1|||
164041131|NCT00364832|592510439|FG005|Extension Year 1|Early Withdrawals|0|||
164041132|NCT00364832|592510440|FG006|Extension Year 1|Early Withdrawals|0|||
164041133|NCT00364832|592510441|FG007|Extension Year 1|Early Withdrawals|0|||
164041134|NCT00364832|592510442|FG008|Extension Year 1|Early Withdrawals|0|||
164041135|NCT00364832|592510443|FG009|Extension Year 1|Early Withdrawals|4|||
164041136|NCT00364832|592510444|FG010|Extension Year 1|Early Withdrawals|2|||
164041137|NCT00364832|592510445|FG011|Extension Year 1|Early Withdrawals|10|||
164098872|NCT00184600|592726940|FG001|Overall Study|Withdrawal by Subject|28|||
164041138|NCT00364832|592510434|FG000|Extension Year 2|Early Withdrawals|0|||
164041139|NCT00364832|592510435|FG001|Extension Year 2|Early Withdrawals|0|||
164098873|NCT00184600|592726941|FG002|Overall Study|Withdrawal by Subject|12|||
164098874|NCT00184600|592726939|FG000|Overall Study|Unclassified|4|||
164098875|NCT00184600|592726940|FG001|Overall Study|Unclassified|5|||
164098876|NCT00184600|592726941|FG002|Overall Study|Unclassified|3|||
164098877|NCT00624065|592726942|FG000|Overall Study|Adverse Event|5|||
163840627|NCT00669903|591787411|FG003|Overall Study|Adverse Event|1|||
163840628|NCT00669903|591787408|FG000|Overall Study|Withdrawal by Subject|0|||
163840629|NCT00669903|591787409|FG001|Overall Study|Withdrawal by Subject|2|||
163840630|NCT00669903|591787410|FG002|Overall Study|Withdrawal by Subject|2|||
163840631|NCT00669903|591787411|FG003|Overall Study|Withdrawal by Subject|2|||
163840632|NCT00669903|591787408|FG000|Overall Study|Lost to Follow-up|1|||
163840633|NCT00669903|591787409|FG001|Overall Study|Lost to Follow-up|1|||
163840634|NCT00669903|591787410|FG002|Overall Study|Lost to Follow-up|0|||
163840635|NCT00669903|591787411|FG003|Overall Study|Lost to Follow-up|1|||
163840636|NCT00669903|591787408|FG000|Overall Study|Protocol Violation|0|||
163840637|NCT00669903|591787409|FG001|Overall Study|Protocol Violation|1|||
163840638|NCT00669903|591787410|FG002|Overall Study|Protocol Violation|0|||
163840639|NCT00669903|591787411|FG003|Overall Study|Protocol Violation|0|||
163840640|NCT00251927|591787412|FG000|Overall Study|Adverse Event|3|||
163840641|NCT00251927|591787413|FG001|Overall Study|Adverse Event|15|||
163840642|NCT00251927|591787412|FG000|Overall Study|Lack of Efficacy|22|||
163840643|NCT00251927|591787413|FG001|Overall Study|Lack of Efficacy|16|||
163840644|NCT00251927|591787412|FG000|Overall Study|Lost to Follow-up|22|||
163840645|NCT00251927|591787413|FG001|Overall Study|Lost to Follow-up|8|||
163840646|NCT00251927|591787412|FG000|Overall Study|Protocol Violation|1|||
163840647|NCT00251927|591787413|FG001|Overall Study|Protocol Violation|2|||
163840648|NCT00251927|591787412|FG000|Overall Study|Pregnancy|2|||
163840649|NCT00251927|591787413|FG001|Overall Study|Pregnancy|0|||
163840650|NCT00251927|591787412|FG000|Overall Study|Withdrawal by Subject|40|||
163840651|NCT00251927|591787413|FG001|Overall Study|Withdrawal by Subject|25|||
163840652|NCT00251927|591787412|FG000|Overall Study|Study-specific discont. achieved|13|||
163840653|NCT00251927|591787413|FG001|Overall Study|Study-specific discont. achieved|2|||
163840654|NCT00251927|591787412|FG000|Overall Study|Study procedure non-compliance|5|||
163840655|NCT00251927|591787413|FG001|Overall Study|Study procedure non-compliance|6|||
163840656|NCT01678820|591787414|FG000|Overall Study|Study Terminated by Sponsor|45|||
163840657|NCT01678820|591787415|FG001|Overall Study|Study Terminated by Sponsor|43|||
163840658|NCT01678820|591787416|FG002|Overall Study|Study Terminated by Sponsor|43|||
163840659|NCT01678820|591787414|FG000|Overall Study|Withdrawal by Subject|2|||
163840660|NCT01678820|591787415|FG001|Overall Study|Withdrawal by Subject|5|||
163840661|NCT01678820|591787416|FG002|Overall Study|Withdrawal by Subject|2|||
163840662|NCT01678820|591787414|FG000|Overall Study|Protocol Specified Criteria|2|||
163840663|NCT01678820|591787415|FG001|Overall Study|Protocol Specified Criteria|3|||
163840664|NCT01678820|591787416|FG002|Overall Study|Protocol Specified Criteria|1|||
163840665|NCT01678820|591787414|FG000|Overall Study|Adverse Event|2|||
163840666|NCT01678820|591787415|FG001|Overall Study|Adverse Event|2|||
163840667|NCT01678820|591787416|FG002|Overall Study|Adverse Event|2|||
163840668|NCT01678820|591787414|FG000|Overall Study|Lost to Follow-up|7|||
163840669|NCT01678820|591787415|FG001|Overall Study|Lost to Follow-up|2|||
163840670|NCT01678820|591787416|FG002|Overall Study|Lost to Follow-up|2|||
163840671|NCT01678820|591787414|FG000|Overall Study|Non-compliance with study drug|0|||
163840672|NCT01678820|591787415|FG001|Overall Study|Non-compliance with study drug|1|||
163840673|NCT01678820|591787416|FG002|Overall Study|Non-compliance with study drug|0|||
163840674|NCT01678820|591787414|FG000|Overall Study|Physician Decision|0|||
163840675|NCT01678820|591787415|FG001|Overall Study|Physician Decision|0|||
163840676|NCT01678820|591787416|FG002|Overall Study|Physician Decision|1|||
163840677|NCT01678820|591787414|FG000|Overall Study|Protocol Violation|4|||
163840678|NCT01678820|591787415|FG001|Overall Study|Protocol Violation|5|||
163840679|NCT01678820|591787416|FG002|Overall Study|Protocol Violation|4|||
163840680|NCT01678820|591787414|FG000|Overall Study|Not treated with double-blind study drug|0|||
163840681|NCT01678820|591787415|FG001|Overall Study|Not treated with double-blind study drug|2|||
163840682|NCT01678820|591787416|FG002|Overall Study|Not treated with double-blind study drug|2|||
163840683|NCT01381874|591787417|FG000|Overall Study|Lost to Follow-up|1|||
163840684|NCT01381874|591787418|FG001|Overall Study|Lost to Follow-up|1|||
163840685|NCT01381874|591787419|FG002|Overall Study|Lost to Follow-up|0|||
163840686|NCT01381874|591787417|FG000|Overall Study|Withdrawal by Subject|9|||
164041140|NCT00364832|592510436|FG002|Extension Year 2|Early Withdrawals|0|||
164098878|NCT00624065|592726943|FG001|Overall Study|Adverse Event|6|||
163939900|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939901|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939902|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939903|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939904|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939905|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939906|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
163939907|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
163939908|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
163939909|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
163939910|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
163939911|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939912|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939913|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939914|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939915|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939916|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939917|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939918|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
163939919|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
163939920|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
163939921|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
163939922|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
163939923|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939924|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939925|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939926|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939927|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939928|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939929|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939930|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
163939931|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
163939932|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
163939933|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
163939934|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
163939935|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939936|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939937|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939938|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939939|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939940|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939941|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939942|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
163939943|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
163939944|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
163939945|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
163939946|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
163939947|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939948|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939949|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939950|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939951|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939952|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939953|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939954|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
163939955|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
163939956|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
163939957|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
163939958|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
163939959|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939960|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939961|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939962|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939963|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
164041141|NCT00364832|592510437|FG003|Extension Year 2|Early Withdrawals|0|||
163939964|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939965|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939966|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
163939967|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
163939968|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
163939969|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
163939970|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
163939971|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939972|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939973|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939974|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939975|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939976|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939977|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939978|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939979|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
163939980|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
163939981|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
163939982|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
163939983|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939984|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939985|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939986|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939987|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939988|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939989|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939990|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939991|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
163939992|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
163939993|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
163939994|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
163939995|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163939996|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163939997|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163939998|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163939999|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163940000|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163940001|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163940002|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163940003|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
163940004|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
163940005|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
163940006|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
163940007|NCT01646177|592149542|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940008|NCT01646177|592149543|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940009|NCT01646177|592149544|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940010|NCT01646177|592149545|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940011|NCT01646177|592149546|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940012|NCT01646177|592149547|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940013|NCT01646177|592149548|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940014|NCT01646177|592149549|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940015|NCT01646177|592149550|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940016|NCT01646177|592149551|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
163940017|NCT01646177|592149552|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
163940018|NCT01646177|592149553|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
163940019|NCT02992691|592149556|FG000|Overall Study|Adverse Event|2|||
163940020|NCT02992691|592149556|FG000|Overall Study|Withdrawal by Subject|1|||
163940021|NCT00588692|592149557|FG000|Overall Study|Withdrawal by Subject|4|||
163940022|NCT00588692|592149558|FG001|Overall Study|Withdrawal by Subject|2|||
163940023|NCT00588692|592149557|FG000|Overall Study|Hip Surgery|0|||
164041142|NCT00364832|592510438|FG004|Extension Year 2|Early Withdrawals|0|||
163940024|NCT00588692|592149558|FG001|Overall Study|Hip Surgery|1|||
163940025|NCT00588692|592149557|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
163940026|NCT00588692|592149558|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
163940027|NCT00588692|592149557|FG000|Overall Study|Cancer|1|||
163940028|NCT00588692|592149558|FG001|Overall Study|Cancer|0|||
163940029|NCT00588692|592149557|FG000|Overall Study|Death|1|||
163940030|NCT00588692|592149558|FG001|Overall Study|Death|0|||
164041143|NCT00364832|592510439|FG005|Extension Year 2|Early Withdrawals|0|||
163840687|NCT01381874|591787418|FG001|Overall Study|Withdrawal by Subject|10|||
163840688|NCT01381874|591787419|FG002|Overall Study|Withdrawal by Subject|9|||
163840689|NCT01381874|591787417|FG000|Overall Study|Other|67|||
163840690|NCT01381874|591787418|FG001|Overall Study|Other|52|||
163840691|NCT01381874|591787419|FG002|Overall Study|Other|67|||
163840692|NCT03283696|591787420|FG000|Overall Study|Physician Decision|5|||
163840693|NCT03283696|591787421|FG001|Overall Study|Physician Decision|6|||
163840694|NCT03283696|591787420|FG000|Overall Study|Withdrawal by Subject|2|||
163840695|NCT03283696|591787421|FG001|Overall Study|Withdrawal by Subject|0|||
163840696|NCT00245856|591787422|FG000|Period Two|Withdrawal by Subject|0|||
163840697|NCT00245856|591787423|FG001|Period Two|Withdrawal by Subject|1|||
163840698|NCT01512745|591787425|FG000|Overall Study|Adverse Event|22|||
163840699|NCT01512745|591787426|FG001|Overall Study|Adverse Event|3|||
163840700|NCT01512745|591787425|FG000|Overall Study|Death|9|||
163840701|NCT01512745|591787426|FG001|Overall Study|Death|13|||
163840702|NCT01512745|591787425|FG000|Overall Study|Withdrawal by Subject|2|||
163840703|NCT01512745|591787426|FG001|Overall Study|Withdrawal by Subject|2|||
163840704|NCT01512745|591787425|FG000|Overall Study|Lost to Follow-up|4|||
163840705|NCT01512745|591787426|FG001|Overall Study|Lost to Follow-up|0|||
163840706|NCT01512745|591787425|FG000|Overall Study|Lack of Efficacy|2|||
163840707|NCT01512745|591787426|FG001|Overall Study|Lack of Efficacy|2|||
163840708|NCT01512745|591787425|FG000|Overall Study|Protocol Violation|1|||
163840709|NCT01512745|591787426|FG001|Overall Study|Protocol Violation|0|||
163840710|NCT00439179|591787427|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
163840711|NCT00439179|591787428|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
163840712|NCT00439179|591787429|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
163840713|NCT00439179|591787430|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
163840714|NCT02761629|591787431|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
163840715|NCT02761629|591787432|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
163840716|NCT02761629|591787431|FG000|Overall Study|Insufficient Therapeutic Response|2|||
163840717|NCT02761629|591787432|FG001|Overall Study|Insufficient Therapeutic Response|7|||
163840718|NCT02761629|591787431|FG000|Overall Study|Failure to Return|2|||
163840719|NCT02761629|591787432|FG001|Overall Study|Failure to Return|4|||
163840720|NCT02761629|591787431|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
163840721|NCT02761629|591787432|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
163840722|NCT02761629|591787431|FG000|Overall Study|Protocol Violation|2|||
163840723|NCT02761629|591787432|FG001|Overall Study|Protocol Violation|2|||
163840724|NCT02761629|591787431|FG000|Overall Study|Withdrawal by Subject|0|||
163840725|NCT02761629|591787432|FG001|Overall Study|Withdrawal by Subject|3|||
163840726|NCT02761629|591787431|FG000|Overall Study|Other|0|||
163840727|NCT02761629|591787432|FG001|Overall Study|Other|2|||
163840728|NCT02761629|591787431|FG000|Overall Study|Lost to Follow-up|4|||
163840729|NCT02761629|591787432|FG001|Overall Study|Lost to Follow-up|1|||
163840730|NCT02761629|591787431|FG000|Overall Study|Randomized But Not Treated|8|||
163840731|NCT02761629|591787432|FG001|Overall Study|Randomized But Not Treated|4|||
163840732|NCT02357810|591787433|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
163840733|NCT02357810|591787433|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
163840734|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Adverse Event|5|||
163840735|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
163840736|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
163840737|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
163840738|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Death|1|||
163840739|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Physician Decision|1|||
163840740|NCT02357810|591787433|FG000|Reached 12 Weeks Response|Other|1|||
163840741|NCT02357810|591787433|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
163840742|NCT02357810|591787433|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
163840743|NCT02357810|591787433|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
163840744|NCT02357810|591787433|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
163840745|NCT02357810|591787433|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
163840746|NCT02357810|591787433|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
163840747|NCT00562978|591787434|FG000|Overall Study|Patient had imaging dose only|1|||
163840748|NCT00562978|591787435|FG001|Overall Study|Patient had imaging dose only|11|||
163840749|NCT00675506|591787437|FG000|Overall Study|Lost to Follow-up|1|||
163840750|NCT00675506|591787438|FG001|Overall Study|Lost to Follow-up|5|||
163840751|NCT00675506|591787437|FG000|Overall Study|Lost interest|3|||
163840752|NCT00675506|591787438|FG001|Overall Study|Lost interest|5|||
163840753|NCT00675506|591787437|FG000|Overall Study|Elevated fasting glucose|2|||
163840754|NCT00675506|591787438|FG001|Overall Study|Elevated fasting glucose|1|||
163840755|NCT00675506|591787437|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
163840756|NCT00675506|591787438|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
163840757|NCT00675506|591787437|FG000|Overall Study|Elevated IGF-1|2|||
163840758|NCT00675506|591787438|FG001|Overall Study|Elevated IGF-1|0|||
163840759|NCT00675506|591787437|FG000|Overall Study|Hypersensitivity Reaction|1|||
163840760|NCT00675506|591787438|FG001|Overall Study|Hypersensitivity Reaction|0|||
163940031|NCT00820170|592149560|FG000|Overall Study|Adverse Event|0|||
163940032|NCT00820170|592149561|FG001|Overall Study|Adverse Event|0|||
163940033|NCT00820170|592149562|FG002|Overall Study|Adverse Event|0|||
163940034|NCT00820170|592149563|FG003|Overall Study|Adverse Event|0|||
163940035|NCT00820170|592149564|FG004|Overall Study|Adverse Event|2|||
163940036|NCT00820170|592149560|FG000|Overall Study|Progressive Disease|0|||
163940037|NCT00820170|592149561|FG001|Overall Study|Progressive Disease|0|||
163940038|NCT00820170|592149562|FG002|Overall Study|Progressive Disease|0|||
164041144|NCT00364832|592510440|FG006|Extension Year 2|Early Withdrawals|0|||
164041145|NCT00364832|592510441|FG007|Extension Year 2|Early Withdrawals|0|||
164041146|NCT00364832|592510442|FG008|Extension Year 2|Early Withdrawals|0|||
164041147|NCT00364832|592510443|FG009|Extension Year 2|Early Withdrawals|5|||
164041148|NCT00364832|592510444|FG010|Extension Year 2|Early Withdrawals|5|||
164041149|NCT00364832|592510445|FG011|Extension Year 2|Early Withdrawals|3|||
164041150|NCT01838213|592510449|FG000|Overall Study|Ineligible|166|||
164041151|NCT01838213|592510450|FG001|Overall Study|Ineligible|191|||
164041152|NCT04882072|592510451|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
164041153|NCT04882072|592510452|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
164041154|NCT04882072|592510451|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
164041155|NCT04882072|592510452|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
164041156|NCT04882072|592510451|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
164041157|NCT04882072|592510452|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
164041158|NCT01548417|592510453|FG000|Overall Study|Withdrawal by Subject|0|||
164041159|NCT01548417|592510454|FG001|Overall Study|Withdrawal by Subject|2|||
164041160|NCT04583969|592510457|FG000|Overall Study|Death|31|||
164041161|NCT04583969|592510458|FG001|Overall Study|Death|38|||
164041162|NCT04583969|592510457|FG000|Overall Study|Lost to Follow-up|16|||
163940039|NCT00820170|592149563|FG003|Overall Study|Progressive Disease|0|||
163940040|NCT00820170|592149564|FG004|Overall Study|Progressive Disease|2|||
163940041|NCT02180243|592149565|FG000|Overall Study|Withdrawal by Subject|12|||
163940042|NCT02180243|592149566|FG001|Overall Study|Withdrawal by Subject|12|||
163940043|NCT02180243|592149565|FG000|Overall Study|Lost to Follow-up|12|||
163940044|NCT02180243|592149566|FG001|Overall Study|Lost to Follow-up|2|||
163940045|NCT01137578|592149567|FG000|Overall Study|Participant requested to Discontinue|3|||
163940046|NCT01137578|592149568|FG001|Overall Study|Participant requested to Discontinue|0|||
163940047|NCT01137578|592149569|FG002|Overall Study|Participant requested to Discontinue|0|||
163940048|NCT01137578|592149567|FG000|Overall Study|Withdrawal by Subject|1|||
163940049|NCT01137578|592149568|FG001|Overall Study|Withdrawal by Subject|0|||
163940050|NCT01137578|592149569|FG002|Overall Study|Withdrawal by Subject|0|||
163940051|NCT01137578|592149567|FG000|Overall Study|Other|12|||
163940052|NCT01137578|592149568|FG001|Overall Study|Other|2|||
163940053|NCT01137578|592149569|FG002|Overall Study|Other|6|||
163940054|NCT03651700|592149572|FG000|Overall Study|Withdrawal by Subject|1|||
163940055|NCT03651700|592149573|FG001|Overall Study|Withdrawal by Subject|0|||
163940056|NCT05479734|592149575|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
163940057|NCT05479734|592149576|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
163940058|NCT05479734|592149575|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
163940059|NCT05479734|592149576|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
163940060|NCT05479734|592149575|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
163940061|NCT05479734|592149576|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
163940062|NCT05479734|592149575|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
163940063|NCT05479734|592149576|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
163940064|NCT01461005|592149577|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
163940065|NCT01426347|592149581|FG000|Overall Study|Lost to Follow-up|0|||
163940066|NCT01426347|592149582|FG001|Overall Study|Lost to Follow-up|3|||
163940067|NCT01426347|592149581|FG000|Overall Study|Protocol Violation|2|||
163940068|NCT01426347|592149582|FG001|Overall Study|Protocol Violation|0|||
163940069|NCT01426347|592149581|FG000|Overall Study|Withdrawal by Subject|5|||
164041163|NCT04583969|592510458|FG001|Overall Study|Lost to Follow-up|13|||
164041164|NCT04583969|592510457|FG000|Overall Study|Protocol Violation|1|||
164041165|NCT04583969|592510458|FG001|Overall Study|Protocol Violation|0|||
164041166|NCT04583969|592510457|FG000|Overall Study|Withdrawal by Subject|3|||
164041167|NCT04583969|592510458|FG001|Overall Study|Withdrawal by Subject|3|||
164041168|NCT04583969|592510457|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
163940070|NCT01426347|592149582|FG001|Overall Study|Withdrawal by Subject|0|||
163940071|NCT00455741|592149583|FG000|Overall Study|Physician Decision|0|||
163940072|NCT00455741|592149584|FG001|Overall Study|Physician Decision|1|||
163940073|NCT00203268|592149585|FG000|Early Treatment|only treated one headache|2|||
163940074|NCT00203268|592149585|FG000|Early Treatment|Lost to Follow-up|1|||
163940075|NCT00203268|592149585|FG000|Early Treatment|Withdrawal by Subject|1|||
163940076|NCT03633799|592149594|FG000|Overall Study|Adverse Event|349|||
163940077|NCT03633799|592149594|FG000|Overall Study|Withdrawal by Subject|288|||
164041169|NCT04583969|592510458|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
164041170|NCT04583969|592510457|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
163840761|NCT00675506|591787437|FG000|Overall Study|Disclosed history of cancer|1|||
163840762|NCT00675506|591787438|FG001|Overall Study|Disclosed history of cancer|0|||
163840763|NCT00675506|591787437|FG000|Overall Study|Declined participation|1|||
163840764|NCT00675506|591787438|FG001|Overall Study|Declined participation|0|||
163840765|NCT00675506|591787437|FG000|Overall Study|Schedule conflict|0|||
163840766|NCT00675506|591787438|FG001|Overall Study|Schedule conflict|1|||
163840767|NCT06173570|591787439|FG000|Overall Study|Adverse Event|1|||
163840768|NCT06173570|591787440|FG001|Overall Study|Adverse Event|0|||
163840769|NCT06173570|591787441|FG002|Overall Study|Adverse Event|0|||
163840770|NCT06173570|591787442|FG003|Overall Study|Adverse Event|2|||
163840771|NCT06173570|591787443|FG004|Overall Study|Adverse Event|0|||
163840772|NCT06173570|591787439|FG000|Overall Study|Lost to Follow-up|1|||
163840773|NCT06173570|591787440|FG001|Overall Study|Lost to Follow-up|0|||
163840774|NCT06173570|591787441|FG002|Overall Study|Lost to Follow-up|0|||
163840775|NCT06173570|591787442|FG003|Overall Study|Lost to Follow-up|0|||
163840776|NCT06173570|591787443|FG004|Overall Study|Lost to Follow-up|2|||
163840777|NCT06173570|591787439|FG000|Overall Study|Protocol Violation|0|||
163840778|NCT06173570|591787440|FG001|Overall Study|Protocol Violation|2|||
163840779|NCT06173570|591787441|FG002|Overall Study|Protocol Violation|0|||
163840780|NCT06173570|591787442|FG003|Overall Study|Protocol Violation|0|||
163840781|NCT06173570|591787443|FG004|Overall Study|Protocol Violation|1|||
163840782|NCT06173570|591787439|FG000|Overall Study|Withdrawal by Subject|0|||
163840783|NCT06173570|591787440|FG001|Overall Study|Withdrawal by Subject|1|||
163840784|NCT06173570|591787441|FG002|Overall Study|Withdrawal by Subject|1|||
163840785|NCT06173570|591787442|FG003|Overall Study|Withdrawal by Subject|1|||
163840786|NCT06173570|591787443|FG004|Overall Study|Withdrawal by Subject|1|||
163840787|NCT06173570|591787439|FG000|Overall Study|Non-compliance with Study Drug|1|||
163840788|NCT06173570|591787440|FG001|Overall Study|Non-compliance with Study Drug|0|||
163840789|NCT06173570|591787441|FG002|Overall Study|Non-compliance with Study Drug|0|||
163840790|NCT06173570|591787442|FG003|Overall Study|Non-compliance with Study Drug|0|||
163840791|NCT06173570|591787443|FG004|Overall Study|Non-compliance with Study Drug|0|||
163840792|NCT06173570|591787439|FG000|Overall Study|Screen Failure|0|||
163840793|NCT06173570|591787440|FG001|Overall Study|Screen Failure|0|||
163840794|NCT06173570|591787441|FG002|Overall Study|Screen Failure|0|||
163840795|NCT06173570|591787442|FG003|Overall Study|Screen Failure|0|||
163840796|NCT06173570|591787443|FG004|Overall Study|Screen Failure|1|||
163840797|NCT06173570|591787439|FG000|Overall Study|Other|2|||
163840798|NCT06173570|591787440|FG001|Overall Study|Other|1|||
163840799|NCT06173570|591787441|FG002|Overall Study|Other|0|||
163840800|NCT06173570|591787442|FG003|Overall Study|Other|2|||
163840801|NCT06173570|591787443|FG004|Overall Study|Other|0|||
163840802|NCT03820323|591787444|FG000|Overall Study|Lost to Follow-up|2|||
163840803|NCT03820323|591787445|FG001|Overall Study|Lost to Follow-up|1|||
163840804|NCT03820323|591787444|FG000|Overall Study|Missed 12-month visit|22|||
163840805|NCT03820323|591787445|FG001|Overall Study|Missed 12-month visit|14|||
163840806|NCT03820323|591787444|FG000|Overall Study|Death|2|||
163840807|NCT03820323|591787445|FG001|Overall Study|Death|1|||
163840808|NCT03820323|591787444|FG000|Overall Study|Transferred out|13|||
163840809|NCT03820323|591787445|FG001|Overall Study|Transferred out|11|||
163840810|NCT03820323|591787444|FG000|Overall Study|Terminated|0|||
163840811|NCT03820323|591787445|FG001|Overall Study|Terminated|3|||
163840812|NCT03820323|591787444|FG000|Overall Study|Withdrawal by Subject|1|||
163840813|NCT03820323|591787445|FG001|Overall Study|Withdrawal by Subject|6|||
163840814|NCT03151395|591787446|FG000|Overall Study|Adverse Event|2|||
163840815|NCT03151395|591787446|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
163840816|NCT03151395|591787446|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
163840817|NCT03151395|591787446|FG000|Overall Study|Unspecified reason|4|||
163840818|NCT00366301|591787447|FG000|Overall Study|Lost to Follow-up|4|||
163840819|NCT00366301|591787448|FG001|Overall Study|Lost to Follow-up|4|||
163840820|NCT00366301|591787449|FG002|Overall Study|Lost to Follow-up|3|||
163840821|NCT00366301|591787450|FG003|Overall Study|Lost to Follow-up|7|||
163840822|NCT00366301|591787447|FG000|Overall Study|Withdrawal by Subject|4|||
163840823|NCT00366301|591787448|FG001|Overall Study|Withdrawal by Subject|2|||
163840824|NCT00366301|591787449|FG002|Overall Study|Withdrawal by Subject|1|||
163840825|NCT00366301|591787450|FG003|Overall Study|Withdrawal by Subject|1|||
163840826|NCT02153359|591787451|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
163940078|NCT03633799|592149594|FG000|Overall Study|Lost to Follow-up|97|||
163940079|NCT03633799|592149594|FG000|Overall Study|Physician Decision|9|||
163840827|NCT02153359|591787452|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
163840828|NCT01348776|591787453|FG000|Overall Study|Lost to Follow-up|3|||
163840829|NCT01372605|591787454|FG000|Overall Study|Death|1|||
163840830|NCT01372605|591787455|FG001|Overall Study|Death|2|||
163840831|NCT01372605|591787454|FG000|Overall Study|Lost to Follow-up|2|||
163840832|NCT01372605|591787455|FG001|Overall Study|Lost to Follow-up|1|||
163840833|NCT01372605|591787454|FG000|Overall Study|Withdrawal by Subject|4|||
163840834|NCT01372605|591787455|FG001|Overall Study|Withdrawal by Subject|7|||
163840835|NCT01372605|591787454|FG000|Overall Study|Moved|3|||
163840836|NCT01372605|591787455|FG001|Overall Study|Moved|0|||
163940080|NCT03633799|592149594|FG000|Overall Study|Protocol Violation|4|||
163940081|NCT03633799|592149594|FG000|Overall Study|Pregnancy|20|||
163940082|NCT03633799|592149594|FG000|Overall Study|other|39|||
163940083|NCT03633799|592149594|FG000|Overall Study|ongoing within third year of study|106|||
163940084|NCT03633799|592149594|FG000|Overall Study|unsuccessful study drug placement|19|||
163940085|NCT03551691|592149597|FG000|Overall Study|Withdrawal by Subject|3|||
163940086|NCT03551691|592149598|FG001|Overall Study|Withdrawal by Subject|3|||
163940087|NCT01876082|592152106|FG000|Overall Study|Withdrawal by Subject|0|||
163940088|NCT01876082|592152107|FG001|Overall Study|Withdrawal by Subject|2|||
163940089|NCT01876082|592152106|FG000|Overall Study|Protocol Violation|1|||
163940090|NCT01876082|592152107|FG001|Overall Study|Protocol Violation|0|||
163940091|NCT01876082|592152106|FG000|Overall Study|Adverse Event|1|||
163940092|NCT01876082|592152107|FG001|Overall Study|Adverse Event|1|||
163940093|NCT01876082|592152106|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
163940094|NCT01876082|592152107|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
163940095|NCT04020185|592152118|FG000|Overall Study|Death|0|||
163940096|NCT04020185|592152119|FG001|Overall Study|Death|0|||
163940097|NCT04020185|592152120|FG002|Overall Study|Death|1|||
163940098|NCT04020185|592152121|FG003|Overall Study|Death|2|||
163940099|NCT04020185|592152122|FG004|Overall Study|Death|1|||
163940100|NCT04020185|592152123|FG005|Overall Study|Death|0|||
163940101|NCT04020185|592152124|FG006|Overall Study|Death|1|||
163940102|NCT04020185|592152125|FG007|Overall Study|Death|0|||
163940103|NCT04020185|592152118|FG000|Overall Study|Consent withdrawn|1|||
163940104|NCT04020185|592152119|FG001|Overall Study|Consent withdrawn|0|||
163940105|NCT04020185|592152120|FG002|Overall Study|Consent withdrawn|0|||
163940106|NCT04020185|592152121|FG003|Overall Study|Consent withdrawn|0|||
163940107|NCT04020185|592152122|FG004|Overall Study|Consent withdrawn|2|||
163940108|NCT04020185|592152123|FG005|Overall Study|Consent withdrawn|0|||
163940109|NCT04020185|592152124|FG006|Overall Study|Consent withdrawn|1|||
163940110|NCT04020185|592152125|FG007|Overall Study|Consent withdrawn|1|||
163940111|NCT04020185|592152118|FG000|Overall Study|Patient in hospice|0|||
163940112|NCT04020185|592152119|FG001|Overall Study|Patient in hospice|1|||
163940113|NCT04020185|592152120|FG002|Overall Study|Patient in hospice|0|||
163940114|NCT04020185|592152121|FG003|Overall Study|Patient in hospice|0|||
163940115|NCT04020185|592152122|FG004|Overall Study|Patient in hospice|0|||
163940116|NCT04020185|592152123|FG005|Overall Study|Patient in hospice|0|||
163940117|NCT04020185|592152124|FG006|Overall Study|Patient in hospice|0|||
163940118|NCT04020185|592152125|FG007|Overall Study|Patient in hospice|0|||
163940119|NCT04020185|592152118|FG000|Overall Study|Continuing on expanded access|0|||
163940120|NCT04020185|592152119|FG001|Overall Study|Continuing on expanded access|0|||
163940121|NCT04020185|592152120|FG002|Overall Study|Continuing on expanded access|0|||
163940122|NCT04020185|592152121|FG003|Overall Study|Continuing on expanded access|0|||
163940123|NCT04020185|592152122|FG004|Overall Study|Continuing on expanded access|0|||
163940124|NCT04020185|592152123|FG005|Overall Study|Continuing on expanded access|0|||
163940125|NCT04020185|592152124|FG006|Overall Study|Continuing on expanded access|1|||
163940126|NCT04020185|592152125|FG007|Overall Study|Continuing on expanded access|1|||
163940127|NCT00527787|592152127|FG000|Overall Study|Adverse Event|14|||
163940128|NCT00527787|592152128|FG001|Overall Study|Adverse Event|24|||
163940129|NCT00527787|592152127|FG000|Overall Study|Withdrawal by Subject|13|||
163940130|NCT00527787|592152128|FG001|Overall Study|Withdrawal by Subject|25|||
163940131|NCT00527787|592152127|FG000|Overall Study|Lost to Follow-up|5|||
163940132|NCT00527787|592152128|FG001|Overall Study|Lost to Follow-up|2|||
163940133|NCT00527787|592152127|FG000|Overall Study|Duodenal Ulcer|1|||
163940134|NCT00527787|592152128|FG001|Overall Study|Duodenal Ulcer|10|||
163940135|NCT00527787|592152127|FG000|Overall Study|misc|5|||
163940136|NCT00527787|592152128|FG001|Overall Study|misc|2|||
163940137|NCT04335591|592152131|FG000|Overall Study|Adverse Event|5|||
163940138|NCT04335591|592152132|FG001|Overall Study|Adverse Event|2|||
163940139|NCT04335591|592152133|FG002|Overall Study|Adverse Event|3|||
163940140|NCT04335591|592152134|FG003|Overall Study|Adverse Event|2|||
163940141|NCT04335591|592152131|FG000|Overall Study|Protocol Violation|1|||
163940142|NCT04335591|592152132|FG001|Overall Study|Protocol Violation|0|||
163940143|NCT04335591|592152133|FG002|Overall Study|Protocol Violation|0|||
163940144|NCT04335591|592152134|FG003|Overall Study|Protocol Violation|0|||
163940145|NCT04335591|592152131|FG000|Overall Study|Withdrawal by Subject|8|||
163940146|NCT04335591|592152132|FG001|Overall Study|Withdrawal by Subject|4|||
163940147|NCT04335591|592152133|FG002|Overall Study|Withdrawal by Subject|4|||
163940148|NCT04335591|592152134|FG003|Overall Study|Withdrawal by Subject|5|||
163940149|NCT04335591|592152131|FG000|Overall Study|Subject planning pregnancy|0|||
163940150|NCT04335591|592152132|FG001|Overall Study|Subject planning pregnancy|1|||
163940151|NCT04335591|592152133|FG002|Overall Study|Subject planning pregnancy|0|||
163940152|NCT04335591|592152134|FG003|Overall Study|Subject planning pregnancy|0|||
163940153|NCT04335591|592152131|FG000|Overall Study|Ukrainian Russian war conflict|4|||
163940154|NCT04335591|592152132|FG001|Overall Study|Ukrainian Russian war conflict|5|||
163940155|NCT04335591|592152133|FG002|Overall Study|Ukrainian Russian war conflict|2|||
163940156|NCT04335591|592152134|FG003|Overall Study|Ukrainian Russian war conflict|0|||
163940157|NCT01939353|592152142|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
163940158|NCT01939353|592152142|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
163940159|NCT01939353|592152142|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
163940160|NCT01939353|592152142|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
163940161|NCT01939353|592152142|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
163940162|NCT04421950|592152146|FG000|Overall Study|Dropped or lost to follow up|4|||
163940163|NCT04421950|592152147|FG001|Overall Study|Dropped or lost to follow up|2|||
163940164|NCT00335140|592152150|FG000|Overall Study|Ineligible|1|||
163940165|NCT04546425|592152151|FG000|Overall Study|Protocol Violation|1|||
163940166|NCT04546425|592152152|FG001|Overall Study|Protocol Violation|1|||
163940167|NCT04546425|592152153|FG002|Overall Study|Protocol Violation|0|||
163940168|NCT04546425|592152154|FG003|Overall Study|Protocol Violation|0|||
163940169|NCT04546425|592152151|FG000|Overall Study|Adverse Event|3|||
163940170|NCT04546425|592152152|FG001|Overall Study|Adverse Event|0|||
163940171|NCT04546425|592152153|FG002|Overall Study|Adverse Event|0|||
163940172|NCT04546425|592152154|FG003|Overall Study|Adverse Event|0|||
163940173|NCT04546425|592152151|FG000|Overall Study|Lost to Follow-up|5|||
163940174|NCT04546425|592152152|FG001|Overall Study|Lost to Follow-up|4|||
163940175|NCT04546425|592152153|FG002|Overall Study|Lost to Follow-up|0|||
163940176|NCT04546425|592152154|FG003|Overall Study|Lost to Follow-up|0|||
163940177|NCT04546425|592152151|FG000|Overall Study|No Longer met eligibility criteria|3|||
163940178|NCT04546425|592152152|FG001|Overall Study|No Longer met eligibility criteria|3|||
163940179|NCT04546425|592152153|FG002|Overall Study|No Longer met eligibility criteria|1|||
163940180|NCT04546425|592152154|FG003|Overall Study|No Longer met eligibility criteria|1|||
163940181|NCT04546425|592152151|FG000|Overall Study|Withdrawal by parent/guardian|6|||
163940182|NCT04546425|592152152|FG001|Overall Study|Withdrawal by parent/guardian|5|||
163940183|NCT04546425|592152153|FG002|Overall Study|Withdrawal by parent/guardian|1|||
163940184|NCT04546425|592152154|FG003|Overall Study|Withdrawal by parent/guardian|1|||
163940185|NCT00737477|592152158|FG000|Overall Study|Adverse Event|9|||
163940186|NCT00737477|592152158|FG000|Overall Study|Death|9|||
163940187|NCT00737477|592152158|FG000|Overall Study|Treatment Refusal|1|||
163940188|NCT00737477|592152158|FG000|Overall Study|Withdrawal by Subject|1|||
163940189|NCT00737477|592152158|FG000|Overall Study|Renal Transplantation|10|||
163940190|NCT00737477|592152158|FG000|Overall Study|Other|4|||
163940191|NCT01132820|592152159|FG000|Overall Study|Ineligible: wrong cell type|1|||
163940192|NCT01132820|592152159|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
163940193|NCT01132820|592152159|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
163940194|NCT01132820|592152159|FG000|Overall Study|Never treated|1|||
163940195|NCT01132820|592152159|FG000|Overall Study|Inadequate data|1|||
163940196|NCT02687035|592152160|FG000|Overall Study|Withdrawal by Subject|1|||
163940197|NCT02687035|592152160|FG000|Overall Study|Death|87|||
163940198|NCT02687035|592152160|FG000|Overall Study|Lost to Follow-up|1|||
163940199|NCT02687035|592152160|FG000|Overall Study|Missed Visit|87|||
163940200|NCT02687035|592152160|FG000|Overall Study|Did not receive Study Device|8|||
163940201|NCT05000216|592152161|FG000|Stage 1|Lost to Follow-up|0|||
163940202|NCT05000216|592152162|FG001|Stage 1|Lost to Follow-up|0|||
163940203|NCT05000216|592152163|FG002|Stage 1|Lost to Follow-up|0|||
163940204|NCT05000216|592152164|FG003|Stage 1|Lost to Follow-up|0|||
163940205|NCT05000216|592152165|FG004|Stage 1|Lost to Follow-up|0|||
163940206|NCT05000216|592152166|FG005|Stage 1|Lost to Follow-up|0|||
163940207|NCT05000216|592152167|FG006|Stage 1|Lost to Follow-up|1|||
163940208|NCT05000216|592152168|FG007|Stage 1|Lost to Follow-up|1|||
163940209|NCT05000216|592152169|FG008|Stage 1|Lost to Follow-up|0|||
163940210|NCT05000216|592152170|FG009|Stage 1|Lost to Follow-up|2|||
163940211|NCT05000216|592152171|FG010|Stage 1|Lost to Follow-up|3|||
163940212|NCT05000216|592152172|FG011|Stage 1|Lost to Follow-up|0|||
163940213|NCT05000216|592152173|FG012|Stage 1|Lost to Follow-up|0|||
163940214|NCT05000216|592152174|FG013|Stage 1|Lost to Follow-up|0|||
163940215|NCT05000216|592152175|FG014|Stage 1|Lost to Follow-up|0|||
163940216|NCT05000216|592152176|FG015|Stage 1|Lost to Follow-up|0|||
163940217|NCT05000216|592152177|FG016|Stage 1|Lost to Follow-up|0|||
163940218|NCT05000216|592152178|FG017|Stage 1|Lost to Follow-up|0|||
163940219|NCT05000216|592152179|FG018|Stage 1|Lost to Follow-up|0|||
163940220|NCT05000216|592152180|FG019|Stage 1|Lost to Follow-up|0|||
163940221|NCT05000216|592152181|FG020|Stage 1|Lost to Follow-up|0|||
163940222|NCT05000216|592152182|FG021|Stage 1|Lost to Follow-up|0|||
163940223|NCT05000216|592152161|FG000|Stage 1|Physician Decision|0|||
163940224|NCT05000216|592152162|FG001|Stage 1|Physician Decision|0|||
163940225|NCT05000216|592152163|FG002|Stage 1|Physician Decision|0|||
163940226|NCT05000216|592152164|FG003|Stage 1|Physician Decision|0|||
163940227|NCT05000216|592152165|FG004|Stage 1|Physician Decision|0|||
163940228|NCT05000216|592152166|FG005|Stage 1|Physician Decision|0|||
163940229|NCT05000216|592152167|FG006|Stage 1|Physician Decision|0|||
163940230|NCT05000216|592152168|FG007|Stage 1|Physician Decision|1|||
163940231|NCT05000216|592152169|FG008|Stage 1|Physician Decision|1|||
163940232|NCT05000216|592152170|FG009|Stage 1|Physician Decision|0|||
164098879|NCT00624065|592726942|FG000|Overall Study|Lost to Follow-up|4|||
163940233|NCT05000216|592152171|FG010|Stage 1|Physician Decision|0|||
163940234|NCT05000216|592152172|FG011|Stage 1|Physician Decision|0|||
163940235|NCT05000216|592152173|FG012|Stage 1|Physician Decision|0|||
164098880|NCT00624065|592726943|FG001|Overall Study|Lost to Follow-up|1|||
163940236|NCT05000216|592152174|FG013|Stage 1|Physician Decision|0|||
163940237|NCT05000216|592152175|FG014|Stage 1|Physician Decision|0|||
163940238|NCT05000216|592152176|FG015|Stage 1|Physician Decision|0|||
163940239|NCT05000216|592152177|FG016|Stage 1|Physician Decision|0|||
163940240|NCT05000216|592152178|FG017|Stage 1|Physician Decision|0|||
163940241|NCT05000216|592152179|FG018|Stage 1|Physician Decision|0|||
163940242|NCT05000216|592152180|FG019|Stage 1|Physician Decision|0|||
163940243|NCT05000216|592152181|FG020|Stage 1|Physician Decision|0|||
163940244|NCT05000216|592152182|FG021|Stage 1|Physician Decision|0|||
163940245|NCT05000216|592152161|FG000|Stage 1|Withdrawal by Subject|0|||
163940246|NCT05000216|592152162|FG001|Stage 1|Withdrawal by Subject|1|||
163940247|NCT05000216|592152163|FG002|Stage 1|Withdrawal by Subject|0|||
163940248|NCT05000216|592152164|FG003|Stage 1|Withdrawal by Subject|0|||
163940249|NCT05000216|592152165|FG004|Stage 1|Withdrawal by Subject|0|||
163940250|NCT05000216|592152166|FG005|Stage 1|Withdrawal by Subject|0|||
163940251|NCT05000216|592152167|FG006|Stage 1|Withdrawal by Subject|0|||
163940252|NCT05000216|592152168|FG007|Stage 1|Withdrawal by Subject|0|||
163940253|NCT05000216|592152169|FG008|Stage 1|Withdrawal by Subject|0|||
163940254|NCT05000216|592152170|FG009|Stage 1|Withdrawal by Subject|3|||
163940255|NCT05000216|592152171|FG010|Stage 1|Withdrawal by Subject|10|||
163940256|NCT05000216|592152172|FG011|Stage 1|Withdrawal by Subject|0|||
163940257|NCT05000216|592152173|FG012|Stage 1|Withdrawal by Subject|0|||
163940258|NCT05000216|592152174|FG013|Stage 1|Withdrawal by Subject|0|||
163940259|NCT05000216|592152175|FG014|Stage 1|Withdrawal by Subject|0|||
163940260|NCT05000216|592152176|FG015|Stage 1|Withdrawal by Subject|0|||
163940261|NCT05000216|592152177|FG016|Stage 1|Withdrawal by Subject|0|||
163940262|NCT05000216|592152178|FG017|Stage 1|Withdrawal by Subject|0|||
163940263|NCT05000216|592152179|FG018|Stage 1|Withdrawal by Subject|0|||
163940264|NCT05000216|592152180|FG019|Stage 1|Withdrawal by Subject|0|||
163940265|NCT05000216|592152181|FG020|Stage 1|Withdrawal by Subject|0|||
163940266|NCT05000216|592152182|FG021|Stage 1|Withdrawal by Subject|0|||
163940267|NCT05000216|592152161|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
163940268|NCT05000216|592152162|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
163940269|NCT05000216|592152163|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
163940270|NCT05000216|592152164|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
163940271|NCT05000216|592152165|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
163940272|NCT05000216|592152166|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
163940273|NCT05000216|592152167|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
163940274|NCT05000216|592152168|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
163940275|NCT05000216|592152169|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
163940276|NCT05000216|592152170|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
163940277|NCT05000216|592152171|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
163940278|NCT05000216|592152172|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
163940279|NCT05000216|592152173|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
163940280|NCT05000216|592152174|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
163940281|NCT05000216|592152175|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
163940282|NCT05000216|592152176|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
163940283|NCT05000216|592152177|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
163940284|NCT05000216|592152178|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
163940285|NCT05000216|592152179|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
163940286|NCT05000216|592152180|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
163940287|NCT05000216|592152181|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
163940288|NCT05000216|592152182|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
163940289|NCT05000216|592152161|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940290|NCT05000216|592152162|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940291|NCT05000216|592152163|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940292|NCT05000216|592152164|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940293|NCT05000216|592152165|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940294|NCT05000216|592152166|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940295|NCT05000216|592152167|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940296|NCT05000216|592152168|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940297|NCT05000216|592152169|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
163940298|NCT05000216|592152170|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940299|NCT05000216|592152171|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940300|NCT05000216|592152172|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940301|NCT05000216|592152173|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940302|NCT05000216|592152174|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940303|NCT05000216|592152175|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940304|NCT05000216|592152176|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940305|NCT05000216|592152177|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940306|NCT05000216|592152178|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940307|NCT05000216|592152179|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940308|NCT05000216|592152180|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940309|NCT05000216|592152181|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940310|NCT05000216|592152182|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
163940311|NCT05000216|592152161|FG000|Stage 1|Other|0|||
163940312|NCT05000216|592152162|FG001|Stage 1|Other|0|||
163940313|NCT05000216|592152163|FG002|Stage 1|Other|0|||
163940314|NCT05000216|592152164|FG003|Stage 1|Other|0|||
163940315|NCT05000216|592152165|FG004|Stage 1|Other|1|||
163940316|NCT05000216|592152166|FG005|Stage 1|Other|0|||
163940317|NCT05000216|592152167|FG006|Stage 1|Other|0|||
163940318|NCT05000216|592152168|FG007|Stage 1|Other|2|||
163940319|NCT05000216|592152169|FG008|Stage 1|Other|0|||
163940320|NCT05000216|592152170|FG009|Stage 1|Other|0|||
163940321|NCT05000216|592152171|FG010|Stage 1|Other|1|||
163940322|NCT05000216|592152172|FG011|Stage 1|Other|1|||
163940323|NCT05000216|592152173|FG012|Stage 1|Other|0|||
163940324|NCT05000216|592152174|FG013|Stage 1|Other|0|||
163940325|NCT05000216|592152175|FG014|Stage 1|Other|0|||
163940326|NCT05000216|592152176|FG015|Stage 1|Other|0|||
163940327|NCT05000216|592152177|FG016|Stage 1|Other|0|||
163940328|NCT05000216|592152178|FG017|Stage 1|Other|0|||
163940329|NCT05000216|592152179|FG018|Stage 1|Other|0|||
163940330|NCT05000216|592152180|FG019|Stage 1|Other|0|||
163940331|NCT05000216|592152181|FG020|Stage 1|Other|0|||
163940332|NCT05000216|592152182|FG021|Stage 1|Other|0|||
163940333|NCT05000216|592152161|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
163940334|NCT05000216|592152162|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
163940335|NCT05000216|592152163|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
163940336|NCT05000216|592152164|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
163940337|NCT05000216|592152165|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
163940338|NCT05000216|592152166|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
163940339|NCT05000216|592152167|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
163940340|NCT05000216|592152168|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
163940341|NCT05000216|592152169|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
163940342|NCT05000216|592152170|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
163940343|NCT05000216|592152171|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
164041171|NCT04583969|592510458|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
164041172|NCT04583969|592510457|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
164041173|NCT04583969|592510458|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
164041174|NCT04583969|592510457|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
164041175|NCT04583969|592510458|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
164041176|NCT04583969|592510457|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
164041177|NCT04583969|592510458|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
164041178|NCT02939976|592510459|FG000|Overall Study|Lost to Follow-up|7|||
164041179|NCT02939976|592510460|FG001|Overall Study|Lost to Follow-up|1|||
164041180|NCT02939976|592510461|FG002|Overall Study|Lost to Follow-up|1|||
164041181|NCT02939976|592510462|FG003|Overall Study|Lost to Follow-up|2|||
163940344|NCT05000216|592152172|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
163940345|NCT05000216|592152173|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
163940346|NCT05000216|592152174|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
163940347|NCT05000216|592152175|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
163940348|NCT05000216|592152176|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
163940349|NCT05000216|592152177|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
164041182|NCT02939976|592510459|FG000|Overall Study|Withdrawal by Subject|4|||
164041183|NCT02939976|592510460|FG001|Overall Study|Withdrawal by Subject|0|||
164041184|NCT02939976|592510461|FG002|Overall Study|Withdrawal by Subject|2|||
164041185|NCT02939976|592510462|FG003|Overall Study|Withdrawal by Subject|4|||
164041186|NCT02939976|592510459|FG000|Overall Study|Due to early study closure|4|||
164041187|NCT02939976|592510460|FG001|Overall Study|Due to early study closure|3|||
164041188|NCT02939976|592510461|FG002|Overall Study|Due to early study closure|2|||
164041189|NCT02939976|592510462|FG003|Overall Study|Due to early study closure|3|||
164041190|NCT01585168|592510467|FG000|Overall Study|Lost to Follow-up|3|||
164041191|NCT01585168|592510468|FG001|Overall Study|Lost to Follow-up|1|||
164041192|NCT01585168|592510469|FG002|Overall Study|Lost to Follow-up|1|||
164041193|NCT01585168|592510470|FG003|Overall Study|Lost to Follow-up|1|||
164041194|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
164041195|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
164041196|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
163940350|NCT05000216|592152178|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
163940351|NCT05000216|592152179|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
163940352|NCT05000216|592152180|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
163940353|NCT05000216|592152181|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
164041197|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
164041198|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
164041199|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
164041200|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
164041201|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
163940354|NCT05000216|592152182|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
163940355|NCT05000216|592152161|FG000|Stage 2|Lost to Follow-up|0|||
163940356|NCT05000216|592152162|FG001|Stage 2|Lost to Follow-up|0|||
163940357|NCT05000216|592152163|FG002|Stage 2|Lost to Follow-up|0|||
163940358|NCT05000216|592152164|FG003|Stage 2|Lost to Follow-up|0|||
163940359|NCT05000216|592152165|FG004|Stage 2|Lost to Follow-up|0|||
163940360|NCT05000216|592152166|FG005|Stage 2|Lost to Follow-up|0|||
163940361|NCT05000216|592152167|FG006|Stage 2|Lost to Follow-up|0|||
163940362|NCT05000216|592152168|FG007|Stage 2|Lost to Follow-up|0|||
163940363|NCT05000216|592152169|FG008|Stage 2|Lost to Follow-up|0|||
163940364|NCT05000216|592152170|FG009|Stage 2|Lost to Follow-up|0|||
163940365|NCT05000216|592152171|FG010|Stage 2|Lost to Follow-up|0|||
163940366|NCT05000216|592152172|FG011|Stage 2|Lost to Follow-up|0|||
163940367|NCT05000216|592152173|FG012|Stage 2|Lost to Follow-up|0|||
163940368|NCT05000216|592152174|FG013|Stage 2|Lost to Follow-up|0|||
163940369|NCT05000216|592152175|FG014|Stage 2|Lost to Follow-up|0|||
163940370|NCT05000216|592152176|FG015|Stage 2|Lost to Follow-up|0|||
163940371|NCT05000216|592152177|FG016|Stage 2|Lost to Follow-up|4|||
163940372|NCT05000216|592152178|FG017|Stage 2|Lost to Follow-up|0|||
163940373|NCT05000216|592152179|FG018|Stage 2|Lost to Follow-up|0|||
163940374|NCT05000216|592152180|FG019|Stage 2|Lost to Follow-up|0|||
163940375|NCT05000216|592152181|FG020|Stage 2|Lost to Follow-up|0|||
163940376|NCT05000216|592152182|FG021|Stage 2|Lost to Follow-up|0|||
163940377|NCT05000216|592152161|FG000|Stage 2|Physician Decision|0|||
163940378|NCT05000216|592152162|FG001|Stage 2|Physician Decision|0|||
163940379|NCT05000216|592152163|FG002|Stage 2|Physician Decision|0|||
163940380|NCT05000216|592152164|FG003|Stage 2|Physician Decision|0|||
163940381|NCT05000216|592152165|FG004|Stage 2|Physician Decision|0|||
163940382|NCT05000216|592152166|FG005|Stage 2|Physician Decision|0|||
163940383|NCT05000216|592152167|FG006|Stage 2|Physician Decision|0|||
163940384|NCT05000216|592152168|FG007|Stage 2|Physician Decision|0|||
163940385|NCT05000216|592152169|FG008|Stage 2|Physician Decision|0|||
163940386|NCT05000216|592152170|FG009|Stage 2|Physician Decision|0|||
163940387|NCT05000216|592152171|FG010|Stage 2|Physician Decision|0|||
163940388|NCT05000216|592152172|FG011|Stage 2|Physician Decision|0|||
164041202|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
164041203|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
164041204|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
164041205|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
164041206|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
164041207|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
164041208|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
164041209|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
164041210|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
164041211|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
164041212|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
164041213|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
164041214|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
164041215|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
164041216|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
164041217|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
164041218|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Other|0|||
164041219|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Other|1|||
164041220|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Other|0|||
164041221|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Other|0|||
164041222|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
164041223|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
164041224|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
164041225|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
164041226|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
164041227|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
164041228|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
164041229|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
164041230|NCT01194414|592510471|FG000|24 Weeks Double Blind Period|Death|0|||
164041231|NCT01194414|592510472|FG001|24 Weeks Double Blind Period|Death|1|||
164041232|NCT01194414|592510473|FG002|24 Weeks Double Blind Period|Death|0|||
164041233|NCT01194414|592510474|FG003|24 Weeks Double Blind Period|Death|0|||
164041234|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
164041235|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
164041236|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
164098881|NCT00624065|592726942|FG000|Overall Study|Consent withdrawn|6|||
163940389|NCT05000216|592152173|FG012|Stage 2|Physician Decision|1|||
163940390|NCT05000216|592152174|FG013|Stage 2|Physician Decision|0|||
163940391|NCT05000216|592152175|FG014|Stage 2|Physician Decision|0|||
163940392|NCT05000216|592152176|FG015|Stage 2|Physician Decision|0|||
163940393|NCT05000216|592152177|FG016|Stage 2|Physician Decision|0|||
163940394|NCT05000216|592152178|FG017|Stage 2|Physician Decision|0|||
163940395|NCT05000216|592152179|FG018|Stage 2|Physician Decision|0|||
163940396|NCT05000216|592152180|FG019|Stage 2|Physician Decision|0|||
163940397|NCT05000216|592152181|FG020|Stage 2|Physician Decision|0|||
163940398|NCT05000216|592152182|FG021|Stage 2|Physician Decision|0|||
163940399|NCT05000216|592152161|FG000|Stage 2|Withdrawal by Subject|0|||
163940400|NCT05000216|592152162|FG001|Stage 2|Withdrawal by Subject|0|||
163940401|NCT05000216|592152163|FG002|Stage 2|Withdrawal by Subject|0|||
163940402|NCT05000216|592152164|FG003|Stage 2|Withdrawal by Subject|0|||
163940403|NCT05000216|592152165|FG004|Stage 2|Withdrawal by Subject|0|||
163940404|NCT05000216|592152166|FG005|Stage 2|Withdrawal by Subject|0|||
163940405|NCT05000216|592152167|FG006|Stage 2|Withdrawal by Subject|0|||
163940406|NCT05000216|592152168|FG007|Stage 2|Withdrawal by Subject|0|||
163940407|NCT05000216|592152169|FG008|Stage 2|Withdrawal by Subject|0|||
163940408|NCT05000216|592152170|FG009|Stage 2|Withdrawal by Subject|0|||
163940409|NCT05000216|592152171|FG010|Stage 2|Withdrawal by Subject|0|||
163940410|NCT05000216|592152172|FG011|Stage 2|Withdrawal by Subject|0|||
163940411|NCT05000216|592152173|FG012|Stage 2|Withdrawal by Subject|0|||
163940412|NCT05000216|592152174|FG013|Stage 2|Withdrawal by Subject|0|||
163940413|NCT05000216|592152175|FG014|Stage 2|Withdrawal by Subject|2|||
163940414|NCT05000216|592152176|FG015|Stage 2|Withdrawal by Subject|0|||
163940415|NCT05000216|592152177|FG016|Stage 2|Withdrawal by Subject|9|||
163940416|NCT05000216|592152178|FG017|Stage 2|Withdrawal by Subject|0|||
163940417|NCT05000216|592152179|FG018|Stage 2|Withdrawal by Subject|0|||
163940418|NCT05000216|592152180|FG019|Stage 2|Withdrawal by Subject|0|||
163940419|NCT05000216|592152181|FG020|Stage 2|Withdrawal by Subject|0|||
163940420|NCT05000216|592152182|FG021|Stage 2|Withdrawal by Subject|0|||
164041237|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
164041238|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
164041239|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
164041240|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
164041241|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
164041242|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
164041243|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
164041244|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
164041245|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
164041246|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
164041247|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
164041248|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
164041249|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
164041250|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
164041251|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
164041252|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
164041253|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
164041254|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
164041255|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
164041256|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
164041257|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
164041258|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Other|2|||
164041259|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Other|1|||
164041260|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Other|0|||
164041261|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Other|0|||
164041262|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
164041263|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
164041264|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
164041265|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
164041266|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
164041267|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
164041268|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
164041269|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
164041270|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
164041271|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
164041272|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
164041273|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
164041274|NCT01194414|592510471|FG000|72 Weeks Open Label Extension|Death|1|||
164041275|NCT01194414|592510472|FG001|72 Weeks Open Label Extension|Death|2|||
164041276|NCT01194414|592510473|FG002|72 Weeks Open Label Extension|Death|0|||
164041277|NCT01194414|592510474|FG003|72 Weeks Open Label Extension|Death|2|||
164041278|NCT01192100|592510475|FG000|Overall Study|Withdrawal by Subject|0|||
164041279|NCT01192100|592510476|FG001|Overall Study|Withdrawal by Subject|0|||
163940421|NCT05000216|592152161|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
163940422|NCT05000216|592152162|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
163940423|NCT05000216|592152163|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
163940424|NCT05000216|592152164|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
163940425|NCT05000216|592152165|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
163940426|NCT05000216|592152166|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
163940427|NCT05000216|592152167|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
163940428|NCT05000216|592152168|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
163940429|NCT05000216|592152169|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
163940430|NCT05000216|592152170|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
163940431|NCT05000216|592152171|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
163940432|NCT05000216|592152172|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
163940433|NCT05000216|592152173|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
163940434|NCT05000216|592152174|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
163940435|NCT05000216|592152175|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
163940436|NCT05000216|592152176|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
163940437|NCT05000216|592152177|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
163940438|NCT05000216|592152178|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
163940439|NCT05000216|592152179|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
163940440|NCT05000216|592152180|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
163940441|NCT05000216|592152181|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
163940442|NCT05000216|592152182|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
163940443|NCT05000216|592152161|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940444|NCT05000216|592152162|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940445|NCT05000216|592152163|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940446|NCT05000216|592152164|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940447|NCT05000216|592152165|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940448|NCT05000216|592152166|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940449|NCT05000216|592152167|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940450|NCT05000216|592152168|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940451|NCT05000216|592152169|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940452|NCT05000216|592152170|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940453|NCT05000216|592152171|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940454|NCT05000216|592152172|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940455|NCT05000216|592152173|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940456|NCT05000216|592152174|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940457|NCT05000216|592152175|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
163940458|NCT05000216|592152176|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940459|NCT05000216|592152177|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
163940460|NCT05000216|592152178|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940461|NCT05000216|592152179|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940462|NCT05000216|592152180|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940463|NCT05000216|592152181|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940464|NCT05000216|592152182|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
163940465|NCT05000216|592152161|FG000|Stage 2|Other reason|0|||
163940466|NCT05000216|592152162|FG001|Stage 2|Other reason|0|||
163940467|NCT05000216|592152163|FG002|Stage 2|Other reason|0|||
163940468|NCT05000216|592152164|FG003|Stage 2|Other reason|0|||
163940469|NCT05000216|592152165|FG004|Stage 2|Other reason|0|||
163940470|NCT05000216|592152166|FG005|Stage 2|Other reason|0|||
163940471|NCT05000216|592152167|FG006|Stage 2|Other reason|0|||
163940472|NCT05000216|592152168|FG007|Stage 2|Other reason|0|||
163940473|NCT05000216|592152169|FG008|Stage 2|Other reason|0|||
163940474|NCT05000216|592152170|FG009|Stage 2|Other reason|0|||
163940475|NCT05000216|592152171|FG010|Stage 2|Other reason|0|||
163940476|NCT05000216|592152172|FG011|Stage 2|Other reason|0|||
163940477|NCT05000216|592152173|FG012|Stage 2|Other reason|0|||
163940478|NCT05000216|592152174|FG013|Stage 2|Other reason|0|||
163940479|NCT05000216|592152175|FG014|Stage 2|Other reason|0|||
163940480|NCT05000216|592152176|FG015|Stage 2|Other reason|0|||
163940481|NCT05000216|592152177|FG016|Stage 2|Other reason|1|||
163940482|NCT05000216|592152178|FG017|Stage 2|Other reason|0|||
163940483|NCT05000216|592152179|FG018|Stage 2|Other reason|0|||
163940484|NCT05000216|592152180|FG019|Stage 2|Other reason|0|||
163940485|NCT05000216|592152181|FG020|Stage 2|Other reason|0|||
163940486|NCT05000216|592152182|FG021|Stage 2|Other reason|0|||
163940487|NCT05000216|592152161|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
163940488|NCT05000216|592152162|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
163940489|NCT05000216|592152163|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
163940490|NCT05000216|592152164|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
163940491|NCT05000216|592152165|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
163940492|NCT05000216|592152166|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
163940493|NCT05000216|592152167|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
163940494|NCT05000216|592152168|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
163940495|NCT05000216|592152169|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
163940496|NCT05000216|592152170|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
163940497|NCT05000216|592152171|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
164098882|NCT00624065|592726943|FG001|Overall Study|Consent withdrawn|5|||
163940498|NCT05000216|592152172|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
163940499|NCT05000216|592152173|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
163940500|NCT05000216|592152174|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
163940501|NCT05000216|592152175|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
163940502|NCT05000216|592152176|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
163940503|NCT05000216|592152177|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
163940504|NCT05000216|592152178|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
163940505|NCT05000216|592152179|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
163940506|NCT05000216|592152180|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
163940507|NCT05000216|592152181|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
163940508|NCT05000216|592152182|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
163940509|NCT05000216|592152161|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940510|NCT05000216|592152162|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940511|NCT05000216|592152163|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940512|NCT05000216|592152164|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940513|NCT05000216|592152165|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940514|NCT05000216|592152166|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940515|NCT05000216|592152167|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940516|NCT05000216|592152168|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940517|NCT05000216|592152169|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940518|NCT05000216|592152170|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940519|NCT05000216|592152171|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940520|NCT05000216|592152172|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940521|NCT05000216|592152173|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940522|NCT05000216|592152174|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940523|NCT05000216|592152175|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940524|NCT05000216|592152176|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
163940525|NCT05000216|592152177|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940526|NCT05000216|592152178|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940527|NCT05000216|592152179|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940528|NCT05000216|592152180|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940529|NCT05000216|592152181|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940530|NCT05000216|592152182|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
163940531|NCT05000216|592152161|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940532|NCT05000216|592152162|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940533|NCT05000216|592152163|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940534|NCT05000216|592152164|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940535|NCT05000216|592152165|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940536|NCT05000216|592152166|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940537|NCT05000216|592152167|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940538|NCT05000216|592152168|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940539|NCT05000216|592152169|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940540|NCT05000216|592152170|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940541|NCT05000216|592152171|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940542|NCT05000216|592152172|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940543|NCT05000216|592152173|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940544|NCT05000216|592152174|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
163940545|NCT05000216|592152175|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940546|NCT05000216|592152176|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
163940547|NCT05000216|592152177|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940548|NCT05000216|592152178|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940549|NCT05000216|592152179|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
163940550|NCT05000216|592152180|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940551|NCT05000216|592152181|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940552|NCT05000216|592152182|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
163940553|NCT03435692|592152183|FG000|Overall Study|Lack of Efficacy|2|||
163940554|NCT03435692|592152184|FG001|Overall Study|Lack of Efficacy|2|||
163940555|NCT03435692|592152185|FG002|Overall Study|Lack of Efficacy|0|||
163940556|NCT00967005|592152186|FG000|Overall Study|Lost to Follow-up|7|||
163940557|NCT00967005|592152187|FG001|Overall Study|Lost to Follow-up|10|||
164041280|NCT01192100|592510477|FG002|Overall Study|Withdrawal by Subject|0|||
163940558|NCT02593123|592152188|FG000|Overall Study|Physician Decision|2|||
163940559|NCT02593123|592152189|FG001|Overall Study|Physician Decision|1|||
163940560|NCT02593123|592152188|FG000|Overall Study|Relapse|1|||
164041281|NCT01192100|592510478|FG003|Overall Study|Withdrawal by Subject|0|||
164041282|NCT01192100|592510479|FG004|Overall Study|Withdrawal by Subject|1|||
163940561|NCT02593123|592152189|FG001|Overall Study|Relapse|1|||
163940562|NCT05071053|592152190|FG000|Overall Study|Progressive disease|30|||
163940563|NCT05071053|592152190|FG000|Overall Study|Adverse Event|5|||
164041283|NCT01192100|592510480|FG005|Overall Study|Withdrawal by Subject|0|||
164041284|NCT01192100|592510475|FG000|Overall Study|Protocol Violation|0|||
163940564|NCT01038427|592152191|FG000|Overall Study|Lost to follow up|1|||
163940565|NCT01038427|592152192|FG001|Overall Study|Lost to follow up|1|||
163940566|NCT01038427|592152193|FG002|Overall Study|Lost to follow up|0|||
163940567|NCT01038427|592152191|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163940568|NCT01038427|592152192|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
163940569|NCT01038427|592152193|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
164041285|NCT01192100|592510476|FG001|Overall Study|Protocol Violation|0|||
163940570|NCT01038427|592152191|FG000|Overall Study|Withdrew consent|0|||
163940571|NCT01038427|592152192|FG001|Overall Study|Withdrew consent|0|||
163940572|NCT01038427|592152193|FG002|Overall Study|Withdrew consent|1|||
163940573|NCT01038427|592152191|FG000|Overall Study|Adverse Event|2|||
163940574|NCT01038427|592152192|FG001|Overall Study|Adverse Event|2|||
163940575|NCT01038427|592152193|FG002|Overall Study|Adverse Event|1|||
163940576|NCT01038427|592152191|FG000|Overall Study|Enrolled in error|0|||
163940577|NCT01038427|592152192|FG001|Overall Study|Enrolled in error|1|||
163940578|NCT01038427|592152193|FG002|Overall Study|Enrolled in error|1|||
163940579|NCT01038427|592152191|FG000|Overall Study|Other|0|||
163940580|NCT01038427|592152192|FG001|Overall Study|Other|2|||
163940581|NCT01038427|592152193|FG002|Overall Study|Other|0|||
163940582|NCT03538938|592152194|FG000|Overall Study|Death|0|||
163940583|NCT03538938|592152195|FG001|Overall Study|Death|0|||
163940584|NCT03538938|592152196|FG002|Overall Study|Death|2|||
163940585|NCT03538938|592152197|FG003|Overall Study|Death|0|||
163940586|NCT03538938|592152198|FG004|Overall Study|Death|0|||
163940587|NCT03538938|592152199|FG005|Overall Study|Death|1|||
163940588|NCT03538938|592152200|FG006|Overall Study|Death|0|||
163940589|NCT03538938|592152201|FG007|Overall Study|Death|1|||
163940590|NCT03538938|592152202|FG008|Overall Study|Death|1|||
163940591|NCT03538938|592152203|FG009|Overall Study|Death|1|||
163940592|NCT03538938|592152204|FG010|Overall Study|Death|0|||
163940593|NCT03538938|592152205|FG011|Overall Study|Death|0|||
163940594|NCT03538938|592152206|FG012|Overall Study|Death|1|||
163940595|NCT03538938|592152207|FG013|Overall Study|Death|1|||
163940596|NCT03538938|592152208|FG014|Overall Study|Death|0|||
163940597|NCT03538938|592152209|FG015|Overall Study|Death|1|||
163940598|NCT03538938|592152194|FG000|Overall Study|Withdrawal by Subject|4|||
163940599|NCT03538938|592152195|FG001|Overall Study|Withdrawal by Subject|6|||
163940600|NCT03538938|592152196|FG002|Overall Study|Withdrawal by Subject|5|||
163940601|NCT03538938|592152197|FG003|Overall Study|Withdrawal by Subject|3|||
163940602|NCT03538938|592152198|FG004|Overall Study|Withdrawal by Subject|0|||
163940603|NCT03538938|592152199|FG005|Overall Study|Withdrawal by Subject|0|||
163940604|NCT03538938|592152200|FG006|Overall Study|Withdrawal by Subject|3|||
163940605|NCT03538938|592152201|FG007|Overall Study|Withdrawal by Subject|1|||
163940606|NCT03538938|592152202|FG008|Overall Study|Withdrawal by Subject|5|||
163940607|NCT03538938|592152203|FG009|Overall Study|Withdrawal by Subject|1|||
163940608|NCT03538938|592152204|FG010|Overall Study|Withdrawal by Subject|2|||
163940609|NCT03538938|592152205|FG011|Overall Study|Withdrawal by Subject|1|||
163940610|NCT03538938|592152206|FG012|Overall Study|Withdrawal by Subject|3|||
163940611|NCT03538938|592152207|FG013|Overall Study|Withdrawal by Subject|0|||
163940612|NCT03538938|592152208|FG014|Overall Study|Withdrawal by Subject|2|||
163940613|NCT03538938|592152209|FG015|Overall Study|Withdrawal by Subject|4|||
163940614|NCT03538938|592152194|FG000|Overall Study|Incarcerated|0|||
163940615|NCT03538938|592152195|FG001|Overall Study|Incarcerated|0|||
163940616|NCT03538938|592152196|FG002|Overall Study|Incarcerated|0|||
163940617|NCT03538938|592152197|FG003|Overall Study|Incarcerated|0|||
163940618|NCT03538938|592152198|FG004|Overall Study|Incarcerated|0|||
163940619|NCT03538938|592152199|FG005|Overall Study|Incarcerated|0|||
163940620|NCT03538938|592152200|FG006|Overall Study|Incarcerated|0|||
163940621|NCT03538938|592152201|FG007|Overall Study|Incarcerated|0|||
163940622|NCT03538938|592152202|FG008|Overall Study|Incarcerated|0|||
163940623|NCT03538938|592152203|FG009|Overall Study|Incarcerated|0|||
163940624|NCT03538938|592152204|FG010|Overall Study|Incarcerated|0|||
163940625|NCT03538938|592152205|FG011|Overall Study|Incarcerated|1|||
163940626|NCT03538938|592152206|FG012|Overall Study|Incarcerated|0|||
163940627|NCT03538938|592152207|FG013|Overall Study|Incarcerated|0|||
163940628|NCT03538938|592152208|FG014|Overall Study|Incarcerated|0|||
163940629|NCT03538938|592152209|FG015|Overall Study|Incarcerated|0|||
163940630|NCT00755105|592152210|FG000|Overall Study|Withdrawal by Subject|9|||
163940631|NCT00755105|592152211|FG001|Overall Study|Withdrawal by Subject|11|||
163940632|NCT00755105|592152212|FG002|Overall Study|Withdrawal by Subject|4|||
163940633|NCT03995316|592152213|FG000|Overall Study|Lost to Follow-up|10|||
163940634|NCT03995316|592152214|FG001|Overall Study|Lost to Follow-up|3|||
163940635|NCT02202785|592152215|FG000|Overall Study|Study Terminated by Sponsor|1|||
164041286|NCT01192100|592510477|FG002|Overall Study|Protocol Violation|0|||
163940636|NCT02202785|592152216|FG001|Overall Study|Study Terminated by Sponsor|6|||
163940637|NCT02202785|592152217|FG002|Overall Study|Study Terminated by Sponsor|4|||
163940638|NCT02202785|592152215|FG000|Overall Study|Withdrawal by Subject|0|||
163940639|NCT02202785|592152216|FG001|Overall Study|Withdrawal by Subject|1|||
163940640|NCT02202785|592152217|FG002|Overall Study|Withdrawal by Subject|0|||
163940641|NCT02202785|592152215|FG000|Overall Study|Lost to Follow-up|0|||
163940642|NCT02202785|592152216|FG001|Overall Study|Lost to Follow-up|1|||
163940643|NCT02202785|592152217|FG002|Overall Study|Lost to Follow-up|0|||
163940644|NCT02202785|592152215|FG000|Overall Study|Reason not Specified|10|||
163940645|NCT02202785|592152216|FG001|Overall Study|Reason not Specified|7|||
163940646|NCT02202785|592152217|FG002|Overall Study|Reason not Specified|13|||
163940647|NCT03945825|592152224|FG000|Overall Study|Enrolled but treatment not administered|0|||
163940648|NCT03945825|592152225|FG001|Overall Study|Enrolled but treatment not administered|0|||
163940649|NCT03945825|592152226|FG002|Overall Study|Enrolled but treatment not administered|0|||
163940650|NCT03945825|592152227|FG003|Overall Study|Enrolled but treatment not administered|0|||
163940651|NCT03945825|592152228|FG004|Overall Study|Enrolled but treatment not administered|1|||
163940652|NCT03945825|592152229|FG005|Overall Study|Enrolled but treatment not administered|0|||
163940653|NCT03945825|592152224|FG000|Overall Study|Lost to Follow-up|1|||
163940654|NCT03945825|592152225|FG001|Overall Study|Lost to Follow-up|5|||
163940655|NCT03945825|592152226|FG002|Overall Study|Lost to Follow-up|0|||
163940656|NCT03945825|592152227|FG003|Overall Study|Lost to Follow-up|1|||
163940657|NCT03945825|592152228|FG004|Overall Study|Lost to Follow-up|2|||
163940658|NCT03945825|592152229|FG005|Overall Study|Lost to Follow-up|2|||
163940659|NCT03945825|592152224|FG000|Overall Study|Withdrawal by Subject|1|||
163940660|NCT03945825|592152225|FG001|Overall Study|Withdrawal by Subject|0|||
163940661|NCT03945825|592152226|FG002|Overall Study|Withdrawal by Subject|1|||
163940662|NCT03945825|592152227|FG003|Overall Study|Withdrawal by Subject|1|||
163940663|NCT03945825|592152228|FG004|Overall Study|Withdrawal by Subject|0|||
163940664|NCT03945825|592152229|FG005|Overall Study|Withdrawal by Subject|1|||
163940665|NCT00664534|592152232|FG000|Overall Study|Adverse Event|2|||
163940666|NCT00664534|592152233|FG001|Overall Study|Adverse Event|3|||
163940667|NCT00664534|592152232|FG000|Overall Study|Lost to Follow-up|6|||
163940668|NCT00664534|592152233|FG001|Overall Study|Lost to Follow-up|10|||
163940669|NCT00664534|592152232|FG000|Overall Study|Protocol Violation|10|||
163940670|NCT00664534|592152233|FG001|Overall Study|Protocol Violation|8|||
163940671|NCT00664534|592152232|FG000|Overall Study|Withdrawal by Subject|7|||
163940672|NCT00664534|592152233|FG001|Overall Study|Withdrawal by Subject|6|||
163940673|NCT00664534|592152232|FG000|Overall Study|Physician Decision|8|||
163940674|NCT00664534|592152233|FG001|Overall Study|Physician Decision|0|||
163940675|NCT00664534|592152232|FG000|Overall Study|Sponsor decision|8|||
163940676|NCT00664534|592152233|FG001|Overall Study|Sponsor decision|6|||
163940677|NCT00600613|592152234|FG000|Overall Study|Protocol Deviation|1|||
163940678|NCT03041792|592152237|FG000|Overall Study|Adverse Event|4|||
163940679|NCT03041792|592152238|FG001|Overall Study|Adverse Event|0|||
163940680|NCT03041792|592152237|FG000|Overall Study|Death in the family|0|||
163940681|NCT03041792|592152238|FG001|Overall Study|Death in the family|2|||
163940682|NCT03041792|592152237|FG000|Overall Study|Randomized but not treated|0|||
163940683|NCT03041792|592152238|FG001|Overall Study|Randomized but not treated|1|||
163940684|NCT00935532|592152239|FG000|Overall Study|Adverse Event|11|||
163940685|NCT00935532|592152240|FG001|Overall Study|Adverse Event|6|||
163940686|NCT00935532|592152239|FG000|Overall Study|Death|1|||
163940687|NCT00935532|592152240|FG001|Overall Study|Death|0|||
163940688|NCT00935532|592152239|FG000|Overall Study|Lost to Follow-up|1|||
163940689|NCT00935532|592152240|FG001|Overall Study|Lost to Follow-up|0|||
163940690|NCT00935532|592152239|FG000|Overall Study|Physician Decision|1|||
163940691|NCT00935532|592152240|FG001|Overall Study|Physician Decision|2|||
163940692|NCT00935532|592152239|FG000|Overall Study|Protocol Violation|2|||
163940693|NCT00935532|592152240|FG001|Overall Study|Protocol Violation|1|||
163940694|NCT00935532|592152239|FG000|Overall Study|Subject Decision|2|||
163940695|NCT00935532|592152240|FG001|Overall Study|Subject Decision|1|||
163940696|NCT00935532|592152239|FG000|Overall Study|Sponsor Decision|0|||
163940697|NCT00935532|592152240|FG001|Overall Study|Sponsor Decision|1|||
163940698|NCT00935532|592152239|FG000|Overall Study|Loss Glucose Control|4|||
163940699|NCT00935532|592152240|FG001|Overall Study|Loss Glucose Control|0|||
163940700|NCT01399918|592152242|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
163940701|NCT00245960|592152243|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
163940702|NCT00245960|592152244|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
163940703|NCT00245960|592152243|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
163940704|NCT00245960|592152244|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
163940705|NCT00245960|592152243|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
163940706|NCT00245960|592152244|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
163940707|NCT00245960|592152243|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
163940708|NCT00245960|592152244|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
163940709|NCT00245960|592152243|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
163940710|NCT00245960|592152244|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
163940711|NCT00245960|592152243|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
164098883|NCT00624065|592726942|FG000|Overall Study|Lack of Efficacy|0|||
164098884|NCT00624065|592726943|FG001|Overall Study|Lack of Efficacy|3|||
163940712|NCT00245960|592152244|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
163940713|NCT00245960|592152243|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
163940714|NCT00245960|592152244|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
163940715|NCT00245960|592152243|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
163940716|NCT00245960|592152244|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
163940717|NCT00245960|592152243|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
163940718|NCT00245960|592152244|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
163940719|NCT00245960|592152243|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
164098885|NCT00624065|592726942|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
164147704|NCT02006732|592902130|FG001|Overall Study|Protocol Violation|1|||
163940720|NCT00245960|592152244|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
163940721|NCT00245960|592152243|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
163940722|NCT00245960|592152244|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
163940723|NCT00245960|592152243|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
163940724|NCT00245960|592152244|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
163940725|NCT01436253|592152245|FG000|Overall Study|Lost to Follow-up|182|||
163940726|NCT01436253|592152245|FG000|Overall Study|Not meeting all eligibility criteria|117|||
163940727|NCT03083665|592152246|FG000|Double-Blind Period|Adverse Event|5|||
163940728|NCT03083665|592152247|FG001|Double-Blind Period|Adverse Event|4|||
163940729|NCT03083665|592152248|FG002|Double-Blind Period|Adverse Event|5|||
163940730|NCT03083665|592152249|FG003|Double-Blind Period|Adverse Event|0|||
163940731|NCT03083665|592152250|FG004|Double-Blind Period|Adverse Event|0|||
163940732|NCT03083665|592152251|FG005|Double-Blind Period|Adverse Event|0|||
163940733|NCT03083665|592152246|FG000|Double-Blind Period|Lack of Efficacy|0|||
163940734|NCT03083665|592152247|FG001|Double-Blind Period|Lack of Efficacy|0|||
163940735|NCT03083665|592152248|FG002|Double-Blind Period|Lack of Efficacy|1|||
163940736|NCT03083665|592152249|FG003|Double-Blind Period|Lack of Efficacy|0|||
163940737|NCT03083665|592152250|FG004|Double-Blind Period|Lack of Efficacy|0|||
163940738|NCT03083665|592152251|FG005|Double-Blind Period|Lack of Efficacy|0|||
163940739|NCT03083665|592152246|FG000|Double-Blind Period|Protocol Violation|1|||
163940740|NCT03083665|592152247|FG001|Double-Blind Period|Protocol Violation|0|||
163940741|NCT03083665|592152248|FG002|Double-Blind Period|Protocol Violation|1|||
163940742|NCT03083665|592152249|FG003|Double-Blind Period|Protocol Violation|0|||
163940743|NCT03083665|592152250|FG004|Double-Blind Period|Protocol Violation|0|||
163940744|NCT03083665|592152251|FG005|Double-Blind Period|Protocol Violation|0|||
163940745|NCT03083665|592152246|FG000|Double-Blind Period|Lost to Follow-up|1|||
163940746|NCT03083665|592152247|FG001|Double-Blind Period|Lost to Follow-up|0|||
163940747|NCT03083665|592152248|FG002|Double-Blind Period|Lost to Follow-up|1|||
163940748|NCT03083665|592152249|FG003|Double-Blind Period|Lost to Follow-up|0|||
163940749|NCT03083665|592152250|FG004|Double-Blind Period|Lost to Follow-up|0|||
163940750|NCT03083665|592152251|FG005|Double-Blind Period|Lost to Follow-up|0|||
163940751|NCT03083665|592152246|FG000|Double-Blind Period|Withdrawal by Subject|3|||
163940752|NCT03083665|592152247|FG001|Double-Blind Period|Withdrawal by Subject|0|||
163940753|NCT03083665|592152248|FG002|Double-Blind Period|Withdrawal by Subject|0|||
163940754|NCT03083665|592152249|FG003|Double-Blind Period|Withdrawal by Subject|0|||
163940755|NCT03083665|592152250|FG004|Double-Blind Period|Withdrawal by Subject|0|||
163940756|NCT03083665|592152251|FG005|Double-Blind Period|Withdrawal by Subject|0|||
163940757|NCT03083665|592152246|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
163940758|NCT03083665|592152247|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163940759|NCT03083665|592152248|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163940760|NCT03083665|592152249|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163940761|NCT03083665|592152250|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163940762|NCT03083665|592152251|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
163940763|NCT03083665|592152246|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
163940764|NCT03083665|592152247|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
163940765|NCT03083665|592152248|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
163940766|NCT03083665|592152249|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
163940767|NCT03083665|592152250|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
163940768|NCT03083665|592152251|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
163940769|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163940770|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163940771|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163940772|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
163940773|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163940774|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
163940775|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163940776|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163940777|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163940778|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163940779|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
163940780|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
163940781|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
163940782|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
163940783|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
163940784|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
163940785|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
164041287|NCT01192100|592510478|FG003|Overall Study|Protocol Violation|1|||
163940786|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
163940787|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163940788|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163940789|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163940790|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163940791|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
163940792|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
163940793|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163940794|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163940795|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163940796|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
163940797|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163940798|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
163940799|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163940800|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163940801|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163940802|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163940803|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
163940804|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
163940805|NCT03083665|592152246|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163940806|NCT03083665|592152247|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163940807|NCT03083665|592152248|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163940808|NCT03083665|592152249|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163940809|NCT03083665|592152250|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
163940810|NCT03083665|592152251|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
163940811|NCT02519348|592152252|FG000|Overall Study|Death|31|||
163940812|NCT02519348|592152253|FG001|Overall Study|Death|74|||
163940813|NCT02519348|592152254|FG002|Overall Study|Death|47|||
163940814|NCT02519348|592152255|FG003|Overall Study|Death|54|||
163940815|NCT02519348|592152256|FG004|Overall Study|Death|63|||
163940816|NCT02519348|592152257|FG005|Overall Study|Death|18|||
163940817|NCT02519348|592152258|FG006|Overall Study|Death|2|||
163940818|NCT02519348|592152259|FG007|Overall Study|Death|5|||
163940819|NCT02519348|592152260|FG008|Overall Study|Death|5|||
163940820|NCT02519348|592152252|FG000|Overall Study|Withdrawal by Subject|4|||
163940821|NCT02519348|592152253|FG001|Overall Study|Withdrawal by Subject|7|||
163940822|NCT02519348|592152254|FG002|Overall Study|Withdrawal by Subject|4|||
163940823|NCT02519348|592152255|FG003|Overall Study|Withdrawal by Subject|3|||
163940824|NCT02519348|592152256|FG004|Overall Study|Withdrawal by Subject|3|||
163940825|NCT02519348|592152257|FG005|Overall Study|Withdrawal by Subject|2|||
163940826|NCT02519348|592152258|FG006|Overall Study|Withdrawal by Subject|0|||
163940827|NCT02519348|592152259|FG007|Overall Study|Withdrawal by Subject|0|||
163940828|NCT02519348|592152260|FG008|Overall Study|Withdrawal by Subject|1|||
163940829|NCT02519348|592152252|FG000|Overall Study|Lost to Follow-up|0|||
163940830|NCT02519348|592152253|FG001|Overall Study|Lost to Follow-up|0|||
163940831|NCT02519348|592152254|FG002|Overall Study|Lost to Follow-up|1|||
163940832|NCT02519348|592152255|FG003|Overall Study|Lost to Follow-up|0|||
163940833|NCT02519348|592152256|FG004|Overall Study|Lost to Follow-up|2|||
163940834|NCT02519348|592152257|FG005|Overall Study|Lost to Follow-up|1|||
163940835|NCT02519348|592152258|FG006|Overall Study|Lost to Follow-up|1|||
163940836|NCT02519348|592152259|FG007|Overall Study|Lost to Follow-up|0|||
163940837|NCT02519348|592152260|FG008|Overall Study|Lost to Follow-up|0|||
163940838|NCT02519348|592152252|FG000|Overall Study|Other|0|||
163940839|NCT02519348|592152253|FG001|Overall Study|Other|3|||
163940840|NCT02519348|592152254|FG002|Overall Study|Other|0|||
163940841|NCT02519348|592152255|FG003|Overall Study|Other|0|||
163940842|NCT02519348|592152256|FG004|Overall Study|Other|1|||
163940843|NCT02519348|592152257|FG005|Overall Study|Other|0|||
163940844|NCT02519348|592152258|FG006|Overall Study|Other|0|||
164041288|NCT01192100|592510479|FG004|Overall Study|Protocol Violation|0|||
164041289|NCT01192100|592510480|FG005|Overall Study|Protocol Violation|0|||
164041290|NCT02057068|592510481|FG000|Overall Study|Withdrawal by Subject|2|||
164041291|NCT02057068|592510482|FG001|Overall Study|Withdrawal by Subject|2|||
164041292|NCT02057068|592510481|FG000|Overall Study|Caregiver (CG) Health|0|||
164041293|NCT02057068|592510482|FG001|Overall Study|Caregiver (CG) Health|2|||
163940845|NCT02519348|592152259|FG007|Overall Study|Other|0|||
163940846|NCT02519348|592152260|FG008|Overall Study|Other|0|||
163940847|NCT02519348|592152252|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
163940848|NCT02519348|592152253|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
163940849|NCT02519348|592152254|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
163940850|NCT02519348|592152255|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
164041294|NCT02057068|592510481|FG000|Overall Study|Carepartner (CP) Health|4|||
164041295|NCT02057068|592510482|FG001|Overall Study|Carepartner (CP) Health|2|||
164041296|NCT02057068|592510481|FG000|Overall Study|Lost to Follow-up|2|||
164041297|NCT02057068|592510482|FG001|Overall Study|Lost to Follow-up|2|||
164041298|NCT01098032|592510485|FG000|Overall Study|Withdrawal by Subject|1|||
164041299|NCT01098032|592510486|FG001|Overall Study|Withdrawal by Subject|1|||
164041300|NCT00841672|592510492|FG000|Overall Study|Adverse Event|7|||
164041301|NCT00841672|592510493|FG001|Overall Study|Adverse Event|16|||
164041302|NCT00841672|592510492|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164041303|NCT00841672|592510493|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164041304|NCT00841672|592510492|FG000|Overall Study|Subject withdrew consent|2|||
164041305|NCT00841672|592510493|FG001|Overall Study|Subject withdrew consent|4|||
164041306|NCT00841672|592510492|FG000|Overall Study|Lost to Follow-up|1|||
164041307|NCT00841672|592510493|FG001|Overall Study|Lost to Follow-up|1|||
164041308|NCT00841672|592510492|FG000|Overall Study|Administrative problems|9|||
164041309|NCT00841672|592510493|FG001|Overall Study|Administrative problems|9|||
164041310|NCT00841672|592510492|FG000|Overall Study|Misrandomized|1|||
164041311|NCT00841672|592510493|FG001|Overall Study|Misrandomized|0|||
164041312|NCT00841672|592510492|FG000|Overall Study|Protocol Deviation|0|||
164041313|NCT00841672|592510493|FG001|Overall Study|Protocol Deviation|1|||
164041314|NCT05563714|592510494|FG000|Overall Study|Death|2|||
164041315|NCT05563714|592510495|FG001|Overall Study|Death|2|||
164041316|NCT05563714|592510496|FG002|Overall Study|Death|0|||
164041317|NCT05563714|592510497|FG003|Overall Study|Death|0|||
164041318|NCT05563714|592510494|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
164041319|NCT05563714|592510495|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
164041320|NCT05563714|592510496|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
164041321|NCT05563714|592510497|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
164041322|NCT05563714|592510494|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
164041323|NCT05563714|592510495|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
164041324|NCT05563714|592510496|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
164041325|NCT05563714|592510497|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
164041326|NCT05563714|592510494|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
164041327|NCT05563714|592510495|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
164041328|NCT05563714|592510496|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
164041329|NCT05563714|592510497|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
164041330|NCT05563714|592510494|FG000|Overall Study|Lost to Follow-up|22|||
164041331|NCT05563714|592510495|FG001|Overall Study|Lost to Follow-up|19|||
164041332|NCT05563714|592510496|FG002|Overall Study|Lost to Follow-up|0|||
164041333|NCT05563714|592510497|FG003|Overall Study|Lost to Follow-up|0|||
164098886|NCT00624065|592726943|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
163840837|NCT01372605|591787454|FG000|Overall Study|Changed medical home|2|||
163840838|NCT01372605|591787455|FG001|Overall Study|Changed medical home|0|||
163840839|NCT01830881|591787459|FG000|Overall Study|Changed decision to have an abortion|0|||
163840840|NCT01830881|591787460|FG001|Overall Study|Changed decision to have an abortion|1|||
163840841|NCT00734214|591787461|FG000|Overall Study|Withdrawal by Subject|3|||
163840842|NCT00734214|591787462|FG001|Overall Study|Withdrawal by Subject|4|||
163840843|NCT00734214|591787461|FG000|Overall Study|MD withdrawal|1|||
163840844|NCT00734214|591787462|FG001|Overall Study|MD withdrawal|0|||
163840845|NCT01320735|591787463|FG000|Overall Study|Adverse Event|3|||
163840846|NCT01320735|591787463|FG000|Overall Study|Withdrawal by Subject|3|||
163840847|NCT01320735|591787463|FG000|Overall Study|Lost to Follow-up|13|||
163840848|NCT01320735|591787463|FG000|Overall Study|Administrative Reason|6|||
163840849|NCT01320735|591787463|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
163840850|NCT01320735|591787463|FG000|Overall Study|Protocol Violation|1|||
163840851|NCT01320735|591787463|FG000|Overall Study|Other|1|||
163840852|NCT01320735|591787463|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
163840853|NCT01320735|591787463|FG000|Overall Study|Investigator Unable to be Contacted|17|||
163840854|NCT04599101|591787464|FG000|Overall Study|Lost to Follow-up|5|||
163840855|NCT04599101|591787465|FG001|Overall Study|Lost to Follow-up|5|||
163840856|NCT05952297|591787466|FG000|Overall Study|Withdrawal by Subject|1|||
163840857|NCT05952297|591787467|FG001|Overall Study|Withdrawal by Subject|0|||
163840858|NCT03856996|591787468|FG000|Overall Study|Withdrawal by Subject|1|||
163840859|NCT03856996|591787469|FG001|Overall Study|Withdrawal by Subject|0|||
163840860|NCT03856996|591787468|FG000|Overall Study|Lost to Follow-up|0|||
163840861|NCT03856996|591787469|FG001|Overall Study|Lost to Follow-up|1|||
163840862|NCT03856996|591787468|FG000|Overall Study|Adverse Event|1|||
163840863|NCT03856996|591787469|FG001|Overall Study|Adverse Event|1|||
163840864|NCT03856996|591787468|FG000|Overall Study|Other|1|||
163840865|NCT03856996|591787469|FG001|Overall Study|Other|0|||
163840866|NCT04362137|591787472|FG000|Overall Study|Death|9|||
163840867|NCT04362137|591787473|FG001|Overall Study|Death|3|||
163940851|NCT02519348|592152256|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
163940852|NCT02519348|592152257|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
163940853|NCT02519348|592152258|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
163940854|NCT02519348|592152259|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
163940855|NCT02519348|592152260|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
163940856|NCT03635099|592152261|FG000|Period 1|Adverse Event|1|||
163940857|NCT03635099|592152262|FG001|Period 1|Adverse Event|0|||
163940858|NCT03635099|592152263|FG002|Period 1|Adverse Event|0|||
163940859|NCT03635099|592152264|FG003|Period 1|Adverse Event|1|||
163940860|NCT03635099|592152265|FG004|Period 1|Adverse Event|0|||
163940861|NCT03635099|592152266|FG005|Period 1|Adverse Event|0|||
163940862|NCT03635099|592152267|FG006|Period 1|Adverse Event|0|||
163940863|NCT03635099|592152268|FG007|Period 1|Adverse Event|0|||
163940864|NCT03635099|592152261|FG000|Period 1|Protocol Violation|0|||
163940865|NCT03635099|592152262|FG001|Period 1|Protocol Violation|0|||
163940866|NCT03635099|592152263|FG002|Period 1|Protocol Violation|1|||
163940867|NCT03635099|592152264|FG003|Period 1|Protocol Violation|0|||
163940868|NCT03635099|592152265|FG004|Period 1|Protocol Violation|0|||
163940869|NCT03635099|592152266|FG005|Period 1|Protocol Violation|0|||
163940870|NCT03635099|592152267|FG006|Period 1|Protocol Violation|0|||
163940871|NCT03635099|592152268|FG007|Period 1|Protocol Violation|0|||
163940872|NCT03635099|592152261|FG000|Period 1|Lost to Follow-up|0|||
163940873|NCT03635099|592152262|FG001|Period 1|Lost to Follow-up|0|||
163940874|NCT03635099|592152263|FG002|Period 1|Lost to Follow-up|1|||
163940875|NCT03635099|592152264|FG003|Period 1|Lost to Follow-up|2|||
163940876|NCT03635099|592152265|FG004|Period 1|Lost to Follow-up|1|||
163940877|NCT03635099|592152266|FG005|Period 1|Lost to Follow-up|0|||
163940878|NCT03635099|592152267|FG006|Period 1|Lost to Follow-up|1|||
163940879|NCT03635099|592152268|FG007|Period 1|Lost to Follow-up|2|||
163940880|NCT03635099|592152261|FG000|Period 1|Withdrawal by Subject|3|||
163940881|NCT03635099|592152262|FG001|Period 1|Withdrawal by Subject|3|||
163940882|NCT03635099|592152263|FG002|Period 1|Withdrawal by Subject|5|||
163940883|NCT03635099|592152264|FG003|Period 1|Withdrawal by Subject|2|||
163940884|NCT03635099|592152265|FG004|Period 1|Withdrawal by Subject|2|||
163940885|NCT03635099|592152266|FG005|Period 1|Withdrawal by Subject|0|||
163940886|NCT03635099|592152267|FG006|Period 1|Withdrawal by Subject|3|||
163940887|NCT03635099|592152268|FG007|Period 1|Withdrawal by Subject|0|||
163940888|NCT03635099|592152261|FG000|Period 1|History of suicidal ideation|0|||
163940889|NCT03635099|592152262|FG001|Period 1|History of suicidal ideation|0|||
163940890|NCT03635099|592152263|FG002|Period 1|History of suicidal ideation|1|||
163940891|NCT03635099|592152264|FG003|Period 1|History of suicidal ideation|0|||
163940892|NCT03635099|592152265|FG004|Period 1|History of suicidal ideation|0|||
163940893|NCT03635099|592152266|FG005|Period 1|History of suicidal ideation|0|||
163940894|NCT03635099|592152267|FG006|Period 1|History of suicidal ideation|0|||
163940895|NCT03635099|592152268|FG007|Period 1|History of suicidal ideation|0|||
163940896|NCT03635099|592152261|FG000|Period 1|pursue other treatment options|0|||
163940897|NCT03635099|592152262|FG001|Period 1|pursue other treatment options|0|||
163940898|NCT03635099|592152263|FG002|Period 1|pursue other treatment options|0|||
163940899|NCT03635099|592152264|FG003|Period 1|pursue other treatment options|0|||
163940900|NCT03635099|592152265|FG004|Period 1|pursue other treatment options|0|||
163940901|NCT03635099|592152266|FG005|Period 1|pursue other treatment options|1|||
163940902|NCT03635099|592152267|FG006|Period 1|pursue other treatment options|0|||
163940903|NCT03635099|592152268|FG007|Period 1|pursue other treatment options|0|||
163940904|NCT03635099|592152261|FG000|Not Eligible for Period 2|Pregnancy|0|||
163940905|NCT03635099|592152262|FG001|Not Eligible for Period 2|Pregnancy|0|||
163940906|NCT03635099|592152263|FG002|Not Eligible for Period 2|Pregnancy|0|||
163940907|NCT03635099|592152264|FG003|Not Eligible for Period 2|Pregnancy|1|||
163940908|NCT03635099|592152265|FG004|Not Eligible for Period 2|Pregnancy|0|||
163940909|NCT03635099|592152266|FG005|Not Eligible for Period 2|Pregnancy|0|||
164041334|NCT00166517|592510501|FG000|Overall Study|Lost to Follow-up|1|||
164041335|NCT00166517|592510502|FG001|Overall Study|Lost to Follow-up|0|||
164041336|NCT00166517|592510501|FG000|Overall Study|Protocol Violation|4|||
163940910|NCT03635099|592152267|FG006|Not Eligible for Period 2|Pregnancy|0|||
163940911|NCT03635099|592152268|FG007|Not Eligible for Period 2|Pregnancy|0|||
163940912|NCT03635099|592152261|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
163940913|NCT03635099|592152262|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940914|NCT03635099|592152263|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940915|NCT03635099|592152264|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940916|NCT03635099|592152265|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940917|NCT03635099|592152266|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940918|NCT03635099|592152267|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940919|NCT03635099|592152268|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
163940920|NCT03635099|592152261|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163940921|NCT03635099|592152262|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163940922|NCT03635099|592152263|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163940923|NCT03635099|592152264|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
164041337|NCT00166517|592510502|FG001|Overall Study|Protocol Violation|1|||
164041338|NCT00166517|592510501|FG000|Overall Study|Withdrawal by Subject|0|||
164041339|NCT00166517|592510502|FG001|Overall Study|Withdrawal by Subject|1|||
164041340|NCT03094611|592510506|FG000|Overall Study|Lack of Efficacy|1|||
164041341|NCT03094611|592510506|FG000|Overall Study|Stem Cell Transplant|1|||
164041342|NCT04285853|592510507|FG000|Overall Study|Withdrawal by Subject|1|||
164041343|NCT04285853|592510508|FG001|Overall Study|Withdrawal by Subject|0|||
164041344|NCT04285853|592510507|FG000|Overall Study|Lost to Follow-up|9|||
164041345|NCT04285853|592510508|FG001|Overall Study|Lost to Follow-up|5|||
164041346|NCT01072448|592510509|FG000|Overall Study|Adverse Event|9|||
164041347|NCT01072448|592510510|FG001|Overall Study|Adverse Event|10|||
164041348|NCT01072448|592510509|FG000|Overall Study|Subject withdrew consent|4|||
164041349|NCT01072448|592510510|FG001|Overall Study|Subject withdrew consent|9|||
164041350|NCT01072448|592510509|FG000|Overall Study|Protocol deviation|3|||
164041351|NCT01072448|592510510|FG001|Overall Study|Protocol deviation|4|||
164041352|NCT01072448|592510509|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164041353|NCT01072448|592510510|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164041354|NCT01072448|592510509|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163840868|NCT04362137|591787472|FG000|Overall Study|Patient decision|6|||
163840869|NCT04362137|591787473|FG001|Overall Study|Patient decision|3|||
163840870|NCT04362137|591787472|FG000|Overall Study|Adverse Event|1|||
163840871|NCT04362137|591787473|FG001|Overall Study|Adverse Event|0|||
163840872|NCT04362137|591787472|FG000|Overall Study|Lost to Follow-up|1|||
163840873|NCT04362137|591787473|FG001|Overall Study|Lost to Follow-up|0|||
163840874|NCT04362137|591787472|FG000|Overall Study|Protocol deviation|1|||
163840875|NCT04362137|591787473|FG001|Overall Study|Protocol deviation|0|||
163840876|NCT03556358|591787481|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
163840877|NCT03556358|591787482|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
163840878|NCT03556358|591787481|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
163840879|NCT03556358|591787482|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
163840880|NCT03556358|591787481|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
163840881|NCT03556358|591787482|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
163840882|NCT03556358|591787481|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
163840883|NCT03556358|591787482|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
163840884|NCT03556358|591787481|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
163840885|NCT03556358|591787482|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
163840886|NCT03556358|591787481|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
163840887|NCT03556358|591787482|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
163840888|NCT03556358|591787481|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
163840889|NCT03556358|591787482|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
163840890|NCT05067933|591787485|FG000|Overall Study|Withdrawal by Subject|2|||
163840891|NCT05067933|591787486|FG001|Overall Study|Withdrawal by Subject|0|||
163840892|NCT05067933|591787487|FG002|Overall Study|Withdrawal by Subject|0|||
163840893|NCT05067933|591787488|FG003|Overall Study|Withdrawal by Subject|0|||
163840894|NCT05067933|591787489|FG004|Overall Study|Withdrawal by Subject|0|||
163840895|NCT05067933|591787490|FG005|Overall Study|Withdrawal by Subject|0|||
163840896|NCT05067933|591787485|FG000|Overall Study|Lost to Follow-up|1|||
163840897|NCT05067933|591787486|FG001|Overall Study|Lost to Follow-up|1|||
163840898|NCT05067933|591787487|FG002|Overall Study|Lost to Follow-up|1|||
163840899|NCT05067933|591787488|FG003|Overall Study|Lost to Follow-up|2|||
163840900|NCT05067933|591787489|FG004|Overall Study|Lost to Follow-up|1|||
163840901|NCT05067933|591787490|FG005|Overall Study|Lost to Follow-up|0|||
163840902|NCT05067933|591787485|FG000|Overall Study|Miscellaneous|1|||
163840903|NCT05067933|591787486|FG001|Overall Study|Miscellaneous|0|||
163840904|NCT05067933|591787487|FG002|Overall Study|Miscellaneous|0|||
163840905|NCT05067933|591787488|FG003|Overall Study|Miscellaneous|0|||
163840906|NCT05067933|591787489|FG004|Overall Study|Miscellaneous|0|||
163840907|NCT05067933|591787490|FG005|Overall Study|Miscellaneous|0|||
163840908|NCT05067933|591787485|FG000|Overall Study|Death|0|||
163840909|NCT05067933|591787486|FG001|Overall Study|Death|0|||
163840910|NCT05067933|591787487|FG002|Overall Study|Death|0|||
163840911|NCT05067933|591787488|FG003|Overall Study|Death|1|||
163840912|NCT05067933|591787489|FG004|Overall Study|Death|0|||
163840913|NCT05067933|591787490|FG005|Overall Study|Death|0|||
163840914|NCT02716038|591787497|FG000|Overall Study|Not evaluable|1|||
163840915|NCT02716038|591787497|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
163840916|NCT02716038|591787497|FG000|Overall Study|Unresectable|3|||
163840917|NCT00550550|591787498|FG000|Overall Study|Adverse Event|13|||
163840918|NCT00550550|591787499|FG001|Overall Study|Adverse Event|5|||
163840919|NCT00550550|591787498|FG000|Overall Study|Treatment Failure|0|||
163840920|NCT00550550|591787499|FG001|Overall Study|Treatment Failure|1|||
163840921|NCT00550550|591787498|FG000|Overall Study|Lost to Follow-up|4|||
163840922|NCT00550550|591787499|FG001|Overall Study|Lost to Follow-up|0|||
164041355|NCT01072448|592510510|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
163940924|NCT03635099|592152265|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
163940925|NCT03635099|592152266|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
163940926|NCT03635099|592152267|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
163940927|NCT03635099|592152268|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
163940928|NCT03635099|592152261|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
163940929|NCT03635099|592152262|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
163940930|NCT03635099|592152263|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
163940931|NCT03635099|592152264|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
163940932|NCT03635099|592152265|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163940933|NCT03635099|592152266|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163940934|NCT03635099|592152267|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163940935|NCT03635099|592152268|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
163940936|NCT03635099|592152261|FG000|Period 2|Adverse Event|0|||
163940937|NCT03635099|592152262|FG001|Period 2|Adverse Event|0|||
163940938|NCT03635099|592152263|FG002|Period 2|Adverse Event|1|||
163940939|NCT03635099|592152264|FG003|Period 2|Adverse Event|0|||
163940940|NCT03635099|592152265|FG004|Period 2|Adverse Event|1|||
163940941|NCT03635099|592152266|FG005|Period 2|Adverse Event|0|||
163940942|NCT03635099|592152267|FG006|Period 2|Adverse Event|0|||
163940943|NCT03635099|592152268|FG007|Period 2|Adverse Event|0|||
163940944|NCT03635099|592152261|FG000|Period 2|Lost to Follow-up|0|||
163940945|NCT03635099|592152262|FG001|Period 2|Lost to Follow-up|0|||
163940946|NCT03635099|592152263|FG002|Period 2|Lost to Follow-up|1|||
163940947|NCT03635099|592152264|FG003|Period 2|Lost to Follow-up|0|||
164041356|NCT01072448|592510509|FG000|Overall Study|Lost to Follow-up|1|||
164041357|NCT01072448|592510510|FG001|Overall Study|Lost to Follow-up|1|||
164041358|NCT01072448|592510509|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164041359|NCT01072448|592510510|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164041360|NCT01072448|592510509|FG000|Overall Study|Death|0|||
164041361|NCT01072448|592510510|FG001|Overall Study|Death|2|||
164041362|NCT00249795|592510512|FG000|Overall Study|Not treated|16|||
164041363|NCT00249795|592510513|FG001|Overall Study|Not treated|14|||
164041364|NCT00249795|592510512|FG000|Overall Study|Symptomatic hypotension|127|||
164041365|NCT00249795|592510513|FG001|Overall Study|Symptomatic hypotension|64|||
164041366|NCT00249795|592510512|FG000|Overall Study|Other Serious Adverse Event|84|||
164041367|NCT00249795|592510513|FG001|Overall Study|Other Serious Adverse Event|93|||
164041368|NCT00249795|592510512|FG000|Overall Study|Qualifying condition not present|26|||
164041369|NCT00249795|592510513|FG001|Overall Study|Qualifying condition not present|29|||
164041370|NCT00249795|592510512|FG000|Overall Study|Withdrawal by Subject|678|||
164041371|NCT00249795|592510513|FG001|Overall Study|Withdrawal by Subject|742|||
164041372|NCT00249795|592510512|FG000|Overall Study|Thromboembolic / outcome event|39|||
164041373|NCT00249795|592510513|FG001|Overall Study|Thromboembolic / outcome event|45|||
164041374|NCT00249795|592510512|FG000|Overall Study|Oral anticoagulant required|2|||
164041375|NCT00249795|592510513|FG001|Overall Study|Oral anticoagulant required|0|||
164041376|NCT00249795|592510512|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
164041377|NCT00249795|592510513|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
164041378|NCT00249795|592510512|FG000|Overall Study|Non-compliance|71|||
164041379|NCT00249795|592510513|FG001|Overall Study|Non-compliance|69|||
164041380|NCT00249795|592510512|FG000|Overall Study|Study drug intolerance|3|||
164041381|NCT00249795|592510513|FG001|Overall Study|Study drug intolerance|3|||
164041382|NCT00249795|592510512|FG000|Overall Study|Other adverse events (non-serious)|188|||
164041383|NCT00249795|592510513|FG001|Overall Study|Other adverse events (non-serious)|159|||
164041384|NCT00249795|592510512|FG000|Overall Study|Physician withdrew consent|71|||
164041385|NCT00249795|592510513|FG001|Overall Study|Physician withdrew consent|63|||
164041386|NCT00249795|592510512|FG000|Overall Study|Surgery / procedure|4|||
164041387|NCT00249795|592510513|FG001|Overall Study|Surgery / procedure|5|||
164041388|NCT00249795|592510512|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
164041389|NCT00249795|592510513|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
164041390|NCT00249795|592510512|FG000|Overall Study|Lightheadedness / dizziness|15|||
164041391|NCT00249795|592510513|FG001|Overall Study|Lightheadedness / dizziness|11|||
164041392|NCT00249795|592510512|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
164041393|NCT00249795|592510513|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
164041394|NCT00249795|592510512|FG000|Overall Study|Other contraindicated medication|1|||
164041395|NCT00249795|592510513|FG001|Overall Study|Other contraindicated medication|1|||
164041396|NCT00249795|592510512|FG000|Overall Study|Event related to cardiac condition|17|||
164041397|NCT00249795|592510513|FG001|Overall Study|Event related to cardiac condition|16|||
164041398|NCT00249795|592510512|FG000|Overall Study|Patient not wish to continue after May08|4|||
164041399|NCT00249795|592510513|FG001|Overall Study|Patient not wish to continue after May08|6|||
164041400|NCT00249795|592510512|FG000|Overall Study|Site not agree to continue after May08|1|||
163940948|NCT03635099|592152265|FG004|Period 2|Lost to Follow-up|4|||
163940949|NCT03635099|592152266|FG005|Period 2|Lost to Follow-up|0|||
163940950|NCT03635099|592152267|FG006|Period 2|Lost to Follow-up|0|||
163940951|NCT03635099|592152268|FG007|Period 2|Lost to Follow-up|0|||
164098887|NCT01387022|592726944|FG000|Overall Study|Death|1|||
164098888|NCT01387022|592726945|FG001|Overall Study|Death|1|||
164098889|NCT01387022|592726944|FG000|Overall Study|Lost to Follow-up|0|||
163840923|NCT00550550|591787498|FG000|Overall Study|Withdrawal by Subject|10|||
164041401|NCT00249795|592510513|FG001|Overall Study|Site not agree to continue after May08|1|||
164041402|NCT00249795|592510512|FG000|Overall Study|Lost to Follow-up|0|||
164041403|NCT00249795|592510513|FG001|Overall Study|Lost to Follow-up|2|||
164041404|NCT00249795|592510512|FG000|Overall Study|Missing|0|||
164041405|NCT00249795|592510513|FG001|Overall Study|Missing|1|||
164041406|NCT00196196|592510517|FG000|Overall Study|Withdrawal by Subject|2|||
164041407|NCT00196196|592510517|FG000|Overall Study|Did not have required condition (hydroce|5|||
164041408|NCT01814826|592510520|FG000|Overall Study|Other|3|||
164041409|NCT01814826|592510521|FG001|Overall Study|Other|5|||
164041410|NCT01814826|592510522|FG002|Overall Study|Other|0|||
164041411|NCT01814826|592510520|FG000|Overall Study|Death|29|||
164041412|NCT01814826|592510521|FG001|Overall Study|Death|24|||
164041413|NCT01814826|592510522|FG002|Overall Study|Death|3|||
164041414|NCT02917629|592510523|FG000|Overall Study|Withdrawal by Subject|0|||
164041415|NCT02917629|592510524|FG001|Overall Study|Withdrawal by Subject|1|||
164041416|NCT03271307|592510525|FG000|Overall Study|Lost to Follow-up|0|||
164041417|NCT03271307|592510526|FG001|Overall Study|Lost to Follow-up|0|||
164041418|NCT03271307|592510527|FG002|Overall Study|Lost to Follow-up|0|||
164041419|NCT03271307|592510528|FG003|Overall Study|Lost to Follow-up|28|||
164041420|NCT03271307|592510529|FG004|Overall Study|Lost to Follow-up|91|||
164041421|NCT01042938|592510530|FG000|Overall Study|Withdrawal by Subject|1|||
164041422|NCT01042938|592510531|FG001|Overall Study|Withdrawal by Subject|1|||
164041423|NCT01042938|592510530|FG000|Overall Study|Protocol Violation|1|||
164041424|NCT01042938|592510531|FG001|Overall Study|Protocol Violation|1|||
164041425|NCT01042938|592510530|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
164041426|NCT01042938|592510531|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
164041427|NCT03136484|592510532|FG000|Overall Study|Withdrawal by Subject|19|||
164041428|NCT03136484|592510533|FG001|Overall Study|Withdrawal by Subject|14|||
164041429|NCT03136484|592510532|FG000|Overall Study|Lost to Follow-up|7|||
164041430|NCT03136484|592510533|FG001|Overall Study|Lost to Follow-up|8|||
164041431|NCT03136484|592510532|FG000|Overall Study|Death|1|||
164041432|NCT03136484|592510533|FG001|Overall Study|Death|0|||
164041433|NCT03032510|592510536|FG000|Overall Study|Adverse Event|5|||
164041434|NCT03032510|592510537|FG001|Overall Study|Adverse Event|2|||
164041435|NCT03032510|592510536|FG000|Overall Study|Lost to Follow-up|8|||
164041436|NCT03032510|592510537|FG001|Overall Study|Lost to Follow-up|7|||
164041437|NCT03032510|592510536|FG000|Overall Study|Withdrawal by Subject|8|||
164041438|NCT03032510|592510537|FG001|Overall Study|Withdrawal by Subject|7|||
164041439|NCT03032510|592510536|FG000|Overall Study|Subject noncompliance|4|||
164041440|NCT03032510|592510537|FG001|Overall Study|Subject noncompliance|2|||
164041441|NCT03032510|592510536|FG000|Overall Study|Physician Decision|2|||
164041442|NCT03032510|592510537|FG001|Overall Study|Physician Decision|0|||
164041443|NCT01601470|592510538|FG000|Period 2 - LCZ696|Physician Decision|1|||
164041444|NCT01203787|592510539|FG000|Overall Study|Death|12|||
164041445|NCT01203787|592510540|FG001|Overall Study|Death|10|||
164041446|NCT01203787|592510539|FG000|Overall Study|Withdrawal by Subject|6|||
163840924|NCT00550550|591787499|FG001|Overall Study|Withdrawal by Subject|8|||
163840925|NCT00550550|591787498|FG000|Overall Study|Protocol Violation|5|||
163840926|NCT00550550|591787499|FG001|Overall Study|Protocol Violation|14|||
163840927|NCT00550550|591787498|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
163840928|NCT00550550|591787499|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
163840929|NCT00550550|591787498|FG000|Overall Study|Randomized But Not Treated|1|||
163840930|NCT00550550|591787499|FG001|Overall Study|Randomized But Not Treated|0|||
163840931|NCT02459093|591787500|FG000|Overall Study|Protocol Violation|6|||
163840932|NCT02459093|591787501|FG001|Overall Study|Protocol Violation|11|||
163840933|NCT02459093|591787500|FG000|Overall Study|Lost to Follow-up|6|||
163840934|NCT02459093|591787501|FG001|Overall Study|Lost to Follow-up|7|||
163840935|NCT00118092|591787502|FG000|Overall Study|Withdrawal by Subject|1|||
163840936|NCT00118092|591787502|FG000|Overall Study|Protocol Violation|1|||
163840937|NCT00591864|591787503|FG000|Overall Study|Incomplete Imaging|5|||
163840938|NCT01103960|591787510|FG000|Overall Study|Adverse Event|2|||
163840939|NCT01103960|591787511|FG001|Overall Study|Adverse Event|1|||
163840940|NCT01103960|591787510|FG000|Overall Study|Withdrawal by Subject|2|||
163840941|NCT01103960|591787511|FG001|Overall Study|Withdrawal by Subject|1|||
163840942|NCT01103960|591787510|FG000|Overall Study|Other|1|||
163840943|NCT01103960|591787511|FG001|Overall Study|Other|0|||
163840944|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163840945|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
164041447|NCT01203787|592510540|FG001|Overall Study|Withdrawal by Subject|2|||
164041448|NCT01203787|592510539|FG000|Overall Study|Lost to Follow-up|2|||
164041449|NCT01203787|592510540|FG001|Overall Study|Lost to Follow-up|0|||
164041450|NCT01203787|592510539|FG000|Overall Study|Adverse Event|11|||
164041451|NCT01203787|592510540|FG001|Overall Study|Adverse Event|15|||
164041452|NCT00431496|592510543|FG000|Overall Study|Adverse Event|3|||
164098890|NCT01387022|592726945|FG001|Overall Study|Lost to Follow-up|3|||
164147705|NCT02006732|592902131|FG002|Overall Study|Protocol Violation|0|||
164041453|NCT00431496|592510543|FG000|Overall Study|Lost to Follow-up|1|||
164041454|NCT00431496|592510543|FG000|Overall Study|Withdrawal by Subject|2|||
164041455|NCT00431496|592510543|FG000|Overall Study|Protocol-specified criteria|5|||
164041456|NCT02343952|592510544|FG000|Study Treatment|Disease Progression|23|||
164041457|NCT02343952|592510544|FG000|Study Treatment|Death|3|||
164041458|NCT02343952|592510544|FG000|Study Treatment|Adverse Event|19|||
164041459|NCT02343952|592510544|FG000|Study Treatment|Withdrawal by Subject|7|||
164041460|NCT02343952|592510544|FG000|Study Treatment|other complicating Diseases|1|||
164041461|NCT02343952|592510544|FG000|Follow up|Withdrawal by Subject|3|||
164041462|NCT02343952|592510544|FG000|Follow up|Death|33|||
164041463|NCT02343952|592510544|FG000|Follow up|Patient does not meet eligibility for study.|1|||
164098891|NCT02076022|592726946|FG000|Overall Study|Withdrawal by Subject|2|||
164098892|NCT02076022|592726947|FG001|Overall Study|Withdrawal by Subject|0|||
163840946|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
163840947|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163840948|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163840949|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163840950|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
163840951|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
163840952|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163840953|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163840954|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163840955|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163840956|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163840957|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
163840958|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
163840959|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
163840960|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
163840961|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163840962|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163840963|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163840964|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
163840965|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163840966|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
163840967|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
163840968|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163840969|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163840970|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163840971|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
163840972|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163840973|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163840974|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
163840975|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163840976|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163840977|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163840978|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
163840979|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
163840980|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
163840981|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
163840982|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163840983|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163840984|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163840985|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
163840986|NCT04921969|591787512|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
163840987|NCT04921969|591787513|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
163840988|NCT04921969|591787514|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163840989|NCT04921969|591787515|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163840990|NCT04921969|591787516|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163840991|NCT04921969|591787517|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163840992|NCT04921969|591787518|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
163840993|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163840994|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163840995|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163840996|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163840997|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163840998|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
163840999|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
164041464|NCT02343952|592510544|FG000|Follow up|Research department closed by the practice.|5|||
163841000|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
164041465|NCT02343952|592510544|FG000|Follow up|Patient went home to Russia|1|||
164147706|NCT02006732|592902132|FG003|Overall Study|Protocol Violation|0|||
163940952|NCT03635099|592152261|FG000|Period 2|Withdrawal by Subject|0|||
163940953|NCT03635099|592152262|FG001|Period 2|Withdrawal by Subject|0|||
163940954|NCT03635099|592152263|FG002|Period 2|Withdrawal by Subject|7|||
163940955|NCT03635099|592152264|FG003|Period 2|Withdrawal by Subject|4|||
164098893|NCT01536405|592726950|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
164098894|NCT01536405|592726951|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
164098895|NCT01536405|592726950|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
164098896|NCT01536405|592726951|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
164098897|NCT01536405|592726950|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
164098898|NCT01536405|592726951|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
164098899|NCT01536405|592726950|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
164098900|NCT01536405|592726951|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
164098901|NCT01536405|592726950|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
163940956|NCT03635099|592152265|FG004|Period 2|Withdrawal by Subject|7|||
163940957|NCT03635099|592152266|FG005|Period 2|Withdrawal by Subject|0|||
163940958|NCT03635099|592152267|FG006|Period 2|Withdrawal by Subject|0|||
163940959|NCT03635099|592152268|FG007|Period 2|Withdrawal by Subject|0|||
163940960|NCT01289210|592152269|FG000|Overall Study|Adverse Event|1|||
163940961|NCT06285240|592152270|FG000|Overall Study|Withdrawal by Subject|2|||
163940962|NCT06285240|592152271|FG001|Overall Study|Withdrawal by Subject|0|||
163940963|NCT06285240|592152272|FG002|Overall Study|Withdrawal by Subject|0|||
163940964|NCT06285240|592152273|FG003|Overall Study|Withdrawal by Subject|0|||
163940965|NCT06285240|592152270|FG000|Overall Study|Serious Adverse Event|0|||
163940966|NCT06285240|592152271|FG001|Overall Study|Serious Adverse Event|0|||
163940967|NCT06285240|592152272|FG002|Overall Study|Serious Adverse Event|1|||
163940968|NCT06285240|592152273|FG003|Overall Study|Serious Adverse Event|0|||
163940969|NCT04844879|592152276|FG000|Overall Study|Death|1|||
163940970|NCT04844879|592152276|FG000|Overall Study|Withdrawal by Subject|1|||
163940971|NCT04844879|592152276|FG000|Overall Study|Adverse Event|1|||
163940972|NCT04103892|592152282|FG000|Overall Study|Adverse Event|0|||
163940973|NCT04103892|592152283|FG001|Overall Study|Adverse Event|0|||
163940974|NCT04103892|592152284|FG002|Overall Study|Adverse Event|0|||
163940975|NCT04103892|592152285|FG003|Overall Study|Adverse Event|3|||
163940976|NCT04103892|592152282|FG000|Overall Study|Lost to Follow-up|0|||
163940977|NCT04103892|592152283|FG001|Overall Study|Lost to Follow-up|0|||
163940978|NCT04103892|592152284|FG002|Overall Study|Lost to Follow-up|2|||
163940979|NCT04103892|592152285|FG003|Overall Study|Lost to Follow-up|0|||
163940980|NCT04103892|592152282|FG000|Overall Study|Protocol Violation|0|||
163940981|NCT04103892|592152283|FG001|Overall Study|Protocol Violation|0|||
163940982|NCT04103892|592152284|FG002|Overall Study|Protocol Violation|1|||
163940983|NCT04103892|592152285|FG003|Overall Study|Protocol Violation|1|||
163940984|NCT04103892|592152282|FG000|Overall Study|Withdrawal by Subject|1|||
163940985|NCT04103892|592152283|FG001|Overall Study|Withdrawal by Subject|0|||
163940986|NCT04103892|592152284|FG002|Overall Study|Withdrawal by Subject|2|||
163940987|NCT04103892|592152285|FG003|Overall Study|Withdrawal by Subject|5|||
163940988|NCT04103892|592152282|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
164041466|NCT02343952|592510544|FG000|Follow up|Disease Progression|1|||
164041467|NCT02343952|592510544|FG000|Follow up|study terminated|1|||
164041468|NCT02671760|592510545|FG000|Overall Study|Lost to Follow-up|0|||
164041469|NCT02671760|592510546|FG001|Overall Study|Lost to Follow-up|1|||
164041470|NCT02671760|592510547|FG002|Overall Study|Lost to Follow-up|0|||
164041471|NCT01931150|592510554|FG000|Overall Study|Withdrawal by Subject|1|||
164041472|NCT01931150|592510555|FG001|Overall Study|Withdrawal by Subject|2|||
164041473|NCT00845845|592510556|FG000|Overall Study|Lost to Follow-up|0|||
164041474|NCT00845845|592510557|FG001|Overall Study|Lost to Follow-up|4|||
164041475|NCT01685203|592510558|FG000|Overall Study|Lost to Follow-up|3|||
164041476|NCT01685203|592510559|FG001|Overall Study|Lost to Follow-up|3|||
164041477|NCT01685203|592510560|FG002|Overall Study|Lost to Follow-up|0|||
164041478|NCT01685203|592510561|FG003|Overall Study|Lost to Follow-up|1|||
164041479|NCT01685203|592510562|FG004|Overall Study|Lost to Follow-up|0|||
164041480|NCT01685203|592510563|FG005|Overall Study|Lost to Follow-up|0|||
164041481|NCT01685203|592510564|FG006|Overall Study|Lost to Follow-up|0|||
164041482|NCT01685203|592510558|FG000|Overall Study|Adverse Event|0|||
164041483|NCT01685203|592510559|FG001|Overall Study|Adverse Event|0|||
164041484|NCT01685203|592510560|FG002|Overall Study|Adverse Event|0|||
163940989|NCT04103892|592152283|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
163940990|NCT04103892|592152284|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
163940991|NCT04103892|592152285|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
164041485|NCT01685203|592510561|FG003|Overall Study|Adverse Event|0|||
163940992|NCT05576662|592152286|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
164041486|NCT01685203|592510562|FG004|Overall Study|Adverse Event|0|||
164041487|NCT01685203|592510563|FG005|Overall Study|Adverse Event|2|||
164041488|NCT01685203|592510564|FG006|Overall Study|Adverse Event|0|||
164041489|NCT01685203|592510558|FG000|Overall Study|Adverse event and withdrew consent|1|||
164098902|NCT01536405|592726951|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
164098903|NCT01536405|592726950|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
163940993|NCT05576662|592152287|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
163940994|NCT05576662|592152286|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
163940995|NCT05576662|592152287|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
163940996|NCT05576662|592152286|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
163940997|NCT05576662|592152287|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
163940998|NCT05576662|592152286|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
163940999|NCT05576662|592152287|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
163941000|NCT00281320|592152288|FG000|Overall Study|Adverse Event|12|||
163941001|NCT00281320|592152289|FG001|Overall Study|Adverse Event|9|||
163941002|NCT00281320|592152288|FG000|Overall Study|Lack of Efficacy|4|||
163941003|NCT00281320|592152289|FG001|Overall Study|Lack of Efficacy|3|||
163941004|NCT00281320|592152288|FG000|Overall Study|Withdrawal by Subject|5|||
163941005|NCT00281320|592152289|FG001|Overall Study|Withdrawal by Subject|6|||
163941006|NCT00281320|592152288|FG000|Overall Study|Lost to Follow-up|1|||
163941007|NCT00281320|592152289|FG001|Overall Study|Lost to Follow-up|2|||
163941008|NCT00281320|592152288|FG000|Overall Study|Other|3|||
163941009|NCT00281320|592152289|FG001|Overall Study|Other|1|||
163941010|NCT03008005|592152296|FG000|Overall Study|Physician Decision|1|||
163941011|NCT03008005|592152297|FG001|Overall Study|Physician Decision|0|||
163941012|NCT03008005|592152298|FG002|Overall Study|Physician Decision|0|||
163941013|NCT03008005|592152296|FG000|Overall Study|Withdrawal by Subject|1|||
164041490|NCT01685203|592510559|FG001|Overall Study|Adverse event and withdrew consent|0|||
164041491|NCT01685203|592510560|FG002|Overall Study|Adverse event and withdrew consent|0|||
164041492|NCT01685203|592510561|FG003|Overall Study|Adverse event and withdrew consent|0|||
164041493|NCT01685203|592510562|FG004|Overall Study|Adverse event and withdrew consent|0|||
164041494|NCT01685203|592510563|FG005|Overall Study|Adverse event and withdrew consent|0|||
164041495|NCT01685203|592510564|FG006|Overall Study|Adverse event and withdrew consent|0|||
164041496|NCT01685203|592510558|FG000|Overall Study|Patient's decision|0|||
164041497|NCT01685203|592510559|FG001|Overall Study|Patient's decision|0|||
164041498|NCT01685203|592510560|FG002|Overall Study|Patient's decision|0|||
164041499|NCT01685203|592510561|FG003|Overall Study|Patient's decision|0|||
164041500|NCT01685203|592510562|FG004|Overall Study|Patient's decision|0|||
164041501|NCT01685203|592510563|FG005|Overall Study|Patient's decision|1|||
164041502|NCT01685203|592510564|FG006|Overall Study|Patient's decision|0|||
164041503|NCT01570309|592510565|FG000|Overall Study|Withdrawal by Subject|3|||
164041504|NCT01570309|592510566|FG001|Overall Study|Withdrawal by Subject|3|||
164041505|NCT04095793|592510567|FG000|Overall Study|Adverse Event|3|||
164041506|NCT04095793|592510567|FG000|Overall Study|Study Terminated by Sponsor|103|||
164041507|NCT04095793|592510567|FG000|Overall Study|Withdrawal by Subject|4|||
164041508|NCT03619837|592510568|FG000|Screening|received organs from HCV-negative donors|47|||
164041509|NCT03619837|592510568|FG000|Screening|died on the wait-list|2|||
164041510|NCT03619837|592510568|FG000|Screening|remained on the wait list|40|||
164041511|NCT03619837|592510568|FG000|Screening|didn't meet eligibility criteria|3|||
164041512|NCT03619837|592510568|FG000|Screening|withdrew consent|2|||
164041513|NCT03619837|592510568|FG000|Screening|never listed for HCV-viremic donor|1|||
164041514|NCT03619837|592510568|FG000|Screening|developed exclusion criteria|2|||
164041515|NCT03619837|592510568|FG000|Screening|excluded by the investigator due to non-compliance|1|||
164041516|NCT04483544|592512413|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
164041517|NCT04483544|592512413|FG000|Post-Treatment|Admitted to hospice|2|||
164041518|NCT04483544|592512413|FG000|Post-Treatment|Study terminated|3|||
164041519|NCT01131078|592512414|FG000|Overall Study|Adverse Event|22|||
164041520|NCT01131078|592512415|FG001|Overall Study|Adverse Event|12|||
164041521|NCT01131078|592512416|FG002|Overall Study|Adverse Event|17|||
164041522|NCT01131078|592512414|FG000|Overall Study|Progressive Disease|58|||
164041523|NCT01131078|592512415|FG001|Overall Study|Progressive Disease|77|||
164041524|NCT01131078|592512416|FG002|Overall Study|Progressive Disease|71|||
164041525|NCT01131078|592512414|FG000|Overall Study|Protocol Violation|1|||
164041526|NCT01131078|592512415|FG001|Overall Study|Protocol Violation|0|||
164041527|NCT01131078|592512416|FG002|Overall Study|Protocol Violation|0|||
164041528|NCT01131078|592512414|FG000|Overall Study|Lost to Follow-up|1|||
164041529|NCT01131078|592512415|FG001|Overall Study|Lost to Follow-up|1|||
164041530|NCT01131078|592512416|FG002|Overall Study|Lost to Follow-up|1|||
164041531|NCT01131078|592512414|FG000|Overall Study|Withdrawal by Subject|2|||
164041532|NCT01131078|592512415|FG001|Overall Study|Withdrawal by Subject|4|||
164041533|NCT01131078|592512416|FG002|Overall Study|Withdrawal by Subject|3|||
164041534|NCT01131078|592512414|FG000|Overall Study|Non-compliance|3|||
164041535|NCT01131078|592512415|FG001|Overall Study|Non-compliance|0|||
163941014|NCT03008005|592152297|FG001|Overall Study|Withdrawal by Subject|0|||
163941015|NCT03008005|592152298|FG002|Overall Study|Withdrawal by Subject|0|||
164041536|NCT01131078|592512416|FG002|Overall Study|Non-compliance|0|||
164041537|NCT01131078|592512414|FG000|Overall Study|Physician Decision|10|||
164041538|NCT01131078|592512415|FG001|Overall Study|Physician Decision|6|||
164041539|NCT01131078|592512416|FG002|Overall Study|Physician Decision|8|||
164041540|NCT01131078|592512414|FG000|Overall Study|Death|4|||
164041541|NCT01131078|592512415|FG001|Overall Study|Death|0|||
164041542|NCT01131078|592512416|FG002|Overall Study|Death|2|||
163941016|NCT03008005|592152296|FG000|Overall Study|Ineligible|0|||
163941017|NCT03008005|592152297|FG001|Overall Study|Ineligible|1|||
163941018|NCT03008005|592152298|FG002|Overall Study|Ineligible|0|||
163941019|NCT05292586|592152299|FG000|Overall Study|Withdrawal by Subject|3|||
163941020|NCT05292586|592152300|FG001|Overall Study|Withdrawal by Subject|10|||
163941021|NCT05292586|592152299|FG000|Overall Study|Randomization error|3|||
163941022|NCT05292586|592152300|FG001|Overall Study|Randomization error|7|||
163941023|NCT05292586|592152299|FG000|Overall Study|Adverse Event|3|||
163941024|NCT05292586|592152300|FG001|Overall Study|Adverse Event|0|||
163941025|NCT05292586|592152299|FG000|Overall Study|Lost to Follow-up|0|||
163941026|NCT05292586|592152300|FG001|Overall Study|Lost to Follow-up|1|||
163941027|NCT05292586|592152299|FG000|Overall Study|Patient refused treatment|1|||
163941028|NCT05292586|592152300|FG001|Overall Study|Patient refused treatment|0|||
163941029|NCT05292586|592152299|FG000|Overall Study|Patient could not travel to the study site|1|||
163941030|NCT05292586|592152300|FG001|Overall Study|Patient could not travel to the study site|0|||
163941031|NCT05292586|592152299|FG000|Overall Study|Technical issues with the masterscope|0|||
163941032|NCT05292586|592152300|FG001|Overall Study|Technical issues with the masterscope|3|||
163941033|NCT05292586|592152299|FG000|Overall Study|Patient moved to a different state|0|||
163941034|NCT05292586|592152300|FG001|Overall Study|Patient moved to a different state|1|||
163941035|NCT00475228|592152301|FG000|Overall Study|Lost to Follow-up|17|||
163941036|NCT00475228|592152302|FG001|Overall Study|Lost to Follow-up|17|||
163941037|NCT02367040|592152315|FG000|Overall Study|Lost to Follow-up|1|||
163941038|NCT02367040|592152316|FG001|Overall Study|Lost to Follow-up|1|||
163941039|NCT02367040|592152315|FG000|Overall Study|Lack of Efficacy|1|||
163941040|NCT02367040|592152316|FG001|Overall Study|Lack of Efficacy|0|||
163941041|NCT02367040|592152315|FG000|Overall Study|Additional primary malignancy|1|||
163941042|NCT02367040|592152316|FG001|Overall Study|Additional primary malignancy|1|||
163941043|NCT02367040|592152315|FG000|Overall Study|AE not associated with clinical disease progression|117|||
163941044|NCT02367040|592152316|FG001|Overall Study|AE not associated with clinical disease progression|12|||
163941045|NCT02367040|592152315|FG000|Overall Study|AE associated with clinical disease progression|1|||
163941046|NCT02367040|592152316|FG001|Overall Study|AE associated with clinical disease progression|4|||
163941047|NCT02367040|592152315|FG000|Overall Study|Physician Decision|2|||
163941048|NCT02367040|592152316|FG001|Overall Study|Physician Decision|8|||
163941049|NCT02367040|592152315|FG000|Overall Study|Non-compliance to study drug|1|||
163941050|NCT02367040|592152316|FG001|Overall Study|Non-compliance to study drug|0|||
163941051|NCT02367040|592152315|FG000|Overall Study|Failure to meet continuation criteria|1|||
163941052|NCT02367040|592152316|FG001|Overall Study|Failure to meet continuation criteria|0|||
163941053|NCT02367040|592152315|FG000|Overall Study|Switching to other therapy|2|||
163941054|NCT02367040|592152316|FG001|Overall Study|Switching to other therapy|0|||
163941055|NCT02367040|592152315|FG000|Overall Study|Withdrawal by Subject|51|||
163941056|NCT02367040|592152316|FG001|Overall Study|Withdrawal by Subject|16|||
163941057|NCT02367040|592152315|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
163941058|NCT02367040|592152316|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163941059|NCT02367040|592152315|FG000|Overall Study|Patient decision|40|||
163841001|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163841002|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163841003|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
163841004|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
163841005|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
163841006|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
163841007|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163841008|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163841009|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
163841010|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
163841011|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
163841012|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
163841013|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
163841014|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163841015|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163841016|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163841017|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
163841018|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
163841019|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
163841020|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
163841021|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163841022|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163841023|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
163841024|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
163941060|NCT02367040|592152316|FG001|Overall Study|Patient decision|14|||
163941061|NCT02367040|592152315|FG000|Overall Study|Required procedure failed|1|||
163941062|NCT02367040|592152316|FG001|Overall Study|Required procedure failed|0|||
163941063|NCT02367040|592152315|FG000|Overall Study|Randomized by mistake with study treatment|1|||
163941064|NCT02367040|592152316|FG001|Overall Study|Randomized by mistake with study treatment|0|||
163941065|NCT02367040|592152315|FG000|Overall Study|Protocol Violation|1|||
163941066|NCT02367040|592152316|FG001|Overall Study|Protocol Violation|0|||
163941067|NCT02367040|592152315|FG000|Overall Study|Progressive disease - radiological progression|54|||
163941068|NCT02367040|592152316|FG001|Overall Study|Progressive disease - radiological progression|80|||
163941069|NCT02367040|592152315|FG000|Overall Study|Progressive disease - clinical progression|6|||
163941070|NCT02367040|592152316|FG001|Overall Study|Progressive disease - clinical progression|6|||
163941071|NCT02367040|592152315|FG000|Overall Study|Drug not administered|3|||
163941072|NCT02367040|592152316|FG001|Overall Study|Drug not administered|2|||
163941073|NCT02367040|592152315|FG000|Overall Study|Progressive disease|0|||
163941074|NCT02367040|592152316|FG001|Overall Study|Progressive disease|1|||
163941075|NCT02367040|592152315|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
163941076|NCT02367040|592152316|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
163941077|NCT02367040|592152315|FG000|Overall Study|Death|2|||
163941078|NCT02367040|592152316|FG001|Overall Study|Death|0|||
163941079|NCT02367040|592152315|FG000|Overall Study|Study terminated by sponsor|19|||
163941080|NCT02367040|592152316|FG001|Overall Study|Study terminated by sponsor|2|||
163941081|NCT02477618|592152317|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
163941082|NCT02477618|592152318|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
163941083|NCT02477618|592152317|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
163941084|NCT02477618|592152318|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
163941085|NCT02477618|592152317|FG000|Overall Study|Adverse Event|1|||
163941086|NCT02477618|592152318|FG001|Overall Study|Adverse Event|1|||
163941087|NCT02477618|592152317|FG000|Overall Study|Transferred Away from Study Site|1|||
163941088|NCT02477618|592152318|FG001|Overall Study|Transferred Away from Study Site|0|||
163941089|NCT02477618|592152317|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
163941090|NCT02477618|592152318|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
163941091|NCT05855967|592152319|FG000|Overall Study|Withdrawal by Subject|7|||
163941092|NCT05855967|592152320|FG001|Overall Study|Withdrawal by Subject|5|||
163941093|NCT05855967|592152319|FG000|Overall Study|Lost to Follow-up|2|||
163941094|NCT05855967|592152320|FG001|Overall Study|Lost to Follow-up|1|||
163941095|NCT02446821|592152321|FG000|Overall Study|Adverse Event|28|||
163941096|NCT02446821|592152321|FG000|Overall Study|Withdrawal by Subject|6|||
163941097|NCT02446821|592152321|FG000|Overall Study|Lost to Follow-up|22|||
163941098|NCT02446821|592152321|FG000|Overall Study|other|9|||
163941099|NCT02446821|592152321|FG000|Overall Study|insertion failure|3|||
163941100|NCT07149155|592152328|FG000|Overall Study|Lost to Follow-up|10|||
163941101|NCT01255631|592154052|FG000|Overall Study|poor enrollment, no data analyzed|9|||
163941102|NCT01255631|592154053|FG001|Overall Study|poor enrollment, no data analyzed|6|||
163941103|NCT00515671|592154054|FG000|Overall Study|Lost to Follow-up|13|||
163941104|NCT00515671|592154055|FG001|Overall Study|Lost to Follow-up|10|||
163941105|NCT00515671|592154054|FG000|Overall Study|Withdrawal by Subject|3|||
163941106|NCT00515671|592154055|FG001|Overall Study|Withdrawal by Subject|5|||
163941107|NCT00515671|592154054|FG000|Overall Study|incarcerated|1|||
163941108|NCT00515671|592154055|FG001|Overall Study|incarcerated|2|||
163941109|NCT01195948|592154058|FG000|Overall Study|Lost to Follow-up|0|||
163941110|NCT01195948|592154059|FG001|Overall Study|Lost to Follow-up|1|||
163941111|NCT01195948|592154060|FG002|Overall Study|Lost to Follow-up|2|||
163941112|NCT00818168|592154070|FG000|Overall Study|Lack of Efficacy|18|||
163941113|NCT00818168|592154070|FG000|Overall Study|Pregnancy|2|||
163941114|NCT00818168|592154070|FG000|Overall Study|Withdrawal by Subject|16|||
163941115|NCT00818168|592154070|FG000|Overall Study|Lost to Follow-up|7|||
163941116|NCT00818168|592154070|FG000|Overall Study|Adverse Event|19|||
163941117|NCT00818168|592154070|FG000|Overall Study|Reason for Non-completion Not reported|6|||
163941118|NCT00818168|592154070|FG000|Overall Study|Participant Moved|2|||
163941119|NCT01077128|592154077|FG000|Overall Study|Adverse Event|8|||
163941120|NCT01077128|592154077|FG000|Overall Study|Lack of Efficacy|1|||
163941121|NCT01077128|592154077|FG000|Overall Study|Disease exacerbation|1|||
163941122|NCT01077128|592154077|FG000|Overall Study|Adverse event and consent withdrawal|1|||
163941123|NCT01077128|592154077|FG000|Overall Study|Adverse event and disease exacerbation|1|||
163941124|NCT01077128|592154077|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
163941125|NCT01077128|592154077|FG000|Overall Study|Other|54|||
163941126|NCT01706705|592154079|FG000|Overall Study|Death|1|||
163941127|NCT01706705|592154079|FG000|Overall Study|Lack of Efficacy|13|||
163941128|NCT01706705|592154079|FG000|Overall Study|Non-clinical|6|||
163941129|NCT02242097|592154081|FG000|Ibrutinib Treatment|Adverse Event|16|||
163941130|NCT02242097|592154081|FG000|Ibrutinib Treatment|Physician Decision|1|||
163941131|NCT02242097|592154081|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
163941132|NCT02242097|592154081|FG000|Ibrutinib Treatment|Death|1|||
163941133|NCT02242097|592154081|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
163941134|NCT02242097|592154081|FG000|Post Therapy Follow Up|Death|3|||
163941135|NCT02242097|592154081|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
163941136|NCT01712061|592154084|FG000|Overall Study|Adverse Event|4|||
163941137|NCT01712061|592154085|FG001|Overall Study|Adverse Event|9|||
163941138|NCT01712061|592154086|FG002|Overall Study|Adverse Event|5|||
163941139|NCT01712061|592154084|FG000|Overall Study|Death|0|||
163941140|NCT01712061|592154085|FG001|Overall Study|Death|0|||
163941141|NCT01712061|592154086|FG002|Overall Study|Death|1|||
163941142|NCT01712061|592154084|FG000|Overall Study|Lost to Follow-up|1|||
163941143|NCT01712061|592154085|FG001|Overall Study|Lost to Follow-up|0|||
163941144|NCT01712061|592154086|FG002|Overall Study|Lost to Follow-up|1|||
163941145|NCT01712061|592154084|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
163941146|NCT01712061|592154085|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
163941147|NCT01712061|592154086|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
163941148|NCT01712061|592154084|FG000|Overall Study|Medication Error Without Associated AE|0|||
163941149|NCT01712061|592154085|FG001|Overall Study|Medication Error Without Associated AE|1|||
163941150|NCT01712061|592154086|FG002|Overall Study|Medication Error Without Associated AE|0|||
163941151|NCT01712061|592154084|FG000|Overall Study|Withdrawal by Subject|1|||
163941152|NCT01712061|592154085|FG001|Overall Study|Withdrawal by Subject|7|||
163941153|NCT01712061|592154086|FG002|Overall Study|Withdrawal by Subject|1|||
163941154|NCT01712061|592154084|FG000|Overall Study|Other|0|||
163941155|NCT01712061|592154085|FG001|Overall Study|Other|3|||
163941156|NCT01712061|592154086|FG002|Overall Study|Other|0|||
163941157|NCT00504777|592154091|FG000|Overall Study|Adverse Event|1|||
163941158|NCT04868539|592154095|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
163941159|NCT04868539|592154096|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
163941160|NCT01572740|592154097|FG000|Overall Study|Adverse Event|1|||
163941161|NCT01572740|592154098|FG001|Overall Study|Adverse Event|1|||
163941162|NCT01572740|592154097|FG000|Overall Study|Withdrawal by Subject|1|||
163941163|NCT01572740|592154098|FG001|Overall Study|Withdrawal by Subject|1|||
163941164|NCT01572740|592154097|FG000|Overall Study|unclassified|4|||
163941165|NCT01572740|592154098|FG001|Overall Study|unclassified|3|||
163941166|NCT01401153|592154099|FG000|First Test Day|Learning disabilities; illness|1|||
163941167|NCT01401153|592154100|FG001|First Test Day|Learning disabilities; illness|10|||
163941168|NCT01401153|592154099|FG000|Second Test Day|illness|0|||
163941169|NCT01401153|592154100|FG001|Second Test Day|illness|5|||
163941170|NCT01677767|592154101|FG000|Overall Study|Adverse Event|1|||
163941171|NCT01677767|592154101|FG000|Overall Study|Death|4|||
163941172|NCT01677767|592154101|FG000|Overall Study|Protocol Violation|4|||
163941173|NCT01677767|592154101|FG000|Overall Study|Withdrawal by Subject|10|||
163941174|NCT01677767|592154101|FG000|Overall Study|Non-compliance by the participants|3|||
163941175|NCT00842244|592154102|FG000|Overall Study|Death|3|||
163941176|NCT00842244|592154102|FG000|Overall Study|Withdrawal by Subject|1|||
163941177|NCT00842244|592154102|FG000|Overall Study|Other|17|||
163941178|NCT01068665|592154103|FG000|Overall Study|Adverse Event|5|||
163941179|NCT01068665|592154104|FG001|Overall Study|Adverse Event|4|||
163941180|NCT01068665|592154103|FG000|Overall Study|Lack of Efficacy|0|||
163941181|NCT01068665|592154104|FG001|Overall Study|Lack of Efficacy|2|||
163941182|NCT01068665|592154103|FG000|Overall Study|Protocol Violation|5|||
163941183|NCT01068665|592154104|FG001|Overall Study|Protocol Violation|2|||
163941184|NCT01068665|592154103|FG000|Overall Study|Withdrawal Criteria|3|||
163941185|NCT01068665|592154104|FG001|Overall Study|Withdrawal Criteria|9|||
163941186|NCT01068665|592154103|FG000|Overall Study|Other|17|||
163941187|NCT01068665|592154104|FG001|Overall Study|Other|12|||
163941188|NCT00839956|592154106|FG000|Overall Study|Adverse Event|2|||
163941189|NCT00839956|592154106|FG000|Overall Study|Lack of Efficacy|6|||
163941190|NCT00839956|592154106|FG000|Overall Study|Physician Decision|1|||
163941191|NCT00839956|592154106|FG000|Overall Study|Withdrawal by Subject|3|||
163941192|NCT00846807|592154109|FG000|Overall Study|Adverse Event|270|||
163941193|NCT00846807|592154109|FG000|Overall Study|Lost to Follow-up|94|||
163941194|NCT00846807|592154109|FG000|Overall Study|Withdrawal by Subject|56|||
163941195|NCT00846807|592154109|FG000|Overall Study|Non compliant with European label|7|||
163941196|NCT00846807|592154109|FG000|Overall Study|Switch to other anticoagulants|89|||
163941197|NCT00846807|592154109|FG000|Overall Study|No prescription after hospital discharge|56|||
164041543|NCT01131078|592512414|FG000|Overall Study|Other|0|||
163941198|NCT00846807|592154109|FG000|Overall Study|Other|60|||
163941199|NCT00737698|592154110|FG000|Overall Study|Withdrawal by Subject|6|||
163941200|NCT00737698|592154111|FG001|Overall Study|Withdrawal by Subject|5|||
163941201|NCT00737698|592154112|FG002|Overall Study|Withdrawal by Subject|3|||
163941202|NCT00737698|592154110|FG000|Overall Study|Death|0|||
163941203|NCT00737698|592154111|FG001|Overall Study|Death|0|||
163941204|NCT00737698|592154112|FG002|Overall Study|Death|1|||
163941205|NCT01067846|592154113|FG000|Overall Study|Lost to Follow-up|17|||
163941206|NCT01067846|592154114|FG001|Overall Study|Lost to Follow-up|19|||
163941207|NCT01067846|592154113|FG000|Overall Study|Withdrawal by Subject|1|||
163941208|NCT01067846|592154114|FG001|Overall Study|Withdrawal by Subject|0|||
163941209|NCT01067846|592154113|FG000|Overall Study|participation in other tx study|1|||
163941210|NCT01067846|592154114|FG001|Overall Study|participation in other tx study|0|||
163941211|NCT02817906|592154115|FG000|Overall Study|Adverse Event|3|||
163941212|NCT02817906|592154116|FG001|Overall Study|Adverse Event|0|||
163941213|NCT02817906|592154115|FG000|Overall Study|Lack of Efficacy|1|||
163941214|NCT02817906|592154116|FG001|Overall Study|Lack of Efficacy|0|||
163941215|NCT02817906|592154115|FG000|Overall Study|Protocol Violation|1|||
164041544|NCT01131078|592512415|FG001|Overall Study|Other|1|||
163941216|NCT02817906|592154116|FG001|Overall Study|Protocol Violation|1|||
163941217|NCT02817906|592154115|FG000|Overall Study|Study Terminated by Sponsor|2|||
163941218|NCT02817906|592154116|FG001|Overall Study|Study Terminated by Sponsor|2|||
163941219|NCT02817906|592154115|FG000|Overall Study|Withdrawal by Subject|7|||
163941220|NCT02817906|592154116|FG001|Overall Study|Withdrawal by Subject|0|||
163941221|NCT02817906|592154115|FG000|Overall Study|Other|2|||
163941222|NCT02817906|592154116|FG001|Overall Study|Other|2|||
163941223|NCT03686423|592154125|FG000|Overall Study|Withdrawal by Subject|9|||
163941224|NCT03686423|592154125|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
164041545|NCT01131078|592512416|FG002|Overall Study|Other|0|||
164041546|NCT02177786|592512417|FG000|Overall Study|Withdrew Consent|2|||
164041547|NCT02177786|592512418|FG001|Overall Study|Withdrew Consent|6|||
164041548|NCT02177786|592512419|FG002|Overall Study|Withdrew Consent|9|||
164041549|NCT02177786|592512420|FG003|Overall Study|Withdrew Consent|5|||
164041550|NCT02177786|592512417|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
164041551|NCT02177786|592512418|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
164041552|NCT02177786|592512419|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
164041553|NCT02177786|592512420|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
164041554|NCT02177786|592512417|FG000|Overall Study|Adverse Event|1|||
164041555|NCT02177786|592512418|FG001|Overall Study|Adverse Event|1|||
164041556|NCT02177786|592512419|FG002|Overall Study|Adverse Event|2|||
164041557|NCT02177786|592512420|FG003|Overall Study|Adverse Event|3|||
164041558|NCT02177786|592512417|FG000|Overall Study|Death|1|||
164041559|NCT02177786|592512418|FG001|Overall Study|Death|1|||
164041560|NCT02177786|592512419|FG002|Overall Study|Death|1|||
164041561|NCT02177786|592512420|FG003|Overall Study|Death|1|||
164041562|NCT02177786|592512417|FG000|Overall Study|Lost to Follow-up|0|||
164041563|NCT02177786|592512418|FG001|Overall Study|Lost to Follow-up|0|||
164041564|NCT02177786|592512419|FG002|Overall Study|Lost to Follow-up|2|||
164041565|NCT02177786|592512420|FG003|Overall Study|Lost to Follow-up|2|||
164041566|NCT02177786|592512417|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164041567|NCT02177786|592512418|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164041568|NCT02177786|592512419|FG002|Overall Study|Non-Compliance with Study Drug|0|||
164041569|NCT02177786|592512420|FG003|Overall Study|Non-Compliance with Study Drug|1|||
164041570|NCT02177786|592512417|FG000|Overall Study|Protocol Violation|0|||
164041571|NCT02177786|592512418|FG001|Overall Study|Protocol Violation|0|||
164041572|NCT02177786|592512419|FG002|Overall Study|Protocol Violation|2|||
164041573|NCT02177786|592512420|FG003|Overall Study|Protocol Violation|0|||
164041574|NCT02177786|592512417|FG000|Overall Study|Progressive Disease|0|||
164041575|NCT02177786|592512418|FG001|Overall Study|Progressive Disease|1|||
164041576|NCT02177786|592512419|FG002|Overall Study|Progressive Disease|0|||
164041577|NCT02177786|592512420|FG003|Overall Study|Progressive Disease|0|||
164041578|NCT02177786|592512417|FG000|Overall Study|Missing study completion status|0|||
164041579|NCT02177786|592512418|FG001|Overall Study|Missing study completion status|1|||
164041580|NCT02177786|592512419|FG002|Overall Study|Missing study completion status|0|||
164041581|NCT02177786|592512420|FG003|Overall Study|Missing study completion status|0|||
164041582|NCT01305941|592512421|FG000|Overall Study|Adverse Event|6|||
164041583|NCT01305941|592512421|FG000|Overall Study|Clinical decline|2|||
164041584|NCT01305941|592512421|FG000|Overall Study|Withdrawal by Subject|1|||
164041585|NCT01305941|592512421|FG000|Overall Study|Death|1|||
164041586|NCT00430027|592512423|FG000|Overall Study|Study terminated|8|||
164041587|NCT01957215|592512424|FG000|Overall Study|Adverse Event|2|||
164041588|NCT01957215|592512425|FG001|Overall Study|Adverse Event|2|||
164041589|NCT01957215|592512424|FG000|Overall Study|Lost to Follow-up|3|||
164041590|NCT01957215|592512425|FG001|Overall Study|Lost to Follow-up|3|||
164041591|NCT01957215|592512424|FG000|Overall Study|Protocol Violation|1|||
164041592|NCT01957215|592512425|FG001|Overall Study|Protocol Violation|2|||
164041593|NCT01957215|592512424|FG000|Overall Study|Withdrawal by Subject|7|||
164041594|NCT01957215|592512425|FG001|Overall Study|Withdrawal by Subject|5|||
164041595|NCT01977040|592512428|FG000|Overall Study|Vasa previa not confirmed|2|||
164041596|NCT03597503|592512432|FG000|Overall Study|Withdrawal by Subject|0|||
164041597|NCT03597503|592512433|FG001|Overall Study|Withdrawal by Subject|2|||
164041598|NCT03597503|592512432|FG000|Overall Study|Lost to Follow-up|1|||
164041599|NCT03597503|592512433|FG001|Overall Study|Lost to Follow-up|2|||
164041600|NCT03597503|592512432|FG000|Overall Study|Protocol Violation|1|||
164098904|NCT01536405|592726951|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
164098905|NCT01536405|592726950|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
163941225|NCT04954326|592154126|FG000|Overall Study|Protocol Violation|0|||
164041601|NCT03597503|592512433|FG001|Overall Study|Protocol Violation|0|||
164041602|NCT02667236|592512436|FG000|Overall Study|Adverse Event|1|||
164041603|NCT02667236|592512437|FG001|Overall Study|Adverse Event|1|||
164041604|NCT02667236|592512436|FG000|Overall Study|Withdrawal by Subject|2|||
164041605|NCT02667236|592512437|FG001|Overall Study|Withdrawal by Subject|0|||
164041606|NCT00634751|592512438|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
164041607|NCT00634751|592512439|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
164041608|NCT00634751|592512440|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
164041609|NCT00634751|592512441|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
163941226|NCT04954326|592154127|FG001|Overall Study|Protocol Violation|1|||
163941227|NCT04954326|592154126|FG000|Overall Study|Death|0|||
163941228|NCT04954326|592154127|FG001|Overall Study|Death|2|||
163941229|NCT04954326|592154126|FG000|Overall Study|Physician Decision|0|||
163941230|NCT04954326|592154127|FG001|Overall Study|Physician Decision|1|||
163941231|NCT01495598|592154130|FG000|Overall Study|Death during follow up period|2|||
163941232|NCT01495598|592154130|FG000|Overall Study|Death on study|1|||
163941233|NCT01495598|592154130|FG000|Overall Study|Lost to Follow-up|3|||
163941234|NCT01495598|592154130|FG000|Overall Study|Physician Decision|8|||
163941235|NCT01110408|592154133|FG000|Overall Study|Protocol Violation|1|||
163941236|NCT01110408|592154134|FG001|Overall Study|Protocol Violation|0|||
163941237|NCT00669877|592154135|FG000|Overall Study|Disease Progression/Death|4|||
163941238|NCT05140915|592154136|FG000|Overall Study|Lost to Follow-up|2|||
163941239|NCT05140915|592154137|FG001|Overall Study|Lost to Follow-up|1|||
163941240|NCT04520659|592154138|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
163941241|NCT04520659|592154139|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
163941242|NCT04520659|592154140|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
163941243|NCT04520659|592154141|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
163941244|NCT04485611|592154146|FG000|Prehabilitation|Physician Decision|1|||
163941245|NCT04879849|592154147|FG000|Overall Study|Lost to Follow-up|0|||
163941246|NCT04879849|592154148|FG001|Overall Study|Lost to Follow-up|0|||
163941247|NCT04879849|592154149|FG002|Overall Study|Lost to Follow-up|0|||
163941248|NCT04879849|592154150|FG003|Overall Study|Lost to Follow-up|1|||
163941249|NCT04879849|592154151|FG004|Overall Study|Lost to Follow-up|0|||
163941250|NCT04879849|592154152|FG005|Overall Study|Lost to Follow-up|0|||
163941251|NCT04879849|592154153|FG006|Overall Study|Lost to Follow-up|0|||
163941252|NCT04879849|592154154|FG007|Overall Study|Lost to Follow-up|0|||
163941253|NCT04879849|592154147|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
163941254|NCT04879849|592154148|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
163941255|NCT04879849|592154149|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
163941256|NCT04879849|592154150|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
163941257|NCT04879849|592154151|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
163941258|NCT04879849|592154152|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
163941259|NCT04879849|592154153|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
163941260|NCT04879849|592154154|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
163941261|NCT04879849|592154147|FG000|Overall Study|Withdrawal by Subject|0|||
163941262|NCT04879849|592154148|FG001|Overall Study|Withdrawal by Subject|0|||
163941263|NCT04879849|592154149|FG002|Overall Study|Withdrawal by Subject|0|||
163941264|NCT04879849|592154150|FG003|Overall Study|Withdrawal by Subject|0|||
163941265|NCT04879849|592154151|FG004|Overall Study|Withdrawal by Subject|2|||
163941266|NCT04879849|592154152|FG005|Overall Study|Withdrawal by Subject|0|||
163941267|NCT04879849|592154153|FG006|Overall Study|Withdrawal by Subject|1|||
163941268|NCT04879849|592154154|FG007|Overall Study|Withdrawal by Subject|0|||
163941269|NCT04879849|592154147|FG000|Overall Study|Progressive Disease|0|||
163941270|NCT04879849|592154148|FG001|Overall Study|Progressive Disease|0|||
163941271|NCT04879849|592154149|FG002|Overall Study|Progressive Disease|1|||
163941272|NCT04879849|592154150|FG003|Overall Study|Progressive Disease|0|||
163941273|NCT04879849|592154151|FG004|Overall Study|Progressive Disease|0|||
163941274|NCT04879849|592154152|FG005|Overall Study|Progressive Disease|0|||
163941275|NCT04879849|592154153|FG006|Overall Study|Progressive Disease|0|||
163941276|NCT04879849|592154154|FG007|Overall Study|Progressive Disease|0|||
163941277|NCT04879849|592154147|FG000|Overall Study|Death|0|||
163941278|NCT04879849|592154148|FG001|Overall Study|Death|0|||
163941279|NCT04879849|592154149|FG002|Overall Study|Death|1|||
163941280|NCT04879849|592154150|FG003|Overall Study|Death|1|||
163941281|NCT04879849|592154151|FG004|Overall Study|Death|1|||
163941282|NCT04879849|592154152|FG005|Overall Study|Death|2|||
163941283|NCT04879849|592154153|FG006|Overall Study|Death|1|||
163941284|NCT04879849|592154154|FG007|Overall Study|Death|2|||
163941285|NCT04879849|592154147|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
163941286|NCT04879849|592154148|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
163941287|NCT04879849|592154149|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
163941288|NCT04879849|592154150|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
163941289|NCT04879849|592154151|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
163941290|NCT04879849|592154152|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
163941291|NCT04879849|592154153|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
163941292|NCT04879849|592154154|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
163941293|NCT04879849|592154147|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163941294|NCT04879849|592154148|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163941295|NCT04879849|592154149|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163941296|NCT04879849|592154150|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163941297|NCT04879849|592154151|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163941298|NCT04879849|592154152|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
164098906|NCT01536405|592726951|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
164098907|NCT01536405|592726950|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
163941299|NCT04879849|592154153|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
163941300|NCT04879849|592154154|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
163941301|NCT04879849|592154147|FG000|Overall Study|Reason Not Specified|1|||
163941302|NCT04879849|592154148|FG001|Overall Study|Reason Not Specified|0|||
163941303|NCT04879849|592154149|FG002|Overall Study|Reason Not Specified|0|||
163941304|NCT04879849|592154150|FG003|Overall Study|Reason Not Specified|0|||
163941305|NCT04879849|592154151|FG004|Overall Study|Reason Not Specified|0|||
163941306|NCT04879849|592154152|FG005|Overall Study|Reason Not Specified|0|||
163941307|NCT04879849|592154153|FG006|Overall Study|Reason Not Specified|0|||
163941308|NCT04879849|592154154|FG007|Overall Study|Reason Not Specified|0|||
163941309|NCT03007420|592154156|FG000|Overall Study|Withdrawal by Subject|0|||
163941310|NCT03007420|592154157|FG001|Overall Study|Withdrawal by Subject|2|||
163941311|NCT03007420|592154156|FG000|Overall Study|Physician Decision|0|||
163941312|NCT03007420|592154157|FG001|Overall Study|Physician Decision|1|||
163941313|NCT02284009|592154161|FG000|Overall Study|Adverse Event|3|||
163941314|NCT02284009|592154162|FG001|Overall Study|Adverse Event|0|||
163941315|NCT02284009|592154161|FG000|Overall Study|Lost to Follow-up|1|||
163941316|NCT02284009|592154162|FG001|Overall Study|Lost to Follow-up|3|||
163941317|NCT02284009|592154161|FG000|Overall Study|Physician Decision|0|||
163941318|NCT02284009|592154162|FG001|Overall Study|Physician Decision|2|||
163941319|NCT02284009|592154161|FG000|Overall Study|Withdrawal by Subject|2|||
163941320|NCT02284009|592154162|FG001|Overall Study|Withdrawal by Subject|5|||
163941321|NCT04147195|592154163|FG000|Overall Study|Adverse Event|0|||
163941322|NCT04147195|592154164|FG001|Overall Study|Adverse Event|3|||
163941323|NCT04147195|592154163|FG000|Overall Study|Study Terminated by Sponsor|4|||
163941324|NCT04147195|592154164|FG001|Overall Study|Study Terminated by Sponsor|2|||
163941325|NCT04147195|592154163|FG000|Overall Study|Withdrawal by Subject|0|||
163941326|NCT04147195|592154164|FG001|Overall Study|Withdrawal by Subject|1|||
163941327|NCT03841526|592154165|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
163941328|NCT03841526|592154166|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163941329|NCT03841526|592154167|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163941330|NCT03841526|592154168|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
163941331|NCT03841526|592154169|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163941332|NCT03841526|592154170|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
163941333|NCT03841526|592154165|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
163941334|NCT03841526|592154166|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
163941335|NCT03841526|592154167|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
163941336|NCT03841526|592154168|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
163941337|NCT03841526|592154169|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
163941338|NCT03841526|592154170|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
163941339|NCT03841526|592154165|FG000|Outpatient Phase Treatment|Physician Decision|0|||
163941340|NCT03841526|592154166|FG001|Outpatient Phase Treatment|Physician Decision|1|||
163941341|NCT03841526|592154167|FG002|Outpatient Phase Treatment|Physician Decision|0|||
163941342|NCT03841526|592154168|FG003|Outpatient Phase Treatment|Physician Decision|0|||
163941343|NCT03841526|592154169|FG004|Outpatient Phase Treatment|Physician Decision|0|||
163941344|NCT03841526|592154170|FG005|Outpatient Phase Treatment|Physician Decision|0|||
163941345|NCT03841526|592154165|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163941346|NCT03841526|592154166|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163941347|NCT03841526|592154167|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
163941348|NCT03841526|592154168|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163941349|NCT03841526|592154169|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
163941350|NCT03841526|592154170|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
163941351|NCT01435772|592154171|FG000|Overall Study|Adverse Event|1|||
163941352|NCT01435772|592154172|FG001|Overall Study|Adverse Event|0|||
163941353|NCT01435772|592154173|FG002|Overall Study|Adverse Event|2|||
163941354|NCT01435772|592154171|FG000|Overall Study|Withdrawal by Subject|0|||
163941355|NCT01435772|592154172|FG001|Overall Study|Withdrawal by Subject|1|||
163941356|NCT01435772|592154173|FG002|Overall Study|Withdrawal by Subject|3|||
163941357|NCT01435772|592154171|FG000|Overall Study|Other - study termination|2|||
163941358|NCT01435772|592154172|FG001|Overall Study|Other - study termination|2|||
163941359|NCT01435772|592154173|FG002|Overall Study|Other - study termination|10|||
163941360|NCT03238963|592154174|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
163941361|NCT03238963|592154175|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
163941362|NCT03238963|592154174|FG000|Overall Study|Withdrawal by Subject|1|||
163941363|NCT03238963|592154175|FG001|Overall Study|Withdrawal by Subject|1|||
163941364|NCT03238963|592154174|FG000|Overall Study|Lost to Follow-up|1|||
163941365|NCT03238963|592154175|FG001|Overall Study|Lost to Follow-up|0|||
163941366|NCT03238963|592154174|FG000|Overall Study|Protocol Violation|1|||
164098908|NCT01536405|592726951|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
164098909|NCT01536405|592726950|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
164041610|NCT00634751|592512438|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
164041611|NCT00634751|592512439|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
164041612|NCT00634751|592512440|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
164098910|NCT01536405|592726951|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
164098911|NCT01536405|592726950|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
164098912|NCT01536405|592726951|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
164098913|NCT01536405|592726950|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
164098914|NCT01536405|592726951|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
164098915|NCT01536405|592726950|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
164098916|NCT01536405|592726951|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
164041613|NCT00634751|592512441|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
164041614|NCT00634751|592512438|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
164041615|NCT00634751|592512439|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
164041616|NCT00634751|592512440|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
164041617|NCT00634751|592512441|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
164041618|NCT00608894|592512442|FG000|Overall Study|Withdrawal by Subject|0|||
164041619|NCT00608894|592512443|FG001|Overall Study|Withdrawal by Subject|2|||
164041620|NCT03654560|592512444|FG000|Overall Study|Death|3|||
164098917|NCT01536405|592726950|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
164098918|NCT01536405|592726951|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
164098919|NCT01844375|592726955|FG000|Overall Study|Protocol Violation|1|||
163841025|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
163841026|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
163841027|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
163841028|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163841029|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163841030|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163841031|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
163841032|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
163841033|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
163841034|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
163841035|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163841036|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163841037|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163841038|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
163841039|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163841040|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
163841041|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
163841042|NCT04921969|591787512|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163841043|NCT04921969|591787513|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163841044|NCT04921969|591787514|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163841045|NCT04921969|591787515|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163841046|NCT04921969|591787516|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
163841047|NCT04921969|591787517|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
163841048|NCT04921969|591787518|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
163841049|NCT04287868|591787519|FG000|Overall Study|Screening fail|1|||
163841050|NCT04287868|591787520|FG001|Overall Study|Screening fail|0|||
163841051|NCT01242176|591788786|FG000|Washout Period of 7 Days|Adverse Event|0|||
163841052|NCT01242176|591788787|FG001|Washout Period of 7 Days|Adverse Event|2|||
163841053|NCT01242176|591788786|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
163841054|NCT01242176|591788787|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
163841055|NCT00358215|591788788|FG000|Overall Study|Ineligibility determined|4|||
163841056|NCT00358215|591788789|FG001|Overall Study|Ineligibility determined|3|||
163841057|NCT00358215|591788788|FG000|Overall Study|Adverse Event|83|||
163841058|NCT00358215|591788789|FG001|Overall Study|Adverse Event|65|||
163841059|NCT00358215|591788788|FG000|Overall Study|Withdrawal by Subject|111|||
163841060|NCT00358215|591788789|FG001|Overall Study|Withdrawal by Subject|102|||
163841061|NCT00358215|591788788|FG000|Overall Study|Participant request|65|||
164041621|NCT03654560|592512445|FG001|Overall Study|Death|1|||
164041622|NCT03654560|592512444|FG000|Overall Study|Lost to Follow-up|1|||
164041623|NCT03654560|592512445|FG001|Overall Study|Lost to Follow-up|0|||
164041624|NCT01235338|592512447|FG000|Overall Study|Adverse Event|3|||
164041625|NCT01235338|592512448|FG001|Overall Study|Adverse Event|2|||
164098920|NCT01844375|592726956|FG001|Overall Study|Protocol Violation|1|||
164098921|NCT03195491|592726957|FG000|Overall Study|Study drug toxicity|25|||
163841062|NCT00358215|591788789|FG001|Overall Study|Participant request|64|||
163841063|NCT00358215|591788788|FG000|Overall Study|Physician Decision|47|||
164041626|NCT01235338|592512447|FG000|Overall Study|Protocol Violation|1|||
163941367|NCT03238963|592154175|FG001|Overall Study|Protocol Violation|1|||
163941368|NCT03238963|592154174|FG000|Overall Study|Adverse Event|1|||
163941369|NCT03238963|592154175|FG001|Overall Study|Adverse Event|0|||
163941370|NCT05823012|592154176|FG000|Titration Period|Adverse Event|1|||
163941371|NCT05823012|592154176|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
163941372|NCT05823012|592154176|FG000|Maintenance Period|Adverse Event|1|||
163941373|NCT05823012|592154176|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
163941374|NCT05823012|592154176|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
163941375|NCT01424813|592154177|FG000|Overall Study|Withdrawal by Subject|3|||
163941376|NCT01424813|592154178|FG001|Overall Study|Withdrawal by Subject|0|||
163941377|NCT01424813|592154177|FG000|Overall Study|Protocol Violation|1|||
163941378|NCT01424813|592154178|FG001|Overall Study|Protocol Violation|0|||
163941379|NCT01424813|592154177|FG000|Overall Study|Other|1|||
163941380|NCT01424813|592154178|FG001|Overall Study|Other|2|||
163941381|NCT01977677|592155919|FG000|Overall Study|Unrelated Adverse Event|0|||
163941382|NCT01977677|592155920|FG001|Overall Study|Unrelated Adverse Event|0|||
163941383|NCT01977677|592155921|FG002|Overall Study|Unrelated Adverse Event|1|||
163941384|NCT01498887|592155922|FG000|Overall Study|Administrative problems|1|||
163941385|NCT01498887|592155923|FG001|Overall Study|Administrative problems|0|||
163941386|NCT01498887|592155922|FG000|Overall Study|Lost to Follow-up|1|||
163941387|NCT01498887|592155923|FG001|Overall Study|Lost to Follow-up|1|||
163941388|NCT01498887|592155922|FG000|Overall Study|Withdrawal by Subject|1|||
163941389|NCT01498887|592155923|FG001|Overall Study|Withdrawal by Subject|0|||
163941390|NCT01498887|592155922|FG000|Overall Study|Protocol Violation|1|||
163941391|NCT01498887|592155923|FG001|Overall Study|Protocol Violation|3|||
163941392|NCT01498887|592155922|FG000|Overall Study|Lack of Efficacy|5|||
163941393|NCT01498887|592155923|FG001|Overall Study|Lack of Efficacy|3|||
163941394|NCT01498887|592155922|FG000|Overall Study|Abnormal result from test procedure|1|||
163941395|NCT01498887|592155923|FG001|Overall Study|Abnormal result from test procedure|1|||
163941396|NCT01498887|592155922|FG000|Overall Study|Abnormal laboratory value|2|||
163941397|NCT01498887|592155923|FG001|Overall Study|Abnormal laboratory value|2|||
163941398|NCT01498887|592155922|FG000|Overall Study|Adverse Event|4|||
163941399|NCT01498887|592155923|FG001|Overall Study|Adverse Event|1|||
163941400|NCT00667225|592155928|FG000|Overall Study|Subject had no more lesions to treat.|1|||
163941401|NCT00667225|592155929|FG001|Overall Study|Subject had no more lesions to treat.|0|||
163941402|NCT00667225|592155928|FG000|Overall Study|Lost to Follow-up|0|||
163941403|NCT00667225|592155929|FG001|Overall Study|Lost to Follow-up|1|||
163941404|NCT02993406|592155930|FG000|Overall Study|Withdrawal by Subject|170|||
163941405|NCT02993406|592155931|FG001|Overall Study|Withdrawal by Subject|196|||
163941406|NCT02993406|592155930|FG000|Overall Study|Physician Decision|3|||
163941407|NCT02993406|592155931|FG001|Overall Study|Physician Decision|5|||
163941408|NCT02993406|592155930|FG000|Overall Study|Lost to Follow-up|12|||
163941409|NCT02993406|592155931|FG001|Overall Study|Lost to Follow-up|13|||
163941410|NCT02993406|592155930|FG000|Overall Study|Unclassifiable Response|105|||
163941411|NCT02993406|592155931|FG001|Overall Study|Unclassifiable Response|139|||
163941412|NCT02993406|592155930|FG000|Overall Study|Administrative decision|1|||
163941413|NCT02993406|592155931|FG001|Overall Study|Administrative decision|0|||
163941414|NCT02993406|592155930|FG000|Overall Study|Sponsor decision|4|||
163941415|NCT02993406|592155931|FG001|Overall Study|Sponsor decision|5|||
163941416|NCT02248818|592155932|FG000|Screening|Protocol Violation|0|||
163941417|NCT02248818|592155933|FG001|Screening|Protocol Violation|0|||
163941418|NCT02248818|592155934|FG002|Screening|Protocol Violation|0|||
163941419|NCT02248818|592155935|FG003|Screening|Protocol Violation|0|||
163941420|NCT02248818|592155936|FG004|Screening|Protocol Violation|0|||
163941421|NCT02248818|592155937|FG005|Screening|Protocol Violation|0|||
163941422|NCT02248818|592155938|FG006|Screening|Protocol Violation|0|||
163941423|NCT02248818|592155939|FG007|Screening|Protocol Violation|0|||
163941424|NCT02248818|592155940|FG008|Screening|Protocol Violation|7|||
163941425|NCT02248818|592155932|FG000|Screening|Study fully enrolled|0|||
163941426|NCT02248818|592155933|FG001|Screening|Study fully enrolled|0|||
163941427|NCT02248818|592155934|FG002|Screening|Study fully enrolled|0|||
163941428|NCT02248818|592155935|FG003|Screening|Study fully enrolled|0|||
163941429|NCT02248818|592155936|FG004|Screening|Study fully enrolled|0|||
163941430|NCT02248818|592155937|FG005|Screening|Study fully enrolled|0|||
163941431|NCT02248818|592155938|FG006|Screening|Study fully enrolled|0|||
163941432|NCT02248818|592155939|FG007|Screening|Study fully enrolled|0|||
163941433|NCT02248818|592155940|FG008|Screening|Study fully enrolled|14|||
163941434|NCT02248818|592155932|FG000|Screening|Physician Decision|0|||
163941435|NCT02248818|592155933|FG001|Screening|Physician Decision|0|||
163941436|NCT02248818|592155934|FG002|Screening|Physician Decision|0|||
163941437|NCT02248818|592155935|FG003|Screening|Physician Decision|0|||
163941438|NCT02248818|592155936|FG004|Screening|Physician Decision|0|||
163941439|NCT02248818|592155937|FG005|Screening|Physician Decision|0|||
163941440|NCT02248818|592155938|FG006|Screening|Physician Decision|0|||
163941441|NCT02248818|592155939|FG007|Screening|Physician Decision|0|||
163941442|NCT02248818|592155940|FG008|Screening|Physician Decision|73|||
163941443|NCT02248818|592155932|FG000|Screening|Withdrawal by Subject|0|||
163941444|NCT02248818|592155933|FG001|Screening|Withdrawal by Subject|0|||
163941445|NCT02248818|592155934|FG002|Screening|Withdrawal by Subject|0|||
163941446|NCT02248818|592155935|FG003|Screening|Withdrawal by Subject|0|||
163941447|NCT02248818|592155936|FG004|Screening|Withdrawal by Subject|0|||
163941448|NCT02248818|592155937|FG005|Screening|Withdrawal by Subject|0|||
163941449|NCT02248818|592155938|FG006|Screening|Withdrawal by Subject|0|||
163941450|NCT02248818|592155939|FG007|Screening|Withdrawal by Subject|0|||
163941451|NCT02248818|592155940|FG008|Screening|Withdrawal by Subject|6|||
163941452|NCT02248818|592155932|FG000|Screening|Lost to Follow-up|0|||
163941453|NCT02248818|592155933|FG001|Screening|Lost to Follow-up|0|||
163941454|NCT02248818|592155934|FG002|Screening|Lost to Follow-up|0|||
163941455|NCT02248818|592155935|FG003|Screening|Lost to Follow-up|0|||
163941456|NCT02248818|592155936|FG004|Screening|Lost to Follow-up|0|||
163941457|NCT02248818|592155937|FG005|Screening|Lost to Follow-up|0|||
163941458|NCT02248818|592155938|FG006|Screening|Lost to Follow-up|0|||
163941459|NCT02248818|592155939|FG007|Screening|Lost to Follow-up|0|||
163941460|NCT02248818|592155940|FG008|Screening|Lost to Follow-up|7|||
163941461|NCT02248818|592155932|FG000|Randomised Study|Administrative - randomization error|0|||
163941462|NCT02248818|592155933|FG001|Randomised Study|Administrative - randomization error|0|||
163941463|NCT02248818|592155934|FG002|Randomised Study|Administrative - randomization error|0|||
163941464|NCT02248818|592155935|FG003|Randomised Study|Administrative - randomization error|0|||
163941465|NCT02248818|592155936|FG004|Randomised Study|Administrative - randomization error|0|||
163941466|NCT02248818|592155937|FG005|Randomised Study|Administrative - randomization error|8|||
163941467|NCT02248818|592155938|FG006|Randomised Study|Administrative - randomization error|0|||
163941468|NCT02248818|592155939|FG007|Randomised Study|Administrative - randomization error|0|||
163941469|NCT02248818|592155940|FG008|Randomised Study|Administrative - randomization error|0|||
163941470|NCT04079868|592155941|FG000|Overall Study|Lost to Follow-up|100|||
163941471|NCT04079868|592155942|FG001|Overall Study|Lost to Follow-up|200|||
163941472|NCT04079868|592155941|FG000|Overall Study|Physician Decision|100|||
163941473|NCT04079868|592155942|FG001|Overall Study|Physician Decision|0|||
163941474|NCT04325282|592155945|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
163941475|NCT04325282|592155946|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
163941476|NCT04325282|592155945|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
163941477|NCT04325282|592155946|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
163941478|NCT00608868|592155951|FG000|Overall Study|Withdrawal by Subject|7|||
163941479|NCT00608868|592155951|FG000|Overall Study|Protocol Violation|3|||
163941480|NCT00608868|592155951|FG000|Overall Study|Lost to Follow-up|2|||
163941481|NCT00608868|592155951|FG000|Overall Study|Adverse Event|1|||
163941482|NCT00608868|592155951|FG000|Overall Study|Physician Decision|2|||
163941483|NCT03338296|592155952|FG000|Overall Study|Adverse Event|0|||
163941484|NCT03338296|592155953|FG001|Overall Study|Adverse Event|1|||
163941485|NCT03338296|592155952|FG000|Overall Study|Withdrawal by Subject|14|||
163941486|NCT03338296|592155953|FG001|Overall Study|Withdrawal by Subject|13|||
163941487|NCT03338296|592155952|FG000|Overall Study|Lost to Follow-up|10|||
163941488|NCT03338296|592155953|FG001|Overall Study|Lost to Follow-up|10|||
163941489|NCT03338296|592155952|FG000|Overall Study|Study Terminated by Sponsor|77|||
163941490|NCT03338296|592155953|FG001|Overall Study|Study Terminated by Sponsor|76|||
163941491|NCT03338296|592155952|FG000|Overall Study|Other|2|||
163941492|NCT03338296|592155953|FG001|Overall Study|Other|7|||
163941493|NCT03338296|592155952|FG000|Overall Study|Missing|0|||
163941494|NCT03338296|592155953|FG001|Overall Study|Missing|1|||
163941495|NCT00702962|592155956|FG000|Overall Study|Progressive disease|0|||
163941496|NCT00702962|592155957|FG001|Overall Study|Progressive disease|1|||
163941497|NCT00702962|592155956|FG000|Overall Study|Hospitalized for other health disorder|1|||
163941498|NCT00702962|592155957|FG001|Overall Study|Hospitalized for other health disorder|0|||
163941499|NCT01252355|592155958|FG000|Overall Study|Adverse Event|9|||
163941500|NCT01252355|592155959|FG001|Overall Study|Adverse Event|17|||
163941501|NCT01252355|592155960|FG002|Overall Study|Adverse Event|22|||
164041627|NCT01235338|592512448|FG001|Overall Study|Protocol Violation|1|||
163941502|NCT01252355|592155958|FG000|Overall Study|Lack of Efficacy|6|||
163941503|NCT01252355|592155959|FG001|Overall Study|Lack of Efficacy|4|||
163941504|NCT01252355|592155960|FG002|Overall Study|Lack of Efficacy|2|||
163941505|NCT01252355|592155958|FG000|Overall Study|Lost to Follow-up|0|||
163941506|NCT01252355|592155959|FG001|Overall Study|Lost to Follow-up|0|||
163941507|NCT01252355|592155960|FG002|Overall Study|Lost to Follow-up|1|||
163941508|NCT01252355|592155958|FG000|Overall Study|Poor Compliance to Protocol|1|||
163941509|NCT01252355|592155959|FG001|Overall Study|Poor Compliance to Protocol|1|||
163941510|NCT01252355|592155960|FG002|Overall Study|Poor Compliance to Protocol|1|||
163941511|NCT01252355|592155958|FG000|Overall Study|Progressive Disease|2|||
164041628|NCT01235338|592512447|FG000|Overall Study|Withdrawal by Subject|5|||
164041629|NCT01235338|592512448|FG001|Overall Study|Withdrawal by Subject|0|||
163941512|NCT01252355|592155959|FG001|Overall Study|Progressive Disease|0|||
163941513|NCT01252355|592155960|FG002|Overall Study|Progressive Disease|0|||
163941514|NCT01252355|592155958|FG000|Overall Study|Sponsor Early Termination of Study|149|||
163941515|NCT01252355|592155959|FG001|Overall Study|Sponsor Early Termination of Study|149|||
163941516|NCT01252355|592155960|FG002|Overall Study|Sponsor Early Termination of Study|146|||
163941517|NCT01252355|592155958|FG000|Overall Study|Randomized but not Treated|2|||
163941518|NCT01252355|592155959|FG001|Overall Study|Randomized but not Treated|0|||
163941519|NCT01252355|592155960|FG002|Overall Study|Randomized but not Treated|0|||
163941520|NCT01252355|592155958|FG000|Overall Study|Other Than Above|8|||
163941521|NCT01252355|592155959|FG001|Overall Study|Other Than Above|7|||
163941522|NCT01252355|592155960|FG002|Overall Study|Other Than Above|7|||
163941523|NCT02175641|592155961|FG000|Overall Study|Death|3|||
163941524|NCT02175641|592155962|FG001|Overall Study|Death|4|||
163941525|NCT02175641|592155961|FG000|Overall Study|Lost to Follow-up|4|||
163941526|NCT02175641|592155962|FG001|Overall Study|Lost to Follow-up|4|||
163941527|NCT02175641|592155961|FG000|Overall Study|Withdrawal by Subject|7|||
163941528|NCT02175641|592155962|FG001|Overall Study|Withdrawal by Subject|4|||
163941529|NCT02175641|592155961|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
163941530|NCT02175641|592155962|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
163941531|NCT02175641|592155961|FG000|Overall Study|Developed Contraindicated Condition|8|||
163941532|NCT02175641|592155962|FG001|Overall Study|Developed Contraindicated Condition|0|||
163941533|NCT01876901|592155965|FG000|Overall Study|Protocol Violation|10|||
163941534|NCT01876901|592155966|FG001|Overall Study|Protocol Violation|2|||
163941535|NCT01876901|592155965|FG000|Overall Study|No or other surgical intervention|7|||
163941536|NCT01876901|592155966|FG001|Overall Study|No or other surgical intervention|5|||
163941537|NCT03031496|592155969|FG000|Period 1|Adverse Event|2|||
163941538|NCT03031496|592155970|FG001|Period 1|Adverse Event|0|||
163941539|NCT03031496|592155969|FG000|Period 1|Withdrawal by Subject|0|||
163941540|NCT03031496|592155970|FG001|Period 1|Withdrawal by Subject|2|||
163941541|NCT03868787|592155972|FG000|Overall Study|Withdrawal by Subject|2|||
163941542|NCT03868787|592155973|FG001|Overall Study|Withdrawal by Subject|1|||
163941543|NCT01399697|592155974|FG000|Overall Study|Adverse Event|13|||
163941544|NCT01399697|592155975|FG001|Overall Study|Adverse Event|3|||
163941545|NCT01399697|592155976|FG002|Overall Study|Adverse Event|1|||
163941546|NCT01399697|592155974|FG000|Overall Study|Lost to Follow-up|2|||
163941547|NCT01399697|592155975|FG001|Overall Study|Lost to Follow-up|0|||
163941548|NCT01399697|592155976|FG002|Overall Study|Lost to Follow-up|0|||
163941549|NCT01399697|592155974|FG000|Overall Study|Withdrawal by Subject|8|||
163941550|NCT01399697|592155975|FG001|Overall Study|Withdrawal by Subject|0|||
163941551|NCT01399697|592155976|FG002|Overall Study|Withdrawal by Subject|0|||
163941552|NCT01399697|592155974|FG000|Overall Study|Investigator Decisión|1|||
163941553|NCT01399697|592155975|FG001|Overall Study|Investigator Decisión|0|||
163941554|NCT01399697|592155976|FG002|Overall Study|Investigator Decisión|2|||
163941555|NCT01399697|592155974|FG000|Overall Study|Lack of Efficacy|9|||
163941556|NCT01399697|592155975|FG001|Overall Study|Lack of Efficacy|0|||
163941557|NCT01399697|592155976|FG002|Overall Study|Lack of Efficacy|1|||
163941558|NCT01399697|592155974|FG000|Overall Study|Protocol Violation|2|||
163941559|NCT01399697|592155975|FG001|Overall Study|Protocol Violation|0|||
163941560|NCT01399697|592155976|FG002|Overall Study|Protocol Violation|0|||
163941561|NCT01399697|592155974|FG000|Overall Study|Non-Compliant|1|||
163941562|NCT01399697|592155975|FG001|Overall Study|Non-Compliant|0|||
163941563|NCT01399697|592155976|FG002|Overall Study|Non-Compliant|0|||
163941564|NCT01399697|592155974|FG000|Overall Study|Inclusion Error|2|||
163941565|NCT01399697|592155975|FG001|Overall Study|Inclusion Error|0|||
163941566|NCT01399697|592155976|FG002|Overall Study|Inclusion Error|0|||
163941567|NCT01399697|592155974|FG000|Overall Study|Positive result for hepatitis B|1|||
163941568|NCT01399697|592155975|FG001|Overall Study|Positive result for hepatitis B|0|||
163941569|NCT01399697|592155976|FG002|Overall Study|Positive result for hepatitis B|0|||
163941570|NCT01399697|592155974|FG000|Overall Study|Clinical RA remission|1|||
163941571|NCT01399697|592155975|FG001|Overall Study|Clinical RA remission|0|||
163941572|NCT01399697|592155976|FG002|Overall Study|Clinical RA remission|0|||
163941573|NCT01399697|592155974|FG000|Overall Study|Sponsor Decision|1|||
163941574|NCT01399697|592155975|FG001|Overall Study|Sponsor Decision|0|||
163941575|NCT01399697|592155976|FG002|Overall Study|Sponsor Decision|0|||
163941576|NCT02807272|592155984|FG000|Overall Study|Death|9|||
163941577|NCT02807272|592155985|FG001|Overall Study|Death|5|||
163941578|NCT02807272|592155986|FG002|Overall Study|Death|2|||
163941579|NCT02807272|592155987|FG003|Overall Study|Death|0|||
163941580|NCT02807272|592155988|FG004|Overall Study|Death|1|||
163941581|NCT02807272|592155984|FG000|Overall Study|Lost to Follow-up|1|||
163941582|NCT02807272|592155985|FG001|Overall Study|Lost to Follow-up|0|||
163941583|NCT02807272|592155986|FG002|Overall Study|Lost to Follow-up|0|||
163941584|NCT02807272|592155987|FG003|Overall Study|Lost to Follow-up|0|||
163941585|NCT02807272|592155988|FG004|Overall Study|Lost to Follow-up|0|||
163941586|NCT02807272|592155984|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
163941587|NCT02807272|592155985|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
163941588|NCT02807272|592155986|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
163941589|NCT02807272|592155987|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
163941590|NCT02807272|592155988|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
163941591|NCT02807272|592155984|FG000|Overall Study|Protocol-defined Disease Progression|0|||
163941592|NCT02807272|592155985|FG001|Overall Study|Protocol-defined Disease Progression|1|||
163941593|NCT02807272|592155986|FG002|Overall Study|Protocol-defined Disease Progression|0|||
163941594|NCT02807272|592155987|FG003|Overall Study|Protocol-defined Disease Progression|0|||
163941595|NCT02807272|592155988|FG004|Overall Study|Protocol-defined Disease Progression|1|||
164041630|NCT01235338|592512447|FG000|Overall Study|Exclusion criteria violations|1|||
164041631|NCT01235338|592512448|FG001|Overall Study|Exclusion criteria violations|1|||
164041632|NCT01235338|592512447|FG000|Overall Study|Positive drug screen|0|||
164041633|NCT01235338|592512448|FG001|Overall Study|Positive drug screen|1|||
164041634|NCT01235338|592512447|FG000|Overall Study|Prohibited meds|1|||
164041635|NCT01235338|592512448|FG001|Overall Study|Prohibited meds|0|||
164041636|NCT05283499|592512450|FG000|Overall Study|Did not receive intervention|1|||
164041637|NCT05283499|592512451|FG001|Overall Study|Did not receive intervention|2|||
164041638|NCT02828644|592512452|FG000|Overall Study|Lost to Follow-up|23|||
164041639|NCT02828644|592512453|FG001|Overall Study|Lost to Follow-up|22|||
164041640|NCT02408484|592512454|FG000|Overall Study|Withdrawal by Subject|3|||
164041641|NCT02408484|592512454|FG000|Overall Study|Not treated during study period|1|||
164041642|NCT01117181|592512458|FG000|Overall Study|Lost to Follow-up|1|||
164041643|NCT01117181|592512459|FG001|Overall Study|Lost to Follow-up|0|||
164041644|NCT01117181|592512458|FG000|Overall Study|Withdrawal by Subject|0|||
164041645|NCT01117181|592512459|FG001|Overall Study|Withdrawal by Subject|2|||
164041646|NCT00524043|592512465|FG000|Overall Study|Lack of Efficacy|15|||
164041647|NCT00524043|592512466|FG001|Overall Study|Lack of Efficacy|13|||
164041648|NCT00524043|592512467|FG002|Overall Study|Lack of Efficacy|14|||
164041649|NCT00524043|592512465|FG000|Overall Study|Withdrawal by Subject|5|||
164041650|NCT00524043|592512466|FG001|Overall Study|Withdrawal by Subject|7|||
164041651|NCT00524043|592512467|FG002|Overall Study|Withdrawal by Subject|7|||
164041652|NCT00524043|592512465|FG000|Overall Study|Adverse Event|5|||
164041653|NCT00524043|592512466|FG001|Overall Study|Adverse Event|2|||
164041654|NCT00524043|592512467|FG002|Overall Study|Adverse Event|7|||
164041655|NCT00524043|592512465|FG000|Overall Study|Lost to Follow-up|3|||
164041656|NCT00524043|592512466|FG001|Overall Study|Lost to Follow-up|5|||
164041657|NCT00524043|592512467|FG002|Overall Study|Lost to Follow-up|3|||
164041658|NCT00524043|592512465|FG000|Overall Study|Various (eg, incarceration)|2|||
164041659|NCT00524043|592512466|FG001|Overall Study|Various (eg, incarceration)|1|||
164041660|NCT00524043|592512467|FG002|Overall Study|Various (eg, incarceration)|0|||
164041661|NCT00517413|592512469|FG000|Overall Study|Adverse Event|7|||
164041662|NCT00517413|592512469|FG000|Overall Study|Death|13|||
164041663|NCT00517413|592512469|FG000|Overall Study|Protocol Violation|15|||
164041664|NCT00517413|592512469|FG000|Overall Study|Withdrawal by Subject|2|||
164041665|NCT00517413|592512469|FG000|Overall Study|Failure to return|1|||
164041666|NCT00517413|592512469|FG000|Overall Study|Other-Reasons|23|||
164041667|NCT03938636|592512470|FG000|Overall Study|Protocol Violation|0|||
164041668|NCT03938636|592512471|FG001|Overall Study|Protocol Violation|1|||
164041669|NCT03938636|592512472|FG002|Overall Study|Protocol Violation|1|||
164041670|NCT03938636|592512470|FG000|Overall Study|Subject withdrew due to death in family|0|||
164041671|NCT03938636|592512471|FG001|Overall Study|Subject withdrew due to death in family|1|||
164041672|NCT03938636|592512472|FG002|Overall Study|Subject withdrew due to death in family|0|||
164041673|NCT03938636|592512470|FG000|Overall Study|Missed visit|0|||
164041674|NCT03938636|592512471|FG001|Overall Study|Missed visit|1|||
164041675|NCT03938636|592512472|FG002|Overall Study|Missed visit|0|||
164041676|NCT03938636|592512470|FG000|Overall Study|Adverse Event|0|||
164041677|NCT03938636|592512471|FG001|Overall Study|Adverse Event|0|||
164041678|NCT03938636|592512472|FG002|Overall Study|Adverse Event|1|||
164041679|NCT03938636|592512470|FG000|Overall Study|Lost to Follow-up|0|||
164041680|NCT03938636|592512471|FG001|Overall Study|Lost to Follow-up|0|||
164041681|NCT03938636|592512472|FG002|Overall Study|Lost to Follow-up|1|||
164041682|NCT00216086|592512473|FG000|Overall Study|Protocol Violation|1|||
164041683|NCT00216086|592512473|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
164041684|NCT00216086|592512473|FG000|Overall Study|Social Reasons|2|||
164041685|NCT01080625|592512480|FG000|Overall Study|Physician Decision|0|||
164041686|NCT01080625|592512481|FG001|Overall Study|Physician Decision|2|||
164041687|NCT01080625|592512482|FG002|Overall Study|Physician Decision|1|||
164041688|NCT00735072|592512487|FG000|Overall Study|interrupted study med during ARV change|1|||
164041689|NCT00735072|592512488|FG001|Overall Study|interrupted study med during ARV change|0|||
164041690|NCT00735072|592512487|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
164041691|NCT00735072|592512488|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
164041692|NCT00911144|592512489|FG000|Overall Study|Withdrawal by Subject|16|||
164041693|NCT00911144|592512490|FG001|Overall Study|Withdrawal by Subject|5|||
164041694|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
164041695|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
164041696|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
164041697|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
164041698|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
164041699|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
164041700|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
164041701|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
164041702|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
164041703|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
164098922|NCT03195491|592726958|FG001|Overall Study|Study drug toxicity|3|||
163941596|NCT02807272|592155984|FG000|Overall Study|Study Terminated by Sponsor|1|||
163941597|NCT02807272|592155985|FG001|Overall Study|Study Terminated by Sponsor|0|||
163941598|NCT02807272|592155986|FG002|Overall Study|Study Terminated by Sponsor|0|||
163941599|NCT02807272|592155987|FG003|Overall Study|Study Terminated by Sponsor|1|||
163941600|NCT02807272|592155988|FG004|Overall Study|Study Terminated by Sponsor|0|||
163941601|NCT02807272|592155984|FG000|Overall Study|Other|1|||
163941602|NCT02807272|592155985|FG001|Overall Study|Other|0|||
163941603|NCT02807272|592155986|FG002|Overall Study|Other|0|||
163941604|NCT02807272|592155987|FG003|Overall Study|Other|0|||
163941605|NCT02807272|592155988|FG004|Overall Study|Other|1|||
163941606|NCT01162863|592155991|FG000|Overall Study|Lack of Efficacy|1|||
163941607|NCT01162863|592155992|FG001|Overall Study|Lack of Efficacy|0|||
163941608|NCT01162863|592155993|FG002|Overall Study|Lack of Efficacy|0|||
163941609|NCT01162863|592155991|FG000|Overall Study|Adverse Event|0|||
163941610|NCT01162863|592155992|FG001|Overall Study|Adverse Event|1|||
163941611|NCT01162863|592155993|FG002|Overall Study|Adverse Event|0|||
163941612|NCT00392925|592155994|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
163941613|NCT00392925|592155995|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
163941614|NCT00392925|592155996|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
163941615|NCT00392925|592155997|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
163941616|NCT00392925|592155994|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
163941617|NCT00392925|592155995|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
163941618|NCT00392925|592155996|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
163941619|NCT00392925|592155997|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
163941620|NCT00392925|592155994|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
163941621|NCT00392925|592155995|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
163941622|NCT00392925|592155996|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
163941623|NCT00392925|592155997|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
163941624|NCT00392925|592155994|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
163941625|NCT00392925|592155995|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
163941626|NCT00392925|592155996|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
163941627|NCT00392925|592155997|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
163941628|NCT00392925|592155994|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
163941629|NCT00392925|592155995|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
163941630|NCT00392925|592155996|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
163941631|NCT00392925|592155997|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
163941632|NCT00392925|592155994|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
163941633|NCT00392925|592155995|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
163941634|NCT00392925|592155996|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
163941635|NCT00392925|592155997|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
163941636|NCT00392925|592155994|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
163941637|NCT00392925|592155995|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
163941638|NCT00392925|592155996|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
163941639|NCT00392925|592155997|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
163941640|NCT00392925|592155994|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
163941641|NCT00392925|592155995|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
163941642|NCT00392925|592155996|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
163941643|NCT00392925|592155997|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
163941644|NCT00392925|592155994|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
163941645|NCT00392925|592155995|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
163941646|NCT00392925|592155996|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
163941647|NCT00392925|592155997|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
163941648|NCT03552523|592155998|FG000|Overall Study|Withdrawal by Subject|1|||
163941649|NCT03552523|592155999|FG001|Overall Study|Withdrawal by Subject|1|||
163941650|NCT04145700|592156000|FG000|Overall Study|Withdrawal by Subject|8|||
163941651|NCT04145700|592156001|FG001|Overall Study|Withdrawal by Subject|3|||
163941652|NCT00780559|592156002|FG000|Overall Study|Lost to Follow-up|2|||
163941653|NCT00780559|592156003|FG001|Overall Study|Lost to Follow-up|7|||
163941654|NCT00780559|592156002|FG000|Overall Study|Death|1|||
163941655|NCT00780559|592156003|FG001|Overall Study|Death|0|||
163941656|NCT01840410|592156007|FG000|Overall Study|Physician Decision|1|||
163941657|NCT01840410|592156008|FG001|Overall Study|Physician Decision|2|||
163941658|NCT01840410|592156007|FG000|Overall Study|Pregnancy|1|||
163941659|NCT01840410|592156008|FG001|Overall Study|Pregnancy|0|||
163941660|NCT01840410|592156007|FG000|Overall Study|Protocol deviation|1|||
163941661|NCT01840410|592156008|FG001|Overall Study|Protocol deviation|0|||
163941662|NCT01840410|592156007|FG000|Overall Study|Lost to Follow-up|1|||
163941663|NCT01840410|592156008|FG001|Overall Study|Lost to Follow-up|0|||
163941664|NCT01840410|592156007|FG000|Overall Study|Withdrawal by Subject|2|||
163941665|NCT01840410|592156008|FG001|Overall Study|Withdrawal by Subject|1|||
163941666|NCT01840410|592156007|FG000|Overall Study|Adverse Event|1|||
164041704|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
164041705|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
164041706|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
164041707|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
164041708|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
164041709|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
164041710|NCT01291511|592512491|FG000|Cross-Titration and Stabilization Phase|Death|1|||
164041711|NCT01291511|592512492|FG001|Cross-Titration and Stabilization Phase|Death|0|||
164041712|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
164041713|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
164041714|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
164041715|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
164041716|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
164041717|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
164041718|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
164041719|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
164041720|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
164041721|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
164041722|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
164041723|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
164041724|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
164041725|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
164041726|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
164041727|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
164041728|NCT01291511|592512491|FG000|Double-blind Relapse Prevention Phase|Death|1|||
164041729|NCT01291511|592512492|FG001|Double-blind Relapse Prevention Phase|Death|0|||
164041730|NCT02640755|592512503|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
164041731|NCT02640755|592512504|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
164041732|NCT02640755|592512503|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
164041733|NCT02640755|592512504|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
164041734|NCT02640755|592512503|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
164041735|NCT02640755|592512504|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
164041736|NCT00865046|592512505|FG000|Overall Study|Lost to Follow-up|1|||
164041737|NCT00865046|592512506|FG001|Overall Study|Lost to Follow-up|4|||
164041738|NCT00865046|592512507|FG002|Overall Study|Lost to Follow-up|0|||
164041739|NCT00865046|592512505|FG000|Overall Study|Death|0|||
164041740|NCT00865046|592512506|FG001|Overall Study|Death|1|||
164041741|NCT00865046|592512507|FG002|Overall Study|Death|1|||
164041742|NCT00865046|592512505|FG000|Overall Study|Withdrawal by Subject|5|||
164041743|NCT00865046|592512506|FG001|Overall Study|Withdrawal by Subject|0|||
164041744|NCT00865046|592512507|FG002|Overall Study|Withdrawal by Subject|0|||
164041745|NCT00329784|592512512|FG000|Overall Study|Lost to Follow-up|0|||
164041746|NCT00329784|592512513|FG001|Overall Study|Lost to Follow-up|1|||
164041747|NCT00329784|592512514|FG002|Overall Study|Lost to Follow-up|0|||
164041748|NCT00329784|592512515|FG003|Overall Study|Lost to Follow-up|0|||
164041749|NCT00329784|592512512|FG000|Overall Study|Withdrawal by Subject|4|||
164041750|NCT00329784|592512513|FG001|Overall Study|Withdrawal by Subject|2|||
164041751|NCT00329784|592512514|FG002|Overall Study|Withdrawal by Subject|0|||
164041752|NCT00329784|592512515|FG003|Overall Study|Withdrawal by Subject|0|||
164041753|NCT00329784|592512512|FG000|Overall Study|Other|1|||
164041754|NCT00329784|592512513|FG001|Overall Study|Other|2|||
164041755|NCT00329784|592512514|FG002|Overall Study|Other|0|||
164041756|NCT00329784|592512515|FG003|Overall Study|Other|0|||
164041757|NCT00654420|592512516|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
164041758|NCT00654420|592512517|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
164041759|NCT00654420|592512518|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
163841064|NCT00358215|591788789|FG001|Overall Study|Physician Decision|39|||
163841065|NCT00358215|591788788|FG000|Overall Study|Lost to Follow-up|16|||
163841066|NCT00358215|591788789|FG001|Overall Study|Lost to Follow-up|22|||
163841067|NCT00358215|591788788|FG000|Overall Study|Death|265|||
163841068|NCT00358215|591788789|FG001|Overall Study|Death|281|||
163841069|NCT00358215|591788788|FG000|Overall Study|Protocol Violation|64|||
163841070|NCT00358215|591788789|FG001|Overall Study|Protocol Violation|59|||
164041760|NCT00654420|592512519|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
163841071|NCT00358215|591788788|FG000|Overall Study|Pregnancy|1|||
163841072|NCT00358215|591788789|FG001|Overall Study|Pregnancy|0|||
163841073|NCT00358215|591788788|FG000|Overall Study|Other|21|||
163841074|NCT00358215|591788789|FG001|Overall Study|Other|14|||
164041761|NCT00654420|592512516|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
164041762|NCT00654420|592512517|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
164041763|NCT00654420|592512518|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
164041764|NCT00654420|592512519|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
164041765|NCT00654420|592512516|FG000|Phase II|Adverse Event|0|||
164041766|NCT00654420|592512517|FG001|Phase II|Adverse Event|0|||
164041767|NCT00654420|592512518|FG002|Phase II|Adverse Event|3|||
164041768|NCT00654420|592512519|FG003|Phase II|Adverse Event|3|||
164041769|NCT00654420|592512516|FG000|Phase II|Lost to Follow-up|0|||
164041770|NCT00654420|592512517|FG001|Phase II|Lost to Follow-up|0|||
164041771|NCT00654420|592512518|FG002|Phase II|Lost to Follow-up|0|||
164041772|NCT00654420|592512519|FG003|Phase II|Lost to Follow-up|1|||
164041773|NCT00654420|592512516|FG000|Phase II|Physician Decision|0|||
164041774|NCT00654420|592512517|FG001|Phase II|Physician Decision|0|||
164041775|NCT00654420|592512518|FG002|Phase II|Physician Decision|0|||
164041776|NCT00654420|592512519|FG003|Phase II|Physician Decision|4|||
164041777|NCT00654420|592512516|FG000|Phase II|Progressive Disease|0|||
164041778|NCT00654420|592512517|FG001|Phase II|Progressive Disease|0|||
164041779|NCT00654420|592512518|FG002|Phase II|Progressive Disease|29|||
164041780|NCT00654420|592512519|FG003|Phase II|Progressive Disease|29|||
164041781|NCT00654420|592512516|FG000|Phase II|Withdrawal by Subject|0|||
164041782|NCT00654420|592512517|FG001|Phase II|Withdrawal by Subject|0|||
164041783|NCT00654420|592512518|FG002|Phase II|Withdrawal by Subject|4|||
164041784|NCT00654420|592512519|FG003|Phase II|Withdrawal by Subject|1|||
164041785|NCT00654420|592512516|FG000|Phase II|Missing Disposition Record|0|||
164041786|NCT00654420|592512517|FG001|Phase II|Missing Disposition Record|0|||
164041787|NCT00654420|592512518|FG002|Phase II|Missing Disposition Record|1|||
164041788|NCT00654420|592512519|FG003|Phase II|Missing Disposition Record|0|||
164041789|NCT01421069|592512522|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
164041790|NCT01421069|592512522|FG000|Parent Study|Failed to return|3|||
164041791|NCT01421069|592512522|FG000|Parent Study|Withdrawal by Subject|1|||
164041792|NCT01421069|592512522|FG000|Parent Study|Lost to Follow-up|2|||
164041793|NCT01421069|592512522|FG000|Parent Study|Lack of Efficacy|1|||
164041794|NCT01421069|592512522|FG000|Overall Period for Extension Study|Other|2|||
164041795|NCT01421069|592512522|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
164041796|NCT01421069|592512522|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
164041797|NCT01421069|592512522|FG000|Overall Period for Extension Study|Pregnancy|1|||
164041798|NCT01421069|592512522|FG000|Overall Period for Extension Study|Adverse Event|1|||
164041799|NCT01421069|592512522|FG000|Overall Period for Extension Study|Protocol Violation|1|||
164041800|NCT01421069|592512522|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
164041801|NCT01421069|592512522|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
164041802|NCT01421069|592512522|FG000|Active Treatment Period|Other|1|||
164041803|NCT01421069|592512522|FG000|Active Treatment Period|No longer willing to participate in study|8|||
164041804|NCT01421069|592512522|FG000|Active Treatment Period|Insufficient clinical response|1|||
164041805|NCT01421069|592512522|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
164041806|NCT01421069|592512522|FG000|Active Treatment Period|Pregnancy|1|||
164041807|NCT01421069|592512522|FG000|Active Treatment Period|Adverse Event|1|||
164041808|NCT01421069|592512522|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
163841075|NCT00358215|591788788|FG000|Overall Study|Did not receive investigational product|2|||
163841076|NCT00358215|591788789|FG001|Overall Study|Did not receive investigational product|3|||
163841077|NCT00871351|591788790|FG000|Overall Study|Withdrawal by Subject|1|||
163841078|NCT00871351|591788791|FG001|Overall Study|Withdrawal by Subject|0|||
163841079|NCT00871351|591788792|FG002|Overall Study|Withdrawal by Subject|0|||
163841080|NCT00871351|591788790|FG000|Overall Study|Adverse Event|3|||
163841081|NCT00871351|591788791|FG001|Overall Study|Adverse Event|1|||
163841082|NCT00871351|591788792|FG002|Overall Study|Adverse Event|0|||
163841083|NCT00744237|591788793|FG000|Overall Study|Lack of Efficacy|1|||
164041809|NCT01421069|592512522|FG000|Active Treatment Period|Enrolled in observational period|29|||
164041810|NCT01421069|592512522|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
164041811|NCT01421069|592512522|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
164041812|NCT01421069|592512522|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
163841084|NCT00744237|591788794|FG001|Overall Study|Lack of Efficacy|1|||
163841085|NCT00744237|591788795|FG002|Overall Study|Lack of Efficacy|0|||
163841086|NCT00744237|591788793|FG000|Overall Study|Withdrawal by Subject|9|||
163841087|NCT00744237|591788794|FG001|Overall Study|Withdrawal by Subject|5|||
163841088|NCT00744237|591788795|FG002|Overall Study|Withdrawal by Subject|3|||
163841089|NCT00744237|591788793|FG000|Overall Study|Lost to Follow-up|1|||
163841090|NCT00744237|591788794|FG001|Overall Study|Lost to Follow-up|1|||
163841091|NCT00744237|591788795|FG002|Overall Study|Lost to Follow-up|1|||
163841092|NCT00744237|591788793|FG000|Overall Study|Protocol Violation|3|||
163841093|NCT00744237|591788794|FG001|Overall Study|Protocol Violation|4|||
163841094|NCT00744237|591788795|FG002|Overall Study|Protocol Violation|3|||
163841095|NCT00744237|591788793|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
163841096|NCT00744237|591788794|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
163841097|NCT00744237|591788795|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
163841098|NCT00744237|591788793|FG000|Overall Study|Dosing Error|1|||
163841099|NCT00744237|591788794|FG001|Overall Study|Dosing Error|0|||
163841100|NCT00744237|591788795|FG002|Overall Study|Dosing Error|1|||
163841101|NCT00744237|591788793|FG000|Overall Study|Study Drug Error|1|||
163941667|NCT01840410|592156008|FG001|Overall Study|Adverse Event|1|||
163941668|NCT00594880|592156009|FG000|Overall Study|Withdrawal by Subject|1|||
163941669|NCT00594880|592156010|FG001|Overall Study|Withdrawal by Subject|1|||
164041813|NCT01421069|592512522|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
164041814|NCT01421069|592512522|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
164041815|NCT01421069|592512522|FG000|2b. Retreatment Period|Protocol Violation|1|||
164041816|NCT01421069|592512522|FG000|Observational Period|Other|1|||
163941670|NCT00594880|592156009|FG000|Overall Study|Lost to Follow-up|1|||
163941671|NCT00594880|592156010|FG001|Overall Study|Lost to Follow-up|0|||
163941672|NCT02206061|592156011|FG000|Overall Study|Withdrawal by Subject|4|||
163941673|NCT02206061|592156012|FG001|Overall Study|Withdrawal by Subject|7|||
163941674|NCT02206061|592156013|FG002|Overall Study|Withdrawal by Subject|1|||
163941675|NCT02206061|592156011|FG000|Overall Study|Lost to Follow-up|14|||
163941676|NCT02206061|592156012|FG001|Overall Study|Lost to Follow-up|7|||
163941677|NCT02206061|592156013|FG002|Overall Study|Lost to Follow-up|20|||
163941678|NCT00694109|592156014|FG000|Overall Study|Physician Decision|3|||
163941679|NCT00694109|592156014|FG000|Overall Study|Adverse Event|74|||
163941680|NCT00694109|592156014|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
163941681|NCT00694109|592156014|FG000|Overall Study|Lack of Efficacy|2|||
163941682|NCT00694109|592156014|FG000|Overall Study|Withdrawal by Subject|13|||
163941683|NCT00694109|592156014|FG000|Overall Study|Pregnancy|1|||
163941684|NCT00694109|592156014|FG000|Overall Study|Enrolled but not treated|1|||
163941685|NCT00694109|592156014|FG000|Overall Study|Other|2|||
163941686|NCT00694109|592156014|FG000|Overall Study|Consented but no additional treatment|3|||
163941687|NCT01077518|592156017|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
163941688|NCT01077518|592156018|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
163941689|NCT01077518|592156019|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
163941690|NCT01077518|592156017|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
163941691|NCT01077518|592156018|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
163941692|NCT01077518|592156019|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
163941693|NCT01077518|592156017|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
163941694|NCT01077518|592156018|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
163941695|NCT01077518|592156019|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
163941696|NCT01077518|592156017|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
163941697|NCT01077518|592156018|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
163941698|NCT01077518|592156019|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
163941699|NCT01077518|592156017|FG000|Optional Ofa Phase|Physician Decision|0|||
163941700|NCT01077518|592156018|FG001|Optional Ofa Phase|Physician Decision|0|||
163941701|NCT01077518|592156019|FG002|Optional Ofa Phase|Physician Decision|1|||
163941702|NCT01077518|592156017|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
163941703|NCT01077518|592156018|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
163941704|NCT01077518|592156019|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
163941705|NCT01077518|592156017|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
163941706|NCT01077518|592156018|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
163941707|NCT01077518|592156019|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
163941708|NCT04958200|592156020|FG000|Overall Study|Withdrawal by Subject|0|||
163941709|NCT04958200|592156021|FG001|Overall Study|Withdrawal by Subject|2|||
163941710|NCT04958200|592156020|FG000|Overall Study|Lost to Follow-up|3|||
163941711|NCT04958200|592156021|FG001|Overall Study|Lost to Follow-up|2|||
163941712|NCT04157400|592156026|FG000|Overall Study|Withdrawal by Subject|1|||
163941713|NCT04157400|592156026|FG000|Overall Study|Lost to Follow-up|3|||
163941714|NCT03852719|592156029|FG000|Overall Study|Withdrawal of consent|8|||
163941715|NCT03852719|592156030|FG001|Overall Study|Withdrawal of consent|8|||
163941716|NCT03852719|592156031|FG002|Overall Study|Withdrawal of consent|9|||
163941717|NCT03852719|592156029|FG000|Overall Study|Physician Decision|5|||
163941718|NCT03852719|592156030|FG001|Overall Study|Physician Decision|4|||
163941719|NCT03852719|592156031|FG002|Overall Study|Physician Decision|1|||
163941720|NCT03852719|592156029|FG000|Overall Study|Pregnancy|2|||
164041817|NCT01421069|592512522|FG000|Observational Period|No longer willing to participate in study|4|||
164041818|NCT01421069|592512522|FG000|Observational Period|Lost to Follow-up|3|||
164041819|NCT02709109|592512529|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
163941721|NCT03852719|592156030|FG001|Overall Study|Pregnancy|1|||
163941722|NCT03852719|592156031|FG002|Overall Study|Pregnancy|0|||
163941723|NCT03852719|592156029|FG000|Overall Study|Death|1|||
164041820|NCT02709109|592512530|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
164041821|NCT02709109|592512531|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
164041822|NCT02709109|592512532|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
164041823|NCT02709109|592512529|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
164147707|NCT02006732|592902129|FG000|Overall Study|Lost to Follow-up|0|||
163941724|NCT03852719|592156030|FG001|Overall Study|Death|0|||
163941725|NCT03852719|592156031|FG002|Overall Study|Death|0|||
163941726|NCT03852719|592156029|FG000|Overall Study|Reason not Specified|3|||
163941727|NCT03852719|592156030|FG001|Overall Study|Reason not Specified|3|||
164041824|NCT02709109|592512530|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
163941728|NCT03852719|592156031|FG002|Overall Study|Reason not Specified|5|||
163941729|NCT03852719|592156029|FG000|Overall Study|Adverse Event|2|||
163941730|NCT03852719|592156030|FG001|Overall Study|Adverse Event|1|||
163941731|NCT03852719|592156031|FG002|Overall Study|Adverse Event|4|||
163941732|NCT03852719|592156029|FG000|Overall Study|Progressive disease|1|||
163941733|NCT03852719|592156030|FG001|Overall Study|Progressive disease|4|||
163941734|NCT03852719|592156031|FG002|Overall Study|Progressive disease|1|||
163941735|NCT03852719|592156029|FG000|Overall Study|Lost to Follow-up|1|||
163941736|NCT03852719|592156030|FG001|Overall Study|Lost to Follow-up|0|||
163941737|NCT03852719|592156031|FG002|Overall Study|Lost to Follow-up|0|||
163941738|NCT04201262|592156032|FG000|Primary Treatment Period|Adverse Event|1|||
163941739|NCT04201262|592156033|FG001|Primary Treatment Period|Adverse Event|2|||
163941740|NCT04201262|592156032|FG000|Primary Treatment Period|Physician Decision|1|||
163941741|NCT04201262|592156033|FG001|Primary Treatment Period|Physician Decision|1|||
163941742|NCT04201262|592156032|FG000|Long-term Extension Period|Death|1|||
163941743|NCT04201262|592156033|FG001|Long-term Extension Period|Death|0|||
163941744|NCT02819024|592156035|FG000|Overall Study|Withdrawal by Subject|1|||
163941745|NCT05217641|592156039|FG000|Overall Study|Lost to Follow-up|1|||
163941746|NCT05217641|592156040|FG001|Overall Study|Lost to Follow-up|1|||
163941747|NCT05217641|592156041|FG002|Overall Study|Lost to Follow-up|0|||
163941748|NCT05217641|592156042|FG003|Overall Study|Lost to Follow-up|1|||
163941749|NCT05217641|592156043|FG004|Overall Study|Lost to Follow-up|1|||
163941750|NCT05217641|592156044|FG005|Overall Study|Lost to Follow-up|0|||
163941751|NCT05217641|592156039|FG000|Overall Study|Withdrawal by Subject|0|||
163941752|NCT05217641|592156040|FG001|Overall Study|Withdrawal by Subject|0|||
163941753|NCT05217641|592156041|FG002|Overall Study|Withdrawal by Subject|0|||
163941754|NCT05217641|592156042|FG003|Overall Study|Withdrawal by Subject|3|||
163941755|NCT05217641|592156043|FG004|Overall Study|Withdrawal by Subject|1|||
163941756|NCT05217641|592156044|FG005|Overall Study|Withdrawal by Subject|0|||
163941757|NCT05217641|592156039|FG000|Overall Study|Other: participant did not specify reason|0|||
163941758|NCT05217641|592156040|FG001|Overall Study|Other: participant did not specify reason|0|||
163941759|NCT05217641|592156041|FG002|Overall Study|Other: participant did not specify reason|0|||
163941760|NCT05217641|592156042|FG003|Overall Study|Other: participant did not specify reason|0|||
163941761|NCT05217641|592156043|FG004|Overall Study|Other: participant did not specify reason|1|||
163941762|NCT05217641|592156044|FG005|Overall Study|Other: participant did not specify reason|0|||
163941763|NCT05217641|592156039|FG000|Overall Study|Extended Follow up|1|||
163941764|NCT05217641|592156040|FG001|Overall Study|Extended Follow up|1|||
163941765|NCT05217641|592156041|FG002|Overall Study|Extended Follow up|0|||
163941766|NCT05217641|592156042|FG003|Overall Study|Extended Follow up|0|||
163941767|NCT05217641|592156043|FG004|Overall Study|Extended Follow up|1|||
163941768|NCT05217641|592156044|FG005|Overall Study|Extended Follow up|0|||
163941769|NCT03682185|592156047|FG000|Overall Study|Lost to Follow-up|4|||
163941770|NCT03682185|592156048|FG001|Overall Study|Lost to Follow-up|7|||
163941771|NCT03682185|592156049|FG002|Overall Study|Lost to Follow-up|4|||
163941772|NCT03682185|592156050|FG003|Overall Study|Lost to Follow-up|7|||
163941773|NCT03682185|592156051|FG004|Overall Study|Lost to Follow-up|1|||
163941774|NCT03682185|592156047|FG000|Overall Study|Withdrawal by Subject|7|||
163941775|NCT03682185|592156048|FG001|Overall Study|Withdrawal by Subject|3|||
163941776|NCT03682185|592156049|FG002|Overall Study|Withdrawal by Subject|7|||
163941777|NCT03682185|592156050|FG003|Overall Study|Withdrawal by Subject|3|||
163941778|NCT03682185|592156051|FG004|Overall Study|Withdrawal by Subject|0|||
163941779|NCT03548220|592156053|FG000|Overall Study|Lost to Follow-up|1|||
163941780|NCT03548220|592156054|FG001|Overall Study|Lost to Follow-up|0|||
163941781|NCT03548220|592156055|FG002|Overall Study|Lost to Follow-up|0|||
163941782|NCT03548220|592156056|FG003|Overall Study|Lost to Follow-up|0|||
163941783|NCT02397447|592156057|FG000|Overall Study|Lost to Follow-up|2|||
163941784|NCT02397447|592156058|FG001|Overall Study|Lost to Follow-up|2|||
163941785|NCT02994069|592156061|FG000|Overall Study|Death|7|||
163941786|NCT02994069|592156062|FG001|Overall Study|Death|13|||
163941787|NCT02994069|592156061|FG000|Overall Study|Adverse Event|1|||
163941788|NCT02994069|592156062|FG001|Overall Study|Adverse Event|0|||
163941789|NCT02994069|592156061|FG000|Overall Study|Other|2|||
163941790|NCT02994069|592156062|FG001|Overall Study|Other|0|||
164098923|NCT03195491|592726957|FG000|Overall Study|Maximum clinical benefit|5|||
164098924|NCT03195491|592726958|FG001|Overall Study|Maximum clinical benefit|0|||
163941791|NCT02994069|592156061|FG000|Overall Study|still on follow up/treatment|5|||
163941792|NCT02994069|592156062|FG001|Overall Study|still on follow up/treatment|6|||
163941793|NCT06926673|592156063|FG000|Overall Study|Lost to Follow-up|0|||
163941794|NCT06926673|592156064|FG001|Overall Study|Lost to Follow-up|0|||
163941795|NCT06926673|592156065|FG002|Overall Study|Lost to Follow-up|0|||
163941796|NCT06926673|592156066|FG003|Overall Study|Lost to Follow-up|1|||
163941797|NCT06926673|592156067|FG004|Overall Study|Lost to Follow-up|0|||
163941798|NCT06926673|592156068|FG005|Overall Study|Lost to Follow-up|0|||
163941799|NCT06926673|592156069|FG006|Overall Study|Lost to Follow-up|0|||
163941800|NCT06926673|592156063|FG000|Overall Study|Physician Decision|0|||
163941801|NCT06926673|592156064|FG001|Overall Study|Physician Decision|0|||
163941802|NCT06926673|592156065|FG002|Overall Study|Physician Decision|0|||
163941803|NCT06926673|592156066|FG003|Overall Study|Physician Decision|0|||
164041825|NCT02709109|592512531|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
164041826|NCT02709109|592512532|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
163841102|NCT00744237|591788794|FG001|Overall Study|Study Drug Error|0|||
163841103|NCT00744237|591788795|FG002|Overall Study|Study Drug Error|0|||
163841104|NCT00744237|591788793|FG000|Overall Study|Prohibited Concomitant Medication|0|||
163841105|NCT00744237|591788794|FG001|Overall Study|Prohibited Concomitant Medication|0|||
163841106|NCT00744237|591788795|FG002|Overall Study|Prohibited Concomitant Medication|1|||
163841107|NCT00744237|591788793|FG000|Overall Study|Poor Compliance|0|||
163841108|NCT00744237|591788794|FG001|Overall Study|Poor Compliance|2|||
163841109|NCT00744237|591788795|FG002|Overall Study|Poor Compliance|0|||
163841110|NCT00744237|591788793|FG000|Overall Study|Administrative. Site Closed|1|||
163841111|NCT00744237|591788794|FG001|Overall Study|Administrative. Site Closed|1|||
163841112|NCT00744237|591788795|FG002|Overall Study|Administrative. Site Closed|1|||
163841113|NCT00744237|591788793|FG000|Overall Study|Adverse Event|9|||
163841114|NCT00744237|591788794|FG001|Overall Study|Adverse Event|13|||
163841115|NCT00744237|591788795|FG002|Overall Study|Adverse Event|5|||
163841116|NCT01118455|591788796|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
163841117|NCT01118455|591788797|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
163841118|NCT05033743|591788798|FG000|Overall Study|Lost to Follow-up|1|||
163841119|NCT05033743|591788798|FG000|Overall Study|Protocol Violation|2|||
163841120|NCT05033743|591788798|FG000|Overall Study|Withdrawal by Subject|1|||
163841121|NCT00452413|591788811|FG000|Overall Study|Progressive Disease|4|||
163841122|NCT00452413|591788812|FG001|Overall Study|Progressive Disease|11|||
163841123|NCT00452413|591788813|FG002|Overall Study|Progressive Disease|30|||
163841124|NCT00452413|591788811|FG000|Overall Study|Withdrawal by Subject|0|||
163841125|NCT00452413|591788812|FG001|Overall Study|Withdrawal by Subject|1|||
163841126|NCT00452413|591788813|FG002|Overall Study|Withdrawal by Subject|4|||
163841127|NCT00452413|591788811|FG000|Overall Study|Adverse Event|0|||
163841128|NCT00452413|591788812|FG001|Overall Study|Adverse Event|0|||
163841129|NCT00452413|591788813|FG002|Overall Study|Adverse Event|5|||
163841130|NCT00452413|591788811|FG000|Overall Study|Physician Decision|0|||
163841131|NCT00452413|591788812|FG001|Overall Study|Physician Decision|0|||
163841132|NCT00452413|591788813|FG002|Overall Study|Physician Decision|4|||
163841133|NCT00452413|591788811|FG000|Overall Study|Death due to study disease|0|||
163841134|NCT00452413|591788812|FG001|Overall Study|Death due to study disease|0|||
163841135|NCT00452413|591788813|FG002|Overall Study|Death due to study disease|2|||
163841136|NCT00452413|591788811|FG000|Overall Study|Death due to adverse event (AE)|0|||
163841137|NCT00452413|591788812|FG001|Overall Study|Death due to adverse event (AE)|0|||
163841138|NCT00452413|591788813|FG002|Overall Study|Death due to adverse event (AE)|1|||
163841139|NCT00452413|591788811|FG000|Overall Study|On treatment|0|||
163841140|NCT00452413|591788812|FG001|Overall Study|On treatment|0|||
163841141|NCT00452413|591788813|FG002|Overall Study|On treatment|3|||
163841142|NCT03119610|591788815|FG000|Overall Study|Adverse Event|1|||
163841143|NCT03119610|591788816|FG001|Overall Study|Adverse Event|0|||
163841144|NCT03119610|591788815|FG000|Overall Study|Lost to Follow-up|0|||
163841145|NCT03119610|591788816|FG001|Overall Study|Lost to Follow-up|1|||
163841146|NCT00114634|591788817|FG000|Overall Study|failure to return forms|3|||
163841147|NCT00684762|591788820|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
163841148|NCT00684762|591788821|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
163841149|NCT03662997|591788837|FG000|Overall Study|Adverse Event|0|||
163841150|NCT03662997|591788838|FG001|Overall Study|Adverse Event|2|||
163841151|NCT03662997|591788839|FG002|Overall Study|Adverse Event|0|||
163841152|NCT03662997|591788840|FG003|Overall Study|Adverse Event|0|||
163841153|NCT00936221|591788847|FG000|Overall Study|Withdrawal by Subject|1|||
163841154|NCT00936221|591788848|FG001|Overall Study|Withdrawal by Subject|1|||
163841155|NCT01844115|591788851|FG000|Overall Study|Adverse Event|4|||
163841156|NCT01844115|591788852|FG001|Overall Study|Adverse Event|22|||
163841157|NCT01844115|591788851|FG000|Overall Study|Lack of Efficacy|1|||
163841158|NCT01844115|591788852|FG001|Overall Study|Lack of Efficacy|4|||
163841159|NCT01844115|591788851|FG000|Overall Study|Protocol Violation|12|||
163841160|NCT01844115|591788852|FG001|Overall Study|Protocol Violation|10|||
163841161|NCT01844115|591788851|FG000|Overall Study|Withdrawal by Subject|11|||
163841162|NCT01844115|591788852|FG001|Overall Study|Withdrawal by Subject|11|||
163841163|NCT01844115|591788851|FG000|Overall Study|Lost to Follow-up|11|||
163841164|NCT01844115|591788852|FG001|Overall Study|Lost to Follow-up|10|||
163841165|NCT01844115|591788851|FG000|Overall Study|Pregnancy|0|||
163841166|NCT01844115|591788852|FG001|Overall Study|Pregnancy|1|||
163841167|NCT00545363|591788853|FG000|Overall Study|Adverse Event|6|||
163841168|NCT00545363|591788854|FG001|Overall Study|Adverse Event|7|||
163841169|NCT00545363|591788853|FG000|Overall Study|Withdrawal by Subject|6|||
163841170|NCT00545363|591788854|FG001|Overall Study|Withdrawal by Subject|5|||
163841171|NCT00545363|591788853|FG000|Overall Study|Non-compliance|3|||
163841172|NCT00545363|591788854|FG001|Overall Study|Non-compliance|1|||
163841173|NCT00545363|591788853|FG000|Overall Study|Did not meet entry criteria|1|||
163841174|NCT00545363|591788854|FG001|Overall Study|Did not meet entry criteria|1|||
164041827|NCT02709109|592512529|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
164041828|NCT02709109|592512530|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
164041829|NCT02709109|592512531|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
164041830|NCT02709109|592512532|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
164041831|NCT02709109|592512529|FG000|Washout Period (28 Days)|Other|2|||
164041832|NCT02709109|592512530|FG001|Washout Period (28 Days)|Other|2|||
164041833|NCT02709109|592512531|FG002|Washout Period (28 Days)|Other|3|||
164041834|NCT02709109|592512532|FG003|Washout Period (28 Days)|Other|0|||
164041835|NCT02709109|592512529|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
164041836|NCT02709109|592512530|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
164041837|NCT02709109|592512531|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
163841175|NCT00545363|591788853|FG000|Overall Study|Lost to Follow-up|2|||
163841176|NCT00545363|591788854|FG001|Overall Study|Lost to Follow-up|0|||
163841177|NCT00545363|591788853|FG000|Overall Study|Other|1|||
163841178|NCT00545363|591788854|FG001|Overall Study|Other|1|||
163841179|NCT00210119|591788855|FG000|Overall Study|Protocol Violation|1|||
163841180|NCT00210119|591788855|FG000|Overall Study|Withdrawal by Subject|1|||
163841181|NCT00951509|591788856|FG000|Overall Study|Withdrawal by Subject|2|||
163841182|NCT03125941|591788858|FG000|Overall Study|did not receive intervention|1|||
163841183|NCT03125941|591788859|FG001|Overall Study|did not receive intervention|2|||
163841184|NCT00406419|591788866|FG000|Overall Study|Death|3|||
163841185|NCT00406419|591788867|FG001|Overall Study|Death|1|||
163841186|NCT00406419|591788868|FG002|Overall Study|Death|4|||
163841187|NCT00406419|591788866|FG000|Overall Study|Protocol Violation|6|||
163841188|NCT00406419|591788867|FG001|Overall Study|Protocol Violation|2|||
163841189|NCT00406419|591788868|FG002|Overall Study|Protocol Violation|5|||
163841190|NCT00406419|591788866|FG000|Overall Study|Study Terminated by Sponsor|260|||
163841191|NCT00406419|591788867|FG001|Overall Study|Study Terminated by Sponsor|288|||
163841192|NCT00406419|591788868|FG002|Overall Study|Study Terminated by Sponsor|282|||
163841193|NCT00406419|591788866|FG000|Overall Study|Withdrawal by Subject|17|||
163841194|NCT00406419|591788867|FG001|Overall Study|Withdrawal by Subject|24|||
163841195|NCT00406419|591788868|FG002|Overall Study|Withdrawal by Subject|26|||
163841196|NCT00406419|591788866|FG000|Overall Study|Lack of Efficacy|12|||
163841197|NCT00406419|591788867|FG001|Overall Study|Lack of Efficacy|1|||
163841198|NCT00406419|591788868|FG002|Overall Study|Lack of Efficacy|6|||
163841199|NCT00406419|591788866|FG000|Overall Study|Non-Compliance with Study Drug|5|||
163841200|NCT00406419|591788867|FG001|Overall Study|Non-Compliance with Study Drug|6|||
163841201|NCT00406419|591788868|FG002|Overall Study|Non-Compliance with Study Drug|3|||
163841202|NCT00406419|591788866|FG000|Overall Study|Adverse Event|10|||
163841203|NCT00406419|591788867|FG001|Overall Study|Adverse Event|12|||
163841204|NCT00406419|591788868|FG002|Overall Study|Adverse Event|16|||
163841205|NCT00406419|591788866|FG000|Overall Study|Lost to Follow-up|11|||
163841206|NCT00406419|591788867|FG001|Overall Study|Lost to Follow-up|10|||
163841207|NCT00406419|591788868|FG002|Overall Study|Lost to Follow-up|5|||
163841208|NCT01461993|591788869|FG000|Overall Study|Withdrawal by Subject|60|||
163841209|NCT01461993|591788870|FG001|Overall Study|Withdrawal by Subject|53|||
163841210|NCT01461993|591788871|FG002|Overall Study|Withdrawal by Subject|16|||
163841211|NCT01461993|591788869|FG000|Overall Study|Lost to Follow-up|44|||
163841212|NCT01461993|591788870|FG001|Overall Study|Lost to Follow-up|48|||
163841213|NCT01461993|591788871|FG002|Overall Study|Lost to Follow-up|22|||
163841214|NCT01461993|591788869|FG000|Overall Study|Protocol Violation|10|||
163841215|NCT01461993|591788870|FG001|Overall Study|Protocol Violation|9|||
163841216|NCT01461993|591788871|FG002|Overall Study|Protocol Violation|7|||
163841217|NCT01461993|591788869|FG000|Overall Study|Adverse Event|9|||
163841218|NCT01461993|591788870|FG001|Overall Study|Adverse Event|11|||
163841219|NCT01461993|591788871|FG002|Overall Study|Adverse Event|3|||
163841220|NCT01461993|591788869|FG000|Overall Study|No longer met eligibility criteria|13|||
163841221|NCT01461993|591788870|FG001|Overall Study|No longer met eligibility criteria|18|||
163841222|NCT01461993|591788871|FG002|Overall Study|No longer met eligibility criteria|10|||
163841223|NCT01461993|591788869|FG000|Overall Study|Did not meet entrance criteria|2|||
163841224|NCT01461993|591788870|FG001|Overall Study|Did not meet entrance criteria|3|||
163841225|NCT01461993|591788871|FG002|Overall Study|Did not meet entrance criteria|0|||
163841226|NCT01461993|591788869|FG000|Overall Study|Other|13|||
163841227|NCT01461993|591788870|FG001|Overall Study|Other|15|||
163841228|NCT01461993|591788871|FG002|Overall Study|Other|6|||
163841229|NCT01821898|591788873|FG000|Overall Study|Withdrawal by Subject|2|||
163841230|NCT01821898|591788874|FG001|Overall Study|Withdrawal by Subject|1|||
163841231|NCT01121484|591788875|FG000|Overall Study|Adverse Event|12|||
163841232|NCT01121484|591788876|FG001|Overall Study|Adverse Event|5|||
164041838|NCT02709109|592512532|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
163841233|NCT01121484|591788875|FG000|Overall Study|Lack of Efficacy|3|||
163841234|NCT01121484|591788876|FG001|Overall Study|Lack of Efficacy|11|||
163841235|NCT01121484|591788875|FG000|Overall Study|Lost to Follow-up|5|||
163841236|NCT01121484|591788876|FG001|Overall Study|Lost to Follow-up|9|||
163841237|NCT01121484|591788875|FG000|Overall Study|Physician Decision|0|||
163841238|NCT01121484|591788876|FG001|Overall Study|Physician Decision|3|||
163841239|NCT01121484|591788875|FG000|Overall Study|Protocol Violation|1|||
163941804|NCT06926673|592156067|FG004|Overall Study|Physician Decision|0|||
163941805|NCT06926673|592156068|FG005|Overall Study|Physician Decision|0|||
163941806|NCT06926673|592156069|FG006|Overall Study|Physician Decision|1|||
163941807|NCT06926673|592156063|FG000|Overall Study|Withdrawal by Subject|0|||
163941808|NCT06926673|592156064|FG001|Overall Study|Withdrawal by Subject|3|||
163941809|NCT06926673|592156065|FG002|Overall Study|Withdrawal by Subject|2|||
163941810|NCT06926673|592156066|FG003|Overall Study|Withdrawal by Subject|1|||
163941811|NCT06926673|592156067|FG004|Overall Study|Withdrawal by Subject|0|||
163941812|NCT06926673|592156068|FG005|Overall Study|Withdrawal by Subject|2|||
163941813|NCT06926673|592156069|FG006|Overall Study|Withdrawal by Subject|0|||
163941814|NCT03345576|592156072|FG000|Overall Study|Withdrawal by Subject|2|||
163941815|NCT03345576|592156073|FG001|Overall Study|Withdrawal by Subject|2|||
163941816|NCT03345576|592156072|FG000|Overall Study|Adverse Event|1|||
163941817|NCT03345576|592156073|FG001|Overall Study|Adverse Event|0|||
163941818|NCT05718466|592157542|FG000|Overall Study|Withdrawal by Subject|1|||
163941819|NCT05718466|592157543|FG001|Overall Study|Withdrawal by Subject|2|||
163941820|NCT05718466|592157542|FG000|Overall Study|Death|0|||
163941821|NCT05718466|592157543|FG001|Overall Study|Death|1|||
163941822|NCT01967147|592157544|FG000|Overall Study|Adverse Event|5|||
163941823|NCT01967147|592157545|FG001|Overall Study|Adverse Event|2|||
163941824|NCT01967147|592157544|FG000|Overall Study|Lack of Efficacy|1|||
163941825|NCT01967147|592157545|FG001|Overall Study|Lack of Efficacy|4|||
163941826|NCT01967147|592157544|FG000|Overall Study|Lost to Follow-up|1|||
163941827|NCT01967147|592157545|FG001|Overall Study|Lost to Follow-up|2|||
163941828|NCT01967147|592157544|FG000|Overall Study|Withdrawal by Subject|2|||
163941829|NCT01967147|592157545|FG001|Overall Study|Withdrawal by Subject|4|||
163941830|NCT01967147|592157544|FG000|Overall Study|Non-compliance with Study Drug|0|||
163941831|NCT01967147|592157545|FG001|Overall Study|Non-compliance with Study Drug|3|||
163941832|NCT01967147|592157544|FG000|Overall Study|Other|4|||
163941833|NCT01967147|592157545|FG001|Overall Study|Other|5|||
163941834|NCT01253135|592157548|FG000|Original Protocol|Protocol Amendment|15|||
163941835|NCT01253135|592157548|FG000|Amended Protocol|Non-compliance|1|||
163941836|NCT00833261|592157549|FG000|Overall Study|Withdrawal by Subject|4|||
163941837|NCT00264303|592157559|FG000|Overall Study|Adverse Event|4|||
163941838|NCT00264303|592157560|FG001|Overall Study|Adverse Event|3|||
163941839|NCT00264303|592157559|FG000|Overall Study|Lack of Efficacy|10|||
163941840|NCT00264303|592157560|FG001|Overall Study|Lack of Efficacy|13|||
163941841|NCT00264303|592157559|FG000|Overall Study|Lost to Follow-up|3|||
163941842|NCT00264303|592157560|FG001|Overall Study|Lost to Follow-up|3|||
163941843|NCT00264303|592157559|FG000|Overall Study|Withdrawal by Subject|2|||
163941844|NCT00264303|592157560|FG001|Overall Study|Withdrawal by Subject|3|||
163941845|NCT00264303|592157559|FG000|Overall Study|Various reasons listed in study report|6|||
163941846|NCT00264303|592157560|FG001|Overall Study|Various reasons listed in study report|7|||
163941847|NCT02815579|592157561|FG000|Overall Study|Non-payment of loan down-payment|16|||
163941848|NCT02815579|592157562|FG001|Overall Study|Non-payment of loan down-payment|0|||
163941849|NCT02815579|592157561|FG000|Overall Study|Withdrawal by Subject|7|||
163941850|NCT02815579|592157562|FG001|Overall Study|Withdrawal by Subject|1|||
163941851|NCT02815579|592157561|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
163941852|NCT02815579|592157562|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
163941853|NCT02815579|592157561|FG000|Overall Study|Lost to Follow-up|7|||
163941854|NCT02815579|592157562|FG001|Overall Study|Lost to Follow-up|4|||
163941855|NCT02815579|592157561|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
163941856|NCT02815579|592157562|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
163941857|NCT02815579|592157561|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
163941858|NCT02815579|592157562|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
163941859|NCT02815579|592157561|FG000|Overall Study|Death|5|||
163941860|NCT02815579|592157562|FG001|Overall Study|Death|4|||
163941861|NCT02815579|592157561|FG000|Overall Study|Imprisoned|0|||
163941862|NCT02815579|592157562|FG001|Overall Study|Imprisoned|2|||
163941863|NCT02815579|592157561|FG000|Overall Study|Did not meet enrollment criteria|0|||
163941864|NCT02815579|592157562|FG001|Overall Study|Did not meet enrollment criteria|1|||
163941865|NCT02389452|592157563|FG000|Overall Study|Lost to Follow-up|13|||
163941866|NCT02389452|592157563|FG000|Overall Study|Adverse Event|1|||
164041839|NCT02709109|592512529|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
164041840|NCT02709109|592512530|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
163941867|NCT02389452|592157563|FG000|Overall Study|Withdrawal by Subject|5|||
163941868|NCT02389452|592157563|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
163941869|NCT02311673|592157564|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
163941870|NCT02311673|592157565|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
163941871|NCT02311673|592157566|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
163941872|NCT02311673|592157567|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
163941873|NCT00414908|592157570|FG000|Overall Study|Protocol Violation|1|||
163941874|NCT00414908|592157571|FG001|Overall Study|Protocol Violation|1|||
163941875|NCT01076153|592157572|FG000|Overall Study|Symptoms improved/resolved|10|||
163941876|NCT01076153|592157572|FG000|Overall Study|Adverse Event|1|||
163941877|NCT04165031|592157573|FG000|Overall Study|Adverse Event|1|||
163941878|NCT04165031|592157574|FG001|Overall Study|Adverse Event|1|||
163941879|NCT04165031|592157575|FG002|Overall Study|Adverse Event|0|||
163941880|NCT04165031|592157576|FG003|Overall Study|Adverse Event|0|||
163941881|NCT04165031|592157577|FG004|Overall Study|Adverse Event|0|||
163941882|NCT04165031|592157578|FG005|Overall Study|Adverse Event|0|||
163941883|NCT04165031|592157573|FG000|Overall Study|Withdrawal by Subject|0|||
163941884|NCT04165031|592157574|FG001|Overall Study|Withdrawal by Subject|0|||
163941885|NCT04165031|592157575|FG002|Overall Study|Withdrawal by Subject|1|||
163941886|NCT04165031|592157576|FG003|Overall Study|Withdrawal by Subject|0|||
163941887|NCT04165031|592157577|FG004|Overall Study|Withdrawal by Subject|0|||
163941888|NCT04165031|592157578|FG005|Overall Study|Withdrawal by Subject|0|||
163941889|NCT03563157|592157583|FG000|Overall Study|Progressive Disease|2|||
163941890|NCT02942277|592157584|FG000|Year 1|Withdrawal by Subject|0|||
163941891|NCT02942277|592157585|FG001|Year 1|Withdrawal by Subject|0|||
163941892|NCT02942277|592157586|FG002|Year 1|Withdrawal by Subject|0|||
163941893|NCT02942277|592157587|FG003|Year 1|Withdrawal by Subject|0|||
163941894|NCT02942277|592157588|FG004|Year 1|Withdrawal by Subject|1|||
163941895|NCT02942277|592157589|FG005|Year 1|Withdrawal by Subject|3|||
163941896|NCT02942277|592157590|FG006|Year 1|Withdrawal by Subject|0|||
163941897|NCT02942277|592157591|FG007|Year 1|Withdrawal by Subject|1|||
163941898|NCT02942277|592157592|FG008|Year 1|Withdrawal by Subject|0|||
163941899|NCT02942277|592157593|FG009|Year 1|Withdrawal by Subject|0|||
163941900|NCT02942277|592157594|FG010|Year 1|Withdrawal by Subject|3|||
163941901|NCT02942277|592157584|FG000|Year 1|Travel|0|||
163941902|NCT02942277|592157585|FG001|Year 1|Travel|1|||
163941903|NCT02942277|592157586|FG002|Year 1|Travel|0|||
163941904|NCT02942277|592157587|FG003|Year 1|Travel|0|||
163941905|NCT02942277|592157588|FG004|Year 1|Travel|4|||
163941906|NCT02942277|592157589|FG005|Year 1|Travel|5|||
163941907|NCT02942277|592157590|FG006|Year 1|Travel|0|||
163941908|NCT02942277|592157591|FG007|Year 1|Travel|0|||
163941909|NCT02942277|592157592|FG008|Year 1|Travel|0|||
163941910|NCT02942277|592157593|FG009|Year 1|Travel|0|||
163941911|NCT02942277|592157594|FG010|Year 1|Travel|8|||
163941912|NCT02942277|592157584|FG000|Year 1|Joined Army|0|||
163941913|NCT02942277|592157585|FG001|Year 1|Joined Army|1|||
163941914|NCT02942277|592157586|FG002|Year 1|Joined Army|0|||
163941915|NCT02942277|592157587|FG003|Year 1|Joined Army|0|||
163941916|NCT02942277|592157588|FG004|Year 1|Joined Army|0|||
163941917|NCT02942277|592157589|FG005|Year 1|Joined Army|0|||
163941918|NCT02942277|592157590|FG006|Year 1|Joined Army|0|||
163941919|NCT02942277|592157591|FG007|Year 1|Joined Army|0|||
163941920|NCT02942277|592157592|FG008|Year 1|Joined Army|0|||
163941921|NCT02942277|592157593|FG009|Year 1|Joined Army|0|||
163941922|NCT02942277|592157594|FG010|Year 1|Joined Army|0|||
163941923|NCT02942277|592157584|FG000|Year 1|Subject met withdrawal criteria|0|||
163941924|NCT02942277|592157585|FG001|Year 1|Subject met withdrawal criteria|0|||
163941925|NCT02942277|592157586|FG002|Year 1|Subject met withdrawal criteria|0|||
163941926|NCT02942277|592157587|FG003|Year 1|Subject met withdrawal criteria|1|||
163941927|NCT02942277|592157588|FG004|Year 1|Subject met withdrawal criteria|0|||
163941928|NCT02942277|592157589|FG005|Year 1|Subject met withdrawal criteria|0|||
163941929|NCT02942277|592157590|FG006|Year 1|Subject met withdrawal criteria|0|||
163941930|NCT02942277|592157591|FG007|Year 1|Subject met withdrawal criteria|0|||
163941931|NCT02942277|592157592|FG008|Year 1|Subject met withdrawal criteria|0|||
163941932|NCT02942277|592157593|FG009|Year 1|Subject met withdrawal criteria|0|||
163941933|NCT02942277|592157594|FG010|Year 1|Subject met withdrawal criteria|0|||
163941934|NCT02942277|592157584|FG000|Year 1|Lost to Follow-up|0|||
163941935|NCT02942277|592157585|FG001|Year 1|Lost to Follow-up|0|||
163941936|NCT02942277|592157586|FG002|Year 1|Lost to Follow-up|0|||
163941937|NCT02942277|592157587|FG003|Year 1|Lost to Follow-up|0|||
163941938|NCT02942277|592157588|FG004|Year 1|Lost to Follow-up|1|||
163941939|NCT02942277|592157589|FG005|Year 1|Lost to Follow-up|0|||
163941940|NCT02942277|592157590|FG006|Year 1|Lost to Follow-up|0|||
163941941|NCT02942277|592157591|FG007|Year 1|Lost to Follow-up|0|||
163941942|NCT02942277|592157592|FG008|Year 1|Lost to Follow-up|0|||
163941943|NCT02942277|592157593|FG009|Year 1|Lost to Follow-up|0|||
163941944|NCT02942277|592157594|FG010|Year 1|Lost to Follow-up|2|||
163941945|NCT02942277|592157584|FG000|Year 1|Protocol Violation|0|||
163941946|NCT02942277|592157585|FG001|Year 1|Protocol Violation|0|||
163941947|NCT02942277|592157586|FG002|Year 1|Protocol Violation|0|||
163941948|NCT02942277|592157587|FG003|Year 1|Protocol Violation|0|||
163941949|NCT02942277|592157588|FG004|Year 1|Protocol Violation|1|||
163941950|NCT02942277|592157589|FG005|Year 1|Protocol Violation|1|||
163941951|NCT02942277|592157590|FG006|Year 1|Protocol Violation|0|||
163941952|NCT02942277|592157591|FG007|Year 1|Protocol Violation|0|||
163941953|NCT02942277|592157592|FG008|Year 1|Protocol Violation|0|||
163941954|NCT02942277|592157593|FG009|Year 1|Protocol Violation|0|||
163941955|NCT02942277|592157594|FG010|Year 1|Protocol Violation|2|||
163941956|NCT02942277|592157584|FG000|Year 1|Pregnancy|0|||
163941957|NCT02942277|592157585|FG001|Year 1|Pregnancy|0|||
163941958|NCT02942277|592157586|FG002|Year 1|Pregnancy|0|||
163941959|NCT02942277|592157587|FG003|Year 1|Pregnancy|0|||
163941960|NCT02942277|592157588|FG004|Year 1|Pregnancy|0|||
163941961|NCT02942277|592157589|FG005|Year 1|Pregnancy|1|||
163941962|NCT02942277|592157590|FG006|Year 1|Pregnancy|0|||
163941963|NCT02942277|592157591|FG007|Year 1|Pregnancy|0|||
163941964|NCT02942277|592157592|FG008|Year 1|Pregnancy|0|||
163941965|NCT02942277|592157593|FG009|Year 1|Pregnancy|0|||
163941966|NCT02942277|592157594|FG010|Year 1|Pregnancy|0|||
163941967|NCT02942277|592157584|FG000|Year 2|Lost to Follow-up|0|||
163941968|NCT02942277|592157585|FG001|Year 2|Lost to Follow-up|0|||
163941969|NCT02942277|592157586|FG002|Year 2|Lost to Follow-up|0|||
163941970|NCT02942277|592157587|FG003|Year 2|Lost to Follow-up|0|||
163941971|NCT02942277|592157588|FG004|Year 2|Lost to Follow-up|2|||
163941972|NCT02942277|592157589|FG005|Year 2|Lost to Follow-up|1|||
163941973|NCT02942277|592157590|FG006|Year 2|Lost to Follow-up|0|||
163941974|NCT02942277|592157591|FG007|Year 2|Lost to Follow-up|0|||
163941975|NCT02942277|592157592|FG008|Year 2|Lost to Follow-up|0|||
163941976|NCT02942277|592157593|FG009|Year 2|Lost to Follow-up|0|||
163941977|NCT02942277|592157594|FG010|Year 2|Lost to Follow-up|0|||
163941978|NCT02942277|592157584|FG000|Year 2|Did not rescreen|0|||
163941979|NCT02942277|592157585|FG001|Year 2|Did not rescreen|0|||
163941980|NCT02942277|592157586|FG002|Year 2|Did not rescreen|1|||
163941981|NCT02942277|592157587|FG003|Year 2|Did not rescreen|1|||
163941982|NCT02942277|592157588|FG004|Year 2|Did not rescreen|9|||
163941983|NCT02942277|592157589|FG005|Year 2|Did not rescreen|6|||
163941984|NCT02942277|592157590|FG006|Year 2|Did not rescreen|0|||
163941985|NCT02942277|592157591|FG007|Year 2|Did not rescreen|1|||
163941986|NCT02942277|592157592|FG008|Year 2|Did not rescreen|0|||
163941987|NCT02942277|592157593|FG009|Year 2|Did not rescreen|0|||
163941988|NCT02942277|592157594|FG010|Year 2|Did not rescreen|21|||
163941989|NCT02942277|592157584|FG000|Year 2|Met withdrawal criteria|0|||
163941990|NCT02942277|592157585|FG001|Year 2|Met withdrawal criteria|0|||
163941991|NCT02942277|592157586|FG002|Year 2|Met withdrawal criteria|0|||
163941992|NCT02942277|592157587|FG003|Year 2|Met withdrawal criteria|0|||
163941993|NCT02942277|592157588|FG004|Year 2|Met withdrawal criteria|1|||
163941994|NCT02942277|592157589|FG005|Year 2|Met withdrawal criteria|2|||
163941995|NCT02942277|592157590|FG006|Year 2|Met withdrawal criteria|0|||
163941996|NCT02942277|592157591|FG007|Year 2|Met withdrawal criteria|0|||
163941997|NCT02942277|592157592|FG008|Year 2|Met withdrawal criteria|0|||
163941998|NCT02942277|592157593|FG009|Year 2|Met withdrawal criteria|0|||
163941999|NCT02942277|592157594|FG010|Year 2|Met withdrawal criteria|1|||
163942000|NCT02942277|592157584|FG000|Year 2|Travel|0|||
163942001|NCT02942277|592157585|FG001|Year 2|Travel|1|||
163942002|NCT02942277|592157586|FG002|Year 2|Travel|0|||
163942003|NCT02942277|592157587|FG003|Year 2|Travel|0|||
163942004|NCT02942277|592157588|FG004|Year 2|Travel|0|||
163942005|NCT02942277|592157589|FG005|Year 2|Travel|1|||
163942006|NCT02942277|592157590|FG006|Year 2|Travel|0|||
163942007|NCT02942277|592157591|FG007|Year 2|Travel|0|||
163942008|NCT02942277|592157592|FG008|Year 2|Travel|0|||
163942009|NCT02942277|592157593|FG009|Year 2|Travel|1|||
163942010|NCT02942277|592157594|FG010|Year 2|Travel|3|||
163942011|NCT02942277|592157584|FG000|Year 2|Non-compliant|0|||
163942012|NCT02942277|592157585|FG001|Year 2|Non-compliant|0|||
163942013|NCT02942277|592157586|FG002|Year 2|Non-compliant|0|||
163942014|NCT02942277|592157587|FG003|Year 2|Non-compliant|0|||
163942015|NCT02942277|592157588|FG004|Year 2|Non-compliant|1|||
163942016|NCT02942277|592157589|FG005|Year 2|Non-compliant|1|||
164041841|NCT02709109|592512531|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
164041842|NCT02709109|592512532|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
164041843|NCT02709109|592512529|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
164041844|NCT02709109|592512530|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
164041845|NCT02709109|592512531|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
164041846|NCT02709109|592512532|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
164041847|NCT02709109|592512529|FG000|Treatment Period 2 (28 Days)|Other|0|||
163942017|NCT02942277|592157590|FG006|Year 2|Non-compliant|0|||
163942018|NCT02942277|592157591|FG007|Year 2|Non-compliant|0|||
163942019|NCT02942277|592157592|FG008|Year 2|Non-compliant|0|||
163942020|NCT02942277|592157593|FG009|Year 2|Non-compliant|0|||
163942021|NCT02942277|592157594|FG010|Year 2|Non-compliant|0|||
163942022|NCT02942277|592157584|FG000|Year 2|Withdrawal by Subject|0|||
163942023|NCT02942277|592157585|FG001|Year 2|Withdrawal by Subject|0|||
163942024|NCT02942277|592157586|FG002|Year 2|Withdrawal by Subject|0|||
163942025|NCT02942277|592157587|FG003|Year 2|Withdrawal by Subject|0|||
163942026|NCT02942277|592157588|FG004|Year 2|Withdrawal by Subject|0|||
163942027|NCT02942277|592157589|FG005|Year 2|Withdrawal by Subject|0|||
163942028|NCT02942277|592157590|FG006|Year 2|Withdrawal by Subject|1|||
163942029|NCT02942277|592157591|FG007|Year 2|Withdrawal by Subject|0|||
163942030|NCT02942277|592157592|FG008|Year 2|Withdrawal by Subject|0|||
163942031|NCT02942277|592157593|FG009|Year 2|Withdrawal by Subject|0|||
163942032|NCT02942277|592157594|FG010|Year 2|Withdrawal by Subject|0|||
163942033|NCT00565773|592157595|FG000|Overall Study|Withdrawal by Subject|1|||
163942034|NCT00565773|592157595|FG000|Overall Study|Physician Decision|1|||
163942035|NCT01240915|592157596|FG000|Overall Study|Adverse Event|0|||
163942036|NCT01240915|592157597|FG001|Overall Study|Adverse Event|0|||
163942037|NCT01240915|592157598|FG002|Overall Study|Adverse Event|0|||
163942038|NCT01240915|592157599|FG003|Overall Study|Adverse Event|1|||
163942039|NCT01240915|592157600|FG004|Overall Study|Adverse Event|0|||
163942040|NCT01240915|592157601|FG005|Overall Study|Adverse Event|2|||
163942041|NCT01240915|592157602|FG006|Overall Study|Adverse Event|0|||
163942042|NCT01240915|592157603|FG007|Overall Study|Adverse Event|0|||
163942043|NCT01240915|592157604|FG008|Overall Study|Adverse Event|1|||
163942044|NCT01240915|592157596|FG000|Overall Study|Lost to Follow-up|0|||
163942045|NCT01240915|592157597|FG001|Overall Study|Lost to Follow-up|0|||
163942046|NCT01240915|592157598|FG002|Overall Study|Lost to Follow-up|0|||
163942047|NCT01240915|592157599|FG003|Overall Study|Lost to Follow-up|0|||
163942048|NCT01240915|592157600|FG004|Overall Study|Lost to Follow-up|1|||
163942049|NCT01240915|592157601|FG005|Overall Study|Lost to Follow-up|1|||
163942050|NCT01240915|592157602|FG006|Overall Study|Lost to Follow-up|0|||
163942051|NCT01240915|592157603|FG007|Overall Study|Lost to Follow-up|1|||
163942052|NCT01240915|592157604|FG008|Overall Study|Lost to Follow-up|1|||
163942053|NCT01240915|592157596|FG000|Overall Study|Withdrawal by Subject|2|||
163942054|NCT01240915|592157597|FG001|Overall Study|Withdrawal by Subject|1|||
163942055|NCT01240915|592157598|FG002|Overall Study|Withdrawal by Subject|0|||
163942056|NCT01240915|592157599|FG003|Overall Study|Withdrawal by Subject|2|||
163942057|NCT01240915|592157600|FG004|Overall Study|Withdrawal by Subject|0|||
163942058|NCT01240915|592157601|FG005|Overall Study|Withdrawal by Subject|4|||
163942059|NCT01240915|592157602|FG006|Overall Study|Withdrawal by Subject|2|||
163942060|NCT01240915|592157603|FG007|Overall Study|Withdrawal by Subject|3|||
163942061|NCT01240915|592157604|FG008|Overall Study|Withdrawal by Subject|3|||
163942062|NCT01240915|592157596|FG000|Overall Study|Other|0|||
163942063|NCT01240915|592157597|FG001|Overall Study|Other|0|||
163942064|NCT01240915|592157598|FG002|Overall Study|Other|0|||
163942065|NCT01240915|592157599|FG003|Overall Study|Other|0|||
163942066|NCT01240915|592157600|FG004|Overall Study|Other|2|||
163942067|NCT01240915|592157601|FG005|Overall Study|Other|0|||
163942068|NCT01240915|592157602|FG006|Overall Study|Other|0|||
163942069|NCT01240915|592157603|FG007|Overall Study|Other|0|||
163942070|NCT01240915|592157604|FG008|Overall Study|Other|0|||
163942071|NCT01240915|592157596|FG000|Overall Study|Insufficient Clinical Response|0|||
163942072|NCT01240915|592157597|FG001|Overall Study|Insufficient Clinical Response|0|||
163942073|NCT01240915|592157598|FG002|Overall Study|Insufficient Clinical Response|0|||
163942074|NCT01240915|592157599|FG003|Overall Study|Insufficient Clinical Response|0|||
163942075|NCT01240915|592157600|FG004|Overall Study|Insufficient Clinical Response|1|||
163942076|NCT01240915|592157601|FG005|Overall Study|Insufficient Clinical Response|3|||
163942077|NCT01240915|592157602|FG006|Overall Study|Insufficient Clinical Response|6|||
163942078|NCT01240915|592157603|FG007|Overall Study|Insufficient Clinical Response|0|||
163942079|NCT01240915|592157604|FG008|Overall Study|Insufficient Clinical Response|3|||
163942080|NCT02574845|592157606|FG000|Overall Study|Consent withdrawn further participation|0|||
163942081|NCT02574845|592157607|FG001|Overall Study|Consent withdrawn further participation|0|||
163942082|NCT02574845|592157608|FG002|Overall Study|Consent withdrawn further participation|0|||
163942083|NCT02574845|592157609|FG003|Overall Study|Consent withdrawn further participation|0|||
163942084|NCT02574845|592157610|FG004|Overall Study|Consent withdrawn further participation|1|||
163942085|NCT02574845|592157611|FG005|Overall Study|Consent withdrawn further participation|0|||
163942086|NCT02574845|592157606|FG000|Overall Study|Adverse Event|0|||
163942087|NCT02574845|592157607|FG001|Overall Study|Adverse Event|1|||
163942088|NCT02574845|592157608|FG002|Overall Study|Adverse Event|0|||
163942089|NCT02574845|592157609|FG003|Overall Study|Adverse Event|0|||
163942090|NCT02574845|592157610|FG004|Overall Study|Adverse Event|0|||
164098925|NCT03195491|592726957|FG000|Overall Study|Lost to Follow-up|1|||
164098926|NCT03195491|592726958|FG001|Overall Study|Lost to Follow-up|0|||
164098927|NCT03195491|592726957|FG000|Overall Study|Death|3|||
164098928|NCT03195491|592726958|FG001|Overall Study|Death|0|||
163942091|NCT02574845|592157611|FG005|Overall Study|Adverse Event|1|||
163942092|NCT04313608|592157616|FG000|Overall Study|Death|12|||
163942093|NCT04313608|592157617|FG001|Overall Study|Death|3|||
163942094|NCT01867333|592157618|FG000|Overall Study|Withdrawal by Subject|1|||
163942095|NCT01867333|592157619|FG001|Overall Study|Withdrawal by Subject|0|||
163942096|NCT01867333|592157618|FG000|Overall Study|Adverse Event|1|||
163942097|NCT01867333|592157619|FG001|Overall Study|Adverse Event|0|||
163942098|NCT01867333|592157618|FG000|Overall Study|Participant choice|1|||
163942099|NCT01867333|592157619|FG001|Overall Study|Participant choice|2|||
163942100|NCT01867333|592157618|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
163942101|NCT01867333|592157619|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
163942102|NCT01867333|592157618|FG000|Overall Study|Death|0|||
163942103|NCT01867333|592157619|FG001|Overall Study|Death|1|||
163942104|NCT01867333|592157618|FG000|Overall Study|Physician Decision|3|||
163942105|NCT01867333|592157619|FG001|Overall Study|Physician Decision|2|||
163942106|NCT01867333|592157618|FG000|Overall Study|Switched to alternative treatment|1|||
163942107|NCT01867333|592157619|FG001|Overall Study|Switched to alternative treatment|0|||
163942108|NCT01145898|592157620|FG000|3-year Treatment|medication change by treating physician|3|||
163942109|NCT01145898|592157621|FG001|3-year Treatment|medication change by treating physician|16|||
163942110|NCT00879775|592157622|FG000|Overall Study|Lost to Follow-up|2|||
164147708|NCT02006732|592902130|FG001|Overall Study|Lost to Follow-up|1|||
163841240|NCT01121484|591788876|FG001|Overall Study|Protocol Violation|0|||
163841241|NCT01121484|591788875|FG000|Overall Study|Withdrawal by Subject|8|||
163841242|NCT01121484|591788876|FG001|Overall Study|Withdrawal by Subject|7|||
163841243|NCT01121484|591788875|FG000|Overall Study|Discontinuation of study by sponsor|0|||
163841244|NCT01121484|591788876|FG001|Overall Study|Discontinuation of study by sponsor|1|||
163841245|NCT01121484|591788875|FG000|Overall Study|Other|3|||
163841246|NCT01121484|591788876|FG001|Overall Study|Other|3|||
163841247|NCT01121484|591788875|FG000|Overall Study|Randomized, not treated|1|||
163841248|NCT01121484|591788876|FG001|Overall Study|Randomized, not treated|4|||
163841249|NCT06390826|591788879|FG000|Overall Study|Never Start Protocol Therapy|1|||
163841250|NCT06390826|591788879|FG000|Overall Study|Adverse Event|1|||
163841251|NCT06390826|591788879|FG000|Overall Study|Disease Progression|8|||
163841252|NCT03679767|591788880|FG000|Overall Study|Death|16|||
163841253|NCT03679767|591788881|FG001|Overall Study|Death|11|||
163841254|NCT03679767|591788882|FG002|Overall Study|Death|17|||
163841255|NCT03679767|591788883|FG003|Overall Study|Death|10|||
163841256|NCT03679767|591788880|FG000|Overall Study|Lost to Follow-up|1|||
163841257|NCT03679767|591788881|FG001|Overall Study|Lost to Follow-up|1|||
163841258|NCT03679767|591788882|FG002|Overall Study|Lost to Follow-up|1|||
163841259|NCT03679767|591788883|FG003|Overall Study|Lost to Follow-up|1|||
163841260|NCT03679767|591788880|FG000|Overall Study|Withdrawal by Subject|0|||
163841261|NCT03679767|591788881|FG001|Overall Study|Withdrawal by Subject|0|||
163841262|NCT03679767|591788882|FG002|Overall Study|Withdrawal by Subject|0|||
163841263|NCT03679767|591788883|FG003|Overall Study|Withdrawal by Subject|1|||
163841264|NCT03679767|591788880|FG000|Overall Study|Follow-up Completed|18|||
163841265|NCT03679767|591788881|FG001|Overall Study|Follow-up Completed|11|||
163841266|NCT03679767|591788882|FG002|Overall Study|Follow-up Completed|11|||
163841267|NCT03679767|591788883|FG003|Overall Study|Follow-up Completed|20|||
163841268|NCT03679767|591788880|FG000|Overall Study|Entered Hospice Care|0|||
163841269|NCT03679767|591788881|FG001|Overall Study|Entered Hospice Care|0|||
163841270|NCT03679767|591788882|FG002|Overall Study|Entered Hospice Care|0|||
163841271|NCT03679767|591788883|FG003|Overall Study|Entered Hospice Care|1|||
163841272|NCT03679767|591788880|FG000|Overall Study|Progressive Disease|0|||
163841273|NCT03679767|591788881|FG001|Overall Study|Progressive Disease|0|||
163841274|NCT03679767|591788882|FG002|Overall Study|Progressive Disease|0|||
163841275|NCT03679767|591788883|FG003|Overall Study|Progressive Disease|1|||
163841276|NCT03915951|591788884|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
163841277|NCT03915951|591788885|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
163841278|NCT03915951|591788884|FG000|Overall Study|Adverse Event|12|||
163841279|NCT03915951|591788885|FG001|Overall Study|Adverse Event|6|||
163841280|NCT03915951|591788884|FG000|Overall Study|Disease progression (radiological)|17|||
163841281|NCT03915951|591788885|FG001|Overall Study|Disease progression (radiological)|15|||
163841282|NCT03915951|591788884|FG000|Overall Study|Disease progression (clinical)|4|||
163841283|NCT03915951|591788885|FG001|Overall Study|Disease progression (clinical)|1|||
163841284|NCT03915951|591788884|FG000|Overall Study|Patient decision|0|||
163841285|NCT03915951|591788885|FG001|Overall Study|Patient decision|4|||
163841286|NCT03915951|591788884|FG000|Overall Study|Investigator decision|0|||
163841287|NCT03915951|591788885|FG001|Overall Study|Investigator decision|1|||
163841288|NCT03915951|591788884|FG000|Overall Study|Consent withdrawn|1|||
163841289|NCT03915951|591788885|FG001|Overall Study|Consent withdrawn|1|||
163841290|NCT03915951|591788884|FG000|Overall Study|Death|0|||
163841291|NCT03915951|591788885|FG001|Overall Study|Death|3|||
163841292|NCT05408468|591788886|FG000|Overall Study|Lost to Follow-up|3|||
163841293|NCT05408468|591788887|FG001|Overall Study|Lost to Follow-up|1|||
163841294|NCT05408468|591788886|FG000|Overall Study|Physician Decision|1|||
163841295|NCT05408468|591788887|FG001|Overall Study|Physician Decision|0|||
163841296|NCT05408468|591788886|FG000|Overall Study|Overwhelmed by clinical situation|3|||
163841297|NCT05408468|591788887|FG001|Overall Study|Overwhelmed by clinical situation|0|||
163841298|NCT05408468|591788886|FG000|Overall Study|Personal illness precluding participation|1|||
163841299|NCT05408468|591788887|FG001|Overall Study|Personal illness precluding participation|0|||
163942111|NCT00879775|592157623|FG001|Overall Study|Lost to Follow-up|1|||
163942112|NCT02440425|592157624|FG000|Overall Study|Death likely due to disease progression|1|||
163942113|NCT02440425|592157624|FG000|Overall Study|Withdrawal by Subject|2|||
163942114|NCT02440425|592157624|FG000|Overall Study|Adverse Event|1|||
163942115|NCT02440425|592157624|FG000|Overall Study|Adverse Event/Ineligible|1|||
163942116|NCT03101462|592157625|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
163942117|NCT03101462|592157626|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
163942118|NCT01669577|592157629|FG000|Overall Study|Death|22|||
163942119|NCT01669577|592157629|FG000|Overall Study|Lost to Follow-up|78|||
163942120|NCT01669577|592157629|FG000|Overall Study|Physician Decision|34|||
163942121|NCT03309813|592157630|FG000|Main Randomized Study|Withdrawal by Subject|1|||
163942122|NCT03309813|592157631|FG001|Main Randomized Study|Withdrawal by Subject|0|||
163942123|NCT00208325|592157632|FG000|Overall Study|Death|18|||
163942124|NCT00208325|592157633|FG001|Overall Study|Death|19|||
163942125|NCT00208325|592157634|FG002|Overall Study|Death|7|||
163942126|NCT00208325|592157635|FG003|Overall Study|Death|5|||
163841300|NCT05408468|591788886|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
163841301|NCT05408468|591788887|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
163841302|NCT02204579|591788892|FG000|Overall Study|Screen failures|2|||
163841303|NCT01396395|591788893|FG000|Overall Study|Withdrawal by Subject|10|||
163841304|NCT01396395|591788894|FG001|Overall Study|Withdrawal by Subject|12|||
163841305|NCT01396395|591788893|FG000|Overall Study|Protocol Violation|3|||
163841306|NCT01396395|591788894|FG001|Overall Study|Protocol Violation|1|||
163841307|NCT01396395|591788893|FG000|Overall Study|Adverse Event|10|||
163841308|NCT01396395|591788894|FG001|Overall Study|Adverse Event|2|||
163841309|NCT01396395|591788893|FG000|Overall Study|Lost to Follow-up|17|||
163841310|NCT01396395|591788894|FG001|Overall Study|Lost to Follow-up|11|||
163841311|NCT01396395|591788893|FG000|Overall Study|Other|0|||
163841312|NCT01396395|591788894|FG001|Overall Study|Other|1|||
163841313|NCT02120664|591788895|FG000|Overall Study|Withdrawal by Subject|0|||
163841314|NCT02120664|591788896|FG001|Overall Study|Withdrawal by Subject|0|||
163841315|NCT02120664|591788897|FG002|Overall Study|Withdrawal by Subject|0|||
163841316|NCT02120664|591788898|FG003|Overall Study|Withdrawal by Subject|1|||
163841317|NCT02120664|591788899|FG004|Overall Study|Withdrawal by Subject|0|||
163841318|NCT02460263|591788900|FG000|Transition Period|Withdrawal by Subject|1|||
163841319|NCT02460263|591788900|FG000|Transition Period|Death|1|||
163841320|NCT03916744|591788901|FG000|Overall Study|Withdrawal by Subject|0|||
163841321|NCT03916744|591788902|FG001|Overall Study|Withdrawal by Subject|1|||
163841322|NCT03916744|591788903|FG002|Overall Study|Withdrawal by Subject|2|||
163841323|NCT03176238|591788906|FG000|Overall Study|Unacceptable AEs|15|||
163841324|NCT03176238|591788907|FG001|Overall Study|Unacceptable AEs|8|||
163841325|NCT03176238|591788906|FG000|Overall Study|Abnormal lab value(s)|2|||
163841326|NCT03176238|591788907|FG001|Overall Study|Abnormal lab value(s)|0|||
163841327|NCT03176238|591788906|FG000|Overall Study|Inter-current illness|0|||
163841328|NCT03176238|591788907|FG001|Overall Study|Inter-current illness|1|||
163841329|NCT03176238|591788906|FG000|Overall Study|Consent withdrawal|14|||
163841330|NCT03176238|591788907|FG001|Overall Study|Consent withdrawal|2|||
163841331|NCT03176238|591788906|FG000|Overall Study|Lost to Follow-up|3|||
163841332|NCT03176238|591788907|FG001|Overall Study|Lost to Follow-up|0|||
163841333|NCT03176238|591788906|FG000|Overall Study|Administrative problems|1|||
163841334|NCT03176238|591788907|FG001|Overall Study|Administrative problems|0|||
163841335|NCT03176238|591788906|FG000|Overall Study|Death|3|||
163841336|NCT03176238|591788907|FG001|Overall Study|Death|0|||
163841337|NCT03176238|591788906|FG000|Overall Study|Disease Progression|133|||
163841338|NCT03176238|591788907|FG001|Overall Study|Disease Progression|22|||
163841339|NCT03176238|591788906|FG000|Overall Study|Tx duration completed per EAP|0|||
163841340|NCT03176238|591788907|FG001|Overall Study|Tx duration completed per EAP|1|||
163841341|NCT03176238|591788906|FG000|Overall Study|Patient is switched to commercial drug|16|||
163841342|NCT03176238|591788907|FG001|Overall Study|Patient is switched to commercial drug|1|||
163841343|NCT03176238|591788906|FG000|Overall Study|Protocol Violation|1|||
163841344|NCT03176238|591788907|FG001|Overall Study|Protocol Violation|0|||
163841345|NCT03176238|591788906|FG000|Overall Study|Changes in the patient's condition|2|||
163841346|NCT03176238|591788907|FG001|Overall Study|Changes in the patient's condition|1|||
163841347|NCT03176238|591788906|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
163841348|NCT03176238|591788907|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
163841349|NCT01351025|591788910|FG000|Week 0 - 20|Lost to Follow-up|2|||
163841350|NCT01351025|591788911|FG001|Week 0 - 20|Lost to Follow-up|1|||
163841351|NCT01351025|591788910|FG000|Week 0 - 20|Withdrawal by Subject|1|||
163841352|NCT01351025|591788911|FG001|Week 0 - 20|Withdrawal by Subject|0|||
163841353|NCT01351025|591788910|FG000|Week 24 - 44|Lost to Follow-up|0|||
163841354|NCT01351025|591788911|FG001|Week 24 - 44|Lost to Follow-up|2|||
163841355|NCT01351025|591788910|FG000|Week 24 - 44|Site closed|0|||
163841356|NCT01351025|591788911|FG001|Week 24 - 44|Site closed|1|||
163841357|NCT01351025|591788910|FG000|Week 24 - 44|unable to get to clinic|1|||
163841358|NCT01351025|591788911|FG001|Week 24 - 44|unable to get to clinic|1|||
163841359|NCT02089230|591788923|FG000|Overall Study|Death|0|||
163841360|NCT02089230|591788924|FG001|Overall Study|Death|0|||
163841361|NCT02089230|591788925|FG002|Overall Study|Death|2|||
163841362|NCT02089230|591788923|FG000|Overall Study|Seeking Alternative Therapy|0|||
163841363|NCT02089230|591788924|FG001|Overall Study|Seeking Alternative Therapy|0|||
163841364|NCT02089230|591788925|FG002|Overall Study|Seeking Alternative Therapy|4|||
163841365|NCT02032173|591790313|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
163841366|NCT02291289|591790317|FG000|Induction Treatment|Withdrawal by Subject|0|||
163841367|NCT02291289|591790318|FG001|Induction Treatment|Withdrawal by Subject|0|||
163841368|NCT02291289|591790319|FG002|Induction Treatment|Withdrawal by Subject|0|||
163841369|NCT02291289|591790320|FG003|Induction Treatment|Withdrawal by Subject|24|||
163841370|NCT02291289|591790321|FG004|Induction Treatment|Withdrawal by Subject|0|||
163841371|NCT02291289|591790322|FG005|Induction Treatment|Withdrawal by Subject|0|||
163841372|NCT02291289|591790323|FG006|Induction Treatment|Withdrawal by Subject|0|||
163841373|NCT02291289|591790324|FG007|Induction Treatment|Withdrawal by Subject|0|||
163841374|NCT02291289|591790325|FG008|Induction Treatment|Withdrawal by Subject|0|||
164098929|NCT03195491|592726957|FG000|Overall Study|Adverse event unrelated to study drug|19|||
163942127|NCT00208325|592157632|FG000|Overall Study|Withdrawal by Subject|0|||
163942128|NCT00208325|592157633|FG001|Overall Study|Withdrawal by Subject|1|||
163942129|NCT00208325|592157634|FG002|Overall Study|Withdrawal by Subject|0|||
163942130|NCT00208325|592157635|FG003|Overall Study|Withdrawal by Subject|0|||
163942131|NCT00208325|592157632|FG000|Overall Study|Revision|4|||
163942132|NCT00208325|592157633|FG001|Overall Study|Revision|1|||
163942133|NCT00208325|592157634|FG002|Overall Study|Revision|0|||
163942134|NCT00208325|592157635|FG003|Overall Study|Revision|4|||
163942135|NCT00208325|592157632|FG000|Overall Study|Lost to Follow-up|1|||
163942136|NCT00208325|592157633|FG001|Overall Study|Lost to Follow-up|0|||
163942137|NCT00208325|592157634|FG002|Overall Study|Lost to Follow-up|2|||
163942138|NCT00208325|592157635|FG003|Overall Study|Lost to Follow-up|0|||
163942139|NCT00208325|592157632|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
163942140|NCT00208325|592157633|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
163942141|NCT00208325|592157634|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
163942142|NCT00208325|592157635|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
163942143|NCT00208325|592157632|FG000|Overall Study|Does not wish to Continue in Study|5|||
163942144|NCT00208325|592157633|FG001|Overall Study|Does not wish to Continue in Study|8|||
163942145|NCT00208325|592157634|FG002|Overall Study|Does not wish to Continue in Study|3|||
163942146|NCT00208325|592157635|FG003|Overall Study|Does not wish to Continue in Study|2|||
163942147|NCT00208325|592157632|FG000|Overall Study|Other|2|||
163942148|NCT00208325|592157633|FG001|Overall Study|Other|1|||
163942149|NCT00208325|592157634|FG002|Overall Study|Other|1|||
163942150|NCT00208325|592157635|FG003|Overall Study|Other|0|||
163942151|NCT00208325|592157632|FG000|Overall Study|Mis-Randomized|17|||
163942152|NCT00208325|592157633|FG001|Overall Study|Mis-Randomized|20|||
163942153|NCT00208325|592157634|FG002|Overall Study|Mis-Randomized|0|||
163942154|NCT00208325|592157635|FG003|Overall Study|Mis-Randomized|0|||
163942155|NCT01327846|592157636|FG000|Core Phase|Subject decision (vital status: missing)|1|||
163942156|NCT01327846|592157637|FG001|Core Phase|Subject decision (vital status: missing)|2|||
163942157|NCT01327846|592157638|FG002|Core Phase|Subject decision (vital status: missing)|2|||
163942158|NCT01327846|592157639|FG003|Core Phase|Subject decision (vital status: missing)|1|||
163942159|NCT01327846|592157636|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
163942160|NCT01327846|592157637|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
163942161|NCT01327846|592157638|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
163942162|NCT01327846|592157639|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
163942163|NCT01327846|592157636|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
163942164|NCT01327846|592157637|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
163942165|NCT01327846|592157638|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
163942166|NCT01327846|592157639|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
163942167|NCT01327846|592157636|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
163942168|NCT01327846|592157637|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
163942169|NCT01327846|592157638|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
163942170|NCT01327846|592157639|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
163942171|NCT01327846|592157636|FG000|Core Phase|Lost to Follow-up|3|||
163942172|NCT01327846|592157637|FG001|Core Phase|Lost to Follow-up|3|||
163942173|NCT01327846|592157638|FG002|Core Phase|Lost to Follow-up|4|||
163942174|NCT01327846|592157639|FG003|Core Phase|Lost to Follow-up|5|||
163942175|NCT01327846|592157636|FG000|Extension Phase|Study terminated by sponsor|1073|||
163942176|NCT01327846|592157637|FG001|Extension Phase|Study terminated by sponsor|1124|||
163942177|NCT01327846|592157638|FG002|Extension Phase|Study terminated by sponsor|1067|||
163942178|NCT01327846|592157639|FG003|Extension Phase|Study terminated by sponsor|1660|||
163942179|NCT01327846|592157636|FG000|Extension Phase|Withdrawal by Subject|20|||
163942180|NCT01327846|592157637|FG001|Extension Phase|Withdrawal by Subject|13|||
163942181|NCT01327846|592157638|FG002|Extension Phase|Withdrawal by Subject|19|||
163942182|NCT01327846|592157639|FG003|Extension Phase|Withdrawal by Subject|37|||
163942183|NCT01327846|592157636|FG000|Extension Phase|Lost to Follow-up|4|||
163942184|NCT01327846|592157637|FG001|Extension Phase|Lost to Follow-up|3|||
163942185|NCT01327846|592157638|FG002|Extension Phase|Lost to Follow-up|4|||
163942186|NCT01327846|592157639|FG003|Extension Phase|Lost to Follow-up|7|||
163942187|NCT01327846|592157636|FG000|Extension Phase|Technical Problems|2|||
163942188|NCT01327846|592157637|FG001|Extension Phase|Technical Problems|4|||
164098930|NCT03195491|592726958|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164098931|NCT03195491|592726957|FG000|Overall Study|Disease progression|266|||
164098932|NCT03195491|592726958|FG001|Overall Study|Disease progression|8|||
164098933|NCT03195491|592726957|FG000|Overall Study|Other reasons|10|||
163942189|NCT01327846|592157638|FG002|Extension Phase|Technical Problems|2|||
164098934|NCT03195491|592726958|FG001|Overall Study|Other reasons|0|||
164098935|NCT03195491|592726957|FG000|Overall Study|Participant withdrew consent|8|||
163942190|NCT01327846|592157639|FG003|Extension Phase|Technical Problems|2|||
163942191|NCT04662931|592157642|FG000|Overall Study|Withdrawal by Subject|17|||
163942192|NCT04662931|592157642|FG000|Overall Study|Death|3|||
163942193|NCT04662931|592157642|FG000|Overall Study|Lost to Follow-up|3|||
163942194|NCT04662931|592157642|FG000|Overall Study|Guardian Decision|1|||
164098936|NCT03195491|592726958|FG001|Overall Study|Participant withdrew consent|1|||
164147709|NCT02006732|592902131|FG002|Overall Study|Lost to Follow-up|0|||
163942195|NCT04343976|592157644|FG000|Overall Study|Withdrawal by Subject|0|||
163942196|NCT04343976|592157645|FG001|Overall Study|Withdrawal by Subject|1|||
163942197|NCT02807883|592157646|FG000|Overall Study|Withdrawal by Subject|2|||
163942198|NCT01254747|592157647|FG000|Overall Study|Unacceptable subjective vision|0|||
163942199|NCT01254747|592157648|FG001|Overall Study|Unacceptable subjective vision|0|||
163942200|NCT01254747|592157649|FG002|Overall Study|Unacceptable subjective vision|0|||
163942201|NCT01254747|592157650|FG003|Overall Study|Unacceptable subjective vision|2|||
163942202|NCT01254747|592157647|FG000|Overall Study|Difficult removal handling|0|||
163942203|NCT01254747|592157648|FG001|Overall Study|Difficult removal handling|0|||
163942204|NCT01254747|592157649|FG002|Overall Study|Difficult removal handling|1|||
163942205|NCT01254747|592157650|FG003|Overall Study|Difficult removal handling|0|||
163942206|NCT01254747|592157647|FG000|Overall Study|Symptoms and problems|0|||
163942207|NCT01254747|592157648|FG001|Overall Study|Symptoms and problems|2|||
163942208|NCT01254747|592157649|FG002|Overall Study|Symptoms and problems|1|||
163942209|NCT01254747|592157650|FG003|Overall Study|Symptoms and problems|0|||
163942210|NCT01254747|592157647|FG000|Overall Study|Lost to Follow-up|0|||
163942211|NCT01254747|592157648|FG001|Overall Study|Lost to Follow-up|0|||
163942212|NCT01254747|592157649|FG002|Overall Study|Lost to Follow-up|1|||
163942213|NCT01254747|592157650|FG003|Overall Study|Lost to Follow-up|0|||
163942214|NCT01254747|592157647|FG000|Overall Study|Biomicroscopy|0|||
163942215|NCT01254747|592157648|FG001|Overall Study|Biomicroscopy|0|||
163942216|NCT01254747|592157649|FG002|Overall Study|Biomicroscopy|1|||
163942217|NCT01254747|592157650|FG003|Overall Study|Biomicroscopy|0|||
163942218|NCT01254747|592157647|FG000|Overall Study|Discomfort|0|||
163942219|NCT01254747|592157648|FG001|Overall Study|Discomfort|4|||
163942220|NCT01254747|592157649|FG002|Overall Study|Discomfort|0|||
163942221|NCT01254747|592157650|FG003|Overall Study|Discomfort|0|||
163942222|NCT02406677|592157651|FG000|Overall Study|Death|16|||
163942223|NCT02406677|592157652|FG001|Overall Study|Death|8|||
163942224|NCT02406677|592157651|FG000|Overall Study|Discharged without P2Y12|1|||
163942225|NCT02406677|592157652|FG001|Overall Study|Discharged without P2Y12|3|||
163942226|NCT02406677|592157651|FG000|Overall Study|Discharged on prasugrel|283|||
163942227|NCT02406677|592157652|FG001|Overall Study|Discharged on prasugrel|587|||
163942228|NCT02406677|592157651|FG000|Overall Study|Withdrawal by Subject|1|||
163942229|NCT02406677|592157652|FG001|Overall Study|Withdrawal by Subject|0|||
163942230|NCT02833077|592157655|FG000|Overall Study|Adverse Event|1|||
163942231|NCT02833077|592157656|FG001|Overall Study|Adverse Event|2|||
163942232|NCT02833077|592157655|FG000|Overall Study|Lost to Follow-up|10|||
163942233|NCT02833077|592157656|FG001|Overall Study|Lost to Follow-up|1|||
163942234|NCT02833077|592157655|FG000|Overall Study|Personal Reasons|6|||
163942235|NCT02833077|592157656|FG001|Overall Study|Personal Reasons|4|||
163942236|NCT02833077|592157655|FG000|Overall Study|Protocol Deviation|0|||
163942237|NCT02833077|592157656|FG001|Overall Study|Protocol Deviation|1|||
163942238|NCT04608773|592157657|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
163942239|NCT04608773|592157658|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
163942240|NCT04608773|592157657|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
163942241|NCT04608773|592157658|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
163942242|NCT04608773|592157657|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
163942243|NCT04608773|592157658|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
163942244|NCT04608773|592157657|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
163942245|NCT04608773|592157658|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
163942246|NCT04608773|592157657|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
164041848|NCT02709109|592512530|FG001|Treatment Period 2 (28 Days)|Other|0|||
164041849|NCT02709109|592512531|FG002|Treatment Period 2 (28 Days)|Other|1|||
164041850|NCT02709109|592512532|FG003|Treatment Period 2 (28 Days)|Other|0|||
164041851|NCT00741260|592512534|FG000|Overall Study|Disease Progression|3|||
164041852|NCT00741260|592512535|FG001|Overall Study|Disease Progression|5|||
164041853|NCT00741260|592512536|FG002|Overall Study|Disease Progression|3|||
163942247|NCT04608773|592157658|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
164041854|NCT00741260|592512537|FG003|Overall Study|Disease Progression|3|||
164041855|NCT00741260|592512538|FG004|Overall Study|Disease Progression|5|||
164041856|NCT00741260|592512539|FG005|Overall Study|Disease Progression|37|||
164041857|NCT00741260|592512540|FG006|Overall Study|Disease Progression|4|||
163942248|NCT00972322|592157659|FG000|Overall Study|Adverse Event|2|||
163942249|NCT00972322|592157660|FG001|Overall Study|Adverse Event|1|||
163942250|NCT00972322|592157659|FG000|Overall Study|Positive drug screen|0|||
163942251|NCT00972322|592157660|FG001|Overall Study|Positive drug screen|1|||
163942252|NCT00972322|592157659|FG000|Overall Study|Lost to Follow-up|0|||
163942253|NCT00972322|592157660|FG001|Overall Study|Lost to Follow-up|1|||
163942254|NCT00972322|592157659|FG000|Overall Study|Consistently high glucose values|1|||
163942255|NCT00972322|592157660|FG001|Overall Study|Consistently high glucose values|0|||
163942256|NCT04531098|592157663|FG000|Stage I|Adverse Event|0|||
163942257|NCT04531098|592157664|FG001|Stage I|Adverse Event|0|||
163942258|NCT04531098|592157665|FG002|Stage I|Adverse Event|3|||
164041858|NCT00741260|592512534|FG000|Overall Study|Death|0|||
163942259|NCT04531098|592157663|FG000|Stage I|Protocol Violation|0|||
163942260|NCT04531098|592157664|FG001|Stage I|Protocol Violation|0|||
164041859|NCT00741260|592512535|FG001|Overall Study|Death|1|||
163942261|NCT04531098|592157665|FG002|Stage I|Protocol Violation|5|||
163942262|NCT04531098|592157663|FG000|Stage I|Withdrawal by Subject|0|||
163942263|NCT04531098|592157664|FG001|Stage I|Withdrawal by Subject|5|||
163942264|NCT04531098|592157665|FG002|Stage I|Withdrawal by Subject|10|||
163942265|NCT04531098|592157663|FG000|Stage II|Adverse Event|1|||
163942266|NCT04531098|592157664|FG001|Stage II|Adverse Event|2|||
163942267|NCT04531098|592157665|FG002|Stage II|Adverse Event|0|||
163942268|NCT04531098|592157663|FG000|Stage II|Protocol Violation|1|||
163942269|NCT04531098|592157664|FG001|Stage II|Protocol Violation|2|||
163942270|NCT04531098|592157665|FG002|Stage II|Protocol Violation|0|||
163942271|NCT04531098|592157663|FG000|Stage II|Withdrawal by Subject|3|||
163942272|NCT04531098|592157664|FG001|Stage II|Withdrawal by Subject|1|||
163942273|NCT04531098|592157665|FG002|Stage II|Withdrawal by Subject|0|||
163942274|NCT04531098|592157663|FG000|Stage II|Moved from study area|8|||
163942275|NCT04531098|592157664|FG001|Stage II|Moved from study area|5|||
163942276|NCT04531098|592157665|FG002|Stage II|Moved from study area|0|||
163942277|NCT00316017|592157666|FG000|Overall Study|Protocol Violation|11|||
163942278|NCT00316017|592157667|FG001|Overall Study|Protocol Violation|13|||
163942279|NCT00316017|592157668|FG002|Overall Study|Protocol Violation|19|||
163942280|NCT00623805|592157674|FG000|Overall Study|Adverse Event|9|||
163942281|NCT00623805|592157675|FG001|Overall Study|Adverse Event|6|||
163942282|NCT00623805|592157674|FG000|Overall Study|Death|2|||
163942283|NCT00623805|592157675|FG001|Overall Study|Death|0|||
163942284|NCT00623805|592157674|FG000|Overall Study|Lack of Efficacy|3|||
163942285|NCT00623805|592157675|FG001|Overall Study|Lack of Efficacy|7|||
163942286|NCT00623805|592157674|FG000|Overall Study|Lost to Follow-up|2|||
163942287|NCT00623805|592157675|FG001|Overall Study|Lost to Follow-up|2|||
163942288|NCT00623805|592157674|FG000|Overall Study|Protocol Violation|1|||
163942289|NCT00623805|592157675|FG001|Overall Study|Protocol Violation|1|||
163942290|NCT00623805|592157674|FG000|Overall Study|Reason not Specified|3|||
163942291|NCT00623805|592157675|FG001|Overall Study|Reason not Specified|6|||
163942292|NCT02671500|592157677|FG000|Overall Study|Lack of Efficacy|12|||
163942293|NCT02671500|592157677|FG000|Overall Study|Lost to Follow-up|2|||
163942294|NCT05235269|592157679|FG000|Overall Study|Adverse Event|1|||
163942295|NCT05235269|592157679|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
163942296|NCT05235269|592157679|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
163942297|NCT03361865|592157680|FG000|Overall Study|Death|17|||
163942298|NCT03361865|592157681|FG001|Overall Study|Death|18|||
163942299|NCT03361865|592157680|FG000|Overall Study|Physician Decision|1|||
163942300|NCT03361865|592157681|FG001|Overall Study|Physician Decision|9|||
163942301|NCT03361865|592157680|FG000|Overall Study|Withdrawal by Subject|1|||
163942302|NCT03361865|592157681|FG001|Overall Study|Withdrawal by Subject|0|||
163942303|NCT03810235|592157682|FG000|Overall Study|Withdrawal by Subject|2|||
163942304|NCT03810235|592157683|FG001|Overall Study|Withdrawal by Subject|0|||
163942305|NCT01647542|592157684|FG000|Overall Study|Major Protocol Deviation|1|||
163942306|NCT01647542|592157685|FG001|Overall Study|Major Protocol Deviation|0|||
163942307|NCT01647542|592157686|FG002|Overall Study|Major Protocol Deviation|0|||
163942308|NCT01647542|592157684|FG000|Overall Study|Adverse Event|4|||
163942309|NCT01647542|592157685|FG001|Overall Study|Adverse Event|5|||
163942310|NCT01647542|592157686|FG002|Overall Study|Adverse Event|4|||
164041860|NCT00741260|592512536|FG002|Overall Study|Death|0|||
164041861|NCT00741260|592512537|FG003|Overall Study|Death|1|||
164041862|NCT00741260|592512538|FG004|Overall Study|Death|2|||
163942311|NCT01647542|592157684|FG000|Overall Study|Lost to Follow-up|0|||
163942312|NCT01647542|592157685|FG001|Overall Study|Lost to Follow-up|2|||
163942313|NCT01647542|592157686|FG002|Overall Study|Lost to Follow-up|2|||
163942314|NCT01647542|592157684|FG000|Overall Study|Withdrawal by Subject|6|||
163942315|NCT01647542|592157685|FG001|Overall Study|Withdrawal by Subject|4|||
163942316|NCT01647542|592157686|FG002|Overall Study|Withdrawal by Subject|0|||
163942317|NCT01647542|592157684|FG000|Overall Study|Study Termination|64|||
163942318|NCT01647542|592157685|FG001|Overall Study|Study Termination|61|||
163942319|NCT01647542|592157686|FG002|Overall Study|Study Termination|65|||
163942320|NCT01647542|592157684|FG000|Overall Study|Lack of Efficacy|1|||
163942321|NCT01647542|592157685|FG001|Overall Study|Lack of Efficacy|1|||
163942322|NCT01647542|592157686|FG002|Overall Study|Lack of Efficacy|0|||
163942323|NCT01647542|592157684|FG000|Overall Study|Death|0|||
163942324|NCT01647542|592157685|FG001|Overall Study|Death|0|||
163942325|NCT01647542|592157686|FG002|Overall Study|Death|1|||
163942326|NCT03843554|592159205|FG000|Overall Study|Physician Decision|0|||
163942327|NCT03843554|592159206|FG001|Overall Study|Physician Decision|2|||
163942328|NCT02218606|592159208|FG000|Overall Study|Adverse Event|1|||
163942329|NCT02218606|592159209|FG001|Overall Study|Adverse Event|1|||
163942330|NCT02218606|592159208|FG000|Overall Study|Death|15|||
163942331|NCT02218606|592159209|FG001|Overall Study|Death|28|||
163942332|NCT02218606|592159208|FG000|Overall Study|Physician Decision|0|||
163942333|NCT02218606|592159209|FG001|Overall Study|Physician Decision|1|||
163942334|NCT02218606|592159208|FG000|Overall Study|Withdrawal by Subject|4|||
163942335|NCT02218606|592159209|FG001|Overall Study|Withdrawal by Subject|0|||
163942336|NCT02218606|592159208|FG000|Overall Study|Noncompliance|1|||
163942337|NCT02218606|592159209|FG001|Overall Study|Noncompliance|0|||
164098937|NCT03195491|592726957|FG000|Overall Study|Participant no longer meets study criteria|0|||
164098938|NCT03195491|592726958|FG001|Overall Study|Participant no longer meets study criteria|1|||
164098939|NCT03195491|592726957|FG000|Overall Study|Participant request to discontinue study treatment|10|||
164098940|NCT03195491|592726958|FG001|Overall Study|Participant request to discontinue study treatment|0|||
164098941|NCT03627091|592726959|FG000|Overall Study|Adverse Event|0|||
164098942|NCT03627091|592726960|FG001|Overall Study|Adverse Event|0|||
164098943|NCT03627091|592726961|FG002|Overall Study|Adverse Event|2|||
164098944|NCT03627091|592726959|FG000|Overall Study|Withdrawal by Subject|2|||
164098945|NCT03627091|592726960|FG001|Overall Study|Withdrawal by Subject|0|||
164098946|NCT03627091|592726961|FG002|Overall Study|Withdrawal by Subject|2|||
164098947|NCT03627091|592726959|FG000|Overall Study|Physician Decision|2|||
164098948|NCT03627091|592726960|FG001|Overall Study|Physician Decision|0|||
164098949|NCT03627091|592726961|FG002|Overall Study|Physician Decision|0|||
164098950|NCT03627091|592726959|FG000|Overall Study|Site terminated by sponsor|0|||
164098951|NCT03627091|592726960|FG001|Overall Study|Site terminated by sponsor|1|||
164098952|NCT03627091|592726961|FG002|Overall Study|Site terminated by sponsor|0|||
164098953|NCT03627091|592726959|FG000|Overall Study|Disease relapse|7|||
164098954|NCT03627091|592726960|FG001|Overall Study|Disease relapse|5|||
164098955|NCT03627091|592726961|FG002|Overall Study|Disease relapse|1|||
164098956|NCT03627091|592726959|FG000|Overall Study|Other|1|||
164098957|NCT03627091|592726960|FG001|Overall Study|Other|0|||
164098958|NCT03627091|592726961|FG002|Overall Study|Other|0|||
164098959|NCT03496623|592726962|FG000|Run-In Period (2 Weeks)|Death|1|||
164098960|NCT03496623|592726963|FG001|Run-In Period (2 Weeks)|Death|0|||
164098961|NCT03496623|592726964|FG002|Run-In Period (2 Weeks)|Death|0|||
164098962|NCT03496623|592726965|FG003|Run-In Period (2 Weeks)|Death|0|||
164041863|NCT00741260|592512539|FG005|Overall Study|Death|2|||
164041864|NCT00741260|592512540|FG006|Overall Study|Death|1|||
164041865|NCT00741260|592512534|FG000|Overall Study|Withdrawal by Subject|0|||
164041866|NCT00741260|592512535|FG001|Overall Study|Withdrawal by Subject|0|||
164041867|NCT00741260|592512536|FG002|Overall Study|Withdrawal by Subject|0|||
164041868|NCT00741260|592512537|FG003|Overall Study|Withdrawal by Subject|0|||
164041869|NCT00741260|592512538|FG004|Overall Study|Withdrawal by Subject|1|||
164041870|NCT00741260|592512539|FG005|Overall Study|Withdrawal by Subject|3|||
164041871|NCT00741260|592512540|FG006|Overall Study|Withdrawal by Subject|1|||
164041872|NCT00741260|592512534|FG000|Overall Study|Physician Decision|1|||
164041873|NCT00741260|592512535|FG001|Overall Study|Physician Decision|1|||
164041874|NCT00741260|592512536|FG002|Overall Study|Physician Decision|0|||
164041875|NCT00741260|592512537|FG003|Overall Study|Physician Decision|0|||
164041876|NCT00741260|592512538|FG004|Overall Study|Physician Decision|0|||
164041877|NCT00741260|592512539|FG005|Overall Study|Physician Decision|0|||
164041878|NCT00741260|592512540|FG006|Overall Study|Physician Decision|0|||
164041879|NCT00741260|592512534|FG000|Overall Study|Other|2|||
164041880|NCT00741260|592512535|FG001|Overall Study|Other|1|||
164041881|NCT00741260|592512536|FG002|Overall Study|Other|1|||
164041882|NCT00741260|592512537|FG003|Overall Study|Other|2|||
164041883|NCT00741260|592512538|FG004|Overall Study|Other|1|||
164041884|NCT00741260|592512539|FG005|Overall Study|Other|3|||
164041885|NCT00741260|592512540|FG006|Overall Study|Other|1|||
164041886|NCT02565615|592512541|FG000|Overall Study|Death|0|||
164041887|NCT02565615|592512542|FG001|Overall Study|Death|1|||
164041888|NCT02565615|592512543|FG002|Overall Study|Death|0|||
164041889|NCT02565615|592512544|FG003|Overall Study|Death|0|||
164041890|NCT02565615|592512545|FG004|Overall Study|Death|4|||
164041891|NCT02565615|592512541|FG000|Overall Study|Not willing to participate in study|2|||
164041892|NCT02565615|592512542|FG001|Overall Study|Not willing to participate in study|21|||
164041893|NCT02565615|592512543|FG002|Overall Study|Not willing to participate in study|0|||
164041894|NCT02565615|592512544|FG003|Overall Study|Not willing to participate in study|1|||
164041895|NCT02565615|592512545|FG004|Overall Study|Not willing to participate in study|169|||
164041896|NCT02565615|592512541|FG000|Overall Study|Lost to Follow-up|0|||
164041897|NCT02565615|592512542|FG001|Overall Study|Lost to Follow-up|4|||
164041898|NCT02565615|592512543|FG002|Overall Study|Lost to Follow-up|0|||
164098963|NCT03496623|592726966|FG004|Run-In Period (2 Weeks)|Death|0|||
164041899|NCT02565615|592512544|FG003|Overall Study|Lost to Follow-up|1|||
164098964|NCT03496623|592726962|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
164098965|NCT03496623|592726963|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164098966|NCT03496623|592726964|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164041900|NCT02565615|592512545|FG004|Overall Study|Lost to Follow-up|765|||
164041901|NCT02565615|592512541|FG000|Overall Study|Not meeting eligibility criteria|0|||
164041902|NCT02565615|592512542|FG001|Overall Study|Not meeting eligibility criteria|7|||
164041903|NCT02565615|592512543|FG002|Overall Study|Not meeting eligibility criteria|0|||
164041904|NCT02565615|592512544|FG003|Overall Study|Not meeting eligibility criteria|0|||
164041905|NCT02565615|592512545|FG004|Overall Study|Not meeting eligibility criteria|25|||
164041906|NCT02565615|592512541|FG000|Overall Study|Reason not defined|0|||
164041907|NCT02565615|592512542|FG001|Overall Study|Reason not defined|2|||
164098967|NCT03496623|592726965|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164098968|NCT03496623|592726966|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
164098969|NCT03496623|592726962|FG000|Period 1 (12 Weeks)|Death|0|||
164098970|NCT03496623|592726963|FG001|Period 1 (12 Weeks)|Death|3|||
164098971|NCT03496623|592726964|FG002|Period 1 (12 Weeks)|Death|0|||
164098972|NCT03496623|592726965|FG003|Period 1 (12 Weeks)|Death|0|||
163942338|NCT02218606|592159208|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
163942339|NCT02218606|592159209|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
163942340|NCT02218606|592159208|FG000|Overall Study|Other|2|||
163942341|NCT02218606|592159209|FG001|Overall Study|Other|1|||
163942342|NCT02218606|592159208|FG000|Overall Study|Never started treatment|0|||
163942343|NCT02218606|592159209|FG001|Overall Study|Never started treatment|1|||
163942344|NCT00890695|592159210|FG000|Overall Study|Protocol Violation|1|||
163942345|NCT00890695|592159211|FG001|Overall Study|Protocol Violation|0|||
163942346|NCT04396366|592159214|FG000|Overall Study|Adverse Event|1|||
163942347|NCT04396366|592159215|FG001|Overall Study|Adverse Event|0|||
163942348|NCT01127893|592159221|FG000|Overall Study|Study Termination by the Sponsor|1|||
163942349|NCT01262677|592159222|FG000|Overall Study|Does not meet entrance criteria|0|||
163942350|NCT01262677|592159223|FG001|Overall Study|Does not meet entrance criteria|2|||
163942351|NCT01262677|592159224|FG002|Overall Study|Does not meet entrance criteria|0|||
163942352|NCT01262677|592159222|FG000|Overall Study|Insufficient clinical response|0|||
163942353|NCT01262677|592159223|FG001|Overall Study|Insufficient clinical response|0|||
163942354|NCT01262677|592159224|FG002|Overall Study|Insufficient clinical response|1|||
163942355|NCT01262677|592159222|FG000|Overall Study|Lost to Follow-up|1|||
163942356|NCT01262677|592159223|FG001|Overall Study|Lost to Follow-up|0|||
163942357|NCT01262677|592159224|FG002|Overall Study|Lost to Follow-up|2|||
163942358|NCT01262677|592159222|FG000|Overall Study|No longer willing to participate|3|||
163942359|NCT01262677|592159223|FG001|Overall Study|No longer willing to participate|3|||
163942360|NCT01262677|592159224|FG002|Overall Study|No longer willing to participate|2|||
163942361|NCT01262677|592159222|FG000|Overall Study|Reason not provided|2|||
163942362|NCT01262677|592159223|FG001|Overall Study|Reason not provided|1|||
163942363|NCT01262677|592159224|FG002|Overall Study|Reason not provided|3|||
163942364|NCT01262677|592159222|FG000|Overall Study|Protocol Violation|0|||
163942365|NCT01262677|592159223|FG001|Overall Study|Protocol Violation|1|||
163942366|NCT01262677|592159224|FG002|Overall Study|Protocol Violation|1|||
163942367|NCT01262677|592159222|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
163942368|NCT01262677|592159223|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
163942369|NCT01262677|592159224|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
163942370|NCT00574873|592159225|FG000|Overall Study|Withdrawal by Subject|18|||
163942371|NCT00574873|592159226|FG001|Overall Study|Withdrawal by Subject|19|||
163942372|NCT00574873|592159225|FG000|Overall Study|Investigator request|18|||
163942373|NCT00574873|592159226|FG001|Overall Study|Investigator request|8|||
163942374|NCT00574873|592159225|FG000|Overall Study|Death|15|||
163942375|NCT00574873|592159226|FG001|Overall Study|Death|14|||
163942376|NCT00574873|592159225|FG000|Overall Study|Lost to Follow-up|14|||
163942377|NCT00574873|592159226|FG001|Overall Study|Lost to Follow-up|5|||
163942378|NCT00574873|592159225|FG000|Overall Study|Other|40|||
163942379|NCT00574873|592159226|FG001|Overall Study|Other|4|||
163942380|NCT00574873|592159225|FG000|Overall Study|Discontinuation of study by sponsor|5|||
163942381|NCT00574873|592159226|FG001|Overall Study|Discontinuation of study by sponsor|199|||
163942382|NCT00574873|592159225|FG000|Overall Study|Blank, site closed per local regulations|2|||
163942383|NCT00574873|592159226|FG001|Overall Study|Blank, site closed per local regulations|2|||
163942384|NCT00574873|592159225|FG000|Overall Study|Extension Study|126|||
163942385|NCT00574873|592159226|FG001|Overall Study|Extension Study|0|||
163942386|NCT02187159|592159229|FG000|Overall Study|Protocol Violation|4|||
163942387|NCT02187159|592159230|FG001|Overall Study|Protocol Violation|6|||
163942388|NCT02187159|592159231|FG002|Overall Study|Protocol Violation|3|||
163942389|NCT02187159|592159232|FG003|Overall Study|Protocol Violation|4|||
163942390|NCT02187159|592159229|FG000|Overall Study|Lack of Efficacy|10|||
163942391|NCT02187159|592159230|FG001|Overall Study|Lack of Efficacy|5|||
163942392|NCT02187159|592159231|FG002|Overall Study|Lack of Efficacy|4|||
163942393|NCT02187159|592159232|FG003|Overall Study|Lack of Efficacy|7|||
163942394|NCT02187159|592159229|FG000|Overall Study|Adverse Event|28|||
163942395|NCT02187159|592159230|FG001|Overall Study|Adverse Event|33|||
164098973|NCT03496623|592726966|FG004|Period 1 (12 Weeks)|Death|0|||
163942396|NCT02187159|592159231|FG002|Overall Study|Adverse Event|42|||
163942397|NCT02187159|592159232|FG003|Overall Study|Adverse Event|50|||
163942398|NCT02187159|592159229|FG000|Overall Study|Withdrawal by Subject|24|||
163942399|NCT02187159|592159230|FG001|Overall Study|Withdrawal by Subject|28|||
163942400|NCT02187159|592159231|FG002|Overall Study|Withdrawal by Subject|25|||
163942401|NCT02187159|592159232|FG003|Overall Study|Withdrawal by Subject|26|||
163942402|NCT02187159|592159229|FG000|Overall Study|Other|3|||
163942403|NCT02187159|592159230|FG001|Overall Study|Other|7|||
163942404|NCT02187159|592159231|FG002|Overall Study|Other|3|||
163942405|NCT02187159|592159232|FG003|Overall Study|Other|9|||
163942406|NCT01283152|592159233|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
163942407|NCT01283152|592159234|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
164098974|NCT03496623|592726962|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
164098975|NCT03496623|592726963|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
164041908|NCT02565615|592512543|FG002|Overall Study|Reason not defined|0|||
164041909|NCT02565615|592512544|FG003|Overall Study|Reason not defined|1|||
164041910|NCT02565615|592512545|FG004|Overall Study|Reason not defined|62|||
164041911|NCT02565615|592512541|FG000|Overall Study|Adverse Event|1|||
164041912|NCT02565615|592512542|FG001|Overall Study|Adverse Event|1|||
164041913|NCT02565615|592512543|FG002|Overall Study|Adverse Event|0|||
164041914|NCT02565615|592512544|FG003|Overall Study|Adverse Event|0|||
164041915|NCT02565615|592512545|FG004|Overall Study|Adverse Event|9|||
164041916|NCT02565615|592512541|FG000|Overall Study|Untreated|0|||
164041917|NCT02565615|592512542|FG001|Overall Study|Untreated|0|||
164041918|NCT02565615|592512543|FG002|Overall Study|Untreated|0|||
164041919|NCT02565615|592512544|FG003|Overall Study|Untreated|0|||
164041920|NCT02565615|592512545|FG004|Overall Study|Untreated|567|||
164041921|NCT01928082|592512547|FG000|Overall Study|Study terminated.|1|||
164041922|NCT01815580|592512548|FG000|Overall Study|Lost to Follow-up|4|||
164041923|NCT01815580|592512549|FG001|Overall Study|Lost to Follow-up|7|||
163942408|NCT01283152|592159233|FG000|Overall Study|Refused HESA|1|||
163942409|NCT01283152|592159234|FG001|Overall Study|Refused HESA|0|||
163942410|NCT00567567|592159235|FG000|Overall Study|Adverse Event|0|||
163942411|NCT00567567|592159236|FG001|Overall Study|Adverse Event|2|||
163942412|NCT00567567|592159237|FG002|Overall Study|Adverse Event|5|||
163942413|NCT00567567|592159235|FG000|Overall Study|Death|8|||
163942414|NCT00567567|592159236|FG001|Overall Study|Death|1|||
163942415|NCT00567567|592159237|FG002|Overall Study|Death|5|||
163942416|NCT00567567|592159235|FG000|Overall Study|Lack of Efficacy|16|||
163942417|NCT00567567|592159236|FG001|Overall Study|Lack of Efficacy|17|||
163942418|NCT00567567|592159237|FG002|Overall Study|Lack of Efficacy|48|||
163942419|NCT00567567|592159235|FG000|Overall Study|Lost to Follow-up|0|||
163942420|NCT00567567|592159236|FG001|Overall Study|Lost to Follow-up|0|||
163942421|NCT00567567|592159237|FG002|Overall Study|Lost to Follow-up|1|||
163942422|NCT00567567|592159235|FG000|Overall Study|Physician Decision|16|||
163942423|NCT00567567|592159236|FG001|Overall Study|Physician Decision|18|||
163942424|NCT00567567|592159237|FG002|Overall Study|Physician Decision|84|||
163942425|NCT00567567|592159235|FG000|Overall Study|Withdrawal by Subject|0|||
163942426|NCT00567567|592159236|FG001|Overall Study|Withdrawal by Subject|0|||
163942427|NCT00567567|592159237|FG002|Overall Study|Withdrawal by Subject|2|||
163942428|NCT00567567|592159235|FG000|Overall Study|Ineligible|4|||
163942429|NCT00567567|592159236|FG001|Overall Study|Ineligible|0|||
163942430|NCT00567567|592159237|FG002|Overall Study|Ineligible|9|||
163942431|NCT00567567|592159235|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
163942432|NCT00567567|592159236|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
163942433|NCT00567567|592159237|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
163942434|NCT00567567|592159235|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
163942435|NCT00567567|592159236|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
163942436|NCT00567567|592159237|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
163942437|NCT00567567|592159235|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
163942438|NCT00567567|592159236|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
163942439|NCT00567567|592159237|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
163942440|NCT03433677|592159238|FG000|Period 1|Protocol Violation|1|||
163942441|NCT03433677|592159239|FG001|Period 1|Protocol Violation|0|||
163942442|NCT03433677|592159238|FG000|Period 2|Withdrawal by Subject|1|||
163942443|NCT03433677|592159239|FG001|Period 2|Withdrawal by Subject|1|||
163942444|NCT03330405|592159240|FG000|Overall Study|Other|1|||
163942445|NCT03330405|592159241|FG001|Overall Study|Other|3|||
163942446|NCT03330405|592159242|FG002|Overall Study|Other|1|||
163942447|NCT03330405|592159243|FG003|Overall Study|Other|0|||
163942448|NCT03330405|592159244|FG004|Overall Study|Other|2|||
163942449|NCT03330405|592159245|FG005|Overall Study|Other|0|||
163942450|NCT03330405|592159246|FG006|Overall Study|Other|1|||
163942451|NCT03330405|592159247|FG007|Overall Study|Other|0|||
164041924|NCT01815580|592512548|FG000|Overall Study|Withdrawal by Subject|3|||
163942452|NCT03330405|592159248|FG008|Overall Study|Other|0|||
164041925|NCT01815580|592512549|FG001|Overall Study|Withdrawal by Subject|4|||
163942453|NCT03330405|592159249|FG009|Overall Study|Other|0|||
163942454|NCT03330405|592159250|FG010|Overall Study|Other|0|||
164041926|NCT01815580|592512548|FG000|Overall Study|Excluded from analysis|5|||
164041927|NCT01815580|592512549|FG001|Overall Study|Excluded from analysis|4|||
164041928|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
163942455|NCT03330405|592159240|FG000|Overall Study|Progressive disease|8|||
163942456|NCT03330405|592159241|FG001|Overall Study|Progressive disease|27|||
163942457|NCT03330405|592159242|FG002|Overall Study|Progressive disease|4|||
163942458|NCT03330405|592159243|FG003|Overall Study|Progressive disease|18|||
163942459|NCT03330405|592159244|FG004|Overall Study|Progressive disease|16|||
163942460|NCT03330405|592159245|FG005|Overall Study|Progressive disease|14|||
163942461|NCT03330405|592159246|FG006|Overall Study|Progressive disease|7|||
163942462|NCT03330405|592159247|FG007|Overall Study|Progressive disease|29|||
164041929|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
164041930|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
164041931|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
164041932|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
163942463|NCT03330405|592159248|FG008|Overall Study|Progressive disease|9|||
163942464|NCT03330405|592159249|FG009|Overall Study|Progressive disease|11|||
163942465|NCT03330405|592159250|FG010|Overall Study|Progressive disease|5|||
163942466|NCT03330405|592159240|FG000|Overall Study|Withdrawal by Subject|1|||
163942467|NCT03330405|592159241|FG001|Overall Study|Withdrawal by Subject|4|||
163942468|NCT03330405|592159242|FG002|Overall Study|Withdrawal by Subject|0|||
163942469|NCT03330405|592159243|FG003|Overall Study|Withdrawal by Subject|1|||
163942470|NCT03330405|592159244|FG004|Overall Study|Withdrawal by Subject|1|||
163942471|NCT03330405|592159245|FG005|Overall Study|Withdrawal by Subject|1|||
163942472|NCT03330405|592159246|FG006|Overall Study|Withdrawal by Subject|0|||
163942473|NCT03330405|592159247|FG007|Overall Study|Withdrawal by Subject|2|||
163942474|NCT03330405|592159248|FG008|Overall Study|Withdrawal by Subject|2|||
163942475|NCT03330405|592159249|FG009|Overall Study|Withdrawal by Subject|1|||
163942476|NCT03330405|592159250|FG010|Overall Study|Withdrawal by Subject|1|||
163942477|NCT03330405|592159240|FG000|Overall Study|Global deterioration of health status|2|||
163942478|NCT03330405|592159241|FG001|Overall Study|Global deterioration of health status|3|||
163942479|NCT03330405|592159242|FG002|Overall Study|Global deterioration of health status|0|||
163942480|NCT03330405|592159243|FG003|Overall Study|Global deterioration of health status|2|||
163942481|NCT03330405|592159244|FG004|Overall Study|Global deterioration of health status|3|||
163942482|NCT03330405|592159245|FG005|Overall Study|Global deterioration of health status|3|||
163942483|NCT03330405|592159246|FG006|Overall Study|Global deterioration of health status|0|||
163942484|NCT03330405|592159247|FG007|Overall Study|Global deterioration of health status|2|||
163942485|NCT03330405|592159248|FG008|Overall Study|Global deterioration of health status|8|||
163942486|NCT03330405|592159249|FG009|Overall Study|Global deterioration of health status|4|||
163942487|NCT03330405|592159250|FG010|Overall Study|Global deterioration of health status|1|||
163942488|NCT03330405|592159240|FG000|Overall Study|Adverse Event|0|||
163942489|NCT03330405|592159241|FG001|Overall Study|Adverse Event|1|||
163942490|NCT03330405|592159242|FG002|Overall Study|Adverse Event|0|||
163942491|NCT03330405|592159243|FG003|Overall Study|Adverse Event|1|||
163942492|NCT03330405|592159244|FG004|Overall Study|Adverse Event|1|||
163942493|NCT03330405|592159245|FG005|Overall Study|Adverse Event|1|||
163942494|NCT03330405|592159246|FG006|Overall Study|Adverse Event|3|||
163942495|NCT03330405|592159247|FG007|Overall Study|Adverse Event|4|||
163942496|NCT03330405|592159248|FG008|Overall Study|Adverse Event|2|||
163942497|NCT03330405|592159249|FG009|Overall Study|Adverse Event|2|||
163942498|NCT03330405|592159250|FG010|Overall Study|Adverse Event|2|||
163942499|NCT03330405|592159240|FG000|Overall Study|Death|0|||
163942500|NCT03330405|592159241|FG001|Overall Study|Death|4|||
163942501|NCT03330405|592159242|FG002|Overall Study|Death|0|||
163942502|NCT03330405|592159243|FG003|Overall Study|Death|0|||
163942503|NCT03330405|592159244|FG004|Overall Study|Death|0|||
163942504|NCT03330405|592159245|FG005|Overall Study|Death|1|||
163942505|NCT03330405|592159246|FG006|Overall Study|Death|0|||
163942506|NCT03330405|592159247|FG007|Overall Study|Death|2|||
163942507|NCT03330405|592159248|FG008|Overall Study|Death|0|||
163942508|NCT03330405|592159249|FG009|Overall Study|Death|0|||
163942509|NCT03330405|592159250|FG010|Overall Study|Death|0|||
163942510|NCT03330405|592159240|FG000|Overall Study|Physician Decision|0|||
163942511|NCT03330405|592159241|FG001|Overall Study|Physician Decision|0|||
163942512|NCT03330405|592159242|FG002|Overall Study|Physician Decision|0|||
163942513|NCT03330405|592159243|FG003|Overall Study|Physician Decision|0|||
163942514|NCT03330405|592159244|FG004|Overall Study|Physician Decision|0|||
163942515|NCT03330405|592159245|FG005|Overall Study|Physician Decision|0|||
163942516|NCT03330405|592159246|FG006|Overall Study|Physician Decision|0|||
163942517|NCT03330405|592159247|FG007|Overall Study|Physician Decision|1|||
163942518|NCT03330405|592159248|FG008|Overall Study|Physician Decision|0|||
163942519|NCT03330405|592159249|FG009|Overall Study|Physician Decision|0|||
163942520|NCT03330405|592159250|FG010|Overall Study|Physician Decision|0|||
163942521|NCT03482466|592159251|FG000|Overall Study|Protocol Violation|2|||
163942522|NCT04833127|592159252|FG000|Overall Study|Lost to Follow-up|1|||
163942523|NCT04833127|592159253|FG001|Overall Study|Lost to Follow-up|1|||
163942524|NCT01736189|592159254|FG000|Overall Study|Violation of registration criteria|41|||
163942525|NCT01736189|592159254|FG000|Overall Study|Protocol Violation|4|||
163942526|NCT01736189|592159254|FG000|Overall Study|Criteria and protocol violations|1|||
163942527|NCT01499303|592159255|FG000|Overall Study|Ongoing|2|||
163942528|NCT01499303|592159256|FG001|Overall Study|Ongoing|1|||
163942529|NCT01499303|592159255|FG000|Overall Study|Withdrawal by Subject|0|||
163942530|NCT01499303|592159256|FG001|Overall Study|Withdrawal by Subject|1|||
163942531|NCT01499303|592159255|FG000|Overall Study|Adverse Event|1|||
163942532|NCT01499303|592159256|FG001|Overall Study|Adverse Event|4|||
163942533|NCT01499303|592159255|FG000|Overall Study|Other|0|||
163942534|NCT01499303|592159256|FG001|Overall Study|Other|1|||
164041933|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
163942535|NCT01896557|592159257|FG000|Clopidogrel Alone|Adverse Event|1|||
163942536|NCT01896557|592159258|FG001|Clopidogrel Alone|Adverse Event|0|||
163942537|NCT01896557|592159257|FG000|Clopidogrel + GI Protector|low adherence|1|||
163942538|NCT01896557|592159258|FG001|Clopidogrel + GI Protector|low adherence|1|||
163942539|NCT01896557|592159257|FG000|Clopidogrel + GI Protector|Reading error|1|||
164041934|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
164041935|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
164041936|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164041937|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164041938|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164041939|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164041940|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164041941|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
164041942|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
164041943|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
164041944|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
164041945|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
164041946|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
164041947|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
164041948|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
164041949|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
164041950|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164041951|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164041952|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164041953|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164041954|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164041955|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
164041956|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
164041957|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164041958|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164041959|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164041960|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164041961|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164041962|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
164041963|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
164041964|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164041965|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164041966|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164041967|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164041968|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164041969|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
164041970|NCT02120352|592512552|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
164041971|NCT02120352|592512553|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
164041972|NCT02120352|592512554|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
164041973|NCT02120352|592512555|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
164041974|NCT02120352|592512556|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
164041975|NCT02120352|592512557|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
164041976|NCT02120352|592512558|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
164041977|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164041978|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
164041979|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
164041980|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
164041981|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164041982|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164041983|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
164041984|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164041985|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
164041986|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164041987|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
164041988|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164041989|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164041990|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
164041991|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164041992|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
164041993|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
164041994|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164041995|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164041996|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164041997|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
164041998|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164041999|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164042000|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
163942540|NCT01896557|592159258|FG001|Clopidogrel + GI Protector|Reading error|3|||
163942541|NCT02383940|592159259|FG000|Overall Study|Adverse Event|1|||
163942542|NCT02383940|592159260|FG001|Overall Study|Adverse Event|0|||
163942543|NCT02383940|592159259|FG000|Overall Study|Lost to Follow-up|2|||
163942544|NCT02383940|592159260|FG001|Overall Study|Lost to Follow-up|2|||
163942545|NCT02383940|592159259|FG000|Overall Study|Physician Decision|2|||
163942546|NCT02383940|592159260|FG001|Overall Study|Physician Decision|0|||
163942547|NCT02383940|592159259|FG000|Overall Study|Withdrawal by Subject|1|||
163942548|NCT02383940|592159260|FG001|Overall Study|Withdrawal by Subject|1|||
163942549|NCT02383940|592159259|FG000|Overall Study|Randomized but not treated|2|||
163942550|NCT02383940|592159260|FG001|Overall Study|Randomized but not treated|0|||
163942551|NCT02383940|592159259|FG000|Overall Study|Other than specified above|1|||
163942552|NCT02383940|592159260|FG001|Overall Study|Other than specified above|0|||
163942553|NCT01517295|592159261|FG000|Overall Study|Physician Decision|1|||
163942554|NCT01517295|592159262|FG001|Overall Study|Physician Decision|0|||
163942555|NCT02672852|592159263|FG000|Part A1|Disease Worsening|1|||
163942556|NCT02672852|592159264|FG001|Part A1|Disease Worsening|0|||
163942557|NCT02672852|592159265|FG002|Part A1|Disease Worsening|0|||
163942558|NCT02672852|592159266|FG003|Part A1|Disease Worsening|0|||
163942559|NCT02672852|592159267|FG004|Part A1|Disease Worsening|0|||
163942560|NCT02672852|592159268|FG005|Part A1|Disease Worsening|0|||
163942561|NCT02672852|592159269|FG006|Part A1|Disease Worsening|0|||
163942562|NCT02672852|592159263|FG000|Part A1|Adverse Event|0|||
163942563|NCT02672852|592159264|FG001|Part A1|Adverse Event|1|||
163942564|NCT02672852|592159265|FG002|Part A1|Adverse Event|0|||
163942565|NCT02672852|592159266|FG003|Part A1|Adverse Event|0|||
163942566|NCT02672852|592159267|FG004|Part A1|Adverse Event|0|||
163942567|NCT02672852|592159268|FG005|Part A1|Adverse Event|0|||
163942568|NCT02672852|592159269|FG006|Part A1|Adverse Event|0|||
163942569|NCT02672852|592159263|FG000|Part A1|Lost to Follow-up|1|||
163942570|NCT02672852|592159264|FG001|Part A1|Lost to Follow-up|2|||
163942571|NCT02672852|592159265|FG002|Part A1|Lost to Follow-up|0|||
163942572|NCT02672852|592159266|FG003|Part A1|Lost to Follow-up|0|||
163942573|NCT02672852|592159267|FG004|Part A1|Lost to Follow-up|0|||
163942574|NCT02672852|592159268|FG005|Part A1|Lost to Follow-up|0|||
163942575|NCT02672852|592159269|FG006|Part A1|Lost to Follow-up|0|||
163942576|NCT02672852|592159263|FG000|Part A1|Withdrawal by Subject|1|||
163942577|NCT02672852|592159264|FG001|Part A1|Withdrawal by Subject|1|||
163942578|NCT02672852|592159265|FG002|Part A1|Withdrawal by Subject|0|||
163942579|NCT02672852|592159266|FG003|Part A1|Withdrawal by Subject|0|||
163942580|NCT02672852|592159267|FG004|Part A1|Withdrawal by Subject|0|||
163942581|NCT02672852|592159268|FG005|Part A1|Withdrawal by Subject|0|||
163942582|NCT02672852|592159269|FG006|Part A1|Withdrawal by Subject|0|||
163942583|NCT02672852|592159263|FG000|Part A2|Disease worsening|0|||
163942584|NCT02672852|592159264|FG001|Part A2|Disease worsening|0|||
163942585|NCT02672852|592159265|FG002|Part A2|Disease worsening|1|||
163942586|NCT02672852|592159266|FG003|Part A2|Disease worsening|0|||
163942587|NCT02672852|592159267|FG004|Part A2|Disease worsening|0|||
163942588|NCT02672852|592159268|FG005|Part A2|Disease worsening|0|||
163942589|NCT02672852|592159269|FG006|Part A2|Disease worsening|0|||
163942590|NCT02672852|592159263|FG000|Part A2|Adverse Event|0|||
163942591|NCT02672852|592159264|FG001|Part A2|Adverse Event|0|||
163942592|NCT02672852|592159265|FG002|Part A2|Adverse Event|3|||
163942593|NCT02672852|592159266|FG003|Part A2|Adverse Event|0|||
163942594|NCT02672852|592159267|FG004|Part A2|Adverse Event|0|||
163942595|NCT02672852|592159268|FG005|Part A2|Adverse Event|0|||
163942596|NCT02672852|592159269|FG006|Part A2|Adverse Event|0|||
163942597|NCT02672852|592159263|FG000|Part A2|Lost to Follow-up|0|||
163942598|NCT02672852|592159264|FG001|Part A2|Lost to Follow-up|0|||
163942599|NCT02672852|592159265|FG002|Part A2|Lost to Follow-up|2|||
163942600|NCT02672852|592159266|FG003|Part A2|Lost to Follow-up|0|||
163942601|NCT02672852|592159267|FG004|Part A2|Lost to Follow-up|0|||
163942602|NCT02672852|592159268|FG005|Part A2|Lost to Follow-up|0|||
163942603|NCT02672852|592159269|FG006|Part A2|Lost to Follow-up|0|||
163942604|NCT02672852|592159263|FG000|Part A2|Withdrawal by Subject|0|||
163942605|NCT02672852|592159264|FG001|Part A2|Withdrawal by Subject|0|||
163942606|NCT02672852|592159265|FG002|Part A2|Withdrawal by Subject|1|||
164042001|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
164147710|NCT02006732|592902132|FG003|Overall Study|Lost to Follow-up|0|||
163942607|NCT02672852|592159266|FG003|Part A2|Withdrawal by Subject|0|||
163942608|NCT02672852|592159267|FG004|Part A2|Withdrawal by Subject|0|||
163942609|NCT02672852|592159268|FG005|Part A2|Withdrawal by Subject|0|||
163942610|NCT02672852|592159269|FG006|Part A2|Withdrawal by Subject|0|||
163942611|NCT02672852|592159263|FG000|Part A2|Other|0|||
163942612|NCT02672852|592159264|FG001|Part A2|Other|0|||
163942613|NCT02672852|592159265|FG002|Part A2|Other|3|||
163942614|NCT02672852|592159266|FG003|Part A2|Other|0|||
163942615|NCT02672852|592159267|FG004|Part A2|Other|0|||
163942616|NCT02672852|592159268|FG005|Part A2|Other|0|||
163942617|NCT02672852|592159269|FG006|Part A2|Other|0|||
163942618|NCT02672852|592159263|FG000|Part A2|Not entered in Part B|0|||
163942619|NCT02672852|592159264|FG001|Part A2|Not entered in Part B|0|||
163942620|NCT02672852|592159265|FG002|Part A2|Not entered in Part B|0|||
163942621|NCT02672852|592159266|FG003|Part A2|Not entered in Part B|4|||
163942622|NCT02672852|592159267|FG004|Part A2|Not entered in Part B|0|||
163942623|NCT02672852|592159268|FG005|Part A2|Not entered in Part B|0|||
163942624|NCT02672852|592159269|FG006|Part A2|Not entered in Part B|0|||
163942625|NCT02672852|592159263|FG000|Part B|Disease worsening|0|||
163942626|NCT02672852|592159264|FG001|Part B|Disease worsening|0|||
163942627|NCT02672852|592159265|FG002|Part B|Disease worsening|0|||
163942628|NCT02672852|592159266|FG003|Part B|Disease worsening|0|||
163942629|NCT02672852|592159267|FG004|Part B|Disease worsening|1|||
163942630|NCT02672852|592159268|FG005|Part B|Disease worsening|0|||
163942631|NCT02672852|592159269|FG006|Part B|Disease worsening|1|||
163942632|NCT02672852|592159263|FG000|Part B|Worsening pre-existing condition|0|||
163942633|NCT02672852|592159264|FG001|Part B|Worsening pre-existing condition|0|||
163942634|NCT02672852|592159265|FG002|Part B|Worsening pre-existing condition|0|||
163942635|NCT02672852|592159266|FG003|Part B|Worsening pre-existing condition|0|||
163942636|NCT02672852|592159267|FG004|Part B|Worsening pre-existing condition|0|||
163942637|NCT02672852|592159268|FG005|Part B|Worsening pre-existing condition|1|||
163942638|NCT02672852|592159269|FG006|Part B|Worsening pre-existing condition|0|||
163942639|NCT02672852|592159263|FG000|Part B|Other adverse event|0|||
163942640|NCT02672852|592159264|FG001|Part B|Other adverse event|0|||
163942641|NCT02672852|592159265|FG002|Part B|Other adverse event|0|||
163942642|NCT02672852|592159266|FG003|Part B|Other adverse event|0|||
163942643|NCT02672852|592159267|FG004|Part B|Other adverse event|3|||
163942644|NCT02672852|592159268|FG005|Part B|Other adverse event|5|||
163942645|NCT02672852|592159269|FG006|Part B|Other adverse event|1|||
163942646|NCT02672852|592159263|FG000|Part B|Lost to Follow-up|0|||
163942647|NCT02672852|592159264|FG001|Part B|Lost to Follow-up|0|||
163942648|NCT02672852|592159265|FG002|Part B|Lost to Follow-up|0|||
163942649|NCT02672852|592159266|FG003|Part B|Lost to Follow-up|0|||
163942650|NCT02672852|592159267|FG004|Part B|Lost to Follow-up|3|||
163942651|NCT02672852|592159268|FG005|Part B|Lost to Follow-up|4|||
163942652|NCT02672852|592159269|FG006|Part B|Lost to Follow-up|1|||
163942653|NCT02672852|592159263|FG000|Part B|Withdrawal by Subject|0|||
163942654|NCT02672852|592159264|FG001|Part B|Withdrawal by Subject|0|||
163942655|NCT02672852|592159265|FG002|Part B|Withdrawal by Subject|0|||
163942656|NCT02672852|592159266|FG003|Part B|Withdrawal by Subject|0|||
163942657|NCT02672852|592159267|FG004|Part B|Withdrawal by Subject|5|||
163942658|NCT02672852|592159268|FG005|Part B|Withdrawal by Subject|0|||
163942659|NCT02672852|592159269|FG006|Part B|Withdrawal by Subject|7|||
163942660|NCT02672852|592159263|FG000|Part B|Other|0|||
163942661|NCT02672852|592159264|FG001|Part B|Other|0|||
163942662|NCT02672852|592159265|FG002|Part B|Other|0|||
163942663|NCT02672852|592159266|FG003|Part B|Other|0|||
163942664|NCT02672852|592159267|FG004|Part B|Other|4|||
163942665|NCT02672852|592159268|FG005|Part B|Other|1|||
163942666|NCT02672852|592159269|FG006|Part B|Other|2|||
163942667|NCT01353859|592159270|FG000|Overall Study|Adverse Event|3|||
163942668|NCT01353859|592159270|FG000|Overall Study|Lack of Efficacy|1|||
163942669|NCT03853551|592159273|FG000|Overall Study|Death|2|||
163942670|NCT03853551|592159273|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
163942671|NCT01923467|592159276|FG000|Overall Study|Lost to Follow-up|62|||
163942672|NCT01923467|592159276|FG000|Overall Study|Subject non-interest|479|||
163942673|NCT01075958|592159277|FG000|Overall Study|Blood sample could not be obtained|44|||
163942674|NCT02636725|592159281|FG000|Overall Study|Adverse Event|1|||
163942675|NCT01696045|592159284|FG000|Overall Study|Study drug toxicity|1|||
163942676|NCT01696045|592159285|FG001|Overall Study|Study drug toxicity|5|||
163942677|NCT01696045|592159284|FG000|Overall Study|Disease progression|2|||
163942678|NCT01696045|592159285|FG001|Overall Study|Disease progression|2|||
163942679|NCT01559129|592159286|FG000|Treatment Phase|Adverse Event|0|||
163942680|NCT01559129|592159287|FG001|Treatment Phase|Adverse Event|2|||
163942681|NCT01559129|592159286|FG000|Treatment Phase|Progressive Disease|1|||
163942682|NCT01559129|592159287|FG001|Treatment Phase|Progressive Disease|1|||
163942683|NCT01559129|592159286|FG000|Treatment Phase|Lack of Efficacy|0|||
163942684|NCT01559129|592159287|FG001|Treatment Phase|Lack of Efficacy|1|||
163942685|NCT01559129|592159286|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
163942686|NCT01559129|592159287|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
163942687|NCT01559129|592159286|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
164042002|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163942688|NCT01559129|592159287|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
163942689|NCT01559129|592159286|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
163942690|NCT01559129|592159287|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
164042003|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
164042004|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
163942691|NCT01559129|592159286|FG000|Open-label Extension Period|Adverse Event|1|||
163942692|NCT01559129|592159287|FG001|Open-label Extension Period|Adverse Event|0|||
163942693|NCT01559129|592159286|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
163942694|NCT01559129|592159287|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
163942695|NCT03525392|592159288|FG000|Overall Study|Adverse Event|1|||
163942696|NCT03525392|592159289|FG001|Overall Study|Adverse Event|0|||
163942697|NCT03525392|592159290|FG002|Overall Study|Adverse Event|2|||
163942698|NCT03525392|592159291|FG003|Overall Study|Adverse Event|0|||
163942699|NCT03525392|592159292|FG004|Overall Study|Adverse Event|0|||
163942700|NCT03525392|592159288|FG000|Overall Study|Progressive disease|0|||
163942701|NCT03525392|592159289|FG001|Overall Study|Progressive disease|1|||
163942702|NCT03525392|592159290|FG002|Overall Study|Progressive disease|1|||
163942703|NCT03525392|592159291|FG003|Overall Study|Progressive disease|3|||
163942704|NCT03525392|592159292|FG004|Overall Study|Progressive disease|1|||
163942705|NCT00831129|592159295|FG000|Overall Study|Adverse Event|0|||
163942706|NCT00831129|592159296|FG001|Overall Study|Adverse Event|1|||
163942707|NCT00831129|592159295|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
163942708|NCT00831129|592159296|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
163942709|NCT04462289|592159300|FG000|Overall Study|Lost to Follow-up|4|||
163942710|NCT04462289|592159301|FG001|Overall Study|Lost to Follow-up|5|||
163942711|NCT04462289|592159300|FG000|Overall Study|Death|0|||
163942712|NCT04462289|592159301|FG001|Overall Study|Death|3|||
163942713|NCT04462289|592159300|FG000|Overall Study|Withdrawal by Subject|1|||
163942714|NCT04462289|592159301|FG001|Overall Study|Withdrawal by Subject|3|||
163942715|NCT00818779|592159302|FG000|Overall Study|Protocol Violation|1|||
163942716|NCT00818779|592159303|FG001|Overall Study|Protocol Violation|0|||
163942717|NCT00818779|592159302|FG000|Overall Study|Lost to Follow-up|1|||
163942718|NCT00818779|592159303|FG001|Overall Study|Lost to Follow-up|0|||
163942719|NCT00818779|592159302|FG000|Overall Study|Adverse Event|4|||
163942720|NCT00818779|592159303|FG001|Overall Study|Adverse Event|1|||
163942721|NCT00132873|592159304|FG000|Overall Study|Adverse Event|3|||
163942722|NCT00132873|592159304|FG000|Overall Study|Lost to Follow-up|1|||
163942723|NCT00132873|592159304|FG000|Overall Study|Lack of Efficacy|1|||
163942724|NCT00132873|592159304|FG000|Overall Study|Withdrawal by Subject|3|||
163942725|NCT00132873|592159304|FG000|Overall Study|Planned Pregnancy|1|||
163942726|NCT04276415|592159305|FG000|Overall Study|Adverse Event|0|||
163942727|NCT04276415|592159306|FG001|Overall Study|Adverse Event|0|||
163942728|NCT04276415|592159307|FG002|Overall Study|Adverse Event|0|||
163942729|NCT04276415|592159308|FG003|Overall Study|Adverse Event|3|||
163942730|NCT04276415|592159309|FG004|Overall Study|Adverse Event|0|||
163942731|NCT04276415|592159310|FG005|Overall Study|Adverse Event|0|||
163942732|NCT04276415|592159305|FG000|Overall Study|Clinical progression|1|||
163942733|NCT04276415|592159306|FG001|Overall Study|Clinical progression|1|||
163942734|NCT04276415|592159307|FG002|Overall Study|Clinical progression|0|||
163942735|NCT04276415|592159308|FG003|Overall Study|Clinical progression|0|||
163942736|NCT04276415|592159309|FG004|Overall Study|Clinical progression|1|||
163942737|NCT04276415|592159310|FG005|Overall Study|Clinical progression|0|||
163942738|NCT04276415|592159305|FG000|Overall Study|Other|0|||
163942739|NCT04276415|592159306|FG001|Overall Study|Other|0|||
163942740|NCT04276415|592159307|FG002|Overall Study|Other|0|||
163942741|NCT04276415|592159308|FG003|Overall Study|Other|1|||
163942742|NCT04276415|592159309|FG004|Overall Study|Other|0|||
163942743|NCT04276415|592159310|FG005|Overall Study|Other|0|||
163942744|NCT04276415|592159305|FG000|Overall Study|Physician Decision|0|||
163942745|NCT04276415|592159306|FG001|Overall Study|Physician Decision|0|||
163942746|NCT04276415|592159307|FG002|Overall Study|Physician Decision|1|||
163942747|NCT04276415|592159308|FG003|Overall Study|Physician Decision|3|||
163942748|NCT04276415|592159309|FG004|Overall Study|Physician Decision|2|||
163942749|NCT04276415|592159310|FG005|Overall Study|Physician Decision|0|||
163942750|NCT04276415|592159305|FG000|Overall Study|Progressive disease|3|||
163942751|NCT04276415|592159306|FG001|Overall Study|Progressive disease|3|||
163942752|NCT04276415|592159307|FG002|Overall Study|Progressive disease|4|||
163942753|NCT04276415|592159308|FG003|Overall Study|Progressive disease|5|||
163942754|NCT04276415|592159309|FG004|Overall Study|Progressive disease|1|||
163942755|NCT04276415|592159310|FG005|Overall Study|Progressive disease|2|||
163942756|NCT04276415|592159305|FG000|Overall Study|Withdrawal by patient|0|||
163942757|NCT04276415|592159306|FG001|Overall Study|Withdrawal by patient|0|||
163942758|NCT04276415|592159307|FG002|Overall Study|Withdrawal by patient|0|||
163942759|NCT04276415|592159308|FG003|Overall Study|Withdrawal by patient|1|||
163942760|NCT04276415|592159309|FG004|Overall Study|Withdrawal by patient|2|||
164042005|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164042006|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164042007|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164042008|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
163942761|NCT04276415|592159310|FG005|Overall Study|Withdrawal by patient|0|||
163942762|NCT01217437|592159317|FG000|Overall Study|Adverse Event|0|||
163942763|NCT01217437|592159318|FG001|Overall Study|Adverse Event|8|||
163942764|NCT01217437|592159317|FG000|Overall Study|Death|5|||
163942765|NCT01217437|592159318|FG001|Overall Study|Death|0|||
163942766|NCT01217437|592159317|FG000|Overall Study|Lack of Efficacy|29|||
164042009|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
163942767|NCT01217437|592159318|FG001|Overall Study|Lack of Efficacy|25|||
163942768|NCT01217437|592159317|FG000|Overall Study|Physician Decision|8|||
163942769|NCT01217437|592159318|FG001|Overall Study|Physician Decision|5|||
163942770|NCT01217437|592159317|FG000|Overall Study|Withdrawal by Subject|0|||
163942771|NCT01217437|592159318|FG001|Overall Study|Withdrawal by Subject|2|||
163942772|NCT01217437|592159317|FG000|Overall Study|Ineligible|1|||
164042010|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164042011|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
164042012|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164042013|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
164042014|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
164042015|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
164042016|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164042017|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164042018|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
164042019|NCT02120352|592512552|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164042020|NCT02120352|592512553|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
164042021|NCT02120352|592512554|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164042022|NCT02120352|592512555|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164042023|NCT02120352|592512556|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164042024|NCT02120352|592512557|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164042025|NCT02120352|592512558|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
164042026|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
164042027|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
164042028|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
164042029|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
164042030|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
164042031|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
164042032|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
164042033|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164042034|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164042035|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164042036|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164042037|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
164042038|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164042039|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
164042040|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164042041|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
164042042|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
164042043|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164042044|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
164042045|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164042046|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
164042047|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164042048|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
164042049|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
164042050|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164042051|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
164042052|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164042053|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
164042054|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164042055|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
164042056|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
164042057|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164042058|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
164042059|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164042060|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
164042061|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164042062|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
164042063|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
164042064|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164042065|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164042066|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164042067|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
164042068|NCT02120352|592512552|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
164042069|NCT02120352|592512553|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
164042070|NCT02120352|592512554|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
164042071|NCT02120352|592512555|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
164042072|NCT02120352|592512556|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
164042073|NCT02120352|592512557|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
164098976|NCT03496623|592726964|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
164098977|NCT03496623|592726965|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
164098978|NCT03496623|592726966|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
164098979|NCT03496623|592726962|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164098980|NCT03496623|592726963|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
164098981|NCT03496623|592726964|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
163841375|NCT02291289|591790326|FG009|Induction Treatment|Withdrawal by Subject|18|||
163841376|NCT02291289|591790327|FG010|Induction Treatment|Withdrawal by Subject|0|||
163841377|NCT02291289|591790328|FG011|Induction Treatment|Withdrawal by Subject|0|||
163841378|NCT02291289|591790329|FG012|Induction Treatment|Withdrawal by Subject|0|||
163841379|NCT02291289|591790317|FG000|Induction Treatment|Adverse Event|0|||
163841380|NCT02291289|591790318|FG001|Induction Treatment|Adverse Event|0|||
163841381|NCT02291289|591790319|FG002|Induction Treatment|Adverse Event|0|||
163841382|NCT02291289|591790320|FG003|Induction Treatment|Adverse Event|3|||
163841383|NCT02291289|591790321|FG004|Induction Treatment|Adverse Event|0|||
163841384|NCT02291289|591790322|FG005|Induction Treatment|Adverse Event|0|||
163841385|NCT02291289|591790323|FG006|Induction Treatment|Adverse Event|0|||
163841386|NCT02291289|591790324|FG007|Induction Treatment|Adverse Event|0|||
163841387|NCT02291289|591790325|FG008|Induction Treatment|Adverse Event|0|||
163841388|NCT02291289|591790326|FG009|Induction Treatment|Adverse Event|1|||
163841389|NCT02291289|591790327|FG010|Induction Treatment|Adverse Event|0|||
163841390|NCT02291289|591790328|FG011|Induction Treatment|Adverse Event|0|||
163841391|NCT02291289|591790329|FG012|Induction Treatment|Adverse Event|0|||
163841392|NCT02291289|591790317|FG000|Induction Treatment|Death|25|||
163841393|NCT02291289|591790318|FG001|Induction Treatment|Death|0|||
163841394|NCT02291289|591790319|FG002|Induction Treatment|Death|0|||
163841395|NCT02291289|591790320|FG003|Induction Treatment|Death|111|||
163841396|NCT02291289|591790321|FG004|Induction Treatment|Death|0|||
163841397|NCT02291289|591790322|FG005|Induction Treatment|Death|0|||
163841398|NCT02291289|591790323|FG006|Induction Treatment|Death|1|||
163841399|NCT02291289|591790324|FG007|Induction Treatment|Death|0|||
163841400|NCT02291289|591790325|FG008|Induction Treatment|Death|0|||
163841401|NCT02291289|591790326|FG009|Induction Treatment|Death|82|||
163841402|NCT02291289|591790327|FG010|Induction Treatment|Death|0|||
163841403|NCT02291289|591790328|FG011|Induction Treatment|Death|0|||
163841404|NCT02291289|591790329|FG012|Induction Treatment|Death|0|||
163841405|NCT02291289|591790317|FG000|Induction Treatment|Lost to Follow-up|1|||
163841406|NCT02291289|591790318|FG001|Induction Treatment|Lost to Follow-up|0|||
163841407|NCT02291289|591790319|FG002|Induction Treatment|Lost to Follow-up|0|||
163841408|NCT02291289|591790320|FG003|Induction Treatment|Lost to Follow-up|12|||
163841409|NCT02291289|591790321|FG004|Induction Treatment|Lost to Follow-up|0|||
163841410|NCT02291289|591790322|FG005|Induction Treatment|Lost to Follow-up|0|||
163841411|NCT02291289|591790323|FG006|Induction Treatment|Lost to Follow-up|0|||
163841412|NCT02291289|591790324|FG007|Induction Treatment|Lost to Follow-up|0|||
163841413|NCT02291289|591790325|FG008|Induction Treatment|Lost to Follow-up|0|||
163841414|NCT02291289|591790326|FG009|Induction Treatment|Lost to Follow-up|9|||
163841415|NCT02291289|591790327|FG010|Induction Treatment|Lost to Follow-up|0|||
163841416|NCT02291289|591790328|FG011|Induction Treatment|Lost to Follow-up|0|||
163841417|NCT02291289|591790329|FG012|Induction Treatment|Lost to Follow-up|0|||
163841418|NCT02291289|591790317|FG000|Induction Treatment|Non-Compliance|0|||
163841419|NCT02291289|591790318|FG001|Induction Treatment|Non-Compliance|0|||
163841420|NCT02291289|591790319|FG002|Induction Treatment|Non-Compliance|0|||
163841421|NCT02291289|591790320|FG003|Induction Treatment|Non-Compliance|1|||
163841422|NCT02291289|591790321|FG004|Induction Treatment|Non-Compliance|0|||
163841423|NCT02291289|591790322|FG005|Induction Treatment|Non-Compliance|0|||
163841424|NCT02291289|591790323|FG006|Induction Treatment|Non-Compliance|0|||
163841425|NCT02291289|591790324|FG007|Induction Treatment|Non-Compliance|0|||
163841426|NCT02291289|591790325|FG008|Induction Treatment|Non-Compliance|0|||
163841427|NCT02291289|591790326|FG009|Induction Treatment|Non-Compliance|1|||
163841428|NCT02291289|591790327|FG010|Induction Treatment|Non-Compliance|0|||
163841429|NCT02291289|591790328|FG011|Induction Treatment|Non-Compliance|0|||
163841430|NCT02291289|591790329|FG012|Induction Treatment|Non-Compliance|0|||
163841431|NCT02291289|591790317|FG000|Induction Treatment|Reason Not Specified|0|||
163841432|NCT02291289|591790318|FG001|Induction Treatment|Reason Not Specified|0|||
163841433|NCT02291289|591790319|FG002|Induction Treatment|Reason Not Specified|0|||
163841434|NCT02291289|591790320|FG003|Induction Treatment|Reason Not Specified|4|||
163841435|NCT02291289|591790321|FG004|Induction Treatment|Reason Not Specified|0|||
163841436|NCT02291289|591790322|FG005|Induction Treatment|Reason Not Specified|0|||
163841437|NCT02291289|591790323|FG006|Induction Treatment|Reason Not Specified|0|||
163841438|NCT02291289|591790324|FG007|Induction Treatment|Reason Not Specified|0|||
163841439|NCT02291289|591790325|FG008|Induction Treatment|Reason Not Specified|0|||
163841440|NCT02291289|591790326|FG009|Induction Treatment|Reason Not Specified|7|||
164098982|NCT03496623|592726965|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163841441|NCT02291289|591790327|FG010|Induction Treatment|Reason Not Specified|0|||
163841442|NCT02291289|591790328|FG011|Induction Treatment|Reason Not Specified|0|||
163841443|NCT02291289|591790329|FG012|Induction Treatment|Reason Not Specified|0|||
163841444|NCT02291289|591790317|FG000|Induction Treatment|Physician Decision|0|||
164098983|NCT03496623|592726966|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
163942773|NCT01217437|592159318|FG001|Overall Study|Ineligible|1|||
163942774|NCT02336451|592159322|FG000|Overall Study|Adverse Event|1|||
163942775|NCT02336451|592159323|FG001|Overall Study|Adverse Event|2|||
163942776|NCT02336451|592159324|FG002|Overall Study|Adverse Event|0|||
163942777|NCT02336451|592159325|FG003|Overall Study|Adverse Event|6|||
163942778|NCT02336451|592159326|FG004|Overall Study|Adverse Event|4|||
163942779|NCT02336451|592159322|FG000|Overall Study|Death|6|||
163942780|NCT02336451|592159323|FG001|Overall Study|Death|2|||
163942781|NCT02336451|592159324|FG002|Overall Study|Death|3|||
163942782|NCT02336451|592159325|FG003|Overall Study|Death|6|||
163942783|NCT02336451|592159326|FG004|Overall Study|Death|6|||
163942784|NCT02336451|592159322|FG000|Overall Study|Physician Decision|9|||
163942785|NCT02336451|592159323|FG001|Overall Study|Physician Decision|6|||
163942786|NCT02336451|592159324|FG002|Overall Study|Physician Decision|7|||
163942787|NCT02336451|592159325|FG003|Overall Study|Physician Decision|16|||
163942788|NCT02336451|592159326|FG004|Overall Study|Physician Decision|3|||
163942789|NCT02336451|592159322|FG000|Overall Study|Progressive disease|23|||
163942790|NCT02336451|592159323|FG001|Overall Study|Progressive disease|26|||
163942791|NCT02336451|592159324|FG002|Overall Study|Progressive disease|2|||
163942792|NCT02336451|592159325|FG003|Overall Study|Progressive disease|14|||
163942793|NCT02336451|592159326|FG004|Overall Study|Progressive disease|4|||
163942794|NCT02336451|592159322|FG000|Overall Study|Protocol Violation|1|||
163942795|NCT02336451|592159323|FG001|Overall Study|Protocol Violation|0|||
163942796|NCT02336451|592159324|FG002|Overall Study|Protocol Violation|0|||
163942797|NCT02336451|592159325|FG003|Overall Study|Protocol Violation|0|||
163942798|NCT02336451|592159326|FG004|Overall Study|Protocol Violation|0|||
163942799|NCT02336451|592159322|FG000|Overall Study|Patient/guardian decision|2|||
163942800|NCT02336451|592159323|FG001|Overall Study|Patient/guardian decision|4|||
163942801|NCT02336451|592159324|FG002|Overall Study|Patient/guardian decision|0|||
163942802|NCT02336451|592159325|FG003|Overall Study|Patient/guardian decision|2|||
163942803|NCT02336451|592159326|FG004|Overall Study|Patient/guardian decision|1|||
163942804|NCT00215137|592161048|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
163942805|NCT00215137|592161049|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
163942806|NCT00215137|592161050|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
163942807|NCT00215137|592161048|FG000|Randomization Period|Lost to Follow-up|0|||
163942808|NCT00215137|592161049|FG001|Randomization Period|Lost to Follow-up|1|||
163942809|NCT00215137|592161050|FG002|Randomization Period|Lost to Follow-up|0|||
163942810|NCT00215137|592161048|FG000|Randomization Period|Withdrawal by Subject|0|||
163942811|NCT00215137|592161049|FG001|Randomization Period|Withdrawal by Subject|1|||
163942812|NCT00215137|592161050|FG002|Randomization Period|Withdrawal by Subject|0|||
163942813|NCT03333876|592161051|FG000|Screening Period|Screen Failure|4|||
163942814|NCT03333876|592161051|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
163942815|NCT03333876|592161051|FG000|Mandibular Advancement|Adverse Event|2|||
163942816|NCT03333876|592161051|FG000|Mandibular Advancement|Product Damage|2|||
163942817|NCT00095498|592161055|FG000|Overall Study|Physician Decision|9|||
163942818|NCT00095498|592161056|FG001|Overall Study|Physician Decision|10|||
163942819|NCT00095498|592161057|FG002|Overall Study|Physician Decision|8|||
163942820|NCT00095498|592161055|FG000|Overall Study|Adverse Event|1|||
163942821|NCT00095498|592161056|FG001|Overall Study|Adverse Event|0|||
163942822|NCT00095498|592161057|FG002|Overall Study|Adverse Event|1|||
163942823|NCT00095498|592161055|FG000|Overall Study|Withdrawal by Subject|15|||
163942824|NCT00095498|592161056|FG001|Overall Study|Withdrawal by Subject|16|||
163942825|NCT00095498|592161057|FG002|Overall Study|Withdrawal by Subject|15|||
163942826|NCT00095498|592161055|FG000|Overall Study|Disease progression|0|||
163942827|NCT00095498|592161056|FG001|Overall Study|Disease progression|1|||
163942828|NCT00095498|592161057|FG002|Overall Study|Disease progression|1|||
163942829|NCT00095498|592161055|FG000|Overall Study|Ineligibility determined|3|||
163942830|NCT00095498|592161056|FG001|Overall Study|Ineligibility determined|0|||
163942831|NCT00095498|592161057|FG002|Overall Study|Ineligibility determined|2|||
163942832|NCT00095498|592161055|FG000|Overall Study|Lost to Follow-up|1|||
163942833|NCT00095498|592161056|FG001|Overall Study|Lost to Follow-up|1|||
163942834|NCT00095498|592161057|FG002|Overall Study|Lost to Follow-up|2|||
163942835|NCT00095498|592161055|FG000|Overall Study|Noncompliance|1|||
163942836|NCT00095498|592161056|FG001|Overall Study|Noncompliance|0|||
163942837|NCT00095498|592161057|FG002|Overall Study|Noncompliance|1|||
163942838|NCT00095498|592161055|FG000|Overall Study|Other|6|||
163942839|NCT00095498|592161056|FG001|Overall Study|Other|7|||
163942840|NCT00095498|592161057|FG002|Overall Study|Other|6|||
163942841|NCT00095498|592161055|FG000|Overall Study|Protocol Violation|0|||
163942842|NCT00095498|592161056|FG001|Overall Study|Protocol Violation|0|||
163942843|NCT00095498|592161057|FG002|Overall Study|Protocol Violation|1|||
163942844|NCT00095498|592161055|FG000|Overall Study|Requirement for alternative therapy|1|||
163942845|NCT00095498|592161056|FG001|Overall Study|Requirement for alternative therapy|0|||
163942846|NCT00095498|592161057|FG002|Overall Study|Requirement for alternative therapy|2|||
163942847|NCT05020327|592161059|FG000|Overall Study|Physician Decision|3|||
163942848|NCT05020327|592161060|FG001|Overall Study|Physician Decision|0|||
163942849|NCT05020327|592161061|FG002|Overall Study|Physician Decision|0|||
163942850|NCT05020327|592161059|FG000|Overall Study|Withdrawal by Subject|1|||
163942851|NCT05020327|592161060|FG001|Overall Study|Withdrawal by Subject|1|||
164042074|NCT02120352|592512558|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
164042075|NCT02120352|592512552|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164042076|NCT02120352|592512553|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164042077|NCT02120352|592512554|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164042078|NCT02120352|592512555|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164042079|NCT02120352|592512556|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164042080|NCT02120352|592512557|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
164042081|NCT02120352|592512558|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
164042082|NCT02427100|592512559|FG000|Overall Study|Lost to Follow-up|0|||
164042083|NCT02427100|592512560|FG001|Overall Study|Lost to Follow-up|2|||
164042084|NCT01610206|592512563|FG000|Overall Study|Adverse Event|10|||
164042085|NCT01610206|592512564|FG001|Overall Study|Adverse Event|30|||
164042086|NCT00842361|592512565|FG000|Overall Study|Protocol Violation|1|||
163942852|NCT05020327|592161061|FG002|Overall Study|Withdrawal by Subject|0|||
163942853|NCT05020327|592161059|FG000|Overall Study|personal/cultural, ineligible|12|||
163942854|NCT05020327|592161060|FG001|Overall Study|personal/cultural, ineligible|0|||
163942855|NCT05020327|592161061|FG002|Overall Study|personal/cultural, ineligible|0|||
163942856|NCT03002220|592161063|FG000|Overall Study|Lack of Efficacy|2|||
163942857|NCT03002220|592161063|FG000|Overall Study|Withdrawal by Subject|3|||
163942858|NCT03002220|592161063|FG000|Overall Study|Adverse Event|2|||
163942859|NCT03002220|592161063|FG000|Overall Study|Disease progression|13|||
163942860|NCT03002220|592161063|FG000|Overall Study|Physician Decision|1|||
163942861|NCT01015560|592161064|FG000|Overall Study|Adverse Event|1|||
163942862|NCT01015560|592161064|FG000|Overall Study|Not protocol specified|1|||
163942863|NCT01015560|592161064|FG000|Overall Study|Withdrawal by Subject|1|||
163942864|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
163942865|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
163942866|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
163942867|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
163942868|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
163942869|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
163942870|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
163942871|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163942872|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163942873|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163942874|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163942875|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
163942876|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Death|1|||
163942877|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Death|2|||
163942878|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Death|2|||
163942879|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Death|0|||
163942880|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Death|0|||
163942881|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Death|0|||
163942882|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163942883|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
163942884|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
163942885|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163942886|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163942887|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
163942888|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
163942889|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163942890|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163942891|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163942892|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163942893|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
163942894|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
163942895|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163942896|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163942897|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163942898|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163942899|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
163942900|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
163942901|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163942902|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163942903|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163942904|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
164042087|NCT00842361|592512566|FG001|Overall Study|Protocol Violation|0|||
164042088|NCT00842361|592512565|FG000|Overall Study|Unclassified|0|||
164042089|NCT00842361|592512566|FG001|Overall Study|Unclassified|2|||
164042090|NCT02186561|592512567|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
164042091|NCT02186561|592512567|FG000|Enrollment|Enrollment Cap Reached|5|||
164042092|NCT02186561|592512567|FG000|Enrollment|Insurance Denial|2|||
164042093|NCT02186561|592512567|FG000|Enrollment|Withdrawal by Subject|2|||
164042094|NCT02186561|592512567|FG000|Enrollment|Investigator Withdrew Consent|1|||
164042095|NCT02186561|592512567|FG000|30-Day Post Index Procedure Visit|Death|1|||
164042096|NCT02186561|592512567|FG000|1- Year Post Index Procedure Visit|Death|1|||
164042097|NCT02186561|592512567|FG000|1- Year Post Index Procedure Visit|Missed|1|||
164042098|NCT00023712|592512570|FG000|Overall Study|Not platinum sensitive|1|||
164042099|NCT00023712|592512571|FG001|Overall Study|Not platinum sensitive|0|||
164042100|NCT00023712|592512570|FG000|Overall Study|Never treated|1|||
164042101|NCT00023712|592512571|FG001|Overall Study|Never treated|1|||
164042102|NCT02999191|592512572|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
164042103|NCT02999191|592512573|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
164042104|NCT02999191|592512574|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
164042105|NCT02079519|592512577|FG000|Overall Study|Disease Progression|9|||
164042106|NCT02079519|592512577|FG000|Overall Study|Adverse Event|1|||
164042107|NCT01802515|592512578|FG000|Overall Study|Withdrawal by Subject|3|||
164042108|NCT01802515|592512579|FG001|Overall Study|Withdrawal by Subject|0|||
164042109|NCT01802515|592512580|FG002|Overall Study|Withdrawal by Subject|0|||
164042110|NCT01993667|592512583|FG000|Overall Study|Insufficient data to analyze|16|||
164042111|NCT01993667|592512584|FG001|Overall Study|Insufficient data to analyze|16|||
164042112|NCT01993667|592512583|FG000|Overall Study|Insufficient altitude reached|3|||
164042113|NCT01993667|592512584|FG001|Overall Study|Insufficient altitude reached|1|||
164042114|NCT01993667|592512583|FG000|Overall Study|Lost to Follow-up|2|||
164042115|NCT01993667|592512584|FG001|Overall Study|Lost to Follow-up|2|||
164042116|NCT01602549|592512585|FG000|Overall Study|Protocol Violation|0|||
164042117|NCT01602549|592512586|FG001|Overall Study|Protocol Violation|1|||
164042118|NCT01602549|592512585|FG000|Overall Study|Withdrawal by Subject|1|||
164042119|NCT01602549|592512586|FG001|Overall Study|Withdrawal by Subject|0|||
163841445|NCT02291289|591790318|FG001|Induction Treatment|Physician Decision|0|||
163841446|NCT02291289|591790319|FG002|Induction Treatment|Physician Decision|0|||
163841447|NCT02291289|591790320|FG003|Induction Treatment|Physician Decision|3|||
163841448|NCT02291289|591790321|FG004|Induction Treatment|Physician Decision|0|||
163841449|NCT02291289|591790322|FG005|Induction Treatment|Physician Decision|0|||
163841450|NCT02291289|591790323|FG006|Induction Treatment|Physician Decision|0|||
163841451|NCT02291289|591790324|FG007|Induction Treatment|Physician Decision|0|||
163841452|NCT02291289|591790325|FG008|Induction Treatment|Physician Decision|0|||
163841453|NCT02291289|591790326|FG009|Induction Treatment|Physician Decision|1|||
163841454|NCT02291289|591790327|FG010|Induction Treatment|Physician Decision|0|||
163841455|NCT02291289|591790328|FG011|Induction Treatment|Physician Decision|0|||
163841456|NCT02291289|591790329|FG012|Induction Treatment|Physician Decision|0|||
163841457|NCT02291289|591790317|FG000|Induction Treatment|Protocol Violation|0|||
163841458|NCT02291289|591790318|FG001|Induction Treatment|Protocol Violation|0|||
163841459|NCT02291289|591790319|FG002|Induction Treatment|Protocol Violation|0|||
163841460|NCT02291289|591790320|FG003|Induction Treatment|Protocol Violation|3|||
163841461|NCT02291289|591790321|FG004|Induction Treatment|Protocol Violation|0|||
163841462|NCT02291289|591790322|FG005|Induction Treatment|Protocol Violation|0|||
163841463|NCT02291289|591790323|FG006|Induction Treatment|Protocol Violation|0|||
163841464|NCT02291289|591790324|FG007|Induction Treatment|Protocol Violation|0|||
163841465|NCT02291289|591790325|FG008|Induction Treatment|Protocol Violation|0|||
163841466|NCT02291289|591790326|FG009|Induction Treatment|Protocol Violation|2|||
163841467|NCT02291289|591790327|FG010|Induction Treatment|Protocol Violation|0|||
164042120|NCT03627494|592512589|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
163841468|NCT02291289|591790328|FG011|Induction Treatment|Protocol Violation|0|||
163841469|NCT02291289|591790329|FG012|Induction Treatment|Protocol Violation|0|||
163841470|NCT02291289|591790317|FG000|Induction Treatment|Missing|4|||
163841471|NCT02291289|591790318|FG001|Induction Treatment|Missing|0|||
163841472|NCT02291289|591790319|FG002|Induction Treatment|Missing|0|||
163841473|NCT02291289|591790320|FG003|Induction Treatment|Missing|14|||
163841474|NCT02291289|591790321|FG004|Induction Treatment|Missing|0|||
163841475|NCT02291289|591790322|FG005|Induction Treatment|Missing|0|||
163841476|NCT02291289|591790323|FG006|Induction Treatment|Missing|0|||
163841477|NCT02291289|591790324|FG007|Induction Treatment|Missing|0|||
163841478|NCT02291289|591790325|FG008|Induction Treatment|Missing|0|||
163841479|NCT02291289|591790326|FG009|Induction Treatment|Missing|54|||
163841480|NCT02291289|591790327|FG010|Induction Treatment|Missing|0|||
163841481|NCT02291289|591790328|FG011|Induction Treatment|Missing|0|||
163841482|NCT02291289|591790329|FG012|Induction Treatment|Missing|0|||
163841483|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
164042121|NCT03627494|592512590|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
163841484|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841485|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841486|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841487|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
164042122|NCT03627494|592512591|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
164042123|NCT03627494|592512592|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042124|NCT03627494|592512593|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042125|NCT03627494|592512594|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042126|NCT03627494|592512595|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042127|NCT03627494|592512596|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042128|NCT03627494|592512597|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042129|NCT03627494|592512598|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042130|NCT03627494|592512599|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042131|NCT03627494|592512600|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
164042132|NCT03627494|592512589|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042133|NCT03627494|592512590|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042134|NCT03627494|592512591|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042135|NCT03627494|592512592|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042136|NCT03627494|592512593|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042137|NCT03627494|592512594|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042138|NCT03627494|592512595|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042139|NCT03627494|592512596|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042140|NCT03627494|592512597|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
164042141|NCT03627494|592512598|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042142|NCT03627494|592512599|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042143|NCT03627494|592512600|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
164042144|NCT03627494|592512589|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042145|NCT03627494|592512590|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042146|NCT03627494|592512591|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042147|NCT03627494|592512592|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042148|NCT03627494|592512593|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042149|NCT03627494|592512594|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042150|NCT03627494|592512595|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042151|NCT03627494|592512596|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042152|NCT03627494|592512597|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042153|NCT03627494|592512598|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
164042154|NCT03627494|592512599|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
164042155|NCT03627494|592512600|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
164042156|NCT03695471|592514628|FG000|Overall Study|Cancellation|1|||
164042157|NCT02859558|592514629|FG000|Step 1|Not Eligible|0|||
164042158|NCT02859558|592514630|FG001|Step 1|Not Eligible|0|||
164042159|NCT02859558|592514631|FG002|Step 1|Not Eligible|0|||
164042160|NCT02859558|592514632|FG003|Step 1|Not Eligible|0|||
164042161|NCT02859558|592514633|FG004|Step 1|Not Eligible|3|||
164042162|NCT02859558|592514629|FG000|Step 1|Lost to Follow-up|1|||
164042163|NCT02859558|592514630|FG001|Step 1|Lost to Follow-up|3|||
164042164|NCT02859558|592514631|FG002|Step 1|Lost to Follow-up|3|||
164042165|NCT02859558|592514632|FG003|Step 1|Lost to Follow-up|0|||
164042166|NCT02859558|592514633|FG004|Step 1|Lost to Follow-up|0|||
164042167|NCT02859558|592514629|FG000|Step 1|Did Not Return to Clinic|2|||
164042168|NCT02859558|592514630|FG001|Step 1|Did Not Return to Clinic|3|||
164042169|NCT02859558|592514631|FG002|Step 1|Did Not Return to Clinic|4|||
164042170|NCT02859558|592514632|FG003|Step 1|Did Not Return to Clinic|0|||
164042171|NCT02859558|592514633|FG004|Step 1|Did Not Return to Clinic|0|||
164042172|NCT02859558|592514629|FG000|Step 1|Moved|0|||
164042173|NCT02859558|592514630|FG001|Step 1|Moved|1|||
164042174|NCT02859558|592514631|FG002|Step 1|Moved|1|||
164042175|NCT02859558|592514632|FG003|Step 1|Moved|0|||
164042176|NCT02859558|592514633|FG004|Step 1|Moved|0|||
164042177|NCT02859558|592514629|FG000|Step 1|Withdrawal By Participant|1|||
164042178|NCT02859558|592514630|FG001|Step 1|Withdrawal By Participant|2|||
164042179|NCT02859558|592514631|FG002|Step 1|Withdrawal By Participant|1|||
164042180|NCT02859558|592514632|FG003|Step 1|Withdrawal By Participant|0|||
164042181|NCT02859558|592514633|FG004|Step 1|Withdrawal By Participant|0|||
164042182|NCT02859558|592514629|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
164042183|NCT02859558|592514630|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164042184|NCT02859558|592514631|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164042185|NCT02859558|592514632|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164042186|NCT02859558|592514633|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
164042187|NCT02859558|592514629|FG000|Step 1|Incarceration|0|||
164042188|NCT02859558|592514630|FG001|Step 1|Incarceration|1|||
164042189|NCT02859558|592514631|FG002|Step 1|Incarceration|0|||
164042190|NCT02859558|592514632|FG003|Step 1|Incarceration|0|||
164042191|NCT02859558|592514633|FG004|Step 1|Incarceration|0|||
164042192|NCT02859558|592514629|FG000|Step 1|Non-Adherence to Study Drug|2|||
164042193|NCT02859558|592514630|FG001|Step 1|Non-Adherence to Study Drug|0|||
164042194|NCT02859558|592514631|FG002|Step 1|Non-Adherence to Study Drug|1|||
164042195|NCT02859558|592514632|FG003|Step 1|Non-Adherence to Study Drug|0|||
164042196|NCT02859558|592514633|FG004|Step 1|Non-Adherence to Study Drug|0|||
164042197|NCT02859558|592514629|FG000|Step 1|Non-Adherence to Study Requirements|3|||
164042198|NCT02859558|592514630|FG001|Step 1|Non-Adherence to Study Requirements|1|||
164042199|NCT02859558|592514631|FG002|Step 1|Non-Adherence to Study Requirements|0|||
164042200|NCT02859558|592514632|FG003|Step 1|Non-Adherence to Study Requirements|0|||
164042201|NCT02859558|592514633|FG004|Step 1|Non-Adherence to Study Requirements|0|||
164042202|NCT02859558|592514629|FG000|Step 1|Virologic Failure|2|||
164042203|NCT02859558|592514630|FG001|Step 1|Virologic Failure|1|||
164042204|NCT02859558|592514631|FG002|Step 1|Virologic Failure|1|||
164042205|NCT02859558|592514632|FG003|Step 1|Virologic Failure|0|||
164042206|NCT02859558|592514633|FG004|Step 1|Virologic Failure|0|||
164042207|NCT02859558|592514629|FG000|Step 2|Lost to Follow-up|3|||
164042208|NCT02859558|592514630|FG001|Step 2|Lost to Follow-up|3|||
164042209|NCT02859558|592514631|FG002|Step 2|Lost to Follow-up|1|||
164042210|NCT02859558|592514632|FG003|Step 2|Lost to Follow-up|0|||
164042211|NCT02859558|592514633|FG004|Step 2|Lost to Follow-up|0|||
164042212|NCT02859558|592514629|FG000|Step 2|Withdrawal by Subject|0|||
164042213|NCT02859558|592514630|FG001|Step 2|Withdrawal by Subject|1|||
164042214|NCT02859558|592514631|FG002|Step 2|Withdrawal by Subject|1|||
164042215|NCT02859558|592514632|FG003|Step 2|Withdrawal by Subject|0|||
164042216|NCT02859558|592514633|FG004|Step 2|Withdrawal by Subject|0|||
164042217|NCT02859558|592514629|FG000|Step 2|Unexpected Closure of Site|0|||
164042218|NCT02859558|592514630|FG001|Step 2|Unexpected Closure of Site|1|||
164042219|NCT02859558|592514631|FG002|Step 2|Unexpected Closure of Site|1|||
164042220|NCT02859558|592514632|FG003|Step 2|Unexpected Closure of Site|0|||
164042221|NCT02859558|592514633|FG004|Step 2|Unexpected Closure of Site|0|||
164042222|NCT02859558|592514629|FG000|Step 2|Death|1|||
164042223|NCT02859558|592514630|FG001|Step 2|Death|0|||
164042224|NCT02859558|592514631|FG002|Step 2|Death|0|||
164042225|NCT02859558|592514632|FG003|Step 2|Death|0|||
164042226|NCT02859558|592514633|FG004|Step 2|Death|0|||
164042227|NCT02859558|592514629|FG000|Step 2|Incarceration|0|||
164042228|NCT02859558|592514630|FG001|Step 2|Incarceration|0|||
164042229|NCT02859558|592514631|FG002|Step 2|Incarceration|1|||
164042230|NCT02859558|592514632|FG003|Step 2|Incarceration|0|||
164042231|NCT02859558|592514633|FG004|Step 2|Incarceration|0|||
164042232|NCT04507360|592514634|FG000|Week 1|Lost to Follow-up|0|||
164042233|NCT04507360|592514635|FG001|Week 1|Lost to Follow-up|0|||
164042234|NCT04507360|592514636|FG002|Week 1|Lost to Follow-up|0|||
164042235|NCT04507360|592514637|FG003|Week 1|Lost to Follow-up|0|||
164042236|NCT04507360|592514638|FG004|Week 1|Lost to Follow-up|0|||
164042237|NCT04507360|592514639|FG005|Week 1|Lost to Follow-up|0|||
164042238|NCT04507360|592514640|FG006|Week 1|Lost to Follow-up|0|||
164042239|NCT04507360|592514641|FG007|Week 1|Lost to Follow-up|0|||
164042240|NCT04507360|592514642|FG008|Week 1|Lost to Follow-up|72|||
164042241|NCT04507360|592514643|FG009|Week 1|Lost to Follow-up|22|||
164042242|NCT04507360|592514644|FG010|Week 1|Lost to Follow-up|10|||
164042243|NCT04507360|592514634|FG000|Week 2|Lost to Follow-up|0|||
164042244|NCT04507360|592514635|FG001|Week 2|Lost to Follow-up|0|||
164042245|NCT04507360|592514636|FG002|Week 2|Lost to Follow-up|0|||
164042246|NCT04507360|592514637|FG003|Week 2|Lost to Follow-up|0|||
164042247|NCT04507360|592514638|FG004|Week 2|Lost to Follow-up|0|||
164042248|NCT04507360|592514639|FG005|Week 2|Lost to Follow-up|0|||
164042249|NCT04507360|592514640|FG006|Week 2|Lost to Follow-up|0|||
164042250|NCT04507360|592514641|FG007|Week 2|Lost to Follow-up|0|||
164042251|NCT04507360|592514642|FG008|Week 2|Lost to Follow-up|121|||
164042252|NCT04507360|592514643|FG009|Week 2|Lost to Follow-up|85|||
164042253|NCT04507360|592514644|FG010|Week 2|Lost to Follow-up|82|||
164042254|NCT04507360|592514634|FG000|Week 3|Lost to Follow-up|0|||
164042255|NCT04507360|592514635|FG001|Week 3|Lost to Follow-up|0|||
164042256|NCT04507360|592514636|FG002|Week 3|Lost to Follow-up|0|||
164042257|NCT04507360|592514637|FG003|Week 3|Lost to Follow-up|0|||
164042258|NCT04507360|592514638|FG004|Week 3|Lost to Follow-up|0|||
164042259|NCT04507360|592514639|FG005|Week 3|Lost to Follow-up|0|||
164042260|NCT04507360|592514640|FG006|Week 3|Lost to Follow-up|0|||
164042261|NCT04507360|592514641|FG007|Week 3|Lost to Follow-up|0|||
164042262|NCT04507360|592514642|FG008|Week 3|Lost to Follow-up|123|||
164042263|NCT04507360|592514643|FG009|Week 3|Lost to Follow-up|92|||
164042264|NCT04507360|592514644|FG010|Week 3|Lost to Follow-up|84|||
164042265|NCT04507360|592514634|FG000|Week 4|Lost to Follow-up|0|||
164042266|NCT04507360|592514635|FG001|Week 4|Lost to Follow-up|0|||
164042267|NCT04507360|592514636|FG002|Week 4|Lost to Follow-up|0|||
164042268|NCT04507360|592514637|FG003|Week 4|Lost to Follow-up|0|||
164042269|NCT04507360|592514638|FG004|Week 4|Lost to Follow-up|0|||
164042270|NCT04507360|592514639|FG005|Week 4|Lost to Follow-up|0|||
164042271|NCT04507360|592514640|FG006|Week 4|Lost to Follow-up|0|||
164042272|NCT04507360|592514641|FG007|Week 4|Lost to Follow-up|0|||
164042273|NCT04507360|592514642|FG008|Week 4|Lost to Follow-up|131|||
164042274|NCT04507360|592514643|FG009|Week 4|Lost to Follow-up|115|||
164042275|NCT04507360|592514644|FG010|Week 4|Lost to Follow-up|102|||
164042276|NCT04507360|592514634|FG000|Week 5|Lost to Follow-up|0|||
164042277|NCT04507360|592514635|FG001|Week 5|Lost to Follow-up|0|||
164042278|NCT04507360|592514636|FG002|Week 5|Lost to Follow-up|0|||
164042279|NCT04507360|592514637|FG003|Week 5|Lost to Follow-up|0|||
164042280|NCT04507360|592514638|FG004|Week 5|Lost to Follow-up|0|||
164042281|NCT04507360|592514639|FG005|Week 5|Lost to Follow-up|0|||
164042282|NCT04507360|592514640|FG006|Week 5|Lost to Follow-up|0|||
164042283|NCT04507360|592514641|FG007|Week 5|Lost to Follow-up|0|||
164042284|NCT04507360|592514642|FG008|Week 5|Lost to Follow-up|103|||
164042285|NCT04507360|592514643|FG009|Week 5|Lost to Follow-up|135|||
164042286|NCT04507360|592514644|FG010|Week 5|Lost to Follow-up|143|||
163942905|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
163942906|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163942907|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
163942908|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163942909|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163942910|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163942911|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
163942912|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
163942913|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
163942914|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
163942915|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
163942916|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
163942917|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
163942918|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163942919|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163942920|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
163942921|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163942922|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163942923|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
163942924|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Site closure|0|||
163942925|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Site closure|0|||
163942926|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Site closure|1|||
163942927|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Site closure|0|||
163942928|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Site closure|0|||
163942929|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Site closure|0|||
163942930|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
163942931|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
163942932|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
163942933|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
163942934|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
163942935|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
163942936|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
163942937|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
163942938|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
163942939|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
163942940|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
163942941|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
163942942|NCT03439254|592161067|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
163942943|NCT03439254|592161068|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
163942944|NCT03439254|592161069|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
163942945|NCT03439254|592161070|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
163942946|NCT03439254|592161071|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
163942947|NCT03439254|592161072|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
163942948|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
163942949|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
163942950|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
163942951|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
163942952|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
163942953|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
163942954|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163942955|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163942956|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163942957|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
163942958|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
163942959|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
163942960|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163942961|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163942962|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163942963|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163942964|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
163942965|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
163942966|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163942967|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163942968|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163942969|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163942970|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
163942971|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
163942972|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163942973|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163942974|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163942975|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163942976|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
163942977|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
163942978|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163942979|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163942980|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163942981|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163942982|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
163942983|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
163942984|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163942985|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163942986|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163942987|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
163942988|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163942989|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
163942990|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163942991|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163942992|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163942993|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
163942994|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
163942995|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
163942996|NCT03439254|592161067|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
163942997|NCT03439254|592161068|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
163942998|NCT03439254|592161069|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
163942999|NCT03439254|592161070|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
163943000|NCT03439254|592161071|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
163943001|NCT03439254|592161072|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
163943002|NCT00128102|592161075|FG000|Overall Study|Site Discontinued|3|||
163943003|NCT00128102|592161076|FG001|Overall Study|Site Discontinued|6|||
163943004|NCT00128102|592161075|FG000|Overall Study|Other|0|||
163943005|NCT00128102|592161076|FG001|Overall Study|Other|1|||
163943006|NCT00128102|592161075|FG000|Overall Study|Progressive Disease|255|||
163943007|NCT00128102|592161076|FG001|Overall Study|Progressive Disease|285|||
163943008|NCT00128102|592161075|FG000|Overall Study|Adverse Event|34|||
163943009|NCT00128102|592161076|FG001|Overall Study|Adverse Event|11|||
163943010|NCT00128102|592161075|FG000|Overall Study|Death|12|||
163943011|NCT00128102|592161076|FG001|Overall Study|Death|13|||
163943012|NCT00128102|592161075|FG000|Overall Study|Physician Decision|3|||
163943013|NCT00128102|592161076|FG001|Overall Study|Physician Decision|3|||
163943014|NCT00128102|592161075|FG000|Overall Study|Withdrawal by Subject|19|||
163943015|NCT00128102|592161076|FG001|Overall Study|Withdrawal by Subject|11|||
163943016|NCT00128102|592161075|FG000|Overall Study|Protocol Violation|2|||
163943017|NCT00128102|592161076|FG001|Overall Study|Protocol Violation|2|||
163943018|NCT01014208|592161080|FG000|Overall Study|Lost to Follow-up|2|||
163943019|NCT01014208|592161081|FG001|Overall Study|Lost to Follow-up|5|||
163943020|NCT01014208|592161080|FG000|Overall Study|Participant Withdrew Consent|12|||
163943021|NCT01014208|592161081|FG001|Overall Study|Participant Withdrew Consent|12|||
163943022|NCT01014208|592161080|FG000|Overall Study|Did Not Receive Study Drug|2|||
163943023|NCT01014208|592161081|FG001|Overall Study|Did Not Receive Study Drug|0|||
163943024|NCT01014208|592161080|FG000|Overall Study|Study Closed/terminated|78|||
163943025|NCT01014208|592161081|FG001|Overall Study|Study Closed/terminated|83|||
163943026|NCT01008410|592161083|FG000|Overall Study|Adverse Event|13|||
163943027|NCT01008410|592161084|FG001|Overall Study|Adverse Event|7|||
163943028|NCT01008410|592161083|FG000|Overall Study|Withdrawal by Subject|6|||
163943029|NCT01008410|592161084|FG001|Overall Study|Withdrawal by Subject|2|||
164042287|NCT04507360|592514634|FG000|Week 8|Lost to Follow-up|0|||
164042288|NCT04507360|592514635|FG001|Week 8|Lost to Follow-up|0|||
163943030|NCT01008410|592161083|FG000|Overall Study|Lost to Follow-up|1|||
163943031|NCT01008410|592161084|FG001|Overall Study|Lost to Follow-up|0|||
163943032|NCT01008410|592161083|FG000|Overall Study|Noncompliance|1|||
163943033|NCT01008410|592161084|FG001|Overall Study|Noncompliance|0|||
163841488|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
163841489|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841490|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841491|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841492|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841493|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
163841494|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
163841495|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
163841496|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Death|0|||
163841497|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Death|29|||
163841498|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Death|16|||
163841499|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Death|0|||
163841500|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Death|188|||
163841501|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Death|107|||
163841502|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Death|0|||
163841503|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Death|1|||
163841504|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Death|1|||
163841505|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Death|0|||
163841506|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Death|46|||
163841507|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Death|19|||
163841508|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Death|0|||
163841509|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Adverse Event|0|||
163841510|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Adverse Event|0|||
163841511|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Adverse Event|0|||
163841512|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Adverse Event|0|||
163841513|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Adverse Event|1|||
163841514|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Adverse Event|1|||
163841515|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Adverse Event|0|||
163841516|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Adverse Event|0|||
163841517|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Adverse Event|0|||
163841518|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Adverse Event|0|||
163841519|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Adverse Event|0|||
163841520|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Adverse Event|0|||
163841521|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Adverse Event|0|||
163841522|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841523|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
163841524|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841525|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841526|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
163841527|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
163841528|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841529|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
163841530|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841531|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841532|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
163841533|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
163841534|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
163841535|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
163841536|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
163841537|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
163841538|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
163841539|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
163841540|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
163841541|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
163841542|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
163841543|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
163841544|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
163841545|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
163841546|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
163841547|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
163841548|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Physician Decision|0|||
163841549|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Physician Decision|2|||
163841550|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Physician Decision|0|||
163841551|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Physician Decision|0|||
163943034|NCT01008410|592161083|FG000|Overall Study|Low Cortisol|2|||
163841552|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Physician Decision|3|||
163841553|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Physician Decision|0|||
163841554|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Physician Decision|0|||
163841555|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Physician Decision|0|||
163841556|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Physician Decision|0|||
163841557|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Physician Decision|0|||
163841558|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Physician Decision|1|||
163943035|NCT01008410|592161084|FG001|Overall Study|Low Cortisol|0|||
163841559|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Physician Decision|3|||
163841560|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Physician Decision|0|||
163841561|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Not Treated|0|||
163841562|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Not Treated|0|||
163841563|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Not Treated|2|||
163841564|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Not Treated|0|||
163841565|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Not Treated|0|||
163841566|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Not Treated|0|||
163841567|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Not Treated|0|||
163841568|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Not Treated|0|||
163841569|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Not Treated|0|||
163841570|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Not Treated|0|||
163841571|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Not Treated|0|||
163841572|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Not Treated|0|||
163841573|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Not Treated|0|||
163841574|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841575|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
163841576|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841577|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841578|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841579|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841580|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841581|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841582|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841583|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841584|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841585|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841586|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
163841587|NCT02291289|591790317|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
163841588|NCT02291289|591790318|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
163841589|NCT02291289|591790319|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
163841590|NCT02291289|591790320|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
163841591|NCT02291289|591790321|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
163841592|NCT02291289|591790322|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
163841593|NCT02291289|591790323|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
163841594|NCT02291289|591790324|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
163841595|NCT02291289|591790325|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
163841596|NCT02291289|591790326|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
163841597|NCT02291289|591790327|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
163841598|NCT02291289|591790328|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
163841599|NCT02291289|591790329|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
163841600|NCT02291289|591790317|FG000|Early Disease Progression|Death|0|||
163841601|NCT02291289|591790318|FG001|Early Disease Progression|Death|0|||
163841602|NCT02291289|591790319|FG002|Early Disease Progression|Death|0|||
163841603|NCT02291289|591790320|FG003|Early Disease Progression|Death|0|||
163841604|NCT02291289|591790321|FG004|Early Disease Progression|Death|0|||
163841605|NCT02291289|591790322|FG005|Early Disease Progression|Death|0|||
163841606|NCT02291289|591790323|FG006|Early Disease Progression|Death|0|||
163841607|NCT02291289|591790324|FG007|Early Disease Progression|Death|0|||
163841608|NCT02291289|591790325|FG008|Early Disease Progression|Death|0|||
163841609|NCT02291289|591790326|FG009|Early Disease Progression|Death|0|||
163841610|NCT02291289|591790327|FG010|Early Disease Progression|Death|0|||
163841611|NCT02291289|591790328|FG011|Early Disease Progression|Death|0|||
163841612|NCT02291289|591790329|FG012|Early Disease Progression|Death|10|||
163841613|NCT02291289|591790317|FG000|Early Disease Progression|Lost to Follow-up|0|||
163841614|NCT02291289|591790318|FG001|Early Disease Progression|Lost to Follow-up|0|||
163841615|NCT02291289|591790319|FG002|Early Disease Progression|Lost to Follow-up|0|||
163841616|NCT02291289|591790320|FG003|Early Disease Progression|Lost to Follow-up|0|||
163841617|NCT02291289|591790321|FG004|Early Disease Progression|Lost to Follow-up|0|||
163841618|NCT02291289|591790322|FG005|Early Disease Progression|Lost to Follow-up|0|||
163841619|NCT02291289|591790323|FG006|Early Disease Progression|Lost to Follow-up|0|||
163841620|NCT02291289|591790324|FG007|Early Disease Progression|Lost to Follow-up|0|||
163841621|NCT02291289|591790325|FG008|Early Disease Progression|Lost to Follow-up|0|||
163841622|NCT02291289|591790326|FG009|Early Disease Progression|Lost to Follow-up|0|||
163841623|NCT02291289|591790327|FG010|Early Disease Progression|Lost to Follow-up|0|||
163943036|NCT01008410|592161083|FG000|Overall Study|Lack of Efficacy|2|||
163841624|NCT02291289|591790328|FG011|Early Disease Progression|Lost to Follow-up|0|||
163841625|NCT02291289|591790329|FG012|Early Disease Progression|Lost to Follow-up|1|||
163841626|NCT02310126|591790332|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
163841627|NCT02310126|591790333|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
163841628|NCT02310126|591790332|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
163841629|NCT02310126|591790333|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
164042289|NCT04507360|592514636|FG002|Week 8|Lost to Follow-up|0|||
164042290|NCT04507360|592514637|FG003|Week 8|Lost to Follow-up|0|||
164042291|NCT04507360|592514638|FG004|Week 8|Lost to Follow-up|0|||
164042292|NCT04507360|592514639|FG005|Week 8|Lost to Follow-up|0|||
164042293|NCT04507360|592514640|FG006|Week 8|Lost to Follow-up|0|||
164042294|NCT04507360|592514641|FG007|Week 8|Lost to Follow-up|0|||
164042295|NCT04507360|592514642|FG008|Week 8|Lost to Follow-up|139|||
164042296|NCT04507360|592514643|FG009|Week 8|Lost to Follow-up|145|||
164042297|NCT04507360|592514644|FG010|Week 8|Lost to Follow-up|152|||
164042298|NCT00400946|592514645|FG000|Overall Study|Ineligible|0|||
164042299|NCT00400946|592514646|FG001|Overall Study|Ineligible|0|||
164042300|NCT00400946|592514647|FG002|Overall Study|Ineligible|0|||
164042301|NCT00400946|592514648|FG003|Overall Study|Ineligible|5|||
164042302|NCT00400946|592514649|FG004|Overall Study|Ineligible|1|||
164042303|NCT00400946|592514645|FG000|Overall Study|Induction Failure|0|||
164042304|NCT00400946|592514646|FG001|Overall Study|Induction Failure|0|||
164042305|NCT00400946|592514647|FG002|Overall Study|Induction Failure|0|||
164042306|NCT00400946|592514648|FG003|Overall Study|Induction Failure|11|||
164042307|NCT00400946|592514649|FG004|Overall Study|Induction Failure|8|||
164042308|NCT00400946|592514645|FG000|Overall Study|Induction Death|0|||
164042309|NCT00400946|592514646|FG001|Overall Study|Induction Death|0|||
164042310|NCT00400946|592514647|FG002|Overall Study|Induction Death|0|||
164042311|NCT00400946|592514648|FG003|Overall Study|Induction Death|13|||
164042312|NCT00400946|592514649|FG004|Overall Study|Induction Death|3|||
164042313|NCT00400946|592514645|FG000|Overall Study|Lost to Follow-up|1|||
164042314|NCT00400946|592514646|FG001|Overall Study|Lost to Follow-up|1|||
164042315|NCT00400946|592514647|FG002|Overall Study|Lost to Follow-up|0|||
164042316|NCT00400946|592514648|FG003|Overall Study|Lost to Follow-up|0|||
164042317|NCT00400946|592514649|FG004|Overall Study|Lost to Follow-up|1|||
164042318|NCT00400946|592514645|FG000|Overall Study|Remission Death|1|||
164042319|NCT00400946|592514646|FG001|Overall Study|Remission Death|1|||
164042320|NCT00400946|592514647|FG002|Overall Study|Remission Death|0|||
164042321|NCT00400946|592514648|FG003|Overall Study|Remission Death|0|||
164042322|NCT00400946|592514649|FG004|Overall Study|Remission Death|1|||
164042323|NCT00400946|592514645|FG000|Overall Study|Relapse|9|||
164042324|NCT00400946|592514646|FG001|Overall Study|Relapse|2|||
164042325|NCT00400946|592514647|FG002|Overall Study|Relapse|1|||
164042326|NCT00400946|592514648|FG003|Overall Study|Relapse|1|||
164042327|NCT00400946|592514649|FG004|Overall Study|Relapse|5|||
164042328|NCT00400946|592514645|FG000|Overall Study|Transplant in CR1|0|||
164042329|NCT00400946|592514646|FG001|Overall Study|Transplant in CR1|0|||
164042330|NCT00400946|592514647|FG002|Overall Study|Transplant in CR1|0|||
164042331|NCT00400946|592514648|FG003|Overall Study|Transplant in CR1|10|||
164042332|NCT00400946|592514649|FG004|Overall Study|Transplant in CR1|1|||
164042333|NCT00400946|592514645|FG000|Overall Study|Withdrawal by Subject|2|||
164042334|NCT00400946|592514646|FG001|Overall Study|Withdrawal by Subject|5|||
164042335|NCT00400946|592514647|FG002|Overall Study|Withdrawal by Subject|1|||
164042336|NCT00400946|592514648|FG003|Overall Study|Withdrawal by Subject|5|||
164042337|NCT00400946|592514649|FG004|Overall Study|Withdrawal by Subject|8|||
164042338|NCT00400946|592514645|FG000|Overall Study|Clinical|1|||
164042339|NCT00400946|592514646|FG001|Overall Study|Clinical|2|||
164042340|NCT00400946|592514647|FG002|Overall Study|Clinical|0|||
164042341|NCT00400946|592514648|FG003|Overall Study|Clinical|2|||
164042342|NCT00400946|592514649|FG004|Overall Study|Clinical|9|||
164042343|NCT00400946|592514645|FG000|Overall Study|Other|0|||
164042344|NCT00400946|592514646|FG001|Overall Study|Other|0|||
164042345|NCT00400946|592514647|FG002|Overall Study|Other|0|||
164042346|NCT00400946|592514648|FG003|Overall Study|Other|0|||
164042347|NCT00400946|592514649|FG004|Overall Study|Other|1|||
164042348|NCT00439309|592514652|FG000|Follow-Up|Death|1|||
164042349|NCT00439309|592514653|FG001|Follow-Up|Death|0|||
164042350|NCT00439309|592514652|FG000|Follow-Up|Lost to Follow-up|2|||
164042351|NCT00439309|592514653|FG001|Follow-Up|Lost to Follow-up|0|||
164042352|NCT00439309|592514652|FG000|Follow-Up|Withdrawal by Subject|0|||
164042353|NCT00439309|592514653|FG001|Follow-Up|Withdrawal by Subject|1|||
164042354|NCT00439309|592514652|FG000|Follow-Up|Late response by subject|0|||
164042355|NCT00439309|592514653|FG001|Follow-Up|Late response by subject|1|||
164042356|NCT02892734|592514654|FG000|Treatment on Study|Progressive Disease|2|||
164042357|NCT02892734|592514654|FG000|Follow up for 2 Years|Death|2|||
164042358|NCT02892734|592514654|FG000|Follow up for 2 Years|Study closed early|1|||
164042359|NCT00608244|592514655|FG000|Overall Study|Adverse Event|1|||
164042360|NCT00608244|592514655|FG000|Overall Study|Low trough levels|1|||
164042361|NCT00688623|592514656|FG000|Overall Study|Adverse Event|22|||
164042362|NCT00688623|592514656|FG000|Overall Study|abnormal lab value|1|||
164042363|NCT00688623|592514656|FG000|Overall Study|Withdrawal by Subject|4|||
164042364|NCT00688623|592514656|FG000|Overall Study|Death|3|||
164042365|NCT00688623|592514656|FG000|Overall Study|disease progression|23|||
164042366|NCT00688623|592514656|FG000|Overall Study|Protocol Violation|2|||
164042367|NCT02000219|592514657|FG000|14-Week Study Period|Physician Decision|1|||
164042368|NCT02000219|592514657|FG000|14-Week Study Period|Adverse Event|1|||
164042369|NCT02000219|592514657|FG000|14-Week Study Period|Underwent transplantation|1|||
164042370|NCT02000219|592514657|FG000|Continuation Period|Withdrawal by Subject|1|||
164042371|NCT02000219|592514657|FG000|Continuation Period|Had liver transplant|2|||
164098984|NCT03496623|592726962|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
164098985|NCT03496623|592726963|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
164098986|NCT03496623|592726964|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
164098987|NCT03496623|592726965|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
164098988|NCT03496623|592726966|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
164098989|NCT03496623|592726962|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164098990|NCT03496623|592726963|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
163841630|NCT01539863|591790336|FG000|Overall Study|Lost to Follow-up|5|||
163841631|NCT01539863|591790337|FG001|Overall Study|Lost to Follow-up|4|||
163943037|NCT01008410|592161084|FG001|Overall Study|Lack of Efficacy|6|||
163943038|NCT01008410|592161083|FG000|Overall Study|Met Exclusion Criterion|0|||
163943039|NCT01008410|592161084|FG001|Overall Study|Met Exclusion Criterion|1|||
163943040|NCT00297427|592161085|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
163943041|NCT00297427|592161086|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
163943042|NCT00297427|592161085|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
163943043|NCT00297427|592161086|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
163943044|NCT00297427|592161085|FG000|Phase 1: Initial Intervention|Death|0|||
163943045|NCT00297427|592161086|FG001|Phase 1: Initial Intervention|Death|1|||
163943046|NCT00297427|592161085|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
163943047|NCT00297427|592161086|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
163943048|NCT00297427|592161085|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
163943049|NCT00297427|592161086|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
163943050|NCT00297427|592161085|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
163943051|NCT00297427|592161086|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
163943052|NCT00297427|592161085|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
163943053|NCT00297427|592161086|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
163943054|NCT00297427|592161085|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
163943055|NCT00297427|592161086|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
163943056|NCT03889704|592161088|FG000|Overall Study|Study terminated due to pandemic|1|||
163943057|NCT04552899|592161091|FG000|Overall Study|Adverse Event|4|||
163943058|NCT04552899|592161092|FG001|Overall Study|Adverse Event|3|||
163943059|NCT04552899|592161091|FG000|Overall Study|Death|4|||
163943060|NCT04552899|592161092|FG001|Overall Study|Death|4|||
163943061|NCT04552899|592161091|FG000|Overall Study|Lost to Follow-up|8|||
163943062|NCT04552899|592161092|FG001|Overall Study|Lost to Follow-up|13|||
163943063|NCT04552899|592161091|FG000|Overall Study|Lung Transplant|4|||
163943064|NCT04552899|592161092|FG001|Overall Study|Lung Transplant|3|||
163943065|NCT04552899|592161091|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
163943066|NCT04552899|592161092|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
163943067|NCT04552899|592161091|FG000|Overall Study|Physician Decision|3|||
163943068|NCT04552899|592161092|FG001|Overall Study|Physician Decision|4|||
163943069|NCT04552899|592161091|FG000|Overall Study|Study Terminated By Sponsor|237|||
163943070|NCT04552899|592161092|FG001|Overall Study|Study Terminated By Sponsor|239|||
163943071|NCT04552899|592161091|FG000|Overall Study|Withdrawal by Subject|15|||
163943072|NCT04552899|592161092|FG001|Overall Study|Withdrawal by Subject|17|||
163943073|NCT02591953|592161095|FG000|Overall Study|Lost to Follow-up|6|||
163943074|NCT02591953|592161096|FG001|Overall Study|Lost to Follow-up|6|||
163943075|NCT00461981|592161097|FG000|Overall Study|Lost to Follow-up|9|||
163943076|NCT00461981|592161098|FG001|Overall Study|Lost to Follow-up|6|||
163943077|NCT00461981|592161097|FG000|Overall Study|Withdrawal by Subject|2|||
163943078|NCT00461981|592161098|FG001|Overall Study|Withdrawal by Subject|3|||
163943079|NCT02060370|592161101|FG000|Overall Study|Physician Decision|1|||
163943080|NCT00731133|592161102|FG000|Overall Study|Withdrawal by Subject|10|||
163943081|NCT00943852|592161103|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943082|NCT00943852|592161104|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943083|NCT00943852|592161105|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943084|NCT00943852|592161106|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
163943085|NCT00943852|592161107|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943086|NCT00943852|592161108|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943087|NCT00943852|592161109|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943088|NCT00943852|592161110|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943089|NCT00943852|592161111|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943090|NCT00943852|592161112|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
163943091|NCT00943852|592161103|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943092|NCT00943852|592161104|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943093|NCT00943852|592161105|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164042372|NCT02000219|592514657|FG000|Continuation Period|Non-compliance with study drug|2|||
164042373|NCT01998906|592514658|FG000|Overall Study|Participants ongoing in follow-up|77|||
164042374|NCT01998906|592514659|FG001|Overall Study|Participants ongoing in follow-up|60|||
164042375|NCT01998906|592514660|FG002|Overall Study|Participants ongoing in follow-up|58|||
164042376|NCT01998906|592514658|FG000|Overall Study|Death|21|||
164042377|NCT01998906|592514659|FG001|Overall Study|Death|30|||
164042378|NCT01998906|592514660|FG002|Overall Study|Death|17|||
164042379|NCT01998906|592514658|FG000|Overall Study|Lack of Efficacy|10|||
164042380|NCT01998906|592514659|FG001|Overall Study|Lack of Efficacy|9|||
164042381|NCT01998906|592514660|FG002|Overall Study|Lack of Efficacy|8|||
164042382|NCT01998906|592514658|FG000|Overall Study|Failure to return|0|||
164042383|NCT01998906|592514659|FG001|Overall Study|Failure to return|2|||
164042384|NCT01998906|592514660|FG002|Overall Study|Failure to return|4|||
164042385|NCT01998906|592514658|FG000|Overall Study|Violation of Selection Criteria|0|||
164042386|NCT01998906|592514659|FG001|Overall Study|Violation of Selection Criteria|0|||
164042387|NCT01998906|592514660|FG002|Overall Study|Violation of Selection Criteria|1|||
164042388|NCT01998906|592514658|FG000|Overall Study|Withdrawal by Subject|1|||
164042389|NCT01998906|592514659|FG001|Overall Study|Withdrawal by Subject|4|||
164042390|NCT01998906|592514660|FG002|Overall Study|Withdrawal by Subject|3|||
164042391|NCT01998906|592514658|FG000|Overall Study|Administrative/Other|2|||
164042392|NCT01998906|592514659|FG001|Overall Study|Administrative/Other|1|||
164042393|NCT01998906|592514660|FG002|Overall Study|Administrative/Other|3|||
164042394|NCT01998906|592514658|FG000|Overall Study|Other|3|||
164042395|NCT01998906|592514659|FG001|Overall Study|Other|8|||
164042396|NCT01998906|592514660|FG002|Overall Study|Other|4|||
164042397|NCT01572844|592514661|FG000|Overall Study|Physician Decision|1|||
164042398|NCT01572844|592514662|FG001|Overall Study|Physician Decision|1|||
164042399|NCT00209092|592514669|FG000|Overall Study|Progression of disease|7|||
164042400|NCT00209092|592514670|FG001|Overall Study|Progression of disease|1|||
164042401|NCT00209092|592514669|FG000|Overall Study|Adverse Event|0|||
164042402|NCT00209092|592514670|FG001|Overall Study|Adverse Event|1|||
164042403|NCT00209092|592514669|FG000|Overall Study|Withdrawal by Subject|1|||
164042404|NCT00209092|592514670|FG001|Overall Study|Withdrawal by Subject|0|||
164042405|NCT00693420|592514671|FG000|Overall Study|Adverse Event|4|||
164042406|NCT00693420|592514672|FG001|Overall Study|Adverse Event|4|||
164042407|NCT00693420|592514671|FG000|Overall Study|Lost to Follow-up|0|||
164042408|NCT00693420|592514672|FG001|Overall Study|Lost to Follow-up|3|||
164042409|NCT00693420|592514671|FG000|Overall Study|Withdrawal by Subject|1|||
164042410|NCT00693420|592514672|FG001|Overall Study|Withdrawal by Subject|0|||
164042411|NCT00693420|592514671|FG000|Overall Study|Protocol Violation|0|||
164042412|NCT00693420|592514672|FG001|Overall Study|Protocol Violation|2|||
164042413|NCT00693420|592514671|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
164042414|NCT00693420|592514672|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
164042415|NCT00693420|592514671|FG000|Overall Study|Personal Reasons|1|||
164042416|NCT00693420|592514672|FG001|Overall Study|Personal Reasons|4|||
164042417|NCT02809118|592514673|FG000|Overall Study|Withdrawal by Subject|0|||
164042418|NCT02809118|592514674|FG001|Overall Study|Withdrawal by Subject|1|||
164042419|NCT02809118|592514675|FG002|Overall Study|Withdrawal by Subject|1|||
164042420|NCT01156363|592514683|FG000|Overall Study|Adverse Event|6|||
164042421|NCT01156363|592514683|FG000|Overall Study|Insufficient Therapeutic Response|5|||
164042422|NCT01156363|592514683|FG000|Overall Study|Failure to Return|1|||
164042423|NCT01156363|592514683|FG000|Overall Study|Refused Treatment|4|||
164042424|NCT01156363|592514683|FG000|Overall Study|Other|6|||
164042425|NCT03135262|592514684|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
164042426|NCT03135262|592514685|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164042427|NCT03135262|592514686|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
163943094|NCT00943852|592161106|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943095|NCT00943852|592161107|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943096|NCT00943852|592161108|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
163943097|NCT00943852|592161109|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943098|NCT00943852|592161110|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943099|NCT00943852|592161111|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
164042428|NCT03135262|592514687|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164042429|NCT03135262|592514688|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
164042430|NCT03135262|592514684|FG000|Overall Study|Progression of disease|0|||
164042431|NCT03135262|592514685|FG001|Overall Study|Progression of disease|0|||
164042432|NCT03135262|592514686|FG002|Overall Study|Progression of disease|0|||
164042433|NCT03135262|592514687|FG003|Overall Study|Progression of disease|1|||
164042434|NCT03135262|592514688|FG004|Overall Study|Progression of disease|0|||
164042435|NCT03135262|592514684|FG000|Overall Study|Death|6|||
164042436|NCT03135262|592514685|FG001|Overall Study|Death|2|||
164042437|NCT03135262|592514686|FG002|Overall Study|Death|2|||
164042438|NCT03135262|592514687|FG003|Overall Study|Death|2|||
164042439|NCT03135262|592514688|FG004|Overall Study|Death|0|||
164042440|NCT03135262|592514684|FG000|Overall Study|Withdrawal by Subject|0|||
164042441|NCT03135262|592514685|FG001|Overall Study|Withdrawal by Subject|0|||
164042442|NCT03135262|592514686|FG002|Overall Study|Withdrawal by Subject|1|||
164042443|NCT03135262|592514687|FG003|Overall Study|Withdrawal by Subject|0|||
164042444|NCT03135262|592514688|FG004|Overall Study|Withdrawal by Subject|1|||
164042445|NCT03135262|592514684|FG000|Overall Study|Study terminated by sponsor|2|||
164042446|NCT03135262|592514685|FG001|Overall Study|Study terminated by sponsor|4|||
164042447|NCT03135262|592514686|FG002|Overall Study|Study terminated by sponsor|4|||
164042448|NCT03135262|592514687|FG003|Overall Study|Study terminated by sponsor|3|||
164042449|NCT03135262|592514688|FG004|Overall Study|Study terminated by sponsor|0|||
164042450|NCT03745989|592514689|FG000|Overall Study|Death|3|||
164042451|NCT03745989|592514690|FG001|Overall Study|Death|7|||
164042452|NCT03745989|592514691|FG002|Overall Study|Death|4|||
164042453|NCT03745989|592514689|FG000|Overall Study|Lost to Follow-up|0|||
164042454|NCT03745989|592514690|FG001|Overall Study|Lost to Follow-up|2|||
164042455|NCT03745989|592514691|FG002|Overall Study|Lost to Follow-up|0|||
164042456|NCT03745989|592514689|FG000|Overall Study|Sponsor Decision|0|||
164042457|NCT03745989|592514690|FG001|Overall Study|Sponsor Decision|2|||
164042458|NCT03745989|592514691|FG002|Overall Study|Sponsor Decision|8|||
164042459|NCT03745989|592514689|FG000|Overall Study|Withdrawal by Subject|0|||
163943100|NCT00943852|592161112|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
163943101|NCT00943852|592161103|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943102|NCT00943852|592161104|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943103|NCT00943852|592161105|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943104|NCT00943852|592161106|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943105|NCT00943852|592161107|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943106|NCT00943852|592161108|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943107|NCT00943852|592161109|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
163943108|NCT00943852|592161110|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943109|NCT00943852|592161111|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943110|NCT00943852|592161112|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
163943111|NCT00943852|592161103|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943112|NCT00943852|592161104|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943113|NCT00943852|592161105|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943114|NCT00943852|592161106|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943115|NCT00943852|592161107|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943116|NCT00943852|592161108|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943117|NCT00943852|592161109|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943118|NCT00943852|592161110|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
163943119|NCT00943852|592161111|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943120|NCT00943852|592161112|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
163943121|NCT00943852|592161103|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163943122|NCT00943852|592161104|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163943123|NCT00943852|592161105|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163943124|NCT00943852|592161106|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163943125|NCT00943852|592161107|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163943126|NCT00943852|592161108|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163943127|NCT00943852|592161109|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
163943128|NCT00943852|592161110|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163943129|NCT00943852|592161111|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163943130|NCT00943852|592161112|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
163943131|NCT01725126|592161117|FG000|Overall Study|Protocol Violation|0|||
163943132|NCT01725126|592161118|FG001|Overall Study|Protocol Violation|1|||
163943133|NCT01725126|592161119|FG002|Overall Study|Protocol Violation|0|||
163943134|NCT01725126|592161120|FG003|Overall Study|Protocol Violation|0|||
163943135|NCT01725126|592161121|FG004|Overall Study|Protocol Violation|0|||
163943136|NCT01725126|592161122|FG005|Overall Study|Protocol Violation|0|||
163943137|NCT01725126|592161117|FG000|Overall Study|Withdrawal by Subject|0|||
163943138|NCT01725126|592161118|FG001|Overall Study|Withdrawal by Subject|0|||
163943139|NCT01725126|592161119|FG002|Overall Study|Withdrawal by Subject|0|||
164042460|NCT03745989|592514690|FG001|Overall Study|Withdrawal by Subject|1|||
164042461|NCT03745989|592514691|FG002|Overall Study|Withdrawal by Subject|3|||
164042462|NCT00047008|592514693|FG000|Overall Study|Withdrawn consent|2|||
164042463|NCT00047008|592514694|FG001|Overall Study|Withdrawn consent|3|||
164042464|NCT00047008|592514693|FG000|Overall Study|Ineligible|9|||
164042465|NCT00047008|592514694|FG001|Overall Study|Ineligible|8|||
164042466|NCT00429572|592514695|FG000|Overall Study|Disease progression|1|||
163943140|NCT01725126|592161120|FG003|Overall Study|Withdrawal by Subject|1|||
163943141|NCT01725126|592161121|FG004|Overall Study|Withdrawal by Subject|0|||
163943142|NCT01725126|592161122|FG005|Overall Study|Withdrawal by Subject|0|||
163943143|NCT01518153|592161125|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
163943144|NCT01518153|592161126|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
163943145|NCT01518153|592161127|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
163943146|NCT01518153|592161125|FG000|Stem Cell Transplant|Death|2|||
163943147|NCT01518153|592161126|FG001|Stem Cell Transplant|Death|0|||
163943148|NCT01518153|592161127|FG002|Stem Cell Transplant|Death|0|||
163943149|NCT01518153|592161125|FG000|Stem Cell Transplant|Secondary graft failure|1|||
163943150|NCT01518153|592161126|FG001|Stem Cell Transplant|Secondary graft failure|0|||
163943151|NCT01518153|592161127|FG002|Stem Cell Transplant|Secondary graft failure|0|||
163943152|NCT01518153|592161125|FG000|Stem Cell Transplant|Adverse Event|1|||
163943153|NCT01518153|592161126|FG001|Stem Cell Transplant|Adverse Event|0|||
163943154|NCT01518153|592161127|FG002|Stem Cell Transplant|Adverse Event|0|||
163943155|NCT01518153|592161125|FG000|Donor Lymphocyte Infusion|Death|0|||
163943156|NCT01518153|592161126|FG001|Donor Lymphocyte Infusion|Death|2|||
163943157|NCT01518153|592161127|FG002|Donor Lymphocyte Infusion|Death|1|||
163943158|NCT02145468|592161134|FG000|Overall Study|Withdrawal by Subject|5|||
163943159|NCT02145468|592161135|FG001|Overall Study|Withdrawal by Subject|8|||
163943160|NCT01803282|592161139|FG000|Overall Study|Progressive Disease|4|||
163943161|NCT01803282|592161140|FG001|Overall Study|Progressive Disease|3|||
163943162|NCT01803282|592161141|FG002|Overall Study|Progressive Disease|6|||
163943163|NCT01803282|592161142|FG003|Overall Study|Progressive Disease|22|||
163943164|NCT01803282|592161143|FG004|Overall Study|Progressive Disease|5|||
163943165|NCT01803282|592161144|FG005|Overall Study|Progressive Disease|8|||
163943166|NCT01803282|592161145|FG006|Overall Study|Progressive Disease|23|||
163943167|NCT01803282|592161146|FG007|Overall Study|Progressive Disease|24|||
163943168|NCT01803282|592161147|FG008|Overall Study|Progressive Disease|3|||
163943169|NCT01803282|592161148|FG009|Overall Study|Progressive Disease|29|||
163943170|NCT01803282|592161149|FG010|Overall Study|Progressive Disease|6|||
163943171|NCT01803282|592161150|FG011|Overall Study|Progressive Disease|11|||
163943172|NCT01803282|592161139|FG000|Overall Study|Death|0|||
163943173|NCT01803282|592161140|FG001|Overall Study|Death|0|||
163943174|NCT01803282|592161141|FG002|Overall Study|Death|0|||
163943175|NCT01803282|592161142|FG003|Overall Study|Death|0|||
163943176|NCT01803282|592161143|FG004|Overall Study|Death|2|||
163943177|NCT01803282|592161144|FG005|Overall Study|Death|1|||
163943178|NCT01803282|592161145|FG006|Overall Study|Death|1|||
163943179|NCT01803282|592161146|FG007|Overall Study|Death|5|||
163943180|NCT01803282|592161147|FG008|Overall Study|Death|1|||
163943181|NCT01803282|592161148|FG009|Overall Study|Death|1|||
163943182|NCT01803282|592161149|FG010|Overall Study|Death|0|||
163943183|NCT01803282|592161150|FG011|Overall Study|Death|0|||
163943184|NCT01803282|592161139|FG000|Overall Study|Withdrew Consent|0|||
163943185|NCT01803282|592161140|FG001|Overall Study|Withdrew Consent|0|||
163943186|NCT01803282|592161141|FG002|Overall Study|Withdrew Consent|0|||
163943187|NCT01803282|592161142|FG003|Overall Study|Withdrew Consent|6|||
163943188|NCT01803282|592161143|FG004|Overall Study|Withdrew Consent|1|||
163943189|NCT01803282|592161144|FG005|Overall Study|Withdrew Consent|0|||
163943190|NCT01803282|592161145|FG006|Overall Study|Withdrew Consent|8|||
163943191|NCT01803282|592161146|FG007|Overall Study|Withdrew Consent|3|||
163943192|NCT01803282|592161147|FG008|Overall Study|Withdrew Consent|1|||
163943193|NCT01803282|592161148|FG009|Overall Study|Withdrew Consent|5|||
163943194|NCT01803282|592161149|FG010|Overall Study|Withdrew Consent|0|||
163943195|NCT01803282|592161150|FG011|Overall Study|Withdrew Consent|1|||
163943196|NCT01803282|592161139|FG000|Overall Study|Investigator's Discretion|0|||
163943197|NCT01803282|592161140|FG001|Overall Study|Investigator's Discretion|0|||
163943198|NCT01803282|592161141|FG002|Overall Study|Investigator's Discretion|0|||
163943199|NCT01803282|592161142|FG003|Overall Study|Investigator's Discretion|7|||
163943200|NCT01803282|592161143|FG004|Overall Study|Investigator's Discretion|2|||
163943201|NCT01803282|592161144|FG005|Overall Study|Investigator's Discretion|1|||
163943202|NCT01803282|592161145|FG006|Overall Study|Investigator's Discretion|7|||
163943203|NCT01803282|592161146|FG007|Overall Study|Investigator's Discretion|10|||
163943204|NCT01803282|592161147|FG008|Overall Study|Investigator's Discretion|6|||
163943205|NCT01803282|592161148|FG009|Overall Study|Investigator's Discretion|7|||
163943206|NCT01803282|592161149|FG010|Overall Study|Investigator's Discretion|1|||
163943207|NCT01803282|592161150|FG011|Overall Study|Investigator's Discretion|0|||
163943208|NCT01803282|592161139|FG000|Overall Study|Adverse Event|0|||
163943209|NCT01803282|592161140|FG001|Overall Study|Adverse Event|0|||
163943210|NCT01803282|592161141|FG002|Overall Study|Adverse Event|0|||
163943211|NCT01803282|592161142|FG003|Overall Study|Adverse Event|0|||
163943212|NCT01803282|592161143|FG004|Overall Study|Adverse Event|0|||
163943213|NCT01803282|592161144|FG005|Overall Study|Adverse Event|0|||
163943214|NCT01803282|592161145|FG006|Overall Study|Adverse Event|1|||
163943215|NCT01803282|592161146|FG007|Overall Study|Adverse Event|2|||
163943216|NCT01803282|592161147|FG008|Overall Study|Adverse Event|0|||
163943217|NCT01803282|592161148|FG009|Overall Study|Adverse Event|1|||
163943218|NCT01803282|592161149|FG010|Overall Study|Adverse Event|0|||
164042467|NCT02773368|592514696|FG000|Overall Study|Lost to Follow-up|4|||
164042468|NCT02773368|592514697|FG001|Overall Study|Lost to Follow-up|1|||
164042469|NCT02773368|592514696|FG000|Overall Study|Withdrawal by Subject|5|||
164042470|NCT02773368|592514697|FG001|Overall Study|Withdrawal by Subject|1|||
164042471|NCT02773368|592514696|FG000|Overall Study|Unclassified|1|||
164042472|NCT02773368|592514697|FG001|Overall Study|Unclassified|1|||
164042473|NCT02773368|592514696|FG000|Overall Study|Missing|0|||
164042474|NCT02773368|592514697|FG001|Overall Study|Missing|1|||
164042475|NCT01929018|592514700|FG000|Overall Study|Lost to Follow-up|1|||
164042476|NCT01929018|592514701|FG001|Overall Study|Lost to Follow-up|0|||
164042477|NCT01929018|592514700|FG000|Overall Study|Hospitalization|0|||
164042478|NCT01929018|592514701|FG001|Overall Study|Hospitalization|1|||
164042479|NCT01047436|592514707|FG000|Overall Study|Protocol Violation|1|||
164042480|NCT01047436|592514708|FG001|Overall Study|Protocol Violation|0|||
164042481|NCT02635867|592514711|FG000|Overall Study|Lost to Follow-up|4|||
164042482|NCT02635867|592514712|FG001|Overall Study|Lost to Follow-up|3|||
164042483|NCT02635867|592514713|FG002|Overall Study|Lost to Follow-up|3|||
164042484|NCT02635867|592514714|FG003|Overall Study|Lost to Follow-up|4|||
164042485|NCT02635867|592514715|FG004|Overall Study|Lost to Follow-up|1|||
164042486|NCT02565576|592514718|FG000|Overall Study|abnormal lab value|2|||
164042487|NCT02565576|592514719|FG001|Overall Study|abnormal lab value|0|||
164042488|NCT02565576|592514718|FG000|Overall Study|subject / guardian decision|1|||
164042489|NCT02565576|592514719|FG001|Overall Study|subject / guardian decision|3|||
164042490|NCT02565576|592514718|FG000|Overall Study|Lost to Follow-up|1|||
164042491|NCT02565576|592514719|FG001|Overall Study|Lost to Follow-up|0|||
164042492|NCT02565576|592514718|FG000|Overall Study|Death|0|||
164042493|NCT02565576|592514719|FG001|Overall Study|Death|2|||
164042494|NCT02565576|592514718|FG000|Overall Study|Adverse Event|1|||
164042495|NCT02565576|592514719|FG001|Overall Study|Adverse Event|0|||
164042496|NCT00282568|592514720|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
164042497|NCT00282568|592514720|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
164042498|NCT00282568|592514720|FG000|Extended Treatment Period|Adverse Event|17|||
164042499|NCT00282568|592514720|FG000|Extended Treatment Period|Non-compliance|4|||
164042500|NCT00282568|592514720|FG000|Extended Treatment Period|Physician Decision|1|||
164042501|NCT00282568|592514720|FG000|Extended Treatment Period|Lost to Follow-up|2|||
164042502|NCT01266070|592514721|FG000|Overall Study|Adverse Event|3|||
163943219|NCT01803282|592161150|FG011|Overall Study|Adverse Event|3|||
163943220|NCT01803282|592161139|FG000|Overall Study|Non-Compliance with Study Drug|0|||
163943221|NCT01803282|592161140|FG001|Overall Study|Non-Compliance with Study Drug|0|||
163943222|NCT01803282|592161141|FG002|Overall Study|Non-Compliance with Study Drug|0|||
163943223|NCT01803282|592161142|FG003|Overall Study|Non-Compliance with Study Drug|1|||
163943224|NCT01803282|592161143|FG004|Overall Study|Non-Compliance with Study Drug|0|||
163943225|NCT01803282|592161144|FG005|Overall Study|Non-Compliance with Study Drug|0|||
163943226|NCT01803282|592161145|FG006|Overall Study|Non-Compliance with Study Drug|0|||
163943227|NCT01803282|592161146|FG007|Overall Study|Non-Compliance with Study Drug|0|||
163943228|NCT01803282|592161147|FG008|Overall Study|Non-Compliance with Study Drug|0|||
163943229|NCT01803282|592161148|FG009|Overall Study|Non-Compliance with Study Drug|0|||
163943230|NCT01803282|592161149|FG010|Overall Study|Non-Compliance with Study Drug|0|||
163943231|NCT01803282|592161150|FG011|Overall Study|Non-Compliance with Study Drug|0|||
163943232|NCT01803282|592161139|FG000|Overall Study|Unknown Reason|0|||
163943233|NCT01803282|592161140|FG001|Overall Study|Unknown Reason|0|||
163943234|NCT01803282|592161141|FG002|Overall Study|Unknown Reason|0|||
163943235|NCT01803282|592161142|FG003|Overall Study|Unknown Reason|0|||
163943236|NCT01803282|592161143|FG004|Overall Study|Unknown Reason|0|||
163943237|NCT01803282|592161144|FG005|Overall Study|Unknown Reason|0|||
163943238|NCT01803282|592161145|FG006|Overall Study|Unknown Reason|0|||
163943239|NCT01803282|592161146|FG007|Overall Study|Unknown Reason|1|||
163943240|NCT01803282|592161147|FG008|Overall Study|Unknown Reason|0|||
163943241|NCT01803282|592161148|FG009|Overall Study|Unknown Reason|0|||
163943242|NCT01803282|592161149|FG010|Overall Study|Unknown Reason|0|||
163943243|NCT01803282|592161150|FG011|Overall Study|Unknown Reason|0|||
163943244|NCT01803282|592161139|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
163943245|NCT01803282|592161140|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
163943246|NCT01803282|592161141|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
163943247|NCT01803282|592161142|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
163943248|NCT01803282|592161143|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
163943249|NCT01803282|592161144|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
163943250|NCT01803282|592161145|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
163943251|NCT01803282|592161146|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
164042503|NCT01266070|592514721|FG000|Overall Study|Protocol Violation|1|||
164042504|NCT00939341|592514722|FG000|Overall Study|Adverse Event|15|||
164042505|NCT00939341|592514722|FG000|Overall Study|Pregnancy|1|||
164042506|NCT00939341|592514722|FG000|Overall Study|Lost to Follow-up|23|||
164042507|NCT00939341|592514722|FG000|Overall Study|Withdrawal by Subject|13|||
164042508|NCT00939341|592514722|FG000|Overall Study|Protocol Violation|6|||
164042509|NCT00939341|592514722|FG000|Overall Study|Incorrect enrolment|8|||
163943252|NCT01803282|592161147|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
163943253|NCT01803282|592161148|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
163943254|NCT01803282|592161149|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
163943255|NCT01803282|592161150|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
163943256|NCT01803282|592161139|FG000|Overall Study|Enrolled but Never Treated|0|||
163943257|NCT01803282|592161140|FG001|Overall Study|Enrolled but Never Treated|0|||
163943258|NCT01803282|592161141|FG002|Overall Study|Enrolled but Never Treated|0|||
163943259|NCT01803282|592161142|FG003|Overall Study|Enrolled but Never Treated|0|||
163943260|NCT01803282|592161143|FG004|Overall Study|Enrolled but Never Treated|1|||
163943261|NCT01803282|592161144|FG005|Overall Study|Enrolled but Never Treated|0|||
163943262|NCT01803282|592161145|FG006|Overall Study|Enrolled but Never Treated|1|||
163943263|NCT01803282|592161146|FG007|Overall Study|Enrolled but Never Treated|1|||
163943264|NCT01803282|592161147|FG008|Overall Study|Enrolled but Never Treated|0|||
163943265|NCT01803282|592161148|FG009|Overall Study|Enrolled but Never Treated|1|||
163943266|NCT01803282|592161149|FG010|Overall Study|Enrolled but Never Treated|0|||
163943267|NCT01803282|592161150|FG011|Overall Study|Enrolled but Never Treated|0|||
163943268|NCT00798434|592161155|FG000|Double-Blind|Adverse Event|22|||
163943269|NCT00798434|592161156|FG001|Double-Blind|Adverse Event|46|||
163943270|NCT00798434|592161155|FG000|Double-Blind|Death|0|||
163943271|NCT00798434|592161156|FG001|Double-Blind|Death|1|||
163943272|NCT00798434|592161155|FG000|Double-Blind|Lost to Follow-up|1|||
163943273|NCT00798434|592161156|FG001|Double-Blind|Lost to Follow-up|0|||
163943274|NCT00798434|592161155|FG000|Double-Blind|Lack of Efficacy|8|||
163943275|NCT00798434|592161156|FG001|Double-Blind|Lack of Efficacy|12|||
163943276|NCT00798434|592161155|FG000|Double-Blind|Withdrawal by Subject|17|||
163943277|NCT00798434|592161156|FG001|Double-Blind|Withdrawal by Subject|14|||
163943278|NCT00798434|592161155|FG000|Double-Blind|Protocol Violation|1|||
163943279|NCT00798434|592161156|FG001|Double-Blind|Protocol Violation|4|||
163943280|NCT00798434|592161155|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
163943281|NCT00798434|592161156|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
163943282|NCT00798434|592161155|FG000|Double-Blind|Other|1|||
163943283|NCT00798434|592161156|FG001|Double-Blind|Other|0|||
163943284|NCT00798434|592161155|FG000|Double-Blind|Not Treated|3|||
163943285|NCT00798434|592161156|FG001|Double-Blind|Not Treated|6|||
163943286|NCT00798434|592161155|FG000|Open-Label|Adverse Event|33|||
163943287|NCT00798434|592161156|FG001|Open-Label|Adverse Event|11|||
163943288|NCT00798434|592161155|FG000|Open-Label|Lack of Efficacy|5|||
163943289|NCT00798434|592161156|FG001|Open-Label|Lack of Efficacy|11|||
163943290|NCT00798434|592161155|FG000|Open-Label|Withdrawal by Subject|2|||
163943291|NCT00798434|592161156|FG001|Open-Label|Withdrawal by Subject|7|||
163943292|NCT00798434|592161155|FG000|Open-Label|Protocol Violation|1|||
163943293|NCT00798434|592161156|FG001|Open-Label|Protocol Violation|0|||
163943294|NCT00798434|592161155|FG000|Open-Label|Other|1|||
163943295|NCT00798434|592161156|FG001|Open-Label|Other|2|||
163943296|NCT00798434|592161155|FG000|Open-Label|Not Treated|0|||
163943297|NCT00798434|592161156|FG001|Open-Label|Not Treated|1|||
163943298|NCT04908631|592161157|FG000|Overall Study|Lost to Follow-up|1|||
163943299|NCT04908631|592161157|FG000|Overall Study|Physician Decision|1|||
163943300|NCT04908631|592161157|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
163943301|NCT06655558|592161158|FG000|Overall Study|Protocol Violation|1|||
163943302|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
163943303|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
163943304|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
163943305|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
163943306|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
163943307|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
163943308|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
163943309|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
163943310|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
163943311|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
163943312|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
163943313|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
164042510|NCT01408732|592514723|FG000|Overall Study|Withdrawal by Subject|2|||
164042511|NCT01408732|592514724|FG001|Overall Study|Withdrawal by Subject|2|||
164042512|NCT00764322|592514726|FG000|Overall Study|Withdrawal by Subject|11|||
164042513|NCT00764322|592514726|FG000|Overall Study|No CYP2D6 genotyping|9|||
164042514|NCT00796003|592514727|FG000|Overall Study|Disease Progression|2|||
163943314|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163943315|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
163943316|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163943317|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163943318|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163943319|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
163943320|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163943321|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
163943322|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
164042515|NCT00796003|592514728|FG001|Overall Study|Disease Progression|13|||
164042516|NCT00796003|592514727|FG000|Overall Study|Adverse Event|1|||
164042517|NCT00796003|592514728|FG001|Overall Study|Adverse Event|7|||
164042518|NCT00796003|592514727|FG000|Overall Study|Specified organ function not met|0|||
164042519|NCT00796003|592514728|FG001|Overall Study|Specified organ function not met|1|||
164042520|NCT00796003|592514727|FG000|Overall Study|Physician Decision|0|||
164042521|NCT00796003|592514728|FG001|Overall Study|Physician Decision|4|||
164042522|NCT00796003|592514727|FG000|Overall Study|Withdrawal by Subject|0|||
164042523|NCT00796003|592514728|FG001|Overall Study|Withdrawal by Subject|1|||
164042524|NCT00796003|592514727|FG000|Overall Study|Other|0|||
164042525|NCT00796003|592514728|FG001|Overall Study|Other|1|||
164042526|NCT00796003|592514727|FG000|Overall Study|Participants Not treated|0|||
164042527|NCT00796003|592514728|FG001|Overall Study|Participants Not treated|2|||
164042528|NCT03185819|592514733|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
164042529|NCT03185819|592514734|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
164042530|NCT03185819|592514735|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
164042531|NCT03185819|592514736|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
164042532|NCT03185819|592514733|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
164042533|NCT03185819|592514734|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
164042534|NCT03185819|592514735|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
164042535|NCT03185819|592514736|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
164042536|NCT03185819|592514733|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
164042537|NCT03185819|592514734|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
164042538|NCT03185819|592514735|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
164042539|NCT03185819|592514736|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
164042540|NCT03185819|592514733|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
164042541|NCT03185819|592514734|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
164042542|NCT03185819|592514735|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
164042543|NCT03185819|592514736|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
164042544|NCT03185819|592514733|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
164042545|NCT03185819|592514734|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
164042546|NCT03185819|592514735|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
164042547|NCT03185819|592514736|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
164042548|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
164042549|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
164042550|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
164042551|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
164042552|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
164042553|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
164042554|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
164042555|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
164042556|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
164042557|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
164042558|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
164042559|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
164042560|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
164042561|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
164042562|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
164042563|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
164042564|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
164042565|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
164042566|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
164042567|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
164042568|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
164042569|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
164042570|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
164042571|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
164042572|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
164042573|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
164042574|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
164042575|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
164042576|NCT03185819|592514733|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
164042577|NCT03185819|592514734|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
164042578|NCT03185819|592514735|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
163943323|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163943324|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163943325|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
163943326|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163943327|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163943328|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
163943329|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163943330|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163943331|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
163943332|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163943333|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
163943334|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
163943335|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163943336|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163943337|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
163943338|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
163943339|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
163943340|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
163943341|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
163943342|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
163943343|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
163943344|NCT03524092|592161167|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
163943345|NCT03524092|592161168|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
163943346|NCT03524092|592161169|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
163943347|NCT03524092|592161170|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
163943348|NCT03524092|592161171|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
163943349|NCT03524092|592161172|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
163943350|NCT03524092|592161167|FG000|Loss of Response Rescue Period|Adverse Event|0|||
163943351|NCT03524092|592161168|FG001|Loss of Response Rescue Period|Adverse Event|0|||
163943352|NCT03524092|592161169|FG002|Loss of Response Rescue Period|Adverse Event|0|||
163943353|NCT03524092|592161170|FG003|Loss of Response Rescue Period|Adverse Event|2|||
163943354|NCT03524092|592161171|FG004|Loss of Response Rescue Period|Adverse Event|0|||
163943355|NCT03524092|592161172|FG005|Loss of Response Rescue Period|Adverse Event|0|||
163943356|NCT03524092|592161167|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
163943357|NCT03524092|592161168|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
163943358|NCT03524092|592161169|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
163943359|NCT03524092|592161170|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
163943360|NCT03524092|592161171|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
163943361|NCT03524092|592161172|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
163943362|NCT03524092|592161167|FG000|Loss of Response Rescue Period|Pregnancy|0|||
163943363|NCT03524092|592161168|FG001|Loss of Response Rescue Period|Pregnancy|0|||
163943364|NCT03524092|592161169|FG002|Loss of Response Rescue Period|Pregnancy|0|||
163943365|NCT03524092|592161170|FG003|Loss of Response Rescue Period|Pregnancy|1|||
163943366|NCT03524092|592161171|FG004|Loss of Response Rescue Period|Pregnancy|0|||
163943367|NCT03524092|592161172|FG005|Loss of Response Rescue Period|Pregnancy|0|||
163943368|NCT03524092|592161167|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163943369|NCT03524092|592161168|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163943370|NCT03524092|592161169|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163943371|NCT03524092|592161170|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
163943372|NCT03524092|592161171|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163943373|NCT03524092|592161172|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
163943374|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163943375|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163943376|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163943377|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163943378|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
163943379|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
163943380|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163943381|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163943382|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163943383|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163943384|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
163943385|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
163943386|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163943387|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
164148070|NCT00247676|592904819|FG000|Overall Study|Death|5|||
164042579|NCT03185819|592514736|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
164042580|NCT00732641|592514737|FG000|Overall Study|Relapse or Progressive Disease|65|||
164042581|NCT00732641|592514738|FG001|Overall Study|Relapse or Progressive Disease|101|||
164042582|NCT00732641|592514737|FG000|Overall Study|Serious Adverse Events|12|||
164042583|NCT00732641|592514738|FG001|Overall Study|Serious Adverse Events|3|||
164042584|NCT00732641|592514737|FG000|Overall Study|Physician Decision|6|||
164042585|NCT00732641|592514738|FG001|Overall Study|Physician Decision|0|||
164042586|NCT00732641|592514737|FG000|Overall Study|Withdrawal by Subject|4|||
164042587|NCT00732641|592514738|FG001|Overall Study|Withdrawal by Subject|2|||
164042588|NCT00732641|592514737|FG000|Overall Study|Unable to Complete|1|||
164042589|NCT00732641|592514738|FG001|Overall Study|Unable to Complete|1|||
164042590|NCT00732641|592514737|FG000|Overall Study|Other|18|||
164042591|NCT00732641|592514738|FG001|Overall Study|Other|5|||
164042592|NCT02910089|592514739|FG000|Overall Study|Lost insurance eligibility|22|||
164042593|NCT02910089|592514740|FG001|Overall Study|Lost insurance eligibility|16|||
164042594|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
164042595|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
164042596|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
164042597|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
164042598|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
164042599|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
164042600|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
164042601|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
164042602|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
164042603|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
164042604|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
164042605|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
164042606|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
164042607|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
164042608|NCT03434041|592514743|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
164042609|NCT03434041|592514744|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
164042610|NCT03434041|592514743|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
164042611|NCT03434041|592514744|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
164042612|NCT03434041|592514743|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
164042613|NCT03434041|592514744|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
164042614|NCT03434041|592514743|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
164042615|NCT03434041|592514744|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
164042616|NCT03447821|592514745|FG000|Overall Study|Withdrawal by Subject|1|||
164042617|NCT03447821|592514746|FG001|Overall Study|Withdrawal by Subject|1|||
164042618|NCT03447821|592514747|FG002|Overall Study|Withdrawal by Subject|0|||
164042619|NCT03447821|592514745|FG000|Overall Study|Lost to Follow-up|0|||
164042620|NCT03447821|592514746|FG001|Overall Study|Lost to Follow-up|0|||
163841632|NCT02693834|591790341|FG000|Baseline Measurement|Withdrawal by Subject|1|||
164042621|NCT03447821|592514747|FG002|Overall Study|Lost to Follow-up|1|||
164042622|NCT02977507|592514748|FG000|Overall Study|Protocol Deviation|1|||
164042623|NCT02977507|592514749|FG001|Overall Study|Protocol Deviation|0|||
163841633|NCT02693834|591790342|FG001|Baseline Measurement|Withdrawal by Subject|0|||
163841634|NCT02693834|591790341|FG000|Baseline Measurement|Adverse Event|1|||
163841635|NCT02693834|591790342|FG001|Baseline Measurement|Adverse Event|0|||
163841636|NCT02693834|591790341|FG000|Week 2 Practice|Adverse Event|0|||
163841637|NCT02693834|591790342|FG001|Week 2 Practice|Adverse Event|1|||
163841638|NCT02111213|591790345|FG000|Overall Study|Withdrawal by Subject|3|||
163841639|NCT02111213|591790346|FG001|Overall Study|Withdrawal by Subject|2|||
163841640|NCT02111213|591790345|FG000|Overall Study|Lost to Follow-up|3|||
163841641|NCT02111213|591790346|FG001|Overall Study|Lost to Follow-up|4|||
163841642|NCT02226172|591790351|FG000|Overall Study|Participant refused further follow-up|4|||
163841643|NCT02226172|591790351|FG000|Overall Study|Other|5|||
163841644|NCT02226172|591790351|FG000|Overall Study|Death|1|||
163841645|NCT02226172|591790351|FG000|Overall Study|Study terminated by sponsor|1|||
163841646|NCT02226172|591790351|FG000|Overall Study|Adverse Event|6|||
163841647|NCT00758160|591790360|FG000|Overall Study|No Longer Requires Study Medication|4|||
163841648|NCT00758160|591790360|FG000|Overall Study|Administration Problems|3|||
163841649|NCT00758160|591790360|FG000|Overall Study|Adverse Event|15|||
163841650|NCT00758160|591790360|FG000|Overall Study|Lack of Efficacy|10|||
163841651|NCT00758160|591790360|FG000|Overall Study|Lost to Follow-up|14|||
163841652|NCT00758160|591790360|FG000|Overall Study|Protocol Violation|12|||
163841653|NCT00758160|591790360|FG000|Overall Study|Withdrawal by Subject|8|||
163841654|NCT01108510|591790364|FG000|Overall Study|Randomized but Not Treated|5|||
163841655|NCT01108510|591790365|FG001|Overall Study|Randomized but Not Treated|1|||
163841656|NCT01108510|591790364|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
163841657|NCT01108510|591790365|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
164042624|NCT02977507|592514748|FG000|Overall Study|Lost to Follow-up|1|||
164042625|NCT02977507|592514749|FG001|Overall Study|Lost to Follow-up|0|||
164042626|NCT01587274|592514752|FG000|Overall Study|Lost to Follow-up|4|||
164042627|NCT01587274|592514753|FG001|Overall Study|Lost to Follow-up|5|||
164042628|NCT01587274|592514754|FG002|Overall Study|Lost to Follow-up|3|||
164042629|NCT03236506|592514760|FG000|Overall Study|Death|1|||
164042630|NCT03236506|592514761|FG001|Overall Study|Death|1|||
164042631|NCT03236506|592514762|FG002|Overall Study|Death|1|||
164042632|NCT03236506|592514760|FG000|Overall Study|Withdrawal by Subject|3|||
164042633|NCT03236506|592514761|FG001|Overall Study|Withdrawal by Subject|3|||
164042634|NCT03236506|592514762|FG002|Overall Study|Withdrawal by Subject|4|||
164042635|NCT03236506|592514760|FG000|Overall Study|Did not initiate treatment|2|||
164042636|NCT03236506|592514761|FG001|Overall Study|Did not initiate treatment|1|||
164042637|NCT03236506|592514762|FG002|Overall Study|Did not initiate treatment|2|||
164042638|NCT00422669|592514771|FG000|Overall Study|The study was terminated early.|98|||
164042639|NCT00422669|592514772|FG001|Overall Study|The study was terminated early.|100|||
164042640|NCT00422669|592514773|FG002|Overall Study|The study was terminated early.|7|||
164042641|NCT00437203|592514783|FG000|Overall Study|Death|0|||
164042642|NCT00437203|592514784|FG001|Overall Study|Death|0|||
164042643|NCT00437203|592514785|FG002|Overall Study|Death|1|||
164042644|NCT00437203|592514786|FG003|Overall Study|Death|0|||
164042645|NCT00437203|592514787|FG004|Overall Study|Death|0|||
164042646|NCT00437203|592514788|FG005|Overall Study|Death|0|||
164042647|NCT00437203|592514789|FG006|Overall Study|Death|0|||
164042648|NCT00437203|592514790|FG007|Overall Study|Death|1|||
164042649|NCT00437203|592514791|FG008|Overall Study|Death|0|||
164042650|NCT00437203|592514792|FG009|Overall Study|Death|1|||
164042651|NCT00437203|592514783|FG000|Overall Study|Adverse Event|1|||
164042652|NCT00437203|592514784|FG001|Overall Study|Adverse Event|1|||
164042653|NCT00437203|592514785|FG002|Overall Study|Adverse Event|0|||
164042654|NCT00437203|592514786|FG003|Overall Study|Adverse Event|0|||
164042655|NCT00437203|592514787|FG004|Overall Study|Adverse Event|0|||
164042656|NCT00437203|592514788|FG005|Overall Study|Adverse Event|0|||
164042657|NCT00437203|592514789|FG006|Overall Study|Adverse Event|0|||
164042658|NCT00437203|592514790|FG007|Overall Study|Adverse Event|1|||
164042659|NCT00437203|592514791|FG008|Overall Study|Adverse Event|0|||
164042660|NCT00437203|592514792|FG009|Overall Study|Adverse Event|1|||
164042661|NCT00437203|592514783|FG000|Overall Study|Study terminated by sponsor|0|||
164042662|NCT00437203|592514784|FG001|Overall Study|Study terminated by sponsor|0|||
164042663|NCT00437203|592514785|FG002|Overall Study|Study terminated by sponsor|0|||
164042664|NCT00437203|592514786|FG003|Overall Study|Study terminated by sponsor|0|||
164042665|NCT00437203|592514787|FG004|Overall Study|Study terminated by sponsor|0|||
164042666|NCT00437203|592514788|FG005|Overall Study|Study terminated by sponsor|0|||
164042667|NCT00437203|592514789|FG006|Overall Study|Study terminated by sponsor|0|||
163943388|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163943389|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163943390|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
163943391|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
163943392|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163943393|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163943394|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163943395|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
163943396|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
164042668|NCT00437203|592514790|FG007|Overall Study|Study terminated by sponsor|0|||
164042669|NCT00437203|592514791|FG008|Overall Study|Study terminated by sponsor|1|||
164042670|NCT00437203|592514792|FG009|Overall Study|Study terminated by sponsor|0|||
164042671|NCT00437203|592514783|FG000|Overall Study|Objective progression or relapse|5|||
164042672|NCT00437203|592514784|FG001|Overall Study|Objective progression or relapse|6|||
164042673|NCT00437203|592514785|FG002|Overall Study|Objective progression or relapse|2|||
164042674|NCT00437203|592514786|FG003|Overall Study|Objective progression or relapse|3|||
163943397|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
164042675|NCT00437203|592514787|FG004|Overall Study|Objective progression or relapse|3|||
164042676|NCT00437203|592514788|FG005|Overall Study|Objective progression or relapse|3|||
164042677|NCT00437203|592514789|FG006|Overall Study|Objective progression or relapse|6|||
164042678|NCT00437203|592514790|FG007|Overall Study|Objective progression or relapse|1|||
164042679|NCT00437203|592514791|FG008|Overall Study|Objective progression or relapse|2|||
164042680|NCT00437203|592514792|FG009|Overall Study|Objective progression or relapse|2|||
164042681|NCT00437203|592514783|FG000|Overall Study|Other|0|||
164042682|NCT00437203|592514784|FG001|Overall Study|Other|1|||
164042683|NCT00437203|592514785|FG002|Overall Study|Other|0|||
164042684|NCT00437203|592514786|FG003|Overall Study|Other|0|||
164042685|NCT00437203|592514787|FG004|Overall Study|Other|0|||
164042686|NCT00437203|592514788|FG005|Overall Study|Other|0|||
164042687|NCT00437203|592514789|FG006|Overall Study|Other|1|||
164042688|NCT00437203|592514790|FG007|Overall Study|Other|0|||
164042689|NCT00437203|592514791|FG008|Overall Study|Other|0|||
164042690|NCT00437203|592514792|FG009|Overall Study|Other|0|||
163943398|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163943399|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163943400|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163943401|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163943402|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
163943403|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
163943404|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163943405|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163943406|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163943407|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163943408|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
163943409|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
163943410|NCT03524092|592161167|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163943411|NCT03524092|592161168|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163943412|NCT03524092|592161169|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163943413|NCT03524092|592161170|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163943414|NCT03524092|592161171|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
163943415|NCT03524092|592161172|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
163943416|NCT03524092|592161167|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163943417|NCT03524092|592161168|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163943418|NCT03524092|592161169|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163943419|NCT03524092|592161170|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163943420|NCT03524092|592161171|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
163943421|NCT03524092|592161172|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
163943422|NCT03524092|592161167|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163943423|NCT03524092|592161168|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163943424|NCT03524092|592161169|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163943425|NCT03524092|592161170|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163943426|NCT03524092|592161171|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
163943427|NCT03524092|592161172|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
163943428|NCT03524092|592161167|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163943429|NCT03524092|592161168|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163943430|NCT03524092|592161169|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163943431|NCT03524092|592161170|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163943432|NCT03524092|592161171|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
163943433|NCT03524092|592161172|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
163943434|NCT03524092|592161167|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163943435|NCT03524092|592161168|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163943436|NCT03524092|592161169|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163943437|NCT03524092|592161170|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163943438|NCT03524092|592161171|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
163943439|NCT03524092|592161172|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
163943440|NCT04893460|592161173|FG000|Overall Study|Lost to Follow-up|18|||
163943441|NCT03578887|592161174|FG000|Overall Study|Withdrawal by Subject|7|||
163943442|NCT03578887|592161175|FG001|Overall Study|Withdrawal by Subject|2|||
163943443|NCT03578887|592161176|FG002|Overall Study|Withdrawal by Subject|1|||
163943444|NCT03578887|592161174|FG000|Overall Study|Lost to Follow-up|13|||
163943445|NCT03578887|592161175|FG001|Overall Study|Lost to Follow-up|1|||
163943446|NCT03578887|592161176|FG002|Overall Study|Lost to Follow-up|4|||
163943447|NCT03578887|592161174|FG000|Overall Study|Physician Decision|0|||
163943448|NCT03578887|592161175|FG001|Overall Study|Physician Decision|1|||
163943449|NCT03578887|592161176|FG002|Overall Study|Physician Decision|1|||
163943450|NCT01099215|592162840|FG000|Overall Study|Withdrawal by Subject|1|||
163943451|NCT01099215|592162841|FG001|Overall Study|Withdrawal by Subject|0|||
163943452|NCT01099215|592162840|FG000|Overall Study|Adverse Event|0|||
163943453|NCT01099215|592162841|FG001|Overall Study|Adverse Event|1|||
163943454|NCT00387426|592162843|FG000|Overall Study|Lack of Response|7|||
163943455|NCT00387426|592162843|FG000|Overall Study|Toxicities|4|||
163943456|NCT00387426|592162843|FG000|Overall Study|Disease Progression|3|||
163943457|NCT03203473|592162844|FG000|Induction Phase|Never started primary treatment|2|||
163943458|NCT03203473|592162845|FG001|Induction Phase|Never started primary treatment|0|||
163943459|NCT03203473|592162846|FG002|Induction Phase|Never started primary treatment|0|||
163943460|NCT03203473|592162844|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
163943461|NCT03203473|592162845|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
163943462|NCT03203473|592162846|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
164042691|NCT03997760|592514793|FG000|Overall Study|Protocol Deviation|0|||
164042692|NCT03997760|592514794|FG001|Overall Study|Protocol Deviation|1|||
164042693|NCT03997760|592514795|FG002|Overall Study|Protocol Deviation|0|||
164042694|NCT03997760|592514796|FG003|Overall Study|Protocol Deviation|0|||
164042695|NCT02566109|592514799|FG000|Overall Study|Withdrawal by Subject|1|||
164042696|NCT01906476|592514800|FG000|Overall Study|Lost to Follow-up|17|||
164042697|NCT01906476|592514801|FG001|Overall Study|Lost to Follow-up|16|||
164042698|NCT00479167|592514804|FG000|Overall Study|Withdrawal by Subject|1|||
164042699|NCT01576406|592514806|FG000|Overall Study|Lost to Follow-up|1|||
164042700|NCT01576406|592514807|FG001|Overall Study|Lost to Follow-up|2|||
164042701|NCT01576406|592514808|FG002|Overall Study|Lost to Follow-up|0|||
164042702|NCT01576406|592514809|FG003|Overall Study|Lost to Follow-up|0|||
164042703|NCT01576406|592514810|FG004|Overall Study|Lost to Follow-up|0|||
164042704|NCT01576406|592514811|FG005|Overall Study|Lost to Follow-up|0|||
164042705|NCT01576406|592514806|FG000|Overall Study|Death|3|||
164042706|NCT01576406|592514807|FG001|Overall Study|Death|4|||
164042707|NCT01576406|592514808|FG002|Overall Study|Death|8|||
164042708|NCT01576406|592514809|FG003|Overall Study|Death|5|||
164042709|NCT01576406|592514810|FG004|Overall Study|Death|7|||
164042710|NCT01576406|592514811|FG005|Overall Study|Death|9|||
164042711|NCT01576406|592514806|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164042712|NCT01576406|592514807|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164042713|NCT01576406|592514808|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
164042714|NCT01576406|592514809|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
164042715|NCT01576406|592514810|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164042716|NCT01576406|592514811|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
164042717|NCT01576406|592514806|FG000|Overall Study|Withdrawal the consent|2|||
164042718|NCT01576406|592514807|FG001|Overall Study|Withdrawal the consent|2|||
164042719|NCT01576406|592514808|FG002|Overall Study|Withdrawal the consent|5|||
164042720|NCT01576406|592514809|FG003|Overall Study|Withdrawal the consent|1|||
164042721|NCT01576406|592514810|FG004|Overall Study|Withdrawal the consent|1|||
164042722|NCT01576406|592514811|FG005|Overall Study|Withdrawal the consent|3|||
164042723|NCT01576406|592514806|FG000|Overall Study|Other|0|||
164042724|NCT01576406|592514807|FG001|Overall Study|Other|0|||
164042725|NCT01576406|592514808|FG002|Overall Study|Other|2|||
164042726|NCT01576406|592514809|FG003|Overall Study|Other|2|||
164042727|NCT01576406|592514810|FG004|Overall Study|Other|0|||
164042728|NCT01576406|592514811|FG005|Overall Study|Other|0|||
164042729|NCT01627782|592514812|FG000|Overall Study|Adverse Event|1|||
164042730|NCT01627782|592514813|FG001|Overall Study|Adverse Event|2|||
164042731|NCT01627782|592514814|FG002|Overall Study|Adverse Event|0|||
164042732|NCT01627782|592514815|FG003|Overall Study|Adverse Event|1|||
164042733|NCT01627782|592514812|FG000|Overall Study|Lack of Efficacy|11|||
164042734|NCT01627782|592514813|FG001|Overall Study|Lack of Efficacy|1|||
164042735|NCT01627782|592514814|FG002|Overall Study|Lack of Efficacy|15|||
164042736|NCT01627782|592514815|FG003|Overall Study|Lack of Efficacy|2|||
164042737|NCT01627782|592514812|FG000|Overall Study|Protocol Violation|1|||
164042738|NCT01627782|592514813|FG001|Overall Study|Protocol Violation|0|||
164042739|NCT01627782|592514814|FG002|Overall Study|Protocol Violation|0|||
164042740|NCT01627782|592514815|FG003|Overall Study|Protocol Violation|0|||
164042741|NCT01627782|592514812|FG000|Overall Study|Withdrawal by Subject|2|||
164042742|NCT01627782|592514813|FG001|Overall Study|Withdrawal by Subject|1|||
164042743|NCT01627782|592514814|FG002|Overall Study|Withdrawal by Subject|0|||
164042744|NCT01627782|592514815|FG003|Overall Study|Withdrawal by Subject|0|||
164042745|NCT01627782|592514812|FG000|Overall Study|Other|0|||
164042746|NCT01627782|592514813|FG001|Overall Study|Other|2|||
164042747|NCT01627782|592514814|FG002|Overall Study|Other|0|||
164042748|NCT01627782|592514815|FG003|Overall Study|Other|3|||
164042749|NCT01627782|592514812|FG000|Overall Study|Randomized But Not Treated|1|||
164042750|NCT01627782|592514813|FG001|Overall Study|Randomized But Not Treated|0|||
164042751|NCT01627782|592514814|FG002|Overall Study|Randomized But Not Treated|0|||
164042752|NCT01627782|592514815|FG003|Overall Study|Randomized But Not Treated|0|||
164042753|NCT01004159|592517596|FG000|Overall Study|Adverse Event|2|||
164042754|NCT01004159|592517596|FG000|Overall Study|Disease Progression|18|||
164042755|NCT04315298|592517602|FG000|Overall Study|Withdrawal by Subject|0|||
164042756|NCT04315298|592517603|FG001|Overall Study|Withdrawal by Subject|0|||
164042757|NCT04315298|592517604|FG002|Overall Study|Withdrawal by Subject|0|||
164042758|NCT04315298|592517605|FG003|Overall Study|Withdrawal by Subject|2|||
164042759|NCT04315298|592517606|FG004|Overall Study|Withdrawal by Subject|2|||
164042760|NCT04315298|592517607|FG005|Overall Study|Withdrawal by Subject|2|||
164042761|NCT04315298|592517608|FG006|Overall Study|Withdrawal by Subject|0|||
164098991|NCT03496623|592726964|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
163841658|NCT01108510|591790364|FG000|Overall Study|Adverse Event|26|||
164042762|NCT04315298|592517609|FG007|Overall Study|Withdrawal by Subject|1|||
164042763|NCT04315298|592517610|FG008|Overall Study|Withdrawal by Subject|1|||
164042764|NCT04315298|592517611|FG009|Overall Study|Withdrawal by Subject|1|||
164042765|NCT04315298|592517612|FG010|Overall Study|Withdrawal by Subject|0|||
164042766|NCT04315298|592517613|FG011|Overall Study|Withdrawal by Subject|0|||
164098992|NCT03496623|592726965|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164042767|NCT04315298|592517614|FG012|Overall Study|Withdrawal by Subject|0|||
164042768|NCT04315298|592517615|FG013|Overall Study|Withdrawal by Subject|0|||
164042769|NCT04315298|592517616|FG014|Overall Study|Withdrawal by Subject|0|||
164042770|NCT04315298|592517617|FG015|Overall Study|Withdrawal by Subject|0|||
164042771|NCT04315298|592517618|FG016|Overall Study|Withdrawal by Subject|0|||
164042772|NCT04315298|592517619|FG017|Overall Study|Withdrawal by Subject|0|||
164042773|NCT04315298|592517620|FG018|Overall Study|Withdrawal by Subject|0|||
164042774|NCT04315298|592517602|FG000|Overall Study|Physician Decision|0|||
164042775|NCT04315298|592517603|FG001|Overall Study|Physician Decision|0|||
164042776|NCT04315298|592517604|FG002|Overall Study|Physician Decision|0|||
164042777|NCT04315298|592517605|FG003|Overall Study|Physician Decision|0|||
164042778|NCT04315298|592517606|FG004|Overall Study|Physician Decision|1|||
164042779|NCT04315298|592517607|FG005|Overall Study|Physician Decision|0|||
164042780|NCT04315298|592517608|FG006|Overall Study|Physician Decision|0|||
164042781|NCT04315298|592517609|FG007|Overall Study|Physician Decision|0|||
164042782|NCT04315298|592517610|FG008|Overall Study|Physician Decision|0|||
164042783|NCT04315298|592517611|FG009|Overall Study|Physician Decision|0|||
164042784|NCT04315298|592517612|FG010|Overall Study|Physician Decision|0|||
164042785|NCT04315298|592517613|FG011|Overall Study|Physician Decision|0|||
164042786|NCT04315298|592517614|FG012|Overall Study|Physician Decision|0|||
164042787|NCT04315298|592517615|FG013|Overall Study|Physician Decision|0|||
164042788|NCT04315298|592517616|FG014|Overall Study|Physician Decision|0|||
164042789|NCT04315298|592517617|FG015|Overall Study|Physician Decision|0|||
164042790|NCT04315298|592517618|FG016|Overall Study|Physician Decision|0|||
164042791|NCT04315298|592517619|FG017|Overall Study|Physician Decision|0|||
164042792|NCT04315298|592517620|FG018|Overall Study|Physician Decision|0|||
164042793|NCT04315298|592517602|FG000|Overall Study|Lost to Follow-up|5|||
164042794|NCT04315298|592517603|FG001|Overall Study|Lost to Follow-up|10|||
164042795|NCT04315298|592517604|FG002|Overall Study|Lost to Follow-up|6|||
164042796|NCT04315298|592517605|FG003|Overall Study|Lost to Follow-up|8|||
164042797|NCT04315298|592517606|FG004|Overall Study|Lost to Follow-up|12|||
164042798|NCT04315298|592517607|FG005|Overall Study|Lost to Follow-up|13|||
164042799|NCT04315298|592517608|FG006|Overall Study|Lost to Follow-up|9|||
164042800|NCT04315298|592517609|FG007|Overall Study|Lost to Follow-up|16|||
164042801|NCT04315298|592517610|FG008|Overall Study|Lost to Follow-up|14|||
164042802|NCT04315298|592517611|FG009|Overall Study|Lost to Follow-up|0|||
164042803|NCT04315298|592517612|FG010|Overall Study|Lost to Follow-up|2|||
164042804|NCT04315298|592517613|FG011|Overall Study|Lost to Follow-up|1|||
164042805|NCT04315298|592517614|FG012|Overall Study|Lost to Follow-up|0|||
164042806|NCT04315298|592517615|FG013|Overall Study|Lost to Follow-up|0|||
164042807|NCT04315298|592517616|FG014|Overall Study|Lost to Follow-up|0|||
164042808|NCT04315298|592517617|FG015|Overall Study|Lost to Follow-up|2|||
164042809|NCT04315298|592517618|FG016|Overall Study|Lost to Follow-up|0|||
164042810|NCT04315298|592517619|FG017|Overall Study|Lost to Follow-up|0|||
164042811|NCT04315298|592517620|FG018|Overall Study|Lost to Follow-up|0|||
164042812|NCT04315298|592517602|FG000|Overall Study|Death|24|||
164042813|NCT04315298|592517603|FG001|Overall Study|Death|60|||
164042814|NCT04315298|592517604|FG002|Overall Study|Death|49|||
164042815|NCT04315298|592517605|FG003|Overall Study|Death|59|||
164042816|NCT04315298|592517606|FG004|Overall Study|Death|70|||
164042817|NCT04315298|592517607|FG005|Overall Study|Death|114|||
164042818|NCT04315298|592517608|FG006|Overall Study|Death|9|||
164042819|NCT04315298|592517609|FG007|Overall Study|Death|12|||
164042820|NCT04315298|592517610|FG008|Overall Study|Death|21|||
164042821|NCT04315298|592517611|FG009|Overall Study|Death|16|||
164042822|NCT04315298|592517612|FG010|Overall Study|Death|40|||
164042823|NCT04315298|592517613|FG011|Overall Study|Death|40|||
164042824|NCT04315298|592517614|FG012|Overall Study|Death|3|||
164042825|NCT04315298|592517615|FG013|Overall Study|Death|4|||
164042826|NCT04315298|592517616|FG014|Overall Study|Death|6|||
164042827|NCT04315298|592517617|FG015|Overall Study|Death|4|||
164042828|NCT04315298|592517618|FG016|Overall Study|Death|3|||
164042829|NCT04315298|592517619|FG017|Overall Study|Death|1|||
164042830|NCT04315298|592517620|FG018|Overall Study|Death|0|||
164042831|NCT01199198|592517621|FG000|Overall Study|Adverse Event|3|||
164042832|NCT01199198|592517622|FG001|Overall Study|Adverse Event|0|||
164042833|NCT01199198|592517621|FG000|Overall Study|Lost to Follow-up|1|||
164042834|NCT01199198|592517622|FG001|Overall Study|Lost to Follow-up|5|||
164042835|NCT01199198|592517621|FG000|Overall Study|Withdrawal by Subject|1|||
164042836|NCT01199198|592517622|FG001|Overall Study|Withdrawal by Subject|2|||
164042837|NCT01199198|592517621|FG000|Overall Study|ICU Transfer|1|||
164042838|NCT01199198|592517622|FG001|Overall Study|ICU Transfer|2|||
164042839|NCT01199198|592517621|FG000|Overall Study|Hospice-care transfer|1|||
164042840|NCT01199198|592517622|FG001|Overall Study|Hospice-care transfer|2|||
164042841|NCT00736385|592517623|FG000|Overall Study|Withdrawal by Subject|2|||
164042842|NCT00736385|592517624|FG001|Overall Study|Withdrawal by Subject|2|||
164042843|NCT00736385|592517623|FG000|Overall Study|Adverse Event|0|||
164042844|NCT00736385|592517624|FG001|Overall Study|Adverse Event|1|||
164042845|NCT03267511|592517625|FG000|Overall Study|Lost to Follow-up|0|||
164042846|NCT03267511|592517626|FG001|Overall Study|Lost to Follow-up|0|||
164042847|NCT03267511|592517627|FG002|Overall Study|Lost to Follow-up|0|||
164042848|NCT03267511|592517628|FG003|Overall Study|Lost to Follow-up|1|||
164042849|NCT03050307|592517629|FG000|Overall Study|Adverse Event|4|||
164042850|NCT03050307|592517630|FG001|Overall Study|Adverse Event|2|||
164042851|NCT03050307|592517629|FG000|Overall Study|Significant Protocol Deviation|0|||
164042852|NCT03050307|592517630|FG001|Overall Study|Significant Protocol Deviation|1|||
164042853|NCT03050307|592517629|FG000|Overall Study|Lost to Follow-up|0|||
164042854|NCT03050307|592517630|FG001|Overall Study|Lost to Follow-up|1|||
164148071|NCT00247676|592904819|FG000|Overall Study|Adverse Event|11|||
163841659|NCT01108510|591790365|FG001|Overall Study|Adverse Event|19|||
163841660|NCT01108510|591790364|FG000|Overall Study|Lost to Follow-up|20|||
163841661|NCT01108510|591790365|FG001|Overall Study|Lost to Follow-up|17|||
163841662|NCT01108510|591790364|FG000|Overall Study|Withdrew Consent|21|||
163841663|NCT01108510|591790365|FG001|Overall Study|Withdrew Consent|15|||
163841664|NCT01108510|591790364|FG000|Overall Study|Investigator's Discretion|12|||
163841665|NCT01108510|591790365|FG001|Overall Study|Investigator's Discretion|10|||
163841666|NCT01108510|591790364|FG000|Overall Study|Participant Noncompliance|5|||
163841667|NCT01108510|591790365|FG001|Overall Study|Participant Noncompliance|7|||
163841668|NCT01108510|591790364|FG000|Overall Study|Lack of Efficacy|3|||
163841669|NCT01108510|591790365|FG001|Overall Study|Lack of Efficacy|0|||
163841670|NCT01108510|591790364|FG000|Overall Study|Pregnancy|0|||
163841671|NCT01108510|591790365|FG001|Overall Study|Pregnancy|3|||
163841672|NCT01108510|591790364|FG000|Overall Study|Death|1|||
163841673|NCT01108510|591790365|FG001|Overall Study|Death|1|||
163841674|NCT00582491|591790366|FG000|Overall Study|Withdrawal by Subject|1|||
163841675|NCT00582491|591790367|FG001|Overall Study|Withdrawal by Subject|0|||
163841676|NCT00779584|591790370|FG000|Overall Study|Protocol Violation|0|||
163841677|NCT00779584|591790371|FG001|Overall Study|Protocol Violation|0|||
163841678|NCT00779584|591790372|FG002|Overall Study|Protocol Violation|0|||
163841679|NCT00779584|591790373|FG003|Overall Study|Protocol Violation|0|||
163841680|NCT00779584|591790374|FG004|Overall Study|Protocol Violation|0|||
163841681|NCT00779584|591790375|FG005|Overall Study|Protocol Violation|1|||
163841682|NCT00779584|591790376|FG006|Overall Study|Protocol Violation|0|||
163841683|NCT00779584|591790377|FG007|Overall Study|Protocol Violation|0|||
163841684|NCT00779584|591790378|FG008|Overall Study|Protocol Violation|0|||
163841685|NCT00779584|591790370|FG000|Overall Study|Withdrawal by Subject|1|||
163841686|NCT00779584|591790371|FG001|Overall Study|Withdrawal by Subject|1|||
163841687|NCT00779584|591790372|FG002|Overall Study|Withdrawal by Subject|2|||
163841688|NCT00779584|591790373|FG003|Overall Study|Withdrawal by Subject|0|||
163841689|NCT00779584|591790374|FG004|Overall Study|Withdrawal by Subject|0|||
163841690|NCT00779584|591790375|FG005|Overall Study|Withdrawal by Subject|2|||
163841691|NCT00779584|591790376|FG006|Overall Study|Withdrawal by Subject|1|||
163841692|NCT00779584|591790377|FG007|Overall Study|Withdrawal by Subject|0|||
163841693|NCT00779584|591790378|FG008|Overall Study|Withdrawal by Subject|0|||
163841694|NCT00779584|591790370|FG000|Overall Study|Lost to Follow-up|0|||
163841695|NCT00779584|591790371|FG001|Overall Study|Lost to Follow-up|0|||
163841696|NCT00779584|591790372|FG002|Overall Study|Lost to Follow-up|0|||
163841697|NCT00779584|591790373|FG003|Overall Study|Lost to Follow-up|0|||
163841698|NCT00779584|591790374|FG004|Overall Study|Lost to Follow-up|1|||
163841699|NCT00779584|591790375|FG005|Overall Study|Lost to Follow-up|0|||
163841700|NCT00779584|591790376|FG006|Overall Study|Lost to Follow-up|0|||
163841701|NCT00779584|591790377|FG007|Overall Study|Lost to Follow-up|0|||
163841702|NCT00779584|591790378|FG008|Overall Study|Lost to Follow-up|0|||
163841703|NCT00779584|591790370|FG000|Overall Study|Progression of Disease|0|||
163841704|NCT00779584|591790371|FG001|Overall Study|Progression of Disease|1|||
163841705|NCT00779584|591790372|FG002|Overall Study|Progression of Disease|2|||
163841706|NCT00779584|591790373|FG003|Overall Study|Progression of Disease|6|||
163841707|NCT00779584|591790374|FG004|Overall Study|Progression of Disease|5|||
163841708|NCT00779584|591790375|FG005|Overall Study|Progression of Disease|1|||
163841709|NCT00779584|591790376|FG006|Overall Study|Progression of Disease|4|||
163841710|NCT00779584|591790377|FG007|Overall Study|Progression of Disease|2|||
163841711|NCT00779584|591790378|FG008|Overall Study|Progression of Disease|1|||
163841712|NCT00779584|591790370|FG000|Overall Study|Adverse Event|1|||
163841713|NCT00779584|591790371|FG001|Overall Study|Adverse Event|0|||
163841714|NCT00779584|591790372|FG002|Overall Study|Adverse Event|2|||
163841715|NCT00779584|591790373|FG003|Overall Study|Adverse Event|0|||
163841716|NCT00779584|591790374|FG004|Overall Study|Adverse Event|0|||
163841717|NCT00779584|591790375|FG005|Overall Study|Adverse Event|0|||
163841718|NCT00779584|591790376|FG006|Overall Study|Adverse Event|2|||
163841719|NCT00779584|591790377|FG007|Overall Study|Adverse Event|1|||
163841720|NCT00779584|591790378|FG008|Overall Study|Adverse Event|1|||
163841721|NCT00779584|591790370|FG000|Overall Study|Symptomatic Deterioration|1|||
163841722|NCT00779584|591790371|FG001|Overall Study|Symptomatic Deterioration|1|||
163841723|NCT00779584|591790372|FG002|Overall Study|Symptomatic Deterioration|1|||
163841724|NCT00779584|591790373|FG003|Overall Study|Symptomatic Deterioration|0|||
163841725|NCT00779584|591790374|FG004|Overall Study|Symptomatic Deterioration|0|||
163841726|NCT00779584|591790375|FG005|Overall Study|Symptomatic Deterioration|1|||
163841727|NCT00779584|591790376|FG006|Overall Study|Symptomatic Deterioration|1|||
163841728|NCT00779584|591790377|FG007|Overall Study|Symptomatic Deterioration|0|||
163841729|NCT00779584|591790378|FG008|Overall Study|Symptomatic Deterioration|0|||
163841730|NCT00779584|591790370|FG000|Overall Study|Ongoing in Study|0|||
164042855|NCT03050307|592517629|FG000|Overall Study|Voluntary Withdrawal|3|||
164042856|NCT03050307|592517630|FG001|Overall Study|Voluntary Withdrawal|4|||
164042857|NCT03050307|592517629|FG000|Overall Study|Reason not Specified|1|||
164042858|NCT03050307|592517630|FG001|Overall Study|Reason not Specified|1|||
164042859|NCT03950440|592517631|FG000|Overall Study|Death|8|||
164042860|NCT03950440|592517632|FG001|Overall Study|Death|2|||
164042861|NCT03950440|592517633|FG002|Overall Study|Death|1|||
164042862|NCT02043509|592517634|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
164042863|NCT02043509|592517635|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
164042864|NCT02043509|592517634|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
164042865|NCT02043509|592517635|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
164042866|NCT02043509|592517634|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
164042867|NCT02043509|592517635|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
164042868|NCT02043509|592517634|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
164042869|NCT02043509|592517635|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
164042870|NCT01685060|592517642|FG000|Overall Study|Rollover patients|16|||
164042871|NCT01685060|592517642|FG000|Overall Study|Adverse Event|12|||
164042872|NCT01685060|592517642|FG000|Overall Study|Progressive disease|69|||
164042873|NCT01685060|592517642|FG000|Overall Study|Physician Decision|14|||
164042874|NCT01685060|592517642|FG000|Overall Study|Subject/guardian decision|20|||
164042875|NCT01685060|592517642|FG000|Overall Study|Lost to Follow-up|1|||
164042876|NCT01685060|592517642|FG000|Overall Study|Death|8|||
164042877|NCT02443155|592517645|FG000|Overall Study|Adverse Event|3|||
164042878|NCT02443155|592517646|FG001|Overall Study|Adverse Event|4|||
164042879|NCT02443155|592517647|FG002|Overall Study|Adverse Event|1|||
164042880|NCT02443155|592517648|FG003|Overall Study|Adverse Event|2|||
164042881|NCT02443155|592517645|FG000|Overall Study|Unclassified|0|||
164042882|NCT02443155|592517646|FG001|Overall Study|Unclassified|0|||
164042883|NCT02443155|592517647|FG002|Overall Study|Unclassified|2|||
164042884|NCT02443155|592517648|FG003|Overall Study|Unclassified|1|||
164042885|NCT02443155|592517645|FG000|Overall Study|Withdrawal by Subject|4|||
164042886|NCT02443155|592517646|FG001|Overall Study|Withdrawal by Subject|7|||
164042887|NCT02443155|592517647|FG002|Overall Study|Withdrawal by Subject|3|||
164042888|NCT02443155|592517648|FG003|Overall Study|Withdrawal by Subject|9|||
164042889|NCT02443155|592517645|FG000|Overall Study|Pregnancy|3|||
164042890|NCT02443155|592517646|FG001|Overall Study|Pregnancy|1|||
164042891|NCT02443155|592517647|FG002|Overall Study|Pregnancy|1|||
164042892|NCT02443155|592517648|FG003|Overall Study|Pregnancy|2|||
164042893|NCT02443155|592517645|FG000|Overall Study|Lost to Follow-up|1|||
164042894|NCT02443155|592517646|FG001|Overall Study|Lost to Follow-up|2|||
164042895|NCT02443155|592517647|FG002|Overall Study|Lost to Follow-up|0|||
164042896|NCT02443155|592517648|FG003|Overall Study|Lost to Follow-up|1|||
164042897|NCT02443155|592517645|FG000|Overall Study|Protocol Violation|1|||
164042898|NCT02443155|592517646|FG001|Overall Study|Protocol Violation|0|||
164042899|NCT02443155|592517647|FG002|Overall Study|Protocol Violation|1|||
164042900|NCT02443155|592517648|FG003|Overall Study|Protocol Violation|1|||
164042901|NCT02443155|592517645|FG000|Overall Study|Death|0|||
164042902|NCT02443155|592517646|FG001|Overall Study|Death|0|||
164042903|NCT02443155|592517647|FG002|Overall Study|Death|1|||
164042904|NCT02443155|592517648|FG003|Overall Study|Death|0|||
164042905|NCT00464620|592517649|FG000|Overall Study|Physician Decision|1|||
164042906|NCT00464620|592517650|FG001|Overall Study|Physician Decision|0|||
164042907|NCT00464620|592517651|FG002|Overall Study|Physician Decision|0|||
164042908|NCT00464620|592517649|FG000|Overall Study|Withdrawal by Subject|1|||
164042909|NCT00464620|592517650|FG001|Overall Study|Withdrawal by Subject|0|||
164042910|NCT00464620|592517651|FG002|Overall Study|Withdrawal by Subject|3|||
164042911|NCT00464620|592517649|FG000|Overall Study|Ineligible sarcoma subtype|0|||
164042912|NCT00464620|592517650|FG001|Overall Study|Ineligible sarcoma subtype|2|||
164042913|NCT00464620|592517651|FG002|Overall Study|Ineligible sarcoma subtype|2|||
164042914|NCT00464620|592517649|FG000|Overall Study|Use of prohibited concomitant medication|0|||
164042915|NCT00464620|592517650|FG001|Overall Study|Use of prohibited concomitant medication|0|||
164042916|NCT00464620|592517651|FG002|Overall Study|Use of prohibited concomitant medication|2|||
164042917|NCT06048809|592517662|FG000|Overall Study|Adverse Event|2|||
164042918|NCT06048809|592517663|FG001|Overall Study|Adverse Event|0|||
164042919|NCT06048809|592517662|FG000|Overall Study|Withdrawal by Subject|1|||
164042920|NCT06048809|592517663|FG001|Overall Study|Withdrawal by Subject|1|||
164042921|NCT02158728|592517664|FG000|Overall Study|no procedure according to CIP done|3|||
164042922|NCT02158728|592517664|FG000|Overall Study|no qualified dataset|24|||
164042923|NCT01536418|592517680|FG000|Overall Study|Protocol Violation|2|||
164042924|NCT01536418|592517681|FG001|Overall Study|Protocol Violation|3|||
164042925|NCT01536418|592517680|FG000|Overall Study|Physician Decision|1|||
164042926|NCT01536418|592517681|FG001|Overall Study|Physician Decision|3|||
164042927|NCT01536418|592517680|FG000|Overall Study|Study closed/terminated|41|||
164042928|NCT01536418|592517681|FG001|Overall Study|Study closed/terminated|37|||
164042929|NCT01536418|592517680|FG000|Overall Study|Lack of Efficacy|10|||
164042930|NCT01536418|592517681|FG001|Overall Study|Lack of Efficacy|16|||
164042931|NCT01536418|592517680|FG000|Overall Study|Adverse Event|9|||
164042932|NCT01536418|592517681|FG001|Overall Study|Adverse Event|4|||
163943463|NCT03203473|592162844|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
163943464|NCT03203473|592162845|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
163943465|NCT03203473|592162846|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
163943466|NCT03203473|592162844|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
163943467|NCT03203473|592162845|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
163943468|NCT03203473|592162846|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
163943469|NCT03203473|592162844|FG000|Arm Allocation Phase|started salvage therapy|0|||
163943470|NCT03203473|592162845|FG001|Arm Allocation Phase|started salvage therapy|5|||
163943471|NCT03203473|592162846|FG002|Arm Allocation Phase|started salvage therapy|0|||
163943472|NCT03203473|592162844|FG000|Arm Allocation Phase|Disease progression|0|||
163943473|NCT03203473|592162845|FG001|Arm Allocation Phase|Disease progression|0|||
163943474|NCT03203473|592162846|FG002|Arm Allocation Phase|Disease progression|37|||
163943475|NCT03203473|592162844|FG000|Arm Allocation Phase|Adverse Event|0|||
163943476|NCT03203473|592162845|FG001|Arm Allocation Phase|Adverse Event|0|||
163943477|NCT03203473|592162846|FG002|Arm Allocation Phase|Adverse Event|11|||
163943478|NCT03203473|592162844|FG000|Arm Allocation Phase|Physician Decision|0|||
163943479|NCT03203473|592162845|FG001|Arm Allocation Phase|Physician Decision|0|||
163943480|NCT03203473|592162846|FG002|Arm Allocation Phase|Physician Decision|3|||
163943481|NCT03203473|592162844|FG000|Arm Allocation Phase|Death|0|||
163943482|NCT03203473|592162845|FG001|Arm Allocation Phase|Death|0|||
163943483|NCT03203473|592162846|FG002|Arm Allocation Phase|Death|1|||
163943484|NCT03203473|592162844|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
163943485|NCT03203473|592162845|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
163943486|NCT03203473|592162846|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
163943487|NCT03203473|592162844|FG000|Arm Allocation Phase|Intercurrent illness|0|||
163943488|NCT03203473|592162845|FG001|Arm Allocation Phase|Intercurrent illness|0|||
163943489|NCT03203473|592162846|FG002|Arm Allocation Phase|Intercurrent illness|1|||
163943490|NCT03203473|592162844|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
163943491|NCT03203473|592162845|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
163943492|NCT03203473|592162846|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
163943493|NCT01732822|592162849|FG000|Overall Study|Withdrawal by Subject|123|||
163943494|NCT01732822|592162850|FG001|Overall Study|Withdrawal by Subject|113|||
163943495|NCT02314780|592162851|FG000|Overall Study|organizational reasons|0|||
163943496|NCT02314780|592162852|FG001|Overall Study|organizational reasons|2|||
163943497|NCT02314780|592162853|FG002|Overall Study|organizational reasons|0|||
163943498|NCT02314780|592162851|FG000|Overall Study|Adverse Event|0|||
163943499|NCT02314780|592162852|FG001|Overall Study|Adverse Event|1|||
163943500|NCT02314780|592162853|FG002|Overall Study|Adverse Event|0|||
163943501|NCT01901432|592162854|FG000|Overall Study|Adverse Event|0|||
163943502|NCT01901432|592162855|FG001|Overall Study|Adverse Event|1|||
163943503|NCT01901432|592162856|FG002|Overall Study|Adverse Event|1|||
163943504|NCT01901432|592162857|FG003|Overall Study|Adverse Event|0|||
163943505|NCT01901432|592162858|FG004|Overall Study|Adverse Event|1|||
163943506|NCT01901432|592162854|FG000|Overall Study|Withdrawal by Subject|0|||
163943507|NCT01901432|592162855|FG001|Overall Study|Withdrawal by Subject|0|||
163943508|NCT01901432|592162856|FG002|Overall Study|Withdrawal by Subject|1|||
163943509|NCT01901432|592162857|FG003|Overall Study|Withdrawal by Subject|0|||
164042933|NCT01536418|592517680|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
164042934|NCT01536418|592517681|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
164042935|NCT01536418|592517680|FG000|Overall Study|Withdrawal by Subject|5|||
164042936|NCT01536418|592517681|FG001|Overall Study|Withdrawal by Subject|3|||
164042937|NCT02658149|592517683|FG000|Overall Study|Physician Decision|1|||
164042938|NCT02658149|592517684|FG001|Overall Study|Physician Decision|0|||
164042939|NCT00711412|592517687|FG000|Induction Treatment|Death|2|||
164042940|NCT00711412|592517687|FG000|Induction Treatment|Adverse Event|1|||
164042941|NCT00711412|592517687|FG000|Induction Treatment|Other|1|||
164042942|NCT00711412|592517687|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
164042943|NCT00711412|592517687|FG000|Evaluated for Combination Treatment|Death|1|||
164042944|NCT00711412|592517687|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
164042945|NCT00711412|592517687|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
164042946|NCT00711412|592517687|FG000|Combination Treatment|Progressive Disease|1|||
164042947|NCT00711412|592517687|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
164042948|NCT00711412|592517687|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
164042949|NCT00711412|592517687|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
164042950|NCT00711412|592517687|FG000|Evaluation for Response and Surgery|Death|1|||
164042951|NCT00711412|592517687|FG000|Survival Follow up Until Death|Other|12|||
163943510|NCT01901432|592162858|FG004|Overall Study|Withdrawal by Subject|5|||
163943511|NCT01901432|592162854|FG000|Overall Study|Physician Decision|0|||
164042952|NCT01680991|592517690|FG000|Overall Study|Adverse Event|1|||
164042953|NCT01680991|592517691|FG001|Overall Study|Adverse Event|0|||
164042954|NCT01680991|592517692|FG002|Overall Study|Adverse Event|0|||
163943512|NCT01901432|592162855|FG001|Overall Study|Physician Decision|0|||
163943513|NCT01901432|592162856|FG002|Overall Study|Physician Decision|0|||
163943514|NCT01901432|592162857|FG003|Overall Study|Physician Decision|0|||
164042955|NCT01680991|592517690|FG000|Overall Study|Death|1|||
163943515|NCT01901432|592162858|FG004|Overall Study|Physician Decision|2|||
163943516|NCT01901432|592162854|FG000|Overall Study|Patient decision to stop study drug|0|||
163943517|NCT01901432|592162855|FG001|Overall Study|Patient decision to stop study drug|0|||
163943518|NCT01901432|592162856|FG002|Overall Study|Patient decision to stop study drug|0|||
163943519|NCT01901432|592162857|FG003|Overall Study|Patient decision to stop study drug|0|||
163943520|NCT01901432|592162858|FG004|Overall Study|Patient decision to stop study drug|1|||
163943521|NCT01077271|592162864|FG000|Overall Study|Parental desire|8|||
163943522|NCT01077271|592162864|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
163943523|NCT01077271|592162864|FG000|Overall Study|Noncompliance|2|||
163943524|NCT01077271|592162864|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
163943525|NCT01077271|592162864|FG000|Overall Study|Changed doctors|2|||
163943526|NCT01077271|592162864|FG000|Overall Study|Parents thought too many injections|2|||
163943527|NCT01077271|592162864|FG000|Overall Study|End of RSV season nearly reached|1|||
163943528|NCT01077271|592162864|FG000|Overall Study|Mother unconvinced of the necessity|1|||
163943529|NCT00166712|592162865|FG000|Overall Study|Death|0|||
163943530|NCT00166712|592162866|FG001|Overall Study|Death|1|||
163943531|NCT00166712|592162865|FG000|Overall Study|Adverse Event|1|||
163943532|NCT00166712|592162866|FG001|Overall Study|Adverse Event|0|||
163943533|NCT00166712|592162865|FG000|Overall Study|Withdrawal by Subject|1|||
163943534|NCT00166712|592162866|FG001|Overall Study|Withdrawal by Subject|2|||
163943535|NCT00166712|592162865|FG000|Overall Study|Physician Decision|0|||
163943536|NCT00166712|592162866|FG001|Overall Study|Physician Decision|2|||
163943537|NCT04684394|592162867|FG000|Overall Study|Death|1|||
163943538|NCT04684394|592162868|FG001|Overall Study|Death|2|||
163943539|NCT04684394|592162867|FG000|Overall Study|Lost to Follow-up|1|||
163943540|NCT04684394|592162868|FG001|Overall Study|Lost to Follow-up|0|||
163943541|NCT04684394|592162867|FG000|Overall Study|Withdrawal by Subject|2|||
163943542|NCT04684394|592162868|FG001|Overall Study|Withdrawal by Subject|0|||
163943543|NCT04684394|592162867|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
163943544|NCT04684394|592162868|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
163943545|NCT03986944|592162869|FG000|Overall Study|Adverse Event|1|||
163943546|NCT03986944|592162870|FG001|Overall Study|Adverse Event|2|||
163943547|NCT03986944|592162871|FG002|Overall Study|Adverse Event|3|||
163943548|NCT03986944|592162869|FG000|Overall Study|Protocol Violation|0|||
163943549|NCT03986944|592162870|FG001|Overall Study|Protocol Violation|1|||
163943550|NCT03986944|592162871|FG002|Overall Study|Protocol Violation|1|||
163943551|NCT03986944|592162869|FG000|Overall Study|Withdrawal by Subject|3|||
163943552|NCT03986944|592162870|FG001|Overall Study|Withdrawal by Subject|5|||
163943553|NCT03986944|592162871|FG002|Overall Study|Withdrawal by Subject|5|||
163943554|NCT03986944|592162869|FG000|Overall Study|Study termination|10|||
163943555|NCT03986944|592162870|FG001|Overall Study|Study termination|10|||
163943556|NCT03986944|592162871|FG002|Overall Study|Study termination|10|||
163943557|NCT03986944|592162869|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
163943558|NCT03986944|592162870|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
163943559|NCT03986944|592162871|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
163943560|NCT03986944|592162869|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
163943561|NCT03986944|592162870|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
163943562|NCT03986944|592162871|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
163943563|NCT01531673|592162873|FG000|Overall Study|Non-Compliance|0|||
163943564|NCT01531673|592162874|FG001|Overall Study|Non-Compliance|0|||
163943565|NCT01531673|592162875|FG002|Overall Study|Non-Compliance|0|||
163943566|NCT01531673|592162876|FG003|Overall Study|Non-Compliance|0|||
163943567|NCT01531673|592162877|FG004|Overall Study|Non-Compliance|0|||
163943568|NCT01531673|592162878|FG005|Overall Study|Non-Compliance|1|||
163943569|NCT01531673|592162879|FG006|Overall Study|Non-Compliance|0|||
163943570|NCT01531673|592162880|FG007|Overall Study|Non-Compliance|0|||
163943571|NCT01531673|592162881|FG008|Overall Study|Non-Compliance|0|||
163943572|NCT01531673|592162882|FG009|Overall Study|Non-Compliance|0|||
163943573|NCT01531673|592162883|FG010|Overall Study|Non-Compliance|0|||
163943574|NCT01531673|592162884|FG011|Overall Study|Non-Compliance|0|||
163943575|NCT01531673|592162885|FG012|Overall Study|Non-Compliance|0|||
163943576|NCT01531673|592162873|FG000|Overall Study|Adverse Event|0|||
163943577|NCT01531673|592162874|FG001|Overall Study|Adverse Event|1|||
163943578|NCT01531673|592162875|FG002|Overall Study|Adverse Event|0|||
163943579|NCT01531673|592162876|FG003|Overall Study|Adverse Event|0|||
163943580|NCT01531673|592162877|FG004|Overall Study|Adverse Event|0|||
163943581|NCT01531673|592162878|FG005|Overall Study|Adverse Event|0|||
163943582|NCT01531673|592162879|FG006|Overall Study|Adverse Event|0|||
163943583|NCT01531673|592162880|FG007|Overall Study|Adverse Event|0|||
163943584|NCT01531673|592162881|FG008|Overall Study|Adverse Event|0|||
163943585|NCT01531673|592162882|FG009|Overall Study|Adverse Event|0|||
163943586|NCT01531673|592162883|FG010|Overall Study|Adverse Event|0|||
163943587|NCT01531673|592162884|FG011|Overall Study|Adverse Event|0|||
163943588|NCT01531673|592162885|FG012|Overall Study|Adverse Event|0|||
163943589|NCT01531673|592162873|FG000|Overall Study|Lost to Follow-up|0|||
163943590|NCT01531673|592162874|FG001|Overall Study|Lost to Follow-up|0|||
163943591|NCT01531673|592162875|FG002|Overall Study|Lost to Follow-up|0|||
163943592|NCT01531673|592162876|FG003|Overall Study|Lost to Follow-up|0|||
163943593|NCT01531673|592162877|FG004|Overall Study|Lost to Follow-up|1|||
163943594|NCT01531673|592162878|FG005|Overall Study|Lost to Follow-up|0|||
163943595|NCT01531673|592162879|FG006|Overall Study|Lost to Follow-up|0|||
163943596|NCT01531673|592162880|FG007|Overall Study|Lost to Follow-up|0|||
163943597|NCT01531673|592162881|FG008|Overall Study|Lost to Follow-up|0|||
163943598|NCT01531673|592162882|FG009|Overall Study|Lost to Follow-up|0|||
163943599|NCT01531673|592162883|FG010|Overall Study|Lost to Follow-up|0|||
163943600|NCT01531673|592162884|FG011|Overall Study|Lost to Follow-up|0|||
163943601|NCT01531673|592162885|FG012|Overall Study|Lost to Follow-up|0|||
163943602|NCT01531673|592162873|FG000|Overall Study|Other|0|||
163943603|NCT01531673|592162874|FG001|Overall Study|Other|0|||
163943604|NCT01531673|592162875|FG002|Overall Study|Other|0|||
163943605|NCT01531673|592162876|FG003|Overall Study|Other|1|||
163943606|NCT01531673|592162877|FG004|Overall Study|Other|0|||
163943607|NCT01531673|592162878|FG005|Overall Study|Other|0|||
163943608|NCT01531673|592162879|FG006|Overall Study|Other|0|||
163943609|NCT01531673|592162880|FG007|Overall Study|Other|0|||
163943610|NCT01531673|592162881|FG008|Overall Study|Other|0|||
163943611|NCT01531673|592162882|FG009|Overall Study|Other|1|||
163943612|NCT01531673|592162883|FG010|Overall Study|Other|0|||
163943613|NCT01531673|592162884|FG011|Overall Study|Other|0|||
163943614|NCT01531673|592162885|FG012|Overall Study|Other|0|||
163943615|NCT00568178|592162886|FG000|Double Blind Base Study|Adverse Event|0|||
163943616|NCT00568178|592162887|FG001|Double Blind Base Study|Adverse Event|2|||
163943617|NCT00568178|592162888|FG002|Double Blind Base Study|Adverse Event|1|||
163943618|NCT00568178|592162889|FG003|Double Blind Base Study|Adverse Event|2|||
163841731|NCT00779584|591790371|FG001|Overall Study|Ongoing in Study|0|||
163841732|NCT00779584|591790372|FG002|Overall Study|Ongoing in Study|0|||
163841733|NCT00779584|591790373|FG003|Overall Study|Ongoing in Study|0|||
163841734|NCT00779584|591790374|FG004|Overall Study|Ongoing in Study|1|||
163841735|NCT00779584|591790375|FG005|Overall Study|Ongoing in Study|1|||
163841736|NCT00779584|591790376|FG006|Overall Study|Ongoing in Study|0|||
163841737|NCT00779584|591790377|FG007|Overall Study|Ongoing in Study|0|||
163841738|NCT00779584|591790378|FG008|Overall Study|Ongoing in Study|0|||
163841739|NCT01115491|591790381|FG000|Overall Study|Death|22|||
163841740|NCT01115491|591790381|FG000|Overall Study|Adverse Event|3|||
163841741|NCT01115491|591790381|FG000|Overall Study|Lost to Follow-up|3|||
163841742|NCT01115491|591790381|FG000|Overall Study|Withdrawal by Subject|1|||
163841743|NCT01115491|591790381|FG000|Overall Study|Physician Decision|1|||
163841744|NCT01868074|591790384|FG000|Overall Study|Lost to Follow-up|3|||
163841745|NCT01868074|591790385|FG001|Overall Study|Lost to Follow-up|2|||
163841746|NCT01868074|591790384|FG000|Overall Study|Withdrawal by Subject|4|||
163841747|NCT01868074|591790385|FG001|Overall Study|Withdrawal by Subject|2|||
163841748|NCT03306043|591790386|FG000|Overall Study|Adverse Event|1|||
163841749|NCT03306043|591790386|FG000|Overall Study|Lost to Follow-up|1|||
163841750|NCT03306043|591790386|FG000|Overall Study|Withdrawal by Subject|2|||
163841751|NCT01544491|591790387|FG000|Overall Study|Withdrawal by Subject|3|||
163841752|NCT01544491|591790388|FG001|Overall Study|Withdrawal by Subject|2|||
163841753|NCT01544491|591790387|FG000|Overall Study|Lost to Follow-up|0|||
163841754|NCT01544491|591790388|FG001|Overall Study|Lost to Follow-up|1|||
163841755|NCT01544491|591790387|FG000|Overall Study|administrative problems|2|||
163841756|NCT01544491|591790388|FG001|Overall Study|administrative problems|0|||
163841757|NCT02494206|591790389|FG000|Overall Study|Adverse Event|1|||
163841758|NCT02494206|591790389|FG000|Overall Study|Disease Progression|1|||
163841759|NCT01013792|591790390|FG000|Overall Study|Study suspended|2|||
163841760|NCT01013792|591790391|FG001|Overall Study|Study suspended|1|||
163841761|NCT01013792|591790390|FG000|Overall Study|Adverse Event|0|||
163841762|NCT01013792|591790391|FG001|Overall Study|Adverse Event|3|||
163841763|NCT01013792|591790390|FG000|Overall Study|Lost to Follow-up|0|||
163841764|NCT01013792|591790391|FG001|Overall Study|Lost to Follow-up|1|||
163841765|NCT01234649|591790392|FG000|Overall Study|Withdrawal by Subject|32|||
163841766|NCT01234649|591790393|FG001|Overall Study|Withdrawal by Subject|26|||
163943619|NCT00568178|592162890|FG004|Double Blind Base Study|Adverse Event|0|||
163943620|NCT00568178|592162891|FG005|Double Blind Base Study|Adverse Event|0|||
163943621|NCT00568178|592162886|FG000|Double Blind Base Study|Lost to Follow-up|1|||
163943622|NCT00568178|592162887|FG001|Double Blind Base Study|Lost to Follow-up|0|||
163943623|NCT00568178|592162888|FG002|Double Blind Base Study|Lost to Follow-up|0|||
163943624|NCT00568178|592162889|FG003|Double Blind Base Study|Lost to Follow-up|1|||
163943625|NCT00568178|592162890|FG004|Double Blind Base Study|Lost to Follow-up|0|||
163943626|NCT00568178|592162891|FG005|Double Blind Base Study|Lost to Follow-up|0|||
163841767|NCT01234649|591790392|FG000|Overall Study|Pregnancy|6|||
163841768|NCT01234649|591790393|FG001|Overall Study|Pregnancy|6|||
163841769|NCT01234649|591790392|FG000|Overall Study|intolerant to side effects|4|||
163841770|NCT01234649|591790393|FG001|Overall Study|intolerant to side effects|3|||
163841771|NCT01234649|591790392|FG000|Overall Study|Allergic reaction|1|||
163841772|NCT01234649|591790393|FG001|Overall Study|Allergic reaction|0|||
163943627|NCT00568178|592162886|FG000|Double Blind Base Study|Physician Decision|1|||
164042956|NCT01680991|592517691|FG001|Overall Study|Death|0|||
164042957|NCT01680991|592517692|FG002|Overall Study|Death|1|||
164042958|NCT01680991|592517690|FG000|Overall Study|Protocol Violation|0|||
164042959|NCT01680991|592517691|FG001|Overall Study|Protocol Violation|1|||
164042960|NCT01680991|592517692|FG002|Overall Study|Protocol Violation|0|||
164042961|NCT01680991|592517690|FG000|Overall Study|Withdrawal by Subject|5|||
164042962|NCT01680991|592517691|FG001|Overall Study|Withdrawal by Subject|1|||
164042963|NCT01680991|592517692|FG002|Overall Study|Withdrawal by Subject|0|||
164042964|NCT01680991|592517690|FG000|Overall Study|Progressive disease (PD)|0|||
164042965|NCT01680991|592517691|FG001|Overall Study|Progressive disease (PD)|10|||
164042966|NCT01680991|592517692|FG002|Overall Study|Progressive disease (PD)|0|||
164042967|NCT01680991|592517690|FG000|Overall Study|Physician Decision|0|||
164042968|NCT01680991|592517691|FG001|Overall Study|Physician Decision|7|||
164042969|NCT01680991|592517692|FG002|Overall Study|Physician Decision|2|||
164042970|NCT01680991|592517690|FG000|Overall Study|Bad physical condition|0|||
164042971|NCT01680991|592517691|FG001|Overall Study|Bad physical condition|0|||
164042972|NCT01680991|592517692|FG002|Overall Study|Bad physical condition|1|||
164042973|NCT01680991|592517690|FG000|Overall Study|PD confirmed in other hospital|1|||
164042974|NCT01680991|592517691|FG001|Overall Study|PD confirmed in other hospital|0|||
164042975|NCT01680991|592517692|FG002|Overall Study|PD confirmed in other hospital|0|||
164042976|NCT02498392|592517693|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
164042977|NCT02498392|592517694|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
164042978|NCT02498392|592517693|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
164042979|NCT02498392|592517694|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
164042980|NCT02498392|592517693|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
164042981|NCT02498392|592517694|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
164042982|NCT02498392|592517693|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
164042983|NCT02498392|592517694|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
164042984|NCT02498392|592517693|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
164042985|NCT02498392|592517694|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
164042986|NCT02498392|592517693|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
164042987|NCT02498392|592517694|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
164042988|NCT06073054|592517695|FG000|Overall Study|Withdrawal by Subject|2|||
164042989|NCT02244619|592517696|FG000|Overall Study|Did not receive study intervention|8|||
164042990|NCT02244619|592517697|FG001|Overall Study|Did not receive study intervention|21|||
164042991|NCT00068822|592517699|FG000|First Randomized Intervention|Lost to Follow-up|1|||
164042992|NCT00068822|592517700|FG001|First Randomized Intervention|Lost to Follow-up|2|||
164042993|NCT00424099|592517703|FG000|Overall Study|Adverse Event|0|||
164042994|NCT00424099|592517704|FG001|Overall Study|Adverse Event|1|||
164042995|NCT00424099|592517705|FG002|Overall Study|Adverse Event|1|||
164042996|NCT00424099|592517706|FG003|Overall Study|Adverse Event|0|||
164042997|NCT00424099|592517703|FG000|Overall Study|Death|0|||
164042998|NCT00424099|592517704|FG001|Overall Study|Death|1|||
164042999|NCT00424099|592517705|FG002|Overall Study|Death|0|||
164043000|NCT00424099|592517706|FG003|Overall Study|Death|0|||
164043001|NCT00424099|592517703|FG000|Overall Study|Illness|2|||
164043002|NCT00424099|592517704|FG001|Overall Study|Illness|0|||
164043003|NCT00424099|592517705|FG002|Overall Study|Illness|1|||
164043004|NCT00424099|592517706|FG003|Overall Study|Illness|4|||
164043005|NCT00424099|592517703|FG000|Overall Study|Lost to Follow-up|0|||
164043006|NCT00424099|592517704|FG001|Overall Study|Lost to Follow-up|0|||
164043007|NCT00424099|592517705|FG002|Overall Study|Lost to Follow-up|3|||
164043008|NCT00424099|592517706|FG003|Overall Study|Lost to Follow-up|0|||
164043009|NCT00424099|592517703|FG000|Overall Study|Hospitalized|1|||
164043010|NCT00424099|592517704|FG001|Overall Study|Hospitalized|2|||
164043011|NCT00424099|592517705|FG002|Overall Study|Hospitalized|1|||
164043012|NCT00424099|592517706|FG003|Overall Study|Hospitalized|3|||
164043013|NCT00424099|592517703|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
164043014|NCT00424099|592517704|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
164043015|NCT00424099|592517705|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
164043016|NCT00424099|592517706|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
164043017|NCT00424099|592517703|FG000|Overall Study|Withdrawal by Subject|1|||
164043018|NCT00424099|592517704|FG001|Overall Study|Withdrawal by Subject|9|||
164043019|NCT00424099|592517705|FG002|Overall Study|Withdrawal by Subject|4|||
164043020|NCT00424099|592517706|FG003|Overall Study|Withdrawal by Subject|6|||
164043021|NCT00424099|592517703|FG000|Overall Study|Physician Decision|0|||
164043022|NCT00424099|592517704|FG001|Overall Study|Physician Decision|0|||
164043023|NCT00424099|592517705|FG002|Overall Study|Physician Decision|1|||
164043024|NCT00424099|592517706|FG003|Overall Study|Physician Decision|0|||
164043025|NCT00424099|592517703|FG000|Overall Study|Missing|0|||
164043026|NCT00424099|592517704|FG001|Overall Study|Missing|0|||
164043027|NCT00424099|592517705|FG002|Overall Study|Missing|1|||
164043028|NCT00424099|592517706|FG003|Overall Study|Missing|0|||
164043029|NCT02417064|592517710|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
164043030|NCT02417064|592517711|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
164043031|NCT02417064|592517712|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
164043032|NCT02417064|592517710|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
164043033|NCT02417064|592517711|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
164043034|NCT02417064|592517712|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
164043035|NCT02417064|592517710|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
164043036|NCT02417064|592517711|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
164043037|NCT02417064|592517712|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
164043038|NCT02417064|592517710|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
164043039|NCT02417064|592517711|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
164043040|NCT02417064|592517712|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
164043041|NCT02417064|592517710|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
164043042|NCT02417064|592517711|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
164043043|NCT02417064|592517712|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
164043044|NCT02417064|592517710|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
164043045|NCT02417064|592517711|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
164043046|NCT02417064|592517712|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
164043047|NCT02417064|592517710|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
164043048|NCT02417064|592517711|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
164043049|NCT02417064|592517712|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
164043050|NCT02417064|592517710|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
164043051|NCT02417064|592517711|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
164043052|NCT02417064|592517712|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
164043053|NCT02417064|592517710|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
164043054|NCT02417064|592517711|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
164043055|NCT02417064|592517712|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
164043056|NCT02417064|592517710|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
164043057|NCT02417064|592517711|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
164043058|NCT02417064|592517712|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
164043059|NCT02417064|592517710|FG000|Follow-up Phase (24 Weeks)|Other|2|||
164043060|NCT02417064|592517711|FG001|Follow-up Phase (24 Weeks)|Other|2|||
164043061|NCT02417064|592517712|FG002|Follow-up Phase (24 Weeks)|Other|3|||
164043062|NCT02437162|592517713|FG000|Overall Study|Protocol Violation|0|||
164043063|NCT02437162|592517714|FG001|Overall Study|Protocol Violation|1|||
164043064|NCT02437162|592517715|FG002|Overall Study|Protocol Violation|0|||
164043065|NCT02437162|592517713|FG000|Overall Study|Randomized but not treated|0|||
164043066|NCT02437162|592517714|FG001|Overall Study|Randomized but not treated|0|||
164043067|NCT02437162|592517715|FG002|Overall Study|Randomized but not treated|1|||
164043068|NCT02437162|592517713|FG000|Overall Study|Study discontinued by Sponsor|93|||
164043069|NCT02437162|592517714|FG001|Overall Study|Study discontinued by Sponsor|98|||
164043070|NCT02437162|592517715|FG002|Overall Study|Study discontinued by Sponsor|97|||
164043071|NCT02437162|592517713|FG000|Overall Study|Withdrawal by Subject|13|||
164043072|NCT02437162|592517714|FG001|Overall Study|Withdrawal by Subject|7|||
164043073|NCT02437162|592517715|FG002|Overall Study|Withdrawal by Subject|9|||
163943628|NCT00568178|592162887|FG001|Double Blind Base Study|Physician Decision|1|||
163943629|NCT00568178|592162888|FG002|Double Blind Base Study|Physician Decision|0|||
163943630|NCT00568178|592162889|FG003|Double Blind Base Study|Physician Decision|1|||
163943631|NCT00568178|592162890|FG004|Double Blind Base Study|Physician Decision|0|||
163943632|NCT00568178|592162891|FG005|Double Blind Base Study|Physician Decision|0|||
163943633|NCT00568178|592162886|FG000|Double Blind Base Study|Protocol Violation|3|||
163943634|NCT00568178|592162887|FG001|Double Blind Base Study|Protocol Violation|2|||
163943635|NCT00568178|592162888|FG002|Double Blind Base Study|Protocol Violation|0|||
163943636|NCT00568178|592162889|FG003|Double Blind Base Study|Protocol Violation|0|||
163943637|NCT00568178|592162890|FG004|Double Blind Base Study|Protocol Violation|0|||
163943638|NCT00568178|592162891|FG005|Double Blind Base Study|Protocol Violation|0|||
163943639|NCT00568178|592162886|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
163943640|NCT00568178|592162887|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
163943641|NCT00568178|592162888|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
163943642|NCT00568178|592162889|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
163943643|NCT00568178|592162890|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
163943644|NCT00568178|592162891|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
163943645|NCT00568178|592162886|FG000|Double Blind Base Study|Progressive Disease|0|||
163943646|NCT00568178|592162887|FG001|Double Blind Base Study|Progressive Disease|0|||
163943647|NCT00568178|592162888|FG002|Double Blind Base Study|Progressive Disease|0|||
163943648|NCT00568178|592162889|FG003|Double Blind Base Study|Progressive Disease|1|||
163943649|NCT00568178|592162890|FG004|Double Blind Base Study|Progressive Disease|0|||
163943650|NCT00568178|592162891|FG005|Double Blind Base Study|Progressive Disease|0|||
163943651|NCT00568178|592162886|FG000|Open Label Extension|Adverse Event|0|||
164043074|NCT02437162|592517713|FG000|Overall Study|Adverse Event|0|||
164043075|NCT02437162|592517714|FG001|Overall Study|Adverse Event|1|||
164043076|NCT02437162|592517715|FG002|Overall Study|Adverse Event|0|||
163943652|NCT00568178|592162887|FG001|Open Label Extension|Adverse Event|0|||
164043077|NCT02437162|592517713|FG000|Overall Study|Lost to Follow-up|1|||
164043078|NCT02437162|592517714|FG001|Overall Study|Lost to Follow-up|0|||
164043079|NCT02437162|592517715|FG002|Overall Study|Lost to Follow-up|1|||
164043080|NCT02437162|592517713|FG000|Overall Study|Death|0|||
164043081|NCT02437162|592517714|FG001|Overall Study|Death|1|||
164043082|NCT02437162|592517715|FG002|Overall Study|Death|0|||
163943653|NCT00568178|592162888|FG002|Open Label Extension|Adverse Event|0|||
163943654|NCT00568178|592162889|FG003|Open Label Extension|Adverse Event|0|||
163943655|NCT00568178|592162890|FG004|Open Label Extension|Adverse Event|11|||
163943656|NCT00568178|592162891|FG005|Open Label Extension|Adverse Event|8|||
163943657|NCT00568178|592162886|FG000|Open Label Extension|Protocol Violation|0|||
163943658|NCT00568178|592162887|FG001|Open Label Extension|Protocol Violation|0|||
163943659|NCT00568178|592162888|FG002|Open Label Extension|Protocol Violation|0|||
163943660|NCT00568178|592162889|FG003|Open Label Extension|Protocol Violation|0|||
163943661|NCT00568178|592162890|FG004|Open Label Extension|Protocol Violation|1|||
163943662|NCT00568178|592162891|FG005|Open Label Extension|Protocol Violation|0|||
163943663|NCT00568178|592162886|FG000|Open Label Extension|Lost to Follow-up|0|||
163943664|NCT00568178|592162887|FG001|Open Label Extension|Lost to Follow-up|0|||
163943665|NCT00568178|592162888|FG002|Open Label Extension|Lost to Follow-up|0|||
163943666|NCT00568178|592162889|FG003|Open Label Extension|Lost to Follow-up|0|||
163943667|NCT00568178|592162890|FG004|Open Label Extension|Lost to Follow-up|6|||
163943668|NCT00568178|592162891|FG005|Open Label Extension|Lost to Follow-up|11|||
163943669|NCT00568178|592162886|FG000|Open Label Extension|Physician Decision|0|||
163943670|NCT00568178|592162887|FG001|Open Label Extension|Physician Decision|0|||
163943671|NCT00568178|592162888|FG002|Open Label Extension|Physician Decision|0|||
163943672|NCT00568178|592162889|FG003|Open Label Extension|Physician Decision|0|||
163943673|NCT00568178|592162890|FG004|Open Label Extension|Physician Decision|9|||
163943674|NCT00568178|592162891|FG005|Open Label Extension|Physician Decision|8|||
163943675|NCT00568178|592162886|FG000|Open Label Extension|Pregnancy|0|||
163943676|NCT00568178|592162887|FG001|Open Label Extension|Pregnancy|0|||
163943677|NCT00568178|592162888|FG002|Open Label Extension|Pregnancy|0|||
163943678|NCT00568178|592162889|FG003|Open Label Extension|Pregnancy|0|||
163943679|NCT00568178|592162890|FG004|Open Label Extension|Pregnancy|0|||
163943680|NCT00568178|592162891|FG005|Open Label Extension|Pregnancy|1|||
163943681|NCT00568178|592162886|FG000|Open Label Extension|Progressive Disease|0|||
163943682|NCT00568178|592162887|FG001|Open Label Extension|Progressive Disease|0|||
163943683|NCT00568178|592162888|FG002|Open Label Extension|Progressive Disease|0|||
163943684|NCT00568178|592162889|FG003|Open Label Extension|Progressive Disease|0|||
163943685|NCT00568178|592162890|FG004|Open Label Extension|Progressive Disease|3|||
163943686|NCT00568178|592162891|FG005|Open Label Extension|Progressive Disease|1|||
163943687|NCT00568178|592162886|FG000|Open Label Extension|Termination of Trial|0|||
163943688|NCT00568178|592162887|FG001|Open Label Extension|Termination of Trial|0|||
163943689|NCT00568178|592162888|FG002|Open Label Extension|Termination of Trial|0|||
163943690|NCT00568178|592162889|FG003|Open Label Extension|Termination of Trial|0|||
163943691|NCT00568178|592162890|FG004|Open Label Extension|Termination of Trial|45|||
163943692|NCT00568178|592162891|FG005|Open Label Extension|Termination of Trial|47|||
163943693|NCT00568178|592162886|FG000|Open Label Extension|Withdrawal by Subject|0|||
163943694|NCT00568178|592162887|FG001|Open Label Extension|Withdrawal by Subject|0|||
163943695|NCT00568178|592162888|FG002|Open Label Extension|Withdrawal by Subject|0|||
163943696|NCT00568178|592162889|FG003|Open Label Extension|Withdrawal by Subject|0|||
163943697|NCT00568178|592162890|FG004|Open Label Extension|Withdrawal by Subject|4|||
163943698|NCT00568178|592162891|FG005|Open Label Extension|Withdrawal by Subject|4|||
163943699|NCT01332630|592162892|FG000|Overall Study|Withdrawal by Subject|3|||
163943700|NCT04476251|592162895|FG000|Overall Study|Not treated|1|||
163943701|NCT01008553|592162896|FG000|Period 1 (Titration Period)|Physician Decision|2|||
163943702|NCT01008553|592162897|FG001|Period 1 (Titration Period)|Physician Decision|0|||
163943703|NCT01008553|592162898|FG002|Period 1 (Titration Period)|Physician Decision|0|||
163943704|NCT01008553|592162896|FG000|Period 1 (Titration Period)|Adverse Event|33|||
163943705|NCT01008553|592162897|FG001|Period 1 (Titration Period)|Adverse Event|0|||
163943706|NCT01008553|592162898|FG002|Period 1 (Titration Period)|Adverse Event|0|||
163943707|NCT01008553|592162896|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
163943708|NCT01008553|592162897|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163943709|NCT01008553|592162898|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
163943710|NCT01008553|592162896|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
163943711|NCT01008553|592162897|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
163943712|NCT01008553|592162898|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
164043083|NCT02437162|592517713|FG000|Overall Study|Other|0|||
163943713|NCT01008553|592162896|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
163943714|NCT01008553|592162897|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163943715|NCT01008553|592162898|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
163943716|NCT01008553|592162896|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
163943717|NCT01008553|592162897|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
164043084|NCT02437162|592517714|FG001|Overall Study|Other|0|||
164043085|NCT02437162|592517715|FG002|Overall Study|Other|1|||
164043086|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
164043087|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
164043088|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
164043089|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
164043090|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
164043091|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
164043092|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
164043093|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
164043094|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
164043095|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
164043096|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
164043097|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
164043098|NCT03321526|592517716|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
164043099|NCT03321526|592517717|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
164043100|NCT03321526|592517716|FG000|Follow-up Phase (2 Weeks)|Other|24|||
164043101|NCT03321526|592517717|FG001|Follow-up Phase (2 Weeks)|Other|24|||
164043102|NCT03097133|592517718|FG000|Overall Study|Lost to Follow-up|3|||
164043103|NCT03097133|592517719|FG001|Overall Study|Lost to Follow-up|2|||
164043104|NCT03097133|592517718|FG000|Overall Study|Withdrawal by Subject|2|||
164043105|NCT03097133|592517719|FG001|Overall Study|Withdrawal by Subject|5|||
164043106|NCT03097133|592517718|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
164043107|NCT03097133|592517719|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
164043108|NCT03097133|592517718|FG000|Overall Study|Other|3|||
164043109|NCT03097133|592517719|FG001|Overall Study|Other|2|||
164043110|NCT03097133|592517718|FG000|Overall Study|Adverse Event|1|||
164043111|NCT03097133|592517719|FG001|Overall Study|Adverse Event|0|||
164043112|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
164043113|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
164043114|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
164043115|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
164043116|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
164043117|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
164043118|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
164043119|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
164043120|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
164043121|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
164043122|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
164043123|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
164043124|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
164043125|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
164043126|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
164043127|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
164043128|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
164043129|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
164043130|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
164043131|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
164043132|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
164043133|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
164043134|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
164043135|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
164043136|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
164043137|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
164043138|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
164043139|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
164043140|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
164043141|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
164043142|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
164043143|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
164043144|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
164043145|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
164098993|NCT03496623|592726966|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
164098994|NCT03496623|592726962|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
164098995|NCT03496623|592726963|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
163841773|NCT01234649|591790392|FG000|Overall Study|Lack of Efficacy|0|||
163841774|NCT01234649|591790393|FG001|Overall Study|Lack of Efficacy|3|||
163841775|NCT00680056|591790397|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
163841776|NCT00680056|591790398|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
163841777|NCT00680056|591790397|FG000|Second Intervention|Protocol Violation|3|||
163943718|NCT01008553|592162898|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
163943719|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
163943720|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
163943721|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
163943722|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
163943723|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
163943724|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
163943725|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
163943726|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
163943727|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
163943728|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
163943729|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
163943730|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
163943731|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
163943732|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
163943733|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
163943734|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
163943735|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
163943736|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
163943737|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163943738|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
163943739|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
163943740|NCT01008553|592162896|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
163943741|NCT01008553|592162897|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
163943742|NCT01008553|592162898|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
163943743|NCT00581555|592162899|FG000|Overall Study|Adverse Event|4|||
163943744|NCT00581555|592162900|FG001|Overall Study|Adverse Event|3|||
163943745|NCT00581555|592162899|FG000|Overall Study|Physician Decision|3|||
163943746|NCT00581555|592162900|FG001|Overall Study|Physician Decision|2|||
163943747|NCT00581555|592162899|FG000|Overall Study|Withdrawal by Subject|18|||
163943748|NCT00581555|592162900|FG001|Overall Study|Withdrawal by Subject|9|||
163943749|NCT00581555|592162899|FG000|Overall Study|Lost to Follow-up|2|||
163943750|NCT00581555|592162900|FG001|Overall Study|Lost to Follow-up|2|||
163943751|NCT00581555|592162899|FG000|Overall Study|Other reasons|16|||
163943752|NCT00581555|592162900|FG001|Overall Study|Other reasons|4|||
163943753|NCT05816330|592162906|FG000|Overall Study|Withdrawal by Subject|4|||
163943754|NCT05816330|592162907|FG001|Overall Study|Withdrawal by Subject|1|||
163943755|NCT00201643|592162908|FG000|Overall Study|Withdrawal by Subject|5|||
163943756|NCT00201643|592162909|FG001|Overall Study|Withdrawal by Subject|4|||
163943757|NCT02787044|592162910|FG000|Overall Study|Lost to Follow-up|15|||
163943758|NCT02787044|592162911|FG001|Overall Study|Lost to Follow-up|19|||
163943759|NCT01638429|592162912|FG000|Overall Study|Withdrawal by Subject|1|||
163943760|NCT02040584|592162913|FG000|Overall Study|Adverse Event|13|||
163943761|NCT02040584|592162914|FG001|Overall Study|Adverse Event|6|||
163943762|NCT02040584|592162913|FG000|Overall Study|Protocol Violation|9|||
163943763|NCT02040584|592162914|FG001|Overall Study|Protocol Violation|11|||
163943764|NCT02040584|592162913|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163943765|NCT02040584|592162914|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163943766|NCT02040584|592162913|FG000|Overall Study|Death|6|||
163943767|NCT02040584|592162914|FG001|Overall Study|Death|3|||
163943768|NCT02040584|592162913|FG000|Overall Study|Transplant rejection/retransplant|0|||
163943769|NCT02040584|592162914|FG001|Overall Study|Transplant rejection/retransplant|1|||
163943770|NCT02040584|592162913|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
163943771|NCT02040584|592162914|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
163943772|NCT02530970|592162932|FG000|Overall Study|Adverse Event|8|||
163943773|NCT02530970|592162932|FG000|Overall Study|Lost to Follow-up|88|||
163943774|NCT02530970|592162932|FG000|Overall Study|Physician Decision|5|||
163943775|NCT02530970|592162932|FG000|Overall Study|Withdrawal by Subject|14|||
163943776|NCT02530970|592162932|FG000|Overall Study|Death|6|||
163943777|NCT02530970|592162932|FG000|Overall Study|Hospitalization|1|||
163943778|NCT02530970|592162932|FG000|Overall Study|Insurance|2|||
164148072|NCT00247676|592904819|FG000|Overall Study|Lack of Efficacy|15|||
163943779|NCT02530970|592162932|FG000|Overall Study|Explant|2|||
163943780|NCT02530970|592162932|FG000|Overall Study|Change in Provider|5|||
163943781|NCT02530970|592162932|FG000|Overall Study|Relocation|3|||
163943782|NCT00743431|592162934|FG000|Overall Study|Toxicity|6|||
163943783|NCT00743431|592162934|FG000|Overall Study|Tumor progression|56|||
163943784|NCT00743431|592162934|FG000|Overall Study|Withdrawal by Subject|13|||
163943785|NCT00743431|592162934|FG000|Overall Study|Death|9|||
163943786|NCT00743431|592162934|FG000|Overall Study|Reason for discontinuation not specified|29|||
163943787|NCT00743431|592162934|FG000|Overall Study|No documentation available|13|||
163943788|NCT03291288|592162935|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
163943789|NCT03291288|592162936|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
163943790|NCT03291288|592162935|FG000|Drug-drug Interaction Phase|Disease progression|1|||
163943791|NCT03291288|592162936|FG001|Drug-drug Interaction Phase|Disease progression|0|||
163943792|NCT03291288|592162935|FG000|Drug-drug Interaction Phase|Other|3|||
163943793|NCT03291288|592162936|FG001|Drug-drug Interaction Phase|Other|0|||
163943794|NCT03291288|592162935|FG000|Pexidartinib Only|Ongoing|0|||
163943795|NCT03291288|592162936|FG001|Pexidartinib Only|Ongoing|2|||
163943796|NCT04978493|592162937|FG000|Overall Study|No reason available|0|||
163943797|NCT04978493|592162938|FG001|Overall Study|No reason available|1|||
163943798|NCT04978493|592162937|FG000|Overall Study|Adverse Event|1|||
163943799|NCT04978493|592162938|FG001|Overall Study|Adverse Event|0|||
163943800|NCT01896726|592162939|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
163943801|NCT01896726|592162939|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
163943802|NCT01128114|592162940|FG000|Overall Study|Treatment Withdrawn|6|||
163943803|NCT01128114|592162940|FG000|Overall Study|Screening Failed|2|||
163943804|NCT02387970|592162941|FG000|Overall Study|Did not complete 1-year follow up|1|||
163943805|NCT02387970|592162942|FG001|Overall Study|Did not complete 1-year follow up|2|||
163943806|NCT02628028|592162943|FG000|Dosing Period|Withdrawal by Subject|0|||
163943807|NCT02628028|592162944|FG001|Dosing Period|Withdrawal by Subject|0|||
163943808|NCT02628028|592162945|FG002|Dosing Period|Withdrawal by Subject|1|||
163943809|NCT02628028|592162946|FG003|Dosing Period|Withdrawal by Subject|0|||
163943810|NCT02628028|592162947|FG004|Dosing Period|Withdrawal by Subject|2|||
163943811|NCT02628028|592162948|FG005|Dosing Period|Withdrawal by Subject|4|||
163943812|NCT02628028|592162949|FG006|Dosing Period|Withdrawal by Subject|1|||
163943813|NCT02628028|592162950|FG007|Dosing Period|Withdrawal by Subject|1|||
163943814|NCT02628028|592162943|FG000|Dosing Period|Adverse Event|0|||
163943815|NCT02628028|592162944|FG001|Dosing Period|Adverse Event|0|||
163943816|NCT02628028|592162945|FG002|Dosing Period|Adverse Event|0|||
163943817|NCT02628028|592162946|FG003|Dosing Period|Adverse Event|0|||
163943818|NCT02628028|592162947|FG004|Dosing Period|Adverse Event|2|||
163943819|NCT02628028|592162948|FG005|Dosing Period|Adverse Event|1|||
163943820|NCT02628028|592162949|FG006|Dosing Period|Adverse Event|3|||
163943821|NCT02628028|592162950|FG007|Dosing Period|Adverse Event|2|||
163943822|NCT02628028|592162943|FG000|Dosing Period|Death|0|||
163943823|NCT02628028|592162944|FG001|Dosing Period|Death|0|||
163943824|NCT02628028|592162945|FG002|Dosing Period|Death|0|||
163943825|NCT02628028|592162946|FG003|Dosing Period|Death|0|||
163943826|NCT02628028|592162947|FG004|Dosing Period|Death|0|||
163943827|NCT02628028|592162948|FG005|Dosing Period|Death|0|||
163943828|NCT02628028|592162949|FG006|Dosing Period|Death|0|||
163943829|NCT02628028|592162950|FG007|Dosing Period|Death|1|||
163943830|NCT02628028|592162943|FG000|Dosing Period|Lack of Efficacy|0|||
163943831|NCT02628028|592162944|FG001|Dosing Period|Lack of Efficacy|0|||
163943832|NCT02628028|592162945|FG002|Dosing Period|Lack of Efficacy|0|||
163943833|NCT02628028|592162946|FG003|Dosing Period|Lack of Efficacy|0|||
163943834|NCT02628028|592162947|FG004|Dosing Period|Lack of Efficacy|3|||
163943835|NCT02628028|592162948|FG005|Dosing Period|Lack of Efficacy|0|||
163943836|NCT02628028|592162949|FG006|Dosing Period|Lack of Efficacy|1|||
163943837|NCT02628028|592162950|FG007|Dosing Period|Lack of Efficacy|0|||
163943838|NCT02628028|592162943|FG000|Dosing Period|Study Terminated by Sponsor|0|||
163943839|NCT02628028|592162944|FG001|Dosing Period|Study Terminated by Sponsor|0|||
163943840|NCT02628028|592162945|FG002|Dosing Period|Study Terminated by Sponsor|0|||
163943841|NCT02628028|592162946|FG003|Dosing Period|Study Terminated by Sponsor|0|||
163943842|NCT02628028|592162947|FG004|Dosing Period|Study Terminated by Sponsor|7|||
163943843|NCT02628028|592162948|FG005|Dosing Period|Study Terminated by Sponsor|6|||
163943844|NCT02628028|592162949|FG006|Dosing Period|Study Terminated by Sponsor|7|||
163943845|NCT02628028|592162950|FG007|Dosing Period|Study Terminated by Sponsor|7|||
163943846|NCT02628028|592162943|FG000|Dosing Period|Physician Decision|0|||
163943847|NCT02628028|592162944|FG001|Dosing Period|Physician Decision|0|||
163943848|NCT02628028|592162945|FG002|Dosing Period|Physician Decision|0|||
163943849|NCT02628028|592162946|FG003|Dosing Period|Physician Decision|0|||
163943850|NCT02628028|592162947|FG004|Dosing Period|Physician Decision|0|||
163943851|NCT02628028|592162948|FG005|Dosing Period|Physician Decision|1|||
163943852|NCT02628028|592162949|FG006|Dosing Period|Physician Decision|0|||
163943853|NCT02628028|592162950|FG007|Dosing Period|Physician Decision|0|||
163943854|NCT02628028|592162943|FG000|Dosing Period|Site Terminated by Sponsor|0|||
163943855|NCT02628028|592162944|FG001|Dosing Period|Site Terminated by Sponsor|0|||
163943856|NCT02628028|592162945|FG002|Dosing Period|Site Terminated by Sponsor|0|||
163943857|NCT02628028|592162946|FG003|Dosing Period|Site Terminated by Sponsor|0|||
163943858|NCT02628028|592162947|FG004|Dosing Period|Site Terminated by Sponsor|0|||
163943859|NCT02628028|592162948|FG005|Dosing Period|Site Terminated by Sponsor|1|||
163943860|NCT02628028|592162949|FG006|Dosing Period|Site Terminated by Sponsor|1|||
163943861|NCT02628028|592162950|FG007|Dosing Period|Site Terminated by Sponsor|0|||
163943862|NCT02628028|592162943|FG000|Dosing Period|Lost to Follow-up|0|||
163943863|NCT02628028|592162944|FG001|Dosing Period|Lost to Follow-up|0|||
163943864|NCT02628028|592162945|FG002|Dosing Period|Lost to Follow-up|0|||
163943865|NCT02628028|592162946|FG003|Dosing Period|Lost to Follow-up|0|||
163943866|NCT02628028|592162947|FG004|Dosing Period|Lost to Follow-up|0|||
163943867|NCT02628028|592162948|FG005|Dosing Period|Lost to Follow-up|0|||
164043146|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
164043147|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
164043148|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
164043149|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
164043150|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
164043151|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
164043152|NCT03605836|592517720|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
164043153|NCT03605836|592517721|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
164043154|NCT03605836|592517722|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
164043155|NCT03605836|592517723|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
164043156|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
164043157|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
164043158|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
164043159|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
164043160|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
164043161|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
164043162|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
164043163|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
164043164|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
164043165|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
164043166|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
164043167|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
164043168|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
164043169|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
164043170|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
164043171|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
164043172|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
164043173|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
164043174|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
164043175|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
164043176|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
164043177|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
164043178|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
164043179|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
164043180|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
164043181|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
164043182|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
164043183|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
164043184|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
164043185|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
164043186|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
164043187|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
164043188|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
164043189|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
164043190|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
164043191|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
164043192|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
164043193|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
164043194|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
164043195|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
164043196|NCT03605836|592517720|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
164043197|NCT03605836|592517721|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
164043198|NCT03605836|592517722|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
164043199|NCT03605836|592517723|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
164043200|NCT00633360|592517727|FG000|Overall Study|Lost to Follow-up|1|||
164043201|NCT00633360|592517728|FG001|Overall Study|Lost to Follow-up|1|||
164043202|NCT00633360|592517727|FG000|Overall Study|Adverse Event|3|||
164043203|NCT00633360|592517728|FG001|Overall Study|Adverse Event|1|||
164043204|NCT00633360|592517727|FG000|Overall Study|Protocol Violation|0|||
164043205|NCT00633360|592517728|FG001|Overall Study|Protocol Violation|1|||
164043206|NCT00610207|592517729|FG000|Overall Study|Lost to Follow-up|3|||
164043207|NCT02348840|592517733|FG000|Overall Study|Withdrawal by Subject|2|||
164043208|NCT02348840|592517734|FG001|Overall Study|Withdrawal by Subject|1|||
164043209|NCT02348840|592517735|FG002|Overall Study|Withdrawal by Subject|0|||
164098996|NCT03496623|592726964|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
164098997|NCT03496623|592726965|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
164098998|NCT03496623|592726966|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
163943868|NCT02628028|592162949|FG006|Dosing Period|Lost to Follow-up|1|||
163943869|NCT02628028|592162950|FG007|Dosing Period|Lost to Follow-up|0|||
163943870|NCT02628028|592162943|FG000|Dosing Period|Other|0|||
163943871|NCT02628028|592162944|FG001|Dosing Period|Other|0|||
163943872|NCT02628028|592162945|FG002|Dosing Period|Other|0|||
163943873|NCT02628028|592162946|FG003|Dosing Period|Other|0|||
163943874|NCT02628028|592162947|FG004|Dosing Period|Other|2|||
163943875|NCT02628028|592162948|FG005|Dosing Period|Other|1|||
163943876|NCT02628028|592162949|FG006|Dosing Period|Other|2|||
163943877|NCT02628028|592162950|FG007|Dosing Period|Other|4|||
163943878|NCT02628028|592162943|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
163943879|NCT02628028|592162944|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
163943880|NCT02628028|592162945|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
163943881|NCT02628028|592162946|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
163943882|NCT02628028|592162947|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
163943883|NCT02628028|592162948|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
163943884|NCT02628028|592162949|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
163943885|NCT02628028|592162950|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
163943886|NCT02628028|592162943|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163943887|NCT02628028|592162944|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163943888|NCT02628028|592162945|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163943889|NCT02628028|592162946|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163943890|NCT02628028|592162947|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163943891|NCT02628028|592162948|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
163943892|NCT02628028|592162949|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
163943893|NCT02628028|592162950|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
163943894|NCT02628028|592162943|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163943895|NCT02628028|592162944|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163943896|NCT02628028|592162945|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163943897|NCT02628028|592162946|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163943898|NCT02628028|592162947|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
163943899|NCT02628028|592162948|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
163943900|NCT02628028|592162949|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
163943901|NCT02628028|592162950|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
163943902|NCT02628028|592162943|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163943903|NCT02628028|592162944|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163943904|NCT02628028|592162945|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163943905|NCT02628028|592162946|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163943906|NCT02628028|592162947|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
163943907|NCT02628028|592162948|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
163943908|NCT02628028|592162949|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
163943909|NCT02628028|592162950|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
163943910|NCT02628028|592162943|FG000|Long-term Extension (LTE) Period|Other|0|||
163943911|NCT02628028|592162944|FG001|Long-term Extension (LTE) Period|Other|0|||
163943912|NCT02628028|592162945|FG002|Long-term Extension (LTE) Period|Other|0|||
163943913|NCT02628028|592162946|FG003|Long-term Extension (LTE) Period|Other|0|||
163943914|NCT02628028|592162947|FG004|Long-term Extension (LTE) Period|Other|0|||
163943915|NCT02628028|592162948|FG005|Long-term Extension (LTE) Period|Other|3|||
163943916|NCT02628028|592162949|FG006|Long-term Extension (LTE) Period|Other|4|||
163943917|NCT02628028|592162950|FG007|Long-term Extension (LTE) Period|Other|3|||
163943918|NCT00586612|592162951|FG000|Primary Phase|Protocol Violation|1|||
163943919|NCT00586612|592162952|FG001|Primary Phase|Protocol Violation|0|||
163943920|NCT00586612|592162951|FG000|Primary Phase|Lost to Follow-up|0|||
163943921|NCT00586612|592162952|FG001|Primary Phase|Lost to Follow-up|1|||
163943922|NCT00586612|592162951|FG000|Primary Phase|Withdrawal by Subject|0|||
163943923|NCT00586612|592162952|FG001|Primary Phase|Withdrawal by Subject|2|||
163943924|NCT00586612|592162951|FG000|Booster Phase|Lost to Follow-up|3|||
163943925|NCT00586612|592162952|FG001|Booster Phase|Lost to Follow-up|1|||
163943926|NCT01743989|592162953|FG000|Treatment Phase|Unstable MR4.0|0|||
163943927|NCT01743989|592162954|FG001|Treatment Phase|Unstable MR4.0|6|||
163943928|NCT01743989|592162955|FG002|Treatment Phase|Unstable MR4.0|263|||
163943929|NCT01743989|592162953|FG000|Treatment Phase|Adverse Event|0|||
163943930|NCT01743989|592162954|FG001|Treatment Phase|Adverse Event|4|||
163943931|NCT01743989|592162955|FG002|Treatment Phase|Adverse Event|67|||
163943932|NCT01743989|592162953|FG000|Treatment Phase|Withdrawal by Subject|1|||
163943933|NCT01743989|592162954|FG001|Treatment Phase|Withdrawal by Subject|3|||
163943934|NCT01743989|592162955|FG002|Treatment Phase|Withdrawal by Subject|28|||
163943935|NCT01743989|592162953|FG000|Treatment Phase|Death|0|||
163943936|NCT01743989|592162954|FG001|Treatment Phase|Death|1|||
163943937|NCT01743989|592162955|FG002|Treatment Phase|Death|3|||
164148073|NCT00247676|592904819|FG000|Overall Study|Other|3|||
164043210|NCT02348840|592517736|FG003|Overall Study|Withdrawal by Subject|0|||
164043211|NCT01025232|592517737|FG000|Overall Study|Study drug no longer available|3|||
164043212|NCT01025232|592517738|FG001|Overall Study|Study drug no longer available|6|||
164043213|NCT03748420|592517741|FG000|Overall Study|No 12 month medication adherence data available|0|||
164043214|NCT03748420|592517742|FG001|Overall Study|No 12 month medication adherence data available|1|||
164043215|NCT03748420|592517741|FG000|Overall Study|Death|24|||
163943938|NCT01743989|592162953|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
163943939|NCT01743989|592162954|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
163943940|NCT01743989|592162955|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
163943941|NCT01743989|592162953|FG000|Treatment Phase|Protocol deviation|0|||
163943942|NCT01743989|592162954|FG001|Treatment Phase|Protocol deviation|0|||
163943943|NCT01743989|592162955|FG002|Treatment Phase|Protocol deviation|3|||
163943944|NCT01743989|592162953|FG000|Treatment Phase|Pregnancy|0|||
163943945|NCT01743989|592162954|FG001|Treatment Phase|Pregnancy|0|||
163943946|NCT01743989|592162955|FG002|Treatment Phase|Pregnancy|2|||
163943947|NCT01743989|592162953|FG000|Treatment Phase|Lost to Follow-up|0|||
163943948|NCT01743989|592162954|FG001|Treatment Phase|Lost to Follow-up|0|||
163943949|NCT01743989|592162955|FG002|Treatment Phase|Lost to Follow-up|2|||
163943950|NCT01743989|592162953|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
163943951|NCT01743989|592162954|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
163943952|NCT01743989|592162955|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
163943953|NCT01743989|592162953|FG000|Treatment Phase|Administrative problems|0|||
163943954|NCT01743989|592162954|FG001|Treatment Phase|Administrative problems|0|||
163943955|NCT01743989|592162955|FG002|Treatment Phase|Administrative problems|1|||
163943956|NCT01743989|592162953|FG000|Treatment Phase|New cancer (CML) therapy|0|||
163943957|NCT01743989|592162954|FG001|Treatment Phase|New cancer (CML) therapy|1|||
163943958|NCT01743989|592162955|FG002|Treatment Phase|New cancer (CML) therapy|0|||
163943959|NCT01743989|592162953|FG000|Treatment Phase|Physician Decision|0|||
163943960|NCT01743989|592162954|FG001|Treatment Phase|Physician Decision|0|||
163943961|NCT01743989|592162955|FG002|Treatment Phase|Physician Decision|3|||
163943962|NCT01743989|592162953|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
163943963|NCT01743989|592162954|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
163943964|NCT01743989|592162955|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
163943965|NCT01743989|592162953|FG000|Treatment Phase|Not randomized by mistake|0|||
163943966|NCT01743989|592162954|FG001|Treatment Phase|Not randomized by mistake|0|||
163943967|NCT01743989|592162955|FG002|Treatment Phase|Not randomized by mistake|1|||
163943968|NCT01743989|592162953|FG000|Treatment Phase|Included by mistake|0|||
163943969|NCT01743989|592162954|FG001|Treatment Phase|Included by mistake|0|||
163943970|NCT01743989|592162955|FG002|Treatment Phase|Included by mistake|1|||
163943971|NCT01743989|592162953|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
163943972|NCT01743989|592162954|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
163943973|NCT01743989|592162955|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
163943974|NCT01743989|592162953|FG000|TFR Phase|Adverse Event|0|||
163943975|NCT01743989|592162954|FG001|TFR Phase|Adverse Event|1|||
163943976|NCT01743989|592162955|FG002|TFR Phase|Adverse Event|0|||
163943977|NCT01743989|592162953|FG000|TFR Phase|Lost to Follow-up|0|||
163943978|NCT01743989|592162954|FG001|TFR Phase|Lost to Follow-up|2|||
163943979|NCT01743989|592162955|FG002|TFR Phase|Lost to Follow-up|0|||
163943980|NCT01743989|592162953|FG000|TFR Phase|Physician Decision|0|||
163943981|NCT01743989|592162954|FG001|TFR Phase|Physician Decision|1|||
163943982|NCT01743989|592162955|FG002|TFR Phase|Physician Decision|0|||
163943983|NCT01743989|592162953|FG000|TFR Phase|Logistical problems|0|||
163943984|NCT01743989|592162954|FG001|TFR Phase|Logistical problems|2|||
163943985|NCT01743989|592162955|FG002|TFR Phase|Logistical problems|0|||
163943986|NCT01743989|592162953|FG000|TFR Phase|Protocol deviation|0|||
163943987|NCT01743989|592162954|FG001|TFR Phase|Protocol deviation|1|||
163943988|NCT01743989|592162955|FG002|TFR Phase|Protocol deviation|0|||
164043216|NCT03748420|592517742|FG001|Overall Study|Death|28|||
164043217|NCT03748420|592517741|FG000|Overall Study|Lost to Follow-up|231|||
164043218|NCT03748420|592517742|FG001|Overall Study|Lost to Follow-up|230|||
164043219|NCT00373880|592517743|FG000|Overall Study|Physician Decision|3|||
163943989|NCT01743989|592162953|FG000|TFR Phase|Withdrawal by Subject|0|||
163943990|NCT01743989|592162954|FG001|TFR Phase|Withdrawal by Subject|2|||
163943991|NCT01743989|592162955|FG002|TFR Phase|Withdrawal by Subject|0|||
164043220|NCT00373880|592517743|FG000|Overall Study|Arrested|1|||
164043221|NCT00373880|592517743|FG000|Overall Study|Protocol Violation|14|||
164043222|NCT01347073|592517744|FG000|Overall Study|Adverse Event|1|||
164148524|NCT01823835|592904895|FG003|Overall Study|Study Termination|0|||
163943992|NCT01743989|592162953|FG000|Re-treatment Phase|Adverse Event|8|||
163943993|NCT01743989|592162954|FG001|Re-treatment Phase|Adverse Event|4|||
163943994|NCT01743989|592162955|FG002|Re-treatment Phase|Adverse Event|0|||
163943995|NCT01743989|592162953|FG000|Re-treatment Phase|Death|1|||
163943996|NCT01743989|592162954|FG001|Re-treatment Phase|Death|1|||
163943997|NCT01743989|592162955|FG002|Re-treatment Phase|Death|0|||
163943998|NCT01743989|592162953|FG000|Re-treatment Phase|Administrative problems|1|||
163943999|NCT01743989|592162954|FG001|Re-treatment Phase|Administrative problems|1|||
163944000|NCT01743989|592162955|FG002|Re-treatment Phase|Administrative problems|0|||
164043223|NCT01347073|592517744|FG000|Overall Study|Liver Transplant|1|||
164043224|NCT00621244|592517746|FG000|Overall Study|Withdrawal by Subject|7|||
164043225|NCT00621244|592517747|FG001|Overall Study|Withdrawal by Subject|3|||
164043226|NCT00621244|592517748|FG002|Overall Study|Withdrawal by Subject|3|||
164043227|NCT00621244|592517749|FG003|Overall Study|Withdrawal by Subject|3|||
164043228|NCT00621244|592517746|FG000|Overall Study|Disease progression|44|||
164043229|NCT00621244|592517747|FG001|Overall Study|Disease progression|20|||
164043230|NCT00621244|592517748|FG002|Overall Study|Disease progression|20|||
164043231|NCT00621244|592517749|FG003|Overall Study|Disease progression|15|||
164043232|NCT00621244|592517746|FG000|Overall Study|Death|3|||
164043233|NCT00621244|592517747|FG001|Overall Study|Death|3|||
164043234|NCT00621244|592517748|FG002|Overall Study|Death|1|||
164043235|NCT00621244|592517749|FG003|Overall Study|Death|1|||
164043236|NCT00621244|592517746|FG000|Overall Study|Adverse Event|27|||
164043237|NCT00621244|592517747|FG001|Overall Study|Adverse Event|7|||
164043238|NCT00621244|592517748|FG002|Overall Study|Adverse Event|9|||
164043239|NCT00621244|592517749|FG003|Overall Study|Adverse Event|2|||
164043240|NCT00621244|592517746|FG000|Overall Study|Administrative problems|5|||
164043241|NCT00621244|592517747|FG001|Overall Study|Administrative problems|1|||
164043242|NCT00621244|592517748|FG002|Overall Study|Administrative problems|0|||
164098999|NCT03496623|592726962|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
163944001|NCT01743989|592162953|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
163944002|NCT01743989|592162954|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
163944003|NCT01743989|592162955|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
163944004|NCT01743989|592162953|FG000|Re-treatment Phase|Unstable MR|1|||
163944005|NCT01743989|592162954|FG001|Re-treatment Phase|Unstable MR|0|||
163944006|NCT01743989|592162955|FG002|Re-treatment Phase|Unstable MR|0|||
163944007|NCT01743989|592162953|FG000|Re-treatment Phase|Physician Decision|0|||
163944008|NCT01743989|592162954|FG001|Re-treatment Phase|Physician Decision|1|||
163944009|NCT01743989|592162955|FG002|Re-treatment Phase|Physician Decision|0|||
163944010|NCT01743989|592162953|FG000|Re-treatment Phase|Lost to Follow-up|0|||
163944011|NCT01743989|592162954|FG001|Re-treatment Phase|Lost to Follow-up|1|||
163944012|NCT01743989|592162955|FG002|Re-treatment Phase|Lost to Follow-up|0|||
163944013|NCT02235311|592162958|FG000|Overall Study|Lost to Follow-up|0|||
163944014|NCT02235311|592162959|FG001|Overall Study|Lost to Follow-up|1|||
163944015|NCT02235311|592162958|FG000|Overall Study|Protocol Violation|0|||
163944016|NCT02235311|592162959|FG001|Overall Study|Protocol Violation|1|||
163944017|NCT04655027|592162960|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
163944018|NCT04655027|592162961|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
163944019|NCT00658788|592162962|FG000|Overall Study|Adverse Event|11|||
163944020|NCT00658788|592162962|FG000|Overall Study|Withdrawal by Subject|13|||
163944021|NCT00658788|592162962|FG000|Overall Study|Lost to Follow-up|18|||
163944022|NCT00658788|592162962|FG000|Overall Study|Treatment Discontinuation|32|||
163944023|NCT00653523|592162963|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
163944024|NCT00653523|592162963|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
163944025|NCT00653523|592162963|FG000|Overall Study|Adverse Event|7|||
163944026|NCT00653523|592162963|FG000|Overall Study|Withdrawal by Subject|6|||
163944027|NCT00653523|592162963|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
163944028|NCT00653523|592162963|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
163944029|NCT05543707|592162968|FG000|Overall Study|Study drug non-compliance/|5|||
163944030|NCT05543707|592162969|FG001|Overall Study|Study drug non-compliance/|0|||
163944031|NCT05543707|592162968|FG000|Overall Study|Withdrawal by Subject|1|||
163944032|NCT05543707|592162969|FG001|Overall Study|Withdrawal by Subject|1|||
163944033|NCT05543707|592162968|FG000|Overall Study|Adverse Event|1|||
163944034|NCT05543707|592162969|FG001|Overall Study|Adverse Event|0|||
163944035|NCT05543707|592162968|FG000|Overall Study|concurrent illness|0|||
163944036|NCT05543707|592162969|FG001|Overall Study|concurrent illness|1|||
163944037|NCT05543707|592162968|FG000|Overall Study|Pregnancy|1|||
163944038|NCT05543707|592162969|FG001|Overall Study|Pregnancy|1|||
163944039|NCT00186888|592162970|FG000|Overall Study|Toxicity|0|||
163944040|NCT00186888|592162971|FG001|Overall Study|Toxicity|1|||
163944041|NCT00186888|592162972|FG002|Overall Study|Toxicity|0|||
163944042|NCT00186888|592162970|FG000|Overall Study|Relapse or progression of disease|4|||
163944043|NCT00186888|592162971|FG001|Overall Study|Relapse or progression of disease|2|||
163944044|NCT00186888|592162972|FG002|Overall Study|Relapse or progression of disease|0|||
163944045|NCT05511038|592162973|FG000|Overall|Withdrawal by Subject|5|||
163944046|NCT05511038|592162974|FG001|Overall|Withdrawal by Subject|3|||
163944047|NCT05511038|592162973|FG000|Overall|Screen Failure|20|||
163944048|NCT05511038|592162974|FG001|Overall|Screen Failure|1|||
163944049|NCT05511038|592162973|FG000|Overall|Physician Decision|3|||
163944050|NCT05511038|592162974|FG001|Overall|Physician Decision|0|||
163944051|NCT05511038|592162973|FG000|Overall|Lost to Follow-up|3|||
163944052|NCT05511038|592162974|FG001|Overall|Lost to Follow-up|0|||
163944053|NCT05511038|592162973|FG000|Overall|Death|1|||
163944054|NCT05511038|592162974|FG001|Overall|Death|0|||
163944055|NCT05511038|592162973|FG000|Screening|Withdrawal by Subject|1|||
164043243|NCT00621244|592517749|FG003|Overall Study|Administrative problems|2|||
164043244|NCT00312728|592517754|FG000|Overall Study|Progressive disease|53|||
163944056|NCT05511038|592162974|FG001|Screening|Withdrawal by Subject|0|||
163944057|NCT05511038|592162973|FG000|Screening|Lost to Follow Up (1 participant)|1|||
163944058|NCT05511038|592162974|FG001|Screening|Lost to Follow Up (1 participant)|0|||
163944059|NCT05511038|592162973|FG000|Screening|Screen Failure|3|||
163944060|NCT05511038|592162974|FG001|Screening|Screen Failure|0|||
163944061|NCT05511038|592162973|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
163944062|NCT05511038|592162974|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
163944063|NCT05511038|592162973|FG000|Treatment|Withdrawal by Subject|5|||
163944064|NCT05511038|592162974|FG001|Treatment|Withdrawal by Subject|3|||
163944065|NCT05511038|592162973|FG000|Treatment|Physician Decision|4|||
163944066|NCT05511038|592162974|FG001|Treatment|Physician Decision|0|||
163944067|NCT05511038|592162973|FG000|Treatment|Lost to Follow-up|2|||
163944068|NCT05511038|592162974|FG001|Treatment|Lost to Follow-up|0|||
163944069|NCT05511038|592162973|FG000|Treatment|Death|1|||
163944070|NCT05511038|592162974|FG001|Treatment|Death|0|||
163944071|NCT05511038|592162973|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
163944072|NCT05511038|592162974|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
163944073|NCT05511038|592162973|FG000|Treatment|Refuse by subject|1|||
163944074|NCT05511038|592162974|FG001|Treatment|Refuse by subject|0|||
163944075|NCT05511038|592162973|FG000|Treatment|Subject did not go to the site for visit|1|||
163944076|NCT05511038|592162974|FG001|Treatment|Subject did not go to the site for visit|0|||
163944077|NCT02108964|592162975|FG000|Overall Study|Progressive disease|15|||
163944078|NCT02108964|592162976|FG001|Overall Study|Progressive disease|31|||
163944079|NCT02108964|592162977|FG002|Overall Study|Progressive disease|54|||
163944080|NCT02108964|592162978|FG003|Overall Study|Progressive disease|7|||
163944081|NCT02108964|592162979|FG004|Overall Study|Progressive disease|20|||
163944082|NCT02108964|592162980|FG005|Overall Study|Progressive disease|4|||
163944083|NCT02108964|592162981|FG006|Overall Study|Progressive disease|6|||
163944084|NCT02108964|592162982|FG007|Overall Study|Progressive disease|33|||
163944085|NCT02108964|592162975|FG000|Overall Study|Physician Decision|1|||
163944086|NCT02108964|592162976|FG001|Overall Study|Physician Decision|5|||
163944087|NCT02108964|592162977|FG002|Overall Study|Physician Decision|7|||
163944088|NCT02108964|592162978|FG003|Overall Study|Physician Decision|1|||
163944089|NCT02108964|592162979|FG004|Overall Study|Physician Decision|2|||
163944090|NCT02108964|592162980|FG005|Overall Study|Physician Decision|1|||
163944091|NCT02108964|592162981|FG006|Overall Study|Physician Decision|1|||
163944092|NCT02108964|592162982|FG007|Overall Study|Physician Decision|3|||
163944093|NCT02108964|592162975|FG000|Overall Study|Adverse Event|0|||
163944094|NCT02108964|592162976|FG001|Overall Study|Adverse Event|0|||
163944095|NCT02108964|592162977|FG002|Overall Study|Adverse Event|4|||
163944096|NCT02108964|592162978|FG003|Overall Study|Adverse Event|0|||
163944097|NCT02108964|592162979|FG004|Overall Study|Adverse Event|1|||
163944098|NCT02108964|592162980|FG005|Overall Study|Adverse Event|0|||
163944099|NCT02108964|592162981|FG006|Overall Study|Adverse Event|3|||
163944100|NCT02108964|592162982|FG007|Overall Study|Adverse Event|2|||
163944101|NCT02108964|592162975|FG000|Overall Study|Death|1|||
163944102|NCT02108964|592162976|FG001|Overall Study|Death|1|||
163944103|NCT02108964|592162977|FG002|Overall Study|Death|4|||
163944104|NCT02108964|592162978|FG003|Overall Study|Death|0|||
163944105|NCT02108964|592162979|FG004|Overall Study|Death|3|||
163944106|NCT02108964|592162980|FG005|Overall Study|Death|0|||
163944107|NCT02108964|592162981|FG006|Overall Study|Death|0|||
163944108|NCT02108964|592162982|FG007|Overall Study|Death|2|||
163944109|NCT02108964|592162975|FG000|Overall Study|Subject/Guardian decision|0|||
163944110|NCT02108964|592162976|FG001|Overall Study|Subject/Guardian decision|1|||
163944111|NCT02108964|592162977|FG002|Overall Study|Subject/Guardian decision|4|||
163944112|NCT02108964|592162978|FG003|Overall Study|Subject/Guardian decision|0|||
163944113|NCT02108964|592162979|FG004|Overall Study|Subject/Guardian decision|2|||
163944114|NCT02108964|592162980|FG005|Overall Study|Subject/Guardian decision|0|||
163944115|NCT02108964|592162981|FG006|Overall Study|Subject/Guardian decision|1|||
163944116|NCT02108964|592162982|FG007|Overall Study|Subject/Guardian decision|2|||
163944117|NCT02108964|592162975|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944118|NCT02108964|592162976|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944119|NCT02108964|592162977|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944120|NCT02108964|592162978|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944121|NCT02108964|592162979|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944122|NCT02108964|592162980|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944123|NCT02108964|592162981|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
163944124|NCT02108964|592162982|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
163944125|NCT03006848|592162983|FG000|Overall Study|Adverse Event|1|||
163944126|NCT03006848|592162983|FG000|Overall Study|Physician Decision|1|||
163944127|NCT03006848|592162983|FG000|Overall Study|Lack of Efficacy|16|||
163944128|NCT03086655|592162986|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
163841778|NCT00680056|591790398|FG001|Second Intervention|Protocol Violation|1|||
163841779|NCT03688711|591790399|FG000|Overall Study|Withdrawal by Subject|0|||
163841780|NCT03688711|591790400|FG001|Overall Study|Withdrawal by Subject|1|||
163841781|NCT05229653|591790401|FG000|Overall Study|Lost to Follow-up|1|||
163841782|NCT05229653|591790402|FG001|Overall Study|Lost to Follow-up|0|||
163841783|NCT01370005|591790403|FG000|Overall Study|Not treated|1|||
163841784|NCT01370005|591790404|FG001|Overall Study|Not treated|0|||
163841785|NCT01370005|591790405|FG002|Overall Study|Not treated|0|||
163841786|NCT01370005|591790403|FG000|Overall Study|Adverse Event|5|||
163841787|NCT01370005|591790404|FG001|Overall Study|Adverse Event|5|||
163841788|NCT01370005|591790405|FG002|Overall Study|Adverse Event|6|||
163841789|NCT01370005|591790403|FG000|Overall Study|Lack of Efficacy|1|||
163841790|NCT01370005|591790404|FG001|Overall Study|Lack of Efficacy|0|||
163841791|NCT01370005|591790405|FG002|Overall Study|Lack of Efficacy|0|||
163841792|NCT01370005|591790403|FG000|Overall Study|Non compliant with protocol|0|||
163841793|NCT01370005|591790404|FG001|Overall Study|Non compliant with protocol|1|||
163841794|NCT01370005|591790405|FG002|Overall Study|Non compliant with protocol|2|||
163841795|NCT01370005|591790403|FG000|Overall Study|Lost to Follow-up|1|||
163841796|NCT01370005|591790404|FG001|Overall Study|Lost to Follow-up|1|||
163841797|NCT01370005|591790405|FG002|Overall Study|Lost to Follow-up|1|||
163841798|NCT01370005|591790403|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
163841799|NCT01370005|591790404|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
163841800|NCT01370005|591790405|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
163841801|NCT01370005|591790403|FG000|Overall Study|Other reason not defined above|3|||
163841802|NCT01370005|591790404|FG001|Overall Study|Other reason not defined above|0|||
163841803|NCT01370005|591790405|FG002|Overall Study|Other reason not defined above|2|||
163841804|NCT03691948|591790406|FG000|Overall Study|Lost to Follow-up|1|||
163841805|NCT03691948|591790407|FG001|Overall Study|Lost to Follow-up|3|||
163841806|NCT02009696|591790408|FG000|Overall Study|Withdrawal by Subject|2|||
163841807|NCT01018563|591790410|FG000|Overall Study|Termination of the study by Sponsor|2|||
163841808|NCT01018563|591790411|FG001|Overall Study|Termination of the study by Sponsor|1|||
163841809|NCT02344537|591790412|FG000|Overall Study|Protocol Violation|1|||
163841810|NCT02344537|591790413|FG001|Overall Study|Protocol Violation|1|||
163841811|NCT02344537|591790412|FG000|Overall Study|Subject started another treatment after wk 6|1|||
163841812|NCT02344537|591790413|FG001|Overall Study|Subject started another treatment after wk 6|0|||
163841813|NCT02344537|591790412|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
163841814|NCT02344537|591790413|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
163841815|NCT05490329|591790416|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
163841816|NCT05490329|591790417|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
163841817|NCT05490329|591790416|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
163841818|NCT05490329|591790417|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
163841819|NCT05490329|591790416|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
163841820|NCT05490329|591790417|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
163841821|NCT04524598|591790418|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
163841822|NCT04524598|591790419|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
163841823|NCT04524598|591790420|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
163841824|NCT04524598|591790421|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
163841825|NCT04524598|591790422|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
163841826|NCT04524598|591790418|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
163841827|NCT04524598|591790419|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
163841828|NCT04524598|591790420|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841829|NCT04524598|591790421|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841830|NCT04524598|591790422|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841831|NCT04524598|591790418|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
163841832|NCT04524598|591790419|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
163841833|NCT04524598|591790420|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
163841834|NCT04524598|591790421|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
163841835|NCT04524598|591790422|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
163841836|NCT04524598|591790418|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
163841837|NCT04524598|591790419|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
163841838|NCT04524598|591790420|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
163944129|NCT03086655|592162987|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
163944130|NCT03086655|592162986|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
163944131|NCT03086655|592162987|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
163944132|NCT03086655|592162986|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
163944133|NCT03086655|592162987|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
163944134|NCT03086655|592162986|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
163944135|NCT03086655|592162987|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
163944136|NCT03086655|592162986|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
163944137|NCT03086655|592162987|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
164043245|NCT00312728|592517754|FG000|Overall Study|Adverse Event|32|||
163944138|NCT03086655|592162986|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
163944139|NCT03086655|592162987|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
163944140|NCT03086655|592162986|FG000|12 Month Follow-up = Final Assessment|Death|0|||
163944141|NCT03086655|592162987|FG001|12 Month Follow-up = Final Assessment|Death|1|||
163944142|NCT00384397|592162988|FG000|Overall Study|Adverse Event|0|||
163944143|NCT00384397|592162989|FG001|Overall Study|Adverse Event|1|||
163944144|NCT00384397|592162990|FG002|Overall Study|Adverse Event|2|||
163944145|NCT00384397|592162988|FG000|Overall Study|Protocol Violation|7|||
163944146|NCT00384397|592162989|FG001|Overall Study|Protocol Violation|15|||
163944147|NCT00384397|592162990|FG002|Overall Study|Protocol Violation|13|||
163841839|NCT04524598|591790421|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
163841840|NCT04524598|591790422|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
163841841|NCT04524598|591790418|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841842|NCT04524598|591790419|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841843|NCT04524598|591790420|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
163841844|NCT04524598|591790421|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
163841845|NCT04524598|591790422|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841846|NCT04524598|591790418|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
163841847|NCT04524598|591790419|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
163841848|NCT04524598|591790420|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
163841849|NCT04524598|591790421|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
163841850|NCT04524598|591790422|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
163841851|NCT04524598|591790418|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841852|NCT04524598|591790419|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841853|NCT04524598|591790420|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841854|NCT04524598|591790421|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
163841855|NCT04524598|591790422|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
163841856|NCT03936777|591790423|FG000|Overall Study|Adverse Event|3|||
163841857|NCT03936777|591790423|FG000|Overall Study|Death|3|||
163841858|NCT03936777|591790423|FG000|Overall Study|Lack of Efficacy|24|||
163841859|NCT03936777|591790423|FG000|Overall Study|Lost to Follow-up|3|||
163841860|NCT03936777|591790423|FG000|Overall Study|Physician Decision|1|||
163841861|NCT03936777|591790423|FG000|Overall Study|Withdrawal by Subject|11|||
163841862|NCT03936777|591790423|FG000|Overall Study|Subjected Weaned of ZX008|1|||
163841863|NCT03936777|591790423|FG000|Overall Study|Missing|6|||
163841864|NCT02306122|591790426|FG000|Initial Physician Randomization|Physician Decision|0|||
163841865|NCT02306122|591790427|FG001|Initial Physician Randomization|Physician Decision|0|||
163841866|NCT02306122|591790428|FG002|Initial Physician Randomization|Physician Decision|0|||
163841867|NCT02306122|591790429|FG003|Initial Physician Randomization|Physician Decision|0|||
163841868|NCT02306122|591790430|FG004|Initial Physician Randomization|Physician Decision|0|||
163841869|NCT02306122|591790431|FG005|Initial Physician Randomization|Physician Decision|0|||
163841870|NCT02306122|591790432|FG006|Initial Physician Randomization|Physician Decision|0|||
163841871|NCT02306122|591790433|FG007|Initial Physician Randomization|Physician Decision|0|||
163841872|NCT02306122|591790434|FG008|Initial Physician Randomization|Physician Decision|1|||
163841873|NCT02306122|591790435|FG009|Initial Physician Randomization|Physician Decision|0|||
163841874|NCT02306122|591790436|FG010|Initial Physician Randomization|Physician Decision|0|||
163841875|NCT03734991|591790439|FG000|Overall Study|Adverse Event|4|||
163841876|NCT03734991|591790440|FG001|Overall Study|Adverse Event|0|||
163841877|NCT03734991|591790439|FG000|Overall Study|Lost to Follow-up|4|||
163841878|NCT03734991|591790440|FG001|Overall Study|Lost to Follow-up|0|||
163841879|NCT03734991|591790439|FG000|Overall Study|Physician Decision|0|||
163841880|NCT03734991|591790440|FG001|Overall Study|Physician Decision|1|||
163841881|NCT03734991|591790439|FG000|Overall Study|Pregnancy|1|||
163841882|NCT03734991|591790440|FG001|Overall Study|Pregnancy|0|||
163841883|NCT03734991|591790439|FG000|Overall Study|Withdrawal by Subject|6|||
163841884|NCT03734991|591790440|FG001|Overall Study|Withdrawal by Subject|3|||
163841885|NCT03734991|591790439|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
163841886|NCT03734991|591790440|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
163841887|NCT03734991|591790439|FG000|Overall Study|Other|2|||
163841888|NCT03734991|591790440|FG001|Overall Study|Other|2|||
163841889|NCT02638623|591790441|FG000|Overall Study|Surgery timing|5|||
163841890|NCT02638623|591790442|FG001|Overall Study|Surgery timing|6|||
163841891|NCT02638623|591790441|FG000|Overall Study|Not given intervention|2|||
163841892|NCT02638623|591790442|FG001|Overall Study|Not given intervention|0|||
163841893|NCT00180713|591790443|FG000|Overall Study|Withdrawal by Subject|2|||
163841894|NCT00180713|591790444|FG001|Overall Study|Withdrawal by Subject|0|||
163841895|NCT00180713|591790443|FG000|Overall Study|Adverse Event|3|||
163841896|NCT00180713|591790444|FG001|Overall Study|Adverse Event|3|||
163841897|NCT05295732|591790445|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
163841898|NCT05295732|591790446|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
164043246|NCT00312728|592517754|FG000|Overall Study|Withdrawal by Subject|10|||
164043247|NCT00312728|592517754|FG000|Overall Study|Required non-protocol cancer treatment|2|||
164043248|NCT00312728|592517754|FG000|Overall Study|Protocol Violation|2|||
164043249|NCT00312728|592517754|FG000|Overall Study|Other|10|||
164043250|NCT00312728|592517754|FG000|Overall Study|Other|1|||
164043251|NCT01634100|592517755|FG000|Overall Study|Withdrawal by Subject|1|||
164043252|NCT01634100|592517756|FG001|Overall Study|Withdrawal by Subject|0|||
164043253|NCT01634100|592517757|FG002|Overall Study|Withdrawal by Subject|1|||
164043254|NCT01634100|592517758|FG003|Overall Study|Withdrawal by Subject|0|||
164043255|NCT01634100|592517759|FG004|Overall Study|Withdrawal by Subject|0|||
164043256|NCT01634100|592517760|FG005|Overall Study|Withdrawal by Subject|0|||
164043257|NCT00338806|592517761|FG000|Acute Phase|Withdrawal by Subject|0|||
164043258|NCT00338806|592517762|FG001|Acute Phase|Withdrawal by Subject|1|||
164043259|NCT00338806|592517761|FG000|Follow-up|Lost to Follow-up|1|||
164043260|NCT00338806|592517762|FG001|Follow-up|Lost to Follow-up|3|||
164043261|NCT00744991|592517763|FG000|Overall Study|Progressive Disease|11|||
164043262|NCT00744991|592517763|FG000|Overall Study|Withdrawal by Subject|8|||
164043263|NCT00744991|592517763|FG000|Overall Study|Physician Decision|3|||
164043264|NCT00744991|592517763|FG000|Overall Study|Adverse Event|2|||
164043265|NCT00744991|592517763|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
164043266|NCT01662986|592517764|FG000|Overall Study|Adverse Event|5|||
164043267|NCT01662986|592517765|FG001|Overall Study|Adverse Event|4|||
164043268|NCT01662986|592517764|FG000|Overall Study|Protocol Violation|2|||
164043269|NCT01662986|592517765|FG001|Overall Study|Protocol Violation|3|||
164043270|NCT01662986|592517764|FG000|Overall Study|Lost to Follow-up|5|||
164043271|NCT01662986|592517765|FG001|Overall Study|Lost to Follow-up|4|||
164043272|NCT01662986|592517764|FG000|Overall Study|Withdrawal by Subject|2|||
164043273|NCT01662986|592517765|FG001|Overall Study|Withdrawal by Subject|2|||
164043274|NCT01662986|592517764|FG000|Overall Study|Not Treated|1|||
164043275|NCT01662986|592517765|FG001|Overall Study|Not Treated|0|||
164043276|NCT01662986|592517764|FG000|Overall Study|Other than stated above|3|||
164043277|NCT01662986|592517765|FG001|Overall Study|Other than stated above|0|||
164043278|NCT01594411|592517768|FG000|Overall Study|Lost to Follow-up|2|||
164043279|NCT00924729|592517769|FG000|Overall Study|insufficient volume for analysis|1|||
164043280|NCT00924729|592517770|FG001|Overall Study|insufficient volume for analysis|0|||
164043281|NCT00924729|592517769|FG000|Overall Study|Protocol Violation|1|||
164043282|NCT00924729|592517770|FG001|Overall Study|Protocol Violation|0|||
164043283|NCT01929707|592517771|FG000|Intervention Period 1|Lost to Follow-up|0|||
164043284|NCT01929707|592517772|FG001|Intervention Period 1|Lost to Follow-up|0|||
164043285|NCT01929707|592517773|FG002|Intervention Period 1|Lost to Follow-up|0|||
164043286|NCT01929707|592517774|FG003|Intervention Period 1|Lost to Follow-up|1|||
164043287|NCT01929707|592517775|FG004|Intervention Period 1|Lost to Follow-up|0|||
164043288|NCT01929707|592517776|FG005|Intervention Period 1|Lost to Follow-up|0|||
164043289|NCT01929707|592517777|FG006|Intervention Period 1|Lost to Follow-up|0|||
164043290|NCT01929707|592517778|FG007|Intervention Period 1|Lost to Follow-up|0|||
164043291|NCT01929707|592517771|FG000|Intervention Period 1|Withdrawal by Subject|0|||
164043292|NCT01929707|592517772|FG001|Intervention Period 1|Withdrawal by Subject|0|||
164043293|NCT01929707|592517773|FG002|Intervention Period 1|Withdrawal by Subject|0|||
164043294|NCT01929707|592517774|FG003|Intervention Period 1|Withdrawal by Subject|2|||
164043295|NCT01929707|592517775|FG004|Intervention Period 1|Withdrawal by Subject|0|||
164043296|NCT01929707|592517776|FG005|Intervention Period 1|Withdrawal by Subject|0|||
164043297|NCT01929707|592517777|FG006|Intervention Period 1|Withdrawal by Subject|0|||
163944148|NCT00384397|592162988|FG000|Overall Study|Lost to Follow-up|11|||
163944149|NCT00384397|592162989|FG001|Overall Study|Lost to Follow-up|13|||
163944150|NCT00384397|592162990|FG002|Overall Study|Lost to Follow-up|3|||
163944151|NCT00384397|592162988|FG000|Overall Study|Withdrawal by Subject|14|||
163944152|NCT00384397|592162989|FG001|Overall Study|Withdrawal by Subject|17|||
163944153|NCT00384397|592162990|FG002|Overall Study|Withdrawal by Subject|15|||
163944154|NCT04531982|592162991|FG000|Overall Study|Withdrawal by Subject|10|||
163944155|NCT04531982|592162992|FG001|Overall Study|Withdrawal by Subject|11|||
163944156|NCT04531982|592162991|FG000|Overall Study|Adverse Event|6|||
163944157|NCT04531982|592162992|FG001|Overall Study|Adverse Event|14|||
163944158|NCT04531982|592162991|FG000|Overall Study|Protocol Violation|6|||
163944159|NCT04531982|592162992|FG001|Overall Study|Protocol Violation|9|||
164043298|NCT01929707|592517778|FG007|Intervention Period 1|Withdrawal by Subject|0|||
164043299|NCT01929707|592517771|FG000|Intervention Period 2|Withdrawal by Subject|0|||
164043300|NCT01929707|592517772|FG001|Intervention Period 2|Withdrawal by Subject|0|||
164043301|NCT01929707|592517773|FG002|Intervention Period 2|Withdrawal by Subject|0|||
164043302|NCT01929707|592517774|FG003|Intervention Period 2|Withdrawal by Subject|0|||
164043303|NCT01929707|592517775|FG004|Intervention Period 2|Withdrawal by Subject|0|||
164043304|NCT01929707|592517776|FG005|Intervention Period 2|Withdrawal by Subject|2|||
164043305|NCT01929707|592517777|FG006|Intervention Period 2|Withdrawal by Subject|0|||
164043306|NCT01929707|592517778|FG007|Intervention Period 2|Withdrawal by Subject|0|||
164043307|NCT00856986|592517785|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
164043308|NCT00856986|592517786|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
164043309|NCT00856986|592517787|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
164043310|NCT00856986|592517788|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
164043311|NCT00856986|592517789|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
164043312|NCT00856986|592517785|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164043313|NCT00856986|592517786|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164043314|NCT00856986|592517787|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164043315|NCT00856986|592517788|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
164043316|NCT00856986|592517789|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
164043317|NCT00856986|592517785|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164043318|NCT00856986|592517786|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164043319|NCT00856986|592517787|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164043320|NCT00856986|592517788|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
164043321|NCT00856986|592517789|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
164043322|NCT00856986|592517785|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164043323|NCT00856986|592517786|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164043324|NCT00856986|592517787|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164043325|NCT00856986|592517788|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
164043326|NCT00856986|592517789|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
164043327|NCT00856986|592517785|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164043328|NCT00856986|592517786|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164043329|NCT00856986|592517787|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164043330|NCT00856986|592517788|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
164043331|NCT00856986|592517789|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
164043332|NCT00856986|592517785|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
164043333|NCT00856986|592517786|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
164043334|NCT00856986|592517787|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
164043335|NCT00856986|592517788|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
164043336|NCT00856986|592517789|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
164043337|NCT00856986|592517785|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
164043338|NCT00856986|592517786|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
164043339|NCT00856986|592517787|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
164043340|NCT00856986|592517788|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
164043341|NCT00856986|592517789|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
164043342|NCT00856986|592517785|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
164043343|NCT00856986|592517786|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
164043344|NCT00856986|592517787|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
164043345|NCT00856986|592517788|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
164043346|NCT00856986|592517789|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
164043347|NCT00856986|592517785|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
164043348|NCT00856986|592517786|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
164043349|NCT00856986|592517787|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
164043350|NCT00856986|592517788|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
164043351|NCT00856986|592517789|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
164043352|NCT00856986|592517785|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
164043353|NCT00856986|592517786|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
164043354|NCT00856986|592517787|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
164043355|NCT00856986|592517788|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
164043356|NCT00856986|592517789|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
164043357|NCT00856986|592517785|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
164043358|NCT00856986|592517786|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
164043359|NCT00856986|592517787|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
164043360|NCT00856986|592517788|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
164043361|NCT00856986|592517789|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
164043362|NCT00856986|592517785|FG000|Main Period, Weeks 0-26|Unclassified|7|||
164043363|NCT00856986|592517786|FG001|Main Period, Weeks 0-26|Unclassified|6|||
164043364|NCT00856986|592517787|FG002|Main Period, Weeks 0-26|Unclassified|7|||
164043365|NCT00856986|592517788|FG003|Main Period, Weeks 0-26|Unclassified|0|||
164043366|NCT00856986|592517789|FG004|Main Period, Weeks 0-26|Unclassified|0|||
164043367|NCT00856986|592517785|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
164043368|NCT00856986|592517786|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
164043369|NCT00856986|592517787|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
164043370|NCT00856986|592517788|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
164043371|NCT00856986|592517789|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
164043372|NCT00856986|592517785|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
164043373|NCT00856986|592517786|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
164043374|NCT00856986|592517787|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
164043375|NCT00856986|592517788|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
164043376|NCT00856986|592517789|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
164043377|NCT00856986|592517785|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
164043378|NCT00856986|592517786|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
164043379|NCT00856986|592517787|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
164043380|NCT00856986|592517788|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
164043381|NCT00856986|592517789|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
164043382|NCT00856986|592517785|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
164043383|NCT00856986|592517786|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
164043384|NCT00856986|592517787|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
164043385|NCT00856986|592517788|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
164043386|NCT00856986|592517789|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
164043387|NCT00856986|592517785|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
164043388|NCT00856986|592517786|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
164043389|NCT00856986|592517787|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
164043390|NCT00856986|592517788|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
164043391|NCT00856986|592517789|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
164043392|NCT00856986|592517785|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
164043393|NCT00856986|592517786|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
164043394|NCT00856986|592517787|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
164043395|NCT00856986|592517788|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
164043396|NCT00856986|592517789|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
164043397|NCT02384993|592517793|FG000|Overall Study|Adverse Event|0|||
164043398|NCT02384993|592517794|FG001|Overall Study|Adverse Event|1|||
164043399|NCT03209362|592517795|FG000|Overall Study|Adverse Event|0|||
164043400|NCT03209362|592517796|FG001|Overall Study|Adverse Event|1|||
164043401|NCT03209362|592517795|FG000|Overall Study|Lost to Follow-up|0|||
164043402|NCT03209362|592517796|FG001|Overall Study|Lost to Follow-up|1|||
164043403|NCT03209362|592517795|FG000|Overall Study|Withdrawal by Subject|2|||
164043404|NCT03209362|592517796|FG001|Overall Study|Withdrawal by Subject|0|||
164043405|NCT03209362|592517795|FG000|Overall Study|Other|0|||
164043406|NCT03209362|592517796|FG001|Overall Study|Other|1|||
164043407|NCT02358863|592519788|FG000|Overall Study|Physician Decision|3|||
164043408|NCT00098865|592519789|FG000|Overall Study|Progressive Disease|6|||
164043409|NCT00098865|592519789|FG000|Overall Study|Adverse Event|2|||
164043410|NCT00098865|592519789|FG000|Overall Study|Alternative Therapy|1|||
164043411|NCT05426460|592519796|FG000|Overall Study|Protocol Violation|1|||
164043412|NCT05426460|592519797|FG001|Overall Study|Protocol Violation|1|||
164043413|NCT05426460|592519798|FG002|Overall Study|Protocol Violation|1|||
164043414|NCT05426460|592519799|FG003|Overall Study|Protocol Violation|0|||
164043415|NCT00653068|592519800|FG000|Overall Study|Death|9|||
164043416|NCT00653068|592519800|FG000|Overall Study|Lack of Efficacy|34|||
164043417|NCT00653068|592519800|FG000|Overall Study|Physician Decision|4|||
164043418|NCT00653068|592519800|FG000|Overall Study|Withdrawal by Subject|1|||
164043419|NCT00653068|592519800|FG000|Overall Study|Ineligible|2|||
164043420|NCT02204410|592519801|FG000|Overall Study|Lost to Follow-up|5|||
164043421|NCT02204410|592519801|FG000|Overall Study|Physician Decision|2|||
164043422|NCT02204410|592519801|FG000|Overall Study|Protocol Violation|1|||
164043423|NCT02204410|592519801|FG000|Overall Study|Withdrawal by Subject|3|||
163841899|NCT05295732|591790447|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
163841900|NCT05295732|591790448|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
163841901|NCT05295732|591790449|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
163841902|NCT05295732|591790445|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
163841903|NCT05295732|591790446|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
163841904|NCT05295732|591790447|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
163841905|NCT05295732|591790448|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
163841906|NCT05295732|591790449|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
163841907|NCT02322814|591790450|FG000|Overall Study|Death|7|||
163841908|NCT02322814|591790451|FG001|Overall Study|Death|29|||
163841909|NCT02322814|591790452|FG002|Overall Study|Death|32|||
163841910|NCT02322814|591790453|FG003|Overall Study|Death|23|||
163841911|NCT02322814|591790454|FG004|Overall Study|Death|14|||
163841912|NCT02322814|591790450|FG000|Overall Study|Lost to Follow-up|1|||
163841913|NCT02322814|591790451|FG001|Overall Study|Lost to Follow-up|3|||
163841914|NCT02322814|591790452|FG002|Overall Study|Lost to Follow-up|3|||
163841915|NCT02322814|591790453|FG003|Overall Study|Lost to Follow-up|1|||
163841916|NCT02322814|591790454|FG004|Overall Study|Lost to Follow-up|0|||
163841917|NCT02322814|591790450|FG000|Overall Study|Various Reasons|2|||
163841918|NCT02322814|591790451|FG001|Overall Study|Various Reasons|0|||
163841919|NCT02322814|591790452|FG002|Overall Study|Various Reasons|1|||
163841920|NCT02322814|591790453|FG003|Overall Study|Various Reasons|1|||
163841921|NCT02322814|591790454|FG004|Overall Study|Various Reasons|0|||
163841922|NCT02322814|591790450|FG000|Overall Study|Progressive Disease|0|||
163841923|NCT02322814|591790451|FG001|Overall Study|Progressive Disease|0|||
163841924|NCT02322814|591790452|FG002|Overall Study|Progressive Disease|0|||
163841925|NCT02322814|591790453|FG003|Overall Study|Progressive Disease|1|||
163841926|NCT02322814|591790454|FG004|Overall Study|Progressive Disease|1|||
163841927|NCT02322814|591790450|FG000|Overall Study|Protocol Violation|1|||
163841928|NCT02322814|591790451|FG001|Overall Study|Protocol Violation|0|||
163841929|NCT02322814|591790452|FG002|Overall Study|Protocol Violation|0|||
163841930|NCT02322814|591790453|FG003|Overall Study|Protocol Violation|0|||
163841931|NCT02322814|591790454|FG004|Overall Study|Protocol Violation|0|||
163841932|NCT02322814|591790450|FG000|Overall Study|Study Terminated by Sponsor|0|||
163841933|NCT02322814|591790451|FG001|Overall Study|Study Terminated by Sponsor|7|||
163841934|NCT02322814|591790452|FG002|Overall Study|Study Terminated by Sponsor|9|||
163841935|NCT02322814|591790453|FG003|Overall Study|Study Terminated by Sponsor|5|||
163841936|NCT02322814|591790454|FG004|Overall Study|Study Terminated by Sponsor|13|||
163841937|NCT02322814|591790450|FG000|Overall Study|Withdrawal by Subject|5|||
163841938|NCT02322814|591790451|FG001|Overall Study|Withdrawal by Subject|4|||
163841939|NCT02322814|591790452|FG002|Overall Study|Withdrawal by Subject|2|||
163841940|NCT02322814|591790453|FG003|Overall Study|Withdrawal by Subject|1|||
163841941|NCT02322814|591790454|FG004|Overall Study|Withdrawal by Subject|3|||
163841942|NCT04152343|591790455|FG000|Overall Study|Transplanted|5|||
164043424|NCT01405027|592519804|FG000|Overall Study|Withdrawn consent|3|||
164043425|NCT01405027|592519805|FG001|Overall Study|Withdrawn consent|0|||
164043426|NCT01405027|592519804|FG000|Overall Study|Lost to Follow-up|16|||
164043427|NCT01405027|592519805|FG001|Overall Study|Lost to Follow-up|24|||
164043428|NCT01405027|592519804|FG000|Overall Study|Investigator judgement|0|||
164043429|NCT01405027|592519805|FG001|Overall Study|Investigator judgement|2|||
164043430|NCT01405027|592519804|FG000|Overall Study|Death|1|||
164043431|NCT01405027|592519805|FG001|Overall Study|Death|0|||
164043432|NCT01405027|592519804|FG000|Overall Study|Other or Unknown|12|||
164043433|NCT01405027|592519805|FG001|Overall Study|Other or Unknown|25|||
164043434|NCT02234050|592519814|FG000|Overall Study|Lack of Efficacy|38|||
164043435|NCT02234050|592519815|FG001|Overall Study|Lack of Efficacy|22|||
164043436|NCT02234050|592519814|FG000|Overall Study|Adverse Event|13|||
164043437|NCT02234050|592519815|FG001|Overall Study|Adverse Event|1|||
164043438|NCT02234050|592519814|FG000|Overall Study|Withdrawal by Subject|4|||
164043439|NCT02234050|592519815|FG001|Overall Study|Withdrawal by Subject|2|||
164043440|NCT02234050|592519814|FG000|Overall Study|Sponsor's decision|6|||
164043441|NCT02234050|592519815|FG001|Overall Study|Sponsor's decision|0|||
164043442|NCT04097028|592519817|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
164043443|NCT04097028|592519817|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
164043444|NCT04097028|592519817|FG000|Overall Study|Disease Progression prior to Surgery|2|||
164043445|NCT04097028|592519817|FG000|Overall Study|Adverse Event prior to Surgery|1|||
164043446|NCT02473289|592519818|FG000|Overall Study|Adverse Event|2|||
164043447|NCT02473289|592519819|FG001|Overall Study|Adverse Event|3|||
164043448|NCT02473289|592519818|FG000|Overall Study|Lost to Follow-up|1|||
164043449|NCT02473289|592519819|FG001|Overall Study|Lost to Follow-up|1|||
164043450|NCT02473289|592519818|FG000|Overall Study|Protocol Violation|0|||
164043451|NCT02473289|592519819|FG001|Overall Study|Protocol Violation|1|||
164043452|NCT02473289|592519818|FG000|Overall Study|Withdrawal of consent|6|||
164043453|NCT02473289|592519819|FG001|Overall Study|Withdrawal of consent|7|||
164043454|NCT02473289|592519818|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
164043455|NCT02473289|592519819|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
164043456|NCT02473289|592519818|FG000|Overall Study|Other|2|||
164043457|NCT02473289|592519819|FG001|Overall Study|Other|0|||
164043458|NCT03285490|592519820|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
164043459|NCT03285490|592519821|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
164043460|NCT03285490|592519820|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
164043461|NCT03285490|592519821|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
164043462|NCT02728206|592519822|FG000|Overall Study|Death|1|||
164043463|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
164043464|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
164043465|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
164043466|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
164043467|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
164043468|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164043469|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
164043470|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164043471|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164043472|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
164043473|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164043474|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
164043475|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164043476|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164043477|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
164043478|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
164043479|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
164043480|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
164043481|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
164043482|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
164043483|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
164043484|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
164043485|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
163841943|NCT04152343|591790455|FG000|Overall Study|Death|20|||
164043486|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
164043487|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
164043488|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
164043489|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
164043490|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
164043491|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
164043492|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
164043493|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
164043494|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
164043495|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
164043496|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
164043497|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
164043498|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
164043499|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
164043500|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
164043501|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
164043502|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
164043503|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
164043504|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
164043505|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
164043506|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
164043507|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
164043508|NCT03689972|592519824|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
164043509|NCT03689972|592519825|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
164043510|NCT03689972|592519826|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
164043511|NCT03689972|592519827|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
164043512|NCT03689972|592519828|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
164043513|NCT03689972|592519824|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164043514|NCT03689972|592519825|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164043515|NCT03689972|592519826|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
164043516|NCT03689972|592519827|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164043517|NCT03689972|592519828|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
164043518|NCT03689972|592519824|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164043519|NCT03689972|592519825|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164043520|NCT03689972|592519826|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
163944160|NCT04531982|592162991|FG000|Overall Study|Non-compliance with study drug|3|||
163944161|NCT04531982|592162992|FG001|Overall Study|Non-compliance with study drug|2|||
163944162|NCT04531982|592162991|FG000|Overall Study|Use of prohibited medication|2|||
163944163|NCT04531982|592162992|FG001|Overall Study|Use of prohibited medication|0|||
163944164|NCT04531982|592162991|FG000|Overall Study|Lost to Follow-up|0|||
163944165|NCT04531982|592162992|FG001|Overall Study|Lost to Follow-up|1|||
163944166|NCT04531982|592162991|FG000|Overall Study|Geopolitical conflict|2|||
163944167|NCT04531982|592162992|FG001|Overall Study|Geopolitical conflict|0|||
163944168|NCT04531982|592162991|FG000|Overall Study|Lack of Efficacy|3|||
163944169|NCT04531982|592162992|FG001|Overall Study|Lack of Efficacy|1|||
163944170|NCT04998812|592162995|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
163944171|NCT04998812|592162996|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
163944172|NCT04998812|592162995|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
163944173|NCT04998812|592162996|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
163944174|NCT04998812|592162995|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
163944175|NCT04998812|592162996|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
163944176|NCT04998812|592162995|FG000|Vaccination Period|Ongoing in study|23|||
163944177|NCT04998812|592162996|FG001|Vaccination Period|Ongoing in study|23|||
163944178|NCT04303780|592162997|FG000|Overall Study|Death|104|||
163944179|NCT04303780|592162998|FG001|Overall Study|Death|85|||
163944180|NCT04303780|592162997|FG000|Overall Study|Lost to Follow-up|5|||
163944181|NCT04303780|592162998|FG001|Overall Study|Lost to Follow-up|2|||
163944182|NCT04303780|592162997|FG000|Overall Study|Withdrawal by Subject|12|||
163944183|NCT04303780|592162998|FG001|Overall Study|Withdrawal by Subject|39|||
163944184|NCT04303780|592162997|FG000|Overall Study|Ongoing in study|50|||
163944185|NCT04303780|592162998|FG001|Overall Study|Ongoing in study|45|||
163944186|NCT03826030|592162999|FG000|Overall Study|Withdrawal by Subject|2|||
163944187|NCT03826030|592163000|FG001|Overall Study|Withdrawal by Subject|0|||
163944188|NCT03826030|592163001|FG002|Overall Study|Withdrawal by Subject|1|||
164043521|NCT03689972|592519827|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
164043522|NCT03689972|592519828|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
163944189|NCT03826030|592162999|FG000|Overall Study|Lost to Follow-up|1|||
163944190|NCT03826030|592163000|FG001|Overall Study|Lost to Follow-up|1|||
164043523|NCT03689972|592519824|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164043524|NCT03689972|592519825|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164043525|NCT03689972|592519826|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
164043526|NCT03689972|592519827|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164043527|NCT03689972|592519828|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
164043528|NCT03689972|592519824|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
164043529|NCT03689972|592519825|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
164043530|NCT03689972|592519826|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
164043531|NCT03689972|592519827|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
164043532|NCT03689972|592519828|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
164043533|NCT03689972|592519824|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
164043534|NCT03689972|592519825|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
164043535|NCT03689972|592519826|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
164043536|NCT03689972|592519827|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
164043537|NCT03689972|592519828|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
164043538|NCT03689972|592519824|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
164043539|NCT03689972|592519825|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
164043540|NCT03689972|592519826|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
164043541|NCT03689972|592519827|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
164043542|NCT03689972|592519828|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
164043543|NCT03689972|592519824|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164043544|NCT03689972|592519825|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164043545|NCT03689972|592519826|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164043546|NCT03689972|592519827|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
164043547|NCT03689972|592519828|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
164043548|NCT03689972|592519824|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
164043549|NCT03689972|592519825|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
164043550|NCT03689972|592519826|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
164043551|NCT03689972|592519827|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
164043552|NCT03689972|592519828|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
164043553|NCT03689972|592519824|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164043554|NCT03689972|592519825|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164043555|NCT03689972|592519826|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164043556|NCT03689972|592519827|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
164043557|NCT03689972|592519828|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
164043558|NCT01131130|592519829|FG000|Period 1 - Baseline|Pregnancy|1|||
164043559|NCT01131130|592519829|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
164043560|NCT03981744|592519830|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
164043561|NCT03981744|592519831|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
164043562|NCT03981744|592519832|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
164043563|NCT03981744|592519833|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
164043564|NCT03981744|592519830|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
164043565|NCT03981744|592519831|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
164043566|NCT03981744|592519832|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
164043567|NCT03981744|592519833|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
164043568|NCT03981744|592519830|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
164099000|NCT03496623|592726963|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
164099001|NCT03496623|592726964|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164099002|NCT03496623|592726965|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164099003|NCT03496623|592726966|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164099004|NCT02543203|592726967|FG000|Overall Study|Unpalatable Fragrance|2|||
163841944|NCT04152343|591790455|FG000|Overall Study|Lost to Follow-up|3|||
163841945|NCT01965938|591790456|FG000|Overall Study|Withdrawal by Subject|1|||
163841946|NCT01965938|591790457|FG001|Overall Study|Withdrawal by Subject|0|||
163841947|NCT01164228|591790458|FG000|Overall Study|Progression|24|||
163841948|NCT01164228|591790459|FG001|Overall Study|Progression|25|||
163841949|NCT01164228|591790458|FG000|Overall Study|Adverse Event|13|||
163841950|NCT01164228|591790459|FG001|Overall Study|Adverse Event|7|||
163841951|NCT01164228|591790458|FG000|Overall Study|Death|1|||
163841952|NCT01164228|591790459|FG001|Overall Study|Death|1|||
163841953|NCT01164228|591790458|FG000|Overall Study|Withdrawal by Subject|2|||
163841954|NCT01164228|591790459|FG001|Overall Study|Withdrawal by Subject|0|||
163841955|NCT01164228|591790458|FG000|Overall Study|Physician Decision|1|||
163841956|NCT01164228|591790459|FG001|Overall Study|Physician Decision|2|||
163841957|NCT01164228|591790458|FG000|Overall Study|Symptomatic deterioration|1|||
163841958|NCT01164228|591790459|FG001|Overall Study|Symptomatic deterioration|0|||
163841959|NCT01164228|591790458|FG000|Overall Study|Never started treatment|1|||
163841960|NCT01164228|591790459|FG001|Overall Study|Never started treatment|3|||
163944191|NCT03826030|592163001|FG002|Overall Study|Lost to Follow-up|1|||
163944192|NCT03826030|592162999|FG000|Overall Study|Too busy to return for visits|1|||
163944193|NCT03826030|592163000|FG001|Overall Study|Too busy to return for visits|0|||
163944194|NCT03826030|592163001|FG002|Overall Study|Too busy to return for visits|0|||
163944195|NCT00379288|592164848|FG000|Overall Study|Adverse Event|5|||
163944196|NCT00379288|592164849|FG001|Overall Study|Adverse Event|6|||
163944197|NCT00379288|592164850|FG002|Overall Study|Adverse Event|2|||
163944198|NCT00379288|592164851|FG003|Overall Study|Adverse Event|0|||
163944199|NCT00379288|592164848|FG000|Overall Study|Treatment Failure|0|||
163944200|NCT00379288|592164849|FG001|Overall Study|Treatment Failure|1|||
163944201|NCT00379288|592164850|FG002|Overall Study|Treatment Failure|0|||
163944202|NCT00379288|592164851|FG003|Overall Study|Treatment Failure|1|||
163944203|NCT00379288|592164848|FG000|Overall Study|Lost to Follow-up|3|||
163944204|NCT00379288|592164849|FG001|Overall Study|Lost to Follow-up|3|||
163944205|NCT00379288|592164850|FG002|Overall Study|Lost to Follow-up|2|||
163944206|NCT00379288|592164851|FG003|Overall Study|Lost to Follow-up|0|||
163944207|NCT00379288|592164848|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
163944208|NCT00379288|592164849|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
163944209|NCT00379288|592164850|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
163944210|NCT00379288|592164851|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
163944211|NCT00379288|592164848|FG000|Overall Study|Subject withdrew-related to study drug|1|||
163944212|NCT00379288|592164849|FG001|Overall Study|Subject withdrew-related to study drug|0|||
163944213|NCT00379288|592164850|FG002|Overall Study|Subject withdrew-related to study drug|0|||
163944214|NCT00379288|592164851|FG003|Overall Study|Subject withdrew-related to study drug|1|||
163944215|NCT00379288|592164848|FG000|Overall Study|Noncompliance with protocol|8|||
163944216|NCT00379288|592164849|FG001|Overall Study|Noncompliance with protocol|6|||
163944217|NCT00379288|592164850|FG002|Overall Study|Noncompliance with protocol|2|||
163944218|NCT00379288|592164851|FG003|Overall Study|Noncompliance with protocol|1|||
163944219|NCT00379288|592164848|FG000|Overall Study|Did not meet protocol eligibility|0|||
163944220|NCT00379288|592164849|FG001|Overall Study|Did not meet protocol eligibility|1|||
163944221|NCT00379288|592164850|FG002|Overall Study|Did not meet protocol eligibility|0|||
163944222|NCT00379288|592164851|FG003|Overall Study|Did not meet protocol eligibility|2|||
163944223|NCT00379288|592164848|FG000|Overall Study|Administrative|2|||
163944224|NCT00379288|592164849|FG001|Overall Study|Administrative|2|||
163944225|NCT00379288|592164850|FG002|Overall Study|Administrative|0|||
163944226|NCT00379288|592164851|FG003|Overall Study|Administrative|1|||
163944227|NCT00591370|592164852|FG000|Overall Study|Not Treated|2|||
163944228|NCT01183260|592164853|FG000|Overall Study|Intraop screen failure|2|||
163944229|NCT01183260|592164854|FG001|Overall Study|Intraop screen failure|0|||
163944230|NCT01183260|592164853|FG000|Overall Study|Withdrawal by Subject|1|||
163944231|NCT01183260|592164854|FG001|Overall Study|Withdrawal by Subject|1|||
163944232|NCT01183260|592164853|FG000|Overall Study|Revised within 30 days|0|||
163944233|NCT01183260|592164854|FG001|Overall Study|Revised within 30 days|1|||
163944234|NCT01183260|592164853|FG000|Overall Study|Death|1|||
163944235|NCT01183260|592164854|FG001|Overall Study|Death|0|||
163944236|NCT01202903|592164856|FG000|Overall Study|Administrative Probelms|1|||
163944237|NCT01202903|592164857|FG001|Overall Study|Administrative Probelms|4|||
163944238|NCT01202903|592164856|FG000|Overall Study|Protocol Violation|0|||
163944239|NCT01202903|592164857|FG001|Overall Study|Protocol Violation|1|||
163944240|NCT01202903|592164856|FG000|Overall Study|Death|1|||
163944241|NCT01202903|592164857|FG001|Overall Study|Death|0|||
163944242|NCT01202903|592164856|FG000|Overall Study|Lost to Follow-up|1|||
163944243|NCT01202903|592164857|FG001|Overall Study|Lost to Follow-up|1|||
163944244|NCT01202903|592164856|FG000|Overall Study|Lack of Efficacy|1|||
163944245|NCT01202903|592164857|FG001|Overall Study|Lack of Efficacy|3|||
163944246|NCT01202903|592164856|FG000|Overall Study|Adverse Event|3|||
163944247|NCT01202903|592164857|FG001|Overall Study|Adverse Event|3|||
163944248|NCT01202903|592164856|FG000|Overall Study|Withdrawal by Subject|4|||
163944249|NCT01202903|592164857|FG001|Overall Study|Withdrawal by Subject|4|||
163944250|NCT01302080|592164858|FG000|Overall Study|Withdrew Consent|92|||
163944251|NCT01302080|592164859|FG001|Overall Study|Withdrew Consent|39|||
163944252|NCT01302080|592164858|FG000|Overall Study|Patient/Family Moved|28|||
163944253|NCT01302080|592164859|FG001|Overall Study|Patient/Family Moved|3|||
163944254|NCT01302080|592164858|FG000|Overall Study|Lost to Follow-up|192|||
163944255|NCT01302080|592164859|FG001|Overall Study|Lost to Follow-up|93|||
163944256|NCT01302080|592164858|FG000|Overall Study|Death|1|||
163944257|NCT01302080|592164859|FG001|Overall Study|Death|0|||
163944258|NCT01302080|592164858|FG000|Overall Study|Other|52|||
163944259|NCT01302080|592164859|FG001|Overall Study|Other|8|||
163944260|NCT01302080|592164858|FG000|Overall Study|Reason Missing For Discontinuation|1|||
163944261|NCT01302080|592164859|FG001|Overall Study|Reason Missing For Discontinuation|0|||
163944262|NCT00837694|592164860|FG000|Overall Study|Lost to Follow-up|2|||
163944263|NCT00837694|592164861|FG001|Overall Study|Lost to Follow-up|0|||
163944264|NCT00837694|592164862|FG002|Overall Study|Lost to Follow-up|2|||
163944265|NCT00837694|592164863|FG003|Overall Study|Lost to Follow-up|1|||
163944266|NCT00837694|592164864|FG004|Overall Study|Lost to Follow-up|1|||
163944267|NCT00837694|592164865|FG005|Overall Study|Lost to Follow-up|1|||
164043569|NCT03981744|592519831|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
164043570|NCT03981744|592519832|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
164043571|NCT03981744|592519833|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
164043572|NCT02782104|592519834|FG000|Overall Study|Other|215|||
164043573|NCT02782104|592519834|FG000|Overall Study|Induction Day 28 Non Responder|9|||
164043574|NCT02782104|592519834|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164043575|NCT02782104|592519834|FG000|Overall Study|Death|8|||
164043576|NCT02782104|592519834|FG000|Overall Study|Pregnancy|6|||
164043577|NCT02782104|592519834|FG000|Overall Study|Withdrawal by Subject|63|||
164043578|NCT02782104|592519834|FG000|Overall Study|Protocol Violation|7|||
164043579|NCT02782104|592519834|FG000|Overall Study|Lack of Efficacy|61|||
164043580|NCT02782104|592519834|FG000|Overall Study|Lost to Follow-up|23|||
164043581|NCT02782104|592519834|FG000|Overall Study|Adverse Event|74|||
164043582|NCT04338321|592519835|FG000|Overall Study|Adverse Event|4|||
164043583|NCT04338321|592519836|FG001|Overall Study|Adverse Event|10|||
164043584|NCT04338321|592519835|FG000|Overall Study|Death|1|||
164043585|NCT04338321|592519836|FG001|Overall Study|Death|1|||
164043586|NCT04338321|592519835|FG000|Overall Study|Lost to Follow-up|4|||
164043587|NCT04338321|592519836|FG001|Overall Study|Lost to Follow-up|9|||
164043588|NCT04338321|592519835|FG000|Overall Study|Withdrawal by Subject|45|||
164043589|NCT04338321|592519836|FG001|Overall Study|Withdrawal by Subject|69|||
164043590|NCT04338321|592519835|FG000|Overall Study|Physician Decision|5|||
164043591|NCT04338321|592519836|FG001|Overall Study|Physician Decision|9|||
164043592|NCT04338321|592519835|FG000|Overall Study|Other|3|||
164043593|NCT04338321|592519836|FG001|Overall Study|Other|10|||
164043594|NCT02438787|592519837|FG000|Overall Study|Adverse Event|1|||
164043595|NCT02438787|592519838|FG001|Overall Study|Adverse Event|0|||
164043596|NCT02438787|592519839|FG002|Overall Study|Adverse Event|2|||
164043597|NCT02438787|592519837|FG000|Overall Study|Lack of Efficacy|1|||
164043598|NCT02438787|592519838|FG001|Overall Study|Lack of Efficacy|2|||
164043599|NCT02438787|592519839|FG002|Overall Study|Lack of Efficacy|0|||
164043600|NCT02438787|592519837|FG000|Overall Study|Lost to Follow-up|0|||
164043601|NCT02438787|592519838|FG001|Overall Study|Lost to Follow-up|1|||
164043602|NCT02438787|592519839|FG002|Overall Study|Lost to Follow-up|0|||
164043603|NCT02438787|592519837|FG000|Overall Study|Protocol Violation|0|||
164043604|NCT02438787|592519838|FG001|Overall Study|Protocol Violation|0|||
164043605|NCT02438787|592519839|FG002|Overall Study|Protocol Violation|1|||
164043606|NCT02438787|592519837|FG000|Overall Study|Withdrawal by Subject|15|||
164043607|NCT02438787|592519838|FG001|Overall Study|Withdrawal by Subject|7|||
164043608|NCT02438787|592519839|FG002|Overall Study|Withdrawal by Subject|10|||
164043609|NCT02438787|592519837|FG000|Overall Study|Study discontinued by sponsor|64|||
164043610|NCT02438787|592519838|FG001|Overall Study|Study discontinued by sponsor|72|||
164043611|NCT02438787|592519839|FG002|Overall Study|Study discontinued by sponsor|69|||
164043612|NCT02438787|592519837|FG000|Overall Study|Other|0|||
164043613|NCT02438787|592519838|FG001|Overall Study|Other|1|||
164043614|NCT02438787|592519839|FG002|Overall Study|Other|0|||
164043615|NCT02438787|592519837|FG000|Overall Study|Site terminated by sponsor|0|||
164043616|NCT02438787|592519838|FG001|Overall Study|Site terminated by sponsor|0|||
164043617|NCT02438787|592519839|FG002|Overall Study|Site terminated by sponsor|1|||
164043618|NCT03412565|592519840|FG000|Overall Study|Lost to Follow-up|0|||
164043619|NCT03412565|592519841|FG001|Overall Study|Lost to Follow-up|0|||
164043620|NCT03412565|592519842|FG002|Overall Study|Lost to Follow-up|1|||
164043621|NCT03412565|592519843|FG003|Overall Study|Lost to Follow-up|0|||
164043622|NCT03412565|592519840|FG000|Overall Study|Physician Decision|0|||
164043623|NCT03412565|592519841|FG001|Overall Study|Physician Decision|0|||
164043624|NCT03412565|592519842|FG002|Overall Study|Physician Decision|0|||
164043625|NCT03412565|592519843|FG003|Overall Study|Physician Decision|1|||
164043626|NCT03412565|592519840|FG000|Overall Study|Withdrawal by Subject|0|||
164043627|NCT03412565|592519841|FG001|Overall Study|Withdrawal by Subject|4|||
163841961|NCT01164228|591790458|FG000|Overall Study|Ineligible|1|||
163841962|NCT01164228|591790459|FG001|Overall Study|Ineligible|0|||
163841963|NCT03311230|591790465|FG000|Overall Study|Withdrawal by Subject|1|||
163841964|NCT03311230|591790466|FG001|Overall Study|Withdrawal by Subject|4|||
164043628|NCT03412565|592519842|FG002|Overall Study|Withdrawal by Subject|5|||
164043629|NCT03412565|592519843|FG003|Overall Study|Withdrawal by Subject|5|||
164043630|NCT03412565|592519840|FG000|Overall Study|Death|1|||
164043631|NCT03412565|592519841|FG001|Overall Study|Death|3|||
164043632|NCT03412565|592519842|FG002|Overall Study|Death|4|||
164043633|NCT03412565|592519843|FG003|Overall Study|Death|5|||
164043634|NCT03412565|592519840|FG000|Overall Study|Data collection ended|0|||
164043635|NCT03412565|592519841|FG001|Overall Study|Data collection ended|41|||
164043636|NCT03412565|592519842|FG002|Overall Study|Data collection ended|41|||
164043637|NCT03412565|592519843|FG003|Overall Study|Data collection ended|40|||
164043638|NCT01989572|592519846|FG000|Overall Study|Lack of Efficacy|35|||
164043639|NCT01989572|592519847|FG001|Overall Study|Lack of Efficacy|48|||
164043640|NCT01989572|592519848|FG002|Overall Study|Lack of Efficacy|48|||
164043641|NCT01989572|592519849|FG003|Overall Study|Lack of Efficacy|43|||
164043642|NCT01989572|592519850|FG004|Overall Study|Lack of Efficacy|71|||
164043643|NCT01989572|592519851|FG005|Overall Study|Lack of Efficacy|79|||
163841965|NCT03311230|591790467|FG002|Overall Study|Withdrawal by Subject|2|||
163841966|NCT03311230|591790468|FG003|Overall Study|Withdrawal by Subject|7|||
163841967|NCT03311230|591790465|FG000|Overall Study|Unrelated injury|0|||
163841968|NCT03311230|591790466|FG001|Overall Study|Unrelated injury|1|||
163841969|NCT03311230|591790467|FG002|Overall Study|Unrelated injury|0|||
163841970|NCT03311230|591790468|FG003|Overall Study|Unrelated injury|0|||
163841971|NCT02998021|591790469|FG000|Overall Study|Withdrawal by Subject|3|||
163841972|NCT02998021|591790470|FG001|Overall Study|Withdrawal by Subject|1|||
163841973|NCT02998021|591790469|FG000|Overall Study|unsafe home|0|||
163841974|NCT02998021|591790470|FG001|Overall Study|unsafe home|1|||
163841975|NCT00309608|591790473|FG000|Overall Study|Adverse Event|1|||
163841976|NCT00309608|591790474|FG001|Overall Study|Adverse Event|5|||
163841977|NCT00309608|591790475|FG002|Overall Study|Adverse Event|3|||
163841978|NCT00309608|591790476|FG003|Overall Study|Adverse Event|2|||
163841979|NCT00309608|591790477|FG004|Overall Study|Adverse Event|3|||
163841980|NCT00309608|591790473|FG000|Overall Study|Protocol Violation|2|||
163841981|NCT00309608|591790474|FG001|Overall Study|Protocol Violation|0|||
163841982|NCT00309608|591790475|FG002|Overall Study|Protocol Violation|0|||
163841983|NCT00309608|591790476|FG003|Overall Study|Protocol Violation|0|||
163841984|NCT00309608|591790477|FG004|Overall Study|Protocol Violation|0|||
163841985|NCT00309608|591790473|FG000|Overall Study|Lost to Follow-up|0|||
163841986|NCT00309608|591790474|FG001|Overall Study|Lost to Follow-up|0|||
163841987|NCT00309608|591790475|FG002|Overall Study|Lost to Follow-up|2|||
163841988|NCT00309608|591790476|FG003|Overall Study|Lost to Follow-up|0|||
163841989|NCT00309608|591790477|FG004|Overall Study|Lost to Follow-up|1|||
163841990|NCT00309608|591790473|FG000|Overall Study|Withdrawal by Subject|1|||
163841991|NCT00309608|591790474|FG001|Overall Study|Withdrawal by Subject|4|||
163841992|NCT00309608|591790475|FG002|Overall Study|Withdrawal by Subject|2|||
163841993|NCT00309608|591790476|FG003|Overall Study|Withdrawal by Subject|0|||
163841994|NCT00309608|591790477|FG004|Overall Study|Withdrawal by Subject|0|||
163841995|NCT00309608|591790473|FG000|Overall Study|Other incl. Lack of efficacy|10|||
163841996|NCT00309608|591790474|FG001|Overall Study|Other incl. Lack of efficacy|4|||
163841997|NCT00309608|591790475|FG002|Overall Study|Other incl. Lack of efficacy|3|||
163841998|NCT00309608|591790476|FG003|Overall Study|Other incl. Lack of efficacy|4|||
163841999|NCT00309608|591790477|FG004|Overall Study|Other incl. Lack of efficacy|0|||
163842000|NCT05200936|591790478|FG000|Overall Study|Withdrawal by Subject|2|||
163842001|NCT05200936|591790479|FG001|Overall Study|Withdrawal by Subject|2|||
163842002|NCT05200936|591790478|FG000|Overall Study|Lost to Follow-up|2|||
163842003|NCT05200936|591790479|FG001|Overall Study|Lost to Follow-up|0|||
163842004|NCT05200936|591790478|FG000|Overall Study|Pregnancy|0|||
163842005|NCT05200936|591790479|FG001|Overall Study|Pregnancy|1|||
163842006|NCT00127413|591790480|FG000|Overall Study|Lost to Follow-up|6|||
163842007|NCT00127413|591790481|FG001|Overall Study|Lost to Follow-up|4|||
163842008|NCT00127413|591790482|FG002|Overall Study|Lost to Follow-up|8|||
163842009|NCT00127413|591790483|FG003|Overall Study|Lost to Follow-up|2|||
163842010|NCT03713021|591790485|FG000|Overall Study|Did not have CT sim scan available|6|||
163842011|NCT03713021|591790485|FG000|Overall Study|Not eligible|4|||
163842012|NCT03713021|591790485|FG000|Overall Study|Issues with TraceIT markers|5|||
163842013|NCT01338012|591790488|FG000|Overall Study|Death|4|||
163842014|NCT01338012|591790488|FG000|Overall Study|Study terminated|4|||
163842015|NCT00154063|591792835|FG000|Overall Study|Adverse Event|4|||
163842016|NCT00154063|591792836|FG001|Overall Study|Adverse Event|8|||
163842017|NCT00154063|591792835|FG000|Overall Study|Protocol Violation|1|||
163842018|NCT00154063|591792836|FG001|Overall Study|Protocol Violation|1|||
163842019|NCT00154063|591792835|FG000|Overall Study|Investigator or Sponsor Request|0|||
163842020|NCT00154063|591792836|FG001|Overall Study|Investigator or Sponsor Request|1|||
163842021|NCT00154063|591792835|FG000|Overall Study|Withdrawal by Subject|4|||
163842022|NCT00154063|591792836|FG001|Overall Study|Withdrawal by Subject|9|||
163842023|NCT00154063|591792835|FG000|Overall Study|Other|3|||
163842024|NCT00154063|591792836|FG001|Overall Study|Other|3|||
163842025|NCT00603265|591792844|FG000|Overall Study|Adverse Event|2|||
163842026|NCT00603265|591792845|FG001|Overall Study|Adverse Event|11|||
163842027|NCT00603265|591792846|FG002|Overall Study|Adverse Event|1|||
163842028|NCT00603265|591792844|FG000|Overall Study|Withdrawal by Subject|1|||
163842029|NCT00603265|591792845|FG001|Overall Study|Withdrawal by Subject|2|||
163842030|NCT00603265|591792846|FG002|Overall Study|Withdrawal by Subject|1|||
163842031|NCT00603265|591792844|FG000|Overall Study|Lack of Efficacy|3|||
163842032|NCT00603265|591792845|FG001|Overall Study|Lack of Efficacy|0|||
163842033|NCT00603265|591792846|FG002|Overall Study|Lack of Efficacy|3|||
163842034|NCT00603265|591792844|FG000|Overall Study|Lost to Follow-up|0|||
163842035|NCT00603265|591792845|FG001|Overall Study|Lost to Follow-up|1|||
163842036|NCT00603265|591792846|FG002|Overall Study|Lost to Follow-up|0|||
163842037|NCT00603265|591792844|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
163842038|NCT00603265|591792845|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
163842039|NCT00603265|591792846|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
163842040|NCT00603265|591792844|FG000|Overall Study|Participant Left Country, No Responses|0|||
163842041|NCT00603265|591792845|FG001|Overall Study|Participant Left Country, No Responses|1|||
163842042|NCT00603265|591792846|FG002|Overall Study|Participant Left Country, No Responses|0|||
163944268|NCT00095056|592164868|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
163944269|NCT00095056|592164869|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
163944270|NCT00095056|592164868|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
163944271|NCT00095056|592164869|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
163944272|NCT00095056|592164868|FG000|Phase A (Weeks 0-12)|Death|1|||
163944273|NCT00095056|592164869|FG001|Phase A (Weeks 0-12)|Death|0|||
163944274|NCT00095056|592164868|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
163944275|NCT00095056|592164869|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
163944276|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
163944277|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
163944278|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
163944279|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
163944280|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
163944281|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
163944282|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
163944283|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
163944284|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Death|3|||
163944285|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Death|1|||
163944286|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
163944287|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
163944288|NCT00095056|592164868|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
163944289|NCT00095056|592164869|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
163944290|NCT00306670|592164873|FG000|Overall Study|patients recruited; Genentech, the st|0|||
163944291|NCT00306670|592164874|FG001|Overall Study|patients recruited; Genentech, the st|2|||
163944292|NCT03446781|592164875|FG000|Overall Study|Lost to Follow-up|11|||
163944293|NCT03446781|592164876|FG001|Overall Study|Lost to Follow-up|5|||
163944294|NCT03446781|592164875|FG000|Overall Study|Withdrawal by Subject|9|||
163944295|NCT03446781|592164876|FG001|Overall Study|Withdrawal by Subject|7|||
163944296|NCT03446781|592164875|FG000|Overall Study|Adverse Event|8|||
163944297|NCT03446781|592164876|FG001|Overall Study|Adverse Event|2|||
163944298|NCT03446781|592164875|FG000|Overall Study|Protocol Violation|0|||
163944299|NCT03446781|592164876|FG001|Overall Study|Protocol Violation|3|||
163944300|NCT02898077|592164883|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
163944301|NCT02898077|592164884|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
163944302|NCT02898077|592164883|FG000|Overall Study|Lost to Follow-up|4|||
163944303|NCT02898077|592164884|FG001|Overall Study|Lost to Follow-up|3|||
163944304|NCT02898077|592164883|FG000|Overall Study|Physician Decision|0|||
163944305|NCT02898077|592164884|FG001|Overall Study|Physician Decision|2|||
163944306|NCT02898077|592164883|FG000|Overall Study|Sponsor Decision|32|||
163944307|NCT02898077|592164884|FG001|Overall Study|Sponsor Decision|13|||
163944308|NCT02898077|592164883|FG000|Overall Study|Withdrawal by Subject|6|||
163944309|NCT02898077|592164884|FG001|Overall Study|Withdrawal by Subject|3|||
163944310|NCT02898077|592164883|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
163944311|NCT02898077|592164884|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
163944312|NCT02898077|592164883|FG000|Overall Study|Ended extension period|3|||
163944313|NCT02898077|592164884|FG001|Overall Study|Ended extension period|0|||
163944314|NCT00996476|592164886|FG000|Overall Study|Withdrawal by Subject|1|||
163944315|NCT00996476|592164887|FG001|Overall Study|Withdrawal by Subject|2|||
163944316|NCT00996476|592164888|FG002|Overall Study|Withdrawal by Subject|1|||
163944317|NCT00996476|592164889|FG003|Overall Study|Withdrawal by Subject|0|||
163944318|NCT00996476|592164890|FG004|Overall Study|Withdrawal by Subject|1|||
163944319|NCT00996476|592164886|FG000|Overall Study|Adverse Event|0|||
163944320|NCT00996476|592164887|FG001|Overall Study|Adverse Event|1|||
163944321|NCT00996476|592164888|FG002|Overall Study|Adverse Event|0|||
163944322|NCT00996476|592164889|FG003|Overall Study|Adverse Event|0|||
164099005|NCT02543203|592726968|FG001|Overall Study|Unpalatable Fragrance|2|||
164099006|NCT02543203|592726967|FG000|Overall Study|Lost to Follow-up|1|||
163944323|NCT00996476|592164890|FG004|Overall Study|Adverse Event|1|||
163944324|NCT01802567|592164891|FG000|Overall Study|Withdrawal by Subject|2|||
163944325|NCT01802567|592164891|FG000|Overall Study|Physician Decision|1|||
163944326|NCT01802567|592164891|FG000|Overall Study|Lack of Efficacy|7|||
163944327|NCT01802567|592164891|FG000|Overall Study|Consented but did not start therapy|7|||
163944328|NCT01802567|592164891|FG000|Overall Study|Protocol Violation|1|||
163944329|NCT01940939|592164892|FG000|Overall Study|Withdrawal by Subject|2|||
163944330|NCT01940939|592164893|FG001|Overall Study|Withdrawal by Subject|8|||
163944331|NCT01470001|592164894|FG000|Overall Study|Lost to Follow-up|1|||
163944332|NCT01470001|592164895|FG001|Overall Study|Lost to Follow-up|1|||
163944333|NCT01470001|592164894|FG000|Overall Study|Physician Decision|2|||
163944334|NCT01470001|592164895|FG001|Overall Study|Physician Decision|0|||
163944335|NCT01470001|592164894|FG000|Overall Study|Withdrawal by Subject|2|||
163944336|NCT01470001|592164895|FG001|Overall Study|Withdrawal by Subject|1|||
163944337|NCT01895101|592164896|FG000|Overall Study|OPCAB procedure|1|||
163944338|NCT01895101|592164897|FG001|Overall Study|OPCAB procedure|1|||
163944339|NCT01895101|592164898|FG002|Overall Study|OPCAB procedure|3|||
163944340|NCT01895101|592164896|FG000|Overall Study|Withdrawal by Subject|0|||
163944341|NCT01895101|592164897|FG001|Overall Study|Withdrawal by Subject|1|||
164043644|NCT01989572|592519846|FG000|Overall Study|Adverse Event|2|||
164043645|NCT01989572|592519847|FG001|Overall Study|Adverse Event|1|||
164043646|NCT01989572|592519848|FG002|Overall Study|Adverse Event|3|||
164043647|NCT01989572|592519849|FG003|Overall Study|Adverse Event|0|||
164043648|NCT01989572|592519850|FG004|Overall Study|Adverse Event|3|||
164043649|NCT01989572|592519851|FG005|Overall Study|Adverse Event|0|||
164043650|NCT01989572|592519846|FG000|Overall Study|Death|0|||
164043651|NCT01989572|592519847|FG001|Overall Study|Death|0|||
164043652|NCT01989572|592519848|FG002|Overall Study|Death|0|||
164043653|NCT01989572|592519849|FG003|Overall Study|Death|0|||
164043654|NCT01989572|592519850|FG004|Overall Study|Death|1|||
164043655|NCT01989572|592519851|FG005|Overall Study|Death|0|||
164043656|NCT01989572|592519846|FG000|Overall Study|Withdrawal by Subject|4|||
164043657|NCT01989572|592519847|FG001|Overall Study|Withdrawal by Subject|1|||
164043658|NCT01989572|592519848|FG002|Overall Study|Withdrawal by Subject|5|||
164043659|NCT01989572|592519849|FG003|Overall Study|Withdrawal by Subject|1|||
164043660|NCT01989572|592519850|FG004|Overall Study|Withdrawal by Subject|12|||
164043661|NCT01989572|592519851|FG005|Overall Study|Withdrawal by Subject|4|||
164043662|NCT01989572|592519846|FG000|Overall Study|complicating disease|1|||
164043663|NCT01989572|592519847|FG001|Overall Study|complicating disease|1|||
164043664|NCT01989572|592519848|FG002|Overall Study|complicating disease|2|||
164043665|NCT01989572|592519849|FG003|Overall Study|complicating disease|0|||
164043666|NCT01989572|592519850|FG004|Overall Study|complicating disease|1|||
164043667|NCT01989572|592519851|FG005|Overall Study|complicating disease|0|||
164043668|NCT01989572|592519846|FG000|Overall Study|error|2|||
164043669|NCT01989572|592519847|FG001|Overall Study|error|1|||
164043670|NCT01989572|592519848|FG002|Overall Study|error|1|||
164043671|NCT01989572|592519849|FG003|Overall Study|error|1|||
164043672|NCT01989572|592519850|FG004|Overall Study|error|1|||
164043673|NCT01989572|592519851|FG005|Overall Study|error|1|||
164043674|NCT01989572|592519846|FG000|Overall Study|maximum dose reached|0|||
164043675|NCT01989572|592519847|FG001|Overall Study|maximum dose reached|1|||
164043676|NCT01989572|592519848|FG002|Overall Study|maximum dose reached|0|||
164043677|NCT01989572|592519849|FG003|Overall Study|maximum dose reached|0|||
164043678|NCT01989572|592519850|FG004|Overall Study|maximum dose reached|1|||
164043679|NCT01989572|592519851|FG005|Overall Study|maximum dose reached|0|||
164043680|NCT01989572|592519846|FG000|Overall Study|unknown/not specify|3|||
164043681|NCT01989572|592519847|FG001|Overall Study|unknown/not specify|4|||
164043682|NCT01989572|592519848|FG002|Overall Study|unknown/not specify|1|||
164043683|NCT01989572|592519849|FG003|Overall Study|unknown/not specify|3|||
164043684|NCT01989572|592519850|FG004|Overall Study|unknown/not specify|3|||
164043685|NCT01989572|592519851|FG005|Overall Study|unknown/not specify|5|||
164043686|NCT01989572|592519846|FG000|Overall Study|not start protocol therapy|5|||
164043687|NCT01989572|592519847|FG001|Overall Study|not start protocol therapy|1|||
164043688|NCT01989572|592519848|FG002|Overall Study|not start protocol therapy|2|||
164043689|NCT01989572|592519849|FG003|Overall Study|not start protocol therapy|3|||
164043690|NCT01989572|592519850|FG004|Overall Study|not start protocol therapy|4|||
164043691|NCT01989572|592519851|FG005|Overall Study|not start protocol therapy|18|||
164043692|NCT01989572|592519846|FG000|Overall Study|alternative therapy|3|||
164043693|NCT01989572|592519847|FG001|Overall Study|alternative therapy|0|||
164043694|NCT01989572|592519848|FG002|Overall Study|alternative therapy|0|||
164043695|NCT01989572|592519849|FG003|Overall Study|alternative therapy|0|||
164043696|NCT01989572|592519850|FG004|Overall Study|alternative therapy|1|||
164043697|NCT01989572|592519851|FG005|Overall Study|alternative therapy|3|||
164043698|NCT00732238|592519856|FG000|Overall Study|Bacteremia|4|||
164043699|NCT00732238|592519857|FG001|Overall Study|Bacteremia|1|||
164043700|NCT00732238|592519856|FG000|Overall Study|Asymptomatic bacteriuria|1|||
164043701|NCT00732238|592519857|FG001|Overall Study|Asymptomatic bacteriuria|0|||
164043702|NCT02280096|592519858|FG000|Overall Study|Pregnancy|1|||
164043703|NCT02280096|592519859|FG001|Overall Study|Pregnancy|0|||
164043704|NCT02280096|592519858|FG000|Overall Study|Functional neurological disorder|1|||
164043705|NCT02280096|592519859|FG001|Overall Study|Functional neurological disorder|0|||
164043706|NCT02280096|592519858|FG000|Overall Study|Lack of attachment|0|||
164043707|NCT02280096|592519859|FG001|Overall Study|Lack of attachment|1|||
164043708|NCT00246376|592519864|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
164043709|NCT00246376|592519865|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
164043710|NCT00246376|592519866|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
164043711|NCT00246376|592519867|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
164043712|NCT00246376|592519868|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
164043713|NCT00246376|592519864|FG000|Overall Study|Adverse Event|2|||
164043714|NCT00246376|592519865|FG001|Overall Study|Adverse Event|3|||
164099007|NCT02543203|592726968|FG001|Overall Study|Lost to Follow-up|0|||
164099008|NCT02543203|592726967|FG000|Overall Study|Increased Irritability|1|||
164043715|NCT00246376|592519866|FG002|Overall Study|Adverse Event|1|||
164043716|NCT00246376|592519867|FG003|Overall Study|Adverse Event|3|||
164043717|NCT00246376|592519868|FG004|Overall Study|Adverse Event|1|||
164043718|NCT00246376|592519864|FG000|Overall Study|Lost to Follow-up|2|||
164043719|NCT00246376|592519865|FG001|Overall Study|Lost to Follow-up|11|||
164043720|NCT00246376|592519866|FG002|Overall Study|Lost to Follow-up|11|||
164099009|NCT02543203|592726968|FG001|Overall Study|Increased Irritability|0|||
164099010|NCT02543203|592726967|FG000|Overall Study|Family|1|||
164099011|NCT02543203|592726968|FG001|Overall Study|Family|2|||
164099012|NCT02543203|592726967|FG000|Overall Study|Negative Behavior|1|||
164099013|NCT02543203|592726968|FG001|Overall Study|Negative Behavior|0|||
164099014|NCT02543203|592726967|FG000|Overall Study|Withdrawal by Subject|0|||
164099015|NCT02543203|592726968|FG001|Overall Study|Withdrawal by Subject|1|||
164099016|NCT00626548|592726971|FG000|Overall Study|Adverse Event|164|||
163944342|NCT01895101|592164898|FG002|Overall Study|Withdrawal by Subject|2|||
163944343|NCT01895101|592164896|FG000|Overall Study|another study, enrolled in other study|0|||
163944344|NCT01895101|592164897|FG001|Overall Study|another study, enrolled in other study|1|||
163944345|NCT01895101|592164898|FG002|Overall Study|another study, enrolled in other study|0|||
163944346|NCT01895101|592164896|FG000|Overall Study|Death|0|||
163944347|NCT01895101|592164897|FG001|Overall Study|Death|1|||
163944348|NCT01895101|592164898|FG002|Overall Study|Death|0|||
163944349|NCT01895101|592164896|FG000|Overall Study|coagulation disorder|0|||
163944350|NCT01895101|592164897|FG001|Overall Study|coagulation disorder|1|||
163944351|NCT01895101|592164898|FG002|Overall Study|coagulation disorder|0|||
163944352|NCT02182947|592164903|FG000|Overall Study|Withdrawal by Subject|7|||
163944353|NCT02182947|592164903|FG000|Overall Study|Lost to Follow-up|3|||
163944354|NCT02182947|592164903|FG000|Overall Study|Failed screening activities|8|||
163944355|NCT02236988|592164904|FG000|Overall Study|Lost to Follow-up|0|||
163944356|NCT02236988|592164905|FG001|Overall Study|Lost to Follow-up|0|||
163944357|NCT02236988|592164906|FG002|Overall Study|Lost to Follow-up|0|||
163944358|NCT02236988|592164907|FG003|Overall Study|Lost to Follow-up|1|||
163944359|NCT02236988|592164904|FG000|Overall Study|Unable to Comply with Study Visits|0|||
163944360|NCT02236988|592164905|FG001|Overall Study|Unable to Comply with Study Visits|0|||
163944361|NCT02236988|592164906|FG002|Overall Study|Unable to Comply with Study Visits|0|||
163944362|NCT02236988|592164907|FG003|Overall Study|Unable to Comply with Study Visits|2|||
163944363|NCT04308590|592164908|FG000|Overall Study|Adverse Event|12|||
163944364|NCT04308590|592164909|FG001|Overall Study|Adverse Event|2|||
163944365|NCT04308590|592164908|FG000|Overall Study|Withdrawal by Subject|10|||
163944366|NCT04308590|592164909|FG001|Overall Study|Withdrawal by Subject|4|||
163944367|NCT04308590|592164908|FG000|Overall Study|Death|1|||
163944368|NCT04308590|592164909|FG001|Overall Study|Death|0|||
163944369|NCT04308590|592164908|FG000|Overall Study|Lost to Follow-up|1|||
163944370|NCT04308590|592164909|FG001|Overall Study|Lost to Follow-up|1|||
163944371|NCT04308590|592164908|FG000|Overall Study|Physician Decision|1|||
163944372|NCT04308590|592164909|FG001|Overall Study|Physician Decision|0|||
163944373|NCT04308590|592164908|FG000|Overall Study|Subject does not want to continue with Pi|0|||
163944374|NCT04308590|592164909|FG001|Overall Study|Subject does not want to continue with Pi|1|||
163944375|NCT01156376|592164911|FG000|Overall Study|Adverse Event|1|||
163944376|NCT01156376|592164912|FG001|Overall Study|Adverse Event|0|||
163944377|NCT01156376|592164913|FG002|Overall Study|Adverse Event|1|||
163944378|NCT01156376|592164911|FG000|Overall Study|Withdrawal by Subject|0|||
163944379|NCT01156376|592164912|FG001|Overall Study|Withdrawal by Subject|0|||
163944380|NCT01156376|592164913|FG002|Overall Study|Withdrawal by Subject|3|||
163944381|NCT01493427|592164914|FG000|Overall Study|Adverse Event|10|||
163944382|NCT01493427|592164914|FG000|Overall Study|Personal Reasons|4|||
163944383|NCT01493427|592164914|FG000|Overall Study|Lost to Follow-up|2|||
163944384|NCT01493427|592164914|FG000|Overall Study|Inability to Follow Instructions|2|||
163944385|NCT01493427|592164914|FG000|Overall Study|Other|2|||
163944386|NCT05775991|592164915|FG000|Overall Study|Withdrawal by Subject|0|||
163944387|NCT05775991|592164916|FG001|Overall Study|Withdrawal by Subject|0|||
163944388|NCT05775991|592164917|FG002|Overall Study|Withdrawal by Subject|2|||
163944389|NCT00939822|592164924|FG000|Overall Study|Lost to Follow-up|1|||
163944390|NCT00939822|592164925|FG001|Overall Study|Lost to Follow-up|0|||
163944391|NCT00939822|592164924|FG000|Overall Study|withdrew from study due to busy schedule|1|||
163944392|NCT00939822|592164925|FG001|Overall Study|withdrew from study due to busy schedule|1|||
163944393|NCT00939822|592164924|FG000|Overall Study|Mental health issues|0|||
163944394|NCT00939822|592164925|FG001|Overall Study|Mental health issues|2|||
163944395|NCT01072630|592164926|FG000|Overall Study|Adverse Event|11|||
163944396|NCT01072630|592164927|FG001|Overall Study|Adverse Event|19|||
163944397|NCT01072630|592164928|FG002|Overall Study|Adverse Event|2|||
163944398|NCT01072630|592164926|FG000|Overall Study|Lack of Efficacy|10|||
163944399|NCT01072630|592164927|FG001|Overall Study|Lack of Efficacy|10|||
163944400|NCT01072630|592164928|FG002|Overall Study|Lack of Efficacy|1|||
163944401|NCT01072630|592164926|FG000|Overall Study|Withdrawal by Subject|8|||
163944402|NCT01072630|592164927|FG001|Overall Study|Withdrawal by Subject|7|||
163944403|NCT01072630|592164928|FG002|Overall Study|Withdrawal by Subject|2|||
163944404|NCT01072630|592164926|FG000|Overall Study|Protocol Violation|10|||
163944405|NCT01072630|592164927|FG001|Overall Study|Protocol Violation|8|||
163944406|NCT01072630|592164928|FG002|Overall Study|Protocol Violation|4|||
163944407|NCT01072630|592164926|FG000|Overall Study|Lost to Follow-up|11|||
163944408|NCT01072630|592164927|FG001|Overall Study|Lost to Follow-up|11|||
163944409|NCT01072630|592164928|FG002|Overall Study|Lost to Follow-up|1|||
164099017|NCT00626548|592726972|FG001|Overall Study|Adverse Event|44|||
164099018|NCT00626548|592726971|FG000|Overall Study|Withdrawal by Subject|42|||
164043721|NCT00246376|592519867|FG003|Overall Study|Lost to Follow-up|16|||
164043722|NCT00246376|592519868|FG004|Overall Study|Lost to Follow-up|13|||
164043723|NCT01872897|592519873|FG000|Overall Study|Withdrawal by Subject|1|||
164043724|NCT01872897|592519874|FG001|Overall Study|Withdrawal by Subject|0|||
164043725|NCT04159701|592519877|FG000|Period 1: Treatment Period|Pregnancy|1|||
164043726|NCT04159701|592519878|FG001|Period 1: Treatment Period|Pregnancy|0|||
164043727|NCT04159701|592519877|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
164043728|NCT04159701|592519878|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
164043729|NCT04159701|592519877|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
164043730|NCT04159701|592519878|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
164043731|NCT04159701|592519877|FG000|Washout Period|site terminated by sponsor|0|||
164043732|NCT04159701|592519878|FG001|Washout Period|site terminated by sponsor|1|||
164043733|NCT04159701|592519877|FG000|Washout Period|study terminated by sponsor|10|||
164043734|NCT04159701|592519878|FG001|Washout Period|study terminated by sponsor|3|||
164043735|NCT04159701|592519877|FG000|Washout Period|Withdrawal by Subject|1|||
164043736|NCT04159701|592519878|FG001|Washout Period|Withdrawal by Subject|0|||
164043737|NCT04159701|592519877|FG000|Washout Period|Inadvertent Enrollment|1|||
164043738|NCT04159701|592519878|FG001|Washout Period|Inadvertent Enrollment|0|||
164043739|NCT04159701|592519877|FG000|Washout Period|Miscellaneous|1|||
164043740|NCT04159701|592519878|FG001|Washout Period|Miscellaneous|0|||
164043741|NCT04159701|592519877|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
164043742|NCT04159701|592519878|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
164043743|NCT04159701|592519877|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
164043744|NCT04159701|592519878|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
164043745|NCT04159701|592519877|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
164043746|NCT04159701|592519878|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
164043747|NCT04159701|592519877|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
164043748|NCT04159701|592519878|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
164043749|NCT04159701|592519877|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
164043750|NCT04159701|592519878|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
164043751|NCT01782885|592519885|FG000|Overall Study|Lost to Follow-up|4|||
164043752|NCT01782885|592519886|FG001|Overall Study|Lost to Follow-up|6|||
164043753|NCT01849562|592519888|FG000|Overall Study|Lost to Follow-up|1|||
164043754|NCT01849562|592519889|FG001|Overall Study|Lost to Follow-up|0|||
164043755|NCT01849562|592519890|FG002|Overall Study|Lost to Follow-up|0|||
164043756|NCT01849562|592519888|FG000|Overall Study|Non-compliance with Study Drug|1|||
164043757|NCT01849562|592519889|FG001|Overall Study|Non-compliance with Study Drug|0|||
164043758|NCT01849562|592519890|FG002|Overall Study|Non-compliance with Study Drug|0|||
164043759|NCT00693693|592519896|FG000|Overall Study|Lost to Follow-up|1|||
164043760|NCT00693693|592519897|FG001|Overall Study|Lost to Follow-up|1|||
164043761|NCT00693693|592519898|FG002|Overall Study|Lost to Follow-up|2|||
164043762|NCT04599972|592519899|FG000|Overall Study|Withdrawal by Subject|6|||
164043763|NCT04599972|592519900|FG001|Overall Study|Withdrawal by Subject|1|||
164043764|NCT04599972|592519899|FG000|Overall Study|Adverse Event|1|||
164043765|NCT04599972|592519900|FG001|Overall Study|Adverse Event|1|||
164043766|NCT04599972|592519899|FG000|Overall Study|Lost to Follow-up|1|||
164043767|NCT04599972|592519900|FG001|Overall Study|Lost to Follow-up|6|||
164043768|NCT04599972|592519899|FG000|Overall Study|Protocol Violation|1|||
164043769|NCT04599972|592519900|FG001|Overall Study|Protocol Violation|0|||
164099019|NCT00626548|592726972|FG001|Overall Study|Withdrawal by Subject|46|||
164099020|NCT00626548|592726971|FG000|Overall Study|Protocol Violation|4|||
164043770|NCT04599972|592519899|FG000|Overall Study|Other reason|1|||
164043771|NCT04599972|592519900|FG001|Overall Study|Other reason|0|||
164099021|NCT00626548|592726972|FG001|Overall Study|Protocol Violation|11|||
163842043|NCT00603265|591792844|FG000|Overall Study|Protocol Violation|1|||
163842044|NCT00603265|591792845|FG001|Overall Study|Protocol Violation|0|||
163842045|NCT00603265|591792846|FG002|Overall Study|Protocol Violation|0|||
163842046|NCT04399551|591792847|FG000|Overall Study|Adverse Event|15|||
163842047|NCT04399551|591792847|FG000|Overall Study|Withdrawal by Subject|6|||
163842048|NCT04399551|591792847|FG000|Overall Study|Physician Decision|3|||
163842049|NCT04399551|591792847|FG000|Overall Study|Lost to Follow-up|2|||
163842050|NCT04399551|591792847|FG000|Overall Study|Protocol Deviation|2|||
163842051|NCT01912781|591792854|FG000|Overall Study|Withdrawal by Subject|2|||
163842052|NCT01912781|591792855|FG001|Overall Study|Withdrawal by Subject|0|||
163842053|NCT03377790|591792858|FG000|Overall Study|Withdrawal by Subject|1|||
163842054|NCT03377790|591792859|FG001|Overall Study|Withdrawal by Subject|0|||
164043772|NCT01690988|592519908|FG000|Overall Study|Withdrawal by Subject|2|||
164043773|NCT01690988|592519909|FG001|Overall Study|Withdrawal by Subject|2|||
164043774|NCT01690988|592519910|FG002|Overall Study|Withdrawal by Subject|3|||
164043775|NCT01690988|592519908|FG000|Overall Study|Physician Decision|0|||
164043776|NCT01690988|592519909|FG001|Overall Study|Physician Decision|0|||
163842055|NCT03377790|591792858|FG000|Overall Study|Adverse Event|1|||
163842056|NCT03377790|591792859|FG001|Overall Study|Adverse Event|0|||
163842057|NCT03377790|591792858|FG000|Overall Study|Lost to Follow-up|0|||
163842058|NCT03377790|591792859|FG001|Overall Study|Lost to Follow-up|2|||
163944410|NCT01072630|592164926|FG000|Overall Study|Noncompliance with study medication|1|||
163944411|NCT01072630|592164927|FG001|Overall Study|Noncompliance with study medication|1|||
163944412|NCT01072630|592164928|FG002|Overall Study|Noncompliance with study medication|1|||
164043777|NCT01690988|592519910|FG002|Overall Study|Physician Decision|1|||
164043778|NCT01690988|592519908|FG000|Overall Study|Operation Cancelled|1|||
164043779|NCT01690988|592519909|FG001|Overall Study|Operation Cancelled|1|||
164043780|NCT01690988|592519910|FG002|Overall Study|Operation Cancelled|0|||
164043781|NCT01690988|592519908|FG000|Overall Study|Determined ineligible|1|||
164043782|NCT01690988|592519909|FG001|Overall Study|Determined ineligible|0|||
164043783|NCT01690988|592519910|FG002|Overall Study|Determined ineligible|0|||
164043784|NCT01690988|592519908|FG000|Overall Study|Death|1|||
164043785|NCT01690988|592519909|FG001|Overall Study|Death|1|||
164043786|NCT01690988|592519910|FG002|Overall Study|Death|1|||
164043787|NCT01690988|592519908|FG000|Overall Study|Sedated|1|||
164043788|NCT01690988|592519909|FG001|Overall Study|Sedated|1|||
164043789|NCT01690988|592519910|FG002|Overall Study|Sedated|2|||
164043790|NCT03696576|592519911|FG000|Overall Study|Soreness of throat after therapy|1|||
164043791|NCT03696576|592519912|FG001|Overall Study|Soreness of throat after therapy|1|||
164043792|NCT03696576|592519911|FG000|Overall Study|Lost to Follow-up|2|||
164043793|NCT03696576|592519912|FG001|Overall Study|Lost to Follow-up|4|||
164043794|NCT01975376|592519915|FG000|Overall Study|Adverse Event|5|||
164043795|NCT01975376|592519916|FG001|Overall Study|Adverse Event|5|||
164043796|NCT01975376|592519915|FG000|Overall Study|Death|65|||
164043797|NCT01975376|592519916|FG001|Overall Study|Death|72|||
164043798|NCT01975376|592519915|FG000|Overall Study|Lost to Follow-up|70|||
164043799|NCT01975376|592519916|FG001|Overall Study|Lost to Follow-up|66|||
164043800|NCT01975376|592519915|FG000|Overall Study|Withdrew consent|68|||
164043801|NCT01975376|592519916|FG001|Overall Study|Withdrew consent|62|||
164043802|NCT01975376|592519915|FG000|Overall Study|Other|2|||
164043803|NCT01975376|592519916|FG001|Overall Study|Other|4|||
164043804|NCT01975376|592519915|FG000|Overall Study|Randomized, Not Treated|16|||
164043805|NCT01975376|592519916|FG001|Overall Study|Randomized, Not Treated|8|||
164043806|NCT01451398|592519920|FG000|Overall Study|Adverse Event|7|||
164043807|NCT01451398|592519921|FG001|Overall Study|Adverse Event|9|||
164043808|NCT01451398|592519920|FG000|Overall Study|Protocol Violation|1|||
164043809|NCT01451398|592519921|FG001|Overall Study|Protocol Violation|2|||
164043810|NCT01451398|592519920|FG000|Overall Study|Physician Decision|1|||
164043811|NCT01451398|592519921|FG001|Overall Study|Physician Decision|1|||
164043812|NCT01451398|592519920|FG000|Overall Study|Withdrawal by Subject|10|||
164043813|NCT01451398|592519921|FG001|Overall Study|Withdrawal by Subject|14|||
164043814|NCT01451398|592519920|FG000|Overall Study|Lost to Follow-up|6|||
164043815|NCT01451398|592519921|FG001|Overall Study|Lost to Follow-up|4|||
164043816|NCT01451398|592519920|FG000|Overall Study|Non-compliance with study drug|1|||
164043817|NCT01451398|592519921|FG001|Overall Study|Non-compliance with study drug|3|||
164043818|NCT01451398|592519920|FG000|Overall Study|Non-compliance with protocol|1|||
164043819|NCT01451398|592519921|FG001|Overall Study|Non-compliance with protocol|1|||
164043820|NCT01451398|592519920|FG000|Overall Study|Moved out of country|0|||
164043821|NCT01451398|592519921|FG001|Overall Study|Moved out of country|1|||
163944413|NCT01072630|592164926|FG000|Overall Study|Noncompliance with study procedures|1|||
163944414|NCT01072630|592164927|FG001|Overall Study|Noncompliance with study procedures|2|||
163944415|NCT01072630|592164928|FG002|Overall Study|Noncompliance with study procedures|1|||
163944416|NCT01072630|592164926|FG000|Overall Study|Other|3|||
163944417|NCT01072630|592164927|FG001|Overall Study|Other|2|||
163944418|NCT01072630|592164928|FG002|Overall Study|Other|1|||
163944419|NCT02683785|592164929|FG000|Overall Study|Withdrawal by Subject|1|||
163944420|NCT02683785|592164930|FG001|Overall Study|Withdrawal by Subject|1|||
163944421|NCT02683785|592164929|FG000|Overall Study|Lost to Follow-up|0|||
163944422|NCT02683785|592164930|FG001|Overall Study|Lost to Follow-up|1|||
163944423|NCT02683785|592164929|FG000|Overall Study|Adverse Event|0|||
163944424|NCT02683785|592164930|FG001|Overall Study|Adverse Event|2|||
163944425|NCT00416195|592164931|FG000|Overall Study|Adverse Event|1|||
163944426|NCT00416195|592164932|FG001|Overall Study|Adverse Event|2|||
163944427|NCT00416195|592164931|FG000|Overall Study|Protocol Violation|1|||
163944428|NCT00416195|592164932|FG001|Overall Study|Protocol Violation|1|||
164043822|NCT01451398|592519920|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
164043823|NCT01451398|592519921|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
164043824|NCT01451398|592519920|FG000|Overall Study|Lack of Efficacy|0|||
164043825|NCT01451398|592519921|FG001|Overall Study|Lack of Efficacy|1|||
163944429|NCT00416195|592164931|FG000|Overall Study|Other|0|||
163944430|NCT00416195|592164932|FG001|Overall Study|Other|1|||
163944431|NCT01305408|592164933|FG000|Overall Study|Adverse Event|10|||
164043826|NCT04449276|592519922|FG000|Overall Study|Adverse Event|1|||
164043827|NCT04449276|592519923|FG001|Overall Study|Adverse Event|2|||
163944432|NCT01305408|592164934|FG001|Overall Study|Adverse Event|7|||
163944433|NCT01305408|592164933|FG000|Overall Study|Lack of Efficacy|3|||
164043828|NCT04449276|592519924|FG002|Overall Study|Adverse Event|0|||
164043829|NCT04449276|592519925|FG003|Overall Study|Adverse Event|0|||
164043830|NCT04449276|592519926|FG004|Overall Study|Adverse Event|2|||
163944434|NCT01305408|592164934|FG001|Overall Study|Lack of Efficacy|4|||
164043831|NCT04449276|592519927|FG005|Overall Study|Adverse Event|0|||
164043832|NCT04449276|592519928|FG006|Overall Study|Adverse Event|0|||
164043833|NCT04449276|592519929|FG007|Overall Study|Adverse Event|1|||
164043834|NCT04449276|592519922|FG000|Overall Study|Withdrawal by Subject|2|||
164043835|NCT04449276|592519923|FG001|Overall Study|Withdrawal by Subject|0|||
164043836|NCT04449276|592519924|FG002|Overall Study|Withdrawal by Subject|0|||
164043837|NCT04449276|592519925|FG003|Overall Study|Withdrawal by Subject|1|||
164043838|NCT04449276|592519926|FG004|Overall Study|Withdrawal by Subject|0|||
164043839|NCT04449276|592519927|FG005|Overall Study|Withdrawal by Subject|0|||
164043840|NCT04449276|592519928|FG006|Overall Study|Withdrawal by Subject|0|||
164043841|NCT04449276|592519929|FG007|Overall Study|Withdrawal by Subject|0|||
164043842|NCT04449276|592519922|FG000|Overall Study|Other|0|||
164043843|NCT04449276|592519923|FG001|Overall Study|Other|2|||
164043844|NCT04449276|592519924|FG002|Overall Study|Other|3|||
164043845|NCT04449276|592519925|FG003|Overall Study|Other|2|||
164043846|NCT04449276|592519926|FG004|Overall Study|Other|0|||
164043847|NCT04449276|592519927|FG005|Overall Study|Other|0|||
164043848|NCT04449276|592519928|FG006|Overall Study|Other|0|||
163944435|NCT01305408|592164933|FG000|Overall Study|Withdrawal by Subject|9|||
163944436|NCT01305408|592164934|FG001|Overall Study|Withdrawal by Subject|9|||
163944437|NCT01305408|592164933|FG000|Overall Study|Protocol Violation|4|||
163944438|NCT01305408|592164934|FG001|Overall Study|Protocol Violation|6|||
163944439|NCT01305408|592164933|FG000|Overall Study|Lost to Follow-up|5|||
163944440|NCT01305408|592164934|FG001|Overall Study|Lost to Follow-up|3|||
163944441|NCT01305408|592164933|FG000|Overall Study|Noncompliance with study medication|0|||
163944442|NCT01305408|592164934|FG001|Overall Study|Noncompliance with study medication|1|||
163944443|NCT01305408|592164933|FG000|Overall Study|Noncompliance with study procedures|0|||
163944444|NCT01305408|592164934|FG001|Overall Study|Noncompliance with study procedures|1|||
163944445|NCT01305408|592164933|FG000|Overall Study|Other|1|||
163944446|NCT01305408|592164934|FG001|Overall Study|Other|0|||
163944447|NCT01877239|592164935|FG000|Overall Study|Adverse Event|4|||
163944448|NCT01877239|592164935|FG000|Overall Study|Disease Remission|1|||
163944449|NCT01877239|592164935|FG000|Overall Study|Withdrawal by Subject|4|||
163944450|NCT01877239|592164935|FG000|Overall Study|Other|2|||
163944451|NCT01877239|592164935|FG000|Overall Study|Lack of Efficacy|4|||
163944452|NCT01877239|592164935|FG000|Overall Study|Data not available|35|||
163944453|NCT01283516|592164939|FG000|Overall Study|Adverse Event|0|||
163944454|NCT01283516|592164940|FG001|Overall Study|Adverse Event|0|||
163944455|NCT01283516|592164941|FG002|Overall Study|Adverse Event|0|||
163944456|NCT01283516|592164942|FG003|Overall Study|Adverse Event|0|||
163944457|NCT01283516|592164943|FG004|Overall Study|Adverse Event|0|||
163944458|NCT01283516|592164944|FG005|Overall Study|Adverse Event|0|||
163944459|NCT01283516|592164945|FG006|Overall Study|Adverse Event|2|||
163944460|NCT01283516|592164946|FG007|Overall Study|Adverse Event|0|||
163944461|NCT01283516|592164947|FG008|Overall Study|Adverse Event|28|||
163944462|NCT01283516|592164939|FG000|Overall Study|Death|0|||
164043849|NCT04449276|592519929|FG007|Overall Study|Other|1|||
164043850|NCT01614795|592519930|FG000|Overall Study|Adverse Event|0|||
163944463|NCT01283516|592164940|FG001|Overall Study|Death|0|||
163944464|NCT01283516|592164941|FG002|Overall Study|Death|0|||
163944465|NCT01283516|592164942|FG003|Overall Study|Death|0|||
163944466|NCT01283516|592164943|FG004|Overall Study|Death|0|||
163944467|NCT01283516|592164944|FG005|Overall Study|Death|1|||
163944468|NCT01283516|592164945|FG006|Overall Study|Death|0|||
163944469|NCT01283516|592164946|FG007|Overall Study|Death|1|||
163944470|NCT01283516|592164947|FG008|Overall Study|Death|12|||
163944471|NCT01283516|592164939|FG000|Overall Study|Disease Progression|2|||
163944472|NCT01283516|592164940|FG001|Overall Study|Disease Progression|2|||
163944473|NCT01283516|592164941|FG002|Overall Study|Disease Progression|3|||
163944474|NCT01283516|592164942|FG003|Overall Study|Disease Progression|3|||
163944475|NCT01283516|592164943|FG004|Overall Study|Disease Progression|13|||
163944476|NCT01283516|592164944|FG005|Overall Study|Disease Progression|8|||
163944477|NCT01283516|592164945|FG006|Overall Study|Disease Progression|6|||
163944478|NCT01283516|592164946|FG007|Overall Study|Disease Progression|3|||
163944479|NCT01283516|592164947|FG008|Overall Study|Disease Progression|139|||
163944480|NCT01283516|592164939|FG000|Overall Study|Withdrawal by Subject|0|||
163944481|NCT01283516|592164940|FG001|Overall Study|Withdrawal by Subject|0|||
163944482|NCT01283516|592164941|FG002|Overall Study|Withdrawal by Subject|0|||
164043851|NCT01614795|592519931|FG001|Overall Study|Adverse Event|0|||
164043852|NCT01614795|592519932|FG002|Overall Study|Adverse Event|1|||
163944483|NCT01283516|592164942|FG003|Overall Study|Withdrawal by Subject|0|||
163944484|NCT01283516|592164943|FG004|Overall Study|Withdrawal by Subject|1|||
163944485|NCT01283516|592164944|FG005|Overall Study|Withdrawal by Subject|0|||
163944486|NCT01283516|592164945|FG006|Overall Study|Withdrawal by Subject|1|||
164043853|NCT01614795|592519933|FG003|Overall Study|Adverse Event|1|||
164043854|NCT01614795|592519930|FG000|Overall Study|Lack of Efficacy|10|||
164043855|NCT01614795|592519931|FG001|Overall Study|Lack of Efficacy|10|||
164043856|NCT01614795|592519932|FG002|Overall Study|Lack of Efficacy|9|||
164043857|NCT01614795|592519933|FG003|Overall Study|Lack of Efficacy|8|||
164043858|NCT01614795|592519930|FG000|Overall Study|Physician Decision|1|||
164043859|NCT01614795|592519931|FG001|Overall Study|Physician Decision|0|||
163944487|NCT01283516|592164946|FG007|Overall Study|Withdrawal by Subject|0|||
163944488|NCT01283516|592164947|FG008|Overall Study|Withdrawal by Subject|36|||
163944489|NCT01283516|592164939|FG000|Overall Study|Administrative problems|0|||
163944490|NCT01283516|592164940|FG001|Overall Study|Administrative problems|0|||
163944491|NCT01283516|592164941|FG002|Overall Study|Administrative problems|0|||
163944492|NCT01283516|592164942|FG003|Overall Study|Administrative problems|0|||
163944493|NCT01283516|592164943|FG004|Overall Study|Administrative problems|0|||
163944494|NCT01283516|592164944|FG005|Overall Study|Administrative problems|1|||
163944495|NCT01283516|592164945|FG006|Overall Study|Administrative problems|1|||
163944496|NCT01283516|592164946|FG007|Overall Study|Administrative problems|1|||
163944497|NCT01283516|592164947|FG008|Overall Study|Administrative problems|39|||
163944498|NCT01283516|592164939|FG000|Overall Study|Lost to Follow-up|0|||
163944499|NCT01283516|592164940|FG001|Overall Study|Lost to Follow-up|0|||
163944500|NCT01283516|592164941|FG002|Overall Study|Lost to Follow-up|0|||
163944501|NCT01283516|592164942|FG003|Overall Study|Lost to Follow-up|0|||
163944502|NCT01283516|592164943|FG004|Overall Study|Lost to Follow-up|0|||
163944503|NCT01283516|592164944|FG005|Overall Study|Lost to Follow-up|0|||
163944504|NCT01283516|592164945|FG006|Overall Study|Lost to Follow-up|0|||
163944505|NCT01283516|592164946|FG007|Overall Study|Lost to Follow-up|0|||
163944506|NCT01283516|592164947|FG008|Overall Study|Lost to Follow-up|1|||
163944507|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
163944508|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
163944509|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
163944510|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
163944511|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
163944512|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
163944513|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
163944514|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
163944515|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
163944516|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
163944517|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Adverse Event|0|||
163944518|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Adverse Event|0|||
163944519|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Adverse Event|3|||
163944520|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Adverse Event|2|||
163944521|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Adverse Event|13|||
163944522|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
163944523|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
163944524|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
163944525|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
163944526|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
163944527|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Patient's wish|0|||
163944528|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Patient's wish|0|||
163944529|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Patient's wish|19|||
163944530|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Patient's wish|9|||
163944531|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Patient's wish|20|||
163944532|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
163944533|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
163944534|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
163944535|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
163944536|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
163944537|NCT00444275|592164950|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
163944538|NCT00444275|592164951|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
163944539|NCT00444275|592164952|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
164043860|NCT01614795|592519932|FG002|Overall Study|Physician Decision|1|||
164043861|NCT01614795|592519933|FG003|Overall Study|Physician Decision|1|||
164043862|NCT01614795|592519930|FG000|Overall Study|Withdrawal by Subject|0|||
164043863|NCT01614795|592519931|FG001|Overall Study|Withdrawal by Subject|1|||
164043864|NCT01614795|592519932|FG002|Overall Study|Withdrawal by Subject|0|||
164043865|NCT01614795|592519933|FG003|Overall Study|Withdrawal by Subject|2|||
164043866|NCT01614795|592519930|FG000|Overall Study|Ineligible|0|||
164043867|NCT01614795|592519931|FG001|Overall Study|Ineligible|1|||
164043868|NCT01614795|592519932|FG002|Overall Study|Ineligible|0|||
164043869|NCT01614795|592519933|FG003|Overall Study|Ineligible|0|||
163944540|NCT00444275|592164953|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
163944541|NCT00444275|592164954|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
163944542|NCT04187326|592164955|FG000|Overall Study|Lost to Follow-up|2|||
163944543|NCT04187326|592164956|FG001|Overall Study|Lost to Follow-up|1|||
163944544|NCT04187326|592164955|FG000|Overall Study|Computer error- task was only partially completed.|0|||
163944545|NCT04187326|592164956|FG001|Overall Study|Computer error- task was only partially completed.|1|||
163944546|NCT00283244|592164957|FG000|Overall Study|Adverse Event|0|||
163944547|NCT00283244|592164958|FG001|Overall Study|Adverse Event|8|||
164043870|NCT00701103|592519934|FG000|Overall Study|Adverse Event|0|||
164043871|NCT00701103|592519935|FG001|Overall Study|Adverse Event|0|||
163944548|NCT00283244|592164959|FG002|Overall Study|Adverse Event|11|||
163944549|NCT00283244|592164957|FG000|Overall Study|Death|4|||
163944550|NCT00283244|592164958|FG001|Overall Study|Death|3|||
163944551|NCT00283244|592164959|FG002|Overall Study|Death|2|||
163944552|NCT00283244|592164957|FG000|Overall Study|Lack of Efficacy|8|||
163944553|NCT00283244|592164958|FG001|Overall Study|Lack of Efficacy|32|||
163944554|NCT00283244|592164959|FG002|Overall Study|Lack of Efficacy|26|||
163944555|NCT00283244|592164957|FG000|Overall Study|Withdrawal by Subject|1|||
163944556|NCT00283244|592164958|FG001|Overall Study|Withdrawal by Subject|2|||
163944557|NCT00283244|592164959|FG002|Overall Study|Withdrawal by Subject|2|||
163944558|NCT00283244|592164957|FG000|Overall Study|Physician Decision|0|||
163944559|NCT00283244|592164958|FG001|Overall Study|Physician Decision|0|||
163944560|NCT00283244|592164959|FG002|Overall Study|Physician Decision|1|||
163944561|NCT00283244|592164957|FG000|Overall Study|Medical illness (other complicating dz)|4|||
163944562|NCT00283244|592164958|FG001|Overall Study|Medical illness (other complicating dz)|3|||
163944563|NCT00283244|592164959|FG002|Overall Study|Medical illness (other complicating dz)|6|||
163944564|NCT00283244|592164957|FG000|Overall Study|Clinical deterioration|1|||
163944565|NCT00283244|592164958|FG001|Overall Study|Clinical deterioration|3|||
163944566|NCT00283244|592164959|FG002|Overall Study|Clinical deterioration|3|||
163944567|NCT05543187|592164962|FG000|Overall Study|Ongoing|3|||
163944568|NCT05543187|592164963|FG001|Overall Study|Ongoing|2|||
163944569|NCT04777864|592164964|FG000|Overall Study|Lost to Follow-up|8|||
163944570|NCT04777864|592164965|FG001|Overall Study|Lost to Follow-up|19|||
163944571|NCT02344290|592164969|FG000|Overall Study|Withdrawal by Subject|315|||
163944572|NCT02344290|592164970|FG001|Overall Study|Withdrawal by Subject|324|||
163944573|NCT02344290|592164969|FG000|Overall Study|Lost to Follow-up|258|||
163944574|NCT02344290|592164970|FG001|Overall Study|Lost to Follow-up|249|||
163944575|NCT02344290|592164969|FG000|Overall Study|Unable to get to clinic|69|||
163944576|NCT02344290|592164970|FG001|Overall Study|Unable to get to clinic|60|||
163944577|NCT02344290|592164969|FG000|Overall Study|Physician Decision|25|||
163944578|NCT02344290|592164970|FG001|Overall Study|Physician Decision|25|||
163944579|NCT02344290|592164969|FG000|Overall Study|Site Closure|15|||
163944580|NCT02344290|592164970|FG001|Overall Study|Site Closure|19|||
163944581|NCT02344290|592164969|FG000|Overall Study|Other|5|||
163944582|NCT02344290|592164970|FG001|Overall Study|Other|3|||
163944583|NCT06748729|592164972|FG000|Overall Study|Withdrawal by Subject|1|||
163944584|NCT00503139|592166748|FG000|Overall Study|Case Report Forms were not collected|4|||
163944585|NCT00503139|592166748|FG000|Overall Study|Protocol Violation|4|||
163944586|NCT00091169|592166752|FG000|Overall Study|Disease progression|3|||
163944587|NCT00091169|592166753|FG001|Overall Study|Disease progression|1|||
163944588|NCT00091169|592166752|FG000|Overall Study|Adverse Event|11|||
163944589|NCT00091169|592166753|FG001|Overall Study|Adverse Event|17|||
163944590|NCT00091169|592166752|FG000|Overall Study|Death|4|||
163944591|NCT00091169|592166753|FG001|Overall Study|Death|1|||
163944592|NCT00091169|592166752|FG000|Overall Study|Withdrawal by Subject|10|||
163944593|NCT00091169|592166753|FG001|Overall Study|Withdrawal by Subject|13|||
163944594|NCT00091169|592166752|FG000|Overall Study|Other|3|||
163944595|NCT00091169|592166753|FG001|Overall Study|Other|4|||
163944596|NCT00091169|592166752|FG000|Overall Study|Not start protocol therapy|26|||
163944597|NCT00091169|592166753|FG001|Overall Study|Not start protocol therapy|17|||
163944598|NCT02735577|592166754|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
163944599|NCT02735577|592166754|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
163944600|NCT00833833|592166755|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163944601|NCT00833833|592166756|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163944602|NCT00833833|592166757|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
163944603|NCT00833833|592166758|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
163944604|NCT00833833|592166759|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163944605|NCT00833833|592166760|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
163944606|NCT00833833|592166755|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
163944607|NCT00833833|592166756|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
163944608|NCT00833833|592166757|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
163944609|NCT00833833|592166758|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
163944610|NCT00833833|592166759|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
163944611|NCT00833833|592166760|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
163944612|NCT00833833|592166755|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
163944613|NCT00833833|592166756|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
163944614|NCT00833833|592166757|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
163944615|NCT00833833|592166758|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
163944616|NCT00833833|592166759|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
163944617|NCT00833833|592166760|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
163944618|NCT00833833|592166755|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
163944619|NCT00833833|592166756|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
163944620|NCT00833833|592166757|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
163944621|NCT00833833|592166758|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
163944622|NCT00833833|592166759|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
163944623|NCT00833833|592166760|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
164099022|NCT00626548|592726971|FG000|Overall Study|Lost to Follow-up|2|||
163944624|NCT00833833|592166755|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
163944625|NCT00833833|592166756|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944626|NCT00833833|592166757|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
163944627|NCT00833833|592166758|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944628|NCT00833833|592166759|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944629|NCT00833833|592166760|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944630|NCT00833833|592166755|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
163944631|NCT00833833|592166756|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
163944632|NCT00833833|592166757|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
163944633|NCT00833833|592166758|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
163944634|NCT00833833|592166759|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
163944635|NCT00833833|592166760|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
163944636|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163944637|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163944638|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163944639|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
163944640|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
163944641|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
163944642|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163944643|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163944644|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163944645|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
163944646|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
163944647|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
163944648|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
163944649|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
163944650|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
163944651|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
163944652|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
163944653|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
163944654|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944655|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944656|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944657|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
163944658|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
163944659|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
163944660|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163944661|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163944662|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163944663|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
163944664|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
163944665|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
163944666|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
163944667|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
163944668|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
163944669|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
163944670|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
163944671|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
163944672|NCT00833833|592166755|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163944673|NCT00833833|592166756|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163944674|NCT00833833|592166757|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163944675|NCT00833833|592166758|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163944676|NCT00833833|592166759|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
163944677|NCT00833833|592166760|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
163944678|NCT02040259|592166761|FG000|Overall Study|Death|280|||
163944679|NCT02040259|592166761|FG000|Overall Study|Lost to Follow-up|76|||
163944680|NCT02040259|592166761|FG000|Overall Study|Assessment not completed|3|||
163944681|NCT02040259|592166761|FG000|Overall Study|Withdrawal by Subject|4|||
163944682|NCT00316602|592166771|FG000|Overall Study|Withdrawal by Subject|3|||
163944683|NCT00316602|592166772|FG001|Overall Study|Withdrawal by Subject|2|||
163944684|NCT00316602|592166771|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
163944685|NCT00316602|592166772|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
163944686|NCT00316602|592166771|FG000|Overall Study|Adverse Event|1|||
163944687|NCT00316602|592166772|FG001|Overall Study|Adverse Event|0|||
163944688|NCT00316602|592166771|FG000|Overall Study|Other|3|||
163944689|NCT00316602|592166772|FG001|Overall Study|Other|6|||
163944690|NCT01142232|592166773|FG000|Overall Study|Adverse Event|1|||
163944691|NCT01142232|592166774|FG001|Overall Study|Adverse Event|2|||
164043872|NCT00701103|592519936|FG002|Overall Study|Adverse Event|1|||
164043873|NCT00701103|592519937|FG003|Overall Study|Adverse Event|1|||
164043874|NCT00701103|592519938|FG004|Overall Study|Adverse Event|0|||
164043875|NCT00701103|592519939|FG005|Overall Study|Adverse Event|1|||
164043876|NCT00701103|592519940|FG006|Overall Study|Adverse Event|1|||
164043877|NCT00701103|592519941|FG007|Overall Study|Adverse Event|0|||
164043878|NCT00701103|592519942|FG008|Overall Study|Adverse Event|0|||
164043879|NCT00701103|592519943|FG009|Overall Study|Adverse Event|2|||
164043880|NCT00701103|592519944|FG010|Overall Study|Adverse Event|0|||
164043881|NCT00701103|592519934|FG000|Overall Study|Progressive Disease|5|||
164043882|NCT00701103|592519935|FG001|Overall Study|Progressive Disease|2|||
164043883|NCT00701103|592519936|FG002|Overall Study|Progressive Disease|6|||
164043884|NCT00701103|592519937|FG003|Overall Study|Progressive Disease|5|||
164043885|NCT00701103|592519938|FG004|Overall Study|Progressive Disease|6|||
164043886|NCT00701103|592519939|FG005|Overall Study|Progressive Disease|5|||
164043887|NCT00701103|592519940|FG006|Overall Study|Progressive Disease|7|||
164043888|NCT00701103|592519941|FG007|Overall Study|Progressive Disease|7|||
164043889|NCT00701103|592519942|FG008|Overall Study|Progressive Disease|8|||
164043890|NCT00701103|592519943|FG009|Overall Study|Progressive Disease|8|||
164043891|NCT00701103|592519944|FG010|Overall Study|Progressive Disease|11|||
164043892|NCT00701103|592519934|FG000|Overall Study|Withdrawal by Subject|0|||
164043893|NCT00701103|592519935|FG001|Overall Study|Withdrawal by Subject|1|||
164043894|NCT00701103|592519936|FG002|Overall Study|Withdrawal by Subject|1|||
164043895|NCT00701103|592519937|FG003|Overall Study|Withdrawal by Subject|0|||
164043896|NCT00701103|592519938|FG004|Overall Study|Withdrawal by Subject|0|||
164043897|NCT00701103|592519939|FG005|Overall Study|Withdrawal by Subject|0|||
164043898|NCT00701103|592519940|FG006|Overall Study|Withdrawal by Subject|0|||
164043899|NCT00701103|592519941|FG007|Overall Study|Withdrawal by Subject|0|||
164043900|NCT00701103|592519942|FG008|Overall Study|Withdrawal by Subject|0|||
164043901|NCT00701103|592519943|FG009|Overall Study|Withdrawal by Subject|0|||
164043902|NCT00701103|592519944|FG010|Overall Study|Withdrawal by Subject|0|||
164043903|NCT00701103|592519934|FG000|Overall Study|Other|0|||
164043904|NCT00701103|592519935|FG001|Overall Study|Other|0|||
164043905|NCT00701103|592519936|FG002|Overall Study|Other|0|||
164043906|NCT00701103|592519937|FG003|Overall Study|Other|0|||
164043907|NCT00701103|592519938|FG004|Overall Study|Other|0|||
164043908|NCT00701103|592519939|FG005|Overall Study|Other|0|||
164043909|NCT00701103|592519940|FG006|Overall Study|Other|0|||
164043910|NCT00701103|592519941|FG007|Overall Study|Other|0|||
164043911|NCT00701103|592519942|FG008|Overall Study|Other|1|||
164043912|NCT00701103|592519943|FG009|Overall Study|Other|1|||
164043913|NCT00701103|592519944|FG010|Overall Study|Other|0|||
164043914|NCT00179517|592519945|FG000|Overall Study|Withdrawal by Subject|2|||
164043915|NCT00179517|592519946|FG001|Overall Study|Withdrawal by Subject|1|||
164043916|NCT01915095|592519947|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
164043917|NCT01915095|592519948|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
164043918|NCT01915095|592519949|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
164043919|NCT01915095|592519950|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
164043920|NCT01915095|592519951|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
164043921|NCT02067533|592519952|FG000|Overall Study|Lost to Follow-up|4|||
164043922|NCT02067533|592519953|FG001|Overall Study|Lost to Follow-up|2|||
164043923|NCT04857892|592519954|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
164043924|NCT04857892|592519955|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164043925|NCT04857892|592519956|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164043926|NCT04857892|592519957|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164043927|NCT04857892|592519958|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
164043928|NCT04857892|592519954|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
164043929|NCT04857892|592519955|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
164043930|NCT04857892|592519956|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
164043931|NCT04857892|592519957|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
164043932|NCT04857892|592519958|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
164043933|NCT04857892|592519954|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164043934|NCT04857892|592519955|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164043935|NCT04857892|592519956|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164043936|NCT04857892|592519957|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
164043937|NCT04857892|592519958|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
164043938|NCT00643448|592519960|FG000|Overall Study|Lack of Efficacy|2|||
164043939|NCT00643448|592519961|FG001|Overall Study|Lack of Efficacy|0|||
164043940|NCT00643448|592519962|FG002|Overall Study|Lack of Efficacy|4|||
164043941|NCT00643448|592519960|FG000|Overall Study|Adverse Event|2|||
164043942|NCT00643448|592519961|FG001|Overall Study|Adverse Event|2|||
164043943|NCT00643448|592519962|FG002|Overall Study|Adverse Event|2|||
164043944|NCT00643448|592519960|FG000|Overall Study|QTcF>550 ms|0|||
164043945|NCT00643448|592519961|FG001|Overall Study|QTcF>550 ms|3|||
164043946|NCT00643448|592519962|FG002|Overall Study|QTcF>550 ms|0|||
164043947|NCT00981682|592519963|FG000|Overall Study|Adverse Event|48|||
164043948|NCT00981682|592519963|FG000|Overall Study|Withdrawal by Subject|52|||
164043949|NCT00981682|592519963|FG000|Overall Study|Lost to Follow-up|14|||
164043950|NCT00981682|592519963|FG000|Overall Study|Lack of Efficacy|13|||
164043951|NCT00981682|592519963|FG000|Overall Study|Protocol Violation|6|||
164043952|NCT00981682|592519963|FG000|Overall Study|administrative|9|||
164043953|NCT02632344|592521558|FG000|Overall Study|Adverse Event|3|||
164043954|NCT02632344|592521558|FG000|Overall Study|Lack of Efficacy|3|||
164043955|NCT02632344|592521558|FG000|Overall Study|Withdrawal by Subject|2|||
164043956|NCT00777257|592521559|FG000|Overall Study|Adverse Event|3|||
164043957|NCT00777257|592521560|FG001|Overall Study|Adverse Event|1|||
164043958|NCT00777257|592521561|FG002|Overall Study|Adverse Event|0|||
164043959|NCT00777257|592521559|FG000|Overall Study|Lost to Follow-up|3|||
164043960|NCT00777257|592521560|FG001|Overall Study|Lost to Follow-up|3|||
164043961|NCT00777257|592521561|FG002|Overall Study|Lost to Follow-up|2|||
164043962|NCT00777257|592521559|FG000|Overall Study|Protocol Violation|2|||
164043963|NCT00777257|592521560|FG001|Overall Study|Protocol Violation|2|||
164043964|NCT00777257|592521561|FG002|Overall Study|Protocol Violation|2|||
164043965|NCT00777257|592521559|FG000|Overall Study|Withdrawal by Subject|3|||
164043966|NCT00777257|592521560|FG001|Overall Study|Withdrawal by Subject|6|||
164043967|NCT00777257|592521561|FG002|Overall Study|Withdrawal by Subject|5|||
164043968|NCT01370499|592521562|FG000|Overall Study|Adverse Event|38|||
164043969|NCT01370499|592521563|FG001|Overall Study|Adverse Event|12|||
164043970|NCT01370499|592521562|FG000|Overall Study|Lack of Efficacy|4|||
164043971|NCT01370499|592521563|FG001|Overall Study|Lack of Efficacy|2|||
164043972|NCT01370499|592521562|FG000|Overall Study|Lost to Follow-up|2|||
164043973|NCT01370499|592521563|FG001|Overall Study|Lost to Follow-up|1|||
164043974|NCT01370499|592521562|FG000|Overall Study|Physician Decision|3|||
164043975|NCT01370499|592521563|FG001|Overall Study|Physician Decision|3|||
164043976|NCT01370499|592521562|FG000|Overall Study|Protocol Violation|5|||
164043977|NCT01370499|592521563|FG001|Overall Study|Protocol Violation|4|||
164043978|NCT01370499|592521562|FG000|Overall Study|Withdrawal by Subject|18|||
164043979|NCT01370499|592521563|FG001|Overall Study|Withdrawal by Subject|7|||
164043980|NCT01370499|592521562|FG000|Overall Study|Sponsor Decision|41|||
164043981|NCT01370499|592521563|FG001|Overall Study|Sponsor Decision|15|||
164043982|NCT04984876|592521564|FG000|Overall Study|Subject decision|2|||
164043983|NCT04984876|592521565|FG001|Overall Study|Subject decision|10|||
164043984|NCT04984876|592521566|FG002|Overall Study|Subject decision|3|||
164043985|NCT04984876|592521567|FG003|Overall Study|Subject decision|3|||
164043986|NCT04984876|592521568|FG004|Overall Study|Subject decision|3|||
164043987|NCT04984876|592521569|FG005|Overall Study|Subject decision|0|||
164043988|NCT04984876|592521564|FG000|Overall Study|Guardian decision|0|||
164043989|NCT04984876|592521565|FG001|Overall Study|Guardian decision|1|||
164043990|NCT04984876|592521566|FG002|Overall Study|Guardian decision|0|||
164043991|NCT04984876|592521567|FG003|Overall Study|Guardian decision|2|||
164043992|NCT04984876|592521568|FG004|Overall Study|Guardian decision|0|||
164043993|NCT04984876|592521569|FG005|Overall Study|Guardian decision|1|||
164043994|NCT04984876|592521564|FG000|Overall Study|Lost to Follow-up|0|||
164043995|NCT04984876|592521565|FG001|Overall Study|Lost to Follow-up|0|||
164043996|NCT04984876|592521566|FG002|Overall Study|Lost to Follow-up|1|||
164043997|NCT04984876|592521567|FG003|Overall Study|Lost to Follow-up|1|||
164043998|NCT04984876|592521568|FG004|Overall Study|Lost to Follow-up|0|||
164043999|NCT04984876|592521569|FG005|Overall Study|Lost to Follow-up|0|||
164099023|NCT00626548|592726972|FG001|Overall Study|Lost to Follow-up|2|||
163842059|NCT03377790|591792858|FG000|Overall Study|Randomized but not treated|1|||
163842060|NCT03377790|591792859|FG001|Overall Study|Randomized but not treated|0|||
163842061|NCT03377790|591792858|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
163842062|NCT03377790|591792859|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
163842063|NCT01533714|591792860|FG000|Overall Study|Adverse Event|0|||
163842064|NCT01533714|591792861|FG001|Overall Study|Adverse Event|1|||
163842065|NCT01533714|591792862|FG002|Overall Study|Adverse Event|2|||
163842066|NCT01533714|591792863|FG003|Overall Study|Adverse Event|2|||
163842067|NCT01533714|591792864|FG004|Overall Study|Adverse Event|2|||
163842068|NCT01533714|591792865|FG005|Overall Study|Adverse Event|1|||
163842069|NCT01533714|591792860|FG000|Overall Study|Lack of Efficacy|0|||
163842070|NCT01533714|591792861|FG001|Overall Study|Lack of Efficacy|0|||
163842071|NCT01533714|591792862|FG002|Overall Study|Lack of Efficacy|0|||
163842072|NCT01533714|591792863|FG003|Overall Study|Lack of Efficacy|0|||
163842073|NCT01533714|591792864|FG004|Overall Study|Lack of Efficacy|0|||
163842074|NCT01533714|591792865|FG005|Overall Study|Lack of Efficacy|1|||
163842075|NCT01533714|591792860|FG000|Overall Study|Withdrawal by Subject|0|||
164044000|NCT04984876|592521564|FG000|Overall Study|Physician Decision|1|||
163842076|NCT01533714|591792861|FG001|Overall Study|Withdrawal by Subject|1|||
163842077|NCT01533714|591792862|FG002|Overall Study|Withdrawal by Subject|0|||
163842078|NCT01533714|591792863|FG003|Overall Study|Withdrawal by Subject|1|||
164044001|NCT04984876|592521565|FG001|Overall Study|Physician Decision|0|||
164044002|NCT04984876|592521566|FG002|Overall Study|Physician Decision|0|||
164044003|NCT04984876|592521567|FG003|Overall Study|Physician Decision|1|||
164044004|NCT04984876|592521568|FG004|Overall Study|Physician Decision|0|||
164044005|NCT04984876|592521569|FG005|Overall Study|Physician Decision|0|||
164044006|NCT04984876|592521564|FG000|Overall Study|Adverse Event|0|||
163944692|NCT01142232|592166775|FG002|Overall Study|Adverse Event|1|||
163944693|NCT01142232|592166776|FG003|Overall Study|Adverse Event|0|||
163944694|NCT01142232|592166777|FG004|Overall Study|Adverse Event|4|||
163944695|NCT01142232|592166773|FG000|Overall Study|Death|0|||
163944696|NCT01142232|592166774|FG001|Overall Study|Death|0|||
163944697|NCT01142232|592166775|FG002|Overall Study|Death|0|||
163944698|NCT01142232|592166776|FG003|Overall Study|Death|0|||
163944699|NCT01142232|592166777|FG004|Overall Study|Death|1|||
163944700|NCT01142232|592166773|FG000|Overall Study|Disease Progression|2|||
163944701|NCT01142232|592166774|FG001|Overall Study|Disease Progression|0|||
163944702|NCT01142232|592166775|FG002|Overall Study|Disease Progression|1|||
163944703|NCT01142232|592166776|FG003|Overall Study|Disease Progression|2|||
163944704|NCT01142232|592166777|FG004|Overall Study|Disease Progression|12|||
163944705|NCT01142232|592166773|FG000|Overall Study|Withdrawal by Subject|0|||
163944706|NCT01142232|592166774|FG001|Overall Study|Withdrawal by Subject|0|||
163944707|NCT01142232|592166775|FG002|Overall Study|Withdrawal by Subject|0|||
163944708|NCT01142232|592166776|FG003|Overall Study|Withdrawal by Subject|1|||
163944709|NCT01142232|592166777|FG004|Overall Study|Withdrawal by Subject|3|||
163944710|NCT01142232|592166773|FG000|Overall Study|Physician Decision|0|||
163944711|NCT01142232|592166774|FG001|Overall Study|Physician Decision|1|||
163944712|NCT01142232|592166775|FG002|Overall Study|Physician Decision|0|||
163944713|NCT01142232|592166776|FG003|Overall Study|Physician Decision|2|||
163944714|NCT01142232|592166777|FG004|Overall Study|Physician Decision|10|||
163944715|NCT01142232|592166773|FG000|Overall Study|Alternative Therapy|0|||
163944716|NCT01142232|592166774|FG001|Overall Study|Alternative Therapy|1|||
163944717|NCT01142232|592166775|FG002|Overall Study|Alternative Therapy|1|||
163944718|NCT01142232|592166776|FG003|Overall Study|Alternative Therapy|0|||
163944719|NCT01142232|592166777|FG004|Overall Study|Alternative Therapy|1|||
163944720|NCT01142232|592166773|FG000|Overall Study|Off Trt for other complicating disease|0|||
163944721|NCT01142232|592166774|FG001|Overall Study|Off Trt for other complicating disease|0|||
163944722|NCT01142232|592166775|FG002|Overall Study|Off Trt for other complicating disease|0|||
163944723|NCT01142232|592166776|FG003|Overall Study|Off Trt for other complicating disease|0|||
163944724|NCT01142232|592166777|FG004|Overall Study|Off Trt for other complicating disease|1|||
163944725|NCT01142232|592166773|FG000|Overall Study|Noncompliance|0|||
163944726|NCT01142232|592166774|FG001|Overall Study|Noncompliance|0|||
163944727|NCT01142232|592166775|FG002|Overall Study|Noncompliance|0|||
163944728|NCT01142232|592166776|FG003|Overall Study|Noncompliance|0|||
163944729|NCT01142232|592166777|FG004|Overall Study|Noncompliance|2|||
163944730|NCT00626990|592166778|FG000|Overall Study|Lack of Efficacy|6|||
163944731|NCT00626990|592166779|FG001|Overall Study|Lack of Efficacy|7|||
163944732|NCT00626990|592166780|FG002|Overall Study|Lack of Efficacy|49|||
163944733|NCT00626990|592166781|FG003|Overall Study|Lack of Efficacy|40|||
163944734|NCT00626990|592166778|FG000|Overall Study|Adverse Event|1|||
163944735|NCT00626990|592166779|FG001|Overall Study|Adverse Event|7|||
163944736|NCT00626990|592166780|FG002|Overall Study|Adverse Event|14|||
163944737|NCT00626990|592166781|FG003|Overall Study|Adverse Event|28|||
163944738|NCT00626990|592166778|FG000|Overall Study|Death|0|||
163944739|NCT00626990|592166779|FG001|Overall Study|Death|1|||
163944740|NCT00626990|592166780|FG002|Overall Study|Death|0|||
163944741|NCT00626990|592166781|FG003|Overall Study|Death|0|||
163944742|NCT00626990|592166778|FG000|Overall Study|Withdrawal by Subject|3|||
163944743|NCT00626990|592166779|FG001|Overall Study|Withdrawal by Subject|1|||
163944744|NCT00626990|592166780|FG002|Overall Study|Withdrawal by Subject|5|||
163944745|NCT00626990|592166781|FG003|Overall Study|Withdrawal by Subject|11|||
163944746|NCT00626990|592166778|FG000|Overall Study|Protocol Violation|0|||
163944747|NCT00626990|592166779|FG001|Overall Study|Protocol Violation|1|||
163944748|NCT00626990|592166780|FG002|Overall Study|Protocol Violation|1|||
163944749|NCT00626990|592166781|FG003|Overall Study|Protocol Violation|0|||
163944750|NCT00626990|592166778|FG000|Overall Study|Various different reasons/missing|4|||
163944751|NCT00626990|592166779|FG001|Overall Study|Various different reasons/missing|8|||
163944752|NCT00626990|592166780|FG002|Overall Study|Various different reasons/missing|8|||
163944753|NCT00626990|592166781|FG003|Overall Study|Various different reasons/missing|16|||
163944754|NCT04138576|592166786|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
163944755|NCT04410523|592166791|FG000|Overall Study|Study terminated by sponsor|1|||
163944756|NCT04410523|592166792|FG001|Overall Study|Study terminated by sponsor|3|||
163944757|NCT04410523|592166793|FG002|Overall Study|Study terminated by sponsor|2|||
163944758|NCT04410523|592166794|FG003|Overall Study|Study terminated by sponsor|6|||
163944759|NCT04410523|592166795|FG004|Overall Study|Study terminated by sponsor|3|||
163944760|NCT04410523|592166796|FG005|Overall Study|Study terminated by sponsor|4|||
163944761|NCT04410523|592166791|FG000|Overall Study|Adverse Event|1|||
163944762|NCT04410523|592166792|FG001|Overall Study|Adverse Event|0|||
163944763|NCT04410523|592166793|FG002|Overall Study|Adverse Event|0|||
163944764|NCT04410523|592166794|FG003|Overall Study|Adverse Event|0|||
163944765|NCT04410523|592166795|FG004|Overall Study|Adverse Event|0|||
163944766|NCT04410523|592166796|FG005|Overall Study|Adverse Event|2|||
163944767|NCT04410523|592166791|FG000|Overall Study|Lost to Follow-up|0|||
163944768|NCT04410523|592166792|FG001|Overall Study|Lost to Follow-up|1|||
163944769|NCT04410523|592166793|FG002|Overall Study|Lost to Follow-up|0|||
164044007|NCT04984876|592521565|FG001|Overall Study|Adverse Event|0|||
164044008|NCT04984876|592521566|FG002|Overall Study|Adverse Event|1|||
164044009|NCT04984876|592521567|FG003|Overall Study|Adverse Event|0|||
164044010|NCT04984876|592521568|FG004|Overall Study|Adverse Event|0|||
164044011|NCT04984876|592521569|FG005|Overall Study|Adverse Event|0|||
164044012|NCT01077193|592521572|FG000|Overall Study|Lost to Follow-up|1|||
164044013|NCT01077193|592521572|FG000|Overall Study|Withdrawal by Subject|2|||
164044014|NCT01077193|592521572|FG000|Overall Study|Lack of Efficacy|1|||
164044015|NCT01077193|592521572|FG000|Overall Study|Study Terminated by Sponsor|40|||
164044016|NCT04960202|592521574|FG000|Overall Study|Other|5|||
164044017|NCT04960202|592521575|FG001|Overall Study|Other|0|||
164044018|NCT04960202|592521574|FG000|Overall Study|Withdrawal by Subject|37|||
164044019|NCT04960202|592521575|FG001|Overall Study|Withdrawal by Subject|43|||
164044020|NCT04960202|592521574|FG000|Overall Study|Lost to Follow-up|20|||
164044021|NCT04960202|592521575|FG001|Overall Study|Lost to Follow-up|16|||
164044022|NCT04960202|592521574|FG000|Overall Study|Death|0|||
164044023|NCT04960202|592521575|FG001|Overall Study|Death|15|||
164044024|NCT03687827|592521580|FG000|Treatment Period 1|Death|0|||
164044025|NCT03687827|592521581|FG001|Treatment Period 1|Death|1|||
164044026|NCT03687827|592521580|FG000|Treatment Period 1|Lost to Follow-up|2|||
164044027|NCT03687827|592521581|FG001|Treatment Period 1|Lost to Follow-up|2|||
164044028|NCT03687827|592521580|FG000|Treatment Period 1|Physician Decision|5|||
164044029|NCT03687827|592521581|FG001|Treatment Period 1|Physician Decision|2|||
164044030|NCT03687827|592521580|FG000|Treatment Period 1|Withdrawal by Subject|7|||
164044031|NCT03687827|592521581|FG001|Treatment Period 1|Withdrawal by Subject|3|||
164044032|NCT03687827|592521580|FG000|Treatment Period 2|Physician Decision|4|||
164044033|NCT03687827|592521581|FG001|Treatment Period 2|Physician Decision|1|||
164044034|NCT03687827|592521580|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164044035|NCT03687827|592521581|FG001|Treatment Period 2|Withdrawal by Subject|2|||
164044036|NCT00981292|592521586|FG000|Day 1|Protocol Violation|1|||
164044037|NCT00981292|592521587|FG001|Day 1|Protocol Violation|0|||
164044038|NCT00981292|592521588|FG002|Day 1|Protocol Violation|0|||
164044039|NCT00981292|592521589|FG003|Day 1|Protocol Violation|0|||
164044040|NCT00981292|592521590|FG004|Day 1|Protocol Violation|0|||
164044041|NCT00981292|592521591|FG005|Day 1|Protocol Violation|2|||
164044042|NCT00981292|592521586|FG000|Day 2|Protocol Violation|2|||
164044043|NCT00981292|592521587|FG001|Day 2|Protocol Violation|0|||
164044044|NCT00981292|592521588|FG002|Day 2|Protocol Violation|0|||
164044045|NCT00981292|592521589|FG003|Day 2|Protocol Violation|0|||
164044046|NCT00981292|592521590|FG004|Day 2|Protocol Violation|0|||
164044047|NCT00981292|592521591|FG005|Day 2|Protocol Violation|0|||
164044048|NCT00981292|592521586|FG000|Day 3|Protocol Violation|0|||
164044049|NCT00981292|592521587|FG001|Day 3|Protocol Violation|0|||
164044050|NCT00981292|592521588|FG002|Day 3|Protocol Violation|0|||
164044051|NCT00981292|592521589|FG003|Day 3|Protocol Violation|0|||
164044052|NCT00981292|592521590|FG004|Day 3|Protocol Violation|0|||
164044053|NCT00981292|592521591|FG005|Day 3|Protocol Violation|1|||
164044054|NCT03377452|592521592|FG000|Overall Study|Refused assessment|0|||
164044055|NCT03377452|592521593|FG001|Overall Study|Refused assessment|2|||
164044056|NCT03377452|592521592|FG000|Overall Study|Lost to Follow-up|5|||
164044057|NCT03377452|592521593|FG001|Overall Study|Lost to Follow-up|4|||
164044058|NCT03464136|592521594|FG000|Overall Study|Lost to Follow-up|5|||
164044059|NCT03464136|592521595|FG001|Overall Study|Lost to Follow-up|8|||
164044060|NCT03464136|592521594|FG000|Overall Study|Withdrawal by Subject|16|||
164044061|NCT03464136|592521595|FG001|Overall Study|Withdrawal by Subject|13|||
164044062|NCT03464136|592521594|FG000|Overall Study|Death|1|||
164044063|NCT03464136|592521595|FG001|Overall Study|Death|0|||
164044064|NCT03464136|592521594|FG000|Overall Study|Other|8|||
164044065|NCT03464136|592521595|FG001|Overall Study|Other|4|||
164044066|NCT03146403|592521596|FG000|Overall Study|Withdrawal by Subject|0|||
164044067|NCT03146403|592521597|FG001|Overall Study|Withdrawal by Subject|3|||
164044068|NCT03146403|592521596|FG000|Overall Study|Lost to Follow-up|2|||
164044069|NCT03146403|592521597|FG001|Overall Study|Lost to Follow-up|0|||
164044070|NCT00481988|592521598|FG000|Overall Study|Withdrawal by Subject|1|||
164044071|NCT00481988|592521599|FG001|Overall Study|Withdrawal by Subject|1|||
164044072|NCT02182999|592521600|FG000|Overall Study|Adverse Event|4|||
164044073|NCT02182999|592521601|FG001|Overall Study|Adverse Event|3|||
164044074|NCT02182999|592521600|FG000|Overall Study|Physician Decision|1|||
164044075|NCT02182999|592521601|FG001|Overall Study|Physician Decision|0|||
164044076|NCT02252588|592521603|FG000|Overall Study|Withdrawal by Subject|4|||
164044077|NCT02252588|592521604|FG001|Overall Study|Withdrawal by Subject|0|||
164044078|NCT00638690|592521609|FG000|Overall Study|Death|655|||
164044079|NCT00638690|592521610|FG001|Overall Study|Death|335|||
164044080|NCT00638690|592521609|FG000|Overall Study|Withdrawal by Subject|22|||
164044081|NCT00638690|592521610|FG001|Overall Study|Withdrawal by Subject|5|||
164044082|NCT00638690|592521609|FG000|Overall Study|Lost to Follow-up|4|||
164044083|NCT00638690|592521610|FG001|Overall Study|Lost to Follow-up|2|||
164044084|NCT02203916|592521613|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164044085|NCT02203916|592521614|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
164044086|NCT02203916|592521615|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
164044087|NCT02203916|592521613|FG000|Overall Study|Major Protocol Deviation|1|||
164099024|NCT00626548|592726971|FG000|Overall Study|Other termination reason|493|||
164099025|NCT00626548|592726972|FG001|Overall Study|Other termination reason|613|||
164099026|NCT00385593|592726973|FG000|Overall Study|Adverse Event|3|||
164099027|NCT00385593|592726974|FG001|Overall Study|Adverse Event|2|||
163944770|NCT04410523|592166794|FG003|Overall Study|Lost to Follow-up|0|||
163944771|NCT04410523|592166795|FG004|Overall Study|Lost to Follow-up|0|||
163944772|NCT04410523|592166796|FG005|Overall Study|Lost to Follow-up|0|||
163944773|NCT04410523|592166791|FG000|Overall Study|Physician Decision|0|||
163944774|NCT04410523|592166792|FG001|Overall Study|Physician Decision|1|||
163944775|NCT04410523|592166793|FG002|Overall Study|Physician Decision|0|||
163944776|NCT04410523|592166794|FG003|Overall Study|Physician Decision|0|||
163944777|NCT04410523|592166795|FG004|Overall Study|Physician Decision|0|||
163944778|NCT04410523|592166796|FG005|Overall Study|Physician Decision|0|||
163944779|NCT04410523|592166791|FG000|Overall Study|Pregnancy|0|||
163944780|NCT04410523|592166792|FG001|Overall Study|Pregnancy|0|||
163944781|NCT04410523|592166793|FG002|Overall Study|Pregnancy|0|||
163944782|NCT04410523|592166794|FG003|Overall Study|Pregnancy|0|||
163944783|NCT04410523|592166795|FG004|Overall Study|Pregnancy|0|||
163944784|NCT04410523|592166796|FG005|Overall Study|Pregnancy|1|||
163944785|NCT04410523|592166791|FG000|Overall Study|Protocol deviation|0|||
163944786|NCT04410523|592166792|FG001|Overall Study|Protocol deviation|0|||
163944787|NCT04410523|592166793|FG002|Overall Study|Protocol deviation|0|||
163944788|NCT04410523|592166794|FG003|Overall Study|Protocol deviation|0|||
163944789|NCT04410523|592166795|FG004|Overall Study|Protocol deviation|0|||
163944790|NCT04410523|592166796|FG005|Overall Study|Protocol deviation|2|||
163944791|NCT04410523|592166791|FG000|Overall Study|Subject decision|2|||
163944792|NCT04410523|592166792|FG001|Overall Study|Subject decision|0|||
163944793|NCT04410523|592166793|FG002|Overall Study|Subject decision|0|||
163944794|NCT04410523|592166794|FG003|Overall Study|Subject decision|1|||
163944795|NCT04410523|592166795|FG004|Overall Study|Subject decision|0|||
163944796|NCT04410523|592166796|FG005|Overall Study|Subject decision|1|||
163944797|NCT00490490|592166797|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
163944798|NCT00490490|592166797|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
163944799|NCT03268603|592166798|FG000|Overall Study|Withdrawal by Subject|6|||
163944800|NCT03268603|592166798|FG000|Overall Study|Physician Decision|1|||
163944801|NCT03268603|592166798|FG000|Overall Study|Withdrawn due to disease progression|2|||
163944802|NCT04939701|592166799|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
163944803|NCT04939701|592166800|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
163944804|NCT04939701|592166801|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
163944805|NCT04939701|592166799|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
163944806|NCT04939701|592166800|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
163944807|NCT04939701|592166801|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
163944808|NCT04939701|592166799|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
163944809|NCT04939701|592166800|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
163944810|NCT04939701|592166801|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
163944811|NCT04939701|592166799|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
163944812|NCT04939701|592166800|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
163944813|NCT04939701|592166801|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
163944814|NCT04939701|592166799|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
163944815|NCT04939701|592166800|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
163944816|NCT04939701|592166801|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
163944817|NCT04939701|592166799|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
163944818|NCT04939701|592166800|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
163944819|NCT04939701|592166801|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
163944820|NCT04939701|592166799|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
163944821|NCT04939701|592166800|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
163944822|NCT04939701|592166801|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
163944823|NCT00772330|592166802|FG000|Overall Study|Lost to Follow-up|3|||
163944824|NCT00734591|592166803|FG000|Screening for Prospective Period|Site did not participate|1604|||
163944825|NCT00734591|592166804|FG001|Screening for Prospective Period|Site did not participate|1488|||
163944826|NCT00734591|592166803|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
163944827|NCT00734591|592166804|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
163944828|NCT00734591|592166803|FG000|Prospective Period|Withdrawal by Subject|11|||
163944829|NCT00734591|592166804|FG001|Prospective Period|Withdrawal by Subject|9|||
163944830|NCT00734591|592166803|FG000|Prospective Period|Lost to Follow-up|37|||
163944831|NCT00734591|592166804|FG001|Prospective Period|Lost to Follow-up|33|||
163944832|NCT00734591|592166803|FG000|Prospective Period|Study Terminated|1|||
163944833|NCT00734591|592166804|FG001|Prospective Period|Study Terminated|0|||
163944834|NCT00734591|592166803|FG000|Prospective Period|Other|2|||
164099028|NCT00385593|592726973|FG000|Overall Study|Withdrawal by Subject|17|||
163944835|NCT00734591|592166804|FG001|Prospective Period|Other|2|||
163944836|NCT03248882|592166807|FG000|Overall Study|Adverse Event|3|||
163944837|NCT03248882|592166808|FG001|Overall Study|Adverse Event|3|||
163944838|NCT03248882|592166809|FG002|Overall Study|Adverse Event|2|||
163944839|NCT03248882|592166810|FG003|Overall Study|Adverse Event|6|||
164044088|NCT02203916|592521614|FG001|Overall Study|Major Protocol Deviation|1|||
164044089|NCT02203916|592521615|FG002|Overall Study|Major Protocol Deviation|0|||
164044090|NCT02203916|592521613|FG000|Overall Study|Lost to Follow-up|0|||
164044091|NCT02203916|592521614|FG001|Overall Study|Lost to Follow-up|1|||
164044092|NCT02203916|592521615|FG002|Overall Study|Lost to Follow-up|0|||
164044093|NCT02203916|592521613|FG000|Overall Study|Voluntary Withdrawal|3|||
164044094|NCT02203916|592521614|FG001|Overall Study|Voluntary Withdrawal|3|||
164044095|NCT02203916|592521615|FG002|Overall Study|Voluntary Withdrawal|8|||
164044096|NCT02203916|592521613|FG000|Overall Study|Lack of Efficacy|3|||
164044097|NCT02203916|592521614|FG001|Overall Study|Lack of Efficacy|0|||
164044098|NCT02203916|592521615|FG002|Overall Study|Lack of Efficacy|0|||
164044099|NCT02203916|592521613|FG000|Overall Study|Reason Not Specified|0|||
164044100|NCT02203916|592521614|FG001|Overall Study|Reason Not Specified|2|||
164044101|NCT02203916|592521615|FG002|Overall Study|Reason Not Specified|1|||
164044102|NCT03152110|592521626|FG000|Overall Study|Withdrawal by Subject|3|||
164044103|NCT00552344|592521636|FG000|Overall Study|Lack of Efficacy|55|||
164044104|NCT00552344|592521636|FG000|Overall Study|Loss of efficacy|75|||
164044105|NCT00552344|592521636|FG000|Overall Study|Lost to Follow-up|8|||
164044106|NCT00552344|592521636|FG000|Overall Study|Withdrawal by Subject|48|||
164044107|NCT00552344|592521636|FG000|Overall Study|SAE, non-fatal|6|||
164044108|NCT00552344|592521636|FG000|Overall Study|AE, non-serious non-fatal|38|||
164044109|NCT00552344|592521636|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
164044110|NCT00552344|592521636|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
164044111|NCT00552344|592521636|FG000|Overall Study|Other Reason|22|||
164044112|NCT04247828|592521639|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
164044113|NCT00045630|592521642|FG000|Overall Study|Adverse Event|1|||
164044114|NCT00045630|592521642|FG000|Overall Study|Refusal unrelated to adverse event|1|||
164044115|NCT00045630|592521642|FG000|Overall Study|Progression/relapse|1|||
164044116|NCT00045630|592521642|FG000|Overall Study|Death|1|||
163944840|NCT03248882|592166811|FG004|Overall Study|Adverse Event|9|||
163944841|NCT03248882|592166807|FG000|Overall Study|Lost to Follow-up|0|||
163944842|NCT03248882|592166808|FG001|Overall Study|Lost to Follow-up|0|||
163944843|NCT03248882|592166809|FG002|Overall Study|Lost to Follow-up|0|||
163944844|NCT03248882|592166810|FG003|Overall Study|Lost to Follow-up|0|||
163944845|NCT03248882|592166811|FG004|Overall Study|Lost to Follow-up|1|||
163944846|NCT03248882|592166807|FG000|Overall Study|Protocol Violation|2|||
163944847|NCT03248882|592166808|FG001|Overall Study|Protocol Violation|0|||
163944848|NCT03248882|592166809|FG002|Overall Study|Protocol Violation|2|||
163944849|NCT03248882|592166810|FG003|Overall Study|Protocol Violation|0|||
163944850|NCT03248882|592166811|FG004|Overall Study|Protocol Violation|1|||
163944851|NCT03248882|592166807|FG000|Overall Study|Withdrawal by Subject|2|||
163944852|NCT03248882|592166808|FG001|Overall Study|Withdrawal by Subject|2|||
163944853|NCT03248882|592166809|FG002|Overall Study|Withdrawal by Subject|3|||
163944854|NCT03248882|592166810|FG003|Overall Study|Withdrawal by Subject|4|||
163944855|NCT03248882|592166811|FG004|Overall Study|Withdrawal by Subject|2|||
163944856|NCT01656200|592166812|FG000|Overall Study|Withdrawal by Subject|1|||
163944857|NCT01461811|592166813|FG000|Overall Study|Adverse Event|2|||
163944858|NCT01461811|592166814|FG001|Overall Study|Adverse Event|1|||
163944859|NCT01461811|592166813|FG000|Overall Study|Subject decision unrelated to an AE|1|||
163944860|NCT01461811|592166814|FG001|Overall Study|Subject decision unrelated to an AE|1|||
163944861|NCT01461811|592166813|FG000|Overall Study|Noncompliance|1|||
163944862|NCT01461811|592166814|FG001|Overall Study|Noncompliance|1|||
163944863|NCT03015129|592166815|FG000|Overall Study|Death|2|||
163944864|NCT03015129|592166816|FG001|Overall Study|Death|2|||
163944865|NCT03015129|592166815|FG000|Overall Study|Lost to Follow-up|0|||
163944866|NCT03015129|592166816|FG001|Overall Study|Lost to Follow-up|1|||
163944867|NCT03015129|592166815|FG000|Overall Study|Progression of disease|38|||
163944868|NCT03015129|592166816|FG001|Overall Study|Progression of disease|33|||
163944869|NCT03015129|592166815|FG000|Overall Study|Adverse Event|0|||
163944870|NCT03015129|592166816|FG001|Overall Study|Adverse Event|4|||
163944871|NCT05032872|592166817|FG000|Overall Study|Adverse Event|1|||
163944872|NCT05032872|592166818|FG001|Overall Study|Adverse Event|0|||
164044117|NCT00045630|592521642|FG000|Overall Study|Ineligible|2|||
164044118|NCT00565812|592521647|FG000|Overall Study|Death|2|||
163944873|NCT05032872|592166817|FG000|Overall Study|Lost to Follow-up|2|||
164044119|NCT00565812|592521648|FG001|Overall Study|Death|1|||
164044120|NCT00565812|592521649|FG002|Overall Study|Death|3|||
164044121|NCT00565812|592521647|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
164044122|NCT00565812|592521648|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
164044123|NCT00565812|592521649|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
163944874|NCT05032872|592166818|FG001|Overall Study|Lost to Follow-up|4|||
163944875|NCT05032872|592166817|FG000|Overall Study|Withdrawal by Subject|4|||
163944876|NCT05032872|592166818|FG001|Overall Study|Withdrawal by Subject|3|||
163944877|NCT00338962|592166819|FG000|Overall Study|Lost to Follow-up|3|||
163944878|NCT00338962|592166820|FG001|Overall Study|Lost to Follow-up|3|||
163944879|NCT00338962|592166821|FG002|Overall Study|Lost to Follow-up|2|||
163944880|NCT00338962|592166822|FG003|Overall Study|Lost to Follow-up|3|||
164044124|NCT00565812|592521647|FG000|Overall Study|Lost to Follow-up|10|||
163944881|NCT00338962|592166819|FG000|Overall Study|Withdrawal by Subject|1|||
163944882|NCT00338962|592166820|FG001|Overall Study|Withdrawal by Subject|0|||
163944883|NCT00338962|592166821|FG002|Overall Study|Withdrawal by Subject|0|||
163944884|NCT00338962|592166822|FG003|Overall Study|Withdrawal by Subject|0|||
163944885|NCT00338962|592166819|FG000|Overall Study|No Transportation|2|||
163944886|NCT00338962|592166820|FG001|Overall Study|No Transportation|0|||
163944887|NCT00338962|592166821|FG002|Overall Study|No Transportation|0|||
163944888|NCT00338962|592166822|FG003|Overall Study|No Transportation|0|||
163944889|NCT00338962|592166819|FG000|Overall Study|Time Constraint|2|||
163944890|NCT00338962|592166820|FG001|Overall Study|Time Constraint|0|||
163944891|NCT00338962|592166821|FG002|Overall Study|Time Constraint|0|||
163944892|NCT00338962|592166822|FG003|Overall Study|Time Constraint|0|||
163944893|NCT00338962|592166819|FG000|Overall Study|Moved|0|||
163944894|NCT00338962|592166820|FG001|Overall Study|Moved|1|||
163944895|NCT00338962|592166821|FG002|Overall Study|Moved|0|||
163944896|NCT00338962|592166822|FG003|Overall Study|Moved|0|||
163944897|NCT00338962|592166819|FG000|Overall Study|Adverse Event|0|||
163944898|NCT00338962|592166820|FG001|Overall Study|Adverse Event|0|||
163944899|NCT00338962|592166821|FG002|Overall Study|Adverse Event|2|||
163944900|NCT00338962|592166822|FG003|Overall Study|Adverse Event|0|||
163944901|NCT00338962|592166819|FG000|Overall Study|Poor Compliance|0|||
163944902|NCT00338962|592166820|FG001|Overall Study|Poor Compliance|0|||
163944903|NCT00338962|592166821|FG002|Overall Study|Poor Compliance|2|||
163944904|NCT00338962|592166822|FG003|Overall Study|Poor Compliance|0|||
163944905|NCT03733314|592166823|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
163944906|NCT03733314|592166824|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
163944907|NCT03733314|592166823|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
163944908|NCT03733314|592166824|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
163944909|NCT03733314|592166823|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
163944910|NCT03733314|592166824|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
163944911|NCT03733314|592166823|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
163944912|NCT03733314|592166824|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
163944913|NCT03733314|592166823|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
163944914|NCT03733314|592166824|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
163944915|NCT03733314|592166823|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
163944916|NCT03733314|592166824|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
163944917|NCT01598662|592166825|FG000|Overall Study|Lost to Follow-up|10|||
163944918|NCT01598662|592166826|FG001|Overall Study|Lost to Follow-up|17|||
163944919|NCT01598662|592166825|FG000|Overall Study|Physician Decision|1|||
163944920|NCT01598662|592166826|FG001|Overall Study|Physician Decision|2|||
163944921|NCT01598662|592166825|FG000|Overall Study|IUD expelled before month 6|0|||
163944922|NCT01598662|592166826|FG001|Overall Study|IUD expelled before month 6|2|||
163944923|NCT00910039|592166827|FG000|Overall Study|Physician Decision|1|||
163944924|NCT04155047|592166832|FG000|Overall Study|Adverse Event|1|||
163944925|NCT04155047|592166833|FG001|Overall Study|Adverse Event|0|||
163944926|NCT04155047|592166832|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
163944927|NCT04155047|592166833|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
163944928|NCT04514510|592166834|FG000|Overall Study|Lost to Follow-up|0|||
163944929|NCT04514510|592166835|FG001|Overall Study|Lost to Follow-up|1|||
163944930|NCT04514510|592166834|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
163944931|NCT04514510|592166835|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
163944932|NCT00821587|592166836|FG000|Overall Study|Physician Decision|0|||
163944933|NCT00821587|592166837|FG001|Overall Study|Physician Decision|1|||
163944934|NCT02781090|592166840|FG000|3-Month Follow-Up|Missed Visit|20|||
163944935|NCT02781090|592166841|FG001|3-Month Follow-Up|Missed Visit|20|||
163944936|NCT02781090|592166840|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
163944937|NCT02781090|592166841|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
163944938|NCT02781090|592166840|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
163944939|NCT02781090|592166841|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
163944940|NCT02781090|592166840|FG000|3-Month Follow-Up|Death|1|||
163944941|NCT02781090|592166841|FG001|3-Month Follow-Up|Death|0|||
163944942|NCT02781090|592166840|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
163944943|NCT02781090|592166841|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
163944944|NCT02781090|592166840|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
163944945|NCT02781090|592166841|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
163944946|NCT02781090|592166840|FG000|6-Month Follow-Up|Death|0|||
163944947|NCT02781090|592166841|FG001|6-Month Follow-Up|Death|1|||
163944948|NCT00643617|592166842|FG000|Overall Study|Death|6|||
163944949|NCT00643617|592166843|FG001|Overall Study|Death|9|||
163944950|NCT00643617|592166842|FG000|Overall Study|Lost to Follow-up|42|||
163944951|NCT00643617|592166843|FG001|Overall Study|Lost to Follow-up|51|||
163944952|NCT02075073|592166844|FG000|Overall Study|Withdrawal by Subject|0|||
163944953|NCT02075073|592166845|FG001|Overall Study|Withdrawal by Subject|1|||
163944954|NCT02075073|592166846|FG002|Overall Study|Withdrawal by Subject|0|||
163944955|NCT01208103|592166853|FG000|Overall Study|Adverse Event|1|||
163944956|NCT01208103|592166853|FG000|Overall Study|Withdrawal by Subject|1|||
163944957|NCT02770612|592166860|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
163944958|NCT02233803|592166861|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
163944959|NCT02233803|592166862|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
163944960|NCT02233803|592166861|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
163944961|NCT02233803|592166862|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
163944962|NCT02233803|592166861|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
163944963|NCT02233803|592166862|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
163944964|NCT02233803|592166861|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
163944965|NCT02233803|592166862|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
163944966|NCT02233803|592166861|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
163944967|NCT02233803|592166862|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
163944968|NCT02233803|592166861|FG000|Washout Period (4-Wks)|Physician Decision|1|||
163944969|NCT02233803|592166862|FG001|Washout Period (4-Wks)|Physician Decision|0|||
163944970|NCT02233803|592166861|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
163944971|NCT02233803|592166862|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
163944972|NCT02233803|592166861|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
163944973|NCT02233803|592166862|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
163944974|NCT02233803|592166861|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
163842079|NCT01533714|591792864|FG004|Overall Study|Withdrawal by Subject|1|||
163842080|NCT01533714|591792865|FG005|Overall Study|Withdrawal by Subject|0|||
163842081|NCT01533714|591792860|FG000|Overall Study|Exclusion criteria|0|||
163944975|NCT02233803|592166862|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
163944976|NCT03846453|592166863|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
163944977|NCT03846453|592166864|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
163944978|NCT03846453|592166865|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
164044125|NCT00565812|592521648|FG001|Overall Study|Lost to Follow-up|8|||
164044126|NCT00565812|592521649|FG002|Overall Study|Lost to Follow-up|8|||
164044127|NCT00565812|592521647|FG000|Overall Study|Withdrawal by Subject|58|||
164044128|NCT00565812|592521648|FG001|Overall Study|Withdrawal by Subject|47|||
164044129|NCT00565812|592521649|FG002|Overall Study|Withdrawal by Subject|48|||
163842082|NCT01533714|591792861|FG001|Overall Study|Exclusion criteria|1|||
163842083|NCT01533714|591792862|FG002|Overall Study|Exclusion criteria|0|||
163842084|NCT01533714|591792863|FG003|Overall Study|Exclusion criteria|0|||
163842085|NCT01533714|591792864|FG004|Overall Study|Exclusion criteria|0|||
163842086|NCT01533714|591792865|FG005|Overall Study|Exclusion criteria|0|||
163842087|NCT01533714|591792860|FG000|Overall Study|Positive for purified protein derivative|0|||
163842088|NCT01533714|591792861|FG001|Overall Study|Positive for purified protein derivative|0|||
163842089|NCT01533714|591792862|FG002|Overall Study|Positive for purified protein derivative|1|||
163842090|NCT01533714|591792863|FG003|Overall Study|Positive for purified protein derivative|0|||
163842091|NCT01533714|591792864|FG004|Overall Study|Positive for purified protein derivative|1|||
163842092|NCT01533714|591792865|FG005|Overall Study|Positive for purified protein derivative|0|||
163842093|NCT01533714|591792860|FG000|Overall Study|Withdrawal criteria|0|||
163842094|NCT01533714|591792861|FG001|Overall Study|Withdrawal criteria|0|||
163842095|NCT01533714|591792862|FG002|Overall Study|Withdrawal criteria|1|||
163842096|NCT01533714|591792863|FG003|Overall Study|Withdrawal criteria|0|||
163842097|NCT01533714|591792864|FG004|Overall Study|Withdrawal criteria|3|||
163842098|NCT01533714|591792865|FG005|Overall Study|Withdrawal criteria|1|||
163842099|NCT01533714|591792860|FG000|Overall Study|Ineligibility reason|0|||
163842100|NCT01533714|591792861|FG001|Overall Study|Ineligibility reason|0|||
163842101|NCT01533714|591792862|FG002|Overall Study|Ineligibility reason|0|||
163842102|NCT01533714|591792863|FG003|Overall Study|Ineligibility reason|1|||
163842103|NCT01533714|591792864|FG004|Overall Study|Ineligibility reason|0|||
163842104|NCT01533714|591792865|FG005|Overall Study|Ineligibility reason|0|||
163842105|NCT02564055|591792866|FG000|Overall Study|Adverse Event|1|||
163842106|NCT02564055|591792867|FG001|Overall Study|Adverse Event|0|||
163842107|NCT02564055|591792868|FG002|Overall Study|Adverse Event|4|||
163842108|NCT02564055|591792869|FG003|Overall Study|Adverse Event|1|||
163842109|NCT02564055|591792870|FG004|Overall Study|Adverse Event|4|||
163842110|NCT02564055|591792871|FG005|Overall Study|Adverse Event|1|||
163842111|NCT02564055|591792866|FG000|Overall Study|Protocol Violation|1|||
163842112|NCT02564055|591792867|FG001|Overall Study|Protocol Violation|0|||
163842113|NCT02564055|591792868|FG002|Overall Study|Protocol Violation|0|||
163842114|NCT02564055|591792869|FG003|Overall Study|Protocol Violation|0|||
163842115|NCT02564055|591792870|FG004|Overall Study|Protocol Violation|0|||
163842116|NCT02564055|591792871|FG005|Overall Study|Protocol Violation|0|||
163842117|NCT02564055|591792866|FG000|Overall Study|Reached stopping criteria|0|||
163842118|NCT02564055|591792867|FG001|Overall Study|Reached stopping criteria|0|||
163842119|NCT02564055|591792868|FG002|Overall Study|Reached stopping criteria|0|||
163842120|NCT02564055|591792869|FG003|Overall Study|Reached stopping criteria|0|||
163842121|NCT02564055|591792870|FG004|Overall Study|Reached stopping criteria|0|||
163842122|NCT02564055|591792871|FG005|Overall Study|Reached stopping criteria|1|||
163842123|NCT02564055|591792866|FG000|Overall Study|Lost to Follow-up|0|||
163944979|NCT03846453|592166863|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
163944980|NCT03846453|592166864|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
163944981|NCT03846453|592166865|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
163944982|NCT03846453|592166863|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
163944983|NCT03846453|592166864|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
163944984|NCT03846453|592166865|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
163944985|NCT03846453|592166863|FG000|Placebo Run-in (14 Days)|Other|2|||
163944986|NCT03846453|592166864|FG001|Placebo Run-in (14 Days)|Other|0|||
163944987|NCT03846453|592166865|FG002|Placebo Run-in (14 Days)|Other|0|||
163944988|NCT03846453|592166863|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
163944989|NCT03846453|592166864|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
163944990|NCT03846453|592166865|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
163944991|NCT03846453|592166863|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
163944992|NCT03846453|592166864|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
163944993|NCT03846453|592166865|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
163944994|NCT03846453|592166863|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
163944995|NCT03846453|592166864|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
163944996|NCT03846453|592166865|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
163944997|NCT03846453|592166863|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
163944998|NCT03846453|592166864|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
163944999|NCT03846453|592166865|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
163945000|NCT03846453|592166863|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
163945001|NCT03846453|592166864|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
163945002|NCT03846453|592166865|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
163945003|NCT01696955|592166866|FG000|Main Study|Protocol Violation|1|||
163945004|NCT01696955|592166867|FG001|Main Study|Protocol Violation|0|||
163945005|NCT01696955|592166866|FG000|Main Study|Withdrawal by Subject|1|||
163945006|NCT01696955|592166867|FG001|Main Study|Withdrawal by Subject|1|||
163945007|NCT05330676|592166870|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
163945008|NCT05330676|592166871|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
163945009|NCT03653208|592166872|FG000|Overall Study|Withdrawal by Subject|0|||
163945010|NCT03653208|592166873|FG001|Overall Study|Withdrawal by Subject|0|||
163945011|NCT03653208|592166874|FG002|Overall Study|Withdrawal by Subject|0|||
163945012|NCT03653208|592166875|FG003|Overall Study|Withdrawal by Subject|0|||
163945013|NCT03653208|592166876|FG004|Overall Study|Withdrawal by Subject|1|||
163945014|NCT03653208|592166877|FG005|Overall Study|Withdrawal by Subject|0|||
163945015|NCT03653208|592166878|FG006|Overall Study|Withdrawal by Subject|0|||
163945016|NCT03653208|592166879|FG007|Overall Study|Withdrawal by Subject|1|||
163945017|NCT03653208|592166880|FG008|Overall Study|Withdrawal by Subject|1|||
163945018|NCT00436605|592166881|FG000|Overall Study|Protocol Violation|3|||
163945019|NCT00573859|592166884|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
163945020|NCT00573859|592166884|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
163945021|NCT02416453|592166885|FG000|Overall Study|Adverse Event|0|||
163945022|NCT02416453|592166886|FG001|Overall Study|Adverse Event|0|||
163945023|NCT02416453|592166887|FG002|Overall Study|Adverse Event|0|||
163945024|NCT02416453|592166888|FG003|Overall Study|Adverse Event|2|||
163945025|NCT02416453|592166889|FG004|Overall Study|Adverse Event|0|||
163945026|NCT02416453|592166890|FG005|Overall Study|Adverse Event|1|||
163945027|NCT02416453|592166891|FG006|Overall Study|Adverse Event|0|||
163945028|NCT02416453|592166892|FG007|Overall Study|Adverse Event|0|||
163945029|NCT02416453|592166893|FG008|Overall Study|Adverse Event|0|||
163945030|NCT02416453|592166894|FG009|Overall Study|Adverse Event|0|||
163945031|NCT02416453|592166895|FG010|Overall Study|Adverse Event|0|||
163945032|NCT02416453|592166885|FG000|Overall Study|Lost to Follow-up|1|||
163945033|NCT02416453|592166886|FG001|Overall Study|Lost to Follow-up|3|||
163945034|NCT02416453|592166887|FG002|Overall Study|Lost to Follow-up|0|||
163945035|NCT02416453|592166888|FG003|Overall Study|Lost to Follow-up|8|||
163945036|NCT02416453|592166889|FG004|Overall Study|Lost to Follow-up|0|||
163945037|NCT02416453|592166890|FG005|Overall Study|Lost to Follow-up|5|||
163945038|NCT02416453|592166891|FG006|Overall Study|Lost to Follow-up|1|||
163945039|NCT02416453|592166892|FG007|Overall Study|Lost to Follow-up|3|||
163945040|NCT02416453|592166893|FG008|Overall Study|Lost to Follow-up|1|||
163945041|NCT02416453|592166894|FG009|Overall Study|Lost to Follow-up|0|||
163945042|NCT02416453|592166895|FG010|Overall Study|Lost to Follow-up|0|||
163945043|NCT02416453|592166885|FG000|Overall Study|Physician Decision|0|||
163945044|NCT02416453|592166886|FG001|Overall Study|Physician Decision|0|||
163945045|NCT02416453|592166887|FG002|Overall Study|Physician Decision|0|||
163945046|NCT02416453|592166888|FG003|Overall Study|Physician Decision|0|||
163945047|NCT02416453|592166889|FG004|Overall Study|Physician Decision|0|||
163945048|NCT02416453|592166890|FG005|Overall Study|Physician Decision|1|||
163945049|NCT02416453|592166891|FG006|Overall Study|Physician Decision|1|||
163945050|NCT02416453|592166892|FG007|Overall Study|Physician Decision|1|||
163945051|NCT02416453|592166893|FG008|Overall Study|Physician Decision|0|||
163945052|NCT02416453|592166894|FG009|Overall Study|Physician Decision|0|||
163945053|NCT02416453|592166895|FG010|Overall Study|Physician Decision|0|||
163945054|NCT02416453|592166885|FG000|Overall Study|Withdrawal by Subject|2|||
163945055|NCT02416453|592166886|FG001|Overall Study|Withdrawal by Subject|0|||
164044130|NCT00565812|592521647|FG000|Overall Study|Work Schedule|5|||
164044131|NCT00565812|592521648|FG001|Overall Study|Work Schedule|3|||
164044132|NCT00565812|592521649|FG002|Overall Study|Work Schedule|1|||
164044133|NCT00565812|592521647|FG000|Overall Study|Protocol Violation|2|||
164044134|NCT00565812|592521648|FG001|Overall Study|Protocol Violation|6|||
164044135|NCT00565812|592521649|FG002|Overall Study|Protocol Violation|4|||
164044136|NCT00565812|592521647|FG000|Overall Study|Adverse Event|41|||
164044137|NCT00565812|592521648|FG001|Overall Study|Adverse Event|54|||
164044138|NCT00565812|592521649|FG002|Overall Study|Adverse Event|40|||
164044139|NCT00565812|592521647|FG000|Overall Study|Jury Duty|1|||
164044140|NCT00565812|592521648|FG001|Overall Study|Jury Duty|0|||
164044141|NCT00565812|592521649|FG002|Overall Study|Jury Duty|0|||
164044142|NCT00565812|592521647|FG000|Overall Study|Relocated Out of Area|5|||
164044143|NCT00565812|592521648|FG001|Overall Study|Relocated Out of Area|8|||
164044144|NCT00565812|592521649|FG002|Overall Study|Relocated Out of Area|9|||
164044145|NCT00565812|592521647|FG000|Overall Study|Sponsor Decision|1|||
164044146|NCT00565812|592521648|FG001|Overall Study|Sponsor Decision|5|||
164044147|NCT00565812|592521649|FG002|Overall Study|Sponsor Decision|1|||
164044148|NCT00565812|592521647|FG000|Overall Study|Domestic Reasons|7|||
164044149|NCT00565812|592521648|FG001|Overall Study|Domestic Reasons|1|||
164044150|NCT00565812|592521649|FG002|Overall Study|Domestic Reasons|3|||
164044151|NCT00565812|592521647|FG000|Overall Study|Research Site Closure|6|||
164044152|NCT00565812|592521648|FG001|Overall Study|Research Site Closure|1|||
164044153|NCT00565812|592521649|FG002|Overall Study|Research Site Closure|8|||
164044154|NCT00565812|592521647|FG000|Overall Study|Surgical Intervention|0|||
164044155|NCT00565812|592521648|FG001|Overall Study|Surgical Intervention|1|||
164044156|NCT00565812|592521649|FG002|Overall Study|Surgical Intervention|2|||
164044157|NCT00565812|592521647|FG000|Overall Study|Low Compliance|1|||
164044158|NCT00565812|592521648|FG001|Overall Study|Low Compliance|0|||
164044159|NCT00565812|592521649|FG002|Overall Study|Low Compliance|1|||
164044160|NCT00565812|592521647|FG000|Overall Study|Follow-up Visit Not Completed|2|||
164044161|NCT00565812|592521648|FG001|Overall Study|Follow-up Visit Not Completed|0|||
164044162|NCT00565812|592521649|FG002|Overall Study|Follow-up Visit Not Completed|1|||
164044163|NCT00565812|592521647|FG000|Overall Study|Physician Decision|2|||
164044164|NCT00565812|592521648|FG001|Overall Study|Physician Decision|0|||
164044165|NCT00565812|592521649|FG002|Overall Study|Physician Decision|0|||
164044166|NCT02896192|592521657|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
164044167|NCT02896192|592521657|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
164044168|NCT02896192|592521657|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
164044169|NCT00383708|592521661|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
164044170|NCT00383708|592521661|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
164044171|NCT00383708|592521661|FG000|Run-in Period|Protocol Violation|4|||
164044172|NCT00383708|592521661|FG000|Run-in Period|Adverse Event|2|||
164044173|NCT00383708|592521661|FG000|Run-in Period|Claustrophobia|1|||
164044174|NCT00383708|592521661|FG000|Co-administration Period|Adverse Event|5|||
164044175|NCT02820038|592521666|FG000|Overall Study|Lost to Follow-up|7|||
164044176|NCT02820038|592521667|FG001|Overall Study|Lost to Follow-up|11|||
164044177|NCT02820038|592521668|FG002|Overall Study|Lost to Follow-up|2|||
164044178|NCT02820038|592521669|FG003|Overall Study|Lost to Follow-up|9|||
164044179|NCT02820038|592521666|FG000|Overall Study|Withdrawal by Subject|3|||
164044180|NCT02820038|592521667|FG001|Overall Study|Withdrawal by Subject|14|||
164044181|NCT02820038|592521668|FG002|Overall Study|Withdrawal by Subject|3|||
164044182|NCT02820038|592521669|FG003|Overall Study|Withdrawal by Subject|13|||
164044183|NCT03934203|592521670|FG000|Overall Study|Adverse Event|0|||
164044184|NCT03934203|592521671|FG001|Overall Study|Adverse Event|0|||
164044185|NCT03934203|592521672|FG002|Overall Study|Adverse Event|1|||
164044186|NCT03934203|592521673|FG003|Overall Study|Adverse Event|0|||
164044187|NCT03934203|592521674|FG004|Overall Study|Adverse Event|1|||
164044188|NCT03934203|592521675|FG005|Overall Study|Adverse Event|0|||
164044189|NCT03934203|592521676|FG006|Overall Study|Adverse Event|2|||
164044190|NCT03934203|592521677|FG007|Overall Study|Adverse Event|0|||
164044191|NCT03934203|592521678|FG008|Overall Study|Adverse Event|0|||
164044192|NCT03934203|592521679|FG009|Overall Study|Adverse Event|0|||
164044193|NCT03934203|592521680|FG010|Overall Study|Adverse Event|0|||
164044194|NCT03934203|592521681|FG011|Overall Study|Adverse Event|0|||
164044195|NCT03934203|592521682|FG012|Overall Study|Adverse Event|0|||
164044196|NCT03934203|592521683|FG013|Overall Study|Adverse Event|1|||
164044197|NCT03934203|592521684|FG014|Overall Study|Adverse Event|0|||
164044198|NCT00899678|592521685|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
164044199|NCT00899678|592521686|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
164044200|NCT00899678|592521687|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
164044201|NCT00899678|592521685|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
164044202|NCT00899678|592521686|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
164044203|NCT00899678|592521687|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
164044204|NCT00899678|592521685|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
164044205|NCT00899678|592521686|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
164044206|NCT00899678|592521687|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
163945056|NCT02416453|592166887|FG002|Overall Study|Withdrawal by Subject|0|||
163945057|NCT02416453|592166888|FG003|Overall Study|Withdrawal by Subject|5|||
163945058|NCT02416453|592166889|FG004|Overall Study|Withdrawal by Subject|1|||
163945059|NCT02416453|592166890|FG005|Overall Study|Withdrawal by Subject|8|||
163945060|NCT02416453|592166891|FG006|Overall Study|Withdrawal by Subject|0|||
163945061|NCT02416453|592166892|FG007|Overall Study|Withdrawal by Subject|8|||
163945062|NCT02416453|592166893|FG008|Overall Study|Withdrawal by Subject|4|||
163945063|NCT02416453|592166894|FG009|Overall Study|Withdrawal by Subject|0|||
163945064|NCT02416453|592166895|FG010|Overall Study|Withdrawal by Subject|0|||
163945065|NCT02416453|592166885|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945066|NCT02416453|592166886|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945067|NCT02416453|592166887|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
163945068|NCT02416453|592166888|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945069|NCT02416453|592166889|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945070|NCT02416453|592166890|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945071|NCT02416453|592166891|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945072|NCT02416453|592166892|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945073|NCT02416453|592166893|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945074|NCT02416453|592166894|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945075|NCT02416453|592166895|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
163945076|NCT02416453|592166885|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945077|NCT02416453|592166886|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945078|NCT02416453|592166887|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945079|NCT02416453|592166888|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945080|NCT02416453|592166889|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945081|NCT02416453|592166890|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
163945082|NCT02416453|592166891|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945083|NCT02416453|592166892|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945084|NCT02416453|592166893|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945085|NCT02416453|592166894|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945086|NCT02416453|592166895|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
163945087|NCT01989169|592166898|FG000|Period 2|Adverse Event|0|||
163945088|NCT01989169|592166899|FG001|Period 2|Adverse Event|1|||
163945089|NCT01114880|592166900|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
163945090|NCT01114880|592166901|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
163945091|NCT01114880|592166900|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
163945092|NCT01114880|592166901|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
163945093|NCT01114880|592166900|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
163945094|NCT01114880|592166901|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
163945095|NCT01114880|592166900|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
163945096|NCT01114880|592166901|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
163945097|NCT01114880|592166900|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
163945098|NCT01114880|592166901|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
163945099|NCT01114880|592166900|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
163945100|NCT01114880|592166901|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
163945101|NCT04531904|592166903|FG000|Overall Study|Lost to Follow-up|1|||
163945102|NCT04531904|592166903|FG000|Overall Study|Death|14|||
163945103|NCT02738853|592166906|FG000|Enrollment|Inclusion/Exclusion not met|21|||
163945104|NCT02738853|592166906|FG000|Enrollment|Withdrawal by Subject|3|||
163945105|NCT02738853|592166906|FG000|Enrollment|Subject treated with commercially available device|6|||
163945106|NCT02738853|592166906|FG000|Enrollment|Study Enrollment Closed|3|||
163945107|NCT02738853|592166906|FG000|Procedure|Death|1|||
163945108|NCT02738853|592166906|FG000|1 Month|Death|2|||
163945109|NCT02738853|592166906|FG000|6 Month|Death|4|||
163945110|NCT02738853|592166906|FG000|6 Month|Withdrawal by Subject|2|||
163945111|NCT02738853|592166906|FG000|1 Year|Death|6|||
163945112|NCT02738853|592166906|FG000|1 Year|Withdrawal by Subject|1|||
163945113|NCT02738853|592166906|FG000|2 Year|Death|2|||
163945114|NCT02738853|592166906|FG000|2 Year|Lost to Follow-up|1|||
163945115|NCT02738853|592166906|FG000|3 Year|Death|2|||
163945116|NCT02738853|592166906|FG000|3 Year|Withdrawal by Subject|1|||
163945117|NCT02738853|592166906|FG000|4 Year|Death|9|||
163945118|NCT02738853|592166906|FG000|5 Year|Lost to Follow-up|4|||
163945119|NCT03519997|592166907|FG000|Overall Study|Adverse Event|4|||
163945120|NCT03519997|592166907|FG000|Overall Study|Withdrawal by Subject|2|||
163945121|NCT03519997|592166907|FG000|Overall Study|Protocol Violation|1|||
163945122|NCT03361605|592166908|FG000|Overall Study|Analyzable data not available|3|||
163945123|NCT03898167|592166909|FG000|Overall Study|Terminated phone call early|7|||
163945124|NCT03898167|592166910|FG001|Overall Study|Terminated phone call early|0|||
163945125|NCT03898167|592166911|FG002|Overall Study|Terminated phone call early|0|||
163945126|NCT03898167|592166909|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
163945127|NCT03898167|592166910|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
163945128|NCT03898167|592166911|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
163945129|NCT02906007|592166912|FG000|Overall Study|Physician Decision|0|||
163945130|NCT02906007|592166913|FG001|Overall Study|Physician Decision|0|||
163945131|NCT02906007|592166914|FG002|Overall Study|Physician Decision|1|||
163945132|NCT02906007|592166912|FG000|Overall Study|Died|1|||
163945133|NCT02906007|592166913|FG001|Overall Study|Died|0|||
163945134|NCT02906007|592166914|FG002|Overall Study|Died|0|||
163945135|NCT04696653|592166915|FG000|Overall Study|left organization|18|||
163945136|NCT04696653|592166915|FG000|Overall Study|Lost to Follow-up|3|||
163945137|NCT03520712|592166916|FG000|Overall Study|Early termination of the study by Sponsor|2|||
163945138|NCT04372121|592166917|FG000|Overall Study|Lost to Follow-up|0|||
163945139|NCT04372121|592166918|FG001|Overall Study|Lost to Follow-up|0|||
163945140|NCT04372121|592166919|FG002|Overall Study|Lost to Follow-up|0|||
163945141|NCT04372121|592166920|FG003|Overall Study|Lost to Follow-up|1|||
163945142|NCT04372121|592166917|FG000|Overall Study|Protocol Violation|0|||
163945143|NCT04372121|592166918|FG001|Overall Study|Protocol Violation|0|||
163945144|NCT04372121|592166919|FG002|Overall Study|Protocol Violation|1|||
163945145|NCT04372121|592166920|FG003|Overall Study|Protocol Violation|0|||
163945146|NCT04372121|592166917|FG000|Overall Study|Withdrawal by Subject|3|||
163945147|NCT04372121|592166918|FG001|Overall Study|Withdrawal by Subject|1|||
163945148|NCT04372121|592166919|FG002|Overall Study|Withdrawal by Subject|0|||
163945149|NCT04372121|592166920|FG003|Overall Study|Withdrawal by Subject|0|||
163945150|NCT04372121|592166917|FG000|Overall Study|Study termination|6|||
163945151|NCT04372121|592166918|FG001|Overall Study|Study termination|5|||
163945152|NCT04372121|592166919|FG002|Overall Study|Study termination|1|||
163945153|NCT04372121|592166920|FG003|Overall Study|Study termination|1|||
163945154|NCT04372121|592166917|FG000|Overall Study|Hysterectomy planned|1|||
163945155|NCT04372121|592166918|FG001|Overall Study|Hysterectomy planned|0|||
163945156|NCT04372121|592166919|FG002|Overall Study|Hysterectomy planned|0|||
163945157|NCT04372121|592166920|FG003|Overall Study|Hysterectomy planned|0|||
163945158|NCT03896152|592168930|FG000|Overall Study|Patient/guardian decision|1|||
163945159|NCT03896152|592168931|FG001|Overall Study|Patient/guardian decision|1|||
163945160|NCT03896152|592168930|FG000|Overall Study|Adverse Event|0|||
163945161|NCT03896152|592168931|FG001|Overall Study|Adverse Event|1|||
163945162|NCT03896152|592168930|FG000|Overall Study|Physician Decision|1|||
163945163|NCT03896152|592168931|FG001|Overall Study|Physician Decision|0|||
163945164|NCT03896152|592168930|FG000|Overall Study|Technical problems|1|||
163945165|NCT03896152|592168931|FG001|Overall Study|Technical problems|0|||
163945166|NCT00224887|592168932|FG000|Overall Study|Pregnancy|6|||
163945167|NCT00224887|592168933|FG001|Overall Study|Pregnancy|6|||
163945168|NCT01659853|592168934|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
163945169|NCT01659853|592168935|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
163945170|NCT01659853|592168934|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
163945171|NCT01659853|592168935|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
163945172|NCT03921723|592168936|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
163945173|NCT03921723|592168936|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
163945174|NCT03046121|592168938|FG000|Overall Study|Death|32|||
163945175|NCT03046121|592168939|FG001|Overall Study|Death|60|||
163945176|NCT03046121|592168938|FG000|Overall Study|Withdrawal by Subject|14|||
163945177|NCT03046121|592168939|FG001|Overall Study|Withdrawal by Subject|12|||
163945178|NCT03214640|592168940|FG000|Overall Study|Protocol Violation|1|||
163945179|NCT03214640|592168941|FG001|Overall Study|Protocol Violation|2|||
163945180|NCT03214640|592168942|FG002|Overall Study|Protocol Violation|1|||
163945181|NCT03214640|592168943|FG003|Overall Study|Protocol Violation|4|||
163945182|NCT00406692|592168951|FG000|Overall Study|Withdrawal by Subject|4|||
163945183|NCT00406692|592168951|FG000|Overall Study|Physician Decision|1|||
163945184|NCT00406692|592168951|FG000|Overall Study|Adverse Event|1|||
163945185|NCT00406692|592168951|FG000|Overall Study|Lack of Efficacy|1|||
163945186|NCT04488770|592168952|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945187|NCT04488770|592168953|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945188|NCT04488770|592168954|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945189|NCT04488770|592168955|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
163945190|NCT04488770|592168956|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945191|NCT04488770|592168957|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945192|NCT04488770|592168958|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945193|NCT04488770|592168959|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945194|NCT04488770|592168960|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945195|NCT04488770|592168961|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945196|NCT04488770|592168962|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945197|NCT04488770|592168963|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945198|NCT04488770|592168964|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
163945199|NCT04488770|592168952|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
163945200|NCT04488770|592168953|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164044207|NCT00899678|592521685|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
164044208|NCT00899678|592521686|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
163945201|NCT04488770|592168954|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945202|NCT04488770|592168955|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164044209|NCT00899678|592521687|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
164044210|NCT00899678|592521685|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
164044211|NCT00899678|592521686|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
164044212|NCT00899678|592521687|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
164044213|NCT00899678|592521685|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
164044214|NCT00899678|592521686|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
164044215|NCT00899678|592521687|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
164044216|NCT00899678|592521685|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
164044217|NCT00899678|592521686|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
164044218|NCT00899678|592521687|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
164044219|NCT00899678|592521685|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
164044220|NCT00899678|592521686|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
164044221|NCT00899678|592521687|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
164044222|NCT00899678|592521685|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
164044223|NCT00899678|592521686|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
164044224|NCT00899678|592521687|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
164044225|NCT00368472|592521694|FG000|Overall Study|Adverse Event|22|||
164044226|NCT00368472|592521694|FG000|Overall Study|Medication non-compliance|4|||
164044227|NCT00368472|592521694|FG000|Overall Study|Protocol Violation|2|||
164044228|NCT00368472|592521694|FG000|Overall Study|Request of Investigator or Sponsor|3|||
164044229|NCT00368472|592521694|FG000|Overall Study|Withdrawal by Subject|40|||
164044230|NCT00368472|592521694|FG000|Overall Study|Diary non-compliance|1|||
164044231|NCT00368472|592521694|FG000|Overall Study|Other|32|||
164044232|NCT00368472|592521694|FG000|Overall Study|Missing Final Disposition Date|1|||
164044233|NCT00422240|592521699|FG000|Overall Study|Lack of Efficacy|1|||
164044234|NCT00422240|592521700|FG001|Overall Study|Lack of Efficacy|2|||
164044235|NCT00422240|592521701|FG002|Overall Study|Lack of Efficacy|0|||
163945203|NCT04488770|592168956|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945204|NCT04488770|592168957|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945205|NCT04488770|592168958|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
164044236|NCT00422240|592521702|FG003|Overall Study|Lack of Efficacy|1|||
164044237|NCT00422240|592521699|FG000|Overall Study|Adverse Event|11|||
164044238|NCT00422240|592521700|FG001|Overall Study|Adverse Event|4|||
164044239|NCT00422240|592521701|FG002|Overall Study|Adverse Event|5|||
164044240|NCT00422240|592521702|FG003|Overall Study|Adverse Event|2|||
164044241|NCT00422240|592521699|FG000|Overall Study|Subject request|21|||
164044242|NCT00422240|592521700|FG001|Overall Study|Subject request|17|||
164044243|NCT00422240|592521701|FG002|Overall Study|Subject request|18|||
164044244|NCT00422240|592521702|FG003|Overall Study|Subject request|30|||
164044245|NCT00422240|592521699|FG000|Overall Study|Protocol Violation|0|||
164044246|NCT00422240|592521700|FG001|Overall Study|Protocol Violation|1|||
164044247|NCT00422240|592521701|FG002|Overall Study|Protocol Violation|0|||
164044248|NCT00422240|592521702|FG003|Overall Study|Protocol Violation|1|||
164044249|NCT00422240|592521699|FG000|Overall Study|Lost to Follow-up|31|||
164044250|NCT00422240|592521700|FG001|Overall Study|Lost to Follow-up|32|||
164044251|NCT00422240|592521701|FG002|Overall Study|Lost to Follow-up|19|||
164044252|NCT00422240|592521702|FG003|Overall Study|Lost to Follow-up|34|||
164044253|NCT00422240|592521699|FG000|Overall Study|Other|1|||
164044254|NCT00422240|592521700|FG001|Overall Study|Other|0|||
164044255|NCT00422240|592521701|FG002|Overall Study|Other|0|||
164044256|NCT00422240|592521702|FG003|Overall Study|Other|1|||
164044257|NCT00422240|592521699|FG000|Overall Study|Pregnancy|3|||
164044258|NCT00422240|592521700|FG001|Overall Study|Pregnancy|1|||
164044259|NCT00422240|592521701|FG002|Overall Study|Pregnancy|1|||
164044260|NCT00422240|592521702|FG003|Overall Study|Pregnancy|2|||
163945206|NCT04488770|592168959|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945207|NCT04488770|592168960|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945208|NCT04488770|592168961|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945209|NCT04488770|592168962|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945210|NCT04488770|592168963|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945211|NCT04488770|592168964|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
163945212|NCT04488770|592168952|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164044261|NCT00901394|592521703|FG000|Overall Study|Physician Decision|1|||
164044262|NCT00901394|592521704|FG001|Overall Study|Physician Decision|1|||
164044263|NCT00901394|592521705|FG002|Overall Study|Physician Decision|2|||
164044264|NCT02650895|592521709|FG000|Overall Study|Withdrawal by Subject|0|||
164044265|NCT02650895|592521710|FG001|Overall Study|Withdrawal by Subject|1|||
164044266|NCT02650895|592521711|FG002|Overall Study|Withdrawal by Subject|0|||
164044267|NCT02650895|592521712|FG003|Overall Study|Withdrawal by Subject|0|||
164044268|NCT02650895|592521713|FG004|Overall Study|Withdrawal by Subject|0|||
164044269|NCT02650895|592521714|FG005|Overall Study|Withdrawal by Subject|0|||
164044270|NCT01167153|592521715|FG000|Overall Study|Non-effective therapy|1|||
163945213|NCT04488770|592168953|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945214|NCT04488770|592168954|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
164044271|NCT01167153|592521716|FG001|Overall Study|Non-effective therapy|4|||
164044272|NCT01167153|592521715|FG000|Overall Study|AE including clinical laboratory AE|2|||
164044273|NCT01167153|592521716|FG001|Overall Study|AE including clinical laboratory AE|8|||
164044274|NCT01167153|592521715|FG000|Overall Study|Hypotension|1|||
164044275|NCT01167153|592521716|FG001|Overall Study|Hypotension|0|||
164044276|NCT01167153|592521715|FG000|Overall Study|Lost to Follow-up|7|||
164044277|NCT01167153|592521716|FG001|Overall Study|Lost to Follow-up|9|||
164044278|NCT01167153|592521715|FG000|Overall Study|Non-compliance to concomitant medication|0|||
164044279|NCT01167153|592521716|FG001|Overall Study|Non-compliance to concomitant medication|2|||
164044280|NCT01167153|592521715|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
164044281|NCT01167153|592521716|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
164044282|NCT01167153|592521715|FG000|Overall Study|Withdrawal consent|1|||
164044283|NCT01167153|592521716|FG001|Overall Study|Withdrawal consent|1|||
164044284|NCT01167153|592521715|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
164044285|NCT01167153|592521716|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
164044286|NCT05643170|592523813|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
164044287|NCT05643170|592523813|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
164044288|NCT00444951|592523820|FG000|Overall Study|Lost to Follow-up|1|||
164044289|NCT00444951|592523821|FG001|Overall Study|Lost to Follow-up|1|||
164044290|NCT00444951|592523822|FG002|Overall Study|Lost to Follow-up|0|||
164044291|NCT00444951|592523820|FG000|Overall Study|Withdrawal by Subject|4|||
164044292|NCT00444951|592523821|FG001|Overall Study|Withdrawal by Subject|5|||
164044293|NCT00444951|592523822|FG002|Overall Study|Withdrawal by Subject|3|||
164044294|NCT02710422|592523823|FG000|Overall Study|Termination of study|9|||
164044295|NCT02710422|592523824|FG001|Overall Study|Termination of study|9|||
164044296|NCT00887822|592523825|FG000|Overall Study|Insufficient therapeutic response|53|||
164044297|NCT00887822|592523826|FG001|Overall Study|Insufficient therapeutic response|55|||
164044298|NCT00887822|592523825|FG000|Overall Study|Adverse Event|14|||
164044299|NCT00887822|592523826|FG001|Overall Study|Adverse Event|17|||
164044300|NCT00887822|592523825|FG000|Overall Study|Failure to return|11|||
164044301|NCT00887822|592523826|FG001|Overall Study|Failure to return|11|||
164044302|NCT00887822|592523825|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
164044303|NCT00887822|592523826|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
164044304|NCT00887822|592523825|FG000|Overall Study|Administrative/Other than specified|5|||
164044305|NCT00887822|592523826|FG001|Overall Study|Administrative/Other than specified|4|||
164044306|NCT00887822|592523825|FG000|Overall Study|Death|2|||
164044307|NCT00887822|592523826|FG001|Overall Study|Death|3|||
164044308|NCT00887822|592523825|FG000|Overall Study|Protocol Violation|0|||
164044309|NCT00887822|592523826|FG001|Overall Study|Protocol Violation|1|||
164044310|NCT00887822|592523825|FG000|Overall Study|Randomized but not treated|0|||
164044311|NCT00887822|592523826|FG001|Overall Study|Randomized but not treated|1|||
164044312|NCT02000622|592523827|FG000|Overall Study|Withdrawal by Subject|5|||
164044313|NCT02000622|592523828|FG001|Overall Study|Withdrawal by Subject|7|||
164044314|NCT02000622|592523827|FG000|Overall Study|Lost to Follow-up|4|||
164044315|NCT02000622|592523828|FG001|Overall Study|Lost to Follow-up|0|||
164044316|NCT02000622|592523827|FG000|Overall Study|Death|159|||
164044317|NCT02000622|592523828|FG001|Overall Study|Death|73|||
164044318|NCT02000622|592523827|FG000|Overall Study|Withdrawn due to site closure|1|||
164044319|NCT02000622|592523828|FG001|Overall Study|Withdrawn due to site closure|0|||
164044320|NCT01462045|592523829|FG000|Overall Study|Family matter|0|||
164044321|NCT01462045|592523830|FG001|Overall Study|Family matter|1|||
164044322|NCT01462045|592523831|FG002|Overall Study|Family matter|0|||
164044323|NCT01938391|592523834|FG000|6 Month Follow up|Withdrawal by Subject|1|||
164044324|NCT01938391|592523834|FG000|12 Month Follow up|Physician Decision|1|||
164044325|NCT01938391|592523834|FG000|12 Month Follow up|Withdrawal by Subject|1|||
164044326|NCT04924114|592523838|FG000|Overall Study|Withdrawal by Subject|0|||
164044327|NCT04924114|592523839|FG001|Overall Study|Withdrawal by Subject|2|||
164044328|NCT04924114|592523840|FG002|Overall Study|Withdrawal by Subject|2|||
164044329|NCT04924114|592523841|FG003|Overall Study|Withdrawal by Subject|0|||
164044330|NCT04924114|592523842|FG004|Overall Study|Withdrawal by Subject|2|||
164044331|NCT03558828|592523846|FG000|Overall Study|Lost to Follow-up|4|||
164044332|NCT03558828|592523847|FG001|Overall Study|Lost to Follow-up|3|||
164044333|NCT03558828|592523848|FG002|Overall Study|Lost to Follow-up|3|||
164044334|NCT03558828|592523849|FG003|Overall Study|Lost to Follow-up|5|||
164044335|NCT03558828|592523850|FG004|Overall Study|Lost to Follow-up|2|||
164044336|NCT03558828|592523851|FG005|Overall Study|Lost to Follow-up|3|||
164044337|NCT03558828|592523846|FG000|Overall Study|dropped before the intervention|1|||
164044338|NCT03558828|592523847|FG001|Overall Study|dropped before the intervention|1|||
164044339|NCT03558828|592523848|FG002|Overall Study|dropped before the intervention|0|||
164044340|NCT03558828|592523849|FG003|Overall Study|dropped before the intervention|0|||
164044341|NCT03558828|592523850|FG004|Overall Study|dropped before the intervention|0|||
164044342|NCT03558828|592523851|FG005|Overall Study|dropped before the intervention|0|||
164044343|NCT00378534|592523852|FG000|Overall Study|Participants did not receive transplant|3|||
164044344|NCT00378534|592523853|FG001|Overall Study|Participants did not receive transplant|0|||
164044345|NCT03671148|592523857|FG000|Overall Study|Adverse Event|3|||
163945215|NCT04488770|592168955|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945216|NCT04488770|592168956|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945217|NCT04488770|592168957|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
163945218|NCT04488770|592168958|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
163945219|NCT04488770|592168959|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945220|NCT04488770|592168960|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945221|NCT04488770|592168961|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945222|NCT04488770|592168962|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945223|NCT04488770|592168963|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945224|NCT04488770|592168964|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
163945225|NCT04488770|592168952|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945226|NCT04488770|592168953|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945227|NCT04488770|592168954|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945228|NCT04488770|592168955|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945229|NCT04488770|592168956|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
163945230|NCT04488770|592168957|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945231|NCT04488770|592168958|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945232|NCT04488770|592168959|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945233|NCT04488770|592168960|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164044346|NCT03671148|592523858|FG001|Overall Study|Adverse Event|2|||
163945234|NCT04488770|592168961|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945235|NCT04488770|592168962|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
164044347|NCT03671148|592523857|FG000|Overall Study|Withdrawal by Subject|8|||
164044348|NCT03671148|592523858|FG001|Overall Study|Withdrawal by Subject|2|||
164044349|NCT03671148|592523857|FG000|Overall Study|Lost to Follow-up|1|||
164044350|NCT03671148|592523858|FG001|Overall Study|Lost to Follow-up|2|||
164044351|NCT03671148|592523857|FG000|Overall Study|Lack of Efficacy|7|||
164044352|NCT03671148|592523858|FG001|Overall Study|Lack of Efficacy|2|||
164044353|NCT03671148|592523857|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
164044354|NCT03671148|592523858|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
163842124|NCT02564055|591792867|FG001|Overall Study|Lost to Follow-up|1|||
163842125|NCT02564055|591792868|FG002|Overall Study|Lost to Follow-up|4|||
163842126|NCT02564055|591792869|FG003|Overall Study|Lost to Follow-up|2|||
163842127|NCT02564055|591792870|FG004|Overall Study|Lost to Follow-up|1|||
163842128|NCT02564055|591792871|FG005|Overall Study|Lost to Follow-up|0|||
163842129|NCT02564055|591792866|FG000|Overall Study|Physician Decision|0|||
163842130|NCT02564055|591792867|FG001|Overall Study|Physician Decision|0|||
163842131|NCT02564055|591792868|FG002|Overall Study|Physician Decision|1|||
163842132|NCT02564055|591792869|FG003|Overall Study|Physician Decision|0|||
163842133|NCT02564055|591792870|FG004|Overall Study|Physician Decision|0|||
163842134|NCT02564055|591792871|FG005|Overall Study|Physician Decision|0|||
163842135|NCT02564055|591792866|FG000|Overall Study|Withdrawal by Subject|4|||
163842136|NCT02564055|591792867|FG001|Overall Study|Withdrawal by Subject|4|||
163842137|NCT02564055|591792868|FG002|Overall Study|Withdrawal by Subject|3|||
163842138|NCT02564055|591792869|FG003|Overall Study|Withdrawal by Subject|3|||
163842139|NCT02564055|591792870|FG004|Overall Study|Withdrawal by Subject|10|||
163945236|NCT04488770|592168963|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945237|NCT04488770|592168964|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
163945238|NCT03547739|592168965|FG000|Overall Study|Death|0|||
163945239|NCT03547739|592168966|FG001|Overall Study|Death|1|||
163945240|NCT03547739|592168967|FG002|Overall Study|Death|5|||
163945241|NCT03547739|592168965|FG000|Overall Study|Adverse Event|24|||
163945242|NCT03547739|592168966|FG001|Overall Study|Adverse Event|11|||
163945243|NCT03547739|592168967|FG002|Overall Study|Adverse Event|13|||
163842140|NCT02564055|591792871|FG005|Overall Study|Withdrawal by Subject|10|||
163945244|NCT03547739|592168965|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
163945245|NCT03547739|592168966|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
164044355|NCT03671148|592523857|FG000|Overall Study|Other|1|||
164044356|NCT03671148|592523858|FG001|Overall Study|Other|0|||
163842141|NCT00919893|591792875|FG000|Overall Study|Protocol Violation|19|||
163842142|NCT00919893|591792876|FG001|Overall Study|Protocol Violation|9|||
163842143|NCT01375959|591792877|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
163842144|NCT01375959|591792878|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
163842145|NCT01375959|591792877|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
163842146|NCT01375959|591792878|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
163842147|NCT01375959|591792877|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
163842148|NCT01375959|591792878|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
163842149|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
163842150|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
163842151|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
164099029|NCT00385593|592726974|FG001|Overall Study|Withdrawal by Subject|7|||
164099030|NCT00385593|592726973|FG000|Overall Study|Lost to Follow-up|12|||
164099031|NCT00385593|592726974|FG001|Overall Study|Lost to Follow-up|8|||
164099032|NCT00385593|592726973|FG000|Overall Study|Protocol Violation|7|||
164099033|NCT00385593|592726974|FG001|Overall Study|Protocol Violation|4|||
164099034|NCT00385593|592726973|FG000|Overall Study|Several reasons|17|||
164099035|NCT00385593|592726974|FG001|Overall Study|Several reasons|15|||
164099036|NCT00385593|592726973|FG000|Overall Study|Incorrect inclusion|2|||
164099037|NCT00385593|592726974|FG001|Overall Study|Incorrect inclusion|0|||
164099038|NCT00385593|592726973|FG000|Overall Study|Incorrect randomization|0|||
164099039|NCT00385593|592726974|FG001|Overall Study|Incorrect randomization|1|||
164099040|NCT03125200|592726977|FG000|Overall Study|Study Termination|0|||
164099041|NCT03125200|592726978|FG001|Overall Study|Study Termination|0|||
164099042|NCT03125200|592726979|FG002|Overall Study|Study Termination|0|||
164099043|NCT03125200|592726980|FG003|Overall Study|Study Termination|1|||
164099044|NCT03125200|592726981|FG004|Overall Study|Study Termination|1|||
164099045|NCT03125200|592726982|FG005|Overall Study|Study Termination|2|||
164099046|NCT03125200|592726983|FG006|Overall Study|Study Termination|1|||
164099047|NCT03125200|592726977|FG000|Overall Study|Clinical Progression|0|||
164099048|NCT03125200|592726978|FG001|Overall Study|Clinical Progression|0|||
164099049|NCT03125200|592726979|FG002|Overall Study|Clinical Progression|0|||
164099050|NCT03125200|592726980|FG003|Overall Study|Clinical Progression|1|||
164099051|NCT03125200|592726981|FG004|Overall Study|Clinical Progression|0|||
164099052|NCT03125200|592726982|FG005|Overall Study|Clinical Progression|1|||
164099053|NCT03125200|592726983|FG006|Overall Study|Clinical Progression|0|||
164099054|NCT03125200|592726977|FG000|Overall Study|Progressive Disease|2|||
164099055|NCT03125200|592726978|FG001|Overall Study|Progressive Disease|1|||
164099056|NCT03125200|592726979|FG002|Overall Study|Progressive Disease|2|||
164099057|NCT03125200|592726980|FG003|Overall Study|Progressive Disease|1|||
164099058|NCT03125200|592726981|FG004|Overall Study|Progressive Disease|2|||
164099059|NCT03125200|592726982|FG005|Overall Study|Progressive Disease|0|||
164099060|NCT03125200|592726983|FG006|Overall Study|Progressive Disease|1|||
164099061|NCT03125200|592726977|FG000|Overall Study|Lack of Efficacy|0|||
164099062|NCT03125200|592726978|FG001|Overall Study|Lack of Efficacy|0|||
164099063|NCT03125200|592726979|FG002|Overall Study|Lack of Efficacy|0|||
164099064|NCT03125200|592726980|FG003|Overall Study|Lack of Efficacy|1|||
164099065|NCT03125200|592726981|FG004|Overall Study|Lack of Efficacy|0|||
164099066|NCT03125200|592726982|FG005|Overall Study|Lack of Efficacy|0|||
164099067|NCT03125200|592726983|FG006|Overall Study|Lack of Efficacy|0|||
164099068|NCT03125200|592726977|FG000|Overall Study|Toxicity|0|||
164099069|NCT03125200|592726978|FG001|Overall Study|Toxicity|0|||
164099070|NCT03125200|592726979|FG002|Overall Study|Toxicity|0|||
164099071|NCT03125200|592726980|FG003|Overall Study|Toxicity|1|||
164099072|NCT03125200|592726981|FG004|Overall Study|Toxicity|0|||
164099073|NCT03125200|592726982|FG005|Overall Study|Toxicity|0|||
164099074|NCT03125200|592726983|FG006|Overall Study|Toxicity|0|||
164099075|NCT03125200|592726977|FG000|Overall Study|Consent Withdrawn by Subject|0|||
164099076|NCT03125200|592726978|FG001|Overall Study|Consent Withdrawn by Subject|1|||
164099077|NCT03125200|592726979|FG002|Overall Study|Consent Withdrawn by Subject|0|||
164099078|NCT03125200|592726980|FG003|Overall Study|Consent Withdrawn by Subject|0|||
164099079|NCT03125200|592726981|FG004|Overall Study|Consent Withdrawn by Subject|1|||
164099080|NCT03125200|592726982|FG005|Overall Study|Consent Withdrawn by Subject|0|||
164099081|NCT03125200|592726983|FG006|Overall Study|Consent Withdrawn by Subject|1|||
164099082|NCT02421952|592726987|FG000|Overall Study|Diary Not Returned|93|||
164099083|NCT02421952|592726987|FG000|Overall Study|Failed seriation task|13|||
164044357|NCT03671148|592523857|FG000|Overall Study|Incomplete Randomization Visit|1|||
164044358|NCT03671148|592523858|FG001|Overall Study|Incomplete Randomization Visit|0|||
164044359|NCT00425945|592523859|FG000|Overall Study|Concern about Supplement|2|||
164044360|NCT00425945|592523860|FG001|Overall Study|Concern about Supplement|0|||
164044361|NCT00425945|592523859|FG000|Overall Study|Inconvenience|0|||
164044362|NCT00425945|592523860|FG001|Overall Study|Inconvenience|2|||
164044363|NCT00425945|592523859|FG000|Overall Study|Lost to Follow-up|0|||
164044364|NCT00425945|592523860|FG001|Overall Study|Lost to Follow-up|2|||
164099084|NCT02421952|592726987|FG000|Overall Study|Subject uncooperative for baseline test|2|||
164099085|NCT02421952|592726987|FG000|Overall Study|Surgery cancelled|1|||
164099086|NCT03041025|592726989|FG000|Overall Study|Adverse Event|0|||
164099087|NCT03041025|592726990|FG001|Overall Study|Adverse Event|0|||
164099088|NCT03041025|592726991|FG002|Overall Study|Adverse Event|1|||
164099089|NCT03041025|592726989|FG000|Overall Study|Lost to Follow-up|1|||
164099090|NCT03041025|592726990|FG001|Overall Study|Lost to Follow-up|0|||
164099091|NCT03041025|592726991|FG002|Overall Study|Lost to Follow-up|0|||
164099092|NCT03041025|592726989|FG000|Overall Study|Withdrawal by Subject|0|||
164099093|NCT03041025|592726990|FG001|Overall Study|Withdrawal by Subject|0|||
164099094|NCT03041025|592726991|FG002|Overall Study|Withdrawal by Subject|1|||
164099095|NCT02963259|592726992|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
164099096|NCT02963259|592726992|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
164099097|NCT02963259|592726992|FG000|Overall Study|Death|1|||
164099098|NCT02963259|592726992|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
164044365|NCT00425945|592523859|FG000|Overall Study|Began hypertension medication|1|||
164044366|NCT00425945|592523860|FG001|Overall Study|Began hypertension medication|0|||
164044367|NCT00425945|592523859|FG000|Overall Study|Began cancer treatments|1|||
164044368|NCT00425945|592523860|FG001|Overall Study|Began cancer treatments|0|||
164044369|NCT00425945|592523859|FG000|Overall Study|Moved from area|0|||
164044370|NCT00425945|592523860|FG001|Overall Study|Moved from area|1|||
164044371|NCT03878160|592523864|FG000|Overall Study|Lost to Follow-up|1|||
164044372|NCT03878160|592523865|FG001|Overall Study|Lost to Follow-up|1|||
164044373|NCT03878160|592523866|FG002|Overall Study|Lost to Follow-up|1|||
164044374|NCT03878160|592523864|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
164044375|NCT03878160|592523865|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
164044376|NCT03878160|592523866|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
164044377|NCT00673816|592523867|FG000|Overall Study|Adverse Event|1|||
164044378|NCT00673816|592523867|FG000|Overall Study|Withdrawal by Subject|1|||
164044379|NCT05618808|592523868|FG000|Overall Study|Withdrawal by Subject|3|||
164044380|NCT05618808|592523869|FG001|Overall Study|Withdrawal by Subject|1|||
164044381|NCT05618808|592523870|FG002|Overall Study|Withdrawal by Subject|3|||
164044382|NCT01804842|592523874|FG000|Overall Study|Adverse Event|1|||
164044383|NCT01804842|592523875|FG001|Overall Study|Adverse Event|1|||
164044384|NCT01804842|592523876|FG002|Overall Study|Adverse Event|0|||
164044385|NCT01804842|592523874|FG000|Overall Study|Lost to Follow-up|1|||
164044386|NCT01804842|592523875|FG001|Overall Study|Lost to Follow-up|0|||
164044387|NCT01804842|592523876|FG002|Overall Study|Lost to Follow-up|0|||
164044388|NCT01804842|592523874|FG000|Overall Study|Non-Compliance|1|||
164044389|NCT01804842|592523875|FG001|Overall Study|Non-Compliance|1|||
164044390|NCT01804842|592523876|FG002|Overall Study|Non-Compliance|0|||
164044391|NCT01804842|592523874|FG000|Overall Study|Personal Reason|0|||
164044392|NCT01804842|592523875|FG001|Overall Study|Personal Reason|0|||
164044393|NCT01804842|592523876|FG002|Overall Study|Personal Reason|1|||
164044394|NCT02365506|592523879|FG000|Overall Study|Investigator's Discretion|0|||
164044395|NCT02365506|592523880|FG001|Overall Study|Investigator's Discretion|0|||
164044396|NCT02365506|592523881|FG002|Overall Study|Investigator's Discretion|1|||
164044397|NCT03774875|592523882|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
164044398|NCT03774875|592523883|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
164044399|NCT03774875|592523882|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
164044400|NCT03774875|592523883|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
164044401|NCT03774875|592523882|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
164044402|NCT03774875|592523883|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
164044403|NCT03774875|592523882|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
164044404|NCT03774875|592523883|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
164044405|NCT03774875|592523882|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
164044406|NCT03774875|592523883|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
164044407|NCT03774875|592523882|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
164044408|NCT03774875|592523883|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
164044409|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
164044410|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
164044411|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
164044412|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
164044413|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
164044414|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
164044415|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
164044416|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
164044417|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
164044418|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
164044419|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
164044420|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
164044421|NCT03774875|592523882|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
164044422|NCT03774875|592523883|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
164044423|NCT02352090|592523884|FG000|Overall Study|general malaise|1|||
164044424|NCT02352090|592523885|FG001|Overall Study|general malaise|0|||
164044425|NCT02352090|592523886|FG002|Overall Study|general malaise|0|||
164044426|NCT02352090|592523884|FG000|Overall Study|non-specified mild side-effects|0|||
164044427|NCT02352090|592523885|FG001|Overall Study|non-specified mild side-effects|0|||
164044428|NCT02352090|592523886|FG002|Overall Study|non-specified mild side-effects|2|||
164044429|NCT06048367|592523889|FG000|Overall Study|Withdrawal by Subject|0|||
164044430|NCT06048367|592523890|FG001|Overall Study|Withdrawal by Subject|1|||
164044431|NCT06048367|592523891|FG002|Overall Study|Withdrawal by Subject|0|||
164044432|NCT06048367|592523892|FG003|Overall Study|Withdrawal by Subject|0|||
164044433|NCT06048367|592523893|FG004|Overall Study|Withdrawal by Subject|0|||
164044434|NCT06048367|592523889|FG000|Overall Study|Withdrawal by Subject|0|||
163842152|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
164044435|NCT06048367|592523890|FG001|Overall Study|Withdrawal by Subject|0|||
164044436|NCT06048367|592523891|FG002|Overall Study|Withdrawal by Subject|1|||
164044437|NCT06048367|592523892|FG003|Overall Study|Withdrawal by Subject|0|||
164044438|NCT06048367|592523893|FG004|Overall Study|Withdrawal by Subject|0|||
164044439|NCT06048367|592523889|FG000|Overall Study|Withdrawal by Subject|0|||
164044440|NCT06048367|592523890|FG001|Overall Study|Withdrawal by Subject|0|||
164044441|NCT06048367|592523891|FG002|Overall Study|Withdrawal by Subject|0|||
164044442|NCT06048367|592523892|FG003|Overall Study|Withdrawal by Subject|1|||
164044443|NCT06048367|592523893|FG004|Overall Study|Withdrawal by Subject|0|||
164044444|NCT06048367|592523889|FG000|Overall Study|Withdrawal by Subject|0|||
164044445|NCT06048367|592523890|FG001|Overall Study|Withdrawal by Subject|0|||
164044446|NCT06048367|592523891|FG002|Overall Study|Withdrawal by Subject|0|||
164044447|NCT06048367|592523892|FG003|Overall Study|Withdrawal by Subject|1|||
164044448|NCT06048367|592523893|FG004|Overall Study|Withdrawal by Subject|0|||
164044449|NCT00413777|592523895|FG000|Fixed-dose Period|Lost to Follow-up|1|||
164044450|NCT00413777|592523896|FG001|Fixed-dose Period|Lost to Follow-up|1|||
164044451|NCT00413777|592523895|FG000|Fixed-dose Period|Adverse Event|2|||
164044452|NCT00413777|592523896|FG001|Fixed-dose Period|Adverse Event|1|||
164044453|NCT00413777|592523895|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
164044454|NCT00413777|592523896|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
164044455|NCT00413777|592523895|FG000|Fixed-dose Period|Withdrew Consent|0|||
163945246|NCT03547739|592168967|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
163945247|NCT03547739|592168965|FG000|Overall Study|Lost to Follow-up|80|||
163945248|NCT03547739|592168966|FG001|Overall Study|Lost to Follow-up|84|||
163945249|NCT03547739|592168967|FG002|Overall Study|Lost to Follow-up|116|||
163945250|NCT01365481|592168975|FG000|Overall Study|Adverse Event|6|||
163945251|NCT01365481|592168976|FG001|Overall Study|Adverse Event|9|||
163945252|NCT01365481|592168977|FG002|Overall Study|Adverse Event|0|||
163945253|NCT01365481|592168978|FG003|Overall Study|Adverse Event|2|||
163945254|NCT01365481|592168975|FG000|Overall Study|Withdrawal by Subject|0|||
163945255|NCT01365481|592168976|FG001|Overall Study|Withdrawal by Subject|2|||
163945256|NCT01365481|592168977|FG002|Overall Study|Withdrawal by Subject|1|||
163945257|NCT01365481|592168978|FG003|Overall Study|Withdrawal by Subject|1|||
163945258|NCT01365481|592168975|FG000|Overall Study|Lost to Follow-up|1|||
163945259|NCT01365481|592168976|FG001|Overall Study|Lost to Follow-up|1|||
163945260|NCT01365481|592168977|FG002|Overall Study|Lost to Follow-up|2|||
163945261|NCT01365481|592168978|FG003|Overall Study|Lost to Follow-up|3|||
163945262|NCT01365481|592168975|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163945263|NCT01365481|592168976|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163945264|NCT01365481|592168977|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163945265|NCT01365481|592168978|FG003|Overall Study|Abnormal laboratory value(s)|0|||
163945266|NCT01365481|592168975|FG000|Overall Study|Administrative problems|0|||
163945267|NCT01365481|592168976|FG001|Overall Study|Administrative problems|1|||
163945268|NCT01365481|592168977|FG002|Overall Study|Administrative problems|0|||
163945269|NCT01365481|592168978|FG003|Overall Study|Administrative problems|0|||
163945270|NCT01365481|592168975|FG000|Overall Study|Protocol deviation|0|||
163945271|NCT01365481|592168976|FG001|Overall Study|Protocol deviation|1|||
163945272|NCT01365481|592168977|FG002|Overall Study|Protocol deviation|0|||
163945273|NCT01365481|592168978|FG003|Overall Study|Protocol deviation|1|||
163945274|NCT01365481|592168975|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
163945275|NCT01365481|592168976|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163945276|NCT01365481|592168977|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
163945277|NCT01365481|592168978|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
163945278|NCT00757627|592168979|FG000|Overall Study|Adverse Event|15|||
163945279|NCT00757627|592168979|FG000|Overall Study|Lack of Efficacy|10|||
163945280|NCT00757627|592168979|FG000|Overall Study|Lost to Follow-up|28|||
163945281|NCT00757627|592168979|FG000|Overall Study|Withdrawal by Subject|27|||
163945282|NCT00757627|592168979|FG000|Overall Study|Other|1|||
163945283|NCT00635661|592168984|FG000|Overall Study|Withdrawal by Subject|4|||
163945284|NCT00468143|592168989|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
163945285|NCT00468143|592168990|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
163945286|NCT00468143|592168989|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
163945287|NCT00468143|592168990|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
163945288|NCT01606670|592168991|FG000|Overall Study|Adverse Event|6|||
163945289|NCT01606670|592168991|FG000|Overall Study|Lack of Efficacy|2|||
163945290|NCT01606670|592168991|FG000|Overall Study|Lost to Follow-up|3|||
163945291|NCT01606670|592168991|FG000|Overall Study|Withdrawal by Subject|3|||
163945292|NCT01606670|592168991|FG000|Overall Study|Other Reason|2|||
163945293|NCT03192475|592169003|FG000|Overall Study|Death|0|||
163945294|NCT03192475|592169004|FG001|Overall Study|Death|1|||
163945295|NCT03192475|592169003|FG000|Overall Study|Lost to Follow-up|13|||
163945296|NCT03192475|592169004|FG001|Overall Study|Lost to Follow-up|8|||
163945297|NCT01641159|592169005|FG000|Overall Study|Lost to Follow-up|2|||
163945298|NCT01641159|592169006|FG001|Overall Study|Lost to Follow-up|1|||
164044456|NCT00413777|592523896|FG001|Fixed-dose Period|Withdrew Consent|1|||
164044457|NCT01678313|592523897|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
164044458|NCT01678313|592523898|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
164044459|NCT01678313|592523897|FG000|Completed the 3-month Therapy|Physician Decision|3|||
164044460|NCT01678313|592523898|FG001|Completed the 3-month Therapy|Physician Decision|4|||
164044461|NCT01678313|592523897|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
164044462|NCT01678313|592523898|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
164044463|NCT01678313|592523897|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
164044464|NCT01678313|592523898|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
164044465|NCT05179057|592523899|FG000|Overall Study|Adverse Event|3|||
164044466|NCT05179057|592523900|FG001|Overall Study|Adverse Event|2|||
164044467|NCT05179057|592523899|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
164044468|NCT05179057|592523900|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
164044469|NCT05179057|592523899|FG000|Overall Study|Study terminated|13|||
164044470|NCT05179057|592523900|FG001|Overall Study|Study terminated|7|||
164044471|NCT05179057|592523899|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
164044472|NCT05179057|592523900|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
164044473|NCT05179057|592523899|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
164044474|NCT05179057|592523900|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
164044475|NCT03345342|592523901|FG000|Open-Label Phase|Adverse Event|30|||
164044476|NCT03345342|592523902|FG001|Open-Label Phase|Adverse Event|0|||
164044477|NCT03345342|592523903|FG002|Open-Label Phase|Adverse Event|0|||
164044478|NCT03345342|592523904|FG003|Open-Label Phase|Adverse Event|0|||
164044479|NCT03345342|592523905|FG004|Open-Label Phase|Adverse Event|0|||
164044480|NCT03345342|592523901|FG000|Open-Label Phase|Death|1|||
164044481|NCT03345342|592523902|FG001|Open-Label Phase|Death|0|||
164044482|NCT03345342|592523903|FG002|Open-Label Phase|Death|0|||
164044483|NCT03345342|592523904|FG003|Open-Label Phase|Death|0|||
164044484|NCT03345342|592523905|FG004|Open-Label Phase|Death|0|||
164044485|NCT03345342|592523901|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
164044486|NCT03345342|592523902|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
164044487|NCT03345342|592523903|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
164044488|NCT03345342|592523904|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
164044489|NCT03345342|592523905|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
164044490|NCT03345342|592523901|FG000|Open-Label Phase|Lack of Efficacy|6|||
164044491|NCT03345342|592523902|FG001|Open-Label Phase|Lack of Efficacy|0|||
164044492|NCT03345342|592523903|FG002|Open-Label Phase|Lack of Efficacy|0|||
164044493|NCT03345342|592523904|FG003|Open-Label Phase|Lack of Efficacy|0|||
164044494|NCT03345342|592523905|FG004|Open-Label Phase|Lack of Efficacy|0|||
164044495|NCT03345342|592523901|FG000|Open-Label Phase|Lost to Follow-up|9|||
164044496|NCT03345342|592523902|FG001|Open-Label Phase|Lost to Follow-up|0|||
164044497|NCT03345342|592523903|FG002|Open-Label Phase|Lost to Follow-up|0|||
164044498|NCT03345342|592523904|FG003|Open-Label Phase|Lost to Follow-up|0|||
164044499|NCT03345342|592523905|FG004|Open-Label Phase|Lost to Follow-up|0|||
164044500|NCT03345342|592523901|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
164044501|NCT03345342|592523902|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
164044502|NCT03345342|592523903|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
164044503|NCT03345342|592523904|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
164044504|NCT03345342|592523905|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
164044505|NCT03345342|592523901|FG000|Open-Label Phase|Physician Decision|4|||
164044506|NCT03345342|592523902|FG001|Open-Label Phase|Physician Decision|0|||
164044507|NCT03345342|592523903|FG002|Open-Label Phase|Physician Decision|0|||
164044508|NCT03345342|592523904|FG003|Open-Label Phase|Physician Decision|0|||
164044509|NCT03345342|592523905|FG004|Open-Label Phase|Physician Decision|0|||
164044510|NCT03345342|592523901|FG000|Open-Label Phase|Protocol Violation|8|||
164044511|NCT03345342|592523902|FG001|Open-Label Phase|Protocol Violation|0|||
164044512|NCT03345342|592523903|FG002|Open-Label Phase|Protocol Violation|0|||
164044513|NCT03345342|592523904|FG003|Open-Label Phase|Protocol Violation|0|||
164044514|NCT03345342|592523905|FG004|Open-Label Phase|Protocol Violation|0|||
164044515|NCT03345342|592523901|FG000|Open-Label Phase|Withdrawal by Subject|57|||
164044516|NCT03345342|592523902|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164044517|NCT03345342|592523903|FG002|Open-Label Phase|Withdrawal by Subject|0|||
164044518|NCT03345342|592523904|FG003|Open-Label Phase|Withdrawal by Subject|0|||
164044519|NCT03345342|592523905|FG004|Open-Label Phase|Withdrawal by Subject|0|||
164044520|NCT03345342|592523901|FG000|Open-Label Phase|Other|15|||
164044521|NCT03345342|592523902|FG001|Open-Label Phase|Other|0|||
164044522|NCT03345342|592523903|FG002|Open-Label Phase|Other|0|||
164044523|NCT03345342|592523904|FG003|Open-Label Phase|Other|0|||
164044524|NCT03345342|592523905|FG004|Open-Label Phase|Other|0|||
164044525|NCT03345342|592523901|FG000|Double-Blind Phase|Adverse Event|0|||
164044526|NCT03345342|592523902|FG001|Double-Blind Phase|Adverse Event|1|||
164044527|NCT03345342|592523903|FG002|Double-Blind Phase|Adverse Event|6|||
164044528|NCT03345342|592523904|FG003|Double-Blind Phase|Adverse Event|0|||
164044529|NCT03345342|592523905|FG004|Double-Blind Phase|Adverse Event|0|||
164044530|NCT03345342|592523901|FG000|Double-Blind Phase|Death|0|||
164044531|NCT03345342|592523902|FG001|Double-Blind Phase|Death|2|||
164099099|NCT02131129|592726993|FG000|Overall Study|Withdrawal by Subject|1|||
163945299|NCT01641159|592169005|FG000|Overall Study|Withdrawal by Subject|0|||
163945300|NCT01641159|592169006|FG001|Overall Study|Withdrawal by Subject|1|||
163945301|NCT00798590|592169007|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
163945302|NCT00798590|592169008|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
163945303|NCT03980808|592169009|FG000|Overall Study|Lost to Follow-up|2|||
163945304|NCT03980808|592169010|FG001|Overall Study|Lost to Follow-up|2|||
163945305|NCT00368927|592169015|FG000|Overall Study|Lost to Follow-up|2|||
163945306|NCT00368927|592169016|FG001|Overall Study|Lost to Follow-up|0|||
163945307|NCT00368927|592169015|FG000|Overall Study|Adverse Event|1|||
163945308|NCT00368927|592169016|FG001|Overall Study|Adverse Event|1|||
163945309|NCT00368927|592169015|FG000|Overall Study|Withdrawal by Subject|1|||
163945310|NCT00368927|592169016|FG001|Overall Study|Withdrawal by Subject|2|||
163945311|NCT00368927|592169015|FG000|Overall Study|Physician Decision|1|||
163945312|NCT00368927|592169016|FG001|Overall Study|Physician Decision|0|||
163945313|NCT00886795|592169017|FG000|Overall Study|Lack of Efficacy|1|||
163945314|NCT02229851|592169018|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
163945315|NCT02229851|592169019|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
163945316|NCT02229851|592169020|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
163945317|NCT02229851|592169021|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
163945318|NCT02229851|592169022|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
163945319|NCT02229851|592169023|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
163945320|NCT02229851|592169024|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
163945321|NCT02229851|592169018|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163945322|NCT02229851|592169019|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
163945323|NCT02229851|592169020|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163945324|NCT02229851|592169021|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163945325|NCT02229851|592169022|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163945326|NCT02229851|592169023|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163945327|NCT02229851|592169024|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
163945328|NCT02229851|592169018|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
163945329|NCT02229851|592169019|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
163945330|NCT02229851|592169020|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
163945331|NCT02229851|592169021|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163945332|NCT02229851|592169022|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163945333|NCT02229851|592169023|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163945334|NCT02229851|592169024|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
163945335|NCT02229851|592169018|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163945336|NCT02229851|592169019|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163945337|NCT02229851|592169020|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
163945338|NCT02229851|592169021|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163945339|NCT02229851|592169022|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163945340|NCT02229851|592169023|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163945341|NCT02229851|592169024|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
163945342|NCT02229851|592169018|FG000|Main Phase (Double-blind Phase)|Death|1|||
163945343|NCT02229851|592169019|FG001|Main Phase (Double-blind Phase)|Death|1|||
163945344|NCT02229851|592169020|FG002|Main Phase (Double-blind Phase)|Death|0|||
163945345|NCT02229851|592169021|FG003|Main Phase (Double-blind Phase)|Death|0|||
163945346|NCT02229851|592169022|FG004|Main Phase (Double-blind Phase)|Death|0|||
163945347|NCT02229851|592169023|FG005|Main Phase (Double-blind Phase)|Death|0|||
163945348|NCT02229851|592169024|FG006|Main Phase (Double-blind Phase)|Death|0|||
163945349|NCT02229851|592169018|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163945350|NCT02229851|592169019|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163945351|NCT02229851|592169020|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163945352|NCT02229851|592169021|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
163945353|NCT02229851|592169022|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
163945354|NCT02229851|592169023|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
163945355|NCT02229851|592169024|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
163945356|NCT02229851|592169018|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
163945357|NCT02229851|592169019|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
163945358|NCT02229851|592169020|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
163945359|NCT02229851|592169021|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
163945360|NCT02229851|592169022|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
163945361|NCT02229851|592169023|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
163945362|NCT02229851|592169024|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
163945363|NCT02229851|592169018|FG000|Extension Phase (Open-label Phase)|Death|0|||
164099100|NCT02131129|592726994|FG001|Overall Study|Withdrawal by Subject|0|||
163945364|NCT02229851|592169019|FG001|Extension Phase (Open-label Phase)|Death|0|||
163945365|NCT02229851|592169020|FG002|Extension Phase (Open-label Phase)|Death|0|||
163945366|NCT02229851|592169021|FG003|Extension Phase (Open-label Phase)|Death|1|||
164099101|NCT01811953|592728799|FG000|Overall Study|Adverse Event|0|||
163945367|NCT02229851|592169022|FG004|Extension Phase (Open-label Phase)|Death|0|||
163945368|NCT02229851|592169023|FG005|Extension Phase (Open-label Phase)|Death|1|||
163945369|NCT02229851|592169024|FG006|Extension Phase (Open-label Phase)|Death|1|||
163945370|NCT01204710|592169027|FG000|Randomization Treatment|Lost to Follow-up|1|||
164044532|NCT03345342|592523903|FG002|Double-Blind Phase|Death|1|||
164044533|NCT03345342|592523904|FG003|Double-Blind Phase|Death|0|||
164044534|NCT03345342|592523905|FG004|Double-Blind Phase|Death|0|||
164044535|NCT03345342|592523901|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
164044536|NCT03345342|592523902|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
164044537|NCT03345342|592523903|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
164044538|NCT03345342|592523904|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
164044539|NCT03345342|592523905|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
164044540|NCT03345342|592523901|FG000|Double-Blind Phase|Lost to Follow-up|0|||
164044541|NCT03345342|592523902|FG001|Double-Blind Phase|Lost to Follow-up|1|||
164044542|NCT03345342|592523903|FG002|Double-Blind Phase|Lost to Follow-up|7|||
164044543|NCT03345342|592523904|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164044544|NCT03345342|592523905|FG004|Double-Blind Phase|Lost to Follow-up|0|||
164044545|NCT03345342|592523901|FG000|Double-Blind Phase|Physician Decision|0|||
164044546|NCT03345342|592523902|FG001|Double-Blind Phase|Physician Decision|1|||
164044547|NCT03345342|592523903|FG002|Double-Blind Phase|Physician Decision|4|||
164044548|NCT03345342|592523904|FG003|Double-Blind Phase|Physician Decision|0|||
164044549|NCT03345342|592523905|FG004|Double-Blind Phase|Physician Decision|0|||
164044550|NCT03345342|592523901|FG000|Double-Blind Phase|Protocol Violation|0|||
164044551|NCT03345342|592523902|FG001|Double-Blind Phase|Protocol Violation|0|||
164044552|NCT03345342|592523903|FG002|Double-Blind Phase|Protocol Violation|1|||
164044553|NCT03345342|592523904|FG003|Double-Blind Phase|Protocol Violation|0|||
164044554|NCT03345342|592523905|FG004|Double-Blind Phase|Protocol Violation|0|||
164044555|NCT03345342|592523901|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
164044556|NCT03345342|592523902|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
164044557|NCT03345342|592523903|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
164044558|NCT03345342|592523904|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
164044559|NCT03345342|592523905|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
164044560|NCT03345342|592523901|FG000|Double-Blind Phase|Other|0|||
164044561|NCT03345342|592523902|FG001|Double-Blind Phase|Other|1|||
164044562|NCT03345342|592523903|FG002|Double-Blind Phase|Other|3|||
164044563|NCT03345342|592523904|FG003|Double-Blind Phase|Other|0|||
164044564|NCT03345342|592523905|FG004|Double-Blind Phase|Other|0|||
164044565|NCT03345342|592523901|FG000|Follow-Up Phase|Adverse Event|0|||
164044566|NCT03345342|592523902|FG001|Follow-Up Phase|Adverse Event|0|||
164044567|NCT03345342|592523903|FG002|Follow-Up Phase|Adverse Event|0|||
164044568|NCT03345342|592523904|FG003|Follow-Up Phase|Adverse Event|0|||
164044569|NCT03345342|592523905|FG004|Follow-Up Phase|Adverse Event|4|||
164044570|NCT03345342|592523901|FG000|Follow-Up Phase|Lost to Follow-up|0|||
164044571|NCT03345342|592523902|FG001|Follow-Up Phase|Lost to Follow-up|0|||
164044572|NCT03345342|592523903|FG002|Follow-Up Phase|Lost to Follow-up|0|||
164044573|NCT03345342|592523904|FG003|Follow-Up Phase|Lost to Follow-up|0|||
164044574|NCT03345342|592523905|FG004|Follow-Up Phase|Lost to Follow-up|6|||
164044575|NCT03345342|592523901|FG000|Follow-Up Phase|Physician Decision|0|||
164044576|NCT03345342|592523902|FG001|Follow-Up Phase|Physician Decision|0|||
164044577|NCT03345342|592523903|FG002|Follow-Up Phase|Physician Decision|0|||
164044578|NCT03345342|592523904|FG003|Follow-Up Phase|Physician Decision|0|||
164044579|NCT03345342|592523905|FG004|Follow-Up Phase|Physician Decision|5|||
164044580|NCT03345342|592523901|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
164044581|NCT03345342|592523902|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
164044582|NCT03345342|592523903|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
164044583|NCT03345342|592523904|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
164044584|NCT03345342|592523905|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
164044585|NCT03345342|592523901|FG000|Follow-Up Phase|Other|0|||
164044586|NCT03345342|592523902|FG001|Follow-Up Phase|Other|0|||
163945371|NCT01204710|592169028|FG001|Randomization Treatment|Lost to Follow-up|0|||
163945372|NCT01204710|592169027|FG000|Randomization Treatment|Withdrawal by Subject|6|||
164044587|NCT03345342|592523903|FG002|Follow-Up Phase|Other|0|||
163945373|NCT01204710|592169028|FG001|Randomization Treatment|Withdrawal by Subject|5|||
163945374|NCT01204710|592169027|FG000|Randomization Treatment|Physician Decision|3|||
163945375|NCT01204710|592169028|FG001|Randomization Treatment|Physician Decision|2|||
163945376|NCT01204710|592169027|FG000|Randomization Treatment|Entry criteria not met|0|||
163945377|NCT01204710|592169028|FG001|Randomization Treatment|Entry criteria not met|1|||
163945378|NCT01204710|592169027|FG000|Randomization Treatment|Adverse Event|4|||
164044588|NCT03345342|592523904|FG003|Follow-Up Phase|Other|3|||
164044589|NCT03345342|592523905|FG004|Follow-Up Phase|Other|1|||
164044590|NCT03375203|592523906|FG000|Overall Study|Protocol Violation|0|||
164044591|NCT03375203|592523907|FG001|Overall Study|Protocol Violation|0|||
164044592|NCT03375203|592523908|FG002|Overall Study|Protocol Violation|1|||
164044593|NCT03375203|592523909|FG003|Overall Study|Protocol Violation|0|||
164044594|NCT03375203|592523910|FG004|Overall Study|Protocol Violation|0|||
164044595|NCT03375203|592523906|FG000|Overall Study|Adverse Event|2|||
164044596|NCT03375203|592523907|FG001|Overall Study|Adverse Event|3|||
164044597|NCT03375203|592523908|FG002|Overall Study|Adverse Event|0|||
164044598|NCT03375203|592523909|FG003|Overall Study|Adverse Event|2|||
164044599|NCT03375203|592523910|FG004|Overall Study|Adverse Event|2|||
164044600|NCT03375203|592523906|FG000|Overall Study|Withdrawal by Subject|3|||
164044601|NCT03375203|592523907|FG001|Overall Study|Withdrawal by Subject|0|||
164044602|NCT03375203|592523908|FG002|Overall Study|Withdrawal by Subject|1|||
164044603|NCT03375203|592523909|FG003|Overall Study|Withdrawal by Subject|0|||
164044604|NCT03375203|592523910|FG004|Overall Study|Withdrawal by Subject|2|||
164044605|NCT03375203|592523906|FG000|Overall Study|Non-compliance with study drug|1|||
164044606|NCT03375203|592523907|FG001|Overall Study|Non-compliance with study drug|0|||
164044607|NCT03375203|592523908|FG002|Overall Study|Non-compliance with study drug|0|||
164044608|NCT03375203|592523909|FG003|Overall Study|Non-compliance with study drug|0|||
164044609|NCT03375203|592523910|FG004|Overall Study|Non-compliance with study drug|0|||
164044610|NCT03375203|592523906|FG000|Overall Study|Randomized, not treated.|0|||
164044611|NCT03375203|592523907|FG001|Overall Study|Randomized, not treated.|1|||
164044612|NCT03375203|592523908|FG002|Overall Study|Randomized, not treated.|0|||
164044613|NCT03375203|592523909|FG003|Overall Study|Randomized, not treated.|0|||
164044614|NCT03375203|592523910|FG004|Overall Study|Randomized, not treated.|0|||
164044615|NCT03107793|592523911|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
164044616|NCT03107793|592523912|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
164044617|NCT03107793|592523913|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
164044618|NCT03107793|592523914|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
164044619|NCT03107793|592523915|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
164044620|NCT03107793|592523911|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
164044621|NCT03107793|592523912|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
164044622|NCT03107793|592523913|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
164044623|NCT03107793|592523914|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
164044624|NCT03107793|592523915|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
164044625|NCT03107793|592523911|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
164044626|NCT03107793|592523912|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
164044627|NCT03107793|592523913|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
164044628|NCT03107793|592523914|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
164044629|NCT03107793|592523915|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
164044630|NCT03107793|592523911|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
164044631|NCT03107793|592523912|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164044632|NCT03107793|592523913|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164044633|NCT03107793|592523914|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164044634|NCT03107793|592523915|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
164044635|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164044636|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
164044637|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
164044638|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164044639|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
164044640|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164044641|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
164044642|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
164044643|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164044644|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
164044645|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164044646|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164044647|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
164044648|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164044649|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
164044650|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164044651|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
164044652|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
164044653|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164044654|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
164044655|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
164044656|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
164044657|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
164044658|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
164044659|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
164044660|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
164044661|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
164044662|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
164044663|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
164044664|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
164044665|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164044666|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
164044667|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164044668|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164044669|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
164044670|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
164044671|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
164044672|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
164044673|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
164044674|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
164044675|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164044676|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164044677|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
164044678|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164044679|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
164044680|NCT03107793|592523911|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164044681|NCT03107793|592523912|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
164044682|NCT03107793|592523913|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
164044683|NCT03107793|592523914|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164044684|NCT03107793|592523915|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
164044685|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
164044686|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
164044687|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
164044688|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
164044689|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
164044690|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164044691|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164044692|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164044693|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
164044694|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
164044695|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
164044696|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
164044697|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
164044698|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
164044699|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
164044700|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Death|0|||
164044701|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Death|0|||
164044702|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Death|0|||
164044703|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Death|0|||
164044704|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Death|1|||
164044705|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164044706|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164044707|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164044708|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
164044709|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
164044710|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
164044711|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
164044712|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
164044713|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
164044714|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
164044715|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
164044716|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
164044717|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
164044718|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
164044719|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
164044720|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164044721|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164044722|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164044723|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
164044724|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
164044725|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164044726|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164044727|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164044728|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
164073175|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
164073176|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
163945379|NCT01204710|592169028|FG001|Randomization Treatment|Adverse Event|2|||
163945380|NCT01204710|592169027|FG000|Randomization Treatment|Sponsor Decision|0|||
163945381|NCT01204710|592169028|FG001|Randomization Treatment|Sponsor Decision|1|||
163945382|NCT01204710|592169027|FG000|Randomization Treatment|Worsening of General condition|0|||
163945383|NCT01204710|592169028|FG001|Randomization Treatment|Worsening of General condition|1|||
163945384|NCT01204710|592169027|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
163945385|NCT01204710|592169028|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
163945386|NCT01204710|592169027|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
163945387|NCT01204710|592169028|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
163945388|NCT01204710|592169027|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
163945389|NCT01204710|592169028|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
163945390|NCT01204710|592169027|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
163945391|NCT01204710|592169028|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
163945392|NCT00680992|592169029|FG000|Overall Study|Complete Resection (as per protocol)|25|||
163945393|NCT00680992|592169030|FG001|Overall Study|Complete Resection (as per protocol)|121|||
163945394|NCT00680992|592169031|FG002|Overall Study|Complete Resection (as per protocol)|0|||
163945395|NCT00680992|592169029|FG000|Overall Study|Administrative Decision|83|||
163945396|NCT00680992|592169030|FG001|Overall Study|Administrative Decision|42|||
163945397|NCT00680992|592169031|FG002|Overall Study|Administrative Decision|5|||
163945398|NCT00680992|592169029|FG000|Overall Study|End of Trial|32|||
163945399|NCT00680992|592169030|FG001|Overall Study|End of Trial|12|||
163945400|NCT00680992|592169031|FG002|Overall Study|End of Trial|3|||
163945401|NCT00680992|592169029|FG000|Overall Study|Withdrawal by Subject|33|||
163945402|NCT00680992|592169030|FG001|Overall Study|Withdrawal by Subject|11|||
163945403|NCT00680992|592169031|FG002|Overall Study|Withdrawal by Subject|1|||
163945404|NCT00680992|592169029|FG000|Overall Study|Adverse Event|21|||
163945405|NCT00680992|592169030|FG001|Overall Study|Adverse Event|19|||
163945406|NCT00680992|592169031|FG002|Overall Study|Adverse Event|1|||
163945407|NCT00680992|592169029|FG000|Overall Study|Other|19|||
163945408|NCT00680992|592169030|FG001|Overall Study|Other|14|||
163945409|NCT00680992|592169031|FG002|Overall Study|Other|1|||
163945410|NCT00680992|592169029|FG000|Overall Study|Disease Progression|21|||
163945411|NCT00680992|592169030|FG001|Overall Study|Disease Progression|9|||
163945412|NCT00680992|592169031|FG002|Overall Study|Disease Progression|0|||
163945413|NCT00680992|592169029|FG000|Overall Study|Lost to Follow-up|12|||
163945414|NCT00680992|592169030|FG001|Overall Study|Lost to Follow-up|14|||
163945415|NCT00680992|592169031|FG002|Overall Study|Lost to Follow-up|0|||
163945416|NCT00680992|592169029|FG000|Overall Study|Noncompliance|4|||
163945417|NCT00680992|592169030|FG001|Overall Study|Noncompliance|6|||
163945418|NCT00680992|592169031|FG002|Overall Study|Noncompliance|0|||
163945419|NCT00680992|592169029|FG000|Overall Study|Requirement for Alternative Therapy|8|||
163945420|NCT00680992|592169030|FG001|Overall Study|Requirement for Alternative Therapy|2|||
163945421|NCT00680992|592169031|FG002|Overall Study|Requirement for Alternative Therapy|0|||
163945422|NCT00680992|592169029|FG000|Overall Study|Pregnancy|5|||
163945423|NCT00680992|592169030|FG001|Overall Study|Pregnancy|0|||
163945424|NCT00680992|592169031|FG002|Overall Study|Pregnancy|1|||
163945425|NCT00680992|592169029|FG000|Overall Study|Death|5|||
163945426|NCT00680992|592169030|FG001|Overall Study|Death|1|||
163945427|NCT00680992|592169031|FG002|Overall Study|Death|0|||
163945428|NCT00680992|592169029|FG000|Overall Study|Ineligibility Determined|0|||
163945429|NCT00680992|592169030|FG001|Overall Study|Ineligibility Determined|1|||
163945430|NCT00680992|592169031|FG002|Overall Study|Ineligibility Determined|0|||
163945431|NCT00151281|592169032|FG000|Overall Study|Not evaluable|3|||
163945432|NCT04047862|592169046|FG000|Overall Study|Death|0|||
163945433|NCT04047862|592169047|FG001|Overall Study|Death|0|||
163945434|NCT04047862|592169048|FG002|Overall Study|Death|4|||
163945435|NCT04047862|592169049|FG003|Overall Study|Death|7|||
163945436|NCT04047862|592169050|FG004|Overall Study|Death|2|||
163945437|NCT04047862|592169051|FG005|Overall Study|Death|4|||
163945438|NCT04047862|592169052|FG006|Overall Study|Death|3|||
163945439|NCT04047862|592169053|FG007|Overall Study|Death|24|||
164044729|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
164044730|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Other|0|||
163945440|NCT04047862|592169054|FG008|Overall Study|Death|24|||
163945441|NCT04047862|592169055|FG009|Overall Study|Death|22|||
163945442|NCT04047862|592169056|FG010|Overall Study|Death|35|||
163945443|NCT04047862|592169057|FG011|Overall Study|Death|18|||
163945444|NCT04047862|592169058|FG012|Overall Study|Death|14|||
163945445|NCT04047862|592169059|FG013|Overall Study|Death|6|||
163945446|NCT04047862|592169060|FG014|Overall Study|Death|19|||
163945447|NCT04047862|592169061|FG015|Overall Study|Death|42|||
163945448|NCT04047862|592169062|FG016|Overall Study|Death|9|||
163945449|NCT04047862|592169063|FG017|Overall Study|Death|8|||
163945450|NCT04047862|592169064|FG018|Overall Study|Death|10|||
163945451|NCT04047862|592169046|FG000|Overall Study|Withdrawal by Subject|0|||
163945452|NCT04047862|592169047|FG001|Overall Study|Withdrawal by Subject|0|||
164044731|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Other|0|||
164044732|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Other|0|||
164099102|NCT01811953|592728800|FG001|Overall Study|Adverse Event|0|||
164099103|NCT01811953|592728801|FG002|Overall Study|Adverse Event|0|||
164099104|NCT01811953|592728802|FG003|Overall Study|Adverse Event|1|||
164099105|NCT01811953|592728803|FG004|Overall Study|Adverse Event|0|||
163945453|NCT04047862|592169048|FG002|Overall Study|Withdrawal by Subject|0|||
163945454|NCT04047862|592169049|FG003|Overall Study|Withdrawal by Subject|5|||
163945455|NCT04047862|592169050|FG004|Overall Study|Withdrawal by Subject|2|||
163945456|NCT04047862|592169051|FG005|Overall Study|Withdrawal by Subject|0|||
163945457|NCT04047862|592169052|FG006|Overall Study|Withdrawal by Subject|1|||
163945458|NCT04047862|592169053|FG007|Overall Study|Withdrawal by Subject|0|||
163945459|NCT04047862|592169054|FG008|Overall Study|Withdrawal by Subject|4|||
163945460|NCT04047862|592169055|FG009|Overall Study|Withdrawal by Subject|4|||
163945461|NCT04047862|592169056|FG010|Overall Study|Withdrawal by Subject|4|||
163945462|NCT04047862|592169057|FG011|Overall Study|Withdrawal by Subject|2|||
163945463|NCT04047862|592169058|FG012|Overall Study|Withdrawal by Subject|3|||
163945464|NCT04047862|592169059|FG013|Overall Study|Withdrawal by Subject|0|||
163945465|NCT04047862|592169060|FG014|Overall Study|Withdrawal by Subject|9|||
163945466|NCT04047862|592169061|FG015|Overall Study|Withdrawal by Subject|5|||
163945467|NCT04047862|592169062|FG016|Overall Study|Withdrawal by Subject|1|||
163945468|NCT04047862|592169063|FG017|Overall Study|Withdrawal by Subject|3|||
163945469|NCT04047862|592169064|FG018|Overall Study|Withdrawal by Subject|1|||
163945470|NCT04047862|592169046|FG000|Overall Study|Lost to Follow-up|0|||
163945471|NCT04047862|592169047|FG001|Overall Study|Lost to Follow-up|0|||
163945472|NCT04047862|592169048|FG002|Overall Study|Lost to Follow-up|1|||
163945473|NCT04047862|592169049|FG003|Overall Study|Lost to Follow-up|0|||
163945474|NCT04047862|592169050|FG004|Overall Study|Lost to Follow-up|0|||
163945475|NCT04047862|592169051|FG005|Overall Study|Lost to Follow-up|0|||
163945476|NCT04047862|592169052|FG006|Overall Study|Lost to Follow-up|0|||
163945477|NCT04047862|592169053|FG007|Overall Study|Lost to Follow-up|1|||
163945478|NCT04047862|592169054|FG008|Overall Study|Lost to Follow-up|0|||
163945479|NCT04047862|592169055|FG009|Overall Study|Lost to Follow-up|1|||
163945480|NCT04047862|592169056|FG010|Overall Study|Lost to Follow-up|0|||
163945481|NCT04047862|592169057|FG011|Overall Study|Lost to Follow-up|3|||
163945482|NCT04047862|592169058|FG012|Overall Study|Lost to Follow-up|0|||
163945483|NCT04047862|592169059|FG013|Overall Study|Lost to Follow-up|0|||
163945484|NCT04047862|592169060|FG014|Overall Study|Lost to Follow-up|2|||
163945485|NCT04047862|592169061|FG015|Overall Study|Lost to Follow-up|2|||
163945486|NCT04047862|592169062|FG016|Overall Study|Lost to Follow-up|1|||
163945487|NCT04047862|592169063|FG017|Overall Study|Lost to Follow-up|0|||
163945488|NCT04047862|592169064|FG018|Overall Study|Lost to Follow-up|0|||
163945489|NCT04047862|592169046|FG000|Overall Study|Physician Decision|0|||
163945490|NCT04047862|592169047|FG001|Overall Study|Physician Decision|0|||
163945491|NCT04047862|592169048|FG002|Overall Study|Physician Decision|0|||
163945492|NCT04047862|592169049|FG003|Overall Study|Physician Decision|1|||
163945493|NCT04047862|592169050|FG004|Overall Study|Physician Decision|0|||
163945494|NCT04047862|592169051|FG005|Overall Study|Physician Decision|0|||
163945495|NCT04047862|592169052|FG006|Overall Study|Physician Decision|0|||
163945496|NCT04047862|592169053|FG007|Overall Study|Physician Decision|0|||
163945497|NCT04047862|592169054|FG008|Overall Study|Physician Decision|0|||
163945498|NCT04047862|592169055|FG009|Overall Study|Physician Decision|0|||
163945499|NCT04047862|592169056|FG010|Overall Study|Physician Decision|0|||
163945500|NCT04047862|592169057|FG011|Overall Study|Physician Decision|0|||
163945501|NCT04047862|592169058|FG012|Overall Study|Physician Decision|0|||
163945502|NCT04047862|592169059|FG013|Overall Study|Physician Decision|0|||
163945503|NCT04047862|592169060|FG014|Overall Study|Physician Decision|1|||
163945504|NCT04047862|592169061|FG015|Overall Study|Physician Decision|0|||
163945505|NCT04047862|592169062|FG016|Overall Study|Physician Decision|1|||
163945506|NCT04047862|592169063|FG017|Overall Study|Physician Decision|0|||
163945507|NCT04047862|592169064|FG018|Overall Study|Physician Decision|0|||
163945508|NCT04047862|592169046|FG000|Overall Study|Completed all Assessments|1|||
163945509|NCT04047862|592169047|FG001|Overall Study|Completed all Assessments|3|||
163945510|NCT04047862|592169048|FG002|Overall Study|Completed all Assessments|1|||
163945511|NCT04047862|592169049|FG003|Overall Study|Completed all Assessments|3|||
163945512|NCT04047862|592169050|FG004|Overall Study|Completed all Assessments|2|||
163945513|NCT04047862|592169051|FG005|Overall Study|Completed all Assessments|5|||
163945514|NCT04047862|592169052|FG006|Overall Study|Completed all Assessments|7|||
163945515|NCT04047862|592169053|FG007|Overall Study|Completed all Assessments|0|||
163945516|NCT04047862|592169054|FG008|Overall Study|Completed all Assessments|0|||
163945517|NCT04047862|592169055|FG009|Overall Study|Completed all Assessments|0|||
163945518|NCT04047862|592169056|FG010|Overall Study|Completed all Assessments|0|||
163945519|NCT04047862|592169057|FG011|Overall Study|Completed all Assessments|0|||
163945520|NCT04047862|592169058|FG012|Overall Study|Completed all Assessments|0|||
163945521|NCT04047862|592169059|FG013|Overall Study|Completed all Assessments|0|||
163945522|NCT04047862|592169060|FG014|Overall Study|Completed all Assessments|0|||
163945523|NCT04047862|592169061|FG015|Overall Study|Completed all Assessments|0|||
163945524|NCT04047862|592169062|FG016|Overall Study|Completed all Assessments|0|||
163945525|NCT04047862|592169063|FG017|Overall Study|Completed all Assessments|0|||
163945526|NCT04047862|592169064|FG018|Overall Study|Completed all Assessments|0|||
163945527|NCT04047862|592169046|FG000|Overall Study|Sponsor Decision|0|||
163945528|NCT04047862|592169047|FG001|Overall Study|Sponsor Decision|0|||
163945529|NCT04047862|592169048|FG002|Overall Study|Sponsor Decision|0|||
163945530|NCT04047862|592169049|FG003|Overall Study|Sponsor Decision|0|||
163945531|NCT04047862|592169050|FG004|Overall Study|Sponsor Decision|0|||
163945532|NCT04047862|592169051|FG005|Overall Study|Sponsor Decision|0|||
163945533|NCT04047862|592169052|FG006|Overall Study|Sponsor Decision|0|||
163945534|NCT04047862|592169053|FG007|Overall Study|Sponsor Decision|13|||
163945535|NCT04047862|592169054|FG008|Overall Study|Sponsor Decision|10|||
163945536|NCT04047862|592169055|FG009|Overall Study|Sponsor Decision|18|||
163945537|NCT04047862|592169056|FG010|Overall Study|Sponsor Decision|3|||
163945538|NCT04047862|592169057|FG011|Overall Study|Sponsor Decision|3|||
163945539|NCT04047862|592169058|FG012|Overall Study|Sponsor Decision|4|||
163945540|NCT04047862|592169059|FG013|Overall Study|Sponsor Decision|0|||
163945541|NCT04047862|592169060|FG014|Overall Study|Sponsor Decision|7|||
164099106|NCT01811953|592728804|FG005|Overall Study|Adverse Event|1|||
164099107|NCT01811953|592728799|FG000|Overall Study|Protocol Violation|0|||
164099108|NCT01811953|592728800|FG001|Overall Study|Protocol Violation|0|||
164099109|NCT01811953|592728801|FG002|Overall Study|Protocol Violation|0|||
164099110|NCT01811953|592728802|FG003|Overall Study|Protocol Violation|0|||
164099111|NCT01811953|592728803|FG004|Overall Study|Protocol Violation|1|||
164099112|NCT01811953|592728804|FG005|Overall Study|Protocol Violation|0|||
164099113|NCT04089735|592728815|FG000|Overall Study|Adverse Event|1|||
164099114|NCT04089735|592728816|FG001|Overall Study|Adverse Event|0|||
164099115|NCT04089735|592728817|FG002|Overall Study|Adverse Event|1|||
164099116|NCT04089735|592728818|FG003|Overall Study|Adverse Event|1|||
164099117|NCT04089735|592728819|FG004|Overall Study|Adverse Event|0|||
164099118|NCT04089735|592728820|FG005|Overall Study|Adverse Event|0|||
164099119|NCT04089735|592728815|FG000|Overall Study|Physician Decision|0|||
164099120|NCT04089735|592728816|FG001|Overall Study|Physician Decision|3|||
163945542|NCT04047862|592169061|FG015|Overall Study|Sponsor Decision|8|||
163945543|NCT04047862|592169062|FG016|Overall Study|Sponsor Decision|9|||
163945544|NCT04047862|592169063|FG017|Overall Study|Sponsor Decision|7|||
164044733|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Other|1|||
164044734|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Other|3|||
164044735|NCT03107793|592523911|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
164044736|NCT03107793|592523912|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
164044737|NCT03107793|592523913|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
164044738|NCT03107793|592523914|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
164044739|NCT03107793|592523915|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
164044740|NCT03277105|592523916|FG000|Overall Study|Death|129|||
164044741|NCT03277105|592523917|FG001|Overall Study|Death|124|||
164044742|NCT03277105|592523916|FG000|Overall Study|Lost to Follow-up|2|||
164044743|NCT03277105|592523917|FG001|Overall Study|Lost to Follow-up|4|||
164044744|NCT03277105|592523916|FG000|Overall Study|Withdrawal by Subject|10|||
164044745|NCT03277105|592523917|FG001|Overall Study|Withdrawal by Subject|10|||
164044746|NCT03277105|592523916|FG000|Overall Study|Other|118|||
164044747|NCT03277105|592523917|FG001|Overall Study|Other|125|||
164044748|NCT05180721|592523921|FG000|Overall Study|Lost to Follow-up|4|||
164044749|NCT02040857|592523925|FG000|Overall Study|Adverse Event|14|||
164044750|NCT02040857|592523925|FG000|Overall Study|Physician Decision|5|||
164044751|NCT02040857|592523925|FG000|Overall Study|Withdrawal by Subject|31|||
164044752|NCT02040857|592523925|FG000|Overall Study|patient non-compliance|3|||
164044753|NCT02040857|592523925|FG000|Overall Study|Lost to Follow-up|2|||
164044754|NCT02040857|592523925|FG000|Overall Study|recurrence|4|||
164044755|NCT02040857|592523925|FG000|Overall Study|ineligible|1|||
164044756|NCT00976963|592523926|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
164044757|NCT00976963|592523927|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
164044758|NCT00976963|592523926|FG000|Overall Study|administrative error|1|||
164044759|NCT00976963|592523927|FG001|Overall Study|administrative error|0|||
164044760|NCT00976963|592523926|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
164044761|NCT00976963|592523927|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
164044762|NCT00608842|592523928|FG000|Overall Study|Participant's Request|0|||
164044763|NCT00608842|592523929|FG001|Overall Study|Participant's Request|1|||
163945545|NCT04047862|592169064|FG018|Overall Study|Sponsor Decision|8|||
163945546|NCT04047862|592169046|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164044764|NCT00608842|592523930|FG002|Overall Study|Participant's Request|2|||
164044765|NCT00608842|592523931|FG003|Overall Study|Participant's Request|1|||
164044766|NCT00608842|592523928|FG000|Overall Study|Lost to Follow-up|1|||
164044767|NCT00608842|592523929|FG001|Overall Study|Lost to Follow-up|0|||
164099121|NCT04089735|592728817|FG002|Overall Study|Physician Decision|0|||
163945547|NCT04047862|592169047|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164099122|NCT04089735|592728818|FG003|Overall Study|Physician Decision|0|||
163945548|NCT04047862|592169048|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945549|NCT04047862|592169049|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
164099123|NCT04089735|592728819|FG004|Overall Study|Physician Decision|0|||
164044768|NCT00608842|592523930|FG002|Overall Study|Lost to Follow-up|0|||
164044769|NCT00608842|592523931|FG003|Overall Study|Lost to Follow-up|0|||
164044770|NCT00285649|592523934|FG000|Overall Study|Lost to Follow-up|6|||
164044771|NCT00285649|592523935|FG001|Overall Study|Lost to Follow-up|4|||
164044772|NCT00285649|592523936|FG002|Overall Study|Lost to Follow-up|4|||
164044773|NCT00285649|592523934|FG000|Overall Study|Withdrawal by Subject|3|||
164044774|NCT00285649|592523935|FG001|Overall Study|Withdrawal by Subject|2|||
164044775|NCT00285649|592523936|FG002|Overall Study|Withdrawal by Subject|2|||
164044776|NCT03077711|592523939|FG000|Overall Study|Lost to Follow-up|2|||
164044777|NCT03077711|592523940|FG001|Overall Study|Lost to Follow-up|2|||
164044778|NCT03077711|592523939|FG000|Overall Study|noncompliant taking medication|2|||
164044779|NCT03077711|592523940|FG001|Overall Study|noncompliant taking medication|0|||
164044780|NCT01819194|592523941|FG000|Overall Study|Loss of study articles|2|||
164044781|NCT01448707|592523944|FG000|Overall Study|Adverse Event|3|||
164044782|NCT01448707|592523945|FG001|Overall Study|Adverse Event|1|||
164044783|NCT01448707|592523944|FG000|Overall Study|Lost to Follow-up|2|||
164044784|NCT01448707|592523945|FG001|Overall Study|Lost to Follow-up|6|||
164044785|NCT01448707|592523944|FG000|Overall Study|Withdrawal by Subject|6|||
164044786|NCT01448707|592523945|FG001|Overall Study|Withdrawal by Subject|7|||
164044787|NCT01448707|592523944|FG000|Overall Study|Other|7|||
164044788|NCT01448707|592523945|FG001|Overall Study|Other|4|||
164044789|NCT02033850|592523946|FG000|Overall Study|Death|1|||
164044790|NCT02033850|592523947|FG001|Overall Study|Death|0|||
164044791|NCT02033850|592523946|FG000|Overall Study|unrelated medical reason|1|||
164044792|NCT02033850|592523947|FG001|Overall Study|unrelated medical reason|1|||
164044793|NCT03215667|592523948|FG000|Overall Study|Physician Decision|4|||
164044794|NCT01997281|592523949|FG000|Overall Study|Withdrawal by Subject|1|||
164044795|NCT01997281|592523950|FG001|Overall Study|Withdrawal by Subject|0|||
164044796|NCT00333970|592523952|FG000|Overall Study|Withdrawal by Subject|13|||
164044797|NCT00333970|592523953|FG001|Overall Study|Withdrawal by Subject|7|||
164044798|NCT00560794|592523954|FG000|Overall Study|Adverse Event|2|||
164044799|NCT00560794|592523954|FG000|Overall Study|Patient was not Compliant|1|||
164044800|NCT00560794|592523954|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
164044801|NCT00560794|592523954|FG000|Overall Study|Hematological Relapse|1|||
164044802|NCT00560794|592523954|FG000|Overall Study|Received Bone Marrow Transplant|6|||
164044803|NCT00614991|592523955|FG000|Overall Study|Adverse Event|3|||
164044804|NCT00614991|592523956|FG001|Overall Study|Adverse Event|3|||
164044805|NCT00614991|592523957|FG002|Overall Study|Adverse Event|0|||
164044806|NCT00614991|592523958|FG003|Overall Study|Adverse Event|0|||
164044807|NCT00614991|592523959|FG004|Overall Study|Adverse Event|1|||
164044808|NCT00614991|592523960|FG005|Overall Study|Adverse Event|0|||
164044809|NCT00441480|592523961|FG000|Overall Study|Protocol Violation|1|||
164044810|NCT00441480|592523962|FG001|Overall Study|Protocol Violation|1|||
164044811|NCT00441480|592523961|FG000|Overall Study|Withdrawal by Subject|2|||
164044812|NCT00441480|592523962|FG001|Overall Study|Withdrawal by Subject|3|||
164044813|NCT01922739|592523963|FG000|Titration/Adjustment Period|Adverse Event|3|||
164044814|NCT01922739|592523963|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
164044815|NCT01922739|592523963|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
164044816|NCT01922739|592523963|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
164044817|NCT01922739|592523963|FG000|Open-label Treatment Period|Adverse Event|6|||
164044818|NCT01922739|592523963|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
164044819|NCT01922739|592523963|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
164044820|NCT01922739|592523963|FG000|Open-label Treatment Period|Protocol Violation|5|||
164044821|NCT01922739|592523963|FG000|Open-label Treatment Period|Pregnancy|1|||
164044822|NCT01922739|592523963|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
164044823|NCT01922739|592523963|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
164044824|NCT01922739|592523963|FG000|Open-label Treatment Period|Physician Decision|1|||
164044825|NCT01922739|592523963|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
164044826|NCT00044213|592523964|FG000|Overall Study|Withdrawal by Subject|50|||
164044827|NCT00044213|592523965|FG001|Overall Study|Withdrawal by Subject|65|||
164044828|NCT00044213|592523966|FG002|Overall Study|Withdrawal by Subject|91|||
164044829|NCT00044213|592523967|FG003|Overall Study|Withdrawal by Subject|83|||
164044830|NCT00044213|592523964|FG000|Overall Study|Death|42|||
164044831|NCT00044213|592523965|FG001|Overall Study|Death|42|||
164044832|NCT00044213|592523966|FG002|Overall Study|Death|42|||
164099124|NCT04089735|592728820|FG005|Overall Study|Physician Decision|0|||
164099125|NCT04089735|592728815|FG000|Overall Study|Withdrawal by Subject|0|||
164044833|NCT00044213|592523967|FG003|Overall Study|Death|49|||
164044834|NCT00044213|592523964|FG000|Overall Study|Lost to Follow-up|8|||
164044835|NCT00044213|592523965|FG001|Overall Study|Lost to Follow-up|5|||
164044836|NCT00044213|592523966|FG002|Overall Study|Lost to Follow-up|5|||
164044837|NCT00044213|592523967|FG003|Overall Study|Lost to Follow-up|4|||
164044838|NCT00880607|592523968|FG000|Overall Study|Physician Decision|2|||
164044839|NCT00880607|592523969|FG001|Overall Study|Physician Decision|2|||
164044840|NCT00880607|592523968|FG000|Overall Study|Protocol Violation|2|||
164044841|NCT00880607|592523969|FG001|Overall Study|Protocol Violation|1|||
164044842|NCT00880607|592523968|FG000|Overall Study|surgery did not extend past L1 level|3|||
164044843|NCT00880607|592523969|FG001|Overall Study|surgery did not extend past L1 level|0|||
164044844|NCT05104749|592523970|FG000|Overall Study|Lost to Follow-up|2|||
164044845|NCT05104749|592523971|FG001|Overall Study|Lost to Follow-up|3|||
164044846|NCT02963766|592523972|FG000|Double-Blind Period|Adverse Event|1|||
164044847|NCT02963766|592523973|FG001|Double-Blind Period|Adverse Event|0|||
164044848|NCT02963766|592523974|FG002|Double-Blind Period|Adverse Event|1|||
164044849|NCT02963766|592523972|FG000|Double-Blind Period|Physician Decision|1|||
164044850|NCT02963766|592523973|FG001|Double-Blind Period|Physician Decision|0|||
164044851|NCT02963766|592523974|FG002|Double-Blind Period|Physician Decision|0|||
164044852|NCT02963766|592523972|FG000|Double-Blind Period|Withdrawal by Subject|1|||
164044853|NCT02963766|592523973|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164044854|NCT02963766|592523974|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164044855|NCT02963766|592523972|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
164044856|NCT02963766|592523973|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
164044857|NCT02963766|592523974|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
164044858|NCT02963766|592523972|FG000|Double-Blind Period|Protocol Violation|1|||
164044859|NCT02963766|592523973|FG001|Double-Blind Period|Protocol Violation|0|||
164044860|NCT02963766|592523974|FG002|Double-Blind Period|Protocol Violation|0|||
164044861|NCT02963766|592523972|FG000|Double-Blind Period|Lost to Follow-up|0|||
164044862|NCT02963766|592523973|FG001|Double-Blind Period|Lost to Follow-up|1|||
164044863|NCT02963766|592523974|FG002|Double-Blind Period|Lost to Follow-up|0|||
164044864|NCT02963766|592523972|FG000|Open Label Extension (OLE)|Physician Decision|1|||
164044865|NCT02963766|592523973|FG001|Open Label Extension (OLE)|Physician Decision|2|||
164044866|NCT02963766|592523974|FG002|Open Label Extension (OLE)|Physician Decision|2|||
164044867|NCT02963766|592523972|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
164044868|NCT02963766|592523973|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
164044869|NCT02963766|592523974|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
164044870|NCT04964557|592523975|FG000|Overall Study|Withdrawal by Subject|3|||
164044871|NCT04964557|592523976|FG001|Overall Study|Withdrawal by Subject|2|||
164044872|NCT04964557|592523975|FG000|Overall Study|Lost to Follow-up|1|||
164044873|NCT04964557|592523976|FG001|Overall Study|Lost to Follow-up|2|||
164044874|NCT04964557|592523975|FG000|Overall Study|Physician Decision|2|||
164044875|NCT04964557|592523976|FG001|Overall Study|Physician Decision|0|||
164044876|NCT04964557|592523975|FG000|Overall Study|Death|3|||
164044877|NCT04964557|592523976|FG001|Overall Study|Death|0|||
164044878|NCT04964557|592523975|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
164044879|NCT04964557|592523976|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
164044880|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Adverse Event|22|||
164044881|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Adverse Event|0|||
164044882|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
164044883|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
164044884|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
164044885|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
164044886|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
164044887|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
164044888|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
164044889|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
164044890|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
164044891|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
164044892|NCT02493868|592523977|FG000|Induction Phase: DE Participants|Other|8|||
164044893|NCT02493868|592523978|FG001|Induction Phase: DE Participants|Other|0|||
164044894|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
164044895|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
164044896|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
164044897|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
164044898|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
164044899|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
164044900|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
164044901|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
164044902|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
164044903|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
164044904|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
164044905|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
164044906|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
164044907|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
164044908|NCT02493868|592523977|FG000|Optimization Phase: DE+TE Participants|Other|10|||
164044909|NCT02493868|592523978|FG001|Optimization Phase: DE+TE Participants|Other|2|||
164044910|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
164044911|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
163945550|NCT04047862|592169050|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945551|NCT04047862|592169051|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945552|NCT04047862|592169052|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945553|NCT04047862|592169053|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
163945554|NCT04047862|592169054|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
163945555|NCT04047862|592169055|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945556|NCT04047862|592169056|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
163945557|NCT04047862|592169057|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945558|NCT04047862|592169058|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945559|NCT04047862|592169059|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
163945560|NCT04047862|592169060|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
163945561|NCT04047862|592169061|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
163945562|NCT04047862|592169062|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
163945563|NCT04047862|592169063|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
163945564|NCT04047862|592169064|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
163945565|NCT04047862|592169046|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945566|NCT04047862|592169047|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945567|NCT04047862|592169048|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945568|NCT04047862|592169049|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945569|NCT04047862|592169050|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945570|NCT04047862|592169051|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945571|NCT04047862|592169052|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945572|NCT04047862|592169053|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945573|NCT04047862|592169054|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945574|NCT04047862|592169055|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945575|NCT04047862|592169056|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945576|NCT04047862|592169057|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945577|NCT04047862|592169058|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945578|NCT04047862|592169059|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945579|NCT04047862|592169060|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945580|NCT04047862|592169061|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
163945581|NCT04047862|592169062|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945582|NCT04047862|592169063|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
163945583|NCT04047862|592169064|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
163945584|NCT04047862|592169046|FG000|Overall Study|Other|0|||
163945585|NCT04047862|592169047|FG001|Overall Study|Other|0|||
163945586|NCT04047862|592169048|FG002|Overall Study|Other|0|||
163945587|NCT04047862|592169049|FG003|Overall Study|Other|0|||
163945588|NCT04047862|592169050|FG004|Overall Study|Other|0|||
163945589|NCT04047862|592169051|FG005|Overall Study|Other|0|||
163945590|NCT04047862|592169052|FG006|Overall Study|Other|0|||
163945591|NCT04047862|592169053|FG007|Overall Study|Other|0|||
163945592|NCT04047862|592169054|FG008|Overall Study|Other|0|||
163945593|NCT04047862|592169055|FG009|Overall Study|Other|0|||
163945594|NCT04047862|592169056|FG010|Overall Study|Other|0|||
163945595|NCT04047862|592169057|FG011|Overall Study|Other|0|||
163945596|NCT04047862|592169058|FG012|Overall Study|Other|0|||
163945597|NCT04047862|592169059|FG013|Overall Study|Other|0|||
163945598|NCT04047862|592169060|FG014|Overall Study|Other|2|||
163945599|NCT04047862|592169061|FG015|Overall Study|Other|1|||
163945600|NCT04047862|592169062|FG016|Overall Study|Other|1|||
163945601|NCT04047862|592169063|FG017|Overall Study|Other|1|||
163945602|NCT04047862|592169064|FG018|Overall Study|Other|0|||
163945603|NCT04349631|592169071|FG000|Overall Study|Lost to Follow-up|3|||
163945604|NCT04349631|592169071|FG000|Overall Study|Withdrawal by Subject|7|||
163945605|NCT00640133|592170342|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
163945606|NCT00640133|592170343|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
163945607|NCT00640133|592170342|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
163945608|NCT00640133|592170343|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
163945609|NCT00640133|592170342|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
163945610|NCT00640133|592170343|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
163945611|NCT00730275|592170344|FG000|Overall Study|Withdrawal by Subject|0|||
164044912|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
164044913|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
164044914|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
163945612|NCT00730275|592170345|FG001|Overall Study|Withdrawal by Subject|0|||
163945613|NCT00730275|592170346|FG002|Overall Study|Withdrawal by Subject|0|||
163945614|NCT00730275|592170347|FG003|Overall Study|Withdrawal by Subject|1|||
163945615|NCT04032613|592170348|FG000|Overall Study|Did not complete post-program assessment|5|||
163945616|NCT04032613|592170349|FG001|Overall Study|Did not complete post-program assessment|2|||
163945617|NCT01744392|592170355|FG000|Overall Study|Physician Decision|1|||
163945618|NCT00299494|592170356|FG000|Overall Study|Withdrawal by Subject|0|||
163945619|NCT00299494|592170357|FG001|Overall Study|Withdrawal by Subject|0|||
163945620|NCT00299494|592170358|FG002|Overall Study|Withdrawal by Subject|0|||
163945621|NCT00299494|592170359|FG003|Overall Study|Withdrawal by Subject|3|||
163945622|NCT00299494|592170360|FG004|Overall Study|Withdrawal by Subject|1|||
163945623|NCT00299494|592170361|FG005|Overall Study|Withdrawal by Subject|4|||
163945624|NCT00299494|592170356|FG000|Overall Study|Physician Decision|0|||
163945625|NCT00299494|592170357|FG001|Overall Study|Physician Decision|0|||
163945626|NCT00299494|592170358|FG002|Overall Study|Physician Decision|0|||
163945627|NCT00299494|592170359|FG003|Overall Study|Physician Decision|0|||
163945628|NCT00299494|592170360|FG004|Overall Study|Physician Decision|1|||
163945629|NCT00299494|592170361|FG005|Overall Study|Physician Decision|0|||
163945630|NCT00299494|592170356|FG000|Overall Study|Death|3|||
163945631|NCT00299494|592170357|FG001|Overall Study|Death|1|||
163945632|NCT00299494|592170358|FG002|Overall Study|Death|4|||
163945633|NCT00299494|592170359|FG003|Overall Study|Death|6|||
163945634|NCT00299494|592170360|FG004|Overall Study|Death|18|||
163945635|NCT00299494|592170361|FG005|Overall Study|Death|19|||
163945636|NCT00299494|592170356|FG000|Overall Study|Lost to Follow-up|0|||
163945637|NCT00299494|592170357|FG001|Overall Study|Lost to Follow-up|0|||
163945638|NCT00299494|592170358|FG002|Overall Study|Lost to Follow-up|0|||
163945639|NCT00299494|592170359|FG003|Overall Study|Lost to Follow-up|0|||
163945640|NCT00299494|592170360|FG004|Overall Study|Lost to Follow-up|3|||
163945641|NCT00299494|592170361|FG005|Overall Study|Lost to Follow-up|1|||
163945642|NCT00299494|592170356|FG000|Overall Study|Other - Unspecified|0|||
163945643|NCT00299494|592170357|FG001|Overall Study|Other - Unspecified|0|||
163945644|NCT00299494|592170358|FG002|Overall Study|Other - Unspecified|0|||
163945645|NCT00299494|592170359|FG003|Overall Study|Other - Unspecified|0|||
163945646|NCT00299494|592170360|FG004|Overall Study|Other - Unspecified|3|||
163945647|NCT00299494|592170361|FG005|Overall Study|Other - Unspecified|1|||
163945648|NCT00299494|592170356|FG000|Overall Study|Other - site closure|0|||
163945649|NCT00299494|592170357|FG001|Overall Study|Other - site closure|0|||
163945650|NCT00299494|592170358|FG002|Overall Study|Other - site closure|0|||
163945651|NCT00299494|592170359|FG003|Overall Study|Other - site closure|1|||
163945652|NCT00299494|592170360|FG004|Overall Study|Other - site closure|1|||
163945653|NCT00299494|592170361|FG005|Overall Study|Other - site closure|1|||
163945654|NCT01417104|592170365|FG000|Overall Study|Withdrawal by Subject|5|||
163945655|NCT01417104|592170366|FG001|Overall Study|Withdrawal by Subject|1|||
163945656|NCT01417104|592170365|FG000|Overall Study|Failure to make contact|0|||
163945657|NCT01417104|592170366|FG001|Overall Study|Failure to make contact|1|||
163945658|NCT01417104|592170365|FG000|Overall Study|Adverse Event|1|||
163945659|NCT01417104|592170366|FG001|Overall Study|Adverse Event|0|||
163945660|NCT00403767|592170369|FG000|Overall Study|Adverse Event|993|||
163945661|NCT00403767|592170370|FG001|Overall Study|Adverse Event|919|||
163945662|NCT00403767|592170369|FG000|Overall Study|Non-compliant with study medication|134|||
163945663|NCT00403767|592170370|FG001|Overall Study|Non-compliant with study medication|164|||
163945664|NCT00403767|592170369|FG000|Overall Study|Consent withdrawn|671|||
163945665|NCT00403767|592170370|FG001|Overall Study|Consent withdrawn|673|||
163945666|NCT00403767|592170369|FG000|Overall Study|Investigator dec./not protocol-related|191|||
163945667|NCT00403767|592170370|FG001|Overall Study|Investigator dec./not protocol-related|178|||
163945668|NCT00403767|592170369|FG000|Overall Study|Lost to Follow-up|6|||
163945669|NCT00403767|592170370|FG001|Overall Study|Lost to Follow-up|8|||
163945670|NCT00403767|592170369|FG000|Overall Study|Protocol Violation|142|||
163945671|NCT00403767|592170370|FG001|Overall Study|Protocol Violation|124|||
163945672|NCT00403767|592170369|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
163945673|NCT00403767|592170370|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
164044915|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
164044916|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
164044917|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
164044918|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
164044919|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
164044920|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
163945674|NCT00403767|592170369|FG000|Overall Study|Study terminated by sponsor|82|||
163945675|NCT00403767|592170370|FG001|Overall Study|Study terminated by sponsor|69|||
163945676|NCT00403767|592170369|FG000|Overall Study|Missing/incomplete data|1|||
163945677|NCT00403767|592170370|FG001|Overall Study|Missing/incomplete data|1|||
163945678|NCT03014011|592170371|FG000|First Intervention|Withdrawal by Subject|1|||
163945679|NCT03014011|592170372|FG001|First Intervention|Withdrawal by Subject|0|||
163945680|NCT03014011|592170371|FG000|Washout|Withdrawal by Subject|1|||
163945681|NCT03014011|592170372|FG001|Washout|Withdrawal by Subject|0|||
163945682|NCT02755818|592170373|FG000|Overall Study|Withdrawal by Subject|0|||
163945683|NCT02755818|592170374|FG001|Overall Study|Withdrawal by Subject|0|||
163945684|NCT02755818|592170375|FG002|Overall Study|Withdrawal by Subject|0|||
163945685|NCT02755818|592170376|FG003|Overall Study|Withdrawal by Subject|2|||
164148525|NCT01823835|592904896|FG004|Overall Study|Study Termination|1|||
164044921|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
164044922|NCT02493868|592523977|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
164044923|NCT02493868|592523978|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
164044924|NCT02493868|592523977|FG000|Follow-up Phase|Lost to Follow-up|1|||
164044925|NCT02493868|592523978|FG001|Follow-up Phase|Lost to Follow-up|0|||
164044926|NCT02493868|592523977|FG000|Follow-up Phase|Withdrawal by Subject|3|||
164044927|NCT02493868|592523978|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164044928|NCT02493868|592523977|FG000|Follow-up Phase|Investigator Decision|5|||
164044929|NCT02493868|592523978|FG001|Follow-up Phase|Investigator Decision|1|||
164044930|NCT02493868|592523977|FG000|Follow-up Phase|Other|2|||
164044931|NCT02493868|592523978|FG001|Follow-up Phase|Other|1|||
164044932|NCT03039569|592523983|FG000|Overall Study|Lost to Follow-up|5|||
164044933|NCT03039569|592523984|FG001|Overall Study|Lost to Follow-up|4|||
164044934|NCT04888507|592526398|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
164044935|NCT00636155|592526399|FG000|Overall Study|Adverse Event|8|||
164044936|NCT00636155|592526399|FG000|Overall Study|Lack of Efficacy|1|||
164044937|NCT00636155|592526399|FG000|Overall Study|Withdrawal by Subject|3|||
164044938|NCT00636155|592526399|FG000|Overall Study|Stem cell transplant|1|||
164044939|NCT00636155|592526399|FG000|Overall Study|Physician Decision|5|||
164044940|NCT00766142|592526400|FG000|Overall Study|Protocol Violation|4|||
164044941|NCT02973997|592526401|FG000|Overall Study|Withdrawal by Subject|4|||
164044942|NCT02973997|592526402|FG001|Overall Study|Withdrawal by Subject|0|||
164044943|NCT02973997|592526401|FG000|Overall Study|Adverse Event|4|||
164044944|NCT02973997|592526402|FG001|Overall Study|Adverse Event|1|||
164044945|NCT02973997|592526401|FG000|Overall Study|Disease Progression|11|||
164044946|NCT02973997|592526402|FG001|Overall Study|Disease Progression|20|||
164044947|NCT02973997|592526401|FG000|Overall Study|Alternative Therapy|3|||
164044948|NCT02973997|592526402|FG001|Overall Study|Alternative Therapy|0|||
164044949|NCT02973997|592526401|FG000|Overall Study|Other complicating disease|0|||
164044950|NCT02973997|592526402|FG001|Overall Study|Other complicating disease|1|||
164044951|NCT02973997|592526401|FG000|Overall Study|Death|0|||
164044952|NCT02973997|592526402|FG001|Overall Study|Death|1|||
164044953|NCT01431521|592526403|FG000|Overall Study|Withdrawal by Subject|0|||
164044954|NCT01431521|592526404|FG001|Overall Study|Withdrawal by Subject|0|||
164044955|NCT01431521|592526405|FG002|Overall Study|Withdrawal by Subject|1|||
164044956|NCT01431521|592526406|FG003|Overall Study|Withdrawal by Subject|0|||
164044957|NCT02045979|592526410|FG000|Overall Study|Informed Consent Withdrawn|2|||
164044958|NCT02045979|592526411|FG001|Overall Study|Informed Consent Withdrawn|0|||
164044959|NCT02045979|592526412|FG002|Overall Study|Informed Consent Withdrawn|1|||
164044960|NCT02045979|592526410|FG000|Overall Study|not specified above|0|||
164044961|NCT02045979|592526411|FG001|Overall Study|not specified above|1|||
164044962|NCT02045979|592526412|FG002|Overall Study|not specified above|0|||
164044963|NCT03287830|592526417|FG000|Overall Study|Withdrawal by Subject|1|||
164044964|NCT03287830|592526418|FG001|Overall Study|Withdrawal by Subject|1|||
164044965|NCT03287830|592526417|FG000|Overall Study|not meeting inclusion criteria|5|||
164044966|NCT03287830|592526418|FG001|Overall Study|not meeting inclusion criteria|12|||
164044967|NCT03598140|592526421|FG000|Overall Study|enrolled but didn't start|1|||
164044968|NCT03598140|592526422|FG001|Overall Study|enrolled but didn't start|0|||
164044969|NCT02155712|592526426|FG000|Overall Study|Death|12|||
164044970|NCT02155712|592526427|FG001|Overall Study|Death|0|||
164044971|NCT02155712|592526426|FG000|Overall Study|Lost to Follow-up|37|||
164044972|NCT02155712|592526427|FG001|Overall Study|Lost to Follow-up|22|||
164044973|NCT02155712|592526426|FG000|Overall Study|Revision of device|4|||
164044974|NCT02155712|592526427|FG001|Overall Study|Revision of device|3|||
164044975|NCT02155712|592526426|FG000|Overall Study|Withdrawal by Subject|39|||
164044976|NCT02155712|592526427|FG001|Overall Study|Withdrawal by Subject|21|||
164044977|NCT02155712|592526426|FG000|Overall Study|Site termination|77|||
164044978|NCT02155712|592526427|FG001|Overall Study|Site termination|19|||
164044979|NCT02155712|592526426|FG000|Overall Study|Sponsor terminated study early|150|||
164044980|NCT02155712|592526427|FG001|Overall Study|Sponsor terminated study early|0|||
164044981|NCT02155712|592526426|FG000|Overall Study|Missed final 5-year protocol visit|0|||
164044982|NCT02155712|592526427|FG001|Overall Study|Missed final 5-year protocol visit|32|||
164044983|NCT02155712|592526426|FG000|Overall Study|Censored because surgery cancelled|6|||
164044984|NCT02155712|592526427|FG001|Overall Study|Censored because surgery cancelled|10|||
164044985|NCT02155712|592526426|FG000|Overall Study|Censored because study device was not implanted|61|||
164044986|NCT02155712|592526427|FG001|Overall Study|Censored because study device was not implanted|66|||
164044987|NCT02155712|592526426|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
164044988|NCT02155712|592526427|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
164044989|NCT02060903|592526428|FG000|Overall Study|Lost to Follow-up|4|||
164044990|NCT02060903|592526429|FG001|Overall Study|Lost to Follow-up|0|||
164044991|NCT02060903|592526428|FG000|Overall Study|Withdrawal by Subject|0|||
164044992|NCT02060903|592526429|FG001|Overall Study|Withdrawal by Subject|7|||
164044993|NCT02418585|592526430|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
164044994|NCT02418585|592526431|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
164044995|NCT02418585|592526430|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
164099126|NCT04089735|592728816|FG001|Overall Study|Withdrawal by Subject|0|||
164099127|NCT04089735|592728817|FG002|Overall Study|Withdrawal by Subject|1|||
164099128|NCT04089735|592728818|FG003|Overall Study|Withdrawal by Subject|0|||
164099129|NCT04089735|592728819|FG004|Overall Study|Withdrawal by Subject|0|||
163945686|NCT02755818|592170373|FG000|Overall Study|withdrawal by PI|0|||
163945687|NCT02755818|592170374|FG001|Overall Study|withdrawal by PI|0|||
163945688|NCT02755818|592170375|FG002|Overall Study|withdrawal by PI|1|||
163945689|NCT02755818|592170376|FG003|Overall Study|withdrawal by PI|1|||
163945690|NCT01152814|592170377|FG000|Overall Study|Lost to Follow-up|2|||
163945691|NCT01280357|592170388|FG000|Overall Study|Excluded no internal monitoring|14|||
163945692|NCT01280357|592170388|FG000|Overall Study|IInsufficient data/No data supplied|12|||
163945693|NCT03284203|592170389|FG000|Overall Study|Lost to Follow-up|3|||
163945694|NCT03682302|592170392|FG000|Overall Study|Lost to Follow-up|1|||
163945695|NCT03682302|592170393|FG001|Overall Study|Lost to Follow-up|2|||
163945696|NCT03682302|592170394|FG002|Overall Study|Lost to Follow-up|0|||
163945697|NCT03682302|592170395|FG003|Overall Study|Lost to Follow-up|1|||
163945698|NCT03682302|592170392|FG000|Overall Study|Study drug was not administered|0|||
163945699|NCT03682302|592170393|FG001|Overall Study|Study drug was not administered|0|||
163945700|NCT03682302|592170394|FG002|Overall Study|Study drug was not administered|1|||
163945701|NCT03682302|592170395|FG003|Overall Study|Study drug was not administered|1|||
163945702|NCT01489891|592170397|FG000|Overall Study|Endoscopy failure|1|||
163945703|NCT01489891|592170398|FG001|Overall Study|Endoscopy failure|0|||
163945704|NCT00532493|592170399|FG000|Overall Study|Death|1|||
163945705|NCT00532493|592170400|FG001|Overall Study|Death|1|||
163945706|NCT00532493|592170399|FG000|Overall Study|Lost to Follow-up|10|||
163945707|NCT00532493|592170400|FG001|Overall Study|Lost to Follow-up|7|||
163945708|NCT00532493|592170399|FG000|Overall Study|Withdrawal by Subject|7|||
163945709|NCT00532493|592170400|FG001|Overall Study|Withdrawal by Subject|9|||
163945710|NCT00532493|592170399|FG000|Overall Study|Physician Decision|1|||
163945711|NCT00532493|592170400|FG001|Overall Study|Physician Decision|6|||
163945712|NCT00532493|592170399|FG000|Overall Study|Adverse Event|6|||
163945713|NCT00532493|592170400|FG001|Overall Study|Adverse Event|5|||
163945714|NCT00532493|592170399|FG000|Overall Study|Protocol Deviation|1|||
163945715|NCT00532493|592170400|FG001|Overall Study|Protocol Deviation|0|||
163945716|NCT00532493|592170399|FG000|Overall Study|Subject Moved Away|3|||
163945717|NCT00532493|592170400|FG001|Overall Study|Subject Moved Away|1|||
163945718|NCT00532493|592170399|FG000|Overall Study|Contraindicative Medication|1|||
163945719|NCT00532493|592170400|FG001|Overall Study|Contraindicative Medication|0|||
163945720|NCT00948766|592170401|FG000|Core Study|Adverse Event|73|||
163945721|NCT00948766|592170402|FG001|Core Study|Adverse Event|51|||
163945722|NCT00948766|592170401|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
163945723|NCT00948766|592170402|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
163945724|NCT00948766|592170401|FG000|Core Study|Patient Withdrew Consent|27|||
163945725|NCT00948766|592170402|FG001|Core Study|Patient Withdrew Consent|46|||
163945726|NCT00948766|592170401|FG000|Core Study|Lost to Follow-up|3|||
163945727|NCT00948766|592170402|FG001|Core Study|Lost to Follow-up|2|||
163945728|NCT00948766|592170401|FG000|Core Study|Administrative Problems|2|||
163945729|NCT00948766|592170402|FG001|Core Study|Administrative Problems|2|||
163945730|NCT00948766|592170401|FG000|Core Study|Death|1|||
163945731|NCT00948766|592170402|FG001|Core Study|Death|1|||
163945732|NCT00948766|592170401|FG000|Core Study|Protocol Deviation|8|||
163945733|NCT00948766|592170402|FG001|Core Study|Protocol Deviation|10|||
163945734|NCT00948766|592170401|FG000|Extension Study|Adverse Event|43|||
163945735|NCT00948766|592170402|FG001|Extension Study|Adverse Event|0|||
163945736|NCT00948766|592170401|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
163945737|NCT00948766|592170402|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
163945738|NCT00948766|592170401|FG000|Extension Study|Study Drug No Longer Required|1|||
163945739|NCT00948766|592170402|FG001|Extension Study|Study Drug No Longer Required|0|||
163945740|NCT00948766|592170401|FG000|Extension Study|Patient Withdrew Consent|32|||
163945741|NCT00948766|592170402|FG001|Extension Study|Patient Withdrew Consent|0|||
163945742|NCT00948766|592170401|FG000|Extension Study|Lost to Follow-up|8|||
163945743|NCT00948766|592170402|FG001|Extension Study|Lost to Follow-up|0|||
163945744|NCT00948766|592170401|FG000|Extension Study|Administrative Problems|1|||
163945745|NCT00948766|592170402|FG001|Extension Study|Administrative Problems|0|||
163945746|NCT00948766|592170401|FG000|Extension Study|Death|4|||
163945747|NCT00948766|592170402|FG001|Extension Study|Death|0|||
163945748|NCT03459443|592170403|FG000|Overall Study|Lack of Efficacy|3|||
163945749|NCT03459443|592170403|FG000|Overall Study|Adverse Event|1|||
163945750|NCT03459443|592170403|FG000|Overall Study|Sponsor's decision to close the study|18|||
163945751|NCT02153073|592170404|FG000|Overall Study|Case Report Forms Uncollected|230|||
163945752|NCT02153073|592170404|FG000|Overall Study|Protocol Deviation|68|||
163945753|NCT03189745|592170405|FG000|Overall Study|Conflict in work schedule of participant|1|||
163945754|NCT03189745|592170406|FG001|Overall Study|Conflict in work schedule of participant|1|||
163945755|NCT03702231|592170407|FG000|Overall Study|Withdrawal by Subject|1|||
163945756|NCT03702231|592170408|FG001|Overall Study|Withdrawal by Subject|0|||
163945757|NCT03702231|592170409|FG002|Overall Study|Withdrawal by Subject|0|||
163945758|NCT03702231|592170407|FG000|Overall Study|Protocol Violation|0|||
163945759|NCT03702231|592170408|FG001|Overall Study|Protocol Violation|0|||
163945760|NCT03702231|592170409|FG002|Overall Study|Protocol Violation|1|||
163945761|NCT03702231|592170407|FG000|Overall Study|Change in CLL Treatment|0|||
163945762|NCT03702231|592170408|FG001|Overall Study|Change in CLL Treatment|0|||
163945763|NCT03702231|592170409|FG002|Overall Study|Change in CLL Treatment|1|||
163945764|NCT03702231|592170407|FG000|Overall Study|COVID Pandemic|1|||
163945765|NCT03702231|592170408|FG001|Overall Study|COVID Pandemic|4|||
163945766|NCT03702231|592170409|FG002|Overall Study|COVID Pandemic|1|||
163945767|NCT03702231|592170407|FG000|Overall Study|Non-compliance|0|||
163945768|NCT03702231|592170408|FG001|Overall Study|Non-compliance|0|||
163945769|NCT03702231|592170409|FG002|Overall Study|Non-compliance|1|||
163945770|NCT01276379|592170410|FG000|Overall Study|Screening failure|40|||
163945771|NCT02729831|592170412|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
163945772|NCT02729831|592170413|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
163945773|NCT02729831|592170414|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
163945774|NCT02729831|592170415|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
163945775|NCT02729831|592170412|FG000|1 Week Post-visit|Lost to Follow-up|43|||
163945776|NCT02729831|592170413|FG001|1 Week Post-visit|Lost to Follow-up|40|||
163945777|NCT02729831|592170414|FG002|1 Week Post-visit|Lost to Follow-up|38|||
163945778|NCT02729831|592170415|FG003|1 Week Post-visit|Lost to Follow-up|36|||
163945779|NCT02729831|592170412|FG000|6 Month Follow-up|Lost to Follow-up|54|||
163945780|NCT02729831|592170413|FG001|6 Month Follow-up|Lost to Follow-up|51|||
163945781|NCT02729831|592170414|FG002|6 Month Follow-up|Lost to Follow-up|48|||
163945782|NCT02729831|592170415|FG003|6 Month Follow-up|Lost to Follow-up|42|||
163945783|NCT02729831|592170412|FG000|6 Month Follow-up|Death|1|||
163945784|NCT02729831|592170413|FG001|6 Month Follow-up|Death|3|||
163945785|NCT02729831|592170414|FG002|6 Month Follow-up|Death|0|||
163945786|NCT02729831|592170415|FG003|6 Month Follow-up|Death|1|||
163945787|NCT00864253|592170416|FG000|Overall Study|Adverse Event|56|||
163945788|NCT00864253|592170417|FG001|Overall Study|Adverse Event|11|||
163945789|NCT00864253|592170416|FG000|Overall Study|Unrelated Adverse Event|3|||
163945790|NCT00864253|592170417|FG001|Overall Study|Unrelated Adverse Event|1|||
163945791|NCT00864253|592170416|FG000|Overall Study|Physician Decision|11|||
163945792|NCT00864253|592170417|FG001|Overall Study|Physician Decision|15|||
163945793|NCT00864253|592170416|FG000|Overall Study|Protocol Violation|0|||
163945794|NCT00864253|592170417|FG001|Overall Study|Protocol Violation|2|||
163945795|NCT00864253|592170416|FG000|Overall Study|Lost to Follow-up|1|||
163945796|NCT00864253|592170417|FG001|Overall Study|Lost to Follow-up|1|||
163945797|NCT00864253|592170416|FG000|Overall Study|Withdrawal by Subject|18|||
163945798|NCT00864253|592170417|FG001|Overall Study|Withdrawal by Subject|18|||
163945799|NCT00864253|592170416|FG000|Overall Study|Death|1|||
163945800|NCT00864253|592170417|FG001|Overall Study|Death|0|||
163945801|NCT00864253|592170416|FG000|Overall Study|Ongoing|2|||
163945802|NCT00864253|592170417|FG001|Overall Study|Ongoing|3|||
163945803|NCT00864253|592170416|FG000|Overall Study|Untreated|7|||
163945804|NCT00864253|592170417|FG001|Overall Study|Untreated|7|||
163945805|NCT01111240|592170419|FG000|Overall Study|Adverse Event|190|||
163945806|NCT01111240|592170419|FG000|Overall Study|Lack of Efficacy|545|||
163945807|NCT01111240|592170419|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
163945808|NCT01111240|592170419|FG000|Overall Study|Other|312|||
163945809|NCT01747551|592170420|FG000|Overall Study|Progressive Disease|24|||
163945810|NCT01747551|592170421|FG001|Overall Study|Progressive Disease|17|||
163945811|NCT01747551|592170420|FG000|Overall Study|Death|3|||
163945812|NCT01747551|592170421|FG001|Overall Study|Death|1|||
163945813|NCT01747551|592170420|FG000|Overall Study|Adverse Event|7|||
164044996|NCT02418585|592526431|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
164044997|NCT02418585|592526430|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
164044998|NCT02418585|592526431|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
164044999|NCT02418585|592526430|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
164045000|NCT02418585|592526431|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
164045001|NCT02418585|592526430|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
163945814|NCT01747551|592170421|FG001|Overall Study|Adverse Event|1|||
163945815|NCT01747551|592170420|FG000|Overall Study|Prolonged Treatment Delay|2|||
163945816|NCT01747551|592170421|FG001|Overall Study|Prolonged Treatment Delay|0|||
163945817|NCT01747551|592170420|FG000|Overall Study|Withdrawal by Subject|3|||
163945818|NCT01747551|592170421|FG001|Overall Study|Withdrawal by Subject|1|||
163945819|NCT01747551|592170420|FG000|Overall Study|Physician Decision|2|||
164045002|NCT02418585|592526431|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
164045003|NCT02418585|592526430|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
164045004|NCT02418585|592526431|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
164045005|NCT02418585|592526430|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
163945820|NCT01747551|592170421|FG001|Overall Study|Physician Decision|1|||
163945821|NCT01747551|592170420|FG000|Overall Study|Other|2|||
163945822|NCT01747551|592170421|FG001|Overall Study|Other|0|||
163945823|NCT01609062|592170422|FG000|Extension Phase|Terminated by Sponsor|14|||
163945824|NCT01609062|592170423|FG001|Extension Phase|Terminated by Sponsor|9|||
163945825|NCT01609062|592170422|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
163945826|NCT01609062|592170423|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
163945827|NCT01609062|592170422|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
163945828|NCT01609062|592170423|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
163945829|NCT03842358|592170428|FG000|Overall Study|Poor DOT probe contact with breast|2|||
163945830|NCT03842358|592170428|FG000|Overall Study|DOT system problem|1|||
163945831|NCT03842358|592170428|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
163945832|NCT03842358|592170428|FG000|Overall Study|No biopsy after physician review|4|||
163945833|NCT03842358|592170428|FG000|Overall Study|Patient withdrew|2|||
163945834|NCT05384938|592170429|FG000|Overall Study|Withdrawal by Subject|8|||
163945835|NCT05384938|592170429|FG000|Overall Study|Lost to Follow-up|6|||
163945836|NCT05384938|592170429|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
163945837|NCT02626455|592170430|FG000|Overall Study|Other|1|||
163945838|NCT02626455|592170431|FG001|Overall Study|Other|1|||
163945839|NCT02626455|592170432|FG002|Overall Study|Other|0|||
163945840|NCT02626455|592170433|FG003|Overall Study|Other|0|||
163945841|NCT02626455|592170434|FG004|Overall Study|Other|0|||
163945842|NCT02626455|592170435|FG005|Overall Study|Other|17|||
163945843|NCT02626455|592170436|FG006|Overall Study|Other|23|||
163945844|NCT02626455|592170430|FG000|Overall Study|Withdrawal by Subject|1|||
163945845|NCT02626455|592170431|FG001|Overall Study|Withdrawal by Subject|0|||
163945846|NCT02626455|592170432|FG002|Overall Study|Withdrawal by Subject|0|||
163945847|NCT02626455|592170433|FG003|Overall Study|Withdrawal by Subject|0|||
163945848|NCT02626455|592170434|FG004|Overall Study|Withdrawal by Subject|0|||
163945849|NCT02626455|592170435|FG005|Overall Study|Withdrawal by Subject|10|||
163945850|NCT02626455|592170436|FG006|Overall Study|Withdrawal by Subject|6|||
163945851|NCT02626455|592170430|FG000|Overall Study|Physician Decision|0|||
163945852|NCT02626455|592170431|FG001|Overall Study|Physician Decision|2|||
163945853|NCT02626455|592170432|FG002|Overall Study|Physician Decision|2|||
163945854|NCT02626455|592170433|FG003|Overall Study|Physician Decision|2|||
163945855|NCT02626455|592170434|FG004|Overall Study|Physician Decision|1|||
163945856|NCT02626455|592170435|FG005|Overall Study|Physician Decision|10|||
163945857|NCT02626455|592170436|FG006|Overall Study|Physician Decision|3|||
163945858|NCT02626455|592170430|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163945859|NCT02626455|592170431|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163945860|NCT02626455|592170432|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163945861|NCT02626455|592170433|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163945862|NCT02626455|592170434|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163945863|NCT02626455|592170435|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
163945864|NCT02626455|592170436|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
163945865|NCT02626455|592170430|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163945866|NCT02626455|592170431|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163945867|NCT02626455|592170432|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163945868|NCT02626455|592170433|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163945869|NCT02626455|592170434|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163945870|NCT02626455|592170435|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
163945871|NCT02626455|592170436|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
163945872|NCT02626455|592170430|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163945873|NCT02626455|592170431|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163945874|NCT02626455|592170432|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163945875|NCT02626455|592170433|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163945876|NCT02626455|592170434|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
163945877|NCT02626455|592170435|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
163945878|NCT02626455|592170436|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
163945879|NCT02626455|592170430|FG000|Overall Study|Patient decision|0|||
163945880|NCT02626455|592170431|FG001|Overall Study|Patient decision|1|||
163945881|NCT02626455|592170432|FG002|Overall Study|Patient decision|0|||
163945882|NCT02626455|592170433|FG003|Overall Study|Patient decision|0|||
163945883|NCT02626455|592170434|FG004|Overall Study|Patient decision|1|||
163945884|NCT02626455|592170435|FG005|Overall Study|Patient decision|36|||
163945885|NCT02626455|592170436|FG006|Overall Study|Patient decision|22|||
164045006|NCT02418585|592526431|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
164045007|NCT02418585|592526430|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
163945886|NCT02626455|592170430|FG000|Overall Study|Protocol Violation|0|||
163945887|NCT02626455|592170431|FG001|Overall Study|Protocol Violation|0|||
163945888|NCT02626455|592170432|FG002|Overall Study|Protocol Violation|0|||
163945889|NCT02626455|592170433|FG003|Overall Study|Protocol Violation|0|||
163945890|NCT02626455|592170434|FG004|Overall Study|Protocol Violation|0|||
163945891|NCT02626455|592170435|FG005|Overall Study|Protocol Violation|0|||
163945892|NCT02626455|592170436|FG006|Overall Study|Protocol Violation|1|||
164045008|NCT02418585|592526431|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
163945893|NCT02626455|592170430|FG000|Overall Study|Progressive disease - radiological progression|0|||
163945894|NCT02626455|592170431|FG001|Overall Study|Progressive disease - radiological progression|0|||
163945895|NCT02626455|592170432|FG002|Overall Study|Progressive disease - radiological progression|0|||
163945896|NCT02626455|592170433|FG003|Overall Study|Progressive disease - radiological progression|0|||
163945897|NCT02626455|592170434|FG004|Overall Study|Progressive disease - radiological progression|0|||
163842153|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
163842154|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
163842155|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
163842156|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
163842157|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
163842158|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
163842159|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
163842160|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
163842161|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
163842162|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
163842163|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
163842164|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
163842165|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
163842166|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
163842167|NCT00365378|591792886|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
163842168|NCT00365378|591792887|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
163842169|NCT00365378|591792888|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
163842170|NCT00365378|591792886|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
163842171|NCT00365378|591792887|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
163842172|NCT00365378|591792888|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
163842173|NCT00365378|591792886|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
163842174|NCT00365378|591792887|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
163842175|NCT00365378|591792888|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
163842176|NCT00365378|591792886|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
163842177|NCT00365378|591792887|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
163842178|NCT00365378|591792888|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
163842179|NCT00365378|591792886|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
163842180|NCT00365378|591792887|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
163842181|NCT00365378|591792888|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
163842182|NCT00365378|591792886|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
163842183|NCT00365378|591792887|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
163842184|NCT00365378|591792888|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
163842185|NCT00365378|591792886|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
163842186|NCT00365378|591792887|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
163842187|NCT00365378|591792888|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
163842188|NCT00365378|591792886|FG000|Extension|Adverse Event|0|||
163842189|NCT00365378|591792887|FG001|Extension|Adverse Event|0|||
163842190|NCT00365378|591792888|FG002|Extension|Adverse Event|1|||
163842191|NCT00365378|591792886|FG000|Extension|Moved|0|||
163842192|NCT00365378|591792887|FG001|Extension|Moved|0|||
163842193|NCT00365378|591792888|FG002|Extension|Moved|8|||
163842194|NCT00365378|591792886|FG000|Extension|Lost to Follow-up|0|||
163842195|NCT00365378|591792887|FG001|Extension|Lost to Follow-up|0|||
163842196|NCT00365378|591792888|FG002|Extension|Lost to Follow-up|57|||
163842197|NCT00365378|591792886|FG000|Extension|Protocol Violation|0|||
163842198|NCT00365378|591792887|FG001|Extension|Protocol Violation|0|||
163842199|NCT00365378|591792888|FG002|Extension|Protocol Violation|2|||
163842200|NCT00365378|591792886|FG000|Extension|Withdrawal by Subject|0|||
163842201|NCT00365378|591792887|FG001|Extension|Withdrawal by Subject|0|||
163842202|NCT00365378|591792888|FG002|Extension|Withdrawal by Subject|98|||
163842203|NCT00365378|591792886|FG000|Extension|Other|0|||
163842204|NCT00365378|591792887|FG001|Extension|Other|0|||
163842205|NCT00365378|591792888|FG002|Extension|Other|31|||
163842206|NCT04741802|591792889|FG000|Overall Study|Death|1|||
163842207|NCT04741802|591792889|FG000|Overall Study|Lost to Follow-up|11|||
163842208|NCT04161807|591792895|FG000|Overall Study|Withdrawal by Subject|2|||
163842209|NCT04161807|591792895|FG000|Overall Study|Performed only 1 treatment|2|||
163842210|NCT00708305|591792898|FG000|Period 1|Protocol Violation|1|||
163842211|NCT00708305|591792899|FG001|Period 1|Protocol Violation|0|||
163842212|NCT00708305|591792900|FG002|Period 1|Protocol Violation|1|||
163842213|NCT00708305|591792901|FG003|Period 1|Protocol Violation|0|||
163842214|NCT00708305|591792898|FG000|Period 1|Other Reason|0|||
163842215|NCT00708305|591792899|FG001|Period 1|Other Reason|0|||
163842216|NCT00708305|591792900|FG002|Period 1|Other Reason|0|||
163842217|NCT00708305|591792901|FG003|Period 1|Other Reason|2|||
163842218|NCT00708305|591792898|FG000|Period 2|Lost to Follow-up|0|||
163842219|NCT00708305|591792899|FG001|Period 2|Lost to Follow-up|1|||
163842220|NCT00708305|591792900|FG002|Period 2|Lost to Follow-up|0|||
163842221|NCT00708305|591792901|FG003|Period 2|Lost to Follow-up|0|||
163842222|NCT00708305|591792898|FG000|Period 2|Protocol Violation|0|||
163842223|NCT00708305|591792899|FG001|Period 2|Protocol Violation|1|||
163842224|NCT00708305|591792900|FG002|Period 2|Protocol Violation|0|||
163842225|NCT00708305|591792901|FG003|Period 2|Protocol Violation|0|||
163842226|NCT00708305|591792898|FG000|Period 2|Other Reason|1|||
163842227|NCT00708305|591792899|FG001|Period 2|Other Reason|0|||
163842228|NCT00708305|591792900|FG002|Period 2|Other Reason|0|||
163842229|NCT00708305|591792901|FG003|Period 2|Other Reason|1|||
163842230|NCT00708305|591792898|FG000|Period 3|Protocol Violation|0|||
163842231|NCT00708305|591792899|FG001|Period 3|Protocol Violation|2|||
163842232|NCT00708305|591792900|FG002|Period 3|Protocol Violation|0|||
163842233|NCT00708305|591792901|FG003|Period 3|Protocol Violation|0|||
163842234|NCT00708305|591792898|FG000|Period 3|Other Reason|1|||
163842235|NCT00708305|591792899|FG001|Period 3|Other Reason|0|||
163842236|NCT00708305|591792900|FG002|Period 3|Other Reason|0|||
163842237|NCT00708305|591792901|FG003|Period 3|Other Reason|0|||
163842238|NCT00192023|591792906|FG000|Period III - Double-Blind|Adverse Event|3|||
163842239|NCT00192023|591792907|FG001|Period III - Double-Blind|Adverse Event|0|||
163842240|NCT00192023|591792906|FG000|Period III - Double-Blind|Physician Decision|2|||
163842241|NCT00192023|591792907|FG001|Period III - Double-Blind|Physician Decision|0|||
163842242|NCT00192023|591792906|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
163842243|NCT00192023|591792907|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
163842244|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
163842245|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
163842246|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
163842247|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
163842248|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
163842249|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
163842250|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
163842251|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
163842252|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
163842253|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
163842254|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
163842255|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
163842256|NCT00192023|591792906|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
163842257|NCT00192023|591792907|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
163842258|NCT02572817|591792935|FG000|Overall Study|Death|6|||
163842259|NCT02572817|591792936|FG001|Overall Study|Death|3|||
163842260|NCT02572817|591792935|FG000|Overall Study|Lost to Follow-up|3|||
163842261|NCT02572817|591792936|FG001|Overall Study|Lost to Follow-up|3|||
163842262|NCT01258660|591792941|FG000|Overall Study|Adverse Event|2|||
163842263|NCT01258660|591792942|FG001|Overall Study|Adverse Event|4|||
163842264|NCT01258660|591792941|FG000|Overall Study|Withdrawal by Subject|3|||
163842265|NCT01258660|591792942|FG001|Overall Study|Withdrawal by Subject|0|||
163945898|NCT02626455|592170435|FG005|Overall Study|Progressive disease - radiological progression|11|||
163945899|NCT02626455|592170436|FG006|Overall Study|Progressive disease - radiological progression|22|||
163945900|NCT02626455|592170430|FG000|Overall Study|Progressive disease - clinical progression|0|||
163945901|NCT02626455|592170431|FG001|Overall Study|Progressive disease - clinical progression|0|||
163945902|NCT02626455|592170432|FG002|Overall Study|Progressive disease - clinical progression|0|||
163945903|NCT02626455|592170433|FG003|Overall Study|Progressive disease - clinical progression|0|||
163945904|NCT02626455|592170434|FG004|Overall Study|Progressive disease - clinical progression|0|||
163945905|NCT02626455|592170435|FG005|Overall Study|Progressive disease - clinical progression|1|||
163945906|NCT02626455|592170436|FG006|Overall Study|Progressive disease - clinical progression|2|||
163945907|NCT02626455|592170430|FG000|Overall Study|Lost to Follow-up|0|||
163945908|NCT02626455|592170431|FG001|Overall Study|Lost to Follow-up|0|||
163945909|NCT02626455|592170432|FG002|Overall Study|Lost to Follow-up|0|||
163945910|NCT02626455|592170433|FG003|Overall Study|Lost to Follow-up|0|||
163945911|NCT02626455|592170434|FG004|Overall Study|Lost to Follow-up|0|||
163945912|NCT02626455|592170435|FG005|Overall Study|Lost to Follow-up|1|||
163945913|NCT02626455|592170436|FG006|Overall Study|Lost to Follow-up|0|||
163945914|NCT02626455|592170430|FG000|Overall Study|AE not associated with clinical disease progression|1|||
163945915|NCT02626455|592170431|FG001|Overall Study|AE not associated with clinical disease progression|1|||
163945916|NCT02626455|592170432|FG002|Overall Study|AE not associated with clinical disease progression|0|||
163945917|NCT02626455|592170433|FG003|Overall Study|AE not associated with clinical disease progression|2|||
163945918|NCT02626455|592170434|FG004|Overall Study|AE not associated with clinical disease progression|1|||
163945919|NCT02626455|592170435|FG005|Overall Study|AE not associated with clinical disease progression|65|||
163945920|NCT02626455|592170436|FG006|Overall Study|AE not associated with clinical disease progression|21|||
163945921|NCT02626455|592170430|FG000|Overall Study|AE associated with clinical disease progression|0|||
163945922|NCT02626455|592170431|FG001|Overall Study|AE associated with clinical disease progression|0|||
163945923|NCT02626455|592170432|FG002|Overall Study|AE associated with clinical disease progression|0|||
163945924|NCT02626455|592170433|FG003|Overall Study|AE associated with clinical disease progression|0|||
163945925|NCT02626455|592170434|FG004|Overall Study|AE associated with clinical disease progression|0|||
163945926|NCT02626455|592170435|FG005|Overall Study|AE associated with clinical disease progression|1|||
163945927|NCT02626455|592170436|FG006|Overall Study|AE associated with clinical disease progression|2|||
163945928|NCT02626455|592170430|FG000|Overall Study|Study intervention never administered|0|||
163945929|NCT02626455|592170431|FG001|Overall Study|Study intervention never administered|0|||
164045009|NCT02418585|592526430|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
164045010|NCT02418585|592526431|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
164045011|NCT02418585|592526430|FG000|Follow-up Phase (24 Weeks)|Other|3|||
164045012|NCT02418585|592526431|FG001|Follow-up Phase (24 Weeks)|Other|2|||
164045013|NCT01024920|592526432|FG000|Overall Study|Progressive disease|47|||
164045014|NCT01024920|592526433|FG001|Overall Study|Progressive disease|25|||
164045015|NCT01024920|592526432|FG000|Overall Study|Adverse Event|8|||
164045016|NCT01024920|592526433|FG001|Overall Study|Adverse Event|4|||
164045017|NCT01024920|592526432|FG000|Overall Study|Lost to Follow-up|0|||
164045018|NCT01024920|592526433|FG001|Overall Study|Lost to Follow-up|1|||
164045019|NCT01024920|592526432|FG000|Overall Study|Patient refusal to continue|4|||
164045020|NCT01024920|592526433|FG001|Overall Study|Patient refusal to continue|0|||
164045021|NCT01024920|592526432|FG000|Overall Study|Other than listed|5|||
164045022|NCT01024920|592526433|FG001|Overall Study|Other than listed|1|||
164045023|NCT01024920|592526432|FG000|Overall Study|Not treated|3|||
164045024|NCT01024920|592526433|FG001|Overall Study|Not treated|0|||
164045025|NCT01024920|592526432|FG000|Overall Study|Protocol Violation|0|||
164045026|NCT01024920|592526433|FG001|Overall Study|Protocol Violation|1|||
164045027|NCT01688999|592526437|FG000|Overall Study|Withdrawal by Subject|5|||
164045028|NCT01688999|592526438|FG001|Overall Study|Withdrawal by Subject|1|||
164045029|NCT01688999|592526439|FG002|Overall Study|Withdrawal by Subject|1|||
164045030|NCT01688999|592526437|FG000|Overall Study|Adverse Event|2|||
164045031|NCT01688999|592526438|FG001|Overall Study|Adverse Event|0|||
164045032|NCT01688999|592526439|FG002|Overall Study|Adverse Event|2|||
164045033|NCT01688999|592526437|FG000|Overall Study|Ineligible/Not treated|1|||
164045034|NCT01688999|592526438|FG001|Overall Study|Ineligible/Not treated|0|||
164045035|NCT01688999|592526439|FG002|Overall Study|Ineligible/Not treated|0|||
164045036|NCT02768103|592526440|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
164045037|NCT03039790|592526459|FG000|Overall Study|Lost to Follow-up|2|||
164045038|NCT03039790|592526460|FG001|Overall Study|Lost to Follow-up|0|||
164045039|NCT03039790|592526461|FG002|Overall Study|Lost to Follow-up|1|||
164045040|NCT03039790|592526462|FG003|Overall Study|Lost to Follow-up|1|||
164045041|NCT03039790|592526463|FG004|Overall Study|Lost to Follow-up|0|||
164045042|NCT03039790|592526464|FG005|Overall Study|Lost to Follow-up|1|||
164045043|NCT03039790|592526465|FG006|Overall Study|Lost to Follow-up|1|||
164045044|NCT03039790|592526466|FG007|Overall Study|Lost to Follow-up|1|||
164045045|NCT03039790|592526467|FG008|Overall Study|Lost to Follow-up|0|||
164045046|NCT03039790|592526468|FG009|Overall Study|Lost to Follow-up|1|||
164045047|NCT03039790|592526469|FG010|Overall Study|Lost to Follow-up|1|||
164045048|NCT03039790|592526470|FG011|Overall Study|Lost to Follow-up|0|||
164045049|NCT03039790|592526471|FG012|Overall Study|Lost to Follow-up|1|||
164045050|NCT03039790|592526472|FG013|Overall Study|Lost to Follow-up|0|||
164045051|NCT03039790|592526473|FG014|Overall Study|Lost to Follow-up|3|||
164045052|NCT03039790|592526474|FG015|Overall Study|Lost to Follow-up|1|||
164045053|NCT03039790|592526475|FG016|Overall Study|Lost to Follow-up|2|||
164045054|NCT03039790|592526476|FG017|Overall Study|Lost to Follow-up|2|||
164045055|NCT03039790|592526477|FG018|Overall Study|Lost to Follow-up|1|||
163842266|NCT01258660|591792941|FG000|Overall Study|due to relocation|2|||
163842267|NCT01258660|591792942|FG001|Overall Study|due to relocation|0|||
163842268|NCT01258660|591792941|FG000|Overall Study|Protocol Violation|0|||
163842269|NCT01258660|591792942|FG001|Overall Study|Protocol Violation|1|||
163842270|NCT01258660|591792941|FG000|Overall Study|Invalid for primary analysis data set|4|||
164045056|NCT03039790|592526478|FG019|Overall Study|Lost to Follow-up|3|||
164045057|NCT03039790|592526459|FG000|Overall Study|Withdrawal of Consent|1|||
164045058|NCT03039790|592526460|FG001|Overall Study|Withdrawal of Consent|0|||
164045059|NCT03039790|592526461|FG002|Overall Study|Withdrawal of Consent|0|||
164045060|NCT03039790|592526462|FG003|Overall Study|Withdrawal of Consent|1|||
163842271|NCT01258660|591792942|FG001|Overall Study|Invalid for primary analysis data set|6|||
163842272|NCT04192630|591792943|FG000|Overall Study|Discontinued before surgery|2|||
163842273|NCT04192630|591792944|FG001|Overall Study|Discontinued before surgery|0|||
163842274|NCT04192630|591792943|FG000|Overall Study|Discontinued after surgery|5|||
163842275|NCT04192630|591792944|FG001|Overall Study|Discontinued after surgery|3|||
163842276|NCT01193582|591792945|FG000|Vaccination Series|Withdrawal by Subject|11|||
163842277|NCT01193582|591792946|FG001|Vaccination Series|Withdrawal by Subject|13|||
163842278|NCT01193582|591792947|FG002|Vaccination Series|Withdrawal by Subject|8|||
163842279|NCT01193582|591792948|FG003|Vaccination Series|Withdrawal by Subject|3|||
163842280|NCT01193582|591792945|FG000|12 Month Follow-up|Death|0|||
163842281|NCT01193582|591792946|FG001|12 Month Follow-up|Death|0|||
163842282|NCT01193582|591792947|FG002|12 Month Follow-up|Death|1|||
163842283|NCT01193582|591792948|FG003|12 Month Follow-up|Death|0|||
163842284|NCT01193582|591792945|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
163842285|NCT01193582|591792946|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
163842286|NCT01193582|591792947|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
163842287|NCT01193582|591792948|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
163842288|NCT01775930|591792954|FG000|Overall Study|Futility stopping boundary met|1|||
163842289|NCT01208415|591792955|FG000|Overall Study|Death|1|||
163842290|NCT01208415|591792955|FG000|Overall Study|Lost to Follow-up|2|||
163842291|NCT01208415|591792955|FG000|Overall Study|Withdrawal by Subject|3|||
164045061|NCT03039790|592526463|FG004|Overall Study|Withdrawal of Consent|0|||
164045062|NCT03039790|592526464|FG005|Overall Study|Withdrawal of Consent|0|||
164045063|NCT03039790|592526465|FG006|Overall Study|Withdrawal of Consent|0|||
164045064|NCT03039790|592526466|FG007|Overall Study|Withdrawal of Consent|0|||
164045065|NCT03039790|592526467|FG008|Overall Study|Withdrawal of Consent|0|||
164045066|NCT03039790|592526468|FG009|Overall Study|Withdrawal of Consent|1|||
164045067|NCT03039790|592526469|FG010|Overall Study|Withdrawal of Consent|0|||
164045068|NCT03039790|592526470|FG011|Overall Study|Withdrawal of Consent|0|||
164045069|NCT03039790|592526471|FG012|Overall Study|Withdrawal of Consent|2|||
164045070|NCT03039790|592526472|FG013|Overall Study|Withdrawal of Consent|0|||
164045071|NCT03039790|592526473|FG014|Overall Study|Withdrawal of Consent|1|||
164045072|NCT03039790|592526474|FG015|Overall Study|Withdrawal of Consent|5|||
164045073|NCT03039790|592526475|FG016|Overall Study|Withdrawal of Consent|3|||
164045074|NCT03039790|592526476|FG017|Overall Study|Withdrawal of Consent|0|||
164045075|NCT03039790|592526477|FG018|Overall Study|Withdrawal of Consent|2|||
164045076|NCT03039790|592526478|FG019|Overall Study|Withdrawal of Consent|5|||
164045077|NCT03039790|592526459|FG000|Overall Study|Death|0|||
164045078|NCT03039790|592526460|FG001|Overall Study|Death|0|||
164045079|NCT03039790|592526461|FG002|Overall Study|Death|0|||
164045080|NCT03039790|592526462|FG003|Overall Study|Death|0|||
164045081|NCT03039790|592526463|FG004|Overall Study|Death|0|||
164045082|NCT03039790|592526464|FG005|Overall Study|Death|0|||
164045083|NCT03039790|592526465|FG006|Overall Study|Death|0|||
164045084|NCT03039790|592526466|FG007|Overall Study|Death|0|||
164045085|NCT03039790|592526467|FG008|Overall Study|Death|0|||
164045086|NCT03039790|592526468|FG009|Overall Study|Death|0|||
164045087|NCT03039790|592526469|FG010|Overall Study|Death|0|||
164045088|NCT03039790|592526470|FG011|Overall Study|Death|0|||
164045089|NCT03039790|592526471|FG012|Overall Study|Death|0|||
164045090|NCT03039790|592526472|FG013|Overall Study|Death|0|||
164045091|NCT03039790|592526473|FG014|Overall Study|Death|0|||
164045092|NCT03039790|592526474|FG015|Overall Study|Death|1|||
164045093|NCT03039790|592526475|FG016|Overall Study|Death|3|||
164045094|NCT03039790|592526476|FG017|Overall Study|Death|0|||
164045095|NCT03039790|592526477|FG018|Overall Study|Death|2|||
164045096|NCT03039790|592526478|FG019|Overall Study|Death|0|||
164045097|NCT03039790|592526459|FG000|Overall Study|Reason, not Specified|1|||
164045098|NCT03039790|592526460|FG001|Overall Study|Reason, not Specified|0|||
164045099|NCT03039790|592526461|FG002|Overall Study|Reason, not Specified|0|||
164045100|NCT03039790|592526462|FG003|Overall Study|Reason, not Specified|0|||
164045101|NCT03039790|592526463|FG004|Overall Study|Reason, not Specified|0|||
164045102|NCT03039790|592526464|FG005|Overall Study|Reason, not Specified|0|||
164045103|NCT03039790|592526465|FG006|Overall Study|Reason, not Specified|0|||
164045104|NCT03039790|592526466|FG007|Overall Study|Reason, not Specified|0|||
164045105|NCT03039790|592526467|FG008|Overall Study|Reason, not Specified|0|||
164045106|NCT03039790|592526468|FG009|Overall Study|Reason, not Specified|0|||
164045107|NCT03039790|592526469|FG010|Overall Study|Reason, not Specified|0|||
164045108|NCT03039790|592526470|FG011|Overall Study|Reason, not Specified|0|||
164045109|NCT03039790|592526471|FG012|Overall Study|Reason, not Specified|0|||
164045110|NCT03039790|592526472|FG013|Overall Study|Reason, not Specified|0|||
164045111|NCT03039790|592526473|FG014|Overall Study|Reason, not Specified|0|||
164045112|NCT03039790|592526474|FG015|Overall Study|Reason, not Specified|0|||
164045113|NCT03039790|592526475|FG016|Overall Study|Reason, not Specified|2|||
164045114|NCT03039790|592526476|FG017|Overall Study|Reason, not Specified|0|||
164045115|NCT03039790|592526477|FG018|Overall Study|Reason, not Specified|1|||
164045116|NCT03039790|592526478|FG019|Overall Study|Reason, not Specified|0|||
164045117|NCT00498368|592526488|FG000|Overall Study|Withdrawal by Subject|3|||
164045118|NCT00498368|592526489|FG001|Overall Study|Withdrawal by Subject|2|||
164045119|NCT02736929|592526495|FG000|Main Study|Lost to Follow-up|7|||
164045120|NCT02736929|592526496|FG001|Main Study|Lost to Follow-up|1|||
164045121|NCT02736929|592526497|FG002|Main Study|Lost to Follow-up|0|||
164045122|NCT02736929|592526495|FG000|Main Study|Withdrawal by Subject|1|||
164045123|NCT02736929|592526496|FG001|Main Study|Withdrawal by Subject|1|||
164045124|NCT02736929|592526497|FG002|Main Study|Withdrawal by Subject|0|||
164045125|NCT02736929|592526495|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
164045126|NCT02736929|592526496|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
164045127|NCT02736929|592526497|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
164045128|NCT02972593|592526498|FG000|Overall Study|Lost to Follow-up|19|||
164045129|NCT02972593|592526499|FG001|Overall Study|Lost to Follow-up|15|||
164045130|NCT02972593|592526498|FG000|Overall Study|Protocol Violation|1|||
164045131|NCT02972593|592526499|FG001|Overall Study|Protocol Violation|0|||
164045132|NCT01855425|592526504|FG000|Overall Study|Physician Decision|20|||
164045133|NCT02148952|592526511|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
164045134|NCT02148952|592526512|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
164045135|NCT02148952|592526511|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
164045136|NCT02148952|592526512|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
164045137|NCT02148952|592526511|FG000|Follow-Up|Lost to Follow-up|219|||
164045138|NCT02148952|592526512|FG001|Follow-Up|Lost to Follow-up|231|||
164045139|NCT02148952|592526511|FG000|Follow-Up|Withdrawal by Subject|46|||
164045140|NCT02148952|592526512|FG001|Follow-Up|Withdrawal by Subject|48|||
164045141|NCT01925014|592526513|FG000|Overall Study|Inappropriate enrollment|4|||
164045142|NCT01925014|592526514|FG001|Overall Study|Inappropriate enrollment|6|||
164045143|NCT01925014|592526513|FG000|Overall Study|Withdrawal by Subject|5|||
164045144|NCT01925014|592526514|FG001|Overall Study|Withdrawal by Subject|13|||
164045145|NCT01487863|592526515|FG000|Overall Study|Death|19|||
164045146|NCT01487863|592526516|FG001|Overall Study|Death|19|||
164045147|NCT01437267|592526520|FG000|Overall Study|Withdrawal by Subject|0|||
164045148|NCT01437267|592526521|FG001|Overall Study|Withdrawal by Subject|0|||
164045149|NCT01437267|592526522|FG002|Overall Study|Withdrawal by Subject|0|||
164045150|NCT01437267|592526523|FG003|Overall Study|Withdrawal by Subject|1|||
164045151|NCT01437267|592526524|FG004|Overall Study|Withdrawal by Subject|0|||
164045152|NCT01437267|592526525|FG005|Overall Study|Withdrawal by Subject|0|||
164045153|NCT01437267|592526520|FG000|Overall Study|Protocol Violation|0|||
164045154|NCT01437267|592526521|FG001|Overall Study|Protocol Violation|1|||
164045155|NCT01437267|592526522|FG002|Overall Study|Protocol Violation|0|||
164045156|NCT01437267|592526523|FG003|Overall Study|Protocol Violation|0|||
164045157|NCT01437267|592526524|FG004|Overall Study|Protocol Violation|0|||
164045158|NCT01437267|592526525|FG005|Overall Study|Protocol Violation|0|||
164045159|NCT01810380|592526528|FG000|Overall Study|Randomised not treated|2|||
164045160|NCT01810380|592526529|FG001|Overall Study|Randomised not treated|1|||
164045161|NCT01810380|592526530|FG002|Overall Study|Randomised not treated|1|||
164045162|NCT01810380|592526528|FG000|Overall Study|Adverse Event|11|||
164045163|NCT01810380|592526529|FG001|Overall Study|Adverse Event|14|||
164045164|NCT01810380|592526530|FG002|Overall Study|Adverse Event|4|||
164045165|NCT01810380|592526528|FG000|Overall Study|Lack of Efficacy|24|||
164045166|NCT01810380|592526529|FG001|Overall Study|Lack of Efficacy|10|||
164045167|NCT01810380|592526530|FG002|Overall Study|Lack of Efficacy|11|||
164045168|NCT01810380|592526528|FG000|Overall Study|Protocol Violation|1|||
164045169|NCT01810380|592526529|FG001|Overall Study|Protocol Violation|0|||
164045170|NCT01810380|592526530|FG002|Overall Study|Protocol Violation|1|||
164045171|NCT01810380|592526528|FG000|Overall Study|Withdrawal by Subject|6|||
164045172|NCT01810380|592526529|FG001|Overall Study|Withdrawal by Subject|0|||
164045173|NCT01810380|592526530|FG002|Overall Study|Withdrawal by Subject|6|||
164045174|NCT01810380|592526528|FG000|Overall Study|Administrative or other reasons|11|||
164045175|NCT01810380|592526529|FG001|Overall Study|Administrative or other reasons|13|||
164045176|NCT01810380|592526530|FG002|Overall Study|Administrative or other reasons|9|||
164045177|NCT00033371|592526531|FG000|Overall Study|Adverse Event|1|||
164045178|NCT00033371|592526532|FG001|Overall Study|Adverse Event|5|||
164045179|NCT00033371|592526531|FG000|Overall Study|Lost to Follow-up|2|||
164045180|NCT00033371|592526532|FG001|Overall Study|Lost to Follow-up|1|||
164045181|NCT00033371|592526531|FG000|Overall Study|Withdrawal by Subject|3|||
164045182|NCT00033371|592526532|FG001|Overall Study|Withdrawal by Subject|3|||
164045183|NCT00033371|592526531|FG000|Overall Study|Disease Progression|0|||
164045184|NCT00033371|592526532|FG001|Overall Study|Disease Progression|1|||
164045185|NCT02699125|592526533|FG000|Placebo|Lost to Follow-up|2|||
164045186|NCT02699125|592526534|FG001|Placebo|Lost to Follow-up|0|||
164045187|NCT02699125|592526533|FG000|Placebo|Protocol Violation|1|||
164045188|NCT02699125|592526534|FG001|Placebo|Protocol Violation|0|||
164045189|NCT02699125|592526533|FG000|Placebo|Withdrawal by Subject|0|||
164045190|NCT02699125|592526534|FG001|Placebo|Withdrawal by Subject|4|||
164045191|NCT02699125|592526533|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
164045192|NCT02699125|592526534|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
164045193|NCT01390038|592526537|FG000|Overall Study|Death|1|||
164045194|NCT01390038|592526537|FG000|Overall Study|Lost to Follow-up|1|||
164045195|NCT01390038|592526537|FG000|Overall Study|Withdrawal by Subject|4|||
164045196|NCT01390038|592526537|FG000|Overall Study|Simpliciti System Removal|2|||
164045197|NCT03799627|592526542|FG000|Overall Study|Adverse Event|1|||
164045198|NCT03799627|592526543|FG001|Overall Study|Adverse Event|2|||
164045199|NCT03799627|592526544|FG002|Overall Study|Adverse Event|0|||
164045200|NCT03799627|592526545|FG003|Overall Study|Adverse Event|0|||
164045201|NCT03799627|592526546|FG004|Overall Study|Adverse Event|2|||
164045202|NCT03799627|592526547|FG005|Overall Study|Adverse Event|5|||
164045203|NCT03799627|592526548|FG006|Overall Study|Adverse Event|0|||
164045204|NCT03799627|592526549|FG007|Overall Study|Adverse Event|2|||
164045205|NCT03799627|592526550|FG008|Overall Study|Adverse Event|0|||
164045206|NCT03799627|592526542|FG000|Overall Study|Physician Decision|2|||
164045207|NCT03799627|592526543|FG001|Overall Study|Physician Decision|2|||
164045208|NCT03799627|592526544|FG002|Overall Study|Physician Decision|0|||
164045209|NCT03799627|592526545|FG003|Overall Study|Physician Decision|0|||
164045210|NCT03799627|592526546|FG004|Overall Study|Physician Decision|2|||
164045211|NCT03799627|592526547|FG005|Overall Study|Physician Decision|2|||
164045212|NCT03799627|592526548|FG006|Overall Study|Physician Decision|0|||
164045213|NCT03799627|592526549|FG007|Overall Study|Physician Decision|0|||
164045214|NCT03799627|592526550|FG008|Overall Study|Physician Decision|0|||
164045215|NCT03799627|592526542|FG000|Overall Study|Withdrawal by Subject|1|||
164045216|NCT03799627|592526543|FG001|Overall Study|Withdrawal by Subject|1|||
164045217|NCT03799627|592526544|FG002|Overall Study|Withdrawal by Subject|0|||
163945930|NCT02626455|592170432|FG002|Overall Study|Study intervention never administered|0|||
163945931|NCT02626455|592170433|FG003|Overall Study|Study intervention never administered|0|||
163945932|NCT02626455|592170434|FG004|Overall Study|Study intervention never administered|0|||
163945933|NCT02626455|592170435|FG005|Overall Study|Study intervention never administered|1|||
163945934|NCT02626455|592170436|FG006|Overall Study|Study intervention never administered|3|||
163945935|NCT06665919|592170437|FG000|Overall Study|Withdrawal by Subject|4|||
163945936|NCT06665919|592170438|FG001|Overall Study|Withdrawal by Subject|4|||
163945937|NCT06665919|592170439|FG002|Overall Study|Withdrawal by Subject|4|||
163945938|NCT06665919|592170437|FG000|Overall Study|Non-compliance to Treatment|4|||
163945939|NCT06665919|592170438|FG001|Overall Study|Non-compliance to Treatment|1|||
164045218|NCT03799627|592526545|FG003|Overall Study|Withdrawal by Subject|2|||
164045219|NCT03799627|592526546|FG004|Overall Study|Withdrawal by Subject|0|||
164045220|NCT03799627|592526547|FG005|Overall Study|Withdrawal by Subject|3|||
164045221|NCT03799627|592526548|FG006|Overall Study|Withdrawal by Subject|0|||
163945940|NCT06665919|592170439|FG002|Overall Study|Non-compliance to Treatment|6|||
163945941|NCT06665919|592170437|FG000|Overall Study|Lost to Follow-up|3|||
163945942|NCT06665919|592170438|FG001|Overall Study|Lost to Follow-up|0|||
163945943|NCT06665919|592170439|FG002|Overall Study|Lost to Follow-up|2|||
163945944|NCT06665919|592170437|FG000|Overall Study|Physician Decision|4|||
163945945|NCT06665919|592170438|FG001|Overall Study|Physician Decision|0|||
163945946|NCT06665919|592170439|FG002|Overall Study|Physician Decision|1|||
163945947|NCT05148962|592170440|FG000|Overall Study|Withdrawal by Subject|1|||
163945948|NCT05148962|592170441|FG001|Overall Study|Withdrawal by Subject|1|||
163945949|NCT05148962|592170442|FG002|Overall Study|Withdrawal by Subject|0|||
163945950|NCT05148962|592170443|FG003|Overall Study|Withdrawal by Subject|1|||
163945951|NCT05148962|592170444|FG004|Overall Study|Withdrawal by Subject|0|||
163945952|NCT05148962|592170440|FG000|Overall Study|Participant was early terminated per protocol|0|||
163945953|NCT05148962|592170441|FG001|Overall Study|Participant was early terminated per protocol|0|||
163945954|NCT05148962|592170442|FG002|Overall Study|Participant was early terminated per protocol|3|||
163945955|NCT05148962|592170443|FG003|Overall Study|Participant was early terminated per protocol|5|||
163945956|NCT05148962|592170444|FG004|Overall Study|Participant was early terminated per protocol|2|||
163945957|NCT05148962|592170440|FG000|Overall Study|Miscellaneous|0|||
163945958|NCT05148962|592170441|FG001|Overall Study|Miscellaneous|0|||
163945959|NCT05148962|592170442|FG002|Overall Study|Miscellaneous|0|||
163945960|NCT05148962|592170443|FG003|Overall Study|Miscellaneous|1|||
163945961|NCT05148962|592170444|FG004|Overall Study|Miscellaneous|0|||
163945962|NCT01200290|592170446|FG000|Treatment Period|Adverse Event|1|||
163945963|NCT01200290|592170446|FG000|Post-Treatment Follow-Up Period|Death|2|||
163945964|NCT01525238|592170447|FG000|Overall Study|Withdrawal by Subject|1|||
163945965|NCT01525238|592170448|FG001|Overall Study|Withdrawal by Subject|0|||
163945966|NCT01525238|592170449|FG002|Overall Study|Withdrawal by Subject|0|||
163945967|NCT00607724|592170450|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
163945968|NCT00607724|592170451|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
163945969|NCT00607724|592170452|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
163945970|NCT00607724|592170453|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163945971|NCT00607724|592170454|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163945972|NCT00607724|592170455|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163945973|NCT00607724|592170456|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
163945974|NCT00607724|592170450|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
163945975|NCT00607724|592170451|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
163945976|NCT00607724|592170452|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
163945977|NCT00607724|592170453|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
163945978|NCT00607724|592170454|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
163945979|NCT00607724|592170455|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
163945980|NCT00607724|592170456|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
163945981|NCT00607724|592170450|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
163945982|NCT00607724|592170451|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
163945983|NCT00607724|592170452|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
163945984|NCT00607724|592170453|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
163945985|NCT00607724|592170454|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
163945986|NCT00607724|592170455|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
163945987|NCT00607724|592170456|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
163945988|NCT00607724|592170450|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
163945989|NCT00607724|592170451|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
164045222|NCT03799627|592526549|FG007|Overall Study|Withdrawal by Subject|0|||
163945990|NCT00607724|592170452|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
164045223|NCT03799627|592526550|FG008|Overall Study|Withdrawal by Subject|0|||
163945991|NCT00607724|592170453|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
163945992|NCT00607724|592170454|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
163945993|NCT00607724|592170455|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
164045224|NCT03799627|592526542|FG000|Overall Study|Lack of Efficacy|0|||
164045225|NCT03799627|592526543|FG001|Overall Study|Lack of Efficacy|0|||
164045226|NCT03799627|592526544|FG002|Overall Study|Lack of Efficacy|0|||
164045227|NCT03799627|592526545|FG003|Overall Study|Lack of Efficacy|1|||
164045228|NCT03799627|592526546|FG004|Overall Study|Lack of Efficacy|0|||
164045229|NCT03799627|592526547|FG005|Overall Study|Lack of Efficacy|0|||
164045230|NCT03799627|592526548|FG006|Overall Study|Lack of Efficacy|0|||
164045231|NCT03799627|592526549|FG007|Overall Study|Lack of Efficacy|0|||
164045232|NCT03799627|592526550|FG008|Overall Study|Lack of Efficacy|0|||
164045233|NCT03799627|592526542|FG000|Overall Study|Lost to Follow-up|0|||
164045234|NCT03799627|592526543|FG001|Overall Study|Lost to Follow-up|0|||
164045235|NCT03799627|592526544|FG002|Overall Study|Lost to Follow-up|0|||
164045236|NCT03799627|592526545|FG003|Overall Study|Lost to Follow-up|0|||
164045237|NCT03799627|592526546|FG004|Overall Study|Lost to Follow-up|0|||
164045238|NCT03799627|592526547|FG005|Overall Study|Lost to Follow-up|0|||
164045239|NCT03799627|592526548|FG006|Overall Study|Lost to Follow-up|1|||
164045240|NCT03799627|592526549|FG007|Overall Study|Lost to Follow-up|0|||
164045241|NCT03799627|592526550|FG008|Overall Study|Lost to Follow-up|1|||
164045242|NCT03799627|592526542|FG000|Overall Study|Death|0|||
164045243|NCT03799627|592526543|FG001|Overall Study|Death|0|||
164045244|NCT03799627|592526544|FG002|Overall Study|Death|0|||
164045245|NCT03799627|592526545|FG003|Overall Study|Death|1|||
164045246|NCT03799627|592526546|FG004|Overall Study|Death|0|||
164045247|NCT03799627|592526547|FG005|Overall Study|Death|0|||
164045248|NCT03799627|592526548|FG006|Overall Study|Death|0|||
164045249|NCT03799627|592526549|FG007|Overall Study|Death|0|||
164045250|NCT03799627|592526550|FG008|Overall Study|Death|0|||
164045251|NCT03799627|592526542|FG000|Overall Study|Study Drug Put on Hold|1|||
164045252|NCT03799627|592526543|FG001|Overall Study|Study Drug Put on Hold|0|||
164045253|NCT03799627|592526544|FG002|Overall Study|Study Drug Put on Hold|0|||
164045254|NCT03799627|592526545|FG003|Overall Study|Study Drug Put on Hold|0|||
164045255|NCT03799627|592526546|FG004|Overall Study|Study Drug Put on Hold|0|||
164045256|NCT03799627|592526547|FG005|Overall Study|Study Drug Put on Hold|0|||
164045257|NCT03799627|592526548|FG006|Overall Study|Study Drug Put on Hold|0|||
164045258|NCT03799627|592526549|FG007|Overall Study|Study Drug Put on Hold|0|||
164045259|NCT03799627|592526550|FG008|Overall Study|Study Drug Put on Hold|0|||
164045260|NCT03799627|592526542|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
164045261|NCT03799627|592526543|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
164045262|NCT03799627|592526544|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
164045263|NCT03799627|592526545|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
164045264|NCT03799627|592526546|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
164045265|NCT03799627|592526547|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
164045266|NCT03799627|592526548|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
164045267|NCT03799627|592526549|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
164045268|NCT03799627|592526550|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
164045269|NCT03799627|592526542|FG000|Overall Study|Kidney Transplantation|1|||
164045270|NCT03799627|592526543|FG001|Overall Study|Kidney Transplantation|0|||
164045271|NCT03799627|592526544|FG002|Overall Study|Kidney Transplantation|0|||
164045272|NCT03799627|592526545|FG003|Overall Study|Kidney Transplantation|1|||
164045273|NCT03799627|592526546|FG004|Overall Study|Kidney Transplantation|1|||
164045274|NCT03799627|592526547|FG005|Overall Study|Kidney Transplantation|0|||
164045275|NCT03799627|592526548|FG006|Overall Study|Kidney Transplantation|0|||
164045276|NCT03799627|592526549|FG007|Overall Study|Kidney Transplantation|0|||
164045277|NCT03799627|592526550|FG008|Overall Study|Kidney Transplantation|0|||
164045278|NCT03799627|592526542|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
164045279|NCT03799627|592526543|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
164045280|NCT03799627|592526544|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
164045281|NCT03799627|592526545|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
164045282|NCT03799627|592526546|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
164045283|NCT03799627|592526547|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
164045284|NCT03799627|592526548|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
164045285|NCT03799627|592526549|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
164045286|NCT03799627|592526550|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
164045287|NCT03799627|592526542|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045288|NCT03799627|592526543|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
164045289|NCT03799627|592526544|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045290|NCT03799627|592526545|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045291|NCT03799627|592526546|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045292|NCT03799627|592526547|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045293|NCT03799627|592526548|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045294|NCT03799627|592526549|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045295|NCT03799627|592526550|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
164045296|NCT03799627|592526542|FG000|Overall Study|Met Exclusion Criteria|0|||
164045297|NCT03799627|592526543|FG001|Overall Study|Met Exclusion Criteria|0|||
164045298|NCT03799627|592526544|FG002|Overall Study|Met Exclusion Criteria|0|||
164045299|NCT03799627|592526545|FG003|Overall Study|Met Exclusion Criteria|1|||
164045300|NCT03799627|592526546|FG004|Overall Study|Met Exclusion Criteria|0|||
164045301|NCT03799627|592526547|FG005|Overall Study|Met Exclusion Criteria|0|||
164045302|NCT03799627|592526548|FG006|Overall Study|Met Exclusion Criteria|0|||
164045303|NCT03799627|592526549|FG007|Overall Study|Met Exclusion Criteria|0|||
164045304|NCT03799627|592526550|FG008|Overall Study|Met Exclusion Criteria|0|||
164045305|NCT03799627|592526542|FG000|Overall Study|Investigational Product Noncompliance|0|||
164045306|NCT03799627|592526543|FG001|Overall Study|Investigational Product Noncompliance|0|||
164045307|NCT03799627|592526544|FG002|Overall Study|Investigational Product Noncompliance|0|||
164045308|NCT03799627|592526545|FG003|Overall Study|Investigational Product Noncompliance|1|||
164045309|NCT03799627|592526546|FG004|Overall Study|Investigational Product Noncompliance|0|||
164045310|NCT03799627|592526547|FG005|Overall Study|Investigational Product Noncompliance|0|||
164045311|NCT03799627|592526548|FG006|Overall Study|Investigational Product Noncompliance|0|||
164045312|NCT03799627|592526549|FG007|Overall Study|Investigational Product Noncompliance|0|||
164045313|NCT03799627|592526550|FG008|Overall Study|Investigational Product Noncompliance|0|||
164045314|NCT03799627|592526542|FG000|Overall Study|Participant Relocation|0|||
164045315|NCT03799627|592526543|FG001|Overall Study|Participant Relocation|0|||
164045316|NCT03799627|592526544|FG002|Overall Study|Participant Relocation|0|||
164045317|NCT03799627|592526545|FG003|Overall Study|Participant Relocation|1|||
164045318|NCT03799627|592526546|FG004|Overall Study|Participant Relocation|0|||
164045319|NCT03799627|592526547|FG005|Overall Study|Participant Relocation|1|||
164045320|NCT03799627|592526548|FG006|Overall Study|Participant Relocation|0|||
164045321|NCT03799627|592526549|FG007|Overall Study|Participant Relocation|0|||
164045322|NCT03799627|592526550|FG008|Overall Study|Participant Relocation|0|||
164045323|NCT03799627|592526542|FG000|Overall Study|Eurofin Issue|0|||
164045324|NCT03799627|592526543|FG001|Overall Study|Eurofin Issue|0|||
164045325|NCT03799627|592526544|FG002|Overall Study|Eurofin Issue|0|||
164045326|NCT03799627|592526545|FG003|Overall Study|Eurofin Issue|0|||
164045327|NCT03799627|592526546|FG004|Overall Study|Eurofin Issue|1|||
164045328|NCT03799627|592526547|FG005|Overall Study|Eurofin Issue|0|||
164045329|NCT03799627|592526548|FG006|Overall Study|Eurofin Issue|0|||
164045330|NCT03799627|592526549|FG007|Overall Study|Eurofin Issue|0|||
164045331|NCT03799627|592526550|FG008|Overall Study|Eurofin Issue|0|||
164045332|NCT03799627|592526542|FG000|Overall Study|Noncompliance with Site Instructions|0|||
164045333|NCT03799627|592526543|FG001|Overall Study|Noncompliance with Site Instructions|0|||
164045334|NCT03799627|592526544|FG002|Overall Study|Noncompliance with Site Instructions|0|||
164045335|NCT03799627|592526545|FG003|Overall Study|Noncompliance with Site Instructions|0|||
164045336|NCT03799627|592526546|FG004|Overall Study|Noncompliance with Site Instructions|1|||
164045337|NCT03799627|592526547|FG005|Overall Study|Noncompliance with Site Instructions|0|||
164045338|NCT03799627|592526548|FG006|Overall Study|Noncompliance with Site Instructions|0|||
164045339|NCT03799627|592526549|FG007|Overall Study|Noncompliance with Site Instructions|0|||
164045340|NCT03799627|592526550|FG008|Overall Study|Noncompliance with Site Instructions|0|||
164045341|NCT03799627|592526542|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045342|NCT03799627|592526543|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045343|NCT03799627|592526544|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045344|NCT03799627|592526545|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045345|NCT03799627|592526546|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
164045346|NCT03799627|592526547|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045347|NCT03799627|592526548|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045348|NCT03799627|592526549|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045349|NCT03799627|592526550|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
164045350|NCT03799627|592526542|FG000|Overall Study|Changes In Hemoglobin Values|1|||
164045351|NCT03799627|592526543|FG001|Overall Study|Changes In Hemoglobin Values|2|||
164045352|NCT03799627|592526544|FG002|Overall Study|Changes In Hemoglobin Values|1|||
164045353|NCT03799627|592526545|FG003|Overall Study|Changes In Hemoglobin Values|0|||
164045354|NCT03799627|592526546|FG004|Overall Study|Changes In Hemoglobin Values|0|||
164045355|NCT03799627|592526547|FG005|Overall Study|Changes In Hemoglobin Values|2|||
164045356|NCT03799627|592526548|FG006|Overall Study|Changes In Hemoglobin Values|1|||
164045357|NCT03799627|592526549|FG007|Overall Study|Changes In Hemoglobin Values|0|||
164045358|NCT03799627|592526550|FG008|Overall Study|Changes In Hemoglobin Values|1|||
164045359|NCT01927068|592526559|FG000|Overall Study|Death|37|||
164045360|NCT01927068|592526560|FG001|Overall Study|Death|3|||
164045361|NCT01927068|592526559|FG000|Overall Study|Withdrawal by Subject|50|||
164045362|NCT01927068|592526560|FG001|Overall Study|Withdrawal by Subject|3|||
164045363|NCT01927068|592526559|FG000|Overall Study|Lost to Follow-up|10|||
164045364|NCT01927068|592526560|FG001|Overall Study|Lost to Follow-up|2|||
164045365|NCT01927068|592526559|FG000|Overall Study|Physician Decision|9|||
164045366|NCT01927068|592526560|FG001|Overall Study|Physician Decision|0|||
164045367|NCT01927068|592526559|FG000|Overall Study|Missed last follow-up visit|2|||
164045368|NCT01927068|592526560|FG001|Overall Study|Missed last follow-up visit|0|||
164045369|NCT01624467|592526561|FG000|Overall Study|Withdrawal by Subject|2|||
164045370|NCT01624467|592526561|FG000|Overall Study|Lost to Follow-up|1|||
164045371|NCT01624467|592526561|FG000|Overall Study|Adverse Event|7|||
164045372|NCT01624467|592526561|FG000|Overall Study|Progressive Disease|19|||
164045373|NCT01624467|592526561|FG000|Overall Study|Per Sponsor Requirement|1|||
164045374|NCT01624467|592526561|FG000|Overall Study|Subject Withdrew from Treatment|1|||
164045375|NCT03964493|592526562|FG000|Overall Study|Withdrawal by Subject|4|||
164045376|NCT03964493|592526563|FG001|Overall Study|Withdrawal by Subject|1|||
164045377|NCT03964493|592526562|FG000|Overall Study|Lost to Follow-up|13|||
164045378|NCT03964493|592526563|FG001|Overall Study|Lost to Follow-up|4|||
164045379|NCT00398138|592526564|FG000|Overall Study|Adverse Event|2|||
164045380|NCT00814307|592526567|FG000|Overall Study|Randomized but not treated|1|||
164045381|NCT00814307|592526568|FG001|Overall Study|Randomized but not treated|0|||
164045382|NCT00814307|592526569|FG002|Overall Study|Randomized but not treated|0|||
164045383|NCT00814307|592526570|FG003|Overall Study|Randomized but not treated|0|||
164045384|NCT00814307|592526567|FG000|Overall Study|Adverse Event|3|||
164045385|NCT00814307|592526568|FG001|Overall Study|Adverse Event|9|||
164045386|NCT00814307|592526569|FG002|Overall Study|Adverse Event|3|||
164045387|NCT00814307|592526570|FG003|Overall Study|Adverse Event|2|||
164045388|NCT00814307|592526567|FG000|Overall Study|Lack of Efficacy|1|||
164045389|NCT00814307|592526568|FG001|Overall Study|Lack of Efficacy|1|||
164045390|NCT00814307|592526569|FG002|Overall Study|Lack of Efficacy|3|||
164045391|NCT00814307|592526570|FG003|Overall Study|Lack of Efficacy|4|||
164045392|NCT00814307|592526567|FG000|Overall Study|Other|1|||
164045393|NCT00814307|592526568|FG001|Overall Study|Other|2|||
164045394|NCT00814307|592526569|FG002|Overall Study|Other|0|||
164045395|NCT00814307|592526570|FG003|Overall Study|Other|1|||
164045396|NCT00814307|592526567|FG000|Overall Study|Protocol Violation|2|||
164045397|NCT00814307|592526568|FG001|Overall Study|Protocol Violation|8|||
164045398|NCT00814307|592526569|FG002|Overall Study|Protocol Violation|1|||
164045399|NCT00814307|592526570|FG003|Overall Study|Protocol Violation|1|||
164045400|NCT00814307|592526567|FG000|Overall Study|Withdrawal by Subject|4|||
164045401|NCT00814307|592526568|FG001|Overall Study|Withdrawal by Subject|6|||
164045402|NCT00814307|592526569|FG002|Overall Study|Withdrawal by Subject|0|||
164045403|NCT00814307|592526570|FG003|Overall Study|Withdrawal by Subject|2|||
164045404|NCT00814307|592526567|FG000|Overall Study|Death|0|||
164045405|NCT00814307|592526568|FG001|Overall Study|Death|1|||
164045406|NCT00814307|592526569|FG002|Overall Study|Death|0|||
164045407|NCT00814307|592526570|FG003|Overall Study|Death|0|||
164045408|NCT01474889|592526571|FG000|Overall Study|Physician Decision|1|||
164045409|NCT01474889|592526572|FG001|Overall Study|Physician Decision|0|||
164045410|NCT01474889|592526573|FG002|Overall Study|Physician Decision|0|||
164045411|NCT01474889|592526571|FG000|Overall Study|Did not meet inclusion|1|||
164045412|NCT01474889|592526572|FG001|Overall Study|Did not meet inclusion|0|||
164045413|NCT01474889|592526573|FG002|Overall Study|Did not meet inclusion|0|||
164045414|NCT01474889|592526571|FG000|Overall Study|Withdrawal by Subject|0|||
164045415|NCT01474889|592526572|FG001|Overall Study|Withdrawal by Subject|1|||
164045416|NCT01474889|592526573|FG002|Overall Study|Withdrawal by Subject|0|||
164045417|NCT02290340|592526575|FG000|Overall Study|Lost to Follow-up|0|||
164045418|NCT02290340|592526576|FG001|Overall Study|Lost to Follow-up|0|||
164045419|NCT02290340|592526577|FG002|Overall Study|Lost to Follow-up|0|||
164045420|NCT02290340|592526578|FG003|Overall Study|Lost to Follow-up|1|||
164045421|NCT02290340|592526575|FG000|Overall Study|Withdrawal by Subject|1|||
164045422|NCT02290340|592526576|FG001|Overall Study|Withdrawal by Subject|0|||
164045423|NCT02290340|592526577|FG002|Overall Study|Withdrawal by Subject|0|||
164045424|NCT02290340|592526578|FG003|Overall Study|Withdrawal by Subject|0|||
164045425|NCT02290340|592526575|FG000|Overall Study|Other|1|||
164045426|NCT02290340|592526576|FG001|Overall Study|Other|0|||
164045427|NCT02290340|592526577|FG002|Overall Study|Other|0|||
164045428|NCT02290340|592526578|FG003|Overall Study|Other|1|||
164045429|NCT00251589|592526580|FG000|Overall Study|Adverse Event|5|||
164045430|NCT00251589|592526581|FG001|Overall Study|Adverse Event|1|||
164045431|NCT00251589|592526582|FG002|Overall Study|Adverse Event|2|||
164045432|NCT00251589|592526583|FG003|Overall Study|Adverse Event|1|||
164045433|NCT00251589|592526580|FG000|Overall Study|Withdrawal by Subject|1|||
164045434|NCT00251589|592526581|FG001|Overall Study|Withdrawal by Subject|1|||
164045435|NCT00251589|592526582|FG002|Overall Study|Withdrawal by Subject|0|||
164045436|NCT00251589|592526583|FG003|Overall Study|Withdrawal by Subject|0|||
164045437|NCT00251589|592526580|FG000|Overall Study|Discontinued due to progressive disease|9|||
164045438|NCT00251589|592526581|FG001|Overall Study|Discontinued due to progressive disease|1|||
164045439|NCT00251589|592526582|FG002|Overall Study|Discontinued due to progressive disease|0|||
164099130|NCT04089735|592728820|FG005|Overall Study|Withdrawal by Subject|0|||
164045440|NCT00251589|592526583|FG003|Overall Study|Discontinued due to progressive disease|1|||
164045441|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
164045442|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
164148526|NCT01823835|592904897|FG005|Overall Study|Study Termination|0|||
164045443|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
164045444|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
164045445|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
163945994|NCT00607724|592170456|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
163945995|NCT00607724|592170450|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163945996|NCT00607724|592170451|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163945997|NCT00607724|592170452|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163945998|NCT00607724|592170453|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
163945999|NCT00607724|592170454|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163946000|NCT00607724|592170455|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163946001|NCT00607724|592170456|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
163946002|NCT01946529|592170462|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
163946003|NCT01946529|592170463|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
163946004|NCT01946529|592170464|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
163946005|NCT01946529|592170462|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
163946006|NCT01946529|592170463|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
163946007|NCT01946529|592170464|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
163946008|NCT00775463|592172281|FG000|Overall Study|Withdrawal by Subject|0|||
163946009|NCT00775463|592172282|FG001|Overall Study|Withdrawal by Subject|1|||
163946010|NCT00775463|592172281|FG000|Overall Study|Adverse Event|7|||
163946011|NCT00775463|592172282|FG001|Overall Study|Adverse Event|9|||
163946012|NCT00775463|592172281|FG000|Overall Study|Protocol Violation|2|||
163946013|NCT00775463|592172282|FG001|Overall Study|Protocol Violation|2|||
163946014|NCT00775463|592172281|FG000|Overall Study|Lost to Follow-up|1|||
163946015|NCT00775463|592172282|FG001|Overall Study|Lost to Follow-up|0|||
163946016|NCT00775463|592172281|FG000|Overall Study|Lack of Efficacy|1|||
163946017|NCT00775463|592172282|FG001|Overall Study|Lack of Efficacy|1|||
163946018|NCT02980731|592172283|FG000|Overall Study|Death|63|||
163946019|NCT02980731|592172283|FG000|Overall Study|Withdrawal by Subject|6|||
163946020|NCT02980731|592172283|FG000|Overall Study|Lost to Follow-up|5|||
163946021|NCT02980731|592172283|FG000|Overall Study|Study terminated by Sponsor|4|||
163946022|NCT02980731|592172283|FG000|Overall Study|Completed survival follow-up period|65|||
163946023|NCT02980731|592172283|FG000|Overall Study|COVID-19 infection|1|||
163946024|NCT02980731|592172283|FG000|Overall Study|Other, not specified|66|||
163946025|NCT03037931|592172284|FG000|Overall Study|Death|354|||
163946026|NCT03037931|592172285|FG001|Overall Study|Death|367|||
163946027|NCT03037931|592172284|FG000|Overall Study|Lost to Follow-up|7|||
163946028|NCT03037931|592172285|FG001|Overall Study|Lost to Follow-up|4|||
163946029|NCT03037931|592172284|FG000|Overall Study|Withdrawal by Subject|48|||
163946030|NCT03037931|592172285|FG001|Overall Study|Withdrawal by Subject|41|||
163946031|NCT02075476|592172286|FG000|Overall Study|Death|2|||
163946032|NCT02075476|592172287|FG001|Overall Study|Death|2|||
163946033|NCT02075476|592172286|FG000|Overall Study|Lost to Follow-up|1|||
163946034|NCT02075476|592172287|FG001|Overall Study|Lost to Follow-up|3|||
163946035|NCT01789567|592172288|FG000|Overall Study|Death|6|||
163946036|NCT02731690|592172289|FG000|Overall Study|Adverse Event|1|||
163946037|NCT02731690|592172289|FG000|Overall Study|Withdrawal by Subject|3|||
163946038|NCT02731690|592172289|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
163946039|NCT00872989|592172290|FG000|Overall Study|Adverse Event|7|||
163946040|NCT00872989|592172291|FG001|Overall Study|Adverse Event|15|||
163946041|NCT00872989|592172290|FG000|Overall Study|Withdrawal by Subject|8|||
163946042|NCT00872989|592172291|FG001|Overall Study|Withdrawal by Subject|5|||
163946043|NCT00872989|592172290|FG000|Overall Study|Progression/relapse|47|||
163946044|NCT00872989|592172291|FG001|Overall Study|Progression/relapse|35|||
163946045|NCT00872989|592172290|FG000|Overall Study|Not protocol specified|3|||
163946046|NCT00872989|592172291|FG001|Overall Study|Not protocol specified|8|||
163946047|NCT02407990|592172292|FG000|Overall Study|Death|2|||
163946048|NCT02407990|592172293|FG001|Overall Study|Death|22|||
163946049|NCT02407990|592172294|FG002|Overall Study|Death|23|||
163946050|NCT02407990|592172295|FG003|Overall Study|Death|7|||
163946051|NCT02407990|592172296|FG004|Overall Study|Death|17|||
164045446|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
164045447|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164045448|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
164045449|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
164045450|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
163946052|NCT02407990|592172297|FG005|Overall Study|Death|16|||
163946053|NCT02407990|592172298|FG006|Overall Study|Death|10|||
163946054|NCT02407990|592172299|FG007|Overall Study|Death|248|||
163946055|NCT02407990|592172292|FG000|Overall Study|Lost to Follow-up|0|||
163946056|NCT02407990|592172293|FG001|Overall Study|Lost to Follow-up|1|||
164045451|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
163946057|NCT02407990|592172294|FG002|Overall Study|Lost to Follow-up|0|||
163946058|NCT02407990|592172295|FG003|Overall Study|Lost to Follow-up|0|||
163946059|NCT02407990|592172296|FG004|Overall Study|Lost to Follow-up|0|||
163946060|NCT02407990|592172297|FG005|Overall Study|Lost to Follow-up|0|||
163946061|NCT02407990|592172298|FG006|Overall Study|Lost to Follow-up|0|||
163946062|NCT02407990|592172299|FG007|Overall Study|Lost to Follow-up|17|||
163946063|NCT02407990|592172292|FG000|Overall Study|Progressive Disease|0|||
163946064|NCT02407990|592172293|FG001|Overall Study|Progressive Disease|0|||
163946065|NCT02407990|592172294|FG002|Overall Study|Progressive Disease|0|||
163946066|NCT02407990|592172295|FG003|Overall Study|Progressive Disease|0|||
163946067|NCT02407990|592172296|FG004|Overall Study|Progressive Disease|0|||
163946068|NCT02407990|592172297|FG005|Overall Study|Progressive Disease|0|||
163946069|NCT02407990|592172298|FG006|Overall Study|Progressive Disease|0|||
163946070|NCT02407990|592172299|FG007|Overall Study|Progressive Disease|1|||
163946071|NCT02407990|592172292|FG000|Overall Study|Withdrawal by Subject|0|||
163946072|NCT02407990|592172293|FG001|Overall Study|Withdrawal by Subject|0|||
163946073|NCT02407990|592172294|FG002|Overall Study|Withdrawal by Subject|0|||
163946074|NCT02407990|592172295|FG003|Overall Study|Withdrawal by Subject|0|||
163946075|NCT02407990|592172296|FG004|Overall Study|Withdrawal by Subject|1|||
163946076|NCT02407990|592172297|FG005|Overall Study|Withdrawal by Subject|0|||
163946077|NCT02407990|592172298|FG006|Overall Study|Withdrawal by Subject|0|||
163946078|NCT02407990|592172299|FG007|Overall Study|Withdrawal by Subject|30|||
163946079|NCT02407990|592172292|FG000|Overall Study|Study Terminated by Sponsor|1|||
163946080|NCT02407990|592172293|FG001|Overall Study|Study Terminated by Sponsor|3|||
163946081|NCT02407990|592172294|FG002|Overall Study|Study Terminated by Sponsor|3|||
163946082|NCT02407990|592172295|FG003|Overall Study|Study Terminated by Sponsor|0|||
163946083|NCT02407990|592172296|FG004|Overall Study|Study Terminated by Sponsor|3|||
163946084|NCT02407990|592172297|FG005|Overall Study|Study Terminated by Sponsor|4|||
163946085|NCT02407990|592172298|FG006|Overall Study|Study Terminated by Sponsor|3|||
163946086|NCT02407990|592172299|FG007|Overall Study|Study Terminated by Sponsor|37|||
163946087|NCT02407990|592172292|FG000|Overall Study|Logistics|0|||
163946088|NCT02407990|592172293|FG001|Overall Study|Logistics|0|||
163946089|NCT02407990|592172294|FG002|Overall Study|Logistics|0|||
163946090|NCT02407990|592172295|FG003|Overall Study|Logistics|0|||
163946091|NCT02407990|592172296|FG004|Overall Study|Logistics|0|||
163946092|NCT02407990|592172297|FG005|Overall Study|Logistics|0|||
163946093|NCT02407990|592172298|FG006|Overall Study|Logistics|0|||
163946094|NCT02407990|592172299|FG007|Overall Study|Logistics|1|||
163946095|NCT02407990|592172292|FG000|Overall Study|Rolled into long-term extension study|0|||
163946096|NCT02407990|592172293|FG001|Overall Study|Rolled into long-term extension study|0|||
163946097|NCT02407990|592172294|FG002|Overall Study|Rolled into long-term extension study|0|||
163946098|NCT02407990|592172295|FG003|Overall Study|Rolled into long-term extension study|0|||
163946099|NCT02407990|592172296|FG004|Overall Study|Rolled into long-term extension study|0|||
163946100|NCT02407990|592172297|FG005|Overall Study|Rolled into long-term extension study|0|||
163946101|NCT02407990|592172298|FG006|Overall Study|Rolled into long-term extension study|0|||
163946102|NCT02407990|592172299|FG007|Overall Study|Rolled into long-term extension study|1|||
163946103|NCT01238900|592172300|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
163946104|NCT01238900|592172300|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
163946105|NCT01994837|592172301|FG000|Overall Study|Progressive disease per protocol|23|||
163946106|NCT01994837|592172301|FG000|Overall Study|Adv event related to progressive disease|3|||
163946107|NCT01994837|592172301|FG000|Overall Study|Fatal progressive disease|2|||
163946108|NCT01994837|592172301|FG000|Overall Study|Adverse event not related to progression|1|||
163946109|NCT01994837|592172301|FG000|Overall Study|Chose palliative care|1|||
163946110|NCT01994837|592172301|FG000|Overall Study|Proceeded to transplant|1|||
163946111|NCT01994837|592172301|FG000|Overall Study|Removed from study due to no response|1|||
163946112|NCT03241927|592172303|FG000|Overall Study|study terminated|1|||
163946113|NCT03241927|592172304|FG001|Overall Study|study terminated|0|||
163946114|NCT03573583|592172305|FG000|Overall Study|Lost to Follow-up|1|||
163946115|NCT03573583|592172306|FG001|Overall Study|Lost to Follow-up|0|||
163946116|NCT03573583|592172305|FG000|Overall Study|Withdrawal by Subject|1|||
163946117|NCT03573583|592172306|FG001|Overall Study|Withdrawal by Subject|1|||
163946118|NCT01198756|592172307|FG000|Overall Study|Adverse Event|0|||
163946119|NCT01198756|592172308|FG001|Overall Study|Adverse Event|0|||
163946120|NCT01198756|592172309|FG002|Overall Study|Adverse Event|0|||
163946121|NCT01198756|592172310|FG003|Overall Study|Adverse Event|1|||
163946122|NCT01198756|592172307|FG000|Overall Study|Protocol Violation|0|||
163946123|NCT01198756|592172308|FG001|Overall Study|Protocol Violation|0|||
163946124|NCT01198756|592172309|FG002|Overall Study|Protocol Violation|0|||
163946125|NCT01198756|592172310|FG003|Overall Study|Protocol Violation|2|||
163946126|NCT01198756|592172307|FG000|Overall Study|Withdrawal by Subject|9|||
163946127|NCT01198756|592172308|FG001|Overall Study|Withdrawal by Subject|4|||
163946128|NCT01198756|592172309|FG002|Overall Study|Withdrawal by Subject|7|||
163946129|NCT01198756|592172310|FG003|Overall Study|Withdrawal by Subject|5|||
163946130|NCT01198756|592172307|FG000|Overall Study|Lost to Follow-up|29|||
163946131|NCT01198756|592172308|FG001|Overall Study|Lost to Follow-up|36|||
163946132|NCT01198756|592172309|FG002|Overall Study|Lost to Follow-up|23|||
163946133|NCT01198756|592172310|FG003|Overall Study|Lost to Follow-up|18|||
163946134|NCT02915302|592172313|FG000|Overall Study|Adverse Event|3|||
163946135|NCT02915302|592172314|FG001|Overall Study|Adverse Event|0|||
163946136|NCT02915302|592172313|FG000|Overall Study|Protocol Violation|20|||
163946137|NCT02915302|592172314|FG001|Overall Study|Protocol Violation|27|||
164045452|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
164045453|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
164045454|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164045455|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164045456|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
164045457|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
164045458|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
164045459|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
164045460|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
164045461|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
164045462|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
164045463|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
164045464|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
164045465|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
164045466|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164045467|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
164045468|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
164045469|NCT03227224|592526586|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
164045470|NCT03227224|592526587|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
164045471|NCT03227224|592526588|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
164045472|NCT03227224|592526589|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
164045473|NCT03227224|592526586|FG000|Follow-up Phase (2 Weeks)|Other|4|||
164045474|NCT03227224|592526587|FG001|Follow-up Phase (2 Weeks)|Other|4|||
164045475|NCT03227224|592526588|FG002|Follow-up Phase (2 Weeks)|Other|6|||
164045476|NCT03227224|592526589|FG003|Follow-up Phase (2 Weeks)|Other|3|||
164045477|NCT03782376|592526592|FG000|Overall Study|Lost to Follow-up|2|||
164045478|NCT03782376|592526593|FG001|Overall Study|Lost to Follow-up|2|||
164045479|NCT03782376|592526592|FG000|Overall Study|Withdrawal by Subject|7|||
164045480|NCT03782376|592526593|FG001|Overall Study|Withdrawal by Subject|11|||
164045481|NCT03782376|592526592|FG000|Overall Study|Death|1|||
164045482|NCT03782376|592526593|FG001|Overall Study|Death|0|||
164045483|NCT03782376|592526592|FG000|Overall Study|Other|16|||
164045484|NCT03782376|592526593|FG001|Overall Study|Other|17|||
164045485|NCT02659098|592526594|FG000|Overall Study|Withdrawal by Subject|7|||
164045486|NCT03039192|592526595|FG000|Overall Study|Lost to Follow-up|4|||
164045487|NCT03039192|592526596|FG001|Overall Study|Lost to Follow-up|4|||
164045488|NCT03039192|592526595|FG000|Overall Study|Adverse event, serious fatal|0|||
164045489|NCT03039192|592526596|FG001|Overall Study|Adverse event, serious fatal|1|||
164045490|NCT03039192|592526595|FG000|Overall Study|Adverse event, non-fatal|0|||
164045491|NCT03039192|592526596|FG001|Overall Study|Adverse event, non-fatal|2|||
164045492|NCT03039192|592526595|FG000|Overall Study|Withdrawal by Subject|6|||
164045493|NCT03039192|592526596|FG001|Overall Study|Withdrawal by Subject|9|||
164045494|NCT03039192|592526595|FG000|Overall Study|Discontinued from treatment phase|19|||
164045495|NCT03039192|592526596|FG001|Overall Study|Discontinued from treatment phase|12|||
164045496|NCT03039192|592526595|FG000|Overall Study|Other|3|||
164045497|NCT03039192|592526596|FG001|Overall Study|Other|2|||
164045498|NCT02407236|592526597|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
164045499|NCT02407236|592526598|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
164045500|NCT02407236|592526599|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
164045501|NCT02407236|592526600|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
164045502|NCT02407236|592526601|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
164045503|NCT02407236|592526602|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
164045504|NCT02407236|592526603|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
164045505|NCT02407236|592526604|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
164045506|NCT02407236|592526605|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
164045507|NCT02407236|592526606|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
164045508|NCT02407236|592526607|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
164045509|NCT02407236|592526608|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
164045510|NCT02407236|592526609|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
164045511|NCT02407236|592526597|FG000|Induction Study (8 Weeks)|Death|0|||
164045512|NCT02407236|592526598|FG001|Induction Study (8 Weeks)|Death|0|||
164045513|NCT02407236|592526599|FG002|Induction Study (8 Weeks)|Death|1|||
164148527|NCT01823835|592904898|FG006|Overall Study|Study Termination|0|||
164045514|NCT02407236|592526600|FG003|Induction Study (8 Weeks)|Death|0|||
164045515|NCT02407236|592526601|FG004|Induction Study (8 Weeks)|Death|0|||
164045516|NCT02407236|592526602|FG005|Induction Study (8 Weeks)|Death|0|||
164045517|NCT02407236|592526603|FG006|Induction Study (8 Weeks)|Death|0|||
164045518|NCT02407236|592526604|FG007|Induction Study (8 Weeks)|Death|0|||
164045519|NCT02407236|592526605|FG008|Induction Study (8 Weeks)|Death|0|||
164045520|NCT02407236|592526606|FG009|Induction Study (8 Weeks)|Death|0|||
164045521|NCT02407236|592526607|FG010|Induction Study (8 Weeks)|Death|0|||
164045522|NCT02407236|592526608|FG011|Induction Study (8 Weeks)|Death|0|||
164045523|NCT02407236|592526609|FG012|Induction Study (8 Weeks)|Death|0|||
164045524|NCT02407236|592526597|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
164045525|NCT02407236|592526598|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
164045526|NCT02407236|592526599|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
164045527|NCT02407236|592526600|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045528|NCT02407236|592526601|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045529|NCT02407236|592526602|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045530|NCT02407236|592526603|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045531|NCT02407236|592526604|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045532|NCT02407236|592526605|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045533|NCT02407236|592526606|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045534|NCT02407236|592526607|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045535|NCT02407236|592526608|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045536|NCT02407236|592526609|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
164045537|NCT02407236|592526597|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045538|NCT02407236|592526598|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045539|NCT02407236|592526599|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
164045540|NCT02407236|592526600|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045541|NCT02407236|592526601|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045542|NCT02407236|592526602|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045543|NCT02407236|592526603|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045544|NCT02407236|592526604|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045545|NCT02407236|592526605|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045546|NCT02407236|592526606|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045547|NCT02407236|592526607|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045548|NCT02407236|592526608|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045549|NCT02407236|592526609|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
164045550|NCT02407236|592526597|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
164045551|NCT02407236|592526598|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
164045552|NCT02407236|592526599|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
164045553|NCT02407236|592526600|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
164045554|NCT02407236|592526601|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
164045555|NCT02407236|592526602|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
164045556|NCT02407236|592526603|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
164045557|NCT02407236|592526604|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
164045558|NCT02407236|592526605|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
164045559|NCT02407236|592526606|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
164045560|NCT02407236|592526607|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
164045561|NCT02407236|592526608|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
164045562|NCT02407236|592526609|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
164045563|NCT02407236|592526597|FG000|Induction Study (8 Weeks)|Other|2|||
164045564|NCT02407236|592526598|FG001|Induction Study (8 Weeks)|Other|1|||
164045565|NCT02407236|592526599|FG002|Induction Study (8 Weeks)|Other|5|||
164045566|NCT02407236|592526600|FG003|Induction Study (8 Weeks)|Other|0|||
164045567|NCT02407236|592526601|FG004|Induction Study (8 Weeks)|Other|0|||
164045568|NCT02407236|592526602|FG005|Induction Study (8 Weeks)|Other|0|||
164045569|NCT02407236|592526603|FG006|Induction Study (8 Weeks)|Other|0|||
164045570|NCT02407236|592526604|FG007|Induction Study (8 Weeks)|Other|0|||
164045571|NCT02407236|592526605|FG008|Induction Study (8 Weeks)|Other|0|||
164045572|NCT02407236|592526606|FG009|Induction Study (8 Weeks)|Other|0|||
164045573|NCT02407236|592526607|FG010|Induction Study (8 Weeks)|Other|0|||
164045574|NCT02407236|592526608|FG011|Induction Study (8 Weeks)|Other|0|||
164045575|NCT02407236|592526609|FG012|Induction Study (8 Weeks)|Other|0|||
164045576|NCT02407236|592526597|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045577|NCT02407236|592526598|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045578|NCT02407236|592526599|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045579|NCT02407236|592526600|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
164045580|NCT02407236|592526601|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
164045581|NCT02407236|592526602|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
164045582|NCT02407236|592526603|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
164045583|NCT02407236|592526604|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
164045584|NCT02407236|592526605|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045585|NCT02407236|592526606|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045586|NCT02407236|592526607|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045587|NCT02407236|592526608|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045588|NCT02407236|592526609|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
164045589|NCT02407236|592526597|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045590|NCT02407236|592526598|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045591|NCT02407236|592526599|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045592|NCT02407236|592526600|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
164045593|NCT02407236|592526601|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
164045594|NCT02407236|592526602|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
164045595|NCT02407236|592526603|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
164045596|NCT02407236|592526604|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
164045597|NCT02407236|592526605|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045598|NCT02407236|592526606|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045599|NCT02407236|592526607|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045600|NCT02407236|592526608|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045601|NCT02407236|592526609|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
164045602|NCT02407236|592526597|FG000|Maintenance Study (44 Weeks)|Other|0|||
164045603|NCT02407236|592526598|FG001|Maintenance Study (44 Weeks)|Other|0|||
164045604|NCT02407236|592526599|FG002|Maintenance Study (44 Weeks)|Other|0|||
164045605|NCT02407236|592526600|FG003|Maintenance Study (44 Weeks)|Other|5|||
164045606|NCT02407236|592526601|FG004|Maintenance Study (44 Weeks)|Other|7|||
164045607|NCT02407236|592526602|FG005|Maintenance Study (44 Weeks)|Other|8|||
164045608|NCT02407236|592526603|FG006|Maintenance Study (44 Weeks)|Other|4|||
164045609|NCT02407236|592526604|FG007|Maintenance Study (44 Weeks)|Other|6|||
164045610|NCT02407236|592526605|FG008|Maintenance Study (44 Weeks)|Other|0|||
164045611|NCT02407236|592526606|FG009|Maintenance Study (44 Weeks)|Other|0|||
164045612|NCT02407236|592526607|FG010|Maintenance Study (44 Weeks)|Other|0|||
164045613|NCT02407236|592526608|FG011|Maintenance Study (44 Weeks)|Other|0|||
164045614|NCT02407236|592526609|FG012|Maintenance Study (44 Weeks)|Other|0|||
164045615|NCT02407236|592526597|FG000|Maintenance Study (44 Weeks)|Death|0|||
164045616|NCT02407236|592526598|FG001|Maintenance Study (44 Weeks)|Death|0|||
164045617|NCT02407236|592526599|FG002|Maintenance Study (44 Weeks)|Death|0|||
164045618|NCT02407236|592526600|FG003|Maintenance Study (44 Weeks)|Death|0|||
164045619|NCT02407236|592526601|FG004|Maintenance Study (44 Weeks)|Death|0|||
164045620|NCT02407236|592526602|FG005|Maintenance Study (44 Weeks)|Death|0|||
164045621|NCT02407236|592526603|FG006|Maintenance Study (44 Weeks)|Death|0|||
164045622|NCT02407236|592526604|FG007|Maintenance Study (44 Weeks)|Death|1|||
164045623|NCT02407236|592526605|FG008|Maintenance Study (44 Weeks)|Death|0|||
164045624|NCT02407236|592526606|FG009|Maintenance Study (44 Weeks)|Death|0|||
164045625|NCT02407236|592526607|FG010|Maintenance Study (44 Weeks)|Death|0|||
164045626|NCT02407236|592526608|FG011|Maintenance Study (44 Weeks)|Death|0|||
164045627|NCT02407236|592526609|FG012|Maintenance Study (44 Weeks)|Death|0|||
164045628|NCT02407236|592526597|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045629|NCT02407236|592526598|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045630|NCT02407236|592526599|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045631|NCT02407236|592526600|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045632|NCT02407236|592526601|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045633|NCT02407236|592526602|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045634|NCT02407236|592526603|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045635|NCT02407236|592526604|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
164045636|NCT02407236|592526605|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
164045637|NCT02407236|592526606|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
164045638|NCT02407236|592526607|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
164045639|NCT02407236|592526608|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
164045640|NCT02407236|592526609|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
164045641|NCT02407236|592526597|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045642|NCT02407236|592526598|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045643|NCT02407236|592526599|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045644|NCT02407236|592526600|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045645|NCT02407236|592526601|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045646|NCT02407236|592526602|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045647|NCT02407236|592526603|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045648|NCT02407236|592526604|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045649|NCT02407236|592526605|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045650|NCT02407236|592526606|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045651|NCT02407236|592526607|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
164045652|NCT02407236|592526608|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045653|NCT02407236|592526609|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
164045654|NCT02407236|592526597|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164045655|NCT02407236|592526598|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164045656|NCT02407236|592526599|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164045657|NCT02407236|592526600|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164099131|NCT04089735|592728815|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
164099132|NCT04089735|592728816|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
164045658|NCT02407236|592526601|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164045659|NCT02407236|592526602|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164045660|NCT02407236|592526603|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
164045661|NCT02407236|592526604|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
163842292|NCT01208415|591792955|FG000|Overall Study|Device not placed|1|||
163842293|NCT01208415|591792955|FG000|Overall Study|Still be eligible for follow-up|33|||
163842294|NCT02340520|591792956|FG000|Overall Study|Lost to Follow-up|1|||
163842295|NCT02340520|591792956|FG000|Overall Study|Patient did not take drug as specified|1|||
163842296|NCT02340520|591792956|FG000|Overall Study|Withdrawal by Subject|1|||
163842297|NCT01586338|591792958|FG000|Overall Study|Adverse Event|3|||
163842298|NCT01586338|591792958|FG000|Overall Study|Lost to Follow-up|1|||
163842299|NCT01586338|591792958|FG000|Overall Study|Withdrawal by participant|3|||
163842300|NCT01586338|591792958|FG000|Overall Study|Other|1|||
163842301|NCT00896454|591792974|FG000|Overall Study|Death|10|||
163842302|NCT00896454|591792974|FG000|Overall Study|Adverse Event|8|||
163842303|NCT00896454|591792974|FG000|Overall Study|Disease Progression|5|||
163842304|NCT00896454|591792974|FG000|Overall Study|Other|4|||
163842305|NCT00896454|591792974|FG000|Overall Study|Requirement for alternative therapy|3|||
163842306|NCT00896454|591792974|FG000|Overall Study|Ongoing in study|2|||
163842307|NCT00896454|591792974|FG000|Overall Study|Withdrawal by Subject|1|||
163842308|NCT05064735|591792976|FG000|Overall Study|Withdrawal by Subject|7|||
163842309|NCT05064735|591792977|FG001|Overall Study|Withdrawal by Subject|8|||
163842310|NCT05064735|591792976|FG000|Overall Study|Lost to Follow-up|7|||
163842311|NCT05064735|591792977|FG001|Overall Study|Lost to Follow-up|2|||
163842312|NCT05064735|591792976|FG000|Overall Study|Physician Decision|2|||
163842313|NCT05064735|591792977|FG001|Overall Study|Physician Decision|1|||
163842314|NCT05064735|591792976|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
163842315|NCT05064735|591792977|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
163842316|NCT05064735|591792976|FG000|Overall Study|Site Closure|7|||
163842317|NCT05064735|591792977|FG001|Overall Study|Site Closure|2|||
163842318|NCT00856661|591792979|FG000|Overall Study|Death|15|||
163842319|NCT00856661|591792980|FG001|Overall Study|Death|18|||
163842320|NCT00856661|591792979|FG000|Overall Study|Protocol Violation|2|||
163842321|NCT00856661|591792980|FG001|Overall Study|Protocol Violation|1|||
163842322|NCT00856661|591792979|FG000|Overall Study|Withdrawal by Subject|1|||
163842323|NCT00856661|591792980|FG001|Overall Study|Withdrawal by Subject|2|||
163842324|NCT00856661|591792979|FG000|Overall Study|Lost to Follow-up|1|||
163842325|NCT00856661|591792980|FG001|Overall Study|Lost to Follow-up|3|||
163842326|NCT00856661|591792979|FG000|Overall Study|Physician Judgement|8|||
163842327|NCT00856661|591792980|FG001|Overall Study|Physician Judgement|5|||
163842328|NCT02301156|591792981|FG000|Overall Study|Adverse Event|13|||
163842329|NCT02301156|591792982|FG001|Overall Study|Adverse Event|14|||
163842330|NCT02301156|591792981|FG000|Overall Study|Death|1|||
163842331|NCT02301156|591792982|FG001|Overall Study|Death|5|||
163842332|NCT02301156|591792981|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
163842333|NCT02301156|591792982|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
163842334|NCT02301156|591792981|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
163842335|NCT02301156|591792982|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
163842336|NCT02301156|591792981|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
163842337|NCT02301156|591792982|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
163842338|NCT02301156|591792981|FG000|Overall Study|Reason not Specified|6|||
163842339|NCT02301156|591792982|FG001|Overall Study|Reason not Specified|3|||
163842340|NCT03797326|591792988|FG000|Overall Study|Lost to Follow-up|1|||
163842341|NCT03797326|591792989|FG001|Overall Study|Lost to Follow-up|0|||
163842342|NCT03797326|591792990|FG002|Overall Study|Lost to Follow-up|0|||
163842343|NCT03797326|591792991|FG003|Overall Study|Lost to Follow-up|1|||
163842344|NCT03797326|591792992|FG004|Overall Study|Lost to Follow-up|0|||
163842345|NCT03797326|591792993|FG005|Overall Study|Lost to Follow-up|0|||
163842346|NCT03797326|591792994|FG006|Overall Study|Lost to Follow-up|0|||
163842347|NCT03797326|591792995|FG007|Overall Study|Lost to Follow-up|0|||
163842348|NCT03797326|591792988|FG000|Overall Study|Withdrawal by Subject|0|||
163842349|NCT03797326|591792989|FG001|Overall Study|Withdrawal by Subject|0|||
163842350|NCT03797326|591792990|FG002|Overall Study|Withdrawal by Subject|1|||
163842351|NCT03797326|591792991|FG003|Overall Study|Withdrawal by Subject|3|||
163842352|NCT03797326|591792992|FG004|Overall Study|Withdrawal by Subject|0|||
163842353|NCT03797326|591792993|FG005|Overall Study|Withdrawal by Subject|2|||
163842354|NCT03797326|591792994|FG006|Overall Study|Withdrawal by Subject|2|||
163842355|NCT03797326|591792995|FG007|Overall Study|Withdrawal by Subject|3|||
163842356|NCT03797326|591792988|FG000|Overall Study|Sponsor Decision|3|||
163842357|NCT03797326|591792989|FG001|Overall Study|Sponsor Decision|3|||
163842358|NCT03797326|591792990|FG002|Overall Study|Sponsor Decision|3|||
163842359|NCT03797326|591792991|FG003|Overall Study|Sponsor Decision|6|||
163842360|NCT03797326|591792992|FG004|Overall Study|Sponsor Decision|0|||
163842361|NCT03797326|591792993|FG005|Overall Study|Sponsor Decision|3|||
163842362|NCT03797326|591792994|FG006|Overall Study|Sponsor Decision|3|||
163842363|NCT03797326|591792995|FG007|Overall Study|Sponsor Decision|2|||
163842364|NCT03797326|591792988|FG000|Overall Study|Death|27|||
163842365|NCT03797326|591792989|FG001|Overall Study|Death|28|||
163842366|NCT03797326|591792990|FG002|Overall Study|Death|95|||
163842367|NCT03797326|591792991|FG003|Overall Study|Death|95|||
163842368|NCT03797326|591792992|FG004|Overall Study|Death|30|||
163946138|NCT02915302|592172313|FG000|Overall Study|Lost to Follow-up|19|||
163946139|NCT02915302|592172314|FG001|Overall Study|Lost to Follow-up|22|||
163946140|NCT02915302|592172313|FG000|Overall Study|Withdrawal by Subject|22|||
163946141|NCT02915302|592172314|FG001|Overall Study|Withdrawal by Subject|29|||
163946142|NCT02915302|592172313|FG000|Overall Study|Other|1|||
163946143|NCT02915302|592172314|FG001|Overall Study|Other|0|||
163946144|NCT04343872|592172317|FG000|Overall Study|Lost to Follow-up|6|||
163946145|NCT04343872|592172318|FG001|Overall Study|Lost to Follow-up|3|||
163946146|NCT01850446|592172319|FG000|Overall Study|Lack of Efficacy|1|||
163946147|NCT01850446|592172320|FG001|Overall Study|Lack of Efficacy|0|||
163946148|NCT01850446|592172319|FG000|Overall Study|Withdrawal by Subject|4|||
163946149|NCT01850446|592172320|FG001|Overall Study|Withdrawal by Subject|0|||
163946150|NCT01850446|592172319|FG000|Overall Study|Protocol Violation|0|||
163946151|NCT01850446|592172320|FG001|Overall Study|Protocol Violation|2|||
163946152|NCT00591721|592172321|FG000|Overall Study|Withdrawal by Subject|10|||
163946153|NCT00591721|592172322|FG001|Overall Study|Withdrawal by Subject|10|||
163946154|NCT00591721|592172321|FG000|Overall Study|Lost to Follow-up|1|||
163946155|NCT00591721|592172322|FG001|Overall Study|Lost to Follow-up|4|||
163946156|NCT00591721|592172321|FG000|Overall Study|Intervention not received|10|||
163946157|NCT00591721|592172322|FG001|Overall Study|Intervention not received|8|||
163946158|NCT01119105|592172323|FG000|Overall Study|Withdrawal by Subject|1|||
163946159|NCT01119105|592172324|FG001|Overall Study|Withdrawal by Subject|1|||
163946160|NCT01119105|592172325|FG002|Overall Study|Withdrawal by Subject|1|||
163946161|NCT01119105|592172323|FG000|Overall Study|Lost to Follow-up|0|||
163946162|NCT01119105|592172324|FG001|Overall Study|Lost to Follow-up|2|||
163946163|NCT01119105|592172325|FG002|Overall Study|Lost to Follow-up|5|||
163946164|NCT01119105|592172323|FG000|Overall Study|Adverse Event|1|||
163946165|NCT01119105|592172324|FG001|Overall Study|Adverse Event|0|||
163946166|NCT01119105|592172325|FG002|Overall Study|Adverse Event|1|||
163946167|NCT01119105|592172323|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
163946168|NCT01119105|592172324|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
163946169|NCT01119105|592172325|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
163946170|NCT01119105|592172323|FG000|Overall Study|Other|1|||
163946171|NCT01119105|592172324|FG001|Overall Study|Other|1|||
163946172|NCT01119105|592172325|FG002|Overall Study|Other|0|||
164099133|NCT04089735|592728817|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
164148528|NCT01823835|592904899|FG007|Overall Study|Study Termination|0|||
163842369|NCT03797326|591792993|FG005|Overall Study|Death|96|||
163842370|NCT03797326|591792994|FG006|Overall Study|Death|97|||
163842371|NCT03797326|591792995|FG007|Overall Study|Death|98|||
163842372|NCT03797326|591792988|FG000|Overall Study|Enrolled in error|0|||
163842373|NCT03797326|591792989|FG001|Overall Study|Enrolled in error|0|||
163842374|NCT03797326|591792990|FG002|Overall Study|Enrolled in error|3|||
163842375|NCT03797326|591792991|FG003|Overall Study|Enrolled in error|2|||
163842376|NCT03797326|591792992|FG004|Overall Study|Enrolled in error|2|||
163842377|NCT03797326|591792993|FG005|Overall Study|Enrolled in error|1|||
163842378|NCT03797326|591792994|FG006|Overall Study|Enrolled in error|1|||
163842379|NCT03797326|591792995|FG007|Overall Study|Enrolled in error|0|||
163842380|NCT03012061|591792996|FG000|Overall Study|Withdrawal by Subject|1|||
163842381|NCT03012061|591792997|FG001|Overall Study|Withdrawal by Subject|5|||
163842382|NCT03012061|591792998|FG002|Overall Study|Withdrawal by Subject|4|||
163842383|NCT03012061|591792996|FG000|Overall Study|Investigator Site Closed|1|||
163842384|NCT03012061|591792997|FG001|Overall Study|Investigator Site Closed|2|||
163842385|NCT03012061|591792998|FG002|Overall Study|Investigator Site Closed|0|||
163842386|NCT03012061|591792996|FG000|Overall Study|Lost to Follow-up|2|||
163842387|NCT03012061|591792997|FG001|Overall Study|Lost to Follow-up|1|||
163842388|NCT03012061|591792998|FG002|Overall Study|Lost to Follow-up|0|||
163842389|NCT03012061|591792996|FG000|Overall Study|Study closed/ Terminated|0|||
163842390|NCT03012061|591792997|FG001|Overall Study|Study closed/ Terminated|0|||
163842391|NCT03012061|591792998|FG002|Overall Study|Study closed/ Terminated|1|||
163842392|NCT03012061|591792996|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
163842393|NCT03012061|591792997|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
163842394|NCT03012061|591792998|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
163842395|NCT03012061|591792996|FG000|Overall Study|Protocol Violation|0|||
163842396|NCT03012061|591792997|FG001|Overall Study|Protocol Violation|0|||
163842397|NCT03012061|591792998|FG002|Overall Study|Protocol Violation|2|||
163842398|NCT03012061|591792996|FG000|Overall Study|Lack of Efficacy|0|||
163842399|NCT03012061|591792997|FG001|Overall Study|Lack of Efficacy|1|||
163842400|NCT03012061|591792998|FG002|Overall Study|Lack of Efficacy|0|||
163842401|NCT03012061|591792996|FG000|Overall Study|Adverse Event|2|||
163842402|NCT03012061|591792997|FG001|Overall Study|Adverse Event|0|||
163842403|NCT03012061|591792998|FG002|Overall Study|Adverse Event|0|||
163842404|NCT02736968|591792999|FG000|Overall Study|Lost to Follow-up|0|||
163842405|NCT02736968|591793000|FG001|Overall Study|Lost to Follow-up|0|||
163842406|NCT02736968|591793001|FG002|Overall Study|Lost to Follow-up|0|||
163842407|NCT02736968|591793002|FG003|Overall Study|Lost to Follow-up|0|||
163842408|NCT02736968|591793003|FG004|Overall Study|Lost to Follow-up|0|||
164045662|NCT02407236|592526605|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
164045663|NCT02407236|592526606|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
164045664|NCT02407236|592526607|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
164045665|NCT02407236|592526608|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
164045666|NCT02407236|592526609|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
164045667|NCT02407236|592526597|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
164045668|NCT02407236|592526598|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
164045669|NCT02407236|592526599|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
164045670|NCT02407236|592526600|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
164045671|NCT02407236|592526601|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
164045672|NCT02407236|592526602|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
164045673|NCT02407236|592526603|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
164045674|NCT02407236|592526604|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
164045675|NCT02407236|592526605|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
164045676|NCT02407236|592526606|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
164045677|NCT02407236|592526607|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
164045678|NCT02407236|592526608|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
164045679|NCT02407236|592526609|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
164045680|NCT03277794|592526612|FG000|Overall Study|Lost to Follow-up|2|||
164045681|NCT03277794|592526613|FG001|Overall Study|Lost to Follow-up|4|||
164045682|NCT03277794|592526612|FG000|Overall Study|Withdrew due to high acuity|1|||
164045683|NCT03277794|592526613|FG001|Overall Study|Withdrew due to high acuity|0|||
164045684|NCT02254304|592526617|FG000|Overall Study|Adverse Event|2|||
164045685|NCT02254304|592526618|FG001|Overall Study|Adverse Event|1|||
164045686|NCT02254304|592526617|FG000|Overall Study|Lost to Follow-up|2|||
164045687|NCT02254304|592526618|FG001|Overall Study|Lost to Follow-up|2|||
164045688|NCT02254304|592526617|FG000|Overall Study|Protocol Violation|1|||
164045689|NCT02254304|592526618|FG001|Overall Study|Protocol Violation|0|||
164045690|NCT02254304|592526617|FG000|Overall Study|Withdrawal by Subject|3|||
164045691|NCT02254304|592526618|FG001|Overall Study|Withdrawal by Subject|0|||
164045692|NCT02254304|592526617|FG000|Overall Study|Injection site pain and Injection fear|1|||
164045693|NCT02254304|592526618|FG001|Overall Study|Injection site pain and Injection fear|0|||
164045694|NCT02254304|592526617|FG000|Overall Study|Personal causes|4|||
164045695|NCT02254304|592526618|FG001|Overall Study|Personal causes|1|||
164045696|NCT02254304|592526617|FG000|Overall Study|Personal decision|1|||
164045697|NCT02254304|592526618|FG001|Overall Study|Personal decision|0|||
164045698|NCT00952419|592526619|FG000|Overall Study|Adverse Event|2|||
164045699|NCT00952419|592526620|FG001|Overall Study|Adverse Event|0|||
164045700|NCT00952419|592526621|FG002|Overall Study|Adverse Event|0|||
164045701|NCT00952419|592526619|FG000|Overall Study|Protocol Violation|3|||
164045702|NCT00952419|592526620|FG001|Overall Study|Protocol Violation|7|||
164045703|NCT00952419|592526621|FG002|Overall Study|Protocol Violation|0|||
164045704|NCT00952419|592526619|FG000|Overall Study|Withdrawal by Subject|1|||
164045705|NCT00952419|592526620|FG001|Overall Study|Withdrawal by Subject|3|||
164045706|NCT00952419|592526621|FG002|Overall Study|Withdrawal by Subject|0|||
164073177|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
164073178|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
164073179|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
164073180|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
164073181|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
164073182|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
164073183|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
164073184|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
164073185|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
164073186|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
164073187|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
164073188|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
164073189|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
164073190|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
164073191|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
164073192|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
164073193|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
163842409|NCT02736968|591793004|FG005|Overall Study|Lost to Follow-up|0|||
164073194|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
164073195|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
164073196|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
164073197|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
164073198|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
164073199|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
164073200|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
163842410|NCT02736968|591793005|FG006|Overall Study|Lost to Follow-up|5|||
163946173|NCT03900416|592172326|FG000|Six Week Follow-up|Lost to Follow-up|1|||
163946174|NCT03900416|592172327|FG001|Six Week Follow-up|Lost to Follow-up|0|||
163946175|NCT03900416|592172326|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
163946176|NCT03900416|592172327|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
163946177|NCT03900416|592172326|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
163946178|NCT03900416|592172327|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
164045707|NCT02266004|592528560|FG000|Overall Study|unrelated adverse event|1|||
164045708|NCT02266004|592528560|FG000|Overall Study|Physician Decision|1|||
164045709|NCT00537771|592528561|FG000|Overall Study|Withdrawal by Subject|6|||
164045710|NCT00537771|592528562|FG001|Overall Study|Withdrawal by Subject|23|||
164045711|NCT00537771|592528561|FG000|Overall Study|Adverse Event|8|||
164045712|NCT00537771|592528562|FG001|Overall Study|Adverse Event|15|||
164045713|NCT00537771|592528561|FG000|Overall Study|Lost to Follow-up|9|||
164045714|NCT00537771|592528562|FG001|Overall Study|Lost to Follow-up|15|||
164045715|NCT00537771|592528561|FG000|Overall Study|Protocol Violation|2|||
164045716|NCT00537771|592528562|FG001|Overall Study|Protocol Violation|6|||
164045717|NCT00537771|592528561|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
164045718|NCT00537771|592528562|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
164045719|NCT02465489|592528565|FG000|Overall Study|Adverse Event|5|||
164045720|NCT01600105|592528566|FG000|Total Participants|Withdrawal by Subject|1|||
164045721|NCT01600105|592528567|FG001|Total Participants|Withdrawal by Subject|0|||
164045722|NCT01600105|592528566|FG000|Total Participants|No images in PACS|10|||
164045723|NCT01600105|592528567|FG001|Total Participants|No images in PACS|0|||
164045724|NCT01600105|592528566|FG000|Total Participants|Insufficient image quality|30|||
164045725|NCT01600105|592528567|FG001|Total Participants|Insufficient image quality|10|||
164045726|NCT01600105|592528566|FG000|Sub Study I|Insufficient image quality|0|||
164045727|NCT01600105|592528567|FG001|Sub Study I|Insufficient image quality|10|||
164045728|NCT01600105|592528566|FG000|Sub Study II|Withdrawal by Subject|1|||
164045729|NCT01600105|592528567|FG001|Sub Study II|Withdrawal by Subject|0|||
164045730|NCT01600105|592528566|FG000|Sub Study II|No images in PACS|1|||
164045731|NCT01600105|592528567|FG001|Sub Study II|No images in PACS|0|||
164045732|NCT01600105|592528566|FG000|Sub Study II|Insufficient image quality|3|||
164045733|NCT01600105|592528567|FG001|Sub Study II|Insufficient image quality|0|||
164045734|NCT01600105|592528566|FG000|Sub Study III|Insufficient image quality|5|||
164045735|NCT01600105|592528567|FG001|Sub Study III|Insufficient image quality|0|||
164045736|NCT01600105|592528566|FG000|Sub Study V|Poor Image Quality|2|||
164045737|NCT01600105|592528567|FG001|Sub Study V|Poor Image Quality|0|||
164045738|NCT01263444|592528568|FG000|Overall Study|Adverse Event|8|||
164045739|NCT01263444|592528568|FG000|Overall Study|Withdrawal by Subject|1|||
164045740|NCT01263444|592528568|FG000|Overall Study|Protocol Violation|1|||
164045741|NCT01764022|592528569|FG000|Overall Study|Death|3|||
164045742|NCT01764022|592528570|FG001|Overall Study|Death|5|||
164045743|NCT01764022|592528569|FG000|Overall Study|Withdrawal by Subject|2|||
164045744|NCT01764022|592528570|FG001|Overall Study|Withdrawal by Subject|6|||
164045745|NCT01764022|592528569|FG000|Overall Study|Lack of Efficacy|0|||
164045746|NCT01764022|592528570|FG001|Overall Study|Lack of Efficacy|1|||
164045747|NCT01764022|592528569|FG000|Overall Study|Physician Decision|0|||
164045748|NCT01764022|592528570|FG001|Overall Study|Physician Decision|2|||
164045749|NCT01764022|592528569|FG000|Overall Study|Lost to Follow-up|2|||
164045750|NCT01764022|592528570|FG001|Overall Study|Lost to Follow-up|0|||
164045751|NCT01764022|592528569|FG000|Overall Study|Protocol Violation|1|||
164045752|NCT01764022|592528570|FG001|Overall Study|Protocol Violation|0|||
163946179|NCT03900416|592172326|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
163946180|NCT03900416|592172327|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
163946181|NCT03900416|592172326|FG000|Twelve Week Follow-up|Adverse Event|1|||
163946182|NCT03900416|592172327|FG001|Twelve Week Follow-up|Adverse Event|1|||
163946183|NCT03900416|592172326|FG000|Six Month Follow-up|Lost to Follow-up|4|||
163946184|NCT03900416|592172327|FG001|Six Month Follow-up|Lost to Follow-up|3|||
163946185|NCT03900416|592172326|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
163946186|NCT03900416|592172327|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
163946187|NCT03207451|592172330|FG000|Overall Study|scheduling conflict|1|||
163946188|NCT03207451|592172331|FG001|Overall Study|scheduling conflict|0|||
163946189|NCT03207451|592172332|FG002|Overall Study|scheduling conflict|2|||
163946190|NCT03207451|592172333|FG003|Overall Study|scheduling conflict|2|||
163946191|NCT03207451|592172330|FG000|Overall Study|Adverse Event|0|||
163946192|NCT03207451|592172331|FG001|Overall Study|Adverse Event|0|||
163946193|NCT03207451|592172332|FG002|Overall Study|Adverse Event|0|||
163946194|NCT03207451|592172333|FG003|Overall Study|Adverse Event|1|||
163946195|NCT00436852|592172334|FG000|Overall Study|Death|23|||
164045753|NCT01899768|592528572|FG000|Part A|Adverse Event|2|||
164045754|NCT01899768|592528572|FG000|Part A|Withdrawal by Subject|1|||
164045755|NCT01899768|592528572|FG000|Part B|Adverse Event|1|||
164045756|NCT01899768|592528572|FG000|Part B|Withdrawal by Subject|1|||
164045757|NCT04043416|592528573|FG000|Washout|Change in health condition|0|||
163946196|NCT00436852|592172335|FG001|Overall Study|Death|34|||
163946197|NCT00436852|592172334|FG000|Overall Study|Lack of Efficacy|9|||
164045758|NCT04043416|592528574|FG001|Washout|Change in health condition|1|||
164045759|NCT00414973|592528575|FG000|Overall Study|Withdrawal by Subject|14|||
163946198|NCT00436852|592172335|FG001|Overall Study|Lack of Efficacy|7|||
163946199|NCT00436852|592172334|FG000|Overall Study|Withdrawal by Subject|2|||
163946200|NCT00436852|592172335|FG001|Overall Study|Withdrawal by Subject|4|||
163946201|NCT00436852|592172334|FG000|Overall Study|Ineligible|1|||
163946202|NCT00436852|592172335|FG001|Overall Study|Ineligible|0|||
163946203|NCT00370682|592172336|FG000|Overall Study|Moved from area|0|||
163946204|NCT00370682|592172337|FG001|Overall Study|Moved from area|2|||
163946205|NCT00370682|592172338|FG002|Overall Study|Moved from area|0|||
163946206|NCT00370682|592172336|FG000|Overall Study|Lost to Follow-up|0|||
163946207|NCT00370682|592172337|FG001|Overall Study|Lost to Follow-up|1|||
163946208|NCT00370682|592172338|FG002|Overall Study|Lost to Follow-up|1|||
163946209|NCT03167359|592172339|FG000|Overall Study|Physician Decision|1|||
163946210|NCT03167359|592172339|FG000|Overall Study|Lost to Follow-up|1|||
163946211|NCT03339583|592172340|FG000|First Intervention (14 Days)|Adverse Event|1|||
163946212|NCT03339583|592172341|FG001|First Intervention (14 Days)|Adverse Event|0|||
163946213|NCT03339583|592172340|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
163946214|NCT03339583|592172341|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
163946215|NCT03339583|592172340|FG000|Second Intervention (14 Days)|Adverse Event|0|||
163946216|NCT03339583|592172341|FG001|Second Intervention (14 Days)|Adverse Event|1|||
163946217|NCT03339583|592172340|FG000|Follow-up (14 Days)|Physician Decision|6|||
163946218|NCT03339583|592172341|FG001|Follow-up (14 Days)|Physician Decision|3|||
163946219|NCT02141620|592172342|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
163946220|NCT02141620|592172343|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
163946221|NCT03651622|592172344|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
163946222|NCT03651622|592172345|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
163946223|NCT03651622|592172346|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
163946224|NCT03651622|592172344|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
163946225|NCT03651622|592172345|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
163946226|NCT03651622|592172346|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
163946227|NCT03651622|592172344|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
163946228|NCT03651622|592172345|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
163946229|NCT03651622|592172346|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
163946230|NCT03651622|592172344|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
163946231|NCT03651622|592172345|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
163946232|NCT03651622|592172346|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
163946233|NCT03651622|592172344|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
163946234|NCT03651622|592172345|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
163946235|NCT03651622|592172346|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
163946236|NCT01519089|592172347|FG000|Overall Study|Adverse Event|4|||
163946237|NCT01519089|592172348|FG001|Overall Study|Adverse Event|4|||
163946238|NCT01519089|592172347|FG000|Overall Study|Lack of Efficacy|0|||
163946239|NCT01519089|592172348|FG001|Overall Study|Lack of Efficacy|2|||
163946240|NCT01519089|592172347|FG000|Overall Study|Lost to Follow-up|1|||
163946241|NCT01519089|592172348|FG001|Overall Study|Lost to Follow-up|0|||
163946242|NCT01519089|592172347|FG000|Overall Study|Withdrawal by Subject|0|||
163946243|NCT01519089|592172348|FG001|Overall Study|Withdrawal by Subject|2|||
163946244|NCT01519089|592172347|FG000|Overall Study|Other|2|||
163946245|NCT01519089|592172348|FG001|Overall Study|Other|6|||
163946246|NCT01519089|592172347|FG000|Overall Study|Not received study drug|0|||
163946247|NCT01519089|592172348|FG001|Overall Study|Not received study drug|1|||
163946248|NCT00307684|592172349|FG000|Open Label Phase|Lack of Efficacy|0|||
163946249|NCT00307684|592172350|FG001|Open Label Phase|Lack of Efficacy|0|||
164045760|NCT00414973|592528576|FG001|Overall Study|Withdrawal by Subject|4|||
164045761|NCT00414973|592528577|FG002|Overall Study|Withdrawal by Subject|1|||
164045762|NCT00414973|592528578|FG003|Overall Study|Withdrawal by Subject|0|||
164045763|NCT00414973|592528575|FG000|Overall Study|Adverse Event|10|||
164045764|NCT00414973|592528576|FG001|Overall Study|Adverse Event|0|||
164045765|NCT00414973|592528577|FG002|Overall Study|Adverse Event|1|||
164045766|NCT00414973|592528578|FG003|Overall Study|Adverse Event|0|||
164045767|NCT00414973|592528575|FG000|Overall Study|Protocol Violation|3|||
164045768|NCT00414973|592528576|FG001|Overall Study|Protocol Violation|4|||
164045769|NCT00414973|592528577|FG002|Overall Study|Protocol Violation|0|||
164045770|NCT00414973|592528578|FG003|Overall Study|Protocol Violation|0|||
164045771|NCT00414973|592528575|FG000|Overall Study|Lost to Follow-up|0|||
164045772|NCT00414973|592528576|FG001|Overall Study|Lost to Follow-up|2|||
164148529|NCT01823835|592904900|FG008|Overall Study|Study Termination|0|||
163946250|NCT00307684|592172351|FG002|Open Label Phase|Lack of Efficacy|3|||
163946251|NCT00307684|592172349|FG000|Open Label Phase|Adverse Event|0|||
163946252|NCT00307684|592172350|FG001|Open Label Phase|Adverse Event|0|||
163946253|NCT00307684|592172351|FG002|Open Label Phase|Adverse Event|16|||
163946254|NCT00307684|592172349|FG000|Open Label Phase|Withdrawal by Subject|0|||
163946255|NCT00307684|592172350|FG001|Open Label Phase|Withdrawal by Subject|0|||
163946256|NCT00307684|592172351|FG002|Open Label Phase|Withdrawal by Subject|15|||
164045773|NCT00414973|592528577|FG002|Overall Study|Lost to Follow-up|0|||
164045774|NCT00414973|592528578|FG003|Overall Study|Lost to Follow-up|0|||
164045775|NCT00414973|592528575|FG000|Overall Study|Sponsor Decision|1|||
164045776|NCT00414973|592528576|FG001|Overall Study|Sponsor Decision|0|||
164045777|NCT00414973|592528577|FG002|Overall Study|Sponsor Decision|0|||
164045778|NCT00414973|592528578|FG003|Overall Study|Sponsor Decision|0|||
164045779|NCT00414973|592528575|FG000|Overall Study|Death|0|||
164045780|NCT00414973|592528576|FG001|Overall Study|Death|0|||
164045781|NCT00414973|592528577|FG002|Overall Study|Death|1|||
164045782|NCT00414973|592528578|FG003|Overall Study|Death|0|||
164045783|NCT01466062|592528579|FG000|Overall Study|Adverse Event|1|||
164045784|NCT01466062|592528579|FG000|Overall Study|Withdrawal by Subject|1|||
164045785|NCT00118040|592528580|FG000|Overall Study|Adverse Event|0|||
164045786|NCT00118040|592528581|FG001|Overall Study|Adverse Event|1|||
164045787|NCT00118040|592528582|FG002|Overall Study|Adverse Event|0|||
164045788|NCT00118040|592528580|FG000|Overall Study|Withdrawal by Subject|0|||
164045789|NCT00118040|592528581|FG001|Overall Study|Withdrawal by Subject|0|||
164045790|NCT00118040|592528582|FG002|Overall Study|Withdrawal by Subject|2|||
164045791|NCT00118040|592528580|FG000|Overall Study|Medical Contraindication|0|||
164045792|NCT00118040|592528581|FG001|Overall Study|Medical Contraindication|0|||
164045793|NCT00118040|592528582|FG002|Overall Study|Medical Contraindication|1|||
164045794|NCT00118040|592528580|FG000|Overall Study|Non-Compliant Participant|1|||
164045795|NCT00118040|592528581|FG001|Overall Study|Non-Compliant Participant|1|||
164045796|NCT00118040|592528582|FG002|Overall Study|Non-Compliant Participant|2|||
164045797|NCT00118040|592528580|FG000|Overall Study|Other|0|||
164045798|NCT00118040|592528581|FG001|Overall Study|Other|0|||
164045799|NCT00118040|592528582|FG002|Overall Study|Other|1|||
164045800|NCT02865928|592528583|FG000|Overall Study|Withdrawal by Subject|1|||
164045801|NCT02865928|592528584|FG001|Overall Study|Withdrawal by Subject|0|||
164045802|NCT02865928|592528583|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
164045803|NCT02865928|592528584|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
164045804|NCT02865928|592528583|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
164045805|NCT02865928|592528584|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
164045806|NCT01196091|592528588|FG000|Overall Study|Adverse Event|22|||
164045807|NCT01196091|592528589|FG001|Overall Study|Adverse Event|27|||
164045808|NCT01196091|592528590|FG002|Overall Study|Adverse Event|26|||
164045809|NCT01196091|592528588|FG000|Overall Study|Death|3|||
164045810|NCT01196091|592528589|FG001|Overall Study|Death|2|||
164045811|NCT01196091|592528590|FG002|Overall Study|Death|2|||
164045812|NCT01196091|592528588|FG000|Overall Study|Entry Criteria Not Met|11|||
164045813|NCT01196091|592528589|FG001|Overall Study|Entry Criteria Not Met|11|||
164045814|NCT01196091|592528590|FG002|Overall Study|Entry Criteria Not Met|10|||
164045815|NCT01196091|592528588|FG000|Overall Study|Lack of Efficacy|15|||
164045816|NCT01196091|592528589|FG001|Overall Study|Lack of Efficacy|12|||
164045817|NCT01196091|592528590|FG002|Overall Study|Lack of Efficacy|17|||
164045818|NCT01196091|592528588|FG000|Overall Study|Lost to Follow-up|5|||
164045819|NCT01196091|592528589|FG001|Overall Study|Lost to Follow-up|5|||
164045820|NCT01196091|592528590|FG002|Overall Study|Lost to Follow-up|6|||
164045821|NCT01196091|592528588|FG000|Overall Study|Parent/Caregiver Decision|0|||
164045822|NCT01196091|592528589|FG001|Overall Study|Parent/Caregiver Decision|0|||
164045823|NCT01196091|592528590|FG002|Overall Study|Parent/Caregiver Decision|1|||
164045824|NCT01196091|592528588|FG000|Overall Study|Withdrawal by Subject|16|||
164045825|NCT01196091|592528589|FG001|Overall Study|Withdrawal by Subject|19|||
164045826|NCT01196091|592528590|FG002|Overall Study|Withdrawal by Subject|22|||
164045827|NCT01196091|592528588|FG000|Overall Study|Physician Decision|3|||
164045828|NCT01196091|592528589|FG001|Overall Study|Physician Decision|3|||
164045829|NCT01196091|592528590|FG002|Overall Study|Physician Decision|4|||
164045830|NCT01196091|592528588|FG000|Overall Study|Protocol Violation|1|||
164045831|NCT01196091|592528589|FG001|Overall Study|Protocol Violation|3|||
164045832|NCT01196091|592528590|FG002|Overall Study|Protocol Violation|3|||
164045833|NCT01196091|592528588|FG000|Overall Study|Sponsor Decision|6|||
164045834|NCT01196091|592528589|FG001|Overall Study|Sponsor Decision|5|||
164045835|NCT01196091|592528590|FG002|Overall Study|Sponsor Decision|4|||
164045836|NCT01196091|592528588|FG000|Overall Study|Excluded Site|5|||
164045837|NCT01196091|592528589|FG001|Overall Study|Excluded Site|11|||
164045838|NCT01196091|592528590|FG002|Overall Study|Excluded Site|8|||
164045839|NCT01196091|592528588|FG000|Overall Study|Randomized, No Study Drug Received|1|||
164045840|NCT01196091|592528589|FG001|Overall Study|Randomized, No Study Drug Received|0|||
164045841|NCT01196091|592528590|FG002|Overall Study|Randomized, No Study Drug Received|1|||
164045842|NCT03733249|592528591|FG000|Overall Study|Death|7|||
164045843|NCT03733249|592528591|FG000|Overall Study|Disease relapse|16|||
164045844|NCT03733249|592528591|FG000|Overall Study|Lost to Follow-up|4|||
164045845|NCT03733249|592528591|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
164045846|NCT03733249|592528591|FG000|Overall Study|Withdrawal by Subject|1|||
164045847|NCT04476108|592528592|FG000|Overall Study|Adverse Event|4|||
164045848|NCT04476108|592528593|FG001|Overall Study|Adverse Event|1|||
164045849|NCT04476108|592528592|FG000|Overall Study|Lost to Follow-up|1|||
164045850|NCT04476108|592528593|FG001|Overall Study|Lost to Follow-up|0|||
164045851|NCT04476108|592528592|FG000|Overall Study|Inadvertent Enrollment|1|||
164148530|NCT01823835|592904901|FG009|Overall Study|Study Termination|0|||
164099134|NCT04089735|592728818|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
164099135|NCT04089735|592728819|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
164099136|NCT04089735|592728820|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
164099137|NCT04123548|592728825|FG000|Overall Study|Withdrawal by Subject|1|||
164099138|NCT04123548|592728825|FG000|Overall Study|Lost to Follow-up|8|||
164099139|NCT04123548|592728825|FG000|Overall Study|Death|4|||
164099140|NCT04123548|592728825|FG000|Overall Study|Reason Not Specified|1|||
164099141|NCT02956460|592728826|FG000|Lens 1|Lost to Follow-up|1|||
164099142|NCT02956460|592728827|FG001|Lens 1|Lost to Follow-up|0|||
164099143|NCT00851877|592728828|FG000|Phase I-1|Death|1|||
164099144|NCT00851877|592728829|FG001|Phase I-1|Death|0|||
164099145|NCT00851877|592728830|FG002|Phase I-1|Death|0|||
164099146|NCT00851877|592728828|FG000|Phase II|Withdrawal by Subject|0|||
164099147|NCT00851877|592728829|FG001|Phase II|Withdrawal by Subject|0|||
164099148|NCT00851877|592728830|FG002|Phase II|Withdrawal by Subject|3|||
164099149|NCT02440711|592728831|FG000|Second Intervention|Lost to Follow-up|1|||
164099150|NCT02440711|592728832|FG001|Second Intervention|Lost to Follow-up|0|||
164045852|NCT04476108|592528593|FG001|Overall Study|Inadvertent Enrollment|0|||
164045853|NCT04476108|592528592|FG000|Overall Study|Protocol Violation|1|||
164045854|NCT04476108|592528593|FG001|Overall Study|Protocol Violation|1|||
164045855|NCT04476108|592528592|FG000|Overall Study|Withdrawal by Subject|1|||
164045856|NCT04476108|592528593|FG001|Overall Study|Withdrawal by Subject|1|||
164045857|NCT00850135|592528594|FG000|Overall Study|Physician Decision|1|||
164045858|NCT02253992|592528595|FG000|Overall Study|Study drug toxicity|1|||
164045859|NCT02253992|592528596|FG001|Overall Study|Study drug toxicity|0|||
164045860|NCT02253992|592528597|FG002|Overall Study|Study drug toxicity|10|||
164045861|NCT02253992|592528595|FG000|Overall Study|Disease progression|4|||
164045862|NCT02253992|592528596|FG001|Overall Study|Disease progression|3|||
164045863|NCT02253992|592528597|FG002|Overall Study|Disease progression|98|||
164045864|NCT02253992|592528595|FG000|Overall Study|Withdrawal by Subject|0|||
164045865|NCT02253992|592528596|FG001|Overall Study|Withdrawal by Subject|0|||
164045866|NCT02253992|592528597|FG002|Overall Study|Withdrawal by Subject|3|||
164045867|NCT02253992|592528595|FG000|Overall Study|Adverse Event|0|||
164045868|NCT02253992|592528596|FG001|Overall Study|Adverse Event|0|||
164045869|NCT02253992|592528597|FG002|Overall Study|Adverse Event|8|||
164045870|NCT02253992|592528595|FG000|Overall Study|Death|0|||
164045871|NCT02253992|592528596|FG001|Overall Study|Death|0|||
164045872|NCT02253992|592528597|FG002|Overall Study|Death|1|||
164045873|NCT02253992|592528595|FG000|Overall Study|Subject discontinued study drug|1|||
164045874|NCT02253992|592528596|FG001|Overall Study|Subject discontinued study drug|0|||
164045875|NCT02253992|592528597|FG002|Overall Study|Subject discontinued study drug|1|||
164045876|NCT02253992|592528595|FG000|Overall Study|Completed treatment as per protocol|0|||
164045877|NCT02253992|592528596|FG001|Overall Study|Completed treatment as per protocol|1|||
164045878|NCT02253992|592528597|FG002|Overall Study|Completed treatment as per protocol|22|||
164045879|NCT02253992|592528595|FG000|Overall Study|Other|0|||
164045880|NCT02253992|592528596|FG001|Overall Study|Other|0|||
164099151|NCT00573066|592728833|FG000|Overall Study|Exclusion criteria|18|||
164099152|NCT00573066|592728833|FG000|Overall Study|IV malfunction|1|||
164099153|NCT00573066|592728833|FG000|Overall Study|Postoperative bleeding|1|||
163842411|NCT02736968|591793006|FG007|Overall Study|Lost to Follow-up|2|||
163842412|NCT02736968|591792999|FG000|Overall Study|COVID-19 Pandemic|0|||
163842413|NCT02736968|591793000|FG001|Overall Study|COVID-19 Pandemic|0|||
163842414|NCT02736968|591793001|FG002|Overall Study|COVID-19 Pandemic|0|||
163842415|NCT02736968|591793002|FG003|Overall Study|COVID-19 Pandemic|0|||
163842416|NCT02736968|591793003|FG004|Overall Study|COVID-19 Pandemic|0|||
163842417|NCT02736968|591793004|FG005|Overall Study|COVID-19 Pandemic|0|||
163842418|NCT02736968|591793005|FG006|Overall Study|COVID-19 Pandemic|2|||
163842419|NCT02736968|591793006|FG007|Overall Study|COVID-19 Pandemic|0|||
163842420|NCT02736968|591792999|FG000|Overall Study|Withdrawal by Subject|0|||
163842421|NCT02736968|591793000|FG001|Overall Study|Withdrawal by Subject|0|||
163842422|NCT02736968|591793001|FG002|Overall Study|Withdrawal by Subject|0|||
163842423|NCT02736968|591793002|FG003|Overall Study|Withdrawal by Subject|0|||
163842424|NCT02736968|591793003|FG004|Overall Study|Withdrawal by Subject|0|||
163842425|NCT02736968|591793004|FG005|Overall Study|Withdrawal by Subject|0|||
163842426|NCT02736968|591793005|FG006|Overall Study|Withdrawal by Subject|1|||
163842427|NCT02736968|591793006|FG007|Overall Study|Withdrawal by Subject|0|||
163842428|NCT03342053|591793007|FG000|Overall Study|Adverse Event|2|||
163842429|NCT03342053|591793008|FG001|Overall Study|Adverse Event|0|||
163842430|NCT03342053|591793007|FG000|Overall Study|Withdrawal by Subject|0|||
163842431|NCT03342053|591793008|FG001|Overall Study|Withdrawal by Subject|1|||
163842432|NCT02294474|591793009|FG000|Overall Study|Adverse Event|7|||
163842433|NCT02294474|591793010|FG001|Overall Study|Adverse Event|7|||
163842434|NCT02294474|591793009|FG000|Overall Study|Lack of Efficacy|2|||
163842435|NCT02294474|591793010|FG001|Overall Study|Lack of Efficacy|1|||
163842436|NCT02294474|591793009|FG000|Overall Study|Protocol Violation|4|||
163842437|NCT02294474|591793010|FG001|Overall Study|Protocol Violation|2|||
164045881|NCT02253992|592528597|FG002|Overall Study|Other|1|||
164045882|NCT00471276|592528598|FG000|Overall Study|Death|2|||
164045883|NCT00471276|592528598|FG000|Overall Study|Adverse Event|16|||
164045884|NCT00471276|592528598|FG000|Overall Study|Protocol Violation|1|||
164045885|NCT00471276|592528598|FG000|Overall Study|Objective progression or relapse|54|||
164045886|NCT00471276|592528598|FG000|Overall Study|Global deterioration of health status|1|||
164045887|NCT00471276|592528598|FG000|Overall Study|Other|3|||
164045888|NCT00471276|592528598|FG000|Overall Study|Refused treatment|6|||
164045889|NCT02324049|592528605|FG000|Part C|Study terminated|11|||
164045890|NCT02159365|592528606|FG000|Overall Study|Disease Progression|23|||
164045891|NCT02159365|592528606|FG000|Overall Study|Other reasons|11|||
164045892|NCT02159365|592528606|FG000|Overall Study|Administrative reason by Sponsor|9|||
164045893|NCT02159365|592528606|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
164045894|NCT02159365|592528606|FG000|Overall Study|Study drug toxicity|7|||
164045895|NCT02159365|592528606|FG000|Overall Study|Maximum clinical benefit|3|||
164045896|NCT02159365|592528606|FG000|Overall Study|Subject request to discontinue treatment|3|||
164045897|NCT02159365|592528606|FG000|Overall Study|Subject withdrew consent|3|||
164045898|NCT02159365|592528606|FG000|Overall Study|Death|1|||
164045899|NCT02159365|592528606|FG000|Overall Study|Lost to Follow-up|1|||
164045900|NCT03198728|592528607|FG000|Overall Study|Adverse Event|10|||
164045901|NCT03198728|592528608|FG001|Overall Study|Adverse Event|5|||
164045902|NCT03198728|592528607|FG000|Overall Study|Lost to Follow-up|21|||
164045903|NCT03198728|592528608|FG001|Overall Study|Lost to Follow-up|7|||
164045904|NCT03198728|592528607|FG000|Overall Study|Physician Decision|7|||
164045905|NCT03198728|592528608|FG001|Overall Study|Physician Decision|2|||
164045906|NCT03198728|592528607|FG000|Overall Study|Withdrawal by Subject|14|||
164045907|NCT03198728|592528608|FG001|Overall Study|Withdrawal by Subject|10|||
164045908|NCT04051944|592528609|FG000|Overall Study|Study ending|1|||
164045909|NCT04051944|592528610|FG001|Overall Study|Study ending|1|||
164045910|NCT04051944|592528609|FG000|Overall Study|Early study termination by participant|1|||
164045911|NCT04051944|592528610|FG001|Overall Study|Early study termination by participant|0|||
164045912|NCT04051944|592528609|FG000|Overall Study|Withdrawal by Subject|2|||
164045913|NCT04051944|592528610|FG001|Overall Study|Withdrawal by Subject|2|||
164045914|NCT04051944|592528609|FG000|Overall Study|Lack of Efficacy|3|||
164045915|NCT04051944|592528610|FG001|Overall Study|Lack of Efficacy|0|||
164045916|NCT04051944|592528609|FG000|Overall Study|Adverse event, non- fatal|1|||
164045917|NCT04051944|592528610|FG001|Overall Study|Adverse event, non- fatal|1|||
164045918|NCT03083470|592528611|FG000|Overall Study|Lost to Follow-up|0|||
164045919|NCT03083470|592528612|FG001|Overall Study|Lost to Follow-up|0|||
164045920|NCT03083470|592528613|FG002|Overall Study|Lost to Follow-up|0|||
164045921|NCT03083470|592528614|FG003|Overall Study|Lost to Follow-up|0|||
164045922|NCT03083470|592528615|FG004|Overall Study|Lost to Follow-up|1|||
164045923|NCT03083470|592528611|FG000|Overall Study|Withdrawal by Subject|0|||
164045924|NCT03083470|592528612|FG001|Overall Study|Withdrawal by Subject|0|||
164045925|NCT03083470|592528613|FG002|Overall Study|Withdrawal by Subject|0|||
164045926|NCT03083470|592528614|FG003|Overall Study|Withdrawal by Subject|0|||
164045927|NCT03083470|592528615|FG004|Overall Study|Withdrawal by Subject|1|||
164045928|NCT01512693|592528616|FG000|Overall Study|Withdrawal by Subject|0|||
164045929|NCT01512693|592528617|FG001|Overall Study|Withdrawal by Subject|1|||
164045930|NCT02139280|592528618|FG000|Overall Study|No longer eligible|2|||
164045931|NCT02139280|592528619|FG001|Overall Study|No longer eligible|0|||
164045932|NCT00736450|592528626|FG000|Overall Study|Not ABC gene eligible|19|||
164045933|NCT00736450|592528626|FG000|Overall Study|Withdrawal by Subject|5|||
164045934|NCT00736450|592528626|FG000|Overall Study|Physician Decision|1|||
164045935|NCT04157751|592528630|FG000|Overall Study|Withdrawal by Subject|12|||
164045936|NCT04157751|592528631|FG001|Overall Study|Withdrawal by Subject|17|||
164045937|NCT04157751|592528630|FG000|Overall Study|Lost to Follow-up|6|||
164045938|NCT04157751|592528631|FG001|Overall Study|Lost to Follow-up|2|||
164045939|NCT04157751|592528630|FG000|Overall Study|Adverse Event|34|||
164045940|NCT04157751|592528631|FG001|Overall Study|Adverse Event|23|||
164045941|NCT04157751|592528630|FG000|Overall Study|Not treated|1|||
164045942|NCT04157751|592528631|FG001|Overall Study|Not treated|5|||
164045943|NCT04157751|592528630|FG000|Overall Study|Other reason not stated above|10|||
164045944|NCT04157751|592528631|FG001|Overall Study|Other reason not stated above|10|||
164045945|NCT04731922|592528632|FG000|Overall Study|Adverse Event|0|||
164045946|NCT04731922|592528633|FG001|Overall Study|Adverse Event|0|||
164045947|NCT04731922|592528634|FG002|Overall Study|Adverse Event|0|||
164045948|NCT04731922|592528635|FG003|Overall Study|Adverse Event|0|||
164045949|NCT04731922|592528636|FG004|Overall Study|Adverse Event|0|||
164045950|NCT04731922|592528637|FG005|Overall Study|Adverse Event|0|||
163842438|NCT02294474|591793009|FG000|Overall Study|Other than specified above|12|||
163842439|NCT02294474|591793010|FG001|Overall Study|Other than specified above|12|||
163842440|NCT02961374|591793011|FG000|Overall Study|Adverse Event|4|||
163842441|NCT00171873|591793012|FG000|Overall Study|Withdrawal by Subject|4|||
163842442|NCT00171873|591793013|FG001|Overall Study|Withdrawal by Subject|2|||
163842443|NCT00171873|591793012|FG000|Overall Study|Adverse Event|5|||
163842444|NCT00171873|591793013|FG001|Overall Study|Adverse Event|0|||
163842445|NCT00171873|591793012|FG000|Overall Study|Switched to Octreotide|0|||
164099154|NCT04129346|592728834|FG000|Overall Study|Death|1|||
164099155|NCT04129346|592728835|FG001|Overall Study|Death|0|||
164099156|NCT05755282|592728836|FG000|Overall Study|Protocol Violation|0|||
164099157|NCT05755282|592728837|FG001|Overall Study|Protocol Violation|1|||
164099158|NCT00627016|592728840|FG000|Overall Study|Adverse Event|1|||
164099159|NCT00627016|592728841|FG001|Overall Study|Adverse Event|1|||
164099160|NCT00627016|592728840|FG000|Overall Study|Protocol Violation|0|||
164099161|NCT00627016|592728841|FG001|Overall Study|Protocol Violation|2|||
164099162|NCT00627016|592728840|FG000|Overall Study|Lost to Follow-up|0|||
164099163|NCT00627016|592728841|FG001|Overall Study|Lost to Follow-up|1|||
164099164|NCT00627016|592728840|FG000|Overall Study|Withdrawal by Subject|2|||
164099165|NCT00627016|592728841|FG001|Overall Study|Withdrawal by Subject|1|||
164099166|NCT00627016|592728840|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
164099167|NCT00627016|592728841|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
164099168|NCT00627016|592728840|FG000|Overall Study|Lack of Efficacy|1|||
164099169|NCT00627016|592728841|FG001|Overall Study|Lack of Efficacy|0|||
164099170|NCT00627016|592728840|FG000|Overall Study|Placed on Excluded Drugs|1|||
164099171|NCT00627016|592728841|FG001|Overall Study|Placed on Excluded Drugs|0|||
164099172|NCT00627016|592728840|FG000|Overall Study|Pregnancy|1|||
164099173|NCT00627016|592728841|FG001|Overall Study|Pregnancy|0|||
164099174|NCT04088760|592728842|FG000|Overall Study|Physician Decision|1|||
164099175|NCT03025880|592728843|FG000|Overall Study|Adverse Event|1|||
164099176|NCT03025880|592728844|FG001|Overall Study|Adverse Event|0|||
164099177|NCT03025880|592728843|FG000|Overall Study|Death|1|||
164099178|NCT03025880|592728844|FG001|Overall Study|Death|1|||
164099179|NCT03025880|592728843|FG000|Overall Study|Withdrawal by Subject|0|||
164099180|NCT03025880|592728844|FG001|Overall Study|Withdrawal by Subject|1|||
164099181|NCT03025880|592728843|FG000|Overall Study|Physician Decision|0|||
164099182|NCT03025880|592728844|FG001|Overall Study|Physician Decision|1|||
164099183|NCT03025880|592728843|FG000|Overall Study|Progressive Disease|12|||
164099184|NCT03025880|592728844|FG001|Overall Study|Progressive Disease|19|||
164099185|NCT01185548|592728846|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
164099186|NCT00086996|592728847|FG000|Overall Study|Adverse Event|29|||
164099187|NCT00086996|592728847|FG000|Overall Study|Death|4|||
164099188|NCT00086996|592728847|FG000|Overall Study|progression/relapse|7|||
164099189|NCT00086996|592728847|FG000|Overall Study|Withdrawal by Subject|13|||
164099190|NCT00086996|592728847|FG000|Overall Study|Other|6|||
164099191|NCT00086996|592728847|FG000|Overall Study|not eligible|5|||
163946257|NCT00307684|592172349|FG000|Open Label Phase|Lost to Follow-up|0|||
164099192|NCT01422538|592728849|FG000|Overall Study|Lost to Follow-up|0|||
164099193|NCT01422538|592728850|FG001|Overall Study|Lost to Follow-up|1|||
164099194|NCT01422538|592728851|FG002|Overall Study|Lost to Follow-up|1|||
163946258|NCT00307684|592172350|FG001|Open Label Phase|Lost to Follow-up|0|||
163946259|NCT00307684|592172351|FG002|Open Label Phase|Lost to Follow-up|11|||
163946260|NCT00307684|592172349|FG000|Open Label Phase|non compliance|0|||
163946261|NCT00307684|592172350|FG001|Open Label Phase|non compliance|0|||
163946262|NCT00307684|592172351|FG002|Open Label Phase|non compliance|5|||
163946263|NCT00307684|592172349|FG000|Open Label Phase|other|0|||
163946264|NCT00307684|592172350|FG001|Open Label Phase|other|0|||
163946265|NCT00307684|592172351|FG002|Open Label Phase|other|6|||
163946266|NCT00307684|592172349|FG000|Double Blind Phase|Lack of Efficacy|2|||
163946267|NCT00307684|592172350|FG001|Double Blind Phase|Lack of Efficacy|5|||
163946268|NCT00307684|592172351|FG002|Double Blind Phase|Lack of Efficacy|0|||
163946269|NCT00356408|592172352|FG000|Overall Study|Adverse Event|9|||
163946270|NCT00356408|592172352|FG000|Overall Study|Lack of Efficacy|36|||
163946271|NCT00356408|592172352|FG000|Overall Study|Lost to Follow-up|2|||
163946272|NCT00356408|592172352|FG000|Overall Study|Withdrawal by Subject|6|||
163946273|NCT00356408|592172352|FG000|Overall Study|Other: Principal investigator discretion|3|||
163946274|NCT00356408|592172352|FG000|Overall Study|Other: Sponsor request|1|||
163946275|NCT00356408|592172352|FG000|Overall Study|Other: Azathioprine stopped|1|||
163946276|NCT00356408|592172352|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
163946277|NCT00356408|592172352|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
163946278|NCT05487586|592172353|FG000|Overall Study|Death|22|||
163946279|NCT05487586|592172353|FG000|Overall Study|Physician Decision|1|||
163946280|NCT05487586|592172353|FG000|Overall Study|Transfer to another hospital|4|||
163946281|NCT05487586|592172353|FG000|Overall Study|Other|1|||
163946282|NCT03223662|592172357|FG000|Overall Study|Physician Decision|1|||
163946283|NCT03223662|592172357|FG000|Overall Study|Study closure|1|||
163946284|NCT00528931|592172358|FG000|Overall Study|Lost to Follow-up|1|||
163946285|NCT00992225|592172359|FG000|Overall Study|Entry Criteria Not Met|8|||
163946286|NCT00992225|592172359|FG000|Overall Study|Adverse Event|2|||
163946287|NCT03122223|592172360|FG000|Overall Study|Withdrawal by Subject|2|||
164099195|NCT01422538|592728849|FG000|Overall Study|Missed visit|0|||
164099196|NCT01422538|592728850|FG001|Overall Study|Missed visit|1|||
164099197|NCT01422538|592728851|FG002|Overall Study|Missed visit|1|||
164099198|NCT02770820|592728852|FG000|Overall Study|Death|1|||
164099199|NCT02770820|592728852|FG000|Overall Study|Physician Decision|2|||
164099200|NCT00312663|592728853|FG000|Immunization Phase|Adverse Event|0|||
164099201|NCT00312663|592728854|FG001|Immunization Phase|Adverse Event|1|||
163842446|NCT00171873|591793013|FG001|Overall Study|Switched to Octreotide|1|||
163842447|NCT02041923|591793014|FG000|Overall Study|Lost to Follow-up|26|||
163842448|NCT02041923|591793015|FG001|Overall Study|Lost to Follow-up|30|||
163842449|NCT02023879|591793019|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
163842450|NCT02023879|591793020|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
164045951|NCT04731922|592528638|FG006|Overall Study|Adverse Event|0|||
164045952|NCT04731922|592528639|FG007|Overall Study|Adverse Event|0|||
164045953|NCT04731922|592528640|FG008|Overall Study|Adverse Event|0|||
164045954|NCT04731922|592528641|FG009|Overall Study|Adverse Event|0|||
164045955|NCT04731922|592528642|FG010|Overall Study|Adverse Event|1|||
164045956|NCT04731922|592528643|FG011|Overall Study|Adverse Event|0|||
164045957|NCT04731922|592528644|FG012|Overall Study|Adverse Event|0|||
164045958|NCT04731922|592528645|FG013|Overall Study|Adverse Event|0|||
164045959|NCT04731922|592528646|FG014|Overall Study|Adverse Event|0|||
164045960|NCT04731922|592528647|FG015|Overall Study|Adverse Event|0|||
164045961|NCT04731922|592528648|FG016|Overall Study|Adverse Event|0|||
164045962|NCT04731922|592528632|FG000|Overall Study|Lost to Follow-up|0|||
164045963|NCT04731922|592528633|FG001|Overall Study|Lost to Follow-up|0|||
164045964|NCT04731922|592528634|FG002|Overall Study|Lost to Follow-up|0|||
164045965|NCT04731922|592528635|FG003|Overall Study|Lost to Follow-up|1|||
164045966|NCT04731922|592528636|FG004|Overall Study|Lost to Follow-up|0|||
164045967|NCT04731922|592528637|FG005|Overall Study|Lost to Follow-up|1|||
164045968|NCT04731922|592528638|FG006|Overall Study|Lost to Follow-up|0|||
164045969|NCT04731922|592528639|FG007|Overall Study|Lost to Follow-up|0|||
164045970|NCT04731922|592528640|FG008|Overall Study|Lost to Follow-up|0|||
164045971|NCT04731922|592528641|FG009|Overall Study|Lost to Follow-up|0|||
164045972|NCT04731922|592528642|FG010|Overall Study|Lost to Follow-up|0|||
164045973|NCT04731922|592528643|FG011|Overall Study|Lost to Follow-up|0|||
164045974|NCT04731922|592528644|FG012|Overall Study|Lost to Follow-up|0|||
164045975|NCT04731922|592528645|FG013|Overall Study|Lost to Follow-up|0|||
164045976|NCT04731922|592528646|FG014|Overall Study|Lost to Follow-up|0|||
164045977|NCT04731922|592528647|FG015|Overall Study|Lost to Follow-up|0|||
164045978|NCT04731922|592528648|FG016|Overall Study|Lost to Follow-up|0|||
164045979|NCT04731922|592528632|FG000|Overall Study|Withdrawal by Subject|1|||
164045980|NCT04731922|592528633|FG001|Overall Study|Withdrawal by Subject|0|||
164045981|NCT04731922|592528634|FG002|Overall Study|Withdrawal by Subject|0|||
164045982|NCT04731922|592528635|FG003|Overall Study|Withdrawal by Subject|0|||
164045983|NCT04731922|592528636|FG004|Overall Study|Withdrawal by Subject|1|||
164045984|NCT04731922|592528637|FG005|Overall Study|Withdrawal by Subject|0|||
164045985|NCT04731922|592528638|FG006|Overall Study|Withdrawal by Subject|1|||
164045986|NCT04731922|592528639|FG007|Overall Study|Withdrawal by Subject|0|||
164045987|NCT04731922|592528640|FG008|Overall Study|Withdrawal by Subject|0|||
164045988|NCT04731922|592528641|FG009|Overall Study|Withdrawal by Subject|0|||
164045989|NCT04731922|592528642|FG010|Overall Study|Withdrawal by Subject|0|||
164045990|NCT04731922|592528643|FG011|Overall Study|Withdrawal by Subject|0|||
164045991|NCT04731922|592528644|FG012|Overall Study|Withdrawal by Subject|0|||
164045992|NCT04731922|592528645|FG013|Overall Study|Withdrawal by Subject|1|||
164045993|NCT04731922|592528646|FG014|Overall Study|Withdrawal by Subject|0|||
164045994|NCT04731922|592528647|FG015|Overall Study|Withdrawal by Subject|0|||
164045995|NCT04731922|592528648|FG016|Overall Study|Withdrawal by Subject|0|||
164045996|NCT04731922|592528632|FG000|Overall Study|Other|0|||
164045997|NCT04731922|592528633|FG001|Overall Study|Other|0|||
164045998|NCT04731922|592528634|FG002|Overall Study|Other|0|||
164045999|NCT04731922|592528635|FG003|Overall Study|Other|0|||
164046000|NCT04731922|592528636|FG004|Overall Study|Other|0|||
164046001|NCT04731922|592528637|FG005|Overall Study|Other|0|||
164046002|NCT04731922|592528638|FG006|Overall Study|Other|1|||
164046003|NCT04731922|592528639|FG007|Overall Study|Other|0|||
164046004|NCT04731922|592528640|FG008|Overall Study|Other|0|||
164046005|NCT04731922|592528641|FG009|Overall Study|Other|0|||
164046006|NCT04731922|592528642|FG010|Overall Study|Other|0|||
164046007|NCT04731922|592528643|FG011|Overall Study|Other|0|||
164046008|NCT04731922|592528644|FG012|Overall Study|Other|0|||
164046009|NCT04731922|592528645|FG013|Overall Study|Other|0|||
164046010|NCT04731922|592528646|FG014|Overall Study|Other|0|||
164046011|NCT04731922|592528647|FG015|Overall Study|Other|0|||
164099202|NCT00312663|592728855|FG002|Immunization Phase|Adverse Event|0|||
164099203|NCT00376623|592728856|FG000|Overall Study|Progressive disease|35|||
164046012|NCT04731922|592528648|FG016|Overall Study|Other|0|||
164046013|NCT00981747|592528655|FG000|Losartan|Withdrawal by Subject|1|||
164046014|NCT00981747|592528655|FG000|Losartan|Death|1|||
164046015|NCT00981747|592528655|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
164046016|NCT03148795|592528663|FG000|Overall Study|Progressive Disease|1|||
164099204|NCT00376623|592728857|FG001|Overall Study|Progressive disease|22|||
164046017|NCT00441012|592528664|FG000|Overall Study|Adverse Event|0|||
164046018|NCT00441012|592528665|FG001|Overall Study|Adverse Event|1|||
164046019|NCT00441012|592528664|FG000|Overall Study|Lost to Follow-up|3|||
164046020|NCT00441012|592528665|FG001|Overall Study|Lost to Follow-up|3|||
164046021|NCT00441012|592528664|FG000|Overall Study|Protocol Violation|10|||
164046022|NCT00441012|592528665|FG001|Overall Study|Protocol Violation|9|||
164099205|NCT00376623|592728858|FG002|Overall Study|Progressive disease|17|||
164046023|NCT00441012|592528664|FG000|Overall Study|Withdrawal by Subject|4|||
164046024|NCT00441012|592528665|FG001|Overall Study|Withdrawal by Subject|0|||
164046025|NCT00441012|592528664|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
164046026|NCT00441012|592528665|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
164046027|NCT04489940|592528666|FG000|Overall Study|Other|2|||
164046028|NCT04489940|592528666|FG000|Overall Study|Withdrawal by Subject|2|||
164046029|NCT04489940|592528666|FG000|Overall Study|Death|5|||
164046030|NCT04489940|592528666|FG000|Overall Study|Lost to Follow-up|1|||
164046031|NCT04498468|592528667|FG000|Overall Study|Lost to Follow-up|3|||
164046032|NCT02092324|592528668|FG000|Overall Study|Adverse Event|1|||
164046033|NCT02092324|592528668|FG000|Overall Study|Lack of Efficacy|6|||
164046034|NCT02092324|592528668|FG000|Overall Study|Proceed to Transplant|3|||
164046035|NCT02092324|592528668|FG000|Overall Study|Physician Decision|7|||
164046036|NCT02092324|592528668|FG000|Overall Study|Misdiagnosis|2|||
164046037|NCT02224274|592528670|FG000|Overall Study|Death|1|||
164046038|NCT02224274|592528671|FG001|Overall Study|Death|0|||
164046039|NCT00499460|592528672|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
164046040|NCT00499460|592528673|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
164046041|NCT00499460|592528672|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
164046042|NCT00499460|592528673|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
164046043|NCT00499460|592528672|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
164046044|NCT00499460|592528673|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
164046045|NCT00887068|592528674|FG000|Overall Study|Withdrawal by Subject|2|||
164046046|NCT00887068|592528675|FG001|Overall Study|Withdrawal by Subject|0|||
164046047|NCT00887068|592528674|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
164046048|NCT00887068|592528675|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
164046049|NCT00090766|592528683|FG000|Overall Study|Nephrectomy Planned|0|||
164046050|NCT00090766|592528684|FG001|Overall Study|Nephrectomy Planned|0|||
164046051|NCT00090766|592528685|FG002|Overall Study|Nephrectomy Planned|1|||
164046052|NCT00090766|592528683|FG000|Overall Study|Death|1|||
164046053|NCT00090766|592528684|FG001|Overall Study|Death|0|||
164046054|NCT00090766|592528685|FG002|Overall Study|Death|0|||
164046055|NCT00090766|592528683|FG000|Overall Study|Admin|0|||
164046056|NCT00090766|592528684|FG001|Overall Study|Admin|2|||
164046057|NCT00090766|592528685|FG002|Overall Study|Admin|0|||
164046058|NCT00090766|592528683|FG000|Overall Study|Lost to Follow-up|2|||
164046059|NCT00090766|592528684|FG001|Overall Study|Lost to Follow-up|0|||
164046060|NCT00090766|592528685|FG002|Overall Study|Lost to Follow-up|2|||
164046061|NCT00804986|592528686|FG000|Overall Study|Adverse Event|0|||
164046062|NCT00804986|592528687|FG001|Overall Study|Adverse Event|1|||
164046063|NCT00804986|592528688|FG002|Overall Study|Adverse Event|2|||
164046064|NCT00804986|592528689|FG003|Overall Study|Adverse Event|1|||
164046065|NCT00804986|592528690|FG004|Overall Study|Adverse Event|3|||
164046066|NCT00804986|592528691|FG005|Overall Study|Adverse Event|0|||
164046067|NCT00804986|592528686|FG000|Overall Study|Lack of Efficacy|0|||
164046068|NCT00804986|592528687|FG001|Overall Study|Lack of Efficacy|0|||
164046069|NCT00804986|592528688|FG002|Overall Study|Lack of Efficacy|0|||
164046070|NCT00804986|592528689|FG003|Overall Study|Lack of Efficacy|1|||
164046071|NCT00804986|592528690|FG004|Overall Study|Lack of Efficacy|0|||
164046072|NCT00804986|592528691|FG005|Overall Study|Lack of Efficacy|3|||
164046073|NCT00804986|592528686|FG000|Overall Study|Lost to Follow-up|0|||
164046074|NCT00804986|592528687|FG001|Overall Study|Lost to Follow-up|0|||
164046075|NCT00804986|592528688|FG002|Overall Study|Lost to Follow-up|0|||
164046076|NCT00804986|592528689|FG003|Overall Study|Lost to Follow-up|1|||
164046077|NCT00804986|592528690|FG004|Overall Study|Lost to Follow-up|1|||
164046078|NCT00804986|592528691|FG005|Overall Study|Lost to Follow-up|3|||
164046079|NCT00804986|592528686|FG000|Overall Study|Protocol Violation|0|||
164046080|NCT00804986|592528687|FG001|Overall Study|Protocol Violation|1|||
164046081|NCT00804986|592528688|FG002|Overall Study|Protocol Violation|0|||
164046082|NCT00804986|592528689|FG003|Overall Study|Protocol Violation|1|||
164046083|NCT00804986|592528690|FG004|Overall Study|Protocol Violation|0|||
164046084|NCT00804986|592528691|FG005|Overall Study|Protocol Violation|0|||
164099206|NCT00376623|592728856|FG000|Overall Study|Lost to Follow-up|0|||
164099207|NCT00376623|592728857|FG001|Overall Study|Lost to Follow-up|1|||
164046085|NCT00804986|592528686|FG000|Overall Study|Withdrawal by Subject|0|||
164099208|NCT00376623|592728858|FG002|Overall Study|Lost to Follow-up|0|||
164099209|NCT00376623|592728856|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
164046086|NCT00804986|592528687|FG001|Overall Study|Withdrawal by Subject|3|||
164046087|NCT00804986|592528688|FG002|Overall Study|Withdrawal by Subject|0|||
164046088|NCT00804986|592528689|FG003|Overall Study|Withdrawal by Subject|3|||
164046089|NCT00804986|592528690|FG004|Overall Study|Withdrawal by Subject|5|||
164046090|NCT00804986|592528691|FG005|Overall Study|Withdrawal by Subject|3|||
164046091|NCT00804986|592528686|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
164046092|NCT00804986|592528687|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
164046093|NCT00804986|592528688|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
164046094|NCT00804986|592528689|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
164046095|NCT00804986|592528690|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
164148531|NCT01823835|592904902|FG010|Overall Study|Study Termination|0|||
163946288|NCT03122223|592172361|FG001|Overall Study|Withdrawal by Subject|2|||
163946289|NCT03122223|592172362|FG002|Overall Study|Withdrawal by Subject|1|||
163946290|NCT03122223|592172363|FG003|Overall Study|Withdrawal by Subject|0|||
163946291|NCT03122223|592172360|FG000|Overall Study|Lost to Follow-up|0|||
163946292|NCT03122223|592172361|FG001|Overall Study|Lost to Follow-up|2|||
163946293|NCT03122223|592172362|FG002|Overall Study|Lost to Follow-up|2|||
163946294|NCT03122223|592172363|FG003|Overall Study|Lost to Follow-up|0|||
163946295|NCT03122223|592172360|FG000|Overall Study|Participant unable to adhere|1|||
163946296|NCT03122223|592172361|FG001|Overall Study|Participant unable to adhere|1|||
163946297|NCT03122223|592172362|FG002|Overall Study|Participant unable to adhere|1|||
163946298|NCT03122223|592172363|FG003|Overall Study|Participant unable to adhere|0|||
163946299|NCT03466073|592172364|FG000|Overall Study|Death|1|||
163946300|NCT03466073|592172365|FG001|Overall Study|Death|0|||
163946301|NCT03466073|592172366|FG002|Overall Study|Death|0|||
163946302|NCT03466073|592172367|FG003|Overall Study|Death|0|||
163946303|NCT03466073|592172368|FG004|Overall Study|Death|0|||
163946304|NCT03466073|592172369|FG005|Overall Study|Death|1|||
163946305|NCT02285153|592172370|FG000|Overall Study|Adverse Event|1|||
163946306|NCT02285153|592172371|FG001|Overall Study|Adverse Event|0|||
163946307|NCT02045875|592172376|FG000|Overall Study|Lost to Follow-up|3|||
163946308|NCT02045875|592172377|FG001|Overall Study|Lost to Follow-up|0|||
163946309|NCT02045875|592172376|FG000|Overall Study|Withdrawal by Subject|4|||
163946310|NCT02045875|592172377|FG001|Overall Study|Withdrawal by Subject|3|||
163946311|NCT01278173|592172380|FG000|Overall Study|Lack of Efficacy|13|||
163946312|NCT01278173|592172380|FG000|Overall Study|Adverse Event|8|||
163946313|NCT01278173|592172380|FG000|Overall Study|Administrative or other reason|4|||
163946314|NCT01278173|592172380|FG000|Overall Study|Protocol Violation|1|||
163946315|NCT01278173|592172380|FG000|Overall Study|Withdrawal by Subject|1|||
163946316|NCT02270515|592172381|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
163946317|NCT02270515|592172381|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
163946318|NCT02270515|592172381|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
163946319|NCT02270515|592172381|FG000|Intervention Period 1: 0-6 Months|Death|7|||
163946320|NCT02270515|592172381|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
163946321|NCT02270515|592172381|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
163946322|NCT02270515|592172381|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
163946323|NCT02270515|592172381|FG000|Intervention Period 2: 6-12 Months|Death|5|||
163946324|NCT02270515|592172381|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
163946325|NCT02270515|592172381|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
163946326|NCT02270515|592172381|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
163946327|NCT02270515|592172381|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
163946328|NCT02270515|592172381|FG000|Intervention Period 3: 12-18 Months|Death|3|||
163946329|NCT02270515|592172381|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
163946330|NCT01607476|592172384|FG000|Overall Study|Withdrawal by Subject|1|||
163946331|NCT01607476|592172385|FG001|Overall Study|Withdrawal by Subject|0|||
163946332|NCT01607476|592172386|FG002|Overall Study|Withdrawal by Subject|1|||
163946333|NCT01607476|592172384|FG000|Overall Study|Lost to Follow-up|0|||
163946334|NCT01607476|592172385|FG001|Overall Study|Lost to Follow-up|0|||
163946335|NCT01607476|592172386|FG002|Overall Study|Lost to Follow-up|2|||
163946336|NCT04445987|592172387|FG000|Overall Study|Adverse Event|0|||
163946337|NCT04445987|592172388|FG001|Overall Study|Adverse Event|0|||
163946338|NCT04445987|592172389|FG002|Overall Study|Adverse Event|1|||
163946339|NCT04445987|592172390|FG003|Overall Study|Adverse Event|0|||
163946340|NCT04445987|592172391|FG004|Overall Study|Adverse Event|4|||
163946341|NCT04445987|592172392|FG005|Overall Study|Adverse Event|0|||
164046096|NCT00804986|592528691|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
164046097|NCT00804986|592528686|FG000|Overall Study|Sponsor Decision|0|||
164046098|NCT00804986|592528687|FG001|Overall Study|Sponsor Decision|1|||
164046099|NCT00804986|592528688|FG002|Overall Study|Sponsor Decision|0|||
163946342|NCT04445987|592172387|FG000|Overall Study|Lost to Follow-up|4|||
163946343|NCT04445987|592172388|FG001|Overall Study|Lost to Follow-up|3|||
163946344|NCT04445987|592172389|FG002|Overall Study|Lost to Follow-up|1|||
163946345|NCT04445987|592172390|FG003|Overall Study|Lost to Follow-up|1|||
163946346|NCT04445987|592172391|FG004|Overall Study|Lost to Follow-up|29|||
163946347|NCT04445987|592172392|FG005|Overall Study|Lost to Follow-up|0|||
163946348|NCT04445987|592172387|FG000|Overall Study|Physician Decision|0|||
163946349|NCT04445987|592172388|FG001|Overall Study|Physician Decision|0|||
163946350|NCT04445987|592172389|FG002|Overall Study|Physician Decision|0|||
163946351|NCT04445987|592172390|FG003|Overall Study|Physician Decision|0|||
163946352|NCT04445987|592172391|FG004|Overall Study|Physician Decision|1|||
163946353|NCT04445987|592172392|FG005|Overall Study|Physician Decision|0|||
163946354|NCT04445987|592172387|FG000|Overall Study|Protocol Violation|1|||
163946355|NCT04445987|592172388|FG001|Overall Study|Protocol Violation|0|||
163946356|NCT04445987|592172389|FG002|Overall Study|Protocol Violation|0|||
163946357|NCT04445987|592172390|FG003|Overall Study|Protocol Violation|0|||
163946358|NCT04445987|592172391|FG004|Overall Study|Protocol Violation|2|||
164046100|NCT00804986|592528689|FG003|Overall Study|Sponsor Decision|0|||
164046101|NCT00804986|592528690|FG004|Overall Study|Sponsor Decision|0|||
164046102|NCT00804986|592528691|FG005|Overall Study|Sponsor Decision|0|||
164046103|NCT00804986|592528686|FG000|Overall Study|Physician Decision|1|||
164046104|NCT00804986|592528687|FG001|Overall Study|Physician Decision|0|||
164046105|NCT00804986|592528688|FG002|Overall Study|Physician Decision|0|||
164046106|NCT00804986|592528689|FG003|Overall Study|Physician Decision|0|||
164046107|NCT00804986|592528690|FG004|Overall Study|Physician Decision|0|||
164046108|NCT00804986|592528691|FG005|Overall Study|Physician Decision|0|||
164046109|NCT03418376|592528693|FG000|Overall Study|Musculoskeletal injury|1|||
164046110|NCT03418376|592528694|FG001|Overall Study|Musculoskeletal injury|2|||
164046111|NCT03418376|592528695|FG002|Overall Study|Musculoskeletal injury|1|||
164046112|NCT03418376|592528696|FG003|Overall Study|Musculoskeletal injury|0|||
164046113|NCT03418376|592528693|FG000|Overall Study|Personal reasons|0|||
164046114|NCT03418376|592528694|FG001|Overall Study|Personal reasons|2|||
164046115|NCT03418376|592528695|FG002|Overall Study|Personal reasons|2|||
164046116|NCT03418376|592528696|FG003|Overall Study|Personal reasons|1|||
164046117|NCT03418376|592528693|FG000|Overall Study|Exacerbation|0|||
164046118|NCT03418376|592528694|FG001|Overall Study|Exacerbation|1|||
164046119|NCT03418376|592528695|FG002|Overall Study|Exacerbation|0|||
164046120|NCT03418376|592528696|FG003|Overall Study|Exacerbation|0|||
164046121|NCT02774291|592528698|FG000|Overall Study|Lost to Follow-up|1|||
164046122|NCT00149890|592528702|FG000|Overall Study|Adverse Event|1|||
164046123|NCT00149890|592528703|FG001|Overall Study|Adverse Event|8|||
164046124|NCT00149890|592528702|FG000|Overall Study|Lack of Efficacy|8|||
164046125|NCT00149890|592528703|FG001|Overall Study|Lack of Efficacy|9|||
164046126|NCT00149890|592528702|FG000|Overall Study|Protocol Violation|1|||
164046127|NCT00149890|592528703|FG001|Overall Study|Protocol Violation|0|||
164046128|NCT00149890|592528702|FG000|Overall Study|Lost to Follow-up|1|||
164046129|NCT00149890|592528703|FG001|Overall Study|Lost to Follow-up|0|||
164046130|NCT00149890|592528702|FG000|Overall Study|Graft Loss|2|||
164046131|NCT00149890|592528703|FG001|Overall Study|Graft Loss|1|||
164046132|NCT01387594|592528704|FG000|Overall Study|Withdrawal by Subject|0|||
164046133|NCT01387594|592528705|FG001|Overall Study|Withdrawal by Subject|2|||
164046134|NCT01387594|592528704|FG000|Overall Study|Lost to Follow-up|0|||
164046135|NCT01387594|592528705|FG001|Overall Study|Lost to Follow-up|1|||
164046136|NCT03073200|592528713|FG000|Double Blind Treatment Period|Protocol Violation|1|||
164046137|NCT03073200|592528714|FG001|Double Blind Treatment Period|Protocol Violation|0|||
164046138|NCT03073200|592528715|FG002|Double Blind Treatment Period|Protocol Violation|0|||
164046139|NCT03073200|592528716|FG003|Double Blind Treatment Period|Protocol Violation|0|||
164046140|NCT03073200|592528717|FG004|Double Blind Treatment Period|Protocol Violation|0|||
164046141|NCT03073200|592528718|FG005|Double Blind Treatment Period|Protocol Violation|0|||
164046142|NCT03073200|592528719|FG006|Double Blind Treatment Period|Protocol Violation|0|||
164046143|NCT03073200|592528720|FG007|Double Blind Treatment Period|Protocol Violation|0|||
164046144|NCT03073200|592528721|FG008|Double Blind Treatment Period|Protocol Violation|0|||
164046145|NCT03073200|592528722|FG009|Double Blind Treatment Period|Protocol Violation|0|||
164046146|NCT03073200|592528723|FG010|Double Blind Treatment Period|Protocol Violation|0|||
164046147|NCT03073200|592528724|FG011|Double Blind Treatment Period|Protocol Violation|0|||
164046148|NCT03073200|592528725|FG012|Double Blind Treatment Period|Protocol Violation|0|||
164046149|NCT03073200|592528726|FG013|Double Blind Treatment Period|Protocol Violation|0|||
164046150|NCT03073200|592528727|FG014|Double Blind Treatment Period|Protocol Violation|0|||
164046151|NCT03073200|592528713|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046152|NCT03073200|592528714|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
164046153|NCT03073200|592528715|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046154|NCT03073200|592528716|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046155|NCT03073200|592528717|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046156|NCT03073200|592528718|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046157|NCT03073200|592528719|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046158|NCT03073200|592528720|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046159|NCT03073200|592528721|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046160|NCT03073200|592528722|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046161|NCT03073200|592528723|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046162|NCT03073200|592528724|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046163|NCT03073200|592528725|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046164|NCT03073200|592528726|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046165|NCT03073200|592528727|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
164046166|NCT03073200|592528713|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
164046167|NCT03073200|592528714|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046168|NCT03073200|592528715|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046169|NCT03073200|592528716|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046170|NCT03073200|592528717|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046171|NCT03073200|592528718|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046172|NCT03073200|592528719|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
164099210|NCT00376623|592728857|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
164099211|NCT00376623|592728858|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
164099212|NCT00376623|592728856|FG000|Overall Study|Not treated with BI 2536|1|||
164099213|NCT00376623|592728857|FG001|Overall Study|Not treated with BI 2536|0|||
164099214|NCT00376623|592728858|FG002|Overall Study|Not treated with BI 2536|0|||
164099215|NCT00376623|592728856|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
164099216|NCT00376623|592728857|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164099217|NCT00376623|592728858|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164099218|NCT00376623|592728856|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
164099219|NCT00376623|592728857|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
164099220|NCT00376623|592728858|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
164099221|NCT00376623|592728856|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
164099222|NCT00376623|592728857|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
164099223|NCT00376623|592728858|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
164099224|NCT00376623|592728856|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
164099225|NCT00376623|592728857|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
164099226|NCT00376623|592728858|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
164099227|NCT00376623|592728856|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164099228|NCT00376623|592728857|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
164099229|NCT00376623|592728858|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
164099230|NCT00376623|592728856|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
164099231|NCT00376623|592728857|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
164099232|NCT00376623|592728858|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
164099233|NCT00376623|592728856|FG000|Overall Study|Increase of tumour markers|0|||
164099234|NCT00376623|592728857|FG001|Overall Study|Increase of tumour markers|1|||
164099235|NCT00376623|592728858|FG002|Overall Study|Increase of tumour markers|0|||
164099236|NCT00376623|592728856|FG000|Overall Study|Bone metastasis|1|||
164099237|NCT00376623|592728857|FG001|Overall Study|Bone metastasis|0|||
164099238|NCT00376623|592728858|FG002|Overall Study|Bone metastasis|0|||
164099239|NCT00286754|592728861|FG000|Overall Study|Adverse Event|2|||
164099240|NCT00286754|592728862|FG001|Overall Study|Adverse Event|2|||
164099241|NCT00286754|592728863|FG002|Overall Study|Adverse Event|3|||
164099242|NCT00286754|592728861|FG000|Overall Study|Withdrawal by Subject|6|||
164099243|NCT00286754|592728862|FG001|Overall Study|Withdrawal by Subject|2|||
164099244|NCT00286754|592728863|FG002|Overall Study|Withdrawal by Subject|0|||
164099245|NCT00286754|592728861|FG000|Overall Study|Lost to Follow-up|12|||
164099246|NCT00286754|592728862|FG001|Overall Study|Lost to Follow-up|14|||
164099247|NCT00286754|592728863|FG002|Overall Study|Lost to Follow-up|6|||
164099248|NCT00286754|592728861|FG000|Overall Study|Moved out of state|0|||
164099249|NCT00286754|592728862|FG001|Overall Study|Moved out of state|0|||
164099250|NCT00286754|592728863|FG002|Overall Study|Moved out of state|1|||
164099251|NCT02661295|592728864|FG000|Overall Study|Death|1|||
164099252|NCT02661295|592728864|FG000|Overall Study|Transferred Out|1|||
164099253|NCT02661295|592728864|FG000|Overall Study|Kidney Transplant|1|||
164099254|NCT02661295|592728864|FG000|Overall Study|Withdrawn due to side effects|8|||
164099255|NCT02661295|592728864|FG000|Overall Study|Withdrawn due to access type|1|||
164099256|NCT02661295|592728864|FG000|Overall Study|Withdrawn due to allergies|1|||
164099257|NCT02661295|592728864|FG000|Overall Study|Withdrawn due to non-compliance|1|||
164099258|NCT02661295|592728864|FG000|Overall Study|Withdrawal by Subject|3|||
164099259|NCT02661295|592728864|FG000|Overall Study|Failed screening|2|||
164099260|NCT00301366|592728865|FG000|Overall Study|Adverse Event|1|||
164099261|NCT01313273|592728866|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
164099262|NCT01313273|592728867|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
164099263|NCT01313273|592728866|FG000|Overall Study|Withdrawal by Subject|1|||
164099264|NCT01313273|592728867|FG001|Overall Study|Withdrawal by Subject|0|||
164099265|NCT01313273|592728866|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
164099266|NCT01313273|592728867|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
164099267|NCT02726581|592728872|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
163842451|NCT02023879|591793021|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
163842452|NCT02023879|591793019|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
163842453|NCT02023879|591793020|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
163842454|NCT02023879|591793021|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
163842455|NCT02023879|591793019|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
163842456|NCT02023879|591793020|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
163842457|NCT02023879|591793021|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
164099268|NCT02726581|592728873|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
164046173|NCT03073200|592528720|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046174|NCT03073200|592528721|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046175|NCT03073200|592528722|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046176|NCT03073200|592528723|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046177|NCT03073200|592528724|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046178|NCT03073200|592528725|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046179|NCT03073200|592528726|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046180|NCT03073200|592528727|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
164046181|NCT03073200|592528713|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046182|NCT03073200|592528714|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046183|NCT03073200|592528715|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046184|NCT03073200|592528716|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
164046185|NCT03073200|592528717|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
164046186|NCT03073200|592528718|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046187|NCT03073200|592528719|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046188|NCT03073200|592528720|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046189|NCT03073200|592528721|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046190|NCT03073200|592528722|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046191|NCT03073200|592528723|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046192|NCT03073200|592528724|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046193|NCT03073200|592528725|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046194|NCT03073200|592528726|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046195|NCT03073200|592528727|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
164046196|NCT03073200|592528713|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
164046197|NCT03073200|592528714|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
164046198|NCT03073200|592528715|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
164046199|NCT03073200|592528716|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
164046200|NCT03073200|592528717|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
164046201|NCT03073200|592528718|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
164046202|NCT03073200|592528719|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
164046203|NCT03073200|592528720|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
164046204|NCT03073200|592528721|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
164046205|NCT03073200|592528722|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
164046206|NCT03073200|592528723|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
164046207|NCT03073200|592528724|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
164046208|NCT03073200|592528725|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
164046209|NCT03073200|592528726|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
164046210|NCT03073200|592528727|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
164046211|NCT03073200|592528713|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046212|NCT03073200|592528714|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046213|NCT03073200|592528715|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046214|NCT03073200|592528716|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046215|NCT03073200|592528717|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
164046216|NCT03073200|592528718|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046217|NCT03073200|592528719|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046218|NCT03073200|592528720|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046219|NCT03073200|592528721|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046220|NCT03073200|592528722|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046221|NCT03073200|592528723|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046222|NCT03073200|592528724|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046223|NCT03073200|592528725|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046224|NCT03073200|592528726|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046225|NCT03073200|592528727|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
164046226|NCT03073200|592528713|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046227|NCT03073200|592528714|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046228|NCT03073200|592528715|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046229|NCT03073200|592528716|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
164046230|NCT03073200|592528717|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
164046231|NCT03073200|592528718|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046232|NCT03073200|592528719|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046233|NCT03073200|592528720|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046234|NCT03073200|592528721|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046235|NCT03073200|592528722|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046236|NCT03073200|592528723|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046237|NCT03073200|592528724|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046238|NCT03073200|592528725|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164148532|NCT01823835|592904903|FG011|Overall Study|Study Termination|1|||
164046239|NCT03073200|592528726|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046240|NCT03073200|592528727|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
164046241|NCT03073200|592528713|FG000|Extension Period|Lost to Follow-up|0|||
164046242|NCT03073200|592528714|FG001|Extension Period|Lost to Follow-up|0|||
164046243|NCT03073200|592528715|FG002|Extension Period|Lost to Follow-up|0|||
164046244|NCT03073200|592528716|FG003|Extension Period|Lost to Follow-up|0|||
164046245|NCT03073200|592528717|FG004|Extension Period|Lost to Follow-up|0|||
164046246|NCT03073200|592528718|FG005|Extension Period|Lost to Follow-up|0|||
164046247|NCT03073200|592528719|FG006|Extension Period|Lost to Follow-up|1|||
164046248|NCT03073200|592528720|FG007|Extension Period|Lost to Follow-up|1|||
164046249|NCT03073200|592528721|FG008|Extension Period|Lost to Follow-up|0|||
164046250|NCT03073200|592528722|FG009|Extension Period|Lost to Follow-up|0|||
164046251|NCT03073200|592528723|FG010|Extension Period|Lost to Follow-up|0|||
164046252|NCT03073200|592528724|FG011|Extension Period|Lost to Follow-up|0|||
164046253|NCT03073200|592528725|FG012|Extension Period|Lost to Follow-up|0|||
164046254|NCT03073200|592528726|FG013|Extension Period|Lost to Follow-up|0|||
164046255|NCT03073200|592528727|FG014|Extension Period|Lost to Follow-up|0|||
164046256|NCT03073200|592528713|FG000|Extension Period|Sponsor Decision|0|||
164046257|NCT03073200|592528714|FG001|Extension Period|Sponsor Decision|0|||
164046258|NCT03073200|592528715|FG002|Extension Period|Sponsor Decision|0|||
164046259|NCT03073200|592528716|FG003|Extension Period|Sponsor Decision|0|||
164046260|NCT03073200|592528717|FG004|Extension Period|Sponsor Decision|0|||
164046261|NCT03073200|592528718|FG005|Extension Period|Sponsor Decision|0|||
164046262|NCT03073200|592528719|FG006|Extension Period|Sponsor Decision|0|||
164046263|NCT03073200|592528720|FG007|Extension Period|Sponsor Decision|0|||
164046264|NCT03073200|592528721|FG008|Extension Period|Sponsor Decision|1|||
164046265|NCT03073200|592528722|FG009|Extension Period|Sponsor Decision|0|||
164046266|NCT03073200|592528723|FG010|Extension Period|Sponsor Decision|0|||
164046267|NCT03073200|592528724|FG011|Extension Period|Sponsor Decision|0|||
164046268|NCT03073200|592528725|FG012|Extension Period|Sponsor Decision|0|||
164046269|NCT03073200|592528726|FG013|Extension Period|Sponsor Decision|0|||
164046270|NCT03073200|592528727|FG014|Extension Period|Sponsor Decision|0|||
164046271|NCT03073200|592528713|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
164046272|NCT03073200|592528714|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
164046273|NCT03073200|592528715|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
164046274|NCT03073200|592528716|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
164046275|NCT03073200|592528717|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
164046276|NCT03073200|592528718|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
164046277|NCT03073200|592528719|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
164046278|NCT03073200|592528720|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
164046279|NCT03073200|592528721|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
164046280|NCT03073200|592528722|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
164046281|NCT03073200|592528723|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
164046282|NCT03073200|592528724|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
164046283|NCT03073200|592528725|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
164046284|NCT03073200|592528726|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
164046285|NCT03073200|592528727|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
164046286|NCT03073200|592528713|FG000|Extension Period|Withdrawal by Subject|0|||
164046287|NCT03073200|592528714|FG001|Extension Period|Withdrawal by Subject|0|||
164046288|NCT03073200|592528715|FG002|Extension Period|Withdrawal by Subject|0|||
164046289|NCT03073200|592528716|FG003|Extension Period|Withdrawal by Subject|0|||
164046290|NCT03073200|592528717|FG004|Extension Period|Withdrawal by Subject|0|||
164046291|NCT03073200|592528718|FG005|Extension Period|Withdrawal by Subject|0|||
164046292|NCT03073200|592528719|FG006|Extension Period|Withdrawal by Subject|1|||
164046293|NCT03073200|592528720|FG007|Extension Period|Withdrawal by Subject|2|||
164046294|NCT03073200|592528721|FG008|Extension Period|Withdrawal by Subject|0|||
164046295|NCT03073200|592528722|FG009|Extension Period|Withdrawal by Subject|0|||
164046296|NCT03073200|592528723|FG010|Extension Period|Withdrawal by Subject|0|||
164046297|NCT03073200|592528724|FG011|Extension Period|Withdrawal by Subject|0|||
164046298|NCT03073200|592528725|FG012|Extension Period|Withdrawal by Subject|0|||
164046299|NCT03073200|592528726|FG013|Extension Period|Withdrawal by Subject|0|||
164046300|NCT03073200|592528727|FG014|Extension Period|Withdrawal by Subject|0|||
164046301|NCT03073200|592528713|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
164099269|NCT02726581|592728874|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
163842458|NCT02023879|591793019|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
163842459|NCT02023879|591793020|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
164046302|NCT03073200|592528714|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046303|NCT03073200|592528715|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046304|NCT03073200|592528716|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046305|NCT03073200|592528717|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046306|NCT03073200|592528718|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046307|NCT03073200|592528719|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046308|NCT03073200|592528720|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046309|NCT03073200|592528721|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046310|NCT03073200|592528722|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046311|NCT03073200|592528723|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046312|NCT03073200|592528724|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
164046313|NCT03073200|592528725|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046314|NCT03073200|592528726|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046315|NCT03073200|592528727|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
164046316|NCT03073200|592528713|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046317|NCT03073200|592528714|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046318|NCT03073200|592528715|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046319|NCT03073200|592528716|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046320|NCT03073200|592528717|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046321|NCT03073200|592528718|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046322|NCT03073200|592528719|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046323|NCT03073200|592528720|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046324|NCT03073200|592528721|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046325|NCT03073200|592528722|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046326|NCT03073200|592528723|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046327|NCT03073200|592528724|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
164046328|NCT03073200|592528725|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046329|NCT03073200|592528726|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046330|NCT03073200|592528727|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
164046331|NCT03073200|592528713|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046332|NCT03073200|592528714|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046333|NCT03073200|592528715|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046334|NCT03073200|592528716|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046335|NCT03073200|592528717|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046336|NCT03073200|592528718|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046337|NCT03073200|592528719|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046338|NCT03073200|592528720|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046339|NCT03073200|592528721|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046340|NCT03073200|592528722|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046341|NCT03073200|592528723|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
164046342|NCT03073200|592528724|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
164046343|NCT03073200|592528725|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046344|NCT03073200|592528726|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046345|NCT03073200|592528727|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
164046346|NCT03073200|592528713|FG000|Randomized Withdrawal Period|Adverse Event|0|||
164046347|NCT03073200|592528714|FG001|Randomized Withdrawal Period|Adverse Event|0|||
164046348|NCT03073200|592528715|FG002|Randomized Withdrawal Period|Adverse Event|0|||
164046349|NCT03073200|592528716|FG003|Randomized Withdrawal Period|Adverse Event|0|||
164046350|NCT03073200|592528717|FG004|Randomized Withdrawal Period|Adverse Event|0|||
164046351|NCT03073200|592528718|FG005|Randomized Withdrawal Period|Adverse Event|0|||
164046352|NCT03073200|592528719|FG006|Randomized Withdrawal Period|Adverse Event|0|||
164046353|NCT03073200|592528720|FG007|Randomized Withdrawal Period|Adverse Event|0|||
164046354|NCT03073200|592528721|FG008|Randomized Withdrawal Period|Adverse Event|0|||
164046355|NCT03073200|592528722|FG009|Randomized Withdrawal Period|Adverse Event|0|||
164046356|NCT03073200|592528723|FG010|Randomized Withdrawal Period|Adverse Event|1|||
164046357|NCT03073200|592528724|FG011|Randomized Withdrawal Period|Adverse Event|0|||
164046358|NCT03073200|592528725|FG012|Randomized Withdrawal Period|Adverse Event|0|||
164046359|NCT03073200|592528726|FG013|Randomized Withdrawal Period|Adverse Event|0|||
164046360|NCT03073200|592528727|FG014|Randomized Withdrawal Period|Adverse Event|0|||
164046361|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046362|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046363|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046364|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046365|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046366|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046367|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046368|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046369|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046370|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
163842460|NCT02023879|591793021|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
163842461|NCT02023879|591793019|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
164046371|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046372|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
164148533|NCT01823835|592904904|FG012|Overall Study|Study Termination|0|||
163946359|NCT04445987|592172392|FG005|Overall Study|Protocol Violation|0|||
163946360|NCT04445987|592172387|FG000|Overall Study|Withdrawal by Subject|4|||
163946361|NCT04445987|592172388|FG001|Overall Study|Withdrawal by Subject|0|||
163946362|NCT04445987|592172389|FG002|Overall Study|Withdrawal by Subject|1|||
163946363|NCT04445987|592172390|FG003|Overall Study|Withdrawal by Subject|0|||
163946364|NCT04445987|592172391|FG004|Overall Study|Withdrawal by Subject|18|||
163946365|NCT04445987|592172392|FG005|Overall Study|Withdrawal by Subject|1|||
163946366|NCT04445987|592172387|FG000|Overall Study|Other reason|0|||
163946367|NCT04445987|592172388|FG001|Overall Study|Other reason|0|||
163946368|NCT04445987|592172389|FG002|Overall Study|Other reason|1|||
163946369|NCT04445987|592172390|FG003|Overall Study|Other reason|0|||
163946370|NCT04445987|592172391|FG004|Overall Study|Other reason|2|||
163946371|NCT04445987|592172392|FG005|Overall Study|Other reason|0|||
163946372|NCT02091206|592172393|FG000|Treatment Period|Adverse Event|0|||
163946373|NCT02091206|592172394|FG001|Treatment Period|Adverse Event|1|||
163946374|NCT02091206|592172395|FG002|Treatment Period|Adverse Event|0|||
163946375|NCT02091206|592172396|FG003|Treatment Period|Adverse Event|0|||
163946376|NCT02091206|592172393|FG000|Treatment Period|Met withdrawal criteria|0|||
163946377|NCT02091206|592172394|FG001|Treatment Period|Met withdrawal criteria|0|||
163946378|NCT02091206|592172395|FG002|Treatment Period|Met withdrawal criteria|1|||
163946379|NCT02091206|592172396|FG003|Treatment Period|Met withdrawal criteria|0|||
163946380|NCT02091206|592172393|FG000|Taper Period|Participant refused study drug|1|||
163946381|NCT02091206|592172394|FG001|Taper Period|Participant refused study drug|0|||
163946382|NCT02091206|592172395|FG002|Taper Period|Participant refused study drug|0|||
163946383|NCT02091206|592172396|FG003|Taper Period|Participant refused study drug|1|||
163946384|NCT02091206|592172393|FG000|Taper Period|Lost to Follow-up|0|||
163946385|NCT02091206|592172394|FG001|Taper Period|Lost to Follow-up|0|||
163946386|NCT02091206|592172395|FG002|Taper Period|Lost to Follow-up|0|||
163946387|NCT02091206|592172396|FG003|Taper Period|Lost to Follow-up|1|||
163946388|NCT03772587|592172402|FG000|Overall Study|COVID-19|0|||
163946389|NCT03772587|592172403|FG001|Overall Study|COVID-19|0|||
163946390|NCT03772587|592172404|FG002|Overall Study|COVID-19|1|||
163946391|NCT03772587|592172405|FG003|Overall Study|COVID-19|1|||
163946392|NCT03772587|592172406|FG004|Overall Study|COVID-19|0|||
163946393|NCT03772587|592172402|FG000|Overall Study|Withdrawal by Subject|1|||
163946394|NCT03772587|592172403|FG001|Overall Study|Withdrawal by Subject|0|||
163946395|NCT03772587|592172404|FG002|Overall Study|Withdrawal by Subject|0|||
163946396|NCT03772587|592172405|FG003|Overall Study|Withdrawal by Subject|0|||
163946397|NCT03772587|592172406|FG004|Overall Study|Withdrawal by Subject|0|||
163946398|NCT02297139|592172407|FG000|Overall Study|Disease progression|0|||
163946399|NCT02297139|592172408|FG001|Overall Study|Disease progression|1|||
163946400|NCT02297139|592172407|FG000|Overall Study|Study drug toxicity|0|||
163946401|NCT02297139|592172408|FG001|Overall Study|Study drug toxicity|4|||
163946402|NCT02297139|592172407|FG000|Overall Study|Participant request to discontinue study treatment|0|||
163946403|NCT02297139|592172408|FG001|Overall Study|Participant request to discontinue study treatment|1|||
163946404|NCT02297139|592172407|FG000|Overall Study|Maximum clinical benefit|1|||
163946405|NCT02297139|592172408|FG001|Overall Study|Maximum clinical benefit|0|||
163946406|NCT02297139|592172407|FG000|Overall Study|Administrative reason by sponsor|0|||
163946407|NCT02297139|592172408|FG001|Overall Study|Administrative reason by sponsor|2|||
163946408|NCT02297139|592172407|FG000|Overall Study|Other reasons|0|||
163946409|NCT02297139|592172408|FG001|Overall Study|Other reasons|8|||
163946410|NCT05051462|592172414|FG000|Overall Study|Lost to Follow-up|1|||
163946411|NCT05051462|592172415|FG001|Overall Study|Lost to Follow-up|8|||
163946412|NCT05051462|592172414|FG000|Overall Study|Withdrawal by Subject|1|||
163946413|NCT05051462|592172415|FG001|Overall Study|Withdrawal by Subject|0|||
163946414|NCT05051462|592172414|FG000|Overall Study|Protocol Violation|0|||
163946415|NCT05051462|592172415|FG001|Overall Study|Protocol Violation|2|||
163946416|NCT02425904|592172416|FG000|Overall Study|Lost to Follow-up|1|||
163946417|NCT02425904|592172417|FG001|Overall Study|Lost to Follow-up|0|||
163946418|NCT02425904|592172416|FG000|Overall Study|Withdrawal by Subject|2|||
163946419|NCT02425904|592172417|FG001|Overall Study|Withdrawal by Subject|0|||
163946420|NCT02425904|592172416|FG000|Overall Study|Death|0|||
163946421|NCT02425904|592172417|FG001|Overall Study|Death|3|||
163946422|NCT05260021|592172418|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
163946423|NCT05260021|592172419|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
163946424|NCT05260021|592172420|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
163946425|NCT05260021|592172418|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
163946426|NCT05260021|592172419|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
163946427|NCT05260021|592172420|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
163946428|NCT05260021|592172418|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
163946429|NCT05260021|592172419|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
163946430|NCT05260021|592172420|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
163946431|NCT05260021|592172418|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
163946432|NCT05260021|592172419|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
163946433|NCT05260021|592172420|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
164148534|NCT01823835|592904905|FG013|Overall Study|Study Termination|0|||
164046373|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046374|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
164046375|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
164046376|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046377|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046378|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046379|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046380|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046381|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046382|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046383|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046384|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046385|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046386|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046387|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046388|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046389|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164046390|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164046391|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046392|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046393|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046394|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046395|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046396|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046397|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046398|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046399|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046400|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046401|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046402|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046403|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046404|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
164046405|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
164046406|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046407|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046408|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046409|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046410|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046411|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046412|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046413|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046414|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046415|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046416|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046417|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046418|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046419|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
164046420|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164046421|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046422|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046423|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046424|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046425|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046426|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046427|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046428|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046429|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046430|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046431|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046432|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046433|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046434|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
164046435|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
164046436|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164148535|NCT01823835|592904906|FG014|Overall Study|Study Termination|0|||
164099270|NCT02726581|592728872|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
164099271|NCT02726581|592728873|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
164099272|NCT02726581|592728874|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
164099273|NCT02726581|592728872|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164099274|NCT02726581|592728873|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164099275|NCT02726581|592728874|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164099276|NCT02726581|592728872|FG000|Treatment Period|Disease progression|47|||
164099277|NCT02726581|592728873|FG001|Treatment Period|Disease progression|50|||
164099278|NCT02726581|592728874|FG002|Treatment Period|Disease progression|16|||
164099279|NCT02726581|592728872|FG000|Treatment Period|Other reasons|9|||
164099280|NCT02726581|592728873|FG001|Treatment Period|Other reasons|8|||
164099281|NCT02726581|592728874|FG002|Treatment Period|Other reasons|2|||
164099282|NCT02726581|592728872|FG000|Treatment Period|Study drug toxicity|6|||
164099283|NCT02726581|592728873|FG001|Treatment Period|Study drug toxicity|3|||
164099284|NCT02726581|592728874|FG002|Treatment Period|Study drug toxicity|2|||
164099285|NCT02726581|592728872|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
164099286|NCT02726581|592728873|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
164099287|NCT02726581|592728874|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
164099288|NCT02726581|592728872|FG000|Treatment Period|Participant withdrew consent|3|||
164099289|NCT02726581|592728873|FG001|Treatment Period|Participant withdrew consent|1|||
164099290|NCT02726581|592728874|FG002|Treatment Period|Participant withdrew consent|1|||
164099291|NCT02726581|592728872|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
164099292|NCT02726581|592728873|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
164099293|NCT02726581|592728874|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
164099294|NCT02726581|592728872|FG000|Treatment Period|Maximum clinical benefit|0|||
164099295|NCT02726581|592728873|FG001|Treatment Period|Maximum clinical benefit|2|||
164099296|NCT02726581|592728874|FG002|Treatment Period|Maximum clinical benefit|0|||
164099297|NCT02726581|592728872|FG000|Treatment Period|Death|1|||
164099298|NCT02726581|592728873|FG001|Treatment Period|Death|0|||
164099299|NCT02726581|592728874|FG002|Treatment Period|Death|0|||
164099300|NCT02726581|592728872|FG000|Treatment Period|Poor/non-compliance|1|||
164099301|NCT02726581|592728873|FG001|Treatment Period|Poor/non-compliance|0|||
164099302|NCT02726581|592728874|FG002|Treatment Period|Poor/non-compliance|0|||
163946434|NCT05260021|592172418|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
163946435|NCT05260021|592172419|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
163946436|NCT05260021|592172420|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
163946437|NCT05597787|592172421|FG000|Overall Study|Withdrawal by Subject|0|||
163946438|NCT05597787|592172422|FG001|Overall Study|Withdrawal by Subject|0|||
163946439|NCT05597787|592172423|FG002|Overall Study|Withdrawal by Subject|1|||
163946440|NCT01144377|592172424|FG000|52 Week Treatment Period|Adverse Event|0|||
163946441|NCT01144377|592172425|FG001|52 Week Treatment Period|Adverse Event|0|||
163946442|NCT01144377|592172426|FG002|52 Week Treatment Period|Adverse Event|3|||
163946443|NCT01144377|592172427|FG003|52 Week Treatment Period|Adverse Event|2|||
163946444|NCT01144377|592172428|FG004|52 Week Treatment Period|Adverse Event|1|||
163946445|NCT01144377|592172424|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
163946446|NCT01144377|592172425|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
163946447|NCT01144377|592172426|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
163946448|NCT01144377|592172427|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
163946449|NCT01144377|592172428|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
163946450|NCT01144377|592172424|FG000|52 Week Treatment Period|Protocol Violation|0|||
163946451|NCT01144377|592172425|FG001|52 Week Treatment Period|Protocol Violation|0|||
163946452|NCT01144377|592172426|FG002|52 Week Treatment Period|Protocol Violation|0|||
163946453|NCT01144377|592172427|FG003|52 Week Treatment Period|Protocol Violation|0|||
163946454|NCT01144377|592172428|FG004|52 Week Treatment Period|Protocol Violation|1|||
163946455|NCT01144377|592172424|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
163946456|NCT01144377|592172425|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
163946457|NCT01144377|592172426|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
163946458|NCT01144377|592172427|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
163946459|NCT01144377|592172428|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
163946460|NCT01144377|592172424|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
163946461|NCT01144377|592172425|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
163946462|NCT01144377|592172426|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
163946463|NCT01144377|592172427|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
163946464|NCT01144377|592172428|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
163946465|NCT01144377|592172424|FG000|52 Week Treatment Period|Sponsor Decision|0|||
163946466|NCT01144377|592172425|FG001|52 Week Treatment Period|Sponsor Decision|0|||
163946467|NCT01144377|592172426|FG002|52 Week Treatment Period|Sponsor Decision|0|||
163946468|NCT01144377|592172427|FG003|52 Week Treatment Period|Sponsor Decision|0|||
163946469|NCT01144377|592172428|FG004|52 Week Treatment Period|Sponsor Decision|1|||
163946470|NCT01144377|592172424|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
163946471|NCT01144377|592172425|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
164099303|NCT02726581|592728872|FG000|Treatment Period|Participant no longer meets study criteria|0|||
164099304|NCT02726581|592728873|FG001|Treatment Period|Participant no longer meets study criteria|1|||
164099305|NCT02726581|592728874|FG002|Treatment Period|Participant no longer meets study criteria|0|||
164099306|NCT01270503|592728876|FG000|Overall Study|Lost to Follow-up|1|||
163946472|NCT01144377|592172426|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
163946473|NCT01144377|592172427|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
163946474|NCT01144377|592172428|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
163946475|NCT01144377|592172424|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163946476|NCT01144377|592172425|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163946477|NCT01144377|592172426|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163946478|NCT01144377|592172427|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
163946479|NCT01144377|592172428|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
163946480|NCT01144377|592172424|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
163946481|NCT01144377|592172425|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163946482|NCT01144377|592172426|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163946483|NCT01144377|592172427|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163946484|NCT01144377|592172428|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
163946485|NCT01241604|592172430|FG000|Screening Period|Screen Failure|3|||
163946486|NCT01241604|592172431|FG001|Screening Period|Screen Failure|0|||
163946487|NCT01241604|592172432|FG002|Screening Period|Screen Failure|0|||
163946488|NCT01214642|592172433|FG000|Overall Study|Progressive Disease|3|||
163946489|NCT01214642|592172434|FG001|Overall Study|Progressive Disease|2|||
163946490|NCT01214642|592172435|FG002|Overall Study|Progressive Disease|3|||
163946491|NCT01214642|592172436|FG003|Overall Study|Progressive Disease|5|||
163946492|NCT01214642|592172437|FG004|Overall Study|Progressive Disease|5|||
163946493|NCT01214642|592172438|FG005|Overall Study|Progressive Disease|3|||
163946494|NCT01214642|592172439|FG006|Overall Study|Progressive Disease|5|||
163946495|NCT01214642|592172440|FG007|Overall Study|Progressive Disease|3|||
163946496|NCT01214642|592172441|FG008|Overall Study|Progressive Disease|10|||
163946497|NCT01214642|592172442|FG009|Overall Study|Progressive Disease|2|||
163946498|NCT01214642|592172443|FG010|Overall Study|Progressive Disease|1|||
163946499|NCT01214642|592172444|FG011|Overall Study|Progressive Disease|4|||
163946500|NCT01214642|592172433|FG000|Overall Study|Adverse Event|0|||
163946501|NCT01214642|592172434|FG001|Overall Study|Adverse Event|1|||
163946502|NCT01214642|592172435|FG002|Overall Study|Adverse Event|0|||
163946503|NCT01214642|592172436|FG003|Overall Study|Adverse Event|0|||
163946504|NCT01214642|592172437|FG004|Overall Study|Adverse Event|0|||
163946505|NCT01214642|592172438|FG005|Overall Study|Adverse Event|0|||
163946506|NCT01214642|592172439|FG006|Overall Study|Adverse Event|1|||
163946507|NCT01214642|592172440|FG007|Overall Study|Adverse Event|0|||
163946508|NCT01214642|592172441|FG008|Overall Study|Adverse Event|0|||
163946509|NCT01214642|592172442|FG009|Overall Study|Adverse Event|1|||
163946510|NCT01214642|592172443|FG010|Overall Study|Adverse Event|1|||
163946511|NCT01214642|592172444|FG011|Overall Study|Adverse Event|0|||
163946512|NCT01214642|592172433|FG000|Overall Study|Death|0|||
163946513|NCT01214642|592172434|FG001|Overall Study|Death|0|||
163946514|NCT01214642|592172435|FG002|Overall Study|Death|1|||
163946515|NCT01214642|592172436|FG003|Overall Study|Death|0|||
163946516|NCT01214642|592172437|FG004|Overall Study|Death|0|||
163946517|NCT01214642|592172438|FG005|Overall Study|Death|0|||
163946518|NCT01214642|592172439|FG006|Overall Study|Death|0|||
163946519|NCT01214642|592172440|FG007|Overall Study|Death|0|||
163946520|NCT01214642|592172441|FG008|Overall Study|Death|0|||
163946521|NCT01214642|592172442|FG009|Overall Study|Death|0|||
163946522|NCT01214642|592172443|FG010|Overall Study|Death|1|||
163946523|NCT01214642|592172444|FG011|Overall Study|Death|0|||
163946524|NCT01214642|592172433|FG000|Overall Study|Withdrawal by Subject|0|||
163946525|NCT01214642|592172434|FG001|Overall Study|Withdrawal by Subject|0|||
163946526|NCT01214642|592172435|FG002|Overall Study|Withdrawal by Subject|1|||
163946527|NCT01214642|592172436|FG003|Overall Study|Withdrawal by Subject|0|||
163946528|NCT01214642|592172437|FG004|Overall Study|Withdrawal by Subject|0|||
163946529|NCT01214642|592172438|FG005|Overall Study|Withdrawal by Subject|0|||
163946530|NCT01214642|592172439|FG006|Overall Study|Withdrawal by Subject|0|||
163946531|NCT01214642|592172440|FG007|Overall Study|Withdrawal by Subject|0|||
163946532|NCT01214642|592172441|FG008|Overall Study|Withdrawal by Subject|3|||
163946533|NCT01214642|592172442|FG009|Overall Study|Withdrawal by Subject|1|||
163946534|NCT01214642|592172443|FG010|Overall Study|Withdrawal by Subject|1|||
163946535|NCT01214642|592172444|FG011|Overall Study|Withdrawal by Subject|0|||
163946536|NCT01214642|592172433|FG000|Overall Study|Physician Decision|0|||
163946537|NCT01214642|592172434|FG001|Overall Study|Physician Decision|0|||
163946538|NCT01214642|592172435|FG002|Overall Study|Physician Decision|1|||
163946539|NCT01214642|592172436|FG003|Overall Study|Physician Decision|1|||
163946540|NCT01214642|592172437|FG004|Overall Study|Physician Decision|1|||
163946541|NCT01214642|592172438|FG005|Overall Study|Physician Decision|0|||
163946542|NCT01214642|592172439|FG006|Overall Study|Physician Decision|0|||
163946543|NCT01214642|592172440|FG007|Overall Study|Physician Decision|0|||
163946544|NCT01214642|592172441|FG008|Overall Study|Physician Decision|0|||
164046437|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046438|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046439|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046440|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046441|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046442|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046443|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046444|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046445|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046446|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046447|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046448|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046449|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
164046450|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
164046451|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046452|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046453|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046454|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046455|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046456|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046457|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046458|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046459|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046460|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046461|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046462|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046463|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046464|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
164046465|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164046466|NCT03073200|592528713|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046467|NCT03073200|592528714|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046468|NCT03073200|592528715|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046469|NCT03073200|592528716|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046470|NCT03073200|592528717|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046471|NCT03073200|592528718|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046472|NCT03073200|592528719|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046473|NCT03073200|592528720|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046474|NCT03073200|592528721|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046475|NCT03073200|592528722|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046476|NCT03073200|592528723|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046477|NCT03073200|592528724|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046478|NCT03073200|592528725|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046479|NCT03073200|592528726|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
164046480|NCT03073200|592528727|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
164046481|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
164046482|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
164046483|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
164046484|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
164046485|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
164046486|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
164046487|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
164046488|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
164046489|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
164148614|NCT04895982|592904922|FG011|Overall Study|Other|0|||
163842462|NCT02023879|591793020|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
163842463|NCT02023879|591793021|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
163842464|NCT02023879|591793019|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
163842465|NCT02023879|591793020|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
163842466|NCT02023879|591793021|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
163842467|NCT02023879|591793019|FG000|Extension Open Label Treatment|Adverse Event|1|||
163842468|NCT02023879|591793020|FG001|Extension Open Label Treatment|Adverse Event|7|||
163842469|NCT02023879|591793021|FG002|Extension Open Label Treatment|Adverse Event|3|||
163842470|NCT02023879|591793019|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
164046490|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
164046491|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
164046492|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
164046493|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
164046494|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
164046495|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
164046496|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164046497|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
164046498|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164046499|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164046500|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
164046501|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
164046502|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164046503|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164046504|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164046505|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
164046506|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164046507|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
164046508|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164046509|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164046510|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
164046511|NCT04757376|592528728|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
164046512|NCT04757376|592528729|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
164046513|NCT04757376|592528730|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
164046514|NCT04757376|592528731|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
164046515|NCT04757376|592528732|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
164046516|NCT04757376|592528728|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164046517|NCT04757376|592528729|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164046518|NCT04757376|592528730|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
164046519|NCT04757376|592528731|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164046520|NCT04757376|592528732|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
164046521|NCT01307046|592528733|FG000|Overall Study|Adverse Event|3|||
164046522|NCT01307046|592528734|FG001|Overall Study|Adverse Event|3|||
164046523|NCT01307046|592528733|FG000|Overall Study|Lack of Efficacy|0|||
164046524|NCT01307046|592528734|FG001|Overall Study|Lack of Efficacy|2|||
164046525|NCT01307046|592528733|FG000|Overall Study|Physician Decision|2|||
164046526|NCT01307046|592528734|FG001|Overall Study|Physician Decision|0|||
164046527|NCT01307046|592528733|FG000|Overall Study|Withdrawal by Subject|1|||
164046528|NCT01307046|592528734|FG001|Overall Study|Withdrawal by Subject|1|||
164046529|NCT01307046|592528733|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
164046530|NCT01307046|592528734|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
164046531|NCT01307046|592528733|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
164046532|NCT01307046|592528734|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
164046533|NCT03898323|592528735|FG000|Overall Study|Physician Decision|1|||
164046534|NCT02569398|592528743|FG000|Overall Study|Adverse Event|0|||
164046535|NCT02569398|592528744|FG001|Overall Study|Adverse Event|1|||
164046536|NCT02569398|592528745|FG002|Overall Study|Adverse Event|6|||
164046537|NCT02569398|592528743|FG000|Overall Study|Withdrawal by Subject|43|||
164046538|NCT02569398|592528744|FG001|Overall Study|Withdrawal by Subject|43|||
164046539|NCT02569398|592528745|FG002|Overall Study|Withdrawal by Subject|30|||
164046540|NCT02569398|592528743|FG000|Overall Study|Study terminated by sponsor|130|||
164046541|NCT02569398|592528744|FG001|Overall Study|Study terminated by sponsor|131|||
164046542|NCT02569398|592528745|FG002|Overall Study|Study terminated by sponsor|134|||
164046543|NCT02569398|592528743|FG000|Overall Study|Other|12|||
164046544|NCT02569398|592528744|FG001|Overall Study|Other|14|||
164046545|NCT02569398|592528745|FG002|Overall Study|Other|13|||
164046546|NCT02116361|592528748|FG000|Overall Study|Pregnancy|0|||
164046547|NCT02116361|592528749|FG001|Overall Study|Pregnancy|0|||
164046548|NCT02116361|592528750|FG002|Overall Study|Pregnancy|0|||
164046549|NCT02116361|592528751|FG003|Overall Study|Pregnancy|1|||
164046550|NCT02116361|592528748|FG000|Overall Study|Protocol Violation|1|||
164046551|NCT02116361|592528749|FG001|Overall Study|Protocol Violation|0|||
164046552|NCT02116361|592528750|FG002|Overall Study|Protocol Violation|0|||
164046553|NCT02116361|592528751|FG003|Overall Study|Protocol Violation|2|||
164046554|NCT02116361|592528748|FG000|Overall Study|Physician Decision|2|||
164046555|NCT02116361|592528749|FG001|Overall Study|Physician Decision|3|||
164046556|NCT02116361|592528750|FG002|Overall Study|Physician Decision|0|||
164046557|NCT02116361|592528751|FG003|Overall Study|Physician Decision|0|||
164046558|NCT02116361|592528748|FG000|Overall Study|Adverse Event|1|||
164046559|NCT02116361|592528749|FG001|Overall Study|Adverse Event|0|||
164046560|NCT02116361|592528750|FG002|Overall Study|Adverse Event|0|||
164046561|NCT02116361|592528751|FG003|Overall Study|Adverse Event|3|||
164046562|NCT02116361|592528748|FG000|Overall Study|Other Reasons|3|||
164046563|NCT02116361|592528749|FG001|Overall Study|Other Reasons|3|||
164046564|NCT02116361|592528750|FG002|Overall Study|Other Reasons|3|||
164046565|NCT02116361|592528751|FG003|Overall Study|Other Reasons|3|||
164046566|NCT02116361|592528748|FG000|Overall Study|Lack of Efficacy|5|||
164046567|NCT02116361|592528749|FG001|Overall Study|Lack of Efficacy|7|||
164046568|NCT02116361|592528750|FG002|Overall Study|Lack of Efficacy|4|||
164046569|NCT02116361|592528751|FG003|Overall Study|Lack of Efficacy|3|||
164046570|NCT02116361|592528748|FG000|Overall Study|Lost to Follow-up|4|||
164046571|NCT02116361|592528749|FG001|Overall Study|Lost to Follow-up|5|||
164046572|NCT02116361|592528750|FG002|Overall Study|Lost to Follow-up|7|||
164046573|NCT02116361|592528751|FG003|Overall Study|Lost to Follow-up|5|||
164046574|NCT02116361|592528748|FG000|Overall Study|Personal Reasons|6|||
164046575|NCT02116361|592528749|FG001|Overall Study|Personal Reasons|6|||
164046576|NCT02116361|592528750|FG002|Overall Study|Personal Reasons|4|||
164046577|NCT02116361|592528751|FG003|Overall Study|Personal Reasons|9|||
164046578|NCT02116361|592528748|FG000|Overall Study|Investigator Decision - Relapse|9|||
164046579|NCT02116361|592528749|FG001|Overall Study|Investigator Decision - Relapse|7|||
164046580|NCT02116361|592528750|FG002|Overall Study|Investigator Decision - Relapse|8|||
164046581|NCT02116361|592528751|FG003|Overall Study|Investigator Decision - Relapse|5|||
164046582|NCT02571972|592528752|FG000|Overall Study|Protocol Violation|2|||
164046583|NCT02571972|592528752|FG000|Overall Study|Withdrawal by Subject|2|||
164046584|NCT04195750|592528753|FG000|Overall Study|Death|245|||
164046585|NCT04195750|592528754|FG001|Overall Study|Death|253|||
164046586|NCT04195750|592528755|FG002|Overall Study|Death|5|||
164046587|NCT04195750|592528753|FG000|Overall Study|Physician Decision|0|||
164046588|NCT04195750|592528754|FG001|Overall Study|Physician Decision|1|||
164046589|NCT04195750|592528755|FG002|Overall Study|Physician Decision|0|||
164046590|NCT04195750|592528753|FG000|Overall Study|Withdrawal by Subject|9|||
164046591|NCT04195750|592528754|FG001|Overall Study|Withdrawal by Subject|8|||
164046592|NCT04195750|592528755|FG002|Overall Study|Withdrawal by Subject|0|||
164046593|NCT04195750|592528753|FG000|Overall Study|Ongoing|120|||
164046594|NCT04195750|592528754|FG001|Overall Study|Ongoing|110|||
164046595|NCT04195750|592528755|FG002|Overall Study|Ongoing|4|||
164046596|NCT02406027|592528756|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164046597|NCT02406027|592528757|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
164046598|NCT02406027|592528758|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
164046599|NCT02406027|592528759|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164046600|NCT02406027|592528760|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164046601|NCT02406027|592528761|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164046602|NCT02406027|592528762|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
164046603|NCT02406027|592528756|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
164046604|NCT02406027|592528757|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164046605|NCT02406027|592528758|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
164046606|NCT02406027|592528759|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164046607|NCT02406027|592528760|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164046608|NCT02406027|592528761|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164046609|NCT02406027|592528762|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
164046610|NCT02406027|592528756|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
164046611|NCT02406027|592528757|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
164046612|NCT02406027|592528758|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
164046613|NCT02406027|592528759|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164046614|NCT02406027|592528760|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164046615|NCT02406027|592528761|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164046616|NCT02406027|592528762|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
164046617|NCT02406027|592528756|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
164046618|NCT02406027|592528757|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164046619|NCT02406027|592528758|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
164046620|NCT02406027|592528759|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164046621|NCT02406027|592528760|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164046622|NCT02406027|592528761|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164046623|NCT02406027|592528762|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
164046624|NCT02406027|592528756|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
164099307|NCT02459951|592728877|FG000|Overall Study|Unable to meet holding requirement|1|||
164046625|NCT02406027|592528757|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
163946545|NCT01214642|592172442|FG009|Overall Study|Physician Decision|0|||
163946546|NCT01214642|592172443|FG010|Overall Study|Physician Decision|0|||
163946547|NCT01214642|592172444|FG011|Overall Study|Physician Decision|2|||
163946548|NCT01639495|592173677|FG000|Overall Study|Lost to Follow-up|6|||
163946549|NCT01639495|592173677|FG000|Overall Study|Consented but didn't have study catheter|4|||
163946550|NCT01639495|592173677|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
163946551|NCT01639495|592173677|FG000|Overall Study|No radiofrequency energy applied|2|||
163946552|NCT02366468|592173681|FG000|Overall Study|Adverse Event|2|||
163946553|NCT02366468|592173682|FG001|Overall Study|Adverse Event|0|||
163946554|NCT02366468|592173681|FG000|Overall Study|Withdrawal by Subject|1|||
163946555|NCT02366468|592173682|FG001|Overall Study|Withdrawal by Subject|5|||
163946556|NCT02366468|592173681|FG000|Overall Study|Lost to Follow-up|2|||
163946557|NCT02366468|592173682|FG001|Overall Study|Lost to Follow-up|0|||
163946558|NCT02366468|592173681|FG000|Overall Study|Death|1|||
163946559|NCT02366468|592173682|FG001|Overall Study|Death|2|||
163946560|NCT02366468|592173681|FG000|Overall Study|Other|0|||
163946561|NCT02366468|592173682|FG001|Overall Study|Other|2|||
163946562|NCT05540717|592173685|FG000|Overall Study|Lost to Follow-up|2|||
163946563|NCT05540717|592173686|FG001|Overall Study|Lost to Follow-up|5|||
163946564|NCT05540717|592173685|FG000|Overall Study|Withdrawal by Subject|6|||
163946565|NCT05540717|592173686|FG001|Overall Study|Withdrawal by Subject|6|||
163946566|NCT05540717|592173685|FG000|Overall Study|Sponsor request|1|||
163946567|NCT05540717|592173686|FG001|Overall Study|Sponsor request|0|||
163946568|NCT05540717|592173685|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
163946569|NCT05540717|592173686|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
163946570|NCT05540717|592173685|FG000|Overall Study|Other|0|||
163946571|NCT05540717|592173686|FG001|Overall Study|Other|1|||
163946572|NCT01144052|592173687|FG000|Overall Study|Withdrawal by Subject|1|||
163946573|NCT01144052|592173688|FG001|Overall Study|Withdrawal by Subject|1|||
163946574|NCT03836716|592173692|FG000|Overall Study|Adverse Event|3|||
163946575|NCT03836716|592173692|FG000|Overall Study|Death|22|||
163946576|NCT03836716|592173692|FG000|Overall Study|Withdrawal by Subject|8|||
163946577|NCT03836716|592173692|FG000|Overall Study|Study terminated by sponsor|87|||
163946578|NCT01879722|592173693|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
163946579|NCT01879722|592173694|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
163946580|NCT01879722|592173695|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
163946581|NCT01879722|592173696|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
163946582|NCT01879722|592173697|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
163946583|NCT01879722|592173698|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
163946584|NCT01879722|592173699|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
163946585|NCT01879722|592173700|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
163946586|NCT01879722|592173701|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
163946587|NCT01879722|592173702|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
163946588|NCT01879722|592173693|FG000|Overall Study|Voluntary Withdrawal|0|||
163946589|NCT01879722|592173694|FG001|Overall Study|Voluntary Withdrawal|0|||
163946590|NCT01879722|592173695|FG002|Overall Study|Voluntary Withdrawal|0|||
163946591|NCT01879722|592173696|FG003|Overall Study|Voluntary Withdrawal|0|||
163946592|NCT01879722|592173697|FG004|Overall Study|Voluntary Withdrawal|0|||
163946593|NCT01879722|592173698|FG005|Overall Study|Voluntary Withdrawal|0|||
163946594|NCT01879722|592173699|FG006|Overall Study|Voluntary Withdrawal|0|||
163946595|NCT01879722|592173700|FG007|Overall Study|Voluntary Withdrawal|0|||
163946596|NCT01879722|592173701|FG008|Overall Study|Voluntary Withdrawal|1|||
163946597|NCT01879722|592173702|FG009|Overall Study|Voluntary Withdrawal|0|||
163946598|NCT01983254|592173703|FG000|Overall Study|Death|6|||
163946599|NCT01983254|592173704|FG001|Overall Study|Death|6|||
163946600|NCT01983254|592173703|FG000|Overall Study|Lost to Follow-up|17|||
163946601|NCT01983254|592173704|FG001|Overall Study|Lost to Follow-up|16|||
163946602|NCT01983254|592173703|FG000|Overall Study|too ill|11|||
163946603|NCT01983254|592173704|FG001|Overall Study|too ill|8|||
163946604|NCT00037830|592173707|FG000|Overall Study|Adverse Event|2|||
163946605|NCT00037830|592173708|FG001|Overall Study|Adverse Event|0|||
163946606|NCT00037830|592173709|FG002|Overall Study|Adverse Event|0|||
163946607|NCT00037830|592173707|FG000|Overall Study|Withdrawal by Subject|4|||
163946608|NCT00037830|592173708|FG001|Overall Study|Withdrawal by Subject|5|||
163946609|NCT00037830|592173709|FG002|Overall Study|Withdrawal by Subject|1|||
163946610|NCT00037830|592173707|FG000|Overall Study|Protocol Violation|2|||
163946611|NCT00037830|592173708|FG001|Overall Study|Protocol Violation|2|||
164099308|NCT04786184|592728878|FG000|Overall Study|Adverse Event|4|||
164099309|NCT04786184|592728879|FG001|Overall Study|Adverse Event|0|||
164099310|NCT04786184|592728878|FG000|Overall Study|Withdrawal by Subject|3|||
163946612|NCT00037830|592173709|FG002|Overall Study|Protocol Violation|0|||
163946613|NCT00037830|592173707|FG000|Overall Study|Unrelated Medical Problem|2|||
163946614|NCT00037830|592173708|FG001|Overall Study|Unrelated Medical Problem|0|||
163946615|NCT00037830|592173709|FG002|Overall Study|Unrelated Medical Problem|0|||
163946616|NCT03582943|592173712|FG000|Allocated to Groups|Withdrawal by Subject|1|||
163946617|NCT03582943|592173713|FG001|Allocated to Groups|Withdrawal by Subject|1|||
164148615|NCT04895982|592904911|FG000|Overall Study|Protocol Violation|0|||
164046626|NCT02406027|592528758|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
164046627|NCT02406027|592528759|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
164046628|NCT02406027|592528760|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
164046629|NCT02406027|592528761|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
164046630|NCT02406027|592528762|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
164046631|NCT02406027|592528756|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
164046632|NCT02406027|592528757|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
164046633|NCT02406027|592528758|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
164046634|NCT02406027|592528759|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
164046635|NCT02406027|592528760|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
164046636|NCT02406027|592528761|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
164046637|NCT02406027|592528762|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
164046638|NCT02406027|592528756|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164046639|NCT02406027|592528757|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164046640|NCT02406027|592528758|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164046641|NCT02406027|592528759|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
164046642|NCT02406027|592528760|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
164046643|NCT02406027|592528761|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
164046644|NCT02406027|592528762|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
164046645|NCT02406027|592528756|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
164046646|NCT02406027|592528757|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
164046647|NCT02406027|592528758|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
164046648|NCT02406027|592528759|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
164046649|NCT02406027|592528760|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
164046650|NCT02406027|592528761|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
164046651|NCT02406027|592528762|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
164046652|NCT02406027|592528756|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164046653|NCT02406027|592528757|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164046654|NCT02406027|592528758|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164046655|NCT02406027|592528759|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164046656|NCT02406027|592528760|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164046657|NCT02406027|592528761|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
164046658|NCT02406027|592528762|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
164046659|NCT02406027|592528756|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164046660|NCT02406027|592528757|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164046661|NCT02406027|592528758|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164046662|NCT02406027|592528759|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164046663|NCT02406027|592528760|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
164046664|NCT02406027|592528761|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164046665|NCT02406027|592528762|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
164046666|NCT04363944|592528763|FG000|Overall Study|Withdrawal by Subject|2|||
164046667|NCT04363944|592528764|FG001|Overall Study|Withdrawal by Subject|0|||
164046668|NCT03559192|592528765|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
164046669|NCT03559192|592528766|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
164046670|NCT03559192|592528767|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
164046671|NCT03559192|592528765|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
164046672|NCT03559192|592528766|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
164046673|NCT03559192|592528767|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
164046674|NCT03559192|592528765|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
164046675|NCT03559192|592528766|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
164046676|NCT03559192|592528767|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
164046677|NCT03559192|592528765|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
164046678|NCT03559192|592528766|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
164046679|NCT03559192|592528767|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
164046680|NCT03559192|592528765|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
164046681|NCT03559192|592528766|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
163842471|NCT02023879|591793020|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
163842472|NCT02023879|591793021|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
163842473|NCT02023879|591793019|FG000|Extension Open Label Treatment|Participant moved|1|||
163842474|NCT02023879|591793020|FG001|Extension Open Label Treatment|Participant moved|2|||
163842475|NCT02023879|591793021|FG002|Extension Open Label Treatment|Participant moved|0|||
163842476|NCT02023879|591793019|FG000|Extension Open Label Treatment|Other than specified above|2|||
163842477|NCT02023879|591793020|FG001|Extension Open Label Treatment|Other than specified above|7|||
163842478|NCT02023879|591793021|FG002|Extension Open Label Treatment|Other than specified above|2|||
163842479|NCT00874432|591793022|FG000|Overall Study|Withdrawal by Subject|1|||
163842480|NCT00874432|591793023|FG001|Overall Study|Withdrawal by Subject|0|||
163842481|NCT00874432|591793024|FG002|Overall Study|Withdrawal by Subject|0|||
164099311|NCT04786184|592728879|FG001|Overall Study|Withdrawal by Subject|1|||
164099312|NCT04786184|592728878|FG000|Overall Study|Lost to Follow-up|4|||
164099313|NCT04786184|592728879|FG001|Overall Study|Lost to Follow-up|2|||
164099314|NCT02255097|592728880|FG000|Overall Study|Death|151|||
164099315|NCT02255097|592728880|FG000|Overall Study|Lost to Follow-up|5|||
164099316|NCT02255097|592728880|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
164099317|NCT02255097|592728880|FG000|Overall Study|Withdrawal by Subject|7|||
164099318|NCT02255097|592728880|FG000|Overall Study|Allocated but not treated|1|||
164099319|NCT04239872|592728881|FG000|Overall Study|Lost to Follow-up|0|||
164099320|NCT04239872|592728882|FG001|Overall Study|Lost to Follow-up|1|||
164099321|NCT03956862|592728885|FG000|Overall Study|Lost to Follow-up|1|||
164099322|NCT03956862|592728886|FG001|Overall Study|Lost to Follow-up|1|||
163946618|NCT03582943|592173712|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
164099323|NCT03956862|592728885|FG000|Overall Study|Withdrawal by Subject|1|||
164099324|NCT03956862|592728886|FG001|Overall Study|Withdrawal by Subject|1|||
163946619|NCT03582943|592173713|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
163946620|NCT03582943|592173712|FG000|Analyzed|Protocol Violation|4|||
163946621|NCT03582943|592173713|FG001|Analyzed|Protocol Violation|1|||
163946622|NCT01631227|592173716|FG000|Overall Study|withdrawn consent|27|||
163946623|NCT01631227|592173717|FG001|Overall Study|withdrawn consent|21|||
163946624|NCT01631227|592173716|FG000|Overall Study|Adverse Event|1|||
163946625|NCT01631227|592173717|FG001|Overall Study|Adverse Event|0|||
163946626|NCT01631227|592173716|FG000|Overall Study|administrative|2|||
163946627|NCT01631227|592173717|FG001|Overall Study|administrative|1|||
163946628|NCT01153321|592173718|FG000|Overall Study|Development of study withdrawal criteria|0|||
163946629|NCT01153321|592173719|FG001|Overall Study|Development of study withdrawal criteria|1|||
163946630|NCT01153321|592173718|FG000|Overall Study|Withdrawal by Subject|0|||
163946631|NCT01153321|592173719|FG001|Overall Study|Withdrawal by Subject|1|||
163946632|NCT01153321|592173718|FG000|Overall Study|Adverse Event|1|||
163946633|NCT01153321|592173719|FG001|Overall Study|Adverse Event|1|||
163946634|NCT01177800|592173721|FG000|Overall Study|Adverse Event|9|||
163946635|NCT01177800|592173722|FG001|Overall Study|Adverse Event|3|||
163946636|NCT01177800|592173721|FG000|Overall Study|Protocol Violation|0|||
163946637|NCT01177800|592173722|FG001|Overall Study|Protocol Violation|1|||
163946638|NCT01177800|592173721|FG000|Overall Study|Physician Decision|1|||
163946639|NCT01177800|592173722|FG001|Overall Study|Physician Decision|0|||
163946640|NCT01177800|592173721|FG000|Overall Study|Withdrawal of informed consent|0|||
163946641|NCT01177800|592173722|FG001|Overall Study|Withdrawal of informed consent|1|||
163946642|NCT03527550|592173723|FG000|Overall Study|Lost to Follow-up|4|||
163946643|NCT03527550|592173724|FG001|Overall Study|Lost to Follow-up|2|||
163946644|NCT03527550|592173723|FG000|Overall Study|Withdrawal by Subject|4|||
163946645|NCT03527550|592173724|FG001|Overall Study|Withdrawal by Subject|1|||
163946646|NCT03527550|592173723|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
163946647|NCT03527550|592173724|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
163946648|NCT03053518|592173729|FG000|Overall Study|Withdrawal by Subject|3|||
163946649|NCT03053518|592173729|FG000|Overall Study|Lost to Follow-up|2|||
163946650|NCT03053518|592173729|FG000|Overall Study|Ineligible|5|||
163946651|NCT02683876|592173730|FG000|Overall Study|samples damaged during shipping|2|||
163946652|NCT02683876|592173731|FG001|Overall Study|samples damaged during shipping|0|||
163946653|NCT01232738|592173732|FG000|Overall Study|Death|3|||
163946654|NCT01232738|592173732|FG000|Overall Study|Physician Decision|2|||
163946655|NCT01232738|592173732|FG000|Overall Study|Lost to Follow-up|1|||
163946656|NCT01232738|592173732|FG000|Overall Study|Withdrawal by Subject|2|||
163946657|NCT01232738|592173732|FG000|Overall Study|Adverse Event|5|||
163946658|NCT03231800|592173737|FG000|Overall Study|Lost to Follow-up|0|||
163946659|NCT03231800|592173738|FG001|Overall Study|Lost to Follow-up|2|||
163946660|NCT03231800|592173737|FG000|Overall Study|Protocol Violation|1|||
163946661|NCT03231800|592173738|FG001|Overall Study|Protocol Violation|1|||
163946662|NCT03231800|592173737|FG000|Overall Study|reason not provided|2|||
163946663|NCT03231800|592173738|FG001|Overall Study|reason not provided|0|||
163946664|NCT00488475|592173739|FG000|Overall Study|Other|1754|||
163946665|NCT00400725|592173750|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
163946666|NCT00400725|592173751|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
163946667|NCT00400725|592173752|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
163946668|NCT00400725|592173750|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
163946669|NCT00400725|592173751|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
163946670|NCT00400725|592173752|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
163946671|NCT00400725|592173750|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
163946672|NCT00400725|592173751|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
163946673|NCT00400725|592173752|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
163946674|NCT00400725|592173750|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
163946675|NCT00400725|592173751|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
163946676|NCT00400725|592173752|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
163946677|NCT00400725|592173750|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
163946678|NCT00400725|592173751|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
164099325|NCT01498120|592728887|FG000|Overall Study|Lost to Follow-up|1|||
164099326|NCT01498120|592728887|FG000|Overall Study|Withdrawal by Subject|5|||
164099327|NCT01498120|592728887|FG000|Overall Study|AE, non-serious non-fatal|3|||
164099328|NCT01498120|592728887|FG000|Overall Study|Other|4|||
164099329|NCT02294604|592728888|FG000|Overall Study|Did not provide samples for culture|0|||
164099330|NCT02294604|592728889|FG001|Overall Study|Did not provide samples for culture|1|||
164099331|NCT02294604|592728890|FG002|Overall Study|Did not provide samples for culture|0|||
164099332|NCT02294604|592728888|FG000|Overall Study|Culture contamination|1|||
164099333|NCT02294604|592728889|FG001|Overall Study|Culture contamination|2|||
164099334|NCT02294604|592728890|FG002|Overall Study|Culture contamination|0|||
164099335|NCT01118312|592728891|FG000|Overall Study|Lost to Follow-up|33|||
164099336|NCT01118312|592728892|FG001|Overall Study|Lost to Follow-up|32|||
164099337|NCT01118312|592728891|FG000|Overall Study|Withdrawal by Subject|1|||
164099338|NCT01118312|592728892|FG001|Overall Study|Withdrawal by Subject|3|||
164099339|NCT01975948|592728893|FG000|Overall Study|Withdrawal by Subject|17|||
164099340|NCT01975948|592728894|FG001|Overall Study|Withdrawal by Subject|21|||
164099341|NCT01975948|592728895|FG002|Overall Study|Withdrawal by Subject|7|||
164099342|NCT01975948|592728896|FG003|Overall Study|Withdrawal by Subject|6|||
164099343|NCT01675765|592728897|FG000|Overall Study|Progressive disease|4|||
164099344|NCT01675765|592728898|FG001|Overall Study|Progressive disease|4|||
164099345|NCT01675765|592728897|FG000|Overall Study|Adverse Event|1|||
164099346|NCT01675765|592728898|FG001|Overall Study|Adverse Event|2|||
164099347|NCT01675765|592728897|FG000|Overall Study|Withdrawal by Subject|2|||
164099348|NCT01675765|592728898|FG001|Overall Study|Withdrawal by Subject|0|||
164099349|NCT01675765|592728897|FG000|Overall Study|Death|1|||
164099350|NCT01675765|592728898|FG001|Overall Study|Death|0|||
164099351|NCT01675765|592728897|FG000|Overall Study|Clinical progression|3|||
164099352|NCT01675765|592728898|FG001|Overall Study|Clinical progression|2|||
164099353|NCT03965091|592728899|FG000|Overall Study|Adverse Event|0|||
164099354|NCT03965091|592728900|FG001|Overall Study|Adverse Event|2|||
164099355|NCT03965091|592728901|FG002|Overall Study|Adverse Event|3|||
164099356|NCT03965091|592728899|FG000|Overall Study|Withdrawal by Subject|11|||
164099357|NCT03965091|592728900|FG001|Overall Study|Withdrawal by Subject|3|||
164099358|NCT03965091|592728901|FG002|Overall Study|Withdrawal by Subject|5|||
164099359|NCT03965091|592728899|FG000|Overall Study|Non-compliance with study drug|0|||
164099360|NCT03965091|592728900|FG001|Overall Study|Non-compliance with study drug|0|||
164099361|NCT03965091|592728901|FG002|Overall Study|Non-compliance with study drug|1|||
164099362|NCT03965091|592728899|FG000|Overall Study|Lost to Follow-up|1|||
164099363|NCT03965091|592728900|FG001|Overall Study|Lost to Follow-up|1|||
164099364|NCT03965091|592728901|FG002|Overall Study|Lost to Follow-up|1|||
164099365|NCT03965091|592728899|FG000|Overall Study|Lack of Efficacy|2|||
164099366|NCT03965091|592728900|FG001|Overall Study|Lack of Efficacy|0|||
164099367|NCT03965091|592728901|FG002|Overall Study|Lack of Efficacy|0|||
164099368|NCT03965091|592728899|FG000|Overall Study|Other than specified|9|||
164099369|NCT03965091|592728900|FG001|Overall Study|Other than specified|11|||
164099370|NCT03965091|592728901|FG002|Overall Study|Other than specified|8|||
164099371|NCT04060147|592728903|FG000|Overall Study|Withdrew consent|1|||
164099372|NCT01534520|592728904|FG000|Overall Study|Adverse Event|0|||
164099373|NCT01534520|592728905|FG001|Overall Study|Adverse Event|1|||
164099374|NCT00565448|592728906|FG000|Overall Study|Adverse Event|1|||
164099375|NCT00565448|592728907|FG001|Overall Study|Adverse Event|2|||
164099376|NCT00565448|592728906|FG000|Overall Study|Disease progression|1|||
164099377|NCT00565448|592728907|FG001|Overall Study|Disease progression|0|||
164099378|NCT00565448|592728906|FG000|Overall Study|Withdrawal by Subject|1|||
164099379|NCT00565448|592728907|FG001|Overall Study|Withdrawal by Subject|0|||
164099380|NCT00193609|592728908|FG000|Overall Study|Lack of Efficacy|2|||
164099381|NCT00193609|592728908|FG000|Overall Study|Adverse Event|2|||
164099382|NCT00302952|592728909|FG000|Overall Study|Physician Decision|1|||
164099383|NCT00302952|592728910|FG001|Overall Study|Physician Decision|1|||
164099384|NCT00302952|592728909|FG000|Overall Study|Withdrawal by Subject|2|||
164099385|NCT00302952|592728910|FG001|Overall Study|Withdrawal by Subject|3|||
164099386|NCT00302952|592728909|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
164099387|NCT00302952|592728910|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
164099388|NCT02979353|592728911|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
163842482|NCT00874432|591793025|FG003|Overall Study|Withdrawal by Subject|0|||
163842483|NCT00874432|591793022|FG000|Overall Study|Physician Decision|1|||
164099389|NCT02979353|592728912|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
163842484|NCT00874432|591793023|FG001|Overall Study|Physician Decision|0|||
163842485|NCT00874432|591793024|FG002|Overall Study|Physician Decision|0|||
164099390|NCT02979353|592728911|FG000|Overall Study|Withdrawal by Subject|16|||
164099391|NCT02979353|592728912|FG001|Overall Study|Withdrawal by Subject|12|||
164099392|NCT02979353|592728911|FG000|Overall Study|Death|10|||
164099393|NCT02979353|592728912|FG001|Overall Study|Death|11|||
164099394|NCT02979353|592728911|FG000|Overall Study|Transfer to Hospice Care|19|||
164099395|NCT02979353|592728912|FG001|Overall Study|Transfer to Hospice Care|14|||
164099396|NCT02979353|592728911|FG000|Overall Study|Lost to Follow-up|1|||
164099397|NCT02979353|592728912|FG001|Overall Study|Lost to Follow-up|5|||
164099398|NCT00857623|592728913|FG000|Overall Study|Adverse Event|5|||
164046682|NCT03559192|592528767|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
164046683|NCT03559192|592528765|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
164046684|NCT03559192|592528766|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
164046685|NCT03559192|592528767|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
164046686|NCT03559192|592528765|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
164046687|NCT03559192|592528766|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
164046688|NCT03559192|592528767|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
164046689|NCT03559192|592528765|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
164046690|NCT03559192|592528766|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
164046691|NCT03559192|592528767|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
164046692|NCT03559192|592528765|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
164046693|NCT03559192|592528766|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
164046694|NCT03559192|592528767|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
164046695|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
164046696|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
164046697|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Death|0|||
164046698|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Death|4|||
164046699|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
164046700|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
164046701|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
164046702|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
164046703|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
164046704|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
164046705|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
164046706|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
164046707|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
164046708|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
164046709|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Other|4|||
164046710|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Other|3|||
164046711|NCT03517722|592528768|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
164046712|NCT03517722|592528769|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
164046713|NCT03517722|592528768|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
164046714|NCT03517722|592528769|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
164046715|NCT03517722|592528768|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
164046716|NCT03517722|592528769|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
164046717|NCT03517722|592528768|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
164046718|NCT03517722|592528769|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
164046719|NCT03517722|592528768|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
164046720|NCT03517722|592528769|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
164046721|NCT01673373|592530460|FG000|Overall Study|Death|2|||
164046722|NCT00166504|592530461|FG000|Overall Study|Adverse Event|3|||
164046723|NCT00166504|592530462|FG001|Overall Study|Adverse Event|3|||
164046724|NCT00166504|592530461|FG000|Overall Study|Lost to Follow-up|1|||
164046725|NCT00166504|592530462|FG001|Overall Study|Lost to Follow-up|1|||
164046726|NCT00166504|592530461|FG000|Overall Study|Withdrawal by Subject|1|||
164046727|NCT00166504|592530462|FG001|Overall Study|Withdrawal by Subject|0|||
164046728|NCT03261037|592530465|FG000|Overall Study|Withdrawal by Subject|2|||
164046729|NCT03261037|592530466|FG001|Overall Study|Withdrawal by Subject|13|||
164046730|NCT03261037|592530467|FG002|Overall Study|Withdrawal by Subject|0|||
164046731|NCT03261037|592530468|FG003|Overall Study|Withdrawal by Subject|18|||
164046732|NCT03261037|592530465|FG000|Overall Study|Non-compliance with study procedures|0|||
164046733|NCT03261037|592530466|FG001|Overall Study|Non-compliance with study procedures|2|||
164046734|NCT03261037|592530467|FG002|Overall Study|Non-compliance with study procedures|0|||
164046735|NCT03261037|592530468|FG003|Overall Study|Non-compliance with study procedures|6|||
164046736|NCT03261037|592530465|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
164046737|NCT03261037|592530466|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
164046738|NCT03261037|592530467|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
164046739|NCT03261037|592530468|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
164046740|NCT03261037|592530465|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
164046741|NCT03261037|592530466|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
164046742|NCT03261037|592530467|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
164046743|NCT03261037|592530468|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
164046744|NCT03261037|592530465|FG000|Overall Study|Diagnosed but protocol deviation|1|||
164046745|NCT03261037|592530466|FG001|Overall Study|Diagnosed but protocol deviation|0|||
164046746|NCT03261037|592530467|FG002|Overall Study|Diagnosed but protocol deviation|0|||
164046747|NCT03261037|592530468|FG003|Overall Study|Diagnosed but protocol deviation|0|||
164099399|NCT00857623|592728914|FG001|Overall Study|Adverse Event|2|||
163946679|NCT00400725|592173752|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
163946680|NCT00400725|592173750|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
163946681|NCT00400725|592173751|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
163946682|NCT00400725|592173752|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
163946683|NCT00400725|592173750|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
163946684|NCT00400725|592173751|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
163946685|NCT00400725|592173752|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
163946686|NCT00400725|592173750|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
163946687|NCT00400725|592173751|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
163946688|NCT00400725|592173752|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
163946689|NCT00400725|592173750|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
163946690|NCT00400725|592173751|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
163946691|NCT00400725|592173752|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
163946692|NCT00252577|592173753|FG000|Overall Study|Lost to Follow-up|20|||
163946693|NCT00560066|592173754|FG000|Overall Study|Death|2|||
163946694|NCT00560066|592173755|FG001|Overall Study|Death|1|||
163946695|NCT00560066|592173754|FG000|Overall Study|Withdrawal by Subject|0|||
163946696|NCT00560066|592173755|FG001|Overall Study|Withdrawal by Subject|3|||
163946697|NCT00560066|592173754|FG000|Overall Study|Lost to Follow-up|4|||
163946698|NCT00560066|592173755|FG001|Overall Study|Lost to Follow-up|10|||
163946699|NCT00560066|592173754|FG000|Overall Study|Protocol Violation|0|||
163946700|NCT00560066|592173755|FG001|Overall Study|Protocol Violation|1|||
163946701|NCT00560066|592173754|FG000|Overall Study|Administrative reason|0|||
163946702|NCT00560066|592173755|FG001|Overall Study|Administrative reason|5|||
163946703|NCT00560066|592173754|FG000|Overall Study|Missing primary reason|0|||
163946704|NCT00560066|592173755|FG001|Overall Study|Missing primary reason|2|||
163946705|NCT01163292|592173756|FG000|Overall Study|Lack of Efficacy|9|||
163946706|NCT01163292|592173757|FG001|Overall Study|Lack of Efficacy|0|||
163946707|NCT01163292|592173756|FG000|Overall Study|Adverse Event|6|||
163946708|NCT01163292|592173757|FG001|Overall Study|Adverse Event|0|||
163946709|NCT01163292|592173756|FG000|Overall Study|Initiation of biological therapy|0|||
163946710|NCT01163292|592173757|FG001|Overall Study|Initiation of biological therapy|15|||
163946711|NCT01163292|592173756|FG000|Overall Study|Sufficient response to adalimumab|8|||
163946712|NCT01163292|592173757|FG001|Overall Study|Sufficient response to adalimumab|0|||
163946713|NCT01163292|592173756|FG000|Overall Study|Refusal to receive adalimumab|7|||
163946714|NCT01163292|592173757|FG001|Overall Study|Refusal to receive adalimumab|0|||
163946715|NCT01163292|592173756|FG000|Overall Study|Economic reasons|6|||
163946716|NCT01163292|592173757|FG001|Overall Study|Economic reasons|0|||
163946717|NCT01163292|592173756|FG000|Overall Study|No further visits|5|||
163946718|NCT01163292|592173757|FG001|Overall Study|No further visits|7|||
163946719|NCT02535091|592173758|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
163946720|NCT02535091|592173759|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
163946721|NCT02535091|592173760|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
163946722|NCT02535091|592173758|FG000|Overall Study|Withdrawal by Subject|14|||
163946723|NCT02535091|592173759|FG001|Overall Study|Withdrawal by Subject|5|||
163946724|NCT02535091|592173760|FG002|Overall Study|Withdrawal by Subject|121|||
163946725|NCT02535091|592173758|FG000|Overall Study|Adverse Event|9|||
163946726|NCT02535091|592173759|FG001|Overall Study|Adverse Event|4|||
163946727|NCT02535091|592173760|FG002|Overall Study|Adverse Event|170|||
163946728|NCT02535091|592173758|FG000|Overall Study|Other|4|||
163946729|NCT02535091|592173759|FG001|Overall Study|Other|3|||
163946730|NCT02535091|592173760|FG002|Overall Study|Other|81|||
163946731|NCT02535091|592173758|FG000|Overall Study|Lost to Follow-up|0|||
163946732|NCT02535091|592173759|FG001|Overall Study|Lost to Follow-up|1|||
163946733|NCT02535091|592173760|FG002|Overall Study|Lost to Follow-up|19|||
163946734|NCT02535091|592173758|FG000|Overall Study|Protocol Violation|0|||
163946735|NCT02535091|592173759|FG001|Overall Study|Protocol Violation|1|||
163946736|NCT02535091|592173760|FG002|Overall Study|Protocol Violation|11|||
163946737|NCT02535091|592173758|FG000|Overall Study|Pregnancy|0|||
163946738|NCT02535091|592173759|FG001|Overall Study|Pregnancy|0|||
163946739|NCT02535091|592173760|FG002|Overall Study|Pregnancy|7|||
163946740|NCT02643472|592173764|FG000|Overall Study|Death|2|||
163946741|NCT02643472|592173765|FG001|Overall Study|Death|5|||
163946742|NCT02643472|592173764|FG000|Overall Study|Withdrawal by Subject|3|||
163946743|NCT02643472|592173765|FG001|Overall Study|Withdrawal by Subject|2|||
163946744|NCT02643472|592173764|FG000|Overall Study|Protocol Violation|0|||
163946745|NCT02643472|592173765|FG001|Overall Study|Protocol Violation|1|||
163946746|NCT02643472|592173764|FG000|Overall Study|Lost to Follow-up|22|||
163946747|NCT02643472|592173765|FG001|Overall Study|Lost to Follow-up|26|||
163946748|NCT01259089|592173770|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163946749|NCT01259089|592173771|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163946750|NCT01259089|592173772|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164046748|NCT03261037|592530465|FG000|Overall Study|Participant did not want to continue the study|0|||
163946751|NCT01259089|592173773|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
163946752|NCT01259089|592173774|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
164099400|NCT00857623|592728913|FG000|Overall Study|Study-specific discontinuation criteria|5|||
164099401|NCT00857623|592728914|FG001|Overall Study|Study-specific discontinuation criteria|3|||
164099402|NCT00857623|592728913|FG000|Overall Study|Withdrawal by Subject|2|||
164099403|NCT00857623|592728914|FG001|Overall Study|Withdrawal by Subject|1|||
164099404|NCT00857623|592728913|FG000|Overall Study|Lack of Efficacy|1|||
164099405|NCT00857623|592728914|FG001|Overall Study|Lack of Efficacy|1|||
164099406|NCT00857623|592728913|FG000|Overall Study|Severe non-compliance to protocol|1|||
164099407|NCT00857623|592728914|FG001|Overall Study|Severe non-compliance to protocol|1|||
164099408|NCT00857623|592728913|FG000|Overall Study|Intake of prohibited medication|0|||
164099409|NCT00857623|592728914|FG001|Overall Study|Intake of prohibited medication|1|||
164099410|NCT00857623|592728913|FG000|Overall Study|Positive for HEP C|0|||
164099411|NCT00857623|592728914|FG001|Overall Study|Positive for HEP C|1|||
164099412|NCT04185909|592728915|FG000|Overall Study|Lost to Follow-up|1|||
164099413|NCT03435081|592728916|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
164099414|NCT03435081|592728917|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
164099415|NCT03435081|592728918|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
164099416|NCT03435081|592728916|FG000|Week 0 to Week 16|Adverse Event|2|||
164099417|NCT03435081|592728917|FG001|Week 0 to Week 16|Adverse Event|2|||
164099418|NCT03435081|592728918|FG002|Week 0 to Week 16|Adverse Event|2|||
164099419|NCT03435081|592728916|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
164099420|NCT03435081|592728917|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
164099421|NCT03435081|592728918|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
164099422|NCT03435081|592728916|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
164099423|NCT03435081|592728917|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
164099424|NCT03435081|592728918|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
164099425|NCT03435081|592728916|FG000|Week 0 to Week 16|Pregnancy|1|||
164099426|NCT03435081|592728917|FG001|Week 0 to Week 16|Pregnancy|0|||
164099427|NCT03435081|592728918|FG002|Week 0 to Week 16|Pregnancy|0|||
164099428|NCT03435081|592728916|FG000|Week 0 to Week 16|Non-compliance|1|||
164099429|NCT03435081|592728917|FG001|Week 0 to Week 16|Non-compliance|0|||
164099430|NCT03435081|592728918|FG002|Week 0 to Week 16|Non-compliance|2|||
164099431|NCT03435081|592728916|FG000|Week 0 to Week 16|Inadequate Response|0|||
163842486|NCT00874432|591793025|FG003|Overall Study|Physician Decision|0|||
163842487|NCT00874432|591793022|FG000|Overall Study|Other|1|||
163842488|NCT00874432|591793023|FG001|Overall Study|Other|2|||
163842489|NCT00874432|591793024|FG002|Overall Study|Other|8|||
163842490|NCT00874432|591793025|FG003|Overall Study|Other|3|||
163842491|NCT05256381|591793026|FG000|Overall Study|Withdrawal by Subject|4|||
164099432|NCT03435081|592728917|FG001|Week 0 to Week 16|Inadequate Response|1|||
164099433|NCT03435081|592728918|FG002|Week 0 to Week 16|Inadequate Response|0|||
164099434|NCT03435081|592728916|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
164099435|NCT03435081|592728917|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
164099436|NCT03435081|592728918|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
164099437|NCT03435081|592728916|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
164099438|NCT03435081|592728917|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
164099439|NCT03435081|592728918|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
164099440|NCT03435081|592728916|FG000|Week 16 to Week 104|Adverse Event|1|||
164099441|NCT03435081|592728917|FG001|Week 16 to Week 104|Adverse Event|0|||
164099442|NCT03435081|592728918|FG002|Week 16 to Week 104|Adverse Event|2|||
164099443|NCT03435081|592728916|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
164099444|NCT03435081|592728917|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
164099445|NCT03435081|592728918|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
164099446|NCT03435081|592728916|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
164099447|NCT03435081|592728917|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
164099448|NCT03435081|592728918|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
164099449|NCT03435081|592728916|FG000|Week 16 to Week 104|Non--Compliance|0|||
164099450|NCT03435081|592728917|FG001|Week 16 to Week 104|Non--Compliance|0|||
164099451|NCT03435081|592728918|FG002|Week 16 to Week 104|Non--Compliance|1|||
164099452|NCT02601560|592728919|FG000|Overall Study|Other|0|||
164099453|NCT02601560|592728920|FG001|Overall Study|Other|0|||
164099454|NCT02601560|592728921|FG002|Overall Study|Other|0|||
164099455|NCT02601560|592728922|FG003|Overall Study|Other|0|||
164099456|NCT02601560|592728923|FG004|Overall Study|Other|0|||
164099457|NCT02601560|592728924|FG005|Overall Study|Other|0|||
164099458|NCT02601560|592728925|FG006|Overall Study|Other|1|||
164099459|NCT02601560|592728926|FG007|Overall Study|Other|0|||
164099460|NCT00420238|592728929|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
164099461|NCT00420238|592728930|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
164099462|NCT00420238|592728929|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
164099463|NCT00420238|592728930|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
164099464|NCT00420238|592728929|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
164099465|NCT00420238|592728930|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
164099466|NCT00420238|592728929|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
164099467|NCT00420238|592728930|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
163842492|NCT05256381|591793027|FG001|Overall Study|Withdrawal by Subject|0|||
164099468|NCT00420238|592728929|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
163946753|NCT01259089|592173775|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
163946754|NCT01259089|592173770|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
163946755|NCT01259089|592173771|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
163946756|NCT01259089|592173772|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
163946757|NCT01259089|592173773|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
163946758|NCT01259089|592173774|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
163946759|NCT01259089|592173775|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
163946760|NCT01259089|592173770|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163946761|NCT01259089|592173771|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163946762|NCT01259089|592173772|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163946763|NCT01259089|592173773|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163946764|NCT01259089|592173774|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
163946765|NCT01259089|592173775|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
163946766|NCT01259089|592173770|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
163946767|NCT01259089|592173771|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
163946768|NCT01259089|592173772|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
163946769|NCT01259089|592173773|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
163946770|NCT01259089|592173774|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
163946771|NCT01259089|592173775|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
163946772|NCT01259089|592173770|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
163946773|NCT01259089|592173771|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
163946774|NCT01259089|592173772|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
163946775|NCT01259089|592173773|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
163946776|NCT01259089|592173774|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
163946777|NCT01259089|592173775|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
163946778|NCT01259089|592173770|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
163946779|NCT01259089|592173771|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163946780|NCT01259089|592173772|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163946781|NCT01259089|592173773|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163946782|NCT01259089|592173774|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163946783|NCT01259089|592173775|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
163946784|NCT01259089|592173770|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
163946785|NCT01259089|592173771|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
163946786|NCT01259089|592173772|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
163946787|NCT01259089|592173773|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
163946788|NCT01259089|592173774|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
163946789|NCT01259089|592173775|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
163946790|NCT01259089|592173770|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
163946791|NCT01259089|592173771|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
163946792|NCT01259089|592173772|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
163946793|NCT01259089|592173773|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
163946794|NCT01259089|592173774|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
163946795|NCT01259089|592173775|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
163946796|NCT01259089|592173770|FG000|Survival Follow up for Two Years|Death|3|||
163946797|NCT01259089|592173771|FG001|Survival Follow up for Two Years|Death|2|||
163946798|NCT01259089|592173772|FG002|Survival Follow up for Two Years|Death|2|||
163946799|NCT01259089|592173773|FG003|Survival Follow up for Two Years|Death|3|||
163946800|NCT01259089|592173774|FG004|Survival Follow up for Two Years|Death|6|||
163946801|NCT01259089|592173775|FG005|Survival Follow up for Two Years|Death|13|||
163946802|NCT01259089|592173770|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
163946803|NCT01259089|592173771|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
163946804|NCT01259089|592173772|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
163946805|NCT01259089|592173773|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
163946806|NCT01259089|592173774|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
163946807|NCT01259089|592173775|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
163946808|NCT01259089|592173770|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
164099469|NCT00420238|592728930|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
164099470|NCT00420238|592728929|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
164099471|NCT00420238|592728930|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
163946809|NCT01259089|592173771|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163946810|NCT01259089|592173772|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163946811|NCT01259089|592173773|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163946812|NCT01259089|592173774|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
163946813|NCT01259089|592173775|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
163946814|NCT01215188|592173776|FG000|Overall Study|Lost to Follow-up|22|||
163946815|NCT01215188|592173777|FG001|Overall Study|Lost to Follow-up|22|||
163946816|NCT01215188|592173778|FG002|Overall Study|Lost to Follow-up|16|||
163946817|NCT01215188|592173776|FG000|Overall Study|Adverse Event|1|||
163946818|NCT01215188|592173777|FG001|Overall Study|Adverse Event|1|||
163946819|NCT01215188|592173778|FG002|Overall Study|Adverse Event|3|||
163946820|NCT01215188|592173776|FG000|Overall Study|Physician Decision|2|||
163946821|NCT01215188|592173777|FG001|Overall Study|Physician Decision|1|||
163946822|NCT01215188|592173778|FG002|Overall Study|Physician Decision|0|||
163946823|NCT01215188|592173776|FG000|Overall Study|Lack of Efficacy|0|||
163946824|NCT01215188|592173777|FG001|Overall Study|Lack of Efficacy|0|||
163946825|NCT01215188|592173778|FG002|Overall Study|Lack of Efficacy|1|||
163946826|NCT01215188|592173776|FG000|Overall Study|Protocol Violation|1|||
163946827|NCT01215188|592173777|FG001|Overall Study|Protocol Violation|1|||
163946828|NCT01215188|592173778|FG002|Overall Study|Protocol Violation|1|||
163946829|NCT01215188|592173776|FG000|Overall Study|Withdrawal by Subject|32|||
163946830|NCT01215188|592173777|FG001|Overall Study|Withdrawal by Subject|34|||
163946831|NCT01215188|592173778|FG002|Overall Study|Withdrawal by Subject|31|||
163946832|NCT00688870|592173779|FG000|Infant Series|Parent or legal guardian request|4|||
163946833|NCT00688870|592173780|FG001|Infant Series|Parent or legal guardian request|0|||
163946834|NCT01151410|592173783|FG000|Overall Study|Withdrawal by Subject|3|||
163946835|NCT01151410|592173784|FG001|Overall Study|Withdrawal by Subject|5|||
163946836|NCT01151410|592173783|FG000|Overall Study|Lost to Follow-up|3|||
163946837|NCT01151410|592173784|FG001|Overall Study|Lost to Follow-up|4|||
163946838|NCT01151410|592173783|FG000|Overall Study|Adverse Event|1|||
163946839|NCT01151410|592173784|FG001|Overall Study|Adverse Event|2|||
163946840|NCT01151410|592173783|FG000|Overall Study|Protocol deviation|2|||
163946841|NCT01151410|592173784|FG001|Overall Study|Protocol deviation|1|||
163946842|NCT01151410|592173783|FG000|Overall Study|Administrative problems|1|||
163946843|NCT01151410|592173784|FG001|Overall Study|Administrative problems|1|||
163946844|NCT01151410|592173783|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
163946845|NCT01151410|592173784|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
163946846|NCT01151410|592173783|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163946847|NCT01151410|592173784|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163946848|NCT01253018|592173785|FG000|Overall Study|Lost to Follow-up|1|||
163946849|NCT01253018|592173786|FG001|Overall Study|Lost to Follow-up|1|||
163946850|NCT01253018|592173785|FG000|Overall Study|Robot Repair Issues|2|||
163946851|NCT01253018|592173786|FG001|Overall Study|Robot Repair Issues|0|||
163946852|NCT01253018|592173785|FG000|Overall Study|Withdrawal by Subject|1|||
163946853|NCT01253018|592173786|FG001|Overall Study|Withdrawal by Subject|1|||
163946854|NCT01593787|592173787|FG000|Overall Study|Adverse Event|1|||
163946855|NCT01593787|592173788|FG001|Overall Study|Adverse Event|0|||
163946856|NCT01593787|592173789|FG002|Overall Study|Adverse Event|0|||
163946857|NCT01133418|592173792|FG000|Overall Study|Lost to Follow-up|5|||
163946858|NCT01133418|592173793|FG001|Overall Study|Lost to Follow-up|6|||
163946859|NCT04150068|592173794|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
163946860|NCT04150068|592173795|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
163946861|NCT04150068|592173796|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
163946862|NCT04150068|592173794|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
163946863|NCT04150068|592173795|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
163946864|NCT04150068|592173796|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
163946865|NCT05316701|592173797|FG000|Overall Study|Adverse Event|0|||
163946866|NCT05316701|592173798|FG001|Overall Study|Adverse Event|1|||
163946867|NCT05316701|592173797|FG000|Overall Study|Death|3|||
163946868|NCT05316701|592173798|FG001|Overall Study|Death|9|||
163946869|NCT05316701|592173797|FG000|Overall Study|Lost to Follow-up|1|||
163946870|NCT05316701|592173798|FG001|Overall Study|Lost to Follow-up|0|||
163946871|NCT05316701|592173797|FG000|Overall Study|Physician Decision|1|||
163946872|NCT05316701|592173798|FG001|Overall Study|Physician Decision|4|||
163946873|NCT05316701|592173797|FG000|Overall Study|Withdrawal by Subject|3|||
163946874|NCT05316701|592173798|FG001|Overall Study|Withdrawal by Subject|5|||
163946875|NCT05316701|592173797|FG000|Overall Study|Progression/Relapse|14|||
163946876|NCT05316701|592173798|FG001|Overall Study|Progression/Relapse|9|||
163946877|NCT05316701|592173797|FG000|Overall Study|Received Standard of Care|1|||
163946878|NCT05316701|592173798|FG001|Overall Study|Received Standard of Care|0|||
164046749|NCT03261037|592530466|FG001|Overall Study|Participant did not want to continue the study|1|||
163946879|NCT05316701|592173797|FG000|Overall Study|Ongoing|70|||
163946880|NCT05316701|592173798|FG001|Overall Study|Ongoing|64|||
163946881|NCT04679935|592173799|FG000|Overall Study|Death|0|||
163946882|NCT04679935|592173800|FG001|Overall Study|Death|1|||
163946883|NCT00969709|592175465|FG000|Overall Study|Adverse Event|3|||
163946884|NCT00969709|592175466|FG001|Overall Study|Adverse Event|13|||
163946885|NCT00969709|592175467|FG002|Overall Study|Adverse Event|26|||
163946886|NCT00969709|592175468|FG003|Overall Study|Adverse Event|12|||
164046750|NCT03261037|592530467|FG002|Overall Study|Participant did not want to continue the study|0|||
163946887|NCT00969709|592175465|FG000|Overall Study|Lack of Efficacy|7|||
163946888|NCT00969709|592175466|FG001|Overall Study|Lack of Efficacy|4|||
163946889|NCT00969709|592175467|FG002|Overall Study|Lack of Efficacy|1|||
163946890|NCT00969709|592175468|FG003|Overall Study|Lack of Efficacy|3|||
163946891|NCT00969709|592175465|FG000|Overall Study|Protocol Violation|9|||
163946892|NCT00969709|592175466|FG001|Overall Study|Protocol Violation|5|||
163946893|NCT00969709|592175467|FG002|Overall Study|Protocol Violation|9|||
163946894|NCT00969709|592175468|FG003|Overall Study|Protocol Violation|10|||
163946895|NCT00969709|592175465|FG000|Overall Study|Withdrawal by Subject|9|||
163946896|NCT00969709|592175466|FG001|Overall Study|Withdrawal by Subject|12|||
163946897|NCT00969709|592175467|FG002|Overall Study|Withdrawal by Subject|11|||
163946898|NCT00969709|592175468|FG003|Overall Study|Withdrawal by Subject|23|||
163946899|NCT00969709|592175465|FG000|Overall Study|Lost to Follow-up|10|||
163946900|NCT00969709|592175466|FG001|Overall Study|Lost to Follow-up|14|||
163946901|NCT00969709|592175467|FG002|Overall Study|Lost to Follow-up|8|||
163946902|NCT00969709|592175468|FG003|Overall Study|Lost to Follow-up|15|||
163946903|NCT00969709|592175465|FG000|Overall Study|Other reasons|0|||
163946904|NCT00969709|592175466|FG001|Overall Study|Other reasons|0|||
163946905|NCT00969709|592175467|FG002|Overall Study|Other reasons|3|||
163946906|NCT00969709|592175468|FG003|Overall Study|Other reasons|0|||
163946907|NCT03695237|592175469|FG000|Overall Study|Withdrawal by Subject|1|||
163946908|NCT03695237|592175470|FG001|Overall Study|Withdrawal by Subject|3|||
163946909|NCT03695237|592175469|FG000|Overall Study|Lost to Follow-up|1|||
163946910|NCT03695237|592175470|FG001|Overall Study|Lost to Follow-up|2|||
163946911|NCT03695237|592175469|FG000|Overall Study|Other, Not Specified|8|||
163946912|NCT03695237|592175470|FG001|Overall Study|Other, Not Specified|2|||
163946913|NCT02516332|592175471|FG000|Overall Study|Withdrawal by Subject|2|||
163946914|NCT02516332|592175472|FG001|Overall Study|Withdrawal by Subject|1|||
163946915|NCT02516332|592175473|FG002|Overall Study|Withdrawal by Subject|2|||
163946916|NCT00055601|592175474|FG000|Overall Study|Protocol Violation|1|||
163946917|NCT00055601|592175475|FG001|Overall Study|Protocol Violation|1|||
163946918|NCT00055601|592175474|FG000|Overall Study|No protocol treatment received|1|||
163946919|NCT00055601|592175475|FG001|Overall Study|No protocol treatment received|1|||
163946920|NCT02217332|592175476|FG000|Overall Study|Adverse Event|3|||
163946921|NCT02217332|592175476|FG000|Overall Study|Dose interruption >1 month|1|||
164046751|NCT03261037|592530468|FG003|Overall Study|Participant did not want to continue the study|0|||
164046752|NCT03261037|592530465|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
164046753|NCT03261037|592530466|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
164046754|NCT03261037|592530467|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
164046755|NCT03261037|592530468|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
164046756|NCT03261037|592530465|FG000|Overall Study|Participant presented clinical improvement|0|||
164046757|NCT03261037|592530466|FG001|Overall Study|Participant presented clinical improvement|2|||
164046758|NCT03261037|592530467|FG002|Overall Study|Participant presented clinical improvement|0|||
164046759|NCT03261037|592530468|FG003|Overall Study|Participant presented clinical improvement|0|||
164046760|NCT03261037|592530465|FG000|Overall Study|Technical difficulties|0|||
164046761|NCT03261037|592530466|FG001|Overall Study|Technical difficulties|0|||
164046762|NCT03261037|592530467|FG002|Overall Study|Technical difficulties|0|||
164046763|NCT03261037|592530468|FG003|Overall Study|Technical difficulties|1|||
164046764|NCT03261037|592530465|FG000|Overall Study|Equipment failed to work|0|||
164046765|NCT03261037|592530466|FG001|Overall Study|Equipment failed to work|0|||
164046766|NCT03261037|592530467|FG002|Overall Study|Equipment failed to work|0|||
164046767|NCT03261037|592530468|FG003|Overall Study|Equipment failed to work|1|||
164046768|NCT03261037|592530465|FG000|Overall Study|End of study for participant and no follow up|0|||
164046769|NCT03261037|592530466|FG001|Overall Study|End of study for participant and no follow up|0|||
164046770|NCT03261037|592530467|FG002|Overall Study|End of study for participant and no follow up|0|||
164046771|NCT03261037|592530468|FG003|Overall Study|End of study for participant and no follow up|1|||
164046772|NCT03261037|592530465|FG000|Overall Study|Participant was too weak to continue in study|1|||
164046773|NCT03261037|592530466|FG001|Overall Study|Participant was too weak to continue in study|0|||
164046774|NCT03261037|592530467|FG002|Overall Study|Participant was too weak to continue in study|0|||
164046775|NCT03261037|592530468|FG003|Overall Study|Participant was too weak to continue in study|0|||
164046776|NCT04423718|592530469|FG000|Main Study|Adverse Event|9|||
164046777|NCT04423718|592530470|FG001|Main Study|Adverse Event|5|||
164046778|NCT04423718|592530471|FG002|Main Study|Adverse Event|8|||
164046779|NCT04423718|592530469|FG000|Main Study|Physician Decision|3|||
164046780|NCT04423718|592530470|FG001|Main Study|Physician Decision|3|||
164046781|NCT04423718|592530471|FG002|Main Study|Physician Decision|2|||
164046782|NCT04423718|592530469|FG000|Main Study|Protocol Violation|0|||
164046783|NCT04423718|592530470|FG001|Main Study|Protocol Violation|0|||
164099472|NCT04384978|592728931|FG000|Overall Study|Withdrawal by Subject|4|||
164099473|NCT04384978|592728932|FG001|Overall Study|Withdrawal by Subject|0|||
164099474|NCT00214422|592728933|FG000|Overall Study|Physician Decision|2|||
164099475|NCT00214422|592728934|FG001|Overall Study|Physician Decision|0|||
164099476|NCT00214422|592728935|FG002|Overall Study|Physician Decision|0|||
163946922|NCT02217332|592175476|FG000|Overall Study|Protocol Violation (eligibility)|1|||
163946923|NCT02217332|592175476|FG000|Overall Study|Withdrawal by Subject|1|||
163946924|NCT02217332|592175476|FG000|Overall Study|Lost to Follow-up|1|||
163946925|NCT02134977|592175484|FG000|Overall Study|Protocol Deviation|102|||
163946926|NCT03828747|592175485|FG000|Double-Blind Treatment Period|Adverse Event|6|||
164046784|NCT04423718|592530471|FG002|Main Study|Protocol Violation|1|||
163946927|NCT03828747|592175486|FG001|Double-Blind Treatment Period|Adverse Event|6|||
163946928|NCT03828747|592175485|FG000|Double-Blind Treatment Period|Death|1|||
163946929|NCT03828747|592175486|FG001|Double-Blind Treatment Period|Death|1|||
163946930|NCT03828747|592175485|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
163946931|NCT03828747|592175486|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
163946932|NCT03828747|592175485|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
163946933|NCT03828747|592175486|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
163946934|NCT03828747|592175485|FG000|Double-Blind Treatment Period|Physician Decision|1|||
163946935|NCT03828747|592175486|FG001|Double-Blind Treatment Period|Physician Decision|4|||
163946936|NCT03828747|592175485|FG000|Double-Blind Treatment Period|Various reasons|5|||
163946937|NCT03828747|592175486|FG001|Double-Blind Treatment Period|Various reasons|3|||
163946938|NCT03828747|592175485|FG000|Open-Label Extension|Adverse Event|9|||
163946939|NCT03828747|592175486|FG001|Open-Label Extension|Adverse Event|7|||
163946940|NCT03828747|592175485|FG000|Open-Label Extension|Death|0|||
163946941|NCT03828747|592175486|FG001|Open-Label Extension|Death|2|||
163946942|NCT03828747|592175485|FG000|Open-Label Extension|Lost to Follow-up|4|||
163946943|NCT03828747|592175486|FG001|Open-Label Extension|Lost to Follow-up|0|||
163946944|NCT03828747|592175485|FG000|Open-Label Extension|Withdrawal by Subject|31|||
163946945|NCT03828747|592175486|FG001|Open-Label Extension|Withdrawal by Subject|30|||
163946946|NCT03828747|592175485|FG000|Open-Label Extension|Various reasons|4|||
163946947|NCT03828747|592175486|FG001|Open-Label Extension|Various reasons|4|||
163946948|NCT03828747|592175485|FG000|Open-Label Extension|Physician Decision|6|||
163946949|NCT03828747|592175486|FG001|Open-Label Extension|Physician Decision|2|||
163946950|NCT01658150|592175487|FG000|Overall Study|Withdrawal by Subject|1|||
163946951|NCT04187989|592175488|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
163946952|NCT04187989|592175489|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
163946953|NCT04187989|592175488|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
163946954|NCT04187989|592175489|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
163946955|NCT03646656|592175490|FG000|Overall Study|Lost to Follow-up|1|||
163946956|NCT03646656|592175491|FG001|Overall Study|Lost to Follow-up|0|||
163946957|NCT03646656|592175490|FG000|Overall Study|Withdrawal by Subject|2|||
163946958|NCT03646656|592175491|FG001|Overall Study|Withdrawal by Subject|0|||
163946959|NCT00127205|592175492|FG000|Overall Study|Adverse Event|228|||
163946960|NCT00127205|592175493|FG001|Overall Study|Adverse Event|387|||
163946961|NCT00127205|592175494|FG002|Overall Study|Adverse Event|273|||
163946962|NCT00127205|592175492|FG000|Overall Study|Death|8|||
163946963|NCT00127205|592175493|FG001|Overall Study|Death|6|||
163946964|NCT00127205|592175494|FG002|Overall Study|Death|5|||
163946965|NCT00127205|592175492|FG000|Overall Study|Withdrawal by Subject|318|||
163946966|NCT00127205|592175493|FG001|Overall Study|Withdrawal by Subject|310|||
163946967|NCT00127205|592175494|FG002|Overall Study|Withdrawal by Subject|172|||
163946968|NCT00127205|592175492|FG000|Overall Study|Other-non protocol specified|142|||
163946969|NCT00127205|592175493|FG001|Overall Study|Other-non protocol specified|129|||
163946970|NCT00127205|592175494|FG002|Overall Study|Other-non protocol specified|77|||
163946971|NCT00127205|592175492|FG000|Overall Study|Data not reported|6|||
163946972|NCT00127205|592175493|FG001|Overall Study|Data not reported|10|||
163946973|NCT00127205|592175494|FG002|Overall Study|Data not reported|1|||
163946974|NCT00127205|592175492|FG000|Overall Study|Progression|127|||
163946975|NCT00127205|592175493|FG001|Overall Study|Progression|131|||
163946976|NCT00127205|592175494|FG002|Overall Study|Progression|84|||
163946977|NCT01327495|592175495|FG000|Overall Study|Adverse Event|2|||
163946978|NCT01327495|592175496|FG001|Overall Study|Adverse Event|1|||
163946979|NCT01327495|592175497|FG002|Overall Study|Adverse Event|1|||
163946980|NCT01327495|592175498|FG003|Overall Study|Adverse Event|0|||
163946981|NCT01327495|592175499|FG004|Overall Study|Adverse Event|0|||
163946982|NCT01327495|592175500|FG005|Overall Study|Adverse Event|2|||
163946983|NCT01327495|592175495|FG000|Overall Study|Withdrawal by Subject|0|||
163946984|NCT01327495|592175496|FG001|Overall Study|Withdrawal by Subject|1|||
163946985|NCT01327495|592175497|FG002|Overall Study|Withdrawal by Subject|1|||
163946986|NCT01327495|592175498|FG003|Overall Study|Withdrawal by Subject|0|||
163946987|NCT01327495|592175499|FG004|Overall Study|Withdrawal by Subject|1|||
163946988|NCT01327495|592175500|FG005|Overall Study|Withdrawal by Subject|0|||
163946989|NCT01327495|592175495|FG000|Overall Study|Physician Decision|0|||
163946990|NCT01327495|592175496|FG001|Overall Study|Physician Decision|0|||
163946991|NCT01327495|592175497|FG002|Overall Study|Physician Decision|0|||
163946992|NCT01327495|592175498|FG003|Overall Study|Physician Decision|0|||
163946993|NCT01327495|592175499|FG004|Overall Study|Physician Decision|2|||
163946994|NCT01327495|592175500|FG005|Overall Study|Physician Decision|0|||
163946995|NCT03377699|592175501|FG000|Overall Study|Withdrawal by Subject|2|||
163946996|NCT03377699|592175502|FG001|Overall Study|Withdrawal by Subject|9|||
163946997|NCT03377699|592175501|FG000|Overall Study|Lost to Follow-up|1|||
163946998|NCT03377699|592175502|FG001|Overall Study|Lost to Follow-up|1|||
163946999|NCT03377699|592175501|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
163947000|NCT03377699|592175502|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
163947001|NCT03377699|592175501|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
163947002|NCT03377699|592175502|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
163947003|NCT03377699|592175501|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
164099477|NCT00214422|592728933|FG000|Overall Study|Developed esophageal ca|1|||
164099478|NCT00214422|592728934|FG001|Overall Study|Developed esophageal ca|0|||
164099479|NCT00214422|592728935|FG002|Overall Study|Developed esophageal ca|0|||
164099480|NCT00214422|592728933|FG000|Overall Study|Pt taken off study|1|||
164099481|NCT00214422|592728934|FG001|Overall Study|Pt taken off study|1|||
164099482|NCT00214422|592728935|FG002|Overall Study|Pt taken off study|0|||
164099483|NCT00214422|592728933|FG000|Overall Study|Disease progression on study|1|||
164099484|NCT00214422|592728934|FG001|Overall Study|Disease progression on study|0|||
164099485|NCT00214422|592728935|FG002|Overall Study|Disease progression on study|0|||
164099486|NCT00214422|592728933|FG000|Overall Study|Unable to make a radiation treatment|0|||
164099487|NCT00214422|592728934|FG001|Overall Study|Unable to make a radiation treatment|0|||
164099488|NCT00214422|592728935|FG002|Overall Study|Unable to make a radiation treatment|1|||
164099489|NCT01993030|592730454|FG000|Overall Study|Adverse Event|0|||
164099490|NCT01993030|592730455|FG001|Overall Study|Adverse Event|4|||
164099491|NCT03785548|592730456|FG000|Overall Study|age > 80|1|||
164099492|NCT03785548|592730457|FG001|Overall Study|age > 80|0|||
164099493|NCT03785548|592730456|FG000|Overall Study|no Postop queries|1|||
164099494|NCT03785548|592730457|FG001|Overall Study|no Postop queries|0|||
164099495|NCT00396279|592730460|FG000|Overall Study|Ongoing in study|26|||
163947004|NCT03377699|592175502|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
163947005|NCT03377699|592175501|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
163947006|NCT03377699|592175502|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
163947007|NCT02580305|592175506|FG000|Overall Study|Adverse Event|15|||
163947008|NCT02580305|592175507|FG001|Overall Study|Adverse Event|19|||
163947009|NCT02580305|592175508|FG002|Overall Study|Adverse Event|10|||
163947010|NCT02580305|592175506|FG000|Overall Study|Lack of Efficacy|5|||
163947011|NCT02580305|592175507|FG001|Overall Study|Lack of Efficacy|0|||
163947012|NCT02580305|592175508|FG002|Overall Study|Lack of Efficacy|2|||
163947013|NCT02580305|592175506|FG000|Overall Study|Protocol Violation|4|||
163947014|NCT02580305|592175507|FG001|Overall Study|Protocol Violation|9|||
163947015|NCT02580305|592175508|FG002|Overall Study|Protocol Violation|6|||
163947016|NCT02580305|592175506|FG000|Overall Study|Lost to Follow-up|4|||
164099496|NCT00396279|592730460|FG000|Overall Study|Disease progression|2|||
164099497|NCT00396279|592730460|FG000|Overall Study|Withdrawal by Subject|1|||
164099498|NCT00396279|592730460|FG000|Overall Study|Physician Decision|1|||
164099499|NCT01882257|592730462|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
164099500|NCT01882257|592730463|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
164099501|NCT01882257|592730464|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
164099502|NCT01882257|592730462|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
164099503|NCT01882257|592730463|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
164099504|NCT01882257|592730464|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
164099505|NCT00830206|592730465|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
164099506|NCT00830206|592730466|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
164099507|NCT00905346|592730470|FG000|Period 1|Withdrawal by Subject|1|||
164099508|NCT00905346|592730471|FG001|Period 1|Withdrawal by Subject|0|||
164099509|NCT03351335|592730472|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
164099510|NCT03351335|592730473|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
163842493|NCT05256381|591793028|FG002|Overall Study|Withdrawal by Subject|2|||
163842494|NCT05256381|591793029|FG003|Overall Study|Withdrawal by Subject|2|||
163842495|NCT05256381|591793030|FG004|Overall Study|Withdrawal by Subject|8|||
163842496|NCT05256381|591793031|FG005|Overall Study|Withdrawal by Subject|6|||
163842497|NCT05256381|591793026|FG000|Overall Study|Physician Decision|0|||
163842498|NCT05256381|591793027|FG001|Overall Study|Physician Decision|0|||
163842499|NCT05256381|591793028|FG002|Overall Study|Physician Decision|1|||
163842500|NCT05256381|591793029|FG003|Overall Study|Physician Decision|0|||
163842501|NCT05256381|591793030|FG004|Overall Study|Physician Decision|2|||
163842502|NCT05256381|591793031|FG005|Overall Study|Physician Decision|0|||
163842503|NCT05256381|591793026|FG000|Overall Study|Death|17|||
163842504|NCT05256381|591793027|FG001|Overall Study|Death|3|||
163842505|NCT05256381|591793028|FG002|Overall Study|Death|4|||
163842506|NCT05256381|591793029|FG003|Overall Study|Death|5|||
163842507|NCT05256381|591793030|FG004|Overall Study|Death|24|||
163842508|NCT05256381|591793031|FG005|Overall Study|Death|21|||
163842509|NCT05256381|591793026|FG000|Overall Study|Other, not specified|0|||
163842510|NCT05256381|591793027|FG001|Overall Study|Other, not specified|0|||
163842511|NCT05256381|591793028|FG002|Overall Study|Other, not specified|0|||
163842512|NCT05256381|591793029|FG003|Overall Study|Other, not specified|0|||
163842513|NCT05256381|591793030|FG004|Overall Study|Other, not specified|2|||
163842514|NCT05256381|591793031|FG005|Overall Study|Other, not specified|1|||
163842515|NCT05256381|591793026|FG000|Overall Study|Study terminated by sponsor|18|||
163842516|NCT05256381|591793027|FG001|Overall Study|Study terminated by sponsor|5|||
163842517|NCT05256381|591793028|FG002|Overall Study|Study terminated by sponsor|5|||
164046785|NCT04423718|592530469|FG000|Main Study|Lost to Follow-up|3|||
164046786|NCT04423718|592530470|FG001|Main Study|Lost to Follow-up|3|||
163842518|NCT05256381|591793029|FG003|Overall Study|Study terminated by sponsor|5|||
163842519|NCT05256381|591793030|FG004|Overall Study|Study terminated by sponsor|18|||
163842520|NCT05256381|591793031|FG005|Overall Study|Study terminated by sponsor|11|||
163842521|NCT05256381|591793026|FG000|Overall Study|Lost to Follow-up|1|||
163842522|NCT05256381|591793027|FG001|Overall Study|Lost to Follow-up|0|||
163842523|NCT05256381|591793028|FG002|Overall Study|Lost to Follow-up|0|||
163842524|NCT05256381|591793029|FG003|Overall Study|Lost to Follow-up|0|||
163842525|NCT05256381|591793030|FG004|Overall Study|Lost to Follow-up|1|||
163842526|NCT05256381|591793031|FG005|Overall Study|Lost to Follow-up|0|||
163842527|NCT00802737|591794714|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
163842528|NCT00802737|591794715|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
163842529|NCT00802737|591794716|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
163842530|NCT00802737|591794714|FG000|Overall Study|Death|6|||
163842531|NCT00802737|591794715|FG001|Overall Study|Death|5|||
163842532|NCT00802737|591794716|FG002|Overall Study|Death|1|||
163842533|NCT00802737|591794714|FG000|Overall Study|Adverse Event|1|||
163842534|NCT00802737|591794715|FG001|Overall Study|Adverse Event|0|||
163842535|NCT00802737|591794716|FG002|Overall Study|Adverse Event|0|||
163842536|NCT00802737|591794714|FG000|Overall Study|Received Prohibited Therapy|1|||
163842537|NCT00802737|591794715|FG001|Overall Study|Received Prohibited Therapy|0|||
163842538|NCT00802737|591794716|FG002|Overall Study|Received Prohibited Therapy|0|||
163842539|NCT00802737|591794714|FG000|Overall Study|Ongoing CLL-Treatment|0|||
163842540|NCT00802737|591794715|FG001|Overall Study|Ongoing CLL-Treatment|1|||
163842541|NCT00802737|591794716|FG002|Overall Study|Ongoing CLL-Treatment|0|||
163842542|NCT00802737|591794714|FG000|Overall Study|Participant too Unwell|0|||
163842543|NCT00802737|591794715|FG001|Overall Study|Participant too Unwell|2|||
163842544|NCT00802737|591794716|FG002|Overall Study|Participant too Unwell|0|||
163842545|NCT03864926|591794717|FG000|Overall Study|Death|0|||
163842546|NCT03864926|591794718|FG001|Overall Study|Death|2|||
163842547|NCT00445601|591794719|FG000|Overall Study|Withdrawal by Subject|11|||
163842548|NCT00445601|591794720|FG001|Overall Study|Withdrawal by Subject|11|||
163842549|NCT00445601|591794719|FG000|Overall Study|TURBT Complication|12|||
163842550|NCT00445601|591794720|FG001|Overall Study|TURBT Complication|8|||
163842551|NCT00445601|591794719|FG000|Overall Study|Incorrect Disease Status|6|||
163842552|NCT00445601|591794720|FG001|Overall Study|Incorrect Disease Status|6|||
163842553|NCT00445601|591794719|FG000|Overall Study|Drug Delivery Issue|2|||
163842554|NCT00445601|591794720|FG001|Overall Study|Drug Delivery Issue|2|||
163842555|NCT00445601|591794719|FG000|Overall Study|Adverse Event|2|||
163842556|NCT00445601|591794720|FG001|Overall Study|Adverse Event|0|||
163842557|NCT00445601|591794719|FG000|Overall Study|Death prior to TURBT|0|||
163842558|NCT00445601|591794720|FG001|Overall Study|Death prior to TURBT|1|||
163842559|NCT01340482|591794721|FG000|Overall Study|Adverse Event|2|||
163842560|NCT01340482|591794722|FG001|Overall Study|Adverse Event|0|||
163842561|NCT01340482|591794723|FG002|Overall Study|Adverse Event|0|||
163842562|NCT00619476|591794724|FG000|Overall Study|Adverse Event|12|||
163842563|NCT00619476|591794725|FG001|Overall Study|Adverse Event|6|||
163842564|NCT00619476|591794726|FG002|Overall Study|Adverse Event|12|||
163842565|NCT00619476|591794727|FG003|Overall Study|Adverse Event|16|||
163842566|NCT00619476|591794724|FG000|Overall Study|Lack of Efficacy|6|||
163842567|NCT00619476|591794725|FG001|Overall Study|Lack of Efficacy|1|||
163842568|NCT00619476|591794726|FG002|Overall Study|Lack of Efficacy|1|||
163842569|NCT00619476|591794727|FG003|Overall Study|Lack of Efficacy|4|||
163842570|NCT00619476|591794724|FG000|Overall Study|Protocol Violation|5|||
163842571|NCT00619476|591794725|FG001|Overall Study|Protocol Violation|4|||
163842572|NCT00619476|591794726|FG002|Overall Study|Protocol Violation|4|||
163842573|NCT00619476|591794727|FG003|Overall Study|Protocol Violation|9|||
163842574|NCT00619476|591794724|FG000|Overall Study|Lost to Follow-up|1|||
163842575|NCT00619476|591794725|FG001|Overall Study|Lost to Follow-up|2|||
163842576|NCT00619476|591794726|FG002|Overall Study|Lost to Follow-up|0|||
163842577|NCT00619476|591794727|FG003|Overall Study|Lost to Follow-up|1|||
163842578|NCT00619476|591794724|FG000|Overall Study|Investigator Discretion|2|||
163842579|NCT00619476|591794725|FG001|Overall Study|Investigator Discretion|2|||
163842580|NCT00619476|591794726|FG002|Overall Study|Investigator Discretion|2|||
163842581|NCT00619476|591794727|FG003|Overall Study|Investigator Discretion|0|||
163842582|NCT00619476|591794724|FG000|Overall Study|Withdrawal by Subject|5|||
163842583|NCT00619476|591794725|FG001|Overall Study|Withdrawal by Subject|7|||
163842584|NCT00619476|591794726|FG002|Overall Study|Withdrawal by Subject|5|||
163842585|NCT00619476|591794727|FG003|Overall Study|Withdrawal by Subject|4|||
163842586|NCT01091428|591794728|FG000|Phase 1|Progressive Disease|24|||
163842587|NCT01091428|591794729|FG001|Phase 1|Progressive Disease|8|||
163842588|NCT01091428|591794730|FG002|Phase 1|Progressive Disease|0|||
163842589|NCT01091428|591794731|FG003|Phase 1|Progressive Disease|0|||
163842590|NCT01091428|591794728|FG000|Phase 1|Symptomatic Deterioration|3|||
163842591|NCT01091428|591794729|FG001|Phase 1|Symptomatic Deterioration|2|||
163842592|NCT01091428|591794730|FG002|Phase 1|Symptomatic Deterioration|0|||
163842593|NCT01091428|591794731|FG003|Phase 1|Symptomatic Deterioration|0|||
164046787|NCT04423718|592530471|FG002|Main Study|Lost to Follow-up|4|||
164099511|NCT03351335|592730474|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
164099512|NCT02736721|592730477|FG000|Overall Study|Adverse Event|8|||
164099513|NCT02736721|592730477|FG000|Overall Study|Lost to Follow-up|3|||
164099514|NCT02736721|592730477|FG000|Overall Study|Other|5|||
163947017|NCT02580305|592175507|FG001|Overall Study|Lost to Follow-up|4|||
163947018|NCT02580305|592175508|FG002|Overall Study|Lost to Follow-up|2|||
163947019|NCT02580305|592175506|FG000|Overall Study|Withdrawal by Subject|11|||
163947020|NCT02580305|592175507|FG001|Overall Study|Withdrawal by Subject|9|||
163947021|NCT02580305|592175508|FG002|Overall Study|Withdrawal by Subject|7|||
163947022|NCT02580305|592175506|FG000|Overall Study|Randomized in error and never treated|4|||
163947023|NCT02580305|592175507|FG001|Overall Study|Randomized in error and never treated|8|||
163947024|NCT02580305|592175508|FG002|Overall Study|Randomized in error and never treated|5|||
163947025|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
163947026|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163947027|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163947028|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163947029|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
163947030|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
163947031|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163947032|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163947033|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163947034|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
163947035|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
163947036|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163947037|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163947038|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163947039|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
163947040|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
163947041|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163947042|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163947043|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163947044|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
163947045|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
163947046|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163947047|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163947048|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163947049|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
163947050|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
163947051|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163947052|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163947053|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163947054|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
163947055|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
163947056|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163947057|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163947058|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163947059|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
163947060|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
163947061|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
164099515|NCT01439880|592730481|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
164099516|NCT01439880|592730482|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
163842594|NCT01091428|591794728|FG000|Phase 1|Adverse Event|2|||
163842595|NCT01091428|591794729|FG001|Phase 1|Adverse Event|0|||
163842596|NCT01091428|591794730|FG002|Phase 1|Adverse Event|0|||
163842597|NCT01091428|591794731|FG003|Phase 1|Adverse Event|0|||
163842598|NCT01091428|591794728|FG000|Phase 1|Withdrawal by Subject|7|||
163842599|NCT01091428|591794729|FG001|Phase 1|Withdrawal by Subject|0|||
163842600|NCT01091428|591794730|FG002|Phase 1|Withdrawal by Subject|0|||
163842601|NCT01091428|591794731|FG003|Phase 1|Withdrawal by Subject|0|||
163842602|NCT01091428|591794728|FG000|Phase 1|Reason not specified|0|||
163842603|NCT01091428|591794729|FG001|Phase 1|Reason not specified|1|||
163842604|NCT01091428|591794730|FG002|Phase 1|Reason not specified|0|||
163842605|NCT01091428|591794731|FG003|Phase 1|Reason not specified|0|||
163842606|NCT01091428|591794728|FG000|Phase 1|Single-Patient IND|2|||
163842607|NCT01091428|591794729|FG001|Phase 1|Single-Patient IND|0|||
163842608|NCT01091428|591794730|FG002|Phase 1|Single-Patient IND|0|||
163842609|NCT01091428|591794731|FG003|Phase 1|Single-Patient IND|0|||
163842610|NCT01091428|591794728|FG000|Phase 2|Progressive Disease|0|||
163842611|NCT01091428|591794729|FG001|Phase 2|Progressive Disease|0|||
164046788|NCT04423718|592530469|FG000|Main Study|Lack of Efficacy|2|||
164046789|NCT04423718|592530470|FG001|Main Study|Lack of Efficacy|1|||
164046790|NCT04423718|592530471|FG002|Main Study|Lack of Efficacy|0|||
164046791|NCT04423718|592530469|FG000|Main Study|Withdrawal by Subject|14|||
164046792|NCT04423718|592530470|FG001|Main Study|Withdrawal by Subject|20|||
164046793|NCT04423718|592530471|FG002|Main Study|Withdrawal by Subject|20|||
164046794|NCT04423718|592530469|FG000|Main Study|Death|10|||
164046795|NCT04423718|592530470|FG001|Main Study|Death|7|||
164046796|NCT04423718|592530471|FG002|Main Study|Death|7|||
164046797|NCT04423718|592530469|FG000|Main Study|COVID-19 pandemic|2|||
164046798|NCT04423718|592530470|FG001|Main Study|COVID-19 pandemic|2|||
163842612|NCT01091428|591794730|FG002|Phase 2|Progressive Disease|44|||
163842613|NCT01091428|591794731|FG003|Phase 2|Progressive Disease|46|||
163842614|NCT01091428|591794728|FG000|Phase 2|Symptomatic Deterioration|0|||
163842615|NCT01091428|591794729|FG001|Phase 2|Symptomatic Deterioration|0|||
163842616|NCT01091428|591794730|FG002|Phase 2|Symptomatic Deterioration|1|||
163842617|NCT01091428|591794731|FG003|Phase 2|Symptomatic Deterioration|6|||
163842618|NCT01091428|591794728|FG000|Phase 2|Adverse Event|0|||
163842619|NCT01091428|591794729|FG001|Phase 2|Adverse Event|0|||
163842620|NCT01091428|591794730|FG002|Phase 2|Adverse Event|12|||
163842621|NCT01091428|591794731|FG003|Phase 2|Adverse Event|5|||
163842622|NCT01091428|591794728|FG000|Phase 2|Withdrawal by Subject|0|||
163842623|NCT01091428|591794729|FG001|Phase 2|Withdrawal by Subject|0|||
163842624|NCT01091428|591794730|FG002|Phase 2|Withdrawal by Subject|9|||
163842625|NCT01091428|591794731|FG003|Phase 2|Withdrawal by Subject|8|||
163842626|NCT01091428|591794728|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
163842627|NCT01091428|591794729|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
163842628|NCT01091428|591794730|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
163842629|NCT01091428|591794731|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
163842630|NCT01091428|591794728|FG000|Phase 2|Reason not specified|0|||
163842631|NCT01091428|591794729|FG001|Phase 2|Reason not specified|0|||
163842632|NCT01091428|591794730|FG002|Phase 2|Reason not specified|4|||
163842633|NCT01091428|591794731|FG003|Phase 2|Reason not specified|3|||
163842634|NCT01091428|591794728|FG000|Phase 2|Physician Decision|0|||
163842635|NCT01091428|591794729|FG001|Phase 2|Physician Decision|0|||
163842636|NCT01091428|591794730|FG002|Phase 2|Physician Decision|2|||
163842637|NCT01091428|591794731|FG003|Phase 2|Physician Decision|0|||
163842638|NCT01282476|591794736|FG000|Overall Study|Death|11|||
163842639|NCT01625910|591794739|FG000|Overall Study|Lost to Follow-up|3|||
163842640|NCT01625910|591794740|FG001|Overall Study|Lost to Follow-up|4|||
163842641|NCT03918239|591794746|FG000|Overall Study|Lost to Follow-up|3|||
163842642|NCT03918239|591794747|FG001|Overall Study|Lost to Follow-up|1|||
163842643|NCT03918239|591794746|FG000|Overall Study|Pregnancy|0|||
163842644|NCT03918239|591794747|FG001|Overall Study|Pregnancy|2|||
163842645|NCT03918239|591794746|FG000|Overall Study|Withdrawal by Subject|3|||
163842646|NCT03918239|591794747|FG001|Overall Study|Withdrawal by Subject|3|||
163842647|NCT03918239|591794746|FG000|Overall Study|positive urine drug screening results|4|||
163842648|NCT03918239|591794747|FG001|Overall Study|positive urine drug screening results|1|||
163842649|NCT01984424|591794752|FG000|Overall Study|Withdrawal by Subject|3|||
163842650|NCT01984424|591794753|FG001|Overall Study|Withdrawal by Subject|5|||
163842651|NCT01984424|591794752|FG000|Overall Study|Sponsor Decision|0|||
163842652|NCT01984424|591794753|FG001|Overall Study|Sponsor Decision|1|||
163842653|NCT01984424|591794752|FG000|Overall Study|Lost to Follow-up|0|||
163842654|NCT01984424|591794753|FG001|Overall Study|Lost to Follow-up|1|||
163842655|NCT00592319|591794754|FG000|Overall Study|Lost to Follow-up|0|||
163842656|NCT00592319|591794755|FG001|Overall Study|Lost to Follow-up|3|||
163842657|NCT01807221|591794758|FG000|Overall Study|Progressive disease|1|||
163842658|NCT01807221|591794759|FG001|Overall Study|Progressive disease|0|||
163842659|NCT01807221|591794760|FG002|Overall Study|Progressive disease|1|||
163842660|NCT01807221|591794761|FG003|Overall Study|Progressive disease|0|||
163842661|NCT01807221|591794762|FG004|Overall Study|Progressive disease|0|||
163842662|NCT01807221|591794763|FG005|Overall Study|Progressive disease|0|||
163842663|NCT01807221|591794758|FG000|Overall Study|Death|7|||
163842664|NCT01807221|591794759|FG001|Overall Study|Death|9|||
163842665|NCT01807221|591794760|FG002|Overall Study|Death|4|||
163842666|NCT01807221|591794761|FG003|Overall Study|Death|2|||
163842667|NCT01807221|591794762|FG004|Overall Study|Death|1|||
163842668|NCT01807221|591794763|FG005|Overall Study|Death|6|||
163842669|NCT01807221|591794758|FG000|Overall Study|Physician Decision|2|||
163842670|NCT01807221|591794759|FG001|Overall Study|Physician Decision|1|||
163842671|NCT01807221|591794760|FG002|Overall Study|Physician Decision|0|||
163842672|NCT01807221|591794761|FG003|Overall Study|Physician Decision|0|||
163842673|NCT01807221|591794762|FG004|Overall Study|Physician Decision|0|||
163842674|NCT01807221|591794763|FG005|Overall Study|Physician Decision|0|||
163842675|NCT01807221|591794758|FG000|Overall Study|Adverse Event|33|||
163842676|NCT01807221|591794759|FG001|Overall Study|Adverse Event|22|||
163842677|NCT01807221|591794760|FG002|Overall Study|Adverse Event|26|||
163842678|NCT01807221|591794761|FG003|Overall Study|Adverse Event|25|||
163842679|NCT01807221|591794762|FG004|Overall Study|Adverse Event|18|||
163947062|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163947063|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163947064|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
163947065|NCT00700427|592175509|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
163947066|NCT00700427|592175510|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163947067|NCT00700427|592175511|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163947068|NCT00700427|592175512|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163947069|NCT00700427|592175513|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
163947070|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163947071|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
163947072|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163947073|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163947074|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
163947075|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163947076|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
163947077|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163947078|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163947079|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
163947080|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163947081|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
163947082|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163947083|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163947084|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
163947085|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163947086|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
163947087|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163947088|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163947089|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
163947090|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163947091|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
163947092|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163947093|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163947094|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
163947095|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163947096|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
163947097|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163947098|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163947099|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
163947100|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163947101|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
163947102|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163947103|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163947104|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
163947105|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163947106|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
163947107|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163947108|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163947109|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
163947110|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163947111|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
163947112|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163947113|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163947114|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
163947115|NCT00700427|592175509|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163947116|NCT00700427|592175510|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
163947117|NCT00700427|592175511|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163947118|NCT00700427|592175512|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163947119|NCT00700427|592175513|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
163947120|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
164046799|NCT04423718|592530471|FG002|Main Study|COVID-19 pandemic|2|||
164046800|NCT04423718|592530469|FG000|Main Study|Other|7|||
164046801|NCT04423718|592530470|FG001|Main Study|Other|3|||
164046802|NCT04423718|592530471|FG002|Main Study|Other|2|||
164046803|NCT04423718|592530469|FG000|Extension Phase|Other|1|||
164046804|NCT04423718|592530470|FG001|Extension Phase|Other|0|||
164099517|NCT01439880|592730481|FG000|SOC-controlled Period (Year 1)|Death|2|||
164099518|NCT01439880|592730482|FG001|SOC-controlled Period (Year 1)|Death|1|||
164099519|NCT01439880|592730481|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
164099520|NCT01439880|592730482|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
164099521|NCT01439880|592730481|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
164099522|NCT01439880|592730482|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
164099523|NCT01439880|592730481|FG000|SOC-controlled Period (Year 1)|Other|8|||
164099524|NCT01439880|592730482|FG001|SOC-controlled Period (Year 1)|Other|13|||
164099525|NCT01439880|592730481|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
164099526|NCT01439880|592730482|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
164099527|NCT01439880|592730481|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
164099528|NCT01439880|592730482|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
164099529|NCT01439880|592730481|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
164099530|NCT01439880|592730482|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
164099531|NCT01439880|592730481|FG000|All-IP Period (Years 2 to 5)|Death|3|||
164099532|NCT01439880|592730482|FG001|All-IP Period (Years 2 to 5)|Death|13|||
164099533|NCT01439880|592730481|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
164099534|NCT01439880|592730482|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
164099535|NCT01439880|592730481|FG000|All-IP Period (Years 2 to 5)|Other|14|||
164099536|NCT01439880|592730482|FG001|All-IP Period (Years 2 to 5)|Other|31|||
164099537|NCT01439880|592730481|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
164099538|NCT01439880|592730482|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
164099539|NCT00829673|592730485|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164099540|NCT00829673|592730486|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164099541|NCT00272779|592730487|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
164099542|NCT00272779|592730488|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
164099543|NCT00272779|592730487|FG000|Baseline Through Week 48|Death before Week 48|4|||
164099544|NCT00272779|592730488|FG001|Baseline Through Week 48|Death before Week 48|4|||
164099545|NCT00272779|592730487|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
164099546|NCT00272779|592730488|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
164099547|NCT00272779|592730487|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
164099548|NCT00272779|592730488|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
164099549|NCT00272779|592730487|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
164099550|NCT00272779|592730488|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
164099551|NCT00272779|592730487|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
164099552|NCT00272779|592730488|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
164099553|NCT00272779|592730487|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
164099554|NCT00272779|592730488|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
164099555|NCT00272779|592730487|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
164099556|NCT00272779|592730488|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
164099557|NCT00272779|592730487|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
164099558|NCT00272779|592730488|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
164099559|NCT00272779|592730487|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
164099560|NCT00272779|592730488|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
164099561|NCT00272779|592730487|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
164099562|NCT00272779|592730488|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
163842680|NCT01807221|591794763|FG005|Overall Study|Adverse Event|21|||
163842681|NCT01807221|591794758|FG000|Overall Study|Protocol Violation|0|||
163842682|NCT01807221|591794759|FG001|Overall Study|Protocol Violation|2|||
163842683|NCT01807221|591794760|FG002|Overall Study|Protocol Violation|1|||
163842684|NCT01807221|591794761|FG003|Overall Study|Protocol Violation|2|||
163842685|NCT01807221|591794762|FG004|Overall Study|Protocol Violation|0|||
163842686|NCT01807221|591794763|FG005|Overall Study|Protocol Violation|1|||
163842687|NCT01807221|591794758|FG000|Overall Study|Non-compliance|1|||
163842688|NCT01807221|591794759|FG001|Overall Study|Non-compliance|2|||
163842689|NCT01807221|591794760|FG002|Overall Study|Non-compliance|0|||
163842690|NCT01807221|591794761|FG003|Overall Study|Non-compliance|1|||
163842691|NCT01807221|591794762|FG004|Overall Study|Non-compliance|0|||
163842692|NCT01807221|591794763|FG005|Overall Study|Non-compliance|0|||
163842693|NCT01807221|591794758|FG000|Overall Study|Logistical difficulties|0|||
163842694|NCT01807221|591794759|FG001|Overall Study|Logistical difficulties|1|||
163842695|NCT01807221|591794760|FG002|Overall Study|Logistical difficulties|0|||
163842696|NCT01807221|591794761|FG003|Overall Study|Logistical difficulties|0|||
163842697|NCT01807221|591794762|FG004|Overall Study|Logistical difficulties|1|||
163842698|NCT01807221|591794763|FG005|Overall Study|Logistical difficulties|0|||
163842699|NCT01807221|591794758|FG000|Overall Study|Withdrawal by Subject|33|||
164099563|NCT00272779|592730487|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
163842700|NCT01807221|591794759|FG001|Overall Study|Withdrawal by Subject|15|||
163842701|NCT01807221|591794760|FG002|Overall Study|Withdrawal by Subject|8|||
163842702|NCT01807221|591794761|FG003|Overall Study|Withdrawal by Subject|14|||
163842703|NCT01807221|591794762|FG004|Overall Study|Withdrawal by Subject|16|||
163947121|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
163947122|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
163947123|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
163947124|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
163947125|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
163947126|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
163947127|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
163947128|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
163947129|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
163947130|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
163947131|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
163947132|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
163947133|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
163947134|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
163947135|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
163947136|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
163947137|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
163947138|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
163947139|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
163947140|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
163947141|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
163947142|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
163947143|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
163947144|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
163947145|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163947146|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163947147|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163947148|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
163947149|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
163947150|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163947151|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163947152|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163947153|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
163947154|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
163947155|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
163947156|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
163947157|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
163947158|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
163947159|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
163947160|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163947161|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163947162|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
163947163|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163947164|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
163947165|NCT00700427|592175509|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
163947166|NCT00700427|592175510|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
163947167|NCT00700427|592175511|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
163947168|NCT00700427|592175512|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
163947169|NCT00700427|592175513|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
163947170|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163947171|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163947172|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163947173|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
163947174|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
163947175|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
163947176|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
163947177|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
163947178|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
163947179|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
163947180|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
164046805|NCT04423718|592530471|FG002|Extension Phase|Other|0|||
164046806|NCT04423718|592530469|FG000|Extension Phase|Logistical problems|0|||
164046807|NCT04423718|592530470|FG001|Extension Phase|Logistical problems|1|||
163947181|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
164046808|NCT04423718|592530471|FG002|Extension Phase|Logistical problems|1|||
164046809|NCT04423718|592530469|FG000|Extension Phase|Physician Decision|1|||
163947182|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
163947183|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
163947184|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
163947185|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163947186|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163947187|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163947188|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
163947189|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
163947190|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163947191|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163947192|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163947193|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
163947194|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
163947195|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163947196|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163947197|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163947198|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
163947199|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
163947200|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163947201|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163947202|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163947203|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
163947204|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
163947205|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163947206|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163947207|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
164046810|NCT04423718|592530470|FG001|Extension Phase|Physician Decision|0|||
164046811|NCT04423718|592530471|FG002|Extension Phase|Physician Decision|1|||
164046812|NCT04423718|592530469|FG000|Extension Phase|Lack of Efficacy|2|||
164046813|NCT04423718|592530470|FG001|Extension Phase|Lack of Efficacy|0|||
164046814|NCT04423718|592530471|FG002|Extension Phase|Lack of Efficacy|1|||
164046815|NCT04423718|592530469|FG000|Extension Phase|Lost to Follow-up|0|||
164046816|NCT04423718|592530470|FG001|Extension Phase|Lost to Follow-up|2|||
164046817|NCT04423718|592530471|FG002|Extension Phase|Lost to Follow-up|3|||
164046818|NCT04423718|592530469|FG000|Extension Phase|Adverse Event|2|||
164046819|NCT04423718|592530470|FG001|Extension Phase|Adverse Event|3|||
164046820|NCT04423718|592530471|FG002|Extension Phase|Adverse Event|1|||
164046821|NCT04423718|592530469|FG000|Extension Phase|Death|4|||
164046822|NCT04423718|592530470|FG001|Extension Phase|Death|7|||
164046823|NCT04423718|592530471|FG002|Extension Phase|Death|2|||
164046824|NCT04423718|592530469|FG000|Extension Phase|Withdrawal by Subject|11|||
164046825|NCT04423718|592530470|FG001|Extension Phase|Withdrawal by Subject|11|||
164046826|NCT04423718|592530471|FG002|Extension Phase|Withdrawal by Subject|7|||
164046827|NCT00589602|592530475|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
164046828|NCT05298774|592530479|FG000|Overall Study|Physician Decision|3|||
164046829|NCT05298774|592530479|FG000|Overall Study|Withdrawal by Subject|2|||
164046830|NCT05298774|592530479|FG000|Overall Study|Lost to Follow-up|3|||
164046831|NCT05298774|592530479|FG000|Overall Study|Screen failure|1|||
164046832|NCT04992507|592530480|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
164046833|NCT04992507|592530481|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
164046834|NCT04992507|592530480|FG000|Overall Study|Death|0|||
164046835|NCT04992507|592530481|FG001|Overall Study|Death|1|||
164046836|NCT01058395|592530482|FG000|Overall Study|Death|2|||
164046837|NCT01058395|592530483|FG001|Overall Study|Death|1|||
164046838|NCT01058395|592530482|FG000|Overall Study|Lost to Follow-up|1|||
164046839|NCT01058395|592530483|FG001|Overall Study|Lost to Follow-up|0|||
164046840|NCT01266876|592530484|FG000|Overall Study|Adverse Event|0|||
164046841|NCT01266876|592530485|FG001|Overall Study|Adverse Event|0|||
164046842|NCT01266876|592530486|FG002|Overall Study|Adverse Event|0|||
164046843|NCT01266876|592530487|FG003|Overall Study|Adverse Event|1|||
164046844|NCT01266876|592530488|FG004|Overall Study|Adverse Event|0|||
164046845|NCT05016037|592530489|FG000|Overall Study|Lost to Follow-up|2|||
163947208|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
163947209|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
164046846|NCT00557323|592530490|FG000|Overall Study|Death|3|||
164046847|NCT00557323|592530490|FG000|Overall Study|Withdrawal by Subject|2|||
164046848|NCT00557323|592530490|FG000|Overall Study|Administrative change|2|||
164046849|NCT04007367|592530491|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
164046850|NCT04007367|592530492|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
164046851|NCT04007367|592530493|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
164099564|NCT00272779|592730488|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
164148616|NCT04895982|592904912|FG001|Overall Study|Protocol Violation|0|||
163947210|NCT00700427|592175509|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163947211|NCT00700427|592175510|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163947212|NCT00700427|592175511|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163947213|NCT00700427|592175512|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
163947214|NCT00700427|592175513|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
163947215|NCT05560243|592175514|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
163947216|NCT05870228|592175516|FG000|Overall Study|Lost to Follow-up|2|||
163947217|NCT05870228|592175517|FG001|Overall Study|Lost to Follow-up|0|||
163947218|NCT05870228|592175516|FG000|Overall Study|Withdrawal by Subject|1|||
163947219|NCT05870228|592175517|FG001|Overall Study|Withdrawal by Subject|0|||
163947220|NCT01871805|592175521|FG000|Phase I|Death|7|||
163947221|NCT01871805|592175522|FG001|Phase I|Death|4|||
163947222|NCT01871805|592175523|FG002|Phase I|Death|6|||
163947223|NCT01871805|592175524|FG003|Phase I|Death|2|||
163947224|NCT01871805|592175525|FG004|Phase I|Death|9|||
163947225|NCT01871805|592175526|FG005|Phase I|Death|0|||
163947226|NCT01871805|592175521|FG000|Phase I|Alive in Survival Follow-up|0|||
163947227|NCT01871805|592175522|FG001|Phase I|Alive in Survival Follow-up|2|||
163947228|NCT01871805|592175523|FG002|Phase I|Alive in Survival Follow-up|4|||
163947229|NCT01871805|592175524|FG003|Phase I|Alive in Survival Follow-up|5|||
163947230|NCT01871805|592175525|FG004|Phase I|Alive in Survival Follow-up|4|||
163947231|NCT01871805|592175526|FG005|Phase I|Alive in Survival Follow-up|0|||
163947232|NCT01871805|592175521|FG000|Phase I|Lost to Follow-up|0|||
163947233|NCT01871805|592175522|FG001|Phase I|Lost to Follow-up|1|||
163947234|NCT01871805|592175523|FG002|Phase I|Lost to Follow-up|3|||
163947235|NCT01871805|592175524|FG003|Phase I|Lost to Follow-up|0|||
163947236|NCT01871805|592175525|FG004|Phase I|Lost to Follow-up|0|||
163947237|NCT01871805|592175526|FG005|Phase I|Lost to Follow-up|0|||
163947238|NCT01871805|592175521|FG000|Phase II|Death|0|||
163947239|NCT01871805|592175522|FG001|Phase II|Death|0|||
163947240|NCT01871805|592175523|FG002|Phase II|Death|0|||
163947241|NCT01871805|592175524|FG003|Phase II|Death|0|||
163947242|NCT01871805|592175525|FG004|Phase II|Death|0|||
163947243|NCT01871805|592175526|FG005|Phase II|Death|45|||
163947244|NCT01871805|592175521|FG000|Phase II|Alive in Survival Follow-up|0|||
163947245|NCT01871805|592175522|FG001|Phase II|Alive in Survival Follow-up|0|||
163947246|NCT01871805|592175523|FG002|Phase II|Alive in Survival Follow-up|0|||
163947247|NCT01871805|592175524|FG003|Phase II|Alive in Survival Follow-up|0|||
163947248|NCT01871805|592175525|FG004|Phase II|Alive in Survival Follow-up|0|||
163947249|NCT01871805|592175526|FG005|Phase II|Alive in Survival Follow-up|29|||
163947250|NCT01871805|592175521|FG000|Phase II|Lost to Follow-up|0|||
163947251|NCT01871805|592175522|FG001|Phase II|Lost to Follow-up|0|||
163947252|NCT01871805|592175523|FG002|Phase II|Lost to Follow-up|0|||
163947253|NCT01871805|592175524|FG003|Phase II|Lost to Follow-up|0|||
163947254|NCT01871805|592175525|FG004|Phase II|Lost to Follow-up|0|||
163947255|NCT01871805|592175526|FG005|Phase II|Lost to Follow-up|13|||
163947256|NCT00859222|592175527|FG000|Overall Study|Adverse Event|2|||
163947257|NCT00859222|592175528|FG001|Overall Study|Adverse Event|3|||
163947258|NCT00859222|592175529|FG002|Overall Study|Adverse Event|6|||
163947259|NCT00859222|592175530|FG003|Overall Study|Adverse Event|24|||
163947260|NCT00859222|592175531|FG004|Overall Study|Adverse Event|15|||
163947261|NCT00859222|592175527|FG000|Overall Study|DLT|1|||
163947262|NCT00859222|592175528|FG001|Overall Study|DLT|0|||
163947263|NCT00859222|592175529|FG002|Overall Study|DLT|0|||
163947264|NCT00859222|592175530|FG003|Overall Study|DLT|0|||
163947265|NCT00859222|592175531|FG004|Overall Study|DLT|0|||
163947266|NCT00941070|592175538|FG000|Overall Study|Patient non-compliant|1|||
163947267|NCT03500159|592175539|FG000|Overall Study|Study Terminated|2|||
163947268|NCT03500159|592175540|FG001|Overall Study|Study Terminated|1|||
163947269|NCT04075994|592175547|FG000|Overall Study|Withdrawal by Subject|8|||
163947270|NCT04075994|592175548|FG001|Overall Study|Withdrawal by Subject|9|||
163947271|NCT04075994|592175547|FG000|Overall Study|Adverse Event|2|||
163947272|NCT04075994|592175548|FG001|Overall Study|Adverse Event|2|||
163947273|NCT04075994|592175547|FG000|Overall Study|Investigator withdrew|3|||
163947274|NCT04075994|592175548|FG001|Overall Study|Investigator withdrew|1|||
163947275|NCT01263665|592175551|FG000|Overall Study|Withdrew Consent|1|||
163947276|NCT01263665|592175551|FG000|Overall Study|Lost to Follow-up|3|||
163947277|NCT01263665|592175551|FG000|Overall Study|Death|2|||
163947278|NCT01263665|592175551|FG000|Overall Study|Amputation above the ankle|1|||
163947279|NCT01263665|592175551|FG000|Overall Study|Surgical Bypass|2|||
163947280|NCT02797080|592175556|FG000|Overall Study|Lost to Follow-up|1|||
163947281|NCT02797080|592175556|FG000|Overall Study|Withdrawal by Subject|1|||
163947282|NCT00951015|592175557|FG000|Randomization Phase 96 Week|Adverse Event|1|||
163947283|NCT00951015|592175558|FG001|Randomization Phase 96 Week|Adverse Event|1|||
163947284|NCT00951015|592175559|FG002|Randomization Phase 96 Week|Adverse Event|2|||
163947285|NCT00951015|592175560|FG003|Randomization Phase 96 Week|Adverse Event|5|||
163947286|NCT00951015|592175561|FG004|Randomization Phase 96 Week|Adverse Event|0|||
163947287|NCT00951015|592175557|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
163947288|NCT00951015|592175558|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
163947289|NCT00951015|592175559|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
164046852|NCT04007367|592530491|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
164046853|NCT04007367|592530492|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
164046854|NCT04007367|592530493|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
164046855|NCT04007367|592530491|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
164046856|NCT04007367|592530492|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
164046857|NCT04007367|592530493|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
164046858|NCT04007367|592530491|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
164046859|NCT04007367|592530492|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
164046860|NCT04007367|592530493|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
164046861|NCT04007367|592530491|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
164046862|NCT04007367|592530492|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
164046863|NCT04007367|592530493|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
164046864|NCT02010567|592530496|FG000|Overall Study|Adverse Event|0|||
164046865|NCT02010567|592530497|FG001|Overall Study|Adverse Event|0|||
164046866|NCT02010567|592530498|FG002|Overall Study|Adverse Event|1|||
164046867|NCT02010567|592530499|FG003|Overall Study|Adverse Event|0|||
164046868|NCT02010567|592530500|FG004|Overall Study|Adverse Event|1|||
164046869|NCT00606229|592530504|FG000|Overall Study|Adverse Event|11|||
164046870|NCT00606229|592530504|FG000|Overall Study|Lack of Efficacy|1|||
164046871|NCT00606229|592530504|FG000|Overall Study|Withdrawal by Subject|4|||
164046872|NCT00606229|592530504|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
164046873|NCT00606229|592530504|FG000|Overall Study|change of residence or other commitments|2|||
164046874|NCT03523715|592530505|FG000|Overall Study|Lost to Follow-up|11|||
164046875|NCT03523715|592530506|FG001|Overall Study|Lost to Follow-up|14|||
164046876|NCT03523715|592530505|FG000|Overall Study|Did not meet inclusion criteria|1|||
164046877|NCT03523715|592530506|FG001|Overall Study|Did not meet inclusion criteria|0|||
164046878|NCT03523715|592530505|FG000|Overall Study|Internally inconsistent reporting|0|||
164046879|NCT03523715|592530506|FG001|Overall Study|Internally inconsistent reporting|2|||
164046880|NCT01526928|592530507|FG000|Overall Study|Progressive Disease|35|||
164046881|NCT01526928|592530508|FG001|Overall Study|Progressive Disease|17|||
164046882|NCT01526928|592530509|FG002|Overall Study|Progressive Disease|150|||
164046883|NCT01526928|592530510|FG003|Overall Study|Progressive Disease|182|||
164046884|NCT01526928|592530511|FG004|Overall Study|Progressive Disease|76|||
164046885|NCT01526928|592530512|FG005|Overall Study|Progressive Disease|4|||
164046886|NCT01526928|592530507|FG000|Overall Study|Adverse Event|2|||
164046887|NCT01526928|592530508|FG001|Overall Study|Adverse Event|1|||
164046888|NCT01526928|592530509|FG002|Overall Study|Adverse Event|29|||
164046889|NCT01526928|592530510|FG003|Overall Study|Adverse Event|40|||
164046890|NCT01526928|592530511|FG004|Overall Study|Adverse Event|13|||
164046891|NCT01526928|592530512|FG005|Overall Study|Adverse Event|2|||
164046892|NCT01526928|592530507|FG000|Overall Study|Death|0|||
164046893|NCT01526928|592530508|FG001|Overall Study|Death|0|||
164046894|NCT01526928|592530509|FG002|Overall Study|Death|3|||
164046895|NCT01526928|592530510|FG003|Overall Study|Death|0|||
164046896|NCT01526928|592530511|FG004|Overall Study|Death|0|||
164046897|NCT01526928|592530512|FG005|Overall Study|Death|0|||
164046898|NCT01526928|592530507|FG000|Overall Study|Withdrawal by Subject|1|||
164046899|NCT01526928|592530508|FG001|Overall Study|Withdrawal by Subject|0|||
164099565|NCT00272779|592730487|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
163842704|NCT01807221|591794763|FG005|Overall Study|Withdrawal by Subject|13|||
163842705|NCT01807221|591794758|FG000|Overall Study|Sponsor decision|2|||
163842706|NCT01807221|591794759|FG001|Overall Study|Sponsor decision|0|||
163842707|NCT01807221|591794760|FG002|Overall Study|Sponsor decision|1|||
163842708|NCT01807221|591794761|FG003|Overall Study|Sponsor decision|1|||
163842709|NCT01807221|591794762|FG004|Overall Study|Sponsor decision|0|||
163842710|NCT01807221|591794763|FG005|Overall Study|Sponsor decision|0|||
163842711|NCT01807221|591794758|FG000|Overall Study|Lost to Follow-up|1|||
163842712|NCT01807221|591794759|FG001|Overall Study|Lost to Follow-up|0|||
163842713|NCT01807221|591794760|FG002|Overall Study|Lost to Follow-up|2|||
163842714|NCT01807221|591794761|FG003|Overall Study|Lost to Follow-up|1|||
163842715|NCT01807221|591794762|FG004|Overall Study|Lost to Follow-up|0|||
163842716|NCT01807221|591794763|FG005|Overall Study|Lost to Follow-up|0|||
163842717|NCT01912222|591794769|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
163842718|NCT01912222|591794770|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
163842719|NCT01912222|591794771|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
163842720|NCT01912222|591794769|FG000|Part B: Treatment Period|Progressive disease|10|||
163842721|NCT01912222|591794770|FG001|Part B: Treatment Period|Progressive disease|12|||
163842722|NCT01912222|591794771|FG002|Part B: Treatment Period|Progressive disease|15|||
164046900|NCT01526928|592530509|FG002|Overall Study|Withdrawal by Subject|13|||
164046901|NCT01526928|592530510|FG003|Overall Study|Withdrawal by Subject|11|||
164046902|NCT01526928|592530511|FG004|Overall Study|Withdrawal by Subject|3|||
164046903|NCT01526928|592530512|FG005|Overall Study|Withdrawal by Subject|0|||
164046904|NCT01526928|592530507|FG000|Overall Study|Physician Decision|0|||
164046905|NCT01526928|592530508|FG001|Overall Study|Physician Decision|0|||
164046906|NCT01526928|592530509|FG002|Overall Study|Physician Decision|2|||
164046907|NCT01526928|592530510|FG003|Overall Study|Physician Decision|5|||
163947290|NCT00951015|592175560|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
164099566|NCT00272779|592730488|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
164099567|NCT00272779|592730487|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
163947291|NCT00951015|592175561|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
163947292|NCT00951015|592175557|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
163947293|NCT00951015|592175558|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
163947294|NCT00951015|592175559|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
163947295|NCT00951015|592175560|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
163947296|NCT00951015|592175561|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
163947297|NCT00951015|592175557|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163947298|NCT00951015|592175558|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163947299|NCT00951015|592175559|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163947300|NCT00951015|592175560|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
163947301|NCT00951015|592175561|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
163947302|NCT00951015|592175557|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
163947303|NCT00951015|592175558|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
163947304|NCT00951015|592175559|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
163947305|NCT00951015|592175560|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
163947306|NCT00951015|592175561|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
163947307|NCT00951015|592175557|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
163947308|NCT00951015|592175558|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
163947309|NCT00951015|592175559|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
163947310|NCT00951015|592175560|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
163947311|NCT00951015|592175561|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
163947312|NCT00951015|592175557|FG000|Open-label Phase|Adverse Event|0|||
163947313|NCT00951015|592175558|FG001|Open-label Phase|Adverse Event|0|||
163947314|NCT00951015|592175559|FG002|Open-label Phase|Adverse Event|0|||
163947315|NCT00951015|592175560|FG003|Open-label Phase|Adverse Event|0|||
163947316|NCT00951015|592175561|FG004|Open-label Phase|Adverse Event|3|||
163947317|NCT00951015|592175557|FG000|Open-label Phase|Lack of Efficacy|0|||
163947318|NCT00951015|592175558|FG001|Open-label Phase|Lack of Efficacy|0|||
163947319|NCT00951015|592175559|FG002|Open-label Phase|Lack of Efficacy|0|||
163947320|NCT00951015|592175560|FG003|Open-label Phase|Lack of Efficacy|0|||
163947321|NCT00951015|592175561|FG004|Open-label Phase|Lack of Efficacy|1|||
163947322|NCT00951015|592175557|FG000|Open-label Phase|Protocol Violation|0|||
163947323|NCT00951015|592175558|FG001|Open-label Phase|Protocol Violation|0|||
163947324|NCT00951015|592175559|FG002|Open-label Phase|Protocol Violation|0|||
163947325|NCT00951015|592175560|FG003|Open-label Phase|Protocol Violation|0|||
163947326|NCT00951015|592175561|FG004|Open-label Phase|Protocol Violation|12|||
163947327|NCT00951015|592175557|FG000|Open-label Phase|Lost to Follow-up|0|||
163947328|NCT00951015|592175558|FG001|Open-label Phase|Lost to Follow-up|0|||
163947329|NCT00951015|592175559|FG002|Open-label Phase|Lost to Follow-up|0|||
163947330|NCT00951015|592175560|FG003|Open-label Phase|Lost to Follow-up|0|||
163947331|NCT00951015|592175561|FG004|Open-label Phase|Lost to Follow-up|12|||
163947332|NCT00951015|592175557|FG000|Open-label Phase|Withdrawal by Subject|0|||
164099568|NCT00272779|592730488|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
164099569|NCT00272779|592730487|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
164099570|NCT00272779|592730488|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
164099571|NCT00272779|592730487|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
164099572|NCT00272779|592730488|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
164099573|NCT00272779|592730487|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
164099574|NCT00272779|592730488|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
164099575|NCT00272779|592730487|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
164099576|NCT00272779|592730488|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
164099577|NCT00272779|592730487|FG000|Baseline Through Week 48|Continuing treatment|385|||
164099578|NCT00272779|592730488|FG001|Baseline Through Week 48|Continuing treatment|368|||
163947333|NCT00951015|592175558|FG001|Open-label Phase|Withdrawal by Subject|0|||
163947334|NCT00951015|592175559|FG002|Open-label Phase|Withdrawal by Subject|0|||
163947335|NCT00951015|592175560|FG003|Open-label Phase|Withdrawal by Subject|0|||
163947336|NCT00951015|592175561|FG004|Open-label Phase|Withdrawal by Subject|14|||
164099579|NCT00272779|592730487|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
164099580|NCT00272779|592730488|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
164099581|NCT00272779|592730487|FG000|Baseline Through Week 48|Never treated|2|||
164099582|NCT00272779|592730488|FG001|Baseline Through Week 48|Never treated|3|||
164099583|NCT00272779|592730487|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
164099584|NCT00272779|592730488|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
163947337|NCT00951015|592175557|FG000|Open-label Phase|Physician Decision|0|||
163947338|NCT00951015|592175558|FG001|Open-label Phase|Physician Decision|0|||
164148617|NCT04895982|592904913|FG002|Overall Study|Protocol Violation|1|||
163947339|NCT00951015|592175559|FG002|Open-label Phase|Physician Decision|0|||
163947340|NCT00951015|592175560|FG003|Open-label Phase|Physician Decision|0|||
163947341|NCT00951015|592175561|FG004|Open-label Phase|Physician Decision|8|||
163947342|NCT01416389|592175562|FG000|Overall Study|Lost to Follow-up|1|||
163947343|NCT01416389|592175563|FG001|Overall Study|Lost to Follow-up|0|||
163947344|NCT01416389|592175562|FG000|Overall Study|Started New Therapy|2|||
163947345|NCT01416389|592175563|FG001|Overall Study|Started New Therapy|0|||
163947346|NCT00929110|592175570|FG000|Overall Study|Adverse Event|40|||
163947347|NCT00929110|592175571|FG001|Overall Study|Adverse Event|29|||
163947348|NCT00929110|592175572|FG002|Overall Study|Adverse Event|18|||
163947349|NCT00929110|592175570|FG000|Overall Study|Subject withdrew consent|40|||
163947350|NCT00929110|592175571|FG001|Overall Study|Subject withdrew consent|23|||
163947351|NCT00929110|592175572|FG002|Overall Study|Subject withdrew consent|26|||
163947352|NCT00929110|592175570|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
163947353|NCT00929110|592175571|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
163947354|NCT00929110|592175572|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
163947355|NCT00929110|592175570|FG000|Overall Study|Lost to Follow-up|7|||
163947356|NCT00929110|592175571|FG001|Overall Study|Lost to Follow-up|7|||
163947357|NCT00929110|592175572|FG002|Overall Study|Lost to Follow-up|3|||
163947358|NCT00929110|592175570|FG000|Overall Study|Protocol deviation|5|||
163947359|NCT00929110|592175571|FG001|Overall Study|Protocol deviation|2|||
163947360|NCT00929110|592175572|FG002|Overall Study|Protocol deviation|4|||
163947361|NCT00929110|592175570|FG000|Overall Study|Administrative problems|4|||
163947362|NCT00929110|592175571|FG001|Overall Study|Administrative problems|1|||
163947363|NCT00929110|592175572|FG002|Overall Study|Administrative problems|2|||
163947364|NCT00929110|592175570|FG000|Overall Study|Death|2|||
163947365|NCT00929110|592175571|FG001|Overall Study|Death|2|||
163947366|NCT00929110|592175572|FG002|Overall Study|Death|2|||
163947367|NCT00929110|592175570|FG000|Overall Study|Abnormal laboratory value(s)|0|||
163947368|NCT00929110|592175571|FG001|Overall Study|Abnormal laboratory value(s)|1|||
163947369|NCT00929110|592175572|FG002|Overall Study|Abnormal laboratory value(s)|0|||
163947370|NCT00929110|592175570|FG000|Overall Study|Abnormal test procedure result(s)|0|||
163947371|NCT00929110|592175571|FG001|Overall Study|Abnormal test procedure result(s)|1|||
163947372|NCT00929110|592175572|FG002|Overall Study|Abnormal test procedure result(s)|1|||
163947373|NCT00929110|592175570|FG000|Overall Study|Patient inability to use the device|0|||
163947374|NCT00929110|592175571|FG001|Overall Study|Patient inability to use the device|1|||
163947375|NCT00929110|592175572|FG002|Overall Study|Patient inability to use the device|0|||
163947376|NCT01258595|592175575|FG000|Overall Study|Lost to Follow-up|1|||
163947377|NCT01258595|592175576|FG001|Overall Study|Lost to Follow-up|0|||
163947378|NCT01258595|592175575|FG000|Overall Study|Withdrawal by Subject|0|||
163947379|NCT01258595|592175576|FG001|Overall Study|Withdrawal by Subject|1|||
163947380|NCT02310100|592175577|FG000|Overall Study|Physician Decision|3|||
163947381|NCT02310100|592175577|FG000|Overall Study|Withdrawal by Subject|10|||
163947382|NCT02310100|592175577|FG000|Overall Study|Enrollment closure|1|||
163947383|NCT02310100|592175577|FG000|Overall Study|Unapproved ablation operator|1|||
163947384|NCT02310100|592175577|FG000|Overall Study|Visit compliance|1|||
163947385|NCT02310100|592175577|FG000|Overall Study|Lost to Follow-up|2|||
163947386|NCT00744757|592175582|FG000|Overall Study|Objective disease progression|7|||
163947387|NCT00744757|592175582|FG000|Overall Study|Physician Decision|5|||
163947388|NCT00744757|592175582|FG000|Overall Study|Withdrawal by Subject|1|||
163947389|NCT00744757|592175582|FG000|Overall Study|Death|6|||
163947390|NCT00744757|592175582|FG000|Overall Study|Adverse Event|2|||
163947391|NCT01820585|592175583|FG000|Overall Study|Adverse Event|9|||
163947392|NCT01820585|592175584|FG001|Overall Study|Adverse Event|13|||
163947393|NCT01820585|592175585|FG002|Overall Study|Adverse Event|23|||
163947394|NCT01820585|592175586|FG003|Overall Study|Adverse Event|34|||
163947395|NCT01820585|592175583|FG000|Overall Study|Lack of Efficacy|9|||
163947396|NCT01820585|592175584|FG001|Overall Study|Lack of Efficacy|7|||
163947397|NCT01820585|592175585|FG002|Overall Study|Lack of Efficacy|5|||
163947398|NCT01820585|592175586|FG003|Overall Study|Lack of Efficacy|1|||
164046908|NCT01526928|592530511|FG004|Overall Study|Physician Decision|0|||
164046909|NCT01526928|592530512|FG005|Overall Study|Physician Decision|0|||
164046910|NCT01526928|592530507|FG000|Overall Study|Other Reason|0|||
164046911|NCT01526928|592530508|FG001|Overall Study|Other Reason|1|||
164046912|NCT01526928|592530509|FG002|Overall Study|Other Reason|11|||
164046913|NCT01526928|592530510|FG003|Overall Study|Other Reason|4|||
163947399|NCT01820585|592175583|FG000|Overall Study|Withdrawal by Subject|3|||
163947400|NCT01820585|592175584|FG001|Overall Study|Withdrawal by Subject|7|||
163947401|NCT01820585|592175585|FG002|Overall Study|Withdrawal by Subject|3|||
163947402|NCT01820585|592175586|FG003|Overall Study|Withdrawal by Subject|8|||
163947403|NCT01820585|592175583|FG000|Overall Study|Lost to Follow-up|3|||
163947404|NCT01820585|592175584|FG001|Overall Study|Lost to Follow-up|3|||
163947405|NCT01820585|592175585|FG002|Overall Study|Lost to Follow-up|0|||
163947406|NCT01820585|592175586|FG003|Overall Study|Lost to Follow-up|3|||
163947407|NCT01820585|592175583|FG000|Overall Study|Protocol Violation|3|||
163947408|NCT01820585|592175584|FG001|Overall Study|Protocol Violation|1|||
163947409|NCT01820585|592175585|FG002|Overall Study|Protocol Violation|1|||
163947410|NCT01820585|592175586|FG003|Overall Study|Protocol Violation|1|||
164046914|NCT01526928|592530511|FG004|Overall Study|Other Reason|1|||
164046915|NCT01526928|592530512|FG005|Overall Study|Other Reason|0|||
163947411|NCT01820585|592175583|FG000|Overall Study|Subject non-compliance|0|||
163947412|NCT01820585|592175584|FG001|Overall Study|Subject non-compliance|0|||
163947413|NCT01820585|592175585|FG002|Overall Study|Subject non-compliance|1|||
163947414|NCT01820585|592175586|FG003|Overall Study|Subject non-compliance|2|||
163947415|NCT01820585|592175583|FG000|Overall Study|at sponsor request|0|||
163947416|NCT01820585|592175584|FG001|Overall Study|at sponsor request|0|||
163947417|NCT01820585|592175585|FG002|Overall Study|at sponsor request|1|||
163947418|NCT01820585|592175586|FG003|Overall Study|at sponsor request|0|||
163947419|NCT01820585|592175583|FG000|Overall Study|Pregnancy|0|||
163947420|NCT01820585|592175584|FG001|Overall Study|Pregnancy|1|||
163947421|NCT01820585|592175585|FG002|Overall Study|Pregnancy|0|||
163947422|NCT01820585|592175586|FG003|Overall Study|Pregnancy|0|||
163947423|NCT01712659|592175587|FG000|Dose Escalation|Physician Decision|0|||
163947424|NCT01712659|592175588|FG001|Dose Escalation|Physician Decision|1|||
163947425|NCT01712659|592175589|FG002|Dose Escalation|Physician Decision|0|||
163947426|NCT01712659|592175590|FG003|Dose Escalation|Physician Decision|0|||
163947427|NCT01712659|592175591|FG004|Dose Escalation|Physician Decision|0|||
163947428|NCT01712659|592175587|FG000|Dose Escalation|Unable to take study drug|0|||
163947429|NCT01712659|592175588|FG001|Dose Escalation|Unable to take study drug|1|||
163947430|NCT01712659|592175589|FG002|Dose Escalation|Unable to take study drug|0|||
163947431|NCT01712659|592175590|FG003|Dose Escalation|Unable to take study drug|0|||
163947432|NCT01712659|592175591|FG004|Dose Escalation|Unable to take study drug|0|||
163947433|NCT01712659|592175587|FG000|Dose Expansion|Early disease progression|1|||
163947434|NCT01712659|592175588|FG001|Dose Expansion|Early disease progression|0|||
163947435|NCT01712659|592175589|FG002|Dose Expansion|Early disease progression|0|||
163947436|NCT01712659|592175590|FG003|Dose Expansion|Early disease progression|0|||
163947437|NCT01712659|592175591|FG004|Dose Expansion|Early disease progression|0|||
163947438|NCT01712659|592175587|FG000|Dose Expansion|Physician Decision|1|||
163947439|NCT01712659|592175588|FG001|Dose Expansion|Physician Decision|0|||
163947440|NCT01712659|592175589|FG002|Dose Expansion|Physician Decision|0|||
163947441|NCT01712659|592175590|FG003|Dose Expansion|Physician Decision|0|||
163947442|NCT01712659|592175591|FG004|Dose Expansion|Physician Decision|0|||
163947443|NCT00548262|592175592|FG000|Overall Study|Death|21|||
163947444|NCT00548262|592175592|FG000|Overall Study|Adverse Event|2|||
163947445|NCT00548262|592175592|FG000|Overall Study|Lack of Efficacy|4|||
163947446|NCT00548262|592175592|FG000|Overall Study|Lost to Follow-up|1|||
163947447|NCT00548262|592175592|FG000|Overall Study|Other|3|||
163947448|NCT00548262|592175592|FG000|Overall Study|Withdrawal by Subject|1|||
163947449|NCT01769326|592175598|FG000|Overall Study|Lost to Follow-up|1|||
163947450|NCT01769326|592175599|FG001|Overall Study|Lost to Follow-up|2|||
163947451|NCT01769326|592175600|FG002|Overall Study|Lost to Follow-up|0|||
163947452|NCT01769326|592175601|FG003|Overall Study|Lost to Follow-up|0|||
163947453|NCT01769326|592175598|FG000|Overall Study|unrelated injry|1|||
163947454|NCT01769326|592175599|FG001|Overall Study|unrelated injry|1|||
163947455|NCT01769326|592175600|FG002|Overall Study|unrelated injry|0|||
163947456|NCT01769326|592175601|FG003|Overall Study|unrelated injry|0|||
163947457|NCT01769326|592175598|FG000|Overall Study|got a job|0|||
163947458|NCT01769326|592175599|FG001|Overall Study|got a job|1|||
163947459|NCT01769326|592175600|FG002|Overall Study|got a job|0|||
163947460|NCT01769326|592175601|FG003|Overall Study|got a job|0|||
163947461|NCT01769326|592175598|FG000|Overall Study|Got sick and could not complete study|0|||
163947462|NCT01769326|592175599|FG001|Overall Study|Got sick and could not complete study|0|||
163947463|NCT01769326|592175600|FG002|Overall Study|Got sick and could not complete study|1|||
163947464|NCT01769326|592175601|FG003|Overall Study|Got sick and could not complete study|0|||
163947465|NCT01036438|592175602|FG000|Overall Study|Adverse Event|7|||
163947466|NCT01036438|592175603|FG001|Overall Study|Adverse Event|8|||
163947467|NCT01036438|592175602|FG000|Overall Study|Death|0|||
163947468|NCT01036438|592175603|FG001|Overall Study|Death|1|||
163947469|NCT01036438|592175602|FG000|Overall Study|No effect of study treatment|3|||
163947470|NCT01036438|592175603|FG001|Overall Study|No effect of study treatment|1|||
163947471|NCT00888927|592175604|FG000|Overall Study|Adverse Event|0|||
163947472|NCT00888927|592175605|FG001|Overall Study|Adverse Event|0|||
163947473|NCT00888927|592175606|FG002|Overall Study|Adverse Event|0|||
163947474|NCT00888927|592175607|FG003|Overall Study|Adverse Event|1|||
163947475|NCT00888927|592175604|FG000|Overall Study|Withdrawal of consent|0|||
163947476|NCT00888927|592175605|FG001|Overall Study|Withdrawal of consent|0|||
163947477|NCT00888927|592175606|FG002|Overall Study|Withdrawal of consent|0|||
163947478|NCT00888927|592175607|FG003|Overall Study|Withdrawal of consent|1|||
163947479|NCT03592745|592175608|FG000|Overall Study|Adverse Event|0|||
163947480|NCT03592745|592175609|FG001|Overall Study|Adverse Event|2|||
163947481|NCT03592745|592175608|FG000|Overall Study|Lost to Follow-up|2|||
163947482|NCT03592745|592175609|FG001|Overall Study|Lost to Follow-up|0|||
163947483|NCT03592745|592175608|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
163947484|NCT03592745|592175609|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
163947485|NCT00293059|592175610|FG000|Overall Study|Adverse Event|12|||
163947486|NCT00293059|592175611|FG001|Overall Study|Adverse Event|4|||
163947487|NCT00293059|592175610|FG000|Overall Study|Lack of Efficacy|2|||
163947488|NCT00293059|592175611|FG001|Overall Study|Lack of Efficacy|0|||
163947489|NCT00293059|592175610|FG000|Overall Study|Lost to Follow-up|2|||
163947490|NCT00293059|592175611|FG001|Overall Study|Lost to Follow-up|3|||
163947491|NCT00293059|592175610|FG000|Overall Study|Pregnancy|1|||
163947492|NCT00293059|592175611|FG001|Overall Study|Pregnancy|1|||
163947493|NCT00293059|592175610|FG000|Overall Study|Protocol Violation|2|||
163947494|NCT00293059|592175611|FG001|Overall Study|Protocol Violation|0|||
163947495|NCT00293059|592175610|FG000|Overall Study|Withdrawal by Subject|11|||
163947496|NCT00293059|592175611|FG001|Overall Study|Withdrawal by Subject|5|||
163947497|NCT00293059|592175610|FG000|Overall Study|Participant moved out of state|1|||
163947498|NCT00293059|592175611|FG001|Overall Study|Participant moved out of state|0|||
163947499|NCT00293059|592175610|FG000|Overall Study|Participant stopped study drug|1|||
163947500|NCT00293059|592175611|FG001|Overall Study|Participant stopped study drug|0|||
163947501|NCT00293059|592175610|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
163947502|NCT00293059|592175611|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
163947503|NCT00293059|592175610|FG000|Overall Study|missing|3|||
163947504|NCT00293059|592175611|FG001|Overall Study|missing|5|||
163947505|NCT04362189|592175615|FG000|Overall Study|Lost to Follow-up|0|||
163947506|NCT04362189|592175616|FG001|Overall Study|Lost to Follow-up|1|||
163947507|NCT04362189|592175615|FG000|Overall Study|Withdrawal by Subject|1|||
163947508|NCT04362189|592175616|FG001|Overall Study|Withdrawal by Subject|0|||
163947509|NCT04362189|592175615|FG000|Overall Study|FDA Clinical Hold|7|||
163947510|NCT04362189|592175616|FG001|Overall Study|FDA Clinical Hold|2|||
163947511|NCT04362189|592175615|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
163947512|NCT04362189|592175616|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
163947513|NCT04362189|592175615|FG000|Overall Study|Adverse Event|0|||
163947514|NCT04362189|592175616|FG001|Overall Study|Adverse Event|2|||
163947515|NCT04362189|592175615|FG000|Overall Study|Death|4|||
163947516|NCT04362189|592175616|FG001|Overall Study|Death|1|||
163947517|NCT02111681|592175617|FG000|Overall Study|Death|5|||
163947518|NCT02111681|592175617|FG000|Overall Study|Lack of Efficacy|2|||
163947519|NCT02111681|592175617|FG000|Overall Study|Progression of disease|4|||
163947520|NCT03981861|592175618|FG000|Overall Study|Withdrawal by Subject|3|||
163947521|NCT04058366|592177507|FG000|Overall Study|Adverse Event|14|||
163947522|NCT04058366|592177507|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
163947523|NCT04058366|592177507|FG000|Overall Study|Commercial drug is available for participants|6|||
163947524|NCT04058366|592177507|FG000|Overall Study|Death|1|||
163947525|NCT04058366|592177507|FG000|Overall Study|Other non-compliance|2|||
163947526|NCT04058366|592177507|FG000|Overall Study|Other|6|||
163947527|NCT02914275|592177511|FG000|Overall Study|Lost to Follow-up|84|||
163947528|NCT02914275|592177512|FG001|Overall Study|Lost to Follow-up|29|||
163947529|NCT02914275|592177511|FG000|Overall Study|Withdrawal by Subject|26|||
163947530|NCT02914275|592177512|FG001|Overall Study|Withdrawal by Subject|10|||
164046916|NCT01526928|592530507|FG000|Overall Study|Lost to Follow-up|0|||
164046917|NCT01526928|592530508|FG001|Overall Study|Lost to Follow-up|0|||
164046918|NCT01526928|592530509|FG002|Overall Study|Lost to Follow-up|0|||
164046919|NCT01526928|592530510|FG003|Overall Study|Lost to Follow-up|1|||
164046920|NCT01526928|592530511|FG004|Overall Study|Lost to Follow-up|0|||
164046921|NCT01526928|592530512|FG005|Overall Study|Lost to Follow-up|0|||
164046922|NCT01526928|592530507|FG000|Overall Study|Protocol Deviation|0|||
164046923|NCT01526928|592530508|FG001|Overall Study|Protocol Deviation|0|||
164046924|NCT01526928|592530509|FG002|Overall Study|Protocol Deviation|0|||
164046925|NCT01526928|592530510|FG003|Overall Study|Protocol Deviation|2|||
164046926|NCT01526928|592530511|FG004|Overall Study|Protocol Deviation|0|||
164046927|NCT01526928|592530512|FG005|Overall Study|Protocol Deviation|0|||
164046928|NCT01526928|592530507|FG000|Overall Study|Missing|0|||
164046929|NCT01526928|592530508|FG001|Overall Study|Missing|0|||
164046930|NCT01526928|592530509|FG002|Overall Study|Missing|1|||
164046931|NCT01526928|592530510|FG003|Overall Study|Missing|0|||
164046932|NCT01526928|592530511|FG004|Overall Study|Missing|2|||
164046933|NCT01526928|592530512|FG005|Overall Study|Missing|0|||
164046934|NCT00942422|592530513|FG000|Overall Study|Withdrawal by Subject|1|||
164046935|NCT00942422|592530513|FG000|Overall Study|Death|1|||
164046936|NCT00942422|592530513|FG000|Overall Study|Progressive diease|1|||
164046937|NCT05559203|592530521|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
164046938|NCT00422903|592530522|FG000|Overall Study|Disease Progression|3|||
164046939|NCT00422903|592530523|FG001|Overall Study|Disease Progression|1|||
164046940|NCT00422903|592530522|FG000|Overall Study|Adverse Event|0|||
163947531|NCT02914275|592177511|FG000|Overall Study|Protocol Violation|1|||
163947532|NCT02914275|592177512|FG001|Overall Study|Protocol Violation|1|||
163947533|NCT02914275|592177511|FG000|Overall Study|Physician Decision|3|||
163947534|NCT02914275|592177512|FG001|Overall Study|Physician Decision|1|||
163947535|NCT02914275|592177511|FG000|Overall Study|Other|4|||
163947536|NCT02914275|592177512|FG001|Overall Study|Other|1|||
163947537|NCT02914275|592177511|FG000|Overall Study|Excluded due to invalid informed consent|3|||
164046941|NCT00422903|592530523|FG001|Overall Study|Adverse Event|2|||
164046942|NCT00422903|592530522|FG000|Overall Study|Informed Consent Withdrawn|1|||
164046943|NCT00422903|592530523|FG001|Overall Study|Informed Consent Withdrawn|2|||
164046944|NCT01947894|592530524|FG000|Overall Study|Other|3|||
164046945|NCT01947894|592530525|FG001|Overall Study|Other|4|||
163947538|NCT02914275|592177512|FG001|Overall Study|Excluded due to invalid informed consent|0|||
163947539|NCT00923260|592177513|FG000|Overall Study|Lost to Follow-up|1|||
163947540|NCT00923260|592177514|FG001|Overall Study|Lost to Follow-up|1|||
163947541|NCT02738203|592177521|FG000|Overall Study|Failed IUD Insertion|2|||
163947542|NCT02738203|592177522|FG001|Overall Study|Failed IUD Insertion|2|||
163947543|NCT02738203|592177521|FG000|Overall Study|Protocol Violation|0|||
163947544|NCT02738203|592177522|FG001|Overall Study|Protocol Violation|1|||
163947545|NCT05087979|592177523|FG000|Overall Study|Converted to general anesthesia|1|||
163947546|NCT05087979|592177524|FG001|Overall Study|Converted to general anesthesia|0|||
163947547|NCT03507777|592177526|FG000|Overall Study|Lost to Follow-up|5|||
163947548|NCT03507777|592177527|FG001|Overall Study|Lost to Follow-up|7|||
163947549|NCT03507777|592177526|FG000|Overall Study|Withdrawal by Subject|6|||
163947550|NCT03507777|592177527|FG001|Overall Study|Withdrawal by Subject|11|||
163947551|NCT03507777|592177526|FG000|Overall Study|Death|30|||
163947552|NCT03507777|592177527|FG001|Overall Study|Death|44|||
163947553|NCT03507777|592177526|FG000|Overall Study|Other Reasons|3|||
163947554|NCT03507777|592177527|FG001|Overall Study|Other Reasons|8|||
163947555|NCT00446043|592177528|FG000|Overall Study|Adverse Event|9|||
163947556|NCT00446043|592177528|FG000|Overall Study|Withdrawal by Subject|70|||
163947557|NCT00446043|592177528|FG000|Overall Study|Protocol Violation|2|||
163947558|NCT00446043|592177528|FG000|Overall Study|Lost to Follow-up|42|||
163947559|NCT00446043|592177528|FG000|Overall Study|Pregnancy|2|||
163947560|NCT02071290|592177533|FG000|Overall Study|Death|1|||
163947561|NCT02071290|592177534|FG001|Overall Study|Death|0|||
163947562|NCT02071290|592177533|FG000|Overall Study|Withdrawal by Subject|0|||
163947563|NCT02071290|592177534|FG001|Overall Study|Withdrawal by Subject|1|||
163947564|NCT02071290|592177533|FG000|Overall Study|Protocol Violation|3|||
163947565|NCT02071290|592177534|FG001|Overall Study|Protocol Violation|5|||
163947566|NCT02071290|592177533|FG000|Overall Study|Physician Decision|0|||
163947567|NCT02071290|592177534|FG001|Overall Study|Physician Decision|1|||
163947568|NCT00964886|592177543|FG000|Overall Study|Lost to Follow-up|2|||
163947569|NCT00964886|592177544|FG001|Overall Study|Lost to Follow-up|2|||
163947570|NCT00964886|592177545|FG002|Overall Study|Lost to Follow-up|6|||
163947571|NCT00964886|592177546|FG003|Overall Study|Lost to Follow-up|4|||
163947572|NCT00964886|592177543|FG000|Overall Study|Withdrawal by Subject|6|||
163947573|NCT00964886|592177544|FG001|Overall Study|Withdrawal by Subject|2|||
163947574|NCT00964886|592177545|FG002|Overall Study|Withdrawal by Subject|5|||
163947575|NCT00964886|592177546|FG003|Overall Study|Withdrawal by Subject|3|||
163947576|NCT00964886|592177543|FG000|Overall Study|Adverse Event|3|||
163947577|NCT00964886|592177544|FG001|Overall Study|Adverse Event|1|||
163947578|NCT00964886|592177545|FG002|Overall Study|Adverse Event|5|||
163947579|NCT00964886|592177546|FG003|Overall Study|Adverse Event|2|||
163947580|NCT00964886|592177543|FG000|Overall Study|Protocol Violation|0|||
163947581|NCT00964886|592177544|FG001|Overall Study|Protocol Violation|2|||
163947582|NCT00964886|592177545|FG002|Overall Study|Protocol Violation|0|||
163947583|NCT00964886|592177546|FG003|Overall Study|Protocol Violation|0|||
163947584|NCT03484273|592177548|FG000|Overall Study|Equipment Malfunction|1|||
163947585|NCT03484273|592177548|FG000|Overall Study|Data excluded from analysis|1|||
163947586|NCT00468104|592177549|FG000|First Intervention|Protocol Violation|2|||
163947587|NCT00468104|592177550|FG001|First Intervention|Protocol Violation|1|||
163947588|NCT00468104|592177549|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
163947589|NCT00468104|592177550|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
163947590|NCT00468104|592177549|FG000|First Intervention|died within 3 weeks|1|||
163947591|NCT00468104|592177550|FG001|First Intervention|died within 3 weeks|0|||
163947592|NCT00468104|592177549|FG000|First Intervention|malposition/blocked chest tube tube|2|||
163947593|NCT00468104|592177550|FG001|First Intervention|malposition/blocked chest tube tube|0|||
163947594|NCT00468104|592177549|FG000|First Intervention|large lung mass with minimal effusion|1|||
163947595|NCT00468104|592177550|FG001|First Intervention|large lung mass with minimal effusion|0|||
163947596|NCT00468104|592177549|FG000|First Intervention|associated prolonged pneumothorax|1|||
163947597|NCT00468104|592177550|FG001|First Intervention|associated prolonged pneumothorax|0|||
163947598|NCT00468104|592177549|FG000|First Intervention|trapped lung|1|||
163947599|NCT00468104|592177550|FG001|First Intervention|trapped lung|0|||
163947600|NCT00468104|592177549|FG000|Second Intervention|Withdrawal by Subject|5|||
163947601|NCT00468104|592177550|FG001|Second Intervention|Withdrawal by Subject|2|||
163947602|NCT00468104|592177549|FG000|Second Intervention|discarded for malposition of chest tube|0|||
163947603|NCT00468104|592177550|FG001|Second Intervention|discarded for malposition of chest tube|2|||
163947604|NCT00324675|592177553|FG000|Overall Study|Adverse Event|1|||
163947605|NCT00324675|592177554|FG001|Overall Study|Adverse Event|0|||
163947606|NCT01941719|592177557|FG000|Overall Study|Lost to Follow-up|20|||
163947607|NCT01941719|592177558|FG001|Overall Study|Lost to Follow-up|19|||
163947608|NCT00381615|592177559|FG000|Overall Study|Withdrawal by Subject|1|||
163947609|NCT00381615|592177560|FG001|Overall Study|Withdrawal by Subject|3|||
163947610|NCT00381615|592177561|FG002|Overall Study|Withdrawal by Subject|0|||
163947611|NCT00381615|592177562|FG003|Overall Study|Withdrawal by Subject|1|||
163947612|NCT00381615|592177559|FG000|Overall Study|Lost to Follow-up|3|||
163947613|NCT00381615|592177560|FG001|Overall Study|Lost to Follow-up|2|||
163947614|NCT00381615|592177561|FG002|Overall Study|Lost to Follow-up|0|||
164099585|NCT00272779|592730487|FG000|Baseline Through Week 96|Death before Week 96|6|||
163842723|NCT01912222|591794769|FG000|Part B: Treatment Period|Adverse Event|1|||
163842724|NCT01912222|591794770|FG001|Part B: Treatment Period|Adverse Event|2|||
163842725|NCT01912222|591794771|FG002|Part B: Treatment Period|Adverse Event|3|||
163842726|NCT01912222|591794769|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
163842727|NCT01912222|591794770|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
163842728|NCT01912222|591794771|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
163842729|NCT01804673|591794772|FG000|Overall Study|Adverse Event|4|||
163842730|NCT01804673|591794772|FG000|Overall Study|Withdrawal by Subject|1|||
163842731|NCT01804673|591794772|FG000|Overall Study|Lack of Efficacy|9|||
163842732|NCT01804673|591794772|FG000|Overall Study|Change to Oral Therapy|37|||
163842733|NCT01804673|591794772|FG000|Overall Study|No Further Therapy Required|84|||
163842734|NCT01804673|591794772|FG000|Overall Study|Use of Prohibited Medication|1|||
163842735|NCT01804673|591794772|FG000|Overall Study|Other|4|||
163842736|NCT01857934|591794773|FG000|Overall Study|Relapse or progression|2|||
163842737|NCT01857934|591794773|FG000|Overall Study|Unacceptable toxicity|3|||
163842738|NCT01857934|591794773|FG000|Overall Study|Unwillingness or inability to comply|2|||
163842739|NCT01857934|591794773|FG000|Overall Study|Physician Decision|3|||
163842740|NCT04012814|591794777|FG000|Overall Study|Lost to Follow-up|4|||
163842741|NCT04012814|591794777|FG000|Overall Study|Withdrawal by Subject|2|||
163842742|NCT04012814|591794777|FG000|Overall Study|Protocol Violation|1|||
163842743|NCT04012814|591794777|FG000|Overall Study|Adverse Event|1|||
163842744|NCT04789577|591794778|FG000|Overall Study|Withdrawal by Subject|1|||
163842745|NCT04789577|591794779|FG001|Overall Study|Withdrawal by Subject|1|||
163842746|NCT04789577|591794780|FG002|Overall Study|Withdrawal by Subject|1|||
163842747|NCT04789577|591794781|FG003|Overall Study|Withdrawal by Subject|3|||
163842748|NCT04789577|591794782|FG004|Overall Study|Withdrawal by Subject|1|||
163842749|NCT04789577|591794783|FG005|Overall Study|Withdrawal by Subject|7|||
163842750|NCT04789577|591794784|FG006|Overall Study|Withdrawal by Subject|1|||
163842751|NCT04789577|591794778|FG000|Overall Study|Lost to Follow-up|7|||
163842752|NCT04789577|591794779|FG001|Overall Study|Lost to Follow-up|12|||
163842753|NCT04789577|591794780|FG002|Overall Study|Lost to Follow-up|7|||
163842754|NCT04789577|591794781|FG003|Overall Study|Lost to Follow-up|10|||
163842755|NCT04789577|591794782|FG004|Overall Study|Lost to Follow-up|8|||
163842756|NCT04789577|591794783|FG005|Overall Study|Lost to Follow-up|6|||
163842757|NCT04789577|591794784|FG006|Overall Study|Lost to Follow-up|10|||
163842758|NCT04789577|591794778|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
163842759|NCT04789577|591794779|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
163842760|NCT04789577|591794780|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
163842761|NCT04789577|591794781|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
163842762|NCT04789577|591794782|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
163842763|NCT04789577|591794783|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
163842764|NCT04789577|591794784|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
163842765|NCT04789577|591794778|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
163842766|NCT04789577|591794779|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
163842767|NCT04789577|591794780|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
163842768|NCT04789577|591794781|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
163842769|NCT04789577|591794782|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
163842770|NCT04789577|591794783|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
163842771|NCT04789577|591794784|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
163842772|NCT02441946|591794785|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
163842773|NCT02441946|591794786|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
163842774|NCT02441946|591794787|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
163842775|NCT02441946|591794785|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
163842776|NCT02441946|591794786|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
163842777|NCT02441946|591794787|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
163842778|NCT02441946|591794785|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
163842779|NCT02441946|591794786|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
163842780|NCT02441946|591794787|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
163842781|NCT02441946|591794785|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
163842782|NCT02441946|591794786|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
163842783|NCT02441946|591794787|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
163842784|NCT02441946|591794785|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
163842785|NCT02441946|591794786|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
163842786|NCT02441946|591794787|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
163842787|NCT02441946|591794785|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
163842788|NCT02441946|591794786|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
163842789|NCT02441946|591794787|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
163842790|NCT02441946|591794785|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
163842791|NCT02441946|591794786|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
163842792|NCT02441946|591794787|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
163947615|NCT00381615|592177562|FG003|Overall Study|Lost to Follow-up|1|||
163947616|NCT00381615|592177559|FG000|Overall Study|Protocol Violation|0|||
163947617|NCT00381615|592177560|FG001|Overall Study|Protocol Violation|0|||
163947618|NCT00381615|592177561|FG002|Overall Study|Protocol Violation|1|||
163947619|NCT00381615|592177562|FG003|Overall Study|Protocol Violation|0|||
163947620|NCT03819634|592177565|FG000|Overall Study|Physician Decision|2|||
163947621|NCT00958841|592177566|FG000|Overall Study|Abnormal laboratory value(s)|1|||
163947622|NCT00958841|592177566|FG000|Overall Study|Abnormal test procedure result(s)|3|||
163947623|NCT00958841|592177566|FG000|Overall Study|Administrative problems|1|||
163947624|NCT00958841|592177566|FG000|Overall Study|Adverse Event|8|||
163947625|NCT00958841|592177566|FG000|Overall Study|New cancer therapy|5|||
163947626|NCT00958841|592177566|FG000|Overall Study|Withdrawal by Subject|1|||
163947627|NCT00958841|592177566|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
163947628|NCT00958841|592177566|FG000|Overall Study|Completed M6/did not enter extension|27|||
163947629|NCT00958841|592177566|FG000|Overall Study|Discontinued prior to M*|28|||
163947630|NCT01125514|592177568|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
163947631|NCT01125514|592177568|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
163947632|NCT01125514|592177568|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
163947633|NCT01125514|592177568|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
163947634|NCT01125514|592177568|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
163947635|NCT01125514|592177568|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
163947636|NCT00858364|592177569|FG000|Overall Study|Administrative Decision|3|||
163947637|NCT00858364|592177570|FG001|Overall Study|Administrative Decision|2|||
163947638|NCT00858364|592177569|FG000|Overall Study|Adverse Event|5|||
163947639|NCT00858364|592177570|FG001|Overall Study|Adverse Event|2|||
163947640|NCT00858364|592177569|FG000|Overall Study|Withdrawal by Subject|44|||
163947641|NCT00858364|592177570|FG001|Overall Study|Withdrawal by Subject|118|||
163947642|NCT00858364|592177569|FG000|Overall Study|Ineligibility Determined|1|||
163947643|NCT00858364|592177570|FG001|Overall Study|Ineligibility Determined|10|||
163947644|NCT00858364|592177569|FG000|Overall Study|Lost to Follow-up|24|||
163947645|NCT00858364|592177570|FG001|Overall Study|Lost to Follow-up|54|||
163947646|NCT00858364|592177569|FG000|Overall Study|Noncompliance|3|||
163947647|NCT00858364|592177570|FG001|Overall Study|Noncompliance|4|||
163947648|NCT00858364|592177569|FG000|Overall Study|Protocol Deviation|0|||
163947649|NCT00858364|592177570|FG001|Overall Study|Protocol Deviation|2|||
163947650|NCT00858364|592177569|FG000|Overall Study|Other|9|||
163947651|NCT00858364|592177570|FG001|Overall Study|Other|17|||
163947652|NCT00858364|592177569|FG000|Overall Study|Missing|1|||
163947653|NCT00858364|592177570|FG001|Overall Study|Missing|1|||
163947654|NCT00858364|592177569|FG000|Overall Study|Still on-study|114|||
163947655|NCT00858364|592177570|FG001|Overall Study|Still on-study|247|||
163947656|NCT01655693|592177574|FG000|Overall Study|Progression of Disease|92|||
163947657|NCT01655693|592177575|FG001|Overall Study|Progression of Disease|76|||
163947658|NCT01655693|592177576|FG002|Overall Study|Progression of Disease|58|||
163947659|NCT01655693|592177574|FG000|Overall Study|Death|8|||
163947660|NCT01655693|592177575|FG001|Overall Study|Death|9|||
163947661|NCT01655693|592177576|FG002|Overall Study|Death|12|||
163947662|NCT01655693|592177574|FG000|Overall Study|Serious Adverse Event|3|||
163947663|NCT01655693|592177575|FG001|Overall Study|Serious Adverse Event|15|||
163947664|NCT01655693|592177576|FG002|Overall Study|Serious Adverse Event|11|||
163947665|NCT01655693|592177574|FG000|Overall Study|Withdrawal by Subject|3|||
163947666|NCT01655693|592177575|FG001|Overall Study|Withdrawal by Subject|2|||
163947667|NCT01655693|592177576|FG002|Overall Study|Withdrawal by Subject|20|||
163947668|NCT01655693|592177574|FG000|Overall Study|Adverse Event|3|||
163947669|NCT01655693|592177575|FG001|Overall Study|Adverse Event|11|||
163947670|NCT01655693|592177576|FG002|Overall Study|Adverse Event|3|||
163947671|NCT01655693|592177574|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
163947672|NCT01655693|592177575|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
163947673|NCT01655693|592177576|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
163947674|NCT01655693|592177574|FG000|Overall Study|Non-Compliance|0|||
163947675|NCT01655693|592177575|FG001|Overall Study|Non-Compliance|0|||
163947676|NCT01655693|592177576|FG002|Overall Study|Non-Compliance|7|||
163947677|NCT01655693|592177574|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
164099586|NCT00272779|592730488|FG001|Baseline Through Week 96|Death before Week 96|5|||
164099587|NCT00272779|592730487|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
163947678|NCT01655693|592177575|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
163947679|NCT01655693|592177576|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
163947680|NCT01655693|592177574|FG000|Overall Study|Protocol Violation|1|||
163947681|NCT01655693|592177575|FG001|Overall Study|Protocol Violation|0|||
163947682|NCT01655693|592177576|FG002|Overall Study|Protocol Violation|3|||
163947683|NCT01655693|592177574|FG000|Overall Study|Lost to Follow-up|1|||
163947684|NCT01655693|592177575|FG001|Overall Study|Lost to Follow-up|0|||
163947685|NCT01655693|592177576|FG002|Overall Study|Lost to Follow-up|1|||
163947686|NCT01655693|592177574|FG000|Overall Study|Screening Failure|1|||
163947687|NCT01655693|592177575|FG001|Overall Study|Screening Failure|0|||
163947688|NCT01655693|592177576|FG002|Overall Study|Screening Failure|0|||
163947689|NCT01655693|592177574|FG000|Overall Study|Other|8|||
163947690|NCT01655693|592177575|FG001|Overall Study|Other|6|||
163947691|NCT01655693|592177576|FG002|Overall Study|Other|15|||
163947692|NCT01012414|592177580|FG000|Overall Study|Withdrawal by Subject|2|||
163947693|NCT01012414|592177580|FG000|Overall Study|Lost to Follow-up|1|||
163947694|NCT01012414|592177580|FG000|Overall Study|Trial was stopped before completed|7|||
163947695|NCT02601300|592177581|FG000|Induction Phase|Lack of Efficacy|2|||
163947696|NCT02601300|592177581|FG000|Induction Phase|Protocol Violation|1|||
163947697|NCT02601300|592177581|FG000|Extension Phase|Withdrawal by Subject|3|||
163947698|NCT02601300|592177581|FG000|Extension Phase|Adverse Event|4|||
163947699|NCT02601300|592177581|FG000|Extension Phase|Lack of Efficacy|10|||
163947700|NCT00291642|592177586|FG000|Overall Study|Adverse Event|1|||
163947701|NCT00291642|592177587|FG001|Overall Study|Adverse Event|0|||
163947702|NCT00291642|592177588|FG002|Overall Study|Adverse Event|1|||
163947703|NCT00291642|592177589|FG003|Overall Study|Adverse Event|0|||
163947704|NCT00291642|592177590|FG004|Overall Study|Adverse Event|1|||
163947705|NCT00291642|592177586|FG000|Overall Study|Patient missed visit|0|||
163947706|NCT00291642|592177587|FG001|Overall Study|Patient missed visit|0|||
163947707|NCT00291642|592177588|FG002|Overall Study|Patient missed visit|1|||
163947708|NCT00291642|592177589|FG003|Overall Study|Patient missed visit|0|||
163947709|NCT00291642|592177590|FG004|Overall Study|Patient missed visit|0|||
163947710|NCT00291642|592177586|FG000|Overall Study|Intake of prohibited medication|1|||
163947711|NCT00291642|592177587|FG001|Overall Study|Intake of prohibited medication|0|||
163947712|NCT00291642|592177588|FG002|Overall Study|Intake of prohibited medication|0|||
163947713|NCT00291642|592177589|FG003|Overall Study|Intake of prohibited medication|0|||
163947714|NCT00291642|592177590|FG004|Overall Study|Intake of prohibited medication|0|||
163947715|NCT02544451|592177594|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
163947716|NCT02544451|592177595|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
163947717|NCT02544451|592177596|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
163947718|NCT02544451|592177597|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
163947719|NCT02544451|592177594|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
163947720|NCT02544451|592177595|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
163947721|NCT02544451|592177596|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
163947722|NCT02544451|592177597|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
163947723|NCT02544451|592177594|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
163947724|NCT02544451|592177595|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
163947725|NCT02544451|592177596|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
163947726|NCT02544451|592177597|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
163947727|NCT02544451|592177594|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
163947728|NCT02544451|592177595|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
163947729|NCT02544451|592177596|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
163947730|NCT02544451|592177597|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
163947731|NCT02544451|592177594|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
163947732|NCT02544451|592177595|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
163947733|NCT02544451|592177596|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
163947734|NCT02544451|592177597|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
163947735|NCT02544451|592177594|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
163947736|NCT02544451|592177595|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
163947737|NCT02544451|592177596|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
163947738|NCT02544451|592177597|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
163947739|NCT03001076|592177601|FG000|Overall Study|Withdrawal by patient|2|||
163947740|NCT03001076|592177602|FG001|Overall Study|Withdrawal by patient|0|||
163947741|NCT03001076|592177601|FG000|Overall Study|Other|1|||
163947742|NCT03001076|592177602|FG001|Overall Study|Other|0|||
163947743|NCT03001076|592177601|FG000|Overall Study|Adverse Event|3|||
164046946|NCT01947894|592530526|FG002|Overall Study|Other|3|||
164046947|NCT01947894|592530524|FG000|Overall Study|Withdrawal by Subject|12|||
164046948|NCT01947894|592530525|FG001|Overall Study|Withdrawal by Subject|4|||
164046949|NCT01947894|592530526|FG002|Overall Study|Withdrawal by Subject|1|||
164046950|NCT01947894|592530524|FG000|Overall Study|Death|12|||
164046951|NCT01947894|592530525|FG001|Overall Study|Death|1|||
164046952|NCT01947894|592530526|FG002|Overall Study|Death|0|||
164046953|NCT01947894|592530524|FG000|Overall Study|Physician Decision|2|||
164046954|NCT01947894|592530525|FG001|Overall Study|Physician Decision|0|||
164099588|NCT00272779|592730488|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
163947744|NCT03001076|592177602|FG001|Overall Study|Adverse Event|3|||
163947745|NCT03001076|592177601|FG000|Overall Study|Sponsor decision|1|||
163947746|NCT03001076|592177602|FG001|Overall Study|Sponsor decision|0|||
163947747|NCT03001076|592177601|FG000|Overall Study|Lost to Follow-up|0|||
163947748|NCT03001076|592177602|FG001|Overall Study|Lost to Follow-up|2|||
163947749|NCT04602221|592177604|FG000|Overall Study|Discontinuation of trial treatment|0|||
163947750|NCT04602221|592177605|FG001|Overall Study|Discontinuation of trial treatment|0|||
164046955|NCT01947894|592530526|FG002|Overall Study|Physician Decision|0|||
164046956|NCT01947894|592530524|FG000|Overall Study|Adverse Event|5|||
164046957|NCT01947894|592530525|FG001|Overall Study|Adverse Event|1|||
163947751|NCT04602221|592177606|FG002|Overall Study|Discontinuation of trial treatment|1|||
163947752|NCT04602221|592177607|FG003|Overall Study|Discontinuation of trial treatment|0|||
163947753|NCT04602221|592177608|FG004|Overall Study|Discontinuation of trial treatment|0|||
163947754|NCT04602221|592177609|FG005|Overall Study|Discontinuation of trial treatment|0|||
163947755|NCT04602221|592177610|FG006|Overall Study|Discontinuation of trial treatment|0|||
163947756|NCT04602221|592177611|FG007|Overall Study|Discontinuation of trial treatment|0|||
163947757|NCT04602221|592177612|FG008|Overall Study|Discontinuation of trial treatment|0|||
163947758|NCT04602221|592177613|FG009|Overall Study|Discontinuation of trial treatment|0|||
163947759|NCT04602221|592177614|FG010|Overall Study|Discontinuation of trial treatment|0|||
163947760|NCT04602221|592177615|FG011|Overall Study|Discontinuation of trial treatment|0|||
163947761|NCT04602221|592177616|FG012|Overall Study|Discontinuation of trial treatment|0|||
163947762|NCT04602221|592177617|FG013|Overall Study|Discontinuation of trial treatment|0|||
163947763|NCT04602221|592177618|FG014|Overall Study|Discontinuation of trial treatment|0|||
163947764|NCT04602221|592177619|FG015|Overall Study|Discontinuation of trial treatment|0|||
163947765|NCT04602221|592177620|FG016|Overall Study|Discontinuation of trial treatment|0|||
163947766|NCT04602221|592177621|FG017|Overall Study|Discontinuation of trial treatment|0|||
163947767|NCT04602221|592177604|FG000|Overall Study|Other than listed|0|||
163947768|NCT04602221|592177605|FG001|Overall Study|Other than listed|0|||
163947769|NCT04602221|592177606|FG002|Overall Study|Other than listed|0|||
163947770|NCT04602221|592177607|FG003|Overall Study|Other than listed|0|||
163947771|NCT04602221|592177608|FG004|Overall Study|Other than listed|0|||
163947772|NCT04602221|592177609|FG005|Overall Study|Other than listed|0|||
163947773|NCT04602221|592177610|FG006|Overall Study|Other than listed|0|||
163947774|NCT04602221|592177611|FG007|Overall Study|Other than listed|0|||
163947775|NCT04602221|592177612|FG008|Overall Study|Other than listed|0|||
163947776|NCT04602221|592177613|FG009|Overall Study|Other than listed|0|||
163947777|NCT04602221|592177614|FG010|Overall Study|Other than listed|0|||
163947778|NCT04602221|592177615|FG011|Overall Study|Other than listed|0|||
163947779|NCT04602221|592177616|FG012|Overall Study|Other than listed|0|||
163947780|NCT04602221|592177617|FG013|Overall Study|Other than listed|0|||
163947781|NCT04602221|592177618|FG014|Overall Study|Other than listed|0|||
163947782|NCT04602221|592177619|FG015|Overall Study|Other than listed|1|||
163947783|NCT04602221|592177620|FG016|Overall Study|Other than listed|0|||
163947784|NCT04602221|592177621|FG017|Overall Study|Other than listed|1|||
163947785|NCT04602221|592177604|FG000|Overall Study|Withdrawal by Subject|0|||
163947786|NCT04602221|592177605|FG001|Overall Study|Withdrawal by Subject|0|||
163947787|NCT04602221|592177606|FG002|Overall Study|Withdrawal by Subject|0|||
163947788|NCT04602221|592177607|FG003|Overall Study|Withdrawal by Subject|0|||
163947789|NCT04602221|592177608|FG004|Overall Study|Withdrawal by Subject|0|||
163947790|NCT04602221|592177609|FG005|Overall Study|Withdrawal by Subject|0|||
163947791|NCT04602221|592177610|FG006|Overall Study|Withdrawal by Subject|0|||
163947792|NCT04602221|592177611|FG007|Overall Study|Withdrawal by Subject|0|||
163947793|NCT04602221|592177612|FG008|Overall Study|Withdrawal by Subject|0|||
163947794|NCT04602221|592177613|FG009|Overall Study|Withdrawal by Subject|0|||
163947795|NCT04602221|592177614|FG010|Overall Study|Withdrawal by Subject|0|||
163947796|NCT04602221|592177615|FG011|Overall Study|Withdrawal by Subject|0|||
163947797|NCT04602221|592177616|FG012|Overall Study|Withdrawal by Subject|1|||
163947798|NCT04602221|592177617|FG013|Overall Study|Withdrawal by Subject|0|||
163947799|NCT04602221|592177618|FG014|Overall Study|Withdrawal by Subject|0|||
163947800|NCT04602221|592177619|FG015|Overall Study|Withdrawal by Subject|0|||
163947801|NCT04602221|592177620|FG016|Overall Study|Withdrawal by Subject|0|||
163947802|NCT04602221|592177621|FG017|Overall Study|Withdrawal by Subject|0|||
163947803|NCT04602221|592177604|FG000|Overall Study|Lost to Follow-up|0|||
163947804|NCT04602221|592177605|FG001|Overall Study|Lost to Follow-up|0|||
163947805|NCT04602221|592177606|FG002|Overall Study|Lost to Follow-up|0|||
163947806|NCT04602221|592177607|FG003|Overall Study|Lost to Follow-up|0|||
163947807|NCT04602221|592177608|FG004|Overall Study|Lost to Follow-up|0|||
163947808|NCT04602221|592177609|FG005|Overall Study|Lost to Follow-up|1|||
163947809|NCT04602221|592177610|FG006|Overall Study|Lost to Follow-up|0|||
163947810|NCT04602221|592177611|FG007|Overall Study|Lost to Follow-up|0|||
163947811|NCT04602221|592177612|FG008|Overall Study|Lost to Follow-up|0|||
163947812|NCT04602221|592177613|FG009|Overall Study|Lost to Follow-up|0|||
163947813|NCT04602221|592177614|FG010|Overall Study|Lost to Follow-up|0|||
163947814|NCT04602221|592177615|FG011|Overall Study|Lost to Follow-up|0|||
163947815|NCT04602221|592177616|FG012|Overall Study|Lost to Follow-up|0|||
163947816|NCT04602221|592177617|FG013|Overall Study|Lost to Follow-up|0|||
163947817|NCT04602221|592177618|FG014|Overall Study|Lost to Follow-up|0|||
163947818|NCT04602221|592177619|FG015|Overall Study|Lost to Follow-up|0|||
163947819|NCT04602221|592177620|FG016|Overall Study|Lost to Follow-up|0|||
163947820|NCT04602221|592177621|FG017|Overall Study|Lost to Follow-up|0|||
163947821|NCT02576587|592177622|FG000|Baseline|Equipment failure|0|||
163947822|NCT02576587|592177623|FG001|Baseline|Equipment failure|1|||
163947823|NCT02576587|592177622|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
163947824|NCT02576587|592177623|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
163947825|NCT02576587|592177622|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
163947826|NCT02576587|592177623|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
163947827|NCT02576587|592177622|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
163947828|NCT02576587|592177623|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
163947829|NCT00844532|592177624|FG000|Overall Study|Death|16|||
163947830|NCT00844532|592177624|FG000|Overall Study|Withdrawal by Subject|16|||
163947831|NCT00844532|592177624|FG000|Overall Study|Lost to Follow-up|7|||
163947832|NCT01080716|592177625|FG000|Part 1|Physician Decision|1|||
163947833|NCT01080716|592177626|FG001|Part 1|Physician Decision|0|||
163947834|NCT01080716|592177627|FG002|Part 1|Physician Decision|0|||
163947835|NCT01080716|592177628|FG003|Part 1|Physician Decision|0|||
163947836|NCT01056718|592177629|FG000|Overall Study|Withdrawal by Subject|2|||
163947837|NCT01056718|592177629|FG000|Overall Study|Ischemia on baseline stress test|1|||
163947838|NCT03590366|592177630|FG000|Overall Study|Adverse Event|0|||
163947839|NCT03590366|592177631|FG001|Overall Study|Adverse Event|3|||
163947840|NCT03590366|592177630|FG000|Overall Study|Lost to Follow-up|3|||
163947841|NCT03590366|592177631|FG001|Overall Study|Lost to Follow-up|3|||
163947842|NCT03590366|592177630|FG000|Overall Study|Withdrawal by Subject|0|||
163947843|NCT03590366|592177631|FG001|Overall Study|Withdrawal by Subject|2|||
163947844|NCT00738894|592177632|FG000|Overall Study|Lost to Follow-up|23|||
163947845|NCT00738894|592177633|FG001|Overall Study|Lost to Follow-up|13|||
163947846|NCT00738894|592177632|FG000|Overall Study|Withdrawal by Subject|10|||
163947847|NCT00738894|592177633|FG001|Overall Study|Withdrawal by Subject|15|||
163947848|NCT00738894|592177632|FG000|Overall Study|Physician Decision|4|||
163947849|NCT00738894|592177633|FG001|Overall Study|Physician Decision|5|||
163947850|NCT00738894|592177632|FG000|Overall Study|Death|2|||
163947851|NCT00738894|592177633|FG001|Overall Study|Death|0|||
163947852|NCT05017103|592177634|FG000|Overall Study|Death|2|||
163947853|NCT02656329|592177635|FG000|Overall Study|Lost to Follow-up|2|||
163947854|NCT02656329|592177636|FG001|Overall Study|Lost to Follow-up|3|||
163947855|NCT02656329|592177635|FG000|Overall Study|Withdrawal by Subject|7|||
163947856|NCT02656329|592177636|FG001|Overall Study|Withdrawal by Subject|6|||
163947857|NCT02656329|592177635|FG000|Overall Study|Study termination by Sponsor|150|||
163947858|NCT02656329|592177636|FG001|Overall Study|Study termination by Sponsor|142|||
163947859|NCT02656329|592177635|FG000|Overall Study|Other than specified above|5|||
163947860|NCT02656329|592177636|FG001|Overall Study|Other than specified above|6|||
163947861|NCT01081665|592177638|FG000|Overall Study|Death|41|||
163947862|NCT01081665|592177638|FG000|Overall Study|Lost to Follow-up|18|||
163947863|NCT01081665|592177638|FG000|Overall Study|Withdrawal by Subject|17|||
163947864|NCT01081665|592177638|FG000|Overall Study|Change of dialysis unit|10|||
163947865|NCT01081665|592177638|FG000|Overall Study|Regulation of iPTH|5|||
164046958|NCT01947894|592530526|FG002|Overall Study|Adverse Event|0|||
164046959|NCT01947894|592530524|FG000|Overall Study|Switched to other growth hormone brand|53|||
164046960|NCT01947894|592530525|FG001|Overall Study|Switched to other growth hormone brand|8|||
164046961|NCT01947894|592530526|FG002|Overall Study|Switched to other growth hormone brand|23|||
164046962|NCT02829775|592530527|FG000|Overall Study|Death|1|||
164046963|NCT02829775|592530527|FG000|Overall Study|Withdrawal by Subject|3|||
164046964|NCT02829775|592530527|FG000|Overall Study|Disease remission|1|||
164046965|NCT02725268|592530534|FG000|Overall Study|Death|58|||
164046966|NCT02725268|592530535|FG001|Overall Study|Death|59|||
164046967|NCT02725268|592530536|FG002|Overall Study|Death|30|||
164046968|NCT02725268|592530537|FG003|Overall Study|Death|16|||
164046969|NCT02725268|592530534|FG000|Overall Study|Lost to Follow-up|4|||
164046970|NCT02725268|592530535|FG001|Overall Study|Lost to Follow-up|3|||
164046971|NCT02725268|592530536|FG002|Overall Study|Lost to Follow-up|0|||
164046972|NCT02725268|592530537|FG003|Overall Study|Lost to Follow-up|1|||
164046973|NCT02725268|592530534|FG000|Overall Study|Site Terminated by Sponsor|0|||
164046974|NCT02725268|592530535|FG001|Overall Study|Site Terminated by Sponsor|1|||
164046975|NCT02725268|592530536|FG002|Overall Study|Site Terminated by Sponsor|0|||
164046976|NCT02725268|592530537|FG003|Overall Study|Site Terminated by Sponsor|0|||
164046977|NCT02725268|592530534|FG000|Overall Study|Withdrawal by Subject|8|||
164046978|NCT02725268|592530535|FG001|Overall Study|Withdrawal by Subject|6|||
164046979|NCT02725268|592530536|FG002|Overall Study|Withdrawal by Subject|8|||
164046980|NCT02725268|592530537|FG003|Overall Study|Withdrawal by Subject|1|||
163947866|NCT01081665|592177638|FG000|Overall Study|Change in renal replacement therapy|2|||
163947867|NCT01081665|592177638|FG000|Overall Study|Adverse Event|1|||
163947868|NCT01081665|592177638|FG000|Overall Study|Lack of Efficacy|1|||
163947869|NCT03026075|592177651|FG000|Overall Study|Physician Decision|1|||
163947870|NCT03381339|592177652|FG000|Overall Study|Protocol Violation|4|||
163947871|NCT03381339|592177653|FG001|Overall Study|Protocol Violation|3|||
163947872|NCT03381339|592177652|FG000|Overall Study|Lost to Follow-up|0|||
163947873|NCT03381339|592177653|FG001|Overall Study|Lost to Follow-up|1|||
163947874|NCT03117998|592177654|FG000|Overall Study|Adverse Event|1|||
163947875|NCT03117998|592177655|FG001|Overall Study|Adverse Event|0|||
163947876|NCT03117998|592177656|FG002|Overall Study|Adverse Event|0|||
163947877|NCT03117998|592177657|FG003|Overall Study|Adverse Event|0|||
164046981|NCT02725268|592530534|FG000|Overall Study|Reason not Specified|2|||
164046982|NCT02725268|592530535|FG001|Overall Study|Reason not Specified|1|||
164046983|NCT02725268|592530536|FG002|Overall Study|Reason not Specified|0|||
164046984|NCT02725268|592530537|FG003|Overall Study|Reason not Specified|0|||
163947878|NCT03117998|592177658|FG004|Overall Study|Adverse Event|0|||
163947879|NCT03117998|592177659|FG005|Overall Study|Adverse Event|0|||
163947880|NCT03117998|592177654|FG000|Overall Study|Withdrawal by Subject|0|||
163947881|NCT03117998|592177655|FG001|Overall Study|Withdrawal by Subject|0|||
163947882|NCT03117998|592177656|FG002|Overall Study|Withdrawal by Subject|2|||
163947883|NCT03117998|592177657|FG003|Overall Study|Withdrawal by Subject|3|||
163947884|NCT03117998|592177658|FG004|Overall Study|Withdrawal by Subject|3|||
163947885|NCT03117998|592177659|FG005|Overall Study|Withdrawal by Subject|0|||
163947886|NCT03117998|592177654|FG000|Overall Study|Physician Decision|0|||
163947887|NCT03117998|592177655|FG001|Overall Study|Physician Decision|1|||
163947888|NCT03117998|592177656|FG002|Overall Study|Physician Decision|1|||
163947889|NCT03117998|592177657|FG003|Overall Study|Physician Decision|0|||
163947890|NCT03117998|592177658|FG004|Overall Study|Physician Decision|0|||
163947891|NCT03117998|592177659|FG005|Overall Study|Physician Decision|0|||
163947892|NCT03117998|592177654|FG000|Overall Study|Lost to Follow-up|0|||
163947893|NCT03117998|592177655|FG001|Overall Study|Lost to Follow-up|0|||
163947894|NCT03117998|592177656|FG002|Overall Study|Lost to Follow-up|0|||
163947895|NCT03117998|592177657|FG003|Overall Study|Lost to Follow-up|1|||
163947896|NCT03117998|592177658|FG004|Overall Study|Lost to Follow-up|4|||
163947897|NCT03117998|592177659|FG005|Overall Study|Lost to Follow-up|0|||
163947898|NCT03117998|592177654|FG000|Overall Study|Subject noncompliance|0|||
163947899|NCT03117998|592177655|FG001|Overall Study|Subject noncompliance|0|||
163947900|NCT03117998|592177656|FG002|Overall Study|Subject noncompliance|1|||
163947901|NCT03117998|592177657|FG003|Overall Study|Subject noncompliance|0|||
163947902|NCT03117998|592177658|FG004|Overall Study|Subject noncompliance|0|||
163947903|NCT03117998|592177659|FG005|Overall Study|Subject noncompliance|2|||
163947904|NCT03117998|592177654|FG000|Overall Study|Protocol Violation|0|||
163947905|NCT03117998|592177655|FG001|Overall Study|Protocol Violation|0|||
163947906|NCT03117998|592177656|FG002|Overall Study|Protocol Violation|0|||
163947907|NCT03117998|592177657|FG003|Overall Study|Protocol Violation|0|||
163947908|NCT03117998|592177658|FG004|Overall Study|Protocol Violation|0|||
163947909|NCT03117998|592177659|FG005|Overall Study|Protocol Violation|1|||
163947910|NCT04927247|592177660|FG000|Overall Study|Other|2|||
163947911|NCT04927247|592177661|FG001|Overall Study|Other|1|||
163947912|NCT04927247|592177660|FG000|Overall Study|Physician Decision|0|||
163947913|NCT04927247|592177661|FG001|Overall Study|Physician Decision|1|||
163947914|NCT04927247|592177660|FG000|Overall Study|Adverse Event|1|||
163947915|NCT04927247|592177661|FG001|Overall Study|Adverse Event|0|||
163947916|NCT02001064|592177663|FG000|Overall Study|Withdrawal by Subject|2|||
163947917|NCT02001064|592177664|FG001|Overall Study|Withdrawal by Subject|1|||
163947918|NCT00432666|592179586|FG000|Main Period|Adverse Event|1|||
163947919|NCT00432666|592179587|FG001|Main Period|Adverse Event|1|||
163947920|NCT00432666|592179586|FG000|Main Period|Consent Withdrawn|1|||
163947921|NCT00432666|592179587|FG001|Main Period|Consent Withdrawn|0|||
163947922|NCT00432666|592179586|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
163947923|NCT00432666|592179587|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
163947924|NCT00432666|592179586|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
163947925|NCT00432666|592179587|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
163947926|NCT00432666|592179586|FG000|Open-Label Extension Period|Adverse Event|5|||
163947927|NCT00432666|592179587|FG001|Open-Label Extension Period|Adverse Event|0|||
163947928|NCT00432666|592179586|FG000|Open-Label Extension Period|Consent withdrawn|10|||
163947929|NCT00432666|592179587|FG001|Open-Label Extension Period|Consent withdrawn|0|||
163947930|NCT00432666|592179586|FG000|Open-Label Extension Period|Physician Decision|3|||
163947931|NCT00432666|592179587|FG001|Open-Label Extension Period|Physician Decision|0|||
163947932|NCT00978627|592179588|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
163947933|NCT00978627|592179589|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
163947934|NCT00978627|592179588|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
163947935|NCT00978627|592179589|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
163947936|NCT00978627|592179588|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
163947937|NCT00978627|592179589|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
163947938|NCT00978627|592179588|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
163947939|NCT00978627|592179589|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
163947940|NCT00978627|592179588|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
163947941|NCT00978627|592179589|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
163947942|NCT00978627|592179588|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
163947943|NCT00978627|592179589|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
163947944|NCT00978627|592179588|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
163947945|NCT00978627|592179589|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
163947946|NCT00978627|592179588|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
163947947|NCT00978627|592179589|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
163947948|NCT00978627|592179588|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
163947949|NCT00978627|592179589|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
163947950|NCT01506453|592179590|FG000|Overall Study|Withdrawal prior to treatment|0|||
163947951|NCT01506453|592179591|FG001|Overall Study|Withdrawal prior to treatment|2|||
163947952|NCT03541174|592179592|FG000|Part 1 Double-Blind|Adverse Event|6|||
163947953|NCT03541174|592179593|FG001|Part 1 Double-Blind|Adverse Event|5|||
163947954|NCT03541174|592179594|FG002|Part 1 Double-Blind|Adverse Event|2|||
163947955|NCT03541174|592179595|FG003|Part 1 Double-Blind|Adverse Event|0|||
163947956|NCT03541174|592179596|FG004|Part 1 Double-Blind|Adverse Event|0|||
163947957|NCT03541174|592179597|FG005|Part 1 Double-Blind|Adverse Event|0|||
163947958|NCT03541174|592179592|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
163947959|NCT03541174|592179593|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
163947960|NCT03541174|592179594|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
163947961|NCT03541174|592179595|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
163947962|NCT03541174|592179596|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
163947963|NCT03541174|592179597|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
163947964|NCT03541174|592179592|FG000|Part 1 Double-Blind|Other reasons|3|||
163947965|NCT03541174|592179593|FG001|Part 1 Double-Blind|Other reasons|2|||
163947966|NCT03541174|592179594|FG002|Part 1 Double-Blind|Other reasons|3|||
163947967|NCT03541174|592179595|FG003|Part 1 Double-Blind|Other reasons|0|||
163947968|NCT03541174|592179596|FG004|Part 1 Double-Blind|Other reasons|0|||
163947969|NCT03541174|592179597|FG005|Part 1 Double-Blind|Other reasons|0|||
163947970|NCT03541174|592179592|FG000|Part 2 Single-Blind|Adverse Event|0|||
163947971|NCT03541174|592179593|FG001|Part 2 Single-Blind|Adverse Event|0|||
163947972|NCT03541174|592179594|FG002|Part 2 Single-Blind|Adverse Event|0|||
163947973|NCT03541174|592179595|FG003|Part 2 Single-Blind|Adverse Event|25|||
163947974|NCT03541174|592179596|FG004|Part 2 Single-Blind|Adverse Event|0|||
163947975|NCT03541174|592179597|FG005|Part 2 Single-Blind|Adverse Event|0|||
163947976|NCT03541174|592179592|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
163947977|NCT03541174|592179593|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
163947978|NCT03541174|592179594|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
163947979|NCT03541174|592179595|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
163947980|NCT03541174|592179596|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
163947981|NCT03541174|592179597|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
163947982|NCT03541174|592179592|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
163947983|NCT03541174|592179593|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
163947984|NCT03541174|592179594|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
163947985|NCT03541174|592179595|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
163947986|NCT03541174|592179596|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
163947987|NCT03541174|592179597|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
163947988|NCT03541174|592179592|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
163947989|NCT03541174|592179593|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
163947990|NCT03541174|592179594|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
163947991|NCT03541174|592179595|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
163947992|NCT03541174|592179596|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
163947993|NCT03541174|592179597|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
163947994|NCT03541174|592179592|FG000|Part 2 Single-Blind|Death|0|||
163947995|NCT03541174|592179593|FG001|Part 2 Single-Blind|Death|0|||
163947996|NCT03541174|592179594|FG002|Part 2 Single-Blind|Death|0|||
163947997|NCT03541174|592179595|FG003|Part 2 Single-Blind|Death|5|||
163947998|NCT03541174|592179596|FG004|Part 2 Single-Blind|Death|0|||
163947999|NCT03541174|592179597|FG005|Part 2 Single-Blind|Death|0|||
163948000|NCT03541174|592179592|FG000|Part 2 Single-Blind|Pregnancy|0|||
163948001|NCT03541174|592179593|FG001|Part 2 Single-Blind|Pregnancy|0|||
163948002|NCT03541174|592179594|FG002|Part 2 Single-Blind|Pregnancy|0|||
163948003|NCT03541174|592179595|FG003|Part 2 Single-Blind|Pregnancy|1|||
163948004|NCT03541174|592179596|FG004|Part 2 Single-Blind|Pregnancy|0|||
163948005|NCT03541174|592179597|FG005|Part 2 Single-Blind|Pregnancy|0|||
163948006|NCT03541174|592179592|FG000|Part 2 Single-Blind|Other reasons|0|||
163948007|NCT03541174|592179593|FG001|Part 2 Single-Blind|Other reasons|0|||
164046985|NCT00117572|592530544|FG000|Overall Study|Site withdrew before starting treatment|2|||
164046986|NCT00117572|592530545|FG001|Overall Study|Site withdrew before starting treatment|3|||
164046987|NCT00117572|592530544|FG000|Overall Study|Withdrawal by Subject|3|||
164046988|NCT00117572|592530545|FG001|Overall Study|Withdrawal by Subject|3|||
164046989|NCT00117572|592530544|FG000|Overall Study|Protocol Violation|1|||
164046990|NCT00117572|592530545|FG001|Overall Study|Protocol Violation|0|||
164046991|NCT01188811|592530550|FG000|Overall Study|Withdrawal by Subject|0|||
164046992|NCT01188811|592530551|FG001|Overall Study|Withdrawal by Subject|2|||
164046993|NCT01188811|592530550|FG000|Overall Study|Adverse Event|6|||
164046994|NCT01188811|592530551|FG001|Overall Study|Adverse Event|0|||
163948008|NCT03541174|592179594|FG002|Part 2 Single-Blind|Other reasons|0|||
163948009|NCT03541174|592179595|FG003|Part 2 Single-Blind|Other reasons|32|||
163948010|NCT03541174|592179596|FG004|Part 2 Single-Blind|Other reasons|0|||
163948011|NCT03541174|592179597|FG005|Part 2 Single-Blind|Other reasons|0|||
163948012|NCT03541174|592179592|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163948013|NCT03541174|592179593|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163948014|NCT03541174|592179594|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163948015|NCT03541174|592179595|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
163948016|NCT03541174|592179596|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
164046995|NCT00654368|592530552|FG000|Overall Study|Ineligibility determined|6|||
163948017|NCT03541174|592179597|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
164046996|NCT00654368|592530553|FG001|Overall Study|Ineligibility determined|0|||
164046997|NCT00654368|592530554|FG002|Overall Study|Ineligibility determined|0|||
164046998|NCT00654368|592530552|FG000|Overall Study|Protocol deviation|3|||
164046999|NCT00654368|592530553|FG001|Overall Study|Protocol deviation|2|||
164047000|NCT00654368|592530554|FG002|Overall Study|Protocol deviation|1|||
164047001|NCT00654368|592530552|FG000|Overall Study|Non-compliance|2|||
164047002|NCT00654368|592530553|FG001|Overall Study|Non-compliance|1|||
164047003|NCT00654368|592530554|FG002|Overall Study|Non-compliance|2|||
164047004|NCT00654368|592530552|FG000|Overall Study|Withdrawal by Subject|5|||
164047005|NCT00654368|592530553|FG001|Overall Study|Withdrawal by Subject|2|||
164047006|NCT00654368|592530554|FG002|Overall Study|Withdrawal by Subject|2|||
164047007|NCT00654368|592530552|FG000|Overall Study|Disease progression|21|||
164047008|NCT00654368|592530553|FG001|Overall Study|Disease progression|31|||
164047009|NCT00654368|592530554|FG002|Overall Study|Disease progression|13|||
164047010|NCT00654368|592530552|FG000|Overall Study|Requirement for alternative therapy|1|||
164047011|NCT00654368|592530553|FG001|Overall Study|Requirement for alternative therapy|1|||
164047012|NCT00654368|592530554|FG002|Overall Study|Requirement for alternative therapy|1|||
164047013|NCT00654368|592530552|FG000|Overall Study|Physician Decision|0|||
164047014|NCT00654368|592530553|FG001|Overall Study|Physician Decision|0|||
164047015|NCT00654368|592530554|FG002|Overall Study|Physician Decision|2|||
164047016|NCT00654368|592530552|FG000|Overall Study|Death|1|||
164047017|NCT00654368|592530553|FG001|Overall Study|Death|0|||
163842793|NCT02441946|591794785|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
163842794|NCT02441946|591794786|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
163842795|NCT02441946|591794787|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
163842796|NCT02441946|591794785|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
163842797|NCT02441946|591794786|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
163842798|NCT02441946|591794787|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
163842799|NCT02441946|591794785|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
163842800|NCT02441946|591794786|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
163842801|NCT02441946|591794787|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
163842802|NCT02441946|591794785|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
163842803|NCT02441946|591794786|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
163842804|NCT02441946|591794787|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
163842805|NCT00579982|591794792|FG000|Overall Study|Adverse Event|4|||
163842806|NCT00579982|591794792|FG000|Overall Study|Protocol Violation|4|||
163842807|NCT00988351|591794793|FG000|Overall Study|Withdrawal by Subject|8|||
163842808|NCT00988351|591794794|FG001|Overall Study|Withdrawal by Subject|0|||
163842809|NCT00988351|591794793|FG000|Overall Study|Lost to Follow-up|6|||
163842810|NCT00988351|591794794|FG001|Overall Study|Lost to Follow-up|9|||
163842811|NCT00988351|591794793|FG000|Overall Study|not using CPAP|5|||
163842812|NCT00988351|591794794|FG001|Overall Study|not using CPAP|3|||
163842813|NCT02038764|591794795|FG000|Overall Study|Adverse Event|0|||
163842814|NCT02038764|591794796|FG001|Overall Study|Adverse Event|0|||
163842815|NCT02038764|591794797|FG002|Overall Study|Adverse Event|1|||
163842816|NCT02038764|591794798|FG003|Overall Study|Adverse Event|0|||
163842817|NCT02038764|591794799|FG004|Overall Study|Adverse Event|0|||
163842818|NCT02038764|591794795|FG000|Overall Study|Lost to Follow-up|0|||
163842819|NCT02038764|591794796|FG001|Overall Study|Lost to Follow-up|1|||
163842820|NCT02038764|591794797|FG002|Overall Study|Lost to Follow-up|0|||
163842821|NCT02038764|591794798|FG003|Overall Study|Lost to Follow-up|0|||
163842822|NCT02038764|591794799|FG004|Overall Study|Lost to Follow-up|0|||
163842823|NCT02038764|591794795|FG000|Overall Study|Withdrawal by Subject|0|||
163842824|NCT02038764|591794796|FG001|Overall Study|Withdrawal by Subject|0|||
163842825|NCT02038764|591794797|FG002|Overall Study|Withdrawal by Subject|0|||
163842826|NCT02038764|591794798|FG003|Overall Study|Withdrawal by Subject|0|||
163842827|NCT02038764|591794799|FG004|Overall Study|Withdrawal by Subject|1|||
163842828|NCT02038764|591794795|FG000|Overall Study|Other|1|||
163842829|NCT02038764|591794796|FG001|Overall Study|Other|0|||
163842830|NCT02038764|591794797|FG002|Overall Study|Other|1|||
163842831|NCT02038764|591794798|FG003|Overall Study|Other|0|||
163842832|NCT02038764|591794799|FG004|Overall Study|Other|0|||
163842833|NCT01464255|591794808|FG000|Overall Study|unresolve corneal staining|0|||
163842834|NCT01464255|591794809|FG001|Overall Study|unresolve corneal staining|1|||
163842835|NCT04175912|591794819|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
163842836|NCT04175912|591794820|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
163842837|NCT04175912|591794819|FG000|Overall Study|Adverse Event|0|||
163842838|NCT04175912|591794820|FG001|Overall Study|Adverse Event|3|||
163842839|NCT04175912|591794819|FG000|Overall Study|Never started treatment|3|||
163842840|NCT04175912|591794820|FG001|Overall Study|Never started treatment|3|||
163842841|NCT04175912|591794819|FG000|Overall Study|Death|0|||
163842842|NCT04175912|591794820|FG001|Overall Study|Death|1|||
163842843|NCT04654468|591794821|FG000|Overall Study|Death|1|||
163842844|NCT04654468|591794821|FG000|Overall Study|Ongoing in the Study|50|||
163842845|NCT01155661|591794822|FG000|Overall Study|Adverse Event|101|||
163842846|NCT01155661|591794822|FG000|Overall Study|Death|1|||
163842847|NCT01155661|591794822|FG000|Overall Study|Lack of Efficacy|32|||
164047018|NCT00654368|592530554|FG002|Overall Study|Death|0|||
164047019|NCT00654368|592530552|FG000|Overall Study|Pregnancy|0|||
163948018|NCT03541174|592179592|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163948019|NCT03541174|592179593|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163948020|NCT03541174|592179594|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163948021|NCT03541174|592179595|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
163948022|NCT03541174|592179596|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
163948023|NCT03541174|592179597|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
163948024|NCT03541174|592179592|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163948025|NCT03541174|592179593|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163948026|NCT03541174|592179594|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163948027|NCT03541174|592179595|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163948028|NCT03541174|592179596|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
163948029|NCT03541174|592179597|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
163948030|NCT03541174|592179592|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163948031|NCT03541174|592179593|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163948032|NCT03541174|592179594|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163948033|NCT03541174|592179595|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
163948034|NCT03541174|592179596|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
163948035|NCT03541174|592179597|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
163948036|NCT03541174|592179592|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163948037|NCT03541174|592179593|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163948038|NCT03541174|592179594|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163948039|NCT03541174|592179595|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163948040|NCT03541174|592179596|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
163948041|NCT03541174|592179597|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
163948042|NCT00605215|592179598|FG000|Overall Study|Death|0|||
163948043|NCT00605215|592179599|FG001|Overall Study|Death|0|||
163948044|NCT00605215|592179600|FG002|Overall Study|Death|1|||
163948045|NCT00605215|592179598|FG000|Overall Study|Adverse Event|19|||
163948046|NCT00605215|592179599|FG001|Overall Study|Adverse Event|21|||
163948047|NCT00605215|592179600|FG002|Overall Study|Adverse Event|26|||
163948048|NCT00605215|592179598|FG000|Overall Study|Refusal to sign the re-consent form|8|||
163948049|NCT00605215|592179599|FG001|Overall Study|Refusal to sign the re-consent form|3|||
163948050|NCT00605215|592179600|FG002|Overall Study|Refusal to sign the re-consent form|3|||
163948051|NCT00605215|592179598|FG000|Overall Study|Withdrawal by Subject|39|||
163948052|NCT00605215|592179599|FG001|Overall Study|Withdrawal by Subject|37|||
163948053|NCT00605215|592179600|FG002|Overall Study|Withdrawal by Subject|27|||
163948054|NCT00605215|592179598|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
163948055|NCT00605215|592179599|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
163948056|NCT00605215|592179600|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
163948057|NCT00605215|592179598|FG000|Overall Study|Protocol Violation|3|||
163948058|NCT00605215|592179599|FG001|Overall Study|Protocol Violation|4|||
163948059|NCT00605215|592179600|FG002|Overall Study|Protocol Violation|1|||
163948060|NCT00605215|592179598|FG000|Overall Study|Pregnancy|8|||
163948061|NCT00605215|592179599|FG001|Overall Study|Pregnancy|5|||
163948062|NCT00605215|592179600|FG002|Overall Study|Pregnancy|4|||
163948063|NCT00605215|592179598|FG000|Overall Study|Lost to Follow-up|8|||
163948064|NCT00605215|592179599|FG001|Overall Study|Lost to Follow-up|5|||
163948065|NCT00605215|592179600|FG002|Overall Study|Lost to Follow-up|2|||
163948066|NCT00605215|592179598|FG000|Overall Study|Other than specified|0|||
163948067|NCT00605215|592179599|FG001|Overall Study|Other than specified|2|||
163948068|NCT00605215|592179600|FG002|Overall Study|Other than specified|1|||
163948069|NCT00275262|592179607|FG000|Overall Study|Adverse Event|2|||
163948070|NCT00275262|592179608|FG001|Overall Study|Adverse Event|0|||
163948071|NCT00275262|592179607|FG000|Overall Study|Disease progression|2|||
163948072|NCT00275262|592179608|FG001|Overall Study|Disease progression|5|||
163948073|NCT00275262|592179607|FG000|Overall Study|Lost to Follow-up|0|||
163948074|NCT00275262|592179608|FG001|Overall Study|Lost to Follow-up|2|||
163948075|NCT00275262|592179607|FG000|Overall Study|Protocol Violation|0|||
163948076|NCT00275262|592179608|FG001|Overall Study|Protocol Violation|2|||
163948077|NCT00275262|592179607|FG000|Overall Study|Death|1|||
163948078|NCT00275262|592179608|FG001|Overall Study|Death|0|||
163948079|NCT00275262|592179607|FG000|Overall Study|Started Chemotherapy|1|||
163948080|NCT00275262|592179608|FG001|Overall Study|Started Chemotherapy|0|||
163948081|NCT00603304|592179621|FG000|Overall Study|Lost to Follow-up|5|||
163948082|NCT00603304|592179622|FG001|Overall Study|Lost to Follow-up|7|||
163948083|NCT00603304|592179621|FG000|Overall Study|Withdrawal by Subject|8|||
163948084|NCT00603304|592179622|FG001|Overall Study|Withdrawal by Subject|5|||
163948085|NCT00603304|592179621|FG000|Overall Study|Protocol Violation|1|||
163948086|NCT00603304|592179622|FG001|Overall Study|Protocol Violation|0|||
164047020|NCT00654368|592530553|FG001|Overall Study|Pregnancy|0|||
164047021|NCT00654368|592530554|FG002|Overall Study|Pregnancy|2|||
163948087|NCT00603304|592179621|FG000|Overall Study|Adverse Event|4|||
163948088|NCT00603304|592179622|FG001|Overall Study|Adverse Event|2|||
164047022|NCT00654368|592530552|FG000|Overall Study|Other|0|||
163948089|NCT00603304|592179621|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
163948090|NCT00603304|592179622|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
163948091|NCT00603304|592179621|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
163948092|NCT00603304|592179622|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
163948093|NCT00603304|592179621|FG000|Overall Study|Exclusionary Medication|2|||
163948094|NCT00603304|592179622|FG001|Overall Study|Exclusionary Medication|3|||
163948095|NCT00603304|592179621|FG000|Overall Study|Non-Compliant|0|||
163948096|NCT00603304|592179622|FG001|Overall Study|Non-Compliant|1|||
163948097|NCT00603304|592179621|FG000|Overall Study|Moved Away|0|||
163948098|NCT00603304|592179622|FG001|Overall Study|Moved Away|2|||
163948099|NCT00603304|592179621|FG000|Overall Study|Other|2|||
163948100|NCT00603304|592179622|FG001|Overall Study|Other|0|||
163948101|NCT00603304|592179621|FG000|Overall Study|Patient Decision|2|||
163948102|NCT00603304|592179622|FG001|Overall Study|Patient Decision|0|||
163948103|NCT01076192|592179623|FG000|Overall Study|Other|197|||
163948104|NCT01290315|592179624|FG000|Overall Study|Adverse Event|0|||
163948105|NCT01290315|592179625|FG001|Overall Study|Adverse Event|0|||
163948106|NCT01290315|592179626|FG002|Overall Study|Adverse Event|0|||
163948107|NCT01290315|592179627|FG003|Overall Study|Adverse Event|3|||
163948108|NCT01290315|592179624|FG000|Overall Study|Selection criteria/compliance|2|||
163948109|NCT01290315|592179625|FG001|Overall Study|Selection criteria/compliance|1|||
163948110|NCT01290315|592179626|FG002|Overall Study|Selection criteria/compliance|0|||
163948111|NCT01290315|592179627|FG003|Overall Study|Selection criteria/compliance|2|||
163948112|NCT01290315|592179624|FG000|Overall Study|Lost to Follow-up|0|||
163948113|NCT01290315|592179625|FG001|Overall Study|Lost to Follow-up|1|||
163948114|NCT01290315|592179626|FG002|Overall Study|Lost to Follow-up|0|||
163948115|NCT01290315|592179627|FG003|Overall Study|Lost to Follow-up|0|||
163948116|NCT01290315|592179624|FG000|Overall Study|Withdrawal by Subject|1|||
163948117|NCT01290315|592179625|FG001|Overall Study|Withdrawal by Subject|1|||
163948118|NCT01290315|592179626|FG002|Overall Study|Withdrawal by Subject|0|||
163948119|NCT01290315|592179627|FG003|Overall Study|Withdrawal by Subject|0|||
163948120|NCT03725085|592179628|FG000|Overall Study|Lost to Follow-up|2|||
163948121|NCT00705679|592179629|FG000|Overall Study|Adverse Event|1|||
163948122|NCT00705679|592179630|FG001|Overall Study|Adverse Event|1|||
163948123|NCT00705679|592179631|FG002|Overall Study|Adverse Event|0|||
163948124|NCT00705679|592179632|FG003|Overall Study|Adverse Event|0|||
163948125|NCT00705679|592179633|FG004|Overall Study|Adverse Event|0|||
163948126|NCT00705679|592179629|FG000|Overall Study|Death|0|||
163948127|NCT00705679|592179630|FG001|Overall Study|Death|0|||
163948128|NCT00705679|592179631|FG002|Overall Study|Death|3|||
163948129|NCT00705679|592179632|FG003|Overall Study|Death|2|||
163948130|NCT00705679|592179633|FG004|Overall Study|Death|1|||
163948131|NCT00705679|592179629|FG000|Overall Study|Lost to Follow-up|32|||
163948132|NCT00705679|592179630|FG001|Overall Study|Lost to Follow-up|60|||
163948133|NCT00705679|592179631|FG002|Overall Study|Lost to Follow-up|44|||
163948134|NCT00705679|592179632|FG003|Overall Study|Lost to Follow-up|30|||
163948135|NCT00705679|592179633|FG004|Overall Study|Lost to Follow-up|35|||
163948136|NCT00705679|592179629|FG000|Overall Study|Physician Decision|0|||
163948137|NCT00705679|592179630|FG001|Overall Study|Physician Decision|1|||
163948138|NCT00705679|592179631|FG002|Overall Study|Physician Decision|0|||
163948139|NCT00705679|592179632|FG003|Overall Study|Physician Decision|1|||
163948140|NCT00705679|592179633|FG004|Overall Study|Physician Decision|0|||
163948141|NCT00705679|592179629|FG000|Overall Study|Withdrawal by Subject|32|||
163948142|NCT00705679|592179630|FG001|Overall Study|Withdrawal by Subject|77|||
163948143|NCT00705679|592179631|FG002|Overall Study|Withdrawal by Subject|68|||
163948144|NCT00705679|592179632|FG003|Overall Study|Withdrawal by Subject|47|||
163948145|NCT00705679|592179633|FG004|Overall Study|Withdrawal by Subject|33|||
163948146|NCT03527173|592179634|FG000|Overall Study|Lost to Follow-up|4|||
163948147|NCT03527173|592179635|FG001|Overall Study|Lost to Follow-up|2|||
163948148|NCT03527173|592179634|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
163948149|NCT03527173|592179635|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
163948150|NCT03527173|592179634|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
163948151|NCT03527173|592179635|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
163948152|NCT03527173|592179634|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
163948153|NCT03527173|592179635|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
163948154|NCT01248780|592179636|FG000|Overall Study|Lack of Efficacy|2|||
163948155|NCT01248780|592179637|FG001|Overall Study|Lack of Efficacy|0|||
163948156|NCT01248780|592179636|FG000|Overall Study|Lost to Follow-up|0|||
163948157|NCT01248780|592179637|FG001|Overall Study|Lost to Follow-up|1|||
163948158|NCT01248780|592179636|FG000|Overall Study|Death|0|||
163948159|NCT01248780|592179637|FG001|Overall Study|Death|1|||
163948160|NCT01248780|592179636|FG000|Overall Study|Adverse Event|2|||
163948161|NCT01248780|592179637|FG001|Overall Study|Adverse Event|7|||
163948162|NCT01248780|592179636|FG000|Overall Study|Protocol Violation|1|||
163948163|NCT01248780|592179637|FG001|Overall Study|Protocol Violation|1|||
163948164|NCT01248780|592179636|FG000|Overall Study|Withdrawal by Subject|4|||
163948165|NCT01248780|592179637|FG001|Overall Study|Withdrawal by Subject|4|||
163948166|NCT01248780|592179636|FG000|Overall Study|Not treated|0|||
163948167|NCT01248780|592179637|FG001|Overall Study|Not treated|1|||
164047023|NCT00654368|592530553|FG001|Overall Study|Other|2|||
164047024|NCT00654368|592530554|FG002|Overall Study|Other|3|||
164047025|NCT00654368|592530552|FG000|Overall Study|Adverse Event|14|||
164047026|NCT00654368|592530553|FG001|Overall Study|Adverse Event|9|||
164047027|NCT00654368|592530554|FG002|Overall Study|Adverse Event|6|||
164047028|NCT04228445|592530558|FG000|Overall Study|Lost to Follow-up|1|||
163948168|NCT01227577|592179640|FG000|Overall Study|Protocol deviation|3|||
163948169|NCT01227577|592179640|FG000|Overall Study|Death|3|||
163948170|NCT01227577|592179640|FG000|Overall Study|Administrative problems|2|||
163948171|NCT01227577|592179640|FG000|Overall Study|Lost to Follow-up|1|||
163948172|NCT01227577|592179640|FG000|Overall Study|Withdrawal by Subject|4|||
163948173|NCT01227577|592179640|FG000|Overall Study|Lack of Efficacy|5|||
163948174|NCT01227577|592179640|FG000|Overall Study|Adverse Event|17|||
163948175|NCT03809429|592179641|FG000|Overall Study|Withdrawal by Subject|7|||
163948176|NCT03809429|592179642|FG001|Overall Study|Withdrawal by Subject|3|||
163948177|NCT03809429|592179641|FG000|Overall Study|Adverse Event|6|||
163948178|NCT03809429|592179642|FG001|Overall Study|Adverse Event|9|||
163948179|NCT03809429|592179641|FG000|Overall Study|COVID-19|3|||
163948180|NCT03809429|592179642|FG001|Overall Study|COVID-19|1|||
163948181|NCT03809429|592179641|FG000|Overall Study|Participant was discontinued by investigator|12|||
163948182|NCT03809429|592179642|FG001|Overall Study|Participant was discontinued by investigator|7|||
163948183|NCT00194987|592179643|FG000|Overall Study|Withdrawal by Subject|0|||
163948184|NCT00194987|592179644|FG001|Overall Study|Withdrawal by Subject|3|||
163948185|NCT01664598|592179645|FG000|Overall Study|Sponsor Decision|1|||
163948186|NCT01664598|592179645|FG000|Overall Study|Withdrawal of Informed Consent|4|||
163948187|NCT01664598|592179645|FG000|Overall Study|Adverse Event|1|||
163948188|NCT02245737|592179650|FG000|Overall Study|Adverse Event|23|||
163948189|NCT02245737|592179651|FG001|Overall Study|Adverse Event|26|||
163948190|NCT02245737|592179652|FG002|Overall Study|Adverse Event|33|||
163948191|NCT02245737|592179650|FG000|Overall Study|Condition Worsened|9|||
163948192|NCT02245737|592179651|FG001|Overall Study|Condition Worsened|10|||
163948193|NCT02245737|592179652|FG002|Overall Study|Condition Worsened|9|||
163948194|NCT02245737|592179650|FG000|Overall Study|Death|2|||
163948195|NCT02245737|592179651|FG001|Overall Study|Death|4|||
163948196|NCT02245737|592179652|FG002|Overall Study|Death|4|||
163948197|NCT02245737|592179650|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
163948198|NCT02245737|592179651|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
163948199|NCT02245737|592179652|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
163948200|NCT02245737|592179650|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
163948201|NCT02245737|592179651|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
163948202|NCT02245737|592179652|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
163948203|NCT02245737|592179650|FG000|Overall Study|Lost to Follow-up|2|||
163948204|NCT02245737|592179651|FG001|Overall Study|Lost to Follow-up|5|||
163948205|NCT02245737|592179652|FG002|Overall Study|Lost to Follow-up|4|||
163948206|NCT02245737|592179650|FG000|Overall Study|Other-determined by Investigator|9|||
163948207|NCT02245737|592179651|FG001|Overall Study|Other-determined by Investigator|10|||
163948208|NCT02245737|592179652|FG002|Overall Study|Other-determined by Investigator|10|||
163948209|NCT02245737|592179650|FG000|Overall Study|Physician Decision|6|||
163948210|NCT02245737|592179651|FG001|Overall Study|Physician Decision|3|||
163948211|NCT02245737|592179652|FG002|Overall Study|Physician Decision|6|||
163948212|NCT02245737|592179650|FG000|Overall Study|Protocol Violation|3|||
163948213|NCT02245737|592179651|FG001|Overall Study|Protocol Violation|2|||
163948214|NCT02245737|592179652|FG002|Overall Study|Protocol Violation|3|||
163948215|NCT02245737|592179650|FG000|Overall Study|Withdrawal by Subject|40|||
163948216|NCT02245737|592179651|FG001|Overall Study|Withdrawal by Subject|41|||
163948217|NCT02245737|592179652|FG002|Overall Study|Withdrawal by Subject|44|||
163948218|NCT02245737|592179650|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
163948219|NCT02245737|592179651|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
163842848|NCT01155661|591794822|FG000|Overall Study|Lost to Follow-up|22|||
163842849|NCT01155661|591794822|FG000|Overall Study|Physician Decision|3|||
163842850|NCT01155661|591794822|FG000|Overall Study|Protocol Violation|35|||
163842851|NCT01155661|591794822|FG000|Overall Study|Withdrawal by Subject|73|||
163842852|NCT01155661|591794822|FG000|Overall Study|Sponsor Decision|13|||
163842853|NCT04844970|591794827|FG000|Overall Study|Adverse Event|0|||
163842854|NCT04844970|591794828|FG001|Overall Study|Adverse Event|1|||
163842855|NCT04844970|591794827|FG000|Overall Study|Withdrawal by Subject|2|||
163842856|NCT04844970|591794828|FG001|Overall Study|Withdrawal by Subject|0|||
163842857|NCT00447954|591794829|FG000|Overall Study|Adverse Event|0|||
163842858|NCT00447954|591794830|FG001|Overall Study|Adverse Event|2|||
163842859|NCT00447954|591794831|FG002|Overall Study|Adverse Event|0|||
163842860|NCT00447954|591794829|FG000|Overall Study|Withdrawal by Subject|0|||
163842861|NCT00447954|591794830|FG001|Overall Study|Withdrawal by Subject|1|||
163842862|NCT00447954|591794831|FG002|Overall Study|Withdrawal by Subject|1|||
163842863|NCT00447954|591794829|FG000|Overall Study|Lost to Follow-up|0|||
163842864|NCT00447954|591794830|FG001|Overall Study|Lost to Follow-up|1|||
163948220|NCT02245737|592179652|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
163948221|NCT02245737|592179650|FG000|Overall Study|Sponsor Decision|445|||
163948222|NCT02245737|592179651|FG001|Overall Study|Sponsor Decision|430|||
163948223|NCT02245737|592179652|FG002|Overall Study|Sponsor Decision|432|||
163948224|NCT00836745|592179656|FG000|Overall Study|Death|2|||
163948225|NCT00836745|592179656|FG000|Overall Study|Lost to Follow-up|10|||
163948226|NCT00836745|592179656|FG000|Overall Study|Adverse Event|3|||
163948227|NCT00836745|592179656|FG000|Overall Study|Objective progression or relapse|4|||
163948228|NCT00836745|592179656|FG000|Overall Study|Other|2|||
163948229|NCT01239043|592179659|FG000|Overall Study|Protocol Violation|2|||
163948230|NCT01239043|592179660|FG001|Overall Study|Protocol Violation|1|||
163948231|NCT02929329|592179663|FG000|Overall Study|Withdrawal by Subject|24|||
163948232|NCT02929329|592179664|FG001|Overall Study|Withdrawal by Subject|21|||
163948233|NCT02929329|592179663|FG000|Overall Study|Lost to Follow-up|26|||
163948234|NCT02929329|592179664|FG001|Overall Study|Lost to Follow-up|20|||
163948235|NCT02929329|592179663|FG000|Overall Study|Death|1054|||
163948236|NCT02929329|592179664|FG001|Overall Study|Death|1051|||
163948237|NCT02121301|592179665|FG000|Overall Study|Protocol Violation|1|||
163948238|NCT02121301|592179666|FG001|Overall Study|Protocol Violation|4|||
163948239|NCT02121301|592179667|FG002|Overall Study|Protocol Violation|1|||
163948240|NCT00434213|592179673|FG000|Overall Study|Adverse Event|12|||
163948241|NCT00434213|592179673|FG000|Overall Study|Lack of Efficacy|9|||
163948242|NCT00434213|592179673|FG000|Overall Study|Lost to Follow-up|14|||
163948243|NCT00434213|592179673|FG000|Overall Study|Withdrawal by Subject|7|||
163948244|NCT00434213|592179673|FG000|Overall Study|Protocol Violation|3|||
163948245|NCT00434213|592179673|FG000|Overall Study|Unable to comply with study visit window|2|||
163948246|NCT00434213|592179673|FG000|Overall Study|Application site reaction|1|||
163948247|NCT00434213|592179673|FG000|Overall Study|Non-compliant to study schedule|1|||
163948248|NCT01699503|592179674|FG000|Overall Study|Death|31|||
163948249|NCT01699503|592179675|FG001|Overall Study|Death|40|||
163948250|NCT01699503|592179674|FG000|Overall Study|Withdrawal by Subject|65|||
163948251|NCT01699503|592179675|FG001|Overall Study|Withdrawal by Subject|57|||
163948252|NCT01699503|592179674|FG000|Overall Study|Lost to Follow-up|121|||
163948253|NCT01699503|592179675|FG001|Overall Study|Lost to Follow-up|117|||
163948254|NCT01699503|592179674|FG000|Overall Study|Excluded due to quality|783|||
163948255|NCT01699503|592179675|FG001|Overall Study|Excluded due to quality|791|||
163948256|NCT01639560|592179678|FG000|Overall Study|Withdrawal by Subject|9|||
163948257|NCT01639560|592179679|FG001|Overall Study|Withdrawal by Subject|14|||
163948258|NCT01639560|592179678|FG000|Overall Study|Lack of Efficacy|1|||
163948259|NCT01639560|592179679|FG001|Overall Study|Lack of Efficacy|2|||
163948260|NCT01639560|592179678|FG000|Overall Study|Lost to Follow-up|9|||
163948261|NCT01639560|592179679|FG001|Overall Study|Lost to Follow-up|11|||
163948262|NCT01639560|592179678|FG000|Overall Study|Adverse Event|0|||
163948263|NCT01639560|592179679|FG001|Overall Study|Adverse Event|2|||
163948264|NCT00774930|592179680|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
163948265|NCT00774930|592179681|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
163948266|NCT00774930|592179680|FG000|DB Phase|Adverse Event|1|||
163948267|NCT00774930|592179681|FG001|DB Phase|Adverse Event|2|||
163948268|NCT00774930|592179680|FG000|DB Phase|Subject Decision|1|||
163948269|NCT00774930|592179681|FG001|DB Phase|Subject Decision|5|||
163948270|NCT00774930|592179680|FG000|DB Phase|Sponsor Decision|0|||
163948271|NCT00774930|592179681|FG001|DB Phase|Sponsor Decision|1|||
163948272|NCT00774930|592179680|FG000|DB Phase|Disease Progression|1|||
163948273|NCT00774930|592179681|FG001|DB Phase|Disease Progression|1|||
163948274|NCT00774930|592179680|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
163948275|NCT00774930|592179681|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
163948276|NCT00774930|592179680|FG000|IOL Phase|Adverse Event|1|||
163948277|NCT00774930|592179681|FG001|IOL Phase|Adverse Event|1|||
163948278|NCT00774930|592179680|FG000|IOL Phase|Subject Decision|4|||
163948279|NCT00774930|592179681|FG001|IOL Phase|Subject Decision|3|||
163948280|NCT00774930|592179680|FG000|IOL Phase|Physician Decision|3|||
163948281|NCT00774930|592179681|FG001|IOL Phase|Physician Decision|2|||
163948282|NCT00774930|592179680|FG000|IOL Phase|Sponsor Decision|1|||
163948283|NCT00774930|592179681|FG001|IOL Phase|Sponsor Decision|0|||
163948284|NCT00774930|592179680|FG000|IOL Phase|Disease Progression|2|||
163948285|NCT00774930|592179681|FG001|IOL Phase|Disease Progression|1|||
163948286|NCT00774930|592179680|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
163948287|NCT00774930|592179681|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
163948288|NCT00774930|592179680|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
163948289|NCT00774930|592179681|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
163948290|NCT00774930|592179680|FG000|IOL Phase|Other|1|||
163948291|NCT00774930|592179681|FG001|IOL Phase|Other|0|||
163948292|NCT00774930|592179680|FG000|IOL Phase|Brain radiation|0|||
164099589|NCT00272779|592730487|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
163948293|NCT00774930|592179681|FG001|IOL Phase|Brain radiation|1|||
163948294|NCT00774930|592179680|FG000|LTOLE Phase|Adverse Event|7|||
163948295|NCT00774930|592179681|FG001|LTOLE Phase|Adverse Event|3|||
163948296|NCT00774930|592179680|FG000|LTOLE Phase|Subject decision|0|||
163948297|NCT00774930|592179681|FG001|LTOLE Phase|Subject decision|5|||
163948298|NCT00774930|592179680|FG000|LTOLE Phase|Physician Decision|4|||
163948299|NCT00774930|592179681|FG001|LTOLE Phase|Physician Decision|1|||
163948300|NCT00774930|592179680|FG000|LTOLE Phase|Sponsor decision|2|||
163948301|NCT00774930|592179681|FG001|LTOLE Phase|Sponsor decision|1|||
163948302|NCT00774930|592179680|FG000|LTOLE Phase|Disease Progression|2|||
163948303|NCT00774930|592179681|FG001|LTOLE Phase|Disease Progression|5|||
163948304|NCT00774930|592179680|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
163948305|NCT00774930|592179681|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
163948306|NCT00774930|592179680|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
163948307|NCT00774930|592179681|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
163948308|NCT00766363|592179687|FG000|Overall Study|Withdrawal by Subject|1|||
163948309|NCT00766363|592179688|FG001|Overall Study|Withdrawal by Subject|0|||
163948310|NCT00766363|592179689|FG002|Overall Study|Withdrawal by Subject|0|||
163948311|NCT00766363|592179690|FG003|Overall Study|Withdrawal by Subject|0|||
163948312|NCT00766363|592179687|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
163948313|NCT00766363|592179688|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
163948314|NCT00766363|592179689|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
163948315|NCT00766363|592179690|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
163948316|NCT03020576|592179691|FG000|Overall Study|Withdrawal by Subject|1|||
163948317|NCT03020576|592179692|FG001|Overall Study|Withdrawal by Subject|2|||
163948318|NCT03292432|592179693|FG000|Overall Study|Lost to Follow-up|11|||
163948319|NCT03292432|592179694|FG001|Overall Study|Lost to Follow-up|8|||
163948320|NCT03292432|592179693|FG000|Overall Study|Death|2|||
163948321|NCT03292432|592179694|FG001|Overall Study|Death|1|||
163948322|NCT03292432|592179693|FG000|Overall Study|Withdrawal by Subject|1|||
163948323|NCT03292432|592179694|FG001|Overall Study|Withdrawal by Subject|2|||
163948324|NCT03292432|592179693|FG000|Overall Study|Site closed before any data collected|1|||
163948325|NCT03292432|592179694|FG001|Overall Study|Site closed before any data collected|0|||
163948326|NCT00911937|592179695|FG000|Overall Study|Death|1|||
163948327|NCT00911937|592179696|FG001|Overall Study|Death|0|||
163948328|NCT00911937|592179695|FG000|Overall Study|Lost to Follow-up|8|||
163948329|NCT00911937|592179696|FG001|Overall Study|Lost to Follow-up|5|||
163948330|NCT00911937|592179695|FG000|Overall Study|Withdrawal by Subject|10|||
163948331|NCT00911937|592179696|FG001|Overall Study|Withdrawal by Subject|7|||
163948332|NCT00911937|592179695|FG000|Overall Study|Withdrawn due to pregnancy|1|||
163948333|NCT00911937|592179696|FG001|Overall Study|Withdrawn due to pregnancy|0|||
163948334|NCT00911937|592179695|FG000|Overall Study|Adverse Event|11|||
163948335|NCT00911937|592179696|FG001|Overall Study|Adverse Event|25|||
163948336|NCT00911937|592179695|FG000|Overall Study|Lack of Efficacy|11|||
163948337|NCT00911937|592179696|FG001|Overall Study|Lack of Efficacy|6|||
163948338|NCT00911937|592179695|FG000|Overall Study|Did not meet inclusion criteria|9|||
163948339|NCT00911937|592179696|FG001|Overall Study|Did not meet inclusion criteria|11|||
163948340|NCT00911937|592179695|FG000|Overall Study|Protocol Violation|14|||
163948341|NCT00911937|592179696|FG001|Overall Study|Protocol Violation|23|||
163948342|NCT00911937|592179695|FG000|Overall Study|Randomized but not treated|13|||
163948343|NCT00911937|592179696|FG001|Overall Study|Randomized but not treated|13|||
163948344|NCT00911937|592179695|FG000|Overall Study|Other|9|||
163948345|NCT00911937|592179696|FG001|Overall Study|Other|5|||
163948346|NCT01498679|592179697|FG000|Overall Study|Adverse Event|1|||
163948347|NCT01498679|592179698|FG001|Overall Study|Adverse Event|4|||
163948348|NCT01498679|592179697|FG000|Overall Study|Lack of Efficacy|72|||
163948349|NCT01498679|592179698|FG001|Overall Study|Lack of Efficacy|12|||
163948350|NCT01498679|592179697|FG000|Overall Study|Protocol Violation|4|||
163948351|NCT01498679|592179698|FG001|Overall Study|Protocol Violation|0|||
163948352|NCT01498679|592179697|FG000|Overall Study|Physician Decision|0|||
163948353|NCT01498679|592179698|FG001|Overall Study|Physician Decision|2|||
163948354|NCT01498679|592179697|FG000|Overall Study|Withdrawal by Subject|12|||
163948355|NCT01498679|592179698|FG001|Overall Study|Withdrawal by Subject|4|||
163948356|NCT00424385|592179700|FG000|Cohort 0|Withdrawal by Subject|5|||
163948357|NCT00424385|592179700|FG000|Cohort 0|Physician Decision|1|||
163948358|NCT00424385|592179700|FG000|Cohort 1|Withdrawal by Subject|1|||
163842865|NCT00447954|591794831|FG002|Overall Study|Lost to Follow-up|0|||
163842866|NCT00447954|591794829|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
163842867|NCT00447954|591794830|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
163842868|NCT00447954|591794831|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
163842869|NCT03757234|591794832|FG000|Overall Study|Adverse Event|0|||
163842870|NCT03757234|591794833|FG001|Overall Study|Adverse Event|0|||
163842871|NCT03757234|591794834|FG002|Overall Study|Adverse Event|0|||
163842872|NCT03757234|591794835|FG003|Overall Study|Adverse Event|0|||
163842873|NCT03757234|591794836|FG004|Overall Study|Adverse Event|1|||
163842874|NCT03757234|591794832|FG000|Overall Study|Lost to Follow-up|1|||
163842875|NCT03757234|591794833|FG001|Overall Study|Lost to Follow-up|0|||
163842876|NCT03757234|591794834|FG002|Overall Study|Lost to Follow-up|0|||
163842877|NCT03757234|591794835|FG003|Overall Study|Lost to Follow-up|0|||
163842878|NCT03757234|591794836|FG004|Overall Study|Lost to Follow-up|1|||
163842879|NCT03757234|591794832|FG000|Overall Study|Withdrawal by Subject|1|||
163842880|NCT03757234|591794833|FG001|Overall Study|Withdrawal by Subject|1|||
163842881|NCT03757234|591794834|FG002|Overall Study|Withdrawal by Subject|0|||
163842882|NCT03757234|591794835|FG003|Overall Study|Withdrawal by Subject|1|||
163948359|NCT02057523|592179701|FG000|Overall Study|Withdrawal by Subject|1|||
163948360|NCT02057523|592179701|FG000|Overall Study|Lack of Efficacy|1|||
163948361|NCT03174431|592179704|FG000|Overall Study|Withdrawal by Subject|14|||
163948362|NCT03174431|592179705|FG001|Overall Study|Withdrawal by Subject|11|||
163948363|NCT03174431|592179704|FG000|Overall Study|alternative treatment|2|||
163948364|NCT03174431|592179705|FG001|Overall Study|alternative treatment|0|||
163948365|NCT03174431|592179704|FG000|Overall Study|Lost to Follow-up|1|||
163948366|NCT03174431|592179705|FG001|Overall Study|Lost to Follow-up|5|||
163948367|NCT02706899|592179713|FG000|Overall Study|Withdrawal by Subject|1|||
163948368|NCT02706899|592179714|FG001|Overall Study|Withdrawal by Subject|0|||
163948369|NCT02706899|592179713|FG000|Overall Study|Death|8|||
163948370|NCT02706899|592179714|FG001|Overall Study|Death|0|||
163948371|NCT02706899|592179713|FG000|Overall Study|Study Termination by Sponsor|4|||
163948372|NCT02706899|592179714|FG001|Overall Study|Study Termination by Sponsor|6|||
163948373|NCT00633880|592179717|FG000|Open Label Titration|Lack of Efficacy|1|||
163948374|NCT00633880|592179718|FG001|Open Label Titration|Lack of Efficacy|0|||
163948375|NCT00633880|592179719|FG002|Open Label Titration|Lack of Efficacy|0|||
163948376|NCT00633880|592179717|FG000|Open Label Titration|Adverse Event|13|||
163948377|NCT00633880|592179718|FG001|Open Label Titration|Adverse Event|0|||
163948378|NCT00633880|592179719|FG002|Open Label Titration|Adverse Event|0|||
163948379|NCT00633880|592179717|FG000|Open Label Titration|Treatment Failure|55|||
163948380|NCT00633880|592179718|FG001|Open Label Titration|Treatment Failure|0|||
163948381|NCT00633880|592179719|FG002|Open Label Titration|Treatment Failure|0|||
163948382|NCT00633880|592179717|FG000|Open Label Titration|Protocol Violation|6|||
163948383|NCT00633880|592179718|FG001|Open Label Titration|Protocol Violation|0|||
163948384|NCT00633880|592179719|FG002|Open Label Titration|Protocol Violation|0|||
163948385|NCT00633880|592179717|FG000|Open Label Titration|Physician Decision|1|||
163948386|NCT00633880|592179718|FG001|Open Label Titration|Physician Decision|0|||
163948387|NCT00633880|592179719|FG002|Open Label Titration|Physician Decision|0|||
163948388|NCT00633880|592179717|FG000|Open Label Titration|Withdrawal by Subject|4|||
163948389|NCT00633880|592179718|FG001|Open Label Titration|Withdrawal by Subject|0|||
163948390|NCT00633880|592179719|FG002|Open Label Titration|Withdrawal by Subject|0|||
163948391|NCT01413503|592179721|FG000|Overall Study|Lost to Follow-up|1|||
163948392|NCT02546921|592179722|FG000|Overall Study|Adverse Event|0|||
163948393|NCT02546921|592179723|FG001|Overall Study|Adverse Event|5|||
163948394|NCT02546921|592179724|FG002|Overall Study|Adverse Event|2|||
163948395|NCT02546921|592179725|FG003|Overall Study|Adverse Event|0|||
163948396|NCT02546921|592179726|FG004|Overall Study|Adverse Event|0|||
163948397|NCT02546921|592179727|FG005|Overall Study|Adverse Event|0|||
163948398|NCT02546921|592179728|FG006|Overall Study|Adverse Event|0|||
163948399|NCT02546921|592179722|FG000|Overall Study|Evidence of Disease Progression|1|||
163948400|NCT02546921|592179723|FG001|Overall Study|Evidence of Disease Progression|0|||
163948401|NCT02546921|592179724|FG002|Overall Study|Evidence of Disease Progression|0|||
163948402|NCT02546921|592179725|FG003|Overall Study|Evidence of Disease Progression|0|||
163948403|NCT02546921|592179726|FG004|Overall Study|Evidence of Disease Progression|1|||
163948404|NCT02546921|592179727|FG005|Overall Study|Evidence of Disease Progression|0|||
163948405|NCT02546921|592179728|FG006|Overall Study|Evidence of Disease Progression|0|||
163948406|NCT02546921|592179722|FG000|Overall Study|Patient Choice|0|||
163948407|NCT02546921|592179723|FG001|Overall Study|Patient Choice|1|||
163948408|NCT02546921|592179724|FG002|Overall Study|Patient Choice|0|||
163948409|NCT02546921|592179725|FG003|Overall Study|Patient Choice|0|||
163948410|NCT02546921|592179726|FG004|Overall Study|Patient Choice|0|||
163948411|NCT02546921|592179727|FG005|Overall Study|Patient Choice|1|||
163948412|NCT02546921|592179728|FG006|Overall Study|Patient Choice|0|||
163948413|NCT01373151|592179729|FG000|Period 1|Lack of Efficacy|3|||
163948414|NCT01373151|592179730|FG001|Period 1|Lack of Efficacy|0|||
163948415|NCT01373151|592179731|FG002|Period 1|Lack of Efficacy|0|||
163948416|NCT01373151|592179732|FG003|Period 1|Lack of Efficacy|0|||
163948417|NCT01373151|592179733|FG004|Period 1|Lack of Efficacy|1|||
163948418|NCT01373151|592179734|FG005|Period 1|Lack of Efficacy|0|||
163948419|NCT01373151|592179735|FG006|Period 1|Lack of Efficacy|0|||
164047029|NCT04228445|592530559|FG001|Overall Study|Lost to Follow-up|1|||
164047030|NCT04228445|592530558|FG000|Overall Study|Physician Decision|1|||
164047031|NCT04228445|592530559|FG001|Overall Study|Physician Decision|2|||
163948420|NCT01373151|592179729|FG000|Period 1|Adverse Event|0|||
163948421|NCT01373151|592179730|FG001|Period 1|Adverse Event|0|||
163948422|NCT01373151|592179731|FG002|Period 1|Adverse Event|1|||
163948423|NCT01373151|592179732|FG003|Period 1|Adverse Event|0|||
163948424|NCT01373151|592179733|FG004|Period 1|Adverse Event|4|||
163948425|NCT01373151|592179734|FG005|Period 1|Adverse Event|3|||
163948426|NCT01373151|592179735|FG006|Period 1|Adverse Event|0|||
163948427|NCT01373151|592179729|FG000|Period 1|Withdrawal by Subject|2|||
163948428|NCT01373151|592179730|FG001|Period 1|Withdrawal by Subject|0|||
163948429|NCT01373151|592179731|FG002|Period 1|Withdrawal by Subject|3|||
163948430|NCT01373151|592179732|FG003|Period 1|Withdrawal by Subject|1|||
163948431|NCT01373151|592179733|FG004|Period 1|Withdrawal by Subject|0|||
163948432|NCT01373151|592179734|FG005|Period 1|Withdrawal by Subject|1|||
163948433|NCT01373151|592179735|FG006|Period 1|Withdrawal by Subject|0|||
163948434|NCT01373151|592179729|FG000|Period 2|Lack of Efficacy|9|||
164099590|NCT00272779|592730488|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
164099591|NCT00272779|592730487|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
164099592|NCT00272779|592730488|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
164099593|NCT00272779|592730487|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
164099594|NCT00272779|592730488|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
164099595|NCT00272779|592730487|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
164099596|NCT00272779|592730488|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
164099597|NCT00272779|592730487|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
164099598|NCT00272779|592730488|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
164099599|NCT00272779|592730487|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
164099600|NCT00272779|592730488|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
164099601|NCT00272779|592730487|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
164099602|NCT00272779|592730488|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
164099603|NCT00272779|592730487|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
164099604|NCT00272779|592730488|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
164099605|NCT00272779|592730487|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
164099606|NCT00272779|592730488|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
164099607|NCT00272779|592730487|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
164099608|NCT00272779|592730488|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
164099609|NCT00272779|592730487|FG000|Baseline Through Week 96|Never treated|2|||
164099610|NCT00272779|592730488|FG001|Baseline Through Week 96|Never treated|3|||
164099611|NCT00272779|592730487|FG000|Baseline Through Week 96|Continuing on treatment|61|||
164099612|NCT00272779|592730488|FG001|Baseline Through Week 96|Continuing on treatment|38|||
164099613|NCT02331394|592730491|FG000|Overall Study|Disease progression|1|||
163842883|NCT03757234|591794836|FG004|Overall Study|Withdrawal by Subject|2|||
163842884|NCT03757234|591794832|FG000|Overall Study|Other|1|||
163842885|NCT03757234|591794833|FG001|Overall Study|Other|1|||
163842886|NCT03757234|591794834|FG002|Overall Study|Other|0|||
163842887|NCT03757234|591794835|FG003|Overall Study|Other|0|||
163842888|NCT03757234|591794836|FG004|Overall Study|Other|0|||
163842889|NCT04908449|591794838|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
164099614|NCT02865850|592730494|FG000|Overall Study|Death|15|||
164099615|NCT02865850|592730495|FG001|Overall Study|Death|19|||
164099616|NCT02865850|592730494|FG000|Overall Study|Withdrawal by Subject|3|||
164099617|NCT02865850|592730495|FG001|Overall Study|Withdrawal by Subject|2|||
164099618|NCT02865850|592730494|FG000|Overall Study|Lost to Follow-up|3|||
164099619|NCT02865850|592730495|FG001|Overall Study|Lost to Follow-up|2|||
164099620|NCT00552669|592730496|FG000|Overall Study|Death|3|||
164099621|NCT00552669|592730497|FG001|Overall Study|Death|7|||
164099622|NCT02098876|592730500|FG000|Overall Study|Withdrawal by Subject|5|||
164099623|NCT02098876|592730501|FG001|Overall Study|Withdrawal by Subject|5|||
164099624|NCT01263704|592730502|FG000|Overall Study|Progressive disease|18|||
164099625|NCT01263704|592730502|FG000|Overall Study|Adverse Event|3|||
164099626|NCT01263704|592730502|FG000|Overall Study|Death|2|||
164099627|NCT01263704|592730502|FG000|Overall Study|Patient withdrew consent|2|||
164099628|NCT01263704|592730502|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
164099629|NCT01263704|592730502|FG000|Overall Study|Lost to Follow-up|1|||
164099630|NCT01263704|592730502|FG000|Overall Study|Colon metastases|1|||
164099631|NCT01263704|592730502|FG000|Overall Study|Principal Investigator (PI) decision|1|||
164099632|NCT01061866|592730505|FG000|Overall Study|Adverse Event|2|||
164099633|NCT00252720|592730506|FG000|Overall Study|Withdrawal by Subject|95|||
164099634|NCT00252720|592730507|FG001|Overall Study|Withdrawal by Subject|97|||
164099635|NCT00252720|592730506|FG000|Overall Study|Death|7|||
164099636|NCT00252720|592730507|FG001|Overall Study|Death|8|||
164099637|NCT00252720|592730506|FG000|Overall Study|Moving|23|||
164099638|NCT00252720|592730507|FG001|Overall Study|Moving|42|||
164099639|NCT00252720|592730506|FG000|Overall Study|Mainly patients lost to follow-up|7|||
164099640|NCT00252720|592730507|FG001|Overall Study|Mainly patients lost to follow-up|18|||
164099641|NCT01010542|592730509|FG000|Overall Study|Adverse Event|0|||
164099642|NCT01010542|592730510|FG001|Overall Study|Adverse Event|1|||
164099643|NCT01010542|592730511|FG002|Overall Study|Adverse Event|0|||
164099644|NCT01010542|592730509|FG000|Overall Study|Lost to Follow-up|0|||
164099645|NCT01010542|592730510|FG001|Overall Study|Lost to Follow-up|1|||
164099646|NCT01010542|592730511|FG002|Overall Study|Lost to Follow-up|0|||
164099647|NCT01010542|592730509|FG000|Overall Study|Withdrawal by Subject|0|||
164099648|NCT01010542|592730510|FG001|Overall Study|Withdrawal by Subject|3|||
164099649|NCT01010542|592730511|FG002|Overall Study|Withdrawal by Subject|2|||
164099650|NCT03204539|592730523|FG000|Overall Study|Loss of funding|0|||
164099651|NCT03204539|592730524|FG001|Overall Study|Loss of funding|1|||
163842890|NCT04908449|591794839|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
163842891|NCT04908449|591794838|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
164099652|NCT00550537|592730527|FG000|Overall Study|Death|18|||
164099653|NCT00550537|592730527|FG000|Overall Study|Adverse Event|20|||
164099654|NCT00550537|592730527|FG000|Overall Study|Disease progression before|46|||
163948435|NCT01373151|592179730|FG001|Period 2|Lack of Efficacy|0|||
163948436|NCT01373151|592179731|FG002|Period 2|Lack of Efficacy|0|||
163948437|NCT01373151|592179732|FG003|Period 2|Lack of Efficacy|1|||
163948438|NCT01373151|592179733|FG004|Period 2|Lack of Efficacy|2|||
163948439|NCT01373151|592179734|FG005|Period 2|Lack of Efficacy|0|||
163948440|NCT01373151|592179735|FG006|Period 2|Lack of Efficacy|3|||
163948441|NCT01373151|592179729|FG000|Period 2|Adverse Event|0|||
163948442|NCT01373151|592179730|FG001|Period 2|Adverse Event|0|||
163948443|NCT01373151|592179731|FG002|Period 2|Adverse Event|3|||
163948444|NCT01373151|592179732|FG003|Period 2|Adverse Event|3|||
163948445|NCT01373151|592179733|FG004|Period 2|Adverse Event|0|||
163948446|NCT01373151|592179734|FG005|Period 2|Adverse Event|0|||
163948447|NCT01373151|592179735|FG006|Period 2|Adverse Event|1|||
163948448|NCT01373151|592179729|FG000|Period 2|subject request to discontinue|0|||
163948449|NCT01373151|592179730|FG001|Period 2|subject request to discontinue|1|||
163948450|NCT01373151|592179731|FG002|Period 2|subject request to discontinue|0|||
163948451|NCT01373151|592179732|FG003|Period 2|subject request to discontinue|0|||
163948452|NCT01373151|592179733|FG004|Period 2|subject request to discontinue|0|||
163948453|NCT01373151|592179734|FG005|Period 2|subject request to discontinue|0|||
163948454|NCT01373151|592179735|FG006|Period 2|subject request to discontinue|0|||
163948455|NCT01373151|592179729|FG000|Period 2|Withdrawal by Subject|0|||
163948456|NCT01373151|592179730|FG001|Period 2|Withdrawal by Subject|0|||
163948457|NCT01373151|592179731|FG002|Period 2|Withdrawal by Subject|0|||
163948458|NCT01373151|592179732|FG003|Period 2|Withdrawal by Subject|1|||
163948459|NCT01373151|592179733|FG004|Period 2|Withdrawal by Subject|0|||
163948460|NCT01373151|592179734|FG005|Period 2|Withdrawal by Subject|0|||
163948461|NCT01373151|592179735|FG006|Period 2|Withdrawal by Subject|0|||
163948462|NCT01373151|592179729|FG000|Period 2|Other|0|||
163948463|NCT01373151|592179730|FG001|Period 2|Other|0|||
163948464|NCT01373151|592179731|FG002|Period 2|Other|1|||
163948465|NCT01373151|592179732|FG003|Period 2|Other|0|||
163948466|NCT01373151|592179733|FG004|Period 2|Other|0|||
163948467|NCT01373151|592179734|FG005|Period 2|Other|0|||
163948468|NCT01373151|592179735|FG006|Period 2|Other|1|||
163948469|NCT01468181|592179742|FG000|Overall Study|Adverse Event|8|||
163948470|NCT01468181|592179743|FG001|Overall Study|Adverse Event|1|||
163948471|NCT01468181|592179744|FG002|Overall Study|Adverse Event|6|||
163948472|NCT01468181|592179745|FG003|Overall Study|Adverse Event|2|||
163948473|NCT01468181|592179746|FG004|Overall Study|Adverse Event|2|||
163948474|NCT01468181|592179742|FG000|Overall Study|Protocol Violation|2|||
163948475|NCT01468181|592179743|FG001|Overall Study|Protocol Violation|0|||
163948476|NCT01468181|592179744|FG002|Overall Study|Protocol Violation|1|||
163948477|NCT01468181|592179745|FG003|Overall Study|Protocol Violation|0|||
163948478|NCT01468181|592179746|FG004|Overall Study|Protocol Violation|1|||
163948479|NCT01468181|592179742|FG000|Overall Study|Physician Decision|0|||
163948480|NCT01468181|592179743|FG001|Overall Study|Physician Decision|0|||
163948481|NCT01468181|592179744|FG002|Overall Study|Physician Decision|0|||
163948482|NCT01468181|592179745|FG003|Overall Study|Physician Decision|1|||
163948483|NCT01468181|592179746|FG004|Overall Study|Physician Decision|1|||
163948484|NCT01468181|592179742|FG000|Overall Study|Lost to Follow-up|0|||
163948485|NCT01468181|592179743|FG001|Overall Study|Lost to Follow-up|0|||
163948486|NCT01468181|592179744|FG002|Overall Study|Lost to Follow-up|1|||
163948487|NCT01468181|592179745|FG003|Overall Study|Lost to Follow-up|0|||
163948488|NCT01468181|592179746|FG004|Overall Study|Lost to Follow-up|1|||
163948489|NCT01468181|592179742|FG000|Overall Study|Withdrawal by Subject|0|||
163948490|NCT01468181|592179743|FG001|Overall Study|Withdrawal by Subject|1|||
163948491|NCT01468181|592179744|FG002|Overall Study|Withdrawal by Subject|0|||
163948492|NCT01468181|592179745|FG003|Overall Study|Withdrawal by Subject|0|||
163948493|NCT01468181|592179746|FG004|Overall Study|Withdrawal by Subject|0|||
163948494|NCT00545753|592179747|FG000|Overall Study|Withdrawal by Subject|0|||
163948495|NCT00545753|592179748|FG001|Overall Study|Withdrawal by Subject|1|||
163948496|NCT00545753|592179749|FG002|Overall Study|Withdrawal by Subject|10|||
163948497|NCT00545753|592179747|FG000|Overall Study|Lost to Follow-up|13|||
163948498|NCT00545753|592179748|FG001|Overall Study|Lost to Follow-up|3|||
163948499|NCT00545753|592179749|FG002|Overall Study|Lost to Follow-up|12|||
163948500|NCT00545753|592179747|FG000|Overall Study|Protocol Violation|3|||
163948501|NCT00545753|592179748|FG001|Overall Study|Protocol Violation|1|||
163948502|NCT00545753|592179749|FG002|Overall Study|Protocol Violation|4|||
163948503|NCT00513305|592179750|FG000|Overall Study|Adverse Event|6|||
163948504|NCT00513305|592179751|FG001|Overall Study|Adverse Event|2|||
163948505|NCT00513305|592179750|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
163948506|NCT00513305|592179751|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
163948507|NCT00513305|592179750|FG000|Overall Study|Lack of Efficacy|8|||
163948508|NCT00513305|592179751|FG001|Overall Study|Lack of Efficacy|13|||
163948509|NCT00513305|592179750|FG000|Overall Study|Withdrawal by Subject|1|||
163948510|NCT00513305|592179751|FG001|Overall Study|Withdrawal by Subject|2|||
163948511|NCT00513305|592179750|FG000|Overall Study|Disease progression|8|||
163948512|NCT00513305|592179751|FG001|Overall Study|Disease progression|5|||
163948513|NCT00513305|592179750|FG000|Overall Study|Eligible for stem cell transplant|1|||
163948514|NCT00513305|592179751|FG001|Overall Study|Eligible for stem cell transplant|0|||
163948515|NCT00513305|592179750|FG000|Overall Study|Hematologic counts did not recover|1|||
164099655|NCT00550537|592730527|FG000|Overall Study|Withdrawal by Subject|7|||
164099656|NCT00550537|592730527|FG000|Overall Study|Change in treatment plan|4|||
164099657|NCT00550537|592730527|FG000|Overall Study|Other complicating ilness|3|||
164099658|NCT00550537|592730527|FG000|Overall Study|Declining performance status|2|||
164099659|NCT00550537|592730527|FG000|Overall Study|Treated closer to home|4|||
164099660|NCT02008565|592730528|FG000|Overall Study|Protocol Violation|1|||
164099661|NCT02008565|592730529|FG001|Overall Study|Protocol Violation|1|||
164099662|NCT02008565|592730530|FG002|Overall Study|Protocol Violation|2|||
164099663|NCT02008565|592730531|FG003|Overall Study|Protocol Violation|0|||
164099664|NCT00617305|592730532|FG000|Overall Study|Adverse Event|4|||
164099665|NCT00617305|592730533|FG001|Overall Study|Adverse Event|0|||
164099666|NCT00617305|592730534|FG002|Overall Study|Adverse Event|0|||
164099667|NCT00617305|592730532|FG000|Overall Study|Death|1|||
164099668|NCT00617305|592730533|FG001|Overall Study|Death|0|||
164099669|NCT00617305|592730534|FG002|Overall Study|Death|0|||
164099670|NCT00617305|592730532|FG000|Overall Study|Physician Decision|1|||
164099671|NCT00617305|592730533|FG001|Overall Study|Physician Decision|0|||
164099672|NCT00617305|592730534|FG002|Overall Study|Physician Decision|0|||
164099673|NCT00617305|592730532|FG000|Overall Study|Protocol Violation|1|||
164099674|NCT00617305|592730533|FG001|Overall Study|Protocol Violation|0|||
164099675|NCT00617305|592730534|FG002|Overall Study|Protocol Violation|1|||
164099676|NCT00617305|592730532|FG000|Overall Study|Withdrawal by Subject|1|||
164099677|NCT00617305|592730533|FG001|Overall Study|Withdrawal by Subject|0|||
164099678|NCT00617305|592730534|FG002|Overall Study|Withdrawal by Subject|0|||
164099679|NCT00537979|592730536|FG000|Overall Study|Adverse Event|2|||
164099680|NCT00537979|592730537|FG001|Overall Study|Adverse Event|2|||
164099681|NCT00537979|592730536|FG000|Overall Study|Withdrawal by Subject|1|||
164099682|NCT00537979|592730537|FG001|Overall Study|Withdrawal by Subject|4|||
164099683|NCT00537979|592730536|FG000|Overall Study|Lost to Follow-up|1|||
164099684|NCT00537979|592730537|FG001|Overall Study|Lost to Follow-up|4|||
164099685|NCT00537979|592730536|FG000|Overall Study|Lack of Efficacy|0|||
164099686|NCT00537979|592730537|FG001|Overall Study|Lack of Efficacy|1|||
164099687|NCT00537979|592730536|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
164099688|NCT00537979|592730537|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
164099689|NCT00537979|592730536|FG000|Overall Study|Death|0|||
164099690|NCT00537979|592730537|FG001|Overall Study|Death|3|||
164099691|NCT00537979|592730536|FG000|Overall Study|Kidney transplant|0|||
163948516|NCT00513305|592179751|FG001|Overall Study|Hematologic counts did not recover|0|||
163948517|NCT00513305|592179750|FG000|Overall Study|Physician Decision|1|||
163948518|NCT00513305|592179751|FG001|Overall Study|Physician Decision|0|||
163948519|NCT00513305|592179750|FG000|Overall Study|Persistent hypocellularity|0|||
163948520|NCT00513305|592179751|FG001|Overall Study|Persistent hypocellularity|1|||
163948521|NCT00513305|592179750|FG000|Overall Study|Sponsor Decision|0|||
163948522|NCT00513305|592179751|FG001|Overall Study|Sponsor Decision|2|||
163948523|NCT01262027|592179753|FG000|Overall Study|Adverse Event|1|||
163948524|NCT01262027|592179753|FG000|Overall Study|Withdrawal by Subject|3|||
163948525|NCT01262027|592179753|FG000|Overall Study|Protocol Violation|1|||
163948526|NCT01011153|592179757|FG000|Overall Study|Less than 78 cases completed|8|||
163948527|NCT01011153|592179758|FG001|Overall Study|Less than 78 cases completed|11|||
163948528|NCT01011153|592179759|FG002|Overall Study|Less than 78 cases completed|9|||
163948529|NCT03014479|592179760|FG000|Overall Study|Adverse Event|0|||
163948530|NCT03014479|592179761|FG001|Overall Study|Adverse Event|1|||
163948531|NCT03014479|592179760|FG000|Overall Study|Voluntary Withdrawal|0|||
163948532|NCT03014479|592179761|FG001|Overall Study|Voluntary Withdrawal|2|||
163948533|NCT03014479|592179760|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
163948534|NCT03014479|592179761|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
163948535|NCT01081132|592179767|FG000|Overall Study|Lack of Efficacy|25|||
163948536|NCT01081132|592179768|FG001|Overall Study|Lack of Efficacy|9|||
163948537|NCT01081132|592179767|FG000|Overall Study|Withdrawal by Subject|13|||
163948538|NCT01081132|592179768|FG001|Overall Study|Withdrawal by Subject|16|||
163948539|NCT01081132|592179767|FG000|Overall Study|Lost to Follow-up|4|||
163948540|NCT01081132|592179768|FG001|Overall Study|Lost to Follow-up|11|||
164099692|NCT00537979|592730537|FG001|Overall Study|Kidney transplant|3|||
164099693|NCT00537979|592730536|FG000|Overall Study|Heart failure|0|||
164099694|NCT00537979|592730537|FG001|Overall Study|Heart failure|1|||
164099695|NCT02193178|592730538|FG000|Overall Study|Lost to Follow-up|1|||
163948541|NCT01081132|592179767|FG000|Overall Study|Adverse Event|3|||
163948542|NCT01081132|592179768|FG001|Overall Study|Adverse Event|9|||
163948543|NCT01081132|592179767|FG000|Overall Study|Non Compliance|4|||
163948544|NCT01081132|592179768|FG001|Overall Study|Non Compliance|2|||
163948545|NCT01081132|592179767|FG000|Overall Study|Lack Of Compliance|0|||
163948546|NCT01081132|592179768|FG001|Overall Study|Lack Of Compliance|1|||
163948547|NCT01081132|592179767|FG000|Overall Study|Missed Visits|1|||
163948548|NCT01081132|592179768|FG001|Overall Study|Missed Visits|1|||
164099696|NCT02193178|592730538|FG000|Overall Study|Dry eyes|1|||
164099697|NCT01059903|592730540|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
164099698|NCT01059903|592730541|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
164099699|NCT03555305|592730542|FG000|Period 1|Physician Decision|0|||
163948549|NCT01081132|592179767|FG000|Overall Study|Stopped Taking Meds|2|||
163948550|NCT01081132|592179768|FG001|Overall Study|Stopped Taking Meds|0|||
163948551|NCT01081132|592179767|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
163948552|NCT01081132|592179768|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
163948553|NCT01081132|592179767|FG000|Overall Study|Declined Taper Phase|0|||
163948554|NCT01081132|592179768|FG001|Overall Study|Declined Taper Phase|1|||
163948555|NCT01081132|592179767|FG000|Overall Study|Protocol Violation|3|||
163948556|NCT01081132|592179768|FG001|Overall Study|Protocol Violation|1|||
163948557|NCT03973931|592179769|FG000|Overall Study|Lost to Follow-up|47|||
163948558|NCT03973931|592179770|FG001|Overall Study|Lost to Follow-up|63|||
163948559|NCT03973931|592179771|FG002|Overall Study|Lost to Follow-up|51|||
163948560|NCT03973931|592179772|FG003|Overall Study|Lost to Follow-up|54|||
163948561|NCT03973931|592179769|FG000|Overall Study|opted out|6|||
163948562|NCT03973931|592179770|FG001|Overall Study|opted out|5|||
163948563|NCT03973931|592179771|FG002|Overall Study|opted out|5|||
163948564|NCT03973931|592179772|FG003|Overall Study|opted out|1|||
163948565|NCT04214600|592181136|FG000|Overall Study|Lost to Follow-up|9|||
163948566|NCT04214600|592181137|FG001|Overall Study|Lost to Follow-up|14|||
163948567|NCT00896051|592181138|FG000|Overall Study|Adverse Event|2|||
163948568|NCT00896051|592181139|FG001|Overall Study|Adverse Event|1|||
163948569|NCT00896051|592181138|FG000|Overall Study|Lost to Follow-up|3|||
163948570|NCT00896051|592181139|FG001|Overall Study|Lost to Follow-up|2|||
163948571|NCT00896051|592181138|FG000|Overall Study|Withdrawal by Subject|3|||
163948572|NCT00896051|592181139|FG001|Overall Study|Withdrawal by Subject|2|||
163948573|NCT00896051|592181138|FG000|Overall Study|Subject noncompliant|1|||
163948574|NCT00896051|592181139|FG001|Overall Study|Subject noncompliant|3|||
163948575|NCT00896051|592181138|FG000|Overall Study|Other|1|||
163948576|NCT00896051|592181139|FG001|Overall Study|Other|1|||
163948577|NCT02935452|592181140|FG000|Overall Study|work and life commintment|3|||
163948578|NCT02935452|592181141|FG001|Overall Study|work and life commintment|1|||
163948579|NCT01813929|592181143|FG000|Overall Study|Withdrawal by Subject|0|||
163948580|NCT01813929|592181144|FG001|Overall Study|Withdrawal by Subject|1|||
163948581|NCT00007345|592181145|FG000|Overall Study|Refused further treatment|0|||
163948582|NCT00007345|592181146|FG001|Overall Study|Refused further treatment|7|||
163948583|NCT00007345|592181145|FG000|Overall Study|Switched to alternative treatment|0|||
163948584|NCT00007345|592181146|FG001|Overall Study|Switched to alternative treatment|3|||
163948585|NCT00007345|592181145|FG000|Overall Study|Intercurrent illness|1|||
163948586|NCT00007345|592181146|FG001|Overall Study|Intercurrent illness|0|||
163948587|NCT00007345|592181145|FG000|Overall Study|Death on study|1|||
163948588|NCT00007345|592181146|FG001|Overall Study|Death on study|1|||
163948589|NCT04433585|592181147|FG000|Overall Study|Withdrawal by Subject|15|||
163948590|NCT04433585|592181148|FG001|Overall Study|Withdrawal by Subject|3|||
163948591|NCT04433585|592181149|FG002|Overall Study|Withdrawal by Subject|15|||
163948592|NCT04433585|592181150|FG003|Overall Study|Withdrawal by Subject|6|||
163948593|NCT04433585|592181147|FG000|Overall Study|Adverse Event|10|||
163948594|NCT04433585|592181148|FG001|Overall Study|Adverse Event|4|||
163948595|NCT04433585|592181149|FG002|Overall Study|Adverse Event|1|||
163948596|NCT04433585|592181150|FG003|Overall Study|Adverse Event|0|||
163948597|NCT04433585|592181147|FG000|Overall Study|Due to the conflict in Ukraine|2|||
163948598|NCT04433585|592181148|FG001|Overall Study|Due to the conflict in Ukraine|1|||
163948599|NCT04433585|592181149|FG002|Overall Study|Due to the conflict in Ukraine|1|||
164047032|NCT04228445|592530558|FG000|Overall Study|Withdrawal by Subject|0|||
164047033|NCT04228445|592530559|FG001|Overall Study|Withdrawal by Subject|1|||
164047034|NCT04228445|592530558|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
163948600|NCT04433585|592181150|FG003|Overall Study|Due to the conflict in Ukraine|2|||
163948601|NCT04433585|592181147|FG000|Overall Study|Physician Decision|1|||
163948602|NCT04433585|592181148|FG001|Overall Study|Physician Decision|2|||
163948603|NCT04433585|592181149|FG002|Overall Study|Physician Decision|0|||
163948604|NCT04433585|592181150|FG003|Overall Study|Physician Decision|0|||
163948605|NCT04433585|592181147|FG000|Overall Study|Lost to Follow-up|1|||
163948606|NCT04433585|592181148|FG001|Overall Study|Lost to Follow-up|1|||
163948607|NCT04433585|592181149|FG002|Overall Study|Lost to Follow-up|1|||
163948608|NCT04433585|592181150|FG003|Overall Study|Lost to Follow-up|0|||
163948609|NCT04433585|592181147|FG000|Overall Study|Lack of Efficacy|0|||
163948610|NCT04433585|592181148|FG001|Overall Study|Lack of Efficacy|1|||
163948611|NCT04433585|592181149|FG002|Overall Study|Lack of Efficacy|1|||
163948612|NCT04433585|592181150|FG003|Overall Study|Lack of Efficacy|1|||
163948613|NCT04433585|592181147|FG000|Overall Study|Death|0|||
163948614|NCT04433585|592181148|FG001|Overall Study|Death|1|||
164047035|NCT04228445|592530559|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
163948615|NCT04433585|592181149|FG002|Overall Study|Death|0|||
164047036|NCT03954704|592530568|FG000|Overall Study|Death|1|||
163948616|NCT04433585|592181150|FG003|Overall Study|Death|0|||
163948617|NCT04988867|592181161|FG000|Overall Study|Study terminated by Sponsor|12|||
163948618|NCT04988867|592181161|FG000|Overall Study|Adverse Event|2|||
163948619|NCT04988867|592181161|FG000|Overall Study|Study drug noncompliance|1|||
163948620|NCT01097707|592181164|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163948621|NCT01097707|592181165|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
163948622|NCT01097707|592181166|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163948623|NCT01097707|592181167|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163948624|NCT01097707|592181168|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
163948625|NCT01097707|592181164|FG000|Overall Study|Adverse Event|4|||
163948626|NCT01097707|592181165|FG001|Overall Study|Adverse Event|2|||
163948627|NCT01097707|592181166|FG002|Overall Study|Adverse Event|3|||
163948628|NCT01097707|592181167|FG003|Overall Study|Adverse Event|1|||
163948629|NCT01097707|592181168|FG004|Overall Study|Adverse Event|3|||
163948630|NCT01097707|592181164|FG000|Overall Study|Entry Criteria Not Met|2|||
163948631|NCT01097707|592181165|FG001|Overall Study|Entry Criteria Not Met|1|||
163948632|NCT01097707|592181166|FG002|Overall Study|Entry Criteria Not Met|1|||
163948633|NCT01097707|592181167|FG003|Overall Study|Entry Criteria Not Met|0|||
163948634|NCT01097707|592181168|FG004|Overall Study|Entry Criteria Not Met|1|||
163948635|NCT01097707|592181164|FG000|Overall Study|Lack of Efficacy|1|||
163948636|NCT01097707|592181165|FG001|Overall Study|Lack of Efficacy|0|||
163948637|NCT01097707|592181166|FG002|Overall Study|Lack of Efficacy|0|||
163948638|NCT01097707|592181167|FG003|Overall Study|Lack of Efficacy|1|||
163948639|NCT01097707|592181168|FG004|Overall Study|Lack of Efficacy|0|||
163948640|NCT01097707|592181164|FG000|Overall Study|Lost to Follow-up|1|||
163948641|NCT01097707|592181165|FG001|Overall Study|Lost to Follow-up|1|||
163948642|NCT01097707|592181166|FG002|Overall Study|Lost to Follow-up|2|||
163948643|NCT01097707|592181167|FG003|Overall Study|Lost to Follow-up|0|||
163948644|NCT01097707|592181168|FG004|Overall Study|Lost to Follow-up|3|||
163948645|NCT01097707|592181164|FG000|Overall Study|Protocol Violation|2|||
163948646|NCT01097707|592181165|FG001|Overall Study|Protocol Violation|2|||
163948647|NCT01097707|592181166|FG002|Overall Study|Protocol Violation|3|||
163948648|NCT01097707|592181167|FG003|Overall Study|Protocol Violation|2|||
163948649|NCT01097707|592181168|FG004|Overall Study|Protocol Violation|2|||
163948650|NCT01097707|592181164|FG000|Overall Study|Sponsor Decision|31|||
163948651|NCT01097707|592181165|FG001|Overall Study|Sponsor Decision|31|||
163948652|NCT01097707|592181166|FG002|Overall Study|Sponsor Decision|34|||
163948653|NCT01097707|592181167|FG003|Overall Study|Sponsor Decision|35|||
163948654|NCT01097707|592181168|FG004|Overall Study|Sponsor Decision|36|||
163948655|NCT01097707|592181164|FG000|Overall Study|Withdrawal by Subject|3|||
163948656|NCT01097707|592181165|FG001|Overall Study|Withdrawal by Subject|6|||
163948657|NCT01097707|592181166|FG002|Overall Study|Withdrawal by Subject|1|||
163948658|NCT01097707|592181167|FG003|Overall Study|Withdrawal by Subject|4|||
163948659|NCT01097707|592181168|FG004|Overall Study|Withdrawal by Subject|3|||
163948660|NCT01097707|592181164|FG000|Overall Study|Reason unknown|0|||
163948661|NCT01097707|592181165|FG001|Overall Study|Reason unknown|0|||
163948662|NCT01097707|592181166|FG002|Overall Study|Reason unknown|0|||
163948663|NCT01097707|592181167|FG003|Overall Study|Reason unknown|0|||
163948664|NCT01097707|592181168|FG004|Overall Study|Reason unknown|1|||
163948665|NCT03212989|592181169|FG000|Overall Study|Physician Decision|8|||
163948666|NCT03775434|592181170|FG000|Overall Study|Adverse Event|2|||
163948667|NCT03775434|592181170|FG000|Overall Study|Withdrawal by Subject|1|||
163948668|NCT03047395|592181171|FG000|Overall Study|Adverse Event|142|||
163948669|NCT03047395|592181171|FG000|Overall Study|Withdrawal by Subject|155|||
163948670|NCT03047395|592181171|FG000|Overall Study|Lost to Follow-up|144|||
163948671|NCT03047395|592181171|FG000|Overall Study|COVID-19 Infection|2|||
163948672|NCT03047395|592181171|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
163948673|NCT03047395|592181171|FG000|Overall Study|Other, Not Specified|117|||
163948674|NCT04811131|592181178|FG000|Overall Study|Adverse Event|0|||
163948675|NCT04811131|592181179|FG001|Overall Study|Adverse Event|0|||
163948676|NCT04811131|592181180|FG002|Overall Study|Adverse Event|1|||
163948677|NCT04811131|592181181|FG003|Overall Study|Adverse Event|0|||
163948678|NCT04811131|592181178|FG000|Overall Study|Lack of Efficacy|0|||
163948679|NCT04811131|592181179|FG001|Overall Study|Lack of Efficacy|0|||
163948680|NCT04811131|592181180|FG002|Overall Study|Lack of Efficacy|0|||
163948681|NCT04811131|592181181|FG003|Overall Study|Lack of Efficacy|1|||
163948682|NCT04811131|592181178|FG000|Overall Study|Lost to Follow-up|0|||
163948683|NCT04811131|592181179|FG001|Overall Study|Lost to Follow-up|1|||
163948684|NCT04811131|592181180|FG002|Overall Study|Lost to Follow-up|0|||
163948685|NCT04811131|592181181|FG003|Overall Study|Lost to Follow-up|0|||
163948686|NCT04811131|592181178|FG000|Overall Study|Sponsor request|31|||
163948687|NCT04811131|592181179|FG001|Overall Study|Sponsor request|35|||
163948688|NCT04811131|592181180|FG002|Overall Study|Sponsor request|27|||
163948689|NCT04811131|592181181|FG003|Overall Study|Sponsor request|10|||
163948690|NCT04811131|592181178|FG000|Overall Study|Withdrawal by Subject|3|||
163948691|NCT04811131|592181179|FG001|Overall Study|Withdrawal by Subject|1|||
163948692|NCT04811131|592181180|FG002|Overall Study|Withdrawal by Subject|3|||
163948693|NCT04811131|592181181|FG003|Overall Study|Withdrawal by Subject|1|||
163948694|NCT00620282|592181189|FG000|Overall Study|Adverse Event|0|||
163948695|NCT00620282|592181190|FG001|Overall Study|Adverse Event|1|||
163948696|NCT00620282|592181191|FG002|Overall Study|Adverse Event|0|||
163948697|NCT00620282|592181189|FG000|Overall Study|Arterial line unable to be placed|0|||
163948698|NCT00620282|592181190|FG001|Overall Study|Arterial line unable to be placed|0|||
163948699|NCT00620282|592181191|FG002|Overall Study|Arterial line unable to be placed|1|||
163948700|NCT00620282|592181189|FG000|Overall Study|Withdrawal by Subject|0|||
163948701|NCT00620282|592181190|FG001|Overall Study|Withdrawal by Subject|1|||
163948702|NCT00620282|592181191|FG002|Overall Study|Withdrawal by Subject|0|||
163948703|NCT02217475|592181192|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
163948704|NCT02217475|592181193|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
163948705|NCT02217475|592181194|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
163948706|NCT02217475|592181192|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
163948707|NCT02217475|592181193|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
163948708|NCT02217475|592181194|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
163948709|NCT02217475|592181192|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
163948710|NCT02217475|592181193|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
163948711|NCT02217475|592181194|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
163948712|NCT02217475|592181192|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
163948713|NCT02217475|592181193|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
163948714|NCT02217475|592181194|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
163948715|NCT02217475|592181192|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
163948716|NCT02217475|592181193|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
163948717|NCT02217475|592181194|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
163948718|NCT02217475|592181192|FG000|Discontinued After Period 1|Adverse Event|1|||
163948719|NCT02217475|592181193|FG001|Discontinued After Period 1|Adverse Event|2|||
163948720|NCT02217475|592181194|FG002|Discontinued After Period 1|Adverse Event|0|||
163948721|NCT02217475|592181192|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
163948722|NCT02217475|592181193|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
163948723|NCT02217475|592181194|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
163948724|NCT02217475|592181192|FG000|Discontinued After Period 1|Physician Decision|0|||
163948725|NCT02217475|592181193|FG001|Discontinued After Period 1|Physician Decision|0|||
163948726|NCT02217475|592181194|FG002|Discontinued After Period 1|Physician Decision|1|||
163948727|NCT02217475|592181192|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
163948728|NCT02217475|592181193|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
163948729|NCT02217475|592181194|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
163948730|NCT02217475|592181192|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
163948731|NCT02217475|592181193|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
163948732|NCT02217475|592181194|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
163948733|NCT02217475|592181192|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
163948734|NCT02217475|592181193|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
163948735|NCT02217475|592181194|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
163948736|NCT02217475|592181192|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
163948737|NCT02217475|592181193|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
163948738|NCT02217475|592181194|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
163948739|NCT02217475|592181192|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
163948740|NCT02217475|592181193|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
163948741|NCT02217475|592181194|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
163948742|NCT01127763|592181195|FG000|Overall Study|Adverse Event|2|||
163948743|NCT01127763|592181195|FG000|Overall Study|Withdrawal by Subject|1|||
163948744|NCT01127763|592181195|FG000|Overall Study|Physician Decision|2|||
163948745|NCT04738292|592181200|FG000|Overall Study|Death|1|||
163948746|NCT03181789|592181202|FG000|Overall Study|Withdrawal by Subject|0|||
163948747|NCT03181789|592181203|FG001|Overall Study|Withdrawal by Subject|1|||
163948748|NCT03181789|592181204|FG002|Overall Study|Withdrawal by Subject|1|||
163948749|NCT03181789|592181205|FG003|Overall Study|Withdrawal by Subject|0|||
163948750|NCT03181789|592181202|FG000|Overall Study|Lost to Follow-up|7|||
163948751|NCT03181789|592181203|FG001|Overall Study|Lost to Follow-up|1|||
163948752|NCT03181789|592181204|FG002|Overall Study|Lost to Follow-up|0|||
163948753|NCT03181789|592181205|FG003|Overall Study|Lost to Follow-up|0|||
163948754|NCT03181789|592181202|FG000|Overall Study|Participant unable to adhere to visit|0|||
163948755|NCT03181789|592181203|FG001|Overall Study|Participant unable to adhere to visit|1|||
163948756|NCT03181789|592181204|FG002|Overall Study|Participant unable to adhere to visit|0|||
163948757|NCT03181789|592181205|FG003|Overall Study|Participant unable to adhere to visit|0|||
163948758|NCT01131182|592181206|FG000|Overall Study|Withdrawal by Subject|1|||
163948759|NCT01131182|592181207|FG001|Overall Study|Withdrawal by Subject|1|||
163948760|NCT01131182|592181206|FG000|Overall Study|Lost to Follow-up|14|||
163948761|NCT01131182|592181207|FG001|Overall Study|Lost to Follow-up|15|||
163948762|NCT01131182|592181206|FG000|Overall Study|Other Reason|1|||
163948763|NCT01131182|592181207|FG001|Overall Study|Other Reason|0|||
163948764|NCT00735475|592181208|FG000|Overall Study|Adverse Event|0|||
163948765|NCT00735475|592181209|FG001|Overall Study|Adverse Event|1|||
163948766|NCT00735475|592181208|FG000|Overall Study|Death|1|||
163948767|NCT00735475|592181209|FG001|Overall Study|Death|1|||
163948768|NCT00735475|592181208|FG000|Overall Study|Lost to Follow-up|3|||
163948769|NCT00735475|592181209|FG001|Overall Study|Lost to Follow-up|3|||
163948770|NCT00735475|592181208|FG000|Overall Study|Physician Decision|0|||
163948771|NCT00735475|592181209|FG001|Overall Study|Physician Decision|1|||
163948772|NCT00735475|592181208|FG000|Overall Study|Withdrawal by Subject|4|||
163948773|NCT00735475|592181209|FG001|Overall Study|Withdrawal by Subject|5|||
163948774|NCT02442336|592181210|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
163948775|NCT02442336|592181210|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
163948776|NCT02442336|592181210|FG000|Overall Study|Lost to Follow-up|11|||
163948777|NCT05086276|592181211|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
163948778|NCT05086276|592181212|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
163948779|NCT00777088|592181213|FG000|Overall Study|PED Treatment not attempted|1|||
163948780|NCT00350103|592181214|FG000|Overall Study|Adverse Event|12|||
163948781|NCT00350103|592181215|FG001|Overall Study|Adverse Event|29|||
163948782|NCT00350103|592181216|FG002|Overall Study|Adverse Event|17|||
163948783|NCT00350103|592181214|FG000|Overall Study|Lack of Efficacy|5|||
163948784|NCT00350103|592181215|FG001|Overall Study|Lack of Efficacy|1|||
163948785|NCT00350103|592181216|FG002|Overall Study|Lack of Efficacy|3|||
163948786|NCT00350103|592181214|FG000|Overall Study|Withdrawal by Subject|6|||
163948787|NCT00350103|592181215|FG001|Overall Study|Withdrawal by Subject|6|||
163948788|NCT00350103|592181216|FG002|Overall Study|Withdrawal by Subject|8|||
163948789|NCT00350103|592181214|FG000|Overall Study|Protocol Violation|0|||
163948790|NCT00350103|592181215|FG001|Overall Study|Protocol Violation|0|||
163948791|NCT00350103|592181216|FG002|Overall Study|Protocol Violation|1|||
163948792|NCT00350103|592181214|FG000|Overall Study|Unsatisfactory Compliance|2|||
163948793|NCT00350103|592181215|FG001|Overall Study|Unsatisfactory Compliance|2|||
163948794|NCT00350103|592181216|FG002|Overall Study|Unsatisfactory Compliance|1|||
163948795|NCT00350103|592181214|FG000|Overall Study|Investigator´s decision|1|||
163948796|NCT00350103|592181215|FG001|Overall Study|Investigator´s decision|1|||
163948797|NCT00350103|592181216|FG002|Overall Study|Investigator´s decision|0|||
163948798|NCT00350103|592181214|FG000|Overall Study|Exclusion criteria met|0|||
163948799|NCT00350103|592181215|FG001|Overall Study|Exclusion criteria met|0|||
163948800|NCT00350103|592181216|FG002|Overall Study|Exclusion criteria met|1|||
163948801|NCT00350103|592181214|FG000|Overall Study|Patient relocated|0|||
163948802|NCT00350103|592181215|FG001|Overall Study|Patient relocated|0|||
163948803|NCT00350103|592181216|FG002|Overall Study|Patient relocated|1|||
163948804|NCT00350103|592181214|FG000|Overall Study|Need for prohibited medication|1|||
163948805|NCT00350103|592181215|FG001|Overall Study|Need for prohibited medication|0|||
163948806|NCT00350103|592181216|FG002|Overall Study|Need for prohibited medication|0|||
163948807|NCT00350103|592181214|FG000|Overall Study|Personal reasons|0|||
163948808|NCT00350103|592181215|FG001|Overall Study|Personal reasons|0|||
163948809|NCT00350103|592181216|FG002|Overall Study|Personal reasons|1|||
163948810|NCT00350103|592181214|FG000|Overall Study|Patient stopped feeling pain|1|||
163948811|NCT00350103|592181215|FG001|Overall Study|Patient stopped feeling pain|0|||
163948812|NCT00350103|592181216|FG002|Overall Study|Patient stopped feeling pain|0|||
163948813|NCT00350103|592181214|FG000|Overall Study|PR greater than 250ms|0|||
163948814|NCT00350103|592181215|FG001|Overall Study|PR greater than 250ms|0|||
163948815|NCT00350103|592181216|FG002|Overall Study|PR greater than 250ms|1|||
163948816|NCT00350103|592181214|FG000|Overall Study|Wrong calculation of QT interval|0|||
163948817|NCT00350103|592181215|FG001|Overall Study|Wrong calculation of QT interval|0|||
163948818|NCT00350103|592181216|FG002|Overall Study|Wrong calculation of QT interval|1|||
163948819|NCT00350103|592181214|FG000|Overall Study|Sponsor mistake|1|||
163948820|NCT00350103|592181215|FG001|Overall Study|Sponsor mistake|0|||
163948821|NCT00350103|592181216|FG002|Overall Study|Sponsor mistake|0|||
163948822|NCT00350103|592181214|FG000|Overall Study|Randomization mistake|0|||
163948823|NCT00350103|592181215|FG001|Overall Study|Randomization mistake|1|||
163948824|NCT00350103|592181216|FG002|Overall Study|Randomization mistake|1|||
163948825|NCT00350103|592181214|FG000|Overall Study|Sponsor´s decision|0|||
163948826|NCT00350103|592181215|FG001|Overall Study|Sponsor´s decision|1|||
163948827|NCT00350103|592181216|FG002|Overall Study|Sponsor´s decision|0|||
163948828|NCT00350103|592181214|FG000|Overall Study|Lost, Reason unknown|1|||
163948829|NCT00350103|592181215|FG001|Overall Study|Lost, Reason unknown|1|||
163948830|NCT00350103|592181216|FG002|Overall Study|Lost, Reason unknown|0|||
163948831|NCT01879553|592181217|FG000|Overall Study|Withdrawal by Subject|1|||
163948832|NCT01879553|592181218|FG001|Overall Study|Withdrawal by Subject|0|||
163948833|NCT00320528|592181219|FG000|Study Period II|Adverse Event|3|||
164047037|NCT03954704|592530569|FG001|Overall Study|Death|1|||
164047038|NCT03954704|592530570|FG002|Overall Study|Death|1|||
163948834|NCT00320528|592181220|FG001|Study Period II|Adverse Event|4|||
163948835|NCT00320528|592181221|FG002|Study Period II|Adverse Event|8|||
163948836|NCT00320528|592181219|FG000|Study Period II|Parent/Caregiver Decision|8|||
163948837|NCT00320528|592181220|FG001|Study Period II|Parent/Caregiver Decision|3|||
163948838|NCT00320528|592181221|FG002|Study Period II|Parent/Caregiver Decision|11|||
163948839|NCT00320528|592181219|FG000|Study Period II|Withdrawal by Subject|0|||
164047039|NCT03954704|592530571|FG003|Overall Study|Death|3|||
163948840|NCT00320528|592181220|FG001|Study Period II|Withdrawal by Subject|1|||
163948841|NCT00320528|592181221|FG002|Study Period II|Withdrawal by Subject|1|||
163948842|NCT00320528|592181219|FG000|Study Period II|Entry Criteria Exclusion|0|||
163948843|NCT00320528|592181220|FG001|Study Period II|Entry Criteria Exclusion|2|||
163948844|NCT00320528|592181221|FG002|Study Period II|Entry Criteria Exclusion|2|||
163948845|NCT00320528|592181219|FG000|Study Period III|Adverse Event|1|||
163948846|NCT00320528|592181220|FG001|Study Period III|Adverse Event|0|||
163948847|NCT00320528|592181221|FG002|Study Period III|Adverse Event|0|||
163948848|NCT00320528|592181219|FG000|Study Period III|Lost to Follow-up|1|||
163948849|NCT00320528|592181220|FG001|Study Period III|Lost to Follow-up|0|||
163948850|NCT00320528|592181221|FG002|Study Period III|Lost to Follow-up|0|||
163948851|NCT00320528|592181219|FG000|Study Period III|Withdrawal by Subject|1|||
163948852|NCT00320528|592181220|FG001|Study Period III|Withdrawal by Subject|1|||
163948853|NCT00320528|592181221|FG002|Study Period III|Withdrawal by Subject|2|||
163948854|NCT00320528|592181219|FG000|Study Period III|Lack of Efficacy|2|||
163948855|NCT00320528|592181220|FG001|Study Period III|Lack of Efficacy|0|||
163948856|NCT00320528|592181221|FG002|Study Period III|Lack of Efficacy|0|||
163948857|NCT00320528|592181219|FG000|Study Period III|Parent/Caregiver Decision|14|||
163948858|NCT00320528|592181220|FG001|Study Period III|Parent/Caregiver Decision|3|||
163948859|NCT00320528|592181221|FG002|Study Period III|Parent/Caregiver Decision|11|||
163948860|NCT00320528|592181219|FG000|Study Period III|Protocol Violation|0|||
163948861|NCT00320528|592181220|FG001|Study Period III|Protocol Violation|1|||
163948862|NCT00320528|592181221|FG002|Study Period III|Protocol Violation|0|||
163948863|NCT00320528|592181219|FG000|Study Period III|Physician Decision|0|||
163948864|NCT00320528|592181220|FG001|Study Period III|Physician Decision|1|||
163948865|NCT00320528|592181221|FG002|Study Period III|Physician Decision|2|||
163948866|NCT00320528|592181219|FG000|Study Period III|Sponsor Decision|0|||
163948867|NCT00320528|592181220|FG001|Study Period III|Sponsor Decision|0|||
163948868|NCT00320528|592181221|FG002|Study Period III|Sponsor Decision|1|||
163948869|NCT00320528|592181219|FG000|Study Period III|Atomoxetine Commercially Available|68|||
163948870|NCT00320528|592181220|FG001|Study Period III|Atomoxetine Commercially Available|25|||
163948871|NCT00320528|592181221|FG002|Study Period III|Atomoxetine Commercially Available|90|||
163948872|NCT04828837|592181222|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
163948873|NCT04828837|592181223|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
163948874|NCT04828837|592181222|FG000|Overall Study|Lost to Follow-up|2|||
163948875|NCT04828837|592181223|FG001|Overall Study|Lost to Follow-up|6|||
163948876|NCT04828837|592181222|FG000|Overall Study|Lack of Efficacy|1|||
163948877|NCT04828837|592181223|FG001|Overall Study|Lack of Efficacy|0|||
163948878|NCT04828837|592181222|FG000|Overall Study|Admitted due to pneumothorax.|1|||
163948879|NCT04828837|592181223|FG001|Overall Study|Admitted due to pneumothorax.|0|||
163948880|NCT04828837|592181222|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
163948881|NCT04828837|592181223|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
163948882|NCT01397422|592181224|FG000|Overall Study|Adverse Event|0|||
163948883|NCT01397422|592181225|FG001|Overall Study|Adverse Event|3|||
163948884|NCT01397422|592181226|FG002|Overall Study|Adverse Event|3|||
163948885|NCT01397422|592181227|FG003|Overall Study|Adverse Event|8|||
163948886|NCT01397422|592181224|FG000|Overall Study|Withdrawal by Subject|1|||
163948887|NCT01397422|592181225|FG001|Overall Study|Withdrawal by Subject|0|||
163948888|NCT01397422|592181226|FG002|Overall Study|Withdrawal by Subject|0|||
163948889|NCT01397422|592181227|FG003|Overall Study|Withdrawal by Subject|0|||
163948890|NCT01397422|592181224|FG000|Overall Study|Increased bradykinesia related to PD|1|||
163948891|NCT01397422|592181225|FG001|Overall Study|Increased bradykinesia related to PD|0|||
163948892|NCT01397422|592181226|FG002|Overall Study|Increased bradykinesia related to PD|0|||
163948893|NCT01397422|592181227|FG003|Overall Study|Increased bradykinesia related to PD|0|||
163948894|NCT00760474|592181233|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
163948895|NCT00760474|592181234|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
163948896|NCT00760474|592181233|FG000|Placebo Washout Period|Other|0|||
163948897|NCT00760474|592181234|FG001|Placebo Washout Period|Other|1|||
163948898|NCT00760474|592181233|FG000|Period 2 (P2)|Lost to Follow-up|1|||
163948899|NCT00760474|592181234|FG001|Period 2 (P2)|Lost to Follow-up|0|||
163948900|NCT00760474|592181233|FG000|Period 2 (P2)|Adverse Event|0|||
164099700|NCT03555305|592730543|FG001|Period 1|Physician Decision|1|||
164099701|NCT03555305|592730542|FG000|Period 1|Adverse Event|0|||
164099702|NCT03555305|592730543|FG001|Period 1|Adverse Event|1|||
164099703|NCT00858845|592730557|FG000|Overall Study|Patient underwent heart transplant.|0|||
164099704|NCT00858845|592730558|FG001|Overall Study|Patient underwent heart transplant.|1|||
164099705|NCT03031847|592730559|FG000|Overall Study|Death|1|||
163948901|NCT00760474|592181234|FG001|Period 2 (P2)|Adverse Event|1|||
163948902|NCT04540887|592181235|FG000|Overall Study|Withdrawal by Subject|2|||
163948903|NCT04664400|592181236|FG000|Overall Study|Withdrawal by Subject|2|||
163948904|NCT02101385|592181239|FG000|Study Treatment|Disease Progression|9|||
163948905|NCT02101385|592181240|FG001|Study Treatment|Disease Progression|3|||
163948906|NCT02101385|592181239|FG000|Study Treatment|Alternative therapy|0|||
163948907|NCT02101385|592181240|FG001|Study Treatment|Alternative therapy|1|||
163948908|NCT02101385|592181239|FG000|Study Treatment|No treatment, per protocol criteria|0|||
163948909|NCT02101385|592181240|FG001|Study Treatment|No treatment, per protocol criteria|4|||
163948910|NCT02101385|592181239|FG000|Study Treatment|Patient Non compliance|0|||
163948911|NCT02101385|592181240|FG001|Study Treatment|Patient Non compliance|2|||
164099706|NCT03031847|592730560|FG001|Overall Study|Death|1|||
163948912|NCT02101385|592181239|FG000|Study Treatment|Withdrawal by Subject|5|||
163948913|NCT02101385|592181240|FG001|Study Treatment|Withdrawal by Subject|2|||
163948914|NCT02101385|592181239|FG000|Study Treatment|screen failure|1|||
163948915|NCT02101385|592181240|FG001|Study Treatment|screen failure|0|||
163948916|NCT02101385|592181239|FG000|Study Treatment|AE/Side Effects/Complications|8|||
163948917|NCT02101385|592181240|FG001|Study Treatment|AE/Side Effects/Complications|0|||
163948918|NCT02101385|592181239|FG000|Study Treatment|Lost to Follow-up|1|||
163948919|NCT02101385|592181240|FG001|Study Treatment|Lost to Follow-up|0|||
163948920|NCT02101385|592181239|FG000|Study Treatment|Disease Progression before treatment|1|||
163948921|NCT02101385|592181240|FG001|Study Treatment|Disease Progression before treatment|0|||
163948922|NCT02101385|592181239|FG000|Study Treatment|Death|1|||
163948923|NCT02101385|592181240|FG001|Study Treatment|Death|0|||
163948924|NCT02101385|592181239|FG000|Follow up|Lost to Follow-up|4|||
163948925|NCT02101385|592181240|FG001|Follow up|Lost to Follow-up|9|||
163948926|NCT02101385|592181239|FG000|Follow up|Refused to follow up|5|||
163948927|NCT02101385|592181240|FG001|Follow up|Refused to follow up|4|||
163948928|NCT02101385|592181239|FG000|Follow up|Death|21|||
163948929|NCT02101385|592181240|FG001|Follow up|Death|39|||
163948930|NCT02101385|592181239|FG000|Follow up|study completed|33|||
163948931|NCT02101385|592181240|FG001|Follow up|study completed|52|||
163948932|NCT02101385|592181239|FG000|Follow up|screen failure|2|||
163948933|NCT02101385|592181240|FG001|Follow up|screen failure|0|||
163948934|NCT02101385|592181239|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
163948935|NCT02101385|592181240|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
163948936|NCT02101385|592181239|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
163948937|NCT02101385|592181240|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
163948938|NCT02101385|592181239|FG000|Follow up|Withdrawal by Subject|2|||
163948939|NCT02101385|592181240|FG001|Follow up|Withdrawal by Subject|2|||
163948940|NCT02101385|592181239|FG000|Follow up|PI requested closure of site|0|||
163948941|NCT02101385|592181240|FG001|Follow up|PI requested closure of site|5|||
163948942|NCT02489968|592181243|FG000|Open-label Treatment Period|Adverse Event|14|||
163948943|NCT02489968|592181244|FG001|Open-label Treatment Period|Adverse Event|7|||
163948944|NCT02489968|592181245|FG002|Open-label Treatment Period|Adverse Event|0|||
163948945|NCT02489968|592181246|FG003|Open-label Treatment Period|Adverse Event|0|||
163948946|NCT02489968|592181247|FG004|Open-label Treatment Period|Adverse Event|0|||
163948947|NCT02489968|592181248|FG005|Open-label Treatment Period|Adverse Event|0|||
163948948|NCT02489968|592181243|FG000|Open-label Treatment Period|Protocol Violation|2|||
163948949|NCT02489968|592181244|FG001|Open-label Treatment Period|Protocol Violation|2|||
163948950|NCT02489968|592181245|FG002|Open-label Treatment Period|Protocol Violation|0|||
163948951|NCT02489968|592181246|FG003|Open-label Treatment Period|Protocol Violation|0|||
163948952|NCT02489968|592181247|FG004|Open-label Treatment Period|Protocol Violation|0|||
163948953|NCT02489968|592181248|FG005|Open-label Treatment Period|Protocol Violation|0|||
163948954|NCT02489968|592181243|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
163948955|NCT02489968|592181244|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
163948956|NCT02489968|592181245|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
163948957|NCT02489968|592181246|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
163948958|NCT02489968|592181247|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
163948959|NCT02489968|592181248|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
163948960|NCT02489968|592181243|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
163948961|NCT02489968|592181244|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
163948962|NCT02489968|592181245|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
163948963|NCT02489968|592181246|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
164047040|NCT03954704|592530572|FG004|Overall Study|Death|2|||
164047041|NCT03954704|592530573|FG005|Overall Study|Death|2|||
164047042|NCT03954704|592530574|FG006|Overall Study|Death|0|||
164047043|NCT03954704|592530568|FG000|Overall Study|Withdrew Consent|0|||
164047044|NCT03954704|592530569|FG001|Overall Study|Withdrew Consent|0|||
164047045|NCT03954704|592530570|FG002|Overall Study|Withdrew Consent|1|||
164047046|NCT03954704|592530571|FG003|Overall Study|Withdrew Consent|0|||
164047047|NCT03954704|592530572|FG004|Overall Study|Withdrew Consent|0|||
164047048|NCT03954704|592530573|FG005|Overall Study|Withdrew Consent|1|||
164047049|NCT03954704|592530574|FG006|Overall Study|Withdrew Consent|0|||
164047050|NCT03954704|592530568|FG000|Overall Study|Lost to Follow-up|0|||
163948964|NCT02489968|592181247|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
163948965|NCT02489968|592181248|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
163948966|NCT02489968|592181243|FG000|Open-label Treatment Period|Other than specified above|204|||
163948967|NCT02489968|592181244|FG001|Open-label Treatment Period|Other than specified above|189|||
163948968|NCT02489968|592181245|FG002|Open-label Treatment Period|Other than specified above|0|||
163948969|NCT02489968|592181246|FG003|Open-label Treatment Period|Other than specified above|0|||
163948970|NCT02489968|592181247|FG004|Open-label Treatment Period|Other than specified above|0|||
164047051|NCT03954704|592530569|FG001|Overall Study|Lost to Follow-up|0|||
164047052|NCT03954704|592530570|FG002|Overall Study|Lost to Follow-up|0|||
164047053|NCT03954704|592530571|FG003|Overall Study|Lost to Follow-up|0|||
163948971|NCT02489968|592181248|FG005|Open-label Treatment Period|Other than specified above|0|||
163948972|NCT02489968|592181243|FG000|Double-blind Treatment Period|Adverse Event|0|||
163948973|NCT02489968|592181244|FG001|Double-blind Treatment Period|Adverse Event|0|||
163948974|NCT02489968|592181245|FG002|Double-blind Treatment Period|Adverse Event|2|||
163948975|NCT02489968|592181246|FG003|Double-blind Treatment Period|Adverse Event|6|||
163948976|NCT02489968|592181247|FG004|Double-blind Treatment Period|Adverse Event|4|||
163948977|NCT02489968|592181248|FG005|Double-blind Treatment Period|Adverse Event|5|||
163948978|NCT02489968|592181243|FG000|Double-blind Treatment Period|Protocol Violation|0|||
163948979|NCT02489968|592181244|FG001|Double-blind Treatment Period|Protocol Violation|0|||
163948980|NCT02489968|592181245|FG002|Double-blind Treatment Period|Protocol Violation|0|||
163948981|NCT02489968|592181246|FG003|Double-blind Treatment Period|Protocol Violation|0|||
163948982|NCT02489968|592181247|FG004|Double-blind Treatment Period|Protocol Violation|1|||
163948983|NCT02489968|592181248|FG005|Double-blind Treatment Period|Protocol Violation|1|||
163948984|NCT02489968|592181243|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
163948985|NCT02489968|592181244|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
163948986|NCT02489968|592181245|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
163948987|NCT02489968|592181246|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
163948988|NCT02489968|592181247|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
163948989|NCT02489968|592181248|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
163948990|NCT02489968|592181243|FG000|Double-blind Treatment Period|Other than specified above|0|||
163948991|NCT02489968|592181244|FG001|Double-blind Treatment Period|Other than specified above|0|||
163948992|NCT02489968|592181245|FG002|Double-blind Treatment Period|Other than specified above|0|||
163948993|NCT02489968|592181246|FG003|Double-blind Treatment Period|Other than specified above|0|||
163948994|NCT02489968|592181247|FG004|Double-blind Treatment Period|Other than specified above|1|||
163948995|NCT02489968|592181248|FG005|Double-blind Treatment Period|Other than specified above|0|||
163948996|NCT01982448|592181253|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
163948997|NCT01982448|592181254|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
163948998|NCT01982448|592181253|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
163948999|NCT01982448|592181254|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
163949000|NCT01982448|592181253|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
163949001|NCT01982448|592181254|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
163949002|NCT01982448|592181253|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
163949003|NCT01982448|592181254|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
163949004|NCT02594163|592182787|FG000|Treatment Period|Progressive disease|2|||
163949005|NCT02594163|592182788|FG001|Treatment Period|Progressive disease|3|||
163949006|NCT02594163|592182787|FG000|Treatment Period|Adverse Event|1|||
163949007|NCT02594163|592182788|FG001|Treatment Period|Adverse Event|5|||
163949008|NCT02594163|592182787|FG000|Treatment Period|Physician Decision|1|||
163949009|NCT02594163|592182788|FG001|Treatment Period|Physician Decision|3|||
163949010|NCT02594163|592182787|FG000|Treatment Period|Study termination by sponsor|2|||
163949011|NCT02594163|592182788|FG001|Treatment Period|Study termination by sponsor|1|||
163949012|NCT02594163|592182787|FG000|Treatment Period|Other, Non-AE|1|||
163949013|NCT02594163|592182788|FG001|Treatment Period|Other, Non-AE|0|||
163949014|NCT02594163|592182787|FG000|Follow-up Period|Withdrawal by Subject|0|||
163949015|NCT02594163|592182788|FG001|Follow-up Period|Withdrawal by Subject|1|||
163949016|NCT02594163|592182787|FG000|Follow-up Period|Study Termination by Sponsor|6|||
163949017|NCT02594163|592182788|FG001|Follow-up Period|Study Termination by Sponsor|4|||
163949018|NCT02594163|592182787|FG000|Follow-up Period|Lost to Follow-up|1|||
163949019|NCT02594163|592182788|FG001|Follow-up Period|Lost to Follow-up|0|||
163949020|NCT02594163|592182787|FG000|Follow-up Period|Death|2|||
163949021|NCT02594163|592182788|FG001|Follow-up Period|Death|5|||
163949022|NCT02594163|592182787|FG000|Follow-up Period|Adverse Event|0|||
163949023|NCT02594163|592182788|FG001|Follow-up Period|Adverse Event|1|||
163949024|NCT02594163|592182787|FG000|Follow-up Period|Progressive Disease|2|||
163949025|NCT02594163|592182788|FG001|Follow-up Period|Progressive Disease|0|||
163949026|NCT02594163|592182787|FG000|Follow-up Period|Physician Decision|0|||
163949027|NCT02594163|592182788|FG001|Follow-up Period|Physician Decision|1|||
163949028|NCT01342341|592182789|FG000|Overall Study|Lost to Follow-up|4|||
163949029|NCT01342341|592182790|FG001|Overall Study|Lost to Follow-up|4|||
163949030|NCT01022268|592182793|FG000|Overall Study|Withdrawal by Subject|1|||
163949031|NCT01022268|592182794|FG001|Overall Study|Withdrawal by Subject|0|||
164047054|NCT03954704|592530572|FG004|Overall Study|Lost to Follow-up|0|||
164047055|NCT03954704|592530573|FG005|Overall Study|Lost to Follow-up|0|||
164047056|NCT03954704|592530574|FG006|Overall Study|Lost to Follow-up|1|||
164047057|NCT03954704|592530568|FG000|Overall Study|Study Terminated by Sponsor|0|||
163949032|NCT01022268|592182793|FG000|Overall Study|Withdrawal by Subject|1|||
163949033|NCT01022268|592182794|FG001|Overall Study|Withdrawal by Subject|0|||
163949034|NCT00734097|592182795|FG000|Screening|Protocol Violation|12|||
163949035|NCT00734097|592182795|FG000|Screening|Withdrawal by Subject|5|||
163949036|NCT00734097|592182795|FG000|Screening|Lost to Follow-up|2|||
163949037|NCT00734097|592182795|FG000|Screening|Unconfirmed pregnancy|1|||
164047058|NCT03954704|592530569|FG001|Overall Study|Study Terminated by Sponsor|0|||
163949038|NCT00734097|592182795|FG000|Open Label|Lost to Follow-up|7|||
163949039|NCT00734097|592182795|FG000|Open Label|Withdrawal by Subject|5|||
163949040|NCT00734097|592182795|FG000|Open Label|Protocol Violation|4|||
163949041|NCT02233543|592182798|FG000|Period 1|Withdrawal by Subject|1|||
163949042|NCT02233543|592182799|FG001|Period 1|Withdrawal by Subject|0|||
163949043|NCT02233543|592182798|FG000|Period 1|Participants required other treatment.|2|||
163949044|NCT02233543|592182799|FG001|Period 1|Participants required other treatment.|3|||
163949045|NCT02233543|592182798|FG000|Period 2|Adverse Event|1|||
163949046|NCT02233543|592182799|FG001|Period 2|Adverse Event|0|||
163949047|NCT02233543|592182798|FG000|Period 2|Participant required other treatment.|0|||
163949048|NCT02233543|592182799|FG001|Period 2|Participant required other treatment.|1|||
163949049|NCT02233543|592182798|FG000|Period 2|COPD exacerbation|1|||
163949050|NCT02233543|592182799|FG001|Period 2|COPD exacerbation|0|||
163949051|NCT01302067|592182800|FG000|Overall Study|Death|0|||
163949052|NCT01302067|592182801|FG001|Overall Study|Death|0|||
163949053|NCT01302067|592182802|FG002|Overall Study|Death|1|||
163949054|NCT01302067|592182800|FG000|Overall Study|Physician Decision|9|||
163949055|NCT01302067|592182801|FG001|Overall Study|Physician Decision|5|||
163949056|NCT01302067|592182802|FG002|Overall Study|Physician Decision|14|||
163949057|NCT01302067|592182800|FG000|Overall Study|Lack of Efficacy|8|||
163949058|NCT01302067|592182801|FG001|Overall Study|Lack of Efficacy|4|||
163949059|NCT01302067|592182802|FG002|Overall Study|Lack of Efficacy|2|||
163949060|NCT01302067|592182800|FG000|Overall Study|Lost to Follow-up|9|||
163949061|NCT01302067|592182801|FG001|Overall Study|Lost to Follow-up|4|||
163949062|NCT01302067|592182802|FG002|Overall Study|Lost to Follow-up|15|||
163949063|NCT01302067|592182800|FG000|Overall Study|Withdrawal by Subject|13|||
163949064|NCT01302067|592182801|FG001|Overall Study|Withdrawal by Subject|6|||
163949065|NCT01302067|592182802|FG002|Overall Study|Withdrawal by Subject|10|||
163949066|NCT01302067|592182800|FG000|Overall Study|Other|1|||
163949067|NCT01302067|592182801|FG001|Overall Study|Other|1|||
163949068|NCT01302067|592182802|FG002|Overall Study|Other|3|||
163949069|NCT01302067|592182800|FG000|Overall Study|Protocol Violation|11|||
163949070|NCT01302067|592182801|FG001|Overall Study|Protocol Violation|0|||
163949071|NCT01302067|592182802|FG002|Overall Study|Protocol Violation|8|||
163949072|NCT01302067|592182800|FG000|Overall Study|Adverse Event|27|||
163949073|NCT01302067|592182801|FG001|Overall Study|Adverse Event|14|||
163949074|NCT01302067|592182802|FG002|Overall Study|Adverse Event|45|||
163949075|NCT01034176|592182803|FG000|Overall Study|Physician Decision|2|||
163949076|NCT01034176|592182804|FG001|Overall Study|Physician Decision|0|||
163949077|NCT01034176|592182803|FG000|Overall Study|Withdrawal by Subject|0|||
163949078|NCT01034176|592182804|FG001|Overall Study|Withdrawal by Subject|1|||
163949079|NCT01034176|592182803|FG000|Overall Study|Lost to Follow-up|0|||
163949080|NCT01034176|592182804|FG001|Overall Study|Lost to Follow-up|1|||
163949081|NCT00266227|592182807|FG000|Initial Treatment|Adverse Event|0|||
163949082|NCT00266227|592182808|FG001|Initial Treatment|Adverse Event|0|||
163949083|NCT00266227|592182809|FG002|Initial Treatment|Adverse Event|13|||
163949084|NCT00266227|592182807|FG000|Initial Treatment|Lost to Follow-up|0|||
163949085|NCT00266227|592182808|FG001|Initial Treatment|Lost to Follow-up|0|||
163949086|NCT00266227|592182809|FG002|Initial Treatment|Lost to Follow-up|6|||
163949087|NCT00266227|592182807|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
163949088|NCT00266227|592182808|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
163949089|NCT00266227|592182809|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
163949090|NCT00266227|592182807|FG000|Initial Treatment|Physician decision to withdraw|0|||
164047059|NCT03954704|592530570|FG002|Overall Study|Study Terminated by Sponsor|1|||
164047060|NCT03954704|592530571|FG003|Overall Study|Study Terminated by Sponsor|0|||
164047061|NCT03954704|592530572|FG004|Overall Study|Study Terminated by Sponsor|1|||
164047062|NCT03954704|592530573|FG005|Overall Study|Study Terminated by Sponsor|4|||
164047063|NCT03954704|592530574|FG006|Overall Study|Study Terminated by Sponsor|2|||
164047064|NCT03954704|592530568|FG000|Overall Study|Enrolled but not Treated|0|||
163949091|NCT00266227|592182808|FG001|Initial Treatment|Physician decision to withdraw|0|||
163949092|NCT00266227|592182809|FG002|Initial Treatment|Physician decision to withdraw|12|||
163949093|NCT00266227|592182807|FG000|Initial Treatment|Pregnancy|0|||
163949094|NCT00266227|592182808|FG001|Initial Treatment|Pregnancy|0|||
164047065|NCT03954704|592530569|FG001|Overall Study|Enrolled but not Treated|0|||
164047066|NCT03954704|592530570|FG002|Overall Study|Enrolled but not Treated|0|||
163949095|NCT00266227|592182809|FG002|Initial Treatment|Pregnancy|1|||
163949096|NCT00266227|592182807|FG000|Retreatment: Up to Week 48|Death|1|||
163949097|NCT00266227|592182808|FG001|Retreatment: Up to Week 48|Death|0|||
163949098|NCT00266227|592182809|FG002|Retreatment: Up to Week 48|Death|0|||
163949099|NCT00266227|592182807|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
163949100|NCT00266227|592182808|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
163949101|NCT00266227|592182809|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
163949102|NCT00266227|592182807|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
163949103|NCT00266227|592182808|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
163949104|NCT00266227|592182809|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
163949105|NCT00266227|592182807|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
164047067|NCT03954704|592530571|FG003|Overall Study|Enrolled but not Treated|0|||
164047068|NCT03954704|592530572|FG004|Overall Study|Enrolled but not Treated|0|||
163949106|NCT00266227|592182808|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
163949107|NCT00266227|592182809|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
163949108|NCT00266227|592182807|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
163949109|NCT00266227|592182808|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
163949110|NCT00266227|592182809|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
163949111|NCT00266227|592182807|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
163949112|NCT00266227|592182808|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
163949113|NCT00266227|592182809|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
163949114|NCT00266227|592182807|FG000|Retreatment: Week 48 to Week 72|Death|1|||
163949115|NCT00266227|592182808|FG001|Retreatment: Week 48 to Week 72|Death|1|||
163949116|NCT00266227|592182809|FG002|Retreatment: Week 48 to Week 72|Death|0|||
163949117|NCT00266227|592182807|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
163949118|NCT00266227|592182808|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
163949119|NCT00266227|592182809|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
163949120|NCT00266227|592182807|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
163949121|NCT00266227|592182808|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
163949122|NCT00266227|592182809|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
163949123|NCT00266227|592182807|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
163949124|NCT00266227|592182808|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
163949125|NCT00266227|592182809|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
163949126|NCT00266227|592182807|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
163949127|NCT00266227|592182808|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
163949128|NCT00266227|592182809|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
163949129|NCT02924428|592182811|FG000|Overall Study|Adverse Event|1|||
163949130|NCT02924428|592182812|FG001|Overall Study|Adverse Event|0|||
163949131|NCT02924428|592182811|FG000|Overall Study|Physician Decision|1|||
163949132|NCT02924428|592182812|FG001|Overall Study|Physician Decision|0|||
163949133|NCT02924428|592182811|FG000|Overall Study|Lost to Follow-up|2|||
163949134|NCT02924428|592182812|FG001|Overall Study|Lost to Follow-up|4|||
163949135|NCT02924428|592182811|FG000|Overall Study|Pregnancy|0|||
163949136|NCT02924428|592182812|FG001|Overall Study|Pregnancy|1|||
163949137|NCT02680002|592182813|FG000|Overall Study|Lost to Follow-up|5|||
163949138|NCT02680002|592182814|FG001|Overall Study|Lost to Follow-up|1|||
163949139|NCT02680002|592182815|FG002|Overall Study|Lost to Follow-up|4|||
163949140|NCT02680002|592182816|FG003|Overall Study|Lost to Follow-up|2|||
163949141|NCT02680002|592182817|FG004|Overall Study|Lost to Follow-up|0|||
163949142|NCT02680002|592182818|FG005|Overall Study|Lost to Follow-up|2|||
163949143|NCT02680002|592182813|FG000|Overall Study|Physician Decision|5|||
163949144|NCT02680002|592182814|FG001|Overall Study|Physician Decision|1|||
163949145|NCT02680002|592182815|FG002|Overall Study|Physician Decision|1|||
163949146|NCT02680002|592182816|FG003|Overall Study|Physician Decision|1|||
163949147|NCT02680002|592182817|FG004|Overall Study|Physician Decision|1|||
163949148|NCT02680002|592182818|FG005|Overall Study|Physician Decision|1|||
163949149|NCT02680002|592182813|FG000|Overall Study|Protocol Violation|1|||
163949150|NCT02680002|592182814|FG001|Overall Study|Protocol Violation|0|||
163949151|NCT02680002|592182815|FG002|Overall Study|Protocol Violation|1|||
163949152|NCT02680002|592182816|FG003|Overall Study|Protocol Violation|0|||
163949153|NCT02680002|592182817|FG004|Overall Study|Protocol Violation|1|||
163949154|NCT02680002|592182818|FG005|Overall Study|Protocol Violation|2|||
163949155|NCT02680002|592182813|FG000|Overall Study|Withdrawal by Subject|0|||
163949156|NCT02680002|592182814|FG001|Overall Study|Withdrawal by Subject|0|||
163949157|NCT02680002|592182815|FG002|Overall Study|Withdrawal by Subject|1|||
163949158|NCT02680002|592182816|FG003|Overall Study|Withdrawal by Subject|0|||
163949159|NCT02680002|592182817|FG004|Overall Study|Withdrawal by Subject|2|||
163949160|NCT02680002|592182818|FG005|Overall Study|Withdrawal by Subject|2|||
163949161|NCT02680002|592182813|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
163949162|NCT02680002|592182814|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
163949163|NCT02680002|592182815|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
163949164|NCT02680002|592182816|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
163949165|NCT02680002|592182817|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
163949166|NCT02680002|592182818|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
163949167|NCT02680002|592182813|FG000|Overall Study|Other|0|||
163949168|NCT02680002|592182814|FG001|Overall Study|Other|1|||
163949169|NCT02680002|592182815|FG002|Overall Study|Other|0|||
163949170|NCT02680002|592182816|FG003|Overall Study|Other|0|||
163949171|NCT02680002|592182817|FG004|Overall Study|Other|1|||
163949172|NCT02680002|592182818|FG005|Overall Study|Other|0|||
163949173|NCT02680002|592182813|FG000|Overall Study|Adverse Event|0|||
163949174|NCT02680002|592182814|FG001|Overall Study|Adverse Event|0|||
163949175|NCT02680002|592182815|FG002|Overall Study|Adverse Event|0|||
163949176|NCT02680002|592182816|FG003|Overall Study|Adverse Event|0|||
163949177|NCT02680002|592182817|FG004|Overall Study|Adverse Event|1|||
164047069|NCT03954704|592530573|FG005|Overall Study|Enrolled but not Treated|1|||
164099707|NCT03031847|592730561|FG002|Overall Study|Death|2|||
163949178|NCT02680002|592182818|FG005|Overall Study|Adverse Event|2|||
163949179|NCT02704754|592182819|FG000|Overall Study|Lost to Follow-up|1|||
163949180|NCT02704754|592182820|FG001|Overall Study|Lost to Follow-up|1|||
163949181|NCT02704754|592182819|FG000|Overall Study|Lack of Efficacy|1|||
163949182|NCT02704754|592182820|FG001|Overall Study|Lack of Efficacy|0|||
163949183|NCT02704754|592182819|FG000|Overall Study|Withdrawal by Subject|1|||
163949184|NCT02704754|592182820|FG001|Overall Study|Withdrawal by Subject|0|||
163949185|NCT00423943|592182823|FG000|Overall Study|Withdrawal by Subject|3|||
163949186|NCT00423943|592182824|FG001|Overall Study|Withdrawal by Subject|1|||
163949187|NCT03730480|592182825|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
163949188|NCT04097301|592182828|FG000|Overall Study|Death|1|||
163949189|NCT04097301|592182828|FG000|Overall Study|Withdrawal by Subject|1|||
163949190|NCT04097301|592182828|FG000|Overall Study|Screening Failure|5|||
163949191|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
163949192|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
163949193|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
163949194|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
163949195|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
163949196|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
163949197|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
163949198|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
163949199|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
163949200|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
163949201|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
163949202|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
163949203|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
163949204|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
163949205|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
163949206|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
163949207|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
163949208|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
163949209|NCT02480153|592182835|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
163949210|NCT02480153|592182836|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
163949211|NCT02480153|592182837|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
163949212|NCT02480153|592182835|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
163949213|NCT02480153|592182836|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
163949214|NCT02480153|592182837|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
163949215|NCT02480153|592182835|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
163949216|NCT02480153|592182836|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
163949217|NCT02480153|592182837|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
163949218|NCT02480153|592182835|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
163949219|NCT02480153|592182836|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
163949220|NCT02480153|592182837|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
163949221|NCT02480153|592182835|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
163949222|NCT02480153|592182836|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
163949223|NCT02480153|592182837|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
163949224|NCT02480153|592182835|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
163949225|NCT02480153|592182836|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
163949226|NCT02480153|592182837|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
163949227|NCT02480153|592182835|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
163949228|NCT02480153|592182836|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
163949229|NCT02480153|592182837|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
163949230|NCT02480153|592182835|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
163949231|NCT02480153|592182836|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
163949232|NCT02480153|592182837|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
163949233|NCT02480153|592182835|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
163949234|NCT02480153|592182836|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
163949235|NCT02480153|592182837|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
163949236|NCT02480153|592182835|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
163949237|NCT02480153|592182836|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
163949238|NCT02480153|592182837|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
164047070|NCT03954704|592530574|FG006|Overall Study|Enrolled but not Treated|0|||
164047071|NCT04035473|592530576|FG000|Screening/Baseline|Death|0|||
164047072|NCT04035473|592530577|FG001|Screening/Baseline|Death|1|||
164047073|NCT04035473|592530576|FG000|Screening/Baseline|Adverse Event|0|||
164047074|NCT04035473|592530577|FG001|Screening/Baseline|Adverse Event|1|||
164047075|NCT04035473|592530576|FG000|Follow-up Period|Adverse Event|2|||
164047076|NCT04035473|592530577|FG001|Follow-up Period|Adverse Event|0|||
164047077|NCT00397891|592530578|FG000|Overall Study|Withdrawal by Subject|1|||
163949239|NCT02480153|592182835|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
163949240|NCT02480153|592182836|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
163949241|NCT02480153|592182837|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
163949242|NCT02480153|592182835|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
163949243|NCT02480153|592182836|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
163949244|NCT02480153|592182837|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
163949245|NCT01403610|592182838|FG000|Overall Study|Withdrawal by Subject|2|||
163949246|NCT01403610|592182839|FG001|Overall Study|Withdrawal by Subject|0|||
163949247|NCT01403610|592182840|FG002|Overall Study|Withdrawal by Subject|0|||
163949248|NCT01403610|592182841|FG003|Overall Study|Withdrawal by Subject|0|||
163949249|NCT01403610|592182838|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
163949250|NCT01403610|592182839|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
163949251|NCT01403610|592182840|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
163949252|NCT01403610|592182841|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
163949253|NCT00901186|592182842|FG000|Overall Study|Lack of Efficacy|0|||
163949254|NCT00901186|592182843|FG001|Overall Study|Lack of Efficacy|1|||
163949255|NCT00901186|592182842|FG000|Overall Study|Abnormal laboratory values|0|||
163949256|NCT00901186|592182843|FG001|Overall Study|Abnormal laboratory values|1|||
163949257|NCT00901186|592182842|FG000|Overall Study|Lost to Follow-up|2|||
163949258|NCT00901186|592182843|FG001|Overall Study|Lost to Follow-up|0|||
163949259|NCT00901186|592182842|FG000|Overall Study|Adverse Event|2|||
163949260|NCT00901186|592182843|FG001|Overall Study|Adverse Event|4|||
163949261|NCT00901186|592182842|FG000|Overall Study|Administration problems|0|||
163949262|NCT00901186|592182843|FG001|Overall Study|Administration problems|1|||
163949263|NCT00901186|592182842|FG000|Overall Study|Protocol deviations|5|||
163949264|NCT00901186|592182843|FG001|Overall Study|Protocol deviations|4|||
163949265|NCT00107120|592182845|FG000|Overall Study|Adverse Event|4|||
163949266|NCT00107120|592182846|FG001|Overall Study|Adverse Event|1|||
163949267|NCT00107120|592182845|FG000|Overall Study|Lack of Efficacy|5|||
163949268|NCT00107120|592182846|FG001|Overall Study|Lack of Efficacy|5|||
163949269|NCT00107120|592182845|FG000|Overall Study|Protocol Violation|3|||
163949270|NCT00107120|592182846|FG001|Overall Study|Protocol Violation|0|||
163949271|NCT00107120|592182845|FG000|Overall Study|Withdrawal by Subject|8|||
163949272|NCT00107120|592182846|FG001|Overall Study|Withdrawal by Subject|9|||
163949273|NCT00107120|592182845|FG000|Overall Study|Lost to Follow-up|8|||
163949274|NCT00107120|592182846|FG001|Overall Study|Lost to Follow-up|6|||
163949275|NCT00107120|592182845|FG000|Overall Study|Pregnancy|0|||
163949276|NCT00107120|592182846|FG001|Overall Study|Pregnancy|1|||
163949277|NCT00107120|592182845|FG000|Overall Study|moving away from site|1|||
163949278|NCT00107120|592182846|FG001|Overall Study|moving away from site|1|||
163949279|NCT00107120|592182845|FG000|Overall Study|death of parent|0|||
163949280|NCT00107120|592182846|FG001|Overall Study|death of parent|1|||
163949281|NCT03241225|592182849|FG000|Overall Study|Lost to Follow-up|2|||
163949282|NCT03241225|592182850|FG001|Overall Study|Lost to Follow-up|1|||
163949283|NCT03241225|592182849|FG000|Overall Study|Protocol Violation|4|||
163949284|NCT03241225|592182850|FG001|Overall Study|Protocol Violation|1|||
163949285|NCT03241225|592182849|FG000|Overall Study|Withdrawal by Subject|1|||
163949286|NCT03241225|592182850|FG001|Overall Study|Withdrawal by Subject|0|||
163949287|NCT00852540|592182851|FG000|Overall Study|Adverse Event|10|||
163949288|NCT00852540|592182852|FG001|Overall Study|Adverse Event|3|||
163949289|NCT00852540|592182851|FG000|Overall Study|Lack of Efficacy|15|||
163949290|NCT00852540|592182852|FG001|Overall Study|Lack of Efficacy|3|||
163949291|NCT00852540|592182851|FG000|Overall Study|Protocol Violation|1|||
163949292|NCT00852540|592182852|FG001|Overall Study|Protocol Violation|2|||
163949293|NCT00852540|592182851|FG000|Overall Study|Lost to Follow-up|2|||
163949294|NCT00852540|592182852|FG001|Overall Study|Lost to Follow-up|3|||
163949295|NCT00852540|592182851|FG000|Overall Study|Investigator Discretion|2|||
163949296|NCT00852540|592182852|FG001|Overall Study|Investigator Discretion|3|||
163949297|NCT00852540|592182851|FG000|Overall Study|Withdrawal by Subject|3|||
163949298|NCT00852540|592182852|FG001|Overall Study|Withdrawal by Subject|1|||
163949299|NCT00852540|592182851|FG000|Overall Study|Did Not Receive Study Drug|3|||
163949300|NCT00852540|592182852|FG001|Overall Study|Did Not Receive Study Drug|3|||
163949301|NCT01635920|592182855|FG000|Overall Study|Adverse Event|1|||
163949302|NCT01635920|592182856|FG001|Overall Study|Adverse Event|0|||
163949303|NCT01635920|592182855|FG000|Overall Study|Lost to Follow-up|0|||
163949304|NCT01635920|592182856|FG001|Overall Study|Lost to Follow-up|1|||
163949305|NCT01635920|592182855|FG000|Overall Study|Subject decision|2|||
163949306|NCT01635920|592182856|FG001|Overall Study|Subject decision|0|||
163949307|NCT00158860|592182873|FG000|Overall Study|Adverse Event|3|||
163949308|NCT00158860|592182874|FG001|Overall Study|Adverse Event|6|||
163949309|NCT00158860|592182873|FG000|Overall Study|Lost to Follow-up|11|||
163949310|NCT00158860|592182874|FG001|Overall Study|Lost to Follow-up|17|||
163949311|NCT00158860|592182873|FG000|Overall Study|Protocol Violation|8|||
163949312|NCT00158860|592182874|FG001|Overall Study|Protocol Violation|23|||
163949313|NCT00158860|592182873|FG000|Overall Study|Withdrawal by Subject|7|||
163949314|NCT00158860|592182874|FG001|Overall Study|Withdrawal by Subject|17|||
163949315|NCT00158860|592182873|FG000|Overall Study|MOVING OUT OF STATE|1|||
163949316|NCT00158860|592182874|FG001|Overall Study|MOVING OUT OF STATE|0|||
164099708|NCT03031847|592730562|FG003|Overall Study|Death|3|||
164099709|NCT03031847|592730559|FG000|Overall Study|Lost to Follow-up|1|||
164099710|NCT03031847|592730560|FG001|Overall Study|Lost to Follow-up|1|||
164099711|NCT03031847|592730561|FG002|Overall Study|Lost to Follow-up|2|||
164099712|NCT03031847|592730562|FG003|Overall Study|Lost to Follow-up|3|||
163842892|NCT04908449|591794839|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
163842893|NCT02401308|591794844|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
163842894|NCT02401308|591794845|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
163842895|NCT01518946|591794846|FG000|Open-label Phase|Other|4|||
163842896|NCT01518946|591794847|FG001|Open-label Phase|Other|0|||
163842897|NCT01518946|591794848|FG002|Open-label Phase|Other|0|||
163842898|NCT01518946|591794846|FG000|Randomized Phase (First Intervention)|Other|0|||
163842899|NCT01518946|591794847|FG001|Randomized Phase (First Intervention)|Other|1|||
163842900|NCT01518946|591794848|FG002|Randomized Phase (First Intervention)|Other|0|||
163842901|NCT00381641|591794849|FG000|Overall Study|Withdrawal by Subject|0|||
163842902|NCT00381641|591794850|FG001|Overall Study|Withdrawal by Subject|2|||
163842903|NCT01681368|591796712|FG000|Overall Study|Refused further treatment|1|||
163842904|NCT01681368|591796712|FG000|Overall Study|Refused further follow up|1|||
163842905|NCT03884231|591796713|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
163842906|NCT03884231|591796713|FG000|Overall Study|Subject Withdrew Consent|1|||
163842907|NCT03884231|591796713|FG000|Overall Study|MRI Scan Not Performed|1|||
163842908|NCT00900627|591796714|FG000|Overall Study|Condition under investigation worsened|4|||
163842909|NCT00900627|591796715|FG001|Overall Study|Condition under investigation worsened|0|||
163842910|NCT00900627|591796716|FG002|Overall Study|Condition under investigation worsened|5|||
163842911|NCT00900627|591796717|FG003|Overall Study|Condition under investigation worsened|3|||
163842912|NCT00900627|591796718|FG004|Overall Study|Condition under investigation worsened|0|||
163842913|NCT00900627|591796719|FG005|Overall Study|Condition under investigation worsened|0|||
163842914|NCT00900627|591796714|FG000|Overall Study|Withdrawal by Subject|1|||
163842915|NCT00900627|591796715|FG001|Overall Study|Withdrawal by Subject|0|||
163842916|NCT00900627|591796716|FG002|Overall Study|Withdrawal by Subject|1|||
163842917|NCT00900627|591796717|FG003|Overall Study|Withdrawal by Subject|0|||
163842918|NCT00900627|591796718|FG004|Overall Study|Withdrawal by Subject|1|||
163842919|NCT00900627|591796719|FG005|Overall Study|Withdrawal by Subject|2|||
163842920|NCT00900627|591796714|FG000|Overall Study|Adverse Event|1|||
163842921|NCT00900627|591796715|FG001|Overall Study|Adverse Event|2|||
163842922|NCT00900627|591796716|FG002|Overall Study|Adverse Event|0|||
163842923|NCT00900627|591796717|FG003|Overall Study|Adverse Event|3|||
163842924|NCT00900627|591796718|FG004|Overall Study|Adverse Event|0|||
163842925|NCT00900627|591796719|FG005|Overall Study|Adverse Event|0|||
163842926|NCT00900627|591796714|FG000|Overall Study|Death|0|||
163842927|NCT00900627|591796715|FG001|Overall Study|Death|0|||
163842928|NCT00900627|591796716|FG002|Overall Study|Death|0|||
163842929|NCT00900627|591796717|FG003|Overall Study|Death|0|||
163842930|NCT00900627|591796718|FG004|Overall Study|Death|28|||
163842931|NCT00900627|591796719|FG005|Overall Study|Death|24|||
163842932|NCT00373295|591796720|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163842933|NCT00373295|591796721|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
163842934|NCT00373295|591796722|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163842935|NCT00373295|591796723|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163842936|NCT00373295|591796724|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
163842937|NCT00373295|591796725|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
163842938|NCT00830947|591796726|FG000|Overall Study|Lost to Follow-up|4|||
163842939|NCT00830947|591796727|FG001|Overall Study|Lost to Follow-up|4|||
163842940|NCT01087723|591796733|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
163842941|NCT01087723|591796734|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
163842942|NCT01087723|591796733|FG000|Overall Study|Withdrawal by Subject|10|||
163842943|NCT01087723|591796734|FG001|Overall Study|Withdrawal by Subject|13|||
163842944|NCT01087723|591796733|FG000|Overall Study|Physician Decision|2|||
163842945|NCT01087723|591796734|FG001|Overall Study|Physician Decision|0|||
163842946|NCT01087723|591796733|FG000|Overall Study|Lost to Follow-up|1|||
163842947|NCT01087723|591796734|FG001|Overall Study|Lost to Follow-up|4|||
163842948|NCT01087723|591796733|FG000|Overall Study|Reason Not Specified|1|||
163842949|NCT01087723|591796734|FG001|Overall Study|Reason Not Specified|2|||
163842950|NCT01868035|591796735|FG000|Overall Study|Lost to Follow-up|3|||
163842951|NCT01868035|591796735|FG000|Overall Study|Withdrawal by Subject|1|||
163842952|NCT01868035|591796735|FG000|Overall Study|Progressive Disease|2|||
163842953|NCT01868035|591796735|FG000|Overall Study|Non-compliance|1|||
163842954|NCT01757665|591796741|FG000|Overall Study|Still on Study - Visit Completed|240|||
163842955|NCT01757665|591796742|FG001|Overall Study|Still on Study - Visit Completed|30|||
163842956|NCT01757665|591796741|FG000|Overall Study|Still on Study - Visit Pending|398|||
163842957|NCT01757665|591796742|FG001|Overall Study|Still on Study - Visit Pending|40|||
163842958|NCT01757665|591796741|FG000|Overall Study|Still on Study - Missed Visit|14|||
163842959|NCT01757665|591796742|FG001|Overall Study|Still on Study - Missed Visit|1|||
163949317|NCT00158860|592182873|FG000|Overall Study|Pregnancy|3|||
163949318|NCT00158860|592182874|FG001|Overall Study|Pregnancy|3|||
163949319|NCT00158860|592182873|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
163949320|NCT00158860|592182874|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
163949321|NCT00158860|592182873|FG000|Overall Study|SPONSOR REQUEST|0|||
163842960|NCT01757665|591796741|FG000|Overall Study|Death|25|||
163842961|NCT01757665|591796742|FG001|Overall Study|Death|8|||
163842962|NCT01757665|591796741|FG000|Overall Study|Explant|1|||
163842963|NCT01757665|591796742|FG001|Overall Study|Explant|2|||
163842964|NCT01757665|591796741|FG000|Overall Study|Withdrawal by Subject|10|||
163842965|NCT01757665|591796742|FG001|Overall Study|Withdrawal by Subject|0|||
163842966|NCT01757665|591796741|FG000|Overall Study|Lost to Follow-up|1|||
163842967|NCT01757665|591796742|FG001|Overall Study|Lost to Follow-up|1|||
163842968|NCT01757665|591796741|FG000|Overall Study|Not Implanted with Device|5|||
163842969|NCT01757665|591796742|FG001|Overall Study|Not Implanted with Device|1|||
163842970|NCT01394250|591796743|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
163842971|NCT01394250|591796744|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
163842972|NCT01394250|591796743|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
163842973|NCT01394250|591796744|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
163842974|NCT01865617|591796746|FG000|Overall Study|Death|27|||
163842975|NCT01865617|591796747|FG001|Overall Study|Death|3|||
163842976|NCT01865617|591796748|FG002|Overall Study|Death|1|||
163842977|NCT01865617|591796749|FG003|Overall Study|Death|1|||
163842978|NCT01865617|591796750|FG004|Overall Study|Death|5|||
163842979|NCT01865617|591796751|FG005|Overall Study|Death|1|||
163842980|NCT01865617|591796752|FG006|Overall Study|Death|11|||
163842981|NCT01865617|591796753|FG007|Overall Study|Death|1|||
163842982|NCT01865617|591796754|FG008|Overall Study|Death|11|||
163842983|NCT01865617|591796755|FG009|Overall Study|Death|3|||
163842984|NCT01865617|591796756|FG010|Overall Study|Death|32|||
163842985|NCT01865617|591796757|FG011|Overall Study|Death|6|||
163842986|NCT01865617|591796758|FG012|Overall Study|Death|13|||
163842987|NCT01865617|591796746|FG000|Overall Study|Lost to Follow-up|2|||
163842988|NCT01865617|591796747|FG001|Overall Study|Lost to Follow-up|0|||
163842989|NCT01865617|591796748|FG002|Overall Study|Lost to Follow-up|0|||
163842990|NCT01865617|591796749|FG003|Overall Study|Lost to Follow-up|0|||
163842991|NCT01865617|591796750|FG004|Overall Study|Lost to Follow-up|0|||
163842992|NCT01865617|591796751|FG005|Overall Study|Lost to Follow-up|0|||
163842993|NCT01865617|591796752|FG006|Overall Study|Lost to Follow-up|0|||
163842994|NCT01865617|591796753|FG007|Overall Study|Lost to Follow-up|0|||
163842995|NCT01865617|591796754|FG008|Overall Study|Lost to Follow-up|0|||
163842996|NCT01865617|591796755|FG009|Overall Study|Lost to Follow-up|0|||
163842997|NCT01865617|591796756|FG010|Overall Study|Lost to Follow-up|0|||
163842998|NCT01865617|591796757|FG011|Overall Study|Lost to Follow-up|0|||
163842999|NCT01865617|591796758|FG012|Overall Study|Lost to Follow-up|0|||
163843000|NCT01865617|591796746|FG000|Overall Study|Withdrawal by Subject|1|||
163843001|NCT01865617|591796747|FG001|Overall Study|Withdrawal by Subject|0|||
163843002|NCT01865617|591796748|FG002|Overall Study|Withdrawal by Subject|0|||
163843003|NCT01865617|591796749|FG003|Overall Study|Withdrawal by Subject|0|||
163843004|NCT01865617|591796750|FG004|Overall Study|Withdrawal by Subject|0|||
163843005|NCT01865617|591796751|FG005|Overall Study|Withdrawal by Subject|0|||
163843006|NCT01865617|591796752|FG006|Overall Study|Withdrawal by Subject|0|||
163843007|NCT01865617|591796753|FG007|Overall Study|Withdrawal by Subject|0|||
163843008|NCT01865617|591796754|FG008|Overall Study|Withdrawal by Subject|0|||
163843009|NCT01865617|591796755|FG009|Overall Study|Withdrawal by Subject|0|||
163843010|NCT01865617|591796756|FG010|Overall Study|Withdrawal by Subject|0|||
163843011|NCT01865617|591796757|FG011|Overall Study|Withdrawal by Subject|0|||
163843012|NCT01865617|591796758|FG012|Overall Study|Withdrawal by Subject|0|||
163843013|NCT01865617|591796746|FG000|Overall Study|Patient proceeded to new therapy|0|||
163843014|NCT01865617|591796747|FG001|Overall Study|Patient proceeded to new therapy|0|||
163843015|NCT01865617|591796748|FG002|Overall Study|Patient proceeded to new therapy|0|||
163843016|NCT01865617|591796749|FG003|Overall Study|Patient proceeded to new therapy|0|||
163843017|NCT01865617|591796750|FG004|Overall Study|Patient proceeded to new therapy|2|||
163843018|NCT01865617|591796751|FG005|Overall Study|Patient proceeded to new therapy|0|||
163843019|NCT01865617|591796752|FG006|Overall Study|Patient proceeded to new therapy|0|||
163843020|NCT01865617|591796753|FG007|Overall Study|Patient proceeded to new therapy|0|||
163843021|NCT01865617|591796754|FG008|Overall Study|Patient proceeded to new therapy|0|||
163843022|NCT01865617|591796755|FG009|Overall Study|Patient proceeded to new therapy|0|||
163843023|NCT01865617|591796756|FG010|Overall Study|Patient proceeded to new therapy|0|||
163843024|NCT01865617|591796757|FG011|Overall Study|Patient proceeded to new therapy|0|||
163843025|NCT01865617|591796758|FG012|Overall Study|Patient proceeded to new therapy|0|||
163843026|NCT01865617|591796746|FG000|Overall Study|Other|0|||
163843027|NCT01865617|591796747|FG001|Overall Study|Other|0|||
163843028|NCT01865617|591796748|FG002|Overall Study|Other|0|||
163843029|NCT01865617|591796749|FG003|Overall Study|Other|0|||
163843030|NCT01865617|591796750|FG004|Overall Study|Other|0|||
163843031|NCT01865617|591796751|FG005|Overall Study|Other|0|||
163949322|NCT00158860|592182874|FG001|Overall Study|SPONSOR REQUEST|1|||
163949323|NCT00158860|592182873|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
163949324|NCT00158860|592182874|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
163949325|NCT00158860|592182873|FG000|Overall Study|Closed per sponsor|0|||
163949326|NCT00158860|592182874|FG001|Overall Study|Closed per sponsor|1|||
163949327|NCT04638920|592182875|FG000|Overall Study|Withdrawal by Subject|5|||
163949328|NCT01801735|592182876|FG000|Overall Study|Adverse Event|79|||
163949329|NCT01801735|592182876|FG000|Overall Study|Lack of Efficacy|28|||
163949330|NCT01801735|592182876|FG000|Overall Study|Withdrawal by Subject|27|||
163949331|NCT01801735|592182876|FG000|Overall Study|Protocol Violation|25|||
163949332|NCT01801735|592182876|FG000|Overall Study|Lost to Follow-up|15|||
163949333|NCT01801735|592182876|FG000|Overall Study|Non-compliance with Trial Drug|13|||
163949334|NCT01801735|592182876|FG000|Overall Study|Physician Decision|3|||
163949335|NCT01801735|592182876|FG000|Overall Study|Death|1|||
163949336|NCT01801735|592182876|FG000|Overall Study|Other, including site closure|19|||
163949337|NCT01435616|592182877|FG000|Overall Study|Adverse Event|39|||
163949338|NCT01435616|592182878|FG001|Overall Study|Adverse Event|21|||
163949339|NCT01435616|592182877|FG000|Overall Study|Death|7|||
163949340|NCT01435616|592182878|FG001|Overall Study|Death|2|||
163949341|NCT01435616|592182877|FG000|Overall Study|Lost to Follow-up|22|||
163949342|NCT01435616|592182878|FG001|Overall Study|Lost to Follow-up|13|||
163949343|NCT01435616|592182877|FG000|Overall Study|Protocol Violation|16|||
163949344|NCT01435616|592182878|FG001|Overall Study|Protocol Violation|13|||
163949345|NCT01435616|592182877|FG000|Overall Study|Withdrawal by Subject|66|||
163949346|NCT01435616|592182878|FG001|Overall Study|Withdrawal by Subject|24|||
163949347|NCT01435616|592182877|FG000|Overall Study|Physician Decision|20|||
163949348|NCT01435616|592182878|FG001|Overall Study|Physician Decision|7|||
163949349|NCT01435616|592182877|FG000|Overall Study|Sponsor Decision|1|||
163949350|NCT01435616|592182878|FG001|Overall Study|Sponsor Decision|0|||
163949351|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|Death|1|||
163949352|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|Death|1|||
163949353|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
163949354|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
163949355|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
163949356|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
163949357|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
163949358|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
163949359|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
163949360|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
163949361|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
163949362|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
163949363|NCT00371683|592182880|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
163949364|NCT00371683|592182881|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
163949365|NCT00371683|592182880|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
163949366|NCT00371683|592182881|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
163949367|NCT00371683|592182880|FG000|Follow-Up Period - Randomized Patients|Death|0|||
163949368|NCT00371683|592182881|FG001|Follow-Up Period - Randomized Patients|Death|2|||
163949369|NCT00371683|592182880|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
163949370|NCT00371683|592182881|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
163949371|NCT00371683|592182880|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
163949372|NCT00371683|592182881|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
163949373|NCT01237587|592182882|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
163949374|NCT01237587|592182883|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
163949375|NCT01237587|592182882|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
163949376|NCT01237587|592182883|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
163949377|NCT01237587|592182882|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
163949378|NCT01237587|592182883|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
163949379|NCT01237587|592182882|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
163949380|NCT01237587|592182883|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
163949381|NCT01237587|592182882|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
163949382|NCT01237587|592182883|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
163949383|NCT01237587|592182882|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
163949384|NCT01237587|592182883|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
164047078|NCT00397891|592530579|FG001|Overall Study|Withdrawal by Subject|0|||
164047079|NCT00397891|592530580|FG002|Overall Study|Withdrawal by Subject|0|||
163949385|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
163949386|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
163949387|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
164047080|NCT00397891|592530581|FG003|Overall Study|Withdrawal by Subject|0|||
164047081|NCT00397891|592530582|FG004|Overall Study|Withdrawal by Subject|1|||
164047082|NCT00796224|592530585|FG000|Overall Study|Adverse Event|1|||
163949388|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
163949389|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
163949390|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
163949391|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
163949392|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
163949393|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
163949394|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
163949395|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
163949396|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
163949397|NCT01237587|592182882|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
163949398|NCT01237587|592182883|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
163949399|NCT01237587|592182882|FG000|Taper Phase|Adverse Event|0|||
163949400|NCT01237587|592182883|FG001|Taper Phase|Adverse Event|2|||
163949401|NCT01237587|592182882|FG000|Taper Phase|Protocol Violation|2|||
163949402|NCT01237587|592182883|FG001|Taper Phase|Protocol Violation|0|||
163949403|NCT01237587|592182882|FG000|Taper Phase|Lack of Efficacy|2|||
163949404|NCT01237587|592182883|FG001|Taper Phase|Lack of Efficacy|5|||
163949405|NCT01237587|592182882|FG000|Taper Phase|Parent/Guardian Decision|0|||
163949406|NCT01237587|592182883|FG001|Taper Phase|Parent/Guardian Decision|2|||
163949407|NCT01237587|592182882|FG000|Taper Phase|Sponsor Decision|1|||
163949408|NCT01237587|592182883|FG001|Taper Phase|Sponsor Decision|0|||
163949409|NCT01237587|592182882|FG000|Taper Phase|Withdrawal by Subject|0|||
163949410|NCT01237587|592182883|FG001|Taper Phase|Withdrawal by Subject|1|||
163949411|NCT01011387|592182885|FG000|Overall Study|Withdrawal by Subject|3|||
163949412|NCT01011387|592182885|FG000|Overall Study|Adverse Event|2|||
163949413|NCT01011387|592182885|FG000|Overall Study|Protocol Violation|1|||
163949414|NCT01139580|592182886|FG000|Overall Study|Adverse Event|5|||
163949415|NCT01139580|592182887|FG001|Overall Study|Adverse Event|4|||
163949416|NCT01139580|592182886|FG000|Overall Study|Lost to Follow-up|9|||
163949417|NCT01139580|592182887|FG001|Overall Study|Lost to Follow-up|1|||
163949418|NCT01139580|592182886|FG000|Overall Study|Lack of Efficacy|0|||
163949419|NCT01139580|592182887|FG001|Overall Study|Lack of Efficacy|2|||
163949420|NCT01139580|592182886|FG000|Overall Study|Withdrawal by Subject|6|||
163949421|NCT01139580|592182887|FG001|Overall Study|Withdrawal by Subject|9|||
163949422|NCT01139580|592182886|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
163949423|NCT01139580|592182887|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
163949424|NCT01139580|592182886|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
163949425|NCT01139580|592182887|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
163949426|NCT01139580|592182886|FG000|Overall Study|Misrandomized|1|||
163949427|NCT01139580|592182887|FG001|Overall Study|Misrandomized|0|||
163949428|NCT01139580|592182886|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
163949429|NCT01139580|592182887|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
163949430|NCT01139580|592182886|FG000|Overall Study|Participant Randomization in Error|0|||
163949431|NCT01139580|592182887|FG001|Overall Study|Participant Randomization in Error|1|||
163949432|NCT01285609|592182888|FG000|Randomized|Progressive Disease|41|||
163949433|NCT01285609|592182889|FG001|Randomized|Progressive Disease|61|||
163949434|NCT01285609|592182888|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
163949435|NCT01285609|592182889|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
163949436|NCT01285609|592182888|FG000|Randomized|Study Drug Toxicity|13|||
163949437|NCT01285609|592182889|FG001|Randomized|Study Drug Toxicity|14|||
163949438|NCT01285609|592182888|FG000|Randomized|Death|5|||
163949439|NCT01285609|592182889|FG001|Randomized|Death|7|||
163949440|NCT01285609|592182888|FG000|Randomized|Withdrawal by Subject|8|||
163949441|NCT01285609|592182889|FG001|Randomized|Withdrawal by Subject|11|||
163949442|NCT01285609|592182888|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
163949443|NCT01285609|592182889|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
163949444|NCT01285609|592182888|FG000|Randomized|Undisclosed Reasons|1|||
163949445|NCT01285609|592182889|FG001|Randomized|Undisclosed Reasons|0|||
163949446|NCT01285609|592182888|FG000|Randomized|Randomized but not Treated|4|||
163949447|NCT01285609|592182889|FG001|Randomized|Randomized but not Treated|4|||
163949448|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
163949449|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
163949450|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
163949451|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
163949452|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
163949453|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
163949454|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
163949455|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
163949456|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Death|11|||
163949457|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Death|3|||
163949458|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
163949459|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
163949460|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Not Reported|0|||
163949461|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Not Reported|2|||
163949462|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
163949463|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
163949464|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
163949465|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
163949466|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
163949467|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
163949468|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
163949469|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
163949470|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
163949471|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
163949472|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
163949473|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
163949474|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
163949475|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
163949476|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
163949477|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
163949478|NCT01285609|592182888|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
163949479|NCT01285609|592182889|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
163949480|NCT01285609|592182888|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
163949481|NCT01285609|592182889|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
163949482|NCT01142115|592182890|FG000|First Intervention|Lack of Efficacy|1|||
163949483|NCT01142115|592182891|FG001|First Intervention|Lack of Efficacy|1|||
163949484|NCT01142115|592182890|FG000|First Intervention|Adverse Event|1|||
163949485|NCT01142115|592182891|FG001|First Intervention|Adverse Event|0|||
163949486|NCT03208036|592182892|FG000|Baseline Assessment|Withdrawal by Subject|1|||
163949487|NCT03208036|592182893|FG001|Baseline Assessment|Withdrawal by Subject|1|||
163949488|NCT03208036|592182892|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
163843032|NCT01865617|591796752|FG006|Overall Study|Other|1|||
163843033|NCT01865617|591796753|FG007|Overall Study|Other|0|||
163843034|NCT01865617|591796754|FG008|Overall Study|Other|0|||
163843035|NCT01865617|591796755|FG009|Overall Study|Other|0|||
163843036|NCT01865617|591796756|FG010|Overall Study|Other|0|||
163843037|NCT01865617|591796757|FG011|Overall Study|Other|0|||
163843038|NCT01865617|591796758|FG012|Overall Study|Other|0|||
163843039|NCT02500979|591796759|FG000|Period 1|Hyperglycemia|1|||
163843040|NCT02500979|591796760|FG001|Period 1|Hyperglycemia|0|||
163843041|NCT02500979|591796759|FG000|Period 1|Severe non-compliance to protocol|0|||
163843042|NCT02500979|591796760|FG001|Period 1|Severe non-compliance to protocol|1|||
163843043|NCT02500979|591796759|FG000|Period 1|Adverse Event|1|||
163843044|NCT02500979|591796760|FG001|Period 1|Adverse Event|0|||
163843045|NCT02500979|591796759|FG000|Period 1|Subject decision|2|||
163843046|NCT02500979|591796760|FG001|Period 1|Subject decision|0|||
163843047|NCT02500979|591796759|FG000|Period 2|Change in risk|1|||
163843048|NCT02500979|591796760|FG001|Period 2|Change in risk|0|||
163843049|NCT01613027|591796763|FG000|Overall Study|Lost to Follow-up|5|||
163843050|NCT01613027|591796763|FG000|Overall Study|Switched Physician|1|||
163843051|NCT01613027|591796763|FG000|Overall Study|Lack of Efficacy|1|||
163843052|NCT01613027|591796763|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
163843053|NCT04267614|591796764|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
163843054|NCT04267614|591796764|FG000|Overall Study|Lost to Follow-up|115|||
163843055|NCT03632434|591796772|FG000|Overall Study|Withdrawal by Subject|2|||
163843056|NCT04297241|591796773|FG000|Overall Study|Withdrawal by Subject|1|||
163843057|NCT04297241|591796773|FG000|Overall Study|Adverse Event|1|||
163843058|NCT04297241|591796773|FG000|Overall Study|Physician Decision|3|||
163843059|NCT02836613|591796780|FG000|Overall Study|Accidental drowning|1|||
163843060|NCT02836613|591796781|FG001|Overall Study|Accidental drowning|0|||
163843061|NCT02836613|591796780|FG000|Overall Study|Lost to Follow-up|0|||
163843062|NCT02836613|591796781|FG001|Overall Study|Lost to Follow-up|1|||
163843063|NCT02836613|591796780|FG000|Overall Study|Withdrawal by Subject|0|||
163843064|NCT02836613|591796781|FG001|Overall Study|Withdrawal by Subject|2|||
163843065|NCT03881059|591796782|FG000|Treatment Period - Part A|Adverse Event|1|||
163843066|NCT03881059|591796783|FG001|Treatment Period - Part A|Adverse Event|3|||
163843067|NCT03881059|591796784|FG002|Treatment Period - Part A|Adverse Event|4|||
163843068|NCT03881059|591796782|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
163949489|NCT03208036|592182893|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
163949490|NCT03208036|592182892|FG000|Intervention|Withdrawal by Subject|3|||
163949491|NCT03208036|592182893|FG001|Intervention|Withdrawal by Subject|2|||
163949492|NCT03208036|592182892|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
163843069|NCT03881059|591796783|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
163843070|NCT03881059|591796784|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
163843071|NCT03881059|591796782|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
164047083|NCT00796224|592530586|FG001|Overall Study|Adverse Event|0|||
164047084|NCT00796224|592530585|FG000|Overall Study|Protocol Violation|0|||
164047085|NCT00796224|592530586|FG001|Overall Study|Protocol Violation|1|||
163949493|NCT03208036|592182893|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
163949494|NCT00700778|592182894|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
163949495|NCT02559895|592182900|FG000|Overall Study|Adverse Event|3|||
163949496|NCT02559895|592182901|FG001|Overall Study|Adverse Event|3|||
163949497|NCT02559895|592182902|FG002|Overall Study|Adverse Event|2|||
163949498|NCT02559895|592182903|FG003|Overall Study|Adverse Event|1|||
163949499|NCT02559895|592182900|FG000|Overall Study|Lack of Efficacy|2|||
163949500|NCT02559895|592182901|FG001|Overall Study|Lack of Efficacy|3|||
163949501|NCT02559895|592182902|FG002|Overall Study|Lack of Efficacy|2|||
163949502|NCT02559895|592182903|FG003|Overall Study|Lack of Efficacy|8|||
163949503|NCT02559895|592182900|FG000|Overall Study|Lost to Follow-up|22|||
163949504|NCT02559895|592182901|FG001|Overall Study|Lost to Follow-up|16|||
163949505|NCT02559895|592182902|FG002|Overall Study|Lost to Follow-up|12|||
163949506|NCT02559895|592182903|FG003|Overall Study|Lost to Follow-up|17|||
163949507|NCT02559895|592182900|FG000|Overall Study|Physician Decision|1|||
163949508|NCT02559895|592182901|FG001|Overall Study|Physician Decision|1|||
163949509|NCT02559895|592182902|FG002|Overall Study|Physician Decision|3|||
163949510|NCT02559895|592182903|FG003|Overall Study|Physician Decision|0|||
163949511|NCT02559895|592182900|FG000|Overall Study|Withdrawal by Subject|16|||
163949512|NCT02559895|592182901|FG001|Overall Study|Withdrawal by Subject|9|||
163949513|NCT02559895|592182902|FG002|Overall Study|Withdrawal by Subject|20|||
163949514|NCT02559895|592182903|FG003|Overall Study|Withdrawal by Subject|9|||
163949515|NCT02559895|592182900|FG000|Overall Study|Study Burden|10|||
163949516|NCT02559895|592182901|FG001|Overall Study|Study Burden|16|||
163949517|NCT02559895|592182902|FG002|Overall Study|Study Burden|12|||
163949518|NCT02559895|592182903|FG003|Overall Study|Study Burden|22|||
163949519|NCT02559895|592182900|FG000|Overall Study|Other|1|||
163949520|NCT02559895|592182901|FG001|Overall Study|Other|5|||
163949521|NCT02559895|592182902|FG002|Overall Study|Other|3|||
163949522|NCT02559895|592182903|FG003|Overall Study|Other|3|||
163949523|NCT03762200|592182905|FG000|Overall Study|Death|2|||
163949524|NCT03738423|592182906|FG000|Overall Study|Withdrawal by Subject|9|||
163949525|NCT03738423|592182907|FG001|Overall Study|Withdrawal by Subject|12|||
163949526|NCT03738423|592182908|FG002|Overall Study|Withdrawal by Subject|9|||
163949527|NCT03738423|592182909|FG003|Overall Study|Withdrawal by Subject|12|||
163949528|NCT03738423|592182910|FG004|Overall Study|Withdrawal by Subject|10|||
163949529|NCT03738423|592182906|FG000|Overall Study|Lack of Efficacy|3|||
163949530|NCT03738423|592182907|FG001|Overall Study|Lack of Efficacy|1|||
163949531|NCT03738423|592182908|FG002|Overall Study|Lack of Efficacy|1|||
163949532|NCT03738423|592182909|FG003|Overall Study|Lack of Efficacy|1|||
163949533|NCT03738423|592182910|FG004|Overall Study|Lack of Efficacy|2|||
163949534|NCT03738423|592182906|FG000|Overall Study|Lost to Follow-up|1|||
163949535|NCT03738423|592182907|FG001|Overall Study|Lost to Follow-up|0|||
163949536|NCT03738423|592182908|FG002|Overall Study|Lost to Follow-up|1|||
163949537|NCT03738423|592182909|FG003|Overall Study|Lost to Follow-up|1|||
163949538|NCT03738423|592182910|FG004|Overall Study|Lost to Follow-up|0|||
163949539|NCT03738423|592182906|FG000|Overall Study|Protocol Violation|1|||
163949540|NCT03738423|592182907|FG001|Overall Study|Protocol Violation|0|||
163949541|NCT03738423|592182908|FG002|Overall Study|Protocol Violation|0|||
163949542|NCT03738423|592182909|FG003|Overall Study|Protocol Violation|0|||
163949543|NCT03738423|592182910|FG004|Overall Study|Protocol Violation|1|||
163949544|NCT03738423|592182906|FG000|Overall Study|Physician Decision|0|||
163949545|NCT03738423|592182907|FG001|Overall Study|Physician Decision|0|||
163949546|NCT03738423|592182908|FG002|Overall Study|Physician Decision|1|||
163949547|NCT03738423|592182909|FG003|Overall Study|Physician Decision|0|||
163949548|NCT03738423|592182910|FG004|Overall Study|Physician Decision|1|||
163949549|NCT03738423|592182906|FG000|Overall Study|Death|0|||
163949550|NCT03738423|592182907|FG001|Overall Study|Death|0|||
163949551|NCT03738423|592182908|FG002|Overall Study|Death|0|||
163949552|NCT03738423|592182909|FG003|Overall Study|Death|0|||
163949553|NCT03738423|592182910|FG004|Overall Study|Death|1|||
163949554|NCT03738423|592182906|FG000|Overall Study|Randomized but never treated|0|||
163949555|NCT03738423|592182907|FG001|Overall Study|Randomized but never treated|0|||
163949556|NCT03738423|592182908|FG002|Overall Study|Randomized but never treated|1|||
163949557|NCT03738423|592182909|FG003|Overall Study|Randomized but never treated|1|||
163949558|NCT03738423|592182910|FG004|Overall Study|Randomized but never treated|0|||
163949559|NCT01865747|592182916|FG000|Overall Study (ITT)|Adverse Event|32|||
163949560|NCT01865747|592182917|FG001|Overall Study (ITT)|Adverse Event|31|||
163949561|NCT01865747|592182916|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
163949562|NCT01865747|592182917|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
163949563|NCT01865747|592182916|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
163949564|NCT01865747|592182917|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
163949565|NCT01865747|592182916|FG000|Overall Study (ITT)|Protocol Violation|1|||
164047086|NCT02177812|592530593|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163949566|NCT01865747|592182917|FG001|Overall Study (ITT)|Protocol Violation|1|||
164099713|NCT02100228|592730564|FG000|Overall Study|Other|19|||
163949567|NCT01865747|592182916|FG000|Overall Study (ITT)|Physician Decision|5|||
163949568|NCT01865747|592182917|FG001|Overall Study (ITT)|Physician Decision|2|||
163949569|NCT01865747|592182916|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
163949570|NCT01865747|592182917|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
163949571|NCT01865747|592182916|FG000|Overall Study (ITT)|Sponsor Decision|0|||
163949572|NCT01865747|592182917|FG001|Overall Study (ITT)|Sponsor Decision|1|||
163949573|NCT01865747|592182916|FG000|Overall Study (ITT)|Progressive Disease|122|||
163949574|NCT01865747|592182917|FG001|Overall Study (ITT)|Progressive Disease|158|||
163949575|NCT01865747|592182916|FG000|Overall Study (ITT)|Reason Not Provided|0|||
163949576|NCT01865747|592182917|FG001|Overall Study (ITT)|Reason Not Provided|1|||
163949577|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
163949578|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
163949579|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
163949580|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
163949581|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
163949582|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
163949583|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
163949584|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
163949585|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
163949586|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
163949587|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
163949588|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
163949589|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
163949590|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
163949591|NCT01865747|592182916|FG000|Primary Intent to Treat (PITT)|Other|0|||
163949592|NCT01865747|592182917|FG001|Primary Intent to Treat (PITT)|Other|1|||
163949593|NCT02592876|592182918|FG000|Overall Study|Withdrawal by Subject|3|||
163949594|NCT02592876|592182919|FG001|Overall Study|Withdrawal by Subject|3|||
163949595|NCT02592876|592182918|FG000|Overall Study|Study Termination by Sponsor|32|||
163949596|NCT02592876|592182919|FG001|Overall Study|Study Termination by Sponsor|27|||
163949597|NCT02592876|592182918|FG000|Overall Study|Lost to Follow-up|0|||
163949598|NCT02592876|592182919|FG001|Overall Study|Lost to Follow-up|1|||
163949599|NCT02592876|592182918|FG000|Overall Study|Death|6|||
163949600|NCT02592876|592182919|FG001|Overall Study|Death|9|||
163949601|NCT00867308|592182920|FG000|Overall Study|Death|1|||
163949602|NCT00867308|592182921|FG001|Overall Study|Death|0|||
163949603|NCT00867308|592182920|FG000|Overall Study|Adverse Event|1|||
163949604|NCT00867308|592182921|FG001|Overall Study|Adverse Event|4|||
163949605|NCT00867308|592182920|FG000|Overall Study|Lack of Efficacy|6|||
163949606|NCT00867308|592182921|FG001|Overall Study|Lack of Efficacy|12|||
163949607|NCT00867308|592182920|FG000|Overall Study|Withdrawal by Subject|1|||
163949608|NCT00867308|592182921|FG001|Overall Study|Withdrawal by Subject|2|||
163949609|NCT00611975|592182924|FG000|Overall Study|Withdrawal by Subject|3|||
163949610|NCT00611975|592182925|FG001|Overall Study|Withdrawal by Subject|7|||
163949611|NCT00611975|592182924|FG000|Overall Study|Pregnancy|2|||
163949612|NCT00611975|592182925|FG001|Overall Study|Pregnancy|1|||
163949613|NCT05618912|592182929|FG000|Overall Study|Lost to Follow-up|14|||
163949614|NCT05618912|592182930|FG001|Overall Study|Lost to Follow-up|19|||
163949615|NCT02383056|592184702|FG000|Overall Study|Adverse Event|1|||
163949616|NCT02383056|592184703|FG001|Overall Study|Adverse Event|0|||
163949617|NCT02383056|592184702|FG000|Overall Study|Lost to Follow-up|0|||
163949618|NCT02383056|592184703|FG001|Overall Study|Lost to Follow-up|2|||
163949619|NCT01775475|592184707|FG000|Overall Study|Death|3|||
163949620|NCT01775475|592184708|FG001|Overall Study|Death|3|||
163949621|NCT02074553|592184716|FG000|Intervention Period 1|Family Emergency|0|||
163949622|NCT02074553|592184717|FG001|Intervention Period 1|Family Emergency|0|||
163949623|NCT02074553|592184718|FG002|Intervention Period 1|Family Emergency|0|||
163949624|NCT02074553|592184719|FG003|Intervention Period 1|Family Emergency|1|||
163949625|NCT02074553|592184720|FG004|Intervention Period 1|Family Emergency|0|||
163949626|NCT02074553|592184721|FG005|Intervention Period 1|Family Emergency|0|||
163949627|NCT02074553|592184722|FG006|Intervention Period 1|Family Emergency|0|||
163949628|NCT02074553|592184723|FG007|Intervention Period 1|Family Emergency|0|||
163949629|NCT02074553|592184716|FG000|Washout Period 1|Adverse Event|1|||
163949630|NCT02074553|592184717|FG001|Washout Period 1|Adverse Event|0|||
163949631|NCT02074553|592184718|FG002|Washout Period 1|Adverse Event|0|||
163949632|NCT02074553|592184719|FG003|Washout Period 1|Adverse Event|0|||
163949633|NCT02074553|592184720|FG004|Washout Period 1|Adverse Event|0|||
163949634|NCT02074553|592184721|FG005|Washout Period 1|Adverse Event|0|||
163949635|NCT02074553|592184722|FG006|Washout Period 1|Adverse Event|0|||
163949636|NCT02074553|592184723|FG007|Washout Period 1|Adverse Event|0|||
163949637|NCT02074553|592184716|FG000|Washout Period 1|Physician Decision|0|||
163949638|NCT02074553|592184717|FG001|Washout Period 1|Physician Decision|0|||
163949639|NCT02074553|592184718|FG002|Washout Period 1|Physician Decision|0|||
163949640|NCT02074553|592184719|FG003|Washout Period 1|Physician Decision|1|||
163949641|NCT02074553|592184720|FG004|Washout Period 1|Physician Decision|0|||
163949642|NCT02074553|592184721|FG005|Washout Period 1|Physician Decision|0|||
163843072|NCT03881059|591796783|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
163843073|NCT03881059|591796784|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
163843074|NCT03881059|591796782|FG000|Treatment Period - Part A|Other reasons|2|||
163843075|NCT03881059|591796783|FG001|Treatment Period - Part A|Other reasons|1|||
163843076|NCT03881059|591796784|FG002|Treatment Period - Part A|Other reasons|0|||
163843077|NCT03881059|591796782|FG000|Treatment Period - Part B|Adverse Event|0|||
163843078|NCT03881059|591796783|FG001|Treatment Period - Part B|Adverse Event|0|||
163843079|NCT03881059|591796784|FG002|Treatment Period - Part B|Adverse Event|3|||
163843080|NCT03881059|591796782|FG000|Treatment Period - Part B|Death|0|||
163843081|NCT03881059|591796783|FG001|Treatment Period - Part B|Death|1|||
163843082|NCT03881059|591796784|FG002|Treatment Period - Part B|Death|1|||
163843083|NCT03881059|591796782|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
163843084|NCT03881059|591796783|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
163843085|NCT03881059|591796784|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
163843086|NCT03881059|591796782|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
163843087|NCT03881059|591796783|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
163843088|NCT03881059|591796784|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
163843089|NCT03881059|591796782|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
163843090|NCT03881059|591796783|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
163843091|NCT03881059|591796784|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
163843092|NCT03881059|591796782|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
163843093|NCT03881059|591796783|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
163843094|NCT03881059|591796784|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
163843095|NCT03881059|591796782|FG000|Treatment Period - Part B|Other reasons|4|||
163843096|NCT03881059|591796783|FG001|Treatment Period - Part B|Other reasons|3|||
163843097|NCT03881059|591796784|FG002|Treatment Period - Part B|Other reasons|3|||
163843098|NCT00786474|591796789|FG000|Overall Study|Death|5|||
163843099|NCT00786474|591796790|FG001|Overall Study|Death|4|||
163843100|NCT00786474|591796789|FG000|Overall Study|Withdrawal by Subject|23|||
163843101|NCT00786474|591796790|FG001|Overall Study|Withdrawal by Subject|31|||
163843102|NCT00786474|591796789|FG000|Overall Study|Lost to Follow-up|3|||
163843103|NCT00786474|591796790|FG001|Overall Study|Lost to Follow-up|3|||
163843104|NCT00786474|591796789|FG000|Overall Study|Physician Decision|2|||
163843105|NCT00786474|591796790|FG001|Overall Study|Physician Decision|1|||
163843106|NCT00786474|591796789|FG000|Overall Study|Other|4|||
163843107|NCT00786474|591796790|FG001|Overall Study|Other|4|||
163843108|NCT04276090|591796791|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
163843109|NCT04276090|591796792|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
163843110|NCT01799720|591796793|FG000|Overall Study|Withdrawal by Subject|3|||
163843111|NCT01799720|591796794|FG001|Overall Study|Withdrawal by Subject|0|||
163843112|NCT01799720|591796795|FG002|Overall Study|Withdrawal by Subject|0|||
163843113|NCT01799720|591796793|FG000|Overall Study|Protocol Violation|0|||
163843114|NCT01799720|591796794|FG001|Overall Study|Protocol Violation|1|||
163843115|NCT01799720|591796795|FG002|Overall Study|Protocol Violation|0|||
163843116|NCT01799720|591796793|FG000|Overall Study|Pregnancy|0|||
163843117|NCT01799720|591796794|FG001|Overall Study|Pregnancy|0|||
163843118|NCT01799720|591796795|FG002|Overall Study|Pregnancy|1|||
163843119|NCT05407311|591796811|FG000|Overall Study|Withdrawal by Subject|5|||
163843120|NCT05407311|591796811|FG000|Overall Study|Protocol Violation|3|||
163843121|NCT05407311|591796811|FG000|Overall Study|Physician Decision|1|||
163843122|NCT05407311|591796811|FG000|Overall Study|Non-compliance|1|||
163843123|NCT01265823|591796812|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
163843124|NCT01265823|591796812|FG000|Overall Study|Failure to Return|4|||
163843125|NCT01265823|591796812|FG000|Overall Study|Protocol Violation|1|||
163843126|NCT01265823|591796812|FG000|Overall Study|Participant Request|1|||
163949643|NCT02074553|592184722|FG006|Washout Period 1|Physician Decision|0|||
163949644|NCT02074553|592184723|FG007|Washout Period 1|Physician Decision|0|||
163949645|NCT02074553|592184716|FG000|Washout Period 1|Other|0|||
163949646|NCT02074553|592184717|FG001|Washout Period 1|Other|0|||
163949647|NCT02074553|592184718|FG002|Washout Period 1|Other|0|||
163949648|NCT02074553|592184719|FG003|Washout Period 1|Other|0|||
163949649|NCT02074553|592184720|FG004|Washout Period 1|Other|0|||
163949650|NCT02074553|592184721|FG005|Washout Period 1|Other|1|||
163949651|NCT02074553|592184722|FG006|Washout Period 1|Other|0|||
163949652|NCT02074553|592184723|FG007|Washout Period 1|Other|0|||
163949653|NCT02074553|592184716|FG000|Washout Period 2|Adverse Event|0|||
163949654|NCT02074553|592184717|FG001|Washout Period 2|Adverse Event|0|||
163949655|NCT02074553|592184718|FG002|Washout Period 2|Adverse Event|0|||
163949656|NCT02074553|592184719|FG003|Washout Period 2|Adverse Event|0|||
163949657|NCT02074553|592184720|FG004|Washout Period 2|Adverse Event|0|||
163949658|NCT02074553|592184721|FG005|Washout Period 2|Adverse Event|0|||
163949659|NCT02074553|592184722|FG006|Washout Period 2|Adverse Event|1|||
163949660|NCT02074553|592184723|FG007|Washout Period 2|Adverse Event|0|||
163949661|NCT02074553|592184716|FG000|Washout Period 2|Physician Decision|0|||
163949662|NCT02074553|592184717|FG001|Washout Period 2|Physician Decision|0|||
163949663|NCT02074553|592184718|FG002|Washout Period 2|Physician Decision|0|||
164099714|NCT02100228|592730565|FG001|Overall Study|Other|19|||
163949664|NCT02074553|592184719|FG003|Washout Period 2|Physician Decision|0|||
163843127|NCT01263106|591796813|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
163843128|NCT01263106|591796814|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
163843129|NCT05027074|591796820|FG000|Overall Study|Death|47|||
163843130|NCT05027074|591796821|FG001|Overall Study|Death|42|||
163843131|NCT05027074|591796822|FG002|Overall Study|Death|39|||
163843132|NCT05027074|591796820|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
163843133|NCT05027074|591796821|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
163843134|NCT05027074|591796822|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
163843135|NCT05027074|591796820|FG000|Overall Study|Site Terminated By Sponsor|3|||
163843136|NCT05027074|591796821|FG001|Overall Study|Site Terminated By Sponsor|0|||
163843137|NCT05027074|591796822|FG002|Overall Study|Site Terminated By Sponsor|2|||
163843138|NCT05027074|591796820|FG000|Overall Study|Withdrawal by Subject|13|||
163843139|NCT05027074|591796821|FG001|Overall Study|Withdrawal by Subject|8|||
163843140|NCT05027074|591796822|FG002|Overall Study|Withdrawal by Subject|10|||
163843141|NCT05027074|591796820|FG000|Overall Study|Lost to Follow-up|2|||
163843142|NCT05027074|591796821|FG001|Overall Study|Lost to Follow-up|4|||
163843143|NCT05027074|591796822|FG002|Overall Study|Lost to Follow-up|3|||
163843144|NCT05027074|591796820|FG000|Overall Study|Status Not Recorded|0|||
163843145|NCT05027074|591796821|FG001|Overall Study|Status Not Recorded|0|||
163843146|NCT05027074|591796822|FG002|Overall Study|Status Not Recorded|1|||
163843147|NCT03169881|591796823|FG000|Overall Study|Incomplete Follow-up|10|||
163843148|NCT03169881|591796824|FG001|Overall Study|Incomplete Follow-up|15|||
163843149|NCT03169881|591796823|FG000|Overall Study|Lost to Follow-up|18|||
163843150|NCT03169881|591796824|FG001|Overall Study|Lost to Follow-up|20|||
163843151|NCT03169881|591796823|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
163843152|NCT03169881|591796824|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
163843153|NCT02180438|591796830|FG000|Overall Study|Lost to Follow-up|1|||
163843154|NCT00785707|591796831|FG000|Overall Study|Lost to Follow-up|7|||
163843155|NCT02090634|591796832|FG000|Overall Study|Lost to Follow-up|0|||
163843156|NCT02090634|591796833|FG001|Overall Study|Lost to Follow-up|1|||
163843157|NCT02090634|591796832|FG000|Overall Study|Death|0|||
163843158|NCT02090634|591796833|FG001|Overall Study|Death|1|||
163843159|NCT02090634|591796832|FG000|Overall Study|Protocol Violation|3|||
163843160|NCT02090634|591796833|FG001|Overall Study|Protocol Violation|1|||
163843161|NCT02090634|591796832|FG000|Overall Study|Adverse Event|2|||
163843162|NCT02090634|591796833|FG001|Overall Study|Adverse Event|0|||
163843163|NCT00147225|591796839|FG000|Overall Study|Withdrawal by Subject|1|||
163843164|NCT00147225|591796840|FG001|Overall Study|Withdrawal by Subject|0|||
163843165|NCT00147225|591796841|FG002|Overall Study|Withdrawal by Subject|1|||
163843166|NCT00147225|591796842|FG003|Overall Study|Withdrawal by Subject|0|||
163843167|NCT00147225|591796843|FG004|Overall Study|Withdrawal by Subject|0|||
163843168|NCT00147225|591796844|FG005|Overall Study|Withdrawal by Subject|1|||
163949665|NCT02074553|592184720|FG004|Washout Period 2|Physician Decision|0|||
163949666|NCT02074553|592184721|FG005|Washout Period 2|Physician Decision|1|||
163949667|NCT02074553|592184722|FG006|Washout Period 2|Physician Decision|0|||
163949668|NCT02074553|592184723|FG007|Washout Period 2|Physician Decision|0|||
163949669|NCT02074553|592184716|FG000|Washout Period 2|Lost to Follow-up|0|||
163949670|NCT02074553|592184717|FG001|Washout Period 2|Lost to Follow-up|0|||
163949671|NCT02074553|592184718|FG002|Washout Period 2|Lost to Follow-up|1|||
163949672|NCT02074553|592184719|FG003|Washout Period 2|Lost to Follow-up|0|||
163949673|NCT02074553|592184720|FG004|Washout Period 2|Lost to Follow-up|0|||
163949674|NCT02074553|592184721|FG005|Washout Period 2|Lost to Follow-up|0|||
163949675|NCT02074553|592184722|FG006|Washout Period 2|Lost to Follow-up|0|||
163949676|NCT02074553|592184723|FG007|Washout Period 2|Lost to Follow-up|0|||
163949677|NCT02074553|592184716|FG000|Washout Period 3|Physician Decision|0|||
163949678|NCT02074553|592184717|FG001|Washout Period 3|Physician Decision|0|||
163949679|NCT02074553|592184718|FG002|Washout Period 3|Physician Decision|0|||
163949680|NCT02074553|592184719|FG003|Washout Period 3|Physician Decision|0|||
163949681|NCT02074553|592184720|FG004|Washout Period 3|Physician Decision|0|||
163949682|NCT02074553|592184721|FG005|Washout Period 3|Physician Decision|0|||
163949683|NCT02074553|592184722|FG006|Washout Period 3|Physician Decision|0|||
163949684|NCT02074553|592184723|FG007|Washout Period 3|Physician Decision|1|||
163949685|NCT02342743|592184724|FG000|Baseline Period|Withdrawal by Subject|3|||
163949686|NCT02342743|592184724|FG000|Baseline Period|Lost to Follow-up|2|||
163949687|NCT02342743|592184724|FG000|Baseline Period|Change in prophylactic medication|3|||
163949688|NCT02342743|592184724|FG000|Baseline Period|Screening failure regarding baseline|7|||
163949689|NCT02342743|592184724|FG000|Treatment Period|Withdrawal by Subject|2|||
163949690|NCT02342743|592184724|FG000|Treatment Period|Lost to Follow-up|8|||
164148618|NCT04895982|592904914|FG003|Overall Study|Protocol Violation|1|||
163843169|NCT00147225|591796839|FG000|Overall Study|Adverse Event|0|||
163843170|NCT00147225|591796840|FG001|Overall Study|Adverse Event|0|||
163843171|NCT00147225|591796841|FG002|Overall Study|Adverse Event|1|||
163843172|NCT00147225|591796842|FG003|Overall Study|Adverse Event|1|||
163843173|NCT00147225|591796843|FG004|Overall Study|Adverse Event|0|||
163843174|NCT00147225|591796844|FG005|Overall Study|Adverse Event|0|||
163949691|NCT02342743|592184724|FG000|Treatment Period|Change in prophylactic medication|1|||
163949692|NCT00686725|592184725|FG000|Overall Study|Adverse Event|1|||
163949693|NCT00686725|592184726|FG001|Overall Study|Adverse Event|1|||
163949694|NCT00686725|592184725|FG000|Overall Study|Progressive Disease|17|||
163949695|NCT00686725|592184726|FG001|Overall Study|Progressive Disease|23|||
163949696|NCT00686725|592184725|FG000|Overall Study|Lost to Follow-up|7|||
163949697|NCT00686725|592184726|FG001|Overall Study|Lost to Follow-up|5|||
163949698|NCT00686725|592184725|FG000|Overall Study|Death|6|||
163949699|NCT00686725|592184726|FG001|Overall Study|Death|3|||
163949700|NCT00686725|592184725|FG000|Overall Study|Withdrawal by Subject|13|||
163949701|NCT00686725|592184726|FG001|Overall Study|Withdrawal by Subject|4|||
163949702|NCT00686725|592184725|FG000|Overall Study|Protocol Violation|1|||
163949703|NCT00686725|592184726|FG001|Overall Study|Protocol Violation|3|||
163949704|NCT00686725|592184725|FG000|Overall Study|Other|1|||
163949705|NCT00686725|592184726|FG001|Overall Study|Other|3|||
163949706|NCT04875676|592184727|FG000|Overall Study|Lost to Follow-up|1|||
163949707|NCT04875676|592184728|FG001|Overall Study|Lost to Follow-up|0|||
163949708|NCT04875676|592184729|FG002|Overall Study|Lost to Follow-up|0|||
163949709|NCT03064035|592184730|FG000|Overall Study|Did not receive allocated intervention|4|||
163949710|NCT03064035|592184731|FG001|Overall Study|Did not receive allocated intervention|2|||
163949711|NCT03064035|592184730|FG000|Overall Study|Lost to Follow-up|1|||
163949712|NCT03064035|592184731|FG001|Overall Study|Lost to Follow-up|1|||
163949713|NCT03602066|592184732|FG000|Overall Study|Withdrawal by Subject|2|||
163949714|NCT03602066|592184733|FG001|Overall Study|Withdrawal by Subject|0|||
163949715|NCT03602066|592184732|FG000|Overall Study|Physician Decision|1|||
163949716|NCT03602066|592184733|FG001|Overall Study|Physician Decision|0|||
163949717|NCT00092495|592184734|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
163949718|NCT00092495|592184735|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
163949719|NCT00092495|592184736|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163949720|NCT00092495|592184737|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
163949721|NCT00092495|592184738|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
163949722|NCT00092495|592184734|FG000|Base Study Vaccination Period|Extended|0|||
163949723|NCT00092495|592184735|FG001|Base Study Vaccination Period|Extended|0|||
163949724|NCT00092495|592184736|FG002|Base Study Vaccination Period|Extended|0|||
163949725|NCT00092495|592184737|FG003|Base Study Vaccination Period|Extended|1|||
163949726|NCT00092495|592184738|FG004|Base Study Vaccination Period|Extended|0|||
163949727|NCT00092495|592184734|FG000|Base Study Vaccination Period|*Clinical AE|1|||
163949728|NCT00092495|592184735|FG001|Base Study Vaccination Period|*Clinical AE|0|||
163949729|NCT00092495|592184736|FG002|Base Study Vaccination Period|*Clinical AE|1|||
163949730|NCT00092495|592184737|FG003|Base Study Vaccination Period|*Clinical AE|2|||
163949731|NCT00092495|592184738|FG004|Base Study Vaccination Period|*Clinical AE|0|||
163949732|NCT00092495|592184734|FG000|Base Study Vaccination Period|*Other reasons|1|||
163949733|NCT00092495|592184735|FG001|Base Study Vaccination Period|*Other reasons|0|||
163949734|NCT00092495|592184736|FG002|Base Study Vaccination Period|*Other reasons|0|||
163949735|NCT00092495|592184737|FG003|Base Study Vaccination Period|*Other reasons|1|||
163949736|NCT00092495|592184738|FG004|Base Study Vaccination Period|*Other reasons|0|||
163949737|NCT00092495|592184734|FG000|Base Study Vaccination Period|*Pregnancy|0|||
163949738|NCT00092495|592184735|FG001|Base Study Vaccination Period|*Pregnancy|2|||
163949739|NCT00092495|592184736|FG002|Base Study Vaccination Period|*Pregnancy|5|||
163949740|NCT00092495|592184737|FG003|Base Study Vaccination Period|*Pregnancy|7|||
163949741|NCT00092495|592184738|FG004|Base Study Vaccination Period|*Pregnancy|0|||
163949742|NCT00092495|592184734|FG000|Base Study Vaccination Period|Adverse Event|1|||
163949743|NCT00092495|592184735|FG001|Base Study Vaccination Period|Adverse Event|0|||
163949744|NCT00092495|592184736|FG002|Base Study Vaccination Period|Adverse Event|0|||
163949745|NCT00092495|592184737|FG003|Base Study Vaccination Period|Adverse Event|3|||
163949746|NCT00092495|592184738|FG004|Base Study Vaccination Period|Adverse Event|0|||
163949747|NCT00092495|592184734|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
163949748|NCT00092495|592184735|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
163949749|NCT00092495|592184736|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
163949750|NCT00092495|592184737|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
163949751|NCT00092495|592184738|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
163949752|NCT00092495|592184734|FG000|Base Study Vaccination Period|Moved|3|||
163949753|NCT00092495|592184735|FG001|Base Study Vaccination Period|Moved|1|||
163949754|NCT00092495|592184736|FG002|Base Study Vaccination Period|Moved|2|||
163949755|NCT00092495|592184737|FG003|Base Study Vaccination Period|Moved|2|||
163949756|NCT00092495|592184738|FG004|Base Study Vaccination Period|Moved|0|||
163949757|NCT00092495|592184734|FG000|Base Study Vaccination Period|Other|1|||
163949758|NCT00092495|592184735|FG001|Base Study Vaccination Period|Other|1|||
163949759|NCT00092495|592184736|FG002|Base Study Vaccination Period|Other|0|||
163949760|NCT00092495|592184737|FG003|Base Study Vaccination Period|Other|2|||
163949761|NCT00092495|592184738|FG004|Base Study Vaccination Period|Other|0|||
163949762|NCT00092495|592184734|FG000|Base Study Vaccination Period|Pregnancy|2|||
163949763|NCT00092495|592184735|FG001|Base Study Vaccination Period|Pregnancy|0|||
164047087|NCT02177812|592530594|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
163949764|NCT00092495|592184736|FG002|Base Study Vaccination Period|Pregnancy|0|||
163843175|NCT00147225|591796839|FG000|Overall Study|Screen Failure|0|||
163843176|NCT00147225|591796840|FG001|Overall Study|Screen Failure|0|||
163843177|NCT00147225|591796841|FG002|Overall Study|Screen Failure|0|||
163843178|NCT00147225|591796842|FG003|Overall Study|Screen Failure|0|||
163843179|NCT00147225|591796843|FG004|Overall Study|Screen Failure|1|||
163843180|NCT00147225|591796844|FG005|Overall Study|Screen Failure|0|||
163843181|NCT00147225|591796839|FG000|Overall Study|Chemotherapy Changed|0|||
163843182|NCT00147225|591796840|FG001|Overall Study|Chemotherapy Changed|0|||
163949765|NCT00092495|592184737|FG003|Base Study Vaccination Period|Pregnancy|0|||
163949766|NCT00092495|592184738|FG004|Base Study Vaccination Period|Pregnancy|0|||
163949767|NCT00092495|592184734|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
163949768|NCT00092495|592184735|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
163949769|NCT00092495|592184736|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
163949770|NCT00092495|592184737|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
163949771|NCT00092495|592184738|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
163949772|NCT00092495|592184734|FG000|Base Study Vaccination Period|Protocol Violation|1|||
163949773|NCT00092495|592184735|FG001|Base Study Vaccination Period|Protocol Violation|0|||
163949774|NCT00092495|592184736|FG002|Base Study Vaccination Period|Protocol Violation|0|||
163949775|NCT00092495|592184737|FG003|Base Study Vaccination Period|Protocol Violation|0|||
163949776|NCT00092495|592184738|FG004|Base Study Vaccination Period|Protocol Violation|0|||
163949777|NCT00092495|592184734|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
163949778|NCT00092495|592184735|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
163949779|NCT00092495|592184736|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
163949780|NCT00092495|592184737|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
163949781|NCT00092495|592184738|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
163949782|NCT00092495|592184734|FG000|Base Study Follow-up Period|Extended|0|||
163949783|NCT00092495|592184735|FG001|Base Study Follow-up Period|Extended|0|||
163949784|NCT00092495|592184736|FG002|Base Study Follow-up Period|Extended|1|||
163949785|NCT00092495|592184737|FG003|Base Study Follow-up Period|Extended|2|||
163949786|NCT00092495|592184738|FG004|Base Study Follow-up Period|Extended|0|||
163949787|NCT00092495|592184734|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
163949788|NCT00092495|592184735|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
163949789|NCT00092495|592184736|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
163949790|NCT00092495|592184737|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
163949791|NCT00092495|592184738|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
163949792|NCT00092495|592184734|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
163949793|NCT00092495|592184735|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
163949794|NCT00092495|592184736|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
163949795|NCT00092495|592184737|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
163949796|NCT00092495|592184738|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
163949797|NCT03103763|592184741|FG000|Overall Study|Death|15|||
163949798|NCT03103763|592184742|FG001|Overall Study|Death|5|||
163949799|NCT03103763|592184743|FG002|Overall Study|Death|5|||
163949800|NCT03103763|592184741|FG000|Overall Study|Withdrawal by Subject|0|||
163949801|NCT03103763|592184742|FG001|Overall Study|Withdrawal by Subject|3|||
163949802|NCT03103763|592184743|FG002|Overall Study|Withdrawal by Subject|2|||
163949803|NCT00938470|592184744|FG000|Overall Study|Disease Progression|3|||
163949804|NCT00938470|592184745|FG001|Overall Study|Disease Progression|0|||
163949805|NCT00938470|592184744|FG000|Overall Study|Alternate Treatment|1|||
163949806|NCT00938470|592184745|FG001|Overall Study|Alternate Treatment|0|||
163949807|NCT00938470|592184744|FG000|Overall Study|Death|3|||
163949808|NCT00938470|592184745|FG001|Overall Study|Death|2|||
163949809|NCT00938470|592184744|FG000|Overall Study|Other Reason|0|||
163949810|NCT00938470|592184745|FG001|Overall Study|Other Reason|1|||
163949811|NCT02336178|592184746|FG000|Overall Study|Lost to Follow-up|1|||
163949812|NCT02336178|592184746|FG000|Overall Study|Protocol Violation|1|||
163949813|NCT02336178|592184746|FG000|Overall Study|Withdrawal by Subject|1|||
163949814|NCT02336178|592184746|FG000|Overall Study|Other|1|||
163949815|NCT03245151|592184747|FG000|Overall Study|Withdrawal by Subject|2|||
163949816|NCT03245151|592184748|FG001|Overall Study|Withdrawal by Subject|0|||
163949817|NCT03245151|592184749|FG002|Overall Study|Withdrawal by Subject|0|||
163949818|NCT03245151|592184750|FG003|Overall Study|Withdrawal by Subject|2|||
163949819|NCT03245151|592184751|FG004|Overall Study|Withdrawal by Subject|1|||
163949820|NCT03245151|592184747|FG000|Overall Study|Death|3|||
163949821|NCT03245151|592184748|FG001|Overall Study|Death|14|||
163949822|NCT03245151|592184749|FG002|Overall Study|Death|9|||
163843183|NCT00147225|591796841|FG002|Overall Study|Chemotherapy Changed|0|||
163949823|NCT03245151|592184750|FG003|Overall Study|Death|16|||
163949824|NCT03245151|592184751|FG004|Overall Study|Death|7|||
163949825|NCT03245151|592184747|FG000|Overall Study|Sponsor's decision|0|||
163949826|NCT03245151|592184748|FG001|Overall Study|Sponsor's decision|1|||
163949827|NCT03245151|592184749|FG002|Overall Study|Sponsor's decision|0|||
164148619|NCT04895982|592904915|FG004|Overall Study|Protocol Violation|1|||
163843184|NCT00147225|591796842|FG003|Overall Study|Chemotherapy Changed|0|||
163843185|NCT00147225|591796843|FG004|Overall Study|Chemotherapy Changed|0|||
163949828|NCT03245151|592184750|FG003|Overall Study|Sponsor's decision|0|||
163949829|NCT03245151|592184751|FG004|Overall Study|Sponsor's decision|0|||
163949830|NCT01970345|592184752|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
163949831|NCT01970345|592184753|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
163949832|NCT01970345|592184752|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
163949833|NCT01970345|592184753|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
163949834|NCT01346475|592184754|FG000|First Intervention|Lost to Follow-up|4|||
163949835|NCT01346475|592184755|FG001|First Intervention|Lost to Follow-up|3|||
163949836|NCT01552603|592184756|FG000|Overall Study|Physician Decision|1|||
163949837|NCT00618618|592184757|FG000|Overall Study|Patient Request|0|||
163949838|NCT00618618|592184758|FG001|Overall Study|Patient Request|0|||
163949839|NCT00618618|592184759|FG002|Overall Study|Patient Request|2|||
163949840|NCT00618618|592184760|FG003|Overall Study|Patient Request|0|||
163949841|NCT00618618|592184757|FG000|Overall Study|Inability to Complete Study Procedures|0|||
163843186|NCT00147225|591796844|FG005|Overall Study|Chemotherapy Changed|1|||
163843187|NCT01032044|591796847|FG000|Overall Study|Protocol Violation|14|||
163843188|NCT01032044|591796848|FG001|Overall Study|Protocol Violation|8|||
163843189|NCT01032044|591796847|FG000|Overall Study|Adverse Event|0|||
163843190|NCT01032044|591796848|FG001|Overall Study|Adverse Event|1|||
163843191|NCT01032044|591796847|FG000|Overall Study|Lost to Follow-up|11|||
163843192|NCT01032044|591796848|FG001|Overall Study|Lost to Follow-up|11|||
163843193|NCT01567865|591796855|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
163843194|NCT01567865|591796856|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
163843195|NCT01567865|591796857|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
163949842|NCT00618618|592184758|FG001|Overall Study|Inability to Complete Study Procedures|1|||
163949843|NCT00618618|592184759|FG002|Overall Study|Inability to Complete Study Procedures|0|||
163949844|NCT00618618|592184760|FG003|Overall Study|Inability to Complete Study Procedures|0|||
163949845|NCT00618618|592184757|FG000|Overall Study|Lost to Follow-up|3|||
163949846|NCT00618618|592184758|FG001|Overall Study|Lost to Follow-up|0|||
163949847|NCT00618618|592184759|FG002|Overall Study|Lost to Follow-up|0|||
163949848|NCT00618618|592184760|FG003|Overall Study|Lost to Follow-up|1|||
163949849|NCT00618618|592184757|FG000|Overall Study|Non-compliance|1|||
163949850|NCT00618618|592184758|FG001|Overall Study|Non-compliance|1|||
163949851|NCT00618618|592184759|FG002|Overall Study|Non-compliance|0|||
163949852|NCT00618618|592184760|FG003|Overall Study|Non-compliance|0|||
163949853|NCT00618618|592184757|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
163949854|NCT00618618|592184758|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
163949855|NCT00618618|592184759|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
163949856|NCT00618618|592184760|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
163949857|NCT00618618|592184757|FG000|Overall Study|Death|0|||
163949858|NCT00618618|592184758|FG001|Overall Study|Death|1|||
163949859|NCT00618618|592184759|FG002|Overall Study|Death|0|||
163949860|NCT00618618|592184760|FG003|Overall Study|Death|0|||
163949861|NCT00621777|592184764|FG000|Open Phase|Adverse Event|20|||
163949862|NCT00621777|592184765|FG001|Open Phase|Adverse Event|0|||
163949863|NCT00621777|592184764|FG000|Open Phase|Did not abstain during open phase|56|||
163949864|NCT00621777|592184765|FG001|Open Phase|Did not abstain during open phase|0|||
163949865|NCT00621777|592184764|FG000|Open Phase|Withdrawal by Subject|17|||
163949866|NCT00621777|592184765|FG001|Open Phase|Withdrawal by Subject|0|||
163949867|NCT00621777|592184764|FG000|Open Phase|administrative|13|||
163949868|NCT00621777|592184765|FG001|Open Phase|administrative|0|||
163949869|NCT00621777|592184764|FG000|Open Phase|Lost to Follow-up|10|||
163949870|NCT00621777|592184765|FG001|Open Phase|Lost to Follow-up|0|||
163949871|NCT00621777|592184764|FG000|Randomized Phase|Adverse Event|3|||
163949872|NCT00621777|592184765|FG001|Randomized Phase|Adverse Event|3|||
163949873|NCT00621777|592184764|FG000|Randomized Phase|Lost to Follow-up|3|||
163949874|NCT00621777|592184765|FG001|Randomized Phase|Lost to Follow-up|3|||
163949875|NCT00621777|592184764|FG000|Randomized Phase|Withdrawal by Subject|1|||
163949876|NCT00621777|592184765|FG001|Randomized Phase|Withdrawal by Subject|9|||
163949877|NCT00621777|592184764|FG000|Randomized Phase|administrative|0|||
163949878|NCT00621777|592184765|FG001|Randomized Phase|administrative|3|||
163949879|NCT00621777|592184764|FG000|Randomized Phase|Death|0|||
163949880|NCT00621777|592184765|FG001|Randomized Phase|Death|1|||
163949881|NCT01236365|592184766|FG000|Overall Study|Lost to Follow-up|0|||
163949882|NCT01236365|592184767|FG001|Overall Study|Lost to Follow-up|2|||
163949883|NCT01236365|592184766|FG000|Overall Study|Moved Out of State|1|||
163949884|NCT01236365|592184767|FG001|Overall Study|Moved Out of State|0|||
163949885|NCT01236365|592184766|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
163949886|NCT01236365|592184767|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
163949887|NCT00558259|592184770|FG000|Overall Study|Adverse Event|50|||
163949888|NCT00558259|592184771|FG001|Overall Study|Adverse Event|81|||
163949889|NCT00558259|592184770|FG000|Overall Study|Protocol Violation|9|||
163949890|NCT00558259|592184771|FG001|Overall Study|Protocol Violation|5|||
163949891|NCT00558259|592184770|FG000|Overall Study|Withdrawal by Subject|12|||
163949892|NCT00558259|592184771|FG001|Overall Study|Withdrawal by Subject|13|||
163949893|NCT00700258|592184778|FG000|Overall Study|Premature discontinuation of documentation|136|||
163949894|NCT00700258|592184778|FG000|Overall Study|Type of study end not documented|1|||
163949895|NCT00700258|592184778|FG000|Overall Study|Lost to Follow-up|81|||
163949896|NCT00700258|592184778|FG000|Overall Study|Premature discontinuation of therapy|1013|||
163949897|NCT00473265|592184779|FG000|Overall Study|Unrelated adverse event|5|||
163949898|NCT00473265|592184779|FG000|Overall Study|Off treatment early|15|||
163949899|NCT02663518|592184782|FG000|Part 1: Phase 1a Escalation|Death|0|||
163949900|NCT02663518|592184783|FG001|Part 1: Phase 1a Escalation|Death|0|||
163949901|NCT02663518|592184784|FG002|Part 1: Phase 1a Escalation|Death|1|||
163949902|NCT02663518|592184785|FG003|Part 1: Phase 1a Escalation|Death|0|||
163949903|NCT02663518|592184786|FG004|Part 1: Phase 1a Escalation|Death|0|||
163949904|NCT02663518|592184787|FG005|Part 1: Phase 1a Escalation|Death|0|||
163949905|NCT02663518|592184788|FG006|Part 1: Phase 1a Escalation|Death|0|||
163949906|NCT02663518|592184789|FG007|Part 1: Phase 1a Escalation|Death|0|||
163949907|NCT02663518|592184790|FG008|Part 1: Phase 1a Escalation|Death|0|||
163949908|NCT02663518|592184791|FG009|Part 1: Phase 1a Escalation|Death|0|||
163949909|NCT02663518|592184792|FG010|Part 1: Phase 1a Escalation|Death|0|||
163949910|NCT02663518|592184793|FG011|Part 1: Phase 1a Escalation|Death|0|||
163949911|NCT02663518|592184794|FG012|Part 1: Phase 1a Escalation|Death|0|||
163949912|NCT02663518|592184795|FG013|Part 1: Phase 1a Escalation|Death|0|||
163949913|NCT02663518|592184782|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949914|NCT02663518|592184783|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949915|NCT02663518|592184784|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
163949916|NCT02663518|592184785|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949917|NCT02663518|592184786|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949918|NCT02663518|592184787|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949919|NCT02663518|592184788|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949920|NCT02663518|592184789|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949921|NCT02663518|592184790|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949922|NCT02663518|592184791|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949923|NCT02663518|592184792|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949924|NCT02663518|592184793|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949925|NCT02663518|592184794|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949926|NCT02663518|592184795|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
163949927|NCT02663518|592184782|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
163949928|NCT02663518|592184783|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
163949929|NCT02663518|592184784|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
163949930|NCT02663518|592184785|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
163949931|NCT02663518|592184786|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949932|NCT02663518|592184787|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949933|NCT02663518|592184788|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949934|NCT02663518|592184789|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949935|NCT02663518|592184790|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949936|NCT02663518|592184791|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949937|NCT02663518|592184792|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949938|NCT02663518|592184793|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949939|NCT02663518|592184794|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949940|NCT02663518|592184795|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
163949941|NCT02663518|592184782|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
163949942|NCT02663518|592184783|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949943|NCT02663518|592184784|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
163949944|NCT02663518|592184785|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
163949945|NCT02663518|592184786|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949946|NCT02663518|592184787|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949947|NCT02663518|592184788|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949948|NCT02663518|592184789|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949949|NCT02663518|592184790|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949950|NCT02663518|592184791|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949951|NCT02663518|592184792|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949952|NCT02663518|592184793|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949953|NCT02663518|592184794|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949954|NCT02663518|592184795|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
163949955|NCT02663518|592184782|FG000|Part 1: Phase 1a Escalation|Other|0|||
163949956|NCT02663518|592184783|FG001|Part 1: Phase 1a Escalation|Other|0|||
163949957|NCT02663518|592184784|FG002|Part 1: Phase 1a Escalation|Other|2|||
163949958|NCT02663518|592184785|FG003|Part 1: Phase 1a Escalation|Other|0|||
163949959|NCT02663518|592184786|FG004|Part 1: Phase 1a Escalation|Other|0|||
163949960|NCT02663518|592184787|FG005|Part 1: Phase 1a Escalation|Other|0|||
163949961|NCT02663518|592184788|FG006|Part 1: Phase 1a Escalation|Other|0|||
163949962|NCT02663518|592184789|FG007|Part 1: Phase 1a Escalation|Other|0|||
163949963|NCT02663518|592184790|FG008|Part 1: Phase 1a Escalation|Other|0|||
163949964|NCT02663518|592184791|FG009|Part 1: Phase 1a Escalation|Other|0|||
163949965|NCT02663518|592184792|FG010|Part 1: Phase 1a Escalation|Other|0|||
163949966|NCT02663518|592184793|FG011|Part 1: Phase 1a Escalation|Other|0|||
163949967|NCT02663518|592184794|FG012|Part 1: Phase 1a Escalation|Other|0|||
163949968|NCT02663518|592184795|FG013|Part 1: Phase 1a Escalation|Other|0|||
163949969|NCT02663518|592184782|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949970|NCT02663518|592184783|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949971|NCT02663518|592184784|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949972|NCT02663518|592184785|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949973|NCT02663518|592184786|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
163949974|NCT02663518|592184787|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949975|NCT02663518|592184788|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
163949976|NCT02663518|592184789|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
163949977|NCT02663518|592184790|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949978|NCT02663518|592184791|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949979|NCT02663518|592184792|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949980|NCT02663518|592184793|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949981|NCT02663518|592184794|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949982|NCT02663518|592184795|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
163949983|NCT02663518|592184782|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949984|NCT02663518|592184783|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949985|NCT02663518|592184784|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949986|NCT02663518|592184785|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949987|NCT02663518|592184786|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
163949988|NCT02663518|592184787|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949989|NCT02663518|592184788|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
163949990|NCT02663518|592184789|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
163949991|NCT02663518|592184790|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949992|NCT02663518|592184791|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949993|NCT02663518|592184792|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949994|NCT02663518|592184793|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949995|NCT02663518|592184794|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949996|NCT02663518|592184795|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
163949997|NCT02663518|592184782|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163949998|NCT02663518|592184783|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163949999|NCT02663518|592184784|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950000|NCT02663518|592184785|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950001|NCT02663518|592184786|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
163950002|NCT02663518|592184787|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950003|NCT02663518|592184788|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950004|NCT02663518|592184789|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
164047088|NCT02177812|592530595|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164047089|NCT02177812|592530596|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164047090|NCT02177812|592530597|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164047091|NCT02177812|592530598|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
164047092|NCT02177812|592530599|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
164047093|NCT02177812|592530600|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
164047094|NCT02177812|592530601|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
164047095|NCT02177812|592530593|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047096|NCT02177812|592530594|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047097|NCT02177812|592530595|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047098|NCT02177812|592530596|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047099|NCT02177812|592530597|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047100|NCT02177812|592530598|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
164047101|NCT02177812|592530599|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
164047102|NCT02177812|592530600|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047103|NCT02177812|592530601|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
164047104|NCT02177812|592530593|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164047105|NCT02177812|592530594|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164047106|NCT02177812|592530595|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164047107|NCT02177812|592530596|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164047108|NCT02177812|592530597|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164047109|NCT02177812|592530598|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164047110|NCT02177812|592530599|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
164047111|NCT02177812|592530600|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
164047112|NCT02177812|592530601|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
164047113|NCT00089999|592530602|FG000|Overall Study|Adverse Event|4|||
164047114|NCT00089999|592530603|FG001|Overall Study|Adverse Event|7|||
163950005|NCT02663518|592184790|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950006|NCT02663518|592184791|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950007|NCT02663518|592184792|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950008|NCT02663518|592184793|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950009|NCT02663518|592184794|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950010|NCT02663518|592184795|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
163950011|NCT02663518|592184782|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950012|NCT02663518|592184783|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950013|NCT02663518|592184784|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950014|NCT02663518|592184785|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950015|NCT02663518|592184786|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
163950016|NCT02663518|592184787|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
163950017|NCT02663518|592184788|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
163950018|NCT02663518|592184789|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
163950019|NCT02663518|592184790|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950020|NCT02663518|592184791|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950021|NCT02663518|592184792|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950022|NCT02663518|592184793|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950023|NCT02663518|592184794|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950024|NCT02663518|592184795|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
163950025|NCT02663518|592184782|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950026|NCT02663518|592184783|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950027|NCT02663518|592184784|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950028|NCT02663518|592184785|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950029|NCT02663518|592184786|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
163950030|NCT02663518|592184787|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950031|NCT02663518|592184788|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
163950032|NCT02663518|592184789|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950033|NCT02663518|592184790|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950034|NCT02663518|592184791|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950035|NCT02663518|592184792|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950036|NCT02663518|592184793|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950037|NCT02663518|592184794|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950038|NCT02663518|592184795|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
163950039|NCT02663518|592184782|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950040|NCT02663518|592184783|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950041|NCT02663518|592184784|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950042|NCT02663518|592184785|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950043|NCT02663518|592184786|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950044|NCT02663518|592184787|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950045|NCT02663518|592184788|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
163950046|NCT02663518|592184789|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950047|NCT02663518|592184790|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950048|NCT02663518|592184791|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950049|NCT02663518|592184792|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950050|NCT02663518|592184793|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950051|NCT02663518|592184794|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950052|NCT02663518|592184795|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
163950053|NCT02663518|592184782|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
163950054|NCT02663518|592184783|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
163950055|NCT02663518|592184784|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
163950056|NCT02663518|592184785|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
163950057|NCT02663518|592184786|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
163950058|NCT02663518|592184787|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
163950059|NCT02663518|592184788|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
163950060|NCT02663518|592184789|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
163950061|NCT02663518|592184790|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
163950062|NCT02663518|592184791|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
163950063|NCT02663518|592184792|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
163950064|NCT02663518|592184793|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
163950065|NCT02663518|592184794|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
163950066|NCT02663518|592184795|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
163950067|NCT02663518|592184782|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950068|NCT02663518|592184783|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950069|NCT02663518|592184784|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950070|NCT02663518|592184785|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950071|NCT02663518|592184786|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950072|NCT02663518|592184787|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950073|NCT02663518|592184788|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950074|NCT02663518|592184789|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950075|NCT02663518|592184790|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950076|NCT02663518|592184791|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950077|NCT02663518|592184792|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950078|NCT02663518|592184793|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950079|NCT02663518|592184794|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
163950080|NCT02663518|592184795|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
163950081|NCT02663518|592184782|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950082|NCT02663518|592184783|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950083|NCT02663518|592184784|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950084|NCT02663518|592184785|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950085|NCT02663518|592184786|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950086|NCT02663518|592184787|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950087|NCT02663518|592184788|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950088|NCT02663518|592184789|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950089|NCT02663518|592184790|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950090|NCT02663518|592184791|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950091|NCT02663518|592184792|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950092|NCT02663518|592184793|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
163950093|NCT02663518|592184794|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950094|NCT02663518|592184795|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
163950095|NCT02663518|592184782|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950096|NCT02663518|592184783|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950097|NCT02663518|592184784|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950098|NCT02663518|592184785|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950099|NCT02663518|592184786|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950100|NCT02663518|592184787|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950101|NCT02663518|592184788|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950102|NCT02663518|592184789|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950103|NCT02663518|592184790|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950104|NCT02663518|592184791|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
163950105|NCT02663518|592184792|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
163950106|NCT02663518|592184793|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
163950107|NCT02663518|592184794|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
163950108|NCT02663518|592184795|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
163950109|NCT02663518|592184782|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
163950110|NCT02663518|592184783|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
163950111|NCT02663518|592184784|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
163950112|NCT02663518|592184785|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
163950113|NCT02663518|592184786|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
163950114|NCT02663518|592184787|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
163950115|NCT02663518|592184788|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
163843196|NCT01567865|591796858|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
163843197|NCT01567865|591796855|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
163843198|NCT01567865|591796856|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
163843199|NCT01567865|591796857|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
163843200|NCT01567865|591796858|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
163843201|NCT01051063|591796871|FG000|Overall Study|Death|2|||
163843202|NCT01051063|591796872|FG001|Overall Study|Death|2|||
163843203|NCT01051063|591796871|FG000|Overall Study|Withdrawal by Subject|1|||
163843204|NCT01051063|591796872|FG001|Overall Study|Withdrawal by Subject|1|||
163843205|NCT01051063|591796871|FG000|Overall Study|Termination of the study|5|||
163843206|NCT01051063|591796872|FG001|Overall Study|Termination of the study|0|||
163843207|NCT01051063|591796871|FG000|Overall Study|Moved from the study site area|1|||
163843208|NCT01051063|591796872|FG001|Overall Study|Moved from the study site area|0|||
163843209|NCT01051063|591796871|FG000|Overall Study|Other|1|||
163843210|NCT01051063|591796872|FG001|Overall Study|Other|0|||
163843211|NCT01051063|591796871|FG000|Overall Study|Lost to Follow-up|0|||
163843212|NCT01051063|591796872|FG001|Overall Study|Lost to Follow-up|1|||
163843213|NCT05569954|591796873|FG000|Overall Study|Lost to Follow-up|3|||
163843214|NCT05569954|591796874|FG001|Overall Study|Lost to Follow-up|4|||
163843215|NCT05569954|591796873|FG000|Overall Study|Protocol Violation|1|||
163843216|NCT05569954|591796874|FG001|Overall Study|Protocol Violation|2|||
163843217|NCT05569954|591796873|FG000|Overall Study|Withdrawal by Subject|4|||
163843218|NCT05569954|591796874|FG001|Overall Study|Withdrawal by Subject|2|||
163843219|NCT03857841|591796884|FG000|Overall Study|Death|1|||
163843220|NCT03857841|591796885|FG001|Overall Study|Death|0|||
163843221|NCT03857841|591796886|FG002|Overall Study|Death|0|||
163843222|NCT03857841|591796887|FG003|Overall Study|Death|0|||
163843223|NCT03857841|591796884|FG000|Overall Study|Study Terminated by Sponsor|1|||
163843224|NCT03857841|591796885|FG001|Overall Study|Study Terminated by Sponsor|0|||
163843225|NCT03857841|591796886|FG002|Overall Study|Study Terminated by Sponsor|0|||
163843226|NCT03857841|591796887|FG003|Overall Study|Study Terminated by Sponsor|0|||
163843227|NCT00384059|591796888|FG000|Infant Series|Not consented|2|||
163843228|NCT00384059|591796889|FG001|Infant Series|Not consented|6|||
163843229|NCT00384059|591796888|FG000|Infant Series|Withdrawal by Subject|2|||
163950116|NCT02663518|592184789|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
163950117|NCT02663518|592184790|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
163950118|NCT02663518|592184791|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
163950119|NCT02663518|592184792|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
163950120|NCT02663518|592184793|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
163950121|NCT02663518|592184794|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
163950122|NCT02663518|592184795|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
163950123|NCT02663518|592184782|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950124|NCT02663518|592184783|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950125|NCT02663518|592184784|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950126|NCT02663518|592184785|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950127|NCT02663518|592184786|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950128|NCT02663518|592184787|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950129|NCT02663518|592184788|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950130|NCT02663518|592184789|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950131|NCT02663518|592184790|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950132|NCT02663518|592184791|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950133|NCT02663518|592184792|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950134|NCT02663518|592184793|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950135|NCT02663518|592184794|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
163950136|NCT02663518|592184795|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
163950137|NCT00006011|592184799|FG000|Overall Study|Disease progression|13|||
163950138|NCT00006011|592184800|FG001|Overall Study|Disease progression|6|||
163950139|NCT00006011|592184801|FG002|Overall Study|Disease progression|26|||
163950140|NCT00006011|592184799|FG000|Overall Study|Refused further treatment|15|||
163950141|NCT00006011|592184800|FG001|Overall Study|Refused further treatment|13|||
163950142|NCT00006011|592184801|FG002|Overall Study|Refused further treatment|26|||
163950143|NCT00006011|592184799|FG000|Overall Study|Adverse Event|15|||
163950144|NCT00006011|592184800|FG001|Overall Study|Adverse Event|39|||
163950145|NCT00006011|592184801|FG002|Overall Study|Adverse Event|5|||
163950146|NCT00006011|592184799|FG000|Overall Study|Death|0|||
163950147|NCT00006011|592184800|FG001|Overall Study|Death|1|||
163950148|NCT00006011|592184801|FG002|Overall Study|Death|2|||
163950149|NCT00006011|592184799|FG000|Overall Study|Other|4|||
163950150|NCT00006011|592184800|FG001|Overall Study|Other|2|||
163950151|NCT00006011|592184801|FG002|Overall Study|Other|5|||
163950152|NCT00006011|592184799|FG000|Overall Study|Ineligible|18|||
163950153|NCT00006011|592184800|FG001|Overall Study|Ineligible|16|||
163950154|NCT00006011|592184801|FG002|Overall Study|Ineligible|9|||
163950155|NCT01004848|592184802|FG000|Overall Study|Lost to Follow-up|55|||
163950156|NCT01004848|592184803|FG001|Overall Study|Lost to Follow-up|45|||
163950157|NCT01236534|592184809|FG000|Overall Study|Adverse Event|3|||
163950158|NCT01236534|592184810|FG001|Overall Study|Adverse Event|0|||
163950159|NCT01844687|592184811|FG000|Visit 1|Protocol Violation|3|||
163950160|NCT01844687|592184811|FG000|Visit 1|Lost to Follow-up|5|||
163950161|NCT01844687|592184811|FG000|Visit 2|Withdrawal by Subject|1|||
163950162|NCT01844687|592184811|FG000|Visit 2|Protocol Violation|1|||
163950163|NCT01844687|592184811|FG000|Visit 3|Lost to Follow-up|1|||
163950164|NCT01844687|592184811|FG000|Visit 3|Withdrawal by Subject|3|||
163950165|NCT01844687|592184811|FG000|Visit 3|child care problems|1|||
163950166|NCT01844687|592184811|FG000|Visit 4|Pregnancy|1|||
163950167|NCT01844687|592184811|FG000|Visit 4|Lost to Follow-up|1|||
163950168|NCT01844687|592184811|FG000|Visit 4|Withdrawal by Subject|2|||
163950169|NCT03215810|592184816|FG000|Overall Study|Still responding to nivolumab|1|||
163950170|NCT03215810|592184816|FG000|Overall Study|Insufficient TIL growth|1|||
163950171|NCT03215810|592184816|FG000|Overall Study|Decline in performance status|1|||
163950172|NCT03215810|592184816|FG000|Overall Study|Withdrawal by Subject|1|||
163950173|NCT02217501|592184826|FG000|Overall Study|Death|3|||
163950174|NCT02217501|592184827|FG001|Overall Study|Death|4|||
163950175|NCT02019667|592184828|FG000|First Intervention (6 Months)|Adverse Event|0|||
163950176|NCT02019667|592184829|FG001|First Intervention (6 Months)|Adverse Event|1|||
163950177|NCT02019667|592184828|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
163950178|NCT02019667|592184829|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
163950179|NCT02019667|592184828|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
163950180|NCT02019667|592184829|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
163950181|NCT02432196|592184833|FG000|Overall Study|Exit - did not receive study device|1|||
163950182|NCT02432196|592184833|FG000|Overall Study|Death|2|||
163950183|NCT02432196|592184833|FG000|Overall Study|Reoperation|3|||
163950184|NCT01942785|592184838|FG000|Overall Study|Adverse Event|2|||
163950185|NCT01942785|592184838|FG000|Overall Study|Withdrawal by Subject|1|||
163950186|NCT01942785|592184838|FG000|Overall Study|Protocol Violation|1|||
163950187|NCT05453201|592184844|FG000|Overall Study|Withdrawal by Subject|1|||
163950188|NCT01934790|592184845|FG000|Treatment|Adverse Event|3|||
163950189|NCT01934790|592184845|FG000|Treatment|Clinical progression|6|||
163950190|NCT01934790|592184845|FG000|Treatment|Radiological progression|4|||
163950191|NCT01934790|592184845|FG000|Treatment|Withdrawal by Subject|2|||
163950192|NCT01934790|592184845|FG000|Treatment|Study drug never administered|1|||
163950193|NCT01934790|592184845|FG000|Active Follow up|Death|20|||
163950194|NCT01934790|592184845|FG000|Active Follow up|Physician Decision|2|||
163950195|NCT01934790|592184845|FG000|Active Follow up|Progressive disease|1|||
163950196|NCT01934790|592184845|FG000|Active Follow up|Other reason|1|||
163950197|NCT00552929|592184850|FG000|Overall Study|Lost to Follow-up|0|||
163950198|NCT00552929|592184851|FG001|Overall Study|Lost to Follow-up|0|||
163950199|NCT00552929|592184852|FG002|Overall Study|Lost to Follow-up|0|||
163950200|NCT00552929|592184853|FG003|Overall Study|Lost to Follow-up|0|||
163950201|NCT00552929|592184854|FG004|Overall Study|Lost to Follow-up|0|||
163950202|NCT00552929|592184855|FG005|Overall Study|Lost to Follow-up|0|||
163950203|NCT00552929|592184856|FG006|Overall Study|Lost to Follow-up|0|||
163950204|NCT00552929|592184857|FG007|Overall Study|Lost to Follow-up|0|||
163950205|NCT00552929|592184858|FG008|Overall Study|Lost to Follow-up|1|||
163950206|NCT00552929|592184859|FG009|Overall Study|Lost to Follow-up|0|||
163950207|NCT00552929|592184850|FG000|Overall Study|Not Eligible|0|||
163950208|NCT00552929|592184851|FG001|Overall Study|Not Eligible|0|||
163950209|NCT00552929|592184852|FG002|Overall Study|Not Eligible|0|||
163950210|NCT00552929|592184853|FG003|Overall Study|Not Eligible|0|||
163950211|NCT00552929|592184854|FG004|Overall Study|Not Eligible|0|||
163950212|NCT00552929|592184855|FG005|Overall Study|Not Eligible|1|||
163950213|NCT00552929|592184856|FG006|Overall Study|Not Eligible|0|||
163950214|NCT00552929|592184857|FG007|Overall Study|Not Eligible|0|||
163950215|NCT00552929|592184858|FG008|Overall Study|Not Eligible|0|||
163950216|NCT00552929|592184859|FG009|Overall Study|Not Eligible|0|||
163950217|NCT01147536|592184862|FG000|Overall Study|Administrative study close|2|||
163950218|NCT01147536|592184862|FG000|Overall Study|Death|1|||
163950219|NCT03647488|592186518|FG000|Overall Study|Progressive disease|10|||
163950220|NCT03647488|592186519|FG001|Overall Study|Progressive disease|0|||
163950221|NCT03647488|592186520|FG002|Overall Study|Progressive disease|0|||
163950222|NCT03647488|592186518|FG000|Overall Study|Adverse Event|5|||
163950223|NCT03647488|592186519|FG001|Overall Study|Adverse Event|0|||
163950224|NCT03647488|592186520|FG002|Overall Study|Adverse Event|0|||
163950225|NCT03647488|592186518|FG000|Overall Study|Clinical progression|2|||
163950226|NCT03647488|592186519|FG001|Overall Study|Clinical progression|0|||
163950227|NCT03647488|592186520|FG002|Overall Study|Clinical progression|0|||
163950228|NCT03647488|592186518|FG000|Overall Study|Participant refused to take investigational product|1|||
163950229|NCT03647488|592186519|FG001|Overall Study|Participant refused to take investigational product|0|||
163950230|NCT03647488|592186520|FG002|Overall Study|Participant refused to take investigational product|0|||
163950231|NCT00153062|592186521|FG000|Overall Study|Death|360|||
163950232|NCT00153062|592186522|FG001|Overall Study|Death|352|||
163950233|NCT00153062|592186523|FG002|Overall Study|Death|369|||
163950234|NCT00153062|592186524|FG003|Overall Study|Death|365|||
163950235|NCT00153062|592186521|FG000|Overall Study|Withdrawal by Subject|14|||
163950236|NCT00153062|592186522|FG001|Overall Study|Withdrawal by Subject|30|||
163950237|NCT00153062|592186523|FG002|Overall Study|Withdrawal by Subject|27|||
163950238|NCT00153062|592186524|FG003|Overall Study|Withdrawal by Subject|28|||
163950239|NCT00153062|592186521|FG000|Overall Study|Lost to Follow-up|12|||
163950240|NCT00153062|592186522|FG001|Overall Study|Lost to Follow-up|20|||
163950241|NCT00153062|592186523|FG002|Overall Study|Lost to Follow-up|15|||
163950242|NCT00153062|592186524|FG003|Overall Study|Lost to Follow-up|16|||
163950243|NCT00153062|592186521|FG000|Overall Study|Adverse Event|0|||
163950244|NCT00153062|592186522|FG001|Overall Study|Adverse Event|1|||
163950245|NCT00153062|592186523|FG002|Overall Study|Adverse Event|1|||
163950246|NCT00153062|592186524|FG003|Overall Study|Adverse Event|0|||
163950247|NCT00153062|592186521|FG000|Overall Study|Protocol Violation|0|||
163950248|NCT00153062|592186522|FG001|Overall Study|Protocol Violation|2|||
163950249|NCT00153062|592186523|FG002|Overall Study|Protocol Violation|1|||
163950250|NCT00153062|592186524|FG003|Overall Study|Protocol Violation|1|||
164047115|NCT00089999|592530602|FG000|Overall Study|Withdrawal by Subject|0|||
164047116|NCT00089999|592530603|FG001|Overall Study|Withdrawal by Subject|4|||
164047117|NCT00089999|592530602|FG000|Overall Study|Lost to Follow-up|2|||
164047118|NCT00089999|592530603|FG001|Overall Study|Lost to Follow-up|1|||
163950251|NCT00153062|592186521|FG000|Overall Study|No disposition data available|1|||
163950252|NCT00153062|592186522|FG001|Overall Study|No disposition data available|1|||
163950253|NCT00153062|592186523|FG002|Overall Study|No disposition data available|1|||
163950254|NCT00153062|592186524|FG003|Overall Study|No disposition data available|1|||
163950255|NCT00153062|592186521|FG000|Overall Study|Other|0|||
163950256|NCT00153062|592186522|FG001|Overall Study|Other|0|||
163950257|NCT00153062|592186523|FG002|Overall Study|Other|1|||
163950258|NCT00153062|592186524|FG003|Overall Study|Other|0|||
163950259|NCT01773291|592186525|FG000|Overall Study|Protocol Violation|1|||
164047119|NCT00089999|592530602|FG000|Overall Study|Radiological Progression of Cancer|52|||
163950260|NCT01773291|592186526|FG001|Overall Study|Protocol Violation|0|||
163950261|NCT01773291|592186527|FG002|Overall Study|Protocol Violation|0|||
163950262|NCT01773291|592186525|FG000|Overall Study|Withdrawal by Subject|0|||
163950263|NCT01773291|592186526|FG001|Overall Study|Withdrawal by Subject|0|||
163950264|NCT01773291|592186527|FG002|Overall Study|Withdrawal by Subject|1|||
163950265|NCT00203476|592186528|FG000|Overall Study|Lost to Follow-up|1|||
163950266|NCT00203476|592186529|FG001|Overall Study|Lost to Follow-up|0|||
163950267|NCT00203476|592186530|FG002|Overall Study|Lost to Follow-up|0|||
163950268|NCT00203476|592186528|FG000|Overall Study|Withdrawal by Subject|0|||
163950269|NCT00203476|592186529|FG001|Overall Study|Withdrawal by Subject|1|||
163950270|NCT00203476|592186530|FG002|Overall Study|Withdrawal by Subject|0|||
163950271|NCT03310268|592186531|FG000|Overall Study|(Not specified)|1|||
163950272|NCT03310268|592186532|FG001|Overall Study|(Not specified)|5|||
163950273|NCT03310268|592186533|FG002|Overall Study|(Not specified)|0|||
163950274|NCT04797650|592186534|FG000|Overall Study|Reason Not Specified|5|||
163950275|NCT04797650|592186535|FG001|Overall Study|Reason Not Specified|12|||
163950276|NCT04797650|592186536|FG002|Overall Study|Reason Not Specified|5|||
163950277|NCT04797650|592186534|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
163950278|NCT04797650|592186535|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
163950279|NCT04797650|592186536|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
163950280|NCT04797650|592186534|FG000|Overall Study|Lack of Efficacy|1|||
163950281|NCT04797650|592186535|FG001|Overall Study|Lack of Efficacy|0|||
163950282|NCT04797650|592186536|FG002|Overall Study|Lack of Efficacy|1|||
163950283|NCT04797650|592186534|FG000|Overall Study|Non-compliance with Study Drug|0|||
163950284|NCT04797650|592186535|FG001|Overall Study|Non-compliance with Study Drug|0|||
163950285|NCT04797650|592186536|FG002|Overall Study|Non-compliance with Study Drug|2|||
163950286|NCT04797650|592186534|FG000|Overall Study|Lost to Follow-up|4|||
163950287|NCT04797650|592186535|FG001|Overall Study|Lost to Follow-up|6|||
163950288|NCT04797650|592186536|FG002|Overall Study|Lost to Follow-up|1|||
163950289|NCT04772898|592186539|FG000|Overall Study|Withdrawal by Subject|0|||
163950290|NCT04772898|592186540|FG001|Overall Study|Withdrawal by Subject|1|||
163950291|NCT00309959|592186542|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
163950292|NCT02937454|592186543|FG000|Overall Study|Adverse Event|0|||
163950293|NCT02937454|592186544|FG001|Overall Study|Adverse Event|1|||
163950294|NCT02937454|592186543|FG000|Overall Study|Death|98|||
163950295|NCT02937454|592186544|FG001|Overall Study|Death|95|||
163950296|NCT02937454|592186543|FG000|Overall Study|Lost to Follow-up|1|||
163950297|NCT02937454|592186544|FG001|Overall Study|Lost to Follow-up|1|||
163950298|NCT02937454|592186543|FG000|Overall Study|Physician Decision|0|||
163950299|NCT02937454|592186544|FG001|Overall Study|Physician Decision|1|||
163950300|NCT02937454|592186543|FG000|Overall Study|Protocol Violation|6|||
163950301|NCT02937454|592186544|FG001|Overall Study|Protocol Violation|10|||
163950302|NCT02937454|592186543|FG000|Overall Study|Withdrawal by Subject|27|||
163950303|NCT02937454|592186544|FG001|Overall Study|Withdrawal by Subject|15|||
163950304|NCT02937454|592186543|FG000|Overall Study|Other|8|||
163950305|NCT02937454|592186544|FG001|Overall Study|Other|5|||
163950306|NCT01253304|592186545|FG000|Overall Study|Adverse Event|0|||
163950307|NCT01253304|592186546|FG001|Overall Study|Adverse Event|0|||
163950308|NCT01253304|592186547|FG002|Overall Study|Adverse Event|0|||
163950309|NCT01253304|592186548|FG003|Overall Study|Adverse Event|1|||
163950310|NCT01888900|592186556|FG000|Overall Study|failed treatment|0|||
163950311|NCT01888900|592186557|FG001|Overall Study|failed treatment|2|||
163950312|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
163950313|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163950314|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163950315|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163950316|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163950317|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
163950318|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
163950319|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163950320|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163950321|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163950322|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163950323|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
163950324|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
163950325|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163950326|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164047120|NCT00089999|592530603|FG001|Overall Study|Radiological Progression of Cancer|44|||
163950327|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163950328|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
163950329|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
164047121|NCT00089999|592530602|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
164148620|NCT04895982|592904916|FG005|Overall Study|Protocol Violation|0|||
163950330|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
163950331|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163950332|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163950333|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163950334|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163950335|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
163950336|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
163950337|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163950338|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163950339|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163950340|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163950341|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
163950342|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
163950343|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163950344|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163950345|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163950346|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163950347|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
163950348|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
163950349|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163950350|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163950351|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163950352|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163950353|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
163950354|NCT01160289|592186558|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
163950355|NCT01160289|592186559|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163950356|NCT01160289|592186560|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163950357|NCT01160289|592186561|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163950358|NCT01160289|592186562|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163950359|NCT01160289|592186563|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
163950360|NCT01160289|592186558|FG000|Post-Randomization Period|Adverse Event|0|||
163950361|NCT01160289|592186559|FG001|Post-Randomization Period|Adverse Event|4|||
163950362|NCT01160289|592186560|FG002|Post-Randomization Period|Adverse Event|4|||
163950363|NCT01160289|592186561|FG003|Post-Randomization Period|Adverse Event|2|||
163950364|NCT01160289|592186562|FG004|Post-Randomization Period|Adverse Event|0|||
163950365|NCT01160289|592186563|FG005|Post-Randomization Period|Adverse Event|0|||
163950366|NCT01160289|592186558|FG000|Post-Randomization Period|Death|0|||
163950367|NCT01160289|592186559|FG001|Post-Randomization Period|Death|0|||
163950368|NCT01160289|592186560|FG002|Post-Randomization Period|Death|0|||
163950369|NCT01160289|592186561|FG003|Post-Randomization Period|Death|1|||
163950370|NCT01160289|592186562|FG004|Post-Randomization Period|Death|0|||
163950371|NCT01160289|592186563|FG005|Post-Randomization Period|Death|0|||
163950372|NCT01160289|592186558|FG000|Post-Randomization Period|Lack of Efficacy|0|||
163950373|NCT01160289|592186559|FG001|Post-Randomization Period|Lack of Efficacy|1|||
163950374|NCT01160289|592186560|FG002|Post-Randomization Period|Lack of Efficacy|0|||
163950375|NCT01160289|592186561|FG003|Post-Randomization Period|Lack of Efficacy|3|||
163950376|NCT01160289|592186562|FG004|Post-Randomization Period|Lack of Efficacy|0|||
163950377|NCT01160289|592186563|FG005|Post-Randomization Period|Lack of Efficacy|0|||
163950378|NCT01160289|592186558|FG000|Post-Randomization Period|Lost to Follow-up|0|||
163950379|NCT01160289|592186559|FG001|Post-Randomization Period|Lost to Follow-up|3|||
163950380|NCT01160289|592186560|FG002|Post-Randomization Period|Lost to Follow-up|2|||
163950381|NCT01160289|592186561|FG003|Post-Randomization Period|Lost to Follow-up|5|||
163950382|NCT01160289|592186562|FG004|Post-Randomization Period|Lost to Follow-up|3|||
163950383|NCT01160289|592186563|FG005|Post-Randomization Period|Lost to Follow-up|4|||
163950384|NCT01160289|592186558|FG000|Post-Randomization Period|Physician Decision|0|||
163950385|NCT01160289|592186559|FG001|Post-Randomization Period|Physician Decision|0|||
163950386|NCT01160289|592186560|FG002|Post-Randomization Period|Physician Decision|1|||
163950387|NCT01160289|592186561|FG003|Post-Randomization Period|Physician Decision|0|||
163950388|NCT01160289|592186562|FG004|Post-Randomization Period|Physician Decision|0|||
163950389|NCT01160289|592186563|FG005|Post-Randomization Period|Physician Decision|0|||
163950390|NCT01160289|592186558|FG000|Post-Randomization Period|Protocol Violation|0|||
163950391|NCT01160289|592186559|FG001|Post-Randomization Period|Protocol Violation|4|||
163950392|NCT01160289|592186560|FG002|Post-Randomization Period|Protocol Violation|2|||
163950393|NCT01160289|592186561|FG003|Post-Randomization Period|Protocol Violation|0|||
163950394|NCT01160289|592186562|FG004|Post-Randomization Period|Protocol Violation|1|||
163950395|NCT01160289|592186563|FG005|Post-Randomization Period|Protocol Violation|3|||
163950396|NCT01160289|592186558|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
163950397|NCT01160289|592186559|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
164047122|NCT00089999|592530603|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
164047123|NCT00089999|592530602|FG000|Overall Study|Death|3|||
164047124|NCT00089999|592530603|FG001|Overall Study|Death|3|||
164047125|NCT00089999|592530602|FG000|Overall Study|Poor General Condition|1|||
164047126|NCT00089999|592530603|FG001|Overall Study|Poor General Condition|0|||
164047127|NCT00089999|592530602|FG000|Overall Study|Clinical Progression|1|||
164047128|NCT00089999|592530603|FG001|Overall Study|Clinical Progression|2|||
163950398|NCT01160289|592186560|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
163950399|NCT01160289|592186561|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
163950400|NCT01160289|592186562|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
163950401|NCT01160289|592186563|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
163950402|NCT01160289|592186558|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
163950403|NCT01160289|592186559|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
163950404|NCT01160289|592186560|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
163950405|NCT01160289|592186561|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
163950406|NCT01160289|592186562|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
163950407|NCT01160289|592186563|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
163950408|NCT01160289|592186558|FG000|Post-Randomization Period|Sponsor Decision|0|||
163950409|NCT01160289|592186559|FG001|Post-Randomization Period|Sponsor Decision|1|||
163950410|NCT01160289|592186560|FG002|Post-Randomization Period|Sponsor Decision|0|||
163950411|NCT01160289|592186561|FG003|Post-Randomization Period|Sponsor Decision|0|||
163950412|NCT01160289|592186562|FG004|Post-Randomization Period|Sponsor Decision|0|||
163950413|NCT01160289|592186563|FG005|Post-Randomization Period|Sponsor Decision|0|||
163950414|NCT01156792|592186568|FG000|Overall Study|Adverse Event|1|||
163950415|NCT01156792|592186568|FG000|Overall Study|Lack of Efficacy|36|||
163950416|NCT01156792|592186568|FG000|Overall Study|Protocol Violation|6|||
163950417|NCT01156792|592186568|FG000|Overall Study|Lost to Follow-up|3|||
163950418|NCT01156792|592186568|FG000|Overall Study|Physician Decision|3|||
163950419|NCT01156792|592186568|FG000|Overall Study|Withdrawal by Subject|9|||
163950420|NCT01156792|592186568|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
163950421|NCT00768079|592186569|FG000|Overall Study|Lost to Follow-up|2|||
163950422|NCT00768079|592186570|FG001|Overall Study|Lost to Follow-up|0|||
163950423|NCT00768079|592186571|FG002|Overall Study|Lost to Follow-up|4|||
163950424|NCT00768079|592186569|FG000|Overall Study|Participant incarcerated|0|||
163950425|NCT00768079|592186570|FG001|Overall Study|Participant incarcerated|1|||
163950426|NCT00768079|592186571|FG002|Overall Study|Participant incarcerated|0|||
163950427|NCT03271021|592186572|FG000|Overall Study|Adverse Event|3|||
163950428|NCT03271021|592186573|FG001|Overall Study|Adverse Event|2|||
163950429|NCT03271021|592186572|FG000|Overall Study|Withdrawal by Subject|36|||
163950430|NCT03271021|592186573|FG001|Overall Study|Withdrawal by Subject|53|||
163950431|NCT03271021|592186572|FG000|Overall Study|Lost to Follow-up|34|||
163950432|NCT03271021|592186573|FG001|Overall Study|Lost to Follow-up|39|||
163950433|NCT03271021|592186572|FG000|Overall Study|Protocol Violation|6|||
163950434|NCT03271021|592186573|FG001|Overall Study|Protocol Violation|4|||
163950435|NCT03271021|592186572|FG000|Overall Study|Abnormal Lab Results|1|||
163950436|NCT03271021|592186573|FG001|Overall Study|Abnormal Lab Results|0|||
163950437|NCT03271021|592186572|FG000|Overall Study|Miscellaneous|9|||
163950438|NCT03271021|592186573|FG001|Overall Study|Miscellaneous|8|||
163950439|NCT01474434|592186574|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
163950440|NCT01474434|592186575|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
163950441|NCT01474434|592186576|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
163950442|NCT01474434|592186577|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
163950443|NCT01474434|592186574|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
163950444|NCT01474434|592186575|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
163950445|NCT01474434|592186576|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
163950446|NCT01474434|592186577|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
163950447|NCT01474434|592186574|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
163950448|NCT01474434|592186575|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
163950449|NCT01474434|592186576|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
163950450|NCT01474434|592186577|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
163950451|NCT02207569|592186580|FG000|1-Month|Death|6|||
163950452|NCT02207569|592186580|FG000|1-Month|Withdrawal by Subject|2|||
163950453|NCT02207569|592186580|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
163950454|NCT02207569|592186580|FG000|6-Month|Death|8|||
163950455|NCT02207569|592186580|FG000|6-Month|Withdrawal by Subject|2|||
163950456|NCT02207569|592186580|FG000|12-Month|Death|14|||
163950457|NCT02207569|592186580|FG000|12-Month|Withdrawal by Subject|2|||
163950458|NCT02207569|592186580|FG000|24-Month|Death|23|||
163950459|NCT02207569|592186580|FG000|24-Month|Withdrawal by Subject|3|||
163950460|NCT02207569|592186580|FG000|36-Month|Death|23|||
163950461|NCT02207569|592186580|FG000|36-Month|Withdrawal by Subject|4|||
163950462|NCT02207569|592186580|FG000|48-Month|Death|25|||
163950463|NCT02207569|592186580|FG000|48-Month|Withdrawal by Subject|2|||
163950464|NCT02207569|592186580|FG000|48-Month|Lost to Follow-up|4|||
163950465|NCT02207569|592186580|FG000|60-Month|Death|1|||
163950466|NCT02207569|592186580|FG000|60-Month|Lost to Follow-up|1|||
163950467|NCT02207569|592186580|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
163950468|NCT02207569|592186580|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
163950469|NCT02585232|592186581|FG000|Overall Study|Lost to Follow-up|8|||
163950470|NCT02585232|592186582|FG001|Overall Study|Lost to Follow-up|8|||
163950471|NCT02585232|592186581|FG000|Overall Study|Withdrawal by Subject|4|||
163950472|NCT02585232|592186582|FG001|Overall Study|Withdrawal by Subject|8|||
163950473|NCT01157676|592186590|FG000|Randomization|Death|1|||
163950474|NCT01157676|592186591|FG001|Randomization|Death|1|||
163950475|NCT01157676|592186590|FG000|Randomization|unresectable|2|||
163950476|NCT01157676|592186591|FG001|Randomization|unresectable|3|||
163950477|NCT01157676|592186590|FG000|Randomization|Withdrawal by Subject|17|||
163950478|NCT01157676|592186591|FG001|Randomization|Withdrawal by Subject|13|||
163950479|NCT01157676|592186590|FG000|Randomization|Physician Decision|1|||
163950480|NCT01157676|592186591|FG001|Randomization|Physician Decision|0|||
163950481|NCT01157676|592186590|FG000|Surgery|underwent open cystectomy|0|||
163950482|NCT01157676|592186591|FG001|Surgery|underwent open cystectomy|4|||
163950483|NCT01157676|592186590|FG000|Surgery|converted to open procedure|0|||
163950484|NCT01157676|592186591|FG001|Surgery|converted to open procedure|5|||
163950485|NCT01157676|592186590|FG000|Surgery|underwent robotic cystectomy|1|||
163950486|NCT01157676|592186591|FG001|Surgery|underwent robotic cystectomy|0|||
163950487|NCT00682890|592186592|FG000|Overall Study|Lost to Follow-up|1|||
163950488|NCT00682890|592186593|FG001|Overall Study|Lost to Follow-up|1|||
163950489|NCT00682890|592186592|FG000|Overall Study|subject moved away|0|||
163950490|NCT00682890|592186593|FG001|Overall Study|subject moved away|1|||
163950491|NCT00682890|592186592|FG000|Overall Study|heavy menstrual bleeding|1|||
163950492|NCT00682890|592186593|FG001|Overall Study|heavy menstrual bleeding|0|||
163950493|NCT00141219|592186597|FG000|Overall Study|Protocol violations|5|||
163950494|NCT00141219|592186598|FG001|Overall Study|Protocol violations|4|||
163950495|NCT00141219|592186597|FG000|Overall Study|Adverse Event|8|||
163950496|NCT00141219|592186598|FG001|Overall Study|Adverse Event|6|||
163950497|NCT00141219|592186597|FG000|Overall Study|Lack of Efficacy|5|||
163950498|NCT00141219|592186598|FG001|Overall Study|Lack of Efficacy|4|||
163950499|NCT00141219|592186597|FG000|Overall Study|Withdrawal by Subject|6|||
163950500|NCT00141219|592186598|FG001|Overall Study|Withdrawal by Subject|2|||
163950501|NCT01577745|592186599|FG000|Overall Study|Withdrawal by Subject|0|||
163950502|NCT01577745|592186600|FG001|Overall Study|Withdrawal by Subject|1|||
163950503|NCT01577745|592186601|FG002|Overall Study|Withdrawal by Subject|0|||
163950504|NCT01577745|592186602|FG003|Overall Study|Withdrawal by Subject|3|||
163950505|NCT01577745|592186603|FG004|Overall Study|Withdrawal by Subject|2|||
163950506|NCT01577745|592186604|FG005|Overall Study|Withdrawal by Subject|0|||
163950507|NCT01577745|592186599|FG000|Overall Study|Death|3|||
163950508|NCT01577745|592186600|FG001|Overall Study|Death|2|||
163950509|NCT01577745|592186601|FG002|Overall Study|Death|2|||
163950510|NCT01577745|592186602|FG003|Overall Study|Death|1|||
163950511|NCT01577745|592186603|FG004|Overall Study|Death|1|||
163950512|NCT01577745|592186604|FG005|Overall Study|Death|3|||
163950513|NCT01577745|592186599|FG000|Overall Study|Physician Decision|0|||
163950514|NCT01577745|592186600|FG001|Overall Study|Physician Decision|0|||
163950515|NCT01577745|592186601|FG002|Overall Study|Physician Decision|0|||
163950516|NCT01577745|592186602|FG003|Overall Study|Physician Decision|1|||
163950517|NCT01577745|592186603|FG004|Overall Study|Physician Decision|1|||
163950518|NCT01577745|592186604|FG005|Overall Study|Physician Decision|0|||
163950519|NCT01577745|592186599|FG000|Overall Study|Lost to Follow-up|0|||
163950520|NCT01577745|592186600|FG001|Overall Study|Lost to Follow-up|0|||
163950521|NCT01577745|592186601|FG002|Overall Study|Lost to Follow-up|0|||
163950522|NCT01577745|592186602|FG003|Overall Study|Lost to Follow-up|0|||
163950523|NCT01577745|592186603|FG004|Overall Study|Lost to Follow-up|0|||
163950524|NCT01577745|592186604|FG005|Overall Study|Lost to Follow-up|1|||
163950525|NCT01577745|592186599|FG000|Overall Study|Alternative Therapy|0|||
163950526|NCT01577745|592186600|FG001|Overall Study|Alternative Therapy|0|||
163950527|NCT01577745|592186601|FG002|Overall Study|Alternative Therapy|0|||
163950528|NCT01577745|592186602|FG003|Overall Study|Alternative Therapy|1|||
163950529|NCT01577745|592186603|FG004|Overall Study|Alternative Therapy|1|||
163950530|NCT01577745|592186604|FG005|Overall Study|Alternative Therapy|0|||
163950531|NCT02325557|592186605|FG000|Overall Study|Progressive disease|1|||
163950532|NCT02325557|592186606|FG001|Overall Study|Progressive disease|0|||
164047129|NCT00089999|592530602|FG000|Overall Study|Physician Decision|2|||
164047130|NCT00089999|592530603|FG001|Overall Study|Physician Decision|2|||
164047131|NCT00089999|592530602|FG000|Overall Study|Patient Underwent Surgery|2|||
164047132|NCT00089999|592530603|FG001|Overall Study|Patient Underwent Surgery|0|||
163950533|NCT02325557|592186607|FG002|Overall Study|Progressive disease|0|||
163950534|NCT02325557|592186608|FG003|Overall Study|Progressive disease|0|||
163950535|NCT02325557|592186605|FG000|Overall Study|Withdrawal by Subject|4|||
163950536|NCT02325557|592186606|FG001|Overall Study|Withdrawal by Subject|0|||
163950537|NCT02325557|592186607|FG002|Overall Study|Withdrawal by Subject|0|||
163950538|NCT02325557|592186608|FG003|Overall Study|Withdrawal by Subject|15|||
163950539|NCT02325557|592186605|FG000|Overall Study|Death|5|||
163950540|NCT02325557|592186606|FG001|Overall Study|Death|1|||
164047133|NCT00089999|592530602|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
163950541|NCT02325557|592186607|FG002|Overall Study|Death|1|||
164047134|NCT00089999|592530603|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
163950542|NCT02325557|592186608|FG003|Overall Study|Death|16|||
163950543|NCT02325557|592186605|FG000|Overall Study|Lost to Follow-up|0|||
163950544|NCT02325557|592186606|FG001|Overall Study|Lost to Follow-up|0|||
164047135|NCT03573804|592530607|FG000|Overall Study|claustrophobia or MRI table problems|10|||
163950545|NCT02325557|592186607|FG002|Overall Study|Lost to Follow-up|1|||
163950546|NCT02325557|592186608|FG003|Overall Study|Lost to Follow-up|1|||
163950547|NCT02325557|592186605|FG000|Overall Study|Other|0|||
163950548|NCT02325557|592186606|FG001|Overall Study|Other|0|||
163950549|NCT02325557|592186607|FG002|Overall Study|Other|0|||
163950550|NCT02325557|592186608|FG003|Overall Study|Other|5|||
163950551|NCT00468559|592186613|FG000|Open-label Treatment Phase|Adverse Event|5|||
163950552|NCT00468559|592186614|FG001|Open-label Treatment Phase|Adverse Event|0|||
163950553|NCT00468559|592186615|FG002|Open-label Treatment Phase|Adverse Event|0|||
163950554|NCT00468559|592186613|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
163950555|NCT00468559|592186614|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
163950556|NCT00468559|592186615|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
163950557|NCT00468559|592186613|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
163950558|NCT00468559|592186614|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
163950559|NCT00468559|592186615|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
163950560|NCT00468559|592186613|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
163950561|NCT00468559|592186614|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
163950562|NCT00468559|592186615|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
163950563|NCT00468559|592186613|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
163950564|NCT00468559|592186614|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
163950565|NCT00468559|592186615|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
163950566|NCT02703259|592186616|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
163950567|NCT02703259|592186617|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
163950568|NCT02703259|592186616|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
163950569|NCT02703259|592186617|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
163950570|NCT02703259|592186616|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
163950571|NCT02703259|592186617|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
163950572|NCT02971761|592186619|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
163950573|NCT02624791|592186620|FG000|Overall Study|Withdrawal by Subject|2|||
163950574|NCT02624791|592186621|FG001|Overall Study|Withdrawal by Subject|0|||
163950575|NCT02624791|592186622|FG002|Overall Study|Withdrawal by Subject|0|||
164047136|NCT04418427|592532690|FG000|Overall Study|Death|0|||
164047137|NCT04418427|592532691|FG001|Overall Study|Death|1|||
164047138|NCT04418427|592532692|FG002|Overall Study|Death|0|||
164047139|NCT04418427|592532690|FG000|Overall Study|Lost to Follow-up|0|||
164047140|NCT04418427|592532691|FG001|Overall Study|Lost to Follow-up|2|||
164047141|NCT04418427|592532692|FG002|Overall Study|Lost to Follow-up|2|||
164047142|NCT04418427|592532690|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
164047143|NCT04418427|592532691|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
164047144|NCT04418427|592532692|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
164047145|NCT04418427|592532690|FG000|Overall Study|Pre-existing medical condition|0|||
164047146|NCT04418427|592532691|FG001|Overall Study|Pre-existing medical condition|1|||
164047147|NCT04418427|592532692|FG002|Overall Study|Pre-existing medical condition|0|||
164047148|NCT01654224|592532693|FG000|Overall Study|Lost to Follow-up|2|||
164047149|NCT01654224|592532694|FG001|Overall Study|Lost to Follow-up|2|||
164047150|NCT01654224|592532693|FG000|Overall Study|Did not receive allocation|1|||
164047151|NCT01654224|592532694|FG001|Overall Study|Did not receive allocation|8|||
164047152|NCT01654224|592532693|FG000|Overall Study|Insufficient blood sample|3|||
164047153|NCT01654224|592532694|FG001|Overall Study|Insufficient blood sample|2|||
164047154|NCT01874353|592532696|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
164047155|NCT01874353|592532697|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
164047156|NCT01874353|592532698|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
164047157|NCT01874353|592532699|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
164047158|NCT01874353|592532696|FG000|Overall Study|Lost to Follow-up|2|||
164047159|NCT01874353|592532697|FG001|Overall Study|Lost to Follow-up|2|||
164047160|NCT01874353|592532698|FG002|Overall Study|Lost to Follow-up|2|||
164047161|NCT01874353|592532699|FG003|Overall Study|Lost to Follow-up|0|||
164047162|NCT01874353|592532696|FG000|Overall Study|Death|110|||
164047163|NCT01874353|592532697|FG001|Overall Study|Death|60|||
164047164|NCT01874353|592532698|FG002|Overall Study|Death|13|||
164047165|NCT01874353|592532699|FG003|Overall Study|Death|7|||
164047166|NCT01874353|592532696|FG000|Overall Study|Withdrawal by Subject|13|||
164047167|NCT01874353|592532697|FG001|Overall Study|Withdrawal by Subject|11|||
164047168|NCT01874353|592532698|FG002|Overall Study|Withdrawal by Subject|0|||
164047169|NCT01874353|592532699|FG003|Overall Study|Withdrawal by Subject|0|||
163950576|NCT02624791|592186623|FG003|Overall Study|Withdrawal by Subject|0|||
163950577|NCT02624791|592186624|FG004|Overall Study|Withdrawal by Subject|0|||
163950578|NCT02624791|592186625|FG005|Overall Study|Withdrawal by Subject|0|||
163950579|NCT01146782|592186629|FG000|Screening Cohort|Screen Failure|187|||
163950580|NCT01146782|592186629|FG000|Screening Cohort|Lost to Follow-up|4|||
163950581|NCT01146782|592186629|FG000|Screening Cohort|Physician Decision|1|||
164047170|NCT03887052|592532700|FG000|Overall Study|Adverse Event|2|||
164099715|NCT02100228|592730564|FG000|Overall Study|Administrative reason|0|||
163950582|NCT01146782|592186629|FG000|Screening Cohort|Withdrawal by Subject|29|||
163950583|NCT01146782|592186629|FG000|Safety Cohort|Screen Failure|61|||
163950584|NCT01146782|592186629|FG000|Safety Cohort|Withdrawal by Subject|4|||
163950585|NCT01146782|592186629|FG000|Safety Cohort|Control AHI <5|4|||
163950586|NCT01146782|592186629|FG000|Safety Cohort|TST <4 hrs|14|||
163950587|NCT01146782|592186629|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
163950588|NCT01146782|592186629|FG000|Primary Endpoint Cohort|Physician Decision|1|||
163950589|NCT01605916|592186630|FG000|Overall Study|Adverse Event|1|||
163950590|NCT01605916|592186631|FG001|Overall Study|Adverse Event|0|||
163950591|NCT01605916|592186632|FG002|Overall Study|Adverse Event|0|||
163950592|NCT01605916|592186633|FG003|Overall Study|Adverse Event|1|||
163950593|NCT01605916|592186634|FG004|Overall Study|Adverse Event|0|||
163950594|NCT01605916|592186630|FG000|Overall Study|Lack of Efficacy|2|||
163950595|NCT01605916|592186631|FG001|Overall Study|Lack of Efficacy|3|||
163950596|NCT01605916|592186632|FG002|Overall Study|Lack of Efficacy|3|||
163950597|NCT01605916|592186633|FG003|Overall Study|Lack of Efficacy|5|||
163950598|NCT01605916|592186634|FG004|Overall Study|Lack of Efficacy|4|||
163950599|NCT01605916|592186630|FG000|Overall Study|Withdrawal by Subject|1|||
163950600|NCT01605916|592186631|FG001|Overall Study|Withdrawal by Subject|1|||
163950601|NCT01605916|592186632|FG002|Overall Study|Withdrawal by Subject|0|||
163950602|NCT01605916|592186633|FG003|Overall Study|Withdrawal by Subject|0|||
163950603|NCT01605916|592186634|FG004|Overall Study|Withdrawal by Subject|2|||
163950604|NCT00470366|592186635|FG000|Overall Study|Adverse Event|3|||
163950605|NCT00470366|592186635|FG000|Overall Study|Poor compliance|1|||
163950606|NCT01021215|592186638|FG000|Overall Study|Lost to Follow-up|3|||
163950607|NCT01021215|592186639|FG001|Overall Study|Lost to Follow-up|0|||
163950608|NCT01103362|592186640|FG000|Overall Study|study terminated|596|||
163950609|NCT02842151|592186641|FG000|Overall Study|Adverse Event|1|||
163950610|NCT02842151|592186641|FG000|Overall Study|Subject moved too far away|1|||
163950611|NCT00438672|592186642|FG000|Overall Study|Lost to Follow-up|7|||
163950612|NCT00438672|592186643|FG001|Overall Study|Lost to Follow-up|9|||
163950613|NCT03965351|592186646|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
163950614|NCT03965351|592186647|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
163950615|NCT03965351|592186646|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
163950616|NCT03965351|592186647|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
163950617|NCT01394978|592186648|FG000|Overall Study|Withdrawal by Subject|2|||
163950618|NCT01394978|592186649|FG001|Overall Study|Withdrawal by Subject|4|||
163950619|NCT01394978|592186648|FG000|Overall Study|Lost to Follow-up|13|||
163950620|NCT01394978|592186649|FG001|Overall Study|Lost to Follow-up|20|||
163950621|NCT01394978|592186648|FG000|Overall Study|Death|6|||
163950622|NCT01394978|592186649|FG001|Overall Study|Death|7|||
163950623|NCT05038163|592186654|FG000|Stage 1|Did not complete survey|374|||
163950624|NCT05038163|592186655|FG001|Stage 1|Did not complete survey|0|||
163950625|NCT05038163|592186656|FG002|Stage 1|Did not complete survey|0|||
163950626|NCT05038163|592186657|FG003|Stage 1|Did not complete survey|0|||
163950627|NCT05038163|592186658|FG004|Stage 1|Did not complete survey|0|||
163950628|NCT05038163|592186659|FG005|Stage 1|Did not complete survey|0|||
163950629|NCT05038163|592186654|FG000|Stage 2|Did not complete Stage 2 survey|0|||
163950630|NCT05038163|592186655|FG001|Stage 2|Did not complete Stage 2 survey|29|||
163950631|NCT05038163|592186656|FG002|Stage 2|Did not complete Stage 2 survey|30|||
163950632|NCT05038163|592186657|FG003|Stage 2|Did not complete Stage 2 survey|24|||
163950633|NCT05038163|592186658|FG004|Stage 2|Did not complete Stage 2 survey|21|||
163950634|NCT05038163|592186659|FG005|Stage 2|Did not complete Stage 2 survey|100|||
163950635|NCT01905150|592186661|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
163950636|NCT01905150|592186662|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
163950637|NCT03562975|592186663|FG000|Overall Study|Death|1|||
163950638|NCT03562975|592186663|FG000|Overall Study|Lost to Follow-up|1|||
163950639|NCT03562975|592186663|FG000|Overall Study|Withdrawal by Subject|1|||
163950640|NCT01758900|592186664|FG000|Overall Study|difficulty for further intubation|7|||
163950641|NCT01758900|592186665|FG001|Overall Study|difficulty for further intubation|8|||
163950642|NCT02631577|592186666|FG000|Overall Study|Death|1|||
163950643|NCT02631577|592186667|FG001|Overall Study|Death|7|||
163950644|NCT02631577|592186666|FG000|Overall Study|Withdrawal by Subject|0|||
163950645|NCT02631577|592186667|FG001|Overall Study|Withdrawal by Subject|3|||
163950646|NCT04577001|592186668|FG000|Overall Study|Subject became ineligible|0|||
163950647|NCT04577001|592186669|FG001|Overall Study|Subject became ineligible|1|||
163950648|NCT00604825|592186670|FG000|Overall Study|Adverse Event|2|||
164047171|NCT03887052|592532700|FG000|Overall Study|Physician Decision|2|||
163950649|NCT00604825|592186671|FG001|Overall Study|Adverse Event|6|||
163950650|NCT00604825|592186672|FG002|Overall Study|Adverse Event|7|||
164047172|NCT03887052|592532700|FG000|Overall Study|Withdrawal by Subject|3|||
164047173|NCT03887052|592532700|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
164047174|NCT03887052|592532700|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
163950651|NCT00604825|592186673|FG003|Overall Study|Adverse Event|4|||
163950652|NCT00604825|592186670|FG000|Overall Study|Lost to Follow-up|0|||
163950653|NCT00604825|592186671|FG001|Overall Study|Lost to Follow-up|3|||
163950654|NCT00604825|592186672|FG002|Overall Study|Lost to Follow-up|1|||
163950655|NCT00604825|592186673|FG003|Overall Study|Lost to Follow-up|0|||
163950656|NCT00604825|592186670|FG000|Overall Study|Protocol Violation|0|||
163950657|NCT00604825|592186671|FG001|Overall Study|Protocol Violation|1|||
163950658|NCT00604825|592186672|FG002|Overall Study|Protocol Violation|0|||
163950659|NCT00604825|592186673|FG003|Overall Study|Protocol Violation|0|||
163950660|NCT00604825|592186670|FG000|Overall Study|Withdrawal by Subject|4|||
163950661|NCT00604825|592186671|FG001|Overall Study|Withdrawal by Subject|3|||
163950662|NCT00604825|592186672|FG002|Overall Study|Withdrawal by Subject|5|||
163950663|NCT00604825|592186673|FG003|Overall Study|Withdrawal by Subject|5|||
163950664|NCT00604825|592186670|FG000|Overall Study|Lack of Efficacy|3|||
163950665|NCT00604825|592186671|FG001|Overall Study|Lack of Efficacy|2|||
163950666|NCT00604825|592186672|FG002|Overall Study|Lack of Efficacy|1|||
163950667|NCT00604825|592186673|FG003|Overall Study|Lack of Efficacy|0|||
163950668|NCT00604825|592186670|FG000|Overall Study|Did not meet eligibility criteria|0|||
163950669|NCT00604825|592186671|FG001|Overall Study|Did not meet eligibility criteria|0|||
163950670|NCT00604825|592186672|FG002|Overall Study|Did not meet eligibility criteria|2|||
163950671|NCT00604825|592186673|FG003|Overall Study|Did not meet eligibility criteria|0|||
163950672|NCT00604825|592186670|FG000|Overall Study|Physician Decision|0|||
163950673|NCT00604825|592186671|FG001|Overall Study|Physician Decision|0|||
163950674|NCT00604825|592186672|FG002|Overall Study|Physician Decision|0|||
163950675|NCT00604825|592186673|FG003|Overall Study|Physician Decision|1|||
163950676|NCT00604825|592186670|FG000|Overall Study|Exclusion criterion met|0|||
163950677|NCT00604825|592186671|FG001|Overall Study|Exclusion criterion met|0|||
163950678|NCT00604825|592186672|FG002|Overall Study|Exclusion criterion met|0|||
163950679|NCT00604825|592186673|FG003|Overall Study|Exclusion criterion met|1|||
163950680|NCT03465904|592186674|FG000|Overall Study|Withdrawal by Subject|9|||
163950681|NCT03465904|592186675|FG001|Overall Study|Withdrawal by Subject|5|||
163950682|NCT03465904|592186674|FG000|Overall Study|Lost to Follow-up|11|||
163950683|NCT03465904|592186675|FG001|Overall Study|Lost to Follow-up|9|||
163950684|NCT03465904|592186674|FG000|Overall Study|Protocol Violation|20|||
163950685|NCT03465904|592186675|FG001|Overall Study|Protocol Violation|15|||
163950686|NCT05593445|592186676|FG000|12-Week DBVC Period|Adverse Event|1|||
163950687|NCT05593445|592186677|FG001|12-Week DBVC Period|Adverse Event|0|||
163950688|NCT05593445|592186678|FG002|12-Week DBVC Period|Adverse Event|0|||
163950689|NCT05593445|592186679|FG003|12-Week DBVC Period|Adverse Event|0|||
163950690|NCT05593445|592186676|FG000|12-Week DBVC Period|Physician Decision|0|||
163950691|NCT05593445|592186677|FG001|12-Week DBVC Period|Physician Decision|1|||
163950692|NCT05593445|592186678|FG002|12-Week DBVC Period|Physician Decision|0|||
163950693|NCT05593445|592186679|FG003|12-Week DBVC Period|Physician Decision|0|||
163950694|NCT05593445|592186676|FG000|12-Week DBVC Period|Protocol Violation|0|||
163950695|NCT05593445|592186677|FG001|12-Week DBVC Period|Protocol Violation|1|||
163950696|NCT05593445|592186678|FG002|12-Week DBVC Period|Protocol Violation|0|||
163950697|NCT05593445|592186679|FG003|12-Week DBVC Period|Protocol Violation|0|||
163950698|NCT05593445|592186676|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
163950699|NCT05593445|592186677|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
163950700|NCT05593445|592186678|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
163950701|NCT05593445|592186679|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
163950702|NCT05593445|592186676|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
163950703|NCT05593445|592186677|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
163950704|NCT05593445|592186678|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
163950705|NCT05593445|592186679|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
163950706|NCT05593445|592186676|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
163950707|NCT05593445|592186677|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
163950708|NCT05593445|592186678|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
163950709|NCT05593445|592186679|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
163950710|NCT05593445|592186676|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
163950711|NCT05593445|592186677|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
163950712|NCT05593445|592186678|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
163950713|NCT05593445|592186679|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
163950714|NCT05593445|592186676|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163950715|NCT05593445|592186677|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163950716|NCT05593445|592186678|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
163950717|NCT05593445|592186679|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
163950718|NCT00812331|592188564|FG000|Overall Study|Adverse Event|1|||
163950719|NCT00812331|592188565|FG001|Overall Study|Adverse Event|0|||
163950720|NCT00812331|592188566|FG002|Overall Study|Adverse Event|0|||
163950721|NCT00812331|592188567|FG003|Overall Study|Adverse Event|0|||
163950722|NCT00812331|592188568|FG004|Overall Study|Adverse Event|0|||
163950723|NCT03694275|592188569|FG000|Overall Study|Adverse Event|0|||
163950724|NCT03694275|592188570|FG001|Overall Study|Adverse Event|1|||
163950725|NCT03694275|592188569|FG000|Overall Study|Reason not Specified|0|||
163950726|NCT03694275|592188570|FG001|Overall Study|Reason not Specified|1|||
163950727|NCT02359877|592188578|FG000|Overall Study|Withdrawal by Subject|1|||
163950728|NCT02359877|592188579|FG001|Overall Study|Withdrawal by Subject|0|||
163950729|NCT02359877|592188580|FG002|Overall Study|Withdrawal by Subject|0|||
163950730|NCT02359877|592188581|FG003|Overall Study|Withdrawal by Subject|2|||
163950731|NCT02359877|592188578|FG000|Overall Study|Adverse Event|0|||
163950732|NCT02359877|592188579|FG001|Overall Study|Adverse Event|0|||
163950733|NCT02359877|592188580|FG002|Overall Study|Adverse Event|0|||
163950734|NCT02359877|592188581|FG003|Overall Study|Adverse Event|1|||
163950735|NCT00910689|592188595|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
163950736|NCT00910689|592188596|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
163950737|NCT00910689|592188597|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
163950738|NCT00910689|592188598|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
163950739|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
163950740|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
163950741|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
163950742|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
163950743|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
163950744|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
163950745|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
163950746|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
163950747|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
163950748|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
163950749|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
163950750|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
163950751|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
163950752|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
163950753|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
163950754|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
163950755|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
163950756|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
163950757|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
163950758|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
163950759|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
163950760|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
163950761|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
163950762|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
163950763|NCT00910689|592188595|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
163950764|NCT00910689|592188596|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
163950765|NCT00910689|592188597|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
163950766|NCT00910689|592188598|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
163950767|NCT00910689|592188595|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
163950768|NCT00910689|592188596|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
163950769|NCT00910689|592188597|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
163950770|NCT00910689|592188598|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
163950771|NCT00910689|592188595|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
163950772|NCT00910689|592188596|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
163950773|NCT00910689|592188597|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
163950774|NCT00910689|592188598|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
163950775|NCT00910689|592188595|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
163950776|NCT00910689|592188596|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
163950777|NCT00910689|592188597|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
163950778|NCT00910689|592188598|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
163950779|NCT00910689|592188595|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
164047175|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
164047176|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
163950780|NCT00910689|592188596|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
163950781|NCT00910689|592188597|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
163950782|NCT00910689|592188598|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
163950783|NCT00910689|592188595|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
163950784|NCT00910689|592188596|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
163950785|NCT00910689|592188597|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
163950786|NCT00910689|592188598|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
163950787|NCT00910689|592188595|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
163950788|NCT00910689|592188596|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
163950789|NCT00910689|592188597|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
163950790|NCT00910689|592188598|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
163950791|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
163950792|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
163950793|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
163950794|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
164047177|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Death|1|||
163843230|NCT00384059|591796889|FG001|Infant Series|Withdrawal by Subject|2|||
163843231|NCT00384059|591796888|FG000|Infant Series|Adverse Event|1|||
163843232|NCT00384059|591796889|FG001|Infant Series|Adverse Event|2|||
163843233|NCT00384059|591796888|FG000|Infant Series|Protocol Violation|1|||
163843234|NCT00384059|591796889|FG001|Infant Series|Protocol Violation|2|||
163843235|NCT00384059|591796888|FG000|Infant Series|Lost to Follow-up|0|||
163843236|NCT00384059|591796889|FG001|Infant Series|Lost to Follow-up|1|||
163843237|NCT00384059|591796888|FG000|After Infant Series|Protocol Violation|2|||
163843238|NCT00384059|591796889|FG001|After Infant Series|Protocol Violation|3|||
163843239|NCT00384059|591796888|FG000|After Infant Series|Withdrawal by Subject|2|||
163843240|NCT00384059|591796889|FG001|After Infant Series|Withdrawal by Subject|2|||
163843241|NCT00384059|591796888|FG000|After Infant Series|Failed to Return|0|||
163843242|NCT00384059|591796889|FG001|After Infant Series|Failed to Return|2|||
163843243|NCT00384059|591796888|FG000|After Infant Series|Adverse Event|0|||
163843244|NCT00384059|591796889|FG001|After Infant Series|Adverse Event|1|||
163843245|NCT00384059|591796888|FG000|After Infant Series|Physician Decision|0|||
163843246|NCT00384059|591796889|FG001|After Infant Series|Physician Decision|1|||
163843247|NCT00384059|591796888|FG000|After Infant Series|Lost to Follow-up|0|||
163843248|NCT00384059|591796889|FG001|After Infant Series|Lost to Follow-up|1|||
163843249|NCT00384059|591796888|FG000|Toddler Dose|Lost to Follow-up|1|||
163843250|NCT00384059|591796889|FG001|Toddler Dose|Lost to Follow-up|1|||
163843251|NCT00384059|591796888|FG000|Toddler Dose|Failed to return|0|||
163843252|NCT00384059|591796889|FG001|Toddler Dose|Failed to return|1|||
163843253|NCT02959138|591798497|FG000|Overall Study|Enrolled but Never Treated|0|||
163843254|NCT02959138|591798498|FG001|Overall Study|Enrolled but Never Treated|1|||
163843255|NCT02959138|591798499|FG002|Overall Study|Enrolled but Never Treated|0|||
163843256|NCT02391038|591798500|FG000|Overall Study|Progressive disease|3|||
163843257|NCT02391038|591798501|FG001|Overall Study|Progressive disease|3|||
163843258|NCT02391038|591798502|FG002|Overall Study|Progressive disease|6|||
163843259|NCT04213989|591798503|FG000|Overall Study|Withdrawal by Subject|3|||
163843260|NCT04213989|591798504|FG001|Overall Study|Withdrawal by Subject|2|||
163843261|NCT04213989|591798503|FG000|Overall Study|Physician Decision|1|||
163843262|NCT04213989|591798504|FG001|Overall Study|Physician Decision|0|||
163843263|NCT04213989|591798503|FG000|Overall Study|Lost to Follow-up|0|||
163843264|NCT04213989|591798504|FG001|Overall Study|Lost to Follow-up|4|||
163843265|NCT01327547|591798505|FG000|Overall Study|Adverse Event|4|||
163843266|NCT01327547|591798506|FG001|Overall Study|Adverse Event|1|||
163843267|NCT01327547|591798505|FG000|Overall Study|Death|1|||
163843268|NCT01327547|591798506|FG001|Overall Study|Death|2|||
163843269|NCT01327547|591798505|FG000|Overall Study|Lost to Follow-up|6|||
163843270|NCT01327547|591798506|FG001|Overall Study|Lost to Follow-up|6|||
163843271|NCT01327547|591798505|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
163843272|NCT01327547|591798506|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
163843273|NCT01327547|591798505|FG000|Overall Study|Withdrawal by Subject|3|||
163843274|NCT01327547|591798506|FG001|Overall Study|Withdrawal by Subject|7|||
163843275|NCT01327547|591798505|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
163843276|NCT01327547|591798506|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
163843277|NCT01327547|591798505|FG000|Overall Study|Protocol Violation|1|||
163843278|NCT01327547|591798506|FG001|Overall Study|Protocol Violation|0|||
163843279|NCT01327547|591798505|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
163843280|NCT01327547|591798506|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
163843281|NCT01327547|591798505|FG000|Overall Study|Required prohibited medication|2|||
163843282|NCT01327547|591798506|FG001|Overall Study|Required prohibited medication|0|||
163843283|NCT01327547|591798505|FG000|Overall Study|Non-compliance with study procedures|1|||
163843284|NCT01327547|591798506|FG001|Overall Study|Non-compliance with study procedures|0|||
163843285|NCT01327547|591798505|FG000|Overall Study|By investigator in subject's interest|0|||
163843286|NCT01327547|591798506|FG001|Overall Study|By investigator in subject's interest|1|||
163843287|NCT03390036|591798509|FG000|Overall Study|Lost to Follow-up|1|||
163843288|NCT03390036|591798510|FG001|Overall Study|Lost to Follow-up|0|||
163843289|NCT03390036|591798511|FG002|Overall Study|Lost to Follow-up|0|||
163843290|NCT03390036|591798509|FG000|Overall Study|Lack of Efficacy|1|||
163843291|NCT03390036|591798510|FG001|Overall Study|Lack of Efficacy|0|||
163843292|NCT03390036|591798511|FG002|Overall Study|Lack of Efficacy|0|||
163843293|NCT01474512|591798521|FG000|Induction Period|Adverse Event|6|||
163843294|NCT01474512|591798522|FG001|Induction Period|Adverse Event|10|||
163843295|NCT01474512|591798523|FG002|Induction Period|Adverse Event|10|||
163843296|NCT01474512|591798524|FG003|Induction Period|Adverse Event|0|||
163843297|NCT01474512|591798525|FG004|Induction Period|Adverse Event|0|||
163843298|NCT01474512|591798526|FG005|Induction Period|Adverse Event|0|||
163843299|NCT01474512|591798527|FG006|Induction Period|Adverse Event|0|||
163843300|NCT01474512|591798528|FG007|Induction Period|Adverse Event|0|||
163843301|NCT01474512|591798529|FG008|Induction Period|Adverse Event|0|||
163843302|NCT01474512|591798530|FG009|Induction Period|Adverse Event|0|||
163843303|NCT01474512|591798531|FG010|Induction Period|Adverse Event|0|||
163843304|NCT01474512|591798532|FG011|Induction Period|Adverse Event|0|||
163843305|NCT01474512|591798533|FG012|Induction Period|Adverse Event|0|||
163843306|NCT01474512|591798534|FG013|Induction Period|Adverse Event|0|||
163843307|NCT01474512|591798535|FG014|Induction Period|Adverse Event|0|||
163950795|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
163950796|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
163950797|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
163950798|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
163950799|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
163950800|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
163950801|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
163950802|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
163950803|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
163950804|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
163950805|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
163950806|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
163950807|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
163950808|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
163950809|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
163950810|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
163950811|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
164047178|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Death|1|||
164047179|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
164047180|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
164047181|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
164047182|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
164047183|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
164047184|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
164047185|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
164047186|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
164047187|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
164047188|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
164047189|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
164047190|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
164047191|NCT03728881|592532701|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
164047192|NCT03728881|592532702|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
164047193|NCT03728881|592532701|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
164047194|NCT03728881|592532702|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
164047195|NCT03728881|592532701|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
164047196|NCT03728881|592532702|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
164047197|NCT04517253|592532705|FG000|Primary Treatment Period|Adverse Event|1|||
164047198|NCT04517253|592532706|FG001|Primary Treatment Period|Adverse Event|0|||
164047199|NCT04517253|592532707|FG002|Primary Treatment Period|Adverse Event|0|||
164047200|NCT04517253|592532705|FG000|Primary Treatment Period|Death|0|||
164047201|NCT04517253|592532706|FG001|Primary Treatment Period|Death|1|||
164047202|NCT04517253|592532707|FG002|Primary Treatment Period|Death|0|||
164047203|NCT04517253|592532705|FG000|Maintenance Period|Withdrawal by Subject|1|||
164047204|NCT04517253|592532706|FG001|Maintenance Period|Withdrawal by Subject|0|||
164047205|NCT04517253|592532707|FG002|Maintenance Period|Withdrawal by Subject|0|||
164047206|NCT04517253|592532705|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
164047207|NCT04517253|592532706|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
164047208|NCT04517253|592532707|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
164047209|NCT04651777|592532708|FG000|Overall Study|Adverse Event|1|||
164047210|NCT04651777|592532708|FG000|Overall Study|Withdrawal by Subject|2|||
164047211|NCT05505734|592532709|FG000|Overall Study|Withdrawal by Subject|51|||
164047212|NCT05505734|592532710|FG001|Overall Study|Withdrawal by Subject|64|||
164047213|NCT05505734|592532709|FG000|Overall Study|Adverse Event|6|||
164047214|NCT05505734|592532710|FG001|Overall Study|Adverse Event|20|||
164047215|NCT05505734|592532709|FG000|Overall Study|Protocol Violation|8|||
164047216|NCT05505734|592532710|FG001|Overall Study|Protocol Violation|15|||
164047217|NCT05505734|592532709|FG000|Overall Study|Lack of therapeutic response|0|||
164047218|NCT05505734|592532710|FG001|Overall Study|Lack of therapeutic response|1|||
164047219|NCT05505734|592532709|FG000|Overall Study|Lost to Follow-up|247|||
164047220|NCT05505734|592532710|FG001|Overall Study|Lost to Follow-up|237|||
164047221|NCT05505734|592532709|FG000|Overall Study|Physician Decision|22|||
164047222|NCT05505734|592532710|FG001|Overall Study|Physician Decision|13|||
164047223|NCT05505734|592532709|FG000|Overall Study|Death|2|||
164047224|NCT05505734|592532710|FG001|Overall Study|Death|1|||
163950812|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
164047225|NCT05505734|592532709|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164047226|NCT05505734|592532710|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164047227|NCT05505734|592532709|FG000|Overall Study|Pregnancy|1|||
164047228|NCT05505734|592532710|FG001|Overall Study|Pregnancy|0|||
164047229|NCT05505734|592532709|FG000|Overall Study|Other|17|||
163950813|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
163950814|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
163950815|NCT00910689|592188595|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
163950816|NCT00910689|592188596|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
163950817|NCT00910689|592188597|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
163950818|NCT00910689|592188598|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
163950819|NCT01290029|592188599|FG000|Overall Study|Other|2|||
163950820|NCT00189488|592188600|FG000|Overall Study|Ineligibility determined|1|||
163950821|NCT00189488|592188601|FG001|Overall Study|Ineligibility determined|0|||
163950822|NCT00189488|592188600|FG000|Overall Study|Protocol deviation|2|||
163950823|NCT00189488|592188601|FG001|Overall Study|Protocol deviation|1|||
163950824|NCT00189488|592188600|FG000|Overall Study|Adverse Event|2|||
163950825|NCT00189488|592188601|FG001|Overall Study|Adverse Event|1|||
163950826|NCT00189488|592188600|FG000|Overall Study|Withdrawal by Subject|2|||
163950827|NCT00189488|592188601|FG001|Overall Study|Withdrawal by Subject|6|||
163950828|NCT00189488|592188600|FG000|Overall Study|Disease progression|2|||
163950829|NCT00189488|592188601|FG001|Overall Study|Disease progression|4|||
163950830|NCT00189488|592188600|FG000|Overall Study|Administrative Decision|0|||
163950831|NCT00189488|592188601|FG001|Overall Study|Administrative Decision|2|||
163950832|NCT00189488|592188600|FG000|Overall Study|Death|5|||
163950833|NCT00189488|592188601|FG001|Overall Study|Death|8|||
163950834|NCT00189488|592188600|FG000|Overall Study|Other|1|||
163950835|NCT00189488|592188601|FG001|Overall Study|Other|0|||
163950836|NCT02349425|592188604|FG000|Period 1|Adverse Event|1|||
163950837|NCT02349425|592188605|FG001|Period 1|Adverse Event|1|||
163950838|NCT02349425|592188606|FG002|Period 1|Adverse Event|0|||
163950839|NCT02349425|592188607|FG003|Period 1|Adverse Event|0|||
163950840|NCT02349425|592188604|FG000|Period 2|Adverse Event|0|||
163950841|NCT02349425|592188605|FG001|Period 2|Adverse Event|1|||
163950842|NCT02349425|592188606|FG002|Period 2|Adverse Event|1|||
163950843|NCT02349425|592188607|FG003|Period 2|Adverse Event|0|||
163950844|NCT00616902|592188608|FG000|Overall Study|Termination of study|6|||
163950845|NCT00616902|592188609|FG001|Overall Study|Termination of study|6|||
163950846|NCT01877837|592188610|FG000|Overall Study|Lost to Follow-up|1|||
163950847|NCT01877837|592188610|FG000|Overall Study|Ineligible|4|||
163950848|NCT00645801|592188611|FG000|Overall Study|unclear if patient took all the medication.|1|||
163950849|NCT00645801|592188612|FG001|Overall Study|unclear if patient took all the medication.|0|||
163950850|NCT00645801|592188611|FG000|Overall Study|Lost to Follow-up|19|||
163950851|NCT00645801|592188612|FG001|Overall Study|Lost to Follow-up|15|||
163950852|NCT00759915|592188613|FG000|Overall Study|Withdrawal by Subject|1|||
163950853|NCT00759915|592188614|FG001|Overall Study|Withdrawal by Subject|0|||
163950854|NCT00759915|592188613|FG000|Overall Study|Adverse Event|0|||
163950855|NCT00759915|592188614|FG001|Overall Study|Adverse Event|1|||
163950856|NCT00932113|592188617|FG000|Overall Study|Lost to Follow-up|1|||
163950857|NCT00932113|592188618|FG001|Overall Study|Lost to Follow-up|0|||
163950858|NCT01190514|592188619|FG000|First Intervention (Period 1)|Adverse Event|1|||
163950859|NCT01190514|592188620|FG001|First Intervention (Period 1)|Adverse Event|0|||
163950860|NCT01190514|592188621|FG002|First Intervention (Period 1)|Adverse Event|0|||
163950861|NCT01190514|592188622|FG003|First Intervention (Period 1)|Adverse Event|0|||
163950862|NCT01190514|592188619|FG000|Third Intervention (Period 3)|Adverse Event|1|||
163950863|NCT01190514|592188620|FG001|Third Intervention (Period 3)|Adverse Event|0|||
163950864|NCT01190514|592188621|FG002|Third Intervention (Period 3)|Adverse Event|0|||
163950865|NCT01190514|592188622|FG003|Third Intervention (Period 3)|Adverse Event|0|||
163950866|NCT00512317|592188623|FG000|Overall Study|Insufficient clinical response|36|||
163950867|NCT00512317|592188623|FG000|Overall Study|Withdrawal by Subject|23|||
163950868|NCT00512317|592188623|FG000|Overall Study|Sponsor closure of study|21|||
163950869|NCT00512317|592188623|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
163950870|NCT00512317|592188623|FG000|Overall Study|Adverse Event|13|||
163950871|NCT00512317|592188623|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
164047230|NCT05505734|592532710|FG001|Overall Study|Other|13|||
164047231|NCT00732472|592532711|FG000|Overall Study|Adverse Event|0|||
164047232|NCT00732472|592532712|FG001|Overall Study|Adverse Event|1|||
163950872|NCT00512317|592188623|FG000|Overall Study|Lost to Follow-up|2|||
163950873|NCT00512317|592188623|FG000|Overall Study|Other|2|||
164047233|NCT00732472|592532713|FG002|Overall Study|Adverse Event|1|||
163950874|NCT01143038|592188624|FG000|Overall Study|Withdrawal by Subject|4|||
163950875|NCT01143038|592188624|FG000|Overall Study|Requirement for alternative therapy|5|||
163950876|NCT01143038|592188624|FG000|Overall Study|Adverse Event|3|||
163950877|NCT01143038|592188624|FG000|Overall Study|Lost to Follow-up|2|||
163950878|NCT01143038|592188624|FG000|Overall Study|Protocol Deviation|1|||
163950879|NCT01143038|592188624|FG000|Overall Study|Death|1|||
163950880|NCT00706433|592188627|FG000|Overall Study|Lost to Follow-up|3|||
163950881|NCT00706433|592188628|FG001|Overall Study|Lost to Follow-up|1|||
163950882|NCT00706433|592188629|FG002|Overall Study|Lost to Follow-up|6|||
164047234|NCT00732472|592532714|FG003|Overall Study|Adverse Event|1|||
163950883|NCT00706433|592188630|FG003|Overall Study|Lost to Follow-up|0|||
163950884|NCT00706433|592188627|FG000|Overall Study|Withdrawal by Subject|1|||
163950885|NCT00706433|592188628|FG001|Overall Study|Withdrawal by Subject|2|||
163950886|NCT00706433|592188629|FG002|Overall Study|Withdrawal by Subject|3|||
163950887|NCT00706433|592188630|FG003|Overall Study|Withdrawal by Subject|1|||
163950888|NCT00706433|592188627|FG000|Overall Study|Adverse Event|0|||
163950889|NCT00706433|592188628|FG001|Overall Study|Adverse Event|0|||
163950890|NCT00706433|592188629|FG002|Overall Study|Adverse Event|1|||
163950891|NCT00706433|592188630|FG003|Overall Study|Adverse Event|0|||
163950892|NCT00706433|592188627|FG000|Overall Study|Protocol Violation|1|||
163950893|NCT00706433|592188628|FG001|Overall Study|Protocol Violation|0|||
163950894|NCT00706433|592188629|FG002|Overall Study|Protocol Violation|0|||
163950895|NCT00706433|592188630|FG003|Overall Study|Protocol Violation|0|||
163950896|NCT00706433|592188627|FG000|Overall Study|new job|0|||
163950897|NCT00706433|592188628|FG001|Overall Study|new job|0|||
163950898|NCT00706433|592188629|FG002|Overall Study|new job|0|||
163950899|NCT00706433|592188630|FG003|Overall Study|new job|1|||
163950900|NCT04101318|592188632|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
163950901|NCT04101318|592188633|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
163950902|NCT04101318|592188632|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
163950903|NCT04101318|592188633|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
163950904|NCT04101318|592188632|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
163950905|NCT04101318|592188633|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
163950906|NCT00717067|592188634|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163950907|NCT00717067|592188635|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163950908|NCT00717067|592188636|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
163950909|NCT00717067|592188637|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163950910|NCT00717067|592188638|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
163950911|NCT02090959|592188639|FG000|Overall Study|Withdrawal by Subject|10|||
163950912|NCT02090959|592188639|FG000|Overall Study|Adverse Event|1|||
163950913|NCT02090959|592188639|FG000|Overall Study|Investigator decision|2|||
163950914|NCT02090959|592188639|FG000|Overall Study|Study termination|6|||
163950915|NCT02090959|592188639|FG000|Overall Study|Enrolled but not treated|1|||
163950916|NCT02090959|592188639|FG000|Overall Study|Transfer for compassionate use medicine|4|||
163950917|NCT02090959|592188639|FG000|Overall Study|Move to medical need program|3|||
163950918|NCT02090959|592188639|FG000|Overall Study|Entered in to other study|34|||
163950919|NCT02090959|592188639|FG000|Overall Study|Switched to commercial supply|88|||
163950920|NCT02090959|592188639|FG000|Overall Study|Other than specified|2|||
163950921|NCT00522873|592188640|FG000|Overall Study|Adverse Event|41|||
163950922|NCT00522873|592188641|FG001|Overall Study|Adverse Event|26|||
163950923|NCT00522873|592188640|FG000|Overall Study|Withdrawal by Subject|20|||
163950924|NCT00522873|592188641|FG001|Overall Study|Withdrawal by Subject|9|||
163950925|NCT00522873|592188640|FG000|Overall Study|Protocol Violation|14|||
163950926|NCT00522873|592188641|FG001|Overall Study|Protocol Violation|4|||
163950927|NCT00522873|592188640|FG000|Overall Study|Lost to Follow-up|11|||
163950928|NCT00522873|592188641|FG001|Overall Study|Lost to Follow-up|3|||
163950929|NCT00522873|592188640|FG000|Overall Study|Personal Reasons|8|||
163950930|NCT00522873|592188641|FG001|Overall Study|Personal Reasons|1|||
163950931|NCT00522873|592188640|FG000|Overall Study|Medication Errors|1|||
163950932|NCT00522873|592188641|FG001|Overall Study|Medication Errors|1|||
163950933|NCT00522873|592188640|FG000|Overall Study|Never Received Medication|1|||
163950934|NCT00522873|592188641|FG001|Overall Study|Never Received Medication|0|||
163950935|NCT00657020|592188642|FG000|PERIOD 1|Adverse Event|0|||
163950936|NCT00657020|592188643|FG001|PERIOD 1|Adverse Event|1|||
163950937|NCT01183234|592188644|FG000|First Intervention|Adverse Event|1|||
163950938|NCT01183234|592188645|FG001|First Intervention|Adverse Event|0|||
163950939|NCT02029846|592188648|FG000|Overall Study|n=1 each arm|1|||
163950940|NCT02029846|592188649|FG001|Overall Study|n=1 each arm|1|||
163950941|NCT02966301|592188653|FG000|Overall Study|Death|2|||
163950942|NCT02966301|592188653|FG000|Overall Study|Withdrawal by Subject|1|||
163950943|NCT00822172|592188654|FG000|Overall Study|Adverse Event|10|||
163950944|NCT00822172|592188655|FG001|Overall Study|Adverse Event|12|||
163950945|NCT00822172|592188654|FG000|Overall Study|Death|1|||
163950946|NCT00822172|592188655|FG001|Overall Study|Death|0|||
164047235|NCT00732472|592532711|FG000|Overall Study|Protocol Violation|0|||
164047236|NCT00732472|592532712|FG001|Overall Study|Protocol Violation|0|||
163950947|NCT00822172|592188654|FG000|Overall Study|Lost to Follow-up|3|||
163950948|NCT00822172|592188655|FG001|Overall Study|Lost to Follow-up|1|||
163950949|NCT00822172|592188654|FG000|Overall Study|Withdrawal by Subject|1|||
163950950|NCT00822172|592188655|FG001|Overall Study|Withdrawal by Subject|4|||
163950951|NCT00822172|592188654|FG000|Overall Study|site closed|0|||
163950952|NCT00822172|592188655|FG001|Overall Study|site closed|1|||
163950953|NCT00822172|592188654|FG000|Overall Study|Other|0|||
163950954|NCT00822172|592188655|FG001|Overall Study|Other|1|||
163950955|NCT00370331|592188657|FG000|Overall Study|Adverse Event|4|||
163950956|NCT00370331|592188658|FG001|Overall Study|Adverse Event|13|||
164047237|NCT00732472|592532713|FG002|Overall Study|Protocol Violation|0|||
163950957|NCT00370331|592188657|FG000|Overall Study|Withdrawal by Subject|2|||
163950958|NCT00370331|592188658|FG001|Overall Study|Withdrawal by Subject|4|||
163950959|NCT00370331|592188657|FG000|Overall Study|Lost to Follow-up|0|||
164047238|NCT00732472|592532714|FG003|Overall Study|Protocol Violation|1|||
164047239|NCT00732472|592532711|FG000|Overall Study|Withdrawal by Subject|0|||
164047240|NCT00732472|592532712|FG001|Overall Study|Withdrawal by Subject|2|||
164047241|NCT00732472|592532713|FG002|Overall Study|Withdrawal by Subject|0|||
164047242|NCT00732472|592532714|FG003|Overall Study|Withdrawal by Subject|1|||
164047243|NCT01023516|592532716|FG000|Overall Study|Voluntary discontinuation|7|||
164047244|NCT01023516|592532717|FG001|Overall Study|Voluntary discontinuation|5|||
164047245|NCT01023516|592532716|FG000|Overall Study|Adverse Event|9|||
164047246|NCT01023516|592532717|FG001|Overall Study|Adverse Event|6|||
164047247|NCT01023516|592532716|FG000|Overall Study|Safety reason|0|||
164047248|NCT01023516|592532717|FG001|Overall Study|Safety reason|3|||
164047249|NCT01023516|592532716|FG000|Overall Study|Study-specific criteria|4|||
164047250|NCT01023516|592532717|FG001|Overall Study|Study-specific criteria|2|||
164047251|NCT01023516|592532716|FG000|Overall Study|Incorrect enrolment|4|||
164047252|NCT01023516|592532717|FG001|Overall Study|Incorrect enrolment|2|||
164047253|NCT03575351|592532720|FG000|Overall Study|Adverse Event|1|||
164047254|NCT03575351|592532721|FG001|Overall Study|Adverse Event|0|||
164047255|NCT03575351|592532720|FG000|Overall Study|Death|2|||
164047256|NCT03575351|592532721|FG001|Overall Study|Death|2|||
164047257|NCT03575351|592532720|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
164047258|NCT03575351|592532721|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
164047259|NCT03575351|592532720|FG000|Overall Study|Lack of Efficacy|28|||
164047260|NCT03575351|592532721|FG001|Overall Study|Lack of Efficacy|0|||
164047261|NCT03575351|592532720|FG000|Overall Study|Withdrawal by Subject|1|||
164047262|NCT03575351|592532721|FG001|Overall Study|Withdrawal by Subject|1|||
164047263|NCT03575351|592532720|FG000|Overall Study|Physician Decision|3|||
164047264|NCT03575351|592532721|FG001|Overall Study|Physician Decision|0|||
164047265|NCT03575351|592532720|FG000|Overall Study|Disease relapse|15|||
164047266|NCT03575351|592532721|FG001|Overall Study|Disease relapse|6|||
164047267|NCT03575351|592532720|FG000|Overall Study|Study drug manufacturing failure|0|||
164047268|NCT03575351|592532721|FG001|Overall Study|Study drug manufacturing failure|1|||
164047269|NCT03575351|592532720|FG000|Overall Study|other reasons|5|||
164047270|NCT03575351|592532721|FG001|Overall Study|other reasons|0|||
164047271|NCT03715205|592532722|FG000|Overall Study|Death|13|||
164047272|NCT03715205|592532722|FG000|Overall Study|Lost to Follow-up|2|||
164047273|NCT03715205|592532722|FG000|Overall Study|Physician Decision|93|||
164047274|NCT03715205|592532722|FG000|Overall Study|Withdrawal by Subject|26|||
164047275|NCT02623699|592532723|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047276|NCT02623699|592532724|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
164047277|NCT02623699|592532725|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047278|NCT02623699|592532726|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047279|NCT02623699|592532727|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047280|NCT02623699|592532728|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047281|NCT02623699|592532729|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
163843308|NCT01474512|591798536|FG015|Induction Period|Adverse Event|0|||
163843309|NCT01474512|591798537|FG016|Induction Period|Adverse Event|0|||
163843310|NCT01474512|591798538|FG017|Induction Period|Adverse Event|0|||
163843311|NCT01474512|591798521|FG000|Induction Period|Lack of Efficacy|7|||
163843312|NCT01474512|591798522|FG001|Induction Period|Lack of Efficacy|1|||
163843313|NCT01474512|591798523|FG002|Induction Period|Lack of Efficacy|0|||
163843314|NCT01474512|591798524|FG003|Induction Period|Lack of Efficacy|0|||
163843315|NCT01474512|591798525|FG004|Induction Period|Lack of Efficacy|0|||
163843316|NCT01474512|591798526|FG005|Induction Period|Lack of Efficacy|0|||
163843317|NCT01474512|591798527|FG006|Induction Period|Lack of Efficacy|0|||
164047282|NCT02623699|592532730|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047283|NCT02623699|592532731|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047284|NCT02623699|592532732|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047285|NCT02623699|592532733|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047286|NCT02623699|592532734|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
164047287|NCT02623699|592532723|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047288|NCT02623699|592532724|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047289|NCT02623699|592532725|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047290|NCT02623699|592532726|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047291|NCT02623699|592532727|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047292|NCT02623699|592532728|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047293|NCT02623699|592532729|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
164047294|NCT02623699|592532730|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047295|NCT02623699|592532731|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047296|NCT02623699|592532732|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047297|NCT02623699|592532733|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047298|NCT02623699|592532734|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
164047299|NCT02623699|592532723|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047300|NCT02623699|592532724|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047301|NCT02623699|592532725|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047302|NCT02623699|592532726|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047303|NCT02623699|592532727|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047304|NCT02623699|592532728|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
164148621|NCT04895982|592904917|FG006|Overall Study|Protocol Violation|0|||
163950960|NCT00370331|592188658|FG001|Overall Study|Lost to Follow-up|3|||
163950961|NCT00370331|592188657|FG000|Overall Study|Lack of Efficacy|0|||
163950962|NCT00370331|592188658|FG001|Overall Study|Lack of Efficacy|1|||
163950963|NCT00370331|592188657|FG000|Overall Study|Non-compliance|0|||
163950964|NCT00370331|592188658|FG001|Overall Study|Non-compliance|1|||
163950965|NCT00370331|592188657|FG000|Overall Study|Protocol Violation|1|||
163950966|NCT00370331|592188658|FG001|Overall Study|Protocol Violation|1|||
163950967|NCT00993668|592188660|FG000|Single-Blind Period|Adverse Event|1|||
163950968|NCT00993668|592188661|FG001|Single-Blind Period|Adverse Event|1|||
163950969|NCT00993668|592188660|FG000|Single-Blind Period|Lack of Efficacy|0|||
163950970|NCT00993668|592188661|FG001|Single-Blind Period|Lack of Efficacy|1|||
163950971|NCT00993668|592188660|FG000|Single-Blind Period|Lost to Follow-up|3|||
163950972|NCT00993668|592188661|FG001|Single-Blind Period|Lost to Follow-up|1|||
163950973|NCT00993668|592188660|FG000|Open-Label Period|Adverse Event|9|||
163950974|NCT00993668|592188661|FG001|Open-Label Period|Adverse Event|8|||
163950975|NCT00993668|592188660|FG000|Open-Label Period|Lack of Efficacy|4|||
163950976|NCT00993668|592188661|FG001|Open-Label Period|Lack of Efficacy|3|||
163950977|NCT00993668|592188660|FG000|Open-Label Period|Withdrawal by Subject|4|||
163950978|NCT00993668|592188661|FG001|Open-Label Period|Withdrawal by Subject|3|||
163950979|NCT00993668|592188660|FG000|Open-Label Period|Lost to Follow-up|6|||
163950980|NCT00993668|592188661|FG001|Open-Label Period|Lost to Follow-up|1|||
163950981|NCT02313233|592188664|FG000|Overall Study|Withdrawal by Subject|1|||
163950982|NCT02313233|592188665|FG001|Overall Study|Withdrawal by Subject|2|||
163950983|NCT02313233|592188664|FG000|Overall Study|Administrative reason|1|||
163950984|NCT02313233|592188665|FG001|Overall Study|Administrative reason|1|||
163950985|NCT02095951|592188666|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
163950986|NCT02095951|592188667|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
163950987|NCT03618823|592188668|FG000|Overall Study|Lost to Follow-up|63|||
163950988|NCT03618823|592188669|FG001|Overall Study|Lost to Follow-up|61|||
163950989|NCT05383508|592188670|FG000|Overall Study|Withdrawal by Subject|1|||
163950990|NCT05383508|592188671|FG001|Overall Study|Withdrawal by Subject|0|||
163950991|NCT05383508|592188672|FG002|Overall Study|Withdrawal by Subject|1|||
163950992|NCT05383508|592188673|FG003|Overall Study|Withdrawal by Subject|1|||
163950993|NCT05383508|592188674|FG004|Overall Study|Withdrawal by Subject|2|||
163950994|NCT05383508|592188675|FG005|Overall Study|Withdrawal by Subject|0|||
163950995|NCT01621568|592188677|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
163950996|NCT01621568|592188678|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
163950997|NCT01621568|592188677|FG000|Week 5-6 No Treatment|Death|1|||
163950998|NCT01621568|592188678|FG001|Week 5-6 No Treatment|Death|0|||
163950999|NCT02930226|592188679|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
163951000|NCT02930226|592188680|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
163951001|NCT02930226|592188681|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
163951002|NCT02930226|592188682|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
163951003|NCT02930226|592188683|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
163951004|NCT02930226|592188684|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
163951005|NCT02224690|592188688|FG000|Overall Study|Adverse Event|8|||
163951006|NCT02224690|592188689|FG001|Overall Study|Adverse Event|1|||
163951007|NCT02224690|592188688|FG000|Overall Study|Met Withdrawal Criteria|4|||
163951008|NCT02224690|592188689|FG001|Overall Study|Met Withdrawal Criteria|0|||
163951009|NCT02224690|592188688|FG000|Overall Study|Use of G-tube|1|||
163951010|NCT02224690|592188689|FG001|Overall Study|Use of G-tube|0|||
163951011|NCT02224690|592188688|FG000|Overall Study|Did not meet eligibility criteria|1|||
163951012|NCT02224690|592188689|FG001|Overall Study|Did not meet eligibility criteria|0|||
163951013|NCT01506609|592188691|FG000|Overall Study|Adverse Event Related to Progression|0|||
163951014|NCT01506609|592188692|FG001|Overall Study|Adverse Event Related to Progression|0|||
163951015|NCT01506609|592188693|FG002|Overall Study|Adverse Event Related to Progression|0|||
163951016|NCT01506609|592188694|FG003|Overall Study|Adverse Event Related to Progression|3|||
163951017|NCT01506609|592188695|FG004|Overall Study|Adverse Event Related to Progression|7|||
163951018|NCT01506609|592188696|FG005|Overall Study|Adverse Event Related to Progression|3|||
164047305|NCT02623699|592532729|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047306|NCT02623699|592532730|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047307|NCT02623699|592532731|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163951019|NCT01506609|592188691|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
164047308|NCT02623699|592532732|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047309|NCT02623699|592532733|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
164047310|NCT02623699|592532734|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
163951020|NCT01506609|592188692|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
163951021|NCT01506609|592188693|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
163951022|NCT01506609|592188694|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
164047311|NCT02623699|592532723|FG000|Part B (Up to 289 Days)|Death|0|||
163951023|NCT01506609|592188695|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
163951024|NCT01506609|592188696|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
164047312|NCT02623699|592532724|FG001|Part B (Up to 289 Days)|Death|0|||
163951025|NCT01506609|592188691|FG000|Overall Study|Withdrawal by Subject|0|||
163951026|NCT01506609|592188692|FG001|Overall Study|Withdrawal by Subject|0|||
163951027|NCT01506609|592188693|FG002|Overall Study|Withdrawal by Subject|0|||
163951028|NCT01506609|592188694|FG003|Overall Study|Withdrawal by Subject|9|||
163951029|NCT01506609|592188695|FG004|Overall Study|Withdrawal by Subject|7|||
163951030|NCT01506609|592188696|FG005|Overall Study|Withdrawal by Subject|7|||
163951031|NCT01506609|592188691|FG000|Overall Study|Lost to Follow-up|0|||
163951032|NCT01506609|592188692|FG001|Overall Study|Lost to Follow-up|0|||
163843318|NCT01474512|591798528|FG007|Induction Period|Lack of Efficacy|0|||
163843319|NCT01474512|591798529|FG008|Induction Period|Lack of Efficacy|0|||
163843320|NCT01474512|591798530|FG009|Induction Period|Lack of Efficacy|0|||
163843321|NCT01474512|591798531|FG010|Induction Period|Lack of Efficacy|0|||
163843322|NCT01474512|591798532|FG011|Induction Period|Lack of Efficacy|0|||
163843323|NCT01474512|591798533|FG012|Induction Period|Lack of Efficacy|0|||
163843324|NCT01474512|591798534|FG013|Induction Period|Lack of Efficacy|0|||
163843325|NCT01474512|591798535|FG014|Induction Period|Lack of Efficacy|0|||
163843326|NCT01474512|591798536|FG015|Induction Period|Lack of Efficacy|0|||
163843327|NCT01474512|591798537|FG016|Induction Period|Lack of Efficacy|0|||
163843328|NCT01474512|591798538|FG017|Induction Period|Lack of Efficacy|0|||
163843329|NCT01474512|591798521|FG000|Induction Period|Withdrawal by Subject|6|||
163843330|NCT01474512|591798522|FG001|Induction Period|Withdrawal by Subject|6|||
163843331|NCT01474512|591798523|FG002|Induction Period|Withdrawal by Subject|5|||
163843332|NCT01474512|591798524|FG003|Induction Period|Withdrawal by Subject|0|||
163843333|NCT01474512|591798525|FG004|Induction Period|Withdrawal by Subject|0|||
163843334|NCT01474512|591798526|FG005|Induction Period|Withdrawal by Subject|0|||
163843335|NCT01474512|591798527|FG006|Induction Period|Withdrawal by Subject|0|||
163843336|NCT01474512|591798528|FG007|Induction Period|Withdrawal by Subject|0|||
163843337|NCT01474512|591798529|FG008|Induction Period|Withdrawal by Subject|0|||
163843338|NCT01474512|591798530|FG009|Induction Period|Withdrawal by Subject|0|||
163843339|NCT01474512|591798531|FG010|Induction Period|Withdrawal by Subject|0|||
163843340|NCT01474512|591798532|FG011|Induction Period|Withdrawal by Subject|0|||
163843341|NCT01474512|591798533|FG012|Induction Period|Withdrawal by Subject|0|||
163843342|NCT01474512|591798534|FG013|Induction Period|Withdrawal by Subject|0|||
163843343|NCT01474512|591798535|FG014|Induction Period|Withdrawal by Subject|0|||
163843344|NCT01474512|591798536|FG015|Induction Period|Withdrawal by Subject|0|||
163843345|NCT01474512|591798537|FG016|Induction Period|Withdrawal by Subject|0|||
163843346|NCT01474512|591798538|FG017|Induction Period|Withdrawal by Subject|0|||
163843347|NCT01474512|591798521|FG000|Induction Period|Protocol Violation|3|||
163843348|NCT01474512|591798522|FG001|Induction Period|Protocol Violation|6|||
163843349|NCT01474512|591798523|FG002|Induction Period|Protocol Violation|0|||
163843350|NCT01474512|591798524|FG003|Induction Period|Protocol Violation|0|||
163843351|NCT01474512|591798525|FG004|Induction Period|Protocol Violation|0|||
163843352|NCT01474512|591798526|FG005|Induction Period|Protocol Violation|0|||
163843353|NCT01474512|591798527|FG006|Induction Period|Protocol Violation|0|||
163843354|NCT01474512|591798528|FG007|Induction Period|Protocol Violation|0|||
163843355|NCT01474512|591798529|FG008|Induction Period|Protocol Violation|0|||
163843356|NCT01474512|591798530|FG009|Induction Period|Protocol Violation|0|||
163843357|NCT01474512|591798531|FG010|Induction Period|Protocol Violation|0|||
163843358|NCT01474512|591798532|FG011|Induction Period|Protocol Violation|0|||
163843359|NCT01474512|591798533|FG012|Induction Period|Protocol Violation|0|||
163843360|NCT01474512|591798534|FG013|Induction Period|Protocol Violation|0|||
163843361|NCT01474512|591798535|FG014|Induction Period|Protocol Violation|0|||
163843362|NCT01474512|591798536|FG015|Induction Period|Protocol Violation|0|||
163843363|NCT01474512|591798537|FG016|Induction Period|Protocol Violation|0|||
163843364|NCT01474512|591798538|FG017|Induction Period|Protocol Violation|0|||
163843365|NCT01474512|591798521|FG000|Induction Period|Sponsor Decision|1|||
163843366|NCT01474512|591798522|FG001|Induction Period|Sponsor Decision|1|||
163843367|NCT01474512|591798523|FG002|Induction Period|Sponsor Decision|1|||
163843368|NCT01474512|591798524|FG003|Induction Period|Sponsor Decision|0|||
163843369|NCT01474512|591798525|FG004|Induction Period|Sponsor Decision|0|||
163843370|NCT01474512|591798526|FG005|Induction Period|Sponsor Decision|0|||
163843371|NCT01474512|591798527|FG006|Induction Period|Sponsor Decision|0|||
163843372|NCT01474512|591798528|FG007|Induction Period|Sponsor Decision|0|||
163843373|NCT01474512|591798529|FG008|Induction Period|Sponsor Decision|0|||
163843374|NCT01474512|591798530|FG009|Induction Period|Sponsor Decision|0|||
163843375|NCT01474512|591798531|FG010|Induction Period|Sponsor Decision|0|||
163951033|NCT01506609|592188693|FG002|Overall Study|Lost to Follow-up|0|||
163843376|NCT01474512|591798532|FG011|Induction Period|Sponsor Decision|0|||
163843377|NCT01474512|591798533|FG012|Induction Period|Sponsor Decision|0|||
163843378|NCT01474512|591798534|FG013|Induction Period|Sponsor Decision|0|||
163843379|NCT01474512|591798535|FG014|Induction Period|Sponsor Decision|0|||
163843380|NCT01474512|591798536|FG015|Induction Period|Sponsor Decision|0|||
163843381|NCT01474512|591798537|FG016|Induction Period|Sponsor Decision|0|||
163951034|NCT01506609|592188694|FG003|Overall Study|Lost to Follow-up|1|||
163951035|NCT01506609|592188695|FG004|Overall Study|Lost to Follow-up|2|||
163843382|NCT01474512|591798538|FG017|Induction Period|Sponsor Decision|0|||
163843383|NCT01474512|591798521|FG000|Induction Period|Lost to Follow-up|1|||
163843384|NCT01474512|591798522|FG001|Induction Period|Lost to Follow-up|0|||
164047313|NCT02623699|592532725|FG002|Part B (Up to 289 Days)|Death|0|||
164047314|NCT02623699|592532726|FG003|Part B (Up to 289 Days)|Death|0|||
164047315|NCT02623699|592532727|FG004|Part B (Up to 289 Days)|Death|0|||
164047316|NCT02623699|592532728|FG005|Part B (Up to 289 Days)|Death|1|||
164047317|NCT02623699|592532729|FG006|Part B (Up to 289 Days)|Death|1|||
164047318|NCT02623699|592532730|FG007|Part B (Up to 289 Days)|Death|0|||
164047319|NCT02623699|592532731|FG008|Part B (Up to 289 Days)|Death|1|||
164047320|NCT02623699|592532732|FG009|Part B (Up to 289 Days)|Death|0|||
164099716|NCT02100228|592730565|FG001|Overall Study|Administrative reason|1|||
163843385|NCT01474512|591798523|FG002|Induction Period|Lost to Follow-up|2|||
163843386|NCT01474512|591798524|FG003|Induction Period|Lost to Follow-up|0|||
163843387|NCT01474512|591798525|FG004|Induction Period|Lost to Follow-up|0|||
163843388|NCT01474512|591798526|FG005|Induction Period|Lost to Follow-up|0|||
163843389|NCT01474512|591798527|FG006|Induction Period|Lost to Follow-up|0|||
163843390|NCT01474512|591798528|FG007|Induction Period|Lost to Follow-up|0|||
163843391|NCT01474512|591798529|FG008|Induction Period|Lost to Follow-up|0|||
163843392|NCT01474512|591798530|FG009|Induction Period|Lost to Follow-up|0|||
163843393|NCT01474512|591798531|FG010|Induction Period|Lost to Follow-up|0|||
163843394|NCT01474512|591798532|FG011|Induction Period|Lost to Follow-up|0|||
163843395|NCT01474512|591798533|FG012|Induction Period|Lost to Follow-up|0|||
163843396|NCT01474512|591798534|FG013|Induction Period|Lost to Follow-up|0|||
163843397|NCT01474512|591798535|FG014|Induction Period|Lost to Follow-up|0|||
163843398|NCT01474512|591798536|FG015|Induction Period|Lost to Follow-up|0|||
163843399|NCT01474512|591798537|FG016|Induction Period|Lost to Follow-up|0|||
163843400|NCT01474512|591798538|FG017|Induction Period|Lost to Follow-up|0|||
163843401|NCT01474512|591798521|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843402|NCT01474512|591798522|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843403|NCT01474512|591798523|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843404|NCT01474512|591798524|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
163843405|NCT01474512|591798525|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
163843406|NCT01474512|591798526|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
163843407|NCT01474512|591798527|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
163843408|NCT01474512|591798528|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843409|NCT01474512|591798529|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843410|NCT01474512|591798530|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843411|NCT01474512|591798531|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843412|NCT01474512|591798532|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843413|NCT01474512|591798533|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843414|NCT01474512|591798534|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843415|NCT01474512|591798535|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843416|NCT01474512|591798536|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843417|NCT01474512|591798537|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843418|NCT01474512|591798538|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
163843419|NCT01474512|591798521|FG000|Maintenance Period|Adverse Event|0|||
163843420|NCT01474512|591798522|FG001|Maintenance Period|Adverse Event|0|||
163843421|NCT01474512|591798523|FG002|Maintenance Period|Adverse Event|0|||
163843422|NCT01474512|591798524|FG003|Maintenance Period|Adverse Event|4|||
163843423|NCT01474512|591798525|FG004|Maintenance Period|Adverse Event|2|||
163843424|NCT01474512|591798526|FG005|Maintenance Period|Adverse Event|7|||
163843425|NCT01474512|591798527|FG006|Maintenance Period|Adverse Event|0|||
163843426|NCT01474512|591798528|FG007|Maintenance Period|Adverse Event|19|||
163843427|NCT01474512|591798529|FG008|Maintenance Period|Adverse Event|1|||
163843428|NCT01474512|591798530|FG009|Maintenance Period|Adverse Event|3|||
163843429|NCT01474512|591798531|FG010|Maintenance Period|Adverse Event|0|||
163843430|NCT01474512|591798532|FG011|Maintenance Period|Adverse Event|0|||
163843431|NCT01474512|591798533|FG012|Maintenance Period|Adverse Event|0|||
163843432|NCT01474512|591798534|FG013|Maintenance Period|Adverse Event|0|||
163843433|NCT01474512|591798535|FG014|Maintenance Period|Adverse Event|0|||
163843434|NCT01474512|591798536|FG015|Maintenance Period|Adverse Event|0|||
163843435|NCT01474512|591798537|FG016|Maintenance Period|Adverse Event|0|||
163843436|NCT01474512|591798538|FG017|Maintenance Period|Adverse Event|0|||
163843437|NCT01474512|591798521|FG000|Maintenance Period|Withdrawal by Subject|0|||
163843438|NCT01474512|591798522|FG001|Maintenance Period|Withdrawal by Subject|0|||
163843439|NCT01474512|591798523|FG002|Maintenance Period|Withdrawal by Subject|0|||
163843440|NCT01474512|591798524|FG003|Maintenance Period|Withdrawal by Subject|6|||
163843441|NCT01474512|591798525|FG004|Maintenance Period|Withdrawal by Subject|2|||
163843442|NCT01474512|591798526|FG005|Maintenance Period|Withdrawal by Subject|3|||
163843443|NCT01474512|591798527|FG006|Maintenance Period|Withdrawal by Subject|1|||
163843444|NCT01474512|591798528|FG007|Maintenance Period|Withdrawal by Subject|6|||
163843445|NCT01474512|591798529|FG008|Maintenance Period|Withdrawal by Subject|3|||
163843446|NCT01474512|591798530|FG009|Maintenance Period|Withdrawal by Subject|1|||
163843447|NCT01474512|591798531|FG010|Maintenance Period|Withdrawal by Subject|0|||
163843448|NCT01474512|591798532|FG011|Maintenance Period|Withdrawal by Subject|0|||
163843449|NCT01474512|591798533|FG012|Maintenance Period|Withdrawal by Subject|0|||
163843450|NCT01474512|591798534|FG013|Maintenance Period|Withdrawal by Subject|0|||
163843451|NCT01474512|591798535|FG014|Maintenance Period|Withdrawal by Subject|0|||
164047321|NCT02623699|592532733|FG010|Part B (Up to 289 Days)|Death|0|||
163951036|NCT01506609|592188696|FG005|Overall Study|Lost to Follow-up|0|||
163951037|NCT01506609|592188691|FG000|Overall Study|Sponsor Discontinued Study|0|||
163951038|NCT01506609|592188692|FG001|Overall Study|Sponsor Discontinued Study|0|||
163951039|NCT01506609|592188693|FG002|Overall Study|Sponsor Discontinued Study|0|||
163951040|NCT01506609|592188694|FG003|Overall Study|Sponsor Discontinued Study|2|||
163951041|NCT01506609|592188695|FG004|Overall Study|Sponsor Discontinued Study|2|||
163951042|NCT01506609|592188696|FG005|Overall Study|Sponsor Discontinued Study|0|||
163951043|NCT01506609|592188691|FG000|Overall Study|Progressive Disease per Protocol|1|||
163951044|NCT01506609|592188692|FG001|Overall Study|Progressive Disease per Protocol|0|||
163951045|NCT01506609|592188693|FG002|Overall Study|Progressive Disease per Protocol|0|||
163951046|NCT01506609|592188694|FG003|Overall Study|Progressive Disease per Protocol|64|||
163951047|NCT01506609|592188695|FG004|Overall Study|Progressive Disease per Protocol|57|||
163951048|NCT01506609|592188696|FG005|Overall Study|Progressive Disease per Protocol|74|||
163951049|NCT01506609|592188691|FG000|Overall Study|Other, Not Specified|0|||
163951050|NCT01506609|592188692|FG001|Overall Study|Other, Not Specified|0|||
163951051|NCT01506609|592188693|FG002|Overall Study|Other, Not Specified|0|||
163951052|NCT01506609|592188694|FG003|Overall Study|Other, Not Specified|10|||
163951053|NCT01506609|592188695|FG004|Overall Study|Other, Not Specified|7|||
163951054|NCT01506609|592188696|FG005|Overall Study|Other, Not Specified|3|||
163951055|NCT01506609|592188691|FG000|Overall Study|Missing / Unknown Reason|1|||
163951056|NCT01506609|592188692|FG001|Overall Study|Missing / Unknown Reason|0|||
163951057|NCT01506609|592188693|FG002|Overall Study|Missing / Unknown Reason|1|||
163951058|NCT01506609|592188694|FG003|Overall Study|Missing / Unknown Reason|4|||
163951059|NCT01506609|592188695|FG004|Overall Study|Missing / Unknown Reason|4|||
163951060|NCT01506609|592188696|FG005|Overall Study|Missing / Unknown Reason|2|||
163951061|NCT01990560|592188703|FG000|Overall Study|Withdrawal by Subject|1|||
163951062|NCT01153958|592188704|FG000|Overall Study|Study Terminated|36|||
163951063|NCT01153958|592188705|FG001|Overall Study|Study Terminated|32|||
163951064|NCT00895154|592188706|FG000|Overall Study|Lost to Follow-up|1|||
163951065|NCT00895154|592188707|FG001|Overall Study|Lost to Follow-up|1|||
163951066|NCT00895154|592188706|FG000|Overall Study|Withdrawal by Subject|0|||
163951067|NCT00895154|592188707|FG001|Overall Study|Withdrawal by Subject|1|||
163951068|NCT01688830|592188713|FG000|Overall Study|Lost to Follow-up|0|||
163951069|NCT01688830|592188714|FG001|Overall Study|Lost to Follow-up|0|||
163951070|NCT01688830|592188715|FG002|Overall Study|Lost to Follow-up|0|||
163951071|NCT01688830|592188716|FG003|Overall Study|Lost to Follow-up|0|||
163951072|NCT01688830|592188717|FG004|Overall Study|Lost to Follow-up|0|||
163951073|NCT01688830|592188718|FG005|Overall Study|Lost to Follow-up|0|||
164047322|NCT02623699|592532734|FG011|Part B (Up to 289 Days)|Death|0|||
164047323|NCT02623699|592532723|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
164047324|NCT02623699|592532724|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
164047325|NCT02623699|592532725|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
164047326|NCT02623699|592532726|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
164047327|NCT02623699|592532727|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
164047328|NCT02623699|592532728|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
164047329|NCT02623699|592532729|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
164047330|NCT02623699|592532730|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
164047331|NCT02623699|592532731|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
164047332|NCT02623699|592532732|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
164047333|NCT02623699|592532733|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
164047334|NCT02623699|592532734|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
164047335|NCT02623699|592532723|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047336|NCT02623699|592532724|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047337|NCT02623699|592532725|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047338|NCT02623699|592532726|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047339|NCT02623699|592532727|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047340|NCT02623699|592532728|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047341|NCT02623699|592532729|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047342|NCT02623699|592532730|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047343|NCT02623699|592532731|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047344|NCT02623699|592532732|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
164047345|NCT02623699|592532733|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
164047346|NCT02623699|592532734|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
163951074|NCT01688830|592188719|FG006|Overall Study|Lost to Follow-up|0|||
163951075|NCT01688830|592188720|FG007|Overall Study|Lost to Follow-up|0|||
163951076|NCT01688830|592188721|FG008|Overall Study|Lost to Follow-up|0|||
163951077|NCT01688830|592188722|FG009|Overall Study|Lost to Follow-up|0|||
163951078|NCT01688830|592188723|FG010|Overall Study|Lost to Follow-up|1|||
163951079|NCT01688830|592188724|FG011|Overall Study|Lost to Follow-up|0|||
163951080|NCT01688830|592188725|FG012|Overall Study|Lost to Follow-up|0|||
163951081|NCT01688830|592188726|FG013|Overall Study|Lost to Follow-up|0|||
164047347|NCT02623699|592532723|FG000|Part C (Up to 236 Days)|Death|0|||
164047348|NCT02623699|592532724|FG001|Part C (Up to 236 Days)|Death|0|||
164047349|NCT02623699|592532725|FG002|Part C (Up to 236 Days)|Death|0|||
164047350|NCT02623699|592532726|FG003|Part C (Up to 236 Days)|Death|0|||
164047351|NCT02623699|592532727|FG004|Part C (Up to 236 Days)|Death|0|||
164047352|NCT02623699|592532728|FG005|Part C (Up to 236 Days)|Death|0|||
163951082|NCT01688830|592188727|FG014|Overall Study|Lost to Follow-up|0|||
163951083|NCT01688830|592188728|FG015|Overall Study|Lost to Follow-up|0|||
163951084|NCT01688830|592188729|FG016|Overall Study|Lost to Follow-up|0|||
163951085|NCT01688830|592188730|FG017|Overall Study|Lost to Follow-up|0|||
163951086|NCT01688830|592188731|FG018|Overall Study|Lost to Follow-up|0|||
163951087|NCT01688830|592188732|FG019|Overall Study|Lost to Follow-up|0|||
163951088|NCT01688830|592188733|FG020|Overall Study|Lost to Follow-up|0|||
163951089|NCT00935818|592188734|FG000|Overall Study|Withdrawal by Subject|45|||
163951090|NCT00935818|592188735|FG001|Overall Study|Withdrawal by Subject|50|||
163951091|NCT00935818|592188734|FG000|Overall Study|Lost to Follow-up|40|||
163951092|NCT00935818|592188735|FG001|Overall Study|Lost to Follow-up|42|||
163951093|NCT00935818|592188734|FG000|Overall Study|Adverse Event|6|||
163951094|NCT00935818|592188735|FG001|Overall Study|Adverse Event|7|||
163951095|NCT00935818|592188734|FG000|Overall Study|Physician Decision|0|||
163951096|NCT00935818|592188735|FG001|Overall Study|Physician Decision|1|||
163951097|NCT01305200|592188736|FG000|Overall Study|Physician Decision|4|||
163951098|NCT01305200|592188737|FG001|Overall Study|Physician Decision|6|||
163951099|NCT01305200|592188738|FG002|Overall Study|Physician Decision|1|||
163951100|NCT01305200|592188736|FG000|Overall Study|Withdrawal by Subject|24|||
163951101|NCT01305200|592188737|FG001|Overall Study|Withdrawal by Subject|21|||
163951102|NCT01305200|592188738|FG002|Overall Study|Withdrawal by Subject|1|||
163951103|NCT01305200|592188736|FG000|Overall Study|Ineligible|1|||
163951104|NCT01305200|592188737|FG001|Overall Study|Ineligible|2|||
163951105|NCT01305200|592188738|FG002|Overall Study|Ineligible|1|||
163951106|NCT01305200|592188736|FG000|Overall Study|Death|0|||
163951107|NCT01305200|592188737|FG001|Overall Study|Death|2|||
163951108|NCT01305200|592188738|FG002|Overall Study|Death|0|||
163951109|NCT05559476|592188739|FG000|Overall Study|Adverse Event|2|||
163951110|NCT05559476|592188740|FG001|Overall Study|Adverse Event|0|||
163951111|NCT05559476|592188739|FG000|Overall Study|Lost to Follow-up|13|||
163951112|NCT05559476|592188740|FG001|Overall Study|Lost to Follow-up|12|||
163951113|NCT05559476|592188739|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
163951114|NCT05559476|592188740|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
163951115|NCT05559476|592188739|FG000|Overall Study|Other|0|||
163951116|NCT05559476|592188740|FG001|Overall Study|Other|2|||
163951117|NCT00925353|592188741|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
163951118|NCT02502799|592191410|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
163951119|NCT02502799|592191411|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
163951120|NCT02502799|592191412|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
163951121|NCT02502799|592191413|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
163951122|NCT02502799|592191410|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
163951123|NCT02502799|592191411|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
163951124|NCT02502799|592191412|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
163951125|NCT02502799|592191413|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
163951126|NCT02502799|592191410|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
163951127|NCT02502799|592191411|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
163951128|NCT02502799|592191412|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
163951129|NCT02502799|592191413|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
163951130|NCT02502799|592191410|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
163951131|NCT02502799|592191411|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
163951132|NCT02502799|592191412|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
163951133|NCT02502799|592191413|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
163951134|NCT02502799|592191410|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
163951135|NCT02502799|592191411|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
163951136|NCT02502799|592191412|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
163951137|NCT02502799|592191413|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
163951138|NCT01589237|592191418|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
163951139|NCT01589237|592191419|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
163951140|NCT01589237|592191420|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
163951141|NCT01589237|592191421|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
164047353|NCT02623699|592532729|FG006|Part C (Up to 236 Days)|Death|0|||
163951142|NCT01589237|592191418|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
163951143|NCT01589237|592191419|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
163951144|NCT01589237|592191420|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
163951145|NCT01589237|592191421|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
163951146|NCT01589237|592191418|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
163951147|NCT01589237|592191419|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
163951148|NCT01589237|592191420|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
163951149|NCT01589237|592191421|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
163951150|NCT01589237|592191418|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
164047354|NCT02623699|592532730|FG007|Part C (Up to 236 Days)|Death|0|||
164047355|NCT02623699|592532731|FG008|Part C (Up to 236 Days)|Death|0|||
163951151|NCT01589237|592191419|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
163951152|NCT01589237|592191420|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
163951153|NCT01589237|592191421|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
163951154|NCT00117845|592191422|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
163951155|NCT03207009|592191423|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
163951156|NCT01491672|592191424|FG000|Overall Study|Lost to Follow-up|0|||
163951157|NCT01491672|592191425|FG001|Overall Study|Lost to Follow-up|4|||
163951158|NCT01491672|592191426|FG002|Overall Study|Lost to Follow-up|1|||
163951159|NCT01491672|592191424|FG000|Overall Study|Withdrawal by Subject|6|||
163951160|NCT01491672|592191425|FG001|Overall Study|Withdrawal by Subject|7|||
163951161|NCT01491672|592191426|FG002|Overall Study|Withdrawal by Subject|0|||
163951162|NCT01491672|592191424|FG000|Overall Study|Adverse Event|8|||
163951163|NCT01491672|592191425|FG001|Overall Study|Adverse Event|10|||
163951164|NCT01491672|592191426|FG002|Overall Study|Adverse Event|4|||
163951165|NCT01491672|592191424|FG000|Overall Study|Disease progression|42|||
163951166|NCT01491672|592191425|FG001|Overall Study|Disease progression|34|||
163951167|NCT01491672|592191426|FG002|Overall Study|Disease progression|6|||
163951168|NCT01491672|592191424|FG000|Overall Study|Protocol deviation|0|||
163951169|NCT01491672|592191425|FG001|Overall Study|Protocol deviation|1|||
163951170|NCT01491672|592191426|FG002|Overall Study|Protocol deviation|0|||
163951171|NCT01491672|592191424|FG000|Overall Study|Death|0|||
163951172|NCT01491672|592191425|FG001|Overall Study|Death|4|||
163951173|NCT01491672|592191426|FG002|Overall Study|Death|0|||
163951174|NCT00642772|592191431|FG000|Overall Study|Lost to Follow-up|3|||
163951175|NCT00642772|592191431|FG000|Overall Study|Withdrawal by Subject|7|||
163951176|NCT02947087|592191432|FG000|Overall Study|Withdrawal by Subject|3|||
163951177|NCT02947087|592191433|FG001|Overall Study|Withdrawal by Subject|2|||
163951178|NCT00545051|592191435|FG000|Overall Study|Adverse Event|7|||
163951179|NCT00545051|592191436|FG001|Overall Study|Adverse Event|3|||
163951180|NCT00545051|592191435|FG000|Overall Study|Death|1|||
163951181|NCT00545051|592191436|FG001|Overall Study|Death|0|||
163951182|NCT00545051|592191435|FG000|Overall Study|Violation of inclusion/exclusion|0|||
163951183|NCT00545051|592191436|FG001|Overall Study|Violation of inclusion/exclusion|2|||
163951184|NCT00545051|592191435|FG000|Overall Study|Protocol Violation|1|||
163951185|NCT00545051|592191436|FG001|Overall Study|Protocol Violation|0|||
163951186|NCT00545051|592191435|FG000|Overall Study|Withdrawal by Subject|0|||
163951187|NCT00545051|592191436|FG001|Overall Study|Withdrawal by Subject|1|||
163951188|NCT00545051|592191435|FG000|Overall Study|Administrative reasons|0|||
163951189|NCT00545051|592191436|FG001|Overall Study|Administrative reasons|1|||
163951190|NCT01375114|592191437|FG000|Overall Study|Lost to Follow-up|1|||
163951191|NCT01375114|592191438|FG001|Overall Study|Lost to Follow-up|0|||
163951192|NCT01375114|592191439|FG002|Overall Study|Lost to Follow-up|1|||
163951193|NCT01375114|592191437|FG000|Overall Study|Disease Progression|3|||
163951194|NCT01375114|592191438|FG001|Overall Study|Disease Progression|2|||
163951195|NCT01375114|592191439|FG002|Overall Study|Disease Progression|2|||
163951196|NCT01375114|592191437|FG000|Overall Study|Patient Changed Mind|0|||
163951197|NCT01375114|592191438|FG001|Overall Study|Patient Changed Mind|0|||
163951198|NCT01375114|592191439|FG002|Overall Study|Patient Changed Mind|2|||
163951199|NCT01375114|592191437|FG000|Overall Study|Pruritus|0|||
163951200|NCT01375114|592191438|FG001|Overall Study|Pruritus|0|||
163951201|NCT01375114|592191439|FG002|Overall Study|Pruritus|1|||
163951202|NCT01375114|592191437|FG000|Overall Study|Restlessness|0|||
163951203|NCT01375114|592191438|FG001|Overall Study|Restlessness|0|||
163951204|NCT01375114|592191439|FG002|Overall Study|Restlessness|1|||
163951205|NCT01375114|592191437|FG000|Overall Study|Diarrhea|0|||
163951206|NCT01375114|592191438|FG001|Overall Study|Diarrhea|0|||
163951207|NCT01375114|592191439|FG002|Overall Study|Diarrhea|1|||
163951208|NCT01375114|592191437|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
163951209|NCT01375114|592191438|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
163951210|NCT01375114|592191439|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
163951211|NCT01375114|592191437|FG000|Overall Study|Nausea|0|||
163951212|NCT01375114|592191438|FG001|Overall Study|Nausea|1|||
163951213|NCT01375114|592191439|FG002|Overall Study|Nausea|0|||
163951214|NCT01375114|592191437|FG000|Overall Study|Increased AST/ALT|0|||
163951215|NCT01375114|592191438|FG001|Overall Study|Increased AST/ALT|1|||
163951216|NCT01375114|592191439|FG002|Overall Study|Increased AST/ALT|0|||
163951217|NCT01375114|592191437|FG000|Overall Study|Vaginal Hemorrhage|0|||
163951218|NCT01375114|592191438|FG001|Overall Study|Vaginal Hemorrhage|1|||
164148622|NCT04895982|592904918|FG007|Overall Study|Protocol Violation|1|||
163951219|NCT01375114|592191439|FG002|Overall Study|Vaginal Hemorrhage|0|||
163951220|NCT01375114|592191437|FG000|Overall Study|Family problem|0|||
163951221|NCT01375114|592191438|FG001|Overall Study|Family problem|1|||
163951222|NCT01375114|592191439|FG002|Overall Study|Family problem|0|||
163951223|NCT01375114|592191437|FG000|Overall Study|Protocol Violation|2|||
163951224|NCT01375114|592191438|FG001|Overall Study|Protocol Violation|0|||
163951225|NCT01375114|592191439|FG002|Overall Study|Protocol Violation|0|||
163951226|NCT04256629|592191446|FG000|Overall Study|Adverse Event|0|||
163951227|NCT04256629|592191447|FG001|Overall Study|Adverse Event|0|||
163951228|NCT04256629|592191448|FG002|Overall Study|Adverse Event|0|||
163951229|NCT04256629|592191449|FG003|Overall Study|Adverse Event|0|||
163951230|NCT04256629|592191450|FG004|Overall Study|Adverse Event|0|||
163951231|NCT04256629|592191451|FG005|Overall Study|Adverse Event|1|||
163951232|NCT04256629|592191446|FG000|Overall Study|Protocol Violation|0|||
163951233|NCT04256629|592191447|FG001|Overall Study|Protocol Violation|1|||
163951234|NCT04256629|592191448|FG002|Overall Study|Protocol Violation|0|||
163951235|NCT04256629|592191449|FG003|Overall Study|Protocol Violation|0|||
163951236|NCT04256629|592191450|FG004|Overall Study|Protocol Violation|0|||
163951237|NCT04256629|592191451|FG005|Overall Study|Protocol Violation|0|||
163951238|NCT01859988|592191452|FG000|Overall Study|Withdrawal by Subject|6|||
163951239|NCT01859988|592191453|FG001|Overall Study|Withdrawal by Subject|3|||
163951240|NCT01859988|592191454|FG002|Overall Study|Withdrawal by Subject|4|||
163951241|NCT01859988|592191455|FG003|Overall Study|Withdrawal by Subject|3|||
163951242|NCT01859988|592191456|FG004|Overall Study|Withdrawal by Subject|2|||
163951243|NCT01859988|592191457|FG005|Overall Study|Withdrawal by Subject|2|||
163951244|NCT01859988|592191452|FG000|Overall Study|Lack of Efficacy|1|||
163951245|NCT01859988|592191453|FG001|Overall Study|Lack of Efficacy|1|||
163951246|NCT01859988|592191454|FG002|Overall Study|Lack of Efficacy|5|||
163951247|NCT01859988|592191455|FG003|Overall Study|Lack of Efficacy|0|||
163951248|NCT01859988|592191456|FG004|Overall Study|Lack of Efficacy|7|||
163951249|NCT01859988|592191457|FG005|Overall Study|Lack of Efficacy|9|||
163951250|NCT01859988|592191452|FG000|Overall Study|Physician Decision|1|||
163951251|NCT01859988|592191453|FG001|Overall Study|Physician Decision|3|||
163951252|NCT01859988|592191454|FG002|Overall Study|Physician Decision|1|||
163951253|NCT01859988|592191455|FG003|Overall Study|Physician Decision|3|||
163951254|NCT01859988|592191456|FG004|Overall Study|Physician Decision|4|||
163951255|NCT01859988|592191457|FG005|Overall Study|Physician Decision|1|||
163951256|NCT01859988|592191452|FG000|Overall Study|Adverse Event|2|||
163951257|NCT01859988|592191453|FG001|Overall Study|Adverse Event|1|||
163951258|NCT01859988|592191454|FG002|Overall Study|Adverse Event|3|||
163951259|NCT01859988|592191455|FG003|Overall Study|Adverse Event|1|||
163951260|NCT01859988|592191456|FG004|Overall Study|Adverse Event|2|||
163951261|NCT01859988|592191457|FG005|Overall Study|Adverse Event|2|||
163951262|NCT01859988|592191452|FG000|Overall Study|Lost to Follow-up|1|||
163951263|NCT01859988|592191453|FG001|Overall Study|Lost to Follow-up|2|||
163951264|NCT01859988|592191454|FG002|Overall Study|Lost to Follow-up|3|||
163951265|NCT01859988|592191455|FG003|Overall Study|Lost to Follow-up|0|||
163951266|NCT01859988|592191456|FG004|Overall Study|Lost to Follow-up|3|||
163951267|NCT01859988|592191457|FG005|Overall Study|Lost to Follow-up|2|||
163951268|NCT01859988|592191452|FG000|Overall Study|Protocol Violation|0|||
163951269|NCT01859988|592191453|FG001|Overall Study|Protocol Violation|0|||
163951270|NCT01859988|592191454|FG002|Overall Study|Protocol Violation|1|||
163951271|NCT01859988|592191455|FG003|Overall Study|Protocol Violation|0|||
163951272|NCT01859988|592191456|FG004|Overall Study|Protocol Violation|0|||
163951273|NCT01859988|592191457|FG005|Overall Study|Protocol Violation|0|||
163951274|NCT01859988|592191452|FG000|Overall Study|Other than specified above|0|||
163951275|NCT01859988|592191453|FG001|Overall Study|Other than specified above|2|||
163951276|NCT01859988|592191454|FG002|Overall Study|Other than specified above|11|||
163951277|NCT01859988|592191455|FG003|Overall Study|Other than specified above|3|||
163951278|NCT01859988|592191456|FG004|Overall Study|Other than specified above|5|||
163951279|NCT01859988|592191457|FG005|Overall Study|Other than specified above|3|||
163951280|NCT00652327|592191458|FG000|Overall Study|Adverse Event|0|||
163951281|NCT00652327|592191459|FG001|Overall Study|Adverse Event|2|||
163951282|NCT00652327|592191458|FG000|Overall Study|Lost to Follow-up|0|||
163951283|NCT00652327|592191459|FG001|Overall Study|Lost to Follow-up|3|||
163951284|NCT00564889|592191460|FG000|Overall Study|Death|7|||
163951285|NCT00564889|592191460|FG000|Overall Study|Adverse Event|12|||
164047356|NCT02623699|592532732|FG009|Part C (Up to 236 Days)|Death|0|||
164047357|NCT02623699|592532733|FG010|Part C (Up to 236 Days)|Death|0|||
164047358|NCT02623699|592532734|FG011|Part C (Up to 236 Days)|Death|1|||
164047359|NCT02623699|592532723|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
164047360|NCT02623699|592532724|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
164047361|NCT02623699|592532725|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
163951286|NCT00564889|592191460|FG000|Overall Study|Alternative treatment|3|||
163951287|NCT00564889|592191460|FG000|Overall Study|Disease progression|3|||
163951288|NCT00564889|592191460|FG000|Overall Study|Other, not specified|4|||
163951289|NCT00635427|592191461|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163951290|NCT00635427|592191462|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
164047362|NCT02623699|592532726|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
164047363|NCT02623699|592532727|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
163951291|NCT00635427|592191463|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
163951292|NCT00635427|592191464|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163951293|NCT00635427|592191465|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
163951294|NCT00635427|592191461|FG000|Overall Study|Death|0|||
163951295|NCT00635427|592191462|FG001|Overall Study|Death|0|||
163951296|NCT00635427|592191463|FG002|Overall Study|Death|0|||
163951297|NCT00635427|592191464|FG003|Overall Study|Death|1|||
164047364|NCT02623699|592532728|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
163951298|NCT00635427|592191465|FG004|Overall Study|Death|0|||
163951299|NCT00635427|592191461|FG000|Overall Study|Termination Of Study By Sponsor|12|||
163951300|NCT00635427|592191462|FG001|Overall Study|Termination Of Study By Sponsor|6|||
163951301|NCT00635427|592191463|FG002|Overall Study|Termination Of Study By Sponsor|10|||
163951302|NCT00635427|592191464|FG003|Overall Study|Termination Of Study By Sponsor|6|||
163951303|NCT00635427|592191465|FG004|Overall Study|Termination Of Study By Sponsor|6|||
163951304|NCT00635427|592191461|FG000|Overall Study|Withdrawal Of Consent|0|||
163951305|NCT00635427|592191462|FG001|Overall Study|Withdrawal Of Consent|0|||
163951306|NCT00635427|592191463|FG002|Overall Study|Withdrawal Of Consent|0|||
163951307|NCT00635427|592191464|FG003|Overall Study|Withdrawal Of Consent|2|||
163951308|NCT00635427|592191465|FG004|Overall Study|Withdrawal Of Consent|2|||
163951309|NCT05753670|592191466|FG000|Overall Study|Withdrawal by Subject|6|||
163951310|NCT05753670|592191467|FG001|Overall Study|Withdrawal by Subject|8|||
163951311|NCT05753670|592191466|FG000|Overall Study|Protocol Violation|3|||
163951312|NCT05753670|592191467|FG001|Overall Study|Protocol Violation|1|||
163951313|NCT00577473|592191470|FG000|Overall Study|Protocol Violation|1|||
163951314|NCT00577473|592191471|FG001|Overall Study|Protocol Violation|4|||
164047365|NCT02623699|592532729|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
164047366|NCT02623699|592532730|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
164047367|NCT02623699|592532731|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
164047368|NCT02623699|592532732|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
164047369|NCT02623699|592532733|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
164047370|NCT02623699|592532734|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
164047371|NCT01426009|592532735|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
163843452|NCT01474512|591798536|FG015|Maintenance Period|Withdrawal by Subject|0|||
163843453|NCT01474512|591798537|FG016|Maintenance Period|Withdrawal by Subject|0|||
163843454|NCT01474512|591798538|FG017|Maintenance Period|Withdrawal by Subject|0|||
163843455|NCT01474512|591798521|FG000|Maintenance Period|Lost to Follow-up|0|||
163843456|NCT01474512|591798522|FG001|Maintenance Period|Lost to Follow-up|0|||
163843457|NCT01474512|591798523|FG002|Maintenance Period|Lost to Follow-up|0|||
163843458|NCT01474512|591798524|FG003|Maintenance Period|Lost to Follow-up|3|||
163843459|NCT01474512|591798525|FG004|Maintenance Period|Lost to Follow-up|3|||
163843460|NCT01474512|591798526|FG005|Maintenance Period|Lost to Follow-up|0|||
163843461|NCT01474512|591798527|FG006|Maintenance Period|Lost to Follow-up|0|||
163843462|NCT01474512|591798528|FG007|Maintenance Period|Lost to Follow-up|2|||
163843463|NCT01474512|591798529|FG008|Maintenance Period|Lost to Follow-up|1|||
163843464|NCT01474512|591798530|FG009|Maintenance Period|Lost to Follow-up|1|||
163843465|NCT01474512|591798531|FG010|Maintenance Period|Lost to Follow-up|0|||
163843466|NCT01474512|591798532|FG011|Maintenance Period|Lost to Follow-up|0|||
163843467|NCT01474512|591798533|FG012|Maintenance Period|Lost to Follow-up|0|||
163843468|NCT01474512|591798534|FG013|Maintenance Period|Lost to Follow-up|0|||
163843469|NCT01474512|591798535|FG014|Maintenance Period|Lost to Follow-up|0|||
163843470|NCT01474512|591798536|FG015|Maintenance Period|Lost to Follow-up|0|||
163843471|NCT01474512|591798537|FG016|Maintenance Period|Lost to Follow-up|0|||
163843472|NCT01474512|591798538|FG017|Maintenance Period|Lost to Follow-up|0|||
163843473|NCT01474512|591798521|FG000|Maintenance Period|Death|0|||
163843474|NCT01474512|591798522|FG001|Maintenance Period|Death|0|||
163843475|NCT01474512|591798523|FG002|Maintenance Period|Death|0|||
163843476|NCT01474512|591798524|FG003|Maintenance Period|Death|0|||
163843477|NCT01474512|591798525|FG004|Maintenance Period|Death|0|||
163843478|NCT01474512|591798526|FG005|Maintenance Period|Death|2|||
163843479|NCT01474512|591798527|FG006|Maintenance Period|Death|0|||
163843480|NCT01474512|591798528|FG007|Maintenance Period|Death|0|||
163843481|NCT01474512|591798529|FG008|Maintenance Period|Death|0|||
163843482|NCT01474512|591798530|FG009|Maintenance Period|Death|0|||
163843483|NCT01474512|591798531|FG010|Maintenance Period|Death|0|||
163843484|NCT01474512|591798532|FG011|Maintenance Period|Death|0|||
163843485|NCT01474512|591798533|FG012|Maintenance Period|Death|0|||
163843486|NCT01474512|591798534|FG013|Maintenance Period|Death|0|||
163843487|NCT01474512|591798535|FG014|Maintenance Period|Death|0|||
163843488|NCT01474512|591798536|FG015|Maintenance Period|Death|0|||
163843489|NCT01474512|591798537|FG016|Maintenance Period|Death|0|||
163843490|NCT01474512|591798538|FG017|Maintenance Period|Death|0|||
163843491|NCT01474512|591798521|FG000|Maintenance Period|Physician Decision|0|||
163843492|NCT01474512|591798522|FG001|Maintenance Period|Physician Decision|0|||
163843493|NCT01474512|591798523|FG002|Maintenance Period|Physician Decision|0|||
163843494|NCT01474512|591798524|FG003|Maintenance Period|Physician Decision|0|||
163843495|NCT01474512|591798525|FG004|Maintenance Period|Physician Decision|0|||
163843496|NCT01474512|591798526|FG005|Maintenance Period|Physician Decision|1|||
163951315|NCT00577473|592191470|FG000|Overall Study|Adverse Event|8|||
163951316|NCT00577473|592191471|FG001|Overall Study|Adverse Event|5|||
163843497|NCT01474512|591798527|FG006|Maintenance Period|Physician Decision|0|||
163843498|NCT01474512|591798528|FG007|Maintenance Period|Physician Decision|2|||
163843499|NCT01474512|591798529|FG008|Maintenance Period|Physician Decision|0|||
163843500|NCT01474512|591798530|FG009|Maintenance Period|Physician Decision|0|||
163951317|NCT00577473|592191470|FG000|Overall Study|Withdrawal by Subject|2|||
163951318|NCT00577473|592191471|FG001|Overall Study|Withdrawal by Subject|6|||
164148623|NCT04895982|592904919|FG008|Overall Study|Protocol Violation|0|||
163951319|NCT00577473|592191470|FG000|Overall Study|Physician Decision|2|||
163951320|NCT00577473|592191471|FG001|Overall Study|Physician Decision|2|||
163951321|NCT00577473|592191470|FG000|Overall Study|Lack of Efficacy|8|||
163951322|NCT00577473|592191471|FG001|Overall Study|Lack of Efficacy|7|||
163951323|NCT02595073|592191472|FG000|Overall Study|Progressive Disease|0|||
163951324|NCT02595073|592191473|FG001|Overall Study|Progressive Disease|1|||
163951325|NCT02595073|592191472|FG000|Overall Study|Protocol Violation|2|||
163951326|NCT02595073|592191473|FG001|Overall Study|Protocol Violation|0|||
163951327|NCT01324440|592191479|FG000|Overall Study|Subject moved|0|||
163951328|NCT01324440|592191480|FG001|Overall Study|Subject moved|1|||
163951329|NCT02884908|592191481|FG000|Overall Study|Lost to Follow-up|13|||
163951330|NCT02884908|592191482|FG001|Overall Study|Lost to Follow-up|18|||
163951331|NCT01293487|592191486|FG000|Overall Study|Lost to Follow-up|0|||
163951332|NCT01293487|592191487|FG001|Overall Study|Lost to Follow-up|0|||
163951333|NCT01293487|592191488|FG002|Overall Study|Lost to Follow-up|0|||
163951334|NCT01293487|592191489|FG003|Overall Study|Lost to Follow-up|1|||
163951335|NCT01293487|592191490|FG004|Overall Study|Lost to Follow-up|0|||
163951336|NCT01293487|592191491|FG005|Overall Study|Lost to Follow-up|0|||
163951337|NCT01293487|592191492|FG006|Overall Study|Lost to Follow-up|0|||
163951338|NCT01293487|592191493|FG007|Overall Study|Lost to Follow-up|0|||
163951339|NCT01293487|592191486|FG000|Overall Study|Withdrawal by Subject|0|||
163951340|NCT01293487|592191487|FG001|Overall Study|Withdrawal by Subject|0|||
163951341|NCT01293487|592191488|FG002|Overall Study|Withdrawal by Subject|0|||
163951342|NCT01293487|592191489|FG003|Overall Study|Withdrawal by Subject|0|||
163951343|NCT01293487|592191490|FG004|Overall Study|Withdrawal by Subject|0|||
163951344|NCT01293487|592191491|FG005|Overall Study|Withdrawal by Subject|0|||
163951345|NCT01293487|592191492|FG006|Overall Study|Withdrawal by Subject|0|||
163951346|NCT01293487|592191493|FG007|Overall Study|Withdrawal by Subject|2|||
163951347|NCT04860297|592191494|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
163843501|NCT01474512|591798531|FG010|Maintenance Period|Physician Decision|0|||
163843502|NCT01474512|591798532|FG011|Maintenance Period|Physician Decision|0|||
163843503|NCT01474512|591798533|FG012|Maintenance Period|Physician Decision|0|||
163843504|NCT01474512|591798534|FG013|Maintenance Period|Physician Decision|0|||
163843505|NCT01474512|591798535|FG014|Maintenance Period|Physician Decision|0|||
163843506|NCT01474512|591798536|FG015|Maintenance Period|Physician Decision|0|||
163843507|NCT01474512|591798537|FG016|Maintenance Period|Physician Decision|0|||
163843508|NCT01474512|591798538|FG017|Maintenance Period|Physician Decision|0|||
163843509|NCT01474512|591798521|FG000|Maintenance Period|Clinical Relapse|0|||
163843510|NCT01474512|591798522|FG001|Maintenance Period|Clinical Relapse|0|||
163843511|NCT01474512|591798523|FG002|Maintenance Period|Clinical Relapse|0|||
163843512|NCT01474512|591798524|FG003|Maintenance Period|Clinical Relapse|1|||
163843513|NCT01474512|591798525|FG004|Maintenance Period|Clinical Relapse|0|||
163843514|NCT01474512|591798526|FG005|Maintenance Period|Clinical Relapse|0|||
163843515|NCT01474512|591798527|FG006|Maintenance Period|Clinical Relapse|0|||
163843516|NCT01474512|591798528|FG007|Maintenance Period|Clinical Relapse|0|||
163843517|NCT01474512|591798529|FG008|Maintenance Period|Clinical Relapse|0|||
163843518|NCT01474512|591798530|FG009|Maintenance Period|Clinical Relapse|0|||
163843519|NCT01474512|591798531|FG010|Maintenance Period|Clinical Relapse|0|||
163843520|NCT01474512|591798532|FG011|Maintenance Period|Clinical Relapse|0|||
163843521|NCT01474512|591798533|FG012|Maintenance Period|Clinical Relapse|0|||
163843522|NCT01474512|591798534|FG013|Maintenance Period|Clinical Relapse|0|||
163843523|NCT01474512|591798535|FG014|Maintenance Period|Clinical Relapse|0|||
163843524|NCT01474512|591798536|FG015|Maintenance Period|Clinical Relapse|0|||
163843525|NCT01474512|591798537|FG016|Maintenance Period|Clinical Relapse|0|||
163843526|NCT01474512|591798538|FG017|Maintenance Period|Clinical Relapse|0|||
163843527|NCT01474512|591798521|FG000|Maintenance Period|Lack of Efficacy|0|||
163951348|NCT04860297|592191495|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
163951349|NCT04860297|592191496|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
163951350|NCT04860297|592191497|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
164099717|NCT02100228|592730564|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
163843528|NCT01474512|591798522|FG001|Maintenance Period|Lack of Efficacy|0|||
163843529|NCT01474512|591798523|FG002|Maintenance Period|Lack of Efficacy|0|||
163843530|NCT01474512|591798524|FG003|Maintenance Period|Lack of Efficacy|1|||
163951351|NCT04860297|592191498|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
163951352|NCT04860297|592191499|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
163951353|NCT04860297|592191500|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
163843531|NCT01474512|591798525|FG004|Maintenance Period|Lack of Efficacy|0|||
163843532|NCT01474512|591798526|FG005|Maintenance Period|Lack of Efficacy|0|||
163843533|NCT01474512|591798527|FG006|Maintenance Period|Lack of Efficacy|0|||
163843534|NCT01474512|591798528|FG007|Maintenance Period|Lack of Efficacy|11|||
163843535|NCT01474512|591798529|FG008|Maintenance Period|Lack of Efficacy|11|||
163951354|NCT04860297|592191501|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
163951355|NCT04860297|592191494|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
163951356|NCT04860297|592191495|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
163951357|NCT04860297|592191496|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
163951358|NCT04860297|592191497|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
163951359|NCT04860297|592191498|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
163951360|NCT04860297|592191499|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
163951361|NCT04860297|592191500|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
163951362|NCT04860297|592191501|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
163951363|NCT04860297|592191494|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
163951364|NCT04860297|592191495|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
163951365|NCT04860297|592191496|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
163951366|NCT04860297|592191497|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
163951367|NCT04860297|592191498|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
163951368|NCT04860297|592191499|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
163951369|NCT04860297|592191500|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
163951370|NCT04860297|592191501|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
163951371|NCT04860297|592191494|FG000|Part B (Booster Dose)|Other Than Specified|0|||
163951372|NCT04860297|592191495|FG001|Part B (Booster Dose)|Other Than Specified|0|||
163951373|NCT04860297|592191496|FG002|Part B (Booster Dose)|Other Than Specified|0|||
163951374|NCT04860297|592191497|FG003|Part B (Booster Dose)|Other Than Specified|0|||
163951375|NCT04860297|592191498|FG004|Part B (Booster Dose)|Other Than Specified|0|||
163951376|NCT04860297|592191499|FG005|Part B (Booster Dose)|Other Than Specified|1|||
163951377|NCT04860297|592191500|FG006|Part B (Booster Dose)|Other Than Specified|1|||
163951378|NCT04860297|592191501|FG007|Part B (Booster Dose)|Other Than Specified|0|||
163843536|NCT01474512|591798530|FG009|Maintenance Period|Lack of Efficacy|12|||
163843537|NCT01474512|591798531|FG010|Maintenance Period|Lack of Efficacy|0|||
163843538|NCT01474512|591798532|FG011|Maintenance Period|Lack of Efficacy|0|||
163843539|NCT01474512|591798533|FG012|Maintenance Period|Lack of Efficacy|0|||
163843540|NCT01474512|591798534|FG013|Maintenance Period|Lack of Efficacy|0|||
163843541|NCT01474512|591798535|FG014|Maintenance Period|Lack of Efficacy|0|||
163843542|NCT01474512|591798536|FG015|Maintenance Period|Lack of Efficacy|0|||
163843543|NCT01474512|591798537|FG016|Maintenance Period|Lack of Efficacy|0|||
163843544|NCT01474512|591798538|FG017|Maintenance Period|Lack of Efficacy|0|||
163843545|NCT01474512|591798521|FG000|Maintenance Period|Protocol Violation|0|||
163843546|NCT01474512|591798522|FG001|Maintenance Period|Protocol Violation|0|||
163843547|NCT01474512|591798523|FG002|Maintenance Period|Protocol Violation|0|||
163843548|NCT01474512|591798524|FG003|Maintenance Period|Protocol Violation|1|||
163843549|NCT01474512|591798525|FG004|Maintenance Period|Protocol Violation|0|||
163843550|NCT01474512|591798526|FG005|Maintenance Period|Protocol Violation|0|||
163843551|NCT01474512|591798527|FG006|Maintenance Period|Protocol Violation|0|||
163843552|NCT01474512|591798528|FG007|Maintenance Period|Protocol Violation|1|||
163843553|NCT01474512|591798529|FG008|Maintenance Period|Protocol Violation|0|||
163843554|NCT01474512|591798530|FG009|Maintenance Period|Protocol Violation|1|||
163843555|NCT01474512|591798531|FG010|Maintenance Period|Protocol Violation|0|||
163843556|NCT01474512|591798532|FG011|Maintenance Period|Protocol Violation|0|||
163843557|NCT01474512|591798533|FG012|Maintenance Period|Protocol Violation|0|||
163843558|NCT01474512|591798534|FG013|Maintenance Period|Protocol Violation|0|||
163843559|NCT01474512|591798535|FG014|Maintenance Period|Protocol Violation|0|||
163843560|NCT01474512|591798536|FG015|Maintenance Period|Protocol Violation|0|||
163843561|NCT01474512|591798537|FG016|Maintenance Period|Protocol Violation|0|||
163843562|NCT01474512|591798538|FG017|Maintenance Period|Protocol Violation|0|||
163843563|NCT01474512|591798521|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
163843564|NCT01474512|591798522|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
163843565|NCT01474512|591798523|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
163843566|NCT01474512|591798524|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
163843567|NCT01474512|591798525|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
163843568|NCT01474512|591798526|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
163843569|NCT01474512|591798527|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
163843570|NCT01474512|591798528|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
163843571|NCT01474512|591798529|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
163843572|NCT01474512|591798530|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
163843573|NCT01474512|591798531|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
163843574|NCT01474512|591798532|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
163843575|NCT01474512|591798533|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
163843576|NCT01474512|591798534|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
163843577|NCT01474512|591798535|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
163843578|NCT01474512|591798536|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
163843579|NCT01474512|591798537|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
163843580|NCT01474512|591798538|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
163843581|NCT01474512|591798521|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
163843582|NCT01474512|591798522|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
163843583|NCT01474512|591798523|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
163843584|NCT01474512|591798524|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
163843585|NCT01474512|591798525|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
163843586|NCT01474512|591798526|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
163843587|NCT01474512|591798527|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
163843588|NCT01474512|591798528|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
163843589|NCT01474512|591798529|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
163843590|NCT01474512|591798530|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
163843591|NCT01474512|591798531|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
163843592|NCT01474512|591798532|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
163843593|NCT01474512|591798533|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
163843594|NCT01474512|591798534|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
163843595|NCT01474512|591798535|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
163843596|NCT01474512|591798536|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
163843597|NCT01474512|591798537|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
163843598|NCT01474512|591798538|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
163843599|NCT01474512|591798521|FG000|Long-Term Extension Period|Adverse Event|0|||
163843600|NCT01474512|591798522|FG001|Long-Term Extension Period|Adverse Event|0|||
163843601|NCT01474512|591798523|FG002|Long-Term Extension Period|Adverse Event|0|||
163843602|NCT01474512|591798524|FG003|Long-Term Extension Period|Adverse Event|0|||
163843603|NCT01474512|591798525|FG004|Long-Term Extension Period|Adverse Event|0|||
163843604|NCT01474512|591798526|FG005|Long-Term Extension Period|Adverse Event|0|||
163843605|NCT01474512|591798527|FG006|Long-Term Extension Period|Adverse Event|0|||
163843606|NCT01474512|591798528|FG007|Long-Term Extension Period|Adverse Event|0|||
163843607|NCT01474512|591798529|FG008|Long-Term Extension Period|Adverse Event|0|||
163843608|NCT01474512|591798530|FG009|Long-Term Extension Period|Adverse Event|0|||
163843609|NCT01474512|591798531|FG010|Long-Term Extension Period|Adverse Event|0|||
163843610|NCT01474512|591798532|FG011|Long-Term Extension Period|Adverse Event|1|||
163843611|NCT01474512|591798533|FG012|Long-Term Extension Period|Adverse Event|57|||
163843612|NCT01474512|591798534|FG013|Long-Term Extension Period|Adverse Event|58|||
163843613|NCT01474512|591798535|FG014|Long-Term Extension Period|Adverse Event|0|||
163843614|NCT01474512|591798536|FG015|Long-Term Extension Period|Adverse Event|0|||
163843615|NCT01474512|591798537|FG016|Long-Term Extension Period|Adverse Event|0|||
163843616|NCT01474512|591798538|FG017|Long-Term Extension Period|Adverse Event|0|||
163843617|NCT01474512|591798521|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
163843618|NCT01474512|591798522|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
163843619|NCT01474512|591798523|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
163843620|NCT01474512|591798524|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
163843621|NCT01474512|591798525|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
163843622|NCT01474512|591798526|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
163843623|NCT01474512|591798527|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
163843624|NCT01474512|591798528|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
163843625|NCT01474512|591798529|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
163843626|NCT01474512|591798530|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
163843627|NCT01474512|591798531|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
163843628|NCT01474512|591798532|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
163843629|NCT01474512|591798533|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
163843630|NCT01474512|591798534|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
163843631|NCT01474512|591798535|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
163843632|NCT01474512|591798536|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
163843633|NCT01474512|591798537|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
163843634|NCT01474512|591798538|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
163843635|NCT01474512|591798521|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
163843636|NCT01474512|591798522|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
163843637|NCT01474512|591798523|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
163843638|NCT01474512|591798524|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
163843639|NCT01474512|591798525|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
163843640|NCT01474512|591798526|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
163843641|NCT01474512|591798527|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
163843642|NCT01474512|591798528|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
163843643|NCT01474512|591798529|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
163843644|NCT01474512|591798530|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
163843645|NCT01474512|591798531|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
163843646|NCT01474512|591798532|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
163843647|NCT01474512|591798533|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
163843648|NCT01474512|591798534|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
163843649|NCT01474512|591798535|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
163843650|NCT01474512|591798536|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
163843651|NCT01474512|591798537|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
163843652|NCT01474512|591798538|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
163951379|NCT04860297|592191494|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
163843653|NCT01474512|591798521|FG000|Long-Term Extension Period|Physician Decision|0|||
163843654|NCT01474512|591798522|FG001|Long-Term Extension Period|Physician Decision|0|||
163843655|NCT01474512|591798523|FG002|Long-Term Extension Period|Physician Decision|0|||
163843656|NCT01474512|591798524|FG003|Long-Term Extension Period|Physician Decision|0|||
163951380|NCT04860297|592191495|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
163951381|NCT04860297|592191496|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
163951382|NCT04860297|592191497|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
163951383|NCT04860297|592191498|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
163951384|NCT04860297|592191499|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
163951385|NCT04860297|592191500|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
163951386|NCT04860297|592191501|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
163951387|NCT04860297|592191494|FG000|Part B (Booster Dose)|Death|0|||
163951388|NCT04860297|592191495|FG001|Part B (Booster Dose)|Death|0|||
163951389|NCT04860297|592191496|FG002|Part B (Booster Dose)|Death|0|||
163951390|NCT04860297|592191497|FG003|Part B (Booster Dose)|Death|0|||
163951391|NCT04860297|592191498|FG004|Part B (Booster Dose)|Death|1|||
163951392|NCT04860297|592191499|FG005|Part B (Booster Dose)|Death|2|||
163951393|NCT04860297|592191500|FG006|Part B (Booster Dose)|Death|1|||
163951394|NCT04860297|592191501|FG007|Part B (Booster Dose)|Death|0|||
163951395|NCT04860297|592191494|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
163951396|NCT04860297|592191495|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
163951397|NCT04860297|592191496|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
163951398|NCT04860297|592191497|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
163951399|NCT04860297|592191498|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
163951400|NCT04860297|592191499|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
163951401|NCT04860297|592191500|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
163951402|NCT04860297|592191501|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
163843657|NCT01474512|591798525|FG004|Long-Term Extension Period|Physician Decision|0|||
163843658|NCT01474512|591798526|FG005|Long-Term Extension Period|Physician Decision|0|||
163843659|NCT01474512|591798527|FG006|Long-Term Extension Period|Physician Decision|0|||
163843660|NCT01474512|591798528|FG007|Long-Term Extension Period|Physician Decision|0|||
163843661|NCT01474512|591798529|FG008|Long-Term Extension Period|Physician Decision|0|||
163843662|NCT01474512|591798530|FG009|Long-Term Extension Period|Physician Decision|0|||
163843663|NCT01474512|591798531|FG010|Long-Term Extension Period|Physician Decision|0|||
163843664|NCT01474512|591798532|FG011|Long-Term Extension Period|Physician Decision|0|||
163843665|NCT01474512|591798533|FG012|Long-Term Extension Period|Physician Decision|21|||
163843666|NCT01474512|591798534|FG013|Long-Term Extension Period|Physician Decision|21|||
163843667|NCT01474512|591798535|FG014|Long-Term Extension Period|Physician Decision|0|||
163843668|NCT01474512|591798536|FG015|Long-Term Extension Period|Physician Decision|0|||
163843669|NCT01474512|591798537|FG016|Long-Term Extension Period|Physician Decision|0|||
163843670|NCT01474512|591798538|FG017|Long-Term Extension Period|Physician Decision|0|||
163843671|NCT01474512|591798521|FG000|Long-Term Extension Period|Clinical Relapse|0|||
163843672|NCT01474512|591798522|FG001|Long-Term Extension Period|Clinical Relapse|0|||
163843673|NCT01474512|591798523|FG002|Long-Term Extension Period|Clinical Relapse|0|||
163843674|NCT01474512|591798524|FG003|Long-Term Extension Period|Clinical Relapse|0|||
163843675|NCT01474512|591798525|FG004|Long-Term Extension Period|Clinical Relapse|0|||
163843676|NCT01474512|591798526|FG005|Long-Term Extension Period|Clinical Relapse|0|||
163843677|NCT01474512|591798527|FG006|Long-Term Extension Period|Clinical Relapse|0|||
163843678|NCT01474512|591798528|FG007|Long-Term Extension Period|Clinical Relapse|0|||
163843679|NCT01474512|591798529|FG008|Long-Term Extension Period|Clinical Relapse|0|||
163843680|NCT01474512|591798530|FG009|Long-Term Extension Period|Clinical Relapse|0|||
163843681|NCT01474512|591798531|FG010|Long-Term Extension Period|Clinical Relapse|0|||
163843682|NCT01474512|591798532|FG011|Long-Term Extension Period|Clinical Relapse|0|||
163843683|NCT01474512|591798533|FG012|Long-Term Extension Period|Clinical Relapse|9|||
163843684|NCT01474512|591798534|FG013|Long-Term Extension Period|Clinical Relapse|9|||
163843685|NCT01474512|591798535|FG014|Long-Term Extension Period|Clinical Relapse|0|||
163843686|NCT01474512|591798536|FG015|Long-Term Extension Period|Clinical Relapse|0|||
163843687|NCT01474512|591798537|FG016|Long-Term Extension Period|Clinical Relapse|0|||
163843688|NCT01474512|591798538|FG017|Long-Term Extension Period|Clinical Relapse|0|||
163843689|NCT01474512|591798521|FG000|Long-Term Extension Period|Death|0|||
163843690|NCT01474512|591798522|FG001|Long-Term Extension Period|Death|0|||
163843691|NCT01474512|591798523|FG002|Long-Term Extension Period|Death|0|||
163843692|NCT01474512|591798524|FG003|Long-Term Extension Period|Death|0|||
163951403|NCT00862719|592191502|FG000|Overall Study|Disease Progression|5|||
163951404|NCT00862719|592191503|FG001|Overall Study|Disease Progression|0|||
163951405|NCT00862719|592191504|FG002|Overall Study|Disease Progression|1|||
163951406|NCT00862719|592191505|FG003|Overall Study|Disease Progression|0|||
163951407|NCT00862719|592191502|FG000|Overall Study|Death|5|||
163951408|NCT00862719|592191503|FG001|Overall Study|Death|6|||
163951409|NCT00862719|592191504|FG002|Overall Study|Death|1|||
163951410|NCT00862719|592191505|FG003|Overall Study|Death|1|||
163843693|NCT01474512|591798525|FG004|Long-Term Extension Period|Death|0|||
163843694|NCT01474512|591798526|FG005|Long-Term Extension Period|Death|0|||
163843695|NCT01474512|591798527|FG006|Long-Term Extension Period|Death|0|||
163951411|NCT00862719|592191502|FG000|Overall Study|Engraftment failure|0|||
163951412|NCT00862719|592191503|FG001|Overall Study|Engraftment failure|0|||
163951413|NCT00862719|592191504|FG002|Overall Study|Engraftment failure|1|||
163951414|NCT00862719|592191505|FG003|Overall Study|Engraftment failure|0|||
163951415|NCT00862719|592191502|FG000|Overall Study|Veno-Occlusive Disease|0|||
163843696|NCT01474512|591798528|FG007|Long-Term Extension Period|Death|0|||
163843697|NCT01474512|591798529|FG008|Long-Term Extension Period|Death|0|||
163843698|NCT01474512|591798530|FG009|Long-Term Extension Period|Death|0|||
163843699|NCT01474512|591798531|FG010|Long-Term Extension Period|Death|0|||
163843700|NCT01474512|591798532|FG011|Long-Term Extension Period|Death|0|||
163843701|NCT01474512|591798533|FG012|Long-Term Extension Period|Death|9|||
163843702|NCT01474512|591798534|FG013|Long-Term Extension Period|Death|9|||
163843703|NCT01474512|591798535|FG014|Long-Term Extension Period|Death|0|||
163843704|NCT01474512|591798536|FG015|Long-Term Extension Period|Death|0|||
163843705|NCT01474512|591798537|FG016|Long-Term Extension Period|Death|0|||
163843706|NCT01474512|591798538|FG017|Long-Term Extension Period|Death|0|||
163843707|NCT01474512|591798521|FG000|Long-Term Extension Period|Sponsor Decision|0|||
163843708|NCT01474512|591798522|FG001|Long-Term Extension Period|Sponsor Decision|0|||
163843709|NCT01474512|591798523|FG002|Long-Term Extension Period|Sponsor Decision|0|||
163843710|NCT01474512|591798524|FG003|Long-Term Extension Period|Sponsor Decision|0|||
163843711|NCT01474512|591798525|FG004|Long-Term Extension Period|Sponsor Decision|0|||
163843712|NCT01474512|591798526|FG005|Long-Term Extension Period|Sponsor Decision|0|||
163843713|NCT01474512|591798527|FG006|Long-Term Extension Period|Sponsor Decision|0|||
163843714|NCT01474512|591798528|FG007|Long-Term Extension Period|Sponsor Decision|0|||
163843715|NCT01474512|591798529|FG008|Long-Term Extension Period|Sponsor Decision|0|||
163843716|NCT01474512|591798530|FG009|Long-Term Extension Period|Sponsor Decision|0|||
163843717|NCT01474512|591798531|FG010|Long-Term Extension Period|Sponsor Decision|0|||
163843718|NCT01474512|591798532|FG011|Long-Term Extension Period|Sponsor Decision|0|||
163843719|NCT01474512|591798533|FG012|Long-Term Extension Period|Sponsor Decision|6|||
163843720|NCT01474512|591798534|FG013|Long-Term Extension Period|Sponsor Decision|6|||
163843721|NCT01474512|591798535|FG014|Long-Term Extension Period|Sponsor Decision|0|||
163843722|NCT01474512|591798536|FG015|Long-Term Extension Period|Sponsor Decision|0|||
163843723|NCT01474512|591798537|FG016|Long-Term Extension Period|Sponsor Decision|0|||
163843724|NCT01474512|591798538|FG017|Long-Term Extension Period|Sponsor Decision|0|||
163843725|NCT01474512|591798521|FG000|Long-Term Extension Period|Protocol Violation|0|||
163843726|NCT01474512|591798522|FG001|Long-Term Extension Period|Protocol Violation|0|||
163843727|NCT01474512|591798523|FG002|Long-Term Extension Period|Protocol Violation|0|||
163843728|NCT01474512|591798524|FG003|Long-Term Extension Period|Protocol Violation|0|||
163843729|NCT01474512|591798525|FG004|Long-Term Extension Period|Protocol Violation|0|||
163843730|NCT01474512|591798526|FG005|Long-Term Extension Period|Protocol Violation|0|||
163843731|NCT01474512|591798527|FG006|Long-Term Extension Period|Protocol Violation|0|||
163843732|NCT01474512|591798528|FG007|Long-Term Extension Period|Protocol Violation|0|||
163843733|NCT01474512|591798529|FG008|Long-Term Extension Period|Protocol Violation|0|||
163843734|NCT01474512|591798530|FG009|Long-Term Extension Period|Protocol Violation|0|||
163843735|NCT01474512|591798531|FG010|Long-Term Extension Period|Protocol Violation|0|||
163843736|NCT01474512|591798532|FG011|Long-Term Extension Period|Protocol Violation|0|||
163843737|NCT01474512|591798533|FG012|Long-Term Extension Period|Protocol Violation|5|||
163843738|NCT01474512|591798534|FG013|Long-Term Extension Period|Protocol Violation|5|||
163843739|NCT01474512|591798535|FG014|Long-Term Extension Period|Protocol Violation|0|||
163843740|NCT01474512|591798536|FG015|Long-Term Extension Period|Protocol Violation|0|||
163843741|NCT01474512|591798537|FG016|Long-Term Extension Period|Protocol Violation|0|||
163843742|NCT01474512|591798538|FG017|Long-Term Extension Period|Protocol Violation|0|||
163843743|NCT01474512|591798521|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843744|NCT01474512|591798522|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843745|NCT01474512|591798523|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843746|NCT01474512|591798524|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843747|NCT01474512|591798525|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843748|NCT01474512|591798526|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843749|NCT01474512|591798527|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843750|NCT01474512|591798528|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843751|NCT01474512|591798529|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843752|NCT01474512|591798530|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843753|NCT01474512|591798531|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843754|NCT01474512|591798532|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843755|NCT01474512|591798533|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
163843756|NCT01474512|591798534|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
163843757|NCT01474512|591798535|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843758|NCT01474512|591798536|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843759|NCT01474512|591798537|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843760|NCT01474512|591798538|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
163843761|NCT01474512|591798521|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843762|NCT01474512|591798522|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843763|NCT01474512|591798523|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843764|NCT01474512|591798524|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843765|NCT01474512|591798525|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
164047372|NCT01426009|592532735|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
164047373|NCT01426009|592532735|FG000|Washout 1|Withdrawal by Subject|1|||
164047374|NCT01426009|592532735|FG000|Washout 1|Personal Reasons|1|||
164047375|NCT01426009|592532735|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
164047376|NCT01426009|592532735|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
164047377|NCT01426009|592532735|FG000|Washout 2|electrive surgery|1|||
164047378|NCT01426009|592532735|FG000|Washout 3|personal reasons|1|||
164047379|NCT01426009|592532735|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
164047380|NCT01426009|592532735|FG000|Washout 4|Lost to Follow-up|1|||
164047381|NCT00515099|592532741|FG000|Overall Study|Lost to Follow-up|0|||
164047382|NCT00515099|592532742|FG001|Overall Study|Lost to Follow-up|4|||
164047383|NCT00515099|592532741|FG000|Overall Study|Withdrawal by Subject|2|||
164047384|NCT00515099|592532742|FG001|Overall Study|Withdrawal by Subject|0|||
164047385|NCT00515099|592532741|FG000|Overall Study|IRB Recommendation|1|||
164047386|NCT00515099|592532742|FG001|Overall Study|IRB Recommendation|0|||
164047387|NCT03342404|592532743|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
164047388|NCT03342404|592532744|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
164047389|NCT03342404|592532743|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
164047390|NCT03342404|592532744|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
164047391|NCT03342404|592532743|FG000|Blinded Treatment Phase|Adverse Event|5|||
164047392|NCT03342404|592532744|FG001|Blinded Treatment Phase|Adverse Event|4|||
164047393|NCT03342404|592532743|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
164047394|NCT03342404|592532744|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
164047395|NCT03342404|592532743|FG000|Blinded Treatment Phase|Other reasons|1|||
164047396|NCT03342404|592532744|FG001|Blinded Treatment Phase|Other reasons|0|||
164047397|NCT03342404|592532743|FG000|Blinded Treatment Phase|Physician Decision|1|||
164047398|NCT03342404|592532744|FG001|Blinded Treatment Phase|Physician Decision|0|||
164047399|NCT03342404|592532743|FG000|Blinded Treatment Phase|Death|1|||
164047400|NCT03342404|592532744|FG001|Blinded Treatment Phase|Death|0|||
164047401|NCT03342404|592532743|FG000|Open-Label Phase|Lost to Follow-up|0|||
164047402|NCT03342404|592532744|FG001|Open-Label Phase|Lost to Follow-up|1|||
164047403|NCT03342404|592532743|FG000|Open-Label Phase|Other reasons|0|||
164047404|NCT03342404|592532744|FG001|Open-Label Phase|Other reasons|1|||
164047405|NCT03342404|592532743|FG000|Open-Label Phase|Adverse Event|0|||
164047406|NCT03342404|592532744|FG001|Open-Label Phase|Adverse Event|3|||
164047407|NCT03342404|592532743|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164047408|NCT03342404|592532744|FG001|Open-Label Phase|Withdrawal by Subject|6|||
164047409|NCT00372489|592532750|FG000|Overall Study|Adverse Event|18|||
164047410|NCT00372489|592532750|FG000|Overall Study|Lack of Efficacy|1|||
164047411|NCT00372489|592532750|FG000|Overall Study|Lost to Follow-up|3|||
164047412|NCT00372489|592532750|FG000|Overall Study|Physician Decision|3|||
164047413|NCT00372489|592532750|FG000|Overall Study|Withdrawal by Subject|5|||
164047414|NCT00372489|592532750|FG000|Overall Study|Patient Relocation|2|||
164047415|NCT00372489|592532750|FG000|Overall Study|Renal transplant|6|||
164047416|NCT00372489|592532750|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
164047417|NCT00772889|592532751|FG000|Overall Study|Adverse Event|7|||
164047418|NCT00772889|592532752|FG001|Overall Study|Adverse Event|4|||
164047419|NCT00772889|592532753|FG002|Overall Study|Adverse Event|0|||
164047420|NCT00772889|592532751|FG000|Overall Study|Withdrawal by Subject|9|||
164047421|NCT00772889|592532752|FG001|Overall Study|Withdrawal by Subject|8|||
164047422|NCT00772889|592532753|FG002|Overall Study|Withdrawal by Subject|9|||
164047423|NCT00772889|592532751|FG000|Overall Study|Lost to Follow-up|6|||
164047424|NCT00772889|592532752|FG001|Overall Study|Lost to Follow-up|6|||
164047425|NCT00772889|592532753|FG002|Overall Study|Lost to Follow-up|7|||
164047426|NCT03323086|592532754|FG000|Overall Study|Lost to Follow-up|3|||
164047427|NCT03323086|592532755|FG001|Overall Study|Lost to Follow-up|2|||
164047428|NCT00355615|592532761|FG000|Randomized Double Blind Period|Adverse Event|1|||
164047429|NCT00355615|592532762|FG001|Randomized Double Blind Period|Adverse Event|0|||
164047430|NCT00355615|592532763|FG002|Randomized Double Blind Period|Adverse Event|0|||
164047431|NCT00355615|592532764|FG003|Randomized Double Blind Period|Adverse Event|0|||
164047432|NCT00355615|592532765|FG004|Randomized Double Blind Period|Adverse Event|0|||
164047433|NCT00355615|592532761|FG000|Randomized Double Blind Period|Protocol Violation|0|||
164047434|NCT00355615|592532762|FG001|Randomized Double Blind Period|Protocol Violation|0|||
164047435|NCT00355615|592532763|FG002|Randomized Double Blind Period|Protocol Violation|1|||
164047436|NCT00355615|592532764|FG003|Randomized Double Blind Period|Protocol Violation|1|||
164047437|NCT00355615|592532765|FG004|Randomized Double Blind Period|Protocol Violation|0|||
164047438|NCT00355615|592532761|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164047439|NCT00355615|592532762|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164047440|NCT00355615|592532763|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164047441|NCT00355615|592532764|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
164047442|NCT00355615|592532765|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
164047443|NCT00355615|592532761|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164047444|NCT00355615|592532762|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164047445|NCT00355615|592532763|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
163951416|NCT00862719|592191503|FG001|Overall Study|Veno-Occlusive Disease|0|||
163951417|NCT00862719|592191504|FG002|Overall Study|Veno-Occlusive Disease|1|||
163951418|NCT00862719|592191505|FG003|Overall Study|Veno-Occlusive Disease|0|||
163951419|NCT01642251|592191506|FG000|Overall Study|Progressive disease|0|||
163951420|NCT01642251|592191507|FG001|Overall Study|Progressive disease|0|||
163951421|NCT01642251|592191508|FG002|Overall Study|Progressive disease|3|||
163951422|NCT01642251|592191509|FG003|Overall Study|Progressive disease|3|||
163951423|NCT01642251|592191506|FG000|Overall Study|Adverse Event|0|||
163951424|NCT01642251|592191507|FG001|Overall Study|Adverse Event|0|||
163951425|NCT01642251|592191508|FG002|Overall Study|Adverse Event|5|||
163951426|NCT01642251|592191509|FG003|Overall Study|Adverse Event|4|||
163951427|NCT01642251|592191506|FG000|Overall Study|Death|0|||
163951428|NCT01642251|592191507|FG001|Overall Study|Death|0|||
163951429|NCT01642251|592191508|FG002|Overall Study|Death|1|||
163951430|NCT01642251|592191509|FG003|Overall Study|Death|3|||
163951431|NCT01642251|592191506|FG000|Overall Study|Withdrawal by Subject|0|||
163951432|NCT01642251|592191507|FG001|Overall Study|Withdrawal by Subject|0|||
163951433|NCT01642251|592191508|FG002|Overall Study|Withdrawal by Subject|1|||
163951434|NCT01642251|592191509|FG003|Overall Study|Withdrawal by Subject|3|||
163951435|NCT01642251|592191506|FG000|Overall Study|Alternative therapy|0|||
163951436|NCT01642251|592191507|FG001|Overall Study|Alternative therapy|0|||
163951437|NCT01642251|592191508|FG002|Overall Study|Alternative therapy|0|||
163951438|NCT01642251|592191509|FG003|Overall Study|Alternative therapy|2|||
163951439|NCT01642251|592191506|FG000|Overall Study|Other complicating disease|0|||
163951440|NCT01642251|592191507|FG001|Overall Study|Other complicating disease|0|||
163951441|NCT01642251|592191508|FG002|Overall Study|Other complicating disease|1|||
163951442|NCT01642251|592191509|FG003|Overall Study|Other complicating disease|0|||
164047446|NCT00355615|592532764|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
164047447|NCT00355615|592532765|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
164047448|NCT00355615|592532761|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164047449|NCT00355615|592532762|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164047450|NCT00355615|592532763|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164047451|NCT00355615|592532764|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
164047452|NCT00355615|592532765|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
164047453|NCT00355615|592532761|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164047454|NCT00355615|592532762|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164047455|NCT00355615|592532763|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164047456|NCT00355615|592532764|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
164047457|NCT00355615|592532765|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
164047458|NCT04259346|592532773|FG000|Overall Study|Lost to Follow-up|1|||
164047459|NCT04259346|592532774|FG001|Overall Study|Lost to Follow-up|3|||
164047460|NCT04259346|592532773|FG000|Overall Study|Protocol Violation|1|||
164047461|NCT04259346|592532774|FG001|Overall Study|Protocol Violation|0|||
164047462|NCT04259346|592532773|FG000|Overall Study|Withdrawal by Subject|1|||
164047463|NCT04259346|592532774|FG001|Overall Study|Withdrawal by Subject|0|||
164047464|NCT04259346|592532773|FG000|Overall Study|Adverse Event|1|||
164047465|NCT04259346|592532774|FG001|Overall Study|Adverse Event|1|||
164047466|NCT00085644|592532777|FG000|Double-Blind Period|Adverse Event|5|||
164047467|NCT00085644|592532778|FG001|Double-Blind Period|Adverse Event|2|||
164047468|NCT00085644|592532779|FG002|Double-Blind Period|Adverse Event|0|||
164047469|NCT00085644|592532777|FG000|Double-Blind Period|Withdrawal by Subject|3|||
164047470|NCT00085644|592532778|FG001|Double-Blind Period|Withdrawal by Subject|0|||
164047471|NCT00085644|592532779|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164047472|NCT00085644|592532777|FG000|Double-Blind Period|Lost to Follow-up|2|||
164047473|NCT00085644|592532778|FG001|Double-Blind Period|Lost to Follow-up|1|||
164047474|NCT00085644|592532779|FG002|Double-Blind Period|Lost to Follow-up|0|||
164047475|NCT00085644|592532777|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
164047476|NCT00085644|592532778|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
164047477|NCT00085644|592532779|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
164047478|NCT00085644|592532777|FG000|Double-Blind Period|Contemplating pregnancy|1|||
164047479|NCT00085644|592532778|FG001|Double-Blind Period|Contemplating pregnancy|0|||
164047480|NCT00085644|592532779|FG002|Double-Blind Period|Contemplating pregnancy|0|||
164047481|NCT00085644|592532777|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
164047482|NCT00085644|592532778|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
164047483|NCT00085644|592532779|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
163951443|NCT01642251|592191506|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
163951444|NCT01642251|592191507|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
164047484|NCT00085644|592532777|FG000|Open-Label Period|Adverse Event|0|||
163951445|NCT01642251|592191508|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
164047485|NCT00085644|592532778|FG001|Open-Label Period|Adverse Event|0|||
164047486|NCT00085644|592532779|FG002|Open-Label Period|Adverse Event|38|||
163951446|NCT01642251|592191509|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
163951447|NCT00998790|592191510|FG000|Overall Study|Withdrawal by Subject|21|||
163843766|NCT01474512|591798526|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843767|NCT01474512|591798527|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843768|NCT01474512|591798528|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843769|NCT01474512|591798529|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843770|NCT01474512|591798530|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843771|NCT01474512|591798531|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843772|NCT01474512|591798532|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
163843773|NCT01474512|591798533|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843774|NCT01474512|591798534|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843775|NCT01474512|591798535|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843776|NCT01474512|591798536|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843777|NCT01474512|591798537|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843778|NCT01474512|591798538|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
163843779|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
163843780|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
163843781|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
163843782|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
163843783|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
163843784|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
163951448|NCT01993927|592191511|FG000|Overall Study|Case Report Forms Uncollected|18|||
163951449|NCT01993927|592191511|FG000|Overall Study|Protocol Violation|11|||
163951450|NCT00287690|592191514|FG000|Overall Study|Protocol Violation|20|||
163951451|NCT00287690|592191515|FG001|Overall Study|Protocol Violation|26|||
163951452|NCT02414932|592191516|FG000|Overall Study|Withdrawal by Subject|2|||
163951453|NCT02414932|592191517|FG001|Overall Study|Withdrawal by Subject|3|||
163951454|NCT02414932|592191516|FG000|Overall Study|Adverse Event|1|||
163951455|NCT02414932|592191517|FG001|Overall Study|Adverse Event|0|||
163951456|NCT00540046|592191518|FG000|Overall Study|Lost to Follow-up|33|||
163951457|NCT00540046|592191519|FG001|Overall Study|Lost to Follow-up|23|||
163951458|NCT00185965|592191527|FG000|Overall Study|Adverse Event|0|||
163951459|NCT00185965|592191528|FG001|Overall Study|Adverse Event|1|||
163951460|NCT02533531|592191529|FG000|Overall Study|Device did not turn on|1|||
163951461|NCT03814187|592191530|FG000|Overall Study|Sponsor's Administrative Decision|0|||
163951462|NCT03814187|592191531|FG001|Overall Study|Sponsor's Administrative Decision|0|||
163951463|NCT03814187|592191532|FG002|Overall Study|Sponsor's Administrative Decision|272|||
163843785|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
163843786|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
163843787|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
163843788|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
163843789|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
163843790|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
163951464|NCT03814187|592191530|FG000|Overall Study|Death|80|||
163951465|NCT03814187|592191531|FG001|Overall Study|Death|81|||
163951466|NCT03814187|592191532|FG002|Overall Study|Death|4|||
163951467|NCT03814187|592191530|FG000|Overall Study|Withdrew Consent|77|||
163951468|NCT03814187|592191531|FG001|Overall Study|Withdrew Consent|78|||
163951469|NCT03814187|592191532|FG002|Overall Study|Withdrew Consent|2|||
163951470|NCT03814187|592191530|FG000|Overall Study|Lost to Follow-up|47|||
163951471|NCT03814187|592191531|FG001|Overall Study|Lost to Follow-up|52|||
163951472|NCT03814187|592191532|FG002|Overall Study|Lost to Follow-up|1|||
163951473|NCT03814187|592191530|FG000|Overall Study|Adverse Event|22|||
163951474|NCT03814187|592191531|FG001|Overall Study|Adverse Event|23|||
163951475|NCT03814187|592191532|FG002|Overall Study|Adverse Event|0|||
163951476|NCT03814187|592191530|FG000|Overall Study|Physician Decision|7|||
163843791|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
163843792|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
163843793|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
163843794|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
163843795|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
163843796|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
163843797|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163951477|NCT03814187|592191531|FG001|Overall Study|Physician Decision|4|||
163951478|NCT03814187|592191532|FG002|Overall Study|Physician Decision|2|||
163951479|NCT03814187|592191530|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
163951480|NCT03814187|592191531|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
163843798|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843799|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843800|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843801|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163951481|NCT03814187|592191532|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
163951482|NCT03814187|592191530|FG000|Overall Study|Other reasons|34|||
163951483|NCT03814187|592191531|FG001|Overall Study|Other reasons|40|||
163951484|NCT03814187|592191532|FG002|Overall Study|Other reasons|2|||
163951485|NCT02047903|592191533|FG000|Overall Study|Adverse Event|14|||
163843802|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843803|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843804|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843805|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843806|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843807|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843808|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843809|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843810|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
163843811|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
163843812|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
163843813|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
163843814|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
163843815|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163951486|NCT02047903|592191533|FG000|Overall Study|Serious adverse event|10|||
163951487|NCT02047903|592191533|FG000|Overall Study|Withdrawal by Subject|16|||
163951488|NCT02047903|592191533|FG000|Overall Study|Lost to Follow-up|4|||
163951489|NCT02047903|592191533|FG000|Overall Study|Reason not listed|6|||
163951490|NCT02047903|592191533|FG000|Overall Study|Not Treated|9|||
163951491|NCT00513604|592191534|FG000|Overall Study|Not treated|2|||
163951492|NCT00513604|592191535|FG001|Overall Study|Not treated|0|||
163951493|NCT00513604|592191536|FG002|Overall Study|Not treated|1|||
163951494|NCT00513604|592191537|FG003|Overall Study|Not treated|0|||
163951495|NCT00513604|592191538|FG004|Overall Study|Not treated|0|||
163951496|NCT00513604|592191534|FG000|Overall Study|Death during treatment|0|||
163843816|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843817|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843818|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843819|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843820|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843821|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843822|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843823|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843824|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843825|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163951497|NCT00513604|592191535|FG001|Overall Study|Death during treatment|3|||
163951498|NCT00513604|592191536|FG002|Overall Study|Death during treatment|2|||
163951499|NCT00513604|592191537|FG003|Overall Study|Death during treatment|0|||
163951500|NCT00513604|592191538|FG004|Overall Study|Death during treatment|0|||
163951501|NCT01014533|592191539|FG000|Overall Study|Protocol Violation|3|||
163951502|NCT01014533|592191540|FG001|Overall Study|Protocol Violation|2|||
163951503|NCT01014533|592191539|FG000|Overall Study|Withdrawal by Subject|2|||
163951504|NCT01014533|592191540|FG001|Overall Study|Withdrawal by Subject|0|||
163951505|NCT01014533|592191539|FG000|Overall Study|unable to come to appointment|0|||
163951506|NCT01014533|592191540|FG001|Overall Study|unable to come to appointment|3|||
163951507|NCT00412061|592191544|FG000|Double Blind Phase|Disease Progression|101|||
163951508|NCT00412061|592191545|FG001|Double Blind Phase|Disease Progression|154|||
163951509|NCT00412061|592191544|FG000|Double Blind Phase|Adverse Event|61|||
163951510|NCT00412061|592191545|FG001|Double Blind Phase|Adverse Event|16|||
163951511|NCT00412061|592191544|FG000|Double Blind Phase|Final Primary Analysis|26|||
163951512|NCT00412061|592191545|FG001|Double Blind Phase|Final Primary Analysis|14|||
163951513|NCT00412061|592191544|FG000|Double Blind Phase|Withdrawal by Subject|18|||
163951514|NCT00412061|592191545|FG001|Double Blind Phase|Withdrawal by Subject|20|||
163951515|NCT00412061|592191544|FG000|Double Blind Phase|Death|6|||
163951516|NCT00412061|592191545|FG001|Double Blind Phase|Death|3|||
163951517|NCT00412061|592191544|FG000|Double Blind Phase|Protocol Violation|3|||
163951518|NCT00412061|592191545|FG001|Double Blind Phase|Protocol Violation|4|||
163951519|NCT00412061|592191544|FG000|Double Blind Phase|New Cander Therapy|1|||
163951520|NCT00412061|592191545|FG001|Double Blind Phase|New Cander Therapy|1|||
163951521|NCT00412061|592191544|FG000|Double Blind Phase|Lost to Follow-up|0|||
163951522|NCT00412061|592191545|FG001|Double Blind Phase|Lost to Follow-up|1|||
163951523|NCT00412061|592191544|FG000|Open Label Phase|Disease Progression|0|||
163951524|NCT00412061|592191545|FG001|Open Label Phase|Disease Progression|86|||
163951525|NCT00412061|592191544|FG000|Open Label Phase|Adverse Event|0|||
163951526|NCT00412061|592191545|FG001|Open Label Phase|Adverse Event|46|||
163843826|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843827|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163951527|NCT00412061|592191544|FG000|Open Label Phase|Withdrawal by Subject|0|||
163951528|NCT00412061|592191545|FG001|Open Label Phase|Withdrawal by Subject|15|||
163843828|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
163843829|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
163843830|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
163951529|NCT00412061|592191544|FG000|Open Label Phase|Administrative Problems|0|||
163951530|NCT00412061|592191545|FG001|Open Label Phase|Administrative Problems|13|||
163951531|NCT00412061|592191544|FG000|Open Label Phase|Death|0|||
163951532|NCT00412061|592191545|FG001|Open Label Phase|Death|7|||
163951533|NCT00412061|592191544|FG000|Open Label Phase|Lost to Follow-up|0|||
163951534|NCT00412061|592191545|FG001|Open Label Phase|Lost to Follow-up|2|||
163951535|NCT00412061|592191544|FG000|Open Label Phase|New Cancer Therapy|0|||
163951536|NCT00412061|592191545|FG001|Open Label Phase|New Cancer Therapy|1|||
163951537|NCT02689518|592191546|FG000|Overall Study|Withdrawal by Subject|3|||
163951538|NCT01942590|592191549|FG000|Overall Study|Withdrawal by Subject|0|||
163951539|NCT01942590|592191550|FG001|Overall Study|Withdrawal by Subject|1|||
163951540|NCT01942590|592191549|FG000|Overall Study|Adverse Event|1|||
163951541|NCT01942590|592191550|FG001|Overall Study|Adverse Event|0|||
163951542|NCT02433340|592191551|FG000|Overall Study|Adverse Event|0|||
163951543|NCT02433340|592191552|FG001|Overall Study|Adverse Event|0|||
163951544|NCT02433340|592191553|FG002|Overall Study|Adverse Event|1|||
163951545|NCT02433340|592191554|FG003|Overall Study|Adverse Event|0|||
163951546|NCT02433340|592191551|FG000|Overall Study|Withdrawal by Subject|1|||
163951547|NCT02433340|592191552|FG001|Overall Study|Withdrawal by Subject|0|||
163951548|NCT02433340|592191553|FG002|Overall Study|Withdrawal by Subject|1|||
163951549|NCT02433340|592191554|FG003|Overall Study|Withdrawal by Subject|2|||
163951550|NCT02433340|592191551|FG000|Overall Study|Lost to Follow-up|0|||
163951551|NCT02433340|592191552|FG001|Overall Study|Lost to Follow-up|1|||
163951552|NCT02433340|592191553|FG002|Overall Study|Lost to Follow-up|0|||
163843831|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
163843832|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
163843833|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843834|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843835|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843836|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843837|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843838|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843839|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843840|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843841|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843842|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843843|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843844|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843845|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843846|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843847|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843848|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
163843849|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
163843850|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
163843851|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
163843852|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
163843853|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
163843854|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
163843855|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
163843856|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
163843857|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
163843858|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
163843859|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
163843860|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
163843861|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
163843862|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
163843863|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
163843864|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
163843865|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
163843866|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
163843867|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
163843868|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
163843869|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843870|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843871|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843872|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843873|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843874|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843875|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843876|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
163951553|NCT02433340|592191554|FG003|Overall Study|Lost to Follow-up|0|||
164047487|NCT00085644|592532777|FG000|Open-Label Period|Withdrawal by Subject|0|||
163951554|NCT02433340|592191551|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
163951555|NCT02433340|592191552|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
163951556|NCT02433340|592191553|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
163951557|NCT02433340|592191554|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
163951558|NCT02433340|592191551|FG000|Overall Study|Other|0|||
164047488|NCT00085644|592532778|FG001|Open-Label Period|Withdrawal by Subject|0|||
164047489|NCT00085644|592532779|FG002|Open-Label Period|Withdrawal by Subject|29|||
164047490|NCT00085644|592532777|FG000|Open-Label Period|Lost to Follow-up|0|||
164047491|NCT00085644|592532778|FG001|Open-Label Period|Lost to Follow-up|0|||
164047492|NCT00085644|592532779|FG002|Open-Label Period|Lost to Follow-up|13|||
164047493|NCT00085644|592532777|FG000|Open-Label Period|Lack of Efficacy|0|||
164047494|NCT00085644|592532778|FG001|Open-Label Period|Lack of Efficacy|0|||
164047495|NCT00085644|592532779|FG002|Open-Label Period|Lack of Efficacy|15|||
164047496|NCT00085644|592532777|FG000|Open-Label Period|Pregnancy|0|||
164047497|NCT00085644|592532778|FG001|Open-Label Period|Pregnancy|0|||
164047498|NCT00085644|592532779|FG002|Open-Label Period|Pregnancy|3|||
164047499|NCT00085644|592532777|FG000|Open-Label Period|Contemplating pregnancy|0|||
164047500|NCT00085644|592532778|FG001|Open-Label Period|Contemplating pregnancy|0|||
164047501|NCT00085644|592532779|FG002|Open-Label Period|Contemplating pregnancy|3|||
164047502|NCT00085644|592532777|FG000|Open-Label Period|Protocol Violation|0|||
164047503|NCT00085644|592532778|FG001|Open-Label Period|Protocol Violation|0|||
164047504|NCT00085644|592532779|FG002|Open-Label Period|Protocol Violation|4|||
164047505|NCT00085644|592532777|FG000|Open-Label Period|Personal reason|0|||
164047506|NCT00085644|592532778|FG001|Open-Label Period|Personal reason|0|||
164047507|NCT00085644|592532779|FG002|Open-Label Period|Personal reason|4|||
164047508|NCT03330106|592532780|FG000|Part A|Withdrawal by Subject|1|||
164047509|NCT03330106|592532781|FG001|Part A|Withdrawal by Subject|1|||
164047510|NCT03330106|592532782|FG002|Part A|Withdrawal by Subject|0|||
164047511|NCT03330106|592532783|FG003|Part A|Withdrawal by Subject|0|||
164047512|NCT03330106|592532780|FG000|Part A|Death|2|||
164047513|NCT03330106|592532781|FG001|Part A|Death|1|||
164047514|NCT03330106|592532782|FG002|Part A|Death|0|||
164047515|NCT03330106|592532783|FG003|Part A|Death|0|||
164047516|NCT03330106|592532780|FG000|Part A|Adverse Event|0|||
164047517|NCT03330106|592532781|FG001|Part A|Adverse Event|1|||
164047518|NCT03330106|592532782|FG002|Part A|Adverse Event|0|||
164047519|NCT03330106|592532783|FG003|Part A|Adverse Event|0|||
164047520|NCT03330106|592532780|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
164047521|NCT03330106|592532781|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
164047522|NCT03330106|592532782|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
164047523|NCT03330106|592532783|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
164047524|NCT03330106|592532780|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
164047525|NCT03330106|592532781|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
164047526|NCT03330106|592532782|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
164047527|NCT03330106|592532783|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
164047528|NCT03330106|592532780|FG000|Part A|Progressive Disease|0|||
164047529|NCT03330106|592532781|FG001|Part A|Progressive Disease|1|||
164047530|NCT03330106|592532782|FG002|Part A|Progressive Disease|0|||
164047531|NCT03330106|592532783|FG003|Part A|Progressive Disease|0|||
164047532|NCT03330106|592532780|FG000|Part B|Lost to Follow-up|0|||
164047533|NCT03330106|592532781|FG001|Part B|Lost to Follow-up|0|||
164047534|NCT03330106|592532782|FG002|Part B|Lost to Follow-up|0|||
164047535|NCT03330106|592532783|FG003|Part B|Lost to Follow-up|1|||
164047536|NCT03330106|592532780|FG000|Part B|Withdrawal by Subject|0|||
164047537|NCT03330106|592532781|FG001|Part B|Withdrawal by Subject|0|||
164047538|NCT03330106|592532782|FG002|Part B|Withdrawal by Subject|4|||
164047539|NCT03330106|592532783|FG003|Part B|Withdrawal by Subject|0|||
164047540|NCT03330106|592532780|FG000|Part B|Death|0|||
164047541|NCT03330106|592532781|FG001|Part B|Death|0|||
164047542|NCT03330106|592532782|FG002|Part B|Death|2|||
164047543|NCT03330106|592532783|FG003|Part B|Death|0|||
164047544|NCT03330106|592532780|FG000|Part B|Clinical Progression|0|||
164047545|NCT03330106|592532781|FG001|Part B|Clinical Progression|0|||
164047546|NCT03330106|592532782|FG002|Part B|Clinical Progression|1|||
164047547|NCT03330106|592532783|FG003|Part B|Clinical Progression|1|||
164047548|NCT03330106|592532780|FG000|Part B|Symptomatic Deterioration|0|||
164047549|NCT03330106|592532781|FG001|Part B|Symptomatic Deterioration|0|||
164047550|NCT03330106|592532782|FG002|Part B|Symptomatic Deterioration|0|||
164047551|NCT03330106|592532783|FG003|Part B|Symptomatic Deterioration|1|||
164047552|NCT03330106|592532780|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
164047553|NCT03330106|592532781|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
164047554|NCT03330106|592532782|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
164047555|NCT03330106|592532783|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
164047556|NCT03330106|592532780|FG000|Part B|Progressive Disease|0|||
164047557|NCT03330106|592532781|FG001|Part B|Progressive Disease|0|||
164047558|NCT03330106|592532782|FG002|Part B|Progressive Disease|11|||
164047559|NCT03330106|592532783|FG003|Part B|Progressive Disease|4|||
164047560|NCT00623766|592532785|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
164047561|NCT00623766|592532786|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
164047562|NCT00623766|592532785|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
164047563|NCT00623766|592532786|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
163951559|NCT02433340|592191552|FG001|Overall Study|Other|1|||
163951560|NCT02433340|592191553|FG002|Overall Study|Other|0|||
163951561|NCT02433340|592191554|FG003|Overall Study|Other|0|||
163951562|NCT01226095|592191555|FG000|Overall Study|Poor compliance|1|||
163951563|NCT04822597|592191560|FG000|Overall Study|Withdrawal by Subject|0|||
163843877|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843878|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843879|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843880|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843881|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843882|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843883|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843884|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
163843885|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
163843886|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
163843887|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
163843888|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
163843889|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
163843890|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
163843891|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
163843892|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
163843893|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
163843894|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
163843895|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
163843896|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
163843897|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
163843898|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
163843899|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
163843900|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
163843901|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
163843902|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
163843903|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
163843904|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
163843905|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843906|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843907|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843908|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843909|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843910|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843911|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843912|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843913|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843914|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843915|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843916|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843917|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843918|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843919|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
163843920|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843921|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
163843922|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
163843923|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843924|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163951564|NCT04822597|592191561|FG001|Overall Study|Withdrawal by Subject|1|||
163951565|NCT04822597|592191562|FG002|Overall Study|Withdrawal by Subject|1|||
163951566|NCT04822597|592191563|FG003|Overall Study|Withdrawal by Subject|0|||
163951567|NCT04822597|592191560|FG000|Overall Study|Physician Decision|0|||
163951568|NCT04822597|592191561|FG001|Overall Study|Physician Decision|0|||
163951569|NCT04822597|592191562|FG002|Overall Study|Physician Decision|1|||
163951570|NCT04822597|592191563|FG003|Overall Study|Physician Decision|1|||
163951571|NCT04822597|592191560|FG000|Overall Study|Subject withdrawn after enrollment|0|||
163951572|NCT04822597|592191561|FG001|Overall Study|Subject withdrawn after enrollment|1|||
163951573|NCT04822597|592191562|FG002|Overall Study|Subject withdrawn after enrollment|0|||
163951574|NCT04822597|592191563|FG003|Overall Study|Subject withdrawn after enrollment|1|||
163951575|NCT04822597|592191560|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
163951576|NCT04822597|592191561|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
163951577|NCT04822597|592191562|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
163951578|NCT04822597|592191563|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
163951579|NCT00911768|592191570|FG000|Overall Study|Protocol Violation|5|||
163951580|NCT00911768|592191571|FG001|Overall Study|Protocol Violation|4|||
163951581|NCT00911768|592191570|FG000|Overall Study|Withdrawal by Subject|1|||
163951582|NCT00911768|592191571|FG001|Overall Study|Withdrawal by Subject|0|||
163951583|NCT02859324|592191573|FG000|Overall Study|Death|4|||
163951584|NCT02859324|592191574|FG001|Overall Study|Death|6|||
163951585|NCT02859324|592191575|FG002|Overall Study|Death|5|||
163951586|NCT02859324|592191573|FG000|Overall Study|Other reasons|3|||
163951587|NCT02859324|592191574|FG001|Overall Study|Other reasons|3|||
163951588|NCT02859324|592191575|FG002|Overall Study|Other reasons|0|||
163951589|NCT02665338|592191577|FG000|Overall Study|Withdrawal by Subject|0|||
163951590|NCT02665338|592191578|FG001|Overall Study|Withdrawal by Subject|1|||
163951591|NCT00998335|592191579|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
163951592|NCT00998335|592191580|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
163951593|NCT05110690|592191581|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
163951594|NCT05110690|592191581|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
163951595|NCT05110690|592191581|FG000|Completion of Intervention|Lost to Follow-up|1|||
163951596|NCT05110690|592191581|FG000|Completion of Intervention|Death|1|||
163951597|NCT05110690|592191581|FG000|Completion of Intervention|Withdrawal by Subject|2|||
163951598|NCT01586910|592193360|FG000|Overall Study|Death|4|||
163951599|NCT01586910|592193361|FG001|Overall Study|Death|4|||
163951600|NCT01586910|592193360|FG000|Overall Study|Withdrawal by Subject|6|||
163951601|NCT01586910|592193361|FG001|Overall Study|Withdrawal by Subject|43|||
163951602|NCT01586910|592193360|FG000|Overall Study|Physician withdrew Subject|5|||
163951603|NCT01586910|592193361|FG001|Overall Study|Physician withdrew Subject|24|||
163951604|NCT00953407|592193362|FG000|Overall Study|Failed inclusion criteria|1|||
163951605|NCT00953407|592193363|FG001|Overall Study|Failed inclusion criteria|1|||
163951606|NCT00953407|592193364|FG002|Overall Study|Failed inclusion criteria|1|||
163951607|NCT00953407|592193365|FG003|Overall Study|Failed inclusion criteria|1|||
163951608|NCT00953407|592193366|FG004|Overall Study|Failed inclusion criteria|1|||
163951609|NCT00953407|592193362|FG000|Overall Study|Lost to Follow-up|0|||
163951610|NCT00953407|592193363|FG001|Overall Study|Lost to Follow-up|0|||
163951611|NCT00953407|592193364|FG002|Overall Study|Lost to Follow-up|0|||
163951612|NCT00953407|592193365|FG003|Overall Study|Lost to Follow-up|1|||
163951613|NCT00953407|592193366|FG004|Overall Study|Lost to Follow-up|0|||
163951614|NCT02186223|592193367|FG000|Overall Study|Not eligible for device placement|6|||
163951615|NCT02186223|592193367|FG000|Overall Study|Unable to obtain femoral access|3|||
163951616|NCT02186223|592193367|FG000|Overall Study|Death|3|||
163951617|NCT02186223|592193367|FG000|Overall Study|Device in place less than 48 hours|9|||
163951618|NCT00252733|592193368|FG000|Overall Study|Withdrawal by Subject|73|||
163951619|NCT00252733|592193369|FG001|Overall Study|Withdrawal by Subject|67|||
163951620|NCT00252733|592193368|FG000|Overall Study|Death|7|||
163951621|NCT00252733|592193369|FG001|Overall Study|Death|5|||
163951622|NCT00252733|592193368|FG000|Overall Study|Lost to Follow-up|12|||
163951623|NCT00252733|592193369|FG001|Overall Study|Lost to Follow-up|6|||
163951624|NCT00252733|592193368|FG000|Overall Study|Multiple Reasons|14|||
163951625|NCT00252733|592193369|FG001|Overall Study|Multiple Reasons|14|||
163951626|NCT01111474|592193370|FG000|Overall Study|Lost to Follow-up|12|||
163951627|NCT00618982|592193371|FG000|Overall Study|Adverse Event|23|||
163951628|NCT00618982|592193371|FG000|Overall Study|Withdrawal by Subject|1|||
163951629|NCT00618982|592193371|FG000|Overall Study|Protocol Violation|1|||
163951630|NCT00618982|592193371|FG000|Overall Study|ongoing, still treated with study med.|25|||
163951631|NCT04289051|592193372|FG000|Overall Study|Lost to Follow-up|0|||
163951632|NCT04289051|592193373|FG001|Overall Study|Lost to Follow-up|0|||
163951633|NCT04289051|592193374|FG002|Overall Study|Lost to Follow-up|2|||
163951634|NCT00156819|592193375|FG000|Overall Study|Lost to Follow-up|1|||
163951635|NCT00156819|592193376|FG001|Overall Study|Lost to Follow-up|1|||
163951636|NCT00156819|592193377|FG002|Overall Study|Lost to Follow-up|3|||
163951637|NCT01689337|592193378|FG000|Overall Study|Study Discontinuation|1|||
163951638|NCT05398237|592193383|FG000|Overall Study|Withdrawal by Subject|1|||
163951639|NCT01312857|592193386|FG000|Overall Study|Adverse Event|1|||
163951640|NCT01312857|592193387|FG001|Overall Study|Adverse Event|1|||
163951641|NCT01312857|592193386|FG000|Overall Study|Lost to Follow-up|2|||
163951642|NCT01312857|592193387|FG001|Overall Study|Lost to Follow-up|0|||
163951643|NCT01312857|592193386|FG000|Overall Study|Physician Decision|3|||
163951644|NCT01312857|592193387|FG001|Overall Study|Physician Decision|0|||
163951645|NCT01312857|592193386|FG000|Overall Study|Withdrawal by Subject|2|||
163951646|NCT01312857|592193387|FG001|Overall Study|Withdrawal by Subject|0|||
163951647|NCT01248065|592193388|FG000|Overall Study|Lost to Follow-up|3|||
163951648|NCT01248065|592193389|FG001|Overall Study|Lost to Follow-up|5|||
163951649|NCT01248065|592193388|FG000|Overall Study|Withdrawal by Subject|14|||
163951650|NCT01248065|592193389|FG001|Overall Study|Withdrawal by Subject|11|||
163951651|NCT01248065|592193388|FG000|Overall Study|Adverse Event|3|||
163951652|NCT01248065|592193389|FG001|Overall Study|Adverse Event|0|||
163951653|NCT01248065|592193388|FG000|Overall Study|Third treatment failure event|3|||
163951654|NCT01248065|592193389|FG001|Overall Study|Third treatment failure event|1|||
163951655|NCT01248065|592193388|FG000|Overall Study|Other|3|||
163951656|NCT01248065|592193389|FG001|Overall Study|Other|5|||
163951657|NCT02781844|592193395|FG000|Treatment Period 1|Adverse Event|0|||
163951658|NCT02781844|592193396|FG001|Treatment Period 1|Adverse Event|0|||
163951659|NCT02781844|592193397|FG002|Treatment Period 1|Adverse Event|0|||
163951660|NCT02781844|592193398|FG003|Treatment Period 1|Adverse Event|0|||
163951661|NCT02781844|592193399|FG004|Treatment Period 1|Adverse Event|0|||
163951662|NCT02781844|592193400|FG005|Treatment Period 1|Adverse Event|1|||
163843925|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843926|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843927|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843928|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843929|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843930|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843931|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843932|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843933|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843934|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843935|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843936|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843937|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
163843938|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843939|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
163843940|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
163843941|NCT01474512|591798521|FG000|Post-Treatment Follow-Up|Death|0|||
163843942|NCT01474512|591798522|FG001|Post-Treatment Follow-Up|Death|0|||
163843943|NCT01474512|591798523|FG002|Post-Treatment Follow-Up|Death|0|||
163843944|NCT01474512|591798524|FG003|Post-Treatment Follow-Up|Death|0|||
163843945|NCT01474512|591798525|FG004|Post-Treatment Follow-Up|Death|0|||
163843946|NCT01474512|591798526|FG005|Post-Treatment Follow-Up|Death|0|||
163843947|NCT01474512|591798527|FG006|Post-Treatment Follow-Up|Death|0|||
163843948|NCT01474512|591798528|FG007|Post-Treatment Follow-Up|Death|0|||
163843949|NCT01474512|591798529|FG008|Post-Treatment Follow-Up|Death|0|||
163843950|NCT01474512|591798530|FG009|Post-Treatment Follow-Up|Death|0|||
163843951|NCT01474512|591798531|FG010|Post-Treatment Follow-Up|Death|0|||
163843952|NCT01474512|591798532|FG011|Post-Treatment Follow-Up|Death|0|||
163843953|NCT01474512|591798533|FG012|Post-Treatment Follow-Up|Death|0|||
163843954|NCT01474512|591798534|FG013|Post-Treatment Follow-Up|Death|0|||
163843955|NCT01474512|591798535|FG014|Post-Treatment Follow-Up|Death|0|||
163843956|NCT01474512|591798536|FG015|Post-Treatment Follow-Up|Death|0|||
163843957|NCT01474512|591798537|FG016|Post-Treatment Follow-Up|Death|1|||
163843958|NCT01474512|591798538|FG017|Post-Treatment Follow-Up|Death|0|||
163843959|NCT01118962|591798541|FG000|Overall Study|Adverse Event|2|||
163843960|NCT01118962|591798541|FG000|Overall Study|Lack of Efficacy|1|||
163843961|NCT01118962|591798541|FG000|Overall Study|Protocol Violation|1|||
163843962|NCT01118962|591798541|FG000|Overall Study|Withdrawal by Subject|4|||
163843963|NCT01118962|591798541|FG000|Overall Study|Pregnancy|1|||
163843964|NCT01118962|591798541|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
163843965|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
163843966|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
163843967|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
163843968|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
163843969|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
163843970|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
163843971|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
163843972|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
163843973|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163843974|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163843975|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163843976|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
163843977|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
163843978|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
163843979|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163843980|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163843981|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163843982|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
163843983|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163843984|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
163843985|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163951663|NCT02781844|592193401|FG006|Treatment Period 1|Adverse Event|0|||
163951664|NCT02781844|592193402|FG007|Treatment Period 1|Adverse Event|0|||
163843986|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163843987|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163843988|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
163843989|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
163843990|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
163843991|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
163843992|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
163843993|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
163843994|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
164047564|NCT00623766|592532785|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
164047565|NCT00623766|592532786|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
164047566|NCT00623766|592532785|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
164047567|NCT00623766|592532786|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
164047568|NCT00623766|592532785|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
164047569|NCT00623766|592532786|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
164047570|NCT00486889|592532788|FG000|Overall Study|Death|3|||
164047571|NCT00486889|592532788|FG000|Overall Study|Non-compliant|2|||
164047572|NCT00486889|592532788|FG000|Overall Study|Withdrawal by Subject|6|||
164047573|NCT02750501|592532789|FG000|Overall Study|Adverse Event|4|||
164047574|NCT02750501|592532789|FG000|Overall Study|Physician Decision|1|||
164047575|NCT02750501|592532789|FG000|Overall Study|Protocol Violation|1|||
164047576|NCT02750501|592532789|FG000|Overall Study|G-tube came out|1|||
164047577|NCT02750501|592532789|FG000|Overall Study|Non-compliant use of PERT|1|||
164047578|NCT00893763|592532790|FG000|Overall Study|extubated|110|||
164047579|NCT00893763|592532791|FG001|Overall Study|extubated|110|||
164047580|NCT01738594|592532792|FG000|Registration and Treatment Start|Adverse Event|0|||
164047581|NCT01738594|592532793|FG001|Registration and Treatment Start|Adverse Event|1|||
164047582|NCT01738594|592532794|FG002|Registration and Treatment Start|Adverse Event|0|||
164047583|NCT01738594|592532795|FG003|Registration and Treatment Start|Adverse Event|0|||
164047584|NCT01738594|592532796|FG004|Registration and Treatment Start|Adverse Event|0|||
164047585|NCT01738594|592532797|FG005|Registration and Treatment Start|Adverse Event|0|||
164047586|NCT01738594|592532798|FG006|Registration and Treatment Start|Adverse Event|0|||
164047587|NCT01738594|592532799|FG007|Registration and Treatment Start|Adverse Event|0|||
164047588|NCT01738594|592532792|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047589|NCT01738594|592532793|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047590|NCT01738594|592532794|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047591|NCT01738594|592532795|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047592|NCT01738594|592532796|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047593|NCT01738594|592532797|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
164047594|NCT01738594|592532798|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047595|NCT01738594|592532799|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
164047596|NCT01738594|592532792|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047597|NCT01738594|592532793|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
164047598|NCT01738594|592532794|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047599|NCT01738594|592532795|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047600|NCT01738594|592532796|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047601|NCT01738594|592532797|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047602|NCT01738594|592532798|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047603|NCT01738594|592532799|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
164047604|NCT01738594|592532792|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047605|NCT01738594|592532793|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047606|NCT01738594|592532794|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047607|NCT01738594|592532795|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047608|NCT01738594|592532796|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047609|NCT01738594|592532797|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
164047610|NCT01738594|592532798|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047611|NCT01738594|592532799|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
164047612|NCT01738594|592532792|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047613|NCT01738594|592532793|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047614|NCT01738594|592532794|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047615|NCT01738594|592532795|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047616|NCT01738594|592532796|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047617|NCT01738594|592532797|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
164047618|NCT01738594|592532798|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047619|NCT01738594|592532799|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
164047620|NCT01738594|592532792|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047621|NCT01738594|592532793|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047622|NCT01738594|592532794|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047623|NCT01738594|592532795|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047624|NCT01738594|592532796|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
164047625|NCT01738594|592532797|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047626|NCT01738594|592532798|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047627|NCT01738594|592532799|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
164047628|NCT01738594|592532792|FG000|Follow up for 1 Year|Death|0|||
164047629|NCT01738594|592532793|FG001|Follow up for 1 Year|Death|0|||
163843995|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
163843996|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
163843997|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163843998|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163843999|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163844000|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
163844001|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
163844002|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
163844003|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163844004|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163844005|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163844006|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
163844007|NCT01089556|591798544|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
163844008|NCT01089556|591798545|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
163844009|NCT01089556|591798546|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163844010|NCT01089556|591798547|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163844011|NCT01089556|591798548|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163844012|NCT01089556|591798549|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
163844013|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
163844014|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
163844015|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
163844016|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
163844017|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
163844018|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
163844019|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
163844020|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
163844021|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163844022|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163844023|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163844024|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
163844025|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163844026|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163844027|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163844028|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
163844029|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
163844030|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
163844031|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163844032|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163844033|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
163844034|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163844035|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163844036|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
163844037|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
163844038|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
163844039|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
163844040|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
163844041|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
163844042|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
163844043|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
163951665|NCT00321373|592193403|FG000|Overall Study|Adverse Event|0|||
163951666|NCT00321373|592193404|FG001|Overall Study|Adverse Event|0|||
163951667|NCT00321373|592193405|FG002|Overall Study|Adverse Event|1|||
163951668|NCT00321373|592193403|FG000|Overall Study|Lost to Follow-up|1|||
163951669|NCT00321373|592193404|FG001|Overall Study|Lost to Follow-up|0|||
163951670|NCT00321373|592193405|FG002|Overall Study|Lost to Follow-up|1|||
163951671|NCT00321373|592193403|FG000|Overall Study|Withdrawal by Subject|1|||
163951672|NCT00321373|592193404|FG001|Overall Study|Withdrawal by Subject|0|||
163951673|NCT00321373|592193405|FG002|Overall Study|Withdrawal by Subject|0|||
163951674|NCT00321373|592193403|FG000|Overall Study|Other|0|||
163951675|NCT00321373|592193404|FG001|Overall Study|Other|0|||
163951676|NCT00321373|592193405|FG002|Overall Study|Other|1|||
163951677|NCT01383499|592193406|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
163951678|NCT01383499|592193407|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163951679|NCT01383499|592193408|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163951680|NCT01383499|592193409|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
163951681|NCT01774487|592193410|FG000|Overall Study|Did not tolerate taste|4|||
163951682|NCT01774487|592193411|FG001|Overall Study|Did not tolerate taste|4|||
163951683|NCT00477334|592193416|FG000|Overall Study|Discontinued prior to taking study drug|106|||
163951684|NCT00477334|592193417|FG001|Overall Study|Discontinued prior to taking study drug|53|||
163951685|NCT00477334|592193416|FG000|Overall Study|Adverse Event|1|||
163951686|NCT00477334|592193417|FG001|Overall Study|Adverse Event|2|||
163844044|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
163844045|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
163844046|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
163844047|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
163844048|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
163844049|NCT01089556|591798544|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
163844050|NCT01089556|591798545|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
163844051|NCT01089556|591798546|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
163844052|NCT01089556|591798547|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
163844053|NCT01089556|591798548|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
163844054|NCT01089556|591798549|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
163844055|NCT00594906|591798550|FG000|Overall Study|Physician Decision|1|||
163844056|NCT00594906|591798551|FG001|Overall Study|Physician Decision|0|||
163844057|NCT00594906|591798550|FG000|Overall Study|Physician Decision|0|||
163844058|NCT00594906|591798551|FG001|Overall Study|Physician Decision|1|||
163844059|NCT00594906|591798550|FG000|Overall Study|Death|0|||
163844060|NCT00594906|591798551|FG001|Overall Study|Death|1|||
163844061|NCT01027364|591798557|FG000|Overall Study|Adverse Event|1|||
163844062|NCT01027364|591798558|FG001|Overall Study|Adverse Event|0|||
163844063|NCT01027364|591798559|FG002|Overall Study|Adverse Event|1|||
163844064|NCT01027364|591798560|FG003|Overall Study|Adverse Event|0|||
163844065|NCT01027364|591798557|FG000|Overall Study|Lost to Follow-up|1|||
163844066|NCT01027364|591798558|FG001|Overall Study|Lost to Follow-up|0|||
163844067|NCT01027364|591798559|FG002|Overall Study|Lost to Follow-up|0|||
163844068|NCT01027364|591798560|FG003|Overall Study|Lost to Follow-up|0|||
163844069|NCT01027364|591798557|FG000|Overall Study|Protocol Violation|1|||
163844070|NCT01027364|591798558|FG001|Overall Study|Protocol Violation|0|||
163844071|NCT01027364|591798559|FG002|Overall Study|Protocol Violation|0|||
163844072|NCT01027364|591798560|FG003|Overall Study|Protocol Violation|1|||
163844073|NCT01027364|591798557|FG000|Overall Study|Withdrawal by Subject|1|||
163844074|NCT01027364|591798558|FG001|Overall Study|Withdrawal by Subject|2|||
163844075|NCT01027364|591798559|FG002|Overall Study|Withdrawal by Subject|0|||
163844076|NCT01027364|591798560|FG003|Overall Study|Withdrawal by Subject|0|||
163844077|NCT02222896|591798561|FG000|Abdomen|Did not qualify|34|||
163844078|NCT02222896|591798562|FG001|Abdomen|Did not qualify|10|||
163844079|NCT02222896|591798563|FG002|Abdomen|Did not qualify|32|||
163844080|NCT02222896|591798561|FG000|Groin|Did not qualify|43|||
163844081|NCT02222896|591798562|FG001|Groin|Did not qualify|9|||
163951687|NCT00477334|592193416|FG000|Overall Study|Withdrawal by Subject|2|||
163951688|NCT00477334|592193417|FG001|Overall Study|Withdrawal by Subject|1|||
163951689|NCT00477334|592193416|FG000|Overall Study|Lost to Follow-up|15|||
163951690|NCT00477334|592193417|FG001|Overall Study|Lost to Follow-up|4|||
163951691|NCT00477334|592193416|FG000|Overall Study|Administrative Problems|39|||
163951692|NCT00477334|592193417|FG001|Overall Study|Administrative Problems|15|||
163951693|NCT00477334|592193416|FG000|Overall Study|Protocol Violation|7|||
163951694|NCT00477334|592193417|FG001|Overall Study|Protocol Violation|1|||
163951695|NCT02572882|592193418|FG000|Overall Study|Withdrawal by Subject|1|||
163951696|NCT02572882|592193418|FG000|Overall Study|Participant received kidney transplant|1|||
163951697|NCT04745026|592193422|FG000|Overall Study|Physician Decision|1|||
163951698|NCT04745026|592193423|FG001|Overall Study|Physician Decision|0|||
163951699|NCT04745026|592193422|FG000|Overall Study|Adverse Event|2|||
163951700|NCT04745026|592193423|FG001|Overall Study|Adverse Event|2|||
163951701|NCT04745026|592193422|FG000|Overall Study|Protocol Violation|1|||
163951702|NCT04745026|592193423|FG001|Overall Study|Protocol Violation|3|||
163951703|NCT04745026|592193422|FG000|Overall Study|Lost to Follow-up|4|||
163951704|NCT04745026|592193423|FG001|Overall Study|Lost to Follow-up|3|||
163951705|NCT04745026|592193422|FG000|Overall Study|Withdrawal by Subject|5|||
163951706|NCT04745026|592193423|FG001|Overall Study|Withdrawal by Subject|5|||
163951707|NCT02292927|592193426|FG000|Overall Study|Protocol Violation|13|||
163951708|NCT02292927|592193427|FG001|Overall Study|Protocol Violation|7|||
163951709|NCT01656733|592193428|FG000|Overall Study|No permission to collect birth outcomes|0|||
163951710|NCT01656733|592193429|FG001|Overall Study|No permission to collect birth outcomes|1|||
163951711|NCT01656733|592193428|FG000|Overall Study|Delivery at another hospital|0|||
163951712|NCT01656733|592193429|FG001|Overall Study|Delivery at another hospital|2|||
163951713|NCT01656733|592193428|FG000|Overall Study|Spontaneous abortion|0|||
163951714|NCT01656733|592193429|FG001|Overall Study|Spontaneous abortion|1|||
163951715|NCT01415531|592193431|FG000|Overall Study|Adverse Event|7|||
163951716|NCT01415531|592193432|FG001|Overall Study|Adverse Event|10|||
163844082|NCT02222896|591798563|FG002|Groin|Did not qualify|40|||
163844083|NCT03772314|591798564|FG000|Overall Study|Adverse Event|7|||
163844084|NCT03772314|591798565|FG001|Overall Study|Adverse Event|2|||
163844085|NCT00119262|591798568|FG000|Overall Study|Lack of Efficacy|0|||
163844086|NCT00119262|591798569|FG001|Overall Study|Lack of Efficacy|3|||
163844087|NCT00119262|591798568|FG000|Overall Study|Withdrawal by Subject|12|||
163844088|NCT00119262|591798569|FG001|Overall Study|Withdrawal by Subject|11|||
163844089|NCT00119262|591798568|FG000|Overall Study|Adverse Event|33|||
163844090|NCT00119262|591798569|FG001|Overall Study|Adverse Event|35|||
164047630|NCT01738594|592532794|FG002|Follow up for 1 Year|Death|0|||
164047631|NCT01738594|592532795|FG003|Follow up for 1 Year|Death|0|||
164047632|NCT01738594|592532796|FG004|Follow up for 1 Year|Death|0|||
164047633|NCT01738594|592532797|FG005|Follow up for 1 Year|Death|1|||
164047634|NCT01738594|592532798|FG006|Follow up for 1 Year|Death|0|||
164047635|NCT01738594|592532799|FG007|Follow up for 1 Year|Death|0|||
164047636|NCT01738594|592532792|FG000|Follow up for 1 Year|Other|0|||
164047637|NCT01738594|592532793|FG001|Follow up for 1 Year|Other|0|||
164047638|NCT01738594|592532794|FG002|Follow up for 1 Year|Other|0|||
164047639|NCT01738594|592532795|FG003|Follow up for 1 Year|Other|0|||
164047640|NCT01738594|592532796|FG004|Follow up for 1 Year|Other|0|||
164047641|NCT01738594|592532797|FG005|Follow up for 1 Year|Other|2|||
164047642|NCT01738594|592532798|FG006|Follow up for 1 Year|Other|0|||
164047643|NCT01738594|592532799|FG007|Follow up for 1 Year|Other|0|||
164047644|NCT00796549|592532800|FG000|Overall Study|Adverse Event|11|||
164047645|NCT00796549|592532800|FG000|Overall Study|not entered|149|||
164047646|NCT00796549|592532800|FG000|Overall Study|Other|2|||
164047647|NCT00796549|592532800|FG000|Overall Study|Progressive disease|56|||
164047648|NCT04107935|592532802|FG000|Overall Study|Death|1|||
164047649|NCT04107935|592532803|FG001|Overall Study|Death|0|||
164047650|NCT00376675|592532804|FG000|Overall Study|Withdrawal by Subject|9|||
164047651|NCT00376675|592532805|FG001|Overall Study|Withdrawal by Subject|2|||
164047652|NCT00376675|592532804|FG000|Overall Study|Adverse Event|10|||
164047653|NCT00376675|592532805|FG001|Overall Study|Adverse Event|5|||
164047654|NCT00376675|592532804|FG000|Overall Study|Other Reason|1|||
164047655|NCT00376675|592532805|FG001|Overall Study|Other Reason|7|||
164047656|NCT00262314|592532821|FG000|Overall Study|Changing physicians|38|||
164047657|NCT00262314|592532821|FG000|Overall Study|Death|12|||
164047658|NCT00262314|592532821|FG000|Overall Study|Patient's decision|92|||
164047659|NCT00262314|592532821|FG000|Overall Study|Other|95|||
164047660|NCT00262314|592532821|FG000|Overall Study|Lost to Follow-up|70|||
164047661|NCT00262314|592532821|FG000|Overall Study|Administrative withdrawal|30|||
164047662|NCT04973085|592532822|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
164047663|NCT04973085|592532823|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
164047664|NCT00959699|592532824|FG000|Treatment Period|Adverse Event|3|||
164047665|NCT00959699|592532825|FG001|Treatment Period|Adverse Event|13|||
164047666|NCT00959699|592532824|FG000|Treatment Period|Lack of Efficacy|15|||
164047667|NCT00959699|592532825|FG001|Treatment Period|Lack of Efficacy|6|||
164047668|NCT00959699|592532824|FG000|Treatment Period|Lost to Follow-up|0|||
164047669|NCT00959699|592532825|FG001|Treatment Period|Lost to Follow-up|1|||
164047670|NCT00959699|592532824|FG000|Treatment Period|Withdrawal by Subject|1|||
164047671|NCT00959699|592532825|FG001|Treatment Period|Withdrawal by Subject|3|||
164047672|NCT00959699|592532824|FG000|Treatment Period|Non-Compliance with Protocol|0|||
164047673|NCT00959699|592532825|FG001|Treatment Period|Non-Compliance with Protocol|1|||
164047674|NCT00959699|592532824|FG000|Treatment Period|Did not receive treatment|0|||
164047675|NCT00959699|592532825|FG001|Treatment Period|Did not receive treatment|1|||
164047676|NCT00959699|592532824|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
164047677|NCT00959699|592532825|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
164047678|NCT00959699|592532824|FG000|Follow-up Period|Lost to Follow-up|3|||
164047679|NCT00959699|592532825|FG001|Follow-up Period|Lost to Follow-up|2|||
164047680|NCT00959699|592532824|FG000|Follow-up Period|Withdrawal by Subject|3|||
164047681|NCT00959699|592532825|FG001|Follow-up Period|Withdrawal by Subject|4|||
164047682|NCT03924427|592532826|FG000|Overall Study|Adverse Event|4|||
164047683|NCT03924427|592532826|FG000|Overall Study|Lack of Efficacy|1|||
164047684|NCT03924427|592532826|FG000|Overall Study|Withdrawal by Subject|1|||
164047685|NCT00609167|592532829|FG000|Overall Study|Withdrawal by Subject|1|||
164047686|NCT00609167|592532830|FG001|Overall Study|Withdrawal by Subject|0|||
164047687|NCT00609167|592532829|FG000|Overall Study|Lack of Efficacy|1|||
164047688|NCT00609167|592532830|FG001|Overall Study|Lack of Efficacy|0|||
164047689|NCT00609167|592532829|FG000|Overall Study|Adverse Event|5|||
164047690|NCT00609167|592532830|FG001|Overall Study|Adverse Event|1|||
164047691|NCT00609167|592532829|FG000|Overall Study|Disease Progression|1|||
164047692|NCT00609167|592532830|FG001|Overall Study|Disease Progression|0|||
164047693|NCT00609167|592532829|FG000|Overall Study|Stem Cell Transplant|0|||
164047694|NCT00609167|592532830|FG001|Overall Study|Stem Cell Transplant|6|||
164047695|NCT00712270|592532831|FG000|Overall Study|Withdrawal by Subject|11|||
164047696|NCT00712270|592532831|FG000|Overall Study|Screen Failure|3|||
164047697|NCT04412668|592532834|FG000|Overall Study|Death - multiple comorbidities|2|||
164047698|NCT04412668|592532835|FG001|Overall Study|Death - multiple comorbidities|0|||
164047699|NCT04412668|592532836|FG002|Overall Study|Death - multiple comorbidities|0|||
164047700|NCT04412668|592532834|FG000|Overall Study|Withdrawal by Subject|3|||
164047701|NCT04412668|592532835|FG001|Overall Study|Withdrawal by Subject|0|||
164047702|NCT04412668|592532836|FG002|Overall Study|Withdrawal by Subject|0|||
164047703|NCT04412668|592532834|FG000|Overall Study|Other than Specified|2|||
164047704|NCT04412668|592532835|FG001|Overall Study|Other than Specified|0|||
164047705|NCT04412668|592532836|FG002|Overall Study|Other than Specified|0|||
164047706|NCT05166603|592532837|FG000|Overall Study|Withdrawal by Subject|68|||
164047707|NCT05166603|592532838|FG001|Overall Study|Withdrawal by Subject|0|||
163951717|NCT01415531|592193431|FG000|Overall Study|Lack of Efficacy|3|||
163951718|NCT01415531|592193432|FG001|Overall Study|Lack of Efficacy|2|||
163951719|NCT01415531|592193431|FG000|Overall Study|Protocol Violation|0|||
163951720|NCT01415531|592193432|FG001|Overall Study|Protocol Violation|1|||
163951721|NCT01415531|592193431|FG000|Overall Study|Withdrawal by Subject|5|||
163951722|NCT01415531|592193432|FG001|Overall Study|Withdrawal by Subject|4|||
163951723|NCT01415531|592193431|FG000|Overall Study|Lost to Follow-up|6|||
163951724|NCT01415531|592193432|FG001|Overall Study|Lost to Follow-up|14|||
163951725|NCT01415531|592193431|FG000|Overall Study|Lack of Compliance|1|||
163951726|NCT01415531|592193432|FG001|Overall Study|Lack of Compliance|4|||
163951727|NCT01415531|592193431|FG000|Overall Study|Other Reasons|3|||
163951728|NCT01415531|592193432|FG001|Overall Study|Other Reasons|2|||
163951729|NCT00122460|592193433|FG000|Overall Study|investigational study phase ongoing|7|||
163951730|NCT00122460|592193434|FG001|Overall Study|investigational study phase ongoing|1|||
163951731|NCT02962960|592193435|FG000|Overall Study|Withdrawal by Subject|1|||
163951732|NCT02962960|592193436|FG001|Overall Study|Withdrawal by Subject|1|||
163951733|NCT02962960|592193437|FG002|Overall Study|Withdrawal by Subject|0|||
163951734|NCT02962960|592193435|FG000|Overall Study|Adverse Event|1|||
163951735|NCT02962960|592193436|FG001|Overall Study|Adverse Event|1|||
163951736|NCT02962960|592193437|FG002|Overall Study|Adverse Event|0|||
163951737|NCT02962960|592193435|FG000|Overall Study|Protocol Violation|1|||
163951738|NCT02962960|592193436|FG001|Overall Study|Protocol Violation|0|||
163951739|NCT02962960|592193437|FG002|Overall Study|Protocol Violation|0|||
163951740|NCT01236339|592193438|FG000|Overall Study|Termination of study by sponsor|11|||
163951741|NCT01236339|592193439|FG001|Overall Study|Termination of study by sponsor|13|||
163951742|NCT02054741|592193440|FG000|Overall Study|Protocol Violation|13|||
163951743|NCT02054741|592193441|FG001|Overall Study|Protocol Violation|2|||
163951744|NCT02054741|592193440|FG000|Overall Study|Withdrawal by Subject|10|||
163951745|NCT02054741|592193441|FG001|Overall Study|Withdrawal by Subject|5|||
163951746|NCT02054741|592193440|FG000|Overall Study|Death|94|||
163951747|NCT02054741|592193441|FG001|Overall Study|Death|90|||
163951748|NCT02054741|592193440|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
163951749|NCT02054741|592193441|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
163951750|NCT00394082|592193442|FG000|Overall Study|Unacceptable toxicity|15|||
163951751|NCT00394082|592193442|FG000|Overall Study|Adverse Event|4|||
163951752|NCT00394082|592193442|FG000|Overall Study|Physician Decision|4|||
163951753|NCT00394082|592193442|FG000|Overall Study|Withdrawal by Subject|2|||
163951754|NCT00394082|592193442|FG000|Overall Study|Other|1|||
163951755|NCT02344004|592193444|FG000|Overall Study|Adverse Event|11|||
163951756|NCT02344004|592193445|FG001|Overall Study|Adverse Event|1|||
163951757|NCT02344004|592193444|FG000|Overall Study|Death|9|||
163951758|NCT02344004|592193445|FG001|Overall Study|Death|7|||
163951759|NCT02344004|592193444|FG000|Overall Study|Physician Decision|4|||
163951760|NCT02344004|592193445|FG001|Overall Study|Physician Decision|1|||
163951761|NCT02344004|592193444|FG000|Overall Study|Withdrawal by Subject|22|||
163951762|NCT02344004|592193445|FG001|Overall Study|Withdrawal by Subject|5|||
163951763|NCT02344004|592193444|FG000|Overall Study|Rescue Medication|2|||
163951764|NCT02344004|592193445|FG001|Overall Study|Rescue Medication|0|||
163951765|NCT02344004|592193444|FG000|Overall Study|Other Not Specified|12|||
163951766|NCT02344004|592193445|FG001|Overall Study|Other Not Specified|0|||
163951767|NCT02344004|592193444|FG000|Overall Study|Protocol Violation|1|||
163951768|NCT02344004|592193445|FG001|Overall Study|Protocol Violation|0|||
163951769|NCT01768117|592193446|FG000|Overall Study|Lost to Follow-up|1|||
163951770|NCT01768117|592193446|FG000|Overall Study|Withdrawal by Subject|2|||
163951771|NCT01768117|592193446|FG000|Overall Study|Protocol Violation|3|||
163951772|NCT01945060|592193447|FG000|Overall Study|Lost to follow up|1|||
163951773|NCT01945060|592193448|FG001|Overall Study|Lost to follow up|0|||
163951774|NCT01945060|592193447|FG000|Overall Study|Distress related to IV access|0|||
163951775|NCT01945060|592193448|FG001|Overall Study|Distress related to IV access|1|||
163951776|NCT00138671|592193449|FG000|Overall Study|Death|0|||
163951777|NCT00138671|592193450|FG001|Overall Study|Death|3|||
164047708|NCT00366444|592534142|FG000|Overall Study|Withdrawal by Subject|1|||
164047709|NCT00366444|592534143|FG001|Overall Study|Withdrawal by Subject|1|||
164047710|NCT00366444|592534142|FG000|Overall Study|Lack of Efficacy|0|||
163951778|NCT00138671|592193449|FG000|Overall Study|Adverse Event|6|||
163951779|NCT00138671|592193450|FG001|Overall Study|Adverse Event|3|||
163951780|NCT00138671|592193449|FG000|Overall Study|Lost to Follow-up|1|||
163951781|NCT00138671|592193450|FG001|Overall Study|Lost to Follow-up|2|||
163951782|NCT00138671|592193449|FG000|Overall Study|Withdrawal by Subject|3|||
163951783|NCT00138671|592193450|FG001|Overall Study|Withdrawal by Subject|5|||
163951784|NCT00138671|592193449|FG000|Overall Study|Other|3|||
163951785|NCT00138671|592193450|FG001|Overall Study|Other|3|||
163951786|NCT02084056|592193453|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
163951787|NCT02084056|592193454|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163951788|NCT02084056|592193455|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163951789|NCT02084056|592193456|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
163951790|NCT02084056|592193453|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
163951791|NCT02084056|592193454|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163951792|NCT02084056|592193455|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163951793|NCT02084056|592193456|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
163951794|NCT01488487|592193457|FG000|Overall Study|Adverse Event|6|||
163951795|NCT01488487|592193457|FG000|Overall Study|Death|1|||
163951796|NCT01488487|592193457|FG000|Overall Study|Withdrawal by Subject|2|||
163951797|NCT00395460|592193458|FG000|Overall Study|Withdrawal by Subject|1|||
163951798|NCT00395460|592193459|FG001|Overall Study|Withdrawal by Subject|0|||
163951799|NCT00938860|592193467|FG000|Overall Study|Adverse Event|2|||
163951800|NCT00938860|592193468|FG001|Overall Study|Adverse Event|1|||
163951801|NCT00938860|592193467|FG000|Overall Study|Abnormal laboratory values|2|||
163951802|NCT00938860|592193468|FG001|Overall Study|Abnormal laboratory values|2|||
163951803|NCT00938860|592193467|FG000|Overall Study|Withdrawal by Subject|11|||
163951804|NCT00938860|592193468|FG001|Overall Study|Withdrawal by Subject|8|||
163951805|NCT00938860|592193467|FG000|Overall Study|Lost to Follow-up|4|||
163951806|NCT00938860|592193468|FG001|Overall Study|Lost to Follow-up|4|||
163951807|NCT00938860|592193467|FG000|Overall Study|Administration problems|2|||
163951808|NCT00938860|592193468|FG001|Overall Study|Administration problems|0|||
163951809|NCT00938860|592193467|FG000|Overall Study|Death|1|||
163951810|NCT00938860|592193468|FG001|Overall Study|Death|1|||
163951811|NCT00938860|592193467|FG000|Overall Study|Protocol Violation|3|||
163951812|NCT00938860|592193468|FG001|Overall Study|Protocol Violation|1|||
163951813|NCT01605019|592193469|FG000|Overall Study|pt did not meet transplant endpoint|3|||
163951814|NCT01605019|592193470|FG001|Overall Study|pt did not meet transplant endpoint|0|||
163951815|NCT04223830|592193474|FG000|Overall Study|Lost to Follow-up|9|||
163951816|NCT04223830|592193474|FG000|Overall Study|Adverse Event|1|||
163951817|NCT00324116|592193475|FG000|Overall Study|Adverse Event|5|||
163951818|NCT00324116|592193475|FG000|Overall Study|Lack of Efficacy|17|||
163951819|NCT00324116|592193475|FG000|Overall Study|Withdrawal by Subject|5|||
163951820|NCT00324116|592193475|FG000|Overall Study|Other|5|||
163951821|NCT01806623|592193476|FG000|Overall Study|Withdrawal by Subject|1|||
163951822|NCT01806623|592193476|FG000|Overall Study|Adverse Event|1|||
163951823|NCT01806623|592193476|FG000|Overall Study|Did not meet the inclusion criteria|56|||
163951824|NCT01737827|592193477|FG000|Overall Study|Adverse Event|3|||
163951825|NCT01737827|592193478|FG001|Overall Study|Adverse Event|6|||
163951826|NCT01737827|592193479|FG002|Overall Study|Adverse Event|0|||
163951827|NCT01737827|592193477|FG000|Overall Study|Lost to Follow-up|0|||
163951828|NCT01737827|592193478|FG001|Overall Study|Lost to Follow-up|1|||
163951829|NCT01737827|592193479|FG002|Overall Study|Lost to Follow-up|0|||
163951830|NCT01737827|592193477|FG000|Overall Study|Physician Decision|0|||
163951831|NCT01737827|592193478|FG001|Overall Study|Physician Decision|2|||
163951832|NCT01737827|592193479|FG002|Overall Study|Physician Decision|0|||
163951833|NCT01737827|592193477|FG000|Overall Study|Progressive Disease|5|||
163951834|NCT01737827|592193478|FG001|Overall Study|Progressive Disease|16|||
163951835|NCT01737827|592193479|FG002|Overall Study|Progressive Disease|2|||
163951836|NCT01737827|592193477|FG000|Overall Study|Study Terminated by Sponsor|0|||
163951837|NCT01737827|592193478|FG001|Overall Study|Study Terminated by Sponsor|1|||
163951838|NCT01737827|592193479|FG002|Overall Study|Study Terminated by Sponsor|0|||
163951839|NCT01737827|592193477|FG000|Overall Study|Subject/Guardian Decision|0|||
163951840|NCT01737827|592193478|FG001|Overall Study|Subject/Guardian Decision|2|||
163951841|NCT01737827|592193479|FG002|Overall Study|Subject/Guardian Decision|0|||
163951842|NCT01451827|592193480|FG000|Overall Study|Adverse Event|2|||
163951843|NCT01451827|592193481|FG001|Overall Study|Adverse Event|0|||
163951844|NCT01451827|592193482|FG002|Overall Study|Adverse Event|1|||
163951845|NCT01451827|592193483|FG003|Overall Study|Adverse Event|1|||
163951846|NCT01451827|592193480|FG000|Overall Study|Protocol deviation|1|||
163951847|NCT01451827|592193481|FG001|Overall Study|Protocol deviation|0|||
163951848|NCT01451827|592193482|FG002|Overall Study|Protocol deviation|0|||
163951849|NCT01451827|592193483|FG003|Overall Study|Protocol deviation|0|||
163951850|NCT01451827|592193480|FG000|Overall Study|Lost to Follow-up|0|||
163951851|NCT01451827|592193481|FG001|Overall Study|Lost to Follow-up|3|||
163951852|NCT01451827|592193482|FG002|Overall Study|Lost to Follow-up|0|||
163951853|NCT01451827|592193483|FG003|Overall Study|Lost to Follow-up|2|||
163951854|NCT01451827|592193480|FG000|Overall Study|Participant met withdrawal criteria|0|||
163951855|NCT01451827|592193481|FG001|Overall Study|Participant met withdrawal criteria|2|||
163951856|NCT01451827|592193482|FG002|Overall Study|Participant met withdrawal criteria|0|||
163951857|NCT01451827|592193483|FG003|Overall Study|Participant met withdrawal criteria|0|||
163951858|NCT01451827|592193480|FG000|Overall Study|Withdrawal by Subject|0|||
163951859|NCT01451827|592193481|FG001|Overall Study|Withdrawal by Subject|0|||
163951860|NCT01451827|592193482|FG002|Overall Study|Withdrawal by Subject|1|||
163951861|NCT01451827|592193483|FG003|Overall Study|Withdrawal by Subject|1|||
164047711|NCT00366444|592534143|FG001|Overall Study|Lack of Efficacy|1|||
163951862|NCT01964924|592193484|FG000|Trametinib Monotherapy|Progression|19|||
163951863|NCT01964924|592193485|FG001|Trametinib Monotherapy|Progression|0|||
163951864|NCT01528345|592193486|FG000|Overall Study|Adverse Event|10|||
163951865|NCT01528345|592193487|FG001|Overall Study|Adverse Event|1|||
163951866|NCT01528345|592193486|FG000|Overall Study|Death|1|||
163951867|NCT01528345|592193487|FG001|Overall Study|Death|1|||
163951868|NCT01528345|592193486|FG000|Overall Study|Non-compliance with study treatment|1|||
163951869|NCT01528345|592193487|FG001|Overall Study|Non-compliance with study treatment|0|||
163951870|NCT01528345|592193486|FG000|Overall Study|Progressive Disease|26|||
163951871|NCT01528345|592193487|FG001|Overall Study|Progressive Disease|40|||
163951872|NCT01528345|592193486|FG000|Overall Study|Study Terminated by Sponsor|4|||
163951873|NCT01528345|592193487|FG001|Overall Study|Study Terminated by Sponsor|8|||
163951874|NCT01528345|592193486|FG000|Overall Study|Subject/Guardian Decision|5|||
163951875|NCT01528345|592193487|FG001|Overall Study|Subject/Guardian Decision|0|||
163951876|NCT01034163|592193488|FG000|Overall Study|Treatment completed as per protocol|8|||
163951877|NCT01034163|592193489|FG001|Overall Study|Treatment completed as per protocol|7|||
163951878|NCT01034163|592193488|FG000|Overall Study|Withdrawal by Subject|8|||
163951879|NCT01034163|592193489|FG001|Overall Study|Withdrawal by Subject|2|||
163951880|NCT01034163|592193488|FG000|Overall Study|Protocol deviation|1|||
163951881|NCT01034163|592193489|FG001|Overall Study|Protocol deviation|0|||
163951882|NCT01034163|592193488|FG000|Overall Study|Disease progression|3|||
163951883|NCT01034163|592193489|FG001|Overall Study|Disease progression|4|||
163951884|NCT01034163|592193488|FG000|Overall Study|Adverse Event|6|||
163951885|NCT01034163|592193489|FG001|Overall Study|Adverse Event|0|||
163951886|NCT01034163|592193488|FG000|Overall Study|Administrative problems|0|||
163951887|NCT01034163|592193489|FG001|Overall Study|Administrative problems|1|||
163951888|NCT01034163|592193488|FG000|Overall Study|Abnormal laboratory value|1|||
163951889|NCT01034163|592193489|FG001|Overall Study|Abnormal laboratory value|0|||
163951890|NCT00528645|592193490|FG000|Overall Study|Adverse Event|3|||
163951891|NCT00296400|592193491|FG000|Overall Study|Adverse Event|7|||
163951892|NCT00296400|592193492|FG001|Overall Study|Adverse Event|7|||
163951893|NCT00296400|592193493|FG002|Overall Study|Adverse Event|7|||
163951894|NCT00296400|592193491|FG000|Overall Study|Withdrawal by Subject|5|||
163951895|NCT00296400|592193492|FG001|Overall Study|Withdrawal by Subject|6|||
163951896|NCT00296400|592193493|FG002|Overall Study|Withdrawal by Subject|2|||
163951897|NCT00296400|592193491|FG000|Overall Study|Incorrect enrollment|2|||
163951898|NCT00296400|592193492|FG001|Overall Study|Incorrect enrollment|0|||
163951899|NCT00296400|592193493|FG002|Overall Study|Incorrect enrollment|0|||
163951900|NCT00296400|592193491|FG000|Overall Study|Protocol Violation|1|||
163951901|NCT00296400|592193492|FG001|Overall Study|Protocol Violation|1|||
163951902|NCT00296400|592193493|FG002|Overall Study|Protocol Violation|1|||
163951903|NCT00296400|592193491|FG000|Overall Study|Lost to Follow-up|1|||
163951904|NCT00296400|592193492|FG001|Overall Study|Lost to Follow-up|1|||
163951905|NCT00296400|592193493|FG002|Overall Study|Lost to Follow-up|2|||
163951906|NCT00296400|592193491|FG000|Overall Study|Study specific discontinuation criteria|0|||
163951907|NCT00296400|592193492|FG001|Overall Study|Study specific discontinuation criteria|0|||
163951908|NCT00296400|592193493|FG002|Overall Study|Study specific discontinuation criteria|1|||
163951909|NCT00296400|592193491|FG000|Overall Study|Visit 10 was performed earlier|0|||
163951910|NCT00296400|592193492|FG001|Overall Study|Visit 10 was performed earlier|1|||
163951911|NCT00296400|592193493|FG002|Overall Study|Visit 10 was performed earlier|0|||
163951912|NCT00296400|592193491|FG000|Overall Study|Pregnancy|1|||
163951913|NCT00296400|592193492|FG001|Overall Study|Pregnancy|2|||
163951914|NCT00296400|592193493|FG002|Overall Study|Pregnancy|0|||
163951915|NCT03406078|592193496|FG000|Overall Study|Death|1|||
163951916|NCT03406078|592193497|FG001|Overall Study|Death|0|||
163951917|NCT03406078|592193496|FG000|Overall Study|Lost to Follow-up|0|||
163951918|NCT03406078|592193497|FG001|Overall Study|Lost to Follow-up|1|||
163951919|NCT03406078|592193496|FG000|Overall Study|Withdrawal by Subject|5|||
163951920|NCT03406078|592193497|FG001|Overall Study|Withdrawal by Subject|2|||
163951921|NCT03538301|592193500|FG000|Overall Study|Adverse Event|1|||
163951922|NCT03538301|592193501|FG001|Overall Study|Adverse Event|4|||
163951923|NCT03538301|592193502|FG002|Overall Study|Adverse Event|4|||
163951924|NCT03538301|592193500|FG000|Overall Study|Death|1|||
163951925|NCT03538301|592193501|FG001|Overall Study|Death|1|||
163951926|NCT03538301|592193502|FG002|Overall Study|Death|0|||
163951927|NCT03538301|592193500|FG000|Overall Study|Physician Decision|0|||
163951928|NCT03538301|592193501|FG001|Overall Study|Physician Decision|1|||
163951929|NCT03538301|592193502|FG002|Overall Study|Physician Decision|0|||
163951930|NCT03538301|592193500|FG000|Overall Study|Protocol Violation|0|||
163951931|NCT03538301|592193501|FG001|Overall Study|Protocol Violation|0|||
163951932|NCT03538301|592193502|FG002|Overall Study|Protocol Violation|1|||
163951933|NCT03538301|592193500|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
163951934|NCT03538301|592193501|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
163951935|NCT03538301|592193502|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
163951936|NCT03616977|592193503|FG000|Period 1|Physician Decision|0|||
163951937|NCT03616977|592193504|FG001|Period 1|Physician Decision|1|||
163951938|NCT03616977|592193503|FG000|Period 3|Adverse Event|1|||
163951939|NCT03616977|592193504|FG001|Period 3|Adverse Event|1|||
163951940|NCT00591851|592193505|FG000|Overall Study|Withdrawal by Subject|3|||
163951941|NCT00591851|592193505|FG000|Overall Study|Adverse Event|2|||
163951942|NCT00591851|592193505|FG000|Overall Study|Progressive Disease|1|||
163951943|NCT00515853|592193506|FG000|Overall Study|Lost to Follow-up|9|||
163951944|NCT00515853|592193507|FG001|Overall Study|Lost to Follow-up|13|||
163951945|NCT00515853|592193506|FG000|Overall Study|Withdrawal by Subject|6|||
163951946|NCT00515853|592193507|FG001|Overall Study|Withdrawal by Subject|4|||
163951947|NCT03798691|592193512|FG000|Overall Study|Lost to Follow-up|2|||
163951948|NCT03798691|592193513|FG001|Overall Study|Lost to Follow-up|2|||
163951949|NCT02808143|592195298|FG000|Maintenance Phase|Disease recurrence|1|||
163951950|NCT02808143|592195299|FG001|Maintenance Phase|Disease recurrence|3|||
163951951|NCT02808143|592195298|FG000|Maintenance Phase|Disease progression|1|||
163951952|NCT02808143|592195299|FG001|Maintenance Phase|Disease progression|2|||
163951953|NCT02808143|592195298|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
163951954|NCT02808143|592195299|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
163951955|NCT02808143|592195298|FG000|Survival Follow-Up|Disease recurrence|0|||
163951956|NCT02808143|592195299|FG001|Survival Follow-Up|Disease recurrence|2|||
163951957|NCT02808143|592195298|FG000|Survival Follow-Up|Adverse Event|0|||
163951958|NCT02808143|592195299|FG001|Survival Follow-Up|Adverse Event|1|||
163951959|NCT02808143|592195298|FG000|Survival Follow-Up|Death|1|||
163951960|NCT02808143|592195299|FG001|Survival Follow-Up|Death|0|||
163951961|NCT01874431|592195300|FG000|Overall Study|Physician Decision|0|||
163951962|NCT01874431|592195301|FG001|Overall Study|Physician Decision|0|||
163951963|NCT01874431|592195302|FG002|Overall Study|Physician Decision|1|||
163951964|NCT01874431|592195303|FG003|Overall Study|Physician Decision|0|||
163951965|NCT01874431|592195304|FG004|Overall Study|Physician Decision|0|||
163951966|NCT01874431|592195305|FG005|Overall Study|Physician Decision|0|||
163951967|NCT01874431|592195306|FG006|Overall Study|Physician Decision|0|||
163951968|NCT01874431|592195307|FG007|Overall Study|Physician Decision|0|||
163951969|NCT01874431|592195300|FG000|Overall Study|Adverse Event|5|||
163951970|NCT01874431|592195301|FG001|Overall Study|Adverse Event|4|||
163951971|NCT01874431|592195302|FG002|Overall Study|Adverse Event|6|||
163951972|NCT01874431|592195303|FG003|Overall Study|Adverse Event|5|||
163951973|NCT01874431|592195304|FG004|Overall Study|Adverse Event|2|||
163951974|NCT01874431|592195305|FG005|Overall Study|Adverse Event|8|||
163951975|NCT01874431|592195306|FG006|Overall Study|Adverse Event|2|||
163951976|NCT01874431|592195307|FG007|Overall Study|Adverse Event|3|||
163951977|NCT01874431|592195300|FG000|Overall Study|Protocol Violation|1|||
163951978|NCT01874431|592195301|FG001|Overall Study|Protocol Violation|1|||
163951979|NCT01874431|592195302|FG002|Overall Study|Protocol Violation|1|||
163951980|NCT01874431|592195303|FG003|Overall Study|Protocol Violation|0|||
163951981|NCT01874431|592195304|FG004|Overall Study|Protocol Violation|3|||
163951982|NCT01874431|592195305|FG005|Overall Study|Protocol Violation|2|||
163951983|NCT01874431|592195306|FG006|Overall Study|Protocol Violation|1|||
163951984|NCT01874431|592195307|FG007|Overall Study|Protocol Violation|1|||
163951985|NCT01874431|592195300|FG000|Overall Study|Non-compliance|0|||
163951986|NCT01874431|592195301|FG001|Overall Study|Non-compliance|0|||
163951987|NCT01874431|592195302|FG002|Overall Study|Non-compliance|0|||
163951988|NCT01874431|592195303|FG003|Overall Study|Non-compliance|0|||
163951989|NCT01874431|592195304|FG004|Overall Study|Non-compliance|1|||
163951990|NCT01874431|592195305|FG005|Overall Study|Non-compliance|0|||
163951991|NCT01874431|592195306|FG006|Overall Study|Non-compliance|1|||
163951992|NCT01874431|592195307|FG007|Overall Study|Non-compliance|0|||
163951993|NCT01874431|592195300|FG000|Overall Study|Logistical difficulties|0|||
163951994|NCT01874431|592195301|FG001|Overall Study|Logistical difficulties|0|||
163951995|NCT01874431|592195302|FG002|Overall Study|Logistical difficulties|0|||
163951996|NCT01874431|592195303|FG003|Overall Study|Logistical difficulties|0|||
163951997|NCT01874431|592195304|FG004|Overall Study|Logistical difficulties|0|||
163951998|NCT01874431|592195305|FG005|Overall Study|Logistical difficulties|0|||
163951999|NCT01874431|592195306|FG006|Overall Study|Logistical difficulties|1|||
163952000|NCT01874431|592195307|FG007|Overall Study|Logistical difficulties|0|||
163952001|NCT01874431|592195300|FG000|Overall Study|Withdrawal by Subject|0|||
163952002|NCT01874431|592195301|FG001|Overall Study|Withdrawal by Subject|0|||
163952003|NCT01874431|592195302|FG002|Overall Study|Withdrawal by Subject|1|||
163952004|NCT01874431|592195303|FG003|Overall Study|Withdrawal by Subject|2|||
163952005|NCT01874431|592195304|FG004|Overall Study|Withdrawal by Subject|1|||
163952006|NCT01874431|592195305|FG005|Overall Study|Withdrawal by Subject|1|||
163952007|NCT01874431|592195306|FG006|Overall Study|Withdrawal by Subject|3|||
163952008|NCT01874431|592195307|FG007|Overall Study|Withdrawal by Subject|0|||
163952009|NCT01874431|592195300|FG000|Overall Study|Sponsor decision|0|||
163952010|NCT01874431|592195301|FG001|Overall Study|Sponsor decision|0|||
163952011|NCT01874431|592195302|FG002|Overall Study|Sponsor decision|0|||
163952012|NCT01874431|592195303|FG003|Overall Study|Sponsor decision|0|||
163952013|NCT01874431|592195304|FG004|Overall Study|Sponsor decision|1|||
163952014|NCT01874431|592195305|FG005|Overall Study|Sponsor decision|0|||
163952015|NCT01874431|592195306|FG006|Overall Study|Sponsor decision|0|||
163952016|NCT01874431|592195307|FG007|Overall Study|Sponsor decision|0|||
163952017|NCT01874431|592195300|FG000|Overall Study|Lost to Follow-up|0|||
163952018|NCT01874431|592195301|FG001|Overall Study|Lost to Follow-up|0|||
163952019|NCT01874431|592195302|FG002|Overall Study|Lost to Follow-up|1|||
163952020|NCT01874431|592195303|FG003|Overall Study|Lost to Follow-up|0|||
163952021|NCT01874431|592195304|FG004|Overall Study|Lost to Follow-up|0|||
163952022|NCT01874431|592195305|FG005|Overall Study|Lost to Follow-up|0|||
163952023|NCT01874431|592195306|FG006|Overall Study|Lost to Follow-up|0|||
163952024|NCT01874431|592195307|FG007|Overall Study|Lost to Follow-up|0|||
163952025|NCT03718533|592195309|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
163952026|NCT03718533|592195309|FG000|Overall Study|Protocol deviation|1|||
163952027|NCT03718533|592195309|FG000|Overall Study|Disease progression|1|||
163952028|NCT03718533|592195309|FG000|Overall Study|Relapse|1|||
163952029|NCT03718533|592195309|FG000|Overall Study|Physician Decision|2|||
163952030|NCT03718533|592195309|FG000|Overall Study|Physician Decision and Adverse Event|1|||
163952031|NCT04275089|592195314|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
163952032|NCT01079663|592195315|FG000|Overall Study|Adverse Event|0|||
163952033|NCT01079663|592195316|FG001|Overall Study|Adverse Event|2|||
163952034|NCT01079663|592195315|FG000|Overall Study|Protocol Violation|0|||
163952035|NCT01079663|592195316|FG001|Overall Study|Protocol Violation|2|||
163952036|NCT03606668|592195320|FG000|Overall Study|Screen Failure|1|||
163952037|NCT03606668|592195320|FG000|Overall Study|Lost to Follow-up|1|||
163952038|NCT01014143|592195321|FG000|Second Intervention|Lost to Follow-up|2|||
163952039|NCT01014143|592195322|FG001|Second Intervention|Lost to Follow-up|0|||
163952040|NCT01014143|592195323|FG002|Second Intervention|Lost to Follow-up|0|||
163952041|NCT02354508|592195325|FG000|Period 1: Core Phase|Adverse Event|1|||
163952042|NCT02354508|592195326|FG001|Period 1: Core Phase|Adverse Event|1|||
163952043|NCT02354508|592195327|FG002|Period 1: Core Phase|Adverse Event|2|||
163952044|NCT02354508|592195325|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
163952045|NCT02354508|592195326|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
163952046|NCT02354508|592195327|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
163952047|NCT02354508|592195325|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
163952048|NCT02354508|592195326|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
163952049|NCT02354508|592195327|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
163952050|NCT02354508|592195325|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
163952051|NCT02354508|592195326|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
163952052|NCT02354508|592195327|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
163952053|NCT02354508|592195325|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
163952054|NCT02354508|592195326|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
163952055|NCT02354508|592195327|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
163952056|NCT02354508|592195325|FG000|Period 2: Extension Phase|Physician Decision|5|||
163952057|NCT02354508|592195326|FG001|Period 2: Extension Phase|Physician Decision|0|||
163952058|NCT02354508|592195327|FG002|Period 2: Extension Phase|Physician Decision|1|||
163952059|NCT02354508|592195325|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
163952060|NCT02354508|592195326|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
163952061|NCT02354508|592195327|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
163952062|NCT02354508|592195325|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
163952063|NCT02354508|592195326|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
163952064|NCT02354508|592195327|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
163952065|NCT02354508|592195325|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
163952066|NCT02354508|592195326|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
163952067|NCT02354508|592195327|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
163952068|NCT04447846|592195330|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
163952069|NCT00461032|592195331|FG000|Overall Study|Adverse Event|5|||
163952070|NCT00461032|592195332|FG001|Overall Study|Adverse Event|6|||
163952071|NCT00461032|592195331|FG000|Overall Study|Lack of Efficacy|5|||
163952072|NCT00461032|592195332|FG001|Overall Study|Lack of Efficacy|1|||
163952073|NCT00461032|592195331|FG000|Overall Study|Lost to Follow-up|7|||
163952074|NCT00461032|592195332|FG001|Overall Study|Lost to Follow-up|12|||
163952075|NCT00461032|592195331|FG000|Overall Study|Protocol Violation|4|||
163952076|NCT00461032|592195332|FG001|Overall Study|Protocol Violation|4|||
163952077|NCT00461032|592195331|FG000|Overall Study|Withdrawal by Subject|7|||
163952078|NCT00461032|592195332|FG001|Overall Study|Withdrawal by Subject|15|||
163952079|NCT00461032|592195331|FG000|Overall Study|Patient Moved or Relocated|2|||
163952080|NCT00461032|592195332|FG001|Overall Study|Patient Moved or Relocated|1|||
163952081|NCT00461032|592195331|FG000|Overall Study|Other|7|||
163952082|NCT00461032|592195332|FG001|Overall Study|Other|5|||
163952083|NCT00297232|592195333|FG000|Overall Study|Lack of Efficacy|7|||
163952084|NCT00297232|592195333|FG000|Overall Study|Lost to Follow-up|10|||
163952085|NCT00297232|592195333|FG000|Overall Study|Adverse Event|63|||
163952086|NCT00297232|592195333|FG000|Overall Study|Voluntary Withdrawal|120|||
163952087|NCT00297232|592195333|FG000|Overall Study|Subject was Noncompliant|9|||
163952088|NCT00297232|592195333|FG000|Overall Study|Death|9|||
163952089|NCT00297232|592195333|FG000|Overall Study|Anti-natalizumab Positive|8|||
163952090|NCT00297232|592195333|FG000|Overall Study|Switched to Commercial Tysabri|22|||
163952091|NCT00297232|592195333|FG000|Overall Study|Disease Progression|8|||
163952092|NCT00297232|592195333|FG000|Overall Study|Fear of PML|10|||
163952093|NCT00297232|592195333|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
163952094|NCT00297232|592195333|FG000|Overall Study|Miscellaneous|5|||
163952095|NCT00297232|592195333|FG000|Overall Study|Sponsor Decision|34|||
163952096|NCT00297232|592195333|FG000|Overall Study|Subject Relocated|7|||
163952097|NCT00297232|592195333|FG000|Overall Study|Subject Withdrew Consent|37|||
163952098|NCT00297232|592195333|FG000|Overall Study|Persistently Positive Antibodies|11|||
163952099|NCT00297232|592195333|FG000|Overall Study|Investigator Withdrew From Program|19|||
163952100|NCT00297232|592195333|FG000|Overall Study|Did Not Enroll to Week 264|34|||
163952101|NCT00297232|592195333|FG000|Overall Study|Did Not Enroll to Week 480|17|||
163952102|NCT00297232|592195333|FG000|Overall Study|No data available after Week 264|161|||
163952103|NCT00297232|592195333|FG000|Overall Study|Other|1|||
163952104|NCT03536143|592195337|FG000|Overall Study|Early termination, Sponsor decision|1|||
163952105|NCT01878214|592195338|FG000|Overall Study|Withdrawal by Subject|18|||
163952106|NCT01878214|592195339|FG001|Overall Study|Withdrawal by Subject|7|||
163952107|NCT01878214|592195338|FG000|Overall Study|Death|0|||
163952108|NCT01878214|592195339|FG001|Overall Study|Death|1|||
163952109|NCT01878214|592195338|FG000|Overall Study|Lost to Follow-up|35|||
163952110|NCT01878214|592195339|FG001|Overall Study|Lost to Follow-up|36|||
163952111|NCT03038438|592195340|FG000|Overall Study|Death|3|||
163952112|NCT03038438|592195340|FG000|Overall Study|Lost to Follow-up|8|||
163952113|NCT03038438|592195340|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
163952114|NCT03038438|592195340|FG000|Overall Study|Withdrawal by Subject|5|||
163952115|NCT03038438|592195340|FG000|Overall Study|No 36-Month Follow-Up|18|||
163952116|NCT01174160|592195341|FG000|Overall Study|Adverse Event|1|||
163952117|NCT01174160|592195342|FG001|Overall Study|Adverse Event|0|||
163952118|NCT01174160|592195341|FG000|Overall Study|Lost to Follow-up|1|||
163952119|NCT01174160|592195342|FG001|Overall Study|Lost to Follow-up|0|||
163952120|NCT01174160|592195341|FG000|Overall Study|Physician Decision|1|||
163952121|NCT01174160|592195342|FG001|Overall Study|Physician Decision|0|||
163952122|NCT01174160|592195341|FG000|Overall Study|Protocol Violation|4|||
163952123|NCT01174160|592195342|FG001|Overall Study|Protocol Violation|6|||
163952124|NCT01174160|592195341|FG000|Overall Study|Withdrawal by Subject|1|||
163952125|NCT01174160|592195342|FG001|Overall Study|Withdrawal by Subject|0|||
163952126|NCT01590017|592195345|FG000|Overall Study|Adverse Event|1|||
163952127|NCT01590017|592195345|FG000|Overall Study|Withdrawal by Subject|1|||
163952128|NCT01590017|592195345|FG000|Overall Study|Lack of Efficacy|1|||
163952129|NCT01590017|592195345|FG000|Overall Study|Physician Decision|1|||
163952130|NCT02038543|592195346|FG000|Overall Study|Screen Failure|0|||
163952131|NCT02038543|592195347|FG001|Overall Study|Screen Failure|0|||
163952132|NCT02038543|592195348|FG002|Overall Study|Screen Failure|0|||
163952133|NCT02038543|592195349|FG003|Overall Study|Screen Failure|1|||
163952134|NCT02038543|592195346|FG000|Overall Study|Withdrawal by Subject|0|||
163952135|NCT02038543|592195347|FG001|Overall Study|Withdrawal by Subject|0|||
163952136|NCT02038543|592195348|FG002|Overall Study|Withdrawal by Subject|0|||
163952137|NCT02038543|592195349|FG003|Overall Study|Withdrawal by Subject|1|||
163952138|NCT00093808|592195350|FG000|Overall Study|Cancel participation before receiving tx|1|||
163952139|NCT00093808|592195350|FG000|Overall Study|Protocol Violation|1|||
163952140|NCT00871780|592195351|FG000|Overall Study|Enrolled But Not Treated|6|||
163952141|NCT00871780|592195351|FG000|Overall Study|Withdrawal by Subject|9|||
163952142|NCT00871780|592195351|FG000|Overall Study|Adverse Event|6|||
163952143|NCT00871780|592195351|FG000|Overall Study|Voluntary Discontinuation|4|||
163952144|NCT00871780|592195351|FG000|Overall Study|Death|1|||
163952145|NCT00871780|592195351|FG000|Overall Study|Physician Decision|1|||
163952146|NCT02647866|592195352|FG000|Overall Study|Adverse Event|0|||
163952147|NCT02647866|592195353|FG001|Overall Study|Adverse Event|0|||
163952148|NCT02647866|592195354|FG002|Overall Study|Adverse Event|2|||
163952149|NCT02647866|592195355|FG003|Overall Study|Adverse Event|2|||
163952150|NCT02647866|592195356|FG004|Overall Study|Adverse Event|1|||
163952151|NCT02647866|592195352|FG000|Overall Study|Disease Worsening|3|||
163952152|NCT02647866|592195353|FG001|Overall Study|Disease Worsening|1|||
163952153|NCT02647866|592195354|FG002|Overall Study|Disease Worsening|0|||
163952154|NCT02647866|592195355|FG003|Overall Study|Disease Worsening|0|||
163952155|NCT02647866|592195356|FG004|Overall Study|Disease Worsening|1|||
163952156|NCT02647866|592195352|FG000|Overall Study|Withdrawal by Subject|1|||
163952157|NCT02647866|592195353|FG001|Overall Study|Withdrawal by Subject|1|||
163952158|NCT02647866|592195354|FG002|Overall Study|Withdrawal by Subject|2|||
163952159|NCT02647866|592195355|FG003|Overall Study|Withdrawal by Subject|4|||
163952160|NCT02647866|592195356|FG004|Overall Study|Withdrawal by Subject|4|||
163952161|NCT02647866|592195352|FG000|Overall Study|Physician Decision|0|||
163952162|NCT02647866|592195353|FG001|Overall Study|Physician Decision|1|||
163952163|NCT02647866|592195354|FG002|Overall Study|Physician Decision|1|||
163952164|NCT02647866|592195355|FG003|Overall Study|Physician Decision|0|||
163952165|NCT02647866|592195356|FG004|Overall Study|Physician Decision|2|||
163952166|NCT02647866|592195352|FG000|Overall Study|Death|0|||
163952167|NCT02647866|592195353|FG001|Overall Study|Death|1|||
163952168|NCT02647866|592195354|FG002|Overall Study|Death|0|||
163952169|NCT02647866|592195355|FG003|Overall Study|Death|0|||
163952170|NCT02647866|592195356|FG004|Overall Study|Death|0|||
163952171|NCT02647866|592195352|FG000|Overall Study|Subject moved to different country|1|||
163952172|NCT02647866|592195353|FG001|Overall Study|Subject moved to different country|0|||
163952173|NCT02647866|592195354|FG002|Overall Study|Subject moved to different country|0|||
163952174|NCT02647866|592195355|FG003|Overall Study|Subject moved to different country|0|||
163952175|NCT02647866|592195356|FG004|Overall Study|Subject moved to different country|0|||
163952176|NCT03406260|592195357|FG000|Period 1|Adverse Event|0|||
163952177|NCT03406260|592195358|FG001|Period 1|Adverse Event|0|||
163952178|NCT03406260|592195359|FG002|Period 1|Adverse Event|0|||
163952179|NCT03406260|592195360|FG003|Period 1|Adverse Event|0|||
163952180|NCT03406260|592195361|FG004|Period 1|Adverse Event|1|||
163952181|NCT03406260|592195362|FG005|Period 1|Adverse Event|0|||
163952182|NCT01029652|592195366|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
163952183|NCT01029652|592195367|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
163952184|NCT01029652|592195366|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
163952185|NCT01029652|592195367|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
163952186|NCT01029652|592195366|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
163952187|NCT01029652|592195367|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
163952188|NCT01029652|592195366|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
163952189|NCT01029652|592195367|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
163952190|NCT01029652|592195366|FG000|Core Study (0-12 Weeks)|Death|0|||
163952191|NCT01029652|592195367|FG001|Core Study (0-12 Weeks)|Death|1|||
163952192|NCT01029652|592195366|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
163952193|NCT01029652|592195367|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
163952194|NCT01029652|592195366|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
163952195|NCT01029652|592195367|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
163952196|NCT01029652|592195366|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
163952197|NCT01029652|592195367|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
163952198|NCT01029652|592195366|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
163952199|NCT01029652|592195367|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
163952200|NCT01029652|592195366|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
163952201|NCT01029652|592195367|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
163952202|NCT01029652|592195366|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
163952203|NCT01029652|592195367|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
163952204|NCT01029652|592195366|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
163952205|NCT01029652|592195367|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
163952206|NCT05767021|592195368|FG000|Overall Study|Adverse Event|2|||
163952207|NCT05767021|592195368|FG000|Overall Study|Protocol Deviation|1|||
163952208|NCT05767021|592195368|FG000|Overall Study|Withdrawal by Subject|1|||
163952209|NCT05767021|592195368|FG000|Overall Study|Physician Decision|1|||
163952210|NCT05767021|592195368|FG000|Overall Study|Lack of Efficacy|11|||
163952211|NCT05767021|592195368|FG000|Overall Study|Assigned Treatment by Mistake|1|||
163952212|NCT00523640|592195373|FG000|Overall Study|Death|1|||
163952213|NCT06377488|592195374|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
163952214|NCT06377488|592195374|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
163952215|NCT06377488|592195374|FG000|Overall Study|Protocol Violation|1|||
163952216|NCT06377488|592195374|FG000|Overall Study|Lost to Follow-up|1|||
163952217|NCT06377488|592195374|FG000|Overall Study|Incorrect Lens Dispensed|2|||
163952218|NCT02399254|592195377|FG000|Overall Study|Physician Decision|2|||
163952219|NCT02334423|592195378|FG000|Overall Study|Protocol Violation|10|||
163952220|NCT02334423|592195379|FG001|Overall Study|Protocol Violation|3|||
163952221|NCT01076647|592195382|FG000|Overall Study|Adverse Event|4|||
163952222|NCT01076647|592195383|FG001|Overall Study|Adverse Event|1|||
163952223|NCT01076647|592195382|FG000|Overall Study|Lack of Efficacy|0|||
163952224|NCT01076647|592195383|FG001|Overall Study|Lack of Efficacy|1|||
163952225|NCT01076647|592195382|FG000|Overall Study|Protocol Violation|7|||
163952226|NCT01076647|592195383|FG001|Overall Study|Protocol Violation|9|||
163952227|NCT01076647|592195382|FG000|Overall Study|Withdrawal criteria|2|||
163952228|NCT01076647|592195383|FG001|Overall Study|Withdrawal criteria|2|||
163952229|NCT01076647|592195382|FG000|Overall Study|Unclassified|12|||
163952230|NCT01076647|592195383|FG001|Overall Study|Unclassified|12|||
163952231|NCT03545503|592195386|FG000|Overall Study|Protocol Violation|14|||
163952232|NCT03545503|592195387|FG001|Overall Study|Protocol Violation|16|||
163952233|NCT04494256|592195388|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
163952234|NCT04494256|592195389|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
163952235|NCT04494256|592195390|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
163952236|NCT04494256|592195391|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
163952237|NCT04494256|592195392|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
163952238|NCT04494256|592195393|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
163952239|NCT04494256|592195394|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
164047712|NCT03763942|592534148|FG000|Overall Study|Lost to Follow-up|114|||
164047713|NCT03763942|592534149|FG001|Overall Study|Lost to Follow-up|54|||
164047714|NCT03763942|592534148|FG000|Overall Study|Protocol Violation|1|||
164047715|NCT03763942|592534149|FG001|Overall Study|Protocol Violation|0|||
163952240|NCT04494256|592195388|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163952241|NCT04494256|592195389|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163952242|NCT04494256|592195390|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
164047716|NCT03763942|592534148|FG000|Overall Study|Withdrawal by Subject|2|||
164148624|NCT04895982|592904920|FG009|Overall Study|Protocol Violation|0|||
163952243|NCT04494256|592195391|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163952244|NCT04494256|592195392|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
163952245|NCT04494256|592195393|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163952246|NCT04494256|592195394|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
163952247|NCT04494256|592195388|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
163952248|NCT04494256|592195389|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
163952249|NCT04494256|592195390|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
163952250|NCT04494256|592195391|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
163952251|NCT04494256|592195392|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
163952252|NCT04494256|592195393|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
163952253|NCT04494256|592195394|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
163952254|NCT04494256|592195388|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952255|NCT04494256|592195389|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952256|NCT04494256|592195390|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952257|NCT04494256|592195391|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
163952258|NCT04494256|592195392|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
163952259|NCT04494256|592195393|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952260|NCT04494256|592195394|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952261|NCT04494256|592195388|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163952262|NCT04494256|592195389|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
163952263|NCT04494256|592195390|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163952264|NCT04494256|592195391|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163952265|NCT04494256|592195392|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
163952266|NCT04494256|592195393|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
163952267|NCT04494256|592195394|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
163952268|NCT04494256|592195388|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
163952269|NCT04494256|592195389|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
163952270|NCT04494256|592195390|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
163952271|NCT04494256|592195391|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
163952272|NCT04494256|592195392|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
163952273|NCT04494256|592195393|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
163952274|NCT04494256|592195394|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
163952275|NCT04494256|592195388|FG000|Part 2: Open Label Period|Death|0|||
163952276|NCT04494256|592195389|FG001|Part 2: Open Label Period|Death|0|||
163952277|NCT04494256|592195390|FG002|Part 2: Open Label Period|Death|0|||
163952278|NCT04494256|592195391|FG003|Part 2: Open Label Period|Death|0|||
163952279|NCT04494256|592195392|FG004|Part 2: Open Label Period|Death|0|||
163952280|NCT04494256|592195393|FG005|Part 2: Open Label Period|Death|4|||
163952281|NCT04494256|592195394|FG006|Part 2: Open Label Period|Death|2|||
163952282|NCT04494256|592195388|FG000|Part 2: Open Label Period|Adverse Event|0|||
163952283|NCT04494256|592195389|FG001|Part 2: Open Label Period|Adverse Event|0|||
163952284|NCT04494256|592195390|FG002|Part 2: Open Label Period|Adverse Event|0|||
163952285|NCT04494256|592195391|FG003|Part 2: Open Label Period|Adverse Event|0|||
163952286|NCT04494256|592195392|FG004|Part 2: Open Label Period|Adverse Event|0|||
163952287|NCT04494256|592195393|FG005|Part 2: Open Label Period|Adverse Event|0|||
163952288|NCT04494256|592195394|FG006|Part 2: Open Label Period|Adverse Event|2|||
163952289|NCT04494256|592195388|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163952290|NCT04494256|592195389|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163952291|NCT04494256|592195390|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163952292|NCT04494256|592195391|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163952293|NCT04494256|592195392|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
163952294|NCT04494256|592195393|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
163952295|NCT04494256|592195394|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
163952296|NCT04494256|592195388|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163952297|NCT04494256|592195389|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163952298|NCT04494256|592195390|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163952299|NCT04494256|592195391|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163952300|NCT04494256|592195392|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163952301|NCT04494256|592195393|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
163952302|NCT04494256|592195394|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
163952303|NCT04494256|592195388|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
164047717|NCT03763942|592534149|FG001|Overall Study|Withdrawal by Subject|0|||
164047718|NCT03763942|592534148|FG000|Overall Study|Other|2|||
164047719|NCT03763942|592534149|FG001|Overall Study|Other|3|||
163844091|NCT00119262|591798568|FG000|Overall Study|other disease|0|||
163844092|NCT00119262|591798569|FG001|Overall Study|other disease|2|||
163844093|NCT00119262|591798568|FG000|Overall Study|ineligble|1|||
163844094|NCT00119262|591798569|FG001|Overall Study|ineligble|2|||
163844095|NCT00119262|591798568|FG000|Overall Study|others|0|||
163844096|NCT00119262|591798569|FG001|Overall Study|others|5|||
163844097|NCT03853317|591798570|FG000|Overall Study|Progressive Disease|5|||
163844098|NCT03853317|591798570|FG000|Overall Study|Adverse Event|1|||
163844099|NCT03853317|591798570|FG000|Overall Study|Death|1|||
163844100|NCT03853317|591798570|FG000|Overall Study|other event|2|||
163844101|NCT01551303|591798577|FG000|Overall Study|failed awareness check on vision test|4|||
163844102|NCT01551303|591798578|FG001|Overall Study|failed awareness check on vision test|7|||
163844103|NCT02141659|591798579|FG000|Overall Study|Major Protocol Deviation|0|||
163844104|NCT02141659|591798580|FG001|Overall Study|Major Protocol Deviation|1|||
163844105|NCT02141659|591798581|FG002|Overall Study|Major Protocol Deviation|0|||
163844106|NCT02141659|591798582|FG003|Overall Study|Major Protocol Deviation|0|||
163844107|NCT02141659|591798583|FG004|Overall Study|Major Protocol Deviation|0|||
163844108|NCT02141659|591798584|FG005|Overall Study|Major Protocol Deviation|0|||
163844109|NCT02141659|591798579|FG000|Overall Study|Lack of Efficacy|0|||
163844110|NCT02141659|591798580|FG001|Overall Study|Lack of Efficacy|0|||
163844111|NCT02141659|591798581|FG002|Overall Study|Lack of Efficacy|0|||
163844112|NCT02141659|591798582|FG003|Overall Study|Lack of Efficacy|0|||
163844113|NCT02141659|591798583|FG004|Overall Study|Lack of Efficacy|0|||
163844114|NCT02141659|591798584|FG005|Overall Study|Lack of Efficacy|1|||
163844115|NCT02141659|591798579|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
163844116|NCT02141659|591798580|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
163844117|NCT02141659|591798581|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
163844118|NCT02141659|591798582|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
163844119|NCT02141659|591798583|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
163844120|NCT02141659|591798584|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
163844121|NCT01927731|591798585|FG000|Overall Study|Graft Failure|1|||
163844122|NCT01927731|591798586|FG001|Overall Study|Graft Failure|2|||
163844123|NCT01927731|591798585|FG000|Overall Study|Physician Decision|2|||
163844124|NCT01927731|591798586|FG001|Overall Study|Physician Decision|3|||
163844125|NCT01927731|591798585|FG000|Overall Study|Withdrawal by Subject|0|||
163844126|NCT01927731|591798586|FG001|Overall Study|Withdrawal by Subject|2|||
163844127|NCT01927731|591798585|FG000|Overall Study|Death|0|||
163844128|NCT01927731|591798586|FG001|Overall Study|Death|3|||
163844129|NCT00305864|591798589|FG000|Overall Study|Ineligible / No protocol treatment|0|||
163844130|NCT00305864|591798590|FG001|Overall Study|Ineligible / No protocol treatment|1|||
163952304|NCT04494256|592195389|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163952305|NCT04494256|592195390|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163952306|NCT04494256|592195391|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163952307|NCT04494256|592195392|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
163952308|NCT04494256|592195393|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
163952309|NCT04494256|592195394|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
163952310|NCT04494256|592195388|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952311|NCT04494256|592195389|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952312|NCT04494256|592195390|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952313|NCT04494256|592195391|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952314|NCT04494256|592195392|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
163952315|NCT04494256|592195393|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
163952316|NCT04494256|592195394|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
163952317|NCT04494256|592195388|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163952318|NCT04494256|592195389|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163952319|NCT04494256|592195390|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163952320|NCT04494256|592195391|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163952321|NCT04494256|592195392|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
163952322|NCT04494256|592195393|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
163952323|NCT04494256|592195394|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
163952324|NCT00262951|592195395|FG000|Overall Study|Progressive disease/relapse|3|||
163952325|NCT00262951|592195395|FG000|Overall Study|Adverse Event|7|||
163952326|NCT00262951|592195395|FG000|Overall Study|Death|1|||
163952327|NCT00262951|592195395|FG000|Overall Study|Withdrawal by Subject|1|||
163952328|NCT00262951|592195395|FG000|Overall Study|Alternative treatment|3|||
163952329|NCT00262951|592195395|FG000|Overall Study|Off treatment for other disease|1|||
163952330|NCT02483585|592195396|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
164099718|NCT02100228|592730565|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
163844131|NCT00305864|591798591|FG002|Overall Study|Ineligible / No protocol treatment|1|||
163844132|NCT00305864|591798592|FG003|Overall Study|Ineligible / No protocol treatment|13|||
163844133|NCT02065570|591798593|FG000|Induction Study|Adverse Event|5|||
163844134|NCT02065570|591798594|FG001|Induction Study|Adverse Event|12|||
163952331|NCT02483585|592195397|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
163952332|NCT02483585|592195396|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
163952333|NCT02483585|592195397|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
163952334|NCT02483585|592195396|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
163952335|NCT02483585|592195397|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
163952336|NCT02483585|592195396|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
163952337|NCT02483585|592195397|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
163952338|NCT02483585|592195396|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
163952339|NCT02483585|592195397|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
163952340|NCT02483585|592195396|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
163952341|NCT02483585|592195397|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
163952342|NCT02483585|592195396|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
163952343|NCT02483585|592195397|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
163952344|NCT00825916|592195401|FG000|Overall Study|Lost to Follow-up|4|||
163952345|NCT00825916|592195402|FG001|Overall Study|Lost to Follow-up|2|||
163952346|NCT00825916|592195403|FG002|Overall Study|Lost to Follow-up|1|||
163952347|NCT01778023|592195404|FG000|Overall Study|Withdrawal by Subject|0|||
163952348|NCT01778023|592195405|FG001|Overall Study|Withdrawal by Subject|3|||
163952349|NCT01098097|592195406|FG000|Overall Study|Adverse Event|17|||
163952350|NCT01098097|592195406|FG000|Overall Study|Lost to Follow-up|18|||
163952351|NCT01098097|592195406|FG000|Overall Study|Status unknown|16|||
163952352|NCT01098097|592195406|FG000|Overall Study|No reason reported|31|||
163952353|NCT01000636|592195407|FG000|Overall Study|Withdrawal by Subject|1|||
163952354|NCT01000636|592195407|FG000|Overall Study|Adverse Event|1|||
163952355|NCT00577577|592195409|FG000|Overall Study|Adverse Event|3|||
163952356|NCT00577577|592195410|FG001|Overall Study|Adverse Event|2|||
163952357|NCT00577577|592195409|FG000|Overall Study|Lost to Follow-up|1|||
163952358|NCT00577577|592195410|FG001|Overall Study|Lost to Follow-up|0|||
163952359|NCT00577577|592195409|FG000|Overall Study|Protocol Violation|0|||
163952360|NCT00577577|592195410|FG001|Overall Study|Protocol Violation|3|||
163952361|NCT00577577|592195409|FG000|Overall Study|Transportation|1|||
163952362|NCT00577577|592195410|FG001|Overall Study|Transportation|0|||
163952363|NCT01090427|592195411|FG000|After Controlled Period|Death|0|||
163952364|NCT01090427|592195412|FG001|After Controlled Period|Death|0|||
163952365|NCT01090427|592195413|FG002|After Controlled Period|Death|0|||
163952366|NCT01090427|592195414|FG003|After Controlled Period|Death|0|||
163952367|NCT01090427|592195415|FG004|After Controlled Period|Death|0|||
163952368|NCT01090427|592195416|FG005|After Controlled Period|Death|1|||
163952369|NCT01090427|592195417|FG006|After Controlled Period|Death|0|||
163952370|NCT01090427|592195411|FG000|After Controlled Period|Lack of Efficacy|0|||
163952371|NCT01090427|592195412|FG001|After Controlled Period|Lack of Efficacy|0|||
163952372|NCT01090427|592195413|FG002|After Controlled Period|Lack of Efficacy|0|||
163952373|NCT01090427|592195414|FG003|After Controlled Period|Lack of Efficacy|0|||
163952374|NCT01090427|592195415|FG004|After Controlled Period|Lack of Efficacy|0|||
163952375|NCT01090427|592195416|FG005|After Controlled Period|Lack of Efficacy|3|||
163952376|NCT01090427|592195417|FG006|After Controlled Period|Lack of Efficacy|2|||
163952377|NCT01090427|592195411|FG000|After Controlled Period|Adverse Event|0|||
163952378|NCT01090427|592195412|FG001|After Controlled Period|Adverse Event|0|||
163952379|NCT01090427|592195413|FG002|After Controlled Period|Adverse Event|0|||
163952380|NCT01090427|592195414|FG003|After Controlled Period|Adverse Event|2|||
163952381|NCT01090427|592195415|FG004|After Controlled Period|Adverse Event|0|||
163952382|NCT01090427|592195416|FG005|After Controlled Period|Adverse Event|1|||
163952383|NCT01090427|592195417|FG006|After Controlled Period|Adverse Event|0|||
163952384|NCT01154010|592195418|FG000|Overall Study|Lost to Follow-up|0|||
163952385|NCT01154010|592195419|FG001|Overall Study|Lost to Follow-up|1|||
163952386|NCT01465347|592195425|FG000|Overall Study|Withdrawal by Subject|1|||
164047720|NCT02200510|592534150|FG000|Overall Study|Death|1|||
164047721|NCT02200510|592534151|FG001|Overall Study|Death|1|||
164047722|NCT02200510|592534150|FG000|Overall Study|Protocol Violation|0|||
164047723|NCT02200510|592534151|FG001|Overall Study|Protocol Violation|1|||
164047724|NCT02200510|592534150|FG000|Overall Study|Lost to Follow-up|7|||
164047725|NCT02200510|592534151|FG001|Overall Study|Lost to Follow-up|1|||
164047726|NCT02200510|592534150|FG000|Overall Study|potential COI - joined study team|1|||
164047727|NCT02200510|592534151|FG001|Overall Study|potential COI - joined study team|0|||
164047728|NCT04969900|592534154|FG000|Overall Study|Physician Decision|1|||
163952387|NCT01465347|592195426|FG001|Overall Study|Withdrawal by Subject|1|||
163952388|NCT01465347|592195425|FG000|Overall Study|Physician Decision|0|||
164047729|NCT04969900|592534155|FG001|Overall Study|Physician Decision|1|||
163952389|NCT01465347|592195426|FG001|Overall Study|Physician Decision|1|||
163952390|NCT01465347|592195425|FG000|Overall Study|Admitted to hospice|0|||
163952391|NCT01465347|592195426|FG001|Overall Study|Admitted to hospice|1|||
163952392|NCT02413333|592195427|FG000|Period 1|Adverse Event|1|||
163952393|NCT02413333|592195428|FG001|Period 1|Adverse Event|0|||
163952394|NCT02413333|592195427|FG000|Period 1|Reason Not Specified|0|||
163952395|NCT02413333|592195428|FG001|Period 1|Reason Not Specified|1|||
163952396|NCT02413333|592195427|FG000|Period 2|Protocol Deviation|1|||
163952397|NCT02413333|592195428|FG001|Period 2|Protocol Deviation|0|||
163952398|NCT00906945|592195429|FG000|Overall Study|Found to be not eligible|0|||
163952399|NCT00906945|592195430|FG001|Overall Study|Found to be not eligible|0|||
163952400|NCT00906945|592195431|FG002|Overall Study|Found to be not eligible|0|||
163952401|NCT00906945|592195432|FG003|Overall Study|Found to be not eligible|1|||
163952402|NCT00906945|592195433|FG004|Overall Study|Found to be not eligible|1|||
163952403|NCT00906945|592195434|FG005|Overall Study|Found to be not eligible|1|||
163952404|NCT00906945|592195429|FG000|Overall Study|Physician Decision|0|||
163952405|NCT00906945|592195430|FG001|Overall Study|Physician Decision|0|||
163952406|NCT00906945|592195431|FG002|Overall Study|Physician Decision|0|||
163952407|NCT00906945|592195432|FG003|Overall Study|Physician Decision|0|||
163952408|NCT00906945|592195433|FG004|Overall Study|Physician Decision|0|||
163952409|NCT00906945|592195434|FG005|Overall Study|Physician Decision|1|||
163952410|NCT02996474|592195435|FG000|Overall Study|Physician Decision|5|||
163952411|NCT01210664|592195437|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
163952412|NCT01210664|592195438|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
163952413|NCT01210664|592195439|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
163952414|NCT01210664|592195440|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
163952415|NCT01210664|592195437|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
163952416|NCT01210664|592195438|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
163952417|NCT01210664|592195439|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
163952418|NCT01210664|592195440|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
163952419|NCT01210664|592195437|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
163952420|NCT01210664|592195438|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
163952421|NCT01210664|592195439|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
163952422|NCT01210664|592195440|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
163952423|NCT01853644|592195441|FG000|Registration and Treatment Start|Did not start treatment|1|||
163952424|NCT01853644|592195441|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
163952425|NCT01853644|592195441|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
163952426|NCT01853644|592195441|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
163952427|NCT01853644|592195441|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
163952428|NCT01853644|592195441|FG000|Continued Treatment After First Response|Adverse Event|2|||
163952429|NCT01853644|592195441|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
163952430|NCT02891837|592195442|FG000|Overall Study|Lost to Follow-up|2|||
163952431|NCT02891837|592195443|FG001|Overall Study|Lost to Follow-up|0|||
163952432|NCT02891837|592195442|FG000|Overall Study|Withdrawal by Subject|1|||
163952433|NCT02891837|592195443|FG001|Overall Study|Withdrawal by Subject|0|||
163952434|NCT05924945|592195444|FG000|Overall Study|Withdrawal by Subject|3|||
163952435|NCT05924945|592195445|FG001|Overall Study|Withdrawal by Subject|4|||
163952436|NCT00928018|592195446|FG000|Overall Study|Withdrawal by Subject|1|||
163952437|NCT00928018|592195447|FG001|Overall Study|Withdrawal by Subject|0|||
163952438|NCT00943111|592195448|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
163952439|NCT00943111|592195449|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
163952440|NCT00943111|592195450|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
163952441|NCT00943111|592195448|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
163952442|NCT00943111|592195449|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
163952443|NCT00943111|592195450|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
163952444|NCT00943111|592195448|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
163952445|NCT00943111|592195449|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
163952446|NCT00943111|592195450|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
163952447|NCT00943111|592195448|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
163952448|NCT00943111|592195449|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
163952449|NCT00943111|592195450|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
164047730|NCT04969900|592534154|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
164047731|NCT04969900|592534155|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
164047732|NCT02881151|592534156|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
164047733|NCT04284787|592534160|FG000|Overall Study|Disease Progression|9|||
164047734|NCT04284787|592534161|FG001|Overall Study|Disease Progression|12|||
164047735|NCT04284787|592534160|FG000|Overall Study|Physician Decision|12|||
164047736|NCT04284787|592534161|FG001|Overall Study|Physician Decision|7|||
164047737|NCT04284787|592534160|FG000|Overall Study|Transplant|5|||
164047738|NCT04284787|592534161|FG001|Overall Study|Transplant|4|||
164047739|NCT04284787|592534160|FG000|Overall Study|Death|1|||
164047740|NCT04284787|592534161|FG001|Overall Study|Death|2|||
164047741|NCT04284787|592534160|FG000|Overall Study|Adverse Event|0|||
164047742|NCT04284787|592534161|FG001|Overall Study|Adverse Event|4|||
164047743|NCT04284787|592534160|FG000|Overall Study|Non-adherence|2|||
164047744|NCT04284787|592534161|FG001|Overall Study|Non-adherence|0|||
164047745|NCT04284787|592534160|FG000|Overall Study|Lack of Efficacy|2|||
164047746|NCT04284787|592534161|FG001|Overall Study|Lack of Efficacy|0|||
164047747|NCT00610714|592534163|FG000|Overall Study|Adverse Event|3|||
163952450|NCT00943111|592195448|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
163952451|NCT00943111|592195449|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
163952452|NCT00943111|592195450|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
163952453|NCT00943111|592195448|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
163952454|NCT00943111|592195449|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
163952455|NCT00943111|592195450|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
163952456|NCT00943111|592195448|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
163952457|NCT00943111|592195449|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
163952458|NCT00943111|592195450|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
163952459|NCT00943111|592195448|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
163952460|NCT00943111|592195449|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
163952461|NCT00943111|592195450|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
163952462|NCT00847808|592195451|FG000|Overall Study|Adverse Event|7|||
163952463|NCT00847808|592195451|FG000|Overall Study|Protocol Violation|1|||
163952464|NCT00847808|592195451|FG000|Overall Study|Lost to Follow-up|1|||
163952465|NCT00847808|592195451|FG000|Overall Study|Withdrawal by Subject|4|||
163952466|NCT00847808|592195451|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
163952467|NCT00847808|592195451|FG000|Overall Study|Participant Took Excluded Medication|1|||
163952468|NCT05326815|592195453|FG000|Overall Study|Withdrawal by Subject|3|||
163952469|NCT05326815|592195453|FG000|Overall Study|Did not complete required labs|6|||
163952470|NCT05326815|592195453|FG000|Overall Study|Screen fail- abnormal labs|5|||
163952471|NCT00979134|592195460|FG000|Overall Study|Disease progression|18|||
163952472|NCT00979134|592195461|FG001|Overall Study|Disease progression|2|||
163952473|NCT00979134|592195462|FG002|Overall Study|Disease progression|5|||
163952474|NCT00979134|592195460|FG000|Overall Study|Adverse Event|0|||
163952475|NCT00979134|592195461|FG001|Overall Study|Adverse Event|0|||
163952476|NCT00979134|592195462|FG002|Overall Study|Adverse Event|2|||
163952477|NCT00979134|592195460|FG000|Overall Study|Withdrawal by Subject|1|||
163952478|NCT00979134|592195461|FG001|Overall Study|Withdrawal by Subject|1|||
163952479|NCT00979134|592195462|FG002|Overall Study|Withdrawal by Subject|2|||
163952480|NCT00979134|592195460|FG000|Overall Study|Lost to Follow-up|2|||
163952481|NCT00979134|592195461|FG001|Overall Study|Lost to Follow-up|2|||
163952482|NCT00979134|592195462|FG002|Overall Study|Lost to Follow-up|0|||
163952483|NCT00979134|592195460|FG000|Overall Study|Death|4|||
163952484|NCT00979134|592195461|FG001|Overall Study|Death|0|||
163952485|NCT00979134|592195462|FG002|Overall Study|Death|26|||
163952486|NCT00979134|592195460|FG000|Overall Study|Other|8|||
163952487|NCT00979134|592195461|FG001|Overall Study|Other|1|||
163952488|NCT00979134|592195462|FG002|Overall Study|Other|5|||
163952489|NCT00729378|592198005|FG000|Baseline|Did not complete study measurements|72|||
163952490|NCT00729378|592198006|FG001|Baseline|Did not complete study measurements|33|||
163952491|NCT00729378|592198005|FG000|Baseline|Withdrawal by Subject|66|||
163952492|NCT00729378|592198006|FG001|Baseline|Withdrawal by Subject|59|||
163952493|NCT00729378|592198005|FG000|12-months|Lost to Follow-up|100|||
163952494|NCT00729378|592198006|FG001|12-months|Lost to Follow-up|65|||
163952495|NCT00729378|592198005|FG000|24-months|Lost to Follow-up|72|||
163952496|NCT00729378|592198006|FG001|24-months|Lost to Follow-up|51|||
163952497|NCT00729378|592198005|FG000|36-months|Lost to Follow-up|15|||
163952498|NCT00729378|592198006|FG001|36-months|Lost to Follow-up|6|||
163952499|NCT00484289|592198016|FG000|Long Term Phase|Adverse Event|1|||
163952500|NCT00484289|592198017|FG001|Long Term Phase|Adverse Event|17|||
163952501|NCT00484289|592198018|FG002|Long Term Phase|Adverse Event|5|||
163952502|NCT00484289|592198016|FG000|Long Term Phase|Withdrawal by Subject|0|||
163952503|NCT00484289|592198017|FG001|Long Term Phase|Withdrawal by Subject|7|||
163952504|NCT00484289|592198018|FG002|Long Term Phase|Withdrawal by Subject|6|||
163952505|NCT00484289|592198016|FG000|Long Term Phase|Inadequate response|2|||
163952506|NCT00484289|592198017|FG001|Long Term Phase|Inadequate response|7|||
163952507|NCT00484289|592198018|FG002|Long Term Phase|Inadequate response|4|||
163952508|NCT00484289|592198016|FG000|Long Term Phase|Other Reason|0|||
163952509|NCT00484289|592198017|FG001|Long Term Phase|Other Reason|5|||
163952510|NCT00484289|592198018|FG002|Long Term Phase|Other Reason|1|||
163952511|NCT00484289|592198016|FG000|Post Marketing Phase|Adverse Event|0|||
163952512|NCT00484289|592198017|FG001|Post Marketing Phase|Adverse Event|1|||
163952513|NCT00484289|592198018|FG002|Post Marketing Phase|Adverse Event|0|||
163952514|NCT00690443|592198019|FG000|Overall Study|Adverse Event|1|||
163952515|NCT00690443|592198020|FG001|Overall Study|Adverse Event|2|||
164047748|NCT00610714|592534164|FG001|Overall Study|Adverse Event|1|||
164047749|NCT00610714|592534163|FG000|Overall Study|Death|12|||
164047750|NCT00610714|592534164|FG001|Overall Study|Death|18|||
163952516|NCT02502097|592198021|FG000|Period 1|Adverse Event|0|||
163952517|NCT02502097|592198022|FG001|Period 1|Adverse Event|0|||
163952518|NCT02502097|592198023|FG002|Period 1|Adverse Event|1|||
164047751|NCT00610714|592534163|FG000|Overall Study|Withdrawal by Subject|9|||
163952519|NCT02502097|592198024|FG003|Period 1|Adverse Event|0|||
163952520|NCT02502097|592198021|FG000|Wash Out Period|Adverse Event|0|||
163952521|NCT02502097|592198022|FG001|Wash Out Period|Adverse Event|1|||
163952522|NCT02502097|592198023|FG002|Wash Out Period|Adverse Event|1|||
163952523|NCT02502097|592198024|FG003|Wash Out Period|Adverse Event|1|||
163952524|NCT02502097|592198021|FG000|Period 2|Adverse Event|0|||
163952525|NCT02502097|592198022|FG001|Period 2|Adverse Event|0|||
163952526|NCT02502097|592198023|FG002|Period 2|Adverse Event|1|||
163952527|NCT02502097|592198024|FG003|Period 2|Adverse Event|0|||
163952528|NCT01776541|592198030|FG000|Overall Study|Administrative Reason|6|||
163952529|NCT01776541|592198031|FG001|Overall Study|Administrative Reason|2|||
163952530|NCT01776541|592198030|FG000|Overall Study|Death|4|||
163952531|NCT01776541|592198031|FG001|Overall Study|Death|0|||
163952532|NCT01776541|592198030|FG000|Overall Study|Lost to Follow-up|27|||
163952533|NCT01776541|592198031|FG001|Overall Study|Lost to Follow-up|48|||
163952534|NCT01776541|592198030|FG000|Overall Study|Unclassified|5|||
163952535|NCT01776541|592198031|FG001|Overall Study|Unclassified|4|||
163952536|NCT01776541|592198030|FG000|Overall Study|Protocol Violation|2|||
163952537|NCT01776541|592198031|FG001|Overall Study|Protocol Violation|1|||
163952538|NCT01776541|592198030|FG000|Overall Study|Withdrawal by Subject|12|||
163952539|NCT01776541|592198031|FG001|Overall Study|Withdrawal by Subject|20|||
163952540|NCT02874924|592198032|FG000|Overall Study|Adverse Event|2|||
163952541|NCT02874924|592198033|FG001|Overall Study|Adverse Event|0|||
163952542|NCT02874924|592198034|FG002|Overall Study|Adverse Event|0|||
163952543|NCT02874924|592198032|FG000|Overall Study|Withdrawal by Subject|1|||
163952544|NCT02874924|592198033|FG001|Overall Study|Withdrawal by Subject|0|||
163952545|NCT02874924|592198034|FG002|Overall Study|Withdrawal by Subject|0|||
163952546|NCT00903006|592198037|FG000|Overall Study|Withdrawal by Subject|2|||
163952547|NCT00903006|592198038|FG001|Overall Study|Withdrawal by Subject|0|||
163952548|NCT00903006|592198039|FG002|Overall Study|Withdrawal by Subject|0|||
163952549|NCT00903006|592198040|FG003|Overall Study|Withdrawal by Subject|0|||
163952550|NCT00903006|592198037|FG000|Overall Study|Progressive Disease|0|||
163844135|NCT02065570|591798595|FG002|Induction Study|Adverse Event|0|||
163844136|NCT02065570|591798596|FG003|Induction Study|Adverse Event|0|||
163844137|NCT02065570|591798593|FG000|Induction Study|Withdrawal by Subject|2|||
163844138|NCT02065570|591798594|FG001|Induction Study|Withdrawal by Subject|3|||
163844139|NCT02065570|591798595|FG002|Induction Study|Withdrawal by Subject|0|||
163844140|NCT02065570|591798596|FG003|Induction Study|Withdrawal by Subject|0|||
163844141|NCT02065570|591798593|FG000|Induction Study|Lost to Follow-up|1|||
163844142|NCT02065570|591798594|FG001|Induction Study|Lost to Follow-up|1|||
163844143|NCT02065570|591798595|FG002|Induction Study|Lost to Follow-up|0|||
163844144|NCT02065570|591798596|FG003|Induction Study|Lost to Follow-up|0|||
163844145|NCT02065570|591798593|FG000|Induction Study|Other, Not Specified|6|||
163844146|NCT02065570|591798594|FG001|Induction Study|Other, Not Specified|5|||
163844147|NCT02065570|591798595|FG002|Induction Study|Other, Not Specified|0|||
163844148|NCT02065570|591798596|FG003|Induction Study|Other, Not Specified|0|||
163844149|NCT02065570|591798593|FG000|Maintenance Study|Adverse Event|0|||
163844150|NCT02065570|591798594|FG001|Maintenance Study|Adverse Event|0|||
163844151|NCT02065570|591798595|FG002|Maintenance Study|Adverse Event|8|||
163844152|NCT02065570|591798596|FG003|Maintenance Study|Adverse Event|8|||
163844153|NCT02065570|591798593|FG000|Maintenance Study|Withdrawal by Subject|0|||
163844154|NCT02065570|591798594|FG001|Maintenance Study|Withdrawal by Subject|0|||
163844155|NCT02065570|591798595|FG002|Maintenance Study|Withdrawal by Subject|1|||
163844156|NCT02065570|591798596|FG003|Maintenance Study|Withdrawal by Subject|4|||
163844157|NCT02065570|591798593|FG000|Maintenance Study|Lost to Follow-up|0|||
163844158|NCT02065570|591798594|FG001|Maintenance Study|Lost to Follow-up|0|||
163844159|NCT02065570|591798595|FG002|Maintenance Study|Lost to Follow-up|2|||
163844160|NCT02065570|591798596|FG003|Maintenance Study|Lost to Follow-up|2|||
163844161|NCT02065570|591798593|FG000|Maintenance Study|Other, Not Specified|0|||
163844162|NCT02065570|591798594|FG001|Maintenance Study|Other, Not Specified|0|||
163844163|NCT02065570|591798595|FG002|Maintenance Study|Other, Not Specified|11|||
163844164|NCT02065570|591798596|FG003|Maintenance Study|Other, Not Specified|5|||
163844165|NCT02743793|591798597|FG000|Overall Study|Death|1|||
163844166|NCT02743793|591798598|FG001|Overall Study|Death|1|||
163844167|NCT02743793|591798597|FG000|Overall Study|Withdrawal by Subject|0|||
163844168|NCT02743793|591798598|FG001|Overall Study|Withdrawal by Subject|1|||
163844169|NCT02743793|591798597|FG000|Overall Study|Screen Failure|4|||
163844170|NCT02743793|591798598|FG001|Overall Study|Screen Failure|0|||
163844171|NCT02743793|591798597|FG000|Overall Study|No Primary Care Physician|0|||
163844172|NCT02743793|591798598|FG001|Overall Study|No Primary Care Physician|1|||
163844173|NCT02743793|591798597|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
163844174|NCT02743793|591798598|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
163844175|NCT02743793|591798597|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
163844176|NCT02743793|591798598|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
163952551|NCT00903006|592198038|FG001|Overall Study|Progressive Disease|3|||
163952552|NCT00903006|592198039|FG002|Overall Study|Progressive Disease|1|||
163952553|NCT00903006|592198040|FG003|Overall Study|Progressive Disease|0|||
163952554|NCT03405792|592198041|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
163952555|NCT03405792|592198042|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
163844177|NCT02589392|591798599|FG000|Overall Study|Adverse Event|1|||
163952556|NCT03405792|592198041|FG000|Overall Study|o Did not receive pembrolizumab|1|||
163952557|NCT03405792|592198042|FG001|Overall Study|o Did not receive pembrolizumab|0|||
163952558|NCT02257567|592198043|FG000|Overall Study|Adverse Event|0|||
163952559|NCT02257567|592198044|FG001|Overall Study|Adverse Event|0|||
163952560|NCT02257567|592198045|FG002|Overall Study|Adverse Event|0|||
163952561|NCT02257567|592198046|FG003|Overall Study|Adverse Event|1|||
163952562|NCT02257567|592198047|FG004|Overall Study|Adverse Event|1|||
163952563|NCT02257567|592198048|FG005|Overall Study|Adverse Event|0|||
163952564|NCT02257567|592198049|FG006|Overall Study|Adverse Event|0|||
163952565|NCT02257567|592198050|FG007|Overall Study|Adverse Event|0|||
163952566|NCT02257567|592198051|FG008|Overall Study|Adverse Event|1|||
163952567|NCT02257567|592198052|FG009|Overall Study|Adverse Event|0|||
163952568|NCT02257567|592198053|FG010|Overall Study|Adverse Event|0|||
163952569|NCT02257567|592198043|FG000|Overall Study|Death|2|||
163952570|NCT02257567|592198044|FG001|Overall Study|Death|2|||
163952571|NCT02257567|592198045|FG002|Overall Study|Death|2|||
163952572|NCT02257567|592198046|FG003|Overall Study|Death|4|||
163952573|NCT02257567|592198047|FG004|Overall Study|Death|15|||
163952574|NCT02257567|592198048|FG005|Overall Study|Death|11|||
163952575|NCT02257567|592198049|FG006|Overall Study|Death|26|||
163952576|NCT02257567|592198050|FG007|Overall Study|Death|30|||
163952577|NCT02257567|592198051|FG008|Overall Study|Death|2|||
163952578|NCT02257567|592198052|FG009|Overall Study|Death|18|||
163952579|NCT02257567|592198053|FG010|Overall Study|Death|65|||
163952580|NCT02257567|592198043|FG000|Overall Study|Lost to Follow-up|0|||
163952581|NCT02257567|592198044|FG001|Overall Study|Lost to Follow-up|0|||
163952582|NCT02257567|592198045|FG002|Overall Study|Lost to Follow-up|0|||
163952583|NCT02257567|592198046|FG003|Overall Study|Lost to Follow-up|0|||
163952584|NCT02257567|592198047|FG004|Overall Study|Lost to Follow-up|2|||
163952585|NCT02257567|592198048|FG005|Overall Study|Lost to Follow-up|2|||
163952586|NCT02257567|592198049|FG006|Overall Study|Lost to Follow-up|0|||
163952587|NCT02257567|592198050|FG007|Overall Study|Lost to Follow-up|0|||
163952588|NCT02257567|592198051|FG008|Overall Study|Lost to Follow-up|0|||
163952589|NCT02257567|592198052|FG009|Overall Study|Lost to Follow-up|1|||
163952590|NCT02257567|592198053|FG010|Overall Study|Lost to Follow-up|1|||
163952591|NCT02257567|592198043|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952592|NCT02257567|592198044|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952593|NCT02257567|592198045|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952594|NCT02257567|592198046|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952595|NCT02257567|592198047|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
163952596|NCT02257567|592198048|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952597|NCT02257567|592198049|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
163952598|NCT02257567|592198050|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952599|NCT02257567|592198051|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952600|NCT02257567|592198052|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952601|NCT02257567|592198053|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
163952602|NCT02257567|592198043|FG000|Overall Study|Physician Decision|0|||
163952603|NCT02257567|592198044|FG001|Overall Study|Physician Decision|0|||
163952604|NCT02257567|592198045|FG002|Overall Study|Physician Decision|0|||
163952605|NCT02257567|592198046|FG003|Overall Study|Physician Decision|0|||
163952606|NCT02257567|592198047|FG004|Overall Study|Physician Decision|0|||
163952607|NCT02257567|592198048|FG005|Overall Study|Physician Decision|0|||
163952608|NCT02257567|592198049|FG006|Overall Study|Physician Decision|0|||
163952609|NCT02257567|592198050|FG007|Overall Study|Physician Decision|2|||
163952610|NCT02257567|592198051|FG008|Overall Study|Physician Decision|0|||
163952611|NCT02257567|592198052|FG009|Overall Study|Physician Decision|1|||
163952612|NCT02257567|592198053|FG010|Overall Study|Physician Decision|0|||
163952613|NCT02257567|592198043|FG000|Overall Study|Withdrawal by Subject|0|||
163952614|NCT02257567|592198044|FG001|Overall Study|Withdrawal by Subject|0|||
163952615|NCT02257567|592198045|FG002|Overall Study|Withdrawal by Subject|2|||
163952616|NCT02257567|592198046|FG003|Overall Study|Withdrawal by Subject|0|||
163952617|NCT02257567|592198047|FG004|Overall Study|Withdrawal by Subject|0|||
163952618|NCT02257567|592198048|FG005|Overall Study|Withdrawal by Subject|6|||
163952619|NCT02257567|592198049|FG006|Overall Study|Withdrawal by Subject|6|||
163952620|NCT02257567|592198050|FG007|Overall Study|Withdrawal by Subject|6|||
163952621|NCT02257567|592198051|FG008|Overall Study|Withdrawal by Subject|1|||
163952622|NCT02257567|592198052|FG009|Overall Study|Withdrawal by Subject|1|||
163952623|NCT02257567|592198053|FG010|Overall Study|Withdrawal by Subject|10|||
163952624|NCT00946101|592198054|FG000|Overall Study|Lost to Follow-up|2|||
163952625|NCT00946101|592198055|FG001|Overall Study|Lost to Follow-up|1|||
163952626|NCT00946101|592198054|FG000|Overall Study|Withdrawal of consent|2|||
163952627|NCT00946101|592198055|FG001|Overall Study|Withdrawal of consent|0|||
163952628|NCT00946101|592198054|FG000|Overall Study|Physician Decision|0|||
163952629|NCT00946101|592198055|FG001|Overall Study|Physician Decision|1|||
163952630|NCT00495586|592198056|FG000|Overall Study|Withdrawal by Subject|4|||
163952631|NCT00495586|592198057|FG001|Overall Study|Withdrawal by Subject|4|||
163952632|NCT01347762|592198058|FG000|Overall Study|Lost to Follow-up|0|||
163952633|NCT01347762|592198059|FG001|Overall Study|Lost to Follow-up|1|||
163952634|NCT01347762|592198060|FG002|Overall Study|Lost to Follow-up|6|||
163952635|NCT01347762|592198061|FG003|Overall Study|Lost to Follow-up|5|||
163952636|NCT01347762|592198058|FG000|Overall Study|Withdrawal by Subject|4|||
163952637|NCT01347762|592198059|FG001|Overall Study|Withdrawal by Subject|1|||
163952638|NCT01347762|592198060|FG002|Overall Study|Withdrawal by Subject|3|||
163952639|NCT01347762|592198061|FG003|Overall Study|Withdrawal by Subject|3|||
163952640|NCT02527343|592198062|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
163952641|NCT02527343|592198063|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163952642|NCT02527343|592198064|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163952643|NCT02527343|592198065|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163952644|NCT02527343|592198066|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163952645|NCT02527343|592198067|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
163952646|NCT02527343|592198062|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
163952647|NCT02527343|592198063|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163952648|NCT02527343|592198064|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163952649|NCT02527343|592198065|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163952650|NCT02527343|592198066|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163952651|NCT02527343|592198067|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
163952652|NCT02527343|592198062|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163952653|NCT02527343|592198063|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
163952654|NCT02527343|592198064|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163952655|NCT02527343|592198065|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163952656|NCT02527343|592198066|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163952657|NCT02527343|592198067|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
163952658|NCT02527343|592198062|FG000|RT Period: Weeks 1 to 52|Other|4|||
163952659|NCT02527343|592198063|FG001|RT Period: Weeks 1 to 52|Other|3|||
163952660|NCT02527343|592198064|FG002|RT Period: Weeks 1 to 52|Other|0|||
163952661|NCT02527343|592198065|FG003|RT Period: Weeks 1 to 52|Other|0|||
163952662|NCT02527343|592198066|FG004|RT Period: Weeks 1 to 52|Other|0|||
163952663|NCT02527343|592198067|FG005|RT Period: Weeks 1 to 52|Other|0|||
163952664|NCT02527343|592198062|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163952665|NCT02527343|592198063|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163952666|NCT02527343|592198064|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
163952667|NCT02527343|592198065|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163952668|NCT02527343|592198066|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163952669|NCT02527343|592198067|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
163952670|NCT02527343|592198062|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163952671|NCT02527343|592198063|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163952672|NCT02527343|592198064|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163952673|NCT02527343|592198065|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
163952674|NCT02527343|592198066|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163952675|NCT02527343|592198067|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
163952676|NCT02527343|592198062|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163952677|NCT02527343|592198063|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163952678|NCT02527343|592198064|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163952679|NCT02527343|592198065|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163952680|NCT02527343|592198066|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
163952681|NCT02527343|592198067|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
163952682|NCT02527343|592198062|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163952683|NCT02527343|592198063|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163952684|NCT02527343|592198064|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163952685|NCT02527343|592198065|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
163952686|NCT02527343|592198066|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
163952687|NCT02527343|592198067|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
163952688|NCT02527343|592198062|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
164047752|NCT00610714|592534164|FG001|Overall Study|Withdrawal by Subject|3|||
164047753|NCT00610714|592534163|FG000|Overall Study|Study completion at 120 PFS events|2|||
164047754|NCT00610714|592534164|FG001|Overall Study|Study completion at 120 PFS events|2|||
163952689|NCT02527343|592198063|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
163952690|NCT02527343|592198064|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
163952691|NCT02527343|592198065|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
164047755|NCT01108263|592534165|FG000|Overall Study|Adverse Event|0|||
164047756|NCT01108263|592534166|FG001|Overall Study|Adverse Event|1|||
163952692|NCT02527343|592198066|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
163952693|NCT02527343|592198067|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
163952694|NCT02527343|592198062|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
163952695|NCT02527343|592198063|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
163952696|NCT02527343|592198064|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
163952697|NCT02527343|592198065|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
163952698|NCT02527343|592198066|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
163952699|NCT02527343|592198067|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
163952700|NCT02527343|592198062|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
163952701|NCT02527343|592198063|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
163952702|NCT02527343|592198064|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
163952703|NCT02527343|592198065|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
163952704|NCT02527343|592198066|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
163952705|NCT02527343|592198067|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
163952706|NCT02527343|592198062|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163952707|NCT02527343|592198063|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163952708|NCT02527343|592198064|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163952709|NCT02527343|592198065|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163952710|NCT02527343|592198066|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
163952711|NCT02527343|592198067|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
163952712|NCT02527343|592198062|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
163952713|NCT02527343|592198063|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
163952714|NCT02527343|592198064|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
163952715|NCT02527343|592198065|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
163952716|NCT02527343|592198066|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
163952717|NCT02527343|592198067|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
163952718|NCT04426851|592198068|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
163952719|NCT04426851|592198069|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
163952720|NCT04426851|592198068|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
163952721|NCT04426851|592198069|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
163952722|NCT03256851|592198071|FG000|Overall Study|Withdrawal by Subject|1|||
163952723|NCT03256851|592198072|FG001|Overall Study|Withdrawal by Subject|0|||
163952724|NCT03625895|592198073|FG000|Overall Study|Protocol Violation|585|||
163952725|NCT01065844|592198074|FG000|Overall Study|Adverse Event|5|||
163952726|NCT02081417|592198075|FG000|Overall Study|Lost to Follow-up|26|||
163952727|NCT02081417|592198076|FG001|Overall Study|Lost to Follow-up|23|||
163952728|NCT02081417|592198075|FG000|Overall Study|Moved Away|1|||
163952729|NCT02081417|592198076|FG001|Overall Study|Moved Away|2|||
163952730|NCT02081417|592198075|FG000|Overall Study|Incarcerated|2|||
163952731|NCT02081417|592198076|FG001|Overall Study|Incarcerated|2|||
163952732|NCT02081417|592198075|FG000|Overall Study|Death|4|||
163952733|NCT02081417|592198076|FG001|Overall Study|Death|3|||
163952734|NCT02081417|592198075|FG000|Overall Study|Withdrawal by Subject|4|||
163952735|NCT02081417|592198076|FG001|Overall Study|Withdrawal by Subject|0|||
163952736|NCT02081417|592198075|FG000|Overall Study|Admitted to Residential Treatment|2|||
163952737|NCT02081417|592198076|FG001|Overall Study|Admitted to Residential Treatment|0|||
163952738|NCT02081417|592198075|FG000|Overall Study|Did not start treatment|17|||
163952739|NCT02081417|592198076|FG001|Overall Study|Did not start treatment|21|||
163952740|NCT01502631|592198084|FG000|Overall Study|Adverse Event|5|||
163952741|NCT01502631|592198085|FG001|Overall Study|Adverse Event|8|||
163952742|NCT01502631|592198084|FG000|Overall Study|Lost to Follow-up|2|||
163952743|NCT01502631|592198085|FG001|Overall Study|Lost to Follow-up|2|||
163952744|NCT01502631|592198084|FG000|Overall Study|Participant withdrew consent|2|||
163952745|NCT01502631|592198085|FG001|Overall Study|Participant withdrew consent|4|||
163952746|NCT01502631|592198084|FG000|Overall Study|Participant non-compliant|1|||
163952747|NCT01502631|592198085|FG001|Overall Study|Participant non-compliant|0|||
163952748|NCT01502631|592198084|FG000|Overall Study|Investigator's decision|0|||
163952749|NCT01502631|592198085|FG001|Overall Study|Investigator's decision|1|||
163952750|NCT01502631|592198084|FG000|Overall Study|Other|10|||
163952751|NCT01502631|592198085|FG001|Overall Study|Other|5|||
163952752|NCT02424734|592198089|FG000|Overall Study|Treatment stopped to be discharged home|2|||
163952753|NCT02424734|592198090|FG001|Overall Study|Treatment stopped to be discharged home|2|||
164047757|NCT02974621|592534168|FG000|Overall Study|Didn't receive study treatment|1|||
163952754|NCT02424734|592198091|FG002|Overall Study|Treatment stopped to be discharged home|0|||
163952755|NCT01445301|592198092|FG000|Overall Study|Adverse Event|15|||
163952756|NCT01445301|592198093|FG001|Overall Study|Adverse Event|25|||
163952757|NCT01445301|592198094|FG002|Overall Study|Adverse Event|4|||
163952758|NCT01445301|592198092|FG000|Overall Study|Lack of Efficacy|0|||
163952759|NCT01445301|592198093|FG001|Overall Study|Lack of Efficacy|1|||
163952760|NCT01445301|592198094|FG002|Overall Study|Lack of Efficacy|0|||
163952761|NCT01445301|592198092|FG000|Overall Study|Protocol Violation|1|||
163952762|NCT01445301|592198093|FG001|Overall Study|Protocol Violation|0|||
163952763|NCT01445301|592198094|FG002|Overall Study|Protocol Violation|0|||
163952764|NCT01445301|592198092|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
163952765|NCT01445301|592198093|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
163844178|NCT02589392|591798600|FG001|Overall Study|Adverse Event|1|||
163844179|NCT02589392|591798599|FG000|Overall Study|Withdrawal by Subject|1|||
163844180|NCT02589392|591798600|FG001|Overall Study|Withdrawal by Subject|2|||
163844181|NCT02589392|591798599|FG000|Overall Study|Protocol Violation|1|||
163844182|NCT02589392|591798600|FG001|Overall Study|Protocol Violation|1|||
163952766|NCT01445301|592198094|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
163952767|NCT01445301|592198092|FG000|Overall Study|Physician Decision|0|||
163952768|NCT01445301|592198093|FG001|Overall Study|Physician Decision|2|||
163952769|NCT01445301|592198094|FG002|Overall Study|Physician Decision|0|||
163952770|NCT01445301|592198092|FG000|Overall Study|Withdrawal by Subject|5|||
163952771|NCT01445301|592198093|FG001|Overall Study|Withdrawal by Subject|6|||
163844183|NCT02589392|591798599|FG000|Overall Study|Lost to Follow-up|2|||
163844184|NCT02589392|591798600|FG001|Overall Study|Lost to Follow-up|2|||
163844185|NCT02589392|591798599|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
163844186|NCT02589392|591798600|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
163844187|NCT00322374|591798602|FG000|Starting Dose|Physician Decision|2|||
163844188|NCT00322374|591798603|FG001|Starting Dose|Physician Decision|0|||
163952772|NCT01445301|592198094|FG002|Overall Study|Withdrawal by Subject|4|||
163952773|NCT00752557|592198095|FG000|Overall Study|Withdrawal by Subject|4|||
163952774|NCT00752557|592198096|FG001|Overall Study|Withdrawal by Subject|3|||
163952775|NCT00752557|592198097|FG002|Overall Study|Withdrawal by Subject|3|||
163952776|NCT00752557|592198095|FG000|Overall Study|Unspecified resaons|0|||
163952777|NCT00752557|592198096|FG001|Overall Study|Unspecified resaons|2|||
163952778|NCT00752557|592198097|FG002|Overall Study|Unspecified resaons|2|||
163952779|NCT00752557|592198095|FG000|Overall Study|Lost to Follow-up|1|||
163952780|NCT00752557|592198096|FG001|Overall Study|Lost to Follow-up|0|||
163952781|NCT00752557|592198097|FG002|Overall Study|Lost to Follow-up|1|||
163952782|NCT02150343|592198098|FG000|Overall Study|Adverse Event|2|||
163952783|NCT02150343|592198099|FG001|Overall Study|Adverse Event|0|||
163952784|NCT02150343|592198100|FG002|Overall Study|Adverse Event|1|||
163952785|NCT02150343|592198101|FG003|Overall Study|Adverse Event|1|||
163952786|NCT02150343|592198098|FG000|Overall Study|Withdrawal by Subject|13|||
163952787|NCT02150343|592198099|FG001|Overall Study|Withdrawal by Subject|10|||
163952788|NCT02150343|592198100|FG002|Overall Study|Withdrawal by Subject|9|||
163952789|NCT02150343|592198101|FG003|Overall Study|Withdrawal by Subject|4|||
163952790|NCT02150343|592198098|FG000|Overall Study|Lost to Follow-up|4|||
163952791|NCT02150343|592198099|FG001|Overall Study|Lost to Follow-up|4|||
163952792|NCT02150343|592198100|FG002|Overall Study|Lost to Follow-up|2|||
163952793|NCT02150343|592198101|FG003|Overall Study|Lost to Follow-up|3|||
163952794|NCT02150343|592198098|FG000|Overall Study|Other|2|||
163952795|NCT02150343|592198099|FG001|Overall Study|Other|6|||
163952796|NCT02150343|592198100|FG002|Overall Study|Other|0|||
163952797|NCT02150343|592198101|FG003|Overall Study|Other|2|||
163952798|NCT00190749|592198102|FG000|Overall Study|Lost to Follow-up|8|||
163952799|NCT00190749|592198103|FG001|Overall Study|Lost to Follow-up|11|||
163952800|NCT00190749|592198102|FG000|Overall Study|Withdrawal by Subject|10|||
163952801|NCT00190749|592198103|FG001|Overall Study|Withdrawal by Subject|6|||
163952802|NCT00190749|592198102|FG000|Overall Study|Protocol Violation|5|||
163952803|NCT00190749|592198103|FG001|Overall Study|Protocol Violation|4|||
163952804|NCT00190749|592198102|FG000|Overall Study|Adverse Event|0|||
163952805|NCT00190749|592198103|FG001|Overall Study|Adverse Event|5|||
163952806|NCT00190749|592198102|FG000|Overall Study|Lack of Efficacy|2|||
163952807|NCT00190749|592198103|FG001|Overall Study|Lack of Efficacy|3|||
163952808|NCT00190749|592198102|FG000|Overall Study|Reason Not Specified|0|||
163952809|NCT00190749|592198103|FG001|Overall Study|Reason Not Specified|2|||
163952810|NCT00190749|592198102|FG000|Overall Study|Sponsor Decision|1|||
163952811|NCT00190749|592198103|FG001|Overall Study|Sponsor Decision|0|||
163952812|NCT00439231|592198104|FG000|Overall Study|Lack of Efficacy|28|||
163952813|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
163952814|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
163952815|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
163952816|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
163952817|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
163952818|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
163952819|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
163844189|NCT00322374|591798604|FG002|Starting Dose|Physician Decision|0|||
163952820|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
163952821|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
163952822|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
163952823|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
163952824|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
163952825|NCT04493502|592198105|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
163952826|NCT04493502|592198106|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
163952827|NCT04493502|592198105|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
163844190|NCT00322374|591798605|FG003|Starting Dose|Physician Decision|0|||
164099719|NCT02100228|592730564|FG000|Overall Study|Non-compliance|0|||
163952828|NCT04493502|592198106|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
163952829|NCT04493502|592198105|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
163952830|NCT04493502|592198106|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
163952831|NCT04493502|592198105|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
163952832|NCT04493502|592198106|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
163952833|NCT04493502|592198105|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
163952834|NCT04493502|592198106|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
163952835|NCT04493502|592198105|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
163952836|NCT04493502|592198106|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
163952837|NCT04493502|592198105|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
163952838|NCT04493502|592198106|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
163952839|NCT02891408|592198107|FG000|Overall Study|Lost to Follow-up|0|||
163952840|NCT02891408|592198108|FG001|Overall Study|Lost to Follow-up|0|||
163952841|NCT02891408|592198109|FG002|Overall Study|Lost to Follow-up|1|||
163952842|NCT02891408|592198110|FG003|Overall Study|Lost to Follow-up|0|||
163952843|NCT02891408|592198111|FG004|Overall Study|Lost to Follow-up|0|||
163952844|NCT02891408|592198112|FG005|Overall Study|Lost to Follow-up|0|||
163952845|NCT02891408|592198113|FG006|Overall Study|Lost to Follow-up|0|||
163952846|NCT00709852|592198114|FG000|Period 1|Adverse Event|2|||
163952847|NCT00709852|592198115|FG001|Period 1|Adverse Event|0|||
163952848|NCT00709852|592198114|FG000|Period 1|Withdrawal by Subject|4|||
163952849|NCT00709852|592198115|FG001|Period 1|Withdrawal by Subject|2|||
163952850|NCT00709852|592198114|FG000|Period 1|Protocol Violation|1|||
163952851|NCT00709852|592198115|FG001|Period 1|Protocol Violation|0|||
163952852|NCT00709852|592198114|FG000|Period 1|Defective scanner|0|||
163952853|NCT00709852|592198115|FG001|Period 1|Defective scanner|1|||
163952854|NCT00709852|592198114|FG000|Period 1|Lost to Follow-up|1|||
163952855|NCT00709852|592198115|FG001|Period 1|Lost to Follow-up|0|||
163952856|NCT00709852|592198114|FG000|Period 2|Protocol Violation|4|||
163952857|NCT00709852|592198115|FG001|Period 2|Protocol Violation|1|||
163952858|NCT00709852|592198114|FG000|Period 2|Adverse Event|1|||
163952859|NCT00709852|592198115|FG001|Period 2|Adverse Event|1|||
163952860|NCT00709852|592198114|FG000|Period 2|Lost to Follow-up|1|||
164047758|NCT02974621|592534169|FG001|Overall Study|Didn't receive study treatment|10|||
164047759|NCT02559115|592534170|FG000|Overall Study|Withdrawal by Subject|3|||
164047760|NCT04288089|592534171|FG000|Overall Study|Ongoing Treatment|2|||
164047761|NCT04288089|592534172|FG001|Overall Study|Ongoing Treatment|1|||
164047762|NCT04288089|592534173|FG002|Overall Study|Ongoing Treatment|1|||
164047763|NCT04288089|592534174|FG003|Overall Study|Ongoing Treatment|4|||
164047764|NCT02354690|592534175|FG000|Overall Study|Physician Decision|1|||
164047765|NCT04556175|592534179|FG000|Overall Study|Study terminated due to COVID-19|8|||
164047766|NCT04556175|592534180|FG001|Overall Study|Study terminated due to COVID-19|8|||
163844191|NCT00322374|591798602|FG000|Starting Dose|Study Drug Toxicity|4|||
163844192|NCT00322374|591798603|FG001|Starting Dose|Study Drug Toxicity|0|||
163844193|NCT00322374|591798604|FG002|Starting Dose|Study Drug Toxicity|0|||
163844194|NCT00322374|591798605|FG003|Starting Dose|Study Drug Toxicity|0|||
163844195|NCT00322374|591798602|FG000|First Escalation|Documented Disease Progression|0|||
163844196|NCT00322374|591798603|FG001|First Escalation|Documented Disease Progression|6|||
163844197|NCT00322374|591798604|FG002|First Escalation|Documented Disease Progression|0|||
163844198|NCT00322374|591798605|FG003|First Escalation|Documented Disease Progression|0|||
163844199|NCT00322374|591798602|FG000|First Escalation|Physician Decision|0|||
163844200|NCT00322374|591798603|FG001|First Escalation|Physician Decision|12|||
163844201|NCT00322374|591798604|FG002|First Escalation|Physician Decision|0|||
163844202|NCT00322374|591798605|FG003|First Escalation|Physician Decision|0|||
163844203|NCT00322374|591798602|FG000|First Escalation|Study Drug Toxicity|0|||
163844204|NCT00322374|591798603|FG001|First Escalation|Study Drug Toxicity|11|||
163844205|NCT00322374|591798604|FG002|First Escalation|Study Drug Toxicity|0|||
163844206|NCT00322374|591798605|FG003|First Escalation|Study Drug Toxicity|0|||
163844207|NCT00322374|591798602|FG000|First Escalation|Participant Request|0|||
163844208|NCT00322374|591798603|FG001|First Escalation|Participant Request|1|||
163844209|NCT00322374|591798604|FG002|First Escalation|Participant Request|0|||
163844210|NCT00322374|591798605|FG003|First Escalation|Participant Request|0|||
163844211|NCT00322374|591798602|FG000|Second Escalation|Physician Decision|0|||
163844212|NCT00322374|591798603|FG001|Second Escalation|Physician Decision|0|||
163844213|NCT00322374|591798604|FG002|Second Escalation|Physician Decision|5|||
163844214|NCT00322374|591798605|FG003|Second Escalation|Physician Decision|0|||
163952861|NCT00709852|592198115|FG001|Period 2|Lost to Follow-up|0|||
163952862|NCT00709852|592198114|FG000|Period 2|No 72-hour follow-up|3|||
163952863|NCT00709852|592198115|FG001|Period 2|No 72-hour follow-up|0|||
163952864|NCT01048671|592198116|FG000|Overall Study|Protocol Violation|0|||
163952865|NCT01048671|592198117|FG001|Overall Study|Protocol Violation|1|||
164047767|NCT05549505|592534181|FG000|Overall Study|Lost to Follow-up|2|||
163952866|NCT01048671|592198118|FG002|Overall Study|Protocol Violation|1|||
163952867|NCT05249829|592198119|FG000|Overall Study|Participant Relocation|0|||
163952868|NCT05249829|592198120|FG001|Overall Study|Participant Relocation|1|||
163952869|NCT05249829|592198121|FG002|Overall Study|Participant Relocation|2|||
163952870|NCT05249829|592198122|FG003|Overall Study|Participant Relocation|2|||
163952871|NCT05249829|592198119|FG000|Overall Study|Withdrawal by Subject|9|||
163952872|NCT05249829|592198120|FG001|Overall Study|Withdrawal by Subject|17|||
163952873|NCT05249829|592198121|FG002|Overall Study|Withdrawal by Subject|40|||
163952874|NCT05249829|592198122|FG003|Overall Study|Withdrawal by Subject|35|||
163952875|NCT05249829|592198119|FG000|Overall Study|Physician Decision|1|||
163952876|NCT05249829|592198120|FG001|Overall Study|Physician Decision|0|||
163952877|NCT05249829|592198121|FG002|Overall Study|Physician Decision|0|||
163952878|NCT05249829|592198122|FG003|Overall Study|Physician Decision|0|||
163952879|NCT05249829|592198119|FG000|Overall Study|Lost to Follow-up|16|||
163952880|NCT05249829|592198120|FG001|Overall Study|Lost to Follow-up|16|||
163952881|NCT05249829|592198121|FG002|Overall Study|Lost to Follow-up|57|||
163952882|NCT05249829|592198122|FG003|Overall Study|Lost to Follow-up|60|||
163952883|NCT05249829|592198119|FG000|Overall Study|Adverse Event|2|||
163952884|NCT05249829|592198120|FG001|Overall Study|Adverse Event|2|||
163952885|NCT05249829|592198121|FG002|Overall Study|Adverse Event|2|||
163952886|NCT05249829|592198122|FG003|Overall Study|Adverse Event|2|||
163952887|NCT05249829|592198119|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
163952888|NCT05249829|592198120|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
163952889|NCT05249829|592198121|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
163952890|NCT05249829|592198122|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
163952891|NCT05249829|592198119|FG000|Overall Study|Protocol Violation|2|||
163952892|NCT05249829|592198120|FG001|Overall Study|Protocol Violation|0|||
163952893|NCT05249829|592198121|FG002|Overall Study|Protocol Violation|5|||
163952894|NCT05249829|592198122|FG003|Overall Study|Protocol Violation|3|||
163952895|NCT05249829|592198119|FG000|Overall Study|Death|0|||
163952896|NCT05249829|592198120|FG001|Overall Study|Death|1|||
163952897|NCT05249829|592198121|FG002|Overall Study|Death|2|||
163952898|NCT05249829|592198122|FG003|Overall Study|Death|4|||
163952899|NCT00196976|592198124|FG000|Primary Study|Migrated from study area|0|||
163952900|NCT00196976|592198125|FG001|Primary Study|Migrated from study area|0|||
163952901|NCT00196976|592198126|FG002|Primary Study|Migrated from study area|0|||
163952902|NCT00196976|592198127|FG003|Primary Study|Migrated from study area|0|||
163952903|NCT00196976|592198128|FG004|Primary Study|Migrated from study area|0|||
163952904|NCT00196976|592198129|FG005|Primary Study|Migrated from study area|0|||
163952905|NCT00196976|592198130|FG006|Primary Study|Migrated from study area|0|||
163952906|NCT00196976|592198131|FG007|Primary Study|Migrated from study area|1|||
163952907|NCT00196976|592198132|FG008|Primary Study|Migrated from study area|0|||
163952908|NCT00196976|592198133|FG009|Primary Study|Migrated from study area|0|||
163952909|NCT00196976|592198134|FG010|Primary Study|Migrated from study area|0|||
163952910|NCT00196976|592198135|FG011|Primary Study|Migrated from study area|0|||
163952911|NCT00196976|592198136|FG012|Primary Study|Migrated from study area|0|||
163952912|NCT00196976|592198137|FG013|Primary Study|Migrated from study area|0|||
163952913|NCT00196976|592198124|FG000|Primary Study|Protocol Violation|0|||
163952914|NCT00196976|592198125|FG001|Primary Study|Protocol Violation|1|||
163952915|NCT00196976|592198126|FG002|Primary Study|Protocol Violation|1|||
163952916|NCT00196976|592198127|FG003|Primary Study|Protocol Violation|0|||
163952917|NCT00196976|592198128|FG004|Primary Study|Protocol Violation|0|||
163952918|NCT00196976|592198129|FG005|Primary Study|Protocol Violation|0|||
163952919|NCT00196976|592198130|FG006|Primary Study|Protocol Violation|0|||
163952920|NCT00196976|592198131|FG007|Primary Study|Protocol Violation|0|||
163952921|NCT00196976|592198132|FG008|Primary Study|Protocol Violation|0|||
163952922|NCT00196976|592198133|FG009|Primary Study|Protocol Violation|0|||
163952923|NCT00196976|592198134|FG010|Primary Study|Protocol Violation|0|||
163952924|NCT00196976|592198135|FG011|Primary Study|Protocol Violation|0|||
163952925|NCT00196976|592198136|FG012|Primary Study|Protocol Violation|0|||
163952926|NCT00196976|592198137|FG013|Primary Study|Protocol Violation|0|||
163952927|NCT00196976|592198124|FG000|Primary Study|Withdrawal by Subject|1|||
163952928|NCT00196976|592198125|FG001|Primary Study|Withdrawal by Subject|0|||
163952929|NCT00196976|592198126|FG002|Primary Study|Withdrawal by Subject|1|||
163952930|NCT00196976|592198127|FG003|Primary Study|Withdrawal by Subject|1|||
163952931|NCT00196976|592198128|FG004|Primary Study|Withdrawal by Subject|2|||
163952932|NCT00196976|592198129|FG005|Primary Study|Withdrawal by Subject|1|||
163952933|NCT00196976|592198130|FG006|Primary Study|Withdrawal by Subject|0|||
164047768|NCT05549505|592534182|FG001|Overall Study|Lost to Follow-up|0|||
163952934|NCT00196976|592198131|FG007|Primary Study|Withdrawal by Subject|0|||
163952935|NCT00196976|592198132|FG008|Primary Study|Withdrawal by Subject|0|||
163952936|NCT00196976|592198133|FG009|Primary Study|Withdrawal by Subject|1|||
163952937|NCT00196976|592198134|FG010|Primary Study|Withdrawal by Subject|0|||
163952938|NCT00196976|592198135|FG011|Primary Study|Withdrawal by Subject|0|||
163952939|NCT00196976|592198136|FG012|Primary Study|Withdrawal by Subject|0|||
163952940|NCT00196976|592198137|FG013|Primary Study|Withdrawal by Subject|0|||
163952941|NCT00196976|592198124|FG000|Primary Study|Lost to Follow-up|0|||
163952942|NCT00196976|592198125|FG001|Primary Study|Lost to Follow-up|0|||
163952943|NCT00196976|592198126|FG002|Primary Study|Lost to Follow-up|0|||
163952944|NCT00196976|592198127|FG003|Primary Study|Lost to Follow-up|0|||
163952945|NCT00196976|592198128|FG004|Primary Study|Lost to Follow-up|1|||
164047769|NCT05549505|592534181|FG000|Overall Study|Withdrawal by Subject|3|||
163844215|NCT00322374|591798602|FG000|Second Escalation|Study Drug Toxicity|0|||
163844216|NCT00322374|591798603|FG001|Second Escalation|Study Drug Toxicity|0|||
163844217|NCT00322374|591798604|FG002|Second Escalation|Study Drug Toxicity|1|||
163952946|NCT00196976|592198129|FG005|Primary Study|Lost to Follow-up|1|||
163952947|NCT00196976|592198130|FG006|Primary Study|Lost to Follow-up|0|||
163952948|NCT00196976|592198131|FG007|Primary Study|Lost to Follow-up|2|||
163952949|NCT00196976|592198132|FG008|Primary Study|Lost to Follow-up|0|||
163952950|NCT00196976|592198133|FG009|Primary Study|Lost to Follow-up|0|||
163844218|NCT00322374|591798605|FG003|Second Escalation|Study Drug Toxicity|0|||
163844219|NCT03382600|591798606|FG000|Overall Study|Adverse Event|3|||
163844220|NCT03382600|591798607|FG001|Overall Study|Adverse Event|3|||
163844221|NCT03382600|591798606|FG000|Overall Study|Clinical Disease Progression|2|||
163844222|NCT03382600|591798607|FG001|Overall Study|Clinical Disease Progression|4|||
163844223|NCT03382600|591798606|FG000|Overall Study|Radiological Progression|40|||
163844224|NCT03382600|591798607|FG001|Overall Study|Radiological Progression|31|||
163844225|NCT03382600|591798606|FG000|Overall Study|Withdrawal by Subject|0|||
163844226|NCT03382600|591798607|FG001|Overall Study|Withdrawal by Subject|1|||
163844227|NCT03382600|591798606|FG000|Overall Study|Other|9|||
163844228|NCT03382600|591798607|FG001|Overall Study|Other|7|||
163844229|NCT02269943|591798608|FG000|Treatment Period|Death|0|||
163844230|NCT02269943|591798609|FG001|Treatment Period|Death|1|||
163844231|NCT02269943|591798608|FG000|Treatment Period|Adverse Event|1|||
163952951|NCT00196976|592198134|FG010|Primary Study|Lost to Follow-up|0|||
163952952|NCT00196976|592198135|FG011|Primary Study|Lost to Follow-up|0|||
163952953|NCT00196976|592198136|FG012|Primary Study|Lost to Follow-up|0|||
163952954|NCT00196976|592198137|FG013|Primary Study|Lost to Follow-up|0|||
163952955|NCT00196976|592198124|FG000|Primary Study|Other|0|||
163952956|NCT00196976|592198125|FG001|Primary Study|Other|0|||
163952957|NCT00196976|592198126|FG002|Primary Study|Other|2|||
163952958|NCT00196976|592198127|FG003|Primary Study|Other|0|||
163952959|NCT00196976|592198128|FG004|Primary Study|Other|0|||
163952960|NCT00196976|592198129|FG005|Primary Study|Other|0|||
163952961|NCT00196976|592198130|FG006|Primary Study|Other|0|||
163952962|NCT00196976|592198131|FG007|Primary Study|Other|0|||
163952963|NCT00196976|592198132|FG008|Primary Study|Other|0|||
163952964|NCT00196976|592198133|FG009|Primary Study|Other|0|||
163952965|NCT00196976|592198134|FG010|Primary Study|Other|0|||
163952966|NCT00196976|592198135|FG011|Primary Study|Other|0|||
163952967|NCT00196976|592198136|FG012|Primary Study|Other|0|||
163952968|NCT00196976|592198137|FG013|Primary Study|Other|0|||
163952969|NCT00196976|592198124|FG000|Booster Study|Withdrawal by Subject|0|||
163952970|NCT00196976|592198125|FG001|Booster Study|Withdrawal by Subject|0|||
163952971|NCT00196976|592198126|FG002|Booster Study|Withdrawal by Subject|0|||
163952972|NCT00196976|592198127|FG003|Booster Study|Withdrawal by Subject|0|||
163952973|NCT00196976|592198128|FG004|Booster Study|Withdrawal by Subject|0|||
163952974|NCT00196976|592198129|FG005|Booster Study|Withdrawal by Subject|0|||
163952975|NCT00196976|592198130|FG006|Booster Study|Withdrawal by Subject|0|||
163952976|NCT00196976|592198131|FG007|Booster Study|Withdrawal by Subject|0|||
163952977|NCT00196976|592198132|FG008|Booster Study|Withdrawal by Subject|0|||
163952978|NCT00196976|592198133|FG009|Booster Study|Withdrawal by Subject|0|||
163952979|NCT00196976|592198134|FG010|Booster Study|Withdrawal by Subject|1|||
163952980|NCT00196976|592198135|FG011|Booster Study|Withdrawal by Subject|0|||
163952981|NCT00196976|592198136|FG012|Booster Study|Withdrawal by Subject|0|||
163952982|NCT00196976|592198137|FG013|Booster Study|Withdrawal by Subject|0|||
163952983|NCT00196976|592198124|FG000|Booster Study|Lost to Follow-up|0|||
163952984|NCT00196976|592198125|FG001|Booster Study|Lost to Follow-up|0|||
163952985|NCT00196976|592198126|FG002|Booster Study|Lost to Follow-up|0|||
163952986|NCT00196976|592198127|FG003|Booster Study|Lost to Follow-up|0|||
163952987|NCT00196976|592198128|FG004|Booster Study|Lost to Follow-up|0|||
163952988|NCT00196976|592198129|FG005|Booster Study|Lost to Follow-up|0|||
163952989|NCT00196976|592198130|FG006|Booster Study|Lost to Follow-up|0|||
163952990|NCT00196976|592198131|FG007|Booster Study|Lost to Follow-up|0|||
163952991|NCT00196976|592198132|FG008|Booster Study|Lost to Follow-up|0|||
163952992|NCT00196976|592198133|FG009|Booster Study|Lost to Follow-up|0|||
163952993|NCT00196976|592198134|FG010|Booster Study|Lost to Follow-up|1|||
163844232|NCT02269943|591798609|FG001|Treatment Period|Adverse Event|10|||
163844233|NCT02269943|591798608|FG000|Treatment Period|Progressive Disease|5|||
163844234|NCT02269943|591798609|FG001|Treatment Period|Progressive Disease|17|||
163844235|NCT02269943|591798608|FG000|Treatment Period|Symptomatic Deterioration|0|||
163952994|NCT00196976|592198135|FG011|Booster Study|Lost to Follow-up|2|||
163952995|NCT00196976|592198136|FG012|Booster Study|Lost to Follow-up|0|||
163952996|NCT00196976|592198137|FG013|Booster Study|Lost to Follow-up|0|||
163952997|NCT01535560|592198138|FG000|Overall Study|Adverse Event|12|||
163952998|NCT01535560|592198139|FG001|Overall Study|Adverse Event|7|||
163952999|NCT01535560|592198138|FG000|Overall Study|Lost to Follow-up|1|||
163953000|NCT01535560|592198139|FG001|Overall Study|Lost to Follow-up|3|||
163953001|NCT01535560|592198138|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
163953002|NCT01535560|592198139|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
163953003|NCT01535560|592198138|FG000|Overall Study|Treatment Failure|21|||
163844236|NCT02269943|591798609|FG001|Treatment Period|Symptomatic Deterioration|2|||
163844237|NCT02269943|591798608|FG000|Follow-Up Survival Period|Death|3|||
163844238|NCT02269943|591798609|FG001|Follow-Up Survival Period|Death|16|||
163844239|NCT02269943|591798608|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
163844240|NCT02269943|591798609|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
163844241|NCT02269943|591798608|FG000|Follow-Up Survival Period|Alive|2|||
163844242|NCT02269943|591798609|FG001|Follow-Up Survival Period|Alive|8|||
163844243|NCT04642469|591798610|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
163844244|NCT04642469|591798611|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
163844245|NCT04642469|591798610|FG000|Overall Study|Death|1|||
163844246|NCT04642469|591798611|FG001|Overall Study|Death|2|||
163844247|NCT04642469|591798610|FG000|Overall Study|Study/site closed following amendment 1|11|||
163844248|NCT04642469|591798611|FG001|Overall Study|Study/site closed following amendment 1|11|||
163844249|NCT04642469|591798610|FG000|Overall Study|Other|1|||
163844250|NCT04642469|591798611|FG001|Overall Study|Other|1|||
163844251|NCT04642469|591798610|FG000|Overall Study|Withdrawal by Subject|1|||
163953004|NCT01535560|592198139|FG001|Overall Study|Treatment Failure|83|||
163953005|NCT01535560|592198138|FG000|Overall Study|Other|0|||
163844252|NCT04642469|591798611|FG001|Overall Study|Withdrawal by Subject|0|||
163844253|NCT02733042|591798612|FG000|Overall Study|Adverse Event|1|||
163844254|NCT02733042|591798613|FG001|Overall Study|Adverse Event|0|||
163953006|NCT01535560|592198139|FG001|Overall Study|Other|1|||
163953007|NCT01535560|592198138|FG000|Overall Study|Randomized in Error|0|||
163953008|NCT01535560|592198139|FG001|Overall Study|Randomized in Error|1|||
163953009|NCT02009761|592198140|FG000|Overall Study|Adverse Event|4|||
163844255|NCT02733042|591798614|FG002|Overall Study|Adverse Event|1|||
163844256|NCT02733042|591798615|FG003|Overall Study|Adverse Event|1|||
163844257|NCT02733042|591798616|FG004|Overall Study|Adverse Event|0|||
163844258|NCT02733042|591798617|FG005|Overall Study|Adverse Event|0|||
163844259|NCT02733042|591798618|FG006|Overall Study|Adverse Event|0|||
163844260|NCT02733042|591798619|FG007|Overall Study|Adverse Event|0|||
163844261|NCT02733042|591798620|FG008|Overall Study|Adverse Event|0|||
163844262|NCT02733042|591798621|FG009|Overall Study|Adverse Event|0|||
163953010|NCT00825825|592198143|FG000|First Medication Period (14 Days)|Adverse Event|1|||
163953011|NCT00825825|592198144|FG001|First Medication Period (14 Days)|Adverse Event|0|||
163953012|NCT00825825|592198145|FG002|First Medication Period (14 Days)|Adverse Event|0|||
163953013|NCT00825825|592198146|FG003|First Medication Period (14 Days)|Adverse Event|0|||
163953014|NCT00825825|592198147|FG004|First Medication Period (14 Days)|Adverse Event|0|||
163953015|NCT00825825|592198148|FG005|First Medication Period (14 Days)|Adverse Event|1|||
163953016|NCT00825825|592198143|FG000|First Medication Period (14 Days)|Physician Decision|2|||
163953017|NCT00825825|592198144|FG001|First Medication Period (14 Days)|Physician Decision|0|||
163953018|NCT00825825|592198145|FG002|First Medication Period (14 Days)|Physician Decision|1|||
163953019|NCT00825825|592198146|FG003|First Medication Period (14 Days)|Physician Decision|0|||
163953020|NCT00825825|592198147|FG004|First Medication Period (14 Days)|Physician Decision|0|||
163953021|NCT00825825|592198148|FG005|First Medication Period (14 Days)|Physician Decision|1|||
163953022|NCT00825825|592198143|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
163953023|NCT00825825|592198144|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
163953024|NCT00825825|592198145|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
163953025|NCT00825825|592198146|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
163953026|NCT00825825|592198147|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
163953027|NCT00825825|592198148|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
163953028|NCT00825825|592198143|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
163953029|NCT00825825|592198144|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
163953030|NCT00825825|592198145|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
163953031|NCT00825825|592198146|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
163953032|NCT00825825|592198147|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
163953033|NCT00825825|592198148|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
163953034|NCT00825825|592198143|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
163953035|NCT00825825|592198144|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
163953036|NCT00825825|592198145|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
163953037|NCT00825825|592198146|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
163953038|NCT00825825|592198147|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
163953039|NCT00825825|592198148|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
163953040|NCT00825825|592198143|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
163953041|NCT00825825|592198144|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
164047770|NCT05549505|592534182|FG001|Overall Study|Withdrawal by Subject|3|||
163844263|NCT02733042|591798622|FG010|Overall Study|Adverse Event|2|||
163844264|NCT02733042|591798623|FG011|Overall Study|Adverse Event|2|||
163844265|NCT02733042|591798624|FG012|Overall Study|Adverse Event|0|||
163844266|NCT02733042|591798625|FG013|Overall Study|Adverse Event|2|||
163844267|NCT02733042|591798626|FG014|Overall Study|Adverse Event|0|||
163844268|NCT02733042|591798627|FG015|Overall Study|Adverse Event|0|||
163844269|NCT02733042|591798628|FG016|Overall Study|Adverse Event|0|||
163953042|NCT00825825|592198145|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
163953043|NCT00825825|592198146|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
163953044|NCT00825825|592198147|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
163953045|NCT00825825|592198148|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
163953046|NCT00825825|592198143|FG000|Third Medication Period (14 Days)|poor data quality|0|||
163953047|NCT00825825|592198144|FG001|Third Medication Period (14 Days)|poor data quality|1|||
163953048|NCT00825825|592198145|FG002|Third Medication Period (14 Days)|poor data quality|0|||
163953049|NCT00825825|592198146|FG003|Third Medication Period (14 Days)|poor data quality|0|||
163953050|NCT00825825|592198147|FG004|Third Medication Period (14 Days)|poor data quality|0|||
163953051|NCT00825825|592198148|FG005|Third Medication Period (14 Days)|poor data quality|0|||
163953052|NCT02649946|592198154|FG000|Overall Study|Withdrawal by Subject|1|||
163953053|NCT02649946|592198155|FG001|Overall Study|Withdrawal by Subject|1|||
163953054|NCT02649946|592198154|FG000|Overall Study|Death|7|||
163953055|NCT02649946|592198155|FG001|Overall Study|Death|9|||
163953056|NCT02649946|592198154|FG000|Overall Study|Physician Decision|1|||
163953057|NCT02649946|592198155|FG001|Overall Study|Physician Decision|0|||
163953058|NCT02649946|592198154|FG000|Overall Study|Lost to Follow-up|2|||
163953059|NCT02649946|592198155|FG001|Overall Study|Lost to Follow-up|1|||
163953060|NCT02649946|592198154|FG000|Overall Study|Erroneously enrolled|1|||
163953061|NCT02649946|592198155|FG001|Overall Study|Erroneously enrolled|0|||
163953062|NCT02649946|592198154|FG000|Overall Study|Missed 6-month follow-up visit|0|||
163953063|NCT02649946|592198155|FG001|Overall Study|Missed 6-month follow-up visit|4|||
163953064|NCT01178385|592198156|FG000|Overall Study|Withdrawal by Subject|2|||
163953065|NCT01178385|592198157|FG001|Overall Study|Withdrawal by Subject|0|||
163953066|NCT00985946|592198158|FG000|Overall Study|Lost to Follow-up|6|||
163953067|NCT00985946|592198158|FG000|Overall Study|Withdrawal by Subject|1|||
163953068|NCT02008877|592198174|FG000|Overall Study|Inevaluable|0|||
163953069|NCT02008877|592198175|FG001|Overall Study|Inevaluable|1|||
163953070|NCT02008877|592198176|FG002|Overall Study|Inevaluable|0|||
163953071|NCT05000931|592198192|FG000|Overall Study|Lost to Follow-up|1|||
163953072|NCT05172050|592198193|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
163953073|NCT05172050|592198194|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
163953074|NCT05172050|592198195|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
163953075|NCT05172050|592198193|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
163953076|NCT05172050|592198194|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
163953077|NCT05172050|592198195|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
163953078|NCT05172050|592198193|FG000|Overall Study|Other|2|||
163953079|NCT05172050|592198194|FG001|Overall Study|Other|2|||
163953080|NCT05172050|592198195|FG002|Overall Study|Other|1|||
163953081|NCT04617275|592198200|FG000|Treatment Period|Adverse Event|1|||
163953082|NCT04617275|592198201|FG001|Treatment Period|Adverse Event|6|||
163953083|NCT04617275|592198202|FG002|Treatment Period|Adverse Event|4|||
163953084|NCT04617275|592198203|FG003|Treatment Period|Adverse Event|6|||
163953085|NCT04617275|592198204|FG004|Treatment Period|Adverse Event|7|||
163953086|NCT04617275|592198205|FG005|Treatment Period|Adverse Event|8|||
163953087|NCT04617275|592198206|FG006|Treatment Period|Adverse Event|0|||
163953088|NCT04617275|592198207|FG007|Treatment Period|Adverse Event|12|||
163953089|NCT04617275|592198200|FG000|Treatment Period|Lost to Follow-up|0|||
163953090|NCT04617275|592198201|FG001|Treatment Period|Lost to Follow-up|0|||
163953091|NCT04617275|592198202|FG002|Treatment Period|Lost to Follow-up|2|||
163953092|NCT04617275|592198203|FG003|Treatment Period|Lost to Follow-up|0|||
163953093|NCT04617275|592198204|FG004|Treatment Period|Lost to Follow-up|0|||
163953094|NCT04617275|592198205|FG005|Treatment Period|Lost to Follow-up|3|||
163953095|NCT04617275|592198206|FG006|Treatment Period|Lost to Follow-up|0|||
163953096|NCT04617275|592198207|FG007|Treatment Period|Lost to Follow-up|2|||
163953097|NCT04617275|592198200|FG000|Treatment Period|No longer meets eligibility criteria|0|||
163953098|NCT04617275|592198201|FG001|Treatment Period|No longer meets eligibility criteria|0|||
163953099|NCT04617275|592198202|FG002|Treatment Period|No longer meets eligibility criteria|0|||
163953100|NCT04617275|592198203|FG003|Treatment Period|No longer meets eligibility criteria|1|||
163953101|NCT04617275|592198204|FG004|Treatment Period|No longer meets eligibility criteria|0|||
163953102|NCT04617275|592198205|FG005|Treatment Period|No longer meets eligibility criteria|0|||
163953103|NCT04617275|592198206|FG006|Treatment Period|No longer meets eligibility criteria|0|||
163953104|NCT04617275|592198207|FG007|Treatment Period|No longer meets eligibility criteria|0|||
163953105|NCT04617275|592198200|FG000|Treatment Period|Other|0|||
163953106|NCT04617275|592198201|FG001|Treatment Period|Other|1|||
163953107|NCT04617275|592198202|FG002|Treatment Period|Other|0|||
163953108|NCT04617275|592198203|FG003|Treatment Period|Other|0|||
163953109|NCT04617275|592198204|FG004|Treatment Period|Other|0|||
163953110|NCT04617275|592198205|FG005|Treatment Period|Other|0|||
163953111|NCT04617275|592198206|FG006|Treatment Period|Other|0|||
163953112|NCT04617275|592198207|FG007|Treatment Period|Other|0|||
163953113|NCT04617275|592198200|FG000|Treatment Period|Withdrawal by Subject|2|||
163953114|NCT04617275|592198201|FG001|Treatment Period|Withdrawal by Subject|0|||
163953115|NCT04617275|592198202|FG002|Treatment Period|Withdrawal by Subject|0|||
163953116|NCT04617275|592198203|FG003|Treatment Period|Withdrawal by Subject|2|||
163953117|NCT04617275|592198204|FG004|Treatment Period|Withdrawal by Subject|2|||
163953118|NCT04617275|592198205|FG005|Treatment Period|Withdrawal by Subject|0|||
163953119|NCT04617275|592198206|FG006|Treatment Period|Withdrawal by Subject|1|||
163953120|NCT04617275|592198207|FG007|Treatment Period|Withdrawal by Subject|2|||
163953121|NCT04617275|592198200|FG000|Follow-up Period|Adverse Event|1|||
163953122|NCT04617275|592198201|FG001|Follow-up Period|Adverse Event|1|||
163953123|NCT04617275|592198202|FG002|Follow-up Period|Adverse Event|2|||
163953124|NCT04617275|592198203|FG003|Follow-up Period|Adverse Event|3|||
163953125|NCT04617275|592198204|FG004|Follow-up Period|Adverse Event|4|||
163953126|NCT04617275|592198205|FG005|Follow-up Period|Adverse Event|3|||
163953127|NCT04617275|592198206|FG006|Follow-up Period|Adverse Event|0|||
163953128|NCT04617275|592198207|FG007|Follow-up Period|Adverse Event|3|||
163953129|NCT04617275|592198200|FG000|Follow-up Period|Lost to Follow-up|0|||
163953130|NCT04617275|592198201|FG001|Follow-up Period|Lost to Follow-up|1|||
163953131|NCT04617275|592198202|FG002|Follow-up Period|Lost to Follow-up|2|||
163953132|NCT04617275|592198203|FG003|Follow-up Period|Lost to Follow-up|0|||
163953133|NCT04617275|592198204|FG004|Follow-up Period|Lost to Follow-up|0|||
163953134|NCT04617275|592198205|FG005|Follow-up Period|Lost to Follow-up|4|||
163953135|NCT04617275|592198206|FG006|Follow-up Period|Lost to Follow-up|0|||
163953136|NCT04617275|592198207|FG007|Follow-up Period|Lost to Follow-up|3|||
163953137|NCT04617275|592198200|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
163953138|NCT04617275|592198201|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
163953139|NCT04617275|592198202|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
163953140|NCT04617275|592198203|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
163953141|NCT04617275|592198204|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
163953142|NCT04617275|592198205|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
163953143|NCT04617275|592198206|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
163953144|NCT04617275|592198207|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
163953145|NCT04617275|592198200|FG000|Follow-up Period|Other|0|||
163953146|NCT04617275|592198201|FG001|Follow-up Period|Other|1|||
163953147|NCT04617275|592198202|FG002|Follow-up Period|Other|0|||
163953148|NCT04617275|592198203|FG003|Follow-up Period|Other|0|||
163953149|NCT04617275|592198204|FG004|Follow-up Period|Other|0|||
163953150|NCT04617275|592198205|FG005|Follow-up Period|Other|0|||
163953151|NCT04617275|592198206|FG006|Follow-up Period|Other|0|||
163953152|NCT04617275|592198207|FG007|Follow-up Period|Other|0|||
163953153|NCT04617275|592198200|FG000|Follow-up Period|Withdrawal by Subject|2|||
163953154|NCT04617275|592198201|FG001|Follow-up Period|Withdrawal by Subject|0|||
163953155|NCT04617275|592198202|FG002|Follow-up Period|Withdrawal by Subject|0|||
163953156|NCT04617275|592198203|FG003|Follow-up Period|Withdrawal by Subject|2|||
163953157|NCT04617275|592198204|FG004|Follow-up Period|Withdrawal by Subject|2|||
163953158|NCT04617275|592198205|FG005|Follow-up Period|Withdrawal by Subject|0|||
163953159|NCT04617275|592198206|FG006|Follow-up Period|Withdrawal by Subject|1|||
163953160|NCT04617275|592198207|FG007|Follow-up Period|Withdrawal by Subject|2|||
163953161|NCT04227704|592198208|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
163953162|NCT04227704|592198209|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
163953163|NCT04227704|592198210|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
163953164|NCT04227704|592198208|FG000|Overall Study|due to C/S being cancelled|1|||
163953165|NCT04227704|592198209|FG001|Overall Study|due to C/S being cancelled|0|||
163953166|NCT04227704|592198210|FG002|Overall Study|due to C/S being cancelled|0|||
163953167|NCT00192647|592200600|FG000|Overall Study|Death|1|||
163953168|NCT00192647|592200601|FG001|Overall Study|Death|1|||
163953169|NCT00192647|592200600|FG000|Overall Study|Adverse Event|35|||
163953170|NCT00192647|592200601|FG001|Overall Study|Adverse Event|29|||
163953171|NCT00192647|592200600|FG000|Overall Study|Laboratory Test Abnormality|4|||
163953172|NCT00192647|592200601|FG001|Overall Study|Laboratory Test Abnormality|2|||
163953173|NCT00192647|592200600|FG000|Overall Study|Insufficient Therapeutic Response|53|||
163953174|NCT00192647|592200601|FG001|Overall Study|Insufficient Therapeutic Response|83|||
163953175|NCT00192647|592200600|FG000|Overall Study|Entry Criteria Violation|6|||
163953176|NCT00192647|592200601|FG001|Overall Study|Entry Criteria Violation|6|||
163953177|NCT00192647|592200600|FG000|Overall Study|Protocol Violation|3|||
163953178|NCT00192647|592200601|FG001|Overall Study|Protocol Violation|1|||
163953179|NCT00192647|592200600|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
163953180|NCT00192647|592200601|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
163953181|NCT00192647|592200600|FG000|Overall Study|Failure to Return|11|||
163953182|NCT00192647|592200601|FG001|Overall Study|Failure to Return|13|||
163953183|NCT00192647|592200600|FG000|Overall Study|Other/Administrative|5|||
163953184|NCT00192647|592200601|FG001|Overall Study|Other/Administrative|3|||
163953185|NCT01765192|592200606|FG000|Treatment Period 1|Adverse Event|0|||
163953186|NCT01765192|592200607|FG001|Treatment Period 1|Adverse Event|1|||
163953187|NCT01765192|592200606|FG000|Washout Period|Voluntary Withdrawal|1|||
163953188|NCT01765192|592200607|FG001|Washout Period|Voluntary Withdrawal|1|||
163953189|NCT01765192|592200606|FG000|Washout Period|Reason not specified|1|||
163953190|NCT01765192|592200607|FG001|Washout Period|Reason not specified|0|||
163953191|NCT01765192|592200606|FG000|Treatment Period 2|Reason not specified|0|||
163953192|NCT01765192|592200607|FG001|Treatment Period 2|Reason not specified|2|||
164099720|NCT02100228|592730565|FG001|Overall Study|Non-compliance|3|||
163953193|NCT01765192|592200606|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
163953194|NCT01765192|592200607|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
163953195|NCT01016977|592200610|FG000|Overall Study|Lost to Follow-up|1|||
163953196|NCT01016977|592200611|FG001|Overall Study|Lost to Follow-up|0|||
163953197|NCT01016977|592200610|FG000|Overall Study|Withdrawal by Subject|2|||
163953198|NCT01016977|592200611|FG001|Overall Study|Withdrawal by Subject|2|||
163953199|NCT03184870|592200617|FG000|Initial Treatment|Death|6|||
163953200|NCT03184870|592200618|FG001|Initial Treatment|Death|6|||
163953201|NCT03184870|592200619|FG002|Initial Treatment|Death|8|||
163953202|NCT03184870|592200620|FG003|Initial Treatment|Death|8|||
163953203|NCT03184870|592200621|FG004|Initial Treatment|Death|6|||
163953204|NCT03184870|592200622|FG005|Initial Treatment|Death|6|||
163953205|NCT03184870|592200623|FG006|Initial Treatment|Death|6|||
163953206|NCT03184870|592200624|FG007|Initial Treatment|Death|7|||
163953207|NCT03184870|592200625|FG008|Initial Treatment|Death|1|||
163953208|NCT03184870|592200626|FG009|Initial Treatment|Death|2|||
163953209|NCT03184870|592200627|FG010|Initial Treatment|Death|26|||
163953210|NCT03184870|592200628|FG011|Initial Treatment|Death|28|||
163953211|NCT03184870|592200629|FG012|Initial Treatment|Death|10|||
163953212|NCT03184870|592200630|FG013|Initial Treatment|Death|33|||
163953213|NCT03184870|592200631|FG014|Initial Treatment|Death|34|||
163953214|NCT03184870|592200632|FG015|Initial Treatment|Death|26|||
163953215|NCT03184870|592200633|FG016|Initial Treatment|Death|20|||
163953216|NCT03184870|592200634|FG017|Initial Treatment|Death|18|||
163953217|NCT03184870|592200617|FG000|Initial Treatment|Other Reasons|2|||
163953218|NCT03184870|592200618|FG001|Initial Treatment|Other Reasons|2|||
163953219|NCT03184870|592200619|FG002|Initial Treatment|Other Reasons|0|||
163953220|NCT03184870|592200620|FG003|Initial Treatment|Other Reasons|1|||
163953221|NCT03184870|592200621|FG004|Initial Treatment|Other Reasons|0|||
163953222|NCT03184870|592200622|FG005|Initial Treatment|Other Reasons|0|||
163953223|NCT03184870|592200623|FG006|Initial Treatment|Other Reasons|0|||
163953224|NCT03184870|592200624|FG007|Initial Treatment|Other Reasons|2|||
163953225|NCT03184870|592200625|FG008|Initial Treatment|Other Reasons|0|||
163953226|NCT03184870|592200626|FG009|Initial Treatment|Other Reasons|0|||
163953227|NCT03184870|592200627|FG010|Initial Treatment|Other Reasons|4|||
163953228|NCT03184870|592200628|FG011|Initial Treatment|Other Reasons|2|||
163953229|NCT03184870|592200629|FG012|Initial Treatment|Other Reasons|2|||
163953230|NCT03184870|592200630|FG013|Initial Treatment|Other Reasons|0|||
163953231|NCT03184870|592200631|FG014|Initial Treatment|Other Reasons|0|||
163953232|NCT03184870|592200632|FG015|Initial Treatment|Other Reasons|1|||
163953233|NCT03184870|592200633|FG016|Initial Treatment|Other Reasons|0|||
163953234|NCT03184870|592200634|FG017|Initial Treatment|Other Reasons|2|||
163953235|NCT03184870|592200617|FG000|Initial Treatment|Lost to Follow-up|2|||
163953236|NCT03184870|592200618|FG001|Initial Treatment|Lost to Follow-up|0|||
163953237|NCT03184870|592200619|FG002|Initial Treatment|Lost to Follow-up|0|||
163953238|NCT03184870|592200620|FG003|Initial Treatment|Lost to Follow-up|1|||
163953239|NCT03184870|592200621|FG004|Initial Treatment|Lost to Follow-up|1|||
163953240|NCT03184870|592200622|FG005|Initial Treatment|Lost to Follow-up|1|||
163953241|NCT03184870|592200623|FG006|Initial Treatment|Lost to Follow-up|0|||
163953242|NCT03184870|592200624|FG007|Initial Treatment|Lost to Follow-up|2|||
163953243|NCT03184870|592200625|FG008|Initial Treatment|Lost to Follow-up|0|||
163953244|NCT03184870|592200626|FG009|Initial Treatment|Lost to Follow-up|0|||
163953245|NCT03184870|592200627|FG010|Initial Treatment|Lost to Follow-up|2|||
163953246|NCT03184870|592200628|FG011|Initial Treatment|Lost to Follow-up|0|||
163953247|NCT03184870|592200629|FG012|Initial Treatment|Lost to Follow-up|2|||
163953248|NCT03184870|592200630|FG013|Initial Treatment|Lost to Follow-up|2|||
163953249|NCT03184870|592200631|FG014|Initial Treatment|Lost to Follow-up|0|||
163953250|NCT03184870|592200632|FG015|Initial Treatment|Lost to Follow-up|0|||
163953251|NCT03184870|592200633|FG016|Initial Treatment|Lost to Follow-up|2|||
163953252|NCT03184870|592200634|FG017|Initial Treatment|Lost to Follow-up|2|||
163953253|NCT03184870|592200617|FG000|Initial Treatment|Withdrawal by Subject|0|||
163953254|NCT03184870|592200618|FG001|Initial Treatment|Withdrawal by Subject|0|||
163953255|NCT03184870|592200619|FG002|Initial Treatment|Withdrawal by Subject|2|||
163953256|NCT03184870|592200620|FG003|Initial Treatment|Withdrawal by Subject|1|||
163953257|NCT03184870|592200621|FG004|Initial Treatment|Withdrawal by Subject|1|||
163953258|NCT03184870|592200622|FG005|Initial Treatment|Withdrawal by Subject|0|||
163953259|NCT03184870|592200623|FG006|Initial Treatment|Withdrawal by Subject|1|||
163953260|NCT03184870|592200624|FG007|Initial Treatment|Withdrawal by Subject|0|||
163953261|NCT03184870|592200625|FG008|Initial Treatment|Withdrawal by Subject|0|||
163953262|NCT03184870|592200626|FG009|Initial Treatment|Withdrawal by Subject|0|||
163953263|NCT03184870|592200627|FG010|Initial Treatment|Withdrawal by Subject|0|||
163953264|NCT03184870|592200628|FG011|Initial Treatment|Withdrawal by Subject|2|||
163953265|NCT03184870|592200629|FG012|Initial Treatment|Withdrawal by Subject|3|||
163953266|NCT03184870|592200630|FG013|Initial Treatment|Withdrawal by Subject|0|||
163953267|NCT03184870|592200631|FG014|Initial Treatment|Withdrawal by Subject|1|||
163953268|NCT03184870|592200632|FG015|Initial Treatment|Withdrawal by Subject|5|||
163953269|NCT03184870|592200633|FG016|Initial Treatment|Withdrawal by Subject|2|||
163953270|NCT03184870|592200634|FG017|Initial Treatment|Withdrawal by Subject|2|||
163953271|NCT03184870|592200617|FG000|Initial Treatment|Moved to crossover treatment|0|||
163953272|NCT03184870|592200618|FG001|Initial Treatment|Moved to crossover treatment|0|||
163953273|NCT03184870|592200619|FG002|Initial Treatment|Moved to crossover treatment|0|||
163953274|NCT03184870|592200620|FG003|Initial Treatment|Moved to crossover treatment|0|||
163953275|NCT03184870|592200621|FG004|Initial Treatment|Moved to crossover treatment|0|||
163953276|NCT03184870|592200622|FG005|Initial Treatment|Moved to crossover treatment|0|||
163953277|NCT03184870|592200623|FG006|Initial Treatment|Moved to crossover treatment|0|||
163844270|NCT02733042|591798629|FG017|Overall Study|Adverse Event|1|||
163844271|NCT02733042|591798630|FG018|Overall Study|Adverse Event|0|||
163844272|NCT02733042|591798612|FG000|Overall Study|Progressive Disease|2|||
163844273|NCT02733042|591798613|FG001|Overall Study|Progressive Disease|1|||
163844274|NCT02733042|591798614|FG002|Overall Study|Progressive Disease|3|||
163844275|NCT02733042|591798615|FG003|Overall Study|Progressive Disease|1|||
163844276|NCT02733042|591798616|FG004|Overall Study|Progressive Disease|2|||
163844277|NCT02733042|591798617|FG005|Overall Study|Progressive Disease|3|||
163844278|NCT02733042|591798618|FG006|Overall Study|Progressive Disease|0|||
163844279|NCT02733042|591798619|FG007|Overall Study|Progressive Disease|3|||
163844280|NCT02733042|591798620|FG008|Overall Study|Progressive Disease|3|||
163953278|NCT03184870|592200624|FG007|Initial Treatment|Moved to crossover treatment|0|||
163953279|NCT03184870|592200625|FG008|Initial Treatment|Moved to crossover treatment|0|||
163953280|NCT03184870|592200626|FG009|Initial Treatment|Moved to crossover treatment|0|||
163953281|NCT03184870|592200627|FG010|Initial Treatment|Moved to crossover treatment|0|||
163953282|NCT03184870|592200628|FG011|Initial Treatment|Moved to crossover treatment|0|||
163953283|NCT03184870|592200629|FG012|Initial Treatment|Moved to crossover treatment|9|||
163953284|NCT03184870|592200630|FG013|Initial Treatment|Moved to crossover treatment|0|||
163953285|NCT03184870|592200631|FG014|Initial Treatment|Moved to crossover treatment|0|||
163953286|NCT03184870|592200632|FG015|Initial Treatment|Moved to crossover treatment|0|||
163953287|NCT03184870|592200633|FG016|Initial Treatment|Moved to crossover treatment|0|||
163953288|NCT03184870|592200634|FG017|Initial Treatment|Moved to crossover treatment|0|||
163953289|NCT03184870|592200617|FG000|Crossover Treatment|Other reasons|0|||
163953290|NCT03184870|592200618|FG001|Crossover Treatment|Other reasons|0|||
163844281|NCT02733042|591798621|FG009|Overall Study|Progressive Disease|2|||
163844282|NCT02733042|591798622|FG010|Overall Study|Progressive Disease|2|||
163844283|NCT02733042|591798623|FG011|Overall Study|Progressive Disease|2|||
163844284|NCT02733042|591798624|FG012|Overall Study|Progressive Disease|8|||
163844285|NCT02733042|591798625|FG013|Overall Study|Progressive Disease|1|||
163844286|NCT02733042|591798626|FG014|Overall Study|Progressive Disease|4|||
163844287|NCT02733042|591798627|FG015|Overall Study|Progressive Disease|7|||
163844288|NCT02733042|591798628|FG016|Overall Study|Progressive Disease|2|||
163844289|NCT02733042|591798629|FG017|Overall Study|Progressive Disease|3|||
163844290|NCT02733042|591798630|FG018|Overall Study|Progressive Disease|4|||
163844291|NCT02733042|591798612|FG000|Overall Study|Withdrawal by Subject|0|||
163844292|NCT02733042|591798613|FG001|Overall Study|Withdrawal by Subject|1|||
163844293|NCT02733042|591798614|FG002|Overall Study|Withdrawal by Subject|2|||
163844294|NCT02733042|591798615|FG003|Overall Study|Withdrawal by Subject|1|||
163844295|NCT02733042|591798616|FG004|Overall Study|Withdrawal by Subject|1|||
163844296|NCT02733042|591798617|FG005|Overall Study|Withdrawal by Subject|0|||
163844297|NCT02733042|591798618|FG006|Overall Study|Withdrawal by Subject|0|||
163844298|NCT02733042|591798619|FG007|Overall Study|Withdrawal by Subject|0|||
163844299|NCT02733042|591798620|FG008|Overall Study|Withdrawal by Subject|1|||
163844300|NCT02733042|591798621|FG009|Overall Study|Withdrawal by Subject|1|||
163844301|NCT02733042|591798622|FG010|Overall Study|Withdrawal by Subject|0|||
163844302|NCT02733042|591798623|FG011|Overall Study|Withdrawal by Subject|2|||
163844303|NCT02733042|591798624|FG012|Overall Study|Withdrawal by Subject|1|||
163844304|NCT02733042|591798625|FG013|Overall Study|Withdrawal by Subject|1|||
163844305|NCT02733042|591798626|FG014|Overall Study|Withdrawal by Subject|0|||
163844306|NCT02733042|591798627|FG015|Overall Study|Withdrawal by Subject|0|||
163844307|NCT02733042|591798628|FG016|Overall Study|Withdrawal by Subject|0|||
163844308|NCT02733042|591798629|FG017|Overall Study|Withdrawal by Subject|0|||
163844309|NCT02733042|591798630|FG018|Overall Study|Withdrawal by Subject|0|||
163844310|NCT02733042|591798612|FG000|Overall Study|Other Reasons|0|||
163844311|NCT02733042|591798613|FG001|Overall Study|Other Reasons|0|||
163844312|NCT02733042|591798614|FG002|Overall Study|Other Reasons|1|||
163844313|NCT02733042|591798615|FG003|Overall Study|Other Reasons|0|||
163844314|NCT02733042|591798616|FG004|Overall Study|Other Reasons|0|||
163844315|NCT02733042|591798617|FG005|Overall Study|Other Reasons|0|||
163844316|NCT02733042|591798618|FG006|Overall Study|Other Reasons|0|||
163844317|NCT02733042|591798619|FG007|Overall Study|Other Reasons|0|||
163844318|NCT02733042|591798620|FG008|Overall Study|Other Reasons|0|||
163844319|NCT02733042|591798621|FG009|Overall Study|Other Reasons|1|||
163844320|NCT02733042|591798622|FG010|Overall Study|Other Reasons|1|||
163844321|NCT02733042|591798623|FG011|Overall Study|Other Reasons|0|||
163844322|NCT02733042|591798624|FG012|Overall Study|Other Reasons|0|||
163844323|NCT02733042|591798625|FG013|Overall Study|Other Reasons|0|||
163844324|NCT02733042|591798626|FG014|Overall Study|Other Reasons|0|||
163953291|NCT03184870|592200619|FG002|Crossover Treatment|Other reasons|0|||
163844325|NCT02733042|591798627|FG015|Overall Study|Other Reasons|1|||
163844326|NCT02733042|591798628|FG016|Overall Study|Other Reasons|0|||
163953292|NCT03184870|592200620|FG003|Crossover Treatment|Other reasons|0|||
163844327|NCT02733042|591798629|FG017|Overall Study|Other Reasons|1|||
163844328|NCT02733042|591798630|FG018|Overall Study|Other Reasons|0|||
163953293|NCT03184870|592200621|FG004|Crossover Treatment|Other reasons|0|||
163953294|NCT03184870|592200622|FG005|Crossover Treatment|Other reasons|0|||
163953295|NCT03184870|592200623|FG006|Crossover Treatment|Other reasons|0|||
163953296|NCT03184870|592200624|FG007|Crossover Treatment|Other reasons|0|||
163953297|NCT03184870|592200625|FG008|Crossover Treatment|Other reasons|0|||
163953298|NCT03184870|592200626|FG009|Crossover Treatment|Other reasons|0|||
163953299|NCT03184870|592200627|FG010|Crossover Treatment|Other reasons|0|||
163953300|NCT03184870|592200628|FG011|Crossover Treatment|Other reasons|0|||
163953301|NCT03184870|592200629|FG012|Crossover Treatment|Other reasons|0|||
163953302|NCT03184870|592200630|FG013|Crossover Treatment|Other reasons|0|||
163953303|NCT03184870|592200631|FG014|Crossover Treatment|Other reasons|0|||
163953304|NCT03184870|592200632|FG015|Crossover Treatment|Other reasons|0|||
163953305|NCT03184870|592200633|FG016|Crossover Treatment|Other reasons|0|||
163953306|NCT03184870|592200634|FG017|Crossover Treatment|Other reasons|2|||
163953307|NCT03184870|592200617|FG000|Crossover Treatment|Death|0|||
163953308|NCT03184870|592200618|FG001|Crossover Treatment|Death|0|||
163953309|NCT03184870|592200619|FG002|Crossover Treatment|Death|0|||
163953310|NCT03184870|592200620|FG003|Crossover Treatment|Death|0|||
163953311|NCT03184870|592200621|FG004|Crossover Treatment|Death|0|||
163953312|NCT03184870|592200622|FG005|Crossover Treatment|Death|0|||
163953313|NCT03184870|592200623|FG006|Crossover Treatment|Death|0|||
163953314|NCT03184870|592200624|FG007|Crossover Treatment|Death|0|||
163953315|NCT03184870|592200625|FG008|Crossover Treatment|Death|0|||
163953316|NCT03184870|592200626|FG009|Crossover Treatment|Death|0|||
163953317|NCT03184870|592200627|FG010|Crossover Treatment|Death|0|||
163844329|NCT02733042|591798612|FG000|Overall Study|Death|0|||
163844330|NCT02733042|591798613|FG001|Overall Study|Death|0|||
163844331|NCT02733042|591798614|FG002|Overall Study|Death|0|||
163844332|NCT02733042|591798615|FG003|Overall Study|Death|0|||
163844333|NCT02733042|591798616|FG004|Overall Study|Death|0|||
163844334|NCT02733042|591798617|FG005|Overall Study|Death|0|||
163844335|NCT02733042|591798618|FG006|Overall Study|Death|1|||
163953318|NCT03184870|592200628|FG011|Crossover Treatment|Death|0|||
163953319|NCT03184870|592200629|FG012|Crossover Treatment|Death|0|||
163953320|NCT03184870|592200630|FG013|Crossover Treatment|Death|0|||
163953321|NCT03184870|592200631|FG014|Crossover Treatment|Death|0|||
163953322|NCT03184870|592200632|FG015|Crossover Treatment|Death|0|||
163953323|NCT03184870|592200633|FG016|Crossover Treatment|Death|0|||
163953324|NCT03184870|592200634|FG017|Crossover Treatment|Death|7|||
163844336|NCT02733042|591798619|FG007|Overall Study|Death|0|||
163844337|NCT02733042|591798620|FG008|Overall Study|Death|1|||
163953325|NCT05081388|592200635|FG000|Overall Study|Adverse Event|1|||
163953326|NCT05081388|592200636|FG001|Overall Study|Adverse Event|0|||
163844338|NCT02733042|591798621|FG009|Overall Study|Death|0|||
163844339|NCT02733042|591798622|FG010|Overall Study|Death|1|||
163844340|NCT02733042|591798623|FG011|Overall Study|Death|0|||
163844341|NCT02733042|591798624|FG012|Overall Study|Death|0|||
163844342|NCT02733042|591798625|FG013|Overall Study|Death|0|||
163844343|NCT02733042|591798626|FG014|Overall Study|Death|1|||
163953327|NCT05081388|592200637|FG002|Overall Study|Adverse Event|0|||
163953328|NCT05081388|592200638|FG003|Overall Study|Adverse Event|0|||
163953329|NCT05081388|592200639|FG004|Overall Study|Adverse Event|0|||
163953330|NCT05081388|592200635|FG000|Overall Study|Lost to Follow-up|0|||
163953331|NCT05081388|592200636|FG001|Overall Study|Lost to Follow-up|1|||
163844344|NCT02733042|591798627|FG015|Overall Study|Death|2|||
163844345|NCT02733042|591798628|FG016|Overall Study|Death|0|||
163844346|NCT02733042|591798629|FG017|Overall Study|Death|0|||
163844347|NCT02733042|591798630|FG018|Overall Study|Death|0|||
163844348|NCT01088529|591798632|FG000|Overall Study|Did not receive study treatment|0|||
163844349|NCT01088529|591798633|FG001|Overall Study|Did not receive study treatment|1|||
163844350|NCT02838628|591798635|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
163844351|NCT02838628|591798636|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
163844352|NCT02838628|591798635|FG000|Recurrence Follow-up Period|Adverse Event|1|||
163844353|NCT02838628|591798636|FG001|Recurrence Follow-up Period|Adverse Event|0|||
163844354|NCT02838628|591798635|FG000|Recurrence Follow-up Period|Non-compliance|0|||
163844355|NCT02838628|591798636|FG001|Recurrence Follow-up Period|Non-compliance|1|||
163844356|NCT02838628|591798635|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
163953332|NCT05081388|592200637|FG002|Overall Study|Lost to Follow-up|0|||
163953333|NCT05081388|592200638|FG003|Overall Study|Lost to Follow-up|0|||
163953334|NCT05081388|592200639|FG004|Overall Study|Lost to Follow-up|0|||
163953335|NCT05081388|592200635|FG000|Overall Study|Subject decision|0|||
163953336|NCT05081388|592200636|FG001|Overall Study|Subject decision|0|||
163953337|NCT05081388|592200637|FG002|Overall Study|Subject decision|0|||
163953338|NCT05081388|592200638|FG003|Overall Study|Subject decision|1|||
163953339|NCT05081388|592200639|FG004|Overall Study|Subject decision|0|||
163844357|NCT02838628|591798636|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
163844358|NCT02838628|591798635|FG000|Recurrence Follow-up Period|Other un-specified|1|||
163844359|NCT02838628|591798636|FG001|Recurrence Follow-up Period|Other un-specified|1|||
163953340|NCT00346632|592200644|FG000|Overall Study|Progressive Disease|2|||
163953341|NCT00346632|592200645|FG001|Overall Study|Progressive Disease|2|||
163844360|NCT02066532|591798640|FG000|Phase II|Withdrawal by Subject|1|||
163844361|NCT02066532|591798641|FG001|Phase II|Withdrawal by Subject|0|||
163844362|NCT02066532|591798642|FG002|Phase II|Withdrawal by Subject|0|||
163844363|NCT02066532|591798643|FG003|Phase II|Withdrawal by Subject|0|||
163844364|NCT02303626|591798644|FG000|Overall Study|Lack of Efficacy|1|||
163844365|NCT02303626|591798645|FG001|Overall Study|Lack of Efficacy|0|||
163844366|NCT02303626|591798646|FG002|Overall Study|Lack of Efficacy|1|||
163844367|NCT02303626|591798644|FG000|Overall Study|Adverse Event|0|||
163844368|NCT02303626|591798645|FG001|Overall Study|Adverse Event|2|||
163844369|NCT02303626|591798646|FG002|Overall Study|Adverse Event|0|||
163844370|NCT02303626|591798644|FG000|Overall Study|Protocol Violation|0|||
163844371|NCT02303626|591798645|FG001|Overall Study|Protocol Violation|1|||
163844372|NCT02303626|591798646|FG002|Overall Study|Protocol Violation|0|||
163844373|NCT02303626|591798644|FG000|Overall Study|Pregnancy|0|||
163844374|NCT02303626|591798645|FG001|Overall Study|Pregnancy|0|||
163844375|NCT02303626|591798646|FG002|Overall Study|Pregnancy|1|||
163844376|NCT02303626|591798644|FG000|Overall Study|Subject Non-Compliance|0|||
163844377|NCT02303626|591798645|FG001|Overall Study|Subject Non-Compliance|0|||
163844378|NCT02303626|591798646|FG002|Overall Study|Subject Non-Compliance|1|||
163844379|NCT05832437|591798647|FG000|Overall Study|time off work|1|||
163844380|NCT05832437|591798648|FG001|Overall Study|time off work|0|||
163844381|NCT05832437|591798649|FG002|Overall Study|time off work|0|||
163844382|NCT05832437|591798650|FG003|Overall Study|time off work|0|||
163844383|NCT00337662|591798651|FG000|Study Period II|Lost to Follow-up|0|||
163844384|NCT00337662|591798652|FG001|Study Period II|Lost to Follow-up|0|||
163844385|NCT00337662|591798653|FG002|Study Period II|Lost to Follow-up|0|||
163844386|NCT00337662|591798654|FG003|Study Period II|Lost to Follow-up|35|||
163844387|NCT00337662|591798651|FG000|Study Period II|Withdrawal by Subject|0|||
163844388|NCT00337662|591798652|FG001|Study Period II|Withdrawal by Subject|0|||
163844389|NCT00337662|591798653|FG002|Study Period II|Withdrawal by Subject|0|||
163844390|NCT00337662|591798654|FG003|Study Period II|Withdrawal by Subject|20|||
163844391|NCT00337662|591798651|FG000|Study Period II|Adverse Event|0|||
163844392|NCT00337662|591798652|FG001|Study Period II|Adverse Event|0|||
163844393|NCT00337662|591798653|FG002|Study Period II|Adverse Event|0|||
163844394|NCT00337662|591798654|FG003|Study Period II|Adverse Event|16|||
163844395|NCT00337662|591798651|FG000|Study Period II|Physician Decision|0|||
163844396|NCT00337662|591798652|FG001|Study Period II|Physician Decision|0|||
163844397|NCT00337662|591798653|FG002|Study Period II|Physician Decision|0|||
163844398|NCT00337662|591798654|FG003|Study Period II|Physician Decision|13|||
163844399|NCT00337662|591798651|FG000|Study Period II|Entry Criteria Not Met|0|||
163844400|NCT00337662|591798652|FG001|Study Period II|Entry Criteria Not Met|0|||
163844401|NCT00337662|591798653|FG002|Study Period II|Entry Criteria Not Met|0|||
163844402|NCT00337662|591798654|FG003|Study Period II|Entry Criteria Not Met|6|||
163844403|NCT00337662|591798651|FG000|Study Period II|Protocol Violation|0|||
163844404|NCT00337662|591798652|FG001|Study Period II|Protocol Violation|0|||
163844405|NCT00337662|591798653|FG002|Study Period II|Protocol Violation|0|||
163844406|NCT00337662|591798654|FG003|Study Period II|Protocol Violation|6|||
163844407|NCT00337662|591798651|FG000|Study Period II|Lack of Efficacy|0|||
163844408|NCT00337662|591798652|FG001|Study Period II|Lack of Efficacy|0|||
163844409|NCT00337662|591798653|FG002|Study Period II|Lack of Efficacy|0|||
163844410|NCT00337662|591798654|FG003|Study Period II|Lack of Efficacy|7|||
163844411|NCT00337662|591798651|FG000|Study Period II|Sponsor Decision|0|||
163844412|NCT00337662|591798652|FG001|Study Period II|Sponsor Decision|0|||
163844413|NCT00337662|591798653|FG002|Study Period II|Sponsor Decision|0|||
163953342|NCT00346632|592200646|FG002|Overall Study|Progressive Disease|4|||
163953343|NCT00346632|592200647|FG003|Overall Study|Progressive Disease|3|||
163953344|NCT00346632|592200648|FG004|Overall Study|Progressive Disease|3|||
163844414|NCT00337662|591798654|FG003|Study Period II|Sponsor Decision|2|||
163844415|NCT00337662|591798651|FG000|Study Period II|Parent/Caregiver Decision|0|||
163844416|NCT00337662|591798652|FG001|Study Period II|Parent/Caregiver Decision|0|||
163844417|NCT00337662|591798653|FG002|Study Period II|Parent/Caregiver Decision|0|||
163844418|NCT00337662|591798654|FG003|Study Period II|Parent/Caregiver Decision|1|||
163844419|NCT00337662|591798651|FG000|Study Period III|Lost to Follow-up|14|||
163844420|NCT00337662|591798652|FG001|Study Period III|Lost to Follow-up|16|||
163844421|NCT00337662|591798653|FG002|Study Period III|Lost to Follow-up|14|||
163844422|NCT00337662|591798654|FG003|Study Period III|Lost to Follow-up|0|||
163844423|NCT00337662|591798651|FG000|Study Period III|Withdrawal by Subject|18|||
163844424|NCT00337662|591798652|FG001|Study Period III|Withdrawal by Subject|14|||
163844425|NCT00337662|591798653|FG002|Study Period III|Withdrawal by Subject|12|||
163844426|NCT00337662|591798654|FG003|Study Period III|Withdrawal by Subject|0|||
163844427|NCT00337662|591798651|FG000|Study Period III|Adverse Event|9|||
163953345|NCT00346632|592200649|FG005|Overall Study|Progressive Disease|1|||
163953346|NCT00346632|592200650|FG006|Overall Study|Progressive Disease|2|||
163953347|NCT00346632|592200651|FG007|Overall Study|Progressive Disease|2|||
163844428|NCT00337662|591798652|FG001|Study Period III|Adverse Event|10|||
163844429|NCT00337662|591798653|FG002|Study Period III|Adverse Event|8|||
163844430|NCT00337662|591798654|FG003|Study Period III|Adverse Event|0|||
163844431|NCT00337662|591798651|FG000|Study Period III|Protocol Violation|3|||
163953348|NCT00346632|592200652|FG008|Overall Study|Progressive Disease|2|||
163844432|NCT00337662|591798652|FG001|Study Period III|Protocol Violation|8|||
163844433|NCT00337662|591798653|FG002|Study Period III|Protocol Violation|2|||
163844434|NCT00337662|591798654|FG003|Study Period III|Protocol Violation|0|||
163844435|NCT00337662|591798651|FG000|Study Period III|Physician Decision|6|||
163844436|NCT00337662|591798652|FG001|Study Period III|Physician Decision|5|||
163844437|NCT00337662|591798653|FG002|Study Period III|Physician Decision|0|||
163844438|NCT00337662|591798654|FG003|Study Period III|Physician Decision|0|||
163844439|NCT00337662|591798651|FG000|Study Period III|Entry Criteria Not Met|4|||
163844440|NCT00337662|591798652|FG001|Study Period III|Entry Criteria Not Met|1|||
163844441|NCT00337662|591798653|FG002|Study Period III|Entry Criteria Not Met|3|||
163844442|NCT00337662|591798654|FG003|Study Period III|Entry Criteria Not Met|0|||
163844443|NCT00337662|591798651|FG000|Study Period III|Lack of Efficacy|4|||
163844444|NCT00337662|591798652|FG001|Study Period III|Lack of Efficacy|4|||
163844445|NCT00337662|591798653|FG002|Study Period III|Lack of Efficacy|2|||
163844446|NCT00337662|591798654|FG003|Study Period III|Lack of Efficacy|0|||
163844447|NCT00337662|591798651|FG000|Study Period III|Parent/Caregiver Decision|0|||
163844448|NCT00337662|591798652|FG001|Study Period III|Parent/Caregiver Decision|0|||
163844449|NCT00337662|591798653|FG002|Study Period III|Parent/Caregiver Decision|2|||
163844450|NCT00337662|591798654|FG003|Study Period III|Parent/Caregiver Decision|0|||
163844451|NCT00337662|591798651|FG000|Study Period III|Sponsor Decision|1|||
163844452|NCT00337662|591798652|FG001|Study Period III|Sponsor Decision|0|||
163844453|NCT00337662|591798653|FG002|Study Period III|Sponsor Decision|1|||
163844454|NCT00337662|591798654|FG003|Study Period III|Sponsor Decision|0|||
163844455|NCT00337662|591798651|FG000|Study Period III|Clinical Relapse|1|||
163844456|NCT00337662|591798652|FG001|Study Period III|Clinical Relapse|0|||
163844457|NCT00337662|591798653|FG002|Study Period III|Clinical Relapse|0|||
163844458|NCT00337662|591798654|FG003|Study Period III|Clinical Relapse|0|||
163844459|NCT00882921|591798655|FG000|Overall Study|Death|2|||
163844460|NCT00882921|591798655|FG000|Overall Study|Other|3|||
163844461|NCT00882921|591798655|FG000|Overall Study|Lost to Follow-up|2|||
163844462|NCT00882921|591798655|FG000|Overall Study|Termination By Investigator|3|||
163844463|NCT00882921|591798655|FG000|Overall Study|Withdrawal Of Consent|1|||
163844464|NCT01233609|591798667|FG000|Overall Study|Death|1|||
163844465|NCT01233609|591798668|FG001|Overall Study|Death|0|||
163844466|NCT01233609|591798667|FG000|Overall Study|Lost to Follow-up|3|||
163844467|NCT01233609|591798668|FG001|Overall Study|Lost to Follow-up|1|||
163844468|NCT01233609|591798667|FG000|Overall Study|Adverse Event|2|||
163844469|NCT01233609|591798668|FG001|Overall Study|Adverse Event|1|||
163844470|NCT01233609|591798667|FG000|Overall Study|Withdrawal by Subject|3|||
163844471|NCT01233609|591798668|FG001|Overall Study|Withdrawal by Subject|0|||
163844472|NCT03391960|591798669|FG000|Overall Study|Protocol Violation|0|||
163844473|NCT03391960|591798670|FG001|Overall Study|Protocol Violation|0|||
163953349|NCT00346632|592200653|FG009|Overall Study|Progressive Disease|2|||
163953350|NCT00346632|592200644|FG000|Overall Study|Adverse Event|0|||
163953351|NCT00346632|592200645|FG001|Overall Study|Adverse Event|0|||
163953352|NCT00346632|592200646|FG002|Overall Study|Adverse Event|0|||
163953353|NCT00346632|592200647|FG003|Overall Study|Adverse Event|0|||
163953354|NCT00346632|592200648|FG004|Overall Study|Adverse Event|1|||
163953355|NCT00346632|592200649|FG005|Overall Study|Adverse Event|1|||
163953356|NCT00346632|592200650|FG006|Overall Study|Adverse Event|1|||
163953357|NCT00346632|592200651|FG007|Overall Study|Adverse Event|0|||
163953358|NCT00346632|592200652|FG008|Overall Study|Adverse Event|0|||
163953359|NCT00346632|592200653|FG009|Overall Study|Adverse Event|0|||
163953360|NCT00346632|592200644|FG000|Overall Study|Death|0|||
163953361|NCT00346632|592200645|FG001|Overall Study|Death|0|||
163953362|NCT00346632|592200646|FG002|Overall Study|Death|1|||
163953363|NCT00346632|592200647|FG003|Overall Study|Death|0|||
163953364|NCT00346632|592200648|FG004|Overall Study|Death|0|||
163953365|NCT00346632|592200649|FG005|Overall Study|Death|0|||
163953366|NCT00346632|592200650|FG006|Overall Study|Death|0|||
163953367|NCT00346632|592200651|FG007|Overall Study|Death|0|||
163953368|NCT00346632|592200652|FG008|Overall Study|Death|0|||
163953369|NCT00346632|592200653|FG009|Overall Study|Death|0|||
163953370|NCT00346632|592200644|FG000|Overall Study|Protocol Violation|0|||
163953371|NCT00346632|592200645|FG001|Overall Study|Protocol Violation|0|||
163953372|NCT00346632|592200646|FG002|Overall Study|Protocol Violation|0|||
163953373|NCT00346632|592200647|FG003|Overall Study|Protocol Violation|0|||
163953374|NCT00346632|592200648|FG004|Overall Study|Protocol Violation|0|||
163953375|NCT00346632|592200649|FG005|Overall Study|Protocol Violation|0|||
163953376|NCT00346632|592200650|FG006|Overall Study|Protocol Violation|1|||
163953377|NCT00346632|592200651|FG007|Overall Study|Protocol Violation|0|||
163953378|NCT00346632|592200652|FG008|Overall Study|Protocol Violation|0|||
163953379|NCT00346632|592200653|FG009|Overall Study|Protocol Violation|0|||
163953380|NCT00346632|592200644|FG000|Overall Study|Withdrawal by Subject|0|||
163953381|NCT00346632|592200645|FG001|Overall Study|Withdrawal by Subject|0|||
163953382|NCT00346632|592200646|FG002|Overall Study|Withdrawal by Subject|0|||
163953383|NCT00346632|592200647|FG003|Overall Study|Withdrawal by Subject|0|||
163953384|NCT00346632|592200648|FG004|Overall Study|Withdrawal by Subject|0|||
163953385|NCT00346632|592200649|FG005|Overall Study|Withdrawal by Subject|0|||
163953386|NCT00346632|592200650|FG006|Overall Study|Withdrawal by Subject|1|||
163953387|NCT00346632|592200651|FG007|Overall Study|Withdrawal by Subject|0|||
163953388|NCT00346632|592200652|FG008|Overall Study|Withdrawal by Subject|0|||
163953389|NCT00346632|592200653|FG009|Overall Study|Withdrawal by Subject|0|||
163953390|NCT00346632|592200644|FG000|Overall Study|Switched to alternative treatment|0|||
163953391|NCT00346632|592200645|FG001|Overall Study|Switched to alternative treatment|0|||
163953392|NCT00346632|592200646|FG002|Overall Study|Switched to alternative treatment|1|||
163953393|NCT00346632|592200647|FG003|Overall Study|Switched to alternative treatment|0|||
163953394|NCT00346632|592200648|FG004|Overall Study|Switched to alternative treatment|0|||
163953395|NCT00346632|592200649|FG005|Overall Study|Switched to alternative treatment|0|||
163953396|NCT00346632|592200650|FG006|Overall Study|Switched to alternative treatment|0|||
163953397|NCT00346632|592200651|FG007|Overall Study|Switched to alternative treatment|0|||
163953398|NCT00346632|592200652|FG008|Overall Study|Switched to alternative treatment|0|||
163953399|NCT00346632|592200653|FG009|Overall Study|Switched to alternative treatment|0|||
163953400|NCT00346632|592200644|FG000|Overall Study|Not Stated|1|||
163953401|NCT00346632|592200645|FG001|Overall Study|Not Stated|1|||
163953402|NCT00346632|592200646|FG002|Overall Study|Not Stated|0|||
163953403|NCT00346632|592200647|FG003|Overall Study|Not Stated|0|||
163953404|NCT00346632|592200648|FG004|Overall Study|Not Stated|0|||
163953405|NCT00346632|592200649|FG005|Overall Study|Not Stated|0|||
163953406|NCT00346632|592200650|FG006|Overall Study|Not Stated|0|||
163953407|NCT00346632|592200651|FG007|Overall Study|Not Stated|2|||
163953408|NCT00346632|592200652|FG008|Overall Study|Not Stated|2|||
163953409|NCT00346632|592200653|FG009|Overall Study|Not Stated|1|||
163953410|NCT00918580|592200654|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
163953411|NCT00918580|592200654|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
163953412|NCT00918580|592200654|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
163953413|NCT00918580|592200654|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
163953414|NCT00918580|592200654|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
163953415|NCT00918580|592200654|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
163953416|NCT00918580|592200654|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
163953417|NCT04882995|592200655|FG000|Overall Study|Withdrawal by Subject|1|||
163953418|NCT04882995|592200656|FG001|Overall Study|Withdrawal by Subject|2|||
163953419|NCT04882995|592200655|FG000|Overall Study|Protocol Violation|4|||
163953420|NCT04882995|592200656|FG001|Overall Study|Protocol Violation|4|||
163953421|NCT04882995|592200655|FG000|Overall Study|Surgery postponed due to COVID|1|||
163953422|NCT04882995|592200656|FG001|Overall Study|Surgery postponed due to COVID|1|||
163953423|NCT03587974|592200657|FG000|Overall Study|caregiver demented, care recipient died|3|||
163953424|NCT03587974|592200658|FG001|Overall Study|caregiver demented, care recipient died|3|||
163953425|NCT03587974|592200657|FG000|Overall Study|Withdrawal by Subject|2|||
163953426|NCT03587974|592200658|FG001|Overall Study|Withdrawal by Subject|1|||
163953427|NCT03486457|592200659|FG000|Up to Month 3|Adverse Event|2|||
163953428|NCT03486457|592200660|FG001|Up to Month 3|Adverse Event|5|||
163953429|NCT03486457|592200659|FG000|Up to Month 3|Lack of Efficacy|1|||
163953430|NCT03486457|592200660|FG001|Up to Month 3|Lack of Efficacy|0|||
163953431|NCT03486457|592200659|FG000|Up to Month 3|Withdrawal by Subject|1|||
163953432|NCT03486457|592200660|FG001|Up to Month 3|Withdrawal by Subject|0|||
163953433|NCT03486457|592200659|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
163953434|NCT03486457|592200660|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
163953435|NCT03486457|592200659|FG000|Up to Month 3|Other|1|||
163953436|NCT03486457|592200660|FG001|Up to Month 3|Other|0|||
163953437|NCT03486457|592200659|FG000|Month 3 to Month 6|Adverse Event|2|||
163953438|NCT03486457|592200660|FG001|Month 3 to Month 6|Adverse Event|0|||
163953439|NCT03486457|592200659|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
163953440|NCT03486457|592200660|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
163953441|NCT03486457|592200659|FG000|Month 3 to Month 6|Pregnancy|0|||
163953442|NCT03486457|592200660|FG001|Month 3 to Month 6|Pregnancy|1|||
163953443|NCT03486457|592200659|FG000|Month 3 to Month 6|Other|1|||
163953444|NCT03486457|592200660|FG001|Month 3 to Month 6|Other|0|||
163953445|NCT00372229|592200661|FG000|Study Phase|Graft loss|0|||
163953446|NCT00372229|592200662|FG001|Study Phase|Graft loss|3|||
163953447|NCT00372229|592200661|FG000|Study Phase|Protocol Violation|3|||
163953448|NCT00372229|592200662|FG001|Study Phase|Protocol Violation|4|||
163953449|NCT00372229|592200661|FG000|Study Phase|Consent withdrawn|16|||
163953450|NCT00372229|592200662|FG001|Study Phase|Consent withdrawn|14|||
163953451|NCT00372229|592200661|FG000|Study Phase|Refused treatment/did not cooperate|3|||
163953452|NCT00372229|592200662|FG001|Study Phase|Refused treatment/did not cooperate|1|||
163953453|NCT00372229|592200661|FG000|Study Phase|Death|3|||
163953454|NCT00372229|592200662|FG001|Study Phase|Death|2|||
163953455|NCT00372229|592200661|FG000|Study Phase|Reason not specified|3|||
163953456|NCT00372229|592200662|FG001|Study Phase|Reason not specified|2|||
163953457|NCT00372229|592200661|FG000|Study Phase|Lost to Follow-up|3|||
163953458|NCT00372229|592200662|FG001|Study Phase|Lost to Follow-up|3|||
163953459|NCT00372229|592200661|FG000|Follow-Up Phase|Graft loss|8|||
163953460|NCT00372229|592200662|FG001|Follow-Up Phase|Graft loss|7|||
163953461|NCT00372229|592200661|FG000|Follow-Up Phase|Consent withdrawn|13|||
163953462|NCT00372229|592200662|FG001|Follow-Up Phase|Consent withdrawn|19|||
163953463|NCT00372229|592200661|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
163953464|NCT00372229|592200662|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
163953465|NCT00372229|592200661|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
163953466|NCT00372229|592200662|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
163953467|NCT00372229|592200661|FG000|Follow-Up Phase|Death|9|||
163953468|NCT00372229|592200662|FG001|Follow-Up Phase|Death|12|||
163953469|NCT00372229|592200661|FG000|Follow-Up Phase|Administrative|1|||
163953470|NCT00372229|592200662|FG001|Follow-Up Phase|Administrative|0|||
163953471|NCT00372229|592200661|FG000|Follow-Up Phase|Reason not specified|2|||
163953472|NCT00372229|592200662|FG001|Follow-Up Phase|Reason not specified|3|||
163953473|NCT00372229|592200661|FG000|Follow-Up Phase|Lost to Follow-up|12|||
163953474|NCT00372229|592200662|FG001|Follow-Up Phase|Lost to Follow-up|10|||
163953475|NCT03235284|592200663|FG000|Overall Study|Adverse Event|1|||
163953476|NCT03235284|592200664|FG001|Overall Study|Adverse Event|2|||
163953477|NCT03235284|592200665|FG002|Overall Study|Adverse Event|1|||
163953478|NCT01382706|592200666|FG000|Overall Study|Adverse Event|1|||
163953479|NCT01382706|592200666|FG000|Overall Study|Withdrawal by Subject|1|||
163953480|NCT04055090|592200667|FG000|Overall Study|screen failure|1|||
163953481|NCT04055090|592200668|FG001|Overall Study|screen failure|0|||
163953482|NCT04055090|592200667|FG000|Overall Study|Withdrawal by Subject|1|||
163953483|NCT04055090|592200668|FG001|Overall Study|Withdrawal by Subject|0|||
163953484|NCT05478499|592200671|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
163953485|NCT05478499|592200672|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
163953486|NCT05478499|592200671|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
163953487|NCT05478499|592200672|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
163953488|NCT05478499|592200671|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
163953489|NCT05478499|592200672|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
163953490|NCT05478499|592200671|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
163953491|NCT05478499|592200672|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
163953492|NCT05478499|592200671|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
163953493|NCT05478499|592200672|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
163953494|NCT05478499|592200671|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
163953495|NCT05478499|592200672|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
163953496|NCT05478499|592200671|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
163953497|NCT05478499|592200672|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
163953498|NCT05478499|592200671|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
163953499|NCT05478499|592200672|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
163953500|NCT05478499|592200671|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
163953501|NCT05478499|592200672|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
163953502|NCT05478499|592200671|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
163953503|NCT05478499|592200672|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
163953504|NCT05478499|592200671|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
163953505|NCT05478499|592200672|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
163953506|NCT00249002|592200676|FG000|Overall Study|Adverse Event|2|||
163953507|NCT00249002|592200676|FG000|Overall Study|Study cancellation|3|||
163953508|NCT00249002|592200676|FG000|Overall Study|Other|2|||
163953509|NCT02319525|592200677|FG000|Overall Study|Withdrawal by Subject|2|||
163953510|NCT02319525|592200678|FG001|Overall Study|Withdrawal by Subject|1|||
163953511|NCT02729753|592200685|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
163953512|NCT02729753|592200686|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
163953513|NCT02842827|592200687|FG000|Overall Study|Adverse Event|0|||
163953514|NCT02842827|592200688|FG001|Overall Study|Adverse Event|1|||
163953515|NCT02842827|592200689|FG002|Overall Study|Adverse Event|0|||
163953516|NCT02842827|592200690|FG003|Overall Study|Adverse Event|1|||
163953517|NCT02842827|592200691|FG004|Overall Study|Adverse Event|0|||
163953518|NCT02842827|592200692|FG005|Overall Study|Adverse Event|1|||
163953519|NCT02842827|592200693|FG006|Overall Study|Adverse Event|0|||
163953520|NCT02842827|592200694|FG007|Overall Study|Adverse Event|0|||
163953521|NCT02842827|592200687|FG000|Overall Study|Death|1|||
163953522|NCT02842827|592200688|FG001|Overall Study|Death|0|||
163953523|NCT02842827|592200689|FG002|Overall Study|Death|2|||
163953524|NCT02842827|592200690|FG003|Overall Study|Death|3|||
163953525|NCT02842827|592200691|FG004|Overall Study|Death|2|||
163953526|NCT02842827|592200692|FG005|Overall Study|Death|1|||
163953527|NCT02842827|592200693|FG006|Overall Study|Death|0|||
163953528|NCT02842827|592200694|FG007|Overall Study|Death|4|||
163953529|NCT02842827|592200687|FG000|Overall Study|Physician Decision|1|||
163953530|NCT02842827|592200688|FG001|Overall Study|Physician Decision|3|||
163953531|NCT02842827|592200689|FG002|Overall Study|Physician Decision|0|||
163953532|NCT02842827|592200690|FG003|Overall Study|Physician Decision|0|||
163953533|NCT02842827|592200691|FG004|Overall Study|Physician Decision|1|||
163953534|NCT02842827|592200692|FG005|Overall Study|Physician Decision|4|||
163953535|NCT02842827|592200693|FG006|Overall Study|Physician Decision|2|||
163953536|NCT02842827|592200694|FG007|Overall Study|Physician Decision|1|||
163953537|NCT02842827|592200687|FG000|Overall Study|Protocol Defined Disease Progression|0|||
163953538|NCT02842827|592200688|FG001|Overall Study|Protocol Defined Disease Progression|0|||
164099721|NCT02100228|592730564|FG000|Overall Study|Lost to Follow-up|0|||
163953539|NCT02842827|592200689|FG002|Overall Study|Protocol Defined Disease Progression|0|||
163953540|NCT02842827|592200690|FG003|Overall Study|Protocol Defined Disease Progression|0|||
163953541|NCT02842827|592200691|FG004|Overall Study|Protocol Defined Disease Progression|0|||
163953542|NCT02842827|592200692|FG005|Overall Study|Protocol Defined Disease Progression|1|||
163953543|NCT02842827|592200693|FG006|Overall Study|Protocol Defined Disease Progression|0|||
163953544|NCT02842827|592200694|FG007|Overall Study|Protocol Defined Disease Progression|0|||
163953545|NCT02842827|592200687|FG000|Overall Study|Participant Withdrawal of Consent|1|||
163953546|NCT02842827|592200688|FG001|Overall Study|Participant Withdrawal of Consent|2|||
163953547|NCT02842827|592200689|FG002|Overall Study|Participant Withdrawal of Consent|2|||
163953548|NCT02842827|592200690|FG003|Overall Study|Participant Withdrawal of Consent|2|||
163953549|NCT02842827|592200691|FG004|Overall Study|Participant Withdrawal of Consent|2|||
163953550|NCT02842827|592200692|FG005|Overall Study|Participant Withdrawal of Consent|1|||
163953551|NCT02842827|592200693|FG006|Overall Study|Participant Withdrawal of Consent|2|||
163953552|NCT02842827|592200694|FG007|Overall Study|Participant Withdrawal of Consent|1|||
163953553|NCT01815138|592200695|FG000|Overall Study|Withdrawal by Subject|0|||
163953554|NCT01815138|592200696|FG001|Overall Study|Withdrawal by Subject|1|||
163953555|NCT01815138|592200695|FG000|Overall Study|Physician Decision|8|||
163953556|NCT01815138|592200696|FG001|Overall Study|Physician Decision|5|||
163953557|NCT00950950|592200698|FG000|Overall Study|Adverse Event|1|||
163953558|NCT00950950|592200699|FG001|Overall Study|Adverse Event|0|||
163953559|NCT00950950|592200698|FG000|Overall Study|Withdrawal by Subject|0|||
163953560|NCT00950950|592200699|FG001|Overall Study|Withdrawal by Subject|1|||
163953561|NCT01047293|592200700|FG000|Overall Study|DLT criteria not fulfilled|1|||
163953562|NCT01047293|592200701|FG001|Overall Study|DLT criteria not fulfilled|1|||
163953563|NCT01047293|592200702|FG002|Overall Study|DLT criteria not fulfilled|0|||
163953564|NCT01047293|592200703|FG003|Overall Study|DLT criteria not fulfilled|0|||
163953565|NCT00757783|592200704|FG000|Overall Study|Adverse Event|0|||
163953566|NCT00757783|592200705|FG001|Overall Study|Adverse Event|2|||
163953567|NCT00757783|592200704|FG000|Overall Study|Lost to Follow-up|1|||
163953568|NCT00757783|592200705|FG001|Overall Study|Lost to Follow-up|1|||
163953569|NCT00757783|592200704|FG000|Overall Study|Protocol Violation|1|||
163953570|NCT00757783|592200705|FG001|Overall Study|Protocol Violation|0|||
163953571|NCT00757783|592200704|FG000|Overall Study|Withdrawal by Subject|2|||
163953572|NCT00757783|592200705|FG001|Overall Study|Withdrawal by Subject|1|||
163953573|NCT00757783|592200704|FG000|Overall Study|Other|1|||
163953574|NCT00757783|592200705|FG001|Overall Study|Other|2|||
163953575|NCT02372136|592200706|FG000|Overall Study|Death|3|||
163953576|NCT02372136|592200707|FG001|Overall Study|Death|1|||
163953577|NCT02679508|592200708|FG000|Healing Phase|Protocol Violation|1|||
163953578|NCT02679508|592200709|FG001|Healing Phase|Protocol Violation|1|||
163953579|NCT02679508|592200708|FG000|Healing Phase|Lost to Follow-up|1|||
163953580|NCT02679508|592200709|FG001|Healing Phase|Lost to Follow-up|0|||
163953581|NCT02679508|592200708|FG000|Maintenance Phase|Adverse Event|12|||
163953582|NCT02679508|592200709|FG001|Maintenance Phase|Adverse Event|2|||
163953583|NCT02679508|592200708|FG000|Maintenance Phase|Lost to Follow-up|0|||
163953584|NCT02679508|592200709|FG001|Maintenance Phase|Lost to Follow-up|1|||
163953585|NCT02679508|592200708|FG000|Maintenance Phase|Withdrawal by Subject|15|||
163953586|NCT02679508|592200709|FG001|Maintenance Phase|Withdrawal by Subject|8|||
163953587|NCT02679508|592200708|FG000|Maintenance Phase|Other|5|||
163953588|NCT02679508|592200709|FG001|Maintenance Phase|Other|4|||
163953589|NCT01588496|592200710|FG000|Overall Study|Withdrawal by Subject|0|||
163953590|NCT01588496|592200711|FG001|Overall Study|Withdrawal by Subject|1|||
163953591|NCT01588496|592200712|FG002|Overall Study|Withdrawal by Subject|0|||
163953592|NCT03143166|592200713|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
163953593|NCT02003573|592200717|FG000|Overall Study|Progressive disease|2|||
163953594|NCT02003573|592200718|FG001|Overall Study|Progressive disease|0|||
163953595|NCT02003573|592200719|FG002|Overall Study|Progressive disease|1|||
163953596|NCT02003573|592200717|FG000|Overall Study|Other Adverse event|0|||
163953597|NCT02003573|592200718|FG001|Overall Study|Other Adverse event|1|||
163953598|NCT02003573|592200719|FG002|Overall Study|Other Adverse event|1|||
163953599|NCT02003573|592200717|FG000|Overall Study|Refuse to take trial medication|0|||
163953600|NCT02003573|592200718|FG001|Overall Study|Refuse to take trial medication|1|||
163953601|NCT02003573|592200719|FG002|Overall Study|Refuse to take trial medication|1|||
163953602|NCT02003573|592200717|FG000|Overall Study|Other than specified|1|||
163953603|NCT02003573|592200718|FG001|Overall Study|Other than specified|2|||
163953604|NCT02003573|592200719|FG002|Overall Study|Other than specified|3|||
163953605|NCT03683823|592200726|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
163953606|NCT03683823|592200727|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
163953607|NCT03683823|592200726|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
163953608|NCT03683823|592200727|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
163953609|NCT03683823|592200726|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
163953610|NCT03683823|592200727|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
163953611|NCT05026710|592200729|FG000|Overall Study|No longer met eligibility criteria|3|||
164047771|NCT05549505|592534181|FG000|Overall Study|Other: Miscellaneous|3|||
164047772|NCT05549505|592534182|FG001|Overall Study|Other: Miscellaneous|6|||
163953612|NCT05026710|592200730|FG001|Overall Study|No longer met eligibility criteria|1|||
163953613|NCT01323972|592200731|FG000|Overall Study|Withdrawal by Subject|1|||
163953614|NCT01323972|592200732|FG001|Overall Study|Withdrawal by Subject|0|||
163953615|NCT01323972|592200733|FG002|Overall Study|Withdrawal by Subject|1|||
163953616|NCT01323972|592200734|FG003|Overall Study|Withdrawal by Subject|0|||
163953617|NCT01323972|592200731|FG000|Overall Study|Migrated/moved from study area|1|||
163953618|NCT01323972|592200732|FG001|Overall Study|Migrated/moved from study area|2|||
163953619|NCT01323972|592200733|FG002|Overall Study|Migrated/moved from study area|0|||
163953620|NCT01323972|592200734|FG003|Overall Study|Migrated/moved from study area|0|||
163953621|NCT01323972|592200731|FG000|Overall Study|Lost to Follow-up|0|||
163953622|NCT01323972|592200732|FG001|Overall Study|Lost to Follow-up|1|||
163953623|NCT01323972|592200733|FG002|Overall Study|Lost to Follow-up|1|||
163953624|NCT01323972|592200734|FG003|Overall Study|Lost to Follow-up|1|||
163953625|NCT00994682|592200735|FG000|Double Bilnd|Withdrawal by Subject|5|||
163953626|NCT00994682|592200736|FG001|Double Bilnd|Withdrawal by Subject|6|||
163953627|NCT00994682|592200735|FG000|Double Bilnd|Lost to Follow-up|3|||
163953628|NCT00994682|592200736|FG001|Double Bilnd|Lost to Follow-up|3|||
163953629|NCT00994682|592200735|FG000|Double Bilnd|Adverse Event|1|||
163953630|NCT00994682|592200736|FG001|Double Bilnd|Adverse Event|0|||
163953631|NCT00994682|592200735|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
163953632|NCT00994682|592200736|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
163953633|NCT00994682|592200735|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
163953634|NCT00994682|592200736|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
163953635|NCT00994682|592200735|FG000|Pioglitazone Open Label|Physician Decision|6|||
163953636|NCT00994682|592200736|FG001|Pioglitazone Open Label|Physician Decision|1|||
163953637|NCT03218397|592200737|FG000|Overall Study|Prior positive blood culture|8|||
163953638|NCT03218397|592200738|FG001|Overall Study|Prior positive blood culture|13|||
163953639|NCT03218397|592200737|FG000|Overall Study|Comfort care|8|||
163953640|NCT03218397|592200738|FG001|Overall Study|Comfort care|5|||
163953641|NCT03218397|592200737|FG000|Overall Study|Comfort care and positive blood culture|1|||
163953642|NCT03218397|592200738|FG001|Overall Study|Comfort care and positive blood culture|0|||
163953643|NCT03218397|592200737|FG000|Overall Study|Comfort care and mixed culture|0|||
163953644|NCT03218397|592200738|FG001|Overall Study|Comfort care and mixed culture|1|||
163953645|NCT03218397|592200737|FG000|Overall Study|Mixed culture|2|||
163953646|NCT03218397|592200738|FG001|Overall Study|Mixed culture|2|||
163953647|NCT03218397|592200737|FG000|Overall Study|Inaccessible hospital records|2|||
163953648|NCT03218397|592200738|FG001|Overall Study|Inaccessible hospital records|5|||
163953649|NCT03218397|592200737|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
163953650|NCT03218397|592200738|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
163953651|NCT03218397|592200737|FG000|Overall Study|Randomized during laboratory off hours|2|||
163953652|NCT03218397|592200738|FG001|Overall Study|Randomized during laboratory off hours|1|||
163953653|NCT01796548|592200741|FG000|Overall Study|Lost to Follow-up|1|||
163953654|NCT01796548|592200741|FG000|Overall Study|Other|2|||
163953655|NCT01049217|592200744|FG000|Overall Study|Adverse Event|2|||
163953656|NCT01049217|592200745|FG001|Overall Study|Adverse Event|1|||
163953657|NCT01049217|592200744|FG000|Overall Study|Lack of Efficacy|1|||
163953658|NCT01049217|592200745|FG001|Overall Study|Lack of Efficacy|1|||
163953659|NCT01049217|592200744|FG000|Overall Study|Lost to Follow-up|3|||
163953660|NCT01049217|592200745|FG001|Overall Study|Lost to Follow-up|8|||
163953661|NCT01049217|592200744|FG000|Overall Study|Withdrawal by Subject|4|||
163953662|NCT01049217|592200745|FG001|Overall Study|Withdrawal by Subject|3|||
163953663|NCT01049217|592200744|FG000|Overall Study|Protocol Violation|1|||
163953664|NCT01049217|592200745|FG001|Overall Study|Protocol Violation|3|||
163953665|NCT01049217|592200744|FG000|Overall Study|Pregnancy|1|||
163953666|NCT01049217|592200745|FG001|Overall Study|Pregnancy|0|||
163953667|NCT01049217|592200744|FG000|Overall Study|Study Terminated by Sponsor|43|||
163953668|NCT01049217|592200745|FG001|Overall Study|Study Terminated by Sponsor|43|||
163953669|NCT01049217|592200744|FG000|Overall Study|Other|1|||
163953670|NCT01049217|592200745|FG001|Overall Study|Other|2|||
163953671|NCT01049217|592200744|FG000|Overall Study|Randomized but not Treated|0|||
163953672|NCT01049217|592200745|FG001|Overall Study|Randomized but not Treated|2|||
163953673|NCT00126503|592200746|FG000|Overall Study|disease progression|23|||
163953674|NCT00126503|592200747|FG001|Overall Study|disease progression|14|||
163953675|NCT00126503|592200746|FG000|Overall Study|Withdrawal by Subject|0|||
163953676|NCT00126503|592200747|FG001|Overall Study|Withdrawal by Subject|1|||
163953677|NCT00126503|592200746|FG000|Overall Study|alternative therapy|1|||
163953678|NCT00126503|592200747|FG001|Overall Study|alternative therapy|1|||
163953679|NCT00126503|592200746|FG000|Overall Study|other complicating disease|4|||
163953680|NCT00126503|592200747|FG001|Overall Study|other complicating disease|1|||
163953681|NCT00126503|592200746|FG000|Overall Study|Death|3|||
163953682|NCT00126503|592200747|FG001|Overall Study|Death|0|||
163953683|NCT00126503|592200746|FG000|Overall Study|Adverse Event|13|||
163953684|NCT00126503|592200747|FG001|Overall Study|Adverse Event|3|||
163953685|NCT00126503|592200746|FG000|Overall Study|non-compliant|1|||
163953686|NCT00126503|592200747|FG001|Overall Study|non-compliant|0|||
163953687|NCT00126503|592200746|FG000|Overall Study|Physician Decision|2|||
163953688|NCT00126503|592200747|FG001|Overall Study|Physician Decision|1|||
163953689|NCT00589121|592200748|FG000|Overall Study|Protocol Violation|2|||
163953690|NCT00589121|592200749|FG001|Overall Study|Protocol Violation|6|||
163953691|NCT00589121|592200748|FG000|Overall Study|No protocol treatment received|0|||
163953692|NCT00589121|592200749|FG001|Overall Study|No protocol treatment received|1|||
163953693|NCT02495792|592200750|FG000|Overall Study|Lost to Follow-up|5|||
163953694|NCT02495792|592200751|FG001|Overall Study|Lost to Follow-up|9|||
163953695|NCT02495792|592200750|FG000|Overall Study|Protocol Violation|32|||
163953696|NCT02495792|592200751|FG001|Overall Study|Protocol Violation|31|||
163953697|NCT03519971|592200752|FG000|Overall Study|Death|142|||
163953698|NCT03519971|592200753|FG001|Overall Study|Death|69|||
163953699|NCT03519971|592200752|FG000|Overall Study|Lost to Follow-up|0|||
163953700|NCT03519971|592200753|FG001|Overall Study|Lost to Follow-up|1|||
163953701|NCT03519971|592200752|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
163953702|NCT03519971|592200753|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
163953703|NCT03519971|592200752|FG000|Overall Study|Withdrawal by Subject|3|||
163953704|NCT03519971|592200753|FG001|Overall Study|Withdrawal by Subject|2|||
163953705|NCT03519971|592200752|FG000|Overall Study|Other|1|||
163953706|NCT03519971|592200753|FG001|Overall Study|Other|0|||
163953707|NCT00925132|592200754|FG000|Overall Study|Withdrawal by Subject|2|||
163953708|NCT00925132|592200755|FG001|Overall Study|Withdrawal by Subject|0|||
163953709|NCT00925132|592200756|FG002|Overall Study|Withdrawal by Subject|0|||
163953710|NCT00925132|592200757|FG003|Overall Study|Withdrawal by Subject|0|||
163953711|NCT00925132|592200758|FG004|Overall Study|Withdrawal by Subject|1|||
163953712|NCT00925132|592200754|FG000|Overall Study|Removed due to disease progression|0|||
163953713|NCT00925132|592200755|FG001|Overall Study|Removed due to disease progression|0|||
163953714|NCT00925132|592200756|FG002|Overall Study|Removed due to disease progression|0|||
163953715|NCT00925132|592200757|FG003|Overall Study|Removed due to disease progression|0|||
163953716|NCT00925132|592200758|FG004|Overall Study|Removed due to disease progression|4|||
163953717|NCT02545933|592200759|FG000|Overall Study|Adverse Event|3|||
163953718|NCT02545933|592200760|FG001|Overall Study|Adverse Event|0|||
163953719|NCT02545933|592200761|FG002|Overall Study|Adverse Event|0|||
163953720|NCT02545933|592200759|FG000|Overall Study|Withdrawal by Subject|2|||
163953721|NCT02545933|592200760|FG001|Overall Study|Withdrawal by Subject|3|||
163953722|NCT02545933|592200761|FG002|Overall Study|Withdrawal by Subject|3|||
163953723|NCT02545933|592200759|FG000|Overall Study|Protocol Violation|1|||
163953724|NCT02545933|592200760|FG001|Overall Study|Protocol Violation|0|||
163953725|NCT02545933|592200761|FG002|Overall Study|Protocol Violation|1|||
163953726|NCT03149549|592200762|FG000|Study Discontinuation--Treatment Period|Death|0|||
163953727|NCT03149549|592200763|FG001|Study Discontinuation--Treatment Period|Death|0|||
163953728|NCT03149549|592200764|FG002|Study Discontinuation--Treatment Period|Death|0|||
163953729|NCT03149549|592200765|FG003|Study Discontinuation--Treatment Period|Death|1|||
163953730|NCT03149549|592200766|FG004|Study Discontinuation--Treatment Period|Death|2|||
163953731|NCT03149549|592200767|FG005|Study Discontinuation--Treatment Period|Death|1|||
163953732|NCT03149549|592200768|FG006|Study Discontinuation--Treatment Period|Death|1|||
163953733|NCT03149549|592200769|FG007|Study Discontinuation--Treatment Period|Death|2|||
163953734|NCT03149549|592200770|FG008|Study Discontinuation--Treatment Period|Death|4|||
163953735|NCT03149549|592200771|FG009|Study Discontinuation--Treatment Period|Death|1|||
163953736|NCT03149549|592200772|FG010|Study Discontinuation--Treatment Period|Death|0|||
163953737|NCT03149549|592200773|FG011|Study Discontinuation--Treatment Period|Death|0|||
163953738|NCT03149549|592200774|FG012|Study Discontinuation--Treatment Period|Death|1|||
163953739|NCT03149549|592200762|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953740|NCT03149549|592200763|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953741|NCT03149549|592200764|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953742|NCT03149549|592200765|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953743|NCT03149549|592200766|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953744|NCT03149549|592200767|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953745|NCT03149549|592200768|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953746|NCT03149549|592200769|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
163953747|NCT03149549|592200770|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953748|NCT03149549|592200771|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953749|NCT03149549|592200772|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953750|NCT03149549|592200773|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
163953751|NCT03149549|592200774|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
163953752|NCT03149549|592200762|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953753|NCT03149549|592200763|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953754|NCT03149549|592200764|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
164047773|NCT00592072|592534185|FG000|Wash Out Period|Lost to Follow-up|1|||
164047774|NCT00592072|592534186|FG001|Wash Out Period|Lost to Follow-up|1|||
164047775|NCT00403390|592534187|FG000|Overall Study|Withdrawal by Subject|1|||
164047776|NCT00403390|592534188|FG001|Overall Study|Withdrawal by Subject|0|||
164047777|NCT00403390|592534187|FG000|Overall Study|samples lost|1|||
164047778|NCT00403390|592534188|FG001|Overall Study|samples lost|0|||
163953755|NCT03149549|592200765|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
163953756|NCT03149549|592200766|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
163953757|NCT03149549|592200767|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
163953758|NCT03149549|592200768|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
163953759|NCT03149549|592200769|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953760|NCT03149549|592200770|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
163953761|NCT03149549|592200771|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953762|NCT03149549|592200772|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953763|NCT03149549|592200773|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953764|NCT03149549|592200774|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
163953765|NCT03149549|592200762|FG000|Study Discontinuation--Treatment Period|Other|0|||
163953766|NCT03149549|592200763|FG001|Study Discontinuation--Treatment Period|Other|0|||
163953767|NCT03149549|592200764|FG002|Study Discontinuation--Treatment Period|Other|0|||
163953768|NCT03149549|592200765|FG003|Study Discontinuation--Treatment Period|Other|0|||
163953769|NCT03149549|592200766|FG004|Study Discontinuation--Treatment Period|Other|0|||
163953770|NCT03149549|592200767|FG005|Study Discontinuation--Treatment Period|Other|0|||
163953771|NCT03149549|592200768|FG006|Study Discontinuation--Treatment Period|Other|0|||
163953772|NCT03149549|592200769|FG007|Study Discontinuation--Treatment Period|Other|1|||
163953773|NCT03149549|592200770|FG008|Study Discontinuation--Treatment Period|Other|0|||
163953774|NCT03149549|592200771|FG009|Study Discontinuation--Treatment Period|Other|1|||
163953775|NCT03149549|592200772|FG010|Study Discontinuation--Treatment Period|Other|0|||
163953776|NCT03149549|592200773|FG011|Study Discontinuation--Treatment Period|Other|0|||
163953777|NCT03149549|592200774|FG012|Study Discontinuation--Treatment Period|Other|0|||
163953778|NCT03149549|592200762|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953779|NCT03149549|592200763|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953780|NCT03149549|592200764|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953781|NCT03149549|592200765|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953782|NCT03149549|592200766|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953783|NCT03149549|592200767|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
163953784|NCT03149549|592200768|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
163953785|NCT03149549|592200769|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953786|NCT03149549|592200770|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
163953787|NCT03149549|592200771|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953788|NCT03149549|592200772|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953789|NCT03149549|592200773|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953790|NCT03149549|592200774|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
163953791|NCT03149549|592200762|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953792|NCT03149549|592200763|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953793|NCT03149549|592200764|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953794|NCT03149549|592200765|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953795|NCT03149549|592200766|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
163953796|NCT03149549|592200767|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953797|NCT03149549|592200768|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953798|NCT03149549|592200769|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
163953799|NCT03149549|592200770|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
163953800|NCT03149549|592200771|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953801|NCT03149549|592200772|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
163953802|NCT03149549|592200773|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
163953803|NCT03149549|592200774|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
163953804|NCT03149549|592200762|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953805|NCT03149549|592200763|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953806|NCT03149549|592200764|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953807|NCT03149549|592200765|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953808|NCT03149549|592200766|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163953809|NCT03149549|592200767|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953810|NCT03149549|592200768|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953811|NCT03149549|592200769|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
163953812|NCT03149549|592200770|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163953813|NCT03149549|592200771|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163953814|NCT03149549|592200772|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
163953815|NCT03149549|592200773|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
163953816|NCT03149549|592200774|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
163953817|NCT03149549|592200762|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
163953818|NCT03149549|592200763|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
163953819|NCT03149549|592200764|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
163953820|NCT03149549|592200765|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
163953821|NCT03149549|592200766|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
163953822|NCT03149549|592200767|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
163953823|NCT03149549|592200768|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
163953824|NCT03149549|592200769|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
163953825|NCT03149549|592200770|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
163953826|NCT03149549|592200771|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
163953827|NCT03149549|592200772|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
163953828|NCT03149549|592200773|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
163953829|NCT03149549|592200774|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
163953830|NCT03149549|592200762|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
163953831|NCT03149549|592200763|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
163953832|NCT03149549|592200764|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
163953833|NCT03149549|592200765|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
163953834|NCT03149549|592200766|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
163953835|NCT03149549|592200767|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
163953836|NCT03149549|592200768|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
163953837|NCT03149549|592200769|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
163953838|NCT03149549|592200770|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
163953839|NCT03149549|592200771|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
163953840|NCT03149549|592200772|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
163953841|NCT03149549|592200773|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
163953842|NCT03149549|592200774|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
163953843|NCT03141905|592200775|FG000|Overall Study|Death|3|||
163953844|NCT03141905|592200776|FG001|Overall Study|Death|2|||
163953845|NCT03141905|592200775|FG000|Overall Study|Withdrawal by Subject|1|||
163953846|NCT03141905|592200776|FG001|Overall Study|Withdrawal by Subject|0|||
163953847|NCT03141905|592200775|FG000|Overall Study|Lost to Follow-up|3|||
163953848|NCT03141905|592200776|FG001|Overall Study|Lost to Follow-up|7|||
163953849|NCT03141905|592200775|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
163953850|NCT03141905|592200776|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
163953851|NCT05180500|592200777|FG000|Overall Study|Adverse Event|1|||
163953852|NCT05180500|592200778|FG001|Overall Study|Adverse Event|0|||
163953853|NCT05180500|592200777|FG000|Overall Study|Withdrawal by Subject|2|||
163953854|NCT05180500|592200778|FG001|Overall Study|Withdrawal by Subject|0|||
163953855|NCT04927884|592200783|FG000|Overall Study|Progressive Disease|2|||
163953856|NCT01775124|592200784|FG000|Core Period|Disease Progression|0|||
163953857|NCT01775124|592200785|FG001|Core Period|Disease Progression|1|||
163953858|NCT01775124|592200784|FG000|Core Period|Physician Decision|1|||
163953859|NCT01775124|592200785|FG001|Core Period|Physician Decision|1|||
163953860|NCT01775124|592200784|FG000|Core Period|Death|0|||
163953861|NCT01775124|592200785|FG001|Core Period|Death|1|||
163953862|NCT01775124|592200784|FG000|Core Period|Administrative problems|1|||
163953863|NCT01775124|592200785|FG001|Core Period|Administrative problems|0|||
163953864|NCT01775124|592200784|FG000|Core Period|Withdrawal by Subject|4|||
163953865|NCT01775124|592200785|FG001|Core Period|Withdrawal by Subject|2|||
163953866|NCT01775124|592200784|FG000|Core Period|Adverse Event|5|||
163953867|NCT01775124|592200785|FG001|Core Period|Adverse Event|5|||
163953868|NCT01775124|592200784|FG000|Extension Period|Adverse Event|3|||
163953869|NCT01775124|592200785|FG001|Extension Period|Adverse Event|2|||
163953870|NCT01775124|592200784|FG000|Extension Period|Physician Decision|0|||
163953871|NCT01775124|592200785|FG001|Extension Period|Physician Decision|2|||
163953872|NCT01775124|592200784|FG000|Extension Period|Administrative problems|0|||
163953873|NCT01775124|592200785|FG001|Extension Period|Administrative problems|1|||
163953874|NCT01775124|592200784|FG000|Extension Period|Lost to Follow-up|0|||
163953875|NCT01775124|592200785|FG001|Extension Period|Lost to Follow-up|1|||
163953876|NCT01775124|592200784|FG000|Extension Period|Withdrawal by Subject|9|||
163953877|NCT01775124|592200785|FG001|Extension Period|Withdrawal by Subject|12|||
163953878|NCT05917470|592200786|FG000|Overall Study|Progressive Disease|1|||
163953879|NCT05917470|592200787|FG001|Overall Study|Progressive Disease|1|||
163953880|NCT05917470|592200788|FG002|Overall Study|Progressive Disease|2|||
163953881|NCT05917470|592200789|FG003|Overall Study|Progressive Disease|3|||
163953882|NCT05917470|592200790|FG004|Overall Study|Progressive Disease|1|||
163953883|NCT05917470|592200791|FG005|Overall Study|Progressive Disease|1|||
163953884|NCT05917470|592200792|FG006|Overall Study|Progressive Disease|0|||
163953885|NCT05917470|592200793|FG007|Overall Study|Progressive Disease|0|||
163953886|NCT05917470|592200786|FG000|Overall Study|Withdrawal by Subject|0|||
163953887|NCT05917470|592200787|FG001|Overall Study|Withdrawal by Subject|0|||
163953888|NCT05917470|592200788|FG002|Overall Study|Withdrawal by Subject|1|||
163953889|NCT05917470|592200789|FG003|Overall Study|Withdrawal by Subject|0|||
163953890|NCT05917470|592200790|FG004|Overall Study|Withdrawal by Subject|0|||
163953891|NCT05917470|592200791|FG005|Overall Study|Withdrawal by Subject|0|||
163953892|NCT05917470|592200792|FG006|Overall Study|Withdrawal by Subject|0|||
164099722|NCT02100228|592730565|FG001|Overall Study|Lost to Follow-up|1|||
163953893|NCT05917470|592200793|FG007|Overall Study|Withdrawal by Subject|0|||
163953894|NCT05917470|592200786|FG000|Overall Study|Sponsor Decision|0|||
163953895|NCT05917470|592200787|FG001|Overall Study|Sponsor Decision|0|||
163953896|NCT05917470|592200788|FG002|Overall Study|Sponsor Decision|1|||
163953897|NCT05917470|592200789|FG003|Overall Study|Sponsor Decision|0|||
163953898|NCT05917470|592200790|FG004|Overall Study|Sponsor Decision|2|||
163953899|NCT05917470|592200791|FG005|Overall Study|Sponsor Decision|1|||
163953900|NCT05917470|592200792|FG006|Overall Study|Sponsor Decision|3|||
163953901|NCT05917470|592200793|FG007|Overall Study|Sponsor Decision|3|||
163953902|NCT05917470|592200786|FG000|Overall Study|Adverse Event|0|||
163953903|NCT05917470|592200787|FG001|Overall Study|Adverse Event|0|||
163953904|NCT05917470|592200788|FG002|Overall Study|Adverse Event|0|||
163953905|NCT05917470|592200789|FG003|Overall Study|Adverse Event|0|||
163953906|NCT05917470|592200790|FG004|Overall Study|Adverse Event|0|||
163953907|NCT05917470|592200791|FG005|Overall Study|Adverse Event|1|||
163953908|NCT05917470|592200792|FG006|Overall Study|Adverse Event|0|||
163953909|NCT05917470|592200793|FG007|Overall Study|Adverse Event|0|||
163953910|NCT02317432|592200794|FG000|Overall Study|Death|4|||
163953911|NCT02317432|592200795|FG001|Overall Study|Death|1|||
163953912|NCT02317432|592200794|FG000|Overall Study|Lost to Follow-up|0|||
163953913|NCT02317432|592200795|FG001|Overall Study|Lost to Follow-up|5|||
163953914|NCT02317432|592200794|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
163953915|NCT02317432|592200795|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
163953916|NCT01328717|592202368|FG000|Overall Study|Adverse Event|1|||
163953917|NCT00346268|592202369|FG000|Overall Study|Adverse Event|1|||
163953918|NCT00346268|592202370|FG001|Overall Study|Adverse Event|0|||
163953919|NCT00346268|592202369|FG000|Overall Study|Protocol Violation|1|||
163953920|NCT00346268|592202370|FG001|Overall Study|Protocol Violation|0|||
163953921|NCT00346268|592202369|FG000|Overall Study|Participant refused|0|||
163953922|NCT00346268|592202370|FG001|Overall Study|Participant refused|3|||
163953923|NCT01036763|592202371|FG000|Overall Study|Adverse Event|25|||
163953924|NCT01036763|592202371|FG000|Overall Study|Lost to Follow-up|28|||
163953925|NCT01036763|592202371|FG000|Overall Study|Other reason (not specified)|40|||
163953926|NCT01177722|592202374|FG000|Overall Study|Serious Adverse Event|0|||
163953927|NCT01177722|592202375|FG001|Overall Study|Serious Adverse Event|0|||
163953928|NCT01177722|592202376|FG002|Overall Study|Serious Adverse Event|1|||
163953929|NCT01177722|592202377|FG003|Overall Study|Serious Adverse Event|0|||
163953930|NCT01177722|592202374|FG000|Overall Study|Protocol Violation|0|||
163953931|NCT01177722|592202375|FG001|Overall Study|Protocol Violation|0|||
163953932|NCT01177722|592202376|FG002|Overall Study|Protocol Violation|1|||
163953933|NCT01177722|592202377|FG003|Overall Study|Protocol Violation|0|||
163953934|NCT01177722|592202374|FG000|Overall Study|Lost to Follow-up|3|||
163953935|NCT01177722|592202375|FG001|Overall Study|Lost to Follow-up|4|||
163953936|NCT01177722|592202376|FG002|Overall Study|Lost to Follow-up|3|||
163953937|NCT01177722|592202377|FG003|Overall Study|Lost to Follow-up|1|||
163953938|NCT01177722|592202374|FG000|Overall Study|Withdrawal by Subject|10|||
163953939|NCT01177722|592202375|FG001|Overall Study|Withdrawal by Subject|6|||
163953940|NCT01177722|592202376|FG002|Overall Study|Withdrawal by Subject|4|||
163953941|NCT01177722|592202377|FG003|Overall Study|Withdrawal by Subject|6|||
163953942|NCT02831387|592202378|FG000|Overall Study|Withdrawal by Subject|1|||
163953943|NCT02831387|592202379|FG001|Overall Study|Withdrawal by Subject|1|||
163953944|NCT02831387|592202378|FG000|Overall Study|Discontinued due to stock recovery|0|||
163953945|NCT02831387|592202379|FG001|Overall Study|Discontinued due to stock recovery|1|||
163953946|NCT01828073|592202380|FG000|Overall Study|Lost to Follow-up|1|||
163953947|NCT01828073|592202381|FG001|Overall Study|Lost to Follow-up|2|||
163953948|NCT02079610|592202383|FG000|Overall Study|Withdrawal by Subject|1|||
163953949|NCT02079610|592202384|FG001|Overall Study|Withdrawal by Subject|1|||
163953950|NCT05220254|592202385|FG000|Overall Study|Withdrawal by Subject|4|||
163953951|NCT05220254|592202385|FG000|Overall Study|Removed due to ineligibility|1|||
163953952|NCT05220254|592202385|FG000|Overall Study|Lost to Follow-up|7|||
163953953|NCT01557283|592202388|FG000|Overall Study|Lost to Follow-up|7|||
163953954|NCT01557283|592202388|FG000|Overall Study|Non-responder|19|||
163953955|NCT01557283|592202388|FG000|Overall Study|Adverse Event|7|||
163953956|NCT01557283|592202388|FG000|Overall Study|Lack of Efficacy|1|||
163953957|NCT01557283|592202388|FG000|Overall Study|Non-compliance|1|||
163953958|NCT01557283|592202388|FG000|Overall Study|Withdrawal by Subject|1|||
163953959|NCT01557283|592202388|FG000|Overall Study|Participant's weight too high for dose|1|||
163953960|NCT01557283|592202388|FG000|Overall Study|Worsening of psoriasis|1|||
163953961|NCT01557283|592202388|FG000|Overall Study|Other|6|||
163953962|NCT02080221|592202389|FG000|Overall Study|Withdrawal by Subject|1|||
163953963|NCT02080221|592202389|FG000|Overall Study|Clinical Progression of Disease|1|||
163953964|NCT03786783|592202390|FG000|Overall Study|Death|1|||
163953965|NCT03786783|592202390|FG000|Overall Study|Physician Decision|6|||
163953966|NCT03786783|592202390|FG000|Overall Study|Withdrawal by Subject|2|||
163953967|NCT03786783|592202390|FG000|Overall Study|Disease Progression|7|||
163953968|NCT03786783|592202390|FG000|Overall Study|Patient/Parent Refusal|4|||
163953969|NCT04279392|592202393|FG000|Overall Study|Physician Decision|1|||
163953970|NCT04279392|592202394|FG001|Overall Study|Physician Decision|0|||
163953971|NCT01981473|592202395|FG000|Overall Study|Incorrect diagnosis of RA|0|||
163953972|NCT01981473|592202396|FG001|Overall Study|Incorrect diagnosis of RA|0|||
163953973|NCT01981473|592202397|FG002|Overall Study|Incorrect diagnosis of RA|1|||
163953974|NCT01981473|592202395|FG000|Overall Study|Received treatment for < 6 months|0|||
163953975|NCT01981473|592202396|FG001|Overall Study|Received treatment for < 6 months|0|||
163953976|NCT01981473|592202397|FG002|Overall Study|Received treatment for < 6 months|1|||
163953977|NCT01981473|592202395|FG000|Overall Study|Received treatment for >24 months|2|||
163953978|NCT01981473|592202396|FG001|Overall Study|Received treatment for >24 months|0|||
163953979|NCT01981473|592202397|FG002|Overall Study|Received treatment for >24 months|6|||
163953980|NCT00738582|592202398|FG000|Combination Therapy|Completed Combination Therapy|1|||
163953981|NCT00738582|592202399|FG001|Combination Therapy|Completed Combination Therapy|0|||
163953982|NCT00738582|592202398|FG000|Combination Therapy|Physician Decision|1|||
163953983|NCT00738582|592202399|FG001|Combination Therapy|Physician Decision|0|||
163953984|NCT00738582|592202398|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
163953985|NCT00738582|592202399|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
163953986|NCT00738582|592202398|FG000|Combination Therapy|Other|5|||
163953987|NCT00738582|592202399|FG001|Combination Therapy|Other|0|||
163953988|NCT00738582|592202398|FG000|Combination Therapy|Adverse Event|16|||
163953989|NCT00738582|592202399|FG001|Combination Therapy|Adverse Event|0|||
163953990|NCT00738582|592202398|FG000|Combination Therapy|Progressive Disease|9|||
163953991|NCT00738582|592202399|FG001|Combination Therapy|Progressive Disease|0|||
163953992|NCT00738582|592202398|FG000|Maintenance Therapy|Other|0|||
163953993|NCT00738582|592202399|FG001|Maintenance Therapy|Other|2|||
163953994|NCT00738582|592202398|FG000|Maintenance Therapy|Adverse Event|0|||
163953995|NCT00738582|592202399|FG001|Maintenance Therapy|Adverse Event|6|||
163953996|NCT00738582|592202398|FG000|Maintenance Therapy|Progressive Disease|0|||
163953997|NCT00738582|592202399|FG001|Maintenance Therapy|Progressive Disease|47|||
163953998|NCT00738582|592202398|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
163953999|NCT00738582|592202399|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
163954000|NCT01052103|592202400|FG000|Overall Study|Adverse Event|10|||
163954001|NCT01052103|592202401|FG001|Overall Study|Adverse Event|6|||
163954002|NCT01052103|592202400|FG000|Overall Study|Entry Criteria Not Met|3|||
163954003|NCT01052103|592202401|FG001|Overall Study|Entry Criteria Not Met|1|||
163954004|NCT01052103|592202400|FG000|Overall Study|Lost to Follow-up|3|||
163954005|NCT01052103|592202401|FG001|Overall Study|Lost to Follow-up|5|||
163954006|NCT01052103|592202400|FG000|Overall Study|Protocol Violation|10|||
163954007|NCT01052103|592202401|FG001|Overall Study|Protocol Violation|4|||
163954008|NCT01052103|592202400|FG000|Overall Study|Scheduling conflict|2|||
163954009|NCT01052103|592202401|FG001|Overall Study|Scheduling conflict|1|||
163954010|NCT01052103|592202400|FG000|Overall Study|Sponsor Decision|2|||
163954011|NCT01052103|592202401|FG001|Overall Study|Sponsor Decision|0|||
163954012|NCT01052103|592202400|FG000|Overall Study|Withdrawal by Subject|3|||
163954013|NCT01052103|592202401|FG001|Overall Study|Withdrawal by Subject|6|||
163954014|NCT01052103|592202400|FG000|Overall Study|Perceived Lack of Efficacy|1|||
163954015|NCT01052103|592202401|FG001|Overall Study|Perceived Lack of Efficacy|0|||
163954016|NCT00666679|592202404|FG000|First Intervention|Lost to Follow-up|1|||
163954017|NCT00666679|592202405|FG001|First Intervention|Lost to Follow-up|0|||
163954018|NCT00666679|592202404|FG000|First Intervention|Protocol Violation|1|||
163954019|NCT00666679|592202405|FG001|First Intervention|Protocol Violation|0|||
163954020|NCT00666679|592202404|FG000|First Intervention|Withdrawal by Subject|1|||
163954021|NCT00666679|592202405|FG001|First Intervention|Withdrawal by Subject|0|||
163954022|NCT00666679|592202404|FG000|First Intervention|Randomized did not start treatment|1|||
163954023|NCT00666679|592202405|FG001|First Intervention|Randomized did not start treatment|1|||
163954024|NCT00666679|592202404|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
163954025|NCT00666679|592202405|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
163954026|NCT00666679|592202404|FG000|Washout Period of 1 Week|Protocol Violation|0|||
163954027|NCT00666679|592202405|FG001|Washout Period of 1 Week|Protocol Violation|1|||
163954028|NCT00666679|592202404|FG000|Second Intervention|Adverse Event|1|||
163954029|NCT00666679|592202405|FG001|Second Intervention|Adverse Event|0|||
163954030|NCT00666679|592202404|FG000|Second Intervention|Death|0|||
163954031|NCT00666679|592202405|FG001|Second Intervention|Death|1|||
163954032|NCT02518490|592202406|FG000|Overall Study|Withdrawal by Subject|1|||
163954033|NCT02518490|592202407|FG001|Overall Study|Withdrawal by Subject|1|||
163954034|NCT00211185|592202408|FG000|Overall Study|Death|2|||
163954035|NCT00211185|592202408|FG000|Overall Study|Disease progression|7|||
163954036|NCT00211185|592202408|FG000|Overall Study|Withdrawal by Subject|6|||
163954037|NCT00211185|592202408|FG000|Overall Study|Physician Decision|5|||
163954038|NCT00552240|592202409|FG000|Overall Study|Adverse Event|9|||
163954039|NCT00552240|592202410|FG001|Overall Study|Adverse Event|9|||
163954040|NCT00552240|592202409|FG000|Overall Study|Protocol Violation|1|||
164047779|NCT00403390|592534187|FG000|Overall Study|non-compliant|1|||
164047780|NCT00403390|592534188|FG001|Overall Study|non-compliant|0|||
164047781|NCT01796106|592534189|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
164047782|NCT01796106|592534190|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
163954041|NCT00552240|592202410|FG001|Overall Study|Protocol Violation|1|||
163954042|NCT00552240|592202409|FG000|Overall Study|Lost to Follow-up|5|||
163954043|NCT00552240|592202410|FG001|Overall Study|Lost to Follow-up|6|||
163954044|NCT00552240|592202409|FG000|Overall Study|Withdrawal by Subject|2|||
163954045|NCT00552240|592202410|FG001|Overall Study|Withdrawal by Subject|2|||
163954046|NCT00552240|592202409|FG000|Overall Study|Lack of Efficacy|6|||
163954047|NCT00552240|592202410|FG001|Overall Study|Lack of Efficacy|0|||
163954048|NCT00552240|592202409|FG000|Overall Study|Other|1|||
163954049|NCT00552240|592202410|FG001|Overall Study|Other|0|||
163954050|NCT02679573|592202411|FG000|Overall Study|Adverse Event|13|||
163954051|NCT02679573|592202412|FG001|Overall Study|Adverse Event|6|||
163954052|NCT02679573|592202411|FG000|Overall Study|Lack of Efficacy|12|||
163954053|NCT02679573|592202412|FG001|Overall Study|Lack of Efficacy|15|||
163954054|NCT02679573|592202411|FG000|Overall Study|Could not complete required study visits|6|||
163954055|NCT02679573|592202412|FG001|Overall Study|Could not complete required study visits|2|||
163954056|NCT02679573|592202411|FG000|Overall Study|Withdrawal by Subject|2|||
163954057|NCT02679573|592202412|FG001|Overall Study|Withdrawal by Subject|9|||
163954058|NCT02679573|592202411|FG000|Overall Study|Death|2|||
163954059|NCT02679573|592202412|FG001|Overall Study|Death|0|||
163954060|NCT02679573|592202411|FG000|Overall Study|Physician Decision|2|||
163954061|NCT02679573|592202412|FG001|Overall Study|Physician Decision|4|||
163954062|NCT02679573|592202411|FG000|Overall Study|Lost to Follow-up|0|||
163954063|NCT02679573|592202412|FG001|Overall Study|Lost to Follow-up|3|||
163954064|NCT02476279|592202413|FG000|Overall Study|Lost to Follow-up|1|||
163954065|NCT02476279|592202414|FG001|Overall Study|Lost to Follow-up|1|||
163954066|NCT02128542|592202415|FG000|Overall Study|Lost to Follow-up|3|||
163954067|NCT02128542|592202416|FG001|Overall Study|Lost to Follow-up|0|||
163954068|NCT02128542|592202415|FG000|Overall Study|Withdrew Consent|1|||
163954069|NCT02128542|592202416|FG001|Overall Study|Withdrew Consent|0|||
163954070|NCT01411215|592202420|FG000|Overall Study|Adverse Event|1|||
163954071|NCT01411215|592202421|FG001|Overall Study|Adverse Event|2|||
163954072|NCT01411215|592202420|FG000|Overall Study|Lack of Efficacy|2|||
163954073|NCT01411215|592202421|FG001|Overall Study|Lack of Efficacy|4|||
163954074|NCT01411215|592202420|FG000|Overall Study|Lost to Follow-up|12|||
163954075|NCT01411215|592202421|FG001|Overall Study|Lost to Follow-up|18|||
163954076|NCT01411215|592202420|FG000|Overall Study|Did not meet entrance criteria|0|||
163954077|NCT01411215|592202421|FG001|Overall Study|Did not meet entrance criteria|1|||
163954078|NCT01411215|592202420|FG000|Overall Study|Study terminated by sponsor|2|||
163954079|NCT01411215|592202421|FG001|Overall Study|Study terminated by sponsor|15|||
163954080|NCT01411215|592202420|FG000|Overall Study|Protocol Violation|3|||
163954081|NCT01411215|592202421|FG001|Overall Study|Protocol Violation|5|||
163954082|NCT01411215|592202420|FG000|Overall Study|Withdrawal by Subject|34|||
163954083|NCT01411215|592202421|FG001|Overall Study|Withdrawal by Subject|21|||
163954084|NCT01411215|592202420|FG000|Overall Study|Other|12|||
163954085|NCT01411215|592202421|FG001|Overall Study|Other|17|||
163954086|NCT01411215|592202420|FG000|Overall Study|Screen failure|0|||
163954087|NCT01411215|592202421|FG001|Overall Study|Screen failure|1|||
163954088|NCT03451162|592202426|FG000|Overall Study|Lost to Follow-up|1|||
163954089|NCT03451162|592202427|FG001|Overall Study|Lost to Follow-up|0|||
163954090|NCT03451162|592202428|FG002|Overall Study|Lost to Follow-up|0|||
163954091|NCT03451162|592202429|FG003|Overall Study|Lost to Follow-up|0|||
163954092|NCT03451162|592202430|FG004|Overall Study|Lost to Follow-up|0|||
163954093|NCT03451162|592202426|FG000|Overall Study|Physician Decision|0|||
163954094|NCT03451162|592202427|FG001|Overall Study|Physician Decision|1|||
163954095|NCT03451162|592202428|FG002|Overall Study|Physician Decision|0|||
163954096|NCT03451162|592202429|FG003|Overall Study|Physician Decision|0|||
163954097|NCT03451162|592202430|FG004|Overall Study|Physician Decision|0|||
163954098|NCT03451162|592202426|FG000|Overall Study|Withdrawal by Subject|1|||
163954099|NCT03451162|592202427|FG001|Overall Study|Withdrawal by Subject|1|||
163954100|NCT03451162|592202428|FG002|Overall Study|Withdrawal by Subject|0|||
163954101|NCT03451162|592202429|FG003|Overall Study|Withdrawal by Subject|0|||
163954102|NCT03451162|592202430|FG004|Overall Study|Withdrawal by Subject|0|||
163954103|NCT03305731|592202431|FG000|Overall Study|Protocol Violation|1|||
163954104|NCT04634825|592202432|FG000|Overall Study|Death|10|||
163954105|NCT04634825|592202433|FG001|Overall Study|Death|3|||
163954106|NCT04634825|592202432|FG000|Overall Study|Lost to Follow-up|1|||
163954107|NCT04634825|592202433|FG001|Overall Study|Lost to Follow-up|0|||
163954108|NCT04634825|592202432|FG000|Overall Study|Study terminated by sponsor|35|||
163954109|NCT04634825|592202433|FG001|Overall Study|Study terminated by sponsor|11|||
163954110|NCT04634825|592202432|FG000|Overall Study|Withdrawal by Subject|2|||
163954111|NCT04634825|592202433|FG001|Overall Study|Withdrawal by Subject|0|||
163954112|NCT01952054|592202434|FG000|Overall Study|Physician Decision|1|||
163954113|NCT01127139|592202435|FG000|Overall Study|Adverse Event|40|||
163954114|NCT01127139|592202435|FG000|Overall Study|Incompliance|12|||
163954115|NCT01127139|592202435|FG000|Overall Study|Lack of Efficacy|4|||
163954116|NCT01127139|592202435|FG000|Overall Study|Reason not specified|1|||
163954117|NCT01100034|592202436|FG000|Overall Study|Lost to Follow-up|11|||
163954118|NCT01100034|592202436|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
163954119|NCT01100034|592202436|FG000|Overall Study|Withdrawal by Subject|4|||
163954120|NCT01100034|592202436|FG000|Overall Study|Sponsor decision|21|||
163954121|NCT01100034|592202436|FG000|Overall Study|Participated in another clinical trial|1|||
163954122|NCT01100034|592202436|FG000|Overall Study|Participants moved to another hospital|4|||
163954123|NCT01100034|592202436|FG000|Overall Study|Site closed due to non-responsiveness|1|||
163954124|NCT00402597|592202437|FG000|Overall Study|Death|15|||
163954125|NCT00402597|592202438|FG001|Overall Study|Death|7|||
163954126|NCT00402597|592202439|FG002|Overall Study|Death|6|||
163954127|NCT00402597|592202440|FG003|Overall Study|Death|4|||
163954128|NCT00402597|592202441|FG004|Overall Study|Death|6|||
163954129|NCT00402597|592202437|FG000|Overall Study|Adverse Event|81|||
163954130|NCT00402597|592202438|FG001|Overall Study|Adverse Event|18|||
163954131|NCT00402597|592202439|FG002|Overall Study|Adverse Event|106|||
163954132|NCT00402597|592202440|FG003|Overall Study|Adverse Event|39|||
163954133|NCT00402597|592202441|FG004|Overall Study|Adverse Event|71|||
163954134|NCT00402597|592202437|FG000|Overall Study|Lost to Follow-up|8|||
163954135|NCT00402597|592202438|FG001|Overall Study|Lost to Follow-up|1|||
163954136|NCT00402597|592202439|FG002|Overall Study|Lost to Follow-up|8|||
163954137|NCT00402597|592202440|FG003|Overall Study|Lost to Follow-up|2|||
163954138|NCT00402597|592202441|FG004|Overall Study|Lost to Follow-up|3|||
163954139|NCT00402597|592202437|FG000|Overall Study|Withdrawal by Subject|57|||
163954140|NCT00402597|592202438|FG001|Overall Study|Withdrawal by Subject|16|||
163954141|NCT00402597|592202439|FG002|Overall Study|Withdrawal by Subject|65|||
163954142|NCT00402597|592202440|FG003|Overall Study|Withdrawal by Subject|15|||
163954143|NCT00402597|592202441|FG004|Overall Study|Withdrawal by Subject|24|||
163954144|NCT00402597|592202437|FG000|Overall Study|reason not specified|30|||
163954145|NCT00402597|592202438|FG001|Overall Study|reason not specified|4|||
163954146|NCT00402597|592202439|FG002|Overall Study|reason not specified|27|||
163954147|NCT00402597|592202440|FG003|Overall Study|reason not specified|14|||
163954148|NCT00402597|592202441|FG004|Overall Study|reason not specified|20|||
163954149|NCT01831856|592202442|FG000|Overall Study|Adverse Event|5|||
163954150|NCT01831856|592202443|FG001|Overall Study|Adverse Event|8|||
163954151|NCT01831856|592202442|FG000|Overall Study|Lack of Efficacy|13|||
163954152|NCT01831856|592202443|FG001|Overall Study|Lack of Efficacy|11|||
163954153|NCT01831856|592202442|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
163954154|NCT01831856|592202443|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
163954155|NCT05208866|592202445|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
163954156|NCT00836095|592202453|FG000|Overall Study|Physician Decision|0|||
163954157|NCT00836095|592202454|FG001|Overall Study|Physician Decision|3|||
163954158|NCT01602562|592202455|FG000|Overall Study|Adverse Event|3|||
163954159|NCT01602562|592202456|FG001|Overall Study|Adverse Event|1|||
163954160|NCT01602562|592202455|FG000|Overall Study|Physician Decision|1|||
163954161|NCT01602562|592202456|FG001|Overall Study|Physician Decision|1|||
163954162|NCT01602562|592202455|FG000|Overall Study|Withdrawal by Subject|1|||
163954163|NCT01602562|592202456|FG001|Overall Study|Withdrawal by Subject|1|||
163954164|NCT04964414|592202458|FG000|Overall Study|Lost to Follow-up|10|||
163954165|NCT04964414|592202459|FG001|Overall Study|Lost to Follow-up|8|||
163954166|NCT04964414|592202458|FG000|Overall Study|Withdrawal by Subject|1|||
163954167|NCT04964414|592202459|FG001|Overall Study|Withdrawal by Subject|1|||
163954168|NCT00232544|592202468|FG000|Overall Study|Lost to Follow-up|20|||
163954169|NCT00232544|592202469|FG001|Overall Study|Lost to Follow-up|15|||
163954170|NCT02581631|592202470|FG000|Overall Study|Disease progression|29|||
163954171|NCT02581631|592202471|FG001|Overall Study|Disease progression|19|||
163954172|NCT02581631|592202472|FG002|Overall Study|Disease progression|13|||
163954173|NCT02581631|592202473|FG003|Overall Study|Disease progression|5|||
163954174|NCT02581631|592202474|FG004|Overall Study|Disease progression|8|||
163954175|NCT02581631|592202470|FG000|Overall Study|Study drug toxicity|4|||
163954176|NCT02581631|592202471|FG001|Overall Study|Study drug toxicity|6|||
163954177|NCT02581631|592202472|FG002|Overall Study|Study drug toxicity|7|||
163954178|NCT02581631|592202473|FG003|Overall Study|Study drug toxicity|0|||
163954179|NCT02581631|592202474|FG004|Overall Study|Study drug toxicity|3|||
163954180|NCT02581631|592202470|FG000|Overall Study|AE unrelated to study drug|3|||
163954181|NCT02581631|592202471|FG001|Overall Study|AE unrelated to study drug|1|||
164047783|NCT04430036|592534191|FG000|Safety Run in Phase|Progression of disease|2|||
164047784|NCT01842334|592534192|FG000|Overall Study|Withdrawal by Subject|3|||
164047785|NCT01842334|592534193|FG001|Overall Study|Withdrawal by Subject|3|||
164047786|NCT01842334|592534192|FG000|Overall Study|Moved away mid-study|0|||
164047787|NCT01842334|592534193|FG001|Overall Study|Moved away mid-study|1|||
164047788|NCT01332851|592534198|FG000|Overall Study|Withdrawal by Subject|4|||
164047789|NCT01332851|592534199|FG001|Overall Study|Withdrawal by Subject|2|||
163954182|NCT02581631|592202472|FG002|Overall Study|AE unrelated to study drug|1|||
163954183|NCT02581631|592202473|FG003|Overall Study|AE unrelated to study drug|0|||
163954184|NCT02581631|592202474|FG004|Overall Study|AE unrelated to study drug|2|||
163954185|NCT02581631|592202470|FG000|Overall Study|Request to discontinue|1|||
164047790|NCT01332851|592534198|FG000|Overall Study|Lost to Follow-up|7|||
164047791|NCT01332851|592534199|FG001|Overall Study|Lost to Follow-up|11|||
163954186|NCT02581631|592202471|FG001|Overall Study|Request to discontinue|0|||
163954187|NCT02581631|592202472|FG002|Overall Study|Request to discontinue|3|||
163954188|NCT02581631|592202473|FG003|Overall Study|Request to discontinue|0|||
163954189|NCT02581631|592202474|FG004|Overall Study|Request to discontinue|1|||
163954190|NCT02581631|592202470|FG000|Overall Study|participant withdrew consent|3|||
163954191|NCT02581631|592202471|FG001|Overall Study|participant withdrew consent|0|||
163954192|NCT02581631|592202472|FG002|Overall Study|participant withdrew consent|1|||
163954193|NCT02581631|592202473|FG003|Overall Study|participant withdrew consent|0|||
163954194|NCT02581631|592202474|FG004|Overall Study|participant withdrew consent|0|||
163954195|NCT02581631|592202470|FG000|Overall Study|Maximum clinical benefit|1|||
163954196|NCT02581631|592202471|FG001|Overall Study|Maximum clinical benefit|7|||
163954197|NCT02581631|592202472|FG002|Overall Study|Maximum clinical benefit|1|||
163954198|NCT02581631|592202473|FG003|Overall Study|Maximum clinical benefit|3|||
163954199|NCT02581631|592202474|FG004|Overall Study|Maximum clinical benefit|13|||
163954200|NCT02581631|592202470|FG000|Overall Study|Other Reasons|1|||
163954201|NCT02581631|592202471|FG001|Overall Study|Other Reasons|0|||
163954202|NCT02581631|592202472|FG002|Overall Study|Other Reasons|2|||
163954203|NCT02581631|592202473|FG003|Overall Study|Other Reasons|2|||
163954204|NCT02581631|592202474|FG004|Overall Study|Other Reasons|3|||
163954205|NCT02581631|592202470|FG000|Overall Study|Poor/Non-Compliance|0|||
163954206|NCT02581631|592202471|FG001|Overall Study|Poor/Non-Compliance|0|||
163954207|NCT02581631|592202472|FG002|Overall Study|Poor/Non-Compliance|1|||
163954208|NCT02581631|592202473|FG003|Overall Study|Poor/Non-Compliance|0|||
163954209|NCT02581631|592202474|FG004|Overall Study|Poor/Non-Compliance|0|||
163954210|NCT00116753|592202475|FG000|Overall Study|Adverse Event|16|||
163954211|NCT00116753|592202476|FG001|Overall Study|Adverse Event|10|||
163954212|NCT00116753|592202477|FG002|Overall Study|Adverse Event|7|||
163954213|NCT00116753|592202475|FG000|Overall Study|Withdrawal by Subject|11|||
163954214|NCT00116753|592202476|FG001|Overall Study|Withdrawal by Subject|12|||
163954215|NCT00116753|592202477|FG002|Overall Study|Withdrawal by Subject|8|||
163954216|NCT00116753|592202475|FG000|Overall Study|Lost to Follow-up|0|||
163954217|NCT00116753|592202476|FG001|Overall Study|Lost to Follow-up|2|||
163954218|NCT00116753|592202477|FG002|Overall Study|Lost to Follow-up|1|||
163954219|NCT00116753|592202475|FG000|Overall Study|Protocol Violation|0|||
163954220|NCT00116753|592202476|FG001|Overall Study|Protocol Violation|0|||
163954221|NCT00116753|592202477|FG002|Overall Study|Protocol Violation|1|||
163954222|NCT00116753|592202475|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
163954223|NCT00116753|592202476|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
163954224|NCT00116753|592202477|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
163954225|NCT00116753|592202475|FG000|Overall Study|Disease Progression|3|||
163954226|NCT00116753|592202476|FG001|Overall Study|Disease Progression|4|||
163954227|NCT00116753|592202477|FG002|Overall Study|Disease Progression|3|||
163954228|NCT00116753|592202475|FG000|Overall Study|Abnormal Echocardiogram|0|||
163954229|NCT00116753|592202476|FG001|Overall Study|Abnormal Echocardiogram|0|||
163954230|NCT00116753|592202477|FG002|Overall Study|Abnormal Echocardiogram|1|||
163954231|NCT00116753|592202475|FG000|Overall Study|Progressive Parkinson's Disease|1|||
163954232|NCT00116753|592202476|FG001|Overall Study|Progressive Parkinson's Disease|0|||
163954233|NCT00116753|592202477|FG002|Overall Study|Progressive Parkinson's Disease|0|||
163954234|NCT00116753|592202475|FG000|Overall Study|Dosing Error|0|||
163954235|NCT00116753|592202476|FG001|Overall Study|Dosing Error|1|||
163954236|NCT00116753|592202477|FG002|Overall Study|Dosing Error|0|||
163954237|NCT01200589|592202478|FG000|Overall Study|Withdrawal by Subject|13|||
163954238|NCT01200589|592202479|FG001|Overall Study|Withdrawal by Subject|11|||
163954239|NCT01200589|592202478|FG000|Overall Study|Physician Decision|2|||
163954240|NCT01200589|592202479|FG001|Overall Study|Physician Decision|2|||
163954241|NCT01200589|592202478|FG000|Overall Study|Lost to Follow-up|5|||
163954242|NCT01200589|592202479|FG001|Overall Study|Lost to Follow-up|4|||
163954243|NCT01200589|592202478|FG000|Overall Study|Study terminated|170|||
163954244|NCT01200589|592202479|FG001|Overall Study|Study terminated|172|||
163954245|NCT00986973|592202480|FG000|Overall Study|Withdrawn by study team|1|||
163954246|NCT00598273|592202481|FG000|Overall Study|Adverse Event|4|||
163954247|NCT00598273|592202482|FG001|Overall Study|Adverse Event|5|||
163954248|NCT00598273|592202483|FG002|Overall Study|Adverse Event|2|||
163954249|NCT00598273|592202481|FG000|Overall Study|Death|6|||
163954250|NCT00598273|592202482|FG001|Overall Study|Death|12|||
163954251|NCT00598273|592202483|FG002|Overall Study|Death|8|||
163954252|NCT00598273|592202481|FG000|Overall Study|Lost to Follow-up|8|||
163954253|NCT00598273|592202482|FG001|Overall Study|Lost to Follow-up|3|||
163954254|NCT00598273|592202483|FG002|Overall Study|Lost to Follow-up|5|||
163954255|NCT00598273|592202481|FG000|Overall Study|Physician Decision|0|||
163954256|NCT00598273|592202482|FG001|Overall Study|Physician Decision|0|||
163954257|NCT00598273|592202483|FG002|Overall Study|Physician Decision|1|||
163954258|NCT00598273|592202481|FG000|Overall Study|Withdrawal by Subject|12|||
163954259|NCT00598273|592202482|FG001|Overall Study|Withdrawal by Subject|10|||
163954260|NCT00598273|592202483|FG002|Overall Study|Withdrawal by Subject|10|||
163954261|NCT00598273|592202481|FG000|Overall Study|Noncompliance|3|||
163954262|NCT00598273|592202482|FG001|Overall Study|Noncompliance|2|||
163954263|NCT00598273|592202483|FG002|Overall Study|Noncompliance|3|||
164047792|NCT01302691|592534200|FG000|Overall Study|Adverse Event|2|||
164047793|NCT01302691|592534201|FG001|Overall Study|Adverse Event|0|||
163954264|NCT00598273|592202481|FG000|Overall Study|Relocation|0|||
163954265|NCT00598273|592202482|FG001|Overall Study|Relocation|2|||
163954266|NCT00598273|592202483|FG002|Overall Study|Relocation|4|||
163954267|NCT00598273|592202481|FG000|Overall Study|Renal transplant|1|||
163954268|NCT00598273|592202482|FG001|Overall Study|Renal transplant|0|||
163954269|NCT00598273|592202483|FG002|Overall Study|Renal transplant|1|||
163954270|NCT00598273|592202481|FG000|Overall Study|Site elected to close|1|||
163954271|NCT00598273|592202482|FG001|Overall Study|Site elected to close|0|||
163954272|NCT00598273|592202483|FG002|Overall Study|Site elected to close|0|||
163954273|NCT00598273|592202481|FG000|Overall Study|Started dialysis|6|||
163954274|NCT00598273|592202482|FG001|Overall Study|Started dialysis|4|||
163954275|NCT00598273|592202483|FG002|Overall Study|Started dialysis|5|||
163954276|NCT01590082|592202484|FG000|Overall Study|Withdrawal by Subject|1|||
163954277|NCT01590082|592202485|FG001|Overall Study|Withdrawal by Subject|0|||
163954278|NCT01590082|592202484|FG000|Overall Study|Ineligible|1|||
163954279|NCT01590082|592202485|FG001|Overall Study|Ineligible|0|||
163954280|NCT02549196|592202486|FG000|Overall Study|Protocol Violation|0|||
163954281|NCT02549196|592202487|FG001|Overall Study|Protocol Violation|0|||
163954282|NCT02549196|592202488|FG002|Overall Study|Protocol Violation|0|||
163954283|NCT02549196|592202489|FG003|Overall Study|Protocol Violation|1|||
163954284|NCT02549196|592202486|FG000|Overall Study|Withdrawal by Subject|1|||
163954285|NCT02549196|592202487|FG001|Overall Study|Withdrawal by Subject|0|||
163954286|NCT02549196|592202488|FG002|Overall Study|Withdrawal by Subject|1|||
163954287|NCT02549196|592202489|FG003|Overall Study|Withdrawal by Subject|0|||
163954288|NCT01442779|592202490|FG000|Overall Study|Withdrawal by Subject|3|||
163954289|NCT01442779|592202490|FG000|Overall Study|Death|3|||
163954290|NCT01442779|592202490|FG000|Overall Study|Non-compliance|1|||
163954291|NCT05195489|592204325|FG000|Overall Study|Lost to Follow-up|1|||
163954292|NCT05195489|592204326|FG001|Overall Study|Lost to Follow-up|0|||
163954293|NCT05195489|592204325|FG000|Overall Study|Protocol Violation|0|||
163954294|NCT05195489|592204326|FG001|Overall Study|Protocol Violation|2|||
163954295|NCT05195489|592204325|FG000|Overall Study|Withdrawal by Subject|1|||
163954296|NCT05195489|592204326|FG001|Overall Study|Withdrawal by Subject|1|||
163954297|NCT05195489|592204325|FG000|Overall Study|Removed|0|||
163954298|NCT05195489|592204326|FG001|Overall Study|Removed|1|||
163954299|NCT00409773|592204328|FG000|Overall Study|Adverse Event|3|||
163954300|NCT00409773|592204329|FG001|Overall Study|Adverse Event|4|||
163954301|NCT00409773|592204330|FG002|Overall Study|Adverse Event|4|||
163954302|NCT00409773|592204331|FG003|Overall Study|Adverse Event|2|||
163954303|NCT00409773|592204332|FG004|Overall Study|Adverse Event|6|||
163954304|NCT00409773|592204328|FG000|Overall Study|Lost to Follow-up|6|||
163954305|NCT00409773|592204329|FG001|Overall Study|Lost to Follow-up|1|||
163954306|NCT00409773|592204330|FG002|Overall Study|Lost to Follow-up|2|||
163954307|NCT00409773|592204331|FG003|Overall Study|Lost to Follow-up|3|||
163954308|NCT00409773|592204332|FG004|Overall Study|Lost to Follow-up|1|||
163954309|NCT00409773|592204328|FG000|Overall Study|Physician Decision|0|||
163954310|NCT00409773|592204329|FG001|Overall Study|Physician Decision|0|||
163954311|NCT00409773|592204330|FG002|Overall Study|Physician Decision|0|||
163954312|NCT00409773|592204331|FG003|Overall Study|Physician Decision|2|||
163954313|NCT00409773|592204332|FG004|Overall Study|Physician Decision|0|||
163954314|NCT00409773|592204328|FG000|Overall Study|Protocol Violation|0|||
163954315|NCT00409773|592204329|FG001|Overall Study|Protocol Violation|2|||
163954316|NCT00409773|592204330|FG002|Overall Study|Protocol Violation|3|||
163954317|NCT00409773|592204331|FG003|Overall Study|Protocol Violation|3|||
163954318|NCT00409773|592204332|FG004|Overall Study|Protocol Violation|1|||
163954319|NCT00409773|592204328|FG000|Overall Study|Withdrawal by Subject|0|||
163954320|NCT00409773|592204329|FG001|Overall Study|Withdrawal by Subject|0|||
163954321|NCT00409773|592204330|FG002|Overall Study|Withdrawal by Subject|0|||
163954322|NCT00409773|592204331|FG003|Overall Study|Withdrawal by Subject|2|||
163954323|NCT00409773|592204332|FG004|Overall Study|Withdrawal by Subject|1|||
163954324|NCT00409773|592204328|FG000|Overall Study|Lack of Eligibility|0|||
163954325|NCT00409773|592204329|FG001|Overall Study|Lack of Eligibility|0|||
163954326|NCT00409773|592204330|FG002|Overall Study|Lack of Eligibility|0|||
163954327|NCT00409773|592204331|FG003|Overall Study|Lack of Eligibility|0|||
163954328|NCT00409773|592204332|FG004|Overall Study|Lack of Eligibility|1|||
163954329|NCT01201343|592204333|FG000|Overall Study|Adverse Event|6|||
163954330|NCT01201343|592204333|FG000|Overall Study|Withdrawal by Subject|5|||
163954331|NCT01201343|592204333|FG000|Overall Study|Lost to Follow-up|2|||
163954332|NCT01201343|592204333|FG000|Overall Study|Lack of Efficacy|2|||
163954333|NCT01201343|592204333|FG000|Overall Study|Participant wrongly included in trial|1|||
163954334|NCT01201343|592204333|FG000|Overall Study|Randomized, not treated|3|||
163954335|NCT01919814|592204334|FG000|Overall Study|Adverse Event|1|||
163954336|NCT01919814|592204335|FG001|Overall Study|Adverse Event|0|||
163954337|NCT01919814|592204334|FG000|Overall Study|Protocol Violation|1|||
163954338|NCT01919814|592204335|FG001|Overall Study|Protocol Violation|0|||
163954339|NCT01919814|592204334|FG000|Overall Study|Withdrawal by Subject|1|||
163954340|NCT01919814|592204335|FG001|Overall Study|Withdrawal by Subject|0|||
163954341|NCT02164383|592204336|FG000|Overall Study|Lost to Follow-up|1|||
163954342|NCT02164383|592204337|FG001|Overall Study|Lost to Follow-up|0|||
163954343|NCT01672723|592204338|FG000|First Intervention|Adverse Event|3|||
163954344|NCT01672723|592204339|FG001|First Intervention|Adverse Event|0|||
163954345|NCT00743275|592204340|FG000|Overall Study|Protocol Violation|0|||
163954346|NCT00743275|592204341|FG001|Overall Study|Protocol Violation|1|||
163954347|NCT03057977|592204345|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
163954348|NCT03057977|592204346|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
163954349|NCT03057977|592204345|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
164047794|NCT01302691|592534200|FG000|Overall Study|Death|0|||
164047795|NCT01302691|592534201|FG001|Overall Study|Death|1|||
164047796|NCT01302691|592534200|FG000|Overall Study|Lost to Follow-up|1|||
164047797|NCT01302691|592534201|FG001|Overall Study|Lost to Follow-up|0|||
164047798|NCT01302691|592534200|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
164047799|NCT01302691|592534201|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
164047800|NCT01302691|592534200|FG000|Overall Study|Physician Decision|0|||
164047801|NCT01302691|592534201|FG001|Overall Study|Physician Decision|1|||
164047802|NCT01302691|592534200|FG000|Overall Study|Protocol Violation|1|||
164047803|NCT01302691|592534201|FG001|Overall Study|Protocol Violation|0|||
164047804|NCT03446612|592534202|FG000|Overall Study|Protocol defined stopping criteria|0|||
164047805|NCT03446612|592534203|FG001|Overall Study|Protocol defined stopping criteria|1|||
164047806|NCT01249157|592534205|FG000|Overall Study|Withdrawal by Subject|1|||
164047807|NCT03796195|592534206|FG000|Overall Study|Study closed early|1|||
164047808|NCT04445051|592534207|FG000|Overall Study|Adverse Event|0|||
164047809|NCT04445051|592534208|FG001|Overall Study|Adverse Event|0|||
164047810|NCT04445051|592534209|FG002|Overall Study|Adverse Event|1|||
164047811|NCT04445051|592534210|FG003|Overall Study|Adverse Event|0|||
164047812|NCT04445051|592534211|FG004|Overall Study|Adverse Event|0|||
164047813|NCT04445051|592534212|FG005|Overall Study|Adverse Event|0|||
164047814|NCT02392468|592534215|FG000|Overall Study|Adverse Event|0|||
164047815|NCT02392468|592534216|FG001|Overall Study|Adverse Event|1|||
164047816|NCT02392468|592534217|FG002|Overall Study|Adverse Event|0|||
164047817|NCT02392468|592534218|FG003|Overall Study|Adverse Event|0|||
164047818|NCT02392468|592534219|FG004|Overall Study|Adverse Event|0|||
164047819|NCT02392468|592534220|FG005|Overall Study|Adverse Event|1|||
164047820|NCT01039428|592534221|FG000|Overall Study|Protocol Violation|1|||
164047821|NCT01039428|592534222|FG001|Overall Study|Protocol Violation|0|||
164047822|NCT01039428|592534221|FG000|Overall Study|Withdrawal by Subject|1|||
164047823|NCT01039428|592534222|FG001|Overall Study|Withdrawal by Subject|0|||
164047824|NCT01313039|592534223|FG000|Overall Study|Physician Decision|1|||
164047825|NCT01313039|592534223|FG000|Overall Study|Adverse Event|1|||
164047826|NCT03630016|592534224|FG000|Overall Study|Poor Sensor Placement|1|||
164047827|NCT05083949|592534225|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
164047828|NCT05083949|592534226|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
164047829|NCT05083949|592534225|FG000|Period 1|Adverse Event|1|||
164047830|NCT05083949|592534226|FG001|Period 1|Adverse Event|1|||
164047831|NCT05083949|592534225|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
164047832|NCT05083949|592534226|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
164047833|NCT05083949|592534225|FG000|Period 2|Adverse Event|0|||
164047834|NCT05083949|592534226|FG001|Period 2|Adverse Event|2|||
164047835|NCT01678560|592534227|FG000|Overall Study|Physician Decision|4|||
164047836|NCT01678560|592534228|FG001|Overall Study|Physician Decision|4|||
164047837|NCT01678560|592534227|FG000|Overall Study|Death|0|||
164047838|NCT01678560|592534228|FG001|Overall Study|Death|1|||
164047839|NCT01678560|592534227|FG000|Overall Study|Withdrawal by Subject|0|||
164047840|NCT01678560|592534228|FG001|Overall Study|Withdrawal by Subject|1|||
164047841|NCT02201472|592534229|FG000|Overall Study|Lack of Efficacy|2|||
164047842|NCT02470429|592534230|FG000|Overall Study|Adverse Event|1|||
164047843|NCT02470429|592534231|FG001|Overall Study|Adverse Event|0|||
163954350|NCT03057977|592204346|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
163954351|NCT03057977|592204345|FG000|Discontinuation From Treatment|Protocol Violation|6|||
163954352|NCT03057977|592204346|FG001|Discontinuation From Treatment|Protocol Violation|5|||
163954353|NCT03057977|592204345|FG000|Discontinuation From Treatment|Not treated|4|||
163954354|NCT03057977|592204346|FG001|Discontinuation From Treatment|Not treated|0|||
163954355|NCT03057977|592204345|FG000|Discontinuation From Treatment|Adverse Event|343|||
163954356|NCT03057977|592204346|FG001|Discontinuation From Treatment|Adverse Event|337|||
163954357|NCT03057977|592204345|FG000|Discontinuation From Treatment|Reason Unknown|0|||
163954358|NCT03057977|592204346|FG001|Discontinuation From Treatment|Reason Unknown|1|||
163954359|NCT03057977|592204345|FG000|Discontinuation From Treatment|Personal Reasons|1|||
163954360|NCT03057977|592204346|FG001|Discontinuation From Treatment|Personal Reasons|1|||
163954361|NCT03057977|592204345|FG000|Discontinuation From Treatment|Unblinded medication|1|||
163954362|NCT03057977|592204346|FG001|Discontinuation From Treatment|Unblinded medication|0|||
163954363|NCT03057977|592204345|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
163954364|NCT03057977|592204346|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
163954365|NCT03057977|592204345|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
163954366|NCT03057977|592204346|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
163954367|NCT03057977|592204345|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
163954368|NCT03057977|592204346|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
163954369|NCT03057977|592204345|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
164148625|NCT04895982|592904921|FG010|Overall Study|Protocol Violation|0|||
163954370|NCT03057977|592204346|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
163954371|NCT03057977|592204345|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
163954372|NCT03057977|592204346|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
163954373|NCT03057977|592204345|FG000|Discontinuation From Treatment|Not attending study visit|3|||
163954374|NCT03057977|592204346|FG001|Discontinuation From Treatment|Not attending study visit|10|||
163954375|NCT03057977|592204345|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
163954376|NCT03057977|592204346|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
163954377|NCT03057977|592204345|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
163954378|NCT03057977|592204346|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
163954379|NCT03057977|592204345|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
163954380|NCT03057977|592204346|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
163954381|NCT03057977|592204345|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
163954382|NCT03057977|592204346|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
163954383|NCT03057977|592204345|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
163954384|NCT03057977|592204346|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
163954385|NCT01201317|592204347|FG000|Overall Study|Withdrawal by Subject|5|||
163954386|NCT01201317|592204348|FG001|Overall Study|Withdrawal by Subject|0|||
163954387|NCT01201317|592204349|FG002|Overall Study|Withdrawal by Subject|3|||
163954388|NCT01201317|592204347|FG000|Overall Study|Adverse Event|2|||
163954389|NCT01201317|592204348|FG001|Overall Study|Adverse Event|2|||
163954390|NCT01201317|592204349|FG002|Overall Study|Adverse Event|2|||
163954391|NCT01201317|592204347|FG000|Overall Study|Screen failure|1|||
163954392|NCT01201317|592204348|FG001|Overall Study|Screen failure|1|||
163954393|NCT01201317|592204349|FG002|Overall Study|Screen failure|0|||
163954394|NCT01201317|592204347|FG000|Overall Study|Protocol Violation|0|||
163954395|NCT01201317|592204348|FG001|Overall Study|Protocol Violation|1|||
163954396|NCT01201317|592204349|FG002|Overall Study|Protocol Violation|1|||
163954397|NCT01201317|592204347|FG000|Overall Study|Death|0|||
163954398|NCT01201317|592204348|FG001|Overall Study|Death|1|||
163954399|NCT01201317|592204349|FG002|Overall Study|Death|0|||
163954400|NCT01201317|592204347|FG000|Overall Study|Study-specific withdrawal criteria|0|||
163954401|NCT01201317|592204348|FG001|Overall Study|Study-specific withdrawal criteria|0|||
163954402|NCT01201317|592204349|FG002|Overall Study|Study-specific withdrawal criteria|1|||
163954403|NCT01201317|592204347|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
163954404|NCT01201317|592204348|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
163954405|NCT01201317|592204349|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
163954406|NCT01201317|592204347|FG000|Overall Study|Decrease in renal function|0|||
163954407|NCT01201317|592204348|FG001|Overall Study|Decrease in renal function|1|||
163954408|NCT01201317|592204349|FG002|Overall Study|Decrease in renal function|0|||
163954409|NCT01201317|592204347|FG000|Overall Study|Lack of Efficacy|1|||
163954410|NCT01201317|592204348|FG001|Overall Study|Lack of Efficacy|0|||
163954411|NCT01201317|592204349|FG002|Overall Study|Lack of Efficacy|0|||
163954412|NCT01201317|592204347|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
163954413|NCT01201317|592204348|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
163954414|NCT01201317|592204349|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
163954415|NCT01350336|592204350|FG000|Overall Study|Lost to Follow-up|31|||
163954416|NCT01350336|592204350|FG000|Overall Study|Withdrawal by Subject|14|||
163954417|NCT01350336|592204350|FG000|Overall Study|Physician Decision|8|||
163954418|NCT01350336|592204350|FG000|Overall Study|Death|4|||
163954419|NCT02795429|592204351|FG000|Overall Study|Adverse Event|1|||
163954420|NCT02795429|592204352|FG001|Overall Study|Adverse Event|2|||
163954421|NCT02795429|592204353|FG002|Overall Study|Adverse Event|1|||
163954422|NCT02795429|592204354|FG003|Overall Study|Adverse Event|2|||
163954423|NCT02795429|592204355|FG004|Overall Study|Adverse Event|1|||
163954424|NCT02795429|592204351|FG000|Overall Study|Death|1|||
163954425|NCT02795429|592204352|FG001|Overall Study|Death|0|||
163954426|NCT02795429|592204353|FG002|Overall Study|Death|1|||
163954427|NCT02795429|592204354|FG003|Overall Study|Death|2|||
163954428|NCT02795429|592204355|FG004|Overall Study|Death|1|||
163954429|NCT02795429|592204351|FG000|Overall Study|Physician Decision|0|||
163954430|NCT02795429|592204352|FG001|Overall Study|Physician Decision|0|||
163954431|NCT02795429|592204353|FG002|Overall Study|Physician Decision|2|||
163954432|NCT02795429|592204354|FG003|Overall Study|Physician Decision|1|||
163954433|NCT02795429|592204355|FG004|Overall Study|Physician Decision|5|||
163954434|NCT02795429|592204351|FG000|Overall Study|Progressive disease|3|||
163954435|NCT02795429|592204352|FG001|Overall Study|Progressive disease|7|||
163954436|NCT02795429|592204353|FG002|Overall Study|Progressive disease|6|||
163954437|NCT02795429|592204354|FG003|Overall Study|Progressive disease|26|||
163954438|NCT02795429|592204355|FG004|Overall Study|Progressive disease|20|||
163954439|NCT02795429|592204351|FG000|Overall Study|Subject/guardian decision|1|||
163954440|NCT02795429|592204352|FG001|Overall Study|Subject/guardian decision|1|||
163954441|NCT02795429|592204353|FG002|Overall Study|Subject/guardian decision|1|||
163954442|NCT02795429|592204354|FG003|Overall Study|Subject/guardian decision|1|||
163954443|NCT02795429|592204355|FG004|Overall Study|Subject/guardian decision|3|||
163954444|NCT04964388|592204356|FG000|Overall Study|Lost to Follow-up|3|||
163954445|NCT04964388|592204357|FG001|Overall Study|Lost to Follow-up|2|||
163954446|NCT00250679|592204358|FG000|Overall Study|Adverse Event|12|||
163954447|NCT00250679|592204359|FG001|Overall Study|Adverse Event|15|||
163954448|NCT00250679|592204360|FG002|Overall Study|Adverse Event|16|||
163954449|NCT00250679|592204358|FG000|Overall Study|Protocol Violation|2|||
163954450|NCT00250679|592204359|FG001|Overall Study|Protocol Violation|4|||
163954451|NCT00250679|592204360|FG002|Overall Study|Protocol Violation|3|||
163954452|NCT00250679|592204358|FG000|Overall Study|Withdrawal by Subject|15|||
163954453|NCT00250679|592204359|FG001|Overall Study|Withdrawal by Subject|18|||
163954454|NCT00250679|592204360|FG002|Overall Study|Withdrawal by Subject|15|||
163954455|NCT00250679|592204358|FG000|Overall Study|Lost to Follow-up|3|||
163954456|NCT00250679|592204359|FG001|Overall Study|Lost to Follow-up|4|||
163954457|NCT00250679|592204360|FG002|Overall Study|Lost to Follow-up|2|||
163954458|NCT00250679|592204358|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
163954459|NCT00250679|592204359|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
163954460|NCT00250679|592204360|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
163954461|NCT00250679|592204358|FG000|Overall Study|Lack of Efficacy|0|||
163954462|NCT00250679|592204359|FG001|Overall Study|Lack of Efficacy|1|||
163954463|NCT00250679|592204360|FG002|Overall Study|Lack of Efficacy|3|||
163954464|NCT00250679|592204358|FG000|Overall Study|Technical Holter issues|1|||
163954465|NCT00250679|592204359|FG001|Overall Study|Technical Holter issues|0|||
163954466|NCT00250679|592204360|FG002|Overall Study|Technical Holter issues|2|||
163954467|NCT00250679|592204358|FG000|Overall Study|Moved|1|||
163954468|NCT00250679|592204359|FG001|Overall Study|Moved|1|||
163954469|NCT00250679|592204360|FG002|Overall Study|Moved|0|||
163954470|NCT00250679|592204358|FG000|Overall Study|Non-compliance|1|||
163954471|NCT00250679|592204359|FG001|Overall Study|Non-compliance|1|||
163954472|NCT00250679|592204360|FG002|Overall Study|Non-compliance|0|||
163954473|NCT00250679|592204358|FG000|Overall Study|various single events: hip surgery,diary|3|||
163954474|NCT00250679|592204359|FG001|Overall Study|various single events: hip surgery,diary|1|||
163954475|NCT00250679|592204360|FG002|Overall Study|various single events: hip surgery,diary|1|||
163954476|NCT00448279|592204361|FG000|Overall Study|Lost to Follow-up|2|||
163954477|NCT00448279|592204362|FG001|Overall Study|Lost to Follow-up|2|||
163954478|NCT00448279|592204361|FG000|Overall Study|Adverse Event|1|||
163954479|NCT00448279|592204362|FG001|Overall Study|Adverse Event|1|||
163954480|NCT00448279|592204361|FG000|Overall Study|Disease progression|16|||
163954481|NCT00448279|592204362|FG001|Overall Study|Disease progression|18|||
163954482|NCT00448279|592204361|FG000|Overall Study|Withdrawal by Subject|4|||
163954483|NCT00448279|592204362|FG001|Overall Study|Withdrawal by Subject|3|||
163954484|NCT00448279|592204361|FG000|Overall Study|Other|6|||
163954485|NCT00448279|592204362|FG001|Overall Study|Other|4|||
163954486|NCT00448279|592204361|FG000|Overall Study|Protocol Violation|0|||
163954487|NCT00448279|592204362|FG001|Overall Study|Protocol Violation|1|||
163954488|NCT03907410|592204363|FG000|Overall Study|Lost to Follow-up|4|||
163954489|NCT03907410|592204364|FG001|Overall Study|Lost to Follow-up|1|||
163954490|NCT03907410|592204365|FG002|Overall Study|Lost to Follow-up|1|||
163954491|NCT03907410|592204363|FG000|Overall Study|Lost to follow-up and research burden|0|||
163954492|NCT03907410|592204364|FG001|Overall Study|Lost to follow-up and research burden|0|||
163954493|NCT03907410|592204365|FG002|Overall Study|Lost to follow-up and research burden|1|||
163954494|NCT04776148|592204366|FG000|Overall Study|Death|249|||
163954495|NCT04776148|592204367|FG001|Overall Study|Death|260|||
163954496|NCT04776148|592204366|FG000|Overall Study|Lost to Follow-up|0|||
163954497|NCT04776148|592204367|FG001|Overall Study|Lost to Follow-up|1|||
163954498|NCT04776148|592204366|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
163954499|NCT04776148|592204367|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
163954500|NCT04776148|592204366|FG000|Overall Study|Withdrawal by Subject|3|||
163954501|NCT04776148|592204367|FG001|Overall Study|Withdrawal by Subject|4|||
163954502|NCT04776148|592204366|FG000|Overall Study|Sponsor Decision|30|||
163954503|NCT04776148|592204367|FG001|Overall Study|Sponsor Decision|15|||
163954504|NCT01155375|592204368|FG000|Overall Study|Adverse Event|1|||
163954505|NCT01155375|592204369|FG001|Overall Study|Adverse Event|0|||
163954506|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
163954507|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
163954508|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
163954509|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
163954510|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
163954511|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
163954512|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
163954513|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
163954514|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
163954515|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
163954516|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
163954517|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
163954518|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
163954519|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
163954520|NCT00757588|592204370|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
163954521|NCT00757588|592204371|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
163954522|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
163954523|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
163954524|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
163954525|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
163954526|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
163954527|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
163954528|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
163954529|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
163954530|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
163954531|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
163954532|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
163954533|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
163954534|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
163954535|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
163954536|NCT00757588|592204370|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
163954537|NCT00757588|592204371|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
163954538|NCT00881608|592204373|FG000|Overall Study|Study prematurely terminated|11|||
163954539|NCT00701220|592204374|FG000|Overall Study|Withdrawal by Subject|0|||
163954540|NCT00701220|592204375|FG001|Overall Study|Withdrawal by Subject|2|||
163954541|NCT00701220|592204374|FG000|Overall Study|Protocol Violation|2|||
163954542|NCT00701220|592204375|FG001|Overall Study|Protocol Violation|0|||
163954543|NCT04018092|592204378|FG000|Overall Study|Withdrawal by Subject|1|||
163954544|NCT04018092|592204379|FG001|Overall Study|Withdrawal by Subject|1|||
163954545|NCT04018092|592204378|FG000|Overall Study|Withdrawal by Subject|1|||
163954546|NCT04018092|592204379|FG001|Overall Study|Withdrawal by Subject|1|||
163954547|NCT06469242|592204380|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
163954548|NCT06469242|592204381|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
163954549|NCT06469242|592204380|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
163954550|NCT06469242|592204381|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
163954551|NCT01205152|592204382|FG000|Overall Study|Death|1|||
163954552|NCT00069108|592204383|FG000|Overall Study|Withdrawal by Subject|5|||
163954553|NCT00069108|592204384|FG001|Overall Study|Withdrawal by Subject|9|||
163954554|NCT00069108|592204383|FG000|Overall Study|Adverse Event|64|||
163954555|NCT00069108|592204384|FG001|Overall Study|Adverse Event|42|||
163954556|NCT00069108|592204383|FG000|Overall Study|Death|6|||
163954557|NCT00069108|592204384|FG001|Overall Study|Death|6|||
163954558|NCT00069108|592204383|FG000|Overall Study|Administration|15|||
163954559|NCT00069108|592204384|FG001|Overall Study|Administration|4|||
163954560|NCT00069108|592204383|FG000|Overall Study|Insufficient therapy|117|||
163954561|NCT00069108|592204384|FG001|Overall Study|Insufficient therapy|144|||
163954562|NCT00069108|592204383|FG000|Overall Study|Violation criteria|1|||
163954563|NCT00069108|592204384|FG001|Overall Study|Violation criteria|4|||
163954564|NCT00069108|592204383|FG000|Overall Study|Refused treatment|5|||
163954565|NCT00069108|592204384|FG001|Overall Study|Refused treatment|10|||
163954566|NCT02783768|592204385|FG000|Overall Study|Lost to Follow-up|1|||
163954567|NCT02783768|592204386|FG001|Overall Study|Lost to Follow-up|0|||
163954568|NCT02208999|592204387|FG000|Overall Study|Lost to Follow-up|1|||
163954569|NCT00319839|592204388|FG000|Overall Study|Adverse Event|5|||
163954570|NCT00319839|592204388|FG000|Overall Study|Withdrawal by Subject|1|||
163954571|NCT00986674|592204389|FG000|Overall Study|Lack of Efficacy|28|||
163954572|NCT00986674|592204390|FG001|Overall Study|Lack of Efficacy|25|||
163954573|NCT00986674|592204391|FG002|Overall Study|Lack of Efficacy|23|||
163954574|NCT00986674|592204389|FG000|Overall Study|Adverse Event|4|||
163954575|NCT00986674|592204390|FG001|Overall Study|Adverse Event|8|||
163954576|NCT00986674|592204391|FG002|Overall Study|Adverse Event|9|||
163954577|NCT00986674|592204389|FG000|Overall Study|Death|5|||
163954578|NCT00986674|592204390|FG001|Overall Study|Death|0|||
163954579|NCT00986674|592204391|FG002|Overall Study|Death|4|||
163954580|NCT00986674|592204389|FG000|Overall Study|Withdrawal by Subject|6|||
163954581|NCT00986674|592204390|FG001|Overall Study|Withdrawal by Subject|2|||
163954582|NCT00986674|592204391|FG002|Overall Study|Withdrawal by Subject|1|||
163954583|NCT00986674|592204389|FG000|Overall Study|alternative therapy|0|||
163954584|NCT00986674|592204390|FG001|Overall Study|alternative therapy|0|||
163954585|NCT00986674|592204391|FG002|Overall Study|alternative therapy|1|||
163954586|NCT00986674|592204389|FG000|Overall Study|not start protocol therapy|4|||
163954587|NCT00986674|592204390|FG001|Overall Study|not start protocol therapy|3|||
163954588|NCT00986674|592204391|FG002|Overall Study|not start protocol therapy|1|||
163954589|NCT00986674|592204389|FG000|Overall Study|unknown/not specify|0|||
163954590|NCT00986674|592204390|FG001|Overall Study|unknown/not specify|7|||
163954591|NCT00986674|592204391|FG002|Overall Study|unknown/not specify|9|||
163954592|NCT01853137|592204392|FG000|Overall Study|Lost to Follow-up|4|||
163954593|NCT01853137|592204393|FG001|Overall Study|Lost to Follow-up|1|||
163954594|NCT03658668|592204394|FG000|Overall Study|Time Commitment|1|||
163954595|NCT03658668|592204395|FG001|Overall Study|Time Commitment|1|||
163954596|NCT01136772|592204398|FG000|Overall Study|Adverse Event|15|||
163954597|NCT01136772|592204399|FG001|Overall Study|Adverse Event|14|||
163954598|NCT01136772|592204398|FG000|Overall Study|Lack of Efficacy|42|||
163954599|NCT01136772|592204399|FG001|Overall Study|Lack of Efficacy|39|||
163954600|NCT01136772|592204398|FG000|Overall Study|Administrative|14|||
163954601|NCT01136772|592204399|FG001|Overall Study|Administrative|12|||
163954602|NCT01136772|592204398|FG000|Overall Study|Withdrawal by Subject|33|||
163954603|NCT01136772|592204399|FG001|Overall Study|Withdrawal by Subject|36|||
163954604|NCT01136772|592204398|FG000|Overall Study|Did not receive injection|10|||
163954605|NCT01136772|592204399|FG001|Overall Study|Did not receive injection|7|||
163954606|NCT01136772|592204398|FG000|Overall Study|Did not follow up after first injection|2|||
163954607|NCT01136772|592204399|FG001|Overall Study|Did not follow up after first injection|2|||
163954608|NCT03881553|592204400|FG000|Overall Study|Discharged prior to participation|1|||
163954609|NCT03881553|592204401|FG001|Overall Study|Discharged prior to participation|1|||
163954610|NCT03881553|592204402|FG002|Overall Study|Discharged prior to participation|0|||
163954611|NCT03881553|592204400|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
163954612|NCT03881553|592204401|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
163954613|NCT03881553|592204402|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
163954614|NCT01718353|592204403|FG000|Overall Study|Lost to Follow-up|0|||
163954615|NCT01718353|592204404|FG001|Overall Study|Lost to Follow-up|1|||
163954616|NCT01718353|592204403|FG000|Overall Study|Principal Investigator's Decision|10|||
163954617|NCT01718353|592204404|FG001|Overall Study|Principal Investigator's Decision|4|||
163954618|NCT01718353|592204403|FG000|Overall Study|Randomized but not treated|2|||
163954619|NCT01718353|592204404|FG001|Overall Study|Randomized but not treated|0|||
163954620|NCT01959516|592204405|FG000|Epoch 1|Adverse Event|4|||
163954621|NCT01959516|592204406|FG001|Epoch 1|Adverse Event|1|||
163954622|NCT01959516|592204405|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
163954623|NCT01959516|592204406|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
163954624|NCT01959516|592204405|FG000|Epoch 1|Subject withdrew consent|3|||
163954625|NCT01959516|592204406|FG001|Epoch 1|Subject withdrew consent|2|||
163954626|NCT01959516|592204405|FG000|Epoch 1|Administrative problems|1|||
163954627|NCT01959516|592204406|FG001|Epoch 1|Administrative problems|0|||
163954628|NCT01959516|592204405|FG000|Epoch 1|Use of prohibited treatment|1|||
163954629|NCT01959516|592204406|FG001|Epoch 1|Use of prohibited treatment|0|||
163954630|NCT01959516|592204405|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
163954631|NCT01959516|592204406|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
163954632|NCT01959516|592204405|FG000|Epoch 1|Protocol deviation|0|||
163954633|NCT01959516|592204406|FG001|Epoch 1|Protocol deviation|1|||
163954634|NCT01959516|592204405|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
163954635|NCT01959516|592204406|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
163954636|NCT01959516|592204405|FG000|Epoch 2|Subject withdrew consent|1|||
163954637|NCT01959516|592204406|FG001|Epoch 2|Subject withdrew consent|0|||
163954638|NCT01959516|592204405|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
163954639|NCT01959516|592204406|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
163954640|NCT01759368|592204409|FG000|Overall Study|Lost to Follow-up|1|||
163954641|NCT01759368|592204410|FG001|Overall Study|Lost to Follow-up|0|||
163954642|NCT01191268|592204411|FG000|Overall Study|Withdrawal by Subject|19|||
163954643|NCT01191268|592204412|FG001|Overall Study|Withdrawal by Subject|25|||
163954644|NCT01191268|592204413|FG002|Overall Study|Withdrawal by Subject|21|||
163954645|NCT01191268|592204411|FG000|Overall Study|Adverse Event|21|||
163954646|NCT01191268|592204412|FG001|Overall Study|Adverse Event|13|||
163954647|NCT01191268|592204413|FG002|Overall Study|Adverse Event|8|||
163954648|NCT01191268|592204411|FG000|Overall Study|Physician Decision|6|||
163954649|NCT01191268|592204412|FG001|Overall Study|Physician Decision|8|||
163954650|NCT01191268|592204413|FG002|Overall Study|Physician Decision|9|||
163954651|NCT01191268|592204411|FG000|Overall Study|Lost to Follow-up|8|||
163954652|NCT01191268|592204412|FG001|Overall Study|Lost to Follow-up|5|||
163954653|NCT01191268|592204413|FG002|Overall Study|Lost to Follow-up|9|||
163954654|NCT01191268|592204411|FG000|Overall Study|Entry Criteria Not Met|3|||
163954655|NCT01191268|592204412|FG001|Overall Study|Entry Criteria Not Met|1|||
164047844|NCT02470429|592534230|FG000|Overall Study|Withdrawal by Subject|1|||
163954656|NCT01191268|592204413|FG002|Overall Study|Entry Criteria Not Met|1|||
163954657|NCT01191268|592204411|FG000|Overall Study|Death|0|||
163954658|NCT01191268|592204412|FG001|Overall Study|Death|1|||
163954659|NCT01191268|592204413|FG002|Overall Study|Death|3|||
163954660|NCT01191268|592204411|FG000|Overall Study|Protocol Violation|1|||
163954661|NCT01191268|592204412|FG001|Overall Study|Protocol Violation|0|||
163954662|NCT01191268|592204413|FG002|Overall Study|Protocol Violation|1|||
163954663|NCT01191268|592204411|FG000|Overall Study|Sponsor Decision|0|||
163954664|NCT01191268|592204412|FG001|Overall Study|Sponsor Decision|2|||
163954665|NCT01191268|592204413|FG002|Overall Study|Sponsor Decision|0|||
163954666|NCT00336895|592204414|FG000|Overall Study|diarrhea|1|||
163954667|NCT00336895|592204414|FG000|Overall Study|nausea and upset stomach|1|||
163954668|NCT00336895|592204414|FG000|Overall Study|Physician Decision|1|||
163954669|NCT00336895|592204414|FG000|Overall Study|screen failed|1|||
163954670|NCT01959334|592204415|FG000|Second Dose|Adverse Event|1|||
163954671|NCT01959334|592204416|FG001|Second Dose|Adverse Event|0|||
163954672|NCT01959334|592204415|FG000|Third Dose|Adverse Event|0|||
163954673|NCT01959334|592204416|FG001|Third Dose|Adverse Event|1|||
163954674|NCT01313689|592204417|FG000|24-Week Randomization 1|Adverse Event|10|||
163954675|NCT01313689|592204418|FG001|24-Week Randomization 1|Adverse Event|5|||
163954676|NCT01313689|592204419|FG002|24-Week Randomization 1|Adverse Event|0|||
163954677|NCT01313689|592204420|FG003|24-Week Randomization 1|Adverse Event|0|||
163954678|NCT01313689|592204421|FG004|24-Week Randomization 1|Adverse Event|0|||
163954679|NCT01313689|592204417|FG000|24-Week Randomization 1|Physician Decision|4|||
163954680|NCT01313689|592204418|FG001|24-Week Randomization 1|Physician Decision|5|||
163954681|NCT01313689|592204419|FG002|24-Week Randomization 1|Physician Decision|0|||
163954682|NCT01313689|592204420|FG003|24-Week Randomization 1|Physician Decision|0|||
163954683|NCT01313689|592204421|FG004|24-Week Randomization 1|Physician Decision|0|||
163954684|NCT01313689|592204417|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
163954685|NCT01313689|592204418|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
163954686|NCT01313689|592204419|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
163954687|NCT01313689|592204420|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
163954688|NCT01313689|592204421|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
163954689|NCT01313689|592204417|FG000|24-Week Randomization 2|Adverse Event|0|||
163954690|NCT01313689|592204418|FG001|24-Week Randomization 2|Adverse Event|0|||
163954691|NCT01313689|592204419|FG002|24-Week Randomization 2|Adverse Event|2|||
163954692|NCT01313689|592204420|FG003|24-Week Randomization 2|Adverse Event|0|||
163954693|NCT01313689|592204421|FG004|24-Week Randomization 2|Adverse Event|8|||
163954694|NCT01313689|592204417|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
163954695|NCT01313689|592204418|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
163954696|NCT01313689|592204419|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
163954697|NCT01313689|592204420|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
163954698|NCT01313689|592204421|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
163954699|NCT01313689|592204417|FG000|24-Week Randomization 2|Physician Decision|0|||
163954700|NCT01313689|592204418|FG001|24-Week Randomization 2|Physician Decision|0|||
163954701|NCT01313689|592204419|FG002|24-Week Randomization 2|Physician Decision|0|||
163954702|NCT01313689|592204420|FG003|24-Week Randomization 2|Physician Decision|0|||
163954703|NCT01313689|592204421|FG004|24-Week Randomization 2|Physician Decision|4|||
163954704|NCT01768637|592204422|FG000|Overall Study|Lost to Follow-up|2|||
163954705|NCT01768637|592204423|FG001|Overall Study|Lost to Follow-up|7|||
163954706|NCT01768637|592204422|FG000|Overall Study|Difficult blood draw|1|||
163954707|NCT01768637|592204423|FG001|Overall Study|Difficult blood draw|0|||
163954708|NCT01054170|592204424|FG000|Overall Study|Protocol Violation|1|||
163954709|NCT01054170|592204425|FG001|Overall Study|Protocol Violation|0|||
163954710|NCT01054170|592204424|FG000|Overall Study|Withdrawal by Subject|3|||
163954711|NCT01054170|592204425|FG001|Overall Study|Withdrawal by Subject|2|||
163954712|NCT01054170|592204424|FG000|Overall Study|Adverse Event|0|||
163954713|NCT01054170|592204425|FG001|Overall Study|Adverse Event|4|||
163954714|NCT02951767|592204426|FG000|Overall Study|Study Terminated By Sponsor|9|||
163954715|NCT02951767|592204426|FG000|Overall Study|Withdrawal by Subject|11|||
163954716|NCT02951767|592204426|FG000|Overall Study|Death|96|||
163954717|NCT02951767|592204426|FG000|Overall Study|Lost to Follow-up|2|||
163954718|NCT02951767|592204426|FG000|Overall Study|Physician Decision|1|||
163954719|NCT01337115|592204427|FG000|Overall Study|Protocol Violation|2|||
163954720|NCT01337115|592204428|FG001|Overall Study|Protocol Violation|0|||
163954721|NCT03426267|592204431|FG000|Overall Study|Physician Decision|1|||
163954722|NCT03426267|592204432|FG001|Overall Study|Physician Decision|4|||
163954723|NCT03426267|592204431|FG000|Overall Study|Lost to Follow-up|1|||
163954724|NCT03426267|592204432|FG001|Overall Study|Lost to Follow-up|0|||
163954725|NCT03426267|592204431|FG000|Overall Study|Withdrawal by Subject|4|||
163954726|NCT03426267|592204432|FG001|Overall Study|Withdrawal by Subject|10|||
164047845|NCT02470429|592534231|FG001|Overall Study|Withdrawal by Subject|0|||
164047846|NCT01300767|592534232|FG000|Overall Study|Discomfort|2|||
164047847|NCT01300767|592534232|FG000|Overall Study|Biomicroscopy|1|||
164047848|NCT01300767|592534232|FG000|Overall Study|Unacceptable fit|1|||
164047849|NCT01602744|592534233|FG000|Overall Study|Death|17|||
164047850|NCT01602744|592534234|FG001|Overall Study|Death|15|||
164047851|NCT01602744|592534233|FG000|Overall Study|Lost to Follow-up|13|||
163954727|NCT03426267|592204431|FG000|Overall Study|Protocol Violation|1|||
163954728|NCT03426267|592204432|FG001|Overall Study|Protocol Violation|3|||
164047852|NCT01602744|592534234|FG001|Overall Study|Lost to Follow-up|8|||
164047853|NCT00606294|592534235|FG000|Overall Study|Withdrawal by Subject|36|||
164047854|NCT00606294|592534236|FG001|Overall Study|Withdrawal by Subject|0|||
163954729|NCT03426267|592204431|FG000|Overall Study|Adverse Event|9|||
163954730|NCT03426267|592204432|FG001|Overall Study|Adverse Event|27|||
163954731|NCT03426267|592204431|FG000|Overall Study|Prohibited Treatment Intake|2|||
163954732|NCT03426267|592204432|FG001|Overall Study|Prohibited Treatment Intake|3|||
163954733|NCT03426267|592204431|FG000|Overall Study|Lack of Efficacy|0|||
163954734|NCT03426267|592204432|FG001|Overall Study|Lack of Efficacy|25|||
164047855|NCT01976624|592534237|FG000|Overall Study|Participants contraindicated|2|||
164148626|NCT04895982|592904922|FG011|Overall Study|Protocol Violation|0|||
163954735|NCT03426267|592204431|FG000|Overall Study|other|3|||
163954736|NCT03426267|592204432|FG001|Overall Study|other|0|||
163954737|NCT00609765|592204435|FG000|Overall Study|Study ended prior to 12 months|1|||
163954738|NCT02054520|592204442|FG000|Overall Study|Adverse Event|1|||
163954739|NCT02054520|592204443|FG001|Overall Study|Adverse Event|4|||
163954740|NCT02054520|592204444|FG002|Overall Study|Adverse Event|2|||
163954741|NCT02054520|592204445|FG003|Overall Study|Adverse Event|1|||
163954742|NCT02054520|592204446|FG004|Overall Study|Adverse Event|1|||
163954743|NCT02054520|592204447|FG005|Overall Study|Adverse Event|0|||
163954744|NCT02054520|592204442|FG000|Overall Study|Lack of Efficacy|7|||
163954745|NCT02054520|592204443|FG001|Overall Study|Lack of Efficacy|0|||
163954746|NCT02054520|592204444|FG002|Overall Study|Lack of Efficacy|2|||
163954747|NCT02054520|592204445|FG003|Overall Study|Lack of Efficacy|1|||
163954748|NCT02054520|592204446|FG004|Overall Study|Lack of Efficacy|3|||
163954749|NCT02054520|592204447|FG005|Overall Study|Lack of Efficacy|2|||
163954750|NCT02054520|592204442|FG000|Overall Study|Withdrawal by Subject|1|||
163954751|NCT02054520|592204443|FG001|Overall Study|Withdrawal by Subject|0|||
163954752|NCT02054520|592204444|FG002|Overall Study|Withdrawal by Subject|0|||
163954753|NCT02054520|592204445|FG003|Overall Study|Withdrawal by Subject|2|||
163954754|NCT02054520|592204446|FG004|Overall Study|Withdrawal by Subject|1|||
163954755|NCT02054520|592204447|FG005|Overall Study|Withdrawal by Subject|0|||
163954756|NCT02054520|592204442|FG000|Overall Study|Physician Decision|0|||
163954757|NCT02054520|592204443|FG001|Overall Study|Physician Decision|1|||
163954758|NCT02054520|592204444|FG002|Overall Study|Physician Decision|0|||
163954759|NCT02054520|592204445|FG003|Overall Study|Physician Decision|1|||
163954760|NCT02054520|592204446|FG004|Overall Study|Physician Decision|0|||
163954761|NCT02054520|592204447|FG005|Overall Study|Physician Decision|1|||
163954762|NCT02054520|592204442|FG000|Overall Study|Study terminated by Sponsor|0|||
163954763|NCT02054520|592204443|FG001|Overall Study|Study terminated by Sponsor|0|||
163954764|NCT02054520|592204444|FG002|Overall Study|Study terminated by Sponsor|2|||
163954765|NCT02054520|592204445|FG003|Overall Study|Study terminated by Sponsor|1|||
163954766|NCT02054520|592204446|FG004|Overall Study|Study terminated by Sponsor|0|||
163954767|NCT02054520|592204447|FG005|Overall Study|Study terminated by Sponsor|0|||
163954768|NCT02027623|592204448|FG000|Overall Study|Lost to Follow-up|3|||
163954769|NCT02027623|592204449|FG001|Overall Study|Lost to Follow-up|3|||
163954770|NCT02027623|592204448|FG000|Overall Study|Withdrawal by Subject|6|||
163954771|NCT02027623|592204449|FG001|Overall Study|Withdrawal by Subject|9|||
163954772|NCT01272804|592204452|FG000|Overall Study|Adverse Event|1|||
163954773|NCT01272804|592204453|FG001|Overall Study|Adverse Event|0|||
163954774|NCT01272804|592204454|FG002|Overall Study|Adverse Event|0|||
163954775|NCT01272804|592204455|FG003|Overall Study|Adverse Event|0|||
163954776|NCT01272804|592204456|FG004|Overall Study|Adverse Event|2|||
163954777|NCT01272804|592204457|FG005|Overall Study|Adverse Event|1|||
163954778|NCT03801915|592204458|FG000|Overall Study|Screen failure|0|||
163954779|NCT03801915|592204459|FG001|Overall Study|Screen failure|0|||
163954780|NCT03801915|592204460|FG002|Overall Study|Screen failure|1|||
163954781|NCT03801915|592204458|FG000|Overall Study|Ineligible|1|||
163954782|NCT03801915|592204459|FG001|Overall Study|Ineligible|0|||
163954783|NCT03801915|592204460|FG002|Overall Study|Ineligible|0|||
163954784|NCT03801915|592204458|FG000|Overall Study|Physician Decision|2|||
163954785|NCT03801915|592204459|FG001|Overall Study|Physician Decision|1|||
163954786|NCT03801915|592204460|FG002|Overall Study|Physician Decision|0|||
163954787|NCT02308020|592204461|FG000|Overall Study|Lost to Follow-up|1|||
163954788|NCT02308020|592204462|FG001|Overall Study|Lost to Follow-up|7|||
163954789|NCT02308020|592204463|FG002|Overall Study|Lost to Follow-up|0|||
163954790|NCT02308020|592204464|FG003|Overall Study|Lost to Follow-up|0|||
163954791|NCT02308020|592204465|FG004|Overall Study|Lost to Follow-up|1|||
163954792|NCT02308020|592204466|FG005|Overall Study|Lost to Follow-up|2|||
163954793|NCT02308020|592204461|FG000|Overall Study|Sponsor Decision|0|||
163954794|NCT02308020|592204462|FG001|Overall Study|Sponsor Decision|8|||
163954795|NCT02308020|592204463|FG002|Overall Study|Sponsor Decision|0|||
163954796|NCT02308020|592204464|FG003|Overall Study|Sponsor Decision|2|||
163954797|NCT02308020|592204465|FG004|Overall Study|Sponsor Decision|2|||
163954798|NCT02308020|592204466|FG005|Overall Study|Sponsor Decision|1|||
163954799|NCT02308020|592204461|FG000|Overall Study|Withdrawal by Subject|3|||
163954800|NCT02308020|592204462|FG001|Overall Study|Withdrawal by Subject|5|||
163954801|NCT02308020|592204463|FG002|Overall Study|Withdrawal by Subject|3|||
163954802|NCT02308020|592204464|FG003|Overall Study|Withdrawal by Subject|2|||
163954803|NCT02308020|592204465|FG004|Overall Study|Withdrawal by Subject|1|||
163954804|NCT02308020|592204466|FG005|Overall Study|Withdrawal by Subject|2|||
163954805|NCT03265938|592204467|FG000|Overall Study|Withdrawal by Subject|1|||
163954806|NCT03265938|592204467|FG000|Overall Study|Physician Decision|1|||
163954807|NCT03265938|592204467|FG000|Overall Study|friable mass|6|||
163954808|NCT01211288|592204468|FG000|Overall Study|Lost to Follow-up|1|||
163954809|NCT01211288|592204469|FG001|Overall Study|Lost to Follow-up|1|||
163954810|NCT01551212|592204470|FG000|Overall Study|Graft loss/Retransplantation|0|||
163954811|NCT01551212|592204471|FG001|Overall Study|Graft loss/Retransplantation|1|||
163954812|NCT01551212|592204470|FG000|Overall Study|Administrative problems|1|||
163954813|NCT01551212|592204471|FG001|Overall Study|Administrative problems|2|||
163954814|NCT01551212|592204470|FG000|Overall Study|Lost to Follow-up|0|||
163954815|NCT01551212|592204471|FG001|Overall Study|Lost to Follow-up|1|||
163954816|NCT01551212|592204470|FG000|Overall Study|Protocol Violation|0|||
163954817|NCT01551212|592204471|FG001|Overall Study|Protocol Violation|1|||
163954818|NCT01551212|592204470|FG000|Overall Study|Withdrawal by Subject|0|||
163954819|NCT01551212|592204471|FG001|Overall Study|Withdrawal by Subject|7|||
163954820|NCT01551212|592204470|FG000|Overall Study|Death|2|||
163954821|NCT01551212|592204471|FG001|Overall Study|Death|4|||
163954822|NCT01551212|592204470|FG000|Overall Study|Never Received Study Treatment|2|||
163954823|NCT01551212|592204471|FG001|Overall Study|Never Received Study Treatment|4|||
163954824|NCT00705523|592204472|FG000|Overall Study|Lost to Follow-up|2|||
163954825|NCT00705523|592204473|FG001|Overall Study|Lost to Follow-up|3|||
163954826|NCT02471833|592204474|FG000|Overall Study|Lost to Follow-up|1|||
163954827|NCT02471833|592204475|FG001|Overall Study|Lost to Follow-up|0|||
163954828|NCT02471833|592204476|FG002|Overall Study|Lost to Follow-up|0|||
163954829|NCT02471833|592204474|FG000|Overall Study|Withdrawal by Subject|2|||
163954830|NCT02471833|592204475|FG001|Overall Study|Withdrawal by Subject|1|||
163954831|NCT02471833|592204476|FG002|Overall Study|Withdrawal by Subject|5|||
163954832|NCT02673515|592204477|FG000|Overall Study|Lack of motivation|2|||
163954833|NCT02673515|592204478|FG001|Overall Study|Lack of motivation|1|||
163954834|NCT02523599|592204481|FG000|Overall Study|Adverse Event|1|||
163954835|NCT02523599|592204482|FG001|Overall Study|Adverse Event|0|||
163954836|NCT02523599|592204481|FG000|Overall Study|Physician Decision|1|||
163954837|NCT02523599|592204482|FG001|Overall Study|Physician Decision|0|||
163954838|NCT02523599|592204481|FG000|Overall Study|Lost to Follow-up|4|||
163954839|NCT02523599|592204482|FG001|Overall Study|Lost to Follow-up|1|||
163954840|NCT02523599|592204481|FG000|Overall Study|Did not return for Day 30 visit|2|||
163954841|NCT02523599|592204482|FG001|Overall Study|Did not return for Day 30 visit|0|||
163954842|NCT01892540|592204483|FG000|Overall Study|Did not complete PET/MRI|0|||
163954843|NCT01892540|592204484|FG001|Overall Study|Did not complete PET/MRI|0|||
163954844|NCT01892540|592204485|FG002|Overall Study|Did not complete PET/MRI|2|||
163954845|NCT01892540|592204483|FG000|Overall Study|Did not fit in scanner|0|||
163954846|NCT01892540|592204484|FG001|Overall Study|Did not fit in scanner|0|||
163954847|NCT01892540|592204485|FG002|Overall Study|Did not fit in scanner|1|||
163954848|NCT01370590|592204486|FG000|Period 1|Adverse Event|8|||
163954849|NCT01370590|592204487|FG001|Period 1|Adverse Event|4|||
163954850|NCT01370590|592204486|FG000|Period 1|Lost to Follow-up|2|||
163954851|NCT01370590|592204487|FG001|Period 1|Lost to Follow-up|2|||
163954852|NCT01370590|592204486|FG000|Period 1|Protocol Violation|2|||
163954853|NCT01370590|592204487|FG001|Period 1|Protocol Violation|2|||
163954854|NCT01370590|592204486|FG000|Period 1|Withdrawal by Subject|4|||
163954855|NCT01370590|592204487|FG001|Period 1|Withdrawal by Subject|2|||
163954856|NCT01370590|592204486|FG000|Period 1|Could not access randomization system|0|||
163954857|NCT01370590|592204487|FG001|Period 1|Could not access randomization system|1|||
163954858|NCT01370590|592204486|FG000|Crossover Washout Period|Adverse Event|1|||
163954859|NCT01370590|592204487|FG001|Crossover Washout Period|Adverse Event|4|||
163954860|NCT01370590|592204486|FG000|Crossover Washout Period|Lost to Follow-up|2|||
163954861|NCT01370590|592204487|FG001|Crossover Washout Period|Lost to Follow-up|0|||
163954862|NCT01370590|592204486|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
163954863|NCT01370590|592204487|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
163954864|NCT01370590|592204486|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
163954865|NCT01370590|592204487|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
163954866|NCT01370590|592204486|FG000|Period 2|Adverse Event|0|||
163954867|NCT01370590|592204487|FG001|Period 2|Adverse Event|1|||
163954868|NCT01370590|592204486|FG000|Period 2|Withdrawal by Subject|1|||
163954869|NCT01370590|592204487|FG001|Period 2|Withdrawal by Subject|1|||
163954870|NCT03110224|592204488|FG000|Overall Study|Death|3|||
163954871|NCT03110224|592204488|FG000|Overall Study|Lost to Follow-up|132|||
163954872|NCT03110224|592204488|FG000|Overall Study|Physician Decision|2|||
163954873|NCT03110224|592204488|FG000|Overall Study|Site Closed by Physician|35|||
163954874|NCT03110224|592204488|FG000|Overall Study|Site Closed by Sponsor|202|||
163954875|NCT03110224|592204488|FG000|Overall Study|Withdrawal by Subject|9|||
163954876|NCT00727311|592204489|FG000|Overall Study|Did not receive drug|316|||
163954877|NCT00727311|592204489|FG000|Overall Study|Missing end of therapy data|205|||
163954878|NCT00727311|592204489|FG000|Overall Study|Adverse Event|58|||
163954879|NCT00727311|592204489|FG000|Overall Study|Lack of Efficacy|242|||
163954880|NCT00727311|592204489|FG000|Overall Study|Lost to Follow-up|73|||
163954881|NCT00727311|592204489|FG000|Overall Study|Withdrawal by Subject|77|||
163954882|NCT00727311|592204489|FG000|Overall Study|Other|97|||
163954883|NCT00727311|592204489|FG000|Overall Study|Multiple reasons|39|||
163954884|NCT03992846|592204490|FG000|Overall Study|Adverse Event|8|||
163954885|NCT03992846|592204491|FG001|Overall Study|Adverse Event|6|||
163954886|NCT03992846|592204492|FG002|Overall Study|Adverse Event|3|||
163954887|NCT03992846|592204490|FG000|Overall Study|Lost to Follow-up|0|||
163954888|NCT03992846|592204491|FG001|Overall Study|Lost to Follow-up|1|||
164047856|NCT01976624|592534237|FG000|Overall Study|Participants age less than 19 years|12|||
163954889|NCT03992846|592204492|FG002|Overall Study|Lost to Follow-up|1|||
163954890|NCT03992846|592204490|FG000|Overall Study|Pregnancy|2|||
163954891|NCT03992846|592204491|FG001|Overall Study|Pregnancy|0|||
163954892|NCT03992846|592204492|FG002|Overall Study|Pregnancy|1|||
163954893|NCT03992846|592204490|FG000|Overall Study|Protocol Violation|1|||
163954894|NCT03992846|592204491|FG001|Overall Study|Protocol Violation|2|||
163954895|NCT03992846|592204492|FG002|Overall Study|Protocol Violation|0|||
163954896|NCT03992846|592204490|FG000|Overall Study|Withdrawal by Subject|8|||
163954897|NCT03992846|592204491|FG001|Overall Study|Withdrawal by Subject|10|||
163954898|NCT03992846|592204492|FG002|Overall Study|Withdrawal by Subject|20|||
163954899|NCT03992846|592204490|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
163954900|NCT03992846|592204491|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
163954901|NCT03992846|592204492|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
163954902|NCT00031551|592206306|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
163954903|NCT00031551|592206307|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
163954904|NCT01440374|592206310|FG000|Part 1: Open-label Phase|Adverse Event|5|||
163954905|NCT01440374|592206311|FG001|Part 1: Open-label Phase|Adverse Event|0|||
163954906|NCT01440374|592206312|FG002|Part 1: Open-label Phase|Adverse Event|0|||
163954907|NCT01440374|592206313|FG003|Part 1: Open-label Phase|Adverse Event|0|||
163954908|NCT01440374|592206310|FG000|Part 1: Open-label Phase|Physician Decision|1|||
163954909|NCT01440374|592206311|FG001|Part 1: Open-label Phase|Physician Decision|0|||
163954910|NCT01440374|592206312|FG002|Part 1: Open-label Phase|Physician Decision|0|||
163954911|NCT01440374|592206313|FG003|Part 1: Open-label Phase|Physician Decision|0|||
163954912|NCT01440374|592206310|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
163954913|NCT01440374|592206311|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
163954914|NCT01440374|592206312|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
163954915|NCT01440374|592206313|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
163954916|NCT01440374|592206310|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
163954917|NCT01440374|592206311|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
163954918|NCT01440374|592206312|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
163954919|NCT01440374|592206313|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
163954920|NCT01440374|592206310|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
163954921|NCT01440374|592206311|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
163954922|NCT01440374|592206312|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
163954923|NCT01440374|592206313|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
163954924|NCT01440374|592206310|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
163954925|NCT01440374|592206311|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
163954926|NCT01440374|592206312|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
163954927|NCT01440374|592206313|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
163954928|NCT01440374|592206310|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
163954929|NCT01440374|592206311|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
163954930|NCT01440374|592206312|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
163954931|NCT01440374|592206313|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
163954932|NCT01440374|592206310|FG000|Part 2; Double-blind Phase|Not treated|0|||
163954933|NCT01440374|592206311|FG001|Part 2; Double-blind Phase|Not treated|0|||
163954934|NCT01440374|592206312|FG002|Part 2; Double-blind Phase|Not treated|1|||
163954935|NCT01440374|592206313|FG003|Part 2; Double-blind Phase|Not treated|0|||
163954936|NCT01440374|592206310|FG000|Part 3: Extension|Withdrawal by Subject|0|||
163954937|NCT01440374|592206311|FG001|Part 3: Extension|Withdrawal by Subject|0|||
163954938|NCT01440374|592206312|FG002|Part 3: Extension|Withdrawal by Subject|0|||
163954939|NCT01440374|592206313|FG003|Part 3: Extension|Withdrawal by Subject|5|||
163954940|NCT01440374|592206310|FG000|Part 3: Extension|Adverse Event|0|||
163954941|NCT01440374|592206311|FG001|Part 3: Extension|Adverse Event|0|||
163954942|NCT01440374|592206312|FG002|Part 3: Extension|Adverse Event|0|||
163954943|NCT01440374|592206313|FG003|Part 3: Extension|Adverse Event|13|||
163954944|NCT01440374|592206310|FG000|Part 3: Extension|Physician Decision|0|||
163954945|NCT01440374|592206311|FG001|Part 3: Extension|Physician Decision|0|||
163954946|NCT01440374|592206312|FG002|Part 3: Extension|Physician Decision|0|||
163954947|NCT01440374|592206313|FG003|Part 3: Extension|Physician Decision|14|||
163954948|NCT04812548|592206314|FG000|Overall Study|Adverse Event|2|||
163954949|NCT04812548|592206315|FG001|Overall Study|Adverse Event|7|||
163954950|NCT04812548|592206314|FG000|Overall Study|HSCT Planned|2|||
164047857|NCT01885104|592534238|FG000|Overall Study|Withdrawal of Consent|1|||
164047858|NCT01885104|592534239|FG001|Overall Study|Withdrawal of Consent|0|||
164047859|NCT01885104|592534238|FG000|Overall Study|Lost to Follow-up|0|||
164047860|NCT01885104|592534239|FG001|Overall Study|Lost to Follow-up|1|||
164047861|NCT01885104|592534238|FG000|Overall Study|Physician Decision|1|||
164047862|NCT01885104|592534239|FG001|Overall Study|Physician Decision|0|||
164047863|NCT00126425|592534241|FG000|Overall Study|Withdrawal by Subject|17|||
163954951|NCT04812548|592206315|FG001|Overall Study|HSCT Planned|3|||
163954952|NCT04812548|592206314|FG000|Overall Study|Progressive Disease|0|||
163954953|NCT04812548|592206315|FG001|Overall Study|Progressive Disease|2|||
163954954|NCT04812548|592206314|FG000|Overall Study|Death|0|||
163954955|NCT04812548|592206315|FG001|Overall Study|Death|1|||
163954956|NCT04812548|592206314|FG000|Overall Study|Post Study Access to Treatment|0|||
163954957|NCT04812548|592206315|FG001|Overall Study|Post Study Access to Treatment|1|||
163954958|NCT04812548|592206314|FG000|Overall Study|Withdrawal by Subject|0|||
163954959|NCT04812548|592206315|FG001|Overall Study|Withdrawal by Subject|1|||
163954960|NCT04812548|592206314|FG000|Overall Study|Physician Decision|1|||
163954961|NCT04812548|592206315|FG001|Overall Study|Physician Decision|0|||
163954962|NCT02141984|592206318|FG000|Overall Study|Lack of Efficacy|2|||
164301035|NCT03938259|593478407|FG000|Overall Study|unable to establish baseline for ventilation|1|||
163954965|NCT00876928|592206322|FG000|Overall Study|Lost to Follow-up|2|||
163954966|NCT00876928|592206323|FG001|Overall Study|Lost to Follow-up|5|||
163954967|NCT00876928|592206322|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
163954968|NCT00876928|592206323|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
163954969|NCT01716117|592206324|FG000|Overall Study|Death|5|||
163954970|NCT01716117|592206325|FG001|Overall Study|Death|2|||
163954971|NCT01716117|592206324|FG000|Overall Study|Withdrawal by Subject|2|||
163954972|NCT01716117|592206325|FG001|Overall Study|Withdrawal by Subject|0|||
163954973|NCT03645057|592206327|FG000|Randomization to Baseline|Lost to Follow-up|1|||
163954974|NCT03645057|592206328|FG001|Randomization to Baseline|Lost to Follow-up|0|||
163954975|NCT03645057|592206329|FG002|Randomization to Baseline|Lost to Follow-up|1|||
163954976|NCT03645057|592206330|FG003|Randomization to Baseline|Lost to Follow-up|0|||
163954977|NCT03645057|592206327|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
163954978|NCT03645057|592206328|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
163954979|NCT03645057|592206329|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
163954980|NCT03645057|592206330|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
163954981|NCT03645057|592206327|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
163954982|NCT03645057|592206328|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
163954983|NCT03645057|592206329|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
163954984|NCT03645057|592206330|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
163954985|NCT03645057|592206327|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
163954986|NCT03645057|592206328|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
163954987|NCT03645057|592206329|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
163954988|NCT03645057|592206330|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
163954989|NCT01171807|592206334|FG000|Overall Study|Treatment failure|2|||
163954990|NCT01171807|592206335|FG001|Overall Study|Treatment failure|4|||
163954991|NCT01171807|592206334|FG000|Overall Study|Non compliance|1|||
163954992|NCT01171807|592206335|FG001|Overall Study|Non compliance|0|||
163954993|NCT01171807|592206334|FG000|Overall Study|Lost to Follow-up|3|||
163954994|NCT01171807|592206335|FG001|Overall Study|Lost to Follow-up|0|||
163954995|NCT01901341|592206336|FG000|Overall Study|Adverse Event|4|||
163954996|NCT01901341|592206337|FG001|Overall Study|Adverse Event|2|||
163954997|NCT01901341|592206336|FG000|Overall Study|Lack of Efficacy|0|||
163954998|NCT01901341|592206337|FG001|Overall Study|Lack of Efficacy|2|||
163954999|NCT01901341|592206336|FG000|Overall Study|Lost to Follow-up|0|||
163955000|NCT01901341|592206337|FG001|Overall Study|Lost to Follow-up|1|||
163955001|NCT01901341|592206336|FG000|Overall Study|Protocol Violation|2|||
163955002|NCT01901341|592206337|FG001|Overall Study|Protocol Violation|0|||
163955003|NCT01901341|592206336|FG000|Overall Study|Study Terminated by Sponsor|13|||
163955004|NCT01901341|592206337|FG001|Overall Study|Study Terminated by Sponsor|15|||
163955005|NCT01901341|592206336|FG000|Overall Study|Withdrawal by Subject|1|||
163955006|NCT01901341|592206337|FG001|Overall Study|Withdrawal by Subject|1|||
163955007|NCT02563522|592206339|FG000|Overall Study|Adverse Event|2|||
163955008|NCT02563522|592206340|FG001|Overall Study|Adverse Event|3|||
163955009|NCT02563522|592206339|FG000|Overall Study|Lost to Follow-up|1|||
163955010|NCT02563522|592206340|FG001|Overall Study|Lost to Follow-up|0|||
163955011|NCT02563522|592206339|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
163955012|NCT02563522|592206340|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
163955013|NCT04874415|592206343|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955014|NCT04874415|592206344|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955015|NCT04874415|592206345|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955016|NCT04874415|592206346|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955017|NCT04874415|592206347|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955018|NCT04874415|592206348|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955019|NCT04874415|592206349|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163955020|NCT04874415|592206350|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955021|NCT04874415|592206351|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
163955022|NCT04874415|592206352|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163955023|NCT04874415|592206353|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955024|NCT04874415|592206354|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163955025|NCT04874415|592206355|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163955026|NCT04874415|592206356|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
163955027|NCT04874415|592206357|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
163955028|NCT04874415|592206358|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
163955029|NCT04874415|592206343|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955030|NCT04874415|592206344|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955031|NCT04874415|592206345|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955032|NCT04874415|592206346|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955033|NCT04874415|592206347|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955034|NCT04874415|592206348|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955035|NCT04874415|592206349|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955036|NCT04874415|592206350|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955037|NCT04874415|592206351|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955038|NCT04874415|592206352|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
163955039|NCT04874415|592206353|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955040|NCT04874415|592206354|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955041|NCT04874415|592206355|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955042|NCT04874415|592206356|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955043|NCT04874415|592206357|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
163955044|NCT04874415|592206358|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
163955045|NCT04874415|592206343|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955046|NCT04874415|592206344|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955047|NCT04874415|592206345|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955048|NCT04874415|592206346|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955049|NCT04874415|592206347|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
163955050|NCT04874415|592206348|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955051|NCT04874415|592206349|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955052|NCT04874415|592206350|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955053|NCT04874415|592206351|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955054|NCT04874415|592206352|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955055|NCT04874415|592206353|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955056|NCT04874415|592206354|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955057|NCT04874415|592206355|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955058|NCT04874415|592206356|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955059|NCT04874415|592206357|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955060|NCT04874415|592206358|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
163955061|NCT05559099|592206359|FG000|Overall Study|Death|5|||
163955062|NCT05559099|592206360|FG001|Overall Study|Death|4|||
163955063|NCT05559099|592206359|FG000|Overall Study|Lost to Follow-up|0|||
163955064|NCT05559099|592206360|FG001|Overall Study|Lost to Follow-up|2|||
163955065|NCT05559099|592206359|FG000|Overall Study|Adverse Event|1|||
163955066|NCT05559099|592206360|FG001|Overall Study|Adverse Event|1|||
163955067|NCT01037244|592206361|FG000|Overall Study|Adverse Event|3|||
163955068|NCT01037244|592206362|FG001|Overall Study|Adverse Event|2|||
163955069|NCT01037244|592206363|FG002|Overall Study|Adverse Event|6|||
163955070|NCT01037244|592206364|FG003|Overall Study|Adverse Event|3|||
163955071|NCT01037244|592206361|FG000|Overall Study|Lack of Efficacy|1|||
163955072|NCT01037244|592206362|FG001|Overall Study|Lack of Efficacy|1|||
163955073|NCT01037244|592206363|FG002|Overall Study|Lack of Efficacy|0|||
163955074|NCT01037244|592206364|FG003|Overall Study|Lack of Efficacy|1|||
163955075|NCT01037244|592206361|FG000|Overall Study|Lost to Follow-up|3|||
163955076|NCT01037244|592206362|FG001|Overall Study|Lost to Follow-up|3|||
163955077|NCT01037244|592206363|FG002|Overall Study|Lost to Follow-up|4|||
163955078|NCT01037244|592206364|FG003|Overall Study|Lost to Follow-up|4|||
163955079|NCT01037244|592206361|FG000|Overall Study|Withdrawal by Subject|1|||
163955080|NCT01037244|592206362|FG001|Overall Study|Withdrawal by Subject|5|||
163955081|NCT01037244|592206363|FG002|Overall Study|Withdrawal by Subject|3|||
163955082|NCT01037244|592206364|FG003|Overall Study|Withdrawal by Subject|5|||
163955083|NCT01037244|592206361|FG000|Overall Study|Partner Withdrew Consent|2|||
163955084|NCT01037244|592206362|FG001|Overall Study|Partner Withdrew Consent|1|||
163955085|NCT01037244|592206363|FG002|Overall Study|Partner Withdrew Consent|0|||
163955086|NCT01037244|592206364|FG003|Overall Study|Partner Withdrew Consent|0|||
163955087|NCT01037244|592206361|FG000|Overall Study|Various|3|||
163955088|NCT01037244|592206362|FG001|Overall Study|Various|2|||
163955089|NCT01037244|592206363|FG002|Overall Study|Various|1|||
163955090|NCT01037244|592206364|FG003|Overall Study|Various|1|||
163955091|NCT00690820|592206365|FG000|Period 1|Withdrawal by Subject|0|||
163955092|NCT00690820|592206366|FG001|Period 1|Withdrawal by Subject|1|||
163955093|NCT00848926|592206367|FG000|Treatment Period|Progressive disease|45|||
163955094|NCT00848926|592206367|FG000|Treatment Period|Adverse Event|20|||
164047864|NCT00126425|592534242|FG001|Overall Study|Withdrawal by Subject|1|||
163955095|NCT00848926|592206367|FG000|Treatment Period|Physician Decision|12|||
163955096|NCT00848926|592206367|FG000|Treatment Period|Withdrawal by Subject|7|||
163955097|NCT00848926|592206367|FG000|Follow-up Period|Lost to Follow-up|7|||
163955098|NCT00848926|592206367|FG000|Follow-up Period|Withdrawal by Subject|3|||
164047865|NCT00126425|592534241|FG000|Overall Study|Lost to Follow-up|8|||
164047866|NCT00126425|592534242|FG001|Overall Study|Lost to Follow-up|4|||
163955099|NCT00848926|592206367|FG000|Follow-up Period|Other|2|||
163955100|NCT00903630|592206368|FG000|Phase 2|Adverse Event|0|||
163955101|NCT00903630|592206369|FG001|Phase 2|Adverse Event|0|||
163955102|NCT00903630|592206370|FG002|Phase 2|Adverse Event|1|||
163955103|NCT04025580|592206371|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
163955104|NCT04025580|592206372|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
163955105|NCT04025580|592206373|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
163955106|NCT02216357|592206374|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
163955107|NCT02216357|592206375|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
163955108|NCT00235326|592206380|FG000|Overall Study|Lost to Follow-up|746|||
163955109|NCT00235326|592206381|FG001|Overall Study|Lost to Follow-up|1400|||
163955110|NCT01790126|592206384|FG000|Overall Study|PSA Progression|12|||
163955111|NCT01790126|592206385|FG001|Overall Study|PSA Progression|16|||
163955112|NCT01790126|592206386|FG002|Overall Study|PSA Progression|16|||
163955113|NCT01790126|592206384|FG000|Overall Study|Other|5|||
163955114|NCT01790126|592206385|FG001|Overall Study|Other|4|||
163955115|NCT01790126|592206386|FG002|Overall Study|Other|8|||
163955116|NCT01790126|592206384|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
163955117|NCT01790126|592206385|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
163955118|NCT01790126|592206386|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
163955119|NCT01790126|592206384|FG000|Overall Study|Withdrawal by Physician|1|||
163955120|NCT01790126|592206385|FG001|Overall Study|Withdrawal by Physician|1|||
163955121|NCT01790126|592206386|FG002|Overall Study|Withdrawal by Physician|2|||
163955122|NCT01790126|592206384|FG000|Overall Study|Withdrawal by Subject|3|||
163955123|NCT01790126|592206385|FG001|Overall Study|Withdrawal by Subject|1|||
163955124|NCT01790126|592206386|FG002|Overall Study|Withdrawal by Subject|2|||
163955125|NCT01790126|592206384|FG000|Overall Study|Lost to Follow-up|1|||
163955126|NCT01790126|592206385|FG001|Overall Study|Lost to Follow-up|0|||
163955127|NCT01790126|592206386|FG002|Overall Study|Lost to Follow-up|1|||
163955128|NCT01790126|592206384|FG000|Overall Study|Adverse Event|0|||
163955129|NCT01790126|592206385|FG001|Overall Study|Adverse Event|2|||
163955130|NCT01790126|592206386|FG002|Overall Study|Adverse Event|0|||
163955131|NCT01790126|592206384|FG000|Overall Study|Death|2|||
163955132|NCT01790126|592206385|FG001|Overall Study|Death|0|||
163955133|NCT01790126|592206386|FG002|Overall Study|Death|0|||
163955134|NCT01790126|592206384|FG000|Overall Study|Radiographic Progression|3|||
163955135|NCT01790126|592206385|FG001|Overall Study|Radiographic Progression|1|||
163955136|NCT01790126|592206386|FG002|Overall Study|Radiographic Progression|0|||
163955137|NCT01477333|592206387|FG000|Overall Study|Adverse Event|1|||
163955138|NCT01477333|592206387|FG000|Overall Study|Withdrawal by Subject|1|||
163955139|NCT01477333|592206387|FG000|Overall Study|Clinical Deterioration|1|||
163955140|NCT00455325|592206388|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
163955141|NCT00455325|592206389|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
163955142|NCT00455325|592206390|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
163955143|NCT00455325|592206391|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
163955144|NCT00455325|592206388|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
163955145|NCT00455325|592206389|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
163955146|NCT00455325|592206390|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
163955147|NCT00455325|592206391|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
163955148|NCT00455325|592206388|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
163955149|NCT00455325|592206389|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
163955150|NCT00455325|592206390|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
163955151|NCT00455325|592206391|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
163955152|NCT00455325|592206388|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
163955153|NCT00455325|592206389|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
163955154|NCT00455325|592206390|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
163955155|NCT00455325|592206391|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
163955156|NCT00455325|592206388|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
163955157|NCT00455325|592206389|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
163955158|NCT00455325|592206390|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
163955159|NCT00455325|592206391|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
163955160|NCT00455325|592206388|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
163955161|NCT00455325|592206389|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
163955162|NCT00455325|592206390|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
163955163|NCT00455325|592206391|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
163955164|NCT00455325|592206388|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
163955165|NCT00455325|592206389|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
163955166|NCT00455325|592206390|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
163955167|NCT00455325|592206391|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
163955168|NCT01178671|592206392|FG000|Overall Study|Adverse Event|4|||
163955169|NCT01178671|592206393|FG001|Overall Study|Adverse Event|6|||
163955170|NCT01178671|592206392|FG000|Overall Study|Protocol Violation|1|||
163955171|NCT01178671|592206393|FG001|Overall Study|Protocol Violation|1|||
163955172|NCT01178671|592206392|FG000|Overall Study|Lack of Efficacy|0|||
163955173|NCT01178671|592206393|FG001|Overall Study|Lack of Efficacy|1|||
163955174|NCT01178671|592206392|FG000|Overall Study|Lost to Follow-up|3|||
163955175|NCT01178671|592206393|FG001|Overall Study|Lost to Follow-up|1|||
163955176|NCT01178671|592206392|FG000|Overall Study|Physician Decision|4|||
163955177|NCT01178671|592206393|FG001|Overall Study|Physician Decision|6|||
163955178|NCT02435966|592206394|FG000|Overall Study|Withdrawal by Subject|0|||
163955179|NCT02435966|592206395|FG001|Overall Study|Withdrawal by Subject|1|||
163955180|NCT02435966|592206396|FG002|Overall Study|Withdrawal by Subject|0|||
163955181|NCT04620811|592206397|FG000|Overall Study|Withdrawal by Subject|18|||
163955182|NCT04620811|592206398|FG001|Overall Study|Withdrawal by Subject|15|||
163955183|NCT04620811|592206397|FG000|Overall Study|Adverse Event|6|||
163955184|NCT04620811|592206398|FG001|Overall Study|Adverse Event|11|||
163955185|NCT04620811|592206397|FG000|Overall Study|Lost to Follow-up|4|||
163955186|NCT04620811|592206398|FG001|Overall Study|Lost to Follow-up|8|||
163955187|NCT04620811|592206397|FG000|Overall Study|Physician Decision|1|||
163955188|NCT04620811|592206398|FG001|Overall Study|Physician Decision|4|||
163955189|NCT04620811|592206397|FG000|Overall Study|Sponsor Decision|0|||
163955190|NCT04620811|592206398|FG001|Overall Study|Sponsor Decision|1|||
163955191|NCT04620811|592206397|FG000|Overall Study|Elevation of ALT or AST|1|||
163955192|NCT04620811|592206398|FG001|Overall Study|Elevation of ALT or AST|0|||
163955193|NCT04620811|592206397|FG000|Overall Study|Other|3|||
163955194|NCT04620811|592206398|FG001|Overall Study|Other|5|||
163955195|NCT01078675|592206400|FG000|Overall Study|Withdrawal by Subject|7|||
163955196|NCT01078675|592206401|FG001|Overall Study|Withdrawal by Subject|3|||
163955197|NCT01078675|592206400|FG000|Overall Study|Protocol Violation|56|||
163955198|NCT01078675|592206401|FG001|Overall Study|Protocol Violation|0|||
163955199|NCT01078675|592206400|FG000|Overall Study|Provided in CRF for specific reasons|2|||
163955200|NCT01078675|592206401|FG001|Overall Study|Provided in CRF for specific reasons|3|||
163955201|NCT01078675|592206400|FG000|Overall Study|Adverse Event|3|||
163955202|NCT01078675|592206401|FG001|Overall Study|Adverse Event|0|||
163955203|NCT00928746|592206402|FG000|Overall Study|Adverse Event|2|||
163955204|NCT00928746|592206402|FG000|Overall Study|Protocol Violation|1|||
163955205|NCT00928746|592206402|FG000|Overall Study|Withdrawal by Subject|1|||
163955206|NCT00928746|592206402|FG000|Overall Study|Other|2|||
163955207|NCT02745392|592206407|FG000|Overall Study|Lost to Follow-up|0|||
163955208|NCT02745392|592206408|FG001|Overall Study|Lost to Follow-up|1|||
163955209|NCT02745392|592206409|FG002|Overall Study|Lost to Follow-up|0|||
163955210|NCT02745392|592206410|FG003|Overall Study|Lost to Follow-up|0|||
163955211|NCT02004353|592206415|FG000|Overall Study|Voluntary participation|1334|||
163955212|NCT01007448|592206425|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
163955213|NCT01007448|592206426|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
163955214|NCT01007448|592206425|FG000|Overall Study|Staph Skin Infection Flare|1|||
163955215|NCT01007448|592206426|FG001|Overall Study|Staph Skin Infection Flare|0|||
163955216|NCT01007448|592206425|FG000|Overall Study|Participant Leaving the Country|1|||
163955217|NCT01007448|592206426|FG001|Overall Study|Participant Leaving the Country|0|||
163955218|NCT01007448|592206425|FG000|Overall Study|Participant Given Prohibited Medication|1|||
163955219|NCT01007448|592206426|FG001|Overall Study|Participant Given Prohibited Medication|0|||
163955220|NCT01007448|592206425|FG000|Overall Study|Progressive Disease|1|||
163955221|NCT01007448|592206426|FG001|Overall Study|Progressive Disease|2|||
163955222|NCT01007448|592206425|FG000|Overall Study|Lack of Efficacy|2|||
163955223|NCT01007448|592206426|FG001|Overall Study|Lack of Efficacy|0|||
163955224|NCT01007448|592206425|FG000|Overall Study|Withdrawal by Subject|2|||
163955225|NCT01007448|592206426|FG001|Overall Study|Withdrawal by Subject|3|||
163955226|NCT01007448|592206425|FG000|Overall Study|Adverse Event|1|||
163955227|NCT01007448|592206426|FG001|Overall Study|Adverse Event|4|||
163955228|NCT02481947|592206427|FG000|Overall Study|Withdrawal by Subject|24|||
163955229|NCT02481947|592206428|FG001|Overall Study|Withdrawal by Subject|10|||
163955230|NCT02481947|592206427|FG000|Overall Study|Lost to Follow-up|11|||
163955231|NCT02481947|592206428|FG001|Overall Study|Lost to Follow-up|5|||
163955232|NCT02481947|592206427|FG000|Overall Study|Adverse Event|6|||
163955233|NCT02481947|592206428|FG001|Overall Study|Adverse Event|11|||
163955234|NCT02481947|592206427|FG000|Overall Study|Physician Decision|4|||
163955235|NCT02481947|592206428|FG001|Overall Study|Physician Decision|5|||
163955236|NCT02481947|592206427|FG000|Overall Study|Protocol Violation|1|||
163955237|NCT02481947|592206428|FG001|Overall Study|Protocol Violation|5|||
163955238|NCT02751320|592206429|FG000|Overall Study|Adverse Event|2|||
163955239|NCT02751320|592206429|FG000|Overall Study|Withdrawal by Subject|1|||
163955240|NCT03426605|592206430|FG000|Overall Study|AML relapse or progression|2|||
163955241|NCT03426605|592206431|FG001|Overall Study|AML relapse or progression|1|||
163955242|NCT03426605|592206432|FG002|Overall Study|AML relapse or progression|2|||
163955243|NCT03426605|592206433|FG003|Overall Study|AML relapse or progression|2|||
163955244|NCT03426605|592206430|FG000|Overall Study|Treatment failure|3|||
163955245|NCT03426605|592206431|FG001|Overall Study|Treatment failure|2|||
163955246|NCT03426605|592206432|FG002|Overall Study|Treatment failure|0|||
163955247|NCT03426605|592206433|FG003|Overall Study|Treatment failure|0|||
163955248|NCT03426605|592206430|FG000|Overall Study|Adverse Event|1|||
163955249|NCT03426605|592206431|FG001|Overall Study|Adverse Event|0|||
163955250|NCT03426605|592206432|FG002|Overall Study|Adverse Event|1|||
163955251|NCT03426605|592206433|FG003|Overall Study|Adverse Event|1|||
163955252|NCT03426605|592206430|FG000|Overall Study|Withdrawal by Subject|0|||
163955253|NCT03426605|592206431|FG001|Overall Study|Withdrawal by Subject|0|||
163955254|NCT03426605|592206432|FG002|Overall Study|Withdrawal by Subject|1|||
163955255|NCT03426605|592206433|FG003|Overall Study|Withdrawal by Subject|1|||
163955256|NCT01886378|592206434|FG000|Overall Study|Adverse Event|1|||
163955257|NCT01886378|592206434|FG000|Overall Study|Withdrawal by Subject|4|||
163955258|NCT03513588|592206437|FG000|Overall Study|Lost to Follow-up|0|||
163955259|NCT03513588|592206438|FG001|Overall Study|Lost to Follow-up|1|||
163955260|NCT03513588|592206439|FG002|Overall Study|Lost to Follow-up|1|||
163955261|NCT03513588|592206437|FG000|Overall Study|Study dosing paused by sponsor|1|||
163955262|NCT03513588|592206438|FG001|Overall Study|Study dosing paused by sponsor|1|||
163955263|NCT03513588|592206439|FG002|Overall Study|Study dosing paused by sponsor|0|||
163955264|NCT03513588|592206437|FG000|Overall Study|Death|0|||
163955265|NCT03513588|592206438|FG001|Overall Study|Death|0|||
163955266|NCT03513588|592206439|FG002|Overall Study|Death|1|||
163955267|NCT01270971|592206440|FG000|Overall Study|Withdrawal by Subject|24|||
163955268|NCT01270971|592206441|FG001|Overall Study|Withdrawal by Subject|11|||
163955269|NCT01270971|592206440|FG000|Overall Study|Lost to Follow-up|18|||
163955270|NCT01270971|592206441|FG001|Overall Study|Lost to Follow-up|5|||
163955271|NCT01270971|592206440|FG000|Overall Study|Adverse Event|1|||
163955272|NCT01270971|592206441|FG001|Overall Study|Adverse Event|2|||
163955273|NCT01270971|592206440|FG000|Overall Study|Non compliance|2|||
163955274|NCT01270971|592206441|FG001|Overall Study|Non compliance|2|||
163955275|NCT01270971|592206440|FG000|Overall Study|Non-specific|7|||
163955276|NCT01270971|592206441|FG001|Overall Study|Non-specific|3|||
163955277|NCT03333837|592206449|FG000|Overall Study|Adverse Event|2|||
163955278|NCT03333837|592206450|FG001|Overall Study|Adverse Event|1|||
163955279|NCT03333837|592206451|FG002|Overall Study|Adverse Event|1|||
163955280|NCT03333837|592206452|FG003|Overall Study|Adverse Event|1|||
163955281|NCT03333837|592206453|FG004|Overall Study|Adverse Event|0|||
163955282|NCT03333837|592206449|FG000|Overall Study|Caregiver withdrew|0|||
163955283|NCT03333837|592206450|FG001|Overall Study|Caregiver withdrew|2|||
163955284|NCT03333837|592206451|FG002|Overall Study|Caregiver withdrew|1|||
163955285|NCT03333837|592206452|FG003|Overall Study|Caregiver withdrew|0|||
163955286|NCT03333837|592206453|FG004|Overall Study|Caregiver withdrew|0|||
163955287|NCT03333837|592206449|FG000|Overall Study|Withdrawal by Subject|0|||
163955288|NCT03333837|592206450|FG001|Overall Study|Withdrawal by Subject|0|||
163955289|NCT03333837|592206451|FG002|Overall Study|Withdrawal by Subject|1|||
163955290|NCT03333837|592206452|FG003|Overall Study|Withdrawal by Subject|1|||
163955291|NCT03333837|592206453|FG004|Overall Study|Withdrawal by Subject|3|||
163955292|NCT03333837|592206449|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163955293|NCT03333837|592206450|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163955294|NCT03333837|592206451|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
163955295|NCT03333837|592206452|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163955296|NCT03333837|592206453|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
163955297|NCT04217590|592206455|FG000|Overall Study|Other|1|||
163955298|NCT04217590|592206456|FG001|Overall Study|Other|1|||
163955299|NCT04217590|592206455|FG000|Overall Study|Withdrawal by Subject|3|||
163955300|NCT04217590|592206456|FG001|Overall Study|Withdrawal by Subject|1|||
163955301|NCT04217590|592206455|FG000|Overall Study|Death|0|||
163955302|NCT04217590|592206456|FG001|Overall Study|Death|1|||
163955303|NCT01013285|592206457|FG000|Overall Study|Death|48|||
163955304|NCT01013285|592206458|FG001|Overall Study|Death|89|||
163955305|NCT02232243|592206461|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
163955306|NCT02232243|592206462|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
163955307|NCT02232243|592206463|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
163955308|NCT00704405|592206464|FG000|Overall Study (NC Population)|Adverse Event|1|||
163955309|NCT00704405|592206465|FG001|Overall Study (NC Population)|Adverse Event|0|||
163955310|NCT00704405|592206466|FG002|Overall Study (NC Population)|Adverse Event|0|||
163955311|NCT00704405|592206467|FG003|Overall Study (NC Population)|Adverse Event|0|||
163955312|NCT00704405|592206468|FG004|Overall Study (NC Population)|Adverse Event|0|||
163955313|NCT00704405|592206464|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
163955314|NCT00704405|592206465|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
163955315|NCT00704405|592206466|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
163955316|NCT00704405|592206467|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
163955317|NCT00704405|592206468|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
163955318|NCT00704405|592206464|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
163955319|NCT00704405|592206465|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
163955320|NCT00704405|592206466|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
163955321|NCT00704405|592206467|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
163955322|NCT00704405|592206468|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
163955323|NCT00704405|592206464|FG000|Overall Study (NC Population)|Other|0|||
163955324|NCT00704405|592206465|FG001|Overall Study (NC Population)|Other|0|||
163955325|NCT00704405|592206466|FG002|Overall Study (NC Population)|Other|0|||
163955326|NCT00704405|592206467|FG003|Overall Study (NC Population)|Other|0|||
163955327|NCT00704405|592206468|FG004|Overall Study (NC Population)|Other|1|||
163955328|NCT00704405|592206464|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
163955329|NCT00704405|592206465|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
163955330|NCT00704405|592206466|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
163955331|NCT00704405|592206467|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
163955332|NCT00704405|592206468|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
163955333|NCT00704405|592206464|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
163955334|NCT00704405|592206465|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
163955335|NCT00704405|592206466|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
163955336|NCT00704405|592206467|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
163955337|NCT00704405|592206468|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
163955338|NCT01395888|592206469|FG000|2-week Run-in Period|Adverse Event|2|||
163955339|NCT01395888|592206470|FG001|2-week Run-in Period|Adverse Event|0|||
163955340|NCT01395888|592206471|FG002|2-week Run-in Period|Adverse Event|0|||
163955341|NCT01395888|592206469|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
163955342|NCT01395888|592206470|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
163955343|NCT01395888|592206471|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
163955344|NCT01395888|592206469|FG000|2-week Run-in Period|Lost to Follow-up|1|||
163955345|NCT01395888|592206470|FG001|2-week Run-in Period|Lost to Follow-up|0|||
163955346|NCT01395888|592206471|FG002|2-week Run-in Period|Lost to Follow-up|0|||
163955347|NCT01395888|592206469|FG000|2-week Run-in Period|Protocol Violation|2|||
163955348|NCT01395888|592206470|FG001|2-week Run-in Period|Protocol Violation|0|||
163955349|NCT01395888|592206471|FG002|2-week Run-in Period|Protocol Violation|0|||
163955350|NCT01395888|592206469|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
163955351|NCT01395888|592206470|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
163955352|NCT01395888|592206471|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
163955353|NCT01395888|592206469|FG000|Treatment Period (TP)|Adverse Event|0|||
163955354|NCT01395888|592206470|FG001|Treatment Period (TP)|Adverse Event|7|||
163955355|NCT01395888|592206471|FG002|Treatment Period (TP)|Adverse Event|6|||
163955356|NCT01395888|592206469|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
163955357|NCT01395888|592206470|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
163955358|NCT01395888|592206471|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
163955359|NCT01395888|592206469|FG000|Treatment Period (TP)|Protocol Violation|0|||
163955360|NCT01395888|592206470|FG001|Treatment Period (TP)|Protocol Violation|1|||
163955361|NCT01395888|592206471|FG002|Treatment Period (TP)|Protocol Violation|5|||
163955362|NCT01395888|592206469|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
163955363|NCT01395888|592206470|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
163955364|NCT01395888|592206471|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
163955365|NCT01395888|592206469|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
163955366|NCT01395888|592206470|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
163955367|NCT01395888|592206471|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
163955368|NCT01946438|592206472|FG000|Overall Study|Adverse Event|0|||
163955369|NCT01946438|592206473|FG001|Overall Study|Adverse Event|0|||
163955370|NCT01946438|592206474|FG002|Overall Study|Adverse Event|0|||
163955371|NCT01946438|592206475|FG003|Overall Study|Adverse Event|1|||
163955372|NCT01946438|592206472|FG000|Overall Study|Serious Adverse event|1|||
163955373|NCT01946438|592206473|FG001|Overall Study|Serious Adverse event|0|||
163955374|NCT01946438|592206474|FG002|Overall Study|Serious Adverse event|0|||
163955375|NCT01946438|592206475|FG003|Overall Study|Serious Adverse event|0|||
163955376|NCT01946438|592206472|FG000|Overall Study|Protocol Violation|0|||
163955377|NCT01946438|592206473|FG001|Overall Study|Protocol Violation|0|||
163955378|NCT01946438|592206474|FG002|Overall Study|Protocol Violation|1|||
163955379|NCT01946438|592206475|FG003|Overall Study|Protocol Violation|0|||
163955380|NCT01946438|592206472|FG000|Overall Study|Withdrawal by Subject|1|||
163955381|NCT01946438|592206473|FG001|Overall Study|Withdrawal by Subject|0|||
163955382|NCT01946438|592206474|FG002|Overall Study|Withdrawal by Subject|0|||
163955383|NCT01946438|592206475|FG003|Overall Study|Withdrawal by Subject|0|||
163955384|NCT02457559|592206476|FG000|Overall Study|Progressive Disease|1|||
163955385|NCT02457559|592206477|FG001|Overall Study|Progressive Disease|2|||
163955386|NCT02457559|592206478|FG002|Overall Study|Progressive Disease|3|||
163955387|NCT02457559|592206479|FG003|Overall Study|Progressive Disease|0|||
163955388|NCT02457559|592206480|FG004|Overall Study|Progressive Disease|0|||
163955389|NCT02457559|592206481|FG005|Overall Study|Progressive Disease|2|||
164047867|NCT00126425|592534241|FG000|Overall Study|Protocol Violation|9|||
163955390|NCT02457559|592206482|FG006|Overall Study|Progressive Disease|1|||
163955391|NCT02457559|592206483|FG007|Overall Study|Progressive Disease|0|||
163955392|NCT02457559|592206484|FG008|Overall Study|Progressive Disease|1|||
163955393|NCT02457559|592206485|FG009|Overall Study|Progressive Disease|1|||
163955394|NCT02457559|592206486|FG010|Overall Study|Progressive Disease|1|||
163955395|NCT02457559|592206476|FG000|Overall Study|Investigator's Discretion|0|||
163955396|NCT02457559|592206477|FG001|Overall Study|Investigator's Discretion|0|||
164047868|NCT00126425|592534242|FG001|Overall Study|Protocol Violation|6|||
164047869|NCT00126425|592534241|FG000|Overall Study|Adverse Event|1|||
163955397|NCT02457559|592206478|FG002|Overall Study|Investigator's Discretion|2|||
163955398|NCT02457559|592206479|FG003|Overall Study|Investigator's Discretion|0|||
163955399|NCT02457559|592206480|FG004|Overall Study|Investigator's Discretion|1|||
163955400|NCT02457559|592206481|FG005|Overall Study|Investigator's Discretion|0|||
163955401|NCT02457559|592206482|FG006|Overall Study|Investigator's Discretion|1|||
163955402|NCT02457559|592206483|FG007|Overall Study|Investigator's Discretion|0|||
163955403|NCT02457559|592206484|FG008|Overall Study|Investigator's Discretion|1|||
163955404|NCT02457559|592206485|FG009|Overall Study|Investigator's Discretion|0|||
163955405|NCT02457559|592206486|FG010|Overall Study|Investigator's Discretion|1|||
163955406|NCT02457559|592206476|FG000|Overall Study|Adverse Event|0|||
163955407|NCT02457559|592206477|FG001|Overall Study|Adverse Event|1|||
163955408|NCT02457559|592206478|FG002|Overall Study|Adverse Event|2|||
163955409|NCT02457559|592206479|FG003|Overall Study|Adverse Event|0|||
163955410|NCT02457559|592206480|FG004|Overall Study|Adverse Event|0|||
163955411|NCT02457559|592206481|FG005|Overall Study|Adverse Event|0|||
163955412|NCT02457559|592206482|FG006|Overall Study|Adverse Event|0|||
163955413|NCT02457559|592206483|FG007|Overall Study|Adverse Event|0|||
163955414|NCT02457559|592206484|FG008|Overall Study|Adverse Event|0|||
163955415|NCT02457559|592206485|FG009|Overall Study|Adverse Event|0|||
163955416|NCT02457559|592206486|FG010|Overall Study|Adverse Event|0|||
163955417|NCT02457559|592206476|FG000|Overall Study|Reason not Specified|1|||
163955418|NCT02457559|592206477|FG001|Overall Study|Reason not Specified|0|||
163955419|NCT02457559|592206478|FG002|Overall Study|Reason not Specified|0|||
163955420|NCT02457559|592206479|FG003|Overall Study|Reason not Specified|0|||
163955421|NCT02457559|592206480|FG004|Overall Study|Reason not Specified|0|||
163955422|NCT02457559|592206481|FG005|Overall Study|Reason not Specified|0|||
163955423|NCT02457559|592206482|FG006|Overall Study|Reason not Specified|0|||
163955424|NCT02457559|592206483|FG007|Overall Study|Reason not Specified|0|||
163955425|NCT02457559|592206484|FG008|Overall Study|Reason not Specified|0|||
163955426|NCT02457559|592206485|FG009|Overall Study|Reason not Specified|2|||
163955427|NCT02457559|592206486|FG010|Overall Study|Reason not Specified|0|||
163955428|NCT02457559|592206476|FG000|Overall Study|Death|0|||
163955429|NCT02457559|592206477|FG001|Overall Study|Death|0|||
163955430|NCT02457559|592206478|FG002|Overall Study|Death|0|||
163955431|NCT02457559|592206479|FG003|Overall Study|Death|0|||
163955432|NCT02457559|592206480|FG004|Overall Study|Death|0|||
163955433|NCT02457559|592206481|FG005|Overall Study|Death|0|||
163955434|NCT02457559|592206482|FG006|Overall Study|Death|0|||
163955435|NCT02457559|592206483|FG007|Overall Study|Death|0|||
163955436|NCT02457559|592206484|FG008|Overall Study|Death|1|||
163955437|NCT02457559|592206485|FG009|Overall Study|Death|1|||
163955438|NCT02457559|592206486|FG010|Overall Study|Death|0|||
163955439|NCT02412371|592206487|FG000|Overall Study|Withdrawal by Subject|0|||
163955440|NCT02412371|592206488|FG001|Overall Study|Withdrawal by Subject|2|||
163955441|NCT02412371|592206489|FG002|Overall Study|Withdrawal by Subject|0|||
163955442|NCT02412371|592206490|FG003|Overall Study|Withdrawal by Subject|1|||
163955443|NCT02412371|592206491|FG004|Overall Study|Withdrawal by Subject|1|||
163955444|NCT02412371|592206492|FG005|Overall Study|Withdrawal by Subject|0|||
163955445|NCT02412371|592206487|FG000|Overall Study|Sponsor Discontinued Study|1|||
163955446|NCT02412371|592206488|FG001|Overall Study|Sponsor Discontinued Study|4|||
163955447|NCT02412371|592206489|FG002|Overall Study|Sponsor Discontinued Study|6|||
163955448|NCT02412371|592206490|FG003|Overall Study|Sponsor Discontinued Study|4|||
163955449|NCT02412371|592206491|FG004|Overall Study|Sponsor Discontinued Study|5|||
163955450|NCT02412371|592206492|FG005|Overall Study|Sponsor Discontinued Study|0|||
163955451|NCT02412371|592206487|FG000|Overall Study|Death|4|||
163955452|NCT02412371|592206488|FG001|Overall Study|Death|2|||
163955453|NCT02412371|592206489|FG002|Overall Study|Death|1|||
163955454|NCT02412371|592206490|FG003|Overall Study|Death|3|||
163955455|NCT02412371|592206491|FG004|Overall Study|Death|5|||
163955456|NCT02412371|592206492|FG005|Overall Study|Death|2|||
163955457|NCT02412371|592206487|FG000|Overall Study|Other|2|||
163955458|NCT02412371|592206488|FG001|Overall Study|Other|1|||
163955459|NCT02412371|592206489|FG002|Overall Study|Other|0|||
163955460|NCT02412371|592206490|FG003|Overall Study|Other|0|||
163955461|NCT02412371|592206491|FG004|Overall Study|Other|1|||
163955462|NCT02412371|592206492|FG005|Overall Study|Other|3|||
163955463|NCT02374671|592206493|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
163955464|NCT02374671|592206494|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
163955465|NCT02374671|592206495|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
163955466|NCT02374671|592206493|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
163955467|NCT02374671|592206494|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
163955468|NCT02374671|592206495|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
163955469|NCT02374671|592206493|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
163955470|NCT02374671|592206494|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
163955471|NCT02374671|592206495|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
163955472|NCT02374671|592206493|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
163955473|NCT02374671|592206494|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
163955474|NCT02374671|592206495|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
163955475|NCT02374671|592206493|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
163955476|NCT02374671|592206494|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
163955477|NCT02374671|592206495|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
163955478|NCT03169101|592206497|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
163955479|NCT03169101|592206498|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
163955480|NCT03169101|592206499|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
163955481|NCT03169101|592206500|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
163955482|NCT02641496|592206501|FG000|Overall Study|Lost to Follow-up|13|||
163955483|NCT02641496|592206502|FG001|Overall Study|Lost to Follow-up|12|||
163955484|NCT02641496|592206501|FG000|Overall Study|Withdrawal by Subject|1|||
163955485|NCT02641496|592206502|FG001|Overall Study|Withdrawal by Subject|0|||
163955486|NCT05590884|592206505|FG000|Overall Study|Withdrawal by Subject|1|||
163955487|NCT05590884|592206506|FG001|Overall Study|Withdrawal by Subject|0|||
163955488|NCT05590884|592206507|FG002|Overall Study|Withdrawal by Subject|0|||
163955489|NCT04134845|592206515|FG000|Overall Study|withdrawl by PI|12|||
163955490|NCT04134845|592206516|FG001|Overall Study|withdrawl by PI|5|||
163955491|NCT03440320|592208268|FG000|Overall Study|Withdrawal by Subject|0|||
163955492|NCT03440320|592208269|FG001|Overall Study|Withdrawal by Subject|1|||
163955493|NCT01912456|592208270|FG000|Period 1|Physician Decision|0|||
163955494|NCT01912456|592208271|FG001|Period 1|Physician Decision|0|||
163955495|NCT01912456|592208272|FG002|Period 1|Physician Decision|1|||
163955496|NCT01912456|592208273|FG003|Period 1|Physician Decision|0|||
163955497|NCT01912456|592208270|FG000|Period 1|non-compliance|1|||
163955498|NCT01912456|592208271|FG001|Period 1|non-compliance|0|||
163955499|NCT01912456|592208272|FG002|Period 1|non-compliance|0|||
163955500|NCT01912456|592208273|FG003|Period 1|non-compliance|1|||
163955501|NCT01912456|592208270|FG000|Period 1|Adverse Event|1|||
163955502|NCT01912456|592208271|FG001|Period 1|Adverse Event|0|||
163955503|NCT01912456|592208272|FG002|Period 1|Adverse Event|0|||
163955504|NCT01912456|592208273|FG003|Period 1|Adverse Event|1|||
163955505|NCT01912456|592208270|FG000|Period 1|Withdrawal by Subject|0|||
163955506|NCT01912456|592208271|FG001|Period 1|Withdrawal by Subject|1|||
163955507|NCT01912456|592208272|FG002|Period 1|Withdrawal by Subject|1|||
163955508|NCT01912456|592208273|FG003|Period 1|Withdrawal by Subject|1|||
163955509|NCT01912456|592208270|FG000|Period 2|Lack of Efficacy|0|||
163955510|NCT01912456|592208271|FG001|Period 2|Lack of Efficacy|2|||
163955511|NCT01912456|592208272|FG002|Period 2|Lack of Efficacy|0|||
163955512|NCT01912456|592208273|FG003|Period 2|Lack of Efficacy|0|||
163955513|NCT01912456|592208270|FG000|Period 2|Adverse Event|0|||
163955514|NCT01912456|592208271|FG001|Period 2|Adverse Event|0|||
163955515|NCT01912456|592208272|FG002|Period 2|Adverse Event|0|||
163955516|NCT01912456|592208273|FG003|Period 2|Adverse Event|1|||
163955517|NCT01340196|592208274|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
163955518|NCT00171704|592208280|FG000|Overall Study|Adverse Event|24|||
163955519|NCT00171704|592208281|FG001|Overall Study|Adverse Event|33|||
163955520|NCT00171704|592208280|FG000|Overall Study|Disease Progression|14|||
163955521|NCT00171704|592208281|FG001|Overall Study|Disease Progression|9|||
163955522|NCT00171704|592208280|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
163955523|NCT00171704|592208281|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
163955524|NCT00171704|592208280|FG000|Overall Study|Administrative Problems|2|||
163955525|NCT00171704|592208281|FG001|Overall Study|Administrative Problems|1|||
163955526|NCT00171704|592208280|FG000|Overall Study|Death|2|||
163955527|NCT00171704|592208281|FG001|Overall Study|Death|2|||
163955528|NCT00171704|592208280|FG000|Overall Study|Withdrawal by Subject|1|||
163955529|NCT00171704|592208281|FG001|Overall Study|Withdrawal by Subject|3|||
163955530|NCT00171704|592208280|FG000|Overall Study|Protocol Violation|0|||
163955531|NCT00171704|592208281|FG001|Overall Study|Protocol Violation|1|||
163955532|NCT00816400|592208286|FG000|Overall Study|Death|2|||
163955533|NCT00816400|592208287|FG001|Overall Study|Death|3|||
163955534|NCT00816400|592208288|FG002|Overall Study|Death|3|||
163955535|NCT00816400|592208289|FG003|Overall Study|Death|3|||
163955536|NCT00816400|592208290|FG004|Overall Study|Death|2|||
163955537|NCT00816400|592208291|FG005|Overall Study|Death|3|||
163955538|NCT00816400|592208292|FG006|Overall Study|Death|2|||
163955539|NCT00816400|592208293|FG007|Overall Study|Death|5|||
163955540|NCT00816400|592208294|FG008|Overall Study|Death|6|||
163955541|NCT00816400|592208286|FG000|Overall Study|In hospice care at the end of the study|0|||
163955542|NCT00816400|592208287|FG001|Overall Study|In hospice care at the end of the study|0|||
163955543|NCT00816400|592208288|FG002|Overall Study|In hospice care at the end of the study|2|||
163955544|NCT00816400|592208289|FG003|Overall Study|In hospice care at the end of the study|0|||
163955545|NCT00816400|592208290|FG004|Overall Study|In hospice care at the end of the study|0|||
163955546|NCT00816400|592208291|FG005|Overall Study|In hospice care at the end of the study|0|||
163955547|NCT00816400|592208292|FG006|Overall Study|In hospice care at the end of the study|0|||
163955548|NCT00816400|592208293|FG007|Overall Study|In hospice care at the end of the study|0|||
163955549|NCT00816400|592208294|FG008|Overall Study|In hospice care at the end of the study|0|||
163955550|NCT00320541|592208295|FG000|Overall Study|Adverse Event|21|||
163955551|NCT00320541|592208296|FG001|Overall Study|Adverse Event|19|||
163955552|NCT00320541|592208295|FG000|Overall Study|Protocol Violation|0|||
163955553|NCT00320541|592208296|FG001|Overall Study|Protocol Violation|1|||
163955554|NCT00320541|592208295|FG000|Overall Study|Withdrawal by Subject|12|||
163955555|NCT00320541|592208296|FG001|Overall Study|Withdrawal by Subject|16|||
163955556|NCT00320541|592208295|FG000|Overall Study|Physician Decision|9|||
163955557|NCT00320541|592208296|FG001|Overall Study|Physician Decision|13|||
163955558|NCT00320541|592208295|FG000|Overall Study|Other|3|||
163955559|NCT00320541|592208296|FG001|Overall Study|Other|4|||
163955560|NCT00320541|592208295|FG000|Overall Study|Sponsor Decision|2|||
163955561|NCT00320541|592208296|FG001|Overall Study|Sponsor Decision|1|||
163955562|NCT00320541|592208295|FG000|Overall Study|Death due to Study Disease|1|||
163955563|NCT00320541|592208296|FG001|Overall Study|Death due to Study Disease|3|||
163955564|NCT00320541|592208295|FG000|Overall Study|Death due to Adverse Event(s)|1|||
163955565|NCT00320541|592208296|FG001|Overall Study|Death due to Adverse Event(s)|0|||
163955566|NCT00320541|592208295|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
163955567|NCT00320541|592208296|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
163955568|NCT01620255|592208302|FG000|Overall Study|Withdrawal by Subject|4|||
163955569|NCT01620255|592208303|FG001|Overall Study|Withdrawal by Subject|1|||
163955570|NCT01620255|592208304|FG002|Overall Study|Withdrawal by Subject|1|||
163955571|NCT01620255|592208305|FG003|Overall Study|Withdrawal by Subject|2|||
163955572|NCT01620255|592208306|FG004|Overall Study|Withdrawal by Subject|4|||
163955573|NCT01620255|592208302|FG000|Overall Study|Participant underwent fecal transplant|0|||
163955574|NCT01620255|592208303|FG001|Overall Study|Participant underwent fecal transplant|0|||
163955575|NCT01620255|592208304|FG002|Overall Study|Participant underwent fecal transplant|1|||
163955576|NCT01620255|592208305|FG003|Overall Study|Participant underwent fecal transplant|0|||
163955577|NCT01620255|592208306|FG004|Overall Study|Participant underwent fecal transplant|0|||
163955578|NCT01620255|592208302|FG000|Overall Study|Non-compliance|0|||
163955579|NCT01620255|592208303|FG001|Overall Study|Non-compliance|1|||
163955580|NCT01620255|592208304|FG002|Overall Study|Non-compliance|0|||
163955581|NCT01620255|592208305|FG003|Overall Study|Non-compliance|0|||
163955582|NCT01620255|592208306|FG004|Overall Study|Non-compliance|0|||
163955583|NCT01620255|592208302|FG000|Overall Study|Adverse Event|0|||
163955584|NCT01620255|592208303|FG001|Overall Study|Adverse Event|4|||
163955585|NCT01620255|592208304|FG002|Overall Study|Adverse Event|0|||
163955586|NCT01620255|592208305|FG003|Overall Study|Adverse Event|1|||
163955587|NCT01620255|592208306|FG004|Overall Study|Adverse Event|1|||
163955588|NCT01620255|592208302|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
163955589|NCT01620255|592208303|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
163955590|NCT01620255|592208304|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
163955591|NCT01620255|592208305|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
163955592|NCT01620255|592208306|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
163955593|NCT01873495|592208316|FG000|Overall Study|Withdrawal by Subject|1|||
163955594|NCT01873495|592208316|FG000|Overall Study|Physician Decision|3|||
163955595|NCT01873495|592208316|FG000|Overall Study|Adverse Event|1|||
163955596|NCT01873495|592208316|FG000|Overall Study|Removed for Transplantation|1|||
163955597|NCT01873495|592208316|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
163955598|NCT04335812|592208319|FG000|Overall Study|Withdrawal by Subject|1|||
163955599|NCT04335812|592208320|FG001|Overall Study|Withdrawal by Subject|3|||
163955600|NCT04335812|592208319|FG000|Overall Study|Lost to Follow-up|12|||
163955601|NCT04335812|592208320|FG001|Overall Study|Lost to Follow-up|12|||
163955602|NCT04335812|592208319|FG000|Overall Study|Did not engage in the intervention|22|||
163955603|NCT04335812|592208320|FG001|Overall Study|Did not engage in the intervention|18|||
163955604|NCT03864146|592208324|FG000|Overall Study|Lost to Follow-up|14|||
163955605|NCT03864146|592208325|FG001|Overall Study|Lost to Follow-up|23|||
163955606|NCT03864146|592208324|FG000|Overall Study|Withdrawal by Subject|3|||
163955607|NCT03864146|592208325|FG001|Overall Study|Withdrawal by Subject|2|||
163955608|NCT00799513|592208331|FG000|Overall Study|Physician Decision|1|||
163955609|NCT00799513|592208331|FG000|Overall Study|Adverse Event|1|||
164047870|NCT00126425|592534242|FG001|Overall Study|Adverse Event|0|||
164047871|NCT00126425|592534241|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
164047872|NCT00126425|592534242|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
164047873|NCT00126425|592534241|FG000|Overall Study|Other|5|||
164047874|NCT00126425|592534242|FG001|Overall Study|Other|0|||
164047875|NCT01316380|592534243|FG000|Overall Study|Adverse Event|0|||
164047876|NCT01316380|592534244|FG001|Overall Study|Adverse Event|2|||
163955610|NCT05062759|592208334|FG000|Overall Study|Death|0|||
163955611|NCT05062759|592208335|FG001|Overall Study|Death|1|||
163955612|NCT05062759|592208334|FG000|Overall Study|Lost to Follow-up|1|||
163955613|NCT05062759|592208335|FG001|Overall Study|Lost to Follow-up|0|||
163955614|NCT04981366|592208336|FG000|Overall Study|Withdrawal by Subject|5|||
163955615|NCT04981366|592208337|FG001|Overall Study|Withdrawal by Subject|4|||
163955616|NCT04981366|592208338|FG002|Overall Study|Withdrawal by Subject|8|||
164047877|NCT01316380|592534245|FG002|Overall Study|Adverse Event|1|||
163955617|NCT04981366|592208336|FG000|Overall Study|Health issues unrelated to the trial|1|||
163955618|NCT04981366|592208337|FG001|Overall Study|Health issues unrelated to the trial|2|||
163955619|NCT04981366|592208338|FG002|Overall Study|Health issues unrelated to the trial|0|||
163955620|NCT04371198|592208339|FG000|Overall Study|inadequate sample|4|||
163955621|NCT01112306|592208340|FG000|Overall Study|Death|175|||
163955622|NCT01112306|592208340|FG000|Overall Study|Lost to Follow-up|9|||
163955623|NCT01112306|592208340|FG000|Overall Study|Withdrawal by Subject|31|||
163955624|NCT01112306|592208340|FG000|Overall Study|Other|70|||
163955625|NCT03214094|592208341|FG000|Overall Study|Case Report Forms Uncollected|14|||
163955626|NCT03214094|592208341|FG000|Overall Study|Protocol Deviation|46|||
163955627|NCT00655486|592208347|FG000|Overall Study|Adverse Event|10|||
163955628|NCT00655486|592208347|FG000|Overall Study|Lack of Efficacy|8|||
163955629|NCT00655486|592208347|FG000|Overall Study|Withdrawal by Subject|4|||
163955630|NCT00655486|592208347|FG000|Overall Study|Protocol Violation|1|||
163955631|NCT00655486|592208347|FG000|Overall Study|Unsatisfactory compliance|2|||
163955632|NCT00655486|592208347|FG000|Overall Study|Other: Pregnancy|1|||
163955633|NCT00655486|592208347|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
163955634|NCT00655486|592208347|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
163955635|NCT00310037|592208348|FG000|Overall Study|Adverse Event|7|||
163955636|NCT00310037|592208349|FG001|Overall Study|Adverse Event|14|||
163955637|NCT00310037|592208348|FG000|Overall Study|Withdrawal by Subject|4|||
163955638|NCT00310037|592208349|FG001|Overall Study|Withdrawal by Subject|3|||
163955639|NCT00310037|592208348|FG000|Overall Study|Progression|6|||
163955640|NCT00310037|592208349|FG001|Overall Study|Progression|0|||
163955641|NCT00310037|592208348|FG000|Overall Study|Non-protocol treatment|1|||
163955642|NCT00310037|592208349|FG001|Overall Study|Non-protocol treatment|0|||
163955643|NCT00440999|592208360|FG000|Overall Study|Adverse Event|0|||
163955644|NCT00440999|592208361|FG001|Overall Study|Adverse Event|2|||
163955645|NCT00440999|592208360|FG000|Overall Study|Lack of Efficacy|6|||
163955646|NCT00440999|592208361|FG001|Overall Study|Lack of Efficacy|7|||
163955647|NCT00440999|592208360|FG000|Overall Study|Lost to Follow-up|19|||
163955648|NCT00440999|592208361|FG001|Overall Study|Lost to Follow-up|12|||
163955649|NCT00440999|592208360|FG000|Overall Study|Protocol Violation|1|||
163955650|NCT00440999|592208361|FG001|Overall Study|Protocol Violation|0|||
163955651|NCT00440999|592208360|FG000|Overall Study|Withdrawal by Subject|2|||
163955652|NCT00440999|592208361|FG001|Overall Study|Withdrawal by Subject|5|||
163955653|NCT00440999|592208360|FG000|Overall Study|Subjets missed the visit|1|||
163955654|NCT00440999|592208361|FG001|Overall Study|Subjets missed the visit|0|||
163955655|NCT00440999|592208360|FG000|Overall Study|Mixed infection at entry|1|||
163955656|NCT00440999|592208361|FG001|Overall Study|Mixed infection at entry|0|||
163955657|NCT00440999|592208360|FG000|Overall Study|P. falciparum malaria|5|||
163955658|NCT00440999|592208361|FG001|Overall Study|P. falciparum malaria|14|||
163955659|NCT00440999|592208360|FG000|Overall Study|Subj left hosp without inform staff|0|||
163955660|NCT00440999|592208361|FG001|Overall Study|Subj left hosp without inform staff|1|||
163955661|NCT04218084|592208362|FG000|Overall Study|Adverse Event|7|||
163955662|NCT04218084|592208363|FG001|Overall Study|Adverse Event|2|||
163955663|NCT04218084|592208362|FG000|Overall Study|Withdrawal of Consent|4|||
163955664|NCT04218084|592208363|FG001|Overall Study|Withdrawal of Consent|5|||
163955665|NCT04218084|592208362|FG000|Overall Study|Physician Decision|1|||
163955666|NCT04218084|592208363|FG001|Overall Study|Physician Decision|1|||
163955667|NCT04218084|592208362|FG000|Overall Study|Lost to Follow-up|1|||
163955668|NCT04218084|592208363|FG001|Overall Study|Lost to Follow-up|1|||
163955669|NCT04218084|592208362|FG000|Overall Study|Non-compliance with study drug|1|||
163955670|NCT04218084|592208363|FG001|Overall Study|Non-compliance with study drug|1|||
163955671|NCT04218084|592208362|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
163955672|NCT04218084|592208363|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
163955673|NCT04218084|592208362|FG000|Overall Study|Other|0|||
163955674|NCT04218084|592208363|FG001|Overall Study|Other|1|||
163955675|NCT04218084|592208362|FG000|Overall Study|Ongoing at data cut-off date|62|||
163955676|NCT04218084|592208363|FG001|Overall Study|Ongoing at data cut-off date|58|||
163955677|NCT05041101|592208364|FG000|Overall Study|Adverse Event|1|||
163955678|NCT05041101|592208365|FG001|Overall Study|Adverse Event|0|||
163955679|NCT05041101|592208366|FG002|Overall Study|Adverse Event|0|||
163955680|NCT05041101|592208364|FG000|Overall Study|Diease Progression|5|||
163955681|NCT05041101|592208365|FG001|Overall Study|Diease Progression|0|||
163955682|NCT05041101|592208366|FG002|Overall Study|Diease Progression|0|||
163955683|NCT03401229|592208367|FG000|Overall Study|Lost to Follow-up|2|||
163955684|NCT03401229|592208368|FG001|Overall Study|Lost to Follow-up|1|||
163955685|NCT03401229|592208367|FG000|Overall Study|Other|1|||
163955686|NCT03401229|592208368|FG001|Overall Study|Other|3|||
163955687|NCT03401229|592208367|FG000|Overall Study|Adverse Event|8|||
163955688|NCT03401229|592208368|FG001|Overall Study|Adverse Event|6|||
163955689|NCT03401229|592208367|FG000|Overall Study|Withdrawal by Subject|29|||
163955690|NCT03401229|592208368|FG001|Overall Study|Withdrawal by Subject|26|||
163955691|NCT03401229|592208367|FG000|Overall Study|COVID-19|0|||
163955692|NCT03401229|592208368|FG001|Overall Study|COVID-19|1|||
163955693|NCT00842985|592208369|FG000|Screening|Did not meet entrance requirements|27|||
163955694|NCT00842985|592208369|FG000|First Intervention|Withdrawal by Subject|3|||
163955695|NCT00842985|592208369|FG000|First Intervention|Protocol Violation|3|||
163955696|NCT00842985|592208369|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
163955697|NCT00842985|592208369|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
163955698|NCT05333224|592208370|FG000|Overall Study - Infants|Lost to Follow-up|1|||
163955699|NCT05333224|592208371|FG001|Overall Study - Infants|Lost to Follow-up|1|||
163955700|NCT01122862|592208373|FG000|Period 1|Protocol Violation|0|||
163955701|NCT01122862|592208374|FG001|Period 1|Protocol Violation|1|||
163955702|NCT01122862|592208375|FG002|Period 1|Protocol Violation|0|||
163955703|NCT01122862|592208373|FG000|Period 2|Adverse Event|0|||
163955704|NCT01122862|592208374|FG001|Period 2|Adverse Event|0|||
163955705|NCT01122862|592208375|FG002|Period 2|Adverse Event|1|||
163955706|NCT00966277|592208378|FG000|Overall Study|Withdrawal by Subject|3|||
163955707|NCT00966277|592208379|FG001|Overall Study|Withdrawal by Subject|0|||
163955708|NCT00966277|592208378|FG000|Overall Study|Ineligible|1|||
163955709|NCT00966277|592208379|FG001|Overall Study|Ineligible|3|||
163955710|NCT00966277|592208378|FG000|Overall Study|Treatment Plan Changed|0|||
163955711|NCT00966277|592208379|FG001|Overall Study|Treatment Plan Changed|1|||
163955712|NCT01249274|592208380|FG000|Overall Study|Lost to Follow-up|3|||
163955713|NCT01249274|592208381|FG001|Overall Study|Lost to Follow-up|4|||
163955714|NCT01249274|592208380|FG000|Overall Study|Received inpatient substance treatment|1|||
163955715|NCT01249274|592208381|FG001|Overall Study|Received inpatient substance treatment|2|||
163955716|NCT01498653|592208382|FG000|Overall Study|Adverse Event|2|||
163955717|NCT01498653|592208383|FG001|Overall Study|Adverse Event|2|||
163955718|NCT01498653|592208382|FG000|Overall Study|Lack of Efficacy|12|||
163955719|NCT01498653|592208383|FG001|Overall Study|Lack of Efficacy|26|||
163955720|NCT01498653|592208382|FG000|Overall Study|Protocol Violation|0|||
163955721|NCT01498653|592208383|FG001|Overall Study|Protocol Violation|4|||
163955722|NCT01498653|592208382|FG000|Overall Study|Lost to Follow-up|1|||
163955723|NCT01498653|592208383|FG001|Overall Study|Lost to Follow-up|0|||
163955724|NCT01498653|592208382|FG000|Overall Study|Physician Decision|2|||
163955725|NCT01498653|592208383|FG001|Overall Study|Physician Decision|0|||
163955726|NCT01498653|592208382|FG000|Overall Study|Withdrawal by Subject|2|||
163955727|NCT01498653|592208383|FG001|Overall Study|Withdrawal by Subject|3|||
163955728|NCT02070588|592208389|FG000|Overall Study|Withdrawal by Subject|29|||
163955729|NCT02070588|592208390|FG001|Overall Study|Withdrawal by Subject|1|||
163955730|NCT02070588|592208391|FG002|Overall Study|Withdrawal by Subject|0|||
163955731|NCT02070588|592208389|FG000|Overall Study|Writhdrawal due to early termination|9|||
163955732|NCT02070588|592208390|FG001|Overall Study|Writhdrawal due to early termination|0|||
163955733|NCT02070588|592208391|FG002|Overall Study|Writhdrawal due to early termination|0|||
163955734|NCT02070588|592208389|FG000|Overall Study|Adverse Event|1|||
163955735|NCT02070588|592208390|FG001|Overall Study|Adverse Event|0|||
163955736|NCT02070588|592208391|FG002|Overall Study|Adverse Event|0|||
163955737|NCT03421431|592208392|FG000|Overall Study|Adverse Event|2|||
163955738|NCT03421431|592208393|FG001|Overall Study|Adverse Event|1|||
163955739|NCT03421431|592208394|FG002|Overall Study|Adverse Event|12|||
163955740|NCT03421431|592208392|FG000|Overall Study|Lost to Follow-up|1|||
163955741|NCT03421431|592208393|FG001|Overall Study|Lost to Follow-up|1|||
163955742|NCT03421431|592208394|FG002|Overall Study|Lost to Follow-up|1|||
163955743|NCT03421431|592208392|FG000|Overall Study|Withdrawal by Subject|3|||
163955744|NCT03421431|592208393|FG001|Overall Study|Withdrawal by Subject|2|||
163955745|NCT03421431|592208394|FG002|Overall Study|Withdrawal by Subject|1|||
163955746|NCT03421431|592208392|FG000|Overall Study|Protocol Violation|0|||
163955747|NCT03421431|592208393|FG001|Overall Study|Protocol Violation|1|||
163955748|NCT03421431|592208394|FG002|Overall Study|Protocol Violation|0|||
163955749|NCT03421431|592208392|FG000|Overall Study|Participant met Stopping Rules|0|||
163955750|NCT03421431|592208393|FG001|Overall Study|Participant met Stopping Rules|1|||
163955751|NCT03421431|592208394|FG002|Overall Study|Participant met Stopping Rules|0|||
163955752|NCT00141726|592208395|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
163955753|NCT02513303|592208400|FG000|Overall Study|Withdrawal by Subject|9|||
163955754|NCT02513303|592208401|FG001|Overall Study|Withdrawal by Subject|7|||
163955755|NCT02513303|592208402|FG002|Overall Study|Withdrawal by Subject|2|||
163955756|NCT02513303|592208400|FG000|Overall Study|Lost to Follow-up|2|||
163955757|NCT02513303|592208401|FG001|Overall Study|Lost to Follow-up|4|||
163955758|NCT02513303|592208402|FG002|Overall Study|Lost to Follow-up|0|||
163955759|NCT02513303|592208400|FG000|Overall Study|Adverse Event|0|||
163955760|NCT02513303|592208401|FG001|Overall Study|Adverse Event|1|||
163955761|NCT02513303|592208402|FG002|Overall Study|Adverse Event|0|||
163955762|NCT02513303|592208400|FG000|Overall Study|Physician Decision|1|||
163955763|NCT02513303|592208401|FG001|Overall Study|Physician Decision|1|||
164047878|NCT01316380|592534243|FG000|Overall Study|Protocol Violation|0|||
164047879|NCT01316380|592534244|FG001|Overall Study|Protocol Violation|0|||
164047880|NCT01316380|592534245|FG002|Overall Study|Protocol Violation|1|||
164047881|NCT01316380|592534243|FG000|Overall Study|Withdrawal by Subject|1|||
164047882|NCT01316380|592534244|FG001|Overall Study|Withdrawal by Subject|2|||
163955764|NCT02513303|592208402|FG002|Overall Study|Physician Decision|0|||
163955765|NCT02513303|592208400|FG000|Overall Study|Death|8|||
163955766|NCT02513303|592208401|FG001|Overall Study|Death|4|||
163955767|NCT02513303|592208402|FG002|Overall Study|Death|2|||
163955768|NCT01691768|592208403|FG000|Overall Study|Death|0|||
163955769|NCT01691768|592208404|FG001|Overall Study|Death|2|||
163955770|NCT01691768|592208403|FG000|Overall Study|Lost to Follow-up|4|||
163955771|NCT01691768|592208404|FG001|Overall Study|Lost to Follow-up|3|||
163955772|NCT01691768|592208403|FG000|Overall Study|Withdrawal by Subject|10|||
164047883|NCT01316380|592534245|FG002|Overall Study|Withdrawal by Subject|0|||
163955773|NCT01691768|592208404|FG001|Overall Study|Withdrawal by Subject|9|||
163955774|NCT01691768|592208403|FG000|Overall Study|Relocated|0|||
163955775|NCT01691768|592208404|FG001|Overall Study|Relocated|1|||
163955776|NCT01691768|592208403|FG000|Overall Study|Investigator decision|1|||
163955777|NCT01691768|592208404|FG001|Overall Study|Investigator decision|1|||
163955778|NCT01920854|592208408|FG000|Overall Study|Withdrawal by Subject|1|||
163955779|NCT01920854|592208409|FG001|Overall Study|Withdrawal by Subject|0|||
163955780|NCT01920854|592208410|FG002|Overall Study|Withdrawal by Subject|0|||
163955781|NCT01920854|592208411|FG003|Overall Study|Withdrawal by Subject|0|||
163955782|NCT01920854|592208412|FG004|Overall Study|Withdrawal by Subject|1|||
163955783|NCT01920854|592208413|FG005|Overall Study|Withdrawal by Subject|0|||
163955784|NCT01920854|592208414|FG006|Overall Study|Withdrawal by Subject|1|||
163955785|NCT00679627|592208415|FG000|Overall Study|Death|41|||
163955786|NCT00679627|592208416|FG001|Overall Study|Death|29|||
163955787|NCT00679627|592208415|FG000|Overall Study|Adverse Event|43|||
163955788|NCT00679627|592208416|FG001|Overall Study|Adverse Event|53|||
163955789|NCT00679627|592208415|FG000|Overall Study|Withdrawal by Subject|168|||
163955790|NCT00679627|592208416|FG001|Overall Study|Withdrawal by Subject|172|||
163955791|NCT00679627|592208415|FG000|Overall Study|Lost to Follow-up|22|||
163955792|NCT00679627|592208416|FG001|Overall Study|Lost to Follow-up|26|||
163955793|NCT00679627|592208415|FG000|Overall Study|Early Study Closure|425|||
163955794|NCT00679627|592208416|FG001|Overall Study|Early Study Closure|405|||
163955795|NCT02382016|592210252|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
163955796|NCT02382016|592210253|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
163955797|NCT02382016|592210252|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
163955798|NCT02382016|592210253|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
163955799|NCT02382016|592210252|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
163955800|NCT02382016|592210253|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
163955801|NCT02382016|592210252|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
163955802|NCT02382016|592210253|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
163955803|NCT02382016|592210252|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
163955804|NCT02382016|592210253|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
163955805|NCT02382016|592210252|FG000|Open-label (OL) Treatment Period|Death|4|||
163955806|NCT02382016|592210253|FG001|Open-label (OL) Treatment Period|Death|0|||
163955807|NCT02382016|592210252|FG000|OL Extension Period|Physician Decision|3|||
163955808|NCT02382016|592210253|FG001|OL Extension Period|Physician Decision|0|||
163955809|NCT02382016|592210252|FG000|OL Extension Period|Death|2|||
163955810|NCT02382016|592210253|FG001|OL Extension Period|Death|0|||
163955811|NCT02382016|592210252|FG000|OL Extension Period|Withdrawal by Subject|1|||
163955812|NCT02382016|592210253|FG001|OL Extension Period|Withdrawal by Subject|0|||
163955813|NCT01729156|592210254|FG000|Overall Study|Withdrawal by Subject|1|||
163955814|NCT01729156|592210255|FG001|Overall Study|Withdrawal by Subject|0|||
163955815|NCT01729156|592210256|FG002|Overall Study|Withdrawal by Subject|0|||
163955816|NCT04363801|592210259|FG000|Overall Study|Death|18|||
163955817|NCT04363801|592210260|FG001|Overall Study|Death|14|||
163955818|NCT04363801|592210261|FG002|Overall Study|Death|16|||
163955819|NCT04363801|592210262|FG003|Overall Study|Death|48|||
163955820|NCT04363801|592210263|FG004|Overall Study|Death|38|||
163955821|NCT04363801|592210259|FG000|Overall Study|Withdrawal by Subject|1|||
163955822|NCT04363801|592210260|FG001|Overall Study|Withdrawal by Subject|6|||
163955823|NCT04363801|592210261|FG002|Overall Study|Withdrawal by Subject|1|||
163955824|NCT04363801|592210262|FG003|Overall Study|Withdrawal by Subject|4|||
163955825|NCT04363801|592210263|FG004|Overall Study|Withdrawal by Subject|14|||
163955826|NCT04363801|592210259|FG000|Overall Study|Sponsor Decision|6|||
163955827|NCT04363801|592210260|FG001|Overall Study|Sponsor Decision|4|||
163955828|NCT04363801|592210261|FG002|Overall Study|Sponsor Decision|10|||
163955829|NCT04363801|592210262|FG003|Overall Study|Sponsor Decision|33|||
163955830|NCT04363801|592210263|FG004|Overall Study|Sponsor Decision|32|||
163955831|NCT04363801|592210259|FG000|Overall Study|Lost to Follow-up|0|||
163955832|NCT04363801|592210260|FG001|Overall Study|Lost to Follow-up|0|||
163955833|NCT04363801|592210261|FG002|Overall Study|Lost to Follow-up|1|||
163955834|NCT04363801|592210262|FG003|Overall Study|Lost to Follow-up|0|||
163955835|NCT04363801|592210263|FG004|Overall Study|Lost to Follow-up|1|||
163955836|NCT01146054|592210264|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
163955837|NCT01146054|592210264|FG000|Overall Study|Rapid tumor progression|2|||
163955838|NCT01146054|592210264|FG000|Overall Study|Other illness precluded treatment|2|||
163955839|NCT01146054|592210264|FG000|Overall Study|Lost to Follow-up|1|||
163955840|NCT01776424|592210267|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
163955841|NCT01776424|592210268|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
163955842|NCT01776424|592210269|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
164047884|NCT01316380|592534243|FG000|Overall Study|Other|0|||
163955843|NCT01776424|592210267|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
163955844|NCT01776424|592210268|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
163955845|NCT01776424|592210269|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
163955846|NCT01776424|592210267|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
163955847|NCT01776424|592210268|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
163955848|NCT01776424|592210269|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
163955849|NCT01776424|592210267|FG000|LTOLE Part (Open Label)|Refused|5|||
163955850|NCT01776424|592210268|FG001|LTOLE Part (Open Label)|Refused|2|||
163955851|NCT01776424|592210269|FG002|LTOLE Part (Open Label)|Refused|11|||
163955852|NCT01776424|592210267|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
163955853|NCT01776424|592210268|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
163955854|NCT01776424|592210269|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
163955855|NCT00819390|592210271|FG000|Overall Study|Lost to Follow-up|1|||
163955856|NCT00819390|592210272|FG001|Overall Study|Lost to Follow-up|1|||
163955857|NCT00819390|592210273|FG002|Overall Study|Lost to Follow-up|0|||
163955858|NCT00819390|592210274|FG003|Overall Study|Lost to Follow-up|0|||
163955859|NCT00819390|592210271|FG000|Overall Study|Withdrawal by Subject|2|||
163955860|NCT00819390|592210272|FG001|Overall Study|Withdrawal by Subject|0|||
163955861|NCT00819390|592210273|FG002|Overall Study|Withdrawal by Subject|0|||
163955862|NCT00819390|592210274|FG003|Overall Study|Withdrawal by Subject|0|||
163955863|NCT00819390|592210271|FG000|Overall Study|Adverse Event|0|||
163955864|NCT00819390|592210272|FG001|Overall Study|Adverse Event|0|||
163955865|NCT00819390|592210273|FG002|Overall Study|Adverse Event|1|||
163955866|NCT00819390|592210274|FG003|Overall Study|Adverse Event|0|||
163955867|NCT02294227|592210275|FG000|Overall Study|Death|0|||
163955868|NCT02294227|592210276|FG001|Overall Study|Death|0|||
163955869|NCT02294227|592210277|FG002|Overall Study|Death|1|||
163955870|NCT02294227|592210275|FG000|Overall Study|Subject/Guardian Decision|6|||
163955871|NCT02294227|592210276|FG001|Overall Study|Subject/Guardian Decision|3|||
163955872|NCT02294227|592210277|FG002|Overall Study|Subject/Guardian Decision|7|||
163955873|NCT02294227|592210275|FG000|Overall Study|Physician Decision|1|||
163955874|NCT02294227|592210276|FG001|Overall Study|Physician Decision|2|||
163955875|NCT02294227|592210277|FG002|Overall Study|Physician Decision|1|||
163955876|NCT02294227|592210275|FG000|Overall Study|Lost to Follow-up|1|||
163955877|NCT02294227|592210276|FG001|Overall Study|Lost to Follow-up|0|||
163955878|NCT02294227|592210277|FG002|Overall Study|Lost to Follow-up|0|||
163955879|NCT02294227|592210275|FG000|Overall Study|Lack of Efficacy|11|||
163955880|NCT02294227|592210276|FG001|Overall Study|Lack of Efficacy|12|||
163955881|NCT02294227|592210277|FG002|Overall Study|Lack of Efficacy|8|||
163955882|NCT02294227|592210275|FG000|Overall Study|Adverse Event|6|||
163955883|NCT02294227|592210276|FG001|Overall Study|Adverse Event|8|||
163955884|NCT02294227|592210277|FG002|Overall Study|Adverse Event|2|||
163955885|NCT00887432|592210278|FG000|Overall Study|Start Excluded Therapy|3|||
163955886|NCT00887432|592210279|FG001|Overall Study|Start Excluded Therapy|0|||
163955887|NCT00887432|592210278|FG000|Overall Study|Did not complete treatment|6|||
163955888|NCT00887432|592210279|FG001|Overall Study|Did not complete treatment|8|||
163955889|NCT00887432|592210278|FG000|Overall Study|Protocol Violation|2|||
163955890|NCT00887432|592210279|FG001|Overall Study|Protocol Violation|3|||
163955891|NCT00887432|592210278|FG000|Overall Study|Withdrawal by Subject|3|||
163955892|NCT00887432|592210279|FG001|Overall Study|Withdrawal by Subject|2|||
163955893|NCT00887432|592210278|FG000|Overall Study|Lost to Follow-up|1|||
163955894|NCT00887432|592210279|FG001|Overall Study|Lost to Follow-up|0|||
163955895|NCT00887432|592210278|FG000|Overall Study|No reason provided|0|||
163955896|NCT00887432|592210279|FG001|Overall Study|No reason provided|1|||
163955897|NCT00899548|592210280|FG000|Overall Study|Physician Decision|3|||
163955898|NCT00551460|592210281|FG000|Overall Study|Adverse Event|1|||
163955899|NCT00551460|592210281|FG000|Overall Study|Withdrawal by Subject|1|||
163955900|NCT00551460|592210281|FG000|Overall Study|Physician Decision|1|||
163955901|NCT00551460|592210281|FG000|Overall Study|Death|7|||
163955902|NCT00551460|592210281|FG000|Overall Study|Ineligible|4|||
163955903|NCT00551460|592210281|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
163955904|NCT00448123|592210282|FG000|Overall Study|Lost to Follow-up|9|||
163955905|NCT00448123|592210283|FG001|Overall Study|Lost to Follow-up|6|||
163955906|NCT00448123|592210282|FG000|Overall Study|Physician Decision|6|||
163955907|NCT00448123|592210283|FG001|Overall Study|Physician Decision|6|||
163955908|NCT00818649|592210284|FG000|Overall Study|Declining performance status|2|||
163955909|NCT00818649|592210284|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
163955910|NCT00818649|592210284|FG000|Overall Study|Adverse Event|1|||
163955911|NCT01275131|592210285|FG000|Period 1|Withdrawal by Subject|1|||
163955912|NCT01275131|592210286|FG001|Period 1|Withdrawal by Subject|0|||
163955913|NCT01275131|592210287|FG002|Period 1|Withdrawal by Subject|3|||
163955914|NCT01275131|592210288|FG003|Period 1|Withdrawal by Subject|2|||
163955915|NCT01275131|592210285|FG000|Period 1|Physician Decision|1|||
163955916|NCT01275131|592210286|FG001|Period 1|Physician Decision|0|||
163955917|NCT01275131|592210287|FG002|Period 1|Physician Decision|0|||
163955918|NCT01275131|592210288|FG003|Period 1|Physician Decision|0|||
163955919|NCT01275131|592210285|FG000|Period 2 (Crossover)|Adverse Event|0|||
163955920|NCT01275131|592210286|FG001|Period 2 (Crossover)|Adverse Event|1|||
163955921|NCT01275131|592210287|FG002|Period 2 (Crossover)|Adverse Event|0|||
163955922|NCT01275131|592210288|FG003|Period 2 (Crossover)|Adverse Event|0|||
163955923|NCT01275131|592210285|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
163955924|NCT01275131|592210286|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
164047885|NCT01316380|592534244|FG001|Overall Study|Other|1|||
163955925|NCT01275131|592210287|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
163955926|NCT01275131|592210288|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
163955927|NCT02112708|592210295|FG000|Baseline|Physician Decision|16|||
163955928|NCT02112708|592210296|FG001|Baseline|Physician Decision|11|||
163955929|NCT02112708|592210295|FG000|Baseline|Lost to Follow-up|12|||
163955930|NCT02112708|592210296|FG001|Baseline|Lost to Follow-up|0|||
163955931|NCT02112708|592210295|FG000|4 Month|Death|0|||
163955932|NCT02112708|592210296|FG001|4 Month|Death|1|||
163955933|NCT02112708|592210295|FG000|4 Month|Withdrawal by Subject|12|||
163955934|NCT02112708|592210296|FG001|4 Month|Withdrawal by Subject|0|||
163955935|NCT00953745|592210297|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
163955936|NCT00953745|592210298|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
163955937|NCT00953745|592210297|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
163955938|NCT00953745|592210298|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
163955939|NCT00953745|592210297|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
163955940|NCT00953745|592210298|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
163955941|NCT00953745|592210297|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
163955942|NCT00953745|592210298|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
163955943|NCT00953745|592210297|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
163955944|NCT00953745|592210298|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
163955945|NCT00953745|592210297|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
163955946|NCT00953745|592210298|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
163955947|NCT00490724|592210299|FG000|Period I|Physician Decision|0|||
163955948|NCT00490724|592210300|FG001|Period I|Physician Decision|0|||
163955949|NCT00490724|592210301|FG002|Period I|Physician Decision|1|||
163955950|NCT00490724|592210299|FG000|Period II|Treatment Discontinuation|3|||
163955951|NCT00490724|592210300|FG001|Period II|Treatment Discontinuation|1|||
163955952|NCT00490724|592210301|FG002|Period II|Treatment Discontinuation|3|||
163955953|NCT00903682|592210304|FG000|Overall Study|Adverse Event|6|||
163955954|NCT00903682|592210305|FG001|Overall Study|Adverse Event|13|||
163955955|NCT00903682|592210304|FG000|Overall Study|Lost to Follow-up|1|||
163955956|NCT00903682|592210305|FG001|Overall Study|Lost to Follow-up|0|||
163955957|NCT00903682|592210304|FG000|Overall Study|Withdrawal by Subject|5|||
163955958|NCT00903682|592210305|FG001|Overall Study|Withdrawal by Subject|0|||
163955959|NCT00903682|592210304|FG000|Overall Study|Pregnancy|0|||
163955960|NCT00903682|592210305|FG001|Overall Study|Pregnancy|1|||
163955961|NCT00903682|592210304|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
163955962|NCT00903682|592210305|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
163955963|NCT00903682|592210304|FG000|Overall Study|Subject Non-Compliant|1|||
163955964|NCT00903682|592210305|FG001|Overall Study|Subject Non-Compliant|0|||
163955965|NCT00903682|592210304|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
163955966|NCT00903682|592210305|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
163955967|NCT00903682|592210304|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
163955968|NCT00903682|592210305|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
163955969|NCT03866473|592210306|FG000|Phase 1|Death|1|||
163955970|NCT03866473|592210307|FG001|Phase 1|Death|0|||
163955971|NCT03866473|592210306|FG000|Phase 2|Death|0|||
163955972|NCT03866473|592210307|FG001|Phase 2|Death|2|||
163955973|NCT03866473|592210306|FG000|Phase 2|Dropped|1|||
163955974|NCT03866473|592210307|FG001|Phase 2|Dropped|1|||
163955975|NCT03866473|592210306|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
163955976|NCT03866473|592210307|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
163955977|NCT03110185|592210308|FG000|Overall Study|Death|0|||
163955978|NCT03110185|592210309|FG001|Overall Study|Death|1|||
163955979|NCT03110185|592210308|FG000|Overall Study|Withdrawal by Subject|2|||
163955980|NCT03110185|592210309|FG001|Overall Study|Withdrawal by Subject|7|||
163955981|NCT03110185|592210308|FG000|Overall Study|Time Constraints|0|||
163955982|NCT03110185|592210309|FG001|Overall Study|Time Constraints|6|||
164047886|NCT01316380|592534245|FG002|Overall Study|Other|1|||
164047887|NCT01316380|592534243|FG000|Overall Study|Not treated|1|||
164047888|NCT01316380|592534244|FG001|Overall Study|Not treated|0|||
164047889|NCT01316380|592534245|FG002|Overall Study|Not treated|0|||
164047890|NCT01894776|592534246|FG000|Overall Study|Withdrawal by Subject|1|||
163955983|NCT03110185|592210308|FG000|Overall Study|Conflict with care|5|||
163955984|NCT03110185|592210309|FG001|Overall Study|Conflict with care|12|||
164047891|NCT00471315|592534248|FG000|Overall Study|Adverse Event|7|||
164047892|NCT00471315|592534248|FG000|Overall Study|Withdrawal by Subject|1|||
163955985|NCT03110185|592210308|FG000|Overall Study|Protocol Violation|1|||
163955986|NCT03110185|592210309|FG001|Overall Study|Protocol Violation|4|||
163955987|NCT03110185|592210308|FG000|Overall Study|MRI Incompatible|2|||
163955988|NCT03110185|592210309|FG001|Overall Study|MRI Incompatible|0|||
163955989|NCT03110185|592210308|FG000|Overall Study|Patient Refusal|0|||
163955990|NCT03110185|592210309|FG001|Overall Study|Patient Refusal|1|||
163955991|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
163955992|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
163955993|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
163955994|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
163955995|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
163955996|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
163955997|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
163955998|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
163955999|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
163956000|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
163956001|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
163956002|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
163956003|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
163956004|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
163956005|NCT00600886|592210310|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
163956006|NCT00600886|592210311|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
163956007|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
163956008|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
163956009|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
163956010|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
163956011|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
163956012|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
163956013|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
163956014|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
163956015|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
163956016|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
163956017|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
163956018|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
163956019|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Death|1|||
163956020|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Death|1|||
163956021|NCT00600886|592210310|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
163956022|NCT00600886|592210311|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
163956023|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
163956024|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
163956025|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
163956026|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
163956027|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
163956028|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
163956029|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
163956030|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
163956031|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
163956032|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
163956033|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
163956034|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
163956035|NCT00600886|592210310|FG000|Extension - After Crossover (CAS)|Death|1|||
163956036|NCT00600886|592210311|FG001|Extension - After Crossover (CAS)|Death|0|||
163956037|NCT03075410|592210312|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
163956038|NCT03075410|592210313|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956039|NCT03075410|592210314|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
163956040|NCT03075410|592210315|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956041|NCT03075410|592210316|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956042|NCT03075410|592210317|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956043|NCT03075410|592210318|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956044|NCT03075410|592210319|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956045|NCT03075410|592210320|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
163956046|NCT03075410|592210312|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
163956047|NCT03075410|592210313|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956048|NCT03075410|592210314|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956049|NCT03075410|592210315|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956050|NCT03075410|592210316|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956051|NCT03075410|592210317|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956052|NCT03075410|592210318|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956053|NCT03075410|592210319|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956054|NCT03075410|592210320|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
163956055|NCT02053792|592210321|FG000|Overall Study|Physician Decision|0|||
163956056|NCT02053792|592210322|FG001|Overall Study|Physician Decision|1|||
163956057|NCT02053792|592210321|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
164047893|NCT02574520|592534252|FG000|Overall Study|Not dosed|2|||
164047894|NCT02574520|592534253|FG001|Overall Study|Not dosed|0|||
164148627|NCT04895982|592904911|FG000|Overall Study|Lost to Follow-up|0|||
163956058|NCT02053792|592210322|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
163956059|NCT02053792|592210321|FG000|Overall Study|Lack of Efficacy|1|||
163956060|NCT02053792|592210322|FG001|Overall Study|Lack of Efficacy|0|||
163956061|NCT02053792|592210321|FG000|Overall Study|Adverse Event|1|||
163956062|NCT02053792|592210322|FG001|Overall Study|Adverse Event|0|||
163956063|NCT02053792|592210321|FG000|Overall Study|Withdrawal by Subject|2|||
163956064|NCT02053792|592210322|FG001|Overall Study|Withdrawal by Subject|2|||
163956065|NCT02053792|592210321|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
163956066|NCT02053792|592210322|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
163956067|NCT02053792|592210321|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
163956068|NCT02053792|592210322|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
163956069|NCT01427751|592210323|FG000|Overall Study|Adverse Event|18|||
163956070|NCT01427751|592210324|FG001|Overall Study|Adverse Event|2|||
163956071|NCT01427751|592210323|FG000|Overall Study|No further treatment benefit expected|5|||
163956072|NCT01427751|592210324|FG001|Overall Study|No further treatment benefit expected|1|||
163956073|NCT01427751|592210323|FG000|Overall Study|Lost to Follow-up|3|||
163956074|NCT01427751|592210324|FG001|Overall Study|Lost to Follow-up|1|||
163956075|NCT01427751|592210323|FG000|Overall Study|Withdrawal of consent|2|||
163956076|NCT01427751|592210324|FG001|Overall Study|Withdrawal of consent|2|||
163956077|NCT01427751|592210323|FG000|Overall Study|Protocol Violation|6|||
163956078|NCT01427751|592210324|FG001|Overall Study|Protocol Violation|4|||
163956079|NCT01427751|592210323|FG000|Overall Study|Death|2|||
163956080|NCT01427751|592210324|FG001|Overall Study|Death|0|||
163956081|NCT01427751|592210323|FG000|Overall Study|Other miscellaneous reasons|6|||
163956082|NCT01427751|592210324|FG001|Overall Study|Other miscellaneous reasons|4|||
163956083|NCT01028027|592210325|FG000|Overall Study|Lost to Follow-up|4|||
163956084|NCT01028027|592210326|FG001|Overall Study|Lost to Follow-up|1|||
163956085|NCT01028027|592210325|FG000|Overall Study|Withdrawal by Subject|5|||
163956086|NCT01028027|592210326|FG001|Overall Study|Withdrawal by Subject|3|||
163956087|NCT01028027|592210325|FG000|Overall Study|Adverse Event|4|||
163956088|NCT01028027|592210326|FG001|Overall Study|Adverse Event|7|||
163956089|NCT01028027|592210325|FG000|Overall Study|Protocol Violation|3|||
163956090|NCT01028027|592210326|FG001|Overall Study|Protocol Violation|1|||
163956091|NCT01028027|592210325|FG000|Overall Study|Lack of Efficacy|0|||
163956092|NCT01028027|592210326|FG001|Overall Study|Lack of Efficacy|1|||
163956093|NCT00368992|592210337|FG000|Overall Study|Ineligible|5|||
163956094|NCT00368992|592210337|FG000|Overall Study|Refused treatment|3|||
163956095|NCT00368992|592210337|FG000|Overall Study|Lack of Efficacy|63|||
163956096|NCT00368992|592210337|FG000|Overall Study|Adverse Event|26|||
163956097|NCT00368992|592210337|FG000|Overall Study|Death|4|||
163956098|NCT00368992|592210337|FG000|Overall Study|Other|9|||
163956099|NCT00790751|592210344|FG000|Overall Study|Protocol non-compliance|16|||
163956100|NCT00790751|592210345|FG001|Overall Study|Protocol non-compliance|16|||
163956101|NCT00790751|592210346|FG002|Overall Study|Protocol non-compliance|10|||
163956102|NCT00790751|592210347|FG003|Overall Study|Protocol non-compliance|11|||
163956103|NCT00790751|592210344|FG000|Overall Study|Lost to Follow-up|4|||
163956104|NCT00790751|592210345|FG001|Overall Study|Lost to Follow-up|9|||
163956105|NCT00790751|592210346|FG002|Overall Study|Lost to Follow-up|4|||
163956106|NCT00790751|592210347|FG003|Overall Study|Lost to Follow-up|5|||
163956107|NCT00790751|592210344|FG000|Overall Study|Adverse Event|5|||
163956108|NCT00790751|592210345|FG001|Overall Study|Adverse Event|3|||
163956109|NCT00790751|592210346|FG002|Overall Study|Adverse Event|5|||
163956110|NCT00790751|592210347|FG003|Overall Study|Adverse Event|4|||
163956111|NCT00790751|592210344|FG000|Overall Study|Requirement for restricted medication|0|||
163956112|NCT00790751|592210345|FG001|Overall Study|Requirement for restricted medication|2|||
163956113|NCT00790751|592210346|FG002|Overall Study|Requirement for restricted medication|0|||
163956114|NCT00790751|592210347|FG003|Overall Study|Requirement for restricted medication|0|||
163956115|NCT00790751|592210344|FG000|Overall Study|Death|0|||
163956116|NCT00790751|592210345|FG001|Overall Study|Death|0|||
163956117|NCT00790751|592210346|FG002|Overall Study|Death|1|||
163956118|NCT00790751|592210347|FG003|Overall Study|Death|0|||
163956119|NCT00790751|592210344|FG000|Overall Study|Physician Decision|0|||
163956120|NCT00790751|592210345|FG001|Overall Study|Physician Decision|0|||
163956121|NCT00790751|592210346|FG002|Overall Study|Physician Decision|0|||
163956122|NCT00790751|592210347|FG003|Overall Study|Physician Decision|1|||
163956123|NCT02427464|592210350|FG000|Overall Study|Adverse Event|6|||
163956124|NCT02427464|592210351|FG001|Overall Study|Adverse Event|1|||
163956125|NCT02427464|592210350|FG000|Overall Study|Lost to Follow-up|16|||
163956126|NCT02427464|592210351|FG001|Overall Study|Lost to Follow-up|5|||
163956127|NCT02427464|592210350|FG000|Overall Study|Physician Decision|2|||
163956128|NCT02427464|592210351|FG001|Overall Study|Physician Decision|0|||
163956129|NCT02427464|592210350|FG000|Overall Study|Withdrawal by Subject|10|||
163956130|NCT02427464|592210351|FG001|Overall Study|Withdrawal by Subject|8|||
163956131|NCT02427464|592210350|FG000|Overall Study|Noncompliance|16|||
163956132|NCT02427464|592210351|FG001|Overall Study|Noncompliance|10|||
163956133|NCT04443153|592210355|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
163956134|NCT04443153|592210356|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
163956135|NCT04443153|592210355|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
163956136|NCT04443153|592210356|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
163956137|NCT04443153|592210355|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
163956138|NCT04443153|592210356|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
163956139|NCT04443153|592210355|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
163956140|NCT04443153|592210356|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
163956141|NCT02572843|592210357|FG000|Accrual|Brain metastasis retrospectively detected|1|||
163956142|NCT02572843|592210357|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
163956143|NCT02572843|592210357|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
163956144|NCT02572843|592210357|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
163956145|NCT02572843|592210357|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
163956146|NCT02572843|592210357|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
163956147|NCT02572843|592210357|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
163956148|NCT02572843|592210357|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
163956149|NCT02572843|592210357|FG000|Surgery|lost to follow up|7|||
163956150|NCT02572843|592210357|FG000|Surgery|Death|1|||
163956151|NCT01078454|592210361|FG000|Overall Study|Adverse Event|1|||
163956152|NCT01078454|592210362|FG001|Overall Study|Adverse Event|1|||
163956153|NCT01078454|592210361|FG000|Overall Study|Death|0|||
163956154|NCT01078454|592210362|FG001|Overall Study|Death|1|||
163956155|NCT04737187|592210363|FG000|Overall Study|Switched to marketed drug|32|||
163956156|NCT04737187|592210364|FG001|Overall Study|Switched to marketed drug|4|||
163956157|NCT04737187|592210363|FG000|Overall Study|Radiological Progressive Disease|145|||
163956158|NCT04737187|592210364|FG001|Overall Study|Radiological Progressive Disease|146|||
163956159|NCT04737187|592210363|FG000|Overall Study|Clinical Progressive Disease|20|||
163956160|NCT04737187|592210364|FG001|Overall Study|Clinical Progressive Disease|20|||
163956161|NCT04737187|592210363|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
163956162|NCT04737187|592210364|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
163956163|NCT04737187|592210363|FG000|Overall Study|Adverse Event|16|||
163956164|NCT04737187|592210364|FG001|Overall Study|Adverse Event|16|||
163956165|NCT04737187|592210363|FG000|Overall Study|Physician Decision|2|||
163956166|NCT04737187|592210364|FG001|Overall Study|Physician Decision|0|||
163956167|NCT04737187|592210363|FG000|Overall Study|Withdrawal by Subject|5|||
163956168|NCT04737187|592210364|FG001|Overall Study|Withdrawal by Subject|8|||
163956169|NCT05227703|592210365|FG000|Overall Study|Adverse Event|2|||
163956170|NCT05227703|592210366|FG001|Overall Study|Adverse Event|6|||
163956171|NCT05227703|592210367|FG002|Overall Study|Adverse Event|4|||
163956172|NCT05227703|592210365|FG000|Overall Study|Lack of Efficacy|4|||
163956173|NCT05227703|592210366|FG001|Overall Study|Lack of Efficacy|0|||
163956174|NCT05227703|592210367|FG002|Overall Study|Lack of Efficacy|1|||
163956175|NCT05227703|592210365|FG000|Overall Study|Physician Decision|2|||
163956176|NCT05227703|592210366|FG001|Overall Study|Physician Decision|2|||
163956177|NCT05227703|592210367|FG002|Overall Study|Physician Decision|1|||
163956178|NCT05227703|592210365|FG000|Overall Study|Protocol Violation|2|||
163956179|NCT05227703|592210366|FG001|Overall Study|Protocol Violation|1|||
163956180|NCT05227703|592210367|FG002|Overall Study|Protocol Violation|0|||
163956181|NCT05227703|592210365|FG000|Overall Study|Withdrawal by Subject|17|||
163956182|NCT05227703|592210366|FG001|Overall Study|Withdrawal by Subject|26|||
163956183|NCT05227703|592210367|FG002|Overall Study|Withdrawal by Subject|32|||
163956184|NCT05227703|592210365|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
163956185|NCT05227703|592210366|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
163956186|NCT05227703|592210367|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
163956187|NCT05227703|592210365|FG000|Overall Study|Other|1|||
163956188|NCT05227703|592210366|FG001|Overall Study|Other|1|||
163956189|NCT05227703|592210367|FG002|Overall Study|Other|0|||
163956190|NCT03464097|592210374|FG000|Overall Study|Withdrawal by Subject|15|||
163956191|NCT03464097|592210375|FG001|Overall Study|Withdrawal by Subject|13|||
163956192|NCT03464097|592210376|FG002|Overall Study|Withdrawal by Subject|11|||
163956193|NCT03464097|592210374|FG000|Overall Study|Study terminated by sponsor|47|||
163956194|NCT03464097|592210375|FG001|Overall Study|Study terminated by sponsor|44|||
163956195|NCT03464097|592210376|FG002|Overall Study|Study terminated by sponsor|40|||
163956196|NCT03464097|592210374|FG000|Overall Study|Pregnancy|0|||
163956197|NCT03464097|592210375|FG001|Overall Study|Pregnancy|1|||
163956198|NCT03464097|592210376|FG002|Overall Study|Pregnancy|0|||
163956199|NCT03464097|592210374|FG000|Overall Study|Other reasons|5|||
163956200|NCT03464097|592210375|FG001|Overall Study|Other reasons|12|||
163956201|NCT03464097|592210376|FG002|Overall Study|Other reasons|14|||
163956202|NCT03464097|592210374|FG000|Overall Study|Lost to Follow-up|0|||
163956203|NCT03464097|592210375|FG001|Overall Study|Lost to Follow-up|1|||
163956204|NCT03464097|592210376|FG002|Overall Study|Lost to Follow-up|1|||
163956205|NCT03464097|592210374|FG000|Overall Study|Lack of Efficacy|11|||
163956206|NCT03464097|592210375|FG001|Overall Study|Lack of Efficacy|18|||
163956207|NCT03464097|592210376|FG002|Overall Study|Lack of Efficacy|30|||
163956208|NCT03464097|592210374|FG000|Overall Study|Death|1|||
163956209|NCT03464097|592210375|FG001|Overall Study|Death|0|||
163956210|NCT03464097|592210376|FG002|Overall Study|Death|0|||
163956211|NCT03464097|592210374|FG000|Overall Study|Adverse Event|13|||
163956212|NCT03464097|592210375|FG001|Overall Study|Adverse Event|6|||
163956213|NCT03464097|592210376|FG002|Overall Study|Adverse Event|8|||
163956214|NCT03035201|592210377|FG000|Overall Study|Death|9|||
163956215|NCT03035201|592210378|FG001|Overall Study|Death|12|||
163956216|NCT03035201|592210379|FG002|Overall Study|Death|9|||
163956217|NCT03035201|592210380|FG003|Overall Study|Death|10|||
163956218|NCT03035201|592210377|FG000|Overall Study|Withdrawal by Subject|51|||
163956219|NCT03035201|592210378|FG001|Overall Study|Withdrawal by Subject|49|||
163956220|NCT03035201|592210379|FG002|Overall Study|Withdrawal by Subject|37|||
163956221|NCT03035201|592210380|FG003|Overall Study|Withdrawal by Subject|46|||
163956222|NCT03035201|592210377|FG000|Overall Study|Lost to Follow-up|67|||
163956223|NCT03035201|592210378|FG001|Overall Study|Lost to Follow-up|51|||
163956224|NCT03035201|592210379|FG002|Overall Study|Lost to Follow-up|64|||
163956225|NCT03035201|592210380|FG003|Overall Study|Lost to Follow-up|69|||
163956226|NCT03432260|592210387|FG000|Overall Study|Lost to Follow-up|1|||
163956227|NCT03432260|592210388|FG001|Overall Study|Lost to Follow-up|1|||
163956228|NCT03432260|592210389|FG002|Overall Study|Lost to Follow-up|0|||
163956229|NCT03432260|592210390|FG003|Overall Study|Lost to Follow-up|0|||
163956230|NCT03432260|592210391|FG004|Overall Study|Lost to Follow-up|1|||
163956231|NCT02186847|592210393|FG000|Overall Study|Protocol Violation|3|||
163956232|NCT02186847|592210394|FG001|Overall Study|Protocol Violation|0|||
163956233|NCT00345293|592210395|FG000|Overall Study|Unable to access line for sample|1|||
163956234|NCT00345293|592210396|FG001|Overall Study|Unable to access line for sample|0|||
163956235|NCT00345293|592210395|FG000|Overall Study|Withdrawal by Subject|1|||
163956236|NCT00345293|592210396|FG001|Overall Study|Withdrawal by Subject|0|||
163956237|NCT01307579|592210397|FG000|Overall Study|Death|3|||
163956238|NCT01307579|592210398|FG001|Overall Study|Death|6|||
163956239|NCT01307579|592210397|FG000|Overall Study|Physician Decision|26|||
163956240|NCT01307579|592210398|FG001|Overall Study|Physician Decision|29|||
163956241|NCT01307579|592210397|FG000|Overall Study|Withdrawal by Subject|7|||
163956242|NCT01307579|592210398|FG001|Overall Study|Withdrawal by Subject|3|||
163956243|NCT01307579|592210397|FG000|Overall Study|Institutional diagnosis of IFD|21|||
163956244|NCT01307579|592210398|FG001|Overall Study|Institutional diagnosis of IFD|36|||
163956245|NCT01307579|592210397|FG000|Overall Study|Begin conditioning for HSCT|42|||
163956246|NCT01307579|592210398|FG001|Overall Study|Begin conditioning for HSCT|44|||
163956247|NCT01307579|592210397|FG000|Overall Study|Refractory or relapsed AML|38|||
163956248|NCT01307579|592210398|FG001|Overall Study|Refractory or relapsed AML|23|||
163956249|NCT01307579|592210397|FG000|Overall Study|Ineligible|3|||
163956250|NCT01307579|592210398|FG001|Overall Study|Ineligible|4|||
163956251|NCT03727438|592210401|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
163956252|NCT03727438|592210402|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
163956253|NCT03727438|592210401|FG000|Intervention Period|Excluded (health)|1|||
163956254|NCT03727438|592210402|FG001|Intervention Period|Excluded (health)|0|||
163956255|NCT03727438|592210401|FG000|Intervention Period|Withdrawal by Subject|3|||
163956256|NCT03727438|592210402|FG001|Intervention Period|Withdrawal by Subject|1|||
163956257|NCT03727438|592210401|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
163956258|NCT03727438|592210402|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
163956259|NCT03727438|592210401|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
163956260|NCT03727438|592210402|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
163956261|NCT03727438|592210401|FG000|8 Week Assessment|Withdrawal by Subject|6|||
163956262|NCT03727438|592210402|FG001|8 Week Assessment|Withdrawal by Subject|1|||
163956263|NCT03727438|592210401|FG000|6 mo Assessment|did not complete assessment|10|||
163956264|NCT03727438|592210402|FG001|6 mo Assessment|did not complete assessment|11|||
163956265|NCT06729606|592210403|FG000|Overall Study|Adverse Event|0|||
163956266|NCT06729606|592210404|FG001|Overall Study|Adverse Event|2|||
163956267|NCT06729606|592210403|FG000|Overall Study|Death|1|||
163956268|NCT06729606|592210404|FG001|Overall Study|Death|0|||
163956269|NCT06729606|592210403|FG000|Overall Study|Physician Decision|0|||
163956270|NCT06729606|592210404|FG001|Overall Study|Physician Decision|1|||
163956271|NCT06729606|592210403|FG000|Overall Study|Withdrawal by Subject|2|||
163956272|NCT06729606|592210404|FG001|Overall Study|Withdrawal by Subject|4|||
163956273|NCT03170349|592210411|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
163956274|NCT03170349|592210411|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
163956275|NCT03170349|592210411|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
163956276|NCT03170349|592210411|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
163956277|NCT03170349|592210411|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
163956278|NCT03170349|592210411|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
163956279|NCT03170349|592210411|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
163956280|NCT03170349|592210411|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
163956281|NCT03170349|592210411|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
163956282|NCT03170349|592210411|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
163956283|NCT03170349|592210411|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
163956284|NCT03170349|592210411|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
163956285|NCT03170349|592210411|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
163956286|NCT03170349|592210411|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
163956287|NCT03170349|592210411|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
163956288|NCT03170349|592210411|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
163956289|NCT00001962|592212171|FG000|Overall Study|Lack of Efficacy|18|||
163956290|NCT00001962|592212171|FG000|Overall Study|Lack of Accrual|6|||
163956291|NCT00001962|592212171|FG000|Overall Study|Death|1|||
163956292|NCT00001962|592212171|FG000|Overall Study|Lost to Follow-up|2|||
163956293|NCT00001962|592212171|FG000|Overall Study|Adverse Event|1|||
163956294|NCT00604279|592212177|FG000|Overall Study|Lack of Efficacy|22|||
163956295|NCT00604279|592212178|FG001|Overall Study|Lack of Efficacy|9|||
163956296|NCT00604279|592212177|FG000|Overall Study|Lost to Follow-up|9|||
163956297|NCT00604279|592212178|FG001|Overall Study|Lost to Follow-up|14|||
163956298|NCT00604279|592212177|FG000|Overall Study|Pregnancy|2|||
163956299|NCT00604279|592212178|FG001|Overall Study|Pregnancy|0|||
163956300|NCT00604279|592212177|FG000|Overall Study|Protocol Violation|3|||
163956301|NCT00604279|592212178|FG001|Overall Study|Protocol Violation|1|||
163956302|NCT00604279|592212177|FG000|Overall Study|Withdrawal by Subject|16|||
163956303|NCT00604279|592212178|FG001|Overall Study|Withdrawal by Subject|5|||
163956304|NCT00604279|592212177|FG000|Overall Study|Adverse Event|4|||
163956305|NCT00604279|592212178|FG001|Overall Study|Adverse Event|5|||
163956306|NCT00604279|592212177|FG000|Overall Study|Other|8|||
163956307|NCT00604279|592212178|FG001|Overall Study|Other|4|||
163956308|NCT03938545|592212179|FG000|Overall Study|Lost to Follow-up|0|||
163956309|NCT03938545|592212180|FG001|Overall Study|Lost to Follow-up|0|||
163956310|NCT03938545|592212181|FG002|Overall Study|Lost to Follow-up|0|||
163956311|NCT03938545|592212182|FG003|Overall Study|Lost to Follow-up|1|||
163956312|NCT03938545|592212179|FG000|Overall Study|Non-compliance with study drug|0|||
163956313|NCT03938545|592212180|FG001|Overall Study|Non-compliance with study drug|0|||
163956314|NCT03938545|592212181|FG002|Overall Study|Non-compliance with study drug|1|||
163956315|NCT03938545|592212182|FG003|Overall Study|Non-compliance with study drug|0|||
163956316|NCT03938545|592212179|FG000|Overall Study|Pregnancy|1|||
163956317|NCT03938545|592212180|FG001|Overall Study|Pregnancy|0|||
163956318|NCT03938545|592212181|FG002|Overall Study|Pregnancy|0|||
163956319|NCT03938545|592212182|FG003|Overall Study|Pregnancy|0|||
163956320|NCT03938545|592212179|FG000|Overall Study|Study terminated by sponsor|6|||
163956321|NCT03938545|592212180|FG001|Overall Study|Study terminated by sponsor|4|||
163956322|NCT03938545|592212181|FG002|Overall Study|Study terminated by sponsor|2|||
163956323|NCT03938545|592212182|FG003|Overall Study|Study terminated by sponsor|4|||
163956324|NCT03938545|592212179|FG000|Overall Study|Withdrawal by Subject|0|||
163956325|NCT03938545|592212180|FG001|Overall Study|Withdrawal by Subject|1|||
163956326|NCT03938545|592212181|FG002|Overall Study|Withdrawal by Subject|0|||
163956327|NCT03938545|592212182|FG003|Overall Study|Withdrawal by Subject|0|||
163956328|NCT03938545|592212179|FG000|Overall Study|Adverse Event|1|||
163956329|NCT03938545|592212180|FG001|Overall Study|Adverse Event|0|||
163956330|NCT03938545|592212181|FG002|Overall Study|Adverse Event|0|||
163956331|NCT03938545|592212182|FG003|Overall Study|Adverse Event|0|||
163956332|NCT00355056|592212183|FG000|Randomization Period|Early Termination|4|||
163956333|NCT00355056|592212184|FG001|Randomization Period|Early Termination|6|||
163956334|NCT01060540|592212185|FG000|Overall Study|Withdrawal by Subject|10|||
163956335|NCT01060540|592212186|FG001|Overall Study|Withdrawal by Subject|20|||
163956336|NCT01060540|592212185|FG000|Overall Study|Lost to Follow-up|52|||
163956337|NCT01060540|592212186|FG001|Overall Study|Lost to Follow-up|43|||
163956338|NCT01060540|592212185|FG000|Overall Study|Death|2|||
163956339|NCT01060540|592212186|FG001|Overall Study|Death|1|||
163956340|NCT01060540|592212185|FG000|Overall Study|Physician Decision|0|||
163956341|NCT01060540|592212186|FG001|Overall Study|Physician Decision|1|||
163956342|NCT02647320|592212190|FG000|Overall Study|Adverse Event|0|||
163956343|NCT02647320|592212191|FG001|Overall Study|Adverse Event|1|||
163956344|NCT02647320|592212192|FG002|Overall Study|Adverse Event|3|||
163956345|NCT02647320|592212193|FG003|Overall Study|Adverse Event|2|||
163956346|NCT02647320|592212194|FG004|Overall Study|Adverse Event|1|||
163956347|NCT02647320|592212190|FG000|Overall Study|Protocol Violation|0|||
163956348|NCT02647320|592212191|FG001|Overall Study|Protocol Violation|0|||
163956349|NCT02647320|592212192|FG002|Overall Study|Protocol Violation|3|||
163956350|NCT02647320|592212193|FG003|Overall Study|Protocol Violation|0|||
163956351|NCT02647320|592212194|FG004|Overall Study|Protocol Violation|0|||
163956352|NCT02647320|592212190|FG000|Overall Study|Withdrawal by Subject|7|||
163956353|NCT02647320|592212191|FG001|Overall Study|Withdrawal by Subject|4|||
163956354|NCT02647320|592212192|FG002|Overall Study|Withdrawal by Subject|2|||
163956355|NCT02647320|592212193|FG003|Overall Study|Withdrawal by Subject|2|||
164047895|NCT02574520|592534254|FG002|Overall Study|Not dosed|5|||
163956356|NCT02647320|592212194|FG004|Overall Study|Withdrawal by Subject|7|||
163956357|NCT02647320|592212190|FG000|Overall Study|Persistent hyperglycemia|0|||
163956358|NCT02647320|592212191|FG001|Overall Study|Persistent hyperglycemia|1|||
163956359|NCT02647320|592212192|FG002|Overall Study|Persistent hyperglycemia|1|||
163956360|NCT02647320|592212193|FG003|Overall Study|Persistent hyperglycemia|1|||
163956361|NCT02647320|592212194|FG004|Overall Study|Persistent hyperglycemia|1|||
164047896|NCT02574520|592534255|FG003|Overall Study|Not dosed|4|||
163956362|NCT02647320|592212190|FG000|Overall Study|Study terminated by sponsor|1|||
163956363|NCT02647320|592212191|FG001|Overall Study|Study terminated by sponsor|1|||
163956364|NCT02647320|592212192|FG002|Overall Study|Study terminated by sponsor|1|||
163956365|NCT02647320|592212193|FG003|Overall Study|Study terminated by sponsor|1|||
163956366|NCT02647320|592212194|FG004|Overall Study|Study terminated by sponsor|2|||
163956367|NCT02647320|592212190|FG000|Overall Study|Reason not provided|0|||
163956368|NCT02647320|592212191|FG001|Overall Study|Reason not provided|0|||
163956369|NCT02647320|592212192|FG002|Overall Study|Reason not provided|1|||
163956370|NCT02647320|592212193|FG003|Overall Study|Reason not provided|0|||
163956371|NCT02647320|592212194|FG004|Overall Study|Reason not provided|2|||
163956372|NCT02647320|592212190|FG000|Overall Study|Lost to Follow-up|1|||
163956373|NCT02647320|592212191|FG001|Overall Study|Lost to Follow-up|1|||
163956374|NCT02647320|592212192|FG002|Overall Study|Lost to Follow-up|0|||
163956375|NCT02647320|592212193|FG003|Overall Study|Lost to Follow-up|0|||
163956376|NCT02647320|592212194|FG004|Overall Study|Lost to Follow-up|0|||
163956377|NCT02647320|592212190|FG000|Overall Study|Develop anemia|1|||
163956378|NCT02647320|592212191|FG001|Overall Study|Develop anemia|0|||
163956379|NCT02647320|592212192|FG002|Overall Study|Develop anemia|0|||
163956380|NCT02647320|592212193|FG003|Overall Study|Develop anemia|0|||
163956381|NCT02647320|592212194|FG004|Overall Study|Develop anemia|0|||
163956382|NCT02647320|592212190|FG000|Overall Study|Lack of Efficacy|0|||
163956383|NCT02647320|592212191|FG001|Overall Study|Lack of Efficacy|0|||
163956384|NCT02647320|592212192|FG002|Overall Study|Lack of Efficacy|0|||
163956385|NCT02647320|592212193|FG003|Overall Study|Lack of Efficacy|1|||
163956386|NCT02647320|592212194|FG004|Overall Study|Lack of Efficacy|0|||
163956387|NCT02647320|592212190|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
163956388|NCT02647320|592212191|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
163956389|NCT02647320|592212192|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
163956390|NCT02647320|592212193|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
163956391|NCT02647320|592212194|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
163956392|NCT00596427|592212195|FG000|Overall Study|Withdrawal by Subject|2|||
164047897|NCT02574520|592534252|FG000|Overall Study|Adverse Event|0|||
164047898|NCT02574520|592534253|FG001|Overall Study|Adverse Event|0|||
164047899|NCT02574520|592534254|FG002|Overall Study|Adverse Event|0|||
164047900|NCT02574520|592534255|FG003|Overall Study|Adverse Event|1|||
164047901|NCT02574520|592534252|FG000|Overall Study|Withdrawal by Subject|0|||
164047902|NCT02574520|592534253|FG001|Overall Study|Withdrawal by Subject|0|||
164047903|NCT02574520|592534254|FG002|Overall Study|Withdrawal by Subject|0|||
164047904|NCT02574520|592534255|FG003|Overall Study|Withdrawal by Subject|1|||
164047905|NCT02574520|592534252|FG000|Overall Study|Other|0|||
164047906|NCT02574520|592534253|FG001|Overall Study|Other|0|||
164047907|NCT02574520|592534254|FG002|Overall Study|Other|0|||
164047908|NCT02574520|592534255|FG003|Overall Study|Other|2|||
164047909|NCT01365091|592534258|FG000|Period 1|Adverse Event|1|||
164047910|NCT01365091|592534259|FG001|Period 1|Adverse Event|0|||
164047911|NCT01365091|592534260|FG002|Period 1|Adverse Event|2|||
164047912|NCT01365091|592534261|FG003|Period 1|Adverse Event|3|||
164047913|NCT01365091|592534258|FG000|Period 1|Positive test result for drugs of abuse|1|||
164047914|NCT01365091|592534259|FG001|Period 1|Positive test result for drugs of abuse|0|||
164047915|NCT01365091|592534260|FG002|Period 1|Positive test result for drugs of abuse|0|||
164047916|NCT01365091|592534261|FG003|Period 1|Positive test result for drugs of abuse|0|||
164047917|NCT01365091|592534258|FG000|Period 1|No longer met study criteria|0|||
164047918|NCT01365091|592534259|FG001|Period 1|No longer met study criteria|1|||
164047919|NCT01365091|592534260|FG002|Period 1|No longer met study criteria|0|||
164047920|NCT01365091|592534261|FG003|Period 1|No longer met study criteria|0|||
164047921|NCT01365091|592534258|FG000|Period 1|Withdrawal by Subject|0|||
164047922|NCT01365091|592534259|FG001|Period 1|Withdrawal by Subject|1|||
164047923|NCT01365091|592534260|FG002|Period 1|Withdrawal by Subject|0|||
164047924|NCT01365091|592534261|FG003|Period 1|Withdrawal by Subject|0|||
164047925|NCT01365091|592534258|FG000|Period 1|Personal reasons|0|||
164047926|NCT01365091|592534259|FG001|Period 1|Personal reasons|0|||
164047927|NCT01365091|592534260|FG002|Period 1|Personal reasons|1|||
164047928|NCT01365091|592534261|FG003|Period 1|Personal reasons|0|||
164047929|NCT01365091|592534258|FG000|Period 2|Withdrawal by Subject|1|||
164047930|NCT01365091|592534259|FG001|Period 2|Withdrawal by Subject|0|||
164047931|NCT01365091|592534260|FG002|Period 2|Withdrawal by Subject|0|||
164047932|NCT01365091|592534261|FG003|Period 2|Withdrawal by Subject|0|||
164047933|NCT01365091|592534258|FG000|Period 2|Adverse Event|0|||
164047934|NCT01365091|592534259|FG001|Period 2|Adverse Event|0|||
164047935|NCT01365091|592534260|FG002|Period 2|Adverse Event|1|||
164047936|NCT01365091|592534261|FG003|Period 2|Adverse Event|0|||
163956393|NCT00596427|592212196|FG001|Overall Study|Withdrawal by Subject|2|||
163956394|NCT00596427|592212195|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
163956395|NCT00596427|592212196|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
163956396|NCT00596427|592212195|FG000|Overall Study|Protocol Violation|1|||
164047937|NCT05307523|592534263|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
164047938|NCT05307523|592534264|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
164047939|NCT05307523|592534263|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
164047940|NCT05307523|592534264|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
164047941|NCT05116683|592534266|FG000|Overall Study|Physician Decision|4|||
164047942|NCT03935594|592534270|FG000|Overall Study|Physician Decision|3|||
164047943|NCT01435122|592534271|FG000|Overall Study|Early withdrawal due to toxicity|8|||
164047944|NCT03864627|592534272|FG000|Overall Study|Adverse Event|0|||
164047945|NCT03864627|592534273|FG001|Overall Study|Adverse Event|1|||
164047946|NCT03864627|592534272|FG000|Overall Study|Lack of Efficacy|0|||
164047947|NCT03864627|592534273|FG001|Overall Study|Lack of Efficacy|1|||
164047948|NCT03864627|592534272|FG000|Overall Study|Lost to Follow-up|0|||
164047949|NCT03864627|592534273|FG001|Overall Study|Lost to Follow-up|1|||
164047950|NCT03864627|592534272|FG000|Overall Study|Withdrawal by Subject|4|||
164047951|NCT03864627|592534273|FG001|Overall Study|Withdrawal by Subject|8|||
163956397|NCT00596427|592212196|FG001|Overall Study|Protocol Violation|0|||
163956398|NCT02401867|592212197|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
163956399|NCT02401867|592212197|FG000|Analysis|Cervical assay could not be conducted|9|||
163956400|NCT01650246|592212198|FG000|Overall Study|Adverse Event|23|||
163956401|NCT01650246|592212198|FG000|Overall Study|Protocol Violation|5|||
163956402|NCT01650246|592212198|FG000|Overall Study|Sponsor terminated study|53|||
163956403|NCT01650246|592212198|FG000|Overall Study|Lost to Follow-up|5|||
163956404|NCT01650246|592212198|FG000|Overall Study|Withdrawal by Subject|26|||
163956405|NCT01650246|592212198|FG000|Overall Study|Death|1|||
163956406|NCT01650246|592212198|FG000|Overall Study|Lack of Efficacy|30|||
163956407|NCT00081770|592212199|FG000|Overall Study|Adverse Event|130|||
163956408|NCT00081770|592212200|FG001|Overall Study|Adverse Event|98|||
163956409|NCT00081770|592212201|FG002|Overall Study|Adverse Event|136|||
163956410|NCT00081770|592212199|FG000|Overall Study|Lack of Efficacy|262|||
163956411|NCT00081770|592212200|FG001|Overall Study|Lack of Efficacy|357|||
163956412|NCT00081770|592212201|FG002|Overall Study|Lack of Efficacy|211|||
163956413|NCT00081770|592212199|FG000|Overall Study|Lost to Follow-up|45|||
163956414|NCT00081770|592212200|FG001|Overall Study|Lost to Follow-up|34|||
163956415|NCT00081770|592212201|FG002|Overall Study|Lost to Follow-up|45|||
163956416|NCT00081770|592212199|FG000|Overall Study|Protocol Violation|15|||
163956417|NCT00081770|592212200|FG001|Overall Study|Protocol Violation|10|||
163956418|NCT00081770|592212201|FG002|Overall Study|Protocol Violation|10|||
163956419|NCT00081770|592212199|FG000|Overall Study|Withdrawal by Subject|45|||
163956420|NCT00081770|592212200|FG001|Overall Study|Withdrawal by Subject|40|||
163956421|NCT00081770|592212201|FG002|Overall Study|Withdrawal by Subject|42|||
163956422|NCT00081770|592212199|FG000|Overall Study|Did not meet protocol eligibility|2|||
163956423|NCT00081770|592212200|FG001|Overall Study|Did not meet protocol eligibility|0|||
163956424|NCT00081770|592212201|FG002|Overall Study|Did not meet protocol eligibility|3|||
163956425|NCT00081770|592212199|FG000|Overall Study|Administrative|1|||
163956426|NCT00081770|592212200|FG001|Overall Study|Administrative|0|||
163956427|NCT00081770|592212201|FG002|Overall Study|Administrative|1|||
163956428|NCT00081770|592212199|FG000|Overall Study|Other|2|||
163956429|NCT00081770|592212200|FG001|Overall Study|Other|7|||
163956430|NCT00081770|592212201|FG002|Overall Study|Other|8|||
163956431|NCT03435497|592212203|FG000|Overall Study|Lost to Follow-up|1|||
163956432|NCT03435497|592212204|FG001|Overall Study|Lost to Follow-up|0|||
163956433|NCT03435497|592212203|FG000|Overall Study|Death|1|||
163956434|NCT03435497|592212204|FG001|Overall Study|Death|0|||
163956435|NCT03435497|592212203|FG000|Overall Study|Withdrawal by Subject|0|||
163956436|NCT03435497|592212204|FG001|Overall Study|Withdrawal by Subject|4|||
163956437|NCT03435497|592212203|FG000|Overall Study|Wrong survey administered|0|||
163956438|NCT03435497|592212204|FG001|Overall Study|Wrong survey administered|2|||
163956439|NCT01072877|592212205|FG000|Overall Study|Lost to Follow-up|1|||
163956440|NCT01072877|592212206|FG001|Overall Study|Lost to Follow-up|1|||
163956441|NCT01072877|592212207|FG002|Overall Study|Lost to Follow-up|0|||
163956442|NCT01072877|592212208|FG003|Overall Study|Lost to Follow-up|2|||
163956443|NCT01072877|592212209|FG004|Overall Study|Lost to Follow-up|0|||
163956444|NCT00601419|592212210|FG000|Overall Study|Lost to Follow-up|3|||
163956445|NCT00601419|592212210|FG000|Overall Study|Missed Visits|1|||
163956446|NCT04281004|592212221|FG000|Overall Study|Physician Decision|1|||
163956447|NCT04281004|592212222|FG001|Overall Study|Physician Decision|0|||
163956448|NCT00701779|592212223|FG000|Overall Study|Adverse Event|6|||
163956449|NCT00701779|592212223|FG000|Overall Study|Lost to Follow-up|1|||
163956450|NCT00701779|592212223|FG000|Overall Study|Withdrawal by Subject|2|||
163956451|NCT02245672|592212224|FG000|Overall Study|Adverse Event|4|||
163956452|NCT02245672|592212225|FG001|Overall Study|Adverse Event|4|||
163956453|NCT02245672|592212226|FG002|Overall Study|Adverse Event|4|||
163956454|NCT02245672|592212224|FG000|Overall Study|Lost to Follow-up|3|||
163956455|NCT02245672|592212225|FG001|Overall Study|Lost to Follow-up|5|||
163956456|NCT02245672|592212226|FG002|Overall Study|Lost to Follow-up|1|||
163956457|NCT02245672|592212224|FG000|Overall Study|Withdrawal by Subject|6|||
163956458|NCT02245672|592212225|FG001|Overall Study|Withdrawal by Subject|3|||
163956459|NCT02245672|592212226|FG002|Overall Study|Withdrawal by Subject|0|||
163956460|NCT02245672|592212224|FG000|Overall Study|Randomized in error (not treated)|0|||
163956461|NCT02245672|592212225|FG001|Overall Study|Randomized in error (not treated)|1|||
164047952|NCT03864627|592534272|FG000|Overall Study|Study terminated by sponsor|0|||
164047953|NCT03864627|592534273|FG001|Overall Study|Study terminated by sponsor|1|||
163956462|NCT02245672|592212226|FG002|Overall Study|Randomized in error (not treated)|0|||
163956463|NCT00971932|592212229|FG000|Overall Study|Withdrawal by Subject|1|||
163956464|NCT00971932|592212229|FG000|Overall Study|Investigator's decision|2|||
163956465|NCT00971932|592212229|FG000|Overall Study|Ongoing|4|||
163956466|NCT01217957|592212230|FG000|Phase 1|Withdrawal by Patient|1|||
163956467|NCT01217957|592212231|FG001|Phase 1|Withdrawal by Patient|0|||
163956468|NCT01217957|592212232|FG002|Phase 1|Withdrawal by Patient|1|||
163956469|NCT01217957|592212233|FG003|Phase 1|Withdrawal by Patient|1|||
163956470|NCT01217957|592212234|FG004|Phase 1|Withdrawal by Patient|0|||
163956471|NCT01217957|592212230|FG000|Phase 2|Withdrawal by Patient|0|||
163956472|NCT01217957|592212231|FG001|Phase 2|Withdrawal by Patient|0|||
163956473|NCT01217957|592212232|FG002|Phase 2|Withdrawal by Patient|0|||
163956474|NCT01217957|592212233|FG003|Phase 2|Withdrawal by Patient|0|||
163956475|NCT01217957|592212234|FG004|Phase 2|Withdrawal by Patient|1|||
163956476|NCT01640054|592212235|FG000|Overall Study|Study-specific disc criteria|1|||
163956477|NCT01640054|592212235|FG000|Overall Study|Lack of Efficacy|3|||
163956478|NCT01640054|592212235|FG000|Overall Study|Adverse Event|2|||
163956479|NCT01206777|592212237|FG000|Overall Study|Death|1|||
163956480|NCT01206777|592212237|FG000|Overall Study|Adverse Event|1|||
163956481|NCT00730171|592212242|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
163956482|NCT00730171|592212242|FG000|Overall Study|Adverse Event|193|||
163956483|NCT00730171|592212242|FG000|Overall Study|Protocol Violation|48|||
163956484|NCT00730171|592212242|FG000|Overall Study|Withdrawal by Subject|202|||
163956485|NCT00730171|592212242|FG000|Overall Study|Lost to Follow-up|121|||
163956486|NCT00730171|592212242|FG000|Overall Study|Insufficient Therapeutic Response|141|||
163956487|NCT00730171|592212242|FG000|Overall Study|Other|61|||
163956488|NCT01256658|592212243|FG000|Period 1|Lost to Follow-up|837|||
163956489|NCT01256658|592212244|FG001|Period 1|Lost to Follow-up|661|||
163956490|NCT01256658|592212243|FG000|Period 1|Withdrawal by Subject|35|||
163956491|NCT01256658|592212244|FG001|Period 1|Withdrawal by Subject|43|||
163956492|NCT01256658|592212243|FG000|Period 1|Death|48|||
163956493|NCT01256658|592212244|FG001|Period 1|Death|44|||
163956494|NCT00719563|592212245|FG000|Overall Study|Adverse Event|16|||
163956495|NCT00719563|592212246|FG001|Overall Study|Adverse Event|13|||
163956496|NCT00719563|592212245|FG000|Overall Study|Medical condition changed|3|||
163956497|NCT00719563|592212246|FG001|Overall Study|Medical condition changed|5|||
163956498|NCT00719563|592212245|FG000|Overall Study|Lack of Efficacy|3|||
163956499|NCT00719563|592212246|FG001|Overall Study|Lack of Efficacy|7|||
163956500|NCT00719563|592212245|FG000|Overall Study|Personal reasons|6|||
163956501|NCT00719563|592212246|FG001|Overall Study|Personal reasons|7|||
163956502|NCT00719563|592212245|FG000|Overall Study|Unknown reasons|4|||
163956503|NCT00719563|592212246|FG001|Overall Study|Unknown reasons|6|||
163956504|NCT00719563|592212245|FG000|Overall Study|Noncompliant|1|||
163956505|NCT00719563|592212246|FG001|Overall Study|Noncompliant|1|||
163956506|NCT00719563|592212245|FG000|Overall Study|Lost to Follow-up|5|||
163956507|NCT00719563|592212246|FG001|Overall Study|Lost to Follow-up|3|||
163956508|NCT02120625|592212251|FG000|Overall Study|Physician Decision|2|||
163956509|NCT02901041|592212254|FG000|Overall Study|Withdrawal by PI|4|||
163956510|NCT02901041|592212255|FG001|Overall Study|Withdrawal by PI|8|||
163956511|NCT02901041|592212254|FG000|Overall Study|Withdrawal by Subject|7|||
163956512|NCT02901041|592212255|FG001|Overall Study|Withdrawal by Subject|3|||
163956513|NCT00762970|592212256|FG000|Overall Study|Withdrawal by Subject|7|||
163956514|NCT00762970|592212257|FG001|Overall Study|Withdrawal by Subject|4|||
163956515|NCT00762970|592212258|FG002|Overall Study|Withdrawal by Subject|0|||
163956516|NCT00762970|592212256|FG000|Overall Study|Protocol Violation|3|||
163956517|NCT00762970|592212257|FG001|Overall Study|Protocol Violation|1|||
163956518|NCT00762970|592212258|FG002|Overall Study|Protocol Violation|1|||
163956519|NCT00762970|592212256|FG000|Overall Study|Lost to Follow-up|1|||
163956520|NCT00762970|592212257|FG001|Overall Study|Lost to Follow-up|2|||
163956521|NCT00762970|592212258|FG002|Overall Study|Lost to Follow-up|0|||
163956522|NCT00762970|592212256|FG000|Overall Study|Difficulty of handling lens|1|||
163956523|NCT00762970|592212257|FG001|Overall Study|Difficulty of handling lens|2|||
163956524|NCT00762970|592212258|FG002|Overall Study|Difficulty of handling lens|0|||
163956525|NCT01480674|592212259|FG000|Overall Study|Death|23|||
163956526|NCT01480674|592212259|FG000|Overall Study|Lost to Follow-up|2|||
163956527|NCT01480674|592212259|FG000|Overall Study|visit not done|10|||
163956528|NCT00975507|592212260|FG000|Overall Study|Adverse Event|1|||
163956529|NCT00975507|592212261|FG001|Overall Study|Adverse Event|0|||
163956530|NCT00975507|592212260|FG000|Overall Study|Lost to Follow-up|7|||
163956531|NCT00975507|592212261|FG001|Overall Study|Lost to Follow-up|1|||
163956532|NCT00975507|592212260|FG000|Overall Study|Protocol Violation|2|||
163956533|NCT00975507|592212261|FG001|Overall Study|Protocol Violation|0|||
163956534|NCT00975507|592212260|FG000|Overall Study|Withdrawal by Subject|10|||
163956535|NCT00975507|592212261|FG001|Overall Study|Withdrawal by Subject|3|||
163956536|NCT03249714|592212262|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
163956537|NCT03249714|592212263|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
163956538|NCT03249714|592212262|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
163956539|NCT03249714|592212263|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
163956540|NCT03249714|592212262|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
163956541|NCT03249714|592212263|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
163956542|NCT03249714|592212262|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
163956543|NCT03249714|592212263|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
163956544|NCT03818204|592212264|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956545|NCT03818204|592212265|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956546|NCT03818204|592212266|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956547|NCT03818204|592212267|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956548|NCT03818204|592212268|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
163956549|NCT03818204|592212269|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956550|NCT03818204|592212270|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956551|NCT03818204|592212271|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956552|NCT03818204|592212272|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956553|NCT03818204|592212273|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956554|NCT03818204|592212274|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956555|NCT03818204|592212275|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956556|NCT03818204|592212276|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956557|NCT03818204|592212277|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
163956558|NCT03818204|592212278|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956559|NCT03818204|592212279|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956560|NCT03818204|592212280|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956561|NCT03818204|592212281|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956562|NCT03818204|592212282|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
163956563|NCT03818204|592212264|FG000|Overall Study|Physician Decision|0|||
163956564|NCT03818204|592212265|FG001|Overall Study|Physician Decision|0|||
163956565|NCT03818204|592212266|FG002|Overall Study|Physician Decision|0|||
163956566|NCT03818204|592212267|FG003|Overall Study|Physician Decision|0|||
163956567|NCT03818204|592212268|FG004|Overall Study|Physician Decision|0|||
163956568|NCT03818204|592212269|FG005|Overall Study|Physician Decision|0|||
163956569|NCT03818204|592212270|FG006|Overall Study|Physician Decision|0|||
163956570|NCT03818204|592212271|FG007|Overall Study|Physician Decision|0|||
163956571|NCT03818204|592212272|FG008|Overall Study|Physician Decision|0|||
163956572|NCT03818204|592212273|FG009|Overall Study|Physician Decision|0|||
163956573|NCT03818204|592212274|FG010|Overall Study|Physician Decision|0|||
163956574|NCT03818204|592212275|FG011|Overall Study|Physician Decision|0|||
163956575|NCT03818204|592212276|FG012|Overall Study|Physician Decision|0|||
163956576|NCT03818204|592212277|FG013|Overall Study|Physician Decision|0|||
163956577|NCT03818204|592212278|FG014|Overall Study|Physician Decision|1|||
163956578|NCT03818204|592212279|FG015|Overall Study|Physician Decision|0|||
163956579|NCT03818204|592212280|FG016|Overall Study|Physician Decision|0|||
163956580|NCT03818204|592212281|FG017|Overall Study|Physician Decision|0|||
163956581|NCT03818204|592212282|FG018|Overall Study|Physician Decision|0|||
163956582|NCT00887250|592212285|FG000|Overall Study|Adverse Event|3|||
163956583|NCT00887250|592212286|FG001|Overall Study|Adverse Event|0|||
163956584|NCT00887250|592212287|FG002|Overall Study|Adverse Event|7|||
163956585|NCT00887250|592212285|FG000|Overall Study|Lack of Efficacy|9|||
163956586|NCT00887250|592212286|FG001|Overall Study|Lack of Efficacy|6|||
163956587|NCT00887250|592212287|FG002|Overall Study|Lack of Efficacy|1|||
163956588|NCT00887250|592212285|FG000|Overall Study|Lost to Follow-up|2|||
163956589|NCT00887250|592212286|FG001|Overall Study|Lost to Follow-up|3|||
163956590|NCT00887250|592212287|FG002|Overall Study|Lost to Follow-up|1|||
163956591|NCT00887250|592212285|FG000|Overall Study|Protocol Violation|2|||
163956592|NCT00887250|592212286|FG001|Overall Study|Protocol Violation|2|||
163956593|NCT00887250|592212287|FG002|Overall Study|Protocol Violation|1|||
163956594|NCT00887250|592212285|FG000|Overall Study|Withdrawal by Subject|2|||
163956595|NCT00887250|592212286|FG001|Overall Study|Withdrawal by Subject|1|||
163956596|NCT00887250|592212287|FG002|Overall Study|Withdrawal by Subject|2|||
163956597|NCT00887250|592212285|FG000|Overall Study|Patient uncooperative|0|||
163956598|NCT00887250|592212286|FG001|Overall Study|Patient uncooperative|0|||
163956599|NCT00887250|592212287|FG002|Overall Study|Patient uncooperative|1|||
163956600|NCT05754333|592212288|FG000|Overall Study|Miscellaneous|3|||
163956601|NCT05754333|592212289|FG001|Overall Study|Miscellaneous|0|||
163956602|NCT05754333|592212290|FG002|Overall Study|Miscellaneous|0|||
163956603|NCT05754333|592212291|FG003|Overall Study|Miscellaneous|0|||
163956604|NCT05754333|592212288|FG000|Overall Study|Lost to Follow-up|2|||
163956605|NCT05754333|592212289|FG001|Overall Study|Lost to Follow-up|1|||
163956606|NCT05754333|592212290|FG002|Overall Study|Lost to Follow-up|0|||
163956607|NCT05754333|592212291|FG003|Overall Study|Lost to Follow-up|1|||
163956608|NCT00879762|592212292|FG000|Overall Study|Lost to Follow-up|3|||
163956609|NCT00879762|592212293|FG001|Overall Study|Lost to Follow-up|1|||
163956610|NCT04754477|592212296|FG000|Overall Study|Withdrawal by Subject|1|||
163956611|NCT02709096|592212301|FG000|Overall Study|non-compliance|1|||
163956612|NCT02709096|592212302|FG001|Overall Study|non-compliance|1|||
163956613|NCT00505284|592212303|FG000|Overall Study|Adverse Event|3|||
163956614|NCT00505284|592212304|FG001|Overall Study|Adverse Event|7|||
163956615|NCT00505284|592212305|FG002|Overall Study|Adverse Event|9|||
163956616|NCT00505284|592212306|FG003|Overall Study|Adverse Event|14|||
163956617|NCT00505284|592212307|FG004|Overall Study|Adverse Event|22|||
163956618|NCT00505284|592212303|FG000|Overall Study|Protocol Violation|0|||
163956619|NCT00505284|592212304|FG001|Overall Study|Protocol Violation|1|||
163956620|NCT00505284|592212305|FG002|Overall Study|Protocol Violation|1|||
163956621|NCT00505284|592212306|FG003|Overall Study|Protocol Violation|0|||
163956622|NCT00505284|592212307|FG004|Overall Study|Protocol Violation|0|||
163956623|NCT00505284|592212303|FG000|Overall Study|Withdrawal by Subject|2|||
163956624|NCT00505284|592212304|FG001|Overall Study|Withdrawal by Subject|6|||
163956625|NCT00505284|592212305|FG002|Overall Study|Withdrawal by Subject|1|||
163956626|NCT00505284|592212306|FG003|Overall Study|Withdrawal by Subject|0|||
163956627|NCT00505284|592212307|FG004|Overall Study|Withdrawal by Subject|6|||
163956628|NCT00505284|592212303|FG000|Overall Study|Lack of Efficacy|0|||
163956629|NCT00505284|592212304|FG001|Overall Study|Lack of Efficacy|1|||
163956630|NCT00505284|592212305|FG002|Overall Study|Lack of Efficacy|1|||
163956631|NCT00505284|592212306|FG003|Overall Study|Lack of Efficacy|1|||
163956632|NCT00505284|592212307|FG004|Overall Study|Lack of Efficacy|1|||
163956633|NCT00505284|592212303|FG000|Overall Study|Physician Decision|0|||
163956634|NCT00505284|592212304|FG001|Overall Study|Physician Decision|1|||
163956635|NCT00505284|592212305|FG002|Overall Study|Physician Decision|0|||
163956636|NCT00505284|592212306|FG003|Overall Study|Physician Decision|0|||
163956637|NCT00505284|592212307|FG004|Overall Study|Physician Decision|0|||
163956638|NCT00505284|592212303|FG000|Overall Study|Other|5|||
163956639|NCT00505284|592212304|FG001|Overall Study|Other|0|||
163956640|NCT00505284|592212305|FG002|Overall Study|Other|0|||
163956641|NCT00505284|592212306|FG003|Overall Study|Other|4|||
163956642|NCT00505284|592212307|FG004|Overall Study|Other|4|||
163956643|NCT00940108|592212308|FG000|Overall Study|Adverse Event|2|||
163956644|NCT00940108|592212309|FG001|Overall Study|Adverse Event|4|||
163956645|NCT00940108|592212310|FG002|Overall Study|Adverse Event|0|||
163956646|NCT00940108|592212311|FG003|Overall Study|Adverse Event|2|||
163956647|NCT00940108|592212308|FG000|Overall Study|Withdrew Consent|2|||
163956648|NCT00940108|592212309|FG001|Overall Study|Withdrew Consent|1|||
163956649|NCT00940108|592212310|FG002|Overall Study|Withdrew Consent|0|||
163956650|NCT00940108|592212311|FG003|Overall Study|Withdrew Consent|1|||
163956651|NCT00940108|592212308|FG000|Overall Study|Dose 2 contraindicated|1|||
163956652|NCT00940108|592212309|FG001|Overall Study|Dose 2 contraindicated|1|||
163956653|NCT00940108|592212310|FG002|Overall Study|Dose 2 contraindicated|0|||
163956654|NCT00940108|592212311|FG003|Overall Study|Dose 2 contraindicated|1|||
163956655|NCT00940108|592212308|FG000|Overall Study|Declined further vaccination|0|||
163956656|NCT00940108|592212309|FG001|Overall Study|Declined further vaccination|1|||
163956657|NCT00940108|592212310|FG002|Overall Study|Declined further vaccination|3|||
163956658|NCT00940108|592212311|FG003|Overall Study|Declined further vaccination|0|||
163956659|NCT00940108|592212308|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
163956660|NCT00940108|592212309|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
163956661|NCT00940108|592212310|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
163956662|NCT00940108|592212311|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
163956663|NCT00940108|592212308|FG000|Overall Study|Viral illness after Dose 1|0|||
163956664|NCT00940108|592212309|FG001|Overall Study|Viral illness after Dose 1|1|||
163956665|NCT00940108|592212310|FG002|Overall Study|Viral illness after Dose 1|0|||
163956666|NCT00940108|592212311|FG003|Overall Study|Viral illness after Dose 1|0|||
163956667|NCT00940108|592212308|FG000|Overall Study|Diagnosed with H1N1|0|||
163956668|NCT00940108|592212309|FG001|Overall Study|Diagnosed with H1N1|0|||
163956669|NCT00940108|592212310|FG002|Overall Study|Diagnosed with H1N1|0|||
163956670|NCT00940108|592212311|FG003|Overall Study|Diagnosed with H1N1|1|||
163956671|NCT03581825|592212312|FG000|Period 1|Lens Discomfort|1|||
163956672|NCT03581825|592212313|FG001|Period 1|Lens Discomfort|0|||
163956673|NCT03581825|592212312|FG000|Period 2|Unsatisfactory Vision to Test|0|||
163956674|NCT03581825|592212313|FG001|Period 2|Unsatisfactory Vision to Test|1|||
163956675|NCT00770341|592212314|FG000|Overall Study|Did not meet eligibility criteria|1|||
163956676|NCT00770341|592212315|FG001|Overall Study|Did not meet eligibility criteria|0|||
163956677|NCT00770341|592212316|FG002|Overall Study|Did not meet eligibility criteria|0|||
163956678|NCT00770341|592212314|FG000|Overall Study|Withdrawal by Subject|0|||
163956679|NCT00770341|592212315|FG001|Overall Study|Withdrawal by Subject|1|||
163956680|NCT00770341|592212316|FG002|Overall Study|Withdrawal by Subject|0|||
163956681|NCT00770341|592212314|FG000|Overall Study|Clinical Adverse Event|3|||
163956682|NCT00770341|592212315|FG001|Overall Study|Clinical Adverse Event|1|||
163956683|NCT00770341|592212316|FG002|Overall Study|Clinical Adverse Event|2|||
163956684|NCT00770341|592212314|FG000|Overall Study|Laboratory adverse event|3|||
163956685|NCT00770341|592212315|FG001|Overall Study|Laboratory adverse event|3|||
163956686|NCT00770341|592212316|FG002|Overall Study|Laboratory adverse event|0|||
163956687|NCT00770341|592212314|FG000|Overall Study|Lack of Efficacy|3|||
163956688|NCT00770341|592212315|FG001|Overall Study|Lack of Efficacy|0|||
163956689|NCT00770341|592212316|FG002|Overall Study|Lack of Efficacy|1|||
163956690|NCT00770341|592212314|FG000|Overall Study|Other|1|||
163956691|NCT00770341|592212315|FG001|Overall Study|Other|0|||
163956692|NCT00770341|592212316|FG002|Overall Study|Other|0|||
163956693|NCT00770341|592212314|FG000|Overall Study|Not treated|1|||
163956694|NCT00770341|592212315|FG001|Overall Study|Not treated|0|||
163956695|NCT00770341|592212316|FG002|Overall Study|Not treated|0|||
163956696|NCT02739360|592212317|FG000|Overall Study|Adverse Event|1|||
163956697|NCT02739360|592212317|FG000|Overall Study|Study terminated by Sponsor|2|||
163956698|NCT02533570|592212318|FG000|Overall Study|Adverse Event|0|||
163956699|NCT02533570|592212319|FG001|Overall Study|Adverse Event|1|||
163956700|NCT02533570|592212320|FG002|Overall Study|Adverse Event|1|||
163956701|NCT00529958|592212321|FG000|2-Year Follow-up|Lost to Follow-up|1|||
163956702|NCT00529958|592212322|FG001|2-Year Follow-up|Lost to Follow-up|2|||
163956703|NCT00529958|592212323|FG002|2-Year Follow-up|Lost to Follow-up|2|||
163956704|NCT00529958|592212321|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
163956705|NCT00529958|592212322|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
163956706|NCT00529958|592212323|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
163956707|NCT00529958|592212321|FG000|5-Year Follow-up|Lost to Follow-up|2|||
163956708|NCT00529958|592212322|FG001|5-Year Follow-up|Lost to Follow-up|3|||
163956709|NCT00529958|592212323|FG002|5-Year Follow-up|Lost to Follow-up|1|||
163956710|NCT00529958|592212321|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
163956711|NCT00529958|592212322|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
163956712|NCT00529958|592212323|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
163956713|NCT03756129|592212324|FG000|Overall Study|Adverse Event|1|||
163956714|NCT03756129|592212325|FG001|Overall Study|Adverse Event|1|||
163956715|NCT03756129|592212326|FG002|Overall Study|Adverse Event|0|||
163956716|NCT03756129|592212327|FG003|Overall Study|Adverse Event|2|||
163956717|NCT03756129|592212328|FG004|Overall Study|Adverse Event|0|||
163956718|NCT03756129|592212329|FG005|Overall Study|Adverse Event|0|||
163956719|NCT03756129|592212324|FG000|Overall Study|Withdrawal by Subject|2|||
163956720|NCT03756129|592212325|FG001|Overall Study|Withdrawal by Subject|1|||
163956721|NCT03756129|592212326|FG002|Overall Study|Withdrawal by Subject|3|||
163956722|NCT03756129|592212327|FG003|Overall Study|Withdrawal by Subject|1|||
163956723|NCT03756129|592212328|FG004|Overall Study|Withdrawal by Subject|1|||
163956724|NCT03756129|592212329|FG005|Overall Study|Withdrawal by Subject|3|||
163956725|NCT03756129|592212324|FG000|Overall Study|Lost to Follow-up|0|||
163956726|NCT03756129|592212325|FG001|Overall Study|Lost to Follow-up|0|||
163956727|NCT03756129|592212326|FG002|Overall Study|Lost to Follow-up|0|||
163956728|NCT03756129|592212327|FG003|Overall Study|Lost to Follow-up|0|||
163956729|NCT03756129|592212328|FG004|Overall Study|Lost to Follow-up|0|||
163956730|NCT03756129|592212329|FG005|Overall Study|Lost to Follow-up|1|||
163956731|NCT03756129|592212324|FG000|Overall Study|Physician Decision|0|||
163956732|NCT03756129|592212325|FG001|Overall Study|Physician Decision|0|||
163956733|NCT03756129|592212326|FG002|Overall Study|Physician Decision|0|||
163956734|NCT03756129|592212327|FG003|Overall Study|Physician Decision|0|||
163956735|NCT03756129|592212328|FG004|Overall Study|Physician Decision|0|||
163956736|NCT03756129|592212329|FG005|Overall Study|Physician Decision|1|||
163956737|NCT01340651|592212330|FG000|Overall Study|Adverse Event|3|||
163956738|NCT01340651|592212330|FG000|Overall Study|Consent Withdrawn|2|||
163956739|NCT01340651|592212330|FG000|Overall Study|Commercial Supply per Sponsor|12|||
163956740|NCT01315353|592212331|FG000|Overall Study|Death|2|||
163956741|NCT01315353|592212332|FG001|Overall Study|Death|1|||
163956742|NCT01315353|592212333|FG002|Overall Study|Death|0|||
163956743|NCT01315353|592212331|FG000|Overall Study|Withdrawal by Subject|2|||
163956744|NCT01315353|592212332|FG001|Overall Study|Withdrawal by Subject|6|||
163956745|NCT01315353|592212333|FG002|Overall Study|Withdrawal by Subject|1|||
163956746|NCT01315353|592212331|FG000|Overall Study|Lost to Follow-up|13|||
163956747|NCT01315353|592212332|FG001|Overall Study|Lost to Follow-up|6|||
163956748|NCT01315353|592212333|FG002|Overall Study|Lost to Follow-up|6|||
163956749|NCT01315353|592212331|FG000|Overall Study|Unwilling to adhere to requirements|5|||
163956750|NCT01315353|592212332|FG001|Overall Study|Unwilling to adhere to requirements|5|||
163956751|NCT01315353|592212333|FG002|Overall Study|Unwilling to adhere to requirements|4|||
163956752|NCT01315353|592212331|FG000|Overall Study|Site closing|7|||
163956753|NCT01315353|592212332|FG001|Overall Study|Site closing|4|||
163956754|NCT01315353|592212333|FG002|Overall Study|Site closing|0|||
163956755|NCT01315353|592212331|FG000|Overall Study|Taken off study by site in error|0|||
163956756|NCT01315353|592212332|FG001|Overall Study|Taken off study by site in error|1|||
163956757|NCT01315353|592212333|FG002|Overall Study|Taken off study by site in error|0|||
163956758|NCT01315353|592212331|FG000|Overall Study|Inadvertent randomization/assignment|0|||
163956759|NCT01315353|592212332|FG001|Overall Study|Inadvertent randomization/assignment|0|||
163956760|NCT01315353|592212333|FG002|Overall Study|Inadvertent randomization/assignment|2|||
163956761|NCT04469270|592212334|FG000|Overall Study|Adverse Event|2|||
163956762|NCT04469270|592212335|FG001|Overall Study|Adverse Event|0|||
163956763|NCT04469270|592212334|FG000|Overall Study|Lost to Follow-up|4|||
163956764|NCT04469270|592212335|FG001|Overall Study|Lost to Follow-up|3|||
163956765|NCT04469270|592212334|FG000|Overall Study|Withdrawal by Subject|7|||
163956766|NCT04469270|592212335|FG001|Overall Study|Withdrawal by Subject|3|||
163956767|NCT04469270|592212334|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
163956768|NCT04469270|592212335|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
163956769|NCT04469270|592212334|FG000|Overall Study|missing|1|||
163956770|NCT04469270|592212335|FG001|Overall Study|missing|0|||
163956771|NCT05572021|592212336|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
163956772|NCT05572021|592212337|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
163956773|NCT05328167|592212338|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
163956774|NCT05328167|592212338|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
163956775|NCT03319849|592212339|FG000|Overall Study|Adverse Event|1|||
163956776|NCT03319849|592212340|FG001|Overall Study|Adverse Event|0|||
163956777|NCT03319849|592212339|FG000|Overall Study|Physician Decision|0|||
163956778|NCT03319849|592212340|FG001|Overall Study|Physician Decision|1|||
163956779|NCT03319849|592212339|FG000|Overall Study|Withdrawal by Subject|0|||
163956780|NCT03319849|592212340|FG001|Overall Study|Withdrawal by Subject|1|||
163956781|NCT03319849|592212339|FG000|Overall Study|COVID-19|0|||
163956782|NCT03319849|592212340|FG001|Overall Study|COVID-19|1|||
163956783|NCT03319849|592212339|FG000|Overall Study|Other|1|||
163956784|NCT03319849|592212340|FG001|Overall Study|Other|2|||
163956785|NCT03319849|592212339|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
163956786|NCT03319849|592212340|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
163956787|NCT03319849|592212339|FG000|Overall Study|Lost to Follow-up|0|||
163956788|NCT03319849|592212340|FG001|Overall Study|Lost to Follow-up|2|||
163956789|NCT00112047|592212345|FG000|Randomized Phase|Lost to Follow-up|26|||
163956790|NCT00112047|592212346|FG001|Randomized Phase|Lost to Follow-up|33|||
163956791|NCT00112047|592212345|FG000|Randomized Phase|Adverse Event|10|||
163956792|NCT00112047|592212346|FG001|Randomized Phase|Adverse Event|10|||
163956793|NCT00112047|592212345|FG000|Randomized Phase|Withrawal of consent|10|||
163956794|NCT00112047|592212346|FG001|Randomized Phase|Withrawal of consent|18|||
163956795|NCT00112047|592212345|FG000|Randomized Phase|Sub-optimal virological response|3|||
163956796|NCT00112047|592212346|FG001|Randomized Phase|Sub-optimal virological response|13|||
163956797|NCT00112047|592212345|FG000|Randomized Phase|Noncompliance|8|||
163956798|NCT00112047|592212346|FG001|Randomized Phase|Noncompliance|4|||
163956799|NCT00112047|592212345|FG000|Randomized Phase|Protocol Violation|2|||
163956800|NCT00112047|592212346|FG001|Randomized Phase|Protocol Violation|0|||
163956801|NCT00112047|592212345|FG000|Randomized Phase|Pregnancy|3|||
163956802|NCT00112047|592212346|FG001|Randomized Phase|Pregnancy|1|||
163956803|NCT00112047|592212345|FG000|Randomized Phase|Death|1|||
163956804|NCT00112047|592212346|FG001|Randomized Phase|Death|3|||
163956805|NCT00112047|592212345|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
163956806|NCT00112047|592212346|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
163956807|NCT00112047|592212345|FG000|Randomized Phase|Inability to swallow pills|0|||
163956808|NCT00112047|592212346|FG001|Randomized Phase|Inability to swallow pills|1|||
163956809|NCT00112047|592212345|FG000|Randomized Phase|Incarceration|3|||
163956810|NCT00112047|592212346|FG001|Randomized Phase|Incarceration|2|||
163956811|NCT00112047|592212345|FG000|Randomized Phase|Moved out of State|0|||
163956812|NCT00112047|592212346|FG001|Randomized Phase|Moved out of State|1|||
163956813|NCT00112047|592212345|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
163956814|NCT00112047|592212346|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
163956815|NCT00112047|592212345|FG000|Randomized Phase|High Hepatitis B DNA|0|||
163956816|NCT00112047|592212346|FG001|Randomized Phase|High Hepatitis B DNA|1|||
163956817|NCT00112047|592212345|FG000|Atripla Phase|Adverse Event|2|||
163956818|NCT00112047|592212346|FG001|Atripla Phase|Adverse Event|1|||
163956819|NCT00112047|592212345|FG000|Atripla Phase|Lost to Follow-up|5|||
163956820|NCT00112047|592212346|FG001|Atripla Phase|Lost to Follow-up|7|||
163956821|NCT00112047|592212345|FG000|Atripla Phase|Pregnancy|0|||
163956822|NCT00112047|592212346|FG001|Atripla Phase|Pregnancy|1|||
163956823|NCT00112047|592212345|FG000|Atripla Phase|Death|0|||
163956824|NCT00112047|592212346|FG001|Atripla Phase|Death|2|||
163956825|NCT00112047|592212345|FG000|Atripla Phase|Withdrew consent|7|||
163956826|NCT00112047|592212346|FG001|Atripla Phase|Withdrew consent|7|||
163956827|NCT00112047|592212345|FG000|Atripla Phase|Sub-optimal virological response|0|||
163956828|NCT00112047|592212346|FG001|Atripla Phase|Sub-optimal virological response|1|||
163956829|NCT00112047|592212345|FG000|Atripla Phase|Non-compliance|1|||
163956830|NCT00112047|592212346|FG001|Atripla Phase|Non-compliance|0|||
163956831|NCT00112047|592212345|FG000|Atripla Phase|Other|3|||
163956832|NCT00112047|592212346|FG001|Atripla Phase|Other|1|||
163956833|NCT04873232|592212350|FG000|Overall Study|Lost to Follow-up|1|||
163956834|NCT04873232|592212351|FG001|Overall Study|Lost to Follow-up|4|||
163956835|NCT04873232|592212350|FG000|Overall Study|Withdrawal by Subject|1|||
163956836|NCT04873232|592212351|FG001|Overall Study|Withdrawal by Subject|0|||
163956837|NCT02101034|592213968|FG000|Overall Study|Enrolled but did not start treatment|0|||
163956838|NCT02101034|592213969|FG001|Overall Study|Enrolled but did not start treatment|0|||
163956839|NCT02101034|592213970|FG002|Overall Study|Enrolled but did not start treatment|1|||
163956840|NCT02101034|592213971|FG003|Overall Study|Enrolled but did not start treatment|0|||
163956841|NCT02101034|592213972|FG004|Overall Study|Enrolled but did not start treatment|0|||
163956842|NCT00995020|592213973|FG000|Overall Study|margin analysis not performed|2|||
163956843|NCT00995020|592213974|FG001|Overall Study|margin analysis not performed|5|||
163956844|NCT00995020|592213973|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
163956845|NCT00995020|592213974|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
163956846|NCT01614197|592213975|FG000|Overall Study|Withdrawal by Subject|0|||
163956847|NCT01614197|592213976|FG001|Overall Study|Withdrawal by Subject|1|||
163956848|NCT01614197|592213977|FG002|Overall Study|Withdrawal by Subject|0|||
163956849|NCT01614197|592213978|FG003|Overall Study|Withdrawal by Subject|0|||
163956850|NCT00876694|592213980|FG000|Overall Study|Adverse Event|10|||
163956851|NCT00876694|592213981|FG001|Overall Study|Adverse Event|7|||
163956852|NCT00876694|592213980|FG000|Overall Study|Subject withdrew consent|6|||
163956853|NCT00876694|592213981|FG001|Overall Study|Subject withdrew consent|4|||
163956854|NCT00876694|592213980|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
163956855|NCT00876694|592213981|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
163956856|NCT00876694|592213980|FG000|Overall Study|Abnormal test procedure result(s)|1|||
163956857|NCT00876694|592213981|FG001|Overall Study|Abnormal test procedure result(s)|0|||
163956858|NCT00876694|592213980|FG000|Overall Study|Administrative problems|1|||
163956859|NCT00876694|592213981|FG001|Overall Study|Administrative problems|1|||
163956860|NCT00876694|592213980|FG000|Overall Study|Death|1|||
163956861|NCT00876694|592213981|FG001|Overall Study|Death|0|||
163956862|NCT00288509|592213982|FG000|Treatment Cycle 1|Adverse Event|1|||
163956863|NCT00288509|592213982|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
163956864|NCT00288509|592213982|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
163956865|NCT00288509|592213982|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
163956866|NCT00288509|592213982|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
163956867|NCT00288509|592213982|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
163956868|NCT00288509|592213982|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
163956869|NCT00288509|592213982|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
163956870|NCT00288509|592213982|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
163956871|NCT00288509|592213982|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
163956872|NCT00288509|592213982|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
163956873|NCT00288509|592213982|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
163956874|NCT00288509|592213982|FG000|Treatment Cycle 4|Physician Decision|4|||
163956875|NCT00288509|592213982|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
163956876|NCT00084266|592213983|FG000|Overall Study|Death|42|||
163956877|NCT00084266|592213984|FG001|Overall Study|Death|39|||
163956878|NCT00084266|592213983|FG000|Overall Study|Adverse Event|8|||
163956879|NCT00084266|592213984|FG001|Overall Study|Adverse Event|5|||
163956880|NCT00084266|592213983|FG000|Overall Study|Lack of Efficacy|2|||
163956881|NCT00084266|592213984|FG001|Overall Study|Lack of Efficacy|4|||
163956882|NCT00084266|592213983|FG000|Overall Study|Lost to Follow-up|5|||
163956883|NCT00084266|592213984|FG001|Overall Study|Lost to Follow-up|3|||
163956884|NCT00084266|592213983|FG000|Overall Study|Participant not willing to participate|3|||
164047954|NCT01388491|592534274|FG000|Overall Study|Adverse Event|10|||
164047955|NCT01388491|592534275|FG001|Overall Study|Adverse Event|9|||
164047956|NCT01388491|592534274|FG000|Overall Study|Sponsor Request|9|||
164047957|NCT01388491|592534275|FG001|Overall Study|Sponsor Request|7|||
164047958|NCT01388491|592534274|FG000|Overall Study|Withdrawal by Subject|6|||
164047959|NCT01388491|592534275|FG001|Overall Study|Withdrawal by Subject|10|||
164047960|NCT01388491|592534274|FG000|Overall Study|Lost to Follow-up|4|||
164047961|NCT01388491|592534275|FG001|Overall Study|Lost to Follow-up|3|||
164047962|NCT01388491|592534274|FG000|Overall Study|Protocol Violation|2|||
164047963|NCT01388491|592534275|FG001|Overall Study|Protocol Violation|0|||
164047964|NCT01388491|592534274|FG000|Overall Study|Noncompliance|2|||
164047965|NCT01388491|592534275|FG001|Overall Study|Noncompliance|0|||
164047966|NCT01388491|592534274|FG000|Overall Study|Pregnancy|1|||
164047967|NCT01388491|592534275|FG001|Overall Study|Pregnancy|0|||
164047968|NCT00112840|592534276|FG000|Overall Study|Physician Decision|1|||
164047969|NCT00112840|592534277|FG001|Overall Study|Physician Decision|0|||
164047970|NCT00112840|592534278|FG002|Overall Study|Physician Decision|0|||
164047971|NCT00112840|592534276|FG000|Overall Study|Withdrawal by Subject|1|||
164047972|NCT00112840|592534277|FG001|Overall Study|Withdrawal by Subject|0|||
164047973|NCT00112840|592534278|FG002|Overall Study|Withdrawal by Subject|1|||
164047974|NCT00112840|592534276|FG000|Overall Study|Protocol Violation|0|||
164047975|NCT00112840|592534277|FG001|Overall Study|Protocol Violation|0|||
164047976|NCT00112840|592534278|FG002|Overall Study|Protocol Violation|5|||
164047977|NCT02875366|592534279|FG000|Overall Study|Adverse Event|0|||
163956885|NCT00084266|592213984|FG001|Overall Study|Participant not willing to participate|8|||
163956886|NCT00084266|592213983|FG000|Overall Study|Other|360|||
163956887|NCT00084266|592213984|FG001|Overall Study|Other|344|||
163956888|NCT00084266|592213983|FG000|Overall Study|Randomized not treated|21|||
163956889|NCT00084266|592213984|FG001|Overall Study|Randomized not treated|20|||
163956890|NCT01215422|592213985|FG000|Overall Study|Relocation|1|||
163956891|NCT01215422|592213986|FG001|Overall Study|Relocation|0|||
163956892|NCT01215422|592213987|FG002|Overall Study|Relocation|0|||
164047978|NCT02875366|592534280|FG001|Overall Study|Adverse Event|2|||
164047979|NCT02875366|592534279|FG000|Overall Study|Noncompliance|0|||
164047980|NCT02875366|592534280|FG001|Overall Study|Noncompliance|1|||
163956893|NCT01215422|592213988|FG003|Overall Study|Relocation|0|||
164047981|NCT00683774|592534281|FG000|Overall Study|Withdrawal by Subject|0|||
164047982|NCT00683774|592534282|FG001|Overall Study|Withdrawal by Subject|1|||
163956894|NCT01215422|592213985|FG000|Overall Study|Failed intubations|0|||
163956895|NCT01215422|592213986|FG001|Overall Study|Failed intubations|0|||
163956896|NCT01215422|592213987|FG002|Overall Study|Failed intubations|3|||
163956897|NCT01215422|592213988|FG003|Overall Study|Failed intubations|8|||
163956898|NCT01215422|592213985|FG000|Overall Study|Did not complete all intubations|7|||
163956899|NCT01215422|592213986|FG001|Overall Study|Did not complete all intubations|0|||
163956900|NCT01215422|592213987|FG002|Overall Study|Did not complete all intubations|0|||
163956901|NCT01215422|592213988|FG003|Overall Study|Did not complete all intubations|0|||
163956902|NCT01386788|592213991|FG000|Overall Study|Lost to Follow-up|2|||
163956903|NCT00462865|592213992|FG000|Overall Study|Adverse Event|1|||
163956904|NCT06336603|592213994|FG000|Overall Study|Withdrawal by Subject|1|||
163956905|NCT06336603|592213994|FG000|Overall Study|Lost to Follow-up|2|||
163956906|NCT01295034|592213998|FG000|Overall Study|Lost to Follow-up|5|||
163956907|NCT01295034|592213999|FG001|Overall Study|Lost to Follow-up|5|||
163956908|NCT00824161|592214001|FG000|Overall Study|Withdrawal by Subject|1|||
163956909|NCT00824161|592214001|FG000|Overall Study|Screen Failure|1|||
163956910|NCT01774110|592214006|FG000|Overall Study|Lost to Follow-up|7|||
163956911|NCT00063154|592214007|FG000|Overall Study|Disease progression|27|||
163956912|NCT00063154|592214007|FG000|Overall Study|Adverse Event|2|||
163956913|NCT00063154|592214007|FG000|Overall Study|Physician Decision|10|||
163956914|NCT00063154|592214007|FG000|Overall Study|Death|3|||
163956915|NCT00063154|592214007|FG000|Overall Study|Reason unspecified|1|||
163956916|NCT00063154|592214007|FG000|Overall Study|Did not receive treatment|8|||
163956917|NCT02699983|592214009|FG000|Overall Study|Withdrawal by Subject|1|||
163956918|NCT02699983|592214010|FG001|Overall Study|Withdrawal by Subject|0|||
163956919|NCT03575143|592214011|FG000|Overall Study|Lost to Follow-up|0|||
163956920|NCT03575143|592214012|FG001|Overall Study|Lost to Follow-up|0|||
163956921|NCT03575143|592214013|FG002|Overall Study|Lost to Follow-up|4|||
163956922|NCT03575143|592214011|FG000|Overall Study|Withdrawal by Subject|0|||
163956923|NCT03575143|592214012|FG001|Overall Study|Withdrawal by Subject|0|||
163956924|NCT03575143|592214013|FG002|Overall Study|Withdrawal by Subject|5|||
163956925|NCT03575143|592214011|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
163956926|NCT03575143|592214012|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
163956927|NCT03575143|592214013|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
163956928|NCT01259726|592214016|FG000|Overall Study|Death|1|||
163956929|NCT01259726|592214017|FG001|Overall Study|Death|0|||
163956930|NCT01259726|592214018|FG002|Overall Study|Death|0|||
163956931|NCT01259726|592214019|FG003|Overall Study|Death|0|||
163956932|NCT01259726|592214016|FG000|Overall Study|Physician Decision|2|||
163956933|NCT01259726|592214017|FG001|Overall Study|Physician Decision|0|||
163956934|NCT01259726|592214018|FG002|Overall Study|Physician Decision|1|||
163956935|NCT01259726|592214019|FG003|Overall Study|Physician Decision|1|||
163956936|NCT01259726|592214016|FG000|Overall Study|Withdrawal by Subject|1|||
163956937|NCT01259726|592214017|FG001|Overall Study|Withdrawal by Subject|3|||
163956938|NCT01259726|592214018|FG002|Overall Study|Withdrawal by Subject|2|||
163956939|NCT01259726|592214019|FG003|Overall Study|Withdrawal by Subject|1|||
163956940|NCT01259726|592214016|FG000|Overall Study|Lost to Follow-up|1|||
163956941|NCT01259726|592214017|FG001|Overall Study|Lost to Follow-up|1|||
163956942|NCT01259726|592214018|FG002|Overall Study|Lost to Follow-up|1|||
163956943|NCT01259726|592214019|FG003|Overall Study|Lost to Follow-up|3|||
163956944|NCT01211197|592214021|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163956945|NCT01211197|592214022|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163956946|NCT01211197|592214023|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
163956947|NCT01211197|592214024|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163956948|NCT01211197|592214025|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163956949|NCT01211197|592214026|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
163956950|NCT01211197|592214021|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
163956951|NCT01211197|592214022|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
163956952|NCT01211197|592214023|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
163956953|NCT01211197|592214024|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
163956954|NCT01211197|592214025|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
163956955|NCT01211197|592214026|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
163956956|NCT00261846|592214027|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
163956957|NCT00261846|592214028|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
163956958|NCT00261846|592214029|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
163956959|NCT00261846|592214030|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956960|NCT00261846|592214031|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956961|NCT00261846|592214032|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956962|NCT00261846|592214033|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956963|NCT00261846|592214034|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956964|NCT00261846|592214035|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956965|NCT00261846|592214036|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956966|NCT00261846|592214037|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
163956967|NCT00261846|592214038|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
164047983|NCT00683774|592534281|FG000|Overall Study|Physician Decision|3|||
164047984|NCT00683774|592534282|FG001|Overall Study|Physician Decision|0|||
164047985|NCT03595176|592534283|FG000|Overall Study|Death|0|||
164047986|NCT03595176|592534284|FG001|Overall Study|Death|2|||
164047987|NCT03595176|592534283|FG000|Overall Study|Lost to Follow-up|0|||
164047988|NCT03595176|592534284|FG001|Overall Study|Lost to Follow-up|1|||
164047989|NCT02735044|592534286|FG000|Overall Study|Adverse Event|3|||
164047990|NCT02735044|592534287|FG001|Overall Study|Adverse Event|3|||
164047991|NCT02735044|592534286|FG000|Overall Study|Lack of Efficacy|1|||
164047992|NCT02735044|592534287|FG001|Overall Study|Lack of Efficacy|0|||
164047993|NCT02735044|592534286|FG000|Overall Study|Poor compliance to protocol|7|||
164047994|NCT02735044|592534287|FG001|Overall Study|Poor compliance to protocol|7|||
164047995|NCT02735044|592534286|FG000|Overall Study|Randomized and not treated|0|||
164047996|NCT02735044|592534287|FG001|Overall Study|Randomized and not treated|2|||
164047997|NCT02735044|592534286|FG000|Overall Study|Other, not specified above|5|||
164047998|NCT02735044|592534287|FG001|Overall Study|Other, not specified above|11|||
164047999|NCT00412113|592534289|FG000|Overall Study|Adverse Event|11|||
164048000|NCT00412113|592534290|FG001|Overall Study|Adverse Event|15|||
164048001|NCT00412113|592534289|FG000|Overall Study|did not receive treatment|1|||
164048002|NCT00412113|592534290|FG001|Overall Study|did not receive treatment|0|||
164048003|NCT01592773|592535975|FG000|Overall Study|Study Terminated by Sponsor|582|||
164048004|NCT01592773|592535975|FG000|Overall Study|Withdrawal by Subject|35|||
164048005|NCT01592773|592535975|FG000|Overall Study|Lost to Follow-up|19|||
164048006|NCT01592773|592535975|FG000|Overall Study|Adverse Event|17|||
164048007|NCT01592773|592535975|FG000|Overall Study|Lack of Efficacy|9|||
164048008|NCT01592773|592535975|FG000|Overall Study|Protocol Violation|2|||
164048009|NCT01592773|592535975|FG000|Overall Study|Inclusion/exclusion not meet|1|||
164048010|NCT01592773|592535975|FG000|Overall Study|Other Reason|1|||
164048011|NCT00740116|592535976|FG000|Overall Study|Withdrawal by Subject|1|||
164048012|NCT00740116|592535977|FG001|Overall Study|Withdrawal by Subject|1|||
164048013|NCT00740116|592535976|FG000|Overall Study|Protocol Violation|1|||
164048014|NCT00740116|592535977|FG001|Overall Study|Protocol Violation|4|||
164048015|NCT00621764|592535978|FG000|Overall Study|Protocol Violation|0|||
164048016|NCT00621764|592535979|FG001|Overall Study|Protocol Violation|0|||
164048017|NCT00621764|592535980|FG002|Overall Study|Protocol Violation|0|||
164048018|NCT00621764|592535981|FG003|Overall Study|Protocol Violation|1|||
164048019|NCT02499172|592535982|FG000|Overall Study|Financial reason|0|||
164048020|NCT02499172|592535983|FG001|Overall Study|Financial reason|0|||
164048021|NCT02499172|592535984|FG002|Overall Study|Financial reason|523|||
164048022|NCT02499172|592535985|FG003|Overall Study|Financial reason|436|||
164048023|NCT02499172|592535982|FG000|Overall Study|Lost to Follow-up|65|||
164048024|NCT02499172|592535983|FG001|Overall Study|Lost to Follow-up|64|||
164048025|NCT02499172|592535984|FG002|Overall Study|Lost to Follow-up|0|||
164048026|NCT02499172|592535985|FG003|Overall Study|Lost to Follow-up|0|||
164048027|NCT01293123|592535986|FG000|Overall Study|Lost to Follow-up|0|||
164048028|NCT01293123|592535987|FG001|Overall Study|Lost to Follow-up|1|||
164048029|NCT00121485|592535988|FG000|Overall Study|Not implanted|1|||
164048030|NCT00121485|592535989|FG001|Overall Study|Not implanted|5|||
164048031|NCT00121485|592535988|FG000|Overall Study|Crossover|0|||
164048032|NCT00121485|592535989|FG001|Overall Study|Crossover|2|||
164048033|NCT01888965|592535999|FG000|Overall Study|Adverse Event|5|||
164048034|NCT01888965|592535999|FG000|Overall Study|Lack of Efficacy|4|||
164048035|NCT04076579|592536000|FG000|Overall Study|Adverse Event|2|||
164048036|NCT04076579|592536001|FG001|Overall Study|Adverse Event|0|||
164048037|NCT04076579|592536000|FG000|Overall Study|discontinued due to toxicity|1|||
164048038|NCT04076579|592536001|FG001|Overall Study|discontinued due to toxicity|0|||
164048039|NCT04076579|592536000|FG000|Overall Study|Physician Decision|1|||
164048040|NCT04076579|592536001|FG001|Overall Study|Physician Decision|0|||
164048041|NCT04076579|592536000|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
164048042|NCT04076579|592536001|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
164048043|NCT04076579|592536000|FG000|Overall Study|Noncompliance|0|||
164048044|NCT04076579|592536001|FG001|Overall Study|Noncompliance|1|||
164048045|NCT04076579|592536000|FG000|Overall Study|Withdrawal by Subject|0|||
164048046|NCT04076579|592536001|FG001|Overall Study|Withdrawal by Subject|2|||
164048047|NCT00186121|592536002|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
164048048|NCT00186121|592536002|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
164048049|NCT00186121|592536002|FG000|Overall Study|Not eligible (no treatment)|1|||
164048050|NCT03650387|592536003|FG000|Overall Study|Withdrawal by Subject|13|||
164048051|NCT03650387|592536003|FG000|Overall Study|Lost to Follow-up|12|||
164048052|NCT03650387|592536003|FG000|Overall Study|Adverse Event (Not related)|1|||
164048053|NCT03650387|592536003|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
164099723|NCT02100228|592730564|FG000|Overall Study|Withdrawal by Subject|27|||
164048054|NCT00417248|592536004|FG000|Overall Study|Study Terminated|6|||
164048055|NCT00417248|592536004|FG000|Overall Study|Death|1|||
164048056|NCT00417248|592536004|FG000|Overall Study|Lack of Efficacy|1|||
164048057|NCT05815758|592536005|FG000|Overall Study|Adverse Event|6|||
164048058|NCT05815758|592536006|FG001|Overall Study|Adverse Event|2|||
164048059|NCT05815758|592536005|FG000|Overall Study|Lost to Follow-up|14|||
163956968|NCT00261846|592214027|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956969|NCT00261846|592214028|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956970|NCT00261846|592214029|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956971|NCT00261846|592214030|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
163956972|NCT00261846|592214031|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956973|NCT00261846|592214032|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956974|NCT00261846|592214033|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956975|NCT00261846|592214034|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956976|NCT00261846|592214035|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
163956977|NCT00261846|592214036|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956978|NCT00261846|592214037|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956979|NCT00261846|592214038|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
163956980|NCT00261846|592214027|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163956981|NCT00261846|592214028|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163956982|NCT00261846|592214029|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163956983|NCT00261846|592214030|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
163956984|NCT00261846|592214031|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
163956985|NCT00261846|592214032|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
163956986|NCT00261846|592214033|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
163956987|NCT00261846|592214034|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
163956988|NCT00261846|592214035|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163956989|NCT00261846|592214036|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
163956990|NCT00261846|592214037|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163956991|NCT00261846|592214038|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
163956992|NCT00261846|592214027|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163956993|NCT00261846|592214028|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163956994|NCT00261846|592214029|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163956995|NCT00261846|592214030|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
163956996|NCT00261846|592214031|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163956997|NCT00261846|592214032|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163956998|NCT00261846|592214033|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163956999|NCT00261846|592214034|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163957000|NCT00261846|592214035|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
163957001|NCT00261846|592214036|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163957002|NCT00261846|592214037|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
163957003|NCT00261846|592214038|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
163957004|NCT00261846|592214027|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
163957005|NCT00261846|592214028|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
163957006|NCT00261846|592214029|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
163957007|NCT00261846|592214030|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
163957008|NCT00261846|592214031|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
163957009|NCT00261846|592214032|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
163957010|NCT00261846|592214033|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
163957011|NCT00261846|592214034|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
163957012|NCT00261846|592214035|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
163957013|NCT00261846|592214036|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
163957014|NCT00261846|592214037|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
163957015|NCT00261846|592214038|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
163957016|NCT00261846|592214027|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
163957017|NCT00261846|592214028|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
163957018|NCT00261846|592214029|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
163957019|NCT00261846|592214030|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
163957020|NCT00261846|592214031|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
163957021|NCT00261846|592214032|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
163957022|NCT00261846|592214033|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
163957023|NCT00261846|592214034|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
163957024|NCT00261846|592214035|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
163957025|NCT00261846|592214036|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
163957026|NCT00261846|592214037|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
163957027|NCT00261846|592214038|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
163957028|NCT00261846|592214027|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
163957029|NCT00261846|592214028|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
163957030|NCT00261846|592214029|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
163957031|NCT00261846|592214030|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
163957032|NCT00261846|592214031|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
163957033|NCT00261846|592214032|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
163957034|NCT00261846|592214033|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
163957035|NCT00261846|592214034|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
163957036|NCT00261846|592214035|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
163957037|NCT00261846|592214036|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
163957038|NCT00261846|592214037|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
163957039|NCT00261846|592214038|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
163957040|NCT04781387|592214041|FG000|Overall Study|Withdrawal by Subject|1|||
163957041|NCT04781387|592214042|FG001|Overall Study|Withdrawal by Subject|0|||
163957042|NCT04781387|592214043|FG002|Overall Study|Withdrawal by Subject|1|||
163957043|NCT04781387|592214041|FG000|Overall Study|Lost to Follow-up|1|||
163957044|NCT04781387|592214042|FG001|Overall Study|Lost to Follow-up|0|||
163957045|NCT04781387|592214043|FG002|Overall Study|Lost to Follow-up|0|||
163957046|NCT01636960|592214044|FG000|Induction Phase|Adverse Event|2|||
163957047|NCT01636960|592214044|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
163957048|NCT01636960|592214044|FG000|Maintenance Phase|Adverse Event|3|||
163957049|NCT01636960|592214044|FG000|Maintenance Phase|Progressive disease|1|||
163957050|NCT01209780|592214045|FG000|Overall Study|Adverse Event|0|||
163957051|NCT01209780|592214046|FG001|Overall Study|Adverse Event|1|||
163957052|NCT01209780|592214047|FG002|Overall Study|Adverse Event|0|||
163957053|NCT01209780|592214048|FG003|Overall Study|Adverse Event|0|||
163957054|NCT01209780|592214049|FG004|Overall Study|Adverse Event|0|||
163957055|NCT01209780|592214045|FG000|Overall Study|Withdrawal by Subject|9|||
163957056|NCT01209780|592214046|FG001|Overall Study|Withdrawal by Subject|2|||
163957057|NCT01209780|592214047|FG002|Overall Study|Withdrawal by Subject|1|||
163957058|NCT01209780|592214048|FG003|Overall Study|Withdrawal by Subject|1|||
163957059|NCT01209780|592214049|FG004|Overall Study|Withdrawal by Subject|0|||
163957060|NCT01209780|592214045|FG000|Overall Study|Lost to Follow-up|17|||
163957061|NCT01209780|592214046|FG001|Overall Study|Lost to Follow-up|12|||
163957062|NCT01209780|592214047|FG002|Overall Study|Lost to Follow-up|3|||
163957063|NCT01209780|592214048|FG003|Overall Study|Lost to Follow-up|9|||
163957064|NCT01209780|592214049|FG004|Overall Study|Lost to Follow-up|4|||
163957065|NCT01209780|592214045|FG000|Overall Study|Protocol Violation|0|||
163957066|NCT01209780|592214046|FG001|Overall Study|Protocol Violation|1|||
163957067|NCT01209780|592214047|FG002|Overall Study|Protocol Violation|0|||
163957068|NCT01209780|592214048|FG003|Overall Study|Protocol Violation|0|||
163957069|NCT01209780|592214049|FG004|Overall Study|Protocol Violation|0|||
163957070|NCT01209780|592214045|FG000|Overall Study|Inappropriate enrollment|0|||
163957071|NCT01209780|592214046|FG001|Overall Study|Inappropriate enrollment|2|||
164048060|NCT05815758|592536006|FG001|Overall Study|Lost to Follow-up|1|||
164048061|NCT05815758|592536005|FG000|Overall Study|Withdrawal by Subject|6|||
164048062|NCT05815758|592536006|FG001|Overall Study|Withdrawal by Subject|6|||
164048063|NCT05815758|592536005|FG000|Overall Study|Protocol Violation|1|||
164048064|NCT05815758|592536006|FG001|Overall Study|Protocol Violation|1|||
164048065|NCT05815758|592536005|FG000|Overall Study|Discontinued|4|||
164048066|NCT05815758|592536006|FG001|Overall Study|Discontinued|4|||
164048067|NCT03661983|592536007|FG000|Open Label Stabilization Phase|Adverse Event|5|||
164048068|NCT03661983|592536008|FG001|Open Label Stabilization Phase|Adverse Event|0|||
164048069|NCT03661983|592536009|FG002|Open Label Stabilization Phase|Adverse Event|0|||
164048070|NCT03661983|592536010|FG003|Open Label Stabilization Phase|Adverse Event|0|||
164048071|NCT03661983|592536007|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
164048072|NCT03661983|592536008|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
164048073|NCT03661983|592536009|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
164048074|NCT03661983|592536010|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
164048075|NCT03661983|592536007|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
164048076|NCT03661983|592536008|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
164048077|NCT03661983|592536009|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
164048078|NCT03661983|592536010|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
164048079|NCT03661983|592536007|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
164048080|NCT03661983|592536008|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
164048081|NCT03661983|592536009|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
164048082|NCT03661983|592536010|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
164048083|NCT03661983|592536007|FG000|Double-blind Randomized Phase|Adverse Event|0|||
164048084|NCT03661983|592536008|FG001|Double-blind Randomized Phase|Adverse Event|1|||
164048085|NCT03661983|592536009|FG002|Double-blind Randomized Phase|Adverse Event|0|||
164048086|NCT03661983|592536010|FG003|Double-blind Randomized Phase|Adverse Event|0|||
164048087|NCT03661983|592536007|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
164048088|NCT03661983|592536008|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
164048089|NCT03661983|592536009|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
163957072|NCT01209780|592214047|FG002|Overall Study|Inappropriate enrollment|0|||
163957073|NCT01209780|592214048|FG003|Overall Study|Inappropriate enrollment|0|||
163957074|NCT01209780|592214049|FG004|Overall Study|Inappropriate enrollment|1|||
163957075|NCT01745848|592214050|FG000|Overall Study|Adverse Event|6|||
163957076|NCT02318797|592214054|FG000|Overall Study|Death|3|||
163957077|NCT02318797|592214055|FG001|Overall Study|Death|6|||
164048090|NCT03661983|592536010|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
164048091|NCT03661983|592536007|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
164048092|NCT03661983|592536008|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
164048093|NCT03661983|592536009|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
163957078|NCT02318797|592214054|FG000|Overall Study|Lost to Follow-up|85|||
163957079|NCT02318797|592214055|FG001|Overall Study|Lost to Follow-up|96|||
163957080|NCT01740323|592214056|FG000|Overall Study|Adverse Event|1|||
163957081|NCT01740323|592214057|FG001|Overall Study|Adverse Event|0|||
163957082|NCT01740323|592214056|FG000|Overall Study|Randomized but did not take study drug|1|||
163957083|NCT01740323|592214057|FG001|Overall Study|Randomized but did not take study drug|0|||
163957084|NCT06338462|592214058|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
163957085|NCT00928447|592214059|FG000|Overall Study|Withdrawal by Subject|1|||
163957086|NCT00928447|592214059|FG000|Overall Study|Investigator's decision|1|||
163957087|NCT01001832|592214061|FG000|Short-term Period|Adverse Event|2|||
163957088|NCT01001832|592214062|FG001|Short-term Period|Adverse Event|3|||
163957089|NCT01001832|592214061|FG000|Long-term Period|Adverse Event|2|||
163957090|NCT01001832|592214062|FG001|Long-term Period|Adverse Event|1|||
163957091|NCT01001832|592214061|FG000|Long-term Period|Withdrawal by Subject|1|||
163957092|NCT01001832|592214062|FG001|Long-term Period|Withdrawal by Subject|0|||
163957093|NCT01001832|592214061|FG000|Long-term Period|Lack of Efficacy|0|||
163957094|NCT01001832|592214062|FG001|Long-term Period|Lack of Efficacy|2|||
163957095|NCT01001832|592214061|FG000|Long-term Period|Other|1|||
163957096|NCT01001832|592214062|FG001|Long-term Period|Other|2|||
163957097|NCT01001832|592214061|FG000|Follow-up Period|Withdrawal by Subject|1|||
163957098|NCT01001832|592214062|FG001|Follow-up Period|Withdrawal by Subject|0|||
163957099|NCT01001832|592214061|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
163957100|NCT01001832|592214062|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
163957101|NCT01001832|592214061|FG000|Follow-up Period|Other|2|||
163957102|NCT01001832|592214062|FG001|Follow-up Period|Other|1|||
163957103|NCT00926211|592214063|FG000|Overall Study|Lost to Follow-up|1|||
163957104|NCT01242800|592214064|FG000|Overall Study|Patient refusal|0|||
163957105|NCT01242800|592214065|FG001|Overall Study|Patient refusal|10|||
163957106|NCT01242800|592214064|FG000|Overall Study|Physician Decision|0|||
163957107|NCT01242800|592214065|FG001|Overall Study|Physician Decision|1|||
163957108|NCT01242800|592214064|FG000|Overall Study|Disease progression|0|||
163957109|NCT01242800|592214065|FG001|Overall Study|Disease progression|3|||
163957110|NCT01242800|592214064|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
163957111|NCT01242800|592214065|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
163957112|NCT01242800|592214064|FG000|Overall Study|Reasons not reported|0|||
163957113|NCT01242800|592214065|FG001|Overall Study|Reasons not reported|4|||
163957114|NCT00511901|592214069|FG000|Overall Study|Withdrawal by Subject|1|||
163957115|NCT00511901|592214070|FG001|Overall Study|Withdrawal by Subject|3|||
163957116|NCT02447172|592214071|FG000|Overall Study|Adverse Event|11|||
163957117|NCT02447172|592214072|FG001|Overall Study|Adverse Event|8|||
163957118|NCT02447172|592214073|FG002|Overall Study|Adverse Event|7|||
163957119|NCT02447172|592214071|FG000|Overall Study|Death|3|||
163957120|NCT02447172|592214072|FG001|Overall Study|Death|1|||
163957121|NCT02447172|592214073|FG002|Overall Study|Death|0|||
163957122|NCT02447172|592214071|FG000|Overall Study|Protocol Violation|2|||
163957123|NCT02447172|592214072|FG001|Overall Study|Protocol Violation|1|||
163957124|NCT02447172|592214073|FG002|Overall Study|Protocol Violation|2|||
163957125|NCT02447172|592214071|FG000|Overall Study|Lost to Follow-up|7|||
163957126|NCT02447172|592214072|FG001|Overall Study|Lost to Follow-up|4|||
163957127|NCT02447172|592214073|FG002|Overall Study|Lost to Follow-up|4|||
163957128|NCT02447172|592214071|FG000|Overall Study|Withdrawal by Subject|5|||
163957129|NCT02447172|592214072|FG001|Overall Study|Withdrawal by Subject|1|||
163957130|NCT02447172|592214073|FG002|Overall Study|Withdrawal by Subject|3|||
163957131|NCT02447172|592214071|FG000|Overall Study|protocol specific treatment unrelated|3|||
163957132|NCT02447172|592214072|FG001|Overall Study|protocol specific treatment unrelated|0|||
163957133|NCT02447172|592214073|FG002|Overall Study|protocol specific treatment unrelated|2|||
163957134|NCT00983931|592214077|FG000|14 Day Washout Period|Physician Decision|1|||
163957135|NCT00585195|592214080|FG000|Overall Study|Adverse Event|0|||
163957136|NCT00585195|592214081|FG001|Overall Study|Adverse Event|0|||
163957137|NCT00585195|592214082|FG002|Overall Study|Adverse Event|0|||
163957138|NCT00585195|592214083|FG003|Overall Study|Adverse Event|0|||
163957139|NCT00585195|592214084|FG004|Overall Study|Adverse Event|2|||
163957140|NCT00585195|592214085|FG005|Overall Study|Adverse Event|1|||
163957141|NCT00585195|592214086|FG006|Overall Study|Adverse Event|0|||
163957142|NCT00585195|592214087|FG007|Overall Study|Adverse Event|1|||
163957143|NCT00585195|592214088|FG008|Overall Study|Adverse Event|0|||
163957144|NCT00585195|592214089|FG009|Overall Study|Adverse Event|0|||
163957145|NCT00585195|592214090|FG010|Overall Study|Adverse Event|3|||
163957146|NCT00585195|592214091|FG011|Overall Study|Adverse Event|0|||
163957147|NCT00585195|592214092|FG012|Overall Study|Adverse Event|8|||
163957148|NCT00585195|592214093|FG013|Overall Study|Adverse Event|6|||
163957149|NCT00585195|592214094|FG014|Overall Study|Adverse Event|4|||
163957150|NCT00585195|592214095|FG015|Overall Study|Adverse Event|1|||
163957151|NCT00585195|592214096|FG016|Overall Study|Adverse Event|14|||
163957152|NCT00585195|592214097|FG017|Overall Study|Adverse Event|9|||
163957153|NCT00585195|592214098|FG018|Overall Study|Adverse Event|2|||
163957154|NCT00585195|592214099|FG019|Overall Study|Adverse Event|3|||
163957155|NCT00585195|592214100|FG020|Overall Study|Adverse Event|1|||
163957156|NCT00585195|592214080|FG000|Overall Study|Progressive Disease|2|||
163957157|NCT00585195|592214081|FG001|Overall Study|Progressive Disease|2|||
163957158|NCT00585195|592214082|FG002|Overall Study|Progressive Disease|5|||
163957159|NCT00585195|592214083|FG003|Overall Study|Progressive Disease|4|||
163957160|NCT00585195|592214084|FG004|Overall Study|Progressive Disease|6|||
163957161|NCT00585195|592214085|FG005|Overall Study|Progressive Disease|4|||
163957162|NCT00585195|592214086|FG006|Overall Study|Progressive Disease|6|||
163957163|NCT00585195|592214087|FG007|Overall Study|Progressive Disease|3|||
163957164|NCT00585195|592214088|FG008|Overall Study|Progressive Disease|0|||
163957165|NCT00585195|592214089|FG009|Overall Study|Progressive Disease|5|||
163957166|NCT00585195|592214090|FG010|Overall Study|Progressive Disease|2|||
163957167|NCT00585195|592214091|FG011|Overall Study|Progressive Disease|25|||
163957168|NCT00585195|592214092|FG012|Overall Study|Progressive Disease|29|||
163957169|NCT00585195|592214093|FG013|Overall Study|Progressive Disease|26|||
163957170|NCT00585195|592214094|FG014|Overall Study|Progressive Disease|21|||
163957171|NCT00585195|592214095|FG015|Overall Study|Progressive Disease|12|||
163957172|NCT00585195|592214096|FG016|Overall Study|Progressive Disease|94|||
163957173|NCT00585195|592214097|FG017|Overall Study|Progressive Disease|42|||
163957174|NCT00585195|592214098|FG018|Overall Study|Progressive Disease|4|||
163957175|NCT00585195|592214099|FG019|Overall Study|Progressive Disease|9|||
163957176|NCT00585195|592214100|FG020|Overall Study|Progressive Disease|8|||
163957177|NCT00585195|592214080|FG000|Overall Study|Withdrawal by Subject|1|||
163957178|NCT00585195|592214081|FG001|Overall Study|Withdrawal by Subject|1|||
163957179|NCT00585195|592214082|FG002|Overall Study|Withdrawal by Subject|2|||
163957180|NCT00585195|592214083|FG003|Overall Study|Withdrawal by Subject|2|||
163957181|NCT00585195|592214084|FG004|Overall Study|Withdrawal by Subject|0|||
163957182|NCT00585195|592214085|FG005|Overall Study|Withdrawal by Subject|0|||
163957183|NCT00585195|592214086|FG006|Overall Study|Withdrawal by Subject|0|||
163957184|NCT00585195|592214087|FG007|Overall Study|Withdrawal by Subject|1|||
163957185|NCT00585195|592214088|FG008|Overall Study|Withdrawal by Subject|0|||
163957186|NCT00585195|592214089|FG009|Overall Study|Withdrawal by Subject|0|||
163957187|NCT00585195|592214090|FG010|Overall Study|Withdrawal by Subject|3|||
163957188|NCT00585195|592214091|FG011|Overall Study|Withdrawal by Subject|8|||
163957189|NCT00585195|592214092|FG012|Overall Study|Withdrawal by Subject|15|||
163957190|NCT00585195|592214093|FG013|Overall Study|Withdrawal by Subject|0|||
163957191|NCT00585195|592214094|FG014|Overall Study|Withdrawal by Subject|3|||
163957192|NCT00585195|592214095|FG015|Overall Study|Withdrawal by Subject|0|||
163957193|NCT00585195|592214096|FG016|Overall Study|Withdrawal by Subject|7|||
163957194|NCT00585195|592214097|FG017|Overall Study|Withdrawal by Subject|1|||
163957195|NCT00585195|592214098|FG018|Overall Study|Withdrawal by Subject|2|||
163957196|NCT00585195|592214099|FG019|Overall Study|Withdrawal by Subject|2|||
163957197|NCT00585195|592214100|FG020|Overall Study|Withdrawal by Subject|0|||
163957198|NCT00585195|592214080|FG000|Overall Study|Other|0|||
163957199|NCT00585195|592214081|FG001|Overall Study|Other|1|||
163957200|NCT00585195|592214082|FG002|Overall Study|Other|1|||
163957201|NCT00585195|592214083|FG003|Overall Study|Other|1|||
163957202|NCT00585195|592214084|FG004|Overall Study|Other|0|||
163957203|NCT00585195|592214085|FG005|Overall Study|Other|1|||
163957204|NCT00585195|592214086|FG006|Overall Study|Other|0|||
163957205|NCT00585195|592214087|FG007|Overall Study|Other|0|||
163957206|NCT00585195|592214088|FG008|Overall Study|Other|2|||
163957207|NCT00585195|592214089|FG009|Overall Study|Other|1|||
163957208|NCT00585195|592214090|FG010|Overall Study|Other|0|||
163957209|NCT00585195|592214091|FG011|Overall Study|Other|19|||
163957210|NCT00585195|592214092|FG012|Overall Study|Other|24|||
163957211|NCT00585195|592214093|FG013|Overall Study|Other|7|||
163957212|NCT00585195|592214094|FG014|Overall Study|Other|11|||
163957213|NCT00585195|592214095|FG015|Overall Study|Other|3|||
163957214|NCT00585195|592214096|FG016|Overall Study|Other|28|||
163957215|NCT00585195|592214097|FG017|Overall Study|Other|12|||
163957216|NCT00585195|592214098|FG018|Overall Study|Other|10|||
163957217|NCT00585195|592214099|FG019|Overall Study|Other|4|||
163957218|NCT00585195|592214100|FG020|Overall Study|Other|2|||
163957219|NCT00585195|592214080|FG000|Overall Study|Randomized not treated|0|||
163957220|NCT00585195|592214081|FG001|Overall Study|Randomized not treated|0|||
163957221|NCT00585195|592214082|FG002|Overall Study|Randomized not treated|1|||
163957222|NCT00585195|592214083|FG003|Overall Study|Randomized not treated|0|||
163957223|NCT00585195|592214084|FG004|Overall Study|Randomized not treated|1|||
163957224|NCT00585195|592214085|FG005|Overall Study|Randomized not treated|0|||
163957225|NCT00585195|592214086|FG006|Overall Study|Randomized not treated|1|||
163957226|NCT00585195|592214087|FG007|Overall Study|Randomized not treated|0|||
163957227|NCT00585195|592214088|FG008|Overall Study|Randomized not treated|0|||
163957228|NCT00585195|592214089|FG009|Overall Study|Randomized not treated|0|||
163957229|NCT00585195|592214090|FG010|Overall Study|Randomized not treated|2|||
163957230|NCT00585195|592214091|FG011|Overall Study|Randomized not treated|0|||
163957231|NCT00585195|592214092|FG012|Overall Study|Randomized not treated|0|||
163957232|NCT00585195|592214093|FG013|Overall Study|Randomized not treated|0|||
163957233|NCT00585195|592214094|FG014|Overall Study|Randomized not treated|0|||
163957234|NCT00585195|592214095|FG015|Overall Study|Randomized not treated|1|||
163957235|NCT00585195|592214096|FG016|Overall Study|Randomized not treated|0|||
163957236|NCT00585195|592214097|FG017|Overall Study|Randomized not treated|1|||
163957237|NCT00585195|592214098|FG018|Overall Study|Randomized not treated|3|||
163957238|NCT00585195|592214099|FG019|Overall Study|Randomized not treated|0|||
163957239|NCT00585195|592214100|FG020|Overall Study|Randomized not treated|2|||
163957240|NCT00585195|592214080|FG000|Overall Study|Death|0|||
163957241|NCT00585195|592214081|FG001|Overall Study|Death|0|||
163957242|NCT00585195|592214082|FG002|Overall Study|Death|0|||
163957243|NCT00585195|592214083|FG003|Overall Study|Death|0|||
163957244|NCT00585195|592214084|FG004|Overall Study|Death|0|||
163957245|NCT00585195|592214085|FG005|Overall Study|Death|0|||
163957246|NCT00585195|592214086|FG006|Overall Study|Death|0|||
163957247|NCT00585195|592214087|FG007|Overall Study|Death|0|||
163957248|NCT00585195|592214088|FG008|Overall Study|Death|1|||
163957249|NCT00585195|592214089|FG009|Overall Study|Death|0|||
163957250|NCT00585195|592214090|FG010|Overall Study|Death|1|||
163957251|NCT00585195|592214091|FG011|Overall Study|Death|1|||
163957252|NCT00585195|592214092|FG012|Overall Study|Death|7|||
163957253|NCT00585195|592214093|FG013|Overall Study|Death|2|||
163957254|NCT00585195|592214094|FG014|Overall Study|Death|8|||
163957255|NCT00585195|592214095|FG015|Overall Study|Death|2|||
163957256|NCT00585195|592214096|FG016|Overall Study|Death|11|||
163957257|NCT00585195|592214097|FG017|Overall Study|Death|0|||
163957258|NCT00585195|592214098|FG018|Overall Study|Death|0|||
163957259|NCT00585195|592214099|FG019|Overall Study|Death|0|||
163957260|NCT00585195|592214100|FG020|Overall Study|Death|1|||
163957261|NCT00585195|592214080|FG000|Overall Study|Lost to Follow-up|0|||
163957262|NCT00585195|592214081|FG001|Overall Study|Lost to Follow-up|0|||
163957263|NCT00585195|592214082|FG002|Overall Study|Lost to Follow-up|0|||
163957264|NCT00585195|592214083|FG003|Overall Study|Lost to Follow-up|0|||
163957265|NCT00585195|592214084|FG004|Overall Study|Lost to Follow-up|0|||
163957266|NCT00585195|592214085|FG005|Overall Study|Lost to Follow-up|0|||
163957267|NCT00585195|592214086|FG006|Overall Study|Lost to Follow-up|0|||
163957268|NCT00585195|592214087|FG007|Overall Study|Lost to Follow-up|0|||
163957269|NCT00585195|592214088|FG008|Overall Study|Lost to Follow-up|0|||
163957270|NCT00585195|592214089|FG009|Overall Study|Lost to Follow-up|0|||
163957271|NCT00585195|592214090|FG010|Overall Study|Lost to Follow-up|0|||
163957272|NCT00585195|592214091|FG011|Overall Study|Lost to Follow-up|0|||
163957273|NCT00585195|592214092|FG012|Overall Study|Lost to Follow-up|1|||
163957274|NCT00585195|592214093|FG013|Overall Study|Lost to Follow-up|0|||
163957275|NCT00585195|592214094|FG014|Overall Study|Lost to Follow-up|0|||
163957276|NCT00585195|592214095|FG015|Overall Study|Lost to Follow-up|0|||
163957277|NCT00585195|592214096|FG016|Overall Study|Lost to Follow-up|0|||
163957278|NCT00585195|592214097|FG017|Overall Study|Lost to Follow-up|2|||
163957279|NCT00585195|592214098|FG018|Overall Study|Lost to Follow-up|0|||
163957280|NCT00585195|592214099|FG019|Overall Study|Lost to Follow-up|0|||
163957281|NCT00585195|592214100|FG020|Overall Study|Lost to Follow-up|0|||
163957282|NCT00585195|592214080|FG000|Overall Study|Site Terminated by Sponsor|0|||
163957283|NCT00585195|592214081|FG001|Overall Study|Site Terminated by Sponsor|0|||
163957284|NCT00585195|592214082|FG002|Overall Study|Site Terminated by Sponsor|0|||
163957285|NCT00585195|592214083|FG003|Overall Study|Site Terminated by Sponsor|0|||
163957286|NCT00585195|592214084|FG004|Overall Study|Site Terminated by Sponsor|0|||
163957287|NCT00585195|592214085|FG005|Overall Study|Site Terminated by Sponsor|0|||
163957288|NCT00585195|592214086|FG006|Overall Study|Site Terminated by Sponsor|0|||
163957289|NCT00585195|592214087|FG007|Overall Study|Site Terminated by Sponsor|0|||
163957290|NCT00585195|592214088|FG008|Overall Study|Site Terminated by Sponsor|0|||
163957291|NCT00585195|592214089|FG009|Overall Study|Site Terminated by Sponsor|0|||
163957292|NCT00585195|592214090|FG010|Overall Study|Site Terminated by Sponsor|0|||
163957293|NCT00585195|592214091|FG011|Overall Study|Site Terminated by Sponsor|0|||
163957294|NCT00585195|592214092|FG012|Overall Study|Site Terminated by Sponsor|1|||
163957295|NCT00585195|592214093|FG013|Overall Study|Site Terminated by Sponsor|0|||
163957296|NCT00585195|592214094|FG014|Overall Study|Site Terminated by Sponsor|0|||
163957297|NCT00585195|592214095|FG015|Overall Study|Site Terminated by Sponsor|0|||
163957298|NCT00585195|592214096|FG016|Overall Study|Site Terminated by Sponsor|0|||
163957299|NCT00585195|592214097|FG017|Overall Study|Site Terminated by Sponsor|0|||
163957300|NCT00585195|592214098|FG018|Overall Study|Site Terminated by Sponsor|0|||
163957301|NCT00585195|592214099|FG019|Overall Study|Site Terminated by Sponsor|0|||
163957302|NCT00585195|592214100|FG020|Overall Study|Site Terminated by Sponsor|0|||
163957303|NCT00585195|592214080|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
163957304|NCT00585195|592214081|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
163957305|NCT00585195|592214082|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
163957306|NCT00585195|592214083|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
163957307|NCT00585195|592214084|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
163957308|NCT00585195|592214085|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
163957309|NCT00585195|592214086|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
163957310|NCT00585195|592214087|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
163957311|NCT00585195|592214088|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
163957312|NCT00585195|592214089|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
163957313|NCT00585195|592214090|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
163957314|NCT00585195|592214091|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
163957315|NCT00585195|592214092|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
163957316|NCT00585195|592214093|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
163957317|NCT00585195|592214094|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
163957318|NCT00585195|592214095|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
163957319|NCT00585195|592214096|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
163957320|NCT00585195|592214097|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
163957321|NCT00585195|592214098|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
163957322|NCT00585195|592214099|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
163957323|NCT00585195|592214100|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
163957324|NCT01163916|592214102|FG000|Overall Study|Withdrawal by Subject|2|||
163957325|NCT01163916|592214103|FG001|Overall Study|Withdrawal by Subject|0|||
163957326|NCT01163916|592214104|FG002|Overall Study|Withdrawal by Subject|2|||
163957327|NCT01163916|592214102|FG000|Overall Study|Adverse Event|2|||
163957328|NCT01163916|592214103|FG001|Overall Study|Adverse Event|0|||
163957329|NCT01163916|592214104|FG002|Overall Study|Adverse Event|1|||
163957330|NCT01163916|592214102|FG000|Overall Study|Lack of Efficacy|2|||
163957331|NCT01163916|592214103|FG001|Overall Study|Lack of Efficacy|0|||
163957332|NCT01163916|592214104|FG002|Overall Study|Lack of Efficacy|1|||
163957333|NCT01163916|592214102|FG000|Overall Study|Other|24|||
163957334|NCT01163916|592214103|FG001|Overall Study|Other|4|||
163957335|NCT01163916|592214104|FG002|Overall Study|Other|16|||
163957336|NCT02337751|592214105|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
163957337|NCT02337751|592214106|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
163957338|NCT02337751|592214105|FG000|Overall Study|Voluntary Withdrawal|6|||
163957339|NCT02337751|592214106|FG001|Overall Study|Voluntary Withdrawal|8|||
163957340|NCT02337751|592214105|FG000|Overall Study|Lack of Efficacy|2|||
163957341|NCT02337751|592214106|FG001|Overall Study|Lack of Efficacy|5|||
163957342|NCT02337751|592214105|FG000|Overall Study|Investigator's Judgement|1|||
163957343|NCT02337751|592214106|FG001|Overall Study|Investigator's Judgement|0|||
163957344|NCT01009580|592214107|FG000|Overall Study|Adverse Event|4|||
163957345|NCT01009580|592214108|FG001|Overall Study|Adverse Event|4|||
163957346|NCT01009580|592214107|FG000|Overall Study|Lack of Efficacy|0|||
163957347|NCT01009580|592214108|FG001|Overall Study|Lack of Efficacy|1|||
163957348|NCT01009580|592214107|FG000|Overall Study|Protocol Violation|2|||
163957349|NCT01009580|592214108|FG001|Overall Study|Protocol Violation|3|||
163957350|NCT01009580|592214107|FG000|Overall Study|Withdrawal Criteria|4|||
163957351|NCT01009580|592214108|FG001|Overall Study|Withdrawal Criteria|6|||
163957352|NCT01009580|592214107|FG000|Overall Study|Unclassified|17|||
163957353|NCT01009580|592214108|FG001|Overall Study|Unclassified|21|||
163957354|NCT05677893|592215905|FG000|Overall Study|Withdrawal by Subject|0|||
163957355|NCT05677893|592215906|FG001|Overall Study|Withdrawal by Subject|0|||
163957356|NCT05677893|592215907|FG002|Overall Study|Withdrawal by Subject|0|||
163957357|NCT05677893|592215908|FG003|Overall Study|Withdrawal by Subject|0|||
163957358|NCT05677893|592215909|FG004|Overall Study|Withdrawal by Subject|1|||
163957359|NCT05677893|592215910|FG005|Overall Study|Withdrawal by Subject|1|||
163957360|NCT05677893|592215911|FG006|Overall Study|Withdrawal by Subject|0|||
163957361|NCT05677893|592215905|FG000|Overall Study|Others|1|||
163957362|NCT05677893|592215906|FG001|Overall Study|Others|0|||
163957363|NCT05677893|592215907|FG002|Overall Study|Others|0|||
163957364|NCT05677893|592215908|FG003|Overall Study|Others|0|||
163957365|NCT05677893|592215909|FG004|Overall Study|Others|0|||
163957366|NCT05677893|592215910|FG005|Overall Study|Others|0|||
163957367|NCT05677893|592215911|FG006|Overall Study|Others|0|||
163957368|NCT03217266|592215912|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
163957369|NCT03217266|592215913|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
163957370|NCT03217266|592215914|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
163957371|NCT03217266|592215915|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
163957372|NCT03217266|592215912|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
163957373|NCT03217266|592215913|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
163957374|NCT03217266|592215914|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
164048094|NCT03661983|592536010|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
164048095|NCT03661983|592536007|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
163957375|NCT03217266|592215915|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
163957376|NCT03217266|592215912|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
163957377|NCT03217266|592215913|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
163957378|NCT03217266|592215914|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
163957379|NCT03217266|592215915|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
163957380|NCT01390181|592215916|FG000|Overall Study|Lost to Follow-up|1|||
163957381|NCT01390181|592215916|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
163957382|NCT01101477|592215922|FG000|Overall Study|Protocol Violation|5|||
163957383|NCT01101477|592215923|FG001|Overall Study|Protocol Violation|3|||
163957384|NCT01101477|592215924|FG002|Overall Study|Protocol Violation|1|||
163957385|NCT00720941|592215925|FG000|Overall Study|Protocol Violation|1|||
163957386|NCT00720941|592215926|FG001|Overall Study|Protocol Violation|2|||
163957387|NCT00720941|592215925|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
163957388|NCT00720941|592215926|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
163957389|NCT00720941|592215925|FG000|Overall Study|Lost to Follow-up|20|||
163957390|NCT00720941|592215926|FG001|Overall Study|Lost to Follow-up|15|||
163957391|NCT00720941|592215925|FG000|Overall Study|Physician Decision|14|||
163957392|NCT00720941|592215926|FG001|Overall Study|Physician Decision|12|||
163957393|NCT00720941|592215925|FG000|Overall Study|Withdrawal by Subject|29|||
163957394|NCT00720941|592215926|FG001|Overall Study|Withdrawal by Subject|36|||
163957395|NCT01222507|592215927|FG000|Overall Study|Physician Decision|1|||
163957396|NCT01222507|592215927|FG000|Overall Study|Withdrawal by Subject|1|||
163957397|NCT03511053|592215928|FG000|Overall Study|Withdrawal by Subject|1|||
163957398|NCT01786174|592215933|FG000|Overall Study|Discontinued Study Drug|2|||
163957399|NCT01786174|592215934|FG001|Overall Study|Discontinued Study Drug|0|||
163957400|NCT03628898|592215936|FG000|Overall Study|Device deficiency|1|||
163957401|NCT03442985|592215937|FG000|Overall Study|Sponsor Request|55|||
163957402|NCT03442985|592215938|FG001|Overall Study|Sponsor Request|60|||
163957403|NCT03442985|592215939|FG002|Overall Study|Sponsor Request|54|||
163957404|NCT03442985|592215937|FG000|Overall Study|Lost to Follow-up|5|||
163957405|NCT03442985|592215938|FG001|Overall Study|Lost to Follow-up|2|||
163957406|NCT03442985|592215939|FG002|Overall Study|Lost to Follow-up|7|||
163957407|NCT03442985|592215937|FG000|Overall Study|Withdrawal by Subject|2|||
163957408|NCT03442985|592215938|FG001|Overall Study|Withdrawal by Subject|3|||
163957409|NCT03442985|592215939|FG002|Overall Study|Withdrawal by Subject|4|||
163957410|NCT03442985|592215937|FG000|Overall Study|Adverse Event|0|||
163957411|NCT03442985|592215938|FG001|Overall Study|Adverse Event|1|||
163957412|NCT03442985|592215939|FG002|Overall Study|Adverse Event|0|||
163957413|NCT00985166|592215940|FG000|Overall Study|Lost to Follow-up|3|||
163957414|NCT00985166|592215941|FG001|Overall Study|Lost to Follow-up|2|||
163957415|NCT00985166|592215942|FG002|Overall Study|Lost to Follow-up|2|||
163957416|NCT00985166|592215940|FG000|Overall Study|Withdrawal by Subject|3|||
163957417|NCT00985166|592215941|FG001|Overall Study|Withdrawal by Subject|2|||
163957418|NCT00985166|592215942|FG002|Overall Study|Withdrawal by Subject|0|||
163957419|NCT00985166|592215940|FG000|Overall Study|Test not done|2|||
163957420|NCT00985166|592215941|FG001|Overall Study|Test not done|0|||
163957421|NCT00985166|592215942|FG002|Overall Study|Test not done|4|||
163957422|NCT00985166|592215940|FG000|Overall Study|Other|1|||
163957423|NCT00985166|592215941|FG001|Overall Study|Other|0|||
163957424|NCT00985166|592215942|FG002|Overall Study|Other|1|||
163957425|NCT00300781|592215943|FG000|Overall Study|Disease Progression|55|||
163957426|NCT00300781|592215944|FG001|Overall Study|Disease Progression|52|||
163957427|NCT00300781|592215943|FG000|Overall Study|Adverse Event|5|||
163957428|NCT00300781|592215944|FG001|Overall Study|Adverse Event|6|||
163957429|NCT00300781|592215943|FG000|Overall Study|Withdrawal by Subject|1|||
163957430|NCT00300781|592215944|FG001|Overall Study|Withdrawal by Subject|2|||
163957431|NCT00300781|592215943|FG000|Overall Study|Physician Decision|1|||
163957432|NCT00300781|592215944|FG001|Overall Study|Physician Decision|0|||
163957433|NCT00300781|592215943|FG000|Overall Study|Not Recorded|0|||
163957434|NCT00300781|592215944|FG001|Overall Study|Not Recorded|1|||
163957435|NCT00300781|592215943|FG000|Overall Study|Symptomatic Deterioration|1|||
163957436|NCT00300781|592215944|FG001|Overall Study|Symptomatic Deterioration|0|||
163957437|NCT00300781|592215943|FG000|Overall Study|Lost to Follow-up|0|||
163957438|NCT00300781|592215944|FG001|Overall Study|Lost to Follow-up|1|||
163957439|NCT00567268|592215951|FG000|Overall Study|Protocol Violation|7|||
163957440|NCT00567268|592215951|FG000|Overall Study|Lost to Follow-up|36|||
163957441|NCT00567268|592215951|FG000|Overall Study|No Visit After First Day of Treatment|2|||
163957442|NCT00567268|592215951|FG000|Overall Study|No Drug Administration|4|||
163957443|NCT00567268|592215951|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
163957444|NCT00294554|592215952|FG000|Overall Study|Lack of Efficacy|0|||
163957445|NCT00294554|592215953|FG001|Overall Study|Lack of Efficacy|1|||
163957446|NCT00294554|592215952|FG000|Overall Study|Physician Decision|0|||
163957447|NCT00294554|592215953|FG001|Overall Study|Physician Decision|1|||
163957448|NCT02598557|592215954|FG000|Overall Study|Withdrawal by Subject|1|||
163957449|NCT02598557|592215955|FG001|Overall Study|Withdrawal by Subject|0|||
163957450|NCT02598557|592215956|FG002|Overall Study|Withdrawal by Subject|1|||
163957451|NCT02598557|592215954|FG000|Overall Study|Participant did not start treatment|2|||
163957452|NCT02598557|592215955|FG001|Overall Study|Participant did not start treatment|1|||
163957453|NCT02598557|592215956|FG002|Overall Study|Participant did not start treatment|1|||
163957454|NCT02598557|592215954|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
163957455|NCT02598557|592215955|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
163957456|NCT02598557|592215956|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
163957457|NCT02598557|592215954|FG000|Overall Study|Adverse Event|1|||
163957458|NCT02598557|592215955|FG001|Overall Study|Adverse Event|1|||
163957459|NCT02598557|592215956|FG002|Overall Study|Adverse Event|0|||
163957460|NCT02864381|592215957|FG000|Overall Study|Death|58|||
163957461|NCT02864381|592215958|FG001|Overall Study|Death|61|||
163957462|NCT02864381|592215957|FG000|Overall Study|Withdrew Consent|5|||
163957463|NCT02864381|592215958|FG001|Overall Study|Withdrew Consent|6|||
163957464|NCT02864381|592215957|FG000|Overall Study|Reason Unknown|7|||
163957465|NCT02864381|592215958|FG001|Overall Study|Reason Unknown|3|||
163957466|NCT02864381|592215957|FG000|Overall Study|Lost to Follow-up|1|||
163957467|NCT02864381|592215958|FG001|Overall Study|Lost to Follow-up|1|||
163957468|NCT02864381|592215957|FG000|Overall Study|Investigator's Discretion|1|||
164048096|NCT03661983|592536008|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
164048097|NCT03661983|592536009|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
164048098|NCT03661983|592536010|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
164048099|NCT02903966|592536011|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
164048100|NCT02903966|592536012|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
164048101|NCT02903966|592536011|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
164048102|NCT02903966|592536012|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
164048103|NCT02903966|592536011|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
164048104|NCT02903966|592536012|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
164048105|NCT00934791|592536013|FG000|Overall Study|Withdrawal by Subject|1|||
164048106|NCT00934791|592536014|FG001|Overall Study|Withdrawal by Subject|0|||
164048107|NCT01320033|592536016|FG000|Overall Study|Lack of Efficacy|0|||
164048108|NCT01320033|592536017|FG001|Overall Study|Lack of Efficacy|0|||
164048109|NCT01320033|592536018|FG002|Overall Study|Lack of Efficacy|1|||
164048110|NCT01320033|592536016|FG000|Overall Study|Adverse Event|9|||
164048111|NCT01320033|592536017|FG001|Overall Study|Adverse Event|7|||
164048112|NCT01320033|592536018|FG002|Overall Study|Adverse Event|8|||
164048113|NCT01320033|592536016|FG000|Overall Study|Withdrawal by Subject|22|||
164048114|NCT01320033|592536017|FG001|Overall Study|Withdrawal by Subject|23|||
164048115|NCT01320033|592536018|FG002|Overall Study|Withdrawal by Subject|23|||
164048116|NCT01320033|592536016|FG000|Overall Study|Protocol Violation|3|||
164048117|NCT01320033|592536017|FG001|Overall Study|Protocol Violation|5|||
164048118|NCT01320033|592536018|FG002|Overall Study|Protocol Violation|3|||
164048119|NCT01320033|592536016|FG000|Overall Study|Lost to Follow-up|22|||
164048120|NCT01320033|592536017|FG001|Overall Study|Lost to Follow-up|26|||
164048121|NCT01320033|592536018|FG002|Overall Study|Lost to Follow-up|17|||
164048122|NCT01320033|592536016|FG000|Overall Study|Other|2|||
164048123|NCT01320033|592536017|FG001|Overall Study|Other|3|||
164048124|NCT01320033|592536018|FG002|Overall Study|Other|1|||
164048125|NCT02425891|592536019|FG000|Overall Study|Death|333|||
164048126|NCT02425891|592536020|FG001|Overall Study|Death|314|||
164048127|NCT02425891|592536019|FG000|Overall Study|Lost to Follow-up|4|||
164048128|NCT02425891|592536020|FG001|Overall Study|Lost to Follow-up|6|||
164048129|NCT02425891|592536019|FG000|Overall Study|Non-Compliance|1|||
164048130|NCT02425891|592536020|FG001|Overall Study|Non-Compliance|1|||
164048131|NCT02425891|592536019|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
164048132|NCT02425891|592536020|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
164048133|NCT02425891|592536019|FG000|Overall Study|Physician Decision|0|||
164048134|NCT02425891|592536020|FG001|Overall Study|Physician Decision|1|||
164048135|NCT02425891|592536019|FG000|Overall Study|Protocol Violation|1|||
164048136|NCT02425891|592536020|FG001|Overall Study|Protocol Violation|1|||
164048137|NCT02425891|592536019|FG000|Overall Study|Study Terminated By Sponsor|85|||
164048138|NCT02425891|592536020|FG001|Overall Study|Study Terminated By Sponsor|95|||
164048139|NCT02425891|592536019|FG000|Overall Study|Withdrawal by Subject|27|||
164048140|NCT02425891|592536020|FG001|Overall Study|Withdrawal by Subject|32|||
164048141|NCT00963469|592536021|FG000|Overall Study|Adverse Event|15|||
164048142|NCT00963469|592536022|FG001|Overall Study|Adverse Event|11|||
164048143|NCT00963469|592536023|FG002|Overall Study|Adverse Event|1|||
164048144|NCT00963469|592536021|FG000|Overall Study|Lack of Efficacy|10|||
164048145|NCT00963469|592536022|FG001|Overall Study|Lack of Efficacy|7|||
164048146|NCT00963469|592536023|FG002|Overall Study|Lack of Efficacy|2|||
164048147|NCT00963469|592536021|FG000|Overall Study|Lost to Follow-up|1|||
164048148|NCT00963469|592536022|FG001|Overall Study|Lost to Follow-up|1|||
164048149|NCT00963469|592536023|FG002|Overall Study|Lost to Follow-up|0|||
164048150|NCT00963469|592536021|FG000|Overall Study|Protocol Violation|5|||
164048151|NCT00963469|592536022|FG001|Overall Study|Protocol Violation|5|||
164048152|NCT00963469|592536023|FG002|Overall Study|Protocol Violation|3|||
164048153|NCT00963469|592536021|FG000|Overall Study|Withdrawal by Subject|4|||
164048154|NCT00963469|592536022|FG001|Overall Study|Withdrawal by Subject|1|||
164048155|NCT00963469|592536023|FG002|Overall Study|Withdrawal by Subject|1|||
164048156|NCT00963469|592536021|FG000|Overall Study|Pre-randomization Adverse Event|1|||
164048157|NCT00963469|592536022|FG001|Overall Study|Pre-randomization Adverse Event|2|||
164048158|NCT00963469|592536023|FG002|Overall Study|Pre-randomization Adverse Event|0|||
164048159|NCT00963469|592536021|FG000|Overall Study|Moved|1|||
164048160|NCT00963469|592536022|FG001|Overall Study|Moved|0|||
164048161|NCT00963469|592536023|FG002|Overall Study|Moved|0|||
164048162|NCT00963469|592536021|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
164048163|NCT00963469|592536022|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
164048164|NCT00963469|592536023|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
164048165|NCT04124952|592536026|FG000|Overall Study|Lost to Follow-up|1|||
164048166|NCT02145429|592536027|FG000|Overall Study|Death|4|||
164048167|NCT02145429|592536028|FG001|Overall Study|Death|5|||
164048168|NCT02145429|592536027|FG000|Overall Study|Lost to Follow-up|4|||
164048169|NCT02145429|592536028|FG001|Overall Study|Lost to Follow-up|3|||
164048170|NCT02145429|592536027|FG000|Overall Study|Withdrawal by Subject|8|||
164048171|NCT02145429|592536028|FG001|Overall Study|Withdrawal by Subject|3|||
164048172|NCT02943577|592536029|FG000|Overall Study|Protocol Violation|0|||
164048173|NCT02943577|592536030|FG001|Overall Study|Protocol Violation|1|||
163957469|NCT02864381|592215958|FG001|Overall Study|Investigator's Discretion|0|||
163957470|NCT02864381|592215957|FG000|Overall Study|Protocol Violation|0|||
163957471|NCT02864381|592215958|FG001|Overall Study|Protocol Violation|1|||
163957472|NCT02986334|592215959|FG000|Overall Study|Withdrawal by Subject|0|||
163957473|NCT02986334|592215960|FG001|Overall Study|Withdrawal by Subject|1|||
163957474|NCT02986334|592215961|FG002|Overall Study|Withdrawal by Subject|2|||
163957475|NCT02986334|592215959|FG000|Overall Study|Lost to Follow-up|1|||
163957476|NCT02986334|592215960|FG001|Overall Study|Lost to Follow-up|2|||
163957477|NCT02986334|592215961|FG002|Overall Study|Lost to Follow-up|1|||
163957478|NCT02986334|592215959|FG000|Overall Study|Adverse Event|0|||
163957479|NCT02986334|592215960|FG001|Overall Study|Adverse Event|2|||
163957480|NCT02986334|592215961|FG002|Overall Study|Adverse Event|1|||
163957481|NCT02986334|592215959|FG000|Overall Study|non compliance in phone ratings|2|||
163957482|NCT02986334|592215960|FG001|Overall Study|non compliance in phone ratings|1|||
163957483|NCT02986334|592215961|FG002|Overall Study|non compliance in phone ratings|2|||
163957484|NCT02986334|592215959|FG000|Overall Study|undisclosed comorbidities|0|||
163957485|NCT02986334|592215960|FG001|Overall Study|undisclosed comorbidities|1|||
163957486|NCT02986334|592215961|FG002|Overall Study|undisclosed comorbidities|1|||
163957487|NCT04142450|592215962|FG000|Overall Study|Screen Failure|1|||
163957488|NCT04142450|592215962|FG000|Overall Study|Lost to Follow-up|1|||
163957489|NCT00120406|592215963|FG000|Overall Study|Death|9|||
163957490|NCT00120406|592215964|FG001|Overall Study|Death|4|||
163957491|NCT00120406|592215963|FG000|Overall Study|Withdrawal by Subject|5|||
163957492|NCT00120406|592215964|FG001|Overall Study|Withdrawal by Subject|7|||
163957493|NCT00120406|592215963|FG000|Overall Study|Lost to Follow-up|5|||
163957494|NCT00120406|592215964|FG001|Overall Study|Lost to Follow-up|2|||
163957495|NCT00120406|592215963|FG000|Overall Study|received non-study stent|0|||
163957496|NCT00120406|592215964|FG001|Overall Study|received non-study stent|2|||
163957497|NCT00120406|592215963|FG000|Overall Study|patient moved but has not withdrawn|0|||
163957498|NCT00120406|592215964|FG001|Overall Study|patient moved but has not withdrawn|1|||
163957499|NCT00667355|592215967|FG000|Overall Study|Adverse Event|5|||
163957500|NCT00667355|592215967|FG000|Overall Study|Lost to Follow-up|1|||
163957501|NCT00667355|592215967|FG000|Overall Study|Other reason was not specified|5|||
163957502|NCT01313637|592215968|FG000|Overall Study|Adverse Event|17|||
163957503|NCT01313637|592215969|FG001|Overall Study|Adverse Event|24|||
163957504|NCT01313637|592215970|FG002|Overall Study|Adverse Event|25|||
163957505|NCT01313637|592215971|FG003|Overall Study|Adverse Event|18|||
163957506|NCT01313637|592215968|FG000|Overall Study|Lack of Efficacy|44|||
163957507|NCT01313637|592215969|FG001|Overall Study|Lack of Efficacy|38|||
163957508|NCT01313637|592215970|FG002|Overall Study|Lack of Efficacy|37|||
163957509|NCT01313637|592215971|FG003|Overall Study|Lack of Efficacy|24|||
163957510|NCT01313637|592215968|FG000|Overall Study|Protocol Violation|4|||
163957511|NCT01313637|592215969|FG001|Overall Study|Protocol Violation|3|||
163957512|NCT01313637|592215970|FG002|Overall Study|Protocol Violation|11|||
163957513|NCT01313637|592215971|FG003|Overall Study|Protocol Violation|5|||
163957514|NCT01313637|592215968|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
163957515|NCT01313637|592215969|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
163957516|NCT01313637|592215970|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
163957517|NCT01313637|592215971|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
163957518|NCT01313637|592215968|FG000|Overall Study|Lost to Follow-up|0|||
163957519|NCT01313637|592215969|FG001|Overall Study|Lost to Follow-up|2|||
163957520|NCT01313637|592215970|FG002|Overall Study|Lost to Follow-up|1|||
163957521|NCT01313637|592215971|FG003|Overall Study|Lost to Follow-up|3|||
163957522|NCT01313637|592215968|FG000|Overall Study|Withdrawal by Subject|11|||
163957523|NCT01313637|592215969|FG001|Overall Study|Withdrawal by Subject|13|||
163957524|NCT01313637|592215970|FG002|Overall Study|Withdrawal by Subject|18|||
163957525|NCT01313637|592215971|FG003|Overall Study|Withdrawal by Subject|15|||
163957526|NCT00795951|592215974|FG000|Overall Study|Lost to Follow-up|1|||
163957527|NCT00795951|592215974|FG000|Overall Study|Withdrawal by Subject|1|||
163957528|NCT00655863|592215976|FG000|Overall Study|Lost to Follow-up|0|||
163957529|NCT00655863|592215977|FG001|Overall Study|Lost to Follow-up|0|||
163957530|NCT00655863|592215978|FG002|Overall Study|Lost to Follow-up|1|||
163957531|NCT01138007|592215979|FG000|Overall Study|Adverse Event|4|||
163957532|NCT01138007|592215980|FG001|Overall Study|Adverse Event|12|||
163957533|NCT01138007|592215981|FG002|Overall Study|Adverse Event|9|||
163957534|NCT01138007|592215979|FG000|Overall Study|Lack of Efficacy|2|||
163957535|NCT01138007|592215980|FG001|Overall Study|Lack of Efficacy|0|||
163957536|NCT01138007|592215981|FG002|Overall Study|Lack of Efficacy|6|||
163957537|NCT01138007|592215979|FG000|Overall Study|Protocol Violation|2|||
163957538|NCT01138007|592215980|FG001|Overall Study|Protocol Violation|3|||
163957539|NCT01138007|592215981|FG002|Overall Study|Protocol Violation|2|||
163957540|NCT01138007|592215979|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
163957541|NCT01138007|592215980|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
163957542|NCT01138007|592215981|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
163957543|NCT01138007|592215979|FG000|Overall Study|Lost to Follow-up|3|||
163957544|NCT01138007|592215980|FG001|Overall Study|Lost to Follow-up|3|||
163957545|NCT01138007|592215981|FG002|Overall Study|Lost to Follow-up|5|||
163957546|NCT01138007|592215979|FG000|Overall Study|Physician Decision|0|||
163957547|NCT01138007|592215980|FG001|Overall Study|Physician Decision|5|||
163957548|NCT01138007|592215981|FG002|Overall Study|Physician Decision|3|||
163957549|NCT01138007|592215979|FG000|Overall Study|Withdrawal by Subject|5|||
163957550|NCT01138007|592215980|FG001|Overall Study|Withdrawal by Subject|6|||
163957551|NCT01138007|592215981|FG002|Overall Study|Withdrawal by Subject|15|||
163957552|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
163957553|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
163957554|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
163957555|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
163957556|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
163957557|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
163957558|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
163957559|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
163957560|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
163957561|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
163957562|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
163957563|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
163957564|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
163957565|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
163957566|NCT03548987|592215982|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
163957567|NCT03548987|592215983|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
163957568|NCT03548987|592215982|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
163957569|NCT03548987|592215983|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
163957570|NCT03548987|592215982|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
163957571|NCT03548987|592215983|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
163957572|NCT03548987|592215982|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
163957573|NCT03548987|592215983|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
163957574|NCT03548987|592215982|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
163957575|NCT03548987|592215983|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
163957576|NCT03548987|592215982|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
163957577|NCT03548987|592215983|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
163957578|NCT03548987|592215982|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
163957579|NCT03548987|592215983|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
163957580|NCT04572841|592215984|FG000|Overall Study|Adverse Event|1|||
163957581|NCT04572841|592215985|FG001|Overall Study|Adverse Event|1|||
163957582|NCT04572841|592215984|FG000|Overall Study|Withdrawal by Subject|2|||
163957583|NCT04572841|592215985|FG001|Overall Study|Withdrawal by Subject|1|||
163957584|NCT04661878|592215986|FG000|Overall Study|Lost to Follow-up|6|||
163957585|NCT04661878|592215987|FG001|Overall Study|Lost to Follow-up|5|||
163957586|NCT00712673|592215992|FG000|Overall Study|Adverse Event|3|||
163957587|NCT00712673|592215993|FG001|Overall Study|Adverse Event|3|||
163957588|NCT00712673|592215994|FG002|Overall Study|Adverse Event|21|||
163957589|NCT00712673|592215995|FG003|Overall Study|Adverse Event|26|||
163957590|NCT00712673|592215992|FG000|Overall Study|Lack of Efficacy|2|||
163957591|NCT00712673|592215993|FG001|Overall Study|Lack of Efficacy|8|||
163957592|NCT00712673|592215994|FG002|Overall Study|Lack of Efficacy|8|||
163957593|NCT00712673|592215995|FG003|Overall Study|Lack of Efficacy|6|||
163957594|NCT00712673|592215992|FG000|Overall Study|Poor Compliance to Protocol|3|||
163957595|NCT00712673|592215993|FG001|Overall Study|Poor Compliance to Protocol|3|||
163957596|NCT00712673|592215994|FG002|Overall Study|Poor Compliance to Protocol|4|||
163957597|NCT00712673|592215995|FG003|Overall Study|Poor Compliance to Protocol|16|||
163957598|NCT00712673|592215992|FG000|Overall Study|Lost to Follow-up|1|||
163957599|NCT00712673|592215993|FG001|Overall Study|Lost to Follow-up|0|||
163957600|NCT00712673|592215994|FG002|Overall Study|Lost to Follow-up|2|||
163957601|NCT00712673|592215995|FG003|Overall Study|Lost to Follow-up|0|||
163957602|NCT00712673|592215992|FG000|Overall Study|Withdrawal by Subject|6|||
163957603|NCT00712673|592215993|FG001|Overall Study|Withdrawal by Subject|7|||
163957604|NCT00712673|592215994|FG002|Overall Study|Withdrawal by Subject|15|||
163957605|NCT00712673|592215995|FG003|Overall Study|Withdrawal by Subject|20|||
163957606|NCT00712673|592215992|FG000|Overall Study|Familial and Personal Reasons|5|||
163957607|NCT00712673|592215993|FG001|Overall Study|Familial and Personal Reasons|0|||
163957608|NCT00712673|592215994|FG002|Overall Study|Familial and Personal Reasons|5|||
163957609|NCT00712673|592215995|FG003|Overall Study|Familial and Personal Reasons|2|||
163957610|NCT00712673|592215992|FG000|Overall Study|Investigator's Decision|1|||
163957611|NCT00712673|592215993|FG001|Overall Study|Investigator's Decision|0|||
163957612|NCT00712673|592215994|FG002|Overall Study|Investigator's Decision|0|||
163957613|NCT00712673|592215995|FG003|Overall Study|Investigator's Decision|0|||
163957614|NCT00712673|592215992|FG000|Overall Study|Protocol Violation|0|||
163957615|NCT00712673|592215993|FG001|Overall Study|Protocol Violation|0|||
163957616|NCT00712673|592215994|FG002|Overall Study|Protocol Violation|2|||
163957617|NCT00712673|592215995|FG003|Overall Study|Protocol Violation|0|||
163957618|NCT01323647|592215996|FG000|Overall Study|Migrated/moved from study area|2|||
164048174|NCT02943577|592536029|FG000|Overall Study|Adverse Event|3|||
163957619|NCT01323647|592215997|FG001|Overall Study|Migrated/moved from study area|0|||
163957620|NCT01323647|592215996|FG000|Overall Study|Withdrawal by Subject|5|||
163957621|NCT01323647|592215997|FG001|Overall Study|Withdrawal by Subject|0|||
163957622|NCT01323647|592215996|FG000|Overall Study|Lost to Follow-up|2|||
163957623|NCT01323647|592215997|FG001|Overall Study|Lost to Follow-up|0|||
163957624|NCT03603028|592215998|FG000|Overall Study|Withdrawal by Subject|1|||
163957625|NCT02768870|592216001|FG000|Overall Study|Death|1|||
163957626|NCT02768870|592216001|FG000|Overall Study|Reoperation|6|||
163957627|NCT02768870|592216001|FG000|Overall Study|Lost to Follow-up|1|||
163957628|NCT02768870|592216001|FG000|Overall Study|Exit|4|||
163957629|NCT02963610|592216002|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
163957630|NCT02203695|592216003|FG000|Overall Study|Patient withdrew consent|1|||
163957631|NCT02203695|592216004|FG001|Overall Study|Patient withdrew consent|1|||
163957632|NCT02203695|592216003|FG000|Overall Study|Started non-study treatment|1|||
163957633|NCT02203695|592216004|FG001|Overall Study|Started non-study treatment|0|||
163957634|NCT00640016|592216005|FG000|Overall Study|Withdrawal by Subject|0|||
163957635|NCT00640016|592216006|FG001|Overall Study|Withdrawal by Subject|1|||
163957636|NCT00640016|592216007|FG002|Overall Study|Withdrawal by Subject|0|||
163957637|NCT00640016|592216008|FG003|Overall Study|Withdrawal by Subject|0|||
163957638|NCT00640016|592216005|FG000|Overall Study|Study termination|2|||
163957639|NCT00640016|592216006|FG001|Overall Study|Study termination|1|||
163957640|NCT00640016|592216007|FG002|Overall Study|Study termination|3|||
163957641|NCT00640016|592216008|FG003|Overall Study|Study termination|2|||
163957642|NCT00640016|592216005|FG000|Overall Study|Adverse Event|0|||
163957643|NCT00640016|592216006|FG001|Overall Study|Adverse Event|0|||
163957644|NCT00640016|592216007|FG002|Overall Study|Adverse Event|0|||
163957645|NCT00640016|592216008|FG003|Overall Study|Adverse Event|1|||
163957646|NCT00846391|592216009|FG000|Overall Study|Physician Decision|0|||
163957647|NCT00846391|592216010|FG001|Overall Study|Physician Decision|0|||
163957648|NCT00846391|592216011|FG002|Overall Study|Physician Decision|1|||
163957649|NCT00846391|592216009|FG000|Overall Study|Study Terminated by Sponsor|1|||
163957650|NCT00846391|592216010|FG001|Overall Study|Study Terminated by Sponsor|2|||
163957651|NCT00846391|592216011|FG002|Overall Study|Study Terminated by Sponsor|2|||
163957652|NCT01287065|592216012|FG000|Treatment Period 1|Adverse Event|0|||
163957653|NCT01287065|592216013|FG001|Treatment Period 1|Adverse Event|0|||
163957654|NCT01287065|592216014|FG002|Treatment Period 1|Adverse Event|0|||
163957655|NCT01287065|592216015|FG003|Treatment Period 1|Adverse Event|0|||
163957656|NCT01287065|592216016|FG004|Treatment Period 1|Adverse Event|1|||
163957657|NCT01287065|592216017|FG005|Treatment Period 1|Adverse Event|0|||
163957658|NCT01287065|592216012|FG000|Treatment Period 1|Withdrawal by Subject|0|||
163957659|NCT01287065|592216013|FG001|Treatment Period 1|Withdrawal by Subject|0|||
163957660|NCT01287065|592216014|FG002|Treatment Period 1|Withdrawal by Subject|0|||
163957661|NCT01287065|592216015|FG003|Treatment Period 1|Withdrawal by Subject|0|||
163957662|NCT01287065|592216016|FG004|Treatment Period 1|Withdrawal by Subject|0|||
163957663|NCT01287065|592216017|FG005|Treatment Period 1|Withdrawal by Subject|1|||
163957664|NCT01580969|592216020|FG000|Overall Study|Physician Decision|3|||
163957665|NCT01580969|592216021|FG001|Overall Study|Physician Decision|0|||
163957666|NCT01580969|592216022|FG002|Overall Study|Physician Decision|0|||
163957667|NCT02019927|592216025|FG000|Overall Study|Lost to Follow-up|2|||
163957668|NCT02019927|592216026|FG001|Overall Study|Lost to Follow-up|4|||
163957669|NCT02019927|592216027|FG002|Overall Study|Lost to Follow-up|1|||
163957670|NCT02019927|592216028|FG003|Overall Study|Lost to Follow-up|2|||
163957671|NCT02019927|592216029|FG004|Overall Study|Lost to Follow-up|3|||
163957672|NCT02019927|592216030|FG005|Overall Study|Lost to Follow-up|1|||
163957673|NCT03181451|592216035|FG000|Overall Study|Adverse Event|0|||
163957674|NCT03181451|592216036|FG001|Overall Study|Adverse Event|1|||
163957675|NCT03181451|592216037|FG002|Overall Study|Adverse Event|0|||
163957676|NCT03181451|592216035|FG000|Overall Study|Withdrawal by Subject|0|||
163957677|NCT03181451|592216036|FG001|Overall Study|Withdrawal by Subject|1|||
163957678|NCT03181451|592216037|FG002|Overall Study|Withdrawal by Subject|0|||
163957679|NCT01259284|592216044|FG000|Overall Study|Study Termination|2|||
163957680|NCT01259284|592216045|FG001|Overall Study|Study Termination|0|||
163957681|NCT01259284|592216046|FG002|Overall Study|Study Termination|0|||
163957682|NCT00069238|592216047|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
163957683|NCT00069238|592216048|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
163957684|NCT00069238|592216049|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
163957685|NCT00069238|592216047|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
163957686|NCT00069238|592216048|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
163957687|NCT00069238|592216049|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
163957688|NCT00069238|592216047|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
163957689|NCT00069238|592216048|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
163957690|NCT00069238|592216049|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
163957691|NCT01326533|592216054|FG000|Overall Study|Lost to Follow-up|2|||
163957692|NCT01326533|592216055|FG001|Overall Study|Lost to Follow-up|0|||
164048175|NCT02943577|592536030|FG001|Overall Study|Adverse Event|2|||
163957693|NCT01326533|592216054|FG000|Overall Study|Withdrawal by Subject|1|||
163957694|NCT01326533|592216055|FG001|Overall Study|Withdrawal by Subject|0|||
163957695|NCT01326533|592216054|FG000|Overall Study|Adverse Event|1|||
163957696|NCT01326533|592216055|FG001|Overall Study|Adverse Event|0|||
163957697|NCT03353350|592216056|FG000|30-week Core Treatment Period|Protocol Violation|1|||
163957698|NCT03353350|592216057|FG001|30-week Core Treatment Period|Protocol Violation|1|||
163957699|NCT03353350|592216058|FG002|30-week Core Treatment Period|Protocol Violation|1|||
163957700|NCT03353350|592216059|FG003|30-week Core Treatment Period|Protocol Violation|0|||
163957701|NCT03353350|592216056|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
163957702|NCT03353350|592216057|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
163957703|NCT03353350|592216058|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
163957704|NCT03353350|592216059|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
163957705|NCT03353350|592216056|FG000|30-week Core Treatment Period|Adverse Event|0|||
163957706|NCT03353350|592216057|FG001|30-week Core Treatment Period|Adverse Event|4|||
163957707|NCT03353350|592216058|FG002|30-week Core Treatment Period|Adverse Event|2|||
163957708|NCT03353350|592216059|FG003|30-week Core Treatment Period|Adverse Event|3|||
163957709|NCT03353350|592216056|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
163957710|NCT03353350|592216057|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
163957711|NCT03353350|592216058|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
163957712|NCT03353350|592216059|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
163957713|NCT03353350|592216056|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
163957714|NCT03353350|592216057|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
163957715|NCT03353350|592216058|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
163957716|NCT03353350|592216059|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
163957717|NCT03353350|592216056|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
163957718|NCT03353350|592216057|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
163957719|NCT03353350|592216058|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
163957720|NCT03353350|592216059|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
163957721|NCT03353350|592216056|FG000|26-week Treatment Extension Period|Adverse Event|1|||
163957722|NCT03353350|592216057|FG001|26-week Treatment Extension Period|Adverse Event|0|||
163957723|NCT03353350|592216058|FG002|26-week Treatment Extension Period|Adverse Event|0|||
163957724|NCT03353350|592216059|FG003|26-week Treatment Extension Period|Adverse Event|1|||
163957725|NCT03353350|592216056|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
163957726|NCT03353350|592216057|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
163957727|NCT03353350|592216058|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
163957728|NCT03353350|592216059|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
163957729|NCT01012713|592216063|FG000|Overall Study|Lack of Efficacy|3|||
163957730|NCT02409368|592216067|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
163957731|NCT02409368|592216068|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
163957732|NCT02409368|592216069|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
163957733|NCT02409368|592216070|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
163957734|NCT02409368|592216067|FG000|ECOG Reclassification|Death|1|||
163957735|NCT02409368|592216068|FG001|ECOG Reclassification|Death|5|||
163957736|NCT02409368|592216069|FG002|ECOG Reclassification|Death|0|||
163957737|NCT02409368|592216070|FG003|ECOG Reclassification|Death|0|||
163957738|NCT02409368|592216067|FG000|ECOG Reclassification|Disease Progression|113|||
163957739|NCT02409368|592216068|FG001|ECOG Reclassification|Disease Progression|382|||
163957740|NCT02409368|592216069|FG002|ECOG Reclassification|Disease Progression|70|||
163957741|NCT02409368|592216070|FG003|ECOG Reclassification|Disease Progression|1|||
163957742|NCT02409368|592216067|FG000|ECOG Reclassification|Lost to Follow-up|1|||
163957743|NCT02409368|592216068|FG001|ECOG Reclassification|Lost to Follow-up|5|||
163957744|NCT02409368|592216069|FG002|ECOG Reclassification|Lost to Follow-up|0|||
163957745|NCT02409368|592216070|FG003|ECOG Reclassification|Lost to Follow-up|0|||
163957746|NCT02409368|592216067|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
163957747|NCT02409368|592216068|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
163957748|NCT02409368|592216069|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
163957749|NCT02409368|592216070|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
163957750|NCT02409368|592216067|FG000|ECOG Reclassification|Poor/non-compliance|0|||
163957751|NCT02409368|592216068|FG001|ECOG Reclassification|Poor/non-compliance|3|||
163957752|NCT02409368|592216069|FG002|ECOG Reclassification|Poor/non-compliance|2|||
163957753|NCT02409368|592216070|FG003|ECOG Reclassification|Poor/non-compliance|0|||
163957754|NCT02409368|592216067|FG000|ECOG Reclassification|Study drug toxicity|17|||
163957755|NCT02409368|592216068|FG001|ECOG Reclassification|Study drug toxicity|42|||
163957756|NCT02409368|592216069|FG002|ECOG Reclassification|Study drug toxicity|7|||
163957757|NCT02409368|592216070|FG003|ECOG Reclassification|Study drug toxicity|0|||
163957758|NCT02409368|592216067|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
163957759|NCT02409368|592216068|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
163957760|NCT02409368|592216069|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
163957761|NCT02409368|592216070|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
163957762|NCT02409368|592216067|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
163957763|NCT02409368|592216068|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
163957764|NCT02409368|592216069|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
163957765|NCT02409368|592216070|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
163957766|NCT02409368|592216067|FG000|ECOG Reclassification|Participant withdrew consent|2|||
163957767|NCT02409368|592216068|FG001|ECOG Reclassification|Participant withdrew consent|3|||
163957768|NCT02409368|592216069|FG002|ECOG Reclassification|Participant withdrew consent|4|||
163957769|NCT02409368|592216070|FG003|ECOG Reclassification|Participant withdrew consent|0|||
163957770|NCT02409368|592216067|FG000|ECOG Reclassification|Other Reasons|5|||
163957771|NCT02409368|592216068|FG001|ECOG Reclassification|Other Reasons|26|||
163957772|NCT02409368|592216069|FG002|ECOG Reclassification|Other Reasons|2|||
163957773|NCT02409368|592216070|FG003|ECOG Reclassification|Other Reasons|0|||
163957774|NCT02409368|592216067|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
163957775|NCT02409368|592216068|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
163957776|NCT02409368|592216069|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
163957777|NCT02409368|592216070|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
163957778|NCT01296347|592216071|FG000|Allocation|Withdrawal by Subject|1|||
163957779|NCT01296347|592216072|FG001|Allocation|Withdrawal by Subject|2|||
163957780|NCT01296347|592216071|FG000|Allocation|Lack of Efficacy|1|||
163957781|NCT01296347|592216072|FG001|Allocation|Lack of Efficacy|2|||
163957782|NCT01296347|592216071|FG000|Allocation|not received infusion|1|||
163957783|NCT01296347|592216072|FG001|Allocation|not received infusion|0|||
163957784|NCT01296347|592216071|FG000|6 Week Follow up|Death|0|||
163957785|NCT01296347|592216072|FG001|6 Week Follow up|Death|1|||
163957786|NCT01296347|592216071|FG000|3 Month Follow up|Death|1|||
163957787|NCT01296347|592216072|FG001|3 Month Follow up|Death|0|||
163957788|NCT01296347|592216071|FG000|3 Month Follow up|Lost to Follow-up|0|||
163957789|NCT01296347|592216072|FG001|3 Month Follow up|Lost to Follow-up|1|||
163957790|NCT01296347|592216071|FG000|6 Month Follow up|Death|2|||
163957791|NCT01296347|592216072|FG001|6 Month Follow up|Death|1|||
163957792|NCT01296347|592216071|FG000|6 Month Follow up|Lost to Follow-up|0|||
163957793|NCT01296347|592216072|FG001|6 Month Follow up|Lost to Follow-up|1|||
163957794|NCT01296347|592216071|FG000|12 Month Follow up|Lost to Follow-up|3|||
163957795|NCT01296347|592216072|FG001|12 Month Follow up|Lost to Follow-up|1|||
163957796|NCT01296347|592216071|FG000|12 Month Follow up|Death|1|||
163957797|NCT01296347|592216072|FG001|12 Month Follow up|Death|1|||
163957798|NCT01296347|592216071|FG000|12 Month Follow up|Withdrawal by Subject|0|||
163957799|NCT01296347|592216072|FG001|12 Month Follow up|Withdrawal by Subject|1|||
163957800|NCT03343301|592216073|FG000|Overall Study|Withdrawal by Subject|1|||
163957801|NCT03343301|592216074|FG001|Overall Study|Withdrawal by Subject|1|||
163957802|NCT03343301|592216073|FG000|Overall Study|Death|0|||
163957803|NCT03343301|592216074|FG001|Overall Study|Death|2|||
163957804|NCT03343301|592216073|FG000|Overall Study|Other|0|||
163957805|NCT03343301|592216074|FG001|Overall Study|Other|6|||
163957806|NCT03343301|592216073|FG000|Overall Study|Missing|2|||
163957807|NCT03343301|592216074|FG001|Overall Study|Missing|0|||
163957808|NCT02668185|592216077|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
163957809|NCT02668185|592216078|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
163957810|NCT02668185|592216077|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
163957811|NCT02668185|592216078|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
163957812|NCT02668185|592216077|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
163957813|NCT02668185|592216078|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
163957814|NCT02668185|592216077|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
163957815|NCT02668185|592216078|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
163957816|NCT01013597|592216079|FG000|Overall Study|Withdrawal by Subject|1|||
163957817|NCT02678247|592216080|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
163957818|NCT02678247|592216081|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
163957819|NCT02678247|592216080|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
163957820|NCT02678247|592216081|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
163957821|NCT02678247|592216080|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
163957822|NCT02678247|592216081|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
163957823|NCT02678247|592216080|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
163957824|NCT02678247|592216081|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
163957825|NCT02678247|592216080|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
163957826|NCT02678247|592216081|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
163957827|NCT02678247|592216080|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
163957828|NCT02678247|592216081|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
163957829|NCT02425644|592217598|FG000|Overall Study|Lost to Follow-up|2|||
163957830|NCT02425644|592217599|FG001|Overall Study|Lost to Follow-up|3|||
163957831|NCT02425644|592217598|FG000|Overall Study|Withdrawal by Subject|41|||
163957832|NCT02425644|592217599|FG001|Overall Study|Withdrawal by Subject|36|||
163957833|NCT02425644|592217598|FG000|Overall Study|Lack of Efficacy|3|||
163957834|NCT02425644|592217599|FG001|Overall Study|Lack of Efficacy|10|||
163957835|NCT02425644|592217598|FG000|Overall Study|Adverse Event|13|||
163957836|NCT02425644|592217599|FG001|Overall Study|Adverse Event|3|||
163957837|NCT02425644|592217598|FG000|Overall Study|Death|0|||
163957838|NCT02425644|592217599|FG001|Overall Study|Death|2|||
163957839|NCT02425644|592217598|FG000|Overall Study|Other|18|||
163957840|NCT02425644|592217599|FG001|Overall Study|Other|17|||
163957841|NCT02720536|592217600|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
163957842|NCT02720536|592217600|FG000|Overall Study|PR - pregnancy|2|||
163957843|NCT02720536|592217600|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
163957844|NCT02720536|592217600|FG000|Overall Study|PR - death|1|||
163957845|NCT02720536|592217600|FG000|Overall Study|PR - adverse event|1|||
163957846|NCT02720536|592217600|FG000|Overall Study|PR - abnormal lab value(s)|1|||
163957847|NCT02720536|592217600|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
163957848|NCT02525861|592217601|FG000|Overall Study|Adverse Event|1|||
163957849|NCT02525861|592217602|FG001|Overall Study|Adverse Event|0|||
163957850|NCT02525861|592217601|FG000|Overall Study|Withdrawal by Subject|0|||
163957851|NCT02525861|592217602|FG001|Overall Study|Withdrawal by Subject|1|||
163957852|NCT02525861|592217601|FG000|Overall Study|Physician Decision|0|||
163957853|NCT02525861|592217602|FG001|Overall Study|Physician Decision|1|||
163957854|NCT01607554|592217606|FG000|Overall Study|Disease progression|2|||
163957855|NCT05580588|592217607|FG000|Overall Study|Lack of Efficacy|12|||
163957856|NCT00756470|592217610|FG000|Overall Study|Withdrawal by Subject|1|||
163957857|NCT00756470|592217610|FG000|Overall Study|Adverse Event|4|||
163957858|NCT00325039|592217611|FG000|Overall Study|Lost to Follow-up|18|||
163957859|NCT00325039|592217612|FG001|Overall Study|Lost to Follow-up|14|||
163957860|NCT01009203|592217614|FG000|Overall Study|Withdrawal by Subject|1|||
163957861|NCT01009203|592217614|FG000|Overall Study|Adverse Event|5|||
163957862|NCT01009203|592217614|FG000|Overall Study|Treatment-unrelated death|1|||
163957863|NCT02974088|592217618|FG000|Overall Study|Lost to Follow-up|0|||
163957864|NCT02974088|592217619|FG001|Overall Study|Lost to Follow-up|2|||
163957865|NCT02974088|592217618|FG000|Overall Study|Adverse Event|0|||
163957866|NCT02974088|592217619|FG001|Overall Study|Adverse Event|1|||
163957867|NCT00892723|592217620|FG000|Overall Study|Lost to Follow-up|1|||
163957868|NCT00892723|592217621|FG001|Overall Study|Lost to Follow-up|3|||
163957869|NCT00892723|592217622|FG002|Overall Study|Lost to Follow-up|1|||
163957870|NCT00892723|592217620|FG000|Overall Study|Withdrawal by Subject|1|||
163957871|NCT00892723|592217621|FG001|Overall Study|Withdrawal by Subject|1|||
163957872|NCT00892723|592217622|FG002|Overall Study|Withdrawal by Subject|1|||
163957873|NCT01032382|592217623|FG000|Overall Study|Disease dissemination|1|||
163957874|NCT01032382|592217624|FG001|Overall Study|Disease dissemination|1|||
163957875|NCT01032382|592217623|FG000|Overall Study|Treatment failure|3|||
163957876|NCT01032382|592217624|FG001|Overall Study|Treatment failure|1|||
163957877|NCT01032382|592217623|FG000|Overall Study|Index lesion relapse|1|||
163957878|NCT01032382|592217624|FG001|Overall Study|Index lesion relapse|3|||
163957879|NCT00985153|592217625|FG000|Overall Study|Lost to Follow-up|16|||
163957880|NCT00985153|592217626|FG001|Overall Study|Lost to Follow-up|19|||
163957881|NCT00985153|592217627|FG002|Overall Study|Lost to Follow-up|17|||
163957882|NCT00985153|592217628|FG003|Overall Study|Lost to Follow-up|20|||
163957883|NCT00985153|592217625|FG000|Overall Study|Protocol Violation|3|||
163957884|NCT00985153|592217626|FG001|Overall Study|Protocol Violation|2|||
163957885|NCT00985153|592217627|FG002|Overall Study|Protocol Violation|4|||
163957886|NCT00985153|592217628|FG003|Overall Study|Protocol Violation|3|||
163957887|NCT00985153|592217625|FG000|Overall Study|Withdrawal by Subject|6|||
163957888|NCT00985153|592217626|FG001|Overall Study|Withdrawal by Subject|11|||
163957889|NCT00985153|592217627|FG002|Overall Study|Withdrawal by Subject|11|||
163957890|NCT00985153|592217628|FG003|Overall Study|Withdrawal by Subject|10|||
163957891|NCT00985153|592217625|FG000|Overall Study|Missed One or More Bleeds|7|||
163957892|NCT00985153|592217626|FG001|Overall Study|Missed One or More Bleeds|7|||
163957893|NCT00985153|592217627|FG002|Overall Study|Missed One or More Bleeds|8|||
163957894|NCT00985153|592217628|FG003|Overall Study|Missed One or More Bleeds|10|||
163957895|NCT00985153|592217625|FG000|Overall Study|Incomplete Safety Follow-up|3|||
163957896|NCT00985153|592217626|FG001|Overall Study|Incomplete Safety Follow-up|5|||
163957897|NCT00985153|592217627|FG002|Overall Study|Incomplete Safety Follow-up|4|||
163957898|NCT00985153|592217628|FG003|Overall Study|Incomplete Safety Follow-up|4|||
163957899|NCT01679405|592217630|FG000|Overall Study|Death|2|||
163957900|NCT01679405|592217631|FG001|Overall Study|Death|5|||
163957901|NCT04508023|592217632|FG000|Overall Study|Withdrawal by Subject|1|||
163957902|NCT04508023|592217633|FG001|Overall Study|Withdrawal by Subject|2|||
163957903|NCT01668667|592217642|FG000|Overall Study|Adverse Event|3|||
163957904|NCT01668667|592217643|FG001|Overall Study|Adverse Event|6|||
163957905|NCT01668667|592217644|FG002|Overall Study|Adverse Event|4|||
163957906|NCT01668667|592217645|FG003|Overall Study|Adverse Event|4|||
163957907|NCT01668667|592217642|FG000|Overall Study|Lack of Efficacy|3|||
163957908|NCT01668667|592217643|FG001|Overall Study|Lack of Efficacy|2|||
163957909|NCT01668667|592217644|FG002|Overall Study|Lack of Efficacy|2|||
163957910|NCT01668667|592217645|FG003|Overall Study|Lack of Efficacy|3|||
163957911|NCT01668667|592217642|FG000|Overall Study|Protocol Violation|6|||
163957912|NCT01668667|592217643|FG001|Overall Study|Protocol Violation|10|||
163957913|NCT01668667|592217644|FG002|Overall Study|Protocol Violation|12|||
163957914|NCT01668667|592217645|FG003|Overall Study|Protocol Violation|5|||
163957915|NCT01668667|592217642|FG000|Overall Study|Lost to Follow-up|9|||
163957916|NCT01668667|592217643|FG001|Overall Study|Lost to Follow-up|4|||
163957917|NCT01668667|592217644|FG002|Overall Study|Lost to Follow-up|7|||
163957918|NCT01668667|592217645|FG003|Overall Study|Lost to Follow-up|6|||
163957919|NCT01668667|592217642|FG000|Overall Study|Physician Decision|3|||
163957920|NCT01668667|592217643|FG001|Overall Study|Physician Decision|0|||
163957921|NCT01668667|592217644|FG002|Overall Study|Physician Decision|1|||
163957922|NCT01668667|592217645|FG003|Overall Study|Physician Decision|0|||
163957923|NCT01668667|592217642|FG000|Overall Study|Withdrawal by Subject|7|||
163957924|NCT01668667|592217643|FG001|Overall Study|Withdrawal by Subject|4|||
163957925|NCT01668667|592217644|FG002|Overall Study|Withdrawal by Subject|5|||
163957926|NCT01668667|592217645|FG003|Overall Study|Withdrawal by Subject|5|||
163957927|NCT02988622|592217646|FG000|Overall Study|Lost to Follow-up|17|||
163957928|NCT03562247|592217647|FG000|Overall Study|Lost to Follow-up|3|||
163957929|NCT03562247|592217648|FG001|Overall Study|Lost to Follow-up|1|||
163957930|NCT03562247|592217649|FG002|Overall Study|Lost to Follow-up|1|||
163957931|NCT01281969|592217652|FG000|Overall Study|not randomized didn't meet criteria|0|||
163957932|NCT01281969|592217653|FG001|Overall Study|not randomized didn't meet criteria|0|||
163957933|NCT01281969|592217654|FG002|Overall Study|not randomized didn't meet criteria|7|||
163957934|NCT01281969|592217652|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
163957935|NCT01281969|592217653|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
163957936|NCT01281969|592217654|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
163957937|NCT01281969|592217652|FG000|Overall Study|not randomized, child consent not given|0|||
163957938|NCT01281969|592217653|FG001|Overall Study|not randomized, child consent not given|0|||
163957939|NCT01281969|592217654|FG002|Overall Study|not randomized, child consent not given|2|||
163957940|NCT04640077|592217655|FG000|Period 1|Withdrawal by Subject|4|||
163957941|NCT04640077|592217656|FG001|Period 1|Withdrawal by Subject|5|||
163957942|NCT04640077|592217657|FG002|Period 1|Withdrawal by Subject|0|||
163957943|NCT04640077|592217655|FG000|Period 1|Adverse Event|1|||
163957944|NCT04640077|592217656|FG001|Period 1|Adverse Event|1|||
163957945|NCT04640077|592217657|FG002|Period 1|Adverse Event|0|||
163957946|NCT04640077|592217655|FG000|Period 1|Screen Failure|2|||
163957947|NCT04640077|592217656|FG001|Period 1|Screen Failure|0|||
163957948|NCT04640077|592217657|FG002|Period 1|Screen Failure|0|||
163957949|NCT04640077|592217655|FG000|Period 2|Withdrawal by Subject|0|||
163957950|NCT04640077|592217656|FG001|Period 2|Withdrawal by Subject|0|||
163957951|NCT04640077|592217657|FG002|Period 2|Withdrawal by Subject|18|||
163957952|NCT04640077|592217655|FG000|Period 2|Adverse Event|0|||
163957953|NCT04640077|592217656|FG001|Period 2|Adverse Event|0|||
163957954|NCT04640077|592217657|FG002|Period 2|Adverse Event|6|||
163957955|NCT04640077|592217655|FG000|Period 2|Lost to Follow-up|0|||
163957956|NCT04640077|592217656|FG001|Period 2|Lost to Follow-up|0|||
163957957|NCT04640077|592217657|FG002|Period 2|Lost to Follow-up|2|||
163957958|NCT04640077|592217655|FG000|Period 2|Death|0|||
163957959|NCT04640077|592217656|FG001|Period 2|Death|0|||
163957960|NCT04640077|592217657|FG002|Period 2|Death|2|||
163957961|NCT04640077|592217655|FG000|Period 2|Progressive Disease|0|||
163957962|NCT04640077|592217656|FG001|Period 2|Progressive Disease|0|||
163957963|NCT04640077|592217657|FG002|Period 2|Progressive Disease|1|||
163957964|NCT04640077|592217655|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
163957965|NCT04640077|592217656|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
163957966|NCT04640077|592217657|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
163957967|NCT02240693|592217658|FG000|Overall Study|Adverse Event|0|||
163957968|NCT02240693|592217659|FG001|Overall Study|Adverse Event|0|||
163957969|NCT02240693|592217660|FG002|Overall Study|Adverse Event|0|||
163957970|NCT02240693|592217661|FG003|Overall Study|Adverse Event|0|||
163957971|NCT02240693|592217662|FG004|Overall Study|Adverse Event|1|||
163957972|NCT02240693|592217658|FG000|Overall Study|Withdrawal by Subject|0|||
163957973|NCT02240693|592217659|FG001|Overall Study|Withdrawal by Subject|0|||
163957974|NCT02240693|592217660|FG002|Overall Study|Withdrawal by Subject|2|||
163957975|NCT02240693|592217661|FG003|Overall Study|Withdrawal by Subject|1|||
163957976|NCT02240693|592217662|FG004|Overall Study|Withdrawal by Subject|0|||
163957977|NCT02240693|592217658|FG000|Overall Study|Other than specified|0|||
163957978|NCT02240693|592217659|FG001|Overall Study|Other than specified|0|||
163957979|NCT02240693|592217660|FG002|Overall Study|Other than specified|2|||
163957980|NCT02240693|592217661|FG003|Overall Study|Other than specified|0|||
163957981|NCT02240693|592217662|FG004|Overall Study|Other than specified|0|||
163957982|NCT02041520|592217663|FG000|Overall Study|Adverse Event|2|||
163957983|NCT02041520|592217664|FG001|Overall Study|Adverse Event|1|||
163957984|NCT02041520|592217663|FG000|Overall Study|Withdrawal by Subject|3|||
163957985|NCT02041520|592217664|FG001|Overall Study|Withdrawal by Subject|4|||
163957986|NCT02041520|592217663|FG000|Overall Study|Protocol Violation|1|||
163957987|NCT02041520|592217664|FG001|Overall Study|Protocol Violation|0|||
163957988|NCT02041520|592217663|FG000|Overall Study|Lost to Follow-up|0|||
163957989|NCT02041520|592217664|FG001|Overall Study|Lost to Follow-up|1|||
163957990|NCT02041520|592217663|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
163957991|NCT02041520|592217664|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
163957992|NCT00413972|592217665|FG000|Overall Study|Adverse Event|2|||
163957993|NCT00413972|592217666|FG001|Overall Study|Adverse Event|1|||
163957994|NCT00413972|592217667|FG002|Overall Study|Adverse Event|0|||
163957995|NCT00413972|592217668|FG003|Overall Study|Adverse Event|0|||
163957996|NCT00413972|592217665|FG000|Overall Study|Lost to Follow-up|1|||
163957997|NCT00413972|592217666|FG001|Overall Study|Lost to Follow-up|2|||
163957998|NCT00413972|592217667|FG002|Overall Study|Lost to Follow-up|1|||
163957999|NCT00413972|592217668|FG003|Overall Study|Lost to Follow-up|0|||
163958000|NCT00413972|592217665|FG000|Overall Study|Withdrawal by Subject|4|||
163958001|NCT00413972|592217666|FG001|Overall Study|Withdrawal by Subject|5|||
163958002|NCT00413972|592217667|FG002|Overall Study|Withdrawal by Subject|7|||
163958003|NCT00413972|592217668|FG003|Overall Study|Withdrawal by Subject|2|||
163958004|NCT00413972|592217665|FG000|Overall Study|Protocol Violation|0|||
163958005|NCT00413972|592217666|FG001|Overall Study|Protocol Violation|0|||
163958006|NCT00413972|592217667|FG002|Overall Study|Protocol Violation|2|||
163958007|NCT00413972|592217668|FG003|Overall Study|Protocol Violation|0|||
163958008|NCT00413972|592217665|FG000|Overall Study|Other|0|||
163958009|NCT00413972|592217666|FG001|Overall Study|Other|0|||
163958010|NCT00413972|592217667|FG002|Overall Study|Other|0|||
163958011|NCT00413972|592217668|FG003|Overall Study|Other|1|||
163958012|NCT00427895|592217671|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958013|NCT00427895|592217672|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958014|NCT00427895|592217673|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958015|NCT00427895|592217674|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
163958016|NCT00427895|592217675|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958017|NCT00427895|592217676|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958018|NCT00427895|592217677|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958019|NCT00427895|592217678|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
163958020|NCT00427895|592217671|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958021|NCT00427895|592217672|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958022|NCT00427895|592217673|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958023|NCT00427895|592217674|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958024|NCT00427895|592217675|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958025|NCT00427895|592217676|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958026|NCT00427895|592217677|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
163958027|NCT00427895|592217678|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
163958028|NCT00427895|592217671|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958029|NCT00427895|592217672|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958030|NCT00427895|592217673|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958031|NCT00427895|592217674|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958032|NCT00427895|592217675|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958033|NCT00427895|592217676|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958034|NCT00427895|592217677|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
163958035|NCT00427895|592217678|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
163958036|NCT00427895|592217671|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
163958037|NCT00427895|592217672|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
163958038|NCT00427895|592217673|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
163958039|NCT00427895|592217674|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
163958040|NCT00427895|592217675|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
163958041|NCT00427895|592217676|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
163958042|NCT00427895|592217677|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
163958043|NCT00427895|592217678|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
163958044|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163958045|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
163958046|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
163958047|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
163958048|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163958049|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163958050|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163958051|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
163958052|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
163958053|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163958054|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
163958055|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
163958056|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
164048176|NCT02943577|592536029|FG000|Overall Study|Lost to Follow-up|0|||
164048177|NCT02943577|592536030|FG001|Overall Study|Lost to Follow-up|1|||
164048178|NCT02943577|592536029|FG000|Overall Study|Withdrawal by Subject|1|||
163958057|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163958058|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163958059|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
163958060|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
164048179|NCT02943577|592536030|FG001|Overall Study|Withdrawal by Subject|1|||
164048180|NCT02943577|592536029|FG000|Overall Study|Pregnancy|1|||
164048181|NCT02943577|592536030|FG001|Overall Study|Pregnancy|0|||
164048182|NCT03991936|592536035|FG000|Overall Study|Lost to Follow-up|1|||
163958061|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
163958062|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163958063|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163958064|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163958065|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163958066|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163958067|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
163958068|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
163958069|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
163958070|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
163958071|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
163958072|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163958073|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163958074|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163958075|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
163958076|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958077|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958078|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958079|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
163958080|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958081|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958082|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958083|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
163958084|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
163958085|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
163958086|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
163958087|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
163958088|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163958089|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163958090|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163958091|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
163958092|NCT00427895|592217671|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163958093|NCT00427895|592217672|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163958094|NCT00427895|592217673|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
163958095|NCT00427895|592217674|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
163958096|NCT00427895|592217675|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163958097|NCT00427895|592217676|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163958098|NCT00427895|592217677|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163958099|NCT00427895|592217678|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
163958100|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163958101|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
163958102|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
163958103|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
163958104|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163958105|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163958106|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163958107|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
163958108|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
164048183|NCT03991936|592536036|FG001|Overall Study|Lost to Follow-up|1|||
164048184|NCT03991936|592536037|FG002|Overall Study|Lost to Follow-up|1|||
164048185|NCT03991936|592536038|FG003|Overall Study|Lost to Follow-up|1|||
163958109|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
163958110|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163958111|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
163958112|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163958113|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163958114|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163958115|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
163958116|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
163958117|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
163958118|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
163958119|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
163958120|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163958121|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163958122|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163958123|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
163958124|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958125|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
163958126|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958127|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958128|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958129|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958130|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958131|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
163958132|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Death|1|||
163958133|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Death|0|||
163958134|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Death|0|||
163958135|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Death|0|||
163958136|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Death|0|||
163958137|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Death|0|||
163958138|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Death|0|||
163958139|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Death|0|||
163958140|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163958141|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163958142|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
163958143|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
163958144|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163958145|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163958146|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163958147|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
163958148|NCT00427895|592217671|FG000|Vax 1/Year 1 Follow-up|Other|0|||
163958149|NCT00427895|592217672|FG001|Vax 1/Year 1 Follow-up|Other|0|||
163958150|NCT00427895|592217673|FG002|Vax 1/Year 1 Follow-up|Other|0|||
163958151|NCT00427895|592217674|FG003|Vax 1/Year 1 Follow-up|Other|2|||
163958152|NCT00427895|592217675|FG004|Vax 1/Year 1 Follow-up|Other|0|||
163958153|NCT00427895|592217676|FG005|Vax 1/Year 1 Follow-up|Other|0|||
163958154|NCT00427895|592217677|FG006|Vax 1/Year 1 Follow-up|Other|0|||
163958155|NCT00427895|592217678|FG007|Vax 1/Year 1 Follow-up|Other|0|||
163958156|NCT00427895|592217671|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
163958157|NCT00427895|592217672|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
163958158|NCT00427895|592217673|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
163958159|NCT00427895|592217674|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
163958160|NCT00427895|592217675|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163958161|NCT00427895|592217676|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163958162|NCT00427895|592217677|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163958163|NCT00427895|592217678|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
163958164|NCT02796560|592217686|FG000|Overall Study|Adverse Event|2|||
163958165|NCT02796560|592217687|FG001|Overall Study|Adverse Event|0|||
163958166|NCT02796560|592217686|FG000|Overall Study|Withdrawal by Subject|2|||
163958167|NCT02796560|592217687|FG001|Overall Study|Withdrawal by Subject|2|||
163958168|NCT03816332|592217689|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
163958169|NCT03816332|592217689|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
163958170|NCT05330312|592217690|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
163958171|NCT05330312|592217691|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
163958172|NCT05330312|592217692|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
163958173|NCT05330312|592217690|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
163958174|NCT05330312|592217691|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
163958175|NCT05330312|592217692|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
163958176|NCT05330312|592217690|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
163958177|NCT05330312|592217691|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
163958178|NCT05330312|592217692|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
163958179|NCT05330312|592217690|FG000|Pivotal Investigation - Part 2|Death|1|||
163958180|NCT05330312|592217691|FG001|Pivotal Investigation - Part 2|Death|4|||
163958181|NCT05330312|592217692|FG002|Pivotal Investigation - Part 2|Death|0|||
163958182|NCT03534284|592217693|FG000|Overall Study|Death|2|||
163958183|NCT03534284|592217694|FG001|Overall Study|Death|3|||
163958184|NCT03534284|592217695|FG002|Overall Study|Death|3|||
163958185|NCT03534284|592217693|FG000|Overall Study|Withdrawal by Subject|5|||
163958186|NCT03534284|592217694|FG001|Overall Study|Withdrawal by Subject|0|||
163958187|NCT03534284|592217695|FG002|Overall Study|Withdrawal by Subject|0|||
163958188|NCT03316300|592217696|FG000|Overall Study|Withdrawal by Subject|3|||
163958189|NCT03316300|592217697|FG001|Overall Study|Withdrawal by Subject|2|||
163958190|NCT03316300|592217696|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
163958191|NCT03316300|592217697|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
163958192|NCT03316300|592217696|FG000|Overall Study|Adverse Event|1|||
163958193|NCT03316300|592217697|FG001|Overall Study|Adverse Event|0|||
163958194|NCT03316300|592217696|FG000|Overall Study|COVID-19|0|||
163958195|NCT03316300|592217697|FG001|Overall Study|COVID-19|1|||
163958196|NCT03164564|592217699|FG000|Overall Study|Death|3|||
163958197|NCT03164564|592217700|FG001|Overall Study|Death|0|||
163958198|NCT03164564|592217699|FG000|Overall Study|Withdrawal by Subject|20|||
163958199|NCT03164564|592217700|FG001|Overall Study|Withdrawal by Subject|15|||
164048186|NCT03991936|592536039|FG004|Overall Study|Lost to Follow-up|1|||
163958200|NCT03164564|592217699|FG000|Overall Study|Lost to Follow-up|2|||
163958201|NCT03164564|592217700|FG001|Overall Study|Lost to Follow-up|0|||
163958202|NCT03164564|592217699|FG000|Overall Study|Physician Decision|0|||
163958203|NCT03164564|592217700|FG001|Overall Study|Physician Decision|1|||
163958204|NCT03164564|592217699|FG000|Overall Study|Adverse Event|0|||
163958205|NCT03164564|592217700|FG001|Overall Study|Adverse Event|1|||
163958206|NCT03164564|592217699|FG000|Overall Study|Ongoing|1586|||
163958207|NCT03164564|592217700|FG001|Overall Study|Ongoing|1586|||
163958208|NCT00423930|592217701|FG000|Overall Study|Withdrawal by Subject|2|||
163958209|NCT04002401|592217702|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
163958210|NCT04002401|592217702|FG000|Overall Study|Death|10|||
163958211|NCT04002401|592217702|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
163958212|NCT04002401|592217702|FG000|Overall Study|Enrolled but Never Treated|1|||
163958213|NCT04002401|592217702|FG000|Overall Study|Lost to Follow-up|1|||
163958214|NCT01910181|592217707|FG000|Overall Study|Death|37|||
163958215|NCT01910181|592217707|FG000|Overall Study|Lost to Follow-up|3|||
163958216|NCT01910181|592217707|FG000|Overall Study|Study Terminated by Sponsor|6|||
163958217|NCT03567434|592217711|FG000|Overall Study|Lost to Follow-up|1|||
163958218|NCT03567434|592217712|FG001|Overall Study|Lost to Follow-up|3|||
163958219|NCT02881957|592217718|FG000|Overall Study|Comfort care|0|||
163958220|NCT02881957|592217719|FG001|Overall Study|Comfort care|1|||
163958221|NCT02881957|592217718|FG000|Overall Study|Concurrent trial enrollment|0|||
163958222|NCT02881957|592217719|FG001|Overall Study|Concurrent trial enrollment|1|||
163958223|NCT02881957|592217718|FG000|Overall Study|Discharged within 48 hours|0|||
163958224|NCT02881957|592217719|FG001|Overall Study|Discharged within 48 hours|1|||
163958225|NCT02881957|592217718|FG000|Overall Study|Withdrawal by Subject|2|||
163958226|NCT02881957|592217719|FG001|Overall Study|Withdrawal by Subject|1|||
163958227|NCT02881957|592217718|FG000|Overall Study|Protocol Violation|1|||
163958228|NCT02881957|592217719|FG001|Overall Study|Protocol Violation|0|||
163958229|NCT05269355|592217725|FG000|Overall Study|Progressive Disease|104|||
163958230|NCT05269355|592217726|FG001|Overall Study|Progressive Disease|68|||
163958231|NCT05269355|592217725|FG000|Overall Study|Study Terminated by Sponsor|87|||
163958232|NCT05269355|592217726|FG001|Overall Study|Study Terminated by Sponsor|29|||
163958233|NCT05269355|592217725|FG000|Overall Study|Adverse Event|15|||
163958234|NCT05269355|592217726|FG001|Overall Study|Adverse Event|8|||
163958235|NCT05269355|592217725|FG000|Overall Study|Withdrawal by Subject|18|||
163958236|NCT05269355|592217726|FG001|Overall Study|Withdrawal by Subject|5|||
163958237|NCT05269355|592217725|FG000|Overall Study|Physician Decision|6|||
163958238|NCT05269355|592217726|FG001|Overall Study|Physician Decision|4|||
163958239|NCT05269355|592217725|FG000|Overall Study|Death|3|||
163958240|NCT05269355|592217726|FG001|Overall Study|Death|5|||
163958241|NCT05269355|592217725|FG000|Overall Study|Other Than Specified|5|||
163958242|NCT05269355|592217726|FG001|Overall Study|Other Than Specified|1|||
163958243|NCT05269355|592217725|FG000|Overall Study|Randomized But Not Treated|1|||
163958244|NCT05269355|592217726|FG001|Overall Study|Randomized But Not Treated|0|||
163958245|NCT01050790|592217727|FG000|Overall Study|Adverse Event|1|||
163958246|NCT03705832|592217728|FG000|Overall Study|Physician Decision|0|||
163958247|NCT03705832|592217729|FG001|Overall Study|Physician Decision|1|||
163958248|NCT03705832|592217728|FG000|Overall Study|Withdrawal by Subject|1|||
163958249|NCT03705832|592217729|FG001|Overall Study|Withdrawal by Subject|0|||
163958250|NCT01880528|592217730|FG000|Overall Study|Other|1|||
163958251|NCT01880528|592217731|FG001|Overall Study|Other|1|||
163958252|NCT00081497|592217732|FG000|Overall Study|Adverse Event|2|||
163958253|NCT00081497|592217733|FG001|Overall Study|Adverse Event|0|||
163958254|NCT00081497|592217732|FG000|Overall Study|Death|0|||
163958255|NCT00081497|592217733|FG001|Overall Study|Death|1|||
163958256|NCT00081497|592217732|FG000|Overall Study|Withdrawal by Subject|1|||
163958257|NCT00081497|592217733|FG001|Overall Study|Withdrawal by Subject|0|||
163958258|NCT00081497|592217732|FG000|Overall Study|Non-compliance|0|||
163958259|NCT00081497|592217733|FG001|Overall Study|Non-compliance|1|||
163958260|NCT01439360|592217734|FG000|Overall Study|Adverse Event|4|||
163958261|NCT01439360|592217735|FG001|Overall Study|Adverse Event|16|||
163958262|NCT01439360|592217734|FG000|Overall Study|Lost to Follow-up|43|||
163958263|NCT01439360|592217735|FG001|Overall Study|Lost to Follow-up|58|||
163958264|NCT01439360|592217734|FG000|Overall Study|Others|10|||
163958265|NCT01439360|592217735|FG001|Overall Study|Others|5|||
163958266|NCT01439360|592217734|FG000|Overall Study|Protocol Violation|1|||
163958267|NCT01439360|592217735|FG001|Overall Study|Protocol Violation|0|||
163958268|NCT01439360|592217734|FG000|Overall Study|Withdrawal by Subject|140|||
163958269|NCT01439360|592217735|FG001|Overall Study|Withdrawal by Subject|129|||
163958270|NCT02390245|592217737|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
163958271|NCT02390245|592217738|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
163958272|NCT02390245|592217739|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
163958273|NCT02390245|592217737|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
163958274|NCT02390245|592217738|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
163958275|NCT02390245|592217739|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
163958276|NCT03769181|592219061|FG000|Overall Study|Adverse Event|1|||
163958277|NCT03769181|592219062|FG001|Overall Study|Adverse Event|0|||
163958278|NCT03769181|592219063|FG002|Overall Study|Adverse Event|2|||
163958279|NCT03769181|592219064|FG003|Overall Study|Adverse Event|4|||
163958280|NCT03769181|592219061|FG000|Overall Study|Withdrawal by Subject|1|||
163958281|NCT03769181|592219062|FG001|Overall Study|Withdrawal by Subject|0|||
163958282|NCT03769181|592219063|FG002|Overall Study|Withdrawal by Subject|2|||
163958283|NCT03769181|592219064|FG003|Overall Study|Withdrawal by Subject|1|||
163958284|NCT03769181|592219061|FG000|Overall Study|Progressive disease|9|||
163958285|NCT03769181|592219062|FG001|Overall Study|Progressive disease|7|||
163958286|NCT03769181|592219063|FG002|Overall Study|Progressive disease|13|||
163958287|NCT03769181|592219064|FG003|Overall Study|Progressive disease|6|||
163958288|NCT03769181|592219061|FG000|Overall Study|Other - Unspecified|2|||
163958289|NCT03769181|592219062|FG001|Overall Study|Other - Unspecified|1|||
163958290|NCT03769181|592219063|FG002|Overall Study|Other - Unspecified|0|||
163958291|NCT03769181|592219064|FG003|Overall Study|Other - Unspecified|0|||
163958292|NCT00826111|592219065|FG000|Overall Study|Lost to Follow-up|0|||
163958293|NCT00826111|592219066|FG001|Overall Study|Lost to Follow-up|1|||
163958294|NCT00826111|592219065|FG000|Overall Study|Protocol Violation|1|||
163958295|NCT00826111|592219066|FG001|Overall Study|Protocol Violation|0|||
163958296|NCT00826111|592219065|FG000|Overall Study|Withdrawal by Subject|5|||
163958297|NCT00826111|592219066|FG001|Overall Study|Withdrawal by Subject|0|||
163958298|NCT00826111|592219065|FG000|Overall Study|Physician Decision|1|||
163958299|NCT00826111|592219066|FG001|Overall Study|Physician Decision|1|||
163958300|NCT01195545|592219067|FG000|Overall Study|Protocol Violation|4|||
163958301|NCT01929980|592219068|FG000|Overall Study|Physician Decision|1|||
163958302|NCT00150969|592219071|FG000|24 Month Main Study|Adverse Event|3|||
163958303|NCT00150969|592219072|FG001|24 Month Main Study|Adverse Event|4|||
163958304|NCT00150969|592219071|FG000|24 Month Main Study|Death|1|||
163958305|NCT00150969|592219072|FG001|24 Month Main Study|Death|1|||
163958306|NCT00150969|592219071|FG000|24 Month Main Study|Lack of Efficacy|1|||
163958307|NCT00150969|592219072|FG001|24 Month Main Study|Lack of Efficacy|8|||
163958308|NCT00150969|592219071|FG000|24 Month Main Study|Lost to Follow-up|3|||
163958309|NCT00150969|592219072|FG001|24 Month Main Study|Lost to Follow-up|2|||
163958310|NCT00150969|592219071|FG000|24 Month Main Study|Protocol Violation|4|||
163958311|NCT00150969|592219072|FG001|24 Month Main Study|Protocol Violation|2|||
163958312|NCT00150969|592219071|FG000|24 Month Main Study|Withdrawal by Subject|7|||
163958313|NCT00150969|592219072|FG001|24 Month Main Study|Withdrawal by Subject|4|||
163958314|NCT00150969|592219071|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
163958315|NCT00150969|592219072|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
163958316|NCT00150969|592219071|FG000|24-48 Month Extension|Lack of Efficacy|0|||
163958317|NCT00150969|592219072|FG001|24-48 Month Extension|Lack of Efficacy|1|||
163958318|NCT00150969|592219071|FG000|24-48 Month Extension|Adverse Event|1|||
163958319|NCT00150969|592219072|FG001|24-48 Month Extension|Adverse Event|3|||
163958320|NCT00150969|592219071|FG000|24-48 Month Extension|Other Reason|81|||
163958321|NCT00150969|592219072|FG001|24-48 Month Extension|Other Reason|91|||
163958322|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
163958323|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
163958324|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
163958325|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
163958326|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
163958327|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
163958328|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
163958329|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
163958330|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
163958331|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
163958332|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
163958333|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
163958334|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
163958335|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
163958336|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
163958337|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
163958338|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
163958339|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
163958340|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
163958341|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
163958342|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
163958343|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
163958344|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
163958345|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
163958346|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
163958347|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
163958348|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
163958349|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
163958350|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
163958351|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
163958352|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Other|10|||
163958353|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Other|7|||
163958354|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Other|8|||
163958355|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Other|8|||
163958356|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Other|0|||
163958357|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
163958358|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
163958359|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
163958360|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
163958361|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
163958362|NCT00615836|592219073|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
163958363|NCT00615836|592219074|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163958364|NCT00615836|592219075|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163958365|NCT00615836|592219076|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163958366|NCT00615836|592219077|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
163958367|NCT01630434|592219078|FG000|Overall Study|Donor lungs turned down|1|||
163958368|NCT01630434|592219079|FG001|Overall Study|Donor lungs turned down|0|||
163958369|NCT01630434|592219078|FG000|Overall Study|Protocol Violation|9|||
163958370|NCT01630434|592219079|FG001|Overall Study|Protocol Violation|4|||
163958371|NCT01630434|592219078|FG000|Overall Study|Death|20|||
163958372|NCT01630434|592219079|FG001|Overall Study|Death|26|||
163958373|NCT00687973|592219080|FG000|Overall Study|Adverse Event|18|||
163958374|NCT00687973|592219081|FG001|Overall Study|Adverse Event|28|||
163958375|NCT00687973|592219080|FG000|Overall Study|Lack of Efficacy|2|||
163958376|NCT00687973|592219081|FG001|Overall Study|Lack of Efficacy|3|||
163958377|NCT00687973|592219080|FG000|Overall Study|Protocol Violation|1|||
163958378|NCT00687973|592219081|FG001|Overall Study|Protocol Violation|2|||
163958379|NCT00687973|592219080|FG000|Overall Study|Administrative Reasons|0|||
163958380|NCT00687973|592219081|FG001|Overall Study|Administrative Reasons|2|||
163958381|NCT00687973|592219080|FG000|Overall Study|Withdrawal by Subject|3|||
163958382|NCT00687973|592219081|FG001|Overall Study|Withdrawal by Subject|3|||
163958383|NCT00511472|592219088|FG000|Overall Study|Clinical Adverse Event|1|||
163958384|NCT00511472|592219089|FG001|Overall Study|Clinical Adverse Event|2|||
163958385|NCT00511472|592219088|FG000|Overall Study|Laboratory Adverse Event|0|||
163958386|NCT00511472|592219089|FG001|Overall Study|Laboratory Adverse Event|2|||
163958387|NCT00511472|592219088|FG000|Overall Study|Not reported|2|||
163958388|NCT00511472|592219089|FG001|Overall Study|Not reported|2|||
163958389|NCT01079741|592219090|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163958390|NCT01079741|592219091|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
163958391|NCT01079741|592219092|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163958392|NCT01079741|592219093|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163958393|NCT01079741|592219094|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
163958394|NCT01079741|592219090|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163958395|NCT01079741|592219091|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163958396|NCT01079741|592219092|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163958397|NCT01079741|592219093|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
163958398|NCT01079741|592219094|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
163958399|NCT00406653|592219095|FG000|Induction Period|Adverse Event|1|||
163958400|NCT00406653|592219096|FG001|Induction Period|Adverse Event|10|||
163958401|NCT00406653|592219097|FG002|Induction Period|Adverse Event|4|||
163958402|NCT00406653|592219098|FG003|Induction Period|Adverse Event|11|||
163958403|NCT00406653|592219099|FG004|Induction Period|Adverse Event|0|||
163958404|NCT00406653|592219100|FG005|Induction Period|Adverse Event|0|||
163958405|NCT00406653|592219101|FG006|Induction Period|Adverse Event|0|||
163958406|NCT00406653|592219095|FG000|Induction Period|Lack of Efficacy|11|||
163958407|NCT00406653|592219096|FG001|Induction Period|Lack of Efficacy|14|||
163958408|NCT00406653|592219097|FG002|Induction Period|Lack of Efficacy|8|||
163958409|NCT00406653|592219098|FG003|Induction Period|Lack of Efficacy|10|||
163958410|NCT00406653|592219099|FG004|Induction Period|Lack of Efficacy|0|||
163958411|NCT00406653|592219100|FG005|Induction Period|Lack of Efficacy|0|||
163958412|NCT00406653|592219101|FG006|Induction Period|Lack of Efficacy|0|||
163958413|NCT00406653|592219095|FG000|Induction Period|Lost to Follow-up|0|||
163958414|NCT00406653|592219096|FG001|Induction Period|Lost to Follow-up|2|||
163958415|NCT00406653|592219097|FG002|Induction Period|Lost to Follow-up|0|||
163958416|NCT00406653|592219098|FG003|Induction Period|Lost to Follow-up|0|||
163958417|NCT00406653|592219099|FG004|Induction Period|Lost to Follow-up|0|||
163958418|NCT00406653|592219100|FG005|Induction Period|Lost to Follow-up|0|||
163958419|NCT00406653|592219101|FG006|Induction Period|Lost to Follow-up|0|||
163958420|NCT00406653|592219095|FG000|Induction Period|Withdrawal of Consent|2|||
163958421|NCT00406653|592219096|FG001|Induction Period|Withdrawal of Consent|5|||
163958422|NCT00406653|592219097|FG002|Induction Period|Withdrawal of Consent|1|||
163958423|NCT00406653|592219098|FG003|Induction Period|Withdrawal of Consent|2|||
163958424|NCT00406653|592219099|FG004|Induction Period|Withdrawal of Consent|0|||
164148628|NCT04895982|592904912|FG001|Overall Study|Lost to Follow-up|0|||
163958425|NCT00406653|592219100|FG005|Induction Period|Withdrawal of Consent|0|||
163958426|NCT00406653|592219101|FG006|Induction Period|Withdrawal of Consent|0|||
163958427|NCT00406653|592219095|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
163958428|NCT00406653|592219096|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
163958429|NCT00406653|592219097|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
163958430|NCT00406653|592219098|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
163958431|NCT00406653|592219099|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
163958432|NCT00406653|592219100|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
163958433|NCT00406653|592219101|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
163958434|NCT00406653|592219095|FG000|Induction Period|Pregnancy|1|||
163958435|NCT00406653|592219096|FG001|Induction Period|Pregnancy|0|||
163958436|NCT00406653|592219097|FG002|Induction Period|Pregnancy|0|||
163958437|NCT00406653|592219098|FG003|Induction Period|Pregnancy|0|||
163958438|NCT00406653|592219099|FG004|Induction Period|Pregnancy|0|||
163958439|NCT00406653|592219100|FG005|Induction Period|Pregnancy|0|||
163958440|NCT00406653|592219101|FG006|Induction Period|Pregnancy|0|||
163958441|NCT00406653|592219095|FG000|Induction Period|Declined participation but followup done|0|||
163958442|NCT00406653|592219096|FG001|Induction Period|Declined participation but followup done|2|||
163958443|NCT00406653|592219097|FG002|Induction Period|Declined participation but followup done|1|||
163958444|NCT00406653|592219098|FG003|Induction Period|Declined participation but followup done|1|||
163958445|NCT00406653|592219099|FG004|Induction Period|Declined participation but followup done|0|||
163958446|NCT00406653|592219100|FG005|Induction Period|Declined participation but followup done|0|||
163958447|NCT00406653|592219101|FG006|Induction Period|Declined participation but followup done|0|||
163958448|NCT00406653|592219095|FG000|Induction Period|Given prohibited drug|0|||
163958449|NCT00406653|592219096|FG001|Induction Period|Given prohibited drug|1|||
163958450|NCT00406653|592219097|FG002|Induction Period|Given prohibited drug|2|||
163958451|NCT00406653|592219098|FG003|Induction Period|Given prohibited drug|0|||
163958452|NCT00406653|592219099|FG004|Induction Period|Given prohibited drug|0|||
163958453|NCT00406653|592219100|FG005|Induction Period|Given prohibited drug|0|||
163958454|NCT00406653|592219101|FG006|Induction Period|Given prohibited drug|0|||
163958455|NCT00406653|592219095|FG000|Induction Period|Incarcerated|0|||
163958456|NCT00406653|592219096|FG001|Induction Period|Incarcerated|0|||
163958457|NCT00406653|592219097|FG002|Induction Period|Incarcerated|1|||
163958458|NCT00406653|592219098|FG003|Induction Period|Incarcerated|0|||
163958459|NCT00406653|592219099|FG004|Induction Period|Incarcerated|0|||
163958460|NCT00406653|592219100|FG005|Induction Period|Incarcerated|0|||
163958461|NCT00406653|592219101|FG006|Induction Period|Incarcerated|0|||
163958462|NCT00406653|592219095|FG000|Induction Period|Patient relocated|0|||
163958463|NCT00406653|592219096|FG001|Induction Period|Patient relocated|0|||
163958464|NCT00406653|592219097|FG002|Induction Period|Patient relocated|1|||
163958465|NCT00406653|592219098|FG003|Induction Period|Patient relocated|0|||
163958466|NCT00406653|592219099|FG004|Induction Period|Patient relocated|0|||
163958467|NCT00406653|592219100|FG005|Induction Period|Patient relocated|0|||
163958468|NCT00406653|592219101|FG006|Induction Period|Patient relocated|0|||
163958469|NCT00406653|592219095|FG000|Maintenance Period|Adverse Event|0|||
163958470|NCT00406653|592219096|FG001|Maintenance Period|Adverse Event|0|||
163958471|NCT00406653|592219097|FG002|Maintenance Period|Adverse Event|0|||
163958472|NCT00406653|592219098|FG003|Maintenance Period|Adverse Event|0|||
163958473|NCT00406653|592219099|FG004|Maintenance Period|Adverse Event|1|||
163958474|NCT00406653|592219100|FG005|Maintenance Period|Adverse Event|1|||
163958475|NCT00406653|592219101|FG006|Maintenance Period|Adverse Event|0|||
163958476|NCT00406653|592219095|FG000|Maintenance Period|Lack of Efficacy|0|||
163958477|NCT00406653|592219096|FG001|Maintenance Period|Lack of Efficacy|0|||
163958478|NCT00406653|592219097|FG002|Maintenance Period|Lack of Efficacy|0|||
163958479|NCT00406653|592219098|FG003|Maintenance Period|Lack of Efficacy|0|||
163958480|NCT00406653|592219099|FG004|Maintenance Period|Lack of Efficacy|20|||
163958481|NCT00406653|592219100|FG005|Maintenance Period|Lack of Efficacy|26|||
163958482|NCT00406653|592219101|FG006|Maintenance Period|Lack of Efficacy|0|||
163958483|NCT00406653|592219095|FG000|Maintenance Period|Lost to Follow-up|0|||
163958484|NCT00406653|592219096|FG001|Maintenance Period|Lost to Follow-up|0|||
163958485|NCT00406653|592219097|FG002|Maintenance Period|Lost to Follow-up|0|||
163958486|NCT00406653|592219098|FG003|Maintenance Period|Lost to Follow-up|0|||
163958487|NCT00406653|592219099|FG004|Maintenance Period|Lost to Follow-up|2|||
163958488|NCT00406653|592219100|FG005|Maintenance Period|Lost to Follow-up|1|||
163958489|NCT00406653|592219101|FG006|Maintenance Period|Lost to Follow-up|0|||
163958490|NCT00406653|592219095|FG000|Maintenance Period|Withdrawal of Consent|0|||
163958491|NCT00406653|592219096|FG001|Maintenance Period|Withdrawal of Consent|0|||
163958492|NCT00406653|592219097|FG002|Maintenance Period|Withdrawal of Consent|0|||
163958493|NCT00406653|592219098|FG003|Maintenance Period|Withdrawal of Consent|0|||
163958494|NCT00406653|592219099|FG004|Maintenance Period|Withdrawal of Consent|2|||
163958495|NCT00406653|592219100|FG005|Maintenance Period|Withdrawal of Consent|0|||
163958496|NCT00406653|592219101|FG006|Maintenance Period|Withdrawal of Consent|0|||
163958497|NCT00406653|592219095|FG000|Maintenance Period|Pregnancy|0|||
163958498|NCT00406653|592219096|FG001|Maintenance Period|Pregnancy|0|||
163958499|NCT00406653|592219097|FG002|Maintenance Period|Pregnancy|0|||
163958500|NCT00406653|592219098|FG003|Maintenance Period|Pregnancy|0|||
163958501|NCT00406653|592219099|FG004|Maintenance Period|Pregnancy|0|||
163958502|NCT00406653|592219100|FG005|Maintenance Period|Pregnancy|1|||
163958503|NCT00406653|592219101|FG006|Maintenance Period|Pregnancy|0|||
163958504|NCT00406653|592219095|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
163958505|NCT00406653|592219096|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
163958506|NCT00406653|592219097|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
163958507|NCT00406653|592219098|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
163958508|NCT00406653|592219099|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
163958509|NCT00406653|592219100|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
163958510|NCT00406653|592219101|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
163958511|NCT00406653|592219095|FG000|Maintenance Period|Error in disease score evaluation|0|||
163958512|NCT00406653|592219096|FG001|Maintenance Period|Error in disease score evaluation|0|||
163958513|NCT00406653|592219097|FG002|Maintenance Period|Error in disease score evaluation|0|||
163958514|NCT00406653|592219098|FG003|Maintenance Period|Error in disease score evaluation|0|||
163958515|NCT00406653|592219099|FG004|Maintenance Period|Error in disease score evaluation|1|||
163958516|NCT00406653|592219100|FG005|Maintenance Period|Error in disease score evaluation|0|||
163958517|NCT00406653|592219101|FG006|Maintenance Period|Error in disease score evaluation|0|||
163958518|NCT00406653|592219095|FG000|Open-Label Period|Death|0|||
163958519|NCT00406653|592219096|FG001|Open-Label Period|Death|0|||
163958520|NCT00406653|592219097|FG002|Open-Label Period|Death|0|||
163958521|NCT00406653|592219098|FG003|Open-Label Period|Death|0|||
163958522|NCT00406653|592219099|FG004|Open-Label Period|Death|0|||
163958523|NCT00406653|592219100|FG005|Open-Label Period|Death|0|||
163958524|NCT00406653|592219101|FG006|Open-Label Period|Death|1|||
163958525|NCT00406653|592219095|FG000|Open-Label Period|Adverse Event|0|||
163958526|NCT00406653|592219096|FG001|Open-Label Period|Adverse Event|0|||
163958527|NCT00406653|592219097|FG002|Open-Label Period|Adverse Event|0|||
163958528|NCT00406653|592219098|FG003|Open-Label Period|Adverse Event|0|||
163958529|NCT00406653|592219099|FG004|Open-Label Period|Adverse Event|0|||
163958530|NCT00406653|592219100|FG005|Open-Label Period|Adverse Event|0|||
163958531|NCT00406653|592219101|FG006|Open-Label Period|Adverse Event|18|||
163958532|NCT00406653|592219095|FG000|Open-Label Period|Lack of Efficacy|0|||
163958533|NCT00406653|592219096|FG001|Open-Label Period|Lack of Efficacy|0|||
163958534|NCT00406653|592219097|FG002|Open-Label Period|Lack of Efficacy|0|||
163958535|NCT00406653|592219098|FG003|Open-Label Period|Lack of Efficacy|0|||
163958536|NCT00406653|592219099|FG004|Open-Label Period|Lack of Efficacy|0|||
163958537|NCT00406653|592219100|FG005|Open-Label Period|Lack of Efficacy|0|||
163958538|NCT00406653|592219101|FG006|Open-Label Period|Lack of Efficacy|160|||
163958539|NCT00406653|592219095|FG000|Open-Label Period|Lost to Follow-up|0|||
163958540|NCT00406653|592219096|FG001|Open-Label Period|Lost to Follow-up|0|||
163958541|NCT00406653|592219097|FG002|Open-Label Period|Lost to Follow-up|0|||
163958542|NCT00406653|592219098|FG003|Open-Label Period|Lost to Follow-up|0|||
163958543|NCT00406653|592219099|FG004|Open-Label Period|Lost to Follow-up|0|||
163958544|NCT00406653|592219100|FG005|Open-Label Period|Lost to Follow-up|0|||
163958545|NCT00406653|592219101|FG006|Open-Label Period|Lost to Follow-up|6|||
163958546|NCT00406653|592219095|FG000|Open-Label Period|Withdrawal of Consent|0|||
163958547|NCT00406653|592219096|FG001|Open-Label Period|Withdrawal of Consent|0|||
163958548|NCT00406653|592219097|FG002|Open-Label Period|Withdrawal of Consent|0|||
163958549|NCT00406653|592219098|FG003|Open-Label Period|Withdrawal of Consent|0|||
163958550|NCT00406653|592219099|FG004|Open-Label Period|Withdrawal of Consent|0|||
163958551|NCT00406653|592219100|FG005|Open-Label Period|Withdrawal of Consent|0|||
163958552|NCT00406653|592219101|FG006|Open-Label Period|Withdrawal of Consent|11|||
163958553|NCT00406653|592219095|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163958554|NCT00406653|592219096|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163958555|NCT00406653|592219097|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163958556|NCT00406653|592219098|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163958557|NCT00406653|592219099|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163958558|NCT00406653|592219100|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
163958559|NCT00406653|592219101|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
163958560|NCT00406653|592219095|FG000|Open-Label Period|Pregnancy|0|||
163958561|NCT00406653|592219096|FG001|Open-Label Period|Pregnancy|0|||
163958562|NCT00406653|592219097|FG002|Open-Label Period|Pregnancy|0|||
163958563|NCT00406653|592219098|FG003|Open-Label Period|Pregnancy|0|||
163958564|NCT00406653|592219099|FG004|Open-Label Period|Pregnancy|0|||
163958565|NCT00406653|592219100|FG005|Open-Label Period|Pregnancy|0|||
163958566|NCT00406653|592219101|FG006|Open-Label Period|Pregnancy|2|||
163958567|NCT00406653|592219095|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
163958568|NCT00406653|592219096|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
163958569|NCT00406653|592219097|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
163958570|NCT00406653|592219098|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
163958571|NCT00406653|592219099|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
163958572|NCT00406653|592219100|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
164148629|NCT04895982|592904913|FG002|Overall Study|Lost to Follow-up|1|||
163958573|NCT00406653|592219101|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
163958574|NCT00406653|592219095|FG000|Open-Label Period|Declined participation but followup done|0|||
163958575|NCT00406653|592219096|FG001|Open-Label Period|Declined participation but followup done|0|||
163958576|NCT00406653|592219097|FG002|Open-Label Period|Declined participation but followup done|0|||
163958577|NCT00406653|592219098|FG003|Open-Label Period|Declined participation but followup done|0|||
163958578|NCT00406653|592219099|FG004|Open-Label Period|Declined participation but followup done|0|||
163958579|NCT00406653|592219100|FG005|Open-Label Period|Declined participation but followup done|0|||
163958580|NCT00406653|592219101|FG006|Open-Label Period|Declined participation but followup done|8|||
163958581|NCT00406653|592219095|FG000|Open-Label Period|Discontinued by Sponsor|0|||
163958582|NCT00406653|592219096|FG001|Open-Label Period|Discontinued by Sponsor|0|||
163958583|NCT00406653|592219097|FG002|Open-Label Period|Discontinued by Sponsor|0|||
163958584|NCT00406653|592219098|FG003|Open-Label Period|Discontinued by Sponsor|0|||
163958585|NCT00406653|592219099|FG004|Open-Label Period|Discontinued by Sponsor|0|||
163958586|NCT00406653|592219100|FG005|Open-Label Period|Discontinued by Sponsor|0|||
163958587|NCT00406653|592219101|FG006|Open-Label Period|Discontinued by Sponsor|1|||
163958588|NCT00406653|592219095|FG000|Open-Label Period|Refused followup|0|||
163958589|NCT00406653|592219096|FG001|Open-Label Period|Refused followup|0|||
163958590|NCT00406653|592219097|FG002|Open-Label Period|Refused followup|0|||
163958591|NCT00406653|592219098|FG003|Open-Label Period|Refused followup|0|||
163958592|NCT00406653|592219099|FG004|Open-Label Period|Refused followup|0|||
163958593|NCT00406653|592219100|FG005|Open-Label Period|Refused followup|0|||
163958594|NCT00406653|592219101|FG006|Open-Label Period|Refused followup|1|||
163958595|NCT00446992|592219102|FG000|Overall Study|Adverse Event|11|||
163958596|NCT00446992|592219102|FG000|Overall Study|Lost to Follow-up|5|||
163958597|NCT02075541|592219103|FG000|Overall Study|Serious Adverse Event|1|||
163958598|NCT02075541|592219104|FG001|Overall Study|Serious Adverse Event|4|||
163958599|NCT02075541|592219103|FG000|Overall Study|Protocol Violation|1|||
163958600|NCT02075541|592219104|FG001|Overall Study|Protocol Violation|0|||
163958601|NCT02075541|592219103|FG000|Overall Study|Withdrawal by Subject|1|||
163958602|NCT02075541|592219104|FG001|Overall Study|Withdrawal by Subject|3|||
163958603|NCT02075541|592219103|FG000|Overall Study|Sponsor study termination|0|||
163958604|NCT02075541|592219104|FG001|Overall Study|Sponsor study termination|1|||
163958605|NCT02075541|592219103|FG000|Overall Study|Other- unable to perform study procedure|1|||
163958606|NCT02075541|592219104|FG001|Overall Study|Other- unable to perform study procedure|0|||
163958607|NCT00731120|592219105|FG000|Overall Study|Adverse Event|7|||
163958608|NCT00731120|592219106|FG001|Overall Study|Adverse Event|6|||
163958609|NCT00731120|592219107|FG002|Overall Study|Adverse Event|8|||
163958610|NCT00731120|592219105|FG000|Overall Study|Lack of Efficacy|4|||
163958611|NCT00731120|592219106|FG001|Overall Study|Lack of Efficacy|5|||
163958612|NCT00731120|592219107|FG002|Overall Study|Lack of Efficacy|4|||
163958613|NCT00731120|592219105|FG000|Overall Study|Noncompliance with Study Drug|3|||
163958614|NCT00731120|592219106|FG001|Overall Study|Noncompliance with Study Drug|3|||
163958615|NCT00731120|592219107|FG002|Overall Study|Noncompliance with Study Drug|1|||
163958616|NCT00731120|592219105|FG000|Overall Study|Protocol Deviations|1|||
163958617|NCT00731120|592219106|FG001|Overall Study|Protocol Deviations|6|||
163958618|NCT00731120|592219107|FG002|Overall Study|Protocol Deviations|1|||
163958619|NCT00731120|592219105|FG000|Overall Study|Withdrawal of Consent|13|||
163958620|NCT00731120|592219106|FG001|Overall Study|Withdrawal of Consent|8|||
163958621|NCT00731120|592219107|FG002|Overall Study|Withdrawal of Consent|4|||
163958622|NCT00731120|592219105|FG000|Overall Study|Lost to Follow-up|10|||
163958623|NCT00731120|592219106|FG001|Overall Study|Lost to Follow-up|15|||
163958624|NCT00731120|592219107|FG002|Overall Study|Lost to Follow-up|17|||
163958625|NCT00731120|592219105|FG000|Overall Study|Other|4|||
163958626|NCT00731120|592219106|FG001|Overall Study|Other|0|||
163958627|NCT00731120|592219107|FG002|Overall Study|Other|1|||
163958628|NCT02349360|592219108|FG000|Overall Study|Withdrawal by Subject|0|||
163958629|NCT02349360|592219109|FG001|Overall Study|Withdrawal by Subject|1|||
163958630|NCT01054846|592219112|FG000|Overall Study|Lost to Follow-up|76|||
163958631|NCT01054846|592219113|FG001|Overall Study|Lost to Follow-up|17|||
163958632|NCT02434939|592219114|FG000|Overall Study|Lack of Efficacy|34|||
163958633|NCT02434939|592219115|FG001|Overall Study|Lack of Efficacy|48|||
163958634|NCT02434939|592219114|FG000|Overall Study|Withdrawal by Subject|3|||
163958635|NCT02434939|592219115|FG001|Overall Study|Withdrawal by Subject|0|||
163958636|NCT02434939|592219114|FG000|Overall Study|Adverse Event|0|||
163958637|NCT02434939|592219115|FG001|Overall Study|Adverse Event|1|||
163958638|NCT00394953|592219116|FG000|First Treatment Period|Adverse Event|1|||
163958639|NCT00394953|592219117|FG001|First Treatment Period|Adverse Event|2|||
163958640|NCT00394953|592219116|FG000|First Treatment Period|Death|6|||
163958641|NCT00394953|592219117|FG001|First Treatment Period|Death|7|||
163958642|NCT00394953|592219116|FG000|First Treatment Period|Lack of Efficacy|1|||
163958643|NCT00394953|592219117|FG001|First Treatment Period|Lack of Efficacy|1|||
163958644|NCT00394953|592219116|FG000|First Treatment Period|Withdrawal by Subject|6|||
163958645|NCT00394953|592219117|FG001|First Treatment Period|Withdrawal by Subject|3|||
163958646|NCT00394953|592219116|FG000|First Treatment Period|Lost to Follow-up|0|||
163958647|NCT00394953|592219117|FG001|First Treatment Period|Lost to Follow-up|1|||
163958648|NCT00394953|592219116|FG000|First Treatment Period|Renal transplant|11|||
163958649|NCT00394953|592219117|FG001|First Treatment Period|Renal transplant|7|||
163958650|NCT00394953|592219116|FG000|First Treatment Period|Not defined|4|||
163958651|NCT00394953|592219117|FG001|First Treatment Period|Not defined|1|||
163958652|NCT00394953|592219116|FG000|Second Treatment Period|Adverse Event|2|||
163958653|NCT00394953|592219117|FG001|Second Treatment Period|Adverse Event|5|||
163958654|NCT00394953|592219116|FG000|Second Treatment Period|Death|8|||
163958655|NCT00394953|592219117|FG001|Second Treatment Period|Death|4|||
163958656|NCT00394953|592219116|FG000|Second Treatment Period|Lack of Efficacy|9|||
163958657|NCT00394953|592219117|FG001|Second Treatment Period|Lack of Efficacy|47|||
163958658|NCT00394953|592219116|FG000|Second Treatment Period|Withdrawal by Subject|3|||
163958659|NCT00394953|592219117|FG001|Second Treatment Period|Withdrawal by Subject|3|||
163958660|NCT00394953|592219116|FG000|Second Treatment Period|Lost to Follow-up|0|||
163958661|NCT00394953|592219117|FG001|Second Treatment Period|Lost to Follow-up|1|||
163958662|NCT00394953|592219116|FG000|Second Treatment Period|Renal transplant|4|||
163958663|NCT00394953|592219117|FG001|Second Treatment Period|Renal transplant|6|||
163958664|NCT00394953|592219116|FG000|Second Treatment Period|Not defined|3|||
163958665|NCT00394953|592219117|FG001|Second Treatment Period|Not defined|8|||
163958666|NCT02446886|592219126|FG000|Overall Study|Adverse Event|1|||
163958667|NCT02446886|592219127|FG001|Overall Study|Adverse Event|3|||
163958668|NCT02446886|592219126|FG000|Overall Study|Withdrawal by Subject|1|||
163958669|NCT02446886|592219127|FG001|Overall Study|Withdrawal by Subject|1|||
163958670|NCT03021954|592219135|FG000|Overall Study|Lost to Follow-up|10|||
163958671|NCT03021954|592219136|FG001|Overall Study|Lost to Follow-up|43|||
163958672|NCT03021954|592219135|FG000|Overall Study|Subjects had avulsion trauma|4|||
163958673|NCT03021954|592219136|FG001|Overall Study|Subjects had avulsion trauma|1|||
163958674|NCT02196714|592219139|FG000|Overall Study|Protocol Violation|0|||
163958675|NCT02196714|592219140|FG001|Overall Study|Protocol Violation|0|||
163958676|NCT02196714|592219141|FG002|Overall Study|Protocol Violation|1|||
163958677|NCT02196714|592219142|FG003|Overall Study|Protocol Violation|0|||
163958678|NCT04079803|592219146|FG000|Overall Study|Withdrawal by Subject|0|||
163958679|NCT04079803|592219147|FG001|Overall Study|Withdrawal by Subject|0|||
163958680|NCT04079803|592219148|FG002|Overall Study|Withdrawal by Subject|1|||
163958681|NCT00807235|592219153|FG000|Overall Study|Adverse Event|1|||
163958682|NCT00807235|592219154|FG001|Overall Study|Adverse Event|0|||
163958683|NCT04677179|592219157|FG000|Induction Treatment Period|Adverse Event|1|||
163958684|NCT04677179|592219158|FG001|Induction Treatment Period|Adverse Event|0|||
163958685|NCT04677179|592219159|FG002|Induction Treatment Period|Adverse Event|0|||
163958686|NCT04677179|592219160|FG003|Induction Treatment Period|Adverse Event|0|||
163958687|NCT04677179|592219161|FG004|Induction Treatment Period|Adverse Event|0|||
163958688|NCT04677179|592219162|FG005|Induction Treatment Period|Adverse Event|0|||
163958689|NCT04677179|592219163|FG006|Induction Treatment Period|Adverse Event|0|||
163958690|NCT04677179|592219164|FG007|Induction Treatment Period|Adverse Event|0|||
163958691|NCT04677179|592219165|FG008|Induction Treatment Period|Adverse Event|0|||
163958692|NCT04677179|592219166|FG009|Induction Treatment Period|Adverse Event|0|||
163958693|NCT04677179|592219157|FG000|Induction Treatment Period|Physician Decision|1|||
163958694|NCT04677179|592219158|FG001|Induction Treatment Period|Physician Decision|0|||
163958695|NCT04677179|592219159|FG002|Induction Treatment Period|Physician Decision|1|||
163958696|NCT04677179|592219160|FG003|Induction Treatment Period|Physician Decision|0|||
163958697|NCT04677179|592219161|FG004|Induction Treatment Period|Physician Decision|0|||
163958698|NCT04677179|592219162|FG005|Induction Treatment Period|Physician Decision|0|||
163958699|NCT04677179|592219163|FG006|Induction Treatment Period|Physician Decision|0|||
163958700|NCT04677179|592219164|FG007|Induction Treatment Period|Physician Decision|0|||
163958701|NCT04677179|592219165|FG008|Induction Treatment Period|Physician Decision|0|||
163958702|NCT04677179|592219166|FG009|Induction Treatment Period|Physician Decision|0|||
163958703|NCT04677179|592219157|FG000|Induction Treatment Period|Protocol Violation|0|||
163958704|NCT04677179|592219158|FG001|Induction Treatment Period|Protocol Violation|1|||
163958705|NCT04677179|592219159|FG002|Induction Treatment Period|Protocol Violation|0|||
163958706|NCT04677179|592219160|FG003|Induction Treatment Period|Protocol Violation|0|||
163958707|NCT04677179|592219161|FG004|Induction Treatment Period|Protocol Violation|0|||
163958708|NCT04677179|592219162|FG005|Induction Treatment Period|Protocol Violation|0|||
163958709|NCT04677179|592219163|FG006|Induction Treatment Period|Protocol Violation|0|||
163958710|NCT04677179|592219164|FG007|Induction Treatment Period|Protocol Violation|0|||
163958711|NCT04677179|592219165|FG008|Induction Treatment Period|Protocol Violation|0|||
163958712|NCT04677179|592219166|FG009|Induction Treatment Period|Protocol Violation|0|||
163958713|NCT04677179|592219157|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
163958714|NCT04677179|592219158|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
163958715|NCT04677179|592219159|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
163958716|NCT04677179|592219160|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
163958717|NCT04677179|592219161|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
163958718|NCT04677179|592219162|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
163958719|NCT04677179|592219163|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
163958720|NCT04677179|592219164|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
163958721|NCT04677179|592219165|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
163958722|NCT04677179|592219166|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
163958723|NCT04677179|592219157|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
163958724|NCT04677179|592219158|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
163958725|NCT04677179|592219159|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
163958726|NCT04677179|592219160|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
163958727|NCT04677179|592219161|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
163958728|NCT04677179|592219162|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
163958729|NCT04677179|592219163|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
163958730|NCT04677179|592219164|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
163958731|NCT04677179|592219165|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
163958732|NCT04677179|592219166|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
163958733|NCT04677179|592219157|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
163958734|NCT04677179|592219158|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
163958735|NCT04677179|592219159|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
163958736|NCT04677179|592219160|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
163958737|NCT04677179|592219161|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
163958738|NCT04677179|592219162|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
163958739|NCT04677179|592219163|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
163958740|NCT04677179|592219164|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
163958741|NCT04677179|592219165|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
163958742|NCT04677179|592219166|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
163958743|NCT04677179|592219157|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958744|NCT04677179|592219158|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958745|NCT04677179|592219159|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958746|NCT04677179|592219160|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
163958747|NCT04677179|592219161|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958748|NCT04677179|592219162|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958749|NCT04677179|592219163|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958750|NCT04677179|592219164|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958751|NCT04677179|592219165|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958752|NCT04677179|592219166|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
163958753|NCT04677179|592219157|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958754|NCT04677179|592219158|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958755|NCT04677179|592219159|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958756|NCT04677179|592219160|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
163958757|NCT04677179|592219161|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
163958758|NCT04677179|592219162|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
163958759|NCT04677179|592219163|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958760|NCT04677179|592219164|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958761|NCT04677179|592219165|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958762|NCT04677179|592219166|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
163958763|NCT04677179|592219157|FG000|Extension Treatment Period|Lack of Efficacy|0|||
163958764|NCT04677179|592219158|FG001|Extension Treatment Period|Lack of Efficacy|0|||
163958765|NCT04677179|592219159|FG002|Extension Treatment Period|Lack of Efficacy|0|||
163958766|NCT04677179|592219160|FG003|Extension Treatment Period|Lack of Efficacy|0|||
163958767|NCT04677179|592219161|FG004|Extension Treatment Period|Lack of Efficacy|0|||
163958768|NCT04677179|592219162|FG005|Extension Treatment Period|Lack of Efficacy|0|||
163958769|NCT04677179|592219163|FG006|Extension Treatment Period|Lack of Efficacy|6|||
163958770|NCT04677179|592219164|FG007|Extension Treatment Period|Lack of Efficacy|0|||
163958771|NCT04677179|592219165|FG008|Extension Treatment Period|Lack of Efficacy|0|||
163958772|NCT04677179|592219166|FG009|Extension Treatment Period|Lack of Efficacy|0|||
163958773|NCT04677179|592219157|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
163958774|NCT04677179|592219158|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
163958775|NCT04677179|592219159|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
163958776|NCT04677179|592219160|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
163958777|NCT04677179|592219161|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
163958778|NCT04677179|592219162|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
163958779|NCT04677179|592219163|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
163958780|NCT04677179|592219164|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
163958781|NCT04677179|592219165|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
163958782|NCT04677179|592219166|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
163958783|NCT04677179|592219157|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
163958784|NCT04677179|592219158|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
163958785|NCT04677179|592219159|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
163958786|NCT04677179|592219160|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
163958787|NCT04677179|592219161|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
163958788|NCT04677179|592219162|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
164148630|NCT04895982|592904914|FG003|Overall Study|Lost to Follow-up|0|||
163958789|NCT04677179|592219163|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
163958790|NCT04677179|592219164|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
163958791|NCT04677179|592219165|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
163958792|NCT04677179|592219166|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
163958793|NCT04677179|592219157|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
163958794|NCT04677179|592219158|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
163958795|NCT04677179|592219159|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
163958796|NCT04677179|592219160|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
163958797|NCT04677179|592219161|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
163958798|NCT04677179|592219162|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
163958799|NCT04677179|592219163|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
163958800|NCT04677179|592219164|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
163958801|NCT04677179|592219165|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
163958802|NCT04677179|592219166|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
163958803|NCT04677179|592219157|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958804|NCT04677179|592219158|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958805|NCT04677179|592219159|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958806|NCT04677179|592219160|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958807|NCT04677179|592219161|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958808|NCT04677179|592219162|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958809|NCT04677179|592219163|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958810|NCT04677179|592219164|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
163958811|NCT04677179|592219165|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
163958812|NCT04677179|592219166|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
163958813|NCT04677179|592219157|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958814|NCT04677179|592219158|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958815|NCT04677179|592219159|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958816|NCT04677179|592219160|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958817|NCT04677179|592219161|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958818|NCT04677179|592219162|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958819|NCT04677179|592219163|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958820|NCT04677179|592219164|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
163958821|NCT04677179|592219165|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958822|NCT04677179|592219166|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
163958823|NCT04677179|592219157|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958824|NCT04677179|592219158|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958825|NCT04677179|592219159|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958826|NCT04677179|592219160|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958827|NCT04677179|592219161|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958828|NCT04677179|592219162|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958829|NCT04677179|592219163|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958830|NCT04677179|592219164|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
163958831|NCT04677179|592219165|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
163958832|NCT04677179|592219166|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
163958833|NCT04677179|592219157|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958834|NCT04677179|592219158|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958835|NCT04677179|592219159|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958836|NCT04677179|592219160|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958837|NCT04677179|592219161|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958838|NCT04677179|592219162|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958839|NCT04677179|592219163|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
163958840|NCT04677179|592219164|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
163958841|NCT04677179|592219165|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
163958842|NCT04677179|592219166|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
163958843|NCT01536015|592219167|FG000|Overall Study|Adverse Event|1|||
163958844|NCT01536015|592219168|FG001|Overall Study|Adverse Event|4|||
163958845|NCT01536015|592219167|FG000|Overall Study|Lost to Follow-up|0|||
163958846|NCT01536015|592219168|FG001|Overall Study|Lost to Follow-up|1|||
163958847|NCT01536015|592219167|FG000|Overall Study|Inclusion Criterion not met|2|||
163958848|NCT01536015|592219168|FG001|Overall Study|Inclusion Criterion not met|0|||
163958849|NCT01536015|592219167|FG000|Overall Study|Study closure|5|||
163958850|NCT01536015|592219168|FG001|Overall Study|Study closure|5|||
163958851|NCT03261700|592219169|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
163958852|NCT03261700|592219170|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
163958853|NCT01204398|592219171|FG000|Overall Study|Adverse Event|1|||
163958854|NCT01723254|592219172|FG000|Overall Study|Conflict with work schedule|0|||
163958855|NCT01723254|592219173|FG001|Overall Study|Conflict with work schedule|0|||
163958856|NCT01723254|592219174|FG002|Overall Study|Conflict with work schedule|0|||
163958857|NCT01723254|592219175|FG003|Overall Study|Conflict with work schedule|0|||
163958858|NCT01723254|592219176|FG004|Overall Study|Conflict with work schedule|0|||
163958859|NCT01723254|592219177|FG005|Overall Study|Conflict with work schedule|0|||
163958860|NCT01723254|592219178|FG006|Overall Study|Conflict with work schedule|0|||
163958861|NCT01723254|592219179|FG007|Overall Study|Conflict with work schedule|1|||
163958862|NCT01723254|592219172|FG000|Overall Study|Personal issues|0|||
163958863|NCT01723254|592219173|FG001|Overall Study|Personal issues|0|||
163958864|NCT01723254|592219174|FG002|Overall Study|Personal issues|0|||
163958865|NCT01723254|592219175|FG003|Overall Study|Personal issues|0|||
163958866|NCT01723254|592219176|FG004|Overall Study|Personal issues|0|||
163958867|NCT01723254|592219177|FG005|Overall Study|Personal issues|1|||
163958868|NCT01723254|592219178|FG006|Overall Study|Personal issues|0|||
163958869|NCT01723254|592219179|FG007|Overall Study|Personal issues|0|||
163958870|NCT01723254|592219172|FG000|Overall Study|No longer have time to participate|0|||
163958871|NCT01723254|592219173|FG001|Overall Study|No longer have time to participate|0|||
163958872|NCT01723254|592219174|FG002|Overall Study|No longer have time to participate|0|||
163958873|NCT01723254|592219175|FG003|Overall Study|No longer have time to participate|1|||
163958874|NCT01723254|592219176|FG004|Overall Study|No longer have time to participate|0|||
163958875|NCT01723254|592219177|FG005|Overall Study|No longer have time to participate|0|||
163958876|NCT01723254|592219178|FG006|Overall Study|No longer have time to participate|0|||
163958877|NCT01723254|592219179|FG007|Overall Study|No longer have time to participate|0|||
163958878|NCT01723254|592219172|FG000|Overall Study|Move/Left to another country/city|0|||
163958879|NCT01723254|592219173|FG001|Overall Study|Move/Left to another country/city|0|||
163958880|NCT01723254|592219174|FG002|Overall Study|Move/Left to another country/city|2|||
163958881|NCT01723254|592219175|FG003|Overall Study|Move/Left to another country/city|1|||
163958882|NCT01723254|592219176|FG004|Overall Study|Move/Left to another country/city|1|||
163958883|NCT01723254|592219177|FG005|Overall Study|Move/Left to another country/city|0|||
163958884|NCT01723254|592219178|FG006|Overall Study|Move/Left to another country/city|0|||
163958885|NCT01723254|592219179|FG007|Overall Study|Move/Left to another country/city|0|||
163958886|NCT01723254|592219172|FG000|Overall Study|Protocol Violation|0|||
163958887|NCT01723254|592219173|FG001|Overall Study|Protocol Violation|1|||
163958888|NCT01723254|592219174|FG002|Overall Study|Protocol Violation|0|||
163958889|NCT01723254|592219175|FG003|Overall Study|Protocol Violation|0|||
163958890|NCT01723254|592219176|FG004|Overall Study|Protocol Violation|0|||
163958891|NCT01723254|592219177|FG005|Overall Study|Protocol Violation|0|||
163958892|NCT01723254|592219178|FG006|Overall Study|Protocol Violation|0|||
163958893|NCT01723254|592219179|FG007|Overall Study|Protocol Violation|0|||
163958894|NCT01723254|592219172|FG000|Overall Study|Withdrawal by Subject|1|||
163958895|NCT01723254|592219173|FG001|Overall Study|Withdrawal by Subject|2|||
163958896|NCT01723254|592219174|FG002|Overall Study|Withdrawal by Subject|1|||
163958897|NCT01723254|592219175|FG003|Overall Study|Withdrawal by Subject|0|||
163958898|NCT01723254|592219176|FG004|Overall Study|Withdrawal by Subject|1|||
163958899|NCT01723254|592219177|FG005|Overall Study|Withdrawal by Subject|1|||
163958900|NCT01723254|592219178|FG006|Overall Study|Withdrawal by Subject|1|||
163958901|NCT01723254|592219179|FG007|Overall Study|Withdrawal by Subject|2|||
163958902|NCT01257425|592219180|FG000|Overall Study|Lack of Efficacy|3|||
163958903|NCT01257425|592219181|FG001|Overall Study|Lack of Efficacy|3|||
163958904|NCT01257425|592219180|FG000|Overall Study|Adverse Event|1|||
163958905|NCT01257425|592219181|FG001|Overall Study|Adverse Event|1|||
163958906|NCT01257425|592219180|FG000|Overall Study|Protocol Violation|1|||
163958907|NCT01257425|592219181|FG001|Overall Study|Protocol Violation|1|||
163958908|NCT01257425|592219180|FG000|Overall Study|Withdrawal by Subject|0|||
163958909|NCT01257425|592219181|FG001|Overall Study|Withdrawal by Subject|1|||
163958910|NCT01257425|592219180|FG000|Overall Study|Death|1|||
163958911|NCT01257425|592219181|FG001|Overall Study|Death|0|||
163958912|NCT02656823|592219186|FG000|Overall Study|Adverse Event|3|||
163958913|NCT02656823|592219186|FG000|Overall Study|Lost to Follow-up|2|||
164048187|NCT00939055|592536040|FG000|Overall Study|Discontinuation prior to procedure|4|||
164048188|NCT00939055|592536041|FG001|Overall Study|Discontinuation prior to procedure|0|||
164048189|NCT00584987|592536044|FG000|Overall Study|Protocol Violation|1|||
164048190|NCT00584987|592536045|FG001|Overall Study|Protocol Violation|1|||
164048191|NCT00584987|592536046|FG002|Overall Study|Protocol Violation|1|||
164048192|NCT00584987|592536047|FG003|Overall Study|Protocol Violation|0|||
164048193|NCT00584987|592536044|FG000|Overall Study|Adverse Event|0|||
164048194|NCT00584987|592536045|FG001|Overall Study|Adverse Event|0|||
164048195|NCT00584987|592536046|FG002|Overall Study|Adverse Event|0|||
164048196|NCT00584987|592536047|FG003|Overall Study|Adverse Event|1|||
164048197|NCT01944462|592536051|FG000|PPPP Educational Program|Lost to Follow-up|60|||
164048198|NCT00808028|592536052|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
164048199|NCT00808028|592536053|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
164048200|NCT00808028|592536054|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
164048201|NCT00808028|592536055|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
164048202|NCT00808028|592536052|FG000|Stage 1 (6 Months)|Other|1|||
164048203|NCT00808028|592536053|FG001|Stage 1 (6 Months)|Other|0|||
164048204|NCT00808028|592536054|FG002|Stage 1 (6 Months)|Other|2|||
164048205|NCT00808028|592536055|FG003|Stage 1 (6 Months)|Other|4|||
164048206|NCT00808028|592536052|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
164048207|NCT00808028|592536053|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
164048208|NCT00808028|592536054|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
164048209|NCT00808028|592536055|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
164048210|NCT00808028|592536052|FG000|Stage 1 (6 Months)|Adverse Event|0|||
164048211|NCT00808028|592536053|FG001|Stage 1 (6 Months)|Adverse Event|0|||
164048212|NCT00808028|592536054|FG002|Stage 1 (6 Months)|Adverse Event|1|||
164048213|NCT00808028|592536055|FG003|Stage 1 (6 Months)|Adverse Event|2|||
164048214|NCT00808028|592536052|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
164048215|NCT00808028|592536053|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
164048216|NCT00808028|592536054|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
164048217|NCT00808028|592536055|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
164048218|NCT00808028|592536052|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
164048219|NCT00808028|592536053|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
164048220|NCT00808028|592536054|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
164048221|NCT00808028|592536055|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
164048222|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
164048223|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
164048224|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
164048225|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
164048226|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
164048227|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
164048228|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
164048229|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
164048230|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
164048231|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
164048232|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
164048233|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
164048234|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
164048235|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
164048236|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
164048237|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
164048238|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
164048239|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
164048240|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
164048241|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
164048242|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
164048243|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
164048244|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
164048245|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
164048246|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
164048247|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
164048248|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
164048249|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
164048250|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
164048251|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
164048252|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
164048253|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
164048254|NCT00808028|592536052|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
164048255|NCT00808028|592536053|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
164048256|NCT00808028|592536054|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
164048257|NCT00808028|592536055|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
164048258|NCT01599585|592536057|FG000|Overall Study|Withdrawal by Subject|16|||
164048259|NCT01599585|592536058|FG001|Overall Study|Withdrawal by Subject|9|||
164048260|NCT01599585|592536057|FG000|Overall Study|Lost to Follow-up|3|||
164048261|NCT01599585|592536058|FG001|Overall Study|Lost to Follow-up|5|||
164048262|NCT01599585|592536057|FG000|Overall Study|randomized did not start treatment|3|||
164048263|NCT01599585|592536058|FG001|Overall Study|randomized did not start treatment|3|||
164048264|NCT00081263|592536059|FG000|Overall Study|clerical error|1|||
164048265|NCT00081263|592536060|FG001|Overall Study|clerical error|0|||
164048266|NCT00081263|592536059|FG000|Overall Study|wrong cell type|7|||
164048267|NCT00081263|592536060|FG001|Overall Study|wrong cell type|5|||
164048268|NCT00081263|592536059|FG000|Overall Study|improper pre-protocol therapy|0|||
164048269|NCT00081263|592536060|FG001|Overall Study|improper pre-protocol therapy|1|||
164048270|NCT00081263|592536059|FG000|Overall Study|Inadequate pathology|0|||
164048271|NCT00081263|592536060|FG001|Overall Study|Inadequate pathology|1|||
164048272|NCT00081263|592536059|FG000|Overall Study|Never treated|4|||
164048273|NCT00081263|592536060|FG001|Overall Study|Never treated|5|||
164048274|NCT00081263|592536059|FG000|Overall Study|Inadequate data|5|||
164048275|NCT00081263|592536060|FG001|Overall Study|Inadequate data|10|||
164048276|NCT01852591|592536061|FG000|Overall Study|Withdrawal by Subject|2|||
164048277|NCT01852591|592536061|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
164048278|NCT01267955|592536068|FG000|Stage 1 (6 Months)|Death|3|||
164048279|NCT01267955|592536068|FG000|Stage 2 (6 Months)|Death|5|||
164048280|NCT01267955|592536068|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
164048281|NCT03070119|592536069|FG000|Overall Study|Adverse Event|0|||
164048282|NCT03070119|592536070|FG001|Overall Study|Adverse Event|0|||
164048283|NCT03070119|592536071|FG002|Overall Study|Adverse Event|1|||
164048284|NCT03070119|592536069|FG000|Overall Study|Lost to Follow-up|0|||
164048285|NCT03070119|592536070|FG001|Overall Study|Lost to Follow-up|1|||
164048286|NCT03070119|592536071|FG002|Overall Study|Lost to Follow-up|0|||
164048287|NCT03070119|592536069|FG000|Overall Study|Consent Withdrawn|6|||
164048288|NCT03070119|592536070|FG001|Overall Study|Consent Withdrawn|5|||
164048289|NCT03070119|592536071|FG002|Overall Study|Consent Withdrawn|3|||
164048290|NCT03070119|592536069|FG000|Overall Study|Investigator Decision|0|||
164048291|NCT03070119|592536070|FG001|Overall Study|Investigator Decision|0|||
164048292|NCT03070119|592536071|FG002|Overall Study|Investigator Decision|1|||
164048293|NCT03070119|592536069|FG000|Overall Study|Death|7|||
164048294|NCT03070119|592536070|FG001|Overall Study|Death|14|||
164048295|NCT03070119|592536071|FG002|Overall Study|Death|5|||
164048296|NCT03070119|592536069|FG000|Overall Study|Disease Progression|5|||
164048297|NCT03070119|592536070|FG001|Overall Study|Disease Progression|7|||
164048298|NCT03070119|592536071|FG002|Overall Study|Disease Progression|7|||
164048299|NCT03070119|592536069|FG000|Overall Study|Reason not Specified|2|||
164048300|NCT03070119|592536070|FG001|Overall Study|Reason not Specified|2|||
164048301|NCT03070119|592536071|FG002|Overall Study|Reason not Specified|1|||
164048302|NCT01996865|592536072|FG000|Induction Period|Protocol Violation|1|||
164048303|NCT01996865|592536073|FG001|Induction Period|Protocol Violation|0|||
164048304|NCT01996865|592536074|FG002|Induction Period|Protocol Violation|0|||
164048305|NCT01996865|592536072|FG000|Induction Period|Progressive Disease|4|||
164048306|NCT01996865|592536073|FG001|Induction Period|Progressive Disease|0|||
164048307|NCT01996865|592536074|FG002|Induction Period|Progressive Disease|0|||
164048308|NCT01996865|592536072|FG000|Induction Period|Lost to Follow-up|10|||
164048309|NCT01996865|592536073|FG001|Induction Period|Lost to Follow-up|0|||
164048310|NCT01996865|592536074|FG002|Induction Period|Lost to Follow-up|0|||
164048311|NCT01996865|592536072|FG000|Induction Period|Other Reasons|13|||
164048312|NCT01996865|592536073|FG001|Induction Period|Other Reasons|0|||
164048313|NCT01996865|592536074|FG002|Induction Period|Other Reasons|0|||
164048314|NCT01996865|592536072|FG000|Induction Period|Adverse Event|20|||
164048315|NCT01996865|592536073|FG001|Induction Period|Adverse Event|0|||
164048316|NCT01996865|592536074|FG002|Induction Period|Adverse Event|0|||
164048317|NCT01996865|592536072|FG000|Induction Period|Withdrawal by Subject|60|||
164048318|NCT01996865|592536073|FG001|Induction Period|Withdrawal by Subject|0|||
164048319|NCT01996865|592536074|FG002|Induction Period|Withdrawal by Subject|0|||
164048320|NCT01996865|592536072|FG000|Induction Period|Death|111|||
164048321|NCT01996865|592536073|FG001|Induction Period|Death|0|||
164048322|NCT01996865|592536074|FG002|Induction Period|Death|0|||
164048323|NCT01996865|592536072|FG000|Maintenance Period|Protocol Violation|0|||
164048324|NCT01996865|592536073|FG001|Maintenance Period|Protocol Violation|1|||
164048325|NCT01996865|592536074|FG002|Maintenance Period|Protocol Violation|1|||
164048326|NCT01996865|592536072|FG000|Maintenance Period|Other reasons|0|||
164048327|NCT01996865|592536073|FG001|Maintenance Period|Other reasons|8|||
164048328|NCT01996865|592536074|FG002|Maintenance Period|Other reasons|5|||
164048329|NCT01996865|592536072|FG000|Maintenance Period|Progressive Disease|0|||
164048330|NCT01996865|592536073|FG001|Maintenance Period|Progressive Disease|6|||
164048331|NCT01996865|592536074|FG002|Maintenance Period|Progressive Disease|23|||
164048332|NCT01996865|592536072|FG000|Maintenance Period|Withdrawal by Subject|0|||
164048333|NCT01996865|592536073|FG001|Maintenance Period|Withdrawal by Subject|18|||
164048334|NCT01996865|592536074|FG002|Maintenance Period|Withdrawal by Subject|4|||
164048335|NCT01996865|592536072|FG000|Maintenance Period|Adverse Event|0|||
164048336|NCT01996865|592536073|FG001|Maintenance Period|Adverse Event|7|||
164048337|NCT01996865|592536074|FG002|Maintenance Period|Adverse Event|7|||
164048338|NCT01996865|592536072|FG000|Maintenance Period|Death|0|||
164048339|NCT01996865|592536073|FG001|Maintenance Period|Death|15|||
164048340|NCT01996865|592536074|FG002|Maintenance Period|Death|3|||
164048341|NCT01996865|592536072|FG000|Maintenance Period|Lost to Follow-up|0|||
164048342|NCT01996865|592536073|FG001|Maintenance Period|Lost to Follow-up|2|||
164048343|NCT01996865|592536074|FG002|Maintenance Period|Lost to Follow-up|0|||
164048344|NCT05304611|592536077|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048345|NCT05304611|592536078|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048346|NCT05304611|592536079|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048347|NCT05304611|592536080|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048348|NCT05304611|592536081|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048349|NCT05304611|592536082|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048350|NCT05304611|592536083|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
164048351|NCT05304611|592536084|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048352|NCT05304611|592536085|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
164048353|NCT05304611|592536086|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048354|NCT05304611|592536087|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048355|NCT05304611|592536088|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
164048356|NCT05304611|592536077|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
164048357|NCT05304611|592536078|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
164048358|NCT05304611|592536079|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
164048359|NCT05304611|592536080|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
164048360|NCT05304611|592536081|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
164048361|NCT05304611|592536082|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
164048362|NCT05304611|592536083|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
164048363|NCT05304611|592536084|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
164048364|NCT05304611|592536085|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
164048365|NCT05304611|592536086|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
164048366|NCT05304611|592536087|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
164048367|NCT05304611|592536088|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
164048368|NCT05304611|592536077|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
164048369|NCT05304611|592536078|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
164048370|NCT05304611|592536079|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
164048371|NCT05304611|592536080|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
164048372|NCT05304611|592536081|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
164048373|NCT05304611|592536082|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
164048374|NCT05304611|592536083|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
164048375|NCT05304611|592536084|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
164048376|NCT05304611|592536085|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
164048377|NCT05304611|592536086|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
164048378|NCT05304611|592536087|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
164048379|NCT05304611|592536088|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
164048380|NCT00963820|592536089|FG000|Dose Escalation Phase|Progressive Disease|3|||
164048381|NCT00963820|592536090|FG001|Dose Escalation Phase|Progressive Disease|3|||
164048382|NCT00963820|592536091|FG002|Dose Escalation Phase|Progressive Disease|3|||
164048383|NCT00963820|592536092|FG003|Dose Escalation Phase|Progressive Disease|3|||
164048384|NCT00963820|592536093|FG004|Dose Escalation Phase|Progressive Disease|4|||
164048385|NCT00963820|592536094|FG005|Dose Escalation Phase|Progressive Disease|3|||
164048386|NCT00963820|592536095|FG006|Dose Escalation Phase|Progressive Disease|3|||
164048387|NCT00963820|592536096|FG007|Dose Escalation Phase|Progressive Disease|2|||
164048388|NCT00963820|592536097|FG008|Dose Escalation Phase|Progressive Disease|0|||
164048389|NCT00963820|592536098|FG009|Dose Escalation Phase|Progressive Disease|0|||
164048390|NCT00963820|592536099|FG010|Dose Escalation Phase|Progressive Disease|0|||
164048391|NCT00963820|592536100|FG011|Dose Escalation Phase|Progressive Disease|0|||
164048392|NCT00963820|592536089|FG000|Dose Escalation Phase|Adverse Event|0|||
164048393|NCT00963820|592536090|FG001|Dose Escalation Phase|Adverse Event|0|||
164048394|NCT00963820|592536091|FG002|Dose Escalation Phase|Adverse Event|0|||
164048395|NCT00963820|592536092|FG003|Dose Escalation Phase|Adverse Event|0|||
164048396|NCT00963820|592536093|FG004|Dose Escalation Phase|Adverse Event|0|||
164048397|NCT00963820|592536094|FG005|Dose Escalation Phase|Adverse Event|0|||
164048398|NCT00963820|592536095|FG006|Dose Escalation Phase|Adverse Event|3|||
164048399|NCT00963820|592536096|FG007|Dose Escalation Phase|Adverse Event|1|||
164048400|NCT00963820|592536097|FG008|Dose Escalation Phase|Adverse Event|0|||
164048401|NCT00963820|592536098|FG009|Dose Escalation Phase|Adverse Event|0|||
164048402|NCT00963820|592536099|FG010|Dose Escalation Phase|Adverse Event|0|||
164048403|NCT00963820|592536100|FG011|Dose Escalation Phase|Adverse Event|0|||
164048404|NCT00963820|592536089|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
164048405|NCT00963820|592536090|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
164048406|NCT00963820|592536091|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
164048407|NCT00963820|592536092|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
164048408|NCT00963820|592536093|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
164048409|NCT00963820|592536094|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
164048410|NCT00963820|592536095|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
164048411|NCT00963820|592536096|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
164048412|NCT00963820|592536097|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
164048413|NCT00963820|592536098|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
164048414|NCT00963820|592536099|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
164048415|NCT00963820|592536100|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
164048416|NCT00963820|592536089|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048417|NCT00963820|592536090|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048418|NCT00963820|592536091|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048419|NCT00963820|592536092|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048420|NCT00963820|592536093|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048421|NCT00963820|592536094|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048422|NCT00963820|592536095|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
164048423|NCT00963820|592536096|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048424|NCT00963820|592536097|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048425|NCT00963820|592536098|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048426|NCT00963820|592536099|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048427|NCT00963820|592536100|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
164048428|NCT00963820|592536089|FG000|Expansion Phase|Progressive Disease|0|||
164048429|NCT00963820|592536090|FG001|Expansion Phase|Progressive Disease|0|||
164048430|NCT00963820|592536091|FG002|Expansion Phase|Progressive Disease|0|||
164048431|NCT00963820|592536092|FG003|Expansion Phase|Progressive Disease|0|||
164048432|NCT00963820|592536093|FG004|Expansion Phase|Progressive Disease|0|||
164048433|NCT00963820|592536094|FG005|Expansion Phase|Progressive Disease|0|||
164048434|NCT00963820|592536095|FG006|Expansion Phase|Progressive Disease|0|||
164048435|NCT00963820|592536096|FG007|Expansion Phase|Progressive Disease|0|||
164048436|NCT00963820|592536097|FG008|Expansion Phase|Progressive Disease|8|||
164048437|NCT00963820|592536098|FG009|Expansion Phase|Progressive Disease|6|||
164048438|NCT00963820|592536099|FG010|Expansion Phase|Progressive Disease|4|||
164048439|NCT00963820|592536100|FG011|Expansion Phase|Progressive Disease|2|||
164048440|NCT00963820|592536089|FG000|Expansion Phase|Adverse Event|0|||
164048441|NCT00963820|592536090|FG001|Expansion Phase|Adverse Event|0|||
164048442|NCT00963820|592536091|FG002|Expansion Phase|Adverse Event|0|||
164048443|NCT00963820|592536092|FG003|Expansion Phase|Adverse Event|0|||
164048444|NCT00963820|592536093|FG004|Expansion Phase|Adverse Event|0|||
164048445|NCT00963820|592536094|FG005|Expansion Phase|Adverse Event|0|||
164048446|NCT00963820|592536095|FG006|Expansion Phase|Adverse Event|0|||
164048447|NCT00963820|592536096|FG007|Expansion Phase|Adverse Event|0|||
164048448|NCT00963820|592536097|FG008|Expansion Phase|Adverse Event|1|||
164048449|NCT00963820|592536098|FG009|Expansion Phase|Adverse Event|3|||
164048450|NCT00963820|592536099|FG010|Expansion Phase|Adverse Event|0|||
164048451|NCT00963820|592536100|FG011|Expansion Phase|Adverse Event|0|||
164048452|NCT00963820|592536089|FG000|Expansion Phase|Withdrawal by Subject|0|||
164048453|NCT00963820|592536090|FG001|Expansion Phase|Withdrawal by Subject|0|||
164048454|NCT00963820|592536091|FG002|Expansion Phase|Withdrawal by Subject|0|||
164048455|NCT00963820|592536092|FG003|Expansion Phase|Withdrawal by Subject|0|||
164048456|NCT00963820|592536093|FG004|Expansion Phase|Withdrawal by Subject|0|||
164048457|NCT00963820|592536094|FG005|Expansion Phase|Withdrawal by Subject|0|||
164048458|NCT00963820|592536095|FG006|Expansion Phase|Withdrawal by Subject|0|||
164048459|NCT00963820|592536096|FG007|Expansion Phase|Withdrawal by Subject|0|||
164048460|NCT00963820|592536097|FG008|Expansion Phase|Withdrawal by Subject|1|||
164048461|NCT00963820|592536098|FG009|Expansion Phase|Withdrawal by Subject|0|||
164048462|NCT00963820|592536099|FG010|Expansion Phase|Withdrawal by Subject|1|||
164048463|NCT00963820|592536100|FG011|Expansion Phase|Withdrawal by Subject|1|||
164048464|NCT00963820|592536089|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048465|NCT00963820|592536090|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048466|NCT00963820|592536091|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048467|NCT00963820|592536092|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048468|NCT00963820|592536093|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048469|NCT00963820|592536094|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048470|NCT00963820|592536095|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048471|NCT00963820|592536096|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048472|NCT00963820|592536097|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048473|NCT00963820|592536098|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048474|NCT00963820|592536099|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
164048475|NCT00963820|592536100|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
164048476|NCT02756845|592536106|FG000|Overall Study|Death|12|||
164048477|NCT02756845|592536107|FG001|Overall Study|Death|2|||
164048478|NCT02756845|592536106|FG000|Overall Study|Withdrawal by Subject|1|||
164048479|NCT02756845|592536107|FG001|Overall Study|Withdrawal by Subject|0|||
164048480|NCT05333289|592536108|FG000|Overall Study|Other|1|||
164048481|NCT05333289|592536109|FG001|Overall Study|Other|0|||
164048482|NCT05333289|592536110|FG002|Overall Study|Other|0|||
164048483|NCT05333289|592536111|FG003|Overall Study|Other|1|||
164048484|NCT05333289|592536112|FG004|Overall Study|Other|1|||
164048485|NCT05333289|592536113|FG005|Overall Study|Other|2|||
164048486|NCT05333289|592536114|FG006|Overall Study|Other|2|||
164048487|NCT05333289|592536115|FG007|Overall Study|Other|0|||
164048488|NCT05333289|592536108|FG000|Overall Study|Withdrawal by Subject|1|||
164048489|NCT05333289|592536109|FG001|Overall Study|Withdrawal by Subject|2|||
164048490|NCT05333289|592536110|FG002|Overall Study|Withdrawal by Subject|2|||
164048491|NCT05333289|592536111|FG003|Overall Study|Withdrawal by Subject|1|||
164048492|NCT05333289|592536112|FG004|Overall Study|Withdrawal by Subject|1|||
164048493|NCT05333289|592536113|FG005|Overall Study|Withdrawal by Subject|2|||
164048494|NCT05333289|592536114|FG006|Overall Study|Withdrawal by Subject|1|||
164048495|NCT05333289|592536115|FG007|Overall Study|Withdrawal by Subject|3|||
164048496|NCT05333289|592536108|FG000|Overall Study|Protocol Violation|1|||
164048497|NCT05333289|592536109|FG001|Overall Study|Protocol Violation|0|||
164048498|NCT05333289|592536110|FG002|Overall Study|Protocol Violation|0|||
164048499|NCT05333289|592536111|FG003|Overall Study|Protocol Violation|0|||
164048500|NCT05333289|592536112|FG004|Overall Study|Protocol Violation|0|||
164048501|NCT05333289|592536113|FG005|Overall Study|Protocol Violation|0|||
164048502|NCT05333289|592536114|FG006|Overall Study|Protocol Violation|0|||
164048503|NCT05333289|592536115|FG007|Overall Study|Protocol Violation|0|||
164048504|NCT05333289|592536108|FG000|Overall Study|Physician Decision|0|||
164048505|NCT05333289|592536109|FG001|Overall Study|Physician Decision|0|||
164048506|NCT05333289|592536110|FG002|Overall Study|Physician Decision|1|||
164048507|NCT05333289|592536111|FG003|Overall Study|Physician Decision|0|||
164048508|NCT05333289|592536112|FG004|Overall Study|Physician Decision|0|||
164048509|NCT05333289|592536113|FG005|Overall Study|Physician Decision|2|||
164048510|NCT05333289|592536114|FG006|Overall Study|Physician Decision|0|||
164048511|NCT05333289|592536115|FG007|Overall Study|Physician Decision|0|||
164048512|NCT05333289|592536108|FG000|Overall Study|Lost to Follow-up|6|||
164048513|NCT05333289|592536109|FG001|Overall Study|Lost to Follow-up|0|||
164048514|NCT05333289|592536110|FG002|Overall Study|Lost to Follow-up|1|||
164048515|NCT05333289|592536111|FG003|Overall Study|Lost to Follow-up|6|||
164048516|NCT05333289|592536112|FG004|Overall Study|Lost to Follow-up|3|||
164048517|NCT05333289|592536113|FG005|Overall Study|Lost to Follow-up|3|||
164048518|NCT05333289|592536114|FG006|Overall Study|Lost to Follow-up|2|||
164048519|NCT05333289|592536115|FG007|Overall Study|Lost to Follow-up|1|||
164048520|NCT05333289|592536108|FG000|Overall Study|Death|1|||
164048521|NCT05333289|592536109|FG001|Overall Study|Death|0|||
164048522|NCT05333289|592536110|FG002|Overall Study|Death|0|||
164048523|NCT05333289|592536111|FG003|Overall Study|Death|0|||
164048524|NCT05333289|592536112|FG004|Overall Study|Death|0|||
164048525|NCT05333289|592536113|FG005|Overall Study|Death|0|||
164048526|NCT05333289|592536114|FG006|Overall Study|Death|0|||
164048527|NCT05333289|592536115|FG007|Overall Study|Death|0|||
164048528|NCT02005211|592536116|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164048529|NCT02005211|592536117|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164048530|NCT02005211|592536118|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164048531|NCT02005211|592536119|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164048532|NCT02005211|592536120|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
164048533|NCT02005211|592536121|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164048534|NCT02005211|592536122|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
164048535|NCT00397631|592536124|FG000|Overall Study|Adverse Event|5|||
164048536|NCT00397631|592536125|FG001|Overall Study|Adverse Event|6|||
164048537|NCT00397631|592536124|FG000|Overall Study|Lack of Efficacy|7|||
164048538|NCT00397631|592536125|FG001|Overall Study|Lack of Efficacy|10|||
164048539|NCT00397631|592536124|FG000|Overall Study|Lost to Follow-up|8|||
164048540|NCT00397631|592536125|FG001|Overall Study|Lost to Follow-up|9|||
164048541|NCT00397631|592536124|FG000|Overall Study|Physician Decision|2|||
164048542|NCT00397631|592536125|FG001|Overall Study|Physician Decision|0|||
164048543|NCT00397631|592536124|FG000|Overall Study|Protocol Violation|0|||
164048544|NCT00397631|592536125|FG001|Overall Study|Protocol Violation|1|||
164048545|NCT00397631|592536124|FG000|Overall Study|Withdrawal by Subject|7|||
164048546|NCT00397631|592536125|FG001|Overall Study|Withdrawal by Subject|14|||
164048547|NCT00397631|592536124|FG000|Overall Study|protocol discontinuation criteria|1|||
164048548|NCT00397631|592536125|FG001|Overall Study|protocol discontinuation criteria|4|||
164048549|NCT02202161|592536126|FG000|Overall Study|Adverse Event|1|||
164048550|NCT02202161|592536127|FG001|Overall Study|Adverse Event|1|||
164048551|NCT02202161|592536128|FG002|Overall Study|Adverse Event|0|||
164048552|NCT02202161|592536129|FG003|Overall Study|Adverse Event|0|||
164048553|NCT02202161|592536130|FG004|Overall Study|Adverse Event|0|||
164048554|NCT02202161|592536131|FG005|Overall Study|Adverse Event|1|||
164048555|NCT02202161|592536132|FG006|Overall Study|Adverse Event|0|||
164048556|NCT02202161|592536133|FG007|Overall Study|Adverse Event|0|||
164048557|NCT02202161|592536126|FG000|Overall Study|Did not meet continuation criteria|0|||
164048558|NCT02202161|592536127|FG001|Overall Study|Did not meet continuation criteria|0|||
164048559|NCT02202161|592536128|FG002|Overall Study|Did not meet continuation criteria|0|||
164048560|NCT02202161|592536129|FG003|Overall Study|Did not meet continuation criteria|0|||
164048561|NCT02202161|592536130|FG004|Overall Study|Did not meet continuation criteria|0|||
164048562|NCT02202161|592536131|FG005|Overall Study|Did not meet continuation criteria|0|||
164048563|NCT02202161|592536132|FG006|Overall Study|Did not meet continuation criteria|0|||
164048564|NCT02202161|592536133|FG007|Overall Study|Did not meet continuation criteria|3|||
164048565|NCT02202161|592536126|FG000|Overall Study|Physician Decision|0|||
164048566|NCT02202161|592536127|FG001|Overall Study|Physician Decision|0|||
164048567|NCT02202161|592536128|FG002|Overall Study|Physician Decision|0|||
164048568|NCT02202161|592536129|FG003|Overall Study|Physician Decision|0|||
164048569|NCT02202161|592536130|FG004|Overall Study|Physician Decision|0|||
164048570|NCT02202161|592536131|FG005|Overall Study|Physician Decision|0|||
164048571|NCT02202161|592536132|FG006|Overall Study|Physician Decision|0|||
164048572|NCT02202161|592536133|FG007|Overall Study|Physician Decision|3|||
164048573|NCT02202161|592536126|FG000|Overall Study|Withdrawal by Subject|0|||
164048574|NCT02202161|592536127|FG001|Overall Study|Withdrawal by Subject|0|||
164048575|NCT02202161|592536128|FG002|Overall Study|Withdrawal by Subject|0|||
164048576|NCT02202161|592536129|FG003|Overall Study|Withdrawal by Subject|0|||
164048577|NCT02202161|592536130|FG004|Overall Study|Withdrawal by Subject|1|||
164048578|NCT02202161|592536131|FG005|Overall Study|Withdrawal by Subject|0|||
164048579|NCT02202161|592536132|FG006|Overall Study|Withdrawal by Subject|0|||
164048580|NCT02202161|592536133|FG007|Overall Study|Withdrawal by Subject|0|||
164048581|NCT03797144|592536135|FG000|Enrollment|Protocol Violation|4|||
164048582|NCT03797144|592536136|FG001|Enrollment|Protocol Violation|1|||
164048583|NCT03797144|592536135|FG000|Surgery|Protocol Violation|1|||
164048584|NCT03797144|592536136|FG001|Surgery|Protocol Violation|0|||
164048585|NCT03797144|592536135|FG000|3 Month|Early termination cut-off date|2|||
164048586|NCT03797144|592536136|FG001|3 Month|Early termination cut-off date|0|||
164048587|NCT03797144|592536135|FG000|12 Month|Early termination cut-off date|8|||
164048588|NCT03797144|592536136|FG001|12 Month|Early termination cut-off date|9|||
164048589|NCT03797144|592536135|FG000|24 Month|Early termination cut-off date|1|||
164048590|NCT03797144|592536136|FG001|24 Month|Early termination cut-off date|1|||
164048591|NCT01878175|592536138|FG000|Overall Study|Developed contraindicated health problem|2|||
164048592|NCT01201967|592536143|FG000|Overall Study|Lost to Follow-up|6|||
164048593|NCT01201967|592536144|FG001|Overall Study|Lost to Follow-up|5|||
164048594|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
164048595|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
164048596|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
164048597|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
164048598|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Other|13|||
164048599|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
164048600|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
164048601|NCT02497287|592536145|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
164048602|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
164048603|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
164048604|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
164048605|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
164048606|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
164048607|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
164048608|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
164048609|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
164048610|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
164048611|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
164048612|NCT02497287|592536145|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
164048613|NCT02497287|592536145|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
164048614|NCT02497287|592536145|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
164048615|NCT02497287|592536145|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
164048616|NCT02497287|592536145|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
164048617|NCT02497287|592536145|FG000|Follow-up Phase (4 Week)|Other|1|||
164048618|NCT01226472|592536146|FG000|Overall Study|Progressive Disease|1|||
164048619|NCT03128307|592536149|FG000|Overall Study|Lost to Follow-up|29|||
164048620|NCT03128307|592536149|FG000|Overall Study|Withdrawal by Subject|5|||
164048621|NCT02972658|592538284|FG000|Overall Study|Adverse Event|0|||
164048622|NCT02972658|592538285|FG001|Overall Study|Adverse Event|3|||
164048623|NCT02972658|592538286|FG002|Overall Study|Adverse Event|0|||
164048624|NCT02972658|592538287|FG003|Overall Study|Adverse Event|2|||
164048625|NCT02972658|592538284|FG000|Overall Study|Other-determined by Investigator|1|||
164048626|NCT02972658|592538285|FG001|Overall Study|Other-determined by Investigator|1|||
164048627|NCT02972658|592538286|FG002|Overall Study|Other-determined by Investigator|0|||
164048628|NCT02972658|592538287|FG003|Overall Study|Other-determined by Investigator|0|||
164048629|NCT02972658|592538284|FG000|Overall Study|Death|0|||
164048630|NCT02972658|592538285|FG001|Overall Study|Death|0|||
164048631|NCT02972658|592538286|FG002|Overall Study|Death|0|||
164048632|NCT02972658|592538287|FG003|Overall Study|Death|1|||
164048633|NCT02972658|592538284|FG000|Overall Study|Lost to Follow-up|0|||
164048634|NCT02972658|592538285|FG001|Overall Study|Lost to Follow-up|1|||
164048635|NCT02972658|592538286|FG002|Overall Study|Lost to Follow-up|1|||
164048636|NCT02972658|592538287|FG003|Overall Study|Lost to Follow-up|2|||
164048637|NCT02972658|592538284|FG000|Overall Study|Progressive Disease|0|||
164048638|NCT02972658|592538285|FG001|Overall Study|Progressive Disease|1|||
164048639|NCT02972658|592538286|FG002|Overall Study|Progressive Disease|0|||
164048640|NCT02972658|592538287|FG003|Overall Study|Progressive Disease|1|||
164048641|NCT02972658|592538284|FG000|Overall Study|Withdrawal by Subject|4|||
164048642|NCT02972658|592538285|FG001|Overall Study|Withdrawal by Subject|4|||
164048643|NCT02972658|592538286|FG002|Overall Study|Withdrawal by Subject|1|||
164048644|NCT02972658|592538287|FG003|Overall Study|Withdrawal by Subject|6|||
164048645|NCT02972658|592538284|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
164048646|NCT02972658|592538285|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
164048647|NCT02972658|592538286|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
164048648|NCT02972658|592538287|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
164048649|NCT02972658|592538284|FG000|Overall Study|Sponsor Decision|70|||
164048650|NCT02972658|592538285|FG001|Overall Study|Sponsor Decision|127|||
164048651|NCT02972658|592538286|FG002|Overall Study|Sponsor Decision|72|||
164048652|NCT02972658|592538287|FG003|Overall Study|Sponsor Decision|119|||
164048653|NCT02785588|592538291|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
164048654|NCT02785588|592538291|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
164048655|NCT03037489|592538292|FG000|Overall Study|Adverse Event|4|||
164048656|NCT03037489|592538293|FG001|Overall Study|Adverse Event|0|||
164048657|NCT03037489|592538292|FG000|Overall Study|Withdrawal by Subject|3|||
164048658|NCT03037489|592538293|FG001|Overall Study|Withdrawal by Subject|0|||
164048659|NCT03031327|592538294|FG000|Overall Study|Withdrawal by Subject|0|||
164048660|NCT03031327|592538295|FG001|Overall Study|Withdrawal by Subject|1|||
164048661|NCT03031327|592538296|FG002|Overall Study|Withdrawal by Subject|1|||
164048662|NCT00669240|592538297|FG000|Overall Study|Lack of Efficacy|33|||
164048663|NCT00669240|592538297|FG000|Overall Study|Withdrawal by Subject|42|||
164048664|NCT00669240|592538297|FG000|Overall Study|Lost to Follow-up|34|||
164048665|NCT00669240|592538297|FG000|Overall Study|Adverse Event|21|||
164048666|NCT00669240|592538297|FG000|Overall Study|Other|19|||
164048667|NCT00669240|592538297|FG000|Overall Study|Enrolled but not treated|15|||
164048668|NCT00669240|592538297|FG000|Overall Study|Enrolled but no dosing record|1|||
164048669|NCT01997892|592538302|FG000|Overall Study|Physician Decision|2|||
164048670|NCT01997892|592538302|FG000|Overall Study|Lost to Follow-up|6|||
164048671|NCT01997892|592538302|FG000|Overall Study|Death|14|||
164048672|NCT01997892|592538302|FG000|Overall Study|Renal transplant|8|||
164048673|NCT01997892|592538302|FG000|Overall Study|Other|3|||
164048674|NCT01997892|592538302|FG000|Overall Study|Study completion data not recorded|35|||
164048675|NCT00364611|592538303|FG000|Overall Study|Did not receive study medication|0|||
164048676|NCT00364611|592538304|FG001|Overall Study|Did not receive study medication|1|||
164048677|NCT00364611|592538303|FG000|Overall Study|Adverse Event|7|||
164048678|NCT00364611|592538304|FG001|Overall Study|Adverse Event|4|||
164048679|NCT00364611|592538303|FG000|Overall Study|Participant's Request|3|||
164048680|NCT00364611|592538304|FG001|Overall Study|Participant's Request|4|||
164048681|NCT00364611|592538303|FG000|Overall Study|Disease Progression|38|||
164048682|NCT00364611|592538304|FG001|Overall Study|Disease Progression|8|||
164048683|NCT00364611|592538303|FG000|Overall Study|Investigator decision|2|||
164048684|NCT00364611|592538304|FG001|Overall Study|Investigator decision|2|||
164048685|NCT00364611|592538303|FG000|Overall Study|Found Ineligible|1|||
164048686|NCT00364611|592538304|FG001|Overall Study|Found Ineligible|0|||
164048687|NCT00364611|592538303|FG000|Overall Study|Presumed CR on Study|0|||
164048688|NCT00364611|592538304|FG001|Overall Study|Presumed CR on Study|1|||
164048689|NCT00364611|592538303|FG000|Overall Study|Receiving Liver Ablation|0|||
164048690|NCT00364611|592538304|FG001|Overall Study|Receiving Liver Ablation|1|||
164048691|NCT02531633|592538305|FG000|Part A (52 Weeks)|Sponsor request|24|||
164048692|NCT02531633|592538306|FG001|Part A (52 Weeks)|Sponsor request|24|||
164048693|NCT02531633|592538307|FG002|Part A (52 Weeks)|Sponsor request|18|||
164048694|NCT02531633|592538308|FG003|Part A (52 Weeks)|Sponsor request|18|||
164048695|NCT02531633|592538309|FG004|Part A (52 Weeks)|Sponsor request|19|||
164048696|NCT02531633|592538310|FG005|Part A (52 Weeks)|Sponsor request|0|||
164048697|NCT02531633|592538311|FG006|Part A (52 Weeks)|Sponsor request|0|||
164048698|NCT02531633|592538312|FG007|Part A (52 Weeks)|Sponsor request|0|||
164048699|NCT02531633|592538313|FG008|Part A (52 Weeks)|Sponsor request|0|||
164048700|NCT02531633|592538314|FG009|Part A (52 Weeks)|Sponsor request|0|||
164048701|NCT02531633|592538305|FG000|Part A (52 Weeks)|Protocol Violation|1|||
164048702|NCT02531633|592538306|FG001|Part A (52 Weeks)|Protocol Violation|0|||
164048703|NCT02531633|592538307|FG002|Part A (52 Weeks)|Protocol Violation|0|||
164048704|NCT02531633|592538308|FG003|Part A (52 Weeks)|Protocol Violation|0|||
164048705|NCT02531633|592538309|FG004|Part A (52 Weeks)|Protocol Violation|0|||
164048706|NCT02531633|592538310|FG005|Part A (52 Weeks)|Protocol Violation|0|||
164048707|NCT02531633|592538311|FG006|Part A (52 Weeks)|Protocol Violation|0|||
164048708|NCT02531633|592538312|FG007|Part A (52 Weeks)|Protocol Violation|0|||
164048709|NCT02531633|592538313|FG008|Part A (52 Weeks)|Protocol Violation|0|||
164048710|NCT02531633|592538314|FG009|Part A (52 Weeks)|Protocol Violation|0|||
164048711|NCT02531633|592538305|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
164048712|NCT02531633|592538306|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
164048713|NCT02531633|592538307|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
164048714|NCT02531633|592538308|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
164048715|NCT02531633|592538309|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
164048716|NCT02531633|592538310|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
164048717|NCT02531633|592538311|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
164048718|NCT02531633|592538312|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
164048719|NCT02531633|592538313|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
164048720|NCT02531633|592538314|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
164048721|NCT02531633|592538305|FG000|Part A (52 Weeks)|Physician Decision|1|||
164048722|NCT02531633|592538306|FG001|Part A (52 Weeks)|Physician Decision|4|||
164048723|NCT02531633|592538307|FG002|Part A (52 Weeks)|Physician Decision|3|||
164048724|NCT02531633|592538308|FG003|Part A (52 Weeks)|Physician Decision|1|||
164048725|NCT02531633|592538309|FG004|Part A (52 Weeks)|Physician Decision|0|||
164048726|NCT02531633|592538310|FG005|Part A (52 Weeks)|Physician Decision|0|||
164048727|NCT02531633|592538311|FG006|Part A (52 Weeks)|Physician Decision|0|||
164048728|NCT02531633|592538312|FG007|Part A (52 Weeks)|Physician Decision|0|||
164048729|NCT02531633|592538313|FG008|Part A (52 Weeks)|Physician Decision|0|||
164048730|NCT02531633|592538314|FG009|Part A (52 Weeks)|Physician Decision|0|||
164048731|NCT02531633|592538305|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
164048732|NCT02531633|592538306|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
164048733|NCT02531633|592538307|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
164048734|NCT02531633|592538308|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
164048735|NCT02531633|592538309|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
164048736|NCT02531633|592538310|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
164048737|NCT02531633|592538311|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
164048738|NCT02531633|592538312|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
164048739|NCT02531633|592538313|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
164048740|NCT02531633|592538314|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
164048741|NCT02531633|592538305|FG000|Part A (52 Weeks)|Other|2|||
164048742|NCT02531633|592538306|FG001|Part A (52 Weeks)|Other|0|||
164048743|NCT02531633|592538307|FG002|Part A (52 Weeks)|Other|0|||
164048744|NCT02531633|592538308|FG003|Part A (52 Weeks)|Other|0|||
164048745|NCT02531633|592538309|FG004|Part A (52 Weeks)|Other|0|||
164048746|NCT02531633|592538310|FG005|Part A (52 Weeks)|Other|0|||
164048747|NCT02531633|592538311|FG006|Part A (52 Weeks)|Other|0|||
164048748|NCT02531633|592538312|FG007|Part A (52 Weeks)|Other|0|||
164048749|NCT02531633|592538313|FG008|Part A (52 Weeks)|Other|0|||
164048750|NCT02531633|592538314|FG009|Part A (52 Weeks)|Other|0|||
164048751|NCT02531633|592538305|FG000|Part B (104 Weeks)|Sponsor request|0|||
164048752|NCT02531633|592538306|FG001|Part B (104 Weeks)|Sponsor request|0|||
164048753|NCT02531633|592538307|FG002|Part B (104 Weeks)|Sponsor request|0|||
164048754|NCT02531633|592538308|FG003|Part B (104 Weeks)|Sponsor request|0|||
164048755|NCT02531633|592538309|FG004|Part B (104 Weeks)|Sponsor request|0|||
164048756|NCT02531633|592538310|FG005|Part B (104 Weeks)|Sponsor request|8|||
164048757|NCT02531633|592538311|FG006|Part B (104 Weeks)|Sponsor request|5|||
164048758|NCT02531633|592538312|FG007|Part B (104 Weeks)|Sponsor request|3|||
164048759|NCT02531633|592538313|FG008|Part B (104 Weeks)|Sponsor request|5|||
164048760|NCT02531633|592538314|FG009|Part B (104 Weeks)|Sponsor request|4|||
164048761|NCT02531633|592538305|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
164048762|NCT02531633|592538306|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
164048763|NCT02531633|592538307|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
164048764|NCT02531633|592538308|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
164048765|NCT02531633|592538309|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
164048766|NCT02531633|592538310|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
164048767|NCT02531633|592538311|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
164048768|NCT02531633|592538312|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
164048769|NCT02531633|592538313|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
164048770|NCT02531633|592538314|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
164048771|NCT02608099|592538321|FG000|Overall Study|Ablation procedure not initiated|3|||
164048772|NCT02608099|592538322|FG001|Overall Study|Ablation procedure not initiated|2|||
164048773|NCT00087594|592538327|FG000|Overall Study|Adverse Event|2|||
164048774|NCT00087594|592538328|FG001|Overall Study|Adverse Event|3|||
164048775|NCT00087594|592538327|FG000|Overall Study|Lost to Follow-up|0|||
164048776|NCT00087594|592538328|FG001|Overall Study|Lost to Follow-up|2|||
164048777|NCT00087594|592538327|FG000|Overall Study|Withdrawal by Subject|4|||
164048778|NCT00087594|592538328|FG001|Overall Study|Withdrawal by Subject|2|||
164048779|NCT00087594|592538327|FG000|Overall Study|Lack of Efficacy|2|||
164048780|NCT00087594|592538328|FG001|Overall Study|Lack of Efficacy|5|||
164048781|NCT01952041|592538329|FG000|Overall Study|Lost to Follow-up|9|||
164048782|NCT01952041|592538330|FG001|Overall Study|Lost to Follow-up|16|||
164048783|NCT01952041|592538329|FG000|Overall Study|Withdrawal by Subject|7|||
164048784|NCT01952041|592538330|FG001|Overall Study|Withdrawal by Subject|5|||
164048785|NCT01952041|592538329|FG000|Overall Study|Death|1|||
164048786|NCT01952041|592538330|FG001|Overall Study|Death|0|||
164048787|NCT01736176|592538331|FG000|Overall Study|Adverse Event|3|||
164048788|NCT01736176|592538331|FG000|Overall Study|Withdrawal by Subject|4|||
164048789|NCT01736176|592538331|FG000|Overall Study|Lack of Efficacy|3|||
164048790|NCT01736176|592538331|FG000|Overall Study|Unable to Complete PEG Placement|1|||
164048791|NCT01569568|592538332|FG000|Overall Study|Physician Decision|0|||
164048792|NCT01569568|592538333|FG001|Overall Study|Physician Decision|2|||
164048793|NCT03657576|592538334|FG000|Overall Study|Death|0|||
164048794|NCT03657576|592538335|FG001|Overall Study|Death|1|||
164048795|NCT03657576|592538336|FG002|Overall Study|Death|1|||
164048796|NCT03657576|592538337|FG003|Overall Study|Death|0|||
164048797|NCT03657576|592538338|FG004|Overall Study|Death|0|||
164048798|NCT03657576|592538339|FG005|Overall Study|Death|0|||
164048799|NCT03657576|592538334|FG000|Overall Study|Withdrawal by Subject|0|||
164048800|NCT03657576|592538335|FG001|Overall Study|Withdrawal by Subject|0|||
164048801|NCT03657576|592538336|FG002|Overall Study|Withdrawal by Subject|0|||
164048802|NCT03657576|592538337|FG003|Overall Study|Withdrawal by Subject|1|||
164048803|NCT03657576|592538338|FG004|Overall Study|Withdrawal by Subject|0|||
164048804|NCT03657576|592538339|FG005|Overall Study|Withdrawal by Subject|0|||
164048805|NCT03657576|592538334|FG000|Overall Study|Screen Fail|0|||
164048806|NCT03657576|592538335|FG001|Overall Study|Screen Fail|0|||
164048807|NCT03657576|592538336|FG002|Overall Study|Screen Fail|0|||
164048808|NCT03657576|592538337|FG003|Overall Study|Screen Fail|0|||
164048809|NCT03657576|592538338|FG004|Overall Study|Screen Fail|0|||
164048810|NCT03657576|592538339|FG005|Overall Study|Screen Fail|5|||
164048811|NCT03657576|592538334|FG000|Overall Study|Disease Progression|1|||
164048812|NCT03657576|592538335|FG001|Overall Study|Disease Progression|1|||
164048813|NCT03657576|592538336|FG002|Overall Study|Disease Progression|0|||
164048814|NCT03657576|592538337|FG003|Overall Study|Disease Progression|5|||
164048815|NCT03657576|592538338|FG004|Overall Study|Disease Progression|0|||
164048816|NCT03657576|592538339|FG005|Overall Study|Disease Progression|0|||
164048817|NCT03657576|592538334|FG000|Overall Study|Insurance Coverage|0|||
164048818|NCT03657576|592538335|FG001|Overall Study|Insurance Coverage|0|||
164048819|NCT03657576|592538336|FG002|Overall Study|Insurance Coverage|0|||
164048820|NCT03657576|592538337|FG003|Overall Study|Insurance Coverage|1|||
164048821|NCT03657576|592538338|FG004|Overall Study|Insurance Coverage|0|||
164048822|NCT03657576|592538339|FG005|Overall Study|Insurance Coverage|0|||
164048823|NCT04437511|592538340|FG000|Overall Study|Adverse Event|50|||
164048824|NCT04437511|592538341|FG001|Overall Study|Adverse Event|21|||
164048825|NCT04437511|592538340|FG000|Overall Study|Death|15|||
164048826|NCT04437511|592538341|FG001|Overall Study|Death|10|||
164048827|NCT04437511|592538340|FG000|Overall Study|Lost to Follow-up|11|||
164048828|NCT04437511|592538341|FG001|Overall Study|Lost to Follow-up|11|||
164048829|NCT04437511|592538340|FG000|Overall Study|Physician Decision|19|||
164048830|NCT04437511|592538341|FG001|Overall Study|Physician Decision|10|||
164048831|NCT04437511|592538340|FG000|Overall Study|Progressive Disease|4|||
164048832|NCT04437511|592538341|FG001|Overall Study|Progressive Disease|7|||
164048833|NCT04437511|592538340|FG000|Overall Study|Withdrawal by Subject|111|||
164048834|NCT04437511|592538341|FG001|Overall Study|Withdrawal by Subject|94|||
164048835|NCT04437511|592538340|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
164048836|NCT04437511|592538341|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
164048837|NCT04437511|592538340|FG000|Overall Study|Continuing Study|7|||
164048838|NCT04437511|592538341|FG001|Overall Study|Continuing Study|5|||
164048839|NCT03093350|592538350|FG000|Overall Study|Death|1|||
164048840|NCT03093350|592538350|FG000|Overall Study|Signed consent, never began treartment|1|||
164048841|NCT00777036|592538354|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
164048842|NCT00777036|592538355|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
164048843|NCT00777036|592538356|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
164048844|NCT00777036|592538357|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
164048845|NCT00777036|592538354|FG000|On Treatment|Administrative Reason By Sponsor|1|||
164048846|NCT00777036|592538355|FG001|On Treatment|Administrative Reason By Sponsor|0|||
164048847|NCT00777036|592538356|FG002|On Treatment|Administrative Reason By Sponsor|9|||
164048848|NCT00777036|592538357|FG003|On Treatment|Administrative Reason By Sponsor|0|||
164048849|NCT00777036|592538354|FG000|On Treatment|Failure to Meet Study Criteria|0|||
164048850|NCT00777036|592538355|FG001|On Treatment|Failure to Meet Study Criteria|1|||
164048851|NCT00777036|592538356|FG002|On Treatment|Failure to Meet Study Criteria|4|||
164048852|NCT00777036|592538357|FG003|On Treatment|Failure to Meet Study Criteria|0|||
164048853|NCT00777036|592538354|FG000|On Treatment|Pregnancy|1|||
164048854|NCT00777036|592538355|FG001|On Treatment|Pregnancy|0|||
164048855|NCT00777036|592538356|FG002|On Treatment|Pregnancy|1|||
164048856|NCT00777036|592538357|FG003|On Treatment|Pregnancy|0|||
164048857|NCT00777036|592538354|FG000|On Treatment|Non-compliance with Study Drug|1|||
164048858|NCT00777036|592538355|FG001|On Treatment|Non-compliance with Study Drug|0|||
164048859|NCT00777036|592538356|FG002|On Treatment|Non-compliance with Study Drug|1|||
164048860|NCT00777036|592538357|FG003|On Treatment|Non-compliance with Study Drug|0|||
164048861|NCT00777036|592538354|FG000|On Treatment|Maximum Clinical Benefit|2|||
164048862|NCT00777036|592538355|FG001|On Treatment|Maximum Clinical Benefit|0|||
164048863|NCT00777036|592538356|FG002|On Treatment|Maximum Clinical Benefit|5|||
164048864|NCT00777036|592538357|FG003|On Treatment|Maximum Clinical Benefit|0|||
164048865|NCT00777036|592538354|FG000|On Treatment|Withdrawal by Subject|0|||
164048866|NCT00777036|592538355|FG001|On Treatment|Withdrawal by Subject|2|||
164048867|NCT00777036|592538356|FG002|On Treatment|Withdrawal by Subject|2|||
164048868|NCT00777036|592538357|FG003|On Treatment|Withdrawal by Subject|0|||
164048869|NCT00777036|592538354|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
164048870|NCT00777036|592538355|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
164048871|NCT00777036|592538356|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
164048872|NCT00777036|592538357|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
164048873|NCT00777036|592538354|FG000|On Treatment|Death|0|||
164048874|NCT00777036|592538355|FG001|On Treatment|Death|2|||
164048875|NCT00777036|592538356|FG002|On Treatment|Death|0|||
164048876|NCT00777036|592538357|FG003|On Treatment|Death|0|||
164048877|NCT00777036|592538354|FG000|On Treatment|Study Drug Toxicity|1|||
164048878|NCT00777036|592538355|FG001|On Treatment|Study Drug Toxicity|0|||
164048879|NCT00777036|592538356|FG002|On Treatment|Study Drug Toxicity|4|||
164048880|NCT00777036|592538357|FG003|On Treatment|Study Drug Toxicity|0|||
164048881|NCT00777036|592538354|FG000|On Treatment|Progressive Disease|6|||
164048882|NCT00777036|592538355|FG001|On Treatment|Progressive Disease|4|||
164048883|NCT00777036|592538356|FG002|On Treatment|Progressive Disease|7|||
164048884|NCT00777036|592538357|FG003|On Treatment|Progressive Disease|0|||
164048885|NCT00777036|592538354|FG000|On Treatment|Not Reported|0|||
164048886|NCT00777036|592538355|FG001|On Treatment|Not Reported|0|||
164048887|NCT00777036|592538356|FG002|On Treatment|Not Reported|2|||
164048888|NCT00777036|592538357|FG003|On Treatment|Not Reported|0|||
164048889|NCT00777036|592538354|FG000|On Treatment|Site Closed|0|||
164048890|NCT00777036|592538355|FG001|On Treatment|Site Closed|1|||
164048891|NCT00777036|592538356|FG002|On Treatment|Site Closed|1|||
164048892|NCT00777036|592538357|FG003|On Treatment|Site Closed|0|||
164048893|NCT00777036|592538354|FG000|Follow-Up|Withdrawal by Subject|0|||
164048894|NCT00777036|592538355|FG001|Follow-Up|Withdrawal by Subject|0|||
164048895|NCT00777036|592538356|FG002|Follow-Up|Withdrawal by Subject|5|||
164048896|NCT00777036|592538357|FG003|Follow-Up|Withdrawal by Subject|0|||
164048897|NCT00777036|592538354|FG000|Follow-Up|Death|1|||
164048898|NCT00777036|592538355|FG001|Follow-Up|Death|9|||
164048899|NCT00777036|592538356|FG002|Follow-Up|Death|0|||
164048900|NCT00777036|592538357|FG003|Follow-Up|Death|0|||
164048901|NCT00777036|592538354|FG000|Follow-Up|Lost to Follow-up|3|||
164048902|NCT00777036|592538355|FG001|Follow-Up|Lost to Follow-up|0|||
164048903|NCT00777036|592538356|FG002|Follow-Up|Lost to Follow-up|0|||
164048904|NCT00777036|592538357|FG003|Follow-Up|Lost to Follow-up|0|||
164048905|NCT00777036|592538354|FG000|Follow-Up|Reason Not Specified|4|||
164048906|NCT00777036|592538355|FG001|Follow-Up|Reason Not Specified|0|||
164048907|NCT00777036|592538356|FG002|Follow-Up|Reason Not Specified|13|||
164048908|NCT00777036|592538357|FG003|Follow-Up|Reason Not Specified|0|||
164048909|NCT00777036|592538354|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
164048910|NCT00777036|592538355|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
164048911|NCT00777036|592538356|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
164048912|NCT00777036|592538357|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
164048913|NCT05564039|592538358|FG000|Overall Study|Adverse Event|1|||
164048914|NCT05564039|592538359|FG001|Overall Study|Adverse Event|0|||
164048915|NCT05564039|592538358|FG000|Overall Study|Death|1|||
164048916|NCT05564039|592538359|FG001|Overall Study|Death|1|||
164048917|NCT05564039|592538358|FG000|Overall Study|Lost to Follow-up|3|||
164048918|NCT05564039|592538359|FG001|Overall Study|Lost to Follow-up|2|||
164048919|NCT05564039|592538358|FG000|Overall Study|Withdrawal by Subject|2|||
164048920|NCT05564039|592538359|FG001|Overall Study|Withdrawal by Subject|0|||
164048921|NCT05564039|592538358|FG000|Overall Study|Inadvertent enrollment|3|||
164048922|NCT05564039|592538359|FG001|Overall Study|Inadvertent enrollment|6|||
164048923|NCT01263470|592538360|FG000|Overall Study|Adverse Event|2|||
164048924|NCT01263470|592538361|FG001|Overall Study|Adverse Event|2|||
164048925|NCT01263470|592538362|FG002|Overall Study|Adverse Event|1|||
164048926|NCT01263470|592538363|FG003|Overall Study|Adverse Event|1|||
164048927|NCT01263470|592538364|FG004|Overall Study|Adverse Event|2|||
164048928|NCT01263470|592538365|FG005|Overall Study|Adverse Event|2|||
164048929|NCT01263470|592538360|FG000|Overall Study|Protocol Violation|0|||
164048930|NCT01263470|592538361|FG001|Overall Study|Protocol Violation|1|||
164048931|NCT01263470|592538362|FG002|Overall Study|Protocol Violation|0|||
164048932|NCT01263470|592538363|FG003|Overall Study|Protocol Violation|0|||
164048933|NCT01263470|592538364|FG004|Overall Study|Protocol Violation|0|||
164048934|NCT01263470|592538365|FG005|Overall Study|Protocol Violation|1|||
164048935|NCT01263470|592538360|FG000|Overall Study|Withdrawal by Subject|0|||
164048936|NCT01263470|592538361|FG001|Overall Study|Withdrawal by Subject|1|||
164048937|NCT01263470|592538362|FG002|Overall Study|Withdrawal by Subject|1|||
164048938|NCT01263470|592538363|FG003|Overall Study|Withdrawal by Subject|2|||
164048939|NCT01263470|592538364|FG004|Overall Study|Withdrawal by Subject|0|||
164048940|NCT01263470|592538365|FG005|Overall Study|Withdrawal by Subject|2|||
164048941|NCT01263470|592538360|FG000|Overall Study|Lack of Efficacy|0|||
164048942|NCT01263470|592538361|FG001|Overall Study|Lack of Efficacy|0|||
164048943|NCT01263470|592538362|FG002|Overall Study|Lack of Efficacy|2|||
164048944|NCT01263470|592538363|FG003|Overall Study|Lack of Efficacy|0|||
164048945|NCT01263470|592538364|FG004|Overall Study|Lack of Efficacy|0|||
164048946|NCT01263470|592538365|FG005|Overall Study|Lack of Efficacy|0|||
164048947|NCT01263470|592538360|FG000|Overall Study|Participant Unavailability|0|||
164048948|NCT01263470|592538361|FG001|Overall Study|Participant Unavailability|1|||
164048949|NCT01263470|592538362|FG002|Overall Study|Participant Unavailability|0|||
164048950|NCT01263470|592538363|FG003|Overall Study|Participant Unavailability|0|||
164048951|NCT01263470|592538364|FG004|Overall Study|Participant Unavailability|0|||
164048952|NCT01263470|592538365|FG005|Overall Study|Participant Unavailability|0|||
164048953|NCT01263470|592538360|FG000|Overall Study|Study Drug Non-compliance|0|||
164048954|NCT01263470|592538361|FG001|Overall Study|Study Drug Non-compliance|0|||
164048955|NCT01263470|592538362|FG002|Overall Study|Study Drug Non-compliance|0|||
164048956|NCT01263470|592538363|FG003|Overall Study|Study Drug Non-compliance|0|||
164048957|NCT01263470|592538364|FG004|Overall Study|Study Drug Non-compliance|1|||
164048958|NCT01263470|592538365|FG005|Overall Study|Study Drug Non-compliance|0|||
164048959|NCT01327573|592538366|FG000|Overall Study|Physician Decision|3|||
164099724|NCT02100228|592730565|FG001|Overall Study|Withdrawal by Subject|37|||
164048960|NCT01327573|592538367|FG001|Overall Study|Physician Decision|1|||
164048961|NCT00729560|592538368|FG000|Overall Study|Withdrawal by Subject|3|||
164048962|NCT03662789|592538369|FG000|Overall Study|Lost to Follow-up|1|||
164048963|NCT03662789|592538370|FG001|Overall Study|Lost to Follow-up|2|||
164048964|NCT03662789|592538369|FG000|Overall Study|Could not perform treadmill test|4|||
164048965|NCT03662789|592538370|FG001|Overall Study|Could not perform treadmill test|4|||
164048966|NCT03662789|592538369|FG000|Overall Study|Death|0|||
164048967|NCT03662789|592538370|FG001|Overall Study|Death|1|||
164048968|NCT02136134|592538371|FG000|Overall Study|Death|170|||
164048969|NCT02136134|592538372|FG001|Overall Study|Death|148|||
164048970|NCT02136134|592538371|FG000|Overall Study|Withdrawal by Subject|19|||
164048971|NCT02136134|592538372|FG001|Overall Study|Withdrawal by Subject|10|||
164048972|NCT02136134|592538371|FG000|Overall Study|Lost to Follow-up|3|||
164048973|NCT02136134|592538372|FG001|Overall Study|Lost to Follow-up|3|||
164048974|NCT02136134|592538371|FG000|Overall Study|Uspecified|55|||
164048975|NCT02136134|592538372|FG001|Overall Study|Uspecified|90|||
164048976|NCT05245071|592538373|FG000|Overall Study|Progressive disease|18|||
164048977|NCT05245071|592538373|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
164048978|NCT05245071|592538373|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
164048979|NCT01602822|592538380|FG000|Overall Study|Adverse Event|11|||
164048980|NCT00853112|592538384|FG000|Overall Study|Randomized but not treated|0|||
164048981|NCT00853112|592538385|FG001|Overall Study|Randomized but not treated|1|||
164048982|NCT00853112|592538386|FG002|Overall Study|Randomized but not treated|0|||
164048983|NCT00853112|592538387|FG003|Overall Study|Randomized but not treated|2|||
164048984|NCT00853112|592538388|FG004|Overall Study|Randomized but not treated|0|||
164048985|NCT00853112|592538389|FG005|Overall Study|Randomized but not treated|0|||
164048986|NCT00853112|592538390|FG006|Overall Study|Randomized but not treated|1|||
164048987|NCT01553591|592538391|FG000|Overall Study|Voluntarily withdrew|94|||
164048988|NCT01553591|592538392|FG001|Overall Study|Voluntarily withdrew|79|||
164048989|NCT01553591|592538393|FG002|Overall Study|Voluntarily withdrew|96|||
164048990|NCT01553591|592538391|FG000|Overall Study|Adverse Event|36|||
164048991|NCT01553591|592538392|FG001|Overall Study|Adverse Event|45|||
164048992|NCT01553591|592538393|FG002|Overall Study|Adverse Event|16|||
164048993|NCT01553591|592538391|FG000|Overall Study|Lost to Follow-up|25|||
164048994|NCT01553591|592538392|FG001|Overall Study|Lost to Follow-up|23|||
164048995|NCT01553591|592538393|FG002|Overall Study|Lost to Follow-up|16|||
164048996|NCT01553591|592538391|FG000|Overall Study|Physician decision: other|11|||
164048997|NCT01553591|592538392|FG001|Overall Study|Physician decision: other|14|||
164048998|NCT01553591|592538393|FG002|Overall Study|Physician decision: other|16|||
164048999|NCT01553591|592538391|FG000|Overall Study|Physician decision: lack of efficacy|2|||
164049000|NCT01553591|592538392|FG001|Overall Study|Physician decision: lack of efficacy|3|||
164049001|NCT01553591|592538393|FG002|Overall Study|Physician decision: lack of efficacy|7|||
164049002|NCT01553591|592538391|FG000|Overall Study|Protocol Violation|3|||
164049003|NCT01553591|592538392|FG001|Overall Study|Protocol Violation|4|||
164049004|NCT01553591|592538393|FG002|Overall Study|Protocol Violation|4|||
164049005|NCT01553591|592538391|FG000|Overall Study|Sponsor decision|1|||
164049006|NCT01553591|592538392|FG001|Overall Study|Sponsor decision|0|||
164049007|NCT01553591|592538393|FG002|Overall Study|Sponsor decision|3|||
164049008|NCT01553591|592538391|FG000|Overall Study|Randomized and never dispensed drug|0|||
164049009|NCT01553591|592538392|FG001|Overall Study|Randomized and never dispensed drug|1|||
164049010|NCT01553591|592538393|FG002|Overall Study|Randomized and never dispensed drug|0|||
164049011|NCT02477800|592538394|FG000|Placebo-Controlled Period|Adverse Event|16|||
164049012|NCT02477800|592538395|FG001|Placebo-Controlled Period|Adverse Event|25|||
164049013|NCT02477800|592538396|FG002|Placebo-Controlled Period|Adverse Event|28|||
164049014|NCT02477800|592538397|FG003|Placebo-Controlled Period|Adverse Event|0|||
164049015|NCT02477800|592538398|FG004|Placebo-Controlled Period|Adverse Event|0|||
164049016|NCT02477800|592538399|FG005|Placebo-Controlled Period|Adverse Event|0|||
164049017|NCT02477800|592538400|FG006|Placebo-Controlled Period|Adverse Event|0|||
164049018|NCT02477800|592538394|FG000|Placebo-Controlled Period|Change of Treatment|1|||
164049019|NCT02477800|592538395|FG001|Placebo-Controlled Period|Change of Treatment|2|||
164049020|NCT02477800|592538396|FG002|Placebo-Controlled Period|Change of Treatment|1|||
164049021|NCT02477800|592538397|FG003|Placebo-Controlled Period|Change of Treatment|0|||
164049022|NCT02477800|592538398|FG004|Placebo-Controlled Period|Change of Treatment|0|||
164049023|NCT02477800|592538399|FG005|Placebo-Controlled Period|Change of Treatment|0|||
164049024|NCT02477800|592538400|FG006|Placebo-Controlled Period|Change of Treatment|0|||
164049025|NCT02477800|592538394|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
164049026|NCT02477800|592538395|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
164049027|NCT02477800|592538396|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
164049028|NCT02477800|592538397|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
164049029|NCT02477800|592538398|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
164049030|NCT02477800|592538399|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
164049031|NCT02477800|592538400|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
164049032|NCT02477800|592538394|FG000|Placebo-Controlled Period|Death|0|||
164049033|NCT02477800|592538395|FG001|Placebo-Controlled Period|Death|3|||
164049034|NCT02477800|592538396|FG002|Placebo-Controlled Period|Death|2|||
164049035|NCT02477800|592538397|FG003|Placebo-Controlled Period|Death|0|||
164049036|NCT02477800|592538398|FG004|Placebo-Controlled Period|Death|0|||
164049037|NCT02477800|592538399|FG005|Placebo-Controlled Period|Death|0|||
164049038|NCT02477800|592538400|FG006|Placebo-Controlled Period|Death|0|||
164049039|NCT02477800|592538394|FG000|Placebo-Controlled Period|Disease Progression|1|||
164049040|NCT02477800|592538395|FG001|Placebo-Controlled Period|Disease Progression|0|||
164099725|NCT02100228|592730564|FG000|Overall Study|Adverse Event|16|||
164049041|NCT02477800|592538396|FG002|Placebo-Controlled Period|Disease Progression|1|||
164049042|NCT02477800|592538397|FG003|Placebo-Controlled Period|Disease Progression|0|||
164049043|NCT02477800|592538398|FG004|Placebo-Controlled Period|Disease Progression|0|||
164049044|NCT02477800|592538399|FG005|Placebo-Controlled Period|Disease Progression|0|||
164049045|NCT02477800|592538400|FG006|Placebo-Controlled Period|Disease Progression|0|||
164049046|NCT02477800|592538394|FG000|Placebo-Controlled Period|Investigator Decision|3|||
164049047|NCT02477800|592538395|FG001|Placebo-Controlled Period|Investigator Decision|2|||
164049048|NCT02477800|592538396|FG002|Placebo-Controlled Period|Investigator Decision|1|||
164049049|NCT02477800|592538397|FG003|Placebo-Controlled Period|Investigator Decision|0|||
164049050|NCT02477800|592538398|FG004|Placebo-Controlled Period|Investigator Decision|0|||
164049051|NCT02477800|592538399|FG005|Placebo-Controlled Period|Investigator Decision|0|||
164049052|NCT02477800|592538400|FG006|Placebo-Controlled Period|Investigator Decision|0|||
164049053|NCT02477800|592538394|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
164049054|NCT02477800|592538395|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
164049055|NCT02477800|592538396|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
164049056|NCT02477800|592538397|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
164049057|NCT02477800|592538398|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
164049058|NCT02477800|592538399|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
164049059|NCT02477800|592538400|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
164049060|NCT02477800|592538394|FG000|Placebo-Controlled Period|Relocation|2|||
164049061|NCT02477800|592538395|FG001|Placebo-Controlled Period|Relocation|0|||
164049062|NCT02477800|592538396|FG002|Placebo-Controlled Period|Relocation|0|||
164049063|NCT02477800|592538397|FG003|Placebo-Controlled Period|Relocation|0|||
164049064|NCT02477800|592538398|FG004|Placebo-Controlled Period|Relocation|0|||
164049065|NCT02477800|592538399|FG005|Placebo-Controlled Period|Relocation|0|||
164049066|NCT02477800|592538400|FG006|Placebo-Controlled Period|Relocation|0|||
164049067|NCT02477800|592538394|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
164049068|NCT02477800|592538395|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
164049069|NCT02477800|592538396|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
164049070|NCT02477800|592538397|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164049071|NCT02477800|592538398|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164049072|NCT02477800|592538399|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164049073|NCT02477800|592538400|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
164049074|NCT02477800|592538394|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
164049075|NCT02477800|592538395|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
164049076|NCT02477800|592538396|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164049077|NCT02477800|592538397|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164049078|NCT02477800|592538398|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164049079|NCT02477800|592538399|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164049080|NCT02477800|592538400|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
164049081|NCT02477800|592538394|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
164049082|NCT02477800|592538395|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
164049083|NCT02477800|592538396|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
164049084|NCT02477800|592538397|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
164049085|NCT02477800|592538398|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
164049086|NCT02477800|592538399|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
164049087|NCT02477800|592538400|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
164049088|NCT02477800|592538394|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
164049089|NCT02477800|592538395|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
164049090|NCT02477800|592538396|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
164049091|NCT02477800|592538397|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164049092|NCT02477800|592538398|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164049093|NCT02477800|592538399|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164049094|NCT02477800|592538400|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
164049095|NCT02477800|592538394|FG000|Placebo-Controlled Period|Reason not Specified|161|||
164049096|NCT02477800|592538395|FG001|Placebo-Controlled Period|Reason not Specified|161|||
164049097|NCT02477800|592538396|FG002|Placebo-Controlled Period|Reason not Specified|189|||
164049098|NCT02477800|592538397|FG003|Placebo-Controlled Period|Reason not Specified|0|||
164049099|NCT02477800|592538398|FG004|Placebo-Controlled Period|Reason not Specified|0|||
164049100|NCT02477800|592538399|FG005|Placebo-Controlled Period|Reason not Specified|0|||
164049101|NCT02477800|592538400|FG006|Placebo-Controlled Period|Reason not Specified|0|||
164049102|NCT02477800|592538394|FG000|Long Term Extension Period|Adverse Event|0|||
164049103|NCT02477800|592538395|FG001|Long Term Extension Period|Adverse Event|0|||
164049104|NCT02477800|592538396|FG002|Long Term Extension Period|Adverse Event|0|||
164049105|NCT02477800|592538397|FG003|Long Term Extension Period|Adverse Event|6|||
164049106|NCT02477800|592538398|FG004|Long Term Extension Period|Adverse Event|2|||
164049107|NCT02477800|592538399|FG005|Long Term Extension Period|Adverse Event|4|||
164049108|NCT02477800|592538400|FG006|Long Term Extension Period|Adverse Event|3|||
164049109|NCT02477800|592538394|FG000|Long Term Extension Period|Death|0|||
164049110|NCT02477800|592538395|FG001|Long Term Extension Period|Death|0|||
164049111|NCT02477800|592538396|FG002|Long Term Extension Period|Death|0|||
164049112|NCT02477800|592538397|FG003|Long Term Extension Period|Death|1|||
164049113|NCT02477800|592538398|FG004|Long Term Extension Period|Death|1|||
164049114|NCT02477800|592538399|FG005|Long Term Extension Period|Death|1|||
164049115|NCT02477800|592538400|FG006|Long Term Extension Period|Death|2|||
164049116|NCT02477800|592538394|FG000|Long Term Extension Period|Consent Withdrawn|0|||
164049117|NCT02477800|592538395|FG001|Long Term Extension Period|Consent Withdrawn|0|||
164049118|NCT02477800|592538396|FG002|Long Term Extension Period|Consent Withdrawn|0|||
164049119|NCT02477800|592538397|FG003|Long Term Extension Period|Consent Withdrawn|10|||
164049120|NCT02477800|592538398|FG004|Long Term Extension Period|Consent Withdrawn|4|||
164049121|NCT02477800|592538399|FG005|Long Term Extension Period|Consent Withdrawn|13|||
164049122|NCT02477800|592538400|FG006|Long Term Extension Period|Consent Withdrawn|16|||
164049123|NCT02477800|592538394|FG000|Long Term Extension Period|Disease Progression|0|||
164049124|NCT02477800|592538395|FG001|Long Term Extension Period|Disease Progression|0|||
164049125|NCT02477800|592538396|FG002|Long Term Extension Period|Disease Progression|0|||
164049126|NCT02477800|592538397|FG003|Long Term Extension Period|Disease Progression|3|||
164049127|NCT02477800|592538398|FG004|Long Term Extension Period|Disease Progression|1|||
164049128|NCT02477800|592538399|FG005|Long Term Extension Period|Disease Progression|1|||
164049129|NCT02477800|592538400|FG006|Long Term Extension Period|Disease Progression|0|||
164049130|NCT02477800|592538394|FG000|Long Term Extension Period|Investigator Decision|0|||
164049131|NCT02477800|592538395|FG001|Long Term Extension Period|Investigator Decision|0|||
164049132|NCT02477800|592538396|FG002|Long Term Extension Period|Investigator Decision|0|||
164049133|NCT02477800|592538397|FG003|Long Term Extension Period|Investigator Decision|0|||
164049134|NCT02477800|592538398|FG004|Long Term Extension Period|Investigator Decision|0|||
164049135|NCT02477800|592538399|FG005|Long Term Extension Period|Investigator Decision|0|||
164049136|NCT02477800|592538400|FG006|Long Term Extension Period|Investigator Decision|2|||
164049137|NCT02477800|592538394|FG000|Long Term Extension Period|Lost to Follow-up|0|||
164049138|NCT02477800|592538395|FG001|Long Term Extension Period|Lost to Follow-up|0|||
164049139|NCT02477800|592538396|FG002|Long Term Extension Period|Lost to Follow-up|0|||
164049140|NCT02477800|592538397|FG003|Long Term Extension Period|Lost to Follow-up|0|||
164049141|NCT02477800|592538398|FG004|Long Term Extension Period|Lost to Follow-up|1|||
164049142|NCT02477800|592538399|FG005|Long Term Extension Period|Lost to Follow-up|3|||
164049143|NCT02477800|592538400|FG006|Long Term Extension Period|Lost to Follow-up|0|||
164049144|NCT02477800|592538394|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
164049145|NCT02477800|592538395|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
164049146|NCT02477800|592538396|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
164049147|NCT02477800|592538397|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
164049148|NCT02477800|592538398|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
164049149|NCT02477800|592538399|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
164049150|NCT02477800|592538400|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
164049151|NCT02477800|592538394|FG000|Long Term Extension Period|Study Visit Burden|0|||
164049152|NCT02477800|592538395|FG001|Long Term Extension Period|Study Visit Burden|0|||
164049153|NCT02477800|592538396|FG002|Long Term Extension Period|Study Visit Burden|0|||
164049154|NCT02477800|592538397|FG003|Long Term Extension Period|Study Visit Burden|3|||
164049155|NCT02477800|592538398|FG004|Long Term Extension Period|Study Visit Burden|0|||
164049156|NCT02477800|592538399|FG005|Long Term Extension Period|Study Visit Burden|2|||
164049157|NCT02477800|592538400|FG006|Long Term Extension Period|Study Visit Burden|2|||
164049158|NCT02477800|592538394|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
164049159|NCT02477800|592538395|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
164049160|NCT02477800|592538396|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
164049161|NCT02477800|592538397|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
164049162|NCT02477800|592538398|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
164049163|NCT02477800|592538399|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
164049164|NCT02477800|592538400|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
164049165|NCT02477800|592538394|FG000|Long Term Extension Period|Reason not Specified|0|||
164049166|NCT02477800|592538395|FG001|Long Term Extension Period|Reason not Specified|0|||
164049167|NCT02477800|592538396|FG002|Long Term Extension Period|Reason not Specified|0|||
164049168|NCT02477800|592538397|FG003|Long Term Extension Period|Reason not Specified|126|||
164049169|NCT02477800|592538398|FG004|Long Term Extension Period|Reason not Specified|140|||
164049170|NCT02477800|592538399|FG005|Long Term Extension Period|Reason not Specified|270|||
164049171|NCT02477800|592538400|FG006|Long Term Extension Period|Reason not Specified|224|||
164049172|NCT03685643|592538408|FG000|Overall Study|Lost to Follow-up|14|||
164049173|NCT03685643|592538409|FG001|Overall Study|Lost to Follow-up|22|||
164049174|NCT00423592|592538412|FG000|Overall Study|Adverse Event (through Week 12)|2|||
164049175|NCT00423592|592538412|FG000|Overall Study|Adverse Event (post Week 12)|5|||
164049176|NCT00062647|592538413|FG000|Overall Study|Death|2|||
164049177|NCT00062647|592538414|FG001|Overall Study|Death|2|||
164049178|NCT00062647|592538413|FG000|Overall Study|Adverse Event|1|||
164049179|NCT00062647|592538414|FG001|Overall Study|Adverse Event|1|||
164049180|NCT00062647|592538413|FG000|Overall Study|Withdrawal by Subject|2|||
164049181|NCT00062647|592538414|FG001|Overall Study|Withdrawal by Subject|1|||
164049182|NCT00062647|592538413|FG000|Overall Study|Protocol Violation|1|||
164049183|NCT00062647|592538414|FG001|Overall Study|Protocol Violation|0|||
164049184|NCT00062647|592538413|FG000|Overall Study|Lost to Follow-up|1|||
164049185|NCT00062647|592538414|FG001|Overall Study|Lost to Follow-up|2|||
164049186|NCT00062647|592538413|FG000|Overall Study|Failed continuation criteria|4|||
164049187|NCT00062647|592538414|FG001|Overall Study|Failed continuation criteria|2|||
164049188|NCT00062647|592538413|FG000|Overall Study|Other|4|||
164049189|NCT00062647|592538414|FG001|Overall Study|Other|4|||
164049190|NCT00062647|592538413|FG000|Overall Study|Never received study treatment|1|||
164049191|NCT00062647|592538414|FG001|Overall Study|Never received study treatment|1|||
164049192|NCT00002981|592538417|FG000|Overall Study|Inevaluable|6|||
164049193|NCT00255008|592538418|FG000|Overall Study|Adverse Event|1|||
164049194|NCT00255008|592538419|FG001|Overall Study|Adverse Event|1|||
164049195|NCT00255008|592538420|FG002|Overall Study|Adverse Event|2|||
164049196|NCT00255008|592538421|FG003|Overall Study|Adverse Event|0|||
164049197|NCT00255008|592538418|FG000|Overall Study|Lost to Follow-up|1|||
164049198|NCT00255008|592538419|FG001|Overall Study|Lost to Follow-up|0|||
164049199|NCT00255008|592538420|FG002|Overall Study|Lost to Follow-up|1|||
164049200|NCT00255008|592538421|FG003|Overall Study|Lost to Follow-up|2|||
164049201|NCT00255008|592538418|FG000|Overall Study|Did not meet viral reduction criteria|4|||
164049202|NCT00255008|592538419|FG001|Overall Study|Did not meet viral reduction criteria|5|||
164049203|NCT00255008|592538420|FG002|Overall Study|Did not meet viral reduction criteria|0|||
164049204|NCT00255008|592538421|FG003|Overall Study|Did not meet viral reduction criteria|1|||
164049205|NCT00255008|592538418|FG000|Overall Study|Withdrew consent|0|||
164049206|NCT00255008|592538419|FG001|Overall Study|Withdrew consent|0|||
164049207|NCT00255008|592538420|FG002|Overall Study|Withdrew consent|2|||
164049208|NCT00255008|592538421|FG003|Overall Study|Withdrew consent|0|||
164049209|NCT00255008|592538418|FG000|Overall Study|Sponsor request|18|||
164049210|NCT00255008|592538419|FG001|Overall Study|Sponsor request|3|||
164049211|NCT00255008|592538420|FG002|Overall Study|Sponsor request|8|||
164049212|NCT00255008|592538421|FG003|Overall Study|Sponsor request|17|||
164049213|NCT00255008|592538418|FG000|Overall Study|Adverse lab experience|1|||
164049214|NCT00255008|592538419|FG001|Overall Study|Adverse lab experience|0|||
164049215|NCT00255008|592538420|FG002|Overall Study|Adverse lab experience|0|||
164049216|NCT00255008|592538421|FG003|Overall Study|Adverse lab experience|0|||
164049217|NCT00255008|592538418|FG000|Overall Study|Other|7|||
164049218|NCT00255008|592538419|FG001|Overall Study|Other|0|||
164049219|NCT00255008|592538420|FG002|Overall Study|Other|3|||
164049220|NCT00255008|592538421|FG003|Overall Study|Other|2|||
164049221|NCT00322387|592538426|FG000|Treatment Period|Adverse Event|0|||
164049222|NCT00322387|592538427|FG001|Treatment Period|Adverse Event|1|||
164049223|NCT00322387|592538426|FG000|Follow-up Period|Final assessment not done|1|||
164049224|NCT00322387|592538427|FG001|Follow-up Period|Final assessment not done|3|||
164049225|NCT00322387|592538426|FG000|Follow-up Period|Death|1|||
164049226|NCT00322387|592538427|FG001|Follow-up Period|Death|0|||
164049227|NCT00707486|592538428|FG000|Overall Study|Withdrawal by Subject|1|||
164049228|NCT02415595|592538437|FG000|Overall Study|Administrative reason by sponsor|39|||
164049229|NCT02415595|592538438|FG001|Overall Study|Administrative reason by sponsor|40|||
164049230|NCT02415595|592538439|FG002|Overall Study|Administrative reason by sponsor|41|||
164049231|NCT02415595|592538440|FG003|Overall Study|Administrative reason by sponsor|39|||
164049232|NCT02415595|592538437|FG000|Overall Study|Adverse Event|1|||
164049233|NCT02415595|592538438|FG001|Overall Study|Adverse Event|3|||
164049234|NCT02415595|592538439|FG002|Overall Study|Adverse Event|5|||
164049235|NCT02415595|592538440|FG003|Overall Study|Adverse Event|10|||
164049236|NCT02415595|592538437|FG000|Overall Study|Lack of Efficacy|4|||
164049237|NCT02415595|592538438|FG001|Overall Study|Lack of Efficacy|4|||
164049238|NCT02415595|592538439|FG002|Overall Study|Lack of Efficacy|0|||
164049239|NCT02415595|592538440|FG003|Overall Study|Lack of Efficacy|0|||
164049240|NCT02415595|592538437|FG000|Overall Study|Lost to Follow-up|1|||
164049241|NCT02415595|592538438|FG001|Overall Study|Lost to Follow-up|3|||
164049242|NCT02415595|592538439|FG002|Overall Study|Lost to Follow-up|1|||
164049243|NCT02415595|592538440|FG003|Overall Study|Lost to Follow-up|1|||
164049244|NCT02415595|592538437|FG000|Overall Study|Poor/Non-compliance|1|||
164049245|NCT02415595|592538438|FG001|Overall Study|Poor/Non-compliance|0|||
164049246|NCT02415595|592538439|FG002|Overall Study|Poor/Non-compliance|1|||
164049247|NCT02415595|592538440|FG003|Overall Study|Poor/Non-compliance|0|||
164049248|NCT02415595|592538437|FG000|Overall Study|Reached stopping criteria|0|||
164049249|NCT02415595|592538438|FG001|Overall Study|Reached stopping criteria|1|||
164049250|NCT02415595|592538439|FG002|Overall Study|Reached stopping criteria|1|||
164049251|NCT02415595|592538440|FG003|Overall Study|Reached stopping criteria|0|||
164049252|NCT02415595|592538437|FG000|Overall Study|Withdrawal by Subject|4|||
164049253|NCT02415595|592538438|FG001|Overall Study|Withdrawal by Subject|0|||
164049254|NCT02415595|592538439|FG002|Overall Study|Withdrawal by Subject|1|||
164049255|NCT02415595|592538440|FG003|Overall Study|Withdrawal by Subject|3|||
164049256|NCT02415595|592538437|FG000|Overall Study|Other|0|||
164049257|NCT02415595|592538438|FG001|Overall Study|Other|1|||
164049258|NCT02415595|592538439|FG002|Overall Study|Other|1|||
164049259|NCT02415595|592538440|FG003|Overall Study|Other|0|||
164049260|NCT01682759|592538448|FG000|Overall Study|Death|2|||
164049261|NCT01682759|592538449|FG001|Overall Study|Death|1|||
164049262|NCT01682759|592538448|FG000|Overall Study|Lost to Follow-up|10|||
164049263|NCT01682759|592538449|FG001|Overall Study|Lost to Follow-up|13|||
164049264|NCT01682759|592538448|FG000|Overall Study|Physician Decision|1|||
164049265|NCT01682759|592538449|FG001|Overall Study|Physician Decision|1|||
164049266|NCT01682759|592538448|FG000|Overall Study|Withdrawal by Subject|56|||
164049267|NCT01682759|592538449|FG001|Overall Study|Withdrawal by Subject|55|||
164049268|NCT01855919|592539798|FG000|Overall Study|Adverse Event|16|||
164049269|NCT01855919|592539799|FG001|Overall Study|Adverse Event|8|||
164049270|NCT01855919|592539798|FG000|Overall Study|Lack of Efficacy|1|||
164049271|NCT01855919|592539799|FG001|Overall Study|Lack of Efficacy|3|||
164049272|NCT01855919|592539798|FG000|Overall Study|Withdrawal by Subject|4|||
164049273|NCT01855919|592539799|FG001|Overall Study|Withdrawal by Subject|10|||
164049274|NCT01855919|592539798|FG000|Overall Study|Entry Criteria Not Met|1|||
164049275|NCT01855919|592539799|FG001|Overall Study|Entry Criteria Not Met|1|||
164049276|NCT01855919|592539798|FG000|Overall Study|Protocol Violation|1|||
164049277|NCT01855919|592539799|FG001|Overall Study|Protocol Violation|4|||
164049278|NCT03958149|592539803|FG000|Overall Study|Withdrawal by Subject|0|||
164049279|NCT03958149|592539804|FG001|Overall Study|Withdrawal by Subject|1|||
164049280|NCT00724243|592539806|FG000|Overall Study|Lack of Efficacy|10|||
164049281|NCT00724243|592539806|FG000|Overall Study|Adverse Event|5|||
164049282|NCT03793010|592539807|FG000|Overall Study|Withdrawal by Subject|5|||
164049283|NCT03793010|592539808|FG001|Overall Study|Withdrawal by Subject|7|||
164049284|NCT03793010|592539807|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
164049285|NCT03793010|592539808|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
164049286|NCT03793010|592539807|FG000|Overall Study|Lost to Follow-up|1|||
164049287|NCT03793010|592539808|FG001|Overall Study|Lost to Follow-up|2|||
164049288|NCT03793010|592539807|FG000|Overall Study|Patient couldn't sit still for injection|1|||
164049289|NCT03793010|592539808|FG001|Overall Study|Patient couldn't sit still for injection|0|||
164049290|NCT03793010|592539807|FG000|Overall Study|Withdrew to pursue other treatment|1|||
164049291|NCT03793010|592539808|FG001|Overall Study|Withdrew to pursue other treatment|0|||
164049292|NCT03793010|592539807|FG000|Overall Study|Did not meet eligibility criteria|1|||
164049293|NCT03793010|592539808|FG001|Overall Study|Did not meet eligibility criteria|0|||
164049294|NCT04097925|592539811|FG000|Overall Study|Withdrawal by Subject|1|||
164049295|NCT02059174|592539833|FG000|Period 1|Withdrawal by Subject|0|||
164049296|NCT02059174|592539834|FG001|Period 1|Withdrawal by Subject|2|||
164049297|NCT02059174|592539833|FG000|Period 2|Withdrawal by Subject|0|||
164049298|NCT02059174|592539834|FG001|Period 2|Withdrawal by Subject|2|||
164049299|NCT02059174|592539833|FG000|Period 2|Protocol Violation|1|||
164049300|NCT02059174|592539834|FG001|Period 2|Protocol Violation|0|||
164049301|NCT02059174|592539833|FG000|Period 3|Physician Decision|1|||
164049302|NCT02059174|592539834|FG001|Period 3|Physician Decision|0|||
164049303|NCT00768040|592539838|FG000|Overall Study|Adverse Event|3|||
164049304|NCT00768040|592539839|FG001|Overall Study|Adverse Event|2|||
164049305|NCT00768040|592539838|FG000|Overall Study|Abnormal laboratory value|1|||
164049306|NCT00768040|592539839|FG001|Overall Study|Abnormal laboratory value|1|||
164049307|NCT00290355|592539848|FG000|Overall Study|Serious adverse event|7|||
164049308|NCT00290355|592539849|FG001|Overall Study|Serious adverse event|4|||
164049309|NCT00290355|592539848|FG000|Overall Study|Study product reactogenicity|1|||
164049310|NCT00290355|592539849|FG001|Overall Study|Study product reactogenicity|0|||
164049311|NCT00290355|592539848|FG000|Overall Study|Protocol Violation|1|||
164049312|NCT00290355|592539849|FG001|Overall Study|Protocol Violation|0|||
164049313|NCT00290355|592539848|FG000|Overall Study|Withdrawal by Subject|2|||
164049314|NCT00290355|592539849|FG001|Overall Study|Withdrawal by Subject|0|||
164049315|NCT00290355|592539848|FG000|Overall Study|Migrated / moved from the study area|1|||
164049316|NCT00290355|592539849|FG001|Overall Study|Migrated / moved from the study area|0|||
164049317|NCT00290355|592539848|FG000|Overall Study|Lost to Follow-up|3|||
164049318|NCT00290355|592539849|FG001|Overall Study|Lost to Follow-up|1|||
164049319|NCT00290355|592539848|FG000|Overall Study|Other|2|||
164049320|NCT00290355|592539849|FG001|Overall Study|Other|0|||
164049321|NCT03345849|592539850|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
164049322|NCT03345849|592539851|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
164049323|NCT03345849|592539852|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
164049324|NCT03345849|592539853|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
164049325|NCT03345849|592539850|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
164049326|NCT03345849|592539851|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
164049327|NCT03345849|592539852|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
164049328|NCT03345849|592539853|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
164049329|NCT03345849|592539850|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
164049330|NCT03345849|592539851|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
164049331|NCT03345849|592539852|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
164049332|NCT03345849|592539853|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
164049333|NCT03345849|592539850|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
164049334|NCT03345849|592539851|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
164049335|NCT03345849|592539852|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
164049336|NCT03345849|592539853|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
164049337|NCT03345849|592539850|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
164049338|NCT03345849|592539851|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
164049339|NCT03345849|592539852|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
164049340|NCT03345849|592539853|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
164049341|NCT03345849|592539850|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
164049342|NCT03345849|592539851|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
164049343|NCT03345849|592539852|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
164049344|NCT03345849|592539853|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
164049345|NCT03345849|592539850|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
164049346|NCT03345849|592539851|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
164049347|NCT03345849|592539852|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
164049348|NCT03345849|592539853|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
164049349|NCT03345849|592539850|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
164049350|NCT03345849|592539851|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
164049351|NCT03345849|592539852|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
164049352|NCT03345849|592539853|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
164049353|NCT03345849|592539850|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164049354|NCT03345849|592539851|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164049355|NCT03345849|592539852|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
164049356|NCT03345849|592539853|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
164049357|NCT03345849|592539850|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
164049358|NCT03345849|592539851|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
164049359|NCT03345849|592539852|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
164049360|NCT03345849|592539853|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
164049361|NCT03345849|592539850|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
164049362|NCT03345849|592539851|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
164049363|NCT03345849|592539852|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
164049364|NCT03345849|592539853|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
164049365|NCT02511106|592539854|FG000|Overall Study|Lost to Follow-up|6|||
164049366|NCT02511106|592539855|FG001|Overall Study|Lost to Follow-up|4|||
164049367|NCT02511106|592539854|FG000|Overall Study|Withdrawal by Subject|24|||
164049368|NCT02511106|592539855|FG001|Overall Study|Withdrawal by Subject|21|||
164049369|NCT02511106|592539854|FG000|Overall Study|Death|42|||
164049370|NCT02511106|592539855|FG001|Overall Study|Death|82|||
164049371|NCT02511106|592539854|FG000|Overall Study|Ongoing study at data cut-off|3|||
164049372|NCT02511106|592539855|FG001|Overall Study|Ongoing study at data cut-off|2|||
164049373|NCT02511106|592539854|FG000|Overall Study|Without specified reason|3|||
164049374|NCT02511106|592539855|FG001|Overall Study|Without specified reason|0|||
164049375|NCT01222767|592539858|FG000|Overall Study|Progressive disease|13|||
164049376|NCT01222767|592539858|FG000|Overall Study|Adverse Event|2|||
164049377|NCT01222767|592539858|FG000|Overall Study|Surgical resection|1|||
164049378|NCT01222767|592539858|FG000|Overall Study|Never treated|1|||
164049379|NCT02773849|592539859|FG000|Overall Study|Lost to Follow-up|11|||
164049380|NCT02773849|592539859|FG000|Overall Study|Death|26|||
164049381|NCT02773849|592539859|FG000|Overall Study|Withdrawal by Subject|5|||
164049382|NCT02773849|592539859|FG000|Overall Study|Withdrawal of Consent|9|||
164049383|NCT02773849|592539859|FG000|Overall Study|Other: not due to lack of tolerability|11|||
164049384|NCT00723489|592539860|FG000|Overall Study|Physician Decision|0|||
164049385|NCT00723489|592539861|FG001|Overall Study|Physician Decision|1|||
164049386|NCT00723489|592539862|FG002|Overall Study|Physician Decision|0|||
164049387|NCT00723489|592539863|FG003|Overall Study|Physician Decision|0|||
164049388|NCT00723489|592539860|FG000|Overall Study|Pregnancy|0|||
164049389|NCT00723489|592539861|FG001|Overall Study|Pregnancy|0|||
164049390|NCT00723489|592539862|FG002|Overall Study|Pregnancy|0|||
164049391|NCT00723489|592539863|FG003|Overall Study|Pregnancy|1|||
164049392|NCT00723489|592539860|FG000|Overall Study|Withdrawal by Subject|0|||
164049393|NCT00723489|592539861|FG001|Overall Study|Withdrawal by Subject|0|||
164049394|NCT00723489|592539862|FG002|Overall Study|Withdrawal by Subject|0|||
164049395|NCT00723489|592539863|FG003|Overall Study|Withdrawal by Subject|1|||
164049396|NCT00723489|592539860|FG000|Overall Study|Seropositive at baseline|1|||
164049397|NCT00723489|592539861|FG001|Overall Study|Seropositive at baseline|0|||
164049398|NCT00723489|592539862|FG002|Overall Study|Seropositive at baseline|0|||
164049399|NCT00723489|592539863|FG003|Overall Study|Seropositive at baseline|0|||
164049400|NCT00723489|592539860|FG000|Overall Study|Prohibited Medication|0|||
164049401|NCT00723489|592539861|FG001|Overall Study|Prohibited Medication|0|||
164049402|NCT00723489|592539862|FG002|Overall Study|Prohibited Medication|0|||
164049403|NCT00723489|592539863|FG003|Overall Study|Prohibited Medication|1|||
164049404|NCT00723489|592539860|FG000|Overall Study|Samples Collected Out of Window|0|||
164049405|NCT00723489|592539861|FG001|Overall Study|Samples Collected Out of Window|3|||
164049406|NCT00723489|592539862|FG002|Overall Study|Samples Collected Out of Window|0|||
164049407|NCT00723489|592539863|FG003|Overall Study|Samples Collected Out of Window|0|||
164049408|NCT02274311|592539870|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
164049409|NCT00508001|592539871|FG000|Overall Study|Adverse Event|2|||
164049410|NCT00508001|592539872|FG001|Overall Study|Adverse Event|0|||
164049411|NCT00508001|592539873|FG002|Overall Study|Adverse Event|4|||
164049412|NCT00508001|592539871|FG000|Overall Study|condition under investigation worsened|13|||
164049413|NCT00508001|592539872|FG001|Overall Study|condition under investigation worsened|7|||
164049414|NCT00508001|592539873|FG002|Overall Study|condition under investigation worsened|1|||
164049415|NCT00508001|592539871|FG000|Overall Study|Death|0|||
164049416|NCT00508001|592539872|FG001|Overall Study|Death|1|||
164049417|NCT00508001|592539873|FG002|Overall Study|Death|1|||
164049418|NCT00508001|592539871|FG000|Overall Study|Withdrawal by Subject|4|||
164049419|NCT00508001|592539872|FG001|Overall Study|Withdrawal by Subject|4|||
164049420|NCT00508001|592539873|FG002|Overall Study|Withdrawal by Subject|1|||
164049421|NCT01685372|592539878|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
164049422|NCT01685372|592539879|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
164049423|NCT03233308|592539880|FG000|Overall Study|Adverse Event|1|||
164049424|NCT03233308|592539880|FG000|Overall Study|Protocol Violation|1|||
164049425|NCT01626859|592539881|FG000|Overall Study|Adverse Event|1|||
164049426|NCT01626859|592539882|FG001|Overall Study|Adverse Event|3|||
164049427|NCT01626859|592539883|FG002|Overall Study|Adverse Event|2|||
164049428|NCT01626859|592539881|FG000|Overall Study|Physician Decision|0|||
164049429|NCT01626859|592539882|FG001|Overall Study|Physician Decision|1|||
164049430|NCT01626859|592539883|FG002|Overall Study|Physician Decision|0|||
164049431|NCT01626859|592539881|FG000|Overall Study|Withdrawal by Subject|1|||
164049432|NCT01626859|592539882|FG001|Overall Study|Withdrawal by Subject|4|||
164049433|NCT01626859|592539883|FG002|Overall Study|Withdrawal by Subject|2|||
164049434|NCT00638989|592539889|FG000|Overall Study|Lost to Follow-up|0|||
164049435|NCT00638989|592539890|FG001|Overall Study|Lost to Follow-up|0|||
164049436|NCT00638989|592539891|FG002|Overall Study|Lost to Follow-up|1|||
164049437|NCT01969565|592539895|FG000|Overall Study|Withdrawal by Subject|1|||
164049438|NCT00832091|592539896|FG000|Overall Study|Adverse Event|1|||
164049439|NCT00832091|592539897|FG001|Overall Study|Adverse Event|1|||
164049440|NCT00832091|592539896|FG000|Overall Study|Protocol Violation|1|||
164049441|NCT00832091|592539897|FG001|Overall Study|Protocol Violation|0|||
164049442|NCT00832091|592539896|FG000|Overall Study|Withdrawal by Subject|2|||
164049443|NCT00832091|592539897|FG001|Overall Study|Withdrawal by Subject|1|||
164049444|NCT00832091|592539896|FG000|Overall Study|Prohibited Medication|1|||
164049445|NCT00832091|592539897|FG001|Overall Study|Prohibited Medication|0|||
164049446|NCT01955005|592539899|FG000|Overall Study|Withdrawal by Subject|3|||
164049447|NCT01955005|592539900|FG001|Overall Study|Withdrawal by Subject|5|||
164049448|NCT01828567|592539901|FG000|Overall Study|Lost to Follow-up|27|||
164049449|NCT01828567|592539902|FG001|Overall Study|Lost to Follow-up|9|||
164049450|NCT01828567|592539901|FG000|Overall Study|Excluded - did not meet criteria|4|||
164049451|NCT01828567|592539902|FG001|Overall Study|Excluded - did not meet criteria|1|||
164049452|NCT03325010|592539911|FG000|Overall Study|Adverse Event|3|||
164049453|NCT03325010|592539912|FG001|Overall Study|Adverse Event|8|||
164049454|NCT03325010|592539911|FG000|Overall Study|Protocol Violation|1|||
164049455|NCT03325010|592539912|FG001|Overall Study|Protocol Violation|8|||
164049456|NCT03325010|592539911|FG000|Overall Study|Withdrawal by Subject|1|||
164049457|NCT03325010|592539912|FG001|Overall Study|Withdrawal by Subject|3|||
164049458|NCT03325010|592539911|FG000|Overall Study|Lost to Follow-up|1|||
164049459|NCT03325010|592539912|FG001|Overall Study|Lost to Follow-up|0|||
164049460|NCT03325010|592539911|FG000|Overall Study|Physician Decision|1|||
164049461|NCT03325010|592539912|FG001|Overall Study|Physician Decision|1|||
164049462|NCT03325010|592539911|FG000|Overall Study|Lack of Efficacy|2|||
164049463|NCT03325010|592539912|FG001|Overall Study|Lack of Efficacy|0|||
164049464|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
164049465|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164049466|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
164049467|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164049468|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
164049469|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164049470|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164049471|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164049472|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
164049473|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
164049474|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
164049475|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164049476|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
164049477|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
164049478|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
164049479|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
164049480|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
164049481|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
164049482|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
164049483|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
164049484|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
164049485|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164049486|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164049487|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
164049488|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Screen failure|0|||
164049489|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Screen failure|1|||
164049490|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Screen failure|2|||
164049491|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Screen failure|0|||
164049492|NCT02614261|592539913|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
164049493|NCT02614261|592539914|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
164049494|NCT02614261|592539915|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
164049495|NCT02614261|592539916|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164049496|NCT02614261|592539913|FG000|Open-Label Extension Phase|Adverse Event|23|||
164049497|NCT02614261|592539914|FG001|Open-Label Extension Phase|Adverse Event|12|||
164049498|NCT02614261|592539915|FG002|Open-Label Extension Phase|Adverse Event|11|||
164049499|NCT02614261|592539916|FG003|Open-Label Extension Phase|Adverse Event|0|||
164049500|NCT02614261|592539913|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
164049501|NCT02614261|592539914|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
164049502|NCT02614261|592539915|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
164049503|NCT02614261|592539916|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
164049504|NCT02614261|592539913|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
164049505|NCT02614261|592539914|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
164049506|NCT02614261|592539915|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
164049507|NCT02614261|592539916|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
164049508|NCT02614261|592539913|FG000|Open-Label Extension Phase|Physician Decision|2|||
164049509|NCT02614261|592539914|FG001|Open-Label Extension Phase|Physician Decision|0|||
164049510|NCT02614261|592539915|FG002|Open-Label Extension Phase|Physician Decision|0|||
164049511|NCT02614261|592539916|FG003|Open-Label Extension Phase|Physician Decision|0|||
164049512|NCT02614261|592539913|FG000|Open-Label Extension Phase|Pregnancy|1|||
164049513|NCT02614261|592539914|FG001|Open-Label Extension Phase|Pregnancy|2|||
164049514|NCT02614261|592539915|FG002|Open-Label Extension Phase|Pregnancy|1|||
164049515|NCT02614261|592539916|FG003|Open-Label Extension Phase|Pregnancy|0|||
164049516|NCT02614261|592539913|FG000|Open-Label Extension Phase|Protocol Violation|3|||
164049517|NCT02614261|592539914|FG001|Open-Label Extension Phase|Protocol Violation|4|||
164049518|NCT02614261|592539915|FG002|Open-Label Extension Phase|Protocol Violation|1|||
164049519|NCT02614261|592539916|FG003|Open-Label Extension Phase|Protocol Violation|0|||
164049520|NCT02614261|592539913|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
164049521|NCT02614261|592539914|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
164049522|NCT02614261|592539915|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
164049523|NCT02614261|592539916|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
164049524|NCT02614261|592539913|FG000|Follow-up Phase|Adverse Event|2|||
164049525|NCT02614261|592539914|FG001|Follow-up Phase|Adverse Event|0|||
164049526|NCT02614261|592539915|FG002|Follow-up Phase|Adverse Event|1|||
164049527|NCT02614261|592539916|FG003|Follow-up Phase|Adverse Event|0|||
164049528|NCT02614261|592539913|FG000|Follow-up Phase|Lost to Follow-up|12|||
164049529|NCT02614261|592539914|FG001|Follow-up Phase|Lost to Follow-up|5|||
164049530|NCT02614261|592539915|FG002|Follow-up Phase|Lost to Follow-up|2|||
164049531|NCT02614261|592539916|FG003|Follow-up Phase|Lost to Follow-up|0|||
164049532|NCT02614261|592539913|FG000|Follow-up Phase|Physician Decision|5|||
164049533|NCT02614261|592539914|FG001|Follow-up Phase|Physician Decision|1|||
164049534|NCT02614261|592539915|FG002|Follow-up Phase|Physician Decision|0|||
164049535|NCT02614261|592539916|FG003|Follow-up Phase|Physician Decision|0|||
164049536|NCT02614261|592539913|FG000|Follow-up Phase|Pregnancy|0|||
164049537|NCT02614261|592539914|FG001|Follow-up Phase|Pregnancy|1|||
164049538|NCT02614261|592539915|FG002|Follow-up Phase|Pregnancy|0|||
164049539|NCT02614261|592539916|FG003|Follow-up Phase|Pregnancy|0|||
164049540|NCT02614261|592539913|FG000|Follow-up Phase|Protocol Violation|1|||
164049541|NCT02614261|592539914|FG001|Follow-up Phase|Protocol Violation|0|||
164049542|NCT02614261|592539915|FG002|Follow-up Phase|Protocol Violation|0|||
164049543|NCT02614261|592539916|FG003|Follow-up Phase|Protocol Violation|0|||
164049544|NCT02614261|592539913|FG000|Follow-up Phase|Withdrawal by Subject|12|||
164049545|NCT02614261|592539914|FG001|Follow-up Phase|Withdrawal by Subject|4|||
164049546|NCT02614261|592539915|FG002|Follow-up Phase|Withdrawal by Subject|11|||
164049547|NCT02614261|592539916|FG003|Follow-up Phase|Withdrawal by Subject|0|||
164049548|NCT02614261|592539913|FG000|Israel Addendum|Withdrawal by Subject|0|||
164049549|NCT02614261|592539914|FG001|Israel Addendum|Withdrawal by Subject|0|||
164049550|NCT02614261|592539915|FG002|Israel Addendum|Withdrawal by Subject|0|||
164049551|NCT02614261|592539916|FG003|Israel Addendum|Withdrawal by Subject|4|||
164049552|NCT03512275|592539918|FG000|Overall Study|Withdrawal by Subject|1|||
164049553|NCT03512275|592539919|FG001|Overall Study|Withdrawal by Subject|3|||
164049554|NCT03512275|592539918|FG000|Overall Study|Physician Decision|0|||
164049555|NCT03512275|592539919|FG001|Overall Study|Physician Decision|1|||
164049556|NCT03512275|592539918|FG000|Overall Study|Lost to Follow-up|0|||
164049557|NCT03512275|592539919|FG001|Overall Study|Lost to Follow-up|3|||
164049558|NCT03512275|592539918|FG000|Overall Study|Other|1|||
164049559|NCT03512275|592539919|FG001|Overall Study|Other|0|||
164049560|NCT00113555|592539920|FG000|Overall Study|Baseline Failure|59|||
164049561|NCT00113555|592539920|FG000|Overall Study|Permanently Explanted|7|||
164049562|NCT00113555|592539920|FG000|Overall Study|Death|1|||
164049563|NCT00113555|592539920|FG000|Overall Study|Missed Followup|4|||
164049564|NCT00113555|592539920|FG000|Overall Study|Lost to Follow-up|8|||
164049565|NCT04474366|592539921|FG000|Overall Study|Lost to Follow-up|2|||
164049566|NCT04474366|592539922|FG001|Overall Study|Lost to Follow-up|5|||
164049567|NCT04063865|592539923|FG000|Overall Study|Physician Decision|1|||
164049568|NCT04063865|592539924|FG001|Overall Study|Physician Decision|3|||
164049569|NCT04063865|592539923|FG000|Overall Study|Study Closed Prior to Completion|4|||
164049570|NCT04063865|592539924|FG001|Overall Study|Study Closed Prior to Completion|4|||
164049571|NCT04063865|592539923|FG000|Overall Study|Withdrawal by Subject|1|||
164049572|NCT04063865|592539924|FG001|Overall Study|Withdrawal by Subject|1|||
164049573|NCT00320190|592539925|FG000|First 12 Months|Completed but did not enter extension|5|||
164049574|NCT00320190|592539926|FG001|First 12 Months|Completed but did not enter extension|3|||
164049575|NCT00320190|592539925|FG000|First 12 Months|Sponsor terminated study|2|||
164049576|NCT00320190|592539926|FG001|First 12 Months|Sponsor terminated study|2|||
164049577|NCT00320190|592539925|FG000|First 12 Months|Lost to Follow-up|0|||
164049578|NCT00320190|592539926|FG001|First 12 Months|Lost to Follow-up|1|||
164049579|NCT00320190|592539925|FG000|First 12 Months|Enrollment failure|0|||
164049580|NCT00320190|592539926|FG001|First 12 Months|Enrollment failure|1|||
164049581|NCT00320190|592539925|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
164049582|NCT00320190|592539926|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
164049583|NCT00320190|592539925|FG000|First 12 Months|Investigator request|0|||
164049584|NCT00320190|592539926|FG001|First 12 Months|Investigator request|1|||
164049585|NCT00320190|592539925|FG000|First 12 Months|Study drug toxicity|0|||
164049586|NCT00320190|592539926|FG001|First 12 Months|Study drug toxicity|1|||
164049587|NCT00320190|592539925|FG000|First 12 Months|Withdrawal by Subject|0|||
164049588|NCT00320190|592539926|FG001|First 12 Months|Withdrawal by Subject|1|||
164049589|NCT00320190|592539925|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
164049590|NCT00320190|592539926|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
164049591|NCT00320190|592539925|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
164049592|NCT00320190|592539926|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
164049593|NCT00320190|592539925|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
164049594|NCT00320190|592539926|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
164049595|NCT01700140|592539927|FG000|Overall Study|Use of rescue drugs|3|||
164049596|NCT01700140|592539928|FG001|Overall Study|Use of rescue drugs|3|||
164049597|NCT01700140|592539929|FG002|Overall Study|Use of rescue drugs|1|||
164049598|NCT01700140|592539927|FG000|Overall Study|Discontinuation of radiotherapy|1|||
164049599|NCT01700140|592539928|FG001|Overall Study|Discontinuation of radiotherapy|0|||
164049600|NCT01700140|592539929|FG002|Overall Study|Discontinuation of radiotherapy|0|||
164049601|NCT01700140|592539927|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
164049602|NCT01700140|592539928|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
164049603|NCT01700140|592539929|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
164049604|NCT01700140|592539927|FG000|Overall Study|Aggravation of symptoms|1|||
164049605|NCT01700140|592539928|FG001|Overall Study|Aggravation of symptoms|0|||
164049606|NCT01700140|592539929|FG002|Overall Study|Aggravation of symptoms|0|||
164049607|NCT01700140|592539927|FG000|Overall Study|Adverse Event|0|||
164049608|NCT01700140|592539928|FG001|Overall Study|Adverse Event|1|||
164049609|NCT01700140|592539929|FG002|Overall Study|Adverse Event|0|||
164049610|NCT01700140|592539927|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
164049611|NCT01700140|592539928|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
164049612|NCT01700140|592539929|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
164049613|NCT01060124|592539930|FG000|Overall Study|Other|16|||
164049614|NCT01060124|592539930|FG000|Overall Study|Adverse Event|14|||
164049615|NCT01060124|592539930|FG000|Overall Study|Withdrawal by Subject|7|||
164049616|NCT00102804|592539933|FG000|Overall Study|Progressive Disease (PD)|307|||
164049617|NCT00102804|592539934|FG001|Overall Study|Progressive Disease (PD)|196|||
164049618|NCT00102804|592539933|FG000|Overall Study|Withdrawal by Subject|46|||
164049619|NCT00102804|592539934|FG001|Overall Study|Withdrawal by Subject|7|||
164049620|NCT00102804|592539933|FG000|Overall Study|Adverse Event|37|||
164049621|NCT00102804|592539934|FG001|Overall Study|Adverse Event|3|||
164049622|NCT00102804|592539933|FG000|Overall Study|Physician Decision|24|||
164049623|NCT00102804|592539934|FG001|Overall Study|Physician Decision|6|||
164049624|NCT00102804|592539933|FG000|Overall Study|Death|5|||
164049625|NCT00102804|592539934|FG001|Overall Study|Death|6|||
164049626|NCT00102804|592539933|FG000|Overall Study|Enrollment Criteria Not Met|6|||
164049627|NCT00102804|592539934|FG001|Overall Study|Enrollment Criteria Not Met|0|||
164049628|NCT00102804|592539933|FG000|Overall Study|Lost to Follow-up|4|||
164049629|NCT00102804|592539934|FG001|Overall Study|Lost to Follow-up|1|||
164049630|NCT00102804|592539933|FG000|Overall Study|Protocol Violation|2|||
164049631|NCT00102804|592539934|FG001|Overall Study|Protocol Violation|1|||
164049632|NCT00102804|592539933|FG000|Overall Study|Satisfactory Response|2|||
164049633|NCT00102804|592539934|FG001|Overall Study|Satisfactory Response|0|||
164049634|NCT00102804|592539933|FG000|Overall Study|Sponsor Decision|1|||
164049635|NCT00102804|592539934|FG001|Overall Study|Sponsor Decision|0|||
164049636|NCT00102804|592539933|FG000|Overall Study|Alive, Receiving Treatment|7|||
164049637|NCT00102804|592539934|FG001|Overall Study|Alive, Receiving Treatment|2|||
164049638|NCT02299206|592539941|FG000|Overall Study|Lost to Follow-up|1|||
164049639|NCT02299206|592539941|FG000|Overall Study|Withdrawal by Subject|1|||
164049640|NCT00691054|592539942|FG000|Overall Study|Withdrawal by Subject|1|||
164049641|NCT00518336|592539943|FG000|Year 7|Lost to Follow-up|2|||
164049642|NCT00518336|592539944|FG001|Year 7|Lost to Follow-up|0|||
164049643|NCT00518336|592539943|FG000|Year 7|Could not attend in time|0|||
164049644|NCT00518336|592539944|FG001|Year 7|Could not attend in time|3|||
164049645|NCT00518336|592539943|FG000|Year 8|Lost to Follow-up|1|||
164049646|NCT00518336|592539944|FG001|Year 8|Lost to Follow-up|1|||
164049647|NCT00518336|592539943|FG000|Year 8|Could not attend in time|0|||
164049648|NCT00518336|592539944|FG001|Year 8|Could not attend in time|1|||
164049649|NCT00518336|592539943|FG000|Year 9|Migrated/moved from study area|1|||
164049650|NCT00518336|592539944|FG001|Year 9|Migrated/moved from study area|1|||
164049651|NCT00518336|592539943|FG000|Year 9|Lost to Follow-up|3|||
164049652|NCT00518336|592539944|FG001|Year 9|Lost to Follow-up|0|||
164049653|NCT00518336|592539943|FG000|Year 9|Personal reasons|1|||
164049654|NCT00518336|592539944|FG001|Year 9|Personal reasons|0|||
164049655|NCT03074318|592539947|FG000|Overall Study|Adverse Event|0|||
164049656|NCT03074318|592539948|FG001|Overall Study|Adverse Event|1|||
164049657|NCT03074318|592539949|FG002|Overall Study|Adverse Event|1|||
164049658|NCT03074318|592539950|FG003|Overall Study|Adverse Event|1|||
164049659|NCT03074318|592539947|FG000|Overall Study|Death|1|||
164049660|NCT03074318|592539948|FG001|Overall Study|Death|0|||
164049661|NCT03074318|592539949|FG002|Overall Study|Death|0|||
164049662|NCT03074318|592539950|FG003|Overall Study|Death|0|||
164049663|NCT03074318|592539947|FG000|Overall Study|Withdrawal by Subject|1|||
164049664|NCT03074318|592539948|FG001|Overall Study|Withdrawal by Subject|2|||
164049665|NCT03074318|592539949|FG002|Overall Study|Withdrawal by Subject|2|||
164049666|NCT03074318|592539950|FG003|Overall Study|Withdrawal by Subject|4|||
164049667|NCT03074318|592539947|FG000|Overall Study|Trial Closure|2|||
164049668|NCT03074318|592539948|FG001|Overall Study|Trial Closure|2|||
164049669|NCT03074318|592539949|FG002|Overall Study|Trial Closure|3|||
164049670|NCT03074318|592539950|FG003|Overall Study|Trial Closure|11|||
164049671|NCT01625897|592541217|FG000|Overall Study|Adverse Event|27|||
164049672|NCT01625897|592541218|FG001|Overall Study|Adverse Event|10|||
164049673|NCT01625897|592541217|FG000|Overall Study|Physician Decision|0|||
164049674|NCT01625897|592541218|FG001|Overall Study|Physician Decision|1|||
164049675|NCT01625897|592541217|FG000|Overall Study|Withdrawal by Subject|25|||
164049676|NCT01625897|592541218|FG001|Overall Study|Withdrawal by Subject|3|||
164049677|NCT03455530|592541219|FG000|Overall Study|Withdrawal by Subject|9|||
164049678|NCT03455530|592541220|FG001|Overall Study|Withdrawal by Subject|1|||
164049679|NCT03455530|592541221|FG002|Overall Study|Withdrawal by Subject|3|||
164049680|NCT03455530|592541222|FG003|Overall Study|Withdrawal by Subject|3|||
164049681|NCT02314637|592541225|FG000|Overall Study|Adverse Event|4|||
164049682|NCT02314637|592541226|FG001|Overall Study|Adverse Event|8|||
164049683|NCT02314637|592541225|FG000|Overall Study|Lack of Efficacy|1|||
164049684|NCT02314637|592541226|FG001|Overall Study|Lack of Efficacy|0|||
164049685|NCT02314637|592541225|FG000|Overall Study|Physician Decision|5|||
164049686|NCT02314637|592541226|FG001|Overall Study|Physician Decision|2|||
164049687|NCT02314637|592541225|FG000|Overall Study|Withdrawal by Subject|5|||
164049688|NCT02314637|592541226|FG001|Overall Study|Withdrawal by Subject|4|||
164049689|NCT02314637|592541225|FG000|Overall Study|Other Reason|1|||
164049690|NCT02314637|592541226|FG001|Overall Study|Other Reason|0|||
164049691|NCT00686699|592541228|FG000|Treatment Period 1|Adverse Event|0|||
164049692|NCT00686699|592541229|FG001|Treatment Period 1|Adverse Event|2|||
164049693|NCT00908895|592541230|FG000|Overall Study|Lost to Follow-up|1|||
164049694|NCT00908895|592541231|FG001|Overall Study|Lost to Follow-up|3|||
164049695|NCT00908895|592541230|FG000|Overall Study|algodystrophy|2|||
164049696|NCT00908895|592541231|FG001|Overall Study|algodystrophy|2|||
164049697|NCT00908895|592541230|FG000|Overall Study|Adverse Event|1|||
164049698|NCT00908895|592541231|FG001|Overall Study|Adverse Event|1|||
164049699|NCT00033514|592541235|FG000|Overall Study|Lost to Follow-up|1|||
164049700|NCT00033514|592541236|FG001|Overall Study|Lost to Follow-up|1|||
164049701|NCT00033514|592541235|FG000|Overall Study|Withdrawal by Subject|0|||
164049702|NCT00033514|592541236|FG001|Overall Study|Withdrawal by Subject|3|||
164049703|NCT04221945|592541239|FG000|Overall Study|Death|103|||
164049704|NCT04221945|592541240|FG001|Overall Study|Death|140|||
164049705|NCT04221945|592541239|FG000|Overall Study|Lost to Follow-up|5|||
164049706|NCT04221945|592541240|FG001|Overall Study|Lost to Follow-up|8|||
164049707|NCT04221945|592541239|FG000|Overall Study|Withdrawal by Subject|21|||
164049708|NCT04221945|592541240|FG001|Overall Study|Withdrawal by Subject|11|||
164049709|NCT04221945|592541239|FG000|Overall Study|Participants Ongoing|400|||
164049710|NCT04221945|592541240|FG001|Overall Study|Participants Ongoing|372|||
164049711|NCT00974090|592541242|FG000|Period 1: Double Blind Period|Adverse Event|2|||
164049712|NCT00974090|592541243|FG001|Period 1: Double Blind Period|Adverse Event|1|||
164049713|NCT00974090|592541242|FG000|Period 1: Double Blind Period|Physician Decision|1|||
164049714|NCT00974090|592541243|FG001|Period 1: Double Blind Period|Physician Decision|0|||
164049715|NCT00974090|592541242|FG000|Period 2: Open-label Period|Adverse Event|4|||
164049716|NCT00974090|592541243|FG001|Period 2: Open-label Period|Adverse Event|6|||
164049717|NCT00974090|592541242|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
164049718|NCT00974090|592541243|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
164049719|NCT00974090|592541242|FG000|Period 2: Open-label Period|Physician Decision|0|||
164049720|NCT00974090|592541243|FG001|Period 2: Open-label Period|Physician Decision|3|||
164049721|NCT00974090|592541242|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
164049722|NCT00974090|592541243|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
164049723|NCT01626872|592541244|FG000|Overall Study|Physician Decision|13|||
164049724|NCT01626872|592541245|FG001|Overall Study|Physician Decision|9|||
164049725|NCT01626872|592541246|FG002|Overall Study|Physician Decision|6|||
164049726|NCT01626872|592541244|FG000|Overall Study|Withdrawal by Subject|19|||
164049727|NCT01626872|592541245|FG001|Overall Study|Withdrawal by Subject|27|||
164049728|NCT01626872|592541246|FG002|Overall Study|Withdrawal by Subject|8|||
164049729|NCT01626872|592541244|FG000|Overall Study|Adverse Event (including Death)|20|||
164049730|NCT01626872|592541245|FG001|Overall Study|Adverse Event (including Death)|28|||
164049731|NCT01626872|592541246|FG002|Overall Study|Adverse Event (including Death)|8|||
164049732|NCT01626872|592541244|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
164049733|NCT01626872|592541245|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
164049734|NCT01626872|592541246|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
164049735|NCT05626751|592541247|FG000|Overall Study|Lost to Follow-up|1|||
164049736|NCT05626751|592541248|FG001|Overall Study|Lost to Follow-up|2|||
164049737|NCT05626751|592541249|FG002|Overall Study|Lost to Follow-up|1|||
164049738|NCT05626751|592541247|FG000|Overall Study|Trial Terminated by Sponsor|39|||
164049739|NCT05626751|592541248|FG001|Overall Study|Trial Terminated by Sponsor|30|||
164049740|NCT05626751|592541249|FG002|Overall Study|Trial Terminated by Sponsor|37|||
164049741|NCT05626751|592541247|FG000|Overall Study|Withdrawal by Subject|7|||
164049742|NCT05626751|592541248|FG001|Overall Study|Withdrawal by Subject|5|||
164049743|NCT05626751|592541249|FG002|Overall Study|Withdrawal by Subject|5|||
164049744|NCT01625000|592541250|FG000|Overall Study|Physician Decision|15|||
164049745|NCT01625000|592541251|FG001|Overall Study|Physician Decision|7|||
164049746|NCT01625000|592541252|FG002|Overall Study|Physician Decision|7|||
164049747|NCT01625000|592541253|FG003|Overall Study|Physician Decision|2|||
164049748|NCT01625000|592541254|FG004|Overall Study|Physician Decision|15|||
164049749|NCT01625000|592541250|FG000|Overall Study|Protocol Violation|3|||
164049750|NCT01625000|592541251|FG001|Overall Study|Protocol Violation|10|||
164049751|NCT01625000|592541252|FG002|Overall Study|Protocol Violation|4|||
164049752|NCT01625000|592541253|FG003|Overall Study|Protocol Violation|1|||
164049753|NCT01625000|592541254|FG004|Overall Study|Protocol Violation|2|||
164049754|NCT01625000|592541250|FG000|Overall Study|Withdrawal by Subject|19|||
164049755|NCT01625000|592541251|FG001|Overall Study|Withdrawal by Subject|16|||
164049756|NCT01625000|592541252|FG002|Overall Study|Withdrawal by Subject|11|||
164049757|NCT01625000|592541253|FG003|Overall Study|Withdrawal by Subject|9|||
164049758|NCT01625000|592541254|FG004|Overall Study|Withdrawal by Subject|17|||
164049759|NCT01625000|592541250|FG000|Overall Study|Adverse Event (including Death)|15|||
164049760|NCT01625000|592541251|FG001|Overall Study|Adverse Event (including Death)|19|||
164049761|NCT01625000|592541252|FG002|Overall Study|Adverse Event (including Death)|11|||
164049762|NCT01625000|592541253|FG003|Overall Study|Adverse Event (including Death)|7|||
164049763|NCT01625000|592541254|FG004|Overall Study|Adverse Event (including Death)|21|||
164049764|NCT03912064|592541255|FG000|Overall Study|Withdrawal by Subject|2|||
164049765|NCT03912064|592541256|FG001|Overall Study|Withdrawal by Subject|0|||
164049766|NCT03912064|592541257|FG002|Overall Study|Withdrawal by Subject|0|||
164049767|NCT03912064|592541255|FG000|Overall Study|Adverse reaction to Ipilimumab|2|||
164049768|NCT03912064|592541256|FG001|Overall Study|Adverse reaction to Ipilimumab|0|||
164049769|NCT03912064|592541257|FG002|Overall Study|Adverse reaction to Ipilimumab|1|||
164049770|NCT03912064|592541255|FG000|Overall Study|Progression/Relapse|7|||
164049771|NCT03912064|592541256|FG001|Overall Study|Progression/Relapse|3|||
164049772|NCT03912064|592541257|FG002|Overall Study|Progression/Relapse|0|||
164049773|NCT03912064|592541255|FG000|Overall Study|Prolonged treatment delays|3|||
164049774|NCT03912064|592541256|FG001|Overall Study|Prolonged treatment delays|2|||
164049775|NCT03912064|592541257|FG002|Overall Study|Prolonged treatment delays|0|||
164049776|NCT03912064|592541255|FG000|Overall Study|Prohibited concomitant treatments|3|||
164049777|NCT03912064|592541256|FG001|Overall Study|Prohibited concomitant treatments|1|||
164049778|NCT03912064|592541257|FG002|Overall Study|Prohibited concomitant treatments|0|||
164049779|NCT01026194|592541258|FG000|Period 1：Double Blind Period|Adverse Event|2|||
164049780|NCT01026194|592541259|FG001|Period 1：Double Blind Period|Adverse Event|1|||
164049781|NCT01026194|592541258|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
164049782|NCT01026194|592541259|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
164049783|NCT01026194|592541258|FG000|Period 1：Double Blind Period|Physician Decision|0|||
164049784|NCT01026194|592541259|FG001|Period 1：Double Blind Period|Physician Decision|4|||
164049785|NCT01026194|592541258|FG000|Period 2：Open-label Period|Adverse Event|4|||
164049786|NCT01026194|592541259|FG001|Period 2：Open-label Period|Adverse Event|5|||
164049787|NCT01026194|592541258|FG000|Period 2：Open-label Period|Physician Decision|3|||
164049788|NCT01026194|592541259|FG001|Period 2：Open-label Period|Physician Decision|1|||
164049789|NCT01026194|592541258|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
164049790|NCT01026194|592541259|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
164049791|NCT04295759|592541260|FG000|Overall Study|Lack of Efficacy|9|||
164049792|NCT04295759|592541260|FG000|Overall Study|Death|1|||
164049793|NCT04295759|592541260|FG000|Overall Study|Withdrawal by Subject|2|||
164049794|NCT04295759|592541260|FG000|Overall Study|Deemed ineligible|1|||
164049795|NCT05740566|592541261|FG000|Overall Study|Death|151|||
164049796|NCT05740566|592541262|FG001|Overall Study|Death|111|||
164049797|NCT05740566|592541261|FG000|Overall Study|Withdrawal by Subject|2|||
164049798|NCT05740566|592541262|FG001|Overall Study|Withdrawal by Subject|0|||
164049799|NCT05740566|592541261|FG000|Overall Study|Ongoing in study|102|||
164049800|NCT05740566|592541262|FG001|Overall Study|Ongoing in study|143|||
164049801|NCT00829010|592541265|FG000|Overall Study|Adverse Event|1|||
164049802|NCT00829010|592541266|FG001|Overall Study|Adverse Event|0|||
164049803|NCT00829010|592541267|FG002|Overall Study|Adverse Event|0|||
164049804|NCT00829010|592541268|FG003|Overall Study|Adverse Event|0|||
164049805|NCT00829010|592541269|FG004|Overall Study|Adverse Event|0|||
164049806|NCT00829010|592541265|FG000|Overall Study|Withdrawal by Subject|0|||
164049807|NCT00829010|592541266|FG001|Overall Study|Withdrawal by Subject|1|||
164049808|NCT00829010|592541267|FG002|Overall Study|Withdrawal by Subject|1|||
164049809|NCT00829010|592541268|FG003|Overall Study|Withdrawal by Subject|0|||
164049810|NCT00829010|592541269|FG004|Overall Study|Withdrawal by Subject|2|||
164049811|NCT00829010|592541265|FG000|Overall Study|Lost to Follow-up|1|||
164049812|NCT00829010|592541266|FG001|Overall Study|Lost to Follow-up|0|||
164049813|NCT00829010|592541267|FG002|Overall Study|Lost to Follow-up|2|||
164049814|NCT00829010|592541268|FG003|Overall Study|Lost to Follow-up|0|||
164049815|NCT00829010|592541269|FG004|Overall Study|Lost to Follow-up|0|||
164049816|NCT00829010|592541265|FG000|Overall Study|Fatality|5|||
164049817|NCT00829010|592541266|FG001|Overall Study|Fatality|4|||
164049818|NCT00829010|592541267|FG002|Overall Study|Fatality|0|||
164049819|NCT00829010|592541268|FG003|Overall Study|Fatality|3|||
164049820|NCT00829010|592541269|FG004|Overall Study|Fatality|0|||
164049821|NCT00829010|592541265|FG000|Overall Study|Migrated/Moved from study area|3|||
164049822|NCT00829010|592541266|FG001|Overall Study|Migrated/Moved from study area|4|||
164049823|NCT00829010|592541267|FG002|Overall Study|Migrated/Moved from study area|0|||
164049824|NCT00829010|592541268|FG003|Overall Study|Migrated/Moved from study area|5|||
164049825|NCT00829010|592541269|FG004|Overall Study|Migrated/Moved from study area|0|||
164049826|NCT06210035|592541270|FG000|Overall Study|Withdrawal by Subject|3|||
164049827|NCT06210035|592541271|FG001|Overall Study|Withdrawal by Subject|0|||
164049828|NCT06210035|592541272|FG002|Overall Study|Withdrawal by Subject|0|||
164049829|NCT01029691|592541273|FG000|Continued APAP to Delivery|Death|0|||
164049830|NCT01029691|592541274|FG001|Continued APAP to Delivery|Death|0|||
164049831|NCT01029691|592541275|FG002|Continued APAP to Delivery|Death|1|||
164049832|NCT05616221|592541280|FG000|Overall Study|Withdrawal by Subject|0|||
164049833|NCT05616221|592541281|FG001|Overall Study|Withdrawal by Subject|1|||
164049834|NCT05616221|592541282|FG002|Overall Study|Withdrawal by Subject|0|||
164049835|NCT05616221|592541283|FG003|Overall Study|Withdrawal by Subject|0|||
164049836|NCT05616221|592541284|FG004|Overall Study|Withdrawal by Subject|0|||
164049837|NCT05616221|592541285|FG005|Overall Study|Withdrawal by Subject|0|||
164049838|NCT05616221|592541280|FG000|Overall Study|Adverse Event|0|||
164049839|NCT05616221|592541281|FG001|Overall Study|Adverse Event|2|||
164049840|NCT05616221|592541282|FG002|Overall Study|Adverse Event|0|||
164049841|NCT05616221|592541283|FG003|Overall Study|Adverse Event|0|||
164049842|NCT05616221|592541284|FG004|Overall Study|Adverse Event|2|||
164049843|NCT05616221|592541285|FG005|Overall Study|Adverse Event|0|||
164049844|NCT04880733|592541286|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
164049845|NCT04880733|592541287|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
164049846|NCT04880733|592541288|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
164049847|NCT04880733|592541286|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
164049848|NCT04880733|592541287|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
164049849|NCT04880733|592541288|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
164049850|NCT04880733|592541286|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
164049851|NCT04880733|592541287|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
164049852|NCT04880733|592541288|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
164049853|NCT04880733|592541286|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
164049854|NCT04880733|592541287|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
164049855|NCT04880733|592541288|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
164049856|NCT04880733|592541286|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
164049857|NCT04880733|592541287|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
164049858|NCT04880733|592541288|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
164049859|NCT00862992|592541289|FG000|Overall Study|Adverse Event|2|||
164049860|NCT00862992|592541290|FG001|Overall Study|Adverse Event|1|||
164049861|NCT00862992|592541291|FG002|Overall Study|Adverse Event|1|||
164049862|NCT00862992|592541289|FG000|Overall Study|Physician Decision|1|||
164049863|NCT00862992|592541290|FG001|Overall Study|Physician Decision|0|||
164049864|NCT00862992|592541291|FG002|Overall Study|Physician Decision|0|||
164049865|NCT00862992|592541289|FG000|Overall Study|Withdrawal by Subject|0|||
164049866|NCT00862992|592541290|FG001|Overall Study|Withdrawal by Subject|0|||
164049867|NCT00862992|592541291|FG002|Overall Study|Withdrawal by Subject|2|||
164049868|NCT05492877|592541292|FG000|Overall Study|Adverse Event|11|||
164049869|NCT05492877|592541293|FG001|Overall Study|Adverse Event|7|||
164049870|NCT05492877|592541292|FG000|Overall Study|Death|1|||
164049871|NCT05492877|592541293|FG001|Overall Study|Death|0|||
164049872|NCT05492877|592541292|FG000|Overall Study|Lost to Follow-up|1|||
164049873|NCT05492877|592541293|FG001|Overall Study|Lost to Follow-up|1|||
164049874|NCT05492877|592541292|FG000|Overall Study|Physician Decision|1|||
164049875|NCT05492877|592541293|FG001|Overall Study|Physician Decision|2|||
164049876|NCT05492877|592541292|FG000|Overall Study|Protocol Violation|1|||
164049877|NCT05492877|592541293|FG001|Overall Study|Protocol Violation|1|||
164049878|NCT05492877|592541292|FG000|Overall Study|Withdrawal by Subject|3|||
164049879|NCT05492877|592541293|FG001|Overall Study|Withdrawal by Subject|7|||
164049880|NCT05492877|592541292|FG000|Overall Study|Reason not specified|6|||
164049881|NCT05492877|592541293|FG001|Overall Study|Reason not specified|4|||
164049882|NCT02871791|592541294|FG000|Phase 1b|Death|0|||
164049883|NCT02871791|592541295|FG001|Phase 1b|Death|1|||
164049884|NCT02871791|592541294|FG000|Phase 1b|progressive disease|6|||
164049885|NCT02871791|592541295|FG001|Phase 1b|progressive disease|2|||
164049886|NCT02871791|592541294|FG000|Phase 2|Death|1|||
164049887|NCT02871791|592541295|FG001|Phase 2|Death|0|||
164049888|NCT02871791|592541294|FG000|Phase 2|Lost to Follow-up|2|||
164049889|NCT02871791|592541295|FG001|Phase 2|Lost to Follow-up|0|||
164049890|NCT03737318|592541305|FG000|Phase 2 (Generalization)|Withdrawal by Subject|4|||
164049891|NCT03737318|592541306|FG001|Phase 2 (Generalization)|Withdrawal by Subject|1|||
164049892|NCT03737318|592541307|FG002|Phase 2 (Generalization)|Withdrawal by Subject|1|||
164049893|NCT00528840|592541311|FG000|Overall Study|Lost to Follow-up|10|||
164049894|NCT00528840|592541311|FG000|Overall Study|Adverse Event|1|||
164049895|NCT00528840|592541311|FG000|Overall Study|Withdrawal by Subject|17|||
164049896|NCT00528840|592541311|FG000|Overall Study|Death|2|||
164049897|NCT00528840|592541311|FG000|Overall Study|Administrative Reasons|1|||
164049898|NCT00528840|592541311|FG000|Overall Study|Other|2|||
164049899|NCT01603628|592541312|FG000|Overall Study|Personal Reasons|1|||
164049900|NCT01603628|592541313|FG001|Overall Study|Personal Reasons|1|||
164049901|NCT01603628|592541314|FG002|Overall Study|Personal Reasons|2|||
164049902|NCT01603628|592541312|FG000|Overall Study|Protocol Violation|1|||
164049903|NCT01603628|592541313|FG001|Overall Study|Protocol Violation|1|||
164049904|NCT01603628|592541314|FG002|Overall Study|Protocol Violation|0|||
164049905|NCT01603628|592541312|FG000|Overall Study|Lost to Follow-up|0|||
164049906|NCT01603628|592541313|FG001|Overall Study|Lost to Follow-up|1|||
164049907|NCT01603628|592541314|FG002|Overall Study|Lost to Follow-up|0|||
164049908|NCT01603628|592541312|FG000|Overall Study|Other Miscellaneous Reason|1|||
164049909|NCT01603628|592541313|FG001|Overall Study|Other Miscellaneous Reason|0|||
164049910|NCT01603628|592541314|FG002|Overall Study|Other Miscellaneous Reason|0|||
164049911|NCT02087241|592541315|FG000|Overall Study|Death|2|||
164049912|NCT02087241|592541316|FG001|Overall Study|Death|1|||
164049913|NCT02087241|592541317|FG002|Overall Study|Death|1|||
164049914|NCT02087241|592541318|FG003|Overall Study|Death|1|||
164049915|NCT02087241|592541315|FG000|Overall Study|Withdrawal by Subject|1|||
164049916|NCT02087241|592541316|FG001|Overall Study|Withdrawal by Subject|0|||
164049917|NCT02087241|592541317|FG002|Overall Study|Withdrawal by Subject|0|||
164049918|NCT02087241|592541318|FG003|Overall Study|Withdrawal by Subject|1|||
164049919|NCT02087241|592541315|FG000|Overall Study|Progressive Disease|0|||
164049920|NCT02087241|592541316|FG001|Overall Study|Progressive Disease|0|||
164049921|NCT02087241|592541317|FG002|Overall Study|Progressive Disease|0|||
164049922|NCT02087241|592541318|FG003|Overall Study|Progressive Disease|1|||
164049923|NCT02087241|592541315|FG000|Overall Study|Study Terminated by Sponsor|0|||
164049924|NCT02087241|592541316|FG001|Overall Study|Study Terminated by Sponsor|2|||
164049925|NCT02087241|592541317|FG002|Overall Study|Study Terminated by Sponsor|0|||
164049926|NCT02087241|592541318|FG003|Overall Study|Study Terminated by Sponsor|4|||
164049927|NCT00836953|592541319|FG000|Overall Study|Withdrawal by Subject|1|||
164049928|NCT00836953|592541319|FG000|Overall Study|Lost to Follow-up|1|||
164049929|NCT02943668|592541320|FG000|Overall Study|Disease Progression|1|||
164049930|NCT01200758|592541321|FG000|Stage I|Death|0|||
164049931|NCT01200758|592541322|FG001|Stage I|Death|1|||
164049932|NCT01200758|592541323|FG002|Stage I|Death|0|||
164049933|NCT01200758|592541324|FG003|Stage I|Death|0|||
164049934|NCT01200758|592541321|FG000|Stage I|Physician Decision|1|||
164049935|NCT01200758|592541322|FG001|Stage I|Physician Decision|1|||
164049936|NCT01200758|592541323|FG002|Stage I|Physician Decision|0|||
164049937|NCT01200758|592541324|FG003|Stage I|Physician Decision|0|||
164049938|NCT01200758|592541321|FG000|Stage I|Lack of Efficacy|2|||
164049939|NCT01200758|592541322|FG001|Stage I|Lack of Efficacy|1|||
164049940|NCT01200758|592541323|FG002|Stage I|Lack of Efficacy|0|||
164049941|NCT01200758|592541324|FG003|Stage I|Lack of Efficacy|0|||
164049942|NCT01200758|592541321|FG000|Stage I|Adverse Event|5|||
164049943|NCT01200758|592541322|FG001|Stage I|Adverse Event|5|||
164049944|NCT01200758|592541323|FG002|Stage I|Adverse Event|0|||
164049945|NCT01200758|592541324|FG003|Stage I|Adverse Event|0|||
164049946|NCT01200758|592541321|FG000|Stage I|Withdrawal by Subject|1|||
164049947|NCT01200758|592541322|FG001|Stage I|Withdrawal by Subject|2|||
164049948|NCT01200758|592541323|FG002|Stage I|Withdrawal by Subject|0|||
164049949|NCT01200758|592541324|FG003|Stage I|Withdrawal by Subject|0|||
164049950|NCT01200758|592541321|FG000|Stage I|Disease Progression|9|||
164049951|NCT01200758|592541322|FG001|Stage I|Disease Progression|7|||
164049952|NCT01200758|592541323|FG002|Stage I|Disease Progression|0|||
164049953|NCT01200758|592541324|FG003|Stage I|Disease Progression|0|||
164049954|NCT01200758|592541321|FG000|Stage 2|Disease Progression|0|||
164049955|NCT01200758|592541322|FG001|Stage 2|Disease Progression|0|||
164049956|NCT01200758|592541323|FG002|Stage 2|Disease Progression|16|||
164049957|NCT01200758|592541324|FG003|Stage 2|Disease Progression|21|||
164049958|NCT01200758|592541321|FG000|Stage 2|Lack of Efficacy|0|||
164049959|NCT01200758|592541322|FG001|Stage 2|Lack of Efficacy|0|||
164049960|NCT01200758|592541323|FG002|Stage 2|Lack of Efficacy|4|||
164049961|NCT01200758|592541324|FG003|Stage 2|Lack of Efficacy|2|||
164049962|NCT01200758|592541321|FG000|Stage 2|Physician Decision|0|||
164049963|NCT01200758|592541322|FG001|Stage 2|Physician Decision|0|||
164049964|NCT01200758|592541323|FG002|Stage 2|Physician Decision|5|||
164049965|NCT01200758|592541324|FG003|Stage 2|Physician Decision|7|||
164049966|NCT01200758|592541321|FG000|Stage 2|Adverse Event|0|||
164049967|NCT01200758|592541322|FG001|Stage 2|Adverse Event|0|||
164049968|NCT01200758|592541323|FG002|Stage 2|Adverse Event|5|||
164049969|NCT01200758|592541324|FG003|Stage 2|Adverse Event|9|||
164049970|NCT01200758|592541321|FG000|Stage 2|Withdrawal by Subject|0|||
164049971|NCT01200758|592541322|FG001|Stage 2|Withdrawal by Subject|0|||
164049972|NCT01200758|592541323|FG002|Stage 2|Withdrawal by Subject|4|||
164049973|NCT01200758|592541324|FG003|Stage 2|Withdrawal by Subject|1|||
164049974|NCT01200758|592541321|FG000|Stage 2|Lost to Follow-up|0|||
164049975|NCT01200758|592541322|FG001|Stage 2|Lost to Follow-up|0|||
164049976|NCT01200758|592541323|FG002|Stage 2|Lost to Follow-up|3|||
164049977|NCT01200758|592541324|FG003|Stage 2|Lost to Follow-up|1|||
164049978|NCT01200758|592541321|FG000|Stage 2|Protocol Violation|0|||
164049979|NCT01200758|592541322|FG001|Stage 2|Protocol Violation|0|||
164049980|NCT01200758|592541323|FG002|Stage 2|Protocol Violation|1|||
164049981|NCT01200758|592541324|FG003|Stage 2|Protocol Violation|4|||
164049982|NCT01200758|592541321|FG000|Stage 2|Death|0|||
164049983|NCT01200758|592541322|FG001|Stage 2|Death|0|||
164049984|NCT01200758|592541323|FG002|Stage 2|Death|3|||
164049985|NCT01200758|592541324|FG003|Stage 2|Death|5|||
164049986|NCT04048876|592541329|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
164049987|NCT04048876|592541330|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
164049988|NCT04048876|592541331|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
164049989|NCT04048876|592541332|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
164049990|NCT04048876|592541329|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
164049991|NCT04048876|592541330|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
164049992|NCT04048876|592541331|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
164049993|NCT04048876|592541332|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
164049994|NCT04048876|592541329|FG000|Placebo Controlled Phase|Adverse Event|0|||
164049995|NCT04048876|592541330|FG001|Placebo Controlled Phase|Adverse Event|1|||
164049996|NCT04048876|592541331|FG002|Placebo Controlled Phase|Adverse Event|0|||
164049997|NCT04048876|592541332|FG003|Placebo Controlled Phase|Adverse Event|0|||
164049998|NCT04048876|592541329|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
164049999|NCT04048876|592541330|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
164050000|NCT04048876|592541331|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
164050001|NCT04048876|592541332|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
164050002|NCT04350372|592541337|FG000|Overall Study|Death|1|||
164050003|NCT03858686|592541339|FG000|Period 1|Adverse Event|1|||
164050004|NCT03858686|592541340|FG001|Period 1|Adverse Event|1|||
164050005|NCT03858686|592541339|FG000|Period 1|Lack of compliance|0|||
164050006|NCT03858686|592541340|FG001|Period 1|Lack of compliance|1|||
164050007|NCT03858686|592541339|FG000|Period 1|Adverse Event|0|||
164050008|NCT03858686|592541340|FG001|Period 1|Adverse Event|1|||
164050009|NCT03858686|592541339|FG000|Period 2|Adverse Event|0|||
164050010|NCT03858686|592541340|FG001|Period 2|Adverse Event|1|||
164050011|NCT03053180|592543237|FG000|Overall Study|Failure to Return|1|||
164050012|NCT01465958|592543242|FG000|Run-in Phase|Protocol Violation|1|||
164050013|NCT01465958|592543243|FG001|Run-in Phase|Protocol Violation|0|||
164050014|NCT01465958|592543242|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
164050015|NCT01465958|592543243|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
164050016|NCT00211536|592543251|FG000|Overall Study|Withdrawal by Subject|2|||
164050017|NCT00211536|592543252|FG001|Overall Study|Withdrawal by Subject|2|||
164050018|NCT00211536|592543251|FG000|Overall Study|Physician Decision|0|||
164050019|NCT00211536|592543252|FG001|Overall Study|Physician Decision|5|||
164050020|NCT00211536|592543251|FG000|Overall Study|Adverse Event|2|||
164050021|NCT00211536|592543252|FG001|Overall Study|Adverse Event|0|||
164050022|NCT02583399|592543253|FG000|Overall Study|Able to be discharged|3|||
164050023|NCT02583399|592543253|FG000|Overall Study|Wanted to use a restricted medication|3|||
164050024|NCT01004861|592543254|FG000|Overall Study|Disease progression|3|||
164050025|NCT01004861|592543255|FG001|Overall Study|Disease progression|4|||
164050026|NCT01004861|592543256|FG002|Overall Study|Disease progression|5|||
164050027|NCT01004861|592543257|FG003|Overall Study|Disease progression|4|||
164050028|NCT01004861|592543258|FG004|Overall Study|Disease progression|4|||
164050029|NCT01004861|592543259|FG005|Overall Study|Disease progression|4|||
164050030|NCT01004861|592543260|FG006|Overall Study|Disease progression|5|||
164050031|NCT01004861|592543261|FG007|Overall Study|Disease progression|1|||
164050032|NCT01004861|592543262|FG008|Overall Study|Disease progression|4|||
164050033|NCT01004861|592543263|FG009|Overall Study|Disease progression|7|||
164050034|NCT01004861|592543264|FG010|Overall Study|Disease progression|6|||
164050035|NCT01004861|592543265|FG011|Overall Study|Disease progression|3|||
164050036|NCT01004861|592543266|FG012|Overall Study|Disease progression|8|||
164050037|NCT01004861|592543254|FG000|Overall Study|Physician Decision|0|||
164050038|NCT01004861|592543255|FG001|Overall Study|Physician Decision|2|||
164050039|NCT01004861|592543256|FG002|Overall Study|Physician Decision|1|||
164050040|NCT01004861|592543257|FG003|Overall Study|Physician Decision|1|||
164050041|NCT01004861|592543258|FG004|Overall Study|Physician Decision|1|||
164050042|NCT01004861|592543259|FG005|Overall Study|Physician Decision|0|||
164050043|NCT01004861|592543260|FG006|Overall Study|Physician Decision|0|||
164050044|NCT01004861|592543261|FG007|Overall Study|Physician Decision|1|||
164050045|NCT01004861|592543262|FG008|Overall Study|Physician Decision|0|||
164050046|NCT01004861|592543263|FG009|Overall Study|Physician Decision|0|||
164050047|NCT01004861|592543264|FG010|Overall Study|Physician Decision|0|||
164050048|NCT01004861|592543265|FG011|Overall Study|Physician Decision|0|||
164050049|NCT01004861|592543266|FG012|Overall Study|Physician Decision|3|||
164050050|NCT01004861|592543254|FG000|Overall Study|Adverse Event|0|||
164050051|NCT01004861|592543255|FG001|Overall Study|Adverse Event|0|||
164050052|NCT01004861|592543256|FG002|Overall Study|Adverse Event|0|||
164050053|NCT01004861|592543257|FG003|Overall Study|Adverse Event|1|||
164050054|NCT01004861|592543258|FG004|Overall Study|Adverse Event|0|||
164050055|NCT01004861|592543259|FG005|Overall Study|Adverse Event|2|||
164050056|NCT01004861|592543260|FG006|Overall Study|Adverse Event|1|||
164050057|NCT01004861|592543261|FG007|Overall Study|Adverse Event|1|||
164050058|NCT01004861|592543262|FG008|Overall Study|Adverse Event|13|||
164050059|NCT01004861|592543263|FG009|Overall Study|Adverse Event|1|||
164050060|NCT01004861|592543264|FG010|Overall Study|Adverse Event|1|||
164050061|NCT01004861|592543265|FG011|Overall Study|Adverse Event|0|||
164050062|NCT01004861|592543266|FG012|Overall Study|Adverse Event|2|||
164050063|NCT01004861|592543254|FG000|Overall Study|Protocol Violation|0|||
164050064|NCT01004861|592543255|FG001|Overall Study|Protocol Violation|0|||
164050065|NCT01004861|592543256|FG002|Overall Study|Protocol Violation|0|||
164050066|NCT01004861|592543257|FG003|Overall Study|Protocol Violation|0|||
164050067|NCT01004861|592543258|FG004|Overall Study|Protocol Violation|1|||
164050068|NCT01004861|592543259|FG005|Overall Study|Protocol Violation|0|||
164050069|NCT01004861|592543260|FG006|Overall Study|Protocol Violation|0|||
164050070|NCT01004861|592543261|FG007|Overall Study|Protocol Violation|0|||
164050071|NCT01004861|592543262|FG008|Overall Study|Protocol Violation|0|||
164050072|NCT01004861|592543263|FG009|Overall Study|Protocol Violation|0|||
164050073|NCT01004861|592543264|FG010|Overall Study|Protocol Violation|0|||
164050074|NCT01004861|592543265|FG011|Overall Study|Protocol Violation|0|||
164050075|NCT01004861|592543266|FG012|Overall Study|Protocol Violation|0|||
164050076|NCT01004861|592543254|FG000|Overall Study|Lost to Follow-up|0|||
164050077|NCT01004861|592543255|FG001|Overall Study|Lost to Follow-up|0|||
164050078|NCT01004861|592543256|FG002|Overall Study|Lost to Follow-up|0|||
164050079|NCT01004861|592543257|FG003|Overall Study|Lost to Follow-up|0|||
164050080|NCT01004861|592543258|FG004|Overall Study|Lost to Follow-up|0|||
164050081|NCT01004861|592543259|FG005|Overall Study|Lost to Follow-up|0|||
164050082|NCT01004861|592543260|FG006|Overall Study|Lost to Follow-up|0|||
164050083|NCT01004861|592543261|FG007|Overall Study|Lost to Follow-up|1|||
164050084|NCT01004861|592543262|FG008|Overall Study|Lost to Follow-up|3|||
164050085|NCT01004861|592543263|FG009|Overall Study|Lost to Follow-up|0|||
164050086|NCT01004861|592543264|FG010|Overall Study|Lost to Follow-up|0|||
164050087|NCT01004861|592543265|FG011|Overall Study|Lost to Follow-up|1|||
164050088|NCT01004861|592543266|FG012|Overall Study|Lost to Follow-up|0|||
164050089|NCT01004861|592543254|FG000|Overall Study|Non-compliance|0|||
164050090|NCT01004861|592543255|FG001|Overall Study|Non-compliance|0|||
164050091|NCT01004861|592543256|FG002|Overall Study|Non-compliance|0|||
164050092|NCT01004861|592543257|FG003|Overall Study|Non-compliance|0|||
164050093|NCT01004861|592543258|FG004|Overall Study|Non-compliance|0|||
164050094|NCT01004861|592543259|FG005|Overall Study|Non-compliance|0|||
164050095|NCT01004861|592543260|FG006|Overall Study|Non-compliance|0|||
164050096|NCT01004861|592543261|FG007|Overall Study|Non-compliance|0|||
164050097|NCT01004861|592543262|FG008|Overall Study|Non-compliance|5|||
164050098|NCT01004861|592543263|FG009|Overall Study|Non-compliance|0|||
164050099|NCT01004861|592543264|FG010|Overall Study|Non-compliance|0|||
164050100|NCT01004861|592543265|FG011|Overall Study|Non-compliance|0|||
164050101|NCT01004861|592543266|FG012|Overall Study|Non-compliance|1|||
164050102|NCT01004861|592543254|FG000|Overall Study|Other|0|||
164050103|NCT01004861|592543255|FG001|Overall Study|Other|0|||
164050104|NCT01004861|592543256|FG002|Overall Study|Other|0|||
164050105|NCT01004861|592543257|FG003|Overall Study|Other|0|||
164050106|NCT01004861|592543258|FG004|Overall Study|Other|0|||
164050107|NCT01004861|592543259|FG005|Overall Study|Other|0|||
164050108|NCT01004861|592543260|FG006|Overall Study|Other|0|||
164050109|NCT01004861|592543261|FG007|Overall Study|Other|0|||
164050110|NCT01004861|592543262|FG008|Overall Study|Other|0|||
164050111|NCT01004861|592543263|FG009|Overall Study|Other|2|||
164050112|NCT01004861|592543264|FG010|Overall Study|Other|1|||
164050113|NCT01004861|592543265|FG011|Overall Study|Other|2|||
164050114|NCT01004861|592543266|FG012|Overall Study|Other|3|||
164050115|NCT01004861|592543254|FG000|Overall Study|Patient decision|0|||
164050116|NCT01004861|592543255|FG001|Overall Study|Patient decision|0|||
164050117|NCT01004861|592543256|FG002|Overall Study|Patient decision|0|||
164050118|NCT01004861|592543257|FG003|Overall Study|Patient decision|0|||
164050119|NCT01004861|592543258|FG004|Overall Study|Patient decision|1|||
164050120|NCT01004861|592543259|FG005|Overall Study|Patient decision|0|||
164050121|NCT01004861|592543260|FG006|Overall Study|Patient decision|1|||
164050122|NCT01004861|592543261|FG007|Overall Study|Patient decision|0|||
164050123|NCT01004861|592543262|FG008|Overall Study|Patient decision|7|||
164050124|NCT01004861|592543263|FG009|Overall Study|Patient decision|1|||
164050125|NCT01004861|592543264|FG010|Overall Study|Patient decision|1|||
164050126|NCT01004861|592543265|FG011|Overall Study|Patient decision|2|||
164050127|NCT01004861|592543266|FG012|Overall Study|Patient decision|3|||
164050128|NCT01004861|592543254|FG000|Overall Study|Transitioned to Phase 4 study|0|||
164050129|NCT01004861|592543255|FG001|Overall Study|Transitioned to Phase 4 study|0|||
164050130|NCT01004861|592543256|FG002|Overall Study|Transitioned to Phase 4 study|0|||
164050131|NCT01004861|592543257|FG003|Overall Study|Transitioned to Phase 4 study|0|||
164050132|NCT01004861|592543258|FG004|Overall Study|Transitioned to Phase 4 study|0|||
164050133|NCT01004861|592543259|FG005|Overall Study|Transitioned to Phase 4 study|0|||
164050134|NCT01004861|592543260|FG006|Overall Study|Transitioned to Phase 4 study|0|||
164050135|NCT01004861|592543261|FG007|Overall Study|Transitioned to Phase 4 study|0|||
164050136|NCT01004861|592543262|FG008|Overall Study|Transitioned to Phase 4 study|2|||
164050137|NCT01004861|592543263|FG009|Overall Study|Transitioned to Phase 4 study|0|||
164050138|NCT01004861|592543264|FG010|Overall Study|Transitioned to Phase 4 study|0|||
164050139|NCT01004861|592543265|FG011|Overall Study|Transitioned to Phase 4 study|0|||
164050140|NCT01004861|592543266|FG012|Overall Study|Transitioned to Phase 4 study|0|||
164050141|NCT01004861|592543254|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050142|NCT01004861|592543255|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050143|NCT01004861|592543256|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050144|NCT01004861|592543257|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050145|NCT01004861|592543258|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050146|NCT01004861|592543259|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050147|NCT01004861|592543260|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050148|NCT01004861|592543261|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050149|NCT01004861|592543262|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
164050150|NCT01004861|592543263|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050151|NCT01004861|592543264|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050152|NCT01004861|592543265|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050153|NCT01004861|592543266|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
164050154|NCT01004861|592543254|FG000|Overall Study|Patient withdrew|0|||
164050155|NCT01004861|592543255|FG001|Overall Study|Patient withdrew|0|||
164050156|NCT01004861|592543256|FG002|Overall Study|Patient withdrew|0|||
164050157|NCT01004861|592543257|FG003|Overall Study|Patient withdrew|0|||
164050158|NCT01004861|592543258|FG004|Overall Study|Patient withdrew|0|||
164050159|NCT01004861|592543259|FG005|Overall Study|Patient withdrew|0|||
164050160|NCT01004861|592543260|FG006|Overall Study|Patient withdrew|0|||
164050161|NCT01004861|592543261|FG007|Overall Study|Patient withdrew|0|||
164050162|NCT01004861|592543262|FG008|Overall Study|Patient withdrew|1|||
164050163|NCT01004861|592543263|FG009|Overall Study|Patient withdrew|0|||
164050164|NCT01004861|592543264|FG010|Overall Study|Patient withdrew|0|||
164050165|NCT01004861|592543265|FG011|Overall Study|Patient withdrew|0|||
164050166|NCT01004861|592543266|FG012|Overall Study|Patient withdrew|0|||
164050167|NCT01004861|592543254|FG000|Overall Study|Surgical resection|0|||
164050168|NCT01004861|592543255|FG001|Overall Study|Surgical resection|0|||
164050169|NCT01004861|592543256|FG002|Overall Study|Surgical resection|0|||
164050170|NCT01004861|592543257|FG003|Overall Study|Surgical resection|0|||
164050171|NCT01004861|592543258|FG004|Overall Study|Surgical resection|0|||
164050172|NCT01004861|592543259|FG005|Overall Study|Surgical resection|0|||
164050173|NCT01004861|592543260|FG006|Overall Study|Surgical resection|0|||
164050174|NCT01004861|592543261|FG007|Overall Study|Surgical resection|0|||
164050175|NCT01004861|592543262|FG008|Overall Study|Surgical resection|1|||
164050176|NCT01004861|592543263|FG009|Overall Study|Surgical resection|0|||
164050177|NCT01004861|592543264|FG010|Overall Study|Surgical resection|0|||
164050178|NCT01004861|592543265|FG011|Overall Study|Surgical resection|0|||
164050179|NCT01004861|592543266|FG012|Overall Study|Surgical resection|0|||
164050180|NCT01004861|592543254|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050181|NCT01004861|592543255|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050182|NCT01004861|592543256|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050183|NCT01004861|592543257|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050184|NCT01004861|592543258|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050185|NCT01004861|592543259|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050186|NCT01004861|592543260|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050187|NCT01004861|592543261|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050188|NCT01004861|592543262|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
164050189|NCT01004861|592543263|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050190|NCT01004861|592543264|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050191|NCT01004861|592543265|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050192|NCT01004861|592543266|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
164050193|NCT01004861|592543254|FG000|Overall Study|Study termination by Sponsor|0|||
164050194|NCT01004861|592543255|FG001|Overall Study|Study termination by Sponsor|0|||
164050195|NCT01004861|592543256|FG002|Overall Study|Study termination by Sponsor|0|||
164050196|NCT01004861|592543257|FG003|Overall Study|Study termination by Sponsor|0|||
164050197|NCT01004861|592543258|FG004|Overall Study|Study termination by Sponsor|0|||
164050198|NCT01004861|592543259|FG005|Overall Study|Study termination by Sponsor|0|||
164050199|NCT01004861|592543260|FG006|Overall Study|Study termination by Sponsor|0|||
164050200|NCT01004861|592543261|FG007|Overall Study|Study termination by Sponsor|0|||
164050201|NCT01004861|592543262|FG008|Overall Study|Study termination by Sponsor|1|||
164050202|NCT01004861|592543263|FG009|Overall Study|Study termination by Sponsor|0|||
164050203|NCT01004861|592543264|FG010|Overall Study|Study termination by Sponsor|0|||
164050204|NCT01004861|592543265|FG011|Overall Study|Study termination by Sponsor|0|||
164050205|NCT01004861|592543266|FG012|Overall Study|Study termination by Sponsor|0|||
164050206|NCT04610827|592543268|FG000|Overall Study|Withdrawal by Subject|1|||
164050207|NCT04610827|592543269|FG001|Overall Study|Withdrawal by Subject|1|||
164050208|NCT04610827|592543270|FG002|Overall Study|Withdrawal by Subject|0|||
164050209|NCT01823991|592543271|FG000|Overall Study|Withdrawal by Subject|8|||
164050210|NCT01823991|592543272|FG001|Overall Study|Withdrawal by Subject|5|||
164050211|NCT00805194|592543273|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
164050212|NCT00805194|592543274|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
164050213|NCT00805194|592543273|FG000|Overall Study|Worsening or AE of underlying disease|64|||
164050214|NCT00805194|592543274|FG001|Overall Study|Worsening or AE of underlying disease|70|||
164050215|NCT00805194|592543273|FG000|Overall Study|Other AE|84|||
164050216|NCT00805194|592543274|FG001|Overall Study|Other AE|73|||
164050217|NCT00805194|592543273|FG000|Overall Study|Protocol Violation|9|||
164050218|NCT00805194|592543274|FG001|Overall Study|Protocol Violation|9|||
164050219|NCT00805194|592543273|FG000|Overall Study|Lost to Follow-up|5|||
164050220|NCT00805194|592543274|FG001|Overall Study|Lost to Follow-up|5|||
164050221|NCT00805194|592543273|FG000|Overall Study|Withdrawal by Subject|60|||
164050222|NCT00805194|592543274|FG001|Overall Study|Withdrawal by Subject|42|||
164050223|NCT00805194|592543273|FG000|Overall Study|Not treated|3|||
164050224|NCT00805194|592543274|FG001|Overall Study|Not treated|4|||
164050225|NCT00805194|592543273|FG000|Overall Study|Reasons other than stated above|20|||
164050226|NCT00805194|592543274|FG001|Overall Study|Reasons other than stated above|16|||
164050227|NCT02185040|592543278|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
164050228|NCT02185040|592543279|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
164050229|NCT02185040|592543280|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
164050230|NCT02185040|592543281|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
164050231|NCT02185040|592543282|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
164050232|NCT02185040|592543283|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
164050233|NCT02185040|592543284|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
164050234|NCT02185040|592543278|FG000|Part 1 Treatment Phase|Adverse Event|1|||
164050235|NCT02185040|592543279|FG001|Part 1 Treatment Phase|Adverse Event|0|||
164050236|NCT02185040|592543280|FG002|Part 1 Treatment Phase|Adverse Event|0|||
164050237|NCT02185040|592543281|FG003|Part 1 Treatment Phase|Adverse Event|2|||
164050238|NCT02185040|592543282|FG004|Part 1 Treatment Phase|Adverse Event|3|||
164050239|NCT02185040|592543283|FG005|Part 1 Treatment Phase|Adverse Event|0|||
164050240|NCT02185040|592543284|FG006|Part 1 Treatment Phase|Adverse Event|0|||
164050241|NCT02185040|592543278|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164050242|NCT02185040|592543279|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
164050243|NCT02185040|592543280|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164050244|NCT02185040|592543281|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164050245|NCT02185040|592543282|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164050246|NCT02185040|592543283|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164050247|NCT02185040|592543284|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
164050248|NCT02185040|592543278|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
164050249|NCT02185040|592543279|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
164050250|NCT02185040|592543280|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
164050251|NCT02185040|592543281|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
164050252|NCT02185040|592543282|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
164050253|NCT02185040|592543283|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
164050254|NCT02185040|592543284|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
164050255|NCT02185040|592543278|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
164050256|NCT02185040|592543279|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
164050257|NCT02185040|592543280|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
164050258|NCT02185040|592543281|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
164050259|NCT02185040|592543282|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
164050260|NCT02185040|592543283|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
164050261|NCT02185040|592543284|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
164050262|NCT02185040|592543278|FG000|Active Treatment Extension Phase|Adverse Event|0|||
164050263|NCT02185040|592543279|FG001|Active Treatment Extension Phase|Adverse Event|0|||
164050264|NCT02185040|592543280|FG002|Active Treatment Extension Phase|Adverse Event|0|||
164050265|NCT02185040|592543281|FG003|Active Treatment Extension Phase|Adverse Event|0|||
164050266|NCT02185040|592543282|FG004|Active Treatment Extension Phase|Adverse Event|0|||
164050267|NCT02185040|592543283|FG005|Active Treatment Extension Phase|Adverse Event|1|||
164050268|NCT02185040|592543284|FG006|Active Treatment Extension Phase|Adverse Event|4|||
164050269|NCT02185040|592543278|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164050270|NCT02185040|592543279|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164050271|NCT02185040|592543280|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164050272|NCT02185040|592543281|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164050273|NCT02185040|592543282|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
164050274|NCT02185040|592543283|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
164050275|NCT02185040|592543284|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
164050276|NCT02185040|592543278|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
164050277|NCT02185040|592543279|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
164050278|NCT02185040|592543280|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
164050279|NCT02185040|592543281|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
164050280|NCT02185040|592543282|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
164050281|NCT02185040|592543283|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
164050282|NCT02185040|592543284|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
164050283|NCT00718887|592543288|FG000|Overall Study|Withdrawal by Subject|3|||
164050284|NCT00718887|592543289|FG001|Overall Study|Withdrawal by Subject|2|||
164050285|NCT00718887|592543288|FG000|Overall Study|Not identified|2|||
164050286|NCT00718887|592543289|FG001|Overall Study|Not identified|7|||
164050287|NCT03557801|592543292|FG000|Overall Study|Protocol Violation|1|||
164050288|NCT03557801|592543293|FG001|Overall Study|Protocol Violation|0|||
164050289|NCT03557801|592543294|FG002|Overall Study|Protocol Violation|0|||
164050290|NCT03557801|592543292|FG000|Overall Study|Withdrawal by Subject|1|||
164050291|NCT03557801|592543293|FG001|Overall Study|Withdrawal by Subject|0|||
164050292|NCT03557801|592543294|FG002|Overall Study|Withdrawal by Subject|3|||
164050293|NCT03557801|592543292|FG000|Overall Study|Lost to Follow-up|0|||
164050294|NCT03557801|592543293|FG001|Overall Study|Lost to Follow-up|1|||
164050295|NCT03557801|592543294|FG002|Overall Study|Lost to Follow-up|0|||
164050296|NCT00535236|592543295|FG000|Overall Study|Adverse Event|1|||
164050297|NCT00535236|592543296|FG001|Overall Study|Adverse Event|0|||
164050298|NCT00535236|592543297|FG002|Overall Study|Adverse Event|9|||
164050299|NCT00535236|592543298|FG003|Overall Study|Adverse Event|3|||
164050300|NCT00535236|592543299|FG004|Overall Study|Adverse Event|3|||
164050301|NCT00535236|592543300|FG005|Overall Study|Adverse Event|0|||
164050302|NCT00535236|592543301|FG006|Overall Study|Adverse Event|5|||
164050303|NCT00535236|592543302|FG007|Overall Study|Adverse Event|1|||
164050304|NCT00535236|592543303|FG008|Overall Study|Adverse Event|2|||
164050305|NCT00535236|592543304|FG009|Overall Study|Adverse Event|1|||
164050306|NCT00535236|592543295|FG000|Overall Study|Lost to Follow-up|1|||
164050307|NCT00535236|592543296|FG001|Overall Study|Lost to Follow-up|2|||
164050308|NCT00535236|592543297|FG002|Overall Study|Lost to Follow-up|0|||
164050309|NCT00535236|592543298|FG003|Overall Study|Lost to Follow-up|0|||
164050310|NCT00535236|592543299|FG004|Overall Study|Lost to Follow-up|2|||
164050311|NCT00535236|592543300|FG005|Overall Study|Lost to Follow-up|0|||
164050312|NCT00535236|592543301|FG006|Overall Study|Lost to Follow-up|0|||
164050313|NCT00535236|592543302|FG007|Overall Study|Lost to Follow-up|0|||
164050314|NCT00535236|592543303|FG008|Overall Study|Lost to Follow-up|6|||
164050315|NCT00535236|592543304|FG009|Overall Study|Lost to Follow-up|1|||
164050316|NCT00535236|592543295|FG000|Overall Study|Physician Decision|0|||
164050317|NCT00535236|592543296|FG001|Overall Study|Physician Decision|0|||
164050318|NCT00535236|592543297|FG002|Overall Study|Physician Decision|0|||
164050319|NCT00535236|592543298|FG003|Overall Study|Physician Decision|0|||
164050320|NCT00535236|592543299|FG004|Overall Study|Physician Decision|1|||
164050321|NCT00535236|592543300|FG005|Overall Study|Physician Decision|0|||
164050322|NCT00535236|592543301|FG006|Overall Study|Physician Decision|1|||
164050323|NCT00535236|592543302|FG007|Overall Study|Physician Decision|0|||
164050324|NCT00535236|592543303|FG008|Overall Study|Physician Decision|0|||
164050325|NCT00535236|592543304|FG009|Overall Study|Physician Decision|0|||
164050326|NCT00535236|592543295|FG000|Overall Study|Protocol Violation|2|||
164050327|NCT00535236|592543296|FG001|Overall Study|Protocol Violation|0|||
164050328|NCT00535236|592543297|FG002|Overall Study|Protocol Violation|1|||
164050329|NCT00535236|592543298|FG003|Overall Study|Protocol Violation|0|||
164050330|NCT00535236|592543299|FG004|Overall Study|Protocol Violation|0|||
164050331|NCT00535236|592543300|FG005|Overall Study|Protocol Violation|0|||
164050332|NCT00535236|592543301|FG006|Overall Study|Protocol Violation|0|||
164050333|NCT00535236|592543302|FG007|Overall Study|Protocol Violation|0|||
164050334|NCT00535236|592543303|FG008|Overall Study|Protocol Violation|1|||
164050335|NCT00535236|592543304|FG009|Overall Study|Protocol Violation|0|||
164050336|NCT00535236|592543295|FG000|Overall Study|Withdrawal by Subject|3|||
164050337|NCT00535236|592543296|FG001|Overall Study|Withdrawal by Subject|0|||
164050338|NCT00535236|592543297|FG002|Overall Study|Withdrawal by Subject|2|||
164050339|NCT00535236|592543298|FG003|Overall Study|Withdrawal by Subject|1|||
164050340|NCT00535236|592543299|FG004|Overall Study|Withdrawal by Subject|6|||
164050341|NCT00535236|592543300|FG005|Overall Study|Withdrawal by Subject|1|||
164050342|NCT00535236|592543301|FG006|Overall Study|Withdrawal by Subject|5|||
164050343|NCT00535236|592543302|FG007|Overall Study|Withdrawal by Subject|0|||
164050344|NCT00535236|592543303|FG008|Overall Study|Withdrawal by Subject|4|||
164050345|NCT00535236|592543304|FG009|Overall Study|Withdrawal by Subject|2|||
164050346|NCT03558503|592543306|FG000|Overall Study|Adverse Event|1|||
164050347|NCT03558503|592543306|FG000|Overall Study|Death|1|||
164050348|NCT03558503|592543306|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
164050349|NCT00561795|592543307|FG000|Overall Study|Adverse Event|3|||
164050350|NCT00561795|592543308|FG001|Overall Study|Adverse Event|3|||
164050351|NCT00561795|592543309|FG002|Overall Study|Adverse Event|0|||
164050352|NCT00561795|592543310|FG003|Overall Study|Adverse Event|0|||
164050353|NCT00561795|592543307|FG000|Overall Study|Study Closed/Terminated|0|||
164050354|NCT00561795|592543308|FG001|Overall Study|Study Closed/Terminated|3|||
164050355|NCT00561795|592543309|FG002|Overall Study|Study Closed/Terminated|0|||
164050356|NCT00561795|592543310|FG003|Overall Study|Study Closed/Terminated|0|||
164050357|NCT00561795|592543307|FG000|Overall Study|Physician Decision|1|||
164050358|NCT00561795|592543308|FG001|Overall Study|Physician Decision|0|||
164050359|NCT00561795|592543309|FG002|Overall Study|Physician Decision|0|||
164050360|NCT00561795|592543310|FG003|Overall Study|Physician Decision|0|||
164050361|NCT02094612|592543311|FG000|Overall Study|Lost to Follow-up|47|||
164050362|NCT02094612|592543312|FG001|Overall Study|Lost to Follow-up|47|||
164050363|NCT02094612|592543311|FG000|Overall Study|Never started ADHD medication|32|||
164050364|NCT02094612|592543312|FG001|Overall Study|Never started ADHD medication|23|||
164050365|NCT04167514|592543313|FG000|Overall Study|Adverse event, not serious|0|||
164050366|NCT04167514|592543314|FG001|Overall Study|Adverse event, not serious|1|||
164050367|NCT04167514|592543313|FG000|Overall Study|Lost to Follow-up|1|||
164050368|NCT04167514|592543314|FG001|Overall Study|Lost to Follow-up|0|||
164050369|NCT04167514|592543313|FG000|Overall Study|Participant Decision|2|||
164050370|NCT04167514|592543314|FG001|Overall Study|Participant Decision|4|||
164050371|NCT04167514|592543313|FG000|Overall Study|Physician Decision|3|||
164050372|NCT04167514|592543314|FG001|Overall Study|Physician Decision|2|||
164050373|NCT04167514|592543313|FG000|Overall Study|Death|14|||
164050374|NCT04167514|592543314|FG001|Overall Study|Death|18|||
164050375|NCT04167514|592543313|FG000|Overall Study|Enrolled but treatment not administered|2|||
164050376|NCT04167514|592543314|FG001|Overall Study|Enrolled but treatment not administered|0|||
164050377|NCT04167514|592543313|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
164050378|NCT04167514|592543314|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
164050379|NCT04167514|592543313|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
164050380|NCT04167514|592543314|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
164050381|NCT02646891|592543315|FG000|Overall Study|Adverse Event|0|||
164050382|NCT02646891|592543316|FG001|Overall Study|Adverse Event|1|||
164050383|NCT02646891|592543317|FG002|Overall Study|Adverse Event|0|||
164050384|NCT02646891|592543318|FG003|Overall Study|Adverse Event|0|||
164050385|NCT02646891|592543319|FG004|Overall Study|Adverse Event|0|||
164050386|NCT02646891|592543320|FG005|Overall Study|Adverse Event|0|||
164050387|NCT02646891|592543321|FG006|Overall Study|Adverse Event|0|||
164099726|NCT02100228|592730565|FG001|Overall Study|Adverse Event|12|||
164050388|NCT02646891|592543322|FG007|Overall Study|Adverse Event|0|||
164050389|NCT02646891|592543323|FG008|Overall Study|Adverse Event|0|||
164050390|NCT02646891|592543324|FG009|Overall Study|Adverse Event|0|||
164099727|NCT02100228|592730564|FG000|Overall Study|Death|1|||
164050391|NCT02646891|592543315|FG000|Overall Study|Lost to Follow-up|0|||
164050392|NCT02646891|592543316|FG001|Overall Study|Lost to Follow-up|0|||
164050393|NCT02646891|592543317|FG002|Overall Study|Lost to Follow-up|0|||
164050394|NCT02646891|592543318|FG003|Overall Study|Lost to Follow-up|0|||
164050395|NCT02646891|592543319|FG004|Overall Study|Lost to Follow-up|0|||
164050396|NCT02646891|592543320|FG005|Overall Study|Lost to Follow-up|0|||
164050397|NCT02646891|592543321|FG006|Overall Study|Lost to Follow-up|2|||
164050398|NCT02646891|592543322|FG007|Overall Study|Lost to Follow-up|2|||
164050399|NCT02646891|592543323|FG008|Overall Study|Lost to Follow-up|2|||
164050400|NCT02646891|592543324|FG009|Overall Study|Lost to Follow-up|2|||
164050401|NCT02646891|592543315|FG000|Overall Study|Protocol Violation|0|||
164050402|NCT02646891|592543316|FG001|Overall Study|Protocol Violation|0|||
164050403|NCT02646891|592543317|FG002|Overall Study|Protocol Violation|0|||
164050404|NCT02646891|592543318|FG003|Overall Study|Protocol Violation|0|||
164050405|NCT02646891|592543319|FG004|Overall Study|Protocol Violation|0|||
164050406|NCT02646891|592543320|FG005|Overall Study|Protocol Violation|0|||
164050407|NCT02646891|592543321|FG006|Overall Study|Protocol Violation|1|||
164050408|NCT02646891|592543322|FG007|Overall Study|Protocol Violation|1|||
164050409|NCT02646891|592543323|FG008|Overall Study|Protocol Violation|0|||
164050410|NCT02646891|592543324|FG009|Overall Study|Protocol Violation|0|||
164050411|NCT02646891|592543315|FG000|Overall Study|Withdrawal by Subject|2|||
164050412|NCT02646891|592543316|FG001|Overall Study|Withdrawal by Subject|0|||
164050413|NCT02646891|592543317|FG002|Overall Study|Withdrawal by Subject|1|||
164050414|NCT02646891|592543318|FG003|Overall Study|Withdrawal by Subject|0|||
164050415|NCT02646891|592543319|FG004|Overall Study|Withdrawal by Subject|0|||
164050416|NCT02646891|592543320|FG005|Overall Study|Withdrawal by Subject|0|||
164050417|NCT02646891|592543321|FG006|Overall Study|Withdrawal by Subject|5|||
164050418|NCT02646891|592543322|FG007|Overall Study|Withdrawal by Subject|9|||
164050419|NCT02646891|592543323|FG008|Overall Study|Withdrawal by Subject|7|||
164050420|NCT02646891|592543324|FG009|Overall Study|Withdrawal by Subject|3|||
164050421|NCT02646891|592543315|FG000|Overall Study|Death|0|||
164050422|NCT02646891|592543316|FG001|Overall Study|Death|0|||
164050423|NCT02646891|592543317|FG002|Overall Study|Death|0|||
164050424|NCT02646891|592543318|FG003|Overall Study|Death|0|||
164050425|NCT02646891|592543319|FG004|Overall Study|Death|0|||
164050426|NCT02646891|592543320|FG005|Overall Study|Death|0|||
164050427|NCT02646891|592543321|FG006|Overall Study|Death|1|||
164050428|NCT02646891|592543322|FG007|Overall Study|Death|1|||
164050429|NCT02646891|592543323|FG008|Overall Study|Death|1|||
164050430|NCT02646891|592543324|FG009|Overall Study|Death|0|||
164050431|NCT01542632|592543325|FG000|Overall Study|Withdrawal of Consent|0|||
164050432|NCT01542632|592543326|FG001|Overall Study|Withdrawal of Consent|0|||
164050433|NCT01542632|592543327|FG002|Overall Study|Withdrawal of Consent|0|||
164050434|NCT01542632|592543328|FG003|Overall Study|Withdrawal of Consent|2|||
164050435|NCT01542632|592543329|FG004|Overall Study|Withdrawal of Consent|3|||
164050436|NCT01542632|592543330|FG005|Overall Study|Withdrawal of Consent|0|||
164050437|NCT01542632|592543325|FG000|Overall Study|Adverse Event|0|||
164050438|NCT01542632|592543326|FG001|Overall Study|Adverse Event|0|||
164050439|NCT01542632|592543327|FG002|Overall Study|Adverse Event|1|||
164050440|NCT01542632|592543328|FG003|Overall Study|Adverse Event|0|||
164050441|NCT01542632|592543329|FG004|Overall Study|Adverse Event|0|||
164050442|NCT01542632|592543330|FG005|Overall Study|Adverse Event|0|||
164050443|NCT01542632|592543325|FG000|Overall Study|Lost to Follow-up|0|||
164050444|NCT01542632|592543326|FG001|Overall Study|Lost to Follow-up|1|||
164050445|NCT01542632|592543327|FG002|Overall Study|Lost to Follow-up|0|||
164050446|NCT01542632|592543328|FG003|Overall Study|Lost to Follow-up|0|||
164050447|NCT01542632|592543329|FG004|Overall Study|Lost to Follow-up|0|||
164050448|NCT01542632|592543330|FG005|Overall Study|Lost to Follow-up|0|||
164050449|NCT01542632|592543325|FG000|Overall Study|Sponsor/Investigator Decision|0|||
164050450|NCT01542632|592543326|FG001|Overall Study|Sponsor/Investigator Decision|0|||
164050451|NCT01542632|592543327|FG002|Overall Study|Sponsor/Investigator Decision|0|||
164050452|NCT01542632|592543328|FG003|Overall Study|Sponsor/Investigator Decision|0|||
164050453|NCT01542632|592543329|FG004|Overall Study|Sponsor/Investigator Decision|1|||
164050454|NCT01542632|592543330|FG005|Overall Study|Sponsor/Investigator Decision|0|||
164050455|NCT03225833|592543331|FG000|Overall Study|Adverse Event|0|||
164050456|NCT03225833|592543332|FG001|Overall Study|Adverse Event|1|||
164050457|NCT03225833|592543333|FG002|Overall Study|Adverse Event|2|||
164050458|NCT03225833|592543334|FG003|Overall Study|Adverse Event|0|||
164050459|NCT03225833|592543335|FG004|Overall Study|Adverse Event|0|||
164050460|NCT03225833|592543336|FG005|Overall Study|Adverse Event|2|||
164050461|NCT03225833|592543331|FG000|Overall Study|Withdrawal by Subject|1|||
164050462|NCT03225833|592543332|FG001|Overall Study|Withdrawal by Subject|0|||
164050463|NCT03225833|592543333|FG002|Overall Study|Withdrawal by Subject|0|||
164050464|NCT03225833|592543334|FG003|Overall Study|Withdrawal by Subject|0|||
164050465|NCT03225833|592543335|FG004|Overall Study|Withdrawal by Subject|1|||
164050466|NCT03225833|592543336|FG005|Overall Study|Withdrawal by Subject|0|||
164050467|NCT03225833|592543331|FG000|Overall Study|Termination of Study by Sponsor|4|||
164050468|NCT03225833|592543332|FG001|Overall Study|Termination of Study by Sponsor|0|||
164050469|NCT03225833|592543333|FG002|Overall Study|Termination of Study by Sponsor|0|||
164050470|NCT03225833|592543334|FG003|Overall Study|Termination of Study by Sponsor|0|||
164050471|NCT03225833|592543335|FG004|Overall Study|Termination of Study by Sponsor|0|||
164050472|NCT03225833|592543336|FG005|Overall Study|Termination of Study by Sponsor|7|||
164050473|NCT03225833|592543331|FG000|Overall Study|Sponsor Decision|0|||
164050474|NCT03225833|592543332|FG001|Overall Study|Sponsor Decision|0|||
164050475|NCT03225833|592543333|FG002|Overall Study|Sponsor Decision|0|||
164050476|NCT03225833|592543334|FG003|Overall Study|Sponsor Decision|0|||
164050477|NCT03225833|592543335|FG004|Overall Study|Sponsor Decision|0|||
164050478|NCT03225833|592543336|FG005|Overall Study|Sponsor Decision|1|||
164050479|NCT06029127|592543338|FG000|Overall Study|Withdrawal by Subject|2|||
164050480|NCT06029127|592543339|FG001|Overall Study|Withdrawal by Subject|0|||
164050481|NCT06029127|592543338|FG000|Overall Study|Lost to Follow-up|1|||
164050482|NCT06029127|592543339|FG001|Overall Study|Lost to Follow-up|0|||
164050483|NCT06029127|592543338|FG000|Overall Study|Study Closed by Sponsor|6|||
164050484|NCT06029127|592543339|FG001|Overall Study|Study Closed by Sponsor|6|||
164050485|NCT06029127|592543338|FG000|Overall Study|Death|12|||
164050486|NCT06029127|592543339|FG001|Overall Study|Death|7|||
164050487|NCT06029127|592543338|FG000|Overall Study|Declined Follow-Up Contact|0|||
164050488|NCT06029127|592543339|FG001|Overall Study|Declined Follow-Up Contact|1|||
164050489|NCT04785144|592543340|FG000|Overall Study|Withdrawal by Subject|4|||
164050490|NCT04785144|592543341|FG001|Overall Study|Withdrawal by Subject|1|||
164050491|NCT04785144|592543342|FG002|Overall Study|Withdrawal by Subject|0|||
164050492|NCT04785144|592543343|FG003|Overall Study|Withdrawal by Subject|0|||
164050493|NCT04785144|592543344|FG004|Overall Study|Withdrawal by Subject|0|||
164050494|NCT04785144|592543345|FG005|Overall Study|Withdrawal by Subject|2|||
164050495|NCT04785144|592543346|FG006|Overall Study|Withdrawal by Subject|2|||
164050496|NCT04785144|592543347|FG007|Overall Study|Withdrawal by Subject|0|||
164050497|NCT04785144|592543348|FG008|Overall Study|Withdrawal by Subject|1|||
164050498|NCT04785144|592543349|FG009|Overall Study|Withdrawal by Subject|0|||
164050499|NCT04785144|592543340|FG000|Overall Study|Lost to Follow-up|1|||
164050500|NCT04785144|592543341|FG001|Overall Study|Lost to Follow-up|0|||
164050501|NCT04785144|592543342|FG002|Overall Study|Lost to Follow-up|0|||
164050502|NCT04785144|592543343|FG003|Overall Study|Lost to Follow-up|0|||
164050503|NCT04785144|592543344|FG004|Overall Study|Lost to Follow-up|1|||
164050504|NCT04785144|592543345|FG005|Overall Study|Lost to Follow-up|2|||
164050505|NCT04785144|592543346|FG006|Overall Study|Lost to Follow-up|1|||
164050506|NCT04785144|592543347|FG007|Overall Study|Lost to Follow-up|2|||
164050507|NCT04785144|592543348|FG008|Overall Study|Lost to Follow-up|4|||
164050508|NCT04785144|592543349|FG009|Overall Study|Lost to Follow-up|1|||
164050509|NCT04785144|592543340|FG000|Overall Study|Protocol Violation|0|||
164050510|NCT04785144|592543341|FG001|Overall Study|Protocol Violation|0|||
164050511|NCT04785144|592543342|FG002|Overall Study|Protocol Violation|0|||
164050512|NCT04785144|592543343|FG003|Overall Study|Protocol Violation|0|||
164050513|NCT04785144|592543344|FG004|Overall Study|Protocol Violation|0|||
164050514|NCT04785144|592543345|FG005|Overall Study|Protocol Violation|0|||
164050515|NCT04785144|592543346|FG006|Overall Study|Protocol Violation|1|||
164050516|NCT04785144|592543347|FG007|Overall Study|Protocol Violation|0|||
164050517|NCT04785144|592543348|FG008|Overall Study|Protocol Violation|0|||
164050518|NCT04785144|592543349|FG009|Overall Study|Protocol Violation|0|||
164050519|NCT04785144|592543340|FG000|Overall Study|Physician Decision|0|||
164050520|NCT04785144|592543341|FG001|Overall Study|Physician Decision|0|||
164050521|NCT04785144|592543342|FG002|Overall Study|Physician Decision|0|||
164050522|NCT04785144|592543343|FG003|Overall Study|Physician Decision|0|||
164050523|NCT04785144|592543344|FG004|Overall Study|Physician Decision|0|||
164050524|NCT04785144|592543345|FG005|Overall Study|Physician Decision|0|||
164050525|NCT04785144|592543346|FG006|Overall Study|Physician Decision|0|||
164050526|NCT04785144|592543347|FG007|Overall Study|Physician Decision|0|||
164050527|NCT04785144|592543348|FG008|Overall Study|Physician Decision|0|||
164050528|NCT04785144|592543349|FG009|Overall Study|Physician Decision|1|||
164050529|NCT04785144|592543340|FG000|Overall Study|Unable to continue due to work schedule|0|||
164050530|NCT04785144|592543341|FG001|Overall Study|Unable to continue due to work schedule|0|||
164050531|NCT04785144|592543342|FG002|Overall Study|Unable to continue due to work schedule|0|||
164050532|NCT04785144|592543343|FG003|Overall Study|Unable to continue due to work schedule|0|||
164050533|NCT04785144|592543344|FG004|Overall Study|Unable to continue due to work schedule|0|||
164050534|NCT04785144|592543345|FG005|Overall Study|Unable to continue due to work schedule|0|||
164050535|NCT04785144|592543346|FG006|Overall Study|Unable to continue due to work schedule|0|||
164050536|NCT04785144|592543347|FG007|Overall Study|Unable to continue due to work schedule|0|||
164050537|NCT04785144|592543348|FG008|Overall Study|Unable to continue due to work schedule|0|||
164050538|NCT04785144|592543349|FG009|Overall Study|Unable to continue due to work schedule|1|||
164050539|NCT00129376|592543350|FG000|Overall Study|Adverse Event|1|||
164050540|NCT00129376|592543350|FG000|Overall Study|Lack of Efficacy|1|||
164050541|NCT01766401|592543353|FG000|Overall Study|Adverse Event|7|||
164050542|NCT01766401|592543354|FG001|Overall Study|Adverse Event|22|||
164050543|NCT01766401|592543353|FG000|Overall Study|Lack of Efficacy|1|||
164050544|NCT01766401|592543354|FG001|Overall Study|Lack of Efficacy|2|||
164050545|NCT01766401|592543353|FG000|Overall Study|Protocol Violation|3|||
164050546|NCT01766401|592543354|FG001|Overall Study|Protocol Violation|8|||
164050547|NCT01766401|592543353|FG000|Overall Study|Withdrawal by Subject|15|||
164050548|NCT01766401|592543354|FG001|Overall Study|Withdrawal by Subject|12|||
164050549|NCT01766401|592543353|FG000|Overall Study|Lost to Follow-up|10|||
164050550|NCT01766401|592543354|FG001|Overall Study|Lost to Follow-up|11|||
164050551|NCT01766401|592543353|FG000|Overall Study|Pregnancy|1|||
164050552|NCT01766401|592543354|FG001|Overall Study|Pregnancy|1|||
164050553|NCT00886587|592543355|FG000|Overall Study|Adverse Event|2|||
164050554|NCT00886587|592543356|FG001|Overall Study|Adverse Event|1|||
164050555|NCT00886587|592543355|FG000|Overall Study|Protocol Violation|2|||
164050556|NCT00886587|592543356|FG001|Overall Study|Protocol Violation|0|||
164050557|NCT00886587|592543355|FG000|Overall Study|Withdrawal by Subject|0|||
164050558|NCT00886587|592543356|FG001|Overall Study|Withdrawal by Subject|1|||
164050559|NCT01108068|592543360|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
164050560|NCT01108068|592543361|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
164050561|NCT00398086|592543362|FG000|Overall Study|Unacceptable Toxicity|2|||
164050562|NCT00398086|592543363|FG001|Overall Study|Unacceptable Toxicity|8|||
164050563|NCT00398086|592543364|FG002|Overall Study|Unacceptable Toxicity|2|||
164050564|NCT00398086|592543362|FG000|Overall Study|Adverse Event|1|||
164050565|NCT00398086|592543363|FG001|Overall Study|Adverse Event|4|||
164050566|NCT00398086|592543364|FG002|Overall Study|Adverse Event|0|||
164050567|NCT00398086|592543362|FG000|Overall Study|Physician Decision|1|||
164050568|NCT00398086|592543363|FG001|Overall Study|Physician Decision|4|||
164050569|NCT00398086|592543364|FG002|Overall Study|Physician Decision|0|||
164050570|NCT00398086|592543362|FG000|Overall Study|Withdrawal by Subject|5|||
164050571|NCT00398086|592543363|FG001|Overall Study|Withdrawal by Subject|7|||
164050572|NCT00398086|592543364|FG002|Overall Study|Withdrawal by Subject|0|||
164050573|NCT00696774|592543365|FG000|Period II|Adverse Event|0|||
164050574|NCT00696774|592543366|FG001|Period II|Adverse Event|0|||
164050575|NCT00696774|592543367|FG002|Period II|Adverse Event|15|||
164050576|NCT00696774|592543365|FG000|Period II|Lost to Follow-up|0|||
164050577|NCT00696774|592543366|FG001|Period II|Lost to Follow-up|0|||
164050578|NCT00696774|592543367|FG002|Period II|Lost to Follow-up|4|||
164050579|NCT00696774|592543365|FG000|Period II|Protocol Violation|0|||
164050580|NCT00696774|592543366|FG001|Period II|Protocol Violation|0|||
164050581|NCT00696774|592543367|FG002|Period II|Protocol Violation|11|||
164050582|NCT00696774|592543365|FG000|Period II|Withdrawal by Subject|0|||
164050583|NCT00696774|592543366|FG001|Period II|Withdrawal by Subject|0|||
164050584|NCT00696774|592543367|FG002|Period II|Withdrawal by Subject|4|||
164050585|NCT00696774|592543365|FG000|Period II|Sponsor Decision|0|||
164050586|NCT00696774|592543366|FG001|Period II|Sponsor Decision|0|||
164050587|NCT00696774|592543367|FG002|Period II|Sponsor Decision|0|||
164050588|NCT00696774|592543365|FG000|Period II|Lack of Efficacy|0|||
164050589|NCT00696774|592543366|FG001|Period II|Lack of Efficacy|0|||
164050590|NCT00696774|592543367|FG002|Period II|Lack of Efficacy|2|||
164050591|NCT00696774|592543365|FG000|Period III|Adverse Event|1|||
164050592|NCT00696774|592543366|FG001|Period III|Adverse Event|1|||
164050593|NCT00696774|592543367|FG002|Period III|Adverse Event|0|||
164050594|NCT00696774|592543365|FG000|Period III|Lost to Follow-up|2|||
164050595|NCT00696774|592543366|FG001|Period III|Lost to Follow-up|1|||
164050596|NCT00696774|592543367|FG002|Period III|Lost to Follow-up|0|||
164050597|NCT00696774|592543365|FG000|Period III|Protocol Violation|1|||
164050598|NCT00696774|592543366|FG001|Period III|Protocol Violation|1|||
164050599|NCT00696774|592543367|FG002|Period III|Protocol Violation|0|||
164050600|NCT00696774|592543365|FG000|Period III|Withdrawal by Subject|1|||
164050601|NCT00696774|592543366|FG001|Period III|Withdrawal by Subject|2|||
164050602|NCT00696774|592543367|FG002|Period III|Withdrawal by Subject|0|||
164050603|NCT00696774|592543365|FG000|Period III|Sponsor Decision|2|||
164050604|NCT00696774|592543366|FG001|Period III|Sponsor Decision|0|||
164050605|NCT00696774|592543367|FG002|Period III|Sponsor Decision|0|||
164050606|NCT00696774|592543365|FG000|Period III|Lack of Efficacy|0|||
164050607|NCT00696774|592543366|FG001|Period III|Lack of Efficacy|2|||
164050608|NCT00696774|592543367|FG002|Period III|Lack of Efficacy|0|||
164050609|NCT00033293|592543374|FG000|Overall Study|Death|0|||
164050610|NCT00033293|592543375|FG001|Overall Study|Death|1|||
164050611|NCT00033293|592543374|FG000|Overall Study|Lack of Efficacy|5|||
164050612|NCT00033293|592543375|FG001|Overall Study|Lack of Efficacy|8|||
164050613|NCT00033293|592543374|FG000|Overall Study|Lost to Follow-up|0|||
164050614|NCT00033293|592543375|FG001|Overall Study|Lost to Follow-up|1|||
164050615|NCT00033293|592543374|FG000|Overall Study|Physician Decision|3|||
164050616|NCT00033293|592543375|FG001|Overall Study|Physician Decision|1|||
164050617|NCT00033293|592543374|FG000|Overall Study|Withdrawal by Subject|1|||
164050618|NCT00033293|592543375|FG001|Overall Study|Withdrawal by Subject|0|||
164050619|NCT00033293|592543374|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
164050620|NCT00033293|592543375|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
164050621|NCT00033293|592543374|FG000|Overall Study|Treatment refused|0|||
164050622|NCT00033293|592543375|FG001|Overall Study|Treatment refused|6|||
164050623|NCT00935701|592543376|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
164050624|NCT02201251|592543377|FG000|Overall Study|Adverse Event|1|||
164050625|NCT02201251|592543378|FG001|Overall Study|Adverse Event|1|||
164050626|NCT02201251|592543377|FG000|Overall Study|Protocol Violation|1|||
164050627|NCT02201251|592543378|FG001|Overall Study|Protocol Violation|0|||
164050628|NCT02201251|592543377|FG000|Overall Study|Noncompliance with Study Drug|0|||
164050629|NCT02201251|592543378|FG001|Overall Study|Noncompliance with Study Drug|1|||
164050630|NCT02201251|592543377|FG000|Overall Study|Withdrawal by Subject|2|||
164050631|NCT02201251|592543378|FG001|Overall Study|Withdrawal by Subject|1|||
164050632|NCT02711553|592543381|FG000|Overall Study|Withdrawal by Subject|2|||
164050633|NCT02711553|592543382|FG001|Overall Study|Withdrawal by Subject|1|||
164050634|NCT02711553|592543383|FG002|Overall Study|Withdrawal by Subject|1|||
164050635|NCT02711553|592543384|FG003|Overall Study|Withdrawal by Subject|0|||
164050636|NCT02711553|592543381|FG000|Overall Study|Lost to Follow-up|3|||
164050637|NCT02711553|592543382|FG001|Overall Study|Lost to Follow-up|3|||
164050638|NCT02711553|592543383|FG002|Overall Study|Lost to Follow-up|6|||
164050639|NCT02711553|592543384|FG003|Overall Study|Lost to Follow-up|3|||
164050640|NCT02711553|592543381|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
164050641|NCT02711553|592543382|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
164050642|NCT02711553|592543383|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
164050643|NCT02711553|592543384|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
164050644|NCT01197794|592543387|FG000|Overall Study|Adverse Event|3|||
164050645|NCT01197794|592543388|FG001|Overall Study|Adverse Event|2|||
164050646|NCT01197794|592543389|FG002|Overall Study|Adverse Event|4|||
164050647|NCT01197794|592543390|FG003|Overall Study|Adverse Event|4|||
164050648|NCT01197794|592543391|FG004|Overall Study|Adverse Event|4|||
164050649|NCT01197794|592543392|FG005|Overall Study|Adverse Event|2|||
164050650|NCT01197794|592543393|FG006|Overall Study|Adverse Event|3|||
164050651|NCT01197794|592543387|FG000|Overall Study|Protocol Violation|0|||
164050652|NCT01197794|592543388|FG001|Overall Study|Protocol Violation|0|||
164050653|NCT01197794|592543389|FG002|Overall Study|Protocol Violation|0|||
164050654|NCT01197794|592543390|FG003|Overall Study|Protocol Violation|0|||
164050655|NCT01197794|592543391|FG004|Overall Study|Protocol Violation|2|||
164050656|NCT01197794|592543392|FG005|Overall Study|Protocol Violation|0|||
164050657|NCT01197794|592543393|FG006|Overall Study|Protocol Violation|1|||
164050658|NCT01197794|592543387|FG000|Overall Study|Development of study withdrawal criteria|3|||
164050659|NCT01197794|592543388|FG001|Overall Study|Development of study withdrawal criteria|0|||
164050660|NCT01197794|592543389|FG002|Overall Study|Development of study withdrawal criteria|0|||
164050661|NCT01197794|592543390|FG003|Overall Study|Development of study withdrawal criteria|1|||
164050662|NCT01197794|592543391|FG004|Overall Study|Development of study withdrawal criteria|0|||
164050663|NCT01197794|592543392|FG005|Overall Study|Development of study withdrawal criteria|0|||
164050664|NCT01197794|592543393|FG006|Overall Study|Development of study withdrawal criteria|1|||
164050665|NCT01197794|592543387|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
164050666|NCT01197794|592543388|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
164050667|NCT01197794|592543389|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
164050668|NCT01197794|592543390|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
164050669|NCT01197794|592543391|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
164050670|NCT01197794|592543392|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
164050671|NCT01197794|592543393|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
164050672|NCT01197794|592543387|FG000|Overall Study|Withdrawal by Subject|3|||
164050673|NCT01197794|592543388|FG001|Overall Study|Withdrawal by Subject|3|||
164050674|NCT01197794|592543389|FG002|Overall Study|Withdrawal by Subject|4|||
164050675|NCT01197794|592543390|FG003|Overall Study|Withdrawal by Subject|1|||
164050676|NCT01197794|592543391|FG004|Overall Study|Withdrawal by Subject|1|||
164050677|NCT01197794|592543392|FG005|Overall Study|Withdrawal by Subject|5|||
164050678|NCT01197794|592543393|FG006|Overall Study|Withdrawal by Subject|6|||
164050679|NCT01197794|592543387|FG000|Overall Study|Lost to Follow-up|1|||
164050680|NCT01197794|592543388|FG001|Overall Study|Lost to Follow-up|1|||
164050681|NCT01197794|592543389|FG002|Overall Study|Lost to Follow-up|0|||
164050682|NCT01197794|592543390|FG003|Overall Study|Lost to Follow-up|1|||
164050683|NCT01197794|592543391|FG004|Overall Study|Lost to Follow-up|0|||
164050684|NCT01197794|592543392|FG005|Overall Study|Lost to Follow-up|1|||
164050685|NCT01197794|592543393|FG006|Overall Study|Lost to Follow-up|0|||
164050686|NCT01197794|592543387|FG000|Overall Study|Other|1|||
164050687|NCT01197794|592543388|FG001|Overall Study|Other|1|||
164050688|NCT01197794|592543389|FG002|Overall Study|Other|3|||
164050689|NCT01197794|592543390|FG003|Overall Study|Other|0|||
164050690|NCT01197794|592543391|FG004|Overall Study|Other|2|||
164050691|NCT01197794|592543392|FG005|Overall Study|Other|2|||
164050692|NCT01197794|592543393|FG006|Overall Study|Other|4|||
164050693|NCT04055844|592543394|FG000|Overall Study|Adverse Event|12|||
164050694|NCT04055844|592543394|FG000|Overall Study|Poor Performance|1|||
164050695|NCT04055844|592543394|FG000|Overall Study|Death|1|||
164050696|NCT03457636|592543399|FG000|Overall Study|Lost to Follow-up|2|||
164050697|NCT03231228|592543406|FG000|Overall Study|Lost to Follow-up|2|||
164050698|NCT03231228|592543407|FG001|Overall Study|Lost to Follow-up|0|||
164050699|NCT03231228|592543406|FG000|Overall Study|Physician Decision|1|||
164050700|NCT03231228|592543407|FG001|Overall Study|Physician Decision|0|||
164050701|NCT03049852|592543418|FG000|Overall Study|Lost to Follow-up|0|||
164050702|NCT03049852|592543419|FG001|Overall Study|Lost to Follow-up|1|||
164050703|NCT03049852|592543420|FG002|Overall Study|Lost to Follow-up|0|||
164050704|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
164050705|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164050706|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164050707|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164050708|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164050709|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
164050710|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
164050711|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164050712|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164050713|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164050714|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164050715|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
164050716|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
164050717|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164050718|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164050719|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164050720|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164050721|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
164050722|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Other|14|||
164050723|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Other|0|||
164050724|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Other|0|||
164050725|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Other|0|||
164050726|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Other|0|||
164050727|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Other|0|||
164050728|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
164050729|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
164050730|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
164050731|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
164050732|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
164050733|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
164050734|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
164050735|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164050736|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164050737|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164050738|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164050739|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
164050740|NCT02141854|592543421|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
164050741|NCT02141854|592543422|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164050742|NCT02141854|592543423|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164050743|NCT02141854|592543424|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164050744|NCT02141854|592543425|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164050745|NCT02141854|592543426|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
164050746|NCT02141854|592543421|FG000|Treatment Period|Protocol Violation|0|||
164050747|NCT02141854|592543422|FG001|Treatment Period|Protocol Violation|1|||
164050748|NCT02141854|592543423|FG002|Treatment Period|Protocol Violation|0|||
164050749|NCT02141854|592543424|FG003|Treatment Period|Protocol Violation|2|||
164050750|NCT02141854|592543425|FG004|Treatment Period|Protocol Violation|2|||
164050751|NCT02141854|592543426|FG005|Treatment Period|Protocol Violation|1|||
164050752|NCT02141854|592543421|FG000|Treatment Period|Noncompliance|0|||
164050753|NCT02141854|592543422|FG001|Treatment Period|Noncompliance|0|||
164050754|NCT02141854|592543423|FG002|Treatment Period|Noncompliance|0|||
164050755|NCT02141854|592543424|FG003|Treatment Period|Noncompliance|1|||
164050756|NCT02141854|592543425|FG004|Treatment Period|Noncompliance|0|||
164050757|NCT02141854|592543426|FG005|Treatment Period|Noncompliance|0|||
164050758|NCT02141854|592543421|FG000|Treatment Period|Lack of Efficacy|0|||
164050759|NCT02141854|592543422|FG001|Treatment Period|Lack of Efficacy|0|||
164050760|NCT02141854|592543423|FG002|Treatment Period|Lack of Efficacy|0|||
164050761|NCT02141854|592543424|FG003|Treatment Period|Lack of Efficacy|1|||
164050762|NCT02141854|592543425|FG004|Treatment Period|Lack of Efficacy|1|||
164050763|NCT02141854|592543426|FG005|Treatment Period|Lack of Efficacy|7|||
164050764|NCT02141854|592543421|FG000|Treatment Period|Pregnancy|0|||
164050765|NCT02141854|592543422|FG001|Treatment Period|Pregnancy|1|||
164099728|NCT02100228|592730565|FG001|Overall Study|Death|1|||
164050766|NCT02141854|592543423|FG002|Treatment Period|Pregnancy|0|||
164050767|NCT02141854|592543424|FG003|Treatment Period|Pregnancy|0|||
164050768|NCT02141854|592543425|FG004|Treatment Period|Pregnancy|0|||
164050769|NCT02141854|592543426|FG005|Treatment Period|Pregnancy|0|||
164050770|NCT02141854|592543421|FG000|Treatment Period|Other|0|||
164050771|NCT02141854|592543422|FG001|Treatment Period|Other|1|||
164050772|NCT02141854|592543423|FG002|Treatment Period|Other|2|||
164050773|NCT02141854|592543424|FG003|Treatment Period|Other|0|||
164050774|NCT02141854|592543425|FG004|Treatment Period|Other|1|||
164050775|NCT02141854|592543426|FG005|Treatment Period|Other|2|||
164050776|NCT02141854|592543421|FG000|Treatment Period|Adverse Event|0|||
164050777|NCT02141854|592543422|FG001|Treatment Period|Adverse Event|2|||
164050778|NCT02141854|592543423|FG002|Treatment Period|Adverse Event|2|||
164050779|NCT02141854|592543424|FG003|Treatment Period|Adverse Event|0|||
164050780|NCT02141854|592543425|FG004|Treatment Period|Adverse Event|2|||
164050781|NCT02141854|592543426|FG005|Treatment Period|Adverse Event|2|||
164050782|NCT02141854|592543421|FG000|Treatment Period|Withdrawal by Subject|0|||
164050783|NCT02141854|592543422|FG001|Treatment Period|Withdrawal by Subject|2|||
164050784|NCT02141854|592543423|FG002|Treatment Period|Withdrawal by Subject|3|||
164050785|NCT02141854|592543424|FG003|Treatment Period|Withdrawal by Subject|3|||
164050786|NCT02141854|592543425|FG004|Treatment Period|Withdrawal by Subject|4|||
164050787|NCT02141854|592543426|FG005|Treatment Period|Withdrawal by Subject|7|||
164050788|NCT02141854|592543421|FG000|Treatment Period|Disease progression|0|||
164050789|NCT02141854|592543422|FG001|Treatment Period|Disease progression|2|||
164050790|NCT02141854|592543423|FG002|Treatment Period|Disease progression|1|||
164099729|NCT00854100|592730576|FG000|Overall Study|Inability to complete the study visits|0|||
164099730|NCT00854100|592730577|FG001|Overall Study|Inability to complete the study visits|0|||
164099731|NCT00854100|592730578|FG002|Overall Study|Inability to complete the study visits|1|||
164099732|NCT00854100|592730576|FG000|Overall Study|Lost to Follow-up|2|||
164099733|NCT00854100|592730577|FG001|Overall Study|Lost to Follow-up|0|||
164099734|NCT00854100|592730578|FG002|Overall Study|Lost to Follow-up|3|||
164099735|NCT00854100|592730576|FG000|Overall Study|Withdrawal by Subject|3|||
164099736|NCT00854100|592730577|FG001|Overall Study|Withdrawal by Subject|1|||
164099737|NCT00854100|592730578|FG002|Overall Study|Withdrawal by Subject|2|||
164099738|NCT00854100|592730576|FG000|Overall Study|Protocol Violation|2|||
164099739|NCT00854100|592730577|FG001|Overall Study|Protocol Violation|4|||
164099740|NCT00854100|592730578|FG002|Overall Study|Protocol Violation|3|||
164099741|NCT00854100|592730576|FG000|Overall Study|Adverse Event|2|||
164099742|NCT00854100|592730577|FG001|Overall Study|Adverse Event|1|||
164099743|NCT00854100|592730578|FG002|Overall Study|Adverse Event|2|||
164099744|NCT02242201|592730580|FG000|Overall Study|preoperative identified neuropathy|2|||
164099745|NCT02242201|592730581|FG001|Overall Study|preoperative identified neuropathy|0|||
164099746|NCT02242201|592730582|FG002|Overall Study|preoperative identified neuropathy|0|||
164099747|NCT02242201|592730580|FG000|Overall Study|planned post-op anticoagulation|1|||
164099748|NCT02242201|592730581|FG001|Overall Study|planned post-op anticoagulation|0|||
164099749|NCT02242201|592730582|FG002|Overall Study|planned post-op anticoagulation|0|||
164099750|NCT02242201|592730580|FG000|Overall Study|changed surgical procedure|1|||
164099751|NCT02242201|592730581|FG001|Overall Study|changed surgical procedure|0|||
164099752|NCT02242201|592730582|FG002|Overall Study|changed surgical procedure|0|||
164099753|NCT02242201|592730580|FG000|Overall Study|postponed surgery|0|||
164099754|NCT02242201|592730581|FG001|Overall Study|postponed surgery|0|||
164099755|NCT02242201|592730582|FG002|Overall Study|postponed surgery|1|||
164099756|NCT02242201|592730580|FG000|Overall Study|preoperative opioid consumption|0|||
164099757|NCT02242201|592730581|FG001|Overall Study|preoperative opioid consumption|1|||
164099758|NCT02242201|592730582|FG002|Overall Study|preoperative opioid consumption|0|||
164099759|NCT00389064|592730583|FG000|Overall Study|Adverse Event|11|||
164099760|NCT00389064|592730584|FG001|Overall Study|Adverse Event|3|||
164099761|NCT00389064|592730583|FG000|Overall Study|Lack of Efficacy|3|||
164099762|NCT00389064|592730584|FG001|Overall Study|Lack of Efficacy|14|||
164099763|NCT00389064|592730583|FG000|Overall Study|Withdrawal by Subject|17|||
164099764|NCT00389064|592730584|FG001|Overall Study|Withdrawal by Subject|27|||
164099765|NCT00389064|592730583|FG000|Overall Study|Physician Decision|2|||
164099766|NCT00389064|592730584|FG001|Overall Study|Physician Decision|2|||
164099767|NCT00389064|592730583|FG000|Overall Study|Lost to Follow-up|1|||
164099768|NCT00389064|592730584|FG001|Overall Study|Lost to Follow-up|2|||
164099769|NCT00389064|592730583|FG000|Overall Study|Protocol Violation|2|||
164050791|NCT02141854|592543424|FG003|Treatment Period|Disease progression|3|||
164050792|NCT02141854|592543425|FG004|Treatment Period|Disease progression|0|||
164099770|NCT00389064|592730584|FG001|Overall Study|Protocol Violation|0|||
164099771|NCT00389064|592730583|FG000|Overall Study|Multiple Reasons|9|||
164099772|NCT00389064|592730584|FG001|Overall Study|Multiple Reasons|11|||
164099773|NCT01223365|592730588|FG000|Open-label Titration Period|Enrolled but not treated|1|||
164099774|NCT01223365|592730588|FG000|Open-label Titration Period|Adverse Event|23|||
164099775|NCT01223365|592730588|FG000|Open-label Titration Period|Lack of Efficacy|3|||
164099776|NCT01223365|592730588|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
164099777|NCT01223365|592730588|FG000|Open-label Titration Period|Protocol Violation|1|||
164099778|NCT01223365|592730588|FG000|Open-label Titration Period|Lost to Follow-up|2|||
164050793|NCT02141854|592543426|FG005|Treatment Period|Disease progression|18|||
164050794|NCT02141854|592543421|FG000|Treatment Period|Lost to Follow-up|0|||
164050795|NCT02141854|592543422|FG001|Treatment Period|Lost to Follow-up|1|||
164099779|NCT01223365|592730588|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
164099780|NCT01223365|592730588|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
164099781|NCT01223365|592730588|FG000|Open-label Titration Period|Starting physical therapy|1|||
164099782|NCT01223365|592730588|FG000|Open-label Treatment Period|Adverse Event|39|||
164050796|NCT02141854|592543423|FG002|Treatment Period|Lost to Follow-up|1|||
164050797|NCT02141854|592543424|FG003|Treatment Period|Lost to Follow-up|1|||
164050798|NCT02141854|592543425|FG004|Treatment Period|Lost to Follow-up|0|||
164050799|NCT02141854|592543426|FG005|Treatment Period|Lost to Follow-up|1|||
164050800|NCT01868594|592543427|FG000|Overall Study|Do not meet inclusion criteria|4|||
164050801|NCT01868594|592543428|FG001|Overall Study|Do not meet inclusion criteria|3|||
164050802|NCT03399786|592543429|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
164050803|NCT03399786|592543430|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164050804|NCT03399786|592543431|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164050805|NCT03399786|592543432|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164050806|NCT03399786|592543429|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
164050807|NCT03399786|592543430|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
164050808|NCT03399786|592543431|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
164050809|NCT03399786|592543432|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
164050810|NCT03399786|592543429|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
164050811|NCT03399786|592543430|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
164050812|NCT03399786|592543431|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
164050813|NCT03399786|592543432|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
164050814|NCT04564027|592544993|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
164050815|NCT04564027|592544994|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
164050816|NCT04564027|592544995|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
164050817|NCT04564027|592544996|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
164050818|NCT05827978|592544997|FG000|Overall Study|Adverse Event|1|||
164050819|NCT05827978|592544998|FG001|Overall Study|Adverse Event|0|||
164050820|NCT05827978|592544999|FG002|Overall Study|Adverse Event|0|||
164050821|NCT05827978|592545000|FG003|Overall Study|Adverse Event|1|||
164050822|NCT05827978|592545001|FG004|Overall Study|Adverse Event|0|||
164050823|NCT05827978|592545002|FG005|Overall Study|Adverse Event|0|||
164050824|NCT05827978|592544997|FG000|Overall Study|Death|1|||
164050825|NCT05827978|592544998|FG001|Overall Study|Death|5|||
164050826|NCT05827978|592544999|FG002|Overall Study|Death|2|||
164050827|NCT05827978|592545000|FG003|Overall Study|Death|3|||
164050828|NCT05827978|592545001|FG004|Overall Study|Death|1|||
164050829|NCT05827978|592545002|FG005|Overall Study|Death|3|||
164050830|NCT05827978|592544997|FG000|Overall Study|Lost to Follow-up|57|||
164050831|NCT05827978|592544998|FG001|Overall Study|Lost to Follow-up|88|||
164050832|NCT05827978|592544999|FG002|Overall Study|Lost to Follow-up|54|||
164050833|NCT05827978|592545000|FG003|Overall Study|Lost to Follow-up|47|||
164050834|NCT05827978|592545001|FG004|Overall Study|Lost to Follow-up|25|||
164050835|NCT05827978|592545002|FG005|Overall Study|Lost to Follow-up|10|||
164050836|NCT05827978|592544997|FG000|Overall Study|Noncompliance with Study Procedures|0|||
164050837|NCT05827978|592544998|FG001|Overall Study|Noncompliance with Study Procedures|1|||
164050838|NCT05827978|592544999|FG002|Overall Study|Noncompliance with Study Procedures|1|||
164050839|NCT05827978|592545000|FG003|Overall Study|Noncompliance with Study Procedures|1|||
164050840|NCT05827978|592545001|FG004|Overall Study|Noncompliance with Study Procedures|1|||
164050841|NCT05827978|592545002|FG005|Overall Study|Noncompliance with Study Procedures|0|||
164050842|NCT05827978|592544997|FG000|Overall Study|Physician Decision|2|||
164050843|NCT05827978|592544998|FG001|Overall Study|Physician Decision|0|||
164050844|NCT05827978|592544999|FG002|Overall Study|Physician Decision|1|||
164050845|NCT05827978|592545000|FG003|Overall Study|Physician Decision|2|||
164050846|NCT05827978|592545001|FG004|Overall Study|Physician Decision|1|||
164050847|NCT05827978|592545002|FG005|Overall Study|Physician Decision|1|||
164050848|NCT05827978|592544997|FG000|Overall Study|Protocol Violation|5|||
164050849|NCT05827978|592544998|FG001|Overall Study|Protocol Violation|2|||
164050850|NCT05827978|592544999|FG002|Overall Study|Protocol Violation|0|||
164050851|NCT05827978|592545000|FG003|Overall Study|Protocol Violation|0|||
164050852|NCT05827978|592545001|FG004|Overall Study|Protocol Violation|0|||
164050853|NCT05827978|592545002|FG005|Overall Study|Protocol Violation|0|||
164050854|NCT05827978|592544997|FG000|Overall Study|Withdrawal by Subject|17|||
164050855|NCT05827978|592544998|FG001|Overall Study|Withdrawal by Subject|16|||
164050856|NCT05827978|592544999|FG002|Overall Study|Withdrawal by Subject|10|||
164050857|NCT05827978|592545000|FG003|Overall Study|Withdrawal by Subject|12|||
164050858|NCT05827978|592545001|FG004|Overall Study|Withdrawal by Subject|10|||
164050859|NCT05827978|592545002|FG005|Overall Study|Withdrawal by Subject|9|||
164050860|NCT05827978|592544997|FG000|Overall Study|Other Than Specified|0|||
164050861|NCT05827978|592544998|FG001|Overall Study|Other Than Specified|0|||
164050862|NCT05827978|592544999|FG002|Overall Study|Other Than Specified|1|||
164050863|NCT05827978|592545000|FG003|Overall Study|Other Than Specified|0|||
164050864|NCT05827978|592545001|FG004|Overall Study|Other Than Specified|2|||
164050865|NCT05827978|592545002|FG005|Overall Study|Other Than Specified|0|||
164050866|NCT04566445|592545003|FG000|Overall Study|Death|4|||
164050867|NCT04566445|592545004|FG001|Overall Study|Death|1|||
164050868|NCT04566445|592545005|FG002|Overall Study|Death|1|||
164050869|NCT04566445|592545003|FG000|Overall Study|Lost to Follow-up|3|||
164050870|NCT04566445|592545004|FG001|Overall Study|Lost to Follow-up|1|||
164050871|NCT04566445|592545005|FG002|Overall Study|Lost to Follow-up|1|||
164050872|NCT04566445|592545003|FG000|Overall Study|Study terminated by sponsor|11|||
164050873|NCT04566445|592545004|FG001|Overall Study|Study terminated by sponsor|17|||
164050874|NCT04566445|592545005|FG002|Overall Study|Study terminated by sponsor|32|||
164050875|NCT04566445|592545003|FG000|Overall Study|Withdrawal by Subject|12|||
164050876|NCT04566445|592545004|FG001|Overall Study|Withdrawal by Subject|14|||
164050877|NCT04566445|592545005|FG002|Overall Study|Withdrawal by Subject|13|||
164050878|NCT04566445|592545003|FG000|Overall Study|Randomized but not treated due to AE|2|||
164050879|NCT04566445|592545004|FG001|Overall Study|Randomized but not treated due to AE|1|||
164050880|NCT04566445|592545005|FG002|Overall Study|Randomized but not treated due to AE|0|||
164050881|NCT04566445|592545003|FG000|Overall Study|Adverse Event|1|||
164050882|NCT04566445|592545004|FG001|Overall Study|Adverse Event|1|||
164050883|NCT04566445|592545005|FG002|Overall Study|Adverse Event|0|||
164050884|NCT00137267|592545008|FG000|Overall Study|Lost to Follow-up|15|||
164050885|NCT00137267|592545009|FG001|Overall Study|Lost to Follow-up|21|||
164050886|NCT02061540|592545014|FG000|Overall Study|Adverse Event|2|||
164050887|NCT02061540|592545014|FG000|Overall Study|Withdrawal by Subject|2|||
164050888|NCT04005755|592545017|FG000|Overall Study|Adverse Event|6|||
164050889|NCT04005755|592545017|FG000|Overall Study|Physician Decision|3|||
164050890|NCT04005755|592545017|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
164050891|NCT04005755|592545017|FG000|Overall Study|Withdrawal by Subject|3|||
164050892|NCT04005755|592545017|FG000|Overall Study|Lost to Follow-up|1|||
164050893|NCT02289833|592545018|FG000|Overall Study|Study discontinuation|0|||
164050894|NCT02289833|592545019|FG001|Overall Study|Study discontinuation|1|||
164050895|NCT02289833|592545018|FG000|Overall Study|Lost to Follow-up|4|||
164050896|NCT02289833|592545019|FG001|Overall Study|Lost to Follow-up|0|||
164050897|NCT02289833|592545018|FG000|Overall Study|Death|23|||
164050898|NCT02289833|592545019|FG001|Overall Study|Death|16|||
164050899|NCT02561273|592545026|FG000|Overall Study|Protocol Violation|1|||
164050900|NCT02561273|592545027|FG001|Overall Study|Protocol Violation|0|||
164050901|NCT00958191|592545028|FG000|Overall Study|Death|4|||
164050902|NCT00958191|592545028|FG000|Overall Study|Lost to Follow-up|5|||
164050903|NCT00958191|592545028|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
164050904|NCT00958191|592545028|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
164050905|NCT00958191|592545028|FG000|Overall Study|Revision of study device|4|||
164050906|NCT00958191|592545028|FG000|Overall Study|Site termination|11|||
164050907|NCT00958191|592545028|FG000|Overall Study|No 5 yr x-rays|56|||
164050908|NCT01642004|592545029|FG000|Randomization|Adverse Event unrelated to study drug|1|||
164050909|NCT01642004|592545030|FG001|Randomization|Adverse Event unrelated to study drug|0|||
164050910|NCT01642004|592545029|FG000|Randomization|Participant withdrew consent|1|||
164050911|NCT01642004|592545030|FG001|Randomization|Participant withdrew consent|6|||
164050912|NCT01642004|592545029|FG000|Randomization|No longer meets study criteria|2|||
164050913|NCT01642004|592545030|FG001|Randomization|No longer meets study criteria|2|||
164050914|NCT01642004|592545029|FG000|Treatment|Disease progression|95|||
164050915|NCT01642004|592545030|FG001|Treatment|Disease progression|79|||
164050916|NCT01642004|592545029|FG000|Treatment|Study drug toxicity|10|||
164050917|NCT01642004|592545030|FG001|Treatment|Study drug toxicity|13|||
164050918|NCT01642004|592545029|FG000|Treatment|Death|1|||
164050919|NCT01642004|592545030|FG001|Treatment|Death|1|||
164050920|NCT01642004|592545029|FG000|Treatment|Adverse event unrelated to study drug|9|||
164050921|NCT01642004|592545030|FG001|Treatment|Adverse event unrelated to study drug|13|||
164050922|NCT01642004|592545029|FG000|Treatment|Maximum clinical benefit|1|||
164050923|NCT01642004|592545030|FG001|Treatment|Maximum clinical benefit|9|||
164050924|NCT01642004|592545029|FG000|Treatment|Poor/non-compliance|1|||
164050925|NCT01642004|592545030|FG001|Treatment|Poor/non-compliance|0|||
164050926|NCT01642004|592545029|FG000|Treatment|No longer meets study criteria|1|||
164050927|NCT01642004|592545030|FG001|Treatment|No longer meets study criteria|2|||
164050928|NCT01642004|592545029|FG000|Treatment|Other reasons|2|||
164050929|NCT01642004|592545030|FG001|Treatment|Other reasons|0|||
164050930|NCT01642004|592545029|FG000|Treatment|Not reported|0|||
164050931|NCT01642004|592545030|FG001|Treatment|Not reported|3|||
164050932|NCT01642004|592545029|FG000|Treatment|Participant request to discontinue study treatment|6|||
164050933|NCT01642004|592545030|FG001|Treatment|Participant request to discontinue study treatment|4|||
164050934|NCT01642004|592545029|FG000|Treatment|Participant withdrew consent|5|||
164050935|NCT01642004|592545030|FG001|Treatment|Participant withdrew consent|5|||
164050936|NCT01818765|592545033|FG000|Overall Study|Death|2|||
164050937|NCT01562327|592545034|FG000|Overall Study|Adverse Event|2|||
164050938|NCT01562327|592545034|FG000|Overall Study|Lack of Efficacy|1|||
164050939|NCT01562327|592545034|FG000|Overall Study|Participant drop-out|1|||
164050940|NCT01562327|592545034|FG000|Overall Study|Infusion not received at 6 month window|4|||
164050941|NCT04554394|592545043|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
164050942|NCT04554394|592545044|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
164050943|NCT04554394|592545043|FG000|Overall Study|Withdrawal by Subject|2|||
164050944|NCT04554394|592545044|FG001|Overall Study|Withdrawal by Subject|2|||
164050945|NCT04554394|592545043|FG000|Overall Study|Lost to Follow-up|2|||
164050946|NCT04554394|592545044|FG001|Overall Study|Lost to Follow-up|2|||
164050947|NCT04554394|592545043|FG000|Overall Study|Physician Decision|1|||
164099783|NCT01223365|592730588|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
164099784|NCT01223365|592730588|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
164099785|NCT01223365|592730588|FG000|Open-label Treatment Period|Protocol Violation|15|||
164099786|NCT01223365|592730588|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
164099787|NCT01223365|592730588|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
164099788|NCT01223365|592730588|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
164099789|NCT01223365|592730588|FG000|Open-label Treatment Period|Moved out of area|2|||
164099790|NCT01223365|592730588|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
164099791|NCT01223365|592730588|FG000|Open-label Treatment Period|"Out of window"|1|||
164099792|NCT01223365|592730588|FG000|Open-label Treatment Period|Starting physical therapy|1|||
164099793|NCT01223365|592730588|FG000|Open-label Treatment Period|Physician Decision|2|||
164099794|NCT03880266|592730589|FG000|Overall Study|Withdrawal by Subject|0|||
164099795|NCT03880266|592730590|FG001|Overall Study|Withdrawal by Subject|1|||
164099796|NCT03880266|592730591|FG002|Overall Study|Withdrawal by Subject|1|||
164099797|NCT03880266|592730592|FG003|Overall Study|Withdrawal by Subject|0|||
164099798|NCT03880266|592730593|FG004|Overall Study|Withdrawal by Subject|0|||
164099799|NCT03880266|592730594|FG005|Overall Study|Withdrawal by Subject|0|||
164099800|NCT03880266|592730595|FG006|Overall Study|Withdrawal by Subject|0|||
164099801|NCT03880266|592730596|FG007|Overall Study|Withdrawal by Subject|0|||
164099802|NCT05472038|592731980|FG000|Overall Study|Adverse Event|0|||
164099803|NCT05472038|592731981|FG001|Overall Study|Adverse Event|0|||
164099804|NCT05472038|592731982|FG002|Overall Study|Adverse Event|1|||
164099805|NCT05472038|592731983|FG003|Overall Study|Adverse Event|0|||
164099806|NCT05472038|592731984|FG004|Overall Study|Adverse Event|0|||
164099807|NCT05472038|592731985|FG005|Overall Study|Adverse Event|0|||
164099808|NCT05472038|592731986|FG006|Overall Study|Adverse Event|0|||
164099809|NCT05472038|592731987|FG007|Overall Study|Adverse Event|0|||
164099810|NCT05472038|592731988|FG008|Overall Study|Adverse Event|0|||
164099811|NCT05472038|592731989|FG009|Overall Study|Adverse Event|0|||
164099812|NCT05472038|592731990|FG010|Overall Study|Adverse Event|0|||
164099813|NCT05472038|592731991|FG011|Overall Study|Adverse Event|0|||
164099814|NCT05472038|592731980|FG000|Overall Study|Death|0|||
164099815|NCT05472038|592731981|FG001|Overall Study|Death|0|||
164099816|NCT05472038|592731982|FG002|Overall Study|Death|0|||
164099817|NCT05472038|592731983|FG003|Overall Study|Death|0|||
164099818|NCT05472038|592731984|FG004|Overall Study|Death|0|||
164099819|NCT05472038|592731985|FG005|Overall Study|Death|1|||
164099820|NCT05472038|592731986|FG006|Overall Study|Death|0|||
164099821|NCT05472038|592731987|FG007|Overall Study|Death|0|||
164099822|NCT05472038|592731988|FG008|Overall Study|Death|0|||
164099823|NCT05472038|592731989|FG009|Overall Study|Death|0|||
164099824|NCT05472038|592731990|FG010|Overall Study|Death|0|||
164099825|NCT05472038|592731991|FG011|Overall Study|Death|0|||
164099826|NCT05472038|592731980|FG000|Overall Study|Lost to Follow-up|1|||
164099827|NCT05472038|592731981|FG001|Overall Study|Lost to Follow-up|3|||
164099828|NCT05472038|592731982|FG002|Overall Study|Lost to Follow-up|3|||
164099829|NCT05472038|592731983|FG003|Overall Study|Lost to Follow-up|9|||
164099830|NCT05472038|592731984|FG004|Overall Study|Lost to Follow-up|2|||
164099831|NCT05472038|592731985|FG005|Overall Study|Lost to Follow-up|2|||
164099832|NCT05472038|592731986|FG006|Overall Study|Lost to Follow-up|1|||
164099833|NCT05472038|592731987|FG007|Overall Study|Lost to Follow-up|0|||
164099834|NCT05472038|592731988|FG008|Overall Study|Lost to Follow-up|1|||
164050948|NCT04554394|592545044|FG001|Overall Study|Physician Decision|1|||
164050949|NCT02795182|592545045|FG000|Overall Study|Death|5|||
164050950|NCT02795182|592545046|FG001|Overall Study|Death|4|||
164099835|NCT05472038|592731989|FG009|Overall Study|Lost to Follow-up|0|||
164099836|NCT05472038|592731990|FG010|Overall Study|Lost to Follow-up|2|||
164099837|NCT05472038|592731991|FG011|Overall Study|Lost to Follow-up|1|||
164099838|NCT05472038|592731980|FG000|Overall Study|Physician Decision|0|||
164099839|NCT05472038|592731981|FG001|Overall Study|Physician Decision|0|||
164099840|NCT05472038|592731982|FG002|Overall Study|Physician Decision|0|||
164099841|NCT05472038|592731983|FG003|Overall Study|Physician Decision|0|||
164050951|NCT02795182|592545047|FG002|Overall Study|Death|4|||
164050952|NCT02795182|592545048|FG003|Overall Study|Death|18|||
164050953|NCT02795182|592545045|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
164050954|NCT02795182|592545046|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
164050955|NCT02795182|592545047|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
164050956|NCT02795182|592545048|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
164050957|NCT02795182|592545045|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
164050958|NCT02795182|592545046|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
164050959|NCT02795182|592545047|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
164050960|NCT02795182|592545048|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
164050961|NCT02795182|592545045|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
164050962|NCT02795182|592545046|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
164050963|NCT02795182|592545047|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
164050964|NCT02795182|592545048|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
164050965|NCT02795182|592545045|FG000|Overall Study|Withdrawal by Subject|4|||
164050966|NCT02795182|592545046|FG001|Overall Study|Withdrawal by Subject|0|||
164050967|NCT02795182|592545047|FG002|Overall Study|Withdrawal by Subject|0|||
164050968|NCT02795182|592545048|FG003|Overall Study|Withdrawal by Subject|3|||
164050969|NCT02795182|592545045|FG000|Overall Study|Lost to Follow-up|0|||
164050970|NCT02795182|592545046|FG001|Overall Study|Lost to Follow-up|0|||
164050971|NCT02795182|592545047|FG002|Overall Study|Lost to Follow-up|1|||
164050972|NCT02795182|592545048|FG003|Overall Study|Lost to Follow-up|1|||
164050973|NCT02795182|592545045|FG000|Overall Study|Roll Over to Long Term Extension|3|||
164050974|NCT02795182|592545046|FG001|Overall Study|Roll Over to Long Term Extension|3|||
164050975|NCT02795182|592545047|FG002|Overall Study|Roll Over to Long Term Extension|2|||
164050976|NCT02795182|592545048|FG003|Overall Study|Roll Over to Long Term Extension|5|||
164050977|NCT02795182|592545045|FG000|Overall Study|Progressive Disease|0|||
164050978|NCT02795182|592545046|FG001|Overall Study|Progressive Disease|1|||
164050979|NCT02795182|592545047|FG002|Overall Study|Progressive Disease|0|||
164050980|NCT02795182|592545048|FG003|Overall Study|Progressive Disease|4|||
164050981|NCT02795182|592545045|FG000|Overall Study|Physician Decision|0|||
164050982|NCT02795182|592545046|FG001|Overall Study|Physician Decision|0|||
164050983|NCT02795182|592545047|FG002|Overall Study|Physician Decision|0|||
164050984|NCT02795182|592545048|FG003|Overall Study|Physician Decision|1|||
164050985|NCT01055457|592545051|FG000|Overall Study|Lost to Follow-up|0|||
164050986|NCT01055457|592545052|FG001|Overall Study|Lost to Follow-up|1|||
164050987|NCT01055457|592545053|FG002|Overall Study|Lost to Follow-up|0|||
164050988|NCT01055457|592545054|FG003|Overall Study|Lost to Follow-up|0|||
164050989|NCT01055457|592545055|FG004|Overall Study|Lost to Follow-up|0|||
164050990|NCT01055457|592545056|FG005|Overall Study|Lost to Follow-up|1|||
164050991|NCT01055457|592545057|FG006|Overall Study|Lost to Follow-up|0|||
164050992|NCT01055457|592545058|FG007|Overall Study|Lost to Follow-up|0|||
164050993|NCT01055457|592545059|FG008|Overall Study|Lost to Follow-up|0|||
164050994|NCT01055457|592545060|FG009|Overall Study|Lost to Follow-up|0|||
164050995|NCT01055457|592545051|FG000|Overall Study|Protocol Violation|0|||
164050996|NCT01055457|592545052|FG001|Overall Study|Protocol Violation|0|||
164050997|NCT01055457|592545053|FG002|Overall Study|Protocol Violation|1|||
164050998|NCT01055457|592545054|FG003|Overall Study|Protocol Violation|1|||
164050999|NCT01055457|592545055|FG004|Overall Study|Protocol Violation|1|||
164051000|NCT01055457|592545056|FG005|Overall Study|Protocol Violation|2|||
164051001|NCT01055457|592545057|FG006|Overall Study|Protocol Violation|1|||
164051002|NCT01055457|592545058|FG007|Overall Study|Protocol Violation|0|||
164051003|NCT01055457|592545059|FG008|Overall Study|Protocol Violation|0|||
164051004|NCT01055457|592545060|FG009|Overall Study|Protocol Violation|1|||
164051005|NCT01055457|592545051|FG000|Overall Study|Subject Disinterest|0|||
164051006|NCT01055457|592545052|FG001|Overall Study|Subject Disinterest|0|||
164051007|NCT01055457|592545053|FG002|Overall Study|Subject Disinterest|0|||
164051008|NCT01055457|592545054|FG003|Overall Study|Subject Disinterest|0|||
164051009|NCT01055457|592545055|FG004|Overall Study|Subject Disinterest|0|||
164051010|NCT01055457|592545056|FG005|Overall Study|Subject Disinterest|0|||
164051011|NCT01055457|592545057|FG006|Overall Study|Subject Disinterest|0|||
164051012|NCT01055457|592545058|FG007|Overall Study|Subject Disinterest|1|||
164051013|NCT01055457|592545059|FG008|Overall Study|Subject Disinterest|0|||
164051014|NCT01055457|592545060|FG009|Overall Study|Subject Disinterest|0|||
164051015|NCT01055457|592545051|FG000|Overall Study|Subject Ineligible|1|||
164051016|NCT01055457|592545052|FG001|Overall Study|Subject Ineligible|0|||
164051017|NCT01055457|592545053|FG002|Overall Study|Subject Ineligible|1|||
164051018|NCT01055457|592545054|FG003|Overall Study|Subject Ineligible|0|||
164051019|NCT01055457|592545055|FG004|Overall Study|Subject Ineligible|1|||
164051020|NCT01055457|592545056|FG005|Overall Study|Subject Ineligible|0|||
164051021|NCT01055457|592545057|FG006|Overall Study|Subject Ineligible|0|||
164051022|NCT01055457|592545058|FG007|Overall Study|Subject Ineligible|0|||
164051023|NCT01055457|592545059|FG008|Overall Study|Subject Ineligible|0|||
164051024|NCT01055457|592545060|FG009|Overall Study|Subject Ineligible|0|||
164051025|NCT01055457|592545051|FG000|Overall Study|Discomfort|0|||
164051026|NCT01055457|592545052|FG001|Overall Study|Discomfort|0|||
164051027|NCT01055457|592545053|FG002|Overall Study|Discomfort|0|||
164051028|NCT01055457|592545054|FG003|Overall Study|Discomfort|0|||
164051029|NCT01055457|592545055|FG004|Overall Study|Discomfort|1|||
164051030|NCT01055457|592545056|FG005|Overall Study|Discomfort|0|||
164051031|NCT01055457|592545057|FG006|Overall Study|Discomfort|0|||
164051032|NCT01055457|592545058|FG007|Overall Study|Discomfort|0|||
164051033|NCT01055457|592545059|FG008|Overall Study|Discomfort|0|||
164051034|NCT01055457|592545060|FG009|Overall Study|Discomfort|0|||
164051035|NCT01055457|592545051|FG000|Overall Study|Pregnancy|0|||
164051036|NCT01055457|592545052|FG001|Overall Study|Pregnancy|0|||
164051037|NCT01055457|592545053|FG002|Overall Study|Pregnancy|0|||
164051038|NCT01055457|592545054|FG003|Overall Study|Pregnancy|1|||
164051039|NCT01055457|592545055|FG004|Overall Study|Pregnancy|0|||
164051040|NCT01055457|592545056|FG005|Overall Study|Pregnancy|0|||
164051041|NCT01055457|592545057|FG006|Overall Study|Pregnancy|0|||
164051042|NCT01055457|592545058|FG007|Overall Study|Pregnancy|0|||
164051043|NCT01055457|592545059|FG008|Overall Study|Pregnancy|0|||
164099842|NCT05472038|592731984|FG004|Overall Study|Physician Decision|1|||
164099843|NCT05472038|592731985|FG005|Overall Study|Physician Decision|0|||
164099844|NCT05472038|592731986|FG006|Overall Study|Physician Decision|0|||
164099845|NCT05472038|592731987|FG007|Overall Study|Physician Decision|0|||
164099846|NCT05472038|592731988|FG008|Overall Study|Physician Decision|0|||
164099847|NCT05472038|592731989|FG009|Overall Study|Physician Decision|0|||
164099848|NCT05472038|592731990|FG010|Overall Study|Physician Decision|0|||
164099849|NCT05472038|592731991|FG011|Overall Study|Physician Decision|0|||
164099850|NCT05472038|592731980|FG000|Overall Study|Withdrawal by Subject|1|||
164099851|NCT05472038|592731981|FG001|Overall Study|Withdrawal by Subject|3|||
164099852|NCT05472038|592731982|FG002|Overall Study|Withdrawal by Subject|1|||
164099853|NCT05472038|592731983|FG003|Overall Study|Withdrawal by Subject|6|||
164099854|NCT05472038|592731984|FG004|Overall Study|Withdrawal by Subject|1|||
164099855|NCT05472038|592731985|FG005|Overall Study|Withdrawal by Subject|3|||
164099856|NCT05472038|592731986|FG006|Overall Study|Withdrawal by Subject|0|||
164099857|NCT05472038|592731987|FG007|Overall Study|Withdrawal by Subject|2|||
164099858|NCT05472038|592731988|FG008|Overall Study|Withdrawal by Subject|3|||
164099859|NCT05472038|592731989|FG009|Overall Study|Withdrawal by Subject|1|||
164099860|NCT05472038|592731990|FG010|Overall Study|Withdrawal by Subject|2|||
164099861|NCT05472038|592731991|FG011|Overall Study|Withdrawal by Subject|2|||
164099862|NCT05472038|592731980|FG000|Overall Study|Protocol Violation|0|||
164099863|NCT05472038|592731981|FG001|Overall Study|Protocol Violation|0|||
164099864|NCT05472038|592731982|FG002|Overall Study|Protocol Violation|0|||
164099865|NCT05472038|592731983|FG003|Overall Study|Protocol Violation|0|||
164099866|NCT05472038|592731984|FG004|Overall Study|Protocol Violation|0|||
164099867|NCT05472038|592731985|FG005|Overall Study|Protocol Violation|0|||
164099868|NCT05472038|592731986|FG006|Overall Study|Protocol Violation|0|||
164099869|NCT05472038|592731987|FG007|Overall Study|Protocol Violation|1|||
164099870|NCT05472038|592731988|FG008|Overall Study|Protocol Violation|1|||
164099871|NCT05472038|592731989|FG009|Overall Study|Protocol Violation|1|||
164099872|NCT05472038|592731990|FG010|Overall Study|Protocol Violation|1|||
164099873|NCT05472038|592731991|FG011|Overall Study|Protocol Violation|1|||
164099874|NCT05472038|592731980|FG000|Overall Study|Not vaccinated|0|||
164099875|NCT05472038|592731981|FG001|Overall Study|Not vaccinated|0|||
164099876|NCT05472038|592731982|FG002|Overall Study|Not vaccinated|0|||
164099877|NCT05472038|592731983|FG003|Overall Study|Not vaccinated|1|||
164099878|NCT05472038|592731984|FG004|Overall Study|Not vaccinated|0|||
164099879|NCT05472038|592731985|FG005|Overall Study|Not vaccinated|0|||
164099880|NCT05472038|592731986|FG006|Overall Study|Not vaccinated|0|||
164099881|NCT05472038|592731987|FG007|Overall Study|Not vaccinated|0|||
164099882|NCT05472038|592731988|FG008|Overall Study|Not vaccinated|0|||
164099883|NCT05472038|592731989|FG009|Overall Study|Not vaccinated|0|||
164099884|NCT05472038|592731990|FG010|Overall Study|Not vaccinated|0|||
164099885|NCT05472038|592731991|FG011|Overall Study|Not vaccinated|0|||
164099886|NCT03235739|592731992|FG000|Overall Study|Withdrawal by Subject|2|||
164099887|NCT03235739|592731993|FG001|Overall Study|Withdrawal by Subject|2|||
164099888|NCT03235739|592731992|FG000|Overall Study|Physician Decision|0|||
164099889|NCT03235739|592731993|FG001|Overall Study|Physician Decision|1|||
164099890|NCT00467896|592731994|FG000|Overall Study|Consent Withdrawal|18|||
164099891|NCT00467896|592731994|FG000|Overall Study|Adverse Event|7|||
164099892|NCT00467896|592731994|FG000|Overall Study|Serious Adverse Event|13|||
164099893|NCT00467896|592731994|FG000|Overall Study|Non-compliance|3|||
164099894|NCT00467896|592731994|FG000|Overall Study|Changed therapy|2|||
164099895|NCT00467896|592731994|FG000|Overall Study|Patient received transplant|2|||
164099896|NCT00467896|592731994|FG000|Overall Study|Patient had atrial septostomy|1|||
164099897|NCT00467896|592731994|FG000|Overall Study|Patient weaned off iloprost|1|||
164051044|NCT01055457|592545060|FG009|Overall Study|Pregnancy|0|||
164051045|NCT01055457|592545051|FG000|Overall Study|Adverse Event|0|||
164099898|NCT00467896|592731994|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
164099899|NCT00467896|592731994|FG000|Overall Study|Started intravenous prostacyclin|1|||
164051046|NCT01055457|592545052|FG001|Overall Study|Adverse Event|0|||
164051047|NCT01055457|592545053|FG002|Overall Study|Adverse Event|0|||
164051048|NCT01055457|592545054|FG003|Overall Study|Adverse Event|1|||
164051049|NCT01055457|592545055|FG004|Overall Study|Adverse Event|0|||
164099900|NCT00467896|592731994|FG000|Overall Study|Started inhaled Remodulin|1|||
164099901|NCT00467896|592731994|FG000|Overall Study|Patient had no improvement|1|||
164099902|NCT02847650|592731995|FG000|Overall Study|Adverse Event|2|||
164099903|NCT02847650|592731996|FG001|Overall Study|Adverse Event|4|||
164099904|NCT02847650|592731995|FG000|Overall Study|Lost to Follow-up|1|||
164051050|NCT01055457|592545056|FG005|Overall Study|Adverse Event|0|||
164051051|NCT01055457|592545057|FG006|Overall Study|Adverse Event|0|||
164051052|NCT01055457|592545058|FG007|Overall Study|Adverse Event|0|||
164051053|NCT01055457|592545059|FG008|Overall Study|Adverse Event|0|||
164051054|NCT01055457|592545060|FG009|Overall Study|Adverse Event|0|||
164051055|NCT02724111|592545061|FG000|Overall Study|Protocol Violation|2|||
164051056|NCT02724111|592545062|FG001|Overall Study|Protocol Violation|5|||
164051057|NCT02996500|592545063|FG000|Overall Study|Adverse Event|1|||
164051058|NCT02996500|592545064|FG001|Overall Study|Adverse Event|1|||
164051059|NCT02996500|592545065|FG002|Overall Study|Adverse Event|4|||
164051060|NCT02996500|592545066|FG003|Overall Study|Adverse Event|3|||
164051061|NCT02996500|592545067|FG004|Overall Study|Adverse Event|1|||
164051062|NCT02996500|592545068|FG005|Overall Study|Adverse Event|2|||
164051063|NCT02996500|592545063|FG000|Overall Study|Lack of Efficacy|0|||
164051064|NCT02996500|592545064|FG001|Overall Study|Lack of Efficacy|0|||
164051065|NCT02996500|592545065|FG002|Overall Study|Lack of Efficacy|0|||
164051066|NCT02996500|592545066|FG003|Overall Study|Lack of Efficacy|0|||
164051067|NCT02996500|592545067|FG004|Overall Study|Lack of Efficacy|2|||
164051068|NCT02996500|592545068|FG005|Overall Study|Lack of Efficacy|0|||
164051069|NCT02996500|592545063|FG000|Overall Study|Lost to Follow-up|1|||
164051070|NCT02996500|592545064|FG001|Overall Study|Lost to Follow-up|0|||
164051071|NCT02996500|592545065|FG002|Overall Study|Lost to Follow-up|0|||
164051072|NCT02996500|592545066|FG003|Overall Study|Lost to Follow-up|0|||
164051073|NCT02996500|592545067|FG004|Overall Study|Lost to Follow-up|0|||
164051074|NCT02996500|592545068|FG005|Overall Study|Lost to Follow-up|1|||
164051075|NCT02996500|592545063|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164051076|NCT02996500|592545064|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
164051077|NCT02996500|592545065|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
164051078|NCT02996500|592545066|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
164051079|NCT02996500|592545067|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
164051080|NCT02996500|592545068|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
164051081|NCT02996500|592545063|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164051082|NCT02996500|592545064|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164051083|NCT02996500|592545065|FG002|Overall Study|Non-Compliance With Study Drug|0|||
164051084|NCT02996500|592545066|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164051085|NCT02996500|592545067|FG004|Overall Study|Non-Compliance With Study Drug|0|||
164051086|NCT02996500|592545068|FG005|Overall Study|Non-Compliance With Study Drug|1|||
164051087|NCT02996500|592545063|FG000|Overall Study|Progressive Disease|1|||
164051088|NCT02996500|592545064|FG001|Overall Study|Progressive Disease|0|||
164051089|NCT02996500|592545065|FG002|Overall Study|Progressive Disease|0|||
164051090|NCT02996500|592545066|FG003|Overall Study|Progressive Disease|0|||
164051091|NCT02996500|592545067|FG004|Overall Study|Progressive Disease|0|||
164051092|NCT02996500|592545068|FG005|Overall Study|Progressive Disease|0|||
164051093|NCT02996500|592545063|FG000|Overall Study|Other|2|||
164051094|NCT02996500|592545064|FG001|Overall Study|Other|0|||
164051095|NCT02996500|592545065|FG002|Overall Study|Other|2|||
164051096|NCT02996500|592545066|FG003|Overall Study|Other|0|||
164051097|NCT02996500|592545067|FG004|Overall Study|Other|0|||
164051098|NCT02996500|592545068|FG005|Overall Study|Other|0|||
164051099|NCT02996500|592545063|FG000|Overall Study|Protocol Violation|0|||
164051100|NCT02996500|592545064|FG001|Overall Study|Protocol Violation|0|||
164051101|NCT02996500|592545065|FG002|Overall Study|Protocol Violation|0|||
164051102|NCT02996500|592545066|FG003|Overall Study|Protocol Violation|1|||
164051103|NCT02996500|592545067|FG004|Overall Study|Protocol Violation|0|||
164051104|NCT02996500|592545068|FG005|Overall Study|Protocol Violation|0|||
164051105|NCT02996500|592545063|FG000|Overall Study|Withdrawal by Subject|3|||
164051106|NCT02996500|592545064|FG001|Overall Study|Withdrawal by Subject|0|||
164051107|NCT02996500|592545065|FG002|Overall Study|Withdrawal by Subject|3|||
164051108|NCT02996500|592545066|FG003|Overall Study|Withdrawal by Subject|0|||
164051109|NCT02996500|592545067|FG004|Overall Study|Withdrawal by Subject|2|||
164051110|NCT02996500|592545068|FG005|Overall Study|Withdrawal by Subject|0|||
164051111|NCT02187224|592545069|FG000|Overall Study|Did not show up for test day|1|||
164051112|NCT02187224|592545070|FG001|Overall Study|Did not show up for test day|0|||
164051113|NCT01010776|592545075|FG000|Main Phase|Withdrawal by Subject|14|||
164051114|NCT01010776|592545075|FG000|Main Phase|Lack of Efficacy|8|||
164099905|NCT02847650|592731996|FG001|Overall Study|Lost to Follow-up|0|||
164051115|NCT01010776|592545075|FG000|Main Phase|Adverse Event|7|||
164051116|NCT01010776|592545075|FG000|Main Phase|Lost to Follow-up|6|||
164051117|NCT01010776|592545075|FG000|Main Phase|Non-compliance to study medication|5|||
164051118|NCT01010776|592545075|FG000|Main Phase|Selection failure|2|||
164051119|NCT01010776|592545075|FG000|Main Phase|Inform consent withdrawal|1|||
164051120|NCT01010776|592545075|FG000|Main Phase|Other|1|||
164051121|NCT01010776|592545075|FG000|Main Phase|Did not received study medication|5|||
164051122|NCT01010776|592545075|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
164051123|NCT01010776|592545075|FG000|Extension Phase|Other|3|||
164051124|NCT02332876|592545076|FG000|Overall Study|Lost to Follow-up|1|||
164051125|NCT02332876|592545077|FG001|Overall Study|Lost to Follow-up|1|||
164051126|NCT01369069|592545081|FG000|Overall Study|Lost to Follow-up|8|||
164051127|NCT01369069|592545082|FG001|Overall Study|Lost to Follow-up|9|||
164051128|NCT01369069|592545081|FG000|Overall Study|Withdrawal by Subject|9|||
164051129|NCT01369069|592545082|FG001|Overall Study|Withdrawal by Subject|7|||
164051130|NCT02573012|592545083|FG000|Overall Study|Adverse Event|5|||
164051131|NCT02573012|592545084|FG001|Overall Study|Adverse Event|5|||
164051132|NCT02573012|592545083|FG000|Overall Study|Lack of Efficacy|5|||
164051133|NCT02573012|592545084|FG001|Overall Study|Lack of Efficacy|4|||
164051134|NCT02573012|592545083|FG000|Overall Study|Non-compliance|1|||
164051135|NCT02573012|592545084|FG001|Overall Study|Non-compliance|2|||
164051136|NCT02573012|592545083|FG000|Overall Study|Withdrawal by Subject|2|||
164099906|NCT02847650|592731995|FG000|Overall Study|Protocol Violation|0|||
164099907|NCT02847650|592731996|FG001|Overall Study|Protocol Violation|1|||
164099908|NCT02847650|592731995|FG000|Overall Study|Withdrawal by Subject|1|||
164099909|NCT02847650|592731996|FG001|Overall Study|Withdrawal by Subject|1|||
164099910|NCT03818581|592731999|FG000|Overall Study|Adverse Event|1|||
164099911|NCT03818581|592732000|FG001|Overall Study|Adverse Event|0|||
164099912|NCT03818581|592732001|FG002|Overall Study|Adverse Event|0|||
164099913|NCT03818581|592732002|FG003|Overall Study|Adverse Event|0|||
164099914|NCT03818581|592732003|FG004|Overall Study|Adverse Event|0|||
164099915|NCT03818581|592731999|FG000|Overall Study|Covid-19|2|||
164099916|NCT03818581|592732000|FG001|Overall Study|Covid-19|0|||
164099917|NCT03818581|592732001|FG002|Overall Study|Covid-19|0|||
164099918|NCT03818581|592732002|FG003|Overall Study|Covid-19|0|||
164099919|NCT03818581|592732003|FG004|Overall Study|Covid-19|1|||
164099920|NCT03818581|592731999|FG000|Overall Study|Withdrawal by Subject|0|||
164099921|NCT03818581|592732000|FG001|Overall Study|Withdrawal by Subject|0|||
164099922|NCT03818581|592732001|FG002|Overall Study|Withdrawal by Subject|0|||
164099923|NCT03818581|592732002|FG003|Overall Study|Withdrawal by Subject|0|||
164099924|NCT03818581|592732003|FG004|Overall Study|Withdrawal by Subject|1|||
164099925|NCT03818581|592731999|FG000|Overall Study|No longer met study criteria|0|||
164099926|NCT03818581|592732000|FG001|Overall Study|No longer met study criteria|0|||
164099927|NCT03818581|592732001|FG002|Overall Study|No longer met study criteria|0|||
164099928|NCT03818581|592732002|FG003|Overall Study|No longer met study criteria|0|||
164099929|NCT03818581|592732003|FG004|Overall Study|No longer met study criteria|1|||
164099930|NCT02378935|592732009|FG000|Overall Study|Lack of Efficacy|10|||
164099931|NCT02378935|592732010|FG001|Overall Study|Lack of Efficacy|0|||
164099932|NCT02378935|592732011|FG002|Overall Study|Lack of Efficacy|2|||
164099933|NCT02378935|592732012|FG003|Overall Study|Lack of Efficacy|6|||
164099934|NCT02378935|592732013|FG004|Overall Study|Lack of Efficacy|0|||
164099935|NCT02378935|592732014|FG005|Overall Study|Lack of Efficacy|0|||
164099936|NCT02378935|592732015|FG006|Overall Study|Lack of Efficacy|0|||
164099937|NCT02378935|592732009|FG000|Overall Study|Death|0|||
164099938|NCT02378935|592732010|FG001|Overall Study|Death|0|||
164099939|NCT02378935|592732011|FG002|Overall Study|Death|1|||
164099940|NCT02378935|592732012|FG003|Overall Study|Death|0|||
164099941|NCT02378935|592732013|FG004|Overall Study|Death|0|||
164099942|NCT02378935|592732014|FG005|Overall Study|Death|0|||
164099943|NCT02378935|592732015|FG006|Overall Study|Death|0|||
164099944|NCT03450057|592732019|FG000|Overall Study|Death|17|||
164099945|NCT03450057|592732019|FG000|Overall Study|ICF withdrawal|4|||
164099946|NCT03450057|592732019|FG000|Overall Study|Lost to Follow-up|2|||
164099947|NCT03214952|592732022|FG000|Overall Study|Protocol Deviation|45|||
164099948|NCT03214952|592732022|FG000|Overall Study|Case Report Forms Uncollected|13|||
164099949|NCT00829790|592732023|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
164099950|NCT00829790|592732024|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
164099951|NCT03935880|592732025|FG000|Overall Study|Lost to Follow-up|0|||
164099952|NCT03935880|592732026|FG001|Overall Study|Lost to Follow-up|1|||
164099953|NCT00365365|592732027|FG000|Overall Study|Randomized but not treated|0|||
164099954|NCT00365365|592732028|FG001|Overall Study|Randomized but not treated|2|||
164099955|NCT00365365|592732029|FG002|Overall Study|Randomized but not treated|0|||
164099956|NCT00365365|592732027|FG000|Overall Study|Poor compliance to protocol|0|||
164099957|NCT00365365|592732028|FG001|Overall Study|Poor compliance to protocol|1|||
164099958|NCT00365365|592732029|FG002|Overall Study|Poor compliance to protocol|0|||
164099959|NCT00365365|592732027|FG000|Overall Study|Lost to Follow-up|3|||
164099960|NCT00365365|592732028|FG001|Overall Study|Lost to Follow-up|3|||
164099961|NCT00365365|592732029|FG002|Overall Study|Lost to Follow-up|3|||
164099962|NCT00365365|592732027|FG000|Overall Study|Death|1|||
164099963|NCT00365365|592732028|FG001|Overall Study|Death|3|||
164099964|NCT00365365|592732029|FG002|Overall Study|Death|0|||
164099965|NCT00365365|592732027|FG000|Overall Study|Subject's request|11|||
164099966|NCT00365365|592732028|FG001|Overall Study|Subject's request|13|||
164099967|NCT00365365|592732029|FG002|Overall Study|Subject's request|1|||
164099968|NCT00365365|592732027|FG000|Overall Study|Disease progression/relapse|9|||
164099969|NCT00365365|592732028|FG001|Overall Study|Disease progression/relapse|6|||
164099970|NCT00365365|592732029|FG002|Overall Study|Disease progression/relapse|7|||
164099971|NCT00365365|592732027|FG000|Overall Study|Adverse Event|6|||
164099972|NCT00365365|592732028|FG001|Overall Study|Adverse Event|6|||
164099973|NCT00365365|592732029|FG002|Overall Study|Adverse Event|3|||
164099974|NCT00365365|592732027|FG000|Overall Study|Moved|2|||
164099975|NCT00365365|592732028|FG001|Overall Study|Moved|0|||
164099976|NCT00365365|592732029|FG002|Overall Study|Moved|0|||
164099977|NCT00365365|592732027|FG000|Overall Study|New cancer|1|||
164099978|NCT00365365|592732028|FG001|Overall Study|New cancer|0|||
164099979|NCT00365365|592732029|FG002|Overall Study|New cancer|0|||
164099980|NCT00365365|592732027|FG000|Overall Study|Withdrew consent|1|||
164099981|NCT00365365|592732028|FG001|Overall Study|Withdrew consent|1|||
164099982|NCT00365365|592732029|FG002|Overall Study|Withdrew consent|0|||
164099983|NCT00365365|592732027|FG000|Overall Study|Second malignancy|0|||
164099984|NCT00365365|592732028|FG001|Overall Study|Second malignancy|1|||
164099985|NCT00365365|592732029|FG002|Overall Study|Second malignancy|0|||
164148631|NCT04895982|592904915|FG004|Overall Study|Lost to Follow-up|0|||
164051137|NCT02573012|592545084|FG001|Overall Study|Withdrawal by Subject|2|||
164051138|NCT02573012|592545083|FG000|Overall Study|Study Ended per Protocol|1|||
164051139|NCT02573012|592545084|FG001|Overall Study|Study Ended per Protocol|0|||
164051140|NCT02573012|592545083|FG000|Overall Study|Physician Decision|1|||
164051141|NCT02573012|592545084|FG001|Overall Study|Physician Decision|2|||
164051142|NCT00882362|592545085|FG000|Overall Study|Adverse Event|13|||
164051143|NCT00882362|592545086|FG001|Overall Study|Adverse Event|10|||
164051144|NCT00882362|592545085|FG000|Overall Study|Withdrawal by Subject|13|||
164051145|NCT00882362|592545086|FG001|Overall Study|Withdrawal by Subject|10|||
164051146|NCT00882362|592545085|FG000|Overall Study|Lack of Efficacy|3|||
164051147|NCT00882362|592545086|FG001|Overall Study|Lack of Efficacy|0|||
164051148|NCT00882362|592545085|FG000|Overall Study|Protocol Violation|7|||
164051149|NCT00882362|592545086|FG001|Overall Study|Protocol Violation|2|||
164051150|NCT00882362|592545085|FG000|Overall Study|Pregnancy|1|||
164051151|NCT00882362|592545086|FG001|Overall Study|Pregnancy|0|||
164051152|NCT00882362|592545085|FG000|Overall Study|Physician Decision|5|||
164051153|NCT00882362|592545086|FG001|Overall Study|Physician Decision|1|||
164051154|NCT00882362|592545085|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
164051155|NCT00882362|592545086|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
164051156|NCT00882362|592545085|FG000|Overall Study|change of residence or other commitments|5|||
164051157|NCT00882362|592545086|FG001|Overall Study|change of residence or other commitments|0|||
164051158|NCT01268514|592545087|FG000|Overall Study|Adverse Event|20|||
164051159|NCT01268514|592545087|FG000|Overall Study|Death|8|||
164051160|NCT01268514|592545087|FG000|Overall Study|Lost to Follow-up|5|||
164051161|NCT01268514|592545087|FG000|Overall Study|Withdrawal by Subject|3|||
164051162|NCT01268514|592545087|FG000|Overall Study|Withdrawal by Surgeon|5|||
164051163|NCT01222416|592545088|FG000|Overall Study|ineligible;metastasis|3|||
164051164|NCT01222416|592545089|FG001|Overall Study|ineligible;metastasis|0|||
164051165|NCT01222416|592545088|FG000|Overall Study|Adverse Event|4|||
164051166|NCT01222416|592545089|FG001|Overall Study|Adverse Event|0|||
164051167|NCT01222416|592545088|FG000|Overall Study|Withdrawal by Subject|5|||
164051168|NCT01222416|592545089|FG001|Overall Study|Withdrawal by Subject|0|||
164051169|NCT01222416|592545088|FG000|Overall Study|scheduling|6|||
164051170|NCT01222416|592545089|FG001|Overall Study|scheduling|0|||
164051171|NCT01222416|592545088|FG000|Overall Study|missed view/scan|1|||
164051172|NCT01222416|592545089|FG001|Overall Study|missed view/scan|0|||
164051173|NCT01222416|592545088|FG000|Overall Study|Death|1|||
164051174|NCT01222416|592545089|FG001|Overall Study|Death|0|||
164051175|NCT03258762|592545096|FG000|Overall Study|Lost to Follow-up|0|||
164051176|NCT03258762|592545097|FG001|Overall Study|Lost to Follow-up|1|||
164051177|NCT02545049|592545104|FG000|Overall Study|Withdrawal by Subject|1|||
164051178|NCT02545049|592545105|FG001|Overall Study|Withdrawal by Subject|7|||
164051179|NCT02545049|592545104|FG000|Overall Study|Lost to Follow-up|4|||
164051180|NCT02545049|592545105|FG001|Overall Study|Lost to Follow-up|6|||
164051181|NCT02545049|592545104|FG000|Overall Study|GCP violations|37|||
164051182|NCT02545049|592545105|FG001|Overall Study|GCP violations|48|||
164051183|NCT04490057|592545107|FG000|Stage 1|Death|1|||
164051184|NCT04490057|592545108|FG001|Stage 1|Death|2|||
164051185|NCT04490057|592545109|FG002|Stage 1|Death|0|||
164051186|NCT04490057|592545110|FG003|Stage 1|Death|0|||
164051187|NCT04490057|592545111|FG004|Stage 1|Death|0|||
164051188|NCT04490057|592545112|FG005|Stage 1|Death|0|||
164051189|NCT04490057|592545113|FG006|Stage 1|Death|0|||
164051190|NCT04490057|592545114|FG007|Stage 1|Death|0|||
164051191|NCT04490057|592545107|FG000|Stage 1|Withdrawal by Subject|2|||
164051192|NCT04490057|592545108|FG001|Stage 1|Withdrawal by Subject|0|||
164051193|NCT04490057|592545109|FG002|Stage 1|Withdrawal by Subject|0|||
164051194|NCT04490057|592545110|FG003|Stage 1|Withdrawal by Subject|0|||
164051195|NCT04490057|592545111|FG004|Stage 1|Withdrawal by Subject|0|||
164051196|NCT04490057|592545112|FG005|Stage 1|Withdrawal by Subject|0|||
164051197|NCT04490057|592545113|FG006|Stage 1|Withdrawal by Subject|0|||
164051198|NCT04490057|592545114|FG007|Stage 1|Withdrawal by Subject|0|||
164051199|NCT04490057|592545107|FG000|Stage 2|Death|0|||
164051200|NCT04490057|592545108|FG001|Stage 2|Death|0|||
164051201|NCT04490057|592545109|FG002|Stage 2|Death|0|||
164051202|NCT04490057|592545110|FG003|Stage 2|Death|0|||
164051203|NCT04490057|592545111|FG004|Stage 2|Death|1|||
164051204|NCT04490057|592545112|FG005|Stage 2|Death|0|||
164051205|NCT04490057|592545113|FG006|Stage 2|Death|0|||
164051206|NCT04490057|592545114|FG007|Stage 2|Death|0|||
164051207|NCT04490057|592545107|FG000|Stage 2|Lost to Follow-up|0|||
164051208|NCT04490057|592545108|FG001|Stage 2|Lost to Follow-up|0|||
164051209|NCT04490057|592545109|FG002|Stage 2|Lost to Follow-up|0|||
164051210|NCT04490057|592545110|FG003|Stage 2|Lost to Follow-up|11|||
164051211|NCT04490057|592545111|FG004|Stage 2|Lost to Follow-up|17|||
164051212|NCT04490057|592545112|FG005|Stage 2|Lost to Follow-up|4|||
164051213|NCT04490057|592545113|FG006|Stage 2|Lost to Follow-up|21|||
164051214|NCT04490057|592545114|FG007|Stage 2|Lost to Follow-up|14|||
164051215|NCT04191096|592545115|FG000|Overall Study|Death|102|||
164051216|NCT04191096|592545116|FG001|Overall Study|Death|89|||
164051217|NCT04191096|592545115|FG000|Overall Study|Lost to Follow-up|1|||
164051218|NCT04191096|592545116|FG001|Overall Study|Lost to Follow-up|1|||
164051219|NCT04191096|592545115|FG000|Overall Study|Withdrawal by Subject|5|||
164099986|NCT00365365|592732027|FG000|Overall Study|Patient/physician decision|0|||
164099987|NCT00365365|592732028|FG001|Overall Study|Patient/physician decision|0|||
164099988|NCT00365365|592732029|FG002|Overall Study|Patient/physician decision|1|||
164099989|NCT00984022|592732030|FG000|Overall Study|Lost to Follow-up|10|||
164099990|NCT00984022|592732031|FG001|Overall Study|Lost to Follow-up|14|||
164099991|NCT02924883|592732034|FG000|Overall Study|Death|39|||
164099992|NCT02924883|592732035|FG001|Overall Study|Death|20|||
164099993|NCT02924883|592732034|FG000|Overall Study|Lost to Follow-up|1|||
164099994|NCT02924883|592732035|FG001|Overall Study|Lost to Follow-up|0|||
164099995|NCT02924883|592732034|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
164099996|NCT02924883|592732035|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
164099997|NCT02924883|592732034|FG000|Overall Study|Protocol Violation|1|||
164099998|NCT02924883|592732035|FG001|Overall Study|Protocol Violation|0|||
164099999|NCT02924883|592732034|FG000|Overall Study|Withdrawal by Subject|22|||
164100000|NCT02924883|592732035|FG001|Overall Study|Withdrawal by Subject|16|||
164100001|NCT02924883|592732034|FG000|Overall Study|Progressive Disease|1|||
164100002|NCT02924883|592732035|FG001|Overall Study|Progressive Disease|0|||
164100003|NCT02924883|592732034|FG000|Overall Study|Study Terminated by Sponsor|69|||
164100004|NCT02924883|592732035|FG001|Overall Study|Study Terminated by Sponsor|32|||
164100005|NCT00004562|592732036|FG000|Overall Study|Lost to Follow-up|102|||
164100006|NCT00004562|592732037|FG001|Overall Study|Lost to Follow-up|91|||
164100007|NCT00102440|592732041|FG000|Overall Study|Lost to Follow-up|25|||
164100008|NCT00102440|592732042|FG001|Overall Study|Lost to Follow-up|18|||
164100009|NCT00102440|592732043|FG002|Overall Study|Lost to Follow-up|21|||
164100010|NCT00102440|592732041|FG000|Overall Study|Adverse Event|16|||
164100011|NCT00102440|592732042|FG001|Overall Study|Adverse Event|23|||
164100012|NCT00102440|592732043|FG002|Overall Study|Adverse Event|8|||
164100013|NCT00102440|592732041|FG000|Overall Study|Gout Flare|10|||
164100014|NCT00102440|592732042|FG001|Overall Study|Gout Flare|28|||
164100015|NCT00102440|592732043|FG002|Overall Study|Gout Flare|9|||
164100016|NCT00102440|592732041|FG000|Overall Study|Personal Reason(s)|19|||
164100017|NCT00102440|592732042|FG001|Overall Study|Personal Reason(s)|13|||
164100018|NCT00102440|592732043|FG002|Overall Study|Personal Reason(s)|13|||
164100019|NCT00102440|592732041|FG000|Overall Study|Other|11|||
164100020|NCT00102440|592732042|FG001|Overall Study|Other|14|||
164100021|NCT00102440|592732043|FG002|Overall Study|Other|14|||
164100022|NCT00102440|592732041|FG000|Overall Study|Protocol Violation|7|||
164100023|NCT00102440|592732042|FG001|Overall Study|Protocol Violation|2|||
164100024|NCT00102440|592732043|FG002|Overall Study|Protocol Violation|1|||
164100025|NCT04627038|592732044|FG000|Overall Study|Adverse Event|36|||
164100026|NCT04627038|592732045|FG001|Overall Study|Adverse Event|8|||
164100027|NCT04627038|592732044|FG000|Overall Study|Lost to Follow-up|1|||
164100028|NCT04627038|592732045|FG001|Overall Study|Lost to Follow-up|0|||
164100029|NCT04627038|592732044|FG000|Overall Study|Physician Decision|0|||
164100030|NCT04627038|592732045|FG001|Overall Study|Physician Decision|1|||
164100031|NCT04627038|592732044|FG000|Overall Study|Protocol Violation|3|||
164100032|NCT04627038|592732045|FG001|Overall Study|Protocol Violation|1|||
164100033|NCT04627038|592732044|FG000|Overall Study|Withdrawal by Subject|13|||
164100034|NCT04627038|592732045|FG001|Overall Study|Withdrawal by Subject|3|||
164100035|NCT04627038|592732044|FG000|Overall Study|Non-compliance with study drug|0|||
164100036|NCT04627038|592732045|FG001|Overall Study|Non-compliance with study drug|1|||
164100037|NCT04627038|592732044|FG000|Overall Study|Prohibited Concomitant Medication|1|||
164100038|NCT04627038|592732045|FG001|Overall Study|Prohibited Concomitant Medication|0|||
164100039|NCT01792635|592732050|FG000|Part B|Adverse Event|0|||
164100040|NCT01792635|592732051|FG001|Part B|Adverse Event|0|||
164100041|NCT01792635|592732052|FG002|Part B|Adverse Event|1|||
164100042|NCT01792635|592732050|FG000|Part B|Study terminated|0|||
164100043|NCT01792635|592732051|FG001|Part B|Study terminated|4|||
164100044|NCT01792635|592732052|FG002|Part B|Study terminated|3|||
164100045|NCT01401647|592732057|FG000|Overall Study|Withdrawal by Subject|1|||
164100046|NCT01401647|592732058|FG001|Overall Study|Withdrawal by Subject|5|||
164100047|NCT01401647|592732059|FG002|Overall Study|Withdrawal by Subject|2|||
164100048|NCT01401647|592732057|FG000|Overall Study|Lost to Follow-up|3|||
164100049|NCT01401647|592732058|FG001|Overall Study|Lost to Follow-up|3|||
164100050|NCT01401647|592732059|FG002|Overall Study|Lost to Follow-up|1|||
164100051|NCT00473330|592732063|FG000|Core Study|Adverse Event|4|||
164100052|NCT00473330|592732064|FG001|Core Study|Adverse Event|4|||
164100053|NCT00473330|592732065|FG002|Core Study|Adverse Event|1|||
164100054|NCT00473330|592732063|FG000|Core Study|Death|6|||
164100055|NCT00473330|592732064|FG001|Core Study|Death|4|||
164100056|NCT00473330|592732065|FG002|Core Study|Death|4|||
164100057|NCT00473330|592732063|FG000|Core Study|Lost to Follow-up|5|||
164100058|NCT00473330|592732064|FG001|Core Study|Lost to Follow-up|5|||
164100059|NCT00473330|592732065|FG002|Core Study|Lost to Follow-up|10|||
164100060|NCT00473330|592732063|FG000|Core Study|Physician Decision|2|||
164100061|NCT00473330|592732064|FG001|Core Study|Physician Decision|1|||
164100062|NCT00473330|592732065|FG002|Core Study|Physician Decision|3|||
164100063|NCT00473330|592732063|FG000|Core Study|Subject Non-compliance|1|||
164100064|NCT00473330|592732064|FG001|Core Study|Subject Non-compliance|2|||
164100065|NCT00473330|592732065|FG002|Core Study|Subject Non-compliance|1|||
164100066|NCT00473330|592732063|FG000|Core Study|Subject Required Other Therapy|0|||
164051220|NCT04191096|592545116|FG001|Overall Study|Withdrawal by Subject|5|||
164051221|NCT04191096|592545115|FG000|Overall Study|Participants Ongoing|518|||
164051222|NCT04191096|592545116|FG001|Overall Study|Participants Ongoing|530|||
164051223|NCT02598661|592545120|FG000|Overall Study|Death|27|||
164051224|NCT02598661|592545121|FG001|Overall Study|Death|34|||
164051225|NCT02598661|592545122|FG002|Overall Study|Death|14|||
164051226|NCT02598661|592545123|FG003|Overall Study|Death|1|||
164051227|NCT02598661|592545124|FG004|Overall Study|Death|0|||
164051228|NCT02598661|592545120|FG000|Overall Study|Lost to Follow-up|2|||
164051229|NCT02598661|592545121|FG001|Overall Study|Lost to Follow-up|3|||
164051230|NCT02598661|592545122|FG002|Overall Study|Lost to Follow-up|2|||
164051231|NCT02598661|592545123|FG003|Overall Study|Lost to Follow-up|0|||
164051232|NCT02598661|592545124|FG004|Overall Study|Lost to Follow-up|0|||
164051233|NCT02598661|592545120|FG000|Overall Study|Withdrawal by Subject|13|||
164051234|NCT02598661|592545121|FG001|Overall Study|Withdrawal by Subject|24|||
164051235|NCT02598661|592545122|FG002|Overall Study|Withdrawal by Subject|14|||
164051236|NCT02598661|592545123|FG003|Overall Study|Withdrawal by Subject|1|||
164051237|NCT02598661|592545124|FG004|Overall Study|Withdrawal by Subject|1|||
164051238|NCT02598661|592545120|FG000|Overall Study|Adverse Event|0|||
164051239|NCT02598661|592545121|FG001|Overall Study|Adverse Event|0|||
164051240|NCT02598661|592545122|FG002|Overall Study|Adverse Event|1|||
164051241|NCT02598661|592545123|FG003|Overall Study|Adverse Event|0|||
164051242|NCT02598661|592545124|FG004|Overall Study|Adverse Event|0|||
164051243|NCT02598661|592545120|FG000|Overall Study|Randomized, Never Treated|0|||
164051244|NCT02598661|592545121|FG001|Overall Study|Randomized, Never Treated|0|||
164051245|NCT02598661|592545122|FG002|Overall Study|Randomized, Never Treated|0|||
164051246|NCT02598661|592545123|FG003|Overall Study|Randomized, Never Treated|0|||
164051247|NCT02598661|592545124|FG004|Overall Study|Randomized, Never Treated|1|||
164051248|NCT00027027|592546758|FG000|Overall Study|Adverse Event|0|||
164051249|NCT00027027|592546759|FG001|Overall Study|Adverse Event|0|||
164051250|NCT00027027|592546760|FG002|Overall Study|Adverse Event|1|||
164051251|NCT00027027|592546761|FG003|Overall Study|Adverse Event|0|||
164051252|NCT00027027|592546762|FG004|Overall Study|Adverse Event|1|||
164051253|NCT00027027|592546758|FG000|Overall Study|Admitted for Signs of PD|0|||
164051254|NCT00027027|592546759|FG001|Overall Study|Admitted for Signs of PD|0|||
164051255|NCT00027027|592546760|FG002|Overall Study|Admitted for Signs of PD|0|||
164051256|NCT00027027|592546761|FG003|Overall Study|Admitted for Signs of PD|0|||
164051257|NCT00027027|592546762|FG004|Overall Study|Admitted for Signs of PD|1|||
164051258|NCT00027027|592546758|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
164051259|NCT00027027|592546759|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
164051260|NCT00027027|592546760|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
164051261|NCT00027027|592546761|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
164051262|NCT00027027|592546762|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
164051263|NCT00027027|592546758|FG000|Overall Study|PD Requiring Surgery|0|||
164051264|NCT00027027|592546759|FG001|Overall Study|PD Requiring Surgery|0|||
164051265|NCT00027027|592546760|FG002|Overall Study|PD Requiring Surgery|1|||
164051266|NCT00027027|592546761|FG003|Overall Study|PD Requiring Surgery|0|||
164051267|NCT00027027|592546762|FG004|Overall Study|PD Requiring Surgery|0|||
164051268|NCT00027027|592546758|FG000|Overall Study|Physician Decision Due To PD|2|||
164051269|NCT00027027|592546759|FG001|Overall Study|Physician Decision Due To PD|3|||
164051270|NCT00027027|592546760|FG002|Overall Study|Physician Decision Due To PD|2|||
164051271|NCT00027027|592546761|FG003|Overall Study|Physician Decision Due To PD|3|||
164051272|NCT00027027|592546762|FG004|Overall Study|Physician Decision Due To PD|5|||
164051273|NCT00027027|592546758|FG000|Overall Study|Withdrawal by Subject|0|||
164051274|NCT00027027|592546759|FG001|Overall Study|Withdrawal by Subject|0|||
164051275|NCT00027027|592546760|FG002|Overall Study|Withdrawal by Subject|0|||
164051276|NCT00027027|592546761|FG003|Overall Study|Withdrawal by Subject|0|||
164051277|NCT00027027|592546762|FG004|Overall Study|Withdrawal by Subject|1|||
164051278|NCT00003389|592546766|FG000|Overall Study|Disease progression|6|||
164051279|NCT00003389|592546767|FG001|Overall Study|Disease progression|1|||
164051280|NCT00003389|592546766|FG000|Overall Study|Adverse Event|13|||
164051281|NCT00003389|592546767|FG001|Overall Study|Adverse Event|2|||
164051282|NCT00003389|592546766|FG000|Overall Study|Death|0|||
164051283|NCT00003389|592546767|FG001|Overall Study|Death|3|||
164051284|NCT00003389|592546766|FG000|Overall Study|Withdrawal by Subject|12|||
164051285|NCT00003389|592546767|FG001|Overall Study|Withdrawal by Subject|5|||
164051286|NCT00003389|592546766|FG000|Overall Study|Alternative therapy|2|||
164051287|NCT00003389|592546767|FG001|Overall Study|Alternative therapy|1|||
164051288|NCT00003389|592546766|FG000|Overall Study|Complicating disease|1|||
164051289|NCT00003389|592546767|FG001|Overall Study|Complicating disease|0|||
164051290|NCT00003389|592546766|FG000|Overall Study|Off-treatment reason missing|31|||
164051291|NCT00003389|592546767|FG001|Overall Study|Off-treatment reason missing|21|||
164051292|NCT00003389|592546766|FG000|Overall Study|Ineligible|33|||
164051293|NCT00003389|592546767|FG001|Overall Study|Ineligible|27|||
164051294|NCT05158244|592546776|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
164051295|NCT05158244|592546777|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164051296|NCT05158244|592546778|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164051297|NCT05158244|592546779|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164051298|NCT05158244|592546780|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
164051299|NCT05158244|592546776|FG000|Overall Study|Withdrawal by Subject|0|||
164051300|NCT05158244|592546777|FG001|Overall Study|Withdrawal by Subject|0|||
164051301|NCT05158244|592546778|FG002|Overall Study|Withdrawal by Subject|1|||
164051302|NCT05158244|592546779|FG003|Overall Study|Withdrawal by Subject|0|||
164051303|NCT05158244|592546780|FG004|Overall Study|Withdrawal by Subject|0|||
164051304|NCT00775138|592546781|FG000|Overall Study|Withdrawal by Subject|0|||
164051305|NCT00775138|592546782|FG001|Overall Study|Withdrawal by Subject|0|||
164051306|NCT00775138|592546783|FG002|Overall Study|Withdrawal by Subject|2|||
164051307|NCT00775138|592546784|FG003|Overall Study|Withdrawal by Subject|2|||
164051308|NCT00775138|592546781|FG000|Overall Study|Adverse Event|0|||
164051309|NCT00775138|592546782|FG001|Overall Study|Adverse Event|0|||
164051310|NCT00775138|592546783|FG002|Overall Study|Adverse Event|1|||
164051311|NCT00775138|592546784|FG003|Overall Study|Adverse Event|0|||
164051312|NCT00712712|592546787|FG000|Overall Study|Protocol Violation|11|||
164051313|NCT00712712|592546787|FG000|Overall Study|Radiofrequency not done|3|||
164051314|NCT00712712|592546787|FG000|Overall Study|Death|8|||
164051315|NCT00712712|592546787|FG000|Overall Study|Withdrawal by Subject|1|||
164051316|NCT02723019|592546788|FG000|Overall Study|Death|17|||
164051317|NCT02723019|592546789|FG001|Overall Study|Death|13|||
164051318|NCT02723019|592546788|FG000|Overall Study|Withdrawal by Subject|11|||
164051319|NCT02723019|592546789|FG001|Overall Study|Withdrawal by Subject|7|||
164051320|NCT02723019|592546788|FG000|Overall Study|Lost to Follow-up|57|||
164051321|NCT02723019|592546789|FG001|Overall Study|Lost to Follow-up|70|||
164051322|NCT00611767|592546791|FG000|Overall Study|Withdrawal by Subject|4|||
164051323|NCT00611767|592546792|FG001|Overall Study|Withdrawal by Subject|1|||
164051324|NCT00611767|592546791|FG000|Overall Study|Thiopental not available|3|||
164051325|NCT00611767|592546792|FG001|Overall Study|Thiopental not available|0|||
164051326|NCT00611767|592546791|FG000|Overall Study|didn't like the medication|1|||
164051327|NCT00611767|592546792|FG001|Overall Study|didn't like the medication|1|||
164051328|NCT00611767|592546791|FG000|Overall Study|Physician Decision|1|||
164051329|NCT00611767|592546792|FG001|Overall Study|Physician Decision|0|||
164051330|NCT02718625|592546793|FG000|Overall Study|Adverse Event|0|||
164051331|NCT02718625|592546794|FG001|Overall Study|Adverse Event|1|||
164051332|NCT02718625|592546793|FG000|Overall Study|Termination of Study by Sponsor|0|||
164051333|NCT02718625|592546794|FG001|Overall Study|Termination of Study by Sponsor|1|||
164051334|NCT00811395|592546795|FG000|Extension Treatment|Adverse Event|1|||
164051335|NCT00811395|592546796|FG001|Extension Treatment|Adverse Event|2|||
164051336|NCT00811395|592546797|FG002|Extension Treatment|Adverse Event|2|||
164051337|NCT00811395|592546798|FG003|Extension Treatment|Adverse Event|2|||
164051338|NCT00811395|592546799|FG004|Extension Treatment|Adverse Event|0|||
164051339|NCT00811395|592546800|FG005|Extension Treatment|Adverse Event|1|||
164051340|NCT00811395|592546795|FG000|Extension Treatment|Progressive disease|1|||
164051341|NCT00811395|592546796|FG001|Extension Treatment|Progressive disease|1|||
164051342|NCT00811395|592546797|FG002|Extension Treatment|Progressive disease|0|||
164051343|NCT00811395|592546798|FG003|Extension Treatment|Progressive disease|0|||
164051344|NCT00811395|592546799|FG004|Extension Treatment|Progressive disease|0|||
164051345|NCT00811395|592546800|FG005|Extension Treatment|Progressive disease|0|||
164051346|NCT00811395|592546795|FG000|Extension Treatment|Participant did not wish to continue|0|||
164051347|NCT00811395|592546796|FG001|Extension Treatment|Participant did not wish to continue|3|||
164051348|NCT00811395|592546797|FG002|Extension Treatment|Participant did not wish to continue|0|||
164051349|NCT00811395|592546798|FG003|Extension Treatment|Participant did not wish to continue|1|||
164051350|NCT00811395|592546799|FG004|Extension Treatment|Participant did not wish to continue|0|||
164051351|NCT00811395|592546800|FG005|Extension Treatment|Participant did not wish to continue|1|||
164051352|NCT00811395|592546795|FG000|Extension Treatment|Other than above|0|||
164051353|NCT00811395|592546796|FG001|Extension Treatment|Other than above|0|||
164051354|NCT00811395|592546797|FG002|Extension Treatment|Other than above|1|||
164051355|NCT00811395|592546798|FG003|Extension Treatment|Other than above|0|||
164051356|NCT00811395|592546799|FG004|Extension Treatment|Other than above|0|||
164051357|NCT00811395|592546800|FG005|Extension Treatment|Other than above|0|||
164051358|NCT01947127|592546805|FG000|Overall Study|Protocol Violation|18|||
164051359|NCT01947127|592546806|FG001|Overall Study|Protocol Violation|38|||
164051360|NCT01947127|592546805|FG000|Overall Study|Withdrawal by Subject|1|||
164051361|NCT01947127|592546806|FG001|Overall Study|Withdrawal by Subject|1|||
164051362|NCT01947127|592546805|FG000|Overall Study|Data loss|4|||
164051363|NCT01947127|592546806|FG001|Overall Study|Data loss|4|||
164051364|NCT00170846|592546807|FG000|Overall Study|Subject withdrew Informed Consent|5|||
164051365|NCT00170846|592546808|FG001|Overall Study|Subject withdrew Informed Consent|12|||
164051366|NCT00170846|592546809|FG002|Overall Study|Subject withdrew Informed Consent|8|||
164051367|NCT00170846|592546807|FG000|Overall Study|Lost to Follow-up|6|||
164051368|NCT00170846|592546808|FG001|Overall Study|Lost to Follow-up|3|||
164051369|NCT00170846|592546809|FG002|Overall Study|Lost to Follow-up|2|||
164051370|NCT00170846|592546807|FG000|Overall Study|Death|0|||
164100067|NCT00473330|592732064|FG001|Core Study|Subject Required Other Therapy|1|||
164100068|NCT00473330|592732065|FG002|Core Study|Subject Required Other Therapy|3|||
164100069|NCT00473330|592732063|FG000|Core Study|Subject's Decision|9|||
164100070|NCT00473330|592732064|FG001|Core Study|Subject's Decision|8|||
164100071|NCT00473330|592732065|FG002|Core Study|Subject's Decision|19|||
164100072|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
164100073|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
164100074|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
164100075|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Death|2|||
164100076|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Death|0|||
164100077|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Death|0|||
164100078|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
164100079|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
164100080|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
164100081|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
164100082|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
164100083|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
164100084|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
164100085|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
164100086|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
164100087|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
164100088|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
164100089|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
164100090|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
164100091|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
164100092|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
164100093|NCT00473330|592732063|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
164100094|NCT00473330|592732064|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
164100095|NCT00473330|592732065|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
164100096|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
164100097|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
164051371|NCT00170846|592546808|FG001|Overall Study|Death|3|||
164051372|NCT00170846|592546809|FG002|Overall Study|Death|3|||
164051373|NCT00170846|592546807|FG000|Overall Study|Reason Missing|0|||
164051374|NCT00170846|592546808|FG001|Overall Study|Reason Missing|1|||
164051375|NCT00170846|592546809|FG002|Overall Study|Reason Missing|0|||
164051376|NCT01021553|592546810|FG000|Overall Study|Adverse Event|1|||
164051377|NCT01021553|592546811|FG001|Overall Study|Adverse Event|0|||
164051378|NCT01021553|592546812|FG002|Overall Study|Adverse Event|0|||
164051379|NCT01021553|592546810|FG000|Overall Study|Lack of Efficacy|2|||
164051380|NCT01021553|592546811|FG001|Overall Study|Lack of Efficacy|2|||
164051381|NCT01021553|592546812|FG002|Overall Study|Lack of Efficacy|0|||
164051382|NCT01021553|592546810|FG000|Overall Study|Protocol Violation|0|||
164051383|NCT01021553|592546811|FG001|Overall Study|Protocol Violation|2|||
164051384|NCT01021553|592546812|FG002|Overall Study|Protocol Violation|2|||
164051385|NCT01021553|592546810|FG000|Overall Study|Lost to Follow-up|0|||
164051386|NCT01021553|592546811|FG001|Overall Study|Lost to Follow-up|0|||
164051387|NCT01021553|592546812|FG002|Overall Study|Lost to Follow-up|1|||
164051388|NCT01021553|592546810|FG000|Overall Study|Withdrawal by Subject|1|||
164051389|NCT01021553|592546811|FG001|Overall Study|Withdrawal by Subject|1|||
164051390|NCT01021553|592546812|FG002|Overall Study|Withdrawal by Subject|0|||
164051391|NCT01950364|592546813|FG000|Overall Study|Adverse Event|3|||
164051392|NCT01950364|592546814|FG001|Overall Study|Adverse Event|0|||
164051393|NCT01950364|592546813|FG000|Overall Study|Stem Cell Transplant|2|||
164051394|NCT01950364|592546814|FG001|Overall Study|Stem Cell Transplant|6|||
164051395|NCT01950364|592546813|FG000|Overall Study|Disease Progression|5|||
164051396|NCT01950364|592546814|FG001|Overall Study|Disease Progression|2|||
164051397|NCT01950364|592546813|FG000|Overall Study|Withdrawal by Subject|0|||
164100098|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
164100099|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Death|2|||
164100100|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Death|2|||
164100101|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Death|1|||
164100102|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
164051398|NCT01950364|592546814|FG001|Overall Study|Withdrawal by Subject|1|||
164051399|NCT01950364|592546813|FG000|Overall Study|Protocol Violation|0|||
164051400|NCT01950364|592546814|FG001|Overall Study|Protocol Violation|1|||
164051401|NCT01469637|592546815|FG000|First Intervention|Unacceptable behavior|0|||
164051402|NCT01469637|592546816|FG001|First Intervention|Unacceptable behavior|1|||
164051403|NCT01469637|592546815|FG000|Second Intervention|Incarcerated|1|||
164051404|NCT01469637|592546816|FG001|Second Intervention|Incarcerated|0|||
164051405|NCT00887913|592546817|FG000|Overall Study|Withdrawal by Subject|6|||
164051406|NCT00572728|592546826|FG000|Overall Study|Withdrawal by Subject|10|||
164051407|NCT00572728|592546826|FG000|Overall Study|Ineligible|3|||
164051408|NCT00572728|592546826|FG000|Overall Study|Enrolled under Amendment 4|5|||
164051409|NCT00572728|592546826|FG000|Overall Study|Offstudy due to complicating disease|1|||
164051410|NCT00572728|592546826|FG000|Overall Study|FLT1 not completed|4|||
164051411|NCT00572728|592546826|FG000|Overall Study|First Chemotherapy not initiated|2|||
164051412|NCT00572728|592546826|FG000|Overall Study|FLT2 not completed|5|||
164051413|NCT00572728|592546826|FG000|Overall Study|Second chemotherapy not initiated|1|||
164051414|NCT00572728|592546826|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
164051415|NCT00572728|592546826|FG000|Overall Study|Pathology missing|1|||
164051416|NCT01833806|592546829|FG000|Overall Study|Alternative treatment|2|||
164051417|NCT01833806|592546829|FG000|Overall Study|Death|5|||
164051418|NCT01833806|592546829|FG000|Overall Study|Physician Decision|1|||
164051419|NCT01833806|592546829|FG000|Overall Study|Lost to Follow-up|1|||
164051420|NCT00415623|592546833|FG000|Overall Study|Adverse Event|3|||
164051421|NCT00415623|592546834|FG001|Overall Study|Adverse Event|4|||
164051422|NCT00415623|592546833|FG000|Overall Study|Death|1|||
164051423|NCT00415623|592546834|FG001|Overall Study|Death|0|||
164051424|NCT00415623|592546833|FG000|Overall Study|Withdrawal by Subject|1|||
164051425|NCT00415623|592546834|FG001|Overall Study|Withdrawal by Subject|1|||
164051426|NCT01708915|592546837|FG000|Overall Study|Adverse Event|1|||
164051427|NCT01708915|592546838|FG001|Overall Study|Adverse Event|0|||
164051428|NCT01708915|592546839|FG002|Overall Study|Adverse Event|9|||
164051429|NCT01708915|592546840|FG003|Overall Study|Adverse Event|13|||
164051430|NCT01708915|592546837|FG000|Overall Study|Lack of Efficacy|84|||
164051431|NCT01708915|592546838|FG001|Overall Study|Lack of Efficacy|60|||
164051432|NCT01708915|592546839|FG002|Overall Study|Lack of Efficacy|35|||
164051433|NCT01708915|592546840|FG003|Overall Study|Lack of Efficacy|15|||
164051434|NCT01708915|592546837|FG000|Overall Study|Protocol Violation|0|||
164051435|NCT01708915|592546838|FG001|Overall Study|Protocol Violation|0|||
164051436|NCT01708915|592546839|FG002|Overall Study|Protocol Violation|0|||
164051437|NCT01708915|592546840|FG003|Overall Study|Protocol Violation|1|||
164051438|NCT01708915|592546837|FG000|Overall Study|Withdrawal by Subject|0|||
164051439|NCT01708915|592546838|FG001|Overall Study|Withdrawal by Subject|1|||
164051440|NCT01708915|592546839|FG002|Overall Study|Withdrawal by Subject|2|||
164051441|NCT01708915|592546840|FG003|Overall Study|Withdrawal by Subject|2|||
164051442|NCT01708915|592546837|FG000|Overall Study|Other reasons than stated above|1|||
164051443|NCT01708915|592546838|FG001|Overall Study|Other reasons than stated above|1|||
164051444|NCT01708915|592546839|FG002|Overall Study|Other reasons than stated above|0|||
164051445|NCT01708915|592546840|FG003|Overall Study|Other reasons than stated above|2|||
164051446|NCT03267576|592546841|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
164051447|NCT03267576|592546842|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
164051448|NCT03267576|592546841|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
164051449|NCT03267576|592546842|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
164051450|NCT02382276|592546847|FG000|Overall Study|Withdrawal by Subject|4|||
164051451|NCT02382276|592546848|FG001|Overall Study|Withdrawal by Subject|8|||
164051452|NCT02382276|592546849|FG002|Overall Study|Withdrawal by Subject|5|||
164051453|NCT02382276|592546847|FG000|Overall Study|Adverse Event|7|||
164051454|NCT02382276|592546848|FG001|Overall Study|Adverse Event|2|||
164051455|NCT02382276|592546849|FG002|Overall Study|Adverse Event|32|||
164051456|NCT02382276|592546847|FG000|Overall Study|Physician Decision|0|||
164051457|NCT02382276|592546848|FG001|Overall Study|Physician Decision|0|||
164051458|NCT02382276|592546849|FG002|Overall Study|Physician Decision|2|||
164051459|NCT01987609|592546854|FG000|Overall Study|Adverse Event|1|||
164051460|NCT01066546|592546855|FG000|Overall Study|Study terminated by sponsor|5|||
164051461|NCT03452397|592546860|FG000|Overall Study|Adverse Event|1|||
164051462|NCT03452397|592546861|FG001|Overall Study|Adverse Event|0|||
164051463|NCT03452397|592546862|FG002|Overall Study|Adverse Event|0|||
164051464|NCT03452397|592546863|FG003|Overall Study|Adverse Event|0|||
164051465|NCT03452397|592546860|FG000|Overall Study|Administrative reason|0|||
164051466|NCT03452397|592546861|FG001|Overall Study|Administrative reason|0|||
164051467|NCT03452397|592546862|FG002|Overall Study|Administrative reason|1|||
164051468|NCT03452397|592546863|FG003|Overall Study|Administrative reason|1|||
164051469|NCT03452397|592546860|FG000|Overall Study|Withdrawal by Subject|0|||
164051470|NCT03452397|592546861|FG001|Overall Study|Withdrawal by Subject|0|||
164051471|NCT03452397|592546862|FG002|Overall Study|Withdrawal by Subject|1|||
164051472|NCT03452397|592546863|FG003|Overall Study|Withdrawal by Subject|0|||
164051473|NCT00125268|592546864|FG000|Overall Study|Withdrawal by Subject|1|||
164051474|NCT00125268|592546865|FG001|Overall Study|Withdrawal by Subject|1|||
164051475|NCT00925522|592546866|FG000|Overall Study|study closed -- business decision|20|||
164051476|NCT02561572|592546867|FG000|Overall Study|Inadequate time before surgery|2|||
164051477|NCT02561572|592546868|FG001|Overall Study|Inadequate time before surgery|1|||
164051478|NCT02561572|592546867|FG000|Overall Study|Protocol Violation|0|||
164051479|NCT02561572|592546868|FG001|Overall Study|Protocol Violation|1|||
164051480|NCT02691468|592546869|FG000|Overall Study|Bronchial blocker use|2|||
164051481|NCT02691468|592546870|FG001|Overall Study|Bronchial blocker use|1|||
164051482|NCT02691468|592546869|FG000|Overall Study|Lost to Follow-up|2|||
164051483|NCT02691468|592546870|FG001|Overall Study|Lost to Follow-up|1|||
164051484|NCT02691468|592546869|FG000|Overall Study|Failure to advance FOB|2|||
164051485|NCT02691468|592546870|FG001|Overall Study|Failure to advance FOB|0|||
164051486|NCT01190020|592546873|FG000|Overall Study|Adverse Event|2|||
164051487|NCT01190020|592546874|FG001|Overall Study|Adverse Event|0|||
164051488|NCT01190020|592546873|FG000|Overall Study|Lost to Follow-up|2|||
164051489|NCT01190020|592546874|FG001|Overall Study|Lost to Follow-up|0|||
164051490|NCT01190020|592546873|FG000|Overall Study|Withdrawal by Subject|3|||
164051491|NCT01190020|592546874|FG001|Overall Study|Withdrawal by Subject|0|||
164051492|NCT00656799|592546877|FG000|Overall Study|Death|2|||
164051493|NCT02422186|592546878|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
164051494|NCT02422186|592546879|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
164051495|NCT02422186|592546878|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
164051496|NCT02422186|592546879|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
164051497|NCT02422186|592546878|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
164051498|NCT02422186|592546879|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
164051499|NCT02422186|592546878|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
164051500|NCT02422186|592546879|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
164051501|NCT02422186|592546878|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
164051502|NCT02422186|592546879|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
164051503|NCT02422186|592546878|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
164051504|NCT02422186|592546879|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
164051505|NCT02422186|592546878|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
164051506|NCT02422186|592546879|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
164051507|NCT02422186|592546878|FG000|Follow-up Phase (2 Weeks)|Other|3|||
164051508|NCT02422186|592546879|FG001|Follow-up Phase (2 Weeks)|Other|0|||
164051509|NCT05281094|592546880|FG000|Overall Study|Adverse Event|1|||
164051510|NCT05281094|592546881|FG001|Overall Study|Adverse Event|0|||
164051511|NCT05281094|592546880|FG000|Overall Study|Lost to Follow-up|29|||
164051512|NCT05281094|592546881|FG001|Overall Study|Lost to Follow-up|22|||
164051513|NCT05281094|592546880|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
164051514|NCT05281094|592546881|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
164051515|NCT05281094|592546880|FG000|Overall Study|Death|1|||
164051516|NCT05281094|592546881|FG001|Overall Study|Death|2|||
164051517|NCT05281094|592546880|FG000|Overall Study|Not pre-specified reason|8|||
164051518|NCT05281094|592546881|FG001|Overall Study|Not pre-specified reason|5|||
164051519|NCT02683668|592546892|FG000|Period 2|Withdrawal by Subject|0|||
164051520|NCT02683668|592546893|FG001|Period 2|Withdrawal by Subject|1|||
164051521|NCT02683668|592546894|FG002|Period 2|Withdrawal by Subject|0|||
164051522|NCT04223778|592546895|FG000|Overall Study|Death|1|||
164051523|NCT04223778|592546896|FG001|Overall Study|Death|1|||
164051524|NCT04223778|592546895|FG000|Overall Study|Lost to Follow-up|4|||
164051525|NCT04223778|592546896|FG001|Overall Study|Lost to Follow-up|5|||
164051526|NCT04223778|592546895|FG000|Overall Study|Physician Decision|10|||
164051527|NCT04223778|592546896|FG001|Overall Study|Physician Decision|6|||
164051528|NCT04223778|592546895|FG000|Overall Study|Withdrawal by Subject|35|||
164051529|NCT04223778|592546896|FG001|Overall Study|Withdrawal by Subject|17|||
164051530|NCT04223778|592546895|FG000|Overall Study|Not Reported|7|||
164051531|NCT04223778|592546896|FG001|Overall Study|Not Reported|8|||
164051532|NCT03893630|592546899|FG000|Overall Study|Lost to Follow-up|5|||
164051533|NCT03893630|592546900|FG001|Overall Study|Lost to Follow-up|4|||
164051534|NCT03893630|592546901|FG002|Overall Study|Lost to Follow-up|2|||
164051535|NCT03893630|592546899|FG000|Overall Study|Withdrawal by Subject|3|||
164051536|NCT03893630|592546900|FG001|Overall Study|Withdrawal by Subject|6|||
164051537|NCT03893630|592546901|FG002|Overall Study|Withdrawal by Subject|3|||
164051538|NCT03893630|592546899|FG000|Overall Study|Discontinued Intervention|0|||
164051539|NCT03893630|592546900|FG001|Overall Study|Discontinued Intervention|4|||
164051540|NCT03893630|592546901|FG002|Overall Study|Discontinued Intervention|2|||
164051541|NCT02390167|592548754|FG000|Overall Study|Lost to Follow-up|1|||
164051542|NCT01265719|592548756|FG000|Overall Study|Does not meet entrance criteria|0|||
164051543|NCT01265719|592548757|FG001|Overall Study|Does not meet entrance criteria|3|||
164051544|NCT01265719|592548756|FG000|Overall Study|Other reasons|2|||
164051545|NCT01265719|592548757|FG001|Overall Study|Other reasons|0|||
164051546|NCT01265719|592548756|FG000|Overall Study|Withdrawal by Subject|8|||
164051547|NCT01265719|592548757|FG001|Overall Study|Withdrawal by Subject|3|||
164051548|NCT01265719|592548756|FG000|Overall Study|Lost to Follow-up|2|||
164051549|NCT01265719|592548757|FG001|Overall Study|Lost to Follow-up|7|||
164051550|NCT01265719|592548756|FG000|Overall Study|Adverse Event|2|||
164051551|NCT01265719|592548757|FG001|Overall Study|Adverse Event|0|||
164051552|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
164051553|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
164051554|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
164051555|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
164051556|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
164051557|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
164051558|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
164051559|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
164051560|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Death|0|||
164051561|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Death|0|||
164051562|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Death|0|||
164051563|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Death|1|||
164051564|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Death|1|||
164051565|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Death|0|||
164051566|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Death|2|||
164051567|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Death|0|||
164051568|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051569|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051570|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051571|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
164051572|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051573|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051574|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051575|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
164051576|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051577|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051578|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051579|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
164051580|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051581|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051582|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051583|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
164051584|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164051585|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164051586|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164051587|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
164051588|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164051589|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
164051590|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
164051591|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
164051592|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164051593|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164051594|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164051595|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
164051596|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164051597|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
164051598|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
164051599|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
164051600|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164051601|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164051602|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164051603|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164051604|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
164051605|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
164051606|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
164051607|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
164051608|NCT02442765|592548758|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164051609|NCT02442765|592548759|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164051610|NCT02442765|592548760|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164051611|NCT02442765|592548761|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164051612|NCT02442765|592548762|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
164051613|NCT02442765|592548763|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164051614|NCT02442765|592548764|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
164051615|NCT02442765|592548765|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
164051616|NCT01693562|592548769|FG000|Escalation Phase|Withdrawal by Subject|0|||
164051617|NCT01693562|592548770|FG001|Escalation Phase|Withdrawal by Subject|1|||
164051618|NCT01693562|592548771|FG002|Escalation Phase|Withdrawal by Subject|0|||
164051619|NCT01693562|592548772|FG003|Escalation Phase|Withdrawal by Subject|0|||
164051620|NCT01693562|592548773|FG004|Escalation Phase|Withdrawal by Subject|0|||
164051621|NCT01693562|592548774|FG005|Escalation Phase|Withdrawal by Subject|2|||
164051622|NCT01693562|592548775|FG006|Escalation Phase|Withdrawal by Subject|0|||
164051623|NCT01693562|592548776|FG007|Escalation Phase|Withdrawal by Subject|0|||
164051624|NCT01693562|592548777|FG008|Escalation Phase|Withdrawal by Subject|0|||
164051625|NCT01693562|592548778|FG009|Escalation Phase|Withdrawal by Subject|0|||
164051626|NCT01693562|592548779|FG010|Escalation Phase|Withdrawal by Subject|0|||
164051627|NCT01693562|592548780|FG011|Escalation Phase|Withdrawal by Subject|0|||
164051628|NCT01693562|592548781|FG012|Escalation Phase|Withdrawal by Subject|0|||
164100103|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
164100104|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
164100105|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
164100106|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
164100107|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
164100108|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
164100109|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
164100110|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
164100111|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
164100112|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
164100113|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
164100114|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
164100115|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
164100116|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
164100117|NCT00473330|592732063|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
164100118|NCT00473330|592732064|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
164100119|NCT00473330|592732065|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
164100120|NCT00336479|592732070|FG000|Overall Study|Adverse Event|8|||
164100121|NCT00336479|592732071|FG001|Overall Study|Adverse Event|11|||
164100122|NCT00336479|592732072|FG002|Overall Study|Adverse Event|18|||
164100123|NCT00336479|592732073|FG003|Overall Study|Adverse Event|4|||
164100124|NCT00336479|592732070|FG000|Overall Study|Noncompliant|1|||
164100125|NCT00336479|592732071|FG001|Overall Study|Noncompliant|7|||
164100126|NCT00336479|592732072|FG002|Overall Study|Noncompliant|3|||
164100127|NCT00336479|592732073|FG003|Overall Study|Noncompliant|0|||
164100128|NCT00336479|592732070|FG000|Overall Study|Physician Decision|2|||
164100129|NCT00336479|592732071|FG001|Overall Study|Physician Decision|3|||
164100130|NCT00336479|592732072|FG002|Overall Study|Physician Decision|1|||
164100131|NCT00336479|592732073|FG003|Overall Study|Physician Decision|0|||
164100132|NCT00336479|592732070|FG000|Overall Study|Lost to Follow-up|3|||
164100133|NCT00336479|592732071|FG001|Overall Study|Lost to Follow-up|2|||
164100134|NCT00336479|592732072|FG002|Overall Study|Lost to Follow-up|0|||
164100135|NCT00336479|592732073|FG003|Overall Study|Lost to Follow-up|0|||
164100136|NCT00336479|592732070|FG000|Overall Study|Withdrawal by Subject|3|||
164100137|NCT00336479|592732071|FG001|Overall Study|Withdrawal by Subject|2|||
164100138|NCT00336479|592732072|FG002|Overall Study|Withdrawal by Subject|3|||
164100139|NCT00336479|592732073|FG003|Overall Study|Withdrawal by Subject|0|||
164100140|NCT00336479|592732070|FG000|Overall Study|Other|0|||
164100141|NCT00336479|592732071|FG001|Overall Study|Other|0|||
164100142|NCT00336479|592732072|FG002|Overall Study|Other|1|||
164100143|NCT00336479|592732073|FG003|Overall Study|Other|0|||
164100144|NCT00336479|592732070|FG000|Overall Study|Virologic Stopping Rule|20|||
164100145|NCT00336479|592732071|FG001|Overall Study|Virologic Stopping Rule|0|||
164100146|NCT00336479|592732072|FG002|Overall Study|Virologic Stopping Rule|0|||
164100147|NCT00336479|592732073|FG003|Overall Study|Virologic Stopping Rule|0|||
164100148|NCT00846495|592732074|FG000|Overall Study|Lost to Follow-up|1|||
164100149|NCT00846495|592732075|FG001|Overall Study|Lost to Follow-up|0|||
164100150|NCT00846495|592732074|FG000|Overall Study|Adverse Event|5|||
164100151|NCT00846495|592732075|FG001|Overall Study|Adverse Event|1|||
164100152|NCT00846495|592732074|FG000|Overall Study|Lack of Efficacy|1|||
164100153|NCT00846495|592732075|FG001|Overall Study|Lack of Efficacy|2|||
164100154|NCT00846495|592732074|FG000|Overall Study|Physician Decision|1|||
164100155|NCT00846495|592732075|FG001|Overall Study|Physician Decision|0|||
164100156|NCT01079988|592732076|FG000|Overall Study|Lost to Follow-up|0|||
164100157|NCT01079988|592732077|FG001|Overall Study|Lost to Follow-up|0|||
164100158|NCT01079988|592732078|FG002|Overall Study|Lost to Follow-up|0|||
164100159|NCT01079988|592732079|FG003|Overall Study|Lost to Follow-up|1|||
164100160|NCT01079988|592732080|FG004|Overall Study|Lost to Follow-up|0|||
164100161|NCT01079988|592732076|FG000|Overall Study|Lack of Efficacy|1|||
164100162|NCT01079988|592732077|FG001|Overall Study|Lack of Efficacy|0|||
164100163|NCT01079988|592732078|FG002|Overall Study|Lack of Efficacy|0|||
164100164|NCT01079988|592732079|FG003|Overall Study|Lack of Efficacy|0|||
164100165|NCT01079988|592732080|FG004|Overall Study|Lack of Efficacy|0|||
164100166|NCT01079988|592732076|FG000|Overall Study|Other|0|||
164100167|NCT01079988|592732077|FG001|Overall Study|Other|0|||
164100168|NCT01079988|592732078|FG002|Overall Study|Other|0|||
164100169|NCT01079988|592732079|FG003|Overall Study|Other|2|||
164100170|NCT01079988|592732080|FG004|Overall Study|Other|1|||
164100171|NCT00468286|592732081|FG000|Overall Study|Adverse Event|1|||
164100172|NCT00468286|592732082|FG001|Overall Study|Adverse Event|6|||
164100173|NCT00468286|592732081|FG000|Overall Study|Protocol Violation|2|||
164100174|NCT00468286|592732082|FG001|Overall Study|Protocol Violation|2|||
164100175|NCT00468286|592732081|FG000|Overall Study|Withdrawal by Subject|4|||
164100176|NCT00468286|592732082|FG001|Overall Study|Withdrawal by Subject|3|||
164100177|NCT00468286|592732081|FG000|Overall Study|Physician Decision|0|||
164100178|NCT00468286|592732082|FG001|Overall Study|Physician Decision|1|||
164100179|NCT02196675|592732084|FG000|Overall Study|Withdrawal by Subject|1|||
164100180|NCT02196675|592732085|FG001|Overall Study|Withdrawal by Subject|0|||
164100181|NCT02196675|592732086|FG002|Overall Study|Withdrawal by Subject|0|||
164100182|NCT02196675|592732084|FG000|Overall Study|Intra-operative surgical exclusion|1|||
164100183|NCT02196675|592732085|FG001|Overall Study|Intra-operative surgical exclusion|1|||
164100184|NCT02196675|592732086|FG002|Overall Study|Intra-operative surgical exclusion|0|||
164100185|NCT02196675|592732084|FG000|Overall Study|Protocol Violation|0|||
164100186|NCT02196675|592732085|FG001|Overall Study|Protocol Violation|1|||
164100187|NCT02196675|592732086|FG002|Overall Study|Protocol Violation|0|||
164100188|NCT02196675|592732084|FG000|Overall Study|Death|0|||
164100189|NCT02196675|592732085|FG001|Overall Study|Death|0|||
164100190|NCT02196675|592732086|FG002|Overall Study|Death|1|||
164100191|NCT01265056|592732087|FG000|Initial Study Period|Withdrawal by Subject|1|||
164100192|NCT01265056|592732088|FG001|Initial Study Period|Withdrawal by Subject|1|||
164100193|NCT01265056|592732087|FG000|Initial Study Period|Withdrawal by Subject|1|||
164100194|NCT01265056|592732088|FG001|Initial Study Period|Withdrawal by Subject|1|||
164100195|NCT01265056|592732087|FG000|Follow up|Lost to Follow-up|7|||
164100196|NCT01265056|592732088|FG001|Follow up|Lost to Follow-up|3|||
164100197|NCT02711852|592732093|FG000|Overall Study|Death|5|||
164100198|NCT02711852|592732093|FG000|Overall Study|Lost to Follow-up|1|||
164100199|NCT02711852|592732093|FG000|Overall Study|Completed follow-up|3|||
164100200|NCT02711852|592732093|FG000|Overall Study|Withdrawal by Subject|1|||
164100201|NCT03459807|592732094|FG000|Overall Study|Withdrawal due to transplant|0|||
164051629|NCT01693562|592548782|FG013|Escalation Phase|Withdrawal by Subject|0|||
164051630|NCT01693562|592548783|FG014|Escalation Phase|Withdrawal by Subject|0|||
164051631|NCT01693562|592548784|FG015|Escalation Phase|Withdrawal by Subject|0|||
164100202|NCT03459807|592732095|FG001|Overall Study|Withdrawal due to transplant|1|||
164100203|NCT01417078|592732099|FG000|Overall Study|Withdrawal by Subject|1|||
164100204|NCT02392000|592732104|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
164100205|NCT02392000|592732104|FG000|Overall Study|Withdrawal by Subject|1|||
164100206|NCT02392000|592732104|FG000|Overall Study|Lost to Follow-up|8|||
164100207|NCT00833937|592732105|FG000|Washout|Withdrawal by Subject|1|||
164100208|NCT00833937|592732106|FG001|Washout|Withdrawal by Subject|0|||
164100209|NCT02612337|592732111|FG000|Overall Study|Lack of Efficacy|1|||
164100210|NCT02612337|592732112|FG001|Overall Study|Lack of Efficacy|0|||
164100211|NCT02612337|592732111|FG000|Overall Study|Withdrawal by Subject|2|||
164100212|NCT02612337|592732112|FG001|Overall Study|Withdrawal by Subject|2|||
164100213|NCT02612337|592732111|FG000|Overall Study|Did not receive study drug|0|||
164100214|NCT02612337|592732112|FG001|Overall Study|Did not receive study drug|1|||
164100215|NCT01697696|592732113|FG000|Overall Study|Study terminated by sponsor|0|||
164100216|NCT01697696|592732114|FG001|Overall Study|Study terminated by sponsor|3|||
164100217|NCT01697696|592732113|FG000|Overall Study|Protocol deviation|1|||
164100218|NCT01697696|592732114|FG001|Overall Study|Protocol deviation|0|||
164100219|NCT01697696|592732113|FG000|Overall Study|Physician Decision|1|||
164100220|NCT01697696|592732114|FG001|Overall Study|Physician Decision|0|||
164100221|NCT01697696|592732113|FG000|Overall Study|Death|4|||
164100222|NCT01697696|592732114|FG001|Overall Study|Death|2|||
164100223|NCT01697696|592732113|FG000|Overall Study|Lost to Follow-up|10|||
164100224|NCT01697696|592732114|FG001|Overall Study|Lost to Follow-up|7|||
164100225|NCT01697696|592732113|FG000|Overall Study|Subject/guardian decision|31|||
164100226|NCT01697696|592732114|FG001|Overall Study|Subject/guardian decision|35|||
164100227|NCT03616106|592732115|FG000|Overall Study|Removed by PI|6|||
164100228|NCT03616106|592732116|FG001|Overall Study|Removed by PI|0|||
164100229|NCT03616106|592732115|FG000|Overall Study|Withdrawal by Subject|1|||
164100230|NCT03616106|592732116|FG001|Overall Study|Withdrawal by Subject|1|||
164051632|NCT01693562|592548785|FG016|Escalation Phase|Withdrawal by Subject|0|||
164100231|NCT03616106|592732115|FG000|Overall Study|Lost to Follow-up|7|||
164100232|NCT03616106|592732116|FG001|Overall Study|Lost to Follow-up|0|||
164100233|NCT01880593|592732117|FG000|Overall Study|Adverse Event|1|||
164051633|NCT01693562|592548786|FG017|Escalation Phase|Withdrawal by Subject|0|||
164051634|NCT01693562|592548787|FG018|Escalation Phase|Withdrawal by Subject|0|||
164051635|NCT01693562|592548788|FG019|Escalation Phase|Withdrawal by Subject|0|||
164100234|NCT01880593|592732118|FG001|Overall Study|Adverse Event|0|||
164100235|NCT01880593|592732117|FG000|Overall Study|Lack of Efficacy|1|||
164100236|NCT01880593|592732118|FG001|Overall Study|Lack of Efficacy|5|||
164100237|NCT01880593|592732117|FG000|Overall Study|Withdrawal by Subject|6|||
164100238|NCT01880593|592732118|FG001|Overall Study|Withdrawal by Subject|1|||
164100239|NCT05275205|592732123|FG000|Overall Study|Adverse Event|1|||
164100240|NCT05275205|592732124|FG001|Overall Study|Adverse Event|2|||
164100241|NCT05275205|592732123|FG000|Overall Study|Physician Decision|1|||
164100242|NCT05275205|592732124|FG001|Overall Study|Physician Decision|1|||
164100243|NCT05275205|592732123|FG000|Overall Study|Withdrawal by Subject|2|||
164100244|NCT05275205|592732124|FG001|Overall Study|Withdrawal by Subject|3|||
164100245|NCT05275205|592732123|FG000|Overall Study|Death|1|||
164100246|NCT05275205|592732124|FG001|Overall Study|Death|0|||
164100247|NCT05275205|592732123|FG000|Overall Study|Patient unable to attend visits|1|||
164100248|NCT05275205|592732124|FG001|Overall Study|Patient unable to attend visits|0|||
164051636|NCT01693562|592548789|FG020|Escalation Phase|Withdrawal by Subject|0|||
164051637|NCT01693562|592548790|FG021|Escalation Phase|Withdrawal by Subject|0|||
164051638|NCT01693562|592548791|FG022|Escalation Phase|Withdrawal by Subject|0|||
164051639|NCT01693562|592548769|FG000|Escalation Phase|Death|4|||
164051640|NCT01693562|592548770|FG001|Escalation Phase|Death|2|||
164051641|NCT01693562|592548771|FG002|Escalation Phase|Death|0|||
164051642|NCT01693562|592548772|FG003|Escalation Phase|Death|3|||
164051643|NCT01693562|592548773|FG004|Escalation Phase|Death|6|||
164051644|NCT01693562|592548774|FG005|Escalation Phase|Death|4|||
164051645|NCT01693562|592548775|FG006|Escalation Phase|Death|0|||
164051646|NCT01693562|592548776|FG007|Escalation Phase|Death|0|||
164051647|NCT01693562|592548777|FG008|Escalation Phase|Death|0|||
164051648|NCT01693562|592548778|FG009|Escalation Phase|Death|0|||
164051649|NCT01693562|592548779|FG010|Escalation Phase|Death|0|||
164051650|NCT01693562|592548780|FG011|Escalation Phase|Death|0|||
164051651|NCT01693562|592548781|FG012|Escalation Phase|Death|0|||
164051652|NCT01693562|592548782|FG013|Escalation Phase|Death|0|||
164051653|NCT01693562|592548783|FG014|Escalation Phase|Death|0|||
164051654|NCT01693562|592548784|FG015|Escalation Phase|Death|0|||
164051655|NCT01693562|592548785|FG016|Escalation Phase|Death|0|||
164051656|NCT01693562|592548786|FG017|Escalation Phase|Death|0|||
164051657|NCT01693562|592548787|FG018|Escalation Phase|Death|0|||
164051658|NCT01693562|592548788|FG019|Escalation Phase|Death|0|||
164051659|NCT01693562|592548789|FG020|Escalation Phase|Death|0|||
164051660|NCT01693562|592548790|FG021|Escalation Phase|Death|0|||
164051661|NCT01693562|592548791|FG022|Escalation Phase|Death|0|||
164051662|NCT01693562|592548769|FG000|Escalation Phase|Lost to Follow-up|0|||
164051663|NCT01693562|592548770|FG001|Escalation Phase|Lost to Follow-up|1|||
164051664|NCT01693562|592548771|FG002|Escalation Phase|Lost to Follow-up|1|||
164051665|NCT01693562|592548772|FG003|Escalation Phase|Lost to Follow-up|0|||
164051666|NCT01693562|592548773|FG004|Escalation Phase|Lost to Follow-up|0|||
164051667|NCT01693562|592548774|FG005|Escalation Phase|Lost to Follow-up|0|||
164051668|NCT01693562|592548775|FG006|Escalation Phase|Lost to Follow-up|0|||
164051669|NCT01693562|592548776|FG007|Escalation Phase|Lost to Follow-up|0|||
164051670|NCT01693562|592548777|FG008|Escalation Phase|Lost to Follow-up|0|||
164051671|NCT01693562|592548778|FG009|Escalation Phase|Lost to Follow-up|0|||
164051672|NCT01693562|592548779|FG010|Escalation Phase|Lost to Follow-up|0|||
164051673|NCT01693562|592548780|FG011|Escalation Phase|Lost to Follow-up|0|||
164051674|NCT01693562|592548781|FG012|Escalation Phase|Lost to Follow-up|0|||
164051675|NCT01693562|592548782|FG013|Escalation Phase|Lost to Follow-up|0|||
164051676|NCT01693562|592548783|FG014|Escalation Phase|Lost to Follow-up|0|||
164051677|NCT01693562|592548784|FG015|Escalation Phase|Lost to Follow-up|0|||
164051678|NCT01693562|592548785|FG016|Escalation Phase|Lost to Follow-up|0|||
164051679|NCT01693562|592548786|FG017|Escalation Phase|Lost to Follow-up|0|||
164051680|NCT01693562|592548787|FG018|Escalation Phase|Lost to Follow-up|0|||
164051681|NCT01693562|592548788|FG019|Escalation Phase|Lost to Follow-up|0|||
164051682|NCT01693562|592548789|FG020|Escalation Phase|Lost to Follow-up|0|||
164051683|NCT01693562|592548790|FG021|Escalation Phase|Lost to Follow-up|0|||
164051684|NCT01693562|592548791|FG022|Escalation Phase|Lost to Follow-up|0|||
164051685|NCT01693562|592548769|FG000|Escalation Phase|Other|0|||
164051686|NCT01693562|592548770|FG001|Escalation Phase|Other|0|||
164051687|NCT01693562|592548771|FG002|Escalation Phase|Other|2|||
164051688|NCT01693562|592548772|FG003|Escalation Phase|Other|0|||
164051689|NCT01693562|592548773|FG004|Escalation Phase|Other|0|||
164051690|NCT01693562|592548774|FG005|Escalation Phase|Other|1|||
164051691|NCT01693562|592548775|FG006|Escalation Phase|Other|0|||
164051692|NCT01693562|592548776|FG007|Escalation Phase|Other|0|||
164051693|NCT01693562|592548777|FG008|Escalation Phase|Other|0|||
164051694|NCT01693562|592548778|FG009|Escalation Phase|Other|0|||
164051695|NCT01693562|592548779|FG010|Escalation Phase|Other|0|||
164051696|NCT01693562|592548780|FG011|Escalation Phase|Other|0|||
164051697|NCT01693562|592548781|FG012|Escalation Phase|Other|0|||
164051698|NCT01693562|592548782|FG013|Escalation Phase|Other|0|||
164051699|NCT01693562|592548783|FG014|Escalation Phase|Other|0|||
164051700|NCT01693562|592548784|FG015|Escalation Phase|Other|0|||
164051701|NCT01693562|592548785|FG016|Escalation Phase|Other|0|||
164051702|NCT01693562|592548786|FG017|Escalation Phase|Other|0|||
164051703|NCT01693562|592548787|FG018|Escalation Phase|Other|0|||
164051704|NCT01693562|592548788|FG019|Escalation Phase|Other|0|||
164051705|NCT01693562|592548789|FG020|Escalation Phase|Other|0|||
164051706|NCT01693562|592548790|FG021|Escalation Phase|Other|0|||
164051707|NCT01693562|592548791|FG022|Escalation Phase|Other|0|||
164051708|NCT01693562|592548769|FG000|Exploration Phase|Withdrawal by Subject|0|||
164051709|NCT01693562|592548770|FG001|Exploration Phase|Withdrawal by Subject|0|||
164051710|NCT01693562|592548771|FG002|Exploration Phase|Withdrawal by Subject|0|||
164051711|NCT01693562|592548772|FG003|Exploration Phase|Withdrawal by Subject|0|||
164051712|NCT01693562|592548773|FG004|Exploration Phase|Withdrawal by Subject|0|||
164051713|NCT01693562|592548774|FG005|Exploration Phase|Withdrawal by Subject|0|||
164051714|NCT01693562|592548775|FG006|Exploration Phase|Withdrawal by Subject|2|||
164051715|NCT01693562|592548776|FG007|Exploration Phase|Withdrawal by Subject|0|||
164051716|NCT01693562|592548777|FG008|Exploration Phase|Withdrawal by Subject|0|||
164051717|NCT01693562|592548778|FG009|Exploration Phase|Withdrawal by Subject|0|||
164051718|NCT01693562|592548779|FG010|Exploration Phase|Withdrawal by Subject|0|||
164051719|NCT01693562|592548780|FG011|Exploration Phase|Withdrawal by Subject|0|||
164051720|NCT01693562|592548781|FG012|Exploration Phase|Withdrawal by Subject|0|||
164051721|NCT01693562|592548782|FG013|Exploration Phase|Withdrawal by Subject|0|||
164051722|NCT01693562|592548783|FG014|Exploration Phase|Withdrawal by Subject|0|||
164051723|NCT01693562|592548784|FG015|Exploration Phase|Withdrawal by Subject|0|||
164051724|NCT01693562|592548785|FG016|Exploration Phase|Withdrawal by Subject|0|||
164051725|NCT01693562|592548786|FG017|Exploration Phase|Withdrawal by Subject|0|||
164051726|NCT01693562|592548787|FG018|Exploration Phase|Withdrawal by Subject|0|||
164051727|NCT01693562|592548788|FG019|Exploration Phase|Withdrawal by Subject|0|||
164051728|NCT01693562|592548789|FG020|Exploration Phase|Withdrawal by Subject|0|||
164051729|NCT01693562|592548790|FG021|Exploration Phase|Withdrawal by Subject|0|||
164051730|NCT01693562|592548791|FG022|Exploration Phase|Withdrawal by Subject|0|||
164051731|NCT01693562|592548769|FG000|Exploration Phase|Death|0|||
164051732|NCT01693562|592548770|FG001|Exploration Phase|Death|0|||
164051733|NCT01693562|592548771|FG002|Exploration Phase|Death|0|||
164051734|NCT01693562|592548772|FG003|Exploration Phase|Death|0|||
164051735|NCT01693562|592548773|FG004|Exploration Phase|Death|0|||
164051736|NCT01693562|592548774|FG005|Exploration Phase|Death|0|||
164051737|NCT01693562|592548775|FG006|Exploration Phase|Death|17|||
164051738|NCT01693562|592548776|FG007|Exploration Phase|Death|0|||
164051739|NCT01693562|592548777|FG008|Exploration Phase|Death|0|||
164051740|NCT01693562|592548778|FG009|Exploration Phase|Death|0|||
164051741|NCT01693562|592548779|FG010|Exploration Phase|Death|0|||
164051742|NCT01693562|592548780|FG011|Exploration Phase|Death|0|||
164051743|NCT01693562|592548781|FG012|Exploration Phase|Death|0|||
164051744|NCT01693562|592548782|FG013|Exploration Phase|Death|0|||
164051745|NCT01693562|592548783|FG014|Exploration Phase|Death|0|||
164051746|NCT01693562|592548784|FG015|Exploration Phase|Death|0|||
164051747|NCT01693562|592548785|FG016|Exploration Phase|Death|0|||
164051748|NCT01693562|592548786|FG017|Exploration Phase|Death|0|||
164051749|NCT01693562|592548787|FG018|Exploration Phase|Death|0|||
164051750|NCT01693562|592548788|FG019|Exploration Phase|Death|0|||
164051751|NCT01693562|592548789|FG020|Exploration Phase|Death|0|||
164051752|NCT01693562|592548790|FG021|Exploration Phase|Death|0|||
164051753|NCT01693562|592548791|FG022|Exploration Phase|Death|0|||
164051754|NCT01693562|592548769|FG000|Exploration Phase|Other|0|||
164051755|NCT01693562|592548770|FG001|Exploration Phase|Other|0|||
164051756|NCT01693562|592548771|FG002|Exploration Phase|Other|0|||
164051757|NCT01693562|592548772|FG003|Exploration Phase|Other|0|||
164051758|NCT01693562|592548773|FG004|Exploration Phase|Other|0|||
164051759|NCT01693562|592548774|FG005|Exploration Phase|Other|0|||
164051760|NCT01693562|592548775|FG006|Exploration Phase|Other|2|||
164051761|NCT01693562|592548776|FG007|Exploration Phase|Other|0|||
164051762|NCT01693562|592548777|FG008|Exploration Phase|Other|0|||
164051763|NCT01693562|592548778|FG009|Exploration Phase|Other|0|||
164051764|NCT01693562|592548779|FG010|Exploration Phase|Other|0|||
164051765|NCT01693562|592548780|FG011|Exploration Phase|Other|0|||
164051766|NCT01693562|592548781|FG012|Exploration Phase|Other|0|||
164051767|NCT01693562|592548782|FG013|Exploration Phase|Other|0|||
164051768|NCT01693562|592548783|FG014|Exploration Phase|Other|0|||
164051769|NCT01693562|592548784|FG015|Exploration Phase|Other|0|||
164051770|NCT01693562|592548785|FG016|Exploration Phase|Other|0|||
164051771|NCT01693562|592548786|FG017|Exploration Phase|Other|0|||
164051772|NCT01693562|592548787|FG018|Exploration Phase|Other|0|||
164051773|NCT01693562|592548788|FG019|Exploration Phase|Other|0|||
164051774|NCT01693562|592548789|FG020|Exploration Phase|Other|0|||
164051775|NCT01693562|592548790|FG021|Exploration Phase|Other|0|||
164051776|NCT01693562|592548791|FG022|Exploration Phase|Other|0|||
164051777|NCT01693562|592548769|FG000|Expansion Phase|Withdrawal by Subject|0|||
164051778|NCT01693562|592548770|FG001|Expansion Phase|Withdrawal by Subject|0|||
164051779|NCT01693562|592548771|FG002|Expansion Phase|Withdrawal by Subject|0|||
164051780|NCT01693562|592548772|FG003|Expansion Phase|Withdrawal by Subject|0|||
164051781|NCT01693562|592548773|FG004|Expansion Phase|Withdrawal by Subject|0|||
164051782|NCT01693562|592548774|FG005|Expansion Phase|Withdrawal by Subject|0|||
164051783|NCT01693562|592548775|FG006|Expansion Phase|Withdrawal by Subject|0|||
164051784|NCT01693562|592548776|FG007|Expansion Phase|Withdrawal by Subject|16|||
164051785|NCT01693562|592548777|FG008|Expansion Phase|Withdrawal by Subject|2|||
164051786|NCT01693562|592548778|FG009|Expansion Phase|Withdrawal by Subject|54|||
164051787|NCT01693562|592548779|FG010|Expansion Phase|Withdrawal by Subject|2|||
164051788|NCT01693562|592548780|FG011|Expansion Phase|Withdrawal by Subject|2|||
164051789|NCT01693562|592548781|FG012|Expansion Phase|Withdrawal by Subject|3|||
164051790|NCT01693562|592548782|FG013|Expansion Phase|Withdrawal by Subject|5|||
164051791|NCT01693562|592548783|FG014|Expansion Phase|Withdrawal by Subject|16|||
164051792|NCT01693562|592548784|FG015|Expansion Phase|Withdrawal by Subject|7|||
164051793|NCT01693562|592548785|FG016|Expansion Phase|Withdrawal by Subject|40|||
164051794|NCT01693562|592548786|FG017|Expansion Phase|Withdrawal by Subject|4|||
164051795|NCT01693562|592548787|FG018|Expansion Phase|Withdrawal by Subject|8|||
164051796|NCT01693562|592548788|FG019|Expansion Phase|Withdrawal by Subject|3|||
164051797|NCT01693562|592548789|FG020|Expansion Phase|Withdrawal by Subject|1|||
164051798|NCT01693562|592548790|FG021|Expansion Phase|Withdrawal by Subject|8|||
164051799|NCT01693562|592548791|FG022|Expansion Phase|Withdrawal by Subject|1|||
164100249|NCT03243630|592732126|FG000|Overall Study|Protocol Violation|1|||
164100250|NCT03243630|592732126|FG000|Overall Study|Physician Decision|1|||
164100251|NCT00939003|592732129|FG000|Double-blind Treatment Period|Adverse Event|1|||
164100252|NCT00939003|592732130|FG001|Double-blind Treatment Period|Adverse Event|1|||
164100253|NCT00939003|592732129|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164100254|NCT00939003|592732130|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
164100255|NCT00939003|592732129|FG000|Double-blind Treatment Period|Pregnancy|0|||
164100256|NCT00939003|592732130|FG001|Double-blind Treatment Period|Pregnancy|1|||
164100257|NCT00939003|592732129|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
164100258|NCT00939003|592732130|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
164100259|NCT00939003|592732129|FG000|Open-label Treatment Period|Adverse Event|4|||
164100260|NCT00939003|592732130|FG001|Open-label Treatment Period|Adverse Event|8|||
164100261|NCT00939003|592732129|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
164100262|NCT00939003|592732130|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
164100263|NCT00939003|592732129|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
164100264|NCT00939003|592732130|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
164100265|NCT00939003|592732129|FG000|Open-label Treatment Period|Pregnancy|1|||
164100266|NCT00939003|592732130|FG001|Open-label Treatment Period|Pregnancy|1|||
164100267|NCT00939003|592732129|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
164100268|NCT00939003|592732130|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
164100269|NCT00939003|592732129|FG000|Open-label Treatment Period|Site Closure|3|||
164100270|NCT00939003|592732130|FG001|Open-label Treatment Period|Site Closure|4|||
164100271|NCT03707912|592732131|FG000|Overall Study|Violation of inclusion criteria|1|||
164100272|NCT03707912|592732132|FG001|Overall Study|Violation of inclusion criteria|0|||
164100273|NCT02186821|592732138|FG000|Overall Study|Adverse Event|9|||
164100274|NCT02186821|592732138|FG000|Overall Study|Death|2|||
164051800|NCT01693562|592548769|FG000|Expansion Phase|Death|0|||
164051801|NCT01693562|592548770|FG001|Expansion Phase|Death|0|||
164051802|NCT01693562|592548771|FG002|Expansion Phase|Death|0|||
164051803|NCT01693562|592548772|FG003|Expansion Phase|Death|0|||
164051804|NCT01693562|592548773|FG004|Expansion Phase|Death|0|||
164051805|NCT01693562|592548774|FG005|Expansion Phase|Death|0|||
164051806|NCT01693562|592548775|FG006|Expansion Phase|Death|0|||
164051807|NCT01693562|592548776|FG007|Expansion Phase|Death|42|||
164051808|NCT01693562|592548777|FG008|Expansion Phase|Death|17|||
164051809|NCT01693562|592548778|FG009|Expansion Phase|Death|208|||
164051810|NCT01693562|592548779|FG010|Expansion Phase|Death|30|||
164051811|NCT01693562|592548780|FG011|Expansion Phase|Death|8|||
164051812|NCT01693562|592548781|FG012|Expansion Phase|Death|19|||
164051813|NCT01693562|592548782|FG013|Expansion Phase|Death|42|||
164051814|NCT01693562|592548783|FG014|Expansion Phase|Death|23|||
164051815|NCT01693562|592548784|FG015|Expansion Phase|Death|23|||
164051816|NCT01693562|592548785|FG016|Expansion Phase|Death|128|||
164051817|NCT01693562|592548786|FG017|Expansion Phase|Death|16|||
164051818|NCT01693562|592548787|FG018|Expansion Phase|Death|36|||
164051819|NCT01693562|592548788|FG019|Expansion Phase|Death|16|||
164051820|NCT01693562|592548789|FG020|Expansion Phase|Death|17|||
164051821|NCT01693562|592548790|FG021|Expansion Phase|Death|35|||
164051822|NCT01693562|592548791|FG022|Expansion Phase|Death|7|||
164051823|NCT01693562|592548769|FG000|Expansion Phase|Lost to Follow-up|0|||
164051824|NCT01693562|592548770|FG001|Expansion Phase|Lost to Follow-up|0|||
164051825|NCT01693562|592548771|FG002|Expansion Phase|Lost to Follow-up|0|||
164051826|NCT01693562|592548772|FG003|Expansion Phase|Lost to Follow-up|0|||
164051827|NCT01693562|592548773|FG004|Expansion Phase|Lost to Follow-up|0|||
164051828|NCT01693562|592548774|FG005|Expansion Phase|Lost to Follow-up|0|||
164051829|NCT01693562|592548775|FG006|Expansion Phase|Lost to Follow-up|0|||
164051830|NCT01693562|592548776|FG007|Expansion Phase|Lost to Follow-up|1|||
164051831|NCT01693562|592548777|FG008|Expansion Phase|Lost to Follow-up|2|||
164051832|NCT01693562|592548778|FG009|Expansion Phase|Lost to Follow-up|10|||
164051833|NCT01693562|592548779|FG010|Expansion Phase|Lost to Follow-up|4|||
164051834|NCT01693562|592548780|FG011|Expansion Phase|Lost to Follow-up|4|||
164100275|NCT02186821|592732138|FG000|Overall Study|Disease progression|32|||
164100276|NCT02186821|592732138|FG000|Overall Study|Protocol Violation|1|||
164100277|NCT02186821|592732138|FG000|Overall Study|Physician Decision|1|||
164051835|NCT01693562|592548781|FG012|Expansion Phase|Lost to Follow-up|1|||
164051836|NCT01693562|592548782|FG013|Expansion Phase|Lost to Follow-up|3|||
164051837|NCT01693562|592548783|FG014|Expansion Phase|Lost to Follow-up|0|||
164051838|NCT01693562|592548784|FG015|Expansion Phase|Lost to Follow-up|1|||
164051839|NCT01693562|592548785|FG016|Expansion Phase|Lost to Follow-up|1|||
164051840|NCT01693562|592548786|FG017|Expansion Phase|Lost to Follow-up|0|||
164051841|NCT01693562|592548787|FG018|Expansion Phase|Lost to Follow-up|2|||
164051842|NCT01693562|592548788|FG019|Expansion Phase|Lost to Follow-up|1|||
164051843|NCT01693562|592548789|FG020|Expansion Phase|Lost to Follow-up|2|||
164051844|NCT01693562|592548790|FG021|Expansion Phase|Lost to Follow-up|2|||
164051845|NCT01693562|592548791|FG022|Expansion Phase|Lost to Follow-up|1|||
164051846|NCT01693562|592548769|FG000|Expansion Phase|Other|0|||
164051847|NCT01693562|592548770|FG001|Expansion Phase|Other|0|||
164051848|NCT01693562|592548771|FG002|Expansion Phase|Other|0|||
164051849|NCT01693562|592548772|FG003|Expansion Phase|Other|0|||
164100278|NCT02186821|592732138|FG000|Overall Study|Study terminated by sponsor|2|||
164051850|NCT01693562|592548773|FG004|Expansion Phase|Other|0|||
164051851|NCT01693562|592548774|FG005|Expansion Phase|Other|0|||
164051852|NCT01693562|592548775|FG006|Expansion Phase|Other|0|||
164051853|NCT01693562|592548776|FG007|Expansion Phase|Other|3|||
164051854|NCT01693562|592548777|FG008|Expansion Phase|Other|1|||
164051855|NCT01693562|592548778|FG009|Expansion Phase|Other|28|||
164051856|NCT01693562|592548779|FG010|Expansion Phase|Other|4|||
164051857|NCT01693562|592548780|FG011|Expansion Phase|Other|7|||
164051858|NCT01693562|592548781|FG012|Expansion Phase|Other|0|||
164051859|NCT01693562|592548782|FG013|Expansion Phase|Other|1|||
164051860|NCT01693562|592548783|FG014|Expansion Phase|Other|1|||
164051861|NCT01693562|592548784|FG015|Expansion Phase|Other|0|||
164051862|NCT01693562|592548785|FG016|Expansion Phase|Other|28|||
164051863|NCT01693562|592548786|FG017|Expansion Phase|Other|0|||
164051864|NCT01693562|592548787|FG018|Expansion Phase|Other|1|||
164051865|NCT01693562|592548788|FG019|Expansion Phase|Other|0|||
164051866|NCT01693562|592548789|FG020|Expansion Phase|Other|1|||
164051867|NCT01693562|592548790|FG021|Expansion Phase|Other|17|||
164051868|NCT01693562|592548791|FG022|Expansion Phase|Other|1|||
164051869|NCT05466240|592548792|FG000|Overall Study|Adverse Event|1|||
164051870|NCT05466240|592548793|FG001|Overall Study|Adverse Event|0|||
164051871|NCT05466240|592548792|FG000|Overall Study|Withdrawal by Subject|1|||
164051872|NCT05466240|592548793|FG001|Overall Study|Withdrawal by Subject|0|||
164051873|NCT02759939|592548794|FG000|Overall Study|Missing data on first outcome assessed|11|||
164051874|NCT02759939|592548795|FG001|Overall Study|Missing data on first outcome assessed|2|||
164051875|NCT02759939|592548796|FG002|Overall Study|Missing data on first outcome assessed|5|||
164051876|NCT02759939|592548797|FG003|Overall Study|Missing data on first outcome assessed|2|||
164051877|NCT02759939|592548794|FG000|Overall Study|Ineligible for T2 and T3|310|||
164051878|NCT02759939|592548795|FG001|Overall Study|Ineligible for T2 and T3|179|||
164051879|NCT02759939|592548796|FG002|Overall Study|Ineligible for T2 and T3|366|||
164051880|NCT02759939|592548797|FG003|Overall Study|Ineligible for T2 and T3|391|||
164051881|NCT02759939|592548794|FG000|Overall Study|Lost to Follow-up|735|||
164051882|NCT02759939|592548795|FG001|Overall Study|Lost to Follow-up|791|||
164051883|NCT02759939|592548796|FG002|Overall Study|Lost to Follow-up|783|||
164051884|NCT02759939|592548797|FG003|Overall Study|Lost to Follow-up|650|||
164051885|NCT04735432|592548798|FG000|Overall Study|Other - due to personal reason|1|||
164051886|NCT04735432|592548799|FG001|Overall Study|Other - due to personal reason|0|||
164051887|NCT04735432|592548798|FG000|Overall Study|Adverse Event|2|||
164051888|NCT04735432|592548799|FG001|Overall Study|Adverse Event|0|||
164051889|NCT04397757|592548800|FG000|Overall Study|Death|3|||
164051890|NCT04397757|592548801|FG001|Overall Study|Death|11|||
164051891|NCT04397757|592548800|FG000|Overall Study|Withdrawal by Subject|2|||
164051892|NCT04397757|592548801|FG001|Overall Study|Withdrawal by Subject|0|||
164051893|NCT04397757|592548800|FG000|Overall Study|Lost to Follow-up|4|||
164051894|NCT04397757|592548801|FG001|Overall Study|Lost to Follow-up|3|||
164051895|NCT02306148|592548802|FG000|Overall Study|Adverse Event|12|||
164051896|NCT02306148|592548803|FG001|Overall Study|Adverse Event|6|||
164051897|NCT02306148|592548802|FG000|Overall Study|Lost to Follow-up|1|||
164051898|NCT02306148|592548803|FG001|Overall Study|Lost to Follow-up|4|||
164051899|NCT04657003|592548804|FG000|Overall Study|Adverse Event|5|||
164051900|NCT04657003|592548805|FG001|Overall Study|Adverse Event|1|||
164051901|NCT04657003|592548806|FG002|Overall Study|Adverse Event|5|||
164051902|NCT04657003|592548804|FG000|Overall Study|Death|0|||
164051903|NCT04657003|592548805|FG001|Overall Study|Death|2|||
164051904|NCT04657003|592548806|FG002|Overall Study|Death|0|||
164051905|NCT04657003|592548804|FG000|Overall Study|Lost to Follow-up|8|||
164051906|NCT04657003|592548805|FG001|Overall Study|Lost to Follow-up|4|||
164051907|NCT04657003|592548806|FG002|Overall Study|Lost to Follow-up|10|||
164051908|NCT04657003|592548804|FG000|Overall Study|Other - As Reported by Investigator|3|||
164051909|NCT04657003|592548805|FG001|Overall Study|Other - As Reported by Investigator|2|||
164051910|NCT04657003|592548806|FG002|Overall Study|Other - As Reported by Investigator|2|||
164051911|NCT04657003|592548804|FG000|Overall Study|Pregnancy|2|||
164051912|NCT04657003|592548805|FG001|Overall Study|Pregnancy|0|||
164051913|NCT04657003|592548806|FG002|Overall Study|Pregnancy|2|||
164051914|NCT04657003|592548804|FG000|Overall Study|Withdrawal by Subject|16|||
164051915|NCT04657003|592548805|FG001|Overall Study|Withdrawal by Subject|7|||
164051916|NCT04657003|592548806|FG002|Overall Study|Withdrawal by Subject|10|||
164051917|NCT02408016|592548808|FG000|Overall Study|Death|6|||
164051918|NCT02408016|592548809|FG001|Overall Study|Death|1|||
164051919|NCT02408016|592548810|FG002|Overall Study|Death|0|||
164051920|NCT02408016|592548808|FG000|Overall Study|Physician Decision|0|||
164051921|NCT02408016|592548809|FG001|Overall Study|Physician Decision|2|||
164051922|NCT02408016|592548810|FG002|Overall Study|Physician Decision|0|||
164051923|NCT03818399|592548811|FG000|Overall Study|Lost to Follow-up|11|||
164051924|NCT03818399|592548811|FG000|Overall Study|Withdrawal by Subject|1|||
164051925|NCT03818399|592548811|FG000|Overall Study|Protocol Violation|2|||
164051926|NCT02987205|592548813|FG000|Overall Study|Adverse Event|1|||
164051927|NCT02987205|592548813|FG000|Overall Study|Withdrawal by Subject|3|||
164051928|NCT02807376|592548815|FG000|Overall Study|Intra-operative exclusion criteria|3|||
164051929|NCT02807376|592548816|FG001|Overall Study|Intra-operative exclusion criteria|0|||
164100279|NCT01313780|592732142|FG000|Overall Study|Lack of Efficacy|4|||
164100280|NCT01313780|592732143|FG001|Overall Study|Lack of Efficacy|2|||
164100281|NCT01313780|592732142|FG000|Overall Study|Adverse Event|6|||
164100282|NCT01313780|592732143|FG001|Overall Study|Adverse Event|11|||
164100283|NCT01313780|592732142|FG000|Overall Study|Withdrawal by Subject|2|||
164100284|NCT01313780|592732143|FG001|Overall Study|Withdrawal by Subject|8|||
164100285|NCT01313780|592732142|FG000|Overall Study|Protocol Violation|10|||
164100286|NCT01313780|592732143|FG001|Overall Study|Protocol Violation|4|||
164100287|NCT01313780|592732142|FG000|Overall Study|missing data|3|||
164100288|NCT01313780|592732143|FG001|Overall Study|missing data|3|||
164100289|NCT01466166|592733350|FG000|Overall Study|Death|1|||
164100290|NCT01466166|592733350|FG000|Overall Study|Lost to Follow-up|7|||
164100291|NCT01466166|592733350|FG000|Overall Study|Infusion Reaction (IR)|27|||
164100292|NCT01466166|592733350|FG000|Overall Study|Adverse Event (Other than IR)|11|||
164100293|NCT01466166|592733350|FG000|Overall Study|Elevated Serum Uric Acid|78|||
164100294|NCT01466166|592733350|FG000|Overall Study|Withdrawal by Subject|13|||
164100295|NCT01466166|592733350|FG000|Overall Study|Sponsor Decision|4|||
164100296|NCT01466166|592733350|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
164100297|NCT01466166|592733350|FG000|Overall Study|Other|20|||
164100298|NCT02262377|592733351|FG000|Overall Study|Lost to Follow-up|5|||
164100299|NCT02262377|592733352|FG001|Overall Study|Lost to Follow-up|6|||
164100300|NCT02262377|592733351|FG000|Overall Study|Found ineligible after enrollment|3|||
164100301|NCT02262377|592733352|FG001|Overall Study|Found ineligible after enrollment|0|||
164100302|NCT02262377|592733351|FG000|Overall Study|Withdrawal by Subject|4|||
164100303|NCT02262377|592733352|FG001|Overall Study|Withdrawal by Subject|0|||
164100304|NCT00371839|592733353|FG000|Overall Study|Death|4|||
164100305|NCT00371839|592733354|FG001|Overall Study|Death|0|||
164100306|NCT00371839|592733355|FG002|Overall Study|Death|0|||
164100307|NCT00371839|592733353|FG000|Overall Study|Withdrawal by Subject|7|||
164100308|NCT00371839|592733354|FG001|Overall Study|Withdrawal by Subject|4|||
164100309|NCT00371839|592733355|FG002|Overall Study|Withdrawal by Subject|0|||
164100310|NCT00371839|592733353|FG000|Overall Study|Lost to Follow-up|6|||
164100311|NCT00371839|592733354|FG001|Overall Study|Lost to Follow-up|3|||
164100312|NCT00371839|592733355|FG002|Overall Study|Lost to Follow-up|2|||
164100313|NCT01511939|592733356|FG000|Overall Study|Withdrawal by Subject|2|||
164100314|NCT01511939|592733357|FG001|Overall Study|Withdrawal by Subject|1|||
164100315|NCT01511939|592733358|FG002|Overall Study|Withdrawal by Subject|0|||
164100316|NCT01591785|592733359|FG000|Overall Study|worsening condition|1|||
164100317|NCT01591785|592733360|FG001|Overall Study|worsening condition|2|||
164100318|NCT01591785|592733359|FG000|Overall Study|Protocol Violation|2|||
164100319|NCT01591785|592733360|FG001|Overall Study|Protocol Violation|0|||
164100320|NCT01591785|592733359|FG000|Overall Study|Lost to Follow-up|1|||
164100321|NCT01591785|592733360|FG001|Overall Study|Lost to Follow-up|0|||
164100322|NCT01049334|592733361|FG000|Overall Study|Withdrawal by Subject|5|||
164100323|NCT01049334|592733362|FG001|Overall Study|Withdrawal by Subject|3|||
164100324|NCT01049334|592733361|FG000|Overall Study|Adverse Event|2|||
164100325|NCT01049334|592733362|FG001|Overall Study|Adverse Event|3|||
164100326|NCT01049334|592733361|FG000|Overall Study|Physician Decision|2|||
164100327|NCT01049334|592733362|FG001|Overall Study|Physician Decision|0|||
164100328|NCT01049334|592733361|FG000|Overall Study|Protocol Violation|0|||
164100329|NCT01049334|592733362|FG001|Overall Study|Protocol Violation|1|||
164100330|NCT02476994|592733369|FG000|Overall Study|Based on feedback from FDA|1|||
164100331|NCT02476994|592733370|FG001|Overall Study|Based on feedback from FDA|0|||
164100332|NCT02246166|592733371|FG000|Overall Study|Protocol Violation|1|||
164100333|NCT02246166|592733372|FG001|Overall Study|Protocol Violation|0|||
164100334|NCT02563561|592733373|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
164100335|NCT02563561|592733374|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
164100336|NCT02563561|592733375|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
164100337|NCT02563561|592733373|FG000|Overall Study|Withdrew of Consent|1|||
164051930|NCT02807376|592548815|FG000|Overall Study|Lost to Follow-up|0|||
164051931|NCT02807376|592548816|FG001|Overall Study|Lost to Follow-up|1|||
164051932|NCT03228836|592548819|FG000|Overall Study|Adverse Event|3|||
164051933|NCT03228836|592548819|FG000|Overall Study|Withdrawal by Subject|1|||
164051934|NCT03228836|592548819|FG000|Overall Study|Death|1|||
164051935|NCT03228836|592548819|FG000|Overall Study|Physician Decision|1|||
164051936|NCT03228836|592548819|FG000|Overall Study|Disease Progression|7|||
164051937|NCT03228836|592548819|FG000|Overall Study|Other|4|||
164051938|NCT00948389|592548820|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
164051939|NCT00948389|592548821|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
164051940|NCT00948389|592548822|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
164051941|NCT00948389|592548823|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
164051942|NCT00948389|592548824|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
164051943|NCT00948389|592548820|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
164051944|NCT00948389|592548821|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
164051945|NCT00948389|592548822|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
164051946|NCT00948389|592548823|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
164051947|NCT00948389|592548824|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
164051948|NCT00948389|592548820|FG000|Overall Study|Both Progression and Toxicity|1|||
164051949|NCT00948389|592548821|FG001|Overall Study|Both Progression and Toxicity|0|||
164051950|NCT00948389|592548822|FG002|Overall Study|Both Progression and Toxicity|0|||
164051951|NCT00948389|592548823|FG003|Overall Study|Both Progression and Toxicity|0|||
164051952|NCT00948389|592548824|FG004|Overall Study|Both Progression and Toxicity|0|||
164051953|NCT00750867|592548845|FG000|Overall Study|Adverse Event|2|||
164051954|NCT04652102|592548846|FG000|Overall Study|Adverse Event|14|||
164051955|NCT04652102|592548847|FG001|Overall Study|Adverse Event|13|||
164051956|NCT04652102|592548846|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
164051957|NCT04652102|592548847|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
164051958|NCT04652102|592548846|FG000|Overall Study|Physician Decision|78|||
164051959|NCT04652102|592548847|FG001|Overall Study|Physician Decision|40|||
164051960|NCT04652102|592548846|FG000|Overall Study|Study Ended by Sponsor|64|||
164051961|NCT04652102|592548847|FG001|Overall Study|Study Ended by Sponsor|17|||
164051962|NCT04652102|592548846|FG000|Overall Study|Withdrawal by Subject|4625|||
164051963|NCT04652102|592548847|FG001|Overall Study|Withdrawal by Subject|5594|||
164051964|NCT04652102|592548846|FG000|Overall Study|Lost to Follow-up|2019|||
164051965|NCT04652102|592548847|FG001|Overall Study|Lost to Follow-up|1082|||
164051966|NCT04652102|592548846|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
164051967|NCT04652102|592548847|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
164051968|NCT04652102|592548846|FG000|Overall Study|Miscellaneous|80|||
164051969|NCT04652102|592548847|FG001|Overall Study|Miscellaneous|64|||
164051970|NCT01756833|592548850|FG000|Overall Study|Withdrawal by Subject|4|||
164051971|NCT01756833|592548851|FG001|Overall Study|Withdrawal by Subject|3|||
164051972|NCT00952588|592548852|FG000|Overall Study|Death|28|||
164051973|NCT00952588|592548853|FG001|Overall Study|Death|13|||
164051974|NCT00952588|592548852|FG000|Overall Study|Withdrawal by Subject|2|||
164051975|NCT00952588|592548853|FG001|Overall Study|Withdrawal by Subject|5|||
164051976|NCT00952588|592548852|FG000|Overall Study|Adverse Event|2|||
164051977|NCT00952588|592548853|FG001|Overall Study|Adverse Event|3|||
164051978|NCT00952588|592548852|FG000|Overall Study|Lost to Follow-up|2|||
164051979|NCT00952588|592548853|FG001|Overall Study|Lost to Follow-up|0|||
164051980|NCT00952588|592548852|FG000|Overall Study|Physician Decision|0|||
164051981|NCT00952588|592548853|FG001|Overall Study|Physician Decision|1|||
164051982|NCT00952588|592548852|FG000|Overall Study|Lack of Efficacy|2|||
164051983|NCT00952588|592548853|FG001|Overall Study|Lack of Efficacy|2|||
164051984|NCT00808132|592548854|FG000|Overall Study|Adverse Event|34|||
164051985|NCT00808132|592548855|FG001|Overall Study|Adverse Event|33|||
164051986|NCT00808132|592548856|FG002|Overall Study|Adverse Event|16|||
164051987|NCT00808132|592548857|FG003|Overall Study|Adverse Event|31|||
164051988|NCT00808132|592548858|FG004|Overall Study|Adverse Event|33|||
164051989|NCT00808132|592548854|FG000|Overall Study|Death|0|||
164051990|NCT00808132|592548855|FG001|Overall Study|Death|0|||
164051991|NCT00808132|592548856|FG002|Overall Study|Death|0|||
164051992|NCT00808132|592548857|FG003|Overall Study|Death|0|||
164051993|NCT00808132|592548858|FG004|Overall Study|Death|1|||
164051994|NCT00808132|592548854|FG000|Overall Study|Physician Decision|0|||
164051995|NCT00808132|592548855|FG001|Overall Study|Physician Decision|1|||
164051996|NCT00808132|592548856|FG002|Overall Study|Physician Decision|0|||
164051997|NCT00808132|592548857|FG003|Overall Study|Physician Decision|0|||
164051998|NCT00808132|592548858|FG004|Overall Study|Physician Decision|0|||
164051999|NCT00808132|592548854|FG000|Overall Study|Lost to Follow-up|8|||
164052000|NCT00808132|592548855|FG001|Overall Study|Lost to Follow-up|10|||
164052001|NCT00808132|592548856|FG002|Overall Study|Lost to Follow-up|11|||
164052002|NCT00808132|592548857|FG003|Overall Study|Lost to Follow-up|8|||
164052003|NCT00808132|592548858|FG004|Overall Study|Lost to Follow-up|9|||
164052004|NCT00808132|592548854|FG000|Overall Study|Protocol Violation|8|||
164052005|NCT00808132|592548855|FG001|Overall Study|Protocol Violation|9|||
164052006|NCT00808132|592548856|FG002|Overall Study|Protocol Violation|4|||
164052007|NCT00808132|592548857|FG003|Overall Study|Protocol Violation|9|||
164052008|NCT00808132|592548858|FG004|Overall Study|Protocol Violation|5|||
164052009|NCT00808132|592548854|FG000|Overall Study|Withdrawal by Subject|27|||
164052010|NCT00808132|592548855|FG001|Overall Study|Withdrawal by Subject|18|||
164052011|NCT00808132|592548856|FG002|Overall Study|Withdrawal by Subject|2|||
164052012|NCT00808132|592548857|FG003|Overall Study|Withdrawal by Subject|7|||
164052013|NCT00808132|592548858|FG004|Overall Study|Withdrawal by Subject|16|||
164052014|NCT00808132|592548854|FG000|Overall Study|Other|6|||
164052015|NCT00808132|592548855|FG001|Overall Study|Other|4|||
164052016|NCT00808132|592548856|FG002|Overall Study|Other|6|||
164052017|NCT00808132|592548857|FG003|Overall Study|Other|2|||
164052018|NCT00808132|592548858|FG004|Overall Study|Other|15|||
164052019|NCT00808132|592548854|FG000|Overall Study|Randomized, but not treated|10|||
164100338|NCT02563561|592733374|FG001|Overall Study|Withdrew of Consent|1|||
164052020|NCT00808132|592548855|FG001|Overall Study|Randomized, but not treated|7|||
164052021|NCT00808132|592548856|FG002|Overall Study|Randomized, but not treated|9|||
164052022|NCT00808132|592548857|FG003|Overall Study|Randomized, but not treated|8|||
164052023|NCT00808132|592548858|FG004|Overall Study|Randomized, but not treated|9|||
164052024|NCT00808132|592548854|FG000|Overall Study|Unsatisfactory response|5|||
164052025|NCT00808132|592548855|FG001|Overall Study|Unsatisfactory response|6|||
164052026|NCT00808132|592548856|FG002|Overall Study|Unsatisfactory response|6|||
164052027|NCT00808132|592548857|FG003|Overall Study|Unsatisfactory response|4|||
164052028|NCT00808132|592548858|FG004|Overall Study|Unsatisfactory response|12|||
164052029|NCT00890201|592548861|FG000|Overall Study|Protocol Violation|5|||
164052030|NCT00890201|592548862|FG001|Overall Study|Protocol Violation|56|||
164052031|NCT01371721|592548863|FG000|Overall Study|Adverse Event|5|||
164052032|NCT01371721|592548864|FG001|Overall Study|Adverse Event|4|||
164052033|NCT01371721|592548865|FG002|Overall Study|Adverse Event|5|||
164052034|NCT01371721|592548863|FG000|Overall Study|Protocol Violation|6|||
164052035|NCT01371721|592548864|FG001|Overall Study|Protocol Violation|4|||
164052036|NCT01371721|592548865|FG002|Overall Study|Protocol Violation|5|||
164052037|NCT01371721|592548863|FG000|Overall Study|Lost to Follow-up|8|||
164052038|NCT01371721|592548864|FG001|Overall Study|Lost to Follow-up|2|||
164052039|NCT01371721|592548865|FG002|Overall Study|Lost to Follow-up|6|||
164052040|NCT01371721|592548863|FG000|Overall Study|Withdrawal by Subject|5|||
164052041|NCT01371721|592548864|FG001|Overall Study|Withdrawal by Subject|7|||
164052042|NCT01371721|592548865|FG002|Overall Study|Withdrawal by Subject|11|||
164052043|NCT01371721|592548863|FG000|Overall Study|Other|2|||
164052044|NCT01371721|592548864|FG001|Overall Study|Other|3|||
164052045|NCT01371721|592548865|FG002|Overall Study|Other|0|||
164052046|NCT01371721|592548863|FG000|Overall Study|Lack of Efficacy|2|||
164052047|NCT01371721|592548864|FG001|Overall Study|Lack of Efficacy|4|||
164052048|NCT01371721|592548865|FG002|Overall Study|Lack of Efficacy|3|||
164052049|NCT01371721|592548863|FG000|Overall Study|Randomized but not treated|1|||
164052050|NCT01371721|592548864|FG001|Overall Study|Randomized but not treated|0|||
164052051|NCT01371721|592548865|FG002|Overall Study|Randomized but not treated|0|||
164052052|NCT01347840|592548866|FG000|Overall Study|Withdrawal by Subject|1|||
164052053|NCT01846208|592548870|FG000|Overall Study|Withdrew prior to treatment|1|||
164052054|NCT01846208|592548871|FG001|Overall Study|Withdrew prior to treatment|1|||
164052055|NCT01846208|592548872|FG002|Overall Study|Withdrew prior to treatment|1|||
164052056|NCT01846208|592548870|FG000|Overall Study|Dosing Symptoms|1|||
164052057|NCT01846208|592548871|FG001|Overall Study|Dosing Symptoms|2|||
164052058|NCT01846208|592548872|FG002|Overall Study|Dosing Symptoms|6|||
164052059|NCT01846208|592548870|FG000|Overall Study|Withdrawal by Subject|5|||
164052060|NCT01846208|592548871|FG001|Overall Study|Withdrawal by Subject|0|||
164052061|NCT01846208|592548872|FG002|Overall Study|Withdrawal by Subject|0|||
164052062|NCT01846208|592548870|FG000|Overall Study|Non-compliance|1|||
164052063|NCT01846208|592548871|FG001|Overall Study|Non-compliance|1|||
164052064|NCT01846208|592548872|FG002|Overall Study|Non-compliance|0|||
164052065|NCT01846208|592548870|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
164052066|NCT01846208|592548871|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
164052067|NCT01846208|592548872|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
164052068|NCT01846208|592548870|FG000|Overall Study|Refused SU OFC|0|||
164052069|NCT01846208|592548871|FG001|Overall Study|Refused SU OFC|0|||
164052070|NCT01846208|592548872|FG002|Overall Study|Refused SU OFC|1|||
164052071|NCT01432938|592548873|FG000|First Intervention|Protocol Violation|1|||
164052072|NCT01432938|592548874|FG001|First Intervention|Protocol Violation|0|||
164052073|NCT01432938|592548873|FG000|First Intervention|Physician Decision|1|||
164052074|NCT01432938|592548874|FG001|First Intervention|Physician Decision|0|||
164052075|NCT01432938|592548873|FG000|Second Intervention|Adverse Event|1|||
164052076|NCT01432938|592548874|FG001|Second Intervention|Adverse Event|0|||
164052077|NCT01875874|592548878|FG000|Overall Study|Death|3|||
164052078|NCT00374127|592548879|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
164052079|NCT00374127|592548879|FG000|Overall Study|Blood could not be drawn.|2|||
164052080|NCT00374127|592548879|FG000|Overall Study|Protocol Violation|5|||
164052081|NCT00374127|592548879|FG000|Overall Study|Pregnancy|1|||
164052082|NCT00281528|592548883|FG000|Overall Study|Progressive Disease|28|||
164052083|NCT00281528|592548884|FG001|Overall Study|Progressive Disease|18|||
164052084|NCT00281528|592548885|FG002|Overall Study|Progressive Disease|27|||
164052085|NCT00281528|592548883|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
164052086|NCT00281528|592548884|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
164052087|NCT00281528|592548885|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
164052088|NCT00281528|592548883|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
164052089|NCT00281528|592548884|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
164052090|NCT00281528|592548885|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
164052091|NCT00281528|592548883|FG000|Overall Study|Physician Decision|11|||
164052092|NCT00281528|592548884|FG001|Overall Study|Physician Decision|4|||
164052093|NCT00281528|592548885|FG002|Overall Study|Physician Decision|5|||
164052094|NCT00281528|592548883|FG000|Overall Study|Protocol Violation|1|||
164100339|NCT02563561|592733375|FG002|Overall Study|Withdrew of Consent|2|||
164052095|NCT00281528|592548884|FG001|Overall Study|Protocol Violation|0|||
164052096|NCT00281528|592548885|FG002|Overall Study|Protocol Violation|1|||
164052097|NCT00281528|592548883|FG000|Overall Study|Withdrawal by Subject|5|||
164052098|NCT00281528|592548884|FG001|Overall Study|Withdrawal by Subject|5|||
164052099|NCT00281528|592548885|FG002|Overall Study|Withdrawal by Subject|7|||
164052100|NCT00281528|592548883|FG000|Overall Study|Other|6|||
164052101|NCT00281528|592548884|FG001|Overall Study|Other|3|||
164052102|NCT00281528|592548885|FG002|Overall Study|Other|5|||
164100340|NCT02563561|592733373|FG000|Overall Study|Lost to Follow-up|1|||
164100341|NCT02563561|592733374|FG001|Overall Study|Lost to Follow-up|1|||
164100342|NCT02563561|592733375|FG002|Overall Study|Lost to Follow-up|0|||
164100343|NCT02563561|592733373|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
164100344|NCT02563561|592733374|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
164100345|NCT02563561|592733375|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
164100346|NCT02563561|592733373|FG000|Overall Study|Investigator Decision|3|||
164100347|NCT02563561|592733374|FG001|Overall Study|Investigator Decision|4|||
164100348|NCT02563561|592733375|FG002|Overall Study|Investigator Decision|2|||
164100349|NCT02563561|592733373|FG000|Overall Study|Sponsor Decision|5|||
164100350|NCT02563561|592733374|FG001|Overall Study|Sponsor Decision|2|||
164100351|NCT02563561|592733375|FG002|Overall Study|Sponsor Decision|4|||
164100352|NCT02563561|592733373|FG000|Overall Study|Other|1|||
164100353|NCT02563561|592733374|FG001|Overall Study|Other|5|||
164100354|NCT02563561|592733375|FG002|Overall Study|Other|2|||
164100355|NCT03769896|592733376|FG000|Open-label Phase|Lack of Efficacy|5|||
164100356|NCT03769896|592733377|FG001|Open-label Phase|Lack of Efficacy|0|||
164100357|NCT03769896|592733376|FG000|Open-label Phase|Adverse Event|3|||
164100358|NCT03769896|592733377|FG001|Open-label Phase|Adverse Event|0|||
164100359|NCT03769896|592733376|FG000|Open-label Phase|Withdrawal by Subject|1|||
164100360|NCT03769896|592733377|FG001|Open-label Phase|Withdrawal by Subject|0|||
164100361|NCT01015703|592733378|FG000|Overall Study|Withdrawal by Subject|0|||
164100362|NCT01015703|592733379|FG001|Overall Study|Withdrawal by Subject|1|||
164100363|NCT01015703|592733380|FG002|Overall Study|Withdrawal by Subject|0|||
164100364|NCT01015703|592733381|FG003|Overall Study|Withdrawal by Subject|0|||
164100365|NCT01015703|592733382|FG004|Overall Study|Withdrawal by Subject|0|||
164100366|NCT01015703|592733378|FG000|Overall Study|Adverse Event|1|||
164100367|NCT01015703|592733379|FG001|Overall Study|Adverse Event|0|||
164100368|NCT01015703|592733380|FG002|Overall Study|Adverse Event|0|||
164100369|NCT01015703|592733381|FG003|Overall Study|Adverse Event|0|||
164100370|NCT01015703|592733382|FG004|Overall Study|Adverse Event|0|||
164100371|NCT01015703|592733378|FG000|Overall Study|Protocol Violation|1|||
164100372|NCT01015703|592733379|FG001|Overall Study|Protocol Violation|0|||
164100373|NCT01015703|592733380|FG002|Overall Study|Protocol Violation|0|||
164100374|NCT01015703|592733381|FG003|Overall Study|Protocol Violation|0|||
164100375|NCT01015703|592733382|FG004|Overall Study|Protocol Violation|0|||
164100376|NCT03122535|592733383|FG000|Overall Study|Lost to Follow-up|68|||
164100377|NCT03122535|592733384|FG001|Overall Study|Lost to Follow-up|68|||
164100378|NCT03122535|592733383|FG000|Overall Study|Physician Decision|3|||
164100379|NCT03122535|592733384|FG001|Overall Study|Physician Decision|3|||
164100380|NCT03122535|592733383|FG000|Overall Study|Withdrawal by Subject|2|||
164100381|NCT03122535|592733384|FG001|Overall Study|Withdrawal by Subject|2|||
164100382|NCT02646124|592733385|FG000|Overall Study|Lost to Follow-up|0|||
164100383|NCT02646124|592733386|FG001|Overall Study|Lost to Follow-up|2|||
164100384|NCT00857454|592733389|FG000|Overall Study|Withdrawal by Subject|2|||
164100385|NCT00857454|592733389|FG000|Overall Study|Lost to Follow-up|1|||
164100386|NCT00857454|592733389|FG000|Overall Study|Adverse Event|2|||
164100387|NCT00857454|592733389|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
164100388|NCT00857454|592733389|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
164100389|NCT00857454|592733389|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
164100390|NCT03154047|592733390|FG000|Overall Study|Death|1|||
164100391|NCT03154047|592733390|FG000|Overall Study|Study terminated by sponsor|76|||
164100392|NCT03154047|592733390|FG000|Overall Study|Withdrawal by Subject|3|||
164100393|NCT00573443|592733391|FG000|Double-Blind Phase|Lost to Follow-up|1|||
164100394|NCT00573443|592733392|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164100395|NCT00573443|592733393|FG002|Double-Blind Phase|Lost to Follow-up|2|||
164100396|NCT00573443|592733391|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
164100397|NCT00573443|592733392|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
164100398|NCT00573443|592733393|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
164100399|NCT00573443|592733391|FG000|Double-Blind Phase|Adverse Event|1|||
164100400|NCT00573443|592733392|FG001|Double-Blind Phase|Adverse Event|5|||
164100401|NCT00573443|592733393|FG002|Double-Blind Phase|Adverse Event|0|||
164100402|NCT00573443|592733391|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
164100403|NCT00573443|592733392|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
164100404|NCT00573443|592733393|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
164100405|NCT00573443|592733391|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
164100406|NCT00573443|592733392|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
164100407|NCT00573443|592733393|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
164100408|NCT00573443|592733391|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
164100409|NCT00573443|592733392|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
164100410|NCT00573443|592733393|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
164100411|NCT00573443|592733391|FG000|Double-Blind Phase|Protocol Violation|0|||
164100412|NCT00573443|592733392|FG001|Double-Blind Phase|Protocol Violation|2|||
164100413|NCT00573443|592733393|FG002|Double-Blind Phase|Protocol Violation|1|||
164100414|NCT00573443|592733391|FG000|Double-Blind Phase|Other|0|||
164100415|NCT00573443|592733392|FG001|Double-Blind Phase|Other|2|||
164100416|NCT00573443|592733393|FG002|Double-Blind Phase|Other|3|||
164100417|NCT00573443|592733391|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
164052103|NCT02520141|592548888|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
164052104|NCT00703781|592548889|FG000|Overall Study|Withdrawal by Subject|1|||
164052105|NCT00703781|592548890|FG001|Overall Study|Withdrawal by Subject|2|||
164052106|NCT00703781|592548889|FG000|Overall Study|Cancelled surgery|1|||
164052107|NCT00703781|592548890|FG001|Overall Study|Cancelled surgery|0|||
164052108|NCT02168816|592548891|FG000|Overall Study|Lost to Follow-up|2|||
164052109|NCT02168816|592548892|FG001|Overall Study|Lost to Follow-up|2|||
164052110|NCT01225211|592548893|FG000|Overall Study|Adverse Event|0|||
164052111|NCT01225211|592548894|FG001|Overall Study|Adverse Event|0|||
164052112|NCT01225211|592548895|FG002|Overall Study|Adverse Event|1|||
164052113|NCT01225211|592548896|FG003|Overall Study|Adverse Event|0|||
164052114|NCT01225211|592548897|FG004|Overall Study|Adverse Event|0|||
164052115|NCT01225211|592548898|FG005|Overall Study|Adverse Event|0|||
164052116|NCT01225211|592548899|FG006|Overall Study|Adverse Event|0|||
164052117|NCT01225211|592548900|FG007|Overall Study|Adverse Event|0|||
164052118|NCT01225211|592548901|FG008|Overall Study|Adverse Event|0|||
164052119|NCT01225211|592548902|FG009|Overall Study|Adverse Event|1|||
164052120|NCT01225211|592548893|FG000|Overall Study|Withdrawal by Subject|0|||
164052121|NCT01225211|592548894|FG001|Overall Study|Withdrawal by Subject|0|||
164052122|NCT01225211|592548895|FG002|Overall Study|Withdrawal by Subject|0|||
164052123|NCT01225211|592548896|FG003|Overall Study|Withdrawal by Subject|0|||
164052124|NCT01225211|592548897|FG004|Overall Study|Withdrawal by Subject|0|||
164052125|NCT01225211|592548898|FG005|Overall Study|Withdrawal by Subject|0|||
164052126|NCT01225211|592548899|FG006|Overall Study|Withdrawal by Subject|1|||
164052127|NCT01225211|592548900|FG007|Overall Study|Withdrawal by Subject|0|||
164052128|NCT01225211|592548901|FG008|Overall Study|Withdrawal by Subject|1|||
164052129|NCT01225211|592548902|FG009|Overall Study|Withdrawal by Subject|3|||
164052130|NCT01225211|592548893|FG000|Overall Study|Other|0|||
164052131|NCT01225211|592548894|FG001|Overall Study|Other|0|||
164052132|NCT01225211|592548895|FG002|Overall Study|Other|0|||
164052133|NCT01225211|592548896|FG003|Overall Study|Other|0|||
164052134|NCT01225211|592548897|FG004|Overall Study|Other|0|||
164052135|NCT01225211|592548898|FG005|Overall Study|Other|0|||
164052136|NCT01225211|592548899|FG006|Overall Study|Other|0|||
164052137|NCT01225211|592548900|FG007|Overall Study|Other|0|||
164052138|NCT01225211|592548901|FG008|Overall Study|Other|0|||
164052139|NCT01225211|592548902|FG009|Overall Study|Other|1|||
164052140|NCT01984294|592548907|FG000|Overall Study|Randomized but Never Treated|0|||
164052141|NCT01984294|592548908|FG001|Overall Study|Randomized but Never Treated|0|||
164052142|NCT01984294|592548909|FG002|Overall Study|Randomized but Never Treated|1|||
164052143|NCT01984294|592548907|FG000|Overall Study|Lack of Efficacy|4|||
164052144|NCT01984294|592548908|FG001|Overall Study|Lack of Efficacy|2|||
164052145|NCT01984294|592548909|FG002|Overall Study|Lack of Efficacy|6|||
164052146|NCT01984294|592548907|FG000|Overall Study|Adverse Event|0|||
164052147|NCT01984294|592548908|FG001|Overall Study|Adverse Event|1|||
164052148|NCT01984294|592548909|FG002|Overall Study|Adverse Event|0|||
164052149|NCT02709889|592548914|FG000|Overall Study|Withdrawal by Subject|11|||
164052150|NCT02709889|592548915|FG001|Overall Study|Withdrawal by Subject|10|||
164052151|NCT02709889|592548916|FG002|Overall Study|Withdrawal by Subject|2|||
164052152|NCT02709889|592548917|FG003|Overall Study|Withdrawal by Subject|12|||
164052153|NCT02709889|592548914|FG000|Overall Study|Death|25|||
164052154|NCT02709889|592548915|FG001|Overall Study|Death|38|||
164052155|NCT02709889|592548916|FG002|Overall Study|Death|4|||
164052156|NCT02709889|592548917|FG003|Overall Study|Death|44|||
164052157|NCT02709889|592548914|FG000|Overall Study|Physician Decision|1|||
164052158|NCT02709889|592548915|FG001|Overall Study|Physician Decision|2|||
164052159|NCT02709889|592548916|FG002|Overall Study|Physician Decision|3|||
164052160|NCT02709889|592548917|FG003|Overall Study|Physician Decision|5|||
164052161|NCT02709889|592548914|FG000|Overall Study|Lost to Follow-up|2|||
164052162|NCT02709889|592548915|FG001|Overall Study|Lost to Follow-up|0|||
164052163|NCT02709889|592548916|FG002|Overall Study|Lost to Follow-up|0|||
164052164|NCT02709889|592548917|FG003|Overall Study|Lost to Follow-up|4|||
164052165|NCT02709889|592548914|FG000|Overall Study|Study Terminated by Sponsor|4|||
164052166|NCT02709889|592548915|FG001|Overall Study|Study Terminated by Sponsor|6|||
164052167|NCT02709889|592548916|FG002|Overall Study|Study Terminated by Sponsor|2|||
164052168|NCT02709889|592548917|FG003|Overall Study|Study Terminated by Sponsor|17|||
164052169|NCT02709889|592548914|FG000|Overall Study|Other, Not Specified|0|||
164052170|NCT02709889|592548915|FG001|Overall Study|Other, Not Specified|1|||
164052171|NCT02709889|592548916|FG002|Overall Study|Other, Not Specified|1|||
164052172|NCT02709889|592548917|FG003|Overall Study|Other, Not Specified|6|||
164052173|NCT00537810|592548918|FG000|Overall Study|Withdrawal by Subject|4|||
164052174|NCT00537810|592548919|FG001|Overall Study|Withdrawal by Subject|11|||
164052175|NCT00537810|592548920|FG002|Overall Study|Withdrawal by Subject|4|||
164052176|NCT00537810|592548921|FG003|Overall Study|Withdrawal by Subject|3|||
164052177|NCT00537810|592548918|FG000|Overall Study|Medically withdrawn|2|||
164052178|NCT00537810|592548919|FG001|Overall Study|Medically withdrawn|2|||
164052179|NCT00537810|592548920|FG002|Overall Study|Medically withdrawn|0|||
164052180|NCT00537810|592548921|FG003|Overall Study|Medically withdrawn|1|||
164052181|NCT00410514|592548922|FG000|Overall Study|Adverse Event|2|||
164052182|NCT00410514|592548923|FG001|Overall Study|Adverse Event|2|||
164052183|NCT00410514|592548924|FG002|Overall Study|Adverse Event|2|||
164052184|NCT00410514|592548922|FG000|Overall Study|Protocol Violation|0|||
164052185|NCT00410514|592548923|FG001|Overall Study|Protocol Violation|1|||
164052186|NCT00410514|592548924|FG002|Overall Study|Protocol Violation|1|||
164052187|NCT00410514|592548922|FG000|Overall Study|Lost to Follow-up|0|||
164052188|NCT00410514|592548923|FG001|Overall Study|Lost to Follow-up|0|||
164052189|NCT00410514|592548924|FG002|Overall Study|Lost to Follow-up|2|||
164052190|NCT00410514|592548922|FG000|Overall Study|Non-compliant with study procedures|0|||
164052191|NCT00410514|592548923|FG001|Overall Study|Non-compliant with study procedures|0|||
164052192|NCT00410514|592548924|FG002|Overall Study|Non-compliant with study procedures|2|||
164052193|NCT02449915|592548926|FG000|Overall Study|Exclusion criteria - drug use|1|||
164052194|NCT02449915|592548927|FG001|Overall Study|Exclusion criteria - drug use|0|||
164052195|NCT02449915|592548926|FG000|Overall Study|Withdrawal by Subject|0|||
164052196|NCT02449915|592548927|FG001|Overall Study|Withdrawal by Subject|2|||
164052197|NCT02449915|592548926|FG000|Overall Study|Intraoperative surgical findings|1|||
164052198|NCT02449915|592548927|FG001|Overall Study|Intraoperative surgical findings|1|||
164052199|NCT02449915|592548926|FG000|Overall Study|Abnormal preop lab|0|||
164052200|NCT02449915|592548927|FG001|Overall Study|Abnormal preop lab|1|||
164052201|NCT01436357|592548928|FG000|Overall Study|Death|5|||
164052202|NCT01436357|592548929|FG001|Overall Study|Death|1|||
164052203|NCT01436357|592548928|FG000|Overall Study|Enrolled but not vaccinated|1|||
164052204|NCT01436357|592548929|FG001|Overall Study|Enrolled but not vaccinated|1|||
164052205|NCT01436357|592548928|FG000|Overall Study|Incarceration|18|||
164052206|NCT01436357|592548929|FG001|Overall Study|Incarceration|20|||
164052207|NCT01436357|592548928|FG000|Overall Study|Lost to Follow-up|67|||
164052208|NCT01436357|592548929|FG001|Overall Study|Lost to Follow-up|61|||
164052209|NCT01436357|592548928|FG000|Overall Study|Protocol Violation|1|||
164052210|NCT01436357|592548929|FG001|Overall Study|Protocol Violation|0|||
164052211|NCT01436357|592548928|FG000|Overall Study|Withdrawal by Subject|26|||
164052212|NCT01436357|592548929|FG001|Overall Study|Withdrawal by Subject|38|||
164052213|NCT01436357|592548928|FG000|Overall Study|Physician Decision|3|||
164052214|NCT01436357|592548929|FG001|Overall Study|Physician Decision|4|||
164052215|NCT01436357|592548928|FG000|Overall Study|Moved out of area|1|||
164052216|NCT01436357|592548929|FG001|Overall Study|Moved out of area|2|||
164052217|NCT01436357|592548928|FG000|Overall Study|Subject in rehab|0|||
164052218|NCT01436357|592548929|FG001|Overall Study|Subject in rehab|1|||
164052219|NCT01021293|592548934|FG000|Overall Study|Serious Adverse Event|2|||
164052220|NCT01021293|592548935|FG001|Overall Study|Serious Adverse Event|1|||
164052221|NCT01021293|592548934|FG000|Overall Study|Adverse Event|2|||
164052222|NCT01021293|592548935|FG001|Overall Study|Adverse Event|1|||
164052223|NCT01021293|592548934|FG000|Overall Study|Withdrawal by Subject|1|||
164052224|NCT01021293|592548935|FG001|Overall Study|Withdrawal by Subject|3|||
164052225|NCT01021293|592548934|FG000|Overall Study|Migrated/moved from study area|6|||
164052226|NCT01021293|592548935|FG001|Overall Study|Migrated/moved from study area|18|||
164052227|NCT01021293|592548934|FG000|Overall Study|Lost to Follow-up|1|||
164052228|NCT01021293|592548935|FG001|Overall Study|Lost to Follow-up|1|||
164052229|NCT04335929|592550750|FG000|Overall Study|Lost to Follow-up|10|||
164052230|NCT00303602|592550752|FG000|Overall Study|Adverse Event|2|||
164052231|NCT00303602|592550753|FG001|Overall Study|Adverse Event|2|||
164052232|NCT00303602|592550752|FG000|Overall Study|Withdrawal by Subject|5|||
164052233|NCT00303602|592550753|FG001|Overall Study|Withdrawal by Subject|6|||
164052234|NCT00303602|592550752|FG000|Overall Study|Lost to Follow-up|5|||
164052235|NCT00303602|592550753|FG001|Overall Study|Lost to Follow-up|2|||
164052236|NCT00303602|592550752|FG000|Overall Study|Protocol entry criteria not met|2|||
164052237|NCT00303602|592550753|FG001|Overall Study|Protocol entry criteria not met|2|||
164052238|NCT00303602|592550752|FG000|Overall Study|Physician Decision|2|||
164052239|NCT00303602|592550753|FG001|Overall Study|Physician Decision|1|||
164052240|NCT00303602|592550752|FG000|Overall Study|Noncompliance|2|||
164052241|NCT00303602|592550753|FG001|Overall Study|Noncompliance|2|||
164052242|NCT00303602|592550752|FG000|Overall Study|Protocol Violation|1|||
164052243|NCT00303602|592550753|FG001|Overall Study|Protocol Violation|0|||
164052244|NCT02491463|592550754|FG000|Overall Study|Withdrawal by Subject|1|||
164052245|NCT02491463|592550755|FG001|Overall Study|Withdrawal by Subject|2|||
164052246|NCT02491463|592550756|FG002|Overall Study|Withdrawal by Subject|0|||
164052247|NCT02491463|592550757|FG003|Overall Study|Withdrawal by Subject|0|||
164052248|NCT02491463|592550754|FG000|Overall Study|Migrated/moved from study area|1|||
164052249|NCT02491463|592550755|FG001|Overall Study|Migrated/moved from study area|5|||
164052250|NCT02491463|592550756|FG002|Overall Study|Migrated/moved from study area|1|||
164052251|NCT02491463|592550757|FG003|Overall Study|Migrated/moved from study area|1|||
164052252|NCT02491463|592550754|FG000|Overall Study|Lost to Follow-up|0|||
164052253|NCT02491463|592550755|FG001|Overall Study|Lost to Follow-up|3|||
164052254|NCT02491463|592550756|FG002|Overall Study|Lost to Follow-up|3|||
164052255|NCT02491463|592550757|FG003|Overall Study|Lost to Follow-up|0|||
164052256|NCT01491802|592550758|FG000|Overall Study|Adverse Event|1|||
164052257|NCT01491802|592550759|FG001|Overall Study|Adverse Event|1|||
164052258|NCT01491802|592550758|FG000|Overall Study|Withdrawal by Subject|0|||
164052259|NCT01491802|592550759|FG001|Overall Study|Withdrawal by Subject|1|||
164052260|NCT01864746|592550762|FG000|Overall Study|Disease recurrence|25|||
164052261|NCT01864746|592550763|FG001|Overall Study|Disease recurrence|40|||
164052262|NCT01864746|592550762|FG000|Overall Study|Second primary invasive nonbreast|2|||
164052263|NCT01864746|592550763|FG001|Overall Study|Second primary invasive nonbreast|3|||
164052264|NCT01864746|592550762|FG000|Overall Study|Death|2|||
164052265|NCT01864746|592550763|FG001|Overall Study|Death|1|||
164052266|NCT01864746|592550762|FG000|Overall Study|Adverse Event|33|||
164052267|NCT01864746|592550763|FG001|Overall Study|Adverse Event|5|||
164052268|NCT01864746|592550762|FG000|Overall Study|Withdrawal by Subject|56|||
164052269|NCT01864746|592550763|FG001|Overall Study|Withdrawal by Subject|41|||
164052270|NCT01864746|592550762|FG000|Overall Study|Physician Decision|5|||
164052271|NCT01864746|592550763|FG001|Overall Study|Physician Decision|6|||
164052272|NCT01005966|592550764|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164052273|NCT01005966|592550765|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164052274|NCT01005966|592550766|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
164052275|NCT01005966|592550767|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
164052276|NCT01005966|592550768|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
164052277|NCT01005966|592550764|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164052278|NCT01005966|592550765|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
164052279|NCT01005966|592550766|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164052280|NCT01005966|592550767|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
164052281|NCT01005966|592550768|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
164052282|NCT01005966|592550764|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164052283|NCT01005966|592550765|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164052284|NCT01005966|592550766|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164052285|NCT01005966|592550767|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
164052286|NCT01005966|592550768|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
164052287|NCT01005966|592550764|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
164052288|NCT01005966|592550765|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
164052289|NCT01005966|592550766|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
164052290|NCT01005966|592550767|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
164052291|NCT01005966|592550768|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
164052292|NCT01005966|592550764|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164052293|NCT01005966|592550765|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164052294|NCT01005966|592550766|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164052295|NCT01005966|592550767|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164052296|NCT01005966|592550768|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164052297|NCT01005966|592550764|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164052298|NCT01005966|592550765|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164052299|NCT01005966|592550766|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
164052300|NCT01005966|592550767|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164052301|NCT01005966|592550768|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
164052302|NCT01005966|592550764|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
164052303|NCT01005966|592550765|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
164052304|NCT01005966|592550766|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
164052305|NCT01005966|592550767|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
164052306|NCT01005966|592550768|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
164052307|NCT01005966|592550764|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164052308|NCT01005966|592550765|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
164052309|NCT01005966|592550766|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164052310|NCT01005966|592550767|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164052311|NCT01005966|592550768|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
164052312|NCT01005966|592550764|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
164052313|NCT01005966|592550765|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
164052314|NCT01005966|592550766|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
164052315|NCT01005966|592550767|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
164052316|NCT01005966|592550768|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
164052317|NCT01347931|592550769|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
164052318|NCT02554721|592550770|FG000|Overall Study|Adverse Event|1|||
164052319|NCT02554721|592550771|FG001|Overall Study|Adverse Event|0|||
164052320|NCT02554721|592550772|FG002|Overall Study|Adverse Event|0|||
164052321|NCT02554721|592550773|FG003|Overall Study|Adverse Event|0|||
164052322|NCT02554721|592550774|FG004|Overall Study|Adverse Event|1|||
164052323|NCT02554721|592550770|FG000|Overall Study|Noncompliance|0|||
164052324|NCT02554721|592550771|FG001|Overall Study|Noncompliance|0|||
164052325|NCT02554721|592550772|FG002|Overall Study|Noncompliance|0|||
164052326|NCT02554721|592550773|FG003|Overall Study|Noncompliance|0|||
164052327|NCT02554721|592550774|FG004|Overall Study|Noncompliance|1|||
164052328|NCT00626327|592550776|FG000|Overall Study|Withdrawal by Subject|21|||
164052329|NCT00626327|592550777|FG001|Overall Study|Withdrawal by Subject|29|||
164052330|NCT00626327|592550778|FG002|Overall Study|Withdrawal by Subject|30|||
164052331|NCT00626327|592550776|FG000|Overall Study|Adverse Event|1|||
164052332|NCT00626327|592550777|FG001|Overall Study|Adverse Event|0|||
164052333|NCT00626327|592550778|FG002|Overall Study|Adverse Event|0|||
164052334|NCT00626327|592550776|FG000|Overall Study|Lost to Follow-up|24|||
164052335|NCT00626327|592550777|FG001|Overall Study|Lost to Follow-up|21|||
164052336|NCT00626327|592550778|FG002|Overall Study|Lost to Follow-up|23|||
164052337|NCT00626327|592550776|FG000|Overall Study|Inappropriate enrollment|4|||
164052338|NCT00626327|592550777|FG001|Overall Study|Inappropriate enrollment|5|||
164052339|NCT00626327|592550778|FG002|Overall Study|Inappropriate enrollment|3|||
164052340|NCT00626327|592550776|FG000|Overall Study|Administrative Reason|2|||
164052341|NCT00626327|592550777|FG001|Overall Study|Administrative Reason|0|||
164052342|NCT00626327|592550778|FG002|Overall Study|Administrative Reason|6|||
164052343|NCT00626327|592550776|FG000|Overall Study|Protocol Violation|26|||
164052344|NCT00626327|592550777|FG001|Overall Study|Protocol Violation|4|||
164052345|NCT00626327|592550778|FG002|Overall Study|Protocol Violation|26|||
164052346|NCT03347279|592550781|FG000|Overall Study|Withdrawal by Subject|8|||
164052347|NCT03347279|592550782|FG001|Overall Study|Withdrawal by Subject|15|||
164052348|NCT03347279|592550781|FG000|Overall Study|Death|0|||
164052349|NCT03347279|592550782|FG001|Overall Study|Death|2|||
164052350|NCT03347279|592550781|FG000|Overall Study|Lost to Follow-up|5|||
164052351|NCT03347279|592550782|FG001|Overall Study|Lost to Follow-up|2|||
164052352|NCT03347279|592550781|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
164052353|NCT03347279|592550782|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
164052354|NCT04880642|592550783|FG000|Randomization|Withdrawal by Subject|2|||
164052355|NCT04880642|592550784|FG001|Randomization|Withdrawal by Subject|3|||
164052356|NCT04880642|592550783|FG000|Treatment Period|Adverse Event|0|||
164052357|NCT04880642|592550784|FG001|Treatment Period|Adverse Event|1|||
164052358|NCT04880642|592550783|FG000|Treatment Period|Death|6|||
164052359|NCT04880642|592550784|FG001|Treatment Period|Death|6|||
164052360|NCT04880642|592550783|FG000|Treatment Period|Lost to Follow-up|1|||
164052361|NCT04880642|592550784|FG001|Treatment Period|Lost to Follow-up|0|||
164052362|NCT04880642|592550783|FG000|Treatment Period|Protocol Violation|0|||
164052363|NCT04880642|592550784|FG001|Treatment Period|Protocol Violation|1|||
164052364|NCT04880642|592550783|FG000|Treatment Period|Withdrawal by Subject|5|||
164052365|NCT04880642|592550784|FG001|Treatment Period|Withdrawal by Subject|3|||
164052366|NCT04880642|592550783|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
164052367|NCT04880642|592550784|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
164052368|NCT04880642|592550783|FG000|Follow-up|Death|4|||
164052369|NCT04880642|592550784|FG001|Follow-up|Death|3|||
164052370|NCT04880642|592550783|FG000|Follow-up|Withdrawal by Subject|1|||
164052371|NCT04880642|592550784|FG001|Follow-up|Withdrawal by Subject|0|||
164052372|NCT00141297|592550785|FG000|Overall Study|Adverse Event|0|||
164052373|NCT00141297|592550786|FG001|Overall Study|Adverse Event|0|||
164052374|NCT00141297|592550787|FG002|Overall Study|Adverse Event|1|||
164052375|NCT00141297|592550788|FG003|Overall Study|Adverse Event|0|||
164052376|NCT00141297|592550789|FG004|Overall Study|Adverse Event|1|||
164052377|NCT00141297|592550790|FG005|Overall Study|Adverse Event|1|||
164052378|NCT00141297|592550791|FG006|Overall Study|Adverse Event|0|||
164052379|NCT00141297|592550792|FG007|Overall Study|Adverse Event|1|||
164052380|NCT00141297|592550793|FG008|Overall Study|Adverse Event|1|||
164052381|NCT00141297|592550794|FG009|Overall Study|Adverse Event|0|||
164052382|NCT00141297|592550785|FG000|Overall Study|Death|1|||
164052383|NCT00141297|592550786|FG001|Overall Study|Death|0|||
164052384|NCT00141297|592550787|FG002|Overall Study|Death|0|||
164052385|NCT00141297|592550788|FG003|Overall Study|Death|0|||
164052386|NCT00141297|592550789|FG004|Overall Study|Death|0|||
164052387|NCT00141297|592550790|FG005|Overall Study|Death|0|||
164052388|NCT00141297|592550791|FG006|Overall Study|Death|0|||
164052389|NCT00141297|592550792|FG007|Overall Study|Death|0|||
164052390|NCT00141297|592550793|FG008|Overall Study|Death|1|||
164052391|NCT00141297|592550794|FG009|Overall Study|Death|0|||
164052392|NCT00141297|592550785|FG000|Overall Study|Withdrawal by Subject|0|||
164052393|NCT00141297|592550786|FG001|Overall Study|Withdrawal by Subject|0|||
164052394|NCT00141297|592550787|FG002|Overall Study|Withdrawal by Subject|0|||
164052395|NCT00141297|592550788|FG003|Overall Study|Withdrawal by Subject|0|||
164052396|NCT00141297|592550789|FG004|Overall Study|Withdrawal by Subject|0|||
164052397|NCT00141297|592550790|FG005|Overall Study|Withdrawal by Subject|0|||
164052398|NCT00141297|592550791|FG006|Overall Study|Withdrawal by Subject|0|||
164052399|NCT00141297|592550792|FG007|Overall Study|Withdrawal by Subject|0|||
164052400|NCT00141297|592550793|FG008|Overall Study|Withdrawal by Subject|1|||
164052401|NCT00141297|592550794|FG009|Overall Study|Withdrawal by Subject|0|||
164052402|NCT00141297|592550785|FG000|Overall Study|Other|0|||
164052403|NCT00141297|592550786|FG001|Overall Study|Other|0|||
164052404|NCT00141297|592550787|FG002|Overall Study|Other|0|||
164052405|NCT00141297|592550788|FG003|Overall Study|Other|1|||
164052406|NCT00141297|592550789|FG004|Overall Study|Other|5|||
164052407|NCT00141297|592550790|FG005|Overall Study|Other|0|||
164052408|NCT00141297|592550791|FG006|Overall Study|Other|0|||
164052409|NCT00141297|592550792|FG007|Overall Study|Other|0|||
164052410|NCT00141297|592550793|FG008|Overall Study|Other|2|||
164052411|NCT00141297|592550794|FG009|Overall Study|Other|0|||
164100418|NCT00573443|592733392|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164100419|NCT00573443|592733393|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
164100420|NCT00573443|592733391|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
164100421|NCT00573443|592733392|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
164100422|NCT00573443|592733393|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
164100423|NCT00573443|592733391|FG000|Open-Label Extension Phase|Adverse Event|3|||
164100424|NCT00573443|592733392|FG001|Open-Label Extension Phase|Adverse Event|0|||
164100425|NCT00573443|592733393|FG002|Open-Label Extension Phase|Adverse Event|0|||
164100426|NCT00573443|592733391|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
164100427|NCT00573443|592733392|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
164100428|NCT00573443|592733393|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
164100429|NCT00573443|592733391|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
164100430|NCT00573443|592733392|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
164100431|NCT00573443|592733393|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
164100432|NCT00573443|592733391|FG000|Open-Label Extension Phase|Protocol Violation|2|||
164052412|NCT00141297|592550785|FG000|Overall Study|Progressive Disease|2|||
164052413|NCT00141297|592550786|FG001|Overall Study|Progressive Disease|3|||
164052414|NCT00141297|592550787|FG002|Overall Study|Progressive Disease|6|||
164052415|NCT00141297|592550788|FG003|Overall Study|Progressive Disease|2|||
164052416|NCT00141297|592550789|FG004|Overall Study|Progressive Disease|15|||
164052417|NCT00141297|592550790|FG005|Overall Study|Progressive Disease|2|||
164052418|NCT00141297|592550791|FG006|Overall Study|Progressive Disease|3|||
164052419|NCT00141297|592550792|FG007|Overall Study|Progressive Disease|3|||
164052420|NCT00141297|592550793|FG008|Overall Study|Progressive Disease|15|||
164052421|NCT00141297|592550794|FG009|Overall Study|Progressive Disease|6|||
164052422|NCT00141297|592550785|FG000|Overall Study|Transitioned|0|||
164052423|NCT00141297|592550786|FG001|Overall Study|Transitioned|0|||
164052424|NCT00141297|592550787|FG002|Overall Study|Transitioned|0|||
164052425|NCT00141297|592550788|FG003|Overall Study|Transitioned|0|||
164052426|NCT00141297|592550789|FG004|Overall Study|Transitioned|1|||
164052427|NCT00141297|592550790|FG005|Overall Study|Transitioned|0|||
164052428|NCT00141297|592550791|FG006|Overall Study|Transitioned|0|||
164052429|NCT00141297|592550792|FG007|Overall Study|Transitioned|0|||
164052430|NCT00141297|592550793|FG008|Overall Study|Transitioned|0|||
164052431|NCT00141297|592550794|FG009|Overall Study|Transitioned|0|||
164052432|NCT00394654|592550795|FG000|Overall Study|Lost to Follow-up|1|||
164052433|NCT00394654|592550796|FG001|Overall Study|Lost to Follow-up|0|||
164052434|NCT00394654|592550795|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
164052435|NCT00394654|592550796|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
164052436|NCT03442595|592550797|FG000|Overall Study|Lost to Follow-up|94|||
164052437|NCT03442595|592550798|FG001|Overall Study|Lost to Follow-up|0|||
164052438|NCT01060150|592550801|FG000|Overall Study|Adverse Event|6|||
164052439|NCT01060150|592550801|FG000|Overall Study|Lost to Follow-up|1|||
164052440|NCT01060150|592550801|FG000|Overall Study|Protocol Violation|6|||
164052441|NCT01060150|592550801|FG000|Overall Study|Withdrawal by Subject|8|||
164052442|NCT01060150|592550801|FG000|Overall Study|Enrolled, but not treated|2|||
164052443|NCT03018340|592550802|FG000|Overall Study|Adverse Event|1|||
164052444|NCT03018340|592550803|FG001|Overall Study|Adverse Event|2|||
164052445|NCT03018340|592550802|FG000|Overall Study|Withdrawal by Subject|0|||
164052446|NCT03018340|592550803|FG001|Overall Study|Withdrawal by Subject|8|||
164052447|NCT03018340|592550802|FG000|Overall Study|Lack of Efficacy|0|||
164052448|NCT03018340|592550803|FG001|Overall Study|Lack of Efficacy|1|||
164052449|NCT03018340|592550802|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
164052450|NCT03018340|592550803|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
164052451|NCT03018340|592550802|FG000|Overall Study|Lost to Follow-up|1|||
164052452|NCT03018340|592550803|FG001|Overall Study|Lost to Follow-up|7|||
164052453|NCT03018340|592550802|FG000|Overall Study|Protocol Violation|3|||
164052454|NCT03018340|592550803|FG001|Overall Study|Protocol Violation|7|||
164052455|NCT03018340|592550802|FG000|Overall Study|Not further specified|0|||
164052456|NCT03018340|592550803|FG001|Overall Study|Not further specified|1|||
164052457|NCT01836549|592550804|FG000|Overall Study|Did not receive study drug|0|||
164052458|NCT01836549|592550805|FG001|Overall Study|Did not receive study drug|0|||
164052459|NCT01836549|592550806|FG002|Overall Study|Did not receive study drug|1|||
164052460|NCT01836549|592550807|FG003|Overall Study|Did not receive study drug|0|||
164052461|NCT01836549|592550808|FG004|Overall Study|Did not receive study drug|0|||
164052462|NCT01836549|592550809|FG005|Overall Study|Did not receive study drug|0|||
164052463|NCT01836549|592550810|FG006|Overall Study|Did not receive study drug|0|||
164052464|NCT01836549|592550804|FG000|Overall Study|Patient declared ineligible|0|||
164052465|NCT01836549|592550805|FG001|Overall Study|Patient declared ineligible|0|||
164052466|NCT01836549|592550806|FG002|Overall Study|Patient declared ineligible|0|||
164052467|NCT01836549|592550807|FG003|Overall Study|Patient declared ineligible|1|||
164052468|NCT01836549|592550808|FG004|Overall Study|Patient declared ineligible|0|||
164052469|NCT01836549|592550809|FG005|Overall Study|Patient declared ineligible|0|||
164052470|NCT01836549|592550810|FG006|Overall Study|Patient declared ineligible|0|||
164052471|NCT01836549|592550804|FG000|Overall Study|Patient inevaluable to start therapy|0|||
164052472|NCT01836549|592550805|FG001|Overall Study|Patient inevaluable to start therapy|0|||
164100433|NCT00573443|592733392|FG001|Open-Label Extension Phase|Protocol Violation|0|||
164100434|NCT00573443|592733393|FG002|Open-Label Extension Phase|Protocol Violation|0|||
164100435|NCT00573443|592733391|FG000|Open-Label Extension Phase|Other|2|||
164100436|NCT00573443|592733392|FG001|Open-Label Extension Phase|Other|0|||
164100437|NCT00573443|592733393|FG002|Open-Label Extension Phase|Other|0|||
164100438|NCT04567186|592733397|FG000|Period 1|COVID-19 related|1|||
164100439|NCT04567186|592733398|FG001|Period 1|COVID-19 related|0|||
164100440|NCT04567186|592733397|FG000|Period 1|Protocol Violation|0|||
164100441|NCT04567186|592733398|FG001|Period 1|Protocol Violation|1|||
164100442|NCT04567186|592733397|FG000|Period 1|Adverse Event|0|||
164100443|NCT04567186|592733398|FG001|Period 1|Adverse Event|2|||
164100444|NCT04567186|592733397|FG000|Period 2|COVID-19 Related|0|||
164100445|NCT04567186|592733398|FG001|Period 2|COVID-19 Related|1|||
164100446|NCT04567186|592733397|FG000|Period 2|Protocol Violation|0|||
164100447|NCT04567186|592733398|FG001|Period 2|Protocol Violation|1|||
164100448|NCT04567186|592733397|FG000|Period 2|Lost to Follow-up|0|||
164100449|NCT04567186|592733398|FG001|Period 2|Lost to Follow-up|1|||
164100450|NCT04567186|592733397|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
164100451|NCT04567186|592733398|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
164100452|NCT04247282|592733399|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
164100453|NCT04247282|592733400|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
164100454|NCT04247282|592733401|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
164100455|NCT04247282|592733402|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
164100456|NCT04247282|592733399|FG000|Overall Study|Refused further treatment|0|||
164100457|NCT04247282|592733400|FG001|Overall Study|Refused further treatment|1|||
164100458|NCT04247282|592733401|FG002|Overall Study|Refused further treatment|0|||
164100459|NCT04247282|592733402|FG003|Overall Study|Refused further treatment|0|||
164100460|NCT02481830|592733404|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
164100461|NCT02481830|592733405|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
164100462|NCT02481830|592733404|FG000|Pre-treatment|Withdrawal by Subject|0|||
164100463|NCT02481830|592733405|FG001|Pre-treatment|Withdrawal by Subject|10|||
164100464|NCT02481830|592733404|FG000|Pre-treatment|Disease Progression|1|||
164100465|NCT02481830|592733405|FG001|Pre-treatment|Disease Progression|1|||
164100466|NCT02481830|592733404|FG000|Pre-treatment|Other reasons|0|||
164100467|NCT02481830|592733405|FG001|Pre-treatment|Other reasons|1|||
164100468|NCT02481830|592733404|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
164100469|NCT02481830|592733405|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
164100470|NCT02481830|592733404|FG000|Treatment|Disease Progression|233|||
164100471|NCT02481830|592733405|FG001|Treatment|Disease Progression|171|||
164100472|NCT02481830|592733404|FG000|Treatment|Study drug toxicity|18|||
164100473|NCT02481830|592733405|FG001|Treatment|Study drug toxicity|38|||
164100474|NCT02481830|592733404|FG000|Treatment|Death|1|||
164100475|NCT02481830|592733405|FG001|Treatment|Death|1|||
164100476|NCT02481830|592733404|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
164100477|NCT02481830|592733405|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
164100478|NCT02481830|592733404|FG000|Treatment|Participants request to discontinue Study treatment|6|||
164100479|NCT02481830|592733405|FG001|Treatment|Participants request to discontinue Study treatment|34|||
164100480|NCT02481830|592733404|FG000|Treatment|Withdrawal by Subject|2|||
164100481|NCT02481830|592733405|FG001|Treatment|Withdrawal by Subject|3|||
164100482|NCT02481830|592733404|FG000|Treatment|Lost to Follow-up|1|||
164100483|NCT02481830|592733405|FG001|Treatment|Lost to Follow-up|0|||
164100484|NCT02481830|592733404|FG000|Treatment|Maximum Clinical Benefit|0|||
164100485|NCT02481830|592733405|FG001|Treatment|Maximum Clinical Benefit|5|||
164100486|NCT02481830|592733404|FG000|Treatment|Administrative reason by sponsor|1|||
164100487|NCT02481830|592733405|FG001|Treatment|Administrative reason by sponsor|1|||
164100488|NCT02481830|592733404|FG000|Treatment|Other reasons|6|||
164100489|NCT02481830|592733405|FG001|Treatment|Other reasons|1|||
164100490|NCT00772941|592733406|FG000|Overall Study|CRFs not available|195|||
164100491|NCT00772941|592733406|FG000|Overall Study|Study not completed|16|||
164100492|NCT00772941|592733406|FG000|Overall Study|Missed Visits|374|||
164100493|NCT00772941|592733406|FG000|Overall Study|Poor Compliance|7|||
164100494|NCT00772941|592733406|FG000|Overall Study|GPSP Violation|90|||
164100495|NCT02714062|592733408|FG000|Overall Study|Adverse Event|0|||
164100496|NCT02714062|592733409|FG001|Overall Study|Adverse Event|0|||
164100497|NCT02714062|592733410|FG002|Overall Study|Adverse Event|2|||
164100498|NCT02714062|592733408|FG000|Overall Study|Withdrawal by Subject|1|||
164100499|NCT02714062|592733409|FG001|Overall Study|Withdrawal by Subject|0|||
164100500|NCT02714062|592733410|FG002|Overall Study|Withdrawal by Subject|1|||
164100501|NCT02714062|592733408|FG000|Overall Study|Protocol Violation|0|||
164100502|NCT02714062|592733409|FG001|Overall Study|Protocol Violation|1|||
164100503|NCT02714062|592733410|FG002|Overall Study|Protocol Violation|0|||
164100504|NCT02682784|592733411|FG000|Overall Study|Withdrawal by Subject|0|||
164100505|NCT02682784|592733412|FG001|Overall Study|Withdrawal by Subject|2|||
164100506|NCT02682784|592733413|FG002|Overall Study|Withdrawal by Subject|1|||
164100507|NCT02682784|592733414|FG003|Overall Study|Withdrawal by Subject|2|||
164100508|NCT02682784|592733411|FG000|Overall Study|Physician Decision|1|||
164100509|NCT02682784|592733412|FG001|Overall Study|Physician Decision|0|||
164100510|NCT02682784|592733413|FG002|Overall Study|Physician Decision|1|||
164100511|NCT02682784|592733414|FG003|Overall Study|Physician Decision|1|||
164100512|NCT01702987|592733415|FG000|Overall Study|Withdrawal by Subject|1|||
164100513|NCT01702987|592733416|FG001|Overall Study|Withdrawal by Subject|0|||
164100514|NCT00467363|592733417|FG000|Overall Study|Lost to Follow-up|80|||
164100515|NCT00467363|592733418|FG001|Overall Study|Lost to Follow-up|70|||
164100516|NCT03181594|592733419|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
164100517|NCT03181594|592733419|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
164100518|NCT03181594|592733419|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
164100519|NCT03181594|592733419|FG000|Initial Study Protocol (12-month FU)|Death|1|||
164100520|NCT03181594|592733419|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
164100521|NCT03181594|592733419|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
164100522|NCT02017223|592733420|FG000|Overall Study|Algorithm problems|2|||
164100523|NCT00365846|592733422|FG000|Overall Study|Lost to Follow-up|1|||
164100524|NCT00904215|592733423|FG000|Overall Study|Adverse Event|25|||
164100525|NCT00904215|592733423|FG000|Overall Study|Protocol Violation|10|||
164100526|NCT00904215|592733423|FG000|Overall Study|Lost to Follow-up|63|||
164100527|NCT00904215|592733423|FG000|Overall Study|Withdrawal by Subject|9|||
164100528|NCT00904215|592733423|FG000|Overall Study|Other|28|||
164100529|NCT00838630|592733427|FG000|First Intervention|Adverse Event|1|||
164100530|NCT00838630|592733428|FG001|First Intervention|Adverse Event|0|||
164100531|NCT00838630|592733427|FG000|Washout: 7 Days|Protocol Violation|1|||
164100532|NCT00838630|592733428|FG001|Washout: 7 Days|Protocol Violation|0|||
164100533|NCT02057458|592733433|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
164100534|NCT02057458|592733434|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
164100535|NCT02057458|592733435|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
164100536|NCT02057458|592733433|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
164100537|NCT02057458|592733434|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
164100538|NCT02057458|592733435|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
164100539|NCT02057458|592733433|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
164100540|NCT02057458|592733434|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
164100541|NCT02057458|592733435|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
164100542|NCT00723710|592733440|FG000|Overall Study|Disease progression|48|||
164100543|NCT00723710|592733440|FG000|Overall Study|Adverse Event|88|||
164100544|NCT00723710|592733440|FG000|Overall Study|Withdrawal by Subject|36|||
164100545|NCT00723710|592733440|FG000|Overall Study|Physician Decision|2|||
164100546|NCT01864174|592733441|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
164100547|NCT01864174|592733442|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
164100548|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
164100549|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
164100550|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
164100551|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
164100552|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
164100553|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
164100554|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Death|1|||
164100555|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Death|0|||
164100556|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
164100557|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
164100558|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
164100559|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
164100560|NCT01864174|592733441|FG000|Double Blind - Compliant Randomized|Other|6|||
164100561|NCT01864174|592733442|FG001|Double Blind - Compliant Randomized|Other|10|||
164100562|NCT01864174|592733441|FG000|Off Treatment Follow-Up|Other|2|||
164100563|NCT01864174|592733442|FG001|Off Treatment Follow-Up|Other|0|||
164100564|NCT01864174|592733441|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
164100565|NCT01864174|592733442|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
164100566|NCT02158663|592733445|FG000|Overall Study|Withdrawal by Subject|5|||
164100567|NCT02158663|592733446|FG001|Overall Study|Withdrawal by Subject|4|||
164100568|NCT00576056|592733447|FG000|Overall Study|Adverse Event|1|||
164100569|NCT00576056|592733447|FG000|Overall Study|Death|1|||
164100570|NCT00576056|592733447|FG000|Overall Study|Lack of Efficacy|1|||
164100571|NCT00576056|592733447|FG000|Overall Study|Withdrawal by Subject|2|||
164100572|NCT00576056|592733447|FG000|Overall Study|did not meet eligibility criteria|8|||
164100573|NCT00576056|592733447|FG000|Overall Study|Physician Decision|1|||
164100574|NCT03197883|592733448|FG000|Overall Study|Adverse Event|1|||
164100575|NCT03197883|592733449|FG001|Overall Study|Adverse Event|1|||
164100576|NCT03197883|592733448|FG000|Overall Study|Lost to Follow-up|1|||
164100577|NCT03197883|592733449|FG001|Overall Study|Lost to Follow-up|0|||
164100578|NCT03197883|592733448|FG000|Overall Study|Protocol Violation|1|||
164100579|NCT03197883|592733449|FG001|Overall Study|Protocol Violation|0|||
164100580|NCT03197883|592733448|FG000|Overall Study|Other (Not Specified)|0|||
164052473|NCT01836549|592550806|FG002|Overall Study|Patient inevaluable to start therapy|0|||
164052474|NCT01836549|592550807|FG003|Overall Study|Patient inevaluable to start therapy|0|||
164052475|NCT01836549|592550808|FG004|Overall Study|Patient inevaluable to start therapy|0|||
164052476|NCT01836549|592550809|FG005|Overall Study|Patient inevaluable to start therapy|0|||
164052477|NCT01836549|592550810|FG006|Overall Study|Patient inevaluable to start therapy|1|||
164052478|NCT02192190|592550811|FG000|Overall Study|Adverse Event|1|||
164052479|NCT02192190|592550812|FG001|Overall Study|Adverse Event|1|||
164052480|NCT02192190|592550813|FG002|Overall Study|Adverse Event|0|||
164052481|NCT02192190|592550814|FG003|Overall Study|Adverse Event|0|||
164052482|NCT02192190|592550815|FG004|Overall Study|Adverse Event|0|||
164052483|NCT02192190|592550816|FG005|Overall Study|Adverse Event|0|||
164052484|NCT02192190|592550811|FG000|Overall Study|Lost to Follow-up|3|||
164052485|NCT02192190|592550812|FG001|Overall Study|Lost to Follow-up|3|||
164052486|NCT02192190|592550813|FG002|Overall Study|Lost to Follow-up|2|||
164052487|NCT02192190|592550814|FG003|Overall Study|Lost to Follow-up|1|||
164052488|NCT02192190|592550815|FG004|Overall Study|Lost to Follow-up|4|||
164052489|NCT02192190|592550816|FG005|Overall Study|Lost to Follow-up|3|||
164052490|NCT02192190|592550811|FG000|Overall Study|Physician Decision|2|||
164052491|NCT02192190|592550812|FG001|Overall Study|Physician Decision|0|||
164052492|NCT02192190|592550813|FG002|Overall Study|Physician Decision|0|||
164052493|NCT02192190|592550814|FG003|Overall Study|Physician Decision|0|||
164052494|NCT02192190|592550815|FG004|Overall Study|Physician Decision|0|||
164052495|NCT02192190|592550816|FG005|Overall Study|Physician Decision|0|||
164052496|NCT02192190|592550811|FG000|Overall Study|Terminated by Sponsor|43|||
164052497|NCT02192190|592550812|FG001|Overall Study|Terminated by Sponsor|23|||
164052498|NCT02192190|592550813|FG002|Overall Study|Terminated by Sponsor|20|||
164052499|NCT02192190|592550814|FG003|Overall Study|Terminated by Sponsor|23|||
164052500|NCT02192190|592550815|FG004|Overall Study|Terminated by Sponsor|21|||
164052501|NCT02192190|592550816|FG005|Overall Study|Terminated by Sponsor|23|||
164052502|NCT02192190|592550811|FG000|Overall Study|Withdrawal by Subject|4|||
164052503|NCT02192190|592550812|FG001|Overall Study|Withdrawal by Subject|1|||
164052504|NCT02192190|592550813|FG002|Overall Study|Withdrawal by Subject|2|||
164052505|NCT02192190|592550814|FG003|Overall Study|Withdrawal by Subject|1|||
164052506|NCT02192190|592550815|FG004|Overall Study|Withdrawal by Subject|5|||
164052507|NCT02192190|592550816|FG005|Overall Study|Withdrawal by Subject|3|||
164052508|NCT02192190|592550811|FG000|Overall Study|Could not Keep Visit Schedule|1|||
164052509|NCT02192190|592550812|FG001|Overall Study|Could not Keep Visit Schedule|0|||
164052510|NCT02192190|592550813|FG002|Overall Study|Could not Keep Visit Schedule|0|||
164052511|NCT02192190|592550814|FG003|Overall Study|Could not Keep Visit Schedule|0|||
164052512|NCT02192190|592550815|FG004|Overall Study|Could not Keep Visit Schedule|0|||
164052513|NCT02192190|592550816|FG005|Overall Study|Could not Keep Visit Schedule|0|||
164052514|NCT02192190|592550811|FG000|Overall Study|Positive Drug Screen|0|||
164052515|NCT02192190|592550812|FG001|Overall Study|Positive Drug Screen|0|||
164052516|NCT02192190|592550813|FG002|Overall Study|Positive Drug Screen|0|||
164052517|NCT02192190|592550814|FG003|Overall Study|Positive Drug Screen|1|||
164052518|NCT02192190|592550815|FG004|Overall Study|Positive Drug Screen|0|||
164052519|NCT02192190|592550816|FG005|Overall Study|Positive Drug Screen|0|||
164052520|NCT02192190|592550811|FG000|Overall Study|Inadequate Pain Relief|0|||
164052521|NCT02192190|592550812|FG001|Overall Study|Inadequate Pain Relief|1|||
164052522|NCT02192190|592550813|FG002|Overall Study|Inadequate Pain Relief|1|||
164052523|NCT02192190|592550814|FG003|Overall Study|Inadequate Pain Relief|0|||
164052524|NCT02192190|592550815|FG004|Overall Study|Inadequate Pain Relief|0|||
164052525|NCT02192190|592550816|FG005|Overall Study|Inadequate Pain Relief|0|||
164052526|NCT00381706|592550817|FG000|Overall Study|Never treated|7|||
164052527|NCT00381706|592550818|FG001|Overall Study|Never treated|2|||
164052528|NCT00381706|592550819|FG002|Overall Study|Never treated|1|||
164052529|NCT02364999|592550820|FG000|Overall Study|Death|136|||
164052530|NCT02364999|592550821|FG001|Overall Study|Death|138|||
164052531|NCT02364999|592550820|FG000|Overall Study|Lost to Follow-up|10|||
164052532|NCT02364999|592550821|FG001|Overall Study|Lost to Follow-up|15|||
164052533|NCT02364999|592550820|FG000|Overall Study|Protocol Violation|3|||
164052534|NCT02364999|592550821|FG001|Overall Study|Protocol Violation|2|||
164052535|NCT02364999|592550820|FG000|Overall Study|Withdrawal by Subject|14|||
164052536|NCT02364999|592550821|FG001|Overall Study|Withdrawal by Subject|14|||
164052537|NCT02364999|592550820|FG000|Overall Study|Other|0|||
164052538|NCT02364999|592550821|FG001|Overall Study|Other|1|||
164052539|NCT02364999|592550820|FG000|Overall Study|Randomized but did not receive treatment|2|||
164052540|NCT02364999|592550821|FG001|Overall Study|Randomized but did not receive treatment|3|||
164052541|NCT00550615|592550822|FG000|Overall Study|Withdrawal by Subject|0|||
164052542|NCT00550615|592550823|FG001|Overall Study|Withdrawal by Subject|0|||
164052543|NCT00550615|592550824|FG002|Overall Study|Withdrawal by Subject|2|||
164052544|NCT00550615|592550825|FG003|Overall Study|Withdrawal by Subject|3|||
164052545|NCT00550615|592550822|FG000|Overall Study|Not evaluable|0|||
164052546|NCT00550615|592550823|FG001|Overall Study|Not evaluable|0|||
164052547|NCT00550615|592550824|FG002|Overall Study|Not evaluable|2|||
164052548|NCT00550615|592550825|FG003|Overall Study|Not evaluable|7|||
164052549|NCT01234337|592550826|FG000|Overall Study|Adverse Event|58|||
164052550|NCT01234337|592550827|FG001|Overall Study|Adverse Event|21|||
164052551|NCT01234337|592550826|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
164052552|NCT01234337|592550827|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
164052553|NCT01234337|592550826|FG000|Overall Study|Investi. decision not protocol driven|5|||
164052554|NCT01234337|592550827|FG001|Overall Study|Investi. decision not protocol driven|6|||
164052555|NCT01234337|592550826|FG000|Overall Study|Non-compliant with study medication|3|||
164052556|NCT01234337|592550827|FG001|Overall Study|Non-compliant with study medication|2|||
164052557|NCT01234337|592550826|FG000|Overall Study|Randomized but not treated|6|||
164052558|NCT01234337|592550827|FG001|Overall Study|Randomized but not treated|4|||
164052559|NCT01234337|592550826|FG000|Overall Study|Lost to Follow-up|0|||
164052560|NCT01234337|592550827|FG001|Overall Study|Lost to Follow-up|1|||
164052561|NCT01234337|592550826|FG000|Overall Study|Protocol Violation|2|||
164052562|NCT01234337|592550827|FG001|Overall Study|Protocol Violation|3|||
164052563|NCT01234337|592550826|FG000|Overall Study|Withdrawal by Subject|11|||
164052564|NCT01234337|592550827|FG001|Overall Study|Withdrawal by Subject|9|||
164052565|NCT01234337|592550826|FG000|Overall Study|Death|0|||
164052566|NCT01234337|592550827|FG001|Overall Study|Death|1|||
164052567|NCT01234337|592550826|FG000|Overall Study|Switch to commercial drug|0|||
164052568|NCT01234337|592550827|FG001|Overall Study|Switch to commercial drug|1|||
164052569|NCT02181504|592550830|FG000|Overall Study|Adverse Event|1|||
164052570|NCT02181504|592550831|FG001|Overall Study|Adverse Event|1|||
164052571|NCT02181504|592550832|FG002|Overall Study|Adverse Event|1|||
164052572|NCT02555722|592550833|FG000|Week 2|Adverse Event|0|||
164052573|NCT02555722|592550834|FG001|Week 2|Adverse Event|1|||
164052574|NCT02555722|592550833|FG000|Week 2|Withdrawal by Subject|1|||
164052575|NCT02555722|592550834|FG001|Week 2|Withdrawal by Subject|0|||
164052576|NCT02555722|592550833|FG000|Month 1|Lens Discomfort|1|||
164052577|NCT02555722|592550834|FG001|Month 1|Lens Discomfort|0|||
164052578|NCT02555722|592550833|FG000|Month 2|Withdrawal by Subject|3|||
164052579|NCT02555722|592550834|FG001|Month 2|Withdrawal by Subject|0|||
164052580|NCT02555722|592550833|FG000|Month 2|Lost to Follow-up|1|||
164052581|NCT02555722|592550834|FG001|Month 2|Lost to Follow-up|0|||
164052582|NCT02584660|592550844|FG000|Overall Study|Adverse Event|4|||
164052583|NCT02584660|592550845|FG001|Overall Study|Adverse Event|0|||
164052584|NCT02584660|592550844|FG000|Overall Study|Lost to Follow-up|3|||
164052585|NCT02584660|592550845|FG001|Overall Study|Lost to Follow-up|4|||
164052586|NCT02584660|592550844|FG000|Overall Study|Protocol Violation|0|||
164052587|NCT02584660|592550845|FG001|Overall Study|Protocol Violation|1|||
164052588|NCT02584660|592550844|FG000|Overall Study|Withdrawal by Subject|0|||
164052589|NCT02584660|592550845|FG001|Overall Study|Withdrawal by Subject|2|||
164052590|NCT02584660|592550844|FG000|Overall Study|Other|0|||
164052591|NCT02584660|592550845|FG001|Overall Study|Other|1|||
164052592|NCT00461552|592550846|FG000|Overall Study|Drug Dispensing error|0|||
164052593|NCT00461552|592550847|FG001|Overall Study|Drug Dispensing error|2|||
164052594|NCT00374452|592550848|FG000|Overall Study|Left clinic before intervention started|4|||
164052595|NCT00374452|592550849|FG001|Overall Study|Left clinic before intervention started|1|||
164052596|NCT00374452|592550848|FG000|Overall Study|Change in job role before intervention|0|||
164052597|NCT00374452|592550849|FG001|Overall Study|Change in job role before intervention|1|||
164052598|NCT00374452|592550848|FG000|Overall Study|Left clinic after intervention started|1|||
164052599|NCT00374452|592550849|FG001|Overall Study|Left clinic after intervention started|1|||
164052600|NCT00374452|592550848|FG000|Overall Study|Withdrawal by Subject|0|||
164052601|NCT00374452|592550849|FG001|Overall Study|Withdrawal by Subject|2|||
164052602|NCT02877134|592550850|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052603|NCT02877134|592550851|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
164052604|NCT02877134|592550852|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052605|NCT02877134|592550853|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052606|NCT02877134|592550854|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052607|NCT02877134|592550855|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
164052608|NCT02877134|592550856|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052609|NCT02877134|592550857|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052610|NCT02877134|592550858|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052611|NCT02877134|592550859|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052612|NCT02877134|592550860|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052613|NCT02877134|592550861|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
164052614|NCT02877134|592550850|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052615|NCT02877134|592550851|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
164052616|NCT02877134|592550852|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052617|NCT02877134|592550853|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
164052618|NCT02877134|592550854|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052619|NCT02877134|592550855|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052620|NCT02877134|592550856|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
164052621|NCT02877134|592550857|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052622|NCT02877134|592550858|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052623|NCT02877134|592550859|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052624|NCT02877134|592550860|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052625|NCT02877134|592550861|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
164052626|NCT02877134|592550850|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
164052627|NCT02877134|592550851|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
164052628|NCT02877134|592550852|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
164052629|NCT02877134|592550853|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
164052630|NCT02877134|592550854|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
164052631|NCT02877134|592550855|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
164052632|NCT02877134|592550856|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
164052633|NCT02877134|592550857|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164052634|NCT02877134|592550858|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164052635|NCT02877134|592550859|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164052636|NCT02877134|592550860|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164052637|NCT02877134|592550861|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
164052638|NCT02877134|592550850|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
164052639|NCT02877134|592550851|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
164052640|NCT02877134|592550852|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
164052641|NCT02877134|592550853|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
164052642|NCT02877134|592550854|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
164052643|NCT02877134|592550855|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
164052644|NCT02877134|592550856|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
164052645|NCT02877134|592550857|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
164052646|NCT02877134|592550858|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
164052647|NCT02877134|592550859|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
164052648|NCT02877134|592550860|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
164052649|NCT02877134|592550861|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
164052650|NCT02877134|592550850|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052651|NCT02877134|592550851|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052652|NCT02877134|592550852|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052653|NCT02877134|592550853|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052654|NCT02877134|592550854|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052655|NCT02877134|592550855|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052656|NCT02877134|592550856|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052657|NCT02877134|592550857|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052658|NCT02877134|592550858|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
164052659|NCT02877134|592550859|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052660|NCT02877134|592550860|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052661|NCT02877134|592550861|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
164052662|NCT02877134|592550850|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052663|NCT02877134|592550851|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052664|NCT02877134|592550852|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052665|NCT02877134|592550853|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052666|NCT02877134|592550854|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052667|NCT02877134|592550855|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052668|NCT02877134|592550856|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
164052669|NCT02877134|592550857|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
164052670|NCT02877134|592550858|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
164052671|NCT02877134|592550859|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
164052672|NCT02877134|592550860|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
164052673|NCT02877134|592550861|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
164052674|NCT02877134|592550850|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052675|NCT02877134|592550851|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052676|NCT02877134|592550852|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052677|NCT02877134|592550853|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052678|NCT02877134|592550854|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052679|NCT02877134|592550855|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052680|NCT02877134|592550856|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052681|NCT02877134|592550857|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
164052682|NCT02877134|592550858|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
164052683|NCT02877134|592550859|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
164052684|NCT02877134|592550860|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052685|NCT02877134|592550861|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
164052686|NCT02877134|592550850|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
164100581|NCT03197883|592733449|FG001|Overall Study|Other (Not Specified)|5|||
164100582|NCT01353664|592733450|FG000|Overall Study|Other|3|||
164100583|NCT01353664|592733450|FG000|Overall Study|Disease Progression|16|||
164100584|NCT03273153|592733451|FG000|Overall Study|Adverse Event|1|||
164100585|NCT03273153|592733452|FG001|Overall Study|Adverse Event|2|||
164100586|NCT03273153|592733451|FG000|Overall Study|Missing|0|||
164100587|NCT03273153|592733452|FG001|Overall Study|Missing|2|||
164100588|NCT03273153|592733451|FG000|Overall Study|Other|3|||
164100589|NCT03273153|592733452|FG001|Overall Study|Other|2|||
164100590|NCT03273153|592733451|FG000|Overall Study|Symptomatic Deterioration|0|||
164100591|NCT03273153|592733452|FG001|Overall Study|Symptomatic Deterioration|1|||
164100592|NCT03273153|592733451|FG000|Overall Study|Progressive Disease|6|||
164100593|NCT03273153|592733452|FG001|Overall Study|Progressive Disease|5|||
164100594|NCT03273153|592733451|FG000|Overall Study|Physician Decision|1|||
164100595|NCT03273153|592733452|FG001|Overall Study|Physician Decision|3|||
164100596|NCT03273153|592733451|FG000|Overall Study|Study Terminated by Sponsor|112|||
164100597|NCT03273153|592733452|FG001|Overall Study|Study Terminated by Sponsor|102|||
164100598|NCT03273153|592733451|FG000|Overall Study|Withdrawal by Subject|26|||
164100599|NCT03273153|592733452|FG001|Overall Study|Withdrawal by Subject|25|||
164100600|NCT03273153|592733451|FG000|Overall Study|Protocol Deviation|3|||
164100601|NCT03273153|592733452|FG001|Overall Study|Protocol Deviation|0|||
164100602|NCT03273153|592733451|FG000|Overall Study|Lost to Follow-up|6|||
164100603|NCT03273153|592733452|FG001|Overall Study|Lost to Follow-up|11|||
164100604|NCT03273153|592733451|FG000|Overall Study|Death|66|||
164100605|NCT03273153|592733452|FG001|Overall Study|Death|69|||
164100606|NCT02409355|592733453|FG000|Overall Study|Withdrawal by Subject|1|||
164100607|NCT02409355|592733454|FG001|Overall Study|Withdrawal by Subject|0|||
164100608|NCT02409355|592733453|FG000|Overall Study|Death|1|||
164100609|NCT02409355|592733454|FG001|Overall Study|Death|1|||
164100610|NCT02409355|592733453|FG000|Overall Study|Study terminated by Sponsor|2|||
164100611|NCT02409355|592733454|FG001|Overall Study|Study terminated by Sponsor|3|||
164100612|NCT01237054|592733455|FG000|Overall Study|imaging 10C0096|1|||
164100613|NCT00838539|592733456|FG000|Overall Study|Disease Progression|2|||
164100614|NCT00838539|592733457|FG001|Overall Study|Disease Progression|4|||
164100615|NCT00838539|592733458|FG002|Overall Study|Disease Progression|3|||
164100616|NCT00838539|592733459|FG003|Overall Study|Disease Progression|2|||
164100617|NCT00838539|592733460|FG004|Overall Study|Disease Progression|4|||
164100618|NCT00838539|592733461|FG005|Overall Study|Disease Progression|2|||
164100619|NCT00838539|592733462|FG006|Overall Study|Disease Progression|3|||
164100620|NCT00838539|592733463|FG007|Overall Study|Disease Progression|4|||
164100621|NCT00838539|592733464|FG008|Overall Study|Disease Progression|4|||
164100622|NCT00838539|592733465|FG009|Overall Study|Disease Progression|5|||
164100623|NCT00838539|592733466|FG010|Overall Study|Disease Progression|1|||
164100624|NCT00838539|592733467|FG011|Overall Study|Disease Progression|4|||
164100625|NCT00838539|592733456|FG000|Overall Study|Adverse Event|1|||
164100626|NCT00838539|592733457|FG001|Overall Study|Adverse Event|1|||
164100627|NCT00838539|592733458|FG002|Overall Study|Adverse Event|1|||
164100628|NCT00838539|592733459|FG003|Overall Study|Adverse Event|1|||
164100629|NCT00838539|592733460|FG004|Overall Study|Adverse Event|2|||
164100630|NCT00838539|592733461|FG005|Overall Study|Adverse Event|1|||
164100631|NCT00838539|592733462|FG006|Overall Study|Adverse Event|0|||
164100632|NCT00838539|592733463|FG007|Overall Study|Adverse Event|2|||
164100633|NCT00838539|592733464|FG008|Overall Study|Adverse Event|0|||
164100634|NCT00838539|592733465|FG009|Overall Study|Adverse Event|1|||
164100635|NCT00838539|592733466|FG010|Overall Study|Adverse Event|2|||
164100636|NCT00838539|592733467|FG011|Overall Study|Adverse Event|0|||
164100637|NCT00838539|592733456|FG000|Overall Study|Withdrawal by Subject|0|||
164100638|NCT00838539|592733457|FG001|Overall Study|Withdrawal by Subject|1|||
164100639|NCT00838539|592733458|FG002|Overall Study|Withdrawal by Subject|0|||
164100640|NCT00838539|592733459|FG003|Overall Study|Withdrawal by Subject|0|||
164100641|NCT00838539|592733460|FG004|Overall Study|Withdrawal by Subject|0|||
164100642|NCT00838539|592733461|FG005|Overall Study|Withdrawal by Subject|0|||
164100643|NCT00838539|592733462|FG006|Overall Study|Withdrawal by Subject|0|||
164100644|NCT00838539|592733463|FG007|Overall Study|Withdrawal by Subject|0|||
164100645|NCT00838539|592733464|FG008|Overall Study|Withdrawal by Subject|0|||
164100646|NCT00838539|592733465|FG009|Overall Study|Withdrawal by Subject|1|||
164100647|NCT00838539|592733466|FG010|Overall Study|Withdrawal by Subject|2|||
164100648|NCT00838539|592733467|FG011|Overall Study|Withdrawal by Subject|0|||
164100649|NCT00838539|592733456|FG000|Overall Study|Death|0|||
164100650|NCT00838539|592733457|FG001|Overall Study|Death|0|||
164100651|NCT00838539|592733458|FG002|Overall Study|Death|0|||
164100652|NCT00838539|592733459|FG003|Overall Study|Death|0|||
164100653|NCT00838539|592733460|FG004|Overall Study|Death|0|||
164100654|NCT00838539|592733461|FG005|Overall Study|Death|0|||
164100655|NCT00838539|592733462|FG006|Overall Study|Death|1|||
164100656|NCT00838539|592733463|FG007|Overall Study|Death|0|||
164100657|NCT00838539|592733464|FG008|Overall Study|Death|0|||
164100658|NCT00838539|592733465|FG009|Overall Study|Death|0|||
164100659|NCT00838539|592733466|FG010|Overall Study|Death|0|||
164100660|NCT00838539|592733467|FG011|Overall Study|Death|0|||
164100661|NCT00838539|592733456|FG000|Overall Study|Physician Decision|0|||
164100662|NCT00838539|592733457|FG001|Overall Study|Physician Decision|0|||
164052687|NCT02877134|592550851|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
164052688|NCT02877134|592550852|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
164052689|NCT02877134|592550853|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
164052690|NCT02877134|592550854|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
164052691|NCT02877134|592550855|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
164052692|NCT02877134|592550856|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
164052693|NCT02877134|592550857|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
164052694|NCT02877134|592550858|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
164052695|NCT02877134|592550859|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
164052696|NCT02877134|592550860|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
164052697|NCT02877134|592550861|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
164052698|NCT00523744|592550862|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
164052699|NCT00523744|592550862|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
164052700|NCT00523744|592550862|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
164052701|NCT00523744|592550862|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
164052702|NCT00523744|592550862|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
164052703|NCT00523744|592550862|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
164052704|NCT01289028|592550863|FG000|Overall Study|Progressive Disease|49|||
164052705|NCT01289028|592550863|FG000|Overall Study|Adverse Event|14|||
164052706|NCT01289028|592550863|FG000|Overall Study|Withdrawal by Subject|6|||
164052707|NCT01289028|592550863|FG000|Overall Study|Death|4|||
164052708|NCT01289028|592550863|FG000|Overall Study|Lack of Efficacy|2|||
164052709|NCT01289028|592550863|FG000|Overall Study|No longer required|2|||
164052710|NCT01289028|592550863|FG000|Overall Study|Lost to Follow-up|2|||
164052711|NCT01289028|592550863|FG000|Overall Study|New Cancer Therapy|2|||
164052712|NCT01289028|592550863|FG000|Overall Study|Abnormal Lab Value|1|||
164052713|NCT01289028|592550863|FG000|Overall Study|Missing reason for discon|1|||
164052714|NCT01040728|592550871|FG000|Overall Study|Adverse Event|4|||
164052715|NCT01040728|592550872|FG001|Overall Study|Adverse Event|8|||
164052716|NCT01040728|592550873|FG002|Overall Study|Adverse Event|0|||
164052717|NCT01040728|592550874|FG003|Overall Study|Adverse Event|4|||
164052718|NCT01040728|592550871|FG000|Overall Study|Withdrawal by Subject|0|||
164052719|NCT01040728|592550872|FG001|Overall Study|Withdrawal by Subject|1|||
164052720|NCT01040728|592550873|FG002|Overall Study|Withdrawal by Subject|1|||
164052721|NCT01040728|592550874|FG003|Overall Study|Withdrawal by Subject|0|||
164052722|NCT01040728|592550871|FG000|Overall Study|Protocol Violation|0|||
164052723|NCT01040728|592550872|FG001|Overall Study|Protocol Violation|0|||
164052724|NCT01040728|592550873|FG002|Overall Study|Protocol Violation|0|||
164052725|NCT01040728|592550874|FG003|Overall Study|Protocol Violation|1|||
164052726|NCT01040728|592550871|FG000|Overall Study|Lack of Efficacy|0|||
164052727|NCT01040728|592550872|FG001|Overall Study|Lack of Efficacy|1|||
164052728|NCT01040728|592550873|FG002|Overall Study|Lack of Efficacy|0|||
164052729|NCT01040728|592550874|FG003|Overall Study|Lack of Efficacy|1|||
164052730|NCT01040728|592550871|FG000|Overall Study|Other reasons not listed above|0|||
164052731|NCT01040728|592550872|FG001|Overall Study|Other reasons not listed above|1|||
164052732|NCT01040728|592550873|FG002|Overall Study|Other reasons not listed above|0|||
164052733|NCT01040728|592550874|FG003|Overall Study|Other reasons not listed above|0|||
164052734|NCT00542425|592550881|FG000|Initial 24 Weeks|Administrative reasons|0|||
164052735|NCT00542425|592550882|FG001|Initial 24 Weeks|Administrative reasons|0|||
164052736|NCT00542425|592550883|FG002|Initial 24 Weeks|Administrative reasons|1|||
164052737|NCT00542425|592550884|FG003|Initial 24 Weeks|Administrative reasons|1|||
164052738|NCT00542425|592550885|FG004|Initial 24 Weeks|Administrative reasons|0|||
164052739|NCT00542425|592550881|FG000|Initial 24 Weeks|Adverse Event|0|||
164052740|NCT00542425|592550882|FG001|Initial 24 Weeks|Adverse Event|1|||
164052741|NCT00542425|592550883|FG002|Initial 24 Weeks|Adverse Event|1|||
164052742|NCT00542425|592550884|FG003|Initial 24 Weeks|Adverse Event|3|||
164052743|NCT00542425|592550885|FG004|Initial 24 Weeks|Adverse Event|2|||
164052744|NCT00542425|592550881|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
164052745|NCT00542425|592550882|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
164052746|NCT00542425|592550883|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
164052747|NCT00542425|592550884|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
164052748|NCT00542425|592550885|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
164052749|NCT00542425|592550881|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
164052750|NCT00542425|592550882|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
164052751|NCT00542425|592550883|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
164052752|NCT00542425|592550884|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
164052753|NCT00542425|592550885|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
164052754|NCT00542425|592550881|FG000|Initial 24 Weeks|Non-compliance|0|||
164052755|NCT00542425|592550882|FG001|Initial 24 Weeks|Non-compliance|0|||
164052756|NCT00542425|592550883|FG002|Initial 24 Weeks|Non-compliance|0|||
164052757|NCT00542425|592550884|FG003|Initial 24 Weeks|Non-compliance|1|||
164052758|NCT00542425|592550885|FG004|Initial 24 Weeks|Non-compliance|1|||
164052759|NCT00542425|592550881|FG000|Initial 24 Weeks|Protocol Violation|0|||
164052760|NCT00542425|592550882|FG001|Initial 24 Weeks|Protocol Violation|0|||
164052761|NCT00542425|592550883|FG002|Initial 24 Weeks|Protocol Violation|0|||
164052762|NCT00542425|592550884|FG003|Initial 24 Weeks|Protocol Violation|1|||
164052763|NCT00542425|592550885|FG004|Initial 24 Weeks|Protocol Violation|0|||
164052764|NCT00542425|592550881|FG000|Initial 24 Weeks|Refusal of treatment|2|||
164052765|NCT00542425|592550882|FG001|Initial 24 Weeks|Refusal of treatment|2|||
164052766|NCT00542425|592550883|FG002|Initial 24 Weeks|Refusal of treatment|1|||
164052767|NCT00542425|592550884|FG003|Initial 24 Weeks|Refusal of treatment|4|||
164052768|NCT00542425|592550885|FG004|Initial 24 Weeks|Refusal of treatment|1|||
164052769|NCT00542425|592550881|FG000|Initial 24 Weeks|Other|0|||
164052770|NCT00542425|592550882|FG001|Initial 24 Weeks|Other|2|||
164052771|NCT00542425|592550883|FG002|Initial 24 Weeks|Other|1|||
164052772|NCT00542425|592550884|FG003|Initial 24 Weeks|Other|0|||
164052773|NCT00542425|592550885|FG004|Initial 24 Weeks|Other|0|||
164052774|NCT00542425|592550881|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
164052775|NCT00542425|592550882|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
164052776|NCT00542425|592550883|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
164052777|NCT00542425|592550884|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
164052778|NCT00542425|592550885|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
164052779|NCT00542425|592550881|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164052780|NCT00542425|592550882|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164052781|NCT00542425|592550883|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
164052782|NCT00542425|592550884|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164052783|NCT00542425|592550885|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
164052784|NCT00542425|592550881|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164052785|NCT00542425|592550882|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
164052786|NCT00542425|592550883|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164052787|NCT00542425|592550884|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164052788|NCT00542425|592550885|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
164052789|NCT00542425|592550881|FG000|Extended 24 Weeks of Treatment|Other|1|||
164052790|NCT00542425|592550882|FG001|Extended 24 Weeks of Treatment|Other|1|||
164052791|NCT00542425|592550883|FG002|Extended 24 Weeks of Treatment|Other|0|||
164052792|NCT00542425|592550884|FG003|Extended 24 Weeks of Treatment|Other|0|||
164052793|NCT00542425|592550885|FG004|Extended 24 Weeks of Treatment|Other|1|||
164052794|NCT01424306|592550886|FG000|Overall Study|Protocol Violation|0|||
164052795|NCT01424306|592550887|FG001|Overall Study|Protocol Violation|0|||
164052796|NCT01424306|592550888|FG002|Overall Study|Protocol Violation|0|||
164052797|NCT01424306|592550889|FG003|Overall Study|Protocol Violation|0|||
164052798|NCT01424306|592550890|FG004|Overall Study|Protocol Violation|1|||
164052799|NCT01424306|592550891|FG005|Overall Study|Protocol Violation|0|||
164052800|NCT02096471|592550894|FG000|Overall Study|Adverse Event|1|||
164052801|NCT02096471|592550894|FG000|Overall Study|Lack of Efficacy|7|||
164052802|NCT02096471|592550894|FG000|Overall Study|Withdrawal by Subject|3|||
164052803|NCT02096471|592550894|FG000|Overall Study|Non-Compliant|2|||
164052804|NCT03344562|592550895|FG000|Overall Study|Withdrawal by Subject|2|||
164052805|NCT03344562|592550896|FG001|Overall Study|Withdrawal by Subject|0|||
164052806|NCT02463331|592550897|FG000|Overall Study|Adverse Event|4|||
164052807|NCT02463331|592550898|FG001|Overall Study|Adverse Event|2|||
164052808|NCT02463331|592550897|FG000|Overall Study|Lost to Follow-up|1|||
164052809|NCT02463331|592550898|FG001|Overall Study|Lost to Follow-up|1|||
164052810|NCT02463331|592550897|FG000|Overall Study|Pregnancy|2|||
164052811|NCT02463331|592550898|FG001|Overall Study|Pregnancy|3|||
164052812|NCT02463331|592550897|FG000|Overall Study|Lack of Efficacy|6|||
164052813|NCT02463331|592550898|FG001|Overall Study|Lack of Efficacy|0|||
164052814|NCT02463331|592550897|FG000|Overall Study|Physician Decision|3|||
164052815|NCT02463331|592550898|FG001|Overall Study|Physician Decision|0|||
164052816|NCT02590406|592550899|FG000|Overall Study|Adverse Event|1|||
164052817|NCT02590406|592550900|FG001|Overall Study|Adverse Event|0|||
164052818|NCT02590406|592550899|FG000|Overall Study|Saturometer malfunction|0|||
164052819|NCT02590406|592550900|FG001|Overall Study|Saturometer malfunction|1|||
164052820|NCT00631969|592550901|FG000|Overall Study|Adverse Event|3|||
164052821|NCT00631969|592550902|FG001|Overall Study|Adverse Event|1|||
164052822|NCT00631969|592550901|FG000|Overall Study|Lack of Efficacy|2|||
164052823|NCT00631969|592550902|FG001|Overall Study|Lack of Efficacy|8|||
164052824|NCT00631969|592550901|FG000|Overall Study|Lost to Follow-up|2|||
164052825|NCT00631969|592550902|FG001|Overall Study|Lost to Follow-up|1|||
164052826|NCT00631969|592550901|FG000|Overall Study|Protocol Violation|1|||
164052827|NCT00631969|592550902|FG001|Overall Study|Protocol Violation|1|||
164052828|NCT00631969|592550901|FG000|Overall Study|Consent Withdrawn|5|||
164052829|NCT00631969|592550902|FG001|Overall Study|Consent Withdrawn|7|||
164052830|NCT00631969|592550901|FG000|Overall Study|Noncompliant With Study Medication|0|||
164052831|NCT00631969|592550902|FG001|Overall Study|Noncompliant With Study Medication|1|||
164052832|NCT00631969|592550901|FG000|Overall Study|No Drug Exposure|2|||
164052833|NCT00631969|592550902|FG001|Overall Study|No Drug Exposure|2|||
164052834|NCT01084096|592552496|FG000|Overall Study|Lost to Follow-up|1501|||
164052835|NCT01084096|592552497|FG001|Overall Study|Lost to Follow-up|1833|||
164052836|NCT01084096|592552496|FG000|Overall Study|Withdrawal by Subject|3|||
164052837|NCT01084096|592552497|FG001|Overall Study|Withdrawal by Subject|0|||
164052838|NCT01084096|592552496|FG000|Overall Study|Woman had a miscarriage|21|||
164052839|NCT01084096|592552497|FG001|Overall Study|Woman had a miscarriage|17|||
164052840|NCT00027846|592552498|FG000|Overall Study|Lost to Follow-up|0|||
164052841|NCT00027846|592552499|FG001|Overall Study|Lost to Follow-up|41|||
164052842|NCT00027846|592552500|FG002|Overall Study|Lost to Follow-up|9|||
164052843|NCT00027846|592552498|FG000|Overall Study|Withdrawal by Subject|0|||
164052844|NCT00027846|592552499|FG001|Overall Study|Withdrawal by Subject|14|||
164052845|NCT00027846|592552500|FG002|Overall Study|Withdrawal by Subject|7|||
164052846|NCT00027846|592552498|FG000|Overall Study|Ineligible for study|2|||
164052847|NCT00027846|592552499|FG001|Overall Study|Ineligible for study|6|||
164052848|NCT00027846|592552500|FG002|Overall Study|Ineligible for study|14|||
164052849|NCT00027846|592552498|FG000|Overall Study|Entry into another COG therapeutic study|0|||
164052850|NCT00027846|592552499|FG001|Overall Study|Entry into another COG therapeutic study|5|||
164052851|NCT00027846|592552500|FG002|Overall Study|Entry into another COG therapeutic study|2|||
164052852|NCT00027846|592552498|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
164052853|NCT00027846|592552499|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
164052854|NCT00027846|592552500|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
164052855|NCT02033369|592552501|FG000|Overall Study|Physician Decision|1|||
164052856|NCT02033369|592552502|FG001|Overall Study|Physician Decision|2|||
164052857|NCT02033369|592552501|FG000|Overall Study|Not a good demographic match|0|||
164052858|NCT02033369|592552502|FG001|Overall Study|Not a good demographic match|2|||
164052859|NCT02033369|592552501|FG000|Overall Study|Withdrawal by Subject|1|||
164052860|NCT02033369|592552502|FG001|Overall Study|Withdrawal by Subject|1|||
164052861|NCT02033369|592552501|FG000|Overall Study|Lost to Follow-up|1|||
164052862|NCT02033369|592552502|FG001|Overall Study|Lost to Follow-up|0|||
164052863|NCT02033369|592552501|FG000|Overall Study|Protocol Violation|2|||
164052864|NCT02033369|592552502|FG001|Overall Study|Protocol Violation|0|||
164052865|NCT00663208|592552505|FG000|Treatment Period|Lost to Follow-up|0|||
164052866|NCT00663208|592552506|FG001|Treatment Period|Lost to Follow-up|1|||
164052867|NCT00663208|592552507|FG002|Treatment Period|Lost to Follow-up|0|||
164052868|NCT00663208|592552508|FG003|Treatment Period|Lost to Follow-up|0|||
164052869|NCT00663208|592552509|FG004|Treatment Period|Lost to Follow-up|0|||
164052870|NCT00663208|592552510|FG005|Treatment Period|Lost to Follow-up|0|||
164052871|NCT00663208|592552511|FG006|Treatment Period|Lost to Follow-up|0|||
164052872|NCT00663208|592552505|FG000|Follow-up Period|Lost to Follow-up|2|||
164052873|NCT00663208|592552506|FG001|Follow-up Period|Lost to Follow-up|0|||
164052874|NCT00663208|592552507|FG002|Follow-up Period|Lost to Follow-up|3|||
164052875|NCT00663208|592552508|FG003|Follow-up Period|Lost to Follow-up|2|||
164052876|NCT00663208|592552509|FG004|Follow-up Period|Lost to Follow-up|0|||
164052877|NCT00663208|592552510|FG005|Follow-up Period|Lost to Follow-up|0|||
164052878|NCT00663208|592552511|FG006|Follow-up Period|Lost to Follow-up|0|||
164052879|NCT00663208|592552505|FG000|Follow-up Period|Other reason|1|||
164052880|NCT00663208|592552506|FG001|Follow-up Period|Other reason|0|||
164052881|NCT00663208|592552507|FG002|Follow-up Period|Other reason|0|||
164052882|NCT00663208|592552508|FG003|Follow-up Period|Other reason|0|||
164052883|NCT00663208|592552509|FG004|Follow-up Period|Other reason|0|||
164052884|NCT00663208|592552510|FG005|Follow-up Period|Other reason|0|||
164052885|NCT00663208|592552511|FG006|Follow-up Period|Other reason|1|||
164052886|NCT01451203|592552512|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
164052887|NCT01451203|592552513|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
164052888|NCT01451203|592552512|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
164052889|NCT01451203|592552513|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
164052890|NCT01451203|592552512|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
164052891|NCT01451203|592552513|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
164052892|NCT01451203|592552512|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
164052893|NCT01451203|592552513|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
164052894|NCT01451203|592552512|FG000|Double-blind Treatment Period|Adverse Event|6|||
164052895|NCT01451203|592552513|FG001|Double-blind Treatment Period|Adverse Event|9|||
164052896|NCT01451203|592552512|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
164052897|NCT01451203|592552513|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
164052898|NCT01451203|592552512|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
164052899|NCT01451203|592552513|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
164052900|NCT01451203|592552512|FG000|Double-blind Treatment Period|Investigator decision|2|||
164052901|NCT01451203|592552513|FG001|Double-blind Treatment Period|Investigator decision|0|||
164052902|NCT01451203|592552512|FG000|Post-treatment Period|Consent withdrawn|2|||
164052903|NCT01451203|592552513|FG001|Post-treatment Period|Consent withdrawn|4|||
164052904|NCT01451203|592552512|FG000|Post-treatment Period|Lack of Efficacy|12|||
164052905|NCT01451203|592552513|FG001|Post-treatment Period|Lack of Efficacy|28|||
164052906|NCT01451203|592552512|FG000|Post-treatment Period|Adverse Event|0|||
164052907|NCT01451203|592552513|FG001|Post-treatment Period|Adverse Event|1|||
164052908|NCT01451203|592552512|FG000|Post-treatment Period|Investigator decision|0|||
164052909|NCT01451203|592552513|FG001|Post-treatment Period|Investigator decision|1|||
164052910|NCT00039377|592552514|FG000|Initial Registration|Adverse Event|2|||
164052911|NCT00039377|592552515|FG001|Initial Registration|Adverse Event|0|||
164052912|NCT00039377|592552516|FG002|Initial Registration|Adverse Event|0|||
164100663|NCT00838539|592733458|FG002|Overall Study|Physician Decision|0|||
164100664|NCT00838539|592733459|FG003|Overall Study|Physician Decision|0|||
164100665|NCT00838539|592733460|FG004|Overall Study|Physician Decision|0|||
164100666|NCT00838539|592733461|FG005|Overall Study|Physician Decision|0|||
164100667|NCT00838539|592733462|FG006|Overall Study|Physician Decision|0|||
164100668|NCT00838539|592733463|FG007|Overall Study|Physician Decision|0|||
164100669|NCT00838539|592733464|FG008|Overall Study|Physician Decision|1|||
164100670|NCT00838539|592733465|FG009|Overall Study|Physician Decision|0|||
164100671|NCT00838539|592733466|FG010|Overall Study|Physician Decision|0|||
164100672|NCT00838539|592733467|FG011|Overall Study|Physician Decision|0|||
164100673|NCT00838539|592733456|FG000|Overall Study|Clinical Progression|0|||
164100674|NCT00838539|592733457|FG001|Overall Study|Clinical Progression|0|||
164100675|NCT00838539|592733458|FG002|Overall Study|Clinical Progression|0|||
164100676|NCT00838539|592733459|FG003|Overall Study|Clinical Progression|0|||
164100677|NCT00838539|592733460|FG004|Overall Study|Clinical Progression|0|||
164100678|NCT00838539|592733461|FG005|Overall Study|Clinical Progression|0|||
164100679|NCT00838539|592733462|FG006|Overall Study|Clinical Progression|1|||
164100680|NCT00838539|592733463|FG007|Overall Study|Clinical Progression|0|||
164100681|NCT00838539|592733464|FG008|Overall Study|Clinical Progression|0|||
164100682|NCT00838539|592733465|FG009|Overall Study|Clinical Progression|0|||
164052913|NCT00039377|592552517|FG003|Initial Registration|Adverse Event|0|||
164052914|NCT00039377|592552514|FG000|Initial Registration|Relapsed|6|||
164052915|NCT00039377|592552515|FG001|Initial Registration|Relapsed|0|||
164052916|NCT00039377|592552516|FG002|Initial Registration|Relapsed|0|||
164052917|NCT00039377|592552517|FG003|Initial Registration|Relapsed|0|||
164052918|NCT00039377|592552514|FG000|Initial Registration|Received non-protocol therapy|11|||
164052919|NCT00039377|592552515|FG001|Initial Registration|Received non-protocol therapy|0|||
164052920|NCT00039377|592552516|FG002|Initial Registration|Received non-protocol therapy|0|||
164052921|NCT00039377|592552517|FG003|Initial Registration|Received non-protocol therapy|0|||
164052922|NCT00039377|592552514|FG000|Initial Registration|Withdrawal by Subject|3|||
164052923|NCT00039377|592552515|FG001|Initial Registration|Withdrawal by Subject|0|||
164052924|NCT00039377|592552516|FG002|Initial Registration|Withdrawal by Subject|0|||
164052925|NCT00039377|592552517|FG003|Initial Registration|Withdrawal by Subject|0|||
164052926|NCT01249404|592552518|FG000|Overall Study|Study treatment not received|0|||
164052927|NCT01249404|592552519|FG001|Overall Study|Study treatment not received|1|||
164052928|NCT01249404|592552520|FG002|Overall Study|Study treatment not received|2|||
164052929|NCT01249404|592552518|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
164052930|NCT01249404|592552519|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
164052931|NCT01249404|592552520|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
164052932|NCT01249404|592552518|FG000|Overall Study|Adverse Event|2|||
164052933|NCT01249404|592552519|FG001|Overall Study|Adverse Event|2|||
164052934|NCT01249404|592552520|FG002|Overall Study|Adverse Event|2|||
164052935|NCT01249404|592552518|FG000|Overall Study|Withdrawal by Subject|2|||
164052936|NCT01249404|592552519|FG001|Overall Study|Withdrawal by Subject|2|||
164052937|NCT01249404|592552520|FG002|Overall Study|Withdrawal by Subject|0|||
164052938|NCT01249404|592552518|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
164052939|NCT01249404|592552519|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
164052940|NCT01249404|592552520|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
164052941|NCT01249404|592552518|FG000|Overall Study|Non compliance to visit schedule|0|||
164052942|NCT01249404|592552519|FG001|Overall Study|Non compliance to visit schedule|1|||
164052943|NCT01249404|592552520|FG002|Overall Study|Non compliance to visit schedule|0|||
164052944|NCT03890731|592552521|FG000|Overall Study|Progressive disease|1|||
164052945|NCT03890731|592552521|FG000|Overall Study|Patient's decision|1|||
164052946|NCT03890731|592552521|FG000|Overall Study|Adverse Event|4|||
164052947|NCT03758612|592552522|FG000|Washout Period|Withdrawal by Subject|0|||
164052948|NCT03758612|592552523|FG001|Washout Period|Withdrawal by Subject|0|||
164052949|NCT03758612|592552524|FG002|Washout Period|Withdrawal by Subject|2|||
164052950|NCT03758612|592552525|FG003|Washout Period|Withdrawal by Subject|0|||
164052951|NCT03758612|592552526|FG004|Washout Period|Withdrawal by Subject|0|||
164052952|NCT03758612|592552527|FG005|Washout Period|Withdrawal by Subject|0|||
164052953|NCT03758612|592552528|FG006|Washout Period|Withdrawal by Subject|0|||
164052954|NCT03758612|592552529|FG007|Washout Period|Withdrawal by Subject|0|||
164052955|NCT03758612|592552530|FG008|Washout Period|Withdrawal by Subject|0|||
164052956|NCT03758612|592552531|FG009|Washout Period|Withdrawal by Subject|0|||
164052957|NCT03758612|592552532|FG010|Washout Period|Withdrawal by Subject|0|||
164052958|NCT03758612|592552533|FG011|Washout Period|Withdrawal by Subject|0|||
164052959|NCT03758612|592552522|FG000|Period 2|Protocol Violation|0|||
164052960|NCT03758612|592552523|FG001|Period 2|Protocol Violation|0|||
164052961|NCT03758612|592552524|FG002|Period 2|Protocol Violation|0|||
164100683|NCT00838539|592733466|FG010|Overall Study|Clinical Progression|0|||
164100684|NCT00838539|592733467|FG011|Overall Study|Clinical Progression|0|||
164100685|NCT00838539|592733456|FG000|Overall Study|Symptomatic Deterioration|0|||
164100686|NCT00838539|592733457|FG001|Overall Study|Symptomatic Deterioration|0|||
164100687|NCT00838539|592733458|FG002|Overall Study|Symptomatic Deterioration|1|||
164100688|NCT00838539|592733459|FG003|Overall Study|Symptomatic Deterioration|1|||
164052962|NCT03758612|592552525|FG003|Period 2|Protocol Violation|0|||
164052963|NCT03758612|592552526|FG004|Period 2|Protocol Violation|1|||
164052964|NCT03758612|592552527|FG005|Period 2|Protocol Violation|0|||
164052965|NCT03758612|592552528|FG006|Period 2|Protocol Violation|0|||
164052966|NCT03758612|592552529|FG007|Period 2|Protocol Violation|0|||
164052967|NCT03758612|592552530|FG008|Period 2|Protocol Violation|0|||
164052968|NCT03758612|592552531|FG009|Period 2|Protocol Violation|0|||
164052969|NCT03758612|592552532|FG010|Period 2|Protocol Violation|0|||
164052970|NCT03758612|592552533|FG011|Period 2|Protocol Violation|0|||
164052971|NCT00945945|592552536|FG000|Overall Study|Adverse Event|15|||
164052972|NCT00945945|592552537|FG001|Overall Study|Adverse Event|35|||
164052973|NCT00945945|592552536|FG000|Overall Study|Withdrawal by Subject|7|||
164052974|NCT00945945|592552537|FG001|Overall Study|Withdrawal by Subject|10|||
164052975|NCT00945945|592552536|FG000|Overall Study|Lost to Follow-up|4|||
164052976|NCT00945945|592552537|FG001|Overall Study|Lost to Follow-up|5|||
164052977|NCT00945945|592552536|FG000|Overall Study|Lack of Efficacy|6|||
164052978|NCT00945945|592552537|FG001|Overall Study|Lack of Efficacy|2|||
164052979|NCT00945945|592552536|FG000|Overall Study|Protocol Violation|4|||
164052980|NCT00945945|592552537|FG001|Overall Study|Protocol Violation|2|||
164052981|NCT00945945|592552536|FG000|Overall Study|Entry Criteria Not Met|0|||
164052982|NCT00945945|592552537|FG001|Overall Study|Entry Criteria Not Met|1|||
164052983|NCT02500901|592552538|FG000|Overall Study|Disease ProgressionDD|2|||
164052984|NCT01191190|592552539|FG000|Overall Study|Withdrawal by Subject|1|||
164052985|NCT01716585|592552540|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
164052986|NCT01716585|592552541|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
164052987|NCT01716585|592552540|FG000|Double-blind Treatment|Adverse Event|2|||
164052988|NCT01716585|592552541|FG001|Double-blind Treatment|Adverse Event|1|||
164052989|NCT01716585|592552540|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
164052990|NCT01716585|592552541|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
164052991|NCT01716585|592552540|FG000|Double-blind Treatment|Lost to Follow-up|2|||
164052992|NCT01716585|592552541|FG001|Double-blind Treatment|Lost to Follow-up|0|||
164052993|NCT01716585|592552540|FG000|Double-blind Treatment|Subject Noncompliant|1|||
164052994|NCT01716585|592552541|FG001|Double-blind Treatment|Subject Noncompliant|0|||
164052995|NCT01716585|592552540|FG000|Double-blind Treatment|Other|1|||
164052996|NCT01716585|592552541|FG001|Double-blind Treatment|Other|0|||
164052997|NCT01716585|592552540|FG000|Open-label Treatment|Adverse Event|0|||
164052998|NCT01716585|592552541|FG001|Open-label Treatment|Adverse Event|2|||
164052999|NCT01716585|592552540|FG000|Open-label Treatment|Virologic Failure|0|||
164053000|NCT01716585|592552541|FG001|Open-label Treatment|Virologic Failure|2|||
164053001|NCT01716585|592552540|FG000|Open-label Treatment|Withdrawal by Subject|0|||
164053002|NCT01716585|592552541|FG001|Open-label Treatment|Withdrawal by Subject|3|||
164053003|NCT04235959|592552542|FG000|Overall Study|Protocol Violation|0|||
164053004|NCT04235959|592552543|FG001|Overall Study|Protocol Violation|1|||
164053005|NCT04235959|592552544|FG002|Overall Study|Protocol Violation|0|||
164053006|NCT04235959|592552542|FG000|Overall Study|Adverse Event|1|||
164053007|NCT04235959|592552543|FG001|Overall Study|Adverse Event|0|||
164053008|NCT04235959|592552544|FG002|Overall Study|Adverse Event|0|||
164053009|NCT00125138|592552545|FG000|Overall Study|Adverse Event|1|||
164053010|NCT00125138|592552546|FG001|Overall Study|Adverse Event|0|||
164053011|NCT00125138|592552547|FG002|Overall Study|Adverse Event|3|||
164053012|NCT00125138|592552548|FG003|Overall Study|Adverse Event|2|||
164053013|NCT00125138|592552545|FG000|Overall Study|Withdrawal by Subject|2|||
164053014|NCT00125138|592552546|FG001|Overall Study|Withdrawal by Subject|3|||
164053015|NCT00125138|592552547|FG002|Overall Study|Withdrawal by Subject|1|||
164053016|NCT00125138|592552548|FG003|Overall Study|Withdrawal by Subject|1|||
164053017|NCT00125138|592552545|FG000|Overall Study|Lack of Efficacy|0|||
164053018|NCT00125138|592552546|FG001|Overall Study|Lack of Efficacy|0|||
164053019|NCT00125138|592552547|FG002|Overall Study|Lack of Efficacy|0|||
164053020|NCT00125138|592552548|FG003|Overall Study|Lack of Efficacy|1|||
164053021|NCT00125138|592552545|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
164053022|NCT00125138|592552546|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
164053023|NCT00125138|592552547|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
164053024|NCT00125138|592552548|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
164053025|NCT00348686|592552549|FG000|Overall Study|Withdrawal by Subject|45|||
164053026|NCT00348686|592552549|FG000|Overall Study|Adverse Event|5|||
164053027|NCT00348686|592552549|FG000|Overall Study|Protocol Violation|6|||
164053028|NCT00348686|592552549|FG000|Overall Study|Lost to Follow-up|2|||
164053029|NCT00348686|592552549|FG000|Overall Study|Multiple Reasons|8|||
164053030|NCT02381795|592552552|FG000|Overall Study|Withdrawal by Subject|1|||
164053031|NCT02381795|592552552|FG000|Overall Study|Study Terminated|2|||
164053032|NCT03798366|592552553|FG000|Overall Study|Lost to Follow-up|0|||
164053033|NCT03798366|592552554|FG001|Overall Study|Lost to Follow-up|1|||
164053034|NCT01117428|592552555|FG000|Overall Study|Lack of Efficacy|1|||
164053035|NCT01117428|592552556|FG001|Overall Study|Lack of Efficacy|0|||
164053036|NCT01117428|592552557|FG002|Overall Study|Lack of Efficacy|0|||
164053037|NCT01117428|592552558|FG003|Overall Study|Lack of Efficacy|0|||
164053038|NCT01117428|592552559|FG004|Overall Study|Lack of Efficacy|0|||
164053039|NCT01117428|592552560|FG005|Overall Study|Lack of Efficacy|0|||
164053040|NCT01117428|592552555|FG000|Overall Study|Adverse Event|4|||
164053041|NCT01117428|592552556|FG001|Overall Study|Adverse Event|0|||
164053042|NCT01117428|592552557|FG002|Overall Study|Adverse Event|0|||
164053043|NCT01117428|592552558|FG003|Overall Study|Adverse Event|0|||
164053044|NCT01117428|592552559|FG004|Overall Study|Adverse Event|1|||
164053045|NCT01117428|592552560|FG005|Overall Study|Adverse Event|2|||
164053046|NCT01117428|592552555|FG000|Overall Study|Death|0|||
164053047|NCT01117428|592552556|FG001|Overall Study|Death|1|||
164053048|NCT01117428|592552557|FG002|Overall Study|Death|2|||
164053049|NCT01117428|592552558|FG003|Overall Study|Death|0|||
164053050|NCT01117428|592552559|FG004|Overall Study|Death|0|||
164053051|NCT01117428|592552560|FG005|Overall Study|Death|1|||
164053052|NCT01117428|592552555|FG000|Overall Study|Physician Decision|0|||
164053053|NCT01117428|592552556|FG001|Overall Study|Physician Decision|1|||
164053054|NCT01117428|592552557|FG002|Overall Study|Physician Decision|0|||
164053055|NCT01117428|592552558|FG003|Overall Study|Physician Decision|0|||
164053056|NCT01117428|592552559|FG004|Overall Study|Physician Decision|0|||
164053057|NCT01117428|592552560|FG005|Overall Study|Physician Decision|0|||
164053058|NCT01117428|592552555|FG000|Overall Study|Withdrawal by Subject|0|||
164053059|NCT01117428|592552556|FG001|Overall Study|Withdrawal by Subject|0|||
164053060|NCT01117428|592552557|FG002|Overall Study|Withdrawal by Subject|1|||
164053061|NCT01117428|592552558|FG003|Overall Study|Withdrawal by Subject|0|||
164053062|NCT01117428|592552559|FG004|Overall Study|Withdrawal by Subject|0|||
164053063|NCT01117428|592552560|FG005|Overall Study|Withdrawal by Subject|0|||
164053064|NCT01117428|592552555|FG000|Overall Study|Progressive disease|15|||
164053065|NCT01117428|592552556|FG001|Overall Study|Progressive disease|27|||
164053066|NCT01117428|592552557|FG002|Overall Study|Progressive disease|10|||
164053067|NCT01117428|592552558|FG003|Overall Study|Progressive disease|12|||
164053068|NCT01117428|592552559|FG004|Overall Study|Progressive disease|16|||
164053069|NCT01117428|592552560|FG005|Overall Study|Progressive disease|17|||
164053070|NCT00474539|592552561|FG000|Infant Series|Withdrawal by Subject|3|||
164053071|NCT00474539|592552562|FG001|Infant Series|Withdrawal by Subject|4|||
164053072|NCT00474539|592552561|FG000|Infant Series|Randomization error|5|||
164053073|NCT00474539|592552562|FG001|Infant Series|Randomization error|0|||
164053074|NCT00474539|592552561|FG000|Infant Series|Lost to Follow-up|2|||
164053075|NCT00474539|592552562|FG001|Infant Series|Lost to Follow-up|1|||
164053076|NCT00474539|592552561|FG000|Infant Series|Protocol Violation|0|||
164053077|NCT00474539|592552562|FG001|Infant Series|Protocol Violation|1|||
164053078|NCT00474539|592552561|FG000|After Infant Series|Lost to Follow-up|3|||
164053079|NCT00474539|592552562|FG001|After Infant Series|Lost to Follow-up|0|||
164053080|NCT00474539|592552561|FG000|After Infant Series|Withdrawal by Subject|1|||
164053081|NCT00474539|592552562|FG001|After Infant Series|Withdrawal by Subject|0|||
164053082|NCT00474539|592552561|FG000|Toddler Dose|Protocol Violation|1|||
164053083|NCT00474539|592552562|FG001|Toddler Dose|Protocol Violation|0|||
164053084|NCT02195531|592552563|FG000|Overall Study|Withdrawal by Subject|1|||
164053085|NCT02195531|592552564|FG001|Overall Study|Withdrawal by Subject|1|||
164053086|NCT02195531|592552565|FG002|Overall Study|Withdrawal by Subject|1|||
164053087|NCT01657253|592552572|FG000|Overall Study|Lost to Follow-up|6|||
164053088|NCT01657253|592552573|FG001|Overall Study|Lost to Follow-up|5|||
164053089|NCT01657253|592552572|FG000|Overall Study|Withdrawal by Subject|11|||
164053090|NCT01657253|592552573|FG001|Overall Study|Withdrawal by Subject|12|||
164053091|NCT01657253|592552572|FG000|Overall Study|Adverse Event|0|||
164053092|NCT01657253|592552573|FG001|Overall Study|Adverse Event|1|||
164053093|NCT01970540|592552574|FG000|Overall Study|Non-treatment-related AE|0|||
164053094|NCT01970540|592552575|FG001|Overall Study|Non-treatment-related AE|0|||
164053095|NCT01970540|592552576|FG002|Overall Study|Non-treatment-related AE|1|||
164053096|NCT01970540|592552574|FG000|Overall Study|Progressive disease|55|||
164053097|NCT01970540|592552575|FG001|Overall Study|Progressive disease|23|||
164053098|NCT01970540|592552576|FG002|Overall Study|Progressive disease|10|||
164053099|NCT01970540|592552574|FG000|Overall Study|Treatment delay over protocol|0|||
164053100|NCT01970540|592552575|FG001|Overall Study|Treatment delay over protocol|0|||
164100689|NCT00838539|592733460|FG004|Overall Study|Symptomatic Deterioration|0|||
164053101|NCT01970540|592552576|FG002|Overall Study|Treatment delay over protocol|1|||
164053102|NCT01970540|592552574|FG000|Overall Study|Physician Decision|7|||
164053103|NCT01970540|592552575|FG001|Overall Study|Physician Decision|2|||
164053104|NCT01970540|592552576|FG002|Overall Study|Physician Decision|0|||
164053105|NCT01970540|592552574|FG000|Overall Study|Clinical progression|0|||
164053106|NCT01970540|592552575|FG001|Overall Study|Clinical progression|1|||
164100690|NCT00838539|592733461|FG005|Overall Study|Symptomatic Deterioration|1|||
164053107|NCT01970540|592552576|FG002|Overall Study|Clinical progression|1|||
164053108|NCT01970540|592552574|FG000|Overall Study|End of study|2|||
164053109|NCT01970540|592552575|FG001|Overall Study|End of study|0|||
164053110|NCT01970540|592552576|FG002|Overall Study|End of study|2|||
164053111|NCT01970540|592552574|FG000|Overall Study|Adverse Event|0|||
164100691|NCT00838539|592733462|FG006|Overall Study|Symptomatic Deterioration|0|||
164053112|NCT01970540|592552575|FG001|Overall Study|Adverse Event|2|||
164053113|NCT01970540|592552576|FG002|Overall Study|Adverse Event|1|||
164053114|NCT01970540|592552574|FG000|Overall Study|Treatment-related AE|4|||
164100692|NCT00838539|592733463|FG007|Overall Study|Symptomatic Deterioration|0|||
164100693|NCT00838539|592733464|FG008|Overall Study|Symptomatic Deterioration|0|||
164100694|NCT00838539|592733465|FG009|Overall Study|Symptomatic Deterioration|1|||
164100695|NCT00838539|592733466|FG010|Overall Study|Symptomatic Deterioration|0|||
164100696|NCT00838539|592733467|FG011|Overall Study|Symptomatic Deterioration|0|||
164100697|NCT01908205|592733468|FG000|Overall Study|Lost to Follow-up|2|||
164100698|NCT01908205|592733469|FG001|Overall Study|Lost to Follow-up|0|||
164100699|NCT01908205|592733468|FG000|Overall Study|Withdrawal by Subject|3|||
164100700|NCT01908205|592733469|FG001|Overall Study|Withdrawal by Subject|1|||
164100701|NCT05323396|592733470|FG000|Overall Study|Lost to Follow-up|1|||
164100702|NCT05323396|592733471|FG001|Overall Study|Lost to Follow-up|35|||
164100703|NCT05323396|592733470|FG000|Overall Study|Pregnancy|1|||
164100704|NCT05323396|592733471|FG001|Overall Study|Pregnancy|0|||
164053115|NCT01970540|592552575|FG001|Overall Study|Treatment-related AE|0|||
164053116|NCT01970540|592552576|FG002|Overall Study|Treatment-related AE|2|||
164053117|NCT01970540|592552574|FG000|Overall Study|Withdrawal by Subject|4|||
164053118|NCT01970540|592552575|FG001|Overall Study|Withdrawal by Subject|0|||
164053119|NCT01970540|592552576|FG002|Overall Study|Withdrawal by Subject|1|||
164053120|NCT01970540|592552574|FG000|Overall Study|Clinical deterioration|1|||
164053121|NCT01970540|592552575|FG001|Overall Study|Clinical deterioration|0|||
164053122|NCT01970540|592552576|FG002|Overall Study|Clinical deterioration|0|||
164053123|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Adverse Event|30|||
164053124|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Adverse Event|25|||
164053125|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Adverse Event|23|||
164053126|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Adverse Event|14|||
164053127|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Death|0|||
164053128|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Death|0|||
164053129|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Death|1|||
164053130|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Death|0|||
164053131|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Physician Decision|0|||
164053132|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Physician Decision|1|||
164053133|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Physician Decision|0|||
164053134|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Physician Decision|1|||
164053135|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
164053136|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
164053137|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
164053138|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
164053139|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Other|6|||
164053140|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Other|1|||
164053141|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Other|0|||
164053142|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Other|2|||
164053143|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
164053144|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
164053145|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
164053146|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
164053147|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
164053148|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
164053149|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
164053150|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
164053151|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
164053152|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
164053153|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
164053154|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
164053155|NCT00242710|592552577|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
164053156|NCT00242710|592552578|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
164053157|NCT00242710|592552579|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
164053158|NCT00242710|592552580|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
164053159|NCT00242710|592552577|FG000|Period Between Core Study and Extension|Adverse Event|2|||
164053160|NCT00242710|592552578|FG001|Period Between Core Study and Extension|Adverse Event|3|||
164053161|NCT00242710|592552579|FG002|Period Between Core Study and Extension|Adverse Event|5|||
164053162|NCT00242710|592552580|FG003|Period Between Core Study and Extension|Adverse Event|2|||
164053163|NCT00242710|592552577|FG000|Period Between Core Study and Extension|Physician Decision|1|||
164053164|NCT00242710|592552578|FG001|Period Between Core Study and Extension|Physician Decision|1|||
164053165|NCT00242710|592552579|FG002|Period Between Core Study and Extension|Physician Decision|0|||
164053166|NCT00242710|592552580|FG003|Period Between Core Study and Extension|Physician Decision|0|||
164053167|NCT00242710|592552577|FG000|Period Between Core Study and Extension|Other|24|||
164100705|NCT03238781|592733477|FG000|Overall Study|Adverse Event|1|||
164100706|NCT03238781|592733478|FG001|Overall Study|Adverse Event|1|||
164053168|NCT00242710|592552578|FG001|Period Between Core Study and Extension|Other|24|||
164053169|NCT00242710|592552579|FG002|Period Between Core Study and Extension|Other|9|||
164053170|NCT00242710|592552580|FG003|Period Between Core Study and Extension|Other|11|||
164100707|NCT03238781|592733479|FG002|Overall Study|Adverse Event|2|||
164100708|NCT03238781|592733477|FG000|Overall Study|Lost to Follow-up|2|||
164100709|NCT03238781|592733478|FG001|Overall Study|Lost to Follow-up|1|||
164100710|NCT03238781|592733479|FG002|Overall Study|Lost to Follow-up|2|||
164100711|NCT03238781|592733477|FG000|Overall Study|Withdrawal by Subject|23|||
164100712|NCT03238781|592733478|FG001|Overall Study|Withdrawal by Subject|14|||
164100713|NCT03238781|592733479|FG002|Overall Study|Withdrawal by Subject|16|||
164100714|NCT03238781|592733477|FG000|Overall Study|Decision by sponsor|0|||
164100715|NCT03238781|592733478|FG001|Overall Study|Decision by sponsor|1|||
164100716|NCT03238781|592733479|FG002|Overall Study|Decision by sponsor|0|||
164100717|NCT04115293|592734809|FG000|Overall Study|Adverse Event|0|||
164100718|NCT04115293|592734810|FG001|Overall Study|Adverse Event|2|||
164100719|NCT04115293|592734809|FG000|Overall Study|Withdrawal by Subject|2|||
164100720|NCT04115293|592734810|FG001|Overall Study|Withdrawal by Subject|1|||
164100721|NCT04115293|592734809|FG000|Overall Study|Physician Decision|1|||
164100722|NCT04115293|592734810|FG001|Overall Study|Physician Decision|0|||
164100723|NCT04115293|592734809|FG000|Overall Study|Death|1|||
164100724|NCT04115293|592734810|FG001|Overall Study|Death|1|||
164100725|NCT02674152|592734811|FG000|Overall Study|Personal Reasons|1|||
164100726|NCT02674152|592734812|FG001|Overall Study|Personal Reasons|0|||
164100727|NCT02674152|592734813|FG002|Overall Study|Personal Reasons|0|||
164100728|NCT02674152|592734814|FG003|Overall Study|Personal Reasons|1|||
164100729|NCT02674152|592734815|FG004|Overall Study|Personal Reasons|1|||
164100730|NCT02674152|592734811|FG000|Overall Study|Other adverse event or clinical progression|0|||
164100731|NCT02674152|592734812|FG001|Overall Study|Other adverse event or clinical progression|1|||
164100732|NCT02674152|592734813|FG002|Overall Study|Other adverse event or clinical progression|0|||
164100733|NCT02674152|592734814|FG003|Overall Study|Other adverse event or clinical progression|3|||
164100734|NCT02674152|592734815|FG004|Overall Study|Other adverse event or clinical progression|0|||
164100735|NCT02674152|592734811|FG000|Overall Study|Dose-limiting toxicity|0|||
164100736|NCT02674152|592734812|FG001|Overall Study|Dose-limiting toxicity|0|||
164053171|NCT00242710|592552577|FG000|Period Between Core Study and Extension|Extension not Available|17|||
164053172|NCT00242710|592552578|FG001|Period Between Core Study and Extension|Extension not Available|21|||
164053173|NCT00242710|592552579|FG002|Period Between Core Study and Extension|Extension not Available|8|||
164053174|NCT00242710|592552580|FG003|Period Between Core Study and Extension|Extension not Available|7|||
164053175|NCT00242710|592552577|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
164053176|NCT00242710|592552578|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
164053177|NCT00242710|592552579|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
164053178|NCT00242710|592552580|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
164053179|NCT00242710|592552577|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
164053180|NCT00242710|592552578|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
164053181|NCT00242710|592552579|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
164053182|NCT00242710|592552580|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
164053183|NCT00242710|592552577|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
164053184|NCT00242710|592552578|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
164053185|NCT00242710|592552579|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
164053186|NCT00242710|592552580|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
164053187|NCT00242710|592552577|FG000|Study Extension (up to Year 2)|Death|0|||
164053188|NCT00242710|592552578|FG001|Study Extension (up to Year 2)|Death|0|||
164053189|NCT00242710|592552579|FG002|Study Extension (up to Year 2)|Death|0|||
164053190|NCT00242710|592552580|FG003|Study Extension (up to Year 2)|Death|1|||
164053191|NCT00242710|592552577|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
164053192|NCT00242710|592552578|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
164053193|NCT00242710|592552579|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
164053194|NCT00242710|592552580|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
164053195|NCT00242710|592552577|FG000|Study Extension (up to Year 2)|Other|3|||
164053196|NCT00242710|592552578|FG001|Study Extension (up to Year 2)|Other|5|||
164053197|NCT00242710|592552579|FG002|Study Extension (up to Year 2)|Other|4|||
164053198|NCT00242710|592552580|FG003|Study Extension (up to Year 2)|Other|3|||
164053199|NCT00242710|592552577|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
164053200|NCT00242710|592552578|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
164053201|NCT00242710|592552579|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
164053202|NCT00242710|592552580|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
164053203|NCT00242710|592552577|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
164053204|NCT00242710|592552578|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
164053205|NCT00242710|592552579|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
164053206|NCT00242710|592552580|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
164053207|NCT01057394|592552581|FG000|Overall Study|Not eligible|0|||
164053208|NCT01057394|592552582|FG001|Overall Study|Not eligible|2|||
164053209|NCT00579527|592552583|FG000|Overall Study|Death|4|||
164053210|NCT02177942|592552593|FG000|Overall Study|Adverse Event|1|||
164100737|NCT02674152|592734813|FG002|Overall Study|Dose-limiting toxicity|0|||
164100738|NCT02674152|592734814|FG003|Overall Study|Dose-limiting toxicity|0|||
164100739|NCT02674152|592734815|FG004|Overall Study|Dose-limiting toxicity|1|||
164100740|NCT02674152|592734811|FG000|Overall Study|Progressive Disease|2|||
164053211|NCT02177942|592552594|FG001|Overall Study|Adverse Event|0|||
164053212|NCT02177942|592552593|FG000|Overall Study|Lost to Follow-up|1|||
164053213|NCT02177942|592552594|FG001|Overall Study|Lost to Follow-up|1|||
164053214|NCT02177942|592552593|FG000|Overall Study|Protocol Violation|4|||
164053215|NCT02177942|592552594|FG001|Overall Study|Protocol Violation|6|||
164053216|NCT02177942|592552593|FG000|Overall Study|Withdrawal by Subject|71|||
164053217|NCT02177942|592552594|FG001|Overall Study|Withdrawal by Subject|81|||
164053218|NCT00702949|592552600|FG000|Overall Study|Refusal|3|||
164053219|NCT00702949|592552601|FG001|Overall Study|Refusal|2|||
164053220|NCT00702949|592552602|FG002|Overall Study|Refusal|2|||
164053221|NCT00702949|592552600|FG000|Overall Study|Adverse Event|1|||
164053222|NCT00702949|592552601|FG001|Overall Study|Adverse Event|6|||
164053223|NCT00702949|592552602|FG002|Overall Study|Adverse Event|3|||
164053224|NCT00702949|592552600|FG000|Overall Study|Other Medical Reason/unknown|1|||
164053225|NCT00702949|592552601|FG001|Overall Study|Other Medical Reason/unknown|1|||
164053226|NCT00702949|592552602|FG002|Overall Study|Other Medical Reason/unknown|3|||
164053227|NCT00598585|592552603|FG000|Overall Study|Lost to Follow-up|1|||
164053228|NCT00598585|592552604|FG001|Overall Study|Lost to Follow-up|0|||
164053229|NCT00545584|592552605|FG000|Overall Study|Only one reason for discontinuation|62|||
164053230|NCT00545584|592552606|FG001|Overall Study|Only one reason for discontinuation|61|||
164053231|NCT00545584|592552607|FG002|Overall Study|Only one reason for discontinuation|48|||
164053232|NCT00545584|592552605|FG000|Overall Study|Two or more reasons for discontinuation|17|||
164053233|NCT00545584|592552606|FG001|Overall Study|Two or more reasons for discontinuation|19|||
164053234|NCT00545584|592552607|FG002|Overall Study|Two or more reasons for discontinuation|8|||
164053235|NCT00135694|592552610|FG000|Overall Study|Adverse Event|17|||
164053236|NCT00135694|592552611|FG001|Overall Study|Adverse Event|4|||
164053237|NCT00135694|592552612|FG002|Overall Study|Adverse Event|0|||
164053238|NCT00135694|592552610|FG000|Overall Study|Death|14|||
164053239|NCT00135694|592552611|FG001|Overall Study|Death|1|||
164053240|NCT00135694|592552612|FG002|Overall Study|Death|2|||
164053241|NCT00135694|592552610|FG000|Overall Study|Lost to Follow-up|8|||
164053242|NCT00135694|592552611|FG001|Overall Study|Lost to Follow-up|7|||
164053243|NCT00135694|592552612|FG002|Overall Study|Lost to Follow-up|1|||
164053244|NCT00135694|592552610|FG000|Overall Study|Withdrawal by Subject|41|||
164053245|NCT00135694|592552611|FG001|Overall Study|Withdrawal by Subject|7|||
164053246|NCT00135694|592552612|FG002|Overall Study|Withdrawal by Subject|4|||
164053247|NCT00135694|592552610|FG000|Overall Study|Protocol Violation|19|||
164053248|NCT00135694|592552611|FG001|Overall Study|Protocol Violation|1|||
164053249|NCT00135694|592552612|FG002|Overall Study|Protocol Violation|0|||
164053250|NCT00135694|592552610|FG000|Overall Study|Hepatitis C related reasons|39|||
164053251|NCT00135694|592552611|FG001|Overall Study|Hepatitis C related reasons|1|||
164053252|NCT00135694|592552612|FG002|Overall Study|Hepatitis C related reasons|0|||
164053253|NCT00135694|592552610|FG000|Overall Study|Ineligible for Random assignment|42|||
164053254|NCT00135694|592552611|FG001|Overall Study|Ineligible for Random assignment|0|||
164053255|NCT00135694|592552612|FG002|Overall Study|Ineligible for Random assignment|0|||
164053256|NCT00660816|592552613|FG000|Overall Study|Adverse Event|1|||
164053257|NCT00660816|592552614|FG001|Overall Study|Adverse Event|2|||
164053258|NCT00660816|592552613|FG000|Overall Study|Withdrawal by Subject|1|||
164053259|NCT00660816|592552614|FG001|Overall Study|Withdrawal by Subject|0|||
164053260|NCT00660816|592552613|FG000|Overall Study|Death|0|||
164053261|NCT00660816|592552614|FG001|Overall Study|Death|2|||
164053262|NCT00660816|592552613|FG000|Overall Study|Lack of Efficacy|1|||
164053263|NCT00660816|592552614|FG001|Overall Study|Lack of Efficacy|0|||
164053264|NCT00660816|592552613|FG000|Overall Study|Physician Decision|0|||
164053265|NCT00660816|592552614|FG001|Overall Study|Physician Decision|2|||
164053266|NCT00660816|592552613|FG000|Overall Study|Protocol Violation|1|||
164053267|NCT00660816|592552614|FG001|Overall Study|Protocol Violation|0|||
164053268|NCT00660816|592552613|FG000|Overall Study|Disease Progression|16|||
164053269|NCT00660816|592552614|FG001|Overall Study|Disease Progression|12|||
164053270|NCT00660816|592552613|FG000|Overall Study|Complicating Disease|0|||
164053271|NCT00660816|592552614|FG001|Overall Study|Complicating Disease|1|||
164100741|NCT02674152|592734812|FG001|Overall Study|Progressive Disease|1|||
164100742|NCT02674152|592734813|FG002|Overall Study|Progressive Disease|1|||
164053272|NCT00998985|592552615|FG000|Overall Study|Withdrawal by Subject|0|||
164053273|NCT00998985|592552616|FG001|Overall Study|Withdrawal by Subject|0|||
164053274|NCT00998985|592552617|FG002|Overall Study|Withdrawal by Subject|0|||
164053275|NCT00998985|592552618|FG003|Overall Study|Withdrawal by Subject|0|||
164053276|NCT00998985|592552619|FG004|Overall Study|Withdrawal by Subject|0|||
164053277|NCT00998985|592552620|FG005|Overall Study|Withdrawal by Subject|0|||
164053278|NCT00998985|592552621|FG006|Overall Study|Withdrawal by Subject|0|||
164053279|NCT00998985|592552622|FG007|Overall Study|Withdrawal by Subject|0|||
164053280|NCT00998985|592552623|FG008|Overall Study|Withdrawal by Subject|1|||
164053281|NCT00998985|592552624|FG009|Overall Study|Withdrawal by Subject|0|||
164053282|NCT00998985|592552625|FG010|Overall Study|Withdrawal by Subject|0|||
164053283|NCT00998985|592552626|FG011|Overall Study|Withdrawal by Subject|0|||
164053284|NCT00998985|592552627|FG012|Overall Study|Withdrawal by Subject|0|||
164053285|NCT00998985|592552628|FG013|Overall Study|Withdrawal by Subject|0|||
164100743|NCT02674152|592734814|FG003|Overall Study|Progressive Disease|13|||
164100744|NCT02674152|592734815|FG004|Overall Study|Progressive Disease|2|||
164100745|NCT02674152|592734811|FG000|Overall Study|Adverse Event|0|||
164100746|NCT02674152|592734812|FG001|Overall Study|Adverse Event|0|||
164100747|NCT02674152|592734813|FG002|Overall Study|Adverse Event|1|||
164100748|NCT02674152|592734814|FG003|Overall Study|Adverse Event|0|||
164100749|NCT02674152|592734815|FG004|Overall Study|Adverse Event|1|||
164100750|NCT03772522|592734816|FG000|Pre-intervention|Withdrawal by Subject|3|||
164100751|NCT03772522|592734817|FG001|Pre-intervention|Withdrawal by Subject|4|||
164100752|NCT03772522|592734816|FG000|Intervention|Withdrawal by Subject|1|||
164053286|NCT00998985|592552615|FG000|Overall Study|Protocol Violation|0|||
164053287|NCT00998985|592552616|FG001|Overall Study|Protocol Violation|0|||
164053288|NCT00998985|592552617|FG002|Overall Study|Protocol Violation|0|||
164053289|NCT00998985|592552618|FG003|Overall Study|Protocol Violation|0|||
164053290|NCT00998985|592552619|FG004|Overall Study|Protocol Violation|0|||
164053291|NCT00998985|592552620|FG005|Overall Study|Protocol Violation|1|||
164053292|NCT00998985|592552621|FG006|Overall Study|Protocol Violation|0|||
164053293|NCT00998985|592552622|FG007|Overall Study|Protocol Violation|0|||
164053294|NCT00998985|592552623|FG008|Overall Study|Protocol Violation|0|||
164053295|NCT00998985|592552624|FG009|Overall Study|Protocol Violation|0|||
164053296|NCT00998985|592552625|FG010|Overall Study|Protocol Violation|0|||
164053297|NCT00998985|592552626|FG011|Overall Study|Protocol Violation|0|||
164053298|NCT00998985|592552627|FG012|Overall Study|Protocol Violation|0|||
164053299|NCT00998985|592552628|FG013|Overall Study|Protocol Violation|0|||
164053300|NCT01601873|592552629|FG000|Overall Study|Lost to Follow-up|2|||
164053301|NCT01601873|592552630|FG001|Overall Study|Lost to Follow-up|3|||
164053302|NCT03196973|592552631|FG000|Overall Study|Adverse Event|1|||
164053303|NCT03196973|592552632|FG001|Overall Study|Adverse Event|1|||
164053304|NCT03196973|592552633|FG002|Overall Study|Adverse Event|2|||
164053305|NCT03196973|592552631|FG000|Overall Study|Lack of Efficacy|2|||
164053306|NCT03196973|592552632|FG001|Overall Study|Lack of Efficacy|6|||
164053307|NCT03196973|592552633|FG002|Overall Study|Lack of Efficacy|1|||
164053308|NCT03196973|592552631|FG000|Overall Study|Lost to Follow-up|4|||
164053309|NCT03196973|592552632|FG001|Overall Study|Lost to Follow-up|3|||
164053310|NCT03196973|592552633|FG002|Overall Study|Lost to Follow-up|2|||
164053311|NCT03196973|592552631|FG000|Overall Study|Consent withdrawn|2|||
164053312|NCT03196973|592552632|FG001|Overall Study|Consent withdrawn|1|||
164053313|NCT03196973|592552633|FG002|Overall Study|Consent withdrawn|0|||
164053314|NCT03196973|592552631|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
164053315|NCT03196973|592552632|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
164053316|NCT03196973|592552633|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
164053317|NCT01610414|592552636|FG000|Study Start - Month 13|Serious Adverse Event|65|||
164053318|NCT01610414|592552637|FG001|Study Start - Month 13|Serious Adverse Event|67|||
164053319|NCT01610414|592552636|FG000|Study Start - Month 13|Adverse Event|14|||
164053320|NCT01610414|592552637|FG001|Study Start - Month 13|Adverse Event|14|||
164053321|NCT01610414|592552636|FG000|Study Start - Month 13|Protocol Violation|3|||
164053322|NCT01610414|592552637|FG001|Study Start - Month 13|Protocol Violation|1|||
164053323|NCT01610414|592552636|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
164053324|NCT01610414|592552637|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
164053325|NCT01610414|592552636|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
164053326|NCT01610414|592552637|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
164053327|NCT01610414|592552636|FG000|Study Start - Month 13|Lost to Follow-up|4|||
164053328|NCT01610414|592552637|FG001|Study Start - Month 13|Lost to Follow-up|6|||
164053329|NCT01610414|592552636|FG000|Study Start - Month 13|Suspected HZ episode|1|||
164053330|NCT01610414|592552637|FG001|Study Start - Month 13|Suspected HZ episode|3|||
164053331|NCT01610414|592552636|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
164053332|NCT01610414|592552637|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
164053333|NCT01610414|592552636|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
164053334|NCT01610414|592552637|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
164053335|NCT01610414|592552636|FG000|Month 13 - Month 25|Adverse Event|8|||
164053336|NCT01610414|592552637|FG001|Month 13 - Month 25|Adverse Event|4|||
164053337|NCT01610414|592552636|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
164053338|NCT01610414|592552637|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
164053339|NCT01610414|592552636|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
164053340|NCT01610414|592552637|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
164053341|NCT01610414|592552636|FG000|Month 13 - Month 25|Protocol Violation|0|||
164053342|NCT01610414|592552637|FG001|Month 13 - Month 25|Protocol Violation|2|||
164053343|NCT01610414|592552636|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
164053344|NCT01610414|592552637|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
164053345|NCT01610414|592552636|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
164053346|NCT01610414|592552637|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
164053347|NCT01610414|592552636|FG000|After Month 25|Study end not reached|48|||
164100753|NCT03772522|592734817|FG001|Intervention|Withdrawal by Subject|0|||
164100754|NCT03772522|592734816|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
164100755|NCT03772522|592734817|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
164053348|NCT01610414|592552637|FG001|After Month 25|Study end not reached|53|||
164100756|NCT00070291|592734821|FG000|Step 1|Withdrawal by Subject|1|||
164053349|NCT02736474|592552639|FG000|Overall Study|Lost to Follow-up|0|||
164053350|NCT02736474|592552640|FG001|Overall Study|Lost to Follow-up|1|||
164053351|NCT00472043|592552642|FG000|Overall Study|Withdrawal by Subject|1|||
164053352|NCT00472043|592552643|FG001|Overall Study|Withdrawal by Subject|0|||
164053353|NCT00472043|592552642|FG000|Overall Study|Death|1|||
164053354|NCT00472043|592552643|FG001|Overall Study|Death|0|||
164053355|NCT04009824|592552645|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
164053356|NCT04009824|592552646|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
164053357|NCT04009824|592552647|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
164053358|NCT04009824|592552648|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
164053359|NCT04009824|592552649|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
164053360|NCT03147495|592552650|FG000|Overall Study|Physician Decision|0|||
164053361|NCT03147495|592552651|FG001|Overall Study|Physician Decision|6|||
164053362|NCT01024946|592552652|FG000|Overall Study|Screen Failure|3|||
164053363|NCT01024946|592552652|FG000|Overall Study|Withdrawal by Subject|1|||
164053364|NCT01024946|592552652|FG000|Overall Study|Adverse Event|1|||
164053365|NCT02483611|592552653|FG000|Overall Study|Protocol Violation|0|||
164053366|NCT02483611|592552654|FG001|Overall Study|Protocol Violation|0|||
164053367|NCT02483611|592552655|FG002|Overall Study|Protocol Violation|1|||
164053368|NCT02608892|592552656|FG000|Overall Study|Lost to Follow-up|1|||
164053369|NCT02608892|592552657|FG001|Overall Study|Lost to Follow-up|0|||
164053370|NCT03032523|592552658|FG000|Overall Study|Withdrawal by Subject|2|||
164053371|NCT03032523|592552659|FG001|Overall Study|Withdrawal by Subject|2|||
164053372|NCT03032523|592552658|FG000|Overall Study|Physician Decision|1|||
164053373|NCT03032523|592552659|FG001|Overall Study|Physician Decision|0|||
164053374|NCT05375838|592552660|FG000|Overall Study|Other|0|||
164053375|NCT05375838|592552661|FG001|Overall Study|Other|0|||
164053376|NCT05375838|592552662|FG002|Overall Study|Other|0|||
164053377|NCT05375838|592552663|FG003|Overall Study|Other|1|||
164053378|NCT05375838|592552664|FG004|Overall Study|Other|1|||
164053379|NCT05375838|592552665|FG005|Overall Study|Other|0|||
164053380|NCT05375838|592552660|FG000|Overall Study|Withdrawal by Subject|2|||
164053381|NCT05375838|592552661|FG001|Overall Study|Withdrawal by Subject|1|||
164053382|NCT05375838|592552662|FG002|Overall Study|Withdrawal by Subject|3|||
164053383|NCT05375838|592552663|FG003|Overall Study|Withdrawal by Subject|2|||
164053384|NCT05375838|592552664|FG004|Overall Study|Withdrawal by Subject|2|||
164053385|NCT05375838|592552665|FG005|Overall Study|Withdrawal by Subject|0|||
164053386|NCT05375838|592552660|FG000|Overall Study|Protocol Violation|0|||
164053387|NCT05375838|592552661|FG001|Overall Study|Protocol Violation|0|||
164053388|NCT05375838|592552662|FG002|Overall Study|Protocol Violation|0|||
164053389|NCT05375838|592552663|FG003|Overall Study|Protocol Violation|0|||
164053390|NCT05375838|592552664|FG004|Overall Study|Protocol Violation|1|||
164053391|NCT05375838|592552665|FG005|Overall Study|Protocol Violation|0|||
164053392|NCT05375838|592552660|FG000|Overall Study|Physician Decision|0|||
164053393|NCT05375838|592552661|FG001|Overall Study|Physician Decision|1|||
164053394|NCT05375838|592552662|FG002|Overall Study|Physician Decision|0|||
164053395|NCT05375838|592552663|FG003|Overall Study|Physician Decision|0|||
164053396|NCT05375838|592552664|FG004|Overall Study|Physician Decision|0|||
164053397|NCT05375838|592552665|FG005|Overall Study|Physician Decision|1|||
164053398|NCT05375838|592552660|FG000|Overall Study|Lost to Follow-up|2|||
164053399|NCT05375838|592552661|FG001|Overall Study|Lost to Follow-up|7|||
164053400|NCT05375838|592552662|FG002|Overall Study|Lost to Follow-up|0|||
164053401|NCT05375838|592552663|FG003|Overall Study|Lost to Follow-up|4|||
164053402|NCT05375838|592552664|FG004|Overall Study|Lost to Follow-up|2|||
164053403|NCT05375838|592552665|FG005|Overall Study|Lost to Follow-up|3|||
164053404|NCT00957723|592552666|FG000|Overall Study|Death|3|||
164053405|NCT00957723|592552666|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
164053406|NCT00957723|592552666|FG000|Overall Study|Lost to Follow-up|8|||
164053407|NCT00957723|592552666|FG000|Overall Study|Withdrawal by Subject|24|||
164053408|NCT00957723|592552666|FG000|Overall Study|Investigative Site Terminated|61|||
164053409|NCT00957723|592552666|FG000|Overall Study|Intercurrent Illness|2|||
164053410|NCT00957723|592552666|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
164053411|NCT00877890|592552667|FG000|Overall Study|Adverse Event|6|||
164053412|NCT00877890|592552668|FG001|Overall Study|Adverse Event|6|||
164053413|NCT00877890|592552667|FG000|Overall Study|Lost to Follow-up|5|||
164053414|NCT00877890|592552668|FG001|Overall Study|Lost to Follow-up|5|||
164053415|NCT00877890|592552667|FG000|Overall Study|Protocol Violation|0|||
164053416|NCT00877890|592552668|FG001|Overall Study|Protocol Violation|1|||
164053417|NCT00877890|592552667|FG000|Overall Study|Withdrawal of Consent|6|||
164053418|NCT00877890|592552668|FG001|Overall Study|Withdrawal of Consent|12|||
164053419|NCT00877890|592552667|FG000|Overall Study|Investigator Decision|0|||
164053420|NCT00877890|592552668|FG001|Overall Study|Investigator Decision|2|||
164053421|NCT00877890|592552667|FG000|Overall Study|Loss of Glucose Control|3|||
164053422|NCT00877890|592552668|FG001|Overall Study|Loss of Glucose Control|4|||
164053423|NCT00984009|592552669|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
164053424|NCT02036476|592552676|FG000|Overall Study|Withdrawal by Subject|2|||
164053425|NCT02036476|592552676|FG000|Overall Study|Progressive Disease|4|||
164053426|NCT02036476|592552676|FG000|Overall Study|Unacceptable Toxicity|2|||
164100757|NCT00070291|592734821|FG000|Step 1|Adverse Event|1|||
164100758|NCT00070291|592734821|FG000|Step 2|Adverse Event|1|||
164100759|NCT03255733|592734822|FG000|Overall Study|Lost to Follow-up|4|||
164100760|NCT02533258|592734824|FG000|Overall Study|Adverse Event|1|||
164100761|NCT02533258|592734824|FG000|Overall Study|Death|2|||
164100762|NCT02533258|592734824|FG000|Overall Study|Other|1|||
164100763|NCT02533258|592734824|FG000|Overall Study|Economic factor|1|||
164100764|NCT02533258|592734824|FG000|Overall Study|Progression of pleural effusion|1|||
164100765|NCT02533258|592734824|FG000|Overall Study|Lack of Efficacy|2|||
164100766|NCT02096211|592734825|FG000|Overall Study|Death|2|||
164100767|NCT02096211|592734825|FG000|Overall Study|Withdrawal by Subject|8|||
164100768|NCT02096211|592734825|FG000|Overall Study|Revision of implant|7|||
164100769|NCT02096211|592734825|FG000|Overall Study|Lost to Follow-up|43|||
164100770|NCT02883452|592734829|FG000|Overall Study|Withdrawal by Subject|1|||
164100771|NCT02883452|592734830|FG001|Overall Study|Withdrawal by Subject|1|||
164100772|NCT02883452|592734831|FG002|Overall Study|Withdrawal by Subject|3|||
164100773|NCT02883452|592734832|FG003|Overall Study|Withdrawal by Subject|0|||
164100774|NCT02883452|592734833|FG004|Overall Study|Withdrawal by Subject|2|||
164100775|NCT02883452|592734834|FG005|Overall Study|Withdrawal by Subject|5|||
164100776|NCT02883452|592734829|FG000|Overall Study|Disease progression|1|||
164100777|NCT02883452|592734830|FG001|Overall Study|Disease progression|0|||
164100778|NCT02883452|592734831|FG002|Overall Study|Disease progression|0|||
164100779|NCT02883452|592734832|FG003|Overall Study|Disease progression|1|||
164100780|NCT02883452|592734833|FG004|Overall Study|Disease progression|4|||
164100781|NCT02883452|592734834|FG005|Overall Study|Disease progression|5|||
164100782|NCT02883452|592734829|FG000|Overall Study|Adverse Event|2|||
164100783|NCT02883452|592734830|FG001|Overall Study|Adverse Event|1|||
164100784|NCT02883452|592734831|FG002|Overall Study|Adverse Event|1|||
164100785|NCT02883452|592734832|FG003|Overall Study|Adverse Event|1|||
164053427|NCT02698176|592552677|FG000|Overall Study|Progressive disease|4|||
164053428|NCT02698176|592552678|FG001|Overall Study|Progressive disease|3|||
164053429|NCT02698176|592552679|FG002|Overall Study|Progressive disease|1|||
164053430|NCT02698176|592552680|FG003|Overall Study|Progressive disease|0|||
164053431|NCT02698176|592552677|FG000|Overall Study|Adverse Event|2|||
164053432|NCT02698176|592552678|FG001|Overall Study|Adverse Event|0|||
164053433|NCT02698176|592552679|FG002|Overall Study|Adverse Event|0|||
164053434|NCT02698176|592552680|FG003|Overall Study|Adverse Event|0|||
164053435|NCT02698176|592552677|FG000|Overall Study|Clinical progression|3|||
164053436|NCT02698176|592552678|FG001|Overall Study|Clinical progression|0|||
164053437|NCT02698176|592552679|FG002|Overall Study|Clinical progression|0|||
164053438|NCT02698176|592552680|FG003|Overall Study|Clinical progression|0|||
164053439|NCT02985684|592552682|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
164053440|NCT02985684|592552682|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
164053441|NCT02985684|592552682|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
164053442|NCT01640353|592554293|FG000|Overall Study|Withdrew prior to treatment|10|||
164053443|NCT01640353|592554293|FG000|Overall Study|Withdrawn from analysis at term site|12|||
164053444|NCT01640353|592554293|FG000|Overall Study|Withdrawal by Subject|5|||
164053445|NCT01640353|592554293|FG000|Overall Study|Death|2|||
164053446|NCT01640353|592554293|FG000|Overall Study|Early site termination|3|||
164053447|NCT01640353|592554293|FG000|Overall Study|Lost to Follow-up|12|||
164053448|NCT01640353|592554293|FG000|Overall Study|Physician Decision|1|||
164053449|NCT01967134|592554294|FG000|Overall Study|Lost to Follow-up|0|||
164053450|NCT01967134|592554295|FG001|Overall Study|Lost to Follow-up|1|||
164053451|NCT01967134|592554296|FG002|Overall Study|Lost to Follow-up|0|||
164053452|NCT00443534|592554297|FG000|Overall Study|Lack of Efficacy|67|||
164053453|NCT00443534|592554297|FG000|Overall Study|Adverse Event|16|||
164053454|NCT00443534|592554297|FG000|Overall Study|Death|9|||
164053455|NCT00443534|592554297|FG000|Overall Study|Withdrawal by Subject|8|||
164053456|NCT00443534|592554297|FG000|Overall Study|Study Terminated by Sponsor|12|||
164053457|NCT00443534|592554297|FG000|Overall Study|Other|10|||
164053458|NCT00443534|592554297|FG000|Overall Study|Enrolled, Not Treated|1|||
164100786|NCT02883452|592734833|FG004|Overall Study|Adverse Event|1|||
164100787|NCT02883452|592734834|FG005|Overall Study|Adverse Event|3|||
164100788|NCT02883452|592734829|FG000|Overall Study|Physician Decision|0|||
164100789|NCT02883452|592734830|FG001|Overall Study|Physician Decision|0|||
164100790|NCT02883452|592734831|FG002|Overall Study|Physician Decision|0|||
164100791|NCT02883452|592734832|FG003|Overall Study|Physician Decision|0|||
164053459|NCT02679222|592554299|FG000|Overall Study|No time for project|1|||
164053460|NCT03419741|592554300|FG000|Overall Study|Adverse Event|1|||
164053461|NCT03419741|592554301|FG001|Overall Study|Adverse Event|0|||
164053462|NCT03419741|592554300|FG000|Overall Study|Withdrawal by Subject|1|||
164053463|NCT03419741|592554301|FG001|Overall Study|Withdrawal by Subject|2|||
164053464|NCT02719028|592554309|FG000|Overall Study|Adverse Event|2|||
164053465|NCT02719028|592554310|FG001|Overall Study|Adverse Event|1|||
164053466|NCT02719028|592554311|FG002|Overall Study|Adverse Event|4|||
164053467|NCT02719028|592554312|FG003|Overall Study|Adverse Event|8|||
164100792|NCT02883452|592734833|FG004|Overall Study|Physician Decision|4|||
164100793|NCT02883452|592734834|FG005|Overall Study|Physician Decision|1|||
164100794|NCT02883452|592734829|FG000|Overall Study|Death|1|||
164053468|NCT02719028|592554309|FG000|Overall Study|Physician Decision|0|||
164053469|NCT02719028|592554310|FG001|Overall Study|Physician Decision|1|||
164053470|NCT02719028|592554311|FG002|Overall Study|Physician Decision|1|||
164053471|NCT02719028|592554312|FG003|Overall Study|Physician Decision|1|||
164053472|NCT02719028|592554309|FG000|Overall Study|Use of prohibited medication|0|||
164053473|NCT02719028|592554310|FG001|Overall Study|Use of prohibited medication|0|||
164053474|NCT02719028|592554311|FG002|Overall Study|Use of prohibited medication|1|||
164053475|NCT02719028|592554312|FG003|Overall Study|Use of prohibited medication|0|||
164053476|NCT02719028|592554309|FG000|Overall Study|Protocol Violation|0|||
164053477|NCT02719028|592554310|FG001|Overall Study|Protocol Violation|0|||
164053478|NCT02719028|592554311|FG002|Overall Study|Protocol Violation|0|||
164053479|NCT02719028|592554312|FG003|Overall Study|Protocol Violation|1|||
164053480|NCT00298766|592554313|FG000|Overall Study|Adverse Event|18|||
164053481|NCT00298766|592554313|FG000|Overall Study|Death|2|||
164053482|NCT00298766|592554313|FG000|Overall Study|Withdrawal by Subject|9|||
164053483|NCT00298766|592554313|FG000|Overall Study|Treatment ongoing|4|||
164053484|NCT00298766|592554313|FG000|Overall Study|Progression of amyloid markers|4|||
164053485|NCT00298766|592554313|FG000|Overall Study|Deterioration in KPS and organ function|1|||
164053486|NCT00298766|592554313|FG000|Overall Study|Subjects overall condition deterioration|4|||
164053487|NCT00298766|592554313|FG000|Overall Study|Other|4|||
164053488|NCT00303719|592554314|FG000|Overall Study|Not evaluable, prior therapies|0|||
164053489|NCT00303719|592554315|FG001|Overall Study|Not evaluable, prior therapies|30|||
164053490|NCT00303719|592554314|FG000|Overall Study|Lost to Follow-up|0|||
164053491|NCT00303719|592554315|FG001|Overall Study|Lost to Follow-up|7|||
164053492|NCT03633461|592554322|FG000|Overall Study|Lost to Follow-up|0|||
164053493|NCT03633461|592554323|FG001|Overall Study|Lost to Follow-up|1|||
164053494|NCT01258738|592554333|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
164053495|NCT01258738|592554334|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
164053496|NCT01258738|592554333|FG000|Double-blind Period|Withdrawal by Subject|2|||
164053497|NCT01258738|592554334|FG001|Double-blind Period|Withdrawal by Subject|2|||
164053498|NCT01258738|592554333|FG000|Double-blind Period|Protocol Violation|1|||
164053499|NCT01258738|592554334|FG001|Double-blind Period|Protocol Violation|1|||
164053500|NCT01258738|592554333|FG000|Double-blind Period|Adverse Event|3|||
164053501|NCT01258738|592554334|FG001|Double-blind Period|Adverse Event|1|||
164053502|NCT01258738|592554333|FG000|Open-label Period|Did not meet inclusion criteria|0|||
164053503|NCT01258738|592554334|FG001|Open-label Period|Did not meet inclusion criteria|1|||
164053504|NCT01258738|592554333|FG000|Open-label Period|Insufficient clinical response|5|||
164053505|NCT01258738|592554334|FG001|Open-label Period|Insufficient clinical response|3|||
164053506|NCT01258738|592554333|FG000|Open-label Period|Lost to Follow-up|0|||
164053507|NCT01258738|592554334|FG001|Open-label Period|Lost to Follow-up|2|||
164053508|NCT01258738|592554333|FG000|Open-label Period|Withdrawal by Subject|5|||
164053509|NCT01258738|592554334|FG001|Open-label Period|Withdrawal by Subject|6|||
164053510|NCT01258738|592554333|FG000|Open-label Period|Protocol Violation|2|||
164053511|NCT01258738|592554334|FG001|Open-label Period|Protocol Violation|2|||
164053512|NCT01258738|592554333|FG000|Open-label Period|Adverse Event|4|||
164053513|NCT01258738|592554334|FG001|Open-label Period|Adverse Event|5|||
164053514|NCT01258738|592554333|FG000|Open-label Period|Other Reasons|0|||
164053515|NCT01258738|592554334|FG001|Open-label Period|Other Reasons|1|||
164053516|NCT01258738|592554333|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
164053517|NCT01258738|592554334|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
164053518|NCT00689611|592554335|FG000|Overall Study|Death|6|||
164053519|NCT00689611|592554336|FG001|Overall Study|Death|9|||
164053520|NCT00689611|592554335|FG000|Overall Study|Withdrawal by Subject|8|||
164053521|NCT00689611|592554336|FG001|Overall Study|Withdrawal by Subject|9|||
164053522|NCT00689611|592554335|FG000|Overall Study|Lost to Follow-up|27|||
164053523|NCT00689611|592554336|FG001|Overall Study|Lost to Follow-up|28|||
164053524|NCT00568399|592554338|FG000|Overall Study|Death|2|||
164053525|NCT00568399|592554338|FG000|Overall Study|Adverse Event|5|||
164053526|NCT00568399|592554338|FG000|Overall Study|Withdrawal by Subject|8|||
164053527|NCT02967562|592554343|FG000|Overall Study|Consent not obtained|1|||
164053528|NCT02967562|592554344|FG001|Overall Study|Consent not obtained|0|||
164053529|NCT02967562|592554343|FG000|Overall Study|High leak precluding analysis|1|||
164053530|NCT02967562|592554344|FG001|Overall Study|High leak precluding analysis|1|||
164053531|NCT00405756|592554345|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
164053532|NCT00405756|592554346|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
164053533|NCT00405756|592554347|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
164100795|NCT02883452|592734830|FG001|Overall Study|Death|0|||
164053534|NCT00405756|592554345|FG000|Double-blind Treatment|Adverse Event|31|||
164100796|NCT02883452|592734831|FG002|Overall Study|Death|1|||
164100797|NCT02883452|592734832|FG003|Overall Study|Death|0|||
164053535|NCT00405756|592554346|FG001|Double-blind Treatment|Adverse Event|27|||
164053536|NCT00405756|592554347|FG002|Double-blind Treatment|Adverse Event|12|||
164053537|NCT00405756|592554345|FG000|Double-blind Treatment|Disease Progression|47|||
164053538|NCT00405756|592554346|FG001|Double-blind Treatment|Disease Progression|81|||
164053539|NCT00405756|592554347|FG002|Double-blind Treatment|Disease Progression|102|||
164100798|NCT02883452|592734833|FG004|Overall Study|Death|0|||
164053540|NCT00405756|592554345|FG000|Double-blind Treatment|Lack of Efficacy|1|||
164053541|NCT00405756|592554346|FG001|Double-blind Treatment|Lack of Efficacy|4|||
164053542|NCT00405756|592554347|FG002|Double-blind Treatment|Lack of Efficacy|2|||
164053543|NCT00405756|592554345|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
164053544|NCT00405756|592554346|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
164053545|NCT00405756|592554347|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
164053546|NCT00405756|592554345|FG000|Double-blind Treatment|Lost to Follow-up|1|||
164053547|NCT00405756|592554346|FG001|Double-blind Treatment|Lost to Follow-up|0|||
164053548|NCT00405756|592554347|FG002|Double-blind Treatment|Lost to Follow-up|0|||
164053549|NCT00405756|592554345|FG000|Double-blind Treatment|Death|4|||
164053550|NCT00405756|592554346|FG001|Double-blind Treatment|Death|4|||
164053551|NCT00405756|592554347|FG002|Double-blind Treatment|Death|4|||
164053552|NCT00405756|592554345|FG000|Double-blind Treatment|Protocol Violation|1|||
164053553|NCT00405756|592554346|FG001|Double-blind Treatment|Protocol Violation|0|||
164053554|NCT00405756|592554347|FG002|Double-blind Treatment|Protocol Violation|2|||
164053555|NCT00405756|592554345|FG000|Double-blind Treatment|Other|7|||
164053556|NCT00405756|592554346|FG001|Double-blind Treatment|Other|4|||
164053557|NCT00405756|592554347|FG002|Double-blind Treatment|Other|4|||
164053558|NCT00405756|592554345|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
164053559|NCT00405756|592554346|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
164053560|NCT00405756|592554347|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
164053561|NCT00405756|592554345|FG000|Open-label Extension|Adverse Event|1|||
164053562|NCT00405756|592554346|FG001|Open-label Extension|Adverse Event|3|||
164053563|NCT00405756|592554347|FG002|Open-label Extension|Adverse Event|7|||
164053564|NCT00405756|592554345|FG000|Open-label Extension|Disease Progression|8|||
164053565|NCT00405756|592554346|FG001|Open-label Extension|Disease Progression|23|||
164053566|NCT00405756|592554347|FG002|Open-label Extension|Disease Progression|26|||
164053567|NCT00405756|592554345|FG000|Open-label Extension|Withdrawal by Subject|2|||
164053568|NCT00405756|592554346|FG001|Open-label Extension|Withdrawal by Subject|3|||
164053569|NCT00405756|592554347|FG002|Open-label Extension|Withdrawal by Subject|3|||
164053570|NCT00405756|592554345|FG000|Open-label Extension|Death|1|||
164053571|NCT00405756|592554346|FG001|Open-label Extension|Death|2|||
164053572|NCT00405756|592554347|FG002|Open-label Extension|Death|4|||
164053573|NCT00405756|592554345|FG000|Open-label Extension|Other|0|||
164053574|NCT00405756|592554346|FG001|Open-label Extension|Other|1|||
164053575|NCT00405756|592554347|FG002|Open-label Extension|Other|7|||
164053576|NCT00405756|592554345|FG000|Follow-up|Ongoing in Follow-up Period|52|||
164053577|NCT00405756|592554346|FG001|Follow-up|Ongoing in Follow-up Period|51|||
164053578|NCT00405756|592554347|FG002|Follow-up|Ongoing in Follow-up Period|60|||
164053579|NCT00405756|592554345|FG000|Follow-up|Death|21|||
164053580|NCT00405756|592554346|FG001|Follow-up|Death|31|||
164053581|NCT00405756|592554347|FG002|Follow-up|Death|24|||
164053582|NCT00405756|592554345|FG000|Follow-up|Lost to Follow-up|2|||
164053583|NCT00405756|592554346|FG001|Follow-up|Lost to Follow-up|8|||
164053584|NCT00405756|592554347|FG002|Follow-up|Lost to Follow-up|4|||
164053585|NCT00286156|592554353|FG000|Overall Study|Missed 12 month visit|0|||
164053586|NCT00286156|592554354|FG001|Overall Study|Missed 12 month visit|0|||
164053587|NCT00286156|592554355|FG002|Overall Study|Missed 12 month visit|1|||
164053588|NCT00286156|592554353|FG000|Overall Study|AE: pulmonary embolus|0|||
164053589|NCT00286156|592554354|FG001|Overall Study|AE: pulmonary embolus|1|||
164053590|NCT00286156|592554355|FG002|Overall Study|AE: pulmonary embolus|0|||
164053591|NCT00286156|592554353|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
164053592|NCT00286156|592554354|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
164053593|NCT00286156|592554355|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
164053594|NCT00286156|592554353|FG000|Overall Study|AE: pneumonia|1|||
164053595|NCT00286156|592554354|FG001|Overall Study|AE: pneumonia|0|||
164053596|NCT00286156|592554355|FG002|Overall Study|AE: pneumonia|0|||
164053597|NCT02870348|592554357|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
164053598|NCT00672139|592554358|FG000|Overall Study|Death|14|||
164053599|NCT00672139|592554359|FG001|Overall Study|Death|23|||
164053600|NCT00672139|592554358|FG000|Overall Study|Withdrawal by Subject|2|||
164053601|NCT00672139|592554359|FG001|Overall Study|Withdrawal by Subject|11|||
164053602|NCT00672139|592554358|FG000|Overall Study|Adverse Event|4|||
164053603|NCT00672139|592554359|FG001|Overall Study|Adverse Event|7|||
164053604|NCT00672139|592554358|FG000|Overall Study|Physician Decision|2|||
164053605|NCT00672139|592554359|FG001|Overall Study|Physician Decision|0|||
164053606|NCT00672139|592554358|FG000|Overall Study|Lack of Efficacy|4|||
164053607|NCT00672139|592554359|FG001|Overall Study|Lack of Efficacy|1|||
164053608|NCT00672139|592554358|FG000|Overall Study|Protocol Violation|1|||
164053609|NCT00672139|592554359|FG001|Overall Study|Protocol Violation|1|||
164053610|NCT00672139|592554358|FG000|Overall Study|hospice discharge, caregiver requests|3|||
164053611|NCT00672139|592554359|FG001|Overall Study|hospice discharge, caregiver requests|2|||
164053612|NCT01051856|592554360|FG000|Overall Study|Withdrawal by Subject|1|||
164053613|NCT01051856|592554361|FG001|Overall Study|Withdrawal by Subject|0|||
164053614|NCT02176226|592554362|FG000|Overall Study|Lost to Follow-up|3|||
164053615|NCT02176226|592554362|FG000|Overall Study|Withdrew prior to treatment|6|||
164053616|NCT01488994|592554369|FG000|Overall Study|Withdrawal by Subject|0|||
164053617|NCT01488994|592554370|FG001|Overall Study|Withdrawal by Subject|1|||
164053618|NCT01072500|592554371|FG000|Overall Study|Death|2|||
164053619|NCT01072500|592554372|FG001|Overall Study|Death|2|||
164053620|NCT01072500|592554371|FG000|Overall Study|Lost to Follow-up|5|||
164053621|NCT01072500|592554372|FG001|Overall Study|Lost to Follow-up|2|||
164053622|NCT01072500|592554371|FG000|Overall Study|Withdrawal by Subject|17|||
164053623|NCT01072500|592554372|FG001|Overall Study|Withdrawal by Subject|10|||
164053624|NCT02908841|592554373|FG000|Overall Study|Physician Decision|4|||
164053625|NCT02908841|592554374|FG001|Overall Study|Physician Decision|0|||
164053626|NCT00103207|592554375|FG000|Overall Study|Adverse Event|3|||
164053627|NCT00103207|592554375|FG000|Overall Study|Death|1|||
164053628|NCT00103207|592554375|FG000|Overall Study|Withdrawal by Subject|2|||
164053629|NCT00103207|592554375|FG000|Overall Study|Other complicating disease|1|||
164053630|NCT00103207|592554375|FG000|Overall Study|Ineligible|4|||
164053631|NCT00103207|592554375|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
164053632|NCT01611558|592554376|FG000|Induction Phase|Study drug toxicity|15|||
164053633|NCT01611558|592554376|FG000|Induction Phase|Disease progression|18|||
164053634|NCT01611558|592554376|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
164053635|NCT01611558|592554376|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
164053636|NCT01611558|592554376|FG000|Induction Phase|Death|1|||
164053637|NCT01611558|592554376|FG000|Maintenance Phase|Withdrawal by Subject|1|||
164053638|NCT01611558|592554376|FG000|Maintenance Phase|Elevated Uric acid|1|||
164053639|NCT01412333|592554391|FG000|Overall Study|Adverse Event|40|||
164053640|NCT01412333|592554392|FG001|Overall Study|Adverse Event|42|||
164053641|NCT01412333|592554391|FG000|Overall Study|Death|5|||
164053642|NCT01412333|592554392|FG001|Overall Study|Death|6|||
164053643|NCT01412333|592554391|FG000|Overall Study|Lack of Efficacy|22|||
164053644|NCT01412333|592554392|FG001|Overall Study|Lack of Efficacy|10|||
164053645|NCT01412333|592554391|FG000|Overall Study|Lost to Follow-up|15|||
164053646|NCT01412333|592554392|FG001|Overall Study|Lost to Follow-up|12|||
164053647|NCT01412333|592554391|FG000|Overall Study|Non-Compliance|3|||
164053648|NCT01412333|592554392|FG001|Overall Study|Non-Compliance|7|||
164053649|NCT01412333|592554391|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164053650|NCT01412333|592554392|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164053651|NCT01412333|592554391|FG000|Overall Study|Other|30|||
164053652|NCT01412333|592554392|FG001|Overall Study|Other|33|||
164053653|NCT01412333|592554391|FG000|Overall Study|Physician Decision|11|||
164053654|NCT01412333|592554392|FG001|Overall Study|Physician Decision|16|||
164053655|NCT01412333|592554391|FG000|Overall Study|Pregnancy|6|||
164053656|NCT01412333|592554392|FG001|Overall Study|Pregnancy|4|||
164053657|NCT01412333|592554391|FG000|Overall Study|Protocol Violation|1|||
164053658|NCT01412333|592554392|FG001|Overall Study|Protocol Violation|2|||
164053659|NCT01412333|592554391|FG000|Overall Study|Study Terminated By Sponsor|3|||
164053660|NCT01412333|592554392|FG001|Overall Study|Study Terminated By Sponsor|2|||
164053661|NCT01412333|592554391|FG000|Overall Study|Withdrawal by Subject|51|||
164053662|NCT01412333|592554392|FG001|Overall Study|Withdrawal by Subject|54|||
164053663|NCT01412333|592554391|FG000|Overall Study|Missing|1|||
164053664|NCT01412333|592554392|FG001|Overall Study|Missing|3|||
164053665|NCT04005885|592554393|FG000|First Intervention|Withdrawal by Subject|1|||
164053666|NCT04005885|592554394|FG001|First Intervention|Withdrawal by Subject|1|||
164053667|NCT04005885|592554393|FG000|Second Intervention|Withdrawal by Subject|0|||
164053668|NCT04005885|592554394|FG001|Second Intervention|Withdrawal by Subject|2|||
164053669|NCT01038635|592554395|FG000|Overall Study|Disease Progression|2|||
164053670|NCT01038635|592554396|FG001|Overall Study|Disease Progression|0|||
164053671|NCT01038635|592554397|FG002|Overall Study|Disease Progression|0|||
164053672|NCT01038635|592554398|FG003|Overall Study|Disease Progression|0|||
164053673|NCT01038635|592554399|FG004|Overall Study|Disease Progression|0|||
164053674|NCT01038635|592554400|FG005|Overall Study|Disease Progression|0|||
164053675|NCT01038635|592554401|FG006|Overall Study|Disease Progression|1|||
164053676|NCT01038635|592554402|FG007|Overall Study|Disease Progression|4|||
164053677|NCT01038635|592554403|FG008|Overall Study|Disease Progression|0|||
164053678|NCT01038635|592554395|FG000|Overall Study|Death|0|||
164053679|NCT01038635|592554396|FG001|Overall Study|Death|0|||
164053680|NCT01038635|592554397|FG002|Overall Study|Death|0|||
164053681|NCT01038635|592554398|FG003|Overall Study|Death|0|||
164053682|NCT01038635|592554399|FG004|Overall Study|Death|1|||
164053683|NCT01038635|592554400|FG005|Overall Study|Death|0|||
164053684|NCT01038635|592554401|FG006|Overall Study|Death|1|||
164053685|NCT01038635|592554402|FG007|Overall Study|Death|1|||
164053686|NCT01038635|592554403|FG008|Overall Study|Death|2|||
164053687|NCT01227252|592554404|FG000|Overall Study|Sponsor Decision|0|||
164053688|NCT01227252|592554405|FG001|Overall Study|Sponsor Decision|1|||
164053689|NCT01227252|592554406|FG002|Overall Study|Sponsor Decision|0|||
164053690|NCT01227252|592554407|FG003|Overall Study|Sponsor Decision|0|||
164053691|NCT01227252|592554404|FG000|Overall Study|Lost to Follow-up|0|||
164053692|NCT01227252|592554405|FG001|Overall Study|Lost to Follow-up|1|||
164053693|NCT01227252|592554406|FG002|Overall Study|Lost to Follow-up|0|||
164053694|NCT01227252|592554407|FG003|Overall Study|Lost to Follow-up|0|||
164053695|NCT01227252|592554404|FG000|Overall Study|Withdrawal by Subject|0|||
164053696|NCT01227252|592554405|FG001|Overall Study|Withdrawal by Subject|1|||
164053697|NCT01227252|592554406|FG002|Overall Study|Withdrawal by Subject|0|||
164053698|NCT01227252|592554407|FG003|Overall Study|Withdrawal by Subject|0|||
164053699|NCT01034709|592554409|FG000|Overall Study|Protocol Violation|9|||
164053700|NCT01034709|592554410|FG001|Overall Study|Protocol Violation|16|||
164053701|NCT03227692|592554411|FG000|Overall Study|Protocol Violation|1|||
164053702|NCT03227692|592554412|FG001|Overall Study|Protocol Violation|1|||
164053703|NCT03227692|592554411|FG000|Overall Study|Lost to Follow-up|4|||
164053704|NCT03227692|592554412|FG001|Overall Study|Lost to Follow-up|2|||
164053705|NCT03227692|592554411|FG000|Overall Study|Adverse Event|0|||
164053706|NCT03227692|592554412|FG001|Overall Study|Adverse Event|2|||
164053707|NCT02447952|592554413|FG000|Overall Study|Adverse Event|2|||
164053708|NCT02447952|592554413|FG000|Overall Study|Physician Decision|1|||
164053709|NCT02447952|592554413|FG000|Overall Study|Withdrawal by Subject|4|||
164053710|NCT01683058|592554415|FG000|Overall Study|Lost to Follow-up|9|||
164053711|NCT01683058|592554415|FG000|Overall Study|Adverse Event|6|||
164053712|NCT01683058|592554415|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
164053713|NCT01683058|592554415|FG000|Overall Study|Withdrawal by Subject|7|||
164053714|NCT01683058|592554415|FG000|Overall Study|Lack of Efficacy|2|||
164053715|NCT01195636|592554416|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
164053716|NCT01195636|592554417|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
164053717|NCT01195636|592554416|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
164053718|NCT01195636|592554417|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
164053719|NCT01195636|592554416|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164053720|NCT01195636|592554417|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
164053721|NCT01195636|592554416|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
164053722|NCT01195636|592554417|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
164053723|NCT01195636|592554416|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
164053724|NCT01195636|592554417|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
164053725|NCT01195636|592554416|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
164053726|NCT01195636|592554417|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
164053727|NCT01195636|592554416|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
164053728|NCT01195636|592554417|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
164053729|NCT01195636|592554416|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
164053730|NCT01195636|592554417|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
164053731|NCT00203294|592554418|FG000|Overall Study|Withdrawal by Subject|8|||
164053732|NCT00203294|592554419|FG001|Overall Study|Withdrawal by Subject|13|||
164053733|NCT01566981|592554420|FG000|Overall Study|Lost to Follow-up|5|||
164053734|NCT01566981|592554421|FG001|Overall Study|Lost to Follow-up|8|||
164053735|NCT02405091|592554424|FG000|Overall Study|Adverse Event|16|||
164053736|NCT02405091|592554425|FG001|Overall Study|Adverse Event|10|||
164053737|NCT02405091|592554426|FG002|Overall Study|Adverse Event|0|||
164053738|NCT02405091|592554424|FG000|Overall Study|Protocol Violation|1|||
164053739|NCT02405091|592554425|FG001|Overall Study|Protocol Violation|0|||
164053740|NCT02405091|592554426|FG002|Overall Study|Protocol Violation|0|||
164053741|NCT02405091|592554424|FG000|Overall Study|Noncompliance|1|||
164053742|NCT02405091|592554425|FG001|Overall Study|Noncompliance|6|||
164053743|NCT02405091|592554426|FG002|Overall Study|Noncompliance|2|||
164053744|NCT02405091|592554424|FG000|Overall Study|Withdrawal by Subject|4|||
164053745|NCT02405091|592554425|FG001|Overall Study|Withdrawal by Subject|8|||
164053746|NCT02405091|592554426|FG002|Overall Study|Withdrawal by Subject|0|||
164053747|NCT02405091|592554424|FG000|Overall Study|Death|0|||
164053748|NCT02405091|592554425|FG001|Overall Study|Death|1|||
164053749|NCT02405091|592554426|FG002|Overall Study|Death|0|||
164053750|NCT02405091|592554424|FG000|Overall Study|Lost to Follow-up|5|||
164053751|NCT02405091|592554425|FG001|Overall Study|Lost to Follow-up|6|||
164053752|NCT02405091|592554426|FG002|Overall Study|Lost to Follow-up|0|||
164053753|NCT02405091|592554424|FG000|Overall Study|Physician Decision|2|||
164053754|NCT02405091|592554425|FG001|Overall Study|Physician Decision|2|||
164053755|NCT02405091|592554426|FG002|Overall Study|Physician Decision|0|||
164053756|NCT01948791|592554433|FG000|Overall Study|Adverse Event|12|||
164053757|NCT01948791|592554433|FG000|Overall Study|Lack of Efficacy|3|||
164053758|NCT01948791|592554433|FG000|Overall Study|Protocol Violation|2|||
164053759|NCT01948791|592554433|FG000|Overall Study|Withdrawal by Subject|5|||
164053760|NCT01948791|592554433|FG000|Overall Study|Lost to Follow-up|6|||
164053761|NCT01948791|592554433|FG000|Overall Study|Management issues|1|||
164053762|NCT01948791|592554433|FG000|Overall Study|Others|7|||
164053763|NCT01948791|592554433|FG000|Overall Study|Screening failure|35|||
164053764|NCT00590031|592554442|FG000|Overall Study|Adverse Event|3|||
164053765|NCT00590031|592554442|FG000|Overall Study|Withdrawal by Subject|1|||
164053766|NCT00590031|592554442|FG000|Overall Study|Metastatic Disease|1|||
164053767|NCT00590031|592554442|FG000|Overall Study|Admin Hold|1|||
164053768|NCT01809327|592554443|FG000|Overall Study|Lost to Follow-up|5|||
164053769|NCT01809327|592554444|FG001|Overall Study|Lost to Follow-up|2|||
164053770|NCT01809327|592554445|FG002|Overall Study|Lost to Follow-up|4|||
164053771|NCT01809327|592554446|FG003|Overall Study|Lost to Follow-up|2|||
164053772|NCT01809327|592554447|FG004|Overall Study|Lost to Follow-up|3|||
164053773|NCT01809327|592554443|FG000|Overall Study|Withdrawal by Subject|6|||
164100799|NCT02883452|592734834|FG005|Overall Study|Death|0|||
164100800|NCT02883452|592734829|FG000|Overall Study|Other|0|||
164100801|NCT02883452|592734830|FG001|Overall Study|Other|0|||
164100802|NCT02883452|592734831|FG002|Overall Study|Other|0|||
164100803|NCT02883452|592734832|FG003|Overall Study|Other|0|||
164100804|NCT02883452|592734833|FG004|Overall Study|Other|0|||
164100805|NCT02883452|592734834|FG005|Overall Study|Other|1|||
164100806|NCT00905840|592734840|FG000|Overall Study|Lost to Follow-up|11|||
164100807|NCT00905840|592734840|FG000|Overall Study|Death|3|||
164100808|NCT00905840|592734840|FG000|Overall Study|Withdrawal by Subject|1|||
164100809|NCT00905840|592734840|FG000|Overall Study|Adverse Event|1|||
164100810|NCT00448019|592734841|FG000|Overall Study|Withdrawal by Subject|3|||
164100811|NCT00448019|592734841|FG000|Overall Study|Disease progression|1|||
164100812|NCT00448019|592734841|FG000|Overall Study|Death|2|||
164100813|NCT00448019|592734841|FG000|Overall Study|Insurance Issues|1|||
164100814|NCT03020615|592734842|FG000|Overall Study|Physician Decision|3|||
164100815|NCT03020615|592734843|FG001|Overall Study|Physician Decision|1|||
164100816|NCT03020615|592734844|FG002|Overall Study|Physician Decision|2|||
164100817|NCT03020615|592734842|FG000|Overall Study|Parent/guardian/patient choice|3|||
164100818|NCT03020615|592734843|FG001|Overall Study|Parent/guardian/patient choice|0|||
164100819|NCT03020615|592734844|FG002|Overall Study|Parent/guardian/patient choice|4|||
164100820|NCT03020615|592734842|FG000|Overall Study|Screen failure|0|||
164100821|NCT03020615|592734843|FG001|Overall Study|Screen failure|0|||
164100822|NCT03020615|592734844|FG002|Overall Study|Screen failure|1|||
164100823|NCT03020615|592734842|FG000|Overall Study|Death|1|||
164100824|NCT03020615|592734843|FG001|Overall Study|Death|0|||
164100825|NCT03020615|592734844|FG002|Overall Study|Death|0|||
164100826|NCT03020615|592734842|FG000|Overall Study|Lost to Follow-up|0|||
164100827|NCT03020615|592734843|FG001|Overall Study|Lost to Follow-up|1|||
164100828|NCT03020615|592734844|FG002|Overall Study|Lost to Follow-up|0|||
164100829|NCT00089661|592734845|FG000|Overall Study|Adverse Event|0|||
164100830|NCT00089661|592734846|FG001|Overall Study|Adverse Event|2|||
164100831|NCT00089661|592734845|FG000|Overall Study|Death|1|||
164100832|NCT00089661|592734846|FG001|Overall Study|Death|0|||
164100833|NCT00089661|592734845|FG000|Overall Study|Lost to Follow-up|0|||
164100834|NCT00089661|592734846|FG001|Overall Study|Lost to Follow-up|3|||
164100835|NCT00089661|592734845|FG000|Overall Study|Withdrawal by Subject|11|||
164100836|NCT00089661|592734846|FG001|Overall Study|Withdrawal by Subject|9|||
164100837|NCT00089661|592734845|FG000|Overall Study|Disease progression|1|||
164100838|NCT00089661|592734846|FG001|Overall Study|Disease progression|3|||
164100839|NCT00089661|592734845|FG000|Overall Study|Ineligibility determined|4|||
164100840|NCT00089661|592734846|FG001|Overall Study|Ineligibility determined|4|||
164100841|NCT00089661|592734845|FG000|Overall Study|Noncompliance|2|||
164100842|NCT00089661|592734846|FG001|Overall Study|Noncompliance|4|||
164100843|NCT00089661|592734845|FG000|Overall Study|Other|2|||
164100844|NCT00089661|592734846|FG001|Overall Study|Other|1|||
164100845|NCT02760368|592734847|FG000|Overall Study|Withdrawal by Subject|8|||
164100846|NCT02760368|592734848|FG001|Overall Study|Withdrawal by Subject|12|||
164100847|NCT02760368|592734849|FG002|Overall Study|Withdrawal by Subject|9|||
164100848|NCT02760368|592734847|FG000|Overall Study|Screen Failure|0|||
164100849|NCT02760368|592734848|FG001|Overall Study|Screen Failure|0|||
164100850|NCT02760368|592734849|FG002|Overall Study|Screen Failure|1|||
164100851|NCT02760368|592734847|FG000|Overall Study|Death|0|||
164100852|NCT02760368|592734848|FG001|Overall Study|Death|1|||
164100853|NCT02760368|592734849|FG002|Overall Study|Death|0|||
164100854|NCT02760368|592734847|FG000|Overall Study|Withdrawal by Sponsor|0|||
164100855|NCT02760368|592734848|FG001|Overall Study|Withdrawal by Sponsor|0|||
164100856|NCT02760368|592734849|FG002|Overall Study|Withdrawal by Sponsor|1|||
164100857|NCT00794963|592734850|FG000|Overall Study|Withdrawal by Subject|1|||
164100858|NCT00794963|592734851|FG001|Overall Study|Withdrawal by Subject|4|||
164100859|NCT01037114|592734852|FG000|Year 20|Others|1|||
164100860|NCT01602419|592734853|FG000|Overall Study|Not treated with Wilate|9|||
164100861|NCT01602419|592734853|FG000|Overall Study|Adverse Drug Reaction|4|||
164100862|NCT01602419|592734853|FG000|Overall Study|Insurance issues|3|||
164100863|NCT01602419|592734853|FG000|Overall Study|Changed treatment centre|1|||
164100864|NCT01602419|592734853|FG000|Overall Study|Treatment centre closed|1|||
164100865|NCT01602419|592734853|FG000|Overall Study|Withdrawal by Subject|5|||
164100866|NCT01602419|592734853|FG000|Overall Study|Lost to Follow-up|6|||
164100867|NCT03620747|592734859|FG000|Overall Study|Participant decision|7|||
164100868|NCT03620747|592734859|FG000|Overall Study|Adverse Event|6|||
164100869|NCT03620747|592734859|FG000|Overall Study|Lack of Efficacy|1|||
164100870|NCT03620747|592734859|FG000|Overall Study|Poor compliance to protocol|2|||
164100871|NCT03620747|592734859|FG000|Overall Study|Other-unspecified|3|||
164100872|NCT00635492|592734862|FG000|Overall Study|Death|12|||
164100873|NCT00635492|592734863|FG001|Overall Study|Death|40|||
164100874|NCT00635492|592734862|FG000|Overall Study|Lost to Follow-up|151|||
164100875|NCT00635492|592734863|FG001|Overall Study|Lost to Follow-up|172|||
164100876|NCT00635492|592734862|FG000|Overall Study|Physician Decision|32|||
164100877|NCT00635492|592734863|FG001|Overall Study|Physician Decision|22|||
164100878|NCT00635492|592734862|FG000|Overall Study|Sponsor decision|2|||
164100879|NCT00635492|592734863|FG001|Overall Study|Sponsor decision|3|||
164053774|NCT01809327|592554444|FG001|Overall Study|Withdrawal by Subject|4|||
164053775|NCT01809327|592554445|FG002|Overall Study|Withdrawal by Subject|4|||
164053776|NCT01809327|592554446|FG003|Overall Study|Withdrawal by Subject|2|||
164053777|NCT01809327|592554447|FG004|Overall Study|Withdrawal by Subject|5|||
164053778|NCT01809327|592554443|FG000|Overall Study|Adverse Event|4|||
164053779|NCT01809327|592554444|FG001|Overall Study|Adverse Event|3|||
164053780|NCT01809327|592554445|FG002|Overall Study|Adverse Event|7|||
164053781|NCT01809327|592554446|FG003|Overall Study|Adverse Event|4|||
164053782|NCT01809327|592554447|FG004|Overall Study|Adverse Event|8|||
164053783|NCT01809327|592554443|FG000|Overall Study|Death|1|||
164053784|NCT01809327|592554444|FG001|Overall Study|Death|0|||
164053785|NCT01809327|592554445|FG002|Overall Study|Death|0|||
164053786|NCT01809327|592554446|FG003|Overall Study|Death|0|||
164053787|NCT01809327|592554447|FG004|Overall Study|Death|0|||
164053788|NCT01809327|592554443|FG000|Overall Study|Protocol Violation|0|||
164053789|NCT01809327|592554444|FG001|Overall Study|Protocol Violation|1|||
164053790|NCT01809327|592554445|FG002|Overall Study|Protocol Violation|0|||
164053791|NCT01809327|592554446|FG003|Overall Study|Protocol Violation|0|||
164053792|NCT01809327|592554447|FG004|Overall Study|Protocol Violation|0|||
164053793|NCT01809327|592554443|FG000|Overall Study|Physician Decision|1|||
164053794|NCT01809327|592554444|FG001|Overall Study|Physician Decision|1|||
164053795|NCT01809327|592554445|FG002|Overall Study|Physician Decision|0|||
164053796|NCT01809327|592554446|FG003|Overall Study|Physician Decision|0|||
164053797|NCT01809327|592554447|FG004|Overall Study|Physician Decision|0|||
164053798|NCT01809327|592554443|FG000|Overall Study|Pregnancy|1|||
164053799|NCT01809327|592554444|FG001|Overall Study|Pregnancy|0|||
164053800|NCT01809327|592554445|FG002|Overall Study|Pregnancy|0|||
164053801|NCT01809327|592554446|FG003|Overall Study|Pregnancy|0|||
164053802|NCT01809327|592554447|FG004|Overall Study|Pregnancy|0|||
164053803|NCT01809327|592554443|FG000|Overall Study|Other|14|||
164053804|NCT01809327|592554444|FG001|Overall Study|Other|15|||
164053805|NCT01809327|592554445|FG002|Overall Study|Other|7|||
164053806|NCT01809327|592554446|FG003|Overall Study|Other|4|||
164053807|NCT01809327|592554447|FG004|Overall Study|Other|9|||
164053808|NCT02802735|592554449|FG000|Overall Study|Withdrawal by Subject|0|||
164053809|NCT02802735|592554450|FG001|Overall Study|Withdrawal by Subject|1|||
164053810|NCT02802735|592554451|FG002|Overall Study|Withdrawal by Subject|0|||
164053811|NCT02802735|592554452|FG003|Overall Study|Withdrawal by Subject|0|||
164053812|NCT02802735|592554453|FG004|Overall Study|Withdrawal by Subject|0|||
164053813|NCT01166386|592554454|FG000|Overall Study|Withdrawal by Subject|3|||
164053814|NCT01166386|592554455|FG001|Overall Study|Withdrawal by Subject|5|||
164053815|NCT03922711|592554460|FG000|Overall Study|Adverse Event|3|||
164053816|NCT03922711|592554461|FG001|Overall Study|Adverse Event|2|||
164053817|NCT03922711|592554462|FG002|Overall Study|Adverse Event|2|||
164053818|NCT03922711|592554460|FG000|Overall Study|Protocol Violation|1|||
164053819|NCT03922711|592554461|FG001|Overall Study|Protocol Violation|0|||
164053820|NCT03922711|592554462|FG002|Overall Study|Protocol Violation|0|||
164053821|NCT03922711|592554460|FG000|Overall Study|Withdrawal by Subject|0|||
164053822|NCT03922711|592554461|FG001|Overall Study|Withdrawal by Subject|3|||
164053823|NCT03922711|592554462|FG002|Overall Study|Withdrawal by Subject|1|||
164053824|NCT03922711|592554460|FG000|Overall Study|Not further specified|0|||
164053825|NCT03922711|592554461|FG001|Overall Study|Not further specified|0|||
164053826|NCT03922711|592554462|FG002|Overall Study|Not further specified|1|||
164053827|NCT00420212|592554463|FG000|Overall Study|Adverse Event|22|||
164053828|NCT00420212|592554464|FG001|Overall Study|Adverse Event|40|||
164053829|NCT00420212|592554465|FG002|Overall Study|Adverse Event|36|||
164053830|NCT00420212|592554463|FG000|Overall Study|Lost to Follow-up|9|||
164053831|NCT00420212|592554464|FG001|Overall Study|Lost to Follow-up|11|||
164053832|NCT00420212|592554465|FG002|Overall Study|Lost to Follow-up|11|||
164053833|NCT00420212|592554463|FG000|Overall Study|Withdrawal by Subject|31|||
164053834|NCT00420212|592554464|FG001|Overall Study|Withdrawal by Subject|22|||
164053835|NCT00420212|592554465|FG002|Overall Study|Withdrawal by Subject|19|||
164053836|NCT00420212|592554463|FG000|Overall Study|Physician Decision|4|||
164053837|NCT00420212|592554464|FG001|Overall Study|Physician Decision|4|||
164053838|NCT00420212|592554465|FG002|Overall Study|Physician Decision|3|||
164053839|NCT00420212|592554463|FG000|Overall Study|Protocol Violation|4|||
164053840|NCT00420212|592554464|FG001|Overall Study|Protocol Violation|4|||
164053841|NCT00420212|592554465|FG002|Overall Study|Protocol Violation|8|||
164053842|NCT00420212|592554463|FG000|Overall Study|Death|0|||
164053843|NCT00420212|592554464|FG001|Overall Study|Death|0|||
164053844|NCT00420212|592554465|FG002|Overall Study|Death|1|||
164053845|NCT00420212|592554463|FG000|Overall Study|Other-Unspecified|21|||
164053846|NCT00420212|592554464|FG001|Overall Study|Other-Unspecified|14|||
164053847|NCT00420212|592554465|FG002|Overall Study|Other-Unspecified|18|||
164053848|NCT02390362|592554466|FG000|Overall Study|Withdrawal by Subject|0|||
164053849|NCT02390362|592554467|FG001|Overall Study|Withdrawal by Subject|1|||
164053850|NCT02551874|592555826|FG000|Overall Study|Lost to Follow-up|0|||
164053851|NCT02551874|592555827|FG001|Overall Study|Lost to Follow-up|2|||
164053852|NCT02551874|592555826|FG000|Overall Study|Pregnancy|0|||
164053853|NCT02551874|592555827|FG001|Overall Study|Pregnancy|1|||
164053854|NCT02551874|592555826|FG000|Overall Study|Reason not reported|10|||
164100880|NCT00635492|592734862|FG000|Overall Study|Withdrawal by Subject|82|||
164100881|NCT00635492|592734863|FG001|Overall Study|Withdrawal by Subject|45|||
164100882|NCT04533594|592734868|FG000|Overall Study|Death|26|||
164100883|NCT02699866|592734874|FG000|Overall Study|Withdrawal by Subject|3|||
164100884|NCT02699866|592734874|FG000|Overall Study|Physician Decision|2|||
164100885|NCT02699866|592734874|FG000|Overall Study|Adverse Event|3|||
164100886|NCT02937870|592734875|FG000|Overall Study|Adverse Event|1|||
164100887|NCT02937870|592734875|FG000|Overall Study|Protocol Deviation|2|||
164100888|NCT01185821|592734876|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164100889|NCT01185821|592734877|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164100890|NCT01185821|592734878|FG002|Overall Study|Abnormal laboratory value(s)|1|||
164100891|NCT01185821|592734879|FG003|Overall Study|Abnormal laboratory value(s)|0|||
164100892|NCT01185821|592734880|FG004|Overall Study|Abnormal laboratory value(s)|0|||
164100893|NCT01185821|592734876|FG000|Overall Study|Protocol Violation|0|||
164100894|NCT01185821|592734877|FG001|Overall Study|Protocol Violation|0|||
164100895|NCT01185821|592734878|FG002|Overall Study|Protocol Violation|0|||
164100896|NCT01185821|592734879|FG003|Overall Study|Protocol Violation|1|||
164100897|NCT01185821|592734880|FG004|Overall Study|Protocol Violation|1|||
164100898|NCT01185821|592734876|FG000|Overall Study|Abnormal test procedure result|0|||
164100899|NCT01185821|592734877|FG001|Overall Study|Abnormal test procedure result|0|||
164100900|NCT01185821|592734878|FG002|Overall Study|Abnormal test procedure result|0|||
164100901|NCT01185821|592734879|FG003|Overall Study|Abnormal test procedure result|0|||
164100902|NCT01185821|592734880|FG004|Overall Study|Abnormal test procedure result|1|||
164100903|NCT01185821|592734876|FG000|Overall Study|Death|0|||
164100904|NCT01185821|592734877|FG001|Overall Study|Death|1|||
164100905|NCT01185821|592734878|FG002|Overall Study|Death|0|||
164100906|NCT01185821|592734879|FG003|Overall Study|Death|0|||
164100907|NCT01185821|592734880|FG004|Overall Study|Death|0|||
164100908|NCT01185821|592734876|FG000|Overall Study|Condition no longer required study drug|0|||
164100909|NCT01185821|592734877|FG001|Overall Study|Condition no longer required study drug|0|||
164100910|NCT01185821|592734878|FG002|Overall Study|Condition no longer required study drug|0|||
164100911|NCT01185821|592734879|FG003|Overall Study|Condition no longer required study drug|0|||
164100912|NCT01185821|592734880|FG004|Overall Study|Condition no longer required study drug|1|||
164100913|NCT01185821|592734876|FG000|Overall Study|Adverse Event|2|||
164100914|NCT01185821|592734877|FG001|Overall Study|Adverse Event|3|||
164100915|NCT01185821|592734878|FG002|Overall Study|Adverse Event|1|||
164100916|NCT01185821|592734879|FG003|Overall Study|Adverse Event|2|||
164100917|NCT01185821|592734880|FG004|Overall Study|Adverse Event|5|||
164100918|NCT01185821|592734876|FG000|Overall Study|Lack of Efficacy|0|||
164100919|NCT01185821|592734877|FG001|Overall Study|Lack of Efficacy|0|||
164100920|NCT01185821|592734878|FG002|Overall Study|Lack of Efficacy|3|||
164100921|NCT01185821|592734879|FG003|Overall Study|Lack of Efficacy|0|||
164100922|NCT01185821|592734880|FG004|Overall Study|Lack of Efficacy|9|||
164100923|NCT01185821|592734876|FG000|Overall Study|Withdrawal by Subject|3|||
164100924|NCT01185821|592734877|FG001|Overall Study|Withdrawal by Subject|2|||
164100925|NCT01185821|592734878|FG002|Overall Study|Withdrawal by Subject|2|||
164100926|NCT01185821|592734879|FG003|Overall Study|Withdrawal by Subject|1|||
164100927|NCT01185821|592734880|FG004|Overall Study|Withdrawal by Subject|3|||
164100928|NCT01185821|592734876|FG000|Overall Study|Lost to Follow-up|1|||
164100929|NCT01185821|592734877|FG001|Overall Study|Lost to Follow-up|1|||
164100930|NCT01185821|592734878|FG002|Overall Study|Lost to Follow-up|2|||
164100931|NCT01185821|592734879|FG003|Overall Study|Lost to Follow-up|1|||
164100932|NCT01185821|592734880|FG004|Overall Study|Lost to Follow-up|2|||
164100933|NCT01185821|592734876|FG000|Overall Study|Administrative problems|0|||
164100934|NCT01185821|592734877|FG001|Overall Study|Administrative problems|0|||
164100935|NCT01185821|592734878|FG002|Overall Study|Administrative problems|1|||
164100936|NCT01185821|592734879|FG003|Overall Study|Administrative problems|1|||
164100937|NCT01185821|592734880|FG004|Overall Study|Administrative problems|2|||
164100938|NCT04263649|592734883|FG000|Overall Study|Adverse Event|53|||
164100939|NCT04263649|592734883|FG000|Overall Study|Lost to Follow-up|3|||
164100940|NCT04263649|592734883|FG000|Overall Study|Death|29|||
164100941|NCT04263649|592734883|FG000|Overall Study|Device deficiency|19|||
164100942|NCT04263649|592734883|FG000|Overall Study|other reasons|11|||
164100943|NCT05169710|592734884|FG000|Overall Study|Adverse Event|1|||
164100944|NCT05169710|592734885|FG001|Overall Study|Adverse Event|2|||
164100945|NCT05169710|592734886|FG002|Overall Study|Adverse Event|2|||
164100946|NCT05169710|592734884|FG000|Overall Study|Lost to Follow-up|0|||
164100947|NCT05169710|592734885|FG001|Overall Study|Lost to Follow-up|0|||
164100948|NCT05169710|592734886|FG002|Overall Study|Lost to Follow-up|1|||
164100949|NCT05169710|592734884|FG000|Overall Study|Withdrawal by Subject|2|||
164100950|NCT05169710|592734885|FG001|Overall Study|Withdrawal by Subject|1|||
164100951|NCT05169710|592734886|FG002|Overall Study|Withdrawal by Subject|0|||
164100952|NCT05169710|592734884|FG000|Overall Study|Other Study Discontinuation Reason|0|||
164100953|NCT05169710|592734885|FG001|Overall Study|Other Study Discontinuation Reason|2|||
164100954|NCT05169710|592734886|FG002|Overall Study|Other Study Discontinuation Reason|0|||
164100955|NCT01208337|592734890|FG000|Overall Study|Death|3|||
164100956|NCT00836056|592734894|FG000|First Intervention|Adverse Event|1|||
164100957|NCT00836056|592734895|FG001|First Intervention|Adverse Event|0|||
164100958|NCT01001208|592734899|FG000|Overall Study|Adverse Event|10|||
164100959|NCT01001208|592734900|FG001|Overall Study|Adverse Event|5|||
164100960|NCT01001208|592734899|FG000|Overall Study|Lost to Follow-up|5|||
164100961|NCT01001208|592734900|FG001|Overall Study|Lost to Follow-up|9|||
164100962|NCT01001208|592734899|FG000|Overall Study|Physician Decision|1|||
164100963|NCT01001208|592734900|FG001|Overall Study|Physician Decision|0|||
164100964|NCT01001208|592734899|FG000|Overall Study|Withdrawal by Subject|4|||
164100965|NCT01001208|592734900|FG001|Overall Study|Withdrawal by Subject|5|||
164100966|NCT01001208|592734899|FG000|Overall Study|Ineligibility Determined|4|||
164100967|NCT01001208|592734900|FG001|Overall Study|Ineligibility Determined|2|||
164100968|NCT01001208|592734899|FG000|Overall Study|Noncompliance|4|||
164100969|NCT01001208|592734900|FG001|Overall Study|Noncompliance|7|||
164100970|NCT01001208|592734899|FG000|Overall Study|Disease Progression|0|||
164100971|NCT01001208|592734900|FG001|Overall Study|Disease Progression|3|||
164100972|NCT01001208|592734899|FG000|Overall Study|Other|0|||
164100973|NCT01001208|592734900|FG001|Overall Study|Other|2|||
164100974|NCT03420300|592734902|FG000|Overall Study|Death|2|||
164100975|NCT03500692|592734910|FG000|Overall Study|Death|163|||
164100976|NCT03500692|592734910|FG000|Overall Study|Lost to Follow-up|75|||
164100977|NCT03500692|592734910|FG000|Overall Study|Termination Reasons|3|||
164100978|NCT02305758|592734911|FG000|Overall Study|Death|27|||
164100979|NCT02305758|592734912|FG001|Overall Study|Death|27|||
164100980|NCT02305758|592734911|FG000|Overall Study|Withdrew consent|9|||
164100981|NCT02305758|592734912|FG001|Overall Study|Withdrew consent|2|||
164100982|NCT02305758|592734911|FG000|Overall Study|Lost to Follow-up|6|||
164100983|NCT02305758|592734912|FG001|Overall Study|Lost to Follow-up|1|||
164100984|NCT02305758|592734911|FG000|Overall Study|Study Terminated by Sponsor|21|||
164100985|NCT02305758|592734912|FG001|Overall Study|Study Terminated by Sponsor|34|||
164053855|NCT02551874|592555827|FG001|Overall Study|Reason not reported|4|||
164100986|NCT02305758|592734911|FG000|Overall Study|Other, not specified|2|||
164100987|NCT02305758|592734912|FG001|Overall Study|Other, not specified|1|||
164053856|NCT02551874|592555826|FG000|Overall Study|Did not receive randomized treatment|0|||
164053857|NCT02551874|592555827|FG001|Overall Study|Did not receive randomized treatment|7|||
164053858|NCT02551874|592555826|FG000|Overall Study|Did not enter long-term study|18|||
164053859|NCT02551874|592555827|FG001|Overall Study|Did not enter long-term study|25|||
164053860|NCT04067310|592555829|FG000|Overall Study|Physician Decision|2|||
164053861|NCT04067310|592555830|FG001|Overall Study|Physician Decision|6|||
164053862|NCT04067310|592555829|FG000|Overall Study|Lost to Follow-up|0|||
164053863|NCT04067310|592555830|FG001|Overall Study|Lost to Follow-up|1|||
164053864|NCT04067310|592555829|FG000|Overall Study|Withdrawal by Subject|3|||
164053865|NCT04067310|592555830|FG001|Overall Study|Withdrawal by Subject|0|||
164053866|NCT01041027|592555831|FG000|Overall Study|Withdrawal by Subject|2|||
164053867|NCT01041027|592555831|FG000|Overall Study|Protocol Violation|1|||
164053868|NCT01041027|592555831|FG000|Overall Study|Delayed Radiation Therapy|1|||
164053869|NCT01041027|592555831|FG000|Overall Study|Adverse Event|4|||
164053870|NCT02493712|592555832|FG000|Overall Study|Withdrawal by Subject|1|||
164053871|NCT02493712|592555833|FG001|Overall Study|Withdrawal by Subject|0|||
164053872|NCT02493712|592555834|FG002|Overall Study|Withdrawal by Subject|2|||
164053873|NCT02493712|592555832|FG000|Overall Study|Protocol Violation|0|||
164053874|NCT02493712|592555833|FG001|Overall Study|Protocol Violation|0|||
164053875|NCT02493712|592555834|FG002|Overall Study|Protocol Violation|1|||
164053876|NCT02493712|592555832|FG000|Overall Study|Lost to Follow-up|1|||
164053877|NCT02493712|592555833|FG001|Overall Study|Lost to Follow-up|0|||
164053878|NCT02493712|592555834|FG002|Overall Study|Lost to Follow-up|0|||
164053879|NCT02493712|592555832|FG000|Overall Study|Physician Decision|0|||
164053880|NCT02493712|592555833|FG001|Overall Study|Physician Decision|1|||
164053881|NCT02493712|592555834|FG002|Overall Study|Physician Decision|0|||
164053882|NCT02493712|592555832|FG000|Overall Study|Lack of Efficacy|0|||
164053883|NCT02493712|592555833|FG001|Overall Study|Lack of Efficacy|5|||
164053884|NCT02493712|592555834|FG002|Overall Study|Lack of Efficacy|3|||
164053885|NCT02528643|592555835|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
164053886|NCT02528643|592555836|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
164053887|NCT02528643|592555835|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
164053888|NCT02528643|592555836|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
164053889|NCT02528643|592555835|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
164053890|NCT02528643|592555836|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
164053891|NCT02528643|592555835|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
164053892|NCT02528643|592555836|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
164100988|NCT01424644|592734914|FG000|Overall Study|Adverse Event|2|||
164100989|NCT01424644|592734915|FG001|Overall Study|Adverse Event|0|||
164053893|NCT02528643|592555835|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
164053894|NCT02528643|592555836|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
164100990|NCT01424644|592734914|FG000|Overall Study|Withdrawal by Subject|9|||
164100991|NCT01424644|592734915|FG001|Overall Study|Withdrawal by Subject|12|||
164100992|NCT01424644|592734914|FG000|Overall Study|Lost to Follow-up|16|||
164100993|NCT01424644|592734915|FG001|Overall Study|Lost to Follow-up|12|||
164053895|NCT02528643|592555835|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
164053896|NCT02528643|592555836|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
164053897|NCT02528643|592555835|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
164053898|NCT02528643|592555836|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
164053899|NCT02058940|592555837|FG000|Overall Study|Discharged from Critical Care Unit|1|||
164053900|NCT04144140|592555838|FG000|Overall Study|Other|0|||
164053901|NCT04144140|592555839|FG001|Overall Study|Other|0|||
164053902|NCT04144140|592555840|FG002|Overall Study|Other|0|||
164053903|NCT04144140|592555841|FG003|Overall Study|Other|0|||
164053904|NCT04144140|592555842|FG004|Overall Study|Other|0|||
164053905|NCT04144140|592555843|FG005|Overall Study|Other|1|||
164053906|NCT04144140|592555844|FG006|Overall Study|Other|0|||
164053907|NCT02146274|592555845|FG000|Overall Study|Protocol Violation|73|||
164053908|NCT03384316|592555848|FG000|Overall Study|Screen failure|0|||
164053909|NCT03384316|592555849|FG001|Overall Study|Screen failure|1|||
164053910|NCT00413231|592555850|FG000|0 to 30-day Post Treatment|Death|5|||
164053911|NCT00413231|592555850|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
164053912|NCT00413231|592555850|FG000|30-day to 365-day Post Treatment|Death|13|||
164053913|NCT00413231|592555850|FG000|365-day to 60-month Post Treatment|Death|36|||
164053914|NCT00413231|592555850|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
164053915|NCT00413231|592555850|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
164053916|NCT00413231|592555850|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
164053917|NCT03287960|592555853|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
164053918|NCT03287960|592555853|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
164053919|NCT01641952|592555854|FG000|Overall Study|Lost to Follow-up|28|||
164053920|NCT01641952|592555854|FG000|Overall Study|Adverse Event|6|||
164053921|NCT00656136|592555855|FG000|Overall Study|Progressive disease|177|||
164053922|NCT00656136|592555856|FG001|Overall Study|Progressive disease|322|||
164053923|NCT00656136|592555855|FG000|Overall Study|Other Adverse Event|5|||
164053924|NCT00656136|592555856|FG001|Overall Study|Other Adverse Event|51|||
164053925|NCT00656136|592555855|FG000|Overall Study|Protocol Violation|2|||
164053926|NCT00656136|592555856|FG001|Overall Study|Protocol Violation|3|||
164053927|NCT00656136|592555855|FG000|Overall Study|Patient refused to take study medication|7|||
164053928|NCT00656136|592555856|FG001|Overall Study|Patient refused to take study medication|10|||
164053929|NCT00656136|592555855|FG000|Overall Study|Unknown and others|4|||
164053930|NCT00656136|592555856|FG001|Overall Study|Unknown and others|4|||
164053931|NCT02516306|592555864|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
164053932|NCT02516306|592555865|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
164053933|NCT00247962|592555868|FG000|Overall Study|Adverse Event|15|||
164053934|NCT00247962|592555869|FG001|Overall Study|Adverse Event|12|||
164053935|NCT00247962|592555868|FG000|Overall Study|Lost to Follow-up|3|||
164053936|NCT00247962|592555869|FG001|Overall Study|Lost to Follow-up|1|||
164053937|NCT00247962|592555868|FG000|Overall Study|Physician Decision|0|||
164053938|NCT00247962|592555869|FG001|Overall Study|Physician Decision|1|||
164053939|NCT00247962|592555868|FG000|Overall Study|Protocol Violation|1|||
164053940|NCT00247962|592555869|FG001|Overall Study|Protocol Violation|1|||
164053941|NCT00247962|592555868|FG000|Overall Study|Withdrawal by Subject|3|||
164053942|NCT00247962|592555869|FG001|Overall Study|Withdrawal by Subject|2|||
164053943|NCT00247962|592555868|FG000|Overall Study|Lack of Efficacy|4|||
164053944|NCT00247962|592555869|FG001|Overall Study|Lack of Efficacy|2|||
164053945|NCT03525613|592555871|FG000|Overall Study|Adverse Event|11|||
164053946|NCT03525613|592555872|FG001|Overall Study|Adverse Event|8|||
164053947|NCT03525613|592555873|FG002|Overall Study|Adverse Event|3|||
164053948|NCT03525613|592555874|FG003|Overall Study|Adverse Event|3|||
164053949|NCT03525613|592555871|FG000|Overall Study|Lost to Follow-up|4|||
164053950|NCT03525613|592555872|FG001|Overall Study|Lost to Follow-up|5|||
164053951|NCT03525613|592555873|FG002|Overall Study|Lost to Follow-up|3|||
164053952|NCT03525613|592555874|FG003|Overall Study|Lost to Follow-up|2|||
164053953|NCT03525613|592555871|FG000|Overall Study|Physician Decision|0|||
164053954|NCT03525613|592555872|FG001|Overall Study|Physician Decision|1|||
164053955|NCT03525613|592555873|FG002|Overall Study|Physician Decision|0|||
164053956|NCT03525613|592555874|FG003|Overall Study|Physician Decision|1|||
164053957|NCT03525613|592555871|FG000|Overall Study|Consent Withdrawal|25|||
164053958|NCT03525613|592555872|FG001|Overall Study|Consent Withdrawal|16|||
164053959|NCT03525613|592555873|FG002|Overall Study|Consent Withdrawal|12|||
164053960|NCT03525613|592555874|FG003|Overall Study|Consent Withdrawal|9|||
164053961|NCT03525613|592555871|FG000|Overall Study|Death|20|||
164053962|NCT03525613|592555872|FG001|Overall Study|Death|9|||
164053963|NCT03525613|592555873|FG002|Overall Study|Death|7|||
164053964|NCT03525613|592555874|FG003|Overall Study|Death|1|||
164053965|NCT03525613|592555871|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
164053966|NCT03525613|592555872|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
164053967|NCT03525613|592555873|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
164053968|NCT03525613|592555874|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
164053969|NCT02120469|592555877|FG000|Overall Study|HER-2/neu-amplified|1|||
164053970|NCT02120469|592555878|FG001|Overall Study|HER-2/neu-amplified|0|||
164053971|NCT02120469|592555879|FG002|Overall Study|HER-2/neu-amplified|1|||
164053972|NCT01012037|592555880|FG000|Overall Study|Adverse Event|0|||
164053973|NCT01012037|592555881|FG001|Overall Study|Adverse Event|8|||
164053974|NCT01012037|592555882|FG002|Overall Study|Adverse Event|3|||
164053975|NCT01012037|592555880|FG000|Overall Study|Protocol Violation|0|||
164053976|NCT01012037|592555881|FG001|Overall Study|Protocol Violation|3|||
164053977|NCT01012037|592555882|FG002|Overall Study|Protocol Violation|5|||
164053978|NCT01012037|592555880|FG000|Overall Study|Withdrawal by Subject|0|||
164053979|NCT01012037|592555881|FG001|Overall Study|Withdrawal by Subject|4|||
164053980|NCT01012037|592555882|FG002|Overall Study|Withdrawal by Subject|1|||
164053981|NCT01012037|592555880|FG000|Overall Study|Other reason (not specified)|1|||
164053982|NCT01012037|592555881|FG001|Overall Study|Other reason (not specified)|1|||
164053983|NCT01012037|592555882|FG002|Overall Study|Other reason (not specified)|1|||
164053984|NCT01142791|592555895|FG000|Overall Study|Alternative Treatment|1|||
164053985|NCT01142791|592555896|FG001|Overall Study|Alternative Treatment|0|||
164053986|NCT01142791|592555895|FG000|Overall Study|Lost to Follow-up|1|||
164053987|NCT01142791|592555896|FG001|Overall Study|Lost to Follow-up|0|||
164053988|NCT01142791|592555895|FG000|Overall Study|Withdrawal by Subject|5|||
164053989|NCT01142791|592555896|FG001|Overall Study|Withdrawal by Subject|0|||
164053990|NCT01142791|592555895|FG000|Overall Study|Received only 1 sonication|0|||
164053991|NCT01142791|592555896|FG001|Overall Study|Received only 1 sonication|6|||
164053992|NCT02178592|592555897|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
164053993|NCT02178592|592555898|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
164053994|NCT02178592|592555897|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
164053995|NCT02178592|592555898|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
164053996|NCT02178592|592555897|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
164053997|NCT02178592|592555898|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
164053998|NCT02178592|592555897|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
164053999|NCT02178592|592555898|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
164054000|NCT02178592|592555897|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
164054001|NCT02178592|592555898|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
164054002|NCT02178592|592555897|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
164054003|NCT02178592|592555898|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
164054004|NCT02178592|592555897|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
164054005|NCT02178592|592555898|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
164054006|NCT02178592|592555897|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
164054007|NCT02178592|592555898|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
164054008|NCT02178592|592555897|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
164054009|NCT02178592|592555898|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
164054010|NCT02178592|592555897|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
164054011|NCT02178592|592555898|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
164054012|NCT02178592|592555897|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
164054013|NCT02178592|592555898|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
164054014|NCT02178592|592555897|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
164054015|NCT02178592|592555898|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
164054016|NCT02975206|592555902|FG000|Overall Study|Withdrawal by Subject|14|||
164054017|NCT02975206|592555903|FG001|Overall Study|Withdrawal by Subject|11|||
164054018|NCT02975206|592555904|FG002|Overall Study|Withdrawal by Subject|11|||
164054019|NCT02975206|592555902|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
164054020|NCT02975206|592555903|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
164054021|NCT02975206|592555904|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
164054022|NCT01981096|592555908|FG000|Overall Study|Parent illness|1|||
164054023|NCT01981096|592555909|FG001|Overall Study|Parent illness|0|||
164054024|NCT01981096|592555908|FG000|Overall Study|Withdrawal by Subject|0|||
164054025|NCT01981096|592555909|FG001|Overall Study|Withdrawal by Subject|1|||
164054026|NCT01981096|592555908|FG000|Overall Study|Lost to Follow-up|2|||
164054027|NCT01981096|592555909|FG001|Overall Study|Lost to Follow-up|0|||
164054028|NCT04129242|592555912|FG000|Overall Study|Physician Decision|1|||
164054029|NCT04129242|592555913|FG001|Overall Study|Physician Decision|1|||
164054030|NCT04129242|592555912|FG000|Overall Study|Protocol Violation|0|||
164054031|NCT04129242|592555913|FG001|Overall Study|Protocol Violation|1|||
164054032|NCT00392210|592555917|FG000|First Voiding Trial|Physician Decision|2|||
164054033|NCT00392210|592555918|FG001|First Voiding Trial|Physician Decision|2|||
164054034|NCT02067104|592555919|FG000|Overall Study|Study termination due to low accrual|4|||
164054035|NCT02067104|592555920|FG001|Overall Study|Study termination due to low accrual|5|||
164054036|NCT02610231|592555921|FG000|Overall Study|Withdrawal by Subject|27|||
164054037|NCT02610231|592555921|FG000|Overall Study|Adverse Event|20|||
164054038|NCT02610231|592555921|FG000|Overall Study|Death|5|||
164054039|NCT02610231|592555921|FG000|Overall Study|Surgery|2|||
164054040|NCT02610231|592555921|FG000|Overall Study|Physician Decision|1|||
164054041|NCT02610231|592555921|FG000|Overall Study|Non Compliance|2|||
164054042|NCT02610231|592555921|FG000|Overall Study|Other|3|||
164054043|NCT01279954|592555929|FG000|Overall Study|Lack of Efficacy|3|||
164054044|NCT01279954|592555930|FG001|Overall Study|Lack of Efficacy|4|||
164100994|NCT01424644|592734914|FG000|Overall Study|Protocol Violation|4|||
164100995|NCT01424644|592734915|FG001|Overall Study|Protocol Violation|3|||
164100996|NCT01424644|592734914|FG000|Overall Study|Administrative Reason|1|||
164100997|NCT01424644|592734915|FG001|Overall Study|Administrative Reason|0|||
164100998|NCT01424644|592734914|FG000|Overall Study|Unable to Classify|1|||
164100999|NCT01424644|592734915|FG001|Overall Study|Unable to Classify|0|||
164101000|NCT05593965|592734916|FG000|1st Intervention (1 Day)|Technical error|1|||
164101001|NCT05593965|592734917|FG001|1st Intervention (1 Day)|Technical error|0|||
164101002|NCT02272777|592734918|FG000|Overall Study|Adverse Event|0|||
164101003|NCT02272777|592734919|FG001|Overall Study|Adverse Event|1|||
164101004|NCT02272777|592734918|FG000|Overall Study|Withdrawal by Subject|0|||
164101005|NCT02272777|592734919|FG001|Overall Study|Withdrawal by Subject|3|||
164101006|NCT02272777|592734918|FG000|Overall Study|Lost to Follow-up|2|||
164101007|NCT02272777|592734919|FG001|Overall Study|Lost to Follow-up|0|||
164101008|NCT02272777|592734918|FG000|Overall Study|Other|2|||
164101009|NCT02272777|592734919|FG001|Overall Study|Other|0|||
164101010|NCT02066922|592734922|FG000|Overall Study|Adverse Event|1|||
164101011|NCT00440297|592734923|FG000|Overall Study|Adverse Event|8|||
164101012|NCT00440297|592734924|FG001|Overall Study|Adverse Event|5|||
164101013|NCT00440297|592734923|FG000|Overall Study|Lost to Follow-up|1|||
164101014|NCT00440297|592734924|FG001|Overall Study|Lost to Follow-up|0|||
164101015|NCT00440297|592734923|FG000|Overall Study|Physician Decision|1|||
164101016|NCT00440297|592734924|FG001|Overall Study|Physician Decision|0|||
164101017|NCT00440297|592734923|FG000|Overall Study|Protocol Violation|11|||
164101018|NCT00440297|592734924|FG001|Overall Study|Protocol Violation|7|||
164101019|NCT00440297|592734923|FG000|Overall Study|Withdrawal by Subject|1|||
164101020|NCT00440297|592734924|FG001|Overall Study|Withdrawal by Subject|6|||
164101021|NCT00440297|592734923|FG000|Overall Study|Randomized by mistake|1|||
164101022|NCT00440297|592734924|FG001|Overall Study|Randomized by mistake|0|||
164101023|NCT02024932|592734925|FG000|Overall Study|Adverse Event|2|||
164101024|NCT02024932|592734926|FG001|Overall Study|Adverse Event|3|||
164101025|NCT02024932|592734927|FG002|Overall Study|Adverse Event|0|||
164101026|NCT02024932|592734928|FG003|Overall Study|Adverse Event|0|||
164101027|NCT02024932|592734929|FG004|Overall Study|Adverse Event|2|||
164101028|NCT02024932|592734930|FG005|Overall Study|Adverse Event|0|||
164101029|NCT02024932|592734925|FG000|Overall Study|Abnormal laboratory value|0|||
164101030|NCT02024932|592734926|FG001|Overall Study|Abnormal laboratory value|0|||
164101031|NCT02024932|592734927|FG002|Overall Study|Abnormal laboratory value|0|||
164101032|NCT02024932|592734928|FG003|Overall Study|Abnormal laboratory value|2|||
164101033|NCT02024932|592734929|FG004|Overall Study|Abnormal laboratory value|0|||
164101034|NCT02024932|592734930|FG005|Overall Study|Abnormal laboratory value|0|||
164101035|NCT02445339|592734931|FG000|Overall Study|Physician Decision|1|||
164101036|NCT02445339|592734932|FG001|Overall Study|Physician Decision|0|||
164101037|NCT02445339|592734931|FG000|Overall Study|Lost to Follow-up|11|||
164101038|NCT02445339|592734932|FG001|Overall Study|Lost to Follow-up|15|||
164101039|NCT03206177|592734933|FG000|Overall Study|Withdrawal by Subject|1|||
164101040|NCT03020641|592734934|FG000|Overall Study|Lost to Follow-up|0|||
164101041|NCT03020641|592734935|FG001|Overall Study|Lost to Follow-up|1|||
164101042|NCT03020641|592734934|FG000|Overall Study|Converted to open surgery|2|||
164101043|NCT03020641|592734935|FG001|Overall Study|Converted to open surgery|1|||
164101044|NCT03020641|592734934|FG000|Overall Study|for surgery not performed|0|||
164101045|NCT03020641|592734935|FG001|Overall Study|for surgery not performed|1|||
164101046|NCT00727961|592734936|FG000|Overall Study|Lost to Follow-up|1|||
164101047|NCT00727961|592734936|FG000|Overall Study|Adverse Event|4|||
164101048|NCT00727961|592734936|FG000|Overall Study|Patient's refusal|2|||
164101049|NCT00727961|592734936|FG000|Overall Study|Progression|30|||
164101050|NCT03161405|592734937|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
164101051|NCT01421277|592734938|FG000|Overall Study|Lack of qualifying event|0|||
164101052|NCT01421277|592734939|FG001|Overall Study|Lack of qualifying event|61|||
164101053|NCT01421277|592734938|FG000|Overall Study|Incomplete baseline data|0|||
164101054|NCT01421277|592734939|FG001|Overall Study|Incomplete baseline data|31|||
164101055|NCT02039908|592734940|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
164101056|NCT02039908|592734941|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
164101057|NCT02039908|592734942|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
164101058|NCT02039908|592734943|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
164101059|NCT02039908|592734940|FG000|Phase 1-Summer|Protocol Violation|6|||
164101060|NCT02039908|592734941|FG001|Phase 1-Summer|Protocol Violation|0|||
164101061|NCT02039908|592734942|FG002|Phase 1-Summer|Protocol Violation|0|||
164101062|NCT02039908|592734943|FG003|Phase 1-Summer|Protocol Violation|0|||
164101063|NCT02039908|592734940|FG000|Phase 2-School Year|Lost to Follow-up|0|||
164101064|NCT02039908|592734941|FG001|Phase 2-School Year|Lost to Follow-up|0|||
164101065|NCT02039908|592734942|FG002|Phase 2-School Year|Lost to Follow-up|1|||
164101066|NCT02039908|592734943|FG003|Phase 2-School Year|Lost to Follow-up|3|||
164101067|NCT02039908|592734940|FG000|Phase 2-School Year|Protocol Violation|0|||
164101068|NCT02039908|592734941|FG001|Phase 2-School Year|Protocol Violation|0|||
164101069|NCT02039908|592734942|FG002|Phase 2-School Year|Protocol Violation|3|||
164101070|NCT02039908|592734943|FG003|Phase 2-School Year|Protocol Violation|0|||
164101071|NCT02039908|592734940|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
164101072|NCT02039908|592734941|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
164101073|NCT02039908|592734942|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
164101074|NCT02039908|592734943|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
164101075|NCT01597245|592734944|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
164101076|NCT01597245|592734945|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
164101077|NCT01597245|592734946|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
164101078|NCT01597245|592734947|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
164101079|NCT01597245|592734948|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164054045|NCT02140762|592555931|FG000|Overall Study|Adverse Event|1|||
164054046|NCT02140762|592555932|FG001|Overall Study|Adverse Event|1|||
164054047|NCT02140762|592555931|FG000|Overall Study|Lost to Follow-up|9|||
164054048|NCT02140762|592555932|FG001|Overall Study|Lost to Follow-up|5|||
164054049|NCT02140762|592555931|FG000|Overall Study|Protocol Violation|1|||
164054050|NCT02140762|592555932|FG001|Overall Study|Protocol Violation|1|||
164054051|NCT02140762|592555931|FG000|Overall Study|Withdrawal by Subject|6|||
164054052|NCT02140762|592555932|FG001|Overall Study|Withdrawal by Subject|4|||
164054053|NCT02140762|592555931|FG000|Overall Study|Other|0|||
164054054|NCT02140762|592555932|FG001|Overall Study|Other|1|||
164054055|NCT01899729|592555933|FG000|Overall Study|Adverse Event|1|||
164054056|NCT01899729|592555934|FG001|Overall Study|Adverse Event|0|||
164054057|NCT01899729|592555935|FG002|Overall Study|Adverse Event|0|||
164054058|NCT01899729|592555936|FG003|Overall Study|Adverse Event|0|||
164054059|NCT01899729|592555937|FG004|Overall Study|Adverse Event|1|||
164054060|NCT01899729|592555933|FG000|Overall Study|Withdrawal by Subject|1|||
164054061|NCT01899729|592555934|FG001|Overall Study|Withdrawal by Subject|2|||
164054062|NCT01899729|592555935|FG002|Overall Study|Withdrawal by Subject|0|||
164054063|NCT01899729|592555936|FG003|Overall Study|Withdrawal by Subject|0|||
164054064|NCT01899729|592555937|FG004|Overall Study|Withdrawal by Subject|0|||
164054065|NCT01899729|592555933|FG000|Overall Study|Lack of Efficacy|0|||
164054066|NCT01899729|592555934|FG001|Overall Study|Lack of Efficacy|0|||
164054067|NCT01899729|592555935|FG002|Overall Study|Lack of Efficacy|2|||
164054068|NCT01899729|592555936|FG003|Overall Study|Lack of Efficacy|0|||
164054069|NCT01899729|592555937|FG004|Overall Study|Lack of Efficacy|1|||
164054070|NCT01454531|592555938|FG000|Overall Study|Adverse Event|14|||
164054071|NCT01454531|592555938|FG000|Overall Study|Withdrawal by Subject|5|||
164054072|NCT01454531|592555938|FG000|Overall Study|Lost to Follow-up|1|||
164101080|NCT01597245|592734949|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101081|NCT01597245|592734950|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101082|NCT01597245|592734951|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101083|NCT01597245|592734952|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101084|NCT01597245|592734953|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101085|NCT01597245|592734954|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101086|NCT01597245|592734955|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101087|NCT01597245|592734956|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101088|NCT01597245|592734957|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101089|NCT01597245|592734958|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101090|NCT01597245|592734959|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101091|NCT01597245|592734960|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101092|NCT01597245|592734961|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101093|NCT01597245|592734962|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101094|NCT01597245|592734963|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101095|NCT01597245|592734964|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
164101096|NCT01597245|592734944|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
164101097|NCT01597245|592734945|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
164101098|NCT01597245|592734946|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
164054073|NCT01454531|592555938|FG000|Overall Study|Physician Decision|1|||
164054074|NCT01454531|592555938|FG000|Overall Study|Delay in IMP administration|1|||
164054075|NCT01454531|592555938|FG000|Overall Study|Other|1|||
164101099|NCT01597245|592734947|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
164101100|NCT01597245|592734948|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101101|NCT01597245|592734949|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101102|NCT01597245|592734950|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101103|NCT01597245|592734951|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101104|NCT01597245|592734952|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101105|NCT01597245|592734953|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101106|NCT01597245|592734954|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101107|NCT01597245|592734955|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101108|NCT01597245|592734956|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101109|NCT01597245|592734957|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101110|NCT01597245|592734958|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101111|NCT01597245|592734959|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101112|NCT01597245|592734960|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164054076|NCT01711359|592555940|FG000|Treatment Period|Withdrawal by Subject|18|||
164054077|NCT01711359|592555941|FG001|Treatment Period|Withdrawal by Subject|7|||
164054078|NCT01711359|592555942|FG002|Treatment Period|Withdrawal by Subject|13|||
164054079|NCT01711359|592555940|FG000|Treatment Period|Lack of Efficacy|13|||
164054080|NCT01711359|592555941|FG001|Treatment Period|Lack of Efficacy|2|||
164054081|NCT01711359|592555942|FG002|Treatment Period|Lack of Efficacy|2|||
164054082|NCT01711359|592555940|FG000|Treatment Period|Adverse Event|8|||
164054083|NCT01711359|592555941|FG001|Treatment Period|Adverse Event|10|||
164054084|NCT01711359|592555942|FG002|Treatment Period|Adverse Event|24|||
164054085|NCT01711359|592555940|FG000|Treatment Period|Physician Decision|4|||
164054086|NCT01711359|592555941|FG001|Treatment Period|Physician Decision|3|||
164054087|NCT01711359|592555942|FG002|Treatment Period|Physician Decision|2|||
164054088|NCT01711359|592555940|FG000|Treatment Period|Death|3|||
164054089|NCT01711359|592555941|FG001|Treatment Period|Death|0|||
164054090|NCT01711359|592555942|FG002|Treatment Period|Death|0|||
164054091|NCT01711359|592555940|FG000|Treatment Period|Entry Criteria Not Met|1|||
164054092|NCT01711359|592555941|FG001|Treatment Period|Entry Criteria Not Met|0|||
164054093|NCT01711359|592555942|FG002|Treatment Period|Entry Criteria Not Met|0|||
164054094|NCT01711359|592555940|FG000|Treatment Period|Sponsor Decision|1|||
164054095|NCT01711359|592555941|FG001|Treatment Period|Sponsor Decision|0|||
164054096|NCT01711359|592555942|FG002|Treatment Period|Sponsor Decision|0|||
164054097|NCT01711359|592555940|FG000|Treatment Period|Lost to Follow-up|1|||
164054098|NCT01711359|592555941|FG001|Treatment Period|Lost to Follow-up|1|||
164054099|NCT01711359|592555942|FG002|Treatment Period|Lost to Follow-up|1|||
164054100|NCT01711359|592555940|FG000|Treatment Period|Randomized, Not Treated|3|||
164054101|NCT01711359|592555941|FG001|Treatment Period|Randomized, Not Treated|1|||
164054102|NCT01711359|592555942|FG002|Treatment Period|Randomized, Not Treated|0|||
164054103|NCT01385098|592555945|FG000|Overall Study|Adverse Event|10|||
164054104|NCT01385098|592555945|FG000|Overall Study|Lost to Follow-up|4|||
164054105|NCT00795717|592555946|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
164054106|NCT00795717|592555947|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
164054107|NCT00795717|592555946|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
164054108|NCT00795717|592555947|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
164054109|NCT00795717|592555946|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
164054110|NCT00795717|592555947|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
164054111|NCT00795717|592555946|FG000|Phase II|too busy|0|||
164054112|NCT00795717|592555947|FG001|Phase II|too busy|1|||
164054113|NCT01021423|592555950|FG000|Overall Study|Study terminated|4|||
164054114|NCT01021423|592555951|FG001|Overall Study|Study terminated|5|||
164054115|NCT00122317|592555952|FG000|Overall Study|Death|3|||
164054116|NCT00122317|592555952|FG000|Overall Study|Adverse Event|4|||
164054117|NCT00122317|592555952|FG000|Overall Study|Physician Decision|2|||
164054118|NCT00122317|592555952|FG000|Overall Study|patient non-compliance|1|||
164054119|NCT00122317|592555952|FG000|Overall Study|Withdrawal by Subject|1|||
164054120|NCT03756285|592555953|FG000|Overall Study|Lost to Follow-up|0|||
164054121|NCT03756285|592555954|FG001|Overall Study|Lost to Follow-up|1|||
164054122|NCT03756285|592555953|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
164054123|NCT03756285|592555954|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
164054124|NCT03756285|592555953|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
164054125|NCT03756285|592555954|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
164054126|NCT06334055|592555955|FG000|Overall Study|Adverse Event|4|||
164054127|NCT06334055|592555955|FG000|Overall Study|Disqualified|72|||
164054128|NCT04728815|592555958|FG000|Overall Study|Lost to Follow-up|3|||
164054129|NCT04728815|592555959|FG001|Overall Study|Lost to Follow-up|0|||
164054130|NCT04728815|592555960|FG002|Overall Study|Lost to Follow-up|0|||
164054131|NCT04728815|592555961|FG003|Overall Study|Lost to Follow-up|1|||
164054132|NCT04728815|592555962|FG004|Overall Study|Lost to Follow-up|1|||
164054133|NCT04728815|592555963|FG005|Overall Study|Lost to Follow-up|0|||
164054134|NCT04728815|592555964|FG006|Overall Study|Lost to Follow-up|2|||
164054135|NCT04728815|592555965|FG007|Overall Study|Lost to Follow-up|0|||
164054136|NCT04728815|592555958|FG000|Overall Study|Physician Decision|0|||
164054137|NCT04728815|592555959|FG001|Overall Study|Physician Decision|0|||
164054138|NCT04728815|592555960|FG002|Overall Study|Physician Decision|1|||
164054139|NCT04728815|592555961|FG003|Overall Study|Physician Decision|0|||
164054140|NCT04728815|592555962|FG004|Overall Study|Physician Decision|0|||
164054141|NCT04728815|592555963|FG005|Overall Study|Physician Decision|0|||
164054142|NCT04728815|592555964|FG006|Overall Study|Physician Decision|0|||
164054143|NCT04728815|592555965|FG007|Overall Study|Physician Decision|0|||
164054144|NCT04728815|592555958|FG000|Overall Study|Treatment drop|0|||
164054145|NCT04728815|592555959|FG001|Overall Study|Treatment drop|2|||
164054146|NCT04728815|592555960|FG002|Overall Study|Treatment drop|1|||
164054147|NCT04728815|592555961|FG003|Overall Study|Treatment drop|0|||
164054148|NCT04728815|592555962|FG004|Overall Study|Treatment drop|3|||
164054149|NCT04728815|592555963|FG005|Overall Study|Treatment drop|1|||
164054150|NCT04728815|592555964|FG006|Overall Study|Treatment drop|3|||
164054151|NCT04728815|592555965|FG007|Overall Study|Treatment drop|0|||
164054152|NCT04728815|592555958|FG000|Overall Study|Study drop|0|||
164054153|NCT04728815|592555959|FG001|Overall Study|Study drop|3|||
164101113|NCT01597245|592734961|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101114|NCT01597245|592734962|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101115|NCT01597245|592734963|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101116|NCT01597245|592734964|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
164101117|NCT01597245|592734944|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
164101118|NCT01597245|592734945|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
164101119|NCT01597245|592734946|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
164101120|NCT01597245|592734947|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
164101121|NCT01597245|592734948|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101122|NCT01597245|592734949|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101123|NCT01597245|592734950|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101124|NCT01597245|592734951|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101125|NCT01597245|592734952|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101126|NCT01597245|592734953|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101127|NCT01597245|592734954|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101128|NCT01597245|592734955|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101129|NCT01597245|592734956|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101130|NCT01597245|592734957|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101131|NCT01597245|592734958|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101132|NCT01597245|592734959|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101133|NCT01597245|592734960|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101134|NCT01597245|592734961|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101135|NCT01597245|592734962|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101136|NCT01597245|592734963|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101137|NCT01597245|592734964|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
164101138|NCT01597245|592734944|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
164101139|NCT01597245|592734945|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
164101140|NCT01597245|592734946|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
164101141|NCT01597245|592734947|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101142|NCT01597245|592734948|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101143|NCT01597245|592734949|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101144|NCT01597245|592734950|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101145|NCT01597245|592734951|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101146|NCT01597245|592734952|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101147|NCT01597245|592734953|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101148|NCT01597245|592734954|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101149|NCT01597245|592734955|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101150|NCT01597245|592734956|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101151|NCT01597245|592734957|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101152|NCT01597245|592734958|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101153|NCT01597245|592734959|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101154|NCT01597245|592734960|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101155|NCT01597245|592734961|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101156|NCT01597245|592734962|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101157|NCT01597245|592734963|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101158|NCT01597245|592734964|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
164101159|NCT01597245|592734944|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
164101160|NCT01597245|592734945|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101161|NCT01597245|592734946|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101162|NCT01597245|592734947|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
164101163|NCT01597245|592734948|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101164|NCT01597245|592734949|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101165|NCT01597245|592734950|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101166|NCT01597245|592734951|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101167|NCT01597245|592734952|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101168|NCT01597245|592734953|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101169|NCT01597245|592734954|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101170|NCT01597245|592734955|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101171|NCT01597245|592734956|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101172|NCT01597245|592734957|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101173|NCT01597245|592734958|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101174|NCT01597245|592734959|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101175|NCT01597245|592734960|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101176|NCT01597245|592734961|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101177|NCT01597245|592734962|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164148632|NCT04895982|592904916|FG005|Overall Study|Lost to Follow-up|1|||
164054154|NCT04728815|592555960|FG002|Overall Study|Study drop|3|||
164054155|NCT04728815|592555961|FG003|Overall Study|Study drop|0|||
164054156|NCT04728815|592555962|FG004|Overall Study|Study drop|0|||
164054157|NCT04728815|592555963|FG005|Overall Study|Study drop|0|||
164054158|NCT04728815|592555964|FG006|Overall Study|Study drop|7|||
164054159|NCT04728815|592555965|FG007|Overall Study|Study drop|0|||
164054160|NCT00957034|592555966|FG000|Overall Study|Adverse Event|0|||
164054161|NCT00957034|592555967|FG001|Overall Study|Adverse Event|1|||
164054162|NCT00957034|592555968|FG002|Overall Study|Adverse Event|1|||
164054163|NCT00957034|592555966|FG000|Overall Study|Sponsor Terminated Study|6|||
164054164|NCT00957034|592555967|FG001|Overall Study|Sponsor Terminated Study|1|||
164054165|NCT00957034|592555968|FG002|Overall Study|Sponsor Terminated Study|5|||
164054166|NCT00957034|592555966|FG000|Overall Study|Withdrawal by Subject|0|||
164054167|NCT00957034|592555967|FG001|Overall Study|Withdrawal by Subject|2|||
164054168|NCT00957034|592555968|FG002|Overall Study|Withdrawal by Subject|0|||
164054169|NCT05315297|592555969|FG000|Overall Study|Lost to Follow-up|6|||
164054170|NCT05315297|592555970|FG001|Overall Study|Lost to Follow-up|4|||
164054171|NCT05315297|592555969|FG000|Overall Study|Withdrawal by Subject|0|||
164054172|NCT05315297|592555970|FG001|Overall Study|Withdrawal by Subject|1|||
164054173|NCT00711009|592558901|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
164054174|NCT00711009|592558902|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
164054175|NCT00711009|592558901|FG000|Overall Study|Withdrawal by Subject|4|||
164054176|NCT00711009|592558902|FG001|Overall Study|Withdrawal by Subject|2|||
164054177|NCT00711009|592558901|FG000|Overall Study|Lost to Follow-up|3|||
164054178|NCT00711009|592558902|FG001|Overall Study|Lost to Follow-up|9|||
164054179|NCT00711009|592558901|FG000|Overall Study|Participant Noncompliant|0|||
164054180|NCT00711009|592558902|FG001|Overall Study|Participant Noncompliant|1|||
164054181|NCT00711009|592558901|FG000|Overall Study|Virologic Failure|2|||
164054182|NCT00711009|592558902|FG001|Overall Study|Virologic Failure|1|||
164054183|NCT00711009|592558901|FG000|Overall Study|Pregnancy|1|||
164054184|NCT00711009|592558902|FG001|Overall Study|Pregnancy|0|||
164054185|NCT00711009|592558901|FG000|Overall Study|Site closing|0|||
164054186|NCT00711009|592558902|FG001|Overall Study|Site closing|1|||
164054187|NCT00711009|592558901|FG000|Overall Study|Dose adjustment|1|||
164054188|NCT00711009|592558902|FG001|Overall Study|Dose adjustment|0|||
164054189|NCT02534324|592558903|FG000|Overall Study|Protocol Violation|4|||
164054190|NCT02534324|592558904|FG001|Overall Study|Protocol Violation|1|||
164054191|NCT02534324|592558903|FG000|Overall Study|Lost to Follow-up|20|||
164054192|NCT02534324|592558904|FG001|Overall Study|Lost to Follow-up|7|||
164054193|NCT02534324|592558903|FG000|Overall Study|Adverse Event|1|||
164054194|NCT02534324|592558904|FG001|Overall Study|Adverse Event|0|||
164054195|NCT01459016|592558907|FG000|Overall Study|Withdrawal by Subject|11|||
164054196|NCT01459016|592558907|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
164054197|NCT02889861|592558908|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
164054198|NCT02039687|592558909|FG000|Overall Study|Adverse Event|0|||
164054199|NCT02039687|592558910|FG001|Overall Study|Adverse Event|0|||
164054200|NCT02039687|592558911|FG002|Overall Study|Adverse Event|1|||
164054201|NCT02039687|592558912|FG003|Overall Study|Adverse Event|0|||
164054202|NCT02039687|592558909|FG000|Overall Study|Withdrawal by Subject|0|||
164054203|NCT02039687|592558910|FG001|Overall Study|Withdrawal by Subject|1|||
164054204|NCT02039687|592558911|FG002|Overall Study|Withdrawal by Subject|0|||
164054205|NCT02039687|592558912|FG003|Overall Study|Withdrawal by Subject|0|||
164054206|NCT02039687|592558909|FG000|Overall Study|treatment assignment could not be confir|0|||
164054207|NCT02039687|592558910|FG001|Overall Study|treatment assignment could not be confir|0|||
164054208|NCT02039687|592558911|FG002|Overall Study|treatment assignment could not be confir|2|||
164054209|NCT02039687|592558912|FG003|Overall Study|treatment assignment could not be confir|0|||
164054210|NCT00305773|592558930|FG000|Overall Study|Death|3|||
164054211|NCT00305773|592558931|FG001|Overall Study|Death|2|||
164054212|NCT00305773|592558930|FG000|Overall Study|Adverse Event|1|||
164054213|NCT00305773|592558931|FG001|Overall Study|Adverse Event|2|||
164054214|NCT00305773|592558930|FG000|Overall Study|Alternative Treatment|4|||
164054215|NCT00305773|592558931|FG001|Overall Study|Alternative Treatment|4|||
164054216|NCT00305773|592558930|FG000|Overall Study|Physician Decision|1|||
164054217|NCT00305773|592558931|FG001|Overall Study|Physician Decision|1|||
164054218|NCT00305773|592558930|FG000|Overall Study|Withdrawal by Subject|1|||
164054219|NCT00305773|592558931|FG001|Overall Study|Withdrawal by Subject|4|||
164054220|NCT00305773|592558930|FG000|Overall Study|Disease Progression|1|||
164054221|NCT00305773|592558931|FG001|Overall Study|Disease Progression|3|||
164054222|NCT00305773|592558930|FG000|Overall Study|All other reasons|3|||
164054223|NCT00305773|592558931|FG001|Overall Study|All other reasons|2|||
164054224|NCT04354870|592558932|FG000|Overall Study|Lost to Follow-up|32|||
164054225|NCT04354870|592558933|FG001|Overall Study|Lost to Follow-up|12|||
164054226|NCT04354870|592558932|FG000|Overall Study|Withdrawal by Subject|10|||
164054227|NCT04354870|592558933|FG001|Overall Study|Withdrawal by Subject|16|||
164054228|NCT04354870|592558932|FG000|Overall Study|Did not complete all study visits|6|||
164054229|NCT04354870|592558933|FG001|Overall Study|Did not complete all study visits|5|||
164054230|NCT04450394|592558934|FG000|Overall Study|Adverse Event|2|||
164054231|NCT04450394|592558935|FG001|Overall Study|Adverse Event|0|||
164054232|NCT04450394|592558936|FG002|Overall Study|Adverse Event|0|||
164054233|NCT04450394|592558934|FG000|Overall Study|Death|0|||
164054234|NCT04450394|592558935|FG001|Overall Study|Death|1|||
164054235|NCT04450394|592558936|FG002|Overall Study|Death|0|||
164054236|NCT04450394|592558934|FG000|Overall Study|Lost to Follow-up|0|||
164054237|NCT04450394|592558935|FG001|Overall Study|Lost to Follow-up|3|||
164054238|NCT04450394|592558936|FG002|Overall Study|Lost to Follow-up|0|||
164054239|NCT04450394|592558934|FG000|Overall Study|Physician Decision|0|||
164054240|NCT04450394|592558935|FG001|Overall Study|Physician Decision|1|||
164054241|NCT04450394|592558936|FG002|Overall Study|Physician Decision|0|||
164054242|NCT04450394|592558934|FG000|Overall Study|Protocol Violation|2|||
164054243|NCT04450394|592558935|FG001|Overall Study|Protocol Violation|0|||
164054244|NCT04450394|592558936|FG002|Overall Study|Protocol Violation|0|||
164054245|NCT04450394|592558934|FG000|Overall Study|Withdrawal by Subject|6|||
164054246|NCT04450394|592558935|FG001|Overall Study|Withdrawal by Subject|9|||
164054247|NCT04450394|592558936|FG002|Overall Study|Withdrawal by Subject|0|||
164054248|NCT01066819|592558937|FG000|Overall Study|Adverse Event|18|||
164054249|NCT01066819|592558938|FG001|Overall Study|Adverse Event|1|||
164054250|NCT01066819|592558939|FG002|Overall Study|Adverse Event|6|||
164054251|NCT01066819|592558940|FG003|Overall Study|Adverse Event|0|||
164054252|NCT01066819|592558941|FG004|Overall Study|Adverse Event|0|||
164054253|NCT01066819|592558942|FG005|Overall Study|Adverse Event|0|||
164054254|NCT01066819|592558937|FG000|Overall Study|Death|5|||
164054255|NCT01066819|592558938|FG001|Overall Study|Death|0|||
164054256|NCT01066819|592558939|FG002|Overall Study|Death|1|||
164054257|NCT01066819|592558940|FG003|Overall Study|Death|0|||
164054258|NCT01066819|592558941|FG004|Overall Study|Death|0|||
164054259|NCT01066819|592558942|FG005|Overall Study|Death|0|||
164054260|NCT01066819|592558937|FG000|Overall Study|Lack of Efficacy|22|||
164054261|NCT01066819|592558938|FG001|Overall Study|Lack of Efficacy|1|||
164054262|NCT01066819|592558939|FG002|Overall Study|Lack of Efficacy|2|||
164054263|NCT01066819|592558940|FG003|Overall Study|Lack of Efficacy|1|||
164054264|NCT01066819|592558941|FG004|Overall Study|Lack of Efficacy|0|||
164054265|NCT01066819|592558942|FG005|Overall Study|Lack of Efficacy|0|||
164054266|NCT01066819|592558937|FG000|Overall Study|Physician Decision|6|||
164054267|NCT01066819|592558938|FG001|Overall Study|Physician Decision|2|||
164054268|NCT01066819|592558939|FG002|Overall Study|Physician Decision|3|||
164054269|NCT01066819|592558940|FG003|Overall Study|Physician Decision|0|||
164054270|NCT01066819|592558941|FG004|Overall Study|Physician Decision|0|||
164054271|NCT01066819|592558942|FG005|Overall Study|Physician Decision|0|||
164054272|NCT01066819|592558937|FG000|Overall Study|Protocol Violation|12|||
164054273|NCT01066819|592558938|FG001|Overall Study|Protocol Violation|6|||
164054274|NCT01066819|592558939|FG002|Overall Study|Protocol Violation|0|||
164054275|NCT01066819|592558940|FG003|Overall Study|Protocol Violation|0|||
164054276|NCT01066819|592558941|FG004|Overall Study|Protocol Violation|0|||
164054277|NCT01066819|592558942|FG005|Overall Study|Protocol Violation|0|||
164054278|NCT01066819|592558937|FG000|Overall Study|Withdrawal by Subject|29|||
164054279|NCT01066819|592558938|FG001|Overall Study|Withdrawal by Subject|11|||
164054280|NCT01066819|592558939|FG002|Overall Study|Withdrawal by Subject|6|||
164054281|NCT01066819|592558940|FG003|Overall Study|Withdrawal by Subject|0|||
164054282|NCT01066819|592558941|FG004|Overall Study|Withdrawal by Subject|0|||
164054283|NCT01066819|592558942|FG005|Overall Study|Withdrawal by Subject|0|||
164054284|NCT01066819|592558937|FG000|Overall Study|Administrative|6|||
164054285|NCT01066819|592558938|FG001|Overall Study|Administrative|4|||
164054286|NCT01066819|592558939|FG002|Overall Study|Administrative|2|||
164054287|NCT01066819|592558940|FG003|Overall Study|Administrative|0|||
164054288|NCT01066819|592558941|FG004|Overall Study|Administrative|0|||
164054289|NCT01066819|592558942|FG005|Overall Study|Administrative|0|||
164054290|NCT01066819|592558937|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
164054291|NCT01066819|592558938|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
164054292|NCT01066819|592558939|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
164054293|NCT01066819|592558940|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
164054294|NCT01066819|592558941|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
164054295|NCT01066819|592558942|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
164054296|NCT01066819|592558937|FG000|Overall Study|Early termination|2|||
164054297|NCT01066819|592558938|FG001|Overall Study|Early termination|0|||
164054298|NCT01066819|592558939|FG002|Overall Study|Early termination|0|||
164054299|NCT01066819|592558940|FG003|Overall Study|Early termination|0|||
164054300|NCT01066819|592558941|FG004|Overall Study|Early termination|0|||
164054301|NCT01066819|592558942|FG005|Overall Study|Early termination|0|||
164054302|NCT01066819|592558937|FG000|Overall Study|Failed to return|298|||
164054303|NCT01066819|592558938|FG001|Overall Study|Failed to return|107|||
164054304|NCT01066819|592558939|FG002|Overall Study|Failed to return|68|||
164054305|NCT01066819|592558940|FG003|Overall Study|Failed to return|7|||
164054306|NCT01066819|592558941|FG004|Overall Study|Failed to return|2|||
164054307|NCT01066819|592558942|FG005|Overall Study|Failed to return|3|||
164054308|NCT01066819|592558937|FG000|Overall Study|Lab test not done|9|||
164054309|NCT01066819|592558938|FG001|Overall Study|Lab test not done|0|||
164054310|NCT01066819|592558939|FG002|Overall Study|Lab test not done|2|||
164054311|NCT01066819|592558940|FG003|Overall Study|Lab test not done|1|||
164054312|NCT01066819|592558941|FG004|Overall Study|Lab test not done|0|||
164054313|NCT01066819|592558942|FG005|Overall Study|Lab test not done|0|||
164054314|NCT01066819|592558937|FG000|Overall Study|Miscellaneous|28|||
164054315|NCT01066819|592558938|FG001|Overall Study|Miscellaneous|10|||
164054316|NCT01066819|592558939|FG002|Overall Study|Miscellaneous|18|||
164054317|NCT01066819|592558940|FG003|Overall Study|Miscellaneous|1|||
164054318|NCT01066819|592558941|FG004|Overall Study|Miscellaneous|0|||
164054319|NCT01066819|592558942|FG005|Overall Study|Miscellaneous|0|||
164054320|NCT01066819|592558937|FG000|Overall Study|Non responders|123|||
164054321|NCT01066819|592558938|FG001|Overall Study|Non responders|2|||
164054322|NCT01066819|592558939|FG002|Overall Study|Non responders|7|||
164054323|NCT01066819|592558940|FG003|Overall Study|Non responders|2|||
164054324|NCT01066819|592558941|FG004|Overall Study|Non responders|0|||
164054325|NCT01066819|592558942|FG005|Overall Study|Non responders|1|||
164054326|NCT01066819|592558937|FG000|Overall Study|Not categorised|9|||
164054327|NCT01066819|592558938|FG001|Overall Study|Not categorised|2|||
164054328|NCT01066819|592558939|FG002|Overall Study|Not categorised|6|||
164054329|NCT01066819|592558940|FG003|Overall Study|Not categorised|1|||
164054330|NCT01066819|592558941|FG004|Overall Study|Not categorised|0|||
164054331|NCT01066819|592558942|FG005|Overall Study|Not categorised|0|||
164054332|NCT01066819|592558937|FG000|Overall Study|Relapse|16|||
164054333|NCT01066819|592558938|FG001|Overall Study|Relapse|4|||
164054334|NCT01066819|592558939|FG002|Overall Study|Relapse|3|||
164054335|NCT01066819|592558940|FG003|Overall Study|Relapse|0|||
164054336|NCT01066819|592558941|FG004|Overall Study|Relapse|0|||
164054337|NCT01066819|592558942|FG005|Overall Study|Relapse|0|||
164054338|NCT01066819|592558937|FG000|Overall Study|Results not available|1|||
164054339|NCT01066819|592558938|FG001|Overall Study|Results not available|0|||
164054340|NCT01066819|592558939|FG002|Overall Study|Results not available|0|||
164054341|NCT01066819|592558940|FG003|Overall Study|Results not available|0|||
164054342|NCT01066819|592558941|FG004|Overall Study|Results not available|0|||
164054343|NCT01066819|592558942|FG005|Overall Study|Results not available|0|||
164054344|NCT01066819|592558937|FG000|Overall Study|Screen failure|1|||
164054345|NCT01066819|592558938|FG001|Overall Study|Screen failure|0|||
164054346|NCT01066819|592558939|FG002|Overall Study|Screen failure|0|||
164054347|NCT01066819|592558940|FG003|Overall Study|Screen failure|0|||
164054348|NCT01066819|592558941|FG004|Overall Study|Screen failure|0|||
164054349|NCT01066819|592558942|FG005|Overall Study|Screen failure|0|||
164054350|NCT01066819|592558937|FG000|Overall Study|Spontaneous cure|1|||
164054351|NCT01066819|592558938|FG001|Overall Study|Spontaneous cure|0|||
164054352|NCT01066819|592558939|FG002|Overall Study|Spontaneous cure|0|||
164054353|NCT01066819|592558940|FG003|Overall Study|Spontaneous cure|0|||
164054354|NCT01066819|592558941|FG004|Overall Study|Spontaneous cure|0|||
164054355|NCT01066819|592558942|FG005|Overall Study|Spontaneous cure|0|||
164054356|NCT01066819|592558937|FG000|Overall Study|Treatment never started|85|||
164054357|NCT01066819|592558938|FG001|Overall Study|Treatment never started|19|||
164054358|NCT01066819|592558939|FG002|Overall Study|Treatment never started|19|||
164054359|NCT01066819|592558940|FG003|Overall Study|Treatment never started|3|||
164054360|NCT01066819|592558941|FG004|Overall Study|Treatment never started|2|||
164054361|NCT01066819|592558942|FG005|Overall Study|Treatment never started|2|||
164054362|NCT01066819|592558937|FG000|Overall Study|Treatment stopped|12|||
164054363|NCT01066819|592558938|FG001|Overall Study|Treatment stopped|1|||
164054364|NCT01066819|592558939|FG002|Overall Study|Treatment stopped|2|||
164054365|NCT01066819|592558940|FG003|Overall Study|Treatment stopped|1|||
164054366|NCT01066819|592558941|FG004|Overall Study|Treatment stopped|0|||
164054367|NCT01066819|592558942|FG005|Overall Study|Treatment stopped|0|||
164054368|NCT01066819|592558937|FG000|Overall Study|Other|5|||
164054369|NCT01066819|592558938|FG001|Overall Study|Other|1|||
164054370|NCT01066819|592558939|FG002|Overall Study|Other|1|||
164054371|NCT01066819|592558940|FG003|Overall Study|Other|0|||
164054372|NCT01066819|592558941|FG004|Overall Study|Other|0|||
164054373|NCT01066819|592558942|FG005|Overall Study|Other|0|||
164054374|NCT02194699|592558943|FG000|Randomised|Did not receive treatment|1|||
164101178|NCT01597245|592734963|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164054375|NCT02194699|592558944|FG001|Randomised|Did not receive treatment|5|||
164054376|NCT02194699|592558943|FG000|Randomised|Without potential for 52 weeks of IP|5|||
164054377|NCT02194699|592558944|FG001|Randomised|Without potential for 52 weeks of IP|5|||
164054378|NCT02194699|592558943|FG000|Randomised|Duplicate patient|2|||
164054379|NCT02194699|592558944|FG001|Randomised|Duplicate patient|1|||
164054380|NCT02194699|592558943|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
164054381|NCT02194699|592558944|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
164054382|NCT02194699|592558943|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
164054383|NCT02194699|592558944|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
164054384|NCT02194699|592558943|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
164054385|NCT02194699|592558944|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
164054386|NCT02194699|592558943|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
164054387|NCT02194699|592558944|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
164054388|NCT02194699|592558943|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
164101179|NCT01597245|592734964|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
164101180|NCT01597245|592734944|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
164101181|NCT01597245|592734945|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
164101182|NCT01597245|592734946|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
164101183|NCT01597245|592734947|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101184|NCT01597245|592734948|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101185|NCT01597245|592734949|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101186|NCT01597245|592734950|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101187|NCT01597245|592734951|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101188|NCT01597245|592734952|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101189|NCT01597245|592734953|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101190|NCT01597245|592734954|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101191|NCT01597245|592734955|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101192|NCT01597245|592734956|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101193|NCT01597245|592734957|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101194|NCT01597245|592734958|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101195|NCT01597245|592734959|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101196|NCT01597245|592734960|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101197|NCT01597245|592734961|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101198|NCT01597245|592734962|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101199|NCT01597245|592734963|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101200|NCT01597245|592734964|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
164101201|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101202|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101203|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101204|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101205|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101206|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
164101207|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
164101208|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101209|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101210|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101211|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101212|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101213|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101214|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101215|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101216|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101217|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101218|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101219|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101220|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101221|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
164101222|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101223|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101224|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101225|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101226|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
164101227|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
164101228|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
164101229|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
164101230|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101231|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
164101232|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101233|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101234|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101235|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101236|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101237|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101238|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101239|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101240|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101241|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101242|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
164101243|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164148633|NCT04895982|592904917|FG006|Overall Study|Lost to Follow-up|0|||
164101244|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101245|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101246|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101247|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101248|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
164101249|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101250|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101251|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
164101252|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101253|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
164101254|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
164101255|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
164101256|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101257|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101258|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164054389|NCT02194699|592558944|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
164054390|NCT02194699|592558943|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
164054391|NCT02194699|592558944|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
164054392|NCT01539720|592558946|FG000|Overall Study|Screen Fail|15|||
164054393|NCT01539720|592558947|FG001|Overall Study|Screen Fail|3|||
164054394|NCT01539720|592558946|FG000|Overall Study|Lost to Follow-up|14|||
164054395|NCT01539720|592558947|FG001|Overall Study|Lost to Follow-up|7|||
164054396|NCT03812224|592558956|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
164054397|NCT03812224|592558957|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164054398|NCT03812224|592558956|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
164054399|NCT03812224|592558957|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
164054400|NCT03812224|592558956|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
164054401|NCT03812224|592558957|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
164054402|NCT03812224|592558956|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
164054403|NCT03812224|592558957|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
164054404|NCT01667731|592558961|FG000|Overall Study|Enrolled but not treated|0|||
164054405|NCT01667731|592558962|FG001|Overall Study|Enrolled but not treated|0|||
164054406|NCT01667731|592558963|FG002|Overall Study|Enrolled but not treated|0|||
164054407|NCT01667731|592558964|FG003|Overall Study|Enrolled but not treated|0|||
164054408|NCT01667731|592558965|FG004|Overall Study|Enrolled but not treated|1|||
164054409|NCT01667731|592558961|FG000|Overall Study|Efficacy Failure|1|||
164054410|NCT01667731|592558962|FG001|Overall Study|Efficacy Failure|12|||
164054411|NCT01667731|592558963|FG002|Overall Study|Efficacy Failure|0|||
164054412|NCT01667731|592558964|FG003|Overall Study|Efficacy Failure|1|||
164054413|NCT01667731|592558965|FG004|Overall Study|Efficacy Failure|24|||
164054414|NCT01667731|592558961|FG000|Overall Study|Lost to Follow-up|2|||
164054415|NCT01667731|592558962|FG001|Overall Study|Lost to Follow-up|3|||
164054416|NCT01667731|592558963|FG002|Overall Study|Lost to Follow-up|1|||
164054417|NCT01667731|592558964|FG003|Overall Study|Lost to Follow-up|1|||
164054418|NCT01667731|592558965|FG004|Overall Study|Lost to Follow-up|2|||
164054419|NCT01667731|592558961|FG000|Overall Study|Subject Withdrew Consent|2|||
164054420|NCT01667731|592558962|FG001|Overall Study|Subject Withdrew Consent|0|||
164054421|NCT01667731|592558963|FG002|Overall Study|Subject Withdrew Consent|1|||
164054422|NCT01667731|592558964|FG003|Overall Study|Subject Withdrew Consent|0|||
164054423|NCT01667731|592558965|FG004|Overall Study|Subject Withdrew Consent|1|||
164054424|NCT01667731|592558961|FG000|Overall Study|Death|0|||
164054425|NCT01667731|592558962|FG001|Overall Study|Death|1|||
164054426|NCT01667731|592558963|FG002|Overall Study|Death|0|||
164054427|NCT01667731|592558964|FG003|Overall Study|Death|0|||
164054428|NCT01667731|592558965|FG004|Overall Study|Death|0|||
164054429|NCT02516605|592558974|FG000|Overall Study|Protocol Violation|0|||
164054430|NCT02516605|592558975|FG001|Overall Study|Protocol Violation|0|||
164054431|NCT02516605|592558976|FG002|Overall Study|Protocol Violation|0|||
164054432|NCT02516605|592558977|FG003|Overall Study|Protocol Violation|0|||
164054433|NCT02516605|592558978|FG004|Overall Study|Protocol Violation|1|||
164054434|NCT02516605|592558974|FG000|Overall Study|Withdrawal by Subject|0|||
164054435|NCT02516605|592558975|FG001|Overall Study|Withdrawal by Subject|0|||
164054436|NCT02516605|592558976|FG002|Overall Study|Withdrawal by Subject|0|||
164054437|NCT02516605|592558977|FG003|Overall Study|Withdrawal by Subject|1|||
164101259|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164054438|NCT02516605|592558978|FG004|Overall Study|Withdrawal by Subject|0|||
164054439|NCT02643420|592558979|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
164054440|NCT02643420|592558980|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
164054441|NCT02643420|592558979|FG000|Overall Study|Withdrawal by Subject|25|||
164054442|NCT02643420|592558980|FG001|Overall Study|Withdrawal by Subject|19|||
164054443|NCT02643420|592558979|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
164054444|NCT02643420|592558980|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
164054445|NCT02643420|592558979|FG000|Overall Study|Lost to Follow-up|6|||
164054446|NCT02643420|592558980|FG001|Overall Study|Lost to Follow-up|10|||
164054447|NCT02643420|592558979|FG000|Overall Study|Investigator Decision|2|||
164054448|NCT02643420|592558980|FG001|Overall Study|Investigator Decision|4|||
164054449|NCT02643420|592558979|FG000|Overall Study|Sponsor decision|1|||
164054450|NCT02643420|592558980|FG001|Overall Study|Sponsor decision|1|||
164054451|NCT02643420|592558979|FG000|Overall Study|Death|0|||
164054452|NCT02643420|592558980|FG001|Overall Study|Death|2|||
164054453|NCT02643420|592558979|FG000|Overall Study|Reason not Specified|8|||
164054454|NCT02643420|592558980|FG001|Overall Study|Reason not Specified|7|||
164054455|NCT02127970|592558981|FG000|Overall Study|Adverse Event|2|||
164054456|NCT02127970|592558982|FG001|Overall Study|Adverse Event|1|||
164054457|NCT02127970|592558981|FG000|Overall Study|Death|1|||
164054458|NCT02127970|592558982|FG001|Overall Study|Death|1|||
164054459|NCT02127970|592558981|FG000|Overall Study|Lost to Follow-up|14|||
164054460|NCT02127970|592558982|FG001|Overall Study|Lost to Follow-up|14|||
164054461|NCT02127970|592558981|FG000|Overall Study|Reason not Specified|4|||
164054462|NCT02127970|592558982|FG001|Overall Study|Reason not Specified|7|||
164054463|NCT02127970|592558981|FG000|Overall Study|Pregnancy|0|||
164054464|NCT02127970|592558982|FG001|Overall Study|Pregnancy|1|||
164054465|NCT02127970|592558981|FG000|Overall Study|Subject Withdrew Consent|5|||
164054466|NCT02127970|592558982|FG001|Overall Study|Subject Withdrew Consent|3|||
164054467|NCT01710709|592558983|FG000|Overall Study|Lost to Follow-up|29|||
164054468|NCT01710709|592558983|FG000|Overall Study|Adverse Event|48|||
164054469|NCT01710709|592558983|FG000|Overall Study|Participant met withdrawal criteria|33|||
164054470|NCT01710709|592558983|FG000|Overall Study|Participant withdrawn by investigator|2|||
164054471|NCT01710709|592558983|FG000|Overall Study|Withdrawal by Subject|53|||
164054472|NCT01710709|592558983|FG000|Overall Study|Protocol Violation|5|||
164054473|NCT01710709|592558983|FG000|Overall Study|Lack of Efficacy|3|||
164054474|NCT01398176|592558985|FG000|Overall Study|Lost to Follow-up|1|||
164054475|NCT01398176|592558986|FG001|Overall Study|Lost to Follow-up|3|||
164054476|NCT01398176|592558985|FG000|Overall Study|Physician Decision|2|||
164054477|NCT01398176|592558986|FG001|Overall Study|Physician Decision|3|||
164054478|NCT01871870|592558990|FG000|Overall Study|Hardware issues|7|||
164054479|NCT01871870|592558990|FG000|Overall Study|hyperglycemia|2|||
164054480|NCT05102734|592558991|FG000|Overall Study|Did not require vasopressors|1|||
164054481|NCT05102734|592558992|FG001|Overall Study|Did not require vasopressors|0|||
164054482|NCT05102734|592558991|FG000|Overall Study|Did not have functioning PA catheter|1|||
164054483|NCT05102734|592558992|FG001|Overall Study|Did not have functioning PA catheter|0|||
164054484|NCT05102734|592558991|FG000|Overall Study|Inadequate video quality|2|||
164054485|NCT05102734|592558992|FG001|Overall Study|Inadequate video quality|0|||
164054486|NCT03055806|592558993|FG000|Overall Study|Adverse Event|0|||
164054487|NCT03055806|592558994|FG001|Overall Study|Adverse Event|0|||
164054488|NCT03055806|592558995|FG002|Overall Study|Adverse Event|1|||
164054489|NCT03055806|592558996|FG003|Overall Study|Adverse Event|1|||
164054490|NCT03055806|592558993|FG000|Overall Study|Lost to Follow-up|0|||
164054491|NCT03055806|592558994|FG001|Overall Study|Lost to Follow-up|3|||
164054492|NCT03055806|592558995|FG002|Overall Study|Lost to Follow-up|6|||
164054493|NCT03055806|592558996|FG003|Overall Study|Lost to Follow-up|7|||
164054494|NCT03055806|592558993|FG000|Overall Study|Physician Decision|1|||
164054495|NCT03055806|592558994|FG001|Overall Study|Physician Decision|0|||
164054496|NCT03055806|592558995|FG002|Overall Study|Physician Decision|0|||
164054497|NCT03055806|592558996|FG003|Overall Study|Physician Decision|1|||
164054498|NCT03055806|592558993|FG000|Overall Study|Protocol Violation|1|||
164054499|NCT03055806|592558994|FG001|Overall Study|Protocol Violation|0|||
164054500|NCT03055806|592558995|FG002|Overall Study|Protocol Violation|0|||
164054501|NCT03055806|592558996|FG003|Overall Study|Protocol Violation|0|||
164054502|NCT03055806|592558993|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
164054503|NCT03055806|592558994|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
164054504|NCT03055806|592558995|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
164054505|NCT03055806|592558996|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
164054506|NCT03055806|592558993|FG000|Overall Study|Withdrawal of consent to continue study|2|||
164054507|NCT03055806|592558994|FG001|Overall Study|Withdrawal of consent to continue study|3|||
164054508|NCT03055806|592558995|FG002|Overall Study|Withdrawal of consent to continue study|4|||
164148634|NCT04895982|592904918|FG007|Overall Study|Lost to Follow-up|0|||
164054509|NCT03055806|592558996|FG003|Overall Study|Withdrawal of consent to continue study|6|||
164054510|NCT03055806|592558993|FG000|Overall Study|Partner not willing to try intercourse|1|||
164054511|NCT03055806|592558994|FG001|Overall Study|Partner not willing to try intercourse|0|||
164054512|NCT03055806|592558995|FG002|Overall Study|Partner not willing to try intercourse|0|||
164054513|NCT03055806|592558996|FG003|Overall Study|Partner not willing to try intercourse|0|||
164054514|NCT00846027|592558997|FG000|Overall Study|Death|3|||
164054515|NCT00846027|592558997|FG000|Overall Study|Disease Progression|30|||
164054516|NCT00846027|592558997|FG000|Overall Study|Toxicity|12|||
164054517|NCT00846027|592558997|FG000|Overall Study|Patient Decision|7|||
164054518|NCT00846027|592558997|FG000|Overall Study|Investigator Discretion|29|||
164054519|NCT00846027|592558997|FG000|Overall Study|Protocol Violation|2|||
164054520|NCT00846027|592558997|FG000|Overall Study|Subject Not Treated|7|||
164054521|NCT04905563|592559000|FG000|Overall Study|Withdrawal by Subject|1|||
164054522|NCT04905563|592559001|FG001|Overall Study|Withdrawal by Subject|0|||
164054523|NCT04905563|592559000|FG000|Overall Study|Standard of care orders entered by resident|1|||
164054524|NCT04905563|592559001|FG001|Overall Study|Standard of care orders entered by resident|0|||
164054525|NCT04905563|592559000|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
164054526|NCT04905563|592559001|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
164054527|NCT04905563|592559000|FG000|Overall Study|Withdrawal by Subject|0|||
164054528|NCT04905563|592559001|FG001|Overall Study|Withdrawal by Subject|1|||
164054529|NCT02418000|592559002|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
164054530|NCT02418000|592559003|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054531|NCT02418000|592559004|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054532|NCT02418000|592559005|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054533|NCT02418000|592559006|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054534|NCT02418000|592559002|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
164054535|NCT02418000|592559003|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164054536|NCT02418000|592559004|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164054537|NCT02418000|592559005|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164054538|NCT02418000|592559006|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
164054539|NCT02418000|592559002|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
164054540|NCT02418000|592559003|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164054541|NCT02418000|592559004|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164054542|NCT02418000|592559005|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164054543|NCT02418000|592559006|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
164054544|NCT02418000|592559002|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054545|NCT02418000|592559003|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
164054546|NCT02418000|592559004|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054547|NCT02418000|592559005|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054548|NCT02418000|592559006|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
164054549|NCT02418000|592559002|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164054550|NCT02418000|592559003|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
164054551|NCT02418000|592559004|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164054552|NCT02418000|592559005|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164054553|NCT02418000|592559006|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
164054554|NCT02418000|592559002|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054555|NCT02418000|592559003|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054556|NCT02418000|592559004|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
164054557|NCT02418000|592559005|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054558|NCT02418000|592559006|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054559|NCT02418000|592559002|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054560|NCT02418000|592559003|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054561|NCT02418000|592559004|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054562|NCT02418000|592559005|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
164054563|NCT02418000|592559006|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054564|NCT02418000|592559002|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164054565|NCT02418000|592559003|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164054566|NCT02418000|592559004|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164054567|NCT02418000|592559005|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
164054568|NCT02418000|592559006|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
164054569|NCT02418000|592559002|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054570|NCT02418000|592559003|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054571|NCT02418000|592559004|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054572|NCT02418000|592559005|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
164054573|NCT02418000|592559006|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
164054574|NCT00490815|592559007|FG000|Overall Study|Adverse Event|2|||
164054575|NCT00490815|592559008|FG001|Overall Study|Adverse Event|3|||
164054576|NCT00490815|592559007|FG000|Overall Study|Withdrawal by Subject|4|||
164054577|NCT00490815|592559008|FG001|Overall Study|Withdrawal by Subject|0|||
164054578|NCT00490815|592559007|FG000|Overall Study|Lost to Follow-up|1|||
164054579|NCT00490815|592559008|FG001|Overall Study|Lost to Follow-up|3|||
164054580|NCT00490815|592559007|FG000|Overall Study|Death|1|||
164054581|NCT00490815|592559008|FG001|Overall Study|Death|3|||
164054582|NCT01904760|592559009|FG000|Overall Study|Protocol Violation|1|||
164054583|NCT01904760|592559010|FG001|Overall Study|Protocol Violation|0|||
164054584|NCT04249076|592559012|FG000|Overall Study|Adverse Event|1|||
164054585|NCT04249076|592559013|FG001|Overall Study|Adverse Event|1|||
164054586|NCT04249076|592559012|FG000|Overall Study|Protocol Violation|1|||
164054587|NCT04249076|592559013|FG001|Overall Study|Protocol Violation|2|||
164054588|NCT04249076|592559012|FG000|Overall Study|Lack of Efficacy|0|||
164054589|NCT04249076|592559013|FG001|Overall Study|Lack of Efficacy|1|||
164054590|NCT04249076|592559012|FG000|Overall Study|Withdrawal by Subject|0|||
164054591|NCT04249076|592559013|FG001|Overall Study|Withdrawal by Subject|1|||
164054592|NCT00732199|592559018|FG000|Overall Study|Withdrawal by Subject|25|||
164054593|NCT00732199|592559019|FG001|Overall Study|Withdrawal by Subject|18|||
164054594|NCT00732199|592559018|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
164054595|NCT00732199|592559019|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
164054596|NCT01284127|592559034|FG000|Overall Study|Adverse Event|2|||
164054597|NCT01284127|592559034|FG000|Overall Study|Withdrawal by Subject|4|||
164054598|NCT01284127|592559034|FG000|Overall Study|Physician Decision|1|||
164054599|NCT02607865|592559036|FG000|Overall Study|Lost to Follow-up|9|||
164054600|NCT02607865|592559037|FG001|Overall Study|Lost to Follow-up|7|||
164054601|NCT02607865|592559038|FG002|Overall Study|Lost to Follow-up|7|||
164054602|NCT02607865|592559039|FG003|Overall Study|Lost to Follow-up|5|||
164054603|NCT02607865|592559036|FG000|Overall Study|Withdrawal by Subject|18|||
164054604|NCT02607865|592559037|FG001|Overall Study|Withdrawal by Subject|18|||
164054605|NCT02607865|592559038|FG002|Overall Study|Withdrawal by Subject|17|||
164054606|NCT02607865|592559039|FG003|Overall Study|Withdrawal by Subject|8|||
164054607|NCT02607865|592559036|FG000|Overall Study|Death|5|||
164054608|NCT02607865|592559037|FG001|Overall Study|Death|4|||
164054609|NCT02607865|592559038|FG002|Overall Study|Death|1|||
164054610|NCT02607865|592559039|FG003|Overall Study|Death|3|||
164054611|NCT02607865|592559036|FG000|Overall Study|Unclassified|1|||
164054612|NCT02607865|592559037|FG001|Overall Study|Unclassified|1|||
164054613|NCT02607865|592559038|FG002|Overall Study|Unclassified|2|||
164054614|NCT02607865|592559039|FG003|Overall Study|Unclassified|0|||
164054615|NCT01351415|592559043|FG000|Overall Study|Withdrawal by Subject|15|||
164054616|NCT01351415|592559044|FG001|Overall Study|Withdrawal by Subject|17|||
164054617|NCT01351415|592559043|FG000|Overall Study|Trial termination by the Sponsor|28|||
164054618|NCT01351415|592559044|FG001|Overall Study|Trial termination by the Sponsor|19|||
164054619|NCT01351415|592559043|FG000|Overall Study|Lost to Follow-up|5|||
164054620|NCT01351415|592559044|FG001|Overall Study|Lost to Follow-up|7|||
164054621|NCT01351415|592559043|FG000|Overall Study|Death|190|||
164054622|NCT01351415|592559044|FG001|Overall Study|Death|187|||
164054623|NCT01351415|592559043|FG000|Overall Study|Physician Decision|2|||
164054624|NCT01351415|592559044|FG001|Overall Study|Physician Decision|3|||
164054625|NCT01351415|592559043|FG000|Overall Study|Reason unknown|0|||
164054626|NCT01351415|592559044|FG001|Overall Study|Reason unknown|2|||
164054627|NCT01351415|592559043|FG000|Overall Study|Never Started|5|||
164054628|NCT01351415|592559044|FG001|Overall Study|Never Started|5|||
164054629|NCT00994890|592559045|FG000|Overall Study|Adverse Event|13|||
164054630|NCT00994890|592559046|FG001|Overall Study|Adverse Event|9|||
164054631|NCT00994890|592559047|FG002|Overall Study|Adverse Event|11|||
164054632|NCT00994890|592559045|FG000|Overall Study|Lack of Efficacy|0|||
164054633|NCT00994890|592559046|FG001|Overall Study|Lack of Efficacy|0|||
164054634|NCT00994890|592559047|FG002|Overall Study|Lack of Efficacy|1|||
164054635|NCT00994890|592559045|FG000|Overall Study|Lost to Follow-up|6|||
164054636|NCT00994890|592559046|FG001|Overall Study|Lost to Follow-up|1|||
164054637|NCT00994890|592559047|FG002|Overall Study|Lost to Follow-up|3|||
164054638|NCT00994890|592559045|FG000|Overall Study|No longer willing to participate|8|||
164054639|NCT00994890|592559046|FG001|Overall Study|No longer willing to participate|5|||
164054640|NCT00994890|592559047|FG002|Overall Study|No longer willing to participate|13|||
164054641|NCT00994890|592559045|FG000|Overall Study|Protocol Violation|2|||
164054642|NCT00994890|592559046|FG001|Overall Study|Protocol Violation|4|||
164054643|NCT00994890|592559047|FG002|Overall Study|Protocol Violation|0|||
164054644|NCT00994890|592559045|FG000|Overall Study|Study terminated by sponsor|199|||
164054645|NCT00994890|592559046|FG001|Overall Study|Study terminated by sponsor|201|||
164054646|NCT00994890|592559047|FG002|Overall Study|Study terminated by sponsor|197|||
164054647|NCT00994890|592559045|FG000|Overall Study|Randomized, but not treated|1|||
164054648|NCT00994890|592559046|FG001|Overall Study|Randomized, but not treated|0|||
164054649|NCT00994890|592559047|FG002|Overall Study|Randomized, but not treated|0|||
164054650|NCT00994890|592559045|FG000|Overall Study|Other|2|||
164054651|NCT00994890|592559046|FG001|Overall Study|Other|2|||
164054652|NCT00994890|592559047|FG002|Overall Study|Other|1|||
164054653|NCT00699582|592559048|FG000|Overall Study|Adverse Event|4|||
164054654|NCT00699582|592559049|FG001|Overall Study|Adverse Event|11|||
164054655|NCT00699582|592559050|FG002|Overall Study|Adverse Event|23|||
164054656|NCT00699582|592559048|FG000|Overall Study|Withdrawal by Subject|6|||
164054657|NCT00699582|592559049|FG001|Overall Study|Withdrawal by Subject|7|||
164054658|NCT00699582|592559050|FG002|Overall Study|Withdrawal by Subject|4|||
164054659|NCT00699582|592559048|FG000|Overall Study|Lack of Efficacy|1|||
164054660|NCT00699582|592559049|FG001|Overall Study|Lack of Efficacy|0|||
164054661|NCT00699582|592559050|FG002|Overall Study|Lack of Efficacy|1|||
164054662|NCT00699582|592559048|FG000|Overall Study|Progressive Disease|1|||
164054663|NCT00699582|592559049|FG001|Overall Study|Progressive Disease|0|||
164054664|NCT00699582|592559050|FG002|Overall Study|Progressive Disease|0|||
164054665|NCT00699582|592559048|FG000|Overall Study|Administrative/Other|4|||
164054666|NCT00699582|592559049|FG001|Overall Study|Administrative/Other|3|||
164054667|NCT00699582|592559050|FG002|Overall Study|Administrative/Other|0|||
164054668|NCT00699582|592559048|FG000|Overall Study|Randomized, Not Treated|2|||
164054669|NCT00699582|592559049|FG001|Overall Study|Randomized, Not Treated|1|||
164101260|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101261|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101262|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101263|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
164101264|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101265|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101266|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101267|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101268|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
164101269|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
164054670|NCT00699582|592559050|FG002|Overall Study|Randomized, Not Treated|0|||
164054671|NCT01849289|592559051|FG000|Overall Study|Adverse Event|3|||
164054672|NCT01849289|592559052|FG001|Overall Study|Adverse Event|3|||
164054673|NCT01849289|592559051|FG000|Overall Study|Protocol Violation|3|||
164054674|NCT01849289|592559052|FG001|Overall Study|Protocol Violation|3|||
164054675|NCT01849289|592559051|FG000|Overall Study|Withdrawal criteria|1|||
164054676|NCT01849289|592559052|FG001|Overall Study|Withdrawal criteria|0|||
164054677|NCT01849289|592559051|FG000|Overall Study|Unclassified|25|||
164054678|NCT01849289|592559052|FG001|Overall Study|Unclassified|18|||
164054679|NCT03480360|592559053|FG000|Overall Study|Death|2|||
164054680|NCT03117309|592559060|FG000|Overall Study|Not meeting inclusion criteria|0|||
164054681|NCT03117309|592559061|FG001|Overall Study|Not meeting inclusion criteria|1|||
164054682|NCT02583711|592559062|FG000|Overall Study|Withdrawal by Subject|0|||
164054683|NCT02583711|592559063|FG001|Overall Study|Withdrawal by Subject|10|||
164054684|NCT02583711|592559064|FG002|Overall Study|Withdrawal by Subject|0|||
164054685|NCT01326910|592559067|FG000|Overall Study|Withdrawal by Subject|3|||
164054686|NCT01326910|592559068|FG001|Overall Study|Withdrawal by Subject|2|||
164054687|NCT01326910|592559067|FG000|Overall Study|Protocol Violation|1|||
164054688|NCT01326910|592559068|FG001|Overall Study|Protocol Violation|1|||
164054689|NCT02274766|592559071|FG000|Overall Study|Withdrawal by Subject|3|||
164054690|NCT02274766|592559072|FG001|Overall Study|Withdrawal by Subject|6|||
164054691|NCT02274766|592559071|FG000|Overall Study|Did Not Receive Study Drug|1|||
164054692|NCT02274766|592559072|FG001|Overall Study|Did Not Receive Study Drug|1|||
164054693|NCT02274766|592559071|FG000|Overall Study|Subject Unwilling to Proceed|0|||
164054694|NCT02274766|592559072|FG001|Overall Study|Subject Unwilling to Proceed|1|||
164054695|NCT02274766|592559071|FG000|Overall Study|Adverse Event|0|||
164054696|NCT02274766|592559072|FG001|Overall Study|Adverse Event|1|||
164054697|NCT00962780|592559086|FG000|Overall Study|Death|0|||
164054698|NCT00962780|592559087|FG001|Overall Study|Death|1|||
164054699|NCT00962780|592559086|FG000|Overall Study|Protocol Violation|9|||
164054700|NCT00962780|592559087|FG001|Overall Study|Protocol Violation|4|||
164054701|NCT00962780|592559086|FG000|Overall Study|Withdrawal by Subject|1|||
164054702|NCT00962780|592559087|FG001|Overall Study|Withdrawal by Subject|8|||
164054703|NCT00962780|592559086|FG000|Overall Study|Other|0|||
164054704|NCT00962780|592559087|FG001|Overall Study|Other|1|||
164054705|NCT02363322|592559088|FG000|Overall Study|Lost to Follow-up|1|||
164054706|NCT02363322|592559089|FG001|Overall Study|Lost to Follow-up|0|||
164054707|NCT02055976|592559090|FG000|Overall Study|Other|0|||
164054708|NCT02055976|592559091|FG001|Overall Study|Other|0|||
164054709|NCT02055976|592559092|FG002|Overall Study|Other|1|||
164054710|NCT02055976|592559093|FG003|Overall Study|Other|0|||
164054711|NCT02055976|592559094|FG004|Overall Study|Other|0|||
164054712|NCT02055976|592559095|FG005|Overall Study|Other|0|||
164054713|NCT02055976|592559096|FG006|Overall Study|Other|0|||
164054714|NCT02055976|592559097|FG007|Overall Study|Other|0|||
164054715|NCT02055976|592559098|FG008|Overall Study|Other|0|||
164054716|NCT02055976|592559090|FG000|Overall Study|Adverse Event|0|||
164101270|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
164101271|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
164101272|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
164101273|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
164101274|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
164101275|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
164101276|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
164101277|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164054717|NCT02055976|592559091|FG001|Overall Study|Adverse Event|0|||
164054718|NCT02055976|592559092|FG002|Overall Study|Adverse Event|0|||
164054719|NCT02055976|592559093|FG003|Overall Study|Adverse Event|0|||
164054720|NCT02055976|592559094|FG004|Overall Study|Adverse Event|0|||
164054721|NCT02055976|592559095|FG005|Overall Study|Adverse Event|1|||
164054722|NCT02055976|592559096|FG006|Overall Study|Adverse Event|1|||
164054723|NCT02055976|592559097|FG007|Overall Study|Adverse Event|0|||
164054724|NCT02055976|592559098|FG008|Overall Study|Adverse Event|0|||
164054725|NCT02055976|592559090|FG000|Overall Study|Does not meet entrance criteria|0|||
164054726|NCT02055976|592559091|FG001|Overall Study|Does not meet entrance criteria|0|||
164054727|NCT02055976|592559092|FG002|Overall Study|Does not meet entrance criteria|0|||
164101278|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101279|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101280|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101281|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101282|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101283|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101284|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
164101285|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101286|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101287|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101288|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101289|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
164101290|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
164101291|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
164101292|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101293|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
164101294|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
164101295|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
164101296|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
164101297|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
164101298|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101299|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101300|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101301|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101302|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101303|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101304|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101305|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
164101306|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101307|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101308|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101309|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101310|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
164101311|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101312|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101313|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101314|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
164101315|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
164101316|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
164101317|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101318|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
164101319|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101320|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101321|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101322|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101323|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101324|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101325|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101326|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
164101327|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164054728|NCT02055976|592559093|FG003|Overall Study|Does not meet entrance criteria|0|||
164054729|NCT02055976|592559094|FG004|Overall Study|Does not meet entrance criteria|0|||
164054730|NCT02055976|592559095|FG005|Overall Study|Does not meet entrance criteria|0|||
164054731|NCT02055976|592559096|FG006|Overall Study|Does not meet entrance criteria|1|||
164054732|NCT02055976|592559097|FG007|Overall Study|Does not meet entrance criteria|0|||
164054733|NCT02055976|592559098|FG008|Overall Study|Does not meet entrance criteria|0|||
164054734|NCT02055976|592559090|FG000|Overall Study|Lost to Follow-up|0|||
164054735|NCT02055976|592559091|FG001|Overall Study|Lost to Follow-up|0|||
164054736|NCT02055976|592559092|FG002|Overall Study|Lost to Follow-up|0|||
164054737|NCT02055976|592559093|FG003|Overall Study|Lost to Follow-up|1|||
164054738|NCT02055976|592559094|FG004|Overall Study|Lost to Follow-up|0|||
164054739|NCT02055976|592559095|FG005|Overall Study|Lost to Follow-up|0|||
164054740|NCT02055976|592559096|FG006|Overall Study|Lost to Follow-up|0|||
164054741|NCT02055976|592559097|FG007|Overall Study|Lost to Follow-up|0|||
164054742|NCT02055976|592559098|FG008|Overall Study|Lost to Follow-up|0|||
164054743|NCT02504424|592559099|FG000|Overall Study|Withdrawal by Subject|2|||
164054744|NCT01503229|592560859|FG000|Overall Study|Withdrew consent|1|||
164101328|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101329|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101330|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164054745|NCT01354964|592560860|FG000|Overall Study|Lost to Follow-up|2|||
164054746|NCT01354964|592560861|FG001|Overall Study|Lost to Follow-up|0|||
164054747|NCT01354964|592560860|FG000|Overall Study|IV access issues|1|||
164054748|NCT01354964|592560861|FG001|Overall Study|IV access issues|1|||
164054749|NCT01354964|592560860|FG000|Overall Study|Physician Decision|1|||
164054750|NCT01354964|592560861|FG001|Overall Study|Physician Decision|0|||
164054751|NCT05604781|592560863|FG000|Overall Study|Lost to Follow-up|3|||
164054752|NCT05604781|592560863|FG000|Overall Study|Adverse Event|1|||
164054753|NCT03922945|592560877|FG000|Overall Study|Adverse Event|1|||
164054754|NCT03922945|592560878|FG001|Overall Study|Adverse Event|1|||
164054755|NCT03922945|592560879|FG002|Overall Study|Adverse Event|2|||
164054756|NCT03922945|592560877|FG000|Overall Study|Lost to Follow-up|13|||
164054757|NCT03922945|592560878|FG001|Overall Study|Lost to Follow-up|9|||
164054758|NCT03922945|592560879|FG002|Overall Study|Lost to Follow-up|20|||
164054759|NCT03922945|592560877|FG000|Overall Study|Lack of Efficacy|2|||
164054760|NCT03922945|592560878|FG001|Overall Study|Lack of Efficacy|0|||
164054761|NCT03922945|592560879|FG002|Overall Study|Lack of Efficacy|1|||
164054762|NCT03922945|592560877|FG000|Overall Study|Protocol Non-Compliance|0|||
164054763|NCT03922945|592560878|FG001|Overall Study|Protocol Non-Compliance|0|||
164054764|NCT03922945|592560879|FG002|Overall Study|Protocol Non-Compliance|1|||
164054765|NCT03922945|592560877|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
164054766|NCT03922945|592560878|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
164054767|NCT03922945|592560879|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
164054768|NCT03922945|592560877|FG000|Overall Study|All Other Personal Reasons|1|||
164054769|NCT03922945|592560878|FG001|Overall Study|All Other Personal Reasons|1|||
164054770|NCT03922945|592560879|FG002|Overall Study|All Other Personal Reasons|2|||
164054771|NCT00313716|592560880|FG000|Overall Study|Death|3|||
164054772|NCT00313716|592560881|FG001|Overall Study|Death|2|||
164054773|NCT00313716|592560882|FG002|Overall Study|Death|9|||
164054774|NCT00313716|592560883|FG003|Overall Study|Death|3|||
164054775|NCT00313716|592560884|FG004|Overall Study|Death|5|||
164054776|NCT00313716|592560885|FG005|Overall Study|Death|9|||
164054777|NCT00313716|592560880|FG000|Overall Study|Lost to Follow-up|2|||
164054778|NCT00313716|592560881|FG001|Overall Study|Lost to Follow-up|5|||
164054779|NCT00313716|592560882|FG002|Overall Study|Lost to Follow-up|2|||
164054780|NCT00313716|592560883|FG003|Overall Study|Lost to Follow-up|1|||
164054781|NCT00313716|592560884|FG004|Overall Study|Lost to Follow-up|0|||
164054782|NCT00313716|592560885|FG005|Overall Study|Lost to Follow-up|4|||
164054783|NCT00313716|592560880|FG000|Overall Study|Withdrawal by Subject|0|||
164054784|NCT00313716|592560881|FG001|Overall Study|Withdrawal by Subject|1|||
164054785|NCT00313716|592560882|FG002|Overall Study|Withdrawal by Subject|1|||
164054786|NCT00313716|592560883|FG003|Overall Study|Withdrawal by Subject|0|||
164054787|NCT00313716|592560884|FG004|Overall Study|Withdrawal by Subject|1|||
164054788|NCT00313716|592560885|FG005|Overall Study|Withdrawal by Subject|0|||
164054789|NCT02927990|592560894|FG000|Overall Study|Protocol Violation|4|||
164054790|NCT02927990|592560894|FG000|Overall Study|Physician Decision|9|||
164054791|NCT02927990|592560894|FG000|Overall Study|Room switched and therefore no study device available|15|||
164054792|NCT02927990|592560894|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
164054793|NCT00960323|592560895|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
164054794|NCT01524900|592560905|FG000|Overall Study|Lost to Follow-up|3|||
164054795|NCT01524900|592560906|FG001|Overall Study|Lost to Follow-up|12|||
164054796|NCT01524900|592560907|FG002|Overall Study|Lost to Follow-up|1|||
164054797|NCT01524900|592560908|FG003|Overall Study|Lost to Follow-up|0|||
164054798|NCT01524900|592560909|FG004|Overall Study|Lost to Follow-up|0|||
164054799|NCT01524900|592560905|FG000|Overall Study|Other reason than stated above|1|||
164054800|NCT01524900|592560906|FG001|Overall Study|Other reason than stated above|1|||
164054801|NCT01524900|592560907|FG002|Overall Study|Other reason than stated above|0|||
164054802|NCT01524900|592560908|FG003|Overall Study|Other reason than stated above|0|||
164054803|NCT01524900|592560909|FG004|Overall Study|Other reason than stated above|0|||
164054804|NCT01524900|592560905|FG000|Overall Study|No reason documented|2|||
164054805|NCT01524900|592560906|FG001|Overall Study|No reason documented|1|||
164054806|NCT01524900|592560907|FG002|Overall Study|No reason documented|0|||
164054807|NCT01524900|592560908|FG003|Overall Study|No reason documented|1|||
164054808|NCT01524900|592560909|FG004|Overall Study|No reason documented|0|||
164054809|NCT00959192|592560910|FG000|Overall Study|Adverse Event|1|||
164054810|NCT00959192|592560911|FG001|Overall Study|Adverse Event|1|||
164054811|NCT00959192|592560912|FG002|Overall Study|Adverse Event|1|||
164054812|NCT00959192|592560913|FG003|Overall Study|Adverse Event|0|||
164054813|NCT00959192|592560910|FG000|Overall Study|Investigator Request|1|||
164054814|NCT00959192|592560911|FG001|Overall Study|Investigator Request|0|||
164054815|NCT00959192|592560912|FG002|Overall Study|Investigator Request|0|||
164054816|NCT00959192|592560913|FG003|Overall Study|Investigator Request|0|||
164054817|NCT00959192|592560910|FG000|Overall Study|Caregiver Request|0|||
164054818|NCT00959192|592560911|FG001|Overall Study|Caregiver Request|0|||
164054819|NCT00959192|592560912|FG002|Overall Study|Caregiver Request|2|||
164054820|NCT00959192|592560913|FG003|Overall Study|Caregiver Request|1|||
164054821|NCT00772031|592560914|FG000|Overall Study|Early termination of trial|12|||
164054822|NCT00772031|592560915|FG001|Overall Study|Early termination of trial|10|||
164101331|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
164101332|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
164101333|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
164101334|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101335|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
164101336|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
164054823|NCT00772031|592560914|FG000|Overall Study|Lost to Follow-up|20|||
164054824|NCT00772031|592560915|FG001|Overall Study|Lost to Follow-up|33|||
164054825|NCT00532441|592560916|FG000|Overall Study|Death|1|||
164054826|NCT00532441|592560917|FG001|Overall Study|Death|0|||
164054827|NCT01603615|592560918|FG000|Overall Study|Did not Receive Treatment|7|||
164054828|NCT01603615|592560918|FG000|Overall Study|Lost to Follow-up|9|||
164054829|NCT01603615|592560918|FG000|Overall Study|Personal Reasons|17|||
164054830|NCT01603615|592560918|FG000|Overall Study|Other Miscellaneous|1|||
164054831|NCT00303329|592560919|FG000|Overall Study|Adverse Event|7|||
164054832|NCT00303329|592560920|FG001|Overall Study|Adverse Event|14|||
164054833|NCT00303329|592560919|FG000|Overall Study|Abnormal Laboratory Values|0|||
164054834|NCT00303329|592560920|FG001|Overall Study|Abnormal Laboratory Values|1|||
164054835|NCT00303329|592560919|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
164054836|NCT00303329|592560920|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164054837|NCT00303329|592560919|FG000|Overall Study|Condition no longer requires study drug|0|||
164054838|NCT00303329|592560920|FG001|Overall Study|Condition no longer requires study drug|8|||
164054839|NCT00303329|592560919|FG000|Overall Study|Protocol Violation|3|||
164054840|NCT00303329|592560920|FG001|Overall Study|Protocol Violation|0|||
164054841|NCT00303329|592560919|FG000|Overall Study|Withdrawal by Subject|9|||
164054842|NCT00303329|592560920|FG001|Overall Study|Withdrawal by Subject|15|||
164054843|NCT00303329|592560919|FG000|Overall Study|Lost to Follow-up|0|||
164054844|NCT00303329|592560920|FG001|Overall Study|Lost to Follow-up|1|||
164054845|NCT00303329|592560919|FG000|Overall Study|Administrative problems|1|||
164054846|NCT00303329|592560920|FG001|Overall Study|Administrative problems|0|||
164054847|NCT00303329|592560919|FG000|Overall Study|Death|2|||
164054848|NCT00303329|592560920|FG001|Overall Study|Death|12|||
164054849|NCT00303329|592560919|FG000|Overall Study|Stopped at end of core|3|||
164054850|NCT00303329|592560920|FG001|Overall Study|Stopped at end of core|9|||
164054851|NCT00303329|592560919|FG000|Overall Study|Stopped at end of extension 1|1|||
164054852|NCT00303329|592560920|FG001|Overall Study|Stopped at end of extension 1|0|||
164054853|NCT01101321|592560927|FG000|Period 1|Withdrawal by Subject|1|||
164054854|NCT01101321|592560928|FG001|Period 1|Withdrawal by Subject|1|||
164054855|NCT01101321|592560927|FG000|Period 1|Adverse Event|3|||
164054856|NCT01101321|592560928|FG001|Period 1|Adverse Event|3|||
164054857|NCT00542321|592560929|FG000|Overall Study|Death|0|||
164054858|NCT00542321|592560930|FG001|Overall Study|Death|1|||
164054859|NCT00525499|592560936|FG000|Overall Study|Lost to Follow-up|2|||
164054860|NCT00525499|592560937|FG001|Overall Study|Lost to Follow-up|4|||
164054861|NCT00525499|592560938|FG002|Overall Study|Lost to Follow-up|1|||
164054862|NCT00525499|592560939|FG003|Overall Study|Lost to Follow-up|4|||
164054863|NCT00525499|592560936|FG000|Overall Study|Adverse Event|0|||
164054864|NCT00525499|592560937|FG001|Overall Study|Adverse Event|1|||
164054865|NCT00525499|592560938|FG002|Overall Study|Adverse Event|0|||
164054866|NCT00525499|592560939|FG003|Overall Study|Adverse Event|1|||
164054867|NCT00525499|592560936|FG000|Overall Study|Withdrawal by Subject|5|||
164054868|NCT00525499|592560937|FG001|Overall Study|Withdrawal by Subject|1|||
164054869|NCT00525499|592560938|FG002|Overall Study|Withdrawal by Subject|5|||
164054870|NCT00525499|592560939|FG003|Overall Study|Withdrawal by Subject|2|||
164054871|NCT00525499|592560936|FG000|Overall Study|Protocol Violation|0|||
164054872|NCT00525499|592560937|FG001|Overall Study|Protocol Violation|1|||
164054873|NCT00525499|592560938|FG002|Overall Study|Protocol Violation|1|||
164054874|NCT00525499|592560939|FG003|Overall Study|Protocol Violation|0|||
164054875|NCT03339999|592560940|FG000|Overall Study|Adverse Event|1|||
164054876|NCT03339999|592560941|FG001|Overall Study|Adverse Event|2|||
164054877|NCT03339999|592560942|FG002|Overall Study|Adverse Event|2|||
164054878|NCT03339999|592560943|FG003|Overall Study|Adverse Event|1|||
164054879|NCT03339999|592560940|FG000|Overall Study|Lack of Efficacy|0|||
164054880|NCT03339999|592560941|FG001|Overall Study|Lack of Efficacy|1|||
164054881|NCT03339999|592560942|FG002|Overall Study|Lack of Efficacy|0|||
164054882|NCT03339999|592560943|FG003|Overall Study|Lack of Efficacy|0|||
164054883|NCT03339999|592560940|FG000|Overall Study|Lost to Follow-up|0|||
164054884|NCT03339999|592560941|FG001|Overall Study|Lost to Follow-up|0|||
164054885|NCT03339999|592560942|FG002|Overall Study|Lost to Follow-up|0|||
164054886|NCT03339999|592560943|FG003|Overall Study|Lost to Follow-up|1|||
164054887|NCT03339999|592560940|FG000|Overall Study|Study Terminated by Sponsor|6|||
164101337|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
164101338|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
164101339|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
164101340|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101341|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101342|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101343|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101344|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101345|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101346|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101347|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
164101348|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101349|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101350|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101351|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101352|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101353|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164101354|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101355|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101356|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164101357|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164101358|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164101359|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
164101360|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101361|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101362|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101363|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164054888|NCT03339999|592560941|FG001|Overall Study|Study Terminated by Sponsor|3|||
164054889|NCT03339999|592560942|FG002|Overall Study|Study Terminated by Sponsor|4|||
164054890|NCT03339999|592560943|FG003|Overall Study|Study Terminated by Sponsor|3|||
164054891|NCT00253747|592560944|FG000|Overall Study|Lost to Follow-up|13|||
164054892|NCT00253747|592560945|FG001|Overall Study|Lost to Follow-up|14|||
164054893|NCT00253747|592560944|FG000|Overall Study|Withdrawal by Subject|10|||
164054894|NCT00253747|592560945|FG001|Overall Study|Withdrawal by Subject|11|||
164054895|NCT00253747|592560944|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
164054896|NCT00253747|592560945|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
164054897|NCT01856920|592560948|FG000|Overall Study|Disease Progression On Study|3|||
164054898|NCT01856920|592560949|FG001|Overall Study|Disease Progression On Study|4|||
164054899|NCT01856920|592560948|FG000|Overall Study|Disease Progression before Treatment|1|||
164054900|NCT01856920|592560949|FG001|Overall Study|Disease Progression before Treatment|0|||
164054901|NCT01856920|592560948|FG000|Overall Study|Ineligible|0|||
164054902|NCT01856920|592560949|FG001|Overall Study|Ineligible|1|||
164054903|NCT01856920|592560948|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
164054904|NCT01856920|592560949|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
164054905|NCT01856920|592560948|FG000|Overall Study|Refused further Treatment|5|||
164054906|NCT01856920|592560949|FG001|Overall Study|Refused further Treatment|1|||
164054907|NCT01856920|592560948|FG000|Overall Study|Other Reasons|0|||
164054908|NCT01856920|592560949|FG001|Overall Study|Other Reasons|1|||
164054909|NCT01856920|592560948|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
164054910|NCT01856920|592560949|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
164054911|NCT03287089|592560953|FG000|Overall Study|Lost to Follow-up|0|||
164054912|NCT03287089|592560954|FG001|Overall Study|Lost to Follow-up|2|||
164054913|NCT03287089|592560953|FG000|Overall Study|Physician Decision|0|||
164054914|NCT03287089|592560954|FG001|Overall Study|Physician Decision|2|||
164054915|NCT03287089|592560953|FG000|Overall Study|Withdrawal by Subject|0|||
164054916|NCT03287089|592560954|FG001|Overall Study|Withdrawal by Subject|2|||
164054917|NCT02275052|592560959|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164054918|NCT02275052|592560960|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
164054919|NCT02275052|592560961|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164054920|NCT02275052|592560962|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
164054921|NCT02275052|592560959|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
164054922|NCT02275052|592560960|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
164054923|NCT02275052|592560961|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
164054924|NCT02275052|592560962|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
164054925|NCT02275052|592560959|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
164054926|NCT02275052|592560960|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
164054927|NCT02275052|592560961|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164054928|NCT02275052|592560962|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
164054929|NCT02275052|592560959|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
164054930|NCT02275052|592560960|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
164054931|NCT02275052|592560961|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
164054932|NCT02275052|592560962|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
164054933|NCT02275052|592560959|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
164054934|NCT02275052|592560960|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164054935|NCT02275052|592560961|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164054936|NCT02275052|592560962|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
164054937|NCT02275052|592560959|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
164054938|NCT02275052|592560960|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
164054939|NCT02275052|592560961|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
164054940|NCT02275052|592560962|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
164054941|NCT02275052|592560959|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
164054942|NCT02275052|592560960|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
164054943|NCT02275052|592560961|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
164054944|NCT02275052|592560962|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
164054945|NCT02275052|592560959|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164054946|NCT02275052|592560960|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
164054947|NCT02275052|592560961|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
164054948|NCT02275052|592560962|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
164054949|NCT02275052|592560959|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164054950|NCT02275052|592560960|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
164054951|NCT02275052|592560961|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
164054952|NCT02275052|592560962|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
164054953|NCT02275052|592560959|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164054954|NCT02275052|592560960|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
164054955|NCT02275052|592560961|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
164054956|NCT02275052|592560962|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
164054957|NCT02275052|592560959|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164054958|NCT02275052|592560960|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164054959|NCT02275052|592560961|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
164054960|NCT02275052|592560962|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
164054961|NCT04601194|592560968|FG000|Overall Study|Lost to Follow-up|7|||
164054962|NCT02630459|592560969|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164054963|NCT02630459|592560970|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
164054964|NCT02630459|592560971|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164054965|NCT02630459|592560972|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
164054966|NCT02630459|592560973|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164054967|NCT02630459|592560974|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164054968|NCT02630459|592560975|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164054969|NCT02630459|592560976|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
164054970|NCT02630459|592560969|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054971|NCT02630459|592560970|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054972|NCT02630459|592560971|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
164054973|NCT02630459|592560972|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054974|NCT02630459|592560973|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054975|NCT02630459|592560974|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054976|NCT02630459|592560975|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054977|NCT02630459|592560976|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
164054978|NCT02630459|592560969|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
164054979|NCT02630459|592560970|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
164054980|NCT02630459|592560971|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
164054981|NCT02630459|592560972|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
164054982|NCT02630459|592560973|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164054983|NCT02630459|592560974|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164054984|NCT02630459|592560975|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164054985|NCT02630459|592560976|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
164054986|NCT02630459|592560969|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
164054987|NCT02630459|592560970|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164054988|NCT02630459|592560971|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164054989|NCT02630459|592560972|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164101364|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164054990|NCT02630459|592560973|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164054991|NCT02630459|592560974|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164054992|NCT02630459|592560975|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164054993|NCT02630459|592560976|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
164054994|NCT02630459|592560969|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164054995|NCT02630459|592560970|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164054996|NCT02630459|592560971|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164054997|NCT02630459|592560972|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164054998|NCT02630459|592560973|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
164054999|NCT02630459|592560974|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
164055000|NCT02630459|592560975|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164055001|NCT02630459|592560976|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
164055002|NCT02630459|592560969|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164055003|NCT02630459|592560970|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164055004|NCT02630459|592560971|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164055005|NCT02630459|592560972|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164055006|NCT02630459|592560973|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
164055007|NCT02630459|592560974|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
164055008|NCT02630459|592560975|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164055009|NCT02630459|592560976|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
164055010|NCT02630459|592560969|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055011|NCT02630459|592560970|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055012|NCT02630459|592560971|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055013|NCT02630459|592560972|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055014|NCT02630459|592560973|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
164055015|NCT02630459|592560974|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055016|NCT02630459|592560975|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055017|NCT02630459|592560976|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
164055018|NCT01797302|592560977|FG000|Overall Study|Lost to Follow-up|16|||
164055019|NCT01797302|592560978|FG001|Overall Study|Lost to Follow-up|23|||
164055020|NCT01797302|592560979|FG002|Overall Study|Lost to Follow-up|22|||
164055021|NCT01797302|592560977|FG000|Overall Study|Withdrawal by Subject|1|||
164055022|NCT01797302|592560978|FG001|Overall Study|Withdrawal by Subject|3|||
164055023|NCT01797302|592560979|FG002|Overall Study|Withdrawal by Subject|4|||
164055024|NCT00783263|592560980|FG000|Overall Study|Adverse Event|3|||
164055025|NCT00783263|592560981|FG001|Overall Study|Adverse Event|0|||
164055026|NCT00783263|592560982|FG002|Overall Study|Adverse Event|2|||
164055027|NCT00783263|592560983|FG003|Overall Study|Adverse Event|1|||
164055028|NCT00783263|592560980|FG000|Overall Study|Lost to Follow-up|1|||
164055029|NCT00783263|592560981|FG001|Overall Study|Lost to Follow-up|1|||
164055030|NCT00783263|592560982|FG002|Overall Study|Lost to Follow-up|0|||
164055031|NCT00783263|592560983|FG003|Overall Study|Lost to Follow-up|0|||
164055032|NCT00783263|592560980|FG000|Overall Study|Withdrawal by Subject|0|||
164055033|NCT00783263|592560981|FG001|Overall Study|Withdrawal by Subject|1|||
164055034|NCT00783263|592560982|FG002|Overall Study|Withdrawal by Subject|1|||
164055035|NCT00783263|592560983|FG003|Overall Study|Withdrawal by Subject|2|||
164055036|NCT00106626|592560984|FG000|Overall Study|Adverse Event|5|||
164055037|NCT00106626|592560985|FG001|Overall Study|Adverse Event|4|||
164055038|NCT00106626|592560986|FG002|Overall Study|Adverse Event|3|||
164055039|NCT00106626|592560987|FG003|Overall Study|Adverse Event|3|||
164055040|NCT00106626|592560984|FG000|Overall Study|Progressive Disease|4|||
164055041|NCT00106626|592560985|FG001|Overall Study|Progressive Disease|1|||
164055042|NCT00106626|592560986|FG002|Overall Study|Progressive Disease|9|||
164055043|NCT00106626|592560987|FG003|Overall Study|Progressive Disease|10|||
164055044|NCT00106626|592560984|FG000|Overall Study|Received radiation on new therapy|1|||
164055045|NCT00106626|592560985|FG001|Overall Study|Received radiation on new therapy|0|||
164055046|NCT00106626|592560986|FG002|Overall Study|Received radiation on new therapy|0|||
164055047|NCT00106626|592560987|FG003|Overall Study|Received radiation on new therapy|0|||
164055048|NCT00106626|592560984|FG000|Overall Study|> 14 day delay in therapy start|0|||
164055049|NCT00106626|592560985|FG001|Overall Study|> 14 day delay in therapy start|1|||
164055050|NCT00106626|592560986|FG002|Overall Study|> 14 day delay in therapy start|0|||
164055051|NCT00106626|592560987|FG003|Overall Study|> 14 day delay in therapy start|0|||
164055052|NCT03018028|592560988|FG000|Overall Study|Withdrawal by Subject|3|||
164055053|NCT03018028|592560989|FG001|Overall Study|Withdrawal by Subject|0|||
164055054|NCT03018028|592560990|FG002|Overall Study|Withdrawal by Subject|1|||
164055055|NCT03018028|592560991|FG003|Overall Study|Withdrawal by Subject|2|||
164055056|NCT03018028|592560992|FG004|Overall Study|Withdrawal by Subject|0|||
164055057|NCT02519777|592560993|FG000|Overall Study|Death|1|||
164055058|NCT02519777|592560994|FG001|Overall Study|Death|0|||
164055059|NCT02519777|592560995|FG002|Overall Study|Death|0|||
164055060|NCT02519777|592560993|FG000|Overall Study|Lost to Follow-up|0|||
164055061|NCT02519777|592560994|FG001|Overall Study|Lost to Follow-up|4|||
164055062|NCT02519777|592560995|FG002|Overall Study|Lost to Follow-up|2|||
164055063|NCT02519777|592560993|FG000|Overall Study|Withdrawal by Subject|3|||
164055064|NCT02519777|592560994|FG001|Overall Study|Withdrawal by Subject|1|||
164055065|NCT02519777|592560995|FG002|Overall Study|Withdrawal by Subject|0|||
164055066|NCT02519777|592560993|FG000|Overall Study|Severe Debilitation|1|||
164055067|NCT02519777|592560994|FG001|Overall Study|Severe Debilitation|1|||
164055068|NCT02519777|592560995|FG002|Overall Study|Severe Debilitation|1|||
164055069|NCT02519777|592560993|FG000|Overall Study|Not able to get to clinic|1|||
164055070|NCT02519777|592560994|FG001|Overall Study|Not able to get to clinic|2|||
164055071|NCT02519777|592560995|FG002|Overall Study|Not able to get to clinic|1|||
164055072|NCT00256204|592560999|FG000|Overall Study|Adverse Event|10|||
164055073|NCT00256204|592561000|FG001|Overall Study|Adverse Event|14|||
164055074|NCT00256204|592561001|FG002|Overall Study|Adverse Event|16|||
164055075|NCT00256204|592561002|FG003|Overall Study|Adverse Event|14|||
164055076|NCT00256204|592560999|FG000|Overall Study|Death|0|||
164055077|NCT00256204|592561000|FG001|Overall Study|Death|1|||
164055078|NCT00256204|592561001|FG002|Overall Study|Death|0|||
164055079|NCT00256204|592561002|FG003|Overall Study|Death|0|||
164055080|NCT00256204|592560999|FG000|Overall Study|Lost to Follow-up|1|||
164055081|NCT00256204|592561000|FG001|Overall Study|Lost to Follow-up|1|||
164055082|NCT00256204|592561001|FG002|Overall Study|Lost to Follow-up|1|||
164055083|NCT00256204|592561002|FG003|Overall Study|Lost to Follow-up|2|||
164055084|NCT00256204|592560999|FG000|Overall Study|Protocol Violation|1|||
164055085|NCT00256204|592561000|FG001|Overall Study|Protocol Violation|0|||
164055086|NCT00256204|592561001|FG002|Overall Study|Protocol Violation|2|||
164055087|NCT00256204|592561002|FG003|Overall Study|Protocol Violation|1|||
164055088|NCT00256204|592560999|FG000|Overall Study|Physician Decision|0|||
164055089|NCT00256204|592561000|FG001|Overall Study|Physician Decision|0|||
164055090|NCT00256204|592561001|FG002|Overall Study|Physician Decision|1|||
164055091|NCT00256204|592561002|FG003|Overall Study|Physician Decision|2|||
164055092|NCT00256204|592560999|FG000|Overall Study|Withdrawal by Subject|17|||
164055093|NCT00256204|592561000|FG001|Overall Study|Withdrawal by Subject|6|||
164055094|NCT00256204|592561001|FG002|Overall Study|Withdrawal by Subject|7|||
164055095|NCT00256204|592561002|FG003|Overall Study|Withdrawal by Subject|5|||
164055096|NCT00256204|592560999|FG000|Overall Study|Need for additional prohibited treatment|38|||
164055097|NCT00256204|592561000|FG001|Overall Study|Need for additional prohibited treatment|28|||
164055098|NCT00256204|592561001|FG002|Overall Study|Need for additional prohibited treatment|27|||
164055099|NCT00256204|592561002|FG003|Overall Study|Need for additional prohibited treatment|25|||
164055100|NCT03490734|592561015|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
164055101|NCT03490734|592561016|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
164055102|NCT03490734|592561017|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
164055103|NCT03490734|592561018|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
164055104|NCT03490734|592561015|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
164055105|NCT03490734|592561016|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
164055106|NCT03490734|592561017|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
164055107|NCT03490734|592561018|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
164055108|NCT03490734|592561015|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
164055109|NCT03490734|592561016|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
164055110|NCT03490734|592561017|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
164055111|NCT03490734|592561018|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
164055112|NCT03490734|592561015|FG000|Post-intervention Scan Visit|Adverse Event|2|||
164055113|NCT03490734|592561016|FG001|Post-intervention Scan Visit|Adverse Event|0|||
164055114|NCT03490734|592561017|FG002|Post-intervention Scan Visit|Adverse Event|0|||
164055115|NCT03490734|592561018|FG003|Post-intervention Scan Visit|Adverse Event|0|||
164055116|NCT03490734|592561015|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
164055117|NCT03490734|592561016|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
164055118|NCT03490734|592561017|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
164055119|NCT03490734|592561018|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
164055120|NCT03490734|592561015|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
164055121|NCT03490734|592561016|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
164101365|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164055122|NCT03490734|592561017|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
164055123|NCT03490734|592561018|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
164055124|NCT04212221|592561026|FG000|Overall Study|Remained on Treatment|0|||
164055125|NCT04212221|592561027|FG001|Overall Study|Remained on Treatment|0|||
164055126|NCT04212221|592561028|FG002|Overall Study|Remained on Treatment|0|||
164055127|NCT04212221|592561029|FG003|Overall Study|Remained on Treatment|1|||
164055128|NCT04212221|592561030|FG004|Overall Study|Remained on Treatment|0|||
164055129|NCT04212221|592561031|FG005|Overall Study|Remained on Treatment|0|||
164055130|NCT04212221|592561032|FG006|Overall Study|Remained on Treatment|3|||
164055131|NCT04212221|592561033|FG007|Overall Study|Remained on Treatment|9|||
164055132|NCT04212221|592561026|FG000|Overall Study|Adverse Event|0|||
164055133|NCT04212221|592561027|FG001|Overall Study|Adverse Event|0|||
164101366|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164055134|NCT04212221|592561028|FG002|Overall Study|Adverse Event|0|||
164055135|NCT04212221|592561029|FG003|Overall Study|Adverse Event|0|||
164055136|NCT04212221|592561030|FG004|Overall Study|Adverse Event|0|||
164055137|NCT04212221|592561031|FG005|Overall Study|Adverse Event|0|||
164055138|NCT04212221|592561032|FG006|Overall Study|Adverse Event|2|||
164055139|NCT04212221|592561033|FG007|Overall Study|Adverse Event|3|||
164055140|NCT04212221|592561026|FG000|Overall Study|Death|0|||
164055141|NCT04212221|592561027|FG001|Overall Study|Death|0|||
164055142|NCT04212221|592561028|FG002|Overall Study|Death|0|||
164055143|NCT04212221|592561029|FG003|Overall Study|Death|0|||
164055144|NCT04212221|592561030|FG004|Overall Study|Death|0|||
164055145|NCT04212221|592561031|FG005|Overall Study|Death|0|||
164055146|NCT04212221|592561032|FG006|Overall Study|Death|0|||
164055147|NCT04212221|592561033|FG007|Overall Study|Death|2|||
164055148|NCT04212221|592561026|FG000|Overall Study|Disease progression according to irRECIST|1|||
164055149|NCT04212221|592561027|FG001|Overall Study|Disease progression according to irRECIST|2|||
164055150|NCT04212221|592561028|FG002|Overall Study|Disease progression according to irRECIST|3|||
164055151|NCT04212221|592561029|FG003|Overall Study|Disease progression according to irRECIST|3|||
164055152|NCT04212221|592561030|FG004|Overall Study|Disease progression according to irRECIST|2|||
164055153|NCT04212221|592561031|FG005|Overall Study|Disease progression according to irRECIST|2|||
164055154|NCT04212221|592561032|FG006|Overall Study|Disease progression according to irRECIST|21|||
164055155|NCT04212221|592561033|FG007|Overall Study|Disease progression according to irRECIST|17|||
164055156|NCT04212221|592561026|FG000|Overall Study|Global Deterioration of Health Status|0|||
164055157|NCT04212221|592561027|FG001|Overall Study|Global Deterioration of Health Status|0|||
164055158|NCT04212221|592561028|FG002|Overall Study|Global Deterioration of Health Status|0|||
164055159|NCT04212221|592561029|FG003|Overall Study|Global Deterioration of Health Status|0|||
164055160|NCT04212221|592561030|FG004|Overall Study|Global Deterioration of Health Status|0|||
164055161|NCT04212221|592561031|FG005|Overall Study|Global Deterioration of Health Status|0|||
164055162|NCT04212221|592561032|FG006|Overall Study|Global Deterioration of Health Status|0|||
164055163|NCT04212221|592561033|FG007|Overall Study|Global Deterioration of Health Status|2|||
164055164|NCT04212221|592561026|FG000|Overall Study|Investigator's Decision|0|||
164055165|NCT04212221|592561027|FG001|Overall Study|Investigator's Decision|0|||
164055166|NCT04212221|592561028|FG002|Overall Study|Investigator's Decision|0|||
164055167|NCT04212221|592561029|FG003|Overall Study|Investigator's Decision|1|||
164055168|NCT04212221|592561030|FG004|Overall Study|Investigator's Decision|0|||
164055169|NCT04212221|592561031|FG005|Overall Study|Investigator's Decision|0|||
164055170|NCT04212221|592561032|FG006|Overall Study|Investigator's Decision|3|||
164055171|NCT04212221|592561033|FG007|Overall Study|Investigator's Decision|0|||
164055172|NCT04212221|592561026|FG000|Overall Study|Participant refused to continue treatment|0|||
164055173|NCT04212221|592561027|FG001|Overall Study|Participant refused to continue treatment|1|||
164055174|NCT04212221|592561028|FG002|Overall Study|Participant refused to continue treatment|0|||
164055175|NCT04212221|592561029|FG003|Overall Study|Participant refused to continue treatment|1|||
164055176|NCT04212221|592561030|FG004|Overall Study|Participant refused to continue treatment|1|||
164055177|NCT04212221|592561031|FG005|Overall Study|Participant refused to continue treatment|2|||
164055178|NCT04212221|592561032|FG006|Overall Study|Participant refused to continue treatment|4|||
164055179|NCT04212221|592561033|FG007|Overall Study|Participant refused to continue treatment|2|||
164055180|NCT04212221|592561026|FG000|Overall Study|Protocol Violation|0|||
164055181|NCT04212221|592561027|FG001|Overall Study|Protocol Violation|0|||
164055182|NCT04212221|592561028|FG002|Overall Study|Protocol Violation|0|||
164055183|NCT04212221|592561029|FG003|Overall Study|Protocol Violation|0|||
164055184|NCT04212221|592561030|FG004|Overall Study|Protocol Violation|0|||
164055185|NCT04212221|592561031|FG005|Overall Study|Protocol Violation|0|||
164055186|NCT04212221|592561032|FG006|Overall Study|Protocol Violation|0|||
164055187|NCT04212221|592561033|FG007|Overall Study|Protocol Violation|1|||
164055188|NCT02692560|592561036|FG000|Overall Study|Withdrawal by Subject|0|||
164055189|NCT02692560|592561037|FG001|Overall Study|Withdrawal by Subject|6|||
164101367|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101368|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
164101369|NCT01597245|592734944|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164055190|NCT00715949|592561040|FG000|Overall Study|could not finish first test|4|||
164055191|NCT00806494|592561043|FG000|Overall Study|Adverse Event|29|||
164055192|NCT00806494|592561043|FG000|Overall Study|Lack of Efficacy|6|||
164055193|NCT00806494|592561043|FG000|Overall Study|Lost to Follow-up|10|||
164101370|NCT01597245|592734945|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164055194|NCT00806494|592561043|FG000|Overall Study|Other|30|||
164055195|NCT00806494|592561043|FG000|Overall Study|Withdrawal by Subject|5|||
164055196|NCT02417935|592561044|FG000|Treatment Period|Adverse Event|12|||
164055197|NCT02417935|592561045|FG001|Treatment Period|Adverse Event|10|||
164055198|NCT02417935|592561044|FG000|Treatment Period|Lost to Follow-up|1|||
164055199|NCT02417935|592561045|FG001|Treatment Period|Lost to Follow-up|0|||
164055200|NCT02417935|592561044|FG000|Treatment Period|Entry Criteria not met|0|||
164055201|NCT02417935|592561045|FG001|Treatment Period|Entry Criteria not met|1|||
164055202|NCT02417935|592561044|FG000|Treatment Period|Protocol Violation|2|||
164055203|NCT02417935|592561045|FG001|Treatment Period|Protocol Violation|1|||
164101371|NCT01597245|592734946|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101372|NCT01597245|592734947|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101373|NCT01597245|592734948|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101374|NCT01597245|592734949|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101375|NCT01597245|592734950|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101376|NCT01597245|592734951|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101377|NCT01597245|592734952|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101378|NCT01597245|592734953|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101379|NCT01597245|592734954|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
164101380|NCT01597245|592734955|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101381|NCT01597245|592734956|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101382|NCT01597245|592734957|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101383|NCT01597245|592734958|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101384|NCT01597245|592734959|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101385|NCT01597245|592734960|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101386|NCT01597245|592734961|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101387|NCT01597245|592734962|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101388|NCT01597245|592734963|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101389|NCT01597245|592734964|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
164101390|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101391|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101392|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101393|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101394|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101395|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101396|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101397|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101398|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101399|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101400|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101401|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101402|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101403|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
164101404|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
164101405|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
164101406|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101407|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101408|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101409|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101410|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
164101411|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101412|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101413|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101414|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101415|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101416|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101417|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101418|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101419|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101420|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101421|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101422|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101423|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101424|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
164101425|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
164101426|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
164101427|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101428|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101429|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101430|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101431|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
164101432|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101433|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101434|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164055204|NCT02417935|592561044|FG000|Treatment Period|Withdrawal by Subject|3|||
164055205|NCT02417935|592561045|FG001|Treatment Period|Withdrawal by Subject|3|||
164055206|NCT02417935|592561044|FG000|Treatment Period|Physician Decision|3|||
164055207|NCT02417935|592561045|FG001|Treatment Period|Physician Decision|1|||
164055208|NCT02850276|592561046|FG000|Overall Study|screen failure|43|||
164055209|NCT02850276|592561046|FG000|Overall Study|Withdrawal by Subject|14|||
164055210|NCT02850276|592561046|FG000|Overall Study|Physician Decision|2|||
164055211|NCT02850276|592561046|FG000|Overall Study|Lost to Follow-up|2|||
164055212|NCT04815291|592561047|FG000|Overall Study|Lost to Follow-up|1|||
164055213|NCT04815291|592561047|FG000|Overall Study|Physician Decision|4|||
164055214|NCT04815291|592561047|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
164055215|NCT02646332|592561051|FG000|Overall Study|Lost to Follow-up|0|||
164055216|NCT02646332|592561052|FG001|Overall Study|Lost to Follow-up|3|||
164055217|NCT01775995|592561053|FG000|Overall Study|Lost to Follow-up|1|||
164055218|NCT01775995|592561054|FG001|Overall Study|Lost to Follow-up|1|||
164055219|NCT02909504|592561055|FG000|Overall Study|Adverse Event|2|||
164055220|NCT02909504|592561055|FG000|Overall Study|Lack of Efficacy|3|||
164055221|NCT02909504|592561055|FG000|Overall Study|Withdrawal by Subject|4|||
164055222|NCT02909504|592561055|FG000|Overall Study|Pregnancy|1|||
164055223|NCT02909504|592561055|FG000|Overall Study|Subject moved|1|||
164055224|NCT02909504|592561055|FG000|Overall Study|Lost to Follow-up|1|||
164055225|NCT04524663|592563055|FG000|Overall Study|Withdrawal by Subject|0|||
164055226|NCT04524663|592563056|FG001|Overall Study|Withdrawal by Subject|2|||
164055227|NCT00911508|592563057|FG000|Overall Study|Lost to Follow-up|27|||
164055228|NCT00911508|592563058|FG001|Overall Study|Lost to Follow-up|18|||
164055229|NCT00911508|592563057|FG000|Overall Study|Withdrawal by Subject|79|||
164055230|NCT00911508|592563058|FG001|Overall Study|Withdrawal by Subject|112|||
164055231|NCT04308668|592563059|FG000|Overall Study|Lost to Follow-up|32|||
164055232|NCT04308668|592563060|FG001|Overall Study|Lost to Follow-up|38|||
164055233|NCT04308668|592563059|FG000|Overall Study|Withdrawal by Subject|4|||
164055234|NCT04308668|592563060|FG001|Overall Study|Withdrawal by Subject|4|||
164055235|NCT01266967|592563061|FG000|Overall Study|Death|69|||
164055236|NCT01266967|592563062|FG001|Overall Study|Death|61|||
164055237|NCT01266967|592563061|FG000|Overall Study|Study Closed/Terminated|15|||
164055238|NCT01266967|592563062|FG001|Overall Study|Study Closed/Terminated|17|||
164055239|NCT01266967|592563061|FG000|Overall Study|Lost to Follow-up|2|||
164055240|NCT01266967|592563062|FG001|Overall Study|Lost to Follow-up|1|||
164055241|NCT01266967|592563061|FG000|Overall Study|Physician Decision|0|||
164055242|NCT01266967|592563062|FG001|Overall Study|Physician Decision|1|||
164055243|NCT01266967|592563061|FG000|Overall Study|Withdrawal by Subject|3|||
164055244|NCT01266967|592563062|FG001|Overall Study|Withdrawal by Subject|3|||
164055245|NCT01519700|592563063|FG000|Overall Study|Death|1|||
164055246|NCT01519700|592563064|FG001|Overall Study|Death|0|||
164055247|NCT01519700|592563065|FG002|Overall Study|Death|0|||
164055248|NCT01519700|592563066|FG003|Overall Study|Death|0|||
164055249|NCT01519700|592563063|FG000|Overall Study|Lost to Follow-up|0|||
164055250|NCT01519700|592563064|FG001|Overall Study|Lost to Follow-up|0|||
164055251|NCT01519700|592563065|FG002|Overall Study|Lost to Follow-up|1|||
164055252|NCT01519700|592563066|FG003|Overall Study|Lost to Follow-up|1|||
164055253|NCT01519700|592563063|FG000|Overall Study|Physician Decision|1|||
164055254|NCT01519700|592563064|FG001|Overall Study|Physician Decision|1|||
164055255|NCT01519700|592563065|FG002|Overall Study|Physician Decision|3|||
164055256|NCT01519700|592563066|FG003|Overall Study|Physician Decision|0|||
164055257|NCT01519700|592563063|FG000|Overall Study|Withdrawal by Subject|5|||
164055258|NCT01519700|592563064|FG001|Overall Study|Withdrawal by Subject|3|||
164055259|NCT01519700|592563065|FG002|Overall Study|Withdrawal by Subject|3|||
164055260|NCT01519700|592563066|FG003|Overall Study|Withdrawal by Subject|2|||
164055261|NCT01519700|592563063|FG000|Overall Study|Other Reason|2|||
164055262|NCT01519700|592563064|FG001|Overall Study|Other Reason|2|||
164055263|NCT01519700|592563065|FG002|Overall Study|Other Reason|0|||
164055264|NCT01519700|592563066|FG003|Overall Study|Other Reason|4|||
164055265|NCT05111548|592563067|FG000|Overall Study|Withdrawal by Subject|2|||
164055266|NCT05111548|592563068|FG001|Overall Study|Withdrawal by Subject|1|||
164055267|NCT05111548|592563067|FG000|Overall Study|Adverse Event|1|||
164055268|NCT05111548|592563068|FG001|Overall Study|Adverse Event|0|||
164055269|NCT00561912|592563075|FG000|Overall Study|ineligible|1|||
164055270|NCT03938857|592563076|FG000|Overall Study|Physician Decision|1|||
164055271|NCT03938857|592563077|FG001|Overall Study|Physician Decision|0|||
164055272|NCT03938857|592563078|FG002|Overall Study|Physician Decision|0|||
164055273|NCT03938857|592563079|FG003|Overall Study|Physician Decision|0|||
164055274|NCT01729559|592563080|FG000|Overall Study|Protocol Violation|31|||
164055275|NCT01729559|592563081|FG001|Overall Study|Protocol Violation|28|||
164055276|NCT02452034|592563086|FG000|Overall Study|Adverse Event|0|||
164055277|NCT02452034|592563087|FG001|Overall Study|Adverse Event|0|||
164055278|NCT02452034|592563088|FG002|Overall Study|Adverse Event|0|||
164055279|NCT02452034|592563089|FG003|Overall Study|Adverse Event|0|||
164055280|NCT02452034|592563090|FG004|Overall Study|Adverse Event|0|||
164055281|NCT02452034|592563091|FG005|Overall Study|Adverse Event|1|||
164055282|NCT02452034|592563086|FG000|Overall Study|Death|0|||
164055283|NCT02452034|592563087|FG001|Overall Study|Death|0|||
164055284|NCT02452034|592563088|FG002|Overall Study|Death|0|||
164055285|NCT02452034|592563089|FG003|Overall Study|Death|0|||
164055286|NCT02452034|592563090|FG004|Overall Study|Death|1|||
164055287|NCT02452034|592563091|FG005|Overall Study|Death|1|||
164055288|NCT02452034|592563086|FG000|Overall Study|Physician Decision|0|||
164055289|NCT02452034|592563087|FG001|Overall Study|Physician Decision|1|||
164055290|NCT02452034|592563088|FG002|Overall Study|Physician Decision|1|||
164055291|NCT02452034|592563089|FG003|Overall Study|Physician Decision|0|||
164055292|NCT02452034|592563090|FG004|Overall Study|Physician Decision|0|||
164055293|NCT02452034|592563091|FG005|Overall Study|Physician Decision|0|||
164055294|NCT02452034|592563086|FG000|Overall Study|Protocol Violation|0|||
164055295|NCT02452034|592563087|FG001|Overall Study|Protocol Violation|0|||
164055296|NCT02452034|592563088|FG002|Overall Study|Protocol Violation|0|||
164055297|NCT02452034|592563089|FG003|Overall Study|Protocol Violation|0|||
164055298|NCT02452034|592563090|FG004|Overall Study|Protocol Violation|0|||
164055299|NCT02452034|592563091|FG005|Overall Study|Protocol Violation|1|||
164055300|NCT02452034|592563086|FG000|Overall Study|Screen Failure|1|||
164055301|NCT02452034|592563087|FG001|Overall Study|Screen Failure|0|||
164055302|NCT02452034|592563088|FG002|Overall Study|Screen Failure|0|||
164055303|NCT02452034|592563089|FG003|Overall Study|Screen Failure|1|||
164055304|NCT02452034|592563090|FG004|Overall Study|Screen Failure|0|||
164055305|NCT02452034|592563091|FG005|Overall Study|Screen Failure|0|||
164055306|NCT02452034|592563086|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
164055307|NCT02452034|592563087|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
164055308|NCT02452034|592563088|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
164055309|NCT02452034|592563089|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
164055310|NCT02452034|592563090|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
164055311|NCT02452034|592563091|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
164055312|NCT01453439|592563096|FG000|Treatment Phase|Withdrawal by Subject|13|||
164055313|NCT01453439|592563097|FG001|Treatment Phase|Withdrawal by Subject|10|||
164055314|NCT01453439|592563096|FG000|Treatment Phase|Suicidal Ideation|2|||
164055315|NCT01453439|592563097|FG001|Treatment Phase|Suicidal Ideation|0|||
164055316|NCT01453439|592563096|FG000|Treatment Phase|Need for higher level of care|1|||
164055317|NCT01453439|592563097|FG001|Treatment Phase|Need for higher level of care|1|||
164055318|NCT01453439|592563096|FG000|Treatment Phase|Therapist conflict of interest|1|||
164055319|NCT01453439|592563097|FG001|Treatment Phase|Therapist conflict of interest|0|||
164055320|NCT01453439|592563096|FG000|Follow-up|Withdrawal by Subject|0|||
164055321|NCT01453439|592563097|FG001|Follow-up|Withdrawal by Subject|1|||
164055322|NCT01453439|592563096|FG000|Follow-up|Lost to Follow-up|5|||
164055323|NCT01453439|592563097|FG001|Follow-up|Lost to Follow-up|10|||
164055324|NCT01014442|592563098|FG000|Overall Study|Adverse Event|0|||
164055325|NCT01014442|592563099|FG001|Overall Study|Adverse Event|8|||
164055326|NCT01014442|592563098|FG000|Overall Study|Withdrawal by Subject|4|||
164055327|NCT01014442|592563099|FG001|Overall Study|Withdrawal by Subject|4|||
164055328|NCT01014442|592563098|FG000|Overall Study|Protocol Violation|2|||
164055329|NCT01014442|592563099|FG001|Overall Study|Protocol Violation|5|||
164055330|NCT01014442|592563098|FG000|Overall Study|Lack of Compliance|0|||
164055331|NCT01014442|592563099|FG001|Overall Study|Lack of Compliance|1|||
164055332|NCT01014442|592563098|FG000|Overall Study|Unspecified Reason|1|||
164055333|NCT01014442|592563099|FG001|Overall Study|Unspecified Reason|1|||
164055334|NCT02074059|592563100|FG000|Overall Study|Death|0|||
164055335|NCT02074059|592563101|FG001|Overall Study|Death|0|||
164055336|NCT02074059|592563102|FG002|Overall Study|Death|0|||
164055337|NCT02074059|592563103|FG003|Overall Study|Death|0|||
164055338|NCT02074059|592563104|FG004|Overall Study|Death|1|||
164055339|NCT02074059|592563105|FG005|Overall Study|Death|1|||
164055340|NCT02242305|592563119|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
164055341|NCT02242305|592563120|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
164055342|NCT02242305|592563119|FG000|Overall Study|Adverse Event|1|||
164055343|NCT02242305|592563120|FG001|Overall Study|Adverse Event|0|||
164055344|NCT02242305|592563119|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
164055345|NCT02242305|592563120|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
164055346|NCT02242305|592563119|FG000|Overall Study|Subject withdraws inform consent|0|||
164055347|NCT02242305|592563120|FG001|Overall Study|Subject withdraws inform consent|4|||
164055348|NCT02242305|592563119|FG000|Overall Study|Lost to Follow-up|2|||
164055349|NCT02242305|592563120|FG001|Overall Study|Lost to Follow-up|0|||
164055350|NCT02543801|592563123|FG000|Overall Study|Protocol Violation|1|||
164055351|NCT02543801|592563124|FG001|Overall Study|Protocol Violation|2|||
164055352|NCT02543801|592563125|FG002|Overall Study|Protocol Violation|0|||
164055353|NCT02543801|592563126|FG003|Overall Study|Protocol Violation|0|||
164055354|NCT01756846|592563127|FG000|Overall Study|Lost to Follow-up|5|||
164055355|NCT01756846|592563128|FG001|Overall Study|Lost to Follow-up|10|||
164055356|NCT01756846|592563127|FG000|Overall Study|Withdrawal by Subject|1|||
164055357|NCT01756846|592563128|FG001|Overall Study|Withdrawal by Subject|2|||
164055358|NCT00352027|592563139|FG000|Overall Study|Progressive disease|3|||
164055359|NCT04118127|592563140|FG000|Overall Study|Trial terminated by sponsor|0|||
164055360|NCT04118127|592563141|FG001|Overall Study|Trial terminated by sponsor|12|||
164055361|NCT04118127|592563140|FG000|Overall Study|Adverse Event|1|||
164055362|NCT04118127|592563141|FG001|Overall Study|Adverse Event|2|||
164055363|NCT04118127|592563140|FG000|Overall Study|Physician Decision|0|||
164055364|NCT04118127|592563141|FG001|Overall Study|Physician Decision|1|||
164055365|NCT04118127|592563140|FG000|Overall Study|Withdrawal by Subject|2|||
164055366|NCT04118127|592563141|FG001|Overall Study|Withdrawal by Subject|1|||
164055367|NCT04491591|592563142|FG000|Overall Study|Accidently randomized|3|||
164055368|NCT04491591|592563143|FG001|Overall Study|Accidently randomized|1|||
164055369|NCT04491591|592563144|FG002|Overall Study|Accidently randomized|0|||
164055370|NCT04491591|592563142|FG000|Overall Study|Did not complete survey|28|||
164055371|NCT04491591|592563143|FG001|Overall Study|Did not complete survey|20|||
164055372|NCT04491591|592563144|FG002|Overall Study|Did not complete survey|3|||
164055373|NCT00636506|592563145|FG000|Overall Study|Lost to Follow-up|8|||
164055374|NCT00636506|592563145|FG000|Overall Study|Explanted|1|||
164055375|NCT00636506|592563145|FG000|Overall Study|Withdrawal by Subject|6|||
164055376|NCT00636506|592563145|FG000|Overall Study|Procedure aborted|1|||
164055377|NCT02607735|592563146|FG000|Primary Study|Randomized but Never Treated|1|||
164055378|NCT02607735|592563147|FG001|Primary Study|Randomized but Never Treated|0|||
164055379|NCT02607735|592563148|FG002|Primary Study|Randomized but Never Treated|0|||
164055380|NCT02607735|592563146|FG000|Primary Study|Lost to Follow-up|4|||
164055381|NCT02607735|592563147|FG001|Primary Study|Lost to Follow-up|0|||
164055382|NCT02607735|592563148|FG002|Primary Study|Lost to Follow-up|0|||
164055383|NCT02607735|592563146|FG000|Primary Study|Withdrew Consent|2|||
164055384|NCT02607735|592563147|FG001|Primary Study|Withdrew Consent|0|||
164055385|NCT02607735|592563148|FG002|Primary Study|Withdrew Consent|0|||
164055386|NCT02607735|592563146|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
164055387|NCT02607735|592563147|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
164055388|NCT02607735|592563148|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
164055389|NCT02607735|592563146|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
164055390|NCT02607735|592563147|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
164055391|NCT02607735|592563148|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
164101435|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101436|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101437|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101438|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101439|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101440|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101441|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101442|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101443|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164055392|NCT01376908|592563149|FG000|Overall Study|Protocol Violation|1|||
164055393|NCT01376908|592563150|FG001|Overall Study|Protocol Violation|1|||
164055394|NCT01376908|592563149|FG000|Overall Study|Withdrawal by Subject|1|||
164055395|NCT01376908|592563150|FG001|Overall Study|Withdrawal by Subject|2|||
164055396|NCT01681836|592563157|FG000|Second Intervention|Withdrawal by Subject|0|||
164055397|NCT01681836|592563158|FG001|Second Intervention|Withdrawal by Subject|1|||
164055398|NCT02394028|592563159|FG000|Induction Phase|Adverse Event|2|||
164055399|NCT02394028|592563160|FG001|Induction Phase|Adverse Event|4|||
164055400|NCT02394028|592563161|FG002|Induction Phase|Adverse Event|1|||
164055401|NCT02394028|592563162|FG003|Induction Phase|Adverse Event|2|||
164055402|NCT02394028|592563163|FG004|Induction Phase|Adverse Event|5|||
164055403|NCT02394028|592563164|FG005|Induction Phase|Adverse Event|2|||
164055404|NCT02394028|592563165|FG006|Induction Phase|Adverse Event|0|||
164055405|NCT02394028|592563166|FG007|Induction Phase|Adverse Event|0|||
164055406|NCT02394028|592563167|FG008|Induction Phase|Adverse Event|0|||
164055407|NCT02394028|592563168|FG009|Induction Phase|Adverse Event|0|||
164055408|NCT02394028|592563169|FG010|Induction Phase|Adverse Event|0|||
164055409|NCT02394028|592563159|FG000|Induction Phase|Lack of Efficacy|3|||
164148635|NCT04895982|592904919|FG008|Overall Study|Lost to Follow-up|1|||
164055410|NCT02394028|592563160|FG001|Induction Phase|Lack of Efficacy|6|||
164055411|NCT02394028|592563161|FG002|Induction Phase|Lack of Efficacy|2|||
164055412|NCT02394028|592563162|FG003|Induction Phase|Lack of Efficacy|17|||
164055413|NCT02394028|592563163|FG004|Induction Phase|Lack of Efficacy|14|||
164055414|NCT02394028|592563164|FG005|Induction Phase|Lack of Efficacy|8|||
164055415|NCT02394028|592563165|FG006|Induction Phase|Lack of Efficacy|17|||
164055416|NCT02394028|592563166|FG007|Induction Phase|Lack of Efficacy|23|||
164055417|NCT02394028|592563167|FG008|Induction Phase|Lack of Efficacy|0|||
164055418|NCT02394028|592563168|FG009|Induction Phase|Lack of Efficacy|0|||
164055419|NCT02394028|592563169|FG010|Induction Phase|Lack of Efficacy|0|||
164055420|NCT02394028|592563159|FG000|Induction Phase|Lost to Follow-up|1|||
164055421|NCT02394028|592563160|FG001|Induction Phase|Lost to Follow-up|0|||
164055422|NCT02394028|592563161|FG002|Induction Phase|Lost to Follow-up|0|||
164055423|NCT02394028|592563162|FG003|Induction Phase|Lost to Follow-up|1|||
164055424|NCT02394028|592563163|FG004|Induction Phase|Lost to Follow-up|0|||
164055425|NCT02394028|592563164|FG005|Induction Phase|Lost to Follow-up|0|||
164055426|NCT02394028|592563165|FG006|Induction Phase|Lost to Follow-up|1|||
164055427|NCT02394028|592563166|FG007|Induction Phase|Lost to Follow-up|0|||
164055428|NCT02394028|592563167|FG008|Induction Phase|Lost to Follow-up|0|||
164055429|NCT02394028|592563168|FG009|Induction Phase|Lost to Follow-up|0|||
164055430|NCT02394028|592563169|FG010|Induction Phase|Lost to Follow-up|0|||
164055431|NCT02394028|592563159|FG000|Induction Phase|Non-compliance|0|||
164055432|NCT02394028|592563160|FG001|Induction Phase|Non-compliance|1|||
164055433|NCT02394028|592563161|FG002|Induction Phase|Non-compliance|3|||
164055434|NCT02394028|592563162|FG003|Induction Phase|Non-compliance|1|||
164055435|NCT02394028|592563163|FG004|Induction Phase|Non-compliance|3|||
164055436|NCT02394028|592563164|FG005|Induction Phase|Non-compliance|0|||
164055437|NCT02394028|592563165|FG006|Induction Phase|Non-compliance|1|||
164055438|NCT02394028|592563166|FG007|Induction Phase|Non-compliance|1|||
164055439|NCT02394028|592563167|FG008|Induction Phase|Non-compliance|0|||
164055440|NCT02394028|592563168|FG009|Induction Phase|Non-compliance|0|||
164055441|NCT02394028|592563169|FG010|Induction Phase|Non-compliance|0|||
164055442|NCT02394028|592563159|FG000|Induction Phase|Physician Decision|0|||
164055443|NCT02394028|592563160|FG001|Induction Phase|Physician Decision|0|||
164055444|NCT02394028|592563161|FG002|Induction Phase|Physician Decision|1|||
164055445|NCT02394028|592563162|FG003|Induction Phase|Physician Decision|4|||
164055446|NCT02394028|592563163|FG004|Induction Phase|Physician Decision|0|||
164055447|NCT02394028|592563164|FG005|Induction Phase|Physician Decision|2|||
164055448|NCT02394028|592563165|FG006|Induction Phase|Physician Decision|1|||
164055449|NCT02394028|592563166|FG007|Induction Phase|Physician Decision|0|||
164055450|NCT02394028|592563167|FG008|Induction Phase|Physician Decision|0|||
164055451|NCT02394028|592563168|FG009|Induction Phase|Physician Decision|0|||
164055452|NCT02394028|592563169|FG010|Induction Phase|Physician Decision|0|||
164055453|NCT02394028|592563159|FG000|Induction Phase|Protocol Violation|0|||
164055454|NCT02394028|592563160|FG001|Induction Phase|Protocol Violation|2|||
164055455|NCT02394028|592563161|FG002|Induction Phase|Protocol Violation|0|||
164055456|NCT02394028|592563162|FG003|Induction Phase|Protocol Violation|3|||
164055457|NCT02394028|592563163|FG004|Induction Phase|Protocol Violation|0|||
164055458|NCT02394028|592563164|FG005|Induction Phase|Protocol Violation|1|||
164055459|NCT02394028|592563165|FG006|Induction Phase|Protocol Violation|1|||
164055460|NCT02394028|592563166|FG007|Induction Phase|Protocol Violation|0|||
164055461|NCT02394028|592563167|FG008|Induction Phase|Protocol Violation|0|||
164055462|NCT02394028|592563168|FG009|Induction Phase|Protocol Violation|0|||
164055463|NCT02394028|592563169|FG010|Induction Phase|Protocol Violation|0|||
164055464|NCT02394028|592563159|FG000|Induction Phase|Withdrawal by Subject|1|||
164055465|NCT02394028|592563160|FG001|Induction Phase|Withdrawal by Subject|2|||
164055466|NCT02394028|592563161|FG002|Induction Phase|Withdrawal by Subject|4|||
164055467|NCT02394028|592563162|FG003|Induction Phase|Withdrawal by Subject|6|||
164055468|NCT02394028|592563163|FG004|Induction Phase|Withdrawal by Subject|7|||
164055469|NCT02394028|592563164|FG005|Induction Phase|Withdrawal by Subject|4|||
164055470|NCT02394028|592563165|FG006|Induction Phase|Withdrawal by Subject|3|||
164055471|NCT02394028|592563166|FG007|Induction Phase|Withdrawal by Subject|6|||
164055472|NCT02394028|592563167|FG008|Induction Phase|Withdrawal by Subject|0|||
164055473|NCT02394028|592563168|FG009|Induction Phase|Withdrawal by Subject|0|||
164055474|NCT02394028|592563169|FG010|Induction Phase|Withdrawal by Subject|0|||
164055475|NCT02394028|592563159|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055476|NCT02394028|592563160|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055477|NCT02394028|592563161|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055478|NCT02394028|592563162|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055479|NCT02394028|592563163|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055480|NCT02394028|592563164|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055481|NCT02394028|592563165|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
164055482|NCT02394028|592563166|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055483|NCT02394028|592563167|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055484|NCT02394028|592563168|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055485|NCT02394028|592563169|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
164055486|NCT02394028|592563159|FG000|Induction Phase|Sponsor decision|0|||
164055487|NCT02394028|592563160|FG001|Induction Phase|Sponsor decision|1|||
164055488|NCT02394028|592563161|FG002|Induction Phase|Sponsor decision|2|||
164055489|NCT02394028|592563162|FG003|Induction Phase|Sponsor decision|0|||
164055490|NCT02394028|592563163|FG004|Induction Phase|Sponsor decision|0|||
164055491|NCT02394028|592563164|FG005|Induction Phase|Sponsor decision|0|||
164055492|NCT02394028|592563165|FG006|Induction Phase|Sponsor decision|0|||
164055493|NCT02394028|592563166|FG007|Induction Phase|Sponsor decision|0|||
164055494|NCT02394028|592563167|FG008|Induction Phase|Sponsor decision|0|||
164055495|NCT02394028|592563168|FG009|Induction Phase|Sponsor decision|0|||
164055496|NCT02394028|592563169|FG010|Induction Phase|Sponsor decision|0|||
164055497|NCT02394028|592563159|FG000|Induction Phase|Technical reason|0|||
164055498|NCT02394028|592563160|FG001|Induction Phase|Technical reason|0|||
164055499|NCT02394028|592563161|FG002|Induction Phase|Technical reason|0|||
164055500|NCT02394028|592563162|FG003|Induction Phase|Technical reason|1|||
164055501|NCT02394028|592563163|FG004|Induction Phase|Technical reason|0|||
164101444|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101445|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101446|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
164101447|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
164101448|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164055502|NCT02394028|592563164|FG005|Induction Phase|Technical reason|0|||
164055503|NCT02394028|592563165|FG006|Induction Phase|Technical reason|0|||
164055504|NCT02394028|592563166|FG007|Induction Phase|Technical reason|0|||
164055505|NCT02394028|592563167|FG008|Induction Phase|Technical reason|0|||
164055506|NCT02394028|592563168|FG009|Induction Phase|Technical reason|0|||
164055507|NCT02394028|592563169|FG010|Induction Phase|Technical reason|0|||
164055508|NCT02394028|592563159|FG000|Induction Phase|:ack of calculation|0|||
164055509|NCT02394028|592563160|FG001|Induction Phase|:ack of calculation|0|||
164055510|NCT02394028|592563161|FG002|Induction Phase|:ack of calculation|0|||
164055511|NCT02394028|592563162|FG003|Induction Phase|:ack of calculation|0|||
164055512|NCT02394028|592563163|FG004|Induction Phase|:ack of calculation|0|||
164055513|NCT02394028|592563164|FG005|Induction Phase|:ack of calculation|0|||
164055514|NCT02394028|592563165|FG006|Induction Phase|:ack of calculation|0|||
164055515|NCT02394028|592563166|FG007|Induction Phase|:ack of calculation|1|||
164055516|NCT02394028|592563167|FG008|Induction Phase|:ack of calculation|0|||
164055517|NCT02394028|592563168|FG009|Induction Phase|:ack of calculation|0|||
164055518|NCT02394028|592563169|FG010|Induction Phase|:ack of calculation|0|||
164055519|NCT02394028|592563159|FG000|Maintenance Phase|Protocol Violation|0|||
164055520|NCT02394028|592563160|FG001|Maintenance Phase|Protocol Violation|0|||
164055521|NCT02394028|592563161|FG002|Maintenance Phase|Protocol Violation|0|||
164055522|NCT02394028|592563162|FG003|Maintenance Phase|Protocol Violation|0|||
164055523|NCT02394028|592563163|FG004|Maintenance Phase|Protocol Violation|0|||
164055524|NCT02394028|592563164|FG005|Maintenance Phase|Protocol Violation|0|||
164055525|NCT02394028|592563165|FG006|Maintenance Phase|Protocol Violation|0|||
164055526|NCT02394028|592563166|FG007|Maintenance Phase|Protocol Violation|0|||
164055527|NCT02394028|592563167|FG008|Maintenance Phase|Protocol Violation|0|||
164055528|NCT02394028|592563168|FG009|Maintenance Phase|Protocol Violation|0|||
164055529|NCT02394028|592563169|FG010|Maintenance Phase|Protocol Violation|1|||
164055530|NCT02394028|592563159|FG000|Maintenance Phase|Physician Decision|0|||
164055531|NCT02394028|592563160|FG001|Maintenance Phase|Physician Decision|0|||
164055532|NCT02394028|592563161|FG002|Maintenance Phase|Physician Decision|0|||
164055533|NCT02394028|592563162|FG003|Maintenance Phase|Physician Decision|0|||
164055534|NCT02394028|592563163|FG004|Maintenance Phase|Physician Decision|0|||
164055535|NCT02394028|592563164|FG005|Maintenance Phase|Physician Decision|0|||
164055536|NCT02394028|592563165|FG006|Maintenance Phase|Physician Decision|0|||
164055537|NCT02394028|592563166|FG007|Maintenance Phase|Physician Decision|0|||
164055538|NCT02394028|592563167|FG008|Maintenance Phase|Physician Decision|1|||
164055539|NCT02394028|592563168|FG009|Maintenance Phase|Physician Decision|3|||
164055540|NCT02394028|592563169|FG010|Maintenance Phase|Physician Decision|2|||
164055541|NCT02394028|592563159|FG000|Maintenance Phase|Lack of Efficacy|0|||
164055542|NCT02394028|592563160|FG001|Maintenance Phase|Lack of Efficacy|0|||
164055543|NCT02394028|592563161|FG002|Maintenance Phase|Lack of Efficacy|0|||
164055544|NCT02394028|592563162|FG003|Maintenance Phase|Lack of Efficacy|0|||
164055545|NCT02394028|592563163|FG004|Maintenance Phase|Lack of Efficacy|0|||
164055546|NCT02394028|592563164|FG005|Maintenance Phase|Lack of Efficacy|0|||
164055547|NCT02394028|592563165|FG006|Maintenance Phase|Lack of Efficacy|0|||
164055548|NCT02394028|592563166|FG007|Maintenance Phase|Lack of Efficacy|0|||
164055549|NCT02394028|592563167|FG008|Maintenance Phase|Lack of Efficacy|7|||
164055550|NCT02394028|592563168|FG009|Maintenance Phase|Lack of Efficacy|25|||
164055551|NCT02394028|592563169|FG010|Maintenance Phase|Lack of Efficacy|33|||
164055552|NCT02394028|592563159|FG000|Maintenance Phase|Death|0|||
164055553|NCT02394028|592563160|FG001|Maintenance Phase|Death|0|||
164055554|NCT02394028|592563161|FG002|Maintenance Phase|Death|0|||
164055555|NCT02394028|592563162|FG003|Maintenance Phase|Death|0|||
164055556|NCT02394028|592563163|FG004|Maintenance Phase|Death|0|||
164055557|NCT02394028|592563164|FG005|Maintenance Phase|Death|0|||
164055558|NCT02394028|592563165|FG006|Maintenance Phase|Death|0|||
164055559|NCT02394028|592563166|FG007|Maintenance Phase|Death|0|||
164101449|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164055560|NCT02394028|592563167|FG008|Maintenance Phase|Death|0|||
164055561|NCT02394028|592563168|FG009|Maintenance Phase|Death|0|||
164055562|NCT02394028|592563169|FG010|Maintenance Phase|Death|1|||
164055563|NCT02394028|592563159|FG000|Maintenance Phase|Adverse Event|0|||
164101450|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164055564|NCT02394028|592563160|FG001|Maintenance Phase|Adverse Event|0|||
164055565|NCT02394028|592563161|FG002|Maintenance Phase|Adverse Event|0|||
164055566|NCT02394028|592563162|FG003|Maintenance Phase|Adverse Event|0|||
164055567|NCT02394028|592563163|FG004|Maintenance Phase|Adverse Event|0|||
164055568|NCT02394028|592563164|FG005|Maintenance Phase|Adverse Event|0|||
164055569|NCT02394028|592563165|FG006|Maintenance Phase|Adverse Event|0|||
164055570|NCT02394028|592563166|FG007|Maintenance Phase|Adverse Event|0|||
164055571|NCT02394028|592563167|FG008|Maintenance Phase|Adverse Event|1|||
164055572|NCT02394028|592563168|FG009|Maintenance Phase|Adverse Event|1|||
164055573|NCT02394028|592563169|FG010|Maintenance Phase|Adverse Event|3|||
164055574|NCT02394028|592563159|FG000|Maintenance Phase|Site closure|0|||
164055575|NCT02394028|592563160|FG001|Maintenance Phase|Site closure|0|||
164055576|NCT02394028|592563161|FG002|Maintenance Phase|Site closure|0|||
164055577|NCT02394028|592563162|FG003|Maintenance Phase|Site closure|0|||
164055578|NCT02394028|592563163|FG004|Maintenance Phase|Site closure|0|||
164055579|NCT02394028|592563164|FG005|Maintenance Phase|Site closure|0|||
164055580|NCT02394028|592563165|FG006|Maintenance Phase|Site closure|0|||
164055581|NCT02394028|592563166|FG007|Maintenance Phase|Site closure|0|||
164055582|NCT02394028|592563167|FG008|Maintenance Phase|Site closure|0|||
164055583|NCT02394028|592563168|FG009|Maintenance Phase|Site closure|1|||
164055584|NCT02394028|592563169|FG010|Maintenance Phase|Site closure|0|||
164055585|NCT02394028|592563159|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164055586|NCT02394028|592563160|FG001|Maintenance Phase|Withdrawal by Subject|0|||
164055587|NCT02394028|592563161|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164055588|NCT02394028|592563162|FG003|Maintenance Phase|Withdrawal by Subject|0|||
164055589|NCT02394028|592563163|FG004|Maintenance Phase|Withdrawal by Subject|0|||
164055590|NCT02394028|592563164|FG005|Maintenance Phase|Withdrawal by Subject|0|||
164055591|NCT02394028|592563165|FG006|Maintenance Phase|Withdrawal by Subject|0|||
164055592|NCT02394028|592563166|FG007|Maintenance Phase|Withdrawal by Subject|0|||
164055593|NCT02394028|592563167|FG008|Maintenance Phase|Withdrawal by Subject|3|||
164055594|NCT02394028|592563168|FG009|Maintenance Phase|Withdrawal by Subject|12|||
164055595|NCT02394028|592563169|FG010|Maintenance Phase|Withdrawal by Subject|12|||
164055596|NCT00742391|592563170|FG000|Overall Study|Adverse Event|2|||
164055597|NCT00742391|592563171|FG001|Overall Study|Adverse Event|1|||
164055598|NCT00742391|592563170|FG000|Overall Study|Lost to Follow-up|1|||
164055599|NCT00742391|592563171|FG001|Overall Study|Lost to Follow-up|0|||
164055600|NCT00742391|592563170|FG000|Overall Study|Protocol Violation|1|||
164055601|NCT00742391|592563171|FG001|Overall Study|Protocol Violation|0|||
164055602|NCT00866606|592563174|FG000|Overall Study|Lost to Follow-up|3|||
164055603|NCT00866606|592563174|FG000|Overall Study|Adverse Event|1|||
164055604|NCT01058356|592563186|FG000|Overall Study|Adverse Event|5|||
164055605|NCT01058356|592563186|FG000|Overall Study|Administration of contraindicated drugs|12|||
164055606|NCT01058356|592563186|FG000|Overall Study|Withdrawal by Subject|21|||
164055607|NCT01058356|592563186|FG000|Overall Study|Lost to Follow-up|4|||
164055608|NCT01277666|592563190|FG000|Overall Study|Adverse Event|26|||
164055609|NCT01277666|592563191|FG001|Overall Study|Adverse Event|25|||
164055610|NCT01277666|592563192|FG002|Overall Study|Adverse Event|20|||
164055611|NCT01277666|592563190|FG000|Overall Study|Lack of Efficacy|8|||
164055612|NCT01277666|592563191|FG001|Overall Study|Lack of Efficacy|20|||
164055613|NCT01277666|592563192|FG002|Overall Study|Lack of Efficacy|12|||
164055614|NCT01277666|592563190|FG000|Overall Study|Protocol Violation|2|||
164055615|NCT01277666|592563191|FG001|Overall Study|Protocol Violation|3|||
164055616|NCT01277666|592563192|FG002|Overall Study|Protocol Violation|2|||
164055617|NCT01277666|592563190|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
164055618|NCT01277666|592563191|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
164055619|NCT01277666|592563192|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
164055620|NCT01277666|592563190|FG000|Overall Study|Lost to Follow-up|1|||
164055621|NCT01277666|592563191|FG001|Overall Study|Lost to Follow-up|1|||
164055622|NCT01277666|592563192|FG002|Overall Study|Lost to Follow-up|2|||
164055623|NCT01277666|592563190|FG000|Overall Study|Withdrawal by Subject|7|||
164055624|NCT01277666|592563191|FG001|Overall Study|Withdrawal by Subject|8|||
164055625|NCT01277666|592563192|FG002|Overall Study|Withdrawal by Subject|6|||
164055626|NCT01277666|592563190|FG000|Overall Study|Death|0|||
164055627|NCT01277666|592563191|FG001|Overall Study|Death|0|||
164055628|NCT01277666|592563192|FG002|Overall Study|Death|1|||
164055629|NCT01657903|592563194|FG000|Overall Study|Lost to Follow-up|1|||
164055630|NCT01657903|592563194|FG000|Overall Study|Withdrawal by Subject|1|||
164055631|NCT00554840|592563195|FG000|Overall Study|Physician Decision|0|||
164055632|NCT00554840|592563196|FG001|Overall Study|Physician Decision|1|||
164055633|NCT02312934|592563199|FG000|Overall Study|Lost to Follow-up|1|||
164055634|NCT02312934|592563200|FG001|Overall Study|Lost to Follow-up|0|||
164055635|NCT02312934|592563199|FG000|Overall Study|Physician Decision|1|||
164055636|NCT02312934|592563200|FG001|Overall Study|Physician Decision|0|||
164055637|NCT03395704|592563202|FG000|Overall Study|Adverse Event|2|||
164055638|NCT03395704|592563203|FG001|Overall Study|Adverse Event|1|||
164055639|NCT03395704|592563202|FG000|Overall Study|Withdrawal by Subject|2|||
164055640|NCT03395704|592563203|FG001|Overall Study|Withdrawal by Subject|1|||
164055641|NCT03395704|592563202|FG000|Overall Study|Physician Decision|0|||
164055642|NCT03395704|592563203|FG001|Overall Study|Physician Decision|1|||
164055643|NCT03359811|592564898|FG000|Overall Study|Protocol Violation|2|||
164055644|NCT03359811|592564899|FG001|Overall Study|Protocol Violation|0|||
164055645|NCT02528331|592564912|FG000|Overall Study|Withdrawal by Subject|2|||
164055646|NCT00386152|592564913|FG000|Overall Study|Adverse Event|6|||
164055647|NCT00386152|592564914|FG001|Overall Study|Adverse Event|5|||
164055648|NCT00386152|592564915|FG002|Overall Study|Adverse Event|4|||
164055649|NCT00386152|592564913|FG000|Overall Study|Chang from original chemo stratification|4|||
164101451|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101452|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
164101453|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101454|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101455|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101456|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101457|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101458|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101459|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101460|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101461|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101462|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101463|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101464|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101465|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101466|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101467|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
164101468|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
164101469|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101470|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101471|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101472|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101473|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
164101474|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101475|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164055650|NCT00386152|592564914|FG001|Overall Study|Chang from original chemo stratification|5|||
164055651|NCT00386152|592564915|FG002|Overall Study|Chang from original chemo stratification|6|||
164055652|NCT00386152|592564913|FG000|Overall Study|Death|3|||
164055653|NCT00386152|592564914|FG001|Overall Study|Death|0|||
164055654|NCT00386152|592564915|FG002|Overall Study|Death|1|||
164055655|NCT00386152|592564913|FG000|Overall Study|Disease progression|7|||
164055656|NCT00386152|592564914|FG001|Overall Study|Disease progression|4|||
164055657|NCT00386152|592564915|FG002|Overall Study|Disease progression|5|||
164055658|NCT00386152|592564913|FG000|Overall Study|Physician Decision|13|||
164055659|NCT00386152|592564914|FG001|Overall Study|Physician Decision|10|||
164055660|NCT00386152|592564915|FG002|Overall Study|Physician Decision|4|||
164055661|NCT00386152|592564913|FG000|Overall Study|Lost to Follow-up|1|||
164055662|NCT00386152|592564914|FG001|Overall Study|Lost to Follow-up|0|||
164055663|NCT00386152|592564915|FG002|Overall Study|Lost to Follow-up|0|||
164055664|NCT00386152|592564913|FG000|Overall Study|Completed chemotherapy|4|||
164055665|NCT00386152|592564914|FG001|Overall Study|Completed chemotherapy|5|||
164055666|NCT00386152|592564915|FG002|Overall Study|Completed chemotherapy|1|||
164055667|NCT00386152|592564913|FG000|Overall Study|Protocol Violation|3|||
164055668|NCT00386152|592564914|FG001|Overall Study|Protocol Violation|5|||
164055669|NCT00386152|592564915|FG002|Overall Study|Protocol Violation|2|||
164055670|NCT00386152|592564913|FG000|Overall Study|Withdrawal by Subject|3|||
164055671|NCT00386152|592564914|FG001|Overall Study|Withdrawal by Subject|6|||
164055672|NCT00386152|592564915|FG002|Overall Study|Withdrawal by Subject|10|||
164055673|NCT02577107|592564916|FG000|Overall Study|Protocol deviation|0|||
164055674|NCT02577107|592564917|FG001|Overall Study|Protocol deviation|1|||
164055675|NCT00577382|592564918|FG000|Overall Study|Adverse Event|0|||
164055676|NCT00577382|592564919|FG001|Overall Study|Adverse Event|6|||
164055677|NCT00577382|592564918|FG000|Overall Study|Withdrawal by Subject|0|||
164055678|NCT00577382|592564919|FG001|Overall Study|Withdrawal by Subject|1|||
164055679|NCT00577382|592564918|FG000|Overall Study|Progressive Disease|17|||
164055680|NCT00577382|592564919|FG001|Overall Study|Progressive Disease|19|||
164055681|NCT00577382|592564918|FG000|Overall Study|Intercurrent Illness|1|||
164055682|NCT00577382|592564919|FG001|Overall Study|Intercurrent Illness|2|||
164055683|NCT00577382|592564918|FG000|Overall Study|Death|1|||
164055684|NCT00577382|592564919|FG001|Overall Study|Death|1|||
164055685|NCT00577382|592564918|FG000|Overall Study|Lost to Follow-up|2|||
164055686|NCT00577382|592564919|FG001|Overall Study|Lost to Follow-up|2|||
164055687|NCT01345162|592564920|FG000|Overall Study|Protocol Violation|2|||
164055688|NCT01345162|592564921|FG001|Overall Study|Protocol Violation|4|||
164055689|NCT03007472|592564923|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
164055690|NCT03007472|592564923|FG000|Overall Study|Death|2|||
164055691|NCT03007472|592564923|FG000|Overall Study|Loss to Follow Up|1|||
164055692|NCT02988115|592564924|FG000|Overall Study|Adverse Event|6|||
164055693|NCT02988115|592564925|FG001|Overall Study|Adverse Event|1|||
164055694|NCT02988115|592564924|FG000|Overall Study|Sponsor Decision|5|||
164055695|NCT02988115|592564925|FG001|Overall Study|Sponsor Decision|2|||
164055696|NCT02988115|592564924|FG000|Overall Study|Withdrawal by Subject|1|||
164055697|NCT02988115|592564925|FG001|Overall Study|Withdrawal by Subject|1|||
164101476|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101477|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101478|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101479|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101480|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101481|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101482|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101483|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101484|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101485|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101486|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101487|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
164101488|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
164101489|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
164101490|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101491|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101492|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101493|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101494|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
164101495|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101496|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101497|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101498|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101499|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101500|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101501|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101502|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101503|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101504|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101505|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101506|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101507|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101508|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101509|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
164101510|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
164101511|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101512|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101513|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101514|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101515|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
164101516|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101517|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101518|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101519|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101520|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101521|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101522|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101523|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101524|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101525|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164055698|NCT02988115|592564924|FG000|Overall Study|Withdrawn by Mistake|1|||
164055699|NCT02988115|592564925|FG001|Overall Study|Withdrawn by Mistake|0|||
164055700|NCT02988115|592564924|FG000|Overall Study|Lost to Follow-up|1|||
164055701|NCT02988115|592564925|FG001|Overall Study|Lost to Follow-up|0|||
164055702|NCT01731951|592564926|FG000|Overall Study|Documented Disease Progression|1|||
164055703|NCT01731951|592564927|FG001|Overall Study|Documented Disease Progression|0|||
164055704|NCT01731951|592564928|FG002|Overall Study|Documented Disease Progression|0|||
164055705|NCT01731951|592564929|FG003|Overall Study|Documented Disease Progression|0|||
164055706|NCT01731951|592564930|FG004|Overall Study|Documented Disease Progression|0|||
164055707|NCT01731951|592564931|FG005|Overall Study|Documented Disease Progression|0|||
164055708|NCT01731951|592564926|FG000|Overall Study|Lost to Follow-up|2|||
164055709|NCT01731951|592564927|FG001|Overall Study|Lost to Follow-up|0|||
164055710|NCT01731951|592564928|FG002|Overall Study|Lost to Follow-up|0|||
164055711|NCT01731951|592564929|FG003|Overall Study|Lost to Follow-up|1|||
164055712|NCT01731951|592564930|FG004|Overall Study|Lost to Follow-up|3|||
164055713|NCT01731951|592564931|FG005|Overall Study|Lost to Follow-up|1|||
164055714|NCT01731951|592564926|FG000|Overall Study|Withdrawal of Consent|1|||
164055715|NCT01731951|592564927|FG001|Overall Study|Withdrawal of Consent|0|||
164055716|NCT01731951|592564928|FG002|Overall Study|Withdrawal of Consent|0|||
164055717|NCT01731951|592564929|FG003|Overall Study|Withdrawal of Consent|0|||
164055718|NCT01731951|592564930|FG004|Overall Study|Withdrawal of Consent|0|||
164055719|NCT01731951|592564931|FG005|Overall Study|Withdrawal of Consent|2|||
164055720|NCT01731951|592564926|FG000|Overall Study|Death|13|||
164055721|NCT01731951|592564927|FG001|Overall Study|Death|15|||
164055722|NCT01731951|592564928|FG002|Overall Study|Death|9|||
164055723|NCT01731951|592564929|FG003|Overall Study|Death|8|||
164055724|NCT01731951|592564930|FG004|Overall Study|Death|9|||
164055725|NCT01731951|592564931|FG005|Overall Study|Death|6|||
164055726|NCT00649220|592564938|FG000|Overall Study|Adverse Event|2|||
164055727|NCT00649220|592564938|FG000|Overall Study|Withdrawal by Subject|1|||
164055728|NCT01977651|592564939|FG000|4 Month Treatment Period|Adverse Event|34|||
164055729|NCT01977651|592564939|FG000|4 Month Treatment Period|Death|3|||
164055730|NCT01977651|592564939|FG000|4 Month Treatment Period|Progressive Disease|43|||
164055731|NCT01977651|592564939|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
164055732|NCT01977651|592564939|FG000|4 Month Treatment Period|Physician Decision|4|||
164055733|NCT01977651|592564939|FG000|1 Year Extension Period|Adverse Event|14|||
164055734|NCT01977651|592564939|FG000|1 Year Extension Period|Death|10|||
164055735|NCT01977651|592564939|FG000|1 Year Extension Period|Lost to Follow-up|2|||
164055736|NCT01977651|592564939|FG000|1 Year Extension Period|Progressive Disease|86|||
164055737|NCT01977651|592564939|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
164055738|NCT01977651|592564939|FG000|1 Year Extension Period|Physician Decision|6|||
164055739|NCT01977651|592564939|FG000|1 Year Extension Period|Miscellaneous|1|||
164055740|NCT01977651|592564939|FG000|Post 1 Year Extension Period|Adverse Event|5|||
164055741|NCT01977651|592564939|FG000|Post 1 Year Extension Period|Death|13|||
164055742|NCT01977651|592564939|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
164055743|NCT01977651|592564939|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
164055744|NCT01977651|592564939|FG000|Post 1 Year Extension Period|Physician Decision|4|||
164055745|NCT01977651|592564939|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
164055746|NCT03380091|592564941|FG000|Overall Study|Withdrawal by Subject|2|||
164055747|NCT03380091|592564942|FG001|Overall Study|Withdrawal by Subject|1|||
164055748|NCT04594213|592564948|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
164055749|NCT04594213|592564949|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
164055750|NCT04594213|592564950|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
164055751|NCT04594213|592564951|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164055752|NCT04594213|592564952|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164055753|NCT04594213|592564953|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
164055754|NCT04594213|592564948|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164055755|NCT04594213|592564949|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
164055756|NCT04594213|592564950|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164055757|NCT04594213|592564951|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164055758|NCT04594213|592564952|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164055759|NCT04594213|592564953|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
164055760|NCT04594213|592564948|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
164055761|NCT04594213|592564949|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164055762|NCT04594213|592564950|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
164055763|NCT04594213|592564951|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164055764|NCT04594213|592564952|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164055765|NCT04594213|592564953|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
164055766|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164055767|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164055768|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164055769|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164055770|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
164055771|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
164055772|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164055773|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164055774|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
164055775|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
164055776|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
164055777|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
164055778|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164055779|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164055780|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164055781|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164055782|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
164055783|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
164055784|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164055785|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164055786|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164101526|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101527|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101528|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101529|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101530|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
164101531|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
164101532|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101533|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164055787|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
164055788|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164055789|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
164055790|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164101534|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164055791|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164055792|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164055793|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
164055794|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164055795|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
164055796|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164055797|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164055798|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
164055799|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
164055800|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
164055801|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
164055802|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164055803|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164055804|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
164055805|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
164055806|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
164055807|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
164055808|NCT04594213|592564948|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
164055809|NCT04594213|592564949|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
164055810|NCT04594213|592564950|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
164055811|NCT04594213|592564951|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
164055812|NCT04594213|592564952|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
164055813|NCT04594213|592564953|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
164055814|NCT01980056|592564955|FG000|Overall Study|Death|1|||
164055815|NCT01980056|592564956|FG001|Overall Study|Death|1|||
164055816|NCT01980056|592564957|FG002|Overall Study|Death|0|||
164055817|NCT00104299|592564958|FG000|Overall Study|Adverse Event|3|||
164055818|NCT00104299|592564959|FG001|Overall Study|Adverse Event|1|||
164055819|NCT00104299|592564958|FG000|Overall Study|Death|2|||
164055820|NCT00104299|592564959|FG001|Overall Study|Death|2|||
164055821|NCT00104299|592564958|FG000|Overall Study|Withdrawal by Subject|2|||
164055822|NCT00104299|592564959|FG001|Overall Study|Withdrawal by Subject|6|||
164055823|NCT00104299|592564958|FG000|Overall Study|Physician Decision|1|||
164055824|NCT00104299|592564959|FG001|Overall Study|Physician Decision|1|||
164055825|NCT00104299|592564958|FG000|Overall Study|To have renal transplant|1|||
164055826|NCT00104299|592564959|FG001|Overall Study|To have renal transplant|0|||
164055827|NCT02906644|592564960|FG000|First 2 Weeks|Withdrawal by Subject|0|||
164055828|NCT02906644|592564961|FG001|First 2 Weeks|Withdrawal by Subject|2|||
164055829|NCT02906644|592564960|FG000|First 2 Weeks|Physician Decision|1|||
164055830|NCT02906644|592564961|FG001|First 2 Weeks|Physician Decision|1|||
164055831|NCT02906644|592564960|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
164055832|NCT02906644|592564961|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
164055833|NCT02906644|592564960|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
164055834|NCT02906644|592564961|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
164055835|NCT03672006|592564964|FG000|Overall Study|exclusion criteria met|0|||
164055836|NCT03672006|592564965|FG001|Overall Study|exclusion criteria met|1|||
164055837|NCT03288987|592564966|FG000|Overall Study|Protocol Violation|10|||
164055838|NCT03288987|592564967|FG001|Overall Study|Protocol Violation|4|||
164055839|NCT00608426|592564968|FG000|Overall Study|Death|32|||
164055840|NCT00608426|592564969|FG001|Overall Study|Death|36|||
164055841|NCT00608426|592564968|FG000|Overall Study|Lost to Follow-up|485|||
164055842|NCT00608426|592564969|FG001|Overall Study|Lost to Follow-up|521|||
164055843|NCT00608426|592564968|FG000|Overall Study|refused, health issues, wrong address|319|||
164055844|NCT00608426|592564969|FG001|Overall Study|refused, health issues, wrong address|348|||
164055845|NCT00761891|592564970|FG000|Overall Study|Withdrawal by Subject|10|||
164055846|NCT00368069|592564971|FG000|Overall Study|Adverse Event|5|||
164101535|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101536|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
164101537|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101538|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101539|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101540|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101541|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101542|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101543|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101544|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101545|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101546|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101547|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101548|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101549|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101550|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101551|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
164101552|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
164101553|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101554|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101555|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101556|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101557|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
164101558|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101559|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101560|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101561|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101562|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101563|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101564|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101565|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101566|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101567|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101568|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101569|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101570|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101571|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101572|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
164101573|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
164101574|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101575|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101576|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101577|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101578|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
164101579|NCT01597245|592734944|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101580|NCT01597245|592734945|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101581|NCT01597245|592734946|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101582|NCT01597245|592734947|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101583|NCT01597245|592734948|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101584|NCT01597245|592734949|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101585|NCT01597245|592734950|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101586|NCT01597245|592734951|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101587|NCT01597245|592734952|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101588|NCT01597245|592734953|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101589|NCT01597245|592734954|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101590|NCT01597245|592734955|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101591|NCT01597245|592734956|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101592|NCT01597245|592734957|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
164055847|NCT00368069|592564972|FG001|Overall Study|Adverse Event|2|||
164055848|NCT00368069|592564971|FG000|Overall Study|Lack of Efficacy|0|||
164055849|NCT00368069|592564972|FG001|Overall Study|Lack of Efficacy|1|||
164055850|NCT00368069|592564971|FG000|Overall Study|Lost to Follow-up|1|||
164055851|NCT00368069|592564972|FG001|Overall Study|Lost to Follow-up|0|||
164055852|NCT00368069|592564971|FG000|Overall Study|Protocol Violation|0|||
164055853|NCT00368069|592564972|FG001|Overall Study|Protocol Violation|2|||
164055854|NCT00368069|592564971|FG000|Overall Study|Withdrawal of Consent|2|||
164055855|NCT00368069|592564972|FG001|Overall Study|Withdrawal of Consent|1|||
164055856|NCT00368069|592564971|FG000|Overall Study|no blood sampling possible|0|||
164101593|NCT01597245|592734958|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101594|NCT01597245|592734959|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101595|NCT01597245|592734960|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101596|NCT01597245|592734961|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101597|NCT01597245|592734962|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101598|NCT01597245|592734963|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101599|NCT01597245|592734964|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
164101600|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101601|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101602|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101603|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101604|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101605|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101606|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101607|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101608|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101609|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101610|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101611|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101612|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101613|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101614|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164055857|NCT00368069|592564972|FG001|Overall Study|no blood sampling possible|1|||
164055858|NCT02764229|592564974|FG000|Overall Study|Withdrawal by Subject|15|||
164055859|NCT02764229|592564974|FG000|Overall Study|Adverse Event|9|||
164055860|NCT02764229|592564974|FG000|Overall Study|Physician Decision|5|||
164055861|NCT02764229|592564974|FG000|Overall Study|Lost to Follow-up|3|||
164055862|NCT02764229|592564974|FG000|Overall Study|Lack of Efficacy|1|||
164055863|NCT02764229|592564974|FG000|Overall Study|Study Stopped by Sponsor|69|||
164055864|NCT00672490|592564975|FG000|Overall Study|Withdrawal by Subject|8|||
164055865|NCT00672490|592564976|FG001|Overall Study|Withdrawal by Subject|8|||
164055866|NCT00672490|592564975|FG000|Overall Study|Lack of Compliance|2|||
164055867|NCT00672490|592564976|FG001|Overall Study|Lack of Compliance|7|||
164055868|NCT00672490|592564975|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
164055869|NCT00672490|592564976|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
164055870|NCT00672490|592564975|FG000|Overall Study|Adverse Event|5|||
164055871|NCT00672490|592564976|FG001|Overall Study|Adverse Event|8|||
164055872|NCT00672490|592564975|FG000|Overall Study|Violation of Concomitant Medicine|1|||
164055873|NCT00672490|592564976|FG001|Overall Study|Violation of Concomitant Medicine|0|||
164055874|NCT00672490|592564975|FG000|Overall Study|Intolerance|0|||
164055875|NCT00672490|592564976|FG001|Overall Study|Intolerance|2|||
164055876|NCT00672490|592564975|FG000|Overall Study|Lost to Follow-up|1|||
164055877|NCT00672490|592564976|FG001|Overall Study|Lost to Follow-up|5|||
164055878|NCT00672490|592564975|FG000|Overall Study|No reason was provided|6|||
164055879|NCT00672490|592564976|FG001|Overall Study|No reason was provided|2|||
164055880|NCT02030067|592564989|FG000|Overall Study|Disease Progression|1|||
164055881|NCT02030067|592564990|FG001|Overall Study|Disease Progression|1|||
164055882|NCT02030067|592564991|FG002|Overall Study|Disease Progression|2|||
164055883|NCT02030067|592564992|FG003|Overall Study|Disease Progression|2|||
164055884|NCT02030067|592564993|FG004|Overall Study|Disease Progression|3|||
164055885|NCT02030067|592564994|FG005|Overall Study|Disease Progression|2|||
164055886|NCT02030067|592564995|FG006|Overall Study|Disease Progression|3|||
164055887|NCT02030067|592564996|FG007|Overall Study|Disease Progression|3|||
164055888|NCT02030067|592564997|FG008|Overall Study|Disease Progression|4|||
164055889|NCT02030067|592564998|FG009|Overall Study|Disease Progression|3|||
164055890|NCT02030067|592564999|FG010|Overall Study|Disease Progression|7|||
164055891|NCT02030067|592565000|FG011|Overall Study|Disease Progression|2|||
164055892|NCT02030067|592565001|FG012|Overall Study|Disease Progression|59|||
164055893|NCT02030067|592564989|FG000|Overall Study|Withdrawal by Subject|0|||
164055894|NCT02030067|592564990|FG001|Overall Study|Withdrawal by Subject|0|||
164055895|NCT02030067|592564991|FG002|Overall Study|Withdrawal by Subject|0|||
164055896|NCT02030067|592564992|FG003|Overall Study|Withdrawal by Subject|1|||
164055897|NCT02030067|592564993|FG004|Overall Study|Withdrawal by Subject|0|||
164055898|NCT02030067|592564994|FG005|Overall Study|Withdrawal by Subject|0|||
164055899|NCT02030067|592564995|FG006|Overall Study|Withdrawal by Subject|0|||
164055900|NCT02030067|592564996|FG007|Overall Study|Withdrawal by Subject|1|||
164055901|NCT02030067|592564997|FG008|Overall Study|Withdrawal by Subject|0|||
164101615|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
164101616|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
164055902|NCT02030067|592564998|FG009|Overall Study|Withdrawal by Subject|0|||
164055903|NCT02030067|592564999|FG010|Overall Study|Withdrawal by Subject|3|||
164055904|NCT02030067|592565000|FG011|Overall Study|Withdrawal by Subject|0|||
164055905|NCT02030067|592565001|FG012|Overall Study|Withdrawal by Subject|6|||
164055906|NCT02030067|592564989|FG000|Overall Study|Physician Decision|0|||
164055907|NCT02030067|592564990|FG001|Overall Study|Physician Decision|0|||
164055908|NCT02030067|592564991|FG002|Overall Study|Physician Decision|0|||
164055909|NCT02030067|592564992|FG003|Overall Study|Physician Decision|0|||
164055910|NCT02030067|592564993|FG004|Overall Study|Physician Decision|0|||
164055911|NCT02030067|592564994|FG005|Overall Study|Physician Decision|0|||
164055912|NCT02030067|592564995|FG006|Overall Study|Physician Decision|0|||
164055913|NCT02030067|592564996|FG007|Overall Study|Physician Decision|0|||
164055914|NCT02030067|592564997|FG008|Overall Study|Physician Decision|0|||
164055915|NCT02030067|592564998|FG009|Overall Study|Physician Decision|0|||
164055916|NCT02030067|592564999|FG010|Overall Study|Physician Decision|1|||
164055917|NCT02030067|592565000|FG011|Overall Study|Physician Decision|0|||
164055918|NCT02030067|592565001|FG012|Overall Study|Physician Decision|3|||
164055919|NCT02030067|592564989|FG000|Overall Study|other reasons|0|||
164055920|NCT02030067|592564990|FG001|Overall Study|other reasons|0|||
164055921|NCT02030067|592564991|FG002|Overall Study|other reasons|0|||
164055922|NCT02030067|592564992|FG003|Overall Study|other reasons|0|||
164055923|NCT02030067|592564993|FG004|Overall Study|other reasons|0|||
164055924|NCT02030067|592564994|FG005|Overall Study|other reasons|1|||
164055925|NCT02030067|592564995|FG006|Overall Study|other reasons|0|||
164055926|NCT02030067|592564996|FG007|Overall Study|other reasons|0|||
164055927|NCT02030067|592564997|FG008|Overall Study|other reasons|2|||
164055928|NCT02030067|592564998|FG009|Overall Study|other reasons|0|||
164055929|NCT02030067|592564999|FG010|Overall Study|other reasons|0|||
164055930|NCT02030067|592565000|FG011|Overall Study|other reasons|0|||
164055931|NCT02030067|592565001|FG012|Overall Study|other reasons|4|||
164055932|NCT02030067|592564989|FG000|Overall Study|Adverse Event|0|||
164055933|NCT02030067|592564990|FG001|Overall Study|Adverse Event|0|||
164055934|NCT02030067|592564991|FG002|Overall Study|Adverse Event|0|||
164055935|NCT02030067|592564992|FG003|Overall Study|Adverse Event|0|||
164055936|NCT02030067|592564993|FG004|Overall Study|Adverse Event|0|||
164055937|NCT02030067|592564994|FG005|Overall Study|Adverse Event|0|||
164055938|NCT02030067|592564995|FG006|Overall Study|Adverse Event|0|||
164055939|NCT02030067|592564996|FG007|Overall Study|Adverse Event|0|||
164055940|NCT02030067|592564997|FG008|Overall Study|Adverse Event|0|||
164055941|NCT02030067|592564998|FG009|Overall Study|Adverse Event|0|||
164055942|NCT02030067|592564999|FG010|Overall Study|Adverse Event|0|||
164055943|NCT02030067|592565000|FG011|Overall Study|Adverse Event|1|||
164055944|NCT02030067|592565001|FG012|Overall Study|Adverse Event|8|||
164055945|NCT00565721|592565003|FG000|Overall Study|Screen Failure|2|||
164055946|NCT00565721|592565003|FG000|Overall Study|Lost to Follow-up|6|||
164055947|NCT00565721|592565003|FG000|Overall Study|Technical Problems|1|||
164055948|NCT00565721|592565003|FG000|Overall Study|Physician Decision|2|||
164055949|NCT00565721|592565003|FG000|Overall Study|Other reasons|6|||
164055950|NCT02813681|592565006|FG000|Overall Study|Physician Decision|5|||
164055951|NCT02813681|592565007|FG001|Overall Study|Physician Decision|5|||
164055952|NCT02813681|592565008|FG002|Overall Study|Physician Decision|0|||
164055953|NCT02813681|592565006|FG000|Overall Study|Lost to Follow-up|0|||
164055954|NCT02813681|592565007|FG001|Overall Study|Lost to Follow-up|1|||
164055955|NCT02813681|592565008|FG002|Overall Study|Lost to Follow-up|0|||
164055956|NCT00529152|592565009|FG000|Overall Study|Adverse Event|2|||
164055957|NCT00529152|592565009|FG000|Overall Study|Withdrawal by Subject|2|||
164055958|NCT00529152|592565009|FG000|Overall Study|Lost to Follow-up|1|||
164055959|NCT04062240|592565013|FG000|Overall Study|equipment malfunction|1|||
164055960|NCT03961529|592565014|FG000|Overall Study|Adverse Event|13|||
164055961|NCT03961529|592565015|FG001|Overall Study|Adverse Event|5|||
164055962|NCT03961529|592565016|FG002|Overall Study|Adverse Event|2|||
164055963|NCT03961529|592565014|FG000|Overall Study|Withdrawal by Subject|17|||
164055964|NCT03961529|592565015|FG001|Overall Study|Withdrawal by Subject|2|||
164055965|NCT03961529|592565016|FG002|Overall Study|Withdrawal by Subject|1|||
164055966|NCT03961529|592565014|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164055967|NCT03961529|592565015|FG001|Overall Study|Withdrawal by parent/guardian|7|||
164055968|NCT03961529|592565016|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164055969|NCT03961529|592565014|FG000|Overall Study|Physician Decision|2|||
164055970|NCT03961529|592565015|FG001|Overall Study|Physician Decision|1|||
164055971|NCT03961529|592565016|FG002|Overall Study|Physician Decision|1|||
164055972|NCT03961529|592565014|FG000|Overall Study|Lost to Follow-up|2|||
164055973|NCT03961529|592565015|FG001|Overall Study|Lost to Follow-up|1|||
164055974|NCT03961529|592565016|FG002|Overall Study|Lost to Follow-up|0|||
164055975|NCT03961529|592565014|FG000|Overall Study|Lack of Efficacy|2|||
164055976|NCT03961529|592565015|FG001|Overall Study|Lack of Efficacy|0|||
164055977|NCT03961529|592565016|FG002|Overall Study|Lack of Efficacy|1|||
164055978|NCT03961529|592565014|FG000|Overall Study|Other|6|||
164055979|NCT03961529|592565015|FG001|Overall Study|Other|1|||
164055980|NCT03961529|592565016|FG002|Overall Study|Other|0|||
164055981|NCT03500419|592565017|FG000|Overall Study|Withdrawal by Subject|2|||
164055982|NCT03500419|592565018|FG001|Overall Study|Withdrawal by Subject|25|||
164055983|NCT01497899|592565019|FG000|Double-Blind Phase|Randomized but not Treated|1|||
164055984|NCT01497899|592565020|FG001|Double-Blind Phase|Randomized but not Treated|0|||
164055985|NCT01497899|592565021|FG002|Double-Blind Phase|Randomized but not Treated|0|||
164055986|NCT01497899|592565022|FG003|Double-Blind Phase|Randomized but not Treated|0|||
164055987|NCT01497899|592565019|FG000|Double-Blind Phase|Adverse Event|1|||
164055988|NCT01497899|592565020|FG001|Double-Blind Phase|Adverse Event|0|||
164055989|NCT01497899|592565021|FG002|Double-Blind Phase|Adverse Event|0|||
164055990|NCT01497899|592565022|FG003|Double-Blind Phase|Adverse Event|0|||
164055991|NCT01497899|592565019|FG000|Double-Blind Phase|Lack of Efficacy|0|||
164055992|NCT01497899|592565020|FG001|Double-Blind Phase|Lack of Efficacy|1|||
164055993|NCT01497899|592565021|FG002|Double-Blind Phase|Lack of Efficacy|0|||
164055994|NCT01497899|592565022|FG003|Double-Blind Phase|Lack of Efficacy|0|||
164055995|NCT01497899|592565019|FG000|Double-Blind Phase|Investigator's Discretion|1|||
164055996|NCT01497899|592565020|FG001|Double-Blind Phase|Investigator's Discretion|0|||
164055997|NCT01497899|592565021|FG002|Double-Blind Phase|Investigator's Discretion|0|||
164055998|NCT01497899|592565022|FG003|Double-Blind Phase|Investigator's Discretion|0|||
164055999|NCT01497899|592565019|FG000|Double-Blind Phase|Withdrew Consent|0|||
164056000|NCT01497899|592565020|FG001|Double-Blind Phase|Withdrew Consent|1|||
164056001|NCT01497899|592565021|FG002|Double-Blind Phase|Withdrew Consent|0|||
164101617|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
164101618|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
164101619|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
164101620|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
164101621|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101622|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101623|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101624|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164056002|NCT01497899|592565022|FG003|Double-Blind Phase|Withdrew Consent|0|||
164056003|NCT01497899|592565019|FG000|Double-Blind Phase|Lost to Follow-up|3|||
164056004|NCT01497899|592565020|FG001|Double-Blind Phase|Lost to Follow-up|2|||
164056005|NCT01497899|592565021|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164056006|NCT01497899|592565022|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164056007|NCT01497899|592565019|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
164056008|NCT01497899|592565020|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
164056009|NCT01497899|592565021|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
164056010|NCT01497899|592565022|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
164056011|NCT01497899|592565019|FG000|Open-Label Extension Phase|Adverse Event|1|||
164056012|NCT01497899|592565020|FG001|Open-Label Extension Phase|Adverse Event|0|||
164056013|NCT01497899|592565021|FG002|Open-Label Extension Phase|Adverse Event|0|||
164056014|NCT01497899|592565022|FG003|Open-Label Extension Phase|Adverse Event|0|||
164056015|NCT01497899|592565019|FG000|Open-Label Extension Phase|Death|1|||
164056016|NCT01497899|592565020|FG001|Open-Label Extension Phase|Death|0|||
164056017|NCT01497899|592565021|FG002|Open-Label Extension Phase|Death|0|||
164056018|NCT01497899|592565022|FG003|Open-Label Extension Phase|Death|0|||
164056019|NCT01497899|592565019|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
164056020|NCT01497899|592565020|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
164056021|NCT01497899|592565021|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
164056022|NCT01497899|592565022|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
164056023|NCT01497899|592565019|FG000|Open-Label Extension Phase|Pregnancy|0|||
164056024|NCT01497899|592565020|FG001|Open-Label Extension Phase|Pregnancy|1|||
164056025|NCT01497899|592565021|FG002|Open-Label Extension Phase|Pregnancy|1|||
164056026|NCT01497899|592565022|FG003|Open-Label Extension Phase|Pregnancy|0|||
164056027|NCT01497899|592565019|FG000|Open-Label Extension Phase|Protocol Violation|0|||
164056028|NCT01497899|592565020|FG001|Open-Label Extension Phase|Protocol Violation|0|||
164056029|NCT01497899|592565021|FG002|Open-Label Extension Phase|Protocol Violation|1|||
164056030|NCT01497899|592565022|FG003|Open-Label Extension Phase|Protocol Violation|0|||
164056031|NCT01497899|592565019|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
164056032|NCT01497899|592565020|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
164056033|NCT01497899|592565021|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
164056034|NCT01497899|592565022|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
164056035|NCT00082628|592565025|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164056036|NCT00082628|592565026|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
164056037|NCT00082628|592565027|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164056038|NCT00082628|592565028|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164056039|NCT00082628|592565029|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
164056040|NCT00082628|592565025|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
164056041|NCT00082628|592565026|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
164056042|NCT00082628|592565027|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
164101625|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164056043|NCT00082628|592565028|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
164056044|NCT00082628|592565029|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
164056045|NCT00082628|592565025|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
164056046|NCT00082628|592565026|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
164056047|NCT00082628|592565027|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
164056048|NCT00082628|592565028|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
164056049|NCT00082628|592565029|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
164056050|NCT00082628|592565025|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
164056051|NCT00082628|592565026|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
164056052|NCT00082628|592565027|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
164056053|NCT00082628|592565028|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
164056054|NCT00082628|592565029|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
164056055|NCT00082628|592565025|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164056056|NCT00082628|592565026|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164056057|NCT00082628|592565027|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164056058|NCT00082628|592565028|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
164056059|NCT00082628|592565029|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
164056060|NCT00082628|592565025|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164056061|NCT00082628|592565026|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164056062|NCT00082628|592565027|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164056063|NCT00082628|592565028|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
164056064|NCT00082628|592565029|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
164056065|NCT00082628|592565025|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
164056066|NCT00082628|592565026|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
164056067|NCT00082628|592565027|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
164056068|NCT00082628|592565028|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
164056069|NCT00082628|592565029|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
164056070|NCT03481634|592565030|FG000|Overall Study|Withdrawal by Subject|16|||
164056071|NCT03481634|592565031|FG001|Overall Study|Withdrawal by Subject|19|||
164056072|NCT03481634|592565032|FG002|Overall Study|Withdrawal by Subject|14|||
164056073|NCT03481634|592565030|FG000|Overall Study|Protocol Violation|1|||
164056074|NCT03481634|592565031|FG001|Overall Study|Protocol Violation|0|||
164056075|NCT03481634|592565032|FG002|Overall Study|Protocol Violation|1|||
164056076|NCT03481634|592565030|FG000|Overall Study|Progressive disease|0|||
164056077|NCT03481634|592565031|FG001|Overall Study|Progressive disease|1|||
164056078|NCT03481634|592565032|FG002|Overall Study|Progressive disease|0|||
164056079|NCT03481634|592565030|FG000|Overall Study|Physician Decision|3|||
164056080|NCT03481634|592565031|FG001|Overall Study|Physician Decision|0|||
164056081|NCT03481634|592565032|FG002|Overall Study|Physician Decision|1|||
164056082|NCT03481634|592565030|FG000|Overall Study|Lost to Follow-up|3|||
164056083|NCT03481634|592565031|FG001|Overall Study|Lost to Follow-up|4|||
164056084|NCT03481634|592565032|FG002|Overall Study|Lost to Follow-up|4|||
164056085|NCT03481634|592565030|FG000|Overall Study|Death|4|||
164056086|NCT03481634|592565031|FG001|Overall Study|Death|8|||
164056087|NCT03481634|592565032|FG002|Overall Study|Death|7|||
164056088|NCT03481634|592565030|FG000|Overall Study|Adverse Event|6|||
164056089|NCT03481634|592565031|FG001|Overall Study|Adverse Event|3|||
164056090|NCT03481634|592565032|FG002|Overall Study|Adverse Event|7|||
164056091|NCT01874288|592565033|FG000|Overall Study|Withdrawal by Subject|1|||
164056092|NCT01874288|592565034|FG001|Overall Study|Withdrawal by Subject|0|||
164056093|NCT01874288|592565035|FG002|Overall Study|Withdrawal by Subject|2|||
164056094|NCT01874288|592565036|FG003|Overall Study|Withdrawal by Subject|1|||
164056095|NCT01874288|592565037|FG004|Overall Study|Withdrawal by Subject|1|||
164056096|NCT01874288|592565033|FG000|Overall Study|Physician Decision|0|||
164101626|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101627|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101628|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101629|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101630|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101631|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101632|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101633|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101634|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101635|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164101636|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164056097|NCT01874288|592565034|FG001|Overall Study|Physician Decision|0|||
164056098|NCT01874288|592565035|FG002|Overall Study|Physician Decision|0|||
164056099|NCT01874288|592565036|FG003|Overall Study|Physician Decision|1|||
164056100|NCT01874288|592565037|FG004|Overall Study|Physician Decision|0|||
164056101|NCT01874288|592565033|FG000|Overall Study|Progressive disease|2|||
164056102|NCT01874288|592565034|FG001|Overall Study|Progressive disease|0|||
164101637|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
164056103|NCT01874288|592565035|FG002|Overall Study|Progressive disease|3|||
164056104|NCT01874288|592565036|FG003|Overall Study|Progressive disease|5|||
164056105|NCT01874288|592565037|FG004|Overall Study|Progressive disease|1|||
164056106|NCT03099304|592565038|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
164056107|NCT03099304|592565039|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
164056108|NCT03099304|592565040|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
164056109|NCT03099304|592565041|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
164056110|NCT03099304|592565042|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
164056111|NCT03099304|592565043|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
164056112|NCT03099304|592565038|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
164056113|NCT03099304|592565039|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
164056114|NCT03099304|592565040|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164056115|NCT03099304|592565041|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164056116|NCT03099304|592565042|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164056117|NCT03099304|592565043|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
164056118|NCT03099304|592565038|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
164056119|NCT03099304|592565039|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
164056120|NCT03099304|592565040|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
164056121|NCT03099304|592565041|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
164056122|NCT03099304|592565042|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
164056123|NCT03099304|592565043|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
164056124|NCT03099304|592565038|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
164056125|NCT03099304|592565039|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
164056126|NCT03099304|592565040|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
164056127|NCT03099304|592565041|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
164056128|NCT03099304|592565042|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
164056129|NCT03099304|592565043|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
164056130|NCT03099304|592565038|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164056131|NCT03099304|592565039|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164056132|NCT03099304|592565040|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
164056133|NCT03099304|592565041|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
164056134|NCT03099304|592565042|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164056135|NCT03099304|592565043|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
164056136|NCT03099304|592565038|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164056137|NCT03099304|592565039|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164056138|NCT03099304|592565040|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
164056139|NCT03099304|592565041|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164056140|NCT03099304|592565042|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164056141|NCT03099304|592565043|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
164056142|NCT03099304|592565038|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
164056143|NCT03099304|592565039|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
164056144|NCT03099304|592565040|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
164056145|NCT03099304|592565041|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
164056146|NCT03099304|592565042|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
164056147|NCT03099304|592565043|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
164056148|NCT03099304|592565038|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
164056149|NCT03099304|592565039|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
164056150|NCT03099304|592565040|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
164056151|NCT03099304|592565041|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
164056152|NCT03099304|592565042|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
164056153|NCT03099304|592565043|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
164056154|NCT03099304|592565038|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164056155|NCT03099304|592565039|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164056156|NCT03099304|592565040|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164056157|NCT03099304|592565041|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
164056158|NCT03099304|592565042|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
164056159|NCT03099304|592565043|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
164056160|NCT03099304|592565038|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
164056161|NCT03099304|592565039|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
164056162|NCT03099304|592565040|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
164056163|NCT03099304|592565041|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
164056164|NCT03099304|592565042|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
164056165|NCT03099304|592565043|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
164056166|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
164101638|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
164056167|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
164056168|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
164056169|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
164056170|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
164056171|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
164056172|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
164056173|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
164056174|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
164056175|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
164056176|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
164056177|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
164056178|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
164056179|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
164056180|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
164056181|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
164056182|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
164056183|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
164056184|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
164056185|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
164056186|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
164056187|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
164056188|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
164056189|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
164056190|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
164056191|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
164056192|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
164056193|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
164056194|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
164056195|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
164056196|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
164056197|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
164056198|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
164056199|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
164056200|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
164056201|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
164056202|NCT03099304|592565038|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
164056203|NCT03099304|592565039|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
164056204|NCT03099304|592565040|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
164056205|NCT03099304|592565041|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
164056206|NCT03099304|592565042|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
164056207|NCT03099304|592565043|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
164056208|NCT01624974|592565044|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
164056209|NCT01624974|592565045|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
164056210|NCT01624974|592565044|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
164056211|NCT01624974|592565045|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
164056212|NCT01624974|592565044|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
164056213|NCT01624974|592565045|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
164056214|NCT01624974|592565044|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
164056215|NCT01624974|592565045|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
164056216|NCT01624974|592565044|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
164056217|NCT01624974|592565045|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
164056218|NCT01624974|592565044|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
164056219|NCT01624974|592565045|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
164056220|NCT01624974|592565044|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
164056221|NCT01624974|592565045|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
164056222|NCT01624974|592565044|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
164056223|NCT01624974|592565045|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
164056224|NCT01624974|592565044|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
164056225|NCT01624974|592565045|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
164056226|NCT01624974|592565044|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
164056227|NCT01624974|592565045|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
164056228|NCT01624974|592565044|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
164056229|NCT01624974|592565045|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
164056230|NCT01624974|592565044|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
164056231|NCT01624974|592565045|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
164056232|NCT02142712|592565046|FG000|Overall Study|Lost to Follow-up|1|||
164056233|NCT02142712|592565047|FG001|Overall Study|Lost to Follow-up|1|||
164056234|NCT02142712|592565048|FG002|Overall Study|Lost to Follow-up|1|||
164056235|NCT02142712|592565049|FG003|Overall Study|Lost to Follow-up|0|||
164056236|NCT00266695|592565050|FG000|Overall Study|Adverse Event|1|||
164056237|NCT00266695|592565050|FG000|Overall Study|Death|9|||
164056238|NCT00266695|592565050|FG000|Overall Study|Physician Decision|1|||
164056239|NCT00266695|592565050|FG000|Overall Study|Lost to Follow-up|3|||
164101639|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
164101640|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
164101641|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
164101642|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101643|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101644|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101645|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101646|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101647|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101648|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101649|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101650|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101651|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101652|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101653|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101654|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101655|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101656|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101657|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101658|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
164101659|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101660|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
164101661|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
164101662|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
164101663|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101664|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101665|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101666|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101667|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101668|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101669|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101670|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101671|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101672|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101673|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101674|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101675|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101676|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101677|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101678|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101679|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101680|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
164101681|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
164101682|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
164101683|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
164101684|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101685|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101686|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101687|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101688|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101689|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101690|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101691|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101692|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101693|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101694|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101695|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101696|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101697|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101698|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101699|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164101700|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
164101701|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164056240|NCT00266695|592565050|FG000|Overall Study|Withdrawal by Subject|15|||
164056241|NCT03480841|592565051|FG000|Overall Study|Lost to Follow-up|2|||
164056242|NCT00606021|592565054|FG000|Induction Phase|Death|73|||
164056243|NCT00606021|592565055|FG001|Induction Phase|Death|0|||
164056244|NCT00606021|592565056|FG002|Induction Phase|Death|0|||
164056245|NCT00606021|592565054|FG000|Induction Phase|Physician Decision|2|||
164056246|NCT00606021|592565055|FG001|Induction Phase|Physician Decision|0|||
164056247|NCT00606021|592565056|FG002|Induction Phase|Physician Decision|0|||
164056248|NCT00606021|592565054|FG000|Induction Phase|Withdrawal by Subject|2|||
164056249|NCT00606021|592565055|FG001|Induction Phase|Withdrawal by Subject|0|||
164056250|NCT00606021|592565056|FG002|Induction Phase|Withdrawal by Subject|0|||
164056251|NCT00606021|592565054|FG000|Induction Phase|Lost to Follow-up|10|||
164056252|NCT00606021|592565055|FG001|Induction Phase|Lost to Follow-up|0|||
164056253|NCT00606021|592565056|FG002|Induction Phase|Lost to Follow-up|0|||
164056254|NCT00606021|592565054|FG000|Maintenance Phase|Death|0|||
164056255|NCT00606021|592565055|FG001|Maintenance Phase|Death|17|||
164056256|NCT00606021|592565056|FG002|Maintenance Phase|Death|15|||
164056257|NCT00606021|592565054|FG000|Maintenance Phase|Physician Decision|0|||
164056258|NCT00606021|592565055|FG001|Maintenance Phase|Physician Decision|1|||
164056259|NCT00606021|592565056|FG002|Maintenance Phase|Physician Decision|0|||
164056260|NCT00606021|592565054|FG000|Maintenance Phase|Lost to Follow-up|0|||
164056261|NCT00606021|592565055|FG001|Maintenance Phase|Lost to Follow-up|5|||
164056262|NCT00606021|592565056|FG002|Maintenance Phase|Lost to Follow-up|2|||
164056263|NCT01362049|592565057|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
164056264|NCT01362049|592565058|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
164056265|NCT01362049|592565059|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
164056266|NCT01362049|592565060|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
164056267|NCT01362049|592565057|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
164056268|NCT01362049|592565058|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
164056269|NCT01362049|592565059|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
164056270|NCT01362049|592565060|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
164056271|NCT00989664|592565065|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
164056272|NCT00989664|592565065|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
164056273|NCT00989664|592565065|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
164056274|NCT00989664|592565065|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
164056275|NCT00989664|592565065|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
164056276|NCT00989664|592565065|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
164056277|NCT00989664|592565065|FG000|Long-Term Follow-Up|Death|3|||
164056278|NCT00095836|592565066|FG000|Overall Study|Lost to Follow-up|1|||
164056279|NCT00095836|592565066|FG000|Overall Study|Adverse Event|1|||
164056280|NCT00095836|592565066|FG000|Overall Study|Death|2|||
164056281|NCT00426842|592565067|FG000|Overall Study|Lost to Follow-up|1|||
164056282|NCT02993783|592565068|FG000|Overall Study|Reason not Specified|6|||
164056283|NCT02993783|592565069|FG001|Overall Study|Reason not Specified|9|||
164056284|NCT02886338|592565070|FG000|Overall Study|Withdrawal by Subject|1|||
164056285|NCT01156012|592565071|FG000|Overall Study|Adverse Event|3|||
164056286|NCT01156012|592565072|FG001|Overall Study|Adverse Event|1|||
164056287|NCT01156012|592565071|FG000|Overall Study|Lost to Follow-up|1|||
164056288|NCT01156012|592565072|FG001|Overall Study|Lost to Follow-up|0|||
164056289|NCT01156012|592565071|FG000|Overall Study|Withdrawal by Subject|1|||
164056290|NCT01156012|592565072|FG001|Overall Study|Withdrawal by Subject|0|||
164056291|NCT01156012|592565071|FG000|Overall Study|use of commercial drug instead of study|0|||
164056292|NCT01156012|592565072|FG001|Overall Study|use of commercial drug instead of study|1|||
164056293|NCT01156012|592565071|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
164056294|NCT01156012|592565072|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
164056295|NCT01707667|592567611|FG000|Period 1|expulsion of colonic sensor catheter|1|||
164056296|NCT01707667|592567612|FG001|Period 1|expulsion of colonic sensor catheter|0|||
164056297|NCT03802331|592567613|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
164056298|NCT03802331|592567614|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
164056299|NCT03432819|592567618|FG000|Overall Study|Lost to Follow-up|2|||
164056300|NCT03432819|592567619|FG001|Overall Study|Lost to Follow-up|2|||
164056301|NCT03432819|592567618|FG000|Overall Study|Withdrawal by Subject|5|||
164056302|NCT03432819|592567619|FG001|Overall Study|Withdrawal by Subject|3|||
164056303|NCT02135848|592567620|FG000|Overall Study|Adverse Event|2|||
164056304|NCT02135848|592567621|FG001|Overall Study|Adverse Event|0|||
164056305|NCT02135848|592567620|FG000|Overall Study|Withdrawal by Subject|1|||
164056306|NCT02135848|592567621|FG001|Overall Study|Withdrawal by Subject|1|||
164056307|NCT00265382|592567622|FG000|Overall Study|Adverse Event|21|||
164056308|NCT00265382|592567622|FG000|Overall Study|Laboratory Abnormality|1|||
164056309|NCT00265382|592567622|FG000|Overall Study|Lost to Follow-up|3|||
164056310|NCT00265382|592567622|FG000|Overall Study|Lack of Efficacy|6|||
164056311|NCT00265382|592567622|FG000|Overall Study|Miscellaneous|6|||
164056312|NCT00265382|592567622|FG000|Overall Study|Withdrawal by Subject|13|||
164101702|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
164056313|NCT00265382|592567622|FG000|Overall Study|Study terminated by sponsor|94|||
164056314|NCT00265382|592567622|FG000|Overall Study|Death|1|||
164056315|NCT01474993|592567627|FG000|Overall Study|Lost to Follow-up|1|||
164056316|NCT01474993|592567628|FG001|Overall Study|Lost to Follow-up|2|||
164056317|NCT01474993|592567627|FG000|Overall Study|Adverse Event|0|||
164056318|NCT01474993|592567628|FG001|Overall Study|Adverse Event|1|||
164056319|NCT00760994|592567631|FG000|Overall Study|Lost to Follow-up|4|||
164056320|NCT00760994|592567632|FG001|Overall Study|Lost to Follow-up|4|||
164056321|NCT00760994|592567633|FG002|Overall Study|Lost to Follow-up|3|||
164056322|NCT03258710|592567634|FG000|Overall Study|Adverse Event|1|||
164056323|NCT03258710|592567634|FG000|Overall Study|Protocol-defined stopping criteria|1|||
164056324|NCT03258710|592567634|FG000|Overall Study|Physician Decision|1|||
164056325|NCT03451630|592567635|FG000|Overall Study|Death|15|||
164056326|NCT03451630|592567636|FG001|Overall Study|Death|16|||
164056327|NCT03451630|592567637|FG002|Overall Study|Death|11|||
164056328|NCT03451630|592567635|FG000|Overall Study|Lost to Follow-up|9|||
164056329|NCT03451630|592567636|FG001|Overall Study|Lost to Follow-up|0|||
164056330|NCT03451630|592567637|FG002|Overall Study|Lost to Follow-up|4|||
164056331|NCT03451630|592567635|FG000|Overall Study|Withdrawal by Subject|0|||
164056332|NCT03451630|592567636|FG001|Overall Study|Withdrawal by Subject|3|||
164056333|NCT03451630|592567637|FG002|Overall Study|Withdrawal by Subject|0|||
164056334|NCT03451630|592567635|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
164056335|NCT03451630|592567636|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
164056336|NCT03451630|592567637|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
164056337|NCT02041533|592567639|FG000|Pre-Treatment Period|Disease Progression|1|||
164056338|NCT02041533|592567640|FG001|Pre-Treatment Period|Disease Progression|1|||
164056339|NCT02041533|592567639|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
164056340|NCT02041533|592567640|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
164056341|NCT02041533|592567639|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
164056342|NCT02041533|592567640|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
164056343|NCT02041533|592567639|FG000|Treatment Period|Disease progression|189|||
164056344|NCT02041533|592567640|FG001|Treatment Period|Disease progression|146|||
164056345|NCT02041533|592567639|FG000|Treatment Period|Study drug toxicity|30|||
164056346|NCT02041533|592567640|FG001|Treatment Period|Study drug toxicity|34|||
164056347|NCT02041533|592567639|FG000|Treatment Period|Death|1|||
164056348|NCT02041533|592567640|FG001|Treatment Period|Death|0|||
164056349|NCT02041533|592567639|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
164056350|NCT02041533|592567640|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
164056351|NCT02041533|592567639|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
164056352|NCT02041533|592567640|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
164056353|NCT02041533|592567639|FG000|Treatment Period|Participant withdrew consent|2|||
164056354|NCT02041533|592567640|FG001|Treatment Period|Participant withdrew consent|2|||
164056355|NCT02041533|592567639|FG000|Treatment Period|Maximum clinical benefit|0|||
164056356|NCT02041533|592567640|FG001|Treatment Period|Maximum clinical benefit|18|||
164056357|NCT02041533|592567639|FG000|Treatment Period|Poor/Non-compliance|1|||
164056358|NCT02041533|592567640|FG001|Treatment Period|Poor/Non-compliance|0|||
164056359|NCT02041533|592567639|FG000|Treatment Period|Administrative reason by sponsor|1|||
164056360|NCT02041533|592567640|FG001|Treatment Period|Administrative reason by sponsor|0|||
164056361|NCT02041533|592567639|FG000|Treatment Period|Other reasons|9|||
164056362|NCT02041533|592567640|FG001|Treatment Period|Other reasons|2|||
164056363|NCT02041533|592567639|FG000|Treatment Period|Not Reported|0|||
164056364|NCT02041533|592567640|FG001|Treatment Period|Not Reported|1|||
164056365|NCT00545740|592567641|FG000|Overall Study|Lack of Efficacy|34|||
164056366|NCT00545740|592567642|FG001|Overall Study|Lack of Efficacy|35|||
164056367|NCT00545740|592567643|FG002|Overall Study|Lack of Efficacy|47|||
164056368|NCT00545740|592567644|FG003|Overall Study|Lack of Efficacy|36|||
164056369|NCT00545740|592567641|FG000|Overall Study|Withdrawal by Subject|17|||
164056370|NCT00545740|592567642|FG001|Overall Study|Withdrawal by Subject|15|||
164056371|NCT00545740|592567643|FG002|Overall Study|Withdrawal by Subject|16|||
164056372|NCT00545740|592567644|FG003|Overall Study|Withdrawal by Subject|18|||
164056373|NCT00545740|592567641|FG000|Overall Study|Adverse Event|10|||
164056374|NCT00545740|592567642|FG001|Overall Study|Adverse Event|18|||
164056375|NCT00545740|592567643|FG002|Overall Study|Adverse Event|19|||
164056376|NCT00545740|592567644|FG003|Overall Study|Adverse Event|9|||
164056377|NCT00545740|592567641|FG000|Overall Study|Lost to Follow-up|7|||
164056378|NCT00545740|592567642|FG001|Overall Study|Lost to Follow-up|5|||
164056379|NCT00545740|592567643|FG002|Overall Study|Lost to Follow-up|5|||
164056380|NCT00545740|592567644|FG003|Overall Study|Lost to Follow-up|6|||
164056381|NCT00545740|592567641|FG000|Overall Study|Protocol Violation|1|||
164056382|NCT00545740|592567642|FG001|Overall Study|Protocol Violation|3|||
164056383|NCT00545740|592567643|FG002|Overall Study|Protocol Violation|1|||
164056384|NCT00545740|592567644|FG003|Overall Study|Protocol Violation|0|||
164056385|NCT00545740|592567641|FG000|Overall Study|Non-compliance|0|||
164056386|NCT00545740|592567642|FG001|Overall Study|Non-compliance|2|||
164056387|NCT00545740|592567643|FG002|Overall Study|Non-compliance|1|||
164056388|NCT00545740|592567644|FG003|Overall Study|Non-compliance|0|||
164056389|NCT00545740|592567641|FG000|Overall Study|Moved|2|||
164056390|NCT00545740|592567642|FG001|Overall Study|Moved|0|||
164056391|NCT00545740|592567643|FG002|Overall Study|Moved|1|||
164056392|NCT00545740|592567644|FG003|Overall Study|Moved|0|||
164056393|NCT00545740|592567641|FG000|Overall Study|Diverticulitis attack|0|||
164056394|NCT00545740|592567642|FG001|Overall Study|Diverticulitis attack|0|||
164056395|NCT00545740|592567643|FG002|Overall Study|Diverticulitis attack|1|||
164056396|NCT00545740|592567644|FG003|Overall Study|Diverticulitis attack|1|||
164056397|NCT00545740|592567641|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
164056398|NCT00545740|592567642|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
164056399|NCT00545740|592567643|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
164056400|NCT00545740|592567644|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
164056401|NCT00545740|592567641|FG000|Overall Study|Site closure|1|||
164056402|NCT00545740|592567642|FG001|Overall Study|Site closure|0|||
164056403|NCT00545740|592567643|FG002|Overall Study|Site closure|0|||
164056404|NCT00545740|592567644|FG003|Overall Study|Site closure|0|||
164056405|NCT00545740|592567641|FG000|Overall Study|Missed visit|1|||
164056406|NCT00545740|592567642|FG001|Overall Study|Missed visit|0|||
164056407|NCT00545740|592567643|FG002|Overall Study|Missed visit|0|||
164056408|NCT00545740|592567644|FG003|Overall Study|Missed visit|0|||
164056409|NCT00545740|592567641|FG000|Overall Study|Physician Decision|0|||
164056410|NCT00545740|592567642|FG001|Overall Study|Physician Decision|0|||
164056411|NCT00545740|592567643|FG002|Overall Study|Physician Decision|3|||
164056412|NCT00545740|592567644|FG003|Overall Study|Physician Decision|0|||
164056413|NCT00545740|592567641|FG000|Overall Study|Accepted only monthly telephone calls|1|||
164056414|NCT00545740|592567642|FG001|Overall Study|Accepted only monthly telephone calls|0|||
164056415|NCT00545740|592567643|FG002|Overall Study|Accepted only monthly telephone calls|0|||
164056416|NCT00545740|592567644|FG003|Overall Study|Accepted only monthly telephone calls|0|||
164056417|NCT00545740|592567641|FG000|Overall Study|Sponsor decision|0|||
164056418|NCT00545740|592567642|FG001|Overall Study|Sponsor decision|1|||
164056419|NCT00545740|592567643|FG002|Overall Study|Sponsor decision|0|||
164056420|NCT00545740|592567644|FG003|Overall Study|Sponsor decision|0|||
164056421|NCT00545740|592567641|FG000|Overall Study|Lack of time|0|||
164056422|NCT00545740|592567642|FG001|Overall Study|Lack of time|1|||
164056423|NCT00545740|592567643|FG002|Overall Study|Lack of time|0|||
164056424|NCT00545740|592567644|FG003|Overall Study|Lack of time|0|||
164056425|NCT00545740|592567641|FG000|Overall Study|Non-adherence to visits|0|||
164056426|NCT00545740|592567642|FG001|Overall Study|Non-adherence to visits|1|||
164056427|NCT00545740|592567643|FG002|Overall Study|Non-adherence to visits|0|||
164056428|NCT00545740|592567644|FG003|Overall Study|Non-adherence to visits|0|||
164056429|NCT00545740|592567641|FG000|Overall Study|Patient difficulties|0|||
164056430|NCT00545740|592567642|FG001|Overall Study|Patient difficulties|1|||
164056431|NCT00545740|592567643|FG002|Overall Study|Patient difficulties|0|||
164056432|NCT00545740|592567644|FG003|Overall Study|Patient difficulties|0|||
164056433|NCT00545740|592567641|FG000|Overall Study|Husband against study|0|||
164056434|NCT00545740|592567642|FG001|Overall Study|Husband against study|0|||
164056435|NCT00545740|592567643|FG002|Overall Study|Husband against study|1|||
164056436|NCT00545740|592567644|FG003|Overall Study|Husband against study|0|||
164056437|NCT02117024|592567645|FG000|Overall Study|Progressive Disease|26|||
164056438|NCT02117024|592567646|FG001|Overall Study|Progressive Disease|9|||
164056439|NCT02117024|592567645|FG000|Overall Study|Significant Clinical Progression|7|||
164056440|NCT02117024|592567646|FG001|Overall Study|Significant Clinical Progression|4|||
164056441|NCT02117024|592567645|FG000|Overall Study|Death|5|||
164056442|NCT02117024|592567646|FG001|Overall Study|Death|0|||
164056443|NCT02117024|592567645|FG000|Overall Study|Withdrawal by Subject|3|||
164056444|NCT02117024|592567646|FG001|Overall Study|Withdrawal by Subject|1|||
164056445|NCT02117024|592567645|FG000|Overall Study|Protocol Violation|1|||
164056446|NCT02117024|592567646|FG001|Overall Study|Protocol Violation|0|||
164056447|NCT02117024|592567645|FG000|Overall Study|Adverse Event|1|||
164056448|NCT02117024|592567646|FG001|Overall Study|Adverse Event|2|||
164056449|NCT02117024|592567645|FG000|Overall Study|Randomized in Error|1|||
164056450|NCT02117024|592567646|FG001|Overall Study|Randomized in Error|0|||
164056451|NCT02117024|592567645|FG000|Overall Study|Patient returned to primary oncologist|0|||
164056452|NCT02117024|592567646|FG001|Overall Study|Patient returned to primary oncologist|1|||
164056453|NCT02117024|592567645|FG000|Overall Study|Patient took treatment break|0|||
164056454|NCT02117024|592567646|FG001|Overall Study|Patient took treatment break|1|||
164056455|NCT02117024|592567645|FG000|Overall Study|Physician Decision|0|||
164056456|NCT02117024|592567646|FG001|Overall Study|Physician Decision|2|||
164056457|NCT01957111|592567647|FG000|Overall Study|Withdrawal by Subject|1|||
164056458|NCT01957111|592567648|FG001|Overall Study|Withdrawal by Subject|1|||
164056459|NCT01646255|592567649|FG000|Overall Study|Adverse Event|7|||
164056460|NCT01646255|592567650|FG001|Overall Study|Adverse Event|8|||
164056461|NCT01646255|592567649|FG000|Overall Study|Lack of Efficacy|2|||
164056462|NCT01646255|592567650|FG001|Overall Study|Lack of Efficacy|0|||
164056463|NCT01646255|592567649|FG000|Overall Study|Withdrawal by Subject|10|||
164056464|NCT01646255|592567650|FG001|Overall Study|Withdrawal by Subject|6|||
164056465|NCT01646255|592567649|FG000|Overall Study|Compliance is not well|1|||
164056466|NCT01646255|592567650|FG001|Overall Study|Compliance is not well|0|||
164056467|NCT01646255|592567649|FG000|Overall Study|Inclusion Criteria Deviation|1|||
164056468|NCT01646255|592567650|FG001|Overall Study|Inclusion Criteria Deviation|0|||
164056469|NCT01468844|592567651|FG000|Overall Study|Adverse Event|1|||
164056470|NCT01468844|592567652|FG001|Overall Study|Adverse Event|0|||
164056471|NCT01468844|592567651|FG000|Overall Study|Withdrawal by Subject|1|||
164056472|NCT01468844|592567652|FG001|Overall Study|Withdrawal by Subject|0|||
164056473|NCT01241318|592567659|FG000|Overall Study|Woman: false pregnancies|27|||
164056474|NCT01241318|592567660|FG001|Overall Study|Woman: false pregnancies|15|||
164056475|NCT01241318|592567659|FG000|Overall Study|Woman: miscarriage/abortion|46|||
164056476|NCT01241318|592567660|FG001|Overall Study|Woman: miscarriage/abortion|38|||
164056477|NCT01241318|592567659|FG000|Overall Study|Withdrawal by Subject|175|||
164056478|NCT01241318|592567660|FG001|Overall Study|Withdrawal by Subject|46|||
164056479|NCT01241318|592567659|FG000|Overall Study|Lost to Follow-up|740|||
164056480|NCT01241318|592567660|FG001|Overall Study|Lost to Follow-up|455|||
164056481|NCT01241318|592567659|FG000|Overall Study|Death|2|||
164056482|NCT01241318|592567660|FG001|Overall Study|Death|4|||
164056483|NCT01241318|592567659|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
164056484|NCT01241318|592567660|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
164056485|NCT01241318|592567659|FG000|Overall Study|Woman: Stillborn infant|129|||
164056486|NCT01241318|592567660|FG001|Overall Study|Woman: Stillborn infant|146|||
164056487|NCT02355665|592567661|FG000|Overall Study|Adverse Event|16|||
164056488|NCT02355665|592567662|FG001|Overall Study|Adverse Event|24|||
164056489|NCT02355665|592567661|FG000|Overall Study|Protocol Violation|2|||
164056490|NCT02355665|592567662|FG001|Overall Study|Protocol Violation|0|||
164056491|NCT02355665|592567661|FG000|Overall Study|Withdrawal by Subject|90|||
164056492|NCT02355665|592567662|FG001|Overall Study|Withdrawal by Subject|100|||
164056493|NCT02355665|592567661|FG000|Overall Study|Lost to Follow-up|131|||
164056494|NCT02355665|592567662|FG001|Overall Study|Lost to Follow-up|103|||
164056495|NCT02355665|592567661|FG000|Overall Study|Death|4|||
164056496|NCT02355665|592567662|FG001|Overall Study|Death|2|||
164056497|NCT02355665|592567661|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
164056498|NCT02355665|592567662|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
164056499|NCT02380703|592567665|FG000|Overall Study|Withdrawal by Subject|12|||
164056500|NCT02380703|592567666|FG001|Overall Study|Withdrawal by Subject|9|||
164056501|NCT02380703|592567665|FG000|Overall Study|Lost to Follow-up|12|||
164056502|NCT02380703|592567666|FG001|Overall Study|Lost to Follow-up|12|||
164056503|NCT02380703|592567665|FG000|Overall Study|Caregiver death|1|||
164056504|NCT02380703|592567666|FG001|Overall Study|Caregiver death|0|||
164056505|NCT02380703|592567665|FG000|Overall Study|Person with dementia (PWD) death|7|||
164056506|NCT02380703|592567666|FG001|Overall Study|Person with dementia (PWD) death|8|||
164056507|NCT02380703|592567665|FG000|Overall Study|Entered Long-term Care|4|||
164056508|NCT02380703|592567666|FG001|Overall Study|Entered Long-term Care|7|||
164056509|NCT03607994|592567667|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
164056510|NCT03607994|592567668|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
164056511|NCT02853318|592567677|FG000|Overall Study|Withdrawal by Subject|1|||
164056512|NCT04490499|592567678|FG000|Overall Study|Withdrawal by Subject|2|||
164056513|NCT01882439|592567684|FG000|Overall Study|Adverse event related to study drug|3|||
164056514|NCT01882439|592567685|FG001|Overall Study|Adverse event related to study drug|8|||
164056515|NCT01882439|592567686|FG002|Overall Study|Adverse event related to study drug|1|||
164056516|NCT01882439|592567687|FG003|Overall Study|Adverse event related to study drug|2|||
164056517|NCT01882439|592567684|FG000|Overall Study|Pregnancy|0|||
164056518|NCT01882439|592567685|FG001|Overall Study|Pregnancy|1|||
164056519|NCT01882439|592567686|FG002|Overall Study|Pregnancy|0|||
164056520|NCT01882439|592567687|FG003|Overall Study|Pregnancy|0|||
164056521|NCT01882439|592567684|FG000|Overall Study|Protocol Violation|2|||
164056522|NCT01882439|592567685|FG001|Overall Study|Protocol Violation|2|||
164056523|NCT01882439|592567686|FG002|Overall Study|Protocol Violation|0|||
164056524|NCT01882439|592567687|FG003|Overall Study|Protocol Violation|1|||
164056525|NCT01882439|592567684|FG000|Overall Study|No longer willing to participate|1|||
164056526|NCT01882439|592567685|FG001|Overall Study|No longer willing to participate|4|||
164056527|NCT01882439|592567686|FG002|Overall Study|No longer willing to participate|2|||
164056528|NCT01882439|592567687|FG003|Overall Study|No longer willing to participate|3|||
164056529|NCT01882439|592567684|FG000|Overall Study|Medication error with no associated AE|0|||
164056530|NCT01882439|592567685|FG001|Overall Study|Medication error with no associated AE|0|||
164056531|NCT01882439|592567686|FG002|Overall Study|Medication error with no associated AE|2|||
164056532|NCT01882439|592567687|FG003|Overall Study|Medication error with no associated AE|0|||
164056533|NCT01882439|592567684|FG000|Overall Study|Insufficient clinical response|1|||
164056534|NCT01882439|592567685|FG001|Overall Study|Insufficient clinical response|4|||
164056535|NCT01882439|592567686|FG002|Overall Study|Insufficient clinical response|4|||
164056536|NCT01882439|592567687|FG003|Overall Study|Insufficient clinical response|2|||
164056537|NCT01882439|592567684|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164056538|NCT01882439|592567685|FG001|Overall Study|Adverse event unrelated to study drug|2|||
164056539|NCT01882439|592567686|FG002|Overall Study|Adverse event unrelated to study drug|1|||
164056540|NCT01882439|592567687|FG003|Overall Study|Adverse event unrelated to study drug|1|||
164056541|NCT03125902|592567692|FG000|Overall Study|Adverse Event|0|||
164056542|NCT03125902|592567693|FG001|Overall Study|Adverse Event|1|||
164056543|NCT03125902|592567692|FG000|Overall Study|Death|119|||
164056544|NCT03125902|592567693|FG001|Overall Study|Death|229|||
164056545|NCT03125902|592567692|FG000|Overall Study|Lost to Follow-up|4|||
164056546|NCT03125902|592567693|FG001|Overall Study|Lost to Follow-up|13|||
164056547|NCT03125902|592567692|FG000|Overall Study|Other|0|||
164056548|NCT03125902|592567693|FG001|Overall Study|Other|4|||
164056549|NCT03125902|592567692|FG000|Overall Study|Physician Decision|2|||
164056550|NCT03125902|592567693|FG001|Overall Study|Physician Decision|1|||
164056551|NCT03125902|592567692|FG000|Overall Study|Progressive Disease|0|||
164056552|NCT03125902|592567693|FG001|Overall Study|Progressive Disease|3|||
164056553|NCT03125902|592567692|FG000|Overall Study|Study Terminated By Sponsor|74|||
164056554|NCT03125902|592567693|FG001|Overall Study|Study Terminated By Sponsor|143|||
164056555|NCT03125902|592567692|FG000|Overall Study|Withdrawal by Subject|21|||
164056556|NCT03125902|592567693|FG001|Overall Study|Withdrawal by Subject|37|||
164056557|NCT01997333|592567694|FG000|Randomization and Treatment|Disease Progression|70|||
164056558|NCT01997333|592567695|FG001|Randomization and Treatment|Disease Progression|159|||
164056559|NCT01997333|592567694|FG000|Randomization and Treatment|Adverse Event|10|||
164056560|NCT01997333|592567695|FG001|Randomization and Treatment|Adverse Event|32|||
164056561|NCT01997333|592567694|FG000|Randomization and Treatment|Physician Decision|0|||
164056562|NCT01997333|592567695|FG001|Randomization and Treatment|Physician Decision|4|||
164056563|NCT01997333|592567694|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
164056564|NCT01997333|592567695|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
164056565|NCT01997333|592567694|FG000|Randomization and Treatment|Did not receive treatment|17|||
164056566|NCT01997333|592567695|FG001|Randomization and Treatment|Did not receive treatment|5|||
164056567|NCT01997333|592567694|FG000|Survival Follow up|Withdrawal by Subject|15|||
164056568|NCT01997333|592567695|FG001|Survival Follow up|Withdrawal by Subject|6|||
164056569|NCT01997333|592567694|FG000|Survival Follow up|Lost to Follow-up|0|||
164056570|NCT01997333|592567695|FG001|Survival Follow up|Lost to Follow-up|6|||
164056571|NCT01997333|592567694|FG000|Survival Follow up|Various|1|||
164056572|NCT01997333|592567695|FG001|Survival Follow up|Various|2|||
164056573|NCT02269709|592567696|FG000|Time of Enrollment|Withdrawal by Subject|3|||
164056574|NCT02269709|592567696|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
164056575|NCT02269709|592567696|FG000|Six Month Follow-up|Lost to Follow-up|12|||
164056576|NCT04411472|592567699|FG000|Overall Study|Adverse Event|5|||
164056577|NCT04411472|592567700|FG001|Overall Study|Adverse Event|10|||
164056578|NCT04411472|592567701|FG002|Overall Study|Adverse Event|1|||
164056579|NCT04411472|592567702|FG003|Overall Study|Adverse Event|0|||
164056580|NCT04411472|592567703|FG004|Overall Study|Adverse Event|0|||
164056581|NCT04411472|592567704|FG005|Overall Study|Adverse Event|0|||
164056582|NCT04411472|592567699|FG000|Overall Study|Protocol Violation|1|||
164056583|NCT04411472|592567700|FG001|Overall Study|Protocol Violation|0|||
164056584|NCT04411472|592567701|FG002|Overall Study|Protocol Violation|0|||
164056585|NCT04411472|592567702|FG003|Overall Study|Protocol Violation|0|||
164056586|NCT04411472|592567703|FG004|Overall Study|Protocol Violation|0|||
164056587|NCT04411472|592567704|FG005|Overall Study|Protocol Violation|0|||
164056588|NCT04411472|592567699|FG000|Overall Study|Withdrawal by Subject|0|||
164056589|NCT04411472|592567700|FG001|Overall Study|Withdrawal by Subject|1|||
164056590|NCT04411472|592567701|FG002|Overall Study|Withdrawal by Subject|0|||
164056591|NCT04411472|592567702|FG003|Overall Study|Withdrawal by Subject|1|||
164056592|NCT04411472|592567703|FG004|Overall Study|Withdrawal by Subject|0|||
164056593|NCT04411472|592567704|FG005|Overall Study|Withdrawal by Subject|0|||
164056594|NCT04411472|592567699|FG000|Overall Study|Physician Decision|1|||
164056595|NCT04411472|592567700|FG001|Overall Study|Physician Decision|0|||
164056596|NCT04411472|592567701|FG002|Overall Study|Physician Decision|0|||
164056597|NCT04411472|592567702|FG003|Overall Study|Physician Decision|0|||
164056598|NCT04411472|592567703|FG004|Overall Study|Physician Decision|0|||
164056599|NCT04411472|592567704|FG005|Overall Study|Physician Decision|0|||
164056600|NCT04411472|592567699|FG000|Overall Study|Study terminated by sponsor|17|||
164056601|NCT04411472|592567700|FG001|Overall Study|Study terminated by sponsor|20|||
164056602|NCT04411472|592567701|FG002|Overall Study|Study terminated by sponsor|3|||
164056603|NCT04411472|592567702|FG003|Overall Study|Study terminated by sponsor|0|||
164056604|NCT04411472|592567703|FG004|Overall Study|Study terminated by sponsor|0|||
164056605|NCT04411472|592567704|FG005|Overall Study|Study terminated by sponsor|0|||
164056606|NCT00440232|592567705|FG000|Overall Study|Lost to Follow-up|1|||
164056607|NCT00440232|592567706|FG001|Overall Study|Lost to Follow-up|1|||
164056608|NCT00440232|592567705|FG000|Overall Study|Unable to treat within allowed time|0|||
164056609|NCT00440232|592567706|FG001|Overall Study|Unable to treat within allowed time|1|||
164056610|NCT00440232|592567705|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
164056611|NCT00440232|592567706|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
164056612|NCT00362297|592567707|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
164056613|NCT00362297|592567708|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
164056614|NCT00819052|592567709|FG000|Overall Study|Adverse Event|0|||
164056615|NCT00819052|592567710|FG001|Overall Study|Adverse Event|5|||
164056616|NCT00819052|592567709|FG000|Overall Study|Protocol Violation|1|||
164056617|NCT00819052|592567710|FG001|Overall Study|Protocol Violation|2|||
164056618|NCT00819052|592567709|FG000|Overall Study|Lost to Follow-up|1|||
164056619|NCT00819052|592567710|FG001|Overall Study|Lost to Follow-up|2|||
164056620|NCT00819052|592567709|FG000|Overall Study|Withdrawal by Subject|1|||
164056621|NCT00819052|592567710|FG001|Overall Study|Withdrawal by Subject|2|||
164056622|NCT00819052|592567709|FG000|Overall Study|Lack of Efficacy|1|||
164056623|NCT00819052|592567710|FG001|Overall Study|Lack of Efficacy|1|||
164056624|NCT00819052|592567709|FG000|Overall Study|Pregnancy|1|||
164056625|NCT00819052|592567710|FG001|Overall Study|Pregnancy|2|||
164056626|NCT00819052|592567709|FG000|Overall Study|Death or events leading to death|1|||
164056627|NCT00819052|592567710|FG001|Overall Study|Death or events leading to death|0|||
164056628|NCT01747655|592567713|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
164056629|NCT01747655|592567714|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
164056630|NCT01747655|592567713|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
164056631|NCT01747655|592567714|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
164056632|NCT01747655|592567713|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
164056633|NCT01747655|592567714|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
164056634|NCT00982111|592567717|FG000|Overall Study|Adverse Event|1|||
164056635|NCT00982111|592567718|FG001|Overall Study|Adverse Event|1|||
164056636|NCT00982111|592567717|FG000|Overall Study|Progressive Disease|46|||
164056637|NCT00982111|592567718|FG001|Overall Study|Progressive Disease|39|||
164056638|NCT00982111|592567717|FG000|Overall Study|Lost to Follow-up|9|||
164056639|NCT00982111|592567718|FG001|Overall Study|Lost to Follow-up|6|||
164056640|NCT00982111|592567717|FG000|Overall Study|New Anti-Cancer Therapy|5|||
164056641|NCT00982111|592567718|FG001|Overall Study|New Anti-Cancer Therapy|5|||
164056642|NCT00982111|592567717|FG000|Overall Study|Medical Decision|1|||
164056643|NCT00982111|592567718|FG001|Overall Study|Medical Decision|0|||
164056644|NCT00982111|592567717|FG000|Overall Study|Withdrawal by Subject|17|||
164056645|NCT00982111|592567718|FG001|Overall Study|Withdrawal by Subject|19|||
164056646|NCT00982111|592567717|FG000|Overall Study|Global Study End|0|||
164056647|NCT00982111|592567718|FG001|Overall Study|Global Study End|1|||
164056648|NCT00982111|592567717|FG000|Overall Study|Sponsor's Decision|0|||
164056649|NCT00982111|592567718|FG001|Overall Study|Sponsor's Decision|1|||
164056650|NCT03769753|592567719|FG000|Overall Study|Not Treated|6|||
164056651|NCT03769753|592567719|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
164056652|NCT01070381|592567720|FG000|Period 2, 1 Week of Wear|Handling|0|||
164056653|NCT01070381|592567721|FG001|Period 2, 1 Week of Wear|Handling|1|||
164056654|NCT01070381|592567720|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
164056655|NCT01070381|592567721|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
164056656|NCT00684073|592567722|FG000|Selection|Selection/non-selection criteria|3|||
164056657|NCT00684073|592567722|FG000|Selection|Death|1|||
164056658|NCT00684073|592567722|FG000|Selection|noncompliance|1|||
164056659|NCT00684073|592567722|FG000|Selection|Lost to Follow-up|1|||
164056660|NCT00684073|592567722|FG000|Selection|request of the sponsor|1|||
164056661|NCT00684073|592567722|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
164056662|NCT01259388|592567724|FG000|Overall Study|Adverse Event|3|||
164056663|NCT01259388|592567725|FG001|Overall Study|Adverse Event|0|||
164056664|NCT01259388|592567724|FG000|Overall Study|Withdrawal by Subject|1|||
164056665|NCT01259388|592567725|FG001|Overall Study|Withdrawal by Subject|1|||
164056666|NCT01259388|592567724|FG000|Overall Study|Physician Decision|1|||
164056667|NCT01259388|592567725|FG001|Overall Study|Physician Decision|0|||
164056668|NCT00620815|592567726|FG000|Overall Study|Adverse Event|1|||
164056669|NCT00620815|592567727|FG001|Overall Study|Adverse Event|1|||
164056670|NCT00620815|592567728|FG002|Overall Study|Adverse Event|2|||
164056671|NCT00620815|592567726|FG000|Overall Study|Withdrawal by Subject|1|||
164056672|NCT00620815|592567727|FG001|Overall Study|Withdrawal by Subject|2|||
164056673|NCT00620815|592567728|FG002|Overall Study|Withdrawal by Subject|0|||
164056674|NCT00620815|592567726|FG000|Overall Study|Lost to Follow-up|1|||
164056675|NCT00620815|592567727|FG001|Overall Study|Lost to Follow-up|6|||
164056676|NCT00620815|592567728|FG002|Overall Study|Lost to Follow-up|3|||
164056677|NCT00620815|592567726|FG000|Overall Study|Inappropriate enrolment|0|||
164056678|NCT00620815|592567727|FG001|Overall Study|Inappropriate enrolment|0|||
164056679|NCT00620815|592567728|FG002|Overall Study|Inappropriate enrolment|1|||
164056680|NCT00620815|592567726|FG000|Overall Study|Protocol Violation|1|||
164056681|NCT00620815|592567727|FG001|Overall Study|Protocol Violation|2|||
164056682|NCT00620815|592567728|FG002|Overall Study|Protocol Violation|1|||
164056683|NCT01230827|592567729|FG000|Overall Study|Lost to Follow-up|0|||
164056684|NCT01230827|592567730|FG001|Overall Study|Lost to Follow-up|0|||
164056685|NCT01230827|592567731|FG002|Overall Study|Lost to Follow-up|1|||
164056686|NCT01230827|592567732|FG003|Overall Study|Lost to Follow-up|3|||
164056687|NCT01230827|592567729|FG000|Overall Study|Withdrawal by Subject|1|||
164056688|NCT01230827|592567730|FG001|Overall Study|Withdrawal by Subject|0|||
164056689|NCT01230827|592567731|FG002|Overall Study|Withdrawal by Subject|3|||
164056690|NCT01230827|592567732|FG003|Overall Study|Withdrawal by Subject|2|||
164056691|NCT01230827|592567729|FG000|Overall Study|Lack of Efficacy|14|||
164056692|NCT01230827|592567730|FG001|Overall Study|Lack of Efficacy|1|||
164056693|NCT01230827|592567731|FG002|Overall Study|Lack of Efficacy|2|||
164056694|NCT01230827|592567732|FG003|Overall Study|Lack of Efficacy|3|||
164056695|NCT01230827|592567729|FG000|Overall Study|Adverse Event|4|||
164056696|NCT01230827|592567730|FG001|Overall Study|Adverse Event|2|||
164056697|NCT01230827|592567731|FG002|Overall Study|Adverse Event|3|||
164056698|NCT01230827|592567732|FG003|Overall Study|Adverse Event|7|||
164056699|NCT01230827|592567729|FG000|Overall Study|Recovery|0|||
164056700|NCT01230827|592567730|FG001|Overall Study|Recovery|6|||
164056701|NCT01230827|592567731|FG002|Overall Study|Recovery|0|||
164056702|NCT01230827|592567732|FG003|Overall Study|Recovery|0|||
164056703|NCT01230827|592567729|FG000|Overall Study|Study terminated by Sponsor|0|||
164056704|NCT01230827|592567730|FG001|Overall Study|Study terminated by Sponsor|2|||
164056705|NCT01230827|592567731|FG002|Overall Study|Study terminated by Sponsor|56|||
164056706|NCT01230827|592567732|FG003|Overall Study|Study terminated by Sponsor|63|||
164056707|NCT00983827|592567733|FG000|Overall Study|Withdrawal by Subject|1|||
164056708|NCT02728804|592567739|FG000|Overall Study|Ineligible|3|||
164056709|NCT02728804|592567739|FG000|Overall Study|Did not complete baseline questionnaire|9|||
164056710|NCT02728804|592567739|FG000|Overall Study|Death|99|||
164056711|NCT01888367|592567740|FG000|Overall Study|Physician Decision|3|||
164056712|NCT01888367|592567741|FG001|Overall Study|Physician Decision|4|||
164056713|NCT01888367|592567742|FG002|Overall Study|Physician Decision|2|||
164056714|NCT01888367|592567740|FG000|Overall Study|Death|2|||
164056715|NCT01888367|592567741|FG001|Overall Study|Death|0|||
164056716|NCT01888367|592567742|FG002|Overall Study|Death|1|||
164056717|NCT01888367|592567740|FG000|Overall Study|Withdrawal by Subject|1|||
164056718|NCT01888367|592567741|FG001|Overall Study|Withdrawal by Subject|0|||
164056719|NCT01888367|592567742|FG002|Overall Study|Withdrawal by Subject|1|||
164056720|NCT01888367|592567740|FG000|Overall Study|Lost to Follow-up|1|||
164056721|NCT01888367|592567741|FG001|Overall Study|Lost to Follow-up|1|||
164056722|NCT01888367|592567742|FG002|Overall Study|Lost to Follow-up|0|||
164056723|NCT01888367|592567740|FG000|Overall Study|Protocol Violation|0|||
164056724|NCT01888367|592567741|FG001|Overall Study|Protocol Violation|0|||
164056725|NCT01888367|592567742|FG002|Overall Study|Protocol Violation|1|||
164056726|NCT01888367|592567740|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
164056727|NCT01888367|592567741|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
164056728|NCT01888367|592567742|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
164056729|NCT00591786|592567743|FG000|Overall Study|Withdrawal of Informed Consent|0|||
164056730|NCT00591786|592567744|FG001|Overall Study|Withdrawal of Informed Consent|0|||
164056731|NCT00591786|592567745|FG002|Overall Study|Withdrawal of Informed Consent|1|||
164056732|NCT00591786|592567746|FG003|Overall Study|Withdrawal of Informed Consent|0|||
164056733|NCT00591786|592567747|FG004|Overall Study|Withdrawal of Informed Consent|0|||
164056734|NCT00591786|592567748|FG005|Overall Study|Withdrawal of Informed Consent|0|||
164056735|NCT00591786|592567749|FG006|Overall Study|Withdrawal of Informed Consent|0|||
164056736|NCT00591786|592567750|FG007|Overall Study|Withdrawal of Informed Consent|0|||
164056737|NCT00591786|592567751|FG008|Overall Study|Withdrawal of Informed Consent|0|||
164056738|NCT00591786|592567752|FG009|Overall Study|Withdrawal of Informed Consent|0|||
164056739|NCT01854918|592567753|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
164056740|NCT01854918|592567754|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
164056741|NCT01854918|592567753|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
164056742|NCT01854918|592567754|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
164056743|NCT01854918|592567753|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
164056744|NCT01854918|592567754|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
164056745|NCT01854918|592567753|FG000|SOC-controlled Period (Year 1)|Death|5|||
164056746|NCT01854918|592567754|FG001|SOC-controlled Period (Year 1)|Death|5|||
164056747|NCT01854918|592567753|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
164056748|NCT01854918|592567754|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
164056749|NCT01854918|592567753|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
164056750|NCT01854918|592567754|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
164056751|NCT01854918|592567753|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
164056752|NCT01854918|592567754|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
164101703|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
164056753|NCT01854918|592567753|FG000|All-IP Period (Years 2 and 3)|Death|5|||
164056754|NCT01854918|592567754|FG001|All-IP Period (Years 2 and 3)|Death|16|||
164056755|NCT01920061|592567758|FG000|Overall Study|Death|1|||
164056756|NCT01920061|592567759|FG001|Overall Study|Death|1|||
164101704|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
164101705|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101706|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164056757|NCT01920061|592567760|FG002|Overall Study|Death|0|||
164056758|NCT01920061|592567761|FG003|Overall Study|Death|1|||
164056759|NCT01920061|592567762|FG004|Overall Study|Death|1|||
164056760|NCT01920061|592567763|FG005|Overall Study|Death|0|||
164056761|NCT01920061|592567764|FG006|Overall Study|Death|0|||
164056762|NCT01920061|592567765|FG007|Overall Study|Death|1|||
164056763|NCT01920061|592567766|FG008|Overall Study|Death|0|||
164056764|NCT01920061|592567767|FG009|Overall Study|Death|1|||
164101707|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101708|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101709|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101710|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101711|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101712|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101713|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101714|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101715|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101716|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101717|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101718|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101719|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101720|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101721|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
164101722|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101723|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
164101724|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
164101725|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
164101726|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101727|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101728|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101729|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101730|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101731|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101732|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101733|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101734|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101735|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101736|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101737|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101738|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101739|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164148636|NCT04895982|592904920|FG009|Overall Study|Lost to Follow-up|0|||
164056765|NCT01920061|592567768|FG010|Overall Study|Death|0|||
164056766|NCT01920061|592567769|FG011|Overall Study|Death|1|||
164056767|NCT01920061|592567770|FG012|Overall Study|Death|0|||
164056768|NCT01920061|592567771|FG013|Overall Study|Death|2|||
164056769|NCT01920061|592567772|FG014|Overall Study|Death|0|||
164056770|NCT01920061|592567773|FG015|Overall Study|Death|0|||
164056771|NCT01920061|592567774|FG016|Overall Study|Death|0|||
164056772|NCT01920061|592567775|FG017|Overall Study|Death|0|||
164056773|NCT01920061|592567776|FG018|Overall Study|Death|1|||
164056774|NCT01920061|592567777|FG019|Overall Study|Death|0|||
164056775|NCT01920061|592567758|FG000|Overall Study|Lost to Follow-up|0|||
164056776|NCT01920061|592567759|FG001|Overall Study|Lost to Follow-up|2|||
164056777|NCT01920061|592567760|FG002|Overall Study|Lost to Follow-up|0|||
164056778|NCT01920061|592567761|FG003|Overall Study|Lost to Follow-up|0|||
164056779|NCT01920061|592567762|FG004|Overall Study|Lost to Follow-up|0|||
164056780|NCT01920061|592567763|FG005|Overall Study|Lost to Follow-up|0|||
164056781|NCT01920061|592567764|FG006|Overall Study|Lost to Follow-up|1|||
164056782|NCT01920061|592567765|FG007|Overall Study|Lost to Follow-up|0|||
164056783|NCT01920061|592567766|FG008|Overall Study|Lost to Follow-up|0|||
164056784|NCT01920061|592567767|FG009|Overall Study|Lost to Follow-up|0|||
164056785|NCT01920061|592567768|FG010|Overall Study|Lost to Follow-up|3|||
164056786|NCT01920061|592567769|FG011|Overall Study|Lost to Follow-up|0|||
164056787|NCT01920061|592567770|FG012|Overall Study|Lost to Follow-up|0|||
164056788|NCT01920061|592567771|FG013|Overall Study|Lost to Follow-up|0|||
164056789|NCT01920061|592567772|FG014|Overall Study|Lost to Follow-up|0|||
164056790|NCT01920061|592567773|FG015|Overall Study|Lost to Follow-up|0|||
164056791|NCT01920061|592567774|FG016|Overall Study|Lost to Follow-up|0|||
164056792|NCT01920061|592567775|FG017|Overall Study|Lost to Follow-up|1|||
164056793|NCT01920061|592567776|FG018|Overall Study|Lost to Follow-up|4|||
164056794|NCT01920061|592567777|FG019|Overall Study|Lost to Follow-up|3|||
164056795|NCT01920061|592567758|FG000|Overall Study|Other|1|||
164056796|NCT01920061|592567759|FG001|Overall Study|Other|1|||
164056797|NCT01920061|592567760|FG002|Overall Study|Other|2|||
164056798|NCT01920061|592567761|FG003|Overall Study|Other|1|||
164056799|NCT01920061|592567762|FG004|Overall Study|Other|0|||
164056800|NCT01920061|592567763|FG005|Overall Study|Other|1|||
164056801|NCT01920061|592567764|FG006|Overall Study|Other|0|||
164056802|NCT01920061|592567765|FG007|Overall Study|Other|0|||
164056803|NCT01920061|592567766|FG008|Overall Study|Other|0|||
164056804|NCT01920061|592567767|FG009|Overall Study|Other|1|||
164056805|NCT01920061|592567768|FG010|Overall Study|Other|1|||
164056806|NCT01920061|592567769|FG011|Overall Study|Other|2|||
164056807|NCT01920061|592567770|FG012|Overall Study|Other|1|||
164056808|NCT01920061|592567771|FG013|Overall Study|Other|4|||
164056809|NCT01920061|592567772|FG014|Overall Study|Other|0|||
164056810|NCT01920061|592567773|FG015|Overall Study|Other|1|||
164056811|NCT01920061|592567774|FG016|Overall Study|Other|1|||
164056812|NCT01920061|592567775|FG017|Overall Study|Other|0|||
164056813|NCT01920061|592567776|FG018|Overall Study|Other|1|||
164056814|NCT01920061|592567777|FG019|Overall Study|Other|1|||
164056815|NCT01920061|592567758|FG000|Overall Study|Participant refused further follow-up|0|||
164056816|NCT01920061|592567759|FG001|Overall Study|Participant refused further follow-up|0|||
164056817|NCT01920061|592567760|FG002|Overall Study|Participant refused further follow-up|0|||
164101740|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101741|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101742|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
164101743|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164101744|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164056818|NCT01920061|592567761|FG003|Overall Study|Participant refused further follow-up|0|||
164056819|NCT01920061|592567762|FG004|Overall Study|Participant refused further follow-up|1|||
164056820|NCT01920061|592567763|FG005|Overall Study|Participant refused further follow-up|1|||
164056821|NCT01920061|592567764|FG006|Overall Study|Participant refused further follow-up|0|||
164056822|NCT01920061|592567765|FG007|Overall Study|Participant refused further follow-up|0|||
164056823|NCT01920061|592567766|FG008|Overall Study|Participant refused further follow-up|1|||
164056824|NCT01920061|592567767|FG009|Overall Study|Participant refused further follow-up|0|||
164056825|NCT01920061|592567768|FG010|Overall Study|Participant refused further follow-up|1|||
164056826|NCT01920061|592567769|FG011|Overall Study|Participant refused further follow-up|0|||
164056827|NCT01920061|592567770|FG012|Overall Study|Participant refused further follow-up|1|||
164056828|NCT01920061|592567771|FG013|Overall Study|Participant refused further follow-up|0|||
164101745|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
164056829|NCT01920061|592567772|FG014|Overall Study|Participant refused further follow-up|1|||
164056830|NCT01920061|592567773|FG015|Overall Study|Participant refused further follow-up|2|||
164056831|NCT01920061|592567774|FG016|Overall Study|Participant refused further follow-up|1|||
164056832|NCT01920061|592567775|FG017|Overall Study|Participant refused further follow-up|1|||
164056833|NCT01920061|592567776|FG018|Overall Study|Participant refused further follow-up|0|||
164056834|NCT01920061|592567777|FG019|Overall Study|Participant refused further follow-up|0|||
164056835|NCT02828982|592567782|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164056836|NCT02828982|592567783|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
164056837|NCT02475564|592567784|FG000|Overall Study|Withdrawal by Subject|1|||
164056838|NCT02475564|592567785|FG001|Overall Study|Withdrawal by Subject|0|||
164056839|NCT02475564|592567784|FG000|Overall Study|Lost to Follow-up|2|||
164056840|NCT02475564|592567785|FG001|Overall Study|Lost to Follow-up|1|||
164056841|NCT02475564|592567784|FG000|Overall Study|Intense Menstrual bleeding|1|||
164056842|NCT02475564|592567785|FG001|Overall Study|Intense Menstrual bleeding|0|||
164056843|NCT02705755|592567786|FG000|Part A (6 Days)|Adverse Event|1|||
164056844|NCT02705755|592567787|FG001|Part A (6 Days)|Adverse Event|0|||
164056845|NCT02705755|592567788|FG002|Part A (6 Days)|Adverse Event|0|||
164056846|NCT02705755|592567789|FG003|Part A (6 Days)|Adverse Event|0|||
164056847|NCT02705755|592567786|FG000|Part A (6 Days)|Physician Decision|3|||
164056848|NCT02705755|592567787|FG001|Part A (6 Days)|Physician Decision|0|||
164056849|NCT02705755|592567788|FG002|Part A (6 Days)|Physician Decision|0|||
164056850|NCT02705755|592567789|FG003|Part A (6 Days)|Physician Decision|0|||
164056851|NCT02705755|592567786|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
164056852|NCT02705755|592567787|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
164056853|NCT02705755|592567788|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
164056854|NCT02705755|592567789|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
164056855|NCT02705755|592567786|FG000|Part C (20 Weeks)|Physician Decision|0|||
164056856|NCT02705755|592567787|FG001|Part C (20 Weeks)|Physician Decision|0|||
164056857|NCT02705755|592567788|FG002|Part C (20 Weeks)|Physician Decision|0|||
164056858|NCT02705755|592567789|FG003|Part C (20 Weeks)|Physician Decision|2|||
164056859|NCT02705755|592567786|FG000|Part C (20 Weeks)|Adverse Event|0|||
164056860|NCT02705755|592567787|FG001|Part C (20 Weeks)|Adverse Event|0|||
164101746|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
164056861|NCT02705755|592567788|FG002|Part C (20 Weeks)|Adverse Event|0|||
164056862|NCT02705755|592567789|FG003|Part C (20 Weeks)|Adverse Event|6|||
164056863|NCT02705755|592567786|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
164056864|NCT02705755|592567787|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
164056865|NCT02705755|592567788|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
164056866|NCT02705755|592567789|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
164056867|NCT01906489|592567790|FG000|Overall Study|Adverse Event|10|||
164056868|NCT01906489|592567791|FG001|Overall Study|Adverse Event|3|||
164056869|NCT01906489|592567790|FG000|Overall Study|Worsening of CKD|6|||
164056870|NCT01906489|592567791|FG001|Overall Study|Worsening of CKD|4|||
164056871|NCT01906489|592567790|FG000|Overall Study|Withdrawal by Subject|5|||
164056872|NCT01906489|592567791|FG001|Overall Study|Withdrawal by Subject|0|||
164056873|NCT01906489|592567790|FG000|Overall Study|Worsening of Anemia|1|||
164056874|NCT01906489|592567791|FG001|Overall Study|Worsening of Anemia|0|||
164056875|NCT01906489|592567790|FG000|Overall Study|Protocol Violation|0|||
164056876|NCT01906489|592567791|FG001|Overall Study|Protocol Violation|1|||
164056877|NCT01906489|592567790|FG000|Overall Study|Non- Compliance|1|||
164056878|NCT01906489|592567791|FG001|Overall Study|Non- Compliance|0|||
164056879|NCT01906489|592567790|FG000|Overall Study|Sponsor Decision|1|||
164056880|NCT01906489|592567791|FG001|Overall Study|Sponsor Decision|0|||
164056881|NCT01906489|592567790|FG000|Overall Study|Lost to Follow-up|1|||
164056882|NCT01906489|592567791|FG001|Overall Study|Lost to Follow-up|1|||
164056883|NCT01906489|592567790|FG000|Overall Study|Other|1|||
164056884|NCT01906489|592567791|FG001|Overall Study|Other|0|||
164056885|NCT03458234|592567792|FG000|Overall Study|Withdrawal by Subject|1|||
164056886|NCT01078389|592569693|FG000|Overall Study|Adverse Event|10|||
164056887|NCT01078389|592569694|FG001|Overall Study|Adverse Event|6|||
164056888|NCT01078389|592569693|FG000|Overall Study|Major Protocol Deviation|2|||
164056889|NCT01078389|592569694|FG001|Overall Study|Major Protocol Deviation|0|||
164056890|NCT01078389|592569693|FG000|Overall Study|Lost to Follow-up|23|||
164056891|NCT01078389|592569694|FG001|Overall Study|Lost to Follow-up|23|||
164056892|NCT01078389|592569693|FG000|Overall Study|Voluntary Withdrawal|20|||
164056893|NCT01078389|592569694|FG001|Overall Study|Voluntary Withdrawal|36|||
164056894|NCT01078389|592569693|FG000|Overall Study|Other|9|||
164056895|NCT01078389|592569694|FG001|Overall Study|Other|2|||
164056896|NCT04823494|592569695|FG000|Overall Study|Programming software malfunction.|1|||
164056897|NCT04823494|592569696|FG001|Overall Study|Programming software malfunction.|0|||
164056898|NCT04823494|592569695|FG000|Overall Study|Withdrawal by Subject|1|||
164056899|NCT04823494|592569696|FG001|Overall Study|Withdrawal by Subject|0|||
164056900|NCT04823494|592569695|FG000|Overall Study|Devices lost|0|||
164056901|NCT04823494|592569696|FG001|Overall Study|Devices lost|1|||
164056902|NCT03726320|592569697|FG000|Overall Study|Lost to Follow-up|2|||
164056903|NCT03726320|592569698|FG001|Overall Study|Lost to Follow-up|4|||
164056904|NCT03726320|592569699|FG002|Overall Study|Lost to Follow-up|0|||
164056905|NCT03726320|592569697|FG000|Overall Study|Time Constraints|4|||
164056906|NCT03726320|592569698|FG001|Overall Study|Time Constraints|1|||
164056907|NCT03726320|592569699|FG002|Overall Study|Time Constraints|0|||
164056908|NCT03726320|592569697|FG000|Overall Study|Ineligible after enrollment|3|||
164056909|NCT03726320|592569698|FG001|Overall Study|Ineligible after enrollment|3|||
164056910|NCT03726320|592569699|FG002|Overall Study|Ineligible after enrollment|0|||
164056911|NCT03726320|592569697|FG000|Overall Study|Clinic / insurance issue|2|||
164056912|NCT03726320|592569698|FG001|Overall Study|Clinic / insurance issue|0|||
164056913|NCT03726320|592569699|FG002|Overall Study|Clinic / insurance issue|0|||
164056914|NCT03726320|592569697|FG000|Overall Study|Language barrier|1|||
164056915|NCT03726320|592569698|FG001|Overall Study|Language barrier|0|||
164056916|NCT03726320|592569699|FG002|Overall Study|Language barrier|0|||
164056917|NCT03726320|592569697|FG000|Overall Study|Provider left the clinic|0|||
164056918|NCT03726320|592569698|FG001|Overall Study|Provider left the clinic|0|||
164056919|NCT03726320|592569699|FG002|Overall Study|Provider left the clinic|1|||
164056920|NCT03691831|592569702|FG000|Overall Study|Lost to Follow-up|16|||
164056921|NCT03691831|592569703|FG001|Overall Study|Lost to Follow-up|12|||
164056922|NCT03691831|592569702|FG000|Overall Study|Withdrawal by Subject|9|||
164056923|NCT03691831|592569703|FG001|Overall Study|Withdrawal by Subject|17|||
164056924|NCT03691831|592569702|FG000|Overall Study|Investigator Decision|2|||
164056925|NCT03691831|592569703|FG001|Overall Study|Investigator Decision|2|||
164056926|NCT02198040|592569704|FG000|Overall Study|Work reasons|0|||
164056927|NCT02198040|592569705|FG001|Overall Study|Work reasons|1|||
164056928|NCT02198040|592569706|FG002|Overall Study|Work reasons|0|||
164056929|NCT02198040|592569704|FG000|Overall Study|Withdrawal by Subject|0|||
164056930|NCT02198040|592569705|FG001|Overall Study|Withdrawal by Subject|0|||
164056931|NCT02198040|592569706|FG002|Overall Study|Withdrawal by Subject|1|||
164056932|NCT00337935|592569707|FG000|Overall Study|Adverse Event|2|||
164056933|NCT00337935|592569708|FG001|Overall Study|Adverse Event|5|||
164056934|NCT00337935|592569707|FG000|Overall Study|Death|2|||
164056935|NCT00337935|592569708|FG001|Overall Study|Death|8|||
164056936|NCT00337935|592569707|FG000|Overall Study|Physician Decision|1|||
164056937|NCT00337935|592569708|FG001|Overall Study|Physician Decision|1|||
164056938|NCT00337935|592569707|FG000|Overall Study|Lost to Follow-up|0|||
164056939|NCT00337935|592569708|FG001|Overall Study|Lost to Follow-up|1|||
164056940|NCT00337935|592569707|FG000|Overall Study|Protocol Violation|4|||
164056941|NCT00337935|592569708|FG001|Overall Study|Protocol Violation|3|||
164056942|NCT00337935|592569707|FG000|Overall Study|Withdrawal by Subject|1|||
164056943|NCT00337935|592569708|FG001|Overall Study|Withdrawal by Subject|7|||
164056944|NCT00337935|592569707|FG000|Overall Study|Other|0|||
164056945|NCT00337935|592569708|FG001|Overall Study|Other|1|||
164056946|NCT00337935|592569707|FG000|Overall Study|Lack of Efficacy|0|||
164056947|NCT00337935|592569708|FG001|Overall Study|Lack of Efficacy|1|||
164056948|NCT01884675|592569709|FG000|Overall Study|Study closed/terminated|3|||
164056949|NCT01884675|592569710|FG001|Overall Study|Study closed/terminated|2|||
164056950|NCT02361307|592569711|FG000|Overall Study|Unstable medical condition.|0|||
164056951|NCT02361307|592569712|FG001|Overall Study|Unstable medical condition.|1|||
164056952|NCT01189201|592569719|FG000|Overall Study|Adverse Event|1|||
164056953|NCT01277757|592569720|FG000|Overall Study|Disease Progression|1|||
164056954|NCT01277757|592569720|FG000|Overall Study|Withdrawal by Subject|1|||
164056955|NCT00240331|592569724|FG000|Overall Study|Withdrawal by Subject|125|||
164056956|NCT00240331|592569725|FG001|Overall Study|Withdrawal by Subject|132|||
164056957|NCT00240331|592569724|FG000|Overall Study|Option selected by investigator|1|||
164056958|NCT00240331|592569725|FG001|Overall Study|Option selected by investigator|2|||
164056959|NCT01409382|592569726|FG000|Overall Study|Lost to Follow-up|1|||
164056960|NCT01409382|592569727|FG001|Overall Study|Lost to Follow-up|1|||
164056961|NCT01409382|592569726|FG000|Overall Study|Protocol Violation|0|||
164056962|NCT01409382|592569727|FG001|Overall Study|Protocol Violation|3|||
164056963|NCT01409382|592569726|FG000|Overall Study|Multiple pregnancy|2|||
164056964|NCT01409382|592569727|FG001|Overall Study|Multiple pregnancy|4|||
164056965|NCT01409382|592569726|FG000|Overall Study|Still pregnant when study ended|13|||
164056966|NCT01409382|592569727|FG001|Overall Study|Still pregnant when study ended|2|||
164056967|NCT01409382|592569726|FG000|Overall Study|Did not manage to get pregnant|64|||
164056968|NCT01409382|592569727|FG001|Overall Study|Did not manage to get pregnant|70|||
164056969|NCT01409382|592569726|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
164056970|NCT01409382|592569727|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
164056971|NCT01233076|592569728|FG000|Period 2, One Week|Lost to Follow-up|1|||
164056972|NCT01233076|592569729|FG001|Period 2, One Week|Lost to Follow-up|0|||
164056973|NCT04563845|592569730|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056974|NCT04563845|592569731|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056975|NCT04563845|592569732|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056976|NCT04563845|592569733|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056977|NCT04563845|592569734|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056978|NCT04563845|592569735|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056979|NCT04563845|592569736|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056980|NCT04563845|592569737|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
164056981|NCT04563845|592569738|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056982|NCT04563845|592569739|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056983|NCT04563845|592569740|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056984|NCT04563845|592569741|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056985|NCT04563845|592569742|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056986|NCT04563845|592569743|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
164056987|NCT04563845|592569730|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056988|NCT04563845|592569731|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056989|NCT04563845|592569732|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056990|NCT04563845|592569733|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056991|NCT04563845|592569734|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
164056992|NCT04563845|592569735|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056993|NCT04563845|592569736|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056994|NCT04563845|592569737|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056995|NCT04563845|592569738|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056996|NCT04563845|592569739|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056997|NCT04563845|592569740|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056998|NCT04563845|592569741|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164056999|NCT04563845|592569742|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164057000|NCT04563845|592569743|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
164057001|NCT04120116|592569744|FG000|Overall Study|Lost to Follow-up|0|||
164057002|NCT04120116|592569745|FG001|Overall Study|Lost to Follow-up|1|||
164057003|NCT04120116|592569746|FG002|Overall Study|Lost to Follow-up|0|||
164057004|NCT04120116|592569747|FG003|Overall Study|Lost to Follow-up|2|||
164057005|NCT04120116|592569744|FG000|Overall Study|Withdrawal by Subject|1|||
164057006|NCT04120116|592569745|FG001|Overall Study|Withdrawal by Subject|0|||
164057007|NCT04120116|592569746|FG002|Overall Study|Withdrawal by Subject|1|||
164057008|NCT04120116|592569747|FG003|Overall Study|Withdrawal by Subject|1|||
164057009|NCT04120116|592569744|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
164057010|NCT04120116|592569745|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
164057011|NCT04120116|592569746|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
164057012|NCT04120116|592569747|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
164057013|NCT02210559|592569752|FG000|Overall Study|Progressive Disease|3|||
164057014|NCT02210559|592569753|FG001|Overall Study|Progressive Disease|2|||
164057015|NCT02210559|592569752|FG000|Overall Study|Adverse Event|2|||
164057016|NCT02210559|592569753|FG001|Overall Study|Adverse Event|2|||
164057017|NCT02210559|592569752|FG000|Overall Study|Physician Decision|1|||
164057018|NCT02210559|592569753|FG001|Overall Study|Physician Decision|0|||
164057019|NCT02210559|592569752|FG000|Overall Study|Withdrawal by Subject|0|||
164057020|NCT02210559|592569753|FG001|Overall Study|Withdrawal by Subject|1|||
164057021|NCT02210559|592569752|FG000|Overall Study|Other than specified|0|||
164057022|NCT02210559|592569753|FG001|Overall Study|Other than specified|1|||
164057023|NCT01287403|592569757|FG000|1st Intervention (1 Day)|Adverse Event|1|||
164057024|NCT01098266|592569758|FG000|Overall Study|Physician Decision|1|||
164057025|NCT01098266|592569759|FG001|Overall Study|Physician Decision|0|||
164057026|NCT01098266|592569758|FG000|Overall Study|Death|3|||
164057027|NCT01098266|592569759|FG001|Overall Study|Death|2|||
164057028|NCT01098266|592569758|FG000|Overall Study|Withdrawal by Subject|3|||
164057029|NCT01098266|592569759|FG001|Overall Study|Withdrawal by Subject|5|||
164057030|NCT01733758|592569760|FG000|Overall Study|Adverse Event|5|||
164057031|NCT01733758|592569761|FG001|Overall Study|Adverse Event|7|||
164057032|NCT01733758|592569762|FG002|Overall Study|Adverse Event|8|||
164057033|NCT01733758|592569763|FG003|Overall Study|Adverse Event|1|||
164057034|NCT01733758|592569760|FG000|Overall Study|Withdrawal by Subject|1|||
164057035|NCT01733758|592569761|FG001|Overall Study|Withdrawal by Subject|1|||
164057036|NCT01733758|592569762|FG002|Overall Study|Withdrawal by Subject|5|||
164057037|NCT01733758|592569763|FG003|Overall Study|Withdrawal by Subject|3|||
164057038|NCT01733758|592569760|FG000|Overall Study|Persistent Hyperglycemia|3|||
164057039|NCT01733758|592569761|FG001|Overall Study|Persistent Hyperglycemia|2|||
164057040|NCT01733758|592569762|FG002|Overall Study|Persistent Hyperglycemia|0|||
164057041|NCT01733758|592569763|FG003|Overall Study|Persistent Hyperglycemia|0|||
164057042|NCT01733758|592569760|FG000|Overall Study|Protocol Violation|0|||
164057043|NCT01733758|592569761|FG001|Overall Study|Protocol Violation|1|||
164057044|NCT01733758|592569762|FG002|Overall Study|Protocol Violation|2|||
164057045|NCT01733758|592569763|FG003|Overall Study|Protocol Violation|2|||
164057046|NCT01733758|592569760|FG000|Overall Study|Non-compliance|1|||
164057047|NCT01733758|592569761|FG001|Overall Study|Non-compliance|0|||
164057048|NCT01733758|592569762|FG002|Overall Study|Non-compliance|0|||
164057049|NCT01733758|592569763|FG003|Overall Study|Non-compliance|0|||
164057050|NCT01733758|592569760|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
164057051|NCT01733758|592569761|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
164057052|NCT01733758|592569762|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
164057053|NCT01733758|592569763|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
164057054|NCT01733758|592569760|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
164057055|NCT01733758|592569761|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
164057056|NCT01733758|592569762|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
164057057|NCT01733758|592569763|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
164057058|NCT02545270|592569768|FG000|Overall Study|technical difficulties|0|||
164057059|NCT02545270|592569769|FG001|Overall Study|technical difficulties|1|||
164057060|NCT02545270|592569770|FG002|Overall Study|technical difficulties|0|||
164057061|NCT02545270|592569768|FG000|Overall Study|Videos being too similar to other|0|||
164057062|NCT02545270|592569769|FG001|Overall Study|Videos being too similar to other|0|||
164057063|NCT02545270|592569770|FG002|Overall Study|Videos being too similar to other|2|||
164057064|NCT00727246|592569771|FG000|Overall Study|could not complete MRI|0|||
164057065|NCT00727246|592569772|FG001|Overall Study|could not complete MRI|1|||
164057066|NCT00727246|592569773|FG002|Overall Study|could not complete MRI|0|||
164057067|NCT00727246|592569774|FG003|Overall Study|could not complete MRI|1|||
164057068|NCT00727246|592569771|FG000|Overall Study|incidental finding|0|||
164057069|NCT00727246|592569772|FG001|Overall Study|incidental finding|0|||
164057070|NCT00727246|592569773|FG002|Overall Study|incidental finding|0|||
164057071|NCT00727246|592569774|FG003|Overall Study|incidental finding|1|||
164057072|NCT00727246|592569771|FG000|Overall Study|withdrawn|0|||
164057073|NCT00727246|592569772|FG001|Overall Study|withdrawn|0|||
164057074|NCT00727246|592569773|FG002|Overall Study|withdrawn|1|||
164057075|NCT00727246|592569774|FG003|Overall Study|withdrawn|0|||
164057076|NCT00661362|592569775|FG000|Overall Study|Adverse Event|5|||
164057077|NCT00661362|592569776|FG001|Overall Study|Adverse Event|4|||
164057078|NCT00661362|592569775|FG000|Overall Study|Incorrect enrollment|2|||
164057079|NCT00661362|592569776|FG001|Overall Study|Incorrect enrollment|0|||
164057080|NCT00661362|592569775|FG000|Overall Study|Study specific discontinuation criteria|4|||
164057081|NCT00661362|592569776|FG001|Overall Study|Study specific discontinuation criteria|11|||
164057082|NCT00661362|592569775|FG000|Overall Study|Withdrawal by Subject|13|||
164057083|NCT00661362|592569776|FG001|Overall Study|Withdrawal by Subject|23|||
164057084|NCT00661362|592569775|FG000|Overall Study|Lost to Follow-up|3|||
164057085|NCT00661362|592569776|FG001|Overall Study|Lost to Follow-up|1|||
164057086|NCT00661362|592569775|FG000|Overall Study|Severe non-compliance to protocol|0|||
164057087|NCT00661362|592569776|FG001|Overall Study|Severe non-compliance to protocol|1|||
164057088|NCT00661362|592569775|FG000|Overall Study|Safety reasons|1|||
164057089|NCT00661362|592569776|FG001|Overall Study|Safety reasons|0|||
164057090|NCT00661362|592569775|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
164057091|NCT00661362|592569776|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
164057092|NCT00535262|592569779|FG000|Overall Study|No funding|3|||
164057093|NCT04382066|592569782|FG000|Overall Study|Adverse Event|1|||
164057094|NCT04382066|592569783|FG001|Overall Study|Adverse Event|0|||
164057095|NCT04382066|592569784|FG002|Overall Study|Adverse Event|0|||
164057096|NCT04382066|592569782|FG000|Overall Study|Death|1|||
164057097|NCT04382066|592569783|FG001|Overall Study|Death|0|||
164057098|NCT04382066|592569784|FG002|Overall Study|Death|1|||
164057099|NCT04738123|592569785|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
164057100|NCT04738123|592569786|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
164057101|NCT04738123|592569785|FG000|Overall Study|Progressive Disease|0|||
164057102|NCT04738123|592569786|FG001|Overall Study|Progressive Disease|4|||
164057103|NCT04738123|592569785|FG000|Overall Study|Adverse Event|8|||
164057104|NCT04738123|592569786|FG001|Overall Study|Adverse Event|7|||
164057105|NCT04738123|592569785|FG000|Overall Study|Other Reasons|0|||
164057106|NCT04738123|592569786|FG001|Overall Study|Other Reasons|1|||
164057107|NCT04738123|592569785|FG000|Overall Study|Suicidal or assaultive behavior|0|||
164057108|NCT04738123|592569786|FG001|Overall Study|Suicidal or assaultive behavior|2|||
164057109|NCT04738123|592569785|FG000|Overall Study|Protocol Violation|2|||
164057110|NCT04738123|592569786|FG001|Overall Study|Protocol Violation|2|||
164057111|NCT04738123|592569785|FG000|Overall Study|Consent Withdrawn|35|||
164057112|NCT04738123|592569786|FG001|Overall Study|Consent Withdrawn|22|||
164057113|NCT00787527|592569787|FG000|Overall Study|Toxicity|3|||
164057114|NCT00083616|592569790|FG000|Overall Study|Disease Progression|16|||
164057115|NCT00083616|592569790|FG000|Overall Study|Lost to Follow-up|1|||
164057116|NCT00083616|592569790|FG000|Overall Study|Physician Decision|2|||
164057117|NCT00083616|592569790|FG000|Overall Study|Withdrawal by Subject|3|||
164057118|NCT00083616|592569790|FG000|Overall Study|Ineligibility determined|2|||
164057119|NCT00083616|592569790|FG000|Overall Study|Non-compliance|1|||
164057120|NCT00083616|592569790|FG000|Overall Study|Other|6|||
164057121|NCT01724021|592569791|FG000|Overall Study|Adverse Event|11|||
164057122|NCT01724021|592569792|FG001|Overall Study|Adverse Event|6|||
164057123|NCT01724021|592569791|FG000|Overall Study|Death|46|||
164057124|NCT01724021|592569792|FG001|Overall Study|Death|58|||
164057125|NCT01724021|592569791|FG000|Overall Study|Participant request/ Withdrew consent|18|||
164057126|NCT01724021|592569792|FG001|Overall Study|Participant request/ Withdrew consent|14|||
164057127|NCT01724021|592569791|FG000|Overall Study|Lost to Follow-up|15|||
164057128|NCT01724021|592569792|FG001|Overall Study|Lost to Follow-up|15|||
164057129|NCT01724021|592569791|FG000|Overall Study|Reason Not Specified|36|||
164057130|NCT01724021|592569792|FG001|Overall Study|Reason Not Specified|39|||
164057131|NCT01724021|592569791|FG000|Overall Study|Missing|1|||
164057132|NCT01724021|592569792|FG001|Overall Study|Missing|1|||
164057133|NCT02500706|592569795|FG000|Overall Study|Adverse Event|0|||
164057134|NCT02500706|592569796|FG001|Overall Study|Adverse Event|0|||
164057135|NCT02500706|592569797|FG002|Overall Study|Adverse Event|1|||
164057136|NCT02500706|592569795|FG000|Overall Study|Lost to Follow-up|0|||
164057137|NCT02500706|592569796|FG001|Overall Study|Lost to Follow-up|1|||
164057138|NCT02500706|592569797|FG002|Overall Study|Lost to Follow-up|1|||
164057139|NCT02500706|592569795|FG000|Overall Study|Withdrawal by Subject|4|||
164057140|NCT02500706|592569796|FG001|Overall Study|Withdrawal by Subject|6|||
164057141|NCT02500706|592569797|FG002|Overall Study|Withdrawal by Subject|4|||
164057142|NCT02500706|592569795|FG000|Overall Study|Unclassified|0|||
164057143|NCT02500706|592569796|FG001|Overall Study|Unclassified|0|||
164057144|NCT02500706|592569797|FG002|Overall Study|Unclassified|1|||
164057145|NCT03644173|592569800|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
164057146|NCT03644173|592569800|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
164057147|NCT03644173|592569800|FG000|Participants at the 1-month Follow up|Death|2|||
164057148|NCT03644173|592569800|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
164057149|NCT03323385|592569801|FG000|Overall Study|Withdrawal by Subject|1|||
164057150|NCT03323385|592569802|FG001|Overall Study|Withdrawal by Subject|2|||
164057151|NCT03323385|592569801|FG000|Overall Study|Noncompliance|0|||
164057152|NCT03323385|592569802|FG001|Overall Study|Noncompliance|1|||
164057153|NCT01000311|592569807|FG000|Overall Study|Adverse Event|2|||
164057154|NCT01000311|592569808|FG001|Overall Study|Adverse Event|5|||
164057155|NCT01000311|592569807|FG000|Overall Study|Withdrawal by Subject|16|||
164057156|NCT01000311|592569808|FG001|Overall Study|Withdrawal by Subject|24|||
164057157|NCT01000311|592569807|FG000|Overall Study|Lost to Follow-up|15|||
164057158|NCT01000311|592569808|FG001|Overall Study|Lost to Follow-up|24|||
164057159|NCT01000311|592569807|FG000|Overall Study|Protocol Violation|1|||
164057160|NCT01000311|592569808|FG001|Overall Study|Protocol Violation|2|||
164057161|NCT01000311|592569807|FG000|Overall Study|Inappropriate enrollment|2|||
164057162|NCT01000311|592569808|FG001|Overall Study|Inappropriate enrollment|0|||
164057163|NCT01000311|592569807|FG000|Overall Study|Administrative reason|9|||
164057164|NCT01000311|592569808|FG001|Overall Study|Administrative reason|15|||
164057165|NCT02146352|592569809|FG000|Overall Study|Death|1|||
164057166|NCT02146352|592569809|FG000|Overall Study|Patient entered hospice care|1|||
164057167|NCT02918006|592569810|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
164057168|NCT02918006|592569811|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
164148637|NCT04895982|592904921|FG010|Overall Study|Lost to Follow-up|0|||
164057169|NCT02918006|592569812|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
164057170|NCT02918006|592569810|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
164057171|NCT02918006|592569811|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
164057172|NCT02918006|592569812|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
164057173|NCT02918006|592569810|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
164057174|NCT02918006|592569811|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
164057175|NCT02918006|592569812|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
164057176|NCT02918006|592569810|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
164057177|NCT02918006|592569811|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
164057178|NCT02918006|592569812|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
164057179|NCT02918006|592569810|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
164057180|NCT02918006|592569811|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
164057181|NCT02918006|592569812|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
164057182|NCT02918006|592569810|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
164057183|NCT02918006|592569811|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
164057184|NCT02918006|592569812|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
164057185|NCT02918006|592569810|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
164057186|NCT02918006|592569811|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
164057187|NCT02918006|592569812|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
164057188|NCT02918006|592569810|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
164057189|NCT02918006|592569811|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
164057190|NCT02918006|592569812|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
164057191|NCT02918006|592569810|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
164057192|NCT02918006|592569811|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
164057193|NCT02918006|592569812|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
164057194|NCT03969589|592569813|FG000|Overall Study|Lost to Follow-up|3|||
164057195|NCT03969589|592569814|FG001|Overall Study|Lost to Follow-up|2|||
164057196|NCT03969589|592569813|FG000|Overall Study|Declined Follow-Up|0|||
164057197|NCT03969589|592569814|FG001|Overall Study|Declined Follow-Up|1|||
164057198|NCT03091920|592569819|FG000|Overall Study|Adverse Event|0|||
164057199|NCT03091920|592569820|FG001|Overall Study|Adverse Event|1|||
164057200|NCT03091920|592569821|FG002|Overall Study|Adverse Event|0|||
164057201|NCT00453349|592569822|FG000|Randomized|Adverse Event|12|||
164057202|NCT00453349|592569823|FG001|Randomized|Adverse Event|11|||
164057203|NCT00453349|592569822|FG000|Randomized|Lack of Efficacy|2|||
164057204|NCT00453349|592569823|FG001|Randomized|Lack of Efficacy|1|||
164057205|NCT00453349|592569822|FG000|Randomized|Lost to Follow-up|7|||
164057206|NCT00453349|592569823|FG001|Randomized|Lost to Follow-up|5|||
164057207|NCT00453349|592569822|FG000|Randomized|Protocol Violation|1|||
164057208|NCT00453349|592569823|FG001|Randomized|Protocol Violation|1|||
164057209|NCT00453349|592569822|FG000|Randomized|Withdrawal by Subject|3|||
164057210|NCT00453349|592569823|FG001|Randomized|Withdrawal by Subject|5|||
164057211|NCT00453349|592569822|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
164057212|NCT00453349|592569823|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
164057213|NCT00453349|592569822|FG000|Completed Study|Adverse Event|12|||
164057214|NCT00453349|592569823|FG001|Completed Study|Adverse Event|11|||
164057215|NCT00453349|592569822|FG000|Completed Study|Lack of Efficacy|2|||
164057216|NCT00453349|592569823|FG001|Completed Study|Lack of Efficacy|1|||
164057217|NCT00453349|592569822|FG000|Completed Study|Lost to Follow-up|7|||
164057218|NCT00453349|592569823|FG001|Completed Study|Lost to Follow-up|5|||
164057219|NCT00453349|592569822|FG000|Completed Study|Protocol Violation|1|||
164057220|NCT00453349|592569823|FG001|Completed Study|Protocol Violation|1|||
164057221|NCT00453349|592569822|FG000|Completed Study|Withdrawal by Subject|3|||
164057222|NCT00453349|592569823|FG001|Completed Study|Withdrawal by Subject|5|||
164057223|NCT00453349|592569822|FG000|Completed Study|Lost to follow up after study treatment|2|||
164057224|NCT00453349|592569823|FG001|Completed Study|Lost to follow up after study treatment|11|||
164057225|NCT00805142|592569824|FG000|Titration Period|Adverse Event|3|||
164057226|NCT00805142|592569825|FG001|Titration Period|Adverse Event|3|||
164057227|NCT00805142|592569824|FG000|Titration Period|Lack of Efficacy|1|||
164057228|NCT00805142|592569825|FG001|Titration Period|Lack of Efficacy|1|||
164057229|NCT00805142|592569824|FG000|Titration Period|Lost to Follow-up|0|||
164057230|NCT00805142|592569825|FG001|Titration Period|Lost to Follow-up|1|||
164057231|NCT00805142|592569824|FG000|Titration Period|Disease Progression|2|||
164057232|NCT00805142|592569825|FG001|Titration Period|Disease Progression|1|||
164057233|NCT00805142|592569824|FG000|Titration Period|Withdrawal of consent|0|||
164057234|NCT00805142|592569825|FG001|Titration Period|Withdrawal of consent|1|||
164057235|NCT00805142|592569824|FG000|Titration Period|Other|0|||
164057236|NCT00805142|592569825|FG001|Titration Period|Other|3|||
164057237|NCT00805142|592569824|FG000|Maintenance Period|Adverse Event|0|||
164057238|NCT00805142|592569825|FG001|Maintenance Period|Adverse Event|1|||
164057239|NCT00805142|592569824|FG000|Maintenance Period|Other|0|||
164057240|NCT00805142|592569825|FG001|Maintenance Period|Other|1|||
164057241|NCT00489216|592569827|FG000|Overall Study|Adverse Event|1|||
164057242|NCT00422942|592569830|FG000|Overall Study|Study terminated by Sponsor|3|||
164057243|NCT01513460|592569837|FG000|Overall Study|Death|0|||
164057244|NCT01513460|592569838|FG001|Overall Study|Death|0|||
164057245|NCT01513460|592569839|FG002|Overall Study|Death|1|||
164057246|NCT01513460|592569837|FG000|Overall Study|Lost to Follow-up|0|||
164057247|NCT01513460|592569838|FG001|Overall Study|Lost to Follow-up|0|||
164057248|NCT01513460|592569839|FG002|Overall Study|Lost to Follow-up|2|||
164057249|NCT01513460|592569837|FG000|Overall Study|Abnormal laboratory value|1|||
164057250|NCT01513460|592569838|FG001|Overall Study|Abnormal laboratory value|0|||
164057251|NCT01513460|592569839|FG002|Overall Study|Abnormal laboratory value|1|||
164057252|NCT01513460|592569837|FG000|Overall Study|Lack of Efficacy|1|||
164057253|NCT01513460|592569838|FG001|Overall Study|Lack of Efficacy|2|||
164057254|NCT01513460|592569839|FG002|Overall Study|Lack of Efficacy|5|||
164057255|NCT01513460|592569837|FG000|Overall Study|Protocol deviations|3|||
164057256|NCT01513460|592569838|FG001|Overall Study|Protocol deviations|4|||
164057257|NCT01513460|592569839|FG002|Overall Study|Protocol deviations|3|||
164057258|NCT01513460|592569837|FG000|Overall Study|Withdrawal by Subject|7|||
164057259|NCT01513460|592569838|FG001|Overall Study|Withdrawal by Subject|8|||
164057260|NCT01513460|592569839|FG002|Overall Study|Withdrawal by Subject|21|||
164057261|NCT01513460|592569837|FG000|Overall Study|Adverse Event|16|||
164057262|NCT01513460|592569838|FG001|Overall Study|Adverse Event|18|||
164057263|NCT01513460|592569839|FG002|Overall Study|Adverse Event|23|||
164057264|NCT01513460|592569837|FG000|Overall Study|Abnormal test procedure|1|||
164057265|NCT01513460|592569838|FG001|Overall Study|Abnormal test procedure|0|||
164057266|NCT01513460|592569839|FG002|Overall Study|Abnormal test procedure|0|||
164057267|NCT00965458|592571910|FG000|Overall Study|Adverse Event|1|||
164057268|NCT00965458|592571911|FG001|Overall Study|Adverse Event|0|||
164057269|NCT00965458|592571910|FG000|Overall Study|Lost to Follow-up|1|||
164057270|NCT00965458|592571911|FG001|Overall Study|Lost to Follow-up|3|||
164057271|NCT00965458|592571910|FG000|Overall Study|Withdrawal by Subject|0|||
164057272|NCT00965458|592571911|FG001|Overall Study|Withdrawal by Subject|1|||
164057273|NCT01545375|592571913|FG000|Overall Study|Adverse Event|2|||
164057274|NCT01545375|592571914|FG001|Overall Study|Adverse Event|1|||
164057275|NCT01545375|592571913|FG000|Overall Study|Lost to Follow-up|34|||
164057276|NCT01545375|592571914|FG001|Overall Study|Lost to Follow-up|31|||
164057277|NCT01545375|592571913|FG000|Overall Study|Protocol Violation|3|||
164057278|NCT01545375|592571914|FG001|Overall Study|Protocol Violation|3|||
164057279|NCT01545375|592571913|FG000|Overall Study|Withdrawal by Subject|58|||
164057280|NCT01545375|592571914|FG001|Overall Study|Withdrawal by Subject|55|||
164057281|NCT04177862|592571916|FG000|Overall Study|Protocol Violation|2|||
164057282|NCT04177862|592571917|FG001|Overall Study|Protocol Violation|7|||
164057283|NCT01846039|592571918|FG000|Overall Study|Protocol Violation|1|||
164057284|NCT01846039|592571918|FG000|Overall Study|Subject Withdrew Consent|1|||
164057285|NCT00594958|592571919|FG000|Overall Study|Withdrawal by Subject|1|||
164057286|NCT00594958|592571920|FG001|Overall Study|Withdrawal by Subject|0|||
164057287|NCT00594958|592571921|FG002|Overall Study|Withdrawal by Subject|1|||
164057288|NCT00594958|592571919|FG000|Overall Study|Adverse Event|4|||
164057289|NCT00594958|592571920|FG001|Overall Study|Adverse Event|1|||
164057290|NCT00594958|592571921|FG002|Overall Study|Adverse Event|2|||
164057291|NCT00594958|592571919|FG000|Overall Study|Pregnancy|0|||
164057292|NCT00594958|592571920|FG001|Overall Study|Pregnancy|2|||
164057293|NCT00594958|592571921|FG002|Overall Study|Pregnancy|0|||
164057294|NCT00594958|592571919|FG000|Overall Study|Protocol Violation|1|||
164057295|NCT00594958|592571920|FG001|Overall Study|Protocol Violation|0|||
164057296|NCT00594958|592571921|FG002|Overall Study|Protocol Violation|2|||
164057297|NCT00594958|592571919|FG000|Overall Study|Lost to Follow-up|5|||
164057298|NCT00594958|592571920|FG001|Overall Study|Lost to Follow-up|0|||
164057299|NCT00594958|592571921|FG002|Overall Study|Lost to Follow-up|3|||
164057300|NCT00594958|592571919|FG000|Overall Study|administrative|3|||
164057301|NCT00594958|592571920|FG001|Overall Study|administrative|0|||
164057302|NCT00594958|592571921|FG002|Overall Study|administrative|2|||
164057303|NCT05637515|592571922|FG000|Overall Study|Withdrawal by Subject|17|||
164057304|NCT05637515|592571923|FG001|Overall Study|Withdrawal by Subject|17|||
164057305|NCT03233009|592571924|FG000|Overall Study|Lost to Follow-up|1|||
164057306|NCT04516291|592571926|FG000|Treatment Period (24 Weeks)|Other|1|||
164057307|NCT04516291|592571927|FG001|Treatment Period (24 Weeks)|Other|0|||
164057308|NCT04516291|592571928|FG002|Treatment Period (24 Weeks)|Other|0|||
164057309|NCT04516291|592571929|FG003|Treatment Period (24 Weeks)|Other|2|||
164057310|NCT04516291|592571930|FG004|Treatment Period (24 Weeks)|Other|2|||
164057311|NCT04516291|592571931|FG005|Treatment Period (24 Weeks)|Other|4|||
164057312|NCT04516291|592571932|FG006|Treatment Period (24 Weeks)|Other|2|||
164057313|NCT04516291|592571933|FG007|Treatment Period (24 Weeks)|Other|0|||
164057314|NCT04516291|592571926|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164057315|NCT04516291|592571927|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
164057316|NCT04516291|592571928|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164057317|NCT04516291|592571929|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164057318|NCT04516291|592571930|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164057319|NCT04516291|592571931|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164057320|NCT04516291|592571932|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164057321|NCT04516291|592571933|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164057322|NCT04516291|592571926|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057323|NCT04516291|592571927|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057324|NCT04516291|592571928|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057325|NCT04516291|592571929|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
164057326|NCT04516291|592571930|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057327|NCT04516291|592571931|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057328|NCT04516291|592571932|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057329|NCT04516291|592571933|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
164057330|NCT04516291|592571926|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057331|NCT04516291|592571927|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164057332|NCT04516291|592571928|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057333|NCT04516291|592571929|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057334|NCT04516291|592571930|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057335|NCT04516291|592571931|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057336|NCT04516291|592571932|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057337|NCT04516291|592571933|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164057338|NCT04516291|592571926|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
164057339|NCT04516291|592571927|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
164057340|NCT04516291|592571928|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
164057341|NCT04516291|592571929|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
164057342|NCT04516291|592571930|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
164057343|NCT04516291|592571931|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
164057344|NCT04516291|592571932|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
164057345|NCT04516291|592571933|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
164057346|NCT04516291|592571926|FG000|Follow-up Period (12 Weeks)|Other|0|||
164057347|NCT04516291|592571927|FG001|Follow-up Period (12 Weeks)|Other|1|||
164057348|NCT04516291|592571928|FG002|Follow-up Period (12 Weeks)|Other|0|||
164057349|NCT04516291|592571929|FG003|Follow-up Period (12 Weeks)|Other|2|||
164057350|NCT04516291|592571930|FG004|Follow-up Period (12 Weeks)|Other|0|||
164057351|NCT04516291|592571931|FG005|Follow-up Period (12 Weeks)|Other|0|||
164057352|NCT04516291|592571932|FG006|Follow-up Period (12 Weeks)|Other|0|||
164057353|NCT04516291|592571933|FG007|Follow-up Period (12 Weeks)|Other|0|||
164057354|NCT04516291|592571926|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057355|NCT04516291|592571927|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057356|NCT04516291|592571928|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057357|NCT04516291|592571929|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057358|NCT04516291|592571930|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
164057359|NCT04516291|592571931|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057360|NCT04516291|592571932|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057361|NCT04516291|592571933|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
164057362|NCT04516291|592571926|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
164057363|NCT04516291|592571927|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
164057364|NCT04516291|592571928|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
164057365|NCT04516291|592571929|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
164057366|NCT04516291|592571930|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
164057367|NCT04516291|592571931|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
164057368|NCT04516291|592571932|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
164057369|NCT04516291|592571933|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
164057370|NCT01855607|592571934|FG000|Overall Study|Withdrawal by Subject|1|||
164057371|NCT01855607|592571934|FG000|Overall Study|Study was terminated|11|||
164057372|NCT02181634|592571935|FG000|Overall Study|Lack of Efficacy|33|||
164101747|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164057373|NCT02181634|592571935|FG000|Overall Study|Adverse Event|17|||
164057374|NCT02181634|592571935|FG000|Overall Study|Physician Decision|8|||
164057375|NCT02181634|592571935|FG000|Overall Study|Withdrawal by Subject|5|||
164057376|NCT02181634|592571935|FG000|Overall Study|Death|2|||
164057377|NCT02181634|592571935|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
164057378|NCT02181634|592571935|FG000|Overall Study|Ineligible|1|||
164057379|NCT02181634|592571935|FG000|Overall Study|Max number of dose reduction|1|||
164057380|NCT02181634|592571935|FG000|Overall Study|Symptomatic progression|1|||
164057381|NCT02181634|592571935|FG000|Overall Study|Patient opted to proceed to surgery|1|||
164057382|NCT03824704|592571946|FG000|Overall Study|Study Terminated by Sponsor|1|||
164057383|NCT02155660|592571949|FG000|Overall Study|Other Reason|8|||
164057384|NCT02155660|592571950|FG001|Overall Study|Other Reason|6|||
164057385|NCT02155660|592571951|FG002|Overall Study|Other Reason|10|||
164057386|NCT02155660|592571952|FG003|Overall Study|Other Reason|10|||
164057387|NCT02155660|592571949|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164057388|NCT02155660|592571950|FG001|Overall Study|Study-specific withdrawal criteria|1|||
164057389|NCT02155660|592571951|FG002|Overall Study|Study-specific withdrawal criteria|1|||
164057390|NCT02155660|592571952|FG003|Overall Study|Study-specific withdrawal criteria|1|||
164057391|NCT02155660|592571949|FG000|Overall Study|Severe non-compliance|0|||
164057392|NCT02155660|592571950|FG001|Overall Study|Severe non-compliance|4|||
164057393|NCT02155660|592571951|FG002|Overall Study|Severe non-compliance|0|||
164057394|NCT02155660|592571952|FG003|Overall Study|Severe non-compliance|1|||
164101748|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164057395|NCT02155660|592571949|FG000|Overall Study|Adverse Event|2|||
164057396|NCT02155660|592571950|FG001|Overall Study|Adverse Event|6|||
164057397|NCT02155660|592571951|FG002|Overall Study|Adverse Event|3|||
164057398|NCT02155660|592571952|FG003|Overall Study|Adverse Event|1|||
164057399|NCT02155660|592571949|FG000|Overall Study|Lost to Follow-up|3|||
164057400|NCT02155660|592571950|FG001|Overall Study|Lost to Follow-up|6|||
164057401|NCT02155660|592571951|FG002|Overall Study|Lost to Follow-up|5|||
164057402|NCT02155660|592571952|FG003|Overall Study|Lost to Follow-up|8|||
164057403|NCT02155660|592571949|FG000|Overall Study|Death|17|||
164057404|NCT02155660|592571950|FG001|Overall Study|Death|19|||
164057405|NCT02155660|592571951|FG002|Overall Study|Death|17|||
164057406|NCT02155660|592571952|FG003|Overall Study|Death|19|||
164057407|NCT02155660|592571949|FG000|Overall Study|Withdrawal by Subject|28|||
164057408|NCT02155660|592571950|FG001|Overall Study|Withdrawal by Subject|31|||
164057409|NCT02155660|592571951|FG002|Overall Study|Withdrawal by Subject|24|||
164057410|NCT02155660|592571952|FG003|Overall Study|Withdrawal by Subject|21|||
164057411|NCT03730987|592571953|FG000|Overall Study|Lost to Follow-up|2|||
164057412|NCT03730987|592571954|FG001|Overall Study|Lost to Follow-up|0|||
164057413|NCT03730987|592571955|FG002|Overall Study|Lost to Follow-up|2|||
164057414|NCT03730987|592571956|FG003|Overall Study|Lost to Follow-up|0|||
164057415|NCT02087085|592571957|FG000|Overall Study|Adverse Event|10|||
164057416|NCT02087085|592571958|FG001|Overall Study|Adverse Event|14|||
164057417|NCT02087085|592571957|FG000|Overall Study|Lack of Efficacy|4|||
164057418|NCT02087085|592571958|FG001|Overall Study|Lack of Efficacy|3|||
164057419|NCT02087085|592571957|FG000|Overall Study|Lost to Follow-up|6|||
164057420|NCT02087085|592571958|FG001|Overall Study|Lost to Follow-up|4|||
164057421|NCT02087085|592571957|FG000|Overall Study|Withdrawal by Subject|9|||
164057422|NCT02087085|592571958|FG001|Overall Study|Withdrawal by Subject|11|||
164057423|NCT02087085|592571957|FG000|Overall Study|Protocol Violation|1|||
164057424|NCT02087085|592571958|FG001|Overall Study|Protocol Violation|0|||
164057425|NCT02087085|592571957|FG000|Overall Study|Study Terminated by Sponsor|87|||
164057426|NCT02087085|592571958|FG001|Overall Study|Study Terminated by Sponsor|80|||
164057427|NCT02087085|592571957|FG000|Overall Study|Other Miscellaneous Reasons|3|||
164057428|NCT02087085|592571958|FG001|Overall Study|Other Miscellaneous Reasons|4|||
164057429|NCT02505945|592571959|FG000|Overall Study|Withdrawal by Subject|13|||
164057430|NCT02505945|592571960|FG001|Overall Study|Withdrawal by Subject|2|||
164057431|NCT02505945|592571959|FG000|Overall Study|Adverse Event|1|||
164057432|NCT02505945|592571960|FG001|Overall Study|Adverse Event|0|||
164057433|NCT02505945|592571959|FG000|Overall Study|Physician Decision|2|||
164057434|NCT02505945|592571960|FG001|Overall Study|Physician Decision|1|||
164057435|NCT02505945|592571959|FG000|Overall Study|Lost to Follow-up|6|||
164057436|NCT02505945|592571960|FG001|Overall Study|Lost to Follow-up|1|||
164057437|NCT00635804|592571961|FG000|Overall Study|Adverse Event|0|||
164057438|NCT00635804|592571962|FG001|Overall Study|Adverse Event|0|||
164057439|NCT00635804|592571963|FG002|Overall Study|Adverse Event|0|||
164057440|NCT00635804|592571964|FG003|Overall Study|Adverse Event|0|||
164057441|NCT00635804|592571965|FG004|Overall Study|Adverse Event|0|||
164057442|NCT00635804|592571966|FG005|Overall Study|Adverse Event|1|||
164057443|NCT00635804|592571967|FG006|Overall Study|Adverse Event|0|||
164057444|NCT00635804|592571968|FG007|Overall Study|Adverse Event|0|||
164057445|NCT00635804|592571961|FG000|Overall Study|Withdrawal by Subject|1|||
164057446|NCT00635804|592571962|FG001|Overall Study|Withdrawal by Subject|0|||
164057447|NCT00635804|592571963|FG002|Overall Study|Withdrawal by Subject|0|||
164057448|NCT00635804|592571964|FG003|Overall Study|Withdrawal by Subject|0|||
164057449|NCT00635804|592571965|FG004|Overall Study|Withdrawal by Subject|0|||
164057450|NCT00635804|592571966|FG005|Overall Study|Withdrawal by Subject|0|||
164057451|NCT00635804|592571967|FG006|Overall Study|Withdrawal by Subject|0|||
164057452|NCT00635804|592571968|FG007|Overall Study|Withdrawal by Subject|0|||
164057453|NCT01425268|592571976|FG000|Overall Study|Withdrawal by Subject|2|||
164057454|NCT01425268|592571977|FG001|Overall Study|Withdrawal by Subject|0|||
164057455|NCT01425268|592571976|FG000|Overall Study|Sponsor Decision|5|||
164057456|NCT01425268|592571977|FG001|Overall Study|Sponsor Decision|0|||
164057457|NCT01425268|592571976|FG000|Overall Study|Physician Decision|1|||
164057458|NCT01425268|592571977|FG001|Overall Study|Physician Decision|0|||
164057459|NCT00719706|592571978|FG000|Overall Study|Adverse Event|5|||
164057460|NCT00719706|592571979|FG001|Overall Study|Adverse Event|4|||
164057461|NCT00719706|592571978|FG000|Overall Study|Withdrawal by Subject|1|||
164057462|NCT00719706|592571979|FG001|Overall Study|Withdrawal by Subject|2|||
164057463|NCT00719706|592571978|FG000|Overall Study|Protocol Violation|3|||
164057464|NCT00719706|592571979|FG001|Overall Study|Protocol Violation|0|||
164057465|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
164057466|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
164057467|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
164057468|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
164057469|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
164057470|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
164057471|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
164148638|NCT04895982|592904922|FG011|Overall Study|Lost to Follow-up|0|||
164057472|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
164057473|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
164057474|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
164057475|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
164057476|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
164057477|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
164057478|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
164057479|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
164057480|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|Other|6|||
164057481|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|Other|6|||
164057482|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|Other|7|||
164057483|NCT02681094|592571980|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
164057484|NCT02681094|592571981|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
164057485|NCT02681094|592571982|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
164057486|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|Participant decision|7|||
164057487|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|Participant decision|10|||
164057488|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|Participant decision|9|||
164057489|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
164057490|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
164057491|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
164057492|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
164057493|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
164057494|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
164057495|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
164057496|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
164057497|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
164057498|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
164057499|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
164057500|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
164057501|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|Other|6|||
164057502|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|Other|6|||
164057503|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|Other|7|||
164057504|NCT02681094|592571980|FG000|2 - Enrolled Participants Set|No treatment given|0|||
164057505|NCT02681094|592571981|FG001|2 - Enrolled Participants Set|No treatment given|1|||
164057506|NCT02681094|592571982|FG002|2 - Enrolled Participants Set|No treatment given|1|||
164057507|NCT01072175|592571983|FG000|Part A (Drug-Drug Interaction)|Death|1|||
164057508|NCT01072175|592571984|FG001|Part A (Drug-Drug Interaction)|Death|0|||
164057509|NCT01072175|592571985|FG002|Part A (Drug-Drug Interaction)|Death|0|||
164057510|NCT01072175|592571986|FG003|Part A (Drug-Drug Interaction)|Death|0|||
164057511|NCT01072175|592571987|FG004|Part A (Drug-Drug Interaction)|Death|0|||
164057512|NCT01072175|592571988|FG005|Part A (Drug-Drug Interaction)|Death|0|||
164057513|NCT01072175|592571989|FG006|Part A (Drug-Drug Interaction)|Death|0|||
164057514|NCT01072175|592571990|FG007|Part A (Drug-Drug Interaction)|Death|0|||
164057515|NCT01072175|592571991|FG008|Part A (Drug-Drug Interaction)|Death|0|||
164057516|NCT01072175|592571992|FG009|Part A (Drug-Drug Interaction)|Death|0|||
164057517|NCT01072175|592571993|FG010|Part A (Drug-Drug Interaction)|Death|0|||
164057518|NCT01072175|592571994|FG011|Part A (Drug-Drug Interaction)|Death|0|||
164057519|NCT01072175|592571995|FG012|Part A (Drug-Drug Interaction)|Death|0|||
164057520|NCT01072175|592571983|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
164057521|NCT01072175|592571984|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057522|NCT01072175|592571985|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057523|NCT01072175|592571986|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057524|NCT01072175|592571987|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057525|NCT01072175|592571988|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057526|NCT01072175|592571989|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057527|NCT01072175|592571990|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057528|NCT01072175|592571991|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057529|NCT01072175|592571992|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057530|NCT01072175|592571993|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057531|NCT01072175|592571994|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057532|NCT01072175|592571995|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
164057533|NCT01072175|592571983|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
164057534|NCT01072175|592571984|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057535|NCT01072175|592571985|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057536|NCT01072175|592571986|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057537|NCT01072175|592571987|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057538|NCT01072175|592571988|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057539|NCT01072175|592571989|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057540|NCT01072175|592571990|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057541|NCT01072175|592571991|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057542|NCT01072175|592571992|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057543|NCT01072175|592571993|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057544|NCT01072175|592571994|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057545|NCT01072175|592571995|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
164057546|NCT01072175|592571983|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
164057547|NCT01072175|592571984|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
164057548|NCT01072175|592571985|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
164057549|NCT01072175|592571986|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
164057550|NCT01072175|592571987|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
164057551|NCT01072175|592571988|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
164057552|NCT01072175|592571989|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
164057553|NCT01072175|592571990|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
164057554|NCT01072175|592571991|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
164057555|NCT01072175|592571992|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
164057556|NCT01072175|592571993|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
164057557|NCT01072175|592571994|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
164057558|NCT01072175|592571995|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
164057559|NCT01072175|592571983|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057560|NCT01072175|592571984|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057561|NCT01072175|592571985|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
164057562|NCT01072175|592571986|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057563|NCT01072175|592571987|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
164057564|NCT01072175|592571988|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057565|NCT01072175|592571989|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057566|NCT01072175|592571990|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057567|NCT01072175|592571991|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057568|NCT01072175|592571992|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057569|NCT01072175|592571993|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057570|NCT01072175|592571994|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057571|NCT01072175|592571995|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
164057572|NCT01072175|592571983|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057573|NCT01072175|592571984|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
164057574|NCT01072175|592571985|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057575|NCT01072175|592571986|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
164057576|NCT01072175|592571987|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
164057577|NCT01072175|592571988|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057578|NCT01072175|592571989|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057579|NCT01072175|592571990|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057580|NCT01072175|592571991|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057581|NCT01072175|592571992|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057582|NCT01072175|592571993|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057583|NCT01072175|592571994|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057584|NCT01072175|592571995|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
164057585|NCT01072175|592571983|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057586|NCT01072175|592571984|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057587|NCT01072175|592571985|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
164057588|NCT01072175|592571986|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
164057589|NCT01072175|592571987|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
164057590|NCT01072175|592571988|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057591|NCT01072175|592571989|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057592|NCT01072175|592571990|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057593|NCT01072175|592571991|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057594|NCT01072175|592571992|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057595|NCT01072175|592571993|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057596|NCT01072175|592571994|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057597|NCT01072175|592571995|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
164057598|NCT01072175|592571983|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057599|NCT01072175|592571984|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
164057600|NCT01072175|592571985|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057601|NCT01072175|592571986|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
164057602|NCT01072175|592571987|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
164057603|NCT01072175|592571988|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057604|NCT01072175|592571989|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057605|NCT01072175|592571990|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057606|NCT01072175|592571991|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057607|NCT01072175|592571992|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057608|NCT01072175|592571993|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057609|NCT01072175|592571994|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057610|NCT01072175|592571995|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
164057611|NCT01072175|592571983|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
164057612|NCT01072175|592571984|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
164057613|NCT01072175|592571985|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
164057614|NCT01072175|592571986|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
164057615|NCT01072175|592571987|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
164057616|NCT01072175|592571988|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
164057617|NCT01072175|592571989|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
164057618|NCT01072175|592571990|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
164057619|NCT01072175|592571991|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
164057620|NCT01072175|592571992|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
164057621|NCT01072175|592571993|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
164057622|NCT01072175|592571994|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
164057623|NCT01072175|592571995|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
164057624|NCT01072175|592571983|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057625|NCT01072175|592571984|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057626|NCT01072175|592571985|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057627|NCT01072175|592571986|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057628|NCT01072175|592571987|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057629|NCT01072175|592571988|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
164057630|NCT01072175|592571989|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
164057631|NCT01072175|592571990|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
164057632|NCT01072175|592571991|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057633|NCT01072175|592571992|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057634|NCT01072175|592571993|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057635|NCT01072175|592571994|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057636|NCT01072175|592571995|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
164057637|NCT01072175|592571983|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057638|NCT01072175|592571984|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057639|NCT01072175|592571985|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057640|NCT01072175|592571986|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057641|NCT01072175|592571987|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057642|NCT01072175|592571988|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057643|NCT01072175|592571989|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
164057644|NCT01072175|592571990|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
164057645|NCT01072175|592571991|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057646|NCT01072175|592571992|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057647|NCT01072175|592571993|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057648|NCT01072175|592571994|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057649|NCT01072175|592571995|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
164057650|NCT01072175|592571983|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057651|NCT01072175|592571984|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057652|NCT01072175|592571985|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057653|NCT01072175|592571986|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057654|NCT01072175|592571987|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057655|NCT01072175|592571988|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
164057656|NCT01072175|592571989|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
164057657|NCT01072175|592571990|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
164057658|NCT01072175|592571991|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057659|NCT01072175|592571992|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057660|NCT01072175|592571993|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057661|NCT01072175|592571994|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057662|NCT01072175|592571995|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
164057663|NCT01072175|592571983|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057664|NCT01072175|592571984|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057665|NCT01072175|592571985|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057666|NCT01072175|592571986|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057667|NCT01072175|592571987|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057668|NCT01072175|592571988|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
164057669|NCT01072175|592571989|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
164057670|NCT01072175|592571990|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057671|NCT01072175|592571991|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057672|NCT01072175|592571992|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057673|NCT01072175|592571993|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057674|NCT01072175|592571994|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057675|NCT01072175|592571995|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
164057676|NCT01072175|592571983|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057677|NCT01072175|592571984|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164101749|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101750|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101751|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101752|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101753|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101754|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101755|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101756|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101757|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101758|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101759|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164057678|NCT01072175|592571985|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057679|NCT01072175|592571986|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057680|NCT01072175|592571987|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057681|NCT01072175|592571988|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057682|NCT01072175|592571989|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057683|NCT01072175|592571990|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057684|NCT01072175|592571991|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
164057685|NCT01072175|592571992|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057686|NCT01072175|592571993|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057687|NCT01072175|592571994|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057688|NCT01072175|592571995|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
164057689|NCT01072175|592571983|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057690|NCT01072175|592571984|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057691|NCT01072175|592571985|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057692|NCT01072175|592571986|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057693|NCT01072175|592571987|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057694|NCT01072175|592571988|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057695|NCT01072175|592571989|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057696|NCT01072175|592571990|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057697|NCT01072175|592571991|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
164057698|NCT01072175|592571992|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057699|NCT01072175|592571993|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057700|NCT01072175|592571994|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057701|NCT01072175|592571995|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
164057702|NCT01072175|592571983|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057703|NCT01072175|592571984|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057704|NCT01072175|592571985|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057705|NCT01072175|592571986|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057706|NCT01072175|592571987|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057707|NCT01072175|592571988|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057708|NCT01072175|592571989|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057709|NCT01072175|592571990|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057710|NCT01072175|592571991|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
164057711|NCT01072175|592571992|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057712|NCT01072175|592571993|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057713|NCT01072175|592571994|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057714|NCT01072175|592571995|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
164057715|NCT01072175|592571983|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057716|NCT01072175|592571984|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057717|NCT01072175|592571985|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057718|NCT01072175|592571986|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164101760|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101761|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101762|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101763|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
164057719|NCT01072175|592571987|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057720|NCT01072175|592571988|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057721|NCT01072175|592571989|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057722|NCT01072175|592571990|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057723|NCT01072175|592571991|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
164057724|NCT01072175|592571992|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057725|NCT01072175|592571993|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057726|NCT01072175|592571994|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057727|NCT01072175|592571995|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
164057728|NCT01072175|592571983|FG000|Part D (HPMC Capsules)|Death|0|||
164057729|NCT01072175|592571984|FG001|Part D (HPMC Capsules)|Death|0|||
164057730|NCT01072175|592571985|FG002|Part D (HPMC Capsules)|Death|0|||
164057731|NCT01072175|592571986|FG003|Part D (HPMC Capsules)|Death|0|||
164057732|NCT01072175|592571987|FG004|Part D (HPMC Capsules)|Death|0|||
164057733|NCT01072175|592571988|FG005|Part D (HPMC Capsules)|Death|0|||
164057734|NCT01072175|592571989|FG006|Part D (HPMC Capsules)|Death|0|||
164057735|NCT01072175|592571990|FG007|Part D (HPMC Capsules)|Death|0|||
164057736|NCT01072175|592571991|FG008|Part D (HPMC Capsules)|Death|0|||
164057737|NCT01072175|592571992|FG009|Part D (HPMC Capsules)|Death|10|||
164057738|NCT01072175|592571993|FG010|Part D (HPMC Capsules)|Death|12|||
164057739|NCT01072175|592571994|FG011|Part D (HPMC Capsules)|Death|28|||
164057740|NCT01072175|592571995|FG012|Part D (HPMC Capsules)|Death|26|||
164057741|NCT01072175|592571983|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
164057742|NCT01072175|592571984|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
164057743|NCT01072175|592571985|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
164057744|NCT01072175|592571986|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
164057745|NCT01072175|592571987|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
164057746|NCT01072175|592571988|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
164057747|NCT01072175|592571989|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
164057748|NCT01072175|592571990|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
164057749|NCT01072175|592571991|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
164057750|NCT01072175|592571992|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
164057751|NCT01072175|592571993|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
164057752|NCT01072175|592571994|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
164057753|NCT01072175|592571995|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
164057754|NCT01072175|592571983|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057755|NCT01072175|592571984|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057756|NCT01072175|592571985|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057757|NCT01072175|592571986|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057758|NCT01072175|592571987|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057759|NCT01072175|592571988|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057760|NCT01072175|592571989|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057761|NCT01072175|592571990|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057762|NCT01072175|592571991|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057763|NCT01072175|592571992|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
164057764|NCT01072175|592571993|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
164057765|NCT01072175|592571994|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
164057766|NCT01072175|592571995|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
164057767|NCT01072175|592571983|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057768|NCT01072175|592571984|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057769|NCT01072175|592571985|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057770|NCT01072175|592571986|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057771|NCT01072175|592571987|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057772|NCT01072175|592571988|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057773|NCT01072175|592571989|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057774|NCT01072175|592571990|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057775|NCT01072175|592571991|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
164057776|NCT01072175|592571992|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
164057777|NCT01072175|592571993|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
164057778|NCT01072175|592571994|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
164057779|NCT01072175|592571995|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
164057780|NCT01072175|592571983|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057781|NCT01072175|592571984|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057782|NCT01072175|592571985|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057783|NCT01072175|592571986|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057784|NCT01072175|592571987|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057785|NCT01072175|592571988|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057786|NCT01072175|592571989|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057787|NCT01072175|592571990|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057788|NCT01072175|592571991|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057789|NCT01072175|592571992|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057790|NCT01072175|592571993|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
164057791|NCT01072175|592571994|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
164057792|NCT01072175|592571995|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
164057793|NCT02839330|592571996|FG000|Overall Study|Adverse Event|0|||
164057794|NCT02839330|592571997|FG001|Overall Study|Adverse Event|1|||
164057795|NCT02839330|592571998|FG002|Overall Study|Adverse Event|2|||
164057796|NCT02839330|592571999|FG003|Overall Study|Adverse Event|2|||
164057797|NCT02839330|592571996|FG000|Overall Study|Death|4|||
164057798|NCT02839330|592571997|FG001|Overall Study|Death|6|||
164057799|NCT02839330|592571998|FG002|Overall Study|Death|1|||
164057800|NCT02839330|592571999|FG003|Overall Study|Death|1|||
164057801|NCT02839330|592571996|FG000|Overall Study|Withdrawal by Subject|27|||
164057802|NCT02839330|592571997|FG001|Overall Study|Withdrawal by Subject|19|||
164057803|NCT02839330|592571998|FG002|Overall Study|Withdrawal by Subject|11|||
164057804|NCT02839330|592571999|FG003|Overall Study|Withdrawal by Subject|13|||
164057805|NCT02839330|592571996|FG000|Overall Study|Lost to Follow-up|22|||
164057806|NCT02839330|592571997|FG001|Overall Study|Lost to Follow-up|27|||
164057807|NCT02839330|592571998|FG002|Overall Study|Lost to Follow-up|29|||
164057808|NCT02839330|592571999|FG003|Overall Study|Lost to Follow-up|25|||
164057809|NCT02839330|592571996|FG000|Overall Study|Administrative Reason|0|||
164057810|NCT02839330|592571997|FG001|Overall Study|Administrative Reason|0|||
164057811|NCT02839330|592571998|FG002|Overall Study|Administrative Reason|0|||
164057812|NCT02839330|592571999|FG003|Overall Study|Administrative Reason|1|||
164057813|NCT02839330|592571996|FG000|Overall Study|Protocol Violation|1|||
164057814|NCT02839330|592571997|FG001|Overall Study|Protocol Violation|2|||
164057815|NCT02839330|592571998|FG002|Overall Study|Protocol Violation|2|||
164057816|NCT02839330|592571999|FG003|Overall Study|Protocol Violation|3|||
164057817|NCT02839330|592571996|FG000|Overall Study|Other reason, not specified|4|||
164057818|NCT02839330|592571997|FG001|Overall Study|Other reason, not specified|3|||
164057819|NCT02839330|592571998|FG002|Overall Study|Other reason, not specified|3|||
164057820|NCT02839330|592571999|FG003|Overall Study|Other reason, not specified|6|||
164057821|NCT00682539|592572000|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
164057822|NCT00682539|592572001|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
164057823|NCT00682539|592572002|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
164057824|NCT00682539|592572000|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
164057825|NCT00682539|592572001|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
164057826|NCT00682539|592572002|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
164057827|NCT02477215|592572012|FG000|Dose Escalation Phase|Physician Decision|1|||
164057828|NCT02477215|592572013|FG001|Dose Escalation Phase|Physician Decision|2|||
164057829|NCT02477215|592572014|FG002|Dose Escalation Phase|Physician Decision|0|||
164057830|NCT02477215|592572012|FG000|Fixed Dose Phase|Physician Decision|0|||
164057831|NCT02477215|592572013|FG001|Fixed Dose Phase|Physician Decision|7|||
164057832|NCT02477215|592572014|FG002|Fixed Dose Phase|Physician Decision|0|||
164057833|NCT00508872|592572015|FG000|Overall Study|Lost to Follow-up|1|||
164057834|NCT00508872|592572015|FG000|Overall Study|Physician Decision|1|||
164057835|NCT00883896|592572016|FG000|Overall Study|Lost to Follow-up|0|||
164057836|NCT00883896|592572017|FG001|Overall Study|Lost to Follow-up|0|||
164057837|NCT00883896|592572018|FG002|Overall Study|Lost to Follow-up|0|||
164057838|NCT00883896|592572019|FG003|Overall Study|Lost to Follow-up|2|||
164057839|NCT00883896|592572016|FG000|Overall Study|Withdrawal by Subject|5|||
164057840|NCT00883896|592572017|FG001|Overall Study|Withdrawal by Subject|0|||
164057841|NCT00883896|592572018|FG002|Overall Study|Withdrawal by Subject|1|||
164057842|NCT00883896|592572019|FG003|Overall Study|Withdrawal by Subject|3|||
164057843|NCT00883896|592572016|FG000|Overall Study|Lack of Efficacy|0|||
164057844|NCT00883896|592572017|FG001|Overall Study|Lack of Efficacy|0|||
164057845|NCT00883896|592572018|FG002|Overall Study|Lack of Efficacy|0|||
164057846|NCT00883896|592572019|FG003|Overall Study|Lack of Efficacy|2|||
164057847|NCT00883896|592572016|FG000|Overall Study|Other|1|||
164057848|NCT00883896|592572017|FG001|Overall Study|Other|0|||
164057849|NCT00883896|592572018|FG002|Overall Study|Other|0|||
164057850|NCT00883896|592572019|FG003|Overall Study|Other|0|||
164057851|NCT02546193|592572020|FG000|Overall Study|Withdrawal by Subject|2|||
164057852|NCT02546193|592572021|FG001|Overall Study|Withdrawal by Subject|0|||
164057853|NCT02546193|592572022|FG002|Overall Study|Withdrawal by Subject|1|||
164057854|NCT02546193|592572023|FG003|Overall Study|Withdrawal by Subject|0|||
164057855|NCT02546193|592572020|FG000|Overall Study|Not eligible at time of induction|4|||
164057856|NCT02546193|592572021|FG001|Overall Study|Not eligible at time of induction|6|||
164057857|NCT02546193|592572022|FG002|Overall Study|Not eligible at time of induction|1|||
164057858|NCT02546193|592572023|FG003|Overall Study|Not eligible at time of induction|0|||
164057859|NCT00310440|592572024|FG000|Overall Study|Lost to Follow-up|17|||
164057860|NCT00310440|592572025|FG001|Overall Study|Lost to Follow-up|8|||
164057861|NCT00310440|592572024|FG000|Overall Study|Withdrawal by Subject|2|||
164057862|NCT00310440|592572025|FG001|Overall Study|Withdrawal by Subject|1|||
164057863|NCT00310440|592572024|FG000|Overall Study|Missed 12 Month Visit|7|||
164057864|NCT00310440|592572025|FG001|Overall Study|Missed 12 Month Visit|4|||
164057865|NCT00792467|592572026|FG000|Overall Study|progression of disease|17|||
164057866|NCT00792467|592572026|FG000|Overall Study|Adverse Event|1|||
164057867|NCT00792467|592572026|FG000|Overall Study|patient request|1|||
164057868|NCT00792467|592572026|FG000|Overall Study|Lost to Follow-up|1|||
164057869|NCT00792467|592572026|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
164057870|NCT00792467|592572026|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
164057871|NCT00438815|592572034|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
164057872|NCT00438815|592572034|FG000|Overall Study|3-month follow-up no longer required|12|||
164057873|NCT00438815|592572034|FG000|Overall Study|Noncompliance with protocol requirements|9|||
164057874|NCT00438815|592572034|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
164057875|NCT00438815|592572034|FG000|Overall Study|Lost to Follow-up|6|||
164057876|NCT00438815|592572034|FG000|Overall Study|Withdrawal by Subject|6|||
164057877|NCT00438815|592572034|FG000|Overall Study|Death|1|||
164057878|NCT01654666|592572035|FG000|Overall Study|Protocol Violation|7|||
164057879|NCT01654666|592572036|FG001|Overall Study|Protocol Violation|4|||
164057880|NCT01654666|592572037|FG002|Overall Study|Protocol Violation|8|||
164057881|NCT01654666|592572035|FG000|Overall Study|Lost to Follow-up|4|||
164057882|NCT01654666|592572036|FG001|Overall Study|Lost to Follow-up|5|||
164057883|NCT01654666|592572037|FG002|Overall Study|Lost to Follow-up|5|||
164057884|NCT01654666|592572035|FG000|Overall Study|Withdrawal by Subject|4|||
164057885|NCT01654666|592572036|FG001|Overall Study|Withdrawal by Subject|4|||
164057886|NCT01654666|592572037|FG002|Overall Study|Withdrawal by Subject|1|||
164057887|NCT01177943|592572039|FG000|First Intervention|Withdrawal by Subject|2|||
164057888|NCT01177943|592572040|FG001|First Intervention|Withdrawal by Subject|0|||
164057889|NCT04225026|592572046|FG000|Overall Study|Withdrawal by Subject|4|||
164057890|NCT04225026|592572046|FG000|Overall Study|Adverse Event|1|||
164057891|NCT04225026|592572046|FG000|Overall Study|Other|1|||
164057892|NCT04225026|592572046|FG000|Overall Study|Death|11|||
164057893|NCT04225026|592572046|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
164057894|NCT00779506|592572049|FG000|Overall Study|Screening Failed|2|||
164057895|NCT00779506|592572049|FG000|Overall Study|Adverse Event|4|||
164057896|NCT00779506|592572049|FG000|Overall Study|Lack of Efficacy|11|||
164057897|NCT00779506|592572049|FG000|Overall Study|Protocol Violation|5|||
164057898|NCT00779506|592572049|FG000|Overall Study|Withdrawal by Subject|6|||
164057899|NCT00779506|592572049|FG000|Overall Study|Lost to Follow-up|1|||
164057900|NCT03982069|592572051|FG000|Overall Study|Lost to Follow-up|5|||
164057901|NCT03982069|592572052|FG001|Overall Study|Lost to Follow-up|5|||
164057902|NCT03982069|592572053|FG002|Overall Study|Lost to Follow-up|3|||
164057903|NCT03982069|592572054|FG003|Overall Study|Lost to Follow-up|5|||
164057904|NCT03982069|592572051|FG000|Overall Study|Physician Decision|0|||
164057905|NCT03982069|592572052|FG001|Overall Study|Physician Decision|1|||
164057906|NCT03982069|592572053|FG002|Overall Study|Physician Decision|0|||
164057907|NCT03982069|592572054|FG003|Overall Study|Physician Decision|0|||
164057908|NCT03982069|592572051|FG000|Overall Study|Withdrawal by Subject|2|||
164057909|NCT03982069|592572052|FG001|Overall Study|Withdrawal by Subject|1|||
164057910|NCT03982069|592572053|FG002|Overall Study|Withdrawal by Subject|5|||
164057911|NCT03982069|592572054|FG003|Overall Study|Withdrawal by Subject|2|||
164057912|NCT03982069|592572051|FG000|Overall Study|Specimen loss|3|||
164057913|NCT03982069|592572052|FG001|Overall Study|Specimen loss|3|||
164057914|NCT03982069|592572053|FG002|Overall Study|Specimen loss|1|||
164057915|NCT03982069|592572054|FG003|Overall Study|Specimen loss|1|||
164057916|NCT00914940|592572055|FG000|D0 to D100 Post-transplant|Death|2|||
164057917|NCT00914940|592572055|FG000|D101 to 2 Years Post-transplant|Death|8|||
164057918|NCT00914940|592572055|FG000|2 Years to 5 Years Post-transplant|Death|3|||
164057919|NCT00690612|592573378|FG000|Overall Study|Adverse Event|1|||
164057920|NCT00690612|592573378|FG000|Overall Study|Withdrawal by Subject|2|||
164057921|NCT01682876|592573379|FG000|Overall Study|Administrative reason|4|||
164057922|NCT01682876|592573380|FG001|Overall Study|Administrative reason|4|||
164057923|NCT01682876|592573381|FG002|Overall Study|Administrative reason|0|||
164057924|NCT01682876|592573382|FG003|Overall Study|Administrative reason|3|||
164057925|NCT01682876|592573379|FG000|Overall Study|Adverse Event|0|||
164057926|NCT01682876|592573380|FG001|Overall Study|Adverse Event|0|||
164057927|NCT01682876|592573381|FG002|Overall Study|Adverse Event|0|||
164057928|NCT01682876|592573382|FG003|Overall Study|Adverse Event|1|||
164057929|NCT01682876|592573379|FG000|Overall Study|Lost to Follow-up|11|||
164057930|NCT01682876|592573380|FG001|Overall Study|Lost to Follow-up|15|||
164057931|NCT01682876|592573381|FG002|Overall Study|Lost to Follow-up|9|||
164057932|NCT01682876|592573382|FG003|Overall Study|Lost to Follow-up|11|||
164057933|NCT01682876|592573379|FG000|Overall Study|Protocol Violation|1|||
164057934|NCT01682876|592573380|FG001|Overall Study|Protocol Violation|1|||
164057935|NCT01682876|592573381|FG002|Overall Study|Protocol Violation|1|||
164057936|NCT01682876|592573382|FG003|Overall Study|Protocol Violation|1|||
164057937|NCT01682876|592573379|FG000|Overall Study|Withdrawal by Subject|4|||
164057938|NCT01682876|592573380|FG001|Overall Study|Withdrawal by Subject|0|||
164057939|NCT01682876|592573381|FG002|Overall Study|Withdrawal by Subject|0|||
164057940|NCT01682876|592573382|FG003|Overall Study|Withdrawal by Subject|2|||
164057941|NCT01682876|592573379|FG000|Overall Study|Other|1|||
164057942|NCT01682876|592573380|FG001|Overall Study|Other|0|||
164057943|NCT01682876|592573381|FG002|Overall Study|Other|1|||
164057944|NCT01682876|592573382|FG003|Overall Study|Other|1|||
164057945|NCT01858701|592573387|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
164057946|NCT01858701|592573388|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
164057947|NCT01858701|592573387|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
164057948|NCT01858701|592573388|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
164057949|NCT01858701|592573387|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
164057950|NCT01858701|592573388|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
164057951|NCT01858701|592573387|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
164057952|NCT01858701|592573388|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
164057953|NCT01674010|592573389|FG000|Open Treatment Phase 1|Adverse Event|10|||
164057954|NCT01674010|592573390|FG001|Open Treatment Phase 1|Adverse Event|0|||
164057955|NCT01674010|592573391|FG002|Open Treatment Phase 1|Adverse Event|0|||
164057956|NCT01674010|592573389|FG000|Open Treatment Phase 1|Death|1|||
164057957|NCT01674010|592573390|FG001|Open Treatment Phase 1|Death|0|||
164057958|NCT01674010|592573391|FG002|Open Treatment Phase 1|Death|0|||
164057959|NCT01674010|592573389|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
164057960|NCT01674010|592573390|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
164057961|NCT01674010|592573391|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
164057962|NCT01674010|592573389|FG000|Open Treatment Phase 1|Physician Decision|9|||
164057963|NCT01674010|592573390|FG001|Open Treatment Phase 1|Physician Decision|0|||
164057964|NCT01674010|592573391|FG002|Open Treatment Phase 1|Physician Decision|0|||
164057965|NCT01674010|592573389|FG000|Open Treatment Phase 1|Protocol Violation|7|||
164057966|NCT01674010|592573390|FG001|Open Treatment Phase 1|Protocol Violation|0|||
164057967|NCT01674010|592573391|FG002|Open Treatment Phase 1|Protocol Violation|0|||
164057968|NCT01674010|592573389|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
164057969|NCT01674010|592573390|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
164057970|NCT01674010|592573391|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
164057971|NCT01674010|592573389|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
164057972|NCT01674010|592573390|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
164057973|NCT01674010|592573391|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
164057974|NCT01674010|592573389|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
164057975|NCT01674010|592573390|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
164057976|NCT01674010|592573391|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
164057977|NCT01674010|592573389|FG000|Randomization Phase 2|Adverse Event|0|||
164057978|NCT01674010|592573390|FG001|Randomization Phase 2|Adverse Event|1|||
164057979|NCT01674010|592573391|FG002|Randomization Phase 2|Adverse Event|1|||
164057980|NCT01674010|592573389|FG000|Randomization Phase 2|Lost to Follow-up|0|||
164057981|NCT01674010|592573390|FG001|Randomization Phase 2|Lost to Follow-up|1|||
164057982|NCT01674010|592573391|FG002|Randomization Phase 2|Lost to Follow-up|2|||
164057983|NCT01674010|592573389|FG000|Randomization Phase 2|Mood episode recurrence|0|||
164057984|NCT01674010|592573390|FG001|Randomization Phase 2|Mood episode recurrence|8|||
164057985|NCT01674010|592573391|FG002|Randomization Phase 2|Mood episode recurrence|2|||
164057986|NCT01674010|592573389|FG000|Randomization Phase 2|Physician Decision|0|||
164057987|NCT01674010|592573390|FG001|Randomization Phase 2|Physician Decision|0|||
164057988|NCT01674010|592573391|FG002|Randomization Phase 2|Physician Decision|2|||
164057989|NCT01674010|592573389|FG000|Randomization Phase 2|Pregnancy|0|||
164057990|NCT01674010|592573390|FG001|Randomization Phase 2|Pregnancy|1|||
164057991|NCT01674010|592573391|FG002|Randomization Phase 2|Pregnancy|1|||
164057992|NCT01674010|592573389|FG000|Randomization Phase 2|Protocol Violation|0|||
164057993|NCT01674010|592573390|FG001|Randomization Phase 2|Protocol Violation|1|||
164057994|NCT01674010|592573391|FG002|Randomization Phase 2|Protocol Violation|1|||
164057995|NCT01674010|592573389|FG000|Randomization Phase 2|Sponsor Decision|0|||
164057996|NCT01674010|592573390|FG001|Randomization Phase 2|Sponsor Decision|42|||
164057997|NCT01674010|592573391|FG002|Randomization Phase 2|Sponsor Decision|45|||
164057998|NCT01674010|592573389|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
164057999|NCT01674010|592573390|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
164058000|NCT01674010|592573391|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
164058001|NCT01020812|592573392|FG000|Overall Study|Physician Decision|1|||
164058002|NCT01020812|592573392|FG000|Overall Study|Withdrawal by Subject|1|||
164058003|NCT01020812|592573392|FG000|Overall Study|Protocol Violation|1|||
164058004|NCT01801475|592573401|FG000|Overall Study|Withdrawal by Subject|0|||
164058005|NCT01801475|592573402|FG001|Overall Study|Withdrawal by Subject|0|||
164058006|NCT01801475|592573403|FG002|Overall Study|Withdrawal by Subject|0|||
164058007|NCT01801475|592573404|FG003|Overall Study|Withdrawal by Subject|0|||
164058008|NCT01801475|592573405|FG004|Overall Study|Withdrawal by Subject|1|||
164058009|NCT01786707|592573408|FG000|Overall Study|Lost to Follow-up|1|||
164058010|NCT01786707|592573409|FG001|Overall Study|Lost to Follow-up|1|||
164058011|NCT00421928|592573410|FG000|Overall Study|Adverse Event|61|||
164058012|NCT00421928|592573411|FG001|Overall Study|Adverse Event|140|||
164058013|NCT00421928|592573412|FG002|Overall Study|Adverse Event|22|||
164058014|NCT00421928|592573410|FG000|Overall Study|Lost to Follow-up|5|||
164058015|NCT00421928|592573411|FG001|Overall Study|Lost to Follow-up|0|||
164058016|NCT00421928|592573412|FG002|Overall Study|Lost to Follow-up|3|||
164058017|NCT00421928|592573410|FG000|Overall Study|Withdrawal by Subject|50|||
164058018|NCT00421928|592573411|FG001|Overall Study|Withdrawal by Subject|48|||
164058019|NCT00421928|592573412|FG002|Overall Study|Withdrawal by Subject|43|||
164058020|NCT00421928|592573410|FG000|Overall Study|Lack of Efficacy|15|||
164058021|NCT00421928|592573411|FG001|Overall Study|Lack of Efficacy|7|||
164058022|NCT00421928|592573412|FG002|Overall Study|Lack of Efficacy|35|||
164058023|NCT00421928|592573410|FG000|Overall Study|Study drug non-compliant|6|||
164058024|NCT00421928|592573411|FG001|Overall Study|Study drug non-compliant|7|||
164058025|NCT00421928|592573412|FG002|Overall Study|Study drug non-compliant|4|||
164058026|NCT00421928|592573410|FG000|Overall Study|All other|26|||
164058027|NCT00421928|592573411|FG001|Overall Study|All other|21|||
164058028|NCT00421928|592573412|FG002|Overall Study|All other|27|||
164058029|NCT00421928|592573410|FG000|Overall Study|Death|0|||
164058030|NCT00421928|592573411|FG001|Overall Study|Death|1|||
164058031|NCT00421928|592573412|FG002|Overall Study|Death|0|||
164058032|NCT00346775|592573419|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
164058033|NCT00346775|592573420|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
164058034|NCT00346775|592573419|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
164058035|NCT00346775|592573420|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
164058036|NCT00346775|592573419|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
164058037|NCT00346775|592573420|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
164058038|NCT02946515|592573421|FG000|Overall Study|Lost to Follow-up|2|||
164058039|NCT02946515|592573422|FG001|Overall Study|Lost to Follow-up|1|||
164058040|NCT01096017|592573432|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
164058041|NCT01096017|592573433|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
164058042|NCT02158949|592573434|FG000|Overall Study|Withdrawal by Subject|1|||
164058043|NCT02158949|592573435|FG001|Overall Study|Withdrawal by Subject|0|||
164058044|NCT02158949|592573434|FG000|Overall Study|Lost to Follow-up|5|||
164058045|NCT02158949|592573435|FG001|Overall Study|Lost to Follow-up|11|||
164058046|NCT00475657|592573437|FG000|Overall Study|Death|1|||
164058047|NCT00475657|592573437|FG000|Overall Study|Sponsor's Decision|3|||
164058048|NCT00408408|592573438|FG000|Overall Study|No follow up data|2|||
164058049|NCT00408408|592573439|FG001|Overall Study|No follow up data|3|||
164058050|NCT00408408|592573440|FG002|Overall Study|No follow up data|0|||
164058051|NCT00408408|592573441|FG003|Overall Study|No follow up data|7|||
164058052|NCT00408408|592573442|FG004|Overall Study|No follow up data|5|||
164058053|NCT00408408|592573443|FG005|Overall Study|No follow up data|3|||
164058054|NCT02898662|592573450|FG000|Overall Study|Adverse Event|1|||
164058055|NCT02898662|592573451|FG001|Overall Study|Adverse Event|0|||
164058056|NCT02898662|592573450|FG000|Overall Study|Loss of asthma control|23|||
164058057|NCT02898662|592573451|FG001|Overall Study|Loss of asthma control|24|||
164058058|NCT02898662|592573450|FG000|Overall Study|Withdrawal by Subject|4|||
164058059|NCT02898662|592573451|FG001|Overall Study|Withdrawal by Subject|1|||
164058060|NCT02898662|592573450|FG000|Overall Study|Technical issue|0|||
164058061|NCT02898662|592573451|FG001|Overall Study|Technical issue|1|||
164058062|NCT02898662|592573450|FG000|Overall Study|Randomized in error|0|||
164058063|NCT02898662|592573451|FG001|Overall Study|Randomized in error|1|||
164058064|NCT02898662|592573450|FG000|Overall Study|Subject decision|1|||
164058065|NCT02898662|592573451|FG001|Overall Study|Subject decision|0|||
164058066|NCT02898662|592573450|FG000|Overall Study|Other|0|||
164058067|NCT02898662|592573451|FG001|Overall Study|Other|1|||
164058068|NCT00399542|592573452|FG000|Overall Study|Adverse Event|18|||
164058069|NCT00399542|592573453|FG001|Overall Study|Adverse Event|15|||
164058070|NCT00399542|592573452|FG000|Overall Study|Protocol Violation|13|||
164058071|NCT00399542|592573453|FG001|Overall Study|Protocol Violation|3|||
164058072|NCT00399542|592573452|FG000|Overall Study|Withdrawal by Subject|28|||
164058073|NCT00399542|592573453|FG001|Overall Study|Withdrawal by Subject|10|||
164058074|NCT00399542|592573452|FG000|Overall Study|Lack of Efficacy|18|||
164058075|NCT00399542|592573453|FG001|Overall Study|Lack of Efficacy|8|||
164058076|NCT00399542|592573452|FG000|Overall Study|Lost to Follow-up|6|||
164058077|NCT00399542|592573453|FG001|Overall Study|Lost to Follow-up|6|||
164058078|NCT00399542|592573452|FG000|Overall Study|Other|1|||
164058079|NCT00399542|592573453|FG001|Overall Study|Other|0|||
164058080|NCT00399542|592573452|FG000|Overall Study|Physician Decision|0|||
164058081|NCT00399542|592573453|FG001|Overall Study|Physician Decision|1|||
164058082|NCT00917553|592573454|FG000|Overall Study|Lost to Follow-up|2|||
164058083|NCT00917553|592573455|FG001|Overall Study|Lost to Follow-up|1|||
164058084|NCT01616173|592573456|FG000|Overall Study|Lost to Follow-up|0|||
164058085|NCT01616173|592573457|FG001|Overall Study|Lost to Follow-up|2|||
164058086|NCT01616173|592573458|FG002|Overall Study|Lost to Follow-up|0|||
164058087|NCT03172026|592573465|FG000|Overall Study|Withdrawal by Subject|1|||
164058088|NCT03172026|592573466|FG001|Overall Study|Withdrawal by Subject|0|||
164058089|NCT03172026|592573465|FG000|Overall Study|COVID restrictions|1|||
164058090|NCT03172026|592573466|FG001|Overall Study|COVID restrictions|0|||
164058091|NCT01430559|592573467|FG000|Overall Study|Adverse Event|7|||
164058092|NCT01430559|592573468|FG001|Overall Study|Adverse Event|3|||
164058093|NCT01430559|592573467|FG000|Overall Study|Entry criteria not met|1|||
164058094|NCT01430559|592573468|FG001|Overall Study|Entry criteria not met|1|||
164058095|NCT01430559|592573467|FG000|Overall Study|Lost to Follow-up|1|||
164058096|NCT01430559|592573468|FG001|Overall Study|Lost to Follow-up|0|||
164058097|NCT01430559|592573467|FG000|Overall Study|Medication error|1|||
164058098|NCT01430559|592573468|FG001|Overall Study|Medication error|0|||
164101764|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164058099|NCT01430559|592573467|FG000|Overall Study|Withdrawal by Subject|3|||
164058100|NCT01430559|592573468|FG001|Overall Study|Withdrawal by Subject|2|||
164058101|NCT01430559|592573467|FG000|Overall Study|Protocol Violation|1|||
164058102|NCT01430559|592573468|FG001|Overall Study|Protocol Violation|0|||
164058103|NCT01430559|592573467|FG000|Overall Study|Other|3|||
164058104|NCT01430559|592573468|FG001|Overall Study|Other|3|||
164058105|NCT01430559|592573467|FG000|Overall Study|Randomized, Not Treated|3|||
164058106|NCT01430559|592573468|FG001|Overall Study|Randomized, Not Treated|3|||
164058107|NCT00504595|592573469|FG000|Overall Study|Lack of Efficacy|1|||
164058108|NCT00504595|592573470|FG001|Overall Study|Lack of Efficacy|0|||
164058109|NCT00504595|592573471|FG002|Overall Study|Lack of Efficacy|0|||
164058110|NCT00504595|592573472|FG003|Overall Study|Lack of Efficacy|0|||
164058111|NCT00504595|592573469|FG000|Overall Study|Other|0|||
164058112|NCT00504595|592573470|FG001|Overall Study|Other|0|||
164058113|NCT00504595|592573471|FG002|Overall Study|Other|2|||
164058114|NCT00504595|592573472|FG003|Overall Study|Other|0|||
164058115|NCT01220024|592573473|FG000|Overall Study|Lost to Follow-up|1|||
164058116|NCT01220024|592573474|FG001|Overall Study|Lost to Follow-up|1|||
164058117|NCT00174460|592573476|FG000|Overall Study|Withdrawal by Subject|0|||
164058118|NCT00174460|592573477|FG001|Overall Study|Withdrawal by Subject|1|||
164058119|NCT00579059|592573478|FG000|Overall Study|Study Canceled at 1 Year|21|||
164058120|NCT00579059|592573479|FG001|Overall Study|Study Canceled at 1 Year|10|||
164058121|NCT00779142|592573480|FG000|Overall Study|Screen Failures|3|||
164058122|NCT04652245|592573481|FG000|Wash-Out Period|Adverse Event|0|||
164058123|NCT04652245|592573482|FG001|Wash-Out Period|Adverse Event|2|||
164058124|NCT04652245|592573481|FG000|Wash-Out Period|Withdrawal by Subject|0|||
164058125|NCT04652245|592573482|FG001|Wash-Out Period|Withdrawal by Subject|2|||
164058126|NCT03137433|592573487|FG000|Overall Study|Withdrawal by Subject|11|||
164058127|NCT03137433|592573488|FG001|Overall Study|Withdrawal by Subject|11|||
164058128|NCT03137433|592573487|FG000|Overall Study|Lost to Follow-up|5|||
164058129|NCT03137433|592573488|FG001|Overall Study|Lost to Follow-up|6|||
164058130|NCT03137433|592573487|FG000|Overall Study|Physician Decision|2|||
164058131|NCT03137433|592573488|FG001|Overall Study|Physician Decision|0|||
164058132|NCT03137433|592573487|FG000|Overall Study|Moved out of study area|1|||
164058133|NCT03137433|592573488|FG001|Overall Study|Moved out of study area|0|||
164058134|NCT03137433|592573487|FG000|Overall Study|Too far out of window due to COVID|0|||
164058135|NCT03137433|592573488|FG001|Overall Study|Too far out of window due to COVID|1|||
164058136|NCT01288911|592573489|FG000|Double-blind Period|Death|11|||
164058137|NCT01288911|592573490|FG001|Double-blind Period|Death|7|||
164058138|NCT01288911|592573489|FG000|Double-blind Period|Lost to Follow-up|0|||
164058139|NCT01288911|592573490|FG001|Double-blind Period|Lost to Follow-up|2|||
164058140|NCT01288911|592573489|FG000|Double-blind Period|Progressive Disease|75|||
164058141|NCT01288911|592573490|FG001|Double-blind Period|Progressive Disease|103|||
164058142|NCT01288911|592573489|FG000|Double-blind Period|Protocol Violation|1|||
164058143|NCT01288911|592573490|FG001|Double-blind Period|Protocol Violation|0|||
164058144|NCT01288911|592573489|FG000|Double-blind Period|Withdrawal by Subject|25|||
164058145|NCT01288911|592573490|FG001|Double-blind Period|Withdrawal by Subject|26|||
164058146|NCT01288911|592573489|FG000|Double-blind Period|Miscellaneous Reason|29|||
164058147|NCT01288911|592573490|FG001|Double-blind Period|Miscellaneous Reason|42|||
164101765|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101766|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
164101767|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
164101768|NCT01597245|592734944|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101769|NCT01597245|592734945|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101770|NCT01597245|592734946|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101771|NCT01597245|592734947|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101772|NCT01597245|592734948|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101773|NCT01597245|592734949|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101774|NCT01597245|592734950|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101775|NCT01597245|592734951|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164058148|NCT01288911|592573489|FG000|Double-blind Period|Randomized but never received study drug|1|||
164058149|NCT01288911|592573490|FG001|Double-blind Period|Randomized but never received study drug|2|||
164101776|NCT01597245|592734952|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101777|NCT01597245|592734953|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101778|NCT01597245|592734954|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101779|NCT01597245|592734955|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101780|NCT01597245|592734956|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164148719|NCT03207867|592904948|FG012|Overall Study|Physician Decision|0|||
164058150|NCT01288911|592573489|FG000|Open-label Period (All Enzalutamide)|Death|0|||
164058151|NCT01288911|592573490|FG001|Open-label Period (All Enzalutamide)|Death|1|||
164058152|NCT01288911|592573489|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
164058153|NCT01288911|592573490|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
164058154|NCT01288911|592573489|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
164058155|NCT01288911|592573490|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
164058156|NCT01288911|592573489|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
164058157|NCT01288911|592573490|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
164058158|NCT01288911|592573489|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
164058159|NCT01288911|592573490|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
164058160|NCT01288911|592573489|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
164058161|NCT01288911|592573490|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
164058162|NCT02452892|592573491|FG000|Week 1 Initial Randommization|Adverse Event|1|||
164058163|NCT02452892|592573492|FG001|Week 1 Initial Randommization|Adverse Event|0|||
164058164|NCT02452892|592573493|FG002|Week 1 Initial Randommization|Adverse Event|0|||
164058165|NCT02452892|592573494|FG003|Week 1 Initial Randommization|Adverse Event|0|||
164058166|NCT02452892|592573491|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
164058167|NCT02452892|592573492|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
164058168|NCT02452892|592573493|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
164058169|NCT02452892|592573494|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
164058170|NCT02452892|592573491|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
164058171|NCT02452892|592573492|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
164058172|NCT02452892|592573493|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
164058173|NCT02452892|592573494|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
164058174|NCT02452892|592573491|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
164058175|NCT02452892|592573492|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
164058176|NCT02452892|592573493|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
164058177|NCT02452892|592573494|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
164058178|NCT02452892|592573491|FG000|Follow-up|Withdrawal by Subject|0|||
164058179|NCT02452892|592573492|FG001|Follow-up|Withdrawal by Subject|0|||
164058180|NCT02452892|592573493|FG002|Follow-up|Withdrawal by Subject|0|||
164058181|NCT02452892|592573494|FG003|Follow-up|Withdrawal by Subject|1|||
164058182|NCT02452892|592573491|FG000|Follow-up|Subject left town on Day 42|1|||
164058183|NCT02452892|592573492|FG001|Follow-up|Subject left town on Day 42|0|||
164058184|NCT02452892|592573493|FG002|Follow-up|Subject left town on Day 42|0|||
164058185|NCT02452892|592573494|FG003|Follow-up|Subject left town on Day 42|0|||
164058186|NCT03742271|592573499|FG000|Overall Study|Unsatisfactory Visual Response|1|||
164058187|NCT03742271|592573499|FG000|Overall Study|Withdrawal by Subject|3|||
164058188|NCT03742271|592573499|FG000|Overall Study|Lost to Follow-up|4|||
164058189|NCT03742271|592573499|FG000|Overall Study|Failed Insertion & removal|3|||
164058190|NCT03742271|592573499|FG000|Overall Study|Protocol Violation|1|||
164058191|NCT02694562|592573500|FG000|Overall Study|Death|8|||
164058192|NCT02694562|592573500|FG000|Overall Study|Protocol Violation|4|||
164058193|NCT02694562|592573500|FG000|Overall Study|Lost to Follow-up|3|||
164058194|NCT02694562|592573500|FG000|Overall Study|Screen Failure|2|||
164058195|NCT02694562|592573500|FG000|Overall Study|Physician Decision|1|||
164058196|NCT03529162|592573503|FG000|Overall Study|Lost to Follow-up|2|||
164058197|NCT03529162|592573504|FG001|Overall Study|Lost to Follow-up|2|||
164058198|NCT00554229|592573509|FG000|Overall Study|Lost to Follow-up|3|||
164058199|NCT00554229|592573510|FG001|Overall Study|Lost to Follow-up|6|||
164058200|NCT00554229|592573509|FG000|Overall Study|Withdrawal by Subject|29|||
164058201|NCT00554229|592573510|FG001|Overall Study|Withdrawal by Subject|37|||
164058202|NCT00554229|592573509|FG000|Overall Study|Adverse Event|71|||
164058203|NCT00554229|592573510|FG001|Overall Study|Adverse Event|39|||
164058204|NCT00554229|592573509|FG000|Overall Study|Protocol Violation|3|||
164058205|NCT00554229|592573510|FG001|Overall Study|Protocol Violation|3|||
164058206|NCT00554229|592573509|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
164058207|NCT00554229|592573510|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
164058208|NCT00554229|592573509|FG000|Overall Study|Randomised but no treatment received|1|||
164058209|NCT00554229|592573510|FG001|Overall Study|Randomised but no treatment received|0|||
164058210|NCT00784836|592573511|FG000|Overall Study|Early Study Termination|3|||
164058211|NCT00517634|592573512|FG000|Second Treatment Period|Withdrawal by Subject|0|||
164058212|NCT00517634|592573513|FG001|Second Treatment Period|Withdrawal by Subject|0|||
164058213|NCT00517634|592573514|FG002|Second Treatment Period|Withdrawal by Subject|0|||
164058214|NCT00517634|592573515|FG003|Second Treatment Period|Withdrawal by Subject|0|||
164058215|NCT00517634|592573516|FG004|Second Treatment Period|Withdrawal by Subject|1|||
164058216|NCT00517634|592573517|FG005|Second Treatment Period|Withdrawal by Subject|0|||
164058217|NCT03143855|592573518|FG000|Overall Study|Withdrawal by Subject|4|||
164058218|NCT03143855|592573519|FG001|Overall Study|Withdrawal by Subject|3|||
164058219|NCT03143855|592573518|FG000|Overall Study|Protocol Violation|1|||
164058220|NCT03143855|592573519|FG001|Overall Study|Protocol Violation|0|||
164058221|NCT03143855|592573518|FG000|Overall Study|Participant experienced withdrawal|0|||
164058222|NCT03143855|592573519|FG001|Overall Study|Participant experienced withdrawal|1|||
164058223|NCT00701064|592573522|FG000|Overall Study|Protocol Violation|1|||
164058224|NCT00701064|592573523|FG001|Overall Study|Protocol Violation|1|||
164058225|NCT00701064|592573522|FG000|Overall Study|Withdrawal by Subject|1|||
164058226|NCT00701064|592573523|FG001|Overall Study|Withdrawal by Subject|1|||
164101781|NCT01597245|592734957|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101782|NCT01597245|592734958|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101783|NCT01597245|592734959|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101784|NCT01597245|592734960|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101785|NCT01597245|592734961|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101786|NCT01597245|592734962|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101787|NCT01597245|592734963|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
164101788|NCT01597245|592734964|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
164101789|NCT00731783|592734965|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
164101790|NCT00731783|592734966|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
164058227|NCT00701064|592573522|FG000|Overall Study|initiated other PTSD treatment|2|||
164058228|NCT00701064|592573523|FG001|Overall Study|initiated other PTSD treatment|2|||
164058229|NCT02613910|592573524|FG000|Overall Study|Termination of study|1|||
164058230|NCT02098733|592573525|FG000|Overall Study|Data Not Available|5|||
164058231|NCT02098733|592573525|FG000|Overall Study|Lost to Follow-up|5|||
164058232|NCT03077646|592573526|FG000|Overall Study|Lost to Follow-up|29|||
164058233|NCT03077646|592573527|FG001|Overall Study|Lost to Follow-up|30|||
164058234|NCT03077646|592573528|FG002|Overall Study|Lost to Follow-up|31|||
164101791|NCT00731783|592734965|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
164101792|NCT00731783|592734966|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
164101793|NCT00731783|592734965|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
164101794|NCT00731783|592734966|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
164101795|NCT00731783|592734965|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
164101796|NCT00731783|592734966|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
164101797|NCT03071575|592736517|FG000|Overall Study|Death|0|||
164101798|NCT03071575|592736518|FG001|Overall Study|Death|1|||
164101799|NCT03071575|592736517|FG000|Overall Study|Lost to Follow-up|5|||
164101800|NCT03071575|592736518|FG001|Overall Study|Lost to Follow-up|11|||
164101801|NCT03071575|592736517|FG000|Overall Study|Withdrawal by Subject|4|||
164101802|NCT03071575|592736518|FG001|Overall Study|Withdrawal by Subject|2|||
164101803|NCT00218257|592736523|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
164101804|NCT00218257|592736524|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
164101805|NCT00579345|592736525|FG000|Overall Study|Withdrawal by Subject|2|||
164101806|NCT00579345|592736526|FG001|Overall Study|Withdrawal by Subject|0|||
164101807|NCT00579345|592736527|FG002|Overall Study|Withdrawal by Subject|0|||
164101808|NCT00579345|592736528|FG003|Overall Study|Withdrawal by Subject|0|||
164101809|NCT00579345|592736529|FG004|Overall Study|Withdrawal by Subject|0|||
164101810|NCT00579345|592736530|FG005|Overall Study|Withdrawal by Subject|0|||
164101811|NCT00579345|592736531|FG006|Overall Study|Withdrawal by Subject|0|||
164101812|NCT00579345|592736532|FG007|Overall Study|Withdrawal by Subject|1|||
164101813|NCT00579345|592736525|FG000|Overall Study|Lost to Follow-up|1|||
164101814|NCT00579345|592736526|FG001|Overall Study|Lost to Follow-up|0|||
164058235|NCT00765726|592573529|FG000|Overall Study|Withdrawal by Subject|1|||
164058236|NCT00765726|592573529|FG000|Overall Study|Discontinuation of study by sponsor|8|||
164058237|NCT02993731|592573530|FG000|Overall Study|Study Termination|101|||
164058238|NCT02993731|592573531|FG001|Overall Study|Study Termination|105|||
164058239|NCT01002573|592575322|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
164058240|NCT01002573|592575323|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
164058241|NCT03808298|592575327|FG000|Overall Study|Adverse Event|3|||
164058242|NCT03808298|592575327|FG000|Overall Study|Physician Decision|1|||
164058243|NCT03808298|592575327|FG000|Overall Study|Withdrawal by Subject|1|||
164058244|NCT03808298|592575327|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
164058245|NCT02713490|592575328|FG000|Overall Study|Withdrawal by Subject|2|||
164058246|NCT02713490|592575329|FG001|Overall Study|Withdrawal by Subject|1|||
164058247|NCT02713490|592575328|FG000|Overall Study|Did not receive study drug|1|||
164058248|NCT02713490|592575329|FG001|Overall Study|Did not receive study drug|0|||
164058249|NCT02713490|592575328|FG000|Overall Study|Met exclusion criteria|0|||
164058250|NCT02713490|592575329|FG001|Overall Study|Met exclusion criteria|1|||
164058251|NCT03039686|592575330|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
164058252|NCT03039686|592575331|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
164058253|NCT03039686|592575332|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
164058254|NCT03039686|592575330|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
164058255|NCT03039686|592575331|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
164058256|NCT03039686|592575332|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
164058257|NCT03039686|592575330|FG000|Double-blind Period|Withdrawal by Subject|2|||
164058258|NCT03039686|592575331|FG001|Double-blind Period|Withdrawal by Subject|2|||
164058259|NCT03039686|592575332|FG002|Double-blind Period|Withdrawal by Subject|1|||
164101815|NCT00579345|592736527|FG002|Overall Study|Lost to Follow-up|0|||
164101816|NCT00579345|592736528|FG003|Overall Study|Lost to Follow-up|0|||
164101817|NCT00579345|592736529|FG004|Overall Study|Lost to Follow-up|0|||
164058260|NCT03039686|592575330|FG000|Double-blind Period|Death|0|||
164101818|NCT00579345|592736530|FG005|Overall Study|Lost to Follow-up|0|||
164101819|NCT00579345|592736531|FG006|Overall Study|Lost to Follow-up|0|||
164058261|NCT03039686|592575331|FG001|Double-blind Period|Death|0|||
164058262|NCT03039686|592575332|FG002|Double-blind Period|Death|1|||
164058263|NCT03039686|592575330|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
164058264|NCT03039686|592575331|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
164058265|NCT03039686|592575332|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
164058266|NCT03039686|592575330|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
164058267|NCT03039686|592575331|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
164058268|NCT03039686|592575332|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
164058269|NCT03039686|592575330|FG000|Open Label Period|Withdrawal by Subject|0|||
164058270|NCT03039686|592575331|FG001|Open Label Period|Withdrawal by Subject|3|||
164058271|NCT03039686|592575332|FG002|Open Label Period|Withdrawal by Subject|1|||
164058272|NCT03868410|592575336|FG000|Overall Study|Physician Decision|0|||
164058273|NCT03868410|592575337|FG001|Overall Study|Physician Decision|1|||
164058274|NCT00134563|592575341|FG000|Overall Study|Not treated due to protocol violation|0|||
164058275|NCT00134563|592575342|FG001|Overall Study|Not treated due to protocol violation|1|||
164058276|NCT00134563|592575343|FG002|Overall Study|Not treated due to protocol violation|1|||
164058277|NCT00134563|592575341|FG000|Overall Study|Adverse Event|29|||
164058278|NCT00134563|592575342|FG001|Overall Study|Adverse Event|37|||
164058279|NCT00134563|592575343|FG002|Overall Study|Adverse Event|38|||
164058280|NCT00134563|592575341|FG000|Overall Study|Lack of Efficacy|24|||
164058281|NCT00134563|592575342|FG001|Overall Study|Lack of Efficacy|14|||
164058282|NCT00134563|592575343|FG002|Overall Study|Lack of Efficacy|17|||
164058283|NCT00134563|592575341|FG000|Overall Study|Protocol Violation|3|||
164058284|NCT00134563|592575342|FG001|Overall Study|Protocol Violation|2|||
164058285|NCT00134563|592575343|FG002|Overall Study|Protocol Violation|5|||
164058286|NCT00134563|592575341|FG000|Overall Study|Lost to Follow-up|4|||
164058287|NCT00134563|592575342|FG001|Overall Study|Lost to Follow-up|0|||
164058288|NCT00134563|592575343|FG002|Overall Study|Lost to Follow-up|2|||
164058289|NCT00134563|592575341|FG000|Overall Study|progressive disease|11|||
164058290|NCT00134563|592575342|FG001|Overall Study|progressive disease|4|||
164058291|NCT00134563|592575343|FG002|Overall Study|progressive disease|2|||
164058292|NCT00134563|592575341|FG000|Overall Study|did not wish to continue|33|||
164058293|NCT00134563|592575342|FG001|Overall Study|did not wish to continue|32|||
164058294|NCT00134563|592575343|FG002|Overall Study|did not wish to continue|26|||
164058295|NCT00134563|592575341|FG000|Overall Study|Reason other than above|0|||
164058296|NCT00134563|592575342|FG001|Overall Study|Reason other than above|2|||
164058297|NCT00134563|592575343|FG002|Overall Study|Reason other than above|5|||
164058298|NCT03382639|592575347|FG000|Overall Study|Adverse Event|2|||
164058299|NCT03382639|592575348|FG001|Overall Study|Adverse Event|0|||
164058300|NCT03382639|592575349|FG002|Overall Study|Adverse Event|1|||
164058301|NCT03382639|592575350|FG003|Overall Study|Adverse Event|1|||
164058302|NCT03382639|592575347|FG000|Overall Study|Lost to Follow-up|1|||
164058303|NCT03382639|592575348|FG001|Overall Study|Lost to Follow-up|0|||
164058304|NCT03382639|592575349|FG002|Overall Study|Lost to Follow-up|0|||
164058305|NCT03382639|592575350|FG003|Overall Study|Lost to Follow-up|0|||
164058306|NCT03382639|592575347|FG000|Overall Study|Withdrawal by Subject|4|||
164058307|NCT03382639|592575348|FG001|Overall Study|Withdrawal by Subject|3|||
164058308|NCT03382639|592575349|FG002|Overall Study|Withdrawal by Subject|2|||
164058309|NCT03382639|592575350|FG003|Overall Study|Withdrawal by Subject|3|||
164058310|NCT03382639|592575347|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
164058311|NCT03382639|592575348|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
164058312|NCT03382639|592575349|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
164058313|NCT03382639|592575350|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
164058314|NCT03382639|592575347|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
164058315|NCT03382639|592575348|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
164058316|NCT03382639|592575349|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
164058317|NCT03382639|592575350|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
164058318|NCT03382639|592575347|FG000|Overall Study|Other|2|||
164058319|NCT03382639|592575348|FG001|Overall Study|Other|0|||
164058320|NCT03382639|592575349|FG002|Overall Study|Other|0|||
164058321|NCT03382639|592575350|FG003|Overall Study|Other|3|||
164058322|NCT02624713|592575353|FG000|Overall Study|Lost to Follow-up|14|||
164058323|NCT02624713|592575354|FG001|Overall Study|Lost to Follow-up|0|||
164058324|NCT00148109|592575355|FG000|Overall Study|Lack of Efficacy|10|||
164058325|NCT00148109|592575356|FG001|Overall Study|Lack of Efficacy|18|||
164058326|NCT00148109|592575355|FG000|Overall Study|Adverse Event|0|||
164058327|NCT00148109|592575356|FG001|Overall Study|Adverse Event|2|||
164058328|NCT00148109|592575355|FG000|Overall Study|Withdrawal by Subject|2|||
164058329|NCT00148109|592575356|FG001|Overall Study|Withdrawal by Subject|0|||
164058330|NCT06104423|592575357|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
164058331|NCT06104423|592575358|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
164058332|NCT06104423|592575359|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
164058333|NCT06104423|592575357|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
164058334|NCT06104423|592575358|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
164101820|NCT00579345|592736532|FG007|Overall Study|Lost to Follow-up|0|||
164101821|NCT00579345|592736525|FG000|Overall Study|Adverse Event|0|||
164058335|NCT06104423|592575359|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
164058336|NCT00351611|592575364|FG000|Overall Study|Adverse Event|11|||
164058337|NCT00351611|592575365|FG001|Overall Study|Adverse Event|3|||
164058338|NCT00351611|592575364|FG000|Overall Study|Death|1|||
164058339|NCT00351611|592575365|FG001|Overall Study|Death|0|||
164058340|NCT00351611|592575364|FG000|Overall Study|Lost to Follow-up|1|||
164058341|NCT00351611|592575365|FG001|Overall Study|Lost to Follow-up|0|||
164101822|NCT00579345|592736526|FG001|Overall Study|Adverse Event|0|||
164101823|NCT00579345|592736527|FG002|Overall Study|Adverse Event|1|||
164101824|NCT00579345|592736528|FG003|Overall Study|Adverse Event|0|||
164101825|NCT00579345|592736529|FG004|Overall Study|Adverse Event|0|||
164101826|NCT00579345|592736530|FG005|Overall Study|Adverse Event|0|||
164101827|NCT00579345|592736531|FG006|Overall Study|Adverse Event|0|||
164101828|NCT00579345|592736532|FG007|Overall Study|Adverse Event|0|||
164101829|NCT00579345|592736525|FG000|Overall Study|Protocol Violation|1|||
164101830|NCT00579345|592736526|FG001|Overall Study|Protocol Violation|0|||
164101831|NCT00579345|592736527|FG002|Overall Study|Protocol Violation|0|||
164101832|NCT00579345|592736528|FG003|Overall Study|Protocol Violation|0|||
164101833|NCT00579345|592736529|FG004|Overall Study|Protocol Violation|0|||
164101834|NCT00579345|592736530|FG005|Overall Study|Protocol Violation|0|||
164058342|NCT00351611|592575364|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
164058343|NCT00351611|592575365|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
164058344|NCT00351611|592575364|FG000|Overall Study|Other|1|||
164058345|NCT00351611|592575365|FG001|Overall Study|Other|0|||
164058346|NCT00351611|592575364|FG000|Overall Study|Protocol Violation|0|||
164058347|NCT00351611|592575365|FG001|Overall Study|Protocol Violation|2|||
164058348|NCT01589185|592575366|FG000|Overall Study|Death|1|||
164101835|NCT00579345|592736531|FG006|Overall Study|Protocol Violation|0|||
164101836|NCT00579345|592736532|FG007|Overall Study|Protocol Violation|1|||
164101837|NCT00579345|592736525|FG000|Overall Study|Death|1|||
164101838|NCT00579345|592736526|FG001|Overall Study|Death|1|||
164101839|NCT00579345|592736527|FG002|Overall Study|Death|1|||
164101840|NCT00579345|592736528|FG003|Overall Study|Death|1|||
164101841|NCT00579345|592736529|FG004|Overall Study|Death|0|||
164101842|NCT00579345|592736530|FG005|Overall Study|Death|0|||
164101843|NCT00579345|592736531|FG006|Overall Study|Death|0|||
164101844|NCT00579345|592736532|FG007|Overall Study|Death|0|||
164101845|NCT02267187|592736538|FG000|Overall Study|Physician Decision|2|||
164101846|NCT02267187|592736538|FG000|Overall Study|Screen fail|3|||
164101847|NCT00712959|592736543|FG000|Overall Study|Protocol Violation|3|||
164101848|NCT00712959|592736544|FG001|Overall Study|Protocol Violation|1|||
164101849|NCT00712959|592736543|FG000|Overall Study|Lost to Follow-up|13|||
164101850|NCT00712959|592736544|FG001|Overall Study|Lost to Follow-up|2|||
164101851|NCT00712959|592736543|FG000|Overall Study|Withdrawal by Subject|3|||
164101852|NCT00712959|592736544|FG001|Overall Study|Withdrawal by Subject|0|||
164101853|NCT00834067|592736545|FG000|Washout of 21 Days|Protocol Violation|0|||
164101854|NCT00834067|592736546|FG001|Washout of 21 Days|Protocol Violation|1|||
164101855|NCT00418561|592736547|FG000|Overall Study|Participant's (guardian's) decision|0|||
164101856|NCT00418561|592736548|FG001|Overall Study|Participant's (guardian's) decision|1|||
164101857|NCT00418561|592736549|FG002|Overall Study|Participant's (guardian's) decision|0|||
164101858|NCT01796171|592736550|FG000|Enrolled|Death|0|||
164101859|NCT01796171|592736551|FG001|Enrolled|Death|0|||
164101860|NCT01796171|592736552|FG002|Enrolled|Death|0|||
164101861|NCT01796171|592736553|FG003|Enrolled|Death|0|||
164101862|NCT01796171|592736554|FG004|Enrolled|Death|0|||
164101863|NCT01796171|592736555|FG005|Enrolled|Death|0|||
164058349|NCT01589185|592575367|FG001|Overall Study|Death|2|||
164101864|NCT01796171|592736556|FG006|Enrolled|Death|0|||
164101865|NCT01796171|592736557|FG007|Enrolled|Death|0|||
164101866|NCT01796171|592736558|FG008|Enrolled|Death|0|||
164101867|NCT01796171|592736559|FG009|Enrolled|Death|0|||
164101868|NCT01796171|592736560|FG010|Enrolled|Death|0|||
164101869|NCT01796171|592736561|FG011|Enrolled|Death|0|||
164101870|NCT01796171|592736562|FG012|Enrolled|Death|0|||
164058350|NCT01589185|592575368|FG002|Overall Study|Death|2|||
164058351|NCT01589185|592575369|FG003|Overall Study|Death|0|||
164058352|NCT01589185|592575370|FG004|Overall Study|Death|1|||
164101871|NCT01796171|592736563|FG013|Enrolled|Death|0|||
164101872|NCT01796171|592736564|FG014|Enrolled|Death|1|||
164101873|NCT01796171|592736550|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
164058353|NCT01589185|592575366|FG000|Overall Study|Lost to Follow-up|1|||
164101874|NCT01796171|592736551|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
164101875|NCT01796171|592736552|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
164101876|NCT01796171|592736553|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
164101877|NCT01796171|592736554|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
164058354|NCT01589185|592575367|FG001|Overall Study|Lost to Follow-up|0|||
164101878|NCT01796171|592736555|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
164101879|NCT01796171|592736556|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
164101880|NCT01796171|592736557|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
164101881|NCT01796171|592736558|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
164101882|NCT01796171|592736559|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
164058355|NCT01589185|592575368|FG002|Overall Study|Lost to Follow-up|2|||
164058356|NCT01589185|592575369|FG003|Overall Study|Lost to Follow-up|3|||
164058357|NCT01589185|592575370|FG004|Overall Study|Lost to Follow-up|0|||
164058358|NCT02708524|592575371|FG000|Overall Study|Adverse Event|0|||
164058359|NCT02708524|592575372|FG001|Overall Study|Adverse Event|1|||
164058360|NCT02708524|592575373|FG002|Overall Study|Adverse Event|0|||
164058361|NCT02708524|592575374|FG003|Overall Study|Adverse Event|0|||
164058362|NCT02708524|592575371|FG000|Overall Study|Lens Discomfort|1|||
164058363|NCT02708524|592575372|FG001|Overall Study|Lens Discomfort|0|||
164058364|NCT02708524|592575373|FG002|Overall Study|Lens Discomfort|1|||
164058365|NCT02708524|592575374|FG003|Overall Study|Lens Discomfort|0|||
164058366|NCT02708524|592575371|FG000|Overall Study|Lost to Follow-up|1|||
164058367|NCT02708524|592575372|FG001|Overall Study|Lost to Follow-up|1|||
164058368|NCT02708524|592575373|FG002|Overall Study|Lost to Follow-up|1|||
164058369|NCT02708524|592575374|FG003|Overall Study|Lost to Follow-up|0|||
164058370|NCT02708524|592575371|FG000|Overall Study|Protocol Violation|0|||
164058371|NCT02708524|592575372|FG001|Overall Study|Protocol Violation|1|||
164058372|NCT02708524|592575373|FG002|Overall Study|Protocol Violation|0|||
164058373|NCT02708524|592575374|FG003|Overall Study|Protocol Violation|0|||
164058374|NCT02708524|592575371|FG000|Overall Study|Withdrawal by Subject|1|||
164058375|NCT02708524|592575372|FG001|Overall Study|Withdrawal by Subject|1|||
164058376|NCT02708524|592575373|FG002|Overall Study|Withdrawal by Subject|0|||
164058377|NCT02708524|592575374|FG003|Overall Study|Withdrawal by Subject|0|||
164058378|NCT02708524|592575371|FG000|Overall Study|Dispensed incorrect study lens|0|||
164058379|NCT02708524|592575372|FG001|Overall Study|Dispensed incorrect study lens|1|||
164058380|NCT02708524|592575373|FG002|Overall Study|Dispensed incorrect study lens|1|||
164058381|NCT02708524|592575374|FG003|Overall Study|Dispensed incorrect study lens|0|||
164058382|NCT02708524|592575371|FG000|Overall Study|Did not wear lens at final visit|0|||
164058383|NCT02708524|592575372|FG001|Overall Study|Did not wear lens at final visit|1|||
164058384|NCT02708524|592575373|FG002|Overall Study|Did not wear lens at final visit|0|||
164058385|NCT02708524|592575374|FG003|Overall Study|Did not wear lens at final visit|0|||
164058386|NCT02708524|592575371|FG000|Overall Study|Subject lost study lens|1|||
164058387|NCT02708524|592575372|FG001|Overall Study|Subject lost study lens|0|||
164058388|NCT02708524|592575373|FG002|Overall Study|Subject lost study lens|0|||
164058389|NCT02708524|592575374|FG003|Overall Study|Subject lost study lens|0|||
164058390|NCT03781167|592575380|FG000|Overall Study|Adverse Event|23|||
164058391|NCT03781167|592575381|FG001|Overall Study|Adverse Event|25|||
164058392|NCT03781167|592575380|FG000|Overall Study|Withdrew consent|16|||
164058393|NCT03781167|592575381|FG001|Overall Study|Withdrew consent|12|||
164058394|NCT03781167|592575380|FG000|Overall Study|Lost to Follow-up|0|||
164058395|NCT03781167|592575381|FG001|Overall Study|Lost to Follow-up|1|||
164058396|NCT03781167|592575380|FG000|Overall Study|Lack of Efficacy|4|||
164058397|NCT03781167|592575381|FG001|Overall Study|Lack of Efficacy|5|||
164058398|NCT03781167|592575380|FG000|Overall Study|Difficulty with drug delivery system|2|||
164058399|NCT03781167|592575381|FG001|Overall Study|Difficulty with drug delivery system|3|||
164058400|NCT03781167|592575380|FG000|Overall Study|Other, not specified|2|||
164058401|NCT03781167|592575381|FG001|Overall Study|Other, not specified|2|||
164058402|NCT00462501|592575382|FG000|Overall Study|Not treated|3|||
164058403|NCT00462501|592575382|FG000|Overall Study|Adverse Event|2|||
164058404|NCT00679354|592575387|FG000|Overall Study|Death|3|||
164058405|NCT00679354|592575387|FG000|Overall Study|Lack of Efficacy|22|||
164058406|NCT00679354|592575387|FG000|Overall Study|Physician Decision|4|||
164058407|NCT00679354|592575387|FG000|Overall Study|Ineligible|1|||
164058408|NCT01258803|592575397|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
164058409|NCT01258803|592575398|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
164058410|NCT01258803|592575399|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
164058411|NCT01258803|592575400|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
164058412|NCT01258803|592575401|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
164058413|NCT01258803|592575402|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
164058414|NCT01258803|592575397|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164058415|NCT01258803|592575398|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
164058416|NCT01258803|592575399|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164058417|NCT01258803|592575400|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164058418|NCT01258803|592575401|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164058419|NCT01258803|592575402|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
164058420|NCT01258803|592575397|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164058421|NCT01258803|592575398|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164058422|NCT01258803|592575399|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
164058423|NCT01258803|592575400|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164058424|NCT01258803|592575401|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164058425|NCT01258803|592575402|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
164058426|NCT01552408|592575403|FG000|Overall Study|Lost to Follow-up|2|||
164058427|NCT01552408|592575404|FG001|Overall Study|Lost to Follow-up|0|||
164058428|NCT01552408|592575403|FG000|Overall Study|Relocation|0|||
164058429|NCT01552408|592575404|FG001|Overall Study|Relocation|1|||
164058430|NCT01552408|592575403|FG000|Overall Study|Withdrawal by Subject|2|||
164058431|NCT01552408|592575404|FG001|Overall Study|Withdrawal by Subject|1|||
164058432|NCT01016912|592575407|FG000|End of Treatment Period|Lack of Efficacy|0|||
164058433|NCT01016912|592575408|FG001|End of Treatment Period|Lack of Efficacy|1|||
164058434|NCT01016912|592575409|FG002|End of Treatment Period|Lack of Efficacy|0|||
164058435|NCT01016912|592575410|FG003|End of Treatment Period|Lack of Efficacy|4|||
164058436|NCT01016912|592575411|FG004|End of Treatment Period|Lack of Efficacy|4|||
164058437|NCT01016912|592575407|FG000|End of Treatment Period|Adverse Event|0|||
164058438|NCT01016912|592575408|FG001|End of Treatment Period|Adverse Event|1|||
164058439|NCT01016912|592575409|FG002|End of Treatment Period|Adverse Event|1|||
164058440|NCT01016912|592575410|FG003|End of Treatment Period|Adverse Event|0|||
164058441|NCT01016912|592575411|FG004|End of Treatment Period|Adverse Event|0|||
164058442|NCT01016912|592575407|FG000|End of Treatment Period|Completed double-blind period only|0|||
164058443|NCT01016912|592575408|FG001|End of Treatment Period|Completed double-blind period only|1|||
164058444|NCT01016912|592575409|FG002|End of Treatment Period|Completed double-blind period only|0|||
164058445|NCT01016912|592575410|FG003|End of Treatment Period|Completed double-blind period only|0|||
164058446|NCT01016912|592575411|FG004|End of Treatment Period|Completed double-blind period only|0|||
164058447|NCT01016912|592575407|FG000|Follow-up Period|Other reason|0|||
164058448|NCT01016912|592575408|FG001|Follow-up Period|Other reason|0|||
164058449|NCT01016912|592575409|FG002|Follow-up Period|Other reason|1|||
164058450|NCT01016912|592575410|FG003|Follow-up Period|Other reason|1|||
164058451|NCT01016912|592575411|FG004|Follow-up Period|Other reason|0|||
164058452|NCT01853397|592575414|FG000|Overall Study|Withdrawal by Subject|0|||
164058453|NCT01853397|592575415|FG001|Overall Study|Withdrawal by Subject|0|||
164058454|NCT01853397|592575416|FG002|Overall Study|Withdrawal by Subject|0|||
164058455|NCT01853397|592575417|FG003|Overall Study|Withdrawal by Subject|1|||
164058456|NCT01853397|592575414|FG000|Overall Study|Subject Noncompliance|0|||
164058457|NCT01853397|592575415|FG001|Overall Study|Subject Noncompliance|0|||
164058458|NCT01853397|592575416|FG002|Overall Study|Subject Noncompliance|0|||
164058459|NCT01853397|592575417|FG003|Overall Study|Subject Noncompliance|1|||
164058460|NCT01632345|592575418|FG000|Treatment: Part I|Adverse Event|1|||
164058461|NCT01632345|592575419|FG001|Treatment: Part I|Adverse Event|4|||
164058462|NCT01632345|592575420|FG002|Treatment: Part I|Adverse Event|2|||
164058463|NCT01632345|592575421|FG003|Treatment: Part I|Adverse Event|1|||
164058464|NCT01632345|592575422|FG004|Treatment: Part I|Adverse Event|3|||
164058465|NCT01632345|592575423|FG005|Treatment: Part I|Adverse Event|0|||
164058466|NCT01632345|592575424|FG006|Treatment: Part I|Adverse Event|0|||
164058467|NCT01632345|592575418|FG000|Treatment: Part I|Lack of Efficacy|0|||
164058468|NCT01632345|592575419|FG001|Treatment: Part I|Lack of Efficacy|1|||
164058469|NCT01632345|592575420|FG002|Treatment: Part I|Lack of Efficacy|0|||
164058470|NCT01632345|592575421|FG003|Treatment: Part I|Lack of Efficacy|1|||
164058471|NCT01632345|592575422|FG004|Treatment: Part I|Lack of Efficacy|1|||
164058472|NCT01632345|592575423|FG005|Treatment: Part I|Lack of Efficacy|0|||
164058473|NCT01632345|592575424|FG006|Treatment: Part I|Lack of Efficacy|0|||
164058474|NCT01632345|592575418|FG000|Treatment: Part I|Lost to Follow-up|3|||
164058475|NCT01632345|592575419|FG001|Treatment: Part I|Lost to Follow-up|2|||
164058476|NCT01632345|592575420|FG002|Treatment: Part I|Lost to Follow-up|1|||
164058477|NCT01632345|592575421|FG003|Treatment: Part I|Lost to Follow-up|3|||
164058478|NCT01632345|592575422|FG004|Treatment: Part I|Lost to Follow-up|4|||
164058479|NCT01632345|592575423|FG005|Treatment: Part I|Lost to Follow-up|0|||
164058480|NCT01632345|592575424|FG006|Treatment: Part I|Lost to Follow-up|0|||
164058481|NCT01632345|592575418|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
164058482|NCT01632345|592575419|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
164058483|NCT01632345|592575420|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
164058484|NCT01632345|592575421|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
164058485|NCT01632345|592575422|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
164058486|NCT01632345|592575423|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
164058487|NCT01632345|592575424|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
164058488|NCT01632345|592575418|FG000|Treatment: Part I|Physician Decision|2|||
164058489|NCT01632345|592575419|FG001|Treatment: Part I|Physician Decision|1|||
164058490|NCT01632345|592575420|FG002|Treatment: Part I|Physician Decision|0|||
164058491|NCT01632345|592575421|FG003|Treatment: Part I|Physician Decision|0|||
164058492|NCT01632345|592575422|FG004|Treatment: Part I|Physician Decision|1|||
164058493|NCT01632345|592575423|FG005|Treatment: Part I|Physician Decision|0|||
164058494|NCT01632345|592575424|FG006|Treatment: Part I|Physician Decision|0|||
164058495|NCT01632345|592575418|FG000|Treatment: Part I|Pregnancy|0|||
164058496|NCT01632345|592575419|FG001|Treatment: Part I|Pregnancy|1|||
164058497|NCT01632345|592575420|FG002|Treatment: Part I|Pregnancy|0|||
164058498|NCT01632345|592575421|FG003|Treatment: Part I|Pregnancy|0|||
164058499|NCT01632345|592575422|FG004|Treatment: Part I|Pregnancy|0|||
164058500|NCT01632345|592575423|FG005|Treatment: Part I|Pregnancy|0|||
164058501|NCT01632345|592575424|FG006|Treatment: Part I|Pregnancy|0|||
164058502|NCT01632345|592575418|FG000|Treatment: Part I|Protocol Deviation|0|||
164058503|NCT01632345|592575419|FG001|Treatment: Part I|Protocol Deviation|0|||
164058504|NCT01632345|592575420|FG002|Treatment: Part I|Protocol Deviation|1|||
164058505|NCT01632345|592575421|FG003|Treatment: Part I|Protocol Deviation|1|||
164058506|NCT01632345|592575422|FG004|Treatment: Part I|Protocol Deviation|0|||
164058507|NCT01632345|592575423|FG005|Treatment: Part I|Protocol Deviation|0|||
164058508|NCT01632345|592575424|FG006|Treatment: Part I|Protocol Deviation|0|||
164058509|NCT01632345|592575418|FG000|Treatment: Part I|Withdrawal by Subject|3|||
164058510|NCT01632345|592575419|FG001|Treatment: Part I|Withdrawal by Subject|4|||
164058511|NCT01632345|592575420|FG002|Treatment: Part I|Withdrawal by Subject|4|||
164058512|NCT01632345|592575421|FG003|Treatment: Part I|Withdrawal by Subject|1|||
164058513|NCT01632345|592575422|FG004|Treatment: Part I|Withdrawal by Subject|4|||
164058514|NCT01632345|592575423|FG005|Treatment: Part I|Withdrawal by Subject|0|||
164058515|NCT01632345|592575424|FG006|Treatment: Part I|Withdrawal by Subject|0|||
164058516|NCT01632345|592575418|FG000|Treatment: Part II|Adverse Event|0|||
164058517|NCT01632345|592575419|FG001|Treatment: Part II|Adverse Event|0|||
164058518|NCT01632345|592575420|FG002|Treatment: Part II|Adverse Event|0|||
164058519|NCT01632345|592575421|FG003|Treatment: Part II|Adverse Event|0|||
164058520|NCT01632345|592575422|FG004|Treatment: Part II|Adverse Event|0|||
164058521|NCT01632345|592575423|FG005|Treatment: Part II|Adverse Event|3|||
164058522|NCT01632345|592575424|FG006|Treatment: Part II|Adverse Event|8|||
164058523|NCT01632345|592575418|FG000|Treatment: Part II|Lost to Follow-up|0|||
164058524|NCT01632345|592575419|FG001|Treatment: Part II|Lost to Follow-up|0|||
164058525|NCT01632345|592575420|FG002|Treatment: Part II|Lost to Follow-up|0|||
164058526|NCT01632345|592575421|FG003|Treatment: Part II|Lost to Follow-up|0|||
164058527|NCT01632345|592575422|FG004|Treatment: Part II|Lost to Follow-up|0|||
164058528|NCT01632345|592575423|FG005|Treatment: Part II|Lost to Follow-up|3|||
164058529|NCT01632345|592575424|FG006|Treatment: Part II|Lost to Follow-up|1|||
164058530|NCT01632345|592575418|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
164058531|NCT01632345|592575419|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
164058532|NCT01632345|592575420|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
164058533|NCT01632345|592575421|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
164058534|NCT01632345|592575422|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
164058535|NCT01632345|592575423|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
164058536|NCT01632345|592575424|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
164058537|NCT01632345|592575418|FG000|Treatment: Part II|Withdrawal by Subject|0|||
164058538|NCT01632345|592575419|FG001|Treatment: Part II|Withdrawal by Subject|0|||
164058539|NCT01632345|592575420|FG002|Treatment: Part II|Withdrawal by Subject|0|||
164058540|NCT01632345|592575421|FG003|Treatment: Part II|Withdrawal by Subject|0|||
164058541|NCT01632345|592575422|FG004|Treatment: Part II|Withdrawal by Subject|0|||
164058542|NCT01632345|592575423|FG005|Treatment: Part II|Withdrawal by Subject|2|||
164058543|NCT01632345|592575424|FG006|Treatment: Part II|Withdrawal by Subject|2|||
164058544|NCT00089505|592575425|FG000|Overall Study|Death|4|||
164058545|NCT00089505|592575426|FG001|Overall Study|Death|1|||
164058546|NCT00089505|592575427|FG002|Overall Study|Death|5|||
164058547|NCT00089505|592575428|FG003|Overall Study|Death|8|||
164058548|NCT00089505|592575425|FG000|Overall Study|Withdrawal by Subject|3|||
164058549|NCT00089505|592575426|FG001|Overall Study|Withdrawal by Subject|0|||
164058550|NCT00089505|592575427|FG002|Overall Study|Withdrawal by Subject|6|||
164058551|NCT00089505|592575428|FG003|Overall Study|Withdrawal by Subject|6|||
164058552|NCT00089505|592575425|FG000|Overall Study|Lost to Follow-up|1|||
164058553|NCT00089505|592575426|FG001|Overall Study|Lost to Follow-up|1|||
164058554|NCT00089505|592575427|FG002|Overall Study|Lost to Follow-up|9|||
164058555|NCT00089505|592575428|FG003|Overall Study|Lost to Follow-up|7|||
164058556|NCT00089505|592575425|FG000|Overall Study|Physician Decision|1|||
164058557|NCT00089505|592575426|FG001|Overall Study|Physician Decision|0|||
164058558|NCT00089505|592575427|FG002|Overall Study|Physician Decision|0|||
164058559|NCT00089505|592575428|FG003|Overall Study|Physician Decision|0|||
164058560|NCT00089505|592575425|FG000|Overall Study|Protocol Violation|0|||
164058561|NCT00089505|592575426|FG001|Overall Study|Protocol Violation|0|||
164058562|NCT00089505|592575427|FG002|Overall Study|Protocol Violation|1|||
164058563|NCT00089505|592575428|FG003|Overall Study|Protocol Violation|0|||
164058564|NCT02431559|592575429|FG000|Overall Study|Adverse Event|0|||
164058565|NCT02431559|592575430|FG001|Overall Study|Adverse Event|1|||
164058566|NCT02431559|592575431|FG002|Overall Study|Adverse Event|0|||
164058567|NCT02431559|592575432|FG003|Overall Study|Adverse Event|4|||
164058568|NCT02431559|592575429|FG000|Overall Study|Progressive disease|2|||
164058569|NCT02431559|592575430|FG001|Overall Study|Progressive disease|1|||
164058570|NCT02431559|592575431|FG002|Overall Study|Progressive disease|4|||
164058571|NCT02431559|592575432|FG003|Overall Study|Progressive disease|22|||
164058572|NCT02431559|592575429|FG000|Overall Study|Withdrawal by Subject|0|||
164058573|NCT02431559|592575430|FG001|Overall Study|Withdrawal by Subject|1|||
164058574|NCT02431559|592575431|FG002|Overall Study|Withdrawal by Subject|0|||
164058575|NCT02431559|592575432|FG003|Overall Study|Withdrawal by Subject|4|||
164058576|NCT02431559|592575429|FG000|Overall Study|Physician Decision|0|||
164058577|NCT02431559|592575430|FG001|Overall Study|Physician Decision|0|||
164058578|NCT02431559|592575431|FG002|Overall Study|Physician Decision|0|||
164058579|NCT02431559|592575432|FG003|Overall Study|Physician Decision|1|||
164058580|NCT02543918|592575433|FG000|Overall Study|Never treated|0|||
164058581|NCT02543918|592575434|FG001|Overall Study|Never treated|1|||
164058582|NCT02543918|592575433|FG000|Overall Study|Lost to Follow-up|1|||
164058583|NCT02543918|592575434|FG001|Overall Study|Lost to Follow-up|1|||
164058584|NCT02543918|592575433|FG000|Overall Study|Withdrawal by Subject|1|||
164058585|NCT02543918|592575434|FG001|Overall Study|Withdrawal by Subject|1|||
164058586|NCT02543918|592575433|FG000|Overall Study|Adverse Event|1|||
164058587|NCT02543918|592575434|FG001|Overall Study|Adverse Event|1|||
164058588|NCT00486720|592575437|FG000|Overall Study|Adverse Event|1|||
164058589|NCT00486720|592575438|FG001|Overall Study|Adverse Event|2|||
164058590|NCT00486720|592575437|FG000|Overall Study|Lack of Efficacy|4|||
164058591|NCT00486720|592575438|FG001|Overall Study|Lack of Efficacy|6|||
164058592|NCT00486720|592575437|FG000|Overall Study|Physician Decision|1|||
164058593|NCT00486720|592575438|FG001|Overall Study|Physician Decision|2|||
164058594|NCT00486720|592575437|FG000|Overall Study|Protocol Violation|1|||
164058595|NCT00486720|592575438|FG001|Overall Study|Protocol Violation|0|||
164058596|NCT00486720|592575437|FG000|Overall Study|Withdrawal by Subject|3|||
164058597|NCT00486720|592575438|FG001|Overall Study|Withdrawal by Subject|1|||
164058598|NCT00486720|592575437|FG000|Overall Study|Progressive Disease|0|||
164058599|NCT00486720|592575438|FG001|Overall Study|Progressive Disease|1|||
164058600|NCT05047601|592575446|FG000|Overall Study|Lost to Follow-up|9|||
164058601|NCT05047601|592575447|FG001|Overall Study|Lost to Follow-up|11|||
164058602|NCT05047601|592575448|FG002|Overall Study|Lost to Follow-up|7|||
164058603|NCT05047601|592575446|FG000|Overall Study|Withdrawal by Subject|25|||
164058604|NCT05047601|592575447|FG001|Overall Study|Withdrawal by Subject|36|||
164058605|NCT05047601|592575448|FG002|Overall Study|Withdrawal by Subject|23|||
164058606|NCT05047601|592575446|FG000|Overall Study|Other|10|||
164058607|NCT05047601|592575447|FG001|Overall Study|Other|6|||
164058608|NCT05047601|592575448|FG002|Overall Study|Other|5|||
164058609|NCT00286234|592575449|FG000|Overall Study|Protocol Violation|1|||
164058610|NCT00286234|592575450|FG001|Overall Study|Protocol Violation|2|||
164058611|NCT00286234|592575451|FG002|Overall Study|Protocol Violation|0|||
164058612|NCT00286234|592575452|FG003|Overall Study|Protocol Violation|1|||
164058613|NCT00286234|592575449|FG000|Overall Study|Physician Decision|1|||
164058614|NCT00286234|592575450|FG001|Overall Study|Physician Decision|0|||
164058615|NCT00286234|592575451|FG002|Overall Study|Physician Decision|0|||
164058616|NCT00286234|592575452|FG003|Overall Study|Physician Decision|1|||
164058617|NCT00286234|592575449|FG000|Overall Study|Adverse Event|0|||
164058618|NCT00286234|592575450|FG001|Overall Study|Adverse Event|0|||
164058619|NCT00286234|592575451|FG002|Overall Study|Adverse Event|0|||
164058620|NCT00286234|592575452|FG003|Overall Study|Adverse Event|1|||
164058621|NCT00286234|592575449|FG000|Overall Study|Adverse Event|0|||
164058622|NCT00286234|592575450|FG001|Overall Study|Adverse Event|0|||
164058623|NCT00286234|592575451|FG002|Overall Study|Adverse Event|0|||
164058624|NCT00286234|592575452|FG003|Overall Study|Adverse Event|1|||
164058625|NCT02924129|592575457|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
164058626|NCT02924129|592575458|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
164058627|NCT02924129|592575457|FG000|Overall Study|Withdrawal by Subject|2|||
164058628|NCT02924129|592575458|FG001|Overall Study|Withdrawal by Subject|2|||
164058629|NCT02924129|592575457|FG000|Overall Study|Physician Decision|1|||
164058630|NCT02924129|592575458|FG001|Overall Study|Physician Decision|0|||
164058631|NCT02924129|592575457|FG000|Overall Study|Missed Visit|0|||
164058632|NCT02924129|592575458|FG001|Overall Study|Missed Visit|1|||
164058633|NCT00302731|592575466|FG000|Overall Study|Lost to Follow-up|1|||
164058634|NCT00302731|592575467|FG001|Overall Study|Lost to Follow-up|2|||
164058635|NCT00302731|592575468|FG002|Overall Study|Lost to Follow-up|0|||
164058636|NCT00302731|592575469|FG003|Overall Study|Lost to Follow-up|0|||
164058637|NCT00302731|592575466|FG000|Overall Study|Adverse Event|0|||
164058638|NCT00302731|592575467|FG001|Overall Study|Adverse Event|2|||
164058639|NCT00302731|592575468|FG002|Overall Study|Adverse Event|2|||
164058640|NCT00302731|592575469|FG003|Overall Study|Adverse Event|0|||
164058641|NCT00302731|592575466|FG000|Overall Study|Withdrawal by Subject|1|||
164058642|NCT00302731|592575467|FG001|Overall Study|Withdrawal by Subject|1|||
164058643|NCT00302731|592575468|FG002|Overall Study|Withdrawal by Subject|0|||
164058644|NCT00302731|592575469|FG003|Overall Study|Withdrawal by Subject|0|||
164058645|NCT00302731|592575466|FG000|Overall Study|Protocol Violation|1|||
164058646|NCT00302731|592575467|FG001|Overall Study|Protocol Violation|0|||
164058647|NCT00302731|592575468|FG002|Overall Study|Protocol Violation|0|||
164058648|NCT00302731|592575469|FG003|Overall Study|Protocol Violation|0|||
164058649|NCT00302731|592575466|FG000|Overall Study|cancer unrelated to study discovered|1|||
164058650|NCT00302731|592575467|FG001|Overall Study|cancer unrelated to study discovered|0|||
164058651|NCT00302731|592575468|FG002|Overall Study|cancer unrelated to study discovered|1|||
164058652|NCT00302731|592575469|FG003|Overall Study|cancer unrelated to study discovered|0|||
164058653|NCT01610752|592575472|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
164058654|NCT01610752|592575473|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
164058655|NCT01610752|592575474|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
164058656|NCT00283062|592575475|FG000|Overall Study|Did not receive any study medication|5|||
164058657|NCT00283062|592575476|FG001|Overall Study|Did not receive any study medication|4|||
164058658|NCT00283062|592575477|FG002|Overall Study|Did not receive any study medication|36|||
164058659|NCT00283062|592575478|FG003|Overall Study|Did not receive any study medication|45|||
164058660|NCT00283062|592575475|FG000|Overall Study|Adverse Event|2|||
164058661|NCT00283062|592575476|FG001|Overall Study|Adverse Event|0|||
164058662|NCT00283062|592575477|FG002|Overall Study|Adverse Event|1|||
164058663|NCT00283062|592575478|FG003|Overall Study|Adverse Event|0|||
164058664|NCT00283062|592575475|FG000|Overall Study|Lost to Follow-up|1|||
164058665|NCT00283062|592575476|FG001|Overall Study|Lost to Follow-up|0|||
164058666|NCT00283062|592575477|FG002|Overall Study|Lost to Follow-up|1|||
164058667|NCT00283062|592575478|FG003|Overall Study|Lost to Follow-up|0|||
164058668|NCT00283062|592575475|FG000|Overall Study|Progressive disease|0|||
164058669|NCT00283062|592575476|FG001|Overall Study|Progressive disease|0|||
164058670|NCT00283062|592575477|FG002|Overall Study|Progressive disease|1|||
164058671|NCT00283062|592575478|FG003|Overall Study|Progressive disease|0|||
164058672|NCT00283062|592575475|FG000|Overall Study|Participant did not wish to continue|3|||
164058673|NCT00283062|592575476|FG001|Overall Study|Participant did not wish to continue|2|||
164058674|NCT00283062|592575477|FG002|Overall Study|Participant did not wish to continue|1|||
164058675|NCT00283062|592575478|FG003|Overall Study|Participant did not wish to continue|0|||
164058676|NCT00283062|592575475|FG000|Overall Study|Undefined|0|||
164058677|NCT00283062|592575476|FG001|Overall Study|Undefined|1|||
164058678|NCT00283062|592575477|FG002|Overall Study|Undefined|1|||
164058679|NCT00283062|592575478|FG003|Overall Study|Undefined|4|||
164058680|NCT00283062|592575475|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
164058681|NCT00283062|592575476|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
164058682|NCT00283062|592575477|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
164058683|NCT00283062|592575478|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
164058684|NCT01843933|592575479|FG000|Overall Study|Data lost|6|||
164058685|NCT01843933|592575480|FG001|Overall Study|Data lost|4|||
164058686|NCT03137173|592575481|FG000|Overall Study|Withdrawal by Subject|8|||
164058687|NCT03137173|592575482|FG001|Overall Study|Withdrawal by Subject|13|||
164058688|NCT03137173|592575481|FG000|Overall Study|Death|1|||
164058689|NCT03137173|592575482|FG001|Overall Study|Death|3|||
164058690|NCT03137173|592575481|FG000|Overall Study|Physician Decision|1|||
164058691|NCT03137173|592575482|FG001|Overall Study|Physician Decision|0|||
164058692|NCT03137173|592575481|FG000|Overall Study|Lost to Follow-up|13|||
164058693|NCT03137173|592575482|FG001|Overall Study|Lost to Follow-up|18|||
164058694|NCT03137173|592575481|FG000|Overall Study|Other reasons|3|||
164058695|NCT03137173|592575482|FG001|Overall Study|Other reasons|2|||
164058696|NCT01535638|592575483|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
164058697|NCT01535638|592575484|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
164058698|NCT01535638|592575485|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
164058699|NCT01535638|592575486|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
164058700|NCT01535638|592575487|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
164058701|NCT01535638|592575488|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
164058702|NCT01535638|592575483|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
164058703|NCT01535638|592575484|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
164058704|NCT01535638|592575485|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
164058705|NCT01535638|592575486|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
164058706|NCT01535638|592575487|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
164058707|NCT01535638|592575488|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
164058708|NCT05060003|592575489|FG000|Overall Study|ctDNA negative|7|||
164058709|NCT03524664|592575490|FG000|Overall Study|Withdrawal by Subject|1|||
164058710|NCT03524664|592575491|FG001|Overall Study|Withdrawal by Subject|2|||
164058711|NCT03524664|592575490|FG000|Overall Study|Lost to Follow-up|4|||
164058712|NCT03524664|592575491|FG001|Overall Study|Lost to Follow-up|13|||
164058713|NCT01482598|592575492|FG000|Overall Study|Death|7|||
164058714|NCT01482598|592575493|FG001|Overall Study|Death|10|||
164058715|NCT01482598|592575492|FG000|Overall Study|Physician Decision|0|||
164058716|NCT01482598|592575493|FG001|Overall Study|Physician Decision|3|||
164058717|NCT01482598|592575492|FG000|Overall Study|Withdrawal by Subject|4|||
164058718|NCT01482598|592575493|FG001|Overall Study|Withdrawal by Subject|5|||
164058719|NCT01482598|592575492|FG000|Overall Study|Lost to Follow-up|5|||
164058720|NCT01482598|592575493|FG001|Overall Study|Lost to Follow-up|4|||
164058721|NCT01373294|592575494|FG000|Overall Study|Adverse Event|1|||
164058722|NCT01373294|592575495|FG001|Overall Study|Adverse Event|0|||
164058723|NCT00423267|592575496|FG000|Period A|Withdrawal by Subject|0|||
164058724|NCT00423267|592575497|FG001|Period A|Withdrawal by Subject|1|||
164058725|NCT00423267|592575496|FG000|Period A|Non-compliance with protocol|1|||
164058726|NCT00423267|592575497|FG001|Period A|Non-compliance with protocol|0|||
164058727|NCT00423267|592575496|FG000|Period A|Administrative|1|||
164058728|NCT00423267|592575497|FG001|Period A|Administrative|0|||
164058729|NCT03702166|592575498|FG000|Overall Study|Lost to Follow-up|1|||
164058730|NCT03702166|592575498|FG000|Overall Study|Withdrawal by Subject|1|||
164101883|NCT01796171|592736560|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
164058731|NCT00827112|592575499|FG000|Overall Study|Adverse Event|2|||
164058732|NCT00827112|592575500|FG001|Overall Study|Adverse Event|0|||
164058733|NCT00827112|592575499|FG000|Overall Study|Lack of Efficacy|2|||
164148720|NCT03207867|592904949|FG013|Overall Study|Physician Decision|0|||
164058734|NCT00827112|592575500|FG001|Overall Study|Lack of Efficacy|0|||
164058735|NCT00827112|592575499|FG000|Overall Study|Lost to Follow-up|3|||
164058736|NCT00827112|592575500|FG001|Overall Study|Lost to Follow-up|2|||
164058737|NCT00827112|592575499|FG000|Overall Study|Pregnancy|0|||
164058738|NCT00827112|592575500|FG001|Overall Study|Pregnancy|1|||
164058739|NCT00827112|592575499|FG000|Overall Study|Protocol Violation|0|||
164058740|NCT00827112|592575500|FG001|Overall Study|Protocol Violation|2|||
164058741|NCT00827112|592575499|FG000|Overall Study|Withdrawal by Subject|2|||
164058742|NCT00827112|592575500|FG001|Overall Study|Withdrawal by Subject|1|||
164058743|NCT00827112|592575499|FG000|Overall Study|Randomized but not treated|5|||
164058744|NCT00827112|592575500|FG001|Overall Study|Randomized but not treated|3|||
164058745|NCT00827112|592575499|FG000|Overall Study|Other|1|||
164058746|NCT00827112|592575500|FG001|Overall Study|Other|3|||
164058747|NCT01333865|592575501|FG000|Overall Study|Adverse Event|2|||
164058748|NCT03512028|592575504|FG000|Overall Study|Withdrawal by Subject|2|||
164058749|NCT03512028|592575505|FG001|Overall Study|Withdrawal by Subject|0|||
164058750|NCT03512028|592575504|FG000|Overall Study|Protocol Violation|2|||
164058751|NCT03512028|592575505|FG001|Overall Study|Protocol Violation|0|||
164058752|NCT02127931|592575508|FG000|Overall Study|Glitch in Game|1|||
164058753|NCT00939094|592575509|FG000|Overall Study|Adverse Event|9|||
164058754|NCT00939094|592575510|FG001|Overall Study|Adverse Event|0|||
164058755|NCT00939094|592575509|FG000|Overall Study|Withdrawal by Subject|1|||
164058756|NCT00939094|592575510|FG001|Overall Study|Withdrawal by Subject|6|||
164058757|NCT00939094|592575509|FG000|Overall Study|Lost to Follow-up|1|||
164058758|NCT00939094|592575510|FG001|Overall Study|Lost to Follow-up|1|||
164058759|NCT00939094|592575509|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164058760|NCT00939094|592575510|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164058761|NCT00939094|592575509|FG000|Overall Study|Severe non-compliance to protocol|0|||
164058762|NCT00939094|592575510|FG001|Overall Study|Severe non-compliance to protocol|1|||
164058763|NCT00939094|592575509|FG000|Overall Study|Study stopped by sponsor|0|||
164058764|NCT00939094|592575510|FG001|Overall Study|Study stopped by sponsor|2|||
164058765|NCT00939094|592575509|FG000|Overall Study|Abnormal ECG findings|1|||
164058766|NCT00939094|592575510|FG001|Overall Study|Abnormal ECG findings|0|||
164058767|NCT02028182|592576946|FG000|Overall Study|Protocol Violation|2|||
164058768|NCT01684930|592576947|FG000|Overall Study|Withdrawal by Subject|3|||
164058769|NCT01684930|592576948|FG001|Overall Study|Withdrawal by Subject|1|||
164058770|NCT01945866|592576949|FG000|Overall Study|Eyes did not complete or were dropped|2|||
164058771|NCT01945866|592576950|FG001|Overall Study|Eyes did not complete or were dropped|0|||
164058772|NCT01336647|592576951|FG000|Overall Study|Lost to Follow-up|4|||
164058773|NCT01336647|592576952|FG001|Overall Study|Lost to Follow-up|1|||
164058774|NCT01336647|592576953|FG002|Overall Study|Lost to Follow-up|3|||
164058775|NCT01018680|592576954|FG000|Overall Study|Adverse Event|23|||
164058776|NCT01018680|592576955|FG001|Overall Study|Adverse Event|40|||
164058777|NCT01018680|592576954|FG000|Overall Study|Withdrawal by Subject|10|||
164058778|NCT01018680|592576955|FG001|Overall Study|Withdrawal by Subject|10|||
164058779|NCT01018680|592576954|FG000|Overall Study|Protocol Violation|5|||
164058780|NCT01018680|592576955|FG001|Overall Study|Protocol Violation|8|||
164058781|NCT01018680|592576954|FG000|Overall Study|Sponsor Decision|6|||
164058782|NCT01018680|592576955|FG001|Overall Study|Sponsor Decision|7|||
164058783|NCT01018680|592576954|FG000|Overall Study|Lack of Efficacy|8|||
164058784|NCT01018680|592576955|FG001|Overall Study|Lack of Efficacy|2|||
164058785|NCT01018680|592576954|FG000|Overall Study|Lost to Follow-up|5|||
164058786|NCT01018680|592576955|FG001|Overall Study|Lost to Follow-up|3|||
164058787|NCT01018680|592576954|FG000|Overall Study|Entry Criteria Not Met|1|||
164058788|NCT01018680|592576955|FG001|Overall Study|Entry Criteria Not Met|4|||
164058789|NCT01018680|592576954|FG000|Overall Study|Physician Decision|3|||
164058790|NCT01018680|592576955|FG001|Overall Study|Physician Decision|1|||
164058791|NCT05056311|592576956|FG000|Overall Study|Lost to Follow-up|14|||
164058792|NCT05056311|592576956|FG000|Overall Study|Withdrawal by Subject|1|||
164058793|NCT05056311|592576956|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
164058794|NCT02600559|592576958|FG000|Overall Study|Withdrawal by Subject|3|||
164058795|NCT02600559|592576958|FG000|Overall Study|Lost to Follow-up|20|||
164058796|NCT00665366|592576963|FG000|Overall Study|Lack of Efficacy|11|||
164058797|NCT00665366|592576964|FG001|Overall Study|Lack of Efficacy|10|||
164058798|NCT00665366|592576963|FG000|Overall Study|Adverse Event|25|||
164058799|NCT00665366|592576964|FG001|Overall Study|Adverse Event|23|||
164058800|NCT00665366|592576963|FG000|Overall Study|Withdrawal by Subject|11|||
164058801|NCT00665366|592576964|FG001|Overall Study|Withdrawal by Subject|14|||
164058802|NCT00665366|592576963|FG000|Overall Study|Lost to Follow-up|3|||
164058803|NCT00665366|592576964|FG001|Overall Study|Lost to Follow-up|5|||
164058804|NCT00665366|592576963|FG000|Overall Study|Poor compliance/noncompliance|3|||
164058805|NCT00665366|592576964|FG001|Overall Study|Poor compliance/noncompliance|5|||
164058806|NCT00665366|592576963|FG000|Overall Study|Pregnancy|1|||
164058807|NCT00665366|592576964|FG001|Overall Study|Pregnancy|0|||
164058808|NCT00665366|592576963|FG000|Overall Study|No longer meets study criteria|0|||
164058809|NCT00665366|592576964|FG001|Overall Study|No longer meets study criteria|1|||
164058810|NCT00665366|592576963|FG000|Overall Study|Other reasons|4|||
164058811|NCT00665366|592576964|FG001|Overall Study|Other reasons|1|||
164058812|NCT03628781|592576966|FG000|Overall Study|Lost to Follow-up|16|||
164058813|NCT03628781|592576967|FG001|Overall Study|Lost to Follow-up|8|||
164058814|NCT03628781|592576966|FG000|Overall Study|Withdrawal by Subject|16|||
164058815|NCT03628781|592576967|FG001|Overall Study|Withdrawal by Subject|1|||
164058816|NCT02718131|592576973|FG000|Overall Study|Withdrawal by Subject|1|||
164058817|NCT02718131|592576974|FG001|Overall Study|Withdrawal by Subject|0|||
164058818|NCT02718131|592576973|FG000|Overall Study|Adverse Event|1|||
164058819|NCT02718131|592576974|FG001|Overall Study|Adverse Event|0|||
164058820|NCT02718131|592576973|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
164058821|NCT02718131|592576974|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
164058822|NCT02406586|592576975|FG000|Overall Study|Lost to Follow-up|0|||
164058823|NCT02406586|592576976|FG001|Overall Study|Lost to Follow-up|4|||
164058824|NCT02406586|592576977|FG002|Overall Study|Lost to Follow-up|2|||
164058825|NCT02406586|592576975|FG000|Overall Study|Withdrawal by Subject|1|||
164058826|NCT02406586|592576976|FG001|Overall Study|Withdrawal by Subject|0|||
164058827|NCT02406586|592576977|FG002|Overall Study|Withdrawal by Subject|0|||
164058828|NCT00285857|592576978|FG000|Overall Study|Withdrawal by Subject|2|||
164058829|NCT00285857|592576978|FG000|Overall Study|Inadequate initial breast cytology|1|||
164058830|NCT00285857|592576978|FG000|Overall Study|Adverse Event|1|||
164058831|NCT01005875|592576990|FG000|Overall Study|Death|3|||
164058832|NCT00606931|592576991|FG000|Overall Study|Withdrawal by Subject|3|||
164058833|NCT01348828|592577003|FG000|Overall Study|Death|20|||
164058834|NCT01348828|592577003|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
164058835|NCT01348828|592577003|FG000|Overall Study|Conversion|2|||
164058836|NCT01348828|592577003|FG000|Overall Study|missed visit|1|||
164058837|NCT04246996|592577005|FG000|Overall Study|Physician Decision|1|||
164058838|NCT04246996|592577006|FG001|Overall Study|Physician Decision|1|||
164058839|NCT04246996|592577005|FG000|Overall Study|Did not meet eligibility criteria|1|||
164058840|NCT04246996|592577006|FG001|Overall Study|Did not meet eligibility criteria|4|||
164058841|NCT02442284|592577007|FG000|Overall Study|Adverse Event|1|||
164058842|NCT02442284|592577007|FG000|Overall Study|Withdrew Consent|2|||
164058843|NCT02442284|592577007|FG000|Overall Study|Lost to Follow-up|3|||
164058844|NCT02442284|592577007|FG000|Overall Study|Other|1|||
164058845|NCT00252499|592577013|FG000|Overall Study|Lost to Follow-up|1|||
164058846|NCT00252499|592577014|FG001|Overall Study|Lost to Follow-up|0|||
164058847|NCT00252499|592577015|FG002|Overall Study|Lost to Follow-up|0|||
164058848|NCT01365468|592577016|FG000|Overall Study|Physician Decision|1|||
164058849|NCT01365468|592577017|FG001|Overall Study|Physician Decision|0|||
164058850|NCT01365468|592577016|FG000|Overall Study|Disease progression|1|||
164058851|NCT01365468|592577017|FG001|Overall Study|Disease progression|0|||
164058852|NCT01365468|592577016|FG000|Overall Study|Lost to Follow-up|2|||
164058853|NCT01365468|592577017|FG001|Overall Study|Lost to Follow-up|0|||
164058854|NCT01521494|592577020|FG000|Overall Study|Adverse Event|1|||
164058855|NCT01521494|592577021|FG001|Overall Study|Adverse Event|2|||
164058856|NCT01521494|592577022|FG002|Overall Study|Adverse Event|9|||
164058857|NCT01521494|592577023|FG003|Overall Study|Adverse Event|6|||
164058858|NCT01521494|592577024|FG004|Overall Study|Adverse Event|2|||
164058859|NCT01521494|592577020|FG000|Overall Study|Lack of Efficacy|0|||
164058860|NCT01521494|592577021|FG001|Overall Study|Lack of Efficacy|0|||
164058861|NCT01521494|592577022|FG002|Overall Study|Lack of Efficacy|0|||
164058862|NCT01521494|592577023|FG003|Overall Study|Lack of Efficacy|0|||
164058863|NCT01521494|592577024|FG004|Overall Study|Lack of Efficacy|2|||
164058864|NCT01521494|592577020|FG000|Overall Study|Withdrawal by Subject|1|||
164058865|NCT01521494|592577021|FG001|Overall Study|Withdrawal by Subject|1|||
164058866|NCT01521494|592577022|FG002|Overall Study|Withdrawal by Subject|0|||
164058867|NCT01521494|592577023|FG003|Overall Study|Withdrawal by Subject|2|||
164058868|NCT01521494|592577024|FG004|Overall Study|Withdrawal by Subject|0|||
164058869|NCT01521494|592577020|FG000|Overall Study|Decrease in serum phosphate|0|||
164058870|NCT01521494|592577021|FG001|Overall Study|Decrease in serum phosphate|2|||
164058871|NCT01521494|592577022|FG002|Overall Study|Decrease in serum phosphate|3|||
164058872|NCT01521494|592577023|FG003|Overall Study|Decrease in serum phosphate|12|||
164058873|NCT01521494|592577024|FG004|Overall Study|Decrease in serum phosphate|0|||
164058874|NCT01521494|592577020|FG000|Overall Study|Decrease in serum calcium|0|||
164058875|NCT01521494|592577021|FG001|Overall Study|Decrease in serum calcium|0|||
164058876|NCT01521494|592577022|FG002|Overall Study|Decrease in serum calcium|0|||
164058877|NCT01521494|592577023|FG003|Overall Study|Decrease in serum calcium|1|||
164058878|NCT01521494|592577024|FG004|Overall Study|Decrease in serum calcium|1|||
164058879|NCT01521494|592577020|FG000|Overall Study|Physician Decision|0|||
164058880|NCT01521494|592577021|FG001|Overall Study|Physician Decision|0|||
164058881|NCT01521494|592577022|FG002|Overall Study|Physician Decision|0|||
164058882|NCT01521494|592577023|FG003|Overall Study|Physician Decision|0|||
164058883|NCT01521494|592577024|FG004|Overall Study|Physician Decision|2|||
164058884|NCT01140646|592577025|FG000|Overall Study|Adverse Event|4|||
164058885|NCT01140646|592577025|FG000|Overall Study|Refused Further Treatment|5|||
164058886|NCT00689728|592577029|FG000|Double-Blind Treatment|Adverse Event|1|||
164058887|NCT00689728|592577030|FG001|Double-Blind Treatment|Adverse Event|0|||
164058888|NCT00689728|592577031|FG002|Double-Blind Treatment|Adverse Event|0|||
164058889|NCT00689728|592577029|FG000|Double-Blind Treatment|Protocol Violation|0|||
164058890|NCT00689728|592577030|FG001|Double-Blind Treatment|Protocol Violation|0|||
164058891|NCT00689728|592577031|FG002|Double-Blind Treatment|Protocol Violation|1|||
164058892|NCT00689728|592577029|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
164058893|NCT00689728|592577030|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
164058894|NCT00689728|592577031|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
164058895|NCT00689728|592577029|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
164058896|NCT00689728|592577030|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
164058897|NCT00689728|592577031|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
164058898|NCT00689728|592577029|FG000|Rescue|Adverse Event|0|||
164058899|NCT00689728|592577030|FG001|Rescue|Adverse Event|1|||
164058900|NCT00689728|592577031|FG002|Rescue|Adverse Event|0|||
164058901|NCT00689728|592577029|FG000|Rescue|Withdrawal by Subject|1|||
164058902|NCT00689728|592577030|FG001|Rescue|Withdrawal by Subject|1|||
164058903|NCT00689728|592577031|FG002|Rescue|Withdrawal by Subject|1|||
164058904|NCT00689728|592577029|FG000|Optional Follow-Up|Adverse Event|1|||
164058905|NCT00689728|592577030|FG001|Optional Follow-Up|Adverse Event|0|||
164058906|NCT00689728|592577031|FG002|Optional Follow-Up|Adverse Event|0|||
164058907|NCT00689728|592577029|FG000|Optional Follow-Up|Lack of Efficacy|0|||
164058908|NCT00689728|592577030|FG001|Optional Follow-Up|Lack of Efficacy|1|||
164058909|NCT00689728|592577031|FG002|Optional Follow-Up|Lack of Efficacy|1|||
164058910|NCT00689728|592577029|FG000|Optional Follow-Up|Lost to Follow-up|0|||
164058911|NCT00689728|592577030|FG001|Optional Follow-Up|Lost to Follow-up|1|||
164058912|NCT00689728|592577031|FG002|Optional Follow-Up|Lost to Follow-up|1|||
164058913|NCT00689728|592577029|FG000|Optional Follow-Up|Protocol Violation|0|||
164058914|NCT00689728|592577030|FG001|Optional Follow-Up|Protocol Violation|0|||
164058915|NCT00689728|592577031|FG002|Optional Follow-Up|Protocol Violation|1|||
164058916|NCT00689728|592577029|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
164058917|NCT00689728|592577030|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
164058918|NCT00689728|592577031|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
164058919|NCT00660829|592577037|FG000|Overall Study|Adverse Event|3|||
164058920|NCT00660829|592577038|FG001|Overall Study|Adverse Event|4|||
164058921|NCT00660829|592577037|FG000|Overall Study|Lack of Efficacy|2|||
164058922|NCT00660829|592577038|FG001|Overall Study|Lack of Efficacy|3|||
164058923|NCT00660829|592577037|FG000|Overall Study|Non-Compliance|0|||
164058924|NCT00660829|592577038|FG001|Overall Study|Non-Compliance|4|||
164058925|NCT00660829|592577037|FG000|Overall Study|Withdrawal by Subject|1|||
164058926|NCT00660829|592577038|FG001|Overall Study|Withdrawal by Subject|2|||
164058927|NCT00660829|592577037|FG000|Overall Study|Lost to Follow-up|3|||
164058928|NCT00660829|592577038|FG001|Overall Study|Lost to Follow-up|2|||
164058929|NCT00660829|592577037|FG000|Overall Study|Other|9|||
164058930|NCT00660829|592577038|FG001|Overall Study|Other|4|||
164058931|NCT03417999|592577039|FG000|Overall Study|Withdrawal by Subject|1|||
164058932|NCT03417999|592577040|FG001|Overall Study|Withdrawal by Subject|0|||
164058933|NCT03417999|592577041|FG002|Overall Study|Withdrawal by Subject|0|||
164058934|NCT03417999|592577039|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
164058935|NCT03417999|592577040|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
164058936|NCT03417999|592577041|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
164058937|NCT03417999|592577039|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
164058938|NCT03417999|592577040|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
164058939|NCT03417999|592577041|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
164058940|NCT03417999|592577039|FG000|Overall Study|Inadequate study staff available to process samples|0|||
164058941|NCT03417999|592577040|FG001|Overall Study|Inadequate study staff available to process samples|0|||
164058942|NCT03417999|592577041|FG002|Overall Study|Inadequate study staff available to process samples|1|||
164058943|NCT02539160|592577046|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
164058944|NCT02539160|592577047|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
164058945|NCT02539160|592577048|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
164058946|NCT02539160|592577049|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
164058947|NCT02539160|592577046|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
164058948|NCT02539160|592577047|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
164058949|NCT02539160|592577048|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
164058950|NCT02539160|592577049|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
164058951|NCT02539160|592577046|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
164058952|NCT02539160|592577047|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
164058953|NCT02539160|592577048|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
164058954|NCT02539160|592577049|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
164058955|NCT01681004|592577050|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
164058956|NCT01681004|592577051|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
164058957|NCT01681004|592577050|FG000|Study Completion|Lost to Follow-up|8|||
164058958|NCT01681004|592577051|FG001|Study Completion|Lost to Follow-up|3|||
164058959|NCT01681004|592577050|FG000|Study Completion|Physician Decision|1|||
164058960|NCT01681004|592577051|FG001|Study Completion|Physician Decision|3|||
164058961|NCT01681004|592577050|FG000|Study Completion|Site Termination|2|||
164058962|NCT01681004|592577051|FG001|Study Completion|Site Termination|1|||
164058963|NCT01681004|592577050|FG000|Study Completion|Death|1|||
164058964|NCT01681004|592577051|FG001|Study Completion|Death|1|||
164058965|NCT00372905|592577052|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
164058966|NCT00372905|592577053|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
164058967|NCT00372905|592577054|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
164101884|NCT01796171|592736561|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
164101885|NCT01796171|592736562|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
164101886|NCT01796171|592736563|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
164101887|NCT01796171|592736564|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
164101888|NCT01796171|592736550|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101889|NCT01796171|592736551|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101890|NCT01796171|592736552|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101891|NCT01796171|592736553|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101892|NCT01796171|592736554|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101893|NCT01796171|592736555|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101894|NCT01796171|592736556|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101895|NCT01796171|592736557|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101896|NCT01796171|592736558|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101897|NCT01796171|592736559|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101898|NCT01796171|592736560|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101899|NCT01796171|592736561|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101900|NCT01796171|592736562|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101901|NCT01796171|592736563|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
164101902|NCT01796171|592736564|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
164101903|NCT01796171|592736550|FG000|Treatment Period With Betalutin|Progressive disease|0|||
164101904|NCT01796171|592736551|FG001|Treatment Period With Betalutin|Progressive disease|1|||
164101905|NCT01796171|592736552|FG002|Treatment Period With Betalutin|Progressive disease|0|||
164101906|NCT01796171|592736553|FG003|Treatment Period With Betalutin|Progressive disease|0|||
164101907|NCT01796171|592736554|FG004|Treatment Period With Betalutin|Progressive disease|0|||
164101908|NCT01796171|592736555|FG005|Treatment Period With Betalutin|Progressive disease|0|||
164101909|NCT01796171|592736556|FG006|Treatment Period With Betalutin|Progressive disease|0|||
164101910|NCT01796171|592736557|FG007|Treatment Period With Betalutin|Progressive disease|0|||
164101911|NCT01796171|592736558|FG008|Treatment Period With Betalutin|Progressive disease|0|||
164058968|NCT00372905|592577055|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
164058969|NCT00372905|592577052|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
164058970|NCT00372905|592577053|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
164058971|NCT00372905|592577054|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
164058972|NCT00372905|592577055|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
164058973|NCT00372905|592577052|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
164058974|NCT00372905|592577053|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
164058975|NCT00372905|592577054|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
164058976|NCT00372905|592577055|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
164058977|NCT00372905|592577052|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
164058978|NCT00372905|592577053|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
164058979|NCT00372905|592577054|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
164058980|NCT00372905|592577055|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
164058981|NCT00372905|592577052|FG000|Follow up Until Relapse or Progression|Study closed|0|||
164058982|NCT00372905|592577053|FG001|Follow up Until Relapse or Progression|Study closed|0|||
164058983|NCT00372905|592577054|FG002|Follow up Until Relapse or Progression|Study closed|0|||
164058984|NCT00372905|592577055|FG003|Follow up Until Relapse or Progression|Study closed|3|||
164058985|NCT00372905|592577052|FG000|Follow up Until Relapse or Progression|Other|0|||
164058986|NCT00372905|592577053|FG001|Follow up Until Relapse or Progression|Other|1|||
164058987|NCT00372905|592577054|FG002|Follow up Until Relapse or Progression|Other|0|||
164058988|NCT00372905|592577055|FG003|Follow up Until Relapse or Progression|Other|0|||
164058989|NCT01728454|592577056|FG000|Stage 1 and 2|Pregnancy|1|||
164058990|NCT01728454|592577057|FG001|Stage 1 and 2|Pregnancy|0|||
164058991|NCT01728454|592577058|FG002|Stage 1 and 2|Pregnancy|0|||
164058992|NCT01728454|592577056|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
164058993|NCT01728454|592577057|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
164058994|NCT01728454|592577058|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
164058995|NCT01728454|592577056|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
164058996|NCT01728454|592577057|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
164058997|NCT01728454|592577058|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
164058998|NCT01728454|592577056|FG000|Stage 1 and 2|Lost to Follow-up|1|||
164058999|NCT01728454|592577057|FG001|Stage 1 and 2|Lost to Follow-up|1|||
164101912|NCT01796171|592736559|FG009|Treatment Period With Betalutin|Progressive disease|0|||
164101913|NCT01796171|592736560|FG010|Treatment Period With Betalutin|Progressive disease|0|||
164101914|NCT01796171|592736561|FG011|Treatment Period With Betalutin|Progressive disease|0|||
164101915|NCT01796171|592736562|FG012|Treatment Period With Betalutin|Progressive disease|0|||
164148721|NCT03207867|592904950|FG014|Overall Study|Physician Decision|2|||
164059000|NCT01728454|592577058|FG002|Stage 1 and 2|Lost to Follow-up|0|||
164059001|NCT01728454|592577056|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
164059002|NCT01728454|592577057|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
164059003|NCT01728454|592577058|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
164059004|NCT01728454|592577056|FG000|Stage 3|Reason Missing|0|||
164101916|NCT01796171|592736563|FG013|Treatment Period With Betalutin|Progressive disease|0|||
164101917|NCT01796171|592736564|FG014|Treatment Period With Betalutin|Progressive disease|0|||
164101918|NCT01796171|592736550|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101919|NCT01796171|592736551|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101920|NCT01796171|592736552|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101921|NCT01796171|592736553|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101922|NCT01796171|592736554|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101923|NCT01796171|592736555|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101924|NCT01796171|592736556|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101925|NCT01796171|592736557|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101926|NCT01796171|592736558|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
164101927|NCT01796171|592736559|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101928|NCT01796171|592736560|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
164101929|NCT01796171|592736561|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
164101930|NCT01796171|592736562|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101931|NCT01796171|592736563|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101932|NCT01796171|592736564|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
164101933|NCT01796171|592736550|FG000|Treatment Period With Betalutin|Physician Decision|0|||
164101934|NCT01796171|592736551|FG001|Treatment Period With Betalutin|Physician Decision|0|||
164101935|NCT01796171|592736552|FG002|Treatment Period With Betalutin|Physician Decision|0|||
164101936|NCT01796171|592736553|FG003|Treatment Period With Betalutin|Physician Decision|0|||
164101937|NCT01796171|592736554|FG004|Treatment Period With Betalutin|Physician Decision|0|||
164101938|NCT01796171|592736555|FG005|Treatment Period With Betalutin|Physician Decision|0|||
164101939|NCT01796171|592736556|FG006|Treatment Period With Betalutin|Physician Decision|0|||
164101940|NCT01796171|592736557|FG007|Treatment Period With Betalutin|Physician Decision|0|||
164101941|NCT01796171|592736558|FG008|Treatment Period With Betalutin|Physician Decision|0|||
164101942|NCT01796171|592736559|FG009|Treatment Period With Betalutin|Physician Decision|0|||
164101943|NCT01796171|592736560|FG010|Treatment Period With Betalutin|Physician Decision|5|||
164101944|NCT01796171|592736561|FG011|Treatment Period With Betalutin|Physician Decision|1|||
164101945|NCT01796171|592736562|FG012|Treatment Period With Betalutin|Physician Decision|1|||
164101946|NCT01796171|592736563|FG013|Treatment Period With Betalutin|Physician Decision|0|||
164101947|NCT01796171|592736564|FG014|Treatment Period With Betalutin|Physician Decision|0|||
164101948|NCT01796171|592736550|FG000|Treatment Period With Betalutin|Death|0|||
164101949|NCT01796171|592736551|FG001|Treatment Period With Betalutin|Death|0|||
164101950|NCT01796171|592736552|FG002|Treatment Period With Betalutin|Death|0|||
164101951|NCT01796171|592736553|FG003|Treatment Period With Betalutin|Death|0|||
164101952|NCT01796171|592736554|FG004|Treatment Period With Betalutin|Death|0|||
164101953|NCT01796171|592736555|FG005|Treatment Period With Betalutin|Death|0|||
164101954|NCT01796171|592736556|FG006|Treatment Period With Betalutin|Death|0|||
164101955|NCT01796171|592736557|FG007|Treatment Period With Betalutin|Death|0|||
164101956|NCT01796171|592736558|FG008|Treatment Period With Betalutin|Death|0|||
164101957|NCT01796171|592736559|FG009|Treatment Period With Betalutin|Death|0|||
164101958|NCT01796171|592736560|FG010|Treatment Period With Betalutin|Death|2|||
164101959|NCT01796171|592736561|FG011|Treatment Period With Betalutin|Death|0|||
164101960|NCT01796171|592736562|FG012|Treatment Period With Betalutin|Death|0|||
164101961|NCT01796171|592736563|FG013|Treatment Period With Betalutin|Death|0|||
164101962|NCT01796171|592736564|FG014|Treatment Period With Betalutin|Death|0|||
164101963|NCT01796171|592736550|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
164101964|NCT01796171|592736551|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
164101965|NCT01796171|592736552|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
164101966|NCT01796171|592736553|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
164101967|NCT01796171|592736554|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
164101968|NCT01796171|592736555|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
164101969|NCT01796171|592736556|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
164101970|NCT01796171|592736557|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
164101971|NCT01796171|592736558|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
164101972|NCT01796171|592736559|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
164101973|NCT01796171|592736560|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
164101974|NCT01796171|592736561|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
164101975|NCT01796171|592736562|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
164101976|NCT01796171|592736563|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
164101977|NCT01796171|592736564|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
164101978|NCT01796171|592736550|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101979|NCT01796171|592736551|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101980|NCT01796171|592736552|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101981|NCT01796171|592736553|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164148722|NCT03207867|592904951|FG015|Overall Study|Physician Decision|1|||
164059005|NCT01728454|592577057|FG001|Stage 3|Reason Missing|0|||
164059006|NCT01728454|592577058|FG002|Stage 3|Reason Missing|1|||
164059007|NCT01728454|592577056|FG000|Stage 3|Subject Required Other Treatment|0|||
164059008|NCT01728454|592577057|FG001|Stage 3|Subject Required Other Treatment|1|||
164059009|NCT01728454|592577058|FG002|Stage 3|Subject Required Other Treatment|0|||
164059010|NCT01728454|592577056|FG000|Stage 3|Pregnancy|1|||
164059011|NCT01728454|592577057|FG001|Stage 3|Pregnancy|0|||
164059012|NCT01728454|592577058|FG002|Stage 3|Pregnancy|0|||
164059013|NCT01728454|592577056|FG000|Stage 3|Withdrew Consent|1|||
164059014|NCT01728454|592577057|FG001|Stage 3|Withdrew Consent|0|||
164059015|NCT01728454|592577058|FG002|Stage 3|Withdrew Consent|1|||
164059016|NCT01728454|592577056|FG000|Stage 3|Non-compliance with Protocol|0|||
164059017|NCT01728454|592577057|FG001|Stage 3|Non-compliance with Protocol|0|||
164059018|NCT01728454|592577058|FG002|Stage 3|Non-compliance with Protocol|1|||
164059019|NCT01728454|592577056|FG000|Stage 3|Lost to Follow-up|0|||
164059020|NCT01728454|592577057|FG001|Stage 3|Lost to Follow-up|3|||
164059021|NCT01728454|592577058|FG002|Stage 3|Lost to Follow-up|1|||
164059022|NCT01728454|592577056|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
164059023|NCT01728454|592577057|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
164059024|NCT01728454|592577058|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
164059025|NCT00695318|592577061|FG000|Overall Study|Lost to Follow-up|1|||
164059026|NCT00695318|592577062|FG001|Overall Study|Lost to Follow-up|0|||
164059027|NCT00695318|592577061|FG000|Overall Study|Withdrawal by Subject|2|||
164059028|NCT00695318|592577062|FG001|Overall Study|Withdrawal by Subject|0|||
164059029|NCT00695318|592577061|FG000|Overall Study|Death|1|||
164059030|NCT00695318|592577062|FG001|Overall Study|Death|1|||
164059031|NCT00695318|592577061|FG000|Overall Study|Study Terminated|1|||
164059032|NCT00695318|592577062|FG001|Overall Study|Study Terminated|0|||
164059033|NCT02058966|592577063|FG000|Open-Label Methamphetamine|Adverse Event|1|||
164059034|NCT02058966|592577063|FG000|First Intervention|Withdrawal by Subject|1|||
164059035|NCT01362062|592577066|FG000|Overall Study|Adverse Event|1|||
164059036|NCT01362062|592577067|FG001|Overall Study|Adverse Event|0|||
164059037|NCT01362062|592577066|FG000|Overall Study|Lost to Follow-up|11|||
164059038|NCT01362062|592577067|FG001|Overall Study|Lost to Follow-up|0|||
164059039|NCT01362062|592577066|FG000|Overall Study|Withdrawal by Subject|2|||
164059040|NCT01362062|592577067|FG001|Overall Study|Withdrawal by Subject|0|||
164059041|NCT01362062|592577066|FG000|Overall Study|Non-compliant participant|2|||
164059042|NCT01362062|592577067|FG001|Overall Study|Non-compliant participant|0|||
164059043|NCT01362062|592577066|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
164059044|NCT01362062|592577067|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
164059045|NCT01362062|592577066|FG000|Overall Study|Had significant improvement|9|||
164059046|NCT01362062|592577067|FG001|Overall Study|Had significant improvement|0|||
164059047|NCT02545504|592577069|FG000|Overall Study|Death|174|||
164059048|NCT02545504|592577070|FG001|Overall Study|Death|168|||
164059049|NCT02545504|592577069|FG000|Overall Study|Unknown reason|30|||
164059050|NCT02545504|592577070|FG001|Overall Study|Unknown reason|32|||
164059051|NCT02545504|592577069|FG000|Overall Study|Withdrew consent|9|||
164059052|NCT02545504|592577070|FG001|Overall Study|Withdrew consent|11|||
164059053|NCT02545504|592577069|FG000|Overall Study|Investigator's discretion|3|||
164059054|NCT02545504|592577070|FG001|Overall Study|Investigator's discretion|1|||
164059055|NCT02545504|592577069|FG000|Overall Study|Lost to Follow-up|2|||
164059056|NCT02545504|592577070|FG001|Overall Study|Lost to Follow-up|2|||
164059057|NCT00434876|592577073|FG000|Overall Study|Lost to Follow-up|1|||
164059058|NCT00434876|592577074|FG001|Overall Study|Lost to Follow-up|1|||
164059059|NCT00758394|592577075|FG000|2nd Intervention Order|Lost to Follow-up|0|||
164059060|NCT00758394|592577076|FG001|2nd Intervention Order|Lost to Follow-up|1|||
164059061|NCT00758394|592577077|FG002|2nd Intervention Order|Lost to Follow-up|0|||
164059062|NCT00758394|592577078|FG003|2nd Intervention Order|Lost to Follow-up|0|||
164059063|NCT00758394|592577075|FG000|3rd Intervention|Lost to Follow-up|1|||
164059064|NCT00758394|592577076|FG001|3rd Intervention|Lost to Follow-up|0|||
164059065|NCT00758394|592577077|FG002|3rd Intervention|Lost to Follow-up|0|||
164059066|NCT00758394|592577078|FG003|3rd Intervention|Lost to Follow-up|1|||
164059067|NCT00508820|592577079|FG000|Overall Study|Adverse Event|6|||
164059068|NCT00508820|592577080|FG001|Overall Study|Adverse Event|10|||
164059069|NCT00508820|592577079|FG000|Overall Study|Death|6|||
164059070|NCT00508820|592577080|FG001|Overall Study|Death|8|||
164059071|NCT00508820|592577079|FG000|Overall Study|Lost to Follow-up|1|||
164059072|NCT00508820|592577080|FG001|Overall Study|Lost to Follow-up|1|||
164101982|NCT01796171|592736554|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101983|NCT01796171|592736555|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164059073|NCT00508820|592577079|FG000|Overall Study|Physician Decision|8|||
164059074|NCT00508820|592577080|FG001|Overall Study|Physician Decision|2|||
164059075|NCT00508820|592577079|FG000|Overall Study|Pregnancy|0|||
164059076|NCT00508820|592577080|FG001|Overall Study|Pregnancy|2|||
164059077|NCT00508820|592577079|FG000|Overall Study|Protocol Violation|2|||
164059078|NCT00508820|592577080|FG001|Overall Study|Protocol Violation|0|||
164059079|NCT00508820|592577079|FG000|Overall Study|Withdrawal by Subject|10|||
164059080|NCT00508820|592577080|FG001|Overall Study|Withdrawal by Subject|12|||
164059081|NCT00508820|592577079|FG000|Overall Study|Other|11|||
164059082|NCT00508820|592577080|FG001|Overall Study|Other|2|||
164059083|NCT00508820|592577079|FG000|Overall Study|Noncompliance|1|||
164059084|NCT00508820|592577080|FG001|Overall Study|Noncompliance|0|||
164059085|NCT00508820|592577079|FG000|Overall Study|Requirement for alternative therapy|7|||
164059086|NCT00508820|592577080|FG001|Overall Study|Requirement for alternative therapy|15|||
164059087|NCT00508820|592577079|FG000|Overall Study|Protocol-specified Criteria|3|||
164059088|NCT00508820|592577080|FG001|Overall Study|Protocol-specified Criteria|12|||
164059089|NCT02926833|592578869|FG000|Overall Study|Death|1|||
164059090|NCT02926833|592578870|FG001|Overall Study|Death|1|||
164059091|NCT02926833|592578871|FG002|Overall Study|Death|2|||
164059092|NCT02926833|592578872|FG003|Overall Study|Death|13|||
164059093|NCT02926833|592578869|FG000|Overall Study|Lost to Follow-up|1|||
164059094|NCT02926833|592578870|FG001|Overall Study|Lost to Follow-up|2|||
164059095|NCT02926833|592578871|FG002|Overall Study|Lost to Follow-up|0|||
164059096|NCT02926833|592578872|FG003|Overall Study|Lost to Follow-up|3|||
164059097|NCT02926833|592578869|FG000|Overall Study|Full Consent Withdrawal|0|||
164059098|NCT02926833|592578870|FG001|Overall Study|Full Consent Withdrawal|0|||
164059099|NCT02926833|592578871|FG002|Overall Study|Full Consent Withdrawal|0|||
164059100|NCT02926833|592578872|FG003|Overall Study|Full Consent Withdrawal|2|||
164059101|NCT02926833|592578869|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
164059102|NCT02926833|592578870|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
164059103|NCT02926833|592578871|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
164059104|NCT02926833|592578872|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
164059105|NCT02926833|592578869|FG000|Overall Study|Investigator Decision|0|||
164059106|NCT02926833|592578870|FG001|Overall Study|Investigator Decision|1|||
164059107|NCT02926833|592578871|FG002|Overall Study|Investigator Decision|0|||
164059108|NCT02926833|592578872|FG003|Overall Study|Investigator Decision|0|||
164059109|NCT02926833|592578869|FG000|Overall Study|Adverse Event|0|||
164059110|NCT02926833|592578870|FG001|Overall Study|Adverse Event|0|||
164059111|NCT02926833|592578871|FG002|Overall Study|Adverse Event|1|||
164059112|NCT02926833|592578872|FG003|Overall Study|Adverse Event|0|||
164059113|NCT02926833|592578869|FG000|Overall Study|Partial Withdrawal of Consent|0|||
164059114|NCT02926833|592578870|FG001|Overall Study|Partial Withdrawal of Consent|0|||
164059115|NCT02926833|592578871|FG002|Overall Study|Partial Withdrawal of Consent|0|||
164059116|NCT02926833|592578872|FG003|Overall Study|Partial Withdrawal of Consent|1|||
164059117|NCT02930889|592578873|FG000|Overall Study|Lost to Follow-up|2|||
164059118|NCT02930889|592578873|FG000|Overall Study|Withdrawal by Subject|6|||
164059119|NCT02930889|592578873|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
164059120|NCT04398030|592578874|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
164059121|NCT04398030|592578875|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
164059122|NCT04398030|592578874|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
164059123|NCT04398030|592578875|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
164059124|NCT01004822|592578876|FG000|Overall Study|Objective progression or relapse|3|||
164059125|NCT01004822|592578877|FG001|Overall Study|Objective progression or relapse|3|||
164059126|NCT01004822|592578878|FG002|Overall Study|Objective progression or relapse|0|||
164059127|NCT01004822|592578879|FG003|Overall Study|Objective progression or relapse|1|||
164059128|NCT01004822|592578880|FG004|Overall Study|Objective progression or relapse|2|||
164059129|NCT01004822|592578881|FG005|Overall Study|Objective progression or relapse|2|||
164059130|NCT01004822|592578882|FG006|Overall Study|Objective progression or relapse|1|||
164059131|NCT01004822|592578883|FG007|Overall Study|Objective progression or relapse|4|||
164059132|NCT01004822|592578876|FG000|Overall Study|Global deterioration of health status|0|||
164059133|NCT01004822|592578877|FG001|Overall Study|Global deterioration of health status|0|||
164059134|NCT01004822|592578878|FG002|Overall Study|Global deterioration of health status|0|||
164059135|NCT01004822|592578879|FG003|Overall Study|Global deterioration of health status|1|||
164059136|NCT01004822|592578880|FG004|Overall Study|Global deterioration of health status|0|||
164059137|NCT01004822|592578881|FG005|Overall Study|Global deterioration of health status|0|||
164059138|NCT01004822|592578882|FG006|Overall Study|Global deterioration of health status|1|||
164059139|NCT01004822|592578883|FG007|Overall Study|Global deterioration of health status|0|||
164059140|NCT01004822|592578876|FG000|Overall Study|No longer willing to continue|0|||
164059141|NCT01004822|592578877|FG001|Overall Study|No longer willing to continue|0|||
164059142|NCT01004822|592578878|FG002|Overall Study|No longer willing to continue|0|||
164059143|NCT01004822|592578879|FG003|Overall Study|No longer willing to continue|1|||
164059144|NCT01004822|592578880|FG004|Overall Study|No longer willing to continue|2|||
164059145|NCT01004822|592578881|FG005|Overall Study|No longer willing to continue|1|||
164059146|NCT01004822|592578882|FG006|Overall Study|No longer willing to continue|1|||
164059147|NCT01004822|592578883|FG007|Overall Study|No longer willing to continue|0|||
164059148|NCT01004822|592578876|FG000|Overall Study|Adverse Event|0|||
164059149|NCT01004822|592578877|FG001|Overall Study|Adverse Event|0|||
164059150|NCT01004822|592578878|FG002|Overall Study|Adverse Event|0|||
164059151|NCT01004822|592578879|FG003|Overall Study|Adverse Event|0|||
164059152|NCT01004822|592578880|FG004|Overall Study|Adverse Event|0|||
164059153|NCT01004822|592578881|FG005|Overall Study|Adverse Event|0|||
164059154|NCT01004822|592578882|FG006|Overall Study|Adverse Event|1|||
164059155|NCT01004822|592578883|FG007|Overall Study|Adverse Event|1|||
164101984|NCT01796171|592736556|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164059156|NCT01004822|592578876|FG000|Overall Study|Other|0|||
164059157|NCT01004822|592578877|FG001|Overall Study|Other|0|||
164059158|NCT01004822|592578878|FG002|Overall Study|Other|4|||
164101985|NCT01796171|592736557|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101986|NCT01796171|592736558|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101987|NCT01796171|592736559|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101988|NCT01796171|592736560|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
164101989|NCT01796171|592736561|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
164101990|NCT01796171|592736562|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101991|NCT01796171|592736563|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101992|NCT01796171|592736564|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
164101993|NCT01796171|592736550|FG000|Follow-up Period|Start of further anticancer therapy|4|||
164101994|NCT01796171|592736551|FG001|Follow-up Period|Start of further anticancer therapy|25|||
164101995|NCT01796171|592736552|FG002|Follow-up Period|Start of further anticancer therapy|2|||
164101996|NCT01796171|592736553|FG003|Follow-up Period|Start of further anticancer therapy|1|||
164101997|NCT01796171|592736554|FG004|Follow-up Period|Start of further anticancer therapy|2|||
164101998|NCT01796171|592736555|FG005|Follow-up Period|Start of further anticancer therapy|2|||
164101999|NCT01796171|592736556|FG006|Follow-up Period|Start of further anticancer therapy|1|||
164102000|NCT01796171|592736557|FG007|Follow-up Period|Start of further anticancer therapy|15|||
164102001|NCT01796171|592736558|FG008|Follow-up Period|Start of further anticancer therapy|2|||
164102002|NCT01796171|592736559|FG009|Follow-up Period|Start of further anticancer therapy|0|||
164102003|NCT01796171|592736560|FG010|Follow-up Period|Start of further anticancer therapy|0|||
164102004|NCT01796171|592736561|FG011|Follow-up Period|Start of further anticancer therapy|0|||
164102005|NCT01796171|592736562|FG012|Follow-up Period|Start of further anticancer therapy|0|||
164102006|NCT01796171|592736563|FG013|Follow-up Period|Start of further anticancer therapy|0|||
164102007|NCT01796171|592736564|FG014|Follow-up Period|Start of further anticancer therapy|0|||
164102008|NCT01796171|592736550|FG000|Follow-up Period|Progressive disease|0|||
164102009|NCT01796171|592736551|FG001|Follow-up Period|Progressive disease|1|||
164102010|NCT01796171|592736552|FG002|Follow-up Period|Progressive disease|0|||
164102011|NCT01796171|592736553|FG003|Follow-up Period|Progressive disease|0|||
164102012|NCT01796171|592736554|FG004|Follow-up Period|Progressive disease|0|||
164102013|NCT01796171|592736555|FG005|Follow-up Period|Progressive disease|0|||
164102014|NCT01796171|592736556|FG006|Follow-up Period|Progressive disease|0|||
164102015|NCT01796171|592736557|FG007|Follow-up Period|Progressive disease|3|||
164102016|NCT01796171|592736558|FG008|Follow-up Period|Progressive disease|0|||
164102017|NCT01796171|592736559|FG009|Follow-up Period|Progressive disease|0|||
164102018|NCT01796171|592736560|FG010|Follow-up Period|Progressive disease|0|||
164102019|NCT01796171|592736561|FG011|Follow-up Period|Progressive disease|0|||
164102020|NCT01796171|592736562|FG012|Follow-up Period|Progressive disease|0|||
164102021|NCT01796171|592736563|FG013|Follow-up Period|Progressive disease|0|||
164102022|NCT01796171|592736564|FG014|Follow-up Period|Progressive disease|0|||
164102023|NCT01796171|592736550|FG000|Follow-up Period|Physician Decision|0|||
164102024|NCT01796171|592736551|FG001|Follow-up Period|Physician Decision|2|||
164102025|NCT01796171|592736552|FG002|Follow-up Period|Physician Decision|0|||
164102026|NCT01796171|592736553|FG003|Follow-up Period|Physician Decision|0|||
164102027|NCT01796171|592736554|FG004|Follow-up Period|Physician Decision|0|||
164102028|NCT01796171|592736555|FG005|Follow-up Period|Physician Decision|0|||
164102029|NCT01796171|592736556|FG006|Follow-up Period|Physician Decision|0|||
164102030|NCT01796171|592736557|FG007|Follow-up Period|Physician Decision|0|||
164102031|NCT01796171|592736558|FG008|Follow-up Period|Physician Decision|0|||
164102032|NCT01796171|592736559|FG009|Follow-up Period|Physician Decision|0|||
164102033|NCT01796171|592736560|FG010|Follow-up Period|Physician Decision|5|||
164059159|NCT01004822|592578879|FG003|Overall Study|Other|1|||
164059160|NCT01004822|592578880|FG004|Overall Study|Other|0|||
164059161|NCT01004822|592578881|FG005|Overall Study|Other|1|||
164059162|NCT01004822|592578882|FG006|Overall Study|Other|0|||
164059163|NCT01004822|592578883|FG007|Overall Study|Other|0|||
164059164|NCT03159455|592578886|FG000|Overall Study|Adverse Event|0|||
164059165|NCT03159455|592578887|FG001|Overall Study|Adverse Event|0|||
164059166|NCT03159455|592578888|FG002|Overall Study|Adverse Event|0|||
164059167|NCT03159455|592578889|FG003|Overall Study|Adverse Event|0|||
164102034|NCT01796171|592736561|FG011|Follow-up Period|Physician Decision|0|||
164102035|NCT01796171|592736562|FG012|Follow-up Period|Physician Decision|0|||
164059168|NCT03159455|592578890|FG004|Overall Study|Adverse Event|0|||
164059169|NCT03159455|592578891|FG005|Overall Study|Adverse Event|1|||
164059170|NCT01714726|592578897|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
164102036|NCT01796171|592736563|FG013|Follow-up Period|Physician Decision|0|||
164102037|NCT01796171|592736564|FG014|Follow-up Period|Physician Decision|0|||
164102038|NCT01796171|592736550|FG000|Follow-up Period|Withdrawal by Subject|0|||
164102039|NCT01796171|592736551|FG001|Follow-up Period|Withdrawal by Subject|1|||
164102040|NCT01796171|592736552|FG002|Follow-up Period|Withdrawal by Subject|0|||
164059171|NCT01714726|592578898|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
164102041|NCT01796171|592736553|FG003|Follow-up Period|Withdrawal by Subject|0|||
164102042|NCT01796171|592736554|FG004|Follow-up Period|Withdrawal by Subject|0|||
164102043|NCT01796171|592736555|FG005|Follow-up Period|Withdrawal by Subject|1|||
164102044|NCT01796171|592736556|FG006|Follow-up Period|Withdrawal by Subject|0|||
164102045|NCT01796171|592736557|FG007|Follow-up Period|Withdrawal by Subject|0|||
164102046|NCT01796171|592736558|FG008|Follow-up Period|Withdrawal by Subject|0|||
164102047|NCT01796171|592736559|FG009|Follow-up Period|Withdrawal by Subject|0|||
164102048|NCT01796171|592736560|FG010|Follow-up Period|Withdrawal by Subject|3|||
164102049|NCT01796171|592736561|FG011|Follow-up Period|Withdrawal by Subject|1|||
164102050|NCT01796171|592736562|FG012|Follow-up Period|Withdrawal by Subject|0|||
164102051|NCT01796171|592736563|FG013|Follow-up Period|Withdrawal by Subject|0|||
164102052|NCT01796171|592736564|FG014|Follow-up Period|Withdrawal by Subject|0|||
164102053|NCT01796171|592736550|FG000|Follow-up Period|Death|0|||
164102054|NCT01796171|592736551|FG001|Follow-up Period|Death|0|||
164102055|NCT01796171|592736552|FG002|Follow-up Period|Death|0|||
164102056|NCT01796171|592736553|FG003|Follow-up Period|Death|0|||
164102057|NCT01796171|592736554|FG004|Follow-up Period|Death|0|||
164102058|NCT01796171|592736555|FG005|Follow-up Period|Death|0|||
164102059|NCT01796171|592736556|FG006|Follow-up Period|Death|1|||
164102060|NCT01796171|592736557|FG007|Follow-up Period|Death|0|||
164102061|NCT01796171|592736558|FG008|Follow-up Period|Death|0|||
164102062|NCT01796171|592736559|FG009|Follow-up Period|Death|0|||
164102063|NCT01796171|592736560|FG010|Follow-up Period|Death|17|||
164102064|NCT01796171|592736561|FG011|Follow-up Period|Death|9|||
164102065|NCT01796171|592736562|FG012|Follow-up Period|Death|1|||
164102066|NCT01796171|592736563|FG013|Follow-up Period|Death|0|||
164102067|NCT01796171|592736564|FG014|Follow-up Period|Death|0|||
164102068|NCT01796171|592736550|FG000|Follow-up Period|Patient transferred to other hospital|0|||
164102069|NCT01796171|592736551|FG001|Follow-up Period|Patient transferred to other hospital|1|||
164102070|NCT01796171|592736552|FG002|Follow-up Period|Patient transferred to other hospital|0|||
164102071|NCT01796171|592736553|FG003|Follow-up Period|Patient transferred to other hospital|0|||
164102072|NCT01796171|592736554|FG004|Follow-up Period|Patient transferred to other hospital|0|||
164102073|NCT01796171|592736555|FG005|Follow-up Period|Patient transferred to other hospital|0|||
164102074|NCT01796171|592736556|FG006|Follow-up Period|Patient transferred to other hospital|0|||
164102075|NCT01796171|592736557|FG007|Follow-up Period|Patient transferred to other hospital|0|||
164102076|NCT01796171|592736558|FG008|Follow-up Period|Patient transferred to other hospital|0|||
164102077|NCT01796171|592736559|FG009|Follow-up Period|Patient transferred to other hospital|0|||
164059172|NCT01714726|592578899|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
164102078|NCT01796171|592736560|FG010|Follow-up Period|Patient transferred to other hospital|0|||
164102079|NCT01796171|592736561|FG011|Follow-up Period|Patient transferred to other hospital|0|||
164102080|NCT01796171|592736562|FG012|Follow-up Period|Patient transferred to other hospital|0|||
164102081|NCT01796171|592736563|FG013|Follow-up Period|Patient transferred to other hospital|0|||
164102082|NCT01796171|592736564|FG014|Follow-up Period|Patient transferred to other hospital|0|||
164102083|NCT01796171|592736550|FG000|Follow-up Period|Sponsor Decision|0|||
164102084|NCT01796171|592736551|FG001|Follow-up Period|Sponsor Decision|0|||
164102085|NCT01796171|592736552|FG002|Follow-up Period|Sponsor Decision|0|||
164102086|NCT01796171|592736553|FG003|Follow-up Period|Sponsor Decision|0|||
164102087|NCT01796171|592736554|FG004|Follow-up Period|Sponsor Decision|0|||
164102088|NCT01796171|592736555|FG005|Follow-up Period|Sponsor Decision|0|||
164102089|NCT01796171|592736556|FG006|Follow-up Period|Sponsor Decision|0|||
164059173|NCT01714726|592578900|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
164059174|NCT01714726|592578897|FG000|Double-Blinded Induction Period|Adverse Event|0|||
164059175|NCT01714726|592578898|FG001|Double-Blinded Induction Period|Adverse Event|1|||
164059176|NCT01714726|592578899|FG002|Double-Blinded Induction Period|Adverse Event|0|||
164059177|NCT01714726|592578900|FG003|Double-Blinded Induction Period|Adverse Event|0|||
164059178|NCT01714726|592578897|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
164059179|NCT01714726|592578898|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
164059180|NCT01714726|592578899|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
164059181|NCT01714726|592578900|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
164059182|NCT01714726|592578897|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
164059183|NCT01714726|592578898|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
164059184|NCT01714726|592578899|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
164059185|NCT01714726|592578900|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
164102090|NCT01796171|592736557|FG007|Follow-up Period|Sponsor Decision|0|||
164102091|NCT01796171|592736558|FG008|Follow-up Period|Sponsor Decision|0|||
164102092|NCT01796171|592736559|FG009|Follow-up Period|Sponsor Decision|0|||
164102093|NCT01796171|592736560|FG010|Follow-up Period|Sponsor Decision|40|||
164059186|NCT01714726|592578897|FG000|Open-Label Period|Other|0|||
164059187|NCT01714726|592578898|FG001|Open-Label Period|Other|0|||
164102094|NCT01796171|592736561|FG011|Follow-up Period|Sponsor Decision|15|||
164102095|NCT01796171|592736562|FG012|Follow-up Period|Sponsor Decision|7|||
164102096|NCT01796171|592736563|FG013|Follow-up Period|Sponsor Decision|0|||
164102097|NCT01796171|592736564|FG014|Follow-up Period|Sponsor Decision|0|||
164102098|NCT00829309|592736565|FG000|Washout: 7 Days|Protocol Violation|1|||
164102099|NCT00829309|592736566|FG001|Washout: 7 Days|Protocol Violation|0|||
164102100|NCT03699020|592736570|FG000|Overall Study|Withdrawal by Subject|3|||
164102101|NCT03699020|592736571|FG001|Overall Study|Withdrawal by Subject|2|||
164102102|NCT02678286|592736572|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
164102103|NCT02678286|592736573|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
164102104|NCT02678286|592736572|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
164102105|NCT02678286|592736573|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
164102106|NCT02678286|592736572|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
164102107|NCT02678286|592736573|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
164102108|NCT02678286|592736572|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
164102109|NCT02678286|592736573|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
164102110|NCT02678286|592736572|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
164102111|NCT02678286|592736573|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
164102112|NCT02077465|592736578|FG000|Overall Study|Withdrew Consent|0|||
164102113|NCT02077465|592736579|FG001|Overall Study|Withdrew Consent|1|||
164102114|NCT02077465|592736578|FG000|Overall Study|Lost to Follow-up|1|||
164102115|NCT02077465|592736579|FG001|Overall Study|Lost to Follow-up|0|||
164102116|NCT03375463|592736581|FG000|Period 1|Lost to Follow-up|0|||
164059188|NCT01714726|592578899|FG002|Open-Label Period|Other|1|||
164059189|NCT01714726|592578900|FG003|Open-Label Period|Other|3|||
164059190|NCT01714726|592578897|FG000|Open-Label Period|Adverse Event|0|||
164059191|NCT01714726|592578898|FG001|Open-Label Period|Adverse Event|0|||
164059192|NCT01714726|592578899|FG002|Open-Label Period|Adverse Event|1|||
164059193|NCT01714726|592578900|FG003|Open-Label Period|Adverse Event|0|||
164059194|NCT01714726|592578897|FG000|Open-Label Period|Withdrawal by Subject|0|||
164059195|NCT01714726|592578898|FG001|Open-Label Period|Withdrawal by Subject|0|||
164059196|NCT01714726|592578899|FG002|Open-Label Period|Withdrawal by Subject|9|||
164059197|NCT01714726|592578900|FG003|Open-Label Period|Withdrawal by Subject|19|||
164059198|NCT01714726|592578897|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
164059199|NCT01714726|592578898|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
164059200|NCT01714726|592578899|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
164059201|NCT01714726|592578900|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
164059202|NCT01714726|592578897|FG000|Open-Label Period|Lost to Follow-up|0|||
164059203|NCT01714726|592578898|FG001|Open-Label Period|Lost to Follow-up|0|||
164059204|NCT01714726|592578899|FG002|Open-Label Period|Lost to Follow-up|3|||
164059205|NCT01714726|592578900|FG003|Open-Label Period|Lost to Follow-up|4|||
164059206|NCT00548340|592578901|FG000|Overall Study|Protocol Violation|2|||
164059207|NCT00548340|592578902|FG001|Overall Study|Protocol Violation|3|||
164059208|NCT00548340|592578903|FG002|Overall Study|Protocol Violation|3|||
164059209|NCT00548340|592578901|FG000|Overall Study|Adverse Event|2|||
164059210|NCT00548340|592578902|FG001|Overall Study|Adverse Event|2|||
164059211|NCT00548340|592578903|FG002|Overall Study|Adverse Event|2|||
164059212|NCT00548340|592578901|FG000|Overall Study|Lost to Follow-up|1|||
164059213|NCT00548340|592578902|FG001|Overall Study|Lost to Follow-up|1|||
164059214|NCT00548340|592578903|FG002|Overall Study|Lost to Follow-up|0|||
164059215|NCT00548340|592578901|FG000|Overall Study|Withdrawal by Subject|2|||
164059216|NCT00548340|592578902|FG001|Overall Study|Withdrawal by Subject|4|||
164059217|NCT00548340|592578903|FG002|Overall Study|Withdrawal by Subject|3|||
164059218|NCT00548340|592578901|FG000|Overall Study|Other|1|||
164059219|NCT00548340|592578902|FG001|Overall Study|Other|1|||
164059220|NCT00548340|592578903|FG002|Overall Study|Other|1|||
164059221|NCT03778021|592578904|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
164059222|NCT03778021|592578905|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
164059223|NCT00679042|592578906|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
164059224|NCT00679042|592578906|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
164059225|NCT00679042|592578906|FG000|5-Year Follow Up|Death|1|||
164059226|NCT00679042|592578906|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
164059227|NCT00679042|592578906|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
164059228|NCT02687815|592578907|FG000|Overall Study|Lost to Follow-up|2|||
164059229|NCT02687815|592578908|FG001|Overall Study|Lost to Follow-up|4|||
164059230|NCT02687815|592578907|FG000|Overall Study|Withdrawal by Subject|2|||
164059231|NCT02687815|592578908|FG001|Overall Study|Withdrawal by Subject|4|||
164059232|NCT00379639|592578909|FG000|Overall Study|Disease Progression|3|||
164059233|NCT00379639|592578910|FG001|Overall Study|Disease Progression|3|||
164059234|NCT00379639|592578911|FG002|Overall Study|Disease Progression|3|||
164059235|NCT00379639|592578912|FG003|Overall Study|Disease Progression|4|||
164059236|NCT00379639|592578913|FG004|Overall Study|Disease Progression|4|||
164059237|NCT00379639|592578909|FG000|Overall Study|Physician Decision|0|||
164059238|NCT00379639|592578910|FG001|Overall Study|Physician Decision|2|||
164059239|NCT00379639|592578911|FG002|Overall Study|Physician Decision|1|||
164059240|NCT00379639|592578912|FG003|Overall Study|Physician Decision|1|||
164102117|NCT03375463|592736582|FG001|Period 1|Lost to Follow-up|0|||
164102118|NCT03375463|592736583|FG002|Period 1|Lost to Follow-up|1|||
164102119|NCT03375463|592736584|FG003|Period 1|Lost to Follow-up|0|||
164102120|NCT03375463|592736585|FG004|Period 1|Lost to Follow-up|0|||
164102121|NCT03375463|592736586|FG005|Period 1|Lost to Follow-up|0|||
164059241|NCT00379639|592578913|FG004|Overall Study|Physician Decision|0|||
164059242|NCT00379639|592578909|FG000|Overall Study|Symptomatic Deterioration|0|||
164059243|NCT00379639|592578910|FG001|Overall Study|Symptomatic Deterioration|0|||
164059244|NCT00379639|592578911|FG002|Overall Study|Symptomatic Deterioration|1|||
164059245|NCT00379639|592578912|FG003|Overall Study|Symptomatic Deterioration|0|||
164059246|NCT00379639|592578913|FG004|Overall Study|Symptomatic Deterioration|1|||
164059247|NCT00379639|592578909|FG000|Overall Study|Adverse Event|0|||
164059248|NCT00379639|592578910|FG001|Overall Study|Adverse Event|0|||
164059249|NCT00379639|592578911|FG002|Overall Study|Adverse Event|1|||
164102122|NCT03375463|592736581|FG000|Period 1|Adverse Event|0|||
164059250|NCT00379639|592578912|FG003|Overall Study|Adverse Event|0|||
164059251|NCT00379639|592578913|FG004|Overall Study|Adverse Event|1|||
164059252|NCT00379639|592578909|FG000|Overall Study|Lost to Follow-up|0|||
164059253|NCT00379639|592578910|FG001|Overall Study|Lost to Follow-up|0|||
164059254|NCT00379639|592578911|FG002|Overall Study|Lost to Follow-up|0|||
164059255|NCT00379639|592578912|FG003|Overall Study|Lost to Follow-up|1|||
164059256|NCT00379639|592578913|FG004|Overall Study|Lost to Follow-up|0|||
164059257|NCT00379639|592578909|FG000|Overall Study|Other|0|||
164059258|NCT00379639|592578910|FG001|Overall Study|Other|0|||
164059259|NCT00379639|592578911|FG002|Overall Study|Other|3|||
164059260|NCT00379639|592578912|FG003|Overall Study|Other|0|||
164059261|NCT00379639|592578913|FG004|Overall Study|Other|0|||
164059262|NCT03053102|592578918|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
164059263|NCT03053102|592578918|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
164059264|NCT03735680|592578921|FG000|Overall Study|Withdrawal by Subject|0|||
164059265|NCT03735680|592578922|FG001|Overall Study|Withdrawal by Subject|1|||
164059266|NCT03735680|592578923|FG002|Overall Study|Withdrawal by Subject|0|||
164059267|NCT03735680|592578924|FG003|Overall Study|Withdrawal by Subject|0|||
164059268|NCT03735680|592578925|FG004|Overall Study|Withdrawal by Subject|0|||
164059269|NCT03735680|592578926|FG005|Overall Study|Withdrawal by Subject|1|||
164059270|NCT03735680|592578921|FG000|Overall Study|Patient unable or unwilling to continue|0|||
164059271|NCT03735680|592578922|FG001|Overall Study|Patient unable or unwilling to continue|0|||
164059272|NCT03735680|592578923|FG002|Overall Study|Patient unable or unwilling to continue|1|||
164059273|NCT03735680|592578924|FG003|Overall Study|Patient unable or unwilling to continue|0|||
164059274|NCT03735680|592578925|FG004|Overall Study|Patient unable or unwilling to continue|0|||
164059275|NCT03735680|592578926|FG005|Overall Study|Patient unable or unwilling to continue|0|||
164059276|NCT02392078|592578930|FG000|Overall Study|Did not have procedure|32|||
164059277|NCT02392078|592578931|FG001|Overall Study|Did not have procedure|43|||
164059278|NCT02392078|592578932|FG002|Overall Study|Did not have procedure|20|||
164059279|NCT02392078|592578933|FG003|Overall Study|Did not have procedure|1|||
164059280|NCT02079077|592578935|FG000|Overall Study|Lost to Follow-up|5|||
164059281|NCT02079077|592578936|FG001|Overall Study|Lost to Follow-up|7|||
164059282|NCT02079077|592578935|FG000|Overall Study|Became STIs Positive|1|||
164059283|NCT02079077|592578936|FG001|Overall Study|Became STIs Positive|2|||
164059284|NCT01928758|592578937|FG000|Overall Study|Lost to Follow-up|14|||
164059285|NCT01928758|592578938|FG001|Overall Study|Lost to Follow-up|9|||
164059286|NCT01928758|592578937|FG000|Overall Study|Withdrawal by Subject|5|||
164059287|NCT01928758|592578938|FG001|Overall Study|Withdrawal by Subject|2|||
164059288|NCT01928758|592578937|FG000|Overall Study|Adverse Event|3|||
164059289|NCT01928758|592578938|FG001|Overall Study|Adverse Event|5|||
164059290|NCT01928758|592578937|FG000|Overall Study|Protocol Violation|3|||
164059291|NCT01928758|592578938|FG001|Overall Study|Protocol Violation|4|||
164059292|NCT03198559|592578939|FG000|Overall Study|Adverse Event|2|||
164059293|NCT03737812|592578940|FG000|Overall Study|Withdrawal by Subject|1|||
164059294|NCT03737812|592578941|FG001|Overall Study|Withdrawal by Subject|2|||
164059295|NCT03737812|592578942|FG002|Overall Study|Withdrawal by Subject|1|||
164059296|NCT03737812|592578940|FG000|Overall Study|Sponsor Discontinued the Study|4|||
164059297|NCT03737812|592578941|FG001|Overall Study|Sponsor Discontinued the Study|3|||
164059298|NCT03737812|592578942|FG002|Overall Study|Sponsor Discontinued the Study|2|||
164059299|NCT03737812|592578940|FG000|Overall Study|Adverse Event|0|||
164059300|NCT03737812|592578941|FG001|Overall Study|Adverse Event|1|||
164059301|NCT03737812|592578942|FG002|Overall Study|Adverse Event|0|||
164059302|NCT03737812|592578940|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
164059303|NCT03737812|592578941|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
164059304|NCT03737812|592578942|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
164059305|NCT01474291|592578946|FG000|Overall Study|Not Evaluable for Efficacy|26|||
164059306|NCT01474291|592578946|FG000|Overall Study|Lack of Treatment Efficacy|88|||
164059307|NCT01474291|592578946|FG000|Overall Study|Adverse Event|53|||
164059308|NCT01474291|592578946|FG000|Overall Study|Lost to Follow-up|29|||
164059309|NCT01474291|592578946|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
164059310|NCT01474291|592578946|FG000|Overall Study|No Reason Reported|10|||
164059311|NCT01474291|592578946|FG000|Overall Study|Death|2|||
164059312|NCT03471507|592578947|FG000|Overall Study|Lost to Follow-up|1|||
164059313|NCT03471507|592578948|FG001|Overall Study|Lost to Follow-up|3|||
164059314|NCT03471507|592578947|FG000|Overall Study|Physician Decision|0|||
164059315|NCT03471507|592578948|FG001|Overall Study|Physician Decision|1|||
164059316|NCT03471507|592578947|FG000|Overall Study|Withdrawal by Subject|2|||
164102123|NCT03375463|592736582|FG001|Period 1|Adverse Event|0|||
164102124|NCT03375463|592736583|FG002|Period 1|Adverse Event|0|||
164102125|NCT03375463|592736584|FG003|Period 1|Adverse Event|0|||
164102126|NCT03375463|592736585|FG004|Period 1|Adverse Event|1|||
164059317|NCT03471507|592578948|FG001|Overall Study|Withdrawal by Subject|1|||
164059318|NCT02557308|592578950|FG000|Overall Study|Withdrawal by Subject|11|||
164059319|NCT02557308|592578951|FG001|Overall Study|Withdrawal by Subject|3|||
164059320|NCT02557308|592578952|FG002|Overall Study|Withdrawal by Subject|2|||
164059321|NCT02557308|592578953|FG003|Overall Study|Withdrawal by Subject|0|||
164059322|NCT02557308|592578954|FG004|Overall Study|Withdrawal by Subject|1|||
164059323|NCT02557308|592578955|FG005|Overall Study|Withdrawal by Subject|0|||
164059324|NCT02557308|592578956|FG006|Overall Study|Withdrawal by Subject|10|||
164059325|NCT02557308|592578957|FG007|Overall Study|Withdrawal by Subject|1|||
164102127|NCT03375463|592736586|FG005|Period 1|Adverse Event|0|||
164102128|NCT03375463|592736581|FG000|Period 2|Lost to Follow-up|1|||
164102129|NCT03375463|592736582|FG001|Period 2|Lost to Follow-up|1|||
164102130|NCT03375463|592736583|FG002|Period 2|Lost to Follow-up|0|||
164102131|NCT03375463|592736584|FG003|Period 2|Lost to Follow-up|0|||
164102132|NCT03375463|592736585|FG004|Period 2|Lost to Follow-up|0|||
164102133|NCT03375463|592736586|FG005|Period 2|Lost to Follow-up|0|||
164102134|NCT01827163|592736587|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
164102135|NCT01827163|592736587|FG000|Overall Study|Adverse Event|9|||
164102136|NCT01745120|592736589|FG000|Overall Study|Investigator decision|1|||
164102137|NCT01745120|592736590|FG001|Overall Study|Investigator decision|0|||
164102138|NCT02909907|592736597|FG000|Overall Study|Withdrawal by Subject|0|||
164102139|NCT02909907|592736598|FG001|Overall Study|Withdrawal by Subject|1|||
164102140|NCT01513174|592736599|FG000|Overall Study|Inclusion Error|1|||
164102141|NCT01513174|592736600|FG001|Overall Study|Inclusion Error|7|||
164102142|NCT01513174|592736599|FG000|Overall Study|Not receive study treatment|3|||
164102143|NCT01513174|592736600|FG001|Overall Study|Not receive study treatment|1|||
164102144|NCT00850174|592736601|FG000|Washout: One Week|Withdrawal by Subject|0|||
164102145|NCT00850174|592736602|FG001|Washout: One Week|Withdrawal by Subject|2|||
164102146|NCT00850174|592736601|FG000|Second Intervention|Withdrawal by Subject|1|||
164102147|NCT00850174|592736602|FG001|Second Intervention|Withdrawal by Subject|0|||
164102148|NCT01900626|592736605|FG000|Overall Study|study was closed due to low enrollment|1|||
164102149|NCT01900626|592736606|FG001|Overall Study|study was closed due to low enrollment|1|||
164102150|NCT01200810|592736609|FG000|Overall Study|Physician Decision|1|||
164102151|NCT01200810|592736610|FG001|Overall Study|Physician Decision|0|||
164102152|NCT01200810|592736609|FG000|Overall Study|Withdrawal by Subject|1|||
164102153|NCT01200810|592736610|FG001|Overall Study|Withdrawal by Subject|2|||
164102154|NCT01200810|592736609|FG000|Overall Study|Sponsor stopped making study drug|3|||
164102155|NCT01200810|592736610|FG001|Overall Study|Sponsor stopped making study drug|3|||
164102156|NCT03500341|592736612|FG000|Overall Study|Withdrawn prior to Completion|2|||
164102157|NCT01294917|592736613|FG000|Overall Study|Relocation|5|||
164102158|NCT01294917|592736613|FG000|Overall Study|Inconvenience|1|||
164102159|NCT03017885|592736614|FG000|Overall Study|Adverse Event|2|||
164102160|NCT03017885|592736615|FG001|Overall Study|Adverse Event|0|||
164102161|NCT03017885|592736616|FG002|Overall Study|Adverse Event|0|||
164102162|NCT03017885|592736617|FG003|Overall Study|Adverse Event|0|||
164102163|NCT03017885|592736618|FG004|Overall Study|Adverse Event|0|||
164102164|NCT03017885|592736619|FG005|Overall Study|Adverse Event|0|||
164102165|NCT03017885|592736614|FG000|Overall Study|Progression of disease|4|||
164102166|NCT03017885|592736615|FG001|Overall Study|Progression of disease|3|||
164102167|NCT03017885|592736616|FG002|Overall Study|Progression of disease|4|||
164102168|NCT03017885|592736617|FG003|Overall Study|Progression of disease|0|||
164102169|NCT03017885|592736618|FG004|Overall Study|Progression of disease|0|||
164102170|NCT03017885|592736619|FG005|Overall Study|Progression of disease|0|||
164102171|NCT03017885|592736614|FG000|Overall Study|Other than listed|1|||
164102172|NCT03017885|592736615|FG001|Overall Study|Other than listed|2|||
164102173|NCT03017885|592736616|FG002|Overall Study|Other than listed|1|||
164102174|NCT03017885|592736617|FG003|Overall Study|Other than listed|0|||
164059326|NCT02557308|592578950|FG000|Overall Study|Disease Progression|0|||
164102175|NCT03017885|592736618|FG004|Overall Study|Other than listed|0|||
164102176|NCT03017885|592736619|FG005|Overall Study|Other than listed|0|||
164102177|NCT03017885|592736614|FG000|Overall Study|Lost to Follow-up|2|||
164102178|NCT03017885|592736615|FG001|Overall Study|Lost to Follow-up|0|||
164102179|NCT03017885|592736616|FG002|Overall Study|Lost to Follow-up|3|||
164102180|NCT03017885|592736617|FG003|Overall Study|Lost to Follow-up|0|||
164102181|NCT03017885|592736618|FG004|Overall Study|Lost to Follow-up|0|||
164102182|NCT03017885|592736619|FG005|Overall Study|Lost to Follow-up|0|||
164102183|NCT03017885|592736614|FG000|Overall Study|Change to other anti-cancer therapy|0|||
164102184|NCT03017885|592736615|FG001|Overall Study|Change to other anti-cancer therapy|0|||
164102185|NCT03017885|592736616|FG002|Overall Study|Change to other anti-cancer therapy|1|||
164102186|NCT03017885|592736617|FG003|Overall Study|Change to other anti-cancer therapy|0|||
164059327|NCT02557308|592578951|FG001|Overall Study|Disease Progression|1|||
164059328|NCT02557308|592578952|FG002|Overall Study|Disease Progression|0|||
164102187|NCT03017885|592736618|FG004|Overall Study|Change to other anti-cancer therapy|0|||
164102188|NCT03017885|592736619|FG005|Overall Study|Change to other anti-cancer therapy|0|||
164059329|NCT02557308|592578953|FG003|Overall Study|Disease Progression|0|||
164059330|NCT02557308|592578954|FG004|Overall Study|Disease Progression|0|||
164059331|NCT02557308|592578955|FG005|Overall Study|Disease Progression|0|||
164059332|NCT02557308|592578956|FG006|Overall Study|Disease Progression|0|||
164059333|NCT02557308|592578957|FG007|Overall Study|Disease Progression|0|||
164059334|NCT02557308|592578950|FG000|Overall Study|Lack of Efficacy|3|||
164059335|NCT02557308|592578951|FG001|Overall Study|Lack of Efficacy|0|||
164059336|NCT02557308|592578952|FG002|Overall Study|Lack of Efficacy|0|||
164059337|NCT02557308|592578953|FG003|Overall Study|Lack of Efficacy|0|||
164059338|NCT02557308|592578954|FG004|Overall Study|Lack of Efficacy|0|||
164059339|NCT02557308|592578955|FG005|Overall Study|Lack of Efficacy|0|||
164059340|NCT02557308|592578956|FG006|Overall Study|Lack of Efficacy|1|||
164059341|NCT02557308|592578957|FG007|Overall Study|Lack of Efficacy|0|||
164059342|NCT02557308|592578950|FG000|Overall Study|Adverse Event|4|||
164059343|NCT02557308|592578951|FG001|Overall Study|Adverse Event|1|||
164059344|NCT02557308|592578952|FG002|Overall Study|Adverse Event|2|||
164059345|NCT02557308|592578953|FG003|Overall Study|Adverse Event|0|||
164059346|NCT02557308|592578954|FG004|Overall Study|Adverse Event|0|||
164059347|NCT02557308|592578955|FG005|Overall Study|Adverse Event|0|||
164059348|NCT02557308|592578956|FG006|Overall Study|Adverse Event|4|||
164059349|NCT02557308|592578957|FG007|Overall Study|Adverse Event|1|||
164059350|NCT02557308|592578950|FG000|Overall Study|Lost to Follow-up|2|||
164059351|NCT02557308|592578951|FG001|Overall Study|Lost to Follow-up|0|||
164059352|NCT02557308|592578952|FG002|Overall Study|Lost to Follow-up|1|||
164059353|NCT02557308|592578953|FG003|Overall Study|Lost to Follow-up|0|||
164059354|NCT02557308|592578954|FG004|Overall Study|Lost to Follow-up|0|||
164059355|NCT02557308|592578955|FG005|Overall Study|Lost to Follow-up|0|||
164059356|NCT02557308|592578956|FG006|Overall Study|Lost to Follow-up|2|||
164059357|NCT02557308|592578957|FG007|Overall Study|Lost to Follow-up|0|||
164059358|NCT02557308|592578950|FG000|Overall Study|Death|1|||
164059359|NCT02557308|592578951|FG001|Overall Study|Death|0|||
164059360|NCT02557308|592578952|FG002|Overall Study|Death|0|||
164059361|NCT02557308|592578953|FG003|Overall Study|Death|0|||
164059362|NCT02557308|592578954|FG004|Overall Study|Death|0|||
164059363|NCT02557308|592578955|FG005|Overall Study|Death|0|||
164059364|NCT02557308|592578956|FG006|Overall Study|Death|0|||
164059365|NCT02557308|592578957|FG007|Overall Study|Death|0|||
164059366|NCT02557308|592578950|FG000|Overall Study|Study Close|98|||
164059367|NCT02557308|592578951|FG001|Overall Study|Study Close|18|||
164059368|NCT02557308|592578952|FG002|Overall Study|Study Close|5|||
164059369|NCT02557308|592578953|FG003|Overall Study|Study Close|3|||
164059370|NCT02557308|592578954|FG004|Overall Study|Study Close|1|||
164059371|NCT02557308|592578955|FG005|Overall Study|Study Close|0|||
164059372|NCT02557308|592578956|FG006|Overall Study|Study Close|123|||
164059373|NCT02557308|592578957|FG007|Overall Study|Study Close|5|||
164059374|NCT02557308|592578950|FG000|Overall Study|Except for study close|5|||
164059375|NCT02557308|592578951|FG001|Overall Study|Except for study close|0|||
164059376|NCT02557308|592578952|FG002|Overall Study|Except for study close|0|||
164059377|NCT02557308|592578953|FG003|Overall Study|Except for study close|0|||
164059378|NCT02557308|592578954|FG004|Overall Study|Except for study close|3|||
164059379|NCT02557308|592578955|FG005|Overall Study|Except for study close|0|||
164059380|NCT02557308|592578956|FG006|Overall Study|Except for study close|6|||
164059381|NCT02557308|592578957|FG007|Overall Study|Except for study close|10|||
164059382|NCT02046993|592578961|FG000|Overall Study|Withdrawal by Subject|2|||
164059383|NCT02046993|592578962|FG001|Overall Study|Withdrawal by Subject|10|||
164059384|NCT02046993|592578961|FG000|Overall Study|Lost to Follow-up|1|||
164059385|NCT02046993|592578962|FG001|Overall Study|Lost to Follow-up|1|||
164059386|NCT00761735|592578970|FG000|Overall Study|Lost to Follow-up|6|||
164059387|NCT00761735|592578970|FG000|Overall Study|Withdrawal by Subject|6|||
164059388|NCT00761735|592578970|FG000|Overall Study|Non-compliance with protocol|1|||
164059389|NCT00761735|592578970|FG000|Overall Study|Administrative|1|||
164059390|NCT03326323|592578971|FG000|Overall Study|Unable to receive ANH protocol|3|||
164059391|NCT00851721|592578976|FG000|Overall Study|planned surgery|1|||
164059392|NCT00851721|592578977|FG001|Overall Study|planned surgery|0|||
164102189|NCT03138967|592736621|FG000|Overall Study|Death|0|||
164102190|NCT03138967|592736622|FG001|Overall Study|Death|1|||
164059393|NCT00851721|592578976|FG000|Overall Study|Death|1|||
164059394|NCT00851721|592578977|FG001|Overall Study|Death|0|||
164059395|NCT00851721|592578976|FG000|Overall Study|Adverse Event|0|||
164059396|NCT00851721|592578977|FG001|Overall Study|Adverse Event|1|||
164059397|NCT04047472|592578978|FG000|Overall Study|Adverse Event|3|||
164059398|NCT04047472|592578979|FG001|Overall Study|Adverse Event|3|||
164059399|NCT04047472|592578978|FG000|Overall Study|Death|0|||
164059400|NCT04047472|592578979|FG001|Overall Study|Death|1|||
164059401|NCT04047472|592578978|FG000|Overall Study|Lost to Follow-up|1|||
164059402|NCT04047472|592578979|FG001|Overall Study|Lost to Follow-up|0|||
164059403|NCT04047472|592578978|FG000|Overall Study|Physician Decision|1|||
164059404|NCT04047472|592578979|FG001|Overall Study|Physician Decision|2|||
164059405|NCT04047472|592578978|FG000|Overall Study|Protocol Violation|1|||
164059406|NCT04047472|592578979|FG001|Overall Study|Protocol Violation|0|||
164059407|NCT04047472|592578978|FG000|Overall Study|Withdrawal by Subject|10|||
164102191|NCT03138967|592736621|FG000|Overall Study|Physician Decision|1|||
164059408|NCT04047472|592578979|FG001|Overall Study|Withdrawal by Subject|10|||
164059409|NCT01218477|592578980|FG000|Overall Study|Disease progression|2|||
164059410|NCT01218477|592578981|FG001|Overall Study|Disease progression|3|||
164059411|NCT01218477|592578982|FG002|Overall Study|Disease progression|6|||
164059412|NCT01218477|592578983|FG003|Overall Study|Disease progression|2|||
164059413|NCT01218477|592578980|FG000|Overall Study|Study drug toxicity|0|||
164059414|NCT01218477|592578981|FG001|Overall Study|Study drug toxicity|2|||
164059415|NCT01218477|592578982|FG002|Overall Study|Study drug toxicity|5|||
164059416|NCT01218477|592578983|FG003|Overall Study|Study drug toxicity|0|||
164059417|NCT01218477|592578980|FG000|Overall Study|No longer meets study criteria|1|||
164059418|NCT01218477|592578981|FG001|Overall Study|No longer meets study criteria|0|||
164059419|NCT01218477|592578982|FG002|Overall Study|No longer meets study criteria|0|||
164059420|NCT01218477|592578983|FG003|Overall Study|No longer meets study criteria|0|||
164059421|NCT01218477|592578980|FG000|Overall Study|Withdrawal by Subject|0|||
164059422|NCT01218477|592578981|FG001|Overall Study|Withdrawal by Subject|0|||
164059423|NCT01218477|592578982|FG002|Overall Study|Withdrawal by Subject|1|||
164059424|NCT01218477|592578983|FG003|Overall Study|Withdrawal by Subject|0|||
164059425|NCT01218477|592578980|FG000|Overall Study|Prepared for cell transplantation|0|||
164059426|NCT01218477|592578981|FG001|Overall Study|Prepared for cell transplantation|1|||
164059427|NCT01218477|592578982|FG002|Overall Study|Prepared for cell transplantation|1|||
164059428|NCT01218477|592578983|FG003|Overall Study|Prepared for cell transplantation|0|||
164059429|NCT01218477|592578980|FG000|Overall Study|Administrative reason by sponsor|0|||
164059430|NCT01218477|592578981|FG001|Overall Study|Administrative reason by sponsor|0|||
164059431|NCT01218477|592578982|FG002|Overall Study|Administrative reason by sponsor|1|||
164059432|NCT01218477|592578983|FG003|Overall Study|Administrative reason by sponsor|0|||
164059433|NCT01218477|592578980|FG000|Overall Study|Maximum clinical benefit|0|||
164059434|NCT01218477|592578981|FG001|Overall Study|Maximum clinical benefit|2|||
164059435|NCT01218477|592578982|FG002|Overall Study|Maximum clinical benefit|0|||
164059436|NCT01218477|592578983|FG003|Overall Study|Maximum clinical benefit|0|||
164059437|NCT01333501|592578987|FG000|Overall Study|Adverse Event|3|||
164059438|NCT01333501|592578988|FG001|Overall Study|Adverse Event|1|||
164059439|NCT01333501|592578987|FG000|Overall Study|Abnormal laboratory value|2|||
164059440|NCT01333501|592578988|FG001|Overall Study|Abnormal laboratory value|1|||
164059441|NCT01333501|592578987|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164059442|NCT01333501|592578988|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
164059443|NCT01333501|592578987|FG000|Overall Study|Withdrawn consent|3|||
164059444|NCT01333501|592578988|FG001|Overall Study|Withdrawn consent|12|||
164059445|NCT01303159|592578989|FG000|Overall Study|Death|16|||
164059446|NCT01303159|592578989|FG000|Overall Study|Study Termination|7|||
164059447|NCT00496782|592578990|FG000|Overall Study|Protocol Violation|1|||
164059448|NCT00496782|592578991|FG001|Overall Study|Protocol Violation|2|||
164059449|NCT02132312|592578993|FG000|Overall Study|Adverse Event|2|||
164059450|NCT02132312|592578994|FG001|Overall Study|Adverse Event|0|||
164059451|NCT02132312|592578993|FG000|Overall Study|Physician Decision|1|||
164059452|NCT02132312|592578994|FG001|Overall Study|Physician Decision|1|||
164059453|NCT02132312|592578993|FG000|Overall Study|Protocol Violation|0|||
164059454|NCT02132312|592578994|FG001|Overall Study|Protocol Violation|1|||
164059455|NCT02132312|592578993|FG000|Overall Study|Withdrawal by Subject|1|||
164059456|NCT02132312|592578994|FG001|Overall Study|Withdrawal by Subject|0|||
164059457|NCT02132312|592578993|FG000|Overall Study|Lost to Follow-up|2|||
164059458|NCT02132312|592578994|FG001|Overall Study|Lost to Follow-up|1|||
164059459|NCT04034225|592578995|FG000|Overall Study|Death|3|||
164059460|NCT04034225|592578995|FG000|Overall Study|Withdrawal by Subject|2|||
164059461|NCT04034225|592578995|FG000|Overall Study|Study termination by Sponsor|18|||
164059462|NCT04034225|592578995|FG000|Overall Study|Physician Decision|1|||
164059463|NCT04034225|592578995|FG000|Overall Study|Lack of Efficacy|1|||
164059464|NCT00955682|592578996|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
164059465|NCT00955682|592578997|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
164059466|NCT00877929|592579003|FG000|Overall Study|Adverse Event|11|||
164059467|NCT00877929|592579004|FG001|Overall Study|Adverse Event|20|||
164059468|NCT00877929|592579003|FG000|Overall Study|Protocol Violation|3|||
164059469|NCT00877929|592579004|FG001|Overall Study|Protocol Violation|3|||
164059470|NCT00877929|592579003|FG000|Overall Study|Lost to Follow-up|0|||
164059471|NCT00877929|592579004|FG001|Overall Study|Lost to Follow-up|1|||
164059472|NCT00877929|592579003|FG000|Overall Study|Withdrawal by Subject|4|||
164059473|NCT00877929|592579004|FG001|Overall Study|Withdrawal by Subject|4|||
164059474|NCT00877929|592579003|FG000|Overall Study|Lack of Efficacy|0|||
164059475|NCT00877929|592579004|FG001|Overall Study|Lack of Efficacy|1|||
164059476|NCT00877929|592579003|FG000|Overall Study|Other reason (not specified)|2|||
164059477|NCT00877929|592579004|FG001|Overall Study|Other reason (not specified)|6|||
164059478|NCT00842829|592579005|FG000|Dose Titration Period|Adverse Event|11|||
164059479|NCT00842829|592579006|FG001|Dose Titration Period|Adverse Event|10|||
164059480|NCT00842829|592579007|FG002|Dose Titration Period|Adverse Event|0|||
164059481|NCT00842829|592579005|FG000|Dose Titration Period|Lack of Efficacy|4|||
164059482|NCT00842829|592579006|FG001|Dose Titration Period|Lack of Efficacy|1|||
164059483|NCT00842829|592579007|FG002|Dose Titration Period|Lack of Efficacy|0|||
164102192|NCT03138967|592736622|FG001|Overall Study|Physician Decision|3|||
164059484|NCT00842829|592579005|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
164059485|NCT00842829|592579006|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
164059486|NCT00842829|592579007|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
164059487|NCT00842829|592579005|FG000|Dose Titration Period|Withdrawal by Subject|2|||
164059488|NCT00842829|592579006|FG001|Dose Titration Period|Withdrawal by Subject|6|||
164059489|NCT00842829|592579007|FG002|Dose Titration Period|Withdrawal by Subject|0|||
164059490|NCT00842829|592579005|FG000|Dose Titration Period|Other|5|||
164059491|NCT00842829|592579006|FG001|Dose Titration Period|Other|4|||
164059492|NCT00842829|592579007|FG002|Dose Titration Period|Other|0|||
164059493|NCT00842829|592579005|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
164059494|NCT00842829|592579006|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
164059495|NCT00842829|592579007|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
164059496|NCT00842829|592579005|FG000|Dose Titration Period|Non-compliance to study drug|2|||
164059497|NCT00842829|592579006|FG001|Dose Titration Period|Non-compliance to study drug|1|||
164059498|NCT00842829|592579007|FG002|Dose Titration Period|Non-compliance to study drug|0|||
164059499|NCT00842829|592579005|FG000|Treatment Period|Adverse Event|0|||
164059500|NCT00842829|592579006|FG001|Treatment Period|Adverse Event|0|||
164059501|NCT00842829|592579007|FG002|Treatment Period|Adverse Event|15|||
164059502|NCT00842829|592579005|FG000|Treatment Period|Lack of Efficacy|0|||
164059503|NCT00842829|592579006|FG001|Treatment Period|Lack of Efficacy|0|||
164059504|NCT00842829|592579007|FG002|Treatment Period|Lack of Efficacy|6|||
164059505|NCT00842829|592579005|FG000|Treatment Period|Unstable persistent cancer pain|0|||
164059506|NCT00842829|592579006|FG001|Treatment Period|Unstable persistent cancer pain|0|||
164059507|NCT00842829|592579007|FG002|Treatment Period|Unstable persistent cancer pain|5|||
164059508|NCT00842829|592579005|FG000|Treatment Period|Withdrawal by Subject|0|||
164059509|NCT00842829|592579006|FG001|Treatment Period|Withdrawal by Subject|0|||
164059510|NCT00842829|592579007|FG002|Treatment Period|Withdrawal by Subject|11|||
164059511|NCT00842829|592579005|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
164059512|NCT00842829|592579006|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
164059513|NCT00842829|592579007|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
164059514|NCT00842829|592579005|FG000|Treatment Period|Protocol Violation|0|||
164059515|NCT00842829|592579006|FG001|Treatment Period|Protocol Violation|0|||
164059516|NCT00842829|592579007|FG002|Treatment Period|Protocol Violation|2|||
164059517|NCT00842829|592579005|FG000|Treatment Period|Other|0|||
164059518|NCT00842829|592579006|FG001|Treatment Period|Other|0|||
164059519|NCT00842829|592579007|FG002|Treatment Period|Other|18|||
164059520|NCT00842829|592579005|FG000|Treatment Period|Non-compliance to study procedures|0|||
164059521|NCT00842829|592579006|FG001|Treatment Period|Non-compliance to study procedures|0|||
164059522|NCT00842829|592579007|FG002|Treatment Period|Non-compliance to study procedures|4|||
164059523|NCT00842829|592579005|FG000|Treatment Period|Unclear completion status|0|||
164059524|NCT00842829|592579006|FG001|Treatment Period|Unclear completion status|0|||
164059525|NCT00842829|592579007|FG002|Treatment Period|Unclear completion status|1|||
164059526|NCT00842829|592579005|FG000|Continuation Period|Adverse Event|0|||
164059527|NCT00842829|592579006|FG001|Continuation Period|Adverse Event|0|||
164059528|NCT00842829|592579007|FG002|Continuation Period|Adverse Event|32|||
164059529|NCT00842829|592579005|FG000|Continuation Period|Lack of Efficacy|0|||
164059530|NCT00842829|592579006|FG001|Continuation Period|Lack of Efficacy|0|||
164059531|NCT00842829|592579007|FG002|Continuation Period|Lack of Efficacy|6|||
164059532|NCT00842829|592579005|FG000|Continuation Period|Unstable persistent cancer pain|0|||
164059533|NCT00842829|592579006|FG001|Continuation Period|Unstable persistent cancer pain|0|||
164059534|NCT00842829|592579007|FG002|Continuation Period|Unstable persistent cancer pain|3|||
164059535|NCT00842829|592579005|FG000|Continuation Period|Withdrawal by Subject|0|||
164059536|NCT00842829|592579006|FG001|Continuation Period|Withdrawal by Subject|0|||
164059537|NCT00842829|592579007|FG002|Continuation Period|Withdrawal by Subject|10|||
164059538|NCT00842829|592579005|FG000|Continuation Period|Other|0|||
164059539|NCT00842829|592579006|FG001|Continuation Period|Other|0|||
164059540|NCT00842829|592579007|FG002|Continuation Period|Other|7|||
164059541|NCT00842829|592579005|FG000|Continuation Period|Non-compliance to study procedures|0|||
164059542|NCT00842829|592579006|FG001|Continuation Period|Non-compliance to study procedures|0|||
164059543|NCT00842829|592579007|FG002|Continuation Period|Non-compliance to study procedures|2|||
164059544|NCT00842829|592579005|FG000|Continuation Period|Non-compliance to study drug|0|||
164059545|NCT00842829|592579006|FG001|Continuation Period|Non-compliance to study drug|0|||
164059546|NCT00842829|592579007|FG002|Continuation Period|Non-compliance to study drug|1|||
164059547|NCT02612194|592579010|FG000|Overall Study|Death|5|||
164059548|NCT02612194|592579011|FG001|Overall Study|Death|0|||
164059549|NCT02612194|592579012|FG002|Overall Study|Death|2|||
164059550|NCT02612194|592579010|FG000|Overall Study|Early Study Termination|1|||
164059551|NCT02612194|592579011|FG001|Overall Study|Early Study Termination|0|||
164059552|NCT02612194|592579012|FG002|Overall Study|Early Study Termination|0|||
164059553|NCT00689299|592579015|FG000|Overall Study|Adverse Event|2|||
164059554|NCT00689299|592579016|FG001|Overall Study|Adverse Event|1|||
164059555|NCT00689299|592579017|FG002|Overall Study|Adverse Event|1|||
164059556|NCT00689299|592579015|FG000|Overall Study|Lost to Follow-up|0|||
164059557|NCT00689299|592579016|FG001|Overall Study|Lost to Follow-up|1|||
164059558|NCT00689299|592579017|FG002|Overall Study|Lost to Follow-up|1|||
164059559|NCT00689299|592579015|FG000|Overall Study|Withdrawal by Subject|4|||
164059560|NCT00689299|592579016|FG001|Overall Study|Withdrawal by Subject|1|||
164059561|NCT00689299|592579017|FG002|Overall Study|Withdrawal by Subject|3|||
164059562|NCT00689299|592579015|FG000|Overall Study|Protocol Violation|1|||
164059563|NCT00689299|592579016|FG001|Overall Study|Protocol Violation|0|||
164059564|NCT00689299|592579017|FG002|Overall Study|Protocol Violation|0|||
164059565|NCT01190839|592579018|FG000|Overall Study|Adverse Event|32|||
164059566|NCT01190839|592579019|FG001|Overall Study|Adverse Event|41|||
164059567|NCT01190839|592579018|FG000|Overall Study|Protocol Violation|2|||
164059568|NCT01190839|592579019|FG001|Overall Study|Protocol Violation|2|||
164059569|NCT01190839|592579018|FG000|Overall Study|Lost to Follow-up|7|||
164059570|NCT01190839|592579019|FG001|Overall Study|Lost to Follow-up|1|||
164059571|NCT01190839|592579018|FG000|Overall Study|Death|1|||
164059572|NCT01190839|592579019|FG001|Overall Study|Death|0|||
164059573|NCT01190839|592579018|FG000|Overall Study|Trial stopped by Sponsor|71|||
164059574|NCT01190839|592579019|FG001|Overall Study|Trial stopped by Sponsor|68|||
164059575|NCT01190839|592579018|FG000|Overall Study|Undefined|35|||
164059576|NCT01190839|592579019|FG001|Overall Study|Undefined|31|||
164059577|NCT01190839|592579018|FG000|Overall Study|Randomized but not treated|2|||
164059578|NCT01190839|592579019|FG001|Overall Study|Randomized but not treated|4|||
164059579|NCT01265511|592579024|FG000|Overall Study|Lack of Efficacy|2|||
164059580|NCT01265511|592579025|FG001|Overall Study|Lack of Efficacy|1|||
164059581|NCT01265511|592579024|FG000|Overall Study|Met stopping rules|0|||
164059582|NCT01265511|592579025|FG001|Overall Study|Met stopping rules|2|||
164059583|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
164059584|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
164059585|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
164059586|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
164059587|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
164059588|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
164059589|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
164059590|NCT00950755|592579029|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
164059591|NCT00950755|592579029|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
164059592|NCT00950755|592579029|FG000|Long-Term Follow-Up|Death|8|||
164059593|NCT03799198|592580894|FG000|Overall Study|Lost to Follow-up|4|||
164059594|NCT03799198|592580895|FG001|Overall Study|Lost to Follow-up|8|||
164059595|NCT03799198|592580894|FG000|Overall Study|Death|0|||
164059596|NCT03799198|592580895|FG001|Overall Study|Death|1|||
164059597|NCT00960869|592580897|FG000|Overall Study|Adverse Event|17|||
164059598|NCT00960869|592580898|FG001|Overall Study|Adverse Event|26|||
164059599|NCT00960869|592580897|FG000|Overall Study|Withdrawal by Subject|16|||
164059600|NCT00960869|592580898|FG001|Overall Study|Withdrawal by Subject|14|||
164059601|NCT00960869|592580897|FG000|Overall Study|Lost to Follow-up|1|||
164059602|NCT00960869|592580898|FG001|Overall Study|Lost to Follow-up|4|||
164059603|NCT00960869|592580897|FG000|Overall Study|Misc|19|||
164059604|NCT00960869|592580898|FG001|Overall Study|Misc|18|||
164059605|NCT02501642|592580899|FG000|Overall Study|Lost to Follow-up|7|||
164059606|NCT02501642|592580900|FG001|Overall Study|Lost to Follow-up|11|||
164059607|NCT01153971|592580904|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
164059608|NCT01153971|592580904|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
164059609|NCT01153971|592580904|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
164059610|NCT01153971|592580904|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
164059611|NCT01153971|592580904|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
164059612|NCT01153971|592580904|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
164059613|NCT01153971|592580904|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
164059614|NCT03410693|592580905|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
164059615|NCT03410693|592580906|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
164059616|NCT03410693|592580905|FG000|Overall Study|Disc trt: Lost to follow up|0|||
164059617|NCT03410693|592580906|FG001|Overall Study|Disc trt: Lost to follow up|1|||
164059618|NCT03410693|592580905|FG000|Overall Study|Disc trt: radiological progression|58|||
164059619|NCT03410693|592580906|FG001|Overall Study|Disc trt: radiological progression|50|||
164059620|NCT03410693|592580905|FG000|Overall Study|Disc trt: Other|1|||
164059621|NCT03410693|592580906|FG001|Overall Study|Disc trt: Other|0|||
164059622|NCT03410693|592580905|FG000|Overall Study|Study drug never administered|1|||
164059623|NCT03410693|592580906|FG001|Overall Study|Study drug never administered|6|||
164059624|NCT03410693|592580905|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
164059625|NCT03410693|592580906|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
164059626|NCT03410693|592580905|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
164059627|NCT03410693|592580906|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
164059628|NCT03410693|592580905|FG000|Overall Study|Disc trt: Physician decision|0|||
164059629|NCT03410693|592580906|FG001|Overall Study|Disc trt: Physician decision|5|||
164059630|NCT03410693|592580905|FG000|Overall Study|Disc trt: clinical progression|1|||
164059631|NCT03410693|592580906|FG001|Overall Study|Disc trt: clinical progression|5|||
164059632|NCT03410693|592580905|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
164059633|NCT03410693|592580906|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
164059634|NCT01789476|592580907|FG000|Overall Study|Lack of Efficacy|6|||
164059635|NCT01789476|592580908|FG001|Overall Study|Lack of Efficacy|2|||
164059636|NCT01789476|592580907|FG000|Overall Study|Adverse Event|1|||
164059637|NCT01789476|592580908|FG001|Overall Study|Adverse Event|0|||
164059638|NCT01789476|592580907|FG000|Overall Study|Unable to get IV access|1|||
164059639|NCT01789476|592580908|FG001|Overall Study|Unable to get IV access|0|||
164059640|NCT00953576|592580909|FG000|Overall Study|Adverse Event|0|||
164059641|NCT00953576|592580910|FG001|Overall Study|Adverse Event|1|||
164059642|NCT00953576|592580909|FG000|Overall Study|Ineligible after Consent|2|||
164059643|NCT00953576|592580910|FG001|Overall Study|Ineligible after Consent|0|||
164059644|NCT00501969|592580911|FG000|Overall Study|Major Protocol Violation|4|||
164059645|NCT00501969|592580911|FG000|Overall Study|Lack of Efficacy|29|||
164059646|NCT00501969|592580911|FG000|Overall Study|Adverse Event|76|||
164059647|NCT00501969|592580911|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
164059648|NCT00501969|592580911|FG000|Overall Study|Subject withdrew consent|51|||
164059649|NCT00501969|592580911|FG000|Overall Study|Lost to Follow-up|4|||
164059650|NCT00501969|592580911|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
164059651|NCT00501969|592580911|FG000|Overall Study|Other: Sponsors Request|10|||
164059652|NCT00501969|592580911|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
164059653|NCT00501969|592580911|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
164059654|NCT00501969|592580911|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
164059655|NCT00501969|592580911|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
164059656|NCT00501969|592580911|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
164059657|NCT00501969|592580911|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
164059658|NCT00501969|592580911|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
164059659|NCT00501969|592580911|FG000|Overall Study|Other: As Required by Local EC|2|||
164059660|NCT00501969|592580911|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
164059661|NCT00501969|592580911|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
164059662|NCT01798056|592580912|FG000|Overall Study|Serious Adverse Event|13|||
164059663|NCT01798056|592580913|FG001|Overall Study|Serious Adverse Event|12|||
164059664|NCT01798056|592580912|FG000|Overall Study|Withdrawal by Subject|12|||
164059665|NCT01798056|592580913|FG001|Overall Study|Withdrawal by Subject|9|||
164059666|NCT01798056|592580912|FG000|Overall Study|Migrated/moved from study area|1|||
164059667|NCT01798056|592580913|FG001|Overall Study|Migrated/moved from study area|1|||
164059668|NCT01798056|592580912|FG000|Overall Study|Lost to Follow-up|1|||
164059669|NCT01798056|592580913|FG001|Overall Study|Lost to Follow-up|1|||
164059670|NCT01798056|592580912|FG000|Overall Study|Other|0|||
164059671|NCT01798056|592580913|FG001|Overall Study|Other|2|||
164059672|NCT01238861|592580914|FG000|Overall Study|Lost to Follow-up|4|||
164059673|NCT01238861|592580915|FG001|Overall Study|Lost to Follow-up|2|||
164059674|NCT01238861|592580916|FG002|Overall Study|Lost to Follow-up|3|||
164059675|NCT01238861|592580917|FG003|Overall Study|Lost to Follow-up|1|||
164059676|NCT01238861|592580918|FG004|Overall Study|Lost to Follow-up|1|||
164059677|NCT01238861|592580919|FG005|Overall Study|Lost to Follow-up|2|||
164059678|NCT01238861|592580914|FG000|Overall Study|Unplanned surgery|1|||
164059679|NCT01238861|592580915|FG001|Overall Study|Unplanned surgery|0|||
164059680|NCT01238861|592580916|FG002|Overall Study|Unplanned surgery|0|||
164059681|NCT01238861|592580917|FG003|Overall Study|Unplanned surgery|0|||
164059682|NCT01238861|592580918|FG004|Overall Study|Unplanned surgery|0|||
164059683|NCT01238861|592580919|FG005|Overall Study|Unplanned surgery|0|||
164059684|NCT01238861|592580914|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
164059685|NCT01238861|592580915|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
164059686|NCT01238861|592580916|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
164059687|NCT01238861|592580917|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
164059688|NCT01238861|592580918|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
164059689|NCT01238861|592580919|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
164059690|NCT01238861|592580914|FG000|Overall Study|Incorrect enrollment/randomization|0|||
164059691|NCT01238861|592580915|FG001|Overall Study|Incorrect enrollment/randomization|0|||
164059692|NCT01238861|592580916|FG002|Overall Study|Incorrect enrollment/randomization|1|||
164059693|NCT01238861|592580917|FG003|Overall Study|Incorrect enrollment/randomization|0|||
164059694|NCT01238861|592580918|FG004|Overall Study|Incorrect enrollment/randomization|1|||
164059695|NCT01238861|592580919|FG005|Overall Study|Incorrect enrollment/randomization|0|||
164059696|NCT01238861|592580914|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
164059697|NCT01238861|592580915|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
164059698|NCT01238861|592580916|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
164059699|NCT01238861|592580917|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
164102193|NCT04604275|592736629|FG000|Washout-1 Week|Withdrawal by Subject|1|||
164059700|NCT01238861|592580918|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
164059701|NCT01238861|592580919|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
164059702|NCT01238861|592580914|FG000|Overall Study|Subject moved out of state/area|0|||
164059703|NCT01238861|592580915|FG001|Overall Study|Subject moved out of state/area|0|||
164059704|NCT01238861|592580916|FG002|Overall Study|Subject moved out of state/area|1|||
164059705|NCT01238861|592580917|FG003|Overall Study|Subject moved out of state/area|1|||
164059706|NCT01238861|592580918|FG004|Overall Study|Subject moved out of state/area|0|||
164059707|NCT01238861|592580919|FG005|Overall Study|Subject moved out of state/area|0|||
164059708|NCT01238861|592580914|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
164059709|NCT01238861|592580915|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
164059710|NCT01238861|592580916|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
164059711|NCT01238861|592580917|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
164059712|NCT01238861|592580918|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
164059713|NCT01238861|592580919|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
164059714|NCT01238861|592580914|FG000|Overall Study|Personal problems|0|||
164059715|NCT01238861|592580915|FG001|Overall Study|Personal problems|0|||
164059716|NCT01238861|592580916|FG002|Overall Study|Personal problems|0|||
164059717|NCT01238861|592580917|FG003|Overall Study|Personal problems|1|||
164059718|NCT01238861|592580918|FG004|Overall Study|Personal problems|0|||
164059719|NCT01238861|592580919|FG005|Overall Study|Personal problems|0|||
164059720|NCT01238861|592580914|FG000|Overall Study|Unable to continue visits|0|||
164059721|NCT01238861|592580915|FG001|Overall Study|Unable to continue visits|0|||
164059722|NCT01238861|592580916|FG002|Overall Study|Unable to continue visits|0|||
164059723|NCT01238861|592580917|FG003|Overall Study|Unable to continue visits|1|||
164059724|NCT01238861|592580918|FG004|Overall Study|Unable to continue visits|0|||
164059725|NCT01238861|592580919|FG005|Overall Study|Unable to continue visits|1|||
164059726|NCT01238861|592580914|FG000|Overall Study|Serious adverse event|0|||
164059727|NCT01238861|592580915|FG001|Overall Study|Serious adverse event|0|||
164059728|NCT01238861|592580916|FG002|Overall Study|Serious adverse event|0|||
164059729|NCT01238861|592580917|FG003|Overall Study|Serious adverse event|0|||
164059730|NCT01238861|592580918|FG004|Overall Study|Serious adverse event|0|||
164059731|NCT01238861|592580919|FG005|Overall Study|Serious adverse event|1|||
164059732|NCT01238861|592580914|FG000|Overall Study|Lack of compliance|0|||
164059733|NCT01238861|592580915|FG001|Overall Study|Lack of compliance|0|||
164102194|NCT04604275|592736630|FG001|Washout-1 Week|Withdrawal by Subject|0|||
164102195|NCT04405570|592736631|FG000|Overall Study|Adverse Event|0|||
164102196|NCT04405570|592736632|FG001|Overall Study|Adverse Event|1|||
164102197|NCT04405570|592736633|FG002|Overall Study|Adverse Event|1|||
164102198|NCT04405570|592736634|FG003|Overall Study|Adverse Event|1|||
164102199|NCT04405570|592736631|FG000|Overall Study|Lost to Follow-up|0|||
164102200|NCT04405570|592736632|FG001|Overall Study|Lost to Follow-up|1|||
164102201|NCT04405570|592736633|FG002|Overall Study|Lost to Follow-up|0|||
164102202|NCT04405570|592736634|FG003|Overall Study|Lost to Follow-up|0|||
164102203|NCT04405570|592736631|FG000|Overall Study|Physician Decision|0|||
164102204|NCT04405570|592736632|FG001|Overall Study|Physician Decision|0|||
164102205|NCT04405570|592736633|FG002|Overall Study|Physician Decision|1|||
164102206|NCT04405570|592736634|FG003|Overall Study|Physician Decision|0|||
164102207|NCT04405570|592736631|FG000|Overall Study|Withdrawal by Subject|0|||
164102208|NCT04405570|592736632|FG001|Overall Study|Withdrawal by Subject|1|||
164102209|NCT04405570|592736633|FG002|Overall Study|Withdrawal by Subject|1|||
164102210|NCT04405570|592736634|FG003|Overall Study|Withdrawal by Subject|0|||
164102211|NCT04405570|592736631|FG000|Overall Study|Randomized not dosed|0|||
164102212|NCT04405570|592736632|FG001|Overall Study|Randomized not dosed|2|||
164102213|NCT04405570|592736633|FG002|Overall Study|Randomized not dosed|0|||
164102214|NCT04405570|592736634|FG003|Overall Study|Randomized not dosed|0|||
164102215|NCT04499963|592736635|FG000|Overall Study|Adverse Event|3|||
164102216|NCT04499963|592736636|FG001|Overall Study|Adverse Event|0|||
164102217|NCT04499963|592736635|FG000|Overall Study|Death|3|||
164102218|NCT04499963|592736636|FG001|Overall Study|Death|0|||
164102219|NCT04499963|592736635|FG000|Overall Study|Lack of Efficacy|7|||
164102220|NCT04499963|592736636|FG001|Overall Study|Lack of Efficacy|0|||
164102221|NCT04499963|592736635|FG000|Overall Study|Lost to Follow-up|2|||
164102222|NCT04499963|592736636|FG001|Overall Study|Lost to Follow-up|0|||
164102223|NCT02648347|592736642|FG000|Overall Study|Death|174|||
164102224|NCT02648347|592736643|FG001|Overall Study|Death|167|||
164059734|NCT01238861|592580916|FG002|Overall Study|Lack of compliance|0|||
164059735|NCT01238861|592580917|FG003|Overall Study|Lack of compliance|0|||
164059736|NCT01238861|592580918|FG004|Overall Study|Lack of compliance|0|||
164059737|NCT01238861|592580919|FG005|Overall Study|Lack of compliance|1|||
164059738|NCT01238861|592580914|FG000|Overall Study|Adverse Event|0|||
164102225|NCT02648347|592736642|FG000|Overall Study|Withdrawal by Subject|16|||
164102226|NCT02648347|592736643|FG001|Overall Study|Withdrawal by Subject|9|||
164102227|NCT02648347|592736642|FG000|Overall Study|Lost to Follow-up|18|||
164102228|NCT02648347|592736643|FG001|Overall Study|Lost to Follow-up|21|||
164059739|NCT01238861|592580915|FG001|Overall Study|Adverse Event|1|||
164059740|NCT01238861|592580916|FG002|Overall Study|Adverse Event|0|||
164059741|NCT01238861|592580917|FG003|Overall Study|Adverse Event|0|||
164059742|NCT01238861|592580918|FG004|Overall Study|Adverse Event|0|||
164059743|NCT01238861|592580919|FG005|Overall Study|Adverse Event|0|||
164059744|NCT01238861|592580914|FG000|Overall Study|Withdrawal by Subject|6|||
164102229|NCT02648347|592736642|FG000|Overall Study|Missing|1|||
164102230|NCT02648347|592736643|FG001|Overall Study|Missing|0|||
164059745|NCT01238861|592580915|FG001|Overall Study|Withdrawal by Subject|5|||
164059746|NCT01238861|592580916|FG002|Overall Study|Withdrawal by Subject|4|||
164059747|NCT01238861|592580917|FG003|Overall Study|Withdrawal by Subject|8|||
164059748|NCT01238861|592580918|FG004|Overall Study|Withdrawal by Subject|10|||
164059749|NCT01238861|592580919|FG005|Overall Study|Withdrawal by Subject|9|||
164102231|NCT03546842|592736645|FG000|Overall Study|Protocol Violation|1|||
164102232|NCT03546842|592736645|FG000|Overall Study|Withdrawal by Subject|2|||
164102233|NCT01723397|592736646|FG000|Study Period 1|Protocol Violation|0|||
164102234|NCT01723397|592736647|FG001|Study Period 1|Protocol Violation|1|||
164102235|NCT01723397|592736646|FG000|Study Period 2|Protocol Violation|0|||
164102236|NCT01723397|592736647|FG001|Study Period 2|Protocol Violation|1|||
164102237|NCT02739997|592736648|FG000|Overall Study|Death|1|||
164102238|NCT02739997|592736648|FG000|Overall Study|Withdrawal by Subject|1|||
164102239|NCT02601625|592736653|FG000|Overall Study|Lost to Follow-up|0|||
164059750|NCT01269346|592580920|FG000|Treatment Phase|Disease progression|3|||
164059751|NCT01269346|592580920|FG000|Treatment Phase|Adverse Event|3|||
164059752|NCT01269346|592580920|FG000|Treatment Phase|Withdrawal by Subject|1|||
164059753|NCT01269346|592580920|FG000|Treatment Phase|Other|2|||
164059754|NCT01269346|592580920|FG000|Extension Phase|Adverse Event|6|||
164059755|NCT01269346|592580920|FG000|Extension Phase|Withdrawal by Subject|4|||
164059756|NCT01269346|592580920|FG000|Extension Phase|Disease progression|22|||
164059757|NCT01269346|592580920|FG000|Extension Phase|Physician decision or participant choice|9|||
164059758|NCT01269346|592580920|FG000|Extension Phase|Clinical progression|1|||
164059759|NCT01269346|592580920|FG000|Extension Phase|Started a prohibited con med|1|||
164059760|NCT00247416|592580921|FG000|Overall Study|3 patients were found to be ineligible|1|||
164059761|NCT00247416|592580922|FG001|Overall Study|3 patients were found to be ineligible|2|||
164059762|NCT02660489|592580931|FG000|Overall Study|Lost to Follow-up|1|||
164059763|NCT02660489|592580932|FG001|Overall Study|Lost to Follow-up|1|||
164059764|NCT02660489|592580931|FG000|Overall Study|Adverse Event|1|||
164059765|NCT02660489|592580932|FG001|Overall Study|Adverse Event|3|||
164059766|NCT02660489|592580931|FG000|Overall Study|no rhinovirus infection|4|||
164059767|NCT02660489|592580932|FG001|Overall Study|no rhinovirus infection|4|||
164059768|NCT00278473|592580933|FG000|Overall Study|drop out|4|||
164059769|NCT00278473|592580934|FG001|Overall Study|drop out|3|||
164059770|NCT02322866|592580935|FG000|Overall Study|Adverse Event|6|||
164059771|NCT02322866|592580936|FG001|Overall Study|Adverse Event|11|||
164059772|NCT02322866|592580935|FG000|Overall Study|Withdrawal of Consent|16|||
164059773|NCT02322866|592580936|FG001|Overall Study|Withdrawal of Consent|25|||
164059774|NCT02322866|592580935|FG000|Overall Study|Lost to Follow-up|36|||
164059775|NCT02322866|592580936|FG001|Overall Study|Lost to Follow-up|39|||
164059776|NCT02322866|592580935|FG000|Overall Study|Protocol Violation|1|||
164059777|NCT02322866|592580936|FG001|Overall Study|Protocol Violation|0|||
164059778|NCT02322866|592580935|FG000|Overall Study|Noncompliance with Treatment|3|||
164059779|NCT02322866|592580936|FG001|Overall Study|Noncompliance with Treatment|4|||
164059780|NCT02322866|592580935|FG000|Overall Study|Lack of Efficacy|3|||
164059781|NCT02322866|592580936|FG001|Overall Study|Lack of Efficacy|1|||
164059782|NCT02322866|592580935|FG000|Overall Study|Other Miscellaneous Reasons|6|||
164059783|NCT02322866|592580936|FG001|Overall Study|Other Miscellaneous Reasons|6|||
164059784|NCT00761761|592580946|FG000|Overall Study|Lost to Follow-up|3|||
164059785|NCT00761761|592580947|FG001|Overall Study|Lost to Follow-up|1|||
164059786|NCT00761761|592580946|FG000|Overall Study|Withdrawal by Subject|3|||
164059787|NCT00761761|592580947|FG001|Overall Study|Withdrawal by Subject|0|||
164059788|NCT04001790|592580952|FG000|Overall Study|Withdrawal by Subject|1|||
164059789|NCT04001790|592580953|FG001|Overall Study|Withdrawal by Subject|2|||
164059790|NCT03472586|592580954|FG000|Overall Study|Physician Decision|6|||
164059791|NCT03472586|592580954|FG000|Overall Study|Death|6|||
164059792|NCT03472586|592580954|FG000|Overall Study|Adverse Event|1|||
164059793|NCT04963231|592580957|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
164059794|NCT04963231|592580958|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
164059795|NCT04963231|592580959|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
164059796|NCT04963231|592580957|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
164059797|NCT04963231|592580958|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
164059798|NCT04963231|592580959|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
164059799|NCT04963231|592580957|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
164059800|NCT04963231|592580958|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
164059801|NCT04963231|592580959|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
164059802|NCT04963231|592580957|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
164059803|NCT04963231|592580958|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
164059804|NCT04963231|592580959|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
164059805|NCT04963231|592580957|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
164059806|NCT04963231|592580958|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
164059807|NCT04963231|592580959|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
164102240|NCT02601625|592736654|FG001|Overall Study|Lost to Follow-up|0|||
164102241|NCT02601625|592736655|FG002|Overall Study|Lost to Follow-up|1|||
164102242|NCT02601625|592736656|FG003|Overall Study|Lost to Follow-up|1|||
164102243|NCT00838279|592736657|FG000|Washout|Protocol Violation|1|||
164102244|NCT00838279|592736658|FG001|Washout|Protocol Violation|0|||
164102245|NCT00838279|592736657|FG000|Washout|Withdrawal by Subject|0|||
164102246|NCT00838279|592736658|FG001|Washout|Withdrawal by Subject|1|||
164102247|NCT04608188|592736659|FG000|Overall Study|Withdrawal by Subject|4|||
164102248|NCT04608188|592736660|FG001|Overall Study|Withdrawal by Subject|8|||
164102249|NCT04419311|592736662|FG000|Overall Study|Lost to Follow-up|1|||
164102250|NCT04419311|592736663|FG001|Overall Study|Lost to Follow-up|0|||
164102251|NCT00965185|592736664|FG000|Overall Study|Lost to Follow-up|2|||
164102252|NCT00965185|592736665|FG001|Overall Study|Lost to Follow-up|0|||
164102253|NCT00965185|592736664|FG000|Overall Study|Withdrawal by Subject|0|||
164102254|NCT00965185|592736665|FG001|Overall Study|Withdrawal by Subject|1|||
164102255|NCT01921062|592736666|FG000|Overall Study|Withdrawal by Subject|0|||
164102256|NCT01921062|592736667|FG001|Overall Study|Withdrawal by Subject|7|||
164102257|NCT01921062|592736666|FG000|Overall Study|Adverse Event|5|||
164102258|NCT01921062|592736667|FG001|Overall Study|Adverse Event|6|||
164102259|NCT01921062|592736666|FG000|Overall Study|Protocol Violation|0|||
164102260|NCT01921062|592736667|FG001|Overall Study|Protocol Violation|1|||
164102261|NCT01921062|592736666|FG000|Overall Study|VMIQ score > 72|4|||
164102262|NCT01921062|592736667|FG001|Overall Study|VMIQ score > 72|1|||
164102263|NCT01921062|592736666|FG000|Overall Study|Logistic error|0|||
164102264|NCT01921062|592736667|FG001|Overall Study|Logistic error|1|||
164102265|NCT03686033|592736668|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
164102266|NCT03686033|592736669|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
164102267|NCT03686033|592736670|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
164102268|NCT03686033|592736671|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
164059808|NCT04963231|592580957|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
164059809|NCT04963231|592580958|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
164059810|NCT04963231|592580959|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
164059811|NCT04963231|592580957|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
164059812|NCT04963231|592580958|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
164059813|NCT04963231|592580959|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
164059814|NCT01059175|592580962|FG000|Overall Study|Death|17|||
164059815|NCT01059175|592580963|FG001|Overall Study|Death|17|||
164059816|NCT01059175|592580962|FG000|Overall Study|Adverse Event|4|||
164059817|NCT01059175|592580963|FG001|Overall Study|Adverse Event|2|||
164102269|NCT03686033|592736672|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
164102270|NCT03686033|592736673|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
164102271|NCT01302548|592736675|FG000|Overall Study|Lost to Follow-up|2|||
164102272|NCT01302548|592736676|FG001|Overall Study|Lost to Follow-up|1|||
164102273|NCT02089997|592736687|FG000|Overall Study|Case report forms uncollected|99|||
164102274|NCT02089997|592736687|FG000|Overall Study|Protocol Violation|147|||
164102275|NCT00095212|592736688|FG000|Overall Study|Withdrawal by Subject|1|||
164059818|NCT01059175|592580962|FG000|Overall Study|Lost to Follow-up|0|||
164059819|NCT01059175|592580963|FG001|Overall Study|Lost to Follow-up|1|||
164059820|NCT02957149|592580964|FG000|Overall Study|Withdrawal by Subject|5|||
164059821|NCT06045026|592580965|FG000|Overall Study|Lost to Follow-up|60|||
164059822|NCT06045026|592580965|FG000|Overall Study|Adverse Event|12|||
164059823|NCT06045026|592580965|FG000|Overall Study|Withdrawal by Subject|3|||
164059824|NCT06045026|592580965|FG000|Overall Study|Enrollment closed|1|||
164059825|NCT02452320|592580971|FG000|Overall Study|Adverse Event|0|||
164059826|NCT02452320|592580972|FG001|Overall Study|Adverse Event|1|||
164059827|NCT01399619|592580973|FG000|Overall Study|Adverse Event|10|||
164059828|NCT01399619|592580974|FG001|Overall Study|Adverse Event|0|||
164059829|NCT01399619|592580975|FG002|Overall Study|Adverse Event|4|||
164059830|NCT01399619|592580976|FG003|Overall Study|Adverse Event|10|||
164059831|NCT01399619|592580973|FG000|Overall Study|Lack of Efficacy|9|||
164059832|NCT01399619|592580974|FG001|Overall Study|Lack of Efficacy|0|||
164059833|NCT01399619|592580975|FG002|Overall Study|Lack of Efficacy|5|||
164059834|NCT01399619|592580976|FG003|Overall Study|Lack of Efficacy|0|||
164059835|NCT01399619|592580973|FG000|Overall Study|Withdrawal by Subject|6|||
164059836|NCT01399619|592580974|FG001|Overall Study|Withdrawal by Subject|0|||
164059837|NCT01399619|592580975|FG002|Overall Study|Withdrawal by Subject|3|||
164059838|NCT01399619|592580976|FG003|Overall Study|Withdrawal by Subject|4|||
164102276|NCT00095212|592736689|FG001|Overall Study|Withdrawal by Subject|3|||
164102277|NCT02374853|592736692|FG000|Overall Study|Surgery Cancelled|5|||
164102278|NCT02374853|592736693|FG001|Overall Study|Surgery Cancelled|11|||
164102279|NCT03681470|592736695|FG000|Overall Study|Lack of Efficacy|3|||
164102280|NCT03681470|592736695|FG000|Overall Study|Lost to Follow-up|1|||
164059839|NCT01399619|592580973|FG000|Overall Study|Protocol Violation|0|||
164102281|NCT03681470|592736695|FG000|Overall Study|Protocol Violation|3|||
164102282|NCT03681470|592736695|FG000|Overall Study|Withdrawal by Subject|1|||
164102283|NCT02335658|592736700|FG000|Overall Study|Adverse Event|18|||
164102284|NCT02335658|592736701|FG001|Overall Study|Adverse Event|12|||
164059840|NCT01399619|592580974|FG001|Overall Study|Protocol Violation|0|||
164059841|NCT01399619|592580975|FG002|Overall Study|Protocol Violation|0|||
164102285|NCT02335658|592736700|FG000|Overall Study|Lack of Efficacy|4|||
164059842|NCT01399619|592580976|FG003|Overall Study|Protocol Violation|1|||
164059843|NCT01399619|592580973|FG000|Overall Study|Not treated|0|||
164059844|NCT01399619|592580974|FG001|Overall Study|Not treated|0|||
164059845|NCT01399619|592580975|FG002|Overall Study|Not treated|0|||
164059846|NCT01399619|592580976|FG003|Overall Study|Not treated|2|||
164059847|NCT03911401|592580979|FG000|Overall Study|Adverse Event|1|||
164059848|NCT03911401|592580980|FG001|Overall Study|Adverse Event|2|||
164059849|NCT03911401|592580981|FG002|Overall Study|Adverse Event|5|||
164059850|NCT03911401|592580979|FG000|Overall Study|Lack of Efficacy|1|||
164059851|NCT03911401|592580980|FG001|Overall Study|Lack of Efficacy|1|||
164059852|NCT03911401|592580981|FG002|Overall Study|Lack of Efficacy|8|||
164059853|NCT03911401|592580979|FG000|Overall Study|Physician Decision|0|||
164059854|NCT03911401|592580980|FG001|Overall Study|Physician Decision|0|||
164059855|NCT03911401|592580981|FG002|Overall Study|Physician Decision|1|||
164059856|NCT03911401|592580979|FG000|Overall Study|Withdrawal by Subject|1|||
164059857|NCT03911401|592580980|FG001|Overall Study|Withdrawal by Subject|2|||
164059858|NCT03911401|592580981|FG002|Overall Study|Withdrawal by Subject|0|||
164059859|NCT03911401|592580979|FG000|Overall Study|Withdrawal by parent/guardian|4|||
164059860|NCT03911401|592580980|FG001|Overall Study|Withdrawal by parent/guardian|4|||
164059861|NCT03911401|592580981|FG002|Overall Study|Withdrawal by parent/guardian|11|||
164059862|NCT05602818|592580982|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
164059863|NCT05602818|592580983|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
164059864|NCT05602818|592580984|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
164059865|NCT05602818|592580985|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
164059866|NCT05602818|592580986|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
164059867|NCT05602818|592580987|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
164059868|NCT05602818|592580988|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
164059869|NCT05602818|592580989|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
164102286|NCT02335658|592736701|FG001|Overall Study|Lack of Efficacy|5|||
164102287|NCT02335658|592736700|FG000|Overall Study|Pregnancy|1|||
164102288|NCT02335658|592736701|FG001|Overall Study|Pregnancy|0|||
164102289|NCT02335658|592736700|FG000|Overall Study|Withdrawal by Subject|13|||
164102290|NCT02335658|592736701|FG001|Overall Study|Withdrawal by Subject|21|||
164102291|NCT02335658|592736700|FG000|Overall Study|non-compliance|2|||
164059870|NCT05602818|592580990|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
164059871|NCT05602818|592580991|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
164059872|NCT05602818|592580992|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
164059873|NCT05602818|592580993|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
164059874|NCT05602818|592580982|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
164059875|NCT05602818|592580983|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
164059876|NCT05602818|592580984|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059877|NCT05602818|592580985|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059878|NCT05602818|592580986|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059879|NCT05602818|592580987|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059880|NCT05602818|592580988|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059881|NCT05602818|592580989|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059882|NCT05602818|592580990|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059883|NCT05602818|592580991|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059884|NCT05602818|592580992|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059885|NCT05602818|592580993|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
164059886|NCT05602818|592580982|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
164059887|NCT05602818|592580983|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059888|NCT05602818|592580984|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059889|NCT05602818|592580985|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059890|NCT05602818|592580986|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059891|NCT05602818|592580987|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059892|NCT05602818|592580988|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059893|NCT05602818|592580989|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059894|NCT05602818|592580990|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059895|NCT05602818|592580991|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059896|NCT05602818|592580992|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059897|NCT05602818|592580993|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
164059898|NCT05602818|592580982|FG000|Qualification Phase (3 Days)|Other|1|||
164059899|NCT05602818|592580983|FG001|Qualification Phase (3 Days)|Other|0|||
164102292|NCT02335658|592736701|FG001|Overall Study|non-compliance|3|||
164059900|NCT05602818|592580984|FG002|Qualification Phase (3 Days)|Other|0|||
164059901|NCT05602818|592580985|FG003|Qualification Phase (3 Days)|Other|0|||
164059902|NCT05602818|592580986|FG004|Qualification Phase (3 Days)|Other|0|||
164102293|NCT02335658|592736700|FG000|Overall Study|other reason|2|||
164102294|NCT02335658|592736701|FG001|Overall Study|other reason|3|||
164059903|NCT05602818|592580987|FG005|Qualification Phase (3 Days)|Other|0|||
164102295|NCT04149964|592736706|FG000|Overall Study|Lost to Follow-up|19|||
164059904|NCT05602818|592580988|FG006|Qualification Phase (3 Days)|Other|0|||
164059905|NCT05602818|592580989|FG007|Qualification Phase (3 Days)|Other|0|||
164059906|NCT05602818|592580990|FG008|Qualification Phase (3 Days)|Other|0|||
164059907|NCT05602818|592580991|FG009|Qualification Phase (3 Days)|Other|0|||
164059908|NCT05602818|592580992|FG010|Qualification Phase (3 Days)|Other|0|||
164059909|NCT05602818|592580993|FG011|Qualification Phase (3 Days)|Other|0|||
164059910|NCT05602818|592580982|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059911|NCT05602818|592580983|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
164059912|NCT05602818|592580984|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059913|NCT05602818|592580985|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059914|NCT05602818|592580986|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059915|NCT05602818|592580987|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059916|NCT05602818|592580988|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059917|NCT05602818|592580989|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059918|NCT05602818|592580990|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059919|NCT05602818|592580991|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059920|NCT05602818|592580992|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059921|NCT05602818|592580993|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
164059922|NCT05602818|592580982|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
164059923|NCT05602818|592580983|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
164059924|NCT05602818|592580984|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
164059925|NCT05602818|592580985|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
164059926|NCT05602818|592580986|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
164059927|NCT05602818|592580987|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
164059928|NCT05602818|592580988|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
164059929|NCT05602818|592580989|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
164059930|NCT05602818|592580990|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
164059931|NCT05602818|592580991|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
164059932|NCT05602818|592580992|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
164059933|NCT05602818|592580993|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
164059934|NCT05602818|592580982|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059935|NCT05602818|592580983|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059936|NCT05602818|592580984|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059937|NCT05602818|592580985|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059938|NCT05602818|592580986|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059939|NCT05602818|592580987|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059940|NCT05602818|592580988|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059941|NCT05602818|592580989|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059942|NCT05602818|592580990|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059943|NCT05602818|592580991|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
164059944|NCT05602818|592580992|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
164059945|NCT05602818|592580993|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
164059946|NCT05602818|592580982|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
164059947|NCT05602818|592580983|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
164059948|NCT05602818|592580984|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
164059949|NCT05602818|592580985|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
164059950|NCT05602818|592580986|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
164059951|NCT05602818|592580987|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
164059952|NCT05602818|592580988|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
164059953|NCT05602818|592580989|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
164059954|NCT05602818|592580990|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
164059955|NCT05602818|592580991|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
164059956|NCT05602818|592580992|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
164059957|NCT05602818|592580993|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
164059958|NCT03417245|592580994|FG000|Overall Study|Adverse Event|1|||
164059959|NCT03417245|592580995|FG001|Overall Study|Adverse Event|0|||
164059960|NCT03417245|592580994|FG000|Overall Study|Protocol Violation|1|||
164059961|NCT03417245|592580995|FG001|Overall Study|Protocol Violation|0|||
164059962|NCT03417245|592580994|FG000|Overall Study|Withdrawal by Subject|1|||
164059963|NCT03417245|592580995|FG001|Overall Study|Withdrawal by Subject|1|||
164059964|NCT00598442|592580996|FG000|Overall Study|Adverse Event|3|||
164059965|NCT00598442|592580997|FG001|Overall Study|Adverse Event|0|||
164059966|NCT00598442|592580998|FG002|Overall Study|Adverse Event|0|||
164059967|NCT00598442|592580996|FG000|Overall Study|Death|19|||
164059968|NCT00598442|592580997|FG001|Overall Study|Death|11|||
164059969|NCT00598442|592580998|FG002|Overall Study|Death|11|||
164059970|NCT00598442|592580996|FG000|Overall Study|Lost to Follow-up|4|||
164059971|NCT00598442|592580997|FG001|Overall Study|Lost to Follow-up|3|||
164059972|NCT00598442|592580998|FG002|Overall Study|Lost to Follow-up|3|||
164059973|NCT00598442|592580996|FG000|Overall Study|Physician Decision|2|||
164059974|NCT00598442|592580997|FG001|Overall Study|Physician Decision|1|||
164059975|NCT00598442|592580998|FG002|Overall Study|Physician Decision|1|||
164059976|NCT00598442|592580996|FG000|Overall Study|Withdrawal by Subject|8|||
164059977|NCT00598442|592580997|FG001|Overall Study|Withdrawal by Subject|16|||
164059978|NCT00598442|592580998|FG002|Overall Study|Withdrawal by Subject|6|||
164059979|NCT00598442|592580996|FG000|Overall Study|Noncompliance|0|||
164059980|NCT00598442|592580997|FG001|Overall Study|Noncompliance|2|||
164059981|NCT00598442|592580998|FG002|Overall Study|Noncompliance|1|||
164059982|NCT00598442|592580996|FG000|Overall Study|Relocation|1|||
164059983|NCT00598442|592580997|FG001|Overall Study|Relocation|4|||
164059984|NCT00598442|592580998|FG002|Overall Study|Relocation|0|||
164059985|NCT00598442|592580996|FG000|Overall Study|Renal transplant|0|||
164059986|NCT00598442|592580997|FG001|Overall Study|Renal transplant|0|||
164059987|NCT00598442|592580998|FG002|Overall Study|Renal transplant|1|||
164059988|NCT00598442|592580996|FG000|Overall Study|Site closed by sponsor|5|||
164059989|NCT00598442|592580997|FG001|Overall Study|Site closed by sponsor|2|||
164059990|NCT00598442|592580998|FG002|Overall Study|Site closed by sponsor|1|||
164059991|NCT00598442|592580996|FG000|Overall Study|Started dialysis|1|||
164059992|NCT00598442|592580997|FG001|Overall Study|Started dialysis|0|||
164059993|NCT00598442|592580998|FG002|Overall Study|Started dialysis|0|||
164059994|NCT01590628|592581011|FG000|Overall Study|Death|2|||
164059995|NCT01590628|592581012|FG001|Overall Study|Death|0|||
164059996|NCT02992743|592581013|FG000|Overall Study|Withdrawal by Subject|1|||
164059997|NCT02992743|592581014|FG001|Overall Study|Withdrawal by Subject|1|||
164059998|NCT02992743|592581013|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
164059999|NCT02992743|592581014|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
164060000|NCT02992743|592581013|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
164060001|NCT02992743|592581014|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
164060002|NCT02992743|592581013|FG000|Overall Study|No measurable disease|1|||
164060003|NCT02992743|592581014|FG001|Overall Study|No measurable disease|0|||
164060004|NCT02992743|592581013|FG000|Overall Study|Lost to Follow-up|0|||
164060005|NCT02992743|592581014|FG001|Overall Study|Lost to Follow-up|1|||
164060006|NCT03290131|592581015|FG000|Overall Study|Adverse Event|22|||
164060007|NCT03290131|592581016|FG001|Overall Study|Adverse Event|57|||
164060008|NCT03290131|592581017|FG002|Overall Study|Adverse Event|11|||
164060009|NCT03290131|592581015|FG000|Overall Study|Withdrawal by Subject|18|||
164060010|NCT03290131|592581016|FG001|Overall Study|Withdrawal by Subject|13|||
164060011|NCT03290131|592581017|FG002|Overall Study|Withdrawal by Subject|8|||
164060012|NCT03290131|592581015|FG000|Overall Study|MS Relapse|2|||
164060013|NCT03290131|592581016|FG001|Overall Study|MS Relapse|1|||
164060014|NCT03290131|592581017|FG002|Overall Study|MS Relapse|0|||
164060015|NCT03290131|592581015|FG000|Overall Study|Unknown reason|0|||
164060016|NCT03290131|592581016|FG001|Overall Study|Unknown reason|1|||
164060017|NCT03290131|592581017|FG002|Overall Study|Unknown reason|0|||
164060018|NCT00381680|592581020|FG000|Overall Study|Adverse Event|9|||
164060019|NCT00381680|592581021|FG001|Overall Study|Adverse Event|3|||
164060020|NCT00381680|592581020|FG000|Overall Study|Death|10|||
164060021|NCT00381680|592581021|FG001|Overall Study|Death|7|||
164060022|NCT00381680|592581020|FG000|Overall Study|Lost to Follow-up|3|||
164060023|NCT00381680|592581021|FG001|Overall Study|Lost to Follow-up|2|||
164060024|NCT00381680|592581020|FG000|Overall Study|Physician Decision|25|||
164060025|NCT00381680|592581021|FG001|Overall Study|Physician Decision|6|||
164060026|NCT00381680|592581020|FG000|Overall Study|Withdrawal by Subject|3|||
164060027|NCT00381680|592581021|FG001|Overall Study|Withdrawal by Subject|1|||
164060028|NCT00381680|592581020|FG000|Overall Study|Entry onto another COG Trial|1|||
164060029|NCT00381680|592581021|FG001|Overall Study|Entry onto another COG Trial|2|||
164060030|NCT00381680|592581020|FG000|Overall Study|Alternative Therapy|11|||
164060031|NCT00381680|592581021|FG001|Overall Study|Alternative Therapy|5|||
164060032|NCT00381680|592581020|FG000|Overall Study|Secondary Malignancy|3|||
164060033|NCT00381680|592581021|FG001|Overall Study|Secondary Malignancy|0|||
164060034|NCT00381680|592581020|FG000|Overall Study|Delay initiation|1|||
164060035|NCT00381680|592581021|FG001|Overall Study|Delay initiation|0|||
164060036|NCT00381680|592581020|FG000|Overall Study|Stem Cell Transplant|26|||
164060037|NCT00381680|592581021|FG001|Overall Study|Stem Cell Transplant|10|||
164060038|NCT00381680|592581020|FG000|Overall Study|Relapse|18|||
164102296|NCT04149964|592736707|FG001|Overall Study|Lost to Follow-up|18|||
164060039|NCT00381680|592581021|FG001|Overall Study|Relapse|9|||
164060040|NCT00381680|592581020|FG000|Overall Study|Induction Failure|4|||
164060041|NCT00381680|592581021|FG001|Overall Study|Induction Failure|1|||
164060042|NCT00381680|592581020|FG000|Overall Study|Progression|1|||
164060043|NCT00381680|592581021|FG001|Overall Study|Progression|1|||
164060044|NCT00381680|592581020|FG000|Overall Study|Other not otherwise specified|7|||
164060045|NCT00381680|592581021|FG001|Overall Study|Other not otherwise specified|2|||
164060046|NCT00381680|592581020|FG000|Overall Study|Ineligible|3|||
164060047|NCT00381680|592581021|FG001|Overall Study|Ineligible|1|||
164060048|NCT03099096|592581022|FG000|Overall Study|Adverse Event|1|||
164060049|NCT03099096|592581022|FG000|Overall Study|Physician Decision|1|||
164060050|NCT00361504|592581025|FG000|Overall Study|Withdrawal by Subject|94|||
164060051|NCT00361504|592581026|FG001|Overall Study|Withdrawal by Subject|31|||
164102297|NCT02032888|592736708|FG000|Treatment Period|Poor compliance/noncompliance|1|||
164102298|NCT02032888|592736709|FG001|Treatment Period|Poor compliance/noncompliance|1|||
164102299|NCT02032888|592736710|FG002|Treatment Period|Poor compliance/noncompliance|0|||
164102300|NCT02032888|592736708|FG000|Treatment Period|Other|1|||
164102301|NCT02032888|592736709|FG001|Treatment Period|Other|1|||
164102302|NCT02032888|592736710|FG002|Treatment Period|Other|0|||
164102303|NCT02032888|592736708|FG000|Follow-up Period|Lost to Follow-up|1|||
164102304|NCT02032888|592736709|FG001|Follow-up Period|Lost to Follow-up|1|||
164102305|NCT02032888|592736710|FG002|Follow-up Period|Lost to Follow-up|0|||
164102306|NCT02032888|592736708|FG000|Follow-up Period|Death|1|||
164102307|NCT02032888|592736709|FG001|Follow-up Period|Death|1|||
164102308|NCT02032888|592736710|FG002|Follow-up Period|Death|0|||
164102309|NCT02032888|592736708|FG000|Follow-up Period|Other|1|||
164102310|NCT02032888|592736709|FG001|Follow-up Period|Other|0|||
164102311|NCT02032888|592736710|FG002|Follow-up Period|Other|0|||
164102312|NCT00837486|592736712|FG000|Blinded-treatment Phase|Physician Decision|1|||
164102313|NCT00837486|592736713|FG001|Blinded-treatment Phase|Physician Decision|0|||
164102314|NCT00837486|592736712|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
164102315|NCT00837486|592736713|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
164102316|NCT00837486|592736712|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
164102317|NCT00837486|592736713|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
164102318|NCT00837486|592736712|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
164102319|NCT00837486|592736713|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
164102320|NCT01577381|592736714|FG000|Overall Study|Discontinued|2|||
164102321|NCT01577381|592736715|FG001|Overall Study|Discontinued|1|||
164102322|NCT01577381|592736716|FG002|Overall Study|Discontinued|2|||
164102323|NCT01577381|592736717|FG003|Overall Study|Discontinued|2|||
164102324|NCT01577381|592736714|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
164102325|NCT01577381|592736715|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
164102326|NCT01577381|592736716|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
164102327|NCT01577381|592736717|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
164102328|NCT01754597|592736718|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
164102329|NCT01754597|592736719|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
164102330|NCT02571907|592738721|FG000|Overall Study|Death|4|||
164102331|NCT02571907|592738721|FG000|Overall Study|Lost to Follow-up|3|||
164102332|NCT02571907|592738721|FG000|Overall Study|Withdrawal by Subject|3|||
164102333|NCT03447353|592738722|FG000|Overall Study|Failure at Screening Visit|2|||
164102334|NCT03447353|592738722|FG000|Overall Study|Lost to Follow-up|4|||
164102335|NCT03447353|592738722|FG000|Overall Study|Scheduling Conflicts|3|||
164102336|NCT03447353|592738722|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
164102337|NCT02175095|592738723|FG000|Overall Study|Withdrawal by Subject|3|||
164102338|NCT02635750|592738724|FG000|Part 1, Period 2|Adverse Event|1|||
164102339|NCT02635750|592738725|FG001|Part 1, Period 2|Adverse Event|0|||
164102340|NCT02635750|592738726|FG002|Part 1, Period 2|Adverse Event|0|||
164102341|NCT00462345|592738729|FG000|Overall Study|Withdrawal by Subject|2|||
164102342|NCT00462345|592738729|FG000|Overall Study|Did not complete second course|1|||
164102343|NCT02642653|592738731|FG000|Overall Study|Adverse Event|2|||
164102344|NCT02642653|592738732|FG001|Overall Study|Adverse Event|0|||
164102345|NCT02875392|592738736|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
164102346|NCT02875392|592738737|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
164102347|NCT00834717|592738741|FG000|First Intervention|Adverse Event|1|||
164102348|NCT00834717|592738742|FG001|First Intervention|Adverse Event|0|||
164102349|NCT00834717|592738741|FG000|First Intervention|Withdrawal by Subject|0|||
164102350|NCT00834717|592738742|FG001|First Intervention|Withdrawal by Subject|1|||
164102351|NCT01660243|592738743|FG000|Overall Study|Adverse Event|1|||
164102352|NCT01660243|592738744|FG001|Overall Study|Adverse Event|0|||
164102353|NCT01660243|592738745|FG002|Overall Study|Adverse Event|1|||
164102354|NCT01660243|592738746|FG003|Overall Study|Adverse Event|0|||
164102355|NCT01660243|592738743|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
164102356|NCT01660243|592738744|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
164102357|NCT01660243|592738745|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
164102358|NCT01660243|592738746|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
164102359|NCT01660243|592738743|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
164102360|NCT01660243|592738744|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
164102361|NCT01660243|592738745|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
164102362|NCT01660243|592738746|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
164102363|NCT01660243|592738743|FG000|Overall Study|Randomization error|0|||
164102364|NCT01660243|592738744|FG001|Overall Study|Randomization error|0|||
164102365|NCT01660243|592738745|FG002|Overall Study|Randomization error|0|||
164102366|NCT01660243|592738746|FG003|Overall Study|Randomization error|1|||
164102367|NCT03025087|592738747|FG000|Overall Study|Physician Decision|3|||
164060052|NCT00361504|592581025|FG000|Overall Study|Lost to Follow-up|40|||
164060053|NCT00361504|592581026|FG001|Overall Study|Lost to Follow-up|7|||
164060054|NCT00361504|592581025|FG000|Overall Study|Adverse Event|203|||
164060055|NCT00361504|592581026|FG001|Overall Study|Adverse Event|82|||
164060056|NCT00361504|592581025|FG000|Overall Study|Lack of Efficacy|72|||
164060057|NCT00361504|592581026|FG001|Overall Study|Lack of Efficacy|7|||
164060058|NCT00361504|592581025|FG000|Overall Study|Resolution of Pain|2|||
164060059|NCT00361504|592581026|FG001|Overall Study|Resolution of Pain|0|||
164060060|NCT00361504|592581025|FG000|Overall Study|Study medication non compliant|42|||
164060061|NCT00361504|592581026|FG001|Overall Study|Study medication non compliant|15|||
164060062|NCT00361504|592581025|FG000|Overall Study|All other|28|||
164060063|NCT00361504|592581026|FG001|Overall Study|All other|3|||
164060064|NCT03764813|592581029|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
164060065|NCT03764813|592581030|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
164060066|NCT03764813|592581031|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
164060067|NCT03764813|592581032|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
164060068|NCT00450814|592581040|FG000|Overall Study|Failed to complete the initial therapy|0|||
164060069|NCT00450814|592581041|FG001|Overall Study|Failed to complete the initial therapy|0|||
164060070|NCT00450814|592581042|FG002|Overall Study|Failed to complete the initial therapy|0|||
164060071|NCT00450814|592581043|FG003|Overall Study|Failed to complete the initial therapy|1|||
164060072|NCT00450814|592581044|FG004|Overall Study|Failed to complete the initial therapy|1|||
164060073|NCT00450814|592581045|FG005|Overall Study|Failed to complete the initial therapy|1|||
164060074|NCT00450814|592581046|FG006|Overall Study|Failed to complete the initial therapy|0|||
164060075|NCT00450814|592581047|FG007|Overall Study|Failed to complete the initial therapy|0|||
164060076|NCT00450814|592581048|FG008|Overall Study|Failed to complete the initial therapy|0|||
164060077|NCT00450814|592581049|FG009|Overall Study|Failed to complete the initial therapy|0|||
164060078|NCT00450814|592581050|FG010|Overall Study|Failed to complete the initial therapy|0|||
164060079|NCT00450814|592581040|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
164060080|NCT00450814|592581041|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
164060081|NCT00450814|592581042|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
164060082|NCT00450814|592581043|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
164060083|NCT00450814|592581044|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
164060084|NCT00450814|592581045|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
164060085|NCT00450814|592581046|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
164060086|NCT00450814|592581047|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
164060087|NCT00450814|592581048|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
164060088|NCT00450814|592581049|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
164060089|NCT00450814|592581050|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
164060090|NCT03602976|592581055|FG000|Overall Study|Withdrawal by Subject|1|||
164060091|NCT04837807|592581056|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
164060092|NCT04837807|592581057|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
164060093|NCT00334893|592581060|FG000|Overall Study|Not Treated|1|||
164060094|NCT00334893|592581061|FG001|Overall Study|Not Treated|0|||
164060095|NCT00920582|592581062|FG000|Overall Study|Lost to Follow-up|5|||
164060096|NCT00920582|592581063|FG001|Overall Study|Lost to Follow-up|1|||
164060097|NCT00920582|592581064|FG002|Overall Study|Lost to Follow-up|2|||
164060098|NCT00920582|592581065|FG003|Overall Study|Lost to Follow-up|0|||
164060099|NCT00920582|592581062|FG000|Overall Study|Withdrawal by Subject|5|||
164060100|NCT00920582|592581063|FG001|Overall Study|Withdrawal by Subject|4|||
164060101|NCT00920582|592581064|FG002|Overall Study|Withdrawal by Subject|6|||
164060102|NCT00920582|592581065|FG003|Overall Study|Withdrawal by Subject|3|||
164060103|NCT00920582|592581062|FG000|Overall Study|Protocol Violation|1|||
164060104|NCT00920582|592581063|FG001|Overall Study|Protocol Violation|0|||
164060105|NCT00920582|592581064|FG002|Overall Study|Protocol Violation|0|||
164060106|NCT00920582|592581065|FG003|Overall Study|Protocol Violation|0|||
164060107|NCT00920582|592581062|FG000|Overall Study|Other|2|||
164060108|NCT00920582|592581063|FG001|Overall Study|Other|1|||
164060109|NCT00920582|592581064|FG002|Overall Study|Other|3|||
164060110|NCT00920582|592581065|FG003|Overall Study|Other|2|||
164060111|NCT03319160|592581066|FG000|Overall Study|Data not available.|7|||
164060112|NCT00665002|592581067|FG000|Overall Study|Progression/relapse during treatment|11|||
164060113|NCT00665002|592581067|FG000|Overall Study|Cytogenetic resistance|1|||
164060114|NCT03604159|592581068|FG000|Overall Study|Lost to Follow-up|6|||
164060115|NCT03604159|592581069|FG001|Overall Study|Lost to Follow-up|7|||
164060116|NCT04533204|592581070|FG000|Overall Study|Unable to understand training instructions|1|||
164060117|NCT04533204|592581071|FG001|Overall Study|Unable to understand training instructions|1|||
164060118|NCT02260791|592581075|FG000|Overall Study|Lost to Follow-up|4|||
164060119|NCT02260791|592581076|FG001|Overall Study|Lost to Follow-up|4|||
164060120|NCT02260791|592581075|FG000|Overall Study|Lack of Efficacy|2|||
164060121|NCT02260791|592581076|FG001|Overall Study|Lack of Efficacy|1|||
164060122|NCT02260791|592581075|FG000|Overall Study|Adverse Event|13|||
164060123|NCT02260791|592581076|FG001|Overall Study|Adverse Event|9|||
164060124|NCT02260791|592581075|FG000|Overall Study|Death|1|||
164060125|NCT02260791|592581076|FG001|Overall Study|Death|0|||
164060126|NCT02260791|592581075|FG000|Overall Study|Withdrawal by Subject|11|||
164060127|NCT02260791|592581076|FG001|Overall Study|Withdrawal by Subject|16|||
164060128|NCT02260791|592581075|FG000|Overall Study|Screen failure|0|||
164060129|NCT02260791|592581076|FG001|Overall Study|Screen failure|1|||
164060130|NCT02260791|592581075|FG000|Overall Study|Protocol deviation|2|||
164060131|NCT02260791|592581076|FG001|Overall Study|Protocol deviation|3|||
164060132|NCT02354599|592581077|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
164060133|NCT02354599|592581078|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
164060134|NCT02354599|592581079|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
164060135|NCT02354599|592581080|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
164060136|NCT02354599|592581081|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
164060137|NCT02354599|592581082|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
164060138|NCT02354599|592581077|FG000|Overall Study|Withdrawal by Subject|1|||
164060139|NCT02354599|592581078|FG001|Overall Study|Withdrawal by Subject|1|||
164060140|NCT02354599|592581079|FG002|Overall Study|Withdrawal by Subject|0|||
164060141|NCT02354599|592581080|FG003|Overall Study|Withdrawal by Subject|0|||
164060142|NCT02354599|592581081|FG004|Overall Study|Withdrawal by Subject|0|||
164060143|NCT02354599|592581082|FG005|Overall Study|Withdrawal by Subject|0|||
164060144|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Death|2|||
164060145|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Death|0|||
164060146|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Adverse Event|33|||
164060147|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Adverse Event|31|||
164060148|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
164060149|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
164060150|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
164060151|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
164060152|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
164060153|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
164060154|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Other|7|||
164060155|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Other|8|||
164060156|NCT00280059|592581083|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
164060157|NCT00280059|592581084|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
164060158|NCT00495794|592581087|FG000|Overall Study|Pharmacist did not activate patient|522|||
164060159|NCT00495794|592581088|FG001|Overall Study|Pharmacist did not activate patient|0|||
164060160|NCT00323479|592581089|FG000|Overall Study|Adverse Event|2|||
164060161|NCT00323479|592581089|FG000|Overall Study|Withdrawal by Subject|2|||
164060162|NCT00323479|592581089|FG000|Overall Study|Protocol Violation|3|||
164060163|NCT00323479|592581089|FG000|Overall Study|house moving|1|||
164060164|NCT03044730|592581092|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
164060165|NCT03044730|592581092|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
164060166|NCT03044730|592581092|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
164060167|NCT03044730|592581092|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
164060168|NCT03044730|592581092|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
164060169|NCT03044730|592581092|FG000|Cycles 4 and Beyond|Adverse Event|1|||
164060170|NCT03044730|592581092|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
164060171|NCT03044730|592581092|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
164060172|NCT03044730|592581092|FG000|On Follow-up for 2 Years|Death|17|||
164060173|NCT01302366|592582667|FG000|Overall Study|patient choice or noncompliance|5|||
164060174|NCT00198107|592582670|FG000|Double-Blind Period|Adverse Event|1|||
164060175|NCT00198107|592582671|FG001|Double-Blind Period|Adverse Event|1|||
164060176|NCT00198107|592582672|FG002|Double-Blind Period|Adverse Event|0|||
164060177|NCT00198107|592582670|FG000|Double-Blind Period|Lack of Efficacy|2|||
164060178|NCT00198107|592582671|FG001|Double-Blind Period|Lack of Efficacy|0|||
164060179|NCT00198107|592582672|FG002|Double-Blind Period|Lack of Efficacy|0|||
164060180|NCT00198107|592582670|FG000|Double-Blind Period|Lost to Follow-up|2|||
164060181|NCT00198107|592582671|FG001|Double-Blind Period|Lost to Follow-up|1|||
164060182|NCT00198107|592582672|FG002|Double-Blind Period|Lost to Follow-up|0|||
164060183|NCT00198107|592582670|FG000|Double-Blind Period|Physician Decision|1|||
164060184|NCT00198107|592582671|FG001|Double-Blind Period|Physician Decision|0|||
164060185|NCT00198107|592582672|FG002|Double-Blind Period|Physician Decision|0|||
164060186|NCT00198107|592582670|FG000|Double-Blind Period|Withdrawal by Subject|0|||
164060187|NCT00198107|592582671|FG001|Double-Blind Period|Withdrawal by Subject|1|||
164060188|NCT00198107|592582672|FG002|Double-Blind Period|Withdrawal by Subject|0|||
164060189|NCT00198107|592582670|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
164060190|NCT00198107|592582671|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
164060191|NCT00198107|592582672|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
164060192|NCT00934661|592582673|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
164060193|NCT00934661|592582674|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
164060194|NCT01013207|592582677|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
164060195|NCT01541644|592582678|FG000|Overall Study|Withdrawal by Subject|3|||
164060196|NCT05064436|592582682|FG000|Overall Study|Other Reasons|1|||
164060197|NCT05064436|592582683|FG001|Overall Study|Other Reasons|0|||
164060198|NCT01342445|592582684|FG000|Overall Study|Experienced side effects|0|||
164060199|NCT01342445|592582685|FG001|Overall Study|Experienced side effects|2|||
164060200|NCT02706327|592582686|FG000|Overall Study|Lost to Follow-up|1|||
164060201|NCT02706327|592582687|FG001|Overall Study|Lost to Follow-up|1|||
164060202|NCT02706327|592582688|FG002|Overall Study|Lost to Follow-up|2|||
164060203|NCT02652793|592582689|FG000|Overall Study|Adverse Event|1|||
164060204|NCT02652793|592582689|FG000|Overall Study|Lost to Follow-up|2|||
164060205|NCT02652793|592582689|FG000|Overall Study|Withdrawal by Subject|1|||
164060206|NCT01982942|592582690|FG000|Overall Study|Adverse Event|10|||
164060207|NCT01982942|592582691|FG001|Overall Study|Adverse Event|5|||
164060208|NCT01982942|592582690|FG000|Overall Study|Lost to Follow-up|4|||
164060209|NCT01982942|592582691|FG001|Overall Study|Lost to Follow-up|3|||
164060210|NCT01982942|592582690|FG000|Overall Study|Multiple sclerosis progression|3|||
164060211|NCT01982942|592582691|FG001|Overall Study|Multiple sclerosis progression|2|||
164060212|NCT01982942|592582690|FG000|Overall Study|Wanted to try therapy not permitted|1|||
164060213|NCT01982942|592582691|FG001|Overall Study|Wanted to try therapy not permitted|0|||
164060214|NCT01982942|592582690|FG000|Overall Study|Subject declined future visits|0|||
164060215|NCT01982942|592582691|FG001|Overall Study|Subject declined future visits|1|||
164060216|NCT01982942|592582690|FG000|Overall Study|Left geographical area|2|||
164060217|NCT01982942|592582691|FG001|Overall Study|Left geographical area|0|||
164060218|NCT01982942|592582690|FG000|Overall Study|Too many pills|1|||
164060219|NCT01982942|592582691|FG001|Overall Study|Too many pills|0|||
164060220|NCT01982942|592582690|FG000|Overall Study|MS Relapse|0|||
164060221|NCT01982942|592582691|FG001|Overall Study|MS Relapse|1|||
164060222|NCT01982942|592582690|FG000|Overall Study|Chose to join a stem cell trial|0|||
164060223|NCT01982942|592582691|FG001|Overall Study|Chose to join a stem cell trial|1|||
164060224|NCT01982942|592582690|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
164060225|NCT01982942|592582691|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
164060226|NCT04511533|592582692|FG000|Treatment|Other|2|||
164060227|NCT04511533|592582692|FG000|Treatment|Withdrawal by Subject|11|||
164060228|NCT04511533|592582692|FG000|Treatment|Death|5|||
164060229|NCT04511533|592582692|FG000|Treatment|Physician Decision|1|||
164060230|NCT04511533|592582692|FG000|Treatment|Progressive Disease|61|||
164060231|NCT04511533|592582692|FG000|Follow-Up|Other|7|||
164060232|NCT04511533|592582692|FG000|Follow-Up|Withdrawal by Subject|5|||
164060233|NCT04511533|592582692|FG000|Follow-Up|Lost to Follow-up|2|||
164060234|NCT04511533|592582692|FG000|Follow-Up|Death|4|||
164060235|NCT01224171|592582693|FG000|Overall Study|Adverse Event|8|||
164060236|NCT01224171|592582694|FG001|Overall Study|Adverse Event|4|||
164060237|NCT01224171|592582693|FG000|Overall Study|Protocol Violation|0|||
164060238|NCT01224171|592582694|FG001|Overall Study|Protocol Violation|1|||
164060239|NCT01224171|592582693|FG000|Overall Study|Lack of Efficacy|5|||
164060240|NCT01224171|592582694|FG001|Overall Study|Lack of Efficacy|1|||
164060241|NCT01224171|592582693|FG000|Overall Study|Withdrawal of Consent|2|||
164060242|NCT01224171|592582694|FG001|Overall Study|Withdrawal of Consent|4|||
164060243|NCT01224171|592582693|FG000|Overall Study|Lost to Follow-up|0|||
164060244|NCT01224171|592582694|FG001|Overall Study|Lost to Follow-up|3|||
164060245|NCT01097057|592582695|FG000|Overall Study|Physician Decision|3|||
164060246|NCT01270139|592582696|FG000|Overall Study|Adverse Event|8|||
164060247|NCT01270139|592582697|FG001|Overall Study|Adverse Event|17|||
164060248|NCT01270139|592582698|FG002|Overall Study|Adverse Event|18|||
164060249|NCT01270139|592582696|FG000|Overall Study|Lost to Follow-up|10|||
164060250|NCT01270139|592582697|FG001|Overall Study|Lost to Follow-up|9|||
164060251|NCT01270139|592582698|FG002|Overall Study|Lost to Follow-up|2|||
164060252|NCT01161173|592582709|FG000|Overall Study|Protocol Violation|13|||
164060253|NCT01161173|592582709|FG000|Overall Study|Lost to Follow-up|7|||
164060254|NCT01161173|592582709|FG000|Overall Study|Progressive Disease|82|||
164060255|NCT01161173|592582709|FG000|Overall Study|Withdrawal of Consent|5|||
164060256|NCT01161173|592582709|FG000|Overall Study|Unacceptable Toxicity|21|||
164060257|NCT01161173|592582709|FG000|Overall Study|Death|194|||
164060258|NCT01161173|592582709|FG000|Overall Study|End of Study|2|||
164060259|NCT01161173|592582709|FG000|Overall Study|Reasons Not Specified|23|||
164060260|NCT01911546|592582710|FG000|Overall Study|Lost to Follow-up|1|||
164060261|NCT01911546|592582710|FG000|Overall Study|Everolimus was discontinued|5|||
164060262|NCT02213666|592582712|FG000|Overall Study|Withdrawal by Subject|1|||
164060263|NCT01319422|592582713|FG000|Overall Study|Withdrawal by Subject|1|||
164060264|NCT01319422|592582714|FG001|Overall Study|Withdrawal by Subject|0|||
164060265|NCT02918968|592582715|FG000|1st Line AAT|Progressive disease|9|||
164060266|NCT02918968|592582716|FG001|1st Line AAT|Progressive disease|4|||
164060267|NCT02918968|592582715|FG000|1st Line AAT|Adverse Event|12|||
164060268|NCT02918968|592582716|FG001|1st Line AAT|Adverse Event|3|||
164060269|NCT02918968|592582715|FG000|1st Line AAT|Physician Decision|4|||
164060270|NCT02918968|592582716|FG001|1st Line AAT|Physician Decision|2|||
164060271|NCT02918968|592582715|FG000|1st Line AAT|Withdrawal by Subject|2|||
164060272|NCT02918968|592582716|FG001|1st Line AAT|Withdrawal by Subject|1|||
164060273|NCT02918968|592582715|FG000|1st Line AAT|Lost to Follow-up|0|||
164060274|NCT02918968|592582716|FG001|1st Line AAT|Lost to Follow-up|1|||
164060275|NCT02918968|592582715|FG000|1st Line AAT|Death|1|||
164060276|NCT02918968|592582716|FG001|1st Line AAT|Death|0|||
164060277|NCT02918968|592582715|FG000|1st Line AAT|Miscellaneous|1|||
164060278|NCT02918968|592582716|FG001|1st Line AAT|Miscellaneous|0|||
164060279|NCT02918968|592582715|FG000|2nd Line AAT|Progressive disease|21|||
164060280|NCT02918968|592582716|FG001|2nd Line AAT|Progressive disease|3|||
164060281|NCT02918968|592582715|FG000|2nd Line AAT|Adverse Event|2|||
164060282|NCT02918968|592582716|FG001|2nd Line AAT|Adverse Event|5|||
164060283|NCT02918968|592582715|FG000|2nd Line AAT|Physician Decision|0|||
164060284|NCT02918968|592582716|FG001|2nd Line AAT|Physician Decision|1|||
164060285|NCT02918968|592582715|FG000|2nd Line AAT|Withdrawal by Subject|2|||
164060286|NCT02918968|592582716|FG001|2nd Line AAT|Withdrawal by Subject|2|||
164060287|NCT02918968|592582715|FG000|2nd Line AAT|Death|0|||
164060288|NCT02918968|592582716|FG001|2nd Line AAT|Death|1|||
164060289|NCT00750061|592582717|FG000|Overall Study|Adverse Event|2|||
164060290|NCT00750061|592582718|FG001|Overall Study|Adverse Event|0|||
164060291|NCT00750061|592582717|FG000|Overall Study|Withdrawal by Subject|0|||
164060292|NCT00750061|592582718|FG001|Overall Study|Withdrawal by Subject|1|||
164060293|NCT00750061|592582717|FG000|Overall Study|Physician Decision|0|||
164060294|NCT00750061|592582718|FG001|Overall Study|Physician Decision|1|||
164060295|NCT03814499|592582721|FG000|Overall Study|Lost to Follow-up|3|||
164060296|NCT01243762|592582725|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164060297|NCT01243762|592582726|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
164060298|NCT01243762|592582727|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164060299|NCT01243762|592582728|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164060300|NCT01243762|592582729|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
164060301|NCT01243762|592582730|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
164060302|NCT01243762|592582731|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
164060303|NCT01243762|592582725|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164060304|NCT01243762|592582726|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
164060305|NCT01243762|592582727|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164060306|NCT01243762|592582728|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
164060307|NCT01243762|592582729|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164060308|NCT01243762|592582730|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164060309|NCT01243762|592582731|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
164060310|NCT01243762|592582725|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
164060311|NCT01243762|592582726|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
164060312|NCT01243762|592582727|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
164060313|NCT01243762|592582728|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
164060314|NCT01243762|592582729|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
164060315|NCT01243762|592582730|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
164060316|NCT01243762|592582731|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
164060317|NCT01243762|592582725|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164060318|NCT01243762|592582726|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
164060319|NCT01243762|592582727|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164060320|NCT01243762|592582728|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164060321|NCT01243762|592582729|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164060322|NCT01243762|592582730|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164060323|NCT01243762|592582731|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
164060324|NCT01243762|592582725|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164060325|NCT01243762|592582726|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
164060326|NCT01243762|592582727|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164060327|NCT01243762|592582728|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164060328|NCT01243762|592582729|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164060329|NCT01243762|592582730|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
164060330|NCT01243762|592582731|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
164060331|NCT01243762|592582725|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
164060332|NCT01243762|592582726|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
164060333|NCT01243762|592582727|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
164060334|NCT01243762|592582728|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
164060335|NCT01243762|592582729|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
164060336|NCT01243762|592582730|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
164060337|NCT01243762|592582731|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
164060338|NCT01243762|592582725|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164060339|NCT01243762|592582726|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
164060340|NCT01243762|592582727|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164060341|NCT01243762|592582728|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164060342|NCT01243762|592582729|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
164060343|NCT01243762|592582730|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164060344|NCT01243762|592582731|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
164060345|NCT01243762|592582725|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164060346|NCT01243762|592582726|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164060347|NCT01243762|592582727|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164060348|NCT01243762|592582728|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
164060349|NCT01243762|592582729|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
164060350|NCT01243762|592582730|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164060351|NCT01243762|592582731|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
164060352|NCT00229931|592582732|FG000|Overall Study|Death|1|||
164060353|NCT00229931|592582733|FG001|Overall Study|Death|0|||
164060354|NCT00229931|592582732|FG000|Overall Study|Lost to Follow-up|3|||
164060355|NCT00229931|592582733|FG001|Overall Study|Lost to Follow-up|2|||
164060356|NCT01374516|592582734|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
164060357|NCT01374516|592582735|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
164060358|NCT01374516|592582734|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
164060359|NCT01374516|592582735|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
164060360|NCT01374516|592582734|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
164060361|NCT01374516|592582735|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
164060362|NCT01374516|592582734|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
164060363|NCT01374516|592582735|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
164060364|NCT01374516|592582734|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
164060365|NCT01374516|592582735|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
164060366|NCT01374516|592582734|FG000|Surveillance Expansion Period|Protocol Violation|386|||
164060367|NCT01374516|592582735|FG001|Surveillance Expansion Period|Protocol Violation|217|||
164060368|NCT01374516|592582734|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
164060369|NCT01374516|592582735|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
164060370|NCT01374516|592582734|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
164060371|NCT01374516|592582735|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
164060372|NCT01374516|592582734|FG000|Surveillance Expansion Period|Serious adverse event|20|||
164060373|NCT01374516|592582735|FG001|Surveillance Expansion Period|Serious adverse event|5|||
164060374|NCT04629534|592582736|FG000|Overall Study|Physician Decision|1|||
164060375|NCT04629534|592582737|FG001|Overall Study|Physician Decision|0|||
164060376|NCT04629534|592582736|FG000|Overall Study|Protocol Violation|0|||
164060377|NCT04629534|592582737|FG001|Overall Study|Protocol Violation|2|||
164060378|NCT03732534|592582738|FG000|Overall Study|Study terminated by Sponsor|6|||
164060379|NCT02190604|592582739|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060380|NCT02190604|592582740|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060381|NCT02190604|592582741|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060382|NCT02190604|592582742|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060383|NCT02190604|592582743|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060384|NCT02190604|592582744|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060385|NCT02190604|592582745|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060386|NCT02190604|592582746|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060387|NCT02190604|592582747|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060388|NCT02190604|592582748|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060389|NCT02190604|592582749|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060390|NCT02190604|592582750|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060391|NCT02190604|592582751|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060392|NCT02190604|592582752|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060393|NCT02190604|592582753|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
164060394|NCT02190604|592582754|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060395|NCT02190604|592582755|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060396|NCT02190604|592582756|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060397|NCT02190604|592582757|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
164060398|NCT02190604|592582739|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060399|NCT02190604|592582740|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060400|NCT02190604|592582741|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060401|NCT02190604|592582742|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060402|NCT02190604|592582743|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060403|NCT02190604|592582744|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060404|NCT02190604|592582745|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060405|NCT02190604|592582746|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060406|NCT02190604|592582747|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060407|NCT02190604|592582748|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060408|NCT02190604|592582749|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060409|NCT02190604|592582750|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060410|NCT02190604|592582751|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060411|NCT02190604|592582752|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
164060412|NCT02190604|592582753|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164102368|NCT03025087|592738748|FG001|Overall Study|Physician Decision|3|||
164060413|NCT02190604|592582754|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060414|NCT02190604|592582755|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060415|NCT02190604|592582756|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060416|NCT02190604|592582757|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
164060417|NCT02797951|592582758|FG000|Overall Study|Adverse Event|4|||
164060418|NCT02797951|592582758|FG000|Overall Study|Death|1|||
164060419|NCT02797951|592582758|FG000|Overall Study|Lack of Efficacy|19|||
164060420|NCT02797951|592582758|FG000|Overall Study|Lost to Follow-up|4|||
164060421|NCT02797951|592582758|FG000|Overall Study|Physician Decision|6|||
164060422|NCT02797951|592582758|FG000|Overall Study|Withdrawal by Subject|15|||
164060423|NCT01901393|592582759|FG000|Overall Study|Adverse Event|1|||
164060424|NCT01901393|592582760|FG001|Overall Study|Adverse Event|0|||
164060425|NCT04585906|592582761|FG000|Overall Study|Lost to Follow-up|8|||
164060426|NCT04585906|592582762|FG001|Overall Study|Lost to Follow-up|5|||
164060427|NCT03125382|592582763|FG000|Randomization|screening failure|1|||
164060428|NCT03125382|592582764|FG001|Randomization|screening failure|4|||
164060429|NCT03125382|592582765|FG002|Randomization|screening failure|2|||
164060430|NCT03125382|592582766|FG003|Randomization|screening failure|0|||
164060431|NCT03125382|592582763|FG000|Follow-up|Death|1|||
164060432|NCT03125382|592582764|FG001|Follow-up|Death|2|||
164060433|NCT03125382|592582765|FG002|Follow-up|Death|1|||
164060434|NCT03125382|592582766|FG003|Follow-up|Death|2|||
164060435|NCT03125382|592582763|FG000|Follow-up|Lost to Follow-up|1|||
164060436|NCT03125382|592582764|FG001|Follow-up|Lost to Follow-up|4|||
164060437|NCT03125382|592582765|FG002|Follow-up|Lost to Follow-up|3|||
164060438|NCT03125382|592582766|FG003|Follow-up|Lost to Follow-up|1|||
164060439|NCT04626947|592582767|FG000|Overall Study|Study terminated|14|||
164060440|NCT00267202|592582768|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
164060441|NCT00267202|592582769|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
164060442|NCT00267202|592582768|FG000|Overall Study|Withdrawal by Subject|12|||
164060443|NCT00267202|592582769|FG001|Overall Study|Withdrawal by Subject|15|||
164060444|NCT00267202|592582768|FG000|Overall Study|Adverse Event|13|||
164060445|NCT00267202|592582769|FG001|Overall Study|Adverse Event|7|||
164060446|NCT00267202|592582768|FG000|Overall Study|Protocol Violation|2|||
164060447|NCT00267202|592582769|FG001|Overall Study|Protocol Violation|3|||
164060448|NCT00267202|592582768|FG000|Overall Study|Administrative problems|2|||
164060449|NCT00267202|592582769|FG001|Overall Study|Administrative problems|1|||
164060450|NCT00267202|592582768|FG000|Overall Study|Lost to Follow-up|3|||
164060451|NCT00267202|592582769|FG001|Overall Study|Lost to Follow-up|0|||
164060452|NCT01428882|592582778|FG000|Overall Study|Lack of Efficacy|2|||
164060453|NCT01428882|592582779|FG001|Overall Study|Lack of Efficacy|7|||
164060454|NCT01428882|592582778|FG000|Overall Study|Protocol Violation|4|||
164060455|NCT01428882|592582779|FG001|Overall Study|Protocol Violation|3|||
164060456|NCT03907072|592582780|FG000|Overall Study|Study Terminated by Sponsor|2|||
164060457|NCT03907072|592582781|FG001|Overall Study|Study Terminated by Sponsor|2|||
164060458|NCT03907072|592582782|FG002|Overall Study|Study Terminated by Sponsor|2|||
164060459|NCT00612456|592582783|FG000|Overall Study|Adverse Event|1|||
164060460|NCT00612456|592582784|FG001|Overall Study|Adverse Event|0|||
164060461|NCT00612456|592582785|FG002|Overall Study|Adverse Event|0|||
164060462|NCT00612456|592582783|FG000|Overall Study|Lack of Efficacy|1|||
164060463|NCT00612456|592582784|FG001|Overall Study|Lack of Efficacy|1|||
164060464|NCT00612456|592582785|FG002|Overall Study|Lack of Efficacy|0|||
164060465|NCT00612456|592582783|FG000|Overall Study|Withdrawal by Subject|0|||
164060466|NCT00612456|592582784|FG001|Overall Study|Withdrawal by Subject|1|||
164060467|NCT00612456|592582785|FG002|Overall Study|Withdrawal by Subject|0|||
164060468|NCT00265109|592582786|FG000|Overall Study|Withdrawal by Subject|5|||
164060469|NCT00265109|592582786|FG000|Overall Study|Adverse Event|1|||
164060470|NCT02463097|592582787|FG000|Overall Study|Withdrawal by Subject|1|||
164060471|NCT01757821|592582788|FG000|Overall Study|Adverse Event|1|||
164060472|NCT03831282|592582789|FG000|Overall Study|Could not place sensor|1|||
164060473|NCT03556202|592582793|FG000|Extension Treatment Period|Adverse Event|18|||
164060474|NCT03556202|592582794|FG001|Extension Treatment Period|Adverse Event|14|||
164060475|NCT03556202|592582795|FG002|Extension Treatment Period|Adverse Event|9|||
164060476|NCT03556202|592582793|FG000|Extension Treatment Period|Death|2|||
164060477|NCT03556202|592582794|FG001|Extension Treatment Period|Death|6|||
164060478|NCT03556202|592582795|FG002|Extension Treatment Period|Death|0|||
164060479|NCT03556202|592582793|FG000|Extension Treatment Period|Lack of Efficacy|5|||
164060480|NCT03556202|592582794|FG001|Extension Treatment Period|Lack of Efficacy|12|||
164060481|NCT03556202|592582795|FG002|Extension Treatment Period|Lack of Efficacy|18|||
164060482|NCT03556202|592582793|FG000|Extension Treatment Period|Lost to Follow-up|9|||
164060483|NCT03556202|592582794|FG001|Extension Treatment Period|Lost to Follow-up|20|||
164060484|NCT03556202|592582795|FG002|Extension Treatment Period|Lost to Follow-up|2|||
164060485|NCT03556202|592582793|FG000|Extension Treatment Period|Pregnancy|2|||
164060486|NCT03556202|592582794|FG001|Extension Treatment Period|Pregnancy|4|||
164060487|NCT03556202|592582795|FG002|Extension Treatment Period|Pregnancy|3|||
164060488|NCT03556202|592582793|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
164060489|NCT03556202|592582794|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
164060490|NCT03556202|592582795|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
164060491|NCT03556202|592582793|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
164060492|NCT03556202|592582794|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
164060493|NCT03556202|592582795|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
164073201|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
164060494|NCT03556202|592582793|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
164060495|NCT03556202|592582794|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
164060496|NCT03556202|592582795|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
164060497|NCT03556202|592582793|FG000|Extension Treatment Period|Physician Decision|0|||
164060498|NCT03556202|592582794|FG001|Extension Treatment Period|Physician Decision|8|||
164060499|NCT03556202|592582795|FG002|Extension Treatment Period|Physician Decision|2|||
164060500|NCT03556202|592582793|FG000|Extension Treatment Period|Protocol Violation|0|||
164060501|NCT03556202|592582794|FG001|Extension Treatment Period|Protocol Violation|1|||
164060502|NCT03556202|592582795|FG002|Extension Treatment Period|Protocol Violation|1|||
164060503|NCT03556202|592582793|FG000|Extension Treatment Period|Sponsor Decision|0|||
164060504|NCT03556202|592582794|FG001|Extension Treatment Period|Sponsor Decision|1|||
164060505|NCT03556202|592582795|FG002|Extension Treatment Period|Sponsor Decision|0|||
164060506|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
164060507|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
164060508|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
164060509|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Death|1|||
164060510|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Death|0|||
164060511|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Death|0|||
164060512|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
164060513|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
164060514|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
164060515|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
164060516|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
164060517|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
164060518|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
164060519|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
164060520|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
164060521|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
164060522|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
164060523|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
164060524|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
164060525|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
164060526|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
164060527|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
164060528|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
164060529|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
164060530|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
164060531|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
164060532|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
164060533|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
164060534|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
164060535|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
164060536|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
164060537|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
164060538|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
164060539|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
164060540|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
164060541|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
164060542|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
164060543|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
164060544|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
164060545|NCT03556202|592582793|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
164060546|NCT03556202|592582794|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
164060547|NCT03556202|592582795|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
164060548|NCT00697255|592582798|FG000|Stage 1a|Insufficient ovarian response|1|||
164060549|NCT00697255|592582799|FG001|Stage 1a|Insufficient ovarian response|0|||
164060550|NCT00697255|592582798|FG000|Stage 1a|Multifollicular growth|1|||
164060551|NCT00697255|592582799|FG001|Stage 1a|Multifollicular growth|0|||
164060552|NCT00697255|592582798|FG000|Stage 1a|Not growing of dominant follicle|1|||
164060553|NCT00697255|592582799|FG001|Stage 1a|Not growing of dominant follicle|0|||
164060554|NCT00697255|592582798|FG000|Stage 1b|Not growing of dominant follicle|0|||
164060555|NCT00697255|592582799|FG001|Stage 1b|Not growing of dominant follicle|1|||
164060556|NCT00697255|592582798|FG000|Stage 1b|Insufficient ovarian response|0|||
164060557|NCT00697255|592582799|FG001|Stage 1b|Insufficient ovarian response|1|||
164060558|NCT05664672|592582800|FG000|Overall Study|Adverse Event|0|||
164060559|NCT05664672|592582801|FG001|Overall Study|Adverse Event|0|||
164060560|NCT05664672|592582802|FG002|Overall Study|Adverse Event|0|||
164060561|NCT05664672|592582803|FG003|Overall Study|Adverse Event|0|||
164102369|NCT03025087|592738749|FG002|Overall Study|Physician Decision|0|||
164102370|NCT03025087|592738750|FG003|Overall Study|Physician Decision|0|||
164102371|NCT03025087|592738751|FG004|Overall Study|Physician Decision|0|||
164102372|NCT03025087|592738747|FG000|Overall Study|Withdrawal by Subject|1|||
164102373|NCT03025087|592738748|FG001|Overall Study|Withdrawal by Subject|1|||
164102374|NCT03025087|592738749|FG002|Overall Study|Withdrawal by Subject|0|||
164102375|NCT03025087|592738750|FG003|Overall Study|Withdrawal by Subject|0|||
164102376|NCT03025087|592738751|FG004|Overall Study|Withdrawal by Subject|0|||
164102377|NCT03025087|592738747|FG000|Overall Study|Unable to complete MRI|2|||
164102378|NCT03025087|592738748|FG001|Overall Study|Unable to complete MRI|2|||
164102379|NCT03025087|592738749|FG002|Overall Study|Unable to complete MRI|0|||
164102380|NCT03025087|592738750|FG003|Overall Study|Unable to complete MRI|0|||
164102381|NCT03025087|592738751|FG004|Overall Study|Unable to complete MRI|0|||
164102382|NCT04299087|592738752|FG000|Overall Study|Lost to Follow-up|2|||
164102383|NCT04299087|592738753|FG001|Overall Study|Lost to Follow-up|1|||
164102384|NCT00594035|592738754|FG000|Overall Study|Lost to Follow-up|1|||
164102385|NCT00594035|592738755|FG001|Overall Study|Lost to Follow-up|1|||
164102386|NCT00594035|592738754|FG000|Overall Study|Withdrawal by Subject|1|||
164102387|NCT00594035|592738755|FG001|Overall Study|Withdrawal by Subject|0|||
164102388|NCT00594035|592738754|FG000|Overall Study|Subject transferred to nursing home|0|||
164102389|NCT00594035|592738755|FG001|Overall Study|Subject transferred to nursing home|1|||
164102390|NCT00594035|592738754|FG000|Overall Study|Subject couldn't return due to job|0|||
164102391|NCT00594035|592738755|FG001|Overall Study|Subject couldn't return due to job|1|||
164102392|NCT00795821|592738756|FG000|Acute Treatment Phase|Adverse Event|23|||
164102393|NCT00795821|592738757|FG001|Acute Treatment Phase|Adverse Event|4|||
164102394|NCT00795821|592738756|FG000|Acute Treatment Phase|Death|1|||
164102395|NCT00795821|592738757|FG001|Acute Treatment Phase|Death|0|||
164102396|NCT00795821|592738756|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
164102397|NCT00795821|592738757|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
164102398|NCT00795821|592738756|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
164102399|NCT00795821|592738757|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
164102400|NCT00795821|592738756|FG000|Acute Treatment Phase|Physician Decision|1|||
164102401|NCT00795821|592738757|FG001|Acute Treatment Phase|Physician Decision|1|||
164102402|NCT00795821|592738756|FG000|Acute Treatment Phase|Protocol Violation|1|||
164102403|NCT00795821|592738757|FG001|Acute Treatment Phase|Protocol Violation|2|||
164102404|NCT00795821|592738756|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
164102405|NCT00795821|592738757|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
164102406|NCT00795821|592738756|FG000|Long-term Extension Phase|Adverse Event|25|||
164102407|NCT00795821|592738757|FG001|Long-term Extension Phase|Adverse Event|32|||
164102408|NCT00795821|592738756|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
164102409|NCT00795821|592738757|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
164102410|NCT00795821|592738756|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
164102411|NCT00795821|592738757|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
164102412|NCT00795821|592738756|FG000|Long-term Extension Phase|Physician Decision|1|||
164102413|NCT00795821|592738757|FG001|Long-term Extension Phase|Physician Decision|2|||
164102414|NCT00795821|592738756|FG000|Long-term Extension Phase|Protocol Violation|3|||
164102415|NCT00795821|592738757|FG001|Long-term Extension Phase|Protocol Violation|5|||
164102416|NCT00795821|592738756|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
164102417|NCT00795821|592738757|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
164102418|NCT00795821|592738756|FG000|Taper Phase|Adverse Event|2|||
164102419|NCT00795821|592738757|FG001|Taper Phase|Adverse Event|0|||
164102420|NCT00795821|592738756|FG000|Taper Phase|Lost to Follow-up|1|||
164102421|NCT00795821|592738757|FG001|Taper Phase|Lost to Follow-up|0|||
164102422|NCT00795821|592738756|FG000|Taper Phase|Physician Decision|2|||
164102423|NCT00795821|592738757|FG001|Taper Phase|Physician Decision|0|||
164102424|NCT00795821|592738756|FG000|Taper Phase|Withdrawal by Subject|4|||
164102425|NCT00795821|592738757|FG001|Taper Phase|Withdrawal by Subject|0|||
164102426|NCT00508651|592738762|FG000|Overall Study|Lost to Follow-up|3|||
164102427|NCT00508651|592738763|FG001|Overall Study|Lost to Follow-up|1|||
164102428|NCT00508651|592738762|FG000|Overall Study|Withdrawal by Subject|1|||
164102429|NCT00508651|592738763|FG001|Overall Study|Withdrawal by Subject|1|||
164102430|NCT03874715|592738766|FG000|Overall Study|Adverse Event|2|||
164102431|NCT03874715|592738767|FG001|Overall Study|Adverse Event|0|||
164102432|NCT03874715|592738766|FG000|Overall Study|Poor compliance to protocol|5|||
164102433|NCT03874715|592738767|FG001|Overall Study|Poor compliance to protocol|1|||
164102434|NCT03874715|592738766|FG000|Overall Study|Withdrawal by Subject|1|||
164102435|NCT03874715|592738767|FG001|Overall Study|Withdrawal by Subject|0|||
164102436|NCT03874715|592738766|FG000|Overall Study|Other-unspecified|1|||
164102437|NCT03874715|592738767|FG001|Overall Study|Other-unspecified|0|||
164102438|NCT00461786|592738770|FG000|Overall Study|Entry Criteria Not Met|2|||
164102439|NCT00461786|592738770|FG000|Overall Study|Inevaluable (Never Treated)|1|||
164102440|NCT00934050|592738771|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
164102441|NCT00934050|592738772|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164102442|NCT00934050|592738773|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164102443|NCT00934050|592738774|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
164148723|NCT03207867|592904952|FG016|Overall Study|Physician Decision|1|||
164060562|NCT05664672|592582804|FG004|Overall Study|Adverse Event|0|||
164060563|NCT05664672|592582805|FG005|Overall Study|Adverse Event|1|||
164060564|NCT05664672|592582800|FG000|Overall Study|Withdrawal by Subject|0|||
164060565|NCT05664672|592582801|FG001|Overall Study|Withdrawal by Subject|1|||
164060566|NCT05664672|592582802|FG002|Overall Study|Withdrawal by Subject|3|||
164060567|NCT05664672|592582803|FG003|Overall Study|Withdrawal by Subject|0|||
164060568|NCT05664672|592582804|FG004|Overall Study|Withdrawal by Subject|5|||
164060569|NCT05664672|592582805|FG005|Overall Study|Withdrawal by Subject|6|||
164060570|NCT05664672|592582800|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
164060571|NCT05664672|592582801|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164060572|NCT05664672|592582802|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164060573|NCT05664672|592582803|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
164060574|NCT05664672|592582804|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
164060575|NCT05664672|592582805|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
164060576|NCT05664672|592582800|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
164060577|NCT05664672|592582801|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164060578|NCT05664672|592582802|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164060579|NCT05664672|592582803|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164060580|NCT05664672|592582804|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164060581|NCT05664672|592582805|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
164060582|NCT02815670|592582808|FG000|Overall Study|Prematurely discontinued of the trial|1|||
164060583|NCT01411917|592582809|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
164060584|NCT01411917|592582810|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
164060585|NCT01815099|592582815|FG000|Overall Study|Lack of Efficacy|1|||
164060586|NCT01815099|592582815|FG000|Overall Study|unable to attend study visits|1|||
164060587|NCT01977573|592582816|FG000|Overall Study|Adverse Event|7|||
164060588|NCT01977573|592582817|FG001|Overall Study|Adverse Event|0|||
164060589|NCT01977573|592582818|FG002|Overall Study|Adverse Event|2|||
164060590|NCT01977573|592582819|FG003|Overall Study|Adverse Event|1|||
164060591|NCT01977573|592582816|FG000|Overall Study|Lost to Follow-up|1|||
164060592|NCT01977573|592582817|FG001|Overall Study|Lost to Follow-up|0|||
164060593|NCT01977573|592582818|FG002|Overall Study|Lost to Follow-up|0|||
164060594|NCT01977573|592582819|FG003|Overall Study|Lost to Follow-up|1|||
164060595|NCT01977573|592582816|FG000|Overall Study|Physician Decision|1|||
164060596|NCT01977573|592582817|FG001|Overall Study|Physician Decision|0|||
164060597|NCT01977573|592582818|FG002|Overall Study|Physician Decision|0|||
164060598|NCT01977573|592582819|FG003|Overall Study|Physician Decision|0|||
164060599|NCT01977573|592582816|FG000|Overall Study|Protocol Violation|3|||
164060600|NCT01977573|592582817|FG001|Overall Study|Protocol Violation|1|||
164060601|NCT01977573|592582818|FG002|Overall Study|Protocol Violation|0|||
164060602|NCT01977573|592582819|FG003|Overall Study|Protocol Violation|0|||
164060603|NCT01977573|592582816|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
164060604|NCT01977573|592582817|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
164060605|NCT01977573|592582818|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
164060606|NCT01977573|592582819|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
164060607|NCT01977573|592582816|FG000|Overall Study|Withdrawal by Subject|6|||
164060608|NCT01977573|592582817|FG001|Overall Study|Withdrawal by Subject|1|||
164060609|NCT01977573|592582818|FG002|Overall Study|Withdrawal by Subject|1|||
164060610|NCT01977573|592582819|FG003|Overall Study|Withdrawal by Subject|1|||
164060611|NCT02513732|592584828|FG000|Overall Study|Lost to Follow-up|11|||
164060612|NCT02513732|592584828|FG000|Overall Study|Death|9|||
164060613|NCT02513732|592584828|FG000|Overall Study|Changing hospital|2|||
164060614|NCT00467051|592584829|FG000|Overall Study|Adverse Event|2|||
164060615|NCT01846442|592584834|FG000|Overall Study|Adverse Event|2|||
164060616|NCT01846442|592584835|FG001|Overall Study|Adverse Event|4|||
164060617|NCT01846442|592584836|FG002|Overall Study|Adverse Event|2|||
164060618|NCT01846442|592584837|FG003|Overall Study|Adverse Event|1|||
164060619|NCT01846442|592584834|FG000|Overall Study|Lost to Follow-up|0|||
164060620|NCT01846442|592584835|FG001|Overall Study|Lost to Follow-up|0|||
164060621|NCT01846442|592584836|FG002|Overall Study|Lost to Follow-up|1|||
164060622|NCT01846442|592584837|FG003|Overall Study|Lost to Follow-up|0|||
164060623|NCT01846442|592584834|FG000|Overall Study|Withdrawal by Subject|3|||
164060624|NCT01846442|592584835|FG001|Overall Study|Withdrawal by Subject|2|||
164060625|NCT01846442|592584836|FG002|Overall Study|Withdrawal by Subject|0|||
164060626|NCT01846442|592584837|FG003|Overall Study|Withdrawal by Subject|1|||
164060627|NCT01846442|592584834|FG000|Overall Study|Left the city/Lost medication|1|||
164060628|NCT01846442|592584835|FG001|Overall Study|Left the city/Lost medication|0|||
164060629|NCT01846442|592584836|FG002|Overall Study|Left the city/Lost medication|1|||
164060630|NCT01846442|592584837|FG003|Overall Study|Left the city/Lost medication|1|||
164060631|NCT03996694|592584838|FG000|First Washout (7 Days)|positive urine drug screen|0|||
164060632|NCT03996694|592584839|FG001|First Washout (7 Days)|positive urine drug screen|0|||
164060633|NCT03996694|592584840|FG002|First Washout (7 Days)|positive urine drug screen|1|||
164060634|NCT03996694|592584841|FG003|First Washout (7 Days)|positive urine drug screen|0|||
164060635|NCT03996694|592584842|FG004|First Washout (7 Days)|positive urine drug screen|0|||
164060636|NCT03996694|592584843|FG005|First Washout (7 Days)|positive urine drug screen|0|||
164060637|NCT03996694|592584838|FG000|First Washout (7 Days)|Adverse Event|0|||
164060638|NCT03996694|592584839|FG001|First Washout (7 Days)|Adverse Event|1|||
164060639|NCT03996694|592584840|FG002|First Washout (7 Days)|Adverse Event|0|||
164060640|NCT03996694|592584841|FG003|First Washout (7 Days)|Adverse Event|0|||
164060641|NCT03996694|592584842|FG004|First Washout (7 Days)|Adverse Event|0|||
164060642|NCT03996694|592584843|FG005|First Washout (7 Days)|Adverse Event|0|||
164060643|NCT03996694|592584838|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
164060644|NCT03996694|592584839|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
164060645|NCT03996694|592584840|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
164060646|NCT03996694|592584841|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
164060647|NCT03996694|592584842|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
164060648|NCT03996694|592584843|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
164060649|NCT03996694|592584838|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
164060650|NCT03996694|592584839|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
164060651|NCT03996694|592584840|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
164060652|NCT03996694|592584841|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
164060653|NCT03996694|592584842|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
164060654|NCT03996694|592584843|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
164060655|NCT02777554|592584848|FG000|Overall Study|Adverse Event|4|||
164060656|NCT02777554|592584849|FG001|Overall Study|Adverse Event|4|||
164060657|NCT02777554|592584850|FG002|Overall Study|Adverse Event|0|||
164060658|NCT02777554|592584851|FG003|Overall Study|Adverse Event|1|||
164060659|NCT02777554|592584852|FG004|Overall Study|Adverse Event|0|||
164060660|NCT02777554|592584853|FG005|Overall Study|Adverse Event|0|||
164060661|NCT02777554|592584848|FG000|Overall Study|Withdrawal by Subject|3|||
164060662|NCT02777554|592584849|FG001|Overall Study|Withdrawal by Subject|1|||
164060663|NCT02777554|592584850|FG002|Overall Study|Withdrawal by Subject|1|||
164060664|NCT02777554|592584851|FG003|Overall Study|Withdrawal by Subject|0|||
164060665|NCT02777554|592584852|FG004|Overall Study|Withdrawal by Subject|0|||
164060666|NCT02777554|592584853|FG005|Overall Study|Withdrawal by Subject|0|||
164060667|NCT02777554|592584848|FG000|Overall Study|Discharged early due to hurricane|22|||
164060668|NCT02777554|592584849|FG001|Overall Study|Discharged early due to hurricane|20|||
164060669|NCT02777554|592584850|FG002|Overall Study|Discharged early due to hurricane|0|||
164060670|NCT02777554|592584851|FG003|Overall Study|Discharged early due to hurricane|0|||
164060671|NCT02777554|592584852|FG004|Overall Study|Discharged early due to hurricane|0|||
164060672|NCT02777554|592584853|FG005|Overall Study|Discharged early due to hurricane|0|||
164060673|NCT02777554|592584848|FG000|Overall Study|Other - Miscellaneous|1|||
164060674|NCT02777554|592584849|FG001|Overall Study|Other - Miscellaneous|0|||
164060675|NCT02777554|592584850|FG002|Overall Study|Other - Miscellaneous|0|||
164060676|NCT02777554|592584851|FG003|Overall Study|Other - Miscellaneous|0|||
164060677|NCT02777554|592584852|FG004|Overall Study|Other - Miscellaneous|0|||
164060678|NCT02777554|592584853|FG005|Overall Study|Other - Miscellaneous|0|||
164060679|NCT02147132|592584854|FG000|Overall Study|Lost to Follow-up|1|||
164060680|NCT02147132|592584855|FG001|Overall Study|Lost to Follow-up|0|||
164060681|NCT02147132|592584856|FG002|Overall Study|Lost to Follow-up|0|||
164060682|NCT02147132|592584857|FG003|Overall Study|Lost to Follow-up|0|||
164060683|NCT01458535|592584862|FG000|Overall Study|Other|0|||
164060684|NCT01458535|592584863|FG001|Overall Study|Other|0|||
164060685|NCT01458535|592584864|FG002|Overall Study|Other|0|||
164060686|NCT01458535|592584865|FG003|Overall Study|Other|0|||
164060687|NCT01458535|592584866|FG004|Overall Study|Other|1|||
164060688|NCT01458535|592584867|FG005|Overall Study|Other|1|||
164060689|NCT01458535|592584862|FG000|Overall Study|Withdrawal by Subject|0|||
164060690|NCT01458535|592584863|FG001|Overall Study|Withdrawal by Subject|0|||
164060691|NCT01458535|592584864|FG002|Overall Study|Withdrawal by Subject|2|||
164060692|NCT01458535|592584865|FG003|Overall Study|Withdrawal by Subject|0|||
164060693|NCT01458535|592584866|FG004|Overall Study|Withdrawal by Subject|1|||
164060694|NCT01458535|592584867|FG005|Overall Study|Withdrawal by Subject|1|||
164060695|NCT01458535|592584862|FG000|Overall Study|Lost to Follow-up|0|||
164060696|NCT01458535|592584863|FG001|Overall Study|Lost to Follow-up|2|||
164060697|NCT01458535|592584864|FG002|Overall Study|Lost to Follow-up|0|||
164060698|NCT01458535|592584865|FG003|Overall Study|Lost to Follow-up|3|||
164060699|NCT01458535|592584866|FG004|Overall Study|Lost to Follow-up|2|||
164060700|NCT01458535|592584867|FG005|Overall Study|Lost to Follow-up|2|||
164060701|NCT01458535|592584862|FG000|Overall Study|Adverse Event|0|||
164060702|NCT01458535|592584863|FG001|Overall Study|Adverse Event|0|||
164060703|NCT01458535|592584864|FG002|Overall Study|Adverse Event|0|||
164060704|NCT01458535|592584865|FG003|Overall Study|Adverse Event|1|||
164060705|NCT01458535|592584866|FG004|Overall Study|Adverse Event|0|||
164060706|NCT01458535|592584867|FG005|Overall Study|Adverse Event|0|||
164060707|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
164060708|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
164060709|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060710|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060711|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060712|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060713|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060714|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060715|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060716|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060717|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060718|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
164060719|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
164060720|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060721|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060722|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060723|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060724|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060725|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
164060726|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060727|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060728|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060729|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
164060730|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
164060731|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060732|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
164060733|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060734|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060735|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060736|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060737|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060738|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060739|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060740|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060741|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060742|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
164060743|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
164060744|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
164060745|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
164060746|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
164060747|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
164060748|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
164060749|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
164060750|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
164060751|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
164060752|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
164060753|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
164060754|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
164060755|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060756|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060757|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060758|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060759|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060760|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
164060761|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060762|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060763|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060764|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060765|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060766|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
164060767|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060768|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060769|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060770|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060771|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060772|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
164060773|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060774|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060775|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060776|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060777|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060778|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
164060779|NCT00151775|592584868|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060780|NCT00151775|592584869|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060781|NCT00151775|592584870|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060782|NCT00151775|592584871|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060783|NCT00151775|592584872|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060784|NCT00151775|592584873|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060785|NCT00151775|592584874|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
164060786|NCT00151775|592584875|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060787|NCT00151775|592584876|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060788|NCT00151775|592584877|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060789|NCT00151775|592584878|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060790|NCT00151775|592584879|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
164060791|NCT00151775|592584868|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060792|NCT00151775|592584869|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060793|NCT00151775|592584870|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060794|NCT00151775|592584871|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060795|NCT00151775|592584872|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060796|NCT00151775|592584873|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
164060797|NCT00151775|592584874|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060798|NCT00151775|592584875|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060799|NCT00151775|592584876|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060800|NCT00151775|592584877|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060801|NCT00151775|592584878|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060802|NCT00151775|592584879|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
164060803|NCT00151775|592584868|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
164060804|NCT00151775|592584869|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
164060805|NCT00151775|592584870|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
164060806|NCT00151775|592584871|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
164060807|NCT00151775|592584872|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
164060808|NCT00151775|592584873|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
164060809|NCT00151775|592584874|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
164060810|NCT00151775|592584875|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
164060811|NCT00151775|592584876|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
164060812|NCT00151775|592584877|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
164060813|NCT00151775|592584878|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
164060814|NCT00151775|592584879|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
164060815|NCT00151775|592584868|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060816|NCT00151775|592584869|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060817|NCT00151775|592584870|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060818|NCT00151775|592584871|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060819|NCT00151775|592584872|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060820|NCT00151775|592584873|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060821|NCT00151775|592584874|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
164060822|NCT00151775|592584875|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060823|NCT00151775|592584876|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060824|NCT00151775|592584877|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060825|NCT00151775|592584878|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060826|NCT00151775|592584879|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
164060827|NCT00151775|592584868|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060828|NCT00151775|592584869|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060829|NCT00151775|592584870|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
164060830|NCT00151775|592584871|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060831|NCT00151775|592584872|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060832|NCT00151775|592584873|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060833|NCT00151775|592584874|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060834|NCT00151775|592584875|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060835|NCT00151775|592584876|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060836|NCT00151775|592584877|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060837|NCT00151775|592584878|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060838|NCT00151775|592584879|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
164060839|NCT00151775|592584868|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060840|NCT00151775|592584869|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060841|NCT00151775|592584870|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
164060842|NCT00151775|592584871|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164148724|NCT03207867|592904953|FG017|Overall Study|Physician Decision|2|||
164060843|NCT00151775|592584872|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060844|NCT00151775|592584873|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060845|NCT00151775|592584874|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060846|NCT00151775|592584875|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060847|NCT00151775|592584876|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060848|NCT00151775|592584877|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060849|NCT00151775|592584878|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060850|NCT00151775|592584879|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
164060851|NCT00151775|592584868|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060852|NCT00151775|592584869|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060853|NCT00151775|592584870|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060854|NCT00151775|592584871|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060855|NCT00151775|592584872|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060856|NCT00151775|592584873|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060857|NCT00151775|592584874|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060858|NCT00151775|592584875|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060859|NCT00151775|592584876|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060860|NCT00151775|592584877|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060861|NCT00151775|592584878|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
164060862|NCT00151775|592584879|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
164060863|NCT00151775|592584868|FG000|Period 4: Open Label|Increased blood pressure|0|||
164060864|NCT00151775|592584869|FG001|Period 4: Open Label|Increased blood pressure|0|||
164060865|NCT00151775|592584870|FG002|Period 4: Open Label|Increased blood pressure|0|||
164102444|NCT00934050|592738775|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164102445|NCT00934050|592738776|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
164102446|NCT00934050|592738771|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
164102447|NCT00934050|592738772|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
164102448|NCT00934050|592738773|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
164102449|NCT00934050|592738774|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
164102450|NCT00934050|592738775|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
164102451|NCT00934050|592738776|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
164102452|NCT00934050|592738771|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164102453|NCT00934050|592738772|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164102454|NCT00934050|592738773|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
164102455|NCT00934050|592738774|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164102456|NCT00934050|592738775|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164102457|NCT00934050|592738776|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
164102458|NCT00934050|592738771|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
164102459|NCT00934050|592738772|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
164102460|NCT00934050|592738773|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
164102461|NCT00934050|592738774|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
164102462|NCT00934050|592738775|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
164102463|NCT00934050|592738776|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
164102464|NCT00934050|592738771|FG000|Enrolled After 15 Dec 2009|Death|0|||
164102465|NCT00934050|592738772|FG001|Enrolled After 15 Dec 2009|Death|0|||
164102466|NCT00934050|592738773|FG002|Enrolled After 15 Dec 2009|Death|0|||
164102467|NCT00934050|592738774|FG003|Enrolled After 15 Dec 2009|Death|0|||
164102468|NCT00934050|592738775|FG004|Enrolled After 15 Dec 2009|Death|0|||
164102469|NCT00934050|592738776|FG005|Enrolled After 15 Dec 2009|Death|1|||
164102470|NCT00934050|592738771|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164102471|NCT00934050|592738772|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164102472|NCT00934050|592738773|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164102473|NCT00934050|592738774|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164102474|NCT00934050|592738775|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
164102475|NCT00934050|592738776|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
164102476|NCT00934050|592738771|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164102477|NCT00934050|592738772|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164102478|NCT00934050|592738773|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164102479|NCT00934050|592738774|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
164060866|NCT00151775|592584871|FG003|Period 4: Open Label|Increased blood pressure|0|||
164060867|NCT00151775|592584872|FG004|Period 4: Open Label|Increased blood pressure|1|||
164060868|NCT00151775|592584873|FG005|Period 4: Open Label|Increased blood pressure|0|||
164060869|NCT00151775|592584874|FG006|Period 4: Open Label|Increased blood pressure|0|||
164060870|NCT00151775|592584875|FG007|Period 4: Open Label|Increased blood pressure|0|||
164060871|NCT00151775|592584876|FG008|Period 4: Open Label|Increased blood pressure|0|||
164102480|NCT00934050|592738775|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
164102481|NCT00934050|592738776|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
164102482|NCT03616535|592738780|FG000|Overall Study|Death|2|||
164102483|NCT03616535|592738781|FG001|Overall Study|Death|0|||
164102484|NCT03616535|592738782|FG002|Overall Study|Death|0|||
164060872|NCT00151775|592584877|FG009|Period 4: Open Label|Increased blood pressure|1|||
164060873|NCT00151775|592584878|FG010|Period 4: Open Label|Increased blood pressure|0|||
164060874|NCT00151775|592584879|FG011|Period 4: Open Label|Increased blood pressure|0|||
164060875|NCT00151775|592584868|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
164060876|NCT00151775|592584869|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
164060877|NCT00151775|592584870|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
164060878|NCT00151775|592584871|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
164060879|NCT00151775|592584872|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
164060880|NCT00151775|592584873|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
164060881|NCT00151775|592584874|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
164060882|NCT00151775|592584875|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
164060883|NCT00151775|592584876|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
164060884|NCT00151775|592584877|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
164060885|NCT00151775|592584878|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
164060886|NCT00151775|592584879|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
164060887|NCT00151775|592584868|FG000|Period 4: Open Label|Adverse Event|0|||
164060888|NCT00151775|592584869|FG001|Period 4: Open Label|Adverse Event|0|||
164060889|NCT00151775|592584870|FG002|Period 4: Open Label|Adverse Event|0|||
164060890|NCT00151775|592584871|FG003|Period 4: Open Label|Adverse Event|0|||
164060891|NCT00151775|592584872|FG004|Period 4: Open Label|Adverse Event|1|||
164060892|NCT00151775|592584873|FG005|Period 4: Open Label|Adverse Event|0|||
164060893|NCT00151775|592584874|FG006|Period 4: Open Label|Adverse Event|0|||
164060894|NCT00151775|592584875|FG007|Period 4: Open Label|Adverse Event|0|||
164060895|NCT00151775|592584876|FG008|Period 4: Open Label|Adverse Event|0|||
164060896|NCT00151775|592584877|FG009|Period 4: Open Label|Adverse Event|2|||
164060897|NCT00151775|592584878|FG010|Period 4: Open Label|Adverse Event|0|||
164060898|NCT00151775|592584879|FG011|Period 4: Open Label|Adverse Event|0|||
164060899|NCT00151775|592584868|FG000|Period 4: Open Label|Lost to Follow-up|0|||
164060900|NCT00151775|592584869|FG001|Period 4: Open Label|Lost to Follow-up|0|||
164060901|NCT00151775|592584870|FG002|Period 4: Open Label|Lost to Follow-up|0|||
164060902|NCT00151775|592584871|FG003|Period 4: Open Label|Lost to Follow-up|0|||
164060903|NCT00151775|592584872|FG004|Period 4: Open Label|Lost to Follow-up|17|||
164060904|NCT00151775|592584873|FG005|Period 4: Open Label|Lost to Follow-up|0|||
164060905|NCT00151775|592584874|FG006|Period 4: Open Label|Lost to Follow-up|0|||
164060906|NCT00151775|592584875|FG007|Period 4: Open Label|Lost to Follow-up|0|||
164060907|NCT00151775|592584876|FG008|Period 4: Open Label|Lost to Follow-up|0|||
164060908|NCT00151775|592584877|FG009|Period 4: Open Label|Lost to Follow-up|7|||
164060909|NCT00151775|592584878|FG010|Period 4: Open Label|Lost to Follow-up|0|||
164060910|NCT00151775|592584879|FG011|Period 4: Open Label|Lost to Follow-up|0|||
164060911|NCT00151775|592584868|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
164060912|NCT00151775|592584869|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
164060913|NCT00151775|592584870|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
164060914|NCT00151775|592584871|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
164060915|NCT00151775|592584872|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
164060916|NCT00151775|592584873|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
164060917|NCT00151775|592584874|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
164060918|NCT00151775|592584875|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
164060919|NCT00151775|592584876|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
164060920|NCT00151775|592584877|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
164060921|NCT00151775|592584878|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
164060922|NCT00151775|592584879|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
164060923|NCT00151775|592584868|FG000|Period 4: Open Label|Other|0|||
164060924|NCT00151775|592584869|FG001|Period 4: Open Label|Other|0|||
164060925|NCT00151775|592584870|FG002|Period 4: Open Label|Other|0|||
164060926|NCT00151775|592584871|FG003|Period 4: Open Label|Other|0|||
164060927|NCT00151775|592584872|FG004|Period 4: Open Label|Other|1|||
164060928|NCT00151775|592584873|FG005|Period 4: Open Label|Other|0|||
164060929|NCT00151775|592584874|FG006|Period 4: Open Label|Other|0|||
164060930|NCT00151775|592584875|FG007|Period 4: Open Label|Other|0|||
164060931|NCT00151775|592584876|FG008|Period 4: Open Label|Other|0|||
164060932|NCT00151775|592584877|FG009|Period 4: Open Label|Other|3|||
164060933|NCT00151775|592584878|FG010|Period 4: Open Label|Other|0|||
164060934|NCT00151775|592584879|FG011|Period 4: Open Label|Other|0|||
164060935|NCT00151775|592584868|FG000|Period 4: Open Label|Physician Decision|0|||
164060936|NCT00151775|592584869|FG001|Period 4: Open Label|Physician Decision|0|||
164060937|NCT00151775|592584870|FG002|Period 4: Open Label|Physician Decision|0|||
164060938|NCT00151775|592584871|FG003|Period 4: Open Label|Physician Decision|0|||
164060939|NCT00151775|592584872|FG004|Period 4: Open Label|Physician Decision|0|||
164060940|NCT00151775|592584873|FG005|Period 4: Open Label|Physician Decision|0|||
164060941|NCT00151775|592584874|FG006|Period 4: Open Label|Physician Decision|0|||
164060942|NCT00151775|592584875|FG007|Period 4: Open Label|Physician Decision|0|||
164060943|NCT00151775|592584876|FG008|Period 4: Open Label|Physician Decision|0|||
164060944|NCT00151775|592584877|FG009|Period 4: Open Label|Physician Decision|2|||
164060945|NCT00151775|592584878|FG010|Period 4: Open Label|Physician Decision|0|||
164102485|NCT03616535|592738783|FG003|Overall Study|Death|1|||
164102486|NCT03616535|592738780|FG000|Overall Study|Lost to Follow-up|2|||
164102487|NCT03616535|592738781|FG001|Overall Study|Lost to Follow-up|1|||
164102488|NCT03616535|592738782|FG002|Overall Study|Lost to Follow-up|0|||
164102489|NCT03616535|592738783|FG003|Overall Study|Lost to Follow-up|2|||
164102490|NCT03616535|592738780|FG000|Overall Study|Withdrawal by Subject|1|||
164060946|NCT00151775|592584879|FG011|Period 4: Open Label|Physician Decision|0|||
164060947|NCT00151775|592584868|FG000|Period 4: Open Label|Protocol Violation|0|||
164060948|NCT00151775|592584869|FG001|Period 4: Open Label|Protocol Violation|0|||
164060949|NCT00151775|592584870|FG002|Period 4: Open Label|Protocol Violation|0|||
164060950|NCT00151775|592584871|FG003|Period 4: Open Label|Protocol Violation|0|||
164060951|NCT00151775|592584872|FG004|Period 4: Open Label|Protocol Violation|1|||
164060952|NCT00151775|592584873|FG005|Period 4: Open Label|Protocol Violation|0|||
164060953|NCT00151775|592584874|FG006|Period 4: Open Label|Protocol Violation|0|||
164102491|NCT03616535|592738781|FG001|Overall Study|Withdrawal by Subject|2|||
164102492|NCT03616535|592738782|FG002|Overall Study|Withdrawal by Subject|5|||
164102493|NCT03616535|592738783|FG003|Overall Study|Withdrawal by Subject|1|||
164102494|NCT03616535|592738780|FG000|Overall Study|Not specified or change in eligibility|2|||
164102495|NCT03616535|592738781|FG001|Overall Study|Not specified or change in eligibility|3|||
164102496|NCT03616535|592738782|FG002|Overall Study|Not specified or change in eligibility|3|||
164102497|NCT03616535|592738783|FG003|Overall Study|Not specified or change in eligibility|1|||
164102498|NCT01083693|592738786|FG000|Overall Study|Adverse Event|1|||
164102499|NCT01083693|592738787|FG001|Overall Study|Adverse Event|1|||
164102500|NCT01083693|592738788|FG002|Overall Study|Adverse Event|0|||
164102501|NCT01083693|592738786|FG000|Overall Study|Lost to Follow-up|2|||
164102502|NCT01083693|592738787|FG001|Overall Study|Lost to Follow-up|0|||
164102503|NCT01083693|592738788|FG002|Overall Study|Lost to Follow-up|2|||
164102504|NCT01083693|592738786|FG000|Overall Study|Lack of effectiveness|13|||
164102505|NCT01083693|592738787|FG001|Overall Study|Lack of effectiveness|2|||
164102506|NCT01083693|592738788|FG002|Overall Study|Lack of effectiveness|2|||
164102507|NCT01083693|592738786|FG000|Overall Study|Patient Moved|0|||
164102508|NCT01083693|592738787|FG001|Overall Study|Patient Moved|1|||
164102509|NCT01083693|592738788|FG002|Overall Study|Patient Moved|0|||
164102510|NCT01083693|592738786|FG000|Overall Study|Complete remission|0|||
164102511|NCT01083693|592738787|FG001|Overall Study|Complete remission|1|||
164102512|NCT01083693|592738788|FG002|Overall Study|Complete remission|0|||
164102513|NCT01083693|592738786|FG000|Overall Study|Other medical condition/surgery|1|||
164102514|NCT01083693|592738787|FG001|Overall Study|Other medical condition/surgery|1|||
164102515|NCT01083693|592738788|FG002|Overall Study|Other medical condition/surgery|0|||
164102516|NCT01083693|592738786|FG000|Overall Study|Withdrawal by Subject|3|||
164102517|NCT01083693|592738787|FG001|Overall Study|Withdrawal by Subject|0|||
164102518|NCT01083693|592738788|FG002|Overall Study|Withdrawal by Subject|2|||
164102519|NCT01083693|592738786|FG000|Overall Study|Reason unknown|0|||
164102520|NCT01083693|592738787|FG001|Overall Study|Reason unknown|0|||
164102521|NCT01083693|592738788|FG002|Overall Study|Reason unknown|1|||
164102522|NCT00834418|592738789|FG000|Overall Study|Adverse Event|0|||
164102523|NCT00834418|592738790|FG001|Overall Study|Adverse Event|2|||
164102524|NCT01705574|592738791|FG000|Double-Blind Phase|Lost to Follow-up|12|||
164102525|NCT01705574|592738792|FG001|Double-Blind Phase|Lost to Follow-up|16|||
164102526|NCT01705574|592738793|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164102527|NCT01705574|592738794|FG003|Double-Blind Phase|Lost to Follow-up|0|||
164102528|NCT01705574|592738791|FG000|Double-Blind Phase|Adverse Event|3|||
164102529|NCT01705574|592738792|FG001|Double-Blind Phase|Adverse Event|10|||
164102530|NCT01705574|592738793|FG002|Double-Blind Phase|Adverse Event|0|||
164102531|NCT01705574|592738794|FG003|Double-Blind Phase|Adverse Event|0|||
164102532|NCT01705574|592738791|FG000|Double-Blind Phase|Withdrew Consent|8|||
164102533|NCT01705574|592738792|FG001|Double-Blind Phase|Withdrew Consent|5|||
164102534|NCT01705574|592738793|FG002|Double-Blind Phase|Withdrew Consent|0|||
164102535|NCT01705574|592738794|FG003|Double-Blind Phase|Withdrew Consent|0|||
164102536|NCT01705574|592738791|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
164102537|NCT01705574|592738792|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
164102538|NCT01705574|592738793|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
164060954|NCT00151775|592584875|FG007|Period 4: Open Label|Protocol Violation|0|||
164060955|NCT00151775|592584876|FG008|Period 4: Open Label|Protocol Violation|0|||
164102539|NCT01705574|592738794|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
164102540|NCT01705574|592738791|FG000|Double-Blind Phase|Pregnancy|1|||
164102541|NCT01705574|592738792|FG001|Double-Blind Phase|Pregnancy|1|||
164102542|NCT01705574|592738793|FG002|Double-Blind Phase|Pregnancy|0|||
164102543|NCT01705574|592738794|FG003|Double-Blind Phase|Pregnancy|0|||
164102544|NCT01705574|592738791|FG000|Double-Blind Phase|Protocol Violation|1|||
164102545|NCT01705574|592738792|FG001|Double-Blind Phase|Protocol Violation|0|||
164102546|NCT01705574|592738793|FG002|Double-Blind Phase|Protocol Violation|0|||
164102547|NCT01705574|592738794|FG003|Double-Blind Phase|Protocol Violation|0|||
164102548|NCT01705574|592738791|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
164102549|NCT01705574|592738792|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
164102550|NCT01705574|592738793|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
164060956|NCT00151775|592584877|FG009|Period 4: Open Label|Protocol Violation|0|||
164060957|NCT00151775|592584878|FG010|Period 4: Open Label|Protocol Violation|0|||
164060958|NCT00151775|592584879|FG011|Period 4: Open Label|Protocol Violation|0|||
164060959|NCT00474994|592584880|FG000|Overall Study|Patient Not treated|1|||
164060960|NCT00474994|592584880|FG000|Overall Study|Patient evaluable for toxicity only|3|||
164060961|NCT00474994|592584880|FG000|Overall Study|Patient found to be ineligible|1|||
164060962|NCT01711736|592584883|FG000|Overall Study|Lost to Follow-up|4|||
164060963|NCT01711736|592584884|FG001|Overall Study|Lost to Follow-up|1|||
164060964|NCT01711736|592584883|FG000|Overall Study|Withdrawal by Subject|6|||
164060965|NCT01711736|592584884|FG001|Overall Study|Withdrawal by Subject|6|||
164060966|NCT01711736|592584883|FG000|Overall Study|Migrated/moved from study area|2|||
164060967|NCT01711736|592584884|FG001|Overall Study|Migrated/moved from study area|1|||
164060968|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Adverse Event|4|||
164060969|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Adverse Event|3|||
164060970|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Adverse Event|0|||
164060971|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Adverse Event|0|||
164060972|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Death|24|||
164060973|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Death|9|||
164060974|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Death|0|||
164060975|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Death|0|||
164060976|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
164060977|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
164060978|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
164060979|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
164060980|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Physician Decision|4|||
164060981|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Physician Decision|1|||
164060982|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Physician Decision|0|||
164060983|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Physician Decision|0|||
164060984|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Progressive disease|1|||
164060985|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Progressive disease|0|||
164060986|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Progressive disease|0|||
164060987|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Progressive disease|0|||
164060988|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
164060989|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
164060990|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
164060991|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
164060992|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
164060993|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
164060994|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
164060995|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
164060996|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
164060997|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
164060998|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
164060999|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
164061000|NCT04579666|592584885|FG000|RTP (Up to Week 52)|Other|2|||
164061001|NCT04579666|592584886|FG001|RTP (Up to Week 52)|Other|0|||
164061002|NCT04579666|592584887|FG002|RTP (Up to Week 52)|Other|0|||
164061003|NCT04579666|592584888|FG003|RTP (Up to Week 52)|Other|0|||
164061004|NCT04579666|592584885|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
164061005|NCT04579666|592584886|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
164061006|NCT04579666|592584887|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
164061007|NCT04579666|592584888|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
164061008|NCT04579666|592584885|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
164061009|NCT04579666|592584886|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
164061010|NCT04579666|592584887|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
164061011|NCT04579666|592584888|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
164061012|NCT04579666|592584885|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
164061013|NCT04579666|592584886|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
164061014|NCT04579666|592584887|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
164061015|NCT04579666|592584888|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
164061016|NCT04579666|592584885|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
164061017|NCT04579666|592584886|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
164061018|NCT04579666|592584887|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
164061019|NCT04579666|592584888|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
164061020|NCT04579666|592584885|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
164061021|NCT04579666|592584886|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
164061022|NCT04579666|592584887|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
164061023|NCT04579666|592584888|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
164061024|NCT05450198|592584889|FG000|Overall Study|Withdrawal by Subject|1|||
164061025|NCT05450198|592584890|FG001|Overall Study|Withdrawal by Subject|1|||
164061026|NCT05450198|592584891|FG002|Overall Study|Withdrawal by Subject|2|||
164061027|NCT05450198|592584892|FG003|Overall Study|Withdrawal by Subject|0|||
164061028|NCT05450198|592584889|FG000|Overall Study|Lost to Follow-up|1|||
164061029|NCT05450198|592584890|FG001|Overall Study|Lost to Follow-up|0|||
164061030|NCT05450198|592584891|FG002|Overall Study|Lost to Follow-up|2|||
164061031|NCT05450198|592584892|FG003|Overall Study|Lost to Follow-up|1|||
164061032|NCT00808665|592584901|FG000|Overall Study|Withdrawal by Subject|1|||
164061033|NCT00808665|592584902|FG001|Overall Study|Withdrawal by Subject|0|||
164061034|NCT00808665|592584901|FG000|Overall Study|only required minimally invasive surgery|1|||
164061035|NCT00808665|592584902|FG001|Overall Study|only required minimally invasive surgery|0|||
164061036|NCT00808665|592584901|FG000|Overall Study|surgery cancelled|1|||
164061037|NCT00808665|592584902|FG001|Overall Study|surgery cancelled|0|||
164061038|NCT00808665|592584901|FG000|Overall Study|required an additional procedure|0|||
164061039|NCT00808665|592584902|FG001|Overall Study|required an additional procedure|1|||
164061040|NCT00808665|592584901|FG000|Overall Study|Physician Decision|3|||
164061041|NCT00808665|592584902|FG001|Overall Study|Physician Decision|1|||
164061042|NCT00808665|592584901|FG000|Overall Study|Medication stopped by resident|0|||
164061043|NCT00808665|592584902|FG001|Overall Study|Medication stopped by resident|1|||
164061044|NCT01694849|592584905|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
164061045|NCT01694849|592584906|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
164061046|NCT01694849|592584907|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
164061047|NCT01694849|592584905|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
164061048|NCT01694849|592584906|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
164061049|NCT01694849|592584907|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
164061050|NCT01694849|592584905|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
164061051|NCT01694849|592584906|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
164061052|NCT01694849|592584907|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
164061053|NCT01694849|592584905|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
164061054|NCT01694849|592584906|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
164061055|NCT01694849|592584907|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
164061056|NCT01694849|592584905|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
164061057|NCT01694849|592584906|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
164061058|NCT01694849|592584907|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
164102551|NCT01705574|592738794|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
164102552|NCT01705574|592738791|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
164102553|NCT01705574|592738792|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
164102554|NCT01705574|592738793|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
164102555|NCT01705574|592738794|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
164102556|NCT01705574|592738791|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
164102557|NCT01705574|592738792|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
164102558|NCT01705574|592738793|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
164102559|NCT01705574|592738794|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
164102560|NCT01705574|592738791|FG000|Open-Label Extension Phase|Adverse Event|3|||
164102561|NCT01705574|592738792|FG001|Open-Label Extension Phase|Adverse Event|0|||
164102562|NCT01705574|592738793|FG002|Open-Label Extension Phase|Adverse Event|0|||
164102563|NCT01705574|592738794|FG003|Open-Label Extension Phase|Adverse Event|1|||
164102564|NCT01705574|592738791|FG000|Open-Label Extension Phase|Death|2|||
164102565|NCT01705574|592738792|FG001|Open-Label Extension Phase|Death|0|||
164102566|NCT01705574|592738793|FG002|Open-Label Extension Phase|Death|1|||
164102567|NCT01705574|592738794|FG003|Open-Label Extension Phase|Death|0|||
164102568|NCT01705574|592738791|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
164102569|NCT01705574|592738792|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
164102570|NCT01705574|592738793|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
164102571|NCT01705574|592738794|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
164102572|NCT01705574|592738791|FG000|Open-Label Extension Phase|Physician Decision|0|||
164102573|NCT01705574|592738792|FG001|Open-Label Extension Phase|Physician Decision|0|||
164102574|NCT01705574|592738793|FG002|Open-Label Extension Phase|Physician Decision|2|||
164102575|NCT01705574|592738794|FG003|Open-Label Extension Phase|Physician Decision|0|||
164102576|NCT01705574|592738791|FG000|Open-Label Extension Phase|Pregnancy|0|||
164102577|NCT01705574|592738792|FG001|Open-Label Extension Phase|Pregnancy|0|||
164102578|NCT01705574|592738793|FG002|Open-Label Extension Phase|Pregnancy|1|||
164102579|NCT01705574|592738794|FG003|Open-Label Extension Phase|Pregnancy|1|||
164102580|NCT00777023|592738795|FG000|Overall Study|Adverse Event|15|||
164102581|NCT00777023|592738796|FG001|Overall Study|Adverse Event|21|||
164102582|NCT00777023|592738797|FG002|Overall Study|Adverse Event|8|||
164102583|NCT00777023|592738795|FG000|Overall Study|Lack of Efficacy|1|||
164102584|NCT00777023|592738796|FG001|Overall Study|Lack of Efficacy|0|||
164102585|NCT00777023|592738797|FG002|Overall Study|Lack of Efficacy|14|||
164102586|NCT00777023|592738795|FG000|Overall Study|Protocol Violation|2|||
164102587|NCT00777023|592738796|FG001|Overall Study|Protocol Violation|1|||
164102588|NCT00777023|592738797|FG002|Overall Study|Protocol Violation|1|||
164102589|NCT00777023|592738795|FG000|Overall Study|Lost to Follow-up|2|||
164061059|NCT01694849|592584905|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
164061060|NCT01694849|592584906|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
164102590|NCT00777023|592738796|FG001|Overall Study|Lost to Follow-up|3|||
164102591|NCT00777023|592738797|FG002|Overall Study|Lost to Follow-up|3|||
164061061|NCT01694849|592584907|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
164061062|NCT01694849|592584905|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
164061063|NCT01694849|592584906|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
164061064|NCT01694849|592584907|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
164061065|NCT01694849|592584905|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
164061066|NCT01694849|592584906|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
164061067|NCT01694849|592584907|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
164061068|NCT01326312|592584909|FG000|Overall Study|Adverse Event|11|||
164061069|NCT01326312|592584910|FG001|Overall Study|Adverse Event|11|||
164061070|NCT01326312|592584911|FG002|Overall Study|Adverse Event|1|||
164061071|NCT01326312|592584909|FG000|Overall Study|Withdrawal by Subject|1|||
164061072|NCT01326312|592584910|FG001|Overall Study|Withdrawal by Subject|2|||
164061073|NCT01326312|592584911|FG002|Overall Study|Withdrawal by Subject|1|||
164061074|NCT01326312|592584909|FG000|Overall Study|Protocol Violation|0|||
164061075|NCT01326312|592584910|FG001|Overall Study|Protocol Violation|1|||
164061076|NCT01326312|592584911|FG002|Overall Study|Protocol Violation|0|||
164061077|NCT01326312|592584909|FG000|Overall Study|Lack of Efficacy|13|||
164061078|NCT01326312|592584910|FG001|Overall Study|Lack of Efficacy|7|||
164061079|NCT01326312|592584911|FG002|Overall Study|Lack of Efficacy|1|||
164061080|NCT01326312|592584909|FG000|Overall Study|Death|1|||
164061081|NCT01326312|592584910|FG001|Overall Study|Death|0|||
164061082|NCT01326312|592584911|FG002|Overall Study|Death|1|||
164061083|NCT01326312|592584909|FG000|Overall Study|progressive disease|0|||
164061084|NCT01326312|592584910|FG001|Overall Study|progressive disease|1|||
164061085|NCT01326312|592584911|FG002|Overall Study|progressive disease|1|||
164061086|NCT01326312|592584909|FG000|Overall Study|Study terminated by Sponsor|8|||
164061087|NCT01326312|592584910|FG001|Overall Study|Study terminated by Sponsor|32|||
164061088|NCT01326312|592584911|FG002|Overall Study|Study terminated by Sponsor|46|||
164061089|NCT01326312|592584909|FG000|Overall Study|Treatment arm terminated|19|||
164061090|NCT01326312|592584910|FG001|Overall Study|Treatment arm terminated|0|||
164061091|NCT01326312|592584911|FG002|Overall Study|Treatment arm terminated|0|||
164061092|NCT01326312|592584909|FG000|Overall Study|QTc > 500|0|||
164061093|NCT01326312|592584910|FG001|Overall Study|QTc > 500|1|||
164061094|NCT01326312|592584911|FG002|Overall Study|QTc > 500|0|||
164061095|NCT00678652|592584916|FG000|Overall Study|Protocol Violation|2|||
164061096|NCT00678652|592584917|FG001|Overall Study|Protocol Violation|0|||
164061097|NCT00678652|592584918|FG002|Overall Study|Protocol Violation|0|||
164061098|NCT00678652|592584919|FG003|Overall Study|Protocol Violation|0|||
164061099|NCT00678652|592584916|FG000|Overall Study|Pregnancy|0|||
164061100|NCT00678652|592584917|FG001|Overall Study|Pregnancy|0|||
164061101|NCT00678652|592584918|FG002|Overall Study|Pregnancy|1|||
164061102|NCT00678652|592584919|FG003|Overall Study|Pregnancy|0|||
164061103|NCT00678652|592584916|FG000|Overall Study|Relocation|1|||
164061104|NCT00678652|592584917|FG001|Overall Study|Relocation|0|||
164061105|NCT00678652|592584918|FG002|Overall Study|Relocation|0|||
164061106|NCT00678652|592584919|FG003|Overall Study|Relocation|0|||
164061107|NCT05146999|592584920|FG000|Overall Study|Withdrew consent|6|||
164061108|NCT05146999|592584921|FG001|Overall Study|Withdrew consent|1|||
164061109|NCT05146999|592584920|FG000|Overall Study|Lost to Follow-up|3|||
164061110|NCT05146999|592584921|FG001|Overall Study|Lost to Follow-up|2|||
164061111|NCT05146999|592584920|FG000|Overall Study|Other|1|||
164061112|NCT05146999|592584921|FG001|Overall Study|Other|3|||
164061113|NCT00383292|592584922|FG000|Overall Study|Adverse Event|4|||
164061114|NCT00383292|592584923|FG001|Overall Study|Adverse Event|1|||
164061115|NCT00383292|592584924|FG002|Overall Study|Adverse Event|2|||
164061116|NCT00383292|592584922|FG000|Overall Study|Death|3|||
164061117|NCT00383292|592584923|FG001|Overall Study|Death|3|||
164061118|NCT00383292|592584924|FG002|Overall Study|Death|3|||
164061119|NCT00383292|592584922|FG000|Overall Study|Physician Decision|4|||
164061120|NCT00383292|592584923|FG001|Overall Study|Physician Decision|0|||
164061121|NCT00383292|592584924|FG002|Overall Study|Physician Decision|1|||
164061122|NCT00383292|592584922|FG000|Overall Study|Withdrawal by Subject|3|||
164061123|NCT00383292|592584923|FG001|Overall Study|Withdrawal by Subject|2|||
164061124|NCT00383292|592584924|FG002|Overall Study|Withdrawal by Subject|2|||
164102592|NCT00777023|592738795|FG000|Overall Study|Death|0|||
164102593|NCT00777023|592738796|FG001|Overall Study|Death|1|||
164061125|NCT00383292|592584922|FG000|Overall Study|Other|1|||
164061126|NCT00383292|592584923|FG001|Overall Study|Other|0|||
164061127|NCT00383292|592584924|FG002|Overall Study|Other|0|||
164061128|NCT03457701|592584934|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
164061129|NCT03457701|592584935|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
164061130|NCT03457701|592584934|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
164061131|NCT03457701|592584935|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
164061132|NCT03329404|592584936|FG000|Overall Study|The study was suspended.|1|||
164061133|NCT03329404|592584937|FG001|Overall Study|The study was suspended.|4|||
164061134|NCT02243306|592584938|FG000|Overall Study|Adverse Event|0|||
164061135|NCT02243306|592584939|FG001|Overall Study|Adverse Event|1|||
164102594|NCT00777023|592738797|FG002|Overall Study|Death|0|||
164061136|NCT02243306|592584938|FG000|Overall Study|Other: Reached stopping criteria|0|||
164061137|NCT02243306|592584939|FG001|Overall Study|Other: Reached stopping criteria|1|||
164061138|NCT02243306|592584938|FG000|Overall Study|Physician Decision|0|||
164061139|NCT02243306|592584939|FG001|Overall Study|Physician Decision|1|||
164061140|NCT02221882|592584940|FG000|Overall Study|Withdrawal by Subject|0|||
164061141|NCT02221882|592584941|FG001|Overall Study|Withdrawal by Subject|0|||
164061142|NCT02221882|592584942|FG002|Overall Study|Withdrawal by Subject|4|||
164061143|NCT02221882|592584943|FG003|Overall Study|Withdrawal by Subject|2|||
164061144|NCT02221882|592584944|FG004|Overall Study|Withdrawal by Subject|2|||
164061145|NCT02221882|592584945|FG005|Overall Study|Withdrawal by Subject|2|||
164061146|NCT02221882|592584940|FG000|Overall Study|Death|0|||
164061147|NCT02221882|592584941|FG001|Overall Study|Death|1|||
164061148|NCT02221882|592584942|FG002|Overall Study|Death|0|||
164061149|NCT02221882|592584943|FG003|Overall Study|Death|0|||
164061150|NCT02221882|592584944|FG004|Overall Study|Death|0|||
164061151|NCT02221882|592584945|FG005|Overall Study|Death|0|||
164061152|NCT04095039|592584951|FG000|Overall Study|Withdrawal by Subject|2|||
164061153|NCT04095039|592584952|FG001|Overall Study|Withdrawal by Subject|16|||
164061154|NCT04095039|592584951|FG000|Overall Study|Transplanted|21|||
164061155|NCT04095039|592584952|FG001|Overall Study|Transplanted|24|||
164061156|NCT04095039|592584951|FG000|Overall Study|Transferred to Non-study Facility|47|||
164061157|NCT04095039|592584952|FG001|Overall Study|Transferred to Non-study Facility|44|||
164061158|NCT04095039|592584951|FG000|Overall Study|Withdrawal from internvention target|0|||
164061159|NCT04095039|592584952|FG001|Overall Study|Withdrawal from internvention target|2|||
164061160|NCT04095039|592584951|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
164061161|NCT04095039|592584952|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
164061162|NCT04095039|592584951|FG000|Overall Study|Cacliphylaxis|0|||
164061163|NCT04095039|592584952|FG001|Overall Study|Cacliphylaxis|1|||
164061164|NCT04095039|592584951|FG000|Overall Study|Pregnancy|1|||
164061165|NCT04095039|592584952|FG001|Overall Study|Pregnancy|0|||
164061166|NCT04768881|592584953|FG000|Overall Study|Completed Study Follow-up|0|||
164061167|NCT04768881|592584954|FG001|Overall Study|Completed Study Follow-up|2|||
164061168|NCT04768881|592584953|FG000|Overall Study|Death|3|||
164061169|NCT04768881|592584954|FG001|Overall Study|Death|2|||
164061170|NCT04768881|592584953|FG000|Overall Study|Study Terminated by Sponsor|2|||
164061171|NCT04768881|592584954|FG001|Overall Study|Study Terminated by Sponsor|2|||
164061172|NCT04768881|592584953|FG000|Overall Study|Withdrawal by Subject|2|||
164102595|NCT00777023|592738795|FG000|Overall Study|Withdrawal by Subject|7|||
164102596|NCT00777023|592738796|FG001|Overall Study|Withdrawal by Subject|7|||
164102597|NCT00777023|592738797|FG002|Overall Study|Withdrawal by Subject|8|||
164102598|NCT00777023|592738795|FG000|Overall Study|Missing data|1|||
164102599|NCT00777023|592738796|FG001|Overall Study|Missing data|1|||
164102600|NCT00777023|592738797|FG002|Overall Study|Missing data|0|||
164102601|NCT00777023|592738795|FG000|Overall Study|Reasons not specified|4|||
164102602|NCT00777023|592738796|FG001|Overall Study|Reasons not specified|4|||
164102603|NCT00777023|592738797|FG002|Overall Study|Reasons not specified|2|||
164102604|NCT00777023|592738795|FG000|Overall Study|Last dose date unknown|3|||
164102605|NCT00777023|592738796|FG001|Overall Study|Last dose date unknown|3|||
164102606|NCT00777023|592738797|FG002|Overall Study|Last dose date unknown|1|||
164102607|NCT02472366|592738798|FG000|Overall Study|Lost to Follow-up|1|||
164102608|NCT02472366|592738799|FG001|Overall Study|Lost to Follow-up|0|||
164102609|NCT04274686|592738800|FG000|Overall Study|Physician Decision|1|||
164102610|NCT04274686|592738801|FG001|Overall Study|Physician Decision|0|||
164102611|NCT01273805|592738804|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
164102612|NCT01273805|592738805|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
164102613|NCT02647944|592738806|FG000|Overall Study|Withdrawal by Subject|0|||
164102614|NCT02647944|592738807|FG001|Overall Study|Withdrawal by Subject|3|||
164102615|NCT02647944|592738806|FG000|Overall Study|Adverse Event|2|||
164102616|NCT02647944|592738807|FG001|Overall Study|Adverse Event|0|||
164102617|NCT02576938|592738819|FG000|Overall Study|Adverse Event|5|||
164102618|NCT02576938|592738820|FG001|Overall Study|Adverse Event|3|||
164102619|NCT02576938|592738821|FG002|Overall Study|Adverse Event|6|||
164102620|NCT02576938|592738819|FG000|Overall Study|Protocol Violation|1|||
164102621|NCT02576938|592738820|FG001|Overall Study|Protocol Violation|1|||
164061173|NCT04768881|592584954|FG001|Overall Study|Withdrawal by Subject|0|||
164061174|NCT04768881|592584953|FG000|Overall Study|Other|2|||
164061175|NCT04768881|592584954|FG001|Overall Study|Other|0|||
164061176|NCT04236986|592584957|FG000|Overall Study|Withdrawal by Subject|3|||
164102622|NCT02576938|592738821|FG002|Overall Study|Protocol Violation|1|||
164102623|NCT02576938|592738819|FG000|Overall Study|Withdrawal by Subject|3|||
164102624|NCT02576938|592738820|FG001|Overall Study|Withdrawal by Subject|2|||
164061177|NCT04236986|592584958|FG001|Overall Study|Withdrawal by Subject|1|||
164061178|NCT01365182|592584961|FG000|Overall Study|Withdrawal by Subject|10|||
164061179|NCT01365182|592584962|FG001|Overall Study|Withdrawal by Subject|13|||
164102625|NCT02576938|592738821|FG002|Overall Study|Withdrawal by Subject|4|||
164102626|NCT02576938|592738819|FG000|Overall Study|Lack of Efficacy|9|||
164102627|NCT02576938|592738820|FG001|Overall Study|Lack of Efficacy|4|||
164061180|NCT01365182|592584963|FG002|Overall Study|Withdrawal by Subject|12|||
164061181|NCT00736840|592584964|FG000|Overall Study|Lost to Follow-up|13|||
164061182|NCT01728194|592584967|FG000|Overall Study|Lost to Follow-up|4|||
164061183|NCT01728194|592584968|FG001|Overall Study|Lost to Follow-up|3|||
164061184|NCT01728194|592584967|FG000|Overall Study|Physician Decision|4|||
164061185|NCT01728194|592584968|FG001|Overall Study|Physician Decision|0|||
164061186|NCT01728194|592584967|FG000|Overall Study|Withdrawal by Subject|7|||
164061187|NCT01728194|592584968|FG001|Overall Study|Withdrawal by Subject|3|||
164061188|NCT01728194|592584967|FG000|Overall Study|Perceived Medication Side Effects|4|||
164061189|NCT01728194|592584968|FG001|Overall Study|Perceived Medication Side Effects|0|||
164061190|NCT01728194|592584967|FG000|Overall Study|Family Member Request|1|||
164061191|NCT01728194|592584968|FG001|Overall Study|Family Member Request|0|||
164061192|NCT02309372|592584969|FG000|Overall Study|Lost to Follow-up|3|||
164061193|NCT02309372|592584970|FG001|Overall Study|Lost to Follow-up|2|||
164061194|NCT01475214|592584973|FG000|Overall Study|Lost to Follow-up|1|||
164061195|NCT01475214|592584974|FG001|Overall Study|Lost to Follow-up|0|||
164061196|NCT01475214|592584975|FG002|Overall Study|Lost to Follow-up|1|||
164061197|NCT01475214|592584973|FG000|Overall Study|Physician Decision|2|||
164061198|NCT01475214|592584974|FG001|Overall Study|Physician Decision|0|||
164061199|NCT01475214|592584975|FG002|Overall Study|Physician Decision|0|||
164061200|NCT01475214|592584973|FG000|Overall Study|Withdrawal by Subject|2|||
164061201|NCT01475214|592584974|FG001|Overall Study|Withdrawal by Subject|4|||
164061202|NCT01475214|592584975|FG002|Overall Study|Withdrawal by Subject|1|||
164061203|NCT00643851|592584976|FG000|Overall Study|Death|0|||
164061204|NCT00643851|592584977|FG001|Overall Study|Death|1|||
164061205|NCT00643851|592584978|FG002|Overall Study|Death|0|||
164061206|NCT00643851|592584976|FG000|Overall Study|Lack of Efficacy|0|||
164061207|NCT00643851|592584977|FG001|Overall Study|Lack of Efficacy|1|||
164061208|NCT00643851|592584978|FG002|Overall Study|Lack of Efficacy|0|||
164061209|NCT00643851|592584976|FG000|Overall Study|Adverse Event|2|||
164061210|NCT00643851|592584977|FG001|Overall Study|Adverse Event|6|||
164061211|NCT00643851|592584978|FG002|Overall Study|Adverse Event|6|||
164061212|NCT00643851|592584976|FG000|Overall Study|Lost to Follow-up|4|||
164061213|NCT00643851|592584977|FG001|Overall Study|Lost to Follow-up|6|||
164061214|NCT00643851|592584978|FG002|Overall Study|Lost to Follow-up|9|||
164061215|NCT00643851|592584976|FG000|Overall Study|Withdrawal by Subject|8|||
164061216|NCT00643851|592584977|FG001|Overall Study|Withdrawal by Subject|15|||
164061217|NCT00643851|592584978|FG002|Overall Study|Withdrawal by Subject|9|||
164061218|NCT00643851|592584976|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
164061219|NCT00643851|592584977|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
164061220|NCT00643851|592584978|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
164061221|NCT03289676|592584979|FG000|Overall Study|Withdrawal by Subject|2|||
164061222|NCT03289676|592584980|FG001|Overall Study|Withdrawal by Subject|0|||
164102628|NCT02576938|592738821|FG002|Overall Study|Lack of Efficacy|0|||
164102629|NCT02576938|592738819|FG000|Overall Study|Lost to Follow-up|2|||
164102630|NCT02576938|592738820|FG001|Overall Study|Lost to Follow-up|0|||
164102631|NCT02576938|592738821|FG002|Overall Study|Lost to Follow-up|1|||
164102632|NCT02576938|592738819|FG000|Overall Study|Physician Decision|0|||
164102633|NCT02576938|592738820|FG001|Overall Study|Physician Decision|1|||
164102634|NCT02576938|592738821|FG002|Overall Study|Physician Decision|0|||
164102635|NCT02576938|592738819|FG000|Overall Study|Met Exclusion Criteria|0|||
164102636|NCT02576938|592738820|FG001|Overall Study|Met Exclusion Criteria|1|||
164102637|NCT02576938|592738821|FG002|Overall Study|Met Exclusion Criteria|0|||
164102638|NCT00640562|592738822|FG000|Overall Study|Adverse Event|8|||
164102639|NCT00640562|592738823|FG001|Overall Study|Adverse Event|5|||
164102640|NCT00640562|592738822|FG000|Overall Study|Lack of Efficacy|1|||
164102641|NCT00640562|592738823|FG001|Overall Study|Lack of Efficacy|4|||
164102642|NCT00640562|592738822|FG000|Overall Study|Protocol Violation|2|||
164102643|NCT00640562|592738823|FG001|Overall Study|Protocol Violation|4|||
164102644|NCT00640562|592738822|FG000|Overall Study|Withdrawal by Subject|6|||
164102645|NCT00640562|592738823|FG001|Overall Study|Withdrawal by Subject|10|||
164102646|NCT00640562|592738822|FG000|Overall Study|Known risperidone intolerance|0|||
164061223|NCT03289676|592584979|FG000|Overall Study|Protocol Violation|2|||
164061224|NCT03289676|592584980|FG001|Overall Study|Protocol Violation|0|||
164061225|NCT03289676|592584979|FG000|Overall Study|Lost to Follow-up|0|||
164061226|NCT03289676|592584980|FG001|Overall Study|Lost to Follow-up|1|||
164061227|NCT01314261|592584983|FG000|Overall Study|Adverse Event|1|||
164102647|NCT00640562|592738823|FG001|Overall Study|Known risperidone intolerance|1|||
164102648|NCT00640562|592738822|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
164102649|NCT00640562|592738823|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
164102650|NCT00640562|592738822|FG000|Overall Study|Low study drug dose|0|||
164061228|NCT01314261|592584984|FG001|Overall Study|Adverse Event|0|||
164061229|NCT01314261|592584985|FG002|Overall Study|Adverse Event|0|||
164061230|NCT01314261|592584986|FG003|Overall Study|Adverse Event|0|||
164061231|NCT01314261|592584983|FG000|Overall Study|Withdrawal by Subject|0|||
164061232|NCT01314261|592584984|FG001|Overall Study|Withdrawal by Subject|3|||
164061233|NCT01314261|592584985|FG002|Overall Study|Withdrawal by Subject|1|||
164102651|NCT00640562|592738823|FG001|Overall Study|Low study drug dose|1|||
164061234|NCT01314261|592584986|FG003|Overall Study|Withdrawal by Subject|0|||
164061235|NCT01314261|592584983|FG000|Overall Study|Lost to Follow-up|1|||
164061236|NCT01314261|592584984|FG001|Overall Study|Lost to Follow-up|0|||
164061237|NCT01314261|592584985|FG002|Overall Study|Lost to Follow-up|2|||
164061238|NCT01314261|592584986|FG003|Overall Study|Lost to Follow-up|2|||
164061239|NCT01314261|592584983|FG000|Overall Study|Virologic Failure|0|||
164061240|NCT01314261|592584984|FG001|Overall Study|Virologic Failure|1|||
164061241|NCT01314261|592584985|FG002|Overall Study|Virologic Failure|0|||
164061242|NCT01314261|592584986|FG003|Overall Study|Virologic Failure|1|||
164061243|NCT01231620|592584987|FG000|Overall Study|Physician Decision|3|||
164061244|NCT01231620|592584988|FG001|Overall Study|Physician Decision|5|||
164061245|NCT01231620|592584989|FG002|Overall Study|Physician Decision|10|||
164061246|NCT01231620|592584987|FG000|Overall Study|Death|12|||
164061247|NCT01231620|592584988|FG001|Overall Study|Death|14|||
164061248|NCT01231620|592584989|FG002|Overall Study|Death|11|||
164061249|NCT01231620|592584987|FG000|Overall Study|Adverse Event|2|||
164061250|NCT01231620|592584988|FG001|Overall Study|Adverse Event|2|||
164061251|NCT01231620|592584989|FG002|Overall Study|Adverse Event|1|||
164061252|NCT01231620|592584987|FG000|Overall Study|Withdrawal by Subject|6|||
164061253|NCT01231620|592584988|FG001|Overall Study|Withdrawal by Subject|6|||
164061254|NCT01231620|592584989|FG002|Overall Study|Withdrawal by Subject|8|||
164061255|NCT01231620|592584987|FG000|Overall Study|Lost to Follow-up|3|||
164061256|NCT01231620|592584988|FG001|Overall Study|Lost to Follow-up|4|||
164061257|NCT01231620|592584989|FG002|Overall Study|Lost to Follow-up|9|||
164061258|NCT02576652|592584993|FG000|Overall Study|Withdrawal by Subject|2|||
164061259|NCT04806334|592584998|FG000|Overall Study|Withdrawal by Subject|1|||
164061260|NCT02811640|592584999|FG000|Overall Study|Technology malfunction|2|||
164061261|NCT03590613|592585010|FG000|Period 2, 4 Days|Physician Decision|0|||
164061262|NCT03590613|592585011|FG001|Period 2, 4 Days|Physician Decision|0|||
164061263|NCT03590613|592585012|FG002|Period 2, 4 Days|Physician Decision|0|||
164061264|NCT03590613|592585013|FG003|Period 2, 4 Days|Physician Decision|1|||
164061265|NCT00951912|592585014|FG000|Overall Study|Lack of Efficacy|1|||
164061266|NCT00951912|592585015|FG001|Overall Study|Lack of Efficacy|0|||
164061267|NCT00951912|592585016|FG002|Overall Study|Lack of Efficacy|0|||
164061268|NCT00951912|592585014|FG000|Overall Study|Adverse Event|0|||
164061269|NCT00951912|592585015|FG001|Overall Study|Adverse Event|1|||
164061270|NCT00951912|592585016|FG002|Overall Study|Adverse Event|1|||
164061271|NCT00951912|592585014|FG000|Overall Study|Lost to Follow-up|2|||
164061272|NCT00951912|592585015|FG001|Overall Study|Lost to Follow-up|2|||
164061273|NCT00951912|592585016|FG002|Overall Study|Lost to Follow-up|0|||
164061274|NCT00951912|592585014|FG000|Overall Study|Physician Decision|1|||
164061275|NCT00951912|592585015|FG001|Overall Study|Physician Decision|0|||
164061276|NCT00951912|592585016|FG002|Overall Study|Physician Decision|1|||
164061277|NCT00951912|592585014|FG000|Overall Study|Withdrawal by Subject|1|||
164061278|NCT00951912|592585015|FG001|Overall Study|Withdrawal by Subject|1|||
164061279|NCT00951912|592585016|FG002|Overall Study|Withdrawal by Subject|0|||
164061280|NCT00951912|592585014|FG000|Overall Study|Other:Depression|1|||
164061281|NCT00951912|592585015|FG001|Overall Study|Other:Depression|0|||
164061282|NCT00951912|592585016|FG002|Overall Study|Other:Depression|0|||
164061283|NCT00951912|592585014|FG000|Overall Study|Other: Colon cancer|1|||
164061284|NCT00951912|592585015|FG001|Overall Study|Other: Colon cancer|0|||
164061285|NCT00951912|592585016|FG002|Overall Study|Other: Colon cancer|0|||
164061286|NCT00951912|592585014|FG000|Overall Study|Other: Stroke|0|||
164061287|NCT00951912|592585015|FG001|Overall Study|Other: Stroke|1|||
164061288|NCT00951912|592585016|FG002|Overall Study|Other: Stroke|0|||
164061289|NCT01377194|592585017|FG000|Overall Study|Adverse Event|3|||
164061290|NCT01377194|592585018|FG001|Overall Study|Adverse Event|12|||
164061291|NCT01377194|592585019|FG002|Overall Study|Adverse Event|19|||
164061292|NCT01377194|592585017|FG000|Overall Study|Lack of Efficacy|3|||
164061293|NCT01377194|592585018|FG001|Overall Study|Lack of Efficacy|3|||
164061294|NCT01377194|592585019|FG002|Overall Study|Lack of Efficacy|3|||
164061295|NCT01377194|592585017|FG000|Overall Study|Protocol Violation|4|||
164061296|NCT01377194|592585018|FG001|Overall Study|Protocol Violation|10|||
164061297|NCT01377194|592585019|FG002|Overall Study|Protocol Violation|6|||
164061298|NCT01377194|592585017|FG000|Overall Study|Withdrawal by Subject|8|||
164061299|NCT01377194|592585018|FG001|Overall Study|Withdrawal by Subject|10|||
164061300|NCT01377194|592585019|FG002|Overall Study|Withdrawal by Subject|7|||
164061301|NCT01377194|592585017|FG000|Overall Study|Lost to Follow-up|14|||
164061302|NCT01377194|592585018|FG001|Overall Study|Lost to Follow-up|8|||
164061303|NCT01377194|592585019|FG002|Overall Study|Lost to Follow-up|11|||
164061304|NCT01207427|592585020|FG000|Double-blind Treatment Period|Adverse Event|0|||
164061305|NCT01207427|592585021|FG001|Double-blind Treatment Period|Adverse Event|1|||
164061306|NCT01207427|592585022|FG002|Double-blind Treatment Period|Adverse Event|0|||
164061307|NCT01207427|592585020|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164061308|NCT01207427|592585021|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164061309|NCT01207427|592585022|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164061310|NCT01207427|592585020|FG000|Double-blind Treatment Period|Protocol Violation|2|||
164061311|NCT01207427|592585021|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164061312|NCT01207427|592585022|FG002|Double-blind Treatment Period|Protocol Violation|1|||
164061313|NCT01207427|592585020|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164061314|NCT01207427|592585021|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164061315|NCT01207427|592585022|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164061316|NCT00422227|592585023|FG000|Overall Study|Adverse Event|3|||
164061317|NCT00422227|592585024|FG001|Overall Study|Adverse Event|8|||
164061318|NCT00422227|592585023|FG000|Overall Study|Lost to Follow-up|1|||
164061319|NCT00422227|592585024|FG001|Overall Study|Lost to Follow-up|3|||
164061320|NCT00422227|592585023|FG000|Overall Study|Withdrawal by Subject|0|||
164061321|NCT00422227|592585024|FG001|Overall Study|Withdrawal by Subject|4|||
164061322|NCT03323034|592586869|FG000|Overall Study|Lack of Efficacy|5|||
164061323|NCT03323034|592586870|FG001|Overall Study|Lack of Efficacy|5|||
164061324|NCT03323034|592586871|FG002|Overall Study|Lack of Efficacy|6|||
164061325|NCT03323034|592586872|FG003|Overall Study|Lack of Efficacy|5|||
164061326|NCT03323034|592586873|FG004|Overall Study|Lack of Efficacy|5|||
164061327|NCT03323034|592586869|FG000|Overall Study|Physician Decision|0|||
164061328|NCT03323034|592586870|FG001|Overall Study|Physician Decision|0|||
164061329|NCT03323034|592586871|FG002|Overall Study|Physician Decision|0|||
164061330|NCT03323034|592586872|FG003|Overall Study|Physician Decision|0|||
164061331|NCT03323034|592586873|FG004|Overall Study|Physician Decision|1|||
164061332|NCT03323034|592586869|FG000|Overall Study|Withdrawal by Subject|1|||
164061333|NCT03323034|592586870|FG001|Overall Study|Withdrawal by Subject|1|||
164061334|NCT03323034|592586871|FG002|Overall Study|Withdrawal by Subject|0|||
164061335|NCT03323034|592586872|FG003|Overall Study|Withdrawal by Subject|1|||
164061336|NCT03323034|592586873|FG004|Overall Study|Withdrawal by Subject|0|||
164061337|NCT02646566|592586875|FG000|Overall Study|Lost to Follow-up|5|||
164061338|NCT02646566|592586876|FG001|Overall Study|Lost to Follow-up|4|||
164061339|NCT02646566|592586877|FG002|Overall Study|Lost to Follow-up|5|||
164061340|NCT02646566|592586875|FG000|Overall Study|Treatment failure|1|||
164061341|NCT02646566|592586876|FG001|Overall Study|Treatment failure|0|||
164061342|NCT02646566|592586877|FG002|Overall Study|Treatment failure|0|||
164061343|NCT04341727|592586885|FG000|Overall Study|Withdrawal by Subject|0|||
164061344|NCT04341727|592586886|FG001|Overall Study|Withdrawal by Subject|0|||
164061345|NCT04341727|592586887|FG002|Overall Study|Withdrawal by Subject|1|||
164061346|NCT04341727|592586888|FG003|Overall Study|Withdrawal by Subject|0|||
164061347|NCT04341727|592586885|FG000|Overall Study|Lost to Follow-up|0|||
164061348|NCT04341727|592586886|FG001|Overall Study|Lost to Follow-up|0|||
164061349|NCT04341727|592586887|FG002|Overall Study|Lost to Follow-up|0|||
164061350|NCT04341727|592586888|FG003|Overall Study|Lost to Follow-up|1|||
164061351|NCT00503035|592586889|FG000|Overall Study|Lost to Follow-up|2|||
164061352|NCT00503035|592586889|FG000|Overall Study|Physician Decision|3|||
164061353|NCT00503035|592586889|FG000|Overall Study|Ineligible|15|||
164061354|NCT05028816|592586892|FG000|Overall Study|Lost to Follow-up|5|||
164061355|NCT05028816|592586893|FG001|Overall Study|Lost to Follow-up|3|||
164061356|NCT05028816|592586892|FG000|Overall Study|Withdrawal by Subject|4|||
164061357|NCT05028816|592586893|FG001|Overall Study|Withdrawal by Subject|1|||
164061358|NCT05028816|592586892|FG000|Overall Study|Physician Decision|1|||
164061359|NCT05028816|592586893|FG001|Overall Study|Physician Decision|0|||
164061360|NCT04576702|592586900|FG000|Overall Study|Death|1|||
164061361|NCT04576702|592586901|FG001|Overall Study|Death|0|||
164061362|NCT04576702|592586902|FG002|Overall Study|Death|0|||
164061363|NCT04576702|592586903|FG003|Overall Study|Death|0|||
164061364|NCT04576702|592586900|FG000|Overall Study|Withdrawal by Subject|0|||
164061365|NCT04576702|592586901|FG001|Overall Study|Withdrawal by Subject|2|||
164061366|NCT04576702|592586902|FG002|Overall Study|Withdrawal by Subject|1|||
164061367|NCT04576702|592586903|FG003|Overall Study|Withdrawal by Subject|0|||
164061368|NCT04576702|592586900|FG000|Overall Study|Lost to Follow-up|3|||
164061369|NCT04576702|592586901|FG001|Overall Study|Lost to Follow-up|3|||
164061370|NCT04576702|592586902|FG002|Overall Study|Lost to Follow-up|3|||
164061371|NCT04576702|592586903|FG003|Overall Study|Lost to Follow-up|4|||
164061372|NCT01151085|592586904|FG000|Overall Study|Lost to Follow-up|31|||
164061373|NCT01151085|592586904|FG000|Overall Study|Protocol Violation|25|||
164061374|NCT00003526|592586905|FG000|Overall Study|Not evaluable|6|||
164061375|NCT02059265|592586906|FG000|Overall Study|Ineligible|4|||
164061376|NCT02985996|592586910|FG000|Overall Study|Withdrawal by Subject|0|||
164061377|NCT02985996|592586911|FG001|Overall Study|Withdrawal by Subject|0|||
164061378|NCT02985996|592586912|FG002|Overall Study|Withdrawal by Subject|1|||
164061379|NCT02985996|592586913|FG003|Overall Study|Withdrawal by Subject|0|||
164061380|NCT02985996|592586914|FG004|Overall Study|Withdrawal by Subject|0|||
164061381|NCT02985996|592586910|FG000|Overall Study|Protocol Violation|0|||
164061382|NCT02985996|592586911|FG001|Overall Study|Protocol Violation|1|||
164061383|NCT02985996|592586912|FG002|Overall Study|Protocol Violation|0|||
164061384|NCT02985996|592586913|FG003|Overall Study|Protocol Violation|0|||
164061385|NCT02985996|592586914|FG004|Overall Study|Protocol Violation|0|||
164061386|NCT00401726|592586915|FG000|Overall Study|Adverse Event|34|||
164061387|NCT00401726|592586916|FG001|Overall Study|Adverse Event|45|||
164061388|NCT00401726|592586915|FG000|Overall Study|Death|0|||
164061389|NCT00401726|592586916|FG001|Overall Study|Death|3|||
164061390|NCT00401726|592586915|FG000|Overall Study|Sponsor Request|0|||
164061391|NCT00401726|592586916|FG001|Overall Study|Sponsor Request|1|||
164061392|NCT00401726|592586915|FG000|Overall Study|Physician Decision|3|||
164061393|NCT00401726|592586916|FG001|Overall Study|Physician Decision|6|||
164061394|NCT00401726|592586915|FG000|Overall Study|Lost to Follow-up|23|||
164061395|NCT00401726|592586916|FG001|Overall Study|Lost to Follow-up|20|||
164061396|NCT00401726|592586915|FG000|Overall Study|Protocol Violation|6|||
164061397|NCT00401726|592586916|FG001|Overall Study|Protocol Violation|3|||
164061398|NCT00401726|592586915|FG000|Overall Study|Withdrawal by Subject|18|||
164061399|NCT00401726|592586916|FG001|Overall Study|Withdrawal by Subject|24|||
164061400|NCT00401726|592586915|FG000|Overall Study|Lack of Efficacy|4|||
164061401|NCT00401726|592586916|FG001|Overall Study|Lack of Efficacy|6|||
164061402|NCT00401726|592586915|FG000|Overall Study|Protocol Deviation|9|||
164061403|NCT00401726|592586916|FG001|Overall Study|Protocol Deviation|4|||
164061404|NCT00814502|592586919|FG000|Overall Study|Adverse Event|1|||
164061405|NCT00814502|592586920|FG001|Overall Study|Adverse Event|0|||
164061406|NCT00814502|592586919|FG000|Overall Study|Withdrawal by Subject|0|||
164061407|NCT00814502|592586920|FG001|Overall Study|Withdrawal by Subject|2|||
164061408|NCT03735849|592586922|FG000|Overall Study|Lost to Follow-up|1|||
164061409|NCT03735849|592586923|FG001|Overall Study|Lost to Follow-up|0|||
164061410|NCT03735849|592586924|FG002|Overall Study|Lost to Follow-up|0|||
164061411|NCT03735849|592586922|FG000|Overall Study|Participant unable to adhere to visit|1|||
164061412|NCT03735849|592586923|FG001|Overall Study|Participant unable to adhere to visit|0|||
164061413|NCT03735849|592586924|FG002|Overall Study|Participant unable to adhere to visit|0|||
164061414|NCT03735849|592586922|FG000|Overall Study|Not Randomized|0|||
164061415|NCT03735849|592586923|FG001|Overall Study|Not Randomized|0|||
164061416|NCT03735849|592586924|FG002|Overall Study|Not Randomized|4|||
164061417|NCT01050998|592586927|FG000|Overall Study|Adverse Event|1|||
164061418|NCT01050998|592586928|FG001|Overall Study|Adverse Event|0|||
164061419|NCT01050998|592586929|FG002|Overall Study|Adverse Event|1|||
164061420|NCT01050998|592586930|FG003|Overall Study|Adverse Event|0|||
164061421|NCT01050998|592586931|FG004|Overall Study|Adverse Event|2|||
164061422|NCT01050998|592586927|FG000|Overall Study|Withdrawal by Subject|0|||
164061423|NCT01050998|592586928|FG001|Overall Study|Withdrawal by Subject|0|||
164061424|NCT01050998|592586929|FG002|Overall Study|Withdrawal by Subject|0|||
164061425|NCT01050998|592586930|FG003|Overall Study|Withdrawal by Subject|1|||
164061426|NCT01050998|592586931|FG004|Overall Study|Withdrawal by Subject|3|||
164061427|NCT01050998|592586927|FG000|Overall Study|Other|3|||
164061428|NCT01050998|592586928|FG001|Overall Study|Other|2|||
164061429|NCT01050998|592586929|FG002|Overall Study|Other|1|||
164061430|NCT01050998|592586930|FG003|Overall Study|Other|1|||
164061431|NCT01050998|592586931|FG004|Overall Study|Other|5|||
164061432|NCT01050998|592586927|FG000|Overall Study|Data integrity issues|0|||
164061433|NCT01050998|592586928|FG001|Overall Study|Data integrity issues|0|||
164061434|NCT01050998|592586929|FG002|Overall Study|Data integrity issues|1|||
164061435|NCT01050998|592586930|FG003|Overall Study|Data integrity issues|1|||
164061436|NCT01050998|592586931|FG004|Overall Study|Data integrity issues|4|||
164061437|NCT01012765|592586936|FG000|Treatment Period 1|Adverse Event|1|||
164061438|NCT01012765|592586937|FG001|Treatment Period 1|Adverse Event|0|||
164061439|NCT01012765|592586938|FG002|Treatment Period 1|Adverse Event|1|||
164061440|NCT01012765|592586939|FG003|Treatment Period 1|Adverse Event|0|||
164061441|NCT01012765|592586940|FG004|Treatment Period 1|Adverse Event|0|||
164061442|NCT01012765|592586941|FG005|Treatment Period 1|Adverse Event|0|||
164061443|NCT01012765|592586936|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164061444|NCT01012765|592586937|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164061445|NCT01012765|592586938|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164061446|NCT01012765|592586939|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164061447|NCT01012765|592586940|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164061448|NCT01012765|592586941|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164061449|NCT01012765|592586936|FG000|Treatment Period 1|Administrative problems|0|||
164061450|NCT01012765|592586937|FG001|Treatment Period 1|Administrative problems|0|||
164061451|NCT01012765|592586938|FG002|Treatment Period 1|Administrative problems|1|||
164061452|NCT01012765|592586939|FG003|Treatment Period 1|Administrative problems|1|||
164061453|NCT01012765|592586940|FG004|Treatment Period 1|Administrative problems|1|||
164061454|NCT01012765|592586941|FG005|Treatment Period 1|Administrative problems|0|||
164061455|NCT01012765|592586936|FG000|Treatment Period 1|Protocol Violation|0|||
164061456|NCT01012765|592586937|FG001|Treatment Period 1|Protocol Violation|0|||
164061457|NCT01012765|592586938|FG002|Treatment Period 1|Protocol Violation|0|||
164061458|NCT01012765|592586939|FG003|Treatment Period 1|Protocol Violation|2|||
164061459|NCT01012765|592586940|FG004|Treatment Period 1|Protocol Violation|1|||
164061460|NCT01012765|592586941|FG005|Treatment Period 1|Protocol Violation|0|||
164061461|NCT01012765|592586936|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164061462|NCT01012765|592586937|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164061463|NCT01012765|592586938|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164061464|NCT01012765|592586939|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164061465|NCT01012765|592586940|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
164061466|NCT01012765|592586941|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
164061467|NCT01012765|592586936|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164102652|NCT00640562|592738822|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
164102653|NCT00640562|592738823|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
164102654|NCT03098394|592738827|FG000|Overall Study|Pregnancy|0|||
164102655|NCT03098394|592738828|FG001|Overall Study|Pregnancy|1|||
164102656|NCT04408794|592738829|FG000|Overall Study|Adverse Event|43|||
164102657|NCT04408794|592738829|FG000|Overall Study|Infrequent study drug usage|43|||
164102658|NCT04408794|592738829|FG000|Overall Study|Lack of Efficacy|61|||
164102659|NCT04408794|592738829|FG000|Overall Study|Lost to Follow-up|33|||
164102660|NCT04408794|592738829|FG000|Overall Study|Non-compliance|6|||
164102661|NCT04408794|592738829|FG000|Overall Study|Physician Decision|1|||
164102662|NCT04408794|592738829|FG000|Overall Study|Pregnancy|6|||
164102663|NCT04408794|592738829|FG000|Overall Study|Protocol Deviation|9|||
164102664|NCT04408794|592738829|FG000|Overall Study|Sheehan-STS Result|1|||
164102665|NCT04408794|592738829|FG000|Overall Study|Withdrawal by Subject|57|||
164102666|NCT04408794|592738829|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
164102667|NCT04408794|592738829|FG000|Overall Study|Never Treated Migraine|5|||
164102668|NCT00571064|592738832|FG000|Overall Study|Adverse Event|13|||
164102669|NCT00571064|592738832|FG000|Overall Study|Protocol Violation|4|||
164102670|NCT00571064|592738832|FG000|Overall Study|Withdrawal by Subject|2|||
164102671|NCT00571064|592738832|FG000|Overall Study|Other|2|||
164102672|NCT00244764|592738833|FG000|Overall Study|Adverse Event|37|||
164102673|NCT00244764|592738833|FG000|Overall Study|Lost to Follow-up|23|||
164102674|NCT00244764|592738833|FG000|Overall Study|Withdrawal by Subject|12|||
164102675|NCT00244764|592738833|FG000|Overall Study|Disease Progression|13|||
164102676|NCT00244764|592738833|FG000|Overall Study|Protocol Violation|2|||
164102677|NCT00244764|592738833|FG000|Overall Study|Death|1|||
164102678|NCT00244764|592738833|FG000|Overall Study|Off Study Medication for >21 Days|1|||
164102679|NCT00244764|592738833|FG000|Overall Study|Declining Performance Status|1|||
164102680|NCT00244764|592738833|FG000|Overall Study|Participant was Hospitalized until Death|1|||
164102681|NCT00244764|592738833|FG000|Overall Study|Primary Investigator Discretion|2|||
164102682|NCT00244764|592738833|FG000|Overall Study|Sponsor Terminated Study|2|||
164102683|NCT00244764|592738833|FG000|Overall Study|Developed Secondary Malignancy|1|||
164102684|NCT01518972|592738836|FG000|Overall Study|Lost to Follow-up|2|||
164102685|NCT01518972|592738837|FG001|Overall Study|Lost to Follow-up|1|||
164102686|NCT01518972|592738836|FG000|Overall Study|Withdrawal by Subject|1|||
164102687|NCT01518972|592738837|FG001|Overall Study|Withdrawal by Subject|0|||
164102688|NCT01518972|592738836|FG000|Overall Study|Moved from area|1|||
164061468|NCT01012765|592586937|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164061469|NCT01012765|592586938|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164061470|NCT01012765|592586939|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164061471|NCT01012765|592586940|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164061472|NCT01012765|592586941|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164061473|NCT01012765|592586936|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
164061474|NCT01012765|592586937|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
164061475|NCT01012765|592586938|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
164061476|NCT01012765|592586939|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
164061477|NCT01012765|592586940|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
164061478|NCT01012765|592586941|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
164061479|NCT01012765|592586936|FG000|Treatment Period 2|Adverse Event|0|||
164061480|NCT01012765|592586937|FG001|Treatment Period 2|Adverse Event|1|||
164061481|NCT01012765|592586938|FG002|Treatment Period 2|Adverse Event|1|||
164061482|NCT01012765|592586939|FG003|Treatment Period 2|Adverse Event|0|||
164061483|NCT01012765|592586940|FG004|Treatment Period 2|Adverse Event|0|||
164102689|NCT01518972|592738837|FG001|Overall Study|Moved from area|0|||
164102690|NCT01518972|592738836|FG000|Overall Study|Transportation problems|1|||
164102691|NCT01518972|592738837|FG001|Overall Study|Transportation problems|0|||
164061484|NCT01012765|592586941|FG005|Treatment Period 2|Adverse Event|0|||
164102692|NCT01518972|592738836|FG000|Overall Study|Exclusionary medical condition|1|||
164102693|NCT01518972|592738837|FG001|Overall Study|Exclusionary medical condition|0|||
164102694|NCT01518972|592738836|FG000|Overall Study|Missed safety visits|0|||
164102695|NCT01518972|592738837|FG001|Overall Study|Missed safety visits|1|||
164061485|NCT01012765|592586936|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164102696|NCT01518972|592738836|FG000|Overall Study|Exclusionary medication|0|||
164102697|NCT01518972|592738837|FG001|Overall Study|Exclusionary medication|1|||
164061486|NCT01012765|592586937|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
164061487|NCT01012765|592586938|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
164061488|NCT01012765|592586939|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164061489|NCT01012765|592586940|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164061490|NCT01012765|592586941|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
164061491|NCT04668157|592586949|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
164102698|NCT01518972|592738836|FG000|Overall Study|Declined medication starting on day 12|0|||
164102699|NCT01518972|592738837|FG001|Overall Study|Declined medication starting on day 12|1|||
164102700|NCT02159950|592738845|FG000|Overall Study|Adverse Event|0|||
164102701|NCT02159950|592738846|FG001|Overall Study|Adverse Event|1|||
164102702|NCT02159950|592738845|FG000|Overall Study|Progression|0|||
164061492|NCT04668157|592586950|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
164061493|NCT04668157|592586949|FG000|Treatment Period (52 Weeks)|Other|0|||
164061494|NCT04668157|592586950|FG001|Treatment Period (52 Weeks)|Other|2|||
164061495|NCT02283411|592586951|FG000|Overall Study|Withdrawal by Subject|3|||
164061496|NCT02283411|592586951|FG000|Overall Study|Screen Failed|28|||
164061497|NCT05437211|592586952|FG000|Overall Study|Patient's decision|1|||
164061498|NCT05437211|592586953|FG001|Overall Study|Patient's decision|1|||
164061499|NCT03282123|592586955|FG000|Overall Study|Withdrawal by Subject|5|||
164061500|NCT00796367|592586959|FG000|Overall Study|Adverse Event|6|||
164061501|NCT00796367|592586960|FG001|Overall Study|Adverse Event|4|||
164061502|NCT00796367|592586961|FG002|Overall Study|Adverse Event|7|||
164061503|NCT00796367|592586959|FG000|Overall Study|Lost to Follow-up|5|||
164061504|NCT00796367|592586960|FG001|Overall Study|Lost to Follow-up|4|||
164061505|NCT00796367|592586961|FG002|Overall Study|Lost to Follow-up|21|||
164061506|NCT00796367|592586959|FG000|Overall Study|Withdrawal by Subject|9|||
164061507|NCT00796367|592586960|FG001|Overall Study|Withdrawal by Subject|11|||
164061508|NCT00796367|592586961|FG002|Overall Study|Withdrawal by Subject|12|||
164061509|NCT00796367|592586959|FG000|Overall Study|Lack of Efficacy|2|||
164061510|NCT00796367|592586960|FG001|Overall Study|Lack of Efficacy|1|||
164061511|NCT00796367|592586961|FG002|Overall Study|Lack of Efficacy|0|||
164061512|NCT00796367|592586959|FG000|Overall Study|non compliance|3|||
164061513|NCT00796367|592586960|FG001|Overall Study|non compliance|1|||
164061514|NCT00796367|592586961|FG002|Overall Study|non compliance|1|||
164061515|NCT00796367|592586959|FG000|Overall Study|Pregnancy|1|||
164061516|NCT00796367|592586960|FG001|Overall Study|Pregnancy|0|||
164061517|NCT00796367|592586961|FG002|Overall Study|Pregnancy|1|||
164061518|NCT00796367|592586959|FG000|Overall Study|Requirement for restricted medication|2|||
164061519|NCT00796367|592586960|FG001|Overall Study|Requirement for restricted medication|0|||
164061520|NCT00796367|592586961|FG002|Overall Study|Requirement for restricted medication|2|||
164061521|NCT00796367|592586959|FG000|Overall Study|other|2|||
164061522|NCT00796367|592586960|FG001|Overall Study|other|4|||
164061523|NCT00796367|592586961|FG002|Overall Study|other|3|||
164061524|NCT02370173|592586964|FG000|Overall Study|Protocol Violation|1|||
164061525|NCT02370173|592586965|FG001|Overall Study|Protocol Violation|1|||
164061526|NCT02370173|592586964|FG000|Overall Study|Withdrawal by Subject|2|||
164061527|NCT02370173|592586965|FG001|Overall Study|Withdrawal by Subject|2|||
164061528|NCT00307736|592586970|FG000|Overall Study|Adverse Event|0|||
164061529|NCT00307736|592586971|FG001|Overall Study|Adverse Event|0|||
164061530|NCT00307736|592586972|FG002|Overall Study|Adverse Event|1|||
164061531|NCT00307736|592586973|FG003|Overall Study|Adverse Event|3|||
164061532|NCT00307736|592586970|FG000|Overall Study|Withdrawal by Subject|0|||
164061533|NCT00307736|592586971|FG001|Overall Study|Withdrawal by Subject|0|||
164061534|NCT00307736|592586972|FG002|Overall Study|Withdrawal by Subject|2|||
164061535|NCT00307736|592586973|FG003|Overall Study|Withdrawal by Subject|0|||
164061536|NCT04604015|592586978|FG000|Overall Study|Incomplete Data Collection|33|||
164061537|NCT02129192|592586981|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
164061538|NCT02129192|592586982|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
164061539|NCT04557189|592586983|FG000|Overall Study|Adverse Event|0|||
164061540|NCT04557189|592586984|FG001|Overall Study|Adverse Event|1|||
164061541|NCT04557189|592586983|FG000|Overall Study|Lost to Follow-up|1|||
164061542|NCT04557189|592586984|FG001|Overall Study|Lost to Follow-up|1|||
164061543|NCT04557189|592586983|FG000|Overall Study|Withdrawal by Subject|2|||
164061544|NCT04557189|592586984|FG001|Overall Study|Withdrawal by Subject|1|||
164061545|NCT04557189|592586983|FG000|Overall Study|Reason not Specified|3|||
164061546|NCT04557189|592586984|FG001|Overall Study|Reason not Specified|6|||
164061547|NCT03575975|592586992|FG000|Overall Study|Lost to Follow-up|1|||
164061548|NCT03575975|592586993|FG001|Overall Study|Lost to Follow-up|0|||
164061549|NCT03575975|592586994|FG002|Overall Study|Lost to Follow-up|0|||
164061550|NCT04369742|592586995|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
164061551|NCT04369742|592586996|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
164061552|NCT04369742|592586995|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
164061553|NCT04369742|592586996|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
164061554|NCT01636076|592586997|FG000|Overall Study|Terminated by sponsor|1|||
164061555|NCT01636076|592586998|FG001|Overall Study|Terminated by sponsor|1|||
164061556|NCT01636076|592586997|FG000|Overall Study|Lack of Efficacy|0|||
164061557|NCT01636076|592586998|FG001|Overall Study|Lack of Efficacy|1|||
164061558|NCT01636076|592586997|FG000|Overall Study|Lost to Follow-up|1|||
164061559|NCT01636076|592586998|FG001|Overall Study|Lost to Follow-up|0|||
164061560|NCT01636076|592586997|FG000|Overall Study|Physician Decision|1|||
164061561|NCT01636076|592586998|FG001|Overall Study|Physician Decision|1|||
164061562|NCT01636076|592586997|FG000|Overall Study|Non-compliance with study treatment|1|||
164061563|NCT01636076|592586998|FG001|Overall Study|Non-compliance with study treatment|1|||
164061564|NCT01636076|592586997|FG000|Overall Study|Adverse Event|6|||
164061565|NCT01636076|592586998|FG001|Overall Study|Adverse Event|11|||
164061566|NCT01636076|592586997|FG000|Overall Study|Withdrawal by Subject|7|||
164061567|NCT01636076|592586998|FG001|Overall Study|Withdrawal by Subject|10|||
164061568|NCT01130831|592586999|FG000|Overall Study|Withdrawal by Subject|7|||
164061569|NCT01130831|592586999|FG000|Overall Study|Death|4|||
164061570|NCT01130831|592586999|FG000|Overall Study|Information was missing|3|||
164061571|NCT01159665|592587000|FG000|Overall Study|Withdrawal by Subject|0|||
164061572|NCT01159665|592587001|FG001|Overall Study|Withdrawal by Subject|1|||
164061573|NCT01159665|592587002|FG002|Overall Study|Withdrawal by Subject|0|||
164061574|NCT01159665|592587003|FG003|Overall Study|Withdrawal by Subject|0|||
164061575|NCT01159665|592587004|FG004|Overall Study|Withdrawal by Subject|0|||
164061576|NCT01159665|592587005|FG005|Overall Study|Withdrawal by Subject|0|||
164061577|NCT02441517|592587006|FG000|Overall Study|Lost to Follow-up|1|||
164061578|NCT02441517|592587006|FG000|Overall Study|Withdrawal by Subject|2|||
164061579|NCT02441517|592587006|FG000|Overall Study|Study Terminated by Sponsor|1|||
164061580|NCT00129220|592587007|FG000|Study Period II|Adverse Event|9|||
164061581|NCT00129220|592587008|FG001|Study Period II|Adverse Event|5|||
164061582|NCT00129220|592587009|FG002|Study Period II|Adverse Event|7|||
164061583|NCT00129220|592587007|FG000|Study Period II|Lack of Efficacy|15|||
164061584|NCT00129220|592587008|FG001|Study Period II|Lack of Efficacy|1|||
164061585|NCT00129220|592587009|FG002|Study Period II|Lack of Efficacy|28|||
164061586|NCT00129220|592587007|FG000|Study Period II|Entry Criteria Not Met|2|||
164061587|NCT00129220|592587008|FG001|Study Period II|Entry Criteria Not Met|0|||
164061588|NCT00129220|592587009|FG002|Study Period II|Entry Criteria Not Met|2|||
164061589|NCT00129220|592587007|FG000|Study Period II|Protocol Violation|4|||
164061590|NCT00129220|592587008|FG001|Study Period II|Protocol Violation|2|||
164061591|NCT00129220|592587009|FG002|Study Period II|Protocol Violation|1|||
164061592|NCT00129220|592587007|FG000|Study Period II|Physician Decision|0|||
164061593|NCT00129220|592587008|FG001|Study Period II|Physician Decision|1|||
164061594|NCT00129220|592587009|FG002|Study Period II|Physician Decision|0|||
164061595|NCT00129220|592587007|FG000|Study Period II|Withdrawal by Subject|1|||
164061596|NCT00129220|592587008|FG001|Study Period II|Withdrawal by Subject|3|||
164061597|NCT00129220|592587009|FG002|Study Period II|Withdrawal by Subject|4|||
164061598|NCT00129220|592587007|FG000|Study Period II|Reason Not Specified|2|||
164061599|NCT00129220|592587008|FG001|Study Period II|Reason Not Specified|0|||
164061600|NCT00129220|592587009|FG002|Study Period II|Reason Not Specified|5|||
164061601|NCT00129220|592587007|FG000|Study Period III|Adverse Event|1|||
164061602|NCT00129220|592587008|FG001|Study Period III|Adverse Event|0|||
164061603|NCT00129220|592587009|FG002|Study Period III|Adverse Event|3|||
164061604|NCT00129220|592587007|FG000|Study Period III|Protocol Violation|1|||
164061605|NCT00129220|592587008|FG001|Study Period III|Protocol Violation|1|||
164061606|NCT00129220|592587009|FG002|Study Period III|Protocol Violation|2|||
164061607|NCT00129220|592587007|FG000|Study Period III|Withdrawal by Subject|1|||
164061608|NCT00129220|592587008|FG001|Study Period III|Withdrawal by Subject|0|||
164061609|NCT00129220|592587009|FG002|Study Period III|Withdrawal by Subject|3|||
164061610|NCT00129220|592587007|FG000|Study Period III|Sponsor Decision|1|||
164061611|NCT00129220|592587008|FG001|Study Period III|Sponsor Decision|0|||
164061612|NCT00129220|592587009|FG002|Study Period III|Sponsor Decision|0|||
164061613|NCT00129220|592587007|FG000|Study Period III|Reason Not Specified|9|||
164061614|NCT00129220|592587008|FG001|Study Period III|Reason Not Specified|0|||
164061615|NCT00129220|592587009|FG002|Study Period III|Reason Not Specified|2|||
164061616|NCT01883362|592587012|FG000|Treatment|Adverse Event|1|||
164061617|NCT01883362|592587013|FG001|Treatment|Adverse Event|8|||
164061618|NCT01883362|592587012|FG000|Treatment|Withdrawal by Subject|6|||
164061619|NCT01883362|592587013|FG001|Treatment|Withdrawal by Subject|2|||
164061620|NCT01883362|592587012|FG000|Treatment|Administrative problems|4|||
164061621|NCT01883362|592587013|FG001|Treatment|Administrative problems|1|||
164061622|NCT01883362|592587012|FG000|Treatment|Relapse|4|||
164061623|NCT01883362|592587013|FG001|Treatment|Relapse|2|||
164061624|NCT01883362|592587012|FG000|Treatment|Randomized, not treated|1|||
164061625|NCT01883362|592587013|FG001|Treatment|Randomized, not treated|1|||
164061626|NCT01883362|592587012|FG000|Post Treatment Follow-up|Protocol Violation|0|||
164061627|NCT01883362|592587013|FG001|Post Treatment Follow-up|Protocol Violation|1|||
164061628|NCT01883362|592587012|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
164061629|NCT01883362|592587013|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
164061630|NCT01883362|592587012|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
164061631|NCT01883362|592587013|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
164061632|NCT01883362|592587012|FG000|Post Treatment Follow-up|Administrative problems|2|||
164061633|NCT01883362|592587013|FG001|Post Treatment Follow-up|Administrative problems|0|||
164061634|NCT01883362|592587012|FG000|Post Treatment Follow-up|Death|8|||
164061635|NCT01883362|592587013|FG001|Post Treatment Follow-up|Death|4|||
164061636|NCT01883362|592587012|FG000|Post Treatment Follow-up|Relapse|1|||
164061637|NCT01883362|592587013|FG001|Post Treatment Follow-up|Relapse|2|||
164061638|NCT01383317|592587014|FG000|Overall Study|Lost to Follow-up|2|||
164061639|NCT01383317|592587015|FG001|Overall Study|Lost to Follow-up|1|||
164061640|NCT01383317|592587014|FG000|Overall Study|Death|1|||
164061641|NCT01383317|592587015|FG001|Overall Study|Death|0|||
164061642|NCT01383317|592587014|FG000|Overall Study|Adverse Event|0|||
164061643|NCT01383317|592587015|FG001|Overall Study|Adverse Event|1|||
164061644|NCT02173158|592587016|FG000|Efficacy Phase|Adverse Event|1|||
164061645|NCT01230489|592587017|FG000|Overall Study|Death|2|||
164102703|NCT02159950|592738846|FG001|Overall Study|Progression|1|||
164061646|NCT01230489|592587017|FG000|Overall Study|Adverse Event|2|||
164061647|NCT01230489|592587017|FG000|Overall Study|Treatment modality changed|1|||
164061648|NCT00686894|592587018|FG000|Overall Study|Relapse|2|||
164061649|NCT00686894|592587018|FG000|Overall Study|Protocol Violation|4|||
164061650|NCT00967343|592587019|FG000|Overall Study|Study termination by sponsor|12|||
164061651|NCT00967343|592587019|FG000|Overall Study|Death|24|||
164061652|NCT00967343|592587019|FG000|Overall Study|Relapse|1|||
164061653|NCT00967343|592587019|FG000|Overall Study|Lost to Follow-up|1|||
164061654|NCT00869362|592588596|FG000|Overall Study|Death|0|||
164061655|NCT00869362|592588597|FG001|Overall Study|Death|2|||
164061656|NCT00869362|592588596|FG000|Overall Study|Lost to Follow-up|1|||
164061657|NCT00869362|592588597|FG001|Overall Study|Lost to Follow-up|3|||
164061658|NCT04887922|592588607|FG000|1st Randomization|Decided not to have surgery|0|||
164061659|NCT04887922|592588608|FG001|1st Randomization|Decided not to have surgery|1|||
164061660|NCT04887922|592588609|FG002|1st Randomization|Decided not to have surgery|0|||
164061661|NCT04887922|592588610|FG003|1st Randomization|Decided not to have surgery|0|||
164061662|NCT04887922|592588611|FG004|1st Randomization|Decided not to have surgery|0|||
164061663|NCT00953017|592588612|FG000|Overall Study|DId not show up for colonoscopy|4|||
164061664|NCT00953017|592588613|FG001|Overall Study|DId not show up for colonoscopy|4|||
164061665|NCT00953017|592588614|FG002|Overall Study|DId not show up for colonoscopy|5|||
164061666|NCT00953017|592588615|FG003|Overall Study|DId not show up for colonoscopy|4|||
164061667|NCT00953017|592588612|FG000|Overall Study|Incomplete data|1|||
164061668|NCT00953017|592588613|FG001|Overall Study|Incomplete data|1|||
164061669|NCT00953017|592588614|FG002|Overall Study|Incomplete data|0|||
164061670|NCT00953017|592588615|FG003|Overall Study|Incomplete data|0|||
164061671|NCT00953017|592588612|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
164061672|NCT00953017|592588613|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
164061673|NCT00953017|592588614|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
164061674|NCT00953017|592588615|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
164061675|NCT00953017|592588612|FG000|Overall Study|Brown stool prior to procedure|0|||
164061676|NCT00953017|592588613|FG001|Overall Study|Brown stool prior to procedure|0|||
164061677|NCT00953017|592588614|FG002|Overall Study|Brown stool prior to procedure|1|||
164061678|NCT00953017|592588615|FG003|Overall Study|Brown stool prior to procedure|0|||
164061679|NCT01548573|592588618|FG000|Overall Study|Death|3|||
164061680|NCT01548573|592588618|FG000|Overall Study|Withdrawal by Subject|2|||
164061681|NCT01366846|592588619|FG000|Overall Study|Withdrawal by Subject|2|||
164061682|NCT01366846|592588620|FG001|Overall Study|Withdrawal by Subject|0|||
164061683|NCT01366846|592588621|FG002|Overall Study|Withdrawal by Subject|0|||
164061684|NCT01366846|592588622|FG003|Overall Study|Withdrawal by Subject|0|||
164061685|NCT01366846|592588619|FG000|Overall Study|Communication Difficulties|1|||
164061686|NCT01366846|592588620|FG001|Overall Study|Communication Difficulties|4|||
164061687|NCT01366846|592588621|FG002|Overall Study|Communication Difficulties|0|||
164061688|NCT01366846|592588622|FG003|Overall Study|Communication Difficulties|1|||
164061689|NCT01366846|592588619|FG000|Overall Study|Scheduling Conflicts|0|||
164061690|NCT01366846|592588620|FG001|Overall Study|Scheduling Conflicts|0|||
164061691|NCT01366846|592588621|FG002|Overall Study|Scheduling Conflicts|1|||
164061692|NCT01366846|592588622|FG003|Overall Study|Scheduling Conflicts|0|||
164061693|NCT00290511|592588623|FG000|Overall Study|Adverse Event|1|||
164061694|NCT00290511|592588623|FG000|Overall Study|Death|1|||
164061695|NCT00290511|592588623|FG000|Overall Study|Physician Decision|1|||
164061696|NCT00290511|592588623|FG000|Overall Study|Withdrawal by Subject|1|||
164061697|NCT00447265|592588626|FG000|Overall Study|Physician Decision|1|||
164061698|NCT00447265|592588627|FG001|Overall Study|Physician Decision|0|||
164061699|NCT04311411|592588628|FG000|Overall Study|Adverse Event|2|||
164061700|NCT04311411|592588629|FG001|Overall Study|Adverse Event|3|||
164061701|NCT04311411|592588630|FG002|Overall Study|Adverse Event|2|||
164061702|NCT04311411|592588628|FG000|Overall Study|Withdrawal by Subject|3|||
164061703|NCT04311411|592588629|FG001|Overall Study|Withdrawal by Subject|3|||
164061704|NCT04311411|592588630|FG002|Overall Study|Withdrawal by Subject|0|||
164061705|NCT01976663|592588634|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
164061706|NCT01976663|592588634|FG000|Overall Study|Personal Reasons|6|||
164061707|NCT01976663|592588634|FG000|Overall Study|Withdrawal by Subject|4|||
164061708|NCT01976663|592588634|FG000|Overall Study|Screen Failure|3|||
164061709|NCT01976663|592588634|FG000|Overall Study|Adverse Event|2|||
164061710|NCT01976663|592588634|FG000|Overall Study|Lost to Follow-up|3|||
164061711|NCT04780776|592588638|FG000|Titration Week 1-5|Lost to Follow-up|2|||
164061712|NCT04780776|592588639|FG001|Titration Week 1-5|Lost to Follow-up|8|||
164061713|NCT04780776|592588638|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
164061714|NCT04780776|592588639|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
164061715|NCT04780776|592588638|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
164061716|NCT04780776|592588639|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
164061717|NCT03113760|592588641|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
164061718|NCT03113760|592588642|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
164061719|NCT03113760|592588643|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
164061720|NCT03113760|592588644|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
164061721|NCT03113760|592588641|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
164061722|NCT03113760|592588642|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
164061723|NCT03113760|592588643|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
164061724|NCT03113760|592588644|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
164061725|NCT03113760|592588641|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
164061726|NCT03113760|592588642|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
164061727|NCT03113760|592588643|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
164061728|NCT03113760|592588644|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
164061729|NCT00465101|592588645|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
164061730|NCT00465101|592588645|FG000|Overall Study|Change in health precluded follow up|4|||
164061731|NCT00465101|592588645|FG000|Overall Study|Did not meet study criteria|4|||
164061732|NCT00465101|592588645|FG000|Overall Study|Lost to Follow-up|5|||
164061733|NCT00465101|592588645|FG000|Overall Study|Other|6|||
164061734|NCT00465101|592588645|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
164061735|NCT00465101|592588645|FG000|Overall Study|Patient postponed procedure|1|||
164061736|NCT00465101|592588645|FG000|Overall Study|Site closed due to IRB expiration|1|||
164061737|NCT00465101|592588645|FG000|Overall Study|Unable to obtain IRB approval|1|||
164061738|NCT00465101|592588645|FG000|Overall Study|Death|3|||
164061739|NCT00465101|592588645|FG000|Overall Study|Withdrawal by Subject|25|||
164061740|NCT00465101|592588645|FG000|Overall Study|Physician Decision|1|||
164061741|NCT00465101|592588645|FG000|Overall Study|Withdrew consent prior to procedure|3|||
164061742|NCT00998166|592588646|FG000|Overall Study|Early Study Termination|8|||
164061743|NCT00933543|592588648|FG000|Overall Study|Adverse Event|2|||
164061744|NCT00933543|592588649|FG001|Overall Study|Adverse Event|1|||
164061745|NCT00933543|592588648|FG000|Overall Study|Lost to Follow-up|0|||
164061746|NCT00933543|592588649|FG001|Overall Study|Lost to Follow-up|1|||
164061747|NCT00933543|592588648|FG000|Overall Study|Withdrawal by Subject|0|||
164061748|NCT00933543|592588649|FG001|Overall Study|Withdrawal by Subject|1|||
164061749|NCT00933543|592588648|FG000|Overall Study|Lack of Efficacy|0|||
164061750|NCT00933543|592588649|FG001|Overall Study|Lack of Efficacy|3|||
164061751|NCT00933543|592588648|FG000|Overall Study|Other|1|||
164061752|NCT00933543|592588649|FG001|Overall Study|Other|1|||
164061753|NCT04988035|592588655|FG000|Overall Study|Death|19|||
164061754|NCT04988035|592588656|FG001|Overall Study|Death|13|||
164061755|NCT04988035|592588655|FG000|Overall Study|Lost to Follow-up|12|||
164061756|NCT04988035|592588656|FG001|Overall Study|Lost to Follow-up|6|||
164061757|NCT04988035|592588655|FG000|Overall Study|Protocol Violation|0|||
164061758|NCT04988035|592588656|FG001|Overall Study|Protocol Violation|1|||
164061759|NCT04988035|592588655|FG000|Overall Study|Withdrawal by Subject|2|||
164061760|NCT04988035|592588656|FG001|Overall Study|Withdrawal by Subject|4|||
164061761|NCT04988035|592588655|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
164061762|NCT04988035|592588656|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
164061763|NCT03532048|592588657|FG000|Overall Study|Lost to Follow-up|12|||
164061764|NCT03532048|592588658|FG001|Overall Study|Lost to Follow-up|17|||
164061765|NCT03532048|592588657|FG000|Overall Study|Withdrawal by Subject|7|||
164061766|NCT03532048|592588658|FG001|Overall Study|Withdrawal by Subject|0|||
164061767|NCT04366258|592588659|FG000|Baseline Assessments|Screen Failure|21|||
164061768|NCT04366258|592588659|FG000|Baseline Assessments|Early Termination|3|||
164061769|NCT00308555|592588660|FG000|Overall Study|Withdrawal by Subject|1|||
164061770|NCT00308555|592588661|FG001|Overall Study|Withdrawal by Subject|0|||
164061771|NCT00308555|592588660|FG000|Overall Study|Physician Decision|2|||
164061772|NCT00308555|592588661|FG001|Overall Study|Physician Decision|0|||
164061773|NCT04113746|592588666|FG000|Overall Study|Lost to Follow-up|4|||
164061774|NCT04113746|592588667|FG001|Overall Study|Lost to Follow-up|4|||
164061775|NCT04246593|592588669|FG000|Overall Study|Withdrawal by Subject|14|||
164061776|NCT04246593|592588670|FG001|Overall Study|Withdrawal by Subject|13|||
164061777|NCT04246593|592588669|FG000|Overall Study|Lost to Follow-up|124|||
164061778|NCT04246593|592588670|FG001|Overall Study|Lost to Follow-up|71|||
164061779|NCT04246593|592588669|FG000|Overall Study|Moved out of area/became ineligible|3|||
164061780|NCT04246593|592588670|FG001|Overall Study|Moved out of area/became ineligible|1|||
164061781|NCT04246593|592588669|FG000|Overall Study|Reason unknown|4|||
164061782|NCT04246593|592588670|FG001|Overall Study|Reason unknown|2|||
164061783|NCT00429026|592588671|FG000|Overall Study|Inevaluable for response.|40|||
164061784|NCT00499694|592588676|FG000|Overall Study|Patient never received treatment.|1|||
164061785|NCT03958045|592588677|FG000|Overall Study|Withdrawal by Subject|1|||
164061786|NCT00674440|592588682|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
164061787|NCT00674440|592588682|FG000|Overall Study|did not have surgery, so unevaluable|7|||
164061788|NCT00674440|592588682|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
164061789|NCT01463631|592588683|FG000|Overall Study|Withdrawal by Subject|0|||
164061790|NCT01463631|592588684|FG001|Overall Study|Withdrawal by Subject|0|||
164061791|NCT01463631|592588685|FG002|Overall Study|Withdrawal by Subject|0|||
164061792|NCT01463631|592588686|FG003|Overall Study|Withdrawal by Subject|1|||
164061793|NCT01463631|592588683|FG000|Overall Study|Death|0|||
164061794|NCT01463631|592588684|FG001|Overall Study|Death|0|||
164061795|NCT01463631|592588685|FG002|Overall Study|Death|1|||
164061796|NCT01463631|592588686|FG003|Overall Study|Death|0|||
164061797|NCT01463631|592588683|FG000|Overall Study|Progressive Disease|0|||
164061798|NCT01463631|592588684|FG001|Overall Study|Progressive Disease|0|||
164061799|NCT01463631|592588685|FG002|Overall Study|Progressive Disease|0|||
164061800|NCT01463631|592588686|FG003|Overall Study|Progressive Disease|5|||
164061801|NCT04409262|592588695|FG000|Overall Study|Adverse Event|0|||
164061802|NCT04409262|592588696|FG001|Overall Study|Adverse Event|2|||
164061803|NCT04409262|592588695|FG000|Overall Study|Death|55|||
164061804|NCT04409262|592588696|FG001|Overall Study|Death|97|||
164061805|NCT04409262|592588695|FG000|Overall Study|Lost to Follow-up|12|||
164061806|NCT04409262|592588696|FG001|Overall Study|Lost to Follow-up|23|||
164061807|NCT04409262|592588695|FG000|Overall Study|Lack of Staff|0|||
164061808|NCT04409262|592588696|FG001|Overall Study|Lack of Staff|1|||
164061809|NCT04409262|592588695|FG000|Overall Study|Protocol Violation|3|||
164061810|NCT04409262|592588696|FG001|Overall Study|Protocol Violation|1|||
164061811|NCT04409262|592588695|FG000|Overall Study|Withdrawal by Subject|5|||
164061812|NCT04409262|592588696|FG001|Overall Study|Withdrawal by Subject|10|||
164061813|NCT00948896|592588699|FG000|Randomization to 24 Months of Age|Death|1|||
164061814|NCT00948896|592588700|FG001|Randomization to 24 Months of Age|Death|0|||
164061815|NCT00948896|592588701|FG002|Randomization to 24 Months of Age|Death|0|||
164061816|NCT00948896|592588702|FG003|Randomization to 24 Months of Age|Death|0|||
164061817|NCT00948896|592588703|FG004|Randomization to 24 Months of Age|Death|2|||
164061818|NCT00948896|592588704|FG005|Randomization to 24 Months of Age|Death|1|||
164061819|NCT00948896|592588705|FG006|Randomization to 24 Months of Age|Death|2|||
164061820|NCT00948896|592588706|FG007|Randomization to 24 Months of Age|Death|1|||
164061821|NCT00948896|592588699|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
164061822|NCT00948896|592588700|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
164061823|NCT00948896|592588701|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
164061824|NCT00948896|592588702|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
164061825|NCT00948896|592588703|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
164061826|NCT00948896|592588704|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
164061827|NCT00948896|592588705|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
164061828|NCT00948896|592588706|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
164061829|NCT00948896|592588699|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
164061830|NCT00948896|592588700|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
164061831|NCT00948896|592588701|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
164061832|NCT00948896|592588702|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
164061833|NCT00948896|592588703|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
164061834|NCT00948896|592588704|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
164061835|NCT00948896|592588705|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
164061836|NCT00948896|592588706|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
164061837|NCT00948896|592588699|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
164061838|NCT00948896|592588700|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
164061839|NCT00948896|592588701|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
164061840|NCT00948896|592588702|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
164061841|NCT00948896|592588703|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
164061842|NCT00948896|592588704|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
164061843|NCT00948896|592588705|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
164061844|NCT00948896|592588706|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
164061845|NCT00948896|592588699|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164061846|NCT00948896|592588700|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
164061847|NCT00948896|592588701|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
164061848|NCT00948896|592588702|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
164061849|NCT00948896|592588703|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164061850|NCT00948896|592588704|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
164061851|NCT00948896|592588705|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164061852|NCT00948896|592588706|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
164061853|NCT00948896|592588699|FG000|24 Months of Age to 36 Months of Age|Death|0|||
164061854|NCT00948896|592588700|FG001|24 Months of Age to 36 Months of Age|Death|2|||
164061855|NCT00948896|592588701|FG002|24 Months of Age to 36 Months of Age|Death|2|||
164061856|NCT00948896|592588702|FG003|24 Months of Age to 36 Months of Age|Death|0|||
164061857|NCT00948896|592588703|FG004|24 Months of Age to 36 Months of Age|Death|0|||
164061858|NCT00948896|592588704|FG005|24 Months of Age to 36 Months of Age|Death|1|||
164061859|NCT00948896|592588705|FG006|24 Months of Age to 36 Months of Age|Death|0|||
164061860|NCT00948896|592588706|FG007|24 Months of Age to 36 Months of Age|Death|0|||
164061861|NCT00948896|592588699|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
164061862|NCT00948896|592588700|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164061863|NCT00948896|592588701|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
164061864|NCT00948896|592588702|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
164061865|NCT00948896|592588703|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164061866|NCT00948896|592588704|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164061867|NCT00948896|592588705|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164061868|NCT00948896|592588706|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
164061869|NCT00948896|592588699|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
164061870|NCT00948896|592588700|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164061871|NCT00948896|592588701|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
164061872|NCT00948896|592588702|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164061873|NCT00948896|592588703|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
164061874|NCT00948896|592588704|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164061875|NCT00948896|592588705|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164061876|NCT00948896|592588706|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
164061877|NCT00948896|592588699|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164061878|NCT00948896|592588700|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164061879|NCT00948896|592588701|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
164061880|NCT00948896|592588702|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164061881|NCT00948896|592588703|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164061882|NCT00948896|592588704|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
164061883|NCT00948896|592588705|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164061884|NCT00948896|592588706|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
164061885|NCT00948896|592588699|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061886|NCT00948896|592588700|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061887|NCT00948896|592588701|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061888|NCT00948896|592588702|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
164061889|NCT00948896|592588703|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061890|NCT00948896|592588704|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061891|NCT00948896|592588705|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061892|NCT00948896|592588706|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
164061893|NCT00945815|592588707|FG000|Overall Study|Death|3|||
164061894|NCT00945815|592588707|FG000|Overall Study|Not protocol specified|1|||
164061895|NCT00945815|592588707|FG000|Overall Study|Ineligible|3|||
164061896|NCT00945815|592588707|FG000|Overall Study|Did not begin protocol therapy|1|||
164061897|NCT01990339|592588712|FG000|Overall Study|Data Not Available|49|||
164061898|NCT01990339|592588712|FG000|Overall Study|Voluntary Withdrawal|1402|||
164061899|NCT01990339|592588712|FG000|Overall Study|Lost to Follow-up|861|||
164061900|NCT01038609|592588713|FG000|Overall Study|Adverse Event|0|||
164061901|NCT01038609|592588714|FG001|Overall Study|Adverse Event|0|||
164061902|NCT01038609|592588715|FG002|Overall Study|Adverse Event|1|||
164061903|NCT01038609|592588716|FG003|Overall Study|Adverse Event|0|||
164061904|NCT01038609|592588717|FG004|Overall Study|Adverse Event|0|||
164061905|NCT01038609|592588713|FG000|Overall Study|Dosing Error|0|||
164061906|NCT01038609|592588714|FG001|Overall Study|Dosing Error|0|||
164061907|NCT01038609|592588715|FG002|Overall Study|Dosing Error|0|||
164061908|NCT01038609|592588716|FG003|Overall Study|Dosing Error|1|||
164061909|NCT01038609|592588717|FG004|Overall Study|Dosing Error|1|||
164061910|NCT01038609|592588713|FG000|Overall Study|Death in the Family|1|||
164061911|NCT01038609|592588714|FG001|Overall Study|Death in the Family|0|||
164061912|NCT01038609|592588715|FG002|Overall Study|Death in the Family|0|||
164061913|NCT01038609|592588716|FG003|Overall Study|Death in the Family|0|||
164061914|NCT01038609|592588717|FG004|Overall Study|Death in the Family|0|||
164061915|NCT01038609|592588713|FG000|Overall Study|Refusal of Blood Draws|0|||
164061916|NCT01038609|592588714|FG001|Overall Study|Refusal of Blood Draws|1|||
164061917|NCT01038609|592588715|FG002|Overall Study|Refusal of Blood Draws|0|||
164061918|NCT01038609|592588716|FG003|Overall Study|Refusal of Blood Draws|0|||
164061919|NCT01038609|592588717|FG004|Overall Study|Refusal of Blood Draws|0|||
164061920|NCT01590810|592588718|FG000|Overall Study|Physician Decision|0|||
164061921|NCT01590810|592588719|FG001|Overall Study|Physician Decision|1|||
164061922|NCT01590810|592588720|FG002|Overall Study|Physician Decision|1|||
164061923|NCT01590810|592588721|FG003|Overall Study|Physician Decision|0|||
164061924|NCT01590810|592588722|FG004|Overall Study|Physician Decision|0|||
164061925|NCT01087944|592588724|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
164061926|NCT01087944|592588725|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
164061927|NCT01087944|592588724|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
164061928|NCT01087944|592588725|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
164061929|NCT00553319|592588726|FG000|Overall Study|Lost to Follow-up|10|||
164061930|NCT00553319|592588727|FG001|Overall Study|Lost to Follow-up|9|||
164061931|NCT00553319|592588728|FG002|Overall Study|Lost to Follow-up|5|||
164061932|NCT00553319|592588726|FG000|Overall Study|wanted treatment elsewhere|2|||
164061933|NCT00553319|592588727|FG001|Overall Study|wanted treatment elsewhere|1|||
164061934|NCT00553319|592588728|FG002|Overall Study|wanted treatment elsewhere|1|||
164061935|NCT00553319|592588726|FG000|Overall Study|non-compliance|0|||
164061936|NCT00553319|592588727|FG001|Overall Study|non-compliance|0|||
164061937|NCT00553319|592588728|FG002|Overall Study|non-compliance|2|||
164061938|NCT00553319|592588726|FG000|Overall Study|incarceration|1|||
164061939|NCT00553319|592588727|FG001|Overall Study|incarceration|0|||
164061940|NCT00553319|592588728|FG002|Overall Study|incarceration|0|||
164061941|NCT00553319|592588726|FG000|Overall Study|moved|1|||
164061942|NCT00553319|592588727|FG001|Overall Study|moved|0|||
164061943|NCT00553319|592588728|FG002|Overall Study|moved|1|||
164061944|NCT01731600|592588730|FG000|Overall Study|Adverse Event|2|||
164061945|NCT01731600|592588731|FG001|Overall Study|Adverse Event|0|||
164061946|NCT01731600|592588730|FG000|Overall Study|Withdrawal criteria|1|||
164061947|NCT01731600|592588731|FG001|Overall Study|Withdrawal criteria|0|||
164061948|NCT01731600|592588730|FG000|Overall Study|Other reasons|3|||
164061949|NCT01731600|592588731|FG001|Overall Study|Other reasons|0|||
164061950|NCT00465894|592588732|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
164061951|NCT00465894|592588733|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
164061952|NCT00465894|592588732|FG000|Treatment For 12 Weeks|Family Issues|1|||
164061953|NCT00465894|592588733|FG001|Treatment For 12 Weeks|Family Issues|1|||
164061954|NCT00465894|592588732|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
164061955|NCT00465894|592588733|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
164061956|NCT01349816|592588734|FG000|Overall Study|Withdrawal by Subject|4|||
164061957|NCT01349816|592588734|FG000|Overall Study|Physician Decision|1|||
164061958|NCT01349816|592588734|FG000|Overall Study|Adverse Event|14|||
164061959|NCT01349816|592588734|FG000|Overall Study|Lost to Follow-up|2|||
164061960|NCT01349816|592588734|FG000|Overall Study|Protocol Violation|1|||
164061961|NCT01349816|592588734|FG000|Overall Study|Protocol-specified criteria|8|||
164061962|NCT03575806|592590864|FG000|Overall Study|Withdrawal by Subject|0|||
164061963|NCT03575806|592590865|FG001|Overall Study|Withdrawal by Subject|2|||
164061964|NCT03575806|592590864|FG000|Overall Study|Protocol Violation|0|||
164061965|NCT03575806|592590865|FG001|Overall Study|Protocol Violation|2|||
164061966|NCT02842736|592590869|FG000|Overall Study|Lost to Follow-up|13|||
164061967|NCT02842736|592590869|FG000|Overall Study|Intervention for menstrual bleeding|17|||
164061968|NCT02842736|592590869|FG000|Overall Study|Withdrawal by Subject|4|||
164061969|NCT02842736|592590869|FG000|Overall Study|Pregnancy|3|||
164061970|NCT02842736|592590869|FG000|Overall Study|Hysterectomy for fibroids|2|||
164061971|NCT02842736|592590869|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
164061972|NCT02842736|592590869|FG000|Overall Study|IUD: Mirena|1|||
164061973|NCT02815540|592590873|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
164061974|NCT00798161|592590874|FG000|Overall Study|Adverse Event|3|||
164061975|NCT00798161|592590875|FG001|Overall Study|Adverse Event|4|||
164061976|NCT00798161|592590876|FG002|Overall Study|Adverse Event|6|||
164061977|NCT00798161|592590877|FG003|Overall Study|Adverse Event|6|||
164061978|NCT00798161|592590878|FG004|Overall Study|Adverse Event|5|||
164061979|NCT00798161|592590879|FG005|Overall Study|Adverse Event|2|||
164061980|NCT00798161|592590880|FG006|Overall Study|Adverse Event|4|||
164061981|NCT00798161|592590874|FG000|Overall Study|Protocol Violation|2|||
164061982|NCT00798161|592590875|FG001|Overall Study|Protocol Violation|1|||
164061983|NCT00798161|592590876|FG002|Overall Study|Protocol Violation|3|||
164061984|NCT00798161|592590877|FG003|Overall Study|Protocol Violation|3|||
164061985|NCT00798161|592590878|FG004|Overall Study|Protocol Violation|3|||
164061986|NCT00798161|592590879|FG005|Overall Study|Protocol Violation|2|||
164061987|NCT00798161|592590880|FG006|Overall Study|Protocol Violation|0|||
164061988|NCT00798161|592590874|FG000|Overall Study|Lost to Follow-up|1|||
164061989|NCT00798161|592590875|FG001|Overall Study|Lost to Follow-up|3|||
164061990|NCT00798161|592590876|FG002|Overall Study|Lost to Follow-up|4|||
164061991|NCT00798161|592590877|FG003|Overall Study|Lost to Follow-up|3|||
164061992|NCT00798161|592590878|FG004|Overall Study|Lost to Follow-up|4|||
164061993|NCT00798161|592590879|FG005|Overall Study|Lost to Follow-up|0|||
164061994|NCT00798161|592590880|FG006|Overall Study|Lost to Follow-up|0|||
164061995|NCT00798161|592590874|FG000|Overall Study|Withdrawal by Subject|5|||
164061996|NCT00798161|592590875|FG001|Overall Study|Withdrawal by Subject|4|||
164061997|NCT00798161|592590876|FG002|Overall Study|Withdrawal by Subject|5|||
164061998|NCT00798161|592590877|FG003|Overall Study|Withdrawal by Subject|4|||
164061999|NCT00798161|592590878|FG004|Overall Study|Withdrawal by Subject|2|||
164062000|NCT00798161|592590879|FG005|Overall Study|Withdrawal by Subject|3|||
164062001|NCT00798161|592590880|FG006|Overall Study|Withdrawal by Subject|1|||
164062002|NCT00798161|592590874|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
164062003|NCT00798161|592590875|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
164062004|NCT00798161|592590876|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
164062005|NCT00798161|592590877|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
164062006|NCT00798161|592590878|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
164062007|NCT00798161|592590879|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
164062008|NCT00798161|592590880|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
164062009|NCT00726882|592590881|FG000|Overall Study|Withdrawal by Subject|5|||
164062010|NCT00726882|592590881|FG000|Overall Study|Lost to Follow-up|7|||
164062011|NCT00726882|592590881|FG000|Overall Study|Other|10|||
164062012|NCT00344968|592590882|FG000|Overall Study|Adverse Event|5|||
164062013|NCT00344968|592590883|FG001|Overall Study|Adverse Event|4|||
164062014|NCT00344968|592590884|FG002|Overall Study|Adverse Event|15|||
164062015|NCT00344968|592590882|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164062016|NCT00344968|592590883|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164062017|NCT00344968|592590884|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164062018|NCT00344968|592590882|FG000|Overall Study|Protocol Violation|2|||
164062019|NCT00344968|592590883|FG001|Overall Study|Protocol Violation|2|||
164062020|NCT00344968|592590884|FG002|Overall Study|Protocol Violation|5|||
164062021|NCT00344968|592590882|FG000|Overall Study|Withdrawal by Subject|14|||
164062022|NCT00344968|592590883|FG001|Overall Study|Withdrawal by Subject|31|||
164062023|NCT00344968|592590884|FG002|Overall Study|Withdrawal by Subject|27|||
164062024|NCT00344968|592590882|FG000|Overall Study|Lost to Follow-up|24|||
164062025|NCT00344968|592590883|FG001|Overall Study|Lost to Follow-up|37|||
164062026|NCT00344968|592590884|FG002|Overall Study|Lost to Follow-up|37|||
164062027|NCT00344968|592590882|FG000|Overall Study|Death|11|||
164062028|NCT00344968|592590883|FG001|Overall Study|Death|27|||
164062029|NCT00344968|592590884|FG002|Overall Study|Death|31|||
164062030|NCT00344968|592590882|FG000|Overall Study|Other|0|||
164062031|NCT00344968|592590883|FG001|Overall Study|Other|1|||
164062032|NCT00344968|592590884|FG002|Overall Study|Other|0|||
164062033|NCT00594568|592590885|FG000|Initial Treatment|Adverse Event|51|||
164062034|NCT00594568|592590886|FG001|Initial Treatment|Adverse Event|121|||
164062035|NCT00594568|592590887|FG002|Initial Treatment|Adverse Event|144|||
164062036|NCT00594568|592590885|FG000|Initial Treatment|Death|6|||
164062037|NCT00594568|592590886|FG001|Initial Treatment|Death|11|||
164062038|NCT00594568|592590887|FG002|Initial Treatment|Death|15|||
164062039|NCT00594568|592590885|FG000|Initial Treatment|Lost to Follow-up|4|||
164062040|NCT00594568|592590886|FG001|Initial Treatment|Lost to Follow-up|1|||
164062041|NCT00594568|592590887|FG002|Initial Treatment|Lost to Follow-up|4|||
164062042|NCT00594568|592590885|FG000|Initial Treatment|Physician Decision|3|||
164062043|NCT00594568|592590886|FG001|Initial Treatment|Physician Decision|2|||
164062044|NCT00594568|592590887|FG002|Initial Treatment|Physician Decision|4|||
164062045|NCT00594568|592590885|FG000|Initial Treatment|Protocol Violation|2|||
164062046|NCT00594568|592590886|FG001|Initial Treatment|Protocol Violation|2|||
164062047|NCT00594568|592590887|FG002|Initial Treatment|Protocol Violation|5|||
164062048|NCT00594568|592590885|FG000|Initial Treatment|Withdrawal by Subject|25|||
164062049|NCT00594568|592590886|FG001|Initial Treatment|Withdrawal by Subject|31|||
164062050|NCT00594568|592590887|FG002|Initial Treatment|Withdrawal by Subject|46|||
164062051|NCT00594568|592590885|FG000|Initial Treatment|Sponsor decision|193|||
164062052|NCT00594568|592590886|FG001|Initial Treatment|Sponsor decision|142|||
164062053|NCT00594568|592590887|FG002|Initial Treatment|Sponsor decision|147|||
164062054|NCT00594568|592590885|FG000|Initial Treatment|Caregiver decision|21|||
164062055|NCT00594568|592590886|FG001|Initial Treatment|Caregiver decision|36|||
164062056|NCT00594568|592590887|FG002|Initial Treatment|Caregiver decision|36|||
164062057|NCT00594568|592590885|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
164062058|NCT00594568|592590886|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
164062059|NCT00594568|592590887|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
164062060|NCT00594568|592590885|FG000|Initial Treatment|Entry criteria exclusion|0|||
164062061|NCT00594568|592590886|FG001|Initial Treatment|Entry criteria exclusion|1|||
164062062|NCT00594568|592590887|FG002|Initial Treatment|Entry criteria exclusion|1|||
164062063|NCT00594568|592590885|FG000|Delayed Start|Death|0|||
164062064|NCT00594568|592590886|FG001|Delayed Start|Death|0|||
164062065|NCT00594568|592590887|FG002|Delayed Start|Death|1|||
164062066|NCT00594568|592590885|FG000|Delayed Start|Adverse Event|12|||
164062067|NCT00594568|592590886|FG001|Delayed Start|Adverse Event|2|||
164062068|NCT00594568|592590887|FG002|Delayed Start|Adverse Event|2|||
164062069|NCT00594568|592590885|FG000|Delayed Start|Withdrawal by Subject|4|||
164062070|NCT00594568|592590886|FG001|Delayed Start|Withdrawal by Subject|3|||
164062071|NCT00594568|592590887|FG002|Delayed Start|Withdrawal by Subject|0|||
164062072|NCT00594568|592590885|FG000|Delayed Start|Physician Decision|0|||
164062073|NCT00594568|592590886|FG001|Delayed Start|Physician Decision|0|||
164062074|NCT00594568|592590887|FG002|Delayed Start|Physician Decision|1|||
164062075|NCT00594568|592590885|FG000|Delayed Start|Lost to Follow-up|0|||
164062076|NCT00594568|592590886|FG001|Delayed Start|Lost to Follow-up|0|||
164062077|NCT00594568|592590887|FG002|Delayed Start|Lost to Follow-up|1|||
164062078|NCT00594568|592590885|FG000|Delayed Start|Caregiver Decision|5|||
164062079|NCT00594568|592590886|FG001|Delayed Start|Caregiver Decision|6|||
164062080|NCT00594568|592590887|FG002|Delayed Start|Caregiver Decision|2|||
164062081|NCT00594568|592590885|FG000|Delayed Start|Sponsor Decision|77|||
164062082|NCT00594568|592590886|FG001|Delayed Start|Sponsor Decision|66|||
164062083|NCT00594568|592590887|FG002|Delayed Start|Sponsor Decision|59|||
164062084|NCT00594568|592590885|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
164062085|NCT00594568|592590886|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
164062086|NCT00594568|592590887|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
164062087|NCT00594568|592590885|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
164062088|NCT00594568|592590886|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
164062089|NCT00594568|592590887|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
164062090|NCT00594568|592590885|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
164102704|NCT00003659|592738847|FG000|Overall Study|Withdrawal by Subject|3|||
164062091|NCT00594568|592590886|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
164062092|NCT00594568|592590887|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
164062093|NCT00594568|592590885|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
164062094|NCT00594568|592590886|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
164062095|NCT00594568|592590887|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
164062096|NCT00594568|592590885|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
164062097|NCT00594568|592590886|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
164062098|NCT00594568|592590887|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
164062099|NCT00594568|592590885|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
164062100|NCT00594568|592590886|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
164062101|NCT00594568|592590887|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
164062102|NCT02526017|592590888|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062103|NCT02526017|592590889|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062104|NCT02526017|592590890|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062105|NCT02526017|592590891|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062106|NCT02526017|592590892|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
164062107|NCT02526017|592590893|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062108|NCT02526017|592590894|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062109|NCT02526017|592590895|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062110|NCT02526017|592590896|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
164062111|NCT00423137|592590900|FG000|Overall Study|Lost to Follow-up|0|||
164062112|NCT00423137|592590901|FG001|Overall Study|Lost to Follow-up|0|||
164062113|NCT00423137|592590902|FG002|Overall Study|Lost to Follow-up|1|||
164062114|NCT00423137|592590903|FG003|Overall Study|Lost to Follow-up|0|||
164062115|NCT00423137|592590900|FG000|Overall Study|Protocol Violation|0|||
164062116|NCT00423137|592590901|FG001|Overall Study|Protocol Violation|0|||
164062117|NCT00423137|592590902|FG002|Overall Study|Protocol Violation|0|||
164062118|NCT00423137|592590903|FG003|Overall Study|Protocol Violation|1|||
164062119|NCT00423137|592590900|FG000|Overall Study|Adverse Event Study disease worse|1|||
164062120|NCT00423137|592590901|FG001|Overall Study|Adverse Event Study disease worse|0|||
164062121|NCT00423137|592590902|FG002|Overall Study|Adverse Event Study disease worse|3|||
164062122|NCT00423137|592590903|FG003|Overall Study|Adverse Event Study disease worse|1|||
164062123|NCT00423137|592590900|FG000|Overall Study|Adverse Event Other|0|||
164062124|NCT00423137|592590901|FG001|Overall Study|Adverse Event Other|0|||
164062125|NCT00423137|592590902|FG002|Overall Study|Adverse Event Other|2|||
164062126|NCT00423137|592590903|FG003|Overall Study|Adverse Event Other|0|||
164062127|NCT04196023|592590904|FG000|Overall Study|Withdrawal by Subject|0|||
164062128|NCT04196023|592590905|FG001|Overall Study|Withdrawal by Subject|1|||
164062129|NCT04196023|592590904|FG000|Overall Study|Adverse Event|3|||
164062130|NCT04196023|592590905|FG001|Overall Study|Adverse Event|1|||
164062131|NCT04196023|592590904|FG000|Overall Study|Lost to Follow-up|0|||
164062132|NCT04196023|592590905|FG001|Overall Study|Lost to Follow-up|1|||
164062133|NCT03358407|592590913|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062134|NCT03358407|592590914|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062135|NCT03358407|592590915|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
164062136|NCT03358407|592590916|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164102705|NCT04022954|592738849|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
164102706|NCT04022954|592738849|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
164102707|NCT04022954|592738849|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
164102708|NCT03872128|592738852|FG000|Overall Study|Dropped out before treatment|1|||
164102709|NCT03872128|592738853|FG001|Overall Study|Dropped out before treatment|0|||
164102710|NCT03872128|592738854|FG002|Overall Study|Dropped out before treatment|4|||
164062137|NCT03358407|592590917|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062138|NCT03358407|592590918|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062139|NCT03358407|592590919|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062140|NCT03358407|592590920|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062141|NCT03358407|592590921|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062142|NCT03358407|592590922|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
164062143|NCT03358407|592590913|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062144|NCT03358407|592590914|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062145|NCT03358407|592590915|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062146|NCT03358407|592590916|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062147|NCT03358407|592590917|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
164102711|NCT03872128|592738852|FG000|Overall Study|Lost to Follow-up|2|||
164102712|NCT03872128|592738853|FG001|Overall Study|Lost to Follow-up|5|||
164102713|NCT03872128|592738854|FG002|Overall Study|Lost to Follow-up|8|||
164062148|NCT03358407|592590918|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164102714|NCT03285594|592738859|FG000|Overall Study|At the Participant's Own Request|10|||
164102715|NCT03285594|592738860|FG001|Overall Study|At the Participant's Own Request|5|||
164102716|NCT03285594|592738861|FG002|Overall Study|At the Participant's Own Request|21|||
164102717|NCT03285594|592738859|FG000|Overall Study|Adverse Event|2|||
164062149|NCT03358407|592590919|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062150|NCT03358407|592590920|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062151|NCT03358407|592590921|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062152|NCT03358407|592590922|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062153|NCT03358407|592590913|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062154|NCT03358407|592590914|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062155|NCT03358407|592590915|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062156|NCT03358407|592590916|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062157|NCT03358407|592590917|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062158|NCT03358407|592590918|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
164062159|NCT03358407|592590919|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062160|NCT03358407|592590920|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
164062161|NCT03358407|592590921|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062162|NCT03358407|592590922|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
164062163|NCT03358407|592590913|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062164|NCT03358407|592590914|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062165|NCT03358407|592590915|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062166|NCT03358407|592590916|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062167|NCT03358407|592590917|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062168|NCT03358407|592590918|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
164062169|NCT03358407|592590919|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062170|NCT03358407|592590920|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
164062171|NCT03358407|592590921|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062172|NCT03358407|592590922|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
164062173|NCT03358407|592590913|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062174|NCT03358407|592590914|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062175|NCT03358407|592590915|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062176|NCT03358407|592590916|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062177|NCT03358407|592590917|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062178|NCT03358407|592590918|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
164062179|NCT03358407|592590919|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
164062180|NCT03358407|592590920|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062181|NCT03358407|592590921|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062182|NCT03358407|592590922|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
164062183|NCT03358407|592590913|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062184|NCT03358407|592590914|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062185|NCT03358407|592590915|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062186|NCT03358407|592590916|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062187|NCT03358407|592590917|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062188|NCT03358407|592590918|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
164062189|NCT03358407|592590919|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
164062190|NCT03358407|592590920|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
164062191|NCT03358407|592590921|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062192|NCT03358407|592590922|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
164062193|NCT00483574|592590923|FG000|Overall Study|Adverse Event|6|||
164062194|NCT00483574|592590924|FG001|Overall Study|Adverse Event|0|||
164062195|NCT00483574|592590923|FG000|Overall Study|Protocol Violation|28|||
164062196|NCT00483574|592590924|FG001|Overall Study|Protocol Violation|9|||
164062197|NCT00483574|592590923|FG000|Overall Study|Lost to Follow-up|16|||
164062198|NCT00483574|592590924|FG001|Overall Study|Lost to Follow-up|4|||
164062199|NCT00483574|592590923|FG000|Overall Study|Withdrawal by Subject|52|||
164062200|NCT00483574|592590924|FG001|Overall Study|Withdrawal by Subject|0|||
164062201|NCT03605758|592590925|FG000|Overall Study|Lost to Follow-up|2|||
164062202|NCT03605758|592590926|FG001|Overall Study|Lost to Follow-up|1|||
164062203|NCT03605758|592590925|FG000|Overall Study|Illness|0|||
164062204|NCT03605758|592590926|FG001|Overall Study|Illness|1|||
164062205|NCT03605758|592590925|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
164062206|NCT03605758|592590926|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
164062207|NCT04753606|592590929|FG000|Overall Study|Adverse Event|1|||
164062208|NCT04753606|592590930|FG001|Overall Study|Adverse Event|0|||
164062209|NCT04753606|592590931|FG002|Overall Study|Adverse Event|0|||
164062210|NCT00489411|592590932|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
164062211|NCT00489411|592590933|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
164102718|NCT03285594|592738860|FG001|Overall Study|Adverse Event|2|||
164102719|NCT03285594|592738861|FG002|Overall Study|Adverse Event|6|||
164102720|NCT03285594|592738859|FG000|Overall Study|Poor Compliance to Protocol|0|||
164062212|NCT00489411|592590932|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
164062213|NCT00489411|592590933|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
164062214|NCT00489411|592590932|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
164062215|NCT00489411|592590933|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
164062216|NCT00489411|592590932|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
164062217|NCT00489411|592590933|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
164062218|NCT00489411|592590932|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
164062219|NCT00489411|592590933|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
164062220|NCT01748162|592590935|FG000|Overall Study|no additional croup episodes to evaluate|2|||
164062221|NCT01748162|592590936|FG001|Overall Study|no additional croup episodes to evaluate|2|||
164062222|NCT01748162|592590935|FG000|Overall Study|participant consented but did not begin|0|||
164062223|NCT01748162|592590936|FG001|Overall Study|participant consented but did not begin|1|||
164062224|NCT01748162|592590935|FG000|Overall Study|reasons not available|3|||
164062225|NCT01748162|592590936|FG001|Overall Study|reasons not available|2|||
164062226|NCT03219372|592590937|FG000|Overall Study|Withdrawal by Subject|1|||
164062227|NCT03219372|592590938|FG001|Overall Study|Withdrawal by Subject|0|||
164062228|NCT03841331|592590939|FG000|Overall Study|Withdrawal by Subject|4|||
164102721|NCT03285594|592738860|FG001|Overall Study|Poor Compliance to Protocol|0|||
164102722|NCT03285594|592738861|FG002|Overall Study|Poor Compliance to Protocol|1|||
164102723|NCT03285594|592738859|FG000|Overall Study|Lost to Follow-up|0|||
164102724|NCT03285594|592738860|FG001|Overall Study|Lost to Follow-up|0|||
164102725|NCT03285594|592738861|FG002|Overall Study|Lost to Follow-up|1|||
164102726|NCT03285594|592738859|FG000|Overall Study|Reason Not Specified|3|||
164062229|NCT03841331|592590940|FG001|Overall Study|Withdrawal by Subject|9|||
164062230|NCT03841331|592590939|FG000|Overall Study|Lost to Follow-up|5|||
164062231|NCT03841331|592590940|FG001|Overall Study|Lost to Follow-up|1|||
164062232|NCT00779857|592590942|FG000|Overall Study|Death|1|||
164062233|NCT00779857|592590942|FG000|Overall Study|Withdrawal by Subject|3|||
164062234|NCT00779857|592590942|FG000|Overall Study|Missed Visit|2|||
164062235|NCT04640168|592590943|FG000|Overall Study|Withdrawal by Subject|8|||
164062236|NCT04640168|592590944|FG001|Overall Study|Withdrawal by Subject|7|||
164062237|NCT04640168|592590943|FG000|Overall Study|Lost to Follow-up|1|||
164062238|NCT04640168|592590944|FG001|Overall Study|Lost to Follow-up|0|||
164062239|NCT04640168|592590943|FG000|Overall Study|Enrolled but not treated|12|||
164062240|NCT04640168|592590944|FG001|Overall Study|Enrolled but not treated|12|||
164062241|NCT00442572|592590948|FG000|Overall Study|Relapse|8|||
164062242|NCT00442572|592590949|FG001|Overall Study|Relapse|1|||
164062243|NCT00442572|592590948|FG000|Overall Study|Lost to Follow-up|0|||
164062244|NCT00442572|592590949|FG001|Overall Study|Lost to Follow-up|1|||
164062245|NCT00442572|592590948|FG000|Overall Study|Withdrawal by Subject|0|||
164062246|NCT00442572|592590949|FG001|Overall Study|Withdrawal by Subject|1|||
164062247|NCT01977625|592590955|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
164102727|NCT03285594|592738860|FG001|Overall Study|Reason Not Specified|4|||
164102728|NCT03285594|592738861|FG002|Overall Study|Reason Not Specified|8|||
164102729|NCT03733444|592738862|FG000|Overall Study|Adverse Event|8|||
164102730|NCT03733444|592738863|FG001|Overall Study|Adverse Event|10|||
164102731|NCT03733444|592738864|FG002|Overall Study|Adverse Event|5|||
164102732|NCT03733444|592738862|FG000|Overall Study|Death|20|||
164102733|NCT03733444|592738863|FG001|Overall Study|Death|19|||
164102734|NCT03733444|592738864|FG002|Overall Study|Death|11|||
164102735|NCT03733444|592738862|FG000|Overall Study|Lost to Follow-up|3|||
164102736|NCT03733444|592738863|FG001|Overall Study|Lost to Follow-up|0|||
164102737|NCT03733444|592738864|FG002|Overall Study|Lost to Follow-up|1|||
164102738|NCT03733444|592738862|FG000|Overall Study|Lack of Efficacy|0|||
164102739|NCT03733444|592738863|FG001|Overall Study|Lack of Efficacy|1|||
164102740|NCT03733444|592738864|FG002|Overall Study|Lack of Efficacy|1|||
164062248|NCT01977625|592590956|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164062249|NCT01977625|592590955|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164062250|NCT01977625|592590956|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164062251|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
164062252|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
164062253|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
164102741|NCT03733444|592738862|FG000|Overall Study|Physician Decision|2|||
164102742|NCT03733444|592738863|FG001|Overall Study|Physician Decision|1|||
164062254|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
164062255|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
164102743|NCT03733444|592738864|FG002|Overall Study|Physician Decision|0|||
164102744|NCT03733444|592738862|FG000|Overall Study|Protocol Violation|2|||
164102745|NCT03733444|592738863|FG001|Overall Study|Protocol Violation|1|||
164062256|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Death|1|||
164062257|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Death|0|||
164062258|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Death|0|||
164102746|NCT03733444|592738864|FG002|Overall Study|Protocol Violation|0|||
164102747|NCT03733444|592738862|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
164102748|NCT03733444|592738863|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
164062259|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Death|0|||
164062260|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Death|0|||
164062261|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
164062262|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
164062263|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
164062264|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
164062265|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
164062266|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
164062267|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
164062268|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
164062269|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
164062270|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
164062271|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
164062272|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
164062273|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
164062274|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
164062275|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
164062276|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
164062277|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
164062278|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
164062279|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
164062280|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
164062281|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
164062282|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
164062283|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
164062284|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
164062285|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
164062286|NCT00634933|592590958|FG000|Part A: Baseline to Week 24|Other|1|||
164062287|NCT00634933|592590959|FG001|Part A: Baseline to Week 24|Other|8|||
164062288|NCT00634933|592590960|FG002|Part A: Baseline to Week 24|Other|5|||
164062289|NCT00634933|592590961|FG003|Part A: Baseline to Week 24|Other|0|||
164062290|NCT00634933|592590962|FG004|Part A: Baseline to Week 24|Other|0|||
164062291|NCT00634933|592590958|FG000|Between Part A and Part B|Physician Decision|0|||
164062292|NCT00634933|592590959|FG001|Between Part A and Part B|Physician Decision|1|||
164062293|NCT00634933|592590960|FG002|Between Part A and Part B|Physician Decision|0|||
164062294|NCT00634933|592590961|FG003|Between Part A and Part B|Physician Decision|0|||
164062295|NCT00634933|592590962|FG004|Between Part A and Part B|Physician Decision|0|||
164062296|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
164062297|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
164062298|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
164062299|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
164062300|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
164062301|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
164062302|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
164062303|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
164062304|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
164062305|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
164062306|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
164062307|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
164062308|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
164062309|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
164062310|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
164062311|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
164062312|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
164062313|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
164062314|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
164062315|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
164062316|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
164062317|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
164062318|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
164062319|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
164062320|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
164062321|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
164062322|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
164062323|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
164062324|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
164062325|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
164062326|NCT00634933|592590958|FG000|Part B: Week 24 to Week 52|Other|0|||
164062327|NCT00634933|592590959|FG001|Part B: Week 24 to Week 52|Other|0|||
164062328|NCT00634933|592590960|FG002|Part B: Week 24 to Week 52|Other|5|||
164062329|NCT00634933|592590961|FG003|Part B: Week 24 to Week 52|Other|0|||
164062330|NCT00634933|592590962|FG004|Part B: Week 24 to Week 52|Other|1|||
164062331|NCT02304484|592590963|FG000|Overall Study|Death|9|||
164062332|NCT02304484|592590963|FG000|Overall Study|Withdrawal by Subject|14|||
164062333|NCT02304484|592590963|FG000|Overall Study|Lost to Follow-up|2|||
164062334|NCT04338685|592590964|FG000|Overall Study|Death|3|||
164062335|NCT04338685|592590965|FG001|Overall Study|Death|4|||
164062336|NCT04338685|592590966|FG002|Overall Study|Death|2|||
164062337|NCT04338685|592590967|FG003|Overall Study|Death|4|||
164062338|NCT04338685|592590968|FG004|Overall Study|Death|4|||
164062339|NCT04338685|592590969|FG005|Overall Study|Death|8|||
164062340|NCT04338685|592590970|FG006|Overall Study|Death|1|||
164062341|NCT04338685|592590971|FG007|Overall Study|Death|0|||
164062342|NCT04338685|592590972|FG008|Overall Study|Death|0|||
164062343|NCT04338685|592590964|FG000|Overall Study|Study terminated by Sponsor|0|||
164062344|NCT04338685|592590965|FG001|Overall Study|Study terminated by Sponsor|0|||
164062345|NCT04338685|592590966|FG002|Overall Study|Study terminated by Sponsor|1|||
164062346|NCT04338685|592590967|FG003|Overall Study|Study terminated by Sponsor|4|||
164062347|NCT04338685|592590968|FG004|Overall Study|Study terminated by Sponsor|0|||
164062348|NCT04338685|592590969|FG005|Overall Study|Study terminated by Sponsor|5|||
164062349|NCT04338685|592590970|FG006|Overall Study|Study terminated by Sponsor|2|||
164062350|NCT04338685|592590971|FG007|Overall Study|Study terminated by Sponsor|4|||
164062351|NCT04338685|592590972|FG008|Overall Study|Study terminated by Sponsor|1|||
164062352|NCT04338685|592590964|FG000|Overall Study|Withdrawal by Subject|1|||
164062353|NCT04338685|592590965|FG001|Overall Study|Withdrawal by Subject|2|||
164062354|NCT04338685|592590966|FG002|Overall Study|Withdrawal by Subject|0|||
164062355|NCT04338685|592590967|FG003|Overall Study|Withdrawal by Subject|2|||
164062356|NCT04338685|592590968|FG004|Overall Study|Withdrawal by Subject|0|||
164062357|NCT04338685|592590969|FG005|Overall Study|Withdrawal by Subject|5|||
164062358|NCT04338685|592590970|FG006|Overall Study|Withdrawal by Subject|1|||
164062359|NCT04338685|592590971|FG007|Overall Study|Withdrawal by Subject|1|||
164062360|NCT04338685|592590972|FG008|Overall Study|Withdrawal by Subject|0|||
164062361|NCT00234533|592590973|FG000|Overall Study|Withdrawal by Subject|6|||
164062362|NCT00234533|592590973|FG000|Overall Study|Adverse Event|2|||
164062363|NCT00234533|592590973|FG000|Overall Study|Enrolled but not treated|3|||
164062364|NCT00976989|592590974|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
164062365|NCT00976989|592590975|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
164062366|NCT00976989|592590976|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
164062367|NCT00976989|592590974|FG000|Overall Study|Death|5|||
164062368|NCT00976989|592590975|FG001|Overall Study|Death|7|||
164062369|NCT00976989|592590976|FG002|Overall Study|Death|10|||
164062370|NCT00976989|592590974|FG000|Overall Study|Refused Treatment|4|||
164062371|NCT00976989|592590975|FG001|Overall Study|Refused Treatment|3|||
164062372|NCT00976989|592590976|FG002|Overall Study|Refused Treatment|5|||
164062373|NCT00976989|592590974|FG000|Overall Study|Failure to Return|2|||
164062374|NCT00976989|592590975|FG001|Overall Study|Failure to Return|1|||
164062375|NCT00976989|592590976|FG002|Overall Study|Failure to Return|0|||
164062376|NCT00976989|592590974|FG000|Overall Study|Recurrence of Disease|0|||
164062377|NCT00976989|592590975|FG001|Overall Study|Recurrence of Disease|1|||
164062378|NCT00976989|592590976|FG002|Overall Study|Recurrence of Disease|0|||
164062379|NCT00976989|592590974|FG000|Overall Study|Other|1|||
164062380|NCT00976989|592590975|FG001|Overall Study|Other|0|||
164062381|NCT00976989|592590976|FG002|Overall Study|Other|1|||
164062382|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
164062383|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
164062384|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
164062385|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
164062386|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
164062387|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
164062388|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
164062389|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
164062390|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
164062391|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
164062392|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
164062393|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
164062394|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
164062395|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
164062396|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
164062397|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
164062398|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
164062399|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
164062400|NCT00570492|592590977|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
164062401|NCT00570492|592590978|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
164062402|NCT00570492|592590979|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
164062403|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
164062404|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
164062405|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
164062406|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
164062407|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
164062408|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
164062409|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
164062410|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
164062411|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
164062412|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
164062413|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
164062414|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
164062415|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
164062416|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
164062417|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
164062418|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
164062419|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
164062420|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
164062421|NCT00570492|592590977|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
164062422|NCT00570492|592590978|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
164062423|NCT00570492|592590979|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
164062424|NCT00908375|592590980|FG000|Overall Study|Withdrawal by Subject|2|||
164062425|NCT00908375|592590981|FG001|Overall Study|Withdrawal by Subject|4|||
164062426|NCT00908375|592590980|FG000|Overall Study|Lost to Follow-up|8|||
164062427|NCT00908375|592590981|FG001|Overall Study|Lost to Follow-up|6|||
164062428|NCT00903357|592590982|FG000|First Intervention|Withdrawal by Subject|5|||
164062429|NCT00903357|592590983|FG001|First Intervention|Withdrawal by Subject|3|||
164062430|NCT00903357|592590982|FG000|First Intervention|Flu|0|||
164062431|NCT00903357|592590983|FG001|First Intervention|Flu|1|||
164062432|NCT00903357|592590982|FG000|Wash Out Period of 2 Weeks|Flu|0|||
164062433|NCT00903357|592590983|FG001|Wash Out Period of 2 Weeks|Flu|1|||
164062434|NCT00903357|592590982|FG000|Second Intervention|Lost to Follow-up|1|||
164062435|NCT00903357|592590983|FG001|Second Intervention|Lost to Follow-up|0|||
164062436|NCT02279888|592590985|FG000|Overall Study|Death|326|||
164062437|NCT02279888|592590985|FG000|Overall Study|Withdrawal by Subject|38|||
164062438|NCT02279888|592590985|FG000|Overall Study|Lost to Follow-up|21|||
164062439|NCT02279888|592590985|FG000|Overall Study|Physician Decision|62|||
164062440|NCT02279888|592590985|FG000|Overall Study|Subject Non-compliance|43|||
164062441|NCT02279888|592590985|FG000|Overall Study|Not implanted|14|||
164062442|NCT02279888|592590985|FG000|Overall Study|Visit not performed|26|||
164062443|NCT00752206|592590986|FG000|Overall Study|Disease progression|8|||
164062444|NCT00752206|592590987|FG001|Overall Study|Disease progression|11|||
164062445|NCT00752206|592590986|FG000|Overall Study|Pregnancy|1|||
164062446|NCT00752206|592590987|FG001|Overall Study|Pregnancy|0|||
164062447|NCT01484691|592590988|FG000|Overall Study|Withdrawal by Subject|1|||
164062448|NCT01484691|592590989|FG001|Overall Study|Withdrawal by Subject|1|||
164062449|NCT01484691|592590990|FG002|Overall Study|Withdrawal by Subject|1|||
164062450|NCT01484691|592590988|FG000|Overall Study|Physician Decision|0|||
164062451|NCT01484691|592590989|FG001|Overall Study|Physician Decision|2|||
164062452|NCT01484691|592590990|FG002|Overall Study|Physician Decision|1|||
164062453|NCT03522506|592590991|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164062454|NCT03522506|592590992|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164062455|NCT03522506|592590993|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
164062456|NCT03522506|592590994|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
164062457|NCT03522506|592590991|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164062458|NCT03522506|592590992|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164062459|NCT03522506|592590993|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
164062460|NCT03522506|592590994|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
164062461|NCT03480243|592590997|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
164062462|NCT03480243|592590997|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
164062463|NCT04365387|592590998|FG000|Overall Study|Adverse Event|4|||
164062464|NCT04365387|592590999|FG001|Overall Study|Adverse Event|2|||
164062465|NCT04365387|592590998|FG000|Overall Study|Participants request|14|||
164062466|NCT04365387|592590999|FG001|Overall Study|Participants request|14|||
164062467|NCT04365387|592590998|FG000|Overall Study|Lost to Follow-up|8|||
164062468|NCT04365387|592590999|FG001|Overall Study|Lost to Follow-up|5|||
164062469|NCT04365387|592590998|FG000|Overall Study|Protocol deviation|3|||
164062470|NCT04365387|592590999|FG001|Overall Study|Protocol deviation|4|||
164062471|NCT04365387|592590998|FG000|Overall Study|Participant compliance with visit schedule|1|||
164062472|NCT04365387|592590999|FG001|Overall Study|Participant compliance with visit schedule|0|||
164062473|NCT04365387|592590998|FG000|Overall Study|Participant incarcerated|1|||
164062474|NCT04365387|592590999|FG001|Overall Study|Participant incarcerated|0|||
164062475|NCT04365387|592590998|FG000|Overall Study|Participant moved out of town (relocated)|0|||
164062476|NCT04365387|592590999|FG001|Overall Study|Participant moved out of town (relocated)|1|||
164062477|NCT04365387|592590998|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
164062478|NCT04365387|592590999|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
164062479|NCT04365387|592590998|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
164062480|NCT04365387|592590999|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
164062481|NCT05770401|592591000|FG000|Overall Study|Lost to Follow-up|5|||
164062482|NCT05770401|592591001|FG001|Overall Study|Lost to Follow-up|4|||
164062483|NCT01683565|592591004|FG000|Overall Study|Lost to Follow-up|2|||
164062484|NCT01683565|592591005|FG001|Overall Study|Lost to Follow-up|0|||
164062485|NCT01683565|592591004|FG000|Overall Study|Discontinued Intervention|1|||
164062486|NCT01683565|592591005|FG001|Overall Study|Discontinued Intervention|1|||
164062487|NCT00764465|592591006|FG000|Overall Study|Adverse Event|2|||
164062488|NCT00764465|592591007|FG001|Overall Study|Adverse Event|0|||
164062489|NCT00764465|592591008|FG002|Overall Study|Adverse Event|0|||
164062490|NCT00764465|592591009|FG003|Overall Study|Adverse Event|1|||
164062491|NCT00764465|592591010|FG004|Overall Study|Adverse Event|1|||
164062492|NCT00764465|592591011|FG005|Overall Study|Adverse Event|1|||
164062493|NCT00764465|592591006|FG000|Overall Study|Withdrawal by Subject|0|||
164062494|NCT00764465|592591007|FG001|Overall Study|Withdrawal by Subject|1|||
164062495|NCT00764465|592591008|FG002|Overall Study|Withdrawal by Subject|1|||
164062496|NCT00764465|592591009|FG003|Overall Study|Withdrawal by Subject|0|||
164062497|NCT00764465|592591010|FG004|Overall Study|Withdrawal by Subject|0|||
164062498|NCT00764465|592591011|FG005|Overall Study|Withdrawal by Subject|0|||
164062499|NCT01195662|592591012|FG000|Double Blind Treatment Period|Adverse Event|4|||
164062500|NCT01195662|592591013|FG001|Double Blind Treatment Period|Adverse Event|1|||
164062501|NCT01195662|592591014|FG002|Double Blind Treatment Period|Adverse Event|2|||
164062502|NCT01195662|592591012|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
164062503|NCT01195662|592591013|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
164062504|NCT01195662|592591014|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
164062505|NCT01195662|592591012|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
164062506|NCT01195662|592591013|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
164062507|NCT01195662|592591014|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
164062508|NCT01195662|592591012|FG000|Double Blind Treatment Period|Administrative reason|2|||
164062509|NCT01195662|592591013|FG001|Double Blind Treatment Period|Administrative reason|1|||
164062510|NCT01195662|592591014|FG002|Double Blind Treatment Period|Administrative reason|1|||
164062511|NCT01195662|592591012|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
164062512|NCT01195662|592591013|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
164062513|NCT01195662|592591014|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
164062514|NCT01195662|592591012|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
164062515|NCT01195662|592591013|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
164062516|NCT01195662|592591014|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
164062517|NCT01195662|592591012|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
164062518|NCT01195662|592591013|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
164062519|NCT01195662|592591014|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
164062520|NCT01195662|592591012|FG000|Double Blind Treatment Period|Non-specified|3|||
164062521|NCT01195662|592591013|FG001|Double Blind Treatment Period|Non-specified|0|||
164062522|NCT01195662|592591014|FG002|Double Blind Treatment Period|Non-specified|0|||
164062523|NCT01195662|592591012|FG000|Double Blind Treatment Period|Missing disposition information|0|||
164062524|NCT01195662|592591013|FG001|Double Blind Treatment Period|Missing disposition information|1|||
164062525|NCT01195662|592591014|FG002|Double Blind Treatment Period|Missing disposition information|1|||
164062526|NCT01195662|592591012|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
164062527|NCT01195662|592591013|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
164062528|NCT01195662|592591014|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
164062529|NCT01195662|592591012|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
164062530|NCT01195662|592591013|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
164062531|NCT01195662|592591014|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
164062532|NCT01326481|592591022|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
164062533|NCT04794491|592591023|FG000|Overall Study|Adverse Event|1|||
164062534|NCT04794491|592591023|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
164062535|NCT04794491|592591023|FG000|Overall Study|Noncompliance With Study Intervention|1|||
164062536|NCT04794491|592591023|FG000|Overall Study|Withdrawal by Subject|2|||
164062537|NCT00242658|592591026|FG000|Overall Study|Lost to Follow-up|22|||
164062538|NCT00242658|592591027|FG001|Overall Study|Lost to Follow-up|19|||
164062539|NCT04524507|592591029|FG000|Overall Study|Lost to Follow-up|2|||
164062540|NCT04524507|592591030|FG001|Overall Study|Lost to Follow-up|4|||
164062541|NCT04524507|592591029|FG000|Overall Study|Withdrawal by Subject|2|||
164062542|NCT04524507|592591030|FG001|Overall Study|Withdrawal by Subject|9|||
164062543|NCT04524507|592591029|FG000|Overall Study|Death|2|||
164062544|NCT04524507|592591030|FG001|Overall Study|Death|10|||
164062545|NCT03039699|592591042|FG000|Overall Study|Incorrect inclusion|5|||
164062546|NCT03039699|592591043|FG001|Overall Study|Incorrect inclusion|4|||
164062547|NCT03039699|592591042|FG000|Overall Study|Lack of data to assess study endpoint|5|||
164062548|NCT03039699|592591043|FG001|Overall Study|Lack of data to assess study endpoint|3|||
164062549|NCT03039699|592591042|FG000|Overall Study|Bacterial infection|12|||
164062550|NCT03039699|592591043|FG001|Overall Study|Bacterial infection|28|||
164062551|NCT00540228|592591044|FG000|Overall Study|Adverse Event|2|||
164062552|NCT00540228|592591045|FG001|Overall Study|Adverse Event|0|||
164062553|NCT00540228|592591046|FG002|Overall Study|Adverse Event|0|||
164062554|NCT00540228|592591047|FG003|Overall Study|Adverse Event|0|||
164062555|NCT00540228|592591048|FG004|Overall Study|Adverse Event|0|||
164062556|NCT00540228|592591044|FG000|Overall Study|Lost to Follow-up|1|||
164062557|NCT00540228|592591045|FG001|Overall Study|Lost to Follow-up|1|||
164062558|NCT00540228|592591046|FG002|Overall Study|Lost to Follow-up|0|||
164062559|NCT00540228|592591047|FG003|Overall Study|Lost to Follow-up|0|||
164062560|NCT00540228|592591048|FG004|Overall Study|Lost to Follow-up|0|||
164062561|NCT02569996|592591049|FG000|Overall Study|Adverse Event|6|||
164062562|NCT02569996|592591049|FG000|Overall Study|Physician Decision|3|||
164062563|NCT02569996|592591049|FG000|Overall Study|Progression of the disease|18|||
164062564|NCT02569996|592591049|FG000|Overall Study|New anti-lymphoma treatment|1|||
164062565|NCT02569996|592591049|FG000|Overall Study|Non-compliance|9|||
164062566|NCT02569996|592591049|FG000|Overall Study|Withdrawal by Subject|5|||
164062567|NCT02569996|592591049|FG000|Overall Study|Lost to Follow-up|5|||
164062568|NCT02569996|592591049|FG000|Overall Study|Complete remission|7|||
164062569|NCT02569996|592591049|FG000|Overall Study|Unknown reason|1|||
164062570|NCT01397409|592591050|FG000|Stage 2|Adverse Event|0|||
164062571|NCT01397409|592591051|FG001|Stage 2|Adverse Event|0|||
164062572|NCT01397409|592591052|FG002|Stage 2|Adverse Event|0|||
164062573|NCT01397409|592591053|FG003|Stage 2|Adverse Event|0|||
164062574|NCT01397409|592591054|FG004|Stage 2|Adverse Event|6|||
164062575|NCT01397409|592591055|FG005|Stage 2|Adverse Event|3|||
164062576|NCT01397409|592591056|FG006|Stage 2|Adverse Event|0|||
164062577|NCT01397409|592591057|FG007|Stage 2|Adverse Event|0|||
164062578|NCT01397409|592591058|FG008|Stage 2|Adverse Event|0|||
164062579|NCT01397409|592591059|FG009|Stage 2|Adverse Event|0|||
164062580|NCT01397409|592591050|FG000|Stage 2|Personal Reasons|0|||
164062581|NCT01397409|592591051|FG001|Stage 2|Personal Reasons|0|||
164062582|NCT01397409|592591052|FG002|Stage 2|Personal Reasons|0|||
164062583|NCT01397409|592591053|FG003|Stage 2|Personal Reasons|0|||
164062584|NCT01397409|592591054|FG004|Stage 2|Personal Reasons|1|||
164062585|NCT01397409|592591055|FG005|Stage 2|Personal Reasons|0|||
164062586|NCT01397409|592591056|FG006|Stage 2|Personal Reasons|0|||
164062587|NCT01397409|592591057|FG007|Stage 2|Personal Reasons|0|||
164062588|NCT01397409|592591058|FG008|Stage 2|Personal Reasons|0|||
164062589|NCT01397409|592591059|FG009|Stage 2|Personal Reasons|0|||
164062590|NCT01397409|592591050|FG000|Stage 2|Other Miscellaneous Reasons|0|||
164062591|NCT01397409|592591051|FG001|Stage 2|Other Miscellaneous Reasons|0|||
164062592|NCT01397409|592591052|FG002|Stage 2|Other Miscellaneous Reasons|0|||
164062593|NCT01397409|592591053|FG003|Stage 2|Other Miscellaneous Reasons|0|||
164062594|NCT01397409|592591054|FG004|Stage 2|Other Miscellaneous Reasons|1|||
164062595|NCT01397409|592591055|FG005|Stage 2|Other Miscellaneous Reasons|1|||
164062596|NCT01397409|592591056|FG006|Stage 2|Other Miscellaneous Reasons|0|||
164062597|NCT01397409|592591057|FG007|Stage 2|Other Miscellaneous Reasons|0|||
164062598|NCT01397409|592591058|FG008|Stage 2|Other Miscellaneous Reasons|0|||
164062599|NCT01397409|592591059|FG009|Stage 2|Other Miscellaneous Reasons|0|||
164062600|NCT01397409|592591050|FG000|Stage 3|Adverse Event|0|||
164062601|NCT01397409|592591051|FG001|Stage 3|Adverse Event|0|||
164062602|NCT01397409|592591052|FG002|Stage 3|Adverse Event|0|||
164062603|NCT01397409|592591053|FG003|Stage 3|Adverse Event|0|||
164102749|NCT03733444|592738864|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
164102750|NCT03733444|592738862|FG000|Overall Study|Study Terminated by Sponsor|203|||
164102751|NCT03733444|592738863|FG001|Overall Study|Study Terminated by Sponsor|209|||
164102752|NCT03733444|592738864|FG002|Overall Study|Study Terminated by Sponsor|221|||
164102753|NCT03733444|592738862|FG000|Overall Study|Withdrawal by Subject|19|||
164062604|NCT01397409|592591054|FG004|Stage 3|Adverse Event|0|||
164062605|NCT01397409|592591055|FG005|Stage 3|Adverse Event|0|||
164062606|NCT01397409|592591056|FG006|Stage 3|Adverse Event|0|||
164062607|NCT01397409|592591057|FG007|Stage 3|Adverse Event|1|||
164062608|NCT01397409|592591058|FG008|Stage 3|Adverse Event|0|||
164062609|NCT01397409|592591059|FG009|Stage 3|Adverse Event|0|||
164062610|NCT01397409|592591050|FG000|Stage 3|Other Miscellaneous Reasons|0|||
164062611|NCT01397409|592591051|FG001|Stage 3|Other Miscellaneous Reasons|0|||
164062612|NCT01397409|592591052|FG002|Stage 3|Other Miscellaneous Reasons|0|||
164062613|NCT01397409|592591053|FG003|Stage 3|Other Miscellaneous Reasons|0|||
164062614|NCT01397409|592591054|FG004|Stage 3|Other Miscellaneous Reasons|0|||
164062615|NCT01397409|592591055|FG005|Stage 3|Other Miscellaneous Reasons|0|||
164062616|NCT01397409|592591056|FG006|Stage 3|Other Miscellaneous Reasons|0|||
164062617|NCT01397409|592591057|FG007|Stage 3|Other Miscellaneous Reasons|1|||
164062618|NCT01397409|592591058|FG008|Stage 3|Other Miscellaneous Reasons|0|||
164062619|NCT01397409|592591059|FG009|Stage 3|Other Miscellaneous Reasons|0|||
164102754|NCT03733444|592738863|FG001|Overall Study|Withdrawal by Subject|18|||
164062620|NCT03418727|592591060|FG000|Overall Study|Adverse Event|1|||
164062621|NCT03418727|592591061|FG001|Overall Study|Adverse Event|2|||
164062622|NCT03418727|592591062|FG002|Overall Study|Adverse Event|0|||
164062623|NCT03418727|592591060|FG000|Overall Study|Withdrawal by Subject|0|||
164062624|NCT03418727|592591061|FG001|Overall Study|Withdrawal by Subject|0|||
164062625|NCT03418727|592591062|FG002|Overall Study|Withdrawal by Subject|2|||
164062626|NCT02451137|592591064|FG000|Overall Study|Randomized but not treated|19|||
164062627|NCT02451137|592591065|FG001|Overall Study|Randomized but not treated|27|||
164062628|NCT02451137|592591064|FG000|Overall Study|Adverse Event|43|||
164062629|NCT02451137|592591065|FG001|Overall Study|Adverse Event|42|||
164062630|NCT02451137|592591064|FG000|Overall Study|Lack of Efficacy|4|||
164062631|NCT02451137|592591065|FG001|Overall Study|Lack of Efficacy|9|||
164062632|NCT02451137|592591064|FG000|Overall Study|Participant decision:discontinue insulin|41|||
164062633|NCT02451137|592591065|FG001|Overall Study|Participant decision:discontinue insulin|43|||
164062634|NCT02451137|592591064|FG000|Overall Study|Hypoglycemia|2|||
164062635|NCT02451137|592591065|FG001|Overall Study|Hypoglycemia|1|||
164062636|NCT02451137|592591064|FG000|Overall Study|Investigator's decision|23|||
164062637|NCT02451137|592591065|FG001|Overall Study|Investigator's decision|19|||
164062638|NCT02451137|592591064|FG000|Overall Study|Lost to Follow-up|53|||
164062639|NCT02451137|592591065|FG001|Overall Study|Lost to Follow-up|61|||
164062640|NCT02451137|592591064|FG000|Overall Study|Physician Decision|6|||
164062641|NCT02451137|592591065|FG001|Overall Study|Physician Decision|5|||
164062642|NCT02451137|592591064|FG000|Overall Study|Sponsor decision|13|||
164062643|NCT02451137|592591065|FG001|Overall Study|Sponsor decision|25|||
164062644|NCT02451137|592591064|FG000|Overall Study|Withdrawal by Subject|40|||
164062645|NCT02451137|592591065|FG001|Overall Study|Withdrawal by Subject|63|||
164062646|NCT02451137|592591064|FG000|Overall Study|Other than specified above|2|||
164062647|NCT02451137|592591065|FG001|Overall Study|Other than specified above|3|||
164062648|NCT02911285|592591066|FG000|Overall Study|Lost to Follow-up|8|||
164062649|NCT02911285|592591067|FG001|Overall Study|Lost to Follow-up|5|||
164062650|NCT02911285|592591066|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
164062651|NCT02911285|592591067|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
164062652|NCT01740297|592592860|FG000|Overall Study|Withdrawal by Subject|4|||
164062653|NCT01740297|592592861|FG001|Overall Study|Withdrawal by Subject|16|||
164062654|NCT01740297|592592862|FG002|Overall Study|Withdrawal by Subject|17|||
164062655|NCT01740297|592592860|FG000|Overall Study|Death|8|||
164062656|NCT01740297|592592861|FG001|Overall Study|Death|46|||
164062657|NCT01740297|592592862|FG002|Overall Study|Death|40|||
164062658|NCT01740297|592592860|FG000|Overall Study|Lost to Follow-up|1|||
164062659|NCT01740297|592592861|FG001|Overall Study|Lost to Follow-up|2|||
164062660|NCT01740297|592592862|FG002|Overall Study|Lost to Follow-up|4|||
164062661|NCT03280628|592592867|FG000|Overall Study|Lost to Follow-up|8|||
164062662|NCT03280628|592592868|FG001|Overall Study|Lost to Follow-up|6|||
164062663|NCT03280628|592592869|FG002|Overall Study|Lost to Follow-up|11|||
164062664|NCT00761462|592592871|FG000|Treatment|Subjects never received study medication|23|||
164062665|NCT00761462|592592872|FG001|Treatment|Subjects never received study medication|12|||
164062666|NCT00761462|592592871|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
164062667|NCT00761462|592592872|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
164062668|NCT00761462|592592871|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
164062669|NCT00761462|592592872|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
164062670|NCT00761462|592592871|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
164062671|NCT00761462|592592872|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
164062672|NCT02163759|592592879|FG000|Overall Study|Withdrawal by Subject|1|||
164062673|NCT02163759|592592880|FG001|Overall Study|Withdrawal by Subject|5|||
164062674|NCT02163759|592592881|FG002|Overall Study|Withdrawal by Subject|1|||
164062675|NCT02163759|592592879|FG000|Overall Study|Adverse Event|0|||
164062676|NCT02163759|592592880|FG001|Overall Study|Adverse Event|0|||
164062677|NCT02163759|592592881|FG002|Overall Study|Adverse Event|1|||
164062678|NCT02163759|592592879|FG000|Overall Study|Death|0|||
164062679|NCT02163759|592592880|FG001|Overall Study|Death|0|||
164062680|NCT02163759|592592881|FG002|Overall Study|Death|1|||
164062681|NCT01479777|592592895|FG000|Overall Study|Physician Decision|2|||
164062682|NCT00451191|592592899|FG000|Overall Study|withdrawal or received alternate tx|15|||
164062683|NCT00451191|592592900|FG001|Overall Study|withdrawal or received alternate tx|11|||
164062684|NCT00656669|592592908|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
164062685|NCT00656669|592592908|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
164062686|NCT00656669|592592908|FG000|AC (Cycles 6-9)|Adverse Event|1|||
164062687|NCT00656669|592592908|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
164062688|NCT00219349|592592913|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
164062689|NCT00219349|592592913|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
164062690|NCT00219349|592592913|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
164062691|NCT00219349|592592913|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
164062692|NCT01241591|592592915|FG000|Overall Study|Lack of Efficacy|5|||
164062693|NCT01241591|592592916|FG001|Overall Study|Lack of Efficacy|2|||
164062694|NCT01241591|592592917|FG002|Overall Study|Lack of Efficacy|2|||
164062695|NCT01241591|592592918|FG003|Overall Study|Lack of Efficacy|3|||
164062696|NCT01241591|592592915|FG000|Overall Study|Protocol Violation|5|||
164062697|NCT01241591|592592916|FG001|Overall Study|Protocol Violation|2|||
164062698|NCT01241591|592592917|FG002|Overall Study|Protocol Violation|3|||
164062699|NCT01241591|592592918|FG003|Overall Study|Protocol Violation|0|||
164062700|NCT01241591|592592915|FG000|Overall Study|Lost to Follow-up|1|||
164062701|NCT01241591|592592916|FG001|Overall Study|Lost to Follow-up|2|||
164062702|NCT01241591|592592917|FG002|Overall Study|Lost to Follow-up|2|||
164062703|NCT01241591|592592918|FG003|Overall Study|Lost to Follow-up|2|||
164062704|NCT01241591|592592915|FG000|Overall Study|Screen Failure|3|||
164062705|NCT01241591|592592916|FG001|Overall Study|Screen Failure|2|||
164062706|NCT01241591|592592917|FG002|Overall Study|Screen Failure|1|||
164062707|NCT01241591|592592918|FG003|Overall Study|Screen Failure|0|||
164062708|NCT01241591|592592915|FG000|Overall Study|Withdrawal by Subject|6|||
164062709|NCT01241591|592592916|FG001|Overall Study|Withdrawal by Subject|4|||
164062710|NCT01241591|592592917|FG002|Overall Study|Withdrawal by Subject|2|||
164062711|NCT01241591|592592918|FG003|Overall Study|Withdrawal by Subject|2|||
164062712|NCT01241591|592592915|FG000|Overall Study|Other|0|||
164062713|NCT01241591|592592916|FG001|Overall Study|Other|1|||
164062714|NCT01241591|592592917|FG002|Overall Study|Other|0|||
164062715|NCT01241591|592592918|FG003|Overall Study|Other|1|||
164062716|NCT01241591|592592915|FG000|Overall Study|Adverse Event|3|||
164062717|NCT01241591|592592916|FG001|Overall Study|Adverse Event|11|||
164062718|NCT01241591|592592917|FG002|Overall Study|Adverse Event|12|||
164062719|NCT01241591|592592918|FG003|Overall Study|Adverse Event|4|||
164062720|NCT01945034|592592919|FG000|Overall Study|Medication Error|0|||
164062721|NCT01945034|592592920|FG001|Overall Study|Medication Error|1|||
164062722|NCT01945034|592592921|FG002|Overall Study|Medication Error|0|||
164062723|NCT01945034|592592919|FG000|Overall Study|Withdrawal by Subject|0|||
164062724|NCT01945034|592592920|FG001|Overall Study|Withdrawal by Subject|3|||
164062725|NCT01945034|592592921|FG002|Overall Study|Withdrawal by Subject|1|||
164062726|NCT01945034|592592919|FG000|Overall Study|Other|0|||
164062727|NCT01945034|592592920|FG001|Overall Study|Other|1|||
164062728|NCT01945034|592592921|FG002|Overall Study|Other|3|||
164062729|NCT01945034|592592919|FG000|Overall Study|Lost to Follow-up|0|||
164062730|NCT01945034|592592920|FG001|Overall Study|Lost to Follow-up|0|||
164062731|NCT01945034|592592921|FG002|Overall Study|Lost to Follow-up|2|||
164062732|NCT01945034|592592919|FG000|Overall Study|Protocol Violation|1|||
164062733|NCT01945034|592592920|FG001|Overall Study|Protocol Violation|0|||
164062734|NCT01945034|592592921|FG002|Overall Study|Protocol Violation|1|||
164062735|NCT00700115|592592924|FG000|Overall Study|Withdrawal by Subject|1|||
164062736|NCT00700115|592592925|FG001|Overall Study|Withdrawal by Subject|0|||
164062737|NCT00700115|592592924|FG000|Overall Study|Lost to Follow-up|0|||
164062738|NCT00700115|592592925|FG001|Overall Study|Lost to Follow-up|1|||
164062739|NCT02389621|592592927|FG000|Treatment Period|Withdrawal by Subject|1|||
164062740|NCT02389621|592592928|FG001|Treatment Period|Withdrawal by Subject|1|||
164062741|NCT02389621|592592927|FG000|Posttreatment Period|Adverse Event|3|||
164062742|NCT02389621|592592928|FG001|Posttreatment Period|Adverse Event|1|||
164062743|NCT02389621|592592927|FG000|Posttreatment Period|Withdrawal by Subject|3|||
164062744|NCT02389621|592592928|FG001|Posttreatment Period|Withdrawal by Subject|2|||
164062745|NCT02389621|592592927|FG000|Posttreatment Period|Lost to Follow-up|1|||
164062746|NCT02389621|592592928|FG001|Posttreatment Period|Lost to Follow-up|1|||
164062747|NCT02389621|592592927|FG000|Posttreatment Period|Other - Miscellaneous|2|||
164062748|NCT02389621|592592928|FG001|Posttreatment Period|Other - Miscellaneous|0|||
164062749|NCT01300741|592592935|FG000|Overall Study|Lens deposits|1|||
164062750|NCT01300741|592592935|FG000|Overall Study|Lost to Follow-up|1|||
164062751|NCT01300741|592592935|FG000|Overall Study|Discomfort|1|||
164062752|NCT04854421|592592936|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
164062753|NCT04854421|592592937|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
164062754|NCT00718809|592592939|FG000|Overall Study|Disease progression|9|||
164062755|NCT00718809|592592940|FG001|Overall Study|Disease progression|7|||
164062756|NCT00718809|592592939|FG000|Overall Study|Adverse Event|1|||
164062757|NCT00718809|592592940|FG001|Overall Study|Adverse Event|1|||
164062758|NCT00718809|592592939|FG000|Overall Study|Withdrawal by Subject|0|||
164062759|NCT00718809|592592940|FG001|Overall Study|Withdrawal by Subject|1|||
164062760|NCT00718809|592592939|FG000|Overall Study|Lost to Follow-up|1|||
164062761|NCT00718809|592592940|FG001|Overall Study|Lost to Follow-up|0|||
164062762|NCT00718809|592592939|FG000|Overall Study|Noncompliance|1|||
164062763|NCT00718809|592592940|FG001|Overall Study|Noncompliance|0|||
164062764|NCT00463385|592592941|FG000|Overall Study|Other|4|||
164062765|NCT00463385|592592942|FG001|Overall Study|Other|3|||
164062766|NCT00463385|592592943|FG002|Overall Study|Other|6|||
164062767|NCT00463385|592592944|FG003|Overall Study|Other|4|||
164062768|NCT00463385|592592941|FG000|Overall Study|Adverse Event|5|||
164062769|NCT00463385|592592942|FG001|Overall Study|Adverse Event|8|||
164062770|NCT00463385|592592943|FG002|Overall Study|Adverse Event|4|||
164062771|NCT00463385|592592944|FG003|Overall Study|Adverse Event|2|||
164062772|NCT00463385|592592941|FG000|Overall Study|Lack of Efficacy|6|||
164062773|NCT00463385|592592942|FG001|Overall Study|Lack of Efficacy|6|||
164062774|NCT00463385|592592943|FG002|Overall Study|Lack of Efficacy|7|||
164062775|NCT00463385|592592944|FG003|Overall Study|Lack of Efficacy|9|||
164062776|NCT00463385|592592941|FG000|Overall Study|Withdrawal by Subject|3|||
164062777|NCT00463385|592592942|FG001|Overall Study|Withdrawal by Subject|3|||
164062778|NCT00463385|592592943|FG002|Overall Study|Withdrawal by Subject|3|||
164062779|NCT00463385|592592944|FG003|Overall Study|Withdrawal by Subject|4|||
164062780|NCT00463385|592592941|FG000|Overall Study|Lost to Follow-up|0|||
164062781|NCT00463385|592592942|FG001|Overall Study|Lost to Follow-up|0|||
164062782|NCT00463385|592592943|FG002|Overall Study|Lost to Follow-up|0|||
164062783|NCT00463385|592592944|FG003|Overall Study|Lost to Follow-up|1|||
164062784|NCT00463385|592592941|FG000|Overall Study|Death|2|||
164062785|NCT00463385|592592942|FG001|Overall Study|Death|1|||
164062786|NCT00463385|592592943|FG002|Overall Study|Death|2|||
164062787|NCT00463385|592592944|FG003|Overall Study|Death|0|||
164062788|NCT00463385|592592941|FG000|Overall Study|Missing|2|||
164062789|NCT00463385|592592942|FG001|Overall Study|Missing|0|||
164062790|NCT00463385|592592943|FG002|Overall Study|Missing|0|||
164062791|NCT00463385|592592944|FG003|Overall Study|Missing|2|||
164062792|NCT00463385|592592941|FG000|Overall Study|1 participant received commercial drug|0|||
164062793|NCT00463385|592592942|FG001|Overall Study|1 participant received commercial drug|1|||
164062794|NCT00463385|592592943|FG002|Overall Study|1 participant received commercial drug|0|||
164062795|NCT00463385|592592944|FG003|Overall Study|1 participant received commercial drug|0|||
164062796|NCT00536991|592592946|FG000|Overall Study|Withdrawal by Subject|10|||
164062797|NCT00536991|592592946|FG000|Overall Study|Physician Decision|1|||
164062798|NCT00536991|592592946|FG000|Overall Study|patient ineligible|2|||
164062799|NCT00054639|592592947|FG000|Overall Study|Lack of Efficacy|1|||
164062800|NCT00054639|592592947|FG000|Overall Study|Physician Decision|1|||
164062801|NCT03246152|592592958|FG000|Overall Study|Lost to Follow-up|2|||
164062802|NCT03246152|592592958|FG000|Overall Study|Protocol Violation|1|||
164062803|NCT04359758|592592961|FG000|Overall Study|Protocol Violation|3|||
164062804|NCT04359758|592592962|FG001|Overall Study|Protocol Violation|2|||
164062805|NCT04145531|592592964|FG000|Part A|Adverse Event|2|||
164062806|NCT04145531|592592965|FG001|Part A|Adverse Event|12|||
164062807|NCT04145531|592592966|FG002|Part A|Adverse Event|6|||
164062808|NCT04145531|592592967|FG003|Part A|Adverse Event|0|||
164062809|NCT04145531|592592964|FG000|Part A|Death|1|||
164062810|NCT04145531|592592965|FG001|Part A|Death|2|||
164062811|NCT04145531|592592966|FG002|Part A|Death|0|||
164062812|NCT04145531|592592967|FG003|Part A|Death|0|||
164062813|NCT04145531|592592964|FG000|Part A|Physician Decision|2|||
164062814|NCT04145531|592592965|FG001|Part A|Physician Decision|5|||
164062815|NCT04145531|592592966|FG002|Part A|Physician Decision|2|||
164062816|NCT04145531|592592967|FG003|Part A|Physician Decision|0|||
164062817|NCT04145531|592592964|FG000|Part A|Progressive disease|0|||
164062818|NCT04145531|592592965|FG001|Part A|Progressive disease|2|||
164062819|NCT04145531|592592966|FG002|Part A|Progressive disease|1|||
164062820|NCT04145531|592592967|FG003|Part A|Progressive disease|0|||
164062821|NCT04145531|592592964|FG000|Part A|Protocol deviation|0|||
164062822|NCT04145531|592592965|FG001|Part A|Protocol deviation|0|||
164062823|NCT04145531|592592966|FG002|Part A|Protocol deviation|1|||
164062824|NCT04145531|592592967|FG003|Part A|Protocol deviation|0|||
164062825|NCT04145531|592592964|FG000|Part A|Withdrawal by parent or guardian|1|||
164062826|NCT04145531|592592965|FG001|Part A|Withdrawal by parent or guardian|0|||
164062827|NCT04145531|592592966|FG002|Part A|Withdrawal by parent or guardian|0|||
164062828|NCT04145531|592592967|FG003|Part A|Withdrawal by parent or guardian|0|||
164062829|NCT04145531|592592964|FG000|Part A|Withdrawal by participant|0|||
164062830|NCT04145531|592592965|FG001|Part A|Withdrawal by participant|0|||
164062831|NCT04145531|592592966|FG002|Part A|Withdrawal by participant|1|||
164062832|NCT04145531|592592967|FG003|Part A|Withdrawal by participant|0|||
164062833|NCT04145531|592592964|FG000|Part A|Other|0|||
164062834|NCT04145531|592592965|FG001|Part A|Other|0|||
164062835|NCT04145531|592592966|FG002|Part A|Other|1|||
164062836|NCT04145531|592592967|FG003|Part A|Other|0|||
164062837|NCT04145531|592592964|FG000|Part B|Adverse Event|0|||
164062838|NCT04145531|592592965|FG001|Part B|Adverse Event|0|||
164062839|NCT04145531|592592966|FG002|Part B|Adverse Event|0|||
164062840|NCT04145531|592592967|FG003|Part B|Adverse Event|21|||
164062841|NCT04145531|592592964|FG000|Part B|Physician Decision|0|||
164062842|NCT04145531|592592965|FG001|Part B|Physician Decision|0|||
164062843|NCT04145531|592592966|FG002|Part B|Physician Decision|0|||
164062844|NCT04145531|592592967|FG003|Part B|Physician Decision|7|||
164062845|NCT04145531|592592964|FG000|Part B|Progressive disease|0|||
164062846|NCT04145531|592592965|FG001|Part B|Progressive disease|0|||
164062847|NCT04145531|592592966|FG002|Part B|Progressive disease|0|||
164062848|NCT04145531|592592967|FG003|Part B|Progressive disease|1|||
164062849|NCT04145531|592592964|FG000|Part B|Recurrent disease|0|||
164062850|NCT04145531|592592965|FG001|Part B|Recurrent disease|0|||
164062851|NCT04145531|592592966|FG002|Part B|Recurrent disease|0|||
164062852|NCT04145531|592592967|FG003|Part B|Recurrent disease|1|||
164062853|NCT04145531|592592964|FG000|Part B|Withdrawal by parent or guardian|0|||
164062854|NCT04145531|592592965|FG001|Part B|Withdrawal by parent or guardian|0|||
164062855|NCT04145531|592592966|FG002|Part B|Withdrawal by parent or guardian|0|||
164062856|NCT04145531|592592967|FG003|Part B|Withdrawal by parent or guardian|3|||
164062857|NCT04145531|592592964|FG000|Part B|Withdrawal by participant|0|||
164062858|NCT04145531|592592965|FG001|Part B|Withdrawal by participant|0|||
164062859|NCT04145531|592592966|FG002|Part B|Withdrawal by participant|0|||
164062860|NCT04145531|592592967|FG003|Part B|Withdrawal by participant|1|||
164062861|NCT04145531|592592964|FG000|Part B|Other|0|||
164062862|NCT04145531|592592965|FG001|Part B|Other|0|||
164062863|NCT04145531|592592966|FG002|Part B|Other|0|||
164062864|NCT04145531|592592967|FG003|Part B|Other|1|||
164062865|NCT02067728|592592968|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
164062866|NCT02067728|592592969|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
164062867|NCT02067728|592592968|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
164062868|NCT02067728|592592969|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
164062869|NCT02067728|592592968|FG000|6 Month Measurements|Unable to attend|114|||
164062870|NCT02067728|592592969|FG001|6 Month Measurements|Unable to attend|97|||
164062871|NCT03557775|592592970|FG000|Overall Study|Withdrawal by Subject|1|||
164062872|NCT03557775|592592971|FG001|Overall Study|Withdrawal by Subject|2|||
164062873|NCT03557775|592592972|FG002|Overall Study|Withdrawal by Subject|4|||
164062874|NCT03557775|592592970|FG000|Overall Study|Physician Decision|0|||
164062875|NCT03557775|592592971|FG001|Overall Study|Physician Decision|1|||
164062876|NCT03557775|592592972|FG002|Overall Study|Physician Decision|0|||
164062877|NCT01725217|592592973|FG000|Overall Study|Withdrawal by Subject|1|||
164062878|NCT01725217|592592974|FG001|Overall Study|Withdrawal by Subject|0|||
164062879|NCT01725217|592592975|FG002|Overall Study|Withdrawal by Subject|0|||
164062880|NCT00585468|592592980|FG000|First Intervention|Withdrawal by Subject|1|||
164062881|NCT00585468|592592981|FG001|First Intervention|Withdrawal by Subject|1|||
164062882|NCT00276458|592592982|FG000|Overall Study|Adverse Event|0|||
164062883|NCT00276458|592592983|FG001|Overall Study|Adverse Event|2|||
164062884|NCT00276458|592592982|FG000|Overall Study|Lost to Follow-up|2|||
164062885|NCT00276458|592592983|FG001|Overall Study|Lost to Follow-up|2|||
164062886|NCT00276458|592592982|FG000|Overall Study|Protocol Violation|4|||
164062887|NCT00276458|592592983|FG001|Overall Study|Protocol Violation|3|||
164062888|NCT00978120|592592984|FG000|Overall Study|Death|0|||
164062889|NCT00978120|592592985|FG001|Overall Study|Death|0|||
164062890|NCT00978120|592592986|FG002|Overall Study|Death|0|||
164062891|NCT00978120|592592987|FG003|Overall Study|Death|1|||
164062892|NCT00978120|592592984|FG000|Overall Study|Lost to Follow-up|0|||
164062893|NCT00978120|592592985|FG001|Overall Study|Lost to Follow-up|0|||
164062894|NCT00978120|592592986|FG002|Overall Study|Lost to Follow-up|3|||
164062895|NCT00978120|592592987|FG003|Overall Study|Lost to Follow-up|0|||
164062896|NCT00978120|592592984|FG000|Overall Study|Withdrawal by Subject|2|||
164062897|NCT00978120|592592985|FG001|Overall Study|Withdrawal by Subject|0|||
164062898|NCT00978120|592592986|FG002|Overall Study|Withdrawal by Subject|0|||
164062899|NCT00978120|592592987|FG003|Overall Study|Withdrawal by Subject|0|||
164062900|NCT00978120|592592984|FG000|Overall Study|Moved out of state|0|||
164062901|NCT00978120|592592985|FG001|Overall Study|Moved out of state|0|||
164062902|NCT00978120|592592986|FG002|Overall Study|Moved out of state|0|||
164062903|NCT00978120|592592987|FG003|Overall Study|Moved out of state|1|||
164062904|NCT01023815|592592989|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
164062905|NCT01023815|592592990|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
164062906|NCT01023815|592592991|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
164062907|NCT01023815|592592992|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
164062908|NCT01023815|592592989|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
164062909|NCT01023815|592592990|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
164062910|NCT01023815|592592991|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
164062911|NCT01023815|592592992|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
164062912|NCT01023815|592592989|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
164062913|NCT01023815|592592990|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
164062914|NCT01023815|592592991|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
164062915|NCT01023815|592592992|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
164062916|NCT01023815|592592989|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
164062917|NCT01023815|592592990|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
164062918|NCT01023815|592592991|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
164062919|NCT01023815|592592992|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
164062920|NCT01023815|592592989|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
164062921|NCT01023815|592592990|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
164062922|NCT01023815|592592991|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
164062923|NCT01023815|592592992|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
164062924|NCT02967055|592592995|FG000|Overall Study|Excluded|40|||
164062925|NCT02967055|592592995|FG000|Overall Study|Screen fail|3|||
164062926|NCT02967055|592592995|FG000|Overall Study|Lost to Follow-up|2|||
164062927|NCT02967055|592592995|FG000|Overall Study|Stopped due to side effects|3|||
164062928|NCT02967055|592592995|FG000|Overall Study|Stopped due to drug cost|1|||
164062929|NCT01298323|592592997|FG000|Overall Study|Adverse Event|2|||
164062930|NCT01298323|592592998|FG001|Overall Study|Adverse Event|4|||
164062931|NCT01298323|592592997|FG000|Overall Study|Death|11|||
164062932|NCT01298323|592592998|FG001|Overall Study|Death|16|||
164062933|NCT01298323|592592997|FG000|Overall Study|Lost to Follow-up|1|||
164062934|NCT01298323|592592998|FG001|Overall Study|Lost to Follow-up|0|||
164062935|NCT01298323|592592997|FG000|Overall Study|Withdrawal by Subject|6|||
164062936|NCT01298323|592592998|FG001|Overall Study|Withdrawal by Subject|3|||
164062937|NCT01298323|592592997|FG000|Overall Study|Protocol Violation|1|||
164062938|NCT01298323|592592998|FG001|Overall Study|Protocol Violation|0|||
164062939|NCT01298323|592592997|FG000|Overall Study|Other|10|||
164062940|NCT01298323|592592998|FG001|Overall Study|Other|9|||
164062941|NCT01298323|592592997|FG000|Overall Study|Ongoing|55|||
164062942|NCT01298323|592592998|FG001|Overall Study|Ongoing|55|||
164062943|NCT01298323|592592997|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164062944|NCT01298323|592592998|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164062945|NCT01761565|592592999|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
164062946|NCT02161380|592593000|FG000|Overall Study|Lost to Follow-up|0|||
164062947|NCT02161380|592593001|FG001|Overall Study|Lost to Follow-up|1|||
164062948|NCT02161380|592593002|FG002|Overall Study|Lost to Follow-up|0|||
164062949|NCT02161380|592593003|FG003|Overall Study|Lost to Follow-up|0|||
164062950|NCT03655951|592593005|FG000|Overall Study|Lost to Follow-up|39|||
164062951|NCT03655951|592593006|FG001|Overall Study|Lost to Follow-up|20|||
164062952|NCT03655951|592593005|FG000|Overall Study|Withdrawal by Subject|0|||
164062953|NCT03655951|592593006|FG001|Overall Study|Withdrawal by Subject|1|||
164062954|NCT01078974|592593011|FG000|Overall Study|Adverse Event|3|||
164062955|NCT01393444|592593012|FG000|Overall Study|Withdrawal by Subject|1|||
164062956|NCT01393444|592593012|FG000|Overall Study|Determined ineligible during screening.|2|||
164062957|NCT01791543|592593014|FG000|Overall Study|Lost to Follow-up|1|||
164062958|NCT01791543|592593014|FG000|Overall Study|Adverse Event|1|||
164062959|NCT00066573|592594398|FG000|Overall Study|Did not received protocol treatment|28|||
164062960|NCT00066573|592594399|FG001|Overall Study|Did not received protocol treatment|28|||
164062961|NCT01646268|592594403|FG000|Overall Study|Adverse Event|6|||
164062962|NCT01646268|592594404|FG001|Overall Study|Adverse Event|7|||
164062963|NCT01646268|592594403|FG000|Overall Study|Lack of Efficacy|1|||
164062964|NCT01646268|592594404|FG001|Overall Study|Lack of Efficacy|3|||
164062965|NCT01646268|592594403|FG000|Overall Study|Protocol Violation|0|||
164062966|NCT01646268|592594404|FG001|Overall Study|Protocol Violation|1|||
164062967|NCT01646268|592594403|FG000|Overall Study|Withdrawal by Subject|2|||
164062968|NCT01646268|592594404|FG001|Overall Study|Withdrawal by Subject|5|||
164062969|NCT01646268|592594403|FG000|Overall Study|Other|2|||
164062970|NCT01646268|592594404|FG001|Overall Study|Other|0|||
164062971|NCT02222246|592594405|FG000|Overall Study|No Emergency Department Visits|27|||
164062972|NCT02222246|592594406|FG001|Overall Study|No Emergency Department Visits|26|||
164062973|NCT02222246|592594405|FG000|Overall Study|Physician Decision|0|||
164062974|NCT02222246|592594406|FG001|Overall Study|Physician Decision|1|||
164062975|NCT01473602|592594409|FG000|Overall Study|Adverse Event|1|||
164062976|NCT01473602|592594410|FG001|Overall Study|Adverse Event|2|||
164062977|NCT01473602|592594409|FG000|Overall Study|Death|0|||
164062978|NCT01473602|592594410|FG001|Overall Study|Death|1|||
164062979|NCT01473602|592594409|FG000|Overall Study|Lost to Follow-up|1|||
164062980|NCT01473602|592594410|FG001|Overall Study|Lost to Follow-up|1|||
164062981|NCT01473602|592594409|FG000|Overall Study|Withdrawal by Subject|5|||
164062982|NCT01473602|592594410|FG001|Overall Study|Withdrawal by Subject|4|||
164062983|NCT01473602|592594409|FG000|Overall Study|Physician Decision|1|||
164062984|NCT01473602|592594410|FG001|Overall Study|Physician Decision|0|||
164062985|NCT00449761|592594412|FG000|Overall Study|Disease progression|12|||
164062986|NCT00449761|592594412|FG000|Overall Study|Death|5|||
164062987|NCT00449761|592594412|FG000|Overall Study|New cancer therapy|1|||
164062988|NCT00560573|592594413|FG000|Overall Study|Death|4|||
164062989|NCT00560573|592594414|FG001|Overall Study|Death|1|||
164062990|NCT00560573|592594415|FG002|Overall Study|Death|4|||
164062991|NCT00560573|592594416|FG003|Overall Study|Death|5|||
164062992|NCT00560573|592594417|FG004|Overall Study|Death|1|||
164062993|NCT00560573|592594418|FG005|Overall Study|Death|10|||
164062994|NCT00560573|592594413|FG000|Overall Study|Lost to Follow-up|0|||
164062995|NCT00560573|592594414|FG001|Overall Study|Lost to Follow-up|0|||
164062996|NCT00560573|592594415|FG002|Overall Study|Lost to Follow-up|0|||
164062997|NCT00560573|592594416|FG003|Overall Study|Lost to Follow-up|1|||
164062998|NCT00560573|592594417|FG004|Overall Study|Lost to Follow-up|1|||
164062999|NCT00560573|592594418|FG005|Overall Study|Lost to Follow-up|0|||
164063000|NCT00560573|592594413|FG000|Overall Study|Withdrawal by Subject|0|||
164063001|NCT00560573|592594414|FG001|Overall Study|Withdrawal by Subject|0|||
164063002|NCT00560573|592594415|FG002|Overall Study|Withdrawal by Subject|0|||
164063003|NCT00560573|592594416|FG003|Overall Study|Withdrawal by Subject|1|||
164063004|NCT00560573|592594417|FG004|Overall Study|Withdrawal by Subject|1|||
164063005|NCT00560573|592594418|FG005|Overall Study|Withdrawal by Subject|0|||
164063006|NCT00560573|592594413|FG000|Overall Study|Other|2|||
164063007|NCT00560573|592594414|FG001|Overall Study|Other|2|||
164063008|NCT00560573|592594415|FG002|Overall Study|Other|2|||
164063009|NCT00560573|592594416|FG003|Overall Study|Other|3|||
164063010|NCT00560573|592594417|FG004|Overall Study|Other|3|||
164063011|NCT00560573|592594418|FG005|Overall Study|Other|3|||
164063012|NCT00560573|592594413|FG000|Overall Study|Enrolled, not treated|0|||
164063013|NCT00560573|592594414|FG001|Overall Study|Enrolled, not treated|0|||
164063014|NCT00560573|592594415|FG002|Overall Study|Enrolled, not treated|0|||
164063015|NCT00560573|592594416|FG003|Overall Study|Enrolled, not treated|0|||
164063016|NCT00560573|592594417|FG004|Overall Study|Enrolled, not treated|1|||
164063017|NCT00560573|592594418|FG005|Overall Study|Enrolled, not treated|0|||
164063018|NCT01422876|592594422|FG000|Week 24|Lost to Follow-up|1|||
164063019|NCT01422876|592594423|FG001|Week 24|Lost to Follow-up|1|||
164063020|NCT01422876|592594424|FG002|Week 24|Lost to Follow-up|2|||
164063021|NCT01422876|592594425|FG003|Week 24|Lost to Follow-up|4|||
164063022|NCT01422876|592594426|FG004|Week 24|Lost to Follow-up|2|||
164063023|NCT01422876|592594427|FG005|Week 24|Lost to Follow-up|0|||
164063024|NCT01422876|592594428|FG006|Week 24|Lost to Follow-up|1|||
164063025|NCT01422876|592594429|FG007|Week 24|Lost to Follow-up|3|||
164063026|NCT01422876|592594430|FG008|Week 24|Lost to Follow-up|3|||
164063027|NCT01422876|592594431|FG009|Week 24|Lost to Follow-up|4|||
164063028|NCT01422876|592594422|FG000|Week 24|Consent withdrawn|5|||
164063029|NCT01422876|592594423|FG001|Week 24|Consent withdrawn|1|||
164063030|NCT01422876|592594424|FG002|Week 24|Consent withdrawn|3|||
164063031|NCT01422876|592594425|FG003|Week 24|Consent withdrawn|4|||
164063032|NCT01422876|592594426|FG004|Week 24|Consent withdrawn|5|||
164063033|NCT01422876|592594427|FG005|Week 24|Consent withdrawn|6|||
164063034|NCT01422876|592594428|FG006|Week 24|Consent withdrawn|5|||
164063035|NCT01422876|592594429|FG007|Week 24|Consent withdrawn|4|||
164063036|NCT01422876|592594430|FG008|Week 24|Consent withdrawn|3|||
164063037|NCT01422876|592594431|FG009|Week 24|Consent withdrawn|6|||
164063038|NCT01422876|592594422|FG000|Week 24|Death|0|||
164063039|NCT01422876|592594423|FG001|Week 24|Death|1|||
164063040|NCT01422876|592594424|FG002|Week 24|Death|0|||
164063041|NCT01422876|592594425|FG003|Week 24|Death|0|||
164063042|NCT01422876|592594426|FG004|Week 24|Death|0|||
164063043|NCT01422876|592594427|FG005|Week 24|Death|0|||
164063044|NCT01422876|592594428|FG006|Week 24|Death|0|||
164063045|NCT01422876|592594429|FG007|Week 24|Death|0|||
164063046|NCT01422876|592594430|FG008|Week 24|Death|0|||
164063047|NCT01422876|592594431|FG009|Week 24|Death|0|||
164063048|NCT01422876|592594422|FG000|Week 52|Lost to Follow-up|3|||
164063049|NCT01422876|592594423|FG001|Week 52|Lost to Follow-up|5|||
164063050|NCT01422876|592594424|FG002|Week 52|Lost to Follow-up|7|||
164063051|NCT01422876|592594425|FG003|Week 52|Lost to Follow-up|5|||
164063052|NCT01422876|592594426|FG004|Week 52|Lost to Follow-up|8|||
164063053|NCT01422876|592594427|FG005|Week 52|Lost to Follow-up|5|||
164063054|NCT01422876|592594428|FG006|Week 52|Lost to Follow-up|5|||
164063055|NCT01422876|592594429|FG007|Week 52|Lost to Follow-up|8|||
164063056|NCT01422876|592594430|FG008|Week 52|Lost to Follow-up|7|||
164063057|NCT01422876|592594431|FG009|Week 52|Lost to Follow-up|8|||
164063058|NCT01422876|592594422|FG000|Week 52|Consent withdrawn|9|||
164063059|NCT01422876|592594423|FG001|Week 52|Consent withdrawn|4|||
164063060|NCT01422876|592594424|FG002|Week 52|Consent withdrawn|6|||
164063061|NCT01422876|592594425|FG003|Week 52|Consent withdrawn|12|||
164063062|NCT01422876|592594426|FG004|Week 52|Consent withdrawn|7|||
164063063|NCT01422876|592594427|FG005|Week 52|Consent withdrawn|12|||
164063064|NCT01422876|592594428|FG006|Week 52|Consent withdrawn|10|||
164063065|NCT01422876|592594429|FG007|Week 52|Consent withdrawn|12|||
164063066|NCT01422876|592594430|FG008|Week 52|Consent withdrawn|13|||
164063067|NCT01422876|592594431|FG009|Week 52|Consent withdrawn|9|||
164063068|NCT01422876|592594422|FG000|Week 52|Death|0|||
164063069|NCT01422876|592594423|FG001|Week 52|Death|1|||
164063070|NCT01422876|592594424|FG002|Week 52|Death|0|||
164063071|NCT01422876|592594425|FG003|Week 52|Death|1|||
164063072|NCT01422876|592594426|FG004|Week 52|Death|0|||
164063073|NCT01422876|592594427|FG005|Week 52|Death|0|||
164063074|NCT01422876|592594428|FG006|Week 52|Death|1|||
164063075|NCT01422876|592594429|FG007|Week 52|Death|3|||
164063076|NCT01422876|592594430|FG008|Week 52|Death|1|||
164063077|NCT01422876|592594431|FG009|Week 52|Death|0|||
164063078|NCT01600755|592594432|FG000|Overall Study|Withdrawal by Subject|6|||
164063079|NCT00938392|592594437|FG000|Overall Study|Adverse Event|0|||
164063080|NCT00938392|592594438|FG001|Overall Study|Adverse Event|1|||
164063081|NCT00938392|592594437|FG000|Overall Study|Withdrawal by Subject|0|||
164063082|NCT00938392|592594438|FG001|Overall Study|Withdrawal by Subject|1|||
164063083|NCT00938392|592594437|FG000|Overall Study|Lost to Follow-up|2|||
164063084|NCT00938392|592594438|FG001|Overall Study|Lost to Follow-up|2|||
164063085|NCT00122954|592594439|FG000|Overall Study|Withdrawal by Subject|2|||
164063086|NCT00122954|592594440|FG001|Overall Study|Withdrawal by Subject|2|||
164063087|NCT00122954|592594439|FG000|Overall Study|Protocol Violation|0|||
164063088|NCT00122954|592594440|FG001|Overall Study|Protocol Violation|1|||
164102755|NCT03733444|592738864|FG002|Overall Study|Withdrawal by Subject|16|||
164063089|NCT00558831|592594441|FG000|Overall Study|Lost to Follow-up|1|||
164063090|NCT02204449|592594442|FG000|Overall Study|Lost to Follow-up|7|||
164063091|NCT02204449|592594443|FG001|Overall Study|Lost to Follow-up|9|||
164063092|NCT02204449|592594442|FG000|Overall Study|Death|0|||
164063093|NCT02204449|592594443|FG001|Overall Study|Death|1|||
164063094|NCT02204449|592594442|FG000|Overall Study|Withdrawal by Subject|0|||
164063095|NCT02204449|592594443|FG001|Overall Study|Withdrawal by Subject|1|||
164063096|NCT02856282|592594444|FG000|Overall Study|Withdrawal by Subject|1|||
164102756|NCT03733444|592738862|FG000|Overall Study|Miscellaneous|1|||
164063097|NCT00057330|592594445|FG000|Overall Study|Adverse Event|9|||
164063098|NCT00057330|592594446|FG001|Overall Study|Adverse Event|12|||
164063099|NCT00057330|592594445|FG000|Overall Study|Death|1|||
164063100|NCT00057330|592594446|FG001|Overall Study|Death|0|||
164063101|NCT00057330|592594445|FG000|Overall Study|Protocol Violation|1|||
164063102|NCT00057330|592594446|FG001|Overall Study|Protocol Violation|1|||
164063103|NCT00057330|592594445|FG000|Overall Study|Withdrawal by Subject|115|||
164063104|NCT00057330|592594446|FG001|Overall Study|Withdrawal by Subject|84|||
164063105|NCT00057330|592594445|FG000|Overall Study|Lost to Follow-up|745|||
164063106|NCT00057330|592594446|FG001|Overall Study|Lost to Follow-up|617|||
164063107|NCT00057330|592594445|FG000|Overall Study|Physician Decision|1|||
164063108|NCT00057330|592594446|FG001|Overall Study|Physician Decision|0|||
164063109|NCT00057330|592594445|FG000|Overall Study|Other|260|||
164063110|NCT00057330|592594446|FG001|Overall Study|Other|206|||
164063111|NCT01491737|592594450|FG000|Overall Study|Withdrawal by Subject|20|||
164063112|NCT01491737|592594451|FG001|Overall Study|Withdrawal by Subject|17|||
164063113|NCT01491737|592594450|FG000|Overall Study|Lost to Follow-up|2|||
164063114|NCT01491737|592594451|FG001|Overall Study|Lost to Follow-up|10|||
164063115|NCT01491737|592594450|FG000|Overall Study|Death|63|||
164063116|NCT01491737|592594451|FG001|Overall Study|Death|57|||
164063117|NCT01491737|592594450|FG000|Overall Study|Study Termination by Sponsor|36|||
164063118|NCT01491737|592594451|FG001|Overall Study|Study Termination by Sponsor|36|||
164063119|NCT01491737|592594450|FG000|Overall Study|Reason Not Specified|8|||
164063120|NCT01491737|592594451|FG001|Overall Study|Reason Not Specified|9|||
164063121|NCT03772574|592594454|FG000|Overall Study|Protocol Violation|2|||
164063122|NCT03772574|592594455|FG001|Overall Study|Protocol Violation|0|||
164063123|NCT03772574|592594456|FG002|Overall Study|Protocol Violation|0|||
164063124|NCT03772574|592594454|FG000|Overall Study|Discomfort|0|||
164063125|NCT03772574|592594455|FG001|Overall Study|Discomfort|5|||
164063126|NCT03772574|592594456|FG002|Overall Study|Discomfort|4|||
164063127|NCT02696382|592594457|FG000|Overall Study|Death|7|||
164102757|NCT03733444|592738863|FG001|Overall Study|Miscellaneous|0|||
164102758|NCT03733444|592738864|FG002|Overall Study|Miscellaneous|1|||
164102759|NCT03733444|592738862|FG000|Overall Study|Not Treated|1|||
164102760|NCT03733444|592738863|FG001|Overall Study|Not Treated|2|||
164102761|NCT03733444|592738864|FG002|Overall Study|Not Treated|1|||
164102762|NCT03637764|592738865|FG000|Overall Study|Adverse Event|2|||
164102763|NCT03637764|592738866|FG001|Overall Study|Adverse Event|0|||
164102764|NCT03637764|592738867|FG002|Overall Study|Adverse Event|0|||
164102765|NCT03637764|592738868|FG003|Overall Study|Adverse Event|1|||
164102766|NCT03637764|592738865|FG000|Overall Study|Progressive Disease|23|||
164102767|NCT03637764|592738866|FG001|Overall Study|Progressive Disease|23|||
164102768|NCT03637764|592738867|FG002|Overall Study|Progressive Disease|18|||
164102769|NCT03637764|592738868|FG003|Overall Study|Progressive Disease|31|||
164102770|NCT03637764|592738865|FG000|Overall Study|Withdrawal by Subject|1|||
164102771|NCT03637764|592738866|FG001|Overall Study|Withdrawal by Subject|3|||
164102772|NCT03637764|592738867|FG002|Overall Study|Withdrawal by Subject|0|||
164102773|NCT03637764|592738868|FG003|Overall Study|Withdrawal by Subject|1|||
164102774|NCT02648438|592738869|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164102775|NCT02648438|592738870|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
164102776|NCT02648438|592738871|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164063128|NCT02696382|592594458|FG001|Overall Study|Death|2|||
164063129|NCT02696382|592594457|FG000|Overall Study|Withdrawal by Subject|5|||
164063130|NCT02696382|592594458|FG001|Overall Study|Withdrawal by Subject|12|||
164063131|NCT02696382|592594457|FG000|Overall Study|Lost to Follow-up|4|||
164063132|NCT02696382|592594458|FG001|Overall Study|Lost to Follow-up|7|||
164063133|NCT00494234|592594459|FG000|Overall Study|Withdrawal by Subject|1|||
164063134|NCT00494234|592594460|FG001|Overall Study|Withdrawal by Subject|0|||
164063135|NCT00494234|592594459|FG000|Overall Study|Disease progression|11|||
164063136|NCT00494234|592594460|FG001|Overall Study|Disease progression|8|||
164063137|NCT00494234|592594459|FG000|Overall Study|Death|2|||
164063138|NCT00494234|592594460|FG001|Overall Study|Death|1|||
164102777|NCT02648438|592738869|FG000|Overall Study|Protocol Violation|2|||
164102778|NCT02648438|592738870|FG001|Overall Study|Protocol Violation|0|||
164102779|NCT02648438|592738871|FG002|Overall Study|Protocol Violation|0|||
164063139|NCT02743117|592594464|FG000|Overall Study|Lost to Follow-up|0|||
164063140|NCT02743117|592594465|FG001|Overall Study|Lost to Follow-up|1|||
164063141|NCT02743117|592594464|FG000|Overall Study|Other|1|||
164063142|NCT02743117|592594465|FG001|Overall Study|Other|0|||
164063143|NCT04983589|592594466|FG000|Overall Study|Withdrawal by Subject|0|||
164063144|NCT04983589|592594467|FG001|Overall Study|Withdrawal by Subject|3|||
164063145|NCT04983589|592594466|FG000|Overall Study|COVID-19 Infection|1|||
164102780|NCT02648438|592738869|FG000|Overall Study|Withdrawal by Subject|1|||
164102781|NCT02648438|592738870|FG001|Overall Study|Withdrawal by Subject|1|||
164102782|NCT02648438|592738871|FG002|Overall Study|Withdrawal by Subject|0|||
164063146|NCT04983589|592594467|FG001|Overall Study|COVID-19 Infection|0|||
164063147|NCT04983589|592594466|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
164063148|NCT04983589|592594467|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
164063149|NCT02940392|592594470|FG000|Overall Study|Lost to Follow-up|3|||
164102783|NCT01854047|592738874|FG000|Overall Study|Lack of Efficacy|1|||
164063150|NCT02940392|592594470|FG000|Overall Study|Retreatment|3|||
164063151|NCT02940392|592594470|FG000|Overall Study|Death|2|||
164063152|NCT00762073|592594473|FG000|Overall Study|Lack of Efficacy|1|||
164063153|NCT00762073|592594474|FG001|Overall Study|Lack of Efficacy|1|||
164063154|NCT00762073|592594475|FG002|Overall Study|Lack of Efficacy|0|||
164063155|NCT00762073|592594476|FG003|Overall Study|Lack of Efficacy|0|||
164063156|NCT00762073|592594473|FG000|Overall Study|Adverse Event|1|||
164063157|NCT00762073|592594474|FG001|Overall Study|Adverse Event|0|||
164063158|NCT00762073|592594475|FG002|Overall Study|Adverse Event|1|||
164063159|NCT00762073|592594476|FG003|Overall Study|Adverse Event|1|||
164063160|NCT00762073|592594473|FG000|Overall Study|Significant Subject Noncompliance|0|||
164063161|NCT00762073|592594474|FG001|Overall Study|Significant Subject Noncompliance|1|||
164063162|NCT00762073|592594475|FG002|Overall Study|Significant Subject Noncompliance|0|||
164063163|NCT00762073|592594476|FG003|Overall Study|Significant Subject Noncompliance|1|||
164063164|NCT00762073|592594473|FG000|Overall Study|Withdrawal by Subject|1|||
164063165|NCT00762073|592594474|FG001|Overall Study|Withdrawal by Subject|2|||
164063166|NCT00762073|592594475|FG002|Overall Study|Withdrawal by Subject|1|||
164063167|NCT00762073|592594476|FG003|Overall Study|Withdrawal by Subject|1|||
164063168|NCT00762073|592594473|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
164063169|NCT00762073|592594474|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
164063170|NCT00762073|592594475|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
164063171|NCT00762073|592594476|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
164063172|NCT02319642|592594477|FG000|Overall Study|Adverse Event|2|||
164063173|NCT02319642|592594478|FG001|Overall Study|Adverse Event|4|||
164063174|NCT02319642|592594477|FG000|Overall Study|Lack of Efficacy|1|||
164063175|NCT02319642|592594478|FG001|Overall Study|Lack of Efficacy|1|||
164063176|NCT02319642|592594477|FG000|Overall Study|Withdrawal by Subject|1|||
164063177|NCT02319642|592594478|FG001|Overall Study|Withdrawal by Subject|1|||
164063178|NCT01265875|592594479|FG000|Overall Study|Uncooperative/unreliable|1|||
164063179|NCT01049360|592594482|FG000|Period 1|Adverse Event|0|||
164063180|NCT01049360|592594483|FG001|Period 1|Adverse Event|1|||
164063181|NCT01049360|592594484|FG002|Period 1|Adverse Event|0|||
164063182|NCT01049360|592594485|FG003|Period 1|Adverse Event|1|||
164063183|NCT01049360|592594486|FG004|Period 1|Adverse Event|0|||
164063184|NCT01049360|592594487|FG005|Period 1|Adverse Event|0|||
164063185|NCT01049360|592594488|FG006|Period 1|Adverse Event|0|||
164063186|NCT01049360|592594489|FG007|Period 1|Adverse Event|1|||
164063187|NCT01049360|592594490|FG008|Period 1|Adverse Event|0|||
164063188|NCT01049360|592594491|FG009|Period 1|Adverse Event|0|||
164063189|NCT01049360|592594492|FG010|Period 1|Adverse Event|0|||
164063190|NCT01049360|592594493|FG011|Period 1|Adverse Event|0|||
164063191|NCT01049360|592594494|FG012|Period 1|Adverse Event|1|||
164063192|NCT01049360|592594495|FG013|Period 1|Adverse Event|1|||
164063193|NCT01049360|592594496|FG014|Period 1|Adverse Event|0|||
164063194|NCT01049360|592594497|FG015|Period 1|Adverse Event|0|||
164063195|NCT01049360|592594498|FG016|Period 1|Adverse Event|1|||
164063196|NCT01049360|592594499|FG017|Period 1|Adverse Event|0|||
164063197|NCT01049360|592594500|FG018|Period 1|Adverse Event|1|||
164063198|NCT01049360|592594501|FG019|Period 1|Adverse Event|0|||
164063199|NCT01049360|592594482|FG000|Period 1|Did not meet inc/exc criteria|0|||
164063200|NCT01049360|592594483|FG001|Period 1|Did not meet inc/exc criteria|0|||
164063201|NCT01049360|592594484|FG002|Period 1|Did not meet inc/exc criteria|0|||
164063202|NCT01049360|592594485|FG003|Period 1|Did not meet inc/exc criteria|0|||
164063203|NCT01049360|592594486|FG004|Period 1|Did not meet inc/exc criteria|0|||
164063204|NCT01049360|592594487|FG005|Period 1|Did not meet inc/exc criteria|0|||
164063205|NCT01049360|592594488|FG006|Period 1|Did not meet inc/exc criteria|0|||
164063206|NCT01049360|592594489|FG007|Period 1|Did not meet inc/exc criteria|1|||
164063207|NCT01049360|592594490|FG008|Period 1|Did not meet inc/exc criteria|1|||
164063208|NCT01049360|592594491|FG009|Period 1|Did not meet inc/exc criteria|0|||
164063209|NCT01049360|592594492|FG010|Period 1|Did not meet inc/exc criteria|0|||
164063210|NCT01049360|592594493|FG011|Period 1|Did not meet inc/exc criteria|0|||
164063211|NCT01049360|592594494|FG012|Period 1|Did not meet inc/exc criteria|0|||
164063212|NCT01049360|592594495|FG013|Period 1|Did not meet inc/exc criteria|0|||
164063213|NCT01049360|592594496|FG014|Period 1|Did not meet inc/exc criteria|0|||
164063214|NCT01049360|592594497|FG015|Period 1|Did not meet inc/exc criteria|0|||
164063215|NCT01049360|592594498|FG016|Period 1|Did not meet inc/exc criteria|0|||
164102784|NCT01854047|592738875|FG001|Overall Study|Lack of Efficacy|0|||
164063216|NCT01049360|592594499|FG017|Period 1|Did not meet inc/exc criteria|0|||
164063217|NCT01049360|592594500|FG018|Period 1|Did not meet inc/exc criteria|0|||
164063218|NCT01049360|592594501|FG019|Period 1|Did not meet inc/exc criteria|0|||
164063219|NCT01049360|592594482|FG000|Period 1|Withdrawal by Subject|0|||
164063220|NCT01049360|592594483|FG001|Period 1|Withdrawal by Subject|0|||
164063221|NCT01049360|592594484|FG002|Period 1|Withdrawal by Subject|0|||
164063222|NCT01049360|592594485|FG003|Period 1|Withdrawal by Subject|0|||
164063223|NCT01049360|592594486|FG004|Period 1|Withdrawal by Subject|0|||
164063224|NCT01049360|592594487|FG005|Period 1|Withdrawal by Subject|0|||
164063225|NCT01049360|592594488|FG006|Period 1|Withdrawal by Subject|0|||
164063226|NCT01049360|592594489|FG007|Period 1|Withdrawal by Subject|0|||
164063227|NCT01049360|592594490|FG008|Period 1|Withdrawal by Subject|1|||
164102785|NCT01854047|592738876|FG002|Overall Study|Lack of Efficacy|0|||
164063228|NCT01049360|592594491|FG009|Period 1|Withdrawal by Subject|0|||
164063229|NCT01049360|592594492|FG010|Period 1|Withdrawal by Subject|1|||
164063230|NCT01049360|592594493|FG011|Period 1|Withdrawal by Subject|0|||
164063231|NCT01049360|592594494|FG012|Period 1|Withdrawal by Subject|1|||
164063232|NCT01049360|592594495|FG013|Period 1|Withdrawal by Subject|0|||
164063233|NCT01049360|592594496|FG014|Period 1|Withdrawal by Subject|0|||
164063234|NCT01049360|592594497|FG015|Period 1|Withdrawal by Subject|0|||
164063235|NCT01049360|592594498|FG016|Period 1|Withdrawal by Subject|0|||
164063236|NCT01049360|592594499|FG017|Period 1|Withdrawal by Subject|0|||
164063237|NCT01049360|592594500|FG018|Period 1|Withdrawal by Subject|0|||
164063238|NCT01049360|592594501|FG019|Period 1|Withdrawal by Subject|0|||
164063239|NCT01049360|592594482|FG000|Period 2|Protocol Violation|0|||
164063240|NCT01049360|592594483|FG001|Period 2|Protocol Violation|0|||
164063241|NCT01049360|592594484|FG002|Period 2|Protocol Violation|0|||
164063242|NCT01049360|592594485|FG003|Period 2|Protocol Violation|1|||
164063243|NCT01049360|592594486|FG004|Period 2|Protocol Violation|0|||
164063244|NCT01049360|592594487|FG005|Period 2|Protocol Violation|0|||
164063245|NCT01049360|592594488|FG006|Period 2|Protocol Violation|0|||
164063246|NCT01049360|592594489|FG007|Period 2|Protocol Violation|0|||
164063247|NCT01049360|592594490|FG008|Period 2|Protocol Violation|0|||
164063248|NCT01049360|592594491|FG009|Period 2|Protocol Violation|0|||
164063249|NCT01049360|592594492|FG010|Period 2|Protocol Violation|0|||
164063250|NCT01049360|592594493|FG011|Period 2|Protocol Violation|0|||
164102786|NCT01854047|592738877|FG003|Overall Study|Lack of Efficacy|0|||
164102787|NCT01854047|592738878|FG004|Overall Study|Lack of Efficacy|0|||
164102788|NCT01854047|592738874|FG000|Overall Study|Poor compliance to protocol|3|||
164102789|NCT01854047|592738875|FG001|Overall Study|Poor compliance to protocol|0|||
164102790|NCT01854047|592738876|FG002|Overall Study|Poor compliance to protocol|2|||
164102791|NCT01854047|592738877|FG003|Overall Study|Poor compliance to protocol|0|||
164102792|NCT01854047|592738878|FG004|Overall Study|Poor compliance to protocol|0|||
164102793|NCT01854047|592738874|FG000|Overall Study|Adverse Event|5|||
164102794|NCT01854047|592738875|FG001|Overall Study|Adverse Event|4|||
164102795|NCT01854047|592738876|FG002|Overall Study|Adverse Event|6|||
164102796|NCT01854047|592738877|FG003|Overall Study|Adverse Event|10|||
164102797|NCT01854047|592738878|FG004|Overall Study|Adverse Event|7|||
164102798|NCT01854047|592738874|FG000|Overall Study|Randomized but not treated|0|||
164102799|NCT01854047|592738875|FG001|Overall Study|Randomized but not treated|1|||
164102800|NCT01854047|592738876|FG002|Overall Study|Randomized but not treated|2|||
164102801|NCT01854047|592738877|FG003|Overall Study|Randomized but not treated|0|||
164102802|NCT01854047|592738878|FG004|Overall Study|Randomized but not treated|4|||
164102803|NCT01854047|592738874|FG000|Overall Study|Other than specified above|3|||
164102804|NCT01854047|592738875|FG001|Overall Study|Other than specified above|3|||
164102805|NCT01854047|592738876|FG002|Overall Study|Other than specified above|3|||
164102806|NCT01854047|592738877|FG003|Overall Study|Other than specified above|5|||
164102807|NCT01854047|592738878|FG004|Overall Study|Other than specified above|8|||
164102808|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
164102809|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
164102810|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
164102811|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
164063251|NCT01049360|592594494|FG012|Period 2|Protocol Violation|0|||
164063252|NCT01049360|592594495|FG013|Period 2|Protocol Violation|0|||
164063253|NCT01049360|592594496|FG014|Period 2|Protocol Violation|1|||
164063254|NCT01049360|592594497|FG015|Period 2|Protocol Violation|1|||
164063255|NCT01049360|592594498|FG016|Period 2|Protocol Violation|0|||
164063256|NCT01049360|592594499|FG017|Period 2|Protocol Violation|0|||
164063257|NCT01049360|592594500|FG018|Period 2|Protocol Violation|0|||
164063258|NCT01049360|592594501|FG019|Period 2|Protocol Violation|0|||
164063259|NCT01049360|592594482|FG000|Period 2|Adverse Event|0|||
164063260|NCT01049360|592594483|FG001|Period 2|Adverse Event|1|||
164063261|NCT01049360|592594484|FG002|Period 2|Adverse Event|0|||
164063262|NCT01049360|592594485|FG003|Period 2|Adverse Event|0|||
164063263|NCT01049360|592594486|FG004|Period 2|Adverse Event|0|||
164063264|NCT01049360|592594487|FG005|Period 2|Adverse Event|0|||
164063265|NCT01049360|592594488|FG006|Period 2|Adverse Event|0|||
164063266|NCT01049360|592594489|FG007|Period 2|Adverse Event|0|||
164063267|NCT01049360|592594490|FG008|Period 2|Adverse Event|1|||
164063268|NCT01049360|592594491|FG009|Period 2|Adverse Event|0|||
164063269|NCT01049360|592594492|FG010|Period 2|Adverse Event|0|||
164063270|NCT01049360|592594493|FG011|Period 2|Adverse Event|0|||
164063271|NCT01049360|592594494|FG012|Period 2|Adverse Event|0|||
164063272|NCT01049360|592594495|FG013|Period 2|Adverse Event|0|||
164063273|NCT01049360|592594496|FG014|Period 2|Adverse Event|0|||
164063274|NCT01049360|592594497|FG015|Period 2|Adverse Event|0|||
164063275|NCT01049360|592594498|FG016|Period 2|Adverse Event|0|||
164102812|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
164102813|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
164063276|NCT01049360|592594499|FG017|Period 2|Adverse Event|0|||
164063277|NCT01049360|592594500|FG018|Period 2|Adverse Event|0|||
164063278|NCT01049360|592594501|FG019|Period 2|Adverse Event|1|||
164063279|NCT01049360|592594482|FG000|Period 2|Withdrawal by Subject|0|||
164063280|NCT01049360|592594483|FG001|Period 2|Withdrawal by Subject|0|||
164063281|NCT01049360|592594484|FG002|Period 2|Withdrawal by Subject|0|||
164063282|NCT01049360|592594485|FG003|Period 2|Withdrawal by Subject|1|||
164063283|NCT01049360|592594486|FG004|Period 2|Withdrawal by Subject|0|||
164063284|NCT01049360|592594487|FG005|Period 2|Withdrawal by Subject|0|||
164063285|NCT01049360|592594488|FG006|Period 2|Withdrawal by Subject|0|||
164063286|NCT01049360|592594489|FG007|Period 2|Withdrawal by Subject|0|||
164063287|NCT01049360|592594490|FG008|Period 2|Withdrawal by Subject|0|||
164063288|NCT01049360|592594491|FG009|Period 2|Withdrawal by Subject|0|||
164063289|NCT01049360|592594492|FG010|Period 2|Withdrawal by Subject|0|||
164102814|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
164102815|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
164102816|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
164102817|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
164102818|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
164102819|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
164102820|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
164102821|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
164102822|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
164102823|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
164102824|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
164102825|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
164102826|NCT01045161|592738879|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
164102827|NCT01045161|592738880|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
164102828|NCT01045161|592738881|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
164102829|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
164102830|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
164102831|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
164102832|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
164102833|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
164102834|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
164102835|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
164102836|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
164102837|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
164102838|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
164102839|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
164102840|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
164102841|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
164102842|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
164102843|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
164102844|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
164102845|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
164102846|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
164102847|NCT01045161|592738879|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
164102848|NCT01045161|592738880|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
164102849|NCT01045161|592738881|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
164102850|NCT02281084|592738885|FG000|Overall Study|Death|21|||
164102851|NCT02281084|592738886|FG001|Overall Study|Death|18|||
164102852|NCT02281084|592738887|FG002|Overall Study|Death|3|||
164102853|NCT02281084|592738888|FG003|Overall Study|Death|5|||
164102854|NCT02281084|592738885|FG000|Overall Study|Adverse Event|1|||
164102855|NCT02281084|592738886|FG001|Overall Study|Adverse Event|0|||
164063290|NCT01049360|592594493|FG011|Period 2|Withdrawal by Subject|0|||
164063291|NCT01049360|592594494|FG012|Period 2|Withdrawal by Subject|0|||
164063292|NCT01049360|592594495|FG013|Period 2|Withdrawal by Subject|0|||
164063293|NCT01049360|592594496|FG014|Period 2|Withdrawal by Subject|1|||
164063294|NCT01049360|592594497|FG015|Period 2|Withdrawal by Subject|0|||
164063295|NCT01049360|592594498|FG016|Period 2|Withdrawal by Subject|0|||
164063296|NCT01049360|592594499|FG017|Period 2|Withdrawal by Subject|0|||
164102856|NCT02281084|592738887|FG002|Overall Study|Adverse Event|0|||
164102857|NCT02281084|592738888|FG003|Overall Study|Adverse Event|0|||
164102858|NCT02281084|592738885|FG000|Overall Study|Withdrawal by Subject|2|||
164102859|NCT02281084|592738886|FG001|Overall Study|Withdrawal by Subject|2|||
164102860|NCT02281084|592738887|FG002|Overall Study|Withdrawal by Subject|0|||
164102861|NCT02281084|592738888|FG003|Overall Study|Withdrawal by Subject|0|||
164102862|NCT02281084|592738885|FG000|Overall Study|Site Closure by Sponsor|5|||
164063297|NCT01049360|592594500|FG018|Period 2|Withdrawal by Subject|0|||
164102863|NCT02281084|592738886|FG001|Overall Study|Site Closure by Sponsor|1|||
164102864|NCT02281084|592738887|FG002|Overall Study|Site Closure by Sponsor|2|||
164063298|NCT01049360|592594501|FG019|Period 2|Withdrawal by Subject|1|||
164063299|NCT01049360|592594482|FG000|Period 2|Lack of Efficacy|0|||
164063300|NCT01049360|592594483|FG001|Period 2|Lack of Efficacy|0|||
164063301|NCT01049360|592594484|FG002|Period 2|Lack of Efficacy|0|||
164063302|NCT01049360|592594485|FG003|Period 2|Lack of Efficacy|0|||
164063303|NCT01049360|592594486|FG004|Period 2|Lack of Efficacy|0|||
164063304|NCT01049360|592594487|FG005|Period 2|Lack of Efficacy|1|||
164063305|NCT01049360|592594488|FG006|Period 2|Lack of Efficacy|0|||
164063306|NCT01049360|592594489|FG007|Period 2|Lack of Efficacy|0|||
164063307|NCT01049360|592594490|FG008|Period 2|Lack of Efficacy|0|||
164063308|NCT01049360|592594491|FG009|Period 2|Lack of Efficacy|0|||
164063309|NCT01049360|592594492|FG010|Period 2|Lack of Efficacy|0|||
164063310|NCT01049360|592594493|FG011|Period 2|Lack of Efficacy|0|||
164063311|NCT01049360|592594494|FG012|Period 2|Lack of Efficacy|0|||
164063312|NCT01049360|592594495|FG013|Period 2|Lack of Efficacy|0|||
164063313|NCT01049360|592594496|FG014|Period 2|Lack of Efficacy|0|||
164063314|NCT01049360|592594497|FG015|Period 2|Lack of Efficacy|0|||
164063315|NCT01049360|592594498|FG016|Period 2|Lack of Efficacy|0|||
164063316|NCT01049360|592594499|FG017|Period 2|Lack of Efficacy|0|||
164063317|NCT01049360|592594500|FG018|Period 2|Lack of Efficacy|0|||
164063318|NCT01049360|592594501|FG019|Period 2|Lack of Efficacy|0|||
164063319|NCT01049360|592594482|FG000|Period 4|Protocol Violation|0|||
164063320|NCT01049360|592594483|FG001|Period 4|Protocol Violation|0|||
164063321|NCT01049360|592594484|FG002|Period 4|Protocol Violation|0|||
164063322|NCT01049360|592594485|FG003|Period 4|Protocol Violation|0|||
164063323|NCT01049360|592594486|FG004|Period 4|Protocol Violation|0|||
164063324|NCT01049360|592594487|FG005|Period 4|Protocol Violation|0|||
164063325|NCT01049360|592594488|FG006|Period 4|Protocol Violation|0|||
164063326|NCT01049360|592594489|FG007|Period 4|Protocol Violation|0|||
164063327|NCT01049360|592594490|FG008|Period 4|Protocol Violation|0|||
164063328|NCT01049360|592594491|FG009|Period 4|Protocol Violation|0|||
164063329|NCT01049360|592594492|FG010|Period 4|Protocol Violation|0|||
164063330|NCT01049360|592594493|FG011|Period 4|Protocol Violation|0|||
164063331|NCT01049360|592594494|FG012|Period 4|Protocol Violation|0|||
164063332|NCT01049360|592594495|FG013|Period 4|Protocol Violation|0|||
164063333|NCT01049360|592594496|FG014|Period 4|Protocol Violation|0|||
164063334|NCT01049360|592594497|FG015|Period 4|Protocol Violation|0|||
164063335|NCT01049360|592594498|FG016|Period 4|Protocol Violation|0|||
164063336|NCT01049360|592594499|FG017|Period 4|Protocol Violation|1|||
164063337|NCT01049360|592594500|FG018|Period 4|Protocol Violation|0|||
164063338|NCT01049360|592594501|FG019|Period 4|Protocol Violation|0|||
164063339|NCT01049360|592594482|FG000|Period 4|Withdrawal by Subject|0|||
164063340|NCT01049360|592594483|FG001|Period 4|Withdrawal by Subject|0|||
164063341|NCT01049360|592594484|FG002|Period 4|Withdrawal by Subject|0|||
164063342|NCT01049360|592594485|FG003|Period 4|Withdrawal by Subject|1|||
164063343|NCT01049360|592594486|FG004|Period 4|Withdrawal by Subject|0|||
164063344|NCT01049360|592594487|FG005|Period 4|Withdrawal by Subject|0|||
164063345|NCT01049360|592594488|FG006|Period 4|Withdrawal by Subject|0|||
164063346|NCT01049360|592594489|FG007|Period 4|Withdrawal by Subject|0|||
164063347|NCT01049360|592594490|FG008|Period 4|Withdrawal by Subject|0|||
164063348|NCT01049360|592594491|FG009|Period 4|Withdrawal by Subject|0|||
164063349|NCT01049360|592594492|FG010|Period 4|Withdrawal by Subject|0|||
164063350|NCT01049360|592594493|FG011|Period 4|Withdrawal by Subject|0|||
164063351|NCT01049360|592594494|FG012|Period 4|Withdrawal by Subject|0|||
164063352|NCT01049360|592594495|FG013|Period 4|Withdrawal by Subject|0|||
164063353|NCT01049360|592594496|FG014|Period 4|Withdrawal by Subject|0|||
164063354|NCT01049360|592594497|FG015|Period 4|Withdrawal by Subject|0|||
164063355|NCT01049360|592594498|FG016|Period 4|Withdrawal by Subject|0|||
164063356|NCT01049360|592594499|FG017|Period 4|Withdrawal by Subject|0|||
164063357|NCT01049360|592594500|FG018|Period 4|Withdrawal by Subject|0|||
164063358|NCT01049360|592594501|FG019|Period 4|Withdrawal by Subject|0|||
164063359|NCT05147311|592594504|FG000|Overall Study|Did not complete survey|2|||
164063360|NCT05147311|592594505|FG001|Overall Study|Did not complete survey|1|||
164063361|NCT05147311|592594504|FG000|Overall Study|Patient too sick|1|||
164063362|NCT05147311|592594505|FG001|Overall Study|Patient too sick|2|||
164063363|NCT05147311|592594504|FG000|Overall Study|Death|0|||
164063364|NCT05147311|592594505|FG001|Overall Study|Death|1|||
164063365|NCT05147311|592594504|FG000|Overall Study|Declined survey|1|||
164063366|NCT05147311|592594505|FG001|Overall Study|Declined survey|0|||
164063367|NCT00145795|592594507|FG000|Overall Study|Adverse Event|1|||
164063368|NCT00145795|592594508|FG001|Overall Study|Adverse Event|0|||
164063369|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Adverse Event|6|||
164063370|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Adverse Event|6|||
164063371|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Death|14|||
164063372|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Death|11|||
164063373|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
164063374|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
164063375|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
164063376|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
164063377|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
164063378|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
164063379|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Disease Progression|1|||
164063380|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Disease Progression|0|||
164148725|NCT03207867|592904954|FG018|Overall Study|Physician Decision|1|||
164102865|NCT02281084|592738888|FG003|Overall Study|Site Closure by Sponsor|0|||
164102866|NCT02957942|592738889|FG000|Overall Study|Withdrawal by Subject|0|||
164102867|NCT02957942|592738890|FG001|Overall Study|Withdrawal by Subject|1|||
164102868|NCT02957942|592738889|FG000|Overall Study|Practicing experiment protocol|0|||
164102869|NCT02957942|592738890|FG001|Overall Study|Practicing experiment protocol|6|||
164102870|NCT02655679|592738893|FG000|Overall Study|Adverse Event|0|||
164102871|NCT02655679|592738894|FG001|Overall Study|Adverse Event|1|||
164102872|NCT02655679|592738895|FG002|Overall Study|Adverse Event|0|||
164102873|NCT02655679|592738896|FG003|Overall Study|Adverse Event|0|||
164102874|NCT02655679|592738897|FG004|Overall Study|Adverse Event|0|||
164102875|NCT02655679|592738893|FG000|Overall Study|Withdrawal by Subject|1|||
164102876|NCT02655679|592738894|FG001|Overall Study|Withdrawal by Subject|1|||
164102877|NCT02655679|592738895|FG002|Overall Study|Withdrawal by Subject|0|||
164102878|NCT02655679|592738896|FG003|Overall Study|Withdrawal by Subject|3|||
164102879|NCT02655679|592738897|FG004|Overall Study|Withdrawal by Subject|1|||
164102880|NCT02655679|592738893|FG000|Overall Study|Inability to Comply with the Protocol|1|||
164102881|NCT02655679|592738894|FG001|Overall Study|Inability to Comply with the Protocol|0|||
164102882|NCT02655679|592738895|FG002|Overall Study|Inability to Comply with the Protocol|0|||
164102883|NCT02655679|592738896|FG003|Overall Study|Inability to Comply with the Protocol|0|||
164102884|NCT02655679|592738897|FG004|Overall Study|Inability to Comply with the Protocol|0|||
164102885|NCT02655679|592738893|FG000|Overall Study|Lost to Follow-up|0|||
164102886|NCT02655679|592738894|FG001|Overall Study|Lost to Follow-up|1|||
164102887|NCT02655679|592738895|FG002|Overall Study|Lost to Follow-up|1|||
164102888|NCT02655679|592738896|FG003|Overall Study|Lost to Follow-up|1|||
164102889|NCT02655679|592738897|FG004|Overall Study|Lost to Follow-up|0|||
164102890|NCT02655679|592738893|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164102891|NCT02655679|592738894|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164102892|NCT02655679|592738895|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164102893|NCT02655679|592738896|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164102894|NCT02655679|592738897|FG004|Overall Study|Other Miscellaneous Reasons|0|||
164102895|NCT03801707|592738898|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
164102896|NCT00819741|592738899|FG000|Overall Study|Adverse Event|5|||
164102897|NCT00819741|592738900|FG001|Overall Study|Adverse Event|2|||
164063381|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
164063382|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
164063383|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
164063384|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
164063385|NCT04419558|592594509|FG000|DB Period (48 Weeks)|Participant Decision|4|||
164063386|NCT04419558|592594510|FG001|DB Period (48 Weeks)|Participant Decision|3|||
164063387|NCT04419558|592594509|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
164063388|NCT04419558|592594510|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
164063389|NCT04419558|592594509|FG000|OLE Period (48 Weeks)|Death|4|||
164063390|NCT04419558|592594510|FG001|OLE Period (48 Weeks)|Death|6|||
164063391|NCT04419558|592594509|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
164063392|NCT04419558|592594510|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
164063393|NCT04419558|592594509|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
164063394|NCT04419558|592594510|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
164063395|NCT01539512|592594514|FG000|Overall Study|Adverse Event|9|||
164063396|NCT01539512|592594515|FG001|Overall Study|Adverse Event|7|||
164063397|NCT01539512|592594514|FG000|Overall Study|Physician Decision|1|||
164063398|NCT01539512|592594515|FG001|Overall Study|Physician Decision|1|||
164063399|NCT01539512|592594514|FG000|Overall Study|Withdrawal by Subject|12|||
164063400|NCT01539512|592594515|FG001|Overall Study|Withdrawal by Subject|5|||
164063401|NCT01539512|592594514|FG000|Overall Study|Richter's Transformation|1|||
164063402|NCT01539512|592594515|FG001|Overall Study|Richter's Transformation|0|||
164063403|NCT02388906|592594516|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
164063404|NCT02388906|592594517|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164063405|NCT02388906|592594516|FG000|Treatment Period|Disease progression|121|||
164063406|NCT02388906|592594517|FG001|Treatment Period|Disease progression|100|||
164063407|NCT02388906|592594516|FG000|Treatment Period|Study drug toxicity|41|||
164063408|NCT02388906|592594517|FG001|Treatment Period|Study drug toxicity|208|||
164063409|NCT02388906|592594516|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
164063410|NCT02388906|592594517|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
164063411|NCT02388906|592594516|FG000|Treatment Period|Participant request to stop treatment|5|||
164063412|NCT02388906|592594517|FG001|Treatment Period|Participant request to stop treatment|9|||
164063413|NCT02388906|592594516|FG000|Treatment Period|Participant withdrew consent|2|||
164063414|NCT02388906|592594517|FG001|Treatment Period|Participant withdrew consent|3|||
164063415|NCT02388906|592594516|FG000|Treatment Period|Poor/non-compliance|0|||
164063416|NCT02388906|592594517|FG001|Treatment Period|Poor/non-compliance|1|||
164063417|NCT02388906|592594516|FG000|Treatment Period|Participant no longer meets study criteria|0|||
164063418|NCT02388906|592594517|FG001|Treatment Period|Participant no longer meets study criteria|1|||
164063419|NCT02388906|592594516|FG000|Treatment Period|Other reasons|3|||
164063420|NCT02388906|592594517|FG001|Treatment Period|Other reasons|3|||
164063421|NCT02400281|592594518|FG000|Overall Study|Adverse Event|0|||
164063422|NCT02400281|592594519|FG001|Overall Study|Adverse Event|0|||
164063423|NCT02400281|592594520|FG002|Overall Study|Adverse Event|1|||
164063424|NCT02400281|592594521|FG003|Overall Study|Adverse Event|0|||
164063425|NCT02400281|592594522|FG004|Overall Study|Adverse Event|1|||
164063426|NCT02400281|592594523|FG005|Overall Study|Adverse Event|0|||
164063427|NCT02400281|592594518|FG000|Overall Study|Physician Decision|0|||
164063428|NCT02400281|592594519|FG001|Overall Study|Physician Decision|0|||
164063429|NCT02400281|592594520|FG002|Overall Study|Physician Decision|1|||
164063430|NCT02400281|592594521|FG003|Overall Study|Physician Decision|0|||
164063431|NCT02400281|592594522|FG004|Overall Study|Physician Decision|0|||
164063432|NCT02400281|592594523|FG005|Overall Study|Physician Decision|0|||
164063433|NCT00412360|592594524|FG000|Overall Study|Lost to Follow-up|0|||
164063434|NCT00412360|592594525|FG001|Overall Study|Lost to Follow-up|1|||
164063435|NCT00412360|592594524|FG000|Overall Study|Not Transplanted|1|||
164063436|NCT00412360|592594525|FG001|Overall Study|Not Transplanted|2|||
164063437|NCT03145207|592594526|FG000|Overall Study|volunteer started taking allergy shots|1|||
164063438|NCT03145207|592594526|FG000|Overall Study|baseline blood pressure high|1|||
164063439|NCT01790633|592594527|FG000|Overall Study|Protocol Violation|1|||
164063440|NCT01790633|592594528|FG001|Overall Study|Protocol Violation|2|||
164063441|NCT01790633|592594527|FG000|Overall Study|Did not have serology performed|47|||
164063442|NCT01790633|592594528|FG001|Overall Study|Did not have serology performed|0|||
164063443|NCT01790633|592594527|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
164063444|NCT01790633|592594528|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
164063445|NCT00157157|592594532|FG000|Overall Study|Withdrawal by Subject|6|||
164063446|NCT00157157|592594532|FG000|Overall Study|Physician Decision|1|||
164063447|NCT00157157|592594532|FG000|Overall Study|Lost to Follow-up|1|||
164063448|NCT00157157|592594532|FG000|Overall Study|Enrolled in another study|1|||
164063449|NCT00157157|592594532|FG000|Overall Study|Met exclusion criteria|1|||
164063450|NCT00157157|592594532|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
164063451|NCT00563706|592595994|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
164063452|NCT00563706|592595995|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164063453|NCT00563706|592595996|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164063454|NCT00563706|592595997|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164063455|NCT00563706|592595998|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
164063456|NCT00563706|592595999|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
164063457|NCT00563706|592596000|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
164063458|NCT00563706|592596001|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
164063459|NCT00563706|592596002|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
164063460|NCT00563706|592595994|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164063461|NCT00563706|592595995|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
164063462|NCT00563706|592595996|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164063463|NCT00563706|592595997|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
164063464|NCT00563706|592595998|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
164063465|NCT00563706|592595999|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164063466|NCT00563706|592596000|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
164063467|NCT00563706|592596001|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
164063468|NCT00563706|592596002|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
164063469|NCT00563706|592595994|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
164063470|NCT00563706|592595995|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
164063471|NCT00563706|592595996|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
164063472|NCT00563706|592595997|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
164063473|NCT00563706|592595998|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
164063474|NCT00563706|592595999|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
164063475|NCT00563706|592596000|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
164063476|NCT00563706|592596001|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
164063477|NCT00563706|592596002|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
164063478|NCT00563706|592595994|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
164063479|NCT00563706|592595995|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063480|NCT00563706|592595996|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063481|NCT00563706|592595997|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063482|NCT00563706|592595998|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063483|NCT00563706|592595999|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063484|NCT00563706|592596000|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063485|NCT00563706|592596001|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
164063486|NCT00563706|592596002|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
164063487|NCT00563706|592595994|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164063488|NCT00563706|592595995|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164102898|NCT00819741|592738899|FG000|Overall Study|Lack of Efficacy|0|||
164102899|NCT00819741|592738900|FG001|Overall Study|Lack of Efficacy|2|||
164102900|NCT00819741|592738899|FG000|Overall Study|Lost to Follow-up|3|||
164102901|NCT00819741|592738900|FG001|Overall Study|Lost to Follow-up|1|||
164102902|NCT00819741|592738899|FG000|Overall Study|Protocol Violation|3|||
164102903|NCT00819741|592738900|FG001|Overall Study|Protocol Violation|4|||
164102904|NCT00819741|592738899|FG000|Overall Study|Withdrawal by Subject|2|||
164102905|NCT00819741|592738900|FG001|Overall Study|Withdrawal by Subject|2|||
164102906|NCT00819741|592738899|FG000|Overall Study|Unclassified|6|||
164102907|NCT00819741|592738900|FG001|Overall Study|Unclassified|0|||
164102908|NCT00819741|592738899|FG000|Overall Study|Reasons unknown|3|||
164102909|NCT00819741|592738900|FG001|Overall Study|Reasons unknown|3|||
164112601|NCT00874822|592774064|FG000|Overall Study|excluded by criteria|8|||
164112602|NCT02854800|592774065|FG000|Overall Study|Protocol Violation|16|||
164112603|NCT02854800|592774066|FG001|Overall Study|Protocol Violation|11|||
164112604|NCT02854800|592774067|FG002|Overall Study|Protocol Violation|3|||
164112605|NCT02854800|592774065|FG000|Overall Study|Withdrawal by Subject|4|||
164112606|NCT02854800|592774066|FG001|Overall Study|Withdrawal by Subject|2|||
164112607|NCT02854800|592774067|FG002|Overall Study|Withdrawal by Subject|3|||
164112608|NCT01634139|592774069|FG000|Overall Study|Non compliant with protocol|1|||
164112609|NCT01634139|592774070|FG001|Overall Study|Non compliant with protocol|0|||
164112610|NCT01634139|592774071|FG002|Overall Study|Non compliant with protocol|0|||
164112611|NCT01634139|592774069|FG000|Overall Study|Consent withdrawn not due to AE|4|||
164112612|NCT01634139|592774070|FG001|Overall Study|Consent withdrawn not due to AE|3|||
164112613|NCT01634139|592774071|FG002|Overall Study|Consent withdrawn not due to AE|2|||
164112614|NCT01634139|592774069|FG000|Overall Study|Other|4|||
164112615|NCT01634139|592774070|FG001|Overall Study|Other|0|||
164112616|NCT01634139|592774071|FG002|Overall Study|Other|3|||
164112617|NCT01634139|592774069|FG000|Overall Study|Lost to Follow-up|0|||
164112618|NCT01634139|592774070|FG001|Overall Study|Lost to Follow-up|2|||
164112619|NCT01634139|592774071|FG002|Overall Study|Lost to Follow-up|0|||
164112620|NCT01634139|592774069|FG000|Overall Study|Not treated|1|||
164112621|NCT01634139|592774070|FG001|Overall Study|Not treated|1|||
164112622|NCT01634139|592774071|FG002|Overall Study|Not treated|0|||
164112623|NCT02627963|592774077|FG000|Overall Study|Randomized but not treated|2|||
164112624|NCT02627963|592774078|FG001|Overall Study|Randomized but not treated|6|||
164112625|NCT01168856|592774079|FG000|Overall Study|Lost to Follow-up|4|||
164112626|NCT01168856|592774080|FG001|Overall Study|Lost to Follow-up|34|||
164112627|NCT01168856|592774079|FG000|Overall Study|Withdrawal by Subject|6|||
164112628|NCT01168856|592774080|FG001|Overall Study|Withdrawal by Subject|8|||
164112629|NCT01168856|592774079|FG000|Overall Study|Physician Decision|2|||
164112630|NCT01168856|592774080|FG001|Overall Study|Physician Decision|1|||
164112631|NCT01168856|592774079|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
164112632|NCT01168856|592774080|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
164112633|NCT01168856|592774079|FG000|Overall Study|Participant received anti-HCV treatment|1|||
164112634|NCT01168856|592774080|FG001|Overall Study|Participant received anti-HCV treatment|0|||
164112635|NCT01168856|592774079|FG000|Overall Study|Death|0|||
164112636|NCT01168856|592774080|FG001|Overall Study|Death|2|||
164112637|NCT01168856|592774079|FG000|Overall Study|Other|1|||
164112638|NCT01168856|592774080|FG001|Overall Study|Other|291|||
164112639|NCT01168856|592774079|FG000|Overall Study|Protocol Violation|4|||
164112640|NCT01168856|592774080|FG001|Overall Study|Protocol Violation|6|||
164112641|NCT05562011|592774081|FG000|Overall Study|Withdrawal by Subject|3|||
164112642|NCT05562011|592774081|FG000|Overall Study|Lost to Follow-up|1|||
164112643|NCT05562011|592774081|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
164112644|NCT05562011|592774081|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
164112645|NCT05562011|592774081|FG000|Overall Study|Device malfunction|13|||
164112646|NCT00387153|592774082|FG000|Overall Study|Adverse Event|1|||
164112647|NCT00387153|592774082|FG000|Overall Study|Disease Progression|3|||
164112648|NCT00387153|592774082|FG000|Overall Study|Lack of Response|4|||
164112649|NCT03073798|592774083|FG000|Overall Study|Adverse Event|1|||
164112650|NCT03073798|592774083|FG000|Overall Study|Withdrawal by Subject|1|||
164112651|NCT04411680|592774088|FG000|Treatment Period|Adverse Event|3|||
164112652|NCT04411680|592774089|FG001|Treatment Period|Adverse Event|0|||
164112653|NCT04411680|592774088|FG000|Treatment Period|Discharged from hospital|18|||
164112654|NCT04411680|592774089|FG001|Treatment Period|Discharged from hospital|7|||
164112655|NCT04411680|592774088|FG000|Treatment Period|Missed 1 or more doses|8|||
164112656|NCT04411680|592774089|FG001|Treatment Period|Missed 1 or more doses|0|||
164112657|NCT04411680|592774088|FG000|Treatment Period|Transferred to another hospital|0|||
164112658|NCT04411680|592774089|FG001|Treatment Period|Transferred to another hospital|1|||
164112659|NCT04411680|592774088|FG000|Follow up Period|Withdrawal by Subject|2|||
164112660|NCT04411680|592774089|FG001|Follow up Period|Withdrawal by Subject|0|||
164112661|NCT04411680|592774088|FG000|Follow up Period|Lost to Follow-up|5|||
164112662|NCT04411680|592774089|FG001|Follow up Period|Lost to Follow-up|6|||
164112663|NCT04411680|592774088|FG000|Follow up Period|Death|11|||
164112664|NCT04411680|592774089|FG001|Follow up Period|Death|8|||
164112665|NCT00840658|592774090|FG000|Overall Study|Death|2|||
164102910|NCT02222818|592740660|FG000|Period 1|Eligibility criteria not met|0|||
164102911|NCT02222818|592740661|FG001|Period 1|Eligibility criteria not met|3|||
164102912|NCT01376037|592740662|FG000|Overall Study|Lost to Follow-up|0|||
164102913|NCT01376037|592740663|FG001|Overall Study|Lost to Follow-up|2|||
164102914|NCT02328040|592740664|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
164102915|NCT02328040|592740665|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
164102916|NCT00835991|592740667|FG000|First Intervention|Adverse Event|0|||
164102917|NCT00835991|592740668|FG001|First Intervention|Adverse Event|1|||
164102918|NCT00835991|592740667|FG000|Washout|Protocol Violation|0|||
164102919|NCT00835991|592740668|FG001|Washout|Protocol Violation|2|||
164102920|NCT00835991|592740667|FG000|Washout|Withdrawal by Subject|3|||
164102921|NCT00835991|592740668|FG001|Washout|Withdrawal by Subject|1|||
164102922|NCT02149420|592740669|FG000|Core Study|Administrative problems|0|||
164102923|NCT02149420|592740670|FG001|Core Study|Administrative problems|1|||
164102924|NCT02149420|592740671|FG002|Core Study|Administrative problems|2|||
164102925|NCT02149420|592740669|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
164102926|NCT02149420|592740670|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
164102927|NCT02149420|592740671|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
164102928|NCT04278560|592740672|FG000|Overall Study|Adverse Event|1|||
164102929|NCT04278560|592740673|FG001|Overall Study|Adverse Event|2|||
164102930|NCT04278560|592740672|FG000|Overall Study|Withdrawal by Subject|0|||
164102931|NCT04278560|592740673|FG001|Overall Study|Withdrawal by Subject|1|||
164102932|NCT00440518|592740675|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
164102933|NCT00440518|592740676|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
164102934|NCT00440518|592740677|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
164102935|NCT00440518|592740675|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
164102936|NCT00440518|592740676|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
164102937|NCT00440518|592740677|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
164102938|NCT00440518|592740675|FG000|Randomized /Titration Period|Protocol Deviation|1|||
164102939|NCT00440518|592740676|FG001|Randomized /Titration Period|Protocol Deviation|0|||
164102940|NCT00440518|592740677|FG002|Randomized /Titration Period|Protocol Deviation|0|||
164102941|NCT00440518|592740675|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
164102942|NCT00440518|592740676|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
164102943|NCT00440518|592740677|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
164102944|NCT00440518|592740675|FG000|Randomized /Titration Period|Other|1|||
164102945|NCT00440518|592740676|FG001|Randomized /Titration Period|Other|0|||
164102946|NCT00440518|592740677|FG002|Randomized /Titration Period|Other|0|||
164102947|NCT00440518|592740675|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
164102948|NCT00440518|592740676|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
164102949|NCT00440518|592740677|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
164102950|NCT00440518|592740675|FG000|Randomized /Titration Period|Adverse Event|2|||
164102951|NCT00440518|592740676|FG001|Randomized /Titration Period|Adverse Event|3|||
164102952|NCT00440518|592740677|FG002|Randomized /Titration Period|Adverse Event|0|||
164102953|NCT00440518|592740675|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
164102954|NCT00440518|592740676|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
164102955|NCT00440518|592740677|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
164102956|NCT00440518|592740675|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
164102957|NCT00440518|592740676|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
164102958|NCT00440518|592740677|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
164063489|NCT00563706|592595996|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164063490|NCT00563706|592595997|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164063491|NCT00563706|592595998|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164063492|NCT00563706|592595999|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164063493|NCT00563706|592596000|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
164063494|NCT00563706|592596001|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
164063495|NCT00563706|592596002|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
164102959|NCT00440518|592740675|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
164102960|NCT00440518|592740676|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
164102961|NCT00440518|592740677|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
164102962|NCT00440518|592740675|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
164102963|NCT00440518|592740676|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
164102964|NCT00440518|592740677|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
164063496|NCT01361308|592596007|FG000|Overall Study|Withdrawal by Subject|9|||
164102965|NCT00440518|592740675|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
164102966|NCT00440518|592740676|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
164102967|NCT00440518|592740677|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
164102968|NCT00440518|592740675|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
164102969|NCT00440518|592740676|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
164102970|NCT00440518|592740677|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
164102971|NCT03570749|592740678|FG000|Overall Study|Ongoing|26|||
164063497|NCT01361308|592596008|FG001|Overall Study|Withdrawal by Subject|13|||
164063498|NCT01361308|592596007|FG000|Overall Study|Physician Decision|3|||
164063499|NCT01361308|592596008|FG001|Overall Study|Physician Decision|3|||
164063500|NCT01361308|592596007|FG000|Overall Study|Lack of Efficacy|2|||
164063501|NCT01361308|592596008|FG001|Overall Study|Lack of Efficacy|0|||
164063502|NCT01361308|592596007|FG000|Overall Study|Protocol Violation|1|||
164063503|NCT01361308|592596008|FG001|Overall Study|Protocol Violation|0|||
164063504|NCT01361308|592596007|FG000|Overall Study|Lost to Follow-up|5|||
164063505|NCT01361308|592596008|FG001|Overall Study|Lost to Follow-up|4|||
164063506|NCT01361308|592596007|FG000|Overall Study|Adverse Event|8|||
164063507|NCT01361308|592596008|FG001|Overall Study|Adverse Event|4|||
164063508|NCT01361308|592596007|FG000|Overall Study|Eligibility Criteria Not Met|2|||
164063509|NCT01361308|592596008|FG001|Overall Study|Eligibility Criteria Not Met|3|||
164063510|NCT01361308|592596007|FG000|Overall Study|Failed C-SSRS|5|||
164063511|NCT01361308|592596008|FG001|Overall Study|Failed C-SSRS|2|||
164063512|NCT01361308|592596007|FG000|Overall Study|Other|0|||
164063513|NCT01361308|592596008|FG001|Overall Study|Other|1|||
164063514|NCT03839693|592596009|FG000|Overall Study|Lost to Follow-up|0|||
164063515|NCT03839693|592596010|FG001|Overall Study|Lost to Follow-up|2|||
164063516|NCT03839693|592596011|FG002|Overall Study|Lost to Follow-up|2|||
164063517|NCT03839693|592596009|FG000|Overall Study|Withdrawal by Subject|1|||
164063518|NCT03839693|592596010|FG001|Overall Study|Withdrawal by Subject|0|||
164063519|NCT03839693|592596011|FG002|Overall Study|Withdrawal by Subject|2|||
164063520|NCT03839693|592596009|FG000|Overall Study|subject moved out of the area|1|||
164063521|NCT03839693|592596010|FG001|Overall Study|subject moved out of the area|0|||
164063522|NCT03839693|592596011|FG002|Overall Study|subject moved out of the area|0|||
164063523|NCT00270205|592596012|FG000|Overall Study|Lost to Follow-up|1|||
164063524|NCT00270205|592596013|FG001|Overall Study|Lost to Follow-up|0|||
164063525|NCT00270205|592596014|FG002|Overall Study|Lost to Follow-up|0|||
164063526|NCT00270205|592596015|FG003|Overall Study|Lost to Follow-up|1|||
164063527|NCT00706901|592596016|FG000|Overall Study|Lost to Follow-up|2|||
164063528|NCT00706901|592596017|FG001|Overall Study|Lost to Follow-up|3|||
164063529|NCT00706901|592596018|FG002|Overall Study|Lost to Follow-up|2|||
164063530|NCT00706901|592596016|FG000|Overall Study|Withdrawal by Subject|4|||
164063531|NCT00706901|592596017|FG001|Overall Study|Withdrawal by Subject|2|||
164063532|NCT00706901|592596018|FG002|Overall Study|Withdrawal by Subject|5|||
164063533|NCT00706901|592596016|FG000|Overall Study|In Jail|1|||
164063534|NCT00706901|592596017|FG001|Overall Study|In Jail|0|||
164063535|NCT00706901|592596018|FG002|Overall Study|In Jail|1|||
164063536|NCT00706901|592596016|FG000|Overall Study|Death|1|||
164063537|NCT00706901|592596017|FG001|Overall Study|Death|0|||
164063538|NCT00706901|592596018|FG002|Overall Study|Death|0|||
164063539|NCT01339273|592596022|FG000|Overall Study|Lost to Follow-up|8|||
164063540|NCT01339273|592596023|FG001|Overall Study|Lost to Follow-up|8|||
164063541|NCT04478994|592596024|FG000|Overall Study|Withdrawal by Subject|1|||
164063542|NCT04478994|592596025|FG001|Overall Study|Withdrawal by Subject|1|||
164063543|NCT00457249|592596026|FG000|Overall Study|Lost to Follow-up|3|||
164063544|NCT00457249|592596027|FG001|Overall Study|Lost to Follow-up|0|||
164063545|NCT00457249|592596026|FG000|Overall Study|Protocol Violation|4|||
164063546|NCT00457249|592596027|FG001|Overall Study|Protocol Violation|1|||
164063547|NCT00457249|592596026|FG000|Overall Study|Withdrawal by Subject|3|||
164063548|NCT00457249|592596027|FG001|Overall Study|Withdrawal by Subject|1|||
164063549|NCT00457249|592596026|FG000|Overall Study|Serious Adverse Events|2|||
164063550|NCT00457249|592596027|FG001|Overall Study|Serious Adverse Events|0|||
164063551|NCT04621227|592596030|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
164063552|NCT04621227|592596030|FG000|Period 3 (29 Days)|Adverse Event|1|||
164063553|NCT04621227|592596030|FG000|Period 8 (2 Days)|Adverse Event|1|||
164063554|NCT02916056|592596031|FG000|Overall Study|Adverse Event|6|||
164063555|NCT02916056|592596031|FG000|Overall Study|Lost to Follow-up|1|||
164063556|NCT02916056|592596031|FG000|Overall Study|Other|12|||
164063557|NCT02916056|592596031|FG000|Overall Study|Protocol Violation|1|||
164063558|NCT02916056|592596031|FG000|Overall Study|Withdrawal by Subject|8|||
164063559|NCT02916056|592596031|FG000|Overall Study|Study Terminated by Sponsor|269|||
164063560|NCT00124709|592596032|FG000|Overall Study|Randomized but did not take medication|3|||
164063561|NCT00124709|592596033|FG001|Overall Study|Randomized but did not take medication|1|||
164063562|NCT00124709|592596032|FG000|Overall Study|Adverse Event|3|||
164063563|NCT00124709|592596033|FG001|Overall Study|Adverse Event|0|||
164063564|NCT00124709|592596032|FG000|Overall Study|Lack of Efficacy|5|||
164063565|NCT00124709|592596033|FG001|Overall Study|Lack of Efficacy|10|||
164063566|NCT00124709|592596032|FG000|Overall Study|Protocol Violation|3|||
164063567|NCT00124709|592596033|FG001|Overall Study|Protocol Violation|5|||
164063568|NCT00124709|592596032|FG000|Overall Study|Withdrawal by Subject|127|||
164063569|NCT00124709|592596033|FG001|Overall Study|Withdrawal by Subject|136|||
164063570|NCT00124709|592596032|FG000|Overall Study|Lost to Follow-up|114|||
164063571|NCT00124709|592596033|FG001|Overall Study|Lost to Follow-up|120|||
164063572|NCT01728376|592596034|FG000|Overall Study|Adverse Event|1|||
164063573|NCT01728376|592596035|FG001|Overall Study|Adverse Event|1|||
164063574|NCT01728376|592596036|FG002|Overall Study|Adverse Event|1|||
164063575|NCT01728376|592596037|FG003|Overall Study|Adverse Event|1|||
164063576|NCT01728376|592596038|FG004|Overall Study|Adverse Event|1|||
164063577|NCT01728376|592596039|FG005|Overall Study|Adverse Event|0|||
164063578|NCT01728376|592596034|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
164063579|NCT01728376|592596035|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
164063580|NCT01728376|592596036|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
164063581|NCT01728376|592596037|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
164063582|NCT01728376|592596038|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
164063583|NCT01728376|592596039|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
164063584|NCT01728376|592596034|FG000|Overall Study|No relevant bacteria|2|||
164063585|NCT01728376|592596035|FG001|Overall Study|No relevant bacteria|0|||
164063586|NCT01728376|592596036|FG002|Overall Study|No relevant bacteria|0|||
164063587|NCT01728376|592596037|FG003|Overall Study|No relevant bacteria|0|||
164063588|NCT01728376|592596038|FG004|Overall Study|No relevant bacteria|1|||
164063589|NCT01728376|592596039|FG005|Overall Study|No relevant bacteria|1|||
164063590|NCT01728376|592596034|FG000|Overall Study|Did not receive treatment|0|||
164063591|NCT01728376|592596035|FG001|Overall Study|Did not receive treatment|1|||
164063592|NCT01728376|592596036|FG002|Overall Study|Did not receive treatment|0|||
164063593|NCT01728376|592596037|FG003|Overall Study|Did not receive treatment|0|||
164063594|NCT01728376|592596038|FG004|Overall Study|Did not receive treatment|0|||
164063595|NCT01728376|592596039|FG005|Overall Study|Did not receive treatment|0|||
164063596|NCT01728376|592596034|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164063597|NCT01728376|592596035|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164063598|NCT01728376|592596036|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164063599|NCT01728376|592596037|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
164063600|NCT01728376|592596038|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
164063601|NCT01728376|592596039|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
164063602|NCT02094573|592596041|FG000|Overall Study|Adverse Event|4|||
164063603|NCT02094573|592596042|FG001|Overall Study|Adverse Event|14|||
164063604|NCT02094573|592596041|FG000|Overall Study|Clinical Progressive Disease|9|||
164063605|NCT02094573|592596042|FG001|Overall Study|Clinical Progressive Disease|13|||
164063606|NCT02094573|592596041|FG000|Overall Study|Death|11|||
164063607|NCT02094573|592596042|FG001|Overall Study|Death|3|||
164063608|NCT02094573|592596041|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
164063609|NCT02094573|592596042|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
164063610|NCT02094573|592596041|FG000|Overall Study|Non-compliance with Study Drug|1|||
164063611|NCT02094573|592596042|FG001|Overall Study|Non-compliance with Study Drug|1|||
164063612|NCT02094573|592596041|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
164063613|NCT02094573|592596042|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
164063614|NCT02094573|592596041|FG000|Overall Study|Physician Decision|4|||
164063615|NCT02094573|592596042|FG001|Overall Study|Physician Decision|4|||
164063616|NCT02094573|592596041|FG000|Overall Study|Site Terminated by Sponsor|10|||
164063617|NCT02094573|592596042|FG001|Overall Study|Site Terminated by Sponsor|17|||
164063618|NCT02094573|592596041|FG000|Overall Study|Withdrawal by Subject|6|||
164063619|NCT02094573|592596042|FG001|Overall Study|Withdrawal by Subject|8|||
164063620|NCT02094573|592596041|FG000|Overall Study|Randomized but not Treated|3|||
164063621|NCT02094573|592596042|FG001|Overall Study|Randomized but not Treated|0|||
164063622|NCT02411110|592596043|FG000|Treatment Period 1|Adverse Event|4|||
164063623|NCT02411110|592596044|FG001|Treatment Period 1|Adverse Event|2|||
164063624|NCT02411110|592596043|FG000|Treatment Period 1|Lost to Follow-up|1|||
164063625|NCT02411110|592596044|FG001|Treatment Period 1|Lost to Follow-up|0|||
164063626|NCT02411110|592596043|FG000|Treatment Period 1|Personal Reasons|2|||
164063627|NCT02411110|592596044|FG001|Treatment Period 1|Personal Reasons|5|||
164063628|NCT02411110|592596043|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
164063629|NCT02411110|592596044|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
164063630|NCT02411110|592596043|FG000|Treatment Period 2|Adverse Event|1|||
164063631|NCT02411110|592596044|FG001|Treatment Period 2|Adverse Event|0|||
164063632|NCT02411110|592596043|FG000|Treatment Period 2|Lost to Follow-up|0|||
164063633|NCT02411110|592596044|FG001|Treatment Period 2|Lost to Follow-up|2|||
164063634|NCT02411110|592596043|FG000|Treatment Period 2|Personal Reasons|0|||
164063635|NCT02411110|592596044|FG001|Treatment Period 2|Personal Reasons|2|||
164063636|NCT00643006|592596050|FG000|Overall Study|Lost to Follow-up|5|||
164063637|NCT00643006|592596051|FG001|Overall Study|Lost to Follow-up|4|||
164063638|NCT01308476|592596052|FG000|Overall Study|Lost to Follow-up|2|||
164063639|NCT01308476|592596053|FG001|Overall Study|Lost to Follow-up|2|||
164063640|NCT01308476|592596052|FG000|Overall Study|Other|1|||
164063641|NCT01308476|592596053|FG001|Overall Study|Other|0|||
164063642|NCT00812968|592596056|FG000|Overall Study|Relapse after erythroid response|6|||
164063643|NCT00812968|592596056|FG000|Overall Study|Disease progression|1|||
164063644|NCT00812968|592596056|FG000|Overall Study|No further treatment required|1|||
164063645|NCT00812968|592596056|FG000|Overall Study|Study closed due to marketing approval|3|||
164063646|NCT00505765|592596058|FG000|Overall Study|Withdrawal by Subject|1|||
164063647|NCT00505765|592596059|FG001|Overall Study|Withdrawal by Subject|0|||
164063648|NCT00505765|592596060|FG002|Overall Study|Withdrawal by Subject|0|||
164063649|NCT00505765|592596058|FG000|Overall Study|Adverse Event|1|||
164102972|NCT03570749|592740679|FG001|Overall Study|Ongoing|25|||
164102973|NCT03570749|592740680|FG002|Overall Study|Ongoing|25|||
164102974|NCT03570749|592740681|FG003|Overall Study|Ongoing|26|||
164102975|NCT03570749|592740682|FG004|Overall Study|Ongoing|140|||
164102976|NCT03570749|592740683|FG005|Overall Study|Ongoing|142|||
164102977|NCT03570749|592740684|FG006|Overall Study|Ongoing|220|||
164102978|NCT03570749|592740678|FG000|Overall Study|Adverse Event|0|||
164102979|NCT03570749|592740679|FG001|Overall Study|Adverse Event|0|||
164102980|NCT03570749|592740680|FG002|Overall Study|Adverse Event|0|||
164102981|NCT03570749|592740681|FG003|Overall Study|Adverse Event|0|||
164102982|NCT03570749|592740682|FG004|Overall Study|Adverse Event|2|||
164102983|NCT03570749|592740683|FG005|Overall Study|Adverse Event|3|||
164102984|NCT03570749|592740684|FG006|Overall Study|Adverse Event|6|||
164102985|NCT03570749|592740678|FG000|Overall Study|Lack of Efficacy|0|||
164102986|NCT03570749|592740679|FG001|Overall Study|Lack of Efficacy|0|||
164102987|NCT03570749|592740680|FG002|Overall Study|Lack of Efficacy|0|||
164102988|NCT03570749|592740681|FG003|Overall Study|Lack of Efficacy|0|||
164102989|NCT03570749|592740682|FG004|Overall Study|Lack of Efficacy|8|||
164102990|NCT03570749|592740683|FG005|Overall Study|Lack of Efficacy|2|||
164102991|NCT03570749|592740684|FG006|Overall Study|Lack of Efficacy|7|||
164102992|NCT03570749|592740678|FG000|Overall Study|Lost to Follow-up|0|||
164102993|NCT03570749|592740679|FG001|Overall Study|Lost to Follow-up|0|||
164102994|NCT03570749|592740680|FG002|Overall Study|Lost to Follow-up|0|||
164102995|NCT03570749|592740681|FG003|Overall Study|Lost to Follow-up|0|||
164102996|NCT03570749|592740682|FG004|Overall Study|Lost to Follow-up|5|||
164102997|NCT03570749|592740683|FG005|Overall Study|Lost to Follow-up|10|||
164102998|NCT03570749|592740684|FG006|Overall Study|Lost to Follow-up|10|||
164102999|NCT03570749|592740678|FG000|Overall Study|Pregnancy|0|||
164103000|NCT03570749|592740679|FG001|Overall Study|Pregnancy|0|||
164103001|NCT03570749|592740680|FG002|Overall Study|Pregnancy|0|||
164103002|NCT03570749|592740681|FG003|Overall Study|Pregnancy|0|||
164103003|NCT03570749|592740682|FG004|Overall Study|Pregnancy|0|||
164103004|NCT03570749|592740683|FG005|Overall Study|Pregnancy|1|||
164103005|NCT03570749|592740684|FG006|Overall Study|Pregnancy|1|||
164063650|NCT00505765|592596059|FG001|Overall Study|Adverse Event|2|||
164063651|NCT00505765|592596060|FG002|Overall Study|Adverse Event|0|||
164063652|NCT00505765|592596058|FG000|Overall Study|Noncompliance|0|||
164063653|NCT00505765|592596059|FG001|Overall Study|Noncompliance|1|||
164063654|NCT00505765|592596060|FG002|Overall Study|Noncompliance|3|||
164063655|NCT01012609|592596062|FG000|Overall Study|Withdrawal by Subject|1|||
164063656|NCT01012609|592596063|FG001|Overall Study|Withdrawal by Subject|1|||
164063657|NCT01453296|592596064|FG000|Treatment Period 1|Adverse Event|0|||
164063658|NCT01453296|592596065|FG001|Treatment Period 1|Adverse Event|1|||
164103006|NCT03570749|592740678|FG000|Overall Study|Screen Fail|0|||
164103007|NCT03570749|592740679|FG001|Overall Study|Screen Fail|0|||
164103008|NCT03570749|592740680|FG002|Overall Study|Screen Fail|0|||
164103009|NCT03570749|592740681|FG003|Overall Study|Screen Fail|0|||
164103010|NCT03570749|592740682|FG004|Overall Study|Screen Fail|0|||
164103011|NCT03570749|592740683|FG005|Overall Study|Screen Fail|0|||
164103012|NCT03570749|592740684|FG006|Overall Study|Screen Fail|1|||
164103013|NCT03570749|592740678|FG000|Overall Study|Withdrawal by Subject|2|||
164103014|NCT03570749|592740679|FG001|Overall Study|Withdrawal by Subject|3|||
164103015|NCT03570749|592740680|FG002|Overall Study|Withdrawal by Subject|2|||
164103016|NCT03570749|592740681|FG003|Overall Study|Withdrawal by Subject|1|||
164103017|NCT03570749|592740682|FG004|Overall Study|Withdrawal by Subject|17|||
164063659|NCT01453296|592596064|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
164063660|NCT01453296|592596065|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
164063661|NCT01453296|592596064|FG000|Treatment Period 2|Adverse Event|1|||
164063662|NCT01453296|592596065|FG001|Treatment Period 2|Adverse Event|0|||
164063663|NCT01453296|592596064|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164063664|NCT01453296|592596065|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164063665|NCT00620776|592596066|FG000|Overall Study|Did not receive treatment|3|||
164063666|NCT00620776|592596067|FG001|Overall Study|Did not receive treatment|5|||
164063667|NCT00620776|592596066|FG000|Overall Study|Adverse Event|2|||
164103018|NCT03570749|592740683|FG005|Overall Study|Withdrawal by Subject|12|||
164103019|NCT03570749|592740684|FG006|Overall Study|Withdrawal by Subject|15|||
164103020|NCT03570749|592740678|FG000|Overall Study|Other|0|||
164103021|NCT03570749|592740679|FG001|Overall Study|Other|0|||
164103022|NCT03570749|592740680|FG002|Overall Study|Other|0|||
164063668|NCT00620776|592596067|FG001|Overall Study|Adverse Event|3|||
164063669|NCT00620776|592596066|FG000|Overall Study|Lack of Efficacy|2|||
164063670|NCT00620776|592596067|FG001|Overall Study|Lack of Efficacy|1|||
164063671|NCT00620776|592596066|FG000|Overall Study|Lost to Follow-up|2|||
164063672|NCT00620776|592596067|FG001|Overall Study|Lost to Follow-up|5|||
164103023|NCT03570749|592740681|FG003|Overall Study|Other|0|||
164103024|NCT03570749|592740682|FG004|Overall Study|Other|17|||
164103025|NCT03570749|592740683|FG005|Overall Study|Other|14|||
164103026|NCT03570749|592740684|FG006|Overall Study|Other|21|||
164103027|NCT00561015|592740685|FG000|Overall Study|Adverse Event|0|||
164103028|NCT00561015|592740686|FG001|Overall Study|Adverse Event|0|||
164103029|NCT00561015|592740687|FG002|Overall Study|Adverse Event|0|||
164103030|NCT00561015|592740688|FG003|Overall Study|Adverse Event|0|||
164063673|NCT00620776|592596066|FG000|Overall Study|Withdrawal by Subject|3|||
164063674|NCT00620776|592596067|FG001|Overall Study|Withdrawal by Subject|2|||
164063675|NCT00761969|592596068|FG000|Overall Study|Death|112|||
164063676|NCT00761969|592596069|FG001|Overall Study|Death|47|||
164063677|NCT00761969|592596068|FG000|Overall Study|Lost to Follow-up|88|||
164063678|NCT00761969|592596069|FG001|Overall Study|Lost to Follow-up|93|||
164063679|NCT03205046|592596072|FG000|Overall Study|Death|10|||
164103031|NCT00561015|592740689|FG004|Overall Study|Adverse Event|1|||
164103032|NCT00561015|592740690|FG005|Overall Study|Adverse Event|0|||
164103033|NCT00561015|592740685|FG000|Overall Study|Lost to Follow-up|2|||
164103034|NCT00561015|592740686|FG001|Overall Study|Lost to Follow-up|0|||
164103035|NCT00561015|592740687|FG002|Overall Study|Lost to Follow-up|0|||
164103036|NCT00561015|592740688|FG003|Overall Study|Lost to Follow-up|1|||
164103037|NCT00561015|592740689|FG004|Overall Study|Lost to Follow-up|0|||
164103038|NCT00561015|592740690|FG005|Overall Study|Lost to Follow-up|3|||
164103039|NCT00561015|592740685|FG000|Overall Study|Participant non-compliance|2|||
164103040|NCT00561015|592740686|FG001|Overall Study|Participant non-compliance|0|||
164103041|NCT00561015|592740687|FG002|Overall Study|Participant non-compliance|0|||
164103042|NCT00561015|592740688|FG003|Overall Study|Participant non-compliance|0|||
164103043|NCT00561015|592740689|FG004|Overall Study|Participant non-compliance|0|||
164103044|NCT00561015|592740690|FG005|Overall Study|Participant non-compliance|0|||
164103045|NCT02146105|592740691|FG000|Overall Study|Adverse Event|1|||
164103046|NCT02146105|592740691|FG000|Overall Study|Withdrawal by Subject|5|||
164103047|NCT03086460|592740692|FG000|Study Participants|Lost to Follow-up|2|||
164103048|NCT03086460|592740692|FG000|Study Participants|Protocol Violation|1|||
164103049|NCT03086460|592740692|FG000|Study Participants|Withdrawal by Subject|6|||
164103050|NCT03086460|592740692|FG000|Treatment A|Lost to Follow-up|1|||
164103051|NCT03086460|592740692|FG000|Treatment A|Protocol Violation|1|||
164103052|NCT03086460|592740692|FG000|Treatment A|Withdrawal by Subject|2|||
164103053|NCT03086460|592740692|FG000|Treatment C|Withdrawal by Subject|2|||
164103054|NCT03086460|592740692|FG000|Treatment E|Lost to Follow-up|1|||
164103055|NCT03086460|592740692|FG000|Treatment E|Withdrawal by Subject|3|||
164103056|NCT02545283|592740695|FG000|Overall Study|Lost to Follow-up|2|||
164103057|NCT02545283|592740696|FG001|Overall Study|Lost to Follow-up|4|||
164103058|NCT02545283|592740695|FG000|Overall Study|Withdrawal by Subject|5|||
164103059|NCT02545283|592740696|FG001|Overall Study|Withdrawal by Subject|9|||
164103060|NCT02545283|592740695|FG000|Overall Study|Death|109|||
164103061|NCT02545283|592740696|FG001|Overall Study|Death|211|||
164103062|NCT02545283|592740695|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
164103063|NCT02545283|592740696|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
164103064|NCT02545283|592740695|FG000|Overall Study|Study Terminated By Sponsor|33|||
164103065|NCT02545283|592740696|FG001|Overall Study|Study Terminated By Sponsor|71|||
164103066|NCT02436005|592740697|FG000|Second Intervention|Adverse Event|0|||
164103067|NCT02436005|592740698|FG001|Second Intervention|Adverse Event|1|||
164103068|NCT00583453|592740699|FG000|Overall Study|discontinued intervention|0|||
164103069|NCT00583453|592740700|FG001|Overall Study|discontinued intervention|2|||
164103070|NCT00905606|592740701|FG000|Period 1|Adverse Event|0|||
164103071|NCT00905606|592740702|FG001|Period 1|Adverse Event|1|||
164103072|NCT00905606|592740701|FG000|Washout|Withdrawal by Subject|1|||
164103073|NCT00905606|592740702|FG001|Washout|Withdrawal by Subject|0|||
164103074|NCT03635320|592740703|FG000|Overall Study|not implanted the device|1|||
164103075|NCT03635320|592740704|FG001|Overall Study|not implanted the device|2|||
164103076|NCT03635320|592740703|FG000|Overall Study|Withdrawal by Subject|11|||
164063680|NCT03205046|592596073|FG001|Overall Study|Death|6|||
164063681|NCT03205046|592596072|FG000|Overall Study|Withdrawal by Subject|1|||
164063682|NCT03205046|592596073|FG001|Overall Study|Withdrawal by Subject|2|||
164063683|NCT03205046|592596072|FG000|Overall Study|Lost to Follow-up|0|||
164103077|NCT03635320|592740704|FG001|Overall Study|Withdrawal by Subject|6|||
164103078|NCT01558635|592740705|FG000|Overall Study|Death|1|||
164103079|NCT01558635|592740705|FG000|Overall Study|Withdrawal by Subject|2|||
164103080|NCT01558635|592740705|FG000|Overall Study|Physician Decision|1|||
164103081|NCT01558635|592740705|FG000|Overall Study|Subject received other treatment|1|||
164103082|NCT01558635|592740705|FG000|Overall Study|Reveal XT was explanted|1|||
164103083|NCT00455312|592740708|FG000|Overall Study|Death|0|||
164103084|NCT00455312|592740709|FG001|Overall Study|Death|1|||
164103085|NCT02659150|592740710|FG000|Subject Enrollment|Physician Decision|3|||
164063684|NCT03205046|592596073|FG001|Overall Study|Lost to Follow-up|1|||
164063685|NCT03205046|592596072|FG000|Overall Study|Study terminated by sponsor|2|||
164103086|NCT02659150|592740710|FG000|Subject Enrollment|Withdrawal by Subject|2|||
164103087|NCT02659150|592740710|FG000|Baseline Imaging|Withdrawal by Subject|1|||
164103088|NCT02659150|592740710|FG000|Baseline Imaging|Physician Decision|1|||
164063686|NCT03205046|592596073|FG001|Overall Study|Study terminated by sponsor|1|||
164063687|NCT01015118|592596075|FG000|Overall Study|Protocol Violation|5|||
164063688|NCT01015118|592596076|FG001|Overall Study|Protocol Violation|6|||
164103089|NCT02659150|592740710|FG000|Study Drug Dosing|Adverse Event|1|||
164103090|NCT02902211|592740713|FG000|First Three Months|Withdrawal by Subject|7|||
164103091|NCT02902211|592740714|FG001|First Three Months|Withdrawal by Subject|3|||
164103092|NCT01363765|592740715|FG000|Overall Study|non-diagnostic|2621|||
164063689|NCT01015118|592596075|FG000|Overall Study|Withdrawal by Subject|103|||
164103093|NCT01363765|592740716|FG001|Overall Study|non-diagnostic|1124|||
164103094|NCT01363765|592740715|FG000|Overall Study|duplicate records|736|||
164103095|NCT01363765|592740716|FG001|Overall Study|duplicate records|3177|||
164103096|NCT01363765|592740715|FG000|Overall Study|non-resident|156|||
164103097|NCT01363765|592740716|FG001|Overall Study|non-resident|76|||
164103098|NCT01363765|592740715|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
164103099|NCT01363765|592740716|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
164103100|NCT01363765|592740715|FG000|Overall Study|smear during intervention|2170|||
164103101|NCT01363765|592740716|FG001|Overall Study|smear during intervention|0|||
164103102|NCT00448591|592740717|FG000|Overall Study|Withdrawal by Subject|178|||
164103103|NCT00448591|592740717|FG000|Overall Study|Progressive Disease|1382|||
164103104|NCT00448591|592740717|FG000|Overall Study|Adverse Event|382|||
164103105|NCT00448591|592740717|FG000|Overall Study|Protocol Violation|41|||
164103106|NCT00448591|592740717|FG000|Overall Study|Lost to Follow-up|19|||
164103107|NCT00448591|592740717|FG000|Overall Study|Treatment Regimen Completed|70|||
164063690|NCT01015118|592596076|FG001|Overall Study|Withdrawal by Subject|27|||
164063691|NCT01015118|592596075|FG000|Overall Study|Other Adverse Event (AE)|141|||
164063692|NCT01015118|592596076|FG001|Overall Study|Other Adverse Event (AE)|33|||
164063693|NCT01015118|592596075|FG000|Overall Study|Worsening or AE of underlying disease|5|||
164063694|NCT01015118|592596076|FG001|Overall Study|Worsening or AE of underlying disease|4|||
164063695|NCT01015118|592596075|FG000|Overall Study|Progressive disease|364|||
164063696|NCT01015118|592596076|FG001|Overall Study|Progressive disease|229|||
164063697|NCT01015118|592596075|FG000|Overall Study|Not treated|9|||
164063698|NCT01015118|592596076|FG001|Overall Study|Not treated|5|||
164063699|NCT01015118|592596075|FG000|Overall Study|Other than stated above|42|||
164063700|NCT01015118|592596076|FG001|Overall Study|Other than stated above|23|||
164063701|NCT00402298|592596089|FG000|Overall Study|Withdrawal by Subject|1|||
164063702|NCT00402298|592596090|FG001|Overall Study|Withdrawal by Subject|0|||
164063703|NCT00480077|592596091|FG000|Overall Study|Death|19|||
164063704|NCT00480077|592596092|FG001|Overall Study|Death|15|||
164063705|NCT00480077|592596091|FG000|Overall Study|early exit|12|||
164063706|NCT00480077|592596092|FG001|Overall Study|early exit|11|||
164063707|NCT00938366|592596097|FG000|Overall Study|Withdrawal by Subject|1|||
164063708|NCT00938366|592596098|FG001|Overall Study|Withdrawal by Subject|0|||
164063709|NCT01215968|592596099|FG000|Overall Study|Adverse Event|0|||
164063710|NCT01215968|592596100|FG001|Overall Study|Adverse Event|2|||
164063711|NCT01215968|592596099|FG000|Overall Study|Protocol Violation|2|||
164063712|NCT01215968|592596100|FG001|Overall Study|Protocol Violation|4|||
164063713|NCT01215968|592596099|FG000|Overall Study|Not received study drug|0|||
164063714|NCT01215968|592596100|FG001|Overall Study|Not received study drug|1|||
164063715|NCT01250418|592596101|FG000|Overall Study|monitor data failure|1|||
164063716|NCT01250418|592596102|FG001|Overall Study|monitor data failure|1|||
164063717|NCT05966129|592596104|FG000|Overall Study|Death|1|||
164063718|NCT05966129|592596105|FG001|Overall Study|Death|2|||
164063719|NCT05966129|592596104|FG000|Overall Study|Lost to Follow-up|63|||
164063720|NCT05966129|592596105|FG001|Overall Study|Lost to Follow-up|66|||
164063721|NCT05966129|592596104|FG000|Overall Study|Protocol Violation|1|||
164063722|NCT05966129|592596105|FG001|Overall Study|Protocol Violation|0|||
164063723|NCT05966129|592596104|FG000|Overall Study|Withdrawal by Subject|26|||
164063724|NCT05966129|592596105|FG001|Overall Study|Withdrawal by Subject|25|||
164063725|NCT05966129|592596104|FG000|Overall Study|Surgery not completed|63|||
164063726|NCT05966129|592596105|FG001|Overall Study|Surgery not completed|69|||
164063727|NCT05966129|592596104|FG000|Overall Study|Surgery logistics issue|2|||
164063728|NCT05966129|592596105|FG001|Overall Study|Surgery logistics issue|1|||
164063729|NCT05182840|592596106|FG000|Run-in Period|Not treated|0|||
164063730|NCT05182840|592596107|FG001|Run-in Period|Not treated|1|||
164063731|NCT05182840|592596108|FG002|Run-in Period|Not treated|0|||
164063732|NCT05182840|592596109|FG003|Run-in Period|Not treated|0|||
164063733|NCT05182840|592596110|FG004|Run-in Period|Not treated|0|||
164063734|NCT05182840|592596111|FG005|Run-in Period|Not treated|0|||
164063735|NCT05182840|592596112|FG006|Run-in Period|Not treated|0|||
164063736|NCT05182840|592596113|FG007|Run-in Period|Not treated|0|||
164063737|NCT05182840|592596114|FG008|Run-in Period|Not treated|0|||
164103108|NCT00448591|592740717|FG000|Overall Study|Other|154|||
164103109|NCT00448591|592740717|FG000|Overall Study|Termination of Study|70|||
164103110|NCT00609674|592740718|FG000|Overall Study|Adverse Event|1|||
164103111|NCT00609674|592740719|FG001|Overall Study|Adverse Event|1|||
164063738|NCT05182840|592596115|FG009|Run-in Period|Not treated|0|||
164063739|NCT05182840|592596106|FG000|Run-in Period|Other reason but not sponsor termination|14|||
164063740|NCT05182840|592596107|FG001|Run-in Period|Other reason but not sponsor termination|18|||
164063741|NCT05182840|592596108|FG002|Run-in Period|Other reason but not sponsor termination|0|||
164063742|NCT05182840|592596109|FG003|Run-in Period|Other reason but not sponsor termination|0|||
164063743|NCT05182840|592596110|FG004|Run-in Period|Other reason but not sponsor termination|0|||
164063744|NCT05182840|592596111|FG005|Run-in Period|Other reason but not sponsor termination|0|||
164063745|NCT05182840|592596112|FG006|Run-in Period|Other reason but not sponsor termination|0|||
164063746|NCT05182840|592596113|FG007|Run-in Period|Other reason but not sponsor termination|0|||
164103112|NCT00609674|592740718|FG000|Overall Study|Protocol Violation|3|||
164103113|NCT00609674|592740719|FG001|Overall Study|Protocol Violation|5|||
164103114|NCT00609674|592740718|FG000|Overall Study|Lost to Follow-up|1|||
164103115|NCT00609674|592740719|FG001|Overall Study|Lost to Follow-up|0|||
164103116|NCT00609674|592740718|FG000|Overall Study|Withdrew consent|2|||
164103117|NCT00609674|592740719|FG001|Overall Study|Withdrew consent|1|||
164103118|NCT00834431|592740720|FG000|First Intervention|Adverse Event|0|||
164103119|NCT00834431|592740721|FG001|First Intervention|Adverse Event|1|||
164103120|NCT00834431|592740720|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164103121|NCT00834431|592740721|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164103122|NCT00556322|592740726|FG000|Overall Study|Insufficient therapeutic response|158|||
164103123|NCT00556322|592740727|FG001|Overall Study|Insufficient therapeutic response|168|||
164103124|NCT00556322|592740726|FG000|Overall Study|Adverse Event|7|||
164103125|NCT00556322|592740727|FG001|Overall Study|Adverse Event|4|||
164103126|NCT00556322|592740726|FG000|Overall Study|Other|4|||
164103127|NCT00556322|592740727|FG001|Overall Study|Other|1|||
164103128|NCT00556322|592740726|FG000|Overall Study|Lost to Follow-up|5|||
164103129|NCT00556322|592740727|FG001|Overall Study|Lost to Follow-up|3|||
164103130|NCT00556322|592740726|FG000|Overall Study|Withdrawal by Subject|19|||
164103131|NCT00556322|592740727|FG001|Overall Study|Withdrawal by Subject|7|||
164103132|NCT00556322|592740726|FG000|Overall Study|Protocol Violation|5|||
164103133|NCT00556322|592740727|FG001|Overall Study|Protocol Violation|1|||
164103134|NCT00556322|592740726|FG000|Overall Study|Ongoing at data cutoff|3|||
164103135|NCT00556322|592740727|FG001|Overall Study|Ongoing at data cutoff|5|||
164103136|NCT00556322|592740726|FG000|Overall Study|Death|20|||
164103137|NCT00556322|592740727|FG001|Overall Study|Death|14|||
164103138|NCT01913405|592740728|FG000|Overall Study|Withdrawal by Subject|1|||
164103139|NCT01913405|592740728|FG000|Overall Study|Adverse Event|1|||
164103140|NCT04400890|592740729|FG000|Overall Study|Withdrawal by Subject|3|||
164103141|NCT04400890|592740730|FG001|Overall Study|Withdrawal by Subject|2|||
164103142|NCT03925532|592740731|FG000|Overall Study|Lost to Follow-up|1|||
164103143|NCT02258074|592740732|FG000|Overall Study|Withdrawal by Subject|1|||
164103144|NCT02258074|592740733|FG001|Overall Study|Withdrawal by Subject|0|||
164103145|NCT02258074|592740734|FG002|Overall Study|Withdrawal by Subject|0|||
164103146|NCT02258074|592740735|FG003|Overall Study|Withdrawal by Subject|0|||
164103147|NCT05446870|592740736|FG000|Overall Study|Death|6|||
164103148|NCT05446870|592740737|FG001|Overall Study|Death|5|||
164103149|NCT05446870|592740736|FG000|Overall Study|Lost to Follow-up|0|||
164103150|NCT05446870|592740737|FG001|Overall Study|Lost to Follow-up|1|||
164103151|NCT05446870|592740736|FG000|Overall Study|Physician Decision|52|||
164103152|NCT05446870|592740737|FG001|Overall Study|Physician Decision|53|||
164103153|NCT05446870|592740736|FG000|Overall Study|Withdrawal by Subject|3|||
164103154|NCT05446870|592740737|FG001|Overall Study|Withdrawal by Subject|3|||
164103155|NCT01615198|592740740|FG000|Overall Study|Withdrawal by Subject|5|||
164103156|NCT01615198|592740741|FG001|Overall Study|Withdrawal by Subject|5|||
164103157|NCT01615198|592740740|FG000|Overall Study|Protocol deviation|1|||
164103158|NCT01615198|592740741|FG001|Overall Study|Protocol deviation|1|||
164103159|NCT01615198|592740740|FG000|Overall Study|Physician Decision|5|||
164103160|NCT01615198|592740741|FG001|Overall Study|Physician Decision|1|||
164103161|NCT01615198|592740740|FG000|Overall Study|Lost to Follow-up|1|||
164103162|NCT01615198|592740741|FG001|Overall Study|Lost to Follow-up|1|||
164103163|NCT01615198|592740740|FG000|Overall Study|Lack of Efficacy|1|||
164103164|NCT01615198|592740741|FG001|Overall Study|Lack of Efficacy|6|||
164103165|NCT01615198|592740740|FG000|Overall Study|Adverse Event|11|||
164103166|NCT01615198|592740741|FG001|Overall Study|Adverse Event|5|||
164103167|NCT01686438|592740742|FG000|Overall Study|Lost to Follow-up|8|||
164103168|NCT01686438|592740743|FG001|Overall Study|Lost to Follow-up|9|||
164103169|NCT01686438|592740744|FG002|Overall Study|Lost to Follow-up|10|||
164103170|NCT01686438|592740742|FG000|Overall Study|Adverse Event|0|||
164103171|NCT01686438|592740743|FG001|Overall Study|Adverse Event|0|||
164103172|NCT01686438|592740744|FG002|Overall Study|Adverse Event|1|||
164103173|NCT01686438|592740742|FG000|Overall Study|Protocol Violation|0|||
164103174|NCT01686438|592740743|FG001|Overall Study|Protocol Violation|0|||
164103175|NCT01686438|592740744|FG002|Overall Study|Protocol Violation|1|||
164103176|NCT01686438|592740742|FG000|Overall Study|Withdrawal by Subject|0|||
164103177|NCT01686438|592740743|FG001|Overall Study|Withdrawal by Subject|0|||
164103178|NCT01686438|592740744|FG002|Overall Study|Withdrawal by Subject|1|||
164103179|NCT00984126|592740745|FG000|Overall Study|Protocol Violation|0|||
164103180|NCT00984126|592740746|FG001|Overall Study|Protocol Violation|0|||
164103181|NCT00984126|592740747|FG002|Overall Study|Protocol Violation|1|||
164103182|NCT00984126|592740748|FG003|Overall Study|Protocol Violation|2|||
164103183|NCT00984126|592740745|FG000|Overall Study|Adverse Event|0|||
164103184|NCT00984126|592740746|FG001|Overall Study|Adverse Event|0|||
164103185|NCT00984126|592740747|FG002|Overall Study|Adverse Event|0|||
164103186|NCT00984126|592740748|FG003|Overall Study|Adverse Event|2|||
164103187|NCT00984126|592740745|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
164103188|NCT00984126|592740746|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
164103189|NCT00984126|592740747|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
164103190|NCT00984126|592740748|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
164103191|NCT00984126|592740745|FG000|Overall Study|Withdrawal criteria|0|||
164103192|NCT00984126|592740746|FG001|Overall Study|Withdrawal criteria|1|||
164103193|NCT00984126|592740747|FG002|Overall Study|Withdrawal criteria|3|||
164103194|NCT00984126|592740748|FG003|Overall Study|Withdrawal criteria|9|||
164103195|NCT01029340|592740751|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
164103196|NCT01029340|592740752|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
164103197|NCT01029340|592740753|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
164103198|NCT01029340|592740754|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
164103199|NCT01029340|592740755|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
164103200|NCT01029340|592740756|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
164103201|NCT01029340|592740751|FG000|Part B Treatment Period|Protocol Violation|0|||
164103202|NCT01029340|592740752|FG001|Part B Treatment Period|Protocol Violation|0|||
164103203|NCT01029340|592740753|FG002|Part B Treatment Period|Protocol Violation|1|||
164103204|NCT01029340|592740754|FG003|Part B Treatment Period|Protocol Violation|0|||
164103205|NCT01029340|592740755|FG004|Part B Treatment Period|Protocol Violation|0|||
164103206|NCT01029340|592740756|FG005|Part B Treatment Period|Protocol Violation|0|||
164103207|NCT01029340|592740751|FG000|Extension Period|Adverse Event|0|||
164103208|NCT01029340|592740752|FG001|Extension Period|Adverse Event|0|||
164103209|NCT01029340|592740753|FG002|Extension Period|Adverse Event|0|||
164103210|NCT01029340|592740754|FG003|Extension Period|Adverse Event|0|||
164103211|NCT01029340|592740755|FG004|Extension Period|Adverse Event|0|||
164103212|NCT01029340|592740756|FG005|Extension Period|Adverse Event|1|||
164103213|NCT01029340|592740751|FG000|Extension Period|starting another study|0|||
164063747|NCT05182840|592596114|FG008|Run-in Period|Other reason but not sponsor termination|0|||
164063748|NCT05182840|592596115|FG009|Run-in Period|Other reason but not sponsor termination|0|||
164063749|NCT05182840|592596106|FG000|Run-in Period|No reason available|2|||
164063750|NCT05182840|592596107|FG001|Run-in Period|No reason available|2|||
164063751|NCT05182840|592596108|FG002|Run-in Period|No reason available|0|||
164063752|NCT05182840|592596109|FG003|Run-in Period|No reason available|0|||
164063753|NCT05182840|592596110|FG004|Run-in Period|No reason available|0|||
164063754|NCT05182840|592596111|FG005|Run-in Period|No reason available|0|||
164063755|NCT05182840|592596112|FG006|Run-in Period|No reason available|0|||
164063756|NCT05182840|592596113|FG007|Run-in Period|No reason available|0|||
164063757|NCT05182840|592596114|FG008|Run-in Period|No reason available|0|||
164063758|NCT05182840|592596115|FG009|Run-in Period|No reason available|0|||
164063759|NCT05182840|592596106|FG000|Run-in Period|Burden of study procedures|2|||
164063760|NCT05182840|592596107|FG001|Run-in Period|Burden of study procedures|2|||
164063761|NCT05182840|592596108|FG002|Run-in Period|Burden of study procedures|0|||
164063762|NCT05182840|592596109|FG003|Run-in Period|Burden of study procedures|0|||
164063763|NCT05182840|592596110|FG004|Run-in Period|Burden of study procedures|0|||
164103214|NCT01029340|592740752|FG001|Extension Period|starting another study|0|||
164103215|NCT01029340|592740753|FG002|Extension Period|starting another study|0|||
164103216|NCT01029340|592740754|FG003|Extension Period|starting another study|0|||
164103217|NCT01029340|592740755|FG004|Extension Period|starting another study|0|||
164103218|NCT01029340|592740756|FG005|Extension Period|starting another study|8|||
164103219|NCT01029340|592740751|FG000|Extension Period|non-compliance|0|||
164103220|NCT01029340|592740752|FG001|Extension Period|non-compliance|0|||
164103221|NCT01029340|592740753|FG002|Extension Period|non-compliance|0|||
164103222|NCT01029340|592740754|FG003|Extension Period|non-compliance|0|||
164103223|NCT01029340|592740755|FG004|Extension Period|non-compliance|0|||
164103224|NCT01029340|592740756|FG005|Extension Period|non-compliance|1|||
164103225|NCT01029340|592740751|FG000|Extension Period|Withdrawal by Subject|0|||
164103226|NCT01029340|592740752|FG001|Extension Period|Withdrawal by Subject|0|||
164103227|NCT01029340|592740753|FG002|Extension Period|Withdrawal by Subject|0|||
164103228|NCT01029340|592740754|FG003|Extension Period|Withdrawal by Subject|0|||
164103229|NCT01029340|592740755|FG004|Extension Period|Withdrawal by Subject|0|||
164103230|NCT01029340|592740756|FG005|Extension Period|Withdrawal by Subject|1|||
164103231|NCT01029340|592740751|FG000|Extension Period|Physician Decision|0|||
164103232|NCT01029340|592740752|FG001|Extension Period|Physician Decision|0|||
164103233|NCT01029340|592740753|FG002|Extension Period|Physician Decision|0|||
164103234|NCT01029340|592740754|FG003|Extension Period|Physician Decision|0|||
164103235|NCT01029340|592740755|FG004|Extension Period|Physician Decision|0|||
164103236|NCT01029340|592740756|FG005|Extension Period|Physician Decision|1|||
164103237|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
164063764|NCT05182840|592596111|FG005|Run-in Period|Burden of study procedures|0|||
164103238|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
164103239|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
164103240|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
164063765|NCT05182840|592596112|FG006|Run-in Period|Burden of study procedures|0|||
164063766|NCT05182840|592596113|FG007|Run-in Period|Burden of study procedures|0|||
164103241|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
164103242|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
164063767|NCT05182840|592596114|FG008|Run-in Period|Burden of study procedures|0|||
164063768|NCT05182840|592596115|FG009|Run-in Period|Burden of study procedures|0|||
164063769|NCT05182840|592596106|FG000|Run-in Period|Change of residence|1|||
164063770|NCT05182840|592596107|FG001|Run-in Period|Change of residence|0|||
164063771|NCT05182840|592596108|FG002|Run-in Period|Change of residence|0|||
164063772|NCT05182840|592596109|FG003|Run-in Period|Change of residence|0|||
164063773|NCT05182840|592596110|FG004|Run-in Period|Change of residence|0|||
164063774|NCT05182840|592596111|FG005|Run-in Period|Change of residence|0|||
164063775|NCT05182840|592596112|FG006|Run-in Period|Change of residence|0|||
164063776|NCT05182840|592596113|FG007|Run-in Period|Change of residence|0|||
164063777|NCT05182840|592596114|FG008|Run-in Period|Change of residence|0|||
164063778|NCT05182840|592596115|FG009|Run-in Period|Change of residence|0|||
164063779|NCT05182840|592596106|FG000|Run-in Period|Adverse Event|5|||
164063780|NCT05182840|592596107|FG001|Run-in Period|Adverse Event|5|||
164063781|NCT05182840|592596108|FG002|Run-in Period|Adverse Event|0|||
164063782|NCT05182840|592596109|FG003|Run-in Period|Adverse Event|0|||
164063783|NCT05182840|592596110|FG004|Run-in Period|Adverse Event|0|||
164063784|NCT05182840|592596111|FG005|Run-in Period|Adverse Event|0|||
164063785|NCT05182840|592596112|FG006|Run-in Period|Adverse Event|0|||
164063786|NCT05182840|592596113|FG007|Run-in Period|Adverse Event|0|||
164063787|NCT05182840|592596114|FG008|Run-in Period|Adverse Event|0|||
164063788|NCT05182840|592596115|FG009|Run-in Period|Adverse Event|0|||
164063789|NCT05182840|592596106|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
164063790|NCT05182840|592596107|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
164063791|NCT05182840|592596108|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063792|NCT05182840|592596109|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063793|NCT05182840|592596110|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063794|NCT05182840|592596111|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063795|NCT05182840|592596112|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063796|NCT05182840|592596113|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063797|NCT05182840|592596114|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063798|NCT05182840|592596115|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
164063799|NCT05182840|592596106|FG000|Treatment Period|Reason missing|0|||
164063800|NCT05182840|592596107|FG001|Treatment Period|Reason missing|0|||
164063801|NCT05182840|592596108|FG002|Treatment Period|Reason missing|1|||
164063802|NCT05182840|592596109|FG003|Treatment Period|Reason missing|0|||
164063803|NCT05182840|592596110|FG004|Treatment Period|Reason missing|0|||
164063804|NCT05182840|592596111|FG005|Treatment Period|Reason missing|0|||
164063805|NCT05182840|592596112|FG006|Treatment Period|Reason missing|0|||
164063806|NCT05182840|592596113|FG007|Treatment Period|Reason missing|0|||
164063807|NCT05182840|592596114|FG008|Treatment Period|Reason missing|0|||
164063808|NCT05182840|592596115|FG009|Treatment Period|Reason missing|0|||
164063809|NCT05182840|592596106|FG000|Treatment Period|Other but not sponsor termination|0|||
164063810|NCT05182840|592596107|FG001|Treatment Period|Other but not sponsor termination|0|||
164063811|NCT05182840|592596108|FG002|Treatment Period|Other but not sponsor termination|8|||
164063812|NCT05182840|592596109|FG003|Treatment Period|Other but not sponsor termination|6|||
164063813|NCT05182840|592596110|FG004|Treatment Period|Other but not sponsor termination|6|||
164063814|NCT05182840|592596111|FG005|Treatment Period|Other but not sponsor termination|7|||
164063815|NCT05182840|592596112|FG006|Treatment Period|Other but not sponsor termination|5|||
164063816|NCT05182840|592596113|FG007|Treatment Period|Other but not sponsor termination|8|||
164063817|NCT05182840|592596114|FG008|Treatment Period|Other but not sponsor termination|7|||
164063818|NCT05182840|592596115|FG009|Treatment Period|Other but not sponsor termination|2|||
164063819|NCT05182840|592596106|FG000|Treatment Period|Protocol deviation|0|||
164063820|NCT05182840|592596107|FG001|Treatment Period|Protocol deviation|0|||
164063821|NCT05182840|592596108|FG002|Treatment Period|Protocol deviation|0|||
164063822|NCT05182840|592596109|FG003|Treatment Period|Protocol deviation|0|||
164063823|NCT05182840|592596110|FG004|Treatment Period|Protocol deviation|0|||
164063824|NCT05182840|592596111|FG005|Treatment Period|Protocol deviation|0|||
164063825|NCT05182840|592596112|FG006|Treatment Period|Protocol deviation|0|||
164063826|NCT05182840|592596113|FG007|Treatment Period|Protocol deviation|0|||
164063827|NCT05182840|592596114|FG008|Treatment Period|Protocol deviation|1|||
164063828|NCT05182840|592596115|FG009|Treatment Period|Protocol deviation|0|||
164063829|NCT05182840|592596106|FG000|Treatment Period|No reason available|0|||
164063830|NCT05182840|592596107|FG001|Treatment Period|No reason available|0|||
164063831|NCT05182840|592596108|FG002|Treatment Period|No reason available|0|||
164063832|NCT05182840|592596109|FG003|Treatment Period|No reason available|1|||
164063833|NCT05182840|592596110|FG004|Treatment Period|No reason available|0|||
164063834|NCT05182840|592596111|FG005|Treatment Period|No reason available|2|||
164063835|NCT05182840|592596112|FG006|Treatment Period|No reason available|0|||
164063836|NCT05182840|592596113|FG007|Treatment Period|No reason available|1|||
164063837|NCT05182840|592596114|FG008|Treatment Period|No reason available|0|||
164063838|NCT05182840|592596115|FG009|Treatment Period|No reason available|0|||
164063839|NCT05182840|592596106|FG000|Treatment Period|Burden of study procedures|0|||
164063840|NCT05182840|592596107|FG001|Treatment Period|Burden of study procedures|0|||
164063841|NCT05182840|592596108|FG002|Treatment Period|Burden of study procedures|0|||
164063842|NCT05182840|592596109|FG003|Treatment Period|Burden of study procedures|0|||
164063843|NCT05182840|592596110|FG004|Treatment Period|Burden of study procedures|1|||
164063844|NCT05182840|592596111|FG005|Treatment Period|Burden of study procedures|0|||
164063845|NCT05182840|592596112|FG006|Treatment Period|Burden of study procedures|0|||
164063846|NCT05182840|592596113|FG007|Treatment Period|Burden of study procedures|0|||
164063847|NCT05182840|592596114|FG008|Treatment Period|Burden of study procedures|0|||
164063848|NCT05182840|592596115|FG009|Treatment Period|Burden of study procedures|0|||
164063849|NCT05182840|592596106|FG000|Treatment Period|Change of residence|0|||
164063850|NCT05182840|592596107|FG001|Treatment Period|Change of residence|0|||
164063851|NCT05182840|592596108|FG002|Treatment Period|Change of residence|0|||
164063852|NCT05182840|592596109|FG003|Treatment Period|Change of residence|0|||
164063853|NCT05182840|592596110|FG004|Treatment Period|Change of residence|0|||
164063854|NCT05182840|592596111|FG005|Treatment Period|Change of residence|1|||
164063855|NCT05182840|592596112|FG006|Treatment Period|Change of residence|0|||
164063856|NCT05182840|592596113|FG007|Treatment Period|Change of residence|0|||
164063857|NCT05182840|592596114|FG008|Treatment Period|Change of residence|0|||
164063858|NCT05182840|592596115|FG009|Treatment Period|Change of residence|0|||
164063859|NCT05182840|592596106|FG000|Treatment Period|Adverse Event|0|||
164063860|NCT05182840|592596107|FG001|Treatment Period|Adverse Event|0|||
164063861|NCT05182840|592596108|FG002|Treatment Period|Adverse Event|4|||
164063862|NCT05182840|592596109|FG003|Treatment Period|Adverse Event|16|||
164063863|NCT05182840|592596110|FG004|Treatment Period|Adverse Event|12|||
164063864|NCT05182840|592596111|FG005|Treatment Period|Adverse Event|6|||
164063865|NCT05182840|592596112|FG006|Treatment Period|Adverse Event|4|||
164063866|NCT05182840|592596113|FG007|Treatment Period|Adverse Event|8|||
164063867|NCT05182840|592596114|FG008|Treatment Period|Adverse Event|16|||
164063868|NCT05182840|592596115|FG009|Treatment Period|Adverse Event|5|||
164063869|NCT05182840|592596106|FG000|Treatment Period|Not treated with study drug|0|||
164063870|NCT05182840|592596107|FG001|Treatment Period|Not treated with study drug|0|||
164063871|NCT05182840|592596108|FG002|Treatment Period|Not treated with study drug|0|||
164063872|NCT05182840|592596109|FG003|Treatment Period|Not treated with study drug|1|||
164063873|NCT05182840|592596110|FG004|Treatment Period|Not treated with study drug|0|||
164063874|NCT05182840|592596111|FG005|Treatment Period|Not treated with study drug|0|||
164063875|NCT05182840|592596112|FG006|Treatment Period|Not treated with study drug|1|||
164063876|NCT05182840|592596113|FG007|Treatment Period|Not treated with study drug|1|||
164063877|NCT05182840|592596114|FG008|Treatment Period|Not treated with study drug|0|||
164063878|NCT05182840|592596115|FG009|Treatment Period|Not treated with study drug|0|||
164063879|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
164063880|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
164063881|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
164063882|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164063883|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164063884|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164063885|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164063886|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164063887|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164063888|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
164063889|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164063890|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164063891|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164063892|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
164063893|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
164063894|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164063895|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
164063896|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164063897|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164063898|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164063899|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164063900|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
164063901|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164063902|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
164063903|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164063904|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164063905|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164063906|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164063907|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
164063908|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
164103243|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
164103244|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
164103245|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
164103246|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
164103247|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
164103248|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
164103249|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
164103250|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
164103251|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
164103252|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
164103253|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
164103254|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
164103255|NCT02009163|592740764|FG000|Open-label Period (Non-randomized)|Other|13|||
164103256|NCT02009163|592740765|FG001|Open-label Period (Non-randomized)|Other|0|||
164103257|NCT02009163|592740766|FG002|Open-label Period (Non-randomized)|Other|0|||
164103258|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
164103259|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
164103260|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
164103261|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
164103262|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
164103263|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
164103264|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Adverse Event|0|||
164103265|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Adverse Event|0|||
164103266|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Adverse Event|6|||
164103267|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
164103268|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
164103269|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
164103270|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
164103271|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
164103272|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
164103273|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Pregnancy|0|||
164103274|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Pregnancy|0|||
164103275|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Pregnancy|2|||
164103276|NCT02009163|592740764|FG000|Randomized-withdrawal Period|Other|0|||
164103277|NCT02009163|592740765|FG001|Randomized-withdrawal Period|Other|9|||
164103278|NCT02009163|592740766|FG002|Randomized-withdrawal Period|Other|5|||
164103279|NCT02453386|592740767|FG000|Overall Study|Adverse Event|22|||
164103280|NCT02453386|592740768|FG001|Overall Study|Adverse Event|30|||
164103281|NCT02453386|592740769|FG002|Overall Study|Adverse Event|15|||
164103282|NCT02453386|592740767|FG000|Overall Study|Protocol Violation|1|||
164103283|NCT02453386|592740768|FG001|Overall Study|Protocol Violation|0|||
164103284|NCT02453386|592740769|FG002|Overall Study|Protocol Violation|1|||
164103285|NCT02453386|592740767|FG000|Overall Study|Withdrawal by Subject|10|||
164103286|NCT02453386|592740768|FG001|Overall Study|Withdrawal by Subject|9|||
164103287|NCT02453386|592740769|FG002|Overall Study|Withdrawal by Subject|9|||
164103288|NCT02453386|592740767|FG000|Overall Study|Sponsor Terminated Study|14|||
164103289|NCT02453386|592740768|FG001|Overall Study|Sponsor Terminated Study|8|||
164103290|NCT02453386|592740769|FG002|Overall Study|Sponsor Terminated Study|11|||
164103291|NCT02453386|592740767|FG000|Overall Study|Subject Terminated by Sponsor|1|||
164103292|NCT02453386|592740768|FG001|Overall Study|Subject Terminated by Sponsor|1|||
164103293|NCT02453386|592740769|FG002|Overall Study|Subject Terminated by Sponsor|1|||
164103294|NCT02453386|592740767|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
164103295|NCT02453386|592740768|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
164103296|NCT02453386|592740769|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
164103297|NCT02453386|592740767|FG000|Overall Study|Lost to Follow-up|0|||
164103298|NCT02453386|592740768|FG001|Overall Study|Lost to Follow-up|0|||
164103299|NCT02453386|592740769|FG002|Overall Study|Lost to Follow-up|1|||
164103300|NCT02453386|592740767|FG000|Overall Study|Other|1|||
164103301|NCT02453386|592740768|FG001|Overall Study|Other|0|||
164103302|NCT02453386|592740769|FG002|Overall Study|Other|1|||
164103303|NCT00359281|592740770|FG000|Overall Study|Adverse Event|1|||
164103304|NCT00359281|592740771|FG001|Overall Study|Adverse Event|0|||
164103305|NCT00359281|592740772|FG002|Overall Study|Adverse Event|0|||
164103306|NCT00359281|592740773|FG003|Overall Study|Adverse Event|0|||
164103307|NCT00359281|592740774|FG004|Overall Study|Adverse Event|0|||
164103308|NCT00359281|592740775|FG005|Overall Study|Adverse Event|0|||
164103309|NCT00359281|592740776|FG006|Overall Study|Adverse Event|1|||
164103310|NCT00359281|592740777|FG007|Overall Study|Adverse Event|0|||
164103311|NCT00359281|592740778|FG008|Overall Study|Adverse Event|0|||
164103312|NCT00359281|592740770|FG000|Overall Study|Withdrawal by Subject|0|||
164103313|NCT00359281|592740771|FG001|Overall Study|Withdrawal by Subject|0|||
164103314|NCT00359281|592740772|FG002|Overall Study|Withdrawal by Subject|0|||
164103315|NCT00359281|592740773|FG003|Overall Study|Withdrawal by Subject|0|||
164103316|NCT00359281|592740774|FG004|Overall Study|Withdrawal by Subject|0|||
164103317|NCT00359281|592740775|FG005|Overall Study|Withdrawal by Subject|0|||
164103318|NCT00359281|592740776|FG006|Overall Study|Withdrawal by Subject|1|||
164103319|NCT00359281|592740777|FG007|Overall Study|Withdrawal by Subject|0|||
164103320|NCT00359281|592740778|FG008|Overall Study|Withdrawal by Subject|0|||
164103321|NCT01415986|592740781|FG000|Overall Study|Lost to Follow-up|1|||
164103322|NCT01474551|592740784|FG000|Overall Study|Death|1|||
164103323|NCT03586726|592740792|FG000|Overall Study|Withdrawal by Subject|1|||
164103324|NCT03122457|592740793|FG000|Overall Study|Withdrawal by Subject|6|||
164103325|NCT03769025|592740798|FG000|Overall Study|Withdrawal by Subject|1|||
164103326|NCT03769025|592740799|FG001|Overall Study|Withdrawal by Subject|1|||
164103327|NCT03769025|592740798|FG000|Overall Study|Lost to Follow-up|4|||
164103328|NCT03769025|592740799|FG001|Overall Study|Lost to Follow-up|3|||
164103329|NCT02911701|592740802|FG000|Overall Study|Withdrawal by Subject|2|||
164103330|NCT02911701|592740803|FG001|Overall Study|Withdrawal by Subject|4|||
164103331|NCT02911701|592740802|FG000|Overall Study|Adverse Event|1|||
164103332|NCT02911701|592740803|FG001|Overall Study|Adverse Event|0|||
164103333|NCT04659603|592740806|FG000|Overall Study|Study terminated by sponsor|0|||
164103334|NCT04659603|592740807|FG001|Overall Study|Study terminated by sponsor|0|||
164103335|NCT04659603|592740808|FG002|Overall Study|Study terminated by sponsor|2|||
164103336|NCT04659603|592740806|FG000|Overall Study|Withdrawal by Subject|0|||
164103337|NCT04659603|592740807|FG001|Overall Study|Withdrawal by Subject|5|||
164103338|NCT04659603|592740808|FG002|Overall Study|Withdrawal by Subject|0|||
164103339|NCT04659603|592740806|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
164103340|NCT04659603|592740807|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
164103341|NCT04659603|592740808|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
164103342|NCT01110005|592740809|FG000|Overall Study|ineligible|1|||
164103343|NCT01110005|592740810|FG001|Overall Study|ineligible|2|||
164103344|NCT01110005|592740809|FG000|Overall Study|missing consent|3|||
164103345|NCT01110005|592740810|FG001|Overall Study|missing consent|2|||
164103346|NCT01110005|592740809|FG000|Overall Study|Withdrawal by Subject|0|||
164103347|NCT01110005|592740810|FG001|Overall Study|Withdrawal by Subject|1|||
164103348|NCT04646213|592740811|FG000|Overall Study|Physician Decision|3|||
164103349|NCT04646213|592740811|FG000|Overall Study|Withdrawal by Subject|2|||
164103350|NCT02441309|592740812|FG000|Overall Study|Disease progression|2|||
164103351|NCT02441309|592740813|FG001|Overall Study|Disease progression|1|||
164103352|NCT02441309|592740814|FG002|Overall Study|Disease progression|2|||
164103353|NCT02441309|592740812|FG000|Overall Study|Adverse Event|0|||
164103354|NCT02441309|592740813|FG001|Overall Study|Adverse Event|1|||
164103355|NCT02441309|592740814|FG002|Overall Study|Adverse Event|0|||
164103356|NCT02441309|592740812|FG000|Overall Study|Withdrawal by Subject|1|||
164103357|NCT02441309|592740813|FG001|Overall Study|Withdrawal by Subject|0|||
164103358|NCT02441309|592740814|FG002|Overall Study|Withdrawal by Subject|1|||
164103359|NCT02658084|592740815|FG000|Overall Study|Withdrawal by Subject|1|||
164103360|NCT02658084|592740816|FG001|Overall Study|Withdrawal by Subject|0|||
164103361|NCT02658084|592740815|FG000|Overall Study|Study Termination|1|||
164103362|NCT02658084|592740816|FG001|Overall Study|Study Termination|0|||
164103363|NCT03290781|592740817|FG000|Overall Study|Adverse Event|5|||
164103364|NCT03290781|592740818|FG001|Overall Study|Adverse Event|7|||
164103365|NCT03290781|592740819|FG002|Overall Study|Adverse Event|4|||
164103366|NCT03290781|592740820|FG003|Overall Study|Adverse Event|1|||
164103367|NCT03290781|592740821|FG004|Overall Study|Adverse Event|0|||
164103368|NCT03290781|592740822|FG005|Overall Study|Adverse Event|0|||
164103369|NCT03290781|592740823|FG006|Overall Study|Adverse Event|0|||
164103370|NCT03290781|592740817|FG000|Overall Study|Death|0|||
164103371|NCT03290781|592740818|FG001|Overall Study|Death|0|||
164103372|NCT03290781|592740819|FG002|Overall Study|Death|1|||
164103373|NCT03290781|592740820|FG003|Overall Study|Death|0|||
164103374|NCT03290781|592740821|FG004|Overall Study|Death|1|||
164103375|NCT03290781|592740822|FG005|Overall Study|Death|0|||
164103376|NCT03290781|592740823|FG006|Overall Study|Death|0|||
164103377|NCT03290781|592740817|FG000|Overall Study|Withdrawal by Subject|6|||
164103378|NCT03290781|592740818|FG001|Overall Study|Withdrawal by Subject|5|||
164103379|NCT03290781|592740819|FG002|Overall Study|Withdrawal by Subject|9|||
164103380|NCT03290781|592740820|FG003|Overall Study|Withdrawal by Subject|10|||
164103381|NCT03290781|592740821|FG004|Overall Study|Withdrawal by Subject|1|||
164103382|NCT03290781|592740822|FG005|Overall Study|Withdrawal by Subject|2|||
164103383|NCT03290781|592740823|FG006|Overall Study|Withdrawal by Subject|0|||
164103384|NCT03290781|592740817|FG000|Overall Study|Physician Decision|0|||
164103385|NCT03290781|592740818|FG001|Overall Study|Physician Decision|1|||
164103386|NCT03290781|592740819|FG002|Overall Study|Physician Decision|0|||
164103387|NCT03290781|592740820|FG003|Overall Study|Physician Decision|0|||
164103388|NCT03290781|592740821|FG004|Overall Study|Physician Decision|0|||
164103389|NCT03290781|592740822|FG005|Overall Study|Physician Decision|0|||
164103390|NCT03290781|592740823|FG006|Overall Study|Physician Decision|0|||
164103391|NCT03290781|592740817|FG000|Overall Study|Site Terminated by Sponsor|1|||
164103392|NCT03290781|592740818|FG001|Overall Study|Site Terminated by Sponsor|0|||
164103393|NCT03290781|592740819|FG002|Overall Study|Site Terminated by Sponsor|2|||
164103394|NCT03290781|592740820|FG003|Overall Study|Site Terminated by Sponsor|1|||
164103395|NCT03290781|592740821|FG004|Overall Study|Site Terminated by Sponsor|0|||
164103396|NCT03290781|592740822|FG005|Overall Study|Site Terminated by Sponsor|0|||
164103397|NCT03290781|592740823|FG006|Overall Study|Site Terminated by Sponsor|0|||
164103398|NCT03290781|592740817|FG000|Overall Study|Lost to Follow-up|0|||
164103399|NCT03290781|592740818|FG001|Overall Study|Lost to Follow-up|0|||
164103400|NCT03290781|592740819|FG002|Overall Study|Lost to Follow-up|0|||
164103401|NCT03290781|592740820|FG003|Overall Study|Lost to Follow-up|1|||
164103402|NCT03290781|592740821|FG004|Overall Study|Lost to Follow-up|0|||
164103403|NCT03290781|592740822|FG005|Overall Study|Lost to Follow-up|0|||
164103404|NCT03290781|592740823|FG006|Overall Study|Lost to Follow-up|0|||
164103405|NCT03290781|592740817|FG000|Overall Study|Protocol Deviation|2|||
164103406|NCT03290781|592740818|FG001|Overall Study|Protocol Deviation|0|||
164103407|NCT03290781|592740819|FG002|Overall Study|Protocol Deviation|0|||
164103408|NCT03290781|592740820|FG003|Overall Study|Protocol Deviation|1|||
164103409|NCT03290781|592740821|FG004|Overall Study|Protocol Deviation|0|||
164103410|NCT03290781|592740822|FG005|Overall Study|Protocol Deviation|0|||
164103411|NCT03290781|592740823|FG006|Overall Study|Protocol Deviation|0|||
164103412|NCT03290781|592740817|FG000|Overall Study|Disease Relapse|32|||
164063909|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
164063910|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164063911|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164063912|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164103413|NCT03290781|592740818|FG001|Overall Study|Disease Relapse|5|||
164103414|NCT03290781|592740819|FG002|Overall Study|Disease Relapse|38|||
164063913|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164063914|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164063915|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164063916|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
164063917|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164063918|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164063919|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164063920|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
164063921|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164063922|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164063923|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
164063924|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164063925|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164063926|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164063927|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
164063928|NCT04242498|592596118|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164063929|NCT04242498|592596119|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
164063930|NCT04242498|592596120|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
164063931|NCT04242498|592596121|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164063932|NCT04242498|592596122|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164063933|NCT04242498|592596123|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164063934|NCT04242498|592596124|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164063935|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164063936|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164063937|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164063938|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164063939|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
164063940|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
164063941|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
164063942|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164063943|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164063944|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164063945|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164063946|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
164063947|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
164063948|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
164063949|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164063950|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164063951|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164103415|NCT03290781|592740820|FG003|Overall Study|Disease Relapse|7|||
164103416|NCT03290781|592740821|FG004|Overall Study|Disease Relapse|3|||
164063952|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164063953|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164063954|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
164063955|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
164063956|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164063957|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164063958|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164063959|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
164063960|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
164063961|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
164063962|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
164063963|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164063964|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164063965|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164063966|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
164063967|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
164063968|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
164063969|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
164063970|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164063971|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164063972|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164063973|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164063974|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
164063975|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164063976|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
164063977|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164063978|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164063979|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164063980|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164063981|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164063982|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
164063983|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
164063984|NCT04242498|592596118|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164063985|NCT04242498|592596119|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164063986|NCT04242498|592596120|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164063987|NCT04242498|592596121|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164063988|NCT04242498|592596122|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
164063989|NCT04242498|592596123|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
164063990|NCT04242498|592596124|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
164063991|NCT02396849|592596126|FG000|Overall Study|Lost to Follow-up|1|||
164063992|NCT02396849|592596127|FG001|Overall Study|Lost to Follow-up|1|||
164063993|NCT02396849|592596126|FG000|Overall Study|Did not tolerate intervention|1|||
164063994|NCT02396849|592596127|FG001|Overall Study|Did not tolerate intervention|1|||
164063995|NCT03328325|592596128|FG000|Overall Study|Lost to Follow-up|4|||
164063996|NCT03328325|592596128|FG000|Overall Study|Physician Decision|1|||
164063997|NCT03328325|592596128|FG000|Overall Study|Withdrawal by Subject|3|||
164063998|NCT03328325|592596128|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
164063999|NCT00931515|592596129|FG000|Overall Study|Lost to Follow-up|2|||
164064000|NCT00931515|592596130|FG001|Overall Study|Lost to Follow-up|5|||
164064001|NCT00985114|592596132|FG000|Overall Study|Adverse Event|1|||
164064002|NCT00985114|592596133|FG001|Overall Study|Adverse Event|0|||
164064003|NCT00985114|592596132|FG000|Overall Study|Withdrawal by Subject|0|||
164064004|NCT00985114|592596133|FG001|Overall Study|Withdrawal by Subject|2|||
164064005|NCT02950831|592596134|FG000|Overall Study|Lost to Follow-up|1|||
164064006|NCT02950831|592596134|FG000|Overall Study|Withdrawal by Subject|3|||
164064007|NCT02950831|592596134|FG000|Overall Study|stimulation trail failure|5|||
164064008|NCT01119118|592596135|FG000|Overall Study|Adverse Event|1|||
164064009|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
164064010|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
164064011|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
164103417|NCT03290781|592740822|FG005|Overall Study|Disease Relapse|1|||
164103418|NCT03290781|592740823|FG006|Overall Study|Disease Relapse|4|||
164103419|NCT03290781|592740817|FG000|Overall Study|Other|3|||
164103420|NCT03290781|592740818|FG001|Overall Study|Other|0|||
164103421|NCT03290781|592740819|FG002|Overall Study|Other|2|||
164103422|NCT03290781|592740820|FG003|Overall Study|Other|2|||
164103423|NCT03290781|592740821|FG004|Overall Study|Other|0|||
164103424|NCT03290781|592740822|FG005|Overall Study|Other|0|||
164103425|NCT03290781|592740823|FG006|Overall Study|Other|0|||
164103426|NCT02820350|592740840|FG000|Overall Study|Withdrawal by Subject|3|||
164103427|NCT02820350|592740840|FG000|Overall Study|Death|4|||
164103428|NCT03697109|592741820|FG000|Open-label (OL) Phase|Adverse Event|24|||
164103429|NCT03697109|592741821|FG001|Open-label (OL) Phase|Adverse Event|0|||
164103430|NCT03697109|592741822|FG002|Open-label (OL) Phase|Adverse Event|0|||
164103431|NCT03697109|592741820|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
164103432|NCT03697109|592741821|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
164103433|NCT03697109|592741822|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
164103434|NCT03697109|592741820|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
164103435|NCT03697109|592741821|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
164103436|NCT03697109|592741822|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
164103437|NCT03697109|592741820|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
164103438|NCT03697109|592741821|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
164103439|NCT03697109|592741822|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
164103440|NCT03697109|592741820|FG000|Open-label (OL) Phase|Physician Decision|2|||
164103441|NCT03697109|592741821|FG001|Open-label (OL) Phase|Physician Decision|0|||
164103442|NCT03697109|592741822|FG002|Open-label (OL) Phase|Physician Decision|0|||
164103443|NCT03697109|592741820|FG000|Open-label (OL) Phase|Death|2|||
164103444|NCT03697109|592741821|FG001|Open-label (OL) Phase|Death|0|||
164103445|NCT03697109|592741822|FG002|Open-label (OL) Phase|Death|0|||
164103446|NCT03697109|592741820|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
164103447|NCT03697109|592741821|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
164103448|NCT03697109|592741822|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
164103449|NCT03697109|592741820|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
164103450|NCT03697109|592741821|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
164103451|NCT03697109|592741822|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
164103452|NCT03697109|592741820|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
164103453|NCT03697109|592741821|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
164103454|NCT03697109|592741822|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
164103455|NCT02301975|592741825|FG000|Overall Study|Adverse Event|8|||
164103456|NCT02301975|592741826|FG001|Overall Study|Adverse Event|3|||
164103457|NCT02301975|592741827|FG002|Overall Study|Adverse Event|2|||
164103458|NCT02301975|592741825|FG000|Overall Study|Lack of Efficacy|1|||
164103459|NCT02301975|592741826|FG001|Overall Study|Lack of Efficacy|1|||
164103460|NCT02301975|592741827|FG002|Overall Study|Lack of Efficacy|1|||
164103461|NCT02301975|592741825|FG000|Overall Study|Protocol Violation|3|||
164103462|NCT02301975|592741826|FG001|Overall Study|Protocol Violation|5|||
164103463|NCT02301975|592741827|FG002|Overall Study|Protocol Violation|3|||
164103464|NCT02301975|592741825|FG000|Overall Study|Lost to Follow-up|0|||
164103465|NCT02301975|592741826|FG001|Overall Study|Lost to Follow-up|2|||
164103466|NCT02301975|592741827|FG002|Overall Study|Lost to Follow-up|2|||
164103467|NCT02301975|592741825|FG000|Overall Study|Physician Decision|4|||
164103468|NCT02301975|592741826|FG001|Overall Study|Physician Decision|2|||
164103469|NCT02301975|592741827|FG002|Overall Study|Physician Decision|3|||
164103470|NCT02301975|592741825|FG000|Overall Study|Withdrawal by Subject|15|||
164103471|NCT02301975|592741826|FG001|Overall Study|Withdrawal by Subject|12|||
164103472|NCT02301975|592741827|FG002|Overall Study|Withdrawal by Subject|11|||
164103473|NCT00163657|592741828|FG000|Overall Study|Death|12|||
164103474|NCT00163657|592741829|FG001|Overall Study|Death|14|||
164103475|NCT00163657|592741830|FG002|Overall Study|Death|19|||
164103476|NCT00163657|592741828|FG000|Overall Study|graft loss|4|||
164103477|NCT00163657|592741829|FG001|Overall Study|graft loss|1|||
164103478|NCT00163657|592741830|FG002|Overall Study|graft loss|2|||
164103479|NCT00163657|592741828|FG000|Overall Study|Withdrawal by Subject|2|||
164103480|NCT00163657|592741829|FG001|Overall Study|Withdrawal by Subject|3|||
164103481|NCT00163657|592741830|FG002|Overall Study|Withdrawal by Subject|2|||
164103482|NCT00163657|592741828|FG000|Overall Study|Physician Decision|0|||
164103483|NCT00163657|592741829|FG001|Overall Study|Physician Decision|1|||
164103484|NCT00163657|592741830|FG002|Overall Study|Physician Decision|1|||
164103485|NCT00163657|592741828|FG000|Overall Study|Non Compliance|1|||
164103486|NCT00163657|592741829|FG001|Overall Study|Non Compliance|0|||
164103487|NCT00163657|592741830|FG002|Overall Study|Non Compliance|0|||
164103488|NCT00163657|592741828|FG000|Overall Study|Lost to Follow-up|1|||
164103489|NCT00163657|592741829|FG001|Overall Study|Lost to Follow-up|3|||
164103490|NCT00163657|592741830|FG002|Overall Study|Lost to Follow-up|10|||
164103491|NCT00163657|592741828|FG000|Overall Study|Other reason|0|||
164103492|NCT00163657|592741829|FG001|Overall Study|Other reason|1|||
164103493|NCT00163657|592741830|FG002|Overall Study|Other reason|3|||
164103494|NCT01319383|592741831|FG000|Overall Study|No ex vivo or in vivo response|4|||
164103495|NCT01319383|592741832|FG001|Overall Study|No ex vivo or in vivo response|0|||
164064012|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
164064013|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
164064014|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
164064015|NCT00828009|592596138|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
164064016|NCT00828009|592596138|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
164064017|NCT00828009|592596138|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
164064018|NCT00828009|592596138|FG000|Step 2 - Maintenance Therapy|Death|1|||
164064019|NCT00828009|592596138|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
164064020|NCT00828009|592596138|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
164064021|NCT00828009|592596138|FG000|Step 2 - Maintenance Therapy|Other|1|||
164064022|NCT01396434|592596143|FG000|Overall Study|Lost to Follow-up|1|||
164064023|NCT01396434|592596144|FG001|Overall Study|Lost to Follow-up|0|||
164064024|NCT01396434|592596145|FG002|Overall Study|Lost to Follow-up|0|||
164064025|NCT01396434|592596143|FG000|Overall Study|Other|10|||
164064026|NCT01396434|592596144|FG001|Overall Study|Other|0|||
164064027|NCT01396434|592596145|FG002|Overall Study|Other|0|||
164064028|NCT04678557|592596146|FG000|Overall Study|Withdrawal by Subject|1|||
164064029|NCT04678557|592596147|FG001|Overall Study|Withdrawal by Subject|0|||
164064030|NCT04678557|592596146|FG000|Overall Study|Lack of Efficacy|0|||
164064031|NCT04678557|592596147|FG001|Overall Study|Lack of Efficacy|13|||
164064032|NCT04678557|592596146|FG000|Overall Study|Safety Evaluation|0|||
164064033|NCT04678557|592596147|FG001|Overall Study|Safety Evaluation|1|||
164064034|NCT02260804|592596148|FG000|Induction Study Period|Protocol Violation|2|||
164064035|NCT02260804|592596149|FG001|Induction Study Period|Protocol Violation|0|||
164064036|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
164064037|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
164064038|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
164064039|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
164064040|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
164064041|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
164064042|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
164064043|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
164064044|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
164064045|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
164064046|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
164064047|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
164064048|NCT02260804|592596148|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
164064049|NCT02260804|592596149|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
164064050|NCT02260804|592596148|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
164064051|NCT02260804|592596149|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
164064052|NCT02260804|592596148|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
164064053|NCT02260804|592596149|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
164064054|NCT02260804|592596148|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
164064055|NCT02260804|592596149|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
164064056|NCT00509223|592598960|FG000|Overall Study|Lost to Follow-up|1|||
164064057|NCT00509223|592598961|FG001|Overall Study|Lost to Follow-up|1|||
164064058|NCT00509223|592598960|FG000|Overall Study|Adverse Event|1|||
164064059|NCT00509223|592598961|FG001|Overall Study|Adverse Event|1|||
164064060|NCT00509223|592598960|FG000|Overall Study|Withdrawal by Subject|25|||
164064061|NCT00509223|592598961|FG001|Overall Study|Withdrawal by Subject|6|||
164064062|NCT00509223|592598960|FG000|Overall Study|Including: subject change of address|5|||
164064063|NCT00509223|592598961|FG001|Overall Study|Including: subject change of address|2|||
164064064|NCT00509223|592598960|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
164064065|NCT00509223|592598961|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
164064066|NCT02985541|592598962|FG000|Overall Study|Withdrawal by Subject|33|||
164064067|NCT02985541|592598962|FG000|Overall Study|Lost to Follow-up|26|||
164064068|NCT02985541|592598962|FG000|Overall Study|Adverse Event|27|||
164064069|NCT02985541|592598962|FG000|Overall Study|Physician Decision|2|||
164064070|NCT02985541|592598962|FG000|Overall Study|Pregnancy|2|||
164064071|NCT02985541|592598962|FG000|Overall Study|Wish for pregnancy|44|||
164064072|NCT02985541|592598962|FG000|Overall Study|Other reason|5|||
164064073|NCT02985541|592598962|FG000|Overall Study|Not valid for analysis|2|||
164064074|NCT02383966|592598963|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
164064075|NCT02383966|592598964|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
164064076|NCT02383966|592598963|FG000|Overall Study|Randomized, but not treated|1|||
164064077|NCT02383966|592598964|FG001|Overall Study|Randomized, but not treated|3|||
164064078|NCT02503215|592598965|FG000|Overall Study|Unable to wear compression stockings|1|||
164064079|NCT02503215|592598965|FG000|Overall Study|Unable to use positive airway pressure|2|||
164064080|NCT02983305|592598970|FG000|Overall Study|incomplete data|2|||
164064081|NCT02983305|592598971|FG001|Overall Study|incomplete data|0|||
164064082|NCT00822237|592598972|FG000|Dose 1 Vaccination|Not vaccinated|3|||
164103496|NCT01319383|592741831|FG000|Overall Study|Physician Decision|3|||
164064083|NCT00822237|592598973|FG001|Dose 1 Vaccination|Not vaccinated|0|||
164064084|NCT00822237|592598972|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
164064085|NCT00822237|592598973|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
164064086|NCT00822237|592598972|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
164064087|NCT00822237|592598973|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
164064088|NCT00822237|592598972|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
164064089|NCT00822237|592598973|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
164064090|NCT00822237|592598972|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
164064091|NCT00822237|592598973|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
164064092|NCT03433482|592598974|FG000|Overall Study|Lost to Follow-up|1|||
164064093|NCT03433482|592598975|FG001|Overall Study|Lost to Follow-up|0|||
164064094|NCT03433482|592598976|FG002|Overall Study|Lost to Follow-up|1|||
164064095|NCT03433482|592598977|FG003|Overall Study|Lost to Follow-up|1|||
164064096|NCT03433482|592598974|FG000|Overall Study|Withdrawal by Subject|0|||
164064097|NCT03433482|592598975|FG001|Overall Study|Withdrawal by Subject|0|||
164064098|NCT03433482|592598976|FG002|Overall Study|Withdrawal by Subject|1|||
164064099|NCT03433482|592598977|FG003|Overall Study|Withdrawal by Subject|0|||
164064100|NCT03433482|592598974|FG000|Overall Study|Unknown reason|0|||
164064101|NCT03433482|592598975|FG001|Overall Study|Unknown reason|0|||
164064102|NCT03433482|592598976|FG002|Overall Study|Unknown reason|2|||
164064103|NCT03433482|592598977|FG003|Overall Study|Unknown reason|0|||
164064104|NCT00437294|592598978|FG000|Overall Study|Adverse Event|5|||
164064105|NCT00437294|592598979|FG001|Overall Study|Adverse Event|4|||
164064106|NCT00437294|592598978|FG000|Overall Study|Death|5|||
164064107|NCT00437294|592598979|FG001|Overall Study|Death|2|||
164064108|NCT00437294|592598978|FG000|Overall Study|Physician Decision|0|||
164064109|NCT00437294|592598979|FG001|Overall Study|Physician Decision|3|||
164064110|NCT00437294|592598978|FG000|Overall Study|Withdrawal by Subject|5|||
164064111|NCT00437294|592598979|FG001|Overall Study|Withdrawal by Subject|0|||
164064112|NCT00437294|592598978|FG000|Overall Study|Progressive Disease|19|||
164064113|NCT00437294|592598979|FG001|Overall Study|Progressive Disease|23|||
164064114|NCT00437294|592598978|FG000|Overall Study|Sponsor Decision|8|||
164064115|NCT00437294|592598979|FG001|Overall Study|Sponsor Decision|9|||
164064116|NCT00437294|592598978|FG000|Overall Study|Protocol Violation|0|||
164064117|NCT00437294|592598979|FG001|Overall Study|Protocol Violation|1|||
164064118|NCT00437294|592598978|FG000|Overall Study|Entry criteria not met|1|||
164064119|NCT00437294|592598979|FG001|Overall Study|Entry criteria not met|1|||
164064120|NCT02064231|592598981|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
164064121|NCT02064231|592598982|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
164064122|NCT02064231|592598983|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
164064123|NCT02064231|592598984|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
164064124|NCT02064231|592598981|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
164064125|NCT02064231|592598982|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
164064126|NCT02064231|592598983|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
164064127|NCT02064231|592598984|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
164064128|NCT02064231|592598981|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
164064129|NCT02064231|592598982|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
164064130|NCT02064231|592598983|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
164064131|NCT02064231|592598984|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
164064132|NCT02064231|592598981|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
164064133|NCT02064231|592598982|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
164064134|NCT02064231|592598983|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
164064135|NCT02064231|592598984|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
164064136|NCT00518531|592598985|FG000|Treatment Period 1|Adverse Event|5|||
164064137|NCT00518531|592598986|FG001|Treatment Period 1|Adverse Event|0|||
164064138|NCT00518531|592598985|FG000|Treatment Period 1|Lost to Follow-up|5|||
164064139|NCT00518531|592598986|FG001|Treatment Period 1|Lost to Follow-up|3|||
164064140|NCT00518531|592598985|FG000|Treatment Period 1|Physician Decision|1|||
164064141|NCT00518531|592598986|FG001|Treatment Period 1|Physician Decision|0|||
164064142|NCT00518531|592598985|FG000|Treatment Period 1|Protocol Violation|2|||
164064143|NCT00518531|592598986|FG001|Treatment Period 1|Protocol Violation|0|||
164064144|NCT00518531|592598985|FG000|Treatment Period 1|Withdrawal by Subject|4|||
164064145|NCT00518531|592598986|FG001|Treatment Period 1|Withdrawal by Subject|6|||
164064146|NCT00518531|592598985|FG000|Treatment Period 1|Early crossover|1|||
164064147|NCT00518531|592598986|FG001|Treatment Period 1|Early crossover|3|||
164064148|NCT00518531|592598985|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164064149|NCT00518531|592598986|FG001|Treatment Period 2|Withdrawal by Subject|8|||
164064150|NCT00518531|592598985|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
164064151|NCT00518531|592598986|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
164064152|NCT00518531|592598985|FG000|Treatment Period 2|Adverse Event|1|||
164064153|NCT00518531|592598986|FG001|Treatment Period 2|Adverse Event|7|||
164064154|NCT00518531|592598985|FG000|Treatment Period 2|Protocol-specified criteria|0|||
164064155|NCT00518531|592598986|FG001|Treatment Period 2|Protocol-specified criteria|1|||
164103497|NCT01319383|592741832|FG001|Overall Study|Physician Decision|0|||
164103498|NCT01319383|592741831|FG000|Overall Study|Lack of Efficacy|5|||
164103499|NCT01319383|592741832|FG001|Overall Study|Lack of Efficacy|9|||
164103500|NCT01319383|592741831|FG000|Overall Study|No in vivo response to interval doses|0|||
164103501|NCT01319383|592741832|FG001|Overall Study|No in vivo response to interval doses|1|||
164103502|NCT01531894|592741835|FG000|Overall Study|Physician Decision|8|||
164103503|NCT01531894|592741835|FG000|Overall Study|Death|1|||
164103504|NCT01735994|592741839|FG000|Overall Study|Withdrawal by Subject|6|||
164103505|NCT01735994|592741840|FG001|Overall Study|Withdrawal by Subject|4|||
164103506|NCT01735994|592741839|FG000|Overall Study|Injury|2|||
164103507|NCT01735994|592741840|FG001|Overall Study|Injury|0|||
164103508|NCT01735994|592741839|FG000|Overall Study|Kicked off team|5|||
164103509|NCT01735994|592741840|FG001|Overall Study|Kicked off team|0|||
164103510|NCT01735994|592741839|FG000|Overall Study|Lost to Follow-up|50|||
164103511|NCT01735994|592741840|FG001|Overall Study|Lost to Follow-up|62|||
164103512|NCT01158118|592741841|FG000|Overall Study|Screen failure|1|||
164103513|NCT01158118|592741842|FG001|Overall Study|Screen failure|0|||
164103514|NCT01158118|592741841|FG000|Overall Study|Donor match was a screen failure|0|||
164103515|NCT01158118|592741842|FG001|Overall Study|Donor match was a screen failure|1|||
164103516|NCT01158118|592741841|FG000|Overall Study|Suffered stroke prior to transplant|0|||
164103517|NCT01158118|592741842|FG001|Overall Study|Suffered stroke prior to transplant|1|||
164103518|NCT01158118|592741841|FG000|Overall Study|Death|0|||
164103519|NCT01158118|592741842|FG001|Overall Study|Death|1|||
164103520|NCT04994535|592741843|FG000|Overall Study|Lost to Follow-up|7|||
164103521|NCT04994535|592741844|FG001|Overall Study|Lost to Follow-up|7|||
164103522|NCT04994535|592741843|FG000|Overall Study|Withdrawal by Subject|10|||
164103523|NCT04994535|592741844|FG001|Overall Study|Withdrawal by Subject|7|||
164103524|NCT04994535|592741843|FG000|Overall Study|Other|1|||
164103525|NCT04994535|592741844|FG001|Overall Study|Other|1|||
164103526|NCT00604162|592741845|FG000|Overall Study|Physician Decision|3|||
164103527|NCT00604162|592741845|FG000|Overall Study|Withdrawal by Subject|1|||
164103528|NCT02246920|592741850|FG000|Overall Study|Adverse Event|3|||
164103529|NCT02246920|592741851|FG001|Overall Study|Adverse Event|1|||
164103530|NCT02246920|592741852|FG002|Overall Study|Adverse Event|1|||
164103531|NCT02246920|592741850|FG000|Overall Study|Lost to Follow-up|2|||
164103532|NCT02246920|592741851|FG001|Overall Study|Lost to Follow-up|1|||
164103533|NCT02246920|592741852|FG002|Overall Study|Lost to Follow-up|0|||
164103534|NCT02246920|592741850|FG000|Overall Study|Protocol Violation|2|||
164103535|NCT02246920|592741851|FG001|Overall Study|Protocol Violation|5|||
164103536|NCT02246920|592741852|FG002|Overall Study|Protocol Violation|1|||
164103537|NCT02246920|592741850|FG000|Overall Study|Withdrawal by Subject|0|||
164103538|NCT02246920|592741851|FG001|Overall Study|Withdrawal by Subject|0|||
164103539|NCT02246920|592741852|FG002|Overall Study|Withdrawal by Subject|1|||
164103540|NCT00960297|592741856|FG000|Overall Study|Physician Decision|1|||
164103541|NCT00960297|592741856|FG000|Overall Study|Venous port infection|1|||
164103542|NCT00960297|592741856|FG000|Overall Study|Disease progression|1|||
164103543|NCT03247972|592741857|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
164103544|NCT03247972|592741857|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
164103545|NCT00968812|592741858|FG000|Overall Study|Adverse Event|30|||
164103546|NCT00968812|592741859|FG001|Overall Study|Adverse Event|46|||
164103547|NCT00968812|592741860|FG002|Overall Study|Adverse Event|33|||
164103548|NCT00968812|592741858|FG000|Overall Study|Death|2|||
164103549|NCT00968812|592741859|FG001|Overall Study|Death|2|||
164103550|NCT00968812|592741860|FG002|Overall Study|Death|1|||
164103551|NCT00968812|592741858|FG000|Overall Study|Lack of Efficacy|9|||
164103552|NCT00968812|592741859|FG001|Overall Study|Lack of Efficacy|7|||
164103553|NCT00968812|592741860|FG002|Overall Study|Lack of Efficacy|16|||
164103554|NCT00968812|592741858|FG000|Overall Study|Lost to Follow-up|17|||
164103555|NCT00968812|592741859|FG001|Overall Study|Lost to Follow-up|12|||
164103556|NCT00968812|592741860|FG002|Overall Study|Lost to Follow-up|11|||
164103557|NCT00968812|592741858|FG000|Overall Study|Physician Decision|8|||
164103558|NCT00968812|592741859|FG001|Overall Study|Physician Decision|5|||
164103559|NCT00968812|592741860|FG002|Overall Study|Physician Decision|9|||
164103560|NCT00968812|592741858|FG000|Overall Study|Protocol Violation|7|||
164103561|NCT00968812|592741859|FG001|Overall Study|Protocol Violation|4|||
164103562|NCT00968812|592741860|FG002|Overall Study|Protocol Violation|3|||
164103563|NCT00968812|592741858|FG000|Overall Study|Withdrawal by Subject|17|||
164103564|NCT00968812|592741859|FG001|Overall Study|Withdrawal by Subject|23|||
164103565|NCT00968812|592741860|FG002|Overall Study|Withdrawal by Subject|25|||
164103566|NCT00968812|592741858|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
164103567|NCT00968812|592741859|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
164103568|NCT00968812|592741860|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
164103569|NCT00968812|592741858|FG000|Overall Study|Noncompliance with study drug|4|||
164103570|NCT00968812|592741859|FG001|Overall Study|Noncompliance with study drug|1|||
164103571|NCT00968812|592741860|FG002|Overall Study|Noncompliance with study drug|6|||
164103572|NCT00968812|592741858|FG000|Overall Study|Unable to take rescue therapy|12|||
164103573|NCT00968812|592741859|FG001|Overall Study|Unable to take rescue therapy|12|||
164103574|NCT00968812|592741860|FG002|Overall Study|Unable to take rescue therapy|17|||
164064156|NCT00518531|592598985|FG000|Treatment Period 2|Non-compliance|1|||
164064157|NCT00518531|592598986|FG001|Treatment Period 2|Non-compliance|2|||
164064158|NCT04888377|592598989|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
164064159|NCT04888377|592598990|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
164064160|NCT04888377|592598989|FG000|Overall Study|Physician Decision|6|||
164064161|NCT04888377|592598990|FG001|Overall Study|Physician Decision|6|||
164064162|NCT04888377|592598989|FG000|Overall Study|Withdrawal by Subject|7|||
164064163|NCT04888377|592598990|FG001|Overall Study|Withdrawal by Subject|3|||
164064164|NCT00526162|592598991|FG000|Overall Study|Device not implanted|3|||
164064165|NCT05279807|592598992|FG000|Overall Study|Withdrawal by Subject|1|||
164064166|NCT05279807|592598993|FG001|Overall Study|Withdrawal by Subject|0|||
164064167|NCT05279807|592598992|FG000|Overall Study|Adverse Event|0|||
164064168|NCT05279807|592598993|FG001|Overall Study|Adverse Event|1|||
164064169|NCT05279807|592598992|FG000|Overall Study|Laboratory Abnormal Results|1|||
164064170|NCT05279807|592598993|FG001|Overall Study|Laboratory Abnormal Results|0|||
164064171|NCT05299359|592598998|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
164064172|NCT05299359|592598999|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
164064173|NCT05299359|592598998|FG000|Main Part: Day 1 up to Day 366|Other|2|||
164064174|NCT05299359|592598999|FG001|Main Part: Day 1 up to Day 366|Other|0|||
164064175|NCT05299359|592598998|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
164064176|NCT05299359|592598999|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
164064177|NCT05299359|592598998|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
164064178|NCT05299359|592598999|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
164064179|NCT05299359|592598998|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
164064180|NCT05299359|592598999|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
164064181|NCT05299359|592598998|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
164064182|NCT05299359|592598999|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
164064183|NCT05299359|592598998|FG000|Extension Part: Day 1 to Day 366|Other|0|||
164064184|NCT05299359|592598999|FG001|Extension Part: Day 1 to Day 366|Other|1|||
164064185|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
164064186|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
164064187|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
164064188|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164064189|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164064190|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164064191|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
164064192|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164064193|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
164064194|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
164064195|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164064196|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164064197|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164064198|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
164064199|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
164064200|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
164064201|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
164064202|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164064203|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164064204|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164064205|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
164064206|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
164064207|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
164064208|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
164064209|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164064210|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164064211|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164064212|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
164064213|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
164064214|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164064215|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164064216|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164064217|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164064218|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164064219|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
164064220|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164064221|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164103575|NCT00968812|592741858|FG000|Overall Study|Other|25|||
164064222|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
164064223|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164064224|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164064225|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164064226|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
164064227|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164064228|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164064229|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
164064230|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164064231|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164064232|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164064233|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
164064234|NCT04242446|592599000|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164064235|NCT04242446|592599001|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
164064236|NCT04242446|592599002|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
164064237|NCT04242446|592599003|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164064238|NCT04242446|592599004|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164064239|NCT04242446|592599005|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164064240|NCT04242446|592599006|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
164064241|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164064242|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164064243|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
164064244|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
164064245|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
164064246|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
164064247|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
164064248|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164064249|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164064250|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
164064251|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
164064252|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
164064253|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
164064254|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
164064255|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164064256|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164064257|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
164064258|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
164064259|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
164064260|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
164064261|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
164064262|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164064263|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164064264|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
164064265|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
164064266|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
164064267|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
164064268|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
164064269|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164064270|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164064271|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
164064272|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
164064273|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
164064274|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
164064275|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
164064276|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164064277|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164064278|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164064279|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
164064280|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164103576|NCT00968812|592741859|FG001|Overall Study|Other|37|||
164103577|NCT00968812|592741860|FG002|Overall Study|Other|40|||
164103578|NCT00834340|592741861|FG000|Washout|Adverse Event|1|||
164103579|NCT00834340|592741862|FG001|Washout|Adverse Event|0|||
164103580|NCT00834340|592741861|FG000|Washout|Withdrawal by Subject|1|||
164103581|NCT00834340|592741862|FG001|Washout|Withdrawal by Subject|0|||
164103582|NCT00395694|592741863|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
164103583|NCT00395694|592741864|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
164103584|NCT00395694|592741863|FG000|Continuation Phase|Adverse Event|1|||
164103585|NCT00395694|592741864|FG001|Continuation Phase|Adverse Event|0|||
164103586|NCT00395694|592741863|FG000|Continuation Phase|Lack of Efficacy|12|||
164103587|NCT00395694|592741864|FG001|Continuation Phase|Lack of Efficacy|11|||
164103588|NCT00395694|592741863|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
164103589|NCT00395694|592741864|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
164103590|NCT00395694|592741863|FG000|Continuation Phase|Poor Compliance|1|||
164103591|NCT00395694|592741864|FG001|Continuation Phase|Poor Compliance|0|||
164103592|NCT00395694|592741863|FG000|Continuation Phase|Withdrawal by Subject|0|||
164103593|NCT00395694|592741864|FG001|Continuation Phase|Withdrawal by Subject|2|||
164103594|NCT02911792|592741867|FG000|Overall Study|Lost to Follow-up|3|||
164103595|NCT02911792|592741868|FG001|Overall Study|Lost to Follow-up|3|||
164103596|NCT02911792|592741869|FG002|Overall Study|Lost to Follow-up|3|||
164103597|NCT02911792|592741870|FG003|Overall Study|Lost to Follow-up|3|||
164064281|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164064282|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
164064283|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164064284|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164064285|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164064286|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164064287|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
164064288|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164064289|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
164064290|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164064291|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164064292|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164064293|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164064294|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
164064295|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164064296|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
164064297|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164064298|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164064299|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164064300|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164064301|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
164064302|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164064303|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
164064304|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164064305|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164064306|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164064307|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164064308|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
164064309|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164064310|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
164064311|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164064312|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164064313|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164064314|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164103598|NCT00840073|592741877|FG000|Second Intervention|Missed 72 hour blood draw|1|||
164103599|NCT00840073|592741878|FG001|Second Intervention|Missed 72 hour blood draw|1|||
164103600|NCT03249454|592741880|FG000|Overall Study|Withdrawal by Subject|0|||
164103601|NCT03249454|592741881|FG001|Overall Study|Withdrawal by Subject|0|||
164103602|NCT03249454|592741882|FG002|Overall Study|Withdrawal by Subject|0|||
164103603|NCT03249454|592741883|FG003|Overall Study|Withdrawal by Subject|0|||
164103604|NCT03249454|592741884|FG004|Overall Study|Withdrawal by Subject|0|||
164103605|NCT03249454|592741885|FG005|Overall Study|Withdrawal by Subject|0|||
164103606|NCT03249454|592741886|FG006|Overall Study|Withdrawal by Subject|0|||
164103607|NCT03249454|592741887|FG007|Overall Study|Withdrawal by Subject|0|||
164103608|NCT03249454|592741888|FG008|Overall Study|Withdrawal by Subject|0|||
164103609|NCT03249454|592741889|FG009|Overall Study|Withdrawal by Subject|1|||
164103610|NCT03249454|592741890|FG010|Overall Study|Withdrawal by Subject|1|||
164103611|NCT03987191|592741891|FG000|Overall Study|COVID-19 related research disruption|0|||
164103612|NCT03987191|592741892|FG001|Overall Study|COVID-19 related research disruption|2|||
164103613|NCT02689505|592741893|FG000|Overall Study|Progressive disease|2|||
164103614|NCT02689505|592741894|FG001|Overall Study|Progressive disease|2|||
164103615|NCT02689505|592741895|FG002|Overall Study|Progressive disease|3|||
164103616|NCT02689505|592741896|FG003|Overall Study|Progressive disease|9|||
164103617|NCT02689505|592741897|FG004|Overall Study|Progressive disease|1|||
164103618|NCT02689505|592741893|FG000|Overall Study|Dose Limiting Toxicity|0|||
164103619|NCT02689505|592741894|FG001|Overall Study|Dose Limiting Toxicity|1|||
164103620|NCT02689505|592741895|FG002|Overall Study|Dose Limiting Toxicity|0|||
164103621|NCT02689505|592741896|FG003|Overall Study|Dose Limiting Toxicity|0|||
164103622|NCT02689505|592741897|FG004|Overall Study|Dose Limiting Toxicity|2|||
164103623|NCT02689505|592741893|FG000|Overall Study|Other AE or clinical progression|0|||
164103624|NCT02689505|592741894|FG001|Overall Study|Other AE or clinical progression|2|||
164103625|NCT02689505|592741895|FG002|Overall Study|Other AE or clinical progression|0|||
164103626|NCT02689505|592741896|FG003|Overall Study|Other AE or clinical progression|2|||
164103627|NCT02689505|592741897|FG004|Overall Study|Other AE or clinical progression|0|||
164064315|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
164064316|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164064317|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
164064318|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164064319|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164064320|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164064321|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164064322|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164064323|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
164064324|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
164064325|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164064326|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164064327|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164064328|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164064329|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164064330|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
164064331|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
164064332|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164064333|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164064334|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164064335|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164064336|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164064337|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
164064338|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
164064339|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164064340|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164064341|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164064342|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164064343|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164064344|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
164064345|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
164064346|NCT04242446|592599000|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164064347|NCT04242446|592599001|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164064348|NCT04242446|592599002|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164064349|NCT04242446|592599003|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164103628|NCT04108858|592741898|FG000|Overall Study|Adverse Event|1|||
164103629|NCT03663179|592741899|FG000|Overall Study|Withdrawal by Subject|2|||
164103630|NCT03663179|592741900|FG001|Overall Study|Withdrawal by Subject|0|||
164103631|NCT03663179|592741899|FG000|Overall Study|Lost to Follow-up|1|||
164103632|NCT03663179|592741900|FG001|Overall Study|Lost to Follow-up|1|||
164103633|NCT03663179|592741899|FG000|Overall Study|Revealed exclusionary condition|1|||
164103634|NCT03663179|592741900|FG001|Overall Study|Revealed exclusionary condition|0|||
164103635|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
164103636|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
164103637|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
164103638|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
164103639|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
164103640|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
164103641|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164103642|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
164103643|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
164103644|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
164103645|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
164103646|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
164103647|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
164103648|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
164103649|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
164103650|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
164103651|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
164103652|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
164103653|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
164103654|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
164103655|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Death|0|||
164103656|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Death|1|||
164103657|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Death|0|||
164103658|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Death|0|||
164103659|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
164103660|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
164103661|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
164103662|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
164103663|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
164103664|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
164103665|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
164103666|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
164103667|NCT01940341|592741901|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164103668|NCT01940341|592741902|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
164103669|NCT01940341|592741903|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164103670|NCT01940341|592741904|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
164103671|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
164103672|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
164103673|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
164103674|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
164103675|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
164103676|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
164103677|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
164103678|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
164103679|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164064350|NCT04242446|592599004|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164064351|NCT04242446|592599005|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
164064352|NCT04242446|592599006|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
164064353|NCT03587116|592599007|FG000|Overall Study|Lost to Follow-up|0|||
164064354|NCT03587116|592599008|FG001|Overall Study|Lost to Follow-up|1|||
164064355|NCT03587116|592599007|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
164064356|NCT03587116|592599008|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
164064357|NCT03587116|592599007|FG000|Overall Study|Withdrawal by Subject|4|||
164064358|NCT03587116|592599008|FG001|Overall Study|Withdrawal by Subject|0|||
164064359|NCT05993299|592599009|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
164064360|NCT05993299|592599009|FG000|Overall Study|Ongoing|4|||
164064361|NCT05644756|592599010|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
164064362|NCT05644756|592599010|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
164064363|NCT03110107|592599011|FG000|Treatment Period|Disease Progression|3|||
164064364|NCT03110107|592599012|FG001|Treatment Period|Disease Progression|9|||
164064365|NCT03110107|592599013|FG002|Treatment Period|Disease Progression|8|||
164064366|NCT03110107|592599014|FG003|Treatment Period|Disease Progression|11|||
164064367|NCT03110107|592599015|FG004|Treatment Period|Disease Progression|8|||
164103680|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164103681|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
164103682|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
164103683|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
164103684|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
164103685|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
164103686|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
164103687|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164103688|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164103689|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
164103690|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
164103691|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
164103692|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
164103693|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
164103694|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
164103695|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164103696|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164103697|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
164103698|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
164103699|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164103700|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164103701|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
164103702|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
164103703|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164103704|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164103705|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
164103706|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
164103707|NCT01940341|592741901|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
164103708|NCT01940341|592741902|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
164103709|NCT01940341|592741903|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
164103710|NCT01940341|592741904|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
164103711|NCT01289262|592741907|FG000|Overall Study|Lost to Follow-up|29|||
164103712|NCT01289262|592741908|FG001|Overall Study|Lost to Follow-up|16|||
164103713|NCT01289262|592741907|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
164103714|NCT01289262|592741908|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
164103715|NCT03792477|592741911|FG000|Overall Study|Adverse Event|0|||
164103716|NCT03792477|592741912|FG001|Overall Study|Adverse Event|0|||
164103717|NCT03792477|592741913|FG002|Overall Study|Adverse Event|0|||
164103718|NCT03792477|592741914|FG003|Overall Study|Adverse Event|1|||
164103719|NCT03792477|592741915|FG004|Overall Study|Adverse Event|0|||
164103720|NCT03792477|592741911|FG000|Overall Study|Lost to Follow-up|0|||
164103721|NCT03792477|592741912|FG001|Overall Study|Lost to Follow-up|0|||
164103722|NCT03792477|592741913|FG002|Overall Study|Lost to Follow-up|2|||
164103723|NCT03792477|592741914|FG003|Overall Study|Lost to Follow-up|0|||
164103724|NCT03792477|592741915|FG004|Overall Study|Lost to Follow-up|0|||
164103725|NCT03792477|592741911|FG000|Overall Study|Other|0|||
164103726|NCT03792477|592741912|FG001|Overall Study|Other|0|||
164103727|NCT03792477|592741913|FG002|Overall Study|Other|0|||
164103728|NCT03792477|592741914|FG003|Overall Study|Other|0|||
164103729|NCT03792477|592741915|FG004|Overall Study|Other|1|||
164103730|NCT00446563|592741918|FG000|Overall Study|Adverse Event|4|||
164103731|NCT00446563|592741919|FG001|Overall Study|Adverse Event|3|||
164103732|NCT00446563|592741918|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164103733|NCT00446563|592741919|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164103734|NCT00446563|592741918|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164064368|NCT03110107|592599016|FG005|Treatment Period|Disease Progression|4|||
164064369|NCT03110107|592599017|FG006|Treatment Period|Disease Progression|6|||
164064370|NCT03110107|592599018|FG007|Treatment Period|Disease Progression|7|||
164064371|NCT03110107|592599019|FG008|Treatment Period|Disease Progression|2|||
164064372|NCT03110107|592599020|FG009|Treatment Period|Disease Progression|10|||
164064373|NCT03110107|592599021|FG010|Treatment Period|Disease Progression|5|||
164064374|NCT03110107|592599022|FG011|Treatment Period|Disease Progression|2|||
164064375|NCT03110107|592599023|FG012|Treatment Period|Disease Progression|0|||
164064376|NCT03110107|592599024|FG013|Treatment Period|Disease Progression|5|||
164064377|NCT03110107|592599025|FG014|Treatment Period|Disease Progression|14|||
164064378|NCT03110107|592599026|FG015|Treatment Period|Disease Progression|14|||
164064379|NCT03110107|592599027|FG016|Treatment Period|Disease Progression|4|||
164103735|NCT00446563|592741919|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164103736|NCT00446563|592741918|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164064380|NCT03110107|592599028|FG017|Treatment Period|Disease Progression|3|||
164064381|NCT03110107|592599029|FG018|Treatment Period|Disease Progression|16|||
164064382|NCT03110107|592599030|FG019|Treatment Period|Disease Progression|14|||
164064383|NCT03110107|592599031|FG020|Treatment Period|Disease Progression|12|||
164064384|NCT03110107|592599032|FG021|Treatment Period|Disease Progression|16|||
164064385|NCT03110107|592599033|FG022|Treatment Period|Disease Progression|18|||
164064386|NCT03110107|592599034|FG023|Treatment Period|Disease Progression|13|||
164064387|NCT03110107|592599035|FG024|Treatment Period|Disease Progression|16|||
164064388|NCT03110107|592599036|FG025|Treatment Period|Disease Progression|31|||
164064389|NCT03110107|592599011|FG000|Treatment Period|Study drug toxicity|1|||
164064390|NCT03110107|592599012|FG001|Treatment Period|Study drug toxicity|0|||
164064391|NCT03110107|592599013|FG002|Treatment Period|Study drug toxicity|1|||
164064392|NCT03110107|592599014|FG003|Treatment Period|Study drug toxicity|2|||
164064393|NCT03110107|592599015|FG004|Treatment Period|Study drug toxicity|0|||
164064394|NCT03110107|592599016|FG005|Treatment Period|Study drug toxicity|3|||
164064395|NCT03110107|592599017|FG006|Treatment Period|Study drug toxicity|1|||
164064396|NCT03110107|592599018|FG007|Treatment Period|Study drug toxicity|1|||
164064397|NCT03110107|592599019|FG008|Treatment Period|Study drug toxicity|3|||
164064398|NCT03110107|592599020|FG009|Treatment Period|Study drug toxicity|2|||
164064399|NCT03110107|592599021|FG010|Treatment Period|Study drug toxicity|0|||
164064400|NCT03110107|592599022|FG011|Treatment Period|Study drug toxicity|2|||
164064401|NCT03110107|592599023|FG012|Treatment Period|Study drug toxicity|0|||
164064402|NCT03110107|592599024|FG013|Treatment Period|Study drug toxicity|0|||
164064403|NCT03110107|592599025|FG014|Treatment Period|Study drug toxicity|2|||
164064404|NCT03110107|592599026|FG015|Treatment Period|Study drug toxicity|3|||
164064405|NCT03110107|592599027|FG016|Treatment Period|Study drug toxicity|3|||
164064406|NCT03110107|592599028|FG017|Treatment Period|Study drug toxicity|3|||
164064407|NCT03110107|592599029|FG018|Treatment Period|Study drug toxicity|1|||
164064408|NCT03110107|592599030|FG019|Treatment Period|Study drug toxicity|2|||
164064409|NCT03110107|592599031|FG020|Treatment Period|Study drug toxicity|2|||
164064410|NCT03110107|592599032|FG021|Treatment Period|Study drug toxicity|0|||
164064411|NCT03110107|592599033|FG022|Treatment Period|Study drug toxicity|2|||
164064412|NCT03110107|592599034|FG023|Treatment Period|Study drug toxicity|6|||
164064413|NCT03110107|592599035|FG024|Treatment Period|Study drug toxicity|7|||
164064414|NCT03110107|592599036|FG025|Treatment Period|Study drug toxicity|6|||
164064415|NCT03110107|592599011|FG000|Treatment Period|Death|0|||
164064416|NCT03110107|592599012|FG001|Treatment Period|Death|0|||
164064417|NCT03110107|592599013|FG002|Treatment Period|Death|0|||
164064418|NCT03110107|592599014|FG003|Treatment Period|Death|0|||
164064419|NCT03110107|592599015|FG004|Treatment Period|Death|0|||
164064420|NCT03110107|592599016|FG005|Treatment Period|Death|0|||
164064421|NCT03110107|592599017|FG006|Treatment Period|Death|0|||
164064422|NCT03110107|592599018|FG007|Treatment Period|Death|0|||
164064423|NCT03110107|592599019|FG008|Treatment Period|Death|0|||
164064424|NCT03110107|592599020|FG009|Treatment Period|Death|0|||
164064425|NCT03110107|592599021|FG010|Treatment Period|Death|0|||
164064426|NCT03110107|592599022|FG011|Treatment Period|Death|0|||
164064427|NCT03110107|592599023|FG012|Treatment Period|Death|1|||
164064428|NCT03110107|592599024|FG013|Treatment Period|Death|0|||
164064429|NCT03110107|592599025|FG014|Treatment Period|Death|0|||
164064430|NCT03110107|592599026|FG015|Treatment Period|Death|0|||
164064431|NCT03110107|592599027|FG016|Treatment Period|Death|0|||
164064432|NCT03110107|592599028|FG017|Treatment Period|Death|0|||
164064433|NCT03110107|592599029|FG018|Treatment Period|Death|0|||
164064434|NCT03110107|592599030|FG019|Treatment Period|Death|0|||
164064435|NCT03110107|592599031|FG020|Treatment Period|Death|0|||
164064436|NCT03110107|592599032|FG021|Treatment Period|Death|0|||
164064437|NCT03110107|592599033|FG022|Treatment Period|Death|0|||
164064438|NCT03110107|592599034|FG023|Treatment Period|Death|0|||
164064439|NCT03110107|592599035|FG024|Treatment Period|Death|0|||
164064440|NCT03110107|592599036|FG025|Treatment Period|Death|0|||
164064441|NCT03110107|592599011|FG000|Treatment Period|Adverse Event|0|||
164064442|NCT03110107|592599012|FG001|Treatment Period|Adverse Event|0|||
164064443|NCT03110107|592599013|FG002|Treatment Period|Adverse Event|1|||
164064444|NCT03110107|592599014|FG003|Treatment Period|Adverse Event|0|||
164064445|NCT03110107|592599015|FG004|Treatment Period|Adverse Event|0|||
164064446|NCT03110107|592599016|FG005|Treatment Period|Adverse Event|2|||
164064447|NCT03110107|592599017|FG006|Treatment Period|Adverse Event|0|||
164064448|NCT03110107|592599018|FG007|Treatment Period|Adverse Event|2|||
164064449|NCT03110107|592599019|FG008|Treatment Period|Adverse Event|0|||
164064450|NCT03110107|592599020|FG009|Treatment Period|Adverse Event|1|||
164064451|NCT03110107|592599021|FG010|Treatment Period|Adverse Event|0|||
164064452|NCT03110107|592599022|FG011|Treatment Period|Adverse Event|0|||
164064453|NCT03110107|592599023|FG012|Treatment Period|Adverse Event|0|||
164064454|NCT03110107|592599024|FG013|Treatment Period|Adverse Event|0|||
164064455|NCT03110107|592599025|FG014|Treatment Period|Adverse Event|0|||
164064456|NCT03110107|592599026|FG015|Treatment Period|Adverse Event|2|||
164064457|NCT03110107|592599027|FG016|Treatment Period|Adverse Event|0|||
164064458|NCT03110107|592599028|FG017|Treatment Period|Adverse Event|1|||
164064459|NCT03110107|592599029|FG018|Treatment Period|Adverse Event|2|||
164103737|NCT00446563|592741919|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
164103738|NCT00446563|592741918|FG000|Overall Study|Withdrawal by Subject|2|||
164103739|NCT00446563|592741919|FG001|Overall Study|Withdrawal by Subject|1|||
164103740|NCT00446563|592741918|FG000|Overall Study|Administrative problems|0|||
164103741|NCT00446563|592741919|FG001|Overall Study|Administrative problems|1|||
164103742|NCT01169558|592741920|FG000|Overall Study|Disease progression|98|||
164103743|NCT01169558|592741920|FG000|Overall Study|Adverse Event|25|||
164103744|NCT01169558|592741920|FG000|Overall Study|Withdrawal of Consent|8|||
164103745|NCT01169558|592741920|FG000|Overall Study|Medical Decision|7|||
164103746|NCT01169558|592741920|FG000|Overall Study|Stable Disease|4|||
164103747|NCT01169558|592741920|FG000|Overall Study|Lost to Follow-up|4|||
164103748|NCT01169558|592741920|FG000|Overall Study|Need for Surgery|4|||
164103749|NCT01169558|592741920|FG000|Overall Study|Non-compliance|2|||
164103750|NCT01169558|592741920|FG000|Overall Study|Protocol Violation|2|||
164103751|NCT01169558|592741920|FG000|Overall Study|Partial response|2|||
164103752|NCT03134222|592741923|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
164103753|NCT03134222|592741924|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
164103754|NCT03134222|592741925|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
164103755|NCT03134222|592741926|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
164103756|NCT03134222|592741927|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
164103757|NCT03134222|592741923|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
164103758|NCT03134222|592741924|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
164103759|NCT03134222|592741925|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
164103760|NCT03134222|592741926|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
164103761|NCT03134222|592741927|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
164103762|NCT03134222|592741923|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164103763|NCT03134222|592741924|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
164103764|NCT03134222|592741925|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164103765|NCT03134222|592741926|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164103766|NCT03134222|592741927|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
164103767|NCT03134222|592741923|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
164103768|NCT03134222|592741924|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
164103769|NCT03134222|592741925|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
164103770|NCT03134222|592741926|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
164103771|NCT03134222|592741927|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
164103772|NCT03134222|592741923|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
164103773|NCT03134222|592741924|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
164103774|NCT03134222|592741925|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
164103775|NCT03134222|592741926|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
164103776|NCT03134222|592741927|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
164103777|NCT03134222|592741923|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
164103778|NCT03134222|592741924|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164103779|NCT03134222|592741925|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164103780|NCT03134222|592741926|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164103781|NCT03134222|592741927|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
164103782|NCT03134222|592741923|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164103783|NCT03134222|592741924|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164103784|NCT03134222|592741925|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164103785|NCT03134222|592741926|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
164103786|NCT03134222|592741927|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
164103787|NCT03134222|592741923|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164103788|NCT03134222|592741924|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
164103789|NCT03134222|592741925|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164103790|NCT03134222|592741926|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164103791|NCT03134222|592741927|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
164103792|NCT02605928|592741928|FG000|Overall Study|Model tuning phase|28|||
164103793|NCT02605928|592741928|FG000|Overall Study|Lack of Efficacy|5|||
164103794|NCT03482882|592741931|FG000|Overall Study|Adverse Event|3|||
164103795|NCT03482882|592741931|FG000|Overall Study|Lost to Follow-up|1|||
164103796|NCT03482882|592741931|FG000|Overall Study|Protocol Violation|2|||
164103797|NCT03482882|592741931|FG000|Overall Study|Not further specified|1|||
164103798|NCT05341622|592741938|FG000|Overall Study|Death|0|||
164103799|NCT05341622|592741939|FG001|Overall Study|Death|0|||
164103800|NCT05341622|592741940|FG002|Overall Study|Death|0|||
164103801|NCT05341622|592741941|FG003|Overall Study|Death|0|||
164103802|NCT05341622|592741942|FG004|Overall Study|Death|1|||
164103803|NCT05341622|592741943|FG005|Overall Study|Death|0|||
164103804|NCT05341622|592741944|FG006|Overall Study|Death|0|||
164103805|NCT05341622|592741945|FG007|Overall Study|Death|1|||
164103806|NCT05341622|592741938|FG000|Overall Study|Invalid Address|0|||
164103807|NCT05341622|592741939|FG001|Overall Study|Invalid Address|1|||
164103808|NCT05341622|592741940|FG002|Overall Study|Invalid Address|0|||
164064460|NCT03110107|592599030|FG019|Treatment Period|Adverse Event|1|||
164064461|NCT03110107|592599031|FG020|Treatment Period|Adverse Event|4|||
164064462|NCT03110107|592599032|FG021|Treatment Period|Adverse Event|2|||
164064463|NCT03110107|592599033|FG022|Treatment Period|Adverse Event|2|||
164064464|NCT03110107|592599034|FG023|Treatment Period|Adverse Event|2|||
164064465|NCT03110107|592599035|FG024|Treatment Period|Adverse Event|2|||
164064466|NCT03110107|592599036|FG025|Treatment Period|Adverse Event|4|||
164064467|NCT03110107|592599011|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
164064468|NCT03110107|592599012|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
164064469|NCT03110107|592599013|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
164064470|NCT03110107|592599014|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
164064471|NCT03110107|592599015|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
164064472|NCT03110107|592599016|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
164064473|NCT03110107|592599017|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
164064474|NCT03110107|592599018|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
164064475|NCT03110107|592599019|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
164064476|NCT03110107|592599020|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
164064477|NCT03110107|592599021|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
164064478|NCT03110107|592599022|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
164064479|NCT03110107|592599023|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
164064480|NCT03110107|592599024|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
164064481|NCT03110107|592599025|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
164064482|NCT03110107|592599026|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
164064483|NCT03110107|592599027|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
164064484|NCT03110107|592599028|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
164064485|NCT03110107|592599029|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
164064486|NCT03110107|592599030|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
164064487|NCT03110107|592599031|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
164064488|NCT03110107|592599032|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
164064489|NCT03110107|592599033|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
164064490|NCT03110107|592599034|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
164064491|NCT03110107|592599035|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
164064492|NCT03110107|592599036|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
164064493|NCT03110107|592599011|FG000|Treatment Period|Participant withdrew consent|0|||
164064494|NCT03110107|592599012|FG001|Treatment Period|Participant withdrew consent|0|||
164064495|NCT03110107|592599013|FG002|Treatment Period|Participant withdrew consent|1|||
164064496|NCT03110107|592599014|FG003|Treatment Period|Participant withdrew consent|0|||
164064497|NCT03110107|592599015|FG004|Treatment Period|Participant withdrew consent|4|||
164064498|NCT03110107|592599016|FG005|Treatment Period|Participant withdrew consent|3|||
164064499|NCT03110107|592599017|FG006|Treatment Period|Participant withdrew consent|0|||
164064500|NCT03110107|592599018|FG007|Treatment Period|Participant withdrew consent|0|||
164064501|NCT03110107|592599019|FG008|Treatment Period|Participant withdrew consent|0|||
164064502|NCT03110107|592599020|FG009|Treatment Period|Participant withdrew consent|1|||
164064503|NCT03110107|592599021|FG010|Treatment Period|Participant withdrew consent|0|||
164064504|NCT03110107|592599022|FG011|Treatment Period|Participant withdrew consent|0|||
164064505|NCT03110107|592599023|FG012|Treatment Period|Participant withdrew consent|0|||
164064506|NCT03110107|592599024|FG013|Treatment Period|Participant withdrew consent|0|||
164064507|NCT03110107|592599025|FG014|Treatment Period|Participant withdrew consent|0|||
164064508|NCT03110107|592599026|FG015|Treatment Period|Participant withdrew consent|0|||
164064509|NCT03110107|592599027|FG016|Treatment Period|Participant withdrew consent|0|||
164064510|NCT03110107|592599028|FG017|Treatment Period|Participant withdrew consent|0|||
164064511|NCT03110107|592599029|FG018|Treatment Period|Participant withdrew consent|0|||
164064512|NCT03110107|592599030|FG019|Treatment Period|Participant withdrew consent|1|||
164064513|NCT03110107|592599031|FG020|Treatment Period|Participant withdrew consent|0|||
164064514|NCT03110107|592599032|FG021|Treatment Period|Participant withdrew consent|2|||
164064515|NCT03110107|592599033|FG022|Treatment Period|Participant withdrew consent|0|||
164064516|NCT03110107|592599034|FG023|Treatment Period|Participant withdrew consent|0|||
164064517|NCT03110107|592599035|FG024|Treatment Period|Participant withdrew consent|0|||
164064518|NCT03110107|592599036|FG025|Treatment Period|Participant withdrew consent|2|||
164064519|NCT03110107|592599011|FG000|Treatment Period|Participants no longer meets study criteria|0|||
164064520|NCT03110107|592599012|FG001|Treatment Period|Participants no longer meets study criteria|0|||
164064521|NCT03110107|592599013|FG002|Treatment Period|Participants no longer meets study criteria|0|||
164064522|NCT03110107|592599014|FG003|Treatment Period|Participants no longer meets study criteria|0|||
164064523|NCT03110107|592599015|FG004|Treatment Period|Participants no longer meets study criteria|0|||
164064524|NCT03110107|592599016|FG005|Treatment Period|Participants no longer meets study criteria|0|||
164103809|NCT05341622|592741941|FG003|Overall Study|Invalid Address|0|||
164103810|NCT05341622|592741942|FG004|Overall Study|Invalid Address|0|||
164103811|NCT05341622|592741943|FG005|Overall Study|Invalid Address|0|||
164103812|NCT05341622|592741944|FG006|Overall Study|Invalid Address|0|||
164103813|NCT05341622|592741945|FG007|Overall Study|Invalid Address|0|||
164103814|NCT05341622|592741938|FG000|Overall Study|Ineligible|26|||
164103815|NCT05341622|592741939|FG001|Overall Study|Ineligible|21|||
164103816|NCT05341622|592741940|FG002|Overall Study|Ineligible|28|||
164103817|NCT05341622|592741941|FG003|Overall Study|Ineligible|24|||
164103818|NCT05341622|592741942|FG004|Overall Study|Ineligible|29|||
164103819|NCT05341622|592741943|FG005|Overall Study|Ineligible|31|||
164103820|NCT05341622|592741944|FG006|Overall Study|Ineligible|28|||
164103821|NCT05341622|592741945|FG007|Overall Study|Ineligible|26|||
164103822|NCT04611789|592741946|FG000|Overall Study|Lost to Follow-up|1|||
164103823|NCT04611789|592741947|FG001|Overall Study|Lost to Follow-up|0|||
164103824|NCT04611789|592741948|FG002|Overall Study|Lost to Follow-up|0|||
164103825|NCT05152576|592741950|FG000|Overall Study|Lost to Follow-up|3|||
164103826|NCT05152576|592741951|FG001|Overall Study|Lost to Follow-up|0|||
164103827|NCT05152576|592741952|FG002|Overall Study|Lost to Follow-up|0|||
164103828|NCT05152576|592741953|FG003|Overall Study|Lost to Follow-up|1|||
164103829|NCT05152576|592741950|FG000|Overall Study|Withdrawal by Subject|0|||
164103830|NCT05152576|592741951|FG001|Overall Study|Withdrawal by Subject|1|||
164103831|NCT05152576|592741952|FG002|Overall Study|Withdrawal by Subject|0|||
164103832|NCT05152576|592741953|FG003|Overall Study|Withdrawal by Subject|1|||
164103833|NCT05152576|592741950|FG000|Overall Study|Other|2|||
164103834|NCT05152576|592741951|FG001|Overall Study|Other|0|||
164103835|NCT05152576|592741952|FG002|Overall Study|Other|0|||
164103836|NCT05152576|592741953|FG003|Overall Study|Other|0|||
164103837|NCT00859430|592741954|FG000|First Intervention|Withdrawal by Subject|0|||
164103838|NCT00859430|592741955|FG001|First Intervention|Withdrawal by Subject|1|||
164103839|NCT01952691|592743872|FG000|Overall Study|Lost to Follow-up|2|||
164103840|NCT00001703|592743873|FG000|Overall Study|progressed disease|2|||
164103841|NCT00001703|592743873|FG000|Overall Study|No evidence of disease|1|||
164103842|NCT00001703|592743873|FG000|Overall Study|recurrent disease|2|||
164103843|NCT02286739|592743874|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
164103844|NCT02286739|592743875|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
164103845|NCT02286739|592743874|FG000|Overall Study|No Verasense type documented|0|||
164103846|NCT02286739|592743875|FG001|Overall Study|No Verasense type documented|23|||
164103847|NCT02286739|592743874|FG000|Overall Study|Adverse Event|1|||
164103848|NCT02286739|592743875|FG001|Overall Study|Adverse Event|2|||
164103849|NCT02286739|592743874|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
164103850|NCT02286739|592743875|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
164103851|NCT00834795|592743876|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
164103852|NCT00834795|592743877|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
164103853|NCT00834795|592743876|FG000|Second Intervention|Adverse Event|1|||
164103854|NCT00834795|592743877|FG001|Second Intervention|Adverse Event|0|||
164103855|NCT02057835|592743882|FG000|Overall Study|Withdrawal by Subject|0|||
164103856|NCT02057835|592743883|FG001|Overall Study|Withdrawal by Subject|2|||
164103857|NCT02057835|592743884|FG002|Overall Study|Withdrawal by Subject|0|||
164103858|NCT02057835|592743885|FG003|Overall Study|Withdrawal by Subject|0|||
164103859|NCT02057835|592743886|FG004|Overall Study|Withdrawal by Subject|0|||
164103860|NCT02057835|592743887|FG005|Overall Study|Withdrawal by Subject|0|||
164103861|NCT02057835|592743888|FG006|Overall Study|Withdrawal by Subject|0|||
164103862|NCT02057835|592743889|FG007|Overall Study|Withdrawal by Subject|0|||
164103863|NCT02057835|592743890|FG008|Overall Study|Withdrawal by Subject|0|||
164103864|NCT02057835|592743891|FG009|Overall Study|Withdrawal by Subject|0|||
164103865|NCT00665925|592743892|FG000|Overall Study|Lack of Efficacy|10|||
164103866|NCT00665925|592743893|FG001|Overall Study|Lack of Efficacy|8|||
164103867|NCT00665925|592743894|FG002|Overall Study|Lack of Efficacy|9|||
164103868|NCT00665925|592743895|FG003|Overall Study|Lack of Efficacy|8|||
164103869|NCT00665925|592743892|FG000|Overall Study|Lost to Follow-up|1|||
164103870|NCT00665925|592743893|FG001|Overall Study|Lost to Follow-up|2|||
164103871|NCT00665925|592743894|FG002|Overall Study|Lost to Follow-up|2|||
164103872|NCT00665925|592743895|FG003|Overall Study|Lost to Follow-up|2|||
164103873|NCT00665925|592743892|FG000|Overall Study|Withdrawal by Subject|2|||
164103874|NCT00665925|592743893|FG001|Overall Study|Withdrawal by Subject|2|||
164103875|NCT00665925|592743894|FG002|Overall Study|Withdrawal by Subject|3|||
164103876|NCT00665925|592743895|FG003|Overall Study|Withdrawal by Subject|2|||
164103877|NCT00665925|592743892|FG000|Overall Study|Physician Decision|0|||
164103878|NCT00665925|592743893|FG001|Overall Study|Physician Decision|0|||
164103879|NCT00665925|592743894|FG002|Overall Study|Physician Decision|1|||
164103880|NCT00665925|592743895|FG003|Overall Study|Physician Decision|2|||
164103881|NCT00665925|592743892|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
164103882|NCT00665925|592743893|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
164103883|NCT00665925|592743894|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
164103884|NCT00665925|592743895|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
164103885|NCT00665925|592743892|FG000|Overall Study|Adverse Event|1|||
164064525|NCT03110107|592599017|FG006|Treatment Period|Participants no longer meets study criteria|0|||
164064526|NCT03110107|592599018|FG007|Treatment Period|Participants no longer meets study criteria|0|||
164064527|NCT03110107|592599019|FG008|Treatment Period|Participants no longer meets study criteria|0|||
164064528|NCT03110107|592599020|FG009|Treatment Period|Participants no longer meets study criteria|0|||
164064529|NCT03110107|592599021|FG010|Treatment Period|Participants no longer meets study criteria|0|||
164064530|NCT03110107|592599022|FG011|Treatment Period|Participants no longer meets study criteria|0|||
164064531|NCT03110107|592599023|FG012|Treatment Period|Participants no longer meets study criteria|0|||
164064532|NCT03110107|592599024|FG013|Treatment Period|Participants no longer meets study criteria|0|||
164064533|NCT03110107|592599025|FG014|Treatment Period|Participants no longer meets study criteria|0|||
164064534|NCT03110107|592599026|FG015|Treatment Period|Participants no longer meets study criteria|0|||
164064535|NCT03110107|592599027|FG016|Treatment Period|Participants no longer meets study criteria|0|||
164064536|NCT03110107|592599028|FG017|Treatment Period|Participants no longer meets study criteria|0|||
164064537|NCT03110107|592599029|FG018|Treatment Period|Participants no longer meets study criteria|0|||
164064538|NCT03110107|592599030|FG019|Treatment Period|Participants no longer meets study criteria|0|||
164064539|NCT03110107|592599031|FG020|Treatment Period|Participants no longer meets study criteria|0|||
164064540|NCT03110107|592599032|FG021|Treatment Period|Participants no longer meets study criteria|0|||
164064541|NCT03110107|592599033|FG022|Treatment Period|Participants no longer meets study criteria|0|||
164064542|NCT03110107|592599034|FG023|Treatment Period|Participants no longer meets study criteria|1|||
164064543|NCT03110107|592599035|FG024|Treatment Period|Participants no longer meets study criteria|0|||
164064544|NCT03110107|592599036|FG025|Treatment Period|Participants no longer meets study criteria|0|||
164064545|NCT03110107|592599011|FG000|Treatment Period|Other Reasons|0|||
164064546|NCT03110107|592599012|FG001|Treatment Period|Other Reasons|0|||
164064547|NCT03110107|592599013|FG002|Treatment Period|Other Reasons|1|||
164064548|NCT03110107|592599014|FG003|Treatment Period|Other Reasons|1|||
164064549|NCT03110107|592599015|FG004|Treatment Period|Other Reasons|0|||
164064550|NCT03110107|592599016|FG005|Treatment Period|Other Reasons|1|||
164064551|NCT03110107|592599017|FG006|Treatment Period|Other Reasons|0|||
164064552|NCT03110107|592599018|FG007|Treatment Period|Other Reasons|0|||
164064553|NCT03110107|592599019|FG008|Treatment Period|Other Reasons|0|||
164064554|NCT03110107|592599020|FG009|Treatment Period|Other Reasons|0|||
164064555|NCT03110107|592599021|FG010|Treatment Period|Other Reasons|0|||
164064556|NCT03110107|592599022|FG011|Treatment Period|Other Reasons|0|||
164064557|NCT03110107|592599023|FG012|Treatment Period|Other Reasons|0|||
164064558|NCT03110107|592599024|FG013|Treatment Period|Other Reasons|0|||
164064559|NCT03110107|592599025|FG014|Treatment Period|Other Reasons|0|||
164064560|NCT03110107|592599026|FG015|Treatment Period|Other Reasons|0|||
164064561|NCT03110107|592599027|FG016|Treatment Period|Other Reasons|0|||
164064562|NCT03110107|592599028|FG017|Treatment Period|Other Reasons|0|||
164064563|NCT03110107|592599029|FG018|Treatment Period|Other Reasons|0|||
164064564|NCT03110107|592599030|FG019|Treatment Period|Other Reasons|0|||
164064565|NCT03110107|592599031|FG020|Treatment Period|Other Reasons|0|||
164064566|NCT03110107|592599032|FG021|Treatment Period|Other Reasons|0|||
164064567|NCT03110107|592599033|FG022|Treatment Period|Other Reasons|0|||
164064568|NCT03110107|592599034|FG023|Treatment Period|Other Reasons|0|||
164064569|NCT03110107|592599035|FG024|Treatment Period|Other Reasons|1|||
164064570|NCT03110107|592599036|FG025|Treatment Period|Other Reasons|0|||
164064571|NCT03985982|592599040|FG000|Double-Blind Phase|Lost to Follow-up|4|||
164064572|NCT03985982|592599041|FG001|Double-Blind Phase|Lost to Follow-up|3|||
164064573|NCT03985982|592599042|FG002|Double-Blind Phase|Lost to Follow-up|0|||
164064574|NCT03985982|592599040|FG000|Double-Blind Phase|Physician Decision|1|||
164064575|NCT03985982|592599041|FG001|Double-Blind Phase|Physician Decision|0|||
164064576|NCT03985982|592599042|FG002|Double-Blind Phase|Physician Decision|0|||
164064577|NCT03985982|592599040|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
164064578|NCT03985982|592599041|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
164064579|NCT03985982|592599042|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
164064580|NCT03985982|592599040|FG000|Double-Blind Phase|COVID-19|1|||
164064581|NCT03985982|592599041|FG001|Double-Blind Phase|COVID-19|0|||
164064582|NCT03985982|592599042|FG002|Double-Blind Phase|COVID-19|0|||
164064583|NCT03985982|592599040|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
164064584|NCT03985982|592599041|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
164064585|NCT03985982|592599042|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
164064586|NCT03985982|592599040|FG000|Open-Label Phase|Lost to Follow-up|0|||
164064587|NCT03985982|592599041|FG001|Open-Label Phase|Lost to Follow-up|0|||
164064588|NCT03985982|592599042|FG002|Open-Label Phase|Lost to Follow-up|13|||
164064589|NCT03985982|592599040|FG000|Open-Label Phase|Physician Decision|0|||
164064590|NCT03985982|592599041|FG001|Open-Label Phase|Physician Decision|0|||
164064591|NCT03985982|592599042|FG002|Open-Label Phase|Physician Decision|2|||
164064592|NCT03985982|592599040|FG000|Open-Label Phase|Withdrawal by Subject|0|||
164064593|NCT03985982|592599041|FG001|Open-Label Phase|Withdrawal by Subject|0|||
164064594|NCT03985982|592599042|FG002|Open-Label Phase|Withdrawal by Subject|11|||
164064595|NCT05981365|592599044|FG000|Period 1|Adverse Event|1|||
164064596|NCT05981365|592599045|FG001|Period 1|Adverse Event|0|||
164103886|NCT00665925|592743893|FG001|Overall Study|Adverse Event|5|||
164103887|NCT00665925|592743894|FG002|Overall Study|Adverse Event|10|||
164103888|NCT00665925|592743895|FG003|Overall Study|Adverse Event|5|||
164103889|NCT00665925|592743892|FG000|Overall Study|Enrolled by mistake|0|||
164103890|NCT00665925|592743893|FG001|Overall Study|Enrolled by mistake|0|||
164103891|NCT00665925|592743894|FG002|Overall Study|Enrolled by mistake|0|||
164103892|NCT00665925|592743895|FG003|Overall Study|Enrolled by mistake|1|||
164103893|NCT00665925|592743892|FG000|Overall Study|Due to exclusion criteria|1|||
164103894|NCT00665925|592743893|FG001|Overall Study|Due to exclusion criteria|0|||
164103895|NCT00665925|592743894|FG002|Overall Study|Due to exclusion criteria|0|||
164103896|NCT00665925|592743895|FG003|Overall Study|Due to exclusion criteria|0|||
164103897|NCT04035187|592743898|FG000|Overall Study|Withdrawal by Subject|2|||
164103898|NCT04035187|592743899|FG001|Overall Study|Withdrawal by Subject|1|||
164103899|NCT04035187|592743900|FG002|Overall Study|Withdrawal by Subject|0|||
164103900|NCT04035187|592743901|FG003|Overall Study|Withdrawal by Subject|0|||
164103901|NCT04035187|592743898|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
164103902|NCT04035187|592743899|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
164103903|NCT04035187|592743900|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
164103904|NCT04035187|592743901|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
164103905|NCT02255149|592743914|FG000|Overall Study|Lost to Follow-up|2|||
164103906|NCT02255149|592743914|FG000|Overall Study|Withdrawal by Subject|1|||
164103907|NCT02255149|592743914|FG000|Overall Study|Withdrawal by PI|1|||
164103908|NCT02255149|592743914|FG000|Overall Study|Implant Failure|1|||
164103909|NCT00373256|592743915|FG000|Overall Study|Adverse Event (AE)|1|||
164103910|NCT00373256|592743916|FG001|Overall Study|Adverse Event (AE)|5|||
164103911|NCT00373256|592743915|FG000|Overall Study|Lost to Follow-up|2|||
164103912|NCT00373256|592743916|FG001|Overall Study|Lost to Follow-up|1|||
164103913|NCT00373256|592743915|FG000|Overall Study|Death|9|||
164103914|NCT00373256|592743916|FG001|Overall Study|Death|8|||
164103915|NCT00373256|592743915|FG000|Overall Study|Objective Progression or Relapse|111|||
164103916|NCT00373256|592743916|FG001|Overall Study|Objective Progression or Relapse|104|||
164103917|NCT00373256|592743915|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
164103918|NCT00373256|592743916|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
164103919|NCT00373256|592743915|FG000|Overall Study|Other|73|||
164103920|NCT00373256|592743916|FG001|Overall Study|Other|107|||
164103921|NCT00373256|592743915|FG000|Overall Study|Protocol Violation|0|||
164103922|NCT00373256|592743916|FG001|Overall Study|Protocol Violation|2|||
164103923|NCT00373256|592743915|FG000|Overall Study|Study Terminated by Sponsor|41|||
164103924|NCT00373256|592743916|FG001|Overall Study|Study Terminated by Sponsor|13|||
164103925|NCT03032172|592743920|FG000|Treatment Period|Adverse Event|0|||
164064597|NCT03927989|592599048|FG000|Overall Study|Withdrawal by Subject|0|||
164064598|NCT03927989|592599049|FG001|Overall Study|Withdrawal by Subject|1|||
164064599|NCT02593175|592599050|FG000|Overall Study|Adverse Event|5|||
164064600|NCT02593175|592599050|FG000|Overall Study|Disease progression|4|||
164064601|NCT00478933|592599051|FG000|Overall Study|Protocol Violation|22|||
164064602|NCT00478933|592599051|FG000|Overall Study|Informed consent not verified|3|||
164064603|NCT00478933|592599051|FG000|Overall Study|Inadequate data available|53|||
164064604|NCT02506101|592599053|FG000|Overall Study|Transportation issues|1|||
164064605|NCT02506101|592599054|FG001|Overall Study|Transportation issues|0|||
164064606|NCT02506101|592599053|FG000|Overall Study|No enrollment and staff unavailability|1|||
164064607|NCT02506101|592599054|FG001|Overall Study|No enrollment and staff unavailability|0|||
164064608|NCT03586427|592599058|FG000|Overall Study|Lost to Follow-up|0|||
164064609|NCT03586427|592599059|FG001|Overall Study|Lost to Follow-up|3|||
164064610|NCT03586427|592599060|FG002|Overall Study|Lost to Follow-up|1|||
164064611|NCT03586427|592599061|FG003|Overall Study|Lost to Follow-up|3|||
164064612|NCT03586427|592599062|FG004|Overall Study|Lost to Follow-up|3|||
164064613|NCT03586427|592599058|FG000|Overall Study|Withdrawal by Subject|0|||
164064614|NCT03586427|592599059|FG001|Overall Study|Withdrawal by Subject|1|||
164064615|NCT03586427|592599060|FG002|Overall Study|Withdrawal by Subject|2|||
164064616|NCT03586427|592599061|FG003|Overall Study|Withdrawal by Subject|1|||
164064617|NCT03586427|592599062|FG004|Overall Study|Withdrawal by Subject|1|||
164064618|NCT03586427|592599058|FG000|Overall Study|Adverse Event|0|||
164064619|NCT03586427|592599059|FG001|Overall Study|Adverse Event|0|||
164064620|NCT03586427|592599060|FG002|Overall Study|Adverse Event|1|||
164064621|NCT03586427|592599061|FG003|Overall Study|Adverse Event|0|||
164064622|NCT03586427|592599062|FG004|Overall Study|Adverse Event|0|||
164064623|NCT03586427|592599058|FG000|Overall Study|Protocol Violation|0|||
164064624|NCT03586427|592599059|FG001|Overall Study|Protocol Violation|0|||
164103926|NCT03032172|592743921|FG001|Treatment Period|Adverse Event|1|||
164103927|NCT03032172|592743922|FG002|Treatment Period|Adverse Event|0|||
164103928|NCT03032172|592743923|FG003|Treatment Period|Adverse Event|0|||
164103929|NCT03032172|592743924|FG004|Treatment Period|Adverse Event|0|||
164103930|NCT03032172|592743925|FG005|Treatment Period|Adverse Event|0|||
164064625|NCT03586427|592599060|FG002|Overall Study|Protocol Violation|1|||
164064626|NCT03586427|592599061|FG003|Overall Study|Protocol Violation|0|||
164103931|NCT03032172|592743926|FG006|Treatment Period|Adverse Event|0|||
164103932|NCT03032172|592743927|FG007|Treatment Period|Adverse Event|0|||
164064627|NCT03586427|592599062|FG004|Overall Study|Protocol Violation|1|||
164064628|NCT03586427|592599058|FG000|Overall Study|Noncompliance with study drug|0|||
164064629|NCT03586427|592599059|FG001|Overall Study|Noncompliance with study drug|0|||
164064630|NCT03586427|592599060|FG002|Overall Study|Noncompliance with study drug|1|||
164064631|NCT03586427|592599061|FG003|Overall Study|Noncompliance with study drug|0|||
164064632|NCT03586427|592599062|FG004|Overall Study|Noncompliance with study drug|0|||
164064633|NCT03193996|592599065|FG000|Overall Study|Withdrawal by Subject|4|||
164064634|NCT03193996|592599065|FG000|Overall Study|Lost to Follow-up|4|||
164064635|NCT03193996|592599065|FG000|Overall Study|Physician Decision|2|||
164064636|NCT03193996|592599065|FG000|Overall Study|Pregnancy|1|||
164064637|NCT03193996|592599065|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
164064638|NCT03193996|592599065|FG000|Overall Study|Complicating disease|1|||
164064639|NCT00593385|592599072|FG000|Overall Study|Death|14|||
164064640|NCT00593385|592599072|FG000|Overall Study|Lost to Follow-up|17|||
164064641|NCT00593385|592599072|FG000|Overall Study|Withdrawal by Subject|9|||
164064642|NCT01471197|592599073|FG000|Overall Study|Disease Progression|4|||
164064643|NCT01471197|592599074|FG001|Overall Study|Disease Progression|2|||
164064644|NCT01471197|592599073|FG000|Overall Study|Death|1|||
164064645|NCT01471197|592599074|FG001|Overall Study|Death|0|||
164064646|NCT01471197|592599073|FG000|Overall Study|Study Drug Toxicity|1|||
164064647|NCT01471197|592599074|FG001|Overall Study|Study Drug Toxicity|0|||
164064648|NCT00924313|592599077|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
164064649|NCT01298362|592599078|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
164064650|NCT01298362|592599079|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
164064651|NCT01207219|592599080|FG000|Overall Study|changed diagnosis during study period|5|||
164064652|NCT01207219|592599081|FG001|Overall Study|changed diagnosis during study period|3|||
164064653|NCT01207219|592599082|FG002|Overall Study|changed diagnosis during study period|1|||
164064654|NCT01207219|592599080|FG000|Overall Study|Lost to Follow-up|6|||
164064655|NCT01207219|592599081|FG001|Overall Study|Lost to Follow-up|8|||
164064656|NCT01207219|592599082|FG002|Overall Study|Lost to Follow-up|6|||
164064657|NCT00924820|592599084|FG000|Overall Study|Death|2|||
164064658|NCT00924820|592599084|FG000|Overall Study|Ineligible, Screen Failure|5|||
164064659|NCT01353586|592599085|FG000|Overall Study|Procedure terminated prior to ablation|3|||
164064660|NCT01353586|592599086|FG001|Overall Study|Procedure terminated prior to ablation|0|||
164064661|NCT01353586|592599085|FG000|Overall Study|Never had insertion of study catheter|4|||
164064662|NCT01353586|592599086|FG001|Overall Study|Never had insertion of study catheter|1|||
164064663|NCT01353586|592599085|FG000|Overall Study|Neurological exam not done|0|||
164064664|NCT01353586|592599086|FG001|Overall Study|Neurological exam not done|1|||
164064665|NCT03992456|592599087|FG000|Overall Study|Withdrawal by Subject|1|||
164064666|NCT03992456|592599088|FG001|Overall Study|Withdrawal by Subject|0|||
164064667|NCT03992456|592599087|FG000|Overall Study|Disease progression|4|||
164064668|NCT03992456|592599088|FG001|Overall Study|Disease progression|5|||
164064669|NCT03992456|592599087|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
164064670|NCT03992456|592599088|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
164064671|NCT01068418|592599089|FG000|Overall Study|Physician Decision|12|||
164064672|NCT00326625|592599092|FG000|Overall Study|Adverse Event|20|||
164064673|NCT00326625|592599093|FG001|Overall Study|Adverse Event|9|||
164064674|NCT00326625|592599092|FG000|Overall Study|Withdrawal by Subject|15|||
164064675|NCT00326625|592599093|FG001|Overall Study|Withdrawal by Subject|12|||
164064676|NCT00326625|592599092|FG000|Overall Study|Death|18|||
164064677|NCT00326625|592599093|FG001|Overall Study|Death|16|||
164064678|NCT00326625|592599092|FG000|Overall Study|Lost to Follow-up|1|||
164064679|NCT00326625|592599093|FG001|Overall Study|Lost to Follow-up|0|||
164064680|NCT00326625|592599092|FG000|Overall Study|prescheduled medical intervention|0|||
164064681|NCT00326625|592599093|FG001|Overall Study|prescheduled medical intervention|1|||
164064682|NCT02594384|592599094|FG000|Overall Study|Disease Progression|3|||
164064683|NCT02594384|592599095|FG001|Overall Study|Disease Progression|7|||
164064684|NCT02594384|592599096|FG002|Overall Study|Disease Progression|0|||
164064685|NCT02594384|592599097|FG003|Overall Study|Disease Progression|2|||
164064686|NCT02594384|592599098|FG004|Overall Study|Disease Progression|2|||
164064687|NCT02594384|592599099|FG005|Overall Study|Disease Progression|12|||
164064688|NCT02594384|592599100|FG006|Overall Study|Disease Progression|5|||
164064689|NCT02594384|592599101|FG007|Overall Study|Disease Progression|5|||
164064690|NCT02594384|592599094|FG000|Overall Study|Adverse Event|0|||
164064691|NCT02594384|592599095|FG001|Overall Study|Adverse Event|1|||
164064692|NCT02594384|592599096|FG002|Overall Study|Adverse Event|4|||
164064693|NCT02594384|592599097|FG003|Overall Study|Adverse Event|1|||
164064694|NCT02594384|592599098|FG004|Overall Study|Adverse Event|0|||
164064695|NCT02594384|592599099|FG005|Overall Study|Adverse Event|6|||
164064696|NCT02594384|592599100|FG006|Overall Study|Adverse Event|1|||
164064697|NCT02594384|592599101|FG007|Overall Study|Adverse Event|1|||
164064698|NCT02594384|592599094|FG000|Overall Study|Withdrawal by Subject|0|||
164064699|NCT02594384|592599095|FG001|Overall Study|Withdrawal by Subject|0|||
164103933|NCT03032172|592743920|FG000|Treatment Period|Lack of Efficacy|0|||
164103934|NCT03032172|592743921|FG001|Treatment Period|Lack of Efficacy|1|||
164103935|NCT03032172|592743922|FG002|Treatment Period|Lack of Efficacy|0|||
164103936|NCT03032172|592743923|FG003|Treatment Period|Lack of Efficacy|0|||
164103937|NCT03032172|592743924|FG004|Treatment Period|Lack of Efficacy|0|||
164103938|NCT03032172|592743925|FG005|Treatment Period|Lack of Efficacy|0|||
164103939|NCT03032172|592743926|FG006|Treatment Period|Lack of Efficacy|0|||
164103940|NCT03032172|592743927|FG007|Treatment Period|Lack of Efficacy|0|||
164103941|NCT03032172|592743920|FG000|Treatment Period|Non-compliance With Study Drug|0|||
164103942|NCT03032172|592743921|FG001|Treatment Period|Non-compliance With Study Drug|1|||
164103943|NCT03032172|592743922|FG002|Treatment Period|Non-compliance With Study Drug|0|||
164103944|NCT03032172|592743923|FG003|Treatment Period|Non-compliance With Study Drug|0|||
164103945|NCT03032172|592743924|FG004|Treatment Period|Non-compliance With Study Drug|0|||
164103946|NCT03032172|592743925|FG005|Treatment Period|Non-compliance With Study Drug|0|||
164103947|NCT03032172|592743926|FG006|Treatment Period|Non-compliance With Study Drug|0|||
164103948|NCT03032172|592743927|FG007|Treatment Period|Non-compliance With Study Drug|0|||
164103949|NCT03032172|592743920|FG000|Treatment Period|Reason Not Specified|0|||
164103950|NCT03032172|592743921|FG001|Treatment Period|Reason Not Specified|4|||
164103951|NCT03032172|592743922|FG002|Treatment Period|Reason Not Specified|1|||
164103952|NCT03032172|592743923|FG003|Treatment Period|Reason Not Specified|0|||
164103953|NCT03032172|592743924|FG004|Treatment Period|Reason Not Specified|0|||
164103954|NCT03032172|592743925|FG005|Treatment Period|Reason Not Specified|0|||
164103955|NCT03032172|592743926|FG006|Treatment Period|Reason Not Specified|0|||
164103956|NCT03032172|592743927|FG007|Treatment Period|Reason Not Specified|0|||
164064700|NCT02594384|592599096|FG002|Overall Study|Withdrawal by Subject|0|||
164064701|NCT02594384|592599097|FG003|Overall Study|Withdrawal by Subject|1|||
164064702|NCT02594384|592599098|FG004|Overall Study|Withdrawal by Subject|0|||
164064703|NCT02594384|592599099|FG005|Overall Study|Withdrawal by Subject|0|||
164064704|NCT02594384|592599100|FG006|Overall Study|Withdrawal by Subject|0|||
164064705|NCT02594384|592599101|FG007|Overall Study|Withdrawal by Subject|1|||
164064706|NCT02594384|592599094|FG000|Overall Study|Physician Decision|0|||
164064707|NCT02594384|592599095|FG001|Overall Study|Physician Decision|0|||
164064708|NCT02594384|592599096|FG002|Overall Study|Physician Decision|0|||
164064709|NCT02594384|592599097|FG003|Overall Study|Physician Decision|0|||
164064710|NCT02594384|592599098|FG004|Overall Study|Physician Decision|0|||
164064711|NCT02594384|592599099|FG005|Overall Study|Physician Decision|1|||
164064712|NCT02594384|592599100|FG006|Overall Study|Physician Decision|2|||
164064713|NCT02594384|592599101|FG007|Overall Study|Physician Decision|0|||
164064714|NCT02594384|592599094|FG000|Overall Study|Progressive Leukocytosis|0|||
164064715|NCT02594384|592599095|FG001|Overall Study|Progressive Leukocytosis|0|||
164064716|NCT02594384|592599096|FG002|Overall Study|Progressive Leukocytosis|1|||
164064717|NCT02594384|592599097|FG003|Overall Study|Progressive Leukocytosis|0|||
164064718|NCT02594384|592599098|FG004|Overall Study|Progressive Leukocytosis|0|||
164064719|NCT02594384|592599099|FG005|Overall Study|Progressive Leukocytosis|0|||
164064720|NCT02594384|592599100|FG006|Overall Study|Progressive Leukocytosis|0|||
164064721|NCT02594384|592599101|FG007|Overall Study|Progressive Leukocytosis|0|||
164064722|NCT02594384|592599094|FG000|Overall Study|Lack of Efficacy|0|||
164064723|NCT02594384|592599095|FG001|Overall Study|Lack of Efficacy|0|||
164064724|NCT02594384|592599096|FG002|Overall Study|Lack of Efficacy|0|||
164064725|NCT02594384|592599097|FG003|Overall Study|Lack of Efficacy|0|||
164064726|NCT02594384|592599098|FG004|Overall Study|Lack of Efficacy|1|||
164064727|NCT02594384|592599099|FG005|Overall Study|Lack of Efficacy|0|||
164064728|NCT02594384|592599100|FG006|Overall Study|Lack of Efficacy|0|||
164064729|NCT02594384|592599101|FG007|Overall Study|Lack of Efficacy|0|||
164064730|NCT02594384|592599094|FG000|Overall Study|Substantial noncompliance|0|||
164064731|NCT02594384|592599095|FG001|Overall Study|Substantial noncompliance|0|||
164064732|NCT02594384|592599096|FG002|Overall Study|Substantial noncompliance|0|||
164064733|NCT02594384|592599097|FG003|Overall Study|Substantial noncompliance|0|||
164064734|NCT02594384|592599098|FG004|Overall Study|Substantial noncompliance|0|||
164064735|NCT02594384|592599099|FG005|Overall Study|Substantial noncompliance|0|||
164064736|NCT02594384|592599100|FG006|Overall Study|Substantial noncompliance|1|||
164064737|NCT02594384|592599101|FG007|Overall Study|Substantial noncompliance|0|||
164064738|NCT03919669|592599104|FG000|Overall Study|Withdrawal by Subject|1|||
164064739|NCT03919669|592599105|FG001|Overall Study|Withdrawal by Subject|0|||
164064740|NCT03919669|592599106|FG002|Overall Study|Withdrawal by Subject|0|||
164064741|NCT00625846|592599107|FG000|Overall Study|Withdrawal by Subject|2|||
164064742|NCT00625846|592599108|FG001|Overall Study|Withdrawal by Subject|0|||
164064743|NCT00625846|592599109|FG002|Overall Study|Withdrawal by Subject|1|||
164064744|NCT00625846|592599110|FG003|Overall Study|Withdrawal by Subject|2|||
164064745|NCT02058849|592599113|FG000|Overall Study|Hospitalization|1|||
164064746|NCT02058849|592599114|FG001|Overall Study|Hospitalization|1|||
164064747|NCT02058849|592599113|FG000|Overall Study|Death|1|||
164103957|NCT03032172|592743920|FG000|Treatment Period|Physician Decision|0|||
164103958|NCT03032172|592743921|FG001|Treatment Period|Physician Decision|2|||
164103959|NCT03032172|592743922|FG002|Treatment Period|Physician Decision|1|||
164103960|NCT03032172|592743923|FG003|Treatment Period|Physician Decision|0|||
164103961|NCT03032172|592743924|FG004|Treatment Period|Physician Decision|0|||
164064748|NCT02058849|592599114|FG001|Overall Study|Death|0|||
164064749|NCT02058849|592599113|FG000|Overall Study|Lost to Follow-up|1|||
164064750|NCT02058849|592599114|FG001|Overall Study|Lost to Follow-up|0|||
164064751|NCT02058849|592599113|FG000|Overall Study|Withdrawal by Subject|4|||
164064752|NCT02058849|592599114|FG001|Overall Study|Withdrawal by Subject|0|||
164064753|NCT02219477|592599115|FG000|Overall Study|Adverse Event|0|||
164064754|NCT02219477|592599116|FG001|Overall Study|Adverse Event|1|||
164064755|NCT02219477|592599117|FG002|Overall Study|Adverse Event|1|||
164064756|NCT02219477|592599115|FG000|Overall Study|Withdrawal by Subject|0|||
164064757|NCT02219477|592599116|FG001|Overall Study|Withdrawal by Subject|1|||
164064758|NCT02219477|592599117|FG002|Overall Study|Withdrawal by Subject|0|||
164064759|NCT01891669|592599119|FG000|Overall Study|Death|0|||
164064760|NCT01891669|592599120|FG001|Overall Study|Death|0|||
164064761|NCT01891669|592599121|FG002|Overall Study|Death|0|||
164064762|NCT01891669|592599122|FG003|Overall Study|Death|0|||
164064763|NCT01891669|592599123|FG004|Overall Study|Death|0|||
164064764|NCT01891669|592599124|FG005|Overall Study|Death|0|||
164064765|NCT01891669|592599125|FG006|Overall Study|Death|0|||
164064766|NCT01891669|592599126|FG007|Overall Study|Death|1|||
164064767|NCT01891669|592599127|FG008|Overall Study|Death|0|||
164064768|NCT01891669|592599128|FG009|Overall Study|Death|1|||
164064769|NCT01891669|592599119|FG000|Overall Study|Withdrawal by Subject|1|||
164064770|NCT01891669|592599120|FG001|Overall Study|Withdrawal by Subject|1|||
164064771|NCT01891669|592599121|FG002|Overall Study|Withdrawal by Subject|0|||
164064772|NCT01891669|592599122|FG003|Overall Study|Withdrawal by Subject|0|||
164064773|NCT01891669|592599123|FG004|Overall Study|Withdrawal by Subject|0|||
164064774|NCT01891669|592599124|FG005|Overall Study|Withdrawal by Subject|0|||
164064775|NCT01891669|592599125|FG006|Overall Study|Withdrawal by Subject|1|||
164064776|NCT01891669|592599126|FG007|Overall Study|Withdrawal by Subject|2|||
164064777|NCT01891669|592599127|FG008|Overall Study|Withdrawal by Subject|1|||
164064778|NCT01891669|592599128|FG009|Overall Study|Withdrawal by Subject|1|||
164064779|NCT01891669|592599119|FG000|Overall Study|Other|1|||
164064780|NCT01891669|592599120|FG001|Overall Study|Other|0|||
164064781|NCT01891669|592599121|FG002|Overall Study|Other|0|||
164064782|NCT01891669|592599122|FG003|Overall Study|Other|0|||
164064783|NCT01891669|592599123|FG004|Overall Study|Other|0|||
164064784|NCT01891669|592599124|FG005|Overall Study|Other|0|||
164064785|NCT01891669|592599125|FG006|Overall Study|Other|0|||
164064786|NCT01891669|592599126|FG007|Overall Study|Other|1|||
164064787|NCT01891669|592599127|FG008|Overall Study|Other|0|||
164064788|NCT01891669|592599128|FG009|Overall Study|Other|0|||
164064789|NCT04298229|592599133|FG000|Overall Study|Physician Decision|1|||
164064790|NCT04298229|592599134|FG001|Overall Study|Physician Decision|1|||
164064791|NCT04298229|592599133|FG000|Overall Study|Withdrawal by Subject|1|||
164064792|NCT04298229|592599134|FG001|Overall Study|Withdrawal by Subject|1|||
164064793|NCT04298229|592599133|FG000|Overall Study|Did not receive IV loop diuretics|2|||
164064794|NCT04298229|592599134|FG001|Overall Study|Did not receive IV loop diuretics|0|||
164064795|NCT00262119|592599135|FG000|Overall Study|Lost to Follow-up|38|||
164064796|NCT00262119|592599136|FG001|Overall Study|Lost to Follow-up|51|||
164064797|NCT00262119|592599137|FG002|Overall Study|Lost to Follow-up|42|||
164064798|NCT00262119|592599135|FG000|Overall Study|Death|20|||
164064799|NCT00262119|592599136|FG001|Overall Study|Death|19|||
164064800|NCT00262119|592599137|FG002|Overall Study|Death|16|||
164064801|NCT00859313|592599138|FG000|Overall Study|Lack of Efficacy|2|||
164064802|NCT00859313|592599138|FG000|Overall Study|Adverse Event|1|||
164064803|NCT00859313|592599138|FG000|Overall Study|staff error|1|||
164064804|NCT00071006|592599139|FG000|Overall Study|Lack of Efficacy|7|||
164064805|NCT00071006|592599139|FG000|Overall Study|Adverse Event|1|||
164064806|NCT00071006|592599139|FG000|Overall Study|Withdrawal by Subject|1|||
164064807|NCT00071006|592599139|FG000|Overall Study|Other|3|||
164064808|NCT05261126|592599144|FG000|Overall Study|Death|0|||
164064809|NCT05261126|592599145|FG001|Overall Study|Death|0|||
164064810|NCT05261126|592599146|FG002|Overall Study|Death|1|||
164064811|NCT05261126|592599147|FG003|Overall Study|Death|0|||
164064812|NCT05261126|592599148|FG004|Overall Study|Death|0|||
164064813|NCT05261126|592599144|FG000|Overall Study|Lost to Follow-up|0|||
164064814|NCT05261126|592599145|FG001|Overall Study|Lost to Follow-up|0|||
164064815|NCT05261126|592599146|FG002|Overall Study|Lost to Follow-up|0|||
164064816|NCT05261126|592599147|FG003|Overall Study|Lost to Follow-up|0|||
164064817|NCT05261126|592599148|FG004|Overall Study|Lost to Follow-up|1|||
164064818|NCT05261126|592599144|FG000|Overall Study|Physician Decision|1|||
164064819|NCT05261126|592599145|FG001|Overall Study|Physician Decision|0|||
164064820|NCT05261126|592599146|FG002|Overall Study|Physician Decision|0|||
164064821|NCT05261126|592599147|FG003|Overall Study|Physician Decision|0|||
164064822|NCT05261126|592599148|FG004|Overall Study|Physician Decision|0|||
164064823|NCT05261126|592599144|FG000|Overall Study|Screen Failure|0|||
164064824|NCT05261126|592599145|FG001|Overall Study|Screen Failure|0|||
164064825|NCT05261126|592599146|FG002|Overall Study|Screen Failure|0|||
164064826|NCT05261126|592599147|FG003|Overall Study|Screen Failure|0|||
164064827|NCT05261126|592599148|FG004|Overall Study|Screen Failure|1|||
164064828|NCT05261126|592599144|FG000|Overall Study|Withdrawal by Subject|1|||
164064829|NCT05261126|592599145|FG001|Overall Study|Withdrawal by Subject|0|||
164064830|NCT05261126|592599146|FG002|Overall Study|Withdrawal by Subject|1|||
164064831|NCT05261126|592599147|FG003|Overall Study|Withdrawal by Subject|1|||
164064832|NCT05261126|592599148|FG004|Overall Study|Withdrawal by Subject|0|||
164064833|NCT05261126|592599144|FG000|Overall Study|Not Recorded|0|||
164064834|NCT05261126|592599145|FG001|Overall Study|Not Recorded|0|||
164064835|NCT05261126|592599146|FG002|Overall Study|Not Recorded|0|||
164064836|NCT05261126|592599147|FG003|Overall Study|Not Recorded|1|||
164064837|NCT05261126|592599148|FG004|Overall Study|Not Recorded|0|||
164064838|NCT05939388|592599149|FG000|Overall Study|Lost to Follow-up|1|||
164064839|NCT03901274|592599150|FG000|Overall Study|Lost to Follow-up|120|||
164064840|NCT03901274|592599151|FG001|Overall Study|Lost to Follow-up|124|||
164064841|NCT03901274|592599150|FG000|Overall Study|Withdrawal by Subject|0|||
164064842|NCT03901274|592599151|FG001|Overall Study|Withdrawal by Subject|6|||
164064843|NCT05570604|592599152|FG000|Overall Study|Lost to Follow-up|1|||
164064844|NCT05570604|592599153|FG001|Overall Study|Lost to Follow-up|5|||
164064845|NCT05570604|592599152|FG000|Overall Study|Illness|2|||
164064846|NCT05570604|592599153|FG001|Overall Study|Illness|2|||
164064847|NCT04527380|592599160|FG000|Overall Study|Lack of Efficacy|0|||
164064848|NCT04527380|592599161|FG001|Overall Study|Lack of Efficacy|1|||
164064849|NCT04527380|592599160|FG000|Overall Study|Withdrawal by Subject|1|||
164064850|NCT04527380|592599161|FG001|Overall Study|Withdrawal by Subject|0|||
164064851|NCT05116241|592599176|FG000|Study|Withdrawal by Subject|5|||
164064852|NCT05116241|592599177|FG001|Study|Withdrawal by Subject|2|||
164064853|NCT05116241|592599178|FG002|Study|Withdrawal by Subject|1|||
164064854|NCT05116241|592599176|FG000|Study|Lost to Follow-up|0|||
164064855|NCT05116241|592599177|FG001|Study|Lost to Follow-up|2|||
164064856|NCT05116241|592599178|FG002|Study|Lost to Follow-up|2|||
164064857|NCT04410991|592599179|FG000|Overall Study|Poor compliance to protocol|5|||
164064858|NCT04410991|592599180|FG001|Overall Study|Poor compliance to protocol|4|||
164064859|NCT04410991|592599179|FG000|Overall Study|Withdrawal by Subject|59|||
164064860|NCT04410991|592599180|FG001|Overall Study|Withdrawal by Subject|55|||
164064861|NCT04410991|592599179|FG000|Overall Study|Other|10|||
164064862|NCT04410991|592599180|FG001|Overall Study|Other|4|||
164064863|NCT01054443|592599187|FG000|Overall Study|Withdrawal by Subject|0|||
164064864|NCT01054443|592599188|FG001|Overall Study|Withdrawal by Subject|0|||
164064865|NCT01054443|592599189|FG002|Overall Study|Withdrawal by Subject|0|||
164064866|NCT01054443|592599190|FG003|Overall Study|Withdrawal by Subject|1|||
164064867|NCT03099265|592600526|FG000|Overall Study|Adverse Event|1|||
164064868|NCT00396318|592600531|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
164064869|NCT00602927|592600532|FG000|Period 1: 13 Days|Protocol Violation|2|||
164064870|NCT00602927|592600533|FG001|Period 1: 13 Days|Protocol Violation|4|||
164064871|NCT00602927|592600532|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
164064872|NCT00602927|592600533|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
164064873|NCT00602927|592600532|FG000|Period 1: 13 Days|Time|1|||
164064874|NCT00602927|592600533|FG001|Period 1: 13 Days|Time|0|||
164064875|NCT00602927|592600532|FG000|Period 1: 13 Days|Claustrophobia|0|||
164064876|NCT00602927|592600533|FG001|Period 1: 13 Days|Claustrophobia|1|||
164064877|NCT00602927|592600532|FG000|Period 2: 14 Days|Protocol Violation|0|||
164064878|NCT00602927|592600533|FG001|Period 2: 14 Days|Protocol Violation|2|||
164064879|NCT00602927|592600532|FG000|Period 3: 13 Days|Protocol Violation|0|||
164064880|NCT00602927|592600533|FG001|Period 3: 13 Days|Protocol Violation|1|||
164064881|NCT00602927|592600532|FG000|Period 3: 13 Days|MRI data quality|2|||
164064882|NCT00602927|592600533|FG001|Period 3: 13 Days|MRI data quality|2|||
164064883|NCT01741259|592600542|FG000|Overall Study|Protocol Violation|6|||
164064884|NCT01741259|592600543|FG001|Overall Study|Protocol Violation|4|||
164064885|NCT01741259|592600542|FG000|Overall Study|Withdrawal by Subject|0|||
164064886|NCT01741259|592600543|FG001|Overall Study|Withdrawal by Subject|2|||
164064887|NCT05604521|592600547|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
164064888|NCT05604521|592600548|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
164064889|NCT05604521|592600547|FG000|Overall Study|Adverse Event|1|||
164064890|NCT05604521|592600548|FG001|Overall Study|Adverse Event|0|||
164064891|NCT02875340|592600549|FG000|Overall Study|Death|2|||
164064892|NCT02875340|592600549|FG000|Overall Study|Withdrawal by Subject|2|||
164064893|NCT02875340|592600549|FG000|Overall Study|Physician Decision|3|||
164064894|NCT02875340|592600549|FG000|Overall Study|Adverse Event|1|||
164064895|NCT03526549|592600552|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
164064896|NCT03526549|592600553|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
164064897|NCT03526549|592600552|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
164064898|NCT03526549|592600553|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
164064899|NCT03526549|592600552|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
164064900|NCT03526549|592600553|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
164064901|NCT03526549|592600552|FG000|Open-label Phase|Adverse Event|4|||
164064902|NCT03526549|592600553|FG001|Open-label Phase|Adverse Event|0|||
164064903|NCT03526549|592600552|FG000|Open-label Phase|Withdrawal by Subject|54|||
164064904|NCT03526549|592600553|FG001|Open-label Phase|Withdrawal by Subject|0|||
164064905|NCT03526549|592600552|FG000|Open-label Phase|Lost to Follow-up|35|||
164064906|NCT03526549|592600553|FG001|Open-label Phase|Lost to Follow-up|0|||
164064907|NCT03526549|592600552|FG000|Open-label Phase|Other than Specified|5|||
164064908|NCT03526549|592600553|FG001|Open-label Phase|Other than Specified|0|||
164064909|NCT03253809|592600561|FG000|Overall Study|Unable to obtain study related data|14|||
164064910|NCT04637815|592600566|FG000|Overall Study|Death|1|||
164064911|NCT04637815|592600567|FG001|Overall Study|Death|0|||
164064912|NCT04637815|592600566|FG000|Overall Study|Lost to Follow-up|5|||
164064913|NCT04637815|592600567|FG001|Overall Study|Lost to Follow-up|2|||
164064914|NCT00455923|592600568|FG000|Overall Study|Pregnancy|0|||
164064915|NCT00455923|592600569|FG001|Overall Study|Pregnancy|2|||
164064916|NCT00455923|592600568|FG000|Overall Study|Other|3|||
164064917|NCT00455923|592600569|FG001|Overall Study|Other|1|||
164064918|NCT02353572|592600570|FG000|Overall Study|Withdrawal by Subject|1|||
164064919|NCT02353572|592600570|FG000|Overall Study|Study terminated|2|||
164064920|NCT02686749|592600579|FG000|Overall Study|terminated for poor enrollment|2|||
164064921|NCT02686749|592600580|FG001|Overall Study|terminated for poor enrollment|2|||
164064922|NCT01244516|592600581|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
164064923|NCT01244516|592600582|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
164064924|NCT01244516|592600583|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
164064925|NCT01244516|592600581|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
164064926|NCT01244516|592600582|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
164064927|NCT01244516|592600583|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
164064928|NCT01244516|592600581|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
164064929|NCT01244516|592600582|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
164064930|NCT01244516|592600583|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
164064931|NCT01244516|592600581|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
164064932|NCT01244516|592600582|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
164064933|NCT01244516|592600583|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
164064934|NCT01244516|592600581|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
164064935|NCT01244516|592600582|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
164064936|NCT01244516|592600583|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
164064937|NCT01244516|592600581|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
164064938|NCT01244516|592600582|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
164064939|NCT01244516|592600583|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
164064940|NCT01244516|592600581|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
164064941|NCT01244516|592600582|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
164064942|NCT01244516|592600583|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
164064943|NCT00483119|592600589|FG000|Overall Study|Adverse Event|0|||
164064944|NCT00483119|592600590|FG001|Overall Study|Adverse Event|1|||
164064945|NCT00483119|592600589|FG000|Overall Study|Physician Decision|1|||
164064946|NCT00483119|592600590|FG001|Overall Study|Physician Decision|0|||
164064947|NCT04409509|592600591|FG000|Overall Study|Failure to meet randomization requirement|1|||
164064948|NCT04409509|592600592|FG001|Overall Study|Failure to meet randomization requirement|0|||
164064949|NCT04409509|592600591|FG000|Overall Study|Adverse Event|0|||
164064950|NCT04409509|592600592|FG001|Overall Study|Adverse Event|1|||
164064951|NCT04409509|592600591|FG000|Overall Study|Death|11|||
164064952|NCT04409509|592600592|FG001|Overall Study|Death|10|||
164064953|NCT04409509|592600591|FG000|Overall Study|Non-compliance with study drug|0|||
164064954|NCT04409509|592600592|FG001|Overall Study|Non-compliance with study drug|1|||
164064955|NCT04409509|592600591|FG000|Overall Study|Lost to Follow-up|0|||
164064956|NCT04409509|592600592|FG001|Overall Study|Lost to Follow-up|3|||
164064957|NCT04409509|592600591|FG000|Overall Study|Withdrawal by Subject|0|||
164064958|NCT04409509|592600592|FG001|Overall Study|Withdrawal by Subject|3|||
164064959|NCT04409509|592600591|FG000|Overall Study|Randomized by mistake|0|||
164064960|NCT04409509|592600592|FG001|Overall Study|Randomized by mistake|1|||
164064961|NCT04409509|592600591|FG000|Overall Study|Other|1|||
164064962|NCT04409509|592600592|FG001|Overall Study|Other|1|||
164064963|NCT04668066|592600593|FG000|Part 1: Treatment Phase|Adverse Event|0|||
164064964|NCT04668066|592600594|FG001|Part 1: Treatment Phase|Adverse Event|0|||
164064965|NCT04668066|592600595|FG002|Part 1: Treatment Phase|Adverse Event|0|||
164064966|NCT04668066|592600596|FG003|Part 1: Treatment Phase|Adverse Event|0|||
164064967|NCT04668066|592600597|FG004|Part 1: Treatment Phase|Adverse Event|0|||
164064968|NCT04668066|592600598|FG005|Part 1: Treatment Phase|Adverse Event|0|||
164064969|NCT04668066|592600599|FG006|Part 1: Treatment Phase|Adverse Event|0|||
164064970|NCT04668066|592600600|FG007|Part 1: Treatment Phase|Adverse Event|0|||
164064971|NCT04668066|592600601|FG008|Part 1: Treatment Phase|Adverse Event|0|||
164064972|NCT04668066|592600602|FG009|Part 1: Treatment Phase|Adverse Event|0|||
164064973|NCT04668066|592600603|FG010|Part 1: Treatment Phase|Adverse Event|0|||
164064974|NCT04668066|592600604|FG011|Part 1: Treatment Phase|Adverse Event|1|||
164064975|NCT04668066|592600605|FG012|Part 1: Treatment Phase|Adverse Event|1|||
164064976|NCT04668066|592600606|FG013|Part 1: Treatment Phase|Adverse Event|0|||
164064977|NCT04668066|592600607|FG014|Part 1: Treatment Phase|Adverse Event|0|||
164064978|NCT04668066|592600608|FG015|Part 1: Treatment Phase|Adverse Event|0|||
164064979|NCT04668066|592600609|FG016|Part 1: Treatment Phase|Adverse Event|0|||
164064980|NCT04668066|592600610|FG017|Part 1: Treatment Phase|Adverse Event|0|||
164103962|NCT03032172|592743925|FG005|Treatment Period|Physician Decision|0|||
164103963|NCT03032172|592743926|FG006|Treatment Period|Physician Decision|0|||
164103964|NCT03032172|592743927|FG007|Treatment Period|Physician Decision|0|||
164103965|NCT03032172|592743920|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164103966|NCT03032172|592743921|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
164103967|NCT03032172|592743922|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
164103968|NCT03032172|592743923|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
164103969|NCT03032172|592743924|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164103970|NCT03032172|592743925|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164103971|NCT03032172|592743926|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164103972|NCT03032172|592743927|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
164103973|NCT03032172|592743920|FG000|Treatment Period|Withdrawal by Subject|2|||
164103974|NCT03032172|592743921|FG001|Treatment Period|Withdrawal by Subject|0|||
164103975|NCT03032172|592743922|FG002|Treatment Period|Withdrawal by Subject|3|||
164103976|NCT03032172|592743923|FG003|Treatment Period|Withdrawal by Subject|0|||
164103977|NCT03032172|592743924|FG004|Treatment Period|Withdrawal by Subject|0|||
164103978|NCT03032172|592743925|FG005|Treatment Period|Withdrawal by Subject|0|||
164103979|NCT03032172|592743926|FG006|Treatment Period|Withdrawal by Subject|0|||
164103980|NCT03032172|592743927|FG007|Treatment Period|Withdrawal by Subject|0|||
164103981|NCT03032172|592743920|FG000|Open-label Extension Period|Death|0|||
164103982|NCT03032172|592743921|FG001|Open-label Extension Period|Death|0|||
164103983|NCT03032172|592743922|FG002|Open-label Extension Period|Death|0|||
164103984|NCT03032172|592743923|FG003|Open-label Extension Period|Death|0|||
164103985|NCT03032172|592743924|FG004|Open-label Extension Period|Death|0|||
164103986|NCT03032172|592743925|FG005|Open-label Extension Period|Death|0|||
164103987|NCT03032172|592743926|FG006|Open-label Extension Period|Death|0|||
164103988|NCT03032172|592743927|FG007|Open-label Extension Period|Death|2|||
164103989|NCT03032172|592743920|FG000|Open-label Extension Period|Reason Not Specified|0|||
164103990|NCT03032172|592743921|FG001|Open-label Extension Period|Reason Not Specified|0|||
164103991|NCT03032172|592743922|FG002|Open-label Extension Period|Reason Not Specified|0|||
164103992|NCT03032172|592743923|FG003|Open-label Extension Period|Reason Not Specified|0|||
164103993|NCT03032172|592743924|FG004|Open-label Extension Period|Reason Not Specified|0|||
164103994|NCT03032172|592743925|FG005|Open-label Extension Period|Reason Not Specified|5|||
164103995|NCT03032172|592743926|FG006|Open-label Extension Period|Reason Not Specified|3|||
164103996|NCT03032172|592743927|FG007|Open-label Extension Period|Reason Not Specified|0|||
164103997|NCT03032172|592743920|FG000|Open-label Extension Period|Pregnancy|0|||
164103998|NCT03032172|592743921|FG001|Open-label Extension Period|Pregnancy|0|||
164103999|NCT03032172|592743922|FG002|Open-label Extension Period|Pregnancy|0|||
164104000|NCT03032172|592743923|FG003|Open-label Extension Period|Pregnancy|0|||
164104001|NCT03032172|592743924|FG004|Open-label Extension Period|Pregnancy|0|||
164104002|NCT03032172|592743925|FG005|Open-label Extension Period|Pregnancy|0|||
164104003|NCT03032172|592743926|FG006|Open-label Extension Period|Pregnancy|1|||
164104004|NCT03032172|592743927|FG007|Open-label Extension Period|Pregnancy|0|||
164104005|NCT03032172|592743920|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164104006|NCT03032172|592743921|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164104007|NCT03032172|592743922|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
164104008|NCT03032172|592743923|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
164104009|NCT03032172|592743924|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
164104010|NCT03032172|592743925|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
164104011|NCT03032172|592743926|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
164104012|NCT03032172|592743927|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
164104013|NCT02718326|592743928|FG000|Overall Study|Adverse Event|4|||
164104014|NCT02718326|592743929|FG001|Overall Study|Adverse Event|9|||
164104015|NCT02718326|592743930|FG002|Overall Study|Adverse Event|0|||
164104016|NCT02718326|592743928|FG000|Overall Study|Death|8|||
164104017|NCT02718326|592743929|FG001|Overall Study|Death|1|||
164104018|NCT02718326|592743930|FG002|Overall Study|Death|2|||
164104019|NCT02718326|592743928|FG000|Overall Study|Withdrawal by Subject|4|||
164104020|NCT02718326|592743929|FG001|Overall Study|Withdrawal by Subject|9|||
164104021|NCT02718326|592743930|FG002|Overall Study|Withdrawal by Subject|6|||
164104022|NCT02718326|592743928|FG000|Overall Study|Lost to Follow-up|18|||
164104023|NCT02718326|592743929|FG001|Overall Study|Lost to Follow-up|5|||
164104024|NCT02718326|592743930|FG002|Overall Study|Lost to Follow-up|14|||
164104025|NCT02718326|592743928|FG000|Overall Study|Protocol Deviation|1|||
164104026|NCT02718326|592743929|FG001|Overall Study|Protocol Deviation|0|||
164104027|NCT02718326|592743930|FG002|Overall Study|Protocol Deviation|0|||
164104028|NCT02718326|592743928|FG000|Overall Study|Pregnancy|1|||
164104029|NCT02718326|592743929|FG001|Overall Study|Pregnancy|0|||
164104030|NCT02718326|592743930|FG002|Overall Study|Pregnancy|0|||
164104031|NCT06195579|592743931|FG000|Overall Study|Withdrawal by Subject|1|||
164104032|NCT03868891|592743932|FG000|Overall Study|Adverse Event|1|||
164104033|NCT03868891|592743933|FG001|Overall Study|Adverse Event|0|||
164064981|NCT04668066|592600611|FG018|Part 1: Treatment Phase|Adverse Event|0|||
164104034|NCT03868891|592743932|FG000|Overall Study|Lost to Follow-up|2|||
164104035|NCT03868891|592743933|FG001|Overall Study|Lost to Follow-up|1|||
164104036|NCT03868891|592743932|FG000|Overall Study|COVID-19 Restrictions|1|||
164104037|NCT03868891|592743933|FG001|Overall Study|COVID-19 Restrictions|2|||
164104038|NCT03049748|592743936|FG000|Overall Study|Lost to Follow-up|1|||
164104039|NCT03049748|592743937|FG001|Overall Study|Lost to Follow-up|0|||
164104040|NCT03049748|592743936|FG000|Overall Study|Death|3|||
164104041|NCT03049748|592743937|FG001|Overall Study|Death|0|||
164104042|NCT03049748|592743936|FG000|Overall Study|Withdrawal by Subject|0|||
164104043|NCT03049748|592743937|FG001|Overall Study|Withdrawal by Subject|3|||
164104044|NCT03049748|592743936|FG000|Overall Study|Protocol Violation|0|||
164104045|NCT03049748|592743937|FG001|Overall Study|Protocol Violation|2|||
164104046|NCT03049748|592743936|FG000|Overall Study|Moved out of state (relocation)|0|||
164104047|NCT03049748|592743937|FG001|Overall Study|Moved out of state (relocation)|1|||
164104048|NCT03437265|592743950|FG000|Overall Study|Protocol Violation|6|||
164104049|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
164104050|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
164104051|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
164064982|NCT04668066|592600593|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064983|NCT04668066|592600594|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064984|NCT04668066|592600595|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
164064985|NCT04668066|592600596|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064986|NCT04668066|592600597|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064987|NCT04668066|592600598|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064988|NCT04668066|592600599|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064989|NCT04668066|592600600|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064990|NCT04668066|592600601|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064991|NCT04668066|592600602|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064992|NCT04668066|592600603|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064993|NCT04668066|592600604|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064994|NCT04668066|592600605|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064995|NCT04668066|592600606|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064996|NCT04668066|592600607|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064997|NCT04668066|592600608|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064998|NCT04668066|592600609|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
164064999|NCT04668066|592600610|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
164065000|NCT04668066|592600611|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
164065001|NCT04668066|592600593|FG000|Part 1: Treatment Phase|Other|0|||
164065002|NCT04668066|592600594|FG001|Part 1: Treatment Phase|Other|0|||
164065003|NCT04668066|592600595|FG002|Part 1: Treatment Phase|Other|0|||
164065004|NCT04668066|592600596|FG003|Part 1: Treatment Phase|Other|0|||
164065005|NCT04668066|592600597|FG004|Part 1: Treatment Phase|Other|0|||
164065006|NCT04668066|592600598|FG005|Part 1: Treatment Phase|Other|0|||
164065007|NCT04668066|592600599|FG006|Part 1: Treatment Phase|Other|0|||
164065008|NCT04668066|592600600|FG007|Part 1: Treatment Phase|Other|0|||
164065009|NCT04668066|592600601|FG008|Part 1: Treatment Phase|Other|0|||
164065010|NCT04668066|592600602|FG009|Part 1: Treatment Phase|Other|0|||
164065011|NCT04668066|592600603|FG010|Part 1: Treatment Phase|Other|0|||
164065012|NCT04668066|592600604|FG011|Part 1: Treatment Phase|Other|1|||
164065013|NCT04668066|592600605|FG012|Part 1: Treatment Phase|Other|0|||
164065014|NCT04668066|592600606|FG013|Part 1: Treatment Phase|Other|0|||
164065015|NCT04668066|592600607|FG014|Part 1: Treatment Phase|Other|0|||
164065016|NCT04668066|592600608|FG015|Part 1: Treatment Phase|Other|0|||
164065017|NCT04668066|592600609|FG016|Part 1: Treatment Phase|Other|0|||
164065018|NCT04668066|592600610|FG017|Part 1: Treatment Phase|Other|0|||
164065019|NCT04668066|592600611|FG018|Part 1: Treatment Phase|Other|0|||
164065020|NCT04668066|592600593|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065021|NCT04668066|592600594|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065022|NCT04668066|592600595|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065023|NCT04668066|592600596|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065024|NCT04668066|592600597|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164104052|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
164104053|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
164065025|NCT04668066|592600598|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065026|NCT04668066|592600599|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065027|NCT04668066|592600600|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065028|NCT04668066|592600601|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065029|NCT04668066|592600602|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065030|NCT04668066|592600603|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065031|NCT04668066|592600604|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065032|NCT04668066|592600605|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
164065033|NCT04668066|592600606|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065034|NCT04668066|592600607|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164104054|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
164065035|NCT04668066|592600608|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
164065036|NCT04668066|592600609|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065037|NCT04668066|592600610|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065038|NCT04668066|592600611|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
164065039|NCT04668066|592600593|FG000|Part 1: Follow-Up|Adverse Event|0|||
164065040|NCT04668066|592600594|FG001|Part 1: Follow-Up|Adverse Event|0|||
164065041|NCT04668066|592600595|FG002|Part 1: Follow-Up|Adverse Event|0|||
164065042|NCT04668066|592600596|FG003|Part 1: Follow-Up|Adverse Event|0|||
164065043|NCT04668066|592600597|FG004|Part 1: Follow-Up|Adverse Event|0|||
164065044|NCT04668066|592600598|FG005|Part 1: Follow-Up|Adverse Event|0|||
164065045|NCT04668066|592600599|FG006|Part 1: Follow-Up|Adverse Event|0|||
164065046|NCT04668066|592600600|FG007|Part 1: Follow-Up|Adverse Event|0|||
164065047|NCT04668066|592600601|FG008|Part 1: Follow-Up|Adverse Event|0|||
164065048|NCT04668066|592600602|FG009|Part 1: Follow-Up|Adverse Event|0|||
164065049|NCT04668066|592600603|FG010|Part 1: Follow-Up|Adverse Event|0|||
164065050|NCT04668066|592600604|FG011|Part 1: Follow-Up|Adverse Event|1|||
164065051|NCT04668066|592600605|FG012|Part 1: Follow-Up|Adverse Event|0|||
164065052|NCT04668066|592600606|FG013|Part 1: Follow-Up|Adverse Event|0|||
164065053|NCT04668066|592600607|FG014|Part 1: Follow-Up|Adverse Event|0|||
164065054|NCT04668066|592600608|FG015|Part 1: Follow-Up|Adverse Event|0|||
164065055|NCT04668066|592600609|FG016|Part 1: Follow-Up|Adverse Event|0|||
164065056|NCT04668066|592600610|FG017|Part 1: Follow-Up|Adverse Event|0|||
164065057|NCT04668066|592600611|FG018|Part 1: Follow-Up|Adverse Event|0|||
164065058|NCT04668066|592600593|FG000|Part 1: Follow-Up|Other|0|||
164065059|NCT04668066|592600594|FG001|Part 1: Follow-Up|Other|0|||
164065060|NCT04668066|592600595|FG002|Part 1: Follow-Up|Other|0|||
164065061|NCT04668066|592600596|FG003|Part 1: Follow-Up|Other|0|||
164065062|NCT04668066|592600597|FG004|Part 1: Follow-Up|Other|0|||
164065063|NCT04668066|592600598|FG005|Part 1: Follow-Up|Other|0|||
164065064|NCT04668066|592600599|FG006|Part 1: Follow-Up|Other|0|||
164065065|NCT04668066|592600600|FG007|Part 1: Follow-Up|Other|0|||
164065066|NCT04668066|592600601|FG008|Part 1: Follow-Up|Other|0|||
164065067|NCT04668066|592600602|FG009|Part 1: Follow-Up|Other|0|||
164065068|NCT04668066|592600603|FG010|Part 1: Follow-Up|Other|0|||
164065069|NCT04668066|592600604|FG011|Part 1: Follow-Up|Other|1|||
164065070|NCT04668066|592600605|FG012|Part 1: Follow-Up|Other|1|||
164065071|NCT04668066|592600606|FG013|Part 1: Follow-Up|Other|0|||
164065072|NCT04668066|592600607|FG014|Part 1: Follow-Up|Other|0|||
164065073|NCT04668066|592600608|FG015|Part 1: Follow-Up|Other|0|||
164065074|NCT04668066|592600609|FG016|Part 1: Follow-Up|Other|0|||
164065075|NCT04668066|592600610|FG017|Part 1: Follow-Up|Other|0|||
164065076|NCT04668066|592600611|FG018|Part 1: Follow-Up|Other|0|||
164065077|NCT04668066|592600593|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065078|NCT04668066|592600594|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065079|NCT04668066|592600595|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065080|NCT04668066|592600596|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065081|NCT04668066|592600597|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065082|NCT04668066|592600598|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065083|NCT04668066|592600599|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065084|NCT04668066|592600600|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065085|NCT04668066|592600601|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065086|NCT04668066|592600602|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065087|NCT04668066|592600603|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065088|NCT04668066|592600604|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065089|NCT04668066|592600605|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
164065090|NCT04668066|592600606|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065091|NCT04668066|592600607|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065092|NCT04668066|592600608|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
164065093|NCT04668066|592600609|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065094|NCT04668066|592600610|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065095|NCT04668066|592600611|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
164065096|NCT04668066|592600593|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065097|NCT04668066|592600594|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065098|NCT04668066|592600595|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065099|NCT04668066|592600596|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065100|NCT04668066|592600597|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065101|NCT04668066|592600598|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065102|NCT04668066|592600599|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065103|NCT04668066|592600600|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065104|NCT04668066|592600601|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065105|NCT04668066|592600602|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164104055|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
164065106|NCT04668066|592600603|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065107|NCT04668066|592600604|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065108|NCT04668066|592600605|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065109|NCT04668066|592600606|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065110|NCT04668066|592600607|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065111|NCT04668066|592600608|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065112|NCT04668066|592600609|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065113|NCT04668066|592600610|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
164065114|NCT04668066|592600611|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
164065115|NCT04668066|592600593|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065116|NCT04668066|592600594|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065117|NCT04668066|592600595|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065118|NCT04668066|592600596|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065119|NCT04668066|592600597|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065120|NCT04668066|592600598|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065121|NCT04668066|592600599|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065122|NCT04668066|592600600|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065123|NCT04668066|592600601|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065124|NCT04668066|592600602|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065125|NCT04668066|592600603|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065126|NCT04668066|592600604|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065127|NCT04668066|592600605|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065128|NCT04668066|592600606|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065129|NCT04668066|592600607|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065130|NCT04668066|592600608|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065131|NCT04668066|592600609|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065132|NCT04668066|592600610|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
164065133|NCT04668066|592600611|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
164065134|NCT04668066|592600593|FG000|Part 2: Treatment Phase|Other|0|||
164065135|NCT04668066|592600594|FG001|Part 2: Treatment Phase|Other|0|||
164065136|NCT04668066|592600595|FG002|Part 2: Treatment Phase|Other|0|||
164065137|NCT04668066|592600596|FG003|Part 2: Treatment Phase|Other|0|||
164065138|NCT04668066|592600597|FG004|Part 2: Treatment Phase|Other|0|||
164065139|NCT04668066|592600598|FG005|Part 2: Treatment Phase|Other|0|||
164065140|NCT04668066|592600599|FG006|Part 2: Treatment Phase|Other|0|||
164065141|NCT04668066|592600600|FG007|Part 2: Treatment Phase|Other|0|||
164065142|NCT04668066|592600601|FG008|Part 2: Treatment Phase|Other|0|||
164065143|NCT04668066|592600602|FG009|Part 2: Treatment Phase|Other|0|||
164065144|NCT04668066|592600603|FG010|Part 2: Treatment Phase|Other|0|||
164065145|NCT04668066|592600604|FG011|Part 2: Treatment Phase|Other|0|||
164065146|NCT04668066|592600605|FG012|Part 2: Treatment Phase|Other|0|||
164065147|NCT04668066|592600606|FG013|Part 2: Treatment Phase|Other|0|||
164065148|NCT04668066|592600607|FG014|Part 2: Treatment Phase|Other|0|||
164065149|NCT04668066|592600608|FG015|Part 2: Treatment Phase|Other|0|||
164065150|NCT04668066|592600609|FG016|Part 2: Treatment Phase|Other|0|||
164065151|NCT04668066|592600610|FG017|Part 2: Treatment Phase|Other|0|||
164065152|NCT04668066|592600611|FG018|Part 2: Treatment Phase|Other|1|||
164065153|NCT04668066|592600593|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065154|NCT04668066|592600594|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065155|NCT04668066|592600595|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065156|NCT04668066|592600596|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065157|NCT04668066|592600597|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065158|NCT04668066|592600598|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065159|NCT04668066|592600599|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065160|NCT04668066|592600600|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065161|NCT04668066|592600601|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065162|NCT04668066|592600602|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065163|NCT04668066|592600603|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065164|NCT04668066|592600604|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065165|NCT04668066|592600605|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065166|NCT04668066|592600606|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065167|NCT04668066|592600607|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065168|NCT04668066|592600608|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065169|NCT04668066|592600609|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065170|NCT04668066|592600610|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
164065171|NCT04668066|592600611|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
164065172|NCT02369874|592600612|FG000|Overall Study|Lost to Follow-up|2|||
164065173|NCT02369874|592600613|FG001|Overall Study|Lost to Follow-up|2|||
164065174|NCT02369874|592600614|FG002|Overall Study|Lost to Follow-up|2|||
164065175|NCT02369874|592600612|FG000|Overall Study|Withdrawal by Subject|7|||
164065176|NCT02369874|592600613|FG001|Overall Study|Withdrawal by Subject|9|||
164065177|NCT02369874|592600614|FG002|Overall Study|Withdrawal by Subject|27|||
164065178|NCT02369874|592600612|FG000|Overall Study|Miscellaneous|1|||
164065179|NCT02369874|592600613|FG001|Overall Study|Miscellaneous|1|||
164065180|NCT02369874|592600614|FG002|Overall Study|Miscellaneous|0|||
164065181|NCT02369874|592600612|FG000|Overall Study|On Treatment/Off Study|34|||
164065182|NCT02369874|592600613|FG001|Overall Study|On Treatment/Off Study|45|||
164065183|NCT02369874|592600614|FG002|Overall Study|On Treatment/Off Study|32|||
164065184|NCT02331680|592600615|FG000|Overall Study|Adverse Event|3|||
164065185|NCT02331680|592600616|FG001|Overall Study|Adverse Event|0|||
164065186|NCT02331680|592600617|FG002|Overall Study|Adverse Event|2|||
164065187|NCT02331680|592600615|FG000|Overall Study|Physician Decision|1|||
164065188|NCT02331680|592600616|FG001|Overall Study|Physician Decision|1|||
164065189|NCT02331680|592600617|FG002|Overall Study|Physician Decision|2|||
164065190|NCT02331680|592600615|FG000|Overall Study|Withdrawal by Subject|0|||
164065191|NCT02331680|592600616|FG001|Overall Study|Withdrawal by Subject|1|||
164065192|NCT02331680|592600617|FG002|Overall Study|Withdrawal by Subject|2|||
164065193|NCT02331680|592600615|FG000|Overall Study|Met withdrawal criteria|2|||
164065194|NCT02331680|592600616|FG001|Overall Study|Met withdrawal criteria|2|||
164065195|NCT02331680|592600617|FG002|Overall Study|Met withdrawal criteria|5|||
164065196|NCT02331680|592600615|FG000|Overall Study|Non-compliance with study drug|0|||
164065197|NCT02331680|592600616|FG001|Overall Study|Non-compliance with study drug|0|||
164065198|NCT02331680|592600617|FG002|Overall Study|Non-compliance with study drug|1|||
164065199|NCT02331680|592600615|FG000|Overall Study|Protocol Violation|0|||
164065200|NCT02331680|592600616|FG001|Overall Study|Protocol Violation|0|||
164065201|NCT02331680|592600617|FG002|Overall Study|Protocol Violation|3|||
164065202|NCT00596466|592600618|FG000|Overall Study|Lack of Efficacy|5|||
164065203|NCT00596466|592600618|FG000|Overall Study|Adverse Event|4|||
164065204|NCT00596466|592600618|FG000|Overall Study|Withdrawal by Subject|2|||
164065205|NCT00596466|592600618|FG000|Overall Study|Protocol Violation|2|||
164065206|NCT00596466|592600618|FG000|Overall Study|Unpecified|2|||
164065207|NCT00596466|592600618|FG000|Overall Study|Enrolled, not treated|2|||
164065208|NCT04505592|592600619|FG000|Overall Study|Death|2|||
164065209|NCT04505592|592600620|FG001|Overall Study|Death|1|||
164065210|NCT04479358|592600623|FG000|Overall Study|Withdrawal by Subject|0|||
164065211|NCT04479358|592600624|FG001|Overall Study|Withdrawal by Subject|0|||
164065212|NCT04479358|592600625|FG002|Overall Study|Withdrawal by Subject|1|||
164065213|NCT04479358|592600626|FG003|Overall Study|Withdrawal by Subject|0|||
164065214|NCT04479358|592600627|FG004|Overall Study|Withdrawal by Subject|0|||
164065215|NCT04479358|592600628|FG005|Overall Study|Withdrawal by Subject|1|||
164065216|NCT01958619|592600646|FG000|Overall Study|Protocol Violation|2|||
164065217|NCT01958619|592600647|FG001|Overall Study|Protocol Violation|0|||
164065218|NCT01958619|592600648|FG002|Overall Study|Protocol Violation|1|||
164065219|NCT01958619|592600649|FG003|Overall Study|Protocol Violation|0|||
164065220|NCT03795233|592600650|FG000|Overall Study|Withdrawal by Subject|2|||
164065221|NCT03795233|592600651|FG001|Overall Study|Withdrawal by Subject|1|||
164065222|NCT03795233|592600650|FG000|Overall Study|Lost to Follow-up|1|||
164065223|NCT03795233|592600651|FG001|Overall Study|Lost to Follow-up|0|||
164065224|NCT03795233|592600650|FG000|Overall Study|Death|1|||
164065225|NCT03795233|592600651|FG001|Overall Study|Death|0|||
164065226|NCT02756182|592600652|FG000|Overall Study|StudyTechnical Difficulties|4|||
164065227|NCT01965600|592600656|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
164065228|NCT01965600|592600657|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
164065229|NCT01965600|592600658|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
164065230|NCT01965600|592600659|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
164065231|NCT01965600|592600656|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
164065232|NCT01965600|592600657|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
164065233|NCT01965600|592600658|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
164065234|NCT01965600|592600659|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
164065235|NCT01965600|592600656|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
164065236|NCT01965600|592600657|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
164065237|NCT01965600|592600658|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
164065238|NCT01965600|592600659|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
164065239|NCT01965600|592600656|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
164065240|NCT01965600|592600657|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
164065241|NCT01965600|592600658|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
164065242|NCT01965600|592600659|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
164065243|NCT01965600|592600656|FG000|Second Intervention|Study terminated by Sponsor|0|||
164065244|NCT01965600|592600657|FG001|Second Intervention|Study terminated by Sponsor|0|||
164065245|NCT01965600|592600658|FG002|Second Intervention|Study terminated by Sponsor|2|||
164065246|NCT01965600|592600659|FG003|Second Intervention|Study terminated by Sponsor|2|||
164065247|NCT01100073|592602110|FG000|Overall Study|Lack of Efficacy|4|||
164065248|NCT01100073|592602110|FG000|Overall Study|Insufficient Tolerability|21|||
164065249|NCT01100073|592602110|FG000|Overall Study|Withdrawal by Subject|13|||
164065250|NCT01100073|592602110|FG000|Overall Study|Lost to Follow-up|39|||
164065251|NCT01100073|592602110|FG000|Overall Study|Lack of effect + patient's wish|2|||
164065252|NCT01100073|592602110|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
164065253|NCT01100073|592602110|FG000|Overall Study|Other|8|||
164065254|NCT01100073|592602110|FG000|Overall Study|Missing|5|||
164065255|NCT00299546|592602111|FG000|Overall Study|Death|3|||
164065256|NCT00299546|592602112|FG001|Overall Study|Death|2|||
164065257|NCT00299546|592602113|FG002|Overall Study|Death|0|||
164065258|NCT00299546|592602111|FG000|Overall Study|Lost to Follow-up|2|||
164065259|NCT00299546|592602112|FG001|Overall Study|Lost to Follow-up|2|||
164065260|NCT00299546|592602113|FG002|Overall Study|Lost to Follow-up|5|||
164065261|NCT00299546|592602111|FG000|Overall Study|Adverse Event|37|||
164065262|NCT00299546|592602112|FG001|Overall Study|Adverse Event|22|||
164104056|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
164104057|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
164104058|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
164104059|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
164104060|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
164104061|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
164104062|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
164104063|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
164104064|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
164104065|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
164104066|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
164104067|NCT01667679|592743962|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
164104068|NCT01667679|592743963|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
164104069|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
164104070|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
164104071|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
164104072|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
164104073|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
164104074|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
164104075|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
164104076|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
164104077|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
164104078|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
164104079|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
164104080|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
164104081|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
164104082|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
164104083|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
164104084|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
164104085|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
164104086|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
164104087|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
164104088|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
164104089|NCT01667679|592743962|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
164104090|NCT01667679|592743963|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
164104091|NCT01175018|592743964|FG000|Overall Study|Adverse Event|3|||
164104092|NCT01175018|592743965|FG001|Overall Study|Adverse Event|1|||
164104093|NCT01788423|592743966|FG000|Overall Study|See Comments in Completed (above)|0|||
164104094|NCT01788423|592743967|FG001|Overall Study|See Comments in Completed (above)|4|||
164104095|NCT01788423|592743968|FG002|Overall Study|See Comments in Completed (above)|5|||
164104096|NCT00835263|592743969|FG000|Second Intervention|Adverse Event|1|||
164104097|NCT00835263|592743970|FG001|Second Intervention|Adverse Event|0|||
164104098|NCT01020474|592743973|FG000|Overall Study|Adverse Event|4|||
164104099|NCT01020474|592743974|FG001|Overall Study|Adverse Event|4|||
164104100|NCT01020474|592743973|FG000|Overall Study|Protocol Violation|0|||
164104101|NCT01020474|592743974|FG001|Overall Study|Protocol Violation|2|||
164104102|NCT01020474|592743973|FG000|Overall Study|Withdrawal by Subject|5|||
164104103|NCT01020474|592743974|FG001|Overall Study|Withdrawal by Subject|7|||
164104104|NCT01020474|592743973|FG000|Overall Study|Other Reasons|1|||
164104105|NCT01020474|592743974|FG001|Overall Study|Other Reasons|1|||
164104106|NCT01020474|592743973|FG000|Overall Study|Insufficient Clinical Response|0|||
164104107|NCT01020474|592743974|FG001|Overall Study|Insufficient Clinical Response|3|||
164104108|NCT00107991|592743975|FG000|Eligibility Assessment|Disease not severe enough|7|||
164104109|NCT00107991|592743975|FG000|Eligibility Assessment|Unwilling to participate|7|||
164104110|NCT00107991|592743975|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
164104111|NCT00107991|592743975|FG000|Eligibility Assessment|Abnormal labs|2|||
164104112|NCT00107991|592743975|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
164104113|NCT00107991|592743975|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
164104114|NCT00107991|592743975|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
164065263|NCT00299546|592602113|FG002|Overall Study|Adverse Event|27|||
164065264|NCT00299546|592602111|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
164065265|NCT00299546|592602112|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
164065266|NCT00299546|592602113|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
164065267|NCT00299546|592602111|FG000|Overall Study|Other|24|||
164065268|NCT00299546|592602112|FG001|Overall Study|Other|26|||
164065269|NCT00299546|592602113|FG002|Overall Study|Other|19|||
164065270|NCT00299546|592602111|FG000|Overall Study|Not treated|0|||
164065271|NCT00299546|592602112|FG001|Overall Study|Not treated|1|||
164065272|NCT00299546|592602113|FG002|Overall Study|Not treated|1|||
164104115|NCT00107991|592743975|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
164104116|NCT00107991|592743975|FG000|12 Week Treatment Period|Adverse Event|1|||
164104117|NCT00107991|592743975|FG000|12 Week Treatment Period|Protocol Violation|1|||
164104118|NCT00107991|592743975|FG000|12 Week Treatment Period|Incarcerated|1|||
164104119|NCT00107991|592743975|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
164104120|NCT03669861|592743976|FG000|Overall Study|Disease Flare|5|||
164104121|NCT03669861|592743976|FG000|Overall Study|Lack of Efficacy|2|||
164104122|NCT02760927|592743977|FG000|Overall Study|Tube Slippage from Device|1|||
164104123|NCT03256695|592743979|FG000|Overall Study|Adverse Event|8|||
164104124|NCT03256695|592743979|FG000|Overall Study|Death|2|||
164104125|NCT03256695|592743979|FG000|Overall Study|Withdrawal by Subject|14|||
164104126|NCT03256695|592743979|FG000|Overall Study|Non-compliance with study drug|1|||
164104127|NCT03256695|592743979|FG000|Overall Study|Lost to Follow-up|3|||
164104128|NCT03256695|592743979|FG000|Overall Study|Lack of Efficacy|3|||
164104129|NCT03256695|592743979|FG000|Overall Study|Protocol Violation|5|||
164104130|NCT03256695|592743979|FG000|Overall Study|Other than specified|3|||
164104131|NCT02964039|592743985|FG000|Overall Study|Medical reason unrelated to study participation|1|||
164104132|NCT02964039|592743986|FG001|Overall Study|Medical reason unrelated to study participation|0|||
164104133|NCT02964039|592743987|FG002|Overall Study|Medical reason unrelated to study participation|3|||
164104134|NCT02964039|592743985|FG000|Overall Study|Research shutdown due to pandemic|2|||
164104135|NCT02964039|592743986|FG001|Overall Study|Research shutdown due to pandemic|0|||
164104136|NCT02964039|592743987|FG002|Overall Study|Research shutdown due to pandemic|1|||
164104137|NCT02964039|592743985|FG000|Overall Study|Withdrawal by Subject|0|||
164104138|NCT02964039|592743986|FG001|Overall Study|Withdrawal by Subject|1|||
164104139|NCT02964039|592743987|FG002|Overall Study|Withdrawal by Subject|0|||
164104140|NCT02964039|592743985|FG000|Overall Study|Lost to Follow-up|1|||
164104141|NCT02964039|592743986|FG001|Overall Study|Lost to Follow-up|0|||
164104142|NCT02964039|592743987|FG002|Overall Study|Lost to Follow-up|1|||
164104143|NCT01103713|592743988|FG000|Overall Study|Lost to Follow-up|2|||
164104144|NCT01103713|592743988|FG000|Overall Study|Withdrawal by Subject|8|||
164104145|NCT01103713|592743988|FG000|Overall Study|Study terminated by sponsor|2|||
164104146|NCT01103713|592743988|FG000|Overall Study|Other|1|||
164104147|NCT02089685|592743989|FG000|Overall Study|Adverse Event|1|||
164104148|NCT02089685|592743990|FG001|Overall Study|Adverse Event|0|||
164104149|NCT02089685|592743991|FG002|Overall Study|Adverse Event|0|||
164104150|NCT02089685|592743992|FG003|Overall Study|Adverse Event|0|||
164104151|NCT02089685|592743993|FG004|Overall Study|Adverse Event|1|||
164104152|NCT02089685|592743994|FG005|Overall Study|Adverse Event|0|||
164104153|NCT02089685|592743989|FG000|Overall Study|Clinical Progression|4|||
164104154|NCT02089685|592743990|FG001|Overall Study|Clinical Progression|0|||
164104155|NCT02089685|592743991|FG002|Overall Study|Clinical Progression|0|||
164104156|NCT02089685|592743992|FG003|Overall Study|Clinical Progression|5|||
164104157|NCT02089685|592743993|FG004|Overall Study|Clinical Progression|1|||
164104158|NCT02089685|592743994|FG005|Overall Study|Clinical Progression|2|||
164104159|NCT02089685|592743989|FG000|Overall Study|Excluded Medication|1|||
164104160|NCT02089685|592743990|FG001|Overall Study|Excluded Medication|0|||
164104161|NCT02089685|592743991|FG002|Overall Study|Excluded Medication|0|||
164104162|NCT02089685|592743992|FG003|Overall Study|Excluded Medication|11|||
164065273|NCT01656850|592602117|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
164065274|NCT01656850|592602118|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
164065275|NCT00326118|592602119|FG000|Active Phase|Withdrawal by Subject|4|||
164065276|NCT00326118|592602120|FG001|Active Phase|Withdrawal by Subject|1|||
164065277|NCT00630994|592602121|FG000|Overall Study|Adverse Event|1|||
164065278|NCT00630994|592602121|FG000|Overall Study|Disease Progression|1|||
164065279|NCT00630994|592602121|FG000|Overall Study|Lack of Efficacy|1|||
164065280|NCT00630994|592602121|FG000|Overall Study|Other|1|||
164065281|NCT05553600|592602124|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
164065282|NCT05553600|592602125|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
164065283|NCT05553600|592602126|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
164065284|NCT05553600|592602127|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
164065285|NCT05553600|592602124|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
164065286|NCT05553600|592602125|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
164065287|NCT05553600|592602126|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
164065288|NCT05553600|592602127|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
164065289|NCT05553600|592602124|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
164065290|NCT05553600|592602125|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
164065291|NCT05553600|592602126|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
164065292|NCT05553600|592602127|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
164065293|NCT05553600|592602124|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
164065294|NCT05553600|592602125|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
164065295|NCT05553600|592602126|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
164065296|NCT05553600|592602127|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
164104163|NCT02089685|592743993|FG004|Overall Study|Excluded Medication|2|||
164104164|NCT02089685|592743994|FG005|Overall Study|Excluded Medication|1|||
164104165|NCT02089685|592743989|FG000|Overall Study|Progressive disease|13|||
164104166|NCT02089685|592743990|FG001|Overall Study|Progressive disease|10|||
164104167|NCT02089685|592743991|FG002|Overall Study|Progressive disease|3|||
164104168|NCT02089685|592743992|FG003|Overall Study|Progressive disease|51|||
164104169|NCT02089685|592743993|FG004|Overall Study|Progressive disease|17|||
164104170|NCT02089685|592743994|FG005|Overall Study|Progressive disease|12|||
164104171|NCT02089685|592743989|FG000|Overall Study|Follow up ended by sponsor|2|||
164104172|NCT02089685|592743990|FG001|Overall Study|Follow up ended by sponsor|2|||
164104173|NCT02089685|592743991|FG002|Overall Study|Follow up ended by sponsor|0|||
164104174|NCT02089685|592743992|FG003|Overall Study|Follow up ended by sponsor|70|||
164104175|NCT02089685|592743993|FG004|Overall Study|Follow up ended by sponsor|26|||
164104176|NCT02089685|592743994|FG005|Overall Study|Follow up ended by sponsor|26|||
164104177|NCT02089685|592743989|FG000|Overall Study|Withdrawal by Subject|0|||
164104178|NCT02089685|592743990|FG001|Overall Study|Withdrawal by Subject|2|||
164104179|NCT02089685|592743991|FG002|Overall Study|Withdrawal by Subject|0|||
164104180|NCT02089685|592743992|FG003|Overall Study|Withdrawal by Subject|8|||
164104181|NCT02089685|592743993|FG004|Overall Study|Withdrawal by Subject|1|||
164104182|NCT02089685|592743994|FG005|Overall Study|Withdrawal by Subject|1|||
164104183|NCT02089685|592743989|FG000|Overall Study|Status not recorded|1|||
164104184|NCT02089685|592743990|FG001|Overall Study|Status not recorded|0|||
164104185|NCT02089685|592743991|FG002|Overall Study|Status not recorded|0|||
164104186|NCT02089685|592743992|FG003|Overall Study|Status not recorded|0|||
164104187|NCT02089685|592743993|FG004|Overall Study|Status not recorded|1|||
164104188|NCT02089685|592743994|FG005|Overall Study|Status not recorded|0|||
164104189|NCT02089685|592743989|FG000|Overall Study|Death|0|||
164104190|NCT02089685|592743990|FG001|Overall Study|Death|0|||
164104191|NCT02089685|592743991|FG002|Overall Study|Death|0|||
164104192|NCT02089685|592743992|FG003|Overall Study|Death|7|||
164104193|NCT02089685|592743993|FG004|Overall Study|Death|2|||
164104194|NCT02089685|592743994|FG005|Overall Study|Death|5|||
164104195|NCT02089685|592743989|FG000|Overall Study|Lost to Follow-up|0|||
164104196|NCT02089685|592743990|FG001|Overall Study|Lost to Follow-up|0|||
164104197|NCT02089685|592743991|FG002|Overall Study|Lost to Follow-up|0|||
164104198|NCT02089685|592743992|FG003|Overall Study|Lost to Follow-up|1|||
164104199|NCT02089685|592743993|FG004|Overall Study|Lost to Follow-up|0|||
164104200|NCT02089685|592743994|FG005|Overall Study|Lost to Follow-up|0|||
164104201|NCT02089685|592743989|FG000|Overall Study|Physician Decision|0|||
164104202|NCT02089685|592743990|FG001|Overall Study|Physician Decision|0|||
164104203|NCT02089685|592743991|FG002|Overall Study|Physician Decision|0|||
164104204|NCT02089685|592743992|FG003|Overall Study|Physician Decision|0|||
164104205|NCT02089685|592743993|FG004|Overall Study|Physician Decision|0|||
164104206|NCT02089685|592743994|FG005|Overall Study|Physician Decision|4|||
164104207|NCT02089685|592743989|FG000|Overall Study|Screen failure|1|||
164104208|NCT02089685|592743990|FG001|Overall Study|Screen failure|0|||
164104209|NCT02089685|592743991|FG002|Overall Study|Screen failure|0|||
164104210|NCT02089685|592743992|FG003|Overall Study|Screen failure|0|||
164104211|NCT02089685|592743993|FG004|Overall Study|Screen failure|0|||
164104212|NCT02089685|592743994|FG005|Overall Study|Screen failure|0|||
164104213|NCT04887415|592743997|FG000|Overall Study|Lost to Follow-up|2|||
164104214|NCT00840411|592743998|FG000|First Intervention|Adverse Event|1|||
164104215|NCT00840411|592743999|FG001|First Intervention|Adverse Event|0|||
164104216|NCT00840411|592743998|FG000|Washout|Withdrawal by Subject|1|||
164104217|NCT00840411|592743999|FG001|Washout|Withdrawal by Subject|0|||
164104218|NCT01576042|592744001|FG000|Overall Study|Physician Decision|2|||
164104219|NCT01576042|592744002|FG001|Overall Study|Physician Decision|0|||
164065297|NCT05553600|592602124|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
164065298|NCT05553600|592602125|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
164065299|NCT05553600|592602126|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
164065300|NCT05553600|592602127|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
164065301|NCT05553600|592602124|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
164065302|NCT05553600|592602125|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
164065303|NCT05553600|592602126|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
164065304|NCT05553600|592602127|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
164104220|NCT03233724|592744003|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164104221|NCT03233724|592744004|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164104222|NCT03233724|592744005|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164104223|NCT03233724|592744006|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
164104224|NCT03233724|592744007|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
164104225|NCT03233724|592744003|FG000|Phase I Dose Escalation|Best interest of participant|1|||
164104226|NCT03233724|592744004|FG001|Phase I Dose Escalation|Best interest of participant|1|||
164104227|NCT03233724|592744005|FG002|Phase I Dose Escalation|Best interest of participant|1|||
164104228|NCT03233724|592744006|FG003|Phase I Dose Escalation|Best interest of participant|0|||
164065305|NCT05553600|592602124|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
164065306|NCT05553600|592602125|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
164065307|NCT05553600|592602126|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
164065308|NCT05553600|592602127|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
164065309|NCT05553600|592602124|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
164065310|NCT05553600|592602125|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
164065311|NCT05553600|592602126|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
164065312|NCT05553600|592602127|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
164065313|NCT05553600|592602124|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
164065314|NCT05553600|592602125|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
164065315|NCT05553600|592602126|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
164065316|NCT05553600|592602127|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
164065317|NCT05553600|592602124|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
164065318|NCT05553600|592602125|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
164065319|NCT05553600|592602126|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
164065320|NCT05553600|592602127|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
164065321|NCT05553600|592602124|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
164065322|NCT05553600|592602125|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
164065323|NCT05553600|592602126|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
164065324|NCT05553600|592602127|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
164065325|NCT05553600|592602124|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
164065326|NCT05553600|592602125|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
164065327|NCT05553600|592602126|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
164065328|NCT05553600|592602127|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
164065329|NCT05027958|592602130|FG000|Overall Study|Lost to Follow-up|1|||
164065330|NCT05027958|592602131|FG001|Overall Study|Lost to Follow-up|1|||
164065331|NCT05027958|592602130|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
164065332|NCT05027958|592602131|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
164065333|NCT05027958|592602130|FG000|Overall Study|Physician Decision|1|||
164065334|NCT05027958|592602131|FG001|Overall Study|Physician Decision|4|||
164065335|NCT05027958|592602130|FG000|Overall Study|Adverse Event|0|||
164065336|NCT05027958|592602131|FG001|Overall Study|Adverse Event|1|||
164065337|NCT03155269|592602132|FG000|Overall Study|Withdrawal by Subject|4|||
164065338|NCT03155269|592602133|FG001|Overall Study|Withdrawal by Subject|5|||
164065339|NCT03155269|592602132|FG000|Overall Study|Lost to Follow-up|1|||
164065340|NCT03155269|592602133|FG001|Overall Study|Lost to Follow-up|2|||
164065341|NCT02871921|592602134|FG000|Overall Study|Withdrawal by Subject|34|||
164065342|NCT02871921|592602135|FG001|Overall Study|Withdrawal by Subject|27|||
164065343|NCT02871921|592602136|FG002|Overall Study|Withdrawal by Subject|27|||
164065344|NCT02871921|592602137|FG003|Overall Study|Withdrawal by Subject|30|||
164065345|NCT00910000|592602138|FG000|Overall Study|Adverse Event|0|||
164065346|NCT00910000|592602139|FG001|Overall Study|Adverse Event|3|||
164065347|NCT00910000|592602140|FG002|Overall Study|Adverse Event|2|||
164065348|NCT00910000|592602141|FG003|Overall Study|Adverse Event|2|||
164065349|NCT00910000|592602142|FG004|Overall Study|Adverse Event|0|||
164065350|NCT00910000|592602143|FG005|Overall Study|Adverse Event|1|||
164065351|NCT00910000|592602138|FG000|Overall Study|Withdrawal by Subject|0|||
164065352|NCT00910000|592602139|FG001|Overall Study|Withdrawal by Subject|0|||
164065353|NCT00910000|592602140|FG002|Overall Study|Withdrawal by Subject|1|||
164065354|NCT00910000|592602141|FG003|Overall Study|Withdrawal by Subject|0|||
164065355|NCT00910000|592602142|FG004|Overall Study|Withdrawal by Subject|1|||
164065356|NCT00910000|592602143|FG005|Overall Study|Withdrawal by Subject|0|||
164065357|NCT00337727|592602145|FG000|Overall Study|Adverse Event|5|||
164065358|NCT00337727|592602146|FG001|Overall Study|Adverse Event|3|||
164065359|NCT00337727|592602145|FG000|Overall Study|Lost to Follow-up|5|||
164065360|NCT00337727|592602146|FG001|Overall Study|Lost to Follow-up|4|||
164065361|NCT00337727|592602145|FG000|Overall Study|Physician Decision|1|||
164065362|NCT00337727|592602146|FG001|Overall Study|Physician Decision|0|||
164065363|NCT00337727|592602145|FG000|Overall Study|Protocol Violation|4|||
164065364|NCT00337727|592602146|FG001|Overall Study|Protocol Violation|0|||
164065365|NCT00337727|592602145|FG000|Overall Study|Withdrawal by Subject|3|||
164065366|NCT00337727|592602146|FG001|Overall Study|Withdrawal by Subject|5|||
164065367|NCT04456998|592602151|FG000|Overall Study|Adverse Event|0|||
164065368|NCT04456998|592602152|FG001|Overall Study|Adverse Event|4|||
164065369|NCT04456998|592602151|FG000|Overall Study|Protocol Deviation|0|||
164065370|NCT04456998|592602152|FG001|Overall Study|Protocol Deviation|1|||
164065371|NCT04456998|592602151|FG000|Overall Study|Withdrawal by Subject|0|||
164065372|NCT04456998|592602152|FG001|Overall Study|Withdrawal by Subject|1|||
164065373|NCT03707145|592602156|FG000|Overall Study|Lost to Follow-up|0|||
164065374|NCT03707145|592602157|FG001|Overall Study|Lost to Follow-up|1|||
164065375|NCT03707145|592602158|FG002|Overall Study|Lost to Follow-up|1|||
164065376|NCT03707145|592602159|FG003|Overall Study|Lost to Follow-up|0|||
164065377|NCT04221477|592602160|FG000|Overall Study|Adverse Event|1|||
164065378|NCT04221477|592602161|FG001|Overall Study|Adverse Event|1|||
164065379|NCT04221477|592602160|FG000|Overall Study|Death|5|||
164065380|NCT04221477|592602161|FG001|Overall Study|Death|4|||
164065381|NCT04221477|592602160|FG000|Overall Study|Lack of Efficacy|1|||
164065382|NCT04221477|592602161|FG001|Overall Study|Lack of Efficacy|2|||
164065383|NCT04221477|592602160|FG000|Overall Study|Lost to Follow-up|1|||
164065384|NCT04221477|592602161|FG001|Overall Study|Lost to Follow-up|2|||
164065385|NCT04221477|592602160|FG000|Overall Study|Non-compliance with Study Drug|1|||
164065386|NCT04221477|592602161|FG001|Overall Study|Non-compliance with Study Drug|0|||
164065387|NCT04221477|592602160|FG000|Overall Study|Reason not Specified|0|||
164065388|NCT04221477|592602161|FG001|Overall Study|Reason not Specified|5|||
164065389|NCT04221477|592602160|FG000|Overall Study|Physician Decision|0|||
164065390|NCT04221477|592602161|FG001|Overall Study|Physician Decision|6|||
164065391|NCT04221477|592602160|FG000|Overall Study|Withdrawal by Subject|10|||
164065392|NCT04221477|592602161|FG001|Overall Study|Withdrawal by Subject|14|||
164065393|NCT04221477|592602160|FG000|Overall Study|Ongoing in the Study|116|||
164065394|NCT04221477|592602161|FG001|Overall Study|Ongoing in the Study|102|||
164065395|NCT04784455|592602162|FG000|Overall Study|Death|4|||
164065396|NCT04882085|592602163|FG000|Overall Study|Death|6|||
164065397|NCT04882085|592602164|FG001|Overall Study|Death|9|||
164065398|NCT04882085|592602163|FG000|Overall Study|Withdrawal by Subject|0|||
164065399|NCT04882085|592602164|FG001|Overall Study|Withdrawal by Subject|3|||
164065400|NCT04882085|592602163|FG000|Overall Study|Randomized not treated|1|||
164065401|NCT04882085|592602164|FG001|Overall Study|Randomized not treated|0|||
164065402|NCT04455620|592602165|FG000|Overall Study|Withdrawal by Subject|0|||
164065403|NCT04455620|592602166|FG001|Overall Study|Withdrawal by Subject|0|||
164065404|NCT04455620|592602167|FG002|Overall Study|Withdrawal by Subject|2|||
164065405|NCT04455620|592602168|FG003|Overall Study|Withdrawal by Subject|0|||
164065406|NCT04455620|592602169|FG004|Overall Study|Withdrawal by Subject|1|||
164065407|NCT04455620|592602165|FG000|Overall Study|Lost to Follow-up|0|||
164065408|NCT04455620|592602166|FG001|Overall Study|Lost to Follow-up|0|||
164065409|NCT04455620|592602167|FG002|Overall Study|Lost to Follow-up|1|||
164065410|NCT04455620|592602168|FG003|Overall Study|Lost to Follow-up|1|||
164065411|NCT04455620|592602169|FG004|Overall Study|Lost to Follow-up|0|||
164065412|NCT04455620|592602165|FG000|Overall Study|Death|1|||
164065413|NCT04455620|592602166|FG001|Overall Study|Death|6|||
164065414|NCT04455620|592602167|FG002|Overall Study|Death|20|||
164065415|NCT04455620|592602168|FG003|Overall Study|Death|1|||
164065416|NCT04455620|592602169|FG004|Overall Study|Death|7|||
164065417|NCT04455620|592602165|FG000|Overall Study|Study Termination|0|||
164065418|NCT04455620|592602166|FG001|Overall Study|Study Termination|2|||
164065419|NCT04455620|592602167|FG002|Overall Study|Study Termination|1|||
164065420|NCT04455620|592602168|FG003|Overall Study|Study Termination|0|||
164065421|NCT04455620|592602169|FG004|Overall Study|Study Termination|6|||
164065422|NCT00965562|592602170|FG000|Overall Study|Lost to Follow-up|1|||
164065423|NCT00965562|592602171|FG001|Overall Study|Lost to Follow-up|2|||
164065424|NCT00965562|592602172|FG002|Overall Study|Lost to Follow-up|3|||
164065425|NCT00965562|592602170|FG000|Overall Study|Withdrawal by Subject|2|||
164065426|NCT00965562|592602171|FG001|Overall Study|Withdrawal by Subject|2|||
164065427|NCT00965562|592602172|FG002|Overall Study|Withdrawal by Subject|0|||
164065428|NCT05681715|592602173|FG000|Training Period (6-weeks)|Adverse Event|3|||
164065429|NCT05681715|592602174|FG001|Training Period (6-weeks)|Adverse Event|0|||
164065430|NCT05681715|592602175|FG002|Training Period (6-weeks)|Adverse Event|0|||
164065431|NCT05681715|592602173|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
164065432|NCT05681715|592602174|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
164065433|NCT05681715|592602175|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
164065434|NCT05681715|592602173|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
164065435|NCT05681715|592602174|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
164065436|NCT05681715|592602175|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
164065437|NCT05681715|592602173|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
164065438|NCT05681715|592602174|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
164065439|NCT05681715|592602175|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
164065440|NCT05681715|592602173|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
164065441|NCT05681715|592602174|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
164065442|NCT05681715|592602175|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
164065443|NCT05681715|592602173|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
164065444|NCT05681715|592602174|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
164065445|NCT05681715|592602175|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
164065446|NCT05681715|592602173|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
164065447|NCT05681715|592602174|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
164065448|NCT05681715|592602175|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
164104229|NCT03233724|592744007|FG004|Phase I Dose Escalation|Best interest of participant|0|||
164104230|NCT03233724|592744003|FG000|Phase I Dose Escalation|Physician Decision|0|||
164104231|NCT03233724|592744004|FG001|Phase I Dose Escalation|Physician Decision|0|||
164104232|NCT03233724|592744005|FG002|Phase I Dose Escalation|Physician Decision|1|||
164104233|NCT03233724|592744006|FG003|Phase I Dose Escalation|Physician Decision|0|||
164104234|NCT03233724|592744007|FG004|Phase I Dose Escalation|Physician Decision|0|||
164104235|NCT03233724|592744003|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164104236|NCT03233724|592744004|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164104237|NCT03233724|592744005|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
164104238|NCT03233724|592744006|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164104239|NCT03233724|592744007|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
164104240|NCT00651820|592744010|FG000|Overall Study|Lost to Follow-up|2|||
164104241|NCT01911676|592744011|FG000|Period 1 of Study|Withdrawal by Subject|4|||
164104242|NCT01911676|592744012|FG001|Period 1 of Study|Withdrawal by Subject|2|||
164104243|NCT01911676|592744013|FG002|Period 1 of Study|Withdrawal by Subject|1|||
164104244|NCT01911676|592744014|FG003|Period 1 of Study|Withdrawal by Subject|2|||
164104245|NCT01911676|592744011|FG000|Period 1 of Study|Physician Decision|2|||
164104246|NCT01911676|592744012|FG001|Period 1 of Study|Physician Decision|0|||
164104247|NCT01911676|592744013|FG002|Period 1 of Study|Physician Decision|0|||
164104248|NCT01911676|592744014|FG003|Period 1 of Study|Physician Decision|1|||
164104249|NCT01911676|592744011|FG000|Period 2 of Study|Physician Decision|2|||
164104250|NCT01911676|592744012|FG001|Period 2 of Study|Physician Decision|0|||
164104251|NCT01911676|592744013|FG002|Period 2 of Study|Physician Decision|0|||
164104252|NCT01911676|592744014|FG003|Period 2 of Study|Physician Decision|1|||
164104253|NCT01911676|592744011|FG000|Period 2 of Study|Lost to Follow-up|0|||
164104254|NCT01911676|592744012|FG001|Period 2 of Study|Lost to Follow-up|0|||
164104255|NCT01911676|592744013|FG002|Period 2 of Study|Lost to Follow-up|0|||
164104256|NCT01911676|592744014|FG003|Period 2 of Study|Lost to Follow-up|1|||
164104257|NCT00773253|592744015|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
164104258|NCT00773253|592744016|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
164104259|NCT00657553|592744020|FG000|Overall Study|low accrual, no analysis run|5|||
164104260|NCT00657553|592744021|FG001|Overall Study|low accrual, no analysis run|5|||
164104261|NCT03173547|592744022|FG000|Overall Study|Adverse Event|2|||
164104262|NCT03173547|592744023|FG001|Overall Study|Adverse Event|0|||
164104263|NCT03173547|592744022|FG000|Overall Study|Withdrawal by Subject|2|||
164104264|NCT03173547|592744023|FG001|Overall Study|Withdrawal by Subject|2|||
164104265|NCT01566721|592744024|FG000|Treatment Period|Withdrawal by Subject|35|||
164104266|NCT01566721|592744025|FG001|Treatment Period|Withdrawal by Subject|9|||
164104267|NCT01566721|592744024|FG000|Treatment Period|Disease Progression/Recurrence|37|||
164104268|NCT01566721|592744025|FG001|Treatment Period|Disease Progression/Recurrence|13|||
164104269|NCT01566721|592744024|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
164104270|NCT01566721|592744025|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
164104271|NCT01566721|592744024|FG000|Treatment Period|Other|13|||
164104272|NCT01566721|592744025|FG001|Treatment Period|Other|2|||
164104273|NCT01566721|592744024|FG000|Treatment Period|Lack of Compliance|5|||
164104274|NCT01566721|592744025|FG001|Treatment Period|Lack of Compliance|1|||
164104275|NCT01566721|592744024|FG000|Treatment Period|Adverse Event|100|||
164104276|NCT01566721|592744025|FG001|Treatment Period|Adverse Event|30|||
164104277|NCT01566721|592744024|FG000|Treatment Period|Pregnancy|1|||
164104278|NCT01566721|592744025|FG001|Treatment Period|Pregnancy|0|||
164104279|NCT01566721|592744024|FG000|Safety Follow-up|Physician Decision|6|||
164104280|NCT01566721|592744025|FG001|Safety Follow-up|Physician Decision|4|||
164104281|NCT01566721|592744024|FG000|Safety Follow-up|Lost to Follow-up|101|||
164104282|NCT01566721|592744025|FG001|Safety Follow-up|Lost to Follow-up|48|||
164104283|NCT01566721|592744024|FG000|Safety Follow-up|Withdrawal by Subject|155|||
164104284|NCT01566721|592744025|FG001|Safety Follow-up|Withdrawal by Subject|49|||
164104285|NCT01566721|592744024|FG000|Safety Follow-up|Death|28|||
164065449|NCT05681715|592602173|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
164065450|NCT05681715|592602174|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
164065451|NCT05681715|592602175|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
164104286|NCT01566721|592744025|FG001|Safety Follow-up|Death|4|||
164104287|NCT01566721|592744024|FG000|Safety Follow-up|Non-compliance|7|||
164065452|NCT05455684|592602176|FG000|Overall Study|Withdrawal by Subject|7|||
164065453|NCT05455684|592602177|FG001|Overall Study|Withdrawal by Subject|4|||
164065454|NCT05455684|592602176|FG000|Overall Study|Lost to Follow-up|3|||
164065455|NCT05455684|592602177|FG001|Overall Study|Lost to Follow-up|3|||
164065456|NCT05455684|592602176|FG000|Overall Study|Adverse Event|2|||
164065457|NCT05455684|592602177|FG001|Overall Study|Adverse Event|3|||
164065458|NCT05455684|592602176|FG000|Overall Study|Protocol Violation|1|||
164065459|NCT05455684|592602177|FG001|Overall Study|Protocol Violation|1|||
164065460|NCT05455684|592602176|FG000|Overall Study|Non-Compliant with study drug|0|||
164065461|NCT05455684|592602177|FG001|Overall Study|Non-Compliant with study drug|1|||
164065462|NCT05455684|592602176|FG000|Overall Study|Other|1|||
164104288|NCT01566721|592744025|FG001|Safety Follow-up|Non-compliance|3|||
164104289|NCT01566721|592744024|FG000|Safety Follow-up|Protocol Violation|7|||
164104290|NCT01566721|592744025|FG001|Safety Follow-up|Protocol Violation|0|||
164104291|NCT01566721|592744024|FG000|Safety Follow-up|Site closure|2|||
164104292|NCT01566721|592744025|FG001|Safety Follow-up|Site closure|3|||
164104293|NCT01566721|592744024|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
164104294|NCT01566721|592744025|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
164104295|NCT01566721|592744024|FG000|Safety Follow-up|Missing|7|||
164104296|NCT01566721|592744025|FG001|Safety Follow-up|Missing|2|||
164104297|NCT01566721|592744024|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
164104298|NCT01566721|592744025|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
164104299|NCT01566721|592744024|FG000|Safety Follow-up|Sponsor decision|1|||
164104300|NCT01566721|592744025|FG001|Safety Follow-up|Sponsor decision|0|||
164104301|NCT01566721|592744024|FG000|Safety Follow-up|Adverse Event|8|||
164104302|NCT01566721|592744025|FG001|Safety Follow-up|Adverse Event|4|||
164104303|NCT00811655|592744031|FG000|Overall Study|Physician Decision|1|||
164104304|NCT00787254|592744033|FG000|Overall Study|Adverse Event|24|||
164065463|NCT05455684|592602177|FG001|Overall Study|Other|2|||
164065464|NCT05455684|592602176|FG000|Overall Study|Randomized but not treated|1|||
164065465|NCT05455684|592602177|FG001|Overall Study|Randomized but not treated|0|||
164065466|NCT05204563|592602178|FG000|Overall Study|Other than Specified|2|||
164065467|NCT05204563|592602179|FG001|Overall Study|Other than Specified|1|||
164065468|NCT05204563|592602178|FG000|Overall Study|Death|18|||
164065469|NCT05204563|592602179|FG001|Overall Study|Death|4|||
164065470|NCT05204563|592602178|FG000|Overall Study|Lost to Follow-up|6|||
164065471|NCT05204563|592602179|FG001|Overall Study|Lost to Follow-up|3|||
164065472|NCT05204563|592602178|FG000|Overall Study|Withdrawal by Subject|12|||
164065473|NCT05204563|592602179|FG001|Overall Study|Withdrawal by Subject|3|||
164065474|NCT05204563|592602178|FG000|Overall Study|Enrolled, Not Treated|1|||
164065475|NCT05204563|592602179|FG001|Overall Study|Enrolled, Not Treated|0|||
164065476|NCT05643573|592602180|FG000|Overall Study|Adverse Event|117|||
164065477|NCT05643573|592602181|FG001|Overall Study|Adverse Event|90|||
164065478|NCT05643573|592602180|FG000|Overall Study|Death|53|||
164065479|NCT05643573|592602181|FG001|Overall Study|Death|57|||
164065480|NCT05643573|592602180|FG000|Overall Study|Lost to Follow-up|6|||
164065481|NCT05643573|592602181|FG001|Overall Study|Lost to Follow-up|3|||
164065482|NCT05643573|592602180|FG000|Overall Study|Other|18|||
164065483|NCT05643573|592602181|FG001|Overall Study|Other|15|||
164065484|NCT05643573|592602180|FG000|Overall Study|Outcome event|64|||
164065485|NCT05643573|592602181|FG001|Overall Study|Outcome event|36|||
164065486|NCT05643573|592602180|FG000|Overall Study|Physician Decision|33|||
164065487|NCT05643573|592602181|FG001|Overall Study|Physician Decision|19|||
164065488|NCT05643573|592602180|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
164065489|NCT05643573|592602181|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
164065490|NCT05643573|592602180|FG000|Overall Study|Site terminated by sponsor|10|||
164065491|NCT05643573|592602181|FG001|Overall Study|Site terminated by sponsor|10|||
164065492|NCT05643573|592602180|FG000|Overall Study|Study terminated by sponsor|1|||
164065493|NCT05643573|592602181|FG001|Overall Study|Study terminated by sponsor|0|||
164065494|NCT05643573|592602180|FG000|Overall Study|Withdrawal by Subject|178|||
164065495|NCT05643573|592602181|FG001|Overall Study|Withdrawal by Subject|130|||
164065496|NCT02268214|592602185|FG000|Overall Study|Subject no longer meets study criteria|0|||
164065497|NCT02268214|592602186|FG001|Overall Study|Subject no longer meets study criteria|2|||
164065498|NCT02268214|592602187|FG002|Overall Study|Subject no longer meets study criteria|0|||
164065499|NCT02268214|592602185|FG000|Overall Study|Pregnancy|2|||
164104305|NCT00787254|592744034|FG001|Overall Study|Adverse Event|23|||
164104306|NCT00787254|592744033|FG000|Overall Study|Protocol Violation|26|||
164104307|NCT00787254|592744034|FG001|Overall Study|Protocol Violation|23|||
164065500|NCT02268214|592602186|FG001|Overall Study|Pregnancy|2|||
164104308|NCT00787254|592744033|FG000|Overall Study|Withdrawal by Subject|16|||
164104309|NCT00787254|592744034|FG001|Overall Study|Withdrawal by Subject|11|||
164104310|NCT00787254|592744033|FG000|Overall Study|Lack of Efficacy|4|||
164065501|NCT02268214|592602187|FG002|Overall Study|Pregnancy|1|||
164065502|NCT02268214|592602185|FG000|Overall Study|Lost to Follow-up|3|||
164065503|NCT02268214|592602186|FG001|Overall Study|Lost to Follow-up|3|||
164065504|NCT02268214|592602187|FG002|Overall Study|Lost to Follow-up|4|||
164065505|NCT02268214|592602185|FG000|Overall Study|Lack of Efficacy|1|||
164065506|NCT02268214|592602186|FG001|Overall Study|Lack of Efficacy|0|||
164104311|NCT00787254|592744034|FG001|Overall Study|Lack of Efficacy|15|||
164104312|NCT00787254|592744033|FG000|Overall Study|NSAIDs discontinuation|1|||
164104313|NCT00787254|592744034|FG001|Overall Study|NSAIDs discontinuation|2|||
164104314|NCT00787254|592744033|FG000|Overall Study|Institution closed|1|||
164104315|NCT00787254|592744034|FG001|Overall Study|Institution closed|0|||
164104316|NCT00787254|592744033|FG000|Overall Study|Physician Decision|4|||
164104317|NCT00787254|592744034|FG001|Overall Study|Physician Decision|8|||
164104318|NCT00119015|592744037|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
164065507|NCT02268214|592602187|FG002|Overall Study|Lack of Efficacy|2|||
164065508|NCT02268214|592602185|FG000|Overall Study|Adverse Event|11|||
164065509|NCT02268214|592602186|FG001|Overall Study|Adverse Event|14|||
164065510|NCT02268214|592602187|FG002|Overall Study|Adverse Event|9|||
164065511|NCT02268214|592602185|FG000|Overall Study|Withdrawal by Subject|4|||
164104319|NCT00119015|592744038|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
164104320|NCT00119015|592744039|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
164104321|NCT05776901|592745447|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
164104322|NCT01958294|592745451|FG000|Overall Study|Clinical Circumstances|2|||
164104323|NCT05265624|592745452|FG000|Overall Study|Lost to Follow-up|3|||
164104324|NCT05265624|592745453|FG001|Overall Study|Lost to Follow-up|0|||
164104325|NCT05265624|592745452|FG000|Overall Study|Withdrawal by Subject|1|||
164104326|NCT05265624|592745453|FG001|Overall Study|Withdrawal by Subject|0|||
164104327|NCT06144424|592745462|FG000|Overall Study|Withdrawal by Subject|2|||
164104328|NCT06144424|592745463|FG001|Overall Study|Withdrawal by Subject|0|||
164104329|NCT06144424|592745462|FG000|Overall Study|Incarceration|1|||
164104330|NCT06144424|592745463|FG001|Overall Study|Incarceration|0|||
164104331|NCT06284525|592745465|FG000|Overall Study|Withdrawal by Subject|1|||
164104332|NCT00834522|592745466|FG000|Washout|Adverse Event|1|||
164104333|NCT00834522|592745467|FG001|Washout|Adverse Event|0|||
164104334|NCT00834522|592745466|FG000|Washout|Withdrawal by Subject|2|||
164104335|NCT00834522|592745467|FG001|Washout|Withdrawal by Subject|1|||
164104336|NCT03165994|592745468|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
164104337|NCT03165994|592745468|FG000|Overall Study|Death|2|||
164104338|NCT03165994|592745468|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
164104339|NCT03165994|592745468|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
164104340|NCT03165994|592745468|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
164104341|NCT03165994|592745468|FG000|Overall Study|Miscellaneous|1|||
164104342|NCT00519194|592745469|FG000|Overall Study|Withdrawal by Subject|9|||
164104343|NCT00519194|592745469|FG000|Overall Study|Death|9|||
164104344|NCT00519194|592745469|FG000|Overall Study|Lost to Follow-up|3|||
164104345|NCT01111461|592745470|FG000|Overall Study|Adverse Event|32|||
164104346|NCT01111461|592745470|FG000|Overall Study|Participant choice|11|||
164104347|NCT01111461|592745470|FG000|Overall Study|Lost to Follow-up|1|||
164104348|NCT01111461|592745470|FG000|Overall Study|Withdrawal by Subject|1|||
164104349|NCT01111461|592745470|FG000|Overall Study|Other|6|||
164065512|NCT02268214|592602186|FG001|Overall Study|Withdrawal by Subject|5|||
164065513|NCT02268214|592602187|FG002|Overall Study|Withdrawal by Subject|10|||
164065514|NCT02268214|592602185|FG000|Overall Study|Subject request to discontinue treatment|10|||
164065515|NCT02268214|592602186|FG001|Overall Study|Subject request to discontinue treatment|8|||
164065516|NCT02268214|592602187|FG002|Overall Study|Subject request to discontinue treatment|6|||
164065517|NCT02268214|592602185|FG000|Overall Study|Poor/non-compliance|2|||
164065518|NCT02268214|592602186|FG001|Overall Study|Poor/non-compliance|1|||
164065519|NCT02268214|592602187|FG002|Overall Study|Poor/non-compliance|2|||
164065520|NCT02268214|592602185|FG000|Overall Study|Other reasons|7|||
164065521|NCT02268214|592602186|FG001|Overall Study|Other reasons|3|||
164065522|NCT02268214|592602187|FG002|Overall Study|Other reasons|3|||
164065523|NCT02268214|592602185|FG000|Overall Study|Not entering long-term period|2|||
164065524|NCT02268214|592602186|FG001|Overall Study|Not entering long-term period|3|||
164065525|NCT02268214|592602187|FG002|Overall Study|Not entering long-term period|5|||
164065526|NCT02951130|592602188|FG000|Overall Study|Protocol Violation|1|||
164065527|NCT02951130|592602189|FG001|Overall Study|Protocol Violation|1|||
164065528|NCT02500732|592602191|FG000|Overall Study|Physician Decision|0|||
164065529|NCT02500732|592602192|FG001|Overall Study|Physician Decision|1|||
164065530|NCT01233284|592602202|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
164065531|NCT01233284|592602203|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164065532|NCT01233284|592602204|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164065533|NCT01233284|592602205|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164065534|NCT01233284|592602206|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
164065535|NCT01233284|592602202|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164065536|NCT01233284|592602203|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
164065537|NCT01233284|592602204|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164065538|NCT01233284|592602205|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164065539|NCT01233284|592602206|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
164104350|NCT03600805|592745483|FG000|Overall Study|Adverse Event|2|||
164104351|NCT03600805|592745484|FG001|Overall Study|Adverse Event|1|||
164104352|NCT03600805|592745485|FG002|Overall Study|Adverse Event|1|||
164104353|NCT03600805|592745486|FG003|Overall Study|Adverse Event|7|||
164104354|NCT03600805|592745483|FG000|Overall Study|Lack of Efficacy|2|||
164104355|NCT03600805|592745484|FG001|Overall Study|Lack of Efficacy|1|||
164104356|NCT03600805|592745485|FG002|Overall Study|Lack of Efficacy|0|||
164104357|NCT03600805|592745486|FG003|Overall Study|Lack of Efficacy|0|||
164104358|NCT03600805|592745483|FG000|Overall Study|Withdrawal by Subject|1|||
164104359|NCT03600805|592745484|FG001|Overall Study|Withdrawal by Subject|0|||
164104360|NCT03600805|592745485|FG002|Overall Study|Withdrawal by Subject|0|||
164065540|NCT01233284|592602202|FG000|Period 1 (4 Weeks)|Other|0|||
164065541|NCT01233284|592602203|FG001|Period 1 (4 Weeks)|Other|0|||
164065542|NCT01233284|592602204|FG002|Period 1 (4 Weeks)|Other|1|||
164065543|NCT01233284|592602205|FG003|Period 1 (4 Weeks)|Other|0|||
164104361|NCT03600805|592745486|FG003|Overall Study|Withdrawal by Subject|1|||
164104362|NCT03600805|592745483|FG000|Overall Study|Other unspecified|14|||
164104363|NCT03600805|592745484|FG001|Overall Study|Other unspecified|6|||
164104364|NCT03600805|592745485|FG002|Overall Study|Other unspecified|7|||
164104365|NCT03600805|592745486|FG003|Overall Study|Other unspecified|11|||
164104366|NCT00804856|592745491|FG000|Overall Study|Progressive Disease|3|||
164104367|NCT00804856|592745492|FG001|Overall Study|Progressive Disease|2|||
164104368|NCT00804856|592745493|FG002|Overall Study|Progressive Disease|4|||
164104369|NCT00804856|592745494|FG003|Overall Study|Progressive Disease|6|||
164104370|NCT00804856|592745495|FG004|Overall Study|Progressive Disease|4|||
164104371|NCT00804856|592745496|FG005|Overall Study|Progressive Disease|1|||
164104372|NCT00804856|592745497|FG006|Overall Study|Progressive Disease|8|||
164104373|NCT00804856|592745498|FG007|Overall Study|Progressive Disease|2|||
164104374|NCT00804856|592745499|FG008|Overall Study|Progressive Disease|4|||
164104375|NCT00804856|592745500|FG009|Overall Study|Progressive Disease|5|||
164104376|NCT00804856|592745501|FG010|Overall Study|Progressive Disease|12|||
164104377|NCT00804856|592745502|FG011|Overall Study|Progressive Disease|2|||
164104378|NCT00804856|592745503|FG012|Overall Study|Progressive Disease|2|||
164104379|NCT00804856|592745504|FG013|Overall Study|Progressive Disease|26|||
164104380|NCT00804856|592745505|FG014|Overall Study|Progressive Disease|20|||
164104381|NCT00804856|592745491|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104382|NCT00804856|592745492|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104383|NCT00804856|592745493|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104384|NCT00804856|592745494|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104385|NCT00804856|592745495|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164104386|NCT00804856|592745496|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104387|NCT00804856|592745497|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104388|NCT00804856|592745498|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104389|NCT00804856|592745499|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104390|NCT00804856|592745500|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104391|NCT00804856|592745501|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104392|NCT00804856|592745502|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104393|NCT00804856|592745503|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104394|NCT00804856|592745504|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
164104395|NCT00804856|592745505|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
164104396|NCT00804856|592745491|FG000|Overall Study|Other Adverse Event|1|||
164104397|NCT00804856|592745492|FG001|Overall Study|Other Adverse Event|1|||
164104398|NCT00804856|592745493|FG002|Overall Study|Other Adverse Event|1|||
164104399|NCT00804856|592745494|FG003|Overall Study|Other Adverse Event|2|||
164104400|NCT00804856|592745495|FG004|Overall Study|Other Adverse Event|2|||
164104401|NCT00804856|592745496|FG005|Overall Study|Other Adverse Event|1|||
164104402|NCT00804856|592745497|FG006|Overall Study|Other Adverse Event|3|||
164104403|NCT00804856|592745498|FG007|Overall Study|Other Adverse Event|0|||
164104404|NCT00804856|592745499|FG008|Overall Study|Other Adverse Event|0|||
164065544|NCT01233284|592602206|FG004|Period 1 (4 Weeks)|Other|0|||
164065545|NCT01233284|592602202|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164065546|NCT01233284|592602203|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164065547|NCT01233284|592602204|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
164065548|NCT01233284|592602205|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164065549|NCT01233284|592602206|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
164065550|NCT01233284|592602202|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164065551|NCT01233284|592602203|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164065552|NCT01233284|592602204|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
164065553|NCT01233284|592602205|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164065554|NCT01233284|592602206|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
164065555|NCT01233284|592602202|FG000|Period 3 (4 Weeks)|Other|0|||
164104405|NCT00804856|592745500|FG009|Overall Study|Other Adverse Event|1|||
164104406|NCT00804856|592745501|FG010|Overall Study|Other Adverse Event|5|||
164104407|NCT00804856|592745502|FG011|Overall Study|Other Adverse Event|2|||
164104408|NCT00804856|592745503|FG012|Overall Study|Other Adverse Event|0|||
164104409|NCT00804856|592745504|FG013|Overall Study|Other Adverse Event|6|||
164104410|NCT00804856|592745505|FG014|Overall Study|Other Adverse Event|13|||
164104411|NCT00804856|592745491|FG000|Overall Study|Non compliance with protocol|0|||
164104412|NCT00804856|592745492|FG001|Overall Study|Non compliance with protocol|0|||
164104413|NCT00804856|592745493|FG002|Overall Study|Non compliance with protocol|0|||
164104414|NCT00804856|592745494|FG003|Overall Study|Non compliance with protocol|0|||
164104415|NCT00804856|592745495|FG004|Overall Study|Non compliance with protocol|0|||
164104416|NCT00804856|592745496|FG005|Overall Study|Non compliance with protocol|0|||
164104417|NCT00804856|592745497|FG006|Overall Study|Non compliance with protocol|0|||
164104418|NCT00804856|592745498|FG007|Overall Study|Non compliance with protocol|0|||
164104419|NCT00804856|592745499|FG008|Overall Study|Non compliance with protocol|0|||
164104420|NCT00804856|592745500|FG009|Overall Study|Non compliance with protocol|0|||
164104421|NCT00804856|592745501|FG010|Overall Study|Non compliance with protocol|0|||
164104422|NCT00804856|592745502|FG011|Overall Study|Non compliance with protocol|0|||
164104423|NCT00804856|592745503|FG012|Overall Study|Non compliance with protocol|0|||
164065556|NCT01233284|592602203|FG001|Period 3 (4 Weeks)|Other|0|||
164104424|NCT00804856|592745504|FG013|Overall Study|Non compliance with protocol|2|||
164104425|NCT00804856|592745505|FG014|Overall Study|Non compliance with protocol|0|||
164104426|NCT00804856|592745491|FG000|Overall Study|Refused to continue medication|0|||
164104427|NCT00804856|592745492|FG001|Overall Study|Refused to continue medication|0|||
164104428|NCT00804856|592745493|FG002|Overall Study|Refused to continue medication|0|||
164104429|NCT00804856|592745494|FG003|Overall Study|Refused to continue medication|1|||
164065557|NCT01233284|592602204|FG002|Period 3 (4 Weeks)|Other|0|||
164065558|NCT01233284|592602205|FG003|Period 3 (4 Weeks)|Other|1|||
164065559|NCT01233284|592602206|FG004|Period 3 (4 Weeks)|Other|0|||
164104430|NCT00804856|592745495|FG004|Overall Study|Refused to continue medication|1|||
164104431|NCT00804856|592745496|FG005|Overall Study|Refused to continue medication|0|||
164104432|NCT00804856|592745497|FG006|Overall Study|Refused to continue medication|0|||
164104433|NCT00804856|592745498|FG007|Overall Study|Refused to continue medication|0|||
164104434|NCT00804856|592745499|FG008|Overall Study|Refused to continue medication|0|||
164104435|NCT00804856|592745500|FG009|Overall Study|Refused to continue medication|0|||
164104436|NCT00804856|592745501|FG010|Overall Study|Refused to continue medication|3|||
164104437|NCT00804856|592745502|FG011|Overall Study|Refused to continue medication|0|||
164104438|NCT00804856|592745503|FG012|Overall Study|Refused to continue medication|1|||
164104439|NCT00804856|592745504|FG013|Overall Study|Refused to continue medication|1|||
164104440|NCT00804856|592745505|FG014|Overall Study|Refused to continue medication|5|||
164104441|NCT00804856|592745491|FG000|Overall Study|Other reason than listed above|0|||
164104442|NCT00804856|592745492|FG001|Overall Study|Other reason than listed above|0|||
164104443|NCT00804856|592745493|FG002|Overall Study|Other reason than listed above|0|||
164104444|NCT00804856|592745494|FG003|Overall Study|Other reason than listed above|0|||
164104445|NCT00804856|592745495|FG004|Overall Study|Other reason than listed above|0|||
164104446|NCT00804856|592745496|FG005|Overall Study|Other reason than listed above|1|||
164104447|NCT00804856|592745497|FG006|Overall Study|Other reason than listed above|0|||
164104448|NCT00804856|592745498|FG007|Overall Study|Other reason than listed above|0|||
164104449|NCT00804856|592745499|FG008|Overall Study|Other reason than listed above|1|||
164104450|NCT00804856|592745500|FG009|Overall Study|Other reason than listed above|0|||
164104451|NCT00804856|592745501|FG010|Overall Study|Other reason than listed above|3|||
164104452|NCT00804856|592745502|FG011|Overall Study|Other reason than listed above|1|||
164104453|NCT00804856|592745503|FG012|Overall Study|Other reason than listed above|1|||
164104454|NCT00804856|592745504|FG013|Overall Study|Other reason than listed above|10|||
164104455|NCT00804856|592745505|FG014|Overall Study|Other reason than listed above|3|||
164104456|NCT03343535|592745506|FG000|Overall Study|Lost to Follow-up|1|||
164104457|NCT03343535|592745506|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
164104458|NCT03343535|592745506|FG000|Overall Study|Death|12|||
164104459|NCT03415308|592745511|FG000|Overall Study|Lost to Follow-up|0|||
164104460|NCT03415308|592745512|FG001|Overall Study|Lost to Follow-up|0|||
164104461|NCT03415308|592745513|FG002|Overall Study|Lost to Follow-up|1|||
164104462|NCT03415308|592745511|FG000|Overall Study|Scheduling Conflicts|0|||
164104463|NCT03415308|592745512|FG001|Overall Study|Scheduling Conflicts|0|||
164104464|NCT03415308|592745513|FG002|Overall Study|Scheduling Conflicts|7|||
164104465|NCT01471353|592745516|FG000|Overall Study|remain on study|3|||
164104466|NCT03123094|592745518|FG000|Overall Study|Withdrawal by Subject|0|||
164104467|NCT03123094|592745519|FG001|Overall Study|Withdrawal by Subject|2|||
164104468|NCT03123094|592745520|FG002|Overall Study|Withdrawal by Subject|1|||
164104469|NCT03123094|592745521|FG003|Overall Study|Withdrawal by Subject|0|||
164104470|NCT03123094|592745522|FG004|Overall Study|Withdrawal by Subject|1|||
164104471|NCT04238754|592745528|FG000|Washout - 1 Week|Lost to Follow-up|1|||
164104472|NCT04238754|592745529|FG001|Washout - 1 Week|Lost to Follow-up|0|||
164104473|NCT01444378|592745534|FG000|Overall Study|Lost to Follow-up|1|||
164104474|NCT01444378|592745534|FG000|Overall Study|Withdrawal by Subject|1|||
164104475|NCT01444378|592745534|FG000|Overall Study|Death|3|||
164104476|NCT01444378|592745534|FG000|Overall Study|Administrative Closure Of The Study|2|||
164104477|NCT01444378|592745534|FG000|Overall Study|Missed Visits|10|||
164104478|NCT00705666|592745535|FG000|Overall Study|No post-treatment questionnaire|279|||
164104479|NCT00705666|592745535|FG000|Overall Study|Withdrawal by Subject|21|||
164104480|NCT00705666|592745535|FG000|Overall Study|Physician Decision|7|||
164104481|NCT00705666|592745535|FG000|Overall Study|Lost to Follow-up|5|||
164104482|NCT00705666|592745535|FG000|Overall Study|Death|1|||
164104483|NCT00705666|592745535|FG000|Overall Study|Adverse Event|4|||
164104484|NCT00705666|592745535|FG000|Overall Study|Other|12|||
164065560|NCT01233284|592602202|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
164065561|NCT01233284|592602203|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
164065562|NCT01233284|592602204|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
164065563|NCT01233284|592602205|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
164065564|NCT01233284|592602206|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
164065565|NCT01233284|592602202|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164065566|NCT01233284|592602203|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164104485|NCT00705666|592745535|FG000|Overall Study|Other|2|||
164104486|NCT00705666|592745535|FG000|Overall Study|Lack of data|3|||
164065567|NCT01233284|592602204|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164065568|NCT01233284|592602205|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
164065569|NCT01233284|592602206|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
164065570|NCT03759340|592602207|FG000|Overall Study|Adverse Event|2|||
164065571|NCT03759340|592602207|FG000|Overall Study|Lost to Follow-up|1|||
164065572|NCT03759340|592602207|FG000|Overall Study|Withdrawal by Subject|15|||
164065573|NCT03759340|592602207|FG000|Overall Study|Study Terminated by Sponsor|38|||
164065574|NCT01869959|592602211|FG000|Randomization Period|Physician Decision|0|||
164065575|NCT01869959|592602212|FG001|Randomization Period|Physician Decision|0|||
164065576|NCT01869959|592602213|FG002|Randomization Period|Physician Decision|0|||
164065577|NCT01869959|592602214|FG003|Randomization Period|Physician Decision|0|||
164065578|NCT01869959|592602215|FG004|Randomization Period|Physician Decision|1|||
164065579|NCT01869959|592602211|FG000|Treatment Period|Adverse Event|1|||
164065580|NCT01869959|592602212|FG001|Treatment Period|Adverse Event|0|||
164065581|NCT01869959|592602213|FG002|Treatment Period|Adverse Event|3|||
164065582|NCT01869959|592602214|FG003|Treatment Period|Adverse Event|1|||
164065583|NCT01869959|592602215|FG004|Treatment Period|Adverse Event|0|||
164065584|NCT01869959|592602211|FG000|Treatment Period|Sponsor decision|0|||
164065585|NCT01869959|592602212|FG001|Treatment Period|Sponsor decision|1|||
164065586|NCT01869959|592602213|FG002|Treatment Period|Sponsor decision|0|||
164065587|NCT01869959|592602214|FG003|Treatment Period|Sponsor decision|1|||
164065588|NCT01869959|592602215|FG004|Treatment Period|Sponsor decision|0|||
164065589|NCT01869959|592602211|FG000|Treatment Period|Withdrawal by Subject|0|||
164065590|NCT01869959|592602212|FG001|Treatment Period|Withdrawal by Subject|1|||
164065591|NCT01869959|592602213|FG002|Treatment Period|Withdrawal by Subject|0|||
164065592|NCT01869959|592602214|FG003|Treatment Period|Withdrawal by Subject|0|||
164065593|NCT01869959|592602215|FG004|Treatment Period|Withdrawal by Subject|0|||
164065594|NCT02711306|592602218|FG000|Overall Study|Withdrawal by Subject|2|||
164065595|NCT02711306|592602219|FG001|Overall Study|Withdrawal by Subject|2|||
164065596|NCT00157820|592602227|FG000|Randomized|Physician Decision|4|||
164065597|NCT00157820|592602228|FG001|Randomized|Physician Decision|2|||
164065598|NCT00157820|592602229|FG002|Randomized|Physician Decision|3|||
164065599|NCT00157820|592602227|FG000|Randomized|Withdrawal by Subject|1|||
164065600|NCT00157820|592602228|FG001|Randomized|Withdrawal by Subject|2|||
164065601|NCT00157820|592602229|FG002|Randomized|Withdrawal by Subject|3|||
164065602|NCT00157820|592602227|FG000|Randomized|Protocol Violation|2|||
164065603|NCT00157820|592602228|FG001|Randomized|Protocol Violation|1|||
164065604|NCT00157820|592602229|FG002|Randomized|Protocol Violation|2|||
164065605|NCT00157820|592602227|FG000|1st 8 Month|Death|7|||
164065606|NCT00157820|592602228|FG001|1st 8 Month|Death|8|||
164065607|NCT00157820|592602229|FG002|1st 8 Month|Death|3|||
164065608|NCT00157820|592602227|FG000|1st 8 Month|Lost to Follow-up|1|||
164065609|NCT00157820|592602228|FG001|1st 8 Month|Lost to Follow-up|2|||
164065610|NCT00157820|592602229|FG002|1st 8 Month|Lost to Follow-up|1|||
164065611|NCT00157820|592602227|FG000|1st 8 Month|Premature cross-over|0|||
164065612|NCT00157820|592602228|FG001|1st 8 Month|Premature cross-over|2|||
164065613|NCT00157820|592602229|FG002|1st 8 Month|Premature cross-over|2|||
164065614|NCT00157820|592602227|FG000|2nd 8 Months|Death|3|||
164065615|NCT00157820|592602228|FG001|2nd 8 Months|Death|1|||
164065616|NCT00157820|592602229|FG002|2nd 8 Months|Death|3|||
164065617|NCT00157820|592602227|FG000|2nd 8 Months|Lost to Follow-up|1|||
164065618|NCT00157820|592602228|FG001|2nd 8 Months|Lost to Follow-up|5|||
164065619|NCT00157820|592602229|FG002|2nd 8 Months|Lost to Follow-up|2|||
164065620|NCT00157820|592602227|FG000|2nd 8 Months|Premature cross-over|1|||
164065621|NCT00157820|592602228|FG001|2nd 8 Months|Premature cross-over|7|||
164065622|NCT00157820|592602229|FG002|2nd 8 Months|Premature cross-over|9|||
164065623|NCT01676818|592602230|FG000|Overall Study|Physician Decision|1|||
164065624|NCT01676818|592602230|FG000|Overall Study|Withdrawal by Subject|1|||
164065625|NCT02207413|592602238|FG000|Overall Study|Withdrawal by Subject|1|||
164065626|NCT02207413|592602239|FG001|Overall Study|Withdrawal by Subject|0|||
164065627|NCT02207413|592602240|FG002|Overall Study|Withdrawal by Subject|0|||
164065628|NCT02207413|592602241|FG003|Overall Study|Withdrawal by Subject|0|||
164065629|NCT02207413|592602242|FG004|Overall Study|Withdrawal by Subject|3|||
164065630|NCT02207413|592602243|FG005|Overall Study|Withdrawal by Subject|7|||
164065631|NCT02207413|592602238|FG000|Overall Study|Lost to Follow-up|0|||
164065632|NCT02207413|592602239|FG001|Overall Study|Lost to Follow-up|0|||
164065633|NCT02207413|592602240|FG002|Overall Study|Lost to Follow-up|0|||
164065634|NCT02207413|592602241|FG003|Overall Study|Lost to Follow-up|1|||
164065635|NCT02207413|592602242|FG004|Overall Study|Lost to Follow-up|1|||
164065636|NCT02207413|592602243|FG005|Overall Study|Lost to Follow-up|5|||
164065637|NCT02207413|592602238|FG000|Overall Study|Adverse Event|0|||
164065638|NCT02207413|592602239|FG001|Overall Study|Adverse Event|0|||
164065639|NCT02207413|592602240|FG002|Overall Study|Adverse Event|0|||
164065640|NCT02207413|592602241|FG003|Overall Study|Adverse Event|0|||
164065641|NCT02207413|592602242|FG004|Overall Study|Adverse Event|2|||
164065642|NCT02207413|592602243|FG005|Overall Study|Adverse Event|1|||
164065643|NCT02207413|592602238|FG000|Overall Study|Migrated/moved from study area|0|||
164065644|NCT02207413|592602239|FG001|Overall Study|Migrated/moved from study area|0|||
164065645|NCT02207413|592602240|FG002|Overall Study|Migrated/moved from study area|0|||
164065646|NCT02207413|592602241|FG003|Overall Study|Migrated/moved from study area|0|||
164065647|NCT02207413|592602242|FG004|Overall Study|Migrated/moved from study area|1|||
164104487|NCT00705666|592745535|FG000|Overall Study|Untreated|5|||
164104488|NCT02645409|592745537|FG000|Overall Study|Withdrawal by Subject|3|||
164104489|NCT02645409|592745538|FG001|Overall Study|Withdrawal by Subject|0|||
164104490|NCT02645409|592745537|FG000|Overall Study|Physician Decision|1|||
164104491|NCT02645409|592745538|FG001|Overall Study|Physician Decision|0|||
164104492|NCT03552393|592745541|FG000|Core Period|Kidney Transplant|1|||
164104493|NCT03552393|592745541|FG000|Core Period|Prohibited Medication|1|||
164104494|NCT03552393|592745541|FG000|Safety Extension Period|Kidney Transplant|4|||
164104495|NCT05646251|592745544|FG000|Overall Study|Physician Decision|1|||
164104496|NCT05646251|592745545|FG001|Overall Study|Physician Decision|0|||
164104497|NCT05646251|592745546|FG002|Overall Study|Physician Decision|2|||
164104498|NCT00465270|592745547|FG000|Overall Study|Death|7|||
164104499|NCT00465270|592745548|FG001|Overall Study|Death|11|||
164104500|NCT00465270|592745547|FG000|Overall Study|Withdrawal by Subject|34|||
164104501|NCT00465270|592745548|FG001|Overall Study|Withdrawal by Subject|78|||
164104502|NCT00465270|592745547|FG000|Overall Study|Lost to Follow-up|60|||
164104503|NCT00465270|592745548|FG001|Overall Study|Lost to Follow-up|67|||
164104504|NCT00465270|592745547|FG000|Overall Study|Investigator request|3|||
164104505|NCT00465270|592745548|FG001|Overall Study|Investigator request|4|||
164104506|NCT02388191|592745549|FG000|Overall Study|Patient did not receive IUD|1|||
164104507|NCT02388191|592745550|FG001|Overall Study|Patient did not receive IUD|0|||
164104508|NCT02530905|592745551|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
164104509|NCT02530905|592745552|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
164104510|NCT02530905|592745553|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
164104511|NCT01136174|592745554|FG000|Overall Study|Adverse Event|0|||
164104512|NCT01136174|592745555|FG001|Overall Study|Adverse Event|0|||
164104513|NCT01136174|592745556|FG002|Overall Study|Adverse Event|0|||
164104514|NCT01136174|592745557|FG003|Overall Study|Adverse Event|4|||
164104515|NCT01249651|592745560|FG000|Overall Study|Withdrawal by Subject|4|||
164104516|NCT01249651|592745560|FG000|Overall Study|Adverse Event|1|||
164104517|NCT01249651|592745560|FG000|Overall Study|Protocol Violation|1|||
164104518|NCT01249651|592745560|FG000|Overall Study|Sponsor Decision|1|||
164104519|NCT03873272|592745567|FG000|Overall Study|Withdrawal by Subject|2|||
164104520|NCT03873272|592745568|FG001|Overall Study|Withdrawal by Subject|0|||
164104521|NCT03873272|592745569|FG002|Overall Study|Withdrawal by Subject|1|||
164104522|NCT03873272|592745567|FG000|Overall Study|Death|0|||
164104523|NCT03873272|592745568|FG001|Overall Study|Death|2|||
164104524|NCT03873272|592745569|FG002|Overall Study|Death|1|||
164104525|NCT03761173|592745570|FG000|Overall Study|Lost to Follow-up|93|||
164104526|NCT03761173|592745570|FG000|Overall Study|Withdrawal by Subject|74|||
164104527|NCT03761173|592745570|FG000|Overall Study|Death|45|||
164104528|NCT03761173|592745570|FG000|Overall Study|Withdrawal for Other Reasons|29|||
164104529|NCT03761173|592745570|FG000|Overall Study|Protocol Violation|1|||
164104530|NCT00316186|592745572|FG000|Overall Study|Adverse Event|6|||
164104531|NCT00316186|592745572|FG000|Overall Study|Disease Progression|4|||
164104532|NCT00316186|592745572|FG000|Overall Study|Lost to Follow-up|1|||
164104533|NCT00316186|592745572|FG000|Overall Study|Other|1|||
164104534|NCT01802320|592745574|FG000|Overall Study|Death|1|||
164104535|NCT01802320|592745574|FG000|Overall Study|Withdrawal by Subject|1|||
164104536|NCT00199901|592746792|FG000|Overall Study|Protocol Violation|2|||
164065648|NCT02207413|592602243|FG005|Overall Study|Migrated/moved from study area|0|||
164065649|NCT04075656|592602244|FG000|Overall Study|Withdrawal by Subject|5|||
164065650|NCT04075656|592602245|FG001|Overall Study|Withdrawal by Subject|5|||
164065651|NCT01519635|592604078|FG000|Overall Study|Withdrawal by Subject|0|||
164065652|NCT01519635|592604079|FG001|Overall Study|Withdrawal by Subject|1|||
164065653|NCT01519635|592604078|FG000|Overall Study|No possibility to put a catheter|1|||
164065654|NCT01519635|592604079|FG001|Overall Study|No possibility to put a catheter|2|||
164065655|NCT00347776|592604080|FG000|1.5 Month Follow-up|Death|2|||
164065656|NCT00347776|592604081|FG001|1.5 Month Follow-up|Death|0|||
164065657|NCT00347776|592604082|FG002|1.5 Month Follow-up|Death|0|||
164065658|NCT00347776|592604080|FG000|1.5 Month Follow-up|reached the endpoint|12|||
164065659|NCT00347776|592604081|FG001|1.5 Month Follow-up|reached the endpoint|8|||
164065660|NCT00347776|592604082|FG002|1.5 Month Follow-up|reached the endpoint|12|||
164065661|NCT00347776|592604080|FG000|6 Month Follow-up|Death|2|||
164065662|NCT00347776|592604081|FG001|6 Month Follow-up|Death|1|||
164065663|NCT00347776|592604082|FG002|6 Month Follow-up|Death|3|||
164065664|NCT00347776|592604080|FG000|6 Month Follow-up|reached endpont|20|||
164065665|NCT00347776|592604081|FG001|6 Month Follow-up|reached endpont|12|||
164065666|NCT00347776|592604082|FG002|6 Month Follow-up|reached endpont|15|||
164065667|NCT00347776|592604080|FG000|12 Month Follow-up|Lost to Follow-up|7|||
164104537|NCT00199901|592746793|FG001|Overall Study|Protocol Violation|0|||
164104538|NCT00199901|592746792|FG000|Overall Study|Withdrawal by Subject|1|||
164104539|NCT00199901|592746793|FG001|Overall Study|Withdrawal by Subject|0|||
164104540|NCT00199901|592746792|FG000|Overall Study|Progressive Disease|24|||
164104541|NCT00199901|592746793|FG001|Overall Study|Progressive Disease|24|||
164104542|NCT06137781|592746801|FG000|Baseline measurements|Lost to Follow-up|2|||
164104543|NCT06137781|592746801|FG000|Baseline measurements|Withdrawal by Subject|1|||
164104544|NCT06137781|592746801|FG000|Baseline measurements|Expedited surgery|1|||
164065668|NCT00347776|592604081|FG001|12 Month Follow-up|Lost to Follow-up|6|||
164065669|NCT00347776|592604082|FG002|12 Month Follow-up|Lost to Follow-up|6|||
164065670|NCT00347776|592604080|FG000|12 Month Follow-up|Death|3|||
164065671|NCT00347776|592604081|FG001|12 Month Follow-up|Death|4|||
164065672|NCT00347776|592604082|FG002|12 Month Follow-up|Death|4|||
164065673|NCT00347776|592604080|FG000|12 Month Follow-up|Reached endpoint|13|||
164065674|NCT00347776|592604081|FG001|12 Month Follow-up|Reached endpoint|6|||
164065675|NCT00347776|592604082|FG002|12 Month Follow-up|Reached endpoint|9|||
164065676|NCT00968539|592604083|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
164065677|NCT00968539|592604084|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
164065678|NCT02074982|592604087|FG000|Overall Study|Adverse Event|15|||
164065679|NCT02074982|592604088|FG001|Overall Study|Adverse Event|7|||
164065680|NCT02074982|592604087|FG000|Overall Study|Lack of Efficacy|6|||
164065681|NCT02074982|592604088|FG001|Overall Study|Lack of Efficacy|1|||
164065682|NCT02074982|592604087|FG000|Overall Study|Lost to Follow-up|9|||
164065683|NCT02074982|592604088|FG001|Overall Study|Lost to Follow-up|10|||
164065684|NCT02074982|592604087|FG000|Overall Study|Non-compliance with study treatment|0|||
164065685|NCT02074982|592604088|FG001|Overall Study|Non-compliance with study treatment|2|||
164065686|NCT02074982|592604087|FG000|Overall Study|Physician Decision|1|||
164065687|NCT02074982|592604088|FG001|Overall Study|Physician Decision|1|||
164065688|NCT02074982|592604087|FG000|Overall Study|Pregnancy|1|||
164065689|NCT02074982|592604088|FG001|Overall Study|Pregnancy|2|||
164065690|NCT02074982|592604087|FG000|Overall Study|Protocol deviation|4|||
164065691|NCT02074982|592604088|FG001|Overall Study|Protocol deviation|3|||
164065692|NCT02074982|592604087|FG000|Overall Study|Technical problems|0|||
164065693|NCT02074982|592604088|FG001|Overall Study|Technical problems|2|||
164065694|NCT02074982|592604087|FG000|Overall Study|Subject/guardian decision|15|||
164065695|NCT02074982|592604088|FG001|Overall Study|Subject/guardian decision|24|||
164065696|NCT02074982|592604087|FG000|Overall Study|Death|0|||
164065697|NCT02074982|592604088|FG001|Overall Study|Death|2|||
164065698|NCT02525627|592604095|FG000|Overall Study|Revision|1|||
164065699|NCT02525627|592604096|FG001|Overall Study|Revision|1|||
164065700|NCT02525627|592604095|FG000|Overall Study|Withdrawal by Subject|1|||
164065701|NCT02525627|592604096|FG001|Overall Study|Withdrawal by Subject|2|||
164065702|NCT02525627|592604095|FG000|Overall Study|Death|1|||
164065703|NCT02525627|592604096|FG001|Overall Study|Death|0|||
164065704|NCT02525627|592604095|FG000|Overall Study|Site terminated|11|||
164065705|NCT02525627|592604096|FG001|Overall Study|Site terminated|10|||
164065706|NCT01160770|592604097|FG000|Overall Study|Adverse Event|10|||
164065707|NCT01160770|592604097|FG000|Overall Study|Protocol Violation|2|||
164065708|NCT01160770|592604097|FG000|Overall Study|Subject/parent/caregiver request|33|||
164065709|NCT01160770|592604097|FG000|Overall Study|Physician Decision|1|||
164065710|NCT01160770|592604097|FG000|Overall Study|Lost to Follow-up|7|||
164065711|NCT01160770|592604097|FG000|Overall Study|Study termination or sponsor request|1|||
164065712|NCT01160770|592604097|FG000|Overall Study|Death|9|||
164065713|NCT01160770|592604097|FG000|Overall Study|Lack of Efficacy|15|||
164065714|NCT01160770|592604097|FG000|Overall Study|Other Reasons|1|||
164065715|NCT00242567|592604098|FG000|Overall Study|Adverse Event|70|||
164065716|NCT00242567|592604099|FG001|Overall Study|Adverse Event|43|||
164065717|NCT00242567|592604098|FG000|Overall Study|Disease Progression|17|||
164065718|NCT00242567|592604099|FG001|Overall Study|Disease Progression|22|||
164065719|NCT00242567|592604098|FG000|Overall Study|Symptomatic deterioration|9|||
164065720|NCT00242567|592604099|FG001|Overall Study|Symptomatic deterioration|3|||
164065721|NCT00242567|592604098|FG000|Overall Study|Lack of Efficacy|2|||
164065722|NCT00242567|592604099|FG001|Overall Study|Lack of Efficacy|2|||
164065723|NCT00242567|592604098|FG000|Overall Study|Lost to Follow-up|9|||
164065724|NCT00242567|592604099|FG001|Overall Study|Lost to Follow-up|19|||
164065725|NCT00242567|592604098|FG000|Overall Study|Withdrawal by Subject|33|||
164065726|NCT00242567|592604099|FG001|Overall Study|Withdrawal by Subject|28|||
164065727|NCT00242567|592604098|FG000|Overall Study|Protocol Violation|12|||
164065728|NCT00242567|592604099|FG001|Overall Study|Protocol Violation|12|||
164065729|NCT00242567|592604098|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
164065730|NCT00242567|592604099|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
164065731|NCT00242567|592604098|FG000|Overall Study|Other|14|||
164065732|NCT00242567|592604099|FG001|Overall Study|Other|9|||
164065733|NCT02116309|592604113|FG000|Overall Study|Lost to Follow-up|0|||
164065734|NCT02116309|592604114|FG001|Overall Study|Lost to Follow-up|1|||
164065735|NCT03292731|592604115|FG000|Overall Study|Protocol Violation|4|||
164065736|NCT03292731|592604116|FG001|Overall Study|Protocol Violation|11|||
164065737|NCT03292731|592604117|FG002|Overall Study|Protocol Violation|1|||
164065738|NCT00471237|592604118|FG000|Overall Study|Adverse Event|6|||
164065739|NCT00471237|592604119|FG001|Overall Study|Adverse Event|5|||
164065740|NCT00471237|592604120|FG002|Overall Study|Adverse Event|4|||
164065741|NCT00471237|592604121|FG003|Overall Study|Adverse Event|8|||
164065742|NCT00471237|592604122|FG004|Overall Study|Adverse Event|7|||
164065743|NCT00471237|592604123|FG005|Overall Study|Adverse Event|5|||
164065744|NCT00471237|592604124|FG006|Overall Study|Adverse Event|0|||
164065745|NCT00471237|592604118|FG000|Overall Study|Lost to Follow-up|1|||
164065746|NCT00471237|592604119|FG001|Overall Study|Lost to Follow-up|1|||
164065747|NCT00471237|592604120|FG002|Overall Study|Lost to Follow-up|0|||
164104545|NCT06137781|592746801|FG000|Intervention period|Lost to Follow-up|2|||
164104546|NCT06137781|592746801|FG000|Intervention period|Withdrawal by Subject|3|||
164104547|NCT06137781|592746801|FG000|Intervention period|Expedited surgery|1|||
164104548|NCT06137781|592746801|FG000|Intervention period|Adverse Event|1|||
164104549|NCT05014828|592746813|FG000|Overall Study|Study Completed by Sponsor|16|||
164104550|NCT05014828|592746814|FG001|Overall Study|Study Completed by Sponsor|16|||
164104551|NCT05014828|592746815|FG002|Overall Study|Study Completed by Sponsor|3|||
164104552|NCT05014828|592746816|FG003|Overall Study|Study Completed by Sponsor|3|||
164104553|NCT05014828|592746813|FG000|Overall Study|Death|11|||
164104554|NCT05014828|592746814|FG001|Overall Study|Death|6|||
164104555|NCT05014828|592746815|FG002|Overall Study|Death|0|||
164104556|NCT05014828|592746816|FG003|Overall Study|Death|0|||
164065748|NCT00471237|592604121|FG003|Overall Study|Lost to Follow-up|2|||
164065749|NCT00471237|592604122|FG004|Overall Study|Lost to Follow-up|3|||
164065750|NCT00471237|592604123|FG005|Overall Study|Lost to Follow-up|0|||
164065751|NCT00471237|592604124|FG006|Overall Study|Lost to Follow-up|0|||
164065752|NCT00471237|592604118|FG000|Overall Study|Protocol Violation|3|||
164065753|NCT00471237|592604119|FG001|Overall Study|Protocol Violation|6|||
164065754|NCT00471237|592604120|FG002|Overall Study|Protocol Violation|3|||
164065755|NCT00471237|592604121|FG003|Overall Study|Protocol Violation|2|||
164065756|NCT00471237|592604122|FG004|Overall Study|Protocol Violation|2|||
164065757|NCT00471237|592604123|FG005|Overall Study|Protocol Violation|4|||
164065758|NCT00471237|592604124|FG006|Overall Study|Protocol Violation|1|||
164065759|NCT00471237|592604118|FG000|Overall Study|Withdrawal by Subject|8|||
164065760|NCT00471237|592604119|FG001|Overall Study|Withdrawal by Subject|6|||
164065761|NCT00471237|592604120|FG002|Overall Study|Withdrawal by Subject|5|||
164065762|NCT00471237|592604121|FG003|Overall Study|Withdrawal by Subject|8|||
164065763|NCT00471237|592604122|FG004|Overall Study|Withdrawal by Subject|7|||
164065764|NCT00471237|592604123|FG005|Overall Study|Withdrawal by Subject|4|||
164065765|NCT00471237|592604124|FG006|Overall Study|Withdrawal by Subject|2|||
164065766|NCT00471237|592604118|FG000|Overall Study|Sponsor terminated study|20|||
164065767|NCT00471237|592604119|FG001|Overall Study|Sponsor terminated study|23|||
164065768|NCT00471237|592604120|FG002|Overall Study|Sponsor terminated study|19|||
164065769|NCT00471237|592604121|FG003|Overall Study|Sponsor terminated study|22|||
164065770|NCT00471237|592604122|FG004|Overall Study|Sponsor terminated study|18|||
164065771|NCT00471237|592604123|FG005|Overall Study|Sponsor terminated study|24|||
164065772|NCT00471237|592604124|FG006|Overall Study|Sponsor terminated study|0|||
164065773|NCT00471237|592604118|FG000|Overall Study|Non-compliance|0|||
164065774|NCT00471237|592604119|FG001|Overall Study|Non-compliance|1|||
164065775|NCT00471237|592604120|FG002|Overall Study|Non-compliance|0|||
164065776|NCT00471237|592604121|FG003|Overall Study|Non-compliance|1|||
164065777|NCT00471237|592604122|FG004|Overall Study|Non-compliance|0|||
164065778|NCT00471237|592604123|FG005|Overall Study|Non-compliance|0|||
164065779|NCT00471237|592604124|FG006|Overall Study|Non-compliance|0|||
164065780|NCT00471237|592604118|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
164065781|NCT00471237|592604119|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
164065782|NCT00471237|592604120|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
164065783|NCT00471237|592604121|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
164065784|NCT00471237|592604122|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
164065785|NCT00471237|592604123|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
164104557|NCT05014828|592746813|FG000|Overall Study|Lost to Follow-up|0|||
164104558|NCT05014828|592746814|FG001|Overall Study|Lost to Follow-up|0|||
164104559|NCT05014828|592746815|FG002|Overall Study|Lost to Follow-up|2|||
164104560|NCT05014828|592746816|FG003|Overall Study|Lost to Follow-up|0|||
164065786|NCT00471237|592604124|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
164065787|NCT00471237|592604118|FG000|Overall Study|Early stopping due to non-efficacy|1|||
164065788|NCT00471237|592604119|FG001|Overall Study|Early stopping due to non-efficacy|0|||
164065789|NCT00471237|592604120|FG002|Overall Study|Early stopping due to non-efficacy|0|||
164065790|NCT00471237|592604121|FG003|Overall Study|Early stopping due to non-efficacy|0|||
164065791|NCT00471237|592604122|FG004|Overall Study|Early stopping due to non-efficacy|1|||
164065792|NCT00471237|592604123|FG005|Overall Study|Early stopping due to non-efficacy|0|||
164065793|NCT00471237|592604124|FG006|Overall Study|Early stopping due to non-efficacy|0|||
164065794|NCT00471237|592604118|FG000|Overall Study|Participant planned to travel to abraod|1|||
164065795|NCT00471237|592604119|FG001|Overall Study|Participant planned to travel to abraod|0|||
164065796|NCT00471237|592604120|FG002|Overall Study|Participant planned to travel to abraod|0|||
164065797|NCT00471237|592604121|FG003|Overall Study|Participant planned to travel to abraod|0|||
164065798|NCT00471237|592604122|FG004|Overall Study|Participant planned to travel to abraod|0|||
164065799|NCT00471237|592604123|FG005|Overall Study|Participant planned to travel to abraod|1|||
164065800|NCT00471237|592604124|FG006|Overall Study|Participant planned to travel to abraod|0|||
164104561|NCT05014828|592746813|FG000|Overall Study|Miscellaneous.|0|||
164065801|NCT00471237|592604118|FG000|Overall Study|High parathyroid hormone|0|||
164065802|NCT00471237|592604119|FG001|Overall Study|High parathyroid hormone|0|||
164104562|NCT05014828|592746814|FG001|Overall Study|Miscellaneous.|1|||
164104563|NCT05014828|592746815|FG002|Overall Study|Miscellaneous.|0|||
164104564|NCT05014828|592746816|FG003|Overall Study|Miscellaneous.|0|||
164065803|NCT00471237|592604120|FG002|Overall Study|High parathyroid hormone|1|||
164065804|NCT00471237|592604121|FG003|Overall Study|High parathyroid hormone|0|||
164065805|NCT00471237|592604122|FG004|Overall Study|High parathyroid hormone|0|||
164065806|NCT00471237|592604123|FG005|Overall Study|High parathyroid hormone|0|||
164065807|NCT00471237|592604124|FG006|Overall Study|High parathyroid hormone|0|||
164065808|NCT00471237|592604118|FG000|Overall Study|Participant lost medication|0|||
164065809|NCT00471237|592604119|FG001|Overall Study|Participant lost medication|0|||
164065810|NCT00471237|592604120|FG002|Overall Study|Participant lost medication|0|||
164065811|NCT00471237|592604121|FG003|Overall Study|Participant lost medication|0|||
164065812|NCT00471237|592604122|FG004|Overall Study|Participant lost medication|1|||
164065813|NCT00471237|592604123|FG005|Overall Study|Participant lost medication|0|||
164065814|NCT00471237|592604124|FG006|Overall Study|Participant lost medication|0|||
164065815|NCT00471237|592604118|FG000|Overall Study|Administration of prohibited medicine|0|||
164065816|NCT00471237|592604119|FG001|Overall Study|Administration of prohibited medicine|0|||
164065817|NCT00471237|592604120|FG002|Overall Study|Administration of prohibited medicine|0|||
164065818|NCT00471237|592604121|FG003|Overall Study|Administration of prohibited medicine|0|||
164065819|NCT00471237|592604122|FG004|Overall Study|Administration of prohibited medicine|1|||
164065820|NCT00471237|592604123|FG005|Overall Study|Administration of prohibited medicine|0|||
164065821|NCT00471237|592604124|FG006|Overall Study|Administration of prohibited medicine|0|||
164065822|NCT00471237|592604118|FG000|Overall Study|Participant shifted residence|0|||
164065823|NCT00471237|592604119|FG001|Overall Study|Participant shifted residence|0|||
164065824|NCT00471237|592604120|FG002|Overall Study|Participant shifted residence|0|||
164065825|NCT00471237|592604121|FG003|Overall Study|Participant shifted residence|0|||
164065826|NCT00471237|592604122|FG004|Overall Study|Participant shifted residence|1|||
164065827|NCT00471237|592604123|FG005|Overall Study|Participant shifted residence|0|||
164065828|NCT00471237|592604124|FG006|Overall Study|Participant shifted residence|0|||
164065829|NCT00471237|592604118|FG000|Overall Study|Participant's decision|0|||
164065830|NCT00471237|592604119|FG001|Overall Study|Participant's decision|0|||
164065831|NCT00471237|592604120|FG002|Overall Study|Participant's decision|0|||
164065832|NCT00471237|592604121|FG003|Overall Study|Participant's decision|0|||
164065833|NCT00471237|592604122|FG004|Overall Study|Participant's decision|0|||
164065834|NCT00471237|592604123|FG005|Overall Study|Participant's decision|1|||
164065835|NCT00471237|592604124|FG006|Overall Study|Participant's decision|0|||
164065836|NCT00848965|592604125|FG000|Overall Study|Adverse Event|1|||
164065837|NCT00848965|592604125|FG000|Overall Study|Withdrawal by Subject|1|||
164065838|NCT00348348|592604126|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
164065839|NCT00348348|592604127|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
164065840|NCT00348348|592604126|FG000|Overall Study|Lack of Efficacy|1|||
164065841|NCT00348348|592604127|FG001|Overall Study|Lack of Efficacy|1|||
164065842|NCT00348348|592604126|FG000|Overall Study|Lost to Follow-up|8|||
164065843|NCT00348348|592604127|FG001|Overall Study|Lost to Follow-up|10|||
164065844|NCT00348348|592604126|FG000|Overall Study|Withdrawal by Subject|4|||
164065845|NCT00348348|592604127|FG001|Overall Study|Withdrawal by Subject|1|||
164065846|NCT00348348|592604126|FG000|Overall Study|Other|7|||
164065847|NCT00348348|592604127|FG001|Overall Study|Other|4|||
164065848|NCT00348348|592604126|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
164065849|NCT00348348|592604127|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
164065850|NCT00348348|592604126|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
164065851|NCT00348348|592604127|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
164065852|NCT00348348|592604126|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
164065853|NCT00348348|592604127|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
164065854|NCT00348348|592604126|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
164065855|NCT00348348|592604127|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
164065856|NCT00348348|592604126|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
164065857|NCT00348348|592604127|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
164065858|NCT00348348|592604126|FG000|Overall Study|Adverse event probably related to study|1|||
164065859|NCT00348348|592604127|FG001|Overall Study|Adverse event probably related to study|0|||
164065860|NCT03710824|592604128|FG000|Overall Study|Withdrawal by Subject|1|||
164065861|NCT03710824|592604128|FG000|Overall Study|Lost to Follow-up|3|||
164065862|NCT03710824|592604128|FG000|Overall Study|Adverse Event|25|||
164065863|NCT03710824|592604128|FG000|Overall Study|Treatment discontinuation|2|||
164065864|NCT01301625|592604138|FG000|Overall Study|Death|5|||
164065865|NCT01301625|592604138|FG000|Overall Study|Not Due|21|||
164065866|NCT01301625|592604138|FG000|Overall Study|Expected|8|||
164065867|NCT01301625|592604138|FG000|Overall Study|Lost to Follow-up|1|||
164065868|NCT05102162|592604144|FG000|Overall Study|Withdrawal by Subject|3|||
164065869|NCT05102162|592604145|FG001|Overall Study|Withdrawal by Subject|0|||
164065870|NCT05102162|592604144|FG000|Overall Study|Baseline cultures negative|4|||
164065871|NCT05102162|592604145|FG001|Overall Study|Baseline cultures negative|2|||
164065872|NCT05102162|592604144|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
164065873|NCT05102162|592604145|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
164065874|NCT05102162|592604144|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
164104565|NCT02682238|592746819|FG000|Overall Study|Lost to Follow-up|0|||
164065875|NCT05102162|592604145|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
164065876|NCT02181673|592604148|FG000|Up to Week 24|Adverse Event|2|||
164065877|NCT02181673|592604149|FG001|Up to Week 24|Adverse Event|0|||
164065878|NCT02181673|592604150|FG002|Up to Week 24|Adverse Event|3|||
164065879|NCT02181673|592604148|FG000|Up to Week 24|Death|1|||
164065880|NCT02181673|592604149|FG001|Up to Week 24|Death|0|||
164065881|NCT02181673|592604150|FG002|Up to Week 24|Death|0|||
164065882|NCT02181673|592604148|FG000|Up to Week 24|Lack of Efficacy|1|||
164065883|NCT02181673|592604149|FG001|Up to Week 24|Lack of Efficacy|0|||
164065884|NCT02181673|592604150|FG002|Up to Week 24|Lack of Efficacy|0|||
164065885|NCT02181673|592604148|FG000|Up to Week 24|Lost to Follow-up|1|||
164065886|NCT02181673|592604149|FG001|Up to Week 24|Lost to Follow-up|0|||
164065887|NCT02181673|592604150|FG002|Up to Week 24|Lost to Follow-up|0|||
164065888|NCT02181673|592604148|FG000|Up to Week 24|Physician Decision|0|||
164065889|NCT02181673|592604149|FG001|Up to Week 24|Physician Decision|0|||
164065890|NCT02181673|592604150|FG002|Up to Week 24|Physician Decision|3|||
164065891|NCT02181673|592604148|FG000|Up to Week 24|Withdrawal by Subject|10|||
164065892|NCT02181673|592604149|FG001|Up to Week 24|Withdrawal by Subject|0|||
164065893|NCT02181673|592604150|FG002|Up to Week 24|Withdrawal by Subject|1|||
164065894|NCT02181673|592604148|FG000|Up to Week 24|Other|2|||
164065895|NCT02181673|592604149|FG001|Up to Week 24|Other|0|||
164065896|NCT02181673|592604150|FG002|Up to Week 24|Other|3|||
164065897|NCT02181673|592604148|FG000|Up to Week 24|Randomized not Treated|0|||
164065898|NCT02181673|592604149|FG001|Up to Week 24|Randomized not Treated|0|||
164065899|NCT02181673|592604150|FG002|Up to Week 24|Randomized not Treated|1|||
164065900|NCT02181673|592604148|FG000|Week 24-Week 60|Adverse Event|0|||
164065901|NCT02181673|592604149|FG001|Week 24-Week 60|Adverse Event|4|||
164065902|NCT02181673|592604150|FG002|Week 24-Week 60|Adverse Event|10|||
164065903|NCT02181673|592604148|FG000|Week 24-Week 60|Other|0|||
164065904|NCT02181673|592604149|FG001|Week 24-Week 60|Other|2|||
164065905|NCT02181673|592604150|FG002|Week 24-Week 60|Other|1|||
164065906|NCT02181673|592604148|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
164065907|NCT02181673|592604149|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
164065908|NCT02181673|592604150|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
164065909|NCT02181673|592604148|FG000|Week 24-Week 60|Pregnancy|0|||
164065910|NCT02181673|592604149|FG001|Week 24-Week 60|Pregnancy|0|||
164065911|NCT02181673|592604150|FG002|Week 24-Week 60|Pregnancy|1|||
164065912|NCT02181673|592604148|FG000|Week 24-Week 60|Lack of Efficacy|0|||
164065913|NCT02181673|592604149|FG001|Week 24-Week 60|Lack of Efficacy|0|||
164065914|NCT02181673|592604150|FG002|Week 24-Week 60|Lack of Efficacy|1|||
164065915|NCT02181673|592604148|FG000|Week 24-Week 60|Lost to Follow-up|0|||
164065916|NCT02181673|592604149|FG001|Week 24-Week 60|Lost to Follow-up|0|||
164065917|NCT02181673|592604150|FG002|Week 24-Week 60|Lost to Follow-up|1|||
164065918|NCT02181673|592604148|FG000|Week 24-Week 60|Physician Decision|0|||
164065919|NCT02181673|592604149|FG001|Week 24-Week 60|Physician Decision|0|||
164065920|NCT02181673|592604150|FG002|Week 24-Week 60|Physician Decision|1|||
164065921|NCT00320801|592604151|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
164065922|NCT00320801|592604152|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
164065923|NCT00320801|592604153|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
164065924|NCT00320801|592604154|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
164065925|NCT00320801|592604151|FG000|Open-label Run-in Period|Adverse Event|33|||
164065926|NCT00320801|592604152|FG001|Open-label Run-in Period|Adverse Event|0|||
164065927|NCT00320801|592604153|FG002|Open-label Run-in Period|Adverse Event|0|||
164065928|NCT00320801|592604154|FG003|Open-label Run-in Period|Adverse Event|0|||
164065929|NCT00320801|592604151|FG000|Open-label Run-in Period|Administrative|10|||
164065930|NCT00320801|592604152|FG001|Open-label Run-in Period|Administrative|0|||
164065931|NCT00320801|592604153|FG002|Open-label Run-in Period|Administrative|0|||
164065932|NCT00320801|592604154|FG003|Open-label Run-in Period|Administrative|0|||
164065933|NCT00320801|592604151|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
164065934|NCT00320801|592604152|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
164065935|NCT00320801|592604153|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
164065936|NCT00320801|592604154|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
164065937|NCT00320801|592604151|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
164065938|NCT00320801|592604152|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
164065939|NCT00320801|592604153|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
164065940|NCT00320801|592604154|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
164065941|NCT00320801|592604151|FG000|Open-label Run-in Period|Did not qualify|1|||
164065942|NCT00320801|592604152|FG001|Open-label Run-in Period|Did not qualify|0|||
164065943|NCT00320801|592604153|FG002|Open-label Run-in Period|Did not qualify|0|||
164065944|NCT00320801|592604154|FG003|Open-label Run-in Period|Did not qualify|0|||
164065945|NCT00320801|592604151|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164065946|NCT00320801|592604152|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164065947|NCT00320801|592604153|FG002|Double-blind Phase|Withdrawal by Subject|1|||
164065948|NCT00320801|592604154|FG003|Double-blind Phase|Withdrawal by Subject|0|||
164065949|NCT00320801|592604151|FG000|Double-blind Phase|Adverse Event|0|||
164065950|NCT00320801|592604152|FG001|Double-blind Phase|Adverse Event|2|||
164065951|NCT00320801|592604153|FG002|Double-blind Phase|Adverse Event|8|||
164065952|NCT00320801|592604154|FG003|Double-blind Phase|Adverse Event|0|||
164104566|NCT02682238|592746820|FG001|Overall Study|Lost to Follow-up|2|||
164104567|NCT02682238|592746819|FG000|Overall Study|Withdrawal by Subject|1|||
164104568|NCT02682238|592746820|FG001|Overall Study|Withdrawal by Subject|0|||
164104569|NCT02682238|592746819|FG000|Overall Study|Adverse Event|1|||
164104570|NCT02682238|592746820|FG001|Overall Study|Adverse Event|0|||
164104571|NCT02682238|592746819|FG000|Overall Study|Non-compliance with Study Drug|1|||
164104572|NCT02682238|592746820|FG001|Overall Study|Non-compliance with Study Drug|0|||
164104573|NCT02682238|592746819|FG000|Overall Study|Non-compliance with Protocol|0|||
164104574|NCT02682238|592746820|FG001|Overall Study|Non-compliance with Protocol|2|||
164104575|NCT01370317|592746821|FG000|Overall Study|Participant withdrew consent|1|||
164104576|NCT01370317|592746822|FG001|Overall Study|Participant withdrew consent|0|||
164104577|NCT01370317|592746821|FG000|Overall Study|Protocol deviation|0|||
164104578|NCT01370317|592746822|FG001|Overall Study|Protocol deviation|1|||
164104579|NCT00075478|592746823|FG000|Overall Study|not eligible|1|||
164104580|NCT00075478|592746824|FG001|Overall Study|not eligible|0|||
164104581|NCT00075478|592746823|FG000|Overall Study|Physician Decision|0|||
164104582|NCT00075478|592746824|FG001|Overall Study|Physician Decision|1|||
164104583|NCT00824291|592746830|FG000|Overall Study|Adverse Event|15|||
164104584|NCT00824291|592746831|FG001|Overall Study|Adverse Event|6|||
164104585|NCT00824291|592746830|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
164104586|NCT00824291|592746831|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
164104587|NCT00824291|592746830|FG000|Overall Study|Lost to Follow-up|11|||
164104588|NCT00824291|592746831|FG001|Overall Study|Lost to Follow-up|9|||
164104589|NCT00824291|592746830|FG000|Overall Study|Non-compliance|1|||
164104590|NCT00824291|592746831|FG001|Overall Study|Non-compliance|1|||
164104591|NCT00824291|592746830|FG000|Overall Study|Protocol Violation|4|||
164104592|NCT00824291|592746831|FG001|Overall Study|Protocol Violation|1|||
164104593|NCT00824291|592746830|FG000|Overall Study|Withdrawal by Subject|14|||
164104594|NCT00824291|592746831|FG001|Overall Study|Withdrawal by Subject|8|||
164104595|NCT00824291|592746830|FG000|Overall Study|Lack of Efficacy|7|||
164104596|NCT00824291|592746831|FG001|Overall Study|Lack of Efficacy|8|||
164104597|NCT00824291|592746830|FG000|Overall Study|Participant on prohibited medication|1|||
164104598|NCT00824291|592746831|FG001|Overall Study|Participant on prohibited medication|0|||
164104599|NCT00123734|592746836|FG000|Overall Study|Death|3|||
164104600|NCT00123734|592746836|FG000|Overall Study|Lost to Follow-up|3|||
164104601|NCT00123734|592746836|FG000|Overall Study|Dropout|1|||
164104602|NCT00123734|592746836|FG000|Overall Study|Withdrawal by Subject|1|||
164104603|NCT00113386|592746837|FG000|Overall Study|Withdrawal by Subject|1|||
164104604|NCT00113386|592746838|FG001|Overall Study|Withdrawal by Subject|0|||
164104605|NCT00113386|592746837|FG000|Overall Study|Physician Decision|0|||
164104606|NCT00113386|592746838|FG001|Overall Study|Physician Decision|1|||
164104607|NCT00113386|592746837|FG000|Overall Study|Toxicity|3|||
164104608|NCT00113386|592746838|FG001|Overall Study|Toxicity|0|||
164104609|NCT00113386|592746837|FG000|Overall Study|Ineligible|1|||
164104610|NCT00113386|592746838|FG001|Overall Study|Ineligible|2|||
164104611|NCT00113386|592746837|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
164104612|NCT00113386|592746838|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
164104613|NCT02849457|592746839|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
164104614|NCT02849457|592746840|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
164104615|NCT02849457|592746841|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
164104616|NCT02849457|592746842|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
164104617|NCT03673670|592746844|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
164104618|NCT03673670|592746845|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164104619|NCT03673670|592746846|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164104620|NCT03673670|592746847|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164104621|NCT03673670|592746848|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164104622|NCT03673670|592746849|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
164104623|NCT03673670|592746844|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
164104624|NCT03673670|592746845|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
164104625|NCT03673670|592746846|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
164104626|NCT03673670|592746847|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
164104627|NCT03673670|592746848|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
164104628|NCT03673670|592746849|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
164104629|NCT03673670|592746844|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
164104630|NCT03673670|592746845|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
164104631|NCT03673670|592746846|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
164104632|NCT03673670|592746847|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
164104633|NCT03673670|592746848|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
164104634|NCT03673670|592746849|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
164104635|NCT03673670|592746844|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164104636|NCT03673670|592746845|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164104637|NCT03673670|592746846|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164065953|NCT00320801|592604151|FG000|Double-blind Phase|Administrative|0|||
164065954|NCT00320801|592604152|FG001|Double-blind Phase|Administrative|0|||
164065955|NCT00320801|592604153|FG002|Double-blind Phase|Administrative|4|||
164065956|NCT00320801|592604154|FG003|Double-blind Phase|Administrative|0|||
164065957|NCT00320801|592604151|FG000|Double-blind Phase|Lack of Efficacy|0|||
164065958|NCT00320801|592604152|FG001|Double-blind Phase|Lack of Efficacy|9|||
164065959|NCT00320801|592604153|FG002|Double-blind Phase|Lack of Efficacy|1|||
164065960|NCT00320801|592604154|FG003|Double-blind Phase|Lack of Efficacy|0|||
164065961|NCT00320801|592604151|FG000|Extension Phase|Withdrawal by Subject|0|||
164065962|NCT00320801|592604152|FG001|Extension Phase|Withdrawal by Subject|0|||
164065963|NCT00320801|592604153|FG002|Extension Phase|Withdrawal by Subject|0|||
164065964|NCT00320801|592604154|FG003|Extension Phase|Withdrawal by Subject|6|||
164065965|NCT00320801|592604151|FG000|Extension Phase|Adverse Event|0|||
164065966|NCT00320801|592604152|FG001|Extension Phase|Adverse Event|0|||
164065967|NCT00320801|592604153|FG002|Extension Phase|Adverse Event|0|||
164065968|NCT00320801|592604154|FG003|Extension Phase|Adverse Event|8|||
164065969|NCT00320801|592604151|FG000|Extension Phase|Administrative|0|||
164065970|NCT00320801|592604152|FG001|Extension Phase|Administrative|0|||
164065971|NCT00320801|592604153|FG002|Extension Phase|Administrative|0|||
164065972|NCT00320801|592604154|FG003|Extension Phase|Administrative|29|||
164065973|NCT00320801|592604151|FG000|Extension Phase|Lack of Efficacy|0|||
164065974|NCT00320801|592604152|FG001|Extension Phase|Lack of Efficacy|0|||
164065975|NCT00320801|592604153|FG002|Extension Phase|Lack of Efficacy|0|||
164065976|NCT00320801|592604154|FG003|Extension Phase|Lack of Efficacy|2|||
164065977|NCT00320801|592604151|FG000|Extension Phase|Lost to Follow-up|0|||
164065978|NCT00320801|592604152|FG001|Extension Phase|Lost to Follow-up|0|||
164065979|NCT00320801|592604153|FG002|Extension Phase|Lost to Follow-up|0|||
164065980|NCT00320801|592604154|FG003|Extension Phase|Lost to Follow-up|3|||
164065981|NCT00491322|592604155|FG000|Overall Study|Protocol Violation|1|||
164065982|NCT00491322|592604156|FG001|Overall Study|Protocol Violation|0|||
164065983|NCT00491322|592604155|FG000|Overall Study|Pregnancy|0|||
164065984|NCT00491322|592604156|FG001|Overall Study|Pregnancy|1|||
164065985|NCT06067191|592604159|FG000|Overall Study|Withdrawal by Subject|0|||
164065986|NCT06067191|592604160|FG001|Overall Study|Withdrawal by Subject|1|||
164065987|NCT00890409|592604164|FG000|Overall Study|Lost to Follow-up|20|||
164065988|NCT00890409|592604165|FG001|Overall Study|Lost to Follow-up|21|||
164065989|NCT03664024|592604168|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
164065990|NCT03664024|592604168|FG000|Overall Study|Lost to Follow-up|2|||
164065991|NCT03664024|592604168|FG000|Overall Study|Withdrawal by Subject|2|||
164065992|NCT03664024|592604168|FG000|Overall Study|Death|80|||
164065993|NCT01157065|592604169|FG000|Overall Study|Death|0|||
164065994|NCT01157065|592604170|FG001|Overall Study|Death|1|||
164065995|NCT02060188|592604173|FG000|Overall Study|Disease Progression|36|||
164065996|NCT02060188|592604174|FG001|Overall Study|Disease Progression|42|||
164065997|NCT02060188|592604175|FG002|Overall Study|Disease Progression|8|||
164065998|NCT02060188|592604176|FG003|Overall Study|Disease Progression|5|||
164065999|NCT02060188|592604177|FG004|Overall Study|Disease Progression|6|||
164066000|NCT02060188|592604178|FG005|Overall Study|Disease Progression|3|||
164066001|NCT02060188|592604179|FG006|Overall Study|Disease Progression|23|||
164066002|NCT02060188|592604180|FG007|Overall Study|Disease Progression|20|||
164066003|NCT02060188|592604181|FG008|Overall Study|Disease Progression|43|||
164066004|NCT02060188|592604173|FG000|Overall Study|Study Drug Toxicity|10|||
164066005|NCT02060188|592604174|FG001|Overall Study|Study Drug Toxicity|18|||
164066006|NCT02060188|592604175|FG002|Overall Study|Study Drug Toxicity|7|||
164066007|NCT02060188|592604176|FG003|Overall Study|Study Drug Toxicity|4|||
164066008|NCT02060188|592604177|FG004|Overall Study|Study Drug Toxicity|3|||
164066009|NCT02060188|592604178|FG005|Overall Study|Study Drug Toxicity|0|||
164066010|NCT02060188|592604179|FG006|Overall Study|Study Drug Toxicity|2|||
164066011|NCT02060188|592604180|FG007|Overall Study|Study Drug Toxicity|5|||
164066012|NCT02060188|592604181|FG008|Overall Study|Study Drug Toxicity|0|||
164066013|NCT02060188|592604173|FG000|Overall Study|Adverse event unrelated to study drug|2|||
164066014|NCT02060188|592604174|FG001|Overall Study|Adverse event unrelated to study drug|5|||
164066015|NCT02060188|592604175|FG002|Overall Study|Adverse event unrelated to study drug|6|||
164066016|NCT02060188|592604176|FG003|Overall Study|Adverse event unrelated to study drug|0|||
164066017|NCT02060188|592604177|FG004|Overall Study|Adverse event unrelated to study drug|1|||
164066018|NCT02060188|592604178|FG005|Overall Study|Adverse event unrelated to study drug|0|||
164066019|NCT02060188|592604179|FG006|Overall Study|Adverse event unrelated to study drug|4|||
164066020|NCT02060188|592604180|FG007|Overall Study|Adverse event unrelated to study drug|4|||
164066021|NCT02060188|592604181|FG008|Overall Study|Adverse event unrelated to study drug|1|||
164066022|NCT02060188|592604173|FG000|Overall Study|Participant request to discontinue study treatment|7|||
164066023|NCT02060188|592604174|FG001|Overall Study|Participant request to discontinue study treatment|7|||
164066024|NCT02060188|592604175|FG002|Overall Study|Participant request to discontinue study treatment|4|||
164066025|NCT02060188|592604176|FG003|Overall Study|Participant request to discontinue study treatment|0|||
164066026|NCT02060188|592604177|FG004|Overall Study|Participant request to discontinue study treatment|0|||
164066027|NCT02060188|592604178|FG005|Overall Study|Participant request to discontinue study treatment|0|||
164066028|NCT02060188|592604179|FG006|Overall Study|Participant request to discontinue study treatment|1|||
164066029|NCT02060188|592604180|FG007|Overall Study|Participant request to discontinue study treatment|1|||
164066030|NCT02060188|592604181|FG008|Overall Study|Participant request to discontinue study treatment|0|||
164066031|NCT02060188|592604173|FG000|Overall Study|Participant withdrew consent|3|||
164066032|NCT02060188|592604174|FG001|Overall Study|Participant withdrew consent|0|||
164066033|NCT02060188|592604175|FG002|Overall Study|Participant withdrew consent|0|||
164066034|NCT02060188|592604176|FG003|Overall Study|Participant withdrew consent|0|||
164066035|NCT02060188|592604177|FG004|Overall Study|Participant withdrew consent|0|||
164066036|NCT02060188|592604178|FG005|Overall Study|Participant withdrew consent|0|||
164066037|NCT02060188|592604179|FG006|Overall Study|Participant withdrew consent|0|||
164066038|NCT02060188|592604180|FG007|Overall Study|Participant withdrew consent|0|||
164066039|NCT02060188|592604181|FG008|Overall Study|Participant withdrew consent|0|||
164066040|NCT02060188|592604173|FG000|Overall Study|Maximum clinical benefit|13|||
164066041|NCT02060188|592604174|FG001|Overall Study|Maximum clinical benefit|38|||
164066042|NCT02060188|592604175|FG002|Overall Study|Maximum clinical benefit|19|||
164066043|NCT02060188|592604176|FG003|Overall Study|Maximum clinical benefit|0|||
164066044|NCT02060188|592604177|FG004|Overall Study|Maximum clinical benefit|0|||
164066045|NCT02060188|592604178|FG005|Overall Study|Maximum clinical benefit|0|||
164066046|NCT02060188|592604179|FG006|Overall Study|Maximum clinical benefit|0|||
164066047|NCT02060188|592604180|FG007|Overall Study|Maximum clinical benefit|10|||
164066048|NCT02060188|592604181|FG008|Overall Study|Maximum clinical benefit|0|||
164066049|NCT02060188|592604173|FG000|Overall Study|Other reason|3|||
164066050|NCT02060188|592604174|FG001|Overall Study|Other reason|7|||
164066051|NCT02060188|592604175|FG002|Overall Study|Other reason|0|||
164066052|NCT02060188|592604176|FG003|Overall Study|Other reason|1|||
164066053|NCT02060188|592604177|FG004|Overall Study|Other reason|0|||
164066054|NCT02060188|592604178|FG005|Overall Study|Other reason|0|||
164066055|NCT02060188|592604179|FG006|Overall Study|Other reason|0|||
164066056|NCT02060188|592604180|FG007|Overall Study|Other reason|9|||
164066057|NCT02060188|592604181|FG008|Overall Study|Other reason|0|||
164066058|NCT02060188|592604173|FG000|Overall Study|Death|0|||
164066059|NCT02060188|592604174|FG001|Overall Study|Death|1|||
164066060|NCT02060188|592604175|FG002|Overall Study|Death|0|||
164066061|NCT02060188|592604176|FG003|Overall Study|Death|0|||
164066062|NCT02060188|592604177|FG004|Overall Study|Death|0|||
164066063|NCT02060188|592604178|FG005|Overall Study|Death|0|||
164066064|NCT02060188|592604179|FG006|Overall Study|Death|0|||
164066065|NCT02060188|592604180|FG007|Overall Study|Death|1|||
164066066|NCT02060188|592604181|FG008|Overall Study|Death|0|||
164066067|NCT02060188|592604173|FG000|Overall Study|Administrative reasons by sponsor|0|||
164066068|NCT02060188|592604174|FG001|Overall Study|Administrative reasons by sponsor|1|||
164066069|NCT02060188|592604175|FG002|Overall Study|Administrative reasons by sponsor|0|||
164066070|NCT02060188|592604176|FG003|Overall Study|Administrative reasons by sponsor|0|||
164066071|NCT02060188|592604177|FG004|Overall Study|Administrative reasons by sponsor|0|||
164066072|NCT02060188|592604178|FG005|Overall Study|Administrative reasons by sponsor|0|||
164066073|NCT02060188|592604179|FG006|Overall Study|Administrative reasons by sponsor|0|||
164066074|NCT02060188|592604180|FG007|Overall Study|Administrative reasons by sponsor|0|||
164066075|NCT02060188|592604181|FG008|Overall Study|Administrative reasons by sponsor|0|||
164066076|NCT02060188|592604173|FG000|Overall Study|Lost to Follow-up|0|||
164066077|NCT02060188|592604174|FG001|Overall Study|Lost to Follow-up|0|||
164066078|NCT02060188|592604175|FG002|Overall Study|Lost to Follow-up|1|||
164066079|NCT02060188|592604176|FG003|Overall Study|Lost to Follow-up|0|||
164066080|NCT02060188|592604177|FG004|Overall Study|Lost to Follow-up|0|||
164066081|NCT02060188|592604178|FG005|Overall Study|Lost to Follow-up|0|||
164066082|NCT02060188|592604179|FG006|Overall Study|Lost to Follow-up|0|||
164066083|NCT02060188|592604180|FG007|Overall Study|Lost to Follow-up|0|||
164066084|NCT02060188|592604181|FG008|Overall Study|Lost to Follow-up|0|||
164066085|NCT03426995|592604182|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066086|NCT03426995|592604183|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066087|NCT03426995|592604184|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
164066088|NCT03426995|592604185|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066089|NCT03426995|592604186|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066090|NCT03426995|592604187|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066091|NCT03426995|592604188|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066092|NCT03426995|592604189|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066093|NCT03426995|592604190|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066094|NCT03426995|592604191|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066095|NCT03426995|592604192|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066096|NCT03426995|592604193|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066097|NCT03426995|592604194|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066098|NCT03426995|592604195|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066099|NCT03426995|592604196|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164112666|NCT00840658|592774091|FG001|Overall Study|Death|2|||
164104638|NCT03673670|592746847|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164104639|NCT03673670|592746848|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
164104640|NCT03673670|592746849|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
164104641|NCT03673670|592746844|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
164104642|NCT03673670|592746845|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
164104643|NCT03673670|592746846|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
164104644|NCT03673670|592746847|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
164104645|NCT03673670|592746848|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
164104646|NCT03673670|592746849|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
164104647|NCT03673670|592746844|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164104648|NCT03673670|592746845|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164104649|NCT03673670|592746846|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164104650|NCT03673670|592746847|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164104651|NCT03673670|592746848|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
164104652|NCT03673670|592746849|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
164104653|NCT03673670|592746844|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
164104654|NCT03673670|592746845|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
164104655|NCT03673670|592746846|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
164104656|NCT03673670|592746847|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
164104657|NCT03673670|592746848|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
164104658|NCT03673670|592746849|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
164104659|NCT01058668|592746850|FG000|Double-blind Treatment Phase|Adverse Event|8|||
164104660|NCT01058668|592746851|FG001|Double-blind Treatment Phase|Adverse Event|15|||
164104661|NCT01058668|592746852|FG002|Double-blind Treatment Phase|Adverse Event|25|||
164104662|NCT01058668|592746850|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
164104663|NCT01058668|592746851|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
164104664|NCT01058668|592746852|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
164104665|NCT01058668|592746850|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
164104666|NCT01058668|592746851|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
164104667|NCT01058668|592746852|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
164104668|NCT01058668|592746850|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
164104669|NCT01058668|592746851|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
164104670|NCT01058668|592746852|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
164104671|NCT01058668|592746850|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
164104672|NCT01058668|592746851|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
164104673|NCT01058668|592746852|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
164104674|NCT01058668|592746850|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
164104675|NCT01058668|592746851|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
164104676|NCT01058668|592746852|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
164104677|NCT01778010|592746855|FG000|Overall Study|Withdrawal by Subject|2|||
164104678|NCT01778010|592746855|FG000|Overall Study|abnormal ECG before meds|1|||
164104679|NCT01778010|592746855|FG000|Overall Study|Arrested|1|||
164104680|NCT01778010|592746855|FG000|Overall Study|rash while on placebo|1|||
164104681|NCT02159183|592746860|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
164104682|NCT02159183|592746861|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
164104683|NCT02159183|592746860|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
164104684|NCT02159183|592746861|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
164104685|NCT02159183|592746860|FG000|Analysis After the 36 Months Follow-up|Death|0|||
164066100|NCT03426995|592604197|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066101|NCT03426995|592604198|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066102|NCT03426995|592604199|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066103|NCT03426995|592604200|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
164066104|NCT03426995|592604182|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066105|NCT03426995|592604183|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066106|NCT03426995|592604184|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066107|NCT03426995|592604185|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066108|NCT03426995|592604186|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066109|NCT03426995|592604187|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
164066110|NCT03426995|592604188|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066111|NCT03426995|592604189|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066112|NCT03426995|592604190|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066113|NCT03426995|592604191|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066114|NCT03426995|592604192|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066115|NCT03426995|592604193|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164104686|NCT02159183|592746861|FG001|Analysis After the 36 Months Follow-up|Death|1|||
164104687|NCT02159183|592746860|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
164104688|NCT02159183|592746861|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
164104689|NCT02159183|592746860|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
164104690|NCT02159183|592746861|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
164104691|NCT02558491|592746863|FG000|First Invention|Withdrawal by Subject|3|||
164104692|NCT02558491|592746864|FG001|First Invention|Withdrawal by Subject|1|||
164104693|NCT02558491|592746863|FG000|First Invention|Data collection issues|1|||
164104694|NCT02558491|592746864|FG001|First Invention|Data collection issues|0|||
164104695|NCT02558491|592746863|FG000|First Invention|Stopping criteria|0|||
164104696|NCT02558491|592746864|FG001|First Invention|Stopping criteria|1|||
164104697|NCT02558491|592746863|FG000|First Invention|Changed parameters during trial|1|||
164104698|NCT02558491|592746864|FG001|First Invention|Changed parameters during trial|0|||
164104699|NCT02558491|592746863|FG000|Second Intervention|Withdrawal by Subject|1|||
164104700|NCT02558491|592746864|FG001|Second Intervention|Withdrawal by Subject|0|||
164104701|NCT02558491|592746863|FG000|Second Intervention|Stopping Criteria|1|||
164104702|NCT02558491|592746864|FG001|Second Intervention|Stopping Criteria|0|||
164104703|NCT00796328|592746865|FG000|Overall Study|experienced hypotension requiring tx|6|||
164104704|NCT03406156|592746872|FG000|Overall Study|Death|9|||
164104705|NCT03406156|592746873|FG001|Overall Study|Death|3|||
164104706|NCT03406156|592746872|FG000|Overall Study|Withdrawal by Subject|1|||
164104707|NCT03406156|592746873|FG001|Overall Study|Withdrawal by Subject|2|||
164104708|NCT03406156|592746872|FG000|Overall Study|COVID-19 infection|1|||
164104709|NCT03406156|592746873|FG001|Overall Study|COVID-19 infection|0|||
164104710|NCT03406156|592746872|FG000|Overall Study|Non-compliance with study procedures|1|||
164104711|NCT03406156|592746873|FG001|Overall Study|Non-compliance with study procedures|1|||
164104712|NCT03406156|592746872|FG000|Overall Study|Lost to Follow-up|0|||
164104713|NCT03406156|592746873|FG001|Overall Study|Lost to Follow-up|2|||
164104714|NCT03406156|592746872|FG000|Overall Study|Other, not specified|72|||
164104715|NCT03406156|592746873|FG001|Overall Study|Other, not specified|28|||
164104716|NCT05479058|592746876|FG000|Overall Study|Withdrawal by Subject|1|||
164104717|NCT05479058|592746877|FG001|Overall Study|Withdrawal by Subject|1|||
164104718|NCT05479058|592746876|FG000|Overall Study|Study terminated by sponsor|10|||
164104719|NCT05479058|592746877|FG001|Overall Study|Study terminated by sponsor|10|||
164104720|NCT05630885|592746878|FG000|Study Completion|Took prohibited medications|2|||
164104721|NCT05630885|592746879|FG001|Study Completion|Took prohibited medications|0|||
164104722|NCT05630885|592746878|FG000|Study Completion|Non-compliance with study drug|1|||
164104723|NCT05630885|592746879|FG001|Study Completion|Non-compliance with study drug|0|||
164104724|NCT05630885|592746878|FG000|Study Completion|Adverse Event|1|||
164104725|NCT05630885|592746879|FG001|Study Completion|Adverse Event|0|||
164104726|NCT05630885|592746878|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
164104727|NCT05630885|592746879|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
164104728|NCT05630885|592746878|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
164104729|NCT05630885|592746879|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
164104730|NCT03419403|592746880|FG000|Overall Study|Withdrawal by Subject|5|||
164104731|NCT03419403|592746881|FG001|Overall Study|Withdrawal by Subject|2|||
164104732|NCT03419403|592746882|FG002|Overall Study|Withdrawal by Subject|5|||
164104733|NCT03419403|592746883|FG003|Overall Study|Withdrawal by Subject|1|||
164104734|NCT03419403|592746880|FG000|Overall Study|Progressive disease (per protocol)|0|||
164104735|NCT03419403|592746881|FG001|Overall Study|Progressive disease (per protocol)|2|||
164104736|NCT03419403|592746882|FG002|Overall Study|Progressive disease (per protocol)|2|||
164104737|NCT03419403|592746883|FG003|Overall Study|Progressive disease (per protocol)|0|||
164104738|NCT03419403|592746880|FG000|Overall Study|Other, not specified|6|||
164104739|NCT03419403|592746881|FG001|Overall Study|Other, not specified|4|||
164104740|NCT03419403|592746882|FG002|Overall Study|Other, not specified|5|||
164104741|NCT03419403|592746883|FG003|Overall Study|Other, not specified|1|||
164104742|NCT03419403|592746880|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
164104743|NCT03419403|592746881|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
164104744|NCT03419403|592746882|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
164104745|NCT03419403|592746883|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
164104746|NCT03084471|592746888|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
164104747|NCT03084471|592746888|FG000|Overall Study|Condition under investigation worsened|84|||
164104748|NCT03084471|592746888|FG000|Overall Study|Lack of therapeutic response|2|||
164104749|NCT03084471|592746888|FG000|Overall Study|Protocol Violation|1|||
164104750|NCT03084471|592746888|FG000|Overall Study|Adverse Event|73|||
164104751|NCT03084471|592746888|FG000|Overall Study|Withdrawal by Subject|12|||
164104752|NCT03084471|592746888|FG000|Overall Study|Disease relapse|181|||
164104753|NCT03084471|592746888|FG000|Overall Study|Subjective disease progression|359|||
164104754|NCT03084471|592746888|FG000|Overall Study|Other (as recorded)|33|||
164104755|NCT03084471|592746888|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
164104756|NCT00251979|592746891|FG000|Overall Study|Protocol Violation|3|||
164104757|NCT00251979|592746892|FG001|Overall Study|Protocol Violation|5|||
164104758|NCT00251979|592746891|FG000|Overall Study|Adverse Event|11|||
164104759|NCT00251979|592746892|FG001|Overall Study|Adverse Event|17|||
164104760|NCT00251979|592746891|FG000|Overall Study|Withdrawal by Subject|13|||
164066116|NCT03426995|592604194|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066117|NCT03426995|592604195|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066118|NCT03426995|592604196|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066119|NCT03426995|592604197|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066120|NCT03426995|592604198|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066121|NCT03426995|592604199|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066122|NCT03426995|592604200|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
164066123|NCT03426995|592604182|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066124|NCT03426995|592604183|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066125|NCT03426995|592604184|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066126|NCT03426995|592604185|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066127|NCT03426995|592604186|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
164066128|NCT03426995|592604187|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
164066129|NCT03426995|592604188|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066130|NCT03426995|592604189|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066131|NCT03426995|592604190|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066132|NCT03426995|592604191|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066133|NCT03426995|592604192|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066134|NCT03426995|592604193|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066135|NCT03426995|592604194|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066136|NCT03426995|592604195|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066137|NCT03426995|592604196|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066138|NCT03426995|592604197|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066139|NCT03426995|592604198|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066140|NCT03426995|592604199|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066141|NCT03426995|592604200|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
164066142|NCT03426995|592604182|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066143|NCT03426995|592604183|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066144|NCT03426995|592604184|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066145|NCT03426995|592604185|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066146|NCT03426995|592604186|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066147|NCT03426995|592604187|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066148|NCT03426995|592604188|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066149|NCT03426995|592604189|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066150|NCT03426995|592604190|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066151|NCT03426995|592604191|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066152|NCT03426995|592604192|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
164066153|NCT03426995|592604193|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066154|NCT03426995|592604194|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066155|NCT03426995|592604195|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066156|NCT03426995|592604196|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066157|NCT03426995|592604197|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066158|NCT03426995|592604198|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066159|NCT03426995|592604199|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066160|NCT03426995|592604200|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
164066161|NCT03426995|592604182|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066162|NCT03426995|592604183|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066163|NCT03426995|592604184|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066164|NCT03426995|592604185|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066165|NCT03426995|592604186|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066166|NCT03426995|592604187|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066167|NCT03426995|592604188|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066168|NCT03426995|592604189|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
164066169|NCT03426995|592604190|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066170|NCT03426995|592604191|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066171|NCT03426995|592604192|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066172|NCT03426995|592604193|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066173|NCT03426995|592604194|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066174|NCT03426995|592604195|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066175|NCT03426995|592604196|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066176|NCT03426995|592604197|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066177|NCT03426995|592604198|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066178|NCT03426995|592604199|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066179|NCT03426995|592604200|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
164066180|NCT03426995|592604182|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066181|NCT03426995|592604183|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066182|NCT03426995|592604184|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066183|NCT03426995|592604185|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066184|NCT03426995|592604186|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066185|NCT03426995|592604187|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066186|NCT03426995|592604188|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066187|NCT03426995|592604189|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066188|NCT03426995|592604190|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066189|NCT03426995|592604191|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066190|NCT03426995|592604192|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066191|NCT03426995|592604193|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066192|NCT03426995|592604194|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066193|NCT03426995|592604195|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066194|NCT03426995|592604196|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
164066195|NCT03426995|592604197|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
164066196|NCT03426995|592604198|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066197|NCT03426995|592604199|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066198|NCT03426995|592604200|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
164066199|NCT03426995|592604182|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066200|NCT03426995|592604183|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066201|NCT03426995|592604184|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066202|NCT03426995|592604185|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066203|NCT03426995|592604186|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066204|NCT03426995|592604187|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066205|NCT03426995|592604188|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066206|NCT03426995|592604189|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066207|NCT03426995|592604190|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066208|NCT03426995|592604191|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066209|NCT03426995|592604192|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066210|NCT03426995|592604193|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066211|NCT03426995|592604194|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066212|NCT03426995|592604195|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066213|NCT03426995|592604196|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
164066214|NCT03426995|592604197|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
164066215|NCT03426995|592604198|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066216|NCT03426995|592604199|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066217|NCT03426995|592604200|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
164066218|NCT01886105|592604201|FG000|Overall Study|Lack of Efficacy|3|||
164066219|NCT03075826|592604206|FG000|Overall Study|Withdrawal by Subject|1|||
164066220|NCT03075826|592604206|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
164066221|NCT00650806|592604208|FG000|Overall Study|Adverse Event|0|||
164066222|NCT00650806|592604209|FG001|Overall Study|Adverse Event|5|||
164066223|NCT00650806|592604210|FG002|Overall Study|Adverse Event|3|||
164066224|NCT00650806|592604211|FG003|Overall Study|Adverse Event|4|||
164066225|NCT00650806|592604208|FG000|Overall Study|Lost to Follow-up|7|||
164066226|NCT00650806|592604209|FG001|Overall Study|Lost to Follow-up|6|||
164066227|NCT00650806|592604210|FG002|Overall Study|Lost to Follow-up|11|||
164066228|NCT00650806|592604211|FG003|Overall Study|Lost to Follow-up|10|||
164066229|NCT00650806|592604208|FG000|Overall Study|Protocol Violation|0|||
164066230|NCT00650806|592604209|FG001|Overall Study|Protocol Violation|0|||
164066231|NCT00650806|592604210|FG002|Overall Study|Protocol Violation|0|||
164066232|NCT00650806|592604211|FG003|Overall Study|Protocol Violation|1|||
164066233|NCT00650806|592604208|FG000|Overall Study|Pregnancy|0|||
164066234|NCT00650806|592604209|FG001|Overall Study|Pregnancy|0|||
164066235|NCT00650806|592604210|FG002|Overall Study|Pregnancy|0|||
164066236|NCT00650806|592604211|FG003|Overall Study|Pregnancy|1|||
164066237|NCT00650806|592604208|FG000|Overall Study|Withdrawal by Subject|7|||
164066238|NCT00650806|592604209|FG001|Overall Study|Withdrawal by Subject|5|||
164066239|NCT00650806|592604210|FG002|Overall Study|Withdrawal by Subject|8|||
164066240|NCT00650806|592604211|FG003|Overall Study|Withdrawal by Subject|6|||
164066241|NCT00650806|592604208|FG000|Overall Study|Noncompliance with study drug regimen|1|||
164066242|NCT00650806|592604209|FG001|Overall Study|Noncompliance with study drug regimen|1|||
164066243|NCT00650806|592604210|FG002|Overall Study|Noncompliance with study drug regimen|0|||
164066244|NCT00650806|592604211|FG003|Overall Study|Noncompliance with study drug regimen|0|||
164066245|NCT00650806|592604208|FG000|Overall Study|Study terminated by sponsor|2|||
164066246|NCT00650806|592604209|FG001|Overall Study|Study terminated by sponsor|3|||
164066247|NCT00650806|592604210|FG002|Overall Study|Study terminated by sponsor|5|||
164066248|NCT00650806|592604211|FG003|Overall Study|Study terminated by sponsor|4|||
164066249|NCT00650806|592604208|FG000|Overall Study|Other|1|||
164066250|NCT00650806|592604209|FG001|Overall Study|Other|1|||
164066251|NCT00650806|592604210|FG002|Overall Study|Other|2|||
164066252|NCT00650806|592604211|FG003|Overall Study|Other|0|||
164066253|NCT02242942|592604212|FG000|Overall Study|Death|17|||
164066254|NCT02242942|592604213|FG001|Overall Study|Death|20|||
164066255|NCT02242942|592604214|FG002|Overall Study|Death|2|||
164066256|NCT02242942|592604212|FG000|Overall Study|Physician Decision|1|||
164066257|NCT02242942|592604213|FG001|Overall Study|Physician Decision|0|||
164066258|NCT02242942|592604214|FG002|Overall Study|Physician Decision|0|||
164066259|NCT02242942|592604212|FG000|Overall Study|Withdrawal by Subject|8|||
164066260|NCT02242942|592604213|FG001|Overall Study|Withdrawal by Subject|10|||
164066261|NCT02242942|592604214|FG002|Overall Study|Withdrawal by Subject|0|||
164066262|NCT02242942|592604212|FG000|Overall Study|On-going in Study|190|||
164066263|NCT02242942|592604213|FG001|Overall Study|On-going in Study|186|||
164066264|NCT02242942|592604214|FG002|Overall Study|On-going in Study|11|||
164066265|NCT04228107|592604218|FG000|Overall Study|Protocol Violation|1|||
164066266|NCT04228107|592604219|FG001|Overall Study|Protocol Violation|0|||
164066267|NCT04228107|592604218|FG000|Overall Study|Withdrawal by Subject|6|||
164066268|NCT04228107|592604219|FG001|Overall Study|Withdrawal by Subject|0|||
164066269|NCT04228107|592604218|FG000|Overall Study|Lost to Follow-up|18|||
164066270|NCT04228107|592604219|FG001|Overall Study|Lost to Follow-up|0|||
164066271|NCT04228107|592604218|FG000|Overall Study|No controller use data|1|||
164066272|NCT04228107|592604219|FG001|Overall Study|No controller use data|0|||
164066273|NCT04228107|592604218|FG000|Overall Study|No medication data collected|1|||
164066274|NCT04228107|592604219|FG001|Overall Study|No medication data collected|0|||
164066275|NCT03792633|592604220|FG000|Overall Study|Alternative Treatment|17|||
164066276|NCT03792633|592604221|FG001|Overall Study|Alternative Treatment|19|||
164066277|NCT03792633|592604220|FG000|Overall Study|Death|2|||
164066278|NCT03792633|592604221|FG001|Overall Study|Death|0|||
164066279|NCT03792633|592604220|FG000|Overall Study|Disease progression|8|||
164066280|NCT03792633|592604221|FG001|Overall Study|Disease progression|9|||
164066281|NCT03792633|592604220|FG000|Overall Study|Lost to Follow-up|1|||
164066282|NCT03792633|592604221|FG001|Overall Study|Lost to Follow-up|1|||
164066283|NCT03792633|592604220|FG000|Overall Study|Screen fail|1|||
164066284|NCT03792633|592604221|FG001|Overall Study|Screen fail|0|||
164066285|NCT03792633|592604220|FG000|Overall Study|Second malignancy|0|||
164066286|NCT03792633|592604221|FG001|Overall Study|Second malignancy|1|||
164066287|NCT00145119|592604222|FG000|Overall Study|Death|45|||
164066288|NCT04411641|592604223|FG000|DB Period|Other|7|||
164066289|NCT04411641|592604224|FG001|DB Period|Other|27|||
164066290|NCT04411641|592604225|FG002|DB Period|Other|0|||
164066291|NCT04411641|592604226|FG003|DB Period|Other|0|||
164066292|NCT04411641|592604223|FG000|DB Period|Withdrawal by Subject|67|||
164066293|NCT04411641|592604224|FG001|DB Period|Withdrawal by Subject|122|||
164066294|NCT04411641|592604225|FG002|DB Period|Withdrawal by Subject|0|||
164066295|NCT04411641|592604226|FG003|DB Period|Withdrawal by Subject|0|||
164066296|NCT04411641|592604223|FG000|DB Period|Progressive disease|76|||
164066297|NCT04411641|592604224|FG001|DB Period|Progressive disease|116|||
164066298|NCT04411641|592604225|FG002|DB Period|Progressive disease|0|||
164066299|NCT04411641|592604226|FG003|DB Period|Progressive disease|0|||
164066300|NCT04411641|592604223|FG000|DB Period|Poor compliance to protocol|1|||
164066301|NCT04411641|592604224|FG001|DB Period|Poor compliance to protocol|5|||
164066302|NCT04411641|592604225|FG002|DB Period|Poor compliance to protocol|0|||
164066303|NCT04411641|592604226|FG003|DB Period|Poor compliance to protocol|0|||
164066304|NCT04411641|592604223|FG000|DB Period|Lack of Efficacy|19|||
164066305|NCT04411641|592604224|FG001|DB Period|Lack of Efficacy|19|||
164066306|NCT04411641|592604225|FG002|DB Period|Lack of Efficacy|0|||
164066307|NCT04411641|592604226|FG003|DB Period|Lack of Efficacy|0|||
164066308|NCT04411641|592604223|FG000|DB Period|Adverse Event|13|||
164066309|NCT04411641|592604224|FG001|DB Period|Adverse Event|29|||
164066310|NCT04411641|592604225|FG002|DB Period|Adverse Event|0|||
164066311|NCT04411641|592604226|FG003|DB Period|Adverse Event|0|||
164066312|NCT04411641|592604223|FG000|DB Period|Randomized and not treated|2|||
164066313|NCT04411641|592604224|FG001|DB Period|Randomized and not treated|2|||
164066314|NCT04411641|592604225|FG002|DB Period|Randomized and not treated|0|||
164066315|NCT04411641|592604226|FG003|DB Period|Randomized and not treated|0|||
164066316|NCT04411641|592604223|FG000|OL|Withdrawal by Subject|0|||
164066317|NCT04411641|592604224|FG001|OL|Withdrawal by Subject|0|||
164066318|NCT04411641|592604225|FG002|OL|Withdrawal by Subject|6|||
164066319|NCT04411641|592604226|FG003|OL|Withdrawal by Subject|17|||
164066320|NCT04411641|592604223|FG000|OL|Progressive disease|0|||
164066321|NCT04411641|592604224|FG001|OL|Progressive disease|0|||
164066322|NCT04411641|592604225|FG002|OL|Progressive disease|1|||
164066323|NCT04411641|592604226|FG003|OL|Progressive disease|2|||
164066324|NCT04411641|592604223|FG000|OL|Poor compliance to protocol|0|||
164066325|NCT04411641|592604224|FG001|OL|Poor compliance to protocol|0|||
164066326|NCT04411641|592604225|FG002|OL|Poor compliance to protocol|1|||
164066327|NCT04411641|592604226|FG003|OL|Poor compliance to protocol|0|||
164066328|NCT04411641|592604223|FG000|OL|Adverse Event|0|||
164066329|NCT04411641|592604224|FG001|OL|Adverse Event|0|||
164066330|NCT04411641|592604225|FG002|OL|Adverse Event|1|||
164066331|NCT04411641|592604226|FG003|OL|Adverse Event|0|||
164066332|NCT04411641|592604223|FG000|OL|Other|0|||
164066333|NCT04411641|592604224|FG001|OL|Other|0|||
164066334|NCT04411641|592604225|FG002|OL|Other|0|||
164066335|NCT04411641|592604226|FG003|OL|Other|6|||
164066336|NCT04342390|592604227|FG000|Overall Study|Lost to Follow-up|3|||
164066337|NCT04342390|592604228|FG001|Overall Study|Lost to Follow-up|0|||
164066338|NCT04584294|592604229|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
164066339|NCT04584294|592604230|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
164066340|NCT04584294|592604229|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
164066341|NCT04584294|592604230|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
164066342|NCT04584294|592604229|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
164066343|NCT04584294|592604230|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
164066344|NCT04584294|592604229|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
164066345|NCT04584294|592604230|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
164066346|NCT04584294|592604229|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
164066347|NCT04584294|592604230|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
164066348|NCT04584294|592604229|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
164066349|NCT04584294|592604230|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
164066350|NCT03205605|592604235|FG000|Overall Study|Withdrawal by Subject|1|||
164066351|NCT01003691|592604236|FG000|Overall Study|Adverse Event|0|||
164066352|NCT01003691|592604237|FG001|Overall Study|Adverse Event|0|||
164066353|NCT01003691|592604238|FG002|Overall Study|Adverse Event|0|||
164066354|NCT01003691|592604239|FG003|Overall Study|Adverse Event|1|||
164066355|NCT01392469|592605801|FG000|Overall Study|Adverse Event|2|||
164066356|NCT01392469|592605801|FG000|Overall Study|Withdrawal by Subject|1|||
164066357|NCT01392469|592605801|FG000|Overall Study|Protocol Violation|1|||
164066358|NCT03443973|592605808|FG000|Double-blind Treatment Period|Adverse Event|5|||
164066359|NCT03443973|592605809|FG001|Double-blind Treatment Period|Adverse Event|19|||
164066360|NCT03443973|592605810|FG002|Double-blind Treatment Period|Adverse Event|0|||
164066361|NCT03443973|592605811|FG003|Double-blind Treatment Period|Adverse Event|0|||
164066362|NCT03443973|592605808|FG000|Double-blind Treatment Period|Death|5|||
164066363|NCT03443973|592605809|FG001|Double-blind Treatment Period|Death|7|||
164066364|NCT03443973|592605810|FG002|Double-blind Treatment Period|Death|0|||
164066365|NCT03443973|592605811|FG003|Double-blind Treatment Period|Death|0|||
164066366|NCT03443973|592605808|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
164066367|NCT03443973|592605809|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
164066368|NCT03443973|592605810|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164066369|NCT03443973|592605811|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
164066370|NCT03443973|592605808|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164066371|NCT03443973|592605809|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164066372|NCT03443973|592605810|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164066373|NCT03443973|592605811|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164066374|NCT03443973|592605808|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
164066375|NCT03443973|592605809|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
164066376|NCT03443973|592605810|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
164066377|NCT03443973|592605811|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
164066378|NCT03443973|592605808|FG000|Double-blind Treatment Period|Physician Decision|5|||
164066379|NCT03443973|592605809|FG001|Double-blind Treatment Period|Physician Decision|6|||
164066380|NCT03443973|592605810|FG002|Double-blind Treatment Period|Physician Decision|0|||
164066381|NCT03443973|592605811|FG003|Double-blind Treatment Period|Physician Decision|0|||
164066382|NCT03443973|592605808|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
164066383|NCT03443973|592605809|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
164066384|NCT03443973|592605810|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
164066385|NCT03443973|592605811|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
164066386|NCT03443973|592605808|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
164066387|NCT03443973|592605809|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
164066388|NCT03443973|592605810|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164066389|NCT03443973|592605811|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
164066390|NCT03443973|592605808|FG000|Open-label Extension Period|Reason Not Specified|0|||
164066391|NCT03443973|592605809|FG001|Open-label Extension Period|Reason Not Specified|0|||
164066392|NCT03443973|592605810|FG002|Open-label Extension Period|Reason Not Specified|3|||
164066393|NCT03443973|592605811|FG003|Open-label Extension Period|Reason Not Specified|0|||
164066394|NCT03443973|592605808|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
164066395|NCT03443973|592605809|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164066396|NCT03443973|592605810|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
164066397|NCT03443973|592605811|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
164066398|NCT04930536|592605812|FG000|Overall Study|Adverse Event|1|||
164066399|NCT04930536|592605813|FG001|Overall Study|Adverse Event|0|||
164066400|NCT04930536|592605812|FG000|Overall Study|Disease Progression|2|||
164066401|NCT04930536|592605813|FG001|Overall Study|Disease Progression|0|||
164066402|NCT04930536|592605812|FG000|Overall Study|Patient Decision|4|||
164066403|NCT04930536|592605813|FG001|Overall Study|Patient Decision|2|||
164066404|NCT04930536|592605812|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
164066405|NCT04930536|592605813|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
164066406|NCT00267020|592605814|FG000|Overall Study|Adverse Event|22|||
164066407|NCT00267020|592605815|FG001|Overall Study|Adverse Event|5|||
164066408|NCT00267020|592605814|FG000|Overall Study|Death|2|||
164066409|NCT00267020|592605815|FG001|Overall Study|Death|1|||
164066410|NCT00267020|592605814|FG000|Overall Study|Withdrawal by Subject|17|||
164066411|NCT00267020|592605815|FG001|Overall Study|Withdrawal by Subject|7|||
164066412|NCT00267020|592605814|FG000|Overall Study|Physician Decision|3|||
164066413|NCT00267020|592605815|FG001|Overall Study|Physician Decision|2|||
164066414|NCT00267020|592605814|FG000|Overall Study|Disease Progression|39|||
164066415|NCT00267020|592605815|FG001|Overall Study|Disease Progression|25|||
164066416|NCT00267020|592605814|FG000|Overall Study|Unrelated Complication|1|||
164066417|NCT00267020|592605815|FG001|Overall Study|Unrelated Complication|1|||
164066418|NCT00267020|592605814|FG000|Overall Study|Sponsor Request|1|||
164066419|NCT00267020|592605815|FG001|Overall Study|Sponsor Request|0|||
164066420|NCT00267020|592605814|FG000|Overall Study|Other|1|||
164066421|NCT00267020|592605815|FG001|Overall Study|Other|2|||
164066422|NCT04292171|592605819|FG000|Overall Study|Pharmacy error|2|||
164066423|NCT04292171|592605820|FG001|Overall Study|Pharmacy error|0|||
164066424|NCT04292171|592605819|FG000|Overall Study|Delivered prior to procedure|0|||
164066425|NCT04292171|592605820|FG001|Overall Study|Delivered prior to procedure|1|||
164066426|NCT04465916|592605821|FG000|Overall Study|Withdrawal by Subject|0|||
164066427|NCT04465916|592605822|FG001|Overall Study|Withdrawal by Subject|1|||
164066428|NCT01605370|592605824|FG000|Overall Study|Adverse Event|1|||
164066429|NCT01605370|592605825|FG001|Overall Study|Adverse Event|0|||
164066430|NCT01317199|592605826|FG000|Dose-escalation Phase 1|Physician Decision|5|||
164066431|NCT01317199|592605827|FG001|Dose-escalation Phase 1|Physician Decision|0|||
164066432|NCT01317199|592605828|FG002|Dose-escalation Phase 1|Physician Decision|0|||
164066433|NCT01317199|592605829|FG003|Dose-escalation Phase 1|Physician Decision|0|||
164066434|NCT01317199|592605826|FG000|Dose-escalation Phase 1|Disease progression|1|||
164066435|NCT01317199|592605827|FG001|Dose-escalation Phase 1|Disease progression|0|||
164066436|NCT01317199|592605828|FG002|Dose-escalation Phase 1|Disease progression|0|||
164066437|NCT01317199|592605829|FG003|Dose-escalation Phase 1|Disease progression|0|||
164066438|NCT01317199|592605826|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
164066439|NCT01317199|592605827|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
164066440|NCT01317199|592605828|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
164066441|NCT01317199|592605829|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
164066442|NCT01317199|592605826|FG000|Randomized Phase 2|Disease progression|0|||
164066443|NCT01317199|592605827|FG001|Randomized Phase 2|Disease progression|3|||
164066444|NCT01317199|592605828|FG002|Randomized Phase 2|Disease progression|7|||
164066445|NCT01317199|592605829|FG003|Randomized Phase 2|Disease progression|5|||
164066446|NCT01317199|592605826|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
164066447|NCT01317199|592605827|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
164066448|NCT01317199|592605828|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
164066449|NCT01317199|592605829|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
164066450|NCT01317199|592605826|FG000|Randomized Phase 2|Adverse Event|0|||
164066451|NCT01317199|592605827|FG001|Randomized Phase 2|Adverse Event|0|||
164066452|NCT01317199|592605828|FG002|Randomized Phase 2|Adverse Event|0|||
164066453|NCT01317199|592605829|FG003|Randomized Phase 2|Adverse Event|1|||
164066454|NCT01317199|592605826|FG000|Randomized Phase 2|Comorbidities|0|||
164066455|NCT01317199|592605827|FG001|Randomized Phase 2|Comorbidities|2|||
164066456|NCT01317199|592605828|FG002|Randomized Phase 2|Comorbidities|2|||
164066457|NCT01317199|592605829|FG003|Randomized Phase 2|Comorbidities|2|||
164066458|NCT01317199|592605826|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
164066459|NCT01317199|592605827|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
164066460|NCT01317199|592605828|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
164066461|NCT01317199|592605829|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
164066462|NCT01317199|592605826|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
164066463|NCT01317199|592605827|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
164066464|NCT01317199|592605828|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
164066465|NCT01317199|592605829|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
164066466|NCT01317199|592605826|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
164066467|NCT01317199|592605827|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
164066468|NCT01317199|592605828|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
164066469|NCT01317199|592605829|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
164066470|NCT01317199|592605826|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
164066471|NCT01317199|592605827|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
164066472|NCT01317199|592605828|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
164066473|NCT01317199|592605829|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
164066474|NCT01353209|592605830|FG000|Overall Study|Adverse Event|1|||
164066475|NCT01353209|592605831|FG001|Overall Study|Adverse Event|1|||
164104761|NCT00251979|592746892|FG001|Overall Study|Withdrawal by Subject|7|||
164066476|NCT03237325|592605835|FG000|Overall Study|Lost to Follow-up|3|||
164066477|NCT03237325|592605836|FG001|Overall Study|Lost to Follow-up|5|||
164066478|NCT03237325|592605835|FG000|Overall Study|Physician Decision|2|||
164066479|NCT03237325|592605836|FG001|Overall Study|Physician Decision|4|||
164066480|NCT03237325|592605835|FG000|Overall Study|Withdrawal by Subject|9|||
164066481|NCT03237325|592605836|FG001|Overall Study|Withdrawal by Subject|12|||
164066482|NCT03237325|592605835|FG000|Overall Study|Noncompliance with Study Procedures|1|||
164066483|NCT03237325|592605836|FG001|Overall Study|Noncompliance with Study Procedures|1|||
164066484|NCT03237325|592605835|FG000|Overall Study|Termination by Sponsor|0|||
164066485|NCT03237325|592605836|FG001|Overall Study|Termination by Sponsor|1|||
164066486|NCT03237325|592605835|FG000|Overall Study|Reason other than described|0|||
164066487|NCT03237325|592605836|FG001|Overall Study|Reason other than described|2|||
164104762|NCT00251979|592746891|FG000|Overall Study|Lost to Follow-up|8|||
164104763|NCT00251979|592746892|FG001|Overall Study|Lost to Follow-up|6|||
164104764|NCT00251979|592746891|FG000|Overall Study|Death|3|||
164104765|NCT00251979|592746892|FG001|Overall Study|Death|5|||
164104766|NCT01878292|592746897|FG000|Randomized|Protocol Violation|1|||
164104767|NCT01878292|592746898|FG001|Randomized|Protocol Violation|0|||
164104768|NCT01878292|592746899|FG002|Randomized|Protocol Violation|0|||
164104769|NCT01878292|592746897|FG000|Randomized|Lost to Follow-up|1|||
164104770|NCT01878292|592746898|FG001|Randomized|Lost to Follow-up|0|||
164104771|NCT01878292|592746899|FG002|Randomized|Lost to Follow-up|0|||
164104772|NCT01878292|592746897|FG000|Randomized|Adverse Event|1|||
164104773|NCT01878292|592746898|FG001|Randomized|Adverse Event|0|||
164104774|NCT01878292|592746899|FG002|Randomized|Adverse Event|0|||
164104775|NCT01878292|592746897|FG000|Double-blind Treatment Period|Other Reasons|2|||
164104776|NCT01878292|592746898|FG001|Double-blind Treatment Period|Other Reasons|0|||
164104777|NCT01878292|592746899|FG002|Double-blind Treatment Period|Other Reasons|0|||
164104778|NCT01878292|592746897|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
164104779|NCT01878292|592746898|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
164104780|NCT01878292|592746899|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
164104781|NCT01878292|592746897|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
164104782|NCT01878292|592746898|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
164104783|NCT01878292|592746899|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
164104784|NCT01878292|592746897|FG000|Double-blind Treatment Period|Protocol Violation|3|||
164104785|NCT01878292|592746898|FG001|Double-blind Treatment Period|Protocol Violation|4|||
164104786|NCT01878292|592746899|FG002|Double-blind Treatment Period|Protocol Violation|2|||
164104787|NCT01878292|592746897|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
164104788|NCT01878292|592746898|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
164104789|NCT01878292|592746899|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
164104790|NCT01878292|592746897|FG000|Double-blind Treatment Period|Adverse Event|4|||
164104791|NCT01878292|592746898|FG001|Double-blind Treatment Period|Adverse Event|9|||
164104792|NCT01878292|592746899|FG002|Double-blind Treatment Period|Adverse Event|8|||
164104793|NCT01878292|592746897|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
164104794|NCT01878292|592746898|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
164104795|NCT01878292|592746899|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
164104796|NCT00323882|592746900|FG000|Overall Study|Adverse Event|2|||
164104797|NCT00323882|592746901|FG001|Overall Study|Adverse Event|1|||
164104798|NCT00323882|592746902|FG002|Overall Study|Adverse Event|1|||
164104799|NCT00323882|592746903|FG003|Overall Study|Adverse Event|1|||
164104800|NCT00323882|592746904|FG004|Overall Study|Adverse Event|3|||
164104801|NCT00323882|592746900|FG000|Overall Study|Disease Progression|6|||
164104802|NCT00323882|592746901|FG001|Overall Study|Disease Progression|4|||
164104803|NCT00323882|592746902|FG002|Overall Study|Disease Progression|10|||
164104804|NCT00323882|592746903|FG003|Overall Study|Disease Progression|5|||
164104805|NCT00323882|592746904|FG004|Overall Study|Disease Progression|22|||
164104806|NCT00323882|592746900|FG000|Overall Study|Death|0|||
164104807|NCT00323882|592746901|FG001|Overall Study|Death|1|||
164104808|NCT00323882|592746902|FG002|Overall Study|Death|1|||
164104809|NCT00323882|592746903|FG003|Overall Study|Death|0|||
164104810|NCT00323882|592746904|FG004|Overall Study|Death|5|||
164104811|NCT00323882|592746900|FG000|Overall Study|Lost to Follow-up|0|||
164104812|NCT00323882|592746901|FG001|Overall Study|Lost to Follow-up|0|||
164104813|NCT00323882|592746902|FG002|Overall Study|Lost to Follow-up|1|||
164104814|NCT00323882|592746903|FG003|Overall Study|Lost to Follow-up|0|||
164104815|NCT00323882|592746904|FG004|Overall Study|Lost to Follow-up|1|||
164104816|NCT00323882|592746900|FG000|Overall Study|Other|0|||
164104817|NCT00323882|592746901|FG001|Overall Study|Other|0|||
164104818|NCT00323882|592746902|FG002|Overall Study|Other|0|||
164104819|NCT00323882|592746903|FG003|Overall Study|Other|1|||
164104820|NCT00323882|592746904|FG004|Overall Study|Other|1|||
164104821|NCT00429416|592746907|FG000|Overall Study|Death|1|||
164104822|NCT02152163|592746909|FG000|Overall Study|Physician Decision|12|||
164104823|NCT02152163|592746910|FG001|Overall Study|Physician Decision|13|||
164104824|NCT06999265|592746911|FG000|Overall Study|Lost to Follow-up|1|||
164104825|NCT06999265|592746912|FG001|Overall Study|Lost to Follow-up|1|||
164066488|NCT02684370|592605837|FG000|Part A|Adverse Event|2|||
164066489|NCT02684370|592605838|FG001|Part A|Adverse Event|0|||
164066490|NCT02684370|592605839|FG002|Part A|Adverse Event|1|||
164104826|NCT00730691|592746914|FG000|Overall Study|Adverse Event|4|||
164104827|NCT00730691|592746915|FG001|Overall Study|Adverse Event|8|||
164104828|NCT00730691|592746916|FG002|Overall Study|Adverse Event|11|||
164104829|NCT00730691|592746917|FG003|Overall Study|Adverse Event|11|||
164066491|NCT02684370|592605840|FG003|Part A|Adverse Event|0|||
164066492|NCT02684370|592605841|FG004|Part A|Adverse Event|0|||
164066493|NCT02684370|592605842|FG005|Part A|Adverse Event|0|||
164066494|NCT02684370|592605837|FG000|Part A|Lost to Follow-up|1|||
164066495|NCT02684370|592605838|FG001|Part A|Lost to Follow-up|1|||
164066496|NCT02684370|592605839|FG002|Part A|Lost to Follow-up|0|||
164066497|NCT02684370|592605840|FG003|Part A|Lost to Follow-up|0|||
164066498|NCT02684370|592605841|FG004|Part A|Lost to Follow-up|0|||
164066499|NCT02684370|592605842|FG005|Part A|Lost to Follow-up|0|||
164066500|NCT02684370|592605837|FG000|Part A|Subject Withdrawal|1|||
164066501|NCT02684370|592605838|FG001|Part A|Subject Withdrawal|0|||
164066502|NCT02684370|592605839|FG002|Part A|Subject Withdrawal|3|||
164066503|NCT02684370|592605840|FG003|Part A|Subject Withdrawal|0|||
164066504|NCT02684370|592605841|FG004|Part A|Subject Withdrawal|0|||
164066505|NCT02684370|592605842|FG005|Part A|Subject Withdrawal|0|||
164066506|NCT02684370|592605837|FG000|Part A|Other|0|||
164066507|NCT02684370|592605838|FG001|Part A|Other|0|||
164066508|NCT02684370|592605839|FG002|Part A|Other|1|||
164066509|NCT02684370|592605840|FG003|Part A|Other|0|||
164066510|NCT02684370|592605841|FG004|Part A|Other|0|||
164066511|NCT02684370|592605842|FG005|Part A|Other|0|||
164066512|NCT02684370|592605837|FG000|Part B|Adverse Event|0|||
164066513|NCT02684370|592605838|FG001|Part B|Adverse Event|0|||
164066514|NCT02684370|592605839|FG002|Part B|Adverse Event|0|||
164066515|NCT02684370|592605840|FG003|Part B|Adverse Event|0|||
164066516|NCT02684370|592605841|FG004|Part B|Adverse Event|2|||
164066517|NCT02684370|592605842|FG005|Part B|Adverse Event|1|||
164066518|NCT02684370|592605837|FG000|Part B|Lost to Follow-up|0|||
164066519|NCT02684370|592605838|FG001|Part B|Lost to Follow-up|0|||
164066520|NCT02684370|592605839|FG002|Part B|Lost to Follow-up|0|||
164066521|NCT02684370|592605840|FG003|Part B|Lost to Follow-up|1|||
164066522|NCT02684370|592605841|FG004|Part B|Lost to Follow-up|2|||
164066523|NCT02684370|592605842|FG005|Part B|Lost to Follow-up|5|||
164066524|NCT02684370|592605837|FG000|Part B|Subject Withdrawal|0|||
164066525|NCT02684370|592605838|FG001|Part B|Subject Withdrawal|0|||
164066526|NCT02684370|592605839|FG002|Part B|Subject Withdrawal|0|||
164066527|NCT02684370|592605840|FG003|Part B|Subject Withdrawal|1|||
164066528|NCT02684370|592605841|FG004|Part B|Subject Withdrawal|1|||
164066529|NCT02684370|592605842|FG005|Part B|Subject Withdrawal|2|||
164066530|NCT00627094|592605844|FG000|Overall Study|Adverse Event|8|||
164066531|NCT00627094|592605845|FG001|Overall Study|Adverse Event|7|||
164066532|NCT00627094|592605844|FG000|Overall Study|Lost to Follow-up|1|||
164066533|NCT00627094|592605845|FG001|Overall Study|Lost to Follow-up|0|||
164066534|NCT00627094|592605844|FG000|Overall Study|Withdrawal by Subject|1|||
164066535|NCT00627094|592605845|FG001|Overall Study|Withdrawal by Subject|1|||
164066536|NCT00627094|592605844|FG000|Overall Study|ulcer healed|1|||
164066537|NCT00627094|592605845|FG001|Overall Study|ulcer healed|7|||
164066538|NCT00627094|592605844|FG000|Overall Study|Other reason|1|||
164066539|NCT00627094|592605845|FG001|Overall Study|Other reason|0|||
164066540|NCT00183170|592605847|FG000|First Intervention|Did not complete study|1|||
164066541|NCT00183170|592605848|FG001|First Intervention|Did not complete study|0|||
164066542|NCT00183170|592605847|FG000|First Intervention|Did not meet targeted BrAC|1|||
164066543|NCT00183170|592605848|FG001|First Intervention|Did not meet targeted BrAC|0|||
164066544|NCT00183170|592605847|FG000|Washout 1 Week|Did not complete study|6|||
164066545|NCT00183170|592605848|FG001|Washout 1 Week|Did not complete study|8|||
164066546|NCT00183170|592605847|FG000|Second Intervention|Did not complete study|1|||
164066547|NCT00183170|592605848|FG001|Second Intervention|Did not complete study|0|||
164066548|NCT00183170|592605847|FG000|Second Intervention|Did not meet targeted BrAC|0|||
164066549|NCT00183170|592605848|FG001|Second Intervention|Did not meet targeted BrAC|2|||
164066550|NCT01165424|592605849|FG000|Overall Study|Clinical adverse experiences|1|||
164066551|NCT01165424|592605849|FG000|Overall Study|Laboratory adverse experiences|1|||
164066552|NCT01165424|592605849|FG000|Overall Study|Did not meet entry criteria|1|||
164066553|NCT01165424|592605849|FG000|Overall Study|Participant moved (relocated)|1|||
164066554|NCT00433771|592605850|FG000|Overall Study|screen fail|14|||
164066555|NCT00433771|592605850|FG000|Overall Study|Treated and later found to be ineligible|2|||
164066556|NCT00433771|592605850|FG000|Overall Study|Death|2|||
164066557|NCT00433771|592605850|FG000|Overall Study|Failure to deploy stent|1|||
164066558|NCT00138658|592605851|FG000|Overall Study|Adverse Event|23|||
164066559|NCT00138658|592605851|FG000|Overall Study|Death|1|||
164066560|NCT00138658|592605851|FG000|Overall Study|Disease Progression|21|||
164066561|NCT00138658|592605851|FG000|Overall Study|Physician Decision|11|||
164066562|NCT00138658|592605851|FG000|Overall Study|Withdrawal by Subject|5|||
164066563|NCT02050373|592605862|FG000|Overall Study|Adverse Event|4|||
164066564|NCT02050373|592605863|FG001|Overall Study|Adverse Event|7|||
164066565|NCT02050373|592605862|FG000|Overall Study|Death|3|||
164066566|NCT02050373|592605863|FG001|Overall Study|Death|3|||
164066567|NCT00807040|592605867|FG000|Overall Study|Death|24|||
164066568|NCT00807040|592605868|FG001|Overall Study|Death|29|||
164066569|NCT00807040|592605867|FG000|Overall Study|Withdrawal by Subject|8|||
164066570|NCT00807040|592605868|FG001|Overall Study|Withdrawal by Subject|6|||
164066571|NCT00807040|592605867|FG000|Overall Study|Lost to Follow-up|4|||
164066572|NCT00807040|592605868|FG001|Overall Study|Lost to Follow-up|6|||
164066573|NCT01067339|592605869|FG000|Overall Study|Withdrawal by Subject|6|||
164066574|NCT01067339|592605870|FG001|Overall Study|Withdrawal by Subject|5|||
164066575|NCT01179191|592605871|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
164066576|NCT01179191|592605871|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
164066577|NCT01179191|592605871|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
164066578|NCT01179191|592605871|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
164066579|NCT01179191|592605871|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
164066580|NCT01179191|592605871|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
164066581|NCT01179191|592605871|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
164066582|NCT01179191|592605871|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
164066583|NCT01179191|592605871|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
164066584|NCT01179191|592605871|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
164066585|NCT01179191|592605871|FG000|Maintenance Phase (8 Weeks)|Other|66|||
164066586|NCT00572910|592605876|FG000|Overall Study|Adverse Event|1|||
164066587|NCT00572910|592605877|FG001|Overall Study|Adverse Event|2|||
164066588|NCT00572910|592605878|FG002|Overall Study|Adverse Event|0|||
164066589|NCT00572910|592605879|FG003|Overall Study|Adverse Event|2|||
164066590|NCT00572910|592605880|FG004|Overall Study|Adverse Event|0|||
164066591|NCT00572910|592605881|FG005|Overall Study|Adverse Event|0|||
164066592|NCT00572910|592605882|FG006|Overall Study|Adverse Event|4|||
164066593|NCT00572910|592605883|FG007|Overall Study|Adverse Event|2|||
164066594|NCT00572910|592605884|FG008|Overall Study|Adverse Event|1|||
164066595|NCT00572910|592605885|FG009|Overall Study|Adverse Event|3|||
164066596|NCT00572910|592605886|FG010|Overall Study|Adverse Event|2|||
164066597|NCT00572910|592605876|FG000|Overall Study|Lost to Follow-up|0|||
164066598|NCT00572910|592605877|FG001|Overall Study|Lost to Follow-up|1|||
164066599|NCT00572910|592605878|FG002|Overall Study|Lost to Follow-up|1|||
164066600|NCT00572910|592605879|FG003|Overall Study|Lost to Follow-up|2|||
164066601|NCT00572910|592605880|FG004|Overall Study|Lost to Follow-up|1|||
164066602|NCT00572910|592605881|FG005|Overall Study|Lost to Follow-up|0|||
164066603|NCT00572910|592605882|FG006|Overall Study|Lost to Follow-up|0|||
164066604|NCT00572910|592605883|FG007|Overall Study|Lost to Follow-up|0|||
164066605|NCT00572910|592605884|FG008|Overall Study|Lost to Follow-up|0|||
164066606|NCT00572910|592605885|FG009|Overall Study|Lost to Follow-up|1|||
164066607|NCT00572910|592605886|FG010|Overall Study|Lost to Follow-up|0|||
164066608|NCT00572910|592605876|FG000|Overall Study|Withdrawal by Subject|3|||
164066609|NCT00572910|592605877|FG001|Overall Study|Withdrawal by Subject|0|||
164066610|NCT00572910|592605878|FG002|Overall Study|Withdrawal by Subject|1|||
164066611|NCT00572910|592605879|FG003|Overall Study|Withdrawal by Subject|0|||
164066612|NCT00572910|592605880|FG004|Overall Study|Withdrawal by Subject|1|||
164066613|NCT00572910|592605881|FG005|Overall Study|Withdrawal by Subject|3|||
164066614|NCT00572910|592605882|FG006|Overall Study|Withdrawal by Subject|0|||
164066615|NCT00572910|592605883|FG007|Overall Study|Withdrawal by Subject|2|||
164066616|NCT00572910|592605884|FG008|Overall Study|Withdrawal by Subject|2|||
164066617|NCT00572910|592605885|FG009|Overall Study|Withdrawal by Subject|2|||
164066618|NCT00572910|592605886|FG010|Overall Study|Withdrawal by Subject|1|||
164066619|NCT01833897|592605892|FG000|Overall Study|Lack of Efficacy|1|||
164066620|NCT01870921|592605893|FG000|Overall Study|Subject decision|80|||
164066621|NCT01870921|592605893|FG000|Overall Study|Severe non-compliance to protocol|7|||
164066622|NCT01870921|592605893|FG000|Overall Study|Subject Lost to Follow up|2|||
164066623|NCT01870921|592605893|FG000|Overall Study|Other|1|||
164066624|NCT00806416|592605894|FG000|Period 1 - Part I|Adverse Event|0|||
164066625|NCT00806416|592605895|FG001|Period 1 - Part I|Adverse Event|1|||
164066626|NCT00806416|592605896|FG002|Period 1 - Part I|Adverse Event|0|||
164066627|NCT00806416|592605897|FG003|Period 1 - Part I|Adverse Event|0|||
164066628|NCT00806416|592605894|FG000|Period 1 - Part I|Lost to Follow-up|0|||
164066629|NCT00806416|592605895|FG001|Period 1 - Part I|Lost to Follow-up|2|||
164066630|NCT00806416|592605896|FG002|Period 1 - Part I|Lost to Follow-up|0|||
164066631|NCT00806416|592605897|FG003|Period 1 - Part I|Lost to Follow-up|0|||
164066632|NCT00806416|592605894|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
164066633|NCT00806416|592605895|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
164066634|NCT00806416|592605896|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
164066635|NCT00806416|592605897|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
164066636|NCT00806416|592605894|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
164066637|NCT00806416|592605895|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
164066638|NCT00806416|592605896|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
164066639|NCT00806416|592605897|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
164066640|NCT01102972|592605903|FG000|Overall Study|Adverse Event|8|||
164066641|NCT01102972|592605904|FG001|Overall Study|Adverse Event|2|||
164066642|NCT01102972|592605903|FG000|Overall Study|Lack of Efficacy|2|||
164066643|NCT01102972|592605904|FG001|Overall Study|Lack of Efficacy|1|||
164066644|NCT01102972|592605903|FG000|Overall Study|Protocol Violation|1|||
164066645|NCT01102972|592605904|FG001|Overall Study|Protocol Violation|0|||
164066646|NCT01102972|592605903|FG000|Overall Study|Lost to Follow-up|10|||
164066647|NCT01102972|592605904|FG001|Overall Study|Lost to Follow-up|5|||
164066648|NCT01102972|592605903|FG000|Overall Study|Investigator Discretion|2|||
164066649|NCT01102972|592605904|FG001|Overall Study|Investigator Discretion|0|||
164066650|NCT01102972|592605903|FG000|Overall Study|Withdrawal by Subject|6|||
164066651|NCT01102972|592605904|FG001|Overall Study|Withdrawal by Subject|6|||
164066652|NCT00227591|592605910|FG000|Overall Study|Withdrawal by Subject|1|||
164066653|NCT01360021|592605911|FG000|Overall Study|Eligibility criteria + other|2|||
164066654|NCT01360021|592605912|FG001|Overall Study|Eligibility criteria + other|1|||
164066655|NCT01360021|592605913|FG002|Overall Study|Eligibility criteria + other|1|||
164066656|NCT01360021|592605911|FG000|Overall Study|Protocol Violation|0|||
164066657|NCT01360021|592605912|FG001|Overall Study|Protocol Violation|0|||
164066658|NCT01360021|592605913|FG002|Overall Study|Protocol Violation|1|||
164066659|NCT01360021|592605911|FG000|Overall Study|Withdrawal by Subject|4|||
164066660|NCT01360021|592605912|FG001|Overall Study|Withdrawal by Subject|0|||
164066661|NCT01360021|592605913|FG002|Overall Study|Withdrawal by Subject|2|||
164066662|NCT01360021|592605911|FG000|Overall Study|Adverse Event|2|||
164066663|NCT01360021|592605912|FG001|Overall Study|Adverse Event|3|||
164066664|NCT01360021|592605913|FG002|Overall Study|Adverse Event|3|||
164066665|NCT05048875|592605915|FG000|Overall Study|Withdrawal by Subject|1|||
164066666|NCT05048875|592605916|FG001|Overall Study|Withdrawal by Subject|0|||
164066667|NCT05048875|592605917|FG002|Overall Study|Withdrawal by Subject|0|||
164066668|NCT05048875|592605918|FG003|Overall Study|Withdrawal by Subject|0|||
164066669|NCT05048875|592605919|FG004|Overall Study|Withdrawal by Subject|0|||
164066670|NCT05048875|592605920|FG005|Overall Study|Withdrawal by Subject|0|||
164066671|NCT05048875|592605921|FG006|Overall Study|Withdrawal by Subject|0|||
164066672|NCT05048875|592605922|FG007|Overall Study|Withdrawal by Subject|0|||
164066673|NCT05048875|592605915|FG000|Overall Study|Adverse Event|0|||
164066674|NCT05048875|592605916|FG001|Overall Study|Adverse Event|0|||
164066675|NCT05048875|592605917|FG002|Overall Study|Adverse Event|0|||
164066676|NCT05048875|592605918|FG003|Overall Study|Adverse Event|1|||
164066677|NCT05048875|592605919|FG004|Overall Study|Adverse Event|0|||
164066678|NCT05048875|592605920|FG005|Overall Study|Adverse Event|0|||
164066679|NCT05048875|592605921|FG006|Overall Study|Adverse Event|0|||
164066680|NCT05048875|592605922|FG007|Overall Study|Adverse Event|0|||
164066681|NCT02255422|592605923|FG000|Overall Study|Withdrawal by Subject|0|||
164066682|NCT02255422|592605924|FG001|Overall Study|Withdrawal by Subject|0|||
164066683|NCT02255422|592605925|FG002|Overall Study|Withdrawal by Subject|0|||
164066684|NCT02255422|592605926|FG003|Overall Study|Withdrawal by Subject|0|||
164066685|NCT02255422|592605927|FG004|Overall Study|Withdrawal by Subject|0|||
164066686|NCT02255422|592605928|FG005|Overall Study|Withdrawal by Subject|0|||
164066687|NCT02255422|592605929|FG006|Overall Study|Withdrawal by Subject|2|||
164066688|NCT02255422|592605923|FG000|Overall Study|Lost to Follow-up|0|||
164066689|NCT02255422|592605924|FG001|Overall Study|Lost to Follow-up|0|||
164066690|NCT02255422|592605925|FG002|Overall Study|Lost to Follow-up|1|||
164066691|NCT02255422|592605926|FG003|Overall Study|Lost to Follow-up|0|||
164066692|NCT02255422|592605927|FG004|Overall Study|Lost to Follow-up|0|||
164066693|NCT02255422|592605928|FG005|Overall Study|Lost to Follow-up|0|||
164066694|NCT02255422|592605929|FG006|Overall Study|Lost to Follow-up|0|||
164066695|NCT03179462|592605937|FG000|Overall Study|screening failure|1|||
164066696|NCT03179462|592605938|FG001|Overall Study|screening failure|2|||
164066697|NCT03179462|592605939|FG002|Overall Study|screening failure|0|||
164066698|NCT04410978|592605948|FG000|Overall Study|Poor compliance to protocol|2|||
164066699|NCT04410978|592605949|FG001|Overall Study|Poor compliance to protocol|4|||
164066700|NCT04410978|592605948|FG000|Overall Study|Withdrawal by Subject|64|||
164066701|NCT04410978|592605949|FG001|Overall Study|Withdrawal by Subject|66|||
164066702|NCT04410978|592605948|FG000|Overall Study|Other|6|||
164066703|NCT04410978|592605949|FG001|Overall Study|Other|7|||
164066704|NCT04410978|592605948|FG000|Overall Study|Missing study status|1|||
164066705|NCT04410978|592605949|FG001|Overall Study|Missing study status|0|||
164066706|NCT05153629|592605950|FG000|Overall Study|Withdrawal by Subject|0|||
164066707|NCT05153629|592605951|FG001|Overall Study|Withdrawal by Subject|2|||
164066708|NCT04089566|592605954|FG000|Overall Study|Death|0|||
164066709|NCT04089566|592605955|FG001|Overall Study|Death|6|||
164066710|NCT04089566|592605956|FG002|Overall Study|Death|10|||
164066711|NCT04089566|592605957|FG003|Overall Study|Death|0|||
164066712|NCT04089566|592605958|FG004|Overall Study|Death|0|||
164066713|NCT04089566|592605959|FG005|Overall Study|Death|0|||
164066714|NCT04089566|592605954|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
164066715|NCT04089566|592605955|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
164066716|NCT04089566|592605956|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
164066717|NCT04089566|592605957|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
164066718|NCT04089566|592605958|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
164066719|NCT04089566|592605959|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
164066720|NCT04089566|592605954|FG000|Overall Study|Reason not Specified|0|||
164066721|NCT04089566|592605955|FG001|Overall Study|Reason not Specified|4|||
164066722|NCT04089566|592605956|FG002|Overall Study|Reason not Specified|4|||
164066723|NCT04089566|592605957|FG003|Overall Study|Reason not Specified|1|||
164066724|NCT04089566|592605958|FG004|Overall Study|Reason not Specified|0|||
164066725|NCT04089566|592605959|FG005|Overall Study|Reason not Specified|0|||
164066726|NCT05403502|592605960|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
164066727|NCT05403502|592605960|FG000|Humalog Lead-In Period|Physician Decision|2|||
164104830|NCT00730691|592746918|FG004|Overall Study|Adverse Event|23|||
164104831|NCT00730691|592746914|FG000|Overall Study|Lack of Efficacy|4|||
164104832|NCT00730691|592746915|FG001|Overall Study|Lack of Efficacy|4|||
164104833|NCT00730691|592746916|FG002|Overall Study|Lack of Efficacy|2|||
164104834|NCT00730691|592746917|FG003|Overall Study|Lack of Efficacy|1|||
164104835|NCT00730691|592746918|FG004|Overall Study|Lack of Efficacy|1|||
164104836|NCT00730691|592746914|FG000|Overall Study|Non-compliance with Study Drug|6|||
164104837|NCT00730691|592746915|FG001|Overall Study|Non-compliance with Study Drug|1|||
164104838|NCT00730691|592746916|FG002|Overall Study|Non-compliance with Study Drug|6|||
164104839|NCT00730691|592746917|FG003|Overall Study|Non-compliance with Study Drug|3|||
164104840|NCT00730691|592746918|FG004|Overall Study|Non-compliance with Study Drug|3|||
164104841|NCT00730691|592746914|FG000|Overall Study|Protocol Deviations|3|||
164104842|NCT00730691|592746915|FG001|Overall Study|Protocol Deviations|5|||
164104843|NCT00730691|592746916|FG002|Overall Study|Protocol Deviations|3|||
164104844|NCT00730691|592746917|FG003|Overall Study|Protocol Deviations|7|||
164104845|NCT00730691|592746918|FG004|Overall Study|Protocol Deviations|5|||
164104846|NCT00730691|592746914|FG000|Overall Study|Withdrawal of Consent|7|||
164104847|NCT00730691|592746915|FG001|Overall Study|Withdrawal of Consent|9|||
164104848|NCT00730691|592746916|FG002|Overall Study|Withdrawal of Consent|3|||
164104849|NCT00730691|592746917|FG003|Overall Study|Withdrawal of Consent|6|||
164104850|NCT00730691|592746918|FG004|Overall Study|Withdrawal of Consent|3|||
164104851|NCT00730691|592746914|FG000|Overall Study|Lost to Follow-up|11|||
164104852|NCT00730691|592746915|FG001|Overall Study|Lost to Follow-up|8|||
164104853|NCT00730691|592746916|FG002|Overall Study|Lost to Follow-up|13|||
164104854|NCT00730691|592746917|FG003|Overall Study|Lost to Follow-up|15|||
164104855|NCT00730691|592746918|FG004|Overall Study|Lost to Follow-up|13|||
164104856|NCT00730691|592746914|FG000|Overall Study|Other|1|||
164104857|NCT00730691|592746915|FG001|Overall Study|Other|1|||
164104858|NCT00730691|592746916|FG002|Overall Study|Other|1|||
164104859|NCT00730691|592746917|FG003|Overall Study|Other|2|||
164104860|NCT00730691|592746918|FG004|Overall Study|Other|2|||
164104861|NCT00813592|592746919|FG000|Overall Study|Disease assessment was not completed per|2|||
164104862|NCT01097577|592746927|FG000|Overall Study|Adverse Event|0|||
164104863|NCT01097577|592746928|FG001|Overall Study|Adverse Event|1|||
164104864|NCT02566850|592749079|FG000|Overall Study|Protocol Violation|1|||
164104865|NCT00682461|592749081|FG000|Overall Study|Adverse Event|5|||
164104866|NCT00682461|592749082|FG001|Overall Study|Adverse Event|7|||
164104867|NCT00682461|592749081|FG000|Overall Study|Lost to Follow-up|8|||
164104868|NCT00682461|592749082|FG001|Overall Study|Lost to Follow-up|5|||
164104869|NCT00682461|592749081|FG000|Overall Study|Withdrawal by Subject|12|||
164104870|NCT00682461|592749082|FG001|Overall Study|Withdrawal by Subject|19|||
164104871|NCT06298396|592749092|FG000|Default MAP|Protocol Violation|1|||
164104872|NCT01528696|592749095|FG000|Overall Study|See detailed description|18|||
164104873|NCT01528696|592749096|FG001|Overall Study|See detailed description|19|||
164104874|NCT01547286|592749099|FG000|Overall Study|Did not meet all eligibility criteria|1|||
164104875|NCT01547286|592749099|FG000|Overall Study|Physician Decision|1|||
164104876|NCT00836472|592749100|FG000|Washout|Adverse Event|1|||
164104877|NCT00836472|592749101|FG001|Washout|Adverse Event|2|||
164104878|NCT00836472|592749100|FG000|Washout|Withdrawal by Subject|1|||
164104879|NCT00836472|592749101|FG001|Washout|Withdrawal by Subject|1|||
164104880|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
164104881|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
164104882|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
164104883|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
164104884|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104885|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104886|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104887|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104888|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104889|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104890|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104891|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104892|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104893|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
164104894|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
164104895|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
164104896|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
164104897|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
164104898|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104899|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104900|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104901|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104902|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104903|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104904|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164066728|NCT05403502|592605960|FG000|Humalog Lead-In Period|Protocol Violation|1|||
164066729|NCT05403502|592605960|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
164066730|NCT05403502|592605960|FG000|Lyumjev Treatment Period|Physician Decision|2|||
164066731|NCT01593761|592605962|FG000|Overall Study|Lost to Follow-up|1|||
164066732|NCT01593761|592605962|FG000|Overall Study|culture negative for MRSA at baseline|5|||
164066733|NCT01593761|592605962|FG000|Overall Study|positive for hepatitis C virus|1|||
164066734|NCT01593761|592605962|FG000|Overall Study|secondary cellulitis|1|||
164066735|NCT02576951|592605963|FG000|Overall Study|Lost to Follow-up|0|||
164066736|NCT02576951|592605964|FG001|Overall Study|Lost to Follow-up|0|||
164066737|NCT02576951|592605965|FG002|Overall Study|Lost to Follow-up|2|||
164066738|NCT02576951|592605966|FG003|Overall Study|Lost to Follow-up|2|||
164066739|NCT02576951|592605963|FG000|Overall Study|Withdrawal by Subject|1|||
164066740|NCT02576951|592605964|FG001|Overall Study|Withdrawal by Subject|0|||
164066741|NCT02576951|592605965|FG002|Overall Study|Withdrawal by Subject|0|||
164066742|NCT02576951|592605966|FG003|Overall Study|Withdrawal by Subject|2|||
164066743|NCT02576951|592605963|FG000|Overall Study|Protocol Violation|0|||
164066744|NCT02576951|592605964|FG001|Overall Study|Protocol Violation|0|||
164066745|NCT02576951|592605965|FG002|Overall Study|Protocol Violation|0|||
164066746|NCT02576951|592605966|FG003|Overall Study|Protocol Violation|1|||
164066747|NCT03505606|592607656|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
164066748|NCT03505606|592607657|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
164066749|NCT03505606|592607658|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
164066750|NCT03505606|592607656|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
164066751|NCT03505606|592607657|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
164066752|NCT03505606|592607658|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
164066753|NCT03505606|592607656|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
164066754|NCT03505606|592607657|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
164066755|NCT03505606|592607658|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
164066756|NCT03505606|592607656|FG000|Overall Study|Poor compliance with refractive correction|0|||
164066757|NCT03505606|592607657|FG001|Overall Study|Poor compliance with refractive correction|0|||
164066758|NCT03505606|592607658|FG002|Overall Study|Poor compliance with refractive correction|1|||
164066759|NCT03505606|592607656|FG000|Overall Study|Insufficient anisometropia|0|||
164066760|NCT03505606|592607657|FG001|Overall Study|Insufficient anisometropia|0|||
164066761|NCT03505606|592607658|FG002|Overall Study|Insufficient anisometropia|2|||
164066762|NCT03505606|592607656|FG000|Overall Study|Ectopia Lentis|0|||
164066763|NCT03505606|592607657|FG001|Overall Study|Ectopia Lentis|0|||
164066764|NCT03505606|592607658|FG002|Overall Study|Ectopia Lentis|1|||
164066765|NCT03505606|592607656|FG000|Overall Study|alternation of amblyopic eye|0|||
164066766|NCT03505606|592607657|FG001|Overall Study|alternation of amblyopic eye|1|||
164066767|NCT03505606|592607658|FG002|Overall Study|alternation of amblyopic eye|0|||
164066768|NCT02087865|592607661|FG000|Overall Study|Withdrawal by Subject|6|||
164066769|NCT02087865|592607662|FG001|Overall Study|Withdrawal by Subject|0|||
164066770|NCT02087865|592607663|FG002|Overall Study|Withdrawal by Subject|1|||
164066771|NCT02087865|592607661|FG000|Overall Study|Lost to Follow-up|0|||
164066772|NCT02087865|592607662|FG001|Overall Study|Lost to Follow-up|0|||
164066773|NCT02087865|592607663|FG002|Overall Study|Lost to Follow-up|1|||
164066774|NCT02087865|592607661|FG000|Overall Study|Drug Non-compliance|0|||
164066775|NCT02087865|592607662|FG001|Overall Study|Drug Non-compliance|2|||
164066776|NCT02087865|592607663|FG002|Overall Study|Drug Non-compliance|0|||
164066777|NCT02087865|592607661|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
164066778|NCT02087865|592607662|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
164066779|NCT02087865|592607663|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
164066780|NCT01319994|592607664|FG000|Overall Study|Protocol Violation|7|||
164066781|NCT01319994|592607665|FG001|Overall Study|Protocol Violation|6|||
164066782|NCT01340794|592607666|FG000|Overall Study|Withdrawal by Subject|0|||
164066783|NCT01340794|592607667|FG001|Overall Study|Withdrawal by Subject|1|||
164066784|NCT01432600|592607674|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
164066785|NCT01432600|592607675|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
164066786|NCT01432600|592607676|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
164066787|NCT00398632|592607677|FG000|Overall Study|Withdrawal by Subject|1|||
164066788|NCT00398632|592607677|FG000|Overall Study|Lack of Efficacy|1|||
164066789|NCT00640614|592607678|FG000|Overall Study|Lost to Follow-up|1|||
164066790|NCT00640614|592607679|FG001|Overall Study|Lost to Follow-up|0|||
164066791|NCT04633434|592607683|FG000|Overall Study|Lost to Follow-up|32|||
164066792|NCT04633434|592607684|FG001|Overall Study|Lost to Follow-up|32|||
164066793|NCT01005680|592607688|FG000|Overall Study|Lost to Follow-up|4|||
164066794|NCT01005680|592607689|FG001|Overall Study|Lost to Follow-up|6|||
164066795|NCT01005680|592607688|FG000|Overall Study|Withdrawal by Subject|1|||
164066796|NCT01005680|592607689|FG001|Overall Study|Withdrawal by Subject|4|||
164066797|NCT01005680|592607688|FG000|Overall Study|Physician Decision|1|||
164066798|NCT01005680|592607689|FG001|Overall Study|Physician Decision|1|||
164066799|NCT00297882|592607691|FG000|Day 14|Lack of Efficacy|12|||
164066800|NCT00297882|592607692|FG001|Day 14|Lack of Efficacy|49|||
164104905|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164066801|NCT00297882|592607691|FG000|Day 28|Lost to Follow-up|13|||
164066802|NCT00297882|592607692|FG001|Day 28|Lost to Follow-up|23|||
164066803|NCT00297882|592607691|FG000|Day 28|Lack of Efficacy|3|||
164066804|NCT00297882|592607692|FG001|Day 28|Lack of Efficacy|0|||
164066805|NCT02118896|592607693|FG000|Overall Study|Death|4|||
164066806|NCT02118896|592607694|FG001|Overall Study|Death|0|||
164066807|NCT02118896|592607695|FG002|Overall Study|Death|4|||
164066808|NCT02118896|592607696|FG003|Overall Study|Death|6|||
164066809|NCT02118896|592607697|FG004|Overall Study|Death|3|||
164066810|NCT02118896|592607698|FG005|Overall Study|Death|1|||
164066811|NCT02118896|592607699|FG006|Overall Study|Death|0|||
164066812|NCT02118896|592607700|FG007|Overall Study|Death|0|||
164066813|NCT02118896|592607701|FG008|Overall Study|Death|0|||
164066814|NCT02118896|592607702|FG009|Overall Study|Death|0|||
164066815|NCT02118896|592607693|FG000|Overall Study|Adverse Event|5|||
164066816|NCT02118896|592607694|FG001|Overall Study|Adverse Event|4|||
164066817|NCT02118896|592607695|FG002|Overall Study|Adverse Event|4|||
164066818|NCT02118896|592607696|FG003|Overall Study|Adverse Event|5|||
164066819|NCT02118896|592607697|FG004|Overall Study|Adverse Event|5|||
164066820|NCT02118896|592607698|FG005|Overall Study|Adverse Event|9|||
164066821|NCT02118896|592607699|FG006|Overall Study|Adverse Event|1|||
164066822|NCT02118896|592607700|FG007|Overall Study|Adverse Event|1|||
164066823|NCT02118896|592607701|FG008|Overall Study|Adverse Event|4|||
164066824|NCT02118896|592607702|FG009|Overall Study|Adverse Event|0|||
164066825|NCT02118896|592607693|FG000|Overall Study|Consent withdrawn|2|||
164066826|NCT02118896|592607694|FG001|Overall Study|Consent withdrawn|0|||
164066827|NCT02118896|592607695|FG002|Overall Study|Consent withdrawn|3|||
164066828|NCT02118896|592607696|FG003|Overall Study|Consent withdrawn|4|||
164066829|NCT02118896|592607697|FG004|Overall Study|Consent withdrawn|1|||
164066830|NCT02118896|592607698|FG005|Overall Study|Consent withdrawn|4|||
164066831|NCT02118896|592607699|FG006|Overall Study|Consent withdrawn|0|||
164066832|NCT02118896|592607700|FG007|Overall Study|Consent withdrawn|0|||
164066833|NCT02118896|592607701|FG008|Overall Study|Consent withdrawn|0|||
164066834|NCT02118896|592607702|FG009|Overall Study|Consent withdrawn|0|||
164066835|NCT02118896|592607693|FG000|Overall Study|Non-compliance|2|||
164066836|NCT02118896|592607694|FG001|Overall Study|Non-compliance|1|||
164066837|NCT02118896|592607695|FG002|Overall Study|Non-compliance|1|||
164066838|NCT02118896|592607696|FG003|Overall Study|Non-compliance|5|||
164066839|NCT02118896|592607697|FG004|Overall Study|Non-compliance|0|||
164066840|NCT02118896|592607698|FG005|Overall Study|Non-compliance|1|||
164066841|NCT02118896|592607699|FG006|Overall Study|Non-compliance|0|||
164066842|NCT02118896|592607700|FG007|Overall Study|Non-compliance|1|||
164066843|NCT02118896|592607701|FG008|Overall Study|Non-compliance|0|||
164066844|NCT02118896|592607702|FG009|Overall Study|Non-compliance|0|||
164066845|NCT02118896|592607693|FG000|Overall Study|Pregnancy|1|||
164066846|NCT02118896|592607694|FG001|Overall Study|Pregnancy|1|||
164066847|NCT02118896|592607695|FG002|Overall Study|Pregnancy|0|||
164066848|NCT02118896|592607696|FG003|Overall Study|Pregnancy|0|||
164066849|NCT02118896|592607697|FG004|Overall Study|Pregnancy|1|||
164066850|NCT02118896|592607698|FG005|Overall Study|Pregnancy|3|||
164066851|NCT02118896|592607699|FG006|Overall Study|Pregnancy|1|||
164066852|NCT02118896|592607700|FG007|Overall Study|Pregnancy|0|||
164066853|NCT02118896|592607701|FG008|Overall Study|Pregnancy|0|||
164066854|NCT02118896|592607702|FG009|Overall Study|Pregnancy|0|||
164066855|NCT02118896|592607693|FG000|Overall Study|Lost to Follow-up|1|||
164066856|NCT02118896|592607694|FG001|Overall Study|Lost to Follow-up|2|||
164066857|NCT02118896|592607695|FG002|Overall Study|Lost to Follow-up|1|||
164104906|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164104907|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
164066858|NCT02118896|592607696|FG003|Overall Study|Lost to Follow-up|0|||
164066859|NCT02118896|592607697|FG004|Overall Study|Lost to Follow-up|2|||
164066860|NCT02118896|592607698|FG005|Overall Study|Lost to Follow-up|1|||
164066861|NCT02118896|592607699|FG006|Overall Study|Lost to Follow-up|0|||
164066862|NCT02118896|592607700|FG007|Overall Study|Lost to Follow-up|0|||
164066863|NCT02118896|592607701|FG008|Overall Study|Lost to Follow-up|0|||
164066864|NCT02118896|592607702|FG009|Overall Study|Lost to Follow-up|0|||
164066865|NCT02118896|592607693|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
164066866|NCT02118896|592607694|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
164066867|NCT02118896|592607695|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
164066868|NCT02118896|592607696|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
164066869|NCT02118896|592607697|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
164104908|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
164066870|NCT02118896|592607698|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
164066871|NCT02118896|592607699|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
164066872|NCT02118896|592607700|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
164066873|NCT02118896|592607701|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
164066874|NCT02118896|592607702|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
164066875|NCT02118896|592607693|FG000|Overall Study|Prohibited medication|0|||
164066876|NCT02118896|592607694|FG001|Overall Study|Prohibited medication|0|||
164066877|NCT02118896|592607695|FG002|Overall Study|Prohibited medication|0|||
164104909|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104910|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
164104911|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104912|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104913|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104914|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104915|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104916|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104917|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104918|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104919|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104920|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104921|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
164104922|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
164104923|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
164104924|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
164104925|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104926|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104927|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104928|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104929|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104930|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104931|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104932|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104933|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104934|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104935|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
164104936|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
164104937|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104938|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
164104939|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104940|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104941|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104942|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104943|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104944|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104945|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104946|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104947|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104948|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104949|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
164104950|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164104951|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104952|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
164104953|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104954|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104955|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104956|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104957|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104958|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104959|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104960|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104961|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104962|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104963|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
164104964|NCT01695239|592749102|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
164104965|NCT01695239|592749103|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104966|NCT01695239|592749104|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104967|NCT01695239|592749105|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104968|NCT01695239|592749106|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104969|NCT01695239|592749107|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104970|NCT01695239|592749108|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104971|NCT01695239|592749109|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104972|NCT01695239|592749110|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104973|NCT01695239|592749111|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164112667|NCT00840658|592774092|FG002|Overall Study|Death|3|||
164104974|NCT01695239|592749112|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104975|NCT01695239|592749113|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104976|NCT01695239|592749114|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104977|NCT01695239|592749115|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
164104978|NCT01695239|592749102|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104979|NCT01695239|592749103|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104980|NCT01695239|592749104|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104981|NCT01695239|592749105|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104982|NCT01695239|592749106|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104983|NCT01695239|592749107|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104984|NCT01695239|592749108|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104985|NCT01695239|592749109|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
164104986|NCT01695239|592749110|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104987|NCT01695239|592749111|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104988|NCT01695239|592749112|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104989|NCT01695239|592749113|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104990|NCT01695239|592749114|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104991|NCT01695239|592749115|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
164104992|NCT01695239|592749102|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104993|NCT01695239|592749103|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104994|NCT01695239|592749104|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104995|NCT01695239|592749105|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104996|NCT01695239|592749106|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104997|NCT01695239|592749107|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104998|NCT01695239|592749108|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164104999|NCT01695239|592749109|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
164066878|NCT02118896|592607696|FG003|Overall Study|Prohibited medication|0|||
164066879|NCT02118896|592607697|FG004|Overall Study|Prohibited medication|1|||
164066880|NCT02118896|592607698|FG005|Overall Study|Prohibited medication|3|||
164066881|NCT02118896|592607699|FG006|Overall Study|Prohibited medication|0|||
164066882|NCT02118896|592607700|FG007|Overall Study|Prohibited medication|0|||
164066883|NCT02118896|592607701|FG008|Overall Study|Prohibited medication|0|||
164066884|NCT02118896|592607702|FG009|Overall Study|Prohibited medication|0|||
164066885|NCT02118896|592607693|FG000|Overall Study|Miscellaneous|1|||
164066886|NCT02118896|592607694|FG001|Overall Study|Miscellaneous|2|||
164066887|NCT02118896|592607695|FG002|Overall Study|Miscellaneous|0|||
164066888|NCT02118896|592607696|FG003|Overall Study|Miscellaneous|2|||
164066889|NCT02118896|592607697|FG004|Overall Study|Miscellaneous|0|||
164066890|NCT02118896|592607698|FG005|Overall Study|Miscellaneous|4|||
164066891|NCT02118896|592607699|FG006|Overall Study|Miscellaneous|0|||
164066892|NCT02118896|592607700|FG007|Overall Study|Miscellaneous|0|||
164105000|NCT01695239|592749110|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164105001|NCT01695239|592749111|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164105002|NCT01695239|592749112|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164105003|NCT01695239|592749113|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164105004|NCT01695239|592749114|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164105005|NCT01695239|592749115|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
164105006|NCT01695239|592749102|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105007|NCT01695239|592749103|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105008|NCT01695239|592749104|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105009|NCT01695239|592749105|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105010|NCT01695239|592749106|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105011|NCT01695239|592749107|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105012|NCT01695239|592749108|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105013|NCT01695239|592749109|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
164066893|NCT02118896|592607701|FG008|Overall Study|Miscellaneous|0|||
164105014|NCT01695239|592749110|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105015|NCT01695239|592749111|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105016|NCT01695239|592749112|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105017|NCT01695239|592749113|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105018|NCT01695239|592749114|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105019|NCT01695239|592749115|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
164105020|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105021|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105022|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164112668|NCT00840658|592774093|FG003|Overall Study|Death|3|||
164066894|NCT02118896|592607702|FG009|Overall Study|Miscellaneous|0|||
164066895|NCT04242264|592607703|FG000|Overall Study|Lost to Follow-up|2|||
164066896|NCT04242264|592607704|FG001|Overall Study|Lost to Follow-up|2|||
164066897|NCT04242264|592607705|FG002|Overall Study|Lost to Follow-up|1|||
164066898|NCT04242264|592607706|FG003|Overall Study|Lost to Follow-up|1|||
164066899|NCT04242264|592607703|FG000|Overall Study|Withdrawal by Subject|1|||
164066900|NCT04242264|592607704|FG001|Overall Study|Withdrawal by Subject|0|||
164066901|NCT04242264|592607705|FG002|Overall Study|Withdrawal by Subject|0|||
164066902|NCT04242264|592607706|FG003|Overall Study|Withdrawal by Subject|0|||
164066903|NCT02329834|592607707|FG000|Overall Study|Physician Decision|1|||
164066904|NCT02329834|592607708|FG001|Overall Study|Physician Decision|0|||
164066905|NCT00578448|592607711|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
164066906|NCT00578448|592607711|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
164066907|NCT00578448|592607711|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
164066908|NCT00578448|592607711|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
164066909|NCT01976104|592607715|FG000|Overall Study|Adverse Event|0|||
164066910|NCT01976104|592607716|FG001|Overall Study|Adverse Event|0|||
164066911|NCT01976104|592607717|FG002|Overall Study|Adverse Event|1|||
164066912|NCT01976104|592607718|FG003|Overall Study|Adverse Event|0|||
164066913|NCT01976104|592607715|FG000|Overall Study|Lost to Follow-up|3|||
164066914|NCT01976104|592607716|FG001|Overall Study|Lost to Follow-up|0|||
164066915|NCT01976104|592607717|FG002|Overall Study|Lost to Follow-up|1|||
164066916|NCT01976104|592607718|FG003|Overall Study|Lost to Follow-up|1|||
164066917|NCT01976104|592607715|FG000|Overall Study|Subject Choice|0|||
164066918|NCT01976104|592607716|FG001|Overall Study|Subject Choice|1|||
164066919|NCT01976104|592607717|FG002|Overall Study|Subject Choice|0|||
164066920|NCT01976104|592607718|FG003|Overall Study|Subject Choice|1|||
164066921|NCT01976104|592607715|FG000|Overall Study|Withdrawal by Subject|3|||
164066922|NCT01976104|592607716|FG001|Overall Study|Withdrawal by Subject|0|||
164066923|NCT01976104|592607717|FG002|Overall Study|Withdrawal by Subject|0|||
164066924|NCT01976104|592607718|FG003|Overall Study|Withdrawal by Subject|1|||
164066925|NCT01976104|592607715|FG000|Overall Study|Other|0|||
164066926|NCT01976104|592607716|FG001|Overall Study|Other|1|||
164066927|NCT01976104|592607717|FG002|Overall Study|Other|0|||
164066928|NCT01976104|592607718|FG003|Overall Study|Other|0|||
164066929|NCT01283009|592607719|FG000|Overall Study|Death|83|||
164066930|NCT01283009|592607720|FG001|Overall Study|Death|78|||
164066931|NCT01283009|592607719|FG000|Overall Study|Study ended early|23|||
164066932|NCT01283009|592607720|FG001|Overall Study|Study ended early|26|||
164066933|NCT01283009|592607719|FG000|Overall Study|Withdrawal by Subject|10|||
164066934|NCT01283009|592607720|FG001|Overall Study|Withdrawal by Subject|8|||
164066935|NCT01283009|592607719|FG000|Overall Study|Physician Decision|1|||
164066936|NCT01283009|592607720|FG001|Overall Study|Physician Decision|1|||
164066937|NCT01283009|592607719|FG000|Overall Study|Lost to Follow-up|1|||
164066938|NCT01283009|592607720|FG001|Overall Study|Lost to Follow-up|0|||
164066939|NCT01283009|592607719|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
164066940|NCT01283009|592607720|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
164066941|NCT04221373|592607721|FG000|Overall Study|Physician Decision|4|||
164066942|NCT04221373|592607722|FG001|Overall Study|Physician Decision|0|||
164066943|NCT04139642|592607732|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
164066944|NCT04139642|592607733|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
164066945|NCT00577031|592607740|FG000|Overall Study|Adverse Event|52|||
164066946|NCT00577031|592607740|FG000|Overall Study|Progression of disease|93|||
164066947|NCT00577031|592607740|FG000|Overall Study|Protocol Violation|5|||
164066948|NCT00577031|592607740|FG000|Overall Study|Participant withdrew consent|13|||
164066949|NCT00577031|592607740|FG000|Overall Study|Participant non-compliance|5|||
164066950|NCT00577031|592607740|FG000|Overall Study|Need for surgery|17|||
164066951|NCT00577031|592607740|FG000|Overall Study|Medical decision|14|||
164066952|NCT00577031|592607740|FG000|Overall Study|Death|6|||
164066953|NCT00557830|592607741|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
164066954|NCT00557830|592607742|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
164066955|NCT00557830|592607743|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
164066956|NCT00557830|592607741|FG000|Screening Treatment Phase|Adverse Event|2|||
164066957|NCT00557830|592607742|FG001|Screening Treatment Phase|Adverse Event|0|||
164066958|NCT00557830|592607743|FG002|Screening Treatment Phase|Adverse Event|0|||
164066959|NCT00557830|592607741|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
164066960|NCT00557830|592607742|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
164066961|NCT00557830|592607743|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
164066962|NCT00538473|592607744|FG000|Overall Study|Adverse Event|1|||
164066963|NCT00538473|592607745|FG001|Overall Study|Adverse Event|0|||
164066964|NCT01569074|592607746|FG000|Overall Study|Study stopped|6|||
164066965|NCT01569074|592607747|FG001|Overall Study|Study stopped|6|||
164066966|NCT01569074|592607748|FG002|Overall Study|Study stopped|8|||
164066967|NCT01569074|592607749|FG003|Overall Study|Study stopped|7|||
164066968|NCT01569074|592607750|FG004|Overall Study|Study stopped|7|||
164066969|NCT01569074|592607746|FG000|Overall Study|Study-specific discontinuation criteria|0|||
164066970|NCT01569074|592607747|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164066971|NCT01569074|592607748|FG002|Overall Study|Study-specific discontinuation criteria|0|||
164105023|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105024|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105025|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105026|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105027|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105028|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
164105029|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
164105030|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105031|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105032|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105033|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
164105034|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
164105035|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
164105036|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
164105037|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
164105038|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
164105039|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
164105040|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
164105041|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
164105042|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
164105043|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
164105044|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
164105045|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
164105046|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
164105047|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
164105048|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105049|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105050|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105051|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105052|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105053|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105054|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105055|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105056|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
164105057|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
164105058|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105059|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105060|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105061|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
164105062|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
164105063|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
164105064|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
164105065|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
164105066|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
164105067|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
164105068|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
164105069|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
164105070|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
164105071|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
164105072|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
164105073|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
164105074|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
164105075|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
164105076|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105077|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105078|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105079|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105080|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105081|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105082|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105083|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105084|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
164105085|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
164105086|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164112669|NCT00840658|592774090|FG000|Overall Study|Lost to Follow-up|3|||
164066972|NCT01569074|592607749|FG003|Overall Study|Study-specific discontinuation criteria|0|||
164066973|NCT01569074|592607750|FG004|Overall Study|Study-specific discontinuation criteria|0|||
164066974|NCT01569074|592607746|FG000|Overall Study|Severe non-compliance to protocol|0|||
164066975|NCT01569074|592607747|FG001|Overall Study|Severe non-compliance to protocol|0|||
164066976|NCT01569074|592607748|FG002|Overall Study|Severe non-compliance to protocol|1|||
164066977|NCT01569074|592607749|FG003|Overall Study|Severe non-compliance to protocol|0|||
164066978|NCT01569074|592607750|FG004|Overall Study|Severe non-compliance to protocol|0|||
164066979|NCT01569074|592607746|FG000|Overall Study|eg change in circumstances|0|||
164066980|NCT01569074|592607747|FG001|Overall Study|eg change in circumstances|2|||
164066981|NCT01569074|592607748|FG002|Overall Study|eg change in circumstances|0|||
164066982|NCT01569074|592607749|FG003|Overall Study|eg change in circumstances|1|||
164066983|NCT01569074|592607750|FG004|Overall Study|eg change in circumstances|1|||
164066984|NCT01569074|592607746|FG000|Overall Study|Adverse Event|1|||
164066985|NCT01569074|592607747|FG001|Overall Study|Adverse Event|0|||
164066986|NCT01569074|592607748|FG002|Overall Study|Adverse Event|3|||
164066987|NCT01569074|592607749|FG003|Overall Study|Adverse Event|0|||
164066988|NCT01569074|592607750|FG004|Overall Study|Adverse Event|0|||
164066989|NCT00669110|592607751|FG000|Overall Study|Adverse Event|4|||
164066990|NCT00669110|592607752|FG001|Overall Study|Adverse Event|3|||
164066991|NCT00669110|592607751|FG000|Overall Study|Caregiver request|3|||
164066992|NCT00669110|592607752|FG001|Overall Study|Caregiver request|2|||
164066993|NCT00669110|592607751|FG000|Overall Study|Physician Decision|0|||
164066994|NCT00669110|592607752|FG001|Overall Study|Physician Decision|1|||
164066995|NCT00669110|592607751|FG000|Overall Study|Lost to Follow-up|1|||
164066996|NCT00669110|592607752|FG001|Overall Study|Lost to Follow-up|0|||
164066997|NCT00669110|592607751|FG000|Overall Study|Protocol Violation|0|||
164066998|NCT00669110|592607752|FG001|Overall Study|Protocol Violation|5|||
164066999|NCT00669110|592607751|FG000|Overall Study|Withdrawal by Subject|0|||
164067000|NCT00669110|592607752|FG001|Overall Study|Withdrawal by Subject|2|||
164067001|NCT05168657|592607755|FG000|Overall Study|Adverse Event|0|||
164067002|NCT05168657|592607756|FG001|Overall Study|Adverse Event|0|||
164067003|NCT05168657|592607757|FG002|Overall Study|Adverse Event|1|||
164067004|NCT05168657|592607758|FG003|Overall Study|Adverse Event|0|||
164067005|NCT05168657|592607759|FG004|Overall Study|Adverse Event|0|||
164067006|NCT05168657|592607760|FG005|Overall Study|Adverse Event|0|||
164067007|NCT05168657|592607761|FG006|Overall Study|Adverse Event|0|||
164067008|NCT05168657|592607762|FG007|Overall Study|Adverse Event|0|||
164067009|NCT00962013|592607763|FG000|Overall Study|Did not have surgery|1|||
164067010|NCT00962013|592607763|FG000|Overall Study|Death|8|||
164067011|NCT00962013|592607763|FG000|Overall Study|Lost to Follow-up|12|||
164067012|NCT00962013|592607763|FG000|Overall Study|Unable/Unwilling to return|6|||
164067013|NCT00962013|592607763|FG000|Overall Study|Withdrawal by Subject|8|||
164067014|NCT00962013|592607763|FG000|Overall Study|Removal of study device|3|||
164067015|NCT00962013|592607763|FG000|Overall Study|Site Termination|24|||
164067016|NCT00962013|592607763|FG000|Overall Study|No 5 year evaluation|6|||
164067017|NCT05275673|592607764|FG000|Overall Study|Study Termination by Sponsor|2|||
164067018|NCT05275673|592607765|FG001|Overall Study|Study Termination by Sponsor|3|||
164067019|NCT05275673|592607764|FG000|Overall Study|Death|1|||
164067020|NCT05275673|592607765|FG001|Overall Study|Death|0|||
164067021|NCT05275673|592607764|FG000|Overall Study|Withdrawal by Subject|1|||
164067022|NCT05275673|592607765|FG001|Overall Study|Withdrawal by Subject|0|||
164067023|NCT02325739|592607766|FG000|Phase I Part|Adverse Event|1|||
164067024|NCT02325739|592607767|FG001|Phase I Part|Adverse Event|0|||
164067025|NCT02325739|592607768|FG002|Phase I Part|Adverse Event|1|||
164067026|NCT02325739|592607769|FG003|Phase I Part|Adverse Event|2|||
164067027|NCT02325739|592607770|FG004|Phase I Part|Adverse Event|3|||
164067028|NCT02325739|592607771|FG005|Phase I Part|Adverse Event|1|||
164067029|NCT02325739|592607772|FG006|Phase I Part|Adverse Event|0|||
164067030|NCT02325739|592607773|FG007|Phase I Part|Adverse Event|2|||
164067031|NCT02325739|592607774|FG008|Phase I Part|Adverse Event|0|||
164067032|NCT02325739|592607775|FG009|Phase I Part|Adverse Event|0|||
164067033|NCT02325739|592607776|FG010|Phase I Part|Adverse Event|0|||
164067034|NCT02325739|592607766|FG000|Phase I Part|Progressive disease|9|||
164067035|NCT02325739|592607767|FG001|Phase I Part|Progressive disease|6|||
164067036|NCT02325739|592607768|FG002|Phase I Part|Progressive disease|3|||
164067037|NCT02325739|592607769|FG003|Phase I Part|Progressive disease|23|||
164067038|NCT02325739|592607770|FG004|Phase I Part|Progressive disease|14|||
164067039|NCT02325739|592607771|FG005|Phase I Part|Progressive disease|6|||
164067040|NCT02325739|592607772|FG006|Phase I Part|Progressive disease|6|||
164067041|NCT02325739|592607773|FG007|Phase I Part|Progressive disease|3|||
164067042|NCT02325739|592607774|FG008|Phase I Part|Progressive disease|0|||
164067043|NCT02325739|592607775|FG009|Phase I Part|Progressive disease|0|||
164067044|NCT02325739|592607776|FG010|Phase I Part|Progressive disease|0|||
164067045|NCT02325739|592607766|FG000|Phase I Part|Subject/guardian decision|1|||
164067046|NCT02325739|592607767|FG001|Phase I Part|Subject/guardian decision|0|||
164067047|NCT02325739|592607768|FG002|Phase I Part|Subject/guardian decision|1|||
164067048|NCT02325739|592607769|FG003|Phase I Part|Subject/guardian decision|1|||
164067049|NCT02325739|592607770|FG004|Phase I Part|Subject/guardian decision|0|||
164105087|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105088|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105089|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
164105090|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105091|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105092|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105093|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105094|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105095|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105096|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105097|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105098|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
164105099|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
164105100|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105101|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105102|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105103|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
164105104|NCT01695239|592749102|FG000|Extension Long-Term Extension Periods|Death|0|||
164105105|NCT01695239|592749103|FG001|Extension Long-Term Extension Periods|Death|0|||
164105106|NCT01695239|592749104|FG002|Extension Long-Term Extension Periods|Death|0|||
164105107|NCT01695239|592749105|FG003|Extension Long-Term Extension Periods|Death|0|||
164105108|NCT01695239|592749106|FG004|Extension Long-Term Extension Periods|Death|0|||
164105109|NCT01695239|592749107|FG005|Extension Long-Term Extension Periods|Death|0|||
164105110|NCT01695239|592749108|FG006|Extension Long-Term Extension Periods|Death|0|||
164105111|NCT01695239|592749109|FG007|Extension Long-Term Extension Periods|Death|0|||
164105112|NCT01695239|592749110|FG008|Extension Long-Term Extension Periods|Death|1|||
164105113|NCT01695239|592749111|FG009|Extension Long-Term Extension Periods|Death|0|||
164105114|NCT01695239|592749112|FG010|Extension Long-Term Extension Periods|Death|0|||
164105115|NCT01695239|592749113|FG011|Extension Long-Term Extension Periods|Death|0|||
164105116|NCT01695239|592749114|FG012|Extension Long-Term Extension Periods|Death|0|||
164105117|NCT01695239|592749115|FG013|Extension Long-Term Extension Periods|Death|0|||
164105118|NCT01695239|592749102|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105119|NCT01695239|592749103|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105120|NCT01695239|592749104|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105121|NCT01695239|592749105|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105122|NCT01695239|592749106|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105123|NCT01695239|592749107|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105124|NCT01695239|592749108|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105125|NCT01695239|592749109|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105126|NCT01695239|592749110|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105127|NCT01695239|592749111|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105128|NCT01695239|592749112|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
164105129|NCT01695239|592749113|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
164105130|NCT01695239|592749114|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
164105131|NCT01695239|592749115|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
164105132|NCT01695239|592749102|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105133|NCT01695239|592749103|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105134|NCT01695239|592749104|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105135|NCT01695239|592749105|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105136|NCT01695239|592749106|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105137|NCT01695239|592749107|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105138|NCT01695239|592749108|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105139|NCT01695239|592749109|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105140|NCT01695239|592749110|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105141|NCT01695239|592749111|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105142|NCT01695239|592749112|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105143|NCT01695239|592749113|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164105144|NCT01695239|592749114|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164105145|NCT01695239|592749115|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
164105146|NCT01695239|592749102|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105147|NCT01695239|592749103|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105148|NCT01695239|592749104|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105149|NCT01695239|592749105|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105150|NCT01695239|592749106|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105151|NCT01695239|592749107|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105152|NCT01695239|592749108|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105153|NCT01695239|592749109|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
164067050|NCT02325739|592607771|FG005|Phase I Part|Subject/guardian decision|0|||
164067051|NCT02325739|592607772|FG006|Phase I Part|Subject/guardian decision|0|||
164067052|NCT02325739|592607773|FG007|Phase I Part|Subject/guardian decision|1|||
164067053|NCT02325739|592607774|FG008|Phase I Part|Subject/guardian decision|0|||
164067054|NCT02325739|592607775|FG009|Phase I Part|Subject/guardian decision|0|||
164067055|NCT02325739|592607776|FG010|Phase I Part|Subject/guardian decision|0|||
164067056|NCT02325739|592607766|FG000|Phase I Part|Death|0|||
164067057|NCT02325739|592607767|FG001|Phase I Part|Death|0|||
164067058|NCT02325739|592607768|FG002|Phase I Part|Death|0|||
164067059|NCT02325739|592607769|FG003|Phase I Part|Death|0|||
164067060|NCT02325739|592607770|FG004|Phase I Part|Death|2|||
164067061|NCT02325739|592607771|FG005|Phase I Part|Death|0|||
164067062|NCT02325739|592607772|FG006|Phase I Part|Death|0|||
164067063|NCT02325739|592607773|FG007|Phase I Part|Death|0|||
164067064|NCT02325739|592607774|FG008|Phase I Part|Death|0|||
164067065|NCT02325739|592607775|FG009|Phase I Part|Death|0|||
164067066|NCT02325739|592607776|FG010|Phase I Part|Death|0|||
164067067|NCT02325739|592607766|FG000|Phase II Part|Adverse Event|0|||
164067068|NCT02325739|592607767|FG001|Phase II Part|Adverse Event|0|||
164067069|NCT02325739|592607768|FG002|Phase II Part|Adverse Event|0|||
164067070|NCT02325739|592607769|FG003|Phase II Part|Adverse Event|0|||
164067071|NCT02325739|592607770|FG004|Phase II Part|Adverse Event|0|||
164067072|NCT02325739|592607771|FG005|Phase II Part|Adverse Event|0|||
164067073|NCT02325739|592607772|FG006|Phase II Part|Adverse Event|0|||
164067074|NCT02325739|592607773|FG007|Phase II Part|Adverse Event|0|||
164067075|NCT02325739|592607774|FG008|Phase II Part|Adverse Event|4|||
164067076|NCT02325739|592607775|FG009|Phase II Part|Adverse Event|5|||
164067077|NCT02325739|592607776|FG010|Phase II Part|Adverse Event|1|||
164067078|NCT02325739|592607766|FG000|Phase II Part|Physician Decision|0|||
164067079|NCT02325739|592607767|FG001|Phase II Part|Physician Decision|0|||
164067080|NCT02325739|592607768|FG002|Phase II Part|Physician Decision|0|||
164067081|NCT02325739|592607769|FG003|Phase II Part|Physician Decision|0|||
164067082|NCT02325739|592607770|FG004|Phase II Part|Physician Decision|0|||
164067083|NCT02325739|592607771|FG005|Phase II Part|Physician Decision|0|||
164067084|NCT02325739|592607772|FG006|Phase II Part|Physician Decision|0|||
164067085|NCT02325739|592607773|FG007|Phase II Part|Physician Decision|0|||
164067086|NCT02325739|592607774|FG008|Phase II Part|Physician Decision|0|||
164067087|NCT02325739|592607775|FG009|Phase II Part|Physician Decision|1|||
164067088|NCT02325739|592607776|FG010|Phase II Part|Physician Decision|0|||
164067089|NCT02325739|592607766|FG000|Phase II Part|Progressive disease|0|||
164067090|NCT02325739|592607767|FG001|Phase II Part|Progressive disease|0|||
164067091|NCT02325739|592607768|FG002|Phase II Part|Progressive disease|0|||
164067092|NCT02325739|592607769|FG003|Phase II Part|Progressive disease|0|||
164067093|NCT02325739|592607770|FG004|Phase II Part|Progressive disease|0|||
164067094|NCT02325739|592607771|FG005|Phase II Part|Progressive disease|0|||
164067095|NCT02325739|592607772|FG006|Phase II Part|Progressive disease|0|||
164067096|NCT02325739|592607773|FG007|Phase II Part|Progressive disease|0|||
164067097|NCT02325739|592607774|FG008|Phase II Part|Progressive disease|22|||
164067098|NCT02325739|592607775|FG009|Phase II Part|Progressive disease|29|||
164067099|NCT02325739|592607776|FG010|Phase II Part|Progressive disease|18|||
164067100|NCT02325739|592607766|FG000|Phase II Part|Subject/guardian decision|0|||
164067101|NCT02325739|592607767|FG001|Phase II Part|Subject/guardian decision|0|||
164067102|NCT02325739|592607768|FG002|Phase II Part|Subject/guardian decision|0|||
164067103|NCT02325739|592607769|FG003|Phase II Part|Subject/guardian decision|0|||
164067104|NCT02325739|592607770|FG004|Phase II Part|Subject/guardian decision|0|||
164067105|NCT02325739|592607771|FG005|Phase II Part|Subject/guardian decision|0|||
164067106|NCT02325739|592607772|FG006|Phase II Part|Subject/guardian decision|0|||
164067107|NCT02325739|592607773|FG007|Phase II Part|Subject/guardian decision|0|||
164067108|NCT02325739|592607774|FG008|Phase II Part|Subject/guardian decision|4|||
164067109|NCT02325739|592607775|FG009|Phase II Part|Subject/guardian decision|1|||
164067110|NCT02325739|592607776|FG010|Phase II Part|Subject/guardian decision|1|||
164067111|NCT02335411|592607777|FG000|Overall Study|Death|223|||
164067112|NCT02335411|592607778|FG001|Overall Study|Death|22|||
164067113|NCT02335411|592607779|FG002|Overall Study|Death|26|||
164067114|NCT02335411|592607777|FG000|Overall Study|Physician Decision|3|||
164067115|NCT02335411|592607778|FG001|Overall Study|Physician Decision|0|||
164067116|NCT02335411|592607779|FG002|Overall Study|Physician Decision|0|||
164067117|NCT02335411|592607777|FG000|Overall Study|Protocol Violation|1|||
164067118|NCT02335411|592607778|FG001|Overall Study|Protocol Violation|0|||
164067119|NCT02335411|592607779|FG002|Overall Study|Protocol Violation|0|||
164067120|NCT02335411|592607777|FG000|Overall Study|Withdrawal by Subject|11|||
164067121|NCT02335411|592607778|FG001|Overall Study|Withdrawal by Subject|0|||
164067122|NCT02335411|592607779|FG002|Overall Study|Withdrawal by Subject|3|||
164067123|NCT02335411|592607777|FG000|Overall Study|Sponsor Decision|12|||
164067124|NCT02335411|592607778|FG001|Overall Study|Sponsor Decision|3|||
164067125|NCT02335411|592607779|FG002|Overall Study|Sponsor Decision|2|||
164067126|NCT02335411|592607777|FG000|Overall Study|Adverse Event|9|||
164067127|NCT02335411|592607778|FG001|Overall Study|Adverse Event|0|||
164067128|NCT02335411|592607779|FG002|Overall Study|Adverse Event|0|||
164067129|NCT03843775|592607780|FG000|Overall Study|Adverse Event|1|||
164067130|NCT03843775|592607781|FG001|Overall Study|Adverse Event|1|||
164105154|NCT01695239|592749110|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105155|NCT01695239|592749111|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105156|NCT01695239|592749112|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105157|NCT01695239|592749113|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105158|NCT01695239|592749114|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
164105159|NCT01695239|592749115|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
164105160|NCT01695239|592749102|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105161|NCT01695239|592749103|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105162|NCT01695239|592749104|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105163|NCT01695239|592749105|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105164|NCT01695239|592749106|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105165|NCT01695239|592749107|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105166|NCT01695239|592749108|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105167|NCT01695239|592749109|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105168|NCT01695239|592749110|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105169|NCT01695239|592749111|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105170|NCT01695239|592749112|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105171|NCT01695239|592749113|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105172|NCT01695239|592749114|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
164105173|NCT01695239|592749115|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
164105174|NCT03502811|592749117|FG000|Overall Study|Death|157|||
164105175|NCT03502811|592749117|FG000|Overall Study|Withdrawal by Subject|105|||
164105176|NCT03502811|592749117|FG000|Overall Study|Lost to Follow-up|26|||
164105177|NCT03502811|592749117|FG000|Overall Study|No Visits (Missed)|31|||
164067131|NCT03843775|592607780|FG000|Overall Study|Lack of Efficacy|2|||
164067132|NCT03843775|592607781|FG001|Overall Study|Lack of Efficacy|6|||
164067133|NCT03843775|592607780|FG000|Overall Study|Withdrawal by Subject|0|||
164067134|NCT03843775|592607781|FG001|Overall Study|Withdrawal by Subject|1|||
164067135|NCT00530621|592607786|FG000|Overall Study|Adverse Event|11|||
164067136|NCT00530621|592607787|FG001|Overall Study|Adverse Event|8|||
164067137|NCT00530621|592607786|FG000|Overall Study|Physician Decision|2|||
164067138|NCT00530621|592607787|FG001|Overall Study|Physician Decision|4|||
164067139|NCT00530621|592607786|FG000|Overall Study|Progressive Disease (PD)|47|||
164067140|NCT00530621|592607787|FG001|Overall Study|Progressive Disease (PD)|40|||
164067141|NCT00530621|592607786|FG000|Overall Study|Sponsor Decision|12|||
164067142|NCT00530621|592607787|FG001|Overall Study|Sponsor Decision|15|||
164067143|NCT00530621|592607786|FG000|Overall Study|Subject Decision|4|||
164067144|NCT00530621|592607787|FG001|Overall Study|Subject Decision|7|||
164067145|NCT00530621|592607786|FG000|Overall Study|Death|3|||
164067146|NCT00530621|592607787|FG001|Overall Study|Death|6|||
164067147|NCT00530621|592607786|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
164067148|NCT00530621|592607787|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
164067149|NCT02596009|592607788|FG000|Overall Study|Administrative problems|0|||
164067150|NCT02596009|592607789|FG001|Overall Study|Administrative problems|1|||
164067151|NCT02596009|592607790|FG002|Overall Study|Administrative problems|0|||
164067152|NCT02596009|592607791|FG003|Overall Study|Administrative problems|0|||
164067153|NCT02596009|592607792|FG004|Overall Study|Administrative problems|0|||
164067154|NCT02596009|592607793|FG005|Overall Study|Administrative problems|0|||
164067155|NCT04611152|592607796|FG000|Overall Study|Adverse Event|9|||
164067156|NCT04611152|592607797|FG001|Overall Study|Adverse Event|8|||
164067157|NCT04611152|592607796|FG000|Overall Study|Non-compliance with study schedule|1|||
164067158|NCT04611152|592607797|FG001|Overall Study|Non-compliance with study schedule|3|||
164067159|NCT04611152|592607796|FG000|Overall Study|Withdrawal by Subject|5|||
164067160|NCT04611152|592607797|FG001|Overall Study|Withdrawal by Subject|6|||
164067161|NCT04611152|592607796|FG000|Overall Study|Lost to Follow-up|11|||
164067162|NCT04611152|592607797|FG001|Overall Study|Lost to Follow-up|2|||
164067163|NCT05012943|592607798|FG000|Overall Study|Adverse Event|2|||
164067164|NCT05012943|592607799|FG001|Overall Study|Adverse Event|1|||
164067165|NCT05012943|592607800|FG002|Overall Study|Adverse Event|0|||
164067166|NCT05012943|592607798|FG000|Overall Study|Withdrawal by Subject|1052|||
164067167|NCT05012943|592607799|FG001|Overall Study|Withdrawal by Subject|1006|||
164105178|NCT03913377|592749118|FG000|Period 1|Test Article no longer available|0|||
164105179|NCT03913377|592749119|FG001|Period 1|Test Article no longer available|1|||
164105180|NCT03913377|592749120|FG002|Period 1|Test Article no longer available|0|||
164105181|NCT03913377|592749118|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
164105182|NCT03913377|592749119|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
164105183|NCT03913377|592749120|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
164105184|NCT05239195|592749121|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
164105185|NCT05239195|592749122|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
164105186|NCT00081653|592749123|FG000|Overall Study|Adverse Event|23|||
164105187|NCT00081653|592749124|FG001|Overall Study|Adverse Event|17|||
164067168|NCT05012943|592607800|FG002|Overall Study|Withdrawal by Subject|20|||
164105188|NCT00081653|592749123|FG000|Overall Study|Lost to Follow-up|2|||
164105189|NCT00081653|592749124|FG001|Overall Study|Lost to Follow-up|4|||
164105190|NCT00081653|592749123|FG000|Overall Study|Refused Treatment|18|||
164105191|NCT00081653|592749124|FG001|Overall Study|Refused Treatment|14|||
164067169|NCT05012943|592607798|FG000|Overall Study|Death|25|||
164067170|NCT05012943|592607799|FG001|Overall Study|Death|17|||
164067171|NCT05012943|592607800|FG002|Overall Study|Death|4|||
164067172|NCT05012943|592607798|FG000|Overall Study|Lost to Follow-up|11|||
164067173|NCT05012943|592607799|FG001|Overall Study|Lost to Follow-up|24|||
164067174|NCT05012943|592607800|FG002|Overall Study|Lost to Follow-up|3|||
164067175|NCT05012943|592607798|FG000|Overall Study|Physician Decision|1|||
164067176|NCT05012943|592607799|FG001|Overall Study|Physician Decision|1|||
164067177|NCT05012943|592607800|FG002|Overall Study|Physician Decision|0|||
164067178|NCT05012943|592607798|FG000|Overall Study|Other than Specified|2|||
164067179|NCT05012943|592607799|FG001|Overall Study|Other than Specified|1|||
164067180|NCT05012943|592607800|FG002|Overall Study|Other than Specified|0|||
164067181|NCT00400985|592607801|FG000|Overall Study|Withdrawal by Subject|5|||
164067182|NCT00400985|592607801|FG000|Overall Study|system modification|8|||
164067183|NCT00400985|592607801|FG000|Overall Study|Death|30|||
164067184|NCT00400985|592607801|FG000|Overall Study|Lost to Follow-up|9|||
164067185|NCT04755283|592607804|FG000|Overall Study|Withdrawal by Subject|14|||
164067186|NCT04755283|592607805|FG001|Overall Study|Withdrawal by Subject|3|||
164067187|NCT04755283|592607806|FG002|Overall Study|Withdrawal by Subject|6|||
164067188|NCT04755283|592607804|FG000|Overall Study|Lost to Follow-up|0|||
164067189|NCT04755283|592607805|FG001|Overall Study|Lost to Follow-up|0|||
164067190|NCT04755283|592607806|FG002|Overall Study|Lost to Follow-up|1|||
164067191|NCT04755283|592607804|FG000|Overall Study|Death|31|||
164067192|NCT04755283|592607805|FG001|Overall Study|Death|36|||
164067193|NCT04755283|592607806|FG002|Overall Study|Death|34|||
164067194|NCT02851069|592607807|FG000|Overall Study|Failure to Return|3|||
164067195|NCT02851069|592607807|FG000|Overall Study|Other|3|||
164067196|NCT01083121|592607808|FG000|Overall Study|Use of Humira outside the approved label|81|||
164067197|NCT04115488|592607809|FG000|Overall Study|Adverse Event|8|||
164067198|NCT04115488|592607810|FG001|Overall Study|Adverse Event|4|||
164067199|NCT04115488|592607809|FG000|Overall Study|Withdrawal by Subject|3|||
164067200|NCT04115488|592607810|FG001|Overall Study|Withdrawal by Subject|6|||
164067201|NCT04115488|592607809|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
164067202|NCT04115488|592607810|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
164067203|NCT04115488|592607809|FG000|Overall Study|Patient 's location change|1|||
164067204|NCT04115488|592607810|FG001|Overall Study|Patient 's location change|0|||
164067205|NCT04115488|592607809|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
164067206|NCT04115488|592607810|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
164067207|NCT00885677|592607811|FG000|Overall Study|Death|40|||
164067208|NCT00885677|592607812|FG001|Overall Study|Death|34|||
164067209|NCT00885677|592607811|FG000|Overall Study|Lost to Follow-up|15|||
164067210|NCT00885677|592607812|FG001|Overall Study|Lost to Follow-up|13|||
164067211|NCT00885677|592607811|FG000|Overall Study|Protocol Violation|54|||
164067212|NCT00885677|592607812|FG001|Overall Study|Protocol Violation|54|||
164067213|NCT00885677|592607811|FG000|Overall Study|premature study closure|41|||
164067214|NCT00885677|592607812|FG001|Overall Study|premature study closure|44|||
164067215|NCT00885677|592607811|FG000|Overall Study|device/lead revision or replacement|7|||
164067216|NCT00885677|592607812|FG001|Overall Study|device/lead revision or replacement|6|||
164067217|NCT00885677|592607811|FG000|Overall Study|Heart transplantation|1|||
164067218|NCT00885677|592607812|FG001|Overall Study|Heart transplantation|0|||
164067219|NCT00885677|592607811|FG000|Overall Study|Inclusion/exclusion not met|25|||
164067220|NCT00885677|592607812|FG001|Overall Study|Inclusion/exclusion not met|27|||
164067221|NCT00167414|592607816|FG000|Overall Study|Death|10|||
164067222|NCT00795886|592607821|FG000|Overall Study|Death|10|||
164067223|NCT05554471|592607822|FG000|Overall Study|Physician Decision|2|||
164067224|NCT05554471|592607823|FG001|Overall Study|Physician Decision|1|||
164067225|NCT05554471|592607822|FG000|Overall Study|Lost to Follow-up|2|||
164067226|NCT05554471|592607823|FG001|Overall Study|Lost to Follow-up|1|||
164067227|NCT05554471|592607822|FG000|Overall Study|Death|0|||
164067228|NCT05554471|592607823|FG001|Overall Study|Death|1|||
164067229|NCT02062385|592607826|FG000|Overall Study|Adverse Event|19|||
164067230|NCT02062385|592607827|FG001|Overall Study|Adverse Event|13|||
164067231|NCT02062385|592607828|FG002|Overall Study|Adverse Event|1|||
164067232|NCT02062385|592607829|FG003|Overall Study|Adverse Event|0|||
164067233|NCT02062385|592607826|FG000|Overall Study|Protocol Violation|1|||
164067234|NCT02062385|592607827|FG001|Overall Study|Protocol Violation|0|||
164067235|NCT02062385|592607828|FG002|Overall Study|Protocol Violation|0|||
164105192|NCT00081653|592749123|FG000|Overall Study|Low bone mineral density|1|||
164067236|NCT02062385|592607829|FG003|Overall Study|Protocol Violation|0|||
164067237|NCT02062385|592607826|FG000|Overall Study|Incomplete EPI by database lock|2|||
164067238|NCT02062385|592607827|FG001|Overall Study|Incomplete EPI by database lock|0|||
164067239|NCT02062385|592607828|FG002|Overall Study|Incomplete EPI by database lock|0|||
164067240|NCT02062385|592607829|FG003|Overall Study|Incomplete EPI by database lock|0|||
164067241|NCT02062385|592607826|FG000|Overall Study|Moved|10|||
164067242|NCT02062385|592607827|FG001|Overall Study|Moved|11|||
164105193|NCT00081653|592749124|FG001|Overall Study|Low bone mineral density|0|||
164067243|NCT02062385|592607828|FG002|Overall Study|Moved|1|||
164067244|NCT02062385|592607829|FG003|Overall Study|Moved|0|||
164067245|NCT02062385|592607826|FG000|Overall Study|Withdrawn by parent/guardian|46|||
164067246|NCT02062385|592607827|FG001|Overall Study|Withdrawn by parent/guardian|41|||
164067247|NCT02062385|592607828|FG002|Overall Study|Withdrawn by parent/guardian|9|||
164067248|NCT02062385|592607829|FG003|Overall Study|Withdrawn by parent/guardian|8|||
164067249|NCT02062385|592607826|FG000|Overall Study|Death|0|||
164067250|NCT02062385|592607827|FG001|Overall Study|Death|0|||
164067251|NCT02062385|592607828|FG002|Overall Study|Death|0|||
164067252|NCT02062385|592607829|FG003|Overall Study|Death|1|||
164067253|NCT02062385|592607826|FG000|Overall Study|Lost to Follow-up|0|||
164067254|NCT02062385|592607827|FG001|Overall Study|Lost to Follow-up|0|||
164067255|NCT02062385|592607828|FG002|Overall Study|Lost to Follow-up|1|||
164067256|NCT02062385|592607829|FG003|Overall Study|Lost to Follow-up|0|||
164067257|NCT03188991|592607830|FG000|Overall Study|Withdrawal by Subject|0|||
164067258|NCT03188991|592607831|FG001|Overall Study|Withdrawal by Subject|0|||
164067259|NCT03188991|592607832|FG002|Overall Study|Withdrawal by Subject|0|||
164067260|NCT03188991|592607833|FG003|Overall Study|Withdrawal by Subject|1|||
164067261|NCT00223990|592607834|FG000|Overall Study|Moved from area|2|||
164067262|NCT00223990|592607835|FG001|Overall Study|Moved from area|1|||
164067263|NCT00223990|592607834|FG000|Overall Study|Withdrawal by Subject|4|||
164067264|NCT00223990|592607835|FG001|Overall Study|Withdrawal by Subject|8|||
164067265|NCT00223990|592607834|FG000|Overall Study|Lost to Follow-up|1|||
164067266|NCT00223990|592607835|FG001|Overall Study|Lost to Follow-up|0|||
164067267|NCT02674568|592609902|FG000|Overall Study|Withdrawal by Subject|5|||
164067268|NCT02674568|592609902|FG000|Overall Study|Death|303|||
164067269|NCT02674568|592609902|FG000|Overall Study|Physician Decision|2|||
164067270|NCT02674568|592609902|FG000|Overall Study|Lost to Follow-up|9|||
164067271|NCT02674568|592609902|FG000|Overall Study|Other, Not Specified|20|||
164067272|NCT01808508|592609905|FG000|Overall Study|Lost to Follow-up|1|||
164067273|NCT01808508|592609906|FG001|Overall Study|Lost to Follow-up|0|||
164067274|NCT01808508|592609907|FG002|Overall Study|Lost to Follow-up|0|||
164067275|NCT01118949|592609908|FG000|Overall Study|Adverse Event|5|||
164067276|NCT01118949|592609908|FG000|Overall Study|Withdrawal by Subject|4|||
164067277|NCT03255226|592609909|FG000|Overall Study|Adverse Event|2|||
164067278|NCT03255226|592609909|FG000|Overall Study|Physician Decision|3|||
164067279|NCT03255226|592609909|FG000|Overall Study|Withdrawal by Subject|1|||
164067280|NCT03255226|592609909|FG000|Overall Study|Serum or blood sodium increased|4|||
164067281|NCT03255226|592609909|FG000|Overall Study|Serum or blood potassium increased|4|||
164067282|NCT00648739|592609910|FG000|Overall Study|Adverse Event|1|||
164067283|NCT00648739|592609911|FG001|Overall Study|Adverse Event|0|||
164067284|NCT00648739|592609912|FG002|Overall Study|Adverse Event|1|||
164067285|NCT00648739|592609913|FG003|Overall Study|Adverse Event|2|||
164067286|NCT00648739|592609914|FG004|Overall Study|Adverse Event|1|||
164067287|NCT00648739|592609915|FG005|Overall Study|Adverse Event|0|||
164067288|NCT00648739|592609916|FG006|Overall Study|Adverse Event|0|||
164067289|NCT00648739|592609910|FG000|Overall Study|Withdrawal by Subject|1|||
164067290|NCT00648739|592609911|FG001|Overall Study|Withdrawal by Subject|0|||
164067291|NCT00648739|592609912|FG002|Overall Study|Withdrawal by Subject|1|||
164067292|NCT00648739|592609913|FG003|Overall Study|Withdrawal by Subject|0|||
164067293|NCT00648739|592609914|FG004|Overall Study|Withdrawal by Subject|0|||
164067294|NCT00648739|592609915|FG005|Overall Study|Withdrawal by Subject|2|||
164067295|NCT00648739|592609916|FG006|Overall Study|Withdrawal by Subject|0|||
164067296|NCT00648739|592609910|FG000|Overall Study|Lack of Efficacy|0|||
164067297|NCT00648739|592609911|FG001|Overall Study|Lack of Efficacy|0|||
164067298|NCT00648739|592609912|FG002|Overall Study|Lack of Efficacy|0|||
164067299|NCT00648739|592609913|FG003|Overall Study|Lack of Efficacy|0|||
164067300|NCT00648739|592609914|FG004|Overall Study|Lack of Efficacy|1|||
164067301|NCT00648739|592609915|FG005|Overall Study|Lack of Efficacy|2|||
164067302|NCT00648739|592609916|FG006|Overall Study|Lack of Efficacy|0|||
164067303|NCT00648739|592609910|FG000|Overall Study|Investigator Considered it Advisable|0|||
164067304|NCT00648739|592609911|FG001|Overall Study|Investigator Considered it Advisable|0|||
164067305|NCT00648739|592609912|FG002|Overall Study|Investigator Considered it Advisable|0|||
164067306|NCT00648739|592609913|FG003|Overall Study|Investigator Considered it Advisable|0|||
164067307|NCT00648739|592609914|FG004|Overall Study|Investigator Considered it Advisable|0|||
164067308|NCT00648739|592609915|FG005|Overall Study|Investigator Considered it Advisable|1|||
164067309|NCT00648739|592609916|FG006|Overall Study|Investigator Considered it Advisable|1|||
164067310|NCT00648739|592609910|FG000|Overall Study|Death|0|||
164067311|NCT00648739|592609911|FG001|Overall Study|Death|1|||
164067312|NCT00648739|592609912|FG002|Overall Study|Death|0|||
164067313|NCT00648739|592609913|FG003|Overall Study|Death|0|||
164067314|NCT00648739|592609914|FG004|Overall Study|Death|0|||
164067315|NCT00648739|592609915|FG005|Overall Study|Death|0|||
164067316|NCT00648739|592609916|FG006|Overall Study|Death|0|||
164067317|NCT00648739|592609910|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
164067318|NCT00648739|592609911|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
164067319|NCT00648739|592609912|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
164067320|NCT00648739|592609913|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
164067321|NCT00648739|592609914|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
164067322|NCT00648739|592609915|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
164067323|NCT00648739|592609916|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
164067324|NCT00648739|592609910|FG000|Overall Study|Follow-up Visits Not Completed|0|||
164067325|NCT00648739|592609911|FG001|Overall Study|Follow-up Visits Not Completed|1|||
164067326|NCT00648739|592609912|FG002|Overall Study|Follow-up Visits Not Completed|0|||
164067327|NCT00648739|592609913|FG003|Overall Study|Follow-up Visits Not Completed|0|||
164067328|NCT00648739|592609914|FG004|Overall Study|Follow-up Visits Not Completed|0|||
164067329|NCT00648739|592609915|FG005|Overall Study|Follow-up Visits Not Completed|0|||
164067330|NCT00648739|592609916|FG006|Overall Study|Follow-up Visits Not Completed|0|||
164067331|NCT03387423|592609921|FG000|Overall Study|Lost to Follow-up|16|||
164067332|NCT03387423|592609922|FG001|Overall Study|Lost to Follow-up|12|||
164067333|NCT03387423|592609923|FG002|Overall Study|Lost to Follow-up|1|||
164067334|NCT03387423|592609924|FG003|Overall Study|Lost to Follow-up|0|||
164067335|NCT03387423|592609921|FG000|Overall Study|Other|0|||
164067336|NCT03387423|592609922|FG001|Overall Study|Other|3|||
164067337|NCT03387423|592609923|FG002|Overall Study|Other|0|||
164067338|NCT03387423|592609924|FG003|Overall Study|Other|0|||
164067339|NCT03387423|592609921|FG000|Overall Study|Administrative Reason|166|||
164067340|NCT03387423|592609922|FG001|Overall Study|Administrative Reason|89|||
164067341|NCT03387423|592609923|FG002|Overall Study|Administrative Reason|17|||
164067342|NCT03387423|592609924|FG003|Overall Study|Administrative Reason|19|||
164067343|NCT03387423|592609921|FG000|Overall Study|Revocation Consent|76|||
164067344|NCT03387423|592609922|FG001|Overall Study|Revocation Consent|32|||
164067345|NCT03387423|592609923|FG002|Overall Study|Revocation Consent|3|||
164067346|NCT03387423|592609924|FG003|Overall Study|Revocation Consent|5|||
164067347|NCT03862807|592609927|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
164067348|NCT04362761|592609928|FG000|Part A (48 Weeks)|Adverse Event|2|||
164067349|NCT04362761|592609928|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
164067350|NCT04362761|592609928|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
164067351|NCT04362761|592609928|FG000|Part A (48 Weeks)|Other|5|||
164067352|NCT04362761|592609928|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
164067353|NCT04362761|592609928|FG000|Part B (86 Weeks)|Other|4|||
164067354|NCT00798707|592609934|FG000|Overall Study|Adverse Event|6|||
164067355|NCT00798707|592609935|FG001|Overall Study|Adverse Event|8|||
164067356|NCT00798707|592609936|FG002|Overall Study|Adverse Event|8|||
164067357|NCT00798707|592609934|FG000|Overall Study|Failed to return|2|||
164067358|NCT00798707|592609935|FG001|Overall Study|Failed to return|2|||
164067359|NCT00798707|592609936|FG002|Overall Study|Failed to return|0|||
164067360|NCT00798707|592609934|FG000|Overall Study|Investigator|0|||
164067361|NCT00798707|592609935|FG001|Overall Study|Investigator|1|||
164067362|NCT00798707|592609936|FG002|Overall Study|Investigator|2|||
164067363|NCT00798707|592609934|FG000|Overall Study|Lack of Efficacy|2|||
164067364|NCT00798707|592609935|FG001|Overall Study|Lack of Efficacy|2|||
164067365|NCT00798707|592609936|FG002|Overall Study|Lack of Efficacy|1|||
164067366|NCT00798707|592609934|FG000|Overall Study|Lost to Follow-up|5|||
164067367|NCT00798707|592609935|FG001|Overall Study|Lost to Follow-up|6|||
164067368|NCT00798707|592609936|FG002|Overall Study|Lost to Follow-up|6|||
164067369|NCT00798707|592609934|FG000|Overall Study|Other|0|||
164067370|NCT00798707|592609935|FG001|Overall Study|Other|1|||
164067371|NCT00798707|592609936|FG002|Overall Study|Other|0|||
164067372|NCT00798707|592609934|FG000|Overall Study|Protocol Violation|4|||
164067373|NCT00798707|592609935|FG001|Overall Study|Protocol Violation|0|||
164067374|NCT00798707|592609936|FG002|Overall Study|Protocol Violation|2|||
164067375|NCT00798707|592609934|FG000|Overall Study|Withdrawal by Subject|3|||
164067376|NCT00798707|592609935|FG001|Overall Study|Withdrawal by Subject|8|||
164067377|NCT00798707|592609936|FG002|Overall Study|Withdrawal by Subject|2|||
164067378|NCT00798707|592609934|FG000|Overall Study|Randomized not treated|4|||
164067379|NCT00798707|592609935|FG001|Overall Study|Randomized not treated|5|||
164067380|NCT00798707|592609936|FG002|Overall Study|Randomized not treated|1|||
164067381|NCT01473589|592609937|FG000|Overall Study|Adverse Event|1|||
164067382|NCT01473589|592609938|FG001|Overall Study|Adverse Event|1|||
164067383|NCT01473589|592609937|FG000|Overall Study|Death|2|||
164067384|NCT01473589|592609938|FG001|Overall Study|Death|0|||
164067385|NCT01473589|592609937|FG000|Overall Study|Lost to Follow-up|2|||
164067386|NCT01473589|592609938|FG001|Overall Study|Lost to Follow-up|2|||
164067387|NCT01473589|592609937|FG000|Overall Study|Protocol Violation|1|||
164067388|NCT01473589|592609938|FG001|Overall Study|Protocol Violation|0|||
164067389|NCT01473589|592609937|FG000|Overall Study|Withdrawal by Subject|5|||
164067390|NCT01473589|592609938|FG001|Overall Study|Withdrawal by Subject|11|||
164067391|NCT01473589|592609937|FG000|Overall Study|Physician Decision|0|||
164067392|NCT01473589|592609938|FG001|Overall Study|Physician Decision|1|||
164067393|NCT01473589|592609937|FG000|Overall Study|Entry criteria not met|0|||
164067394|NCT01473589|592609938|FG001|Overall Study|Entry criteria not met|1|||
164067395|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
164067396|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
164067397|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
164067398|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
164067399|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
164067400|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
164067401|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
164067402|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
164067403|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
164067404|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
164067405|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
164067406|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
164067407|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
164067408|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
164067409|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
164067410|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
164067411|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
164067412|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
164067413|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
164067414|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
164067415|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
164067416|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
164067417|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
164067418|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
164067419|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
164067420|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
164067421|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
164067422|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
164067423|NCT01299272|592609939|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
164067424|NCT01299272|592609940|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
164067425|NCT01299272|592609941|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
164067426|NCT01299272|592609942|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
164067427|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
164067428|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
164067429|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
164067430|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
164067431|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
164067432|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
164067433|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
164067434|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
164067435|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
164067436|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
164067437|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
164067438|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
164067439|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
164067440|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
164067441|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
164067442|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
164067443|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
164067444|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
164067445|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
164067446|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
164067447|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
164067448|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
164067449|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
164067450|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
164067451|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
164067452|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
164067453|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
164067454|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
164067455|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
164067456|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
164067457|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
164067458|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
164067459|NCT01299272|592609939|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
164067460|NCT01299272|592609940|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
164067461|NCT01299272|592609941|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
164067462|NCT01299272|592609942|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
164105194|NCT00081653|592749123|FG000|Overall Study|Bone loss|2|||
164067463|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
164067464|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
164067465|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
164067466|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
164067467|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
164067468|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
164067469|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
164067470|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
164067471|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
164067472|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
164067473|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
164067474|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
164067475|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
164067476|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
164067477|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
164067478|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
164067479|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
164067480|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
164067481|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
164067482|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
164067483|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
164067484|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
164067485|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
164067486|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
164067487|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
164067488|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
164067489|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
164067490|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
164067491|NCT01299272|592609939|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
164067492|NCT01299272|592609940|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
164067493|NCT01299272|592609941|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
164067494|NCT01299272|592609942|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
164067495|NCT03926728|592609943|FG000|Overall Study|Withdrawal by Subject|0|||
164067496|NCT03926728|592609944|FG001|Overall Study|Withdrawal by Subject|1|||
164067497|NCT03926728|592609945|FG002|Overall Study|Withdrawal by Subject|1|||
164067498|NCT03926728|592609946|FG003|Overall Study|Withdrawal by Subject|0|||
164067499|NCT03926728|592609947|FG004|Overall Study|Withdrawal by Subject|0|||
164067500|NCT03926728|592609948|FG005|Overall Study|Withdrawal by Subject|1|||
164067501|NCT03926728|592609949|FG006|Overall Study|Withdrawal by Subject|1|||
164067502|NCT03926728|592609950|FG007|Overall Study|Withdrawal by Subject|0|||
164067503|NCT03926728|592609951|FG008|Overall Study|Withdrawal by Subject|0|||
164067504|NCT03926728|592609952|FG009|Overall Study|Withdrawal by Subject|1|||
164067505|NCT03926728|592609953|FG010|Overall Study|Withdrawal by Subject|0|||
164067506|NCT03926728|592609954|FG011|Overall Study|Withdrawal by Subject|0|||
164067507|NCT03669640|592609959|FG000|Overall Study|Study Terminated by Sponsor|0|||
164067508|NCT03669640|592609960|FG001|Overall Study|Study Terminated by Sponsor|0|||
164067509|NCT03669640|592609961|FG002|Overall Study|Study Terminated by Sponsor|0|||
164067510|NCT03669640|592609962|FG003|Overall Study|Study Terminated by Sponsor|0|||
164067511|NCT03669640|592609963|FG004|Overall Study|Study Terminated by Sponsor|1|||
164067512|NCT03669640|592609964|FG005|Overall Study|Study Terminated by Sponsor|0|||
164067513|NCT03669640|592609959|FG000|Overall Study|Lost to Follow-up|0|||
164067514|NCT03669640|592609960|FG001|Overall Study|Lost to Follow-up|0|||
164067515|NCT03669640|592609961|FG002|Overall Study|Lost to Follow-up|2|||
164067516|NCT03669640|592609962|FG003|Overall Study|Lost to Follow-up|0|||
164067517|NCT03669640|592609963|FG004|Overall Study|Lost to Follow-up|0|||
164067518|NCT03669640|592609964|FG005|Overall Study|Lost to Follow-up|0|||
164067519|NCT03669640|592609959|FG000|Overall Study|Death|0|||
164067520|NCT03669640|592609960|FG001|Overall Study|Death|0|||
164067521|NCT03669640|592609961|FG002|Overall Study|Death|1|||
164067522|NCT03669640|592609962|FG003|Overall Study|Death|0|||
164067523|NCT03669640|592609963|FG004|Overall Study|Death|0|||
164067524|NCT03669640|592609964|FG005|Overall Study|Death|0|||
164067525|NCT03669640|592609959|FG000|Overall Study|Withdrawal by Subject|1|||
164067526|NCT03669640|592609960|FG001|Overall Study|Withdrawal by Subject|2|||
164067527|NCT03669640|592609961|FG002|Overall Study|Withdrawal by Subject|1|||
164067528|NCT03669640|592609962|FG003|Overall Study|Withdrawal by Subject|0|||
164067529|NCT03669640|592609963|FG004|Overall Study|Withdrawal by Subject|1|||
164067530|NCT03669640|592609964|FG005|Overall Study|Withdrawal by Subject|3|||
164067531|NCT03669640|592609959|FG000|Overall Study|Protocol Violation|1|||
164067532|NCT03669640|592609960|FG001|Overall Study|Protocol Violation|0|||
164067533|NCT03669640|592609961|FG002|Overall Study|Protocol Violation|0|||
164067534|NCT03669640|592609962|FG003|Overall Study|Protocol Violation|0|||
164067535|NCT03669640|592609963|FG004|Overall Study|Protocol Violation|0|||
164067536|NCT03669640|592609964|FG005|Overall Study|Protocol Violation|0|||
164067537|NCT03669640|592609959|FG000|Overall Study|Physician Decision|0|||
164067538|NCT03669640|592609960|FG001|Overall Study|Physician Decision|2|||
164067539|NCT03669640|592609961|FG002|Overall Study|Physician Decision|0|||
164067540|NCT03669640|592609962|FG003|Overall Study|Physician Decision|0|||
164067541|NCT03669640|592609963|FG004|Overall Study|Physician Decision|0|||
164067542|NCT03669640|592609964|FG005|Overall Study|Physician Decision|0|||
164067543|NCT03669640|592609959|FG000|Overall Study|Disease Relapse|1|||
164067544|NCT03669640|592609960|FG001|Overall Study|Disease Relapse|0|||
164067545|NCT03669640|592609961|FG002|Overall Study|Disease Relapse|0|||
164067546|NCT03669640|592609962|FG003|Overall Study|Disease Relapse|0|||
164067547|NCT03669640|592609963|FG004|Overall Study|Disease Relapse|0|||
164067548|NCT03669640|592609964|FG005|Overall Study|Disease Relapse|0|||
164067549|NCT03669640|592609959|FG000|Overall Study|Adverse Event|2|||
164067550|NCT03669640|592609960|FG001|Overall Study|Adverse Event|1|||
164067551|NCT03669640|592609961|FG002|Overall Study|Adverse Event|0|||
164067552|NCT03669640|592609962|FG003|Overall Study|Adverse Event|0|||
164067553|NCT03669640|592609963|FG004|Overall Study|Adverse Event|1|||
164067554|NCT03669640|592609964|FG005|Overall Study|Adverse Event|0|||
164067555|NCT03722849|592609967|FG000|Overall Study|Withdrawal by Subject|1|||
164067556|NCT03722849|592609968|FG001|Overall Study|Withdrawal by Subject|1|||
164067557|NCT03993288|592609969|FG000|Overall Study|Lost to Follow-up|2|||
164067558|NCT03993288|592609970|FG001|Overall Study|Lost to Follow-up|1|||
164067559|NCT03993288|592609969|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
164067560|NCT03993288|592609970|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
164067561|NCT03993288|592609969|FG000|Overall Study|wrong randomization|0|||
164067562|NCT03993288|592609970|FG001|Overall Study|wrong randomization|1|||
164067563|NCT03993288|592609969|FG000|Overall Study|improper enrollment|0|||
164067564|NCT03993288|592609970|FG001|Overall Study|improper enrollment|1|||
164067565|NCT03993288|592609969|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
164067566|NCT03993288|592609970|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
164067567|NCT03993288|592609969|FG000|Overall Study|developed SAE|2|||
164067568|NCT03993288|592609970|FG001|Overall Study|developed SAE|0|||
164067569|NCT03993288|592609969|FG000|Overall Study|consent withdrawal|1|||
164067570|NCT03993288|592609970|FG001|Overall Study|consent withdrawal|0|||
164067571|NCT03993288|592609969|FG000|Overall Study|did not follow the treatment schedule|1|||
164067572|NCT03993288|592609970|FG001|Overall Study|did not follow the treatment schedule|0|||
164067573|NCT03993288|592609969|FG000|Overall Study|did not follow the treatment regimen|1|||
164067574|NCT03993288|592609970|FG001|Overall Study|did not follow the treatment regimen|0|||
164067575|NCT03993288|592609969|FG000|Overall Study|Adverse Event|1|||
164067576|NCT03993288|592609970|FG001|Overall Study|Adverse Event|0|||
164067577|NCT03993288|592609969|FG000|Overall Study|Withdrawal by Subject|1|||
164067578|NCT03993288|592609970|FG001|Overall Study|Withdrawal by Subject|1|||
164067579|NCT02729545|592609971|FG000|Overall Study|Pregnancy|1|||
164067580|NCT02729545|592609972|FG001|Overall Study|Pregnancy|1|||
164067581|NCT02729545|592609971|FG000|Overall Study|Lost to Follow-up|0|||
164067582|NCT02729545|592609972|FG001|Overall Study|Lost to Follow-up|1|||
164067583|NCT02729545|592609971|FG000|Overall Study|Withdrawal by Subject|2|||
164067584|NCT02729545|592609972|FG001|Overall Study|Withdrawal by Subject|3|||
164067585|NCT03533608|592609973|FG000|Overall Study|Withdrawal by Subject|3|||
164067586|NCT03533608|592609973|FG000|Overall Study|Physician Decision|2|||
164067587|NCT00915473|592609974|FG000|Screening|Withdrawal by Subject|1|||
164067588|NCT00915473|592609975|FG001|Screening|Withdrawal by Subject|0|||
164067589|NCT00915473|592609974|FG000|4-week Follow Up|Lost to Follow-up|1|||
164067590|NCT00915473|592609975|FG001|4-week Follow Up|Lost to Follow-up|5|||
164067591|NCT01389024|592609976|FG000|Overall Study|Withdrawal by Subject|0|||
164067592|NCT01389024|592609977|FG001|Overall Study|Withdrawal by Subject|1|||
164067593|NCT01389024|592609976|FG000|Overall Study|Lost to Follow-up|1|||
164067594|NCT01389024|592609977|FG001|Overall Study|Lost to Follow-up|0|||
164067595|NCT00529802|592609979|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
164067596|NCT00529802|592609979|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
164067597|NCT00529802|592609979|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
164067598|NCT00529802|592609979|FG000|Evaluable for Primary Endpoint|Death|1|||
164067599|NCT00529802|592609979|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
164067600|NCT00529802|592609979|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
164067601|NCT00529802|592609979|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
164067602|NCT02209454|592609980|FG000|Second Period|Adverse Event|1|||
164067603|NCT02209454|592609981|FG001|Second Period|Adverse Event|0|||
164067604|NCT00826176|592609989|FG000|Overall Study|Lost to Follow-up|1|||
164067605|NCT00826176|592609990|FG001|Overall Study|Lost to Follow-up|0|||
164067606|NCT00826176|592609989|FG000|Overall Study|Subject Withdrew Consent|3|||
164067607|NCT00826176|592609990|FG001|Overall Study|Subject Withdrew Consent|0|||
164067608|NCT00826176|592609989|FG000|Overall Study|Administrative|9|||
164067609|NCT00826176|592609990|FG001|Overall Study|Administrative|0|||
164067610|NCT00740480|592609991|FG000|Overall Study|Adverse Event|1|||
164105195|NCT00081653|592749124|FG001|Overall Study|Bone loss|0|||
164105196|NCT00081653|592749123|FG000|Overall Study|Participant leaving country|1|||
164105197|NCT00081653|592749124|FG001|Overall Study|Participant leaving country|0|||
164105198|NCT00081653|592749123|FG000|Overall Study|Loss of bone mass|0|||
164105199|NCT00081653|592749124|FG001|Overall Study|Loss of bone mass|2|||
164105200|NCT00736190|592749127|FG000|Overall Study|Pregnancy|1|||
164105201|NCT00736190|592749127|FG000|Overall Study|Withdrawal by Subject|1|||
164105202|NCT00736190|592749127|FG000|Overall Study|Adverse Event|1|||
164105203|NCT03246503|592749128|FG000|Overall Study|Lost to Follow-up|23|||
164105204|NCT03246503|592749128|FG000|Overall Study|Withdrawal by Subject|20|||
164105205|NCT03246503|592749128|FG000|Overall Study|Physician Decision|5|||
164105206|NCT03246503|592749128|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
164105207|NCT02197416|592749129|FG000|Overall Study|Other reasons|0|||
164105208|NCT02197416|592749130|FG001|Overall Study|Other reasons|2|||
164105209|NCT02197416|592749131|FG002|Overall Study|Other reasons|5|||
164105210|NCT02197416|592749129|FG000|Overall Study|Withdrawal by Subject|0|||
164105211|NCT02197416|592749130|FG001|Overall Study|Withdrawal by Subject|2|||
164105212|NCT02197416|592749131|FG002|Overall Study|Withdrawal by Subject|1|||
164105213|NCT02197416|592749129|FG000|Overall Study|Protocol Violation|1|||
164105214|NCT02197416|592749130|FG001|Overall Study|Protocol Violation|0|||
164105215|NCT02197416|592749131|FG002|Overall Study|Protocol Violation|1|||
164105216|NCT02197416|592749129|FG000|Overall Study|Adverse Event|0|||
164105217|NCT02197416|592749130|FG001|Overall Study|Adverse Event|0|||
164105218|NCT02197416|592749131|FG002|Overall Study|Adverse Event|1|||
164105219|NCT03689400|592749132|FG000|Overall Study|Lost to Follow-up|4|||
164105220|NCT01204294|592749133|FG000|Overall Study|Adverse Event|2|||
164105221|NCT01204294|592749134|FG001|Overall Study|Adverse Event|6|||
164105222|NCT01204294|592749135|FG002|Overall Study|Adverse Event|0|||
164105223|NCT01204294|592749136|FG003|Overall Study|Adverse Event|7|||
164105224|NCT01204294|592749137|FG004|Overall Study|Adverse Event|1|||
164105225|NCT01204294|592749138|FG005|Overall Study|Adverse Event|4|||
164105226|NCT01204294|592749139|FG006|Overall Study|Adverse Event|0|||
164105227|NCT01204294|592749133|FG000|Overall Study|Protocol Violation|1|||
164105228|NCT01204294|592749134|FG001|Overall Study|Protocol Violation|0|||
164105229|NCT01204294|592749135|FG002|Overall Study|Protocol Violation|2|||
164105230|NCT01204294|592749136|FG003|Overall Study|Protocol Violation|1|||
164105231|NCT01204294|592749137|FG004|Overall Study|Protocol Violation|0|||
164105232|NCT01204294|592749138|FG005|Overall Study|Protocol Violation|0|||
164105233|NCT01204294|592749139|FG006|Overall Study|Protocol Violation|0|||
164105234|NCT01204294|592749133|FG000|Overall Study|Withdrawal by Subject|0|||
164105235|NCT01204294|592749134|FG001|Overall Study|Withdrawal by Subject|2|||
164105236|NCT01204294|592749135|FG002|Overall Study|Withdrawal by Subject|2|||
164105237|NCT01204294|592749136|FG003|Overall Study|Withdrawal by Subject|1|||
164105238|NCT01204294|592749137|FG004|Overall Study|Withdrawal by Subject|1|||
164105239|NCT01204294|592749138|FG005|Overall Study|Withdrawal by Subject|1|||
164105240|NCT01204294|592749139|FG006|Overall Study|Withdrawal by Subject|2|||
164105241|NCT01204294|592749133|FG000|Overall Study|Lack of Efficacy|0|||
164105242|NCT01204294|592749134|FG001|Overall Study|Lack of Efficacy|0|||
164105243|NCT01204294|592749135|FG002|Overall Study|Lack of Efficacy|0|||
164105244|NCT01204294|592749136|FG003|Overall Study|Lack of Efficacy|2|||
164105245|NCT01204294|592749137|FG004|Overall Study|Lack of Efficacy|0|||
164105246|NCT01204294|592749138|FG005|Overall Study|Lack of Efficacy|0|||
164105247|NCT01204294|592749139|FG006|Overall Study|Lack of Efficacy|0|||
164105248|NCT01204294|592749133|FG000|Overall Study|Other (house moving)|0|||
164105249|NCT01204294|592749134|FG001|Overall Study|Other (house moving)|0|||
164105250|NCT01204294|592749135|FG002|Overall Study|Other (house moving)|1|||
164105251|NCT01204294|592749136|FG003|Overall Study|Other (house moving)|0|||
164105252|NCT01204294|592749137|FG004|Overall Study|Other (house moving)|0|||
164105253|NCT01204294|592749138|FG005|Overall Study|Other (house moving)|0|||
164105254|NCT01204294|592749139|FG006|Overall Study|Other (house moving)|0|||
164105255|NCT03128723|592749140|FG000|Overall Study|Withdrawal by Subject|2|||
164105256|NCT02075463|592749141|FG000|Overall Study|Adverse Event|3|||
164105257|NCT02075463|592749141|FG000|Overall Study|Par. reached stopping criteria|4|||
164105258|NCT02075463|592749141|FG000|Overall Study|Withdrawal by Subject|1|||
164105259|NCT00392665|592749142|FG000|Overall Study|Death|16|||
164105260|NCT00392665|592749143|FG001|Overall Study|Death|14|||
164105261|NCT00392665|592749142|FG000|Overall Study|Lost to Follow-up|1|||
164105262|NCT00392665|592749143|FG001|Overall Study|Lost to Follow-up|1|||
164105263|NCT02294786|592749146|FG000|Overall Study|Withdrawal by Subject|0|||
164105264|NCT02294786|592749147|FG001|Overall Study|Withdrawal by Subject|1|||
164105265|NCT02294786|592749146|FG000|Overall Study|Physician Decision|6|||
164105266|NCT02294786|592749147|FG001|Overall Study|Physician Decision|7|||
164105267|NCT02294786|592749146|FG000|Overall Study|Lost to Follow-up|1|||
164105268|NCT02294786|592749147|FG001|Overall Study|Lost to Follow-up|2|||
164105269|NCT02294786|592749146|FG000|Overall Study|Protocol Violation|1|||
164105270|NCT02294786|592749147|FG001|Overall Study|Protocol Violation|0|||
164105271|NCT02294786|592749146|FG000|Overall Study|Adverse Event|1|||
164105272|NCT02294786|592749147|FG001|Overall Study|Adverse Event|1|||
164105273|NCT02294786|592749146|FG000|Overall Study|Death|2|||
164105274|NCT02294786|592749147|FG001|Overall Study|Death|3|||
164105275|NCT01663233|592749148|FG000|Overall Study|Withdrawal by Subject|3|||
164105276|NCT01663233|592749149|FG001|Overall Study|Withdrawal by Subject|2|||
164105277|NCT01663233|592749148|FG000|Overall Study|Protocol Deviation|1|||
164105278|NCT01663233|592749149|FG001|Overall Study|Protocol Deviation|4|||
164105279|NCT01663233|592749148|FG000|Overall Study|Lost to Follow-up|0|||
164105280|NCT01663233|592749149|FG001|Overall Study|Lost to Follow-up|1|||
164105281|NCT02105272|592749156|FG000|Overall Study|Adverse Event|1|||
164105282|NCT02105272|592749157|FG001|Overall Study|Adverse Event|2|||
164105283|NCT02105272|592749156|FG000|Overall Study|Physician Decision|0|||
164105284|NCT02105272|592749157|FG001|Overall Study|Physician Decision|1|||
164105285|NCT02105272|592749156|FG000|Overall Study|Protocol Violation|2|||
164105286|NCT02105272|592749157|FG001|Overall Study|Protocol Violation|0|||
164105287|NCT02105272|592749156|FG000|Overall Study|Withdrawal by Subject|2|||
164105288|NCT02105272|592749157|FG001|Overall Study|Withdrawal by Subject|0|||
164105289|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Adverse Event|11|||
164105290|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Adverse Event|23|||
164105291|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Adverse Event|29|||
164105292|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Adverse Event|2|||
164105293|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Adverse Event|8|||
164105294|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
164105295|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
164105296|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
164105297|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
164105298|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
164105299|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
164105300|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
164105301|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
164067611|NCT00740480|592609991|FG000|Overall Study|Physician Decision|1|||
164067612|NCT03079869|592609997|FG000|Overall Study|Adverse Event|6|||
164067613|NCT03079869|592609998|FG001|Overall Study|Adverse Event|8|||
164067614|NCT03079869|592609997|FG000|Overall Study|Withdrawal by Subject|4|||
164067615|NCT03079869|592609998|FG001|Overall Study|Withdrawal by Subject|1|||
164067616|NCT03079869|592609997|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
164067617|NCT03079869|592609998|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
164067618|NCT01325701|592609999|FG000|Overall Study|Adverse Event|12|||
164067619|NCT01325701|592610000|FG001|Overall Study|Adverse Event|0|||
164067620|NCT01325701|592609999|FG000|Overall Study|Protocol Violation|1|||
164067621|NCT01325701|592610000|FG001|Overall Study|Protocol Violation|0|||
164067622|NCT01325701|592609999|FG000|Overall Study|Physician Decision|2|||
164067623|NCT01325701|592610000|FG001|Overall Study|Physician Decision|2|||
164067624|NCT01325701|592609999|FG000|Overall Study|Withdrawal by Subject|2|||
164067625|NCT01325701|592610000|FG001|Overall Study|Withdrawal by Subject|1|||
164067626|NCT01325701|592609999|FG000|Overall Study|Rollerover Extension Study|4|||
164067627|NCT01325701|592610000|FG001|Overall Study|Rollerover Extension Study|0|||
164067628|NCT04484805|592610009|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
164067629|NCT04484805|592610010|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
164067630|NCT04484805|592610009|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
164067631|NCT04484805|592610010|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
164067632|NCT00539006|592610013|FG000|Pre-treatment|Other|0|||
164067633|NCT00539006|592610014|FG001|Pre-treatment|Other|1|||
164067634|NCT00539006|592610015|FG002|Pre-treatment|Other|0|||
164067635|NCT00539006|592610016|FG003|Pre-treatment|Other|0|||
164067636|NCT00539006|592610013|FG000|Treatment Period 1|Lost to Follow-up|0|||
164067637|NCT00539006|592610014|FG001|Treatment Period 1|Lost to Follow-up|0|||
164067638|NCT00539006|592610015|FG002|Treatment Period 1|Lost to Follow-up|1|||
164067639|NCT00539006|592610016|FG003|Treatment Period 1|Lost to Follow-up|0|||
164067640|NCT00539006|592610013|FG000|Treatment Period 1|Protocol Violation|0|||
164067641|NCT00539006|592610014|FG001|Treatment Period 1|Protocol Violation|0|||
164067642|NCT00539006|592610015|FG002|Treatment Period 1|Protocol Violation|1|||
164067643|NCT00539006|592610016|FG003|Treatment Period 1|Protocol Violation|0|||
164067644|NCT00539006|592610013|FG000|Treatment Period 1|Lack of Efficacy|0|||
164067645|NCT00539006|592610014|FG001|Treatment Period 1|Lack of Efficacy|0|||
164067646|NCT00539006|592610015|FG002|Treatment Period 1|Lack of Efficacy|0|||
164067647|NCT00539006|592610016|FG003|Treatment Period 1|Lack of Efficacy|1|||
164105302|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
164105303|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
164105304|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
164105305|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
164067648|NCT00539006|592610013|FG000|Washout|Adverse Event|2|||
164067649|NCT00539006|592610014|FG001|Washout|Adverse Event|1|||
164105306|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
164105307|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
164105308|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
164112670|NCT00840658|592774091|FG001|Overall Study|Lost to Follow-up|1|||
164105309|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164105310|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
164105311|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164105312|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164105313|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
164105314|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
164105315|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
164105316|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
164105317|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
164105318|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
164105319|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
164105320|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
164105321|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
164105322|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
164105323|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
164105324|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Move|0|||
164105325|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Move|1|||
164105326|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Move|0|||
164105327|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Move|0|||
164105328|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Move|0|||
164105329|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164105330|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164105331|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164105332|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
164105333|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
164105334|NCT00318461|592749160|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
164105335|NCT00318461|592749161|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
164105336|NCT00318461|592749162|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
164105337|NCT00318461|592749163|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
164105338|NCT00318461|592749164|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
164105339|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Work commitment|0|||
164105340|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Work commitment|0|||
164105341|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Work commitment|0|||
164105342|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Work commitment|0|||
164105343|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Work commitment|1|||
164105344|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Investigator decision|0|||
164105345|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Investigator decision|0|||
164105346|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Investigator decision|0|||
164105347|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Investigator decision|0|||
164105348|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Investigator decision|1|||
164105349|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Lack of time|1|||
164105350|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Lack of time|0|||
164105351|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Lack of time|0|||
164105352|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Lack of time|0|||
164105353|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Lack of time|0|||
164105354|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164105355|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164105356|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164105357|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
164105358|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
164105359|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
164067650|NCT00539006|592610015|FG002|Washout|Adverse Event|0|||
164067651|NCT00539006|592610016|FG003|Washout|Adverse Event|0|||
164067652|NCT00539006|592610013|FG000|Washout|Protocol Violation|1|||
164067653|NCT00539006|592610014|FG001|Washout|Protocol Violation|1|||
164067654|NCT00539006|592610015|FG002|Washout|Protocol Violation|0|||
164067655|NCT00539006|592610016|FG003|Washout|Protocol Violation|0|||
164067656|NCT00539006|592610013|FG000|Washout|Withdrawal by Subject|0|||
164067657|NCT00539006|592610014|FG001|Washout|Withdrawal by Subject|2|||
164067658|NCT00539006|592610015|FG002|Washout|Withdrawal by Subject|0|||
164067659|NCT00539006|592610016|FG003|Washout|Withdrawal by Subject|0|||
164067660|NCT00539006|592610013|FG000|Washout|Failed to meet continuation criteria|16|||
164067661|NCT00539006|592610014|FG001|Washout|Failed to meet continuation criteria|5|||
164067662|NCT00539006|592610015|FG002|Washout|Failed to meet continuation criteria|14|||
164067663|NCT00539006|592610016|FG003|Washout|Failed to meet continuation criteria|6|||
164105360|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
164105361|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
164105362|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
164105363|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
164105364|NCT00318461|592749160|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164112671|NCT00840658|592774092|FG002|Overall Study|Lost to Follow-up|2|||
164067664|NCT00539006|592610013|FG000|Washout|Other|1|||
164105365|NCT00318461|592749161|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164105366|NCT00318461|592749162|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164105367|NCT00318461|592749163|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
164105368|NCT00318461|592749164|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
164105369|NCT00318461|592749160|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164105370|NCT00318461|592749161|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
164105371|NCT00318461|592749162|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164105372|NCT00318461|592749163|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164105373|NCT00318461|592749164|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
164105374|NCT00318461|592749160|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
164105375|NCT00318461|592749161|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
164105376|NCT00318461|592749162|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
164105377|NCT00318461|592749163|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
164105378|NCT00318461|592749164|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
164105379|NCT00318461|592749160|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
164105380|NCT00318461|592749161|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
164105381|NCT00318461|592749162|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
164105382|NCT00318461|592749163|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
164105383|NCT00318461|592749164|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
164105384|NCT00318461|592749160|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
164105385|NCT00318461|592749161|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
164105386|NCT00318461|592749162|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
164105387|NCT00318461|592749163|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
164105388|NCT00318461|592749164|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
164105389|NCT00318461|592749160|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
164105390|NCT00318461|592749161|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
164105391|NCT00318461|592749162|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
164105392|NCT00318461|592749163|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
164105393|NCT00318461|592749164|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
164105394|NCT00505622|592749165|FG000|Overall Study|Adverse Event|5|||
164105395|NCT00505622|592749166|FG001|Overall Study|Adverse Event|6|||
164105396|NCT00505622|592749167|FG002|Overall Study|Adverse Event|4|||
164105397|NCT00505622|592749165|FG000|Overall Study|Protocol Violation|1|||
164105398|NCT00505622|592749166|FG001|Overall Study|Protocol Violation|1|||
164105399|NCT00505622|592749167|FG002|Overall Study|Protocol Violation|0|||
164105400|NCT00505622|592749165|FG000|Overall Study|Withdrawal by Subject|0|||
164105401|NCT00505622|592749166|FG001|Overall Study|Withdrawal by Subject|3|||
164105402|NCT00505622|592749167|FG002|Overall Study|Withdrawal by Subject|2|||
164105403|NCT00505622|592749165|FG000|Overall Study|Study termination by sponsor|115|||
164105404|NCT00505622|592749166|FG001|Overall Study|Study termination by sponsor|98|||
164105405|NCT00505622|592749167|FG002|Overall Study|Study termination by sponsor|90|||
164105406|NCT00796653|592749168|FG000|Overall Study|Adverse Event|19|||
164105407|NCT00796653|592749169|FG001|Overall Study|Adverse Event|16|||
164105408|NCT00796653|592749170|FG002|Overall Study|Adverse Event|16|||
164105409|NCT00796653|592749171|FG003|Overall Study|Adverse Event|16|||
164105410|NCT00796653|592749168|FG000|Overall Study|Lost to Follow-up|2|||
164105411|NCT00796653|592749169|FG001|Overall Study|Lost to Follow-up|1|||
164105412|NCT00796653|592749170|FG002|Overall Study|Lost to Follow-up|2|||
164105413|NCT00796653|592749171|FG003|Overall Study|Lost to Follow-up|3|||
164105414|NCT00796653|592749168|FG000|Overall Study|Withdrawal by Subject|16|||
164105415|NCT00796653|592749169|FG001|Overall Study|Withdrawal by Subject|8|||
164105416|NCT00796653|592749170|FG002|Overall Study|Withdrawal by Subject|8|||
164105417|NCT00796653|592749171|FG003|Overall Study|Withdrawal by Subject|13|||
164105418|NCT00796653|592749168|FG000|Overall Study|Lack of Efficacy|8|||
164105419|NCT00796653|592749169|FG001|Overall Study|Lack of Efficacy|1|||
164105420|NCT00796653|592749170|FG002|Overall Study|Lack of Efficacy|3|||
164105421|NCT00796653|592749171|FG003|Overall Study|Lack of Efficacy|2|||
164105422|NCT00796653|592749168|FG000|Overall Study|Non compliance with protocol|2|||
164105423|NCT00796653|592749169|FG001|Overall Study|Non compliance with protocol|2|||
164105424|NCT00796653|592749170|FG002|Overall Study|Non compliance with protocol|0|||
164105425|NCT00796653|592749171|FG003|Overall Study|Non compliance with protocol|2|||
164105426|NCT00796653|592749168|FG000|Overall Study|Other reason not described above|4|||
164105427|NCT00796653|592749169|FG001|Overall Study|Other reason not described above|9|||
164105428|NCT00796653|592749170|FG002|Overall Study|Other reason not described above|7|||
164105429|NCT00796653|592749171|FG003|Overall Study|Other reason not described above|4|||
164105430|NCT02414152|592749176|FG000|Overall Study|Withdrawal by Subject|1|||
164105431|NCT02414152|592749176|FG000|Overall Study|Lack of Efficacy|1|||
164105432|NCT01757392|592749177|FG000|Overall Study|Withdrawal by Subject|1|||
164105433|NCT01757392|592749177|FG000|Overall Study|Screen Fail|3|||
164105434|NCT00841698|592749184|FG000|First Intervention|Withdrawal by Subject|1|||
164105435|NCT00841698|592749185|FG001|First Intervention|Withdrawal by Subject|0|||
164067665|NCT00539006|592610014|FG001|Washout|Other|1|||
164067666|NCT00539006|592610015|FG002|Washout|Other|2|||
164067667|NCT00539006|592610016|FG003|Washout|Other|3|||
164067668|NCT00539006|592610013|FG000|Treatment Period 2|Protocol Violation|1|||
164067669|NCT00539006|592610014|FG001|Treatment Period 2|Protocol Violation|0|||
164067670|NCT00539006|592610015|FG002|Treatment Period 2|Protocol Violation|0|||
164067671|NCT00539006|592610016|FG003|Treatment Period 2|Protocol Violation|0|||
164067672|NCT00539006|592610013|FG000|Treatment Period 2|Other|0|||
164067673|NCT00539006|592610014|FG001|Treatment Period 2|Other|1|||
164067674|NCT00539006|592610015|FG002|Treatment Period 2|Other|0|||
164067675|NCT00539006|592610016|FG003|Treatment Period 2|Other|0|||
164067676|NCT03733301|592610017|FG000|Overall Study|Screen Fail|1|||
164067677|NCT03733301|592610018|FG001|Overall Study|Screen Fail|0|||
164067678|NCT03733301|592610019|FG002|Overall Study|Screen Fail|0|||
164067679|NCT03733301|592610017|FG000|Overall Study|Non-compliance|1|||
164067680|NCT03733301|592610018|FG001|Overall Study|Non-compliance|0|||
164067681|NCT03733301|592610019|FG002|Overall Study|Non-compliance|0|||
164067682|NCT03733301|592610017|FG000|Overall Study|Lack of Efficacy|2|||
164067683|NCT03733301|592610018|FG001|Overall Study|Lack of Efficacy|3|||
164067684|NCT03733301|592610019|FG002|Overall Study|Lack of Efficacy|0|||
164067685|NCT03733301|592610017|FG000|Overall Study|Adverse Event|0|||
164067686|NCT03733301|592610018|FG001|Overall Study|Adverse Event|1|||
164067687|NCT03733301|592610019|FG002|Overall Study|Adverse Event|3|||
164067688|NCT03733301|592610017|FG000|Overall Study|Withdrawal by Subject|3|||
164067689|NCT03733301|592610018|FG001|Overall Study|Withdrawal by Subject|5|||
164067690|NCT03733301|592610019|FG002|Overall Study|Withdrawal by Subject|1|||
164067691|NCT01275170|592610026|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
164067692|NCT01275170|592610027|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067693|NCT01275170|592610028|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067694|NCT01275170|592610029|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067695|NCT01275170|592610030|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067696|NCT01275170|592610031|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067697|NCT01275170|592610032|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067698|NCT01275170|592610033|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
164067699|NCT03917654|592610038|FG000|Year 1|Withdrawal by Subject|1|||
164067700|NCT03917654|592610039|FG001|Year 1|Withdrawal by Subject|0|||
164067701|NCT03917654|592610040|FG002|Year 1|Withdrawal by Subject|0|||
164067702|NCT03917654|592610041|FG003|Year 1|Withdrawal by Subject|0|||
164067703|NCT03917654|592610042|FG004|Year 1|Withdrawal by Subject|0|||
164067704|NCT03917654|592610043|FG005|Year 1|Withdrawal by Subject|1|||
164067705|NCT03917654|592610044|FG006|Year 1|Withdrawal by Subject|6|||
164067706|NCT03917654|592610045|FG007|Year 1|Withdrawal by Subject|2|||
164067707|NCT03917654|592610046|FG008|Year 1|Withdrawal by Subject|5|||
164067708|NCT03917654|592610047|FG009|Year 1|Withdrawal by Subject|3|||
164067709|NCT03917654|592610048|FG010|Year 1|Withdrawal by Subject|1|||
164067710|NCT03917654|592610049|FG011|Year 1|Withdrawal by Subject|0|||
164067711|NCT03917654|592610038|FG000|Year 1|Travel|0|||
164067712|NCT03917654|592610039|FG001|Year 1|Travel|1|||
164067713|NCT03917654|592610040|FG002|Year 1|Travel|1|||
164067714|NCT03917654|592610041|FG003|Year 1|Travel|0|||
164067715|NCT03917654|592610042|FG004|Year 1|Travel|4|||
164067716|NCT03917654|592610043|FG005|Year 1|Travel|4|||
164067717|NCT03917654|592610044|FG006|Year 1|Travel|10|||
164067718|NCT03917654|592610045|FG007|Year 1|Travel|8|||
164067719|NCT03917654|592610046|FG008|Year 1|Travel|2|||
164067720|NCT03917654|592610047|FG009|Year 1|Travel|5|||
164067721|NCT03917654|592610048|FG010|Year 1|Travel|3|||
164067722|NCT03917654|592610049|FG011|Year 1|Travel|3|||
164067723|NCT03917654|592610038|FG000|Year 1|Subject moved away from site|0|||
164067724|NCT03917654|592610039|FG001|Year 1|Subject moved away from site|1|||
164067725|NCT03917654|592610040|FG002|Year 1|Subject moved away from site|0|||
164067726|NCT03917654|592610041|FG003|Year 1|Subject moved away from site|0|||
164067727|NCT03917654|592610042|FG004|Year 1|Subject moved away from site|0|||
164067728|NCT03917654|592610043|FG005|Year 1|Subject moved away from site|0|||
164067729|NCT03917654|592610044|FG006|Year 1|Subject moved away from site|1|||
164067730|NCT03917654|592610045|FG007|Year 1|Subject moved away from site|2|||
164067731|NCT03917654|592610046|FG008|Year 1|Subject moved away from site|1|||
164067732|NCT03917654|592610047|FG009|Year 1|Subject moved away from site|0|||
164067733|NCT03917654|592610048|FG010|Year 1|Subject moved away from site|0|||
164067734|NCT03917654|592610049|FG011|Year 1|Subject moved away from site|3|||
164067735|NCT03917654|592610038|FG000|Year 1|Spouse/Family member request|0|||
164067736|NCT03917654|592610039|FG001|Year 1|Spouse/Family member request|0|||
164067737|NCT03917654|592610040|FG002|Year 1|Spouse/Family member request|1|||
164067738|NCT03917654|592610041|FG003|Year 1|Spouse/Family member request|0|||
164067739|NCT03917654|592610042|FG004|Year 1|Spouse/Family member request|1|||
164067740|NCT03917654|592610043|FG005|Year 1|Spouse/Family member request|0|||
164067741|NCT03917654|592610044|FG006|Year 1|Spouse/Family member request|0|||
164067742|NCT03917654|592610045|FG007|Year 1|Spouse/Family member request|2|||
164067743|NCT03917654|592610046|FG008|Year 1|Spouse/Family member request|0|||
164067744|NCT03917654|592610047|FG009|Year 1|Spouse/Family member request|0|||
164067745|NCT03917654|592610048|FG010|Year 1|Spouse/Family member request|0|||
164067746|NCT03917654|592610049|FG011|Year 1|Spouse/Family member request|1|||
164067747|NCT03917654|592610038|FG000|Year 1|Death|0|||
164067748|NCT03917654|592610039|FG001|Year 1|Death|0|||
164067749|NCT03917654|592610040|FG002|Year 1|Death|0|||
164067750|NCT03917654|592610041|FG003|Year 1|Death|0|||
164067751|NCT03917654|592610042|FG004|Year 1|Death|0|||
164067752|NCT03917654|592610043|FG005|Year 1|Death|0|||
164067753|NCT03917654|592610044|FG006|Year 1|Death|0|||
164067754|NCT03917654|592610045|FG007|Year 1|Death|0|||
164067755|NCT03917654|592610046|FG008|Year 1|Death|1|||
164067756|NCT03917654|592610047|FG009|Year 1|Death|1|||
164067757|NCT03917654|592610048|FG010|Year 1|Death|0|||
164067758|NCT03917654|592610049|FG011|Year 1|Death|0|||
164067759|NCT03917654|592610038|FG000|Year 1|Lost to Follow-up|0|||
164067760|NCT03917654|592610039|FG001|Year 1|Lost to Follow-up|0|||
164067761|NCT03917654|592610040|FG002|Year 1|Lost to Follow-up|0|||
164067762|NCT03917654|592610041|FG003|Year 1|Lost to Follow-up|0|||
164067763|NCT03917654|592610042|FG004|Year 1|Lost to Follow-up|0|||
164067764|NCT03917654|592610043|FG005|Year 1|Lost to Follow-up|0|||
164067765|NCT03917654|592610044|FG006|Year 1|Lost to Follow-up|2|||
164067766|NCT03917654|592610045|FG007|Year 1|Lost to Follow-up|0|||
164067767|NCT03917654|592610046|FG008|Year 1|Lost to Follow-up|0|||
164067768|NCT03917654|592610047|FG009|Year 1|Lost to Follow-up|0|||
164067769|NCT03917654|592610048|FG010|Year 1|Lost to Follow-up|0|||
164067770|NCT03917654|592610049|FG011|Year 1|Lost to Follow-up|0|||
164067771|NCT03917654|592610038|FG000|Year 1|Missed visits|0|||
164067772|NCT03917654|592610039|FG001|Year 1|Missed visits|0|||
164067773|NCT03917654|592610040|FG002|Year 1|Missed visits|0|||
164067774|NCT03917654|592610041|FG003|Year 1|Missed visits|0|||
164067775|NCT03917654|592610042|FG004|Year 1|Missed visits|0|||
164067776|NCT03917654|592610043|FG005|Year 1|Missed visits|0|||
164067777|NCT03917654|592610044|FG006|Year 1|Missed visits|0|||
164067778|NCT03917654|592610045|FG007|Year 1|Missed visits|0|||
164067779|NCT03917654|592610046|FG008|Year 1|Missed visits|0|||
164067780|NCT03917654|592610047|FG009|Year 1|Missed visits|0|||
164067781|NCT03917654|592610048|FG010|Year 1|Missed visits|1|||
164067782|NCT03917654|592610049|FG011|Year 1|Missed visits|1|||
164067783|NCT03917654|592610038|FG000|Year 1|Pregnancy|0|||
164067784|NCT03917654|592610039|FG001|Year 1|Pregnancy|0|||
164067785|NCT03917654|592610040|FG002|Year 1|Pregnancy|0|||
164067786|NCT03917654|592610041|FG003|Year 1|Pregnancy|0|||
164067787|NCT03917654|592610042|FG004|Year 1|Pregnancy|0|||
164067788|NCT03917654|592610043|FG005|Year 1|Pregnancy|0|||
164067789|NCT03917654|592610044|FG006|Year 1|Pregnancy|0|||
164067790|NCT03917654|592610045|FG007|Year 1|Pregnancy|1|||
164067791|NCT03917654|592610046|FG008|Year 1|Pregnancy|0|||
164067792|NCT03917654|592610047|FG009|Year 1|Pregnancy|1|||
164067793|NCT03917654|592610048|FG010|Year 1|Pregnancy|0|||
164067794|NCT03917654|592610049|FG011|Year 1|Pregnancy|0|||
164067795|NCT03917654|592610038|FG000|Year 2|Travel|1|||
164067796|NCT03917654|592610039|FG001|Year 2|Travel|0|||
164067797|NCT03917654|592610040|FG002|Year 2|Travel|0|||
164067798|NCT03917654|592610041|FG003|Year 2|Travel|0|||
164067799|NCT03917654|592610042|FG004|Year 2|Travel|1|||
164067800|NCT03917654|592610043|FG005|Year 2|Travel|1|||
164067801|NCT03917654|592610044|FG006|Year 2|Travel|2|||
164067802|NCT03917654|592610045|FG007|Year 2|Travel|1|||
164067803|NCT03917654|592610046|FG008|Year 2|Travel|0|||
164067804|NCT03917654|592610047|FG009|Year 2|Travel|1|||
164067805|NCT03917654|592610048|FG010|Year 2|Travel|0|||
164067806|NCT03917654|592610049|FG011|Year 2|Travel|1|||
164067807|NCT03917654|592610038|FG000|Year 2|Married|1|||
164067808|NCT03917654|592610039|FG001|Year 2|Married|0|||
164067809|NCT03917654|592610040|FG002|Year 2|Married|0|||
164067810|NCT03917654|592610041|FG003|Year 2|Married|0|||
164067811|NCT03917654|592610042|FG004|Year 2|Married|0|||
164067812|NCT03917654|592610043|FG005|Year 2|Married|0|||
164067813|NCT03917654|592610044|FG006|Year 2|Married|1|||
164067814|NCT03917654|592610045|FG007|Year 2|Married|1|||
164067815|NCT03917654|592610046|FG008|Year 2|Married|0|||
164067816|NCT03917654|592610047|FG009|Year 2|Married|0|||
164067817|NCT03917654|592610048|FG010|Year 2|Married|0|||
164067818|NCT03917654|592610049|FG011|Year 2|Married|0|||
164067819|NCT03917654|592610038|FG000|Year 2|Subject moved away from site|1|||
164067820|NCT03917654|592610039|FG001|Year 2|Subject moved away from site|0|||
164067821|NCT03917654|592610040|FG002|Year 2|Subject moved away from site|0|||
164067822|NCT03917654|592610041|FG003|Year 2|Subject moved away from site|0|||
164067823|NCT03917654|592610042|FG004|Year 2|Subject moved away from site|1|||
164067824|NCT03917654|592610043|FG005|Year 2|Subject moved away from site|0|||
164067825|NCT03917654|592610044|FG006|Year 2|Subject moved away from site|2|||
164067826|NCT03917654|592610045|FG007|Year 2|Subject moved away from site|3|||
164067827|NCT03917654|592610046|FG008|Year 2|Subject moved away from site|0|||
164067828|NCT03917654|592610047|FG009|Year 2|Subject moved away from site|2|||
164067829|NCT03917654|592610048|FG010|Year 2|Subject moved away from site|0|||
164067830|NCT03917654|592610049|FG011|Year 2|Subject moved away from site|1|||
164067831|NCT03917654|592610038|FG000|Year 2|Year 2 Screening failure|0|||
164067832|NCT03917654|592610039|FG001|Year 2|Year 2 Screening failure|1|||
164067833|NCT03917654|592610040|FG002|Year 2|Year 2 Screening failure|0|||
164067834|NCT03917654|592610041|FG003|Year 2|Year 2 Screening failure|0|||
164067835|NCT03917654|592610042|FG004|Year 2|Year 2 Screening failure|2|||
164067836|NCT03917654|592610043|FG005|Year 2|Year 2 Screening failure|0|||
164067837|NCT03917654|592610044|FG006|Year 2|Year 2 Screening failure|4|||
164067838|NCT03917654|592610045|FG007|Year 2|Year 2 Screening failure|3|||
164067839|NCT03917654|592610046|FG008|Year 2|Year 2 Screening failure|10|||
164067840|NCT03917654|592610047|FG009|Year 2|Year 2 Screening failure|2|||
164067841|NCT03917654|592610048|FG010|Year 2|Year 2 Screening failure|1|||
164067842|NCT03917654|592610049|FG011|Year 2|Year 2 Screening failure|1|||
164067843|NCT03917654|592610038|FG000|Year 2|Death|0|||
164067844|NCT03917654|592610039|FG001|Year 2|Death|0|||
164067845|NCT03917654|592610040|FG002|Year 2|Death|0|||
164067846|NCT03917654|592610041|FG003|Year 2|Death|0|||
164067847|NCT03917654|592610042|FG004|Year 2|Death|0|||
164067848|NCT03917654|592610043|FG005|Year 2|Death|1|||
164067849|NCT03917654|592610044|FG006|Year 2|Death|0|||
164067850|NCT03917654|592610045|FG007|Year 2|Death|0|||
164067851|NCT03917654|592610046|FG008|Year 2|Death|1|||
164067852|NCT03917654|592610047|FG009|Year 2|Death|1|||
164067853|NCT03917654|592610048|FG010|Year 2|Death|0|||
164067854|NCT03917654|592610049|FG011|Year 2|Death|0|||
164067855|NCT03917654|592610038|FG000|Year 2|Withdrawal by Subject|0|||
164067856|NCT03917654|592610039|FG001|Year 2|Withdrawal by Subject|0|||
164067857|NCT03917654|592610040|FG002|Year 2|Withdrawal by Subject|0|||
164067858|NCT03917654|592610041|FG003|Year 2|Withdrawal by Subject|0|||
164067859|NCT03917654|592610042|FG004|Year 2|Withdrawal by Subject|0|||
164067860|NCT03917654|592610043|FG005|Year 2|Withdrawal by Subject|0|||
164067861|NCT03917654|592610044|FG006|Year 2|Withdrawal by Subject|3|||
164067862|NCT03917654|592610045|FG007|Year 2|Withdrawal by Subject|0|||
164067863|NCT03917654|592610046|FG008|Year 2|Withdrawal by Subject|2|||
164067864|NCT03917654|592610047|FG009|Year 2|Withdrawal by Subject|5|||
164067865|NCT03917654|592610048|FG010|Year 2|Withdrawal by Subject|0|||
164067866|NCT03917654|592610049|FG011|Year 2|Withdrawal by Subject|0|||
164067867|NCT03917654|592610038|FG000|Year 2|Spouse/family member request|0|||
164067868|NCT03917654|592610039|FG001|Year 2|Spouse/family member request|0|||
164067869|NCT03917654|592610040|FG002|Year 2|Spouse/family member request|0|||
164067870|NCT03917654|592610041|FG003|Year 2|Spouse/family member request|0|||
164067871|NCT03917654|592610042|FG004|Year 2|Spouse/family member request|0|||
164067872|NCT03917654|592610043|FG005|Year 2|Spouse/family member request|0|||
164067873|NCT03917654|592610044|FG006|Year 2|Spouse/family member request|1|||
164067874|NCT03917654|592610045|FG007|Year 2|Spouse/family member request|0|||
164067875|NCT03917654|592610046|FG008|Year 2|Spouse/family member request|0|||
164067876|NCT03917654|592610047|FG009|Year 2|Spouse/family member request|0|||
164067877|NCT03917654|592610048|FG010|Year 2|Spouse/family member request|0|||
164067878|NCT03917654|592610049|FG011|Year 2|Spouse/family member request|0|||
164067879|NCT03917654|592610038|FG000|Year 2|Lost to Follow-up|0|||
164067880|NCT03917654|592610039|FG001|Year 2|Lost to Follow-up|0|||
164067881|NCT03917654|592610040|FG002|Year 2|Lost to Follow-up|0|||
164067882|NCT03917654|592610041|FG003|Year 2|Lost to Follow-up|0|||
164067883|NCT03917654|592610042|FG004|Year 2|Lost to Follow-up|0|||
164067884|NCT03917654|592610043|FG005|Year 2|Lost to Follow-up|0|||
164067885|NCT03917654|592610044|FG006|Year 2|Lost to Follow-up|1|||
164067886|NCT03917654|592610045|FG007|Year 2|Lost to Follow-up|0|||
164067887|NCT03917654|592610046|FG008|Year 2|Lost to Follow-up|1|||
164067888|NCT03917654|592610047|FG009|Year 2|Lost to Follow-up|0|||
164067889|NCT03917654|592610048|FG010|Year 2|Lost to Follow-up|0|||
164067890|NCT03917654|592610049|FG011|Year 2|Lost to Follow-up|1|||
164067891|NCT03917654|592610038|FG000|Year 2|Adverse Event|0|||
164067892|NCT03917654|592610039|FG001|Year 2|Adverse Event|0|||
164067893|NCT03917654|592610040|FG002|Year 2|Adverse Event|0|||
164067894|NCT03917654|592610041|FG003|Year 2|Adverse Event|0|||
164067895|NCT03917654|592610042|FG004|Year 2|Adverse Event|0|||
164067896|NCT03917654|592610043|FG005|Year 2|Adverse Event|0|||
164067897|NCT03917654|592610044|FG006|Year 2|Adverse Event|0|||
164067898|NCT03917654|592610045|FG007|Year 2|Adverse Event|0|||
164067899|NCT03917654|592610046|FG008|Year 2|Adverse Event|0|||
164067900|NCT03917654|592610047|FG009|Year 2|Adverse Event|1|||
164067901|NCT03917654|592610048|FG010|Year 2|Adverse Event|0|||
164067902|NCT03917654|592610049|FG011|Year 2|Adverse Event|0|||
164067903|NCT04636437|592610050|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
164067904|NCT04636437|592610051|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
164067905|NCT04636437|592610052|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
164067906|NCT04636437|592610050|FG000|Overall Study|Started weight loss drug/program|2|||
164067907|NCT04636437|592610051|FG001|Overall Study|Started weight loss drug/program|1|||
164067908|NCT04636437|592610052|FG002|Overall Study|Started weight loss drug/program|1|||
164067909|NCT04636437|592610050|FG000|Overall Study|Lost to Follow-up|3|||
164067910|NCT04636437|592610051|FG001|Overall Study|Lost to Follow-up|1|||
164067911|NCT04636437|592610052|FG002|Overall Study|Lost to Follow-up|4|||
164067912|NCT04636437|592610050|FG000|Overall Study|Participant or physician decision|3|||
164067913|NCT04636437|592610051|FG001|Overall Study|Participant or physician decision|1|||
164067914|NCT04636437|592610052|FG002|Overall Study|Participant or physician decision|1|||
164067915|NCT00816166|592610053|FG000|Overall Study|Lost to Follow-up|6|||
164067916|NCT00816166|592610054|FG001|Overall Study|Lost to Follow-up|10|||
164067917|NCT00816166|592610053|FG000|Overall Study|Death|4|||
164067918|NCT00816166|592610054|FG001|Overall Study|Death|2|||
164067919|NCT01071278|592610055|FG000|Overall Study|Premature Discontinuation|254|||
164067920|NCT01071278|592610055|FG000|Overall Study|Completion Status Unknown|459|||
164067921|NCT02684162|592610056|FG000|Overall Study|Physician Decision|0|||
164067922|NCT02684162|592610057|FG001|Overall Study|Physician Decision|1|||
164067923|NCT02684162|592610058|FG002|Overall Study|Physician Decision|0|||
164067924|NCT03743571|592610062|FG000|Overall Study|Withdrawal by Subject|1|||
164067925|NCT03743571|592610063|FG001|Overall Study|Withdrawal by Subject|1|||
164067926|NCT03743571|592610062|FG000|Overall Study|Lost to Follow-up|1|||
164067927|NCT03743571|592610063|FG001|Overall Study|Lost to Follow-up|2|||
164067928|NCT01489865|592610064|FG000|Overall Study|Progression of Disease|4|||
164067929|NCT01489865|592610065|FG001|Overall Study|Progression of Disease|2|||
164067930|NCT01489865|592610066|FG002|Overall Study|Progression of Disease|2|||
164067931|NCT01489865|592610067|FG003|Overall Study|Progression of Disease|3|||
164067932|NCT01489865|592610068|FG004|Overall Study|Progression of Disease|1|||
164067933|NCT01489865|592610069|FG005|Overall Study|Progression of Disease|6|||
164067934|NCT01489865|592610070|FG006|Overall Study|Progression of Disease|3|||
164067935|NCT01489865|592610071|FG007|Overall Study|Progression of Disease|0|||
164067936|NCT01489865|592610072|FG008|Overall Study|Progression of Disease|23|||
164067937|NCT01489865|592610064|FG000|Overall Study|Adverse Event|2|||
164067938|NCT01489865|592610065|FG001|Overall Study|Adverse Event|0|||
164067939|NCT01489865|592610066|FG002|Overall Study|Adverse Event|0|||
164067940|NCT01489865|592610067|FG003|Overall Study|Adverse Event|0|||
164067941|NCT01489865|592610068|FG004|Overall Study|Adverse Event|1|||
164067942|NCT01489865|592610069|FG005|Overall Study|Adverse Event|0|||
164067943|NCT01489865|592610070|FG006|Overall Study|Adverse Event|2|||
164067944|NCT01489865|592610071|FG007|Overall Study|Adverse Event|0|||
164067945|NCT01489865|592610072|FG008|Overall Study|Adverse Event|5|||
164067946|NCT01489865|592610064|FG000|Overall Study|Death|0|||
164067947|NCT01489865|592610065|FG001|Overall Study|Death|1|||
164067948|NCT01489865|592610066|FG002|Overall Study|Death|0|||
164067949|NCT01489865|592610067|FG003|Overall Study|Death|0|||
164067950|NCT01489865|592610068|FG004|Overall Study|Death|1|||
164067951|NCT01489865|592610069|FG005|Overall Study|Death|0|||
164067952|NCT01489865|592610070|FG006|Overall Study|Death|0|||
164067953|NCT01489865|592610071|FG007|Overall Study|Death|0|||
164067954|NCT01489865|592610072|FG008|Overall Study|Death|2|||
164067955|NCT01489865|592610064|FG000|Overall Study|Withdrawal by Subject|0|||
164067956|NCT01489865|592610065|FG001|Overall Study|Withdrawal by Subject|0|||
164067957|NCT01489865|592610066|FG002|Overall Study|Withdrawal by Subject|0|||
164067958|NCT01489865|592610067|FG003|Overall Study|Withdrawal by Subject|0|||
164067959|NCT01489865|592610068|FG004|Overall Study|Withdrawal by Subject|0|||
164067960|NCT01489865|592610069|FG005|Overall Study|Withdrawal by Subject|1|||
164067961|NCT01489865|592610070|FG006|Overall Study|Withdrawal by Subject|1|||
164067962|NCT01489865|592610071|FG007|Overall Study|Withdrawal by Subject|0|||
164067963|NCT01489865|592610072|FG008|Overall Study|Withdrawal by Subject|2|||
164067964|NCT01489865|592610064|FG000|Overall Study|Shifted|0|||
164067965|NCT01489865|592610065|FG001|Overall Study|Shifted|0|||
164067966|NCT01489865|592610066|FG002|Overall Study|Shifted|1|||
164067967|NCT01489865|592610067|FG003|Overall Study|Shifted|0|||
164067968|NCT01489865|592610068|FG004|Overall Study|Shifted|0|||
164067969|NCT01489865|592610069|FG005|Overall Study|Shifted|0|||
164067970|NCT01489865|592610070|FG006|Overall Study|Shifted|0|||
164067971|NCT01489865|592610071|FG007|Overall Study|Shifted|0|||
164067972|NCT01489865|592610072|FG008|Overall Study|Shifted|0|||
164067973|NCT00972309|592610073|FG000|Overall Study|Switched to alternative treatment|0|||
164067974|NCT00972309|592610074|FG001|Overall Study|Switched to alternative treatment|2|||
164067975|NCT00972309|592610073|FG000|Overall Study|Refused further treatment|0|||
164067976|NCT00972309|592610074|FG001|Overall Study|Refused further treatment|1|||
164067977|NCT00972309|592610073|FG000|Overall Study|Late determination of ineligibility|0|||
164067978|NCT00972309|592610074|FG001|Overall Study|Late determination of ineligibility|1|||
164067979|NCT00972309|592610073|FG000|Overall Study|Second malignancy|1|||
164067980|NCT00972309|592610074|FG001|Overall Study|Second malignancy|1|||
164067981|NCT00972309|592610073|FG000|Overall Study|Visa issues|0|||
164067982|NCT00972309|592610074|FG001|Overall Study|Visa issues|1|||
164067983|NCT00972309|592610073|FG000|Overall Study|Secondary cancer (SCC)|0|||
164067984|NCT00972309|592610074|FG001|Overall Study|Secondary cancer (SCC)|1|||
164067985|NCT00972309|592610073|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
164067986|NCT00972309|592610074|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
164067987|NCT00972309|592610073|FG000|Overall Study|Lost to Follow-up|1|||
164067988|NCT00972309|592610074|FG001|Overall Study|Lost to Follow-up|1|||
164067989|NCT00972309|592610073|FG000|Overall Study|Disease progression on study|10|||
164067990|NCT00972309|592610074|FG001|Overall Study|Disease progression on study|4|||
164067991|NCT01058707|592610085|FG000|Overall Study|Disease Progression|15|||
164067992|NCT01058707|592610086|FG001|Overall Study|Disease Progression|20|||
164067993|NCT01058707|592610087|FG002|Overall Study|Disease Progression|20|||
164067994|NCT01058707|592610088|FG003|Overall Study|Disease Progression|15|||
164067995|NCT01058707|592610089|FG004|Overall Study|Disease Progression|23|||
164067996|NCT01058707|592610090|FG005|Overall Study|Disease Progression|10|||
164067997|NCT01058707|592610091|FG006|Overall Study|Disease Progression|12|||
164067998|NCT01058707|592610085|FG000|Overall Study|Adverse Event|11|||
164067999|NCT01058707|592610086|FG001|Overall Study|Adverse Event|4|||
164068000|NCT01058707|592610087|FG002|Overall Study|Adverse Event|7|||
164068001|NCT01058707|592610088|FG003|Overall Study|Adverse Event|6|||
164068002|NCT01058707|592610089|FG004|Overall Study|Adverse Event|7|||
164068003|NCT01058707|592610090|FG005|Overall Study|Adverse Event|3|||
164068004|NCT01058707|592610091|FG006|Overall Study|Adverse Event|1|||
164068005|NCT01058707|592610085|FG000|Overall Study|Subject Decision|5|||
164068006|NCT01058707|592610086|FG001|Overall Study|Subject Decision|3|||
164068007|NCT01058707|592610087|FG002|Overall Study|Subject Decision|3|||
164068008|NCT01058707|592610088|FG003|Overall Study|Subject Decision|1|||
164068009|NCT01058707|592610089|FG004|Overall Study|Subject Decision|2|||
164068010|NCT01058707|592610090|FG005|Overall Study|Subject Decision|3|||
164068011|NCT01058707|592610091|FG006|Overall Study|Subject Decision|6|||
164068012|NCT01058707|592610085|FG000|Overall Study|Lost to Follow-up|0|||
164068013|NCT01058707|592610086|FG001|Overall Study|Lost to Follow-up|0|||
164068014|NCT01058707|592610087|FG002|Overall Study|Lost to Follow-up|1|||
164068015|NCT01058707|592610088|FG003|Overall Study|Lost to Follow-up|0|||
164068016|NCT01058707|592610089|FG004|Overall Study|Lost to Follow-up|0|||
164068017|NCT01058707|592610090|FG005|Overall Study|Lost to Follow-up|0|||
164068018|NCT01058707|592610091|FG006|Overall Study|Lost to Follow-up|0|||
164068019|NCT01058707|592610085|FG000|Overall Study|Reason Not Specified|0|||
164068020|NCT01058707|592610086|FG001|Overall Study|Reason Not Specified|3|||
164068021|NCT01058707|592610087|FG002|Overall Study|Reason Not Specified|2|||
164068022|NCT01058707|592610088|FG003|Overall Study|Reason Not Specified|0|||
164068023|NCT01058707|592610089|FG004|Overall Study|Reason Not Specified|7|||
164068024|NCT01058707|592610090|FG005|Overall Study|Reason Not Specified|1|||
164068025|NCT01058707|592610091|FG006|Overall Study|Reason Not Specified|7|||
164068026|NCT01821391|592610092|FG000|Overall Study|Adverse Event|1|||
164068027|NCT01821391|592610093|FG001|Overall Study|Adverse Event|0|||
164068028|NCT03417102|592610095|FG000|Overall Study|Adverse Event|0|||
164068029|NCT03417102|592610096|FG001|Overall Study|Adverse Event|1|||
164068030|NCT03417102|592610095|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
164068031|NCT03417102|592610096|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
164068032|NCT03417102|592610095|FG000|Overall Study|Other|0|||
164068033|NCT03417102|592610096|FG001|Overall Study|Other|1|||
164068034|NCT01017731|592611417|FG000|Overall Study|Lost to Follow-up|2|||
164068035|NCT01017731|592611417|FG000|Overall Study|Withdrawal by Subject|3|||
164068036|NCT01017731|592611417|FG000|Overall Study|Physician Decision|2|||
164068037|NCT01017731|592611417|FG000|Overall Study|Adverse Event|1|||
164068038|NCT00685763|592611419|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
164068039|NCT00685763|592611419|FG000|Overall Study|Protocol Violation|1|||
164068040|NCT00698009|592611423|FG000|Overall Study|Withdrawal by Subject|1|||
164068041|NCT00564486|592611427|FG000|Overall Study|Adverse Event|0|||
164068042|NCT00564486|592611428|FG001|Overall Study|Adverse Event|1|||
164068043|NCT00564486|592611429|FG002|Overall Study|Adverse Event|0|||
164068044|NCT00564486|592611430|FG003|Overall Study|Adverse Event|0|||
164068045|NCT00564486|592611427|FG000|Overall Study|Withdrawal by Subject|4|||
164068046|NCT00564486|592611428|FG001|Overall Study|Withdrawal by Subject|0|||
164068047|NCT00564486|592611429|FG002|Overall Study|Withdrawal by Subject|0|||
164068048|NCT00564486|592611430|FG003|Overall Study|Withdrawal by Subject|5|||
164068049|NCT00564486|592611427|FG000|Overall Study|Subject refused to have blood drawn|0|||
164068050|NCT00564486|592611428|FG001|Overall Study|Subject refused to have blood drawn|0|||
164068051|NCT00564486|592611429|FG002|Overall Study|Subject refused to have blood drawn|1|||
164068052|NCT00564486|592611430|FG003|Overall Study|Subject refused to have blood drawn|0|||
164068053|NCT00564486|592611427|FG000|Overall Study|Lost to Follow-up|3|||
164068054|NCT00564486|592611428|FG001|Overall Study|Lost to Follow-up|0|||
164068055|NCT00564486|592611429|FG002|Overall Study|Lost to Follow-up|2|||
164068056|NCT00564486|592611430|FG003|Overall Study|Lost to Follow-up|2|||
164068057|NCT03457727|592611440|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
164068058|NCT03457727|592611441|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
164068059|NCT03457727|592611442|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
164068060|NCT03457727|592611443|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
164068061|NCT00929201|592611444|FG000|Period 1|Withdrawal by Subject|0|||
164068062|NCT00929201|592611445|FG001|Period 1|Withdrawal by Subject|1|||
164068063|NCT00464308|592611451|FG000|Overall Study|Adverse Event|22|||
164068064|NCT00464308|592611452|FG001|Overall Study|Adverse Event|27|||
164068065|NCT00464308|592611453|FG002|Overall Study|Adverse Event|16|||
164068066|NCT00464308|592611451|FG000|Overall Study|Lost to Follow-up|29|||
164068067|NCT00464308|592611452|FG001|Overall Study|Lost to Follow-up|19|||
164068068|NCT00464308|592611453|FG002|Overall Study|Lost to Follow-up|20|||
164068069|NCT00464308|592611451|FG000|Overall Study|Patient discontinued and other reasons|17|||
164068070|NCT00464308|592611452|FG001|Overall Study|Patient discontinued and other reasons|17|||
164068071|NCT00464308|592611453|FG002|Overall Study|Patient discontinued and other reasons|23|||
164068072|NCT00464308|592611451|FG000|Overall Study|Physician Decision|1|||
164068073|NCT00464308|592611452|FG001|Overall Study|Physician Decision|0|||
164068074|NCT00464308|592611453|FG002|Overall Study|Physician Decision|0|||
164068075|NCT01721200|592611454|FG000|Overall Study|Lost to Follow-up|3|||
164068076|NCT01721200|592611455|FG001|Overall Study|Lost to Follow-up|5|||
164068077|NCT01513759|592611456|FG000|Overall Study|Protocol Violation|4|||
164068078|NCT01513759|592611456|FG000|Overall Study|Death during catheter placement|1|||
164068079|NCT03606109|592611457|FG000|Overall Study|Lost to Follow-up|2|||
164068080|NCT03606109|592611458|FG001|Overall Study|Lost to Follow-up|1|||
164068081|NCT03286426|592611459|FG000|Overall Study|Physician Decision|3|||
164068082|NCT01817764|592611460|FG000|Overall Study|Adverse Event|7|||
164068083|NCT01817764|592611461|FG001|Overall Study|Adverse Event|10|||
164068084|NCT01817764|592611460|FG000|Overall Study|Lack of Efficacy|9|||
164068085|NCT01817764|592611461|FG001|Overall Study|Lack of Efficacy|7|||
164068086|NCT01817764|592611460|FG000|Overall Study|Protocol Violation|7|||
164068087|NCT01817764|592611461|FG001|Overall Study|Protocol Violation|5|||
164068088|NCT01817764|592611460|FG000|Overall Study|Lost to Follow-up|1|||
164068089|NCT01817764|592611461|FG001|Overall Study|Lost to Follow-up|4|||
164068090|NCT01817764|592611460|FG000|Overall Study|Withdrawal by Subject|10|||
164068091|NCT01817764|592611461|FG001|Overall Study|Withdrawal by Subject|12|||
164068092|NCT01956123|592611462|FG000|COS Cycle 2|Protocol Violation|8|||
164068093|NCT01956123|592611463|FG001|COS Cycle 2|Protocol Violation|3|||
164068094|NCT01956123|592611464|FG002|COS Cycle 2|Protocol Violation|0|||
164068095|NCT01956123|592611465|FG003|COS Cycle 2|Protocol Violation|0|||
164068096|NCT01956123|592611462|FG000|COS Cycle 2|Adverse Event|3|||
164068097|NCT01956123|592611463|FG001|COS Cycle 2|Adverse Event|4|||
164068098|NCT01956123|592611464|FG002|COS Cycle 2|Adverse Event|0|||
164068099|NCT01956123|592611465|FG003|COS Cycle 2|Adverse Event|0|||
164068100|NCT01956123|592611462|FG000|COS Cycle 2|Personal Reasons|2|||
164068101|NCT01956123|592611463|FG001|COS Cycle 2|Personal Reasons|0|||
164068102|NCT01956123|592611464|FG002|COS Cycle 2|Personal Reasons|0|||
164068103|NCT01956123|592611465|FG003|COS Cycle 2|Personal Reasons|0|||
164068104|NCT01956123|592611462|FG000|COS Cycle 2|Withdrawal by Subject|1|||
164068105|NCT01956123|592611463|FG001|COS Cycle 2|Withdrawal by Subject|0|||
164068106|NCT01956123|592611464|FG002|COS Cycle 2|Withdrawal by Subject|0|||
164068107|NCT01956123|592611465|FG003|COS Cycle 2|Withdrawal by Subject|0|||
164068108|NCT01956123|592611462|FG000|COS Cycle 3|Protocol Violation|0|||
164068109|NCT01956123|592611463|FG001|COS Cycle 3|Protocol Violation|0|||
164068110|NCT01956123|592611464|FG002|COS Cycle 3|Protocol Violation|2|||
164068111|NCT01956123|592611465|FG003|COS Cycle 3|Protocol Violation|1|||
164068112|NCT01956123|592611462|FG000|COS Cycle 3|Adverse Event|0|||
164068113|NCT01956123|592611463|FG001|COS Cycle 3|Adverse Event|0|||
164068114|NCT01956123|592611464|FG002|COS Cycle 3|Adverse Event|3|||
164068115|NCT01956123|592611465|FG003|COS Cycle 3|Adverse Event|0|||
164068116|NCT01956123|592611462|FG000|COS Cycle 3|Personal Reasons|0|||
164068117|NCT01956123|592611463|FG001|COS Cycle 3|Personal Reasons|0|||
164068118|NCT01956123|592611464|FG002|COS Cycle 3|Personal Reasons|1|||
164068119|NCT01956123|592611465|FG003|COS Cycle 3|Personal Reasons|0|||
164068120|NCT01956123|592611462|FG000|COS Cycle 3|Withdrawal by Subject|0|||
164068121|NCT01956123|592611463|FG001|COS Cycle 3|Withdrawal by Subject|0|||
164068122|NCT01956123|592611464|FG002|COS Cycle 3|Withdrawal by Subject|0|||
164068123|NCT01956123|592611465|FG003|COS Cycle 3|Withdrawal by Subject|1|||
164068124|NCT00366678|592611466|FG000|Infant Series|Withdrawal by Subject|8|||
164068125|NCT00366678|592611467|FG001|Infant Series|Withdrawal by Subject|6|||
164068126|NCT00366678|592611468|FG002|Infant Series|Withdrawal by Subject|0|||
164068127|NCT00366678|592611466|FG000|Infant Series|Protocol Violation|4|||
164068128|NCT00366678|592611467|FG001|Infant Series|Protocol Violation|3|||
164068129|NCT00366678|592611468|FG002|Infant Series|Protocol Violation|0|||
164068130|NCT00366678|592611466|FG000|Infant Series|Failed to return|1|||
164068131|NCT00366678|592611467|FG001|Infant Series|Failed to return|1|||
164068132|NCT00366678|592611468|FG002|Infant Series|Failed to return|0|||
164068133|NCT00366678|592611466|FG000|Infant Series|Adverse Event|1|||
164068134|NCT00366678|592611467|FG001|Infant Series|Adverse Event|0|||
164068135|NCT00366678|592611468|FG002|Infant Series|Adverse Event|0|||
164068136|NCT00366678|592611466|FG000|After Infant|Withdrawal by Subject|8|||
164068137|NCT00366678|592611467|FG001|After Infant|Withdrawal by Subject|4|||
164068138|NCT00366678|592611468|FG002|After Infant|Withdrawal by Subject|0|||
164068139|NCT00366678|592611466|FG000|After Infant|Lost to Follow-up|2|||
164068140|NCT00366678|592611467|FG001|After Infant|Lost to Follow-up|1|||
164068141|NCT00366678|592611468|FG002|After Infant|Lost to Follow-up|0|||
164068142|NCT00366678|592611466|FG000|After Infant|Failed to return|5|||
164068143|NCT00366678|592611467|FG001|After Infant|Failed to return|5|||
164068144|NCT00366678|592611468|FG002|After Infant|Failed to return|0|||
164068145|NCT00366678|592611466|FG000|After Infant|Adverse Event|1|||
164068146|NCT00366678|592611467|FG001|After Infant|Adverse Event|0|||
164068147|NCT00366678|592611468|FG002|After Infant|Adverse Event|0|||
164068148|NCT00366678|592611466|FG000|After Infant|Protocol Violation|1|||
164068149|NCT00366678|592611467|FG001|After Infant|Protocol Violation|0|||
164068150|NCT00366678|592611468|FG002|After Infant|Protocol Violation|0|||
164068151|NCT00366678|592611466|FG000|Toddler Dose|Protocol Violation|2|||
164068152|NCT00366678|592611467|FG001|Toddler Dose|Protocol Violation|1|||
164068153|NCT00366678|592611468|FG002|Toddler Dose|Protocol Violation|0|||
164068154|NCT00366678|592611466|FG000|Toddler Dose|Failed to return|1|||
164105436|NCT04078022|592749192|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
164105437|NCT04078022|592749193|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
164105438|NCT01250912|592749194|FG000|Overall Study|Lost to Follow-up|1|||
164105439|NCT00191815|592749195|FG000|Overall Study|Adverse Event|2|||
164105440|NCT00191815|592749195|FG000|Overall Study|Disease progression or relapse|24|||
164105441|NCT00191815|592749195|FG000|Overall Study|Death|2|||
164105442|NCT00191815|592749195|FG000|Overall Study|Protocol Violation|3|||
164105443|NCT00191815|592749195|FG000|Overall Study|Physician Decision|2|||
164105444|NCT00191815|592749195|FG000|Overall Study|Withdrawal by Subject|7|||
164105445|NCT01929863|592749196|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
164105446|NCT01929863|592749197|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
164105447|NCT01929863|592749196|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
164105448|NCT01929863|592749197|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
164105449|NCT01929863|592749196|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
164105450|NCT01929863|592749197|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
164105451|NCT01348789|592749203|FG000|Overall Study|Protocol Violation|2|||
164105452|NCT01348789|592749203|FG000|Overall Study|Withdrawal by Subject|2|||
164105453|NCT00415363|592749210|FG000|Overall Study|Withdrawal by Subject|4|||
164105454|NCT00415363|592749211|FG001|Overall Study|Withdrawal by Subject|4|||
164105455|NCT00415363|592749210|FG000|Overall Study|Adverse Event|4|||
164105456|NCT00415363|592749211|FG001|Overall Study|Adverse Event|4|||
164105457|NCT00415363|592749210|FG000|Overall Study|Lost to Follow-up|2|||
164105458|NCT00415363|592749211|FG001|Overall Study|Lost to Follow-up|1|||
164105459|NCT00415363|592749210|FG000|Overall Study|Physician Decision|3|||
164105460|NCT00415363|592749211|FG001|Overall Study|Physician Decision|1|||
164105461|NCT00415363|592749210|FG000|Overall Study|Death|16|||
164105462|NCT00415363|592749211|FG001|Overall Study|Death|12|||
164105463|NCT00415363|592749210|FG000|Overall Study|Progressive disease|26|||
164105464|NCT00415363|592749211|FG001|Overall Study|Progressive disease|32|||
164105465|NCT03123471|592749212|FG000|Placebo-controlled Phase|Adverse Event|3|||
164105466|NCT03123471|592749213|FG001|Placebo-controlled Phase|Adverse Event|8|||
164105467|NCT03123471|592749212|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
164105468|NCT03123471|592749213|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
164105469|NCT03123471|592749212|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
164105470|NCT03123471|592749213|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
164105471|NCT03123471|592749212|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
164105472|NCT03123471|592749213|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
164105473|NCT03123471|592749212|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
164105474|NCT03123471|592749213|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
164105475|NCT03123471|592749212|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
164105476|NCT03123471|592749213|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
164105477|NCT03123471|592749212|FG000|Placebo-controlled Phase|Miscellaneous|0|||
164105478|NCT03123471|592749213|FG001|Placebo-controlled Phase|Miscellaneous|1|||
164105479|NCT03123471|592749212|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
164105480|NCT03123471|592749213|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
164105481|NCT03123471|592749212|FG000|Apremilast Extension Phase|Adverse Event|1|||
164105482|NCT03123471|592749213|FG001|Apremilast Extension Phase|Adverse Event|5|||
164105483|NCT03123471|592749212|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
164105484|NCT03123471|592749213|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
164105485|NCT03123471|592749212|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
164105486|NCT03123471|592749213|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
164105487|NCT02358538|592749216|FG000|Through Week 26|Adverse Event|0|||
164105488|NCT02358538|592749217|FG001|Through Week 26|Adverse Event|1|||
164105489|NCT02358538|592749218|FG002|Through Week 26|Adverse Event|1|||
164105490|NCT02358538|592749219|FG003|Through Week 26|Adverse Event|2|||
164105491|NCT02358538|592749216|FG000|Through Week 26|Lack of Efficacy|1|||
164105492|NCT02358538|592749217|FG001|Through Week 26|Lack of Efficacy|1|||
164105493|NCT02358538|592749218|FG002|Through Week 26|Lack of Efficacy|3|||
164105494|NCT02358538|592749219|FG003|Through Week 26|Lack of Efficacy|3|||
164105495|NCT02358538|592749216|FG000|Through Week 26|Withdrawal by Subject|1|||
164105496|NCT02358538|592749217|FG001|Through Week 26|Withdrawal by Subject|0|||
164105497|NCT02358538|592749218|FG002|Through Week 26|Withdrawal by Subject|0|||
164105498|NCT02358538|592749219|FG003|Through Week 26|Withdrawal by Subject|0|||
164105499|NCT02358538|592749216|FG000|Through Week 26|Non-Compliance|0|||
164105500|NCT02358538|592749217|FG001|Through Week 26|Non-Compliance|0|||
164105501|NCT02358538|592749218|FG002|Through Week 26|Non-Compliance|1|||
164105502|NCT02358538|592749219|FG003|Through Week 26|Non-Compliance|0|||
164105503|NCT02358538|592749216|FG000|Through Week 26|Family did not see benefit from IP|1|||
164105504|NCT02358538|592749217|FG001|Through Week 26|Family did not see benefit from IP|0|||
164105505|NCT02358538|592749218|FG002|Through Week 26|Family did not see benefit from IP|0|||
164105506|NCT02358538|592749219|FG003|Through Week 26|Family did not see benefit from IP|0|||
164105507|NCT02358538|592749216|FG000|52 Week Extension Period|Lack of Efficacy|0|||
164105508|NCT02358538|592749217|FG001|52 Week Extension Period|Lack of Efficacy|0|||
164105509|NCT02358538|592749218|FG002|52 Week Extension Period|Lack of Efficacy|2|||
164068155|NCT00366678|592611467|FG001|Toddler Dose|Failed to return|0|||
164068156|NCT00366678|592611468|FG002|Toddler Dose|Failed to return|0|||
164068157|NCT00366678|592611466|FG000|Toddler Dose|Withdrawal by Subject|1|||
164068158|NCT00366678|592611467|FG001|Toddler Dose|Withdrawal by Subject|0|||
164068159|NCT00366678|592611468|FG002|Toddler Dose|Withdrawal by Subject|0|||
164068160|NCT00366678|592611466|FG000|Toddler Dose|protocol deviation|1|||
164068161|NCT00366678|592611467|FG001|Toddler Dose|protocol deviation|0|||
164068162|NCT00366678|592611468|FG002|Toddler Dose|protocol deviation|0|||
164068163|NCT00388674|592611479|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
164068164|NCT00388674|592611480|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
164068165|NCT00388674|592611479|FG000|Initial Treatment|Adverse Event|22|||
164068166|NCT00388674|592611480|FG001|Initial Treatment|Adverse Event|87|||
164068167|NCT00388674|592611479|FG000|Initial Treatment|Death|215|||
164068168|NCT00388674|592611480|FG001|Initial Treatment|Death|216|||
164068169|NCT00388674|592611479|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
164068170|NCT00388674|592611480|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
164068171|NCT00388674|592611479|FG000|Initial Treatment|HCC|12|||
164068172|NCT00388674|592611480|FG001|Initial Treatment|HCC|20|||
164068173|NCT00388674|592611479|FG000|Initial Treatment|Lost to Follow-up|526|||
164068174|NCT00388674|592611480|FG001|Initial Treatment|Lost to Follow-up|624|||
164068175|NCT00388674|592611479|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
164068176|NCT00388674|592611480|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
164068177|NCT00388674|592611479|FG000|Initial Treatment|Never Treated with Study Medication|1|||
164068178|NCT00388674|592611480|FG001|Initial Treatment|Never Treated with Study Medication|7|||
164068179|NCT00388674|592611479|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
164068180|NCT00388674|592611480|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
164068181|NCT00388674|592611479|FG000|Initial Treatment|Not Defined|125|||
164068182|NCT00388674|592611480|FG001|Initial Treatment|Not Defined|172|||
164068183|NCT00388674|592611479|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
164068184|NCT00388674|592611480|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
164068185|NCT00388674|592611479|FG000|Initial Treatment|Pregnancy|26|||
164068186|NCT00388674|592611480|FG001|Initial Treatment|Pregnancy|16|||
164068187|NCT00388674|592611479|FG000|Initial Treatment|Study Drug Toxicity|5|||
164068188|NCT00388674|592611480|FG001|Initial Treatment|Study Drug Toxicity|92|||
164068189|NCT00388674|592611479|FG000|Initial Treatment|Participant Request|501|||
164068190|NCT00388674|592611480|FG001|Initial Treatment|Participant Request|673|||
164068191|NCT00388674|592611479|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
164068192|NCT00388674|592611480|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
164068193|NCT00388674|592611479|FG000|Initial Treatment|Not Reported|10|||
164068194|NCT00388674|592611480|FG001|Initial Treatment|Not Reported|12|||
164068195|NCT00388674|592611479|FG000|End of Study|Administrative Reason By Sponsor|299|||
164068196|NCT00388674|592611480|FG001|End of Study|Administrative Reason By Sponsor|253|||
164068197|NCT00388674|592611479|FG000|End of Study|Death|239|||
164068198|NCT00388674|592611480|FG001|End of Study|Death|262|||
164068199|NCT00388674|592611479|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
164068200|NCT00388674|592611480|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
164068201|NCT00388674|592611479|FG000|End of Study|HCC|8|||
164068202|NCT00388674|592611480|FG001|End of Study|HCC|7|||
164068203|NCT00388674|592611479|FG000|End of Study|Lost to Follow-up|587|||
164068204|NCT00388674|592611480|FG001|End of Study|Lost to Follow-up|715|||
164068205|NCT00388674|592611479|FG000|End of Study|Malignancy (Non-HCC)|1|||
164068206|NCT00388674|592611480|FG001|End of Study|Malignancy (Non-HCC)|1|||
164068207|NCT00388674|592611479|FG000|End of Study|Non-Study Related Comorbidities|3|||
164068208|NCT00388674|592611480|FG001|End of Study|Non-Study Related Comorbidities|4|||
164068209|NCT00388674|592611479|FG000|End of Study|Not Defined|135|||
164068210|NCT00388674|592611480|FG001|End of Study|Not Defined|214|||
164068211|NCT00388674|592611479|FG000|End of Study|Participant Withdrew Consent|437|||
164068212|NCT00388674|592611480|FG001|End of Study|Participant Withdrew Consent|673|||
164068213|NCT00388674|592611479|FG000|End of Study|No Off-Treatment Status Data|22|||
164068214|NCT00388674|592611480|FG001|End of Study|No Off-Treatment Status Data|30|||
164068215|NCT00388674|592611479|FG000|End of Study|Not Reported|0|||
164068216|NCT00388674|592611480|FG001|End of Study|Not Reported|1|||
164068217|NCT01569594|592611487|FG000|Overall Study|Physician Decision|4|||
164068218|NCT01569594|592611487|FG000|Overall Study|Death|13|||
164068219|NCT01569594|592611487|FG000|Overall Study|Lost to Follow-up|22|||
164068220|NCT01569594|592611487|FG000|Overall Study|Adverse Event|2|||
164068221|NCT01569594|592611487|FG000|Overall Study|Withdrawal by Subject|13|||
164068222|NCT01569594|592611487|FG000|Overall Study|Other|4|||
164068223|NCT01569594|592611487|FG000|Overall Study|No ECM used|9|||
164068224|NCT01965431|592611488|FG000|Overall Study|Adverse Event|0|||
164068225|NCT01965431|592611489|FG001|Overall Study|Adverse Event|1|||
164068226|NCT01965431|592611490|FG002|Overall Study|Adverse Event|0|||
164068227|NCT01965431|592611491|FG003|Overall Study|Adverse Event|0|||
164068228|NCT01965431|592611492|FG004|Overall Study|Adverse Event|0|||
164068229|NCT01965431|592611493|FG005|Overall Study|Adverse Event|0|||
164068230|NCT01965431|592611488|FG000|Overall Study|Other than stated above|6|||
164068231|NCT01965431|592611489|FG001|Overall Study|Other than stated above|5|||
164068232|NCT01965431|592611490|FG002|Overall Study|Other than stated above|6|||
164105510|NCT02358538|592749219|FG003|52 Week Extension Period|Lack of Efficacy|4|||
164105511|NCT01686477|592749220|FG000|Feeding Intervention|Death|1|||
164105512|NCT01686477|592749221|FG001|Feeding Intervention|Death|0|||
164105513|NCT01686477|592749222|FG002|Feeding Intervention|Death|1|||
164105514|NCT01686477|592749220|FG000|Feeding Intervention|Withdrawal by Subject|0|||
164105515|NCT01686477|592749221|FG001|Feeding Intervention|Withdrawal by Subject|6|||
164105516|NCT01686477|592749222|FG002|Feeding Intervention|Withdrawal by Subject|0|||
164105517|NCT01686477|592749220|FG000|Feeding Intervention|Physician Decision|1|||
164105518|NCT01686477|592749221|FG001|Feeding Intervention|Physician Decision|2|||
164105519|NCT01686477|592749222|FG002|Feeding Intervention|Physician Decision|0|||
164105520|NCT01686477|592749220|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
164105521|NCT01686477|592749221|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
164105522|NCT01686477|592749222|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
164105523|NCT01686477|592749220|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
164105524|NCT01686477|592749221|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
164105525|NCT01686477|592749222|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
164105526|NCT01686477|592749220|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
164105527|NCT01686477|592749221|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
164105528|NCT01686477|592749222|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
164105529|NCT01686477|592749220|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
164105530|NCT01686477|592749221|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
164105531|NCT01686477|592749222|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
164105532|NCT01686477|592749220|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
164105533|NCT01686477|592749221|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
164105534|NCT01686477|592749222|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
164105535|NCT01686477|592749220|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
164105536|NCT01686477|592749221|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
164105537|NCT01686477|592749222|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
164105538|NCT01686477|592749220|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
164105539|NCT01686477|592749221|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
164105540|NCT01686477|592749222|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
164105541|NCT02178787|592749224|FG000|Overall Study|Lost to Follow-up|1|||
164105542|NCT02178787|592749225|FG001|Overall Study|Lost to Follow-up|0|||
164105543|NCT02178787|592749224|FG000|Overall Study|Withdrawal by Subject|0|||
164105544|NCT02178787|592749225|FG001|Overall Study|Withdrawal by Subject|2|||
164105545|NCT02178787|592749224|FG000|Overall Study|No TCD window|3|||
164105546|NCT02178787|592749225|FG001|Overall Study|No TCD window|7|||
164105547|NCT02178787|592749224|FG000|Overall Study|Physician Decision|1|||
164105548|NCT02178787|592749225|FG001|Overall Study|Physician Decision|0|||
164105549|NCT01588236|592749230|FG000|Overall Study|Adverse Event|5|||
164105550|NCT01588236|592749231|FG001|Overall Study|Adverse Event|4|||
164105551|NCT01588236|592749232|FG002|Overall Study|Adverse Event|1|||
164105552|NCT01588236|592749230|FG000|Overall Study|Lost to Follow-up|8|||
164105553|NCT01588236|592749231|FG001|Overall Study|Lost to Follow-up|13|||
164105554|NCT01588236|592749232|FG002|Overall Study|Lost to Follow-up|6|||
164068233|NCT01965431|592611491|FG003|Overall Study|Other than stated above|6|||
164068234|NCT01965431|592611492|FG004|Overall Study|Other than stated above|6|||
164068235|NCT01965431|592611493|FG005|Overall Study|Other than stated above|6|||
164068236|NCT04635631|592611494|FG000|Overall Study|Adverse Event|1|||
164068237|NCT04635631|592611494|FG000|Overall Study|Progressive disease|13|||
164068238|NCT04635631|592611494|FG000|Overall Study|Withdrawal by Subject|1|||
164068239|NCT00943826|592611495|FG000|Concurrent Phase|Adverse Event|50|||
164068240|NCT00943826|592611496|FG001|Concurrent Phase|Adverse Event|27|||
164068241|NCT00943826|592611495|FG000|Concurrent Phase|Withdrew consent|3|||
164068242|NCT00943826|592611496|FG001|Concurrent Phase|Withdrew consent|7|||
164068243|NCT00943826|592611495|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
164068244|NCT00943826|592611496|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
164068245|NCT00943826|592611495|FG000|Concurrent Phase|Administrative reasons|2|||
164068246|NCT00943826|592611496|FG001|Concurrent Phase|Administrative reasons|1|||
164105555|NCT01588236|592749230|FG000|Overall Study|Physician Decision|1|||
164105556|NCT01588236|592749231|FG001|Overall Study|Physician Decision|2|||
164105557|NCT01588236|592749232|FG002|Overall Study|Physician Decision|0|||
164068247|NCT00943826|592611495|FG000|Concurrent Phase|Protocol Violation|1|||
164068248|NCT00943826|592611496|FG001|Concurrent Phase|Protocol Violation|0|||
164068249|NCT00943826|592611495|FG000|Maintenance Phase|Adverse Event|31|||
164068250|NCT00943826|592611496|FG001|Maintenance Phase|Adverse Event|30|||
164068251|NCT00943826|592611495|FG000|Maintenance Phase|Withdrew consent|2|||
164105558|NCT01588236|592749230|FG000|Overall Study|Protocol Violation|0|||
164105559|NCT01588236|592749231|FG001|Overall Study|Protocol Violation|1|||
164105560|NCT01588236|592749232|FG002|Overall Study|Protocol Violation|1|||
164105561|NCT01588236|592749230|FG000|Overall Study|Withdrawal by Subject|14|||
164105562|NCT01588236|592749231|FG001|Overall Study|Withdrawal by Subject|16|||
164068252|NCT00943826|592611496|FG001|Maintenance Phase|Withdrew consent|4|||
164068253|NCT00943826|592611495|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
164068254|NCT00943826|592611496|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
164068255|NCT00943826|592611495|FG000|Maintenance Phase|Administrative reasons|4|||
164068256|NCT00943826|592611496|FG001|Maintenance Phase|Administrative reasons|1|||
164068257|NCT00943826|592611495|FG000|Maintenance Phase|Failure to return|0|||
164068258|NCT00943826|592611496|FG001|Maintenance Phase|Failure to return|1|||
164068259|NCT00943826|592611495|FG000|Monotherapy Phase|Adverse Event|42|||
164068260|NCT00943826|592611496|FG001|Monotherapy Phase|Adverse Event|5|||
164068261|NCT00943826|592611495|FG000|Monotherapy Phase|Administrative reasons|11|||
164068262|NCT00943826|592611496|FG001|Monotherapy Phase|Administrative reasons|5|||
164068263|NCT00943826|592611495|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
164068264|NCT00943826|592611496|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
164068265|NCT00943826|592611495|FG000|Monotherapy Phase|Withdrew Consent|2|||
164105563|NCT01588236|592749232|FG002|Overall Study|Withdrawal by Subject|18|||
164105564|NCT01588236|592749230|FG000|Overall Study|Exclusion Criteria met during study|2|||
164105565|NCT01588236|592749231|FG001|Overall Study|Exclusion Criteria met during study|1|||
164105566|NCT01588236|592749232|FG002|Overall Study|Exclusion Criteria met during study|0|||
164105567|NCT01588236|592749230|FG000|Overall Study|sponsor decision|1|||
164105568|NCT01588236|592749231|FG001|Overall Study|sponsor decision|6|||
164105569|NCT01588236|592749232|FG002|Overall Study|sponsor decision|2|||
164105570|NCT02430480|592749233|FG000|Overall Study|Death|1|||
164105571|NCT02430480|592749233|FG000|Overall Study|Anesthesia concerns|1|||
164105572|NCT02430480|592749233|FG000|Overall Study|Progressed on treatment|1|||
164105573|NCT01030133|592749234|FG000|Overall Study|failed to experience pain at level 7/10|2|||
164105574|NCT01030133|592749235|FG001|Overall Study|failed to experience pain at level 7/10|2|||
164105575|NCT04493684|592749236|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
164105576|NCT04493684|592749237|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105577|NCT04493684|592749238|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
164105578|NCT04493684|592749239|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105579|NCT04493684|592749240|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105580|NCT04493684|592749241|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
164105581|NCT04493684|592749242|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105582|NCT04493684|592749243|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105583|NCT04493684|592749244|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105584|NCT04493684|592749245|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105585|NCT04493684|592749246|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105586|NCT04493684|592749247|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105587|NCT04493684|592749248|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105588|NCT04493684|592749249|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105589|NCT04493684|592749250|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105590|NCT04493684|592749251|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105591|NCT04493684|592749252|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
164105592|NCT04493684|592749236|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
164105593|NCT04493684|592749237|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105594|NCT04493684|592749238|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105595|NCT04493684|592749239|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105596|NCT04493684|592749240|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105597|NCT04493684|592749241|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105598|NCT04493684|592749242|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105599|NCT04493684|592749243|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105600|NCT04493684|592749244|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105601|NCT04493684|592749245|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105602|NCT04493684|592749246|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105603|NCT04493684|592749247|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105604|NCT04493684|592749248|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105605|NCT04493684|592749249|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105606|NCT04493684|592749250|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105607|NCT04493684|592749251|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164105608|NCT04493684|592749252|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
164068266|NCT00943826|592611496|FG001|Monotherapy Phase|Withdrew Consent|3|||
164068267|NCT00943826|592611495|FG000|Monotherapy Phase|Failure to return|2|||
164068268|NCT00943826|592611496|FG001|Monotherapy Phase|Failure to return|1|||
164068269|NCT00943826|592611495|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
164068270|NCT00943826|592611496|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
164068271|NCT00943826|592611495|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
164068272|NCT00943826|592611496|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
164068273|NCT00943826|592611495|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
164068274|NCT00943826|592611496|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
164068275|NCT00943826|592611495|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
164068276|NCT00943826|592611496|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
164068277|NCT04764669|592611497|FG000|Overall Study|Adverse Event|1|||
164068278|NCT04764669|592611498|FG001|Overall Study|Adverse Event|0|||
164068279|NCT04764669|592611499|FG002|Overall Study|Adverse Event|1|||
164068280|NCT04764669|592611500|FG003|Overall Study|Adverse Event|0|||
164068281|NCT04764669|592611497|FG000|Overall Study|Subject Choice|0|||
164068282|NCT04764669|592611498|FG001|Overall Study|Subject Choice|0|||
164068283|NCT04764669|592611499|FG002|Overall Study|Subject Choice|1|||
164068284|NCT04764669|592611500|FG003|Overall Study|Subject Choice|0|||
164068285|NCT04764669|592611497|FG000|Overall Study|Withdrawal by Subject|2|||
164068286|NCT04764669|592611498|FG001|Overall Study|Withdrawal by Subject|0|||
164068287|NCT04764669|592611499|FG002|Overall Study|Withdrawal by Subject|0|||
164068288|NCT04764669|592611500|FG003|Overall Study|Withdrawal by Subject|0|||
164068289|NCT00877799|592611502|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
164068290|NCT00877799|592611503|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
164068291|NCT00877799|592611504|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
164068292|NCT00877799|592611505|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
164068293|NCT00877799|592611506|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
164068294|NCT00877799|592611502|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
164068295|NCT00877799|592611503|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
164068296|NCT00877799|592611504|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
164068297|NCT00877799|592611505|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
164068298|NCT00877799|592611506|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
164068299|NCT00877799|592611502|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164068300|NCT00877799|592611503|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
164068301|NCT00877799|592611504|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164068302|NCT00877799|592611505|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164068303|NCT00877799|592611506|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
164068304|NCT00877799|592611502|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164068305|NCT00877799|592611503|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164068306|NCT00877799|592611504|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164068307|NCT00877799|592611505|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
164068308|NCT00877799|592611506|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
164068309|NCT00877799|592611502|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
164068310|NCT00877799|592611503|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
164068311|NCT00877799|592611504|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
164068312|NCT00877799|592611505|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
164068313|NCT00877799|592611506|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
164068314|NCT04054011|592611507|FG000|Overall Study|COVID|3|||
164068315|NCT00592007|592611508|FG000|Overall Study|Withdrawal by Subject|1|||
164068316|NCT00592007|592611508|FG000|Overall Study|patient ineligible (out of lab range)|1|||
164068317|NCT00595127|592611509|FG000|Overall Study|Death|6|||
164068318|NCT00595127|592611509|FG000|Overall Study|Relapsed|3|||
164068319|NCT00595127|592611509|FG000|Overall Study|joined another trial|1|||
164068320|NCT01785472|592611510|FG000|Overall Study|Adverse Event|5|||
164068321|NCT01785472|592611511|FG001|Overall Study|Adverse Event|4|||
164068322|NCT01785472|592611512|FG002|Overall Study|Adverse Event|6|||
164068323|NCT01785472|592611510|FG000|Overall Study|Lack of Efficacy|2|||
164068324|NCT01785472|592611511|FG001|Overall Study|Lack of Efficacy|0|||
164068325|NCT01785472|592611512|FG002|Overall Study|Lack of Efficacy|1|||
164068326|NCT01785472|592611510|FG000|Overall Study|Lost to Follow-up|1|||
164068327|NCT01785472|592611511|FG001|Overall Study|Lost to Follow-up|2|||
164068328|NCT01785472|592611512|FG002|Overall Study|Lost to Follow-up|0|||
164068329|NCT01785472|592611510|FG000|Overall Study|Physician Decision|1|||
164068330|NCT01785472|592611511|FG001|Overall Study|Physician Decision|1|||
164068331|NCT01785472|592611512|FG002|Overall Study|Physician Decision|1|||
164068332|NCT01785472|592611510|FG000|Overall Study|Protocol deviation|0|||
164068333|NCT01785472|592611511|FG001|Overall Study|Protocol deviation|2|||
164068334|NCT01785472|592611512|FG002|Overall Study|Protocol deviation|2|||
164068335|NCT01785472|592611510|FG000|Overall Study|Subject/guardian decision|15|||
164068336|NCT01785472|592611511|FG001|Overall Study|Subject/guardian decision|10|||
164068337|NCT01785472|592611512|FG002|Overall Study|Subject/guardian decision|11|||
164068338|NCT01785472|592611510|FG000|Overall Study|Technical problems|0|||
164068339|NCT01785472|592611511|FG001|Overall Study|Technical problems|0|||
164068340|NCT01785472|592611512|FG002|Overall Study|Technical problems|1|||
164068341|NCT01803464|592611514|FG000|Overall Study|Incomplete data|0|||
164068342|NCT01803464|592611515|FG001|Overall Study|Incomplete data|0|||
164068343|NCT01803464|592611516|FG002|Overall Study|Incomplete data|4|||
164068344|NCT01803464|592611517|FG003|Overall Study|Incomplete data|0|||
164112672|NCT00840658|592774093|FG003|Overall Study|Lost to Follow-up|1|||
164068345|NCT01803464|592611514|FG000|Overall Study|Withdrawal by Subject|1|||
164068346|NCT01803464|592611515|FG001|Overall Study|Withdrawal by Subject|0|||
164068347|NCT01803464|592611516|FG002|Overall Study|Withdrawal by Subject|0|||
164068348|NCT01803464|592611517|FG003|Overall Study|Withdrawal by Subject|0|||
164068349|NCT01125358|592611523|FG000|Overall Study|Adverse Event|3|||
164068350|NCT01125358|592611524|FG001|Overall Study|Adverse Event|0|||
164105609|NCT04493684|592749236|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105610|NCT04493684|592749237|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105611|NCT04493684|592749238|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105612|NCT04493684|592749239|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105613|NCT04493684|592749240|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105614|NCT04493684|592749241|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105615|NCT04493684|592749242|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
164105616|NCT04493684|592749243|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105617|NCT04493684|592749244|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105618|NCT04493684|592749245|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105619|NCT04493684|592749246|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105620|NCT04493684|592749247|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105621|NCT04493684|592749248|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105622|NCT04493684|592749249|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105623|NCT04493684|592749250|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105624|NCT04493684|592749251|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105625|NCT04493684|592749252|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
164105626|NCT04493684|592749236|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
164105627|NCT04493684|592749237|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105628|NCT04493684|592749238|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105629|NCT04493684|592749239|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105630|NCT04493684|592749240|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105631|NCT04493684|592749241|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105632|NCT04493684|592749242|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105633|NCT04493684|592749243|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105634|NCT04493684|592749244|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105635|NCT04493684|592749245|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105636|NCT04493684|592749246|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105637|NCT04493684|592749247|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105638|NCT04493684|592749248|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105639|NCT04493684|592749249|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105640|NCT04493684|592749250|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105641|NCT04493684|592749251|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105642|NCT04493684|592749252|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
164105643|NCT04493684|592749236|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105644|NCT04493684|592749237|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105645|NCT04493684|592749238|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105646|NCT04493684|592749239|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105647|NCT04493684|592749240|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105648|NCT04493684|592749241|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
164105649|NCT04493684|592749242|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105650|NCT04493684|592749243|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105651|NCT04493684|592749244|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105652|NCT04493684|592749245|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105653|NCT04493684|592749246|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105654|NCT04493684|592749247|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105655|NCT04493684|592749248|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105656|NCT04493684|592749249|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105657|NCT04493684|592749250|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105658|NCT04493684|592749251|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105659|NCT04493684|592749252|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
164105660|NCT04493684|592749236|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105661|NCT04493684|592749237|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164112673|NCT02372006|592774098|FG000|Overall Study|Progressive disease|8|||
164068351|NCT01125358|592611525|FG002|Overall Study|Adverse Event|0|||
164068352|NCT01125358|592611526|FG003|Overall Study|Adverse Event|2|||
164068353|NCT01125358|592611523|FG000|Overall Study|Perceived Lack of Efficacy|6|||
164068354|NCT01125358|592611524|FG001|Overall Study|Perceived Lack of Efficacy|3|||
164068355|NCT01125358|592611525|FG002|Overall Study|Perceived Lack of Efficacy|7|||
164068356|NCT01125358|592611526|FG003|Overall Study|Perceived Lack of Efficacy|4|||
164068357|NCT01125358|592611523|FG000|Overall Study|Protocol Violation|1|||
164068358|NCT01125358|592611524|FG001|Overall Study|Protocol Violation|0|||
164068359|NCT01125358|592611525|FG002|Overall Study|Protocol Violation|0|||
164068360|NCT01125358|592611526|FG003|Overall Study|Protocol Violation|0|||
164068361|NCT01125358|592611523|FG000|Overall Study|Sponsor Decision|0|||
164068362|NCT01125358|592611524|FG001|Overall Study|Sponsor Decision|0|||
164068363|NCT01125358|592611525|FG002|Overall Study|Sponsor Decision|1|||
164068364|NCT01125358|592611526|FG003|Overall Study|Sponsor Decision|1|||
164068365|NCT01125358|592611523|FG000|Overall Study|Withdrawal by Subject|2|||
164068366|NCT01125358|592611524|FG001|Overall Study|Withdrawal by Subject|1|||
164068367|NCT01125358|592611525|FG002|Overall Study|Withdrawal by Subject|1|||
164068368|NCT01125358|592611526|FG003|Overall Study|Withdrawal by Subject|1|||
164068369|NCT02628418|592611529|FG000|Overall Study|Lost to Follow-up|1|||
164068370|NCT02628418|592611530|FG001|Overall Study|Lost to Follow-up|2|||
164068371|NCT03159611|592611534|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
164068372|NCT03159611|592611535|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
164068373|NCT03159611|592611534|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
164068374|NCT03159611|592611535|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
164068375|NCT03159611|592611534|FG000|Overall Study|Protocol Violation|7|||
164068376|NCT03159611|592611535|FG001|Overall Study|Protocol Violation|4|||
164068377|NCT03159611|592611534|FG000|Overall Study|Adverse Event|1|||
164068378|NCT03159611|592611535|FG001|Overall Study|Adverse Event|0|||
164068379|NCT03159611|592611534|FG000|Overall Study|Withdrawal by Subject|1|||
164068380|NCT03159611|592611535|FG001|Overall Study|Withdrawal by Subject|1|||
164068381|NCT03159611|592611534|FG000|Overall Study|Non-compliance with protocol requirement|3|||
164068382|NCT03159611|592611535|FG001|Overall Study|Non-compliance with protocol requirement|2|||
164068383|NCT03159611|592611534|FG000|Overall Study|Inability to perform procedures|1|||
164068384|NCT03159611|592611535|FG001|Overall Study|Inability to perform procedures|0|||
164068385|NCT00605839|592611538|FG000|Overall Study|Protocol Violation|1|||
164068386|NCT00605839|592611539|FG001|Overall Study|Protocol Violation|0|||
164068387|NCT00605839|592611540|FG002|Overall Study|Protocol Violation|0|||
164068388|NCT00352664|592611544|FG000|Overall Study|Withdrawal by Subject|7|||
164068389|NCT00352664|592611545|FG001|Overall Study|Withdrawal by Subject|0|||
164068390|NCT01608321|592611550|FG000|Overall Study|Withdrawal by Subject|1|||
164068391|NCT01608321|592611551|FG001|Overall Study|Withdrawal by Subject|0|||
164068392|NCT01875731|592611552|FG000|Overall Study|Fail to obtain lab sample|1|||
164068393|NCT01875731|592611553|FG001|Overall Study|Fail to obtain lab sample|0|||
164068394|NCT03222856|592611556|FG000|Overall Study|Adverse Event|6|||
164068395|NCT03222856|592611556|FG000|Overall Study|Death|1|||
164068396|NCT01035229|592613362|FG000|Overall Study|Adverse Event|61|||
164068397|NCT01035229|592613363|FG001|Overall Study|Adverse Event|14|||
164068398|NCT01035229|592613362|FG000|Overall Study|Withdrawal by Subject|20|||
164068399|NCT01035229|592613363|FG001|Overall Study|Withdrawal by Subject|7|||
164068400|NCT01035229|592613362|FG000|Overall Study|Lost to Follow-up|1|||
164068401|NCT01035229|592613363|FG001|Overall Study|Lost to Follow-up|0|||
164068402|NCT01035229|592613362|FG000|Overall Study|Administrative problems|1|||
164068403|NCT01035229|592613363|FG001|Overall Study|Administrative problems|1|||
164068404|NCT01035229|592613362|FG000|Overall Study|Death|13|||
164068405|NCT01035229|592613363|FG001|Overall Study|Death|5|||
164068406|NCT01035229|592613362|FG000|Overall Study|New cancer therapy|2|||
164068407|NCT01035229|592613363|FG001|Overall Study|New cancer therapy|0|||
164068408|NCT01035229|592613362|FG000|Overall Study|Protocol Violation|0|||
164068409|NCT01035229|592613363|FG001|Overall Study|Protocol Violation|2|||
164068410|NCT01035229|592613362|FG000|Overall Study|Sponsor's decision to end study|3|||
164068411|NCT01035229|592613363|FG001|Overall Study|Sponsor's decision to end study|3|||
164068412|NCT01035229|592613362|FG000|Overall Study|Disease Progression|261|||
164068413|NCT01035229|592613363|FG001|Overall Study|Disease Progression|152|||
164068414|NCT00359073|592613364|FG000|Overall Study|Withdrawal by Subject|1|||
164068415|NCT00359073|592613365|FG001|Overall Study|Withdrawal by Subject|1|||
164068416|NCT00359073|592613364|FG000|Overall Study|Eligibility criteria no longer met|3|||
164068417|NCT00359073|592613365|FG001|Overall Study|Eligibility criteria no longer met|0|||
164068418|NCT00359073|592613364|FG000|Overall Study|developed RV16 antibody|0|||
164068419|NCT00359073|592613365|FG001|Overall Study|developed RV16 antibody|1|||
164068420|NCT00684645|592613366|FG000|Overall Study|Death|2|||
164068421|NCT00684645|592613366|FG000|Overall Study|Progressive disease|67|||
164068422|NCT00684645|592613366|FG000|Overall Study|Adverse Event|27|||
164068423|NCT00684645|592613366|FG000|Overall Study|Lost to Follow-up|3|||
164068424|NCT00684645|592613366|FG000|Overall Study|Other|15|||
164068425|NCT01819467|592613371|FG000|Overall Study|Physician Decision|20|||
164068426|NCT01819467|592613372|FG001|Overall Study|Physician Decision|9|||
164068427|NCT03514121|592613373|FG000|Overall Study|Withdrawal by Subject|0|||
164068428|NCT03514121|592613374|FG001|Overall Study|Withdrawal by Subject|0|||
164068429|NCT03514121|592613375|FG002|Overall Study|Withdrawal by Subject|0|||
164068430|NCT03514121|592613376|FG003|Overall Study|Withdrawal by Subject|0|||
164068431|NCT03514121|592613377|FG004|Overall Study|Withdrawal by Subject|1|||
164068432|NCT03514121|592613378|FG005|Overall Study|Withdrawal by Subject|2|||
164068433|NCT03514121|592613379|FG006|Overall Study|Withdrawal by Subject|1|||
164068434|NCT03514121|592613380|FG007|Overall Study|Withdrawal by Subject|1|||
164068435|NCT03514121|592613381|FG008|Overall Study|Withdrawal by Subject|7|||
164068436|NCT03514121|592613382|FG009|Overall Study|Withdrawal by Subject|2|||
164068437|NCT03514121|592613373|FG000|Overall Study|Death|0|||
164068438|NCT03514121|592613374|FG001|Overall Study|Death|0|||
164068439|NCT03514121|592613375|FG002|Overall Study|Death|0|||
164068440|NCT03514121|592613376|FG003|Overall Study|Death|0|||
164068441|NCT03514121|592613377|FG004|Overall Study|Death|0|||
164068442|NCT03514121|592613378|FG005|Overall Study|Death|3|||
164068443|NCT03514121|592613379|FG006|Overall Study|Death|2|||
164068444|NCT03514121|592613380|FG007|Overall Study|Death|1|||
164068445|NCT03514121|592613381|FG008|Overall Study|Death|26|||
164068446|NCT03514121|592613382|FG009|Overall Study|Death|3|||
164068447|NCT03514121|592613373|FG000|Overall Study|Lost to Follow-up|0|||
164068448|NCT03514121|592613374|FG001|Overall Study|Lost to Follow-up|0|||
164068449|NCT03514121|592613375|FG002|Overall Study|Lost to Follow-up|1|||
164068450|NCT03514121|592613376|FG003|Overall Study|Lost to Follow-up|0|||
164068451|NCT03514121|592613377|FG004|Overall Study|Lost to Follow-up|0|||
164068452|NCT03514121|592613378|FG005|Overall Study|Lost to Follow-up|0|||
164068453|NCT03514121|592613379|FG006|Overall Study|Lost to Follow-up|0|||
164068454|NCT03514121|592613380|FG007|Overall Study|Lost to Follow-up|0|||
164068455|NCT03514121|592613381|FG008|Overall Study|Lost to Follow-up|1|||
164068456|NCT03514121|592613382|FG009|Overall Study|Lost to Follow-up|0|||
164068457|NCT03514121|592613373|FG000|Overall Study|Adverse Event|0|||
164068458|NCT03514121|592613374|FG001|Overall Study|Adverse Event|0|||
164068459|NCT03514121|592613375|FG002|Overall Study|Adverse Event|0|||
164068460|NCT03514121|592613376|FG003|Overall Study|Adverse Event|0|||
164068461|NCT03514121|592613377|FG004|Overall Study|Adverse Event|0|||
164068462|NCT03514121|592613378|FG005|Overall Study|Adverse Event|0|||
164068463|NCT03514121|592613379|FG006|Overall Study|Adverse Event|1|||
164068464|NCT03514121|592613380|FG007|Overall Study|Adverse Event|0|||
164068465|NCT03514121|592613381|FG008|Overall Study|Adverse Event|0|||
164068466|NCT03514121|592613382|FG009|Overall Study|Adverse Event|0|||
164068467|NCT03514121|592613373|FG000|Overall Study|Other|0|||
164068468|NCT03514121|592613374|FG001|Overall Study|Other|1|||
164068469|NCT03514121|592613375|FG002|Overall Study|Other|1|||
164068470|NCT03514121|592613376|FG003|Overall Study|Other|0|||
164068471|NCT03514121|592613377|FG004|Overall Study|Other|1|||
164068472|NCT03514121|592613378|FG005|Overall Study|Other|2|||
164068473|NCT03514121|592613379|FG006|Overall Study|Other|3|||
164068474|NCT03514121|592613380|FG007|Overall Study|Other|2|||
164068475|NCT03514121|592613381|FG008|Overall Study|Other|7|||
164068476|NCT03514121|592613382|FG009|Overall Study|Other|3|||
164068477|NCT03514121|592613373|FG000|Overall Study|Study termination by Sponsor|0|||
164068478|NCT03514121|592613374|FG001|Overall Study|Study termination by Sponsor|0|||
164068479|NCT03514121|592613375|FG002|Overall Study|Study termination by Sponsor|0|||
164068480|NCT03514121|592613376|FG003|Overall Study|Study termination by Sponsor|0|||
164068481|NCT03514121|592613377|FG004|Overall Study|Study termination by Sponsor|0|||
164068482|NCT03514121|592613378|FG005|Overall Study|Study termination by Sponsor|0|||
164068483|NCT03514121|592613379|FG006|Overall Study|Study termination by Sponsor|0|||
164068484|NCT03514121|592613380|FG007|Overall Study|Study termination by Sponsor|0|||
164068485|NCT03514121|592613381|FG008|Overall Study|Study termination by Sponsor|11|||
164068486|NCT03514121|592613382|FG009|Overall Study|Study termination by Sponsor|3|||
164068487|NCT03514121|592613373|FG000|Overall Study|Investigator decision|0|||
164068488|NCT03514121|592613374|FG001|Overall Study|Investigator decision|0|||
164068489|NCT03514121|592613375|FG002|Overall Study|Investigator decision|0|||
164068490|NCT03514121|592613376|FG003|Overall Study|Investigator decision|0|||
164068491|NCT03514121|592613377|FG004|Overall Study|Investigator decision|0|||
164068492|NCT03514121|592613378|FG005|Overall Study|Investigator decision|0|||
164068493|NCT03514121|592613379|FG006|Overall Study|Investigator decision|0|||
164068494|NCT03514121|592613380|FG007|Overall Study|Investigator decision|0|||
164068495|NCT03514121|592613381|FG008|Overall Study|Investigator decision|1|||
164068496|NCT03514121|592613382|FG009|Overall Study|Investigator decision|0|||
164068497|NCT00391092|592613383|FG000|Overall Study|Death|78|||
164068498|NCT00391092|592613384|FG001|Overall Study|Death|81|||
164068499|NCT00391092|592613383|FG000|Overall Study|Lost to Follow-up|13|||
164068500|NCT00391092|592613384|FG001|Overall Study|Lost to Follow-up|18|||
164068501|NCT00391092|592613383|FG000|Overall Study|Alive on treatment|29|||
164068502|NCT00391092|592613384|FG001|Overall Study|Alive on treatment|33|||
164068503|NCT00391092|592613383|FG000|Overall Study|Alive in follow-up|88|||
164068504|NCT00391092|592613384|FG001|Overall Study|Alive in follow-up|84|||
164068505|NCT02545868|592613389|FG000|Overall Study|Lack of Efficacy|1|||
164068506|NCT02545868|592613390|FG001|Overall Study|Lack of Efficacy|1|||
164068507|NCT02545868|592613391|FG002|Overall Study|Lack of Efficacy|0|||
164068508|NCT02545868|592613389|FG000|Overall Study|Lost to Follow-up|1|||
164068509|NCT02545868|592613390|FG001|Overall Study|Lost to Follow-up|5|||
164068510|NCT02545868|592613391|FG002|Overall Study|Lost to Follow-up|1|||
164068511|NCT02545868|592613389|FG000|Overall Study|Non-compliance|1|||
164068512|NCT02545868|592613390|FG001|Overall Study|Non-compliance|1|||
164105662|NCT04493684|592749238|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105663|NCT04493684|592749239|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105664|NCT04493684|592749240|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105665|NCT04493684|592749241|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105666|NCT04493684|592749242|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105667|NCT04493684|592749243|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105668|NCT04493684|592749244|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105669|NCT04493684|592749245|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105670|NCT04493684|592749246|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105671|NCT04493684|592749247|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
164105672|NCT04493684|592749248|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105673|NCT04493684|592749249|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105674|NCT04493684|592749250|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105675|NCT04493684|592749251|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105676|NCT04493684|592749252|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
164105677|NCT04493684|592749236|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105678|NCT04493684|592749237|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105679|NCT04493684|592749238|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105680|NCT04493684|592749239|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105681|NCT04493684|592749240|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105682|NCT04493684|592749241|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105683|NCT04493684|592749242|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105684|NCT04493684|592749243|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105685|NCT04493684|592749244|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105686|NCT04493684|592749245|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105687|NCT04493684|592749246|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105688|NCT04493684|592749247|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105689|NCT04493684|592749248|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105690|NCT04493684|592749249|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105691|NCT04493684|592749250|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105692|NCT04493684|592749251|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
164105693|NCT04493684|592749252|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
164105694|NCT04493684|592749236|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105695|NCT04493684|592749237|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105696|NCT04493684|592749238|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105697|NCT04493684|592749239|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105698|NCT04493684|592749240|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105699|NCT04493684|592749241|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105700|NCT04493684|592749242|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105701|NCT04493684|592749243|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105702|NCT04493684|592749244|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105703|NCT04493684|592749245|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164068513|NCT02545868|592613391|FG002|Overall Study|Non-compliance|1|||
164068514|NCT02545868|592613389|FG000|Overall Study|Treatment change|21|||
164068515|NCT02545868|592613390|FG001|Overall Study|Treatment change|19|||
164068516|NCT02545868|592613391|FG002|Overall Study|Treatment change|22|||
164068517|NCT02545868|592613389|FG000|Overall Study|Physician Decision|1|||
164068518|NCT02545868|592613390|FG001|Overall Study|Physician Decision|1|||
164068519|NCT02545868|592613391|FG002|Overall Study|Physician Decision|1|||
164068520|NCT02545868|592613389|FG000|Overall Study|Withdrawal by Subject|6|||
164068521|NCT02545868|592613390|FG001|Overall Study|Withdrawal by Subject|7|||
164068522|NCT02545868|592613391|FG002|Overall Study|Withdrawal by Subject|9|||
164068523|NCT01777191|592613392|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
164068524|NCT01777191|592613393|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
164068525|NCT01777191|592613392|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
164068526|NCT01777191|592613393|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
164068527|NCT01777191|592613392|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
164068528|NCT01777191|592613393|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
164068529|NCT01777191|592613392|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
164068530|NCT01777191|592613393|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
164068531|NCT01777191|592613392|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
164068532|NCT01777191|592613393|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
164068533|NCT01777191|592613392|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
164068534|NCT01777191|592613393|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
164068535|NCT01777191|592613392|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
164068536|NCT01777191|592613393|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
164068537|NCT01777191|592613392|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
164068538|NCT01777191|592613393|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
164068539|NCT01777191|592613392|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
164068540|NCT01777191|592613393|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
164068541|NCT01777191|592613392|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
164068542|NCT01777191|592613393|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
164068543|NCT01777191|592613392|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
164068544|NCT01777191|592613393|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
164068545|NCT03286400|592613398|FG000|Overall Study|Death|10|||
164068546|NCT03286400|592613398|FG000|Overall Study|Lost to Follow-up|10|||
164068547|NCT03286400|592613398|FG000|Overall Study|Physician Decision|1|||
164068548|NCT03286400|592613398|FG000|Overall Study|Scheduling difficulty|4|||
164068549|NCT00568776|592613401|FG000|Overall Study|Adverse Event|8|||
164068550|NCT00568776|592613402|FG001|Overall Study|Adverse Event|8|||
164068551|NCT00568776|592613403|FG002|Overall Study|Adverse Event|10|||
164068552|NCT00568776|592613404|FG003|Overall Study|Adverse Event|8|||
164068553|NCT00568776|592613401|FG000|Overall Study|Death|0|||
164068554|NCT00568776|592613402|FG001|Overall Study|Death|1|||
164068555|NCT00568776|592613403|FG002|Overall Study|Death|4|||
164068556|NCT00568776|592613404|FG003|Overall Study|Death|3|||
164068557|NCT00568776|592613401|FG000|Overall Study|Physician Decision|0|||
164068558|NCT00568776|592613402|FG001|Overall Study|Physician Decision|2|||
164068559|NCT00568776|592613403|FG002|Overall Study|Physician Decision|0|||
164068560|NCT00568776|592613404|FG003|Overall Study|Physician Decision|0|||
164068561|NCT00568776|592613401|FG000|Overall Study|Lack of Efficacy|2|||
164068562|NCT00568776|592613402|FG001|Overall Study|Lack of Efficacy|2|||
164068563|NCT00568776|592613403|FG002|Overall Study|Lack of Efficacy|2|||
164068564|NCT00568776|592613404|FG003|Overall Study|Lack of Efficacy|4|||
164068565|NCT00568776|592613401|FG000|Overall Study|Lost to Follow-up|1|||
164068566|NCT00568776|592613402|FG001|Overall Study|Lost to Follow-up|1|||
164068567|NCT00568776|592613403|FG002|Overall Study|Lost to Follow-up|1|||
164068568|NCT00568776|592613404|FG003|Overall Study|Lost to Follow-up|1|||
164068569|NCT00568776|592613401|FG000|Overall Study|Protocol Violation|1|||
164068570|NCT00568776|592613402|FG001|Overall Study|Protocol Violation|0|||
164068571|NCT00568776|592613403|FG002|Overall Study|Protocol Violation|1|||
164068572|NCT00568776|592613404|FG003|Overall Study|Protocol Violation|1|||
164068573|NCT00568776|592613401|FG000|Overall Study|Withdrawal by Subject|13|||
164068574|NCT00568776|592613402|FG001|Overall Study|Withdrawal by Subject|15|||
164068575|NCT00568776|592613403|FG002|Overall Study|Withdrawal by Subject|13|||
164068576|NCT00568776|592613404|FG003|Overall Study|Withdrawal by Subject|7|||
164068577|NCT00568776|592613401|FG000|Overall Study|Loss of Caregiver|0|||
164068578|NCT00568776|592613402|FG001|Overall Study|Loss of Caregiver|2|||
164068579|NCT00568776|592613403|FG002|Overall Study|Loss of Caregiver|1|||
164068580|NCT00568776|592613404|FG003|Overall Study|Loss of Caregiver|2|||
164068581|NCT00568776|592613401|FG000|Overall Study|Sponsor Decision|2|||
164068582|NCT00568776|592613402|FG001|Overall Study|Sponsor Decision|2|||
164068583|NCT00568776|592613403|FG002|Overall Study|Sponsor Decision|41|||
164068584|NCT00568776|592613404|FG003|Overall Study|Sponsor Decision|42|||
164068585|NCT00568776|592613401|FG000|Overall Study|Miscellaeneous|3|||
164068586|NCT00568776|592613402|FG001|Overall Study|Miscellaeneous|3|||
164068587|NCT00568776|592613403|FG002|Overall Study|Miscellaeneous|1|||
164068588|NCT00568776|592613404|FG003|Overall Study|Miscellaeneous|4|||
164068589|NCT03576131|592613405|FG000|Overall Study|Investigator decision|0|||
164068590|NCT03576131|592613406|FG001|Overall Study|Investigator decision|0|||
164068591|NCT03576131|592613407|FG002|Overall Study|Investigator decision|0|||
164068592|NCT03576131|592613408|FG003|Overall Study|Investigator decision|1|||
164068593|NCT03576131|592613409|FG004|Overall Study|Investigator decision|0|||
164068594|NCT03576131|592613410|FG005|Overall Study|Investigator decision|1|||
164068595|NCT03576131|592613411|FG006|Overall Study|Investigator decision|0|||
164068596|NCT03576131|592613412|FG007|Overall Study|Investigator decision|0|||
164068597|NCT03576131|592613405|FG000|Overall Study|Withdrawal by Subject|1|||
164068598|NCT03576131|592613406|FG001|Overall Study|Withdrawal by Subject|1|||
164068599|NCT03576131|592613407|FG002|Overall Study|Withdrawal by Subject|0|||
164068600|NCT03576131|592613408|FG003|Overall Study|Withdrawal by Subject|1|||
164068601|NCT03576131|592613409|FG004|Overall Study|Withdrawal by Subject|2|||
164068602|NCT03576131|592613410|FG005|Overall Study|Withdrawal by Subject|3|||
164068603|NCT03576131|592613411|FG006|Overall Study|Withdrawal by Subject|1|||
164068604|NCT03576131|592613412|FG007|Overall Study|Withdrawal by Subject|0|||
164068605|NCT03576131|592613405|FG000|Overall Study|Death|3|||
164068606|NCT03576131|592613406|FG001|Overall Study|Death|3|||
164068607|NCT03576131|592613407|FG002|Overall Study|Death|1|||
164068608|NCT03576131|592613408|FG003|Overall Study|Death|5|||
164068609|NCT03576131|592613409|FG004|Overall Study|Death|4|||
164068610|NCT03576131|592613410|FG005|Overall Study|Death|1|||
164068611|NCT03576131|592613411|FG006|Overall Study|Death|0|||
164068612|NCT03576131|592613412|FG007|Overall Study|Death|1|||
164068613|NCT03576131|592613405|FG000|Overall Study|New anti-cancer treatment|5|||
164068614|NCT03576131|592613406|FG001|Overall Study|New anti-cancer treatment|1|||
164068615|NCT03576131|592613407|FG002|Overall Study|New anti-cancer treatment|2|||
164068616|NCT03576131|592613408|FG003|Overall Study|New anti-cancer treatment|3|||
164068617|NCT03576131|592613409|FG004|Overall Study|New anti-cancer treatment|0|||
164068618|NCT03576131|592613410|FG005|Overall Study|New anti-cancer treatment|0|||
164068619|NCT03576131|592613411|FG006|Overall Study|New anti-cancer treatment|0|||
164068620|NCT03576131|592613412|FG007|Overall Study|New anti-cancer treatment|0|||
164068621|NCT03576131|592613405|FG000|Overall Study|Unspecified reason|0|||
164068622|NCT03576131|592613406|FG001|Overall Study|Unspecified reason|0|||
164068623|NCT03576131|592613407|FG002|Overall Study|Unspecified reason|1|||
164068624|NCT03576131|592613408|FG003|Overall Study|Unspecified reason|1|||
164068625|NCT03576131|592613409|FG004|Overall Study|Unspecified reason|1|||
164068626|NCT03576131|592613410|FG005|Overall Study|Unspecified reason|1|||
164068627|NCT03576131|592613411|FG006|Overall Study|Unspecified reason|0|||
164068628|NCT03576131|592613412|FG007|Overall Study|Unspecified reason|0|||
164068629|NCT03576131|592613405|FG000|Overall Study|Subject non-compliance|0|||
164068630|NCT03576131|592613406|FG001|Overall Study|Subject non-compliance|0|||
164068631|NCT03576131|592613407|FG002|Overall Study|Subject non-compliance|0|||
164068632|NCT03576131|592613408|FG003|Overall Study|Subject non-compliance|0|||
164068633|NCT03576131|592613409|FG004|Overall Study|Subject non-compliance|0|||
164068634|NCT03576131|592613410|FG005|Overall Study|Subject non-compliance|1|||
164068635|NCT03576131|592613411|FG006|Overall Study|Subject non-compliance|0|||
164068636|NCT03576131|592613412|FG007|Overall Study|Subject non-compliance|0|||
164068637|NCT01563029|592613415|FG000|Overall Study|Adverse Event|1|||
164068638|NCT01563029|592613416|FG001|Overall Study|Adverse Event|0|||
164068639|NCT01563029|592613417|FG002|Overall Study|Adverse Event|1|||
164068640|NCT01563029|592613418|FG003|Overall Study|Adverse Event|2|||
164068641|NCT01563029|592613419|FG004|Overall Study|Adverse Event|1|||
164068642|NCT01563029|592613415|FG000|Overall Study|Lack of Efficacy|42|||
164068643|NCT01563029|592613416|FG001|Overall Study|Lack of Efficacy|16|||
164068644|NCT01563029|592613417|FG002|Overall Study|Lack of Efficacy|23|||
164068645|NCT01563029|592613418|FG003|Overall Study|Lack of Efficacy|21|||
164068646|NCT01563029|592613419|FG004|Overall Study|Lack of Efficacy|19|||
164068647|NCT01563029|592613415|FG000|Overall Study|Protocol Violation|1|||
164068648|NCT01563029|592613416|FG001|Overall Study|Protocol Violation|2|||
164068649|NCT01563029|592613417|FG002|Overall Study|Protocol Violation|3|||
164068650|NCT01563029|592613418|FG003|Overall Study|Protocol Violation|1|||
164068651|NCT01563029|592613419|FG004|Overall Study|Protocol Violation|3|||
164068652|NCT01563029|592613415|FG000|Overall Study|Protocol defined stopping criteria|1|||
164068653|NCT01563029|592613416|FG001|Overall Study|Protocol defined stopping criteria|0|||
164068654|NCT01563029|592613417|FG002|Overall Study|Protocol defined stopping criteria|0|||
164068655|NCT01563029|592613418|FG003|Overall Study|Protocol defined stopping criteria|0|||
164068656|NCT01563029|592613419|FG004|Overall Study|Protocol defined stopping criteria|0|||
164068657|NCT01563029|592613415|FG000|Overall Study|Lost to Follow-up|1|||
164068658|NCT01563029|592613416|FG001|Overall Study|Lost to Follow-up|0|||
164068659|NCT01563029|592613417|FG002|Overall Study|Lost to Follow-up|1|||
164068660|NCT01563029|592613418|FG003|Overall Study|Lost to Follow-up|1|||
164068661|NCT01563029|592613419|FG004|Overall Study|Lost to Follow-up|1|||
164068662|NCT01563029|592613415|FG000|Overall Study|Physician Decision|3|||
164068663|NCT01563029|592613416|FG001|Overall Study|Physician Decision|5|||
164068664|NCT01563029|592613417|FG002|Overall Study|Physician Decision|2|||
164068665|NCT01563029|592613418|FG003|Overall Study|Physician Decision|4|||
164068666|NCT01563029|592613419|FG004|Overall Study|Physician Decision|2|||
164068667|NCT01563029|592613415|FG000|Overall Study|Withdrawal by Subject|4|||
164068668|NCT01563029|592613416|FG001|Overall Study|Withdrawal by Subject|1|||
164068669|NCT01563029|592613417|FG002|Overall Study|Withdrawal by Subject|3|||
164068670|NCT01563029|592613418|FG003|Overall Study|Withdrawal by Subject|4|||
164068671|NCT01563029|592613419|FG004|Overall Study|Withdrawal by Subject|3|||
164068672|NCT03069365|592613420|FG000|Overall Study|Adverse Event|1|||
164068673|NCT02780115|592613421|FG000|Overall Study|Withdrawal by Subject|0|||
164068674|NCT02780115|592613422|FG001|Overall Study|Withdrawal by Subject|1|||
164068675|NCT02780115|592613423|FG002|Overall Study|Withdrawal by Subject|1|||
164068676|NCT02780115|592613424|FG003|Overall Study|Withdrawal by Subject|0|||
164068677|NCT02780115|592613425|FG004|Overall Study|Withdrawal by Subject|0|||
164068678|NCT02780115|592613421|FG000|Overall Study|Adverse Event|0|||
164068679|NCT02780115|592613422|FG001|Overall Study|Adverse Event|0|||
164068680|NCT02780115|592613423|FG002|Overall Study|Adverse Event|0|||
164068681|NCT02780115|592613424|FG003|Overall Study|Adverse Event|1|||
164068682|NCT02780115|592613425|FG004|Overall Study|Adverse Event|1|||
164068683|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
164068684|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
164068685|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
164068686|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
164068687|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
164068688|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
164068689|NCT00566631|592613426|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
164068690|NCT00566631|592613426|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
164068691|NCT00566631|592613426|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
164068692|NCT00566631|592613426|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
164068693|NCT00566631|592613426|FG000|Part 2: Extension Phase|Adverse Event|11|||
164068694|NCT00566631|592613426|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
164068695|NCT00566631|592613426|FG000|Part 2: Extension Phase|Death|1|||
164068696|NCT00566631|592613426|FG000|Part 2: Extension Phase|Other|5|||
164068697|NCT02860039|592613428|FG000|Overall Study|Death|4|||
164068698|NCT02860039|592613429|FG001|Overall Study|Death|0|||
164068699|NCT02860039|592613428|FG000|Overall Study|Lost to Follow-up|2|||
164068700|NCT02860039|592613429|FG001|Overall Study|Lost to Follow-up|2|||
164068701|NCT02860039|592613428|FG000|Overall Study|Protocol Violation|3|||
164068702|NCT02860039|592613429|FG001|Overall Study|Protocol Violation|1|||
164068703|NCT02860039|592613428|FG000|Overall Study|Withdrawal by Subject|1|||
164068704|NCT02860039|592613429|FG001|Overall Study|Withdrawal by Subject|0|||
164068705|NCT02860039|592613428|FG000|Overall Study|Not otherwise eligible|1|||
164068706|NCT02860039|592613429|FG001|Overall Study|Not otherwise eligible|1|||
164068707|NCT01257737|592613430|FG000|Overall Study|Lost to Follow-up|1|||
164068708|NCT01257737|592613431|FG001|Overall Study|Lost to Follow-up|2|||
164068709|NCT01257737|592613430|FG000|Overall Study|Liver transplant|1|||
164068710|NCT01257737|592613431|FG001|Overall Study|Liver transplant|0|||
164068711|NCT01257737|592613430|FG000|Overall Study|Relocation out of the country|0|||
164068712|NCT01257737|592613431|FG001|Overall Study|Relocation out of the country|1|||
164068713|NCT01257737|592613430|FG000|Overall Study|Withdrew from study|0|||
164068714|NCT01257737|592613431|FG001|Overall Study|Withdrew from study|1|||
164068715|NCT02723786|592613434|FG000|Overall Study|Lost to Follow-up|1|||
164068716|NCT00127192|592613438|FG000|Overall Study|Adverse Event|0|||
164068717|NCT00127192|592613439|FG001|Overall Study|Adverse Event|1|||
164068718|NCT00127192|592613440|FG002|Overall Study|Adverse Event|1|||
164068719|NCT00127192|592613441|FG003|Overall Study|Adverse Event|1|||
164068720|NCT00127192|592613442|FG004|Overall Study|Adverse Event|0|||
164068721|NCT00127192|592613438|FG000|Overall Study|Lack of Efficacy|2|||
164068722|NCT00127192|592613439|FG001|Overall Study|Lack of Efficacy|0|||
164068723|NCT00127192|592613440|FG002|Overall Study|Lack of Efficacy|0|||
164068724|NCT00127192|592613441|FG003|Overall Study|Lack of Efficacy|0|||
164068725|NCT00127192|592613442|FG004|Overall Study|Lack of Efficacy|2|||
164068726|NCT00127192|592613438|FG000|Overall Study|Withdrawal by Subject|0|||
164068727|NCT00127192|592613439|FG001|Overall Study|Withdrawal by Subject|0|||
164068728|NCT00127192|592613440|FG002|Overall Study|Withdrawal by Subject|1|||
164068729|NCT00127192|592613441|FG003|Overall Study|Withdrawal by Subject|0|||
164068730|NCT00127192|592613442|FG004|Overall Study|Withdrawal by Subject|3|||
164068731|NCT00127192|592613438|FG000|Overall Study|Adverse event in pre-treatment period|1|||
164068732|NCT00127192|592613439|FG001|Overall Study|Adverse event in pre-treatment period|0|||
164068733|NCT00127192|592613440|FG002|Overall Study|Adverse event in pre-treatment period|0|||
164068734|NCT00127192|592613441|FG003|Overall Study|Adverse event in pre-treatment period|0|||
164068735|NCT00127192|592613442|FG004|Overall Study|Adverse event in pre-treatment period|0|||
164068736|NCT03170271|592613445|FG000|Overall Study|Adverse Event|7|||
164068737|NCT03170271|592613446|FG001|Overall Study|Adverse Event|2|||
164068738|NCT03170271|592613445|FG000|Overall Study|Lost to Follow-up|0|||
164068739|NCT03170271|592613446|FG001|Overall Study|Lost to Follow-up|1|||
164068740|NCT03170271|592613445|FG000|Overall Study|Physician Decision|1|||
164068741|NCT03170271|592613446|FG001|Overall Study|Physician Decision|0|||
164068742|NCT03170271|592613445|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
164068743|NCT03170271|592613446|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
164068744|NCT03170271|592613445|FG000|Overall Study|Withdrawal by Subject|17|||
164068745|NCT03170271|592613446|FG001|Overall Study|Withdrawal by Subject|5|||
164068746|NCT03170271|592613445|FG000|Overall Study|Other|2|||
164068747|NCT03170271|592613446|FG001|Overall Study|Other|2|||
164068748|NCT03170271|592613445|FG000|Overall Study|Randomized in error|4|||
164068749|NCT03170271|592613446|FG001|Overall Study|Randomized in error|0|||
164068750|NCT01036594|592613460|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
164068751|NCT01036594|592613461|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
164068752|NCT01036594|592613460|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
164068753|NCT01036594|592613461|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
164068754|NCT01036594|592613460|FG000|Week 12 Evaluation|Adverse Event|5|||
164068755|NCT01036594|592613461|FG001|Week 12 Evaluation|Adverse Event|0|||
164068756|NCT01036594|592613460|FG000|Week 12 Evaluation|Physician Decision|1|||
164068757|NCT01036594|592613461|FG001|Week 12 Evaluation|Physician Decision|0|||
164068758|NCT01036594|592613460|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
164068759|NCT01036594|592613461|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
164068760|NCT01036594|592613460|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
164068761|NCT01036594|592613461|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
164068762|NCT01036594|592613460|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
164068763|NCT01036594|592613461|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
164068764|NCT01036594|592613460|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
164068765|NCT01036594|592613461|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
164068766|NCT01036594|592613460|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
164068767|NCT01036594|592613461|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
164068768|NCT01612780|592613464|FG000|Overall Study|Treatment not completed|1|||
164068769|NCT01612780|592613464|FG000|Overall Study|Withdrawal by Subject|5|||
164068770|NCT03466060|592613465|FG000|Period 1|Test Lens Damage|0|||
164068771|NCT03466060|592613466|FG001|Period 1|Test Lens Damage|2|||
164068772|NCT03466060|592613467|FG002|Period 1|Test Lens Damage|0|||
164068773|NCT03466060|592613468|FG003|Period 1|Test Lens Damage|0|||
164068774|NCT03466060|592613469|FG004|Period 1|Test Lens Damage|0|||
164068775|NCT03466060|592613470|FG005|Period 1|Test Lens Damage|0|||
164068776|NCT03466060|592613465|FG000|Period 1|Withdrawal by Subject|0|||
164068777|NCT03466060|592613466|FG001|Period 1|Withdrawal by Subject|0|||
164068778|NCT03466060|592613467|FG002|Period 1|Withdrawal by Subject|2|||
164068779|NCT03466060|592613468|FG003|Period 1|Withdrawal by Subject|0|||
164068780|NCT03466060|592613469|FG004|Period 1|Withdrawal by Subject|0|||
164068781|NCT03466060|592613470|FG005|Period 1|Withdrawal by Subject|0|||
164068782|NCT03466060|592613465|FG000|Period 1|Lost to Follow-up|0|||
164068783|NCT03466060|592613466|FG001|Period 1|Lost to Follow-up|0|||
164068784|NCT03466060|592613467|FG002|Period 1|Lost to Follow-up|0|||
164068785|NCT03466060|592613468|FG003|Period 1|Lost to Follow-up|1|||
164068786|NCT03466060|592613469|FG004|Period 1|Lost to Follow-up|0|||
164068787|NCT03466060|592613470|FG005|Period 1|Lost to Follow-up|0|||
164068788|NCT03466060|592613465|FG000|Period 1|Grade 2 Conjunctivitis|0|||
164068789|NCT03466060|592613466|FG001|Period 1|Grade 2 Conjunctivitis|0|||
164068790|NCT03466060|592613467|FG002|Period 1|Grade 2 Conjunctivitis|1|||
164068791|NCT03466060|592613468|FG003|Period 1|Grade 2 Conjunctivitis|0|||
164068792|NCT03466060|592613469|FG004|Period 1|Grade 2 Conjunctivitis|0|||
164068793|NCT03466060|592613470|FG005|Period 1|Grade 2 Conjunctivitis|0|||
164068794|NCT03466060|592613465|FG000|Period 2|Lens Handling Difficulties|0|||
164068795|NCT03466060|592613466|FG001|Period 2|Lens Handling Difficulties|0|||
164068796|NCT03466060|592613467|FG002|Period 2|Lens Handling Difficulties|1|||
164068797|NCT03466060|592613468|FG003|Period 2|Lens Handling Difficulties|0|||
164068798|NCT03466060|592613469|FG004|Period 2|Lens Handling Difficulties|0|||
164068799|NCT03466060|592613470|FG005|Period 2|Lens Handling Difficulties|0|||
164068800|NCT03345485|592613473|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
164068801|NCT03345485|592613474|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
164068802|NCT03345485|592613475|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
164068803|NCT03345485|592613476|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
164068804|NCT03345485|592613477|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
164068805|NCT03345485|592613478|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
164068806|NCT03345485|592613479|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
164068807|NCT03345485|592613480|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
164068808|NCT03345485|592613481|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
164068809|NCT03345485|592613482|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
164068810|NCT03345485|592613483|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
164068811|NCT03345485|592613484|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
164068812|NCT03345485|592613485|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
164068813|NCT02985515|592613486|FG000|Olfaction Testing|Lost to Follow-up|0|||
164068814|NCT02985515|592613487|FG001|Olfaction Testing|Lost to Follow-up|5|||
164068815|NCT02985515|592613486|FG000|Olfaction Testing|Protocol Violation|0|||
164068816|NCT02985515|592613487|FG001|Olfaction Testing|Protocol Violation|3|||
164068817|NCT01610284|592613488|FG000|Randomization Phase|Adverse Event|1|||
164068818|NCT01610284|592613489|FG001|Randomization Phase|Adverse Event|0|||
164068819|NCT01610284|592613488|FG000|Randomization Phase|Physician Decision|1|||
164068820|NCT01610284|592613489|FG001|Randomization Phase|Physician Decision|1|||
164068821|NCT01610284|592613488|FG000|Randomization Phase|Death|0|||
164068822|NCT01610284|592613489|FG001|Randomization Phase|Death|1|||
164068823|NCT01610284|592613488|FG000|Treatment Phase|Adverse Event|80|||
164068824|NCT01610284|592613489|FG001|Treatment Phase|Adverse Event|12|||
164068825|NCT01610284|592613488|FG000|Treatment Phase|Lost to Follow-up|1|||
164068826|NCT01610284|592613489|FG001|Treatment Phase|Lost to Follow-up|0|||
164068827|NCT01610284|592613488|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
164068828|NCT01610284|592613489|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
164068829|NCT01610284|592613488|FG000|Treatment Phase|Physician Decision|27|||
164068830|NCT01610284|592613489|FG001|Treatment Phase|Physician Decision|24|||
164068831|NCT01610284|592613488|FG000|Treatment Phase|Progressive Disease|377|||
164068832|NCT01610284|592613489|FG001|Treatment Phase|Progressive Disease|486|||
164068833|NCT01610284|592613488|FG000|Treatment Phase|Protocol Deviation|2|||
164068834|NCT01610284|592613489|FG001|Treatment Phase|Protocol Deviation|3|||
164068835|NCT01610284|592613488|FG000|Treatment Phase|Study terminated by Sponsor|18|||
164068836|NCT01610284|592613489|FG001|Treatment Phase|Study terminated by Sponsor|15|||
164112674|NCT02372006|592774099|FG001|Overall Study|Progressive disease|7|||
164068837|NCT01610284|592613488|FG000|Treatment Phase|Subject/Guardian Decision|55|||
164068838|NCT01610284|592613489|FG001|Treatment Phase|Subject/Guardian Decision|23|||
164068839|NCT01610284|592613488|FG000|Treatment Phase|Death|6|||
164068840|NCT01610284|592613489|FG001|Treatment Phase|Death|5|||
164068841|NCT01610284|592613488|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
164068842|NCT01610284|592613489|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
164068843|NCT01610284|592613488|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
164068844|NCT01610284|592613489|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
164068845|NCT01610284|592613488|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
164068846|NCT01610284|592613489|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
164068847|NCT01610284|592613488|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
164068848|NCT01610284|592613489|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
164068849|NCT01610284|592613488|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
164068850|NCT01610284|592613489|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
164068851|NCT01610284|592613488|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
164068852|NCT01610284|592613489|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
164068853|NCT03020966|592613490|FG000|Overall Study|Withdrawal by Subject|2|||
164068854|NCT03020966|592613491|FG001|Overall Study|Withdrawal by Subject|0|||
164068855|NCT01856257|592613492|FG000|Overall Study|Death|2|||
164068856|NCT01856257|592613493|FG001|Overall Study|Death|0|||
164068857|NCT01856257|592613494|FG002|Overall Study|Death|0|||
164068858|NCT01856257|592613495|FG003|Overall Study|Death|0|||
164068859|NCT01856257|592613492|FG000|Overall Study|Physician Decision|0|||
164068860|NCT01856257|592613493|FG001|Overall Study|Physician Decision|0|||
164068861|NCT01856257|592613494|FG002|Overall Study|Physician Decision|0|||
164068862|NCT01856257|592613495|FG003|Overall Study|Physician Decision|1|||
164068863|NCT01856257|592613492|FG000|Overall Study|Withdrawal by Subject|1|||
164068864|NCT01856257|592613493|FG001|Overall Study|Withdrawal by Subject|1|||
164068865|NCT01856257|592613494|FG002|Overall Study|Withdrawal by Subject|0|||
164068866|NCT01856257|592613495|FG003|Overall Study|Withdrawal by Subject|0|||
164068867|NCT01856257|592613492|FG000|Overall Study|Donor complication|0|||
164068868|NCT01856257|592613493|FG001|Overall Study|Donor complication|0|||
164068869|NCT01856257|592613494|FG002|Overall Study|Donor complication|0|||
164068870|NCT01856257|592613495|FG003|Overall Study|Donor complication|1|||
164068871|NCT04935931|592613499|FG000|Overall Study|Withdrawal by Subject|1|||
164068872|NCT00424632|592613502|FG000|Overall Study|Death|0|||
164068873|NCT00424632|592613503|FG001|Overall Study|Death|0|||
164068874|NCT00424632|592613504|FG002|Overall Study|Death|0|||
164068875|NCT00424632|592613505|FG003|Overall Study|Death|0|||
164068876|NCT00424632|592613506|FG004|Overall Study|Death|0|||
164068877|NCT00424632|592613507|FG005|Overall Study|Death|2|||
164068878|NCT00424632|592613508|FG006|Overall Study|Death|0|||
164068879|NCT00424632|592613509|FG007|Overall Study|Death|0|||
164068880|NCT00424632|592613510|FG008|Overall Study|Death|0|||
164068881|NCT00424632|592613511|FG009|Overall Study|Death|0|||
164068882|NCT00424632|592613502|FG000|Overall Study|Adverse Event|0|||
164068883|NCT00424632|592613503|FG001|Overall Study|Adverse Event|0|||
164068884|NCT00424632|592613504|FG002|Overall Study|Adverse Event|0|||
164068885|NCT00424632|592613505|FG003|Overall Study|Adverse Event|0|||
164068886|NCT00424632|592613506|FG004|Overall Study|Adverse Event|0|||
164068887|NCT00424632|592613507|FG005|Overall Study|Adverse Event|0|||
164068888|NCT00424632|592613508|FG006|Overall Study|Adverse Event|0|||
164068889|NCT00424632|592613509|FG007|Overall Study|Adverse Event|0|||
164068890|NCT00424632|592613510|FG008|Overall Study|Adverse Event|3|||
164068891|NCT00424632|592613511|FG009|Overall Study|Adverse Event|2|||
164068892|NCT00424632|592613502|FG000|Overall Study|Global deterioration of health status|0|||
164068893|NCT00424632|592613503|FG001|Overall Study|Global deterioration of health status|0|||
164068894|NCT00424632|592613504|FG002|Overall Study|Global deterioration of health status|0|||
164068895|NCT00424632|592613505|FG003|Overall Study|Global deterioration of health status|1|||
164068896|NCT00424632|592613506|FG004|Overall Study|Global deterioration of health status|1|||
164068897|NCT00424632|592613507|FG005|Overall Study|Global deterioration of health status|0|||
164068898|NCT00424632|592613508|FG006|Overall Study|Global deterioration of health status|0|||
164068899|NCT00424632|592613509|FG007|Overall Study|Global deterioration of health status|0|||
164068900|NCT00424632|592613510|FG008|Overall Study|Global deterioration of health status|0|||
164068901|NCT00424632|592613511|FG009|Overall Study|Global deterioration of health status|0|||
164068902|NCT00424632|592613502|FG000|Overall Study|Objective progression or relapse|1|||
164068903|NCT00424632|592613503|FG001|Overall Study|Objective progression or relapse|1|||
164068904|NCT00424632|592613504|FG002|Overall Study|Objective progression or relapse|1|||
164068905|NCT00424632|592613505|FG003|Overall Study|Objective progression or relapse|2|||
164068906|NCT00424632|592613506|FG004|Overall Study|Objective progression or relapse|2|||
164068907|NCT00424632|592613507|FG005|Overall Study|Objective progression or relapse|13|||
164068908|NCT00424632|592613508|FG006|Overall Study|Objective progression or relapse|7|||
164068909|NCT00424632|592613509|FG007|Overall Study|Objective progression or relapse|3|||
164068910|NCT00424632|592613510|FG008|Overall Study|Objective progression or relapse|12|||
164068911|NCT00424632|592613511|FG009|Overall Study|Objective progression or relapse|4|||
164068912|NCT00424632|592613502|FG000|Overall Study|Other|0|||
164068913|NCT00424632|592613503|FG001|Overall Study|Other|0|||
164068914|NCT00424632|592613504|FG002|Overall Study|Other|0|||
164068915|NCT00424632|592613505|FG003|Overall Study|Other|1|||
164068916|NCT00424632|592613506|FG004|Overall Study|Other|0|||
164068917|NCT00424632|592613507|FG005|Overall Study|Other|0|||
164068918|NCT00424632|592613508|FG006|Overall Study|Other|0|||
164068919|NCT00424632|592613509|FG007|Overall Study|Other|0|||
164068920|NCT00424632|592613510|FG008|Overall Study|Other|1|||
164068921|NCT00424632|592613511|FG009|Overall Study|Other|0|||
164068922|NCT01984229|592613512|FG000|Safety Follow-up Period|Adverse Event|1|||
164068923|NCT01984229|592613513|FG001|Safety Follow-up Period|Adverse Event|1|||
164068924|NCT01984229|592613512|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
164068925|NCT01984229|592613513|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
164068926|NCT02072174|592613514|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
164068927|NCT02072174|592613515|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
164068928|NCT02072174|592613514|FG000|Overall Study|Protocol Violation|16|||
164068929|NCT02072174|592613515|FG001|Overall Study|Protocol Violation|23|||
164068930|NCT02072174|592613514|FG000|Overall Study|Physician Decision|0|||
164068931|NCT02072174|592613515|FG001|Overall Study|Physician Decision|1|||
164068932|NCT02072174|592613514|FG000|Overall Study|Non-compliance with protocol requirement|2|||
164068933|NCT02072174|592613515|FG001|Overall Study|Non-compliance with protocol requirement|0|||
164068934|NCT05674721|592613516|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
164068935|NCT05674721|592613517|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
164068936|NCT05674721|592613516|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
164068937|NCT05674721|592613517|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
164068938|NCT03506425|592613532|FG000|Overall Study|Adverse Event|1|||
164068939|NCT03506425|592613533|FG001|Overall Study|Adverse Event|3|||
164068940|NCT03506425|592613534|FG002|Overall Study|Adverse Event|0|||
164068941|NCT03506425|592613532|FG000|Overall Study|Death|1|||
164068942|NCT03506425|592613533|FG001|Overall Study|Death|0|||
164068943|NCT03506425|592613534|FG002|Overall Study|Death|0|||
164068944|NCT03506425|592613532|FG000|Overall Study|Withdrawal by Subject|0|||
164068945|NCT03506425|592613533|FG001|Overall Study|Withdrawal by Subject|0|||
164068946|NCT03506425|592613534|FG002|Overall Study|Withdrawal by Subject|1|||
164068947|NCT03930615|592613535|FG000|Overall Study|Death|9|||
164068948|NCT03930615|592613536|FG001|Overall Study|Death|3|||
164068949|NCT03930615|592613535|FG000|Overall Study|Lost to Follow-up|1|||
164068950|NCT03930615|592613536|FG001|Overall Study|Lost to Follow-up|2|||
164068951|NCT03930615|592613535|FG000|Overall Study|Physician Decision|3|||
164068952|NCT03930615|592613536|FG001|Overall Study|Physician Decision|4|||
164068953|NCT03930615|592613535|FG000|Overall Study|Withdrawal by Subject|13|||
164068954|NCT03930615|592613536|FG001|Overall Study|Withdrawal by Subject|2|||
164068955|NCT03930615|592613535|FG000|Overall Study|Not treated|1|||
164068956|NCT03930615|592613536|FG001|Overall Study|Not treated|1|||
164068957|NCT02864953|592613539|FG000|Overall Study|Adverse Event|22|||
164068958|NCT02864953|592613540|FG001|Overall Study|Adverse Event|19|||
164068959|NCT02864953|592613539|FG000|Overall Study|Withdrawal by Subject|1|||
164068960|NCT02864953|592613540|FG001|Overall Study|Withdrawal by Subject|0|||
164068961|NCT02864953|592613539|FG000|Overall Study|Physician Decision|4|||
164068962|NCT02864953|592613540|FG001|Overall Study|Physician Decision|2|||
164068963|NCT02864953|592613539|FG000|Overall Study|Death|3|||
164068964|NCT02864953|592613540|FG001|Overall Study|Death|13|||
164068965|NCT02864953|592613539|FG000|Overall Study|Reason not specified|14|||
164068966|NCT02864953|592613540|FG001|Overall Study|Reason not specified|12|||
164068967|NCT02864953|592613539|FG000|Overall Study|Withdrew Prior to Dosing|9|||
164068968|NCT02864953|592613540|FG001|Overall Study|Withdrew Prior to Dosing|8|||
164068969|NCT00981019|592613541|FG000|Overall Study|Did not respond|65|||
164068970|NCT00981019|592613541|FG000|Overall Study|Did not match target population|94|||
164068971|NCT00981019|592613541|FG000|Overall Study|Inadvertent exclusion|239|||
164068972|NCT00981019|592613541|FG000|Overall Study|Hit the survey after closure|79|||
164068973|NCT00358670|592613542|FG000|Overall Study|Adverse Event|26|||
164068974|NCT00358670|592613543|FG001|Overall Study|Adverse Event|29|||
164068975|NCT00358670|592613542|FG000|Overall Study|Lack of Efficacy|20|||
164068976|NCT00358670|592613543|FG001|Overall Study|Lack of Efficacy|23|||
164068977|NCT00358670|592613542|FG000|Overall Study|Protocol Violation|6|||
164068978|NCT00358670|592613543|FG001|Overall Study|Protocol Violation|9|||
164068979|NCT00358670|592613542|FG000|Overall Study|Lost to Follow-up|4|||
164068980|NCT00358670|592613543|FG001|Overall Study|Lost to Follow-up|5|||
164068981|NCT00358670|592613542|FG000|Overall Study|Withdrawal by Subject|13|||
164068982|NCT00358670|592613543|FG001|Overall Study|Withdrawal by Subject|24|||
164105704|NCT04493684|592749246|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105705|NCT04493684|592749247|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164112675|NCT02372006|592774100|FG002|Overall Study|Progressive disease|34|||
164068983|NCT00358670|592613542|FG000|Overall Study|Protocol Defined Clinical Event|0|||
164068984|NCT00358670|592613543|FG001|Overall Study|Protocol Defined Clinical Event|1|||
164068985|NCT00358670|592613542|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
164068986|NCT00358670|592613543|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
164068987|NCT00358670|592613542|FG000|Overall Study|Administrative|153|||
164068988|NCT00358670|592613543|FG001|Overall Study|Administrative|125|||
164068989|NCT00865306|592613544|FG000|Controlled Trial|Lost to Follow-up|1|||
164068990|NCT00865306|592613545|FG001|Controlled Trial|Lost to Follow-up|1|||
164068991|NCT00865306|592613544|FG000|Controlled Trial|Difficulty commuting|2|||
164068992|NCT00865306|592613545|FG001|Controlled Trial|Difficulty commuting|0|||
164068993|NCT00865306|592613544|FG000|Controlled Trial|Improved btw baseline and first session|1|||
164068994|NCT00865306|592613545|FG001|Controlled Trial|Improved btw baseline and first session|0|||
164068995|NCT00865306|592613544|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
164068996|NCT00865306|592613545|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
164068997|NCT00865306|592613544|FG000|Controlled Trial|Withdrawal by Subject|0|||
164068998|NCT00865306|592613545|FG001|Controlled Trial|Withdrawal by Subject|1|||
164068999|NCT05083559|592613546|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
164069000|NCT05083559|592613547|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
164069001|NCT05083559|592613546|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
164069002|NCT05083559|592613547|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
164069003|NCT05083559|592613546|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
164069004|NCT05083559|592613547|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
164069005|NCT02704130|592613548|FG000|Overall Study|Physician Decision|5|||
164069006|NCT02704130|592613549|FG001|Overall Study|Physician Decision|3|||
164069007|NCT05378269|592615252|FG000|Overall Study|Protocol Violation|1|||
164069008|NCT05378269|592615253|FG001|Overall Study|Protocol Violation|0|||
164069009|NCT05378269|592615254|FG002|Overall Study|Protocol Violation|2|||
164069010|NCT05378269|592615255|FG003|Overall Study|Protocol Violation|0|||
164069011|NCT05378269|592615256|FG004|Overall Study|Protocol Violation|0|||
164069012|NCT00602979|592615259|FG000|Overall Study|Lost to Follow-up|3|||
164069013|NCT00602979|592615260|FG001|Overall Study|Lost to Follow-up|2|||
164069014|NCT00602979|592615261|FG002|Overall Study|Lost to Follow-up|3|||
164069015|NCT00602979|592615262|FG003|Overall Study|Lost to Follow-up|2|||
164069016|NCT00602979|592615263|FG004|Overall Study|Lost to Follow-up|3|||
164069017|NCT00602979|592615259|FG000|Overall Study|Failed Intubation|0|||
164069018|NCT00602979|592615260|FG001|Overall Study|Failed Intubation|1|||
164069019|NCT00602979|592615261|FG002|Overall Study|Failed Intubation|0|||
164069020|NCT00602979|592615262|FG003|Overall Study|Failed Intubation|1|||
164069021|NCT00602979|592615263|FG004|Overall Study|Failed Intubation|0|||
164069022|NCT01461369|592615264|FG000|Overall Study|Lack of Efficacy|2|||
164069023|NCT01461369|592615265|FG001|Overall Study|Lack of Efficacy|0|||
164069024|NCT01461369|592615266|FG002|Overall Study|Lack of Efficacy|6|||
164069025|NCT01461369|592615264|FG000|Overall Study|Lost to Follow-up|0|||
164069026|NCT01461369|592615265|FG001|Overall Study|Lost to Follow-up|0|||
164069027|NCT01461369|592615266|FG002|Overall Study|Lost to Follow-up|3|||
164069028|NCT01461369|592615264|FG000|Overall Study|Adverse Event|9|||
164069029|NCT01461369|592615265|FG001|Overall Study|Adverse Event|12|||
164069030|NCT01461369|592615266|FG002|Overall Study|Adverse Event|4|||
164069031|NCT01461369|592615264|FG000|Overall Study|Protocol Violation|1|||
164069032|NCT01461369|592615265|FG001|Overall Study|Protocol Violation|2|||
164069033|NCT01461369|592615266|FG002|Overall Study|Protocol Violation|2|||
164069034|NCT01461369|592615264|FG000|Overall Study|Withdrawal by Subject|1|||
164069035|NCT01461369|592615265|FG001|Overall Study|Withdrawal by Subject|3|||
164069036|NCT01461369|592615266|FG002|Overall Study|Withdrawal by Subject|2|||
164069037|NCT00734617|592615271|FG000|Overall Study|Adverse Event|4|||
164069038|NCT00734617|592615272|FG001|Overall Study|Adverse Event|7|||
164069039|NCT00734617|592615271|FG000|Overall Study|Withdrawal by Subject|103|||
164069040|NCT00734617|592615272|FG001|Overall Study|Withdrawal by Subject|95|||
164069041|NCT03692078|592615275|FG000|Overall Study|Adverse Event|0|||
164069042|NCT03692078|592615276|FG001|Overall Study|Adverse Event|0|||
164069043|NCT03692078|592615277|FG002|Overall Study|Adverse Event|0|||
164069044|NCT03692078|592615278|FG003|Overall Study|Adverse Event|0|||
164069045|NCT03692078|592615279|FG004|Overall Study|Adverse Event|0|||
164069046|NCT03692078|592615280|FG005|Overall Study|Adverse Event|1|||
164069047|NCT03692078|592615281|FG006|Overall Study|Adverse Event|0|||
164069048|NCT03692078|592615275|FG000|Overall Study|Enrollment Closed|5|||
164069049|NCT03692078|592615276|FG001|Overall Study|Enrollment Closed|0|||
164069050|NCT03692078|592615277|FG002|Overall Study|Enrollment Closed|0|||
164069051|NCT03692078|592615278|FG003|Overall Study|Enrollment Closed|0|||
164069052|NCT03692078|592615279|FG004|Overall Study|Enrollment Closed|0|||
164069053|NCT03692078|592615280|FG005|Overall Study|Enrollment Closed|0|||
164069054|NCT03692078|592615281|FG006|Overall Study|Enrollment Closed|0|||
164069055|NCT03692078|592615275|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
164069056|NCT03692078|592615276|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
164069057|NCT03692078|592615277|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
164069058|NCT03692078|592615278|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
164069059|NCT03692078|592615279|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
164069060|NCT03692078|592615280|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
164069061|NCT03692078|592615281|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
164069062|NCT03692078|592615275|FG000|Overall Study|Withdrawal by Subject|0|||
164069063|NCT03692078|592615276|FG001|Overall Study|Withdrawal by Subject|2|||
164069064|NCT03692078|592615277|FG002|Overall Study|Withdrawal by Subject|0|||
164069065|NCT03692078|592615278|FG003|Overall Study|Withdrawal by Subject|1|||
164069066|NCT03692078|592615279|FG004|Overall Study|Withdrawal by Subject|5|||
164069067|NCT03692078|592615280|FG005|Overall Study|Withdrawal by Subject|3|||
164069068|NCT03692078|592615281|FG006|Overall Study|Withdrawal by Subject|3|||
164069069|NCT01615822|592615285|FG000|Period 1|Withdrawal by Subject|0|||
164069070|NCT01615822|592615286|FG001|Period 1|Withdrawal by Subject|1|||
164069071|NCT01615822|592615287|FG002|Period 1|Withdrawal by Subject|0|||
164069072|NCT01615822|592615285|FG000|Period 1|Adverse Event|1|||
164069073|NCT01615822|592615286|FG001|Period 1|Adverse Event|1|||
164069074|NCT01615822|592615287|FG002|Period 1|Adverse Event|0|||
164069075|NCT01615822|592615285|FG000|Period 2|Lost to Follow-up|0|||
164069076|NCT01615822|592615286|FG001|Period 2|Lost to Follow-up|1|||
164069077|NCT01615822|592615287|FG002|Period 2|Lost to Follow-up|2|||
164069078|NCT02861534|592615288|FG000|Overall Study|Death|541|||
164069079|NCT02861534|592615289|FG001|Overall Study|Death|552|||
164069080|NCT02861534|592615288|FG000|Overall Study|Lost to Follow-up|14|||
164069081|NCT02861534|592615289|FG001|Overall Study|Lost to Follow-up|14|||
164069082|NCT02861534|592615288|FG000|Overall Study|Site Terminated by Sponsor|4|||
164069083|NCT02861534|592615289|FG001|Overall Study|Site Terminated by Sponsor|3|||
164069084|NCT02861534|592615288|FG000|Overall Study|Withdrawal by Subject|15|||
164069085|NCT02861534|592615289|FG001|Overall Study|Withdrawal by Subject|18|||
164069086|NCT02886494|592615290|FG000|Overall Study|Adverse Event|1|||
164105706|NCT04493684|592749248|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105707|NCT04493684|592749249|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164069087|NCT02886494|592615291|FG001|Overall Study|Adverse Event|0|||
164069088|NCT02886494|592615290|FG000|Overall Study|Withdrawal by Subject|12|||
164069089|NCT02886494|592615291|FG001|Overall Study|Withdrawal by Subject|3|||
164069090|NCT02886494|592615290|FG000|Overall Study|Protocol Violation|4|||
164069091|NCT02886494|592615291|FG001|Overall Study|Protocol Violation|1|||
164069092|NCT00769132|592615295|FG000|Period 1|Adverse Event|1|||
164069093|NCT00769132|592615296|FG001|Period 1|Adverse Event|0|||
164069094|NCT00769132|592615297|FG002|Period 1|Adverse Event|0|||
164069095|NCT00769132|592615298|FG003|Period 1|Adverse Event|1|||
164069096|NCT00769132|592615295|FG000|Period 2|Withdrawal by Subject|0|||
164069097|NCT00769132|592615296|FG001|Period 2|Withdrawal by Subject|0|||
164069098|NCT00769132|592615297|FG002|Period 2|Withdrawal by Subject|0|||
164069099|NCT00769132|592615298|FG003|Period 2|Withdrawal by Subject|1|||
164069100|NCT00769132|592615295|FG000|Period 3|Withdrawal by Subject|1|||
164069101|NCT00769132|592615296|FG001|Period 3|Withdrawal by Subject|0|||
164069102|NCT00769132|592615297|FG002|Period 3|Withdrawal by Subject|0|||
164069103|NCT00769132|592615298|FG003|Period 3|Withdrawal by Subject|0|||
164069104|NCT00769132|592615295|FG000|Period 4|Withdrawal by Subject|0|||
164069105|NCT00769132|592615296|FG001|Period 4|Withdrawal by Subject|1|||
164069106|NCT00769132|592615297|FG002|Period 4|Withdrawal by Subject|0|||
164069107|NCT00769132|592615298|FG003|Period 4|Withdrawal by Subject|0|||
164069108|NCT00537056|592615302|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
164069109|NCT00244881|592615303|FG000|Overall Study|Withdrawal by Subject|3|||
164069110|NCT01060007|592615307|FG000|Overall Study|Withdrawal by Subject|1|||
164069111|NCT01060007|592615307|FG000|Overall Study|Inevaluable for response at surgery|3|||
164069112|NCT00445458|592615308|FG000|Overall Study|Disease Progression|3|||
164069113|NCT00445458|592615309|FG001|Overall Study|Disease Progression|4|||
164069114|NCT00445458|592615310|FG002|Overall Study|Disease Progression|54|||
164069115|NCT00445458|592615311|FG003|Overall Study|Disease Progression|27|||
164069116|NCT00445458|592615308|FG000|Overall Study|Withdrawal by Subject|0|||
164069117|NCT00445458|592615309|FG001|Overall Study|Withdrawal by Subject|0|||
164069118|NCT00445458|592615310|FG002|Overall Study|Withdrawal by Subject|7|||
164069119|NCT00445458|592615311|FG003|Overall Study|Withdrawal by Subject|0|||
164069120|NCT00445458|592615308|FG000|Overall Study|Adverse Event|0|||
164069121|NCT00445458|592615309|FG001|Overall Study|Adverse Event|0|||
164069122|NCT00445458|592615310|FG002|Overall Study|Adverse Event|3|||
164069123|NCT00445458|592615311|FG003|Overall Study|Adverse Event|0|||
164069124|NCT00445458|592615308|FG000|Overall Study|Death|0|||
164069125|NCT00445458|592615309|FG001|Overall Study|Death|1|||
164069126|NCT00445458|592615310|FG002|Overall Study|Death|2|||
164069127|NCT00445458|592615311|FG003|Overall Study|Death|0|||
164069128|NCT00445458|592615308|FG000|Overall Study|Physician Decision|0|||
164069129|NCT00445458|592615309|FG001|Overall Study|Physician Decision|0|||
164069130|NCT00445458|592615310|FG002|Overall Study|Physician Decision|1|||
164069131|NCT00445458|592615311|FG003|Overall Study|Physician Decision|1|||
164069132|NCT00445458|592615308|FG000|Overall Study|Surgery|0|||
164069133|NCT00445458|592615309|FG001|Overall Study|Surgery|0|||
164069134|NCT00445458|592615310|FG002|Overall Study|Surgery|1|||
164069135|NCT00445458|592615311|FG003|Overall Study|Surgery|0|||
164069136|NCT01393626|592615316|FG000|Overall Study|Adverse Event|2|||
164069137|NCT01393626|592615317|FG001|Overall Study|Adverse Event|1|||
164069138|NCT01393626|592615318|FG002|Overall Study|Adverse Event|5|||
164069139|NCT01393626|592615319|FG003|Overall Study|Adverse Event|0|||
164069140|NCT01393626|592615316|FG000|Overall Study|Did not meet entrance criteria|1|||
164069141|NCT01393626|592615317|FG001|Overall Study|Did not meet entrance criteria|0|||
164105708|NCT04493684|592749250|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105709|NCT04493684|592749251|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
164105710|NCT04493684|592749252|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
164105711|NCT05710718|592750408|FG000|Overall Study|Withdrawal by Subject|5|||
164105712|NCT05710718|592750409|FG001|Overall Study|Withdrawal by Subject|1|||
164105713|NCT05710718|592750408|FG000|Overall Study|Lost to Follow-up|0|||
164105714|NCT05710718|592750409|FG001|Overall Study|Lost to Follow-up|1|||
164105715|NCT05710718|592750408|FG000|Overall Study|Death|0|||
164105716|NCT05710718|592750409|FG001|Overall Study|Death|1|||
164105717|NCT04372238|592750410|FG000|Overall Study|Duplicate|3|||
164105718|NCT04372238|592750411|FG001|Overall Study|Duplicate|3|||
164105719|NCT04372238|592750410|FG000|Overall Study|Did not consent for data linkage|6|||
164105720|NCT04372238|592750411|FG001|Overall Study|Did not consent for data linkage|10|||
164105721|NCT05005442|592750412|FG000|Overall Study|Death|14|||
164105722|NCT05005442|592750413|FG001|Overall Study|Death|10|||
164105723|NCT05005442|592750414|FG002|Overall Study|Death|8|||
164105724|NCT05005442|592750415|FG003|Overall Study|Death|22|||
164105725|NCT05005442|592750416|FG004|Overall Study|Death|13|||
164105726|NCT05005442|592750417|FG005|Overall Study|Death|15|||
164105727|NCT05005442|592750412|FG000|Overall Study|Lost to Follow-up|0|||
164105728|NCT05005442|592750413|FG001|Overall Study|Lost to Follow-up|2|||
164105729|NCT05005442|592750414|FG002|Overall Study|Lost to Follow-up|0|||
164105730|NCT05005442|592750415|FG003|Overall Study|Lost to Follow-up|0|||
164105731|NCT05005442|592750416|FG004|Overall Study|Lost to Follow-up|1|||
164105732|NCT05005442|592750417|FG005|Overall Study|Lost to Follow-up|0|||
164105733|NCT05005442|592750412|FG000|Overall Study|Physician Decision|0|||
164105734|NCT05005442|592750413|FG001|Overall Study|Physician Decision|0|||
164105735|NCT05005442|592750414|FG002|Overall Study|Physician Decision|1|||
164105736|NCT05005442|592750415|FG003|Overall Study|Physician Decision|0|||
164105737|NCT05005442|592750416|FG004|Overall Study|Physician Decision|2|||
164105738|NCT05005442|592750417|FG005|Overall Study|Physician Decision|0|||
164105739|NCT05005442|592750412|FG000|Overall Study|Sponsor decision|26|||
164105740|NCT05005442|592750413|FG001|Overall Study|Sponsor decision|26|||
164105741|NCT05005442|592750414|FG002|Overall Study|Sponsor decision|10|||
164105742|NCT05005442|592750415|FG003|Overall Study|Sponsor decision|5|||
164105743|NCT05005442|592750416|FG004|Overall Study|Sponsor decision|9|||
164105744|NCT05005442|592750417|FG005|Overall Study|Sponsor decision|12|||
164105745|NCT05005442|592750412|FG000|Overall Study|Withdrawal by Subject|2|||
164105746|NCT05005442|592750413|FG001|Overall Study|Withdrawal by Subject|2|||
164105747|NCT05005442|592750414|FG002|Overall Study|Withdrawal by Subject|1|||
164105748|NCT05005442|592750415|FG003|Overall Study|Withdrawal by Subject|3|||
164105749|NCT05005442|592750416|FG004|Overall Study|Withdrawal by Subject|0|||
164105750|NCT05005442|592750417|FG005|Overall Study|Withdrawal by Subject|5|||
164105751|NCT05005442|592750412|FG000|Overall Study|Site terminated by sponsor|0|||
164105752|NCT05005442|592750413|FG001|Overall Study|Site terminated by sponsor|2|||
164105753|NCT05005442|592750414|FG002|Overall Study|Site terminated by sponsor|0|||
164105754|NCT05005442|592750415|FG003|Overall Study|Site terminated by sponsor|0|||
164105755|NCT05005442|592750416|FG004|Overall Study|Site terminated by sponsor|0|||
164105756|NCT05005442|592750417|FG005|Overall Study|Site terminated by sponsor|1|||
164105757|NCT03696160|592750418|FG000|Overall Study|Withdrew before IMP dosing|2|||
164105758|NCT03696160|592750419|FG001|Overall Study|Withdrew before IMP dosing|3|||
164105759|NCT00334815|592750420|FG000|Overall Study|Adverse Event|3|||
164105760|NCT00334815|592750421|FG001|Overall Study|Adverse Event|2|||
164105761|NCT00334815|592750420|FG000|Overall Study|Death|0|||
164105762|NCT00334815|592750421|FG001|Overall Study|Death|2|||
164105763|NCT00334815|592750420|FG000|Overall Study|Progression|1|||
164105764|NCT00334815|592750421|FG001|Overall Study|Progression|0|||
164105765|NCT00334815|592750420|FG000|Overall Study|ineligible|1|||
164105766|NCT00334815|592750421|FG001|Overall Study|ineligible|1|||
164105767|NCT00334815|592750420|FG000|Overall Study|patient refused treatment|0|||
164105768|NCT00334815|592750421|FG001|Overall Study|patient refused treatment|1|||
164105769|NCT00334815|592750420|FG000|Overall Study|Physician Decision|2|||
164105770|NCT00334815|592750421|FG001|Overall Study|Physician Decision|4|||
164105771|NCT05604170|592750422|FG000|Overall Study|Lack of Efficacy|5|||
164105772|NCT05604170|592750422|FG000|Overall Study|Adverse Event|6|||
164105773|NCT05604170|592750422|FG000|Overall Study|Physician Decision|6|||
164105774|NCT05604170|592750422|FG000|Overall Study|Lost to Follow-up|6|||
164105775|NCT05604170|592750422|FG000|Overall Study|Withdrawal by Subject|11|||
164105776|NCT05604170|592750422|FG000|Overall Study|Early study termination by sponsor|77|||
164105777|NCT05604170|592750422|FG000|Overall Study|Other|6|||
164105778|NCT03317899|592750428|FG000|Overall Study|Death|6|||
164105779|NCT03317899|592750429|FG001|Overall Study|Death|9|||
164105780|NCT01056484|592750431|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
164105781|NCT01056484|592750432|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
164105782|NCT01056484|592750431|FG000|Randomized Controlled Trial|Physician Decision|1|||
164105783|NCT01056484|592750432|FG001|Randomized Controlled Trial|Physician Decision|0|||
164105784|NCT01056484|592750431|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
164105785|NCT01056484|592750432|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
164105786|NCT00446966|592750435|FG000|Overall Study|Lost to Follow-up|10|||
164105787|NCT00446966|592750436|FG001|Overall Study|Lost to Follow-up|7|||
164069142|NCT01393626|592615318|FG002|Overall Study|Did not meet entrance criteria|0|||
164069143|NCT01393626|592615319|FG003|Overall Study|Did not meet entrance criteria|0|||
164069144|NCT01393626|592615316|FG000|Overall Study|Lack of Efficacy|6|||
164069145|NCT01393626|592615317|FG001|Overall Study|Lack of Efficacy|6|||
164069146|NCT01393626|592615318|FG002|Overall Study|Lack of Efficacy|4|||
164069147|NCT01393626|592615319|FG003|Overall Study|Lack of Efficacy|1|||
164069148|NCT01393626|592615316|FG000|Overall Study|Lost to Follow-up|1|||
164069149|NCT01393626|592615317|FG001|Overall Study|Lost to Follow-up|1|||
164069150|NCT01393626|592615318|FG002|Overall Study|Lost to Follow-up|1|||
164069151|NCT01393626|592615319|FG003|Overall Study|Lost to Follow-up|0|||
164069152|NCT01393626|592615316|FG000|Overall Study|Withdrawal by Subject|6|||
164069153|NCT01393626|592615317|FG001|Overall Study|Withdrawal by Subject|4|||
164069154|NCT01393626|592615318|FG002|Overall Study|Withdrawal by Subject|0|||
164069155|NCT01393626|592615319|FG003|Overall Study|Withdrawal by Subject|0|||
164069156|NCT01393626|592615316|FG000|Overall Study|Other|1|||
164069157|NCT01393626|592615317|FG001|Overall Study|Other|0|||
164069158|NCT01393626|592615318|FG002|Overall Study|Other|0|||
164069159|NCT01393626|592615319|FG003|Overall Study|Other|0|||
164069160|NCT01393626|592615316|FG000|Overall Study|Protocol Violation|1|||
164069161|NCT01393626|592615317|FG001|Overall Study|Protocol Violation|0|||
164069162|NCT01393626|592615318|FG002|Overall Study|Protocol Violation|2|||
164069163|NCT01393626|592615319|FG003|Overall Study|Protocol Violation|0|||
164069164|NCT02426125|592615320|FG000|Overall Study|Lost to Follow-up|14|||
164069165|NCT02426125|592615321|FG001|Overall Study|Lost to Follow-up|12|||
164069166|NCT02426125|592615320|FG000|Overall Study|Withdrawal by Subject|13|||
164069167|NCT02426125|592615321|FG001|Overall Study|Withdrawal by Subject|14|||
164069168|NCT02426125|592615320|FG000|Overall Study|Death|185|||
164069169|NCT02426125|592615321|FG001|Overall Study|Death|200|||
164069170|NCT02426125|592615320|FG000|Overall Study|Randomized, But Never Treated|5|||
164069171|NCT02426125|592615321|FG001|Overall Study|Randomized, But Never Treated|2|||
164069172|NCT00077766|592615324|FG000|Overall Study|Adverse Event|1|||
164069173|NCT00077766|592615325|FG001|Overall Study|Adverse Event|1|||
164069174|NCT00077766|592615324|FG000|Overall Study|Withdrawal by Subject|4|||
164069175|NCT00077766|592615325|FG001|Overall Study|Withdrawal by Subject|3|||
164069176|NCT00077766|592615324|FG000|Overall Study|Death|12|||
164069177|NCT00077766|592615325|FG001|Overall Study|Death|10|||
164069178|NCT00077766|592615324|FG000|Overall Study|Lost to Follow-up|2|||
164069179|NCT00077766|592615325|FG001|Overall Study|Lost to Follow-up|0|||
164069180|NCT00077766|592615324|FG000|Overall Study|Protocol Violation|1|||
164069181|NCT00077766|592615325|FG001|Overall Study|Protocol Violation|0|||
164069182|NCT00077766|592615324|FG000|Overall Study|Kidney Transplantation|9|||
164069183|NCT00077766|592615325|FG001|Overall Study|Kidney Transplantation|5|||
164069184|NCT00077766|592615324|FG000|Overall Study|Transplantation|5|||
164069185|NCT00077766|592615325|FG001|Overall Study|Transplantation|1|||
164069186|NCT00077766|592615324|FG000|Overall Study|Investigators Discretion|1|||
164069187|NCT00077766|592615325|FG001|Overall Study|Investigators Discretion|0|||
164069188|NCT00077766|592615324|FG000|Overall Study|Participant's decision|1|||
164069189|NCT00077766|592615325|FG001|Overall Study|Participant's decision|0|||
164069190|NCT00077766|592615324|FG000|Overall Study|Dialysis Discontinued|1|||
164069191|NCT00077766|592615325|FG001|Overall Study|Dialysis Discontinued|0|||
164069192|NCT00077766|592615324|FG000|Overall Study|Dialysis|0|||
164069193|NCT00077766|592615325|FG001|Overall Study|Dialysis|1|||
164069194|NCT00077766|592615324|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
164105788|NCT01440803|592750437|FG000|Overall Study|Met study stopping rule|2|||
164105789|NCT01440803|592750438|FG001|Overall Study|Met study stopping rule|1|||
164105790|NCT01440803|592750437|FG000|Overall Study|Lost to Follow-up|0|||
164069195|NCT00077766|592615325|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
164069196|NCT00077766|592615324|FG000|Overall Study|Started Nocturnal Dialysis|0|||
164069197|NCT00077766|592615325|FG001|Overall Study|Started Nocturnal Dialysis|1|||
164069198|NCT00077766|592615324|FG000|Overall Study|Stop Dialysis|0|||
164069199|NCT00077766|592615325|FG001|Overall Study|Stop Dialysis|1|||
164069200|NCT00077766|592615324|FG000|Overall Study|Participants Vacation|2|||
164069201|NCT00077766|592615325|FG001|Overall Study|Participants Vacation|1|||
164069202|NCT00938015|592615326|FG000|Overall Study|Death|2|||
164069203|NCT00938015|592615326|FG000|Overall Study|Lost to Follow-up|32|||
164069204|NCT00938015|592615326|FG000|Overall Study|Adverse Event|32|||
164069205|NCT00938015|592615326|FG000|Overall Study|Non-responder|52|||
164069206|NCT00938015|592615326|FG000|Overall Study|Reason not related to Etanercept|29|||
164069207|NCT03186794|592615327|FG000|Overall Study|Physician Decision|2|||
164105791|NCT01440803|592750438|FG001|Overall Study|Lost to Follow-up|2|||
164069208|NCT03186794|592615327|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
164069209|NCT02057549|592615329|FG000|Overall Study|Lost to Follow-up|1|||
164069210|NCT02057549|592615330|FG001|Overall Study|Lost to Follow-up|0|||
164069211|NCT02057549|592615329|FG000|Overall Study|Physician Decision|1|||
164069212|NCT02057549|592615330|FG001|Overall Study|Physician Decision|0|||
164069213|NCT02057549|592615329|FG000|Overall Study|Withdrawal by Subject|1|||
164069214|NCT02057549|592615330|FG001|Overall Study|Withdrawal by Subject|0|||
164069215|NCT01418365|592615333|FG000|First Intervention|Withdrawal by Subject|0|||
164148726|NCT03207867|592904955|FG019|Overall Study|Physician Decision|3|||
164105792|NCT01440803|592750437|FG000|Overall Study|Withdrawal by Subject|0|||
164105793|NCT01440803|592750438|FG001|Overall Study|Withdrawal by Subject|1|||
164105794|NCT01492439|592750440|FG000|Overall Study|Withdrew from RTE|4|||
164105795|NCT01492439|592750441|FG001|Overall Study|Withdrew from RTE|9|||
164105796|NCT00673660|592750442|FG000|Overall Study|Lost to Follow-up|107|||
164105797|NCT01527006|592750443|FG000|Core Study|Adverse Event|0|||
164105798|NCT01527006|592750444|FG001|Core Study|Adverse Event|2|||
164105799|NCT01527006|592750443|FG000|Core Study|Lost to Follow-up|0|||
164105800|NCT01527006|592750444|FG001|Core Study|Lost to Follow-up|1|||
164105801|NCT01527006|592750443|FG000|Core Study|Subject Choice|1|||
164105802|NCT01527006|592750444|FG001|Core Study|Subject Choice|0|||
164105803|NCT01527006|592750443|FG000|Core Study|Inadequate Therapeutic Effect|1|||
164105804|NCT01527006|592750444|FG001|Core Study|Inadequate Therapeutic Effect|0|||
164105805|NCT01527006|592750443|FG000|Core Study|Withdrawal by Subject|0|||
164105806|NCT01527006|592750444|FG001|Core Study|Withdrawal by Subject|1|||
164105807|NCT01527006|592750443|FG000|Core Study|Other|0|||
164105808|NCT01527006|592750444|FG001|Core Study|Other|2|||
164105809|NCT01527006|592750443|FG000|Extension Phase|Adverse Event|4|||
164105810|NCT01527006|592750444|FG001|Extension Phase|Adverse Event|2|||
164105811|NCT01527006|592750443|FG000|Extension Phase|Lost to Follow-up|0|||
164105812|NCT01527006|592750444|FG001|Extension Phase|Lost to Follow-up|1|||
164105813|NCT01527006|592750443|FG000|Extension Phase|Subject Choice|1|||
164105814|NCT01527006|592750444|FG001|Extension Phase|Subject Choice|1|||
164105815|NCT01527006|592750443|FG000|Extension Phase|Inadequate therapeutic effect|1|||
164105816|NCT01527006|592750444|FG001|Extension Phase|Inadequate therapeutic effect|1|||
164105817|NCT01527006|592750443|FG000|Extension Phase|Other|0|||
164105818|NCT01527006|592750444|FG001|Extension Phase|Other|3|||
164105819|NCT00933686|592750445|FG000|Overall Study|Protocol Violation|0|||
164105820|NCT00933686|592750446|FG001|Overall Study|Protocol Violation|1|||
164105821|NCT00933686|592750445|FG000|Overall Study|Lost to Follow-up|2|||
164105822|NCT00933686|592750446|FG001|Overall Study|Lost to Follow-up|2|||
164105823|NCT00933686|592750445|FG000|Overall Study|Withdrawal by Subject|6|||
164105824|NCT00933686|592750446|FG001|Overall Study|Withdrawal by Subject|5|||
164105825|NCT00933686|592750445|FG000|Overall Study|Adverse Event|1|||
164105826|NCT00933686|592750446|FG001|Overall Study|Adverse Event|1|||
164105827|NCT00933686|592750445|FG000|Overall Study|Physician Decision|1|||
164105828|NCT00933686|592750446|FG001|Overall Study|Physician Decision|0|||
164105829|NCT00933686|592750445|FG000|Overall Study|Failure to show up at endpoint visits|0|||
164105830|NCT00933686|592750446|FG001|Overall Study|Failure to show up at endpoint visits|2|||
164105831|NCT01383486|592750447|FG000|Overall Study|Lost to Follow-up|10|||
164105832|NCT01383486|592750447|FG000|Overall Study|Incomplete information for analysis|2|||
164105833|NCT01383486|592750447|FG000|Overall Study|Did not take any product|6|||
164105834|NCT00245063|592750448|FG000|Overall Study|Adverse Event|6|||
164105835|NCT00245063|592750449|FG001|Overall Study|Adverse Event|5|||
164105836|NCT00245063|592750448|FG000|Overall Study|Death|1|||
164105837|NCT00245063|592750449|FG001|Overall Study|Death|0|||
164105838|NCT01839279|592750452|FG000|Overall Study|Adverse Event|4|||
164105839|NCT01839279|592750453|FG001|Overall Study|Adverse Event|1|||
164105840|NCT01839279|592750454|FG002|Overall Study|Adverse Event|1|||
164105841|NCT01839279|592750452|FG000|Overall Study|Withdrawal by Subject|4|||
164105842|NCT01839279|592750453|FG001|Overall Study|Withdrawal by Subject|1|||
164105843|NCT01839279|592750454|FG002|Overall Study|Withdrawal by Subject|1|||
164105844|NCT01839279|592750452|FG000|Overall Study|Classified as 'Other'|5|||
164105845|NCT01839279|592750453|FG001|Overall Study|Classified as 'Other'|0|||
164105846|NCT01839279|592750454|FG002|Overall Study|Classified as 'Other'|0|||
164105847|NCT05919823|592750458|FG000|Pre-Treatment Period|Screen failure|1|||
164069216|NCT01418365|592615334|FG001|First Intervention|Withdrawal by Subject|1|||
164069217|NCT01418365|592615333|FG000|First Intervention|Non-compliance|1|||
164069218|NCT01418365|592615334|FG001|First Intervention|Non-compliance|0|||
164069219|NCT01418365|592615333|FG000|Second Intervention|Withdrawal by Subject|0|||
164069220|NCT01418365|592615334|FG001|Second Intervention|Withdrawal by Subject|1|||
164069221|NCT02575807|592615339|FG000|Overall Study|Death|8|||
164069222|NCT02575807|592615340|FG001|Overall Study|Death|3|||
164069223|NCT02575807|592615341|FG002|Overall Study|Death|7|||
164105848|NCT05919823|592750459|FG001|Pre-Treatment Period|Screen failure|0|||
164105849|NCT05919823|592750460|FG002|Pre-Treatment Period|Screen failure|0|||
164069224|NCT02575807|592615342|FG003|Overall Study|Death|0|||
164105850|NCT05919823|592750461|FG003|Pre-Treatment Period|Screen failure|0|||
164105851|NCT05919823|592750458|FG000|Pre-Treatment Period|Protocol Violation|0|||
164105852|NCT05919823|592750459|FG001|Pre-Treatment Period|Protocol Violation|1|||
164069225|NCT02575807|592615343|FG004|Overall Study|Death|1|||
164069226|NCT02575807|592615339|FG000|Overall Study|Study terminated by Sponsor|0|||
164105853|NCT05919823|592750460|FG002|Pre-Treatment Period|Protocol Violation|0|||
164105854|NCT05919823|592750461|FG003|Pre-Treatment Period|Protocol Violation|0|||
164105855|NCT05919823|592750458|FG000|Double-Blind Period|Adverse Event|8|||
164105856|NCT05919823|592750459|FG001|Double-Blind Period|Adverse Event|9|||
164105857|NCT05919823|592750460|FG002|Double-Blind Period|Adverse Event|0|||
164105858|NCT05919823|592750461|FG003|Double-Blind Period|Adverse Event|0|||
164105859|NCT05919823|592750458|FG000|Double-Blind Period|Protocol Violation|2|||
164148727|NCT03207867|592904956|FG020|Overall Study|Physician Decision|0|||
164105860|NCT05919823|592750459|FG001|Double-Blind Period|Protocol Violation|1|||
164105861|NCT05919823|592750460|FG002|Double-Blind Period|Protocol Violation|0|||
164105862|NCT05919823|592750461|FG003|Double-Blind Period|Protocol Violation|0|||
164105863|NCT05919823|592750458|FG000|Double-Blind Period|Participant withdrew consent|11|||
164069227|NCT02575807|592615340|FG001|Overall Study|Study terminated by Sponsor|1|||
164069228|NCT02575807|592615341|FG002|Overall Study|Study terminated by Sponsor|7|||
164069229|NCT02575807|592615342|FG003|Overall Study|Study terminated by Sponsor|0|||
164069230|NCT02575807|592615343|FG004|Overall Study|Study terminated by Sponsor|1|||
164069231|NCT02575807|592615339|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
164069232|NCT02575807|592615340|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
164069233|NCT02575807|592615341|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
164069234|NCT02575807|592615342|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
164069235|NCT02575807|592615343|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
164069236|NCT02575807|592615339|FG000|Overall Study|Terminated due to physician decision|0|||
164069237|NCT02575807|592615340|FG001|Overall Study|Terminated due to physician decision|0|||
164069238|NCT02575807|592615341|FG002|Overall Study|Terminated due to physician decision|1|||
164069239|NCT02575807|592615342|FG003|Overall Study|Terminated due to physician decision|0|||
164069240|NCT02575807|592615343|FG004|Overall Study|Terminated due to physician decision|0|||
164069241|NCT02575807|592615339|FG000|Overall Study|Subject ineligible - medical implant|0|||
164069242|NCT02575807|592615340|FG001|Overall Study|Subject ineligible - medical implant|0|||
164069243|NCT02575807|592615341|FG002|Overall Study|Subject ineligible - medical implant|0|||
164069244|NCT02575807|592615342|FG003|Overall Study|Subject ineligible - medical implant|1|||
164105864|NCT05919823|592750459|FG001|Double-Blind Period|Participant withdrew consent|7|||
164105865|NCT05919823|592750460|FG002|Double-Blind Period|Participant withdrew consent|0|||
164105866|NCT05919823|592750461|FG003|Double-Blind Period|Participant withdrew consent|0|||
164105867|NCT05919823|592750458|FG000|Double-Blind Period|Other reasons|2|||
164105868|NCT05919823|592750459|FG001|Double-Blind Period|Other reasons|3|||
164105869|NCT05919823|592750460|FG002|Double-Blind Period|Other reasons|0|||
164105870|NCT05919823|592750461|FG003|Double-Blind Period|Other reasons|0|||
164105871|NCT05919823|592750458|FG000|Open Label Period|Adverse Event|0|||
164105872|NCT05919823|592750459|FG001|Open Label Period|Adverse Event|0|||
164105873|NCT05919823|592750460|FG002|Open Label Period|Adverse Event|2|||
164105874|NCT05919823|592750461|FG003|Open Label Period|Adverse Event|4|||
164105875|NCT05919823|592750458|FG000|Open Label Period|Lost to Follow-up|0|||
164105876|NCT05919823|592750459|FG001|Open Label Period|Lost to Follow-up|0|||
164105877|NCT05919823|592750460|FG002|Open Label Period|Lost to Follow-up|1|||
164105878|NCT05919823|592750461|FG003|Open Label Period|Lost to Follow-up|0|||
164105879|NCT05919823|592750458|FG000|Open Label Period|Protocol Violation|0|||
164105880|NCT05919823|592750459|FG001|Open Label Period|Protocol Violation|0|||
164105881|NCT05919823|592750460|FG002|Open Label Period|Protocol Violation|0|||
164105882|NCT05919823|592750461|FG003|Open Label Period|Protocol Violation|1|||
164105883|NCT05919823|592750458|FG000|Open Label Period|Participant withdrew consent|0|||
164105884|NCT05919823|592750459|FG001|Open Label Period|Participant withdrew consent|0|||
164105885|NCT05919823|592750460|FG002|Open Label Period|Participant withdrew consent|8|||
164105886|NCT05919823|592750461|FG003|Open Label Period|Participant withdrew consent|6|||
164105887|NCT05919823|592750458|FG000|Open Label Period|Death|0|||
164105888|NCT05919823|592750459|FG001|Open Label Period|Death|0|||
164105889|NCT05919823|592750460|FG002|Open Label Period|Death|0|||
164105890|NCT05919823|592750461|FG003|Open Label Period|Death|1|||
164105891|NCT05919823|592750458|FG000|Open Label Period|Other reasons|0|||
164105892|NCT05919823|592750459|FG001|Open Label Period|Other reasons|0|||
164105893|NCT05919823|592750460|FG002|Open Label Period|Other reasons|9|||
164105894|NCT05919823|592750461|FG003|Open Label Period|Other reasons|5|||
164105895|NCT01648582|592750462|FG000|Overall Study|Adverse Event|6|||
164105896|NCT01648582|592750463|FG001|Overall Study|Adverse Event|11|||
164105897|NCT01648582|592750464|FG002|Overall Study|Adverse Event|2|||
164105898|NCT01648582|592750462|FG000|Overall Study|Lost to Follow-up|9|||
164105899|NCT01648582|592750463|FG001|Overall Study|Lost to Follow-up|6|||
164105900|NCT01648582|592750464|FG002|Overall Study|Lost to Follow-up|8|||
164105901|NCT01648582|592750462|FG000|Overall Study|Protocol Violation|1|||
164105902|NCT01648582|592750463|FG001|Overall Study|Protocol Violation|2|||
164105903|NCT01648582|592750464|FG002|Overall Study|Protocol Violation|1|||
164105904|NCT01648582|592750462|FG000|Overall Study|Withdrawal by Subject|15|||
164105905|NCT01648582|592750463|FG001|Overall Study|Withdrawal by Subject|17|||
164105906|NCT01648582|592750464|FG002|Overall Study|Withdrawal by Subject|17|||
164105907|NCT01648582|592750462|FG000|Overall Study|Physician Decision|0|||
164105908|NCT01648582|592750463|FG001|Overall Study|Physician Decision|1|||
164105909|NCT01648582|592750464|FG002|Overall Study|Physician Decision|3|||
164069245|NCT02575807|592615343|FG004|Overall Study|Subject ineligible - medical implant|0|||
164069246|NCT02575807|592615339|FG000|Overall Study|Withdrawal by Subject|0|||
164105910|NCT01648582|592750462|FG000|Overall Study|Death|1|||
164105911|NCT01648582|592750463|FG001|Overall Study|Death|0|||
164105912|NCT01648582|592750464|FG002|Overall Study|Death|0|||
164105913|NCT01648582|592750462|FG000|Overall Study|Sponsor Decision|0|||
164069247|NCT02575807|592615340|FG001|Overall Study|Withdrawal by Subject|0|||
164069248|NCT02575807|592615341|FG002|Overall Study|Withdrawal by Subject|1|||
164069249|NCT02575807|592615342|FG003|Overall Study|Withdrawal by Subject|1|||
164069250|NCT02575807|592615343|FG004|Overall Study|Withdrawal by Subject|2|||
164069251|NCT03319368|592615344|FG000|Overall Study|Discharge swabs not collected from resident|57|||
164069252|NCT03319368|592615345|FG001|Overall Study|Discharge swabs not collected from resident|46|||
164069253|NCT02180659|592615348|FG000|Overall Study|Adverse Event|1|||
164069254|NCT02180659|592615349|FG001|Overall Study|Adverse Event|0|||
164069255|NCT02180659|592615348|FG000|Overall Study|Lost to Follow-up|4|||
164069256|NCT02180659|592615349|FG001|Overall Study|Lost to Follow-up|2|||
164069257|NCT02180659|592615348|FG000|Overall Study|Subject incarcerated during conduct|1|||
164069258|NCT02180659|592615349|FG001|Overall Study|Subject incarcerated during conduct|0|||
164069259|NCT02180659|592615348|FG000|Overall Study|Withdrawal by Subject|0|||
164069260|NCT02180659|592615349|FG001|Overall Study|Withdrawal by Subject|2|||
164069261|NCT02180659|592615348|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
164069262|NCT02180659|592615349|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
164069263|NCT04150107|592615350|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
164069264|NCT04150107|592615351|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
164069265|NCT04150107|592615350|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
164069266|NCT04150107|592615351|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
164069267|NCT00824993|592615356|FG000|Overall Study|Withdrawal by Subject|1|||
164069268|NCT00824993|592615357|FG001|Overall Study|Withdrawal by Subject|1|||
164069269|NCT00824993|592615356|FG000|Overall Study|Malignancy Relapse|9|||
164069270|NCT00824993|592615357|FG001|Overall Study|Malignancy Relapse|10|||
164069271|NCT00824993|592615356|FG000|Overall Study|Rapid Bone Loss|0|||
164069272|NCT00824993|592615357|FG001|Overall Study|Rapid Bone Loss|1|||
164069273|NCT00824993|592615356|FG000|Overall Study|Non-Compliant|2|||
164069274|NCT00824993|592615357|FG001|Overall Study|Non-Compliant|1|||
164069275|NCT00824993|592615356|FG000|Overall Study|Insurance Issue|2|||
164069276|NCT00824993|592615357|FG001|Overall Study|Insurance Issue|1|||
164069277|NCT00824993|592615356|FG000|Overall Study|Death|0|||
164069278|NCT00824993|592615357|FG001|Overall Study|Death|3|||
164069279|NCT00440193|592615358|FG000|Treatment Period|Adverse Event|74|||
164069280|NCT00440193|592615359|FG001|Treatment Period|Adverse Event|67|||
164069281|NCT00440193|592615358|FG000|Treatment Period|Death|19|||
164069282|NCT00440193|592615359|FG001|Treatment Period|Death|22|||
164069283|NCT00440193|592615358|FG000|Treatment Period|Lack of Efficacy|0|||
164069284|NCT00440193|592615359|FG001|Treatment Period|Lack of Efficacy|1|||
164069285|NCT00440193|592615358|FG000|Treatment Period|Lost to Follow-up|12|||
164069286|NCT00440193|592615359|FG001|Treatment Period|Lost to Follow-up|18|||
164069287|NCT00440193|592615358|FG000|Treatment Period|Physician Decision|3|||
164069288|NCT00440193|592615359|FG001|Treatment Period|Physician Decision|6|||
164069289|NCT00440193|592615358|FG000|Treatment Period|Protocol Violation|16|||
164069290|NCT00440193|592615359|FG001|Treatment Period|Protocol Violation|19|||
164069291|NCT00440193|592615358|FG000|Treatment Period|Withdrawal by Subject|36|||
164069292|NCT00440193|592615359|FG001|Treatment Period|Withdrawal by Subject|77|||
164069293|NCT00440193|592615358|FG000|Treatment Period|Clinical endpoint reached|28|||
164069294|NCT00440193|592615359|FG001|Treatment Period|Clinical endpoint reached|25|||
164069295|NCT00440193|592615358|FG000|Treatment Period|Study terminated by sponsor|102|||
164069296|NCT00440193|592615359|FG001|Treatment Period|Study terminated by sponsor|94|||
164069297|NCT00440193|592615358|FG000|Treatment Period|Protocol driven decision point|2|||
164069298|NCT00440193|592615359|FG001|Treatment Period|Protocol driven decision point|2|||
164069299|NCT00440193|592615358|FG000|Treatment Period|Switch to commercial drug|0|||
164069300|NCT00440193|592615359|FG001|Treatment Period|Switch to commercial drug|2|||
164069301|NCT00440193|592615358|FG000|Treatment Period|Technical problems|1|||
164069302|NCT00440193|592615359|FG001|Treatment Period|Technical problems|1|||
164069303|NCT00440193|592615358|FG000|Treatment Period|Participant convenience|5|||
164069304|NCT00440193|592615359|FG001|Treatment Period|Participant convenience|2|||
164069305|NCT00440193|592615358|FG000|Treatment Period|Participant did not receive treatment|7|||
164069306|NCT00440193|592615359|FG001|Treatment Period|Participant did not receive treatment|13|||
164069307|NCT00440193|592615358|FG000|Treatment Period|Site closed by investigator|0|||
164069308|NCT00440193|592615359|FG001|Treatment Period|Site closed by investigator|2|||
164069309|NCT00440193|592615358|FG000|Observational Period|Adverse Event|2|||
164069310|NCT00440193|592615359|FG001|Observational Period|Adverse Event|2|||
164069311|NCT00440193|592615358|FG000|Observational Period|Death|15|||
164069312|NCT00440193|592615359|FG001|Observational Period|Death|20|||
164069313|NCT00440193|592615358|FG000|Observational Period|Lost to Follow-up|12|||
164069314|NCT00440193|592615359|FG001|Observational Period|Lost to Follow-up|8|||
164069315|NCT00440193|592615358|FG000|Observational Period|Protocol Violation|1|||
164069316|NCT00440193|592615359|FG001|Observational Period|Protocol Violation|0|||
164069317|NCT00440193|592615358|FG000|Observational Period|Withdrawal by Subject|11|||
164069318|NCT00440193|592615359|FG001|Observational Period|Withdrawal by Subject|8|||
164069319|NCT00440193|592615358|FG000|Observational Period|Physician Decision|1|||
164069320|NCT00440193|592615359|FG001|Observational Period|Physician Decision|0|||
164069321|NCT00440193|592615358|FG000|Observational Period|Clinical endpoint reached|1|||
164069322|NCT00440193|592615359|FG001|Observational Period|Clinical endpoint reached|0|||
164069323|NCT00440193|592615358|FG000|Observational Period|Participant convenience|2|||
164069324|NCT00440193|592615359|FG001|Observational Period|Participant convenience|0|||
164069325|NCT00834366|592615360|FG000|Treatment Period 1|Adverse Event|1|||
164069326|NCT00834366|592615361|FG001|Treatment Period 1|Adverse Event|1|||
164069327|NCT03409328|592615367|FG000|Overall Study|Lost to Follow-up|6|||
164069328|NCT03409328|592615368|FG001|Overall Study|Lost to Follow-up|3|||
164069329|NCT00518011|592615369|FG000|Overall Study|Death|1|||
164069330|NCT00518011|592615370|FG001|Overall Study|Death|1|||
164069331|NCT00518011|592615369|FG000|Overall Study|Adverse Event|2|||
164069332|NCT00518011|592615370|FG001|Overall Study|Adverse Event|3|||
164069333|NCT00518011|592615369|FG000|Overall Study|Disease Progression|2|||
164069334|NCT00518011|592615370|FG001|Overall Study|Disease Progression|2|||
164069335|NCT00518011|592615369|FG000|Overall Study|Other Reasons|3|||
164069336|NCT00518011|592615370|FG001|Overall Study|Other Reasons|2|||
164069337|NCT00518011|592615369|FG000|Overall Study|Withdrawal by Subject|1|||
164069338|NCT00518011|592615370|FG001|Overall Study|Withdrawal by Subject|0|||
164069339|NCT02998645|592615371|FG000|Treatment Period 1|Adverse Event|6|||
164069340|NCT02998645|592615371|FG000|Treatment Period 1|Death|5|||
164069341|NCT02998645|592615371|FG000|Treatment Period 1|Technical Problems|4|||
164069342|NCT02998645|592615371|FG000|Treatment Period 1|Lack of Efficacy|2|||
164069343|NCT02998645|592615371|FG000|Treatment Period 1|Progressive disease|1|||
164069344|NCT02998645|592615371|FG000|Treatment Period 1|Subject/guardian decision|1|||
164069345|NCT02998645|592615371|FG000|Treatment Period 2|Lack of Efficacy|5|||
164069346|NCT02998645|592615371|FG000|Treatment Period 2|Adverse Event|2|||
164069347|NCT02998645|592615371|FG000|Treatment Period 2|Progressive disease|2|||
164069348|NCT02998645|592615371|FG000|Treatment Period 2|Physician Decision|1|||
164069349|NCT00090259|592615372|FG000|Overall Study|Lost to Follow-up|30|||
164069350|NCT00090259|592615373|FG001|Overall Study|Lost to Follow-up|26|||
164069351|NCT00090259|592615372|FG000|Overall Study|Withdrawal by Subject|21|||
164069352|NCT00090259|592615373|FG001|Overall Study|Withdrawal by Subject|15|||
164069353|NCT00090259|592615372|FG000|Overall Study|Investigator site closed|11|||
164069354|NCT00090259|592615373|FG001|Overall Study|Investigator site closed|7|||
164069355|NCT00478673|592615374|FG000|30-Days Post-Procedure|Death|2|||
164069356|NCT00478673|592615374|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
164069357|NCT00478673|592615374|FG000|30-Days Post-Procedure|Missed Visit|7|||
164069358|NCT00478673|592615374|FG000|12-Months Post-Procedure|Death|23|||
164069359|NCT00478673|592615374|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
164069360|NCT00478673|592615374|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
164069361|NCT00478673|592615374|FG000|12-Months Post-Procedure|Missed Visit|25|||
164069362|NCT00478673|592615374|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
164069363|NCT03701516|592615375|FG000|Period 1|Lost to Follow-up|0|||
164069364|NCT03701516|592615376|FG001|Period 1|Lost to Follow-up|1|||
164069365|NCT03701516|592615375|FG000|Period 1|Adverse Event|0|||
164069366|NCT03701516|592615376|FG001|Period 1|Adverse Event|2|||
164069367|NCT03701516|592615375|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
164069368|NCT03701516|592615376|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
164069369|NCT03701516|592615375|FG000|Period 1|Non Compliance to Protocol|2|||
164069370|NCT03701516|592615376|FG001|Period 1|Non Compliance to Protocol|1|||
164069371|NCT03701516|592615375|FG000|Period 1|Withdrawal by Subject|0|||
164069372|NCT03701516|592615376|FG001|Period 1|Withdrawal by Subject|1|||
164069373|NCT03701516|592615375|FG000|Period 2|failed to meet all eligibility creiteria|1|||
164069374|NCT03701516|592615376|FG001|Period 2|failed to meet all eligibility creiteria|0|||
164069375|NCT03701516|592615375|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
164069376|NCT03701516|592615376|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
164069377|NCT03644927|592615382|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
164069378|NCT03644927|592615383|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
164069379|NCT00956813|592615384|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
164069380|NCT00956813|592615385|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
164069381|NCT00956813|592615384|FG000|Flaxseed and Placebo|Ineligible|3|||
164069382|NCT00956813|592615385|FG001|Flaxseed and Placebo|Ineligible|1|||
164069383|NCT04797637|592615386|FG000|Overall Study|Lost to Follow-up|23|||
164069384|NCT04797637|592615387|FG001|Overall Study|Lost to Follow-up|32|||
164069385|NCT04797637|592615386|FG000|Overall Study|Withdrawal by Subject|0|||
164069386|NCT04797637|592615387|FG001|Overall Study|Withdrawal by Subject|1|||
164069387|NCT02380248|592615388|FG000|Overall Study|Lost to Follow-up|11|||
164069388|NCT02380248|592615388|FG000|Overall Study|Withdrawal by Subject|3|||
164069389|NCT03083639|592615389|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
164069390|NCT03083639|592615390|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
164069391|NCT03083639|592615389|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
164069392|NCT03083639|592615390|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
164069393|NCT00960687|592615391|FG000|Washout Period of 7 Days|Adverse Event|3|||
164069394|NCT00960687|592615392|FG001|Washout Period of 7 Days|Adverse Event|2|||
164069395|NCT00960687|592615391|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
164069396|NCT00960687|592615392|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164069397|NCT03611751|592615399|FG000|Pre-treatment|Randomized but not treated|1|||
164069398|NCT03611751|592615400|FG001|Pre-treatment|Randomized but not treated|1|||
164069399|NCT03611751|592615401|FG002|Pre-treatment|Randomized but not treated|0|||
164069400|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
164069401|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
164069402|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
164069403|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
164069404|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
164069405|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
164069406|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
164069407|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
164069408|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
164069409|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
164069410|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
164069411|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
164069412|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
164069413|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
164069414|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
164069415|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
164069416|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
164069417|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
164069418|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
164069419|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
164069420|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
164069421|NCT03611751|592615399|FG000|Treatment Week 0 - Week 16|Death|0|||
164069422|NCT03611751|592615400|FG001|Treatment Week 0 - Week 16|Death|0|||
164069423|NCT03611751|592615401|FG002|Treatment Week 0 - Week 16|Death|1|||
164069424|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
164069425|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
164069426|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
164069427|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
164069428|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
164069429|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
164069430|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
164069431|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164069432|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
164069433|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
164069434|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
164069435|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
164069436|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
164069437|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
164069438|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
164069439|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
164069440|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
164069441|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
164069442|NCT03611751|592615399|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
164069443|NCT03611751|592615400|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
164069444|NCT03611751|592615401|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
164069445|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
164069446|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
164069447|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
164069448|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
164069449|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
164069450|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
164069451|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
164069452|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
164069453|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
164069454|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
164069455|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
164069456|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
164069457|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
164069458|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
164069459|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
164069460|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
164069461|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
164069462|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
164069463|NCT03611751|592615399|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
164069464|NCT03611751|592615400|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
164069465|NCT03611751|592615401|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
164069466|NCT01023022|592615402|FG000|Overall Study|Death|5|||
164069467|NCT01023022|592615402|FG000|Overall Study|Lost to Follow-up|7|||
164069468|NCT01023022|592615402|FG000|Overall Study|due to technical issues|2|||
164069469|NCT03128931|592615404|FG000|Overall Study|Physician Decision|1|||
164069470|NCT03128931|592615404|FG000|Overall Study|Equipment Issues|3|||
164069471|NCT01371006|592617294|FG000|Overall Study|Adverse Event|1|||
164069472|NCT01371006|592617295|FG001|Overall Study|Adverse Event|0|||
164069473|NCT03256526|592617296|FG000|Overall Study|Adverse Event|1|||
164069474|NCT03256526|592617297|FG001|Overall Study|Adverse Event|0|||
164069475|NCT03256526|592617298|FG002|Overall Study|Adverse Event|1|||
164069476|NCT03256526|592617296|FG000|Overall Study|Lost to Follow-up|1|||
164069477|NCT03256526|592617297|FG001|Overall Study|Lost to Follow-up|0|||
164069478|NCT03256526|592617298|FG002|Overall Study|Lost to Follow-up|2|||
164069479|NCT00891527|592617299|FG000|Overall Study|Withdrawal by Subject|2|||
164069480|NCT01186744|592617300|FG000|Overall Study|Lack of Efficacy|156|||
164069481|NCT01186744|592617301|FG001|Overall Study|Lack of Efficacy|99|||
164069482|NCT01186744|592617302|FG002|Overall Study|Lack of Efficacy|0|||
164069483|NCT01186744|592617303|FG003|Overall Study|Lack of Efficacy|2|||
164069484|NCT01186744|592617304|FG004|Overall Study|Lack of Efficacy|2|||
164069485|NCT01186744|592617305|FG005|Overall Study|Lack of Efficacy|5|||
164069486|NCT01186744|592617300|FG000|Overall Study|Protocol Violation|1|||
164069487|NCT01186744|592617301|FG001|Overall Study|Protocol Violation|2|||
164069488|NCT01186744|592617302|FG002|Overall Study|Protocol Violation|0|||
164069489|NCT01186744|592617303|FG003|Overall Study|Protocol Violation|1|||
164069490|NCT01186744|592617304|FG004|Overall Study|Protocol Violation|1|||
164069491|NCT01186744|592617305|FG005|Overall Study|Protocol Violation|2|||
164069492|NCT01186744|592617300|FG000|Overall Study|Lost to Follow-up|15|||
164069493|NCT01186744|592617301|FG001|Overall Study|Lost to Follow-up|16|||
164069494|NCT01186744|592617302|FG002|Overall Study|Lost to Follow-up|2|||
164069495|NCT01186744|592617303|FG003|Overall Study|Lost to Follow-up|1|||
164069496|NCT01186744|592617304|FG004|Overall Study|Lost to Follow-up|1|||
164069497|NCT01186744|592617305|FG005|Overall Study|Lost to Follow-up|4|||
164069498|NCT01186744|592617300|FG000|Overall Study|Screen failure|1|||
164069499|NCT01186744|592617301|FG001|Overall Study|Screen failure|1|||
164069500|NCT01186744|592617302|FG002|Overall Study|Screen failure|0|||
164069501|NCT01186744|592617303|FG003|Overall Study|Screen failure|1|||
164069502|NCT01186744|592617304|FG004|Overall Study|Screen failure|0|||
164069503|NCT01186744|592617305|FG005|Overall Study|Screen failure|0|||
164069504|NCT01186744|592617300|FG000|Overall Study|Withdrawal by Subject|14|||
164069505|NCT01186744|592617301|FG001|Overall Study|Withdrawal by Subject|10|||
164069506|NCT01186744|592617302|FG002|Overall Study|Withdrawal by Subject|2|||
164069507|NCT01186744|592617303|FG003|Overall Study|Withdrawal by Subject|5|||
164069508|NCT01186744|592617304|FG004|Overall Study|Withdrawal by Subject|0|||
164069509|NCT01186744|592617305|FG005|Overall Study|Withdrawal by Subject|6|||
164069510|NCT01186744|592617300|FG000|Overall Study|Study terminated by Sponsor|1|||
164069511|NCT01186744|592617301|FG001|Overall Study|Study terminated by Sponsor|0|||
164069512|NCT01186744|592617302|FG002|Overall Study|Study terminated by Sponsor|0|||
164069513|NCT01186744|592617303|FG003|Overall Study|Study terminated by Sponsor|0|||
164069514|NCT01186744|592617304|FG004|Overall Study|Study terminated by Sponsor|0|||
164069515|NCT01186744|592617305|FG005|Overall Study|Study terminated by Sponsor|0|||
164069516|NCT01186744|592617300|FG000|Overall Study|Other|9|||
164069517|NCT01186744|592617301|FG001|Overall Study|Other|10|||
164069518|NCT01186744|592617302|FG002|Overall Study|Other|1|||
164069519|NCT01186744|592617303|FG003|Overall Study|Other|2|||
164069520|NCT01186744|592617304|FG004|Overall Study|Other|1|||
164069521|NCT01186744|592617305|FG005|Overall Study|Other|5|||
164069522|NCT01186744|592617300|FG000|Overall Study|Adverse Event|10|||
164069523|NCT01186744|592617301|FG001|Overall Study|Adverse Event|14|||
164069524|NCT01186744|592617302|FG002|Overall Study|Adverse Event|1|||
164069525|NCT01186744|592617303|FG003|Overall Study|Adverse Event|0|||
164069526|NCT01186744|592617304|FG004|Overall Study|Adverse Event|1|||
164069527|NCT01186744|592617305|FG005|Overall Study|Adverse Event|4|||
164069528|NCT01186744|592617300|FG000|Overall Study|Death|1|||
164069529|NCT01186744|592617301|FG001|Overall Study|Death|0|||
164069530|NCT01186744|592617302|FG002|Overall Study|Death|0|||
164105914|NCT01648582|592750463|FG001|Overall Study|Sponsor Decision|1|||
164105915|NCT01648582|592750464|FG002|Overall Study|Sponsor Decision|1|||
164105916|NCT02321098|592750469|FG000|12 Weeks Treament|Lost to Follow-up|1|||
164069531|NCT01186744|592617303|FG003|Overall Study|Death|0|||
164069532|NCT01186744|592617304|FG004|Overall Study|Death|0|||
164069533|NCT01186744|592617305|FG005|Overall Study|Death|0|||
164069534|NCT03515837|592617309|FG000|Overall Study|Death|219|||
164069535|NCT03515837|592617310|FG001|Overall Study|Death|227|||
164069536|NCT03515837|592617309|FG000|Overall Study|Lost to Follow-up|0|||
164069537|NCT03515837|592617310|FG001|Overall Study|Lost to Follow-up|1|||
164069538|NCT03515837|592617309|FG000|Overall Study|Withdrawal by Subject|0|||
164069539|NCT03515837|592617310|FG001|Overall Study|Withdrawal by Subject|4|||
164069540|NCT03515837|592617309|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
164069541|NCT03515837|592617310|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
164069542|NCT02325401|592617311|FG000|Overall Study|Withdrawal by Subject|0|||
164069543|NCT02325401|592617312|FG001|Overall Study|Withdrawal by Subject|1|||
164069544|NCT02325401|592617313|FG002|Overall Study|Withdrawal by Subject|1|||
164069545|NCT01856686|592617314|FG000|Overall Study|Lost to Follow-up|5|||
164069546|NCT01856686|592617315|FG001|Overall Study|Lost to Follow-up|11|||
164069547|NCT02406742|592617318|FG000|Overall Study|Progression of Disease|5|||
164069548|NCT02406742|592617319|FG001|Overall Study|Progression of Disease|1|||
164069549|NCT02406742|592617320|FG002|Overall Study|Progression of Disease|6|||
164069550|NCT02406742|592617318|FG000|Overall Study|Adverse Event|3|||
164069551|NCT02406742|592617319|FG001|Overall Study|Adverse Event|0|||
164069552|NCT02406742|592617320|FG002|Overall Study|Adverse Event|2|||
164069553|NCT02406742|592617318|FG000|Overall Study|Death|1|||
164069554|NCT02406742|592617319|FG001|Overall Study|Death|0|||
164069555|NCT02406742|592617320|FG002|Overall Study|Death|0|||
164069556|NCT02406742|592617318|FG000|Overall Study|Lack of Efficacy|0|||
164069557|NCT02406742|592617319|FG001|Overall Study|Lack of Efficacy|0|||
164069558|NCT02406742|592617320|FG002|Overall Study|Lack of Efficacy|1|||
164069559|NCT02406742|592617318|FG000|Overall Study|Withdrawal by Participant|1|||
164069560|NCT02406742|592617319|FG001|Overall Study|Withdrawal by Participant|2|||
164069561|NCT02406742|592617320|FG002|Overall Study|Withdrawal by Participant|0|||
164069562|NCT02406742|592617318|FG000|Overall Study|Physician Decision|1|||
164069563|NCT02406742|592617319|FG001|Overall Study|Physician Decision|2|||
164069564|NCT02406742|592617320|FG002|Overall Study|Physician Decision|1|||
164069565|NCT02406742|592617318|FG000|Overall Study|Transition to other treatment|2|||
164069566|NCT02406742|592617319|FG001|Overall Study|Transition to other treatment|0|||
164069567|NCT02406742|592617320|FG002|Overall Study|Transition to other treatment|1|||
164069568|NCT02406742|592617318|FG000|Overall Study|Other Reasons|1|||
164069569|NCT02406742|592617319|FG001|Overall Study|Other Reasons|11|||
164069570|NCT02406742|592617320|FG002|Overall Study|Other Reasons|5|||
164069571|NCT02367729|592617321|FG000|Overall Study|Organic disorder diagnosed|2|||
164069572|NCT02367729|592617322|FG001|Overall Study|Organic disorder diagnosed|1|||
164069573|NCT02367729|592617321|FG000|Overall Study|Adverse Event|1|||
164069574|NCT02367729|592617322|FG001|Overall Study|Adverse Event|2|||
164069575|NCT02367729|592617321|FG000|Overall Study|Withdrawal by Subject|0|||
164069576|NCT02367729|592617322|FG001|Overall Study|Withdrawal by Subject|5|||
164069577|NCT00759174|592617323|FG000|Overall Study|Other|0|||
164069578|NCT00759174|592617324|FG001|Overall Study|Other|2|||
164069579|NCT01890109|592617325|FG000|Overall Study|Withdrawal by Subject|0|||
164069580|NCT01890109|592617326|FG001|Overall Study|Withdrawal by Subject|3|||
164069581|NCT01890109|592617325|FG000|Overall Study|Lost to Follow-up|1|||
164069582|NCT01890109|592617326|FG001|Overall Study|Lost to Follow-up|2|||
164069583|NCT01643928|592617327|FG000|Overall Study|Lost to Follow-up|1|||
164069584|NCT01643928|592617328|FG001|Overall Study|Lost to Follow-up|0|||
164069585|NCT01643928|592617329|FG002|Overall Study|Lost to Follow-up|2|||
164069586|NCT01643928|592617330|FG003|Overall Study|Lost to Follow-up|0|||
164069587|NCT01643928|592617331|FG004|Overall Study|Lost to Follow-up|0|||
164069588|NCT01643928|592617327|FG000|Overall Study|Withdrawal by Subject|2|||
164069589|NCT01643928|592617328|FG001|Overall Study|Withdrawal by Subject|0|||
164069590|NCT01643928|592617329|FG002|Overall Study|Withdrawal by Subject|0|||
164069591|NCT01643928|592617330|FG003|Overall Study|Withdrawal by Subject|1|||
164069592|NCT01643928|592617331|FG004|Overall Study|Withdrawal by Subject|0|||
164069593|NCT01643928|592617327|FG000|Overall Study|Pregnancy|0|||
164069594|NCT01643928|592617328|FG001|Overall Study|Pregnancy|0|||
164069595|NCT01643928|592617329|FG002|Overall Study|Pregnancy|0|||
164069596|NCT01643928|592617330|FG003|Overall Study|Pregnancy|1|||
164069597|NCT01643928|592617331|FG004|Overall Study|Pregnancy|0|||
164069598|NCT01643928|592617327|FG000|Overall Study|Other|5|||
164069599|NCT01643928|592617328|FG001|Overall Study|Other|1|||
164069600|NCT01643928|592617329|FG002|Overall Study|Other|1|||
164069601|NCT01643928|592617330|FG003|Overall Study|Other|0|||
164069602|NCT01643928|592617331|FG004|Overall Study|Other|0|||
164069603|NCT01643928|592617327|FG000|Overall Study|Adverse Event|2|||
164105917|NCT02321098|592750470|FG001|12 Weeks Treament|Lost to Follow-up|1|||
164105918|NCT02321098|592750471|FG002|12 Weeks Treament|Lost to Follow-up|0|||
164069604|NCT01643928|592617328|FG001|Overall Study|Adverse Event|1|||
164069605|NCT01643928|592617329|FG002|Overall Study|Adverse Event|0|||
164069606|NCT01643928|592617330|FG003|Overall Study|Adverse Event|1|||
164069607|NCT01643928|592617331|FG004|Overall Study|Adverse Event|2|||
164069608|NCT00996632|592617333|FG000|Overall Study|Physician Decision|0|||
164069609|NCT00996632|592617334|FG001|Overall Study|Physician Decision|0|||
164069610|NCT00916617|592617340|FG000|Overall Study|Adverse Event|3|||
164069611|NCT00916617|592617341|FG001|Overall Study|Adverse Event|2|||
164069612|NCT00916617|592617342|FG002|Overall Study|Adverse Event|6|||
164069613|NCT00916617|592617343|FG003|Overall Study|Adverse Event|3|||
164069614|NCT00916617|592617340|FG000|Overall Study|Withdrawal by Subject|3|||
164069615|NCT00916617|592617341|FG001|Overall Study|Withdrawal by Subject|2|||
164069616|NCT00916617|592617342|FG002|Overall Study|Withdrawal by Subject|0|||
164069617|NCT00916617|592617343|FG003|Overall Study|Withdrawal by Subject|1|||
164069618|NCT00916617|592617340|FG000|Overall Study|Caregiver Request|3|||
164069619|NCT00916617|592617341|FG001|Overall Study|Caregiver Request|2|||
164069620|NCT00916617|592617342|FG002|Overall Study|Caregiver Request|1|||
164069621|NCT00916617|592617343|FG003|Overall Study|Caregiver Request|0|||
164069622|NCT00916617|592617340|FG000|Overall Study|Physician Decision|1|||
164069623|NCT00916617|592617341|FG001|Overall Study|Physician Decision|1|||
164069624|NCT00916617|592617342|FG002|Overall Study|Physician Decision|0|||
164069625|NCT00916617|592617343|FG003|Overall Study|Physician Decision|0|||
164069626|NCT00916617|592617340|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
164069627|NCT00916617|592617341|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
164069628|NCT00916617|592617342|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
164069629|NCT00916617|592617343|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
164069630|NCT00916617|592617340|FG000|Overall Study|Lost to Follow-up|2|||
164069631|NCT00916617|592617341|FG001|Overall Study|Lost to Follow-up|1|||
164069632|NCT00916617|592617342|FG002|Overall Study|Lost to Follow-up|0|||
164069633|NCT00916617|592617343|FG003|Overall Study|Lost to Follow-up|0|||
164069634|NCT00916617|592617340|FG000|Overall Study|Lack of Efficacy|1|||
164069635|NCT00916617|592617341|FG001|Overall Study|Lack of Efficacy|0|||
164069636|NCT00916617|592617342|FG002|Overall Study|Lack of Efficacy|0|||
164069637|NCT00916617|592617343|FG003|Overall Study|Lack of Efficacy|0|||
164069638|NCT00916617|592617340|FG000|Overall Study|Other|2|||
164069639|NCT00916617|592617341|FG001|Overall Study|Other|0|||
164069640|NCT00916617|592617342|FG002|Overall Study|Other|0|||
164069641|NCT00916617|592617343|FG003|Overall Study|Other|2|||
164069642|NCT00499252|592617345|FG000|Overall Study|Adverse Event|3|||
164069643|NCT00499252|592617345|FG000|Overall Study|Refused further treatment|2|||
164069644|NCT00499252|592617345|FG000|Overall Study|Ineligible|4|||
164069645|NCT00499252|592617345|FG000|Overall Study|<no further label>|3|||
164069646|NCT02230332|592617346|FG000|Overall Study|Adverse Event|2|||
164069647|NCT02230332|592617347|FG001|Overall Study|Adverse Event|1|||
164069648|NCT02230332|592617346|FG000|Overall Study|Lost to Follow-up|1|||
164069649|NCT02230332|592617347|FG001|Overall Study|Lost to Follow-up|0|||
164069650|NCT02230332|592617346|FG000|Overall Study|Protocol Violation|1|||
164069651|NCT02230332|592617347|FG001|Overall Study|Protocol Violation|0|||
164069652|NCT01260194|592617349|FG000|Overall Study|Withdrawal of Consent|1|||
164069653|NCT02086968|592617351|FG000|Overall Study|Adverse Event|1|||
164069654|NCT02086968|592617352|FG001|Overall Study|Adverse Event|5|||
164069655|NCT02086968|592617351|FG000|Overall Study|Lost to Follow-up|2|||
164069656|NCT02086968|592617352|FG001|Overall Study|Lost to Follow-up|3|||
164069657|NCT02086968|592617351|FG000|Overall Study|Study drug received outside protocol|0|||
164069658|NCT02086968|592617352|FG001|Overall Study|Study drug received outside protocol|1|||
164069659|NCT02086968|592617351|FG000|Overall Study|Physician Decision|4|||
164069660|NCT02086968|592617352|FG001|Overall Study|Physician Decision|0|||
164069661|NCT02086968|592617351|FG000|Overall Study|Withdrawal by Subject|1|||
164069662|NCT02086968|592617352|FG001|Overall Study|Withdrawal by Subject|4|||
164069663|NCT00556166|592617358|FG000|Overall Study|Withdrawal by Subject|1|||
164069664|NCT03359473|592617359|FG000|Overall Study|Adverse Event|0|||
164069665|NCT03359473|592617360|FG001|Overall Study|Adverse Event|2|||
164069666|NCT03359473|592617361|FG002|Overall Study|Adverse Event|5|||
164069667|NCT03359473|592617362|FG003|Overall Study|Adverse Event|3|||
164069668|NCT03359473|592617359|FG000|Overall Study|Lost to Follow-up|0|||
164069669|NCT03359473|592617360|FG001|Overall Study|Lost to Follow-up|1|||
164069670|NCT03359473|592617361|FG002|Overall Study|Lost to Follow-up|0|||
164069671|NCT03359473|592617362|FG003|Overall Study|Lost to Follow-up|0|||
164069672|NCT03359473|592617359|FG000|Overall Study|Physician Decision|0|||
164069673|NCT03359473|592617360|FG001|Overall Study|Physician Decision|1|||
164069674|NCT03359473|592617361|FG002|Overall Study|Physician Decision|0|||
164069675|NCT03359473|592617362|FG003|Overall Study|Physician Decision|1|||
164069676|NCT03359473|592617359|FG000|Overall Study|Withdrawal by Subject|1|||
164069677|NCT03359473|592617360|FG001|Overall Study|Withdrawal by Subject|2|||
164069678|NCT03359473|592617361|FG002|Overall Study|Withdrawal by Subject|1|||
164069679|NCT03359473|592617362|FG003|Overall Study|Withdrawal by Subject|0|||
164069680|NCT03359473|592617359|FG000|Overall Study|Protocol-defined stopping criteria|1|||
164069681|NCT03359473|592617360|FG001|Overall Study|Protocol-defined stopping criteria|0|||
164069682|NCT03359473|592617361|FG002|Overall Study|Protocol-defined stopping criteria|0|||
164069683|NCT03359473|592617362|FG003|Overall Study|Protocol-defined stopping criteria|1|||
164069684|NCT04101721|592617366|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
164069685|NCT04101721|592617367|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
164069686|NCT04101721|592617366|FG000|Overall Study|Death|0|||
164069687|NCT04101721|592617367|FG001|Overall Study|Death|1|||
164069688|NCT04101721|592617366|FG000|Overall Study|Lost to Follow-up|0|||
164069689|NCT04101721|592617367|FG001|Overall Study|Lost to Follow-up|3|||
164069690|NCT01215955|592617368|FG000|Overall Study|Adverse Event|1|||
164069691|NCT01215955|592617369|FG001|Overall Study|Adverse Event|4|||
164069692|NCT01215955|592617370|FG002|Overall Study|Adverse Event|2|||
164069693|NCT01215955|592617371|FG003|Overall Study|Adverse Event|3|||
164069694|NCT01215955|592617368|FG000|Overall Study|Death|2|||
164069695|NCT01215955|592617369|FG001|Overall Study|Death|0|||
164069696|NCT01215955|592617370|FG002|Overall Study|Death|1|||
164069697|NCT01215955|592617371|FG003|Overall Study|Death|3|||
164069698|NCT01215955|592617368|FG000|Overall Study|Entry Criteria Not Met|1|||
164069699|NCT01215955|592617369|FG001|Overall Study|Entry Criteria Not Met|3|||
164069700|NCT01215955|592617370|FG002|Overall Study|Entry Criteria Not Met|4|||
164069701|NCT01215955|592617371|FG003|Overall Study|Entry Criteria Not Met|7|||
164069702|NCT01215955|592617368|FG000|Overall Study|Lack of Efficacy|1|||
164069703|NCT01215955|592617369|FG001|Overall Study|Lack of Efficacy|2|||
164069704|NCT01215955|592617370|FG002|Overall Study|Lack of Efficacy|1|||
164069705|NCT01215955|592617371|FG003|Overall Study|Lack of Efficacy|0|||
164069706|NCT01215955|592617368|FG000|Overall Study|Lost to Follow-up|4|||
164069707|NCT01215955|592617369|FG001|Overall Study|Lost to Follow-up|4|||
164069708|NCT01215955|592617370|FG002|Overall Study|Lost to Follow-up|8|||
164069709|NCT01215955|592617371|FG003|Overall Study|Lost to Follow-up|9|||
164069710|NCT01215955|592617368|FG000|Overall Study|Physician Decision|4|||
164069711|NCT01215955|592617369|FG001|Overall Study|Physician Decision|10|||
164069712|NCT01215955|592617370|FG002|Overall Study|Physician Decision|8|||
164069713|NCT01215955|592617371|FG003|Overall Study|Physician Decision|11|||
164069714|NCT01215955|592617368|FG000|Overall Study|Protocol Violation|17|||
164069715|NCT01215955|592617369|FG001|Overall Study|Protocol Violation|13|||
164069716|NCT01215955|592617370|FG002|Overall Study|Protocol Violation|8|||
164069717|NCT01215955|592617371|FG003|Overall Study|Protocol Violation|8|||
164069718|NCT01215955|592617368|FG000|Overall Study|Sponsor Decision|1|||
164069719|NCT01215955|592617369|FG001|Overall Study|Sponsor Decision|2|||
164069720|NCT01215955|592617370|FG002|Overall Study|Sponsor Decision|0|||
164069721|NCT01215955|592617371|FG003|Overall Study|Sponsor Decision|1|||
164069722|NCT01215955|592617368|FG000|Overall Study|Withdrawal by Subject|14|||
164069723|NCT01215955|592617369|FG001|Overall Study|Withdrawal by Subject|15|||
164069724|NCT01215955|592617370|FG002|Overall Study|Withdrawal by Subject|13|||
164069725|NCT01215955|592617371|FG003|Overall Study|Withdrawal by Subject|9|||
164069726|NCT01215955|592617368|FG000|Overall Study|Quality Issues|0|||
164069727|NCT01215955|592617369|FG001|Overall Study|Quality Issues|0|||
164069728|NCT01215955|592617370|FG002|Overall Study|Quality Issues|3|||
164069729|NCT01215955|592617371|FG003|Overall Study|Quality Issues|2|||
164069730|NCT05013749|592617372|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
164069731|NCT05013749|592617373|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
164069732|NCT05013749|592617372|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
164069733|NCT05013749|592617373|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
164069734|NCT02858076|592617374|FG000|Overall Study|Death|6|||
164069735|NCT02858076|592617375|FG001|Overall Study|Death|3|||
164069736|NCT02858076|592617374|FG000|Overall Study|Withdrawal by Subject|1|||
164069737|NCT02858076|592617375|FG001|Overall Study|Withdrawal by Subject|5|||
164069738|NCT02858076|592617374|FG000|Overall Study|Lost to Follow-up|2|||
164069739|NCT02858076|592617375|FG001|Overall Study|Lost to Follow-up|7|||
164069740|NCT02858076|592617374|FG000|Overall Study|Completed Out of Window|1|||
164069741|NCT02858076|592617375|FG001|Overall Study|Completed Out of Window|3|||
164069742|NCT02643394|592617376|FG000|Overall Study|Protocol Violation|4|||
164069743|NCT02643394|592617377|FG001|Overall Study|Protocol Violation|5|||
164069744|NCT00943384|592617378|FG000|Overall Study|Dispositioned prior to treatment|23|||
164069745|NCT00943384|592617378|FG000|Overall Study|Treated off protocol-protocol violation|5|||
164069746|NCT00943384|592617378|FG000|Overall Study|Lost to Follow-up|16|||
164069747|NCT00943384|592617378|FG000|Overall Study|Withdrawal by Subject|5|||
164069748|NCT00096200|592617379|FG000|Overall Study|Adverse Event|0|||
164069749|NCT00096200|592617380|FG001|Overall Study|Adverse Event|4|||
164069750|NCT00096200|592617381|FG002|Overall Study|Adverse Event|0|||
164069751|NCT00096200|592617379|FG000|Overall Study|Withdrawal by Subject|1|||
164069752|NCT00096200|592617380|FG001|Overall Study|Withdrawal by Subject|2|||
164069753|NCT00096200|592617381|FG002|Overall Study|Withdrawal by Subject|0|||
164069754|NCT00096200|592617379|FG000|Overall Study|Ineligible pathology|0|||
164069755|NCT00096200|592617380|FG001|Overall Study|Ineligible pathology|1|||
164069756|NCT00096200|592617381|FG002|Overall Study|Ineligible pathology|0|||
164069757|NCT03014570|592617389|FG000|Overall Study|COVID-19 Restrictions|38|||
164069758|NCT03014570|592617390|FG001|Overall Study|COVID-19 Restrictions|24|||
164069759|NCT03014570|592617389|FG000|Overall Study|Death|70|||
164069760|NCT03014570|592617390|FG001|Overall Study|Death|79|||
164069761|NCT03014570|592617389|FG000|Overall Study|Transfer from facility|11|||
164069762|NCT03014570|592617390|FG001|Overall Study|Transfer from facility|14|||
164069763|NCT03014570|592617389|FG000|Overall Study|Hospitalized|5|||
164069764|NCT03014570|592617390|FG001|Overall Study|Hospitalized|3|||
164069765|NCT03014570|592617389|FG000|Overall Study|Transfer within facility|1|||
164069766|NCT03014570|592617390|FG001|Overall Study|Transfer within facility|0|||
164069767|NCT03014570|592617389|FG000|Overall Study|Site refusal|0|||
164069768|NCT03014570|592617390|FG001|Overall Study|Site refusal|11|||
164069769|NCT01154673|592617391|FG000|Overall Study|Lost to Follow-up|1|||
164069770|NCT01154673|592617392|FG001|Overall Study|Lost to Follow-up|0|||
164069771|NCT01154673|592617391|FG000|Overall Study|moved out of province|1|||
164069772|NCT01154673|592617392|FG001|Overall Study|moved out of province|0|||
164069773|NCT01216319|592617396|FG000|Overall Study|Lost to Follow-up|2|||
164069774|NCT01216319|592617396|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
164069775|NCT02666768|592617399|FG000|Overall Study|Withdrawal by Subject|4|||
164069776|NCT03151226|592617400|FG000|Overall Study|Withdrawal by Subject|2|||
164069777|NCT03151226|592617400|FG000|Overall Study|not wear device correctly|1|||
164069778|NCT00903409|592617401|FG000|Overall Study|Adverse Event|11|||
164069779|NCT00903409|592617402|FG001|Overall Study|Adverse Event|9|||
164069780|NCT00903409|592617401|FG000|Overall Study|Non-compliance with Protocol|1|||
164069781|NCT00903409|592617402|FG001|Overall Study|Non-compliance with Protocol|1|||
164069782|NCT00903409|592617401|FG000|Overall Study|Laboratory Abnormality|2|||
164069783|NCT00903409|592617402|FG001|Overall Study|Laboratory Abnormality|0|||
164069784|NCT00903409|592617401|FG000|Overall Study|Withdrawal by Subject|8|||
164069785|NCT00903409|592617402|FG001|Overall Study|Withdrawal by Subject|8|||
164069786|NCT00903409|592617401|FG000|Overall Study|Other|2|||
164069787|NCT00903409|592617402|FG001|Overall Study|Other|3|||
164069788|NCT00903409|592617401|FG000|Overall Study|Lost to Follow-up|2|||
164069789|NCT00903409|592617402|FG001|Overall Study|Lost to Follow-up|6|||
164069790|NCT03239340|592617403|FG000|Overall Study|Other|26|||
164069791|NCT03239340|592617403|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
164069792|NCT03239340|592617403|FG000|Overall Study|Death|40|||
164069793|NCT03239340|592617403|FG000|Overall Study|Lost to Follow-up|2|||
164069794|NCT03239340|592617403|FG000|Overall Study|Physician Decision|16|||
164069795|NCT03239340|592617403|FG000|Overall Study|Withdrawal by Subject|27|||
164069796|NCT03539952|592617405|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
164069797|NCT03539952|592617406|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
164069798|NCT03539952|592617405|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
164069799|NCT03539952|592617406|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
164069800|NCT03539952|592617405|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
164069801|NCT03539952|592617406|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
164069802|NCT03539952|592617405|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
164069803|NCT03539952|592617406|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
164069804|NCT03539952|592617405|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
164069805|NCT03539952|592617406|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
164069806|NCT03539952|592617405|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
164069807|NCT03539952|592617406|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
164069808|NCT03539952|592617405|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
164069809|NCT03539952|592617406|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
164069810|NCT02184988|592617407|FG000|Overall Study|Pregnancy|2|||
164069811|NCT02184988|592617407|FG000|Overall Study|Adverse Event|2|||
164069812|NCT02184988|592617407|FG000|Overall Study|moving away/travelling/unable to complet|6|||
164069813|NCT02184988|592617407|FG000|Overall Study|work scheduling issues|4|||
164069814|NCT02184988|592617407|FG000|Overall Study|various other reasons|9|||
164069815|NCT02184988|592617407|FG000|Overall Study|Lost to Follow-up|32|||
164069816|NCT00777920|592617408|FG000|Overall Study|Adverse Event|39|||
164069817|NCT00777920|592617408|FG000|Overall Study|Withdrawal of Consent|4|||
164069818|NCT00777920|592617408|FG000|Overall Study|Lost to Follow-up|1|||
164069819|NCT00777920|592617408|FG000|Overall Study|Investigator's discretion|1|||
164069820|NCT00777920|592617408|FG000|Overall Study|Clinical status did not improve|1|||
164069821|NCT00777920|592617408|FG000|Overall Study|Other, not specified|4|||
164069822|NCT02332655|592617409|FG000|Overall Study|Lack of Efficacy|1|||
164069823|NCT01977482|592617410|FG000|Overall Study|Adverse Event|0|||
164069824|NCT01977482|592617411|FG001|Overall Study|Adverse Event|1|||
164069825|NCT01977482|592617412|FG002|Overall Study|Adverse Event|1|||
164069826|NCT01977482|592617413|FG003|Overall Study|Adverse Event|0|||
164069827|NCT01977482|592617414|FG004|Overall Study|Adverse Event|2|||
164069828|NCT01977482|592617415|FG005|Overall Study|Adverse Event|0|||
164069829|NCT01977482|592617410|FG000|Overall Study|Lost to Follow-up|1|||
164069830|NCT01977482|592617411|FG001|Overall Study|Lost to Follow-up|0|||
164069831|NCT01977482|592617412|FG002|Overall Study|Lost to Follow-up|0|||
164069832|NCT01977482|592617413|FG003|Overall Study|Lost to Follow-up|0|||
164069833|NCT01977482|592617414|FG004|Overall Study|Lost to Follow-up|0|||
164069834|NCT01977482|592617415|FG005|Overall Study|Lost to Follow-up|0|||
164069835|NCT01977482|592617410|FG000|Overall Study|Physician Decision|0|||
164069836|NCT01977482|592617411|FG001|Overall Study|Physician Decision|1|||
164069837|NCT01977482|592617412|FG002|Overall Study|Physician Decision|0|||
164069838|NCT01977482|592617413|FG003|Overall Study|Physician Decision|0|||
164069839|NCT01977482|592617414|FG004|Overall Study|Physician Decision|0|||
164069840|NCT01977482|592617415|FG005|Overall Study|Physician Decision|0|||
164069841|NCT01977482|592617410|FG000|Overall Study|Protocol Violation|0|||
164069842|NCT01977482|592617411|FG001|Overall Study|Protocol Violation|0|||
164069843|NCT01977482|592617412|FG002|Overall Study|Protocol Violation|1|||
164069844|NCT01977482|592617413|FG003|Overall Study|Protocol Violation|0|||
164069845|NCT01977482|592617414|FG004|Overall Study|Protocol Violation|0|||
164069846|NCT01977482|592617415|FG005|Overall Study|Protocol Violation|0|||
164069847|NCT01977482|592617410|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
164069848|NCT01977482|592617411|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
164069849|NCT01977482|592617412|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
164069850|NCT01977482|592617413|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
164069851|NCT01977482|592617414|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
164069852|NCT01977482|592617415|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
164069853|NCT01977482|592617410|FG000|Overall Study|Withdrawal by Subject|2|||
164148728|NCT03207867|592904957|FG021|Overall Study|Physician Decision|0|||
164069854|NCT01977482|592617411|FG001|Overall Study|Withdrawal by Subject|4|||
164069855|NCT01977482|592617412|FG002|Overall Study|Withdrawal by Subject|1|||
164069856|NCT01977482|592617413|FG003|Overall Study|Withdrawal by Subject|3|||
164069857|NCT01977482|592617414|FG004|Overall Study|Withdrawal by Subject|1|||
164069858|NCT01977482|592617415|FG005|Overall Study|Withdrawal by Subject|5|||
164069859|NCT01964898|592618646|FG000|Overall Study|ineligible post-randomization|1|||
164069860|NCT01964898|592618647|FG001|Overall Study|ineligible post-randomization|1|||
164069861|NCT01964898|592618646|FG000|Overall Study|did not receive the allocated interventi|2|||
164069862|NCT01964898|592618647|FG001|Overall Study|did not receive the allocated interventi|1|||
164069863|NCT01964898|592618646|FG000|Overall Study|Lost to Follow-up|3|||
164069864|NCT01964898|592618647|FG001|Overall Study|Lost to Follow-up|5|||
164069865|NCT01964898|592618646|FG000|Overall Study|Withdrawal by Subject|1|||
164069866|NCT01964898|592618647|FG001|Overall Study|Withdrawal by Subject|0|||
164069867|NCT02428231|592618650|FG000|Overall Study|Other|10|||
164069868|NCT02428231|592618651|FG001|Overall Study|Other|16|||
164069869|NCT02428231|592618650|FG000|Overall Study|Required Symptomatic Therapy|0|||
164069870|NCT02428231|592618651|FG001|Overall Study|Required Symptomatic Therapy|1|||
164105919|NCT02321098|592750469|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
164105920|NCT02321098|592750470|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
164105921|NCT02321098|592750471|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
164105922|NCT02321098|592750469|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
164105923|NCT02321098|592750470|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
164105924|NCT02321098|592750471|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
164105925|NCT02321098|592750469|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
164069871|NCT02428231|592618650|FG000|Overall Study|Adverse Event|3|||
164069872|NCT02428231|592618651|FG001|Overall Study|Adverse Event|0|||
164069873|NCT02957682|592618654|FG000|Overall Study|Adverse Event|64|||
164069874|NCT02957682|592618655|FG001|Overall Study|Adverse Event|67|||
164069875|NCT02957682|592618654|FG000|Overall Study|Poor Compliance to Protocol|30|||
164069876|NCT02957682|592618655|FG001|Overall Study|Poor Compliance to Protocol|26|||
164069877|NCT02957682|592618654|FG000|Overall Study|Physician Decision|4|||
164069878|NCT02957682|592618655|FG001|Overall Study|Physician Decision|4|||
164069879|NCT02957682|592618654|FG000|Overall Study|Study Terminated by Sponsor|4|||
164069880|NCT02957682|592618655|FG001|Overall Study|Study Terminated by Sponsor|3|||
164069881|NCT02957682|592618654|FG000|Overall Study|Subject Moved|10|||
164069882|NCT02957682|592618655|FG001|Overall Study|Subject Moved|16|||
164069883|NCT02957682|592618654|FG000|Overall Study|Withdrawal by Subject|64|||
164069884|NCT02957682|592618655|FG001|Overall Study|Withdrawal by Subject|33|||
164069885|NCT02957682|592618654|FG000|Overall Study|Related to IMP Administration|3|||
164069886|NCT02957682|592618655|FG001|Overall Study|Related to IMP Administration|6|||
164069887|NCT02957682|592618654|FG000|Overall Study|Non-disclosed|16|||
164069888|NCT02957682|592618655|FG001|Overall Study|Non-disclosed|12|||
164069889|NCT02957682|592618654|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
164069890|NCT02957682|592618655|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
164069891|NCT02953262|592618656|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
164069892|NCT02953262|592618657|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
164069893|NCT02953262|592618658|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
164069894|NCT02953262|592618659|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
164069895|NCT03284424|592618660|FG000|Overall Study|Death|70|||
164069896|NCT03284424|592618661|FG001|Overall Study|Death|24|||
164069897|NCT03284424|592618660|FG000|Overall Study|Lost to Follow-up|3|||
164069898|NCT03284424|592618661|FG001|Overall Study|Lost to Follow-up|1|||
164069899|NCT03284424|592618660|FG000|Overall Study|Physician Decision|1|||
164069900|NCT03284424|592618661|FG001|Overall Study|Physician Decision|2|||
164069901|NCT03284424|592618660|FG000|Overall Study|Withdrawal by Subject|4|||
164069902|NCT03284424|592618661|FG001|Overall Study|Withdrawal by Subject|5|||
164069903|NCT03284424|592618660|FG000|Overall Study|Sponsor's decision|27|||
164069904|NCT03284424|592618661|FG001|Overall Study|Sponsor's decision|22|||
164069905|NCT00765999|592618662|FG000|Overall Study|Adverse Event|203|||
164069906|NCT00765999|592618662|FG000|Overall Study|Insufficient Therapeutic Response|100|||
164069907|NCT00765999|592618662|FG000|Overall Study|Protocol Violation|95|||
164105926|NCT02321098|592750470|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
164105927|NCT02321098|592750471|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
164105928|NCT03261167|592750476|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
164148729|NCT03207867|592904958|FG022|Overall Study|Physician Decision|0|||
164069908|NCT00765999|592618662|FG000|Overall Study|Consent Withdrawn|202|||
164069909|NCT00765999|592618662|FG000|Overall Study|Lost to Follow-up|131|||
164069910|NCT00765999|592618662|FG000|Overall Study|Study Terminated by Sponsor|2|||
164069911|NCT00765999|592618662|FG000|Overall Study|Other Miscellaneous Reasons|51|||
164069912|NCT00203892|592618664|FG000|Overall Study|Physician Decision|1|||
164069913|NCT00203892|592618665|FG001|Overall Study|Physician Decision|2|||
164069914|NCT00203892|592618666|FG002|Overall Study|Physician Decision|0|||
164069915|NCT00203892|592618664|FG000|Overall Study|Death|1|||
164069916|NCT00203892|592618665|FG001|Overall Study|Death|0|||
164069917|NCT00203892|592618666|FG002|Overall Study|Death|0|||
164069918|NCT03829462|592618670|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
164069919|NCT03829462|592618671|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
164069920|NCT03829462|592618670|FG000|Overall Study|No treatment due to progression disease|0|||
164069921|NCT03829462|592618671|FG001|Overall Study|No treatment due to progression disease|1|||
164069922|NCT02341482|592618672|FG000|Overall Study|Adverse Event|1|||
164069923|NCT03000075|592618676|FG000|Part A|Adverse Event|4|||
164069924|NCT03000075|592618677|FG001|Part A|Adverse Event|0|||
164069925|NCT03000075|592618678|FG002|Part A|Adverse Event|0|||
164069926|NCT03000075|592618679|FG003|Part A|Adverse Event|0|||
164069927|NCT03000075|592618680|FG004|Part A|Adverse Event|0|||
164069928|NCT03000075|592618681|FG005|Part A|Adverse Event|0|||
164069929|NCT03000075|592618682|FG006|Part A|Adverse Event|0|||
164069930|NCT03000075|592618676|FG000|Part B|Not dosed due to AE|0|||
164069931|NCT03000075|592618677|FG001|Part B|Not dosed due to AE|0|||
164069932|NCT03000075|592618678|FG002|Part B|Not dosed due to AE|0|||
164069933|NCT03000075|592618679|FG003|Part B|Not dosed due to AE|0|||
164069934|NCT03000075|592618680|FG004|Part B|Not dosed due to AE|0|||
164069935|NCT03000075|592618681|FG005|Part B|Not dosed due to AE|2|||
164069936|NCT03000075|592618682|FG006|Part B|Not dosed due to AE|1|||
164069937|NCT03000075|592618676|FG000|Part B|Adverse Event|0|||
164069938|NCT03000075|592618677|FG001|Part B|Adverse Event|0|||
164069939|NCT03000075|592618678|FG002|Part B|Adverse Event|0|||
164069940|NCT03000075|592618679|FG003|Part B|Adverse Event|0|||
164069941|NCT03000075|592618680|FG004|Part B|Adverse Event|1|||
164069942|NCT03000075|592618681|FG005|Part B|Adverse Event|0|||
164069943|NCT03000075|592618682|FG006|Part B|Adverse Event|0|||
164069944|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
164069945|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
164069946|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Death|5|||
164069947|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Death|2|||
164069948|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
164069949|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
164069950|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
164069951|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
164069952|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
164069953|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
164069954|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Relapse|1|||
164069955|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Relapse|0|||
164069956|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
164069957|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
164069958|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
164069959|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
164069960|NCT00111007|592618683|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
164069961|NCT00111007|592618684|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
164069962|NCT00111007|592618683|FG000|Active Follow-up|Adverse Event|1|||
164069963|NCT00111007|592618684|FG001|Active Follow-up|Adverse Event|0|||
164069964|NCT00111007|592618683|FG000|Active Follow-up|Death|2|||
164069965|NCT00111007|592618684|FG001|Active Follow-up|Death|0|||
164069966|NCT00111007|592618683|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
164069967|NCT00111007|592618684|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
164069968|NCT00111007|592618683|FG000|Long Term Follow-up|Death|34|||
164069969|NCT00111007|592618684|FG001|Long Term Follow-up|Death|39|||
164069970|NCT00111007|592618683|FG000|Long Term Follow-up|Lost to Follow-up|1|||
164069971|NCT00111007|592618684|FG001|Long Term Follow-up|Lost to Follow-up|1|||
164069972|NCT00111007|592618683|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
164069973|NCT00111007|592618684|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
164069974|NCT00111007|592618683|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
164069975|NCT00111007|592618684|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
164069976|NCT00111007|592618683|FG000|Long Term Follow-up|Missing|10|||
164069977|NCT00111007|592618684|FG001|Long Term Follow-up|Missing|3|||
164069978|NCT01495793|592618685|FG000|Overall Study|Lost to Follow-up|1|||
164069979|NCT01495793|592618685|FG000|Overall Study|Violation of inclusion criteria|1|||
164069980|NCT03332212|592618686|FG000|Overall Study|Not treated|0|||
164069981|NCT03332212|592618687|FG001|Overall Study|Not treated|1|||
164069982|NCT03332212|592618688|FG002|Overall Study|Not treated|0|||
164069983|NCT03332212|592618689|FG003|Overall Study|Not treated|0|||
164069984|NCT03332212|592618686|FG000|Overall Study|Adverse Event|0|||
164069985|NCT03332212|592618687|FG001|Overall Study|Adverse Event|0|||
164069986|NCT03332212|592618688|FG002|Overall Study|Adverse Event|0|||
164069987|NCT03332212|592618689|FG003|Overall Study|Adverse Event|1|||
164069988|NCT03332212|592618686|FG000|Overall Study|worsening of disease under study|1|||
164069989|NCT03332212|592618687|FG001|Overall Study|worsening of disease under study|1|||
164069990|NCT03332212|592618688|FG002|Overall Study|worsening of disease under study|0|||
164069991|NCT03332212|592618689|FG003|Overall Study|worsening of disease under study|0|||
164069992|NCT02362646|592618690|FG000|Overall Study|Death|15|||
164069993|NCT02362646|592618691|FG001|Overall Study|Death|8|||
164069994|NCT02362646|592618690|FG000|Overall Study|Withdrawal by Subject|2|||
164069995|NCT02362646|592618691|FG001|Overall Study|Withdrawal by Subject|2|||
164069996|NCT02362646|592618690|FG000|Overall Study|received transplant|21|||
164069997|NCT02362646|592618691|FG001|Overall Study|received transplant|14|||
164069998|NCT00929864|592618695|FG000|Overall Study|Death|1|||
164069999|NCT00929864|592618696|FG001|Overall Study|Death|1|||
164070000|NCT00929864|592618695|FG000|Overall Study|Adverse Event|11|||
164070001|NCT00929864|592618696|FG001|Overall Study|Adverse Event|30|||
164070002|NCT00929864|592618695|FG000|Overall Study|Lack of Efficacy|19|||
164070003|NCT00929864|592618696|FG001|Overall Study|Lack of Efficacy|16|||
164070004|NCT00929864|592618695|FG000|Overall Study|Lost to Follow-up|7|||
164070005|NCT00929864|592618696|FG001|Overall Study|Lost to Follow-up|12|||
164070006|NCT00929864|592618695|FG000|Overall Study|Withdrawal by Subject|20|||
164070007|NCT00929864|592618696|FG001|Overall Study|Withdrawal by Subject|9|||
164070008|NCT00929864|592618695|FG000|Overall Study|No longer met criteria|2|||
164070009|NCT00929864|592618696|FG001|Overall Study|No longer met criteria|1|||
164070010|NCT00929864|592618695|FG000|Overall Study|Poor or non-compliance|3|||
164070011|NCT00929864|592618696|FG001|Overall Study|Poor or non-compliance|3|||
164070012|NCT00929864|592618695|FG000|Overall Study|Pregnancy|0|||
164070013|NCT00929864|592618696|FG001|Overall Study|Pregnancy|3|||
164070014|NCT00929864|592618695|FG000|Overall Study|Administrative reason by Sponsor|1|||
164070015|NCT00929864|592618696|FG001|Overall Study|Administrative reason by Sponsor|1|||
164070016|NCT00929864|592618695|FG000|Overall Study|Non-specified|2|||
164070017|NCT00929864|592618696|FG001|Overall Study|Non-specified|7|||
164070018|NCT03728257|592618697|FG000|Overall Study|Death|3|||
164070019|NCT03728257|592618698|FG001|Overall Study|Death|0|||
164070020|NCT03940742|592618699|FG000|Overall Study|Lost to Follow-up|0|||
164070021|NCT03940742|592618700|FG001|Overall Study|Lost to Follow-up|0|||
164070022|NCT03940742|592618701|FG002|Overall Study|Lost to Follow-up|0|||
164070023|NCT03940742|592618702|FG003|Overall Study|Lost to Follow-up|1|||
164070024|NCT03428217|592618704|FG000|Overall Study|Death|89|||
164070025|NCT03428217|592618705|FG001|Overall Study|Death|93|||
164070026|NCT03428217|592618704|FG000|Overall Study|Withdrawal by Subject|8|||
164070027|NCT03428217|592618705|FG001|Overall Study|Withdrawal by Subject|7|||
164070028|NCT03428217|592618704|FG000|Overall Study|Lost to Follow-up|1|||
164070029|NCT03428217|592618705|FG001|Overall Study|Lost to Follow-up|3|||
164070030|NCT03428217|592618704|FG000|Overall Study|Study terminated by sponsor|124|||
164070031|NCT03428217|592618705|FG001|Overall Study|Study terminated by sponsor|118|||
164070032|NCT03428217|592618704|FG000|Overall Study|Other, Not Specified|1|||
164070033|NCT03428217|592618705|FG001|Overall Study|Other, Not Specified|0|||
164070034|NCT00621309|592618706|FG000|Overall Study|Withdrawal by Subject|2|||
164070035|NCT00621309|592618707|FG001|Overall Study|Withdrawal by Subject|0|||
164070036|NCT00621309|592618708|FG002|Overall Study|Withdrawal by Subject|1|||
164070037|NCT00621309|592618709|FG003|Overall Study|Withdrawal by Subject|1|||
164070038|NCT00621309|592618710|FG004|Overall Study|Withdrawal by Subject|1|||
164070039|NCT00621309|592618711|FG005|Overall Study|Withdrawal by Subject|1|||
164070040|NCT00905437|592618712|FG000|Overall Study|Adverse Event|3|||
164070041|NCT00905437|592618713|FG001|Overall Study|Adverse Event|2|||
164070042|NCT00905437|592618712|FG000|Overall Study|Lost to Follow-up|0|||
164070043|NCT00905437|592618713|FG001|Overall Study|Lost to Follow-up|1|||
164070044|NCT00905437|592618712|FG000|Overall Study|Withdrawal by Subject|0|||
164070045|NCT00905437|592618713|FG001|Overall Study|Withdrawal by Subject|1|||
164105929|NCT03261167|592750477|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
164105930|NCT03261167|592750476|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
164105931|NCT03261167|592750477|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
164105932|NCT03261167|592750476|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
164105933|NCT03261167|592750477|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
164105934|NCT03261167|592750476|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
164105935|NCT03261167|592750477|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
164105936|NCT03261167|592750476|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
164105937|NCT03261167|592750477|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
164105938|NCT03199963|592750483|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
164070046|NCT00905437|592618712|FG000|Overall Study|Other|5|||
164105939|NCT03199963|592750484|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
164105940|NCT03199963|592750483|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
164105941|NCT03199963|592750484|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
164105942|NCT03199963|592750483|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
164105943|NCT03199963|592750484|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
164070047|NCT00905437|592618713|FG001|Overall Study|Other|6|||
164070048|NCT05246111|592618714|FG000|Period 01|NOT ELIGIBLE IC5|1|||
164070049|NCT05246111|592618715|FG001|Period 01|NOT ELIGIBLE IC5|0|||
164070050|NCT01306968|592618718|FG000|Overall Study|Lost to Follow-up|1|||
164070051|NCT01306968|592618719|FG001|Overall Study|Lost to Follow-up|1|||
164070052|NCT01306968|592618720|FG002|Overall Study|Lost to Follow-up|0|||
164070053|NCT01306968|592618721|FG003|Overall Study|Lost to Follow-up|0|||
164070054|NCT01306968|592618718|FG000|Overall Study|Physician Decision|0|||
164070055|NCT01306968|592618719|FG001|Overall Study|Physician Decision|1|||
164070056|NCT01306968|592618720|FG002|Overall Study|Physician Decision|0|||
164070057|NCT01306968|592618721|FG003|Overall Study|Physician Decision|0|||
164070058|NCT01306968|592618718|FG000|Overall Study|Relocated and left active duty|0|||
164070059|NCT01306968|592618719|FG001|Overall Study|Relocated and left active duty|1|||
164070060|NCT01306968|592618720|FG002|Overall Study|Relocated and left active duty|1|||
164070061|NCT01306968|592618721|FG003|Overall Study|Relocated and left active duty|1|||
164070062|NCT01306968|592618718|FG000|Overall Study|Withdrew - time commitment|0|||
164070063|NCT01306968|592618719|FG001|Overall Study|Withdrew - time commitment|0|||
164070064|NCT01306968|592618720|FG002|Overall Study|Withdrew - time commitment|0|||
164070065|NCT01306968|592618721|FG003|Overall Study|Withdrew - time commitment|2|||
164070066|NCT01306968|592618718|FG000|Overall Study|Withdrew over privacy concerns|0|||
164070067|NCT01306968|592618719|FG001|Overall Study|Withdrew over privacy concerns|0|||
164070068|NCT01306968|592618720|FG002|Overall Study|Withdrew over privacy concerns|0|||
164070069|NCT01306968|592618721|FG003|Overall Study|Withdrew over privacy concerns|1|||
164070070|NCT02736695|592618722|FG000|Overall Study|Ineligible|6|||
164070071|NCT02736695|592618723|FG001|Overall Study|Ineligible|0|||
164070072|NCT01329562|592618726|FG000|Overall Study|Protocol Violation|5|||
164070073|NCT01329562|592618727|FG001|Overall Study|Protocol Violation|3|||
164070074|NCT01329562|592618726|FG000|Overall Study|Lost to Follow-up|1|||
164070075|NCT01329562|592618727|FG001|Overall Study|Lost to Follow-up|1|||
164070076|NCT01329562|592618726|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
164070077|NCT01329562|592618727|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
164070078|NCT01329562|592618726|FG000|Overall Study|Physician Decision|0|||
164070079|NCT01329562|592618727|FG001|Overall Study|Physician Decision|1|||
164070080|NCT03252015|592618728|FG000|Overall Study|Withdrawal by Subject|0|||
164070081|NCT03252015|592618729|FG001|Overall Study|Withdrawal by Subject|1|||
164070082|NCT03252015|592618730|FG002|Overall Study|Withdrawal by Subject|1|||
164070083|NCT03252015|592618731|FG003|Overall Study|Withdrawal by Subject|0|||
164070084|NCT03252015|592618728|FG000|Overall Study|Adverse Event|1|||
164070085|NCT03252015|592618729|FG001|Overall Study|Adverse Event|0|||
164070086|NCT03252015|592618730|FG002|Overall Study|Adverse Event|0|||
164070087|NCT03252015|592618731|FG003|Overall Study|Adverse Event|1|||
164070088|NCT04993339|592618732|FG000|Overall Study|Lost to Follow-up|0|||
164070089|NCT04993339|592618733|FG001|Overall Study|Lost to Follow-up|1|||
164070090|NCT04993339|592618732|FG000|Overall Study|no MRI scan|3|||
164070091|NCT04993339|592618733|FG001|Overall Study|no MRI scan|1|||
164070092|NCT00061568|592618734|FG000|Overall Study|Lost to Follow-up|12|||
164070093|NCT00061568|592618735|FG001|Overall Study|Lost to Follow-up|0|||
164070094|NCT00061568|592618734|FG000|Overall Study|Death|6|||
164070095|NCT00061568|592618735|FG001|Overall Study|Death|0|||
164070096|NCT00061568|592618734|FG000|Overall Study|Withdrawal by Subject|1|||
164070097|NCT00061568|592618735|FG001|Overall Study|Withdrawal by Subject|0|||
164070098|NCT01381068|592618736|FG000|Overall Study|Death|1|||
164070099|NCT01381068|592618737|FG001|Overall Study|Death|0|||
164070100|NCT00797316|592618738|FG000|Overall Study|Administrative problems|1|||
164070101|NCT00797316|592618739|FG001|Overall Study|Administrative problems|0|||
164070102|NCT00797316|592618738|FG000|Overall Study|Adverse Event|5|||
164070103|NCT00797316|592618739|FG001|Overall Study|Adverse Event|3|||
164070104|NCT00797316|592618738|FG000|Overall Study|Lost to Follow-up|4|||
164070105|NCT00797316|592618739|FG001|Overall Study|Lost to Follow-up|8|||
164070106|NCT00797316|592618738|FG000|Overall Study|Protocol Deviation|1|||
164070107|NCT00797316|592618739|FG001|Overall Study|Protocol Deviation|2|||
164070108|NCT00797316|592618738|FG000|Overall Study|Patient withdrew consent|12|||
164070109|NCT00797316|592618739|FG001|Overall Study|Patient withdrew consent|6|||
164070110|NCT00797316|592618738|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164070111|NCT00797316|592618739|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164070112|NCT00402779|592618742|FG000|Overall Study|Screen Failure|77|||
164070113|NCT00402779|592618743|FG001|Overall Study|Screen Failure|76|||
164070114|NCT01907516|592618748|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
164070115|NCT01907516|592618749|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
164070116|NCT01907516|592618748|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
164070117|NCT01907516|592618749|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
164070118|NCT01907516|592618748|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
164070119|NCT01907516|592618749|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
164070120|NCT01907516|592618748|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
164070121|NCT01907516|592618749|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
164070122|NCT03075215|592618753|FG000|12-Month Primary Endpoint|Death|152|||
164070123|NCT03075215|592618753|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
164070124|NCT03075215|592618753|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
164112676|NCT02372006|592774098|FG000|Overall Study|Dose limiting toxicity|0|||
164070125|NCT03075215|592618753|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
164070126|NCT00690573|592618762|FG000|Overall Study|Lack of Efficacy|8|||
164070127|NCT00690573|592618762|FG000|Overall Study|Withdrawal by Subject|1|||
164070128|NCT02146365|592618763|FG000|Overall Study|Lost to Follow-up|2|||
164070129|NCT02146365|592618764|FG001|Overall Study|Lost to Follow-up|1|||
164070130|NCT02146365|592618765|FG002|Overall Study|Lost to Follow-up|3|||
164070131|NCT02146365|592618766|FG003|Overall Study|Lost to Follow-up|3|||
164070132|NCT02146365|592618767|FG004|Overall Study|Lost to Follow-up|1|||
164070133|NCT02146365|592618768|FG005|Overall Study|Lost to Follow-up|1|||
164070134|NCT02146365|592618769|FG006|Overall Study|Lost to Follow-up|0|||
164070135|NCT02146365|592618770|FG007|Overall Study|Lost to Follow-up|1|||
164070136|NCT02146365|592618763|FG000|Overall Study|Withdrawal by Subject|1|||
164070137|NCT02146365|592618764|FG001|Overall Study|Withdrawal by Subject|2|||
164070138|NCT02146365|592618765|FG002|Overall Study|Withdrawal by Subject|1|||
164070139|NCT02146365|592618766|FG003|Overall Study|Withdrawal by Subject|5|||
164070140|NCT02146365|592618767|FG004|Overall Study|Withdrawal by Subject|1|||
164070141|NCT02146365|592618768|FG005|Overall Study|Withdrawal by Subject|0|||
164070142|NCT02146365|592618769|FG006|Overall Study|Withdrawal by Subject|0|||
164070143|NCT02146365|592618770|FG007|Overall Study|Withdrawal by Subject|0|||
164070144|NCT02146365|592618763|FG000|Overall Study|Unable to Comply with Protocol|0|||
164070145|NCT02146365|592618764|FG001|Overall Study|Unable to Comply with Protocol|1|||
164070146|NCT02146365|592618765|FG002|Overall Study|Unable to Comply with Protocol|1|||
164070147|NCT02146365|592618766|FG003|Overall Study|Unable to Comply with Protocol|0|||
164070148|NCT02146365|592618767|FG004|Overall Study|Unable to Comply with Protocol|0|||
164070149|NCT02146365|592618768|FG005|Overall Study|Unable to Comply with Protocol|0|||
164070150|NCT02146365|592618769|FG006|Overall Study|Unable to Comply with Protocol|0|||
164070151|NCT02146365|592618770|FG007|Overall Study|Unable to Comply with Protocol|0|||
164070152|NCT02146365|592618763|FG000|Overall Study|Other|1|||
164070153|NCT02146365|592618764|FG001|Overall Study|Other|0|||
164070154|NCT02146365|592618765|FG002|Overall Study|Other|2|||
164070155|NCT02146365|592618766|FG003|Overall Study|Other|1|||
164070156|NCT02146365|592618767|FG004|Overall Study|Other|0|||
164070157|NCT02146365|592618768|FG005|Overall Study|Other|0|||
164070158|NCT02146365|592618769|FG006|Overall Study|Other|0|||
164070159|NCT02146365|592618770|FG007|Overall Study|Other|0|||
164070160|NCT00975000|592618771|FG000|Overall Study|Other|1|||
164070161|NCT00975000|592618772|FG001|Overall Study|Other|0|||
164070162|NCT00975000|592618771|FG000|Overall Study|Adverse Event|1|||
164070163|NCT00975000|592618772|FG001|Overall Study|Adverse Event|1|||
164070164|NCT00975000|592618771|FG000|Overall Study|Withdrawal by Subject|2|||
164070165|NCT00975000|592618772|FG001|Overall Study|Withdrawal by Subject|2|||
164070166|NCT00975000|592618771|FG000|Overall Study|Lost to Follow-up|0|||
164070167|NCT00975000|592618772|FG001|Overall Study|Lost to Follow-up|1|||
164070168|NCT00975000|592618771|FG000|Overall Study|Protocol-specified Criteria|1|||
164070169|NCT00975000|592618772|FG001|Overall Study|Protocol-specified Criteria|0|||
164070170|NCT00975000|592618771|FG000|Overall Study|Non-compliance|0|||
164070171|NCT00975000|592618772|FG001|Overall Study|Non-compliance|1|||
164070172|NCT01126359|592618775|FG000|First Intervention (20-minutes)|Physician Decision|0|||
164070173|NCT01126359|592618776|FG001|First Intervention (20-minutes)|Physician Decision|1|||
164070174|NCT00526227|592618783|FG000|Overall Study|Device not implanted|1|||
164070175|NCT00526227|592618783|FG000|Overall Study|Death|1|||
164070176|NCT01525407|592618784|FG000|Overall Study|Change in recipient treatment plan|2|||
164070177|NCT01525407|592618785|FG001|Overall Study|Change in recipient treatment plan|2|||
164070178|NCT01525407|592618784|FG000|Overall Study|Withdrawal by Subject|0|||
164070179|NCT01525407|592618785|FG001|Overall Study|Withdrawal by Subject|1|||
164070180|NCT01525407|592618784|FG000|Overall Study|Transplant was delayed|0|||
164070181|NCT01525407|592618785|FG001|Overall Study|Transplant was delayed|1|||
164070182|NCT01525407|592618784|FG000|Overall Study|Delay in Transplant|1|||
164070183|NCT01525407|592618785|FG001|Overall Study|Delay in Transplant|0|||
164070184|NCT05257109|592618786|FG000|Overall Study|Withdrawal by Subject|1|||
164070185|NCT05257109|592618787|FG001|Overall Study|Withdrawal by Subject|0|||
164070186|NCT05257109|592618788|FG002|Overall Study|Withdrawal by Subject|0|||
164070187|NCT05257109|592618789|FG003|Overall Study|Withdrawal by Subject|0|||
164070188|NCT00858234|592620302|FG000|Overall Study|Adverse Event|6|||
164070189|NCT00858234|592620302|FG000|Overall Study|Progressive disease|2|||
164070190|NCT00858234|592620302|FG000|Overall Study|Status unknown|1|||
164070191|NCT01678924|592620303|FG000|Overall Study|Adverse Event|1|||
164070192|NCT01678924|592620304|FG001|Overall Study|Adverse Event|1|||
164070193|NCT01678924|592620305|FG002|Overall Study|Adverse Event|0|||
164070194|NCT01678924|592620306|FG003|Overall Study|Adverse Event|1|||
164070195|NCT01678924|592620303|FG000|Overall Study|Lack of Efficacy|7|||
164070196|NCT01678924|592620304|FG001|Overall Study|Lack of Efficacy|2|||
164070197|NCT01678924|592620305|FG002|Overall Study|Lack of Efficacy|0|||
164070198|NCT01678924|592620306|FG003|Overall Study|Lack of Efficacy|5|||
164070199|NCT01678924|592620303|FG000|Overall Study|Lost to Follow-up|0|||
164070200|NCT01678924|592620304|FG001|Overall Study|Lost to Follow-up|4|||
164070201|NCT01678924|592620305|FG002|Overall Study|Lost to Follow-up|0|||
164070202|NCT01678924|592620306|FG003|Overall Study|Lost to Follow-up|2|||
164070203|NCT01678924|592620303|FG000|Overall Study|Personal Reasons|2|||
164070204|NCT01678924|592620304|FG001|Overall Study|Personal Reasons|2|||
164070205|NCT01678924|592620305|FG002|Overall Study|Personal Reasons|2|||
164070206|NCT01678924|592620306|FG003|Overall Study|Personal Reasons|7|||
164070207|NCT01678924|592620303|FG000|Overall Study|Withdrawal by Subject|0|||
164070208|NCT01678924|592620304|FG001|Overall Study|Withdrawal by Subject|3|||
164070209|NCT01678924|592620305|FG002|Overall Study|Withdrawal by Subject|0|||
164070210|NCT01678924|592620306|FG003|Overall Study|Withdrawal by Subject|2|||
164070211|NCT01678924|592620303|FG000|Overall Study|Unable to attend scheduled visits|0|||
164070212|NCT01678924|592620304|FG001|Overall Study|Unable to attend scheduled visits|0|||
164070213|NCT01678924|592620305|FG002|Overall Study|Unable to attend scheduled visits|0|||
164070214|NCT01678924|592620306|FG003|Overall Study|Unable to attend scheduled visits|1|||
164070215|NCT02253654|592620307|FG000|Overall Study|Withdrawal by Subject|12|||
164070216|NCT02253654|592620308|FG001|Overall Study|Withdrawal by Subject|4|||
164070217|NCT02253654|592620307|FG000|Overall Study|Decision by Sponsor|1|||
164070218|NCT02253654|592620308|FG001|Overall Study|Decision by Sponsor|1|||
164070219|NCT02253654|592620307|FG000|Overall Study|Lost to Follow-up|2|||
164070220|NCT02253654|592620308|FG001|Overall Study|Lost to Follow-up|5|||
164070221|NCT02253654|592620307|FG000|Overall Study|Death|4|||
164070222|NCT02253654|592620308|FG001|Overall Study|Death|7|||
164070223|NCT02253654|592620307|FG000|Overall Study|Did Not Receive Study Treatment|4|||
164070224|NCT02253654|592620308|FG001|Overall Study|Did Not Receive Study Treatment|1|||
164070225|NCT01614925|592620309|FG000|Overall Study|Withdrawal by Subject|1|||
164070226|NCT01614925|592620310|FG001|Overall Study|Withdrawal by Subject|0|||
164070227|NCT01614925|592620309|FG000|Overall Study|Protocol Violation|3|||
164070228|NCT01614925|592620310|FG001|Overall Study|Protocol Violation|2|||
164070229|NCT01652573|592620319|FG000|Overall Study|Adverse Event|0|||
164070230|NCT01652573|592620320|FG001|Overall Study|Adverse Event|1|||
164070231|NCT01052038|592620321|FG000|Overall Study|Lost to Follow-up|2|||
164070232|NCT01052038|592620322|FG001|Overall Study|Lost to Follow-up|3|||
164070233|NCT01052038|592620323|FG002|Overall Study|Lost to Follow-up|1|||
164070234|NCT01052038|592620321|FG000|Overall Study|Protocol Violation|2|||
164070235|NCT01052038|592620322|FG001|Overall Study|Protocol Violation|3|||
164070236|NCT01052038|592620323|FG002|Overall Study|Protocol Violation|3|||
164070237|NCT03349437|592620324|FG000|Screening|Screen Fail|4|||
164070238|NCT03349437|592620325|FG001|Screening|Screen Fail|0|||
164070239|NCT03349437|592620326|FG002|Screening|Screen Fail|0|||
164070240|NCT03349437|592620324|FG000|Screening|Withdrawn|1|||
164070241|NCT03349437|592620325|FG001|Screening|Withdrawn|0|||
164070242|NCT03349437|592620326|FG002|Screening|Withdrawn|0|||
164070243|NCT05723835|592620331|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
164070244|NCT05723835|592620332|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
164070245|NCT05723835|592620333|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
164070246|NCT05723835|592620334|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
164070247|NCT05723835|592620335|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
164070248|NCT05723835|592620336|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
164070249|NCT05723835|592620337|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
164070250|NCT05723835|592620338|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
164070251|NCT05226286|592620339|FG000|Overall Study|Screen failures prior to implant|62|||
164070252|NCT05226286|592620339|FG000|Overall Study|Withdrawal by Subject|13|||
164070253|NCT05226286|592620339|FG000|Overall Study|Lost to Follow-up|3|||
164070254|NCT05226286|592620339|FG000|Overall Study|Physician Decision|1|||
164070255|NCT05226286|592620339|FG000|Overall Study|Adverse Event|1|||
164070256|NCT05226286|592620339|FG000|Overall Study|Death|1|||
164070257|NCT05226286|592620339|FG000|Overall Study|Device explant with no planned replacement|1|||
164070258|NCT05226286|592620339|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
164070259|NCT05226286|592620339|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
164070260|NCT00602641|592620340|FG000|Overall Study|Never started protocol therapy|6|||
164070261|NCT00602641|592620341|FG001|Overall Study|Never started protocol therapy|2|||
164070262|NCT00602641|592620340|FG000|Overall Study|Still on treatment at time of analysis|8|||
164070263|NCT00602641|592620341|FG001|Overall Study|Still on treatment at time of analysis|15|||
164070264|NCT00602641|592620340|FG000|Overall Study|Adverse Event|62|||
164070265|NCT00602641|592620341|FG001|Overall Study|Adverse Event|53|||
164070266|NCT00602641|592620340|FG000|Overall Study|Disease progression|38|||
164070267|NCT00602641|592620341|FG001|Overall Study|Disease progression|55|||
164070268|NCT00602641|592620340|FG000|Overall Study|Death|6|||
164070269|NCT00602641|592620341|FG001|Overall Study|Death|5|||
164070270|NCT00602641|592620340|FG000|Overall Study|Withdrawal by Subject|15|||
164070271|NCT00602641|592620341|FG001|Overall Study|Withdrawal by Subject|12|||
164070272|NCT00602641|592620340|FG000|Overall Study|Alternative therapy|5|||
164070273|NCT00602641|592620341|FG001|Overall Study|Alternative therapy|2|||
164070274|NCT00602641|592620340|FG000|Overall Study|Other Complicating Disease|5|||
164070275|NCT00602641|592620341|FG001|Overall Study|Other Complicating Disease|2|||
164070276|NCT00602641|592620340|FG000|Overall Study|Physician Decision|5|||
164070277|NCT00602641|592620341|FG001|Overall Study|Physician Decision|4|||
164070278|NCT00602641|592620340|FG000|Overall Study|Administrative Closure|1|||
164070279|NCT00602641|592620341|FG001|Overall Study|Administrative Closure|1|||
164070280|NCT00602641|592620340|FG000|Overall Study|Other|3|||
164070281|NCT00602641|592620341|FG001|Overall Study|Other|1|||
164070282|NCT03901339|592620342|FG000|Overall Study|Death|220|||
164070283|NCT03901339|592620343|FG001|Overall Study|Death|192|||
164070284|NCT03901339|592620342|FG000|Overall Study|Informed consent withdrawn|13|||
164070285|NCT03901339|592620343|FG001|Overall Study|Informed consent withdrawn|40|||
164070286|NCT03901339|592620342|FG000|Overall Study|Sponsor request|30|||
164070287|NCT03901339|592620343|FG001|Overall Study|Sponsor request|23|||
164070288|NCT03901339|592620342|FG000|Overall Study|Reason not specified|5|||
164070289|NCT03901339|592620343|FG001|Overall Study|Reason not specified|7|||
164070290|NCT03901339|592620342|FG000|Overall Study|Lost to Follow-up|4|||
164070291|NCT03901339|592620343|FG001|Overall Study|Lost to Follow-up|7|||
164070292|NCT03901339|592620342|FG000|Overall Study|Covid19|0|||
164070293|NCT03901339|592620343|FG001|Overall Study|Covid19|2|||
164070294|NCT01988337|592620346|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
164070295|NCT00457418|592620347|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
164070296|NCT00457418|592620347|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
164070297|NCT00457418|592620347|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
164070298|NCT00457418|592620347|FG000|Post PK Maintenance|Adverse Event|10|||
164070299|NCT00457418|592620347|FG000|Post PK Maintenance|Progression of Disease|6|||
164070300|NCT00457418|592620347|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
164070301|NCT00457418|592620347|FG000|Post PK Maintenance|Lost to Follow-up|1|||
164070302|NCT03387735|592620350|FG000|Overall Study|Lost to Follow-up|4|||
164070303|NCT03387735|592620351|FG001|Overall Study|Lost to Follow-up|8|||
164070304|NCT03387735|592620350|FG000|Overall Study|Death|4|||
164070305|NCT03387735|592620351|FG001|Overall Study|Death|8|||
164070306|NCT03099161|592620352|FG000|Overall Study|Adverse Event|0|||
164070307|NCT03099161|592620353|FG001|Overall Study|Adverse Event|0|||
164070308|NCT03099161|592620354|FG002|Overall Study|Adverse Event|2|||
164070309|NCT03099161|592620352|FG000|Overall Study|Physician Decision|2|||
164070310|NCT03099161|592620353|FG001|Overall Study|Physician Decision|0|||
164070311|NCT03099161|592620354|FG002|Overall Study|Physician Decision|0|||
164070312|NCT03099161|592620352|FG000|Overall Study|Progressive Disease|1|||
164070313|NCT03099161|592620353|FG001|Overall Study|Progressive Disease|4|||
164070314|NCT03099161|592620354|FG002|Overall Study|Progressive Disease|1|||
164070315|NCT00110084|592620357|FG000|Overall Study|Adverse Event|9|||
164070316|NCT00110084|592620357|FG000|Overall Study|Death|1|||
164070317|NCT00110084|592620357|FG000|Overall Study|Patient Refusal|10|||
164070318|NCT00110084|592620357|FG000|Overall Study|Alternate Therapy|5|||
164070319|NCT00110084|592620357|FG000|Overall Study|Intercurrent Illness|1|||
164070320|NCT00110084|592620357|FG000|Overall Study|Other|2|||
164070321|NCT04854707|592620359|FG000|Overall Study|Lack of Efficacy|78|||
164070322|NCT04854707|592620360|FG001|Overall Study|Lack of Efficacy|59|||
164070323|NCT04854707|592620361|FG002|Overall Study|Lack of Efficacy|30|||
164070324|NCT05302414|592620365|FG000|Pretest to Posttest|Lost to Follow-up|12|||
164070325|NCT05302414|592620366|FG001|Pretest to Posttest|Lost to Follow-up|8|||
164070326|NCT05302414|592620367|FG002|Pretest to Posttest|Lost to Follow-up|8|||
164070327|NCT05302414|592620365|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
164070328|NCT05302414|592620366|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
164070329|NCT05302414|592620367|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
164070330|NCT00742859|592620368|FG000|Overall Study|Adverse Event|5|||
164070331|NCT00742859|592620369|FG001|Overall Study|Adverse Event|6|||
164070332|NCT00742859|592620370|FG002|Overall Study|Adverse Event|3|||
164070333|NCT00742859|592620371|FG003|Overall Study|Adverse Event|1|||
164070334|NCT00742859|592620368|FG000|Overall Study|Death|1|||
164070335|NCT00742859|592620369|FG001|Overall Study|Death|0|||
164070336|NCT00742859|592620370|FG002|Overall Study|Death|0|||
164070337|NCT00742859|592620371|FG003|Overall Study|Death|1|||
164070338|NCT00742859|592620368|FG000|Overall Study|Physician Decision|1|||
164070339|NCT00742859|592620369|FG001|Overall Study|Physician Decision|2|||
164070340|NCT00742859|592620370|FG002|Overall Study|Physician Decision|0|||
164070341|NCT00742859|592620371|FG003|Overall Study|Physician Decision|0|||
164070342|NCT00742859|592620368|FG000|Overall Study|Withdrawal by Subject|4|||
164070343|NCT00742859|592620369|FG001|Overall Study|Withdrawal by Subject|2|||
164105944|NCT03199963|592750483|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
164070344|NCT00742859|592620370|FG002|Overall Study|Withdrawal by Subject|4|||
164070345|NCT00742859|592620371|FG003|Overall Study|Withdrawal by Subject|1|||
164070346|NCT00742859|592620368|FG000|Overall Study|Endpoint|0|||
164070347|NCT00742859|592620369|FG001|Overall Study|Endpoint|1|||
164070348|NCT00742859|592620370|FG002|Overall Study|Endpoint|1|||
164112677|NCT02372006|592774099|FG001|Overall Study|Dose limiting toxicity|1|||
164070349|NCT00742859|592620371|FG003|Overall Study|Endpoint|2|||
164070350|NCT00742859|592620368|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
164070351|NCT00742859|592620369|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
164070352|NCT00742859|592620370|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
164070353|NCT00742859|592620371|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
164070354|NCT00742859|592620368|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
164070355|NCT00742859|592620369|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
164070356|NCT00742859|592620370|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
164070357|NCT00742859|592620371|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
164070358|NCT00742859|592620368|FG000|Overall Study|Sponsor request patient out of town|0|||
164070359|NCT00742859|592620369|FG001|Overall Study|Sponsor request patient out of town|0|||
164070360|NCT00742859|592620370|FG002|Overall Study|Sponsor request patient out of town|1|||
164070361|NCT00742859|592620371|FG003|Overall Study|Sponsor request patient out of town|1|||
164070362|NCT00742859|592620368|FG000|Overall Study|Site error|0|||
164070363|NCT00742859|592620369|FG001|Overall Study|Site error|0|||
164070364|NCT00742859|592620370|FG002|Overall Study|Site error|1|||
164070365|NCT00742859|592620371|FG003|Overall Study|Site error|1|||
164070366|NCT01346501|592620375|FG000|Overall Study|Initiated Other Biological Agents|3|||
164070367|NCT01346501|592620376|FG001|Overall Study|Initiated Other Biological Agents|1|||
164070368|NCT01346501|592620375|FG000|Overall Study|Other|8|||
164070369|NCT01346501|592620376|FG001|Overall Study|Other|12|||
164070370|NCT02564952|592620379|FG000|Overall Study|Adverse Event|6|||
164070371|NCT02564952|592620379|FG000|Overall Study|Lost to Follow-up|1|||
164070372|NCT02564952|592620379|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
164070373|NCT02564952|592620379|FG000|Overall Study|Withdrawal by Subject|1|||
164070374|NCT02564952|592620379|FG000|Overall Study|Low Efficacy|1|||
164070375|NCT02564952|592620379|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164070376|NCT01071083|592620386|FG000|Overall Study|Adverse Event|1|||
164070377|NCT01071083|592620387|FG001|Overall Study|Adverse Event|0|||
164070378|NCT01071083|592620388|FG002|Overall Study|Adverse Event|1|||
164070379|NCT01071083|592620389|FG003|Overall Study|Adverse Event|0|||
164070380|NCT01071083|592620390|FG004|Overall Study|Adverse Event|1|||
164070381|NCT01071083|592620386|FG000|Overall Study|Withdrawal by Subject|3|||
164070382|NCT01071083|592620387|FG001|Overall Study|Withdrawal by Subject|0|||
164070383|NCT01071083|592620388|FG002|Overall Study|Withdrawal by Subject|2|||
164070384|NCT01071083|592620389|FG003|Overall Study|Withdrawal by Subject|0|||
164105945|NCT03199963|592750484|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
164105946|NCT03199963|592750483|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
164105947|NCT03199963|592750484|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
164105948|NCT03199963|592750483|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
164105949|NCT03199963|592750484|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
164105950|NCT03930732|592750485|FG000|Overall Study|Adverse Event|9|||
164105951|NCT03930732|592750486|FG001|Overall Study|Adverse Event|7|||
164105952|NCT03930732|592750485|FG000|Overall Study|Poor compliance to protocol|0|||
164105953|NCT03930732|592750486|FG001|Overall Study|Poor compliance to protocol|1|||
164105954|NCT03930732|592750485|FG000|Overall Study|Withdrawal by Subject|23|||
164070385|NCT01071083|592620390|FG004|Overall Study|Withdrawal by Subject|3|||
164070386|NCT01071083|592620386|FG000|Overall Study|Physician Decision|1|||
164070387|NCT01071083|592620387|FG001|Overall Study|Physician Decision|0|||
164070388|NCT01071083|592620388|FG002|Overall Study|Physician Decision|0|||
164070389|NCT01071083|592620389|FG003|Overall Study|Physician Decision|1|||
164070390|NCT01071083|592620390|FG004|Overall Study|Physician Decision|1|||
164070391|NCT01071083|592620386|FG000|Overall Study|Early Rescue|1|||
164070392|NCT01071083|592620387|FG001|Overall Study|Early Rescue|0|||
164070393|NCT01071083|592620388|FG002|Overall Study|Early Rescue|0|||
164070394|NCT01071083|592620389|FG003|Overall Study|Early Rescue|0|||
164070395|NCT01071083|592620390|FG004|Overall Study|Early Rescue|1|||
164070396|NCT01071083|592620386|FG000|Overall Study|Subject Moved|0|||
164105955|NCT03930732|592750486|FG001|Overall Study|Withdrawal by Subject|11|||
164105956|NCT03930732|592750485|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
164105957|NCT03930732|592750486|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
164105958|NCT03930732|592750485|FG000|Overall Study|Other reason not related to COVID-19|5|||
164105959|NCT03930732|592750486|FG001|Overall Study|Other reason not related to COVID-19|8|||
164105960|NCT00835692|592750490|FG000|First Intervention|Withdrawal by Subject|1|||
164070397|NCT01071083|592620387|FG001|Overall Study|Subject Moved|1|||
164070398|NCT01071083|592620388|FG002|Overall Study|Subject Moved|0|||
164070399|NCT01071083|592620389|FG003|Overall Study|Subject Moved|0|||
164070400|NCT01071083|592620390|FG004|Overall Study|Subject Moved|0|||
164070401|NCT01071083|592620386|FG000|Overall Study|Images Not Usable (Motion)|0|||
164070402|NCT01071083|592620387|FG001|Overall Study|Images Not Usable (Motion)|1|||
164070403|NCT01071083|592620388|FG002|Overall Study|Images Not Usable (Motion)|0|||
164070404|NCT01071083|592620389|FG003|Overall Study|Images Not Usable (Motion)|0|||
164070405|NCT01071083|592620390|FG004|Overall Study|Images Not Usable (Motion)|0|||
164070406|NCT01071083|592620386|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
164070407|NCT01071083|592620387|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
164070408|NCT01071083|592620388|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
164070409|NCT01071083|592620389|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
164105961|NCT00835692|592750491|FG001|First Intervention|Withdrawal by Subject|0|||
164070410|NCT01071083|592620390|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
164070411|NCT01071083|592620386|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
164070412|NCT01071083|592620387|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
164070413|NCT01071083|592620388|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
164070414|NCT01071083|592620389|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
164070415|NCT01071083|592620390|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
164070416|NCT01071083|592620386|FG000|Overall Study|Subject Refused to Continue|1|||
164070417|NCT01071083|592620387|FG001|Overall Study|Subject Refused to Continue|0|||
164070418|NCT01071083|592620388|FG002|Overall Study|Subject Refused to Continue|0|||
164070419|NCT01071083|592620389|FG003|Overall Study|Subject Refused to Continue|0|||
164070420|NCT01071083|592620390|FG004|Overall Study|Subject Refused to Continue|0|||
164070421|NCT00038467|592620391|FG000|Overall Study|Adverse Event|170|||
164070422|NCT00038467|592620392|FG001|Overall Study|Adverse Event|145|||
164070423|NCT00038467|592620391|FG000|Overall Study|Withdrawal by Subject|150|||
164070424|NCT00038467|592620392|FG001|Overall Study|Withdrawal by Subject|107|||
164070425|NCT00038467|592620391|FG000|Overall Study|Protocol Violation|19|||
164070426|NCT00038467|592620392|FG001|Overall Study|Protocol Violation|22|||
164070427|NCT00038467|592620391|FG000|Overall Study|Death|22|||
164070428|NCT00038467|592620392|FG001|Overall Study|Death|16|||
164070429|NCT00038467|592620391|FG000|Overall Study|Lost to Follow-up|15|||
164070430|NCT00038467|592620392|FG001|Overall Study|Lost to Follow-up|10|||
164070431|NCT00038467|592620391|FG000|Overall Study|Recurrence|109|||
164070432|NCT00038467|592620392|FG001|Overall Study|Recurrence|179|||
164070433|NCT00038467|592620391|FG000|Overall Study|Randomized, but not treated|31|||
164070434|NCT00038467|592620392|FG001|Overall Study|Randomized, but not treated|35|||
164070435|NCT00038467|592620391|FG000|Overall Study|Other|26|||
164070436|NCT00038467|592620392|FG001|Overall Study|Other|28|||
164070437|NCT03972709|592620393|FG000|Overall Study|Withdrawal by Subject|18|||
164070438|NCT03972709|592620394|FG001|Overall Study|Withdrawal by Subject|7|||
164070439|NCT03972709|592620395|FG002|Overall Study|Withdrawal by Subject|14|||
164070440|NCT03972709|592620393|FG000|Overall Study|Study Terminated by Sponsor|48|||
164070441|NCT03972709|592620394|FG001|Overall Study|Study Terminated by Sponsor|25|||
164070442|NCT03972709|592620395|FG002|Overall Study|Study Terminated by Sponsor|50|||
164070443|NCT03972709|592620393|FG000|Overall Study|Physician Decision|1|||
164070444|NCT03972709|592620394|FG001|Overall Study|Physician Decision|0|||
164070445|NCT03972709|592620395|FG002|Overall Study|Physician Decision|0|||
164070446|NCT03972709|592620393|FG000|Overall Study|COVID-19|0|||
164070447|NCT03972709|592620394|FG001|Overall Study|COVID-19|1|||
164070448|NCT03972709|592620395|FG002|Overall Study|COVID-19|1|||
164070449|NCT03972709|592620393|FG000|Overall Study|Lost to Follow-up|6|||
164070450|NCT03972709|592620394|FG001|Overall Study|Lost to Follow-up|1|||
164070451|NCT03972709|592620395|FG002|Overall Study|Lost to Follow-up|2|||
164070452|NCT03972709|592620393|FG000|Overall Study|Death|5|||
164070453|NCT03972709|592620394|FG001|Overall Study|Death|1|||
164070454|NCT03972709|592620395|FG002|Overall Study|Death|4|||
164070455|NCT03972709|592620393|FG000|Overall Study|Adverse Event|3|||
164070456|NCT03972709|592620394|FG001|Overall Study|Adverse Event|1|||
164070457|NCT03972709|592620395|FG002|Overall Study|Adverse Event|4|||
164070458|NCT03972709|592620393|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
164070459|NCT03972709|592620394|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
164070460|NCT03972709|592620395|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
164070461|NCT03972709|592620393|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
164105962|NCT03644550|592750492|FG000|Overall Study|Withdrawal by Subject|3|||
164105963|NCT03644550|592750492|FG000|Overall Study|Progressive disease|15|||
164105964|NCT01218867|592750493|FG000|Overall Study|Death during treatment|0|||
164105965|NCT01218867|592750494|FG001|Overall Study|Death during treatment|0|||
164105966|NCT01218867|592750495|FG002|Overall Study|Death during treatment|0|||
164105967|NCT01218867|592750496|FG003|Overall Study|Death during treatment|0|||
164105968|NCT01218867|592750497|FG004|Overall Study|Death during treatment|0|||
164105969|NCT01218867|592750498|FG005|Overall Study|Death during treatment|0|||
164070462|NCT03972709|592620394|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
164070463|NCT03972709|592620395|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
164070464|NCT03972709|592620393|FG000|Overall Study|Subject Unable to be Contacted|0|||
164070465|NCT03972709|592620394|FG001|Overall Study|Subject Unable to be Contacted|1|||
164070466|NCT03972709|592620395|FG002|Overall Study|Subject Unable to be Contacted|0|||
164070467|NCT03972709|592620393|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
164070468|NCT03972709|592620394|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
164070469|NCT03972709|592620395|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
164070470|NCT03972709|592620393|FG000|Overall Study|Subject Moved|0|||
164070471|NCT03972709|592620394|FG001|Overall Study|Subject Moved|1|||
164070472|NCT03972709|592620395|FG002|Overall Study|Subject Moved|0|||
164105970|NCT01218867|592750499|FG006|Overall Study|Death during treatment|1|||
164105971|NCT01218867|592750500|FG007|Overall Study|Death during treatment|0|||
164105972|NCT01218867|592750501|FG008|Overall Study|Death during treatment|0|||
164070473|NCT03972709|592620393|FG000|Overall Study|Missed Study Visits|1|||
164070474|NCT03972709|592620394|FG001|Overall Study|Missed Study Visits|0|||
164070475|NCT03972709|592620395|FG002|Overall Study|Missed Study Visits|0|||
164070476|NCT01523301|592620396|FG000|Overall Study|Adverse Event|25|||
164070477|NCT01523301|592620397|FG001|Overall Study|Adverse Event|16|||
164070478|NCT01523301|592620396|FG000|Overall Study|Lack of Efficacy|0|||
164070479|NCT01523301|592620397|FG001|Overall Study|Lack of Efficacy|2|||
164070480|NCT01523301|592620396|FG000|Overall Study|Protocol Violation|3|||
164070481|NCT01523301|592620397|FG001|Overall Study|Protocol Violation|4|||
164070482|NCT01523301|592620396|FG000|Overall Study|Lost to Follow-up|1|||
164070483|NCT01523301|592620397|FG001|Overall Study|Lost to Follow-up|0|||
164070484|NCT01523301|592620396|FG000|Overall Study|Withdrawal by Subject|6|||
164070485|NCT01523301|592620397|FG001|Overall Study|Withdrawal by Subject|8|||
164070486|NCT01523301|592620396|FG000|Overall Study|Other Reason|0|||
164070487|NCT01523301|592620397|FG001|Overall Study|Other Reason|2|||
164070488|NCT01339000|592620398|FG000|Overall Study|study closed due to lack of drug supply|1|||
164070489|NCT01339000|592620399|FG001|Overall Study|study closed due to lack of drug supply|0|||
164070490|NCT00728988|592620400|FG000|Overall Study|Not Treated|2|||
164070491|NCT00728988|592620401|FG001|Overall Study|Not Treated|2|||
164070492|NCT00728988|592620400|FG000|Overall Study|Death|1|||
164070493|NCT00728988|592620401|FG001|Overall Study|Death|1|||
164070494|NCT00728988|592620400|FG000|Overall Study|Adverse Event|3|||
164070495|NCT00728988|592620401|FG001|Overall Study|Adverse Event|2|||
164070496|NCT00728988|592620400|FG000|Overall Study|Other|85|||
164070497|NCT00728988|592620401|FG001|Overall Study|Other|77|||
164070498|NCT00728988|592620400|FG000|Overall Study|Withdrawal by Subject|2|||
164070499|NCT00728988|592620401|FG001|Overall Study|Withdrawal by Subject|6|||
164070500|NCT02017535|592620404|FG000|Overall Study|Withdrawal by Subject|1|||
164070501|NCT02017535|592620405|FG001|Overall Study|Withdrawal by Subject|0|||
164070502|NCT02017535|592620406|FG002|Overall Study|Withdrawal by Subject|0|||
164070503|NCT02017535|592620407|FG003|Overall Study|Withdrawal by Subject|0|||
164070504|NCT05511428|592620408|FG000|Overall Study|Withdrawal by Subject|1|||
164070505|NCT05511428|592620408|FG000|Overall Study|Adverse Event|1|||
164070506|NCT04088734|592620409|FG000|Overall Study|Other, Not Specified|5|||
164070507|NCT00664066|592620414|FG000|Overall Study|Study terminated|3|||
164070508|NCT00481871|592620416|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
164070509|NCT00481871|592620417|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
164070510|NCT00481871|592620418|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
164070511|NCT00481871|592620419|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
164070512|NCT00481871|592620420|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
164070513|NCT00902486|592620426|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
164070514|NCT00902486|592620427|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
164105973|NCT01218867|592750502|FG009|Overall Study|Death during treatment|0|||
164105974|NCT01218867|592750503|FG010|Overall Study|Death during treatment|0|||
164105975|NCT02591420|592751736|FG000|Overall Study|Lost to Follow-up|0|||
164105976|NCT02591420|592751737|FG001|Overall Study|Lost to Follow-up|1|||
164105977|NCT02591420|592751738|FG002|Overall Study|Lost to Follow-up|2|||
164105978|NCT04241458|592751739|FG000|Overall Study|Withdrawal by Subject|0|||
164105979|NCT04241458|592751740|FG001|Overall Study|Withdrawal by Subject|0|||
164105980|NCT04241458|592751741|FG002|Overall Study|Withdrawal by Subject|0|||
164105981|NCT04241458|592751742|FG003|Overall Study|Withdrawal by Subject|0|||
164105982|NCT04241458|592751743|FG004|Overall Study|Withdrawal by Subject|1|||
164105983|NCT04970810|592751746|FG000|Overall Study|deemed ineligible after randomization|3|||
164105984|NCT04970810|592751747|FG001|Overall Study|deemed ineligible after randomization|0|||
164105985|NCT04970810|592751748|FG002|Overall Study|deemed ineligible after randomization|4|||
164105986|NCT04742491|592751749|FG000|Overall Study|Death|2|||
164105987|NCT04742491|592751750|FG001|Overall Study|Death|0|||
164070515|NCT00902486|592620428|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
164070516|NCT00902486|592620429|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
164105988|NCT04742491|592751749|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
164105989|NCT04742491|592751750|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
164070517|NCT00902486|592620430|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
164070518|NCT00902486|592620431|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
164070519|NCT00902486|592620426|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
164070520|NCT00902486|592620427|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164105990|NCT04742491|592751749|FG000|Overall Study|Lost to Follow-up|6|||
164105991|NCT04742491|592751750|FG001|Overall Study|Lost to Follow-up|8|||
164070521|NCT00902486|592620428|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164070522|NCT00902486|592620429|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164070523|NCT00902486|592620430|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
164070524|NCT00902486|592620431|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
164070525|NCT00902486|592620426|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164070526|NCT00902486|592620427|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164105992|NCT04742491|592751749|FG000|Overall Study|Withdrawal by Subject|4|||
164105993|NCT04742491|592751750|FG001|Overall Study|Withdrawal by Subject|2|||
164105994|NCT04742491|592751749|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
164105995|NCT04742491|592751750|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
164105996|NCT04742491|592751749|FG000|Overall Study|Participant refused further participation|2|||
164105997|NCT04742491|592751750|FG001|Overall Study|Participant refused further participation|7|||
164105998|NCT04742491|592751749|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
164105999|NCT04742491|592751750|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
164106000|NCT04742491|592751749|FG000|Overall Study|Other reasons|3|||
164106001|NCT04742491|592751750|FG001|Overall Study|Other reasons|4|||
164106002|NCT00716625|592751751|FG000|Overall Study|Safety was not Assessable|1|||
164106003|NCT04349267|592751752|FG000|Overall Study|Adverse Event|0|||
164106004|NCT04349267|592751753|FG001|Overall Study|Adverse Event|0|||
164106005|NCT04349267|592751754|FG002|Overall Study|Adverse Event|0|||
164106006|NCT04349267|592751755|FG003|Overall Study|Adverse Event|0|||
164106007|NCT04349267|592751756|FG004|Overall Study|Adverse Event|0|||
164106008|NCT04349267|592751757|FG005|Overall Study|Adverse Event|1|||
164106009|NCT04349267|592751758|FG006|Overall Study|Adverse Event|0|||
164106010|NCT04349267|592751752|FG000|Overall Study|Other reason|0|||
164106011|NCT04349267|592751753|FG001|Overall Study|Other reason|1|||
164106012|NCT04349267|592751754|FG002|Overall Study|Other reason|0|||
164106013|NCT04349267|592751755|FG003|Overall Study|Other reason|0|||
164106014|NCT04349267|592751756|FG004|Overall Study|Other reason|1|||
164106015|NCT04349267|592751757|FG005|Overall Study|Other reason|1|||
164106016|NCT04349267|592751758|FG006|Overall Study|Other reason|1|||
164106017|NCT04349267|592751752|FG000|Overall Study|Disease Progression|2|||
164106018|NCT04349267|592751753|FG001|Overall Study|Disease Progression|0|||
164106019|NCT04349267|592751754|FG002|Overall Study|Disease Progression|2|||
164106020|NCT04349267|592751755|FG003|Overall Study|Disease Progression|3|||
164070527|NCT00902486|592620428|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164070528|NCT00902486|592620429|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
164070529|NCT00902486|592620430|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
164070530|NCT00902486|592620431|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
164070531|NCT00902486|592620426|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164070532|NCT00902486|592620427|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164070533|NCT00902486|592620428|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164070534|NCT00902486|592620429|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
164070535|NCT00902486|592620430|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164070536|NCT00902486|592620431|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
164070537|NCT00902486|592620426|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164070538|NCT00902486|592620427|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164070539|NCT00902486|592620428|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164070540|NCT00902486|592620429|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
164070541|NCT00902486|592620430|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164070542|NCT00902486|592620431|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
164070543|NCT00902486|592620426|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164070544|NCT00902486|592620427|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164070545|NCT00902486|592620428|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164070546|NCT00902486|592620429|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
164070547|NCT00902486|592620430|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
164070548|NCT00902486|592620431|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
164070549|NCT00902486|592620426|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164070550|NCT00902486|592620427|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164070551|NCT00902486|592620428|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
164070552|NCT00902486|592620429|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
164070553|NCT00902486|592620430|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164070554|NCT00902486|592620431|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
164070555|NCT00902486|592620426|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164070556|NCT00902486|592620427|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164070557|NCT00902486|592620428|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164070558|NCT00902486|592620429|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164070559|NCT00902486|592620430|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
164106021|NCT04349267|592751756|FG004|Overall Study|Disease Progression|3|||
164106022|NCT04349267|592751757|FG005|Overall Study|Disease Progression|7|||
164106023|NCT04349267|592751758|FG006|Overall Study|Disease Progression|10|||
164106024|NCT04349267|592751752|FG000|Overall Study|Participant withdrew consent|0|||
164106025|NCT04349267|592751753|FG001|Overall Study|Participant withdrew consent|1|||
164106026|NCT04349267|592751754|FG002|Overall Study|Participant withdrew consent|0|||
164106027|NCT04349267|592751755|FG003|Overall Study|Participant withdrew consent|0|||
164106028|NCT04349267|592751756|FG004|Overall Study|Participant withdrew consent|0|||
164070560|NCT00902486|592620431|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
164070561|NCT00902486|592620426|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164070562|NCT00902486|592620427|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164070563|NCT00902486|592620428|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164070564|NCT00902486|592620429|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
164070565|NCT00902486|592620430|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164070566|NCT00902486|592620431|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
164070567|NCT00902486|592620426|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164070568|NCT00902486|592620427|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164070569|NCT00902486|592620428|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
164070570|NCT00902486|592620429|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164070571|NCT00902486|592620430|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164070572|NCT00902486|592620431|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
164070573|NCT00902486|592620426|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
164070574|NCT00902486|592620427|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
164070575|NCT00902486|592620428|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
164070576|NCT00902486|592620429|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
164070577|NCT00902486|592620430|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
164070578|NCT00902486|592620431|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
164070579|NCT01843660|592620432|FG000|Overall Study|Other|30|||
164070580|NCT00209560|592620433|FG000|Overall Study|Lack of Efficacy|1|||
164070581|NCT00209560|592620434|FG001|Overall Study|Lack of Efficacy|0|||
164070582|NCT04439110|592620435|FG000|Overall Study|Ineligible|2|||
164070583|NCT04439110|592620435|FG000|Overall Study|Adverse Event|4|||
164070584|NCT04439110|592620435|FG000|Overall Study|Death|2|||
164070585|NCT04439110|592620435|FG000|Overall Study|Disease proression|25|||
164070586|NCT04439110|592620435|FG000|Overall Study|Withdrawal by Subject|1|||
164070587|NCT04439110|592620435|FG000|Overall Study|Alternative therapy|1|||
164070588|NCT04439110|592620435|FG000|Overall Study|Other complicating disease|1|||
164070589|NCT04439110|592620435|FG000|Overall Study|Personal reasons|1|||
164070590|NCT04439110|592620435|FG000|Overall Study|Still on treatment|1|||
164070591|NCT01721369|592620438|FG000|Overall Study|Not initial etiological diagnosis|12|||
164070592|NCT01211613|592621799|FG000|Overall Study|Lost to Follow-up|2|||
164070593|NCT01211613|592621800|FG001|Overall Study|Lost to Follow-up|2|||
164070594|NCT01211613|592621801|FG002|Overall Study|Lost to Follow-up|2|||
164070595|NCT01211613|592621799|FG000|Overall Study|Withdrawal by Subject|1|||
164070596|NCT01211613|592621800|FG001|Overall Study|Withdrawal by Subject|0|||
164070597|NCT01211613|592621801|FG002|Overall Study|Withdrawal by Subject|0|||
164070598|NCT03853213|592621802|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
164070599|NCT03853213|592621803|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
164070600|NCT03853213|592621802|FG000|Overall Study|Other (e.g., too busy)|0|||
164070601|NCT03853213|592621803|FG001|Overall Study|Other (e.g., too busy)|2|||
164070602|NCT03044431|592621804|FG000|Overall Study|Lost to Follow-up|59|||
164070603|NCT04470622|592621805|FG000|Overall Study|Withdrawal by Subject|0|||
164070604|NCT04470622|592621806|FG001|Overall Study|Withdrawal by Subject|1|||
164070605|NCT04470622|592621805|FG000|Overall Study|Screen Failure|0|||
164070606|NCT04470622|592621806|FG001|Overall Study|Screen Failure|1|||
164070607|NCT04470622|592621805|FG000|Overall Study|Death|0|||
164070608|NCT04470622|592621806|FG001|Overall Study|Death|1|||
164070609|NCT02576054|592621809|FG000|Overall Study|Withdrawal by Subject|1|||
164070610|NCT00791154|592621812|FG000|Overall Study|Noncompliance|0|||
164070611|NCT00791154|592621813|FG001|Overall Study|Noncompliance|1|||
164070612|NCT00791154|592621814|FG002|Overall Study|Noncompliance|0|||
164070613|NCT00791154|592621815|FG003|Overall Study|Noncompliance|0|||
164070614|NCT00791154|592621816|FG004|Overall Study|Noncompliance|1|||
164070615|NCT00791154|592621817|FG005|Overall Study|Noncompliance|1|||
164070616|NCT00791154|592621818|FG006|Overall Study|Noncompliance|1|||
164070617|NCT00791154|592621812|FG000|Overall Study|Adverse Event|0|||
164070618|NCT00791154|592621813|FG001|Overall Study|Adverse Event|0|||
164070619|NCT00791154|592621814|FG002|Overall Study|Adverse Event|0|||
164070620|NCT00791154|592621815|FG003|Overall Study|Adverse Event|0|||
164070621|NCT00791154|592621816|FG004|Overall Study|Adverse Event|2|||
164070622|NCT00791154|592621817|FG005|Overall Study|Adverse Event|0|||
164070623|NCT00791154|592621818|FG006|Overall Study|Adverse Event|1|||
164070624|NCT00791154|592621812|FG000|Overall Study|Full Consent withdrawn|1|||
164070625|NCT00791154|592621813|FG001|Overall Study|Full Consent withdrawn|3|||
164070626|NCT00791154|592621814|FG002|Overall Study|Full Consent withdrawn|0|||
164070627|NCT00791154|592621815|FG003|Overall Study|Full Consent withdrawn|0|||
164070628|NCT00791154|592621816|FG004|Overall Study|Full Consent withdrawn|1|||
164070629|NCT00791154|592621817|FG005|Overall Study|Full Consent withdrawn|3|||
164070630|NCT00791154|592621818|FG006|Overall Study|Full Consent withdrawn|1|||
164070631|NCT00791154|592621812|FG000|Overall Study|Lost to Follow-up|0|||
164070632|NCT00791154|592621813|FG001|Overall Study|Lost to Follow-up|0|||
164070633|NCT00791154|592621814|FG002|Overall Study|Lost to Follow-up|0|||
164070634|NCT00791154|592621815|FG003|Overall Study|Lost to Follow-up|1|||
164070635|NCT00791154|592621816|FG004|Overall Study|Lost to Follow-up|2|||
164070636|NCT00791154|592621817|FG005|Overall Study|Lost to Follow-up|0|||
164070637|NCT00791154|592621818|FG006|Overall Study|Lost to Follow-up|4|||
164070638|NCT00791154|592621812|FG000|Overall Study|Death|5|||
164070639|NCT00791154|592621813|FG001|Overall Study|Death|4|||
164070640|NCT00791154|592621814|FG002|Overall Study|Death|4|||
164070641|NCT00791154|592621815|FG003|Overall Study|Death|7|||
164070642|NCT00791154|592621816|FG004|Overall Study|Death|54|||
164070643|NCT00791154|592621817|FG005|Overall Study|Death|54|||
164070644|NCT00791154|592621818|FG006|Overall Study|Death|52|||
164070645|NCT00791154|592621812|FG000|Overall Study|Other event|0|||
164070646|NCT00791154|592621813|FG001|Overall Study|Other event|0|||
164070647|NCT00791154|592621814|FG002|Overall Study|Other event|2|||
164070648|NCT00791154|592621815|FG003|Overall Study|Other event|0|||
164070649|NCT00791154|592621816|FG004|Overall Study|Other event|2|||
164070650|NCT00791154|592621817|FG005|Overall Study|Other event|4|||
164070651|NCT00791154|592621818|FG006|Overall Study|Other event|2|||
164070652|NCT00953927|592621819|FG000|Overall Study|Lost to Follow-up|61|||
164070653|NCT00953927|592621820|FG001|Overall Study|Lost to Follow-up|65|||
164070654|NCT00953927|592621819|FG000|Overall Study|Withdrawal by Subject|36|||
164070655|NCT00953927|592621820|FG001|Overall Study|Withdrawal by Subject|25|||
164070656|NCT00953927|592621819|FG000|Overall Study|Death|7|||
164070657|NCT00953927|592621820|FG001|Overall Study|Death|4|||
164070658|NCT00953927|592621819|FG000|Overall Study|Other study discontinuation|1|||
164070659|NCT00953927|592621820|FG001|Overall Study|Other study discontinuation|1|||
164070660|NCT00934622|592621821|FG000|Overall Study|Lost to Follow-up|7|||
164070661|NCT00934622|592621821|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
164070662|NCT00468312|592621824|FG000|Overall Study|Adverse Event|2|||
164070663|NCT00468312|592621825|FG001|Overall Study|Adverse Event|1|||
164070664|NCT00468312|592621824|FG000|Overall Study|Lack of Efficacy|0|||
164070665|NCT00468312|592621825|FG001|Overall Study|Lack of Efficacy|1|||
164070666|NCT00468312|592621824|FG000|Overall Study|Withdrawal by Subject|0|||
164070667|NCT00468312|592621825|FG001|Overall Study|Withdrawal by Subject|1|||
164070668|NCT00468312|592621824|FG000|Overall Study|Protocol Violation|2|||
164070669|NCT00468312|592621825|FG001|Overall Study|Protocol Violation|1|||
164070670|NCT00468312|592621824|FG000|Overall Study|Did not meet protocol eligibility|0|||
164070671|NCT00468312|592621825|FG001|Overall Study|Did not meet protocol eligibility|1|||
164070672|NCT01396161|592621826|FG000|Overall Study|Withdrawal by Subject|0|||
164070673|NCT01396161|592621827|FG001|Overall Study|Withdrawal by Subject|0|||
164070674|NCT01396161|592621828|FG002|Overall Study|Withdrawal by Subject|0|||
164070675|NCT01396161|592621829|FG003|Overall Study|Withdrawal by Subject|0|||
164070676|NCT01396161|592621830|FG004|Overall Study|Withdrawal by Subject|1|||
164070677|NCT01396161|592621831|FG005|Overall Study|Withdrawal by Subject|0|||
164070678|NCT01396161|592621832|FG006|Overall Study|Withdrawal by Subject|0|||
164070679|NCT01396161|592621826|FG000|Overall Study|Other|0|||
164070680|NCT01396161|592621827|FG001|Overall Study|Other|0|||
164070681|NCT01396161|592621828|FG002|Overall Study|Other|0|||
164070682|NCT01396161|592621829|FG003|Overall Study|Other|0|||
164070683|NCT01396161|592621830|FG004|Overall Study|Other|0|||
164070684|NCT01396161|592621831|FG005|Overall Study|Other|0|||
164070685|NCT01396161|592621832|FG006|Overall Study|Other|1|||
164070686|NCT02962739|592621833|FG000|Overall Study|Withdrawal by Subject|0|||
164070687|NCT02962739|592621834|FG001|Overall Study|Withdrawal by Subject|1|||
164070688|NCT02962739|592621835|FG002|Overall Study|Withdrawal by Subject|0|||
164070689|NCT02962739|592621836|FG003|Overall Study|Withdrawal by Subject|0|||
164070690|NCT02962739|592621837|FG004|Overall Study|Withdrawal by Subject|0|||
164070691|NCT02962739|592621838|FG005|Overall Study|Withdrawal by Subject|0|||
164070692|NCT02962739|592621833|FG000|Overall Study|Protocol Violation|0|||
164070693|NCT02962739|592621834|FG001|Overall Study|Protocol Violation|0|||
164070694|NCT02962739|592621835|FG002|Overall Study|Protocol Violation|1|||
164070695|NCT02962739|592621836|FG003|Overall Study|Protocol Violation|0|||
164070696|NCT02962739|592621837|FG004|Overall Study|Protocol Violation|1|||
164070697|NCT02962739|592621838|FG005|Overall Study|Protocol Violation|0|||
164070698|NCT03343054|592621839|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
164070699|NCT03343054|592621840|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
164106029|NCT04349267|592751757|FG005|Overall Study|Participant withdrew consent|0|||
164070700|NCT03343054|592621841|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
164070701|NCT03343054|592621839|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
164070702|NCT03343054|592621840|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
164070703|NCT03343054|592621841|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
164070704|NCT03343054|592621839|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
164070705|NCT03343054|592621840|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
164070706|NCT03343054|592621841|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
164070707|NCT03343054|592621839|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
164070708|NCT03343054|592621840|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
164070709|NCT03343054|592621841|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
164070710|NCT00981409|592621846|FG000|Overall Study|Adverse Event|4|||
164070711|NCT00981409|592621847|FG001|Overall Study|Adverse Event|0|||
164070712|NCT00981409|592621846|FG000|Overall Study|Protocol Violation|0|||
164070713|NCT00981409|592621847|FG001|Overall Study|Protocol Violation|1|||
164070714|NCT00981409|592621846|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
164070715|NCT00981409|592621847|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
164070716|NCT00450177|592621848|FG000|Overall Study|Adverse Event|7|||
164070717|NCT00450177|592621849|FG001|Overall Study|Adverse Event|4|||
164070718|NCT00450177|592621848|FG000|Overall Study|Withdrawal by Subject|1|||
164070719|NCT00450177|592621849|FG001|Overall Study|Withdrawal by Subject|6|||
164070720|NCT00450177|592621848|FG000|Overall Study|Withdrawal by Primary Team|1|||
164070721|NCT00450177|592621849|FG001|Overall Study|Withdrawal by Primary Team|1|||
164070722|NCT03869684|592621854|FG000|Overall Study|Adverse Event|0|||
164070723|NCT03869684|592621855|FG001|Overall Study|Adverse Event|3|||
164070724|NCT03869684|592621856|FG002|Overall Study|Adverse Event|1|||
164070725|NCT03869684|592621854|FG000|Overall Study|Withdrawal by Subject|1|||
164070726|NCT03869684|592621855|FG001|Overall Study|Withdrawal by Subject|0|||
164070727|NCT03869684|592621856|FG002|Overall Study|Withdrawal by Subject|0|||
164070728|NCT03869684|592621854|FG000|Overall Study|Lost to Follow-up|1|||
164070729|NCT03869684|592621855|FG001|Overall Study|Lost to Follow-up|0|||
164070730|NCT03869684|592621856|FG002|Overall Study|Lost to Follow-up|0|||
164070731|NCT03869684|592621854|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
164070732|NCT03869684|592621855|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
164070733|NCT03869684|592621856|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
164070734|NCT04056299|592621857|FG000|Overall Study|Sponsor discontinued study|3|||
164070735|NCT04056299|592621858|FG001|Overall Study|Sponsor discontinued study|3|||
164070736|NCT01227954|592621863|FG000|Overall Study|Protocol Violation|6|||
164070737|NCT01227954|592621863|FG000|Overall Study|No protocol treatment|7|||
164070738|NCT00078312|592621867|FG000|Overall Study|Adverse Event|43|||
164070739|NCT00078312|592621867|FG000|Overall Study|Lack of Efficacy|15|||
164070740|NCT00078312|592621867|FG000|Overall Study|Lost to Follow-up|41|||
164070741|NCT00078312|592621867|FG000|Overall Study|Physician Decision|9|||
164070742|NCT00078312|592621867|FG000|Overall Study|Protocol Violation|3|||
164070743|NCT00078312|592621867|FG000|Overall Study|Withdrawal by Subject|33|||
164070744|NCT00078312|592621867|FG000|Overall Study|Miscellaneous|33|||
164070745|NCT01268683|592621870|FG000|Overall Study|Lost to Follow-up|1|||
164070746|NCT01268683|592621870|FG000|Overall Study|Death|1|||
164070747|NCT04256759|592621873|FG000|Overall Study|Physician Decision|1|||
164070748|NCT04256759|592621873|FG000|Overall Study|Lack of Efficacy|1|||
164070749|NCT03901352|592621878|FG000|Double-blind Phase|Adverse Event|6|||
164070750|NCT03901352|592621879|FG001|Double-blind Phase|Adverse Event|4|||
164070751|NCT03901352|592621878|FG000|Double-blind Phase|Death|1|||
164070752|NCT03901352|592621879|FG001|Double-blind Phase|Death|0|||
164070753|NCT03901352|592621878|FG000|Double-blind Phase|Lack of Efficacy|0|||
164070754|NCT03901352|592621879|FG001|Double-blind Phase|Lack of Efficacy|1|||
164070755|NCT03901352|592621878|FG000|Double-blind Phase|Protocol Violation|0|||
164070756|NCT03901352|592621879|FG001|Double-blind Phase|Protocol Violation|1|||
164070757|NCT03901352|592621878|FG000|Double-blind Phase|Withdrawal by Subject|10|||
164070758|NCT03901352|592621879|FG001|Double-blind Phase|Withdrawal by Subject|8|||
164070759|NCT03901352|592621878|FG000|Open-label Extension Phase|Adverse Event|24|||
164070760|NCT03901352|592621879|FG001|Open-label Extension Phase|Adverse Event|0|||
164070761|NCT03901352|592621878|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
164070762|NCT03901352|592621879|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
164070763|NCT03901352|592621878|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
164070764|NCT03901352|592621879|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
164070765|NCT03901352|592621878|FG000|Open-label Extension Phase|Other|1|||
164070766|NCT03901352|592621879|FG001|Open-label Extension Phase|Other|0|||
164070767|NCT01826201|592621882|FG000|Overall Study|Non compliance with protocol|4|||
164070768|NCT02742818|592621883|FG000|Overall Study|Adverse Event|0|||
164070769|NCT02742818|592621884|FG001|Overall Study|Adverse Event|1|||
164070770|NCT02742818|592621883|FG000|Overall Study|Protocol Violation|0|||
164070771|NCT02742818|592621884|FG001|Overall Study|Protocol Violation|1|||
164070772|NCT04701658|592621885|FG000|Overall Study|Lost to Follow-up|6|||
164070773|NCT05349188|592621890|FG000|Overall Study|Withdrawal by Subject|1|||
164070774|NCT05349188|592621891|FG001|Overall Study|Withdrawal by Subject|0|||
164070775|NCT03193190|592621903|FG000|Stage 1|Arm Terminated by Sponsor|0|||
164070776|NCT03193190|592621904|FG001|Stage 1|Arm Terminated by Sponsor|0|||
164070777|NCT03193190|592621905|FG002|Stage 1|Arm Terminated by Sponsor|0|||
164070778|NCT03193190|592621906|FG003|Stage 1|Arm Terminated by Sponsor|1|||
164070779|NCT03193190|592621907|FG004|Stage 1|Arm Terminated by Sponsor|0|||
164070780|NCT03193190|592621908|FG005|Stage 1|Arm Terminated by Sponsor|2|||
164070781|NCT03193190|592621909|FG006|Stage 1|Arm Terminated by Sponsor|0|||
164070782|NCT03193190|592621910|FG007|Stage 1|Arm Terminated by Sponsor|0|||
164070783|NCT03193190|592621911|FG008|Stage 1|Arm Terminated by Sponsor|0|||
164070784|NCT03193190|592621912|FG009|Stage 1|Arm Terminated by Sponsor|0|||
164070785|NCT03193190|592621913|FG010|Stage 1|Arm Terminated by Sponsor|0|||
164070786|NCT03193190|592621914|FG011|Stage 1|Arm Terminated by Sponsor|0|||
164070787|NCT03193190|592621915|FG012|Stage 1|Arm Terminated by Sponsor|0|||
164070788|NCT03193190|592621916|FG013|Stage 1|Arm Terminated by Sponsor|0|||
164070789|NCT03193190|592621917|FG014|Stage 1|Arm Terminated by Sponsor|0|||
164070790|NCT03193190|592621918|FG015|Stage 1|Arm Terminated by Sponsor|0|||
164070791|NCT03193190|592621903|FG000|Stage 1|Death|22|||
164070792|NCT03193190|592621904|FG001|Stage 1|Death|8|||
164070793|NCT03193190|592621905|FG002|Stage 1|Death|23|||
164070794|NCT03193190|592621906|FG003|Stage 1|Death|14|||
164070795|NCT03193190|592621907|FG004|Stage 1|Death|34|||
164070796|NCT03193190|592621908|FG005|Stage 1|Death|28|||
164070797|NCT03193190|592621909|FG006|Stage 1|Death|19|||
164070798|NCT03193190|592621910|FG007|Stage 1|Death|21|||
164070799|NCT03193190|592621911|FG008|Stage 1|Death|14|||
164070800|NCT03193190|592621912|FG009|Stage 1|Death|10|||
164070801|NCT03193190|592621913|FG010|Stage 1|Death|59|||
164070802|NCT03193190|592621914|FG011|Stage 1|Death|14|||
164070803|NCT03193190|592621915|FG012|Stage 1|Death|14|||
164070804|NCT03193190|592621916|FG013|Stage 1|Death|0|||
164070805|NCT03193190|592621917|FG014|Stage 1|Death|0|||
164070806|NCT03193190|592621918|FG015|Stage 1|Death|0|||
164070807|NCT03193190|592621903|FG000|Stage 1|Lost to Follow-up|2|||
164070808|NCT03193190|592621904|FG001|Stage 1|Lost to Follow-up|1|||
164070809|NCT03193190|592621905|FG002|Stage 1|Lost to Follow-up|1|||
164070810|NCT03193190|592621906|FG003|Stage 1|Lost to Follow-up|0|||
164070811|NCT03193190|592621907|FG004|Stage 1|Lost to Follow-up|0|||
164070812|NCT03193190|592621908|FG005|Stage 1|Lost to Follow-up|0|||
164070813|NCT03193190|592621909|FG006|Stage 1|Lost to Follow-up|1|||
164070814|NCT03193190|592621910|FG007|Stage 1|Lost to Follow-up|0|||
164070815|NCT03193190|592621911|FG008|Stage 1|Lost to Follow-up|0|||
164070816|NCT03193190|592621912|FG009|Stage 1|Lost to Follow-up|0|||
164070817|NCT03193190|592621913|FG010|Stage 1|Lost to Follow-up|0|||
164070818|NCT03193190|592621914|FG011|Stage 1|Lost to Follow-up|0|||
164070819|NCT03193190|592621915|FG012|Stage 1|Lost to Follow-up|0|||
164070820|NCT03193190|592621916|FG013|Stage 1|Lost to Follow-up|0|||
164070821|NCT03193190|592621917|FG014|Stage 1|Lost to Follow-up|0|||
164070822|NCT03193190|592621918|FG015|Stage 1|Lost to Follow-up|0|||
164070823|NCT03193190|592621903|FG000|Stage 1|Reason not Specified|1|||
164070824|NCT03193190|592621904|FG001|Stage 1|Reason not Specified|0|||
164070825|NCT03193190|592621905|FG002|Stage 1|Reason not Specified|0|||
164070826|NCT03193190|592621906|FG003|Stage 1|Reason not Specified|1|||
164070827|NCT03193190|592621907|FG004|Stage 1|Reason not Specified|0|||
164070828|NCT03193190|592621908|FG005|Stage 1|Reason not Specified|1|||
164070829|NCT03193190|592621909|FG006|Stage 1|Reason not Specified|2|||
164070830|NCT03193190|592621910|FG007|Stage 1|Reason not Specified|2|||
164070831|NCT03193190|592621911|FG008|Stage 1|Reason not Specified|0|||
164070832|NCT03193190|592621912|FG009|Stage 1|Reason not Specified|1|||
164070833|NCT03193190|592621913|FG010|Stage 1|Reason not Specified|3|||
164070834|NCT03193190|592621914|FG011|Stage 1|Reason not Specified|0|||
164070835|NCT03193190|592621915|FG012|Stage 1|Reason not Specified|1|||
164070836|NCT03193190|592621916|FG013|Stage 1|Reason not Specified|0|||
164070837|NCT03193190|592621917|FG014|Stage 1|Reason not Specified|0|||
164070838|NCT03193190|592621918|FG015|Stage 1|Reason not Specified|0|||
164070839|NCT03193190|592621903|FG000|Stage 1|Physician Decision|0|||
164070840|NCT03193190|592621904|FG001|Stage 1|Physician Decision|0|||
164070841|NCT03193190|592621905|FG002|Stage 1|Physician Decision|0|||
164070842|NCT03193190|592621906|FG003|Stage 1|Physician Decision|0|||
164070843|NCT03193190|592621907|FG004|Stage 1|Physician Decision|0|||
164070844|NCT03193190|592621908|FG005|Stage 1|Physician Decision|0|||
164070845|NCT03193190|592621909|FG006|Stage 1|Physician Decision|0|||
164070846|NCT03193190|592621910|FG007|Stage 1|Physician Decision|0|||
164070847|NCT03193190|592621911|FG008|Stage 1|Physician Decision|0|||
164070848|NCT03193190|592621912|FG009|Stage 1|Physician Decision|0|||
164070849|NCT03193190|592621913|FG010|Stage 1|Physician Decision|0|||
164070850|NCT03193190|592621914|FG011|Stage 1|Physician Decision|1|||
164070851|NCT03193190|592621915|FG012|Stage 1|Physician Decision|0|||
164070852|NCT03193190|592621916|FG013|Stage 1|Physician Decision|0|||
164070853|NCT03193190|592621917|FG014|Stage 1|Physician Decision|0|||
164070854|NCT03193190|592621918|FG015|Stage 1|Physician Decision|0|||
164070855|NCT03193190|592621903|FG000|Stage 1|Progressive Disease|1|||
164070856|NCT03193190|592621904|FG001|Stage 1|Progressive Disease|0|||
164070857|NCT03193190|592621905|FG002|Stage 1|Progressive Disease|0|||
164070858|NCT03193190|592621906|FG003|Stage 1|Progressive Disease|0|||
164070859|NCT03193190|592621907|FG004|Stage 1|Progressive Disease|0|||
164070860|NCT03193190|592621908|FG005|Stage 1|Progressive Disease|0|||
164070861|NCT03193190|592621909|FG006|Stage 1|Progressive Disease|0|||
164070862|NCT03193190|592621910|FG007|Stage 1|Progressive Disease|0|||
164070863|NCT03193190|592621911|FG008|Stage 1|Progressive Disease|0|||
164070864|NCT03193190|592621912|FG009|Stage 1|Progressive Disease|0|||
164070865|NCT03193190|592621913|FG010|Stage 1|Progressive Disease|0|||
164070866|NCT03193190|592621914|FG011|Stage 1|Progressive Disease|0|||
164070867|NCT03193190|592621915|FG012|Stage 1|Progressive Disease|0|||
164070868|NCT03193190|592621916|FG013|Stage 1|Progressive Disease|0|||
164070869|NCT03193190|592621917|FG014|Stage 1|Progressive Disease|0|||
164070870|NCT03193190|592621918|FG015|Stage 1|Progressive Disease|0|||
164070871|NCT03193190|592621903|FG000|Stage 1|Study Terminated By Sponsor|3|||
164070872|NCT03193190|592621904|FG001|Stage 1|Study Terminated By Sponsor|0|||
164070873|NCT03193190|592621905|FG002|Stage 1|Study Terminated By Sponsor|0|||
164070874|NCT03193190|592621906|FG003|Stage 1|Study Terminated By Sponsor|0|||
164070875|NCT03193190|592621907|FG004|Stage 1|Study Terminated By Sponsor|6|||
164070876|NCT03193190|592621908|FG005|Stage 1|Study Terminated By Sponsor|0|||
164070877|NCT03193190|592621909|FG006|Stage 1|Study Terminated By Sponsor|0|||
164070878|NCT03193190|592621910|FG007|Stage 1|Study Terminated By Sponsor|0|||
164070879|NCT03193190|592621911|FG008|Stage 1|Study Terminated By Sponsor|0|||
164070880|NCT03193190|592621912|FG009|Stage 1|Study Terminated By Sponsor|0|||
164070881|NCT03193190|592621913|FG010|Stage 1|Study Terminated By Sponsor|0|||
164070882|NCT03193190|592621914|FG011|Stage 1|Study Terminated By Sponsor|0|||
164070883|NCT03193190|592621915|FG012|Stage 1|Study Terminated By Sponsor|0|||
164070884|NCT03193190|592621916|FG013|Stage 1|Study Terminated By Sponsor|0|||
164070885|NCT03193190|592621917|FG014|Stage 1|Study Terminated By Sponsor|0|||
164070886|NCT03193190|592621918|FG015|Stage 1|Study Terminated By Sponsor|0|||
164070887|NCT03193190|592621903|FG000|Stage 1|Withdrawal by Subject|6|||
164070888|NCT03193190|592621904|FG001|Stage 1|Withdrawal by Subject|0|||
164070889|NCT03193190|592621905|FG002|Stage 1|Withdrawal by Subject|1|||
164070890|NCT03193190|592621906|FG003|Stage 1|Withdrawal by Subject|0|||
164070891|NCT03193190|592621907|FG004|Stage 1|Withdrawal by Subject|2|||
164070892|NCT03193190|592621908|FG005|Stage 1|Withdrawal by Subject|0|||
164070893|NCT03193190|592621909|FG006|Stage 1|Withdrawal by Subject|3|||
164070894|NCT03193190|592621910|FG007|Stage 1|Withdrawal by Subject|2|||
164070895|NCT03193190|592621911|FG008|Stage 1|Withdrawal by Subject|2|||
164070896|NCT03193190|592621912|FG009|Stage 1|Withdrawal by Subject|4|||
164070897|NCT03193190|592621913|FG010|Stage 1|Withdrawal by Subject|9|||
164070898|NCT03193190|592621914|FG011|Stage 1|Withdrawal by Subject|1|||
164070899|NCT03193190|592621915|FG012|Stage 1|Withdrawal by Subject|0|||
164070900|NCT03193190|592621916|FG013|Stage 1|Withdrawal by Subject|0|||
164070901|NCT03193190|592621917|FG014|Stage 1|Withdrawal by Subject|0|||
164070902|NCT03193190|592621918|FG015|Stage 1|Withdrawal by Subject|0|||
164070903|NCT03193190|592621903|FG000|Stage 2|Death|0|||
164070904|NCT03193190|592621904|FG001|Stage 2|Death|0|||
164070905|NCT03193190|592621905|FG002|Stage 2|Death|0|||
164070906|NCT03193190|592621906|FG003|Stage 2|Death|0|||
164070907|NCT03193190|592621907|FG004|Stage 2|Death|0|||
164070908|NCT03193190|592621908|FG005|Stage 2|Death|0|||
164070909|NCT03193190|592621909|FG006|Stage 2|Death|0|||
164070910|NCT03193190|592621910|FG007|Stage 2|Death|0|||
164070911|NCT03193190|592621911|FG008|Stage 2|Death|0|||
164070912|NCT03193190|592621912|FG009|Stage 2|Death|0|||
164070913|NCT03193190|592621913|FG010|Stage 2|Death|0|||
164070914|NCT03193190|592621914|FG011|Stage 2|Death|0|||
164070915|NCT03193190|592621915|FG012|Stage 2|Death|0|||
164070916|NCT03193190|592621916|FG013|Stage 2|Death|14|||
164070917|NCT03193190|592621917|FG014|Stage 2|Death|4|||
164070918|NCT03193190|592621918|FG015|Stage 2|Death|1|||
164070919|NCT03193190|592621903|FG000|Stage 2|Lost to Follow-up|0|||
164070920|NCT03193190|592621904|FG001|Stage 2|Lost to Follow-up|0|||
164070921|NCT03193190|592621905|FG002|Stage 2|Lost to Follow-up|0|||
164070922|NCT03193190|592621906|FG003|Stage 2|Lost to Follow-up|0|||
164070923|NCT03193190|592621907|FG004|Stage 2|Lost to Follow-up|0|||
164070924|NCT03193190|592621908|FG005|Stage 2|Lost to Follow-up|0|||
164070925|NCT03193190|592621909|FG006|Stage 2|Lost to Follow-up|0|||
164070926|NCT03193190|592621910|FG007|Stage 2|Lost to Follow-up|0|||
164070927|NCT03193190|592621911|FG008|Stage 2|Lost to Follow-up|0|||
164070928|NCT03193190|592621912|FG009|Stage 2|Lost to Follow-up|0|||
164070929|NCT03193190|592621913|FG010|Stage 2|Lost to Follow-up|0|||
164070930|NCT03193190|592621914|FG011|Stage 2|Lost to Follow-up|0|||
164070931|NCT03193190|592621915|FG012|Stage 2|Lost to Follow-up|0|||
164070932|NCT03193190|592621916|FG013|Stage 2|Lost to Follow-up|0|||
164070933|NCT03193190|592621917|FG014|Stage 2|Lost to Follow-up|1|||
164070934|NCT03193190|592621918|FG015|Stage 2|Lost to Follow-up|0|||
164070935|NCT03193190|592621903|FG000|Stage 2|Withdrawal by Subject|0|||
164070936|NCT03193190|592621904|FG001|Stage 2|Withdrawal by Subject|0|||
164070937|NCT03193190|592621905|FG002|Stage 2|Withdrawal by Subject|0|||
164070938|NCT03193190|592621906|FG003|Stage 2|Withdrawal by Subject|0|||
164070939|NCT03193190|592621907|FG004|Stage 2|Withdrawal by Subject|0|||
164070940|NCT03193190|592621908|FG005|Stage 2|Withdrawal by Subject|0|||
164070941|NCT03193190|592621909|FG006|Stage 2|Withdrawal by Subject|0|||
164070942|NCT03193190|592621910|FG007|Stage 2|Withdrawal by Subject|0|||
164070943|NCT03193190|592621911|FG008|Stage 2|Withdrawal by Subject|0|||
164070944|NCT03193190|592621912|FG009|Stage 2|Withdrawal by Subject|0|||
164070945|NCT03193190|592621913|FG010|Stage 2|Withdrawal by Subject|0|||
164070946|NCT03193190|592621914|FG011|Stage 2|Withdrawal by Subject|0|||
164070947|NCT03193190|592621915|FG012|Stage 2|Withdrawal by Subject|0|||
164070948|NCT03193190|592621916|FG013|Stage 2|Withdrawal by Subject|1|||
164070949|NCT03193190|592621917|FG014|Stage 2|Withdrawal by Subject|1|||
164070950|NCT03193190|592621918|FG015|Stage 2|Withdrawal by Subject|0|||
164070951|NCT03532295|592621919|FG000|Overall Study|Did not start treatment|0|||
164070952|NCT03532295|592621920|FG001|Overall Study|Did not start treatment|2|||
164070953|NCT05004181|592621921|FG000|Overall Study|Withdrawal of consent|0|||
164070954|NCT05004181|592621922|FG001|Overall Study|Withdrawal of consent|0|||
164070955|NCT05004181|592621923|FG002|Overall Study|Withdrawal of consent|1|||
164070956|NCT05004181|592621924|FG003|Overall Study|Withdrawal of consent|3|||
164070957|NCT05004181|592621925|FG004|Overall Study|Withdrawal of consent|3|||
164070958|NCT05004181|592621926|FG005|Overall Study|Withdrawal of consent|0|||
164070959|NCT05004181|592621927|FG006|Overall Study|Withdrawal of consent|30|||
164070960|NCT05004181|592621928|FG007|Overall Study|Withdrawal of consent|9|||
164070961|NCT05004181|592621929|FG008|Overall Study|Withdrawal of consent|3|||
164070962|NCT05004181|592621930|FG009|Overall Study|Withdrawal of consent|2|||
164070963|NCT05004181|592621931|FG010|Overall Study|Withdrawal of consent|5|||
164070964|NCT05004181|592621932|FG011|Overall Study|Withdrawal of consent|1|||
164070965|NCT05004181|592621921|FG000|Overall Study|Lost to Follow-up|2|||
164070966|NCT05004181|592621922|FG001|Overall Study|Lost to Follow-up|4|||
164070967|NCT05004181|592621923|FG002|Overall Study|Lost to Follow-up|2|||
164070968|NCT05004181|592621924|FG003|Overall Study|Lost to Follow-up|3|||
164070969|NCT05004181|592621925|FG004|Overall Study|Lost to Follow-up|5|||
164070970|NCT05004181|592621926|FG005|Overall Study|Lost to Follow-up|2|||
164070971|NCT05004181|592621927|FG006|Overall Study|Lost to Follow-up|15|||
164070972|NCT05004181|592621928|FG007|Overall Study|Lost to Follow-up|12|||
164070973|NCT05004181|592621929|FG008|Overall Study|Lost to Follow-up|38|||
164070974|NCT05004181|592621930|FG009|Overall Study|Lost to Follow-up|6|||
164070975|NCT05004181|592621931|FG010|Overall Study|Lost to Follow-up|6|||
164070976|NCT05004181|592621932|FG011|Overall Study|Lost to Follow-up|0|||
164070977|NCT05004181|592621921|FG000|Overall Study|Death|0|||
164070978|NCT05004181|592621922|FG001|Overall Study|Death|0|||
164070979|NCT05004181|592621923|FG002|Overall Study|Death|0|||
164070980|NCT05004181|592621924|FG003|Overall Study|Death|0|||
164070981|NCT05004181|592621925|FG004|Overall Study|Death|0|||
164070982|NCT05004181|592621926|FG005|Overall Study|Death|0|||
164070983|NCT05004181|592621927|FG006|Overall Study|Death|1|||
164070984|NCT05004181|592621928|FG007|Overall Study|Death|0|||
164070985|NCT05004181|592621929|FG008|Overall Study|Death|2|||
164070986|NCT05004181|592621930|FG009|Overall Study|Death|0|||
164070987|NCT05004181|592621931|FG010|Overall Study|Death|0|||
164070988|NCT05004181|592621932|FG011|Overall Study|Death|0|||
164070989|NCT05004181|592621921|FG000|Overall Study|Physician Decision|0|||
164070990|NCT05004181|592621922|FG001|Overall Study|Physician Decision|0|||
164070991|NCT05004181|592621923|FG002|Overall Study|Physician Decision|0|||
164070992|NCT05004181|592621924|FG003|Overall Study|Physician Decision|0|||
164070993|NCT05004181|592621925|FG004|Overall Study|Physician Decision|0|||
164070994|NCT05004181|592621926|FG005|Overall Study|Physician Decision|0|||
164070995|NCT05004181|592621927|FG006|Overall Study|Physician Decision|2|||
164070996|NCT05004181|592621928|FG007|Overall Study|Physician Decision|0|||
164070997|NCT05004181|592621929|FG008|Overall Study|Physician Decision|7|||
164070998|NCT05004181|592621930|FG009|Overall Study|Physician Decision|0|||
164070999|NCT05004181|592621931|FG010|Overall Study|Physician Decision|0|||
164071000|NCT05004181|592621932|FG011|Overall Study|Physician Decision|0|||
164071001|NCT05004181|592621921|FG000|Overall Study|Withdrawal by Subject|2|||
164071002|NCT05004181|592621922|FG001|Overall Study|Withdrawal by Subject|3|||
164071003|NCT05004181|592621923|FG002|Overall Study|Withdrawal by Subject|2|||
164071004|NCT05004181|592621924|FG003|Overall Study|Withdrawal by Subject|2|||
164071005|NCT05004181|592621925|FG004|Overall Study|Withdrawal by Subject|4|||
164071006|NCT05004181|592621926|FG005|Overall Study|Withdrawal by Subject|2|||
164071007|NCT05004181|592621927|FG006|Overall Study|Withdrawal by Subject|4|||
164071008|NCT05004181|592621928|FG007|Overall Study|Withdrawal by Subject|22|||
164071009|NCT05004181|592621929|FG008|Overall Study|Withdrawal by Subject|8|||
164071010|NCT05004181|592621930|FG009|Overall Study|Withdrawal by Subject|1|||
164071011|NCT05004181|592621931|FG010|Overall Study|Withdrawal by Subject|3|||
164071012|NCT05004181|592621932|FG011|Overall Study|Withdrawal by Subject|2|||
164071013|NCT05004181|592621921|FG000|Overall Study|Protocol Violation|2|||
164071014|NCT05004181|592621922|FG001|Overall Study|Protocol Violation|3|||
164071015|NCT05004181|592621923|FG002|Overall Study|Protocol Violation|0|||
164071016|NCT05004181|592621924|FG003|Overall Study|Protocol Violation|0|||
164071017|NCT05004181|592621925|FG004|Overall Study|Protocol Violation|1|||
164071018|NCT05004181|592621926|FG005|Overall Study|Protocol Violation|0|||
164071019|NCT05004181|592621927|FG006|Overall Study|Protocol Violation|16|||
164071020|NCT05004181|592621928|FG007|Overall Study|Protocol Violation|18|||
164071021|NCT05004181|592621929|FG008|Overall Study|Protocol Violation|2|||
164071022|NCT05004181|592621930|FG009|Overall Study|Protocol Violation|2|||
164071023|NCT05004181|592621931|FG010|Overall Study|Protocol Violation|2|||
164071024|NCT05004181|592621932|FG011|Overall Study|Protocol Violation|1|||
164071025|NCT05004181|592621921|FG000|Overall Study|Not further specified|1|||
164071026|NCT05004181|592621922|FG001|Overall Study|Not further specified|0|||
164071027|NCT05004181|592621923|FG002|Overall Study|Not further specified|0|||
164071028|NCT05004181|592621924|FG003|Overall Study|Not further specified|0|||
164071029|NCT05004181|592621925|FG004|Overall Study|Not further specified|0|||
164071030|NCT05004181|592621926|FG005|Overall Study|Not further specified|0|||
164071031|NCT05004181|592621927|FG006|Overall Study|Not further specified|1|||
164071032|NCT05004181|592621928|FG007|Overall Study|Not further specified|0|||
164071033|NCT05004181|592621929|FG008|Overall Study|Not further specified|2|||
164071034|NCT05004181|592621930|FG009|Overall Study|Not further specified|1|||
164071035|NCT05004181|592621931|FG010|Overall Study|Not further specified|0|||
164071036|NCT05004181|592621932|FG011|Overall Study|Not further specified|1|||
164106030|NCT04349267|592751758|FG006|Overall Study|Participant withdrew consent|1|||
164106031|NCT04618211|592751759|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
164106032|NCT04618211|592751760|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
164106033|NCT04618211|592751761|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
164106034|NCT04618211|592751759|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
164106035|NCT04618211|592751760|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
164106036|NCT04618211|592751761|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
164106037|NCT04618211|592751759|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
164106038|NCT04618211|592751760|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
164106039|NCT04618211|592751761|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
164106040|NCT01244620|592751764|FG000|Overall Study|Study terminated|4|||
164106041|NCT01244620|592751765|FG001|Overall Study|Study terminated|4|||
164106042|NCT01244620|592751766|FG002|Overall Study|Study terminated|4|||
164106043|NCT01244620|592751767|FG003|Overall Study|Study terminated|4|||
164106044|NCT00848536|592751768|FG000|Overall Study|Adverse Event|2|||
164106045|NCT00848536|592751769|FG001|Overall Study|Adverse Event|2|||
164106046|NCT00848536|592751768|FG000|Overall Study|Withdrawal by Subject|0|||
164106047|NCT00848536|592751769|FG001|Overall Study|Withdrawal by Subject|1|||
164106048|NCT00848536|592751768|FG000|Overall Study|Protocol Violation|0|||
164106049|NCT00848536|592751769|FG001|Overall Study|Protocol Violation|1|||
164106050|NCT00848536|592751768|FG000|Overall Study|Noncompliance|1|||
164106051|NCT00848536|592751769|FG001|Overall Study|Noncompliance|0|||
164106052|NCT00848536|592751768|FG000|Overall Study|Inadequate Control of IOP|1|||
164106053|NCT00848536|592751769|FG001|Overall Study|Inadequate Control of IOP|1|||
164106054|NCT00848536|592751768|FG000|Overall Study|Patient Moved|0|||
164106055|NCT00848536|592751769|FG001|Overall Study|Patient Moved|2|||
164106056|NCT01175135|592751770|FG000|Overall Study|Adverse Event|2|||
164106057|NCT01175135|592751771|FG001|Overall Study|Adverse Event|5|||
164106058|NCT01175135|592751772|FG002|Overall Study|Adverse Event|3|||
164106059|NCT01175135|592751773|FG003|Overall Study|Adverse Event|4|||
164106060|NCT01175135|592751770|FG000|Overall Study|Death|1|||
164106061|NCT01175135|592751771|FG001|Overall Study|Death|0|||
164106062|NCT01175135|592751772|FG002|Overall Study|Death|0|||
164106063|NCT01175135|592751773|FG003|Overall Study|Death|0|||
164106064|NCT01175135|592751770|FG000|Overall Study|Lack of Efficacy|4|||
164106065|NCT01175135|592751771|FG001|Overall Study|Lack of Efficacy|5|||
164106066|NCT01175135|592751772|FG002|Overall Study|Lack of Efficacy|0|||
164106067|NCT01175135|592751773|FG003|Overall Study|Lack of Efficacy|5|||
164106068|NCT01175135|592751770|FG000|Overall Study|Lost to Follow-up|1|||
164106069|NCT01175135|592751771|FG001|Overall Study|Lost to Follow-up|2|||
164106070|NCT01175135|592751772|FG002|Overall Study|Lost to Follow-up|0|||
164106071|NCT01175135|592751773|FG003|Overall Study|Lost to Follow-up|0|||
164106072|NCT01175135|592751770|FG000|Overall Study|Protocol Violation|1|||
164106073|NCT01175135|592751771|FG001|Overall Study|Protocol Violation|1|||
164106074|NCT01175135|592751772|FG002|Overall Study|Protocol Violation|0|||
164106075|NCT01175135|592751773|FG003|Overall Study|Protocol Violation|0|||
164106076|NCT01175135|592751770|FG000|Overall Study|Withdrawal by Subject|4|||
164106077|NCT01175135|592751771|FG001|Overall Study|Withdrawal by Subject|8|||
164106078|NCT01175135|592751772|FG002|Overall Study|Withdrawal by Subject|5|||
164106079|NCT01175135|592751773|FG003|Overall Study|Withdrawal by Subject|5|||
164106080|NCT01175135|592751770|FG000|Overall Study|Other|3|||
164106081|NCT01175135|592751771|FG001|Overall Study|Other|1|||
164106082|NCT01175135|592751772|FG002|Overall Study|Other|3|||
164106083|NCT01175135|592751773|FG003|Overall Study|Other|0|||
164106084|NCT01175135|592751770|FG000|Overall Study|Randomized But Not Treated|0|||
164106085|NCT01175135|592751771|FG001|Overall Study|Randomized But Not Treated|0|||
164106086|NCT01175135|592751772|FG002|Overall Study|Randomized But Not Treated|1|||
164106087|NCT01175135|592751773|FG003|Overall Study|Randomized But Not Treated|0|||
164106088|NCT00466167|592751774|FG000|Overall Study|Adverse Event|8|||
164106089|NCT00466167|592751775|FG001|Overall Study|Adverse Event|8|||
164106090|NCT00466167|592751776|FG002|Overall Study|Adverse Event|7|||
164106091|NCT00466167|592751774|FG000|Overall Study|Lack of Efficacy|2|||
164106092|NCT00466167|592751775|FG001|Overall Study|Lack of Efficacy|0|||
164106093|NCT00466167|592751776|FG002|Overall Study|Lack of Efficacy|3|||
164106094|NCT00466167|592751774|FG000|Overall Study|Protocol Violation|1|||
164106095|NCT00466167|592751775|FG001|Overall Study|Protocol Violation|1|||
164106096|NCT00466167|592751776|FG002|Overall Study|Protocol Violation|2|||
164106097|NCT00466167|592751774|FG000|Overall Study|Lost to Follow-up|3|||
164106098|NCT00466167|592751775|FG001|Overall Study|Lost to Follow-up|2|||
164106099|NCT00466167|592751776|FG002|Overall Study|Lost to Follow-up|2|||
164106100|NCT00466167|592751774|FG000|Overall Study|Withdrawal by Subject|4|||
164106101|NCT00466167|592751775|FG001|Overall Study|Withdrawal by Subject|1|||
164106102|NCT00466167|592751776|FG002|Overall Study|Withdrawal by Subject|6|||
164106103|NCT00466167|592751774|FG000|Overall Study|patient did not meet inclusion criteria|1|||
164106104|NCT00466167|592751775|FG001|Overall Study|patient did not meet inclusion criteria|0|||
164106105|NCT00466167|592751776|FG002|Overall Study|patient did not meet inclusion criteria|1|||
164106106|NCT00466167|592751774|FG000|Overall Study|Not treated|1|||
164106107|NCT00466167|592751775|FG001|Overall Study|Not treated|0|||
164106108|NCT00466167|592751776|FG002|Overall Study|Not treated|0|||
164106109|NCT03534193|592751779|FG000|Overall Study|Lost to Follow-up|1|||
164106110|NCT03534193|592751780|FG001|Overall Study|Lost to Follow-up|3|||
164106111|NCT04414930|592751781|FG000|Overall Study|Withdrawal by Subject|1|||
164106112|NCT04414930|592751782|FG001|Overall Study|Withdrawal by Subject|3|||
164106113|NCT05470699|592751783|FG000|Overall Study|Did not receive intervention|13|||
164106114|NCT05470699|592751783|FG000|Overall Study|Ineligible|1|||
164106115|NCT03325881|592751784|FG000|Overall Study|Protocol Violation|0|||
164106116|NCT03325881|592751785|FG001|Overall Study|Protocol Violation|1|||
164106117|NCT03325881|592751784|FG000|Overall Study|Withdrawal by Subject|0|||
164106118|NCT03325881|592751785|FG001|Overall Study|Withdrawal by Subject|2|||
164106119|NCT03325881|592751784|FG000|Overall Study|Lack of Efficacy|2|||
164106120|NCT03325881|592751785|FG001|Overall Study|Lack of Efficacy|0|||
164106121|NCT03325881|592751784|FG000|Overall Study|Not treated|1|||
164106122|NCT03325881|592751785|FG001|Overall Study|Not treated|0|||
164106123|NCT03676634|592751786|FG000|Overall Study|Red blood cell loss|1|||
164106124|NCT03676634|592751786|FG000|Overall Study|Out-of-limit pulse|2|||
164106125|NCT00829712|592751791|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164106126|NCT00829712|592751792|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164106127|NCT02294981|592751793|FG000|Overall Study|Lost to Follow-up|1|||
164106128|NCT04128761|592751794|FG000|Overall Study|Lost to Follow-up|5|||
164106129|NCT04128761|592751795|FG001|Overall Study|Lost to Follow-up|6|||
164106130|NCT06539676|592751796|FG000|Overall Study|Early study termination|1|||
164106131|NCT06539676|592751797|FG001|Overall Study|Early study termination|0|||
164106132|NCT06539676|592751798|FG002|Overall Study|Early study termination|6|||
164106133|NCT00909038|592751805|FG000|Overall Study|Protocol Violation|187|||
164106134|NCT00909038|592751805|FG000|Overall Study|Non-evaluable Subjects|230|||
164106135|NCT00207090|592751806|FG000|Overall Study|Study drug toxicity|3|||
164106136|NCT00207090|592751806|FG000|Overall Study|Chest wall mass larger|1|||
164106137|NCT00207090|592751806|FG000|Overall Study|Disease progression/relapse|2|||
164106138|NCT00207090|592751806|FG000|Overall Study|Physician Decision|1|||
164106139|NCT01895335|592751811|FG000|Overall Study|Adverse Event|106|||
164106140|NCT01895335|592751811|FG000|Overall Study|Lack of Efficacy|53|||
164106141|NCT01895335|592751811|FG000|Overall Study|Poor Compliance to Protocol|11|||
164106142|NCT01895335|592751811|FG000|Overall Study|Included But Not treated|1|||
164106143|NCT01895335|592751811|FG000|Overall Study|Other than Specified Above|44|||
164106144|NCT03480763|592751812|FG000|Overall Study|Withdrawal by Subject|18|||
164106145|NCT03480763|592751813|FG001|Overall Study|Withdrawal by Subject|10|||
164106146|NCT03480763|592751812|FG000|Overall Study|Lost to Follow-up|4|||
164106147|NCT03480763|592751813|FG001|Overall Study|Lost to Follow-up|7|||
164106148|NCT03480763|592751812|FG000|Overall Study|non-study pneumococcal vaccine|1|||
164106149|NCT03480763|592751813|FG001|Overall Study|non-study pneumococcal vaccine|0|||
164106150|NCT03480763|592751812|FG000|Overall Study|oncological treatment|0|||
164106151|NCT03480763|592751813|FG001|Overall Study|oncological treatment|2|||
164106152|NCT03480763|592751812|FG000|Overall Study|pain with vaccination|1|||
164106153|NCT03480763|592751813|FG001|Overall Study|pain with vaccination|0|||
164106154|NCT01647828|592751816|FG000|Overall Study|Death|3|||
164106155|NCT01647828|592751817|FG001|Overall Study|Death|4|||
164106156|NCT01647828|592751818|FG002|Overall Study|Death|4|||
164106157|NCT01647828|592751819|FG003|Overall Study|Death|5|||
164106158|NCT01647828|592751820|FG004|Overall Study|Death|6|||
164106159|NCT01647828|592751821|FG005|Overall Study|Death|3|||
164106160|NCT01647828|592751822|FG006|Overall Study|Death|10|||
164106161|NCT01647828|592751823|FG007|Overall Study|Death|60|||
164106162|NCT01647828|592751824|FG008|Overall Study|Death|71|||
164106163|NCT01647828|592751816|FG000|Overall Study|Withdrawal by Subject|2|||
164106164|NCT01647828|592751817|FG001|Overall Study|Withdrawal by Subject|0|||
164106165|NCT01647828|592751818|FG002|Overall Study|Withdrawal by Subject|0|||
164106166|NCT01647828|592751819|FG003|Overall Study|Withdrawal by Subject|1|||
164106167|NCT01647828|592751820|FG004|Overall Study|Withdrawal by Subject|0|||
164106168|NCT01647828|592751821|FG005|Overall Study|Withdrawal by Subject|0|||
164106169|NCT01647828|592751822|FG006|Overall Study|Withdrawal by Subject|1|||
164106170|NCT01647828|592751823|FG007|Overall Study|Withdrawal by Subject|0|||
164106171|NCT01647828|592751824|FG008|Overall Study|Withdrawal by Subject|2|||
164106172|NCT01647828|592751816|FG000|Overall Study|Study terminated by Sponsor|0|||
164106173|NCT01647828|592751817|FG001|Overall Study|Study terminated by Sponsor|0|||
164106174|NCT01647828|592751818|FG002|Overall Study|Study terminated by Sponsor|0|||
164106175|NCT01647828|592751819|FG003|Overall Study|Study terminated by Sponsor|0|||
164106176|NCT01647828|592751820|FG004|Overall Study|Study terminated by Sponsor|0|||
164106177|NCT01647828|592751821|FG005|Overall Study|Study terminated by Sponsor|0|||
164106178|NCT01647828|592751822|FG006|Overall Study|Study terminated by Sponsor|1|||
164106179|NCT01647828|592751823|FG007|Overall Study|Study terminated by Sponsor|26|||
164106180|NCT01647828|592751824|FG008|Overall Study|Study terminated by Sponsor|16|||
164106181|NCT01647828|592751816|FG000|Overall Study|Lost to Follow-up|0|||
164106182|NCT01647828|592751817|FG001|Overall Study|Lost to Follow-up|0|||
164106183|NCT01647828|592751818|FG002|Overall Study|Lost to Follow-up|0|||
164106184|NCT01647828|592751819|FG003|Overall Study|Lost to Follow-up|0|||
164106185|NCT01647828|592751820|FG004|Overall Study|Lost to Follow-up|0|||
164106186|NCT01647828|592751821|FG005|Overall Study|Lost to Follow-up|0|||
164106187|NCT01647828|592751822|FG006|Overall Study|Lost to Follow-up|0|||
164106188|NCT01647828|592751823|FG007|Overall Study|Lost to Follow-up|2|||
164106189|NCT01647828|592751824|FG008|Overall Study|Lost to Follow-up|0|||
164106190|NCT00115063|592751825|FG000|Overall Study|Lost to Follow-up|98|||
164106191|NCT00115063|592751826|FG001|Overall Study|Lost to Follow-up|104|||
164106192|NCT00115063|592751825|FG000|Overall Study|Death|1|||
164106193|NCT00115063|592751826|FG001|Overall Study|Death|0|||
164106194|NCT00185458|592751831|FG000|Contraception Phase|Adverse Event|37|||
164106195|NCT00185458|592751831|FG000|Contraception Phase|Lost to Follow-up|10|||
164106196|NCT00185458|592751831|FG000|Contraception Phase|Protocol Violation|2|||
164106197|NCT00185458|592751831|FG000|Contraception Phase|Physician Decision|2|||
164106198|NCT00185458|592751831|FG000|Contraception Phase|Withdrawal by Subject|7|||
164106199|NCT00185458|592751831|FG000|HRT Phase|Adverse Event|18|||
164106200|NCT00185458|592751831|FG000|HRT Phase|Lost to Follow-up|4|||
164106201|NCT00185458|592751831|FG000|HRT Phase|Protocol Violation|2|||
164106202|NCT00185458|592751831|FG000|HRT Phase|Withdrawal by Subject|3|||
164106203|NCT00830024|592751832|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164106204|NCT00830024|592751833|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164106205|NCT02554890|592751834|FG000|Double-blind|Adverse Event|45|||
164106206|NCT02554890|592751835|FG001|Double-blind|Adverse Event|51|||
164106207|NCT02554890|592751834|FG000|Double-blind|Death|6|||
164106208|NCT02554890|592751835|FG001|Double-blind|Death|4|||
164106209|NCT02554890|592751834|FG000|Double-blind|Protocol Violation|1|||
164106210|NCT02554890|592751835|FG001|Double-blind|Protocol Violation|1|||
164106211|NCT02554890|592751834|FG000|Double-blind|Physician Decision|4|||
164106212|NCT02554890|592751835|FG001|Double-blind|Physician Decision|3|||
164106213|NCT02554890|592751834|FG000|Double-blind|Subject/Guardian decision|21|||
164106214|NCT02554890|592751835|FG001|Double-blind|Subject/Guardian decision|16|||
164106215|NCT02554890|592751834|FG000|Double-blind|Lost to Follow-up|7|||
164106216|NCT02554890|592751835|FG001|Double-blind|Lost to Follow-up|5|||
164106217|NCT02554890|592751834|FG000|Double-blind|Technical problems|1|||
164071037|NCT03868059|592621934|FG000|Overall Study|Adverse Event|3|||
164071038|NCT03868059|592621934|FG000|Overall Study|Lost to Follow-up|3|||
164071039|NCT03868059|592621934|FG000|Overall Study|Withdrawal by Subject|6|||
164071040|NCT04278872|592621935|FG000|Overall Study|Adverse Event|1|||
164071041|NCT04278872|592621936|FG001|Overall Study|Adverse Event|0|||
164071042|NCT04278872|592621935|FG000|Overall Study|Protocol Violation|0|||
164071043|NCT04278872|592621936|FG001|Overall Study|Protocol Violation|1|||
164071044|NCT04278872|592621935|FG000|Overall Study|Study Termination|2|||
164071045|NCT04278872|592621936|FG001|Overall Study|Study Termination|0|||
164071046|NCT02392377|592621937|FG000|Overall Study|Withdrawal by Subject|0|||
164071047|NCT02392377|592621938|FG001|Overall Study|Withdrawal by Subject|1|||
164071048|NCT01298661|592621939|FG000|Overall Study|Withdrawal by Subject|2|||
164071049|NCT01298661|592621940|FG001|Overall Study|Withdrawal by Subject|0|||
164071050|NCT01298661|592621941|FG002|Overall Study|Withdrawal by Subject|2|||
164071051|NCT01607398|592623136|FG000|Overall Study|Adverse Event|0|||
164071052|NCT01607398|592623137|FG001|Overall Study|Adverse Event|2|||
164071053|NCT01607398|592623136|FG000|Overall Study|Severe COPD|2|||
164071054|NCT01607398|592623137|FG001|Overall Study|Severe COPD|0|||
164071055|NCT02239692|592623138|FG000|Overall Study|Incomplete colonoscopy|1|||
164071056|NCT02239692|592623139|FG001|Overall Study|Incomplete colonoscopy|2|||
164071057|NCT02239692|592623138|FG000|Overall Study|Adverse Event|0|||
164071058|NCT02239692|592623139|FG001|Overall Study|Adverse Event|1|||
164071059|NCT02239692|592623138|FG000|Overall Study|Physician Decision|0|||
164071060|NCT02239692|592623139|FG001|Overall Study|Physician Decision|1|||
164071061|NCT02239692|592623138|FG000|Overall Study|Lost to Follow-up|1|||
164071062|NCT02239692|592623139|FG001|Overall Study|Lost to Follow-up|4|||
164071063|NCT02239692|592623138|FG000|Overall Study|Withdrawal by Subject|3|||
164071064|NCT02239692|592623139|FG001|Overall Study|Withdrawal by Subject|5|||
164071065|NCT02239692|592623138|FG000|Overall Study|Other reason|1|||
164071066|NCT02239692|592623139|FG001|Overall Study|Other reason|0|||
164071067|NCT01901146|592623141|FG000|Neoadjuvant Phase|Death|1|||
164071068|NCT01901146|592623142|FG001|Neoadjuvant Phase|Death|2|||
164071069|NCT01901146|592623143|FG002|Neoadjuvant Phase|Death|0|||
164071070|NCT01901146|592623144|FG003|Neoadjuvant Phase|Death|0|||
164071071|NCT01901146|592623145|FG004|Neoadjuvant Phase|Death|0|||
164106218|NCT02554890|592751835|FG001|Double-blind|Technical problems|0|||
164106219|NCT02554890|592751834|FG000|Double-blind|Withdrawal by Subject|5|||
164106220|NCT02554890|592751835|FG001|Double-blind|Withdrawal by Subject|6|||
164106221|NCT02554890|592751834|FG000|Double-blind|Noncompliance with study treatment|6|||
164106222|NCT02554890|592751835|FG001|Double-blind|Noncompliance with study treatment|5|||
164106223|NCT02554890|592751834|FG000|Open-label|Adverse Event|0|||
164106224|NCT02554890|592751835|FG001|Open-label|Adverse Event|30|||
164071072|NCT01901146|592623141|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
164071073|NCT01901146|592623142|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
164071074|NCT01901146|592623143|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
164071075|NCT01901146|592623144|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
164106225|NCT02554890|592751834|FG000|Open-label|Death|0|||
164106226|NCT02554890|592751835|FG001|Open-label|Death|1|||
164106227|NCT02554890|592751834|FG000|Open-label|Physician Decision|0|||
164106228|NCT02554890|592751835|FG001|Open-label|Physician Decision|1|||
164106229|NCT02554890|592751834|FG000|Open-label|Subject/Guardian decision|0|||
164106230|NCT02554890|592751835|FG001|Open-label|Subject/Guardian decision|11|||
164106231|NCT02554890|592751834|FG000|Open-label|Lost to Follow-up|0|||
164106232|NCT02554890|592751835|FG001|Open-label|Lost to Follow-up|7|||
164106233|NCT02554890|592751834|FG000|Open-label|Technical problems|0|||
164106234|NCT02554890|592751835|FG001|Open-label|Technical problems|1|||
164106235|NCT02554890|592751834|FG000|Open-label|Withdrawal by Subject|0|||
164106236|NCT02554890|592751835|FG001|Open-label|Withdrawal by Subject|1|||
164106237|NCT03649477|592751840|FG000|Overall Study|Adverse Event|2|||
164106238|NCT03649477|592751841|FG001|Overall Study|Adverse Event|0|||
164106239|NCT03649477|592751842|FG002|Overall Study|Adverse Event|0|||
164106240|NCT04544410|592751843|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164106241|NCT04544410|592751844|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164106242|NCT04544410|592751843|FG000|Double-blind Treatment Period|Adverse Event|1|||
164106243|NCT04544410|592751844|FG001|Double-blind Treatment Period|Adverse Event|0|||
164106244|NCT04544410|592751843|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164106245|NCT04544410|592751844|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
164106246|NCT04544410|592751843|FG000|Double-blind Treatment Period|Protocol Violation|1|||
164106247|NCT04544410|592751844|FG001|Double-blind Treatment Period|Protocol Violation|0|||
164106248|NCT04544410|592751843|FG000|Open-Label Treatment Period|Study Terminated|15|||
164106249|NCT04544410|592751844|FG001|Open-Label Treatment Period|Study Terminated|19|||
164106250|NCT04544410|592751843|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
164106251|NCT04544410|592751844|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
164106252|NCT04544410|592751843|FG000|Open-Label Treatment Period|Adverse Event|0|||
164106253|NCT04544410|592751844|FG001|Open-Label Treatment Period|Adverse Event|1|||
164106254|NCT04544410|592751843|FG000|Open-Label Treatment Period|Physician Decision|1|||
164106255|NCT04544410|592751844|FG001|Open-Label Treatment Period|Physician Decision|0|||
164106256|NCT04544410|592751843|FG000|Open-Label Treatment Period|Other|0|||
164106257|NCT04544410|592751844|FG001|Open-Label Treatment Period|Other|1|||
164106258|NCT03599193|592753209|FG000|Overall Study|Adverse Event|0|||
164106259|NCT03599193|592753210|FG001|Overall Study|Adverse Event|2|||
164106260|NCT03599193|592753209|FG000|Overall Study|Withdrawal by Subject|1|||
164106261|NCT03599193|592753210|FG001|Overall Study|Withdrawal by Subject|0|||
164106262|NCT03599193|592753209|FG000|Overall Study|Protocol Violation|1|||
164106263|NCT03599193|592753210|FG001|Overall Study|Protocol Violation|0|||
164106264|NCT03599193|592753209|FG000|Overall Study|Lost to Follow-up|0|||
164106265|NCT03599193|592753210|FG001|Overall Study|Lost to Follow-up|1|||
164106266|NCT01750294|592753211|FG000|Overall Study|Withdrawal by Subject|1|||
164106267|NCT01750294|592753211|FG000|Overall Study|Safety Endpoint|1|||
164106268|NCT01624233|592753212|FG000|Period 2 - Induction|Adverse Event|1|||
164106269|NCT01624233|592753212|FG000|Period 3 - Maintenance|Adverse Event|2|||
164106270|NCT01624233|592753212|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
164106271|NCT01624233|592753212|FG000|Period 3 - Maintenance|Physician Decision|2|||
164106272|NCT01624233|592753212|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
164106273|NCT01624233|592753212|FG000|Period 4 - Drug Free Period|Relapsed|61|||
164106274|NCT01624233|592753212|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
164106275|NCT01624233|592753212|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
164106276|NCT01624233|592753212|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
164106277|NCT01624233|592753212|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
164106278|NCT01624233|592753212|FG000|Period 6: Follow-up|Adverse Event|3|||
164106279|NCT01624233|592753212|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
164106280|NCT01624233|592753212|FG000|Period 6: Follow-up|Physician Decision|1|||
164106281|NCT01624233|592753212|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
164106282|NCT03121586|592753215|FG000|Overall Study|Study terminated by sponsor|0|||
164106283|NCT03121586|592753216|FG001|Overall Study|Study terminated by sponsor|0|||
164106284|NCT03121586|592753217|FG002|Overall Study|Study terminated by sponsor|99|||
164106285|NCT03121586|592753215|FG000|Overall Study|Withdrawal by Subject|37|||
164106286|NCT03121586|592753216|FG001|Overall Study|Withdrawal by Subject|14|||
164106287|NCT03121586|592753217|FG002|Overall Study|Withdrawal by Subject|9|||
164106288|NCT03121586|592753215|FG000|Overall Study|Not further specified|6|||
164106289|NCT03121586|592753216|FG001|Overall Study|Not further specified|11|||
164106290|NCT03121586|592753217|FG002|Overall Study|Not further specified|10|||
164106291|NCT03121586|592753215|FG000|Overall Study|Adverse Event|16|||
164106292|NCT03121586|592753216|FG001|Overall Study|Adverse Event|5|||
164106293|NCT03121586|592753217|FG002|Overall Study|Adverse Event|6|||
164106294|NCT03121586|592753215|FG000|Overall Study|Protocol Violation|0|||
164106295|NCT03121586|592753216|FG001|Overall Study|Protocol Violation|5|||
164106296|NCT03121586|592753217|FG002|Overall Study|Protocol Violation|0|||
164106297|NCT03121586|592753215|FG000|Overall Study|Lack of Efficacy|3|||
164106298|NCT03121586|592753216|FG001|Overall Study|Lack of Efficacy|3|||
164106299|NCT03121586|592753217|FG002|Overall Study|Lack of Efficacy|1|||
164106300|NCT03121586|592753215|FG000|Overall Study|Physician Decision|2|||
164106301|NCT03121586|592753216|FG001|Overall Study|Physician Decision|2|||
164106302|NCT03121586|592753217|FG002|Overall Study|Physician Decision|0|||
164071076|NCT01901146|592623145|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
164071077|NCT01901146|592623141|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
164071078|NCT01901146|592623142|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
164071079|NCT01901146|592623143|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
164071080|NCT01901146|592623144|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
164071081|NCT01901146|592623145|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
164071082|NCT01901146|592623141|FG000|Neoadjuvant Phase|Physician Decision|1|||
164071083|NCT01901146|592623142|FG001|Neoadjuvant Phase|Physician Decision|2|||
164071084|NCT01901146|592623143|FG002|Neoadjuvant Phase|Physician Decision|0|||
164071085|NCT01901146|592623144|FG003|Neoadjuvant Phase|Physician Decision|0|||
164071086|NCT01901146|592623145|FG004|Neoadjuvant Phase|Physician Decision|0|||
164071087|NCT01901146|592623141|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
164071088|NCT01901146|592623142|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
164071089|NCT01901146|592623143|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
164071090|NCT01901146|592623144|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
164071091|NCT01901146|592623145|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
164071092|NCT01901146|592623141|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164071093|NCT01901146|592623142|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
164071094|NCT01901146|592623143|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164071095|NCT01901146|592623144|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164071096|NCT01901146|592623145|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
164071097|NCT01901146|592623141|FG000|Adjuvant Phase|Other|0|||
164071098|NCT01901146|592623142|FG001|Adjuvant Phase|Other|0|||
164071099|NCT01901146|592623143|FG002|Adjuvant Phase|Other|1|||
164071100|NCT01901146|592623144|FG003|Adjuvant Phase|Other|0|||
164071101|NCT01901146|592623145|FG004|Adjuvant Phase|Other|0|||
164071102|NCT01901146|592623141|FG000|Adjuvant Phase|Death|0|||
164071103|NCT01901146|592623142|FG001|Adjuvant Phase|Death|0|||
164071104|NCT01901146|592623143|FG002|Adjuvant Phase|Death|0|||
164071105|NCT01901146|592623144|FG003|Adjuvant Phase|Death|0|||
164071106|NCT01901146|592623145|FG004|Adjuvant Phase|Death|3|||
164071107|NCT01901146|592623141|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
164071108|NCT01901146|592623142|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
164071109|NCT01901146|592623143|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
164071110|NCT01901146|592623144|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
164071111|NCT01901146|592623145|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
164071112|NCT01901146|592623141|FG000|Adjuvant Phase|Physician Decision|0|||
164071113|NCT01901146|592623142|FG001|Adjuvant Phase|Physician Decision|0|||
164071114|NCT01901146|592623143|FG002|Adjuvant Phase|Physician Decision|9|||
164071115|NCT01901146|592623144|FG003|Adjuvant Phase|Physician Decision|2|||
164071116|NCT01901146|592623145|FG004|Adjuvant Phase|Physician Decision|4|||
164071117|NCT01901146|592623141|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
164071118|NCT01901146|592623142|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
164071119|NCT01901146|592623143|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
164071120|NCT01901146|592623144|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
164071121|NCT01901146|592623145|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
164071122|NCT02675426|592623146|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
164071123|NCT02675426|592623147|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
164071124|NCT02675426|592623148|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
164071125|NCT02675426|592623149|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
164071126|NCT02675426|592623146|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
164071127|NCT02675426|592623147|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
164071128|NCT02675426|592623148|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
164071129|NCT02675426|592623149|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
164071130|NCT02675426|592623146|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
164071131|NCT02675426|592623147|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
164071132|NCT02675426|592623148|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
164071133|NCT02675426|592623149|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
164071134|NCT02675426|592623146|FG000|Period 1: Week 1 to Week 12|Other|2|||
164071135|NCT02675426|592623147|FG001|Period 1: Week 1 to Week 12|Other|1|||
164071136|NCT02675426|592623148|FG002|Period 1: Week 1 to Week 12|Other|0|||
164071137|NCT02675426|592623149|FG003|Period 1: Week 1 to Week 12|Other|2|||
164071138|NCT02675426|592623146|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
164071139|NCT02675426|592623147|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
164071140|NCT02675426|592623148|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
164071141|NCT02675426|592623149|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
164071142|NCT02675426|592623146|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
164071143|NCT02675426|592623147|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
164071144|NCT02675426|592623148|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
164071145|NCT02675426|592623149|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
164071146|NCT02675426|592623146|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
164071147|NCT02675426|592623147|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
164071148|NCT02675426|592623148|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
164071149|NCT02675426|592623149|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
164106303|NCT03121586|592753215|FG000|Overall Study|Noncompliance with study drug|5|||
164106304|NCT03121586|592753216|FG001|Overall Study|Noncompliance with study drug|3|||
164106305|NCT03121586|592753217|FG002|Overall Study|Noncompliance with study drug|5|||
164106306|NCT03121586|592753215|FG000|Overall Study|Lost to Follow-up|4|||
164106307|NCT03121586|592753216|FG001|Overall Study|Lost to Follow-up|2|||
164106308|NCT03121586|592753217|FG002|Overall Study|Lost to Follow-up|0|||
164106309|NCT03121586|592753215|FG000|Overall Study|Death|2|||
164106310|NCT03121586|592753216|FG001|Overall Study|Death|0|||
164106311|NCT03121586|592753217|FG002|Overall Study|Death|0|||
164106312|NCT06381102|592753218|FG000|Washout 5 Days|Withdrawal by Subject|0|||
164106313|NCT06381102|592753219|FG001|Washout 5 Days|Withdrawal by Subject|2|||
164106314|NCT02832063|592753221|FG000|Overall Study|Adverse Event|2|||
164106315|NCT02832063|592753222|FG001|Overall Study|Adverse Event|1|||
164106316|NCT02832063|592753221|FG000|Overall Study|Physician Decision|5|||
164106317|NCT02832063|592753222|FG001|Overall Study|Physician Decision|7|||
164106318|NCT02832063|592753221|FG000|Overall Study|Lost to Follow-up|15|||
164106319|NCT02832063|592753222|FG001|Overall Study|Lost to Follow-up|8|||
164106320|NCT02832063|592753221|FG000|Overall Study|Withdrawal by Subject|10|||
164106321|NCT02832063|592753222|FG001|Overall Study|Withdrawal by Subject|21|||
164106322|NCT02832063|592753221|FG000|Overall Study|Other|2|||
164106323|NCT02832063|592753222|FG001|Overall Study|Other|1|||
164106324|NCT03733730|592753223|FG000|Overall Study|Lost to Follow-up|1|||
164106325|NCT03733730|592753224|FG001|Overall Study|Lost to Follow-up|32|||
164106326|NCT03733730|592753223|FG000|Overall Study|Other|1|||
164106327|NCT03733730|592753224|FG001|Overall Study|Other|0|||
164106328|NCT03733730|592753223|FG000|Overall Study|Adverse Event|0|||
164106329|NCT03733730|592753224|FG001|Overall Study|Adverse Event|4|||
164106330|NCT03733730|592753223|FG000|Overall Study|Death|0|||
164106331|NCT03733730|592753224|FG001|Overall Study|Death|5|||
164106332|NCT03733730|592753223|FG000|Overall Study|Withdrawal by Subject|0|||
164106333|NCT03733730|592753224|FG001|Overall Study|Withdrawal by Subject|8|||
164106334|NCT00772603|592753225|FG000|Overall Study|Withdrawal by Subject|11|||
164106335|NCT00772603|592753226|FG001|Overall Study|Withdrawal by Subject|10|||
164106336|NCT00772603|592753227|FG002|Overall Study|Withdrawal by Subject|6|||
164106337|NCT00772603|592753225|FG000|Overall Study|Adverse Event|37|||
164106338|NCT00772603|592753226|FG001|Overall Study|Adverse Event|18|||
164106339|NCT00772603|592753227|FG002|Overall Study|Adverse Event|10|||
164106340|NCT00772603|592753225|FG000|Overall Study|Subject Non-compliance|1|||
164106341|NCT00772603|592753226|FG001|Overall Study|Subject Non-compliance|6|||
164106342|NCT00772603|592753227|FG002|Overall Study|Subject Non-compliance|4|||
164071150|NCT02675426|592623146|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
164071151|NCT02675426|592623147|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
164071152|NCT02675426|592623148|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
164071153|NCT02675426|592623149|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
164071154|NCT02675426|592623146|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
164071155|NCT02675426|592623147|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
164071156|NCT02675426|592623148|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
164071157|NCT02675426|592623149|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
164071158|NCT02675426|592623146|FG000|Period 2: Week 12 to Week 260|Other|8|||
164071159|NCT02675426|592623147|FG001|Period 2: Week 12 to Week 260|Other|12|||
164071160|NCT02675426|592623148|FG002|Period 2: Week 12 to Week 260|Other|23|||
164071161|NCT02675426|592623149|FG003|Period 2: Week 12 to Week 260|Other|15|||
164071162|NCT03724968|592623152|FG000|Overall Study|Insurance issues|0|||
164071163|NCT03724968|592623153|FG001|Overall Study|Insurance issues|1|||
164071164|NCT03724968|592623152|FG000|Overall Study|Study closed|0|||
164071165|NCT03724968|592623153|FG001|Overall Study|Study closed|1|||
164071166|NCT01784419|592623154|FG000|Overall Study|Adverse Event|3|||
164071167|NCT02237118|592623155|FG000|Overall Study|Protocol Violation|0|||
164071168|NCT02237118|592623156|FG001|Overall Study|Protocol Violation|1|||
164071169|NCT02237118|592623155|FG000|Overall Study|consent withdrawn|1|||
164071170|NCT02237118|592623156|FG001|Overall Study|consent withdrawn|0|||
164071171|NCT00080288|592623157|FG000|Overall Study|Adverse Event|7|||
164071172|NCT00080288|592623158|FG001|Overall Study|Adverse Event|4|||
164071173|NCT00080288|592623157|FG000|Overall Study|Lost to Follow-up|3|||
164106343|NCT00772603|592753225|FG000|Overall Study|Protocol Violation|0|||
164071174|NCT00080288|592623158|FG001|Overall Study|Lost to Follow-up|5|||
164106344|NCT00772603|592753226|FG001|Overall Study|Protocol Violation|1|||
164106345|NCT00772603|592753227|FG002|Overall Study|Protocol Violation|1|||
164106346|NCT00772603|592753225|FG000|Overall Study|Lost to Follow-up|1|||
164106347|NCT00772603|592753226|FG001|Overall Study|Lost to Follow-up|5|||
164106348|NCT00772603|592753227|FG002|Overall Study|Lost to Follow-up|2|||
164106349|NCT00772603|592753225|FG000|Overall Study|Physician Decision|0|||
164106350|NCT00772603|592753226|FG001|Overall Study|Physician Decision|0|||
164106351|NCT00772603|592753227|FG002|Overall Study|Physician Decision|1|||
164106352|NCT00772603|592753225|FG000|Overall Study|Other|2|||
164106353|NCT00772603|592753226|FG001|Overall Study|Other|0|||
164106354|NCT00772603|592753227|FG002|Overall Study|Other|2|||
164106355|NCT00835575|592753228|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
164106356|NCT00835575|592753229|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
164106357|NCT01564394|592753232|FG000|Overall Study|Withdrawal by Subject|6|||
164106358|NCT01564394|592753233|FG001|Overall Study|Withdrawal by Subject|10|||
164106359|NCT00859521|592753234|FG000|Washout|Withdrawal by Subject|0|||
164106360|NCT00859521|592753235|FG001|Washout|Withdrawal by Subject|1|||
164106361|NCT01609257|592753236|FG000|Overall Study|Lost to Follow-up|2|||
164106362|NCT01609257|592753237|FG001|Overall Study|Lost to Follow-up|1|||
164106363|NCT01609257|592753236|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
164106364|NCT01609257|592753237|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
164106365|NCT01609257|592753236|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
164106366|NCT01609257|592753237|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
164106367|NCT02125461|592753238|FG000|Overall Study|Withdrawal by Subject|30|||
164106368|NCT02125461|592753239|FG001|Overall Study|Withdrawal by Subject|16|||
164106369|NCT02125461|592753238|FG000|Overall Study|Lost to Follow-up|8|||
164106370|NCT02125461|592753239|FG001|Overall Study|Lost to Follow-up|3|||
164106371|NCT02125461|592753238|FG000|Overall Study|Death|260|||
164106372|NCT02125461|592753239|FG001|Overall Study|Death|149|||
164106373|NCT02125461|592753238|FG000|Overall Study|Missing Termination Reason|0|||
164106374|NCT02125461|592753239|FG001|Overall Study|Missing Termination Reason|1|||
164106375|NCT03552484|592753248|FG000|Overall Study|Death|6|||
164106376|NCT03552484|592753249|FG001|Overall Study|Death|4|||
164106377|NCT03552484|592753248|FG000|Overall Study|Lost to Follow-up|0|||
164106378|NCT03552484|592753249|FG001|Overall Study|Lost to Follow-up|16|||
164106379|NCT03499353|592753250|FG000|Treatment|Adverse Event|3|||
164106380|NCT03499353|592753250|FG000|Treatment|Progressive Disease|10|||
164106381|NCT03499353|592753250|FG000|Treatment|Other|1|||
164106382|NCT03499353|592753250|FG000|Treatment|Withdrawal by Subject|2|||
164106383|NCT03499353|592753250|FG000|Long-Term Follow-up|Death|2|||
164106384|NCT03499353|592753250|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
164106385|NCT03499353|592753250|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
164106386|NCT02241551|592753251|FG000|Overall Study|Adverse Event|1|||
164106387|NCT02241551|592753252|FG001|Overall Study|Adverse Event|0|||
164071175|NCT00080288|592623157|FG000|Overall Study|Physician Decision|6|||
164071176|NCT00080288|592623158|FG001|Overall Study|Physician Decision|2|||
164071177|NCT00080288|592623157|FG000|Overall Study|Withdrawal by Subject|3|||
164071178|NCT00080288|592623158|FG001|Overall Study|Withdrawal by Subject|16|||
164071179|NCT00080288|592623157|FG000|Overall Study|Miscellaneous|11|||
164071180|NCT00080288|592623158|FG001|Overall Study|Miscellaneous|11|||
164071181|NCT03978117|592623163|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
164071182|NCT03978117|592623164|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
164071183|NCT03978117|592623163|FG000|Overall Study|Lost to Follow-up|4|||
164071184|NCT03978117|592623164|FG001|Overall Study|Lost to Follow-up|4|||
164071185|NCT03976076|592623165|FG000|Overall Study|Withdrawal by Subject|2|||
164071186|NCT00414011|592623166|FG000|Overall Study|Physician Decision|3|||
164071187|NCT00414011|592623166|FG000|Overall Study|Withdrawal by Subject|2|||
164071188|NCT02923115|592623167|FG000|Overall Study|Lost to Follow-up|0|||
164071189|NCT02923115|592623168|FG001|Overall Study|Lost to Follow-up|0|||
164071190|NCT02923115|592623169|FG002|Overall Study|Lost to Follow-up|0|||
164071191|NCT02923115|592623170|FG003|Overall Study|Lost to Follow-up|1|||
164071192|NCT02923115|592623171|FG004|Overall Study|Lost to Follow-up|0|||
164071193|NCT02923115|592623172|FG005|Overall Study|Lost to Follow-up|0|||
164071194|NCT02923115|592623167|FG000|Overall Study|Withdrawal by Subject|0|||
164071195|NCT02923115|592623168|FG001|Overall Study|Withdrawal by Subject|1|||
164071196|NCT02923115|592623169|FG002|Overall Study|Withdrawal by Subject|0|||
164071197|NCT02923115|592623170|FG003|Overall Study|Withdrawal by Subject|0|||
164071198|NCT02923115|592623171|FG004|Overall Study|Withdrawal by Subject|0|||
164071199|NCT02923115|592623172|FG005|Overall Study|Withdrawal by Subject|0|||
164071200|NCT02923115|592623167|FG000|Overall Study|Randomized, but not dosed|0|||
164071201|NCT02923115|592623168|FG001|Overall Study|Randomized, but not dosed|0|||
164071202|NCT02923115|592623169|FG002|Overall Study|Randomized, but not dosed|3|||
164071203|NCT02923115|592623170|FG003|Overall Study|Randomized, but not dosed|1|||
164071204|NCT02923115|592623171|FG004|Overall Study|Randomized, but not dosed|5|||
164071205|NCT02923115|592623172|FG005|Overall Study|Randomized, but not dosed|0|||
164106388|NCT00469898|592753259|FG000|Overall Study|Adverse Event|7|||
164106389|NCT00469898|592753259|FG000|Overall Study|Withdrawal by Subject|4|||
164106390|NCT00469898|592753259|FG000|Overall Study|Death|4|||
164106391|NCT00469898|592753259|FG000|Overall Study|Disease progression|9|||
164106392|NCT00469898|592753259|FG000|Overall Study|Decreased performance status|1|||
164106393|NCT02663349|592753262|FG000|Overall Study|Withdrawal by Subject|6|||
164071206|NCT01296152|592623173|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
164071207|NCT01875991|592623174|FG000|Overall Study|Withdrawal by Subject|6|||
164071208|NCT01875991|592623175|FG001|Overall Study|Withdrawal by Subject|6|||
164071209|NCT01875991|592623174|FG000|Overall Study|Sponsor Decision|1|||
164071210|NCT01875991|592623175|FG001|Overall Study|Sponsor Decision|0|||
164071211|NCT03981614|592623176|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
164106394|NCT02751424|592753270|FG000|Part 2|Adverse Event|0|||
164106395|NCT02751424|592753271|FG001|Part 2|Adverse Event|0|||
164071212|NCT03981614|592623177|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
164071213|NCT03981614|592623178|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
164071214|NCT00756652|592623179|FG000|Original Phase|Withdrawal by Subject|864|||
164071215|NCT00756652|592623180|FG001|Original Phase|Withdrawal by Subject|23|||
164071216|NCT00756652|592623179|FG000|Original Phase|Lost to Follow-up|601|||
164071217|NCT00756652|592623180|FG001|Original Phase|Lost to Follow-up|0|||
164071218|NCT00756652|592623179|FG000|Original Phase|Other Discontinuation|797|||
164071219|NCT00756652|592623180|FG001|Original Phase|Other Discontinuation|5|||
164071220|NCT00756652|592623179|FG000|Original Phase|Participant Noncompliance|18622|||
164071221|NCT00756652|592623180|FG001|Original Phase|Participant Noncompliance|424|||
164071222|NCT00756652|592623179|FG000|Original Phase|Unknown Discontinuation Reason|2|||
164071223|NCT00756652|592623180|FG001|Original Phase|Unknown Discontinuation Reason|0|||
164071224|NCT00756652|592623179|FG000|Original Phase|Participants without data|3259|||
164071225|NCT00756652|592623180|FG001|Original Phase|Participants without data|466|||
164071226|NCT00756652|592623179|FG000|Original Phase|Death|168|||
164071227|NCT00756652|592623180|FG001|Original Phase|Death|1|||
164071228|NCT00756652|592623179|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
164071229|NCT00756652|592623180|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
164071230|NCT00756652|592623179|FG000|Re-Op Phase|Withdrawal by Subject|62|||
164071231|NCT00756652|592623180|FG001|Re-Op Phase|Withdrawal by Subject|0|||
164071232|NCT00756652|592623179|FG000|Re-Op Phase|Death|6|||
164071233|NCT00756652|592623180|FG001|Re-Op Phase|Death|0|||
164071234|NCT00756652|592623179|FG000|Re-Op Phase|Lost to Follow-up|340|||
164071235|NCT00756652|592623180|FG001|Re-Op Phase|Lost to Follow-up|0|||
164071236|NCT00756652|592623179|FG000|Re-Op Phase|Site Closed|2454|||
164071237|NCT00756652|592623180|FG001|Re-Op Phase|Site Closed|0|||
164071238|NCT00756652|592623179|FG000|Re-Op Phase|Withdrawn after explant|14|||
164071239|NCT00756652|592623180|FG001|Re-Op Phase|Withdrawn after explant|0|||
164071240|NCT04732728|592623181|FG000|Overall Study|Death|12|||
164071241|NCT04732728|592623181|FG000|Overall Study|Withdrawn|136|||
164071242|NCT04971226|592623182|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
164071243|NCT04971226|592623183|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
164071244|NCT04971226|592623184|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
164071245|NCT04971226|592623185|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
164071246|NCT04971226|592623182|FG000|Overall Study|Adverse Event|6|||
164071247|NCT04971226|592623183|FG001|Overall Study|Adverse Event|5|||
164071248|NCT04971226|592623184|FG002|Overall Study|Adverse Event|11|||
164071249|NCT04971226|592623185|FG003|Overall Study|Adverse Event|10|||
164071250|NCT04971226|592623182|FG000|Overall Study|Progressive disease|2|||
164071251|NCT04971226|592623183|FG001|Overall Study|Progressive disease|0|||
164071252|NCT04971226|592623184|FG002|Overall Study|Progressive disease|3|||
164071253|NCT04971226|592623185|FG003|Overall Study|Progressive disease|1|||
164071254|NCT04971226|592623182|FG000|Overall Study|Protocol Deviation|1|||
164071255|NCT04971226|592623183|FG001|Overall Study|Protocol Deviation|0|||
164071256|NCT04971226|592623184|FG002|Overall Study|Protocol Deviation|1|||
164071257|NCT04971226|592623185|FG003|Overall Study|Protocol Deviation|1|||
164071258|NCT04971226|592623182|FG000|Overall Study|Subject Decision|0|||
164071259|NCT04971226|592623183|FG001|Overall Study|Subject Decision|1|||
164071260|NCT04971226|592623184|FG002|Overall Study|Subject Decision|1|||
164071261|NCT04971226|592623185|FG003|Overall Study|Subject Decision|1|||
164071262|NCT04971226|592623182|FG000|Overall Study|Pregnancy|0|||
164071263|NCT04971226|592623183|FG001|Overall Study|Pregnancy|0|||
164071264|NCT04971226|592623184|FG002|Overall Study|Pregnancy|0|||
164071265|NCT04971226|592623185|FG003|Overall Study|Pregnancy|1|||
164071266|NCT04971226|592623182|FG000|Overall Study|Participants not treated|1|||
164071267|NCT04971226|592623183|FG001|Overall Study|Participants not treated|0|||
164071268|NCT04971226|592623184|FG002|Overall Study|Participants not treated|2|||
164071269|NCT04971226|592623185|FG003|Overall Study|Participants not treated|1|||
164071270|NCT06065176|592623189|FG000|Overall Study|Lost to Follow-up|11|||
164071271|NCT06065176|592623190|FG001|Overall Study|Lost to Follow-up|11|||
164071272|NCT06065176|592623191|FG002|Overall Study|Lost to Follow-up|10|||
164071273|NCT06065176|592623189|FG000|Overall Study|Withdrawal by Subject|1|||
164071274|NCT06065176|592623190|FG001|Overall Study|Withdrawal by Subject|1|||
164071275|NCT06065176|592623191|FG002|Overall Study|Withdrawal by Subject|2|||
164071276|NCT06065176|592623189|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
164071277|NCT06065176|592623190|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
164071278|NCT06065176|592623191|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
164071279|NCT04521608|592623192|FG000|Overall Study|Death|8|||
164071280|NCT04521608|592623193|FG001|Overall Study|Death|9|||
164071281|NCT04521608|592623192|FG000|Overall Study|Withdrawal by Subject|25|||
164071282|NCT04521608|592623193|FG001|Overall Study|Withdrawal by Subject|18|||
164071283|NCT04521608|592623192|FG000|Overall Study|Disease Progression|3|||
164071284|NCT04521608|592623193|FG001|Overall Study|Disease Progression|10|||
164071285|NCT04521608|592623192|FG000|Overall Study|Complicating Disease|6|||
164071286|NCT04521608|592623193|FG001|Overall Study|Complicating Disease|3|||
164071287|NCT04521608|592623192|FG000|Overall Study|Lost Contact|25|||
164071288|NCT04521608|592623193|FG001|Overall Study|Lost Contact|27|||
164071289|NCT04521608|592623192|FG000|Overall Study|Ineligible|1|||
164071290|NCT04521608|592623193|FG001|Overall Study|Ineligible|0|||
164071291|NCT04521608|592623192|FG000|Overall Study|Refused Further Study Participation|13|||
164071292|NCT04521608|592623193|FG001|Overall Study|Refused Further Study Participation|7|||
164071293|NCT03889197|592623194|FG000|Overall Study|Withdrawal by Subject|1|||
164071294|NCT03889197|592623195|FG001|Overall Study|Withdrawal by Subject|0|||
164071295|NCT03889197|592623194|FG000|Overall Study|Physician Decision|0|||
164071296|NCT03889197|592623195|FG001|Overall Study|Physician Decision|1|||
164071297|NCT03889197|592623194|FG000|Overall Study|met exclusion criteria|0|||
164071298|NCT03889197|592623195|FG001|Overall Study|met exclusion criteria|1|||
164071299|NCT03889197|592623194|FG000|Overall Study|Protocol Violation|1|||
164071300|NCT03889197|592623195|FG001|Overall Study|Protocol Violation|0|||
164071301|NCT04083378|592623198|FG000|Overall Study|Death|18|||
164071302|NCT04083378|592623199|FG001|Overall Study|Death|4|||
164071303|NCT04083378|592623198|FG000|Overall Study|Lost to Follow-up|4|||
164071304|NCT04083378|592623199|FG001|Overall Study|Lost to Follow-up|0|||
164071305|NCT05824273|592623200|FG000|Overall Study|Lost to Follow-up|16|||
164071306|NCT05824273|592623201|FG001|Overall Study|Lost to Follow-up|13|||
164071307|NCT04644237|592623207|FG000|Overall Study|Death|4|||
164071308|NCT04644237|592623208|FG001|Overall Study|Death|2|||
164071309|NCT04644237|592623207|FG000|Overall Study|Adverse Event|18|||
164071310|NCT04644237|592623208|FG001|Overall Study|Adverse Event|19|||
164071311|NCT04644237|592623207|FG000|Overall Study|Progressive Disease|61|||
164071312|NCT04644237|592623208|FG001|Overall Study|Progressive Disease|23|||
164071313|NCT04644237|592623207|FG000|Overall Study|Clinical Progression|4|||
164071314|NCT04644237|592623208|FG001|Overall Study|Clinical Progression|1|||
164071315|NCT04644237|592623207|FG000|Overall Study|Withdrawal by Subject|4|||
164071316|NCT04644237|592623208|FG001|Overall Study|Withdrawal by Subject|2|||
164071317|NCT04644237|592623207|FG000|Overall Study|Physician Decision|4|||
164071318|NCT04644237|592623208|FG001|Overall Study|Physician Decision|0|||
164071319|NCT04644237|592623207|FG000|Overall Study|Other|6|||
164071320|NCT04644237|592623208|FG001|Overall Study|Other|3|||
164071321|NCT04644237|592623207|FG000|Overall Study|Randomized but not Treated|1|||
164071322|NCT04644237|592623208|FG001|Overall Study|Randomized but not Treated|0|||
164071323|NCT03131817|592623209|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
164071324|NCT02061293|592623211|FG000|Overall Study|Elevated Blood Pressure|1|||
164071325|NCT02061293|592623212|FG001|Overall Study|Elevated Blood Pressure|1|||
164071326|NCT02949219|592623219|FG000|Overall Study|Withdrawal by Subject|1|||
164071327|NCT03494816|592623220|FG000|Overall Study|Protocol Violation|2|||
164071328|NCT03494816|592623220|FG000|Overall Study|Physician Decision|2|||
164071329|NCT03494816|592623220|FG000|Overall Study|Did not start trial treatment|1|||
164071330|NCT03494816|592623220|FG000|Overall Study|Adverse Event|1|||
164071331|NCT00633217|592623234|FG000|Overall Study|Adverse Event|5|||
164071332|NCT00633217|592623235|FG001|Overall Study|Adverse Event|9|||
164071333|NCT00633217|592623234|FG000|Overall Study|Lack of Efficacy|0|||
164071334|NCT00633217|592623235|FG001|Overall Study|Lack of Efficacy|2|||
164071335|NCT00633217|592623234|FG000|Overall Study|Protocol Violation|3|||
164071336|NCT00633217|592623235|FG001|Overall Study|Protocol Violation|7|||
164071337|NCT00633217|592623234|FG000|Overall Study|Lost to Follow-up|2|||
164071338|NCT00633217|592623235|FG001|Overall Study|Lost to Follow-up|2|||
164071339|NCT00633217|592623234|FG000|Overall Study|Investigator Discretion|2|||
164071340|NCT00633217|592623235|FG001|Overall Study|Investigator Discretion|0|||
164071341|NCT00633217|592623234|FG000|Overall Study|Withdrew Consent|3|||
164071342|NCT00633217|592623235|FG001|Overall Study|Withdrew Consent|3|||
164071343|NCT05838755|592623236|FG000|Overall Study|Adverse Event|1|||
164071344|NCT05838755|592623237|FG001|Overall Study|Adverse Event|0|||
164071345|NCT05838755|592623238|FG002|Overall Study|Adverse Event|0|||
164071346|NCT05838755|592623236|FG000|Overall Study|Lack of Efficacy|1|||
164071347|NCT05838755|592623237|FG001|Overall Study|Lack of Efficacy|0|||
164071348|NCT05838755|592623238|FG002|Overall Study|Lack of Efficacy|1|||
164071349|NCT05838755|592623236|FG000|Overall Study|Lost to Follow-up|0|||
164071350|NCT05838755|592623237|FG001|Overall Study|Lost to Follow-up|1|||
164071351|NCT05838755|592623238|FG002|Overall Study|Lost to Follow-up|4|||
164071352|NCT05838755|592623236|FG000|Overall Study|Withdrawal by Subject|0|||
164071353|NCT05838755|592623237|FG001|Overall Study|Withdrawal by Subject|2|||
164071354|NCT05838755|592623238|FG002|Overall Study|Withdrawal by Subject|0|||
164071355|NCT05838755|592623236|FG000|Overall Study|Study terminated by sponsor|26|||
164071356|NCT05838755|592623237|FG001|Overall Study|Study terminated by sponsor|27|||
164071357|NCT05838755|592623238|FG002|Overall Study|Study terminated by sponsor|26|||
164071358|NCT05838755|592623236|FG000|Overall Study|Randomized, not treated|2|||
164071359|NCT05838755|592623237|FG001|Overall Study|Randomized, not treated|0|||
164071360|NCT05838755|592623238|FG002|Overall Study|Randomized, not treated|1|||
164071361|NCT05838755|592623236|FG000|Overall Study|Pregnancy|0|||
164071362|NCT05838755|592623237|FG001|Overall Study|Pregnancy|1|||
164071363|NCT05838755|592623238|FG002|Overall Study|Pregnancy|0|||
164071364|NCT01283282|592623239|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
164071365|NCT01283282|592623240|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
164071366|NCT01283282|592623239|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
164071367|NCT01283282|592623240|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
164106396|NCT02751424|592753272|FG002|Part 2|Adverse Event|0|||
164071368|NCT01283282|592623239|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
164071369|NCT01283282|592623240|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
164071370|NCT01682681|592623241|FG000|Overall Study|Lack of Efficacy|62|||
164071371|NCT01682681|592623241|FG000|Overall Study|Withdrawal by Subject|1|||
164071372|NCT01682681|592623241|FG000|Overall Study|Moved to other hospital|10|||
164071373|NCT01682681|592623241|FG000|Overall Study|Lost to Follow-up|174|||
164071374|NCT01682681|592623241|FG000|Overall Study|Adverse Event|46|||
164071375|NCT01682681|592623241|FG000|Overall Study|tapering of topiramate|5|||
164071376|NCT01682681|592623241|FG000|Overall Study|Other|21|||
164071377|NCT01682681|592623241|FG000|Overall Study|Low compliance|13|||
164071378|NCT02044094|592623244|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
164071379|NCT02044094|592623244|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
164071380|NCT02044094|592623244|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
164071381|NCT02044094|592623244|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
164071382|NCT02044094|592623244|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
164071383|NCT02044094|592623244|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
164071384|NCT02044094|592623244|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
164071385|NCT02044094|592623244|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
164071386|NCT00005879|592623245|FG000|Overall Study|Withdrawal by Subject|8|||
164071387|NCT00005879|592623246|FG001|Overall Study|Withdrawal by Subject|10|||
164071388|NCT01238172|592623247|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
164071389|NCT01238172|592623248|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
164071390|NCT01238172|592623247|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
164071391|NCT01238172|592623248|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
164071392|NCT05022121|592623249|FG000|Overall Study|Lack of Efficacy|1|||
164071393|NCT05022121|592623250|FG001|Overall Study|Lack of Efficacy|0|||
164071394|NCT05022121|592623249|FG000|Overall Study|Lost to Follow-up|0|||
164071395|NCT05022121|592623250|FG001|Overall Study|Lost to Follow-up|2|||
164071396|NCT01020773|592625048|FG000|Overall Study|Withdrawal by Subject|4|||
164071397|NCT01020773|592625049|FG001|Overall Study|Withdrawal by Subject|3|||
164071398|NCT03302299|592625050|FG000|Overall Study|Protocol Violation|1|||
164071399|NCT01458132|592625051|FG000|Overall Study|Other|15|||
164071400|NCT01458132|592625052|FG001|Overall Study|Other|3|||
164071401|NCT01788163|592625058|FG000|Overall Study|Other|53|||
164071402|NCT01788163|592625059|FG001|Overall Study|Other|0|||
164071403|NCT01788163|592625060|FG002|Overall Study|Other|0|||
164071404|NCT01788163|592625061|FG003|Overall Study|Other|0|||
164071405|NCT01788163|592625062|FG004|Overall Study|Other|0|||
164106397|NCT02751424|592753273|FG003|Part 2|Adverse Event|0|||
164106398|NCT02751424|592753274|FG004|Part 2|Adverse Event|0|||
164106399|NCT02751424|592753275|FG005|Part 2|Adverse Event|0|||
164106400|NCT02751424|592753276|FG006|Part 2|Adverse Event|0|||
164106401|NCT02751424|592753277|FG007|Part 2|Adverse Event|5|||
164106402|NCT02751424|592753278|FG008|Part 2|Adverse Event|0|||
164106403|NCT02699463|592753283|FG000|Overall Study|Lost to Follow-up|11|||
164106404|NCT02699463|592753284|FG001|Overall Study|Lost to Follow-up|8|||
164106405|NCT02699463|592753283|FG000|Overall Study|Withdrawal by Subject|4|||
164106406|NCT02699463|592753284|FG001|Overall Study|Withdrawal by Subject|1|||
164106407|NCT02488239|592753285|FG000|Overall Study|Death|3|||
164106408|NCT02488239|592753285|FG000|Overall Study|Withdrawal by Subject|3|||
164106409|NCT02488239|592753285|FG000|Overall Study|Physician Decision|2|||
164106410|NCT02488239|592753285|FG000|Overall Study|Consent ineligible|1|||
164106411|NCT02488239|592753285|FG000|Overall Study|Did not undergo implant procedure|1|||
164106412|NCT01370733|592753289|FG000|Overall Study|Withdrawal by Subject|8|||
164106413|NCT01370733|592753290|FG001|Overall Study|Withdrawal by Subject|8|||
164106414|NCT01370733|592753289|FG000|Overall Study|Lost to Follow-up|3|||
164106415|NCT01370733|592753290|FG001|Overall Study|Lost to Follow-up|0|||
164071406|NCT01788163|592625063|FG005|Overall Study|Other|7|||
164071407|NCT01788163|592625064|FG006|Overall Study|Other|1|||
164071408|NCT01788163|592625065|FG007|Overall Study|Other|48|||
164071409|NCT01788163|592625066|FG008|Overall Study|Other|15|||
164071410|NCT01788163|592625058|FG000|Overall Study|Withdrawal by Subject|2|||
164071411|NCT01788163|592625059|FG001|Overall Study|Withdrawal by Subject|0|||
164106416|NCT01370733|592753289|FG000|Overall Study|Adverse Event|2|||
164106417|NCT01370733|592753290|FG001|Overall Study|Adverse Event|4|||
164071412|NCT01788163|592625060|FG002|Overall Study|Withdrawal by Subject|0|||
164106418|NCT01370733|592753289|FG000|Overall Study|Lack of Efficacy|3|||
164071413|NCT01788163|592625061|FG003|Overall Study|Withdrawal by Subject|0|||
164106419|NCT01370733|592753290|FG001|Overall Study|Lack of Efficacy|5|||
164106420|NCT01370733|592753289|FG000|Overall Study|Physician Decision|0|||
164106421|NCT01370733|592753290|FG001|Overall Study|Physician Decision|2|||
164106422|NCT01370733|592753289|FG000|Overall Study|Protocol Violation|1|||
164106423|NCT01370733|592753290|FG001|Overall Study|Protocol Violation|3|||
164106424|NCT01188681|592753293|FG000|Overall Study|bladder cancer|0|||
164106425|NCT01188681|592753294|FG001|Overall Study|bladder cancer|0|||
164106426|NCT01188681|592753295|FG002|Overall Study|bladder cancer|1|||
164106427|NCT01188681|592753296|FG003|Overall Study|bladder cancer|0|||
164071414|NCT01788163|592625062|FG004|Overall Study|Withdrawal by Subject|0|||
164071415|NCT01788163|592625063|FG005|Overall Study|Withdrawal by Subject|0|||
164071416|NCT01788163|592625064|FG006|Overall Study|Withdrawal by Subject|0|||
164071417|NCT01788163|592625065|FG007|Overall Study|Withdrawal by Subject|0|||
164071418|NCT01788163|592625066|FG008|Overall Study|Withdrawal by Subject|1|||
164071419|NCT02803138|592625069|FG000|Overall Study|Failure to return|38|||
164071420|NCT02803138|592625069|FG000|Overall Study|Insufficient virological response|2|||
164071421|NCT02803138|592625069|FG000|Overall Study|Withdrawn consent|1|||
164071422|NCT02803138|592625069|FG000|Overall Study|Death|1|||
164071423|NCT02803138|592625069|FG000|Overall Study|Other, not specified|28|||
164071424|NCT00424515|592625070|FG000|Overall Study|Progressive Disease|10|||
164071425|NCT00424515|592625071|FG001|Overall Study|Progressive Disease|11|||
164071426|NCT00424515|592625070|FG000|Overall Study|Adverse Event|0|||
164071427|NCT00424515|592625071|FG001|Overall Study|Adverse Event|1|||
164071428|NCT00424515|592625070|FG000|Overall Study|Intercurrent Illness|0|||
164071429|NCT00424515|592625071|FG001|Overall Study|Intercurrent Illness|1|||
164071430|NCT00424515|592625070|FG000|Overall Study|Withdrawal by Subject|1|||
164071431|NCT00424515|592625071|FG001|Overall Study|Withdrawal by Subject|0|||
164071432|NCT04318535|592625072|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
164071433|NCT04318535|592625073|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
164071434|NCT04318535|592625074|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
164071435|NCT00021229|592625076|FG000|Overall Study|Adverse Event|10|||
164071436|NCT00021229|592625077|FG001|Overall Study|Adverse Event|5|||
164071437|NCT00021229|592625078|FG002|Overall Study|Adverse Event|2|||
164071438|NCT00021229|592625076|FG000|Overall Study|Death|0|||
164071439|NCT00021229|592625077|FG001|Overall Study|Death|1|||
164071440|NCT00021229|592625078|FG002|Overall Study|Death|0|||
164071441|NCT00021229|592625076|FG000|Overall Study|Withdrawal by Subject|7|||
164071442|NCT00021229|592625077|FG001|Overall Study|Withdrawal by Subject|7|||
164071443|NCT00021229|592625078|FG002|Overall Study|Withdrawal by Subject|1|||
164071444|NCT00021229|592625076|FG000|Overall Study|Progressive Disease|15|||
164071445|NCT00021229|592625077|FG001|Overall Study|Progressive Disease|19|||
164071446|NCT00021229|592625078|FG002|Overall Study|Progressive Disease|12|||
164071447|NCT00021229|592625076|FG000|Overall Study|Protocol Violation|1|||
164071448|NCT00021229|592625077|FG001|Overall Study|Protocol Violation|1|||
164071449|NCT00021229|592625078|FG002|Overall Study|Protocol Violation|0|||
164071450|NCT00021229|592625076|FG000|Overall Study|Physician Decision|0|||
164071451|NCT00021229|592625077|FG001|Overall Study|Physician Decision|0|||
164071452|NCT00021229|592625078|FG002|Overall Study|Physician Decision|1|||
164071453|NCT00021229|592625076|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
164071454|NCT00021229|592625077|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
164071455|NCT00021229|592625078|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
164071456|NCT00297492|592625082|FG000|Set Quit Date|Lost to Follow-up|7|||
164071457|NCT00297492|592625083|FG001|Set Quit Date|Lost to Follow-up|13|||
164071458|NCT00297492|592625084|FG002|Set Quit Date|Lost to Follow-up|5|||
164071459|NCT00297492|592625082|FG000|6 Month Follow-up|Lost to Follow-up|63|||
164071460|NCT00297492|592625083|FG001|6 Month Follow-up|Lost to Follow-up|49|||
164071461|NCT00297492|592625084|FG002|6 Month Follow-up|Lost to Follow-up|27|||
164071462|NCT02156466|592625085|FG000|Overall Study|Adverse Event|0|||
164071463|NCT02156466|592625086|FG001|Overall Study|Adverse Event|0|||
164071464|NCT02156466|592625087|FG002|Overall Study|Adverse Event|1|||
164071465|NCT02156466|592625088|FG003|Overall Study|Adverse Event|1|||
164071466|NCT02156466|592625089|FG004|Overall Study|Adverse Event|0|||
164071467|NCT02156466|592625085|FG000|Overall Study|Quantiferon Positivity|0|||
164071468|NCT02156466|592625086|FG001|Overall Study|Quantiferon Positivity|0|||
164071469|NCT02156466|592625087|FG002|Overall Study|Quantiferon Positivity|0|||
164071470|NCT02156466|592625088|FG003|Overall Study|Quantiferon Positivity|1|||
164071471|NCT02156466|592625089|FG004|Overall Study|Quantiferon Positivity|0|||
164071472|NCT00569231|592625090|FG000|Overall Study|Study unrelated surgery|1|||
164071473|NCT00569231|592625090|FG000|Overall Study|Airfare expense|2|||
164071474|NCT00569231|592625090|FG000|Overall Study|Withdrawal by Subject|1|||
164071475|NCT00569231|592625090|FG000|Overall Study|Car accident injury|1|||
164071476|NCT00569231|592625090|FG000|Overall Study|Non-compliance|2|||
164071477|NCT03456726|592625091|FG000|Overall Study|Disease Progression|6|||
164071478|NCT03456726|592625092|FG001|Overall Study|Disease Progression|1|||
164071479|NCT03456726|592625091|FG000|Overall Study|Adverse Event|4|||
164071480|NCT03456726|592625092|FG001|Overall Study|Adverse Event|2|||
164071481|NCT03456726|592625091|FG000|Overall Study|Withdrawal by Subject|1|||
164071482|NCT03456726|592625092|FG001|Overall Study|Withdrawal by Subject|0|||
164071483|NCT03456726|592625091|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
164071484|NCT03456726|592625092|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
164071485|NCT00306852|592625093|FG000|Overall Study|Death|14|||
164071486|NCT00306852|592625094|FG001|Overall Study|Death|14|||
164071487|NCT00306852|592625093|FG000|Overall Study|Lost to Follow-up|15|||
164071488|NCT00306852|592625094|FG001|Overall Study|Lost to Follow-up|24|||
164071489|NCT00817778|592625095|FG000|Overall Study|Adverse Event|1|||
164071490|NCT00817778|592625096|FG001|Overall Study|Adverse Event|0|||
164071491|NCT00817778|592625095|FG000|Overall Study|Withdrawal by Subject|1|||
164071492|NCT00817778|592625096|FG001|Overall Study|Withdrawal by Subject|1|||
164071493|NCT00817778|592625095|FG000|Overall Study|Protocol Violation|0|||
164071494|NCT00817778|592625096|FG001|Overall Study|Protocol Violation|1|||
164071495|NCT00817778|592625095|FG000|Overall Study|Study-specific discontinuation criteria|0|||
164071496|NCT00817778|592625096|FG001|Overall Study|Study-specific discontinuation criteria|1|||
164071497|NCT00817778|592625095|FG000|Overall Study|Poor venous access|1|||
164071498|NCT00817778|592625096|FG001|Overall Study|Poor venous access|0|||
164071499|NCT00883740|592625097|FG000|First Intervention|Lost to Follow-up|1|||
164071500|NCT00883740|592625098|FG001|First Intervention|Lost to Follow-up|0|||
164071501|NCT00883740|592625097|FG000|First Intervention|No longer willing to participate|2|||
164071502|NCT00883740|592625098|FG001|First Intervention|No longer willing to participate|0|||
164071503|NCT00883740|592625097|FG000|First Intervention|Protocol Violation|3|||
164071504|NCT00883740|592625098|FG001|First Intervention|Protocol Violation|6|||
164071505|NCT00883740|592625097|FG000|First Intervention|Adverse Event|1|||
164071506|NCT00883740|592625098|FG001|First Intervention|Adverse Event|2|||
164071507|NCT00883740|592625097|FG000|Second Intervention|Protocol Violation|1|||
164071508|NCT00883740|592625098|FG001|Second Intervention|Protocol Violation|0|||
164071509|NCT00883740|592625097|FG000|Second Intervention|No longer willing to participate|0|||
164071510|NCT00883740|592625098|FG001|Second Intervention|No longer willing to participate|1|||
164071511|NCT00103259|592625099|FG000|Overall Study|Death|3|||
164071512|NCT00103259|592625100|FG001|Overall Study|Death|2|||
164071513|NCT00103259|592625099|FG000|Overall Study|Withdrawal by Subject|2|||
164071514|NCT00103259|592625100|FG001|Overall Study|Withdrawal by Subject|3|||
164071515|NCT00103259|592625099|FG000|Overall Study|alternative therapy|1|||
164071516|NCT00103259|592625100|FG001|Overall Study|alternative therapy|0|||
164071517|NCT00103259|592625099|FG000|Overall Study|other (reasons were not specified)|2|||
164071518|NCT00103259|592625100|FG001|Overall Study|other (reasons were not specified)|1|||
164071519|NCT00103259|592625099|FG000|Overall Study|ineligible/no protocol therapy|4|||
164071520|NCT00103259|592625100|FG001|Overall Study|ineligible/no protocol therapy|6|||
164071521|NCT03224234|592625101|FG000|Main Study|Lost to Follow-up|5|||
164071522|NCT03224234|592625102|FG001|Main Study|Lost to Follow-up|5|||
164071523|NCT02610842|592625103|FG000|Overall Study|Lost to Follow-up|5|||
164071524|NCT02494583|592625106|FG000|Overall Study|Death|224|||
164071525|NCT02494583|592625107|FG001|Overall Study|Death|214|||
164071526|NCT02494583|592625108|FG002|Overall Study|Death|225|||
164071527|NCT02494583|592625106|FG000|Overall Study|Lost to Follow-up|1|||
164071528|NCT02494583|592625107|FG001|Overall Study|Lost to Follow-up|0|||
164071529|NCT02494583|592625108|FG002|Overall Study|Lost to Follow-up|0|||
164071530|NCT02494583|592625106|FG000|Overall Study|Protocol Violation|1|||
164071531|NCT02494583|592625107|FG001|Overall Study|Protocol Violation|2|||
164071532|NCT02494583|592625108|FG002|Overall Study|Protocol Violation|0|||
164071533|NCT02494583|592625106|FG000|Overall Study|Screen Failure|0|||
164071534|NCT02494583|592625107|FG001|Overall Study|Screen Failure|1|||
164071535|NCT02494583|592625108|FG002|Overall Study|Screen Failure|0|||
164071536|NCT02494583|592625106|FG000|Overall Study|Transferred to Extension Study|15|||
164071537|NCT02494583|592625107|FG001|Overall Study|Transferred to Extension Study|15|||
164071538|NCT02494583|592625108|FG002|Overall Study|Transferred to Extension Study|6|||
164071539|NCT02494583|592625106|FG000|Overall Study|Did Not Continue on Extension Study|8|||
164071540|NCT02494583|592625107|FG001|Overall Study|Did Not Continue on Extension Study|10|||
164071541|NCT02494583|592625108|FG002|Overall Study|Did Not Continue on Extension Study|4|||
164071542|NCT02494583|592625106|FG000|Overall Study|Withdrawal by Subject|7|||
164071543|NCT02494583|592625107|FG001|Overall Study|Withdrawal by Subject|15|||
164071544|NCT02494583|592625108|FG002|Overall Study|Withdrawal by Subject|15|||
164071545|NCT00627458|592625109|FG000|Overall Study|Migrated from study area|1|||
164071546|NCT00627458|592625110|FG001|Overall Study|Migrated from study area|0|||
164071547|NCT00627458|592625111|FG002|Overall Study|Migrated from study area|1|||
164071548|NCT00627458|592625109|FG000|Overall Study|Withdrawal by Subject|2|||
164071549|NCT00627458|592625110|FG001|Overall Study|Withdrawal by Subject|6|||
164071550|NCT00627458|592625111|FG002|Overall Study|Withdrawal by Subject|5|||
164071551|NCT00627458|592625109|FG000|Overall Study|Lost to Follow-up|1|||
164071552|NCT00627458|592625110|FG001|Overall Study|Lost to Follow-up|1|||
164071553|NCT00627458|592625111|FG002|Overall Study|Lost to Follow-up|0|||
164071554|NCT03151707|592625112|FG000|Overall Study|Lost to Follow-up|6|||
164071555|NCT04439149|592625113|FG000|Overall Study|Ineligible|1|||
164071556|NCT04439149|592625113|FG000|Overall Study|Never start protocol therapy|1|||
164071557|NCT04439149|592625113|FG000|Overall Study|Adverse Event|4|||
164071558|NCT04439149|592625113|FG000|Overall Study|Disease Progression|14|||
164071559|NCT04439149|592625113|FG000|Overall Study|Complicating disease|1|||
164071560|NCT04439149|592625113|FG000|Overall Study|Withdrawal by Subject|3|||
164071561|NCT02617446|592625114|FG000|Overall Study|Withdrawal by Subject|0|||
164071562|NCT02617446|592625115|FG001|Overall Study|Withdrawal by Subject|2|||
164071563|NCT02617446|592625116|FG002|Overall Study|Withdrawal by Subject|0|||
164071564|NCT02617446|592625114|FG000|Overall Study|Adverse Event|1|||
164071565|NCT02617446|592625115|FG001|Overall Study|Adverse Event|0|||
164071566|NCT02617446|592625116|FG002|Overall Study|Adverse Event|5|||
164071567|NCT02617446|592625114|FG000|Overall Study|Lost to Follow-up|3|||
164071568|NCT02617446|592625115|FG001|Overall Study|Lost to Follow-up|0|||
164071569|NCT02617446|592625116|FG002|Overall Study|Lost to Follow-up|0|||
164071570|NCT02617446|592625114|FG000|Overall Study|Death|0|||
164071571|NCT02617446|592625115|FG001|Overall Study|Death|0|||
164071572|NCT02617446|592625116|FG002|Overall Study|Death|2|||
164071573|NCT00530088|592625125|FG000|Overall Study|Disease Progression|4|||
164071574|NCT00530088|592625125|FG000|Overall Study|Physician Decision|4|||
164071575|NCT00530088|592625125|FG000|Overall Study|Other Not Specified|2|||
164071576|NCT05264506|592625128|FG000|Overall Study|Adverse Event|59|||
164071577|NCT05264506|592625128|FG000|Overall Study|Lost to Follow-up|204|||
164071578|NCT05264506|592625128|FG000|Overall Study|Protocol Violation|185|||
164071579|NCT05264506|592625128|FG000|Overall Study|Pregnancy|60|||
164071580|NCT05264506|592625128|FG000|Overall Study|Physician Decision|6|||
164071581|NCT05264506|592625128|FG000|Overall Study|Non-compliance with Study Drug|29|||
164071582|NCT05264506|592625128|FG000|Overall Study|Study termination|677|||
164071583|NCT05264506|592625128|FG000|Overall Study|Withdrawal by Subject|208|||
164071584|NCT05264506|592625128|FG000|Overall Study|Discontinued prior treatment|89|||
164071585|NCT00644228|592625129|FG000|Randomization & Eligibility|Ineligible|31|||
164071586|NCT00644228|592625130|FG001|Randomization & Eligibility|Ineligible|21|||
164071587|NCT00644228|592625129|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
164071588|NCT00644228|592625130|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
164071589|NCT00644228|592625129|FG000|Randomization & Eligibility|Invalid Consent|0|||
164071590|NCT00644228|592625130|FG001|Randomization & Eligibility|Invalid Consent|1|||
164071591|NCT00644228|592625129|FG000|Induction Therapy|Adverse Event|22|||
164071592|NCT00644228|592625130|FG001|Induction Therapy|Adverse Event|55|||
164071593|NCT00644228|592625129|FG000|Induction Therapy|Withdrawal by Subject|10|||
164071594|NCT00644228|592625130|FG001|Induction Therapy|Withdrawal by Subject|3|||
164071595|NCT00644228|592625129|FG000|Induction Therapy|Progression/Relapse|24|||
164071596|NCT00644228|592625130|FG001|Induction Therapy|Progression/Relapse|12|||
164071597|NCT00644228|592625129|FG000|Induction Therapy|Death|3|||
164071598|NCT00644228|592625130|FG001|Induction Therapy|Death|7|||
164071599|NCT00644228|592625129|FG000|Induction Therapy|Not Protocol-Specified|24|||
164071600|NCT00644228|592625130|FG001|Induction Therapy|Not Protocol-Specified|28|||
164071601|NCT00644228|592625129|FG000|Maintenance|Adverse Event|27|||
164071602|NCT00644228|592625130|FG001|Maintenance|Adverse Event|31|||
164071603|NCT00644228|592625129|FG000|Maintenance|Withdrawal by Subject|6|||
164071604|NCT00644228|592625130|FG001|Maintenance|Withdrawal by Subject|4|||
164071605|NCT00644228|592625129|FG000|Maintenance|Progression/Relapse|67|||
164071606|NCT00644228|592625130|FG001|Maintenance|Progression/Relapse|42|||
164071607|NCT00644228|592625129|FG000|Maintenance|Death|3|||
164071608|NCT00644228|592625130|FG001|Maintenance|Death|3|||
164071609|NCT00644228|592625129|FG000|Maintenance|Not Protocol-Specified|14|||
164071610|NCT00644228|592625130|FG001|Maintenance|Not Protocol-Specified|15|||
164071611|NCT00644228|592625129|FG000|Maintenance|On Treatment|26|||
164071612|NCT00644228|592625130|FG001|Maintenance|On Treatment|40|||
164071613|NCT06078124|592625131|FG000|Overall Study|Lost to Follow-up|14|||
164071614|NCT06078124|592625132|FG001|Overall Study|Lost to Follow-up|14|||
164071615|NCT03252756|592625141|FG000|Overall Study|Protocol Violation|2|||
164071616|NCT03252756|592625142|FG001|Overall Study|Protocol Violation|4|||
164071617|NCT03252756|592625141|FG000|Overall Study|COVID-19 Pandemic|1|||
164071618|NCT03252756|592625142|FG001|Overall Study|COVID-19 Pandemic|1|||
164071619|NCT03252756|592625141|FG000|Overall Study|Study Drug Expiration|0|||
164071620|NCT03252756|592625142|FG001|Overall Study|Study Drug Expiration|1|||
164071621|NCT04066894|592625143|FG000|Overall Study|Lack of Efficacy|1|||
164071622|NCT04066894|592625143|FG000|Overall Study|Screen Failure|1|||
164071623|NCT01500434|592625144|FG000|Overall Study|Death|1|||
164071624|NCT01500434|592625144|FG000|Overall Study|Withdrawal by Subject|1|||
164071625|NCT01500434|592625144|FG000|Overall Study|Missed 12-month follow-up|5|||
164071626|NCT00083226|592625145|FG000|Overall Study|Lack of Efficacy|19|||
164071627|NCT00083226|592625145|FG000|Overall Study|Adverse Event|9|||
164071628|NCT00083226|592625145|FG000|Overall Study|Death|4|||
164071629|NCT00083226|592625145|FG000|Overall Study|Withdrawal by Subject|4|||
164071630|NCT00083226|592625145|FG000|Overall Study|Other|2|||
164071631|NCT00083226|592625145|FG000|Overall Study|ineligible or not receiving treatment|4|||
164071632|NCT00909857|592625146|FG000|Overall Study|Withdrawal by Subject|6|||
164071633|NCT00909857|592625147|FG001|Overall Study|Withdrawal by Subject|10|||
164071634|NCT00909857|592625146|FG000|Overall Study|Adverse Event|5|||
164071635|NCT00909857|592625147|FG001|Overall Study|Adverse Event|5|||
164071636|NCT00909857|592625146|FG000|Overall Study|Lost to Follow-up|2|||
164071637|NCT00909857|592625147|FG001|Overall Study|Lost to Follow-up|5|||
164071638|NCT00909857|592625146|FG000|Overall Study|Protocol Violation|2|||
164071639|NCT00909857|592625147|FG001|Overall Study|Protocol Violation|1|||
164071640|NCT00909857|592625146|FG000|Overall Study|Pregnancy|1|||
164071641|NCT00909857|592625147|FG001|Overall Study|Pregnancy|0|||
164071642|NCT00909857|592625146|FG000|Overall Study|Other|1|||
164071643|NCT00909857|592625147|FG001|Overall Study|Other|0|||
164071644|NCT00909857|592625146|FG000|Overall Study|Did not receive study medication|19|||
164071645|NCT00909857|592625147|FG001|Overall Study|Did not receive study medication|24|||
164071646|NCT00604175|592625154|FG000|Entry Through Week 28|Death|2|||
164106428|NCT01188681|592753293|FG000|Overall Study|Withdrawal by Subject|0|||
164106429|NCT01188681|592753294|FG001|Overall Study|Withdrawal by Subject|0|||
164106430|NCT01188681|592753295|FG002|Overall Study|Withdrawal by Subject|0|||
164106431|NCT01188681|592753296|FG003|Overall Study|Withdrawal by Subject|1|||
164106432|NCT01848938|592753306|FG000|Overall Study|Lost to Follow-up|1|||
164106433|NCT01848938|592753307|FG001|Overall Study|Lost to Follow-up|1|||
164106434|NCT00909753|592753310|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
164106435|NCT00909753|592753311|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
164106436|NCT00909753|592753310|FG000|Period: Second Intervention|Protocol Violation|1|||
164106437|NCT00909753|592753311|FG001|Period: Second Intervention|Protocol Violation|0|||
164106438|NCT00835536|592753312|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
164106439|NCT00835536|592753313|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
164106440|NCT03804983|592753321|FG000|Overall Study|Adverse Event|0|||
164106441|NCT03804983|592753322|FG001|Overall Study|Adverse Event|1|||
164106442|NCT03804983|592753321|FG000|Overall Study|Family Obligation|1|||
164106443|NCT03804983|592753322|FG001|Overall Study|Family Obligation|0|||
164106444|NCT03600376|592753323|FG000|Overall Study|Adverse Event|1|||
164106445|NCT03600376|592753324|FG001|Overall Study|Adverse Event|1|||
164106446|NCT03600376|592753323|FG000|Overall Study|Transferred to other facility|1|||
164106447|NCT03600376|592753324|FG001|Overall Study|Transferred to other facility|0|||
164106448|NCT03600376|592753323|FG000|Overall Study|Investigator Decision|0|||
164106449|NCT03600376|592753324|FG001|Overall Study|Investigator Decision|4|||
164106450|NCT03600376|592753323|FG000|Overall Study|Determined to be ineligible for study|0|||
164106451|NCT03600376|592753324|FG001|Overall Study|Determined to be ineligible for study|1|||
164106452|NCT04827394|592753330|FG000|Overall Study|Physician Decision|0|||
164106453|NCT04827394|592753331|FG001|Overall Study|Physician Decision|2|||
164106454|NCT01154231|592753332|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
164106455|NCT01154231|592753332|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
164106456|NCT06041256|592753333|FG000|Overall Study|Withdrawal by Subject|1|||
164106457|NCT06041256|592753334|FG001|Overall Study|Withdrawal by Subject|0|||
164106458|NCT06041256|592753335|FG002|Overall Study|Withdrawal by Subject|3|||
164106459|NCT06041256|592753336|FG003|Overall Study|Withdrawal by Subject|1|||
164106460|NCT06041256|592753337|FG004|Overall Study|Withdrawal by Subject|1|||
164106461|NCT06041256|592753333|FG000|Overall Study|Rescue|17|||
164106462|NCT06041256|592753334|FG001|Overall Study|Rescue|6|||
164106463|NCT06041256|592753335|FG002|Overall Study|Rescue|9|||
164106464|NCT06041256|592753336|FG003|Overall Study|Rescue|6|||
164106465|NCT06041256|592753337|FG004|Overall Study|Rescue|2|||
164106466|NCT03578809|592754886|FG000|Overall Study|Death|0|||
164106467|NCT03578809|592754887|FG001|Overall Study|Death|2|||
164106468|NCT03578809|592754888|FG002|Overall Study|Death|0|||
164106469|NCT03578809|592754889|FG003|Overall Study|Death|1|||
164106470|NCT03578809|592754886|FG000|Overall Study|Lost to Follow-up|0|||
164106471|NCT03578809|592754887|FG001|Overall Study|Lost to Follow-up|1|||
164106472|NCT03578809|592754888|FG002|Overall Study|Lost to Follow-up|0|||
164106473|NCT03578809|592754889|FG003|Overall Study|Lost to Follow-up|0|||
164106474|NCT03578809|592754886|FG000|Overall Study|Withdrawal by Subject|3|||
164106475|NCT03578809|592754887|FG001|Overall Study|Withdrawal by Subject|5|||
164106476|NCT03578809|592754888|FG002|Overall Study|Withdrawal by Subject|2|||
164106477|NCT03578809|592754889|FG003|Overall Study|Withdrawal by Subject|0|||
164106478|NCT03578809|592754886|FG000|Overall Study|Other|3|||
164106479|NCT03578809|592754887|FG001|Overall Study|Other|6|||
164106480|NCT03578809|592754888|FG002|Overall Study|Other|2|||
164106481|NCT03578809|592754889|FG003|Overall Study|Other|8|||
164106482|NCT00835705|592754890|FG000|First Intervention|Difficulty with vein|1|||
164071647|NCT00604175|592625155|FG001|Entry Through Week 28|Death|0|||
164071648|NCT00604175|592625156|FG002|Entry Through Week 28|Death|0|||
164071649|NCT00604175|592625154|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
164071650|NCT00604175|592625155|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
164071651|NCT00604175|592625156|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
164071652|NCT00604175|592625154|FG000|Entry Through Week 28|Lost to Follow-up|4|||
164071653|NCT00604175|592625155|FG001|Entry Through Week 28|Lost to Follow-up|3|||
164071654|NCT00604175|592625156|FG002|Entry Through Week 28|Lost to Follow-up|0|||
164106483|NCT00835705|592754891|FG001|First Intervention|Difficulty with vein|0|||
164106484|NCT00835705|592754890|FG000|Second Intervention|Difficulty with vein|1|||
164106485|NCT00835705|592754891|FG001|Second Intervention|Difficulty with vein|0|||
164106486|NCT01116739|592754892|FG000|Overall Study|Child had 2 years of HS|110|||
164106487|NCT01116739|592754893|FG001|Overall Study|Child had 2 years of HS|128|||
164106488|NCT01116739|592754892|FG000|Overall Study|Withdrawal by Subject|6|||
164106489|NCT01116739|592754893|FG001|Overall Study|Withdrawal by Subject|0|||
164106490|NCT01116739|592754892|FG000|Overall Study|child too young|2|||
164106491|NCT01116739|592754893|FG001|Overall Study|child too young|6|||
164106492|NCT01116739|592754892|FG000|Overall Study|child not enrolled in head start|10|||
164106493|NCT01116739|592754893|FG001|Overall Study|child not enrolled in head start|2|||
164106494|NCT01116739|592754892|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
164106495|NCT01116739|592754893|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
164106496|NCT05090839|592754894|FG000|Overall Study|Lost to Follow-up|2|||
164071655|NCT00604175|592625154|FG000|Entry Through Week 28|Ineligible|1|||
164071656|NCT00604175|592625155|FG001|Entry Through Week 28|Ineligible|0|||
164071657|NCT00604175|592625156|FG002|Entry Through Week 28|Ineligible|0|||
164071658|NCT00604175|592625154|FG000|Entry Through Week 28|Did not start intervention|2|||
164106497|NCT05090839|592754895|FG001|Overall Study|Lost to Follow-up|3|||
164106498|NCT05090839|592754896|FG002|Overall Study|Lost to Follow-up|1|||
164106499|NCT05090839|592754897|FG003|Overall Study|Lost to Follow-up|1|||
164106500|NCT01987765|592754900|FG000|Overall Study|Protocol Violation|65|||
164106501|NCT01987765|592754900|FG000|Overall Study|Lost to Follow-up|37|||
164106502|NCT00443651|592754903|FG000|Overall Study|Death|1|||
164106503|NCT00443651|592754904|FG001|Overall Study|Death|5|||
164106504|NCT00443651|592754903|FG000|Overall Study|Adverse Event|5|||
164106505|NCT00443651|592754904|FG001|Overall Study|Adverse Event|6|||
164106506|NCT00443651|592754903|FG000|Overall Study|Lost to Follow-up|18|||
164106507|NCT00443651|592754904|FG001|Overall Study|Lost to Follow-up|12|||
164106508|NCT00443651|592754903|FG000|Overall Study|Patient's/Guardian's Decision|58|||
164106509|NCT00443651|592754904|FG001|Overall Study|Patient's/Guardian's Decision|30|||
164106510|NCT00443651|592754903|FG000|Overall Study|Physician Decision|13|||
164106511|NCT00443651|592754904|FG001|Overall Study|Physician Decision|4|||
164106512|NCT00443651|592754903|FG000|Overall Study|Pregnancy|0|||
164106513|NCT00443651|592754904|FG001|Overall Study|Pregnancy|1|||
164106514|NCT03606174|592754907|FG000|Overall Study|Death|37|||
164106515|NCT03606174|592754908|FG001|Overall Study|Death|15|||
164106516|NCT03606174|592754909|FG002|Overall Study|Death|15|||
164106517|NCT03606174|592754910|FG003|Overall Study|Death|7|||
164106518|NCT03606174|592754911|FG004|Overall Study|Death|35|||
164106519|NCT03606174|592754912|FG005|Overall Study|Death|12|||
164106520|NCT03606174|592754913|FG006|Overall Study|Death|35|||
164106521|NCT03606174|592754914|FG007|Overall Study|Death|8|||
164071659|NCT00604175|592625155|FG001|Entry Through Week 28|Did not start intervention|0|||
164071660|NCT00604175|592625156|FG002|Entry Through Week 28|Did not start intervention|1|||
164071661|NCT00604175|592625154|FG000|Week 29 Through Week 72|Death|0|||
164071662|NCT00604175|592625155|FG001|Week 29 Through Week 72|Death|0|||
164071663|NCT00604175|592625156|FG002|Week 29 Through Week 72|Death|1|||
164071664|NCT00604175|592625154|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
164071665|NCT00604175|592625155|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
164071666|NCT00604175|592625156|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
164071667|NCT00604175|592625154|FG000|Week 29 Through Week 72|Site closure|0|||
164071668|NCT00604175|592625155|FG001|Week 29 Through Week 72|Site closure|1|||
164071669|NCT00604175|592625156|FG002|Week 29 Through Week 72|Site closure|0|||
164071670|NCT00604175|592625154|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
164071671|NCT00604175|592625155|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
164071672|NCT00604175|592625156|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
164071673|NCT03353415|592625157|FG000|Masked CGM Wear|Lost to Follow-up|2|||
164071674|NCT03353415|592625157|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
164071675|NCT03205163|592625158|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
164071676|NCT03205163|592625159|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
164071677|NCT00131937|592625160|FG000|Overall Study|Adverse Event|3|||
164071678|NCT00131937|592625160|FG000|Overall Study|Withdrawal by Subject|2|||
164071679|NCT00131937|592625160|FG000|Overall Study|Physician Decision|1|||
164071680|NCT00131937|592625160|FG000|Overall Study|Disease Progression|7|||
164071681|NCT00131937|592625160|FG000|Overall Study|Alternative therapy|1|||
164071682|NCT04647253|592625163|FG000|Overall Study|Death ≤ 365 Days|16|||
164071683|NCT04647253|592625164|FG001|Overall Study|Death ≤ 365 Days|7|||
164071684|NCT04647253|592625163|FG000|Overall Study|Physician Decision|0|||
164071685|NCT04647253|592625164|FG001|Overall Study|Physician Decision|1|||
164071686|NCT04647253|592625163|FG000|Overall Study|Withdrawal by Subject|7|||
164071687|NCT04647253|592625164|FG001|Overall Study|Withdrawal by Subject|2|||
164071688|NCT04647253|592625163|FG000|Overall Study|Missed 12-Month Visit|9|||
164071689|NCT04647253|592625164|FG001|Overall Study|Missed 12-Month Visit|7|||
164071690|NCT04647253|592625163|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
164071691|NCT04647253|592625164|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
164071692|NCT04502862|592625167|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
164106522|NCT03606174|592754915|FG008|Overall Study|Death|5|||
164106523|NCT03606174|592754916|FG009|Overall Study|Death|3|||
164106524|NCT03606174|592754917|FG010|Overall Study|Death|0|||
164106525|NCT03606174|592754907|FG000|Overall Study|Lost to Follow-up|0|||
164106526|NCT03606174|592754908|FG001|Overall Study|Lost to Follow-up|0|||
164106527|NCT03606174|592754909|FG002|Overall Study|Lost to Follow-up|0|||
164106528|NCT03606174|592754910|FG003|Overall Study|Lost to Follow-up|0|||
164106529|NCT03606174|592754911|FG004|Overall Study|Lost to Follow-up|1|||
164071693|NCT04502862|592625168|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
164071694|NCT04502862|592625167|FG000|Overall Study|Withdrawal by Subject|1|||
164106530|NCT03606174|592754912|FG005|Overall Study|Lost to Follow-up|1|||
164106531|NCT03606174|592754913|FG006|Overall Study|Lost to Follow-up|0|||
164106532|NCT03606174|592754914|FG007|Overall Study|Lost to Follow-up|0|||
164106533|NCT03606174|592754915|FG008|Overall Study|Lost to Follow-up|0|||
164106534|NCT03606174|592754916|FG009|Overall Study|Lost to Follow-up|0|||
164106535|NCT03606174|592754917|FG010|Overall Study|Lost to Follow-up|0|||
164106536|NCT03606174|592754907|FG000|Overall Study|Withdrawal by Subject|6|||
164106537|NCT03606174|592754908|FG001|Overall Study|Withdrawal by Subject|0|||
164106538|NCT03606174|592754909|FG002|Overall Study|Withdrawal by Subject|0|||
164106539|NCT03606174|592754910|FG003|Overall Study|Withdrawal by Subject|1|||
164106540|NCT03606174|592754911|FG004|Overall Study|Withdrawal by Subject|2|||
164106541|NCT03606174|592754912|FG005|Overall Study|Withdrawal by Subject|1|||
164106542|NCT03606174|592754913|FG006|Overall Study|Withdrawal by Subject|4|||
164106543|NCT03606174|592754914|FG007|Overall Study|Withdrawal by Subject|0|||
164106544|NCT03606174|592754915|FG008|Overall Study|Withdrawal by Subject|0|||
164106545|NCT03606174|592754916|FG009|Overall Study|Withdrawal by Subject|0|||
164106546|NCT03606174|592754917|FG010|Overall Study|Withdrawal by Subject|1|||
164106547|NCT03606174|592754907|FG000|Overall Study|Study Terminated by Sponsor|5|||
164106548|NCT03606174|592754908|FG001|Overall Study|Study Terminated by Sponsor|7|||
164106549|NCT03606174|592754909|FG002|Overall Study|Study Terminated by Sponsor|3|||
164106550|NCT03606174|592754910|FG003|Overall Study|Study Terminated by Sponsor|0|||
164106551|NCT03606174|592754911|FG004|Overall Study|Study Terminated by Sponsor|11|||
164106552|NCT03606174|592754912|FG005|Overall Study|Study Terminated by Sponsor|6|||
164106553|NCT03606174|592754913|FG006|Overall Study|Study Terminated by Sponsor|12|||
164106554|NCT03606174|592754914|FG007|Overall Study|Study Terminated by Sponsor|1|||
164106555|NCT03606174|592754915|FG008|Overall Study|Study Terminated by Sponsor|3|||
164106556|NCT03606174|592754916|FG009|Overall Study|Study Terminated by Sponsor|1|||
164106557|NCT03606174|592754917|FG010|Overall Study|Study Terminated by Sponsor|2|||
164106558|NCT03606174|592754907|FG000|Overall Study|Miscellaneous|1|||
164106559|NCT03606174|592754908|FG001|Overall Study|Miscellaneous|1|||
164106560|NCT03606174|592754909|FG002|Overall Study|Miscellaneous|0|||
164106561|NCT03606174|592754910|FG003|Overall Study|Miscellaneous|1|||
164106562|NCT03606174|592754911|FG004|Overall Study|Miscellaneous|4|||
164106563|NCT03606174|592754912|FG005|Overall Study|Miscellaneous|7|||
164106564|NCT03606174|592754913|FG006|Overall Study|Miscellaneous|5|||
164106565|NCT03606174|592754914|FG007|Overall Study|Miscellaneous|0|||
164106566|NCT03606174|592754915|FG008|Overall Study|Miscellaneous|0|||
164106567|NCT03606174|592754916|FG009|Overall Study|Miscellaneous|0|||
164106568|NCT03606174|592754917|FG010|Overall Study|Miscellaneous|1|||
164106569|NCT01205035|592754923|FG000|Overall Study|Withdrawal by Subject|1|||
164106570|NCT01205035|592754924|FG001|Overall Study|Withdrawal by Subject|0|||
164106571|NCT01205035|592754923|FG000|Overall Study|Physician Decision|1|||
164106572|NCT01205035|592754924|FG001|Overall Study|Physician Decision|0|||
164106573|NCT01896934|592754925|FG000|Overall Study|Adverse Event|1|||
164106574|NCT01896934|592754925|FG000|Overall Study|Withdrawal by Subject|1|||
164106575|NCT00316277|592754927|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
164106576|NCT00316277|592754928|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
164106577|NCT00316277|592754927|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
164106578|NCT00316277|592754928|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
164106579|NCT00316277|592754927|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
164106580|NCT00316277|592754928|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
164106581|NCT00316277|592754927|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
164106582|NCT00316277|592754928|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
164106583|NCT00316277|592754927|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
164106584|NCT00316277|592754928|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
164106585|NCT00927069|592754929|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
164106586|NCT00927069|592754930|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
164106587|NCT00927069|592754931|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
164106588|NCT00927069|592754932|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
164106589|NCT00927069|592754929|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
164106590|NCT00927069|592754930|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
164106591|NCT00927069|592754931|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
164106592|NCT00927069|592754932|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
164106593|NCT00927069|592754929|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
164106594|NCT00927069|592754930|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
164106595|NCT00927069|592754931|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
164106596|NCT00927069|592754932|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
164106597|NCT00927069|592754929|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
164106598|NCT00927069|592754930|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
164106599|NCT00927069|592754931|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
164106600|NCT00927069|592754932|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
164106601|NCT00927069|592754929|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
164106602|NCT00927069|592754930|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
164106603|NCT00927069|592754931|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
164106604|NCT00927069|592754932|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
164106605|NCT01572662|592754933|FG000|Overall Study|Withdrawal by Subject|1|||
164106606|NCT01572662|592754934|FG001|Overall Study|Withdrawal by Subject|0|||
164106607|NCT01572662|592754933|FG000|Overall Study|Physician Decision|0|||
164106608|NCT01572662|592754934|FG001|Overall Study|Physician Decision|1|||
164071695|NCT04502862|592625168|FG001|Overall Study|Withdrawal by Subject|0|||
164071696|NCT04502862|592625167|FG000|Overall Study|Adverse Event|1|||
164071697|NCT04502862|592625168|FG001|Overall Study|Adverse Event|1|||
164071698|NCT02038959|592626630|FG000|Overall Study|Withdrawal by Subject|6|||
164071699|NCT02038959|592626631|FG001|Overall Study|Withdrawal by Subject|8|||
164071700|NCT00819091|592626637|FG000|Overall Study|Adverse Event|3|||
164071701|NCT00819091|592626638|FG001|Overall Study|Adverse Event|5|||
164071702|NCT00819091|592626637|FG000|Overall Study|Protocol Violation|0|||
164071703|NCT00819091|592626638|FG001|Overall Study|Protocol Violation|1|||
164071704|NCT00819091|592626637|FG000|Overall Study|Lost to Follow-up|2|||
164071705|NCT00819091|592626638|FG001|Overall Study|Lost to Follow-up|0|||
164071706|NCT00819091|592626637|FG000|Overall Study|Withdrawal by Subject|1|||
164071707|NCT00819091|592626638|FG001|Overall Study|Withdrawal by Subject|2|||
164071708|NCT00819091|592626637|FG000|Overall Study|Other|1|||
164071709|NCT00819091|592626638|FG001|Overall Study|Other|2|||
164071710|NCT00265239|592626639|FG000|Overall Study|Adverse Event|2|||
164071711|NCT00265239|592626640|FG001|Overall Study|Adverse Event|1|||
164071712|NCT04071366|592626641|FG000|Part 1: Open-label (29 Days)|Death|4|||
164071713|NCT04071366|592626642|FG001|Part 1: Open-label (29 Days)|Death|2|||
164071714|NCT04071366|592626643|FG002|Part 1: Open-label (29 Days)|Death|8|||
164071715|NCT04071366|592626644|FG003|Part 1: Open-label (29 Days)|Death|0|||
164071716|NCT04071366|592626645|FG004|Part 1: Open-label (29 Days)|Death|0|||
164071717|NCT04071366|592626641|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164071718|NCT04071366|592626642|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164071719|NCT04071366|592626643|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
164071720|NCT04071366|592626644|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164071721|NCT04071366|592626645|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
164071722|NCT04071366|592626641|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
164071723|NCT04071366|592626642|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
164071724|NCT04071366|592626643|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
164071725|NCT04071366|592626644|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
164071726|NCT04071366|592626645|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
164071727|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Death|0|||
164071728|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Death|0|||
164071729|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Death|0|||
164071730|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Death|2|||
164071731|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Death|2|||
164071732|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164071733|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164071734|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164071735|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
164071736|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
164071737|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
164071738|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
164071739|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
164071740|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
164071741|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
164071742|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
164071743|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
164071744|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
164071745|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
164071746|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
164071747|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164071748|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164071749|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164071750|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
164071751|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
164071752|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164071753|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164071754|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164071755|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
164071756|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
164071757|NCT04071366|592626641|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164071758|NCT04071366|592626642|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164071759|NCT04071366|592626643|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164071760|NCT04071366|592626644|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
164071761|NCT04071366|592626645|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
164071762|NCT01858558|592626648|FG000|Overall Study|Death|1|||
164071763|NCT01858558|592626649|FG001|Overall Study|Death|1|||
164071764|NCT01858558|592626648|FG000|Overall Study|Lost to Follow-up|1|||
164071765|NCT01858558|592626649|FG001|Overall Study|Lost to Follow-up|0|||
164071766|NCT01858558|592626648|FG000|Overall Study|Disease progression|3|||
164106609|NCT03364192|592754935|FG000|Overall Study|Ineligible|10|||
164106610|NCT03364192|592754935|FG000|Overall Study|Withdrawal by Subject|5|||
164106611|NCT03364192|592754935|FG000|Overall Study|Lost to Follow-up|1|||
164106612|NCT04692155|592754936|FG000|Overall Study|Death|1|||
164106613|NCT04547192|592754937|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
164106614|NCT04547192|592754938|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
164106615|NCT04547192|592754939|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
164106616|NCT04547192|592754940|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
164106617|NCT04547192|592754937|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
164106618|NCT04547192|592754938|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
164106619|NCT04547192|592754939|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
164106620|NCT04547192|592754940|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
164106621|NCT04547192|592754937|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
164106622|NCT04547192|592754938|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
164106623|NCT04547192|592754939|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
164106624|NCT04547192|592754940|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
164106625|NCT04547192|592754937|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
164106626|NCT04547192|592754938|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
164106627|NCT04547192|592754939|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
164106628|NCT04547192|592754940|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
164106629|NCT04547192|592754937|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
164106630|NCT04547192|592754938|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
164106631|NCT04547192|592754939|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
164106632|NCT04547192|592754940|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
164106633|NCT01535222|592754941|FG000|Overall Study|Inclusion/exclusion|0|||
164071767|NCT01858558|592626649|FG001|Overall Study|Disease progression|1|||
164106634|NCT01535222|592754942|FG001|Overall Study|Inclusion/exclusion|0|||
164106635|NCT01535222|592754943|FG002|Overall Study|Inclusion/exclusion|1|||
164106636|NCT01535222|592754944|FG003|Overall Study|Inclusion/exclusion|0|||
164106637|NCT01535222|592754945|FG004|Overall Study|Inclusion/exclusion|0|||
164106638|NCT01535222|592754946|FG005|Overall Study|Inclusion/exclusion|0|||
164106639|NCT00935012|592754949|FG000|Overall Study|Death|19|||
164106640|NCT00935012|592754949|FG000|Overall Study|Withdrawal by Subject|3|||
164106641|NCT00935012|592754949|FG000|Overall Study|Other|5|||
164106642|NCT00935012|592754949|FG000|Overall Study|Adverse Event|2|||
164106643|NCT01442155|592754950|FG000|Overall Study|Complete remission|35|||
164106644|NCT01442155|592754950|FG000|Overall Study|Recurrence|26|||
164106645|NCT01442155|592754950|FG000|Overall Study|Adverse Event|2|||
164106646|NCT01442155|592754950|FG000|Overall Study|Lost to Follow-up|2|||
164106647|NCT01590563|592754955|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
164106648|NCT01484912|592754958|FG000|Overall Study|Withdrawal by Subject|1|||
164106649|NCT01484912|592754959|FG001|Overall Study|Withdrawal by Subject|0|||
164106650|NCT01484912|592754958|FG000|Overall Study|Physician Decision|0|||
164071768|NCT01858558|592626648|FG000|Overall Study|Product contamination|2|||
164071769|NCT01858558|592626649|FG001|Overall Study|Product contamination|0|||
164071770|NCT01858558|592626648|FG000|Overall Study|Failed expansion of cell product|2|||
164071771|NCT01858558|592626649|FG001|Overall Study|Failed expansion of cell product|0|||
164071772|NCT01336608|592626650|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
164071773|NCT01336608|592626651|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164071774|NCT01336608|592626652|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164071775|NCT01336608|592626653|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
164071776|NCT01336608|592626650|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
164071777|NCT01336608|592626651|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164071778|NCT01336608|592626652|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164071779|NCT01336608|592626653|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
164071780|NCT01336608|592626650|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
164071781|NCT01336608|592626651|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
164106651|NCT01484912|592754959|FG001|Overall Study|Physician Decision|1|||
164106652|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
164106653|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
164106654|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
164106655|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
164106656|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
164106657|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
164106658|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Death|9|||
164106659|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Death|7|||
164071782|NCT01336608|592626652|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
164071783|NCT01336608|592626653|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
164071784|NCT01336608|592626650|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
164071785|NCT01336608|592626651|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
164106660|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Death|14|||
164106661|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Death|7|||
164106662|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Death|0|||
164106663|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Death|0|||
164106664|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
164071786|NCT01336608|592626652|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
164071787|NCT01336608|592626653|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
164071788|NCT01336608|592626650|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
164071789|NCT01336608|592626651|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164071790|NCT01336608|592626652|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164071791|NCT01336608|592626653|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
164071792|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
164071793|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
164071794|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
164071795|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
164071796|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164071797|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
164071798|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164071799|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
164071800|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
164071801|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
164071802|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
164071803|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
164071804|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
164071805|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
164071806|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164071807|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
164071808|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
164071809|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
164071810|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
164071811|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
164071812|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164071813|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
164071814|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164071815|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
164071816|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
164071817|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
164071818|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
164071819|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
164071820|NCT01336608|592626650|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
164071821|NCT01336608|592626651|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
164071822|NCT01336608|592626652|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
164071823|NCT01336608|592626653|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
164071824|NCT00399490|592626658|FG000|Overall Study|Adverse Event|19|||
164071825|NCT00399490|592626658|FG000|Overall Study|Lack of Efficacy|31|||
164071826|NCT00399490|592626658|FG000|Overall Study|Lost to Follow-up|5|||
164071827|NCT00399490|592626658|FG000|Overall Study|Withdrawal by Subject|18|||
164071828|NCT00399490|592626658|FG000|Overall Study|Other|25|||
164071829|NCT02437890|592626659|FG000|Overall Study|Non-compliance to study drug|0|||
164071830|NCT02437890|592626660|FG001|Overall Study|Non-compliance to study drug|1|||
164071831|NCT02437890|592626661|FG002|Overall Study|Non-compliance to study drug|0|||
164071832|NCT02437890|592626662|FG003|Overall Study|Non-compliance to study drug|0|||
164071833|NCT02437890|592626663|FG004|Overall Study|Non-compliance to study drug|1|||
164071834|NCT02437890|592626659|FG000|Overall Study|Sponsor's decision|1|||
164071835|NCT02437890|592626660|FG001|Overall Study|Sponsor's decision|1|||
164071836|NCT02437890|592626661|FG002|Overall Study|Sponsor's decision|4|||
164071837|NCT02437890|592626662|FG003|Overall Study|Sponsor's decision|0|||
164071838|NCT02437890|592626663|FG004|Overall Study|Sponsor's decision|2|||
164071839|NCT02437890|592626659|FG000|Overall Study|Physician Decision|0|||
164071840|NCT02437890|592626660|FG001|Overall Study|Physician Decision|0|||
164071841|NCT02437890|592626661|FG002|Overall Study|Physician Decision|0|||
164071842|NCT02437890|592626662|FG003|Overall Study|Physician Decision|1|||
164071843|NCT02437890|592626663|FG004|Overall Study|Physician Decision|0|||
164071844|NCT02437890|592626659|FG000|Overall Study|Unable to attend visit(s)|1|||
164071845|NCT02437890|592626660|FG001|Overall Study|Unable to attend visit(s)|0|||
164071846|NCT02437890|592626661|FG002|Overall Study|Unable to attend visit(s)|0|||
164071847|NCT02437890|592626662|FG003|Overall Study|Unable to attend visit(s)|0|||
164071848|NCT02437890|592626663|FG004|Overall Study|Unable to attend visit(s)|0|||
164071849|NCT02437890|592626659|FG000|Overall Study|Lack of Efficacy|1|||
164071850|NCT02437890|592626660|FG001|Overall Study|Lack of Efficacy|3|||
164071851|NCT02437890|592626661|FG002|Overall Study|Lack of Efficacy|0|||
164071852|NCT02437890|592626662|FG003|Overall Study|Lack of Efficacy|3|||
164071853|NCT02437890|592626663|FG004|Overall Study|Lack of Efficacy|1|||
164106665|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
164106666|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
164106667|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
164106668|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
164106669|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
164106670|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Other Event|49|||
164106671|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Other Event|52|||
164106672|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Other Event|41|||
164106673|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Other Event|58|||
164106674|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Other Event|0|||
164106675|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Other Event|0|||
164106676|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
164106677|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
164106678|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
164106679|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
164106680|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
164106681|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
164106682|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
164106683|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
164106684|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
164106685|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
164106686|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
164106687|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
164106688|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
164106689|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
164106690|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
164106691|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
164106692|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
164106693|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
164106694|NCT00205777|592754962|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
164106695|NCT00205777|592754963|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
164106696|NCT00205777|592754964|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
164106697|NCT00205777|592754965|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
164106698|NCT00205777|592754966|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
164106699|NCT00205777|592754967|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
164106700|NCT00205777|592754962|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
164106701|NCT00205777|592754963|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
164106702|NCT00205777|592754964|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
164106703|NCT00205777|592754965|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
164106704|NCT00205777|592754966|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
164106705|NCT00205777|592754967|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
164106706|NCT00205777|592754962|FG000|Completed Core Study, Entered SE I|Other Event|52|||
164106707|NCT00205777|592754963|FG001|Completed Core Study, Entered SE I|Other Event|46|||
164106708|NCT00205777|592754964|FG002|Completed Core Study, Entered SE I|Other Event|47|||
164106709|NCT00205777|592754965|FG003|Completed Core Study, Entered SE I|Other Event|50|||
164106710|NCT00205777|592754966|FG004|Completed Core Study, Entered SE I|Other Event|0|||
164106711|NCT00205777|592754967|FG005|Completed Core Study, Entered SE I|Other Event|0|||
164106712|NCT00205777|592754962|FG000|Study Extension I|Adverse Event|57|||
164106713|NCT00205777|592754963|FG001|Study Extension I|Adverse Event|0|||
164106714|NCT00205777|592754964|FG002|Study Extension I|Adverse Event|0|||
164106715|NCT00205777|592754965|FG003|Study Extension I|Adverse Event|61|||
164106716|NCT00205777|592754966|FG004|Study Extension I|Adverse Event|58|||
164106717|NCT00205777|592754967|FG005|Study Extension I|Adverse Event|0|||
164106718|NCT00205777|592754962|FG000|Study Extension I|Death|5|||
164106719|NCT00205777|592754963|FG001|Study Extension I|Death|0|||
164106720|NCT00205777|592754964|FG002|Study Extension I|Death|0|||
164106721|NCT00205777|592754965|FG003|Study Extension I|Death|1|||
164106722|NCT00205777|592754966|FG004|Study Extension I|Death|2|||
164106723|NCT00205777|592754967|FG005|Study Extension I|Death|0|||
164106724|NCT00205777|592754962|FG000|Study Extension I|Withdrawal by Subject|99|||
164106725|NCT00205777|592754963|FG001|Study Extension I|Withdrawal by Subject|0|||
164106726|NCT00205777|592754964|FG002|Study Extension I|Withdrawal by Subject|0|||
164106727|NCT00205777|592754965|FG003|Study Extension I|Withdrawal by Subject|106|||
164106728|NCT00205777|592754966|FG004|Study Extension I|Withdrawal by Subject|89|||
164106729|NCT00205777|592754967|FG005|Study Extension I|Withdrawal by Subject|0|||
164106730|NCT00205777|592754962|FG000|Study Extension I|Protocol Violation|4|||
164106731|NCT00205777|592754963|FG001|Study Extension I|Protocol Violation|0|||
164106732|NCT00205777|592754964|FG002|Study Extension I|Protocol Violation|0|||
164106733|NCT00205777|592754965|FG003|Study Extension I|Protocol Violation|8|||
164106734|NCT00205777|592754966|FG004|Study Extension I|Protocol Violation|8|||
164106735|NCT00205777|592754967|FG005|Study Extension I|Protocol Violation|0|||
164106736|NCT00205777|592754962|FG000|Study Extension I|Lack of Efficacy|0|||
164106737|NCT00205777|592754963|FG001|Study Extension I|Lack of Efficacy|0|||
164071854|NCT02437890|592626659|FG000|Overall Study|Adverse Event|4|||
164071855|NCT02437890|592626660|FG001|Overall Study|Adverse Event|9|||
164071856|NCT02437890|592626661|FG002|Overall Study|Adverse Event|5|||
164071857|NCT02437890|592626662|FG003|Overall Study|Adverse Event|11|||
164071858|NCT02437890|592626663|FG004|Overall Study|Adverse Event|7|||
164071859|NCT02437890|592626659|FG000|Overall Study|Withdrawal by Subject|1|||
164071860|NCT02437890|592626660|FG001|Overall Study|Withdrawal by Subject|2|||
164071861|NCT02437890|592626661|FG002|Overall Study|Withdrawal by Subject|6|||
164071862|NCT02437890|592626662|FG003|Overall Study|Withdrawal by Subject|5|||
164071863|NCT02437890|592626663|FG004|Overall Study|Withdrawal by Subject|5|||
164071864|NCT02437890|592626659|FG000|Overall Study|Death|0|||
164071865|NCT02437890|592626660|FG001|Overall Study|Death|0|||
164071866|NCT02437890|592626661|FG002|Overall Study|Death|0|||
164071867|NCT02437890|592626662|FG003|Overall Study|Death|2|||
164071868|NCT02437890|592626663|FG004|Overall Study|Death|0|||
164071869|NCT02328547|592626664|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
164071870|NCT02328547|592626665|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
164071871|NCT02328547|592626664|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164071872|NCT02328547|592626665|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
164071873|NCT00344305|592626666|FG000|Overall Study|Lost to Follow-up|2|||
164071874|NCT00344305|592626667|FG001|Overall Study|Lost to Follow-up|0|||
164071875|NCT00344305|592626666|FG000|Overall Study|Participant was not contacted in window|0|||
164071876|NCT00344305|592626667|FG001|Overall Study|Participant was not contacted in window|1|||
164071877|NCT01190098|592626668|FG000|Overall Study|Adverse Event|2|||
164071878|NCT01190098|592626669|FG001|Overall Study|Adverse Event|0|||
164071879|NCT01190098|592626668|FG000|Overall Study|Patient coomorbidity|0|||
164071880|NCT01190098|592626669|FG001|Overall Study|Patient coomorbidity|1|||
164071881|NCT01190098|592626668|FG000|Overall Study|Lack of transportation|1|||
164071882|NCT01190098|592626669|FG001|Overall Study|Lack of transportation|0|||
164071883|NCT01190098|592626668|FG000|Overall Study|Other|0|||
164071884|NCT01190098|592626669|FG001|Overall Study|Other|1|||
164071885|NCT01422720|592626671|FG000|Overall Study|Adverse Event|16|||
164071886|NCT01422720|592626671|FG000|Overall Study|Lack of Efficacy|1|||
164071887|NCT01422720|592626671|FG000|Overall Study|Withdrawal by Subject|4|||
164071888|NCT01422720|592626671|FG000|Overall Study|Ineligibility|1|||
164071889|NCT01796860|592626675|FG000|Overall Study|Withdrawal by Subject|3|||
164071890|NCT01537549|592626682|FG000|Overall Study|Lost to Follow-up|1|||
164071891|NCT01537549|592626682|FG000|Overall Study|Withdrawal by Subject|2|||
164071892|NCT01286207|592626683|FG000|Overall Study|Adverse Event|27|||
164071893|NCT01286207|592626684|FG001|Overall Study|Adverse Event|41|||
164071894|NCT01286207|592626685|FG002|Overall Study|Adverse Event|8|||
164071895|NCT01286207|592626683|FG000|Overall Study|Lost to Follow-up|49|||
164071896|NCT01286207|592626684|FG001|Overall Study|Lost to Follow-up|43|||
164071897|NCT01286207|592626685|FG002|Overall Study|Lost to Follow-up|20|||
164071898|NCT01286207|592626683|FG000|Overall Study|Withdrawal by Subject|93|||
164071899|NCT01286207|592626684|FG001|Overall Study|Withdrawal by Subject|79|||
164071900|NCT01286207|592626685|FG002|Overall Study|Withdrawal by Subject|41|||
164071901|NCT01286207|592626683|FG000|Overall Study|Lack of Response|92|||
164071902|NCT01286207|592626684|FG001|Overall Study|Lack of Response|38|||
164071903|NCT01286207|592626685|FG002|Overall Study|Lack of Response|8|||
164071904|NCT01286207|592626683|FG000|Overall Study|Other|37|||
164071905|NCT01286207|592626684|FG001|Overall Study|Other|47|||
164071906|NCT01286207|592626685|FG002|Overall Study|Other|13|||
164071907|NCT00068406|592626692|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
164071908|NCT00068406|592626692|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
164071909|NCT02609178|592626693|FG000|First Crown|Withdrawal by Subject|0|||
164071910|NCT02609178|592626694|FG001|First Crown|Withdrawal by Subject|0|||
164071911|NCT02609178|592626695|FG002|First Crown|Withdrawal by Subject|1|||
164071912|NCT02609178|592626696|FG003|First Crown|Withdrawal by Subject|1|||
164071913|NCT02609178|592626697|FG004|First Crown|Withdrawal by Subject|0|||
164071914|NCT02609178|592626698|FG005|First Crown|Withdrawal by Subject|0|||
164071915|NCT00902265|592626701|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
164071916|NCT00902265|592626701|FG000|Overall Study|Adverse Event|2|||
164071917|NCT00902265|592626701|FG000|Overall Study|Lack of Efficacy|2|||
164071918|NCT00902265|592626701|FG000|Overall Study|Protocol Violation|1|||
164071919|NCT02866695|592626702|FG000|Overall Study|Adverse Event|1|||
164071920|NCT02866695|592626702|FG000|Overall Study|Lost to Follow-up|1|||
164071921|NCT05016765|592626703|FG000|Overall Study|Lost to Follow-up|4|||
164071922|NCT03891875|592626706|FG000|Overall Study|Withdrawal by Subject|20|||
164071923|NCT03891875|592626707|FG001|Overall Study|Withdrawal by Subject|3|||
164071924|NCT03891875|592626706|FG000|Overall Study|Adverse Event|10|||
164071925|NCT03891875|592626707|FG001|Overall Study|Adverse Event|4|||
164071926|NCT03891875|592626706|FG000|Overall Study|Physician Decision|1|||
164071927|NCT03891875|592626707|FG001|Overall Study|Physician Decision|1|||
164071928|NCT03891875|592626706|FG000|Overall Study|Protocol Violation|1|||
164071929|NCT03891875|592626707|FG001|Overall Study|Protocol Violation|0|||
164071930|NCT03891875|592626706|FG000|Overall Study|Lost to Follow-up|1|||
164071931|NCT03891875|592626707|FG001|Overall Study|Lost to Follow-up|0|||
164071932|NCT03891875|592626706|FG000|Overall Study|COVID-19 infection|1|||
164071933|NCT03891875|592626707|FG001|Overall Study|COVID-19 infection|0|||
164071934|NCT00285012|592626723|FG000|Assigned to Study Treatment (Tx)|Other|2|||
164071935|NCT00285012|592626724|FG001|Assigned to Study Treatment (Tx)|Other|3|||
164106738|NCT00205777|592754964|FG002|Study Extension I|Lack of Efficacy|0|||
164106739|NCT00205777|592754965|FG003|Study Extension I|Lack of Efficacy|1|||
164106740|NCT00205777|592754966|FG004|Study Extension I|Lack of Efficacy|2|||
164106741|NCT00205777|592754967|FG005|Study Extension I|Lack of Efficacy|0|||
164106742|NCT00205777|592754962|FG000|Study Extension I|Failed to return|15|||
164106743|NCT00205777|592754963|FG001|Study Extension I|Failed to return|0|||
164106744|NCT00205777|592754964|FG002|Study Extension I|Failed to return|0|||
164106745|NCT00205777|592754965|FG003|Study Extension I|Failed to return|17|||
164106746|NCT00205777|592754966|FG004|Study Extension I|Failed to return|13|||
164106747|NCT00205777|592754967|FG005|Study Extension I|Failed to return|0|||
164106748|NCT00205777|592754962|FG000|Study Extension I|Other Event|34|||
164106749|NCT00205777|592754963|FG001|Study Extension I|Other Event|0|||
164106750|NCT00205777|592754964|FG002|Study Extension I|Other Event|0|||
164106751|NCT00205777|592754965|FG003|Study Extension I|Other Event|34|||
164106752|NCT00205777|592754966|FG004|Study Extension I|Other Event|29|||
164106753|NCT00205777|592754967|FG005|Study Extension I|Other Event|0|||
164106754|NCT00205777|592754962|FG000|Study Extension I|Withdrawn as per protocol|0|||
164106755|NCT00205777|592754963|FG001|Study Extension I|Withdrawn as per protocol|0|||
164106756|NCT00205777|592754964|FG002|Study Extension I|Withdrawn as per protocol|1070|||
164106757|NCT00205777|592754965|FG003|Study Extension I|Withdrawn as per protocol|0|||
164106758|NCT00205777|592754966|FG004|Study Extension I|Withdrawn as per protocol|0|||
164106759|NCT00205777|592754967|FG005|Study Extension I|Withdrawn as per protocol|0|||
164106760|NCT00205777|592754962|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
164106761|NCT00205777|592754963|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
164106762|NCT00205777|592754964|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
164106763|NCT00205777|592754965|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
164106764|NCT00205777|592754966|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
164106765|NCT00205777|592754967|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
164106766|NCT00205777|592754962|FG000|Study Extension II|Adverse Event|0|||
164106767|NCT00205777|592754963|FG001|Study Extension II|Adverse Event|0|||
164106768|NCT00205777|592754964|FG002|Study Extension II|Adverse Event|0|||
164106769|NCT00205777|592754965|FG003|Study Extension II|Adverse Event|14|||
164106770|NCT00205777|592754966|FG004|Study Extension II|Adverse Event|0|||
164071936|NCT00285012|592626723|FG000|Received Study Tx|Death|2|||
164071937|NCT00285012|592626724|FG001|Received Study Tx|Death|1|||
164071938|NCT00285012|592626723|FG000|Received Study Tx|Adverse Event|5|||
164071939|NCT00285012|592626724|FG001|Received Study Tx|Adverse Event|11|||
164071940|NCT00285012|592626723|FG000|Received Study Tx|Lack of Efficacy|0|||
164071941|NCT00285012|592626724|FG001|Received Study Tx|Lack of Efficacy|3|||
164071942|NCT00285012|592626723|FG000|Received Study Tx|Lost to Follow-up|29|||
164071943|NCT00285012|592626724|FG001|Received Study Tx|Lost to Follow-up|31|||
164071944|NCT00285012|592626723|FG000|Received Study Tx|Withdrawal by Subject|31|||
164071945|NCT00285012|592626724|FG001|Received Study Tx|Withdrawal by Subject|43|||
164071946|NCT00285012|592626723|FG000|Received Study Tx|Other|5|||
164071947|NCT00285012|592626724|FG001|Received Study Tx|Other|5|||
164071948|NCT05631093|592626727|FG000|Overall Study|Death|0|||
164071949|NCT05631093|592626728|FG001|Overall Study|Death|1|||
164071950|NCT05631093|592626727|FG000|Overall Study|Lost to Follow-up|1|||
164071951|NCT05631093|592626728|FG001|Overall Study|Lost to Follow-up|2|||
164071952|NCT05631093|592626727|FG000|Overall Study|Physician Decision|1|||
164071953|NCT05631093|592626728|FG001|Overall Study|Physician Decision|0|||
164071954|NCT05631093|592626727|FG000|Overall Study|Withdrawal by Subject|4|||
164071955|NCT05631093|592626728|FG001|Overall Study|Withdrawal by Subject|1|||
164071956|NCT05631093|592626727|FG000|Overall Study|Ongoing|353|||
164071957|NCT05631093|592626728|FG001|Overall Study|Ongoing|177|||
164071958|NCT05631093|592626727|FG000|Overall Study|Adverse Event|0|||
164071959|NCT05631093|592626728|FG001|Overall Study|Adverse Event|1|||
164071960|NCT02873195|592626729|FG000|Overall Study|Ineligible|5|||
164106771|NCT00205777|592754967|FG005|Study Extension II|Adverse Event|30|||
164106772|NCT00205777|592754962|FG000|Study Extension II|Death|0|||
164106773|NCT00205777|592754963|FG001|Study Extension II|Death|0|||
164106774|NCT00205777|592754964|FG002|Study Extension II|Death|0|||
164106775|NCT00205777|592754965|FG003|Study Extension II|Death|2|||
164106776|NCT00205777|592754966|FG004|Study Extension II|Death|0|||
164106777|NCT00205777|592754967|FG005|Study Extension II|Death|5|||
164106778|NCT00205777|592754962|FG000|Study Extension II|Withdrawal by Subject|0|||
164106779|NCT00205777|592754963|FG001|Study Extension II|Withdrawal by Subject|0|||
164071961|NCT02873195|592626730|FG001|Overall Study|Ineligible|0|||
164071962|NCT03107715|592626731|FG000|Overall Study|did not deliver at the home hospital|4|||
164071963|NCT03107715|592626732|FG001|Overall Study|did not deliver at the home hospital|6|||
164071964|NCT03107715|592626731|FG000|Overall Study|infant stillborn|0|||
164106780|NCT00205777|592754964|FG002|Study Extension II|Withdrawal by Subject|0|||
164106781|NCT00205777|592754965|FG003|Study Extension II|Withdrawal by Subject|35|||
164071965|NCT03107715|592626732|FG001|Overall Study|infant stillborn|1|||
164071966|NCT04223193|592626735|FG000|Overall Study|Adverse Event|6|||
164071967|NCT04223193|592626736|FG001|Overall Study|Adverse Event|36|||
164071968|NCT04223193|592626735|FG000|Overall Study|Lack of Efficacy|2|||
164071969|NCT04223193|592626736|FG001|Overall Study|Lack of Efficacy|2|||
164071970|NCT04223193|592626735|FG000|Overall Study|Lost to Follow-up|1|||
164071971|NCT04223193|592626736|FG001|Overall Study|Lost to Follow-up|1|||
164071972|NCT04223193|592626735|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
164071973|NCT04223193|592626736|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164071974|NCT04223193|592626735|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
164071975|NCT04223193|592626736|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164071976|NCT04223193|592626735|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164071977|NCT04223193|592626736|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164071978|NCT04223193|592626735|FG000|Overall Study|Physician Decision|0|||
164071979|NCT04223193|592626736|FG001|Overall Study|Physician Decision|1|||
164071980|NCT04223193|592626735|FG000|Overall Study|Protocol Violation|1|||
164071981|NCT04223193|592626736|FG001|Overall Study|Protocol Violation|1|||
164071982|NCT04223193|592626735|FG000|Overall Study|Site Terminated by Sponsor|1|||
164071983|NCT04223193|592626736|FG001|Overall Study|Site Terminated by Sponsor|3|||
164071984|NCT04223193|592626735|FG000|Overall Study|Withdrawal by Subject|5|||
164071985|NCT04223193|592626736|FG001|Overall Study|Withdrawal by Subject|6|||
164071986|NCT04223193|592626735|FG000|Overall Study|Other|3|||
164071987|NCT04223193|592626736|FG001|Overall Study|Other|6|||
164071988|NCT03594175|592626737|FG000|Overall Study|Not treated|8|||
164071989|NCT03594175|592626738|FG001|Overall Study|Not treated|1|||
164071990|NCT03594175|592626739|FG002|Overall Study|Not treated|5|||
164071991|NCT03594175|592626737|FG000|Overall Study|Adverse Event|3|||
164071992|NCT03594175|592626738|FG001|Overall Study|Adverse Event|0|||
164071993|NCT03594175|592626739|FG002|Overall Study|Adverse Event|0|||
164071994|NCT03594175|592626737|FG000|Overall Study|Withdrawal by Subject|3|||
164071995|NCT03594175|592626738|FG001|Overall Study|Withdrawal by Subject|0|||
164071996|NCT03594175|592626739|FG002|Overall Study|Withdrawal by Subject|0|||
164071997|NCT03594175|592626737|FG000|Overall Study|Protocol Violation|2|||
164071998|NCT03594175|592626738|FG001|Overall Study|Protocol Violation|2|||
164071999|NCT03594175|592626739|FG002|Overall Study|Protocol Violation|2|||
164072000|NCT03732677|592626740|FG000|Overall Study|Terminated the study|154|||
164072001|NCT03732677|592626741|FG001|Overall Study|Terminated the study|197|||
164072002|NCT03732677|592626740|FG000|Overall Study|Continuing study off treatment|379|||
164072003|NCT03732677|592626741|FG001|Overall Study|Continuing study off treatment|333|||
164072004|NCT00096031|592626743|FG000|Overall Study|Adverse Event|3|||
164072005|NCT00096031|592626743|FG000|Overall Study|Lack of Efficacy|42|||
164072006|NCT00096031|592626743|FG000|Overall Study|Death|4|||
164072007|NCT00096031|592626743|FG000|Overall Study|Withdrawal by Subject|1|||
164072008|NCT00096031|592626743|FG000|Overall Study|Ineligible|8|||
164072009|NCT00096031|592626743|FG000|Overall Study|Not protocol specified|5|||
164072010|NCT00483717|592626744|FG000|Overall Study|Protocol Violation|5|||
164072011|NCT00483717|592626745|FG001|Overall Study|Protocol Violation|7|||
164072012|NCT00483717|592626744|FG000|Overall Study|Time of dosing missing|1|||
164072013|NCT00483717|592626745|FG001|Overall Study|Time of dosing missing|1|||
164072014|NCT00483717|592626744|FG000|Overall Study|No treatment for migraine|16|||
164072015|NCT00483717|592626745|FG001|Overall Study|No treatment for migraine|13|||
164072016|NCT00483717|592626744|FG000|Overall Study|Lost to Follow-up|1|||
164072017|NCT00483717|592626745|FG001|Overall Study|Lost to Follow-up|0|||
164072018|NCT00483717|592626744|FG000|Overall Study|Withdrawal by Subject|1|||
164072019|NCT00483717|592626745|FG001|Overall Study|Withdrawal by Subject|0|||
164072020|NCT03878108|592626746|FG000|Overall Study|Adverse Event|1|||
164072021|NCT03878108|592626747|FG001|Overall Study|Adverse Event|0|||
164072022|NCT04822701|592626752|FG000|Overall Study|Not treated|2|||
164072023|NCT04822701|592626753|FG001|Overall Study|Not treated|0|||
164072024|NCT04822701|592626752|FG000|Overall Study|Lost to Follow-up|1|||
164072025|NCT04822701|592626753|FG001|Overall Study|Lost to Follow-up|0|||
164072026|NCT04822701|592626752|FG000|Overall Study|Withdrawal by Subject|1|||
164072027|NCT04822701|592626753|FG001|Overall Study|Withdrawal by Subject|0|||
164072028|NCT02706353|592626754|FG000|Dose Level 1|Disease Progression|1|||
164072029|NCT02706353|592626755|FG001|Dose Level 1|Disease Progression|0|||
164072030|NCT02706353|592626756|FG002|Dose Level 1|Disease Progression|0|||
164072031|NCT02706353|592626757|FG003|Dose Level 1|Disease Progression|0|||
164072032|NCT02706353|592626758|FG004|Dose Level 1|Disease Progression|0|||
164072033|NCT02706353|592626759|FG005|Dose Level 1|Disease Progression|0|||
164072034|NCT02706353|592626754|FG000|Dose Level 3|Disease Progression|0|||
164072035|NCT02706353|592626755|FG001|Dose Level 3|Disease Progression|0|||
164072036|NCT02706353|592626756|FG002|Dose Level 3|Disease Progression|2|||
164072037|NCT02706353|592626757|FG003|Dose Level 3|Disease Progression|0|||
164072038|NCT02706353|592626758|FG004|Dose Level 3|Disease Progression|0|||
164072039|NCT02706353|592626759|FG005|Dose Level 3|Disease Progression|0|||
164072040|NCT02706353|592626754|FG000|Dose Level 4|Disease Progression|0|||
164072041|NCT02706353|592626755|FG001|Dose Level 4|Disease Progression|0|||
164106782|NCT00205777|592754966|FG004|Study Extension II|Withdrawal by Subject|0|||
164148730|NCT03207867|592904959|FG023|Overall Study|Physician Decision|0|||
164106783|NCT00205777|592754967|FG005|Study Extension II|Withdrawal by Subject|59|||
164106784|NCT00205777|592754962|FG000|Study Extension II|Protocol Violation|0|||
164106785|NCT00205777|592754963|FG001|Study Extension II|Protocol Violation|0|||
164106786|NCT00205777|592754964|FG002|Study Extension II|Protocol Violation|0|||
164106787|NCT00205777|592754965|FG003|Study Extension II|Protocol Violation|1|||
164106788|NCT00205777|592754966|FG004|Study Extension II|Protocol Violation|0|||
164106789|NCT00205777|592754967|FG005|Study Extension II|Protocol Violation|10|||
164106790|NCT00205777|592754962|FG000|Study Extension II|Lack of Efficacy|0|||
164106791|NCT00205777|592754963|FG001|Study Extension II|Lack of Efficacy|0|||
164106792|NCT00205777|592754964|FG002|Study Extension II|Lack of Efficacy|0|||
164106793|NCT00205777|592754965|FG003|Study Extension II|Lack of Efficacy|0|||
164106794|NCT00205777|592754966|FG004|Study Extension II|Lack of Efficacy|0|||
164106795|NCT00205777|592754967|FG005|Study Extension II|Lack of Efficacy|1|||
164106796|NCT00205777|592754962|FG000|Study Extension II|Failed to return|0|||
164106797|NCT00205777|592754963|FG001|Study Extension II|Failed to return|0|||
164106798|NCT00205777|592754964|FG002|Study Extension II|Failed to return|0|||
164106799|NCT00205777|592754965|FG003|Study Extension II|Failed to return|14|||
164106800|NCT00205777|592754966|FG004|Study Extension II|Failed to return|0|||
164106801|NCT00205777|592754967|FG005|Study Extension II|Failed to return|26|||
164106802|NCT00205777|592754962|FG000|Study Extension II|Other Event|0|||
164106803|NCT00205777|592754963|FG001|Study Extension II|Other Event|0|||
164106804|NCT00205777|592754964|FG002|Study Extension II|Other Event|0|||
164106805|NCT00205777|592754965|FG003|Study Extension II|Other Event|12|||
164106806|NCT00205777|592754966|FG004|Study Extension II|Other Event|0|||
164106807|NCT00205777|592754967|FG005|Study Extension II|Other Event|20|||
164106808|NCT00205777|592754962|FG000|Study Extension II|Enrolled but not treated|0|||
164106809|NCT00205777|592754963|FG001|Study Extension II|Enrolled but not treated|0|||
164106810|NCT00205777|592754964|FG002|Study Extension II|Enrolled but not treated|0|||
164106811|NCT00205777|592754965|FG003|Study Extension II|Enrolled but not treated|71|||
164106812|NCT00205777|592754966|FG004|Study Extension II|Enrolled but not treated|0|||
164106813|NCT00205777|592754967|FG005|Study Extension II|Enrolled but not treated|131|||
164106814|NCT00700739|592754968|FG000|Overall Study|Lost to Follow-up|4|||
164106815|NCT00700739|592754969|FG001|Overall Study|Lost to Follow-up|4|||
164106816|NCT01983969|592754973|FG000|Overall Study|Disease Progression|0|||
164106817|NCT01983969|592754974|FG001|Overall Study|Disease Progression|1|||
164106818|NCT01983969|592754975|FG002|Overall Study|Disease Progression|0|||
164106819|NCT03719040|592754976|FG000|Overall Study|Withdrawal by Subject|177|||
164106820|NCT03719040|592754976|FG000|Overall Study|Lost to Follow-up|26|||
164106821|NCT00268203|592754977|FG000|Overall Study|Lost to Follow-up|92|||
164106822|NCT00268203|592754977|FG000|Overall Study|Withdrawal by Subject|9|||
164106823|NCT00268203|592754977|FG000|Overall Study|Received Other NHL Therapy|7|||
164106824|NCT00268203|592754977|FG000|Overall Study|Progressive Disease|359|||
164106825|NCT00268203|592754977|FG000|Overall Study|Death|84|||
164106826|NCT00268203|592754977|FG000|Overall Study|Reason Not Specified|34|||
164106827|NCT00268203|592754977|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
164106828|NCT04589650|592754980|FG000|Overall Study|Subject decision|6|||
164106829|NCT04589650|592754981|FG001|Overall Study|Subject decision|2|||
164106830|NCT04589650|592754982|FG002|Overall Study|Subject decision|2|||
164106831|NCT04589650|592754983|FG003|Overall Study|Subject decision|0|||
164106832|NCT04589650|592754984|FG004|Overall Study|Subject decision|0|||
164106833|NCT04589650|592754985|FG005|Overall Study|Subject decision|0|||
164106834|NCT04589650|592754980|FG000|Overall Study|Adverse Event|3|||
164106835|NCT04589650|592754981|FG001|Overall Study|Adverse Event|1|||
164106836|NCT04589650|592754982|FG002|Overall Study|Adverse Event|1|||
164106837|NCT04589650|592754983|FG003|Overall Study|Adverse Event|1|||
164106838|NCT04589650|592754984|FG004|Overall Study|Adverse Event|0|||
164106839|NCT04589650|592754985|FG005|Overall Study|Adverse Event|1|||
164106840|NCT04589650|592754980|FG000|Overall Study|Physician Decision|1|||
164106841|NCT04589650|592754981|FG001|Overall Study|Physician Decision|1|||
164106842|NCT04589650|592754982|FG002|Overall Study|Physician Decision|0|||
164106843|NCT04589650|592754983|FG003|Overall Study|Physician Decision|0|||
164106844|NCT04589650|592754984|FG004|Overall Study|Physician Decision|0|||
164106845|NCT04589650|592754985|FG005|Overall Study|Physician Decision|0|||
164106846|NCT04589650|592754980|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164106847|NCT04589650|592754981|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164106848|NCT04589650|592754982|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
164106849|NCT04589650|592754983|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164106850|NCT04589650|592754984|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
164106851|NCT04589650|592754985|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
164106852|NCT04589650|592754980|FG000|Overall Study|Death|0|||
164106853|NCT04589650|592754981|FG001|Overall Study|Death|0|||
164106854|NCT04589650|592754982|FG002|Overall Study|Death|0|||
164106855|NCT04589650|592754983|FG003|Overall Study|Death|1|||
164106856|NCT04589650|592754984|FG004|Overall Study|Death|0|||
164106857|NCT04589650|592754985|FG005|Overall Study|Death|0|||
164106858|NCT04589650|592754980|FG000|Overall Study|Guardian Decision|0|||
164106859|NCT04589650|592754981|FG001|Overall Study|Guardian Decision|0|||
164106860|NCT04589650|592754982|FG002|Overall Study|Guardian Decision|0|||
164072042|NCT02706353|592626756|FG002|Dose Level 4|Disease Progression|0|||
164072043|NCT02706353|592626757|FG003|Dose Level 4|Disease Progression|1|||
164072044|NCT02706353|592626758|FG004|Dose Level 4|Disease Progression|0|||
164072045|NCT02706353|592626759|FG005|Dose Level 4|Disease Progression|0|||
164072046|NCT02706353|592626754|FG000|Dose Level 4|Toxicity|0|||
164072047|NCT02706353|592626755|FG001|Dose Level 4|Toxicity|0|||
164072048|NCT02706353|592626756|FG002|Dose Level 4|Toxicity|0|||
164072049|NCT02706353|592626757|FG003|Dose Level 4|Toxicity|1|||
164072050|NCT02706353|592626758|FG004|Dose Level 4|Toxicity|0|||
164072051|NCT02706353|592626759|FG005|Dose Level 4|Toxicity|0|||
164072052|NCT02706353|592626754|FG000|Dose Level 4|Death|0|||
164072053|NCT02706353|592626755|FG001|Dose Level 4|Death|0|||
164072054|NCT02706353|592626756|FG002|Dose Level 4|Death|0|||
164072055|NCT02706353|592626757|FG003|Dose Level 4|Death|1|||
164072056|NCT02706353|592626758|FG004|Dose Level 4|Death|0|||
164072057|NCT02706353|592626759|FG005|Dose Level 4|Death|0|||
164072058|NCT02706353|592626754|FG000|Dose Level 5|Toxicity|0|||
164072059|NCT02706353|592626755|FG001|Dose Level 5|Toxicity|0|||
164072060|NCT02706353|592626756|FG002|Dose Level 5|Toxicity|0|||
164072061|NCT02706353|592626757|FG003|Dose Level 5|Toxicity|0|||
164072062|NCT02706353|592626758|FG004|Dose Level 5|Toxicity|1|||
164072063|NCT02706353|592626759|FG005|Dose Level 5|Toxicity|0|||
164072064|NCT02706353|592626754|FG000|Dose Level 5|Disease Progression|0|||
164072065|NCT02706353|592626755|FG001|Dose Level 5|Disease Progression|0|||
164072066|NCT02706353|592626756|FG002|Dose Level 5|Disease Progression|0|||
164072067|NCT02706353|592626757|FG003|Dose Level 5|Disease Progression|0|||
164072068|NCT02706353|592626758|FG004|Dose Level 5|Disease Progression|3|||
164072069|NCT02706353|592626759|FG005|Dose Level 5|Disease Progression|2|||
164072070|NCT02706353|592626754|FG000|Dose Level 5|Death|0|||
164072071|NCT02706353|592626755|FG001|Dose Level 5|Death|0|||
164072072|NCT02706353|592626756|FG002|Dose Level 5|Death|0|||
164072073|NCT02706353|592626757|FG003|Dose Level 5|Death|0|||
164072074|NCT02706353|592626758|FG004|Dose Level 5|Death|1|||
164072075|NCT02706353|592626759|FG005|Dose Level 5|Death|6|||
164072076|NCT02706353|592626754|FG000|Dose Level 5|Withdrawal by Subject|0|||
164072077|NCT02706353|592626755|FG001|Dose Level 5|Withdrawal by Subject|0|||
164072078|NCT02706353|592626756|FG002|Dose Level 5|Withdrawal by Subject|0|||
164072079|NCT02706353|592626757|FG003|Dose Level 5|Withdrawal by Subject|0|||
164072080|NCT02706353|592626758|FG004|Dose Level 5|Withdrawal by Subject|0|||
164072081|NCT02706353|592626759|FG005|Dose Level 5|Withdrawal by Subject|2|||
164072082|NCT03560466|592626760|FG000|Overall Study|Adverse Event|1|||
164072083|NCT03560466|592626761|FG001|Overall Study|Adverse Event|2|||
164072084|NCT03560466|592626762|FG002|Overall Study|Adverse Event|0|||
164072085|NCT03560466|592626760|FG000|Overall Study|Poor Compliance to Protocol|0|||
164072086|NCT03560466|592626761|FG001|Overall Study|Poor Compliance to Protocol|2|||
164072087|NCT03560466|592626762|FG002|Overall Study|Poor Compliance to Protocol|0|||
164072088|NCT03560466|592626760|FG000|Overall Study|Other|6|||
164072089|NCT03560466|592626761|FG001|Overall Study|Other|8|||
164072090|NCT03560466|592626762|FG002|Overall Study|Other|1|||
164072091|NCT00545441|592628478|FG000|Overall Study|Fistula draining at 6 months|2|||
164072092|NCT00545441|592628479|FG001|Overall Study|Fistula draining at 6 months|4|||
164072093|NCT00545441|592628478|FG000|Overall Study|Lost to Follow-up|9|||
164072094|NCT00545441|592628479|FG001|Overall Study|Lost to Follow-up|5|||
164072095|NCT00545441|592628478|FG000|Overall Study|Technical failure|0|||
164072096|NCT00545441|592628479|FG001|Overall Study|Technical failure|1|||
164072097|NCT00545441|592628478|FG000|Overall Study|Withdrawal by Subject|1|||
164072098|NCT00545441|592628479|FG001|Overall Study|Withdrawal by Subject|1|||
164072099|NCT00545441|592628478|FG000|Overall Study|Persistence or recurrence of fistula|5|||
164072100|NCT00545441|592628479|FG001|Overall Study|Persistence or recurrence of fistula|2|||
164072101|NCT00545441|592628478|FG000|Overall Study|Patients were not treated|1|||
164072102|NCT00545441|592628479|FG001|Overall Study|Patients were not treated|3|||
164072103|NCT03911960|592628480|FG000|Overall Study|Lost to Follow-up|5|||
164072104|NCT03911960|592628481|FG001|Overall Study|Lost to Follow-up|3|||
164072105|NCT04723173|592628486|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
164072106|NCT02996448|592628487|FG000|Overall Study|Study terminated due to adverse effects|3|||
164072107|NCT00606801|592628488|FG000|Intervention|Protocol Violation|3|||
164072108|NCT00606801|592628489|FG001|Intervention|Protocol Violation|3|||
164072109|NCT02082262|592628490|FG000|Overall Study|Withdrawal by Subject|3|||
164072110|NCT02082262|592628490|FG000|Overall Study|Adverse Event|48|||
164106861|NCT04589650|592754983|FG003|Overall Study|Guardian Decision|1|||
164106862|NCT04589650|592754984|FG004|Overall Study|Guardian Decision|0|||
164072111|NCT01726335|592628495|FG000|Overall Study|Lost to Follow-up|2|||
164072112|NCT01726335|592628495|FG000|Overall Study|Withdrawal by Subject|15|||
164072113|NCT01726335|592628495|FG000|Overall Study|Adverse Event|4|||
164072114|NCT01726335|592628495|FG000|Overall Study|Lost to Follow-up|2|||
164072115|NCT01726335|592628495|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
164072116|NCT01586624|592628496|FG000|Overall Study|Adverse Event|3|||
164072117|NCT01586624|592628497|FG001|Overall Study|Adverse Event|0|||
164072118|NCT01586624|592628498|FG002|Overall Study|Adverse Event|2|||
164072119|NCT01586624|592628499|FG003|Overall Study|Adverse Event|1|||
164072120|NCT01586624|592628500|FG004|Overall Study|Adverse Event|3|||
164072121|NCT01586624|592628501|FG005|Overall Study|Adverse Event|3|||
164072122|NCT01586624|592628502|FG006|Overall Study|Adverse Event|2|||
164072123|NCT01586624|592628503|FG007|Overall Study|Adverse Event|3|||
164072124|NCT01586624|592628496|FG000|Overall Study|Physician Decision|0|||
164072125|NCT01586624|592628497|FG001|Overall Study|Physician Decision|1|||
164072126|NCT01586624|592628498|FG002|Overall Study|Physician Decision|1|||
164072127|NCT01586624|592628499|FG003|Overall Study|Physician Decision|0|||
164072128|NCT01586624|592628500|FG004|Overall Study|Physician Decision|2|||
164072129|NCT01586624|592628501|FG005|Overall Study|Physician Decision|0|||
164072130|NCT01586624|592628502|FG006|Overall Study|Physician Decision|1|||
164072131|NCT01586624|592628503|FG007|Overall Study|Physician Decision|1|||
164072132|NCT01586624|592628496|FG000|Overall Study|Withdrawal by Subject|0|||
164072133|NCT01586624|592628497|FG001|Overall Study|Withdrawal by Subject|0|||
164072134|NCT01586624|592628498|FG002|Overall Study|Withdrawal by Subject|0|||
164072135|NCT01586624|592628499|FG003|Overall Study|Withdrawal by Subject|1|||
164072136|NCT01586624|592628500|FG004|Overall Study|Withdrawal by Subject|0|||
164072137|NCT01586624|592628501|FG005|Overall Study|Withdrawal by Subject|0|||
164072138|NCT01586624|592628502|FG006|Overall Study|Withdrawal by Subject|0|||
164072139|NCT01586624|592628503|FG007|Overall Study|Withdrawal by Subject|0|||
164072140|NCT01586624|592628496|FG000|Overall Study|Evidence of disease progression|1|||
164072141|NCT01586624|592628497|FG001|Overall Study|Evidence of disease progression|3|||
164072142|NCT01586624|592628498|FG002|Overall Study|Evidence of disease progression|2|||
164072143|NCT01586624|592628499|FG003|Overall Study|Evidence of disease progression|5|||
164072144|NCT01586624|592628500|FG004|Overall Study|Evidence of disease progression|3|||
164072145|NCT01586624|592628501|FG005|Overall Study|Evidence of disease progression|5|||
164072146|NCT01586624|592628502|FG006|Overall Study|Evidence of disease progression|4|||
164072147|NCT01586624|592628503|FG007|Overall Study|Evidence of disease progression|6|||
164072148|NCT01586624|592628496|FG000|Overall Study|Screen failure (no treatment received)|0|||
164072149|NCT01586624|592628497|FG001|Overall Study|Screen failure (no treatment received)|0|||
164072150|NCT01586624|592628498|FG002|Overall Study|Screen failure (no treatment received)|0|||
164072151|NCT01586624|592628499|FG003|Overall Study|Screen failure (no treatment received)|0|||
164072152|NCT01586624|592628500|FG004|Overall Study|Screen failure (no treatment received)|0|||
164072153|NCT01586624|592628501|FG005|Overall Study|Screen failure (no treatment received)|0|||
164072154|NCT01586624|592628502|FG006|Overall Study|Screen failure (no treatment received)|1|||
164072155|NCT01586624|592628503|FG007|Overall Study|Screen failure (no treatment received)|0|||
164072156|NCT00647426|592628515|FG000|Overall Study|Withdrawal by Subject|2|||
164072157|NCT02748616|592628521|FG000|Overall Study|Lost to Follow-up|1|||
164072158|NCT02748616|592628521|FG000|Overall Study|Withdrawal by Subject|2|||
164072159|NCT02748616|592628521|FG000|Overall Study|Physician Decision|2|||
164072160|NCT02748616|592628521|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
164072161|NCT02018042|592628522|FG000|Overall Study|Withdrawal by Subject|1|||
164072162|NCT03231709|592628523|FG000|Treatment Period 1|Reason not Specified|0|||
164072163|NCT03231709|592628524|FG001|Treatment Period 1|Reason not Specified|1|||
164072164|NCT03231709|592628523|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
164072165|NCT03231709|592628524|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
164072166|NCT02419469|592628525|FG000|Overall Study|Withdrawal by Subject|1|||
164072167|NCT01785875|592628526|FG000|Overall Study|Withdrawal by Subject|41|||
164072168|NCT01785875|592628527|FG001|Overall Study|Withdrawal by Subject|34|||
164072169|NCT01785875|592628528|FG002|Overall Study|Withdrawal by Subject|36|||
164072170|NCT01785875|592628526|FG000|Overall Study|Lost to Follow-up|19|||
164072171|NCT01785875|592628527|FG001|Overall Study|Lost to Follow-up|22|||
164072172|NCT01785875|592628528|FG002|Overall Study|Lost to Follow-up|6|||
164072173|NCT01785875|592628526|FG000|Overall Study|Death|27|||
164072174|NCT01785875|592628527|FG001|Overall Study|Death|16|||
164072175|NCT01785875|592628528|FG002|Overall Study|Death|7|||
164072176|NCT01785875|592628526|FG000|Overall Study|Sponsor Decision|0|||
164072177|NCT01785875|592628527|FG001|Overall Study|Sponsor Decision|2|||
164072178|NCT01785875|592628528|FG002|Overall Study|Sponsor Decision|0|||
164072179|NCT01785875|592628526|FG000|Overall Study|Protocol Specified Criteria|207|||
164072180|NCT01785875|592628527|FG001|Overall Study|Protocol Specified Criteria|214|||
164072181|NCT01785875|592628528|FG002|Overall Study|Protocol Specified Criteria|55|||
164072182|NCT01785875|592628526|FG000|Overall Study|Missing|0|||
164072183|NCT01785875|592628527|FG001|Overall Study|Missing|1|||
164072184|NCT01785875|592628528|FG002|Overall Study|Missing|3|||
164072185|NCT04840901|592628531|FG000|Overall Study|Lost to Follow-up|3|||
164072186|NCT04840901|592628532|FG001|Overall Study|Lost to Follow-up|1|||
164072187|NCT04840901|592628531|FG000|Overall Study|Moved|1|||
164072188|NCT04840901|592628532|FG001|Overall Study|Moved|0|||
164072189|NCT04840901|592628531|FG000|Overall Study|Unable to comply with study schedule|0|||
164072190|NCT04840901|592628532|FG001|Overall Study|Unable to comply with study schedule|1|||
164072191|NCT04840901|592628531|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
164072192|NCT04840901|592628532|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
164072193|NCT01414062|592628533|FG000|Overall Study|Lost to Follow-up|3|||
164072194|NCT01414062|592628534|FG001|Overall Study|Lost to Follow-up|2|||
164072195|NCT01414062|592628533|FG000|Overall Study|Left Country|1|||
164072196|NCT01414062|592628534|FG001|Overall Study|Left Country|1|||
164072197|NCT01414062|592628533|FG000|Overall Study|Family Disapproval|1|||
164072198|NCT01414062|592628534|FG001|Overall Study|Family Disapproval|0|||
164072199|NCT01414062|592628533|FG000|Overall Study|Withdrawal by Subject|0|||
164072200|NCT01414062|592628534|FG001|Overall Study|Withdrawal by Subject|1|||
164072201|NCT04075292|592628535|FG000|Overall Study|Withdrawal by Subject|1|||
164072202|NCT04075292|592628536|FG001|Overall Study|Withdrawal by Subject|9|||
164072203|NCT04075292|592628535|FG000|Overall Study|Death|2|||
164072204|NCT04075292|592628536|FG001|Overall Study|Death|5|||
164072205|NCT04075292|592628535|FG000|Overall Study|Remained on study at time of DCO|74|||
164072206|NCT04075292|592628536|FG001|Overall Study|Remained on study at time of DCO|64|||
164072207|NCT01988493|592628538|FG000|Overall Study|Randomized but not treated|0|||
164072208|NCT01988493|592628539|FG001|Overall Study|Randomized but not treated|0|||
164072209|NCT01988493|592628540|FG002|Overall Study|Randomized but not treated|0|||
164072210|NCT01988493|592628541|FG003|Overall Study|Randomized but not treated|0|||
164072211|NCT01988493|592628542|FG004|Overall Study|Randomized but not treated|1|||
164072212|NCT00185731|592628547|FG000|Overall Study|Withdrawal by Subject|1|||
164072213|NCT00185731|592628547|FG000|Overall Study|Not Eligible|1|||
164072214|NCT03087773|592628548|FG000|Overall Study|Withdrawal by Subject|8|||
164072215|NCT03087773|592628549|FG001|Overall Study|Withdrawal by Subject|4|||
164072216|NCT03087773|592628548|FG000|Overall Study|Lost to Follow-up|12|||
164072217|NCT03087773|592628549|FG001|Overall Study|Lost to Follow-up|8|||
164072218|NCT05144477|592628552|FG000|Overall Study|Withdrawal by Subject|1|||
164072219|NCT05144477|592628553|FG001|Overall Study|Withdrawal by Subject|1|||
164072220|NCT01787188|592628558|FG000|Overall Study|Adverse Event|2|||
164072221|NCT01787188|592628559|FG001|Overall Study|Adverse Event|4|||
164072222|NCT01787188|592628560|FG002|Overall Study|Adverse Event|6|||
164072223|NCT01787188|592628558|FG000|Overall Study|Lack of Efficacy|7|||
164072224|NCT01787188|592628559|FG001|Overall Study|Lack of Efficacy|3|||
164072225|NCT01787188|592628560|FG002|Overall Study|Lack of Efficacy|5|||
164072226|NCT01787188|592628558|FG000|Overall Study|Non-compliance with Study Drug|0|||
164072227|NCT01787188|592628559|FG001|Overall Study|Non-compliance with Study Drug|1|||
164072228|NCT01787188|592628560|FG002|Overall Study|Non-compliance with Study Drug|0|||
164072229|NCT01787188|592628558|FG000|Overall Study|Withdrawal by Subject|4|||
164072230|NCT01787188|592628559|FG001|Overall Study|Withdrawal by Subject|3|||
164072231|NCT01787188|592628560|FG002|Overall Study|Withdrawal by Subject|2|||
164072232|NCT01787188|592628558|FG000|Overall Study|Protocol Violation|3|||
164072233|NCT01787188|592628559|FG001|Overall Study|Protocol Violation|2|||
164072234|NCT01787188|592628560|FG002|Overall Study|Protocol Violation|3|||
164072235|NCT01787188|592628558|FG000|Overall Study|Lost to Follow-up|1|||
164072236|NCT01787188|592628559|FG001|Overall Study|Lost to Follow-up|2|||
164072237|NCT01787188|592628560|FG002|Overall Study|Lost to Follow-up|2|||
164072238|NCT01787188|592628558|FG000|Overall Study|Other, including patient moved|0|||
164072239|NCT01787188|592628559|FG001|Overall Study|Other, including patient moved|3|||
164072240|NCT01787188|592628560|FG002|Overall Study|Other, including patient moved|0|||
164072241|NCT00854607|592628561|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
164072242|NCT01783483|592628567|FG000|Overall Study|Death|3|||
164072243|NCT01783483|592628568|FG001|Overall Study|Death|3|||
164072244|NCT01783483|592628567|FG000|Overall Study|Lost to Follow-up|14|||
164072245|NCT01783483|592628568|FG001|Overall Study|Lost to Follow-up|10|||
164072246|NCT01783483|592628567|FG000|Overall Study|Withdrawal by Subject|2|||
164072247|NCT01783483|592628568|FG001|Overall Study|Withdrawal by Subject|1|||
164072248|NCT01783483|592628567|FG000|Overall Study|Physician Decision|1|||
164072249|NCT01783483|592628568|FG001|Overall Study|Physician Decision|1|||
164072250|NCT02268045|592628569|FG000|Overall Study|Death|4|||
164072251|NCT02268045|592628570|FG001|Overall Study|Death|4|||
164072252|NCT02268045|592628569|FG000|Overall Study|Disease Progression|2|||
164072253|NCT02268045|592628570|FG001|Overall Study|Disease Progression|1|||
164072254|NCT02268045|592628569|FG000|Overall Study|Adverse Event|7|||
164072255|NCT02268045|592628570|FG001|Overall Study|Adverse Event|7|||
164072256|NCT02268045|592628569|FG000|Overall Study|Withdrawal by Subject|2|||
164072257|NCT02268045|592628570|FG001|Overall Study|Withdrawal by Subject|6|||
164072258|NCT02268045|592628569|FG000|Overall Study|Physician Decision|0|||
164072259|NCT02268045|592628570|FG001|Overall Study|Physician Decision|1|||
164072260|NCT02268045|592628569|FG000|Overall Study|Protocol Violation|1|||
164072261|NCT02268045|592628570|FG001|Overall Study|Protocol Violation|1|||
164072262|NCT01766310|592628571|FG000|Overall Study|Lost to Follow-up|1|||
164072263|NCT01766310|592628572|FG001|Overall Study|Lost to Follow-up|3|||
164072264|NCT00835068|592628573|FG000|Overall Study|Death|1|||
164072265|NCT00835068|592628574|FG001|Overall Study|Death|0|||
164072266|NCT00835068|592628573|FG000|Overall Study|Adverse Event|0|||
164072267|NCT00835068|592628574|FG001|Overall Study|Adverse Event|1|||
164072268|NCT00835068|592628573|FG000|Overall Study|Other|8|||
164072269|NCT00835068|592628574|FG001|Overall Study|Other|0|||
164072270|NCT00835068|592628573|FG000|Overall Study|Withdrawal by Subject|1|||
164072271|NCT00835068|592628574|FG001|Overall Study|Withdrawal by Subject|0|||
164072272|NCT01591499|592628575|FG000|Baseline Visit|Withdrawal by Subject|0|||
164072273|NCT01591499|592628576|FG001|Baseline Visit|Withdrawal by Subject|2|||
164072274|NCT01591499|592628577|FG002|Baseline Visit|Withdrawal by Subject|0|||
164072275|NCT01591499|592628578|FG003|Baseline Visit|Withdrawal by Subject|2|||
164072276|NCT01591499|592628575|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
164072277|NCT01591499|592628576|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
164072278|NCT01591499|592628577|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
164072279|NCT01591499|592628578|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
164072280|NCT01591499|592628575|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
164072281|NCT01591499|592628576|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
164072282|NCT01591499|592628577|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
164072283|NCT01591499|592628578|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
164072284|NCT02125734|592628579|FG000|Period 2|Adverse Event|0|||
164072285|NCT02125734|592628580|FG001|Period 2|Adverse Event|1|||
164072286|NCT01308762|592628581|FG000|Overall Study|Protocol Violation|0|||
164072287|NCT01308762|592628582|FG001|Overall Study|Protocol Violation|1|||
164072288|NCT01308762|592628583|FG002|Overall Study|Protocol Violation|0|||
164072289|NCT00646282|592628584|FG000|Overall Study|Protocol terminated|4|||
164072290|NCT00646282|592628585|FG001|Overall Study|Protocol terminated|4|||
164072291|NCT01556490|592628586|FG000|Randomized Patients Summary|Protocol Violation|22|||
164072292|NCT01556490|592628587|FG001|Randomized Patients Summary|Protocol Violation|23|||
164072293|NCT01556490|592628586|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
164072294|NCT01556490|592628587|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
164072295|NCT00902278|592628588|FG000|Overall Study|Physician Decision|1|||
164072296|NCT00902278|592628589|FG001|Overall Study|Physician Decision|0|||
164072297|NCT00902278|592628590|FG002|Overall Study|Physician Decision|2|||
164072298|NCT00902278|592628591|FG003|Overall Study|Physician Decision|0|||
164072299|NCT00902278|592628592|FG004|Overall Study|Physician Decision|1|||
164072300|NCT00902278|592628588|FG000|Overall Study|Lost to Follow-up|3|||
164072301|NCT00902278|592628589|FG001|Overall Study|Lost to Follow-up|2|||
164072302|NCT00902278|592628590|FG002|Overall Study|Lost to Follow-up|3|||
164072303|NCT00902278|592628591|FG003|Overall Study|Lost to Follow-up|0|||
164072304|NCT00902278|592628592|FG004|Overall Study|Lost to Follow-up|1|||
164072305|NCT01652872|592628595|FG000|Overall Study|Death|36|||
164072306|NCT01652872|592628596|FG001|Overall Study|Death|39|||
164072307|NCT01652872|592628595|FG000|Overall Study|Lost to Follow-up|28|||
164072308|NCT01652872|592628596|FG001|Overall Study|Lost to Follow-up|23|||
164072309|NCT01652872|592628595|FG000|Overall Study|Decision by sponsor|5|||
164072310|NCT01652872|592628596|FG001|Overall Study|Decision by sponsor|7|||
164072311|NCT01652872|592628595|FG000|Overall Study|Withdrawal by Subject|76|||
164072312|NCT01652872|592628596|FG001|Overall Study|Withdrawal by Subject|84|||
164072313|NCT00758706|592628597|FG000|Overall Study|Adverse Event|4|||
164072314|NCT00758706|592628598|FG001|Overall Study|Adverse Event|4|||
164072315|NCT03985293|592628605|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
164072316|NCT03985293|592628606|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
164072317|NCT03985293|592628607|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
164072318|NCT03985293|592628608|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
164072319|NCT03985293|592628609|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
164072320|NCT03985293|592628610|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
164072321|NCT03985293|592628605|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
164072322|NCT03985293|592628606|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
164072323|NCT03985293|592628607|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
164072324|NCT03985293|592628608|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
164072325|NCT03985293|592628609|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
164072326|NCT03985293|592628610|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
164072327|NCT03985293|592628605|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
164072328|NCT03985293|592628606|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
164072329|NCT03985293|592628607|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
164072330|NCT03985293|592628608|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
164072331|NCT03985293|592628609|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
164072332|NCT03985293|592628610|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
164072333|NCT03985293|592628605|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
164072334|NCT03985293|592628606|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
164072335|NCT03985293|592628607|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
164072336|NCT03985293|592628608|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
164072337|NCT03985293|592628609|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
164072338|NCT03985293|592628610|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
164072339|NCT03985293|592628605|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
164072340|NCT03985293|592628606|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
164072341|NCT03985293|592628607|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
164072342|NCT03985293|592628608|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
164072343|NCT03985293|592628609|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
164072344|NCT03985293|592628610|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
164072345|NCT03985293|592628605|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
164072346|NCT03985293|592628606|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
164072347|NCT03985293|592628607|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
164072348|NCT03985293|592628608|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
164072349|NCT03985293|592628609|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
164072350|NCT03985293|592628610|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
164072351|NCT03985293|592628605|FG000|FOLLOW-UP|Lost to Follow-up|0|||
164072352|NCT03985293|592628606|FG001|FOLLOW-UP|Lost to Follow-up|0|||
164072353|NCT03985293|592628607|FG002|FOLLOW-UP|Lost to Follow-up|1|||
164072354|NCT03985293|592628608|FG003|FOLLOW-UP|Lost to Follow-up|0|||
164072355|NCT03985293|592628609|FG004|FOLLOW-UP|Lost to Follow-up|0|||
164072356|NCT03985293|592628610|FG005|FOLLOW-UP|Lost to Follow-up|0|||
164072357|NCT02588651|592628611|FG000|Overall Study|Adverse Event|1|||
164072358|NCT02588651|592628611|FG000|Overall Study|Withdrawal by Subject|2|||
164072359|NCT02588651|592628611|FG000|Overall Study|Death|1|||
164072360|NCT02588651|592628611|FG000|Overall Study|Lack of Efficacy|13|||
164072361|NCT02588651|592628611|FG000|Overall Study|Lost to Follow-up|1|||
164072362|NCT02588651|592628611|FG000|Overall Study|Physician Decision|1|||
164072363|NCT02588651|592628611|FG000|Overall Study|Disease progression|2|||
164072364|NCT05899218|592628612|FG000|Overall Study|Lost to Follow-up|2|||
164072365|NCT05899218|592628613|FG001|Overall Study|Lost to Follow-up|2|||
164072366|NCT05899218|592628612|FG000|Overall Study|deemed ineligible out of country|1|||
164072367|NCT05899218|592628613|FG001|Overall Study|deemed ineligible out of country|0|||
164072368|NCT02587325|592628618|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
164072369|NCT02587325|592628619|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
164072370|NCT02587325|592628620|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
164072371|NCT02587325|592628621|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
164072372|NCT02587325|592628622|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
164072373|NCT02587325|592628618|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164072374|NCT02587325|592628619|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164072375|NCT02587325|592628620|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164072376|NCT02587325|592628621|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
164072377|NCT02587325|592628622|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
164072378|NCT02587325|592628618|FG000|32-Week Optional Extension Part|Adverse Event|0|||
164072379|NCT02587325|592628619|FG001|32-Week Optional Extension Part|Adverse Event|0|||
164072380|NCT02587325|592628620|FG002|32-Week Optional Extension Part|Adverse Event|1|||
164072381|NCT02587325|592628621|FG003|32-Week Optional Extension Part|Adverse Event|0|||
164072382|NCT02587325|592628622|FG004|32-Week Optional Extension Part|Adverse Event|0|||
164072383|NCT02587325|592628618|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
164072384|NCT02587325|592628619|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
164072385|NCT02587325|592628620|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
164072386|NCT02587325|592628621|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
164072387|NCT02587325|592628622|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
164072388|NCT00390572|592628623|FG000|Overall Study|Lost to Follow-up|8|||
164072389|NCT00390572|592628624|FG001|Overall Study|Lost to Follow-up|4|||
164072390|NCT00390572|592628623|FG000|Overall Study|health condition|0|||
164072391|NCT00390572|592628624|FG001|Overall Study|health condition|1|||
164072392|NCT02913261|592628631|FG000|Overall Study|Technical problems|0|||
164072393|NCT02913261|592628632|FG001|Overall Study|Technical problems|1|||
164072394|NCT02913261|592628631|FG000|Overall Study|Lack of Efficacy|32|||
164072395|NCT02913261|592628632|FG001|Overall Study|Lack of Efficacy|69|||
164072396|NCT02913261|592628631|FG000|Overall Study|Adverse Event|27|||
164072397|NCT02913261|592628632|FG001|Overall Study|Adverse Event|5|||
164072398|NCT02913261|592628631|FG000|Overall Study|Death|25|||
164072399|NCT02913261|592628632|FG001|Overall Study|Death|22|||
164072400|NCT02913261|592628631|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
164072401|NCT02913261|592628632|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
164072402|NCT02913261|592628631|FG000|Overall Study|Disease relapse|8|||
164072403|NCT02913261|592628632|FG001|Overall Study|Disease relapse|13|||
164072404|NCT02913261|592628631|FG000|Overall Study|Physician Decision|8|||
164072405|NCT02913261|592628632|FG001|Overall Study|Physician Decision|9|||
164072406|NCT02913261|592628631|FG000|Overall Study|Subject/guardian decision|4|||
164072407|NCT02913261|592628632|FG001|Overall Study|Subject/guardian decision|6|||
164072408|NCT02913261|592628631|FG000|Overall Study|Graft loss|2|||
164072409|NCT02913261|592628632|FG001|Overall Study|Graft loss|0|||
164072410|NCT02304302|592628657|FG000|Overall Study|Adverse Event|2|||
164072411|NCT02304302|592628658|FG001|Overall Study|Adverse Event|3|||
164072412|NCT02304302|592628657|FG000|Overall Study|Lost to Follow-up|1|||
164072413|NCT02304302|592628658|FG001|Overall Study|Lost to Follow-up|4|||
164072414|NCT02304302|592628657|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
164072415|NCT02304302|592628658|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
164072416|NCT00391118|592628659|FG000|Overall Study|Adverse Event|3|||
164072417|NCT00391118|592628660|FG001|Overall Study|Adverse Event|10|||
164072418|NCT00391118|592628661|FG002|Overall Study|Adverse Event|7|||
164072419|NCT00391118|592628659|FG000|Overall Study|Lost to Follow-up|0|||
164072420|NCT00391118|592628660|FG001|Overall Study|Lost to Follow-up|2|||
164072421|NCT00391118|592628661|FG002|Overall Study|Lost to Follow-up|3|||
164072422|NCT00391118|592628659|FG000|Overall Study|Withdrawal by Subject|0|||
164072423|NCT00391118|592628660|FG001|Overall Study|Withdrawal by Subject|9|||
164072424|NCT00391118|592628661|FG002|Overall Study|Withdrawal by Subject|1|||
164072425|NCT00391118|592628659|FG000|Overall Study|Death|0|||
164072426|NCT00391118|592628660|FG001|Overall Study|Death|1|||
164072427|NCT00391118|592628661|FG002|Overall Study|Death|0|||
164072428|NCT00391118|592628659|FG000|Overall Study|Physician Decision|0|||
164072429|NCT00391118|592628660|FG001|Overall Study|Physician Decision|3|||
164072430|NCT00391118|592628661|FG002|Overall Study|Physician Decision|0|||
164072431|NCT00391118|592628659|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
164072432|NCT00391118|592628660|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
164072433|NCT00391118|592628661|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
164072434|NCT00391118|592628659|FG000|Overall Study|Progressive Disease|7|||
164072435|NCT00391118|592628660|FG001|Overall Study|Progressive Disease|26|||
164072436|NCT00391118|592628661|FG002|Overall Study|Progressive Disease|43|||
164072437|NCT00391118|592628659|FG000|Overall Study|Sponsor Decision|0|||
164072438|NCT00391118|592628660|FG001|Overall Study|Sponsor Decision|1|||
164072439|NCT00391118|592628661|FG002|Overall Study|Sponsor Decision|3|||
164072440|NCT00391118|592628659|FG000|Overall Study|Protocol Violation|1|||
164072441|NCT00391118|592628660|FG001|Overall Study|Protocol Violation|0|||
164072442|NCT00391118|592628661|FG002|Overall Study|Protocol Violation|0|||
164072443|NCT03078192|592628664|FG000|Overall Study|Withdrawal by Subject|2|||
164072444|NCT03078192|592628665|FG001|Overall Study|Withdrawal by Subject|1|||
164072445|NCT03078192|592628664|FG000|Overall Study|screen failure|0|||
164072446|NCT03078192|592628665|FG001|Overall Study|screen failure|3|||
164072447|NCT01311505|592628666|FG000|First Intervention Period|Protocol Violation|0|||
164072448|NCT01311505|592628667|FG001|First Intervention Period|Protocol Violation|1|||
164072449|NCT01074307|592630445|FG000|Overall Study|No primary endpoint evaluation|14|||
164072450|NCT01074307|592630446|FG001|Overall Study|No primary endpoint evaluation|6|||
164072451|NCT01074307|592630445|FG000|Overall Study|Exclusion criterion|0|||
164072452|NCT01074307|592630446|FG001|Overall Study|Exclusion criterion|1|||
164072453|NCT01074307|592630445|FG000|Overall Study|Protocol Violation|8|||
164072454|NCT01074307|592630446|FG001|Overall Study|Protocol Violation|5|||
164072455|NCT02703454|592630454|FG000|Overall Study|Not treated|1|||
164072456|NCT02703454|592630455|FG001|Overall Study|Not treated|3|||
164072457|NCT02703454|592630454|FG000|Overall Study|Withdrawal by Subject|4|||
164072458|NCT02703454|592630455|FG001|Overall Study|Withdrawal by Subject|3|||
164072459|NCT02703454|592630454|FG000|Overall Study|Lost to Follow-up|1|||
164072460|NCT02703454|592630455|FG001|Overall Study|Lost to Follow-up|2|||
164072461|NCT02703454|592630454|FG000|Overall Study|Study discontinuation|5|||
164072462|NCT02703454|592630455|FG001|Overall Study|Study discontinuation|8|||
164072463|NCT02284373|592630456|FG000|Overall Study|Withdrawal by Subject|0|||
164072464|NCT02284373|592630457|FG001|Overall Study|Withdrawal by Subject|1|||
164072465|NCT02284373|592630458|FG002|Overall Study|Withdrawal by Subject|0|||
164072466|NCT02284373|592630456|FG000|Overall Study|Other|0|||
164072467|NCT02284373|592630457|FG001|Overall Study|Other|1|||
164072468|NCT02284373|592630458|FG002|Overall Study|Other|0|||
164072469|NCT02284373|592630456|FG000|Overall Study|Lost to Follow-up|0|||
164072470|NCT02284373|592630457|FG001|Overall Study|Lost to Follow-up|1|||
164072471|NCT02284373|592630458|FG002|Overall Study|Lost to Follow-up|0|||
164072472|NCT02016755|592630459|FG000|Overall Study|Major amputation of index limb|2|||
164072473|NCT02016755|592630459|FG000|Overall Study|Adverse Event|2|||
164072474|NCT02016755|592630459|FG000|Overall Study|Physician Decision|1|||
164072475|NCT02016755|592630459|FG000|Overall Study|Death|2|||
164072476|NCT03174925|592630471|FG000|Overall Study|Elastographic images not retrievable|2|||
164072477|NCT03174925|592630471|FG000|Overall Study|Elastography image not interpretable|1|||
164072478|NCT04247594|592630474|FG000|Overall Study|Withdrawal by Subject|4|||
164072479|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
164072480|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
164072481|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
164072482|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
164072483|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
164072484|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
164072485|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
164072486|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
164072487|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164072488|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164072489|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164072490|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
164072491|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
164072492|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164072493|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164072494|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
164106863|NCT04589650|592754985|FG005|Overall Study|Guardian Decision|0|||
164072495|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
164072496|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
164072497|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
164072498|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
164072499|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
164072500|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
164072501|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
164072502|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
164072503|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
164072504|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164072505|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
164072506|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164072507|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
164072508|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164072509|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164072510|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
164072511|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
164072512|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164072513|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
164072514|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
164072515|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164072516|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164072517|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
164072518|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
164072519|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
164072520|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
164072521|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
164072522|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
164072523|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
164072524|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
164072525|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
164072526|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
164072527|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
164072528|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
164072529|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164072530|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
164072531|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164072532|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164072533|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164072534|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
164072535|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
164072536|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
164072537|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
164072538|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
164072539|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
164072540|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
164072541|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
164072542|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
164072543|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
164072544|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
164072545|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
164072546|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
164072547|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
164072548|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
164072549|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
164072550|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
164072551|NCT04440163|592630476|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
164072552|NCT04440163|592630477|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
164072553|NCT04440163|592630478|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
164072554|NCT04440163|592630479|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
164072555|NCT04440163|592630480|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
164072556|NCT04440163|592630481|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
164072557|NCT04440163|592630482|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
164106864|NCT02923349|592754986|FG000|Overall Study|Other|1|||
164072558|NCT04440163|592630483|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
164072559|NCT04440163|592630476|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
164072560|NCT04440163|592630477|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
164072561|NCT04440163|592630478|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
164072562|NCT04440163|592630479|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
164072563|NCT04440163|592630480|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
164072564|NCT04440163|592630481|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
164072565|NCT04440163|592630482|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
164072566|NCT04440163|592630483|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
164072567|NCT04440163|592630476|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072568|NCT04440163|592630477|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072569|NCT04440163|592630478|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072570|NCT04440163|592630479|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
164072571|NCT04440163|592630480|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072572|NCT04440163|592630481|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072573|NCT04440163|592630482|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072574|NCT04440163|592630483|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
164072575|NCT00589693|592630487|FG000|Overall Study|randomized in error|12|||
164072576|NCT00589693|592630488|FG001|Overall Study|randomized in error|6|||
164072577|NCT00589693|592630487|FG000|Overall Study|Adverse Event|4|||
164072578|NCT00589693|592630488|FG001|Overall Study|Adverse Event|4|||
164072579|NCT00589693|592630487|FG000|Overall Study|Death|26|||
164072580|NCT00589693|592630488|FG001|Overall Study|Death|16|||
164072581|NCT00589693|592630487|FG000|Overall Study|Lack of Efficacy|0|||
164072582|NCT00589693|592630488|FG001|Overall Study|Lack of Efficacy|1|||
164072583|NCT00589693|592630487|FG000|Overall Study|Lost to Follow-up|1|||
164072584|NCT00589693|592630488|FG001|Overall Study|Lost to Follow-up|0|||
164072585|NCT00589693|592630487|FG000|Overall Study|Physician Decision|0|||
164072586|NCT00589693|592630488|FG001|Overall Study|Physician Decision|1|||
164072587|NCT00589693|592630487|FG000|Overall Study|Protocol Violation|1|||
164072588|NCT00589693|592630488|FG001|Overall Study|Protocol Violation|1|||
164072589|NCT01128153|592630489|FG000|Overall Study|Adverse Event|1|||
164072590|NCT01128153|592630490|FG001|Overall Study|Adverse Event|3|||
164072591|NCT01128153|592630489|FG000|Overall Study|Condition under investigation worsened|8|||
164072592|NCT01128153|592630490|FG001|Overall Study|Condition under investigation worsened|7|||
164072593|NCT01128153|592630489|FG000|Overall Study|Withdrawal by Subject|2|||
164072594|NCT01128153|592630490|FG001|Overall Study|Withdrawal by Subject|3|||
164072595|NCT01128153|592630489|FG000|Overall Study|Incorrect enrolment to study|2|||
164072596|NCT01128153|592630490|FG001|Overall Study|Incorrect enrolment to study|1|||
164072597|NCT01128153|592630489|FG000|Overall Study|Protocol Violation|2|||
164072598|NCT01128153|592630490|FG001|Overall Study|Protocol Violation|0|||
164072599|NCT01128153|592630489|FG000|Overall Study|Developed discontinuation criteria|1|||
164072600|NCT01128153|592630490|FG001|Overall Study|Developed discontinuation criteria|1|||
164072601|NCT01954082|592630491|FG000|Overall Study|Study Suspension|42|||
164072602|NCT01954082|592630492|FG001|Overall Study|Study Suspension|36|||
164072603|NCT01954082|592630491|FG000|Overall Study|Adverse Event|10|||
164072604|NCT01954082|592630492|FG001|Overall Study|Adverse Event|4|||
164072605|NCT01954082|592630491|FG000|Overall Study|Intolerance|0|||
164072606|NCT01954082|592630492|FG001|Overall Study|Intolerance|1|||
164072607|NCT01954082|592630491|FG000|Overall Study|Non-compliance|6|||
164072608|NCT01954082|592630492|FG001|Overall Study|Non-compliance|4|||
164072609|NCT01954082|592630491|FG000|Overall Study|Physician Decision|2|||
164072610|NCT01954082|592630492|FG001|Overall Study|Physician Decision|0|||
164072611|NCT01954082|592630491|FG000|Overall Study|Parent Decision|1|||
164072612|NCT01954082|592630492|FG001|Overall Study|Parent Decision|0|||
164072613|NCT01954082|592630491|FG000|Overall Study|Withdrawal by Subject|0|||
164072614|NCT01954082|592630492|FG001|Overall Study|Withdrawal by Subject|1|||
164072615|NCT01954082|592630491|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
164072616|NCT01954082|592630492|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
164072617|NCT01954082|592630491|FG000|Overall Study|Redirection of Care|0|||
164072618|NCT01954082|592630492|FG001|Overall Study|Redirection of Care|2|||
164072619|NCT01954082|592630491|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
164072620|NCT01954082|592630492|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
164072621|NCT01954082|592630491|FG000|Overall Study|Comfort Care|0|||
164072622|NCT01954082|592630492|FG001|Overall Study|Comfort Care|1|||
164072623|NCT01954082|592630491|FG000|Overall Study|Infant Moved|0|||
164072624|NCT01954082|592630492|FG001|Overall Study|Infant Moved|1|||
164072625|NCT01954082|592630491|FG000|Overall Study|Randomized not Treated|4|||
164072626|NCT01954082|592630492|FG001|Overall Study|Randomized not Treated|2|||
164072627|NCT01682512|592630493|FG000|Overall Study|Adverse Event|6|||
164072628|NCT01682512|592630494|FG001|Overall Study|Adverse Event|5|||
164072629|NCT01682512|592630495|FG002|Overall Study|Adverse Event|2|||
164072630|NCT01682512|592630493|FG000|Overall Study|Withdrawal by Subject|2|||
164072631|NCT01682512|592630494|FG001|Overall Study|Withdrawal by Subject|6|||
164072632|NCT01682512|592630495|FG002|Overall Study|Withdrawal by Subject|3|||
164072633|NCT01682512|592630493|FG000|Overall Study|Physician Decision|0|||
164072634|NCT01682512|592630494|FG001|Overall Study|Physician Decision|2|||
164072635|NCT01682512|592630495|FG002|Overall Study|Physician Decision|0|||
164072636|NCT01682512|592630493|FG000|Overall Study|Study terminated by sponsor|46|||
164072637|NCT01682512|592630494|FG001|Overall Study|Study terminated by sponsor|43|||
164072638|NCT01682512|592630495|FG002|Overall Study|Study terminated by sponsor|0|||
164072639|NCT01682512|592630493|FG000|Overall Study|Lost to Follow-up|3|||
164072640|NCT01682512|592630494|FG001|Overall Study|Lost to Follow-up|0|||
164072641|NCT01682512|592630495|FG002|Overall Study|Lost to Follow-up|2|||
164072642|NCT01682512|592630493|FG000|Overall Study|Protocol Violation|2|||
164072643|NCT01682512|592630494|FG001|Overall Study|Protocol Violation|3|||
164072644|NCT01682512|592630495|FG002|Overall Study|Protocol Violation|2|||
164072645|NCT01682512|592630493|FG000|Overall Study|Primary lack of efficacy|10|||
164072646|NCT01682512|592630494|FG001|Overall Study|Primary lack of efficacy|7|||
164072647|NCT01682512|592630495|FG002|Overall Study|Primary lack of efficacy|7|||
164072648|NCT01682512|592630493|FG000|Overall Study|Secondary lack of efficacy|1|||
164072649|NCT01682512|592630494|FG001|Overall Study|Secondary lack of efficacy|1|||
164072650|NCT01682512|592630495|FG002|Overall Study|Secondary lack of efficacy|0|||
164072651|NCT01682512|592630493|FG000|Overall Study|Other than stated above|2|||
164072652|NCT01682512|592630494|FG001|Overall Study|Other than stated above|4|||
164072653|NCT01682512|592630495|FG002|Overall Study|Other than stated above|2|||
164072654|NCT01377233|592630496|FG000|Open-label|Adverse Event|1|||
164072655|NCT01377233|592630497|FG001|Open-label|Adverse Event|0|||
164072656|NCT01377233|592630498|FG002|Open-label|Adverse Event|0|||
164072657|NCT01377233|592630499|FG003|Open-label|Adverse Event|0|||
164072658|NCT01377233|592630500|FG004|Open-label|Adverse Event|0|||
164072659|NCT01377233|592630496|FG000|Open-label|Withdrawal by Subject|3|||
164072660|NCT01377233|592630497|FG001|Open-label|Withdrawal by Subject|0|||
164072661|NCT01377233|592630498|FG002|Open-label|Withdrawal by Subject|0|||
164072662|NCT01377233|592630499|FG003|Open-label|Withdrawal by Subject|0|||
164072663|NCT01377233|592630500|FG004|Open-label|Withdrawal by Subject|0|||
164072664|NCT01377233|592630496|FG000|Double-blind|Adverse Event|0|||
164072665|NCT01377233|592630497|FG001|Double-blind|Adverse Event|1|||
164072666|NCT01377233|592630498|FG002|Double-blind|Adverse Event|2|||
164072667|NCT01377233|592630499|FG003|Double-blind|Adverse Event|2|||
164072668|NCT01377233|592630500|FG004|Double-blind|Adverse Event|0|||
164072669|NCT01377233|592630496|FG000|Double-blind|Protocol Violation|0|||
164072670|NCT01377233|592630497|FG001|Double-blind|Protocol Violation|0|||
164072671|NCT01377233|592630498|FG002|Double-blind|Protocol Violation|0|||
164072672|NCT01377233|592630499|FG003|Double-blind|Protocol Violation|0|||
164072673|NCT01377233|592630500|FG004|Double-blind|Protocol Violation|1|||
164072674|NCT01377233|592630496|FG000|Double-blind|Withdrawal by Subject|0|||
164072675|NCT01377233|592630497|FG001|Double-blind|Withdrawal by Subject|0|||
164072676|NCT01377233|592630498|FG002|Double-blind|Withdrawal by Subject|0|||
164072677|NCT01377233|592630499|FG003|Double-blind|Withdrawal by Subject|1|||
164072678|NCT01377233|592630500|FG004|Double-blind|Withdrawal by Subject|0|||
164072679|NCT01377233|592630496|FG000|Double-blind|Administrative or other|0|||
164072680|NCT01377233|592630497|FG001|Double-blind|Administrative or other|0|||
164072681|NCT01377233|592630498|FG002|Double-blind|Administrative or other|0|||
164072682|NCT01377233|592630499|FG003|Double-blind|Administrative or other|1|||
164072683|NCT01377233|592630500|FG004|Double-blind|Administrative or other|1|||
164072684|NCT03137082|592630501|FG000|Overall Study|Withdrawal by Subject|1|||
164072685|NCT03137082|592630502|FG001|Overall Study|Withdrawal by Subject|1|||
164072686|NCT03137082|592630501|FG000|Overall Study|Lost to Follow-up|1|||
164072687|NCT03137082|592630502|FG001|Overall Study|Lost to Follow-up|0|||
164072688|NCT00417027|592630503|FG000|Overall Study|Protocol Violation|0|||
164072689|NCT00417027|592630504|FG001|Overall Study|Protocol Violation|5|||
164072690|NCT00417027|592630505|FG002|Overall Study|Protocol Violation|5|||
164072691|NCT04285983|592630506|FG000|Overall Study|Protocol Violation|6|||
164072692|NCT02787785|592630507|FG000|Overall Study|Death|3|||
164072693|NCT02787785|592630508|FG001|Overall Study|Death|4|||
164106865|NCT02923349|592754987|FG001|Overall Study|Other|2|||
164072694|NCT02787785|592630507|FG000|Overall Study|Lost to Follow-up|1|||
164072695|NCT02787785|592630508|FG001|Overall Study|Lost to Follow-up|1|||
164072696|NCT02787785|592630507|FG000|Overall Study|Withdrawal by Subject|0|||
164072697|NCT02787785|592630508|FG001|Overall Study|Withdrawal by Subject|5|||
164072698|NCT01440595|592630519|FG000|Overall Study|Lost to Follow-up|0|||
164072699|NCT01440595|592630520|FG001|Overall Study|Lost to Follow-up|1|||
164072700|NCT01440595|592630521|FG002|Overall Study|Lost to Follow-up|0|||
164072701|NCT01440595|592630519|FG000|Overall Study|Study terminated by sponsor.|1|||
164072702|NCT01440595|592630520|FG001|Overall Study|Study terminated by sponsor.|2|||
164072703|NCT01440595|592630521|FG002|Overall Study|Study terminated by sponsor.|1|||
164072704|NCT01850108|592630522|FG000|Overall Study|Lost to Follow-up|4|||
164072705|NCT01850108|592630522|FG000|Overall Study|Not eligible|1|||
164072706|NCT01850108|592630522|FG000|Overall Study|Failed engraftment|2|||
164072707|NCT01850108|592630522|FG000|Overall Study|Physician Decision|1|||
164072708|NCT01447628|592630525|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
164072709|NCT01447628|592630526|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
164106866|NCT02923349|592754988|FG002|Overall Study|Other|4|||
164072710|NCT01447628|592630527|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
164072711|NCT01447628|592630528|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
164072712|NCT00965263|592630537|FG000|Overall Study|Physician Decision|2|||
164072713|NCT00965263|592630538|FG001|Overall Study|Physician Decision|0|||
164072714|NCT00965263|592630537|FG000|Overall Study|Family emergency|0|||
164072715|NCT00965263|592630538|FG001|Overall Study|Family emergency|1|||
164072716|NCT00965263|592630537|FG000|Overall Study|Protocol Violation|0|||
164072717|NCT00965263|592630538|FG001|Overall Study|Protocol Violation|2|||
164072718|NCT03496207|592630539|FG000|Base Study|Adverse Event|0|||
164072719|NCT03496207|592630540|FG001|Base Study|Adverse Event|0|||
164072720|NCT03496207|592630541|FG002|Base Study|Adverse Event|1|||
164072721|NCT03496207|592630542|FG003|Base Study|Adverse Event|1|||
164072722|NCT03496207|592630543|FG004|Base Study|Adverse Event|4|||
164072723|NCT03496207|592630539|FG000|Base Study|Death|0|||
164072724|NCT03496207|592630540|FG001|Base Study|Death|0|||
164072725|NCT03496207|592630541|FG002|Base Study|Death|0|||
164072726|NCT03496207|592630542|FG003|Base Study|Death|0|||
164072727|NCT03496207|592630543|FG004|Base Study|Death|1|||
164072728|NCT03496207|592630539|FG000|Base Study|Withdrawal by Subject|0|||
164072729|NCT03496207|592630540|FG001|Base Study|Withdrawal by Subject|0|||
164072730|NCT03496207|592630541|FG002|Base Study|Withdrawal by Subject|1|||
164072731|NCT03496207|592630542|FG003|Base Study|Withdrawal by Subject|0|||
164072732|NCT03496207|592630543|FG004|Base Study|Withdrawal by Subject|1|||
164072733|NCT03496207|592630539|FG000|Extension Period|Adverse Event|0|||
164072734|NCT03496207|592630540|FG001|Extension Period|Adverse Event|0|||
164072735|NCT03496207|592630541|FG002|Extension Period|Adverse Event|0|||
164072736|NCT03496207|592630542|FG003|Extension Period|Adverse Event|1|||
164072737|NCT03496207|592630543|FG004|Extension Period|Adverse Event|1|||
164072738|NCT03496207|592630539|FG000|Extension Period|Death|1|||
164072739|NCT03496207|592630540|FG001|Extension Period|Death|0|||
164072740|NCT03496207|592630541|FG002|Extension Period|Death|0|||
164072741|NCT03496207|592630542|FG003|Extension Period|Death|1|||
164072742|NCT03496207|592630543|FG004|Extension Period|Death|2|||
164072743|NCT03496207|592630539|FG000|Extension Period|Withdrawal by Subject|1|||
164072744|NCT03496207|592630540|FG001|Extension Period|Withdrawal by Subject|0|||
164072745|NCT03496207|592630541|FG002|Extension Period|Withdrawal by Subject|0|||
164072746|NCT03496207|592630542|FG003|Extension Period|Withdrawal by Subject|1|||
164072747|NCT03496207|592630543|FG004|Extension Period|Withdrawal by Subject|1|||
164072748|NCT03496207|592630539|FG000|Extension Period|Elevated hemoglobin levels|0|||
164072749|NCT03496207|592630540|FG001|Extension Period|Elevated hemoglobin levels|0|||
164072750|NCT03496207|592630541|FG002|Extension Period|Elevated hemoglobin levels|0|||
164072751|NCT03496207|592630542|FG003|Extension Period|Elevated hemoglobin levels|0|||
164072752|NCT03496207|592630543|FG004|Extension Period|Elevated hemoglobin levels|1|||
164072753|NCT02756078|592630544|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
164072754|NCT02756078|592630545|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
164072755|NCT02756078|592630544|FG000|Period 1|Lost to Follow-up|0|||
164072756|NCT02756078|592630545|FG001|Period 1|Lost to Follow-up|2|||
164072757|NCT02756078|592630544|FG000|Period 1|Protocol Violation|0|||
164072758|NCT02756078|592630545|FG001|Period 1|Protocol Violation|1|||
164072759|NCT02756078|592630544|FG000|Period 1|Adverse Event|1|||
164072760|NCT02756078|592630545|FG001|Period 1|Adverse Event|10|||
164072761|NCT02756078|592630544|FG000|Period 1|Withdrawal by Subject|6|||
164072762|NCT02756078|592630545|FG001|Period 1|Withdrawal by Subject|6|||
164072763|NCT02756078|592630544|FG000|Period 1|Lens Discomfort|2|||
164072764|NCT02756078|592630545|FG001|Period 1|Lens Discomfort|2|||
164072765|NCT02756078|592630544|FG000|Period 2|Adverse Event|3|||
164072766|NCT02756078|592630545|FG001|Period 2|Adverse Event|5|||
164072767|NCT02756078|592630544|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
164072768|NCT02756078|592630545|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
164072769|NCT02756078|592630544|FG000|Period 2|Withdrawal by Subject|3|||
164072770|NCT02756078|592630545|FG001|Period 2|Withdrawal by Subject|1|||
164072771|NCT00810615|592630546|FG000|Overall Study|Withdrawal by Subject|1|||
164072772|NCT00810615|592630547|FG001|Overall Study|Withdrawal by Subject|1|||
164072773|NCT02058368|592630550|FG000|Overall Study|Adverse Event|15|||
164072774|NCT02058368|592630551|FG001|Overall Study|Adverse Event|20|||
164072775|NCT02058368|592630550|FG000|Overall Study|Lack of Efficacy|0|||
164072776|NCT02058368|592630551|FG001|Overall Study|Lack of Efficacy|1|||
164072777|NCT02058368|592630550|FG000|Overall Study|Protocol Violation|0|||
164072778|NCT02058368|592630551|FG001|Overall Study|Protocol Violation|4|||
164072779|NCT02058368|592630550|FG000|Overall Study|Lost to Follow-up|2|||
164072780|NCT02058368|592630551|FG001|Overall Study|Lost to Follow-up|0|||
164072781|NCT02058368|592630550|FG000|Overall Study|Physician Decision|2|||
164072782|NCT02058368|592630551|FG001|Overall Study|Physician Decision|3|||
164072783|NCT02058368|592630550|FG000|Overall Study|Withdrawal by Subject|22|||
164072784|NCT02058368|592630551|FG001|Overall Study|Withdrawal by Subject|26|||
164072785|NCT02181842|592630552|FG000|Overall Study|Case Report Forms Uncollected|2|||
164072786|NCT02441179|592630553|FG000|Overall Study|Withdrawal by Subject|1|||
164072787|NCT02441179|592630554|FG001|Overall Study|Withdrawal by Subject|1|||
164072788|NCT01488071|592630555|FG000|Overall Study|Adverse Event|15|||
164072789|NCT01488071|592630556|FG001|Overall Study|Adverse Event|23|||
164072790|NCT01488071|592630555|FG000|Overall Study|Lack of Efficacy|11|||
164072791|NCT01488071|592630556|FG001|Overall Study|Lack of Efficacy|17|||
164072792|NCT01488071|592630555|FG000|Overall Study|Non-compliance with study drug|2|||
164072793|NCT01488071|592630556|FG001|Overall Study|Non-compliance with study drug|0|||
164072794|NCT01488071|592630555|FG000|Overall Study|Protocol Violation|5|||
164072795|NCT01488071|592630556|FG001|Overall Study|Protocol Violation|7|||
164072796|NCT01488071|592630555|FG000|Overall Study|Withdrawal of Consent|14|||
164072797|NCT01488071|592630556|FG001|Overall Study|Withdrawal of Consent|12|||
164072798|NCT01488071|592630555|FG000|Overall Study|Lost to Follow-up|1|||
164072799|NCT01488071|592630556|FG001|Overall Study|Lost to Follow-up|0|||
164072800|NCT01488071|592630555|FG000|Overall Study|Administrative or Other Reason(s)|5|||
164072801|NCT01488071|592630556|FG001|Overall Study|Administrative or Other Reason(s)|4|||
164072802|NCT02139306|592630557|FG000|Overall Study|Withdrawal by Subject|4|||
164072803|NCT02139306|592630558|FG001|Overall Study|Withdrawal by Subject|6|||
164072804|NCT02139306|592630557|FG000|Overall Study|Adverse Event|3|||
164072805|NCT02139306|592630558|FG001|Overall Study|Adverse Event|4|||
164072806|NCT02139306|592630557|FG000|Overall Study|Physician Decision|0|||
164072807|NCT02139306|592630558|FG001|Overall Study|Physician Decision|1|||
164072808|NCT02139306|592630557|FG000|Overall Study|Other Unspecified|2|||
164072809|NCT02139306|592630558|FG001|Overall Study|Other Unspecified|3|||
164072810|NCT02139306|592630557|FG000|Overall Study|Protocol Violation|4|||
164072811|NCT02139306|592630558|FG001|Overall Study|Protocol Violation|0|||
164072812|NCT04449354|592630559|FG000|Overall Study|Withdrawal by Subject|1|||
164072813|NCT05789420|592630560|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
164072814|NCT05789420|592630560|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
164072815|NCT02278952|592630561|FG000|Overall Study|Insufficient Sample|6|||
164072816|NCT01220128|592630562|FG000|Overall Study|Progressive disease|0|||
164072817|NCT01220128|592630563|FG001|Overall Study|Progressive disease|0|||
164072818|NCT01220128|592630564|FG002|Overall Study|Progressive disease|2|||
164072819|NCT01220128|592630565|FG003|Overall Study|Progressive disease|0|||
164072820|NCT01220128|592630566|FG004|Overall Study|Progressive disease|0|||
164072821|NCT01220128|592630567|FG005|Overall Study|Progressive disease|0|||
164072822|NCT01220128|592630568|FG006|Overall Study|Progressive disease|0|||
164072823|NCT01220128|592630562|FG000|Overall Study|Sponsor study termination|0|||
164072824|NCT01220128|592630563|FG001|Overall Study|Sponsor study termination|1|||
164072825|NCT01220128|592630564|FG002|Overall Study|Sponsor study termination|0|||
164072826|NCT01220128|592630565|FG003|Overall Study|Sponsor study termination|0|||
164072827|NCT01220128|592630566|FG004|Overall Study|Sponsor study termination|0|||
164072828|NCT01220128|592630567|FG005|Overall Study|Sponsor study termination|0|||
164072829|NCT01220128|592630568|FG006|Overall Study|Sponsor study termination|1|||
164072830|NCT01220128|592630562|FG000|Overall Study|Adverse event, serious fatal|2|||
164072831|NCT01220128|592630563|FG001|Overall Study|Adverse event, serious fatal|0|||
164072832|NCT01220128|592630564|FG002|Overall Study|Adverse event, serious fatal|0|||
164072833|NCT01220128|592630565|FG003|Overall Study|Adverse event, serious fatal|0|||
164072834|NCT01220128|592630566|FG004|Overall Study|Adverse event, serious fatal|0|||
164072835|NCT01220128|592630567|FG005|Overall Study|Adverse event, serious fatal|0|||
164072836|NCT01220128|592630568|FG006|Overall Study|Adverse event, serious fatal|1|||
164072837|NCT01220128|592630562|FG000|Overall Study|Adverse event, non-fatal|1|||
164072838|NCT01220128|592630563|FG001|Overall Study|Adverse event, non-fatal|0|||
164072839|NCT01220128|592630564|FG002|Overall Study|Adverse event, non-fatal|0|||
164072840|NCT01220128|592630565|FG003|Overall Study|Adverse event, non-fatal|0|||
164072841|NCT01220128|592630566|FG004|Overall Study|Adverse event, non-fatal|0|||
164072842|NCT01220128|592630567|FG005|Overall Study|Adverse event, non-fatal|0|||
164072843|NCT01220128|592630568|FG006|Overall Study|Adverse event, non-fatal|3|||
164072844|NCT01220128|592630562|FG000|Overall Study|Other|0|||
164072845|NCT01220128|592630563|FG001|Overall Study|Other|0|||
164072846|NCT01220128|592630564|FG002|Overall Study|Other|1|||
164072847|NCT01220128|592630565|FG003|Overall Study|Other|0|||
164072848|NCT01220128|592630566|FG004|Overall Study|Other|0|||
164072849|NCT01220128|592630567|FG005|Overall Study|Other|0|||
164072850|NCT01220128|592630568|FG006|Overall Study|Other|0|||
164072851|NCT01220128|592630562|FG000|Overall Study|Consent withdrawn by subject|1|||
164072852|NCT01220128|592630563|FG001|Overall Study|Consent withdrawn by subject|0|||
164072853|NCT01220128|592630564|FG002|Overall Study|Consent withdrawn by subject|0|||
164072854|NCT01220128|592630565|FG003|Overall Study|Consent withdrawn by subject|0|||
164072855|NCT01220128|592630566|FG004|Overall Study|Consent withdrawn by subject|0|||
164072856|NCT01220128|592630567|FG005|Overall Study|Consent withdrawn by subject|0|||
164072857|NCT01220128|592630568|FG006|Overall Study|Consent withdrawn by subject|0|||
164072858|NCT00532779|592630572|FG000|Overall Study|Adverse Event|122|||
164072859|NCT00532779|592630573|FG001|Overall Study|Adverse Event|112|||
164072860|NCT00532779|592630574|FG002|Overall Study|Adverse Event|56|||
164072861|NCT00532779|592630572|FG000|Overall Study|Lost to Follow-up|76|||
164072862|NCT00532779|592630573|FG001|Overall Study|Lost to Follow-up|65|||
164072863|NCT00532779|592630574|FG002|Overall Study|Lost to Follow-up|66|||
164072864|NCT00532779|592630572|FG000|Overall Study|Withdrawal by Subject|63|||
164072865|NCT00532779|592630573|FG001|Overall Study|Withdrawal by Subject|60|||
164072866|NCT00532779|592630574|FG002|Overall Study|Withdrawal by Subject|90|||
164106867|NCT02923349|592754989|FG003|Overall Study|Other|1|||
164106868|NCT02923349|592754990|FG004|Overall Study|Other|3|||
164106869|NCT02923349|592754991|FG005|Overall Study|Other|0|||
164106870|NCT02923349|592754992|FG006|Overall Study|Other|1|||
164106871|NCT02923349|592754986|FG000|Overall Study|Withdrawal by Subject|2|||
164106872|NCT02923349|592754987|FG001|Overall Study|Withdrawal by Subject|2|||
164106873|NCT02923349|592754988|FG002|Overall Study|Withdrawal by Subject|8|||
164106874|NCT02923349|592754989|FG003|Overall Study|Withdrawal by Subject|10|||
164106875|NCT02923349|592754990|FG004|Overall Study|Withdrawal by Subject|12|||
164106876|NCT02923349|592754991|FG005|Overall Study|Withdrawal by Subject|3|||
164106877|NCT02923349|592754992|FG006|Overall Study|Withdrawal by Subject|0|||
164106878|NCT02923349|592754986|FG000|Overall Study|Physician Decision|0|||
164106879|NCT02923349|592754987|FG001|Overall Study|Physician Decision|0|||
164106880|NCT02923349|592754988|FG002|Overall Study|Physician Decision|0|||
164106881|NCT02923349|592754989|FG003|Overall Study|Physician Decision|1|||
164106882|NCT02923349|592754990|FG004|Overall Study|Physician Decision|1|||
164106883|NCT02923349|592754991|FG005|Overall Study|Physician Decision|0|||
164106884|NCT02923349|592754992|FG006|Overall Study|Physician Decision|2|||
164106885|NCT02923349|592754986|FG000|Overall Study|Lost to Follow-up|0|||
164106886|NCT02923349|592754987|FG001|Overall Study|Lost to Follow-up|0|||
164106887|NCT02923349|592754988|FG002|Overall Study|Lost to Follow-up|3|||
164106888|NCT02923349|592754989|FG003|Overall Study|Lost to Follow-up|0|||
164106889|NCT02923349|592754990|FG004|Overall Study|Lost to Follow-up|1|||
164106890|NCT02923349|592754991|FG005|Overall Study|Lost to Follow-up|1|||
164106891|NCT02923349|592754992|FG006|Overall Study|Lost to Follow-up|0|||
164106892|NCT02923349|592754986|FG000|Overall Study|Death|1|||
164106893|NCT02923349|592754987|FG001|Overall Study|Death|0|||
164106894|NCT02923349|592754988|FG002|Overall Study|Death|2|||
164106895|NCT02923349|592754989|FG003|Overall Study|Death|4|||
164106896|NCT02923349|592754990|FG004|Overall Study|Death|2|||
164106897|NCT02923349|592754991|FG005|Overall Study|Death|3|||
164106898|NCT02923349|592754992|FG006|Overall Study|Death|0|||
164106899|NCT00950989|592754993|FG000|Overall Study|Death|0|||
164106900|NCT00950989|592754994|FG001|Overall Study|Death|0|||
164106901|NCT00950989|592754995|FG002|Overall Study|Death|1|||
164106902|NCT00950989|592754996|FG003|Overall Study|Death|0|||
164106903|NCT00950989|592754993|FG000|Overall Study|Administrative Decision|0|||
164106904|NCT00950989|592754994|FG001|Overall Study|Administrative Decision|1|||
164106905|NCT00950989|592754995|FG002|Overall Study|Administrative Decision|0|||
164106906|NCT00950989|592754996|FG003|Overall Study|Administrative Decision|0|||
164106907|NCT00950989|592754993|FG000|Overall Study|Disease Progression|0|||
164106908|NCT00950989|592754994|FG001|Overall Study|Disease Progression|0|||
164106909|NCT00950989|592754995|FG002|Overall Study|Disease Progression|1|||
164106910|NCT00950989|592754996|FG003|Overall Study|Disease Progression|0|||
164106911|NCT00950989|592754993|FG000|Overall Study|Withdrawal by Subject|2|||
164106912|NCT00950989|592754994|FG001|Overall Study|Withdrawal by Subject|1|||
164106913|NCT00950989|592754995|FG002|Overall Study|Withdrawal by Subject|0|||
164106914|NCT00950989|592754996|FG003|Overall Study|Withdrawal by Subject|0|||
164106915|NCT00950989|592754993|FG000|Overall Study|Adverse Event|2|||
164106916|NCT00950989|592754994|FG001|Overall Study|Adverse Event|1|||
164106917|NCT00950989|592754995|FG002|Overall Study|Adverse Event|1|||
164106918|NCT00950989|592754996|FG003|Overall Study|Adverse Event|0|||
164106919|NCT00796562|592754997|FG000|Overall Study|Death|49|||
164106920|NCT05655520|592754998|FG000|Overall Study|Adverse Event|2|||
164106921|NCT05655520|592754999|FG001|Overall Study|Adverse Event|3|||
164106922|NCT05655520|592754998|FG000|Overall Study|Physician Decision|2|||
164106923|NCT05655520|592754999|FG001|Overall Study|Physician Decision|0|||
164106924|NCT05655520|592754998|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164106925|NCT05655520|592754999|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164106926|NCT05655520|592754998|FG000|Overall Study|Lost to Follow-up|1|||
164106927|NCT05655520|592754999|FG001|Overall Study|Lost to Follow-up|0|||
164106928|NCT05655520|592754998|FG000|Overall Study|Withdrawal by Subject|4|||
164106929|NCT05655520|592754999|FG001|Overall Study|Withdrawal by Subject|4|||
164106930|NCT05655520|592754998|FG000|Overall Study|Study Terminated by Sponsor|61|||
164106931|NCT05655520|592754999|FG001|Overall Study|Study Terminated by Sponsor|68|||
164106932|NCT00424047|592755000|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
164106933|NCT00424047|592755001|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
164106934|NCT00424047|592755000|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
164106935|NCT00424047|592755001|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
164106936|NCT00424047|592755000|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
164106937|NCT00424047|592755001|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
164106938|NCT00424047|592755000|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
164106939|NCT00424047|592755001|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
164106940|NCT00424047|592755000|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
164106941|NCT00424047|592755001|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
164106942|NCT00424047|592755000|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
164106943|NCT00424047|592755001|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
164148731|NCT03207867|592904936|FG000|Overall Study|Progressive Disease|7|||
164106944|NCT00424047|592755000|FG000|On Study at Time of Unblinding|Adverse Event|22|||
164106945|NCT00424047|592755001|FG001|On Study at Time of Unblinding|Adverse Event|12|||
164106946|NCT00424047|592755000|FG000|On Study at Time of Unblinding|Progression of disease|92|||
164106947|NCT00424047|592755001|FG001|On Study at Time of Unblinding|Progression of disease|128|||
164106948|NCT00424047|592755000|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
164106949|NCT00424047|592755001|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
164106950|NCT00424047|592755000|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
164106951|NCT00424047|592755001|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
164106952|NCT00424047|592755000|FG000|On Study at Time of Unblinding|Death|11|||
164106953|NCT00424047|592755001|FG001|On Study at Time of Unblinding|Death|11|||
164106954|NCT00424047|592755000|FG000|On Study at Time of Unblinding|Other|5|||
164106955|NCT00424047|592755001|FG001|On Study at Time of Unblinding|Other|4|||
164106956|NCT00424047|592755000|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
164106957|NCT00424047|592755001|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
164106958|NCT00424047|592755000|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
164106959|NCT00424047|592755001|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
164106960|NCT00424047|592755000|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
164106961|NCT00424047|592755001|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
164106962|NCT00424047|592755000|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
164106963|NCT00424047|592755001|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
164106964|NCT00424047|592755000|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
164106965|NCT00424047|592755001|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
164106966|NCT01229150|592755005|FG000|Overall Study|Toxicity|2|||
164106967|NCT01229150|592755006|FG001|Overall Study|Toxicity|2|||
164106968|NCT01229150|592755007|FG002|Overall Study|Toxicity|0|||
164106969|NCT01229150|592755008|FG003|Overall Study|Toxicity|0|||
164106970|NCT05248204|592755009|FG000|Overall Study|Lost to Follow-up|13|||
164106971|NCT05248204|592755010|FG001|Overall Study|Lost to Follow-up|13|||
164106972|NCT05248204|592755009|FG000|Overall Study|Protocol Violation|1|||
164106973|NCT05248204|592755010|FG001|Overall Study|Protocol Violation|0|||
164106974|NCT03100344|592755011|FG000|Overall Study|Adverse Event|0|||
164106975|NCT03100344|592755012|FG001|Overall Study|Adverse Event|3|||
164106976|NCT03100344|592755013|FG002|Overall Study|Adverse Event|2|||
164106977|NCT03100344|592755014|FG003|Overall Study|Adverse Event|3|||
164106978|NCT03100344|592755011|FG000|Overall Study|Lack of Efficacy|2|||
164106979|NCT03100344|592755012|FG001|Overall Study|Lack of Efficacy|0|||
164106980|NCT03100344|592755013|FG002|Overall Study|Lack of Efficacy|0|||
164106981|NCT03100344|592755014|FG003|Overall Study|Lack of Efficacy|0|||
164106982|NCT03100344|592755011|FG000|Overall Study|Protocol Violation|1|||
164106983|NCT03100344|592755012|FG001|Overall Study|Protocol Violation|0|||
164106984|NCT03100344|592755013|FG002|Overall Study|Protocol Violation|0|||
164106985|NCT03100344|592755014|FG003|Overall Study|Protocol Violation|0|||
164106986|NCT03100344|592755011|FG000|Overall Study|Withdrawal by Subject|10|||
164106987|NCT03100344|592755012|FG001|Overall Study|Withdrawal by Subject|7|||
164106988|NCT03100344|592755013|FG002|Overall Study|Withdrawal by Subject|4|||
164106989|NCT03100344|592755014|FG003|Overall Study|Withdrawal by Subject|8|||
164106990|NCT03100344|592755011|FG000|Overall Study|Lost to Follow-up|1|||
164106991|NCT03100344|592755012|FG001|Overall Study|Lost to Follow-up|1|||
164106992|NCT03100344|592755013|FG002|Overall Study|Lost to Follow-up|1|||
164106993|NCT03100344|592755014|FG003|Overall Study|Lost to Follow-up|1|||
164106994|NCT01010503|592755015|FG000|Overall Study|Adverse Event|1|||
164106995|NCT01010503|592755015|FG000|Overall Study|Death|1|||
164106996|NCT00725322|592755016|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
164106997|NCT00725322|592755017|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
164106998|NCT00725322|592755016|FG000|Washout (28 Days)|Protocol Violation|0|||
164106999|NCT00725322|592755017|FG001|Washout (28 Days)|Protocol Violation|1|||
164107000|NCT05871151|592755018|FG000|Overall Study|Lost to Follow-up|1|||
164107001|NCT05871151|592755019|FG001|Overall Study|Lost to Follow-up|0|||
164107002|NCT05871151|592755018|FG000|Overall Study|Unrelated illness|0|||
164107003|NCT05871151|592755019|FG001|Overall Study|Unrelated illness|1|||
164107004|NCT01963728|592755020|FG000|Overall Study|Study terminated early|0|||
164107005|NCT01963728|592755021|FG001|Overall Study|Study terminated early|1|||
164107006|NCT04406194|592756001|FG000|Period 1|Withdrawal by Subject|0|||
164107007|NCT04406194|592756002|FG001|Period 1|Withdrawal by Subject|1|||
164107008|NCT02888756|592756003|FG000|Analytical Treatment Interruption|Physician Decision|10|||
164107009|NCT02888756|592756004|FG001|Analytical Treatment Interruption|Physician Decision|6|||
164107010|NCT02888756|592756005|FG002|Analytical Treatment Interruption|Physician Decision|5|||
164107011|NCT00928057|592756006|FG000|Overall Study|Adverse Event|1|||
164107012|NCT00928057|592756007|FG001|Overall Study|Adverse Event|2|||
164107013|NCT00928057|592756006|FG000|Overall Study|Withdrawal by Subject|1|||
164107014|NCT00928057|592756007|FG001|Overall Study|Withdrawal by Subject|0|||
164107015|NCT00928057|592756006|FG000|Overall Study|Lost to Follow-up|0|||
164107016|NCT00928057|592756007|FG001|Overall Study|Lost to Follow-up|1|||
164107017|NCT00928057|592756006|FG000|Overall Study|Protocol Violation|0|||
164107018|NCT00928057|592756007|FG001|Overall Study|Protocol Violation|1|||
164107019|NCT03206749|592756008|FG000|Overall Study|Withdrawal of consent|5|||
164072867|NCT00532779|592630572|FG000|Overall Study|Lack of Efficacy|12|||
164072868|NCT00532779|592630573|FG001|Overall Study|Lack of Efficacy|12|||
164072869|NCT00532779|592630574|FG002|Overall Study|Lack of Efficacy|40|||
164072870|NCT00532779|592630572|FG000|Overall Study|Protocol Violation|5|||
164072871|NCT00532779|592630573|FG001|Overall Study|Protocol Violation|9|||
164072872|NCT00532779|592630574|FG002|Overall Study|Protocol Violation|7|||
164072873|NCT00532779|592630572|FG000|Overall Study|Pregnancy|2|||
164072874|NCT00532779|592630573|FG001|Overall Study|Pregnancy|5|||
164072875|NCT00532779|592630574|FG002|Overall Study|Pregnancy|3|||
164072876|NCT00532779|592630572|FG000|Overall Study|Death|0|||
164072877|NCT00532779|592630573|FG001|Overall Study|Death|1|||
164072878|NCT00532779|592630574|FG002|Overall Study|Death|0|||
164072879|NCT00532779|592630572|FG000|Overall Study|Drug noncompliance, moved, other|14|||
164072880|NCT00532779|592630573|FG001|Overall Study|Drug noncompliance, moved, other|23|||
164072881|NCT00532779|592630574|FG002|Overall Study|Drug noncompliance, moved, other|29|||
164072882|NCT00828516|592630581|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
164072883|NCT00689273|592630582|FG000|Overall Study|Adverse Event|3|||
164072884|NCT00689273|592630583|FG001|Overall Study|Adverse Event|1|||
164072885|NCT00689273|592630582|FG000|Overall Study|Lack of Efficacy|3|||
164072886|NCT00689273|592630583|FG001|Overall Study|Lack of Efficacy|0|||
164072887|NCT00689273|592630582|FG000|Overall Study|Lost to Follow-up|0|||
164072888|NCT00689273|592630583|FG001|Overall Study|Lost to Follow-up|2|||
164072889|NCT00689273|592630582|FG000|Overall Study|Other|6|||
164072890|NCT00689273|592630583|FG001|Overall Study|Other|2|||
164072891|NCT00689273|592630582|FG000|Overall Study|Randomized but not Treated|1|||
164072892|NCT00689273|592630583|FG001|Overall Study|Randomized but not Treated|0|||
164072893|NCT02787746|592630586|FG000|Overall Study|Adverse Event|42|||
164072894|NCT02787746|592630586|FG000|Overall Study|Withdrawal by Subject|65|||
164072895|NCT02787746|592630586|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
164072896|NCT03703297|592630591|FG000|Overall Study|Death|115|||
164072897|NCT03703297|592630592|FG001|Overall Study|Death|0|||
164072898|NCT03703297|592630593|FG002|Overall Study|Death|144|||
164072899|NCT03703297|592630591|FG000|Overall Study|Withdrawal by Subject|9|||
164072900|NCT03703297|592630592|FG001|Overall Study|Withdrawal by Subject|0|||
164072901|NCT03703297|592630593|FG002|Overall Study|Withdrawal by Subject|11|||
164072902|NCT03703297|592630591|FG000|Overall Study|Ongoing at the time of DCO|140|||
164072903|NCT03703297|592630592|FG001|Overall Study|Ongoing at the time of DCO|200|||
164072904|NCT03703297|592630593|FG002|Overall Study|Ongoing at the time of DCO|111|||
164072905|NCT01142466|592632730|FG000|Overall Study|Adverse Event|2|||
164072906|NCT01142466|592632731|FG001|Overall Study|Adverse Event|1|||
164072907|NCT01142466|592632730|FG000|Overall Study|Withdrawal by Subject|1|||
164072908|NCT01142466|592632731|FG001|Overall Study|Withdrawal by Subject|1|||
164072909|NCT00700310|592632736|FG000|Overall Study|Adverse Event|6|||
164072910|NCT00700310|592632737|FG001|Overall Study|Adverse Event|10|||
164072911|NCT00700310|592632738|FG002|Overall Study|Adverse Event|5|||
164072912|NCT00700310|592632739|FG003|Overall Study|Adverse Event|11|||
164072913|NCT00700310|592632736|FG000|Overall Study|Lost to Follow-up|4|||
164072914|NCT00700310|592632737|FG001|Overall Study|Lost to Follow-up|1|||
164072915|NCT00700310|592632738|FG002|Overall Study|Lost to Follow-up|0|||
164072916|NCT00700310|592632739|FG003|Overall Study|Lost to Follow-up|1|||
164072917|NCT00700310|592632736|FG000|Overall Study|Withdrawal by Subject|8|||
164072918|NCT00700310|592632737|FG001|Overall Study|Withdrawal by Subject|9|||
164072919|NCT00700310|592632738|FG002|Overall Study|Withdrawal by Subject|8|||
164072920|NCT00700310|592632739|FG003|Overall Study|Withdrawal by Subject|8|||
164072921|NCT00700310|592632736|FG000|Overall Study|Lack of Efficacy|0|||
164072922|NCT00700310|592632737|FG001|Overall Study|Lack of Efficacy|3|||
164072923|NCT00700310|592632738|FG002|Overall Study|Lack of Efficacy|0|||
164072924|NCT00700310|592632739|FG003|Overall Study|Lack of Efficacy|1|||
164072925|NCT00700310|592632736|FG000|Overall Study|Administrative/Other|1|||
164072926|NCT00700310|592632737|FG001|Overall Study|Administrative/Other|3|||
164072927|NCT00700310|592632738|FG002|Overall Study|Administrative/Other|1|||
164072928|NCT00700310|592632739|FG003|Overall Study|Administrative/Other|3|||
164072929|NCT00700310|592632736|FG000|Overall Study|Randomized, Not Treated|2|||
164072930|NCT00700310|592632737|FG001|Overall Study|Randomized, Not Treated|0|||
164072931|NCT00700310|592632738|FG002|Overall Study|Randomized, Not Treated|2|||
164072932|NCT00700310|592632739|FG003|Overall Study|Randomized, Not Treated|2|||
164072933|NCT02414854|592632740|FG000|Overall Study|Adverse Event|9|||
164072934|NCT02414854|592632741|FG001|Overall Study|Adverse Event|7|||
164072935|NCT02414854|592632742|FG002|Overall Study|Adverse Event|1|||
164072936|NCT02414854|592632743|FG003|Overall Study|Adverse Event|12|||
164072937|NCT02414854|592632740|FG000|Overall Study|Poor compliance to protocol|1|||
164072938|NCT02414854|592632741|FG001|Overall Study|Poor compliance to protocol|1|||
164072939|NCT02414854|592632742|FG002|Overall Study|Poor compliance to protocol|2|||
164072940|NCT02414854|592632743|FG003|Overall Study|Poor compliance to protocol|2|||
164072941|NCT02414854|592632740|FG000|Overall Study|Other than specified above|12|||
164072942|NCT02414854|592632741|FG001|Overall Study|Other than specified above|37|||
164072943|NCT02414854|592632742|FG002|Overall Study|Other than specified above|17|||
164072944|NCT02414854|592632743|FG003|Overall Study|Other than specified above|37|||
164107020|NCT03206749|592756009|FG001|Overall Study|Withdrawal of consent|3|||
164107021|NCT03206749|592756010|FG002|Overall Study|Withdrawal of consent|6|||
164107022|NCT03206749|592756008|FG000|Overall Study|Lost to Follow-up|0|||
164107023|NCT03206749|592756009|FG001|Overall Study|Lost to Follow-up|0|||
164107024|NCT03206749|592756010|FG002|Overall Study|Lost to Follow-up|1|||
164107025|NCT03497130|592756012|FG000|Overall Study|Lost to Follow-up|1|||
164107026|NCT03497130|592756013|FG001|Overall Study|Lost to Follow-up|1|||
164107027|NCT04345653|592756016|FG000|Overall Study|Withdrawal by Subject|2|||
164107028|NCT03214588|592756017|FG000|Overall Study|Adverse Event|1|||
164107029|NCT03214588|592756018|FG001|Overall Study|Adverse Event|0|||
164107030|NCT03214588|592756019|FG002|Overall Study|Adverse Event|2|||
164107031|NCT03214588|592756017|FG000|Overall Study|Reason Not Specified|0|||
164107032|NCT03214588|592756018|FG001|Overall Study|Reason Not Specified|1|||
164107033|NCT03214588|592756019|FG002|Overall Study|Reason Not Specified|0|||
164107034|NCT00418938|592756020|FG000|Overall Study|Reimbursement|1|||
164107035|NCT00418938|592756021|FG001|Overall Study|Reimbursement|0|||
164107036|NCT00418938|592756020|FG000|Overall Study|Administrative decision|3|||
164107037|NCT00418938|592756021|FG001|Overall Study|Administrative decision|3|||
164107038|NCT00418938|592756020|FG000|Overall Study|Withdrawal by Subject|16|||
164107039|NCT00418938|592756021|FG001|Overall Study|Withdrawal by Subject|15|||
164107040|NCT00418938|592756020|FG000|Overall Study|Lost to Follow-up|1|||
164107041|NCT00418938|592756021|FG001|Overall Study|Lost to Follow-up|3|||
164107042|NCT00418938|592756020|FG000|Overall Study|Adverse Event|1|||
164107043|NCT00418938|592756021|FG001|Overall Study|Adverse Event|1|||
164107044|NCT00418938|592756020|FG000|Overall Study|On-going|1|||
164107045|NCT00418938|592756021|FG001|Overall Study|On-going|1|||
164107046|NCT00418938|592756020|FG000|Overall Study|Ineligibility Determined|1|||
164107047|NCT00418938|592756021|FG001|Overall Study|Ineligibility Determined|0|||
164107048|NCT00003470|592756028|FG000|Overall Study|Not evaluable|6|||
164107049|NCT01794845|592756033|FG000|Overall Study|Withdrawal by Subject|1|||
164107050|NCT03498560|592756035|FG000|Overall Study|Found Ineligible|2|||
164107051|NCT03498560|592756035|FG000|Overall Study|Withdrawal by Subject|14|||
164072945|NCT01355523|592632744|FG000|Overall Study|Withdrawal by Subject|1|||
164072946|NCT01355523|592632745|FG001|Overall Study|Withdrawal by Subject|4|||
164072947|NCT01355523|592632744|FG000|Overall Study|Lost to Follow-up|0|||
164072948|NCT01355523|592632745|FG001|Overall Study|Lost to Follow-up|2|||
164072949|NCT01355523|592632744|FG000|Overall Study|Protocol Violation|0|||
164072950|NCT01355523|592632745|FG001|Overall Study|Protocol Violation|2|||
164072951|NCT01355523|592632744|FG000|Overall Study|Adverse Event|0|||
164072952|NCT01355523|592632745|FG001|Overall Study|Adverse Event|2|||
164072953|NCT00303316|592632746|FG000|Overall Study|Protocol Violation|1|||
164072954|NCT00303316|592632747|FG001|Overall Study|Protocol Violation|0|||
164072955|NCT00303316|592632746|FG000|Overall Study|Lost to Follow-up|0|||
164072956|NCT00303316|592632747|FG001|Overall Study|Lost to Follow-up|1|||
164072957|NCT00303316|592632746|FG000|Overall Study|Withdrawal by Subject|1|||
164072958|NCT00303316|592632747|FG001|Overall Study|Withdrawal by Subject|2|||
164072959|NCT02162511|592632750|FG000|Overall Study|Lack of Efficacy|0|||
164072960|NCT02162511|592632751|FG001|Overall Study|Lack of Efficacy|0|||
164072961|NCT02162511|592632752|FG002|Overall Study|Lack of Efficacy|2|||
164072962|NCT01160198|592632753|FG000|Overall Study|Withdrawal by Subject|2|||
164072963|NCT01160198|592632754|FG001|Overall Study|Withdrawal by Subject|1|||
164072964|NCT01160198|592632755|FG002|Overall Study|Withdrawal by Subject|0|||
164072965|NCT01160198|592632753|FG000|Overall Study|Adverse Event|0|||
164072966|NCT01160198|592632754|FG001|Overall Study|Adverse Event|1|||
164072967|NCT01160198|592632755|FG002|Overall Study|Adverse Event|0|||
164072968|NCT01160198|592632753|FG000|Overall Study|Lost to Follow-up|0|||
164072969|NCT01160198|592632754|FG001|Overall Study|Lost to Follow-up|1|||
164072970|NCT01160198|592632755|FG002|Overall Study|Lost to Follow-up|0|||
164072971|NCT01160198|592632753|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
164072972|NCT01160198|592632754|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
164072973|NCT01160198|592632755|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
164072974|NCT01408576|592632756|FG000|Overall Study|Lack of Efficacy|17|||
164072975|NCT01408576|592632757|FG001|Overall Study|Lack of Efficacy|30|||
164072976|NCT01408576|592632758|FG002|Overall Study|Lack of Efficacy|48|||
164072977|NCT01408576|592632756|FG000|Overall Study|Protocol Violation|1|||
164107052|NCT03498560|592756035|FG000|Overall Study|Lost to Follow-up|4|||
164107053|NCT03498560|592756035|FG000|Overall Study|Death|1|||
164107054|NCT00867360|592756036|FG000|Overall Study|Withdrawal by Subject|1|||
164107055|NCT00867360|592756037|FG001|Overall Study|Withdrawal by Subject|0|||
164107056|NCT00867360|592756036|FG000|Overall Study|Physician Decision|0|||
164072978|NCT01408576|592632757|FG001|Overall Study|Protocol Violation|2|||
164072979|NCT01408576|592632758|FG002|Overall Study|Protocol Violation|2|||
164072980|NCT01408576|592632756|FG000|Overall Study|Lost to Follow-up|10|||
164072981|NCT01408576|592632757|FG001|Overall Study|Lost to Follow-up|9|||
164072982|NCT01408576|592632758|FG002|Overall Study|Lost to Follow-up|17|||
164072983|NCT01408576|592632756|FG000|Overall Study|Withdrawal by Subject|34|||
164107057|NCT00867360|592756037|FG001|Overall Study|Physician Decision|1|||
164107058|NCT01004510|592756038|FG000|Overall Study|Adverse Event|1|||
164107059|NCT02911025|592756040|FG000|Overall Study|Lost to Follow-up|3|||
164107060|NCT00436163|592756041|FG000|Overall Study|Lost to Follow-up|2|||
164107061|NCT00436163|592756041|FG000|Overall Study|Adverse Event|1|||
164107062|NCT02597049|592756042|FG000|Overall Study|Lost to Follow-up|0|||
164107063|NCT02597049|592756043|FG001|Overall Study|Lost to Follow-up|3|||
164107064|NCT02597049|592756044|FG002|Overall Study|Lost to Follow-up|2|||
164107065|NCT02597049|592756042|FG000|Overall Study|Withdrawal by Subject|2|||
164107066|NCT02597049|592756043|FG001|Overall Study|Withdrawal by Subject|2|||
164107067|NCT02597049|592756044|FG002|Overall Study|Withdrawal by Subject|1|||
164107068|NCT02597049|592756042|FG000|Overall Study|Adverse Event|2|||
164107069|NCT02597049|592756043|FG001|Overall Study|Adverse Event|0|||
164107070|NCT02597049|592756044|FG002|Overall Study|Adverse Event|0|||
164107071|NCT02597049|592756042|FG000|Overall Study|Death|2|||
164107072|NCT02597049|592756043|FG001|Overall Study|Death|0|||
164107073|NCT02597049|592756044|FG002|Overall Study|Death|0|||
164107074|NCT02597049|592756042|FG000|Overall Study|Noncompliant with Study Visits|1|||
164107075|NCT02597049|592756043|FG001|Overall Study|Noncompliant with Study Visits|0|||
164107076|NCT02597049|592756044|FG002|Overall Study|Noncompliant with Study Visits|0|||
164107077|NCT06647173|592756050|FG000|Overall Study|Lost to Follow-up|24|||
164107078|NCT03250117|592756053|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
164107079|NCT03250117|592756054|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
164107080|NCT03250117|592756055|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
164107081|NCT03250117|592756056|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
164107082|NCT04063878|592756057|FG000|Overall Study|Withdrawal by Subject|2|||
164107083|NCT04063878|592756057|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
164107084|NCT02751827|592756058|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
164107085|NCT02751827|592756059|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
164107086|NCT02751827|592756060|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
164107087|NCT01248728|592756061|FG000|Overall Study|Adverse Event|1|||
164107088|NCT01248728|592756062|FG001|Overall Study|Adverse Event|1|||
164107089|NCT01248728|592756061|FG000|Overall Study|Withdrawal by Subject|2|||
164107090|NCT01248728|592756062|FG001|Overall Study|Withdrawal by Subject|1|||
164107091|NCT01248728|592756061|FG000|Overall Study|Lack of Efficacy|1|||
164107092|NCT01248728|592756062|FG001|Overall Study|Lack of Efficacy|0|||
164107093|NCT01841554|592756063|FG000|Overall Study|Death|7|||
164107094|NCT01841554|592756063|FG000|Overall Study|No Implantation|1|||
164107095|NCT01841554|592756063|FG000|Overall Study|Discontinued Follow Up|5|||
164107096|NCT01841554|592756063|FG000|Overall Study|Study exit due to secondary intervention|6|||
164107097|NCT00147498|592756064|FG000|Overall Study|Adverse Event|1|||
164107098|NCT00147498|592756065|FG001|Overall Study|Adverse Event|6|||
164107099|NCT00147498|592756066|FG002|Overall Study|Adverse Event|7|||
164107100|NCT00147498|592756067|FG003|Overall Study|Adverse Event|3|||
164107101|NCT00147498|592756064|FG000|Overall Study|Lack of Efficacy|1|||
164107102|NCT00147498|592756065|FG001|Overall Study|Lack of Efficacy|1|||
164107103|NCT00147498|592756066|FG002|Overall Study|Lack of Efficacy|1|||
164107104|NCT00147498|592756067|FG003|Overall Study|Lack of Efficacy|8|||
164107105|NCT00147498|592756064|FG000|Overall Study|Laboratory abnormality|0|||
164107106|NCT00147498|592756065|FG001|Overall Study|Laboratory abnormality|0|||
164107107|NCT00147498|592756066|FG002|Overall Study|Laboratory abnormality|2|||
164107108|NCT00147498|592756067|FG003|Overall Study|Laboratory abnormality|0|||
164107109|NCT00147498|592756064|FG000|Overall Study|Participant defaulted|0|||
164107110|NCT00147498|592756065|FG001|Overall Study|Participant defaulted|1|||
164107111|NCT00147498|592756066|FG002|Overall Study|Participant defaulted|4|||
164107112|NCT00147498|592756067|FG003|Overall Study|Participant defaulted|3|||
164107113|NCT00147498|592756064|FG000|Overall Study|Other|1|||
164107114|NCT00147498|592756065|FG001|Overall Study|Other|1|||
164107115|NCT00147498|592756066|FG002|Overall Study|Other|3|||
164107116|NCT00147498|592756067|FG003|Overall Study|Other|3|||
164107117|NCT01838681|592756068|FG000|Period A|Adverse Event|39|||
164107118|NCT01838681|592756069|FG001|Period A|Adverse Event|0|||
164107119|NCT01838681|592756070|FG002|Period A|Adverse Event|0|||
164107120|NCT01838681|592756071|FG003|Period A|Adverse Event|0|||
164107121|NCT01838681|592756068|FG000|Period A|Lack of Efficacy|21|||
164107122|NCT01838681|592756069|FG001|Period A|Lack of Efficacy|0|||
164107123|NCT01838681|592756070|FG002|Period A|Lack of Efficacy|0|||
164107124|NCT01838681|592756071|FG003|Period A|Lack of Efficacy|0|||
164107125|NCT01838681|592756068|FG000|Period A|Early response|148|||
164107126|NCT01838681|592756069|FG001|Period A|Early response|0|||
164107127|NCT01838681|592756070|FG002|Period A|Early response|0|||
164107128|NCT01838681|592756071|FG003|Period A|Early response|0|||
164107129|NCT01838681|592756068|FG000|Period A|Withdrawal by Subject|70|||
164107130|NCT01838681|592756069|FG001|Period A|Withdrawal by Subject|0|||
164107131|NCT01838681|592756070|FG002|Period A|Withdrawal by Subject|0|||
164107132|NCT01838681|592756071|FG003|Period A|Withdrawal by Subject|0|||
164107133|NCT01838681|592756068|FG000|Period A|Protocol Violation|16|||
164107134|NCT01838681|592756069|FG001|Period A|Protocol Violation|0|||
164107135|NCT01838681|592756070|FG002|Period A|Protocol Violation|0|||
164107136|NCT01838681|592756071|FG003|Period A|Protocol Violation|0|||
164107137|NCT01838681|592756068|FG000|Period A|Non-compliance with IMP|6|||
164107138|NCT01838681|592756069|FG001|Period A|Non-compliance with IMP|0|||
164107139|NCT01838681|592756070|FG002|Period A|Non-compliance with IMP|0|||
164107140|NCT01838681|592756071|FG003|Period A|Non-compliance with IMP|0|||
164107141|NCT01838681|592756068|FG000|Period A|Lost to Follow-up|4|||
164107142|NCT01838681|592756069|FG001|Period A|Lost to Follow-up|0|||
164107143|NCT01838681|592756070|FG002|Period A|Lost to Follow-up|0|||
164107144|NCT01838681|592756071|FG003|Period A|Lost to Follow-up|0|||
164107145|NCT01838681|592756068|FG000|Period A|Withdrawal before treatment|4|||
164107146|NCT01838681|592756069|FG001|Period A|Withdrawal before treatment|0|||
164107147|NCT01838681|592756070|FG002|Period A|Withdrawal before treatment|0|||
164107148|NCT01838681|592756071|FG003|Period A|Withdrawal before treatment|0|||
164107149|NCT01838681|592756068|FG000|Period A|Administrative or other reasons|17|||
164107150|NCT01838681|592756069|FG001|Period A|Administrative or other reasons|0|||
164107151|NCT01838681|592756070|FG002|Period A|Administrative or other reasons|0|||
164107152|NCT01838681|592756071|FG003|Period A|Administrative or other reasons|0|||
164107153|NCT01838681|592756068|FG000|Period B/A+|Adverse Event|0|||
164107154|NCT01838681|592756069|FG001|Period B/A+|Adverse Event|13|||
164107155|NCT01838681|592756070|FG002|Period B/A+|Adverse Event|27|||
164107156|NCT01838681|592756071|FG003|Period B/A+|Adverse Event|16|||
164107157|NCT01838681|592756068|FG000|Period B/A+|Lack of Efficacy|0|||
164107158|NCT01838681|592756069|FG001|Period B/A+|Lack of Efficacy|9|||
164107159|NCT01838681|592756070|FG002|Period B/A+|Lack of Efficacy|11|||
164107160|NCT01838681|592756071|FG003|Period B/A+|Lack of Efficacy|6|||
164107161|NCT01838681|592756068|FG000|Period B/A+|Withdrawal by Subject|0|||
164107162|NCT01838681|592756069|FG001|Period B/A+|Withdrawal by Subject|28|||
164107163|NCT01838681|592756070|FG002|Period B/A+|Withdrawal by Subject|35|||
164107164|NCT01838681|592756071|FG003|Period B/A+|Withdrawal by Subject|47|||
164107165|NCT01838681|592756068|FG000|Period B/A+|Protocol Violation|0|||
164107166|NCT01838681|592756069|FG001|Period B/A+|Protocol Violation|1|||
164107167|NCT01838681|592756070|FG002|Period B/A+|Protocol Violation|4|||
164107168|NCT01838681|592756071|FG003|Period B/A+|Protocol Violation|6|||
164107169|NCT01838681|592756068|FG000|Period B/A+|Non-compliance with IMP|0|||
164107170|NCT01838681|592756069|FG001|Period B/A+|Non-compliance with IMP|2|||
164107171|NCT01838681|592756070|FG002|Period B/A+|Non-compliance with IMP|3|||
164107172|NCT01838681|592756071|FG003|Period B/A+|Non-compliance with IMP|3|||
164107173|NCT01838681|592756068|FG000|Period B/A+|Lost to Follow-up|0|||
164107174|NCT01838681|592756069|FG001|Period B/A+|Lost to Follow-up|2|||
164107175|NCT01838681|592756070|FG002|Period B/A+|Lost to Follow-up|5|||
164107176|NCT01838681|592756071|FG003|Period B/A+|Lost to Follow-up|11|||
164107177|NCT01838681|592756068|FG000|Period B/A+|Withdrawal before treatment|0|||
164107178|NCT01838681|592756069|FG001|Period B/A+|Withdrawal before treatment|1|||
164107179|NCT01838681|592756070|FG002|Period B/A+|Withdrawal before treatment|0|||
164107180|NCT01838681|592756071|FG003|Period B/A+|Withdrawal before treatment|0|||
164107181|NCT01838681|592756068|FG000|Period B/A+|Administrative or other reasons|0|||
164107182|NCT01838681|592756069|FG001|Period B/A+|Administrative or other reasons|6|||
164107183|NCT01838681|592756070|FG002|Period B/A+|Administrative or other reasons|10|||
164107184|NCT01838681|592756071|FG003|Period B/A+|Administrative or other reasons|28|||
164107185|NCT01473953|592756074|FG000|Overall Study|Other|1|||
164107186|NCT01473953|592756075|FG001|Overall Study|Other|0|||
164107187|NCT01473953|592756076|FG002|Overall Study|Other|0|||
164107188|NCT01473953|592756077|FG003|Overall Study|Other|0|||
164107189|NCT01473953|592756078|FG004|Overall Study|Other|0|||
164107190|NCT00312897|592756079|FG000|Overall Study|Adverse Event|1|||
164107191|NCT00312897|592756080|FG001|Overall Study|Adverse Event|0|||
164107192|NCT00312897|592756079|FG000|Overall Study|Lost to Follow-up|2|||
164107193|NCT00312897|592756080|FG001|Overall Study|Lost to Follow-up|0|||
164107194|NCT00312897|592756079|FG000|Overall Study|Physician Decision|1|||
164107195|NCT00312897|592756080|FG001|Overall Study|Physician Decision|0|||
164107196|NCT00312897|592756079|FG000|Overall Study|Withdrawal by Subject|1|||
164107197|NCT00312897|592756080|FG001|Overall Study|Withdrawal by Subject|3|||
164107198|NCT00312897|592756079|FG000|Overall Study|Pregnancy|1|||
164107199|NCT00312897|592756080|FG001|Overall Study|Pregnancy|0|||
164107200|NCT00312897|592756079|FG000|Overall Study|discontinued prior to getting treatment|0|||
164107201|NCT00312897|592756080|FG001|Overall Study|discontinued prior to getting treatment|3|||
164107202|NCT00902538|592756081|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
164107203|NCT00902538|592756082|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164107204|NCT00902538|592756083|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164107205|NCT00902538|592756084|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164107206|NCT00902538|592756085|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164107207|NCT00902538|592756086|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
164107208|NCT00902538|592756081|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
164107209|NCT00902538|592756082|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164107210|NCT00902538|592756083|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164107211|NCT00902538|592756084|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164148732|NCT03207867|592904937|FG001|Overall Study|Progressive Disease|7|||
164072984|NCT01408576|592632757|FG001|Overall Study|Withdrawal by Subject|60|||
164072985|NCT01408576|592632758|FG002|Overall Study|Withdrawal by Subject|66|||
164072986|NCT01408576|592632756|FG000|Overall Study|Sponsor terminated study|89|||
164072987|NCT01408576|592632757|FG001|Overall Study|Sponsor terminated study|333|||
164072988|NCT01408576|592632758|FG002|Overall Study|Sponsor terminated study|330|||
164072989|NCT01408576|592632756|FG000|Overall Study|AE, serious fatal|4|||
164072990|NCT01408576|592632757|FG001|Overall Study|AE, serious fatal|4|||
164072991|NCT01408576|592632758|FG002|Overall Study|AE, serious fatal|1|||
164072992|NCT01408576|592632756|FG000|Overall Study|SAE, non-fatal|11|||
164072993|NCT01408576|592632757|FG001|Overall Study|SAE, non-fatal|23|||
164072994|NCT01408576|592632758|FG002|Overall Study|SAE, non-fatal|14|||
164072995|NCT01408576|592632756|FG000|Overall Study|AE, non-serious non-fatal|12|||
164072996|NCT01408576|592632757|FG001|Overall Study|AE, non-serious non-fatal|19|||
164072997|NCT01408576|592632758|FG002|Overall Study|AE, non-serious non-fatal|11|||
164072998|NCT01408576|592632756|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164107212|NCT00902538|592756085|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164107213|NCT00902538|592756086|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
164107214|NCT00902538|592756081|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
164107215|NCT00902538|592756082|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164107216|NCT00902538|592756083|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164107217|NCT00902538|592756084|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164107218|NCT00902538|592756085|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164107219|NCT00902538|592756086|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
164107220|NCT00902538|592756081|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
164107221|NCT00902538|592756082|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164107222|NCT00902538|592756083|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164107223|NCT00902538|592756084|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164107224|NCT00902538|592756085|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164107225|NCT00902538|592756086|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
164107226|NCT00902538|592756081|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
164107227|NCT00902538|592756082|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164107228|NCT00902538|592756083|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164107229|NCT00902538|592756084|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164107230|NCT00902538|592756085|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164107231|NCT00902538|592756086|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
164107232|NCT00902538|592756081|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
164107233|NCT00902538|592756082|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
164107234|NCT00902538|592756083|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
164107235|NCT00902538|592756084|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
164107236|NCT00902538|592756085|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
164107237|NCT00902538|592756086|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
164107238|NCT00902538|592756081|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
164107239|NCT00902538|592756082|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
164107240|NCT00902538|592756083|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
164107241|NCT00902538|592756084|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
164107242|NCT00902538|592756085|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
164107243|NCT00902538|592756086|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
164107244|NCT00902538|592756081|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
164107245|NCT00902538|592756082|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164107246|NCT00902538|592756083|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
164107247|NCT00902538|592756084|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164107248|NCT00902538|592756085|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164107249|NCT00902538|592756086|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
164107250|NCT00902538|592756081|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
164107251|NCT00902538|592756082|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
164107252|NCT00902538|592756083|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
164107253|NCT00902538|592756084|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
164107254|NCT00902538|592756085|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
164107255|NCT00902538|592756086|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
164107256|NCT00902538|592756081|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
164107257|NCT00902538|592756082|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
164107258|NCT00902538|592756083|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
164107259|NCT00902538|592756084|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
164107260|NCT00902538|592756085|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
164107261|NCT00902538|592756086|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
164107262|NCT00902538|592756081|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
164107263|NCT00902538|592756082|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
164107264|NCT00902538|592756083|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
164107265|NCT00902538|592756084|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
164107266|NCT00902538|592756085|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
164107267|NCT00902538|592756086|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
164107268|NCT00902538|592756081|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
164107269|NCT00902538|592756082|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
164107270|NCT00902538|592756083|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
164107271|NCT00902538|592756084|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
164107272|NCT00902538|592756085|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
164107273|NCT00902538|592756086|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
164107274|NCT00902538|592756081|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164107275|NCT00902538|592756082|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
164107276|NCT00902538|592756083|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164107277|NCT00902538|592756084|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164107278|NCT00902538|592756085|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164107279|NCT00902538|592756086|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
164107280|NCT00902538|592756081|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164107281|NCT00902538|592756082|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
164107282|NCT00902538|592756083|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164107283|NCT00902538|592756084|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164107284|NCT00902538|592756085|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164107285|NCT00902538|592756086|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
164107286|NCT00902538|592756081|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
164107287|NCT00902538|592756082|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
164107288|NCT00902538|592756083|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
164107289|NCT00902538|592756084|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
164107290|NCT00902538|592756085|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
164107291|NCT00902538|592756086|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
164107292|NCT00902538|592756081|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164107293|NCT00902538|592756082|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164107294|NCT00902538|592756083|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164107295|NCT00902538|592756084|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
164107296|NCT00902538|592756085|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
164107297|NCT00902538|592756086|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
164107298|NCT00902538|592756081|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164107299|NCT00902538|592756082|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164107300|NCT00902538|592756083|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164107301|NCT00902538|592756084|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
164107302|NCT00902538|592756085|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164107303|NCT00902538|592756086|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
164107304|NCT06336356|592756087|FG000|Overall Study|Withdrawal by Subject|1|||
164107305|NCT06336356|592756088|FG001|Overall Study|Withdrawal by Subject|0|||
164107306|NCT06336356|592756087|FG000|Overall Study|Lost to Follow Up|1|||
164107307|NCT06336356|592756088|FG001|Overall Study|Lost to Follow Up|0|||
164107308|NCT03215706|592756094|FG000|Randomization|Adverse Event unrelated to study drug|1|||
164107309|NCT03215706|592756095|FG001|Randomization|Adverse Event unrelated to study drug|0|||
164107310|NCT03215706|592756094|FG000|Randomization|participant withdrew consent|1|||
164107311|NCT03215706|592756095|FG001|Randomization|participant withdrew consent|3|||
164107312|NCT03215706|592756094|FG000|Randomization|no longer meets study criteria|1|||
164107313|NCT03215706|592756095|FG001|Randomization|no longer meets study criteria|4|||
164107314|NCT03215706|592756094|FG000|Randomization|other reasons|0|||
164107315|NCT03215706|592756095|FG001|Randomization|other reasons|2|||
164107316|NCT03215706|592756094|FG000|Treatment Period|Disease Progression|184|||
164107317|NCT03215706|592756095|FG001|Treatment Period|Disease Progression|174|||
164107318|NCT03215706|592756094|FG000|Treatment Period|Study Drug Toxicity|70|||
164107319|NCT03215706|592756095|FG001|Treatment Period|Study Drug Toxicity|24|||
164107320|NCT03215706|592756094|FG000|Treatment Period|Death|7|||
164107321|NCT03215706|592756095|FG001|Treatment Period|Death|1|||
164107322|NCT03215706|592756094|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
164107323|NCT03215706|592756095|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
164107324|NCT03215706|592756094|FG000|Treatment Period|Request to D/C treatment|2|||
164107325|NCT03215706|592756095|FG001|Treatment Period|Request to D/C treatment|10|||
164107326|NCT03215706|592756094|FG000|Treatment Period|Participant withdrew consent|4|||
164107327|NCT03215706|592756095|FG001|Treatment Period|Participant withdrew consent|5|||
164107328|NCT03215706|592756094|FG000|Treatment Period|Lost to Follow-up|0|||
164107329|NCT03215706|592756095|FG001|Treatment Period|Lost to Follow-up|1|||
164107330|NCT03215706|592756094|FG000|Treatment Period|Administrative reason by sponsor|0|||
164107331|NCT03215706|592756095|FG001|Treatment Period|Administrative reason by sponsor|2|||
164107332|NCT03215706|592756094|FG000|Treatment Period|other reasons|10|||
164107333|NCT03215706|592756095|FG001|Treatment Period|other reasons|5|||
164107334|NCT03215706|592756094|FG000|Treatment Period|Not reported|1|||
164107335|NCT03215706|592756095|FG001|Treatment Period|Not reported|0|||
164107336|NCT03114891|592756097|FG000|First Treatment Round|Lost to Follow-up|0|||
164107337|NCT03114891|592756098|FG001|First Treatment Round|Lost to Follow-up|1|||
164107338|NCT03114891|592756099|FG002|First Treatment Round|Lost to Follow-up|1|||
164107339|NCT03114891|592756100|FG003|First Treatment Round|Lost to Follow-up|0|||
164107340|NCT03114891|592756097|FG000|First Treatment Round|Withdrawal by Subject|0|||
164107341|NCT03114891|592756098|FG001|First Treatment Round|Withdrawal by Subject|2|||
164107342|NCT03114891|592756099|FG002|First Treatment Round|Withdrawal by Subject|0|||
164107343|NCT03114891|592756100|FG003|First Treatment Round|Withdrawal by Subject|1|||
164107344|NCT03114891|592756097|FG000|3 Week Break|Lost to Follow-up|1|||
164107345|NCT03114891|592756098|FG001|3 Week Break|Lost to Follow-up|0|||
164107346|NCT03114891|592756099|FG002|3 Week Break|Lost to Follow-up|0|||
164107347|NCT03114891|592756100|FG003|3 Week Break|Lost to Follow-up|1|||
164107348|NCT03114891|592756097|FG000|3 Week Break|Withdrawal by Subject|0|||
164107349|NCT03114891|592756098|FG001|3 Week Break|Withdrawal by Subject|1|||
164107350|NCT03114891|592756099|FG002|3 Week Break|Withdrawal by Subject|0|||
164107351|NCT03114891|592756100|FG003|3 Week Break|Withdrawal by Subject|0|||
164107352|NCT03114891|592756097|FG000|Second Treatment Round|Lost to Follow-up|1|||
164107353|NCT03114891|592756098|FG001|Second Treatment Round|Lost to Follow-up|0|||
164107354|NCT03114891|592756099|FG002|Second Treatment Round|Lost to Follow-up|0|||
164107355|NCT03114891|592756100|FG003|Second Treatment Round|Lost to Follow-up|0|||
164107356|NCT03114891|592756097|FG000|Second Treatment Round|Physician Decision|1|||
164107357|NCT03114891|592756098|FG001|Second Treatment Round|Physician Decision|0|||
164107358|NCT03114891|592756099|FG002|Second Treatment Round|Physician Decision|0|||
164107359|NCT03114891|592756100|FG003|Second Treatment Round|Physician Decision|0|||
164107360|NCT03506633|592758216|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
164107361|NCT03506633|592758217|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
164107362|NCT03247686|592758222|FG000|Overall Study|Withdrawal by Subject|1|||
164107363|NCT03247686|592758223|FG001|Overall Study|Withdrawal by Subject|2|||
164107364|NCT02302716|592758224|FG000|Overall Study|Adverse Event|1|||
164107365|NCT02302716|592758225|FG001|Overall Study|Adverse Event|1|||
164107366|NCT02302716|592758224|FG000|Overall Study|Death|0|||
164107367|NCT02302716|592758225|FG001|Overall Study|Death|1|||
164107368|NCT02302716|592758224|FG000|Overall Study|Lack of Efficacy|0|||
164107369|NCT02302716|592758225|FG001|Overall Study|Lack of Efficacy|1|||
164107370|NCT02302716|592758224|FG000|Overall Study|Lost to Follow-up|2|||
164107371|NCT02302716|592758225|FG001|Overall Study|Lost to Follow-up|4|||
164107372|NCT02302716|592758224|FG000|Overall Study|Physician Decision|3|||
164107373|NCT02302716|592758225|FG001|Overall Study|Physician Decision|4|||
164107374|NCT02302716|592758224|FG000|Overall Study|Withdrawal by Subject|13|||
164107375|NCT02302716|592758225|FG001|Overall Study|Withdrawal by Subject|7|||
164107376|NCT02302716|592758224|FG000|Overall Study|Protocol Violation|0|||
164107377|NCT02302716|592758225|FG001|Overall Study|Protocol Violation|1|||
164107378|NCT00830258|592758226|FG000|First Intervention|Adverse Event|1|||
164107379|NCT00830258|592758227|FG001|First Intervention|Adverse Event|0|||
164107380|NCT00830258|592758226|FG000|Washout: 7 Days|Protocol Violation|1|||
164107381|NCT00830258|592758227|FG001|Washout: 7 Days|Protocol Violation|0|||
164107382|NCT00798603|592758228|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
164107383|NCT00798603|592758228|FG000|Overall Study|Withdrawal by Subject|10|||
164107384|NCT00798603|592758228|FG000|Overall Study|Adverse Event|22|||
164107385|NCT00798603|592758228|FG000|Overall Study|Physician Decision|1|||
164107386|NCT00798603|592758228|FG000|Overall Study|Lack of insurance coverage|1|||
164107387|NCT02997176|592758233|FG000|Overall Study|Adverse Event|0|||
164107388|NCT02997176|592758234|FG001|Overall Study|Adverse Event|0|||
164107389|NCT02997176|592758235|FG002|Overall Study|Adverse Event|0|||
164107390|NCT02997176|592758236|FG003|Overall Study|Adverse Event|8|||
164107391|NCT02997176|592758233|FG000|Overall Study|Progressive Disease|1|||
164107392|NCT02997176|592758234|FG001|Overall Study|Progressive Disease|0|||
164107393|NCT02997176|592758235|FG002|Overall Study|Progressive Disease|1|||
164107394|NCT02997176|592758236|FG003|Overall Study|Progressive Disease|1|||
164107395|NCT02997176|592758233|FG000|Overall Study|Death|0|||
164107396|NCT02997176|592758234|FG001|Overall Study|Death|0|||
164107397|NCT02997176|592758235|FG002|Overall Study|Death|1|||
164107398|NCT02997176|592758236|FG003|Overall Study|Death|1|||
164107399|NCT02997176|592758233|FG000|Overall Study|Withdrawal by Subject|0|||
164107400|NCT02997176|592758234|FG001|Overall Study|Withdrawal by Subject|2|||
164107401|NCT02997176|592758235|FG002|Overall Study|Withdrawal by Subject|0|||
164107402|NCT02997176|592758236|FG003|Overall Study|Withdrawal by Subject|1|||
164107403|NCT05511935|592758237|FG000|Overall Study|Lost to Follow-up|9|||
164107404|NCT05511935|592758238|FG001|Overall Study|Lost to Follow-up|27|||
164107405|NCT04523480|592758239|FG000|Overall Study|Lost to Follow-up|30|||
164107406|NCT04523480|592758240|FG001|Overall Study|Lost to Follow-up|35|||
164107407|NCT04523480|592758241|FG002|Overall Study|Lost to Follow-up|0|||
164107408|NCT04102345|592758242|FG000|Overall Study|Withdrawal by Subject|1|||
164107409|NCT04102345|592758243|FG001|Overall Study|Withdrawal by Subject|0|||
164107410|NCT01015287|592758246|FG000|Overall Study|Death|21|||
164107411|NCT01015287|592758247|FG001|Overall Study|Death|16|||
164107412|NCT01015287|592758246|FG000|Overall Study|Adverse Event|1|||
164107413|NCT01015287|592758247|FG001|Overall Study|Adverse Event|0|||
164107414|NCT01015287|592758246|FG000|Overall Study|Sponsor Decision|3|||
164107415|NCT01015287|592758247|FG001|Overall Study|Sponsor Decision|7|||
164107416|NCT01015287|592758246|FG000|Overall Study|Physician Decision|19|||
164107417|NCT01015287|592758247|FG001|Overall Study|Physician Decision|21|||
164107418|NCT01015287|592758246|FG000|Overall Study|Withdrawal by Subject|14|||
164107419|NCT01015287|592758247|FG001|Overall Study|Withdrawal by Subject|19|||
164107420|NCT01015287|592758246|FG000|Overall Study|Entry Criteria not Met|11|||
164107421|NCT01015287|592758247|FG001|Overall Study|Entry Criteria not Met|14|||
164107422|NCT01015287|592758246|FG000|Overall Study|Lost to Follow-up|2|||
164107423|NCT01015287|592758247|FG001|Overall Study|Lost to Follow-up|1|||
164107424|NCT01015287|592758246|FG000|Overall Study|Protocol Violation|1|||
164107425|NCT01015287|592758247|FG001|Overall Study|Protocol Violation|1|||
164107426|NCT01592240|592758248|FG000|Overall Study|Adverse Event|1|||
164107427|NCT01592240|592758249|FG001|Overall Study|Adverse Event|0|||
164107428|NCT01592240|592758250|FG002|Overall Study|Adverse Event|0|||
164107429|NCT01592240|592758251|FG003|Overall Study|Adverse Event|1|||
164107430|NCT01592240|592758252|FG004|Overall Study|Adverse Event|1|||
164107431|NCT01592240|592758253|FG005|Overall Study|Adverse Event|0|||
164107432|NCT01592240|592758254|FG006|Overall Study|Adverse Event|0|||
164107433|NCT01592240|592758248|FG000|Overall Study|Death|0|||
164107434|NCT01592240|592758249|FG001|Overall Study|Death|1|||
164107435|NCT01592240|592758250|FG002|Overall Study|Death|0|||
164107436|NCT01592240|592758251|FG003|Overall Study|Death|0|||
164107437|NCT01592240|592758252|FG004|Overall Study|Death|0|||
164107438|NCT01592240|592758253|FG005|Overall Study|Death|0|||
164107439|NCT01592240|592758254|FG006|Overall Study|Death|0|||
164107440|NCT01592240|592758248|FG000|Overall Study|Lost to Follow-up|1|||
164107441|NCT01592240|592758249|FG001|Overall Study|Lost to Follow-up|3|||
164107442|NCT01592240|592758250|FG002|Overall Study|Lost to Follow-up|1|||
164107443|NCT01592240|592758251|FG003|Overall Study|Lost to Follow-up|0|||
164107444|NCT01592240|592758252|FG004|Overall Study|Lost to Follow-up|3|||
164107445|NCT01592240|592758253|FG005|Overall Study|Lost to Follow-up|2|||
164107446|NCT01592240|592758254|FG006|Overall Study|Lost to Follow-up|0|||
164107447|NCT01592240|592758248|FG000|Overall Study|Protocol Violation|0|||
164107448|NCT01592240|592758249|FG001|Overall Study|Protocol Violation|0|||
164107449|NCT01592240|592758250|FG002|Overall Study|Protocol Violation|0|||
164107450|NCT01592240|592758251|FG003|Overall Study|Protocol Violation|0|||
164107451|NCT01592240|592758252|FG004|Overall Study|Protocol Violation|0|||
164107452|NCT01592240|592758253|FG005|Overall Study|Protocol Violation|1|||
164107453|NCT01592240|592758254|FG006|Overall Study|Protocol Violation|0|||
164107454|NCT01592240|592758248|FG000|Overall Study|Withdrawal by Subject|0|||
164107455|NCT01592240|592758249|FG001|Overall Study|Withdrawal by Subject|4|||
164107456|NCT01592240|592758250|FG002|Overall Study|Withdrawal by Subject|4|||
164107457|NCT01592240|592758251|FG003|Overall Study|Withdrawal by Subject|1|||
164107458|NCT01592240|592758252|FG004|Overall Study|Withdrawal by Subject|3|||
164107459|NCT01592240|592758253|FG005|Overall Study|Withdrawal by Subject|0|||
164107460|NCT01592240|592758254|FG006|Overall Study|Withdrawal by Subject|2|||
164107461|NCT01592240|592758248|FG000|Overall Study|Other|0|||
164107462|NCT01592240|592758249|FG001|Overall Study|Other|3|||
164107463|NCT01592240|592758250|FG002|Overall Study|Other|1|||
164107464|NCT01592240|592758251|FG003|Overall Study|Other|1|||
164107465|NCT01592240|592758252|FG004|Overall Study|Other|0|||
164107466|NCT01592240|592758253|FG005|Overall Study|Other|0|||
164107467|NCT01592240|592758254|FG006|Overall Study|Other|1|||
164107468|NCT01592240|592758248|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
164107469|NCT01592240|592758249|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
164107470|NCT01592240|592758250|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
164107471|NCT01592240|592758251|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
164107472|NCT01592240|592758252|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
164107473|NCT01592240|592758253|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
164107474|NCT01592240|592758254|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
164107475|NCT01117623|592758255|FG000|Overall Study|Adverse Event|0|||
164107476|NCT01117623|592758256|FG001|Overall Study|Adverse Event|2|||
164107477|NCT01117623|592758257|FG002|Overall Study|Adverse Event|4|||
164107478|NCT01117623|592758258|FG003|Overall Study|Adverse Event|0|||
164107479|NCT01117623|592758259|FG004|Overall Study|Adverse Event|2|||
164107480|NCT01117623|592758260|FG005|Overall Study|Adverse Event|0|||
164107481|NCT01117623|592758261|FG006|Overall Study|Adverse Event|0|||
164107482|NCT01117623|592758262|FG007|Overall Study|Adverse Event|2|||
164107483|NCT01117623|592758255|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
164107484|NCT01117623|592758256|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
164107485|NCT01117623|592758257|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
164107486|NCT01117623|592758258|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
164107487|NCT01117623|592758259|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
164107488|NCT01117623|592758260|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
164107489|NCT01117623|592758261|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
164107490|NCT01117623|592758262|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
164107491|NCT01117623|592758255|FG000|Overall Study|Withdrawal by Subject|0|||
164107492|NCT01117623|592758256|FG001|Overall Study|Withdrawal by Subject|0|||
164107493|NCT01117623|592758257|FG002|Overall Study|Withdrawal by Subject|2|||
164107494|NCT01117623|592758258|FG003|Overall Study|Withdrawal by Subject|0|||
164107495|NCT01117623|592758259|FG004|Overall Study|Withdrawal by Subject|0|||
164107496|NCT01117623|592758260|FG005|Overall Study|Withdrawal by Subject|1|||
164107497|NCT01117623|592758261|FG006|Overall Study|Withdrawal by Subject|1|||
164107498|NCT01117623|592758262|FG007|Overall Study|Withdrawal by Subject|1|||
164107499|NCT01117623|592758255|FG000|Overall Study|Non-compliance with study medication|0|||
164107500|NCT01117623|592758256|FG001|Overall Study|Non-compliance with study medication|0|||
164107501|NCT01117623|592758257|FG002|Overall Study|Non-compliance with study medication|0|||
164107502|NCT01117623|592758258|FG003|Overall Study|Non-compliance with study medication|0|||
164107503|NCT01117623|592758259|FG004|Overall Study|Non-compliance with study medication|0|||
164107504|NCT01117623|592758260|FG005|Overall Study|Non-compliance with study medication|0|||
164107505|NCT01117623|592758261|FG006|Overall Study|Non-compliance with study medication|0|||
164107506|NCT01117623|592758262|FG007|Overall Study|Non-compliance with study medication|1|||
164107507|NCT01117623|592758255|FG000|Overall Study|Invest. text: completed all planned txs|0|||
164107508|NCT01117623|592758256|FG001|Overall Study|Invest. text: completed all planned txs|0|||
164107509|NCT01117623|592758257|FG002|Overall Study|Invest. text: completed all planned txs|0|||
164107510|NCT01117623|592758258|FG003|Overall Study|Invest. text: completed all planned txs|0|||
164107511|NCT01117623|592758259|FG004|Overall Study|Invest. text: completed all planned txs|0|||
164107512|NCT01117623|592758260|FG005|Overall Study|Invest. text: completed all planned txs|1|||
164107513|NCT01117623|592758261|FG006|Overall Study|Invest. text: completed all planned txs|0|||
164107514|NCT01117623|592758262|FG007|Overall Study|Invest. text: completed all planned txs|0|||
164107515|NCT02727192|592758269|FG000|Overall Study|Lost to Follow-up|1|||
164107516|NCT02727192|592758270|FG001|Overall Study|Lost to Follow-up|0|||
164107517|NCT02727192|592758271|FG002|Overall Study|Lost to Follow-up|0|||
164107518|NCT05497557|592758273|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
164107519|NCT05497557|592758274|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
164107520|NCT05497557|592758275|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
164107521|NCT00488774|592758277|FG000|Overall Study|Withdrawal of consent|2|||
164107522|NCT00488774|592758278|FG001|Overall Study|Withdrawal of consent|2|||
164107523|NCT00488774|592758279|FG002|Overall Study|Withdrawal of consent|2|||
164107524|NCT00488774|592758280|FG003|Overall Study|Withdrawal of consent|0|||
164107525|NCT00488774|592758277|FG000|Overall Study|Other|6|||
164107526|NCT00488774|592758278|FG001|Overall Study|Other|3|||
164107527|NCT00488774|592758279|FG002|Overall Study|Other|2|||
164107528|NCT00488774|592758280|FG003|Overall Study|Other|2|||
164107529|NCT00488774|592758277|FG000|Overall Study|Lost to Follow-up|0|||
164107530|NCT00488774|592758278|FG001|Overall Study|Lost to Follow-up|0|||
164107531|NCT00488774|592758279|FG002|Overall Study|Lost to Follow-up|1|||
164107532|NCT00488774|592758280|FG003|Overall Study|Lost to Follow-up|1|||
164107533|NCT04590027|592758281|FG000|Overall Study|Lost to Follow-up|17|||
164107534|NCT04590027|592758282|FG001|Overall Study|Lost to Follow-up|14|||
164107535|NCT04590027|592758281|FG000|Overall Study|Protocol Violation|0|||
164107536|NCT04590027|592758282|FG001|Overall Study|Protocol Violation|3|||
164107537|NCT05523895|592758283|FG000|Overall Study|Adverse Event|2|||
164107538|NCT05523895|592758284|FG001|Overall Study|Adverse Event|1|||
164107539|NCT05523895|592758285|FG002|Overall Study|Adverse Event|1|||
164107540|NCT05523895|592758283|FG000|Overall Study|Lost to Follow-up|0|||
164107541|NCT05523895|592758284|FG001|Overall Study|Lost to Follow-up|1|||
164107542|NCT05523895|592758285|FG002|Overall Study|Lost to Follow-up|2|||
164107543|NCT05523895|592758283|FG000|Overall Study|Noncompliance with study drug|1|||
164107544|NCT05523895|592758284|FG001|Overall Study|Noncompliance with study drug|1|||
164107545|NCT05523895|592758285|FG002|Overall Study|Noncompliance with study drug|1|||
164107546|NCT05523895|592758283|FG000|Overall Study|Protocol Violation|0|||
164107547|NCT05523895|592758284|FG001|Overall Study|Protocol Violation|2|||
164107548|NCT05523895|592758285|FG002|Overall Study|Protocol Violation|0|||
164107549|NCT05523895|592758283|FG000|Overall Study|Withdrawal by Subject|1|||
164107550|NCT05523895|592758284|FG001|Overall Study|Withdrawal by Subject|3|||
164107551|NCT05523895|592758285|FG002|Overall Study|Withdrawal by Subject|1|||
164107552|NCT05523895|592758283|FG000|Overall Study|Not further specified|0|||
164107553|NCT05523895|592758284|FG001|Overall Study|Not further specified|3|||
164107554|NCT05523895|592758285|FG002|Overall Study|Not further specified|1|||
164107555|NCT03674892|592758286|FG000|Overall Study|Lack of Efficacy|5|||
164107556|NCT03674892|592758286|FG000|Overall Study|Lost to Follow-up|3|||
164107557|NCT03674892|592758286|FG000|Overall Study|Migraine|2|||
164107558|NCT03674892|592758286|FG000|Overall Study|Excessive Tearing|1|||
164107559|NCT03674892|592758286|FG000|Overall Study|Increased Eye Pain|1|||
164107560|NCT03674892|592758286|FG000|Overall Study|Increased Facial Pain|1|||
164107561|NCT03674892|592758286|FG000|Overall Study|Sinus Irritation|1|||
164107562|NCT03674892|592758286|FG000|Overall Study|Sinus Infection|1|||
164107563|NCT05099380|592758287|FG000|Overall Study|Subject enrolled in error|1|||
164107564|NCT05099380|592758288|FG001|Overall Study|Subject enrolled in error|0|||
164107565|NCT05099380|592758287|FG000|Overall Study|Study Procedure|1|||
164107566|NCT05099380|592758288|FG001|Overall Study|Study Procedure|0|||
164107567|NCT05099380|592758287|FG000|Overall Study|Protocol Violation|1|||
164107568|NCT05099380|592758288|FG001|Overall Study|Protocol Violation|0|||
164107569|NCT05099380|592758287|FG000|Overall Study|Adverse Event|1|||
164107570|NCT05099380|592758288|FG001|Overall Study|Adverse Event|1|||
164107571|NCT05099380|592758287|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
164107572|NCT05099380|592758288|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
164107573|NCT01959672|592758294|FG000|Overall Study|Death|1|||
164107574|NCT02392195|592758295|FG000|Overall Study|Lost to Follow-up|4|||
164107575|NCT02392195|592758295|FG000|Overall Study|Withdrawal by Subject|4|||
164107576|NCT03605342|592758298|FG000|Overall Study|Withdrawal by Subject|9|||
164107577|NCT03605342|592758299|FG001|Overall Study|Withdrawal by Subject|7|||
164107578|NCT03605342|592758298|FG000|Overall Study|Lost to Follow-up|1|||
164107579|NCT03605342|592758299|FG001|Overall Study|Lost to Follow-up|1|||
164107580|NCT02842853|592758302|FG000|Overall Study|Non-compliance with the protocol|3|||
164107581|NCT02842853|592758303|FG001|Overall Study|Non-compliance with the protocol|7|||
164107582|NCT02842853|592758304|FG002|Overall Study|Non-compliance with the protocol|2|||
164107583|NCT02842853|592758305|FG003|Overall Study|Non-compliance with the protocol|5|||
164107584|NCT02842853|592758302|FG000|Overall Study|Subject met exclusion criteria|0|||
164107585|NCT02842853|592758303|FG001|Overall Study|Subject met exclusion criteria|1|||
164107586|NCT02842853|592758304|FG002|Overall Study|Subject met exclusion criteria|0|||
164107587|NCT02842853|592758305|FG003|Overall Study|Subject met exclusion criteria|0|||
164107588|NCT02842853|592758302|FG000|Overall Study|Withdrawal by Subject|11|||
164107589|NCT02842853|592758303|FG001|Overall Study|Withdrawal by Subject|13|||
164107590|NCT02842853|592758304|FG002|Overall Study|Withdrawal by Subject|9|||
164107591|NCT02842853|592758305|FG003|Overall Study|Withdrawal by Subject|8|||
164107592|NCT02842853|592758302|FG000|Overall Study|Lost to Follow-up|9|||
164107593|NCT02842853|592758303|FG001|Overall Study|Lost to Follow-up|13|||
164107594|NCT02842853|592758304|FG002|Overall Study|Lost to Follow-up|10|||
164107595|NCT02842853|592758305|FG003|Overall Study|Lost to Follow-up|11|||
164107596|NCT04089553|592758306|FG000|Overall Study|Death|1|||
164107597|NCT04089553|592758307|FG001|Overall Study|Death|1|||
164107598|NCT04089553|592758306|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
164107599|NCT04089553|592758307|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
164107600|NCT04089553|592758306|FG000|Overall Study|Withdrawal by Subject|3|||
164107601|NCT04089553|592758307|FG001|Overall Study|Withdrawal by Subject|3|||
164107602|NCT04089553|592758306|FG000|Overall Study|Physician Decision|1|||
164107603|NCT04089553|592758307|FG001|Overall Study|Physician Decision|0|||
164107604|NCT04089553|592758306|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
164107605|NCT04089553|592758307|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
164107606|NCT04089553|592758306|FG000|Overall Study|Other|1|||
164107607|NCT04089553|592758307|FG001|Overall Study|Other|0|||
164107608|NCT04089553|592758306|FG000|Overall Study|Adverse Event|1|||
164107609|NCT04089553|592758307|FG001|Overall Study|Adverse Event|1|||
164107610|NCT04723693|592758314|FG000|Overall Study|Withdrawal by Subject|2|||
164107611|NCT03366792|592758317|FG000|Overall Study|Withdrawal by Subject|7|||
164107612|NCT03366792|592758317|FG000|Overall Study|Lost to Follow-up|2|||
164107613|NCT03366792|592758317|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
164107614|NCT03366792|592758317|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
164107615|NCT01808651|592758318|FG000|Study Period 1|Lost to Follow-up|1|||
164107616|NCT01808651|592758319|FG001|Study Period 1|Lost to Follow-up|3|||
164107617|NCT01808651|592758320|FG002|Study Period 1|Lost to Follow-up|0|||
164107618|NCT01808651|592758318|FG000|Study Period 1|Protocol Violation|1|||
164107619|NCT01808651|592758319|FG001|Study Period 1|Protocol Violation|0|||
164107620|NCT01808651|592758320|FG002|Study Period 1|Protocol Violation|1|||
164107621|NCT01808651|592758318|FG000|Study Period 1|Physician Decision|3|||
164107622|NCT01808651|592758319|FG001|Study Period 1|Physician Decision|2|||
164107623|NCT01808651|592758320|FG002|Study Period 1|Physician Decision|0|||
164107624|NCT01808651|592758318|FG000|Study Period 1|Lack of Efficacy|2|||
164107625|NCT01808651|592758319|FG001|Study Period 1|Lack of Efficacy|1|||
164107626|NCT01808651|592758320|FG002|Study Period 1|Lack of Efficacy|0|||
164107627|NCT01808651|592758318|FG000|Study Period 1|Adverse Event|10|||
164107628|NCT01808651|592758319|FG001|Study Period 1|Adverse Event|4|||
164107629|NCT01808651|592758320|FG002|Study Period 1|Adverse Event|1|||
164107630|NCT01808651|592758318|FG000|Study Period 1|Participant Decision|9|||
164107631|NCT01808651|592758319|FG001|Study Period 1|Participant Decision|7|||
164107632|NCT01808651|592758320|FG002|Study Period 1|Participant Decision|3|||
164107633|NCT00841542|592758321|FG000|Period 1|Adverse Event|1|||
164107634|NCT00841542|592758322|FG001|Period 1|Adverse Event|0|||
164107635|NCT00924638|592758323|FG000|Overall Study|Death|3|||
164107636|NCT00924638|592758324|FG001|Overall Study|Death|2|||
164107637|NCT00924638|592758323|FG000|Overall Study|Lost to Follow-up|1|||
164107638|NCT00924638|592758324|FG001|Overall Study|Lost to Follow-up|1|||
164107639|NCT00924638|592758323|FG000|Overall Study|Withdrawal by Subject|5|||
164107640|NCT00924638|592758324|FG001|Overall Study|Withdrawal by Subject|7|||
164107641|NCT00924638|592758323|FG000|Overall Study|Physician Decision|3|||
164107642|NCT00924638|592758324|FG001|Overall Study|Physician Decision|3|||
164107643|NCT01316055|592758325|FG000|Overall Study|Lost to Follow-up|1|||
164107644|NCT01316055|592758326|FG001|Overall Study|Lost to Follow-up|0|||
164107645|NCT01316055|592758327|FG002|Overall Study|Lost to Follow-up|0|||
164107646|NCT02679729|592758329|FG000|Overall Study|Lost to Follow-up|0|||
164107647|NCT02679729|592758330|FG001|Overall Study|Lost to Follow-up|1|||
164107648|NCT02679729|592758331|FG002|Overall Study|Lost to Follow-up|0|||
164107649|NCT02679729|592758332|FG003|Overall Study|Lost to Follow-up|0|||
164107650|NCT02679729|592758333|FG004|Overall Study|Lost to Follow-up|1|||
164107651|NCT02679729|592758334|FG005|Overall Study|Lost to Follow-up|0|||
164107652|NCT02679729|592758335|FG006|Overall Study|Lost to Follow-up|0|||
164107653|NCT02679729|592758336|FG007|Overall Study|Lost to Follow-up|0|||
164107654|NCT02679729|592758337|FG008|Overall Study|Lost to Follow-up|0|||
164107655|NCT02679729|592758329|FG000|Overall Study|Participant decision|0|||
164107656|NCT02679729|592758330|FG001|Overall Study|Participant decision|1|||
164107657|NCT02679729|592758331|FG002|Overall Study|Participant decision|0|||
164107658|NCT02679729|592758332|FG003|Overall Study|Participant decision|0|||
164107659|NCT02679729|592758333|FG004|Overall Study|Participant decision|0|||
164107660|NCT02679729|592758334|FG005|Overall Study|Participant decision|0|||
164107661|NCT02679729|592758335|FG006|Overall Study|Participant decision|1|||
164107662|NCT02679729|592758336|FG007|Overall Study|Participant decision|0|||
164107663|NCT02679729|592758337|FG008|Overall Study|Participant decision|0|||
164107664|NCT01442376|592758343|FG000|Overall Study|Adverse Event|0|||
164107665|NCT01442376|592758344|FG001|Overall Study|Adverse Event|3|||
164107666|NCT01442376|592758345|FG002|Overall Study|Adverse Event|2|||
164107667|NCT01442376|592758343|FG000|Overall Study|Death|0|||
164107668|NCT01442376|592758344|FG001|Overall Study|Death|1|||
164107669|NCT01442376|592758345|FG002|Overall Study|Death|1|||
164107670|NCT01442376|592758343|FG000|Overall Study|Withdrawal of consent|0|||
164107671|NCT01442376|592758344|FG001|Overall Study|Withdrawal of consent|0|||
164107672|NCT01442376|592758345|FG002|Overall Study|Withdrawal of consent|1|||
164107673|NCT01442376|592758343|FG000|Overall Study|Patients not treated|2|||
164107674|NCT01442376|592758344|FG001|Overall Study|Patients not treated|3|||
164107675|NCT01442376|592758345|FG002|Overall Study|Patients not treated|1|||
164107676|NCT01442376|592758343|FG000|Overall Study|Not eligible for subsequent cycles|1|||
164107677|NCT01442376|592758344|FG001|Overall Study|Not eligible for subsequent cycles|2|||
164107678|NCT01442376|592758345|FG002|Overall Study|Not eligible for subsequent cycles|0|||
164107679|NCT04404725|592758346|FG000|First Intervention|Withdrawal by Subject|0|||
164107680|NCT04404725|592758347|FG001|First Intervention|Withdrawal by Subject|2|||
164107681|NCT04404725|592758346|FG000|Second Intervention|Adverse Event|1|||
164107682|NCT04404725|592758347|FG001|Second Intervention|Adverse Event|1|||
164107683|NCT04404725|592758346|FG000|Second Intervention|Withdrawal by Subject|0|||
164107684|NCT04404725|592758347|FG001|Second Intervention|Withdrawal by Subject|1|||
164107685|NCT01075516|592758348|FG000|Overall Study|Death|5|||
164107686|NCT01075516|592758349|FG001|Overall Study|Death|9|||
164107687|NCT01075516|592758348|FG000|Overall Study|Lost to Follow-up|10|||
164107688|NCT01075516|592758349|FG001|Overall Study|Lost to Follow-up|2|||
164107689|NCT01075516|592758348|FG000|Overall Study|Withdrawal by Subject|3|||
164107690|NCT01075516|592758349|FG001|Overall Study|Withdrawal by Subject|5|||
164107691|NCT00674128|592758352|FG000|Overall Study|Withdrawal by Subject|25|||
164107692|NCT00674128|592758353|FG001|Overall Study|Withdrawal by Subject|23|||
164107693|NCT04631562|592758354|FG000|Overall Study|Withdrawal by Subject|0|||
164107694|NCT04631562|592758355|FG001|Overall Study|Withdrawal by Subject|0|||
164107695|NCT04631562|592758356|FG002|Overall Study|Withdrawal by Subject|0|||
164107696|NCT04631562|592758357|FG003|Overall Study|Withdrawal by Subject|0|||
164107697|NCT04631562|592758358|FG004|Overall Study|Withdrawal by Subject|0|||
164107698|NCT04631562|592758359|FG005|Overall Study|Withdrawal by Subject|0|||
164107699|NCT04631562|592758360|FG006|Overall Study|Withdrawal by Subject|0|||
164107700|NCT04631562|592758361|FG007|Overall Study|Withdrawal by Subject|1|||
164107701|NCT04631562|592758362|FG008|Overall Study|Withdrawal by Subject|0|||
164107702|NCT04631562|592758354|FG000|Overall Study|Other|0|||
164107703|NCT04631562|592758355|FG001|Overall Study|Other|0|||
164107704|NCT04631562|592758356|FG002|Overall Study|Other|0|||
164107705|NCT04631562|592758357|FG003|Overall Study|Other|0|||
164107706|NCT04631562|592758358|FG004|Overall Study|Other|0|||
164107707|NCT04631562|592758359|FG005|Overall Study|Other|0|||
164107708|NCT04631562|592758360|FG006|Overall Study|Other|0|||
164107709|NCT04631562|592758361|FG007|Overall Study|Other|0|||
164107710|NCT04631562|592758362|FG008|Overall Study|Other|1|||
164107711|NCT04631562|592758354|FG000|Overall Study|Lost to Follow-up|0|||
164107712|NCT04631562|592758355|FG001|Overall Study|Lost to Follow-up|0|||
164107713|NCT04631562|592758356|FG002|Overall Study|Lost to Follow-up|0|||
164107714|NCT04631562|592758357|FG003|Overall Study|Lost to Follow-up|1|||
164107715|NCT04631562|592758358|FG004|Overall Study|Lost to Follow-up|0|||
164107716|NCT04631562|592758359|FG005|Overall Study|Lost to Follow-up|0|||
164107717|NCT04631562|592758360|FG006|Overall Study|Lost to Follow-up|0|||
164107718|NCT04631562|592758361|FG007|Overall Study|Lost to Follow-up|0|||
164107719|NCT04631562|592758362|FG008|Overall Study|Lost to Follow-up|0|||
164107720|NCT04631562|592758354|FG000|Overall Study|Adverse Event|0|||
164107721|NCT04631562|592758355|FG001|Overall Study|Adverse Event|0|||
164107722|NCT04631562|592758356|FG002|Overall Study|Adverse Event|0|||
164107723|NCT04631562|592758357|FG003|Overall Study|Adverse Event|0|||
164107724|NCT04631562|592758358|FG004|Overall Study|Adverse Event|0|||
164107725|NCT04631562|592758359|FG005|Overall Study|Adverse Event|0|||
164107726|NCT04631562|592758360|FG006|Overall Study|Adverse Event|1|||
164107727|NCT04631562|592758361|FG007|Overall Study|Adverse Event|0|||
164107728|NCT04631562|592758362|FG008|Overall Study|Adverse Event|0|||
164107729|NCT03503318|592758364|FG000|Overall Study|Death|1|||
164107730|NCT03503318|592758365|FG001|Overall Study|Death|0|||
164107731|NCT03503318|592758366|FG002|Overall Study|Death|4|||
164107732|NCT03503318|592758364|FG000|Overall Study|Adverse Event|3|||
164107733|NCT03503318|592758365|FG001|Overall Study|Adverse Event|4|||
164107734|NCT03503318|592758366|FG002|Overall Study|Adverse Event|2|||
164107735|NCT03503318|592758364|FG000|Overall Study|Withdrawal by Subject|12|||
164107736|NCT03503318|592758365|FG001|Overall Study|Withdrawal by Subject|17|||
164107737|NCT03503318|592758366|FG002|Overall Study|Withdrawal by Subject|16|||
164107738|NCT03503318|592758364|FG000|Overall Study|Protocol Violation|5|||
164107739|NCT03503318|592758365|FG001|Overall Study|Protocol Violation|0|||
164107740|NCT03503318|592758366|FG002|Overall Study|Protocol Violation|3|||
164107741|NCT03503318|592758364|FG000|Overall Study|Lost to Follow-up|17|||
164107742|NCT03503318|592758365|FG001|Overall Study|Lost to Follow-up|15|||
164107743|NCT03503318|592758366|FG002|Overall Study|Lost to Follow-up|12|||
164107744|NCT03503318|592758364|FG000|Overall Study|Other than specified|1|||
164107745|NCT03503318|592758365|FG001|Overall Study|Other than specified|3|||
164107746|NCT03503318|592758366|FG002|Overall Study|Other than specified|3|||
164107747|NCT02139826|592758368|FG000|Overall Study|Adverse Event|1|||
164107748|NCT01825798|592758369|FG000|Overall Study|Adverse Event|1|||
164107749|NCT01825798|592758370|FG001|Overall Study|Adverse Event|5|||
164107750|NCT01825798|592758369|FG000|Overall Study|Lost to Follow-up|1|||
164107751|NCT01825798|592758370|FG001|Overall Study|Lost to Follow-up|0|||
164107752|NCT01559363|592758376|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
164107753|NCT01559363|592758377|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
164107754|NCT01559363|592758378|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
164107755|NCT01559363|592758379|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
164107756|NCT01559363|592758380|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
164107757|NCT01559363|592758381|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
164107758|NCT01559363|592758376|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
164107759|NCT01559363|592758377|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
164107760|NCT01559363|592758378|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
164107761|NCT01559363|592758379|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
164107762|NCT01559363|592758380|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
164107763|NCT01559363|592758381|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
164107764|NCT01559363|592758376|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
164107765|NCT01559363|592758377|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
164107766|NCT01559363|592758378|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164107767|NCT01559363|592758379|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164107768|NCT01559363|592758380|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164107769|NCT01559363|592758381|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
164107770|NCT01559363|592758376|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
164107771|NCT01559363|592758377|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164107772|NCT01559363|592758378|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
164107773|NCT01559363|592758379|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164107774|NCT01559363|592758380|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164107775|NCT01559363|592758381|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
164107776|NCT01559363|592758376|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164107777|NCT01559363|592758377|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
164107778|NCT01559363|592758378|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164107779|NCT01559363|592758379|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164107780|NCT01559363|592758380|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164107781|NCT01559363|592758381|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
164107782|NCT01559363|592758376|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164107783|NCT01559363|592758377|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164107784|NCT01559363|592758378|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164107785|NCT01559363|592758379|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
164107786|NCT01559363|592758380|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
164107787|NCT01559363|592758381|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
164107788|NCT01559363|592758376|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164107789|NCT01559363|592758377|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164107790|NCT01559363|592758378|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164107791|NCT01559363|592758379|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
164107792|NCT01559363|592758380|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164107793|NCT01559363|592758381|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
164107794|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
164107795|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
164107796|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
164107797|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
164107798|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
164107799|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107800|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107801|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107802|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107803|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107804|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107805|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107806|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107807|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107808|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107809|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107810|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107811|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107812|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107813|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107814|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107815|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107816|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107817|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107818|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107819|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
164107820|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107821|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
164107822|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107823|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107824|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107825|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107826|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107827|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107828|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107829|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107830|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107831|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107832|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107833|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107834|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107835|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107836|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107837|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107838|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107839|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107840|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107841|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107842|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107843|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107844|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107845|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
164107846|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107847|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
164107848|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107849|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107850|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107851|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107852|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107853|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107854|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107855|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107856|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107857|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107858|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107859|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107860|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107861|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107862|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107863|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107864|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107865|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107866|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107867|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107868|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107869|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107870|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107871|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
164107872|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
164107873|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107874|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
164107875|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
164107876|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
164107877|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107878|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107879|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107880|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107881|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107882|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107883|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107884|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107885|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107886|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107887|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107888|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107889|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107890|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107891|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107892|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107893|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107894|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107895|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107896|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107897|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
164107898|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
164107899|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
164107900|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
164107901|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
164107902|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
164107903|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107904|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107905|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107906|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107907|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107908|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107909|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107910|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107911|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107912|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107913|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107914|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107915|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107916|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107917|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107918|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107919|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107920|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107921|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107922|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107923|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
164107924|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|moved|0|||
164107925|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|moved|1|||
164107926|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|moved|1|||
164107927|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|moved|0|||
164107928|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|moved|0|||
164107929|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|moved|0|||
164107930|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|moved|0|||
164107931|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|moved|0|||
164107932|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|moved|0|||
164107933|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|moved|0|||
164107934|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|moved|0|||
164107935|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|moved|0|||
164107936|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|moved|0|||
164107937|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|moved|0|||
164107938|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|moved|0|||
164107939|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|moved|0|||
164107940|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|moved|0|||
164107941|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|moved|0|||
164107942|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|moved|0|||
164107943|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|moved|0|||
164107944|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|moved|0|||
164107945|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|moved|0|||
164107946|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|moved|0|||
164107947|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|moved|0|||
164107948|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|moved|0|||
164107949|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|moved|0|||
164107950|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107951|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107952|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107953|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
164107954|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107955|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107956|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107957|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107958|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107959|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107960|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107961|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107962|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107963|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107964|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107965|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107966|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107967|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107968|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107969|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107970|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107971|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107972|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107973|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107974|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107975|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
164107976|NCT00112437|592758382|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107977|NCT00112437|592758383|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107978|NCT00112437|592758384|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107979|NCT00112437|592758385|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107980|NCT00112437|592758386|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
164107981|NCT00112437|592758387|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107982|NCT00112437|592758388|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107983|NCT00112437|592758389|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107984|NCT00112437|592758390|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107985|NCT00112437|592758391|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107986|NCT00112437|592758392|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107987|NCT00112437|592758393|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107988|NCT00112437|592758394|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107989|NCT00112437|592758395|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107990|NCT00112437|592758396|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107991|NCT00112437|592758397|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107992|NCT00112437|592758398|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107993|NCT00112437|592758399|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107994|NCT00112437|592758400|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107995|NCT00112437|592758401|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107996|NCT00112437|592758402|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107997|NCT00112437|592758403|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107998|NCT00112437|592758404|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164107999|NCT00112437|592758405|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164108000|NCT00112437|592758406|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164108001|NCT00112437|592758407|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
164108002|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
164108003|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
164108004|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
164108005|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
164108006|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
164108007|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
164108008|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
164108009|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
164108010|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
164108011|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
164108012|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
164108013|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
164108014|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
164108015|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
164108016|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
164108017|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
164108018|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
164108019|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
164108020|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
164108021|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
164108022|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
164108023|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
164108024|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
164108025|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
164108026|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
164108027|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
164108028|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108029|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108030|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108031|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108032|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108033|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
164108034|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
164108035|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108036|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108037|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
164108038|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108039|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108040|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108041|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108042|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108043|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108044|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108045|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108046|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108047|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108048|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108049|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108050|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108051|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108052|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108053|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
164108054|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108055|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108056|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108057|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108058|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108059|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108060|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108061|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108062|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
164108063|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108064|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108065|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108066|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108067|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108068|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108069|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108070|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108071|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108072|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108073|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108074|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108075|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108076|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108077|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108078|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108079|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
164108080|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108081|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108082|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108083|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108084|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108085|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108086|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108087|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108088|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
164108089|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108090|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108091|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108092|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108093|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108094|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108095|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108096|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108097|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108098|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108099|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108100|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108101|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108102|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108103|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108104|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108105|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
164108106|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108107|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108108|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108109|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108110|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108111|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
164108112|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
164108113|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
164108114|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
164108115|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
164108116|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108117|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108118|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108119|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108120|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108121|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108122|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108123|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108124|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108125|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108126|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108127|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108128|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108129|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108130|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108131|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
164108132|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108133|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108134|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164148733|NCT03207867|592904938|FG002|Overall Study|Progressive Disease|9|||
164108135|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108136|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108137|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108138|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108139|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108140|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108141|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
164108142|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108143|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108144|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108145|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108146|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108147|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108148|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108149|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108150|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108151|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108152|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108153|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108154|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108155|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108156|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108157|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
164108158|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108159|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108160|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108161|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108162|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108163|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108164|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108165|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108166|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108167|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
164108168|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108169|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108170|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108171|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108172|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108173|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108174|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108175|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108176|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108177|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108178|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108179|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108180|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108181|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108182|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108183|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
164108184|NCT00112437|592758382|FG000|Year 2 (12-Month Extension)|Moved|0|||
164108185|NCT00112437|592758383|FG001|Year 2 (12-Month Extension)|Moved|0|||
164108186|NCT00112437|592758384|FG002|Year 2 (12-Month Extension)|Moved|0|||
164108187|NCT00112437|592758385|FG003|Year 2 (12-Month Extension)|Moved|0|||
164108188|NCT00112437|592758386|FG004|Year 2 (12-Month Extension)|Moved|0|||
164108189|NCT00112437|592758387|FG005|Year 2 (12-Month Extension)|Moved|0|||
164108190|NCT00112437|592758388|FG006|Year 2 (12-Month Extension)|Moved|0|||
164108191|NCT00112437|592758389|FG007|Year 2 (12-Month Extension)|Moved|0|||
164108192|NCT00112437|592758390|FG008|Year 2 (12-Month Extension)|Moved|0|||
164108193|NCT00112437|592758391|FG009|Year 2 (12-Month Extension)|Moved|1|||
164108194|NCT00112437|592758392|FG010|Year 2 (12-Month Extension)|Moved|0|||
164108195|NCT00112437|592758393|FG011|Year 2 (12-Month Extension)|Moved|0|||
164108196|NCT00112437|592758394|FG012|Year 2 (12-Month Extension)|Moved|0|||
164108197|NCT00112437|592758395|FG013|Year 2 (12-Month Extension)|Moved|0|||
164108198|NCT00112437|592758396|FG014|Year 2 (12-Month Extension)|Moved|0|||
164108199|NCT00112437|592758397|FG015|Year 2 (12-Month Extension)|Moved|0|||
164108200|NCT00112437|592758398|FG016|Year 2 (12-Month Extension)|Moved|0|||
164108201|NCT00112437|592758399|FG017|Year 2 (12-Month Extension)|Moved|0|||
164108202|NCT00112437|592758400|FG018|Year 2 (12-Month Extension)|Moved|0|||
164108203|NCT00112437|592758401|FG019|Year 2 (12-Month Extension)|Moved|0|||
164108204|NCT00112437|592758402|FG020|Year 2 (12-Month Extension)|Moved|0|||
164108205|NCT00112437|592758403|FG021|Year 2 (12-Month Extension)|Moved|0|||
164108206|NCT00112437|592758404|FG022|Year 2 (12-Month Extension)|Moved|0|||
164108207|NCT00112437|592758405|FG023|Year 2 (12-Month Extension)|Moved|0|||
164108208|NCT00112437|592758406|FG024|Year 2 (12-Month Extension)|Moved|0|||
164108209|NCT00112437|592758407|FG025|Year 2 (12-Month Extension)|Moved|0|||
164108210|NCT00112437|592758382|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
164108211|NCT00112437|592758383|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
164108212|NCT00112437|592758384|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
164108213|NCT00112437|592758385|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
164108214|NCT00112437|592758386|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
164108215|NCT00112437|592758387|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
164108216|NCT00112437|592758388|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
164108217|NCT00112437|592758389|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
164108218|NCT00112437|592758390|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
164108219|NCT00112437|592758391|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
164108220|NCT00112437|592758392|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
164108221|NCT00112437|592758393|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
164108222|NCT00112437|592758394|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
164108223|NCT00112437|592758395|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
164108224|NCT00112437|592758396|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
164108225|NCT00112437|592758397|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
164108226|NCT00112437|592758398|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
164108227|NCT00112437|592758399|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
164108228|NCT00112437|592758400|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
164108229|NCT00112437|592758401|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
164108230|NCT00112437|592758402|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
164108231|NCT00112437|592758403|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
164108232|NCT00112437|592758404|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
164108233|NCT00112437|592758405|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
164108234|NCT00112437|592758406|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
164108235|NCT00112437|592758407|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
164108236|NCT00112437|592758382|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108237|NCT00112437|592758383|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108238|NCT00112437|592758384|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108239|NCT00112437|592758385|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108240|NCT00112437|592758386|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108241|NCT00112437|592758387|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108242|NCT00112437|592758388|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108243|NCT00112437|592758389|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108244|NCT00112437|592758390|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108245|NCT00112437|592758391|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108246|NCT00112437|592758392|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108247|NCT00112437|592758393|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
164108248|NCT00112437|592758394|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108249|NCT00112437|592758395|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
164108250|NCT00112437|592758396|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108251|NCT00112437|592758397|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
164108252|NCT00112437|592758398|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108253|NCT00112437|592758399|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108254|NCT00112437|592758400|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
164108255|NCT00112437|592758401|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108256|NCT00112437|592758402|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108257|NCT00112437|592758403|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108258|NCT00112437|592758404|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108259|NCT00112437|592758405|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108260|NCT00112437|592758406|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108261|NCT00112437|592758407|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
164108262|NCT00112437|592758382|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108263|NCT00112437|592758383|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108264|NCT00112437|592758384|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108265|NCT00112437|592758385|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108266|NCT00112437|592758386|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108267|NCT00112437|592758387|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108268|NCT00112437|592758388|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108269|NCT00112437|592758389|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108270|NCT00112437|592758390|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108271|NCT00112437|592758391|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108272|NCT00112437|592758392|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108273|NCT00112437|592758393|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108274|NCT00112437|592758394|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108275|NCT00112437|592758395|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108276|NCT00112437|592758396|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108277|NCT00112437|592758397|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
164108278|NCT00112437|592758398|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108279|NCT00112437|592758399|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108280|NCT00112437|592758400|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108281|NCT00112437|592758401|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108282|NCT00112437|592758402|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108283|NCT00112437|592758403|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108284|NCT00112437|592758404|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108285|NCT00112437|592758405|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108286|NCT00112437|592758406|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108287|NCT00112437|592758407|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
164108288|NCT00112437|592758382|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108289|NCT00112437|592758383|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108290|NCT00112437|592758384|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108291|NCT00112437|592758385|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108292|NCT00112437|592758386|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108293|NCT00112437|592758387|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108294|NCT00112437|592758388|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108295|NCT00112437|592758389|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108296|NCT00112437|592758390|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108297|NCT00112437|592758391|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108298|NCT00112437|592758392|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108299|NCT00112437|592758393|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108300|NCT00112437|592758394|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108301|NCT00112437|592758395|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108302|NCT00112437|592758396|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108303|NCT00112437|592758397|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
164108304|NCT00112437|592758398|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108305|NCT00112437|592758399|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108306|NCT00112437|592758400|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108307|NCT00112437|592758401|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108308|NCT00112437|592758402|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108309|NCT00112437|592758403|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108310|NCT00112437|592758404|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108311|NCT00112437|592758405|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108312|NCT00112437|592758406|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108313|NCT00112437|592758407|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
164108314|NCT00112437|592758382|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108315|NCT00112437|592758383|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108316|NCT00112437|592758384|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108317|NCT00112437|592758385|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108318|NCT00112437|592758386|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108319|NCT00112437|592758387|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108320|NCT00112437|592758388|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108321|NCT00112437|592758389|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108322|NCT00112437|592758390|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108323|NCT00112437|592758391|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108324|NCT00112437|592758392|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108325|NCT00112437|592758393|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
164108326|NCT00112437|592758394|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108327|NCT00112437|592758395|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108328|NCT00112437|592758396|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
164108329|NCT00112437|592758397|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108330|NCT00112437|592758398|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108331|NCT00112437|592758399|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108332|NCT00112437|592758400|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108333|NCT00112437|592758401|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108334|NCT00112437|592758402|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108335|NCT00112437|592758403|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108336|NCT00112437|592758404|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108337|NCT00112437|592758405|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108338|NCT00112437|592758406|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108339|NCT00112437|592758407|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
164108340|NCT00112437|592758382|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108341|NCT00112437|592758383|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108342|NCT00112437|592758384|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108343|NCT00112437|592758385|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108344|NCT00112437|592758386|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108345|NCT00112437|592758387|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108346|NCT00112437|592758388|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108347|NCT00112437|592758389|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108348|NCT00112437|592758390|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108349|NCT00112437|592758391|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108350|NCT00112437|592758392|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
164108351|NCT00112437|592758393|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
164108352|NCT00112437|592758394|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108353|NCT00112437|592758395|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108354|NCT00112437|592758396|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108355|NCT00112437|592758397|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108356|NCT00112437|592758398|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108357|NCT00112437|592758399|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108358|NCT00112437|592758400|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108359|NCT00112437|592758401|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108360|NCT00112437|592758402|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108361|NCT00112437|592758403|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108362|NCT00112437|592758404|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108363|NCT00112437|592758405|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108364|NCT00112437|592758406|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108365|NCT00112437|592758407|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
164108366|NCT00112437|592758382|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108367|NCT00112437|592758383|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108368|NCT00112437|592758384|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108369|NCT00112437|592758385|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108370|NCT00112437|592758386|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108371|NCT00112437|592758387|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108372|NCT00112437|592758388|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108373|NCT00112437|592758389|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108374|NCT00112437|592758390|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108375|NCT00112437|592758391|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108376|NCT00112437|592758392|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108377|NCT00112437|592758393|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108378|NCT00112437|592758394|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108379|NCT00112437|592758395|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108380|NCT00112437|592758396|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108381|NCT00112437|592758397|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108382|NCT00112437|592758398|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108383|NCT00112437|592758399|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108384|NCT00112437|592758400|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108385|NCT00112437|592758401|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108386|NCT00112437|592758402|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
164108387|NCT00112437|592758403|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
164108388|NCT00112437|592758404|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108389|NCT00112437|592758405|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108390|NCT00112437|592758406|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108391|NCT00112437|592758407|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
164108392|NCT00112437|592758382|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108393|NCT00112437|592758383|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108394|NCT00112437|592758384|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108395|NCT00112437|592758385|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108396|NCT00112437|592758386|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108397|NCT00112437|592758387|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108398|NCT00112437|592758388|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108399|NCT00112437|592758389|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108400|NCT00112437|592758390|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108401|NCT00112437|592758391|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108402|NCT00112437|592758392|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108403|NCT00112437|592758393|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108404|NCT00112437|592758394|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108405|NCT00112437|592758395|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108406|NCT00112437|592758396|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108407|NCT00112437|592758397|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108408|NCT00112437|592758398|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108409|NCT00112437|592758399|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108410|NCT00112437|592758400|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108411|NCT00112437|592758401|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108412|NCT00112437|592758402|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
164108413|NCT00112437|592758403|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108414|NCT00112437|592758404|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108415|NCT00112437|592758405|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108416|NCT00112437|592758406|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108417|NCT00112437|592758407|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
164108418|NCT00112437|592758382|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108419|NCT00112437|592758383|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108420|NCT00112437|592758384|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108421|NCT00112437|592758385|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108422|NCT00112437|592758386|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108423|NCT00112437|592758387|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108424|NCT00112437|592758388|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108425|NCT00112437|592758389|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108426|NCT00112437|592758390|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108427|NCT00112437|592758391|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108428|NCT00112437|592758392|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108429|NCT00112437|592758393|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108430|NCT00112437|592758394|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108431|NCT00112437|592758395|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108432|NCT00112437|592758396|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108433|NCT00112437|592758397|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108434|NCT00112437|592758398|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108435|NCT00112437|592758399|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108436|NCT00112437|592758400|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108437|NCT00112437|592758401|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108438|NCT00112437|592758402|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108439|NCT00112437|592758403|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
164108440|NCT00112437|592758404|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108441|NCT00112437|592758405|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108442|NCT00112437|592758406|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108443|NCT00112437|592758407|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
164108444|NCT00112437|592758382|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108445|NCT00112437|592758383|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108446|NCT00112437|592758384|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108447|NCT00112437|592758385|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108448|NCT00112437|592758386|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108449|NCT00112437|592758387|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108450|NCT00112437|592758388|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108451|NCT00112437|592758389|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108452|NCT00112437|592758390|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108453|NCT00112437|592758391|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108454|NCT00112437|592758392|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108455|NCT00112437|592758393|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108456|NCT00112437|592758394|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108457|NCT00112437|592758395|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108458|NCT00112437|592758396|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108459|NCT00112437|592758397|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108460|NCT00112437|592758398|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108461|NCT00112437|592758399|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108462|NCT00112437|592758400|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108463|NCT00112437|592758401|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108464|NCT00112437|592758402|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108465|NCT00112437|592758403|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
164108466|NCT00112437|592758404|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108467|NCT00112437|592758405|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108468|NCT00112437|592758406|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108469|NCT00112437|592758407|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
164108470|NCT00112437|592758382|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108471|NCT00112437|592758383|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108472|NCT00112437|592758384|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108473|NCT00112437|592758385|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108474|NCT00112437|592758386|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108475|NCT00112437|592758387|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108476|NCT00112437|592758388|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108477|NCT00112437|592758389|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108478|NCT00112437|592758390|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108479|NCT00112437|592758391|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108480|NCT00112437|592758392|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108481|NCT00112437|592758393|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108482|NCT00112437|592758394|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108483|NCT00112437|592758395|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108484|NCT00112437|592758396|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108485|NCT00112437|592758397|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108486|NCT00112437|592758398|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108487|NCT00112437|592758399|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108488|NCT00112437|592758400|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108489|NCT00112437|592758401|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108490|NCT00112437|592758402|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
164108491|NCT00112437|592758403|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
164108492|NCT00112437|592758404|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108493|NCT00112437|592758405|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108494|NCT00112437|592758406|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108495|NCT00112437|592758407|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
164108496|NCT00112437|592758382|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108497|NCT00112437|592758383|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108498|NCT00112437|592758384|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108499|NCT00112437|592758385|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108500|NCT00112437|592758386|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108501|NCT00112437|592758387|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108502|NCT00112437|592758388|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108503|NCT00112437|592758389|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108504|NCT00112437|592758390|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108505|NCT00112437|592758391|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108506|NCT00112437|592758392|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108507|NCT00112437|592758393|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108508|NCT00112437|592758394|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108509|NCT00112437|592758395|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108510|NCT00112437|592758396|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108511|NCT00112437|592758397|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108512|NCT00112437|592758398|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108513|NCT00112437|592758399|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108514|NCT00112437|592758400|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108515|NCT00112437|592758401|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108516|NCT00112437|592758402|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108517|NCT00112437|592758403|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108518|NCT00112437|592758404|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
164108519|NCT00112437|592758405|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
164108520|NCT00112437|592758406|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
164108521|NCT00112437|592758407|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
164108522|NCT00112437|592758382|FG000|Years 6-10 (60-Month Extension)|Death|0|||
164108523|NCT00112437|592758383|FG001|Years 6-10 (60-Month Extension)|Death|0|||
164108524|NCT00112437|592758384|FG002|Years 6-10 (60-Month Extension)|Death|0|||
164108525|NCT00112437|592758385|FG003|Years 6-10 (60-Month Extension)|Death|0|||
164108526|NCT00112437|592758386|FG004|Years 6-10 (60-Month Extension)|Death|0|||
164108527|NCT00112437|592758387|FG005|Years 6-10 (60-Month Extension)|Death|0|||
164108528|NCT00112437|592758388|FG006|Years 6-10 (60-Month Extension)|Death|0|||
164108529|NCT00112437|592758389|FG007|Years 6-10 (60-Month Extension)|Death|0|||
164108530|NCT00112437|592758390|FG008|Years 6-10 (60-Month Extension)|Death|0|||
164108531|NCT00112437|592758391|FG009|Years 6-10 (60-Month Extension)|Death|0|||
164108532|NCT00112437|592758392|FG010|Years 6-10 (60-Month Extension)|Death|0|||
164108533|NCT00112437|592758393|FG011|Years 6-10 (60-Month Extension)|Death|0|||
164108534|NCT00112437|592758394|FG012|Years 6-10 (60-Month Extension)|Death|0|||
164108535|NCT00112437|592758395|FG013|Years 6-10 (60-Month Extension)|Death|0|||
164108536|NCT00112437|592758396|FG014|Years 6-10 (60-Month Extension)|Death|0|||
164108537|NCT00112437|592758397|FG015|Years 6-10 (60-Month Extension)|Death|0|||
164108538|NCT00112437|592758398|FG016|Years 6-10 (60-Month Extension)|Death|0|||
164108539|NCT00112437|592758399|FG017|Years 6-10 (60-Month Extension)|Death|0|||
164108540|NCT00112437|592758400|FG018|Years 6-10 (60-Month Extension)|Death|0|||
164108541|NCT00112437|592758401|FG019|Years 6-10 (60-Month Extension)|Death|0|||
164108542|NCT00112437|592758402|FG020|Years 6-10 (60-Month Extension)|Death|0|||
164108543|NCT00112437|592758403|FG021|Years 6-10 (60-Month Extension)|Death|0|||
164108544|NCT00112437|592758404|FG022|Years 6-10 (60-Month Extension)|Death|0|||
164108545|NCT00112437|592758405|FG023|Years 6-10 (60-Month Extension)|Death|2|||
164108546|NCT00112437|592758406|FG024|Years 6-10 (60-Month Extension)|Death|0|||
164108547|NCT00112437|592758407|FG025|Years 6-10 (60-Month Extension)|Death|0|||
164148734|NCT03207867|592904939|FG003|Overall Study|Progressive Disease|10|||
164108548|NCT00112437|592758382|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108549|NCT00112437|592758383|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108550|NCT00112437|592758384|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108551|NCT00112437|592758385|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108552|NCT00112437|592758386|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108553|NCT00112437|592758387|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108554|NCT00112437|592758388|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108555|NCT00112437|592758389|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108556|NCT00112437|592758390|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108557|NCT00112437|592758391|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108558|NCT00112437|592758392|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108559|NCT00112437|592758393|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108560|NCT00112437|592758394|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108561|NCT00112437|592758395|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108562|NCT00112437|592758396|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108563|NCT00112437|592758397|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108564|NCT00112437|592758398|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108565|NCT00112437|592758399|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108566|NCT00112437|592758400|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108567|NCT00112437|592758401|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108568|NCT00112437|592758402|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108569|NCT00112437|592758403|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108570|NCT00112437|592758404|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108571|NCT00112437|592758405|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108572|NCT00112437|592758406|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
164108573|NCT00112437|592758407|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
164108574|NCT00112437|592758382|FG000|Years 6-10 (60-Month Extension)|Other|0|||
164108575|NCT00112437|592758383|FG001|Years 6-10 (60-Month Extension)|Other|0|||
164108576|NCT00112437|592758384|FG002|Years 6-10 (60-Month Extension)|Other|0|||
164108577|NCT00112437|592758385|FG003|Years 6-10 (60-Month Extension)|Other|0|||
164108578|NCT00112437|592758386|FG004|Years 6-10 (60-Month Extension)|Other|0|||
164108579|NCT00112437|592758387|FG005|Years 6-10 (60-Month Extension)|Other|0|||
164108580|NCT00112437|592758388|FG006|Years 6-10 (60-Month Extension)|Other|0|||
164108581|NCT00112437|592758389|FG007|Years 6-10 (60-Month Extension)|Other|0|||
164108582|NCT00112437|592758390|FG008|Years 6-10 (60-Month Extension)|Other|0|||
164108583|NCT00112437|592758391|FG009|Years 6-10 (60-Month Extension)|Other|0|||
164108584|NCT00112437|592758392|FG010|Years 6-10 (60-Month Extension)|Other|0|||
164108585|NCT00112437|592758393|FG011|Years 6-10 (60-Month Extension)|Other|0|||
164108586|NCT00112437|592758394|FG012|Years 6-10 (60-Month Extension)|Other|0|||
164108587|NCT00112437|592758395|FG013|Years 6-10 (60-Month Extension)|Other|0|||
164108588|NCT00112437|592758396|FG014|Years 6-10 (60-Month Extension)|Other|0|||
164108589|NCT00112437|592758397|FG015|Years 6-10 (60-Month Extension)|Other|0|||
164108590|NCT00112437|592758398|FG016|Years 6-10 (60-Month Extension)|Other|0|||
164108591|NCT00112437|592758399|FG017|Years 6-10 (60-Month Extension)|Other|0|||
164108592|NCT00112437|592758400|FG018|Years 6-10 (60-Month Extension)|Other|0|||
164108593|NCT00112437|592758401|FG019|Years 6-10 (60-Month Extension)|Other|0|||
164108594|NCT00112437|592758402|FG020|Years 6-10 (60-Month Extension)|Other|0|||
164108595|NCT00112437|592758403|FG021|Years 6-10 (60-Month Extension)|Other|0|||
164108596|NCT00112437|592758404|FG022|Years 6-10 (60-Month Extension)|Other|0|||
164108597|NCT00112437|592758405|FG023|Years 6-10 (60-Month Extension)|Other|0|||
164108598|NCT00112437|592758406|FG024|Years 6-10 (60-Month Extension)|Other|1|||
164108599|NCT00112437|592758407|FG025|Years 6-10 (60-Month Extension)|Other|0|||
164108600|NCT00112437|592758382|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108601|NCT00112437|592758383|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108602|NCT00112437|592758384|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108603|NCT00112437|592758385|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108604|NCT00112437|592758386|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108605|NCT00112437|592758387|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108606|NCT00112437|592758388|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108607|NCT00112437|592758389|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108608|NCT00112437|592758390|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108609|NCT00112437|592758391|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108610|NCT00112437|592758392|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108611|NCT00112437|592758393|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108612|NCT00112437|592758394|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108613|NCT00112437|592758395|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108614|NCT00112437|592758396|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108615|NCT00112437|592758397|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108616|NCT00112437|592758398|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108617|NCT00112437|592758399|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164148735|NCT03207867|592904940|FG004|Overall Study|Progressive Disease|11|||
164108618|NCT00112437|592758400|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108619|NCT00112437|592758401|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108620|NCT00112437|592758402|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108621|NCT00112437|592758403|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108622|NCT00112437|592758404|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108623|NCT00112437|592758405|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
164108624|NCT00112437|592758406|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108625|NCT00112437|592758407|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
164108626|NCT00112437|592758382|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108627|NCT00112437|592758383|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108628|NCT00112437|592758384|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108629|NCT00112437|592758385|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108630|NCT00112437|592758386|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108631|NCT00112437|592758387|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108632|NCT00112437|592758388|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108633|NCT00112437|592758389|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108634|NCT00112437|592758390|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108635|NCT00112437|592758391|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108636|NCT00112437|592758392|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108637|NCT00112437|592758393|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108638|NCT00112437|592758394|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108639|NCT00112437|592758395|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108640|NCT00112437|592758396|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108641|NCT00112437|592758397|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108642|NCT00112437|592758398|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108643|NCT00112437|592758399|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108644|NCT00112437|592758400|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108645|NCT00112437|592758401|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108646|NCT00112437|592758402|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108647|NCT00112437|592758403|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108648|NCT00112437|592758404|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
164108649|NCT00112437|592758405|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
164108650|NCT00112437|592758406|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
164108651|NCT00112437|592758407|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
164108652|NCT01824576|592758409|FG000|Overall Study|Device deficiency|2|||
164108653|NCT03218787|592758415|FG000|Overall Study|Lost to Follow-up|12|||
164108654|NCT03218787|592758415|FG000|Overall Study|Withdrawal by Subject|72|||
164108655|NCT03218787|592758415|FG000|Overall Study|Physician Decision|11|||
164108656|NCT03218787|592758415|FG000|Overall Study|Death|111|||
164108657|NCT02896296|592758416|FG000|Overall Study|Adverse Event|1|||
164108658|NCT02896296|592758416|FG000|Overall Study|Lost to Follow-up|19|||
164108659|NCT02896296|592758416|FG000|Overall Study|Pregnancy|1|||
164108660|NCT02896296|592758416|FG000|Overall Study|Physician Decision|2|||
164108661|NCT02896296|592758416|FG000|Overall Study|Withdrawal by Subject|10|||
164108662|NCT02896296|592758416|FG000|Overall Study|Site closing|7|||
164108663|NCT02896296|592758416|FG000|Overall Study|Incarceration|1|||
164108664|NCT02896296|592758416|FG000|Overall Study|Relocation|1|||
164108665|NCT01120028|592758419|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
164108666|NCT01120028|592758420|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
164108667|NCT01120028|592758421|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
164108668|NCT01120028|592758422|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
164108669|NCT01120028|592758419|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
164108670|NCT01120028|592758420|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
164108671|NCT01120028|592758421|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
164108672|NCT01120028|592758422|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
164108673|NCT04633564|592758423|FG000|Period 1|Adverse Event|28|||
164108674|NCT04633564|592758424|FG001|Period 1|Adverse Event|19|||
164108675|NCT04633564|592758423|FG000|Period 1|Death|8|||
164108676|NCT04633564|592758424|FG001|Period 1|Death|7|||
164108677|NCT04633564|592758423|FG000|Period 1|Lost to Follow-up|3|||
164108678|NCT04633564|592758424|FG001|Period 1|Lost to Follow-up|5|||
164108679|NCT04633564|592758423|FG000|Period 1|Physician Decision|4|||
164108680|NCT04633564|592758424|FG001|Period 1|Physician Decision|12|||
164108681|NCT04633564|592758423|FG000|Period 1|Protocol Violation|0|||
164108682|NCT04633564|592758424|FG001|Period 1|Protocol Violation|1|||
164108683|NCT04633564|592758423|FG000|Period 1|Withdrawal by Subject|10|||
164108684|NCT04633564|592758424|FG001|Period 1|Withdrawal by Subject|8|||
164108685|NCT04633564|592758423|FG000|Period 1|Progressive disease|47|||
164108686|NCT04633564|592758424|FG001|Period 1|Progressive disease|51|||
164108687|NCT04633564|592758423|FG000|Period 1|Terminated by Sponsor|8|||
164108688|NCT04633564|592758424|FG001|Period 1|Terminated by Sponsor|6|||
164108689|NCT04633564|592758423|FG000|Period 2|Adverse Event|3|||
164108690|NCT04633564|592758424|FG001|Period 2|Adverse Event|4|||
164108691|NCT04633564|592758423|FG000|Period 2|Death|0|||
164108692|NCT04633564|592758424|FG001|Period 2|Death|2|||
164108693|NCT04633564|592758423|FG000|Period 2|Lost to Follow-up|0|||
164108694|NCT04633564|592758424|FG001|Period 2|Lost to Follow-up|1|||
164108695|NCT04633564|592758423|FG000|Period 2|Physician Decision|2|||
164108696|NCT04633564|592758424|FG001|Period 2|Physician Decision|4|||
164108697|NCT04633564|592758423|FG000|Period 2|Withdrawal by Subject|5|||
164108698|NCT04633564|592758424|FG001|Period 2|Withdrawal by Subject|1|||
164108699|NCT04633564|592758423|FG000|Period 2|Progressive Disease|74|||
164108700|NCT04633564|592758424|FG001|Period 2|Progressive Disease|82|||
164108701|NCT04633564|592758423|FG000|Period 2|Terminated by Sponsor|9|||
164108702|NCT04633564|592758424|FG001|Period 2|Terminated by Sponsor|3|||
164108703|NCT01279486|592758425|FG000|Overall Study|Lost to Follow-up|1|||
164108704|NCT04198363|592758426|FG000|Overall Study|Adverse Event|1|||
164108705|NCT04198363|592758427|FG001|Overall Study|Adverse Event|1|||
164108706|NCT04198363|592758426|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
164108707|NCT04198363|592758427|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
164108708|NCT04198363|592758426|FG000|Overall Study|Reason not Specified|1|||
164108709|NCT04198363|592758427|FG001|Overall Study|Reason not Specified|0|||
164108710|NCT00640341|592760110|FG000|Overall Study|Adverse Event|0|||
164108711|NCT00640341|592760111|FG001|Overall Study|Adverse Event|0|||
164108712|NCT00640341|592760112|FG002|Overall Study|Adverse Event|1|||
164108713|NCT00640341|592760110|FG000|Overall Study|Positive Slit Lamp Findings|0|||
164108714|NCT00640341|592760111|FG001|Overall Study|Positive Slit Lamp Findings|0|||
164108715|NCT00640341|592760112|FG002|Overall Study|Positive Slit Lamp Findings|1|||
164108716|NCT00640341|592760110|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
164108717|NCT00640341|592760111|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
164108718|NCT00640341|592760112|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
164108719|NCT00640341|592760110|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
164108720|NCT00640341|592760111|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
164108721|NCT00640341|592760112|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
164108722|NCT00640341|592760110|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
164108723|NCT00640341|592760111|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
164108724|NCT00640341|592760112|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
164108725|NCT00640341|592760110|FG000|Overall Study|Lost to Follow-up|2|||
164108726|NCT00640341|592760111|FG001|Overall Study|Lost to Follow-up|0|||
164108727|NCT00640341|592760112|FG002|Overall Study|Lost to Follow-up|0|||
164108728|NCT00640341|592760110|FG000|Overall Study|Withdrawal by Subject|4|||
164108729|NCT00640341|592760111|FG001|Overall Study|Withdrawal by Subject|0|||
164108730|NCT00640341|592760112|FG002|Overall Study|Withdrawal by Subject|1|||
164108731|NCT00640341|592760110|FG000|Overall Study|Unacceptable Lens Movement|1|||
164108732|NCT00640341|592760111|FG001|Overall Study|Unacceptable Lens Movement|0|||
164108733|NCT00640341|592760112|FG002|Overall Study|Unacceptable Lens Movement|0|||
164108734|NCT00640341|592760110|FG000|Overall Study|Poor fit/Uncomfortable|4|||
164108735|NCT00640341|592760111|FG001|Overall Study|Poor fit/Uncomfortable|0|||
164108736|NCT00640341|592760112|FG002|Overall Study|Poor fit/Uncomfortable|0|||
164108737|NCT00640341|592760110|FG000|Overall Study|Ineligable at Baseline|5|||
164108738|NCT00640341|592760111|FG001|Overall Study|Ineligable at Baseline|3|||
164108739|NCT00640341|592760112|FG002|Overall Study|Ineligable at Baseline|2|||
164108740|NCT00640341|592760110|FG000|Overall Study|Adverse event and positive slit lamp|1|||
164108741|NCT00640341|592760111|FG001|Overall Study|Adverse event and positive slit lamp|0|||
164108742|NCT00640341|592760112|FG002|Overall Study|Adverse event and positive slit lamp|0|||
164108743|NCT01541215|592760115|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
164108744|NCT01541215|592760116|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
164108745|NCT01541215|592760115|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
164108746|NCT01541215|592760116|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
164108747|NCT01541215|592760115|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
164108748|NCT01541215|592760116|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
164108749|NCT01541215|592760115|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
164108750|NCT01541215|592760116|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
164108751|NCT01541215|592760115|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
164108752|NCT01541215|592760116|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
164108753|NCT01541215|592760115|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
164108754|NCT01541215|592760116|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
164108755|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Subject request|8|||
164108756|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Subject request|11|||
164108757|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
164108758|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
164108759|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
164108760|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
164108761|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
164108762|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
164108763|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
164108764|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
164108765|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
164108766|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
164108767|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Death|1|||
164108768|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Death|0|||
164108769|NCT00521586|592760119|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
164108770|NCT00521586|592760120|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
164108771|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
164108772|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
164108773|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
164108774|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
164108775|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
164108776|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
164108777|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
164108778|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
164108779|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
164108780|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
164108781|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
164108782|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
164108783|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
164108784|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
164108785|NCT00521586|592760119|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
164108786|NCT00521586|592760120|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
164108787|NCT00521586|592760119|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
164108788|NCT00521586|592760120|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
164108789|NCT00521586|592760119|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
164108790|NCT00521586|592760120|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
164108791|NCT00521586|592760119|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
164108792|NCT00521586|592760120|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
164108793|NCT00529763|592760121|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
164108794|NCT00529763|592760122|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
164108795|NCT00529763|592760123|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
164108796|NCT00529763|592760121|FG000|Overall Study|Death|1|||
164108797|NCT00529763|592760122|FG001|Overall Study|Death|1|||
164108798|NCT00529763|592760123|FG002|Overall Study|Death|1|||
164108799|NCT00529763|592760121|FG000|Overall Study|Disease Progression|10|||
164108800|NCT00529763|592760122|FG001|Overall Study|Disease Progression|16|||
164108801|NCT00529763|592760123|FG002|Overall Study|Disease Progression|11|||
164108802|NCT00529763|592760121|FG000|Overall Study|Lost to Follow-up|1|||
164108803|NCT00529763|592760122|FG001|Overall Study|Lost to Follow-up|2|||
164108804|NCT00529763|592760123|FG002|Overall Study|Lost to Follow-up|3|||
164108805|NCT00529763|592760121|FG000|Overall Study|Stem Cell Transplant|0|||
164108806|NCT00529763|592760122|FG001|Overall Study|Stem Cell Transplant|3|||
164108807|NCT00529763|592760123|FG002|Overall Study|Stem Cell Transplant|1|||
164108808|NCT00529763|592760121|FG000|Overall Study|Study Drug Toxicity|3|||
164108809|NCT00529763|592760122|FG001|Overall Study|Study Drug Toxicity|6|||
164108810|NCT00529763|592760123|FG002|Overall Study|Study Drug Toxicity|4|||
164108811|NCT00529763|592760121|FG000|Overall Study|Participant Withdrew Consent|2|||
164108812|NCT00529763|592760122|FG001|Overall Study|Participant Withdrew Consent|3|||
164108813|NCT00529763|592760123|FG002|Overall Study|Participant Withdrew Consent|4|||
164108814|NCT00529763|592760121|FG000|Overall Study|Other reasons|2|||
164108815|NCT00529763|592760122|FG001|Overall Study|Other reasons|0|||
164108816|NCT00529763|592760123|FG002|Overall Study|Other reasons|2|||
164108817|NCT00529763|592760121|FG000|Overall Study|Participant request to discontinue treatment|1|||
164108818|NCT00529763|592760122|FG001|Overall Study|Participant request to discontinue treatment|1|||
164108819|NCT00529763|592760123|FG002|Overall Study|Participant request to discontinue treatment|3|||
164108820|NCT03669250|592760124|FG000|Overall Study|Adverse Event|0|||
164108821|NCT03669250|592760125|FG001|Overall Study|Adverse Event|0|||
164108822|NCT03669250|592760126|FG002|Overall Study|Adverse Event|0|||
164108823|NCT03669250|592760127|FG003|Overall Study|Adverse Event|0|||
164108824|NCT03669250|592760128|FG004|Overall Study|Adverse Event|1|||
164108825|NCT03669250|592760129|FG005|Overall Study|Adverse Event|0|||
164108826|NCT03669250|592760124|FG000|Overall Study|Withdrawal by Subject|0|||
164108827|NCT03669250|592760125|FG001|Overall Study|Withdrawal by Subject|1|||
164108828|NCT03669250|592760126|FG002|Overall Study|Withdrawal by Subject|0|||
164108829|NCT03669250|592760127|FG003|Overall Study|Withdrawal by Subject|1|||
164108830|NCT03669250|592760128|FG004|Overall Study|Withdrawal by Subject|0|||
164108831|NCT03669250|592760129|FG005|Overall Study|Withdrawal by Subject|0|||
164108832|NCT00828321|592760130|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
164108833|NCT00828321|592760131|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
164108834|NCT00828321|592760130|FG000|Second Intervention|Protocol Violation|0|||
164108835|NCT00828321|592760131|FG001|Second Intervention|Protocol Violation|1|||
164108836|NCT00691704|592760133|FG000|Induction Therapy|Disease Progression|1|||
164108837|NCT00691704|592760133|FG000|Induction Therapy|Active Hepatitis|1|||
164108838|NCT00691704|592760133|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
164108839|NCT00691704|592760133|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
164108840|NCT00691704|592760133|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
164108841|NCT01993186|592760134|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
164108842|NCT01993186|592760135|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
164108843|NCT01993186|592760134|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
164108844|NCT01993186|592760135|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
164108845|NCT01993186|592760134|FG000|Open-Label Extension Period|Other, Not Specified|0|||
164108846|NCT01993186|592760135|FG001|Open-Label Extension Period|Other, Not Specified|1|||
164108847|NCT01993186|592760134|FG000|Open-Label Extension Period|Adverse Event|1|||
164108848|NCT01993186|592760135|FG001|Open-Label Extension Period|Adverse Event|0|||
164108849|NCT01993186|592760134|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
164108850|NCT01993186|592760135|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
164108851|NCT01993186|592760134|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
164108852|NCT01993186|592760135|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
164108853|NCT01993186|592760134|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
164108854|NCT01993186|592760135|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
164108855|NCT02451696|592760136|FG000|Overall Study|Surgery postponed|1|||
164108856|NCT02451696|592760137|FG001|Overall Study|Surgery postponed|0|||
164108857|NCT00198133|592760138|FG000|Overall Study|Disease progression|2|||
164108858|NCT00198133|592760139|FG001|Overall Study|Disease progression|5|||
164108859|NCT00198133|592760138|FG000|Overall Study|Adverse Event|1|||
164108860|NCT00198133|592760139|FG001|Overall Study|Adverse Event|3|||
164108861|NCT00198133|592760138|FG000|Overall Study|Withdrawal by Subject|1|||
164108862|NCT00198133|592760139|FG001|Overall Study|Withdrawal by Subject|0|||
164108863|NCT00198133|592760138|FG000|Overall Study|Physician Decision|1|||
164108864|NCT00198133|592760139|FG001|Overall Study|Physician Decision|0|||
164108865|NCT01557751|592760140|FG000|Overall Study|Physician Decision|3|||
164108866|NCT02752074|592760141|FG000|Overall Study|Lost to Follow-up|1|||
164108867|NCT02752074|592760142|FG001|Overall Study|Lost to Follow-up|4|||
164108868|NCT02752074|592760141|FG000|Overall Study|Death|146|||
164108869|NCT02752074|592760142|FG001|Overall Study|Death|129|||
164108870|NCT02752074|592760141|FG000|Overall Study|Withdrawal by Subject|9|||
164108871|NCT02752074|592760142|FG001|Overall Study|Withdrawal by Subject|10|||
164108872|NCT00840216|592760143|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
164108873|NCT00840216|592760144|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
164108874|NCT03276754|592760145|FG000|Overall Study|Withdrawal of informed consent|4|||
164108875|NCT03276754|592760145|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
164108876|NCT03276754|592760145|FG000|Overall Study|Lost to Follow-up|27|||
164108877|NCT03276754|592760145|FG000|Overall Study|No data reported at Month 24|31|||
164108878|NCT03276754|592760145|FG000|Overall Study|Death|39|||
164108879|NCT00545792|592760146|FG000|Overall Study|Withdrawal by Subject|1|||
164108880|NCT05041361|592760148|FG000|Overall Study|Lost to Follow-up|1|||
164108881|NCT05041361|592760149|FG001|Overall Study|Lost to Follow-up|3|||
164108882|NCT01642277|592760150|FG000|Overall Study|Adverse Event|10|||
164108883|NCT01642277|592760151|FG001|Overall Study|Adverse Event|0|||
164108884|NCT01642277|592760150|FG000|Overall Study|Physician Decision|2|||
164108885|NCT01642277|592760151|FG001|Overall Study|Physician Decision|0|||
164108886|NCT01642277|592760150|FG000|Overall Study|Protocol Violation|1|||
164108887|NCT01642277|592760151|FG001|Overall Study|Protocol Violation|0|||
164108888|NCT01642277|592760150|FG000|Overall Study|Withdrawal by Subject|11|||
164108889|NCT01642277|592760151|FG001|Overall Study|Withdrawal by Subject|0|||
164108890|NCT03679598|592760152|FG000|Overall Study|Adverse Event|2|||
164108891|NCT03679598|592760153|FG001|Overall Study|Adverse Event|0|||
164108892|NCT00918645|592760158|FG000|Overall Study|Withdrawal by Subject|1|||
164108893|NCT05133180|592760159|FG000|Overall Study|Withdrawal of consent|1|||
164108894|NCT05133180|592760160|FG001|Overall Study|Withdrawal of consent|1|||
164108895|NCT05133180|592760159|FG000|Overall Study|Lost to Follow-up|1|||
164108896|NCT05133180|592760160|FG001|Overall Study|Lost to Follow-up|1|||
164108897|NCT05133180|592760159|FG000|Overall Study|Documented disease progression|0|||
164108898|NCT05133180|592760160|FG001|Overall Study|Documented disease progression|1|||
164108899|NCT02157974|592760161|FG000|Overall Study|Withdrawal by Subject|0|||
164108900|NCT02157974|592760162|FG001|Overall Study|Withdrawal by Subject|1|||
164108901|NCT02157974|592760163|FG002|Overall Study|Withdrawal by Subject|0|||
164108902|NCT02157974|592760164|FG003|Overall Study|Withdrawal by Subject|0|||
164108903|NCT02157974|592760165|FG004|Overall Study|Withdrawal by Subject|0|||
164108904|NCT02157974|592760161|FG000|Overall Study|Screen Failure|0|||
164108905|NCT02157974|592760162|FG001|Overall Study|Screen Failure|1|||
164108906|NCT02157974|592760163|FG002|Overall Study|Screen Failure|0|||
164108907|NCT02157974|592760164|FG003|Overall Study|Screen Failure|0|||
164108908|NCT02157974|592760165|FG004|Overall Study|Screen Failure|0|||
164108909|NCT02157974|592760161|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164108910|NCT02157974|592760162|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
164108911|NCT02157974|592760163|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164108912|NCT02157974|592760164|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164108913|NCT02157974|592760165|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
164108914|NCT00216736|592760167|FG000|Overall Study|Lost to Follow-up|1|||
164108915|NCT00216736|592760168|FG001|Overall Study|Lost to Follow-up|1|||
164108916|NCT02622386|592760169|FG000|First Assignment|Withdrawal by Subject|3|||
164108917|NCT02622386|592760170|FG001|First Assignment|Withdrawal by Subject|2|||
164108918|NCT02622386|592760169|FG000|Washout|Withdrawal by Subject|4|||
164108919|NCT02622386|592760170|FG001|Washout|Withdrawal by Subject|4|||
164108920|NCT02622386|592760169|FG000|Second Assignment|Withdrawal by Subject|0|||
164108921|NCT02622386|592760170|FG001|Second Assignment|Withdrawal by Subject|2|||
164108922|NCT00807495|592760172|FG000|Overall Study|Adverse Event|6|||
164108923|NCT00807495|592760173|FG001|Overall Study|Adverse Event|3|||
164108924|NCT00807495|592760174|FG002|Overall Study|Adverse Event|1|||
164108925|NCT00807495|592760175|FG003|Overall Study|Adverse Event|1|||
164108926|NCT00807495|592760176|FG004|Overall Study|Adverse Event|2|||
164108927|NCT00807495|592760172|FG000|Overall Study|Withdrawal by Patient|2|||
164108928|NCT00807495|592760173|FG001|Overall Study|Withdrawal by Patient|0|||
164108929|NCT00807495|592760174|FG002|Overall Study|Withdrawal by Patient|1|||
164108930|NCT00807495|592760175|FG003|Overall Study|Withdrawal by Patient|0|||
164108931|NCT00807495|592760176|FG004|Overall Study|Withdrawal by Patient|0|||
164108932|NCT00807495|592760172|FG000|Overall Study|Reason Not Specified|0|||
164108933|NCT00807495|592760173|FG001|Overall Study|Reason Not Specified|3|||
164108934|NCT00807495|592760174|FG002|Overall Study|Reason Not Specified|2|||
164108935|NCT00807495|592760175|FG003|Overall Study|Reason Not Specified|0|||
164108936|NCT00807495|592760176|FG004|Overall Study|Reason Not Specified|3|||
164108937|NCT05274763|592760177|FG000|Overall Study|Lost to Follow-up|1|||
164108938|NCT00463684|592760182|FG000|Overall Study|Withdrawal by Subject|1|||
164108939|NCT00463684|592760182|FG000|Overall Study|Lost to Follow-up|3|||
164108940|NCT01906372|592760183|FG000|Overall Study|Withdrawal by Subject|2|||
164108941|NCT03629054|592760184|FG000|Period 2 (4 Days)|Not treated|0|||
164108942|NCT03629054|592760185|FG001|Period 2 (4 Days)|Not treated|1|||
164108943|NCT03808376|592760186|FG000|Overall Study|Withdrawal by Subject|10|||
164108944|NCT02462837|592760187|FG000|Overall Study|pt developed hives|1|||
164108945|NCT02462837|592760188|FG001|Overall Study|pt developed hives|0|||
164108946|NCT02462837|592760187|FG000|Overall Study|Withdrawal by Subject|1|||
164108947|NCT02462837|592760188|FG001|Overall Study|Withdrawal by Subject|0|||
164108948|NCT00748566|592760192|FG000|Overall Study|Adverse Event|49|||
164108949|NCT00748566|592760192|FG000|Overall Study|Death|1|||
164108950|NCT00748566|592760192|FG000|Overall Study|Lack of Efficacy|12|||
164108951|NCT00748566|592760192|FG000|Overall Study|Lost to Follow-up|1|||
164108952|NCT00748566|592760192|FG000|Overall Study|Protocol Violation|13|||
164108953|NCT00748566|592760192|FG000|Overall Study|Withdrawal by Subject|22|||
164108954|NCT00748566|592760192|FG000|Overall Study|Study terminated by sponsor|5|||
164108955|NCT00748566|592760192|FG000|Overall Study|Other|9|||
164108956|NCT00989950|592760193|FG000|Randomized Phase|Protocol Violation|1|||
164108957|NCT00989950|592760194|FG001|Randomized Phase|Protocol Violation|0|||
164108958|NCT00989950|592760195|FG002|Randomized Phase|Protocol Violation|0|||
164108959|NCT00989950|592760196|FG003|Randomized Phase|Protocol Violation|0|||
164108960|NCT00989950|592760193|FG000|Randomized Phase|Adverse Event|0|||
164108961|NCT00989950|592760194|FG001|Randomized Phase|Adverse Event|1|||
164108962|NCT00989950|592760195|FG002|Randomized Phase|Adverse Event|0|||
164108963|NCT00989950|592760196|FG003|Randomized Phase|Adverse Event|0|||
164108964|NCT00624286|592760199|FG000|Overall Study|Protocol Deviation|7|||
164108965|NCT00624286|592760200|FG001|Overall Study|Protocol Deviation|9|||
164108966|NCT00624286|592760199|FG000|Overall Study|Adverse Event|6|||
164108967|NCT00624286|592760200|FG001|Overall Study|Adverse Event|3|||
164108968|NCT00624286|592760199|FG000|Overall Study|Withdrawal by Subject|5|||
164108969|NCT00624286|592760200|FG001|Overall Study|Withdrawal by Subject|4|||
164108970|NCT00624286|592760199|FG000|Overall Study|Lost to Follow-up|3|||
164108971|NCT00624286|592760200|FG001|Overall Study|Lost to Follow-up|2|||
164108972|NCT00624286|592760199|FG000|Overall Study|Administrative problems|3|||
164108973|NCT00624286|592760200|FG001|Overall Study|Administrative problems|0|||
164108974|NCT00624286|592760199|FG000|Overall Study|Lack of Efficacy|1|||
164108975|NCT00624286|592760200|FG001|Overall Study|Lack of Efficacy|6|||
164108976|NCT00624286|592760199|FG000|Overall Study|Not stated|0|||
164108977|NCT00624286|592760200|FG001|Overall Study|Not stated|1|||
164108978|NCT00624286|592760199|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164108979|NCT00624286|592760200|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164108980|NCT00624286|592760199|FG000|Overall Study|Death|0|||
164108981|NCT00624286|592760200|FG001|Overall Study|Death|1|||
164108982|NCT02845336|592760203|FG000|Overall Study|Lost to Follow-up|3|||
164108983|NCT02845336|592760204|FG001|Overall Study|Lost to Follow-up|1|||
164108984|NCT02845336|592760203|FG000|Overall Study|Inability to get medication|2|||
164108985|NCT02845336|592760204|FG001|Overall Study|Inability to get medication|0|||
164108986|NCT03488108|592760205|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
164108987|NCT03488108|592760206|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164108988|NCT03488108|592760205|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
164108989|NCT03488108|592760206|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
164108990|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Refused|1|||
164108991|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Refused|3|||
164108992|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Medical|0|||
164108993|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Medical|1|||
164108994|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
164108995|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
164108996|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
164108997|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
164108998|NCT02054715|592760208|FG000|Baseline/Follow-up 1|No Reason|0|||
164108999|NCT02054715|592760209|FG001|Baseline/Follow-up 1|No Reason|1|||
164109000|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
164109001|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
164109002|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Ineligible|3|||
164109003|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Ineligible|0|||
164109004|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Hospitalization|1|||
164109005|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Hospitalization|0|||
164109006|NCT02054715|592760208|FG000|Baseline/Follow-up 1|Changed Mind|1|||
164109007|NCT02054715|592760209|FG001|Baseline/Follow-up 1|Changed Mind|0|||
164109008|NCT02054715|592760208|FG000|Follow-up 2|Lost to Followup|3|||
164109009|NCT02054715|592760209|FG001|Follow-up 2|Lost to Followup|1|||
164109010|NCT02054715|592760208|FG000|Follow-up 2|Refused|3|||
164109011|NCT02054715|592760209|FG001|Follow-up 2|Refused|2|||
164109012|NCT02054715|592760208|FG000|Follow-up 2|Followup Not Completed|3|||
164109013|NCT02054715|592760209|FG001|Follow-up 2|Followup Not Completed|4|||
164109014|NCT02054715|592760208|FG000|Follow-up 2|Ineligible|4|||
164109015|NCT02054715|592760209|FG001|Follow-up 2|Ineligible|5|||
164109016|NCT02054715|592760208|FG000|Follow-up 2|Death|3|||
164109017|NCT02054715|592760209|FG001|Follow-up 2|Death|3|||
164109018|NCT02054715|592760208|FG000|Follow-up 2|Hospitalization|0|||
164109019|NCT02054715|592760209|FG001|Follow-up 2|Hospitalization|2|||
164109020|NCT02054715|592760208|FG000|Follow-up 2|Changed MD/Facility|0|||
164109021|NCT02054715|592760209|FG001|Follow-up 2|Changed MD/Facility|1|||
164109022|NCT02054715|592760208|FG000|Follow-up 2|Changed Mind|0|||
164109023|NCT02054715|592760209|FG001|Follow-up 2|Changed Mind|1|||
164109024|NCT02054715|592760208|FG000|Follow-up 2|No Reason|2|||
164109025|NCT02054715|592760209|FG001|Follow-up 2|No Reason|0|||
164109026|NCT02054715|592760208|FG000|Follow-up 2|Treatment Change or Delay|1|||
164109027|NCT02054715|592760209|FG001|Follow-up 2|Treatment Change or Delay|0|||
164109028|NCT02252016|592760210|FG000|Overall Study|Lost to Follow-up|2|||
164109029|NCT02252016|592760211|FG001|Overall Study|Lost to Follow-up|1|||
164109030|NCT02252016|592760210|FG000|Overall Study|Physician Decision|1|||
164109031|NCT02252016|592760211|FG001|Overall Study|Physician Decision|0|||
164109032|NCT02252016|592760210|FG000|Overall Study|Withdrawal by Subject|0|||
164109033|NCT02252016|592760211|FG001|Overall Study|Withdrawal by Subject|2|||
164109034|NCT02471807|592760212|FG000|Overall Study|Death|14|||
164109035|NCT02471807|592760212|FG000|Overall Study|Withdrawal by Subject|2|||
164109036|NCT02471807|592760212|FG000|Overall Study|Explant|5|||
164109037|NCT02471807|592760212|FG000|Overall Study|Lost to Follow-up|1|||
164109038|NCT00834873|592760213|FG000|First Intervention|Adverse Event|0|||
164109039|NCT00834873|592760214|FG001|First Intervention|Adverse Event|1|||
164109040|NCT01653704|592760218|FG000|Overall Study|Technical failure during recording|1|||
164109041|NCT01653704|592760219|FG001|Overall Study|Technical failure during recording|1|||
164109042|NCT01653704|592760218|FG000|Overall Study|Performance not reflective of training|1|||
164109043|NCT01653704|592760219|FG001|Overall Study|Performance not reflective of training|0|||
164109044|NCT03966911|592760221|FG000|Overall Study|Adverse Event|1|||
164109045|NCT03966911|592760222|FG001|Overall Study|Adverse Event|1|||
164109046|NCT03966911|592760221|FG000|Overall Study|Withdrawal by Subject|8|||
164109047|NCT03966911|592760222|FG001|Overall Study|Withdrawal by Subject|2|||
164109048|NCT03966911|592760221|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
164109049|NCT03966911|592760222|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
164109050|NCT00985751|592760223|FG000|Overall Study|Adverse Event|0|||
164109051|NCT00985751|592760224|FG001|Overall Study|Adverse Event|0|||
164109052|NCT00985751|592760225|FG002|Overall Study|Adverse Event|0|||
164109053|NCT00985751|592760226|FG003|Overall Study|Adverse Event|0|||
164109054|NCT00985751|592760227|FG004|Overall Study|Adverse Event|1|||
164109055|NCT01960296|592760228|FG000|Overall Study|Postponed surgery|1|||
164109056|NCT01960296|592760229|FG001|Overall Study|Postponed surgery|0|||
164109057|NCT01960296|592760228|FG000|Overall Study|Received different procedure|1|||
164109058|NCT01960296|592760229|FG001|Overall Study|Received different procedure|3|||
164109059|NCT02611323|592760230|FG000|Overall Study|Death|3|||
164109060|NCT02611323|592760231|FG001|Overall Study|Death|1|||
164109061|NCT02611323|592760232|FG002|Overall Study|Death|0|||
164109062|NCT02611323|592760233|FG003|Overall Study|Death|0|||
164109063|NCT02611323|592760234|FG004|Overall Study|Death|1|||
164109064|NCT02611323|592760235|FG005|Overall Study|Death|1|||
164109065|NCT02611323|592760236|FG006|Overall Study|Death|8|||
164109066|NCT02611323|592760237|FG007|Overall Study|Death|0|||
164109067|NCT02611323|592760238|FG008|Overall Study|Death|4|||
164109068|NCT02611323|592760239|FG009|Overall Study|Death|6|||
164109069|NCT02611323|592760240|FG010|Overall Study|Death|26|||
164109070|NCT02611323|592760230|FG000|Overall Study|Lost to Follow-up|1|||
164109071|NCT02611323|592760231|FG001|Overall Study|Lost to Follow-up|0|||
164109072|NCT02611323|592760232|FG002|Overall Study|Lost to Follow-up|0|||
164109073|NCT02611323|592760233|FG003|Overall Study|Lost to Follow-up|0|||
164109074|NCT02611323|592760234|FG004|Overall Study|Lost to Follow-up|0|||
164109075|NCT02611323|592760235|FG005|Overall Study|Lost to Follow-up|0|||
164109076|NCT02611323|592760236|FG006|Overall Study|Lost to Follow-up|3|||
164109077|NCT02611323|592760237|FG007|Overall Study|Lost to Follow-up|0|||
164109078|NCT02611323|592760238|FG008|Overall Study|Lost to Follow-up|0|||
164109079|NCT02611323|592760239|FG009|Overall Study|Lost to Follow-up|0|||
164109080|NCT02611323|592760240|FG010|Overall Study|Lost to Follow-up|2|||
164109081|NCT02611323|592760230|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109082|NCT02611323|592760231|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109083|NCT02611323|592760232|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109084|NCT02611323|592760233|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109085|NCT02611323|592760234|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109086|NCT02611323|592760235|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109087|NCT02611323|592760236|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109088|NCT02611323|592760237|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109089|NCT02611323|592760238|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109090|NCT02611323|592760239|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
164109091|NCT02611323|592760240|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
164109092|NCT02611323|592760230|FG000|Overall Study|Progressive Disease|0|||
164109093|NCT02611323|592760231|FG001|Overall Study|Progressive Disease|0|||
164109094|NCT02611323|592760232|FG002|Overall Study|Progressive Disease|0|||
164109095|NCT02611323|592760233|FG003|Overall Study|Progressive Disease|0|||
164109096|NCT02611323|592760234|FG004|Overall Study|Progressive Disease|0|||
164109097|NCT02611323|592760235|FG005|Overall Study|Progressive Disease|0|||
164109098|NCT02611323|592760236|FG006|Overall Study|Progressive Disease|0|||
164109099|NCT02611323|592760237|FG007|Overall Study|Progressive Disease|0|||
164109100|NCT02611323|592760238|FG008|Overall Study|Progressive Disease|0|||
164109101|NCT02611323|592760239|FG009|Overall Study|Progressive Disease|0|||
164109102|NCT02611323|592760240|FG010|Overall Study|Progressive Disease|1|||
164109103|NCT02611323|592760230|FG000|Overall Study|Withdrawal by Subject|1|||
164109104|NCT02611323|592760231|FG001|Overall Study|Withdrawal by Subject|0|||
164109105|NCT02611323|592760232|FG002|Overall Study|Withdrawal by Subject|0|||
164109106|NCT02611323|592760233|FG003|Overall Study|Withdrawal by Subject|0|||
164109107|NCT02611323|592760234|FG004|Overall Study|Withdrawal by Subject|0|||
164109108|NCT02611323|592760235|FG005|Overall Study|Withdrawal by Subject|0|||
164109109|NCT02611323|592760236|FG006|Overall Study|Withdrawal by Subject|0|||
164109110|NCT02611323|592760237|FG007|Overall Study|Withdrawal by Subject|1|||
164109111|NCT02611323|592760238|FG008|Overall Study|Withdrawal by Subject|0|||
164109112|NCT02611323|592760239|FG009|Overall Study|Withdrawal by Subject|1|||
164109113|NCT02611323|592760240|FG010|Overall Study|Withdrawal by Subject|0|||
164109114|NCT01899053|592760241|FG000|Overall Study|Progressive Disease|4|||
164109115|NCT01899053|592760242|FG001|Overall Study|Progressive Disease|0|||
164109116|NCT01899053|592760243|FG002|Overall Study|Progressive Disease|3|||
164109117|NCT01899053|592760244|FG003|Overall Study|Progressive Disease|0|||
164109118|NCT01899053|592760245|FG004|Overall Study|Progressive Disease|3|||
164109119|NCT01899053|592760246|FG005|Overall Study|Progressive Disease|1|||
164109120|NCT01899053|592760247|FG006|Overall Study|Progressive Disease|1|||
164109121|NCT01899053|592760248|FG007|Overall Study|Progressive Disease|1|||
164109122|NCT01899053|592760249|FG008|Overall Study|Progressive Disease|4|||
164109123|NCT01899053|592760250|FG009|Overall Study|Progressive Disease|3|||
164109124|NCT01899053|592760251|FG010|Overall Study|Progressive Disease|12|||
164109125|NCT01899053|592760252|FG011|Overall Study|Progressive Disease|5|||
164109126|NCT01899053|592760253|FG012|Overall Study|Progressive Disease|8|||
164109127|NCT01899053|592760254|FG013|Overall Study|Progressive Disease|17|||
164109128|NCT01899053|592760241|FG000|Overall Study|Adverse Event|1|||
164109129|NCT01899053|592760242|FG001|Overall Study|Adverse Event|1|||
164109130|NCT01899053|592760243|FG002|Overall Study|Adverse Event|1|||
164109131|NCT01899053|592760244|FG003|Overall Study|Adverse Event|3|||
164109132|NCT01899053|592760245|FG004|Overall Study|Adverse Event|1|||
164109133|NCT01899053|592760246|FG005|Overall Study|Adverse Event|1|||
164109134|NCT01899053|592760247|FG006|Overall Study|Adverse Event|1|||
164109135|NCT01899053|592760248|FG007|Overall Study|Adverse Event|0|||
164109136|NCT01899053|592760249|FG008|Overall Study|Adverse Event|2|||
164109137|NCT01899053|592760250|FG009|Overall Study|Adverse Event|0|||
164109138|NCT01899053|592760251|FG010|Overall Study|Adverse Event|3|||
164109139|NCT01899053|592760252|FG011|Overall Study|Adverse Event|1|||
164109140|NCT01899053|592760253|FG012|Overall Study|Adverse Event|2|||
164109141|NCT01899053|592760254|FG013|Overall Study|Adverse Event|2|||
164109142|NCT01899053|592760241|FG000|Overall Study|Reason Not Specified|0|||
164109143|NCT01899053|592760242|FG001|Overall Study|Reason Not Specified|0|||
164109144|NCT01899053|592760243|FG002|Overall Study|Reason Not Specified|0|||
164109145|NCT01899053|592760244|FG003|Overall Study|Reason Not Specified|0|||
164109146|NCT01899053|592760245|FG004|Overall Study|Reason Not Specified|0|||
164109147|NCT01899053|592760246|FG005|Overall Study|Reason Not Specified|0|||
164109148|NCT01899053|592760247|FG006|Overall Study|Reason Not Specified|1|||
164109149|NCT01899053|592760248|FG007|Overall Study|Reason Not Specified|0|||
164109150|NCT01899053|592760249|FG008|Overall Study|Reason Not Specified|0|||
164109151|NCT01899053|592760250|FG009|Overall Study|Reason Not Specified|0|||
164109152|NCT01899053|592760251|FG010|Overall Study|Reason Not Specified|0|||
164109153|NCT01899053|592760252|FG011|Overall Study|Reason Not Specified|0|||
164109154|NCT01899053|592760253|FG012|Overall Study|Reason Not Specified|1|||
164109155|NCT01899053|592760254|FG013|Overall Study|Reason Not Specified|0|||
164109156|NCT01899053|592760241|FG000|Overall Study|Withdrawal by Subject|1|||
164109157|NCT01899053|592760242|FG001|Overall Study|Withdrawal by Subject|1|||
164109158|NCT01899053|592760243|FG002|Overall Study|Withdrawal by Subject|2|||
164109159|NCT01899053|592760244|FG003|Overall Study|Withdrawal by Subject|0|||
164109160|NCT01899053|592760245|FG004|Overall Study|Withdrawal by Subject|2|||
164109161|NCT01899053|592760246|FG005|Overall Study|Withdrawal by Subject|0|||
164109162|NCT01899053|592760247|FG006|Overall Study|Withdrawal by Subject|0|||
164109163|NCT01899053|592760248|FG007|Overall Study|Withdrawal by Subject|1|||
164109164|NCT01899053|592760249|FG008|Overall Study|Withdrawal by Subject|0|||
164109165|NCT01899053|592760250|FG009|Overall Study|Withdrawal by Subject|0|||
164109166|NCT01899053|592760251|FG010|Overall Study|Withdrawal by Subject|0|||
164109167|NCT01899053|592760252|FG011|Overall Study|Withdrawal by Subject|0|||
164109168|NCT01899053|592760253|FG012|Overall Study|Withdrawal by Subject|1|||
164109169|NCT01899053|592760254|FG013|Overall Study|Withdrawal by Subject|1|||
164109170|NCT01899053|592760241|FG000|Overall Study|Protocol Violation|0|||
164109171|NCT01899053|592760242|FG001|Overall Study|Protocol Violation|0|||
164109172|NCT01899053|592760243|FG002|Overall Study|Protocol Violation|1|||
164109173|NCT01899053|592760244|FG003|Overall Study|Protocol Violation|0|||
164109174|NCT01899053|592760245|FG004|Overall Study|Protocol Violation|0|||
164109175|NCT01899053|592760246|FG005|Overall Study|Protocol Violation|0|||
164109176|NCT01899053|592760247|FG006|Overall Study|Protocol Violation|0|||
164109177|NCT01899053|592760248|FG007|Overall Study|Protocol Violation|0|||
164109178|NCT01899053|592760249|FG008|Overall Study|Protocol Violation|0|||
164109179|NCT01899053|592760250|FG009|Overall Study|Protocol Violation|0|||
164109180|NCT01899053|592760251|FG010|Overall Study|Protocol Violation|0|||
164109181|NCT01899053|592760252|FG011|Overall Study|Protocol Violation|0|||
164109182|NCT01899053|592760253|FG012|Overall Study|Protocol Violation|0|||
164109183|NCT01899053|592760254|FG013|Overall Study|Protocol Violation|0|||
164109184|NCT01899053|592760241|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
164109185|NCT01899053|592760242|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
164109186|NCT01899053|592760243|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109187|NCT01899053|592760244|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109188|NCT01899053|592760245|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109189|NCT01899053|592760246|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109190|NCT01899053|592760247|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109191|NCT01899053|592760248|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109192|NCT01899053|592760249|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109193|NCT01899053|592760250|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109194|NCT01899053|592760251|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
164109195|NCT01899053|592760252|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109196|NCT01899053|592760253|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109197|NCT01899053|592760254|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
164109198|NCT01899053|592760241|FG000|Overall Study|Symptomatic Deterioration|0|||
164109199|NCT01899053|592760242|FG001|Overall Study|Symptomatic Deterioration|0|||
164109200|NCT01899053|592760243|FG002|Overall Study|Symptomatic Deterioration|0|||
164109201|NCT01899053|592760244|FG003|Overall Study|Symptomatic Deterioration|0|||
164109202|NCT01899053|592760245|FG004|Overall Study|Symptomatic Deterioration|0|||
164109203|NCT01899053|592760246|FG005|Overall Study|Symptomatic Deterioration|1|||
164109204|NCT01899053|592760247|FG006|Overall Study|Symptomatic Deterioration|0|||
164109205|NCT01899053|592760248|FG007|Overall Study|Symptomatic Deterioration|1|||
164109206|NCT01899053|592760249|FG008|Overall Study|Symptomatic Deterioration|0|||
164109207|NCT01899053|592760250|FG009|Overall Study|Symptomatic Deterioration|0|||
164109208|NCT01899053|592760251|FG010|Overall Study|Symptomatic Deterioration|0|||
164109209|NCT01899053|592760252|FG011|Overall Study|Symptomatic Deterioration|1|||
164109210|NCT01899053|592760253|FG012|Overall Study|Symptomatic Deterioration|2|||
164109211|NCT01899053|592760254|FG013|Overall Study|Symptomatic Deterioration|0|||
164109212|NCT03531827|592760259|FG000|Overall Study|Adverse Event|2|||
164109213|NCT03531827|592760260|FG001|Overall Study|Adverse Event|0|||
164109214|NCT03531827|592760259|FG000|Overall Study|Progressive disease|1|||
164109215|NCT03531827|592760260|FG001|Overall Study|Progressive disease|0|||
164109216|NCT03500094|592760264|FG000|Overall Study|Withdrawal by Subject|1|||
164109217|NCT03500094|592760264|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
164109218|NCT03500094|592760264|FG000|Overall Study|Lost to Follow-up|1|||
164109219|NCT01891357|592760265|FG000|Overall Study|Protocol Violation|3|||
164109220|NCT00557245|592762101|FG000|Overall Study|Lost to Follow-up|7|||
164109221|NCT00557245|592762102|FG001|Overall Study|Lost to Follow-up|8|||
164109222|NCT00557245|592762103|FG002|Overall Study|Lost to Follow-up|10|||
164109223|NCT00557245|592762101|FG000|Overall Study|Ineligible|5|||
164109224|NCT00557245|592762102|FG001|Overall Study|Ineligible|4|||
164109225|NCT00557245|592762103|FG002|Overall Study|Ineligible|2|||
164109226|NCT02658019|592762104|FG000|Overall Study|Adverse Event|1|||
164109227|NCT02316223|592762106|FG000|Overall Study|Lack of Efficacy|0|||
164109228|NCT02316223|592762107|FG001|Overall Study|Lack of Efficacy|1|||
164109229|NCT02316223|592762108|FG002|Overall Study|Lack of Efficacy|1|||
164109230|NCT02316223|592762106|FG000|Overall Study|Lost to Follow-up|27|||
164109231|NCT02316223|592762107|FG001|Overall Study|Lost to Follow-up|34|||
164109232|NCT02316223|592762108|FG002|Overall Study|Lost to Follow-up|36|||
164109233|NCT02316223|592762106|FG000|Overall Study|COPD Diagnosis|3|||
164109234|NCT02316223|592762107|FG001|Overall Study|COPD Diagnosis|2|||
164109235|NCT02316223|592762108|FG002|Overall Study|COPD Diagnosis|3|||
164109236|NCT02316223|592762106|FG000|Overall Study|Reside outside study area|1|||
164109237|NCT02316223|592762107|FG001|Overall Study|Reside outside study area|1|||
164109238|NCT02316223|592762108|FG002|Overall Study|Reside outside study area|1|||
164109239|NCT02316223|592762106|FG000|Overall Study|No asthma|2|||
164109240|NCT02316223|592762107|FG001|Overall Study|No asthma|0|||
164109241|NCT02316223|592762108|FG002|Overall Study|No asthma|0|||
164109242|NCT02316223|592762106|FG000|Overall Study|Discontinued by PI|11|||
164109243|NCT02316223|592762107|FG001|Overall Study|Discontinued by PI|19|||
164109244|NCT02316223|592762108|FG002|Overall Study|Discontinued by PI|3|||
164109245|NCT03234907|592762110|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
164109246|NCT03234907|592762111|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
164109247|NCT03234907|592762112|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164109248|NCT03234907|592762113|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164109249|NCT03234907|592762114|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164109250|NCT03234907|592762115|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
164109251|NCT03234907|592762110|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
164109252|NCT03234907|592762111|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
164109253|NCT03234907|592762112|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164109254|NCT03234907|592762113|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164109255|NCT03234907|592762114|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164109256|NCT03234907|592762115|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
164109257|NCT03234907|592762110|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
164109258|NCT03234907|592762111|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164109259|NCT03234907|592762112|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164109260|NCT03234907|592762113|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164109261|NCT03234907|592762114|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164109262|NCT03234907|592762115|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
164109263|NCT03234907|592762110|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
164109264|NCT03234907|592762111|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
164109265|NCT03234907|592762112|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164109266|NCT03234907|592762113|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164109267|NCT03234907|592762114|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164109268|NCT03234907|592762115|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
164109269|NCT03234907|592762110|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
164109270|NCT03234907|592762111|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
164109271|NCT03234907|592762112|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
164109272|NCT03234907|592762113|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
164109273|NCT03234907|592762114|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
164109274|NCT03234907|592762115|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
164109275|NCT03234907|592762110|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
164109276|NCT03234907|592762111|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
164109277|NCT03234907|592762112|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
164109278|NCT03234907|592762113|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
164109279|NCT03234907|592762114|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
164109280|NCT03234907|592762115|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
164109281|NCT03234907|592762110|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
164109282|NCT03234907|592762111|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
164109283|NCT03234907|592762112|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
164109284|NCT03234907|592762113|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
164109285|NCT03234907|592762114|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
164109286|NCT03234907|592762115|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
164109287|NCT02986139|592762118|FG000|Overall Study|Sponsor Decision|1|||
164109288|NCT02986139|592762119|FG001|Overall Study|Sponsor Decision|2|||
164109289|NCT02986139|592762118|FG000|Overall Study|Withdrawal by Subject|0|||
164109290|NCT02986139|592762119|FG001|Overall Study|Withdrawal by Subject|1|||
164109291|NCT02986139|592762118|FG000|Overall Study|Lost to Follow-up|0|||
164109292|NCT02986139|592762119|FG001|Overall Study|Lost to Follow-up|1|||
164109293|NCT02583048|592762120|FG000|Overall Study|Withdrawal by Subject|0|||
164109294|NCT02583048|592762121|FG001|Overall Study|Withdrawal by Subject|1|||
164109295|NCT02583048|592762122|FG002|Overall Study|Withdrawal by Subject|0|||
164109296|NCT02583048|592762120|FG000|Overall Study|Failed to meet eligibility criterion|0|||
164109297|NCT02583048|592762121|FG001|Overall Study|Failed to meet eligibility criterion|0|||
164109298|NCT02583048|592762122|FG002|Overall Study|Failed to meet eligibility criterion|1|||
164109299|NCT00414726|592762126|FG000|Overall Study|Withdrawal by Subject|0|||
164109300|NCT00414726|592762127|FG001|Overall Study|Withdrawal by Subject|1|||
164109301|NCT02107196|592762128|FG000|12-week Treatment Period|Adverse Event|6|||
164109302|NCT02107196|592762129|FG001|12-week Treatment Period|Adverse Event|3|||
164109303|NCT02107196|592762128|FG000|12-week Treatment Period|Lack of Efficacy|2|||
164109304|NCT02107196|592762129|FG001|12-week Treatment Period|Lack of Efficacy|1|||
164109305|NCT02107196|592762128|FG000|12-week Treatment Period|Lost to Follow-up|3|||
164109306|NCT02107196|592762129|FG001|12-week Treatment Period|Lost to Follow-up|6|||
164109307|NCT02107196|592762128|FG000|12-week Treatment Period|Physician Decision|0|||
164109308|NCT02107196|592762129|FG001|12-week Treatment Period|Physician Decision|1|||
164109309|NCT02107196|592762128|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
164109310|NCT02107196|592762129|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
164109311|NCT02107196|592762128|FG000|12-week Treatment Period|Protocol Violation|7|||
164109312|NCT02107196|592762129|FG001|12-week Treatment Period|Protocol Violation|8|||
164109313|NCT02107196|592762128|FG000|12-week Treatment Period|Reason Missing|11|||
164109314|NCT02107196|592762129|FG001|12-week Treatment Period|Reason Missing|8|||
164109315|NCT02107196|592762128|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
164109316|NCT02107196|592762129|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
164109317|NCT02107196|592762128|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
164109318|NCT02107196|592762129|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
164109319|NCT02107196|592762128|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
164109320|NCT02107196|592762129|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
164109321|NCT02107196|592762128|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
164109322|NCT02107196|592762129|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
164109323|NCT00516295|592762130|FG000|Overall Study|Lack of Efficacy|2|||
164109324|NCT00516295|592762131|FG001|Overall Study|Lack of Efficacy|0|||
164109325|NCT00516295|592762132|FG002|Overall Study|Lack of Efficacy|0|||
164109326|NCT00516295|592762130|FG000|Overall Study|Ineligible|1|||
164109327|NCT00516295|592762131|FG001|Overall Study|Ineligible|0|||
164109328|NCT00516295|592762132|FG002|Overall Study|Ineligible|0|||
164109329|NCT00660660|592762137|FG000|Overall Study|Adverse Event|1|||
164109330|NCT00660660|592762138|FG001|Overall Study|Adverse Event|0|||
164109331|NCT00660660|592762137|FG000|Overall Study|Lost to Follow-up|0|||
164109332|NCT00660660|592762138|FG001|Overall Study|Lost to Follow-up|6|||
164109333|NCT00660660|592762137|FG000|Overall Study|Lack of Efficacy|0|||
164109334|NCT00660660|592762138|FG001|Overall Study|Lack of Efficacy|2|||
164109335|NCT00660660|592762137|FG000|Overall Study|Withdrawal by Subject|3|||
164109336|NCT00660660|592762138|FG001|Overall Study|Withdrawal by Subject|0|||
164109337|NCT00660660|592762137|FG000|Overall Study|Incorrect enrollment and other|0|||
164109338|NCT00660660|592762138|FG001|Overall Study|Incorrect enrollment and other|1|||
164109339|NCT00660660|592762137|FG000|Overall Study|New medication after randomization|1|||
164109340|NCT00660660|592762138|FG001|Overall Study|New medication after randomization|0|||
164109341|NCT02651987|592762139|FG000|Overall Study|Adverse Event|2|||
164109342|NCT02651987|592762140|FG001|Overall Study|Adverse Event|2|||
164109343|NCT02651987|592762139|FG000|Overall Study|Consent Withdrawn|2|||
164109344|NCT02651987|592762140|FG001|Overall Study|Consent Withdrawn|0|||
164109345|NCT02651987|592762139|FG000|Overall Study|Local PD|0|||
164109346|NCT02651987|592762140|FG001|Overall Study|Local PD|2|||
164109347|NCT02651987|592762139|FG000|Overall Study|Investigator Decision|1|||
164109348|NCT02651987|592762140|FG001|Overall Study|Investigator Decision|1|||
164109349|NCT01630616|592762141|FG000|Overall Study|Adverse Event|0|||
164109350|NCT01630616|592762142|FG001|Overall Study|Adverse Event|0|||
164109351|NCT01630616|592762143|FG002|Overall Study|Adverse Event|0|||
164109352|NCT01630616|592762144|FG003|Overall Study|Adverse Event|1|||
164109353|NCT01630616|592762145|FG004|Overall Study|Adverse Event|0|||
164109354|NCT01630616|592762146|FG005|Overall Study|Adverse Event|0|||
164109355|NCT01630616|592762141|FG000|Overall Study|Withdrawal by Subject|0|||
164109356|NCT01630616|592762142|FG001|Overall Study|Withdrawal by Subject|0|||
164109357|NCT01630616|592762143|FG002|Overall Study|Withdrawal by Subject|0|||
164109358|NCT01630616|592762144|FG003|Overall Study|Withdrawal by Subject|2|||
164109359|NCT01630616|592762145|FG004|Overall Study|Withdrawal by Subject|0|||
164109360|NCT01630616|592762146|FG005|Overall Study|Withdrawal by Subject|0|||
164109361|NCT02725515|592762147|FG000|Overall Study|Refused infusion (no study treatment)|1|||
164148736|NCT03207867|592904941|FG005|Overall Study|Progressive Disease|10|||
164109362|NCT02725515|592762148|FG001|Overall Study|Refused infusion (no study treatment)|0|||
164109363|NCT02725515|592762147|FG000|Overall Study|Loss of Improvement per Protocol|14|||
164109364|NCT02725515|592762148|FG001|Overall Study|Loss of Improvement per Protocol|25|||
164109365|NCT02725515|592762147|FG000|Overall Study|Withdrawal by Subject|2|||
164109366|NCT02725515|592762148|FG001|Overall Study|Withdrawal by Subject|1|||
164109367|NCT02725515|592762147|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164109368|NCT02725515|592762148|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164109369|NCT02725515|592762147|FG000|Overall Study|Lost to Follow-up|1|||
164109370|NCT02725515|592762148|FG001|Overall Study|Lost to Follow-up|1|||
164109371|NCT02725515|592762147|FG000|Overall Study|Adverse Event|7|||
164109372|NCT02725515|592762148|FG001|Overall Study|Adverse Event|2|||
164109373|NCT02725515|592762147|FG000|Overall Study|No Documented Disease Improvement|0|||
164109374|NCT02725515|592762148|FG001|Overall Study|No Documented Disease Improvement|1|||
164109375|NCT02725515|592762147|FG000|Overall Study|Completed Study Under Original Protocol|0|||
164109376|NCT02725515|592762148|FG001|Overall Study|Completed Study Under Original Protocol|1|||
164109377|NCT02725515|592762147|FG000|Overall Study|Lack of Response|0|||
164109378|NCT02725515|592762148|FG001|Overall Study|Lack of Response|1|||
164109379|NCT00640393|592762154|FG000|Part 1|Lost to Follow-up|2|||
164109380|NCT00640393|592762155|FG001|Part 1|Lost to Follow-up|0|||
164109381|NCT00640393|592762156|FG002|Part 1|Lost to Follow-up|0|||
164109382|NCT00640393|592762154|FG000|Part 1|Withdrawal by Subject|3|||
164109383|NCT00640393|592762155|FG001|Part 1|Withdrawal by Subject|0|||
164109384|NCT00640393|592762156|FG002|Part 1|Withdrawal by Subject|0|||
164109385|NCT00640393|592762154|FG000|Randomization|Withdrawn per protocol|17|||
164109386|NCT00640393|592762155|FG001|Randomization|Withdrawn per protocol|0|||
164109387|NCT00640393|592762156|FG002|Randomization|Withdrawn per protocol|0|||
164109388|NCT00640393|592762154|FG000|Randomization|Never randomized by site|2|||
164109389|NCT00640393|592762155|FG001|Randomization|Never randomized by site|0|||
164109390|NCT00640393|592762156|FG002|Randomization|Never randomized by site|0|||
164109391|NCT00640393|592762154|FG000|Part 2|Lost to Follow-up|0|||
164109392|NCT00640393|592762155|FG001|Part 2|Lost to Follow-up|2|||
164109393|NCT00640393|592762156|FG002|Part 2|Lost to Follow-up|2|||
164109394|NCT00640393|592762154|FG000|Part 2|Withdrawal by Subject|0|||
164109395|NCT00640393|592762155|FG001|Part 2|Withdrawal by Subject|6|||
164109396|NCT00640393|592762156|FG002|Part 2|Withdrawal by Subject|1|||
164109397|NCT00640393|592762154|FG000|Part 2|Non-adherence|0|||
164109398|NCT00640393|592762155|FG001|Part 2|Non-adherence|1|||
164109399|NCT00640393|592762156|FG002|Part 2|Non-adherence|0|||
164109400|NCT00640393|592762154|FG000|Part 2|Adverse Event|0|||
164109401|NCT00640393|592762155|FG001|Part 2|Adverse Event|1|||
164109402|NCT00640393|592762156|FG002|Part 2|Adverse Event|0|||
164109403|NCT01380782|592762157|FG000|Overall Study|Adverse Event|0|||
164109404|NCT01380782|592762158|FG001|Overall Study|Adverse Event|1|||
164109405|NCT01380782|592762159|FG002|Overall Study|Adverse Event|0|||
164109406|NCT01380782|592762160|FG003|Overall Study|Adverse Event|0|||
164109407|NCT01380782|592762157|FG000|Overall Study|Death|1|||
164109408|NCT01380782|592762158|FG001|Overall Study|Death|0|||
164109409|NCT01380782|592762159|FG002|Overall Study|Death|0|||
164109410|NCT01380782|592762160|FG003|Overall Study|Death|0|||
164109411|NCT01380782|592762157|FG000|Overall Study|Lack of Efficacy|10|||
164109412|NCT01380782|592762158|FG001|Overall Study|Lack of Efficacy|9|||
164109413|NCT01380782|592762159|FG002|Overall Study|Lack of Efficacy|10|||
164109414|NCT01380782|592762160|FG003|Overall Study|Lack of Efficacy|3|||
164109415|NCT01380782|592762157|FG000|Overall Study|Physician Decision|1|||
164109416|NCT01380782|592762158|FG001|Overall Study|Physician Decision|0|||
164109417|NCT01380782|592762159|FG002|Overall Study|Physician Decision|0|||
164109418|NCT01380782|592762160|FG003|Overall Study|Physician Decision|0|||
164109419|NCT01380782|592762157|FG000|Overall Study|Withdrawal by Subject|0|||
164109420|NCT01380782|592762158|FG001|Overall Study|Withdrawal by Subject|0|||
164109421|NCT01380782|592762159|FG002|Overall Study|Withdrawal by Subject|1|||
164109422|NCT01380782|592762160|FG003|Overall Study|Withdrawal by Subject|1|||
164109423|NCT01403194|592762164|FG000|Overall Study|Screen Failure|2|||
164109424|NCT01403194|592762164|FG000|Overall Study|Lost to Follow-up|8|||
164109425|NCT01701063|592762165|FG000|Overall Study|Lost to Follow-up|0|||
164109426|NCT01701063|592762166|FG001|Overall Study|Lost to Follow-up|1|||
164109427|NCT01701063|592762167|FG002|Overall Study|Lost to Follow-up|0|||
164109428|NCT01701063|592762165|FG000|Overall Study|Withdrawal by Subject|0|||
164109429|NCT01701063|592762166|FG001|Overall Study|Withdrawal by Subject|0|||
164109430|NCT01701063|592762167|FG002|Overall Study|Withdrawal by Subject|1|||
164109431|NCT01701063|592762165|FG000|Overall Study|Other|0|||
164109432|NCT01701063|592762166|FG001|Overall Study|Other|0|||
164109433|NCT01701063|592762167|FG002|Overall Study|Other|1|||
164109434|NCT03428750|592762168|FG000|Overall Study|Withdrawal by Subject|11|||
164109435|NCT03428750|592762169|FG001|Overall Study|Withdrawal by Subject|10|||
164109436|NCT03428750|592762168|FG000|Overall Study|Lost to Follow-up|3|||
164109437|NCT03428750|592762169|FG001|Overall Study|Lost to Follow-up|9|||
164109438|NCT03428750|592762168|FG000|Overall Study|Adverse Event|9|||
164109439|NCT03428750|592762169|FG001|Overall Study|Adverse Event|1|||
164109440|NCT03428750|592762168|FG000|Overall Study|Protocol Violation|1|||
164109441|NCT03428750|592762169|FG001|Overall Study|Protocol Violation|0|||
164109442|NCT03428750|592762168|FG000|Overall Study|Administrative|0|||
164109443|NCT03428750|592762169|FG001|Overall Study|Administrative|1|||
164109444|NCT00274651|592762172|FG000|Overall Study|Adverse Event|6|||
164109445|NCT00274651|592762173|FG001|Overall Study|Adverse Event|3|||
164109446|NCT00274651|592762172|FG000|Overall Study|Lack of Efficacy|13|||
164109447|NCT00274651|592762173|FG001|Overall Study|Lack of Efficacy|6|||
164109448|NCT00274651|592762172|FG000|Overall Study|Death|1|||
164109449|NCT00274651|592762173|FG001|Overall Study|Death|3|||
164109450|NCT00274651|592762172|FG000|Overall Study|Withdrawal by Subject|0|||
164109451|NCT00274651|592762173|FG001|Overall Study|Withdrawal by Subject|1|||
164109452|NCT00274651|592762172|FG000|Overall Study|Physician Decision|8|||
164109453|NCT00274651|592762173|FG001|Overall Study|Physician Decision|7|||
164109454|NCT04474405|592762174|FG000|Overall Study|Withdrawal by Subject|0|||
164109455|NCT04474405|592762175|FG001|Overall Study|Withdrawal by Subject|0|||
164109456|NCT04474405|592762176|FG002|Overall Study|Withdrawal by Subject|1|||
164109457|NCT04474405|592762177|FG003|Overall Study|Withdrawal by Subject|0|||
164109458|NCT04474405|592762178|FG004|Overall Study|Withdrawal by Subject|1|||
164109459|NCT04474405|592762179|FG005|Overall Study|Withdrawal by Subject|0|||
164109460|NCT04474405|592762174|FG000|Overall Study|Other|0|||
164109461|NCT04474405|592762175|FG001|Overall Study|Other|0|||
164109462|NCT04474405|592762176|FG002|Overall Study|Other|0|||
164109463|NCT04474405|592762177|FG003|Overall Study|Other|0|||
164109464|NCT04474405|592762178|FG004|Overall Study|Other|3|||
164109465|NCT04474405|592762179|FG005|Overall Study|Other|0|||
164109466|NCT03446768|592762180|FG000|Overall Study|Withdrawal by Subject|0|||
164109467|NCT03446768|592762181|FG001|Overall Study|Withdrawal by Subject|1|||
164109468|NCT01604941|592762185|FG000|Overall Study|Adverse Event|1|||
164109469|NCT01604941|592762186|FG001|Overall Study|Adverse Event|2|||
164109470|NCT01604941|592762187|FG002|Overall Study|Adverse Event|0|||
164109471|NCT01604941|592762188|FG003|Overall Study|Adverse Event|0|||
164109472|NCT01604941|592762189|FG004|Overall Study|Adverse Event|1|||
164109473|NCT01604941|592762190|FG005|Overall Study|Adverse Event|5|||
164109474|NCT01604941|592762185|FG000|Overall Study|Non-compliance|1|||
164109475|NCT01604941|592762186|FG001|Overall Study|Non-compliance|0|||
164109476|NCT01604941|592762187|FG002|Overall Study|Non-compliance|0|||
164109477|NCT01604941|592762188|FG003|Overall Study|Non-compliance|0|||
164109478|NCT01604941|592762189|FG004|Overall Study|Non-compliance|0|||
164109479|NCT01604941|592762190|FG005|Overall Study|Non-compliance|0|||
164109480|NCT01604941|592762185|FG000|Overall Study|Participant Decision|0|||
164109481|NCT01604941|592762186|FG001|Overall Study|Participant Decision|0|||
164109482|NCT01604941|592762187|FG002|Overall Study|Participant Decision|0|||
164109483|NCT01604941|592762188|FG003|Overall Study|Participant Decision|0|||
164109484|NCT01604941|592762189|FG004|Overall Study|Participant Decision|0|||
164109485|NCT01604941|592762190|FG005|Overall Study|Participant Decision|2|||
164109486|NCT01604941|592762185|FG000|Overall Study|Early Study Termination|9|||
164109487|NCT01604941|592762186|FG001|Overall Study|Early Study Termination|2|||
164109488|NCT01604941|592762187|FG002|Overall Study|Early Study Termination|3|||
164109489|NCT01604941|592762188|FG003|Overall Study|Early Study Termination|3|||
164109490|NCT01604941|592762189|FG004|Overall Study|Early Study Termination|0|||
164109491|NCT01604941|592762190|FG005|Overall Study|Early Study Termination|0|||
164109492|NCT01410227|592762191|FG000|Overall Study|Adverse Event|1|||
164109493|NCT01410227|592762192|FG001|Overall Study|Adverse Event|0|||
164109494|NCT01410227|592762193|FG002|Overall Study|Adverse Event|0|||
164109495|NCT01410227|592762194|FG003|Overall Study|Adverse Event|0|||
164109496|NCT01410227|592762191|FG000|Overall Study|Withdrawal by Subject|3|||
164109497|NCT01410227|592762192|FG001|Overall Study|Withdrawal by Subject|0|||
164109498|NCT01410227|592762193|FG002|Overall Study|Withdrawal by Subject|1|||
164109499|NCT01410227|592762194|FG003|Overall Study|Withdrawal by Subject|0|||
164109500|NCT01410227|592762191|FG000|Overall Study|Pregnancy|0|||
164109501|NCT01410227|592762192|FG001|Overall Study|Pregnancy|0|||
164109502|NCT01410227|592762193|FG002|Overall Study|Pregnancy|0|||
164109503|NCT01410227|592762194|FG003|Overall Study|Pregnancy|1|||
164109504|NCT01410227|592762191|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
164109505|NCT01410227|592762192|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
164109506|NCT01410227|592762193|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
164109507|NCT01410227|592762194|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
164109508|NCT00606281|592762195|FG000|Overall Study|Adverse Event|11|||
164109509|NCT00606281|592762196|FG001|Overall Study|Adverse Event|12|||
164109510|NCT00606281|592762195|FG000|Overall Study|Death|1|||
164109511|NCT00606281|592762196|FG001|Overall Study|Death|0|||
164109512|NCT00606281|592762195|FG000|Overall Study|Lack of Efficacy|28|||
164109513|NCT00606281|592762196|FG001|Overall Study|Lack of Efficacy|35|||
164109514|NCT00606281|592762195|FG000|Overall Study|Physician Decision|0|||
164109515|NCT00606281|592762196|FG001|Overall Study|Physician Decision|1|||
164109516|NCT00606281|592762195|FG000|Overall Study|Protocol Violation|3|||
164109517|NCT00606281|592762196|FG001|Overall Study|Protocol Violation|3|||
164109518|NCT00606281|592762195|FG000|Overall Study|Withdrawal by Subject|11|||
164109519|NCT00606281|592762196|FG001|Overall Study|Withdrawal by Subject|13|||
164109520|NCT00606281|592762195|FG000|Overall Study|Progression to depressive phase|1|||
164109521|NCT00606281|592762196|FG001|Overall Study|Progression to depressive phase|1|||
164109522|NCT00606281|592762195|FG000|Overall Study|Change of residence or other commitments|1|||
164109523|NCT00606281|592762196|FG001|Overall Study|Change of residence or other commitments|1|||
164109524|NCT00540423|592762198|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164109525|NCT00540423|592762199|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164109526|NCT00540423|592762200|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164109527|NCT00540423|592762198|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
164109528|NCT00540423|592762199|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
164109529|NCT00540423|592762200|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
164109530|NCT03131895|592762201|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
164109531|NCT03131895|592762202|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
164109532|NCT03131895|592762203|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
164109533|NCT03131895|592762204|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
164109534|NCT03131895|592762201|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
164109535|NCT03131895|592762202|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
164109536|NCT03131895|592762203|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
164109537|NCT03131895|592762204|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
164109538|NCT03131895|592762201|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164109539|NCT03131895|592762202|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
164109540|NCT03131895|592762203|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164109541|NCT03131895|592762204|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164109542|NCT03131895|592762201|FG000|Washout Period (at Least 5 Days)|Other|0|||
164109543|NCT03131895|592762202|FG001|Washout Period (at Least 5 Days)|Other|0|||
164109544|NCT03131895|592762203|FG002|Washout Period (at Least 5 Days)|Other|2|||
164109545|NCT03131895|592762204|FG003|Washout Period (at Least 5 Days)|Other|0|||
164109546|NCT03131895|592762201|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
164109547|NCT03131895|592762202|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
164109548|NCT03131895|592762203|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
164109549|NCT03131895|592762204|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
164109550|NCT03131895|592762201|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
164109551|NCT03131895|592762202|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
164109552|NCT03131895|592762203|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
164109553|NCT03131895|592762204|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
164109554|NCT00731939|592762209|FG000|Overall Study|Adverse Event|6|||
164109555|NCT00731939|592762209|FG000|Overall Study|Lost to Follow-up|15|||
164109556|NCT00731939|592762209|FG000|Overall Study|Not implanted with study device|9|||
164109557|NCT00731939|592762209|FG000|Overall Study|Withdrawal by Subject|2|||
164109558|NCT00731939|592762209|FG000|Overall Study|Did not meet enrollment criteria|2|||
164109559|NCT02213263|592762210|FG000|Overall Study|Insufficient clinical response|4|||
164109560|NCT02213263|592762211|FG001|Overall Study|Insufficient clinical response|3|||
164109561|NCT02213263|592762210|FG000|Overall Study|Lost to Follow-up|0|||
164109562|NCT02213263|592762211|FG001|Overall Study|Lost to Follow-up|1|||
164109563|NCT02213263|592762210|FG000|Overall Study|No longer willing to participate|3|||
164109564|NCT02213263|592762211|FG001|Overall Study|No longer willing to participate|4|||
164109565|NCT02213263|592762210|FG000|Overall Study|Progressive disease|20|||
164109566|NCT02213263|592762211|FG001|Overall Study|Progressive disease|14|||
164109567|NCT02213263|592762210|FG000|Overall Study|Protocol Violation|0|||
164109568|NCT02213263|592762211|FG001|Overall Study|Protocol Violation|1|||
164109569|NCT02213263|592762210|FG000|Overall Study|Adverse Event|1|||
164109570|NCT02213263|592762211|FG001|Overall Study|Adverse Event|3|||
164109571|NCT05752721|592762212|FG000|Overall Study|Lost to Follow-up|22|||
164109572|NCT05752721|592762213|FG001|Overall Study|Lost to Follow-up|20|||
164109573|NCT05752721|592762212|FG000|Overall Study|Withdrawal by Subject|15|||
164109574|NCT05752721|592762213|FG001|Overall Study|Withdrawal by Subject|12|||
164109575|NCT00263588|592762214|FG000|Overall Study|Death|54|||
164109576|NCT00263588|592762215|FG001|Overall Study|Death|90|||
164109577|NCT00263588|592762214|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
164109578|NCT00263588|592762215|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
164109579|NCT00263588|592762214|FG000|Overall Study|Lost to Follow-up|7|||
164109580|NCT00263588|592762215|FG001|Overall Study|Lost to Follow-up|10|||
164109581|NCT00263588|592762214|FG000|Overall Study|Withdrawal by Subject|3|||
164109582|NCT00263588|592762215|FG001|Overall Study|Withdrawal by Subject|4|||
164109583|NCT00263588|592762214|FG000|Overall Study|Protocol Violation|0|||
164109584|NCT00263588|592762215|FG001|Overall Study|Protocol Violation|1|||
164109585|NCT00263588|592762214|FG000|Overall Study|Investigator decision|7|||
164109586|NCT00263588|592762215|FG001|Overall Study|Investigator decision|15|||
164109587|NCT00263588|592762214|FG000|Overall Study|Sponsor terminated study|0|||
164109588|NCT00263588|592762215|FG001|Overall Study|Sponsor terminated study|1|||
164109589|NCT01075282|592762223|FG000|Overall Study|Withdrawal by Subject|11|||
164109590|NCT01075282|592762224|FG001|Overall Study|Withdrawal by Subject|7|||
164109591|NCT01075282|592762225|FG002|Overall Study|Withdrawal by Subject|11|||
164109592|NCT01075282|592762223|FG000|Overall Study|Adverse Event|9|||
164109593|NCT01075282|592762224|FG001|Overall Study|Adverse Event|8|||
164109594|NCT01075282|592762225|FG002|Overall Study|Adverse Event|5|||
164109595|NCT01075282|592762223|FG000|Overall Study|Entry Criteria Not Met|3|||
164109596|NCT01075282|592762224|FG001|Overall Study|Entry Criteria Not Met|2|||
164109597|NCT01075282|592762225|FG002|Overall Study|Entry Criteria Not Met|0|||
164109598|NCT01075282|592762223|FG000|Overall Study|Lost to Follow-up|3|||
164109599|NCT01075282|592762224|FG001|Overall Study|Lost to Follow-up|3|||
164109600|NCT01075282|592762225|FG002|Overall Study|Lost to Follow-up|3|||
164109601|NCT01075282|592762223|FG000|Overall Study|Physician Decision|3|||
164109602|NCT01075282|592762224|FG001|Overall Study|Physician Decision|3|||
164109603|NCT01075282|592762225|FG002|Overall Study|Physician Decision|3|||
164109604|NCT01075282|592762223|FG000|Overall Study|Lack of Efficacy|1|||
164109605|NCT01075282|592762224|FG001|Overall Study|Lack of Efficacy|1|||
164109606|NCT01075282|592762225|FG002|Overall Study|Lack of Efficacy|0|||
164109607|NCT01075282|592762223|FG000|Overall Study|Treatment Non-compliance|1|||
164109608|NCT01075282|592762224|FG001|Overall Study|Treatment Non-compliance|2|||
164109609|NCT01075282|592762225|FG002|Overall Study|Treatment Non-compliance|2|||
164109610|NCT01075282|592762223|FG000|Overall Study|Protocol Violation|0|||
164109611|NCT01075282|592762224|FG001|Overall Study|Protocol Violation|2|||
164109612|NCT01075282|592762225|FG002|Overall Study|Protocol Violation|1|||
164109613|NCT01075282|592762223|FG000|Overall Study|Death|0|||
164109614|NCT01075282|592762224|FG001|Overall Study|Death|1|||
164109615|NCT01075282|592762225|FG002|Overall Study|Death|2|||
164109616|NCT00367133|592762226|FG000|2 Years|Death|20|||
164109617|NCT00367133|592762227|FG001|2 Years|Death|12|||
164109618|NCT00367133|592762228|FG002|2 Years|Death|12|||
164109619|NCT00367133|592762226|FG000|2 Years|Dropped|34|||
164109620|NCT00367133|592762227|FG001|2 Years|Dropped|19|||
164109621|NCT00367133|592762228|FG002|2 Years|Dropped|33|||
164109622|NCT00367133|592762226|FG000|2 Years|Missed visit|4|||
164109623|NCT00367133|592762227|FG001|2 Years|Missed visit|5|||
164109624|NCT00367133|592762228|FG002|2 Years|Missed visit|4|||
164109625|NCT00847535|592762229|FG000|Overall Study|Withdrawal by Subject|2|||
164109626|NCT00847535|592762230|FG001|Overall Study|Withdrawal by Subject|1|||
164109627|NCT00847535|592762231|FG002|Overall Study|Withdrawal by Subject|1|||
164109628|NCT00847535|592762229|FG000|Overall Study|Lost to Follow-up|0|||
164109629|NCT00847535|592762230|FG001|Overall Study|Lost to Follow-up|1|||
164109630|NCT00847535|592762231|FG002|Overall Study|Lost to Follow-up|0|||
164109631|NCT00906399|592762232|FG000|Year 1|Randomized But Not Treated|0|||
164109632|NCT00906399|592762233|FG001|Year 1|Randomized But Not Treated|1|||
164109633|NCT00906399|592762234|FG002|Year 1|Randomized But Not Treated|3|||
164109634|NCT00906399|592762235|FG003|Year 1|Randomized But Not Treated|0|||
164109635|NCT00906399|592762236|FG004|Year 1|Randomized But Not Treated|0|||
164109636|NCT00906399|592762237|FG005|Year 1|Randomized But Not Treated|0|||
164109637|NCT00906399|592762238|FG006|Year 1|Randomized But Not Treated|0|||
164109638|NCT00906399|592762232|FG000|Year 1|Adverse Event|4|||
164109639|NCT00906399|592762233|FG001|Year 1|Adverse Event|22|||
164109640|NCT00906399|592762234|FG002|Year 1|Adverse Event|24|||
164109641|NCT00906399|592762235|FG003|Year 1|Adverse Event|0|||
164109642|NCT00906399|592762236|FG004|Year 1|Adverse Event|0|||
164109643|NCT00906399|592762237|FG005|Year 1|Adverse Event|0|||
164109644|NCT00906399|592762238|FG006|Year 1|Adverse Event|0|||
164109645|NCT00906399|592762232|FG000|Year 1|Lost to Follow-up|4|||
164109646|NCT00906399|592762233|FG001|Year 1|Lost to Follow-up|4|||
164109647|NCT00906399|592762234|FG002|Year 1|Lost to Follow-up|2|||
164109648|NCT00906399|592762235|FG003|Year 1|Lost to Follow-up|0|||
164109649|NCT00906399|592762236|FG004|Year 1|Lost to Follow-up|0|||
164109650|NCT00906399|592762237|FG005|Year 1|Lost to Follow-up|0|||
164109651|NCT00906399|592762238|FG006|Year 1|Lost to Follow-up|0|||
164109652|NCT00906399|592762232|FG000|Year 1|Withdrawal by Subject|30|||
164109653|NCT00906399|592762233|FG001|Year 1|Withdrawal by Subject|32|||
164109654|NCT00906399|592762234|FG002|Year 1|Withdrawal by Subject|36|||
164109655|NCT00906399|592762235|FG003|Year 1|Withdrawal by Subject|0|||
164109656|NCT00906399|592762236|FG004|Year 1|Withdrawal by Subject|0|||
164109657|NCT00906399|592762237|FG005|Year 1|Withdrawal by Subject|0|||
164109658|NCT00906399|592762238|FG006|Year 1|Withdrawal by Subject|0|||
164109659|NCT00906399|592762232|FG000|Year 1|Physician Decision|0|||
164109660|NCT00906399|592762233|FG001|Year 1|Physician Decision|1|||
164109661|NCT00906399|592762234|FG002|Year 1|Physician Decision|3|||
164109662|NCT00906399|592762235|FG003|Year 1|Physician Decision|0|||
164109663|NCT00906399|592762236|FG004|Year 1|Physician Decision|0|||
164109664|NCT00906399|592762237|FG005|Year 1|Physician Decision|0|||
164109665|NCT00906399|592762238|FG006|Year 1|Physician Decision|0|||
164109666|NCT00906399|592762232|FG000|Year 1|Death|2|||
164109667|NCT00906399|592762233|FG001|Year 1|Death|1|||
164109668|NCT00906399|592762234|FG002|Year 1|Death|1|||
164109669|NCT00906399|592762235|FG003|Year 1|Death|0|||
164109670|NCT00906399|592762236|FG004|Year 1|Death|0|||
164109671|NCT00906399|592762237|FG005|Year 1|Death|0|||
164109672|NCT00906399|592762238|FG006|Year 1|Death|0|||
164109673|NCT00906399|592762232|FG000|Year 1|Other|4|||
164109674|NCT00906399|592762233|FG001|Year 1|Other|2|||
164109675|NCT00906399|592762234|FG002|Year 1|Other|7|||
164109676|NCT00906399|592762235|FG003|Year 1|Other|0|||
164109677|NCT00906399|592762236|FG004|Year 1|Other|0|||
164109678|NCT00906399|592762237|FG005|Year 1|Other|0|||
164109679|NCT00906399|592762238|FG006|Year 1|Other|0|||
164109680|NCT00906399|592762232|FG000|Year 2|Adverse Event|0|||
164109681|NCT00906399|592762233|FG001|Year 2|Adverse Event|0|||
164109682|NCT00906399|592762234|FG002|Year 2|Adverse Event|0|||
164109683|NCT00906399|592762235|FG003|Year 2|Adverse Event|9|||
164109684|NCT00906399|592762236|FG004|Year 2|Adverse Event|8|||
164109685|NCT00906399|592762237|FG005|Year 2|Adverse Event|11|||
164109686|NCT00906399|592762238|FG006|Year 2|Adverse Event|6|||
164109687|NCT00906399|592762232|FG000|Year 2|Lost to Follow-up|0|||
164109688|NCT00906399|592762233|FG001|Year 2|Lost to Follow-up|0|||
164109689|NCT00906399|592762234|FG002|Year 2|Lost to Follow-up|0|||
164109690|NCT00906399|592762235|FG003|Year 2|Lost to Follow-up|1|||
164109691|NCT00906399|592762236|FG004|Year 2|Lost to Follow-up|4|||
164109692|NCT00906399|592762237|FG005|Year 2|Lost to Follow-up|2|||
164109693|NCT00906399|592762238|FG006|Year 2|Lost to Follow-up|4|||
164109694|NCT00906399|592762232|FG000|Year 2|Withdrawal by Subject|0|||
164109695|NCT00906399|592762233|FG001|Year 2|Withdrawal by Subject|0|||
164109696|NCT00906399|592762234|FG002|Year 2|Withdrawal by Subject|0|||
164109697|NCT00906399|592762235|FG003|Year 2|Withdrawal by Subject|17|||
164109698|NCT00906399|592762236|FG004|Year 2|Withdrawal by Subject|18|||
164109699|NCT00906399|592762237|FG005|Year 2|Withdrawal by Subject|27|||
164109700|NCT00906399|592762238|FG006|Year 2|Withdrawal by Subject|13|||
164109701|NCT00906399|592762232|FG000|Year 2|Physician Decision|0|||
164109702|NCT00906399|592762233|FG001|Year 2|Physician Decision|0|||
164109703|NCT00906399|592762234|FG002|Year 2|Physician Decision|0|||
164109704|NCT00906399|592762235|FG003|Year 2|Physician Decision|0|||
164109705|NCT00906399|592762236|FG004|Year 2|Physician Decision|2|||
164109706|NCT00906399|592762237|FG005|Year 2|Physician Decision|6|||
164109707|NCT00906399|592762238|FG006|Year 2|Physician Decision|3|||
164109708|NCT00906399|592762232|FG000|Year 2|Death|0|||
164109709|NCT00906399|592762233|FG001|Year 2|Death|0|||
164109710|NCT00906399|592762234|FG002|Year 2|Death|0|||
164109711|NCT00906399|592762235|FG003|Year 2|Death|1|||
164109712|NCT00906399|592762236|FG004|Year 2|Death|0|||
164109713|NCT00906399|592762237|FG005|Year 2|Death|0|||
164109714|NCT00906399|592762238|FG006|Year 2|Death|3|||
164109715|NCT00906399|592762232|FG000|Year 2|Other|0|||
164109716|NCT00906399|592762233|FG001|Year 2|Other|0|||
164109717|NCT00906399|592762234|FG002|Year 2|Other|0|||
164109718|NCT00906399|592762235|FG003|Year 2|Other|2|||
164109719|NCT00906399|592762236|FG004|Year 2|Other|3|||
164109720|NCT00906399|592762237|FG005|Year 2|Other|1|||
164109721|NCT00906399|592762238|FG006|Year 2|Other|0|||
164109722|NCT02055547|592762250|FG000|Overall Study|Protocol Violation|0|||
164109723|NCT02055547|592762251|FG001|Overall Study|Protocol Violation|0|||
164109724|NCT02055547|592762252|FG002|Overall Study|Protocol Violation|1|||
164109725|NCT02055547|592762253|FG003|Overall Study|Protocol Violation|0|||
164109726|NCT02055547|592762254|FG004|Overall Study|Protocol Violation|0|||
164109727|NCT02055547|592762255|FG005|Overall Study|Protocol Violation|0|||
164109728|NCT02055547|592762256|FG006|Overall Study|Protocol Violation|1|||
164109729|NCT02055547|592762257|FG007|Overall Study|Protocol Violation|0|||
164109730|NCT02055547|592762258|FG008|Overall Study|Protocol Violation|0|||
164109731|NCT02055547|592762259|FG009|Overall Study|Protocol Violation|0|||
164109732|NCT02055547|592762260|FG010|Overall Study|Protocol Violation|0|||
164109733|NCT02055547|592762261|FG011|Overall Study|Protocol Violation|0|||
164109734|NCT02055547|592762262|FG012|Overall Study|Protocol Violation|0|||
164109735|NCT02055547|592762263|FG013|Overall Study|Protocol Violation|0|||
164109736|NCT02055547|592762264|FG014|Overall Study|Protocol Violation|0|||
164109737|NCT02055547|592762265|FG015|Overall Study|Protocol Violation|0|||
164109738|NCT02055547|592762266|FG016|Overall Study|Protocol Violation|0|||
164109739|NCT02055547|592762267|FG017|Overall Study|Protocol Violation|0|||
164109740|NCT02055547|592762268|FG018|Overall Study|Protocol Violation|0|||
164109741|NCT02055547|592762250|FG000|Overall Study|Physician Decision|0|||
164109742|NCT02055547|592762251|FG001|Overall Study|Physician Decision|1|||
164109743|NCT02055547|592762252|FG002|Overall Study|Physician Decision|1|||
164109744|NCT02055547|592762253|FG003|Overall Study|Physician Decision|0|||
164109745|NCT02055547|592762254|FG004|Overall Study|Physician Decision|1|||
164109746|NCT02055547|592762255|FG005|Overall Study|Physician Decision|0|||
164109747|NCT02055547|592762256|FG006|Overall Study|Physician Decision|0|||
164109748|NCT02055547|592762257|FG007|Overall Study|Physician Decision|0|||
164109749|NCT02055547|592762258|FG008|Overall Study|Physician Decision|0|||
164109750|NCT02055547|592762259|FG009|Overall Study|Physician Decision|1|||
164109751|NCT02055547|592762260|FG010|Overall Study|Physician Decision|1|||
164109752|NCT02055547|592762261|FG011|Overall Study|Physician Decision|0|||
164109753|NCT02055547|592762262|FG012|Overall Study|Physician Decision|0|||
164109754|NCT02055547|592762263|FG013|Overall Study|Physician Decision|0|||
164109755|NCT02055547|592762264|FG014|Overall Study|Physician Decision|0|||
164109756|NCT02055547|592762265|FG015|Overall Study|Physician Decision|0|||
164109757|NCT02055547|592762266|FG016|Overall Study|Physician Decision|0|||
164109758|NCT02055547|592762267|FG017|Overall Study|Physician Decision|0|||
164109759|NCT02055547|592762268|FG018|Overall Study|Physician Decision|0|||
164109760|NCT02055547|592762250|FG000|Overall Study|Adverse Event|0|||
164109761|NCT02055547|592762251|FG001|Overall Study|Adverse Event|0|||
164109762|NCT02055547|592762252|FG002|Overall Study|Adverse Event|0|||
164109763|NCT02055547|592762253|FG003|Overall Study|Adverse Event|0|||
164109764|NCT02055547|592762254|FG004|Overall Study|Adverse Event|0|||
164109765|NCT02055547|592762255|FG005|Overall Study|Adverse Event|0|||
164109766|NCT02055547|592762256|FG006|Overall Study|Adverse Event|1|||
164109767|NCT02055547|592762257|FG007|Overall Study|Adverse Event|0|||
164109768|NCT02055547|592762258|FG008|Overall Study|Adverse Event|1|||
164109769|NCT02055547|592762259|FG009|Overall Study|Adverse Event|0|||
164109770|NCT02055547|592762260|FG010|Overall Study|Adverse Event|0|||
164109771|NCT02055547|592762261|FG011|Overall Study|Adverse Event|0|||
164109772|NCT02055547|592762262|FG012|Overall Study|Adverse Event|0|||
164109773|NCT02055547|592762263|FG013|Overall Study|Adverse Event|0|||
164109774|NCT02055547|592762264|FG014|Overall Study|Adverse Event|0|||
164109775|NCT02055547|592762265|FG015|Overall Study|Adverse Event|0|||
164109776|NCT02055547|592762266|FG016|Overall Study|Adverse Event|0|||
164109777|NCT02055547|592762267|FG017|Overall Study|Adverse Event|0|||
164109778|NCT02055547|592762268|FG018|Overall Study|Adverse Event|0|||
164109779|NCT02055547|592762250|FG000|Overall Study|Withdrawal by Subject|0|||
164109780|NCT02055547|592762251|FG001|Overall Study|Withdrawal by Subject|0|||
164109781|NCT02055547|592762252|FG002|Overall Study|Withdrawal by Subject|0|||
164109782|NCT02055547|592762253|FG003|Overall Study|Withdrawal by Subject|0|||
164109783|NCT02055547|592762254|FG004|Overall Study|Withdrawal by Subject|0|||
164109784|NCT02055547|592762255|FG005|Overall Study|Withdrawal by Subject|1|||
164109785|NCT02055547|592762256|FG006|Overall Study|Withdrawal by Subject|0|||
164109786|NCT02055547|592762257|FG007|Overall Study|Withdrawal by Subject|0|||
164109787|NCT02055547|592762258|FG008|Overall Study|Withdrawal by Subject|1|||
164109788|NCT02055547|592762259|FG009|Overall Study|Withdrawal by Subject|0|||
164109789|NCT02055547|592762260|FG010|Overall Study|Withdrawal by Subject|0|||
164109790|NCT02055547|592762261|FG011|Overall Study|Withdrawal by Subject|0|||
164109791|NCT02055547|592762262|FG012|Overall Study|Withdrawal by Subject|0|||
164109792|NCT02055547|592762263|FG013|Overall Study|Withdrawal by Subject|1|||
164109793|NCT02055547|592762264|FG014|Overall Study|Withdrawal by Subject|0|||
164109794|NCT02055547|592762265|FG015|Overall Study|Withdrawal by Subject|1|||
164109795|NCT02055547|592762266|FG016|Overall Study|Withdrawal by Subject|0|||
164109796|NCT02055547|592762267|FG017|Overall Study|Withdrawal by Subject|0|||
164109797|NCT02055547|592762268|FG018|Overall Study|Withdrawal by Subject|0|||
164109798|NCT02055547|592762250|FG000|Overall Study|Lost to Follow-up|0|||
164109799|NCT02055547|592762251|FG001|Overall Study|Lost to Follow-up|0|||
164109800|NCT02055547|592762252|FG002|Overall Study|Lost to Follow-up|1|||
164109801|NCT02055547|592762253|FG003|Overall Study|Lost to Follow-up|0|||
164109802|NCT02055547|592762254|FG004|Overall Study|Lost to Follow-up|0|||
164109803|NCT02055547|592762255|FG005|Overall Study|Lost to Follow-up|0|||
164109804|NCT02055547|592762256|FG006|Overall Study|Lost to Follow-up|0|||
164109805|NCT02055547|592762257|FG007|Overall Study|Lost to Follow-up|0|||
164109806|NCT02055547|592762258|FG008|Overall Study|Lost to Follow-up|0|||
164109807|NCT02055547|592762259|FG009|Overall Study|Lost to Follow-up|0|||
164109808|NCT02055547|592762260|FG010|Overall Study|Lost to Follow-up|0|||
164109809|NCT02055547|592762261|FG011|Overall Study|Lost to Follow-up|0|||
164109810|NCT02055547|592762262|FG012|Overall Study|Lost to Follow-up|0|||
164109811|NCT02055547|592762263|FG013|Overall Study|Lost to Follow-up|0|||
164109812|NCT02055547|592762264|FG014|Overall Study|Lost to Follow-up|0|||
164109813|NCT02055547|592762265|FG015|Overall Study|Lost to Follow-up|0|||
164109814|NCT02055547|592762266|FG016|Overall Study|Lost to Follow-up|0|||
164109815|NCT02055547|592762267|FG017|Overall Study|Lost to Follow-up|0|||
164109816|NCT02055547|592762268|FG018|Overall Study|Lost to Follow-up|0|||
164109817|NCT01456221|592762269|FG000|Overall Study|Withdrawal by Subject|56|||
164109818|NCT01456221|592762270|FG001|Overall Study|Withdrawal by Subject|49|||
164109819|NCT01456221|592762269|FG000|Overall Study|Lost to Follow-up|1|||
164109820|NCT01456221|592762270|FG001|Overall Study|Lost to Follow-up|4|||
164109821|NCT01456221|592762269|FG000|Overall Study|Received medication|3|||
164109822|NCT01456221|592762270|FG001|Overall Study|Received medication|2|||
164109823|NCT01456221|592762269|FG000|Overall Study|Incomplete data|4|||
164109824|NCT01456221|592762270|FG001|Overall Study|Incomplete data|2|||
164109825|NCT01986647|592762271|FG000|Overall Study|Lost to Follow-up|4|||
164109826|NCT01986647|592762272|FG001|Overall Study|Lost to Follow-up|1|||
164109827|NCT01986647|592762273|FG002|Overall Study|Lost to Follow-up|4|||
164109828|NCT01986647|592762274|FG003|Overall Study|Lost to Follow-up|4|||
164109829|NCT01986647|592762271|FG000|Overall Study|Withdrawal by Subject|1|||
164109830|NCT01986647|592762272|FG001|Overall Study|Withdrawal by Subject|3|||
164109831|NCT01986647|592762273|FG002|Overall Study|Withdrawal by Subject|2|||
164109832|NCT01986647|592762274|FG003|Overall Study|Withdrawal by Subject|3|||
164109833|NCT01986647|592762271|FG000|Overall Study|Health|5|||
164109834|NCT01986647|592762272|FG001|Overall Study|Health|3|||
164109835|NCT01986647|592762273|FG002|Overall Study|Health|6|||
164109836|NCT01986647|592762274|FG003|Overall Study|Health|4|||
164109837|NCT02003391|592762275|FG000|Overall Study|Withdrawal by Subject|2|||
164109838|NCT02003391|592762276|FG001|Overall Study|Withdrawal by Subject|1|||
164109839|NCT02003391|592762275|FG000|Overall Study|Protocol Violation|0|||
164109840|NCT02003391|592762276|FG001|Overall Study|Protocol Violation|1|||
164109841|NCT02003391|592762275|FG000|Overall Study|Adverse Event|1|||
164109842|NCT02003391|592762276|FG001|Overall Study|Adverse Event|0|||
164109843|NCT00243347|592762277|FG000|Overall Study|Lack of Efficacy|4|||
164109844|NCT00243347|592762277|FG000|Overall Study|Adverse Event|2|||
164109845|NCT00243347|592762277|FG000|Overall Study|Death|1|||
164109846|NCT00243347|592762277|FG000|Overall Study|Withdrawal by Subject|5|||
164109847|NCT00243347|592762277|FG000|Overall Study|Condition worsened|7|||
164109848|NCT02011945|592762279|FG000|Overall Study|Participant requested to Discontinue|0|||
164109849|NCT02011945|592762280|FG001|Overall Study|Participant requested to Discontinue|1|||
164109850|NCT02011945|592762281|FG002|Overall Study|Participant requested to Discontinue|1|||
164109851|NCT02011945|592762279|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
164109852|NCT02011945|592762280|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
164109853|NCT02011945|592762281|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
164109854|NCT02011945|592762279|FG000|Overall Study|Study Drug Toxicity|0|||
164109855|NCT02011945|592762280|FG001|Overall Study|Study Drug Toxicity|0|||
164109856|NCT02011945|592762281|FG002|Overall Study|Study Drug Toxicity|1|||
164109857|NCT02011945|592762279|FG000|Overall Study|Treatment Failure|0|||
164109858|NCT02011945|592762280|FG001|Overall Study|Treatment Failure|7|||
164109859|NCT02011945|592762281|FG002|Overall Study|Treatment Failure|6|||
164109860|NCT02011945|592762279|FG000|Overall Study|No Longer Meets Study Criteria|1|||
164109861|NCT02011945|592762280|FG001|Overall Study|No Longer Meets Study Criteria|0|||
164109862|NCT02011945|592762281|FG002|Overall Study|No Longer Meets Study Criteria|0|||
164109863|NCT02011945|592762279|FG000|Overall Study|Proceeded to stem cell transplant|0|||
164109864|NCT02011945|592762280|FG001|Overall Study|Proceeded to stem cell transplant|0|||
164109865|NCT02011945|592762281|FG002|Overall Study|Proceeded to stem cell transplant|1|||
164109866|NCT02011945|592762279|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
164109867|NCT02011945|592762280|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
164109868|NCT02011945|592762281|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
164109869|NCT00258856|592763576|FG000|Overall Study|Lost to Follow-up|1|||
164109870|NCT00258856|592763577|FG001|Overall Study|Lost to Follow-up|0|||
164109871|NCT00258856|592763578|FG002|Overall Study|Lost to Follow-up|2|||
164109872|NCT00258856|592763579|FG003|Overall Study|Lost to Follow-up|0|||
164109873|NCT00258856|592763576|FG000|Overall Study|Non-compliance|2|||
164109874|NCT00258856|592763577|FG001|Overall Study|Non-compliance|0|||
164109875|NCT00258856|592763578|FG002|Overall Study|Non-compliance|0|||
164109876|NCT00258856|592763579|FG003|Overall Study|Non-compliance|1|||
164109877|NCT02488109|592763582|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
164109878|NCT02488109|592763583|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
164109879|NCT02488109|592763582|FG000|12-month Follow-Up|Lost to Follow-up|4|||
164109880|NCT02488109|592763583|FG001|12-month Follow-Up|Lost to Follow-up|7|||
164109881|NCT03969641|592763586|FG000|Overall Study|Lost to Follow-up|5|||
164109882|NCT03969641|592763587|FG001|Overall Study|Lost to Follow-up|3|||
164109883|NCT03969641|592763586|FG000|Overall Study|Withdrawal by Subject|1|||
164109884|NCT03969641|592763587|FG001|Overall Study|Withdrawal by Subject|2|||
164109885|NCT03969641|592763586|FG000|Overall Study|Found to be ineligible|1|||
164109886|NCT03969641|592763587|FG001|Overall Study|Found to be ineligible|1|||
164109887|NCT03969641|592763586|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
164109888|NCT03969641|592763587|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
164109889|NCT03969641|592763586|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
164109890|NCT03969641|592763587|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
164109891|NCT03969641|592763586|FG000|Overall Study|Elective termination|0|||
164109892|NCT03969641|592763587|FG001|Overall Study|Elective termination|1|||
164109893|NCT00754052|592763592|FG000|Overall Study|Study terminated by Sponsor|5|||
164109894|NCT00754052|592763593|FG001|Overall Study|Study terminated by Sponsor|3|||
164109895|NCT01919112|592763599|FG000|Secondary Analysis-day 30|Death|1|||
164109896|NCT01919112|592763600|FG001|Secondary Analysis-day 30|Death|1|||
164109897|NCT01919112|592763601|FG002|Secondary Analysis-day 30|Death|1|||
164109898|NCT01919112|592763599|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
164109899|NCT01919112|592763600|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
164109900|NCT01919112|592763601|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
164109901|NCT00835666|592763602|FG000|Washout|Protocol Violation|1|||
164109902|NCT00835666|592763603|FG001|Washout|Protocol Violation|0|||
164109903|NCT00835666|592763602|FG000|Washout|Withdrawal by Subject|1|||
164109904|NCT00835666|592763603|FG001|Washout|Withdrawal by Subject|0|||
164109905|NCT00635648|592763604|FG000|Overall Study|Adverse Event|12|||
164109906|NCT00635648|592763604|FG000|Overall Study|Withdrawal by Subject|9|||
164109907|NCT00635648|592763604|FG000|Overall Study|Physician Decision|4|||
164109908|NCT00635648|592763604|FG000|Overall Study|Rapid progression of baseline disease|4|||
164109909|NCT00635648|592763604|FG000|Overall Study|Use of other antifungal agent needed|1|||
164109910|NCT00635648|592763604|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
164109911|NCT00635648|592763604|FG000|Overall Study|Noncompliance with protocol|1|||
164109912|NCT00635648|592763604|FG000|Overall Study|Other reason|2|||
164109913|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
164109914|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
164109915|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
164109916|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
164109917|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
164109918|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
164109919|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
164109920|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
164109921|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
164109922|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
164109923|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
164109924|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
164109925|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
164109926|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
164109927|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
164109928|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
164109929|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
164109930|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
164109931|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
164109932|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
164109933|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
164109934|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
164109935|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
164109936|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
164109937|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
164109938|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
164109939|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
164109940|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
164109941|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
164109942|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
164109943|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
164109944|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
164109945|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
164109946|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
164109947|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
164109948|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
164109949|NCT04194801|592763605|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
164109950|NCT04194801|592763606|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
164109951|NCT04194801|592763607|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
164109952|NCT04194801|592763605|FG000|Part Ib/II End of Study|Death|2|||
164109953|NCT04194801|592763606|FG001|Part Ib/II End of Study|Death|3|||
164109954|NCT04194801|592763607|FG002|Part Ib/II End of Study|Death|3|||
164109955|NCT04194801|592763605|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
164109956|NCT04194801|592763606|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
164109957|NCT04194801|592763607|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
164109958|NCT04194801|592763605|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
164109959|NCT04194801|592763606|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
164109960|NCT04194801|592763607|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
164109961|NCT04194801|592763605|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
164109962|NCT04194801|592763606|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
164109963|NCT04194801|592763607|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
164109964|NCT04194801|592763605|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
164109965|NCT04194801|592763606|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
164109966|NCT04194801|592763607|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
164109967|NCT00294047|592763608|FG000|Month 48|Adverse Event|28|||
164109968|NCT00294047|592763609|FG001|Month 48|Adverse Event|13|||
164109969|NCT00294047|592763608|FG000|Month 48|Protocol Violation|4|||
164109970|NCT00294047|592763609|FG001|Month 48|Protocol Violation|4|||
164109971|NCT00294047|592763608|FG000|Month 48|Withdrawal by Subject|111|||
164109972|NCT00294047|592763609|FG001|Month 48|Withdrawal by Subject|115|||
164109973|NCT00294047|592763608|FG000|Month 48|Lost to Follow-up|272|||
164109974|NCT00294047|592763609|FG001|Month 48|Lost to Follow-up|287|||
164109975|NCT00294047|592763608|FG000|Month 48|Other|10|||
164109976|NCT00294047|592763609|FG001|Month 48|Other|14|||
164109977|NCT00294047|592763608|FG000|Month 84|Adverse Event|4|||
164109978|NCT00294047|592763609|FG001|Month 84|Adverse Event|2|||
164109979|NCT00294047|592763608|FG000|Month 84|Protocol Violation|1|||
164109980|NCT00294047|592763609|FG001|Month 84|Protocol Violation|1|||
164109981|NCT00294047|592763608|FG000|Month 84|Withdrawal by Subject|33|||
164109982|NCT00294047|592763609|FG001|Month 84|Withdrawal by Subject|31|||
164109983|NCT00294047|592763608|FG000|Month 84|Lost to Follow-up|187|||
164109984|NCT00294047|592763609|FG001|Month 84|Lost to Follow-up|190|||
164109985|NCT00294047|592763608|FG000|Month 84|Absent Cervix|2|||
164109986|NCT00294047|592763609|FG001|Month 84|Absent Cervix|0|||
164109987|NCT00294047|592763608|FG000|Month 84|Work related reasons|4|||
164109988|NCT00294047|592763609|FG001|Month 84|Work related reasons|2|||
164109989|NCT00294047|592763608|FG000|Month 84|Center closed, subject did not transfer|1|||
164109990|NCT00294047|592763609|FG001|Month 84|Center closed, subject did not transfer|0|||
164109991|NCT00294047|592763608|FG000|Month 84|Family problems|2|||
164109992|NCT00294047|592763609|FG001|Month 84|Family problems|2|||
164109993|NCT00294047|592763608|FG000|Month 84|Lack of time|3|||
164109994|NCT00294047|592763609|FG001|Month 84|Lack of time|1|||
164109995|NCT00294047|592763608|FG000|Month 84|Personal reason|2|||
164109996|NCT00294047|592763609|FG001|Month 84|Personal reason|4|||
164109997|NCT00294047|592763608|FG000|Month 84|Subject does not want male physician|1|||
164109998|NCT00294047|592763609|FG001|Month 84|Subject does not want male physician|0|||
164109999|NCT00294047|592763608|FG000|Month 84|Transport reimbursement delayed|0|||
164110000|NCT00294047|592763609|FG001|Month 84|Transport reimbursement delayed|1|||
164110001|NCT00294047|592763608|FG000|Month 84|Unable to reach study site|1|||
164110002|NCT00294047|592763609|FG001|Month 84|Unable to reach study site|0|||
164110003|NCT00294047|592763608|FG000|Month 84|Under investigation locally|1|||
164110004|NCT00294047|592763609|FG001|Month 84|Under investigation locally|0|||
164110005|NCT00294047|592763608|FG000|Month 84|Visit missed|0|||
164110006|NCT00294047|592763609|FG001|Month 84|Visit missed|1|||
164110007|NCT00294047|592763608|FG000|Month 84|No consent for Month 84 Follow-up|731|||
164110008|NCT00294047|592763609|FG001|Month 84|No consent for Month 84 Follow-up|754|||
164110009|NCT00506831|592763610|FG000|Overall Study|Death|1|||
164110010|NCT00506831|592763610|FG000|Overall Study|Withdrawal by Subject|1|||
164110011|NCT00608322|592763616|FG000|Overall Study|Death|2|||
164110012|NCT00608322|592763617|FG001|Overall Study|Death|1|||
164110013|NCT04002648|592763618|FG000|Overall Study|Lost to Follow-up|2|||
164110014|NCT04002648|592763619|FG001|Overall Study|Lost to Follow-up|0|||
164110015|NCT02280863|592763630|FG000|Integrated Platform|Met stopping criteria|0|||
164110016|NCT02280863|592763631|FG001|Integrated Platform|Met stopping criteria|1|||
164110017|NCT03158727|592763634|FG000|Overall Study|Withdrawal by Subject|2|||
164110018|NCT03158727|592763635|FG001|Overall Study|Withdrawal by Subject|6|||
164110019|NCT03158727|592763634|FG000|Overall Study|Death|11|||
164110020|NCT03158727|592763635|FG001|Overall Study|Death|12|||
164110021|NCT03158727|592763634|FG000|Overall Study|Lost to Follow-up|1|||
164110022|NCT03158727|592763635|FG001|Overall Study|Lost to Follow-up|0|||
164110023|NCT03158727|592763634|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
164110024|NCT03158727|592763635|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
164110025|NCT03158727|592763634|FG000|Overall Study|Visit 11 not done by mistake|0|||
164110026|NCT03158727|592763635|FG001|Overall Study|Visit 11 not done by mistake|1|||
164110027|NCT03158727|592763634|FG000|Overall Study|Enrolled, not treated|1|||
164110028|NCT03158727|592763635|FG001|Overall Study|Enrolled, not treated|0|||
164110029|NCT00985439|592763636|FG000|Overall Study|Adverse Event|0|||
164110030|NCT00985439|592763637|FG001|Overall Study|Adverse Event|0|||
164110031|NCT00985439|592763638|FG002|Overall Study|Adverse Event|1|||
164110032|NCT00985439|592763639|FG003|Overall Study|Adverse Event|0|||
164110033|NCT01174186|592763640|FG000|Overall Study|Lost to Follow-up|0|||
164110034|NCT01174186|592763641|FG001|Overall Study|Lost to Follow-up|1|||
164110035|NCT01174186|592763640|FG000|Overall Study|Withdrawal by Subject|0|||
164110036|NCT01174186|592763641|FG001|Overall Study|Withdrawal by Subject|2|||
164110037|NCT00918684|592763642|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
164110038|NCT00918684|592763642|FG000|Treatment Phase|Lack of Efficacy|6|||
164110039|NCT00918684|592763642|FG000|Treatment Phase|Lost to Follow-up|2|||
164110040|NCT00918684|592763642|FG000|Treatment Phase|Physician Decision|8|||
164110041|NCT00918684|592763642|FG000|Treatment Phase|Protocol Violation|1|||
164110042|NCT00918684|592763642|FG000|Treatment Phase|Withdrawal by Subject|8|||
164110043|NCT00402103|592763643|FG000|Overall Study|Adverse Event|60|||
164110044|NCT00402103|592763644|FG001|Overall Study|Adverse Event|7|||
164110045|NCT00402103|592763643|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164110046|NCT00402103|592763644|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164110047|NCT00402103|592763643|FG000|Overall Study|Condition no longer requires study drug|2|||
164110048|NCT00402103|592763644|FG001|Overall Study|Condition no longer requires study drug|0|||
164110049|NCT00402103|592763643|FG000|Overall Study|Protocol Deviation|8|||
164110050|NCT00402103|592763644|FG001|Overall Study|Protocol Deviation|0|||
164110051|NCT00402103|592763643|FG000|Overall Study|Patient withdrew consent|12|||
164110052|NCT00402103|592763644|FG001|Overall Study|Patient withdrew consent|1|||
164110053|NCT00402103|592763643|FG000|Overall Study|Lost to Follow-up|6|||
164110054|NCT00402103|592763644|FG001|Overall Study|Lost to Follow-up|3|||
164110055|NCT00402103|592763643|FG000|Overall Study|Administrative problems|2|||
164110056|NCT00402103|592763644|FG001|Overall Study|Administrative problems|0|||
164110057|NCT00484679|592763645|FG000|Overall Study|Withdrawal by Subject|3|||
164110058|NCT00418145|592763648|FG000|Overall Study|study terminated|6|||
164110059|NCT00472212|592763649|FG000|Overall Study|Lost to Follow-up|6|||
164110060|NCT00472212|592763650|FG001|Overall Study|Lost to Follow-up|4|||
164110061|NCT00425308|592763651|FG000|Overall Study|Adverse Event|2|||
164110062|NCT00425308|592763652|FG001|Overall Study|Adverse Event|1|||
164110063|NCT00425308|592763651|FG000|Overall Study|Withdrawal by Subject|1|||
164110064|NCT00425308|592763652|FG001|Overall Study|Withdrawal by Subject|0|||
164110065|NCT00425308|592763651|FG000|Overall Study|Death|1|||
164110066|NCT00425308|592763652|FG001|Overall Study|Death|0|||
164110067|NCT01252953|592763654|FG000|Overall Study|Withdrawal by Subject|16|||
164110068|NCT01252953|592763655|FG001|Overall Study|Withdrawal by Subject|17|||
164110069|NCT01252953|592763654|FG000|Overall Study|Lost to Follow-up|22|||
164110070|NCT01252953|592763655|FG001|Overall Study|Lost to Follow-up|21|||
164110071|NCT00101439|592763662|FG000|Period 2|Withdrawal by Subject|0|||
164110072|NCT00101439|592763663|FG001|Period 2|Withdrawal by Subject|2|||
164110073|NCT00863330|592763669|FG000|Overall Study|study terminated early due to administra|6|||
164110074|NCT00487435|592763670|FG000|Overall Study|Adverse Event|146|||
164110075|NCT00487435|592763670|FG000|Overall Study|Death|2|||
164110076|NCT00487435|592763670|FG000|Overall Study|Lack of Efficacy|33|||
164110077|NCT00487435|592763670|FG000|Overall Study|Lost to Follow-up|54|||
164110078|NCT00487435|592763670|FG000|Overall Study|Pregnancy|2|||
164110079|NCT00487435|592763670|FG000|Overall Study|Withdrawal by Subject|132|||
164110080|NCT00487435|592763670|FG000|Overall Study|Resolution Of Pain|1|||
164110081|NCT00487435|592763670|FG000|Overall Study|Study Medication Non-Compliant|32|||
164110082|NCT00487435|592763670|FG000|Overall Study|Other|83|||
164110083|NCT01087502|592763677|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
164110084|NCT01087502|592763678|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
164110085|NCT01087502|592763677|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
164110086|NCT01087502|592763678|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
164110087|NCT01087502|592763677|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
164110088|NCT01087502|592763678|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
164110089|NCT01087502|592763677|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
164110090|NCT01087502|592763678|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
164110091|NCT01087502|592763677|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
164110092|NCT01087502|592763678|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
164110093|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
164110094|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
164110095|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
164110096|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
164110097|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
164110098|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
164110099|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
164110100|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
164110101|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
164110102|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
164110103|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
164110104|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
164110105|NCT01087502|592763677|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
164110106|NCT01087502|592763678|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
164110107|NCT01151618|592763679|FG000|Overall Study|Adverse Event|2|||
164110108|NCT01151618|592763679|FG000|Overall Study|Withdrawal by Subject|7|||
164110109|NCT00868998|592763680|FG000|Overall Study|Screen Failure|1|||
164110110|NCT00868998|592763680|FG000|Overall Study|Withdrawal by Subject|1|||
164110111|NCT00868998|592763680|FG000|Overall Study|Progression of disease|2|||
164110112|NCT00868998|592763680|FG000|Overall Study|Death|1|||
164110113|NCT01483820|592763682|FG000|Overall Study|Lack of Efficacy|6|||
164110114|NCT01483820|592763682|FG000|Overall Study|Adverse Event|1|||
164110115|NCT01483820|592763682|FG000|Overall Study|Death|1|||
164110116|NCT00474188|592763686|FG000|Overall Study|Withdrawal by Subject|1|||
164110117|NCT00474188|592763686|FG000|Overall Study|Study discontinued by sponsor|5|||
164110118|NCT05412121|592763687|FG000|Overall Study|Withdrawal by Subject|4|||
164110119|NCT05412121|592763687|FG000|Overall Study|Physician Decision|1|||
164110120|NCT05412121|592763687|FG000|Overall Study|Lost to Follow-up|5|||
164110121|NCT03541252|592763688|FG000|Overall Study|Withdrawal by Subject|1|||
164110122|NCT02272803|592763689|FG000|Overall Study|Disease progression|16|||
164110123|NCT02272803|592763690|FG001|Overall Study|Disease progression|8|||
164110124|NCT02272803|592763689|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
164110125|NCT02272803|592763690|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
164110126|NCT02272803|592763689|FG000|Overall Study|Study drug toxicity|4|||
164110127|NCT02272803|592763690|FG001|Overall Study|Study drug toxicity|9|||
164110128|NCT02272803|592763689|FG000|Overall Study|Participant request to discontinue study treatment|3|||
164110129|NCT02272803|592763690|FG001|Overall Study|Participant request to discontinue study treatment|7|||
164110130|NCT02272803|592763689|FG000|Overall Study|Maximum clinical benefit|4|||
164110131|NCT02272803|592763690|FG001|Overall Study|Maximum clinical benefit|2|||
164110132|NCT02272803|592763689|FG000|Overall Study|Poor/non-compliance|2|||
164110133|NCT02272803|592763690|FG001|Overall Study|Poor/non-compliance|2|||
164110134|NCT02272803|592763689|FG000|Overall Study|Withdrawal by Subject|2|||
164110135|NCT02272803|592763690|FG001|Overall Study|Withdrawal by Subject|1|||
164110136|NCT02272803|592763689|FG000|Overall Study|Death|0|||
164110137|NCT02272803|592763690|FG001|Overall Study|Death|1|||
164110138|NCT02272803|592763689|FG000|Overall Study|Other reasons|1|||
164110139|NCT02272803|592763690|FG001|Overall Study|Other reasons|3|||
164110140|NCT02272803|592763689|FG000|Overall Study|Administrative reason by sponsor|5|||
164110141|NCT02272803|592763690|FG001|Overall Study|Administrative reason by sponsor|4|||
164110142|NCT03961204|592763692|FG000|Overall Study|Withdrawal by Subject|2|||
164110143|NCT03961204|592763692|FG000|Overall Study|Lost to Follow-up|3|||
164110144|NCT03961204|592763692|FG000|Overall Study|Other|1|||
164110145|NCT03961204|592763692|FG000|Overall Study|Missing|1|||
164110146|NCT02218216|592763693|FG000|Overall Study|Study terminated before completed|6|||
164110147|NCT02218216|592763694|FG001|Overall Study|Study terminated before completed|0|||
164110148|NCT02218216|592763695|FG002|Overall Study|Study terminated before completed|0|||
164110149|NCT02452463|592763698|FG000|Overall Study|Death|1|||
164110150|NCT02452463|592763699|FG001|Overall Study|Death|0|||
164110151|NCT02452463|592763700|FG002|Overall Study|Death|0|||
164110152|NCT02452463|592763698|FG000|Overall Study|Study Suspended|1|||
164110153|NCT02452463|592763699|FG001|Overall Study|Study Suspended|0|||
164110154|NCT02452463|592763700|FG002|Overall Study|Study Suspended|0|||
164110155|NCT02452463|592763698|FG000|Overall Study|Recommended by DSMB|0|||
164110156|NCT02452463|592763699|FG001|Overall Study|Recommended by DSMB|1|||
164110157|NCT02452463|592763700|FG002|Overall Study|Recommended by DSMB|0|||
164110158|NCT02452463|592763698|FG000|Overall Study|Withdrawal by Subject|0|||
164110159|NCT02452463|592763699|FG001|Overall Study|Withdrawal by Subject|1|||
164110160|NCT02452463|592763700|FG002|Overall Study|Withdrawal by Subject|0|||
164110161|NCT05740098|592763701|FG000|Overall Study|Lost to Follow-up|26|||
164110162|NCT05740098|592763702|FG001|Overall Study|Lost to Follow-up|17|||
164110163|NCT05740098|592763703|FG002|Overall Study|Lost to Follow-up|21|||
164110164|NCT01073631|592763704|FG000|Overall Study|Death|82|||
164110165|NCT01073631|592763704|FG000|Overall Study|Adverse Event|24|||
164110166|NCT01073631|592763704|FG000|Overall Study|Other|63|||
164110167|NCT03067987|592763705|FG000|Overall Study|Lost to Follow-up|7|||
164110168|NCT03067987|592763706|FG001|Overall Study|Lost to Follow-up|10|||
164110169|NCT03067987|592763705|FG000|Overall Study|Protocol Violation|1|||
164110170|NCT03067987|592763706|FG001|Overall Study|Protocol Violation|2|||
164110171|NCT03067987|592763705|FG000|Overall Study|Withdrawal by Subject|2|||
164110172|NCT03067987|592763706|FG001|Overall Study|Withdrawal by Subject|1|||
164110173|NCT03733145|592763707|FG000|Overall Study|screenfail|3|||
164110174|NCT03733145|592763708|FG001|Overall Study|screenfail|3|||
164110175|NCT03733145|592763709|FG002|Overall Study|screenfail|2|||
164110176|NCT00829764|592763710|FG000|First Intervention|Adverse Event|1|||
164110177|NCT00829764|592763711|FG001|First Intervention|Adverse Event|0|||
164110178|NCT00829764|592763710|FG000|First Intervention|Withdrawal by Subject|1|||
164110179|NCT00829764|592763711|FG001|First Intervention|Withdrawal by Subject|1|||
164110180|NCT01098851|592765322|FG000|Overall Study|Equipment failure|1|||
164110181|NCT01098851|592765323|FG001|Overall Study|Equipment failure|0|||
164110182|NCT03087786|592765324|FG000|Overall Study|Withdrawal by Subject|2|||
164110183|NCT03087786|592765325|FG001|Overall Study|Withdrawal by Subject|0|||
164110184|NCT00183196|592765327|FG000|Overall Study|Withdrawal by Subject|18|||
164110185|NCT00183196|592765328|FG001|Overall Study|Withdrawal by Subject|11|||
164110186|NCT00183196|592765329|FG002|Overall Study|Withdrawal by Subject|13|||
164110187|NCT00183196|592765327|FG000|Overall Study|Adverse Event|1|||
164110188|NCT00183196|592765328|FG001|Overall Study|Adverse Event|2|||
164110189|NCT00183196|592765329|FG002|Overall Study|Adverse Event|2|||
164110190|NCT00183196|592765327|FG000|Overall Study|Legal event|1|||
164110191|NCT00183196|592765328|FG001|Overall Study|Legal event|1|||
164110192|NCT00183196|592765329|FG002|Overall Study|Legal event|1|||
164110193|NCT00183196|592765327|FG000|Overall Study|Required more intensive care|0|||
164110194|NCT00183196|592765328|FG001|Overall Study|Required more intensive care|1|||
164110195|NCT00183196|592765329|FG002|Overall Study|Required more intensive care|2|||
164110196|NCT00385736|592765330|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
164110197|NCT00385736|592765331|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
164110198|NCT00385736|592765332|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
164110199|NCT00385736|592765330|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
164110200|NCT00385736|592765331|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
164110201|NCT00385736|592765332|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
164110202|NCT00385736|592765330|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
164110203|NCT00385736|592765331|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
164110204|NCT00385736|592765332|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
164110205|NCT00385736|592765330|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
164110206|NCT00385736|592765331|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
164110207|NCT00385736|592765332|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
164110208|NCT00385736|592765330|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
164110209|NCT00385736|592765331|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
164110210|NCT00385736|592765332|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
164110211|NCT00385736|592765330|FG000|Efficacy Analysis Set - Induction|Other|0|||
164110212|NCT00385736|592765331|FG001|Efficacy Analysis Set - Induction|Other|0|||
164110213|NCT00385736|592765332|FG002|Efficacy Analysis Set - Induction|Other|1|||
164110214|NCT00385736|592765330|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
164110215|NCT00385736|592765331|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
164110216|NCT00385736|592765332|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
164110217|NCT00385736|592765330|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
164110218|NCT00385736|592765331|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
164110219|NCT00385736|592765332|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
164110220|NCT00385736|592765330|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
164110221|NCT00385736|592765331|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
164110222|NCT00385736|592765332|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
164110223|NCT00385736|592765330|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
164110224|NCT00385736|592765331|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
164110225|NCT00385736|592765332|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
164110226|NCT00385736|592765330|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
164110227|NCT00385736|592765331|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
164110228|NCT00385736|592765332|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
164110229|NCT00385736|592765330|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
164110230|NCT00385736|592765331|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
164110231|NCT00385736|592765332|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
164110232|NCT00385736|592765330|FG000|Safety Analysis Set|Adverse Event|23|||
164110233|NCT00385736|592765331|FG001|Safety Analysis Set|Adverse Event|15|||
164110234|NCT00385736|592765332|FG002|Safety Analysis Set|Adverse Event|23|||
164110235|NCT00385736|592765330|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
164110236|NCT00385736|592765331|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
164110237|NCT00385736|592765332|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
164110238|NCT00385736|592765330|FG000|Safety Analysis Set|Lost to Follow-up|0|||
164110239|NCT00385736|592765331|FG001|Safety Analysis Set|Lost to Follow-up|2|||
164110240|NCT00385736|592765332|FG002|Safety Analysis Set|Lost to Follow-up|2|||
164110241|NCT00385736|592765330|FG000|Safety Analysis Set|Lack of Efficacy|38|||
164110242|NCT00385736|592765331|FG001|Safety Analysis Set|Lack of Efficacy|16|||
164110243|NCT00385736|592765332|FG002|Safety Analysis Set|Lack of Efficacy|31|||
164110244|NCT00385736|592765330|FG000|Safety Analysis Set|Protocol Violation|2|||
164110245|NCT00385736|592765331|FG001|Safety Analysis Set|Protocol Violation|1|||
164110246|NCT00385736|592765332|FG002|Safety Analysis Set|Protocol Violation|6|||
164110247|NCT00385736|592765330|FG000|Safety Analysis Set|Other|1|||
164110248|NCT00385736|592765331|FG001|Safety Analysis Set|Other|4|||
164110249|NCT00385736|592765332|FG002|Safety Analysis Set|Other|4|||
164110250|NCT02906917|592765340|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
164110251|NCT02906917|592765341|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
164110252|NCT02906917|592765340|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
164110253|NCT02906917|592765341|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
164110254|NCT02906917|592765340|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
164110255|NCT02906917|592765341|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
164110256|NCT02906917|592765340|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
164110257|NCT02906917|592765341|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
164110258|NCT02906917|592765340|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
164110259|NCT02906917|592765341|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
164110260|NCT02906917|592765340|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
164110261|NCT02906917|592765341|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
164110262|NCT02906917|592765340|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
164110263|NCT02906917|592765341|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
164110264|NCT02906917|592765340|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
164110265|NCT02906917|592765341|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
164110266|NCT00687739|592765342|FG000|Overall Study|Lost to Follow-up|2|||
164110267|NCT00687739|592765343|FG001|Overall Study|Lost to Follow-up|2|||
164110268|NCT00687739|592765344|FG002|Overall Study|Lost to Follow-up|1|||
164110269|NCT00687739|592765345|FG003|Overall Study|Lost to Follow-up|2|||
164110270|NCT00687739|592765342|FG000|Overall Study|Adverse Event|0|||
164110271|NCT00687739|592765343|FG001|Overall Study|Adverse Event|1|||
164110272|NCT00687739|592765344|FG002|Overall Study|Adverse Event|1|||
164110273|NCT00687739|592765345|FG003|Overall Study|Adverse Event|0|||
164110274|NCT02043132|592765352|FG000|Overall Study|Lost to Follow-up|1|||
164110275|NCT02043132|592765353|FG001|Overall Study|Lost to Follow-up|1|||
164110276|NCT02043132|592765352|FG000|Overall Study|screen failures|4|||
164110277|NCT02043132|592765353|FG001|Overall Study|screen failures|8|||
164110278|NCT02554877|592765354|FG000|Overall Study|Adverse Event|2|||
164110279|NCT02554877|592765355|FG001|Overall Study|Adverse Event|0|||
164110280|NCT02554877|592765356|FG002|Overall Study|Adverse Event|0|||
164110281|NCT02554877|592765357|FG003|Overall Study|Adverse Event|1|||
164110282|NCT02554877|592765354|FG000|Overall Study|Lost to Follow-up|1|||
164110283|NCT02554877|592765355|FG001|Overall Study|Lost to Follow-up|1|||
164110284|NCT02554877|592765356|FG002|Overall Study|Lost to Follow-up|1|||
164110285|NCT02554877|592765357|FG003|Overall Study|Lost to Follow-up|2|||
164110286|NCT02554877|592765354|FG000|Overall Study|Did not meet entrance criteria|0|||
164110287|NCT02554877|592765355|FG001|Overall Study|Did not meet entrance criteria|0|||
164110288|NCT02554877|592765356|FG002|Overall Study|Did not meet entrance criteria|1|||
164110289|NCT02554877|592765357|FG003|Overall Study|Did not meet entrance criteria|0|||
164110290|NCT02554877|592765354|FG000|Overall Study|No longer met eligibility criteria|1|||
164110291|NCT02554877|592765355|FG001|Overall Study|No longer met eligibility criteria|0|||
164110292|NCT02554877|592765356|FG002|Overall Study|No longer met eligibility criteria|1|||
164110293|NCT02554877|592765357|FG003|Overall Study|No longer met eligibility criteria|1|||
164110294|NCT02554877|592765354|FG000|Overall Study|Protocol Violation|3|||
164110295|NCT02554877|592765355|FG001|Overall Study|Protocol Violation|1|||
164110296|NCT02554877|592765356|FG002|Overall Study|Protocol Violation|1|||
164110297|NCT02554877|592765357|FG003|Overall Study|Protocol Violation|0|||
164110298|NCT02554877|592765354|FG000|Overall Study|Other|1|||
164110299|NCT02554877|592765355|FG001|Overall Study|Other|3|||
164110300|NCT02554877|592765356|FG002|Overall Study|Other|0|||
164110301|NCT02554877|592765357|FG003|Overall Study|Other|3|||
164110302|NCT02554877|592765354|FG000|Overall Study|Insufficient clinical response|4|||
164110303|NCT02554877|592765355|FG001|Overall Study|Insufficient clinical response|0|||
164110304|NCT02554877|592765356|FG002|Overall Study|Insufficient clinical response|0|||
164110305|NCT02554877|592765357|FG003|Overall Study|Insufficient clinical response|0|||
164110306|NCT02554877|592765354|FG000|Overall Study|No longer willing to participate|0|||
164110307|NCT02554877|592765355|FG001|Overall Study|No longer willing to participate|2|||
164110308|NCT02554877|592765356|FG002|Overall Study|No longer willing to participate|2|||
164110309|NCT02554877|592765357|FG003|Overall Study|No longer willing to participate|0|||
164110310|NCT03827395|592765358|FG000|Overall Study|Lost to Follow-up|1|||
164110311|NCT03827395|592765359|FG001|Overall Study|Lost to Follow-up|0|||
164110312|NCT03827395|592765358|FG000|Overall Study|Protocol Violation|1|||
164110313|NCT03827395|592765359|FG001|Overall Study|Protocol Violation|0|||
164110314|NCT03827395|592765358|FG000|Overall Study|Became ineligible after enrollment|1|||
164110315|NCT03827395|592765359|FG001|Overall Study|Became ineligible after enrollment|2|||
164110316|NCT01537887|592765360|FG000|Period 1|Physician Decision|0|||
164110317|NCT01537887|592765361|FG001|Period 1|Physician Decision|0|||
164110318|NCT01537887|592765362|FG002|Period 1|Physician Decision|0|||
164110319|NCT01537887|592765363|FG003|Period 1|Physician Decision|0|||
164110320|NCT01537887|592765364|FG004|Period 1|Physician Decision|1|||
164110321|NCT01537887|592765365|FG005|Period 1|Physician Decision|1|||
164110322|NCT01537887|592765360|FG000|Period 1|Did not receive treatment|0|||
164110323|NCT01537887|592765361|FG001|Period 1|Did not receive treatment|0|||
164110324|NCT01537887|592765362|FG002|Period 1|Did not receive treatment|1|||
164110325|NCT01537887|592765363|FG003|Period 1|Did not receive treatment|0|||
164110326|NCT01537887|592765364|FG004|Period 1|Did not receive treatment|0|||
164110327|NCT01537887|592765365|FG005|Period 1|Did not receive treatment|0|||
164110328|NCT01537887|592765360|FG000|Period 2|Withdrawal by Subject|0|||
164110329|NCT01537887|592765361|FG001|Period 2|Withdrawal by Subject|1|||
164110330|NCT01537887|592765362|FG002|Period 2|Withdrawal by Subject|0|||
164110331|NCT01537887|592765363|FG003|Period 2|Withdrawal by Subject|0|||
164110332|NCT01537887|592765364|FG004|Period 2|Withdrawal by Subject|0|||
164110333|NCT01537887|592765365|FG005|Period 2|Withdrawal by Subject|0|||
164110334|NCT01537887|592765360|FG000|Period 3|Adverse Event|0|||
164110335|NCT01537887|592765361|FG001|Period 3|Adverse Event|0|||
164110336|NCT01537887|592765362|FG002|Period 3|Adverse Event|1|||
164110337|NCT01537887|592765363|FG003|Period 3|Adverse Event|0|||
164110338|NCT01537887|592765364|FG004|Period 3|Adverse Event|0|||
164110339|NCT01537887|592765365|FG005|Period 3|Adverse Event|0|||
164110340|NCT01537887|592765360|FG000|Period 3|Withdrawal by Subject|0|||
164110341|NCT01537887|592765361|FG001|Period 3|Withdrawal by Subject|1|||
164110342|NCT01537887|592765362|FG002|Period 3|Withdrawal by Subject|0|||
164110343|NCT01537887|592765363|FG003|Period 3|Withdrawal by Subject|0|||
164110344|NCT01537887|592765364|FG004|Period 3|Withdrawal by Subject|0|||
164110345|NCT01537887|592765365|FG005|Period 3|Withdrawal by Subject|0|||
164110346|NCT01370083|592765366|FG000|Overall Study|Lost to Follow-up|2|||
164110347|NCT01370083|592765367|FG001|Overall Study|Lost to Follow-up|0|||
164110348|NCT01370083|592765366|FG000|Overall Study|Adverse Event|0|||
164110349|NCT01370083|592765367|FG001|Overall Study|Adverse Event|1|||
164110350|NCT02450539|592765368|FG000|Overall Study|Withdrawal by Subject|12|||
164110351|NCT02450539|592765369|FG001|Overall Study|Withdrawal by Subject|6|||
164110352|NCT02450539|592765368|FG000|Overall Study|Lost to Follow-up|4|||
164110353|NCT02450539|592765369|FG001|Overall Study|Lost to Follow-up|1|||
164110354|NCT01438060|592765371|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
164110355|NCT01438060|592765372|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
164110356|NCT01438060|592765371|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
164110357|NCT01438060|592765372|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
164110358|NCT01438060|592765371|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
164110359|NCT01438060|592765372|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
164110360|NCT01438060|592765371|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
164110361|NCT01438060|592765372|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
164110362|NCT01438060|592765371|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
164110363|NCT01438060|592765372|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
164110364|NCT01438060|592765371|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
164110365|NCT01438060|592765372|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
164110366|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
164110367|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
164110368|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
164110369|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
164110370|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
164110371|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
164110372|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
164110373|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
164110374|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
164110375|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
164110376|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
164110377|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
164110378|NCT01438060|592765371|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
164110379|NCT01438060|592765372|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
164110380|NCT01438060|592765371|FG000|On Study Beyond Week 140|Adverse Event|0|||
164110381|NCT01438060|592765372|FG001|On Study Beyond Week 140|Adverse Event|2|||
164110382|NCT01438060|592765371|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
164110383|NCT01438060|592765372|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
164110384|NCT01438060|592765371|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
164110385|NCT01438060|592765372|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
164110386|NCT01438060|592765371|FG000|On Study Beyond Week 140|Death|0|||
164110387|NCT01438060|592765372|FG001|On Study Beyond Week 140|Death|1|||
164110388|NCT01438060|592765371|FG000|On Study Beyond Week 140|Other Reason|0|||
164110389|NCT01438060|592765372|FG001|On Study Beyond Week 140|Other Reason|3|||
164110390|NCT01964950|592765373|FG000|Overall Study|Protocol Violation|25|||
164110391|NCT03602339|592765374|FG000|Overall Study|Withdrawal by Subject|9|||
164110392|NCT03602339|592765374|FG000|Overall Study|Physician Decision|2|||
164110393|NCT03602339|592765374|FG000|Overall Study|Other reason|4|||
164110394|NCT01190865|592765386|FG000|Overall Study|Withdrawal by Subject|1|||
164110395|NCT01190865|592765386|FG000|Overall Study|Non-compliance|2|||
164110396|NCT00829452|592765388|FG000|First Intervention|Withdrawal by Subject|0|||
164110397|NCT00829452|592765389|FG001|First Intervention|Withdrawal by Subject|1|||
164110398|NCT00829452|592765388|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
164110399|NCT00829452|592765389|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
164110400|NCT00829452|592765388|FG000|Second Intervention|Physician Decision|0|||
164110401|NCT00829452|592765389|FG001|Second Intervention|Physician Decision|1|||
164110402|NCT02615249|592765390|FG000|Overall Study|Withdrawal by Subject|1|||
164110403|NCT05098743|592765401|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
164110404|NCT05098743|592765402|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
164110405|NCT05098743|592765401|FG000|Overall Study|Lost to Follow-up|1|||
164110406|NCT05098743|592765402|FG001|Overall Study|Lost to Follow-up|2|||
164110407|NCT04060251|592765403|FG000|Overall Study|Study terminated due to low enrollment.|7|||
164110408|NCT04060251|592765404|FG001|Overall Study|Study terminated due to low enrollment.|5|||
164110409|NCT04060251|592765405|FG002|Overall Study|Study terminated due to low enrollment.|7|||
164110410|NCT04060251|592765403|FG000|Overall Study|Adverse Event|1|||
164110411|NCT04060251|592765404|FG001|Overall Study|Adverse Event|1|||
164110412|NCT04060251|592765405|FG002|Overall Study|Adverse Event|0|||
164110413|NCT01663896|592765406|FG000|Overall Study|Various reasons|43|||
164110414|NCT00842309|592765413|FG000|Overall Study|Withdrawal by Subject|3|||
164110415|NCT00842309|592765414|FG001|Overall Study|Withdrawal by Subject|1|||
164110416|NCT02670551|592765415|FG000|Overall Study|Adverse Event|4|||
164110417|NCT02670551|592765416|FG001|Overall Study|Adverse Event|7|||
164110418|NCT02670551|592765417|FG002|Overall Study|Adverse Event|9|||
164110419|NCT02670551|592765415|FG000|Overall Study|Lack of Efficacy|2|||
164110420|NCT02670551|592765416|FG001|Overall Study|Lack of Efficacy|0|||
164110421|NCT02670551|592765417|FG002|Overall Study|Lack of Efficacy|3|||
164110422|NCT02670551|592765415|FG000|Overall Study|Withdrawal of Consent|6|||
164110423|NCT02670551|592765416|FG001|Overall Study|Withdrawal of Consent|3|||
164110424|NCT02670551|592765417|FG002|Overall Study|Withdrawal of Consent|8|||
164110425|NCT02670551|592765415|FG000|Overall Study|Lost to Follow-up|5|||
164110426|NCT02670551|592765416|FG001|Overall Study|Lost to Follow-up|7|||
164110427|NCT02670551|592765417|FG002|Overall Study|Lost to Follow-up|6|||
164110428|NCT02670551|592765415|FG000|Overall Study|Protocol Violation|1|||
164110429|NCT02670551|592765416|FG001|Overall Study|Protocol Violation|0|||
164110430|NCT02670551|592765417|FG002|Overall Study|Protocol Violation|0|||
164110431|NCT02670551|592765415|FG000|Overall Study|Noncompliance with study drug|3|||
164110432|NCT02670551|592765416|FG001|Overall Study|Noncompliance with study drug|3|||
164110433|NCT02670551|592765417|FG002|Overall Study|Noncompliance with study drug|2|||
164110434|NCT02670551|592765415|FG000|Overall Study|Other Miscellaneous Reasons|2|||
164110435|NCT02670551|592765416|FG001|Overall Study|Other Miscellaneous Reasons|3|||
164110436|NCT02670551|592765417|FG002|Overall Study|Other Miscellaneous Reasons|3|||
164110437|NCT02670551|592765415|FG000|Overall Study|Did Not Receive Treatment|5|||
164110438|NCT02670551|592765416|FG001|Overall Study|Did Not Receive Treatment|3|||
164110439|NCT02670551|592765417|FG002|Overall Study|Did Not Receive Treatment|0|||
164110440|NCT04476277|592765418|FG000|Overall Study|Withdrawal by Subject|0|||
164110441|NCT04476277|592765419|FG001|Overall Study|Withdrawal by Subject|0|||
164110442|NCT04476277|592765420|FG002|Overall Study|Withdrawal by Subject|1|||
164110443|NCT04476277|592765421|FG003|Overall Study|Withdrawal by Subject|0|||
164110444|NCT01962298|592765422|FG000|Overall Study|Protocol Violation|1|||
164110445|NCT01962298|592765423|FG001|Overall Study|Protocol Violation|0|||
164110446|NCT01962298|592765424|FG002|Overall Study|Protocol Violation|1|||
164110447|NCT01962298|592765425|FG003|Overall Study|Protocol Violation|1|||
164110448|NCT01962298|592765426|FG004|Overall Study|Protocol Violation|0|||
164110449|NCT01962298|592765422|FG000|Overall Study|Data quality insufficient|2|||
164110450|NCT01962298|592765423|FG001|Overall Study|Data quality insufficient|0|||
164110451|NCT01962298|592765424|FG002|Overall Study|Data quality insufficient|3|||
164110452|NCT01962298|592765425|FG003|Overall Study|Data quality insufficient|1|||
164110453|NCT01962298|592765426|FG004|Overall Study|Data quality insufficient|4|||
164110454|NCT01962298|592765422|FG000|Overall Study|Insufficient data|0|||
164110455|NCT01962298|592765423|FG001|Overall Study|Insufficient data|2|||
164110456|NCT01962298|592765424|FG002|Overall Study|Insufficient data|1|||
164110457|NCT01962298|592765425|FG003|Overall Study|Insufficient data|0|||
164110458|NCT01962298|592765426|FG004|Overall Study|Insufficient data|1|||
164110459|NCT01962298|592765422|FG000|Overall Study|Incorrect data recorded|0|||
164110460|NCT01962298|592765423|FG001|Overall Study|Incorrect data recorded|1|||
164110461|NCT01962298|592765424|FG002|Overall Study|Incorrect data recorded|0|||
164110462|NCT01962298|592765425|FG003|Overall Study|Incorrect data recorded|0|||
164110463|NCT01962298|592765426|FG004|Overall Study|Incorrect data recorded|0|||
164110464|NCT01962298|592765422|FG000|Overall Study|Physician Decision|0|||
164110465|NCT01962298|592765423|FG001|Overall Study|Physician Decision|1|||
164110466|NCT01962298|592765424|FG002|Overall Study|Physician Decision|0|||
164110467|NCT01962298|592765425|FG003|Overall Study|Physician Decision|0|||
164110468|NCT01962298|592765426|FG004|Overall Study|Physician Decision|1|||
164110469|NCT01576705|592765427|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
164110470|NCT01576705|592765428|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
164110471|NCT01576705|592765429|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
164110472|NCT01576705|592765430|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
164110473|NCT01576705|592765427|FG000|Overall Study|invalid ICF|0|||
164110474|NCT01576705|592765428|FG001|Overall Study|invalid ICF|1|||
164110475|NCT01576705|592765429|FG002|Overall Study|invalid ICF|0|||
164110476|NCT01576705|592765430|FG003|Overall Study|invalid ICF|0|||
164110477|NCT03727139|592765431|FG000|Overall Study|Protocol Violation|60|||
164110478|NCT00566722|592765432|FG000|Overall Study|Adverse Event|0|||
164110479|NCT00566722|592765433|FG001|Overall Study|Adverse Event|1|||
164110480|NCT00566722|592765434|FG002|Overall Study|Adverse Event|0|||
164110481|NCT00566722|592765432|FG000|Overall Study|Withdrawal by Subject|0|||
164110482|NCT00566722|592765433|FG001|Overall Study|Withdrawal by Subject|0|||
164110483|NCT00566722|592765434|FG002|Overall Study|Withdrawal by Subject|1|||
164110484|NCT00566722|592765432|FG000|Overall Study|Lost to Follow-up|1|||
164110485|NCT00566722|592765433|FG001|Overall Study|Lost to Follow-up|1|||
164110486|NCT00566722|592765434|FG002|Overall Study|Lost to Follow-up|1|||
164110487|NCT00566722|592765432|FG000|Overall Study|Lack of Efficacy|1|||
164110488|NCT00566722|592765433|FG001|Overall Study|Lack of Efficacy|2|||
164110489|NCT00566722|592765434|FG002|Overall Study|Lack of Efficacy|4|||
164110490|NCT00566722|592765432|FG000|Overall Study|Did not meet exclusion criteria|0|||
164110491|NCT00566722|592765433|FG001|Overall Study|Did not meet exclusion criteria|0|||
164110492|NCT00566722|592765434|FG002|Overall Study|Did not meet exclusion criteria|2|||
164110493|NCT00566722|592765432|FG000|Overall Study|Serious adverse event|0|||
164110494|NCT00566722|592765433|FG001|Overall Study|Serious adverse event|1|||
164110495|NCT00566722|592765434|FG002|Overall Study|Serious adverse event|0|||
164110496|NCT00566722|592765432|FG000|Overall Study|Noncompliant with drug administration|0|||
164110497|NCT00566722|592765433|FG001|Overall Study|Noncompliant with drug administration|0|||
164110498|NCT00566722|592765434|FG002|Overall Study|Noncompliant with drug administration|1|||
164110499|NCT00858403|592765435|FG000|Overall Study|Withdrawal by Subject|1|||
164110500|NCT00858403|592765435|FG000|Overall Study|Death|3|||
164110501|NCT00858403|592765435|FG000|Overall Study|Disease Progression|1|||
164110502|NCT02264977|592765436|FG000|Overall Study|Death|3|||
164110503|NCT02264977|592765436|FG000|Overall Study|Physician Decision|1|||
164110504|NCT02264977|592765436|FG000|Overall Study|Refuse to return|1|||
164110505|NCT03573544|592765437|FG000|Overall Study|Adverse Event|0|||
164110506|NCT03573544|592765438|FG001|Overall Study|Adverse Event|0|||
164110507|NCT03573544|592765439|FG002|Overall Study|Adverse Event|0|||
164110508|NCT03573544|592765440|FG003|Overall Study|Adverse Event|3|||
164110509|NCT03573544|592765441|FG004|Overall Study|Adverse Event|1|||
164110510|NCT03573544|592765442|FG005|Overall Study|Adverse Event|0|||
164110511|NCT03573544|592765443|FG006|Overall Study|Adverse Event|2|||
164110512|NCT03573544|592765444|FG007|Overall Study|Adverse Event|0|||
164110513|NCT03573544|592765437|FG000|Overall Study|Physician Decision|0|||
164110514|NCT03573544|592765438|FG001|Overall Study|Physician Decision|0|||
164110515|NCT03573544|592765439|FG002|Overall Study|Physician Decision|0|||
164110516|NCT03573544|592765440|FG003|Overall Study|Physician Decision|0|||
164110517|NCT03573544|592765441|FG004|Overall Study|Physician Decision|0|||
164110518|NCT03573544|592765442|FG005|Overall Study|Physician Decision|0|||
164110519|NCT03573544|592765443|FG006|Overall Study|Physician Decision|1|||
164110520|NCT03573544|592765444|FG007|Overall Study|Physician Decision|0|||
164110521|NCT03573544|592765437|FG000|Overall Study|Withdrawal by Subject|2|||
164110522|NCT03573544|592765438|FG001|Overall Study|Withdrawal by Subject|0|||
164110523|NCT03573544|592765439|FG002|Overall Study|Withdrawal by Subject|0|||
164110524|NCT03573544|592765440|FG003|Overall Study|Withdrawal by Subject|1|||
164110525|NCT03573544|592765441|FG004|Overall Study|Withdrawal by Subject|1|||
164110526|NCT03573544|592765442|FG005|Overall Study|Withdrawal by Subject|1|||
164110527|NCT03573544|592765443|FG006|Overall Study|Withdrawal by Subject|0|||
164110528|NCT03573544|592765444|FG007|Overall Study|Withdrawal by Subject|1|||
164110529|NCT03573544|592765437|FG000|Overall Study|Disease progression|3|||
164110530|NCT03573544|592765438|FG001|Overall Study|Disease progression|3|||
164110531|NCT03573544|592765439|FG002|Overall Study|Disease progression|6|||
164110532|NCT03573544|592765440|FG003|Overall Study|Disease progression|4|||
164110533|NCT03573544|592765441|FG004|Overall Study|Disease progression|5|||
164110534|NCT03573544|592765442|FG005|Overall Study|Disease progression|7|||
164110535|NCT03573544|592765443|FG006|Overall Study|Disease progression|6|||
164110536|NCT03573544|592765444|FG007|Overall Study|Disease progression|7|||
164110537|NCT03105297|592765448|FG000|Baseline Phase (Day 1)|Other|21|||
164110538|NCT03105297|592765448|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
164110539|NCT03105297|592765448|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
164110540|NCT00714051|592765449|FG000|Overall Study|Withdrawal by Subject|1|||
164110541|NCT00714051|592765450|FG001|Overall Study|Withdrawal by Subject|0|||
164110542|NCT00714051|592765449|FG000|Overall Study|Death|0|||
164110543|NCT00714051|592765450|FG001|Overall Study|Death|1|||
164110544|NCT00227370|592765451|FG000|Overall Study|Withdrawal by Subject|1|||
164110545|NCT00227370|592765452|FG001|Overall Study|Withdrawal by Subject|2|||
164110546|NCT00227370|592765451|FG000|Overall Study|Death|3|||
164110547|NCT00227370|592765452|FG001|Overall Study|Death|4|||
164110548|NCT00227370|592765451|FG000|Overall Study|Adverse Event|6|||
164110549|NCT00227370|592765452|FG001|Overall Study|Adverse Event|11|||
164110550|NCT00227370|592765451|FG000|Overall Study|Physician Decision|9|||
164110551|NCT00227370|592765452|FG001|Overall Study|Physician Decision|6|||
164110552|NCT00227370|592765451|FG000|Overall Study|Other reasons|2|||
164110553|NCT00227370|592765452|FG001|Overall Study|Other reasons|1|||
164110554|NCT03846193|592765453|FG000|Overall Study|Physician Decision|0|||
164110555|NCT03846193|592765454|FG001|Overall Study|Physician Decision|0|||
164110556|NCT03846193|592765455|FG002|Overall Study|Physician Decision|1|||
164110557|NCT03846193|592765456|FG003|Overall Study|Physician Decision|0|||
164110558|NCT03846193|592765457|FG004|Overall Study|Physician Decision|0|||
164110559|NCT03846193|592765453|FG000|Overall Study|Lost to Follow-up|0|||
164110560|NCT03846193|592765454|FG001|Overall Study|Lost to Follow-up|0|||
164110561|NCT03846193|592765455|FG002|Overall Study|Lost to Follow-up|0|||
164110562|NCT03846193|592765456|FG003|Overall Study|Lost to Follow-up|0|||
164110563|NCT03846193|592765457|FG004|Overall Study|Lost to Follow-up|1|||
164110564|NCT03846193|592765453|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164110565|NCT03846193|592765454|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164110566|NCT03846193|592765455|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164110567|NCT03846193|592765456|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
164110568|NCT03846193|592765457|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
164110569|NCT01390948|592765458|FG000|Overall Study|End of Study|1|||
164110570|NCT01390948|592765459|FG001|Overall Study|End of Study|0|||
164110571|NCT01390948|592765460|FG002|Overall Study|End of Study|0|||
164110572|NCT01390948|592765458|FG000|Overall Study|Withdrew consent|2|||
164110573|NCT01390948|592765459|FG001|Overall Study|Withdrew consent|2|||
164110574|NCT01390948|592765460|FG002|Overall Study|Withdrew consent|0|||
164110575|NCT01390948|592765458|FG000|Overall Study|Progressive Disease|2|||
164110576|NCT01390948|592765459|FG001|Overall Study|Progressive Disease|5|||
164110577|NCT01390948|592765460|FG002|Overall Study|Progressive Disease|0|||
164110578|NCT01390948|592765458|FG000|Overall Study|Death during follow-up|10|||
164110579|NCT01390948|592765459|FG001|Overall Study|Death during follow-up|11|||
164110580|NCT01390948|592765460|FG002|Overall Study|Death during follow-up|1|||
164110581|NCT01131260|592765467|FG000|Overall Study|Randomization error|5|||
164110582|NCT01131260|592765468|FG001|Overall Study|Randomization error|1|||
164110583|NCT01131260|592765467|FG000|Overall Study|Declined to continue participation|8|||
164110584|NCT01131260|592765468|FG001|Overall Study|Declined to continue participation|13|||
164110585|NCT01131260|592765467|FG000|Overall Study|Physician Decision|22|||
164110586|NCT01131260|592765468|FG001|Overall Study|Physician Decision|24|||
164110587|NCT01131260|592765467|FG000|Overall Study|Technical problems|7|||
164110588|NCT01131260|592765468|FG001|Overall Study|Technical problems|6|||
164110589|NCT01131260|592765467|FG000|Overall Study|Staff error|2|||
164110590|NCT01131260|592765468|FG001|Overall Study|Staff error|1|||
164110591|NCT01131260|592765467|FG000|Overall Study|Ineligible|0|||
164110592|NCT01131260|592765468|FG001|Overall Study|Ineligible|2|||
164110593|NCT00849797|592765473|FG000|First Intervention|bad veins|1|||
164110594|NCT00849797|592765474|FG001|First Intervention|bad veins|0|||
164110595|NCT00849797|592765473|FG000|First Intervention|Adverse Event|0|||
164110596|NCT00849797|592765474|FG001|First Intervention|Adverse Event|1|||
164110597|NCT00849797|592765473|FG000|Washout: One Week|Withdrawal by Subject|0|||
164110598|NCT00849797|592765474|FG001|Washout: One Week|Withdrawal by Subject|2|||
164110599|NCT01494532|592765475|FG000|Overall Study|Adverse Event|4|||
164110600|NCT01494532|592765476|FG001|Overall Study|Adverse Event|1|||
164110601|NCT01494532|592765477|FG002|Overall Study|Adverse Event|8|||
164110602|NCT01494532|592765478|FG003|Overall Study|Adverse Event|6|||
164110603|NCT01494532|592765479|FG004|Overall Study|Adverse Event|5|||
164110604|NCT01494532|592765480|FG005|Overall Study|Adverse Event|0|||
164110605|NCT01494532|592765475|FG000|Overall Study|Lack of Efficacy|0|||
164110606|NCT01494532|592765476|FG001|Overall Study|Lack of Efficacy|0|||
164110607|NCT01494532|592765477|FG002|Overall Study|Lack of Efficacy|0|||
164110608|NCT01494532|592765478|FG003|Overall Study|Lack of Efficacy|0|||
164110609|NCT01494532|592765479|FG004|Overall Study|Lack of Efficacy|2|||
164110610|NCT01494532|592765480|FG005|Overall Study|Lack of Efficacy|0|||
164110611|NCT01494532|592765475|FG000|Overall Study|Protocol deviation|2|||
164110612|NCT01494532|592765476|FG001|Overall Study|Protocol deviation|1|||
164110613|NCT01494532|592765477|FG002|Overall Study|Protocol deviation|3|||
164110614|NCT01494532|592765478|FG003|Overall Study|Protocol deviation|2|||
164110615|NCT01494532|592765479|FG004|Overall Study|Protocol deviation|3|||
164110616|NCT01494532|592765480|FG005|Overall Study|Protocol deviation|0|||
164110617|NCT01494532|592765475|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164110618|NCT01494532|592765476|FG001|Overall Study|Protocol-defined stopping criteria|0|||
164110619|NCT01494532|592765477|FG002|Overall Study|Protocol-defined stopping criteria|1|||
164110620|NCT01494532|592765478|FG003|Overall Study|Protocol-defined stopping criteria|0|||
164110621|NCT01494532|592765479|FG004|Overall Study|Protocol-defined stopping criteria|0|||
164110622|NCT01494532|592765480|FG005|Overall Study|Protocol-defined stopping criteria|0|||
164110623|NCT01494532|592765475|FG000|Overall Study|Lost to Follow-up|1|||
164110624|NCT01494532|592765476|FG001|Overall Study|Lost to Follow-up|0|||
164110625|NCT01494532|592765477|FG002|Overall Study|Lost to Follow-up|0|||
164110626|NCT01494532|592765478|FG003|Overall Study|Lost to Follow-up|2|||
164110627|NCT01494532|592765479|FG004|Overall Study|Lost to Follow-up|0|||
164110628|NCT01494532|592765480|FG005|Overall Study|Lost to Follow-up|0|||
164110629|NCT01494532|592765475|FG000|Overall Study|Physician Decision|0|||
164110630|NCT01494532|592765476|FG001|Overall Study|Physician Decision|1|||
164110631|NCT01494532|592765477|FG002|Overall Study|Physician Decision|1|||
164110632|NCT01494532|592765478|FG003|Overall Study|Physician Decision|2|||
164110633|NCT01494532|592765479|FG004|Overall Study|Physician Decision|0|||
164110634|NCT01494532|592765480|FG005|Overall Study|Physician Decision|0|||
164110635|NCT01494532|592765475|FG000|Overall Study|Withdrawal by Subject|3|||
164110636|NCT01494532|592765476|FG001|Overall Study|Withdrawal by Subject|1|||
164110637|NCT01494532|592765477|FG002|Overall Study|Withdrawal by Subject|4|||
164110638|NCT01494532|592765478|FG003|Overall Study|Withdrawal by Subject|3|||
164110639|NCT01494532|592765479|FG004|Overall Study|Withdrawal by Subject|2|||
164110640|NCT01494532|592765480|FG005|Overall Study|Withdrawal by Subject|0|||
164110641|NCT00679081|592765481|FG000|Overall Study|Lost to Follow-up|1|||
164110642|NCT01675596|592765485|FG000|Overall Study|Death|6|||
164110643|NCT01675596|592765485|FG000|Overall Study|Exit with other reason|1|||
164110644|NCT01675596|592765485|FG000|Overall Study|Missed Visit|1|||
164110645|NCT01139762|592765486|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
164110646|NCT01139762|592765487|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
164110647|NCT01139762|592765488|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
164110648|NCT01139762|592765486|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
164110649|NCT01139762|592765487|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
164110650|NCT01139762|592765488|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
164110651|NCT01139762|592765486|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
164110652|NCT01139762|592765487|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
164110653|NCT01139762|592765488|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
164110654|NCT01139762|592765486|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
164110655|NCT01139762|592765487|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
164110656|NCT01139762|592765488|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
164110657|NCT01139762|592765486|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
164110658|NCT01139762|592765487|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
164110659|NCT01139762|592765488|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
164110660|NCT01139762|592765486|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
164110661|NCT01139762|592765487|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
164110662|NCT01139762|592765488|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
164110663|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
164110664|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
164110665|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
164110666|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Death|0|||
164110667|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Death|1|||
164110668|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Death|1|||
164110669|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
164110670|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
164148737|NCT03207867|592904942|FG006|Overall Study|Progressive Disease|9|||
164110671|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
164110672|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
164110673|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
164110674|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
164110675|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
164110676|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
164110677|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
164110678|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
164110679|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
164110680|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
164110681|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
164110682|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
164110683|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
164110684|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
164110685|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
164110686|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
164110687|NCT01139762|592765486|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
164110688|NCT01139762|592765487|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
164110689|NCT01139762|592765488|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
164110690|NCT01018862|592765495|FG000|Overall Study|Adverse Event|2|||
164110691|NCT01018862|592765496|FG001|Overall Study|Adverse Event|0|||
164110692|NCT01018862|592765497|FG002|Overall Study|Adverse Event|6|||
164110693|NCT01018862|592765495|FG000|Overall Study|Lack of Efficacy|1|||
164110694|NCT01018862|592765496|FG001|Overall Study|Lack of Efficacy|0|||
164110695|NCT01018862|592765497|FG002|Overall Study|Lack of Efficacy|2|||
164110696|NCT01018862|592765495|FG000|Overall Study|Lost to Follow-up|3|||
164110697|NCT01018862|592765496|FG001|Overall Study|Lost to Follow-up|1|||
164110698|NCT01018862|592765497|FG002|Overall Study|Lost to Follow-up|0|||
164110699|NCT01018862|592765495|FG000|Overall Study|Protocol Violation|1|||
164110700|NCT01018862|592765496|FG001|Overall Study|Protocol Violation|3|||
164110701|NCT01018862|592765497|FG002|Overall Study|Protocol Violation|3|||
164110702|NCT01018862|592765495|FG000|Overall Study|Withdrawal by Subject|1|||
164110703|NCT01018862|592765496|FG001|Overall Study|Withdrawal by Subject|2|||
164110704|NCT01018862|592765497|FG002|Overall Study|Withdrawal by Subject|1|||
164110705|NCT01018862|592765495|FG000|Overall Study|administrative problems|5|||
164110706|NCT01018862|592765496|FG001|Overall Study|administrative problems|4|||
164110707|NCT01018862|592765497|FG002|Overall Study|administrative problems|4|||
164110708|NCT01968031|592765501|FG000|Overall Study|Adverse Event|13|||
164110709|NCT01968031|592765502|FG001|Overall Study|Adverse Event|10|||
164110710|NCT01968031|592765503|FG002|Overall Study|Adverse Event|22|||
164110711|NCT01968031|592765501|FG000|Overall Study|Withdrawal by Subject|3|||
164110712|NCT01968031|592765502|FG001|Overall Study|Withdrawal by Subject|7|||
164110713|NCT01968031|592765503|FG002|Overall Study|Withdrawal by Subject|3|||
164110714|NCT01968031|592765501|FG000|Overall Study|Did not meet entry criteria|1|||
164110715|NCT01968031|592765502|FG001|Overall Study|Did not meet entry criteria|1|||
164110716|NCT01968031|592765503|FG002|Overall Study|Did not meet entry criteria|1|||
164110717|NCT01968031|592765501|FG000|Overall Study|Noncompliance|0|||
164110718|NCT01968031|592765502|FG001|Overall Study|Noncompliance|0|||
164110719|NCT01968031|592765503|FG002|Overall Study|Noncompliance|2|||
164110720|NCT01968031|592765501|FG000|Overall Study|Failed inclusion criteria|0|||
164110721|NCT01968031|592765502|FG001|Overall Study|Failed inclusion criteria|2|||
164110722|NCT01968031|592765503|FG002|Overall Study|Failed inclusion criteria|0|||
164110723|NCT01968031|592765501|FG000|Overall Study|Death|0|||
164110724|NCT01968031|592765502|FG001|Overall Study|Death|0|||
164110725|NCT01968031|592765503|FG002|Overall Study|Death|1|||
164110726|NCT01968031|592765501|FG000|Overall Study|Prohibited concomitant medication|1|||
164110727|NCT01968031|592765502|FG001|Overall Study|Prohibited concomitant medication|0|||
164110728|NCT01968031|592765503|FG002|Overall Study|Prohibited concomitant medication|0|||
164110729|NCT01404988|592765506|FG000|Overall Study|Death|2|||
164110730|NCT01404988|592765507|FG001|Overall Study|Death|0|||
164110731|NCT01404988|592765508|FG002|Overall Study|Death|2|||
164110732|NCT01404988|592765506|FG000|Overall Study|Adverse Event|1|||
164110733|NCT01404988|592765507|FG001|Overall Study|Adverse Event|0|||
164110734|NCT01404988|592765508|FG002|Overall Study|Adverse Event|0|||
164110735|NCT01404988|592765506|FG000|Overall Study|Withdrawal by Subject|2|||
164110736|NCT01404988|592765507|FG001|Overall Study|Withdrawal by Subject|2|||
164110737|NCT01404988|592765508|FG002|Overall Study|Withdrawal by Subject|0|||
164110738|NCT01404988|592765506|FG000|Overall Study|Lost to Follow-up|1|||
164110739|NCT01404988|592765507|FG001|Overall Study|Lost to Follow-up|2|||
164110740|NCT01404988|592765508|FG002|Overall Study|Lost to Follow-up|1|||
164110741|NCT04594252|592765509|FG000|Overall Study|Adverse Event|0|||
164110742|NCT04594252|592765510|FG001|Overall Study|Adverse Event|2|||
164110743|NCT04573309|592767255|FG000|Overall Study|Protocol Violation|1|||
164110744|NCT04573309|592767256|FG001|Overall Study|Protocol Violation|0|||
164110745|NCT01691430|592767259|FG000|Overall Study|Death|17|||
164110746|NCT01691430|592767260|FG001|Overall Study|Death|16|||
164110747|NCT01691430|592767259|FG000|Overall Study|Withdrawal by Subject|5|||
164110748|NCT01691430|592767260|FG001|Overall Study|Withdrawal by Subject|1|||
164110749|NCT01691430|592767259|FG000|Overall Study|Lost to Follow-up|0|||
164110750|NCT01691430|592767260|FG001|Overall Study|Lost to Follow-up|3|||
164110751|NCT01894230|592767261|FG000|Overall Study|Lost to Follow-up|2|||
164110752|NCT01894230|592767262|FG001|Overall Study|Lost to Follow-up|2|||
164110753|NCT01894230|592767261|FG000|Overall Study|Withdrawal by Subject|4|||
164110754|NCT01894230|592767262|FG001|Overall Study|Withdrawal by Subject|4|||
164110755|NCT01894230|592767261|FG000|Overall Study|Non-adherent|0|||
164110756|NCT01894230|592767262|FG001|Overall Study|Non-adherent|1|||
164110757|NCT01894230|592767261|FG000|Overall Study|Death|1|||
164110758|NCT01894230|592767262|FG001|Overall Study|Death|0|||
164110759|NCT01109849|592767263|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
164110760|NCT01109849|592767264|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
164110761|NCT01109849|592767265|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
164110762|NCT01109849|592767266|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
164110763|NCT01109849|592767267|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
164110764|NCT01109849|592767263|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
164110765|NCT01109849|592767264|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164110766|NCT01109849|592767265|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164110767|NCT01109849|592767266|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164110768|NCT01109849|592767267|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
164110769|NCT01109849|592767263|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
164110770|NCT01109849|592767264|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
164110771|NCT01109849|592767265|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
164110772|NCT01109849|592767266|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
164110773|NCT01109849|592767267|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
164110774|NCT01109849|592767263|FG000|Initial Randomization: ADHD Treatment|move away|2|||
164110775|NCT01109849|592767264|FG001|Initial Randomization: ADHD Treatment|move away|7|||
164110776|NCT01109849|592767265|FG002|Initial Randomization: ADHD Treatment|move away|0|||
164110777|NCT01109849|592767266|FG003|Initial Randomization: ADHD Treatment|move away|0|||
164110778|NCT01109849|592767267|FG004|Initial Randomization: ADHD Treatment|move away|0|||
164110779|NCT01109849|592767263|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
164110780|NCT01109849|592767264|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
164110781|NCT01109849|592767265|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
164110782|NCT01109849|592767266|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
164110783|NCT01109849|592767267|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
164110784|NCT01109849|592767263|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
164110785|NCT01109849|592767264|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
164110786|NCT01109849|592767265|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
164110787|NCT01109849|592767266|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
164110788|NCT01109849|592767267|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
164110789|NCT02219009|592767270|FG000|Overall Study|Withdrawal by Subject|5|||
164110790|NCT02219009|592767271|FG001|Overall Study|Withdrawal by Subject|1|||
164110791|NCT02219009|592767270|FG000|Overall Study|Adverse Event|2|||
164110792|NCT02219009|592767271|FG001|Overall Study|Adverse Event|4|||
164110793|NCT02219009|592767270|FG000|Overall Study|Lost to Follow-up|2|||
164110794|NCT02219009|592767271|FG001|Overall Study|Lost to Follow-up|2|||
164110795|NCT02219009|592767270|FG000|Overall Study|Protocol deviation|1|||
164110796|NCT02219009|592767271|FG001|Overall Study|Protocol deviation|0|||
164110797|NCT02219009|592767270|FG000|Overall Study|Physician Decision|0|||
164110798|NCT02219009|592767271|FG001|Overall Study|Physician Decision|1|||
164110799|NCT02259348|592767272|FG000|Overall Study|Donors|6|||
164110800|NCT02259348|592767272|FG000|Overall Study|Death|4|||
164110801|NCT01622660|592767273|FG000|Overall Study|Adverse Event|1|||
164110802|NCT02485158|592767275|FG000|Overall Study|Withdrawal by Subject|3|||
164110803|NCT02485158|592767275|FG000|Overall Study|expected drug side effect|1|||
164110804|NCT02664415|592767276|FG000|Overall Study|Adverse Event|1|||
164110805|NCT02664415|592767277|FG001|Overall Study|Adverse Event|0|||
164110806|NCT00642993|592767278|FG000|Overall Study|Adverse Event|85|||
164110807|NCT00642993|592767279|FG001|Overall Study|Adverse Event|4|||
164110808|NCT00642993|592767278|FG000|Overall Study|Lost to Follow-up|8|||
164110809|NCT00642993|592767279|FG001|Overall Study|Lost to Follow-up|4|||
164110810|NCT00642993|592767278|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
164110811|NCT00642993|592767279|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
164110812|NCT00642993|592767278|FG000|Overall Study|Protocol Violation|1|||
164110813|NCT00642993|592767279|FG001|Overall Study|Protocol Violation|4|||
164110814|NCT00642993|592767278|FG000|Overall Study|Did not meet protocol eligibility|0|||
164110815|NCT00642993|592767279|FG001|Overall Study|Did not meet protocol eligibility|1|||
164110816|NCT00642993|592767278|FG000|Overall Study|Administrative|1|||
164110817|NCT00642993|592767279|FG001|Overall Study|Administrative|0|||
164110818|NCT02034513|592767280|FG000|Overall Study|Adverse Event|11|||
164110819|NCT02034513|592767281|FG001|Overall Study|Adverse Event|10|||
164110820|NCT02034513|592767280|FG000|Overall Study|Lack of Efficacy|0|||
164110821|NCT02034513|592767281|FG001|Overall Study|Lack of Efficacy|1|||
164110822|NCT02034513|592767280|FG000|Overall Study|Lost to Follow-up|6|||
164110823|NCT02034513|592767281|FG001|Overall Study|Lost to Follow-up|7|||
164110824|NCT02034513|592767280|FG000|Overall Study|Pregnancy|0|||
164110825|NCT02034513|592767281|FG001|Overall Study|Pregnancy|3|||
164110826|NCT02034513|592767280|FG000|Overall Study|Protocol Violation|7|||
164110827|NCT02034513|592767281|FG001|Overall Study|Protocol Violation|10|||
164110828|NCT02034513|592767280|FG000|Overall Study|Withdrawal by Subject|25|||
164110829|NCT02034513|592767281|FG001|Overall Study|Withdrawal by Subject|25|||
164110830|NCT02034513|592767280|FG000|Overall Study|Unclassified|0|||
164110831|NCT02034513|592767281|FG001|Overall Study|Unclassified|1|||
164110832|NCT00960154|592767282|FG000|Overall Study|Study termination|25|||
164110833|NCT00960154|592767283|FG001|Overall Study|Study termination|25|||
164110834|NCT00757705|592767284|FG000|Overall Study|Adverse Event|19|||
164110835|NCT00757705|592767284|FG000|Overall Study|Lost to Follow-up|16|||
164110836|NCT00757705|592767284|FG000|Overall Study|Withdrawal by Subject|25|||
164110837|NCT00757705|592767284|FG000|Overall Study|Insufficient Response|26|||
164110838|NCT00757705|592767284|FG000|Overall Study|Ineligible to continue|8|||
164110839|NCT00757705|592767284|FG000|Overall Study|Non-compliant|9|||
164110840|NCT00757705|592767284|FG000|Overall Study|Other|18|||
164110841|NCT04408924|592767288|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
164110842|NCT04408924|592767288|FG000|Overall Study|Lost to Follow-up|3|||
164110843|NCT04408924|592767288|FG000|Overall Study|Withdrawal by Subject|5|||
164110844|NCT04408924|592767288|FG000|Overall Study|Sponsor Decision|2|||
164110845|NCT00486434|592767289|FG000|Overall Study|Withdrawal by Subject|34|||
164110846|NCT00486434|592767290|FG001|Overall Study|Withdrawal by Subject|39|||
164110847|NCT00486434|592767289|FG000|Overall Study|Adverse Event|118|||
164110848|NCT00486434|592767290|FG001|Overall Study|Adverse Event|44|||
164110849|NCT00486434|592767289|FG000|Overall Study|Protocol Violation|22|||
164110850|NCT00486434|592767290|FG001|Overall Study|Protocol Violation|21|||
164110851|NCT00486434|592767289|FG000|Overall Study|Lack of Efficacy|12|||
164110852|NCT00486434|592767290|FG001|Overall Study|Lack of Efficacy|19|||
164110853|NCT00486434|592767289|FG000|Overall Study|Lost to Follow-up|2|||
164110854|NCT00486434|592767290|FG001|Overall Study|Lost to Follow-up|3|||
164110855|NCT00486434|592767289|FG000|Overall Study|Death|1|||
164110856|NCT00486434|592767290|FG001|Overall Study|Death|2|||
164110857|NCT00486434|592767289|FG000|Overall Study|Personal reasons|5|||
164110858|NCT00486434|592767290|FG001|Overall Study|Personal reasons|6|||
164110859|NCT02218541|592767291|FG000|Overall Study|Lost to Follow-up|2|||
164110860|NCT02218541|592767292|FG001|Overall Study|Lost to Follow-up|1|||
164110861|NCT02218541|592767291|FG000|Overall Study|Implant Failure|4|||
164110862|NCT02218541|592767292|FG001|Overall Study|Implant Failure|1|||
164110863|NCT04661202|592767293|FG000|Overall Study|Withdrawal by Subject|1|||
164110864|NCT04661202|592767294|FG001|Overall Study|Withdrawal by Subject|1|||
164110865|NCT04661202|592767293|FG000|Overall Study|Lack of Efficacy|2|||
164110866|NCT04661202|592767294|FG001|Overall Study|Lack of Efficacy|0|||
164110867|NCT00856349|592767295|FG000|Overall Study|Death|418|||
164110868|NCT00856349|592767295|FG000|Overall Study|Withdrawal by Subject|116|||
164110869|NCT00856349|592767295|FG000|Overall Study|Lost to Follow-up|91|||
164110870|NCT00856349|592767295|FG000|Overall Study|Protocol Violation|38|||
164110871|NCT00856349|592767295|FG000|Overall Study|Physician Decision|13|||
164110872|NCT00856349|592767295|FG000|Overall Study|Subject relocation|104|||
164110873|NCT00856349|592767295|FG000|Overall Study|Device explant|33|||
164110874|NCT00856349|592767295|FG000|Overall Study|Site closure|78|||
164110875|NCT00856349|592767295|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
164110876|NCT02313558|592767298|FG000|Overall Study|Withdrawal by Subject|2|||
164110877|NCT02313558|592767299|FG001|Overall Study|Withdrawal by Subject|0|||
164110878|NCT02313558|592767298|FG000|Overall Study|Lost to Follow-up|4|||
164110879|NCT02313558|592767299|FG001|Overall Study|Lost to Follow-up|4|||
164110880|NCT04158687|592767301|FG000|Overall Study|Adverse Event|2|||
164110881|NCT04158687|592767302|FG001|Overall Study|Adverse Event|3|||
164110882|NCT04158687|592767303|FG002|Overall Study|Adverse Event|0|||
164110883|NCT04158687|592767304|FG003|Overall Study|Adverse Event|3|||
164110884|NCT04158687|592767301|FG000|Overall Study|Lost to Follow-up|5|||
164110885|NCT04158687|592767302|FG001|Overall Study|Lost to Follow-up|12|||
164110886|NCT04158687|592767303|FG002|Overall Study|Lost to Follow-up|4|||
164110887|NCT04158687|592767304|FG003|Overall Study|Lost to Follow-up|5|||
164110888|NCT04158687|592767301|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
164110889|NCT04158687|592767302|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
164110890|NCT04158687|592767303|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
164110891|NCT04158687|592767304|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
164110892|NCT04158687|592767301|FG000|Overall Study|Non-Compliance with Study Medication|2|||
164110893|NCT04158687|592767302|FG001|Overall Study|Non-Compliance with Study Medication|2|||
164110894|NCT04158687|592767303|FG002|Overall Study|Non-Compliance with Study Medication|3|||
164110895|NCT04158687|592767304|FG003|Overall Study|Non-Compliance with Study Medication|0|||
164110896|NCT04158687|592767301|FG000|Overall Study|Investigator Decision|0|||
164110897|NCT04158687|592767302|FG001|Overall Study|Investigator Decision|0|||
164110898|NCT04158687|592767303|FG002|Overall Study|Investigator Decision|2|||
164110899|NCT04158687|592767304|FG003|Overall Study|Investigator Decision|0|||
164110900|NCT04158687|592767301|FG000|Overall Study|Protocol Violation|0|||
164110901|NCT04158687|592767302|FG001|Overall Study|Protocol Violation|2|||
164110902|NCT04158687|592767303|FG002|Overall Study|Protocol Violation|1|||
164110903|NCT04158687|592767304|FG003|Overall Study|Protocol Violation|0|||
164110904|NCT04158687|592767301|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
164110905|NCT04158687|592767302|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
164110906|NCT04158687|592767303|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
164110907|NCT04158687|592767304|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
164110908|NCT04158687|592767301|FG000|Overall Study|Reason not Specified|3|||
164110909|NCT04158687|592767302|FG001|Overall Study|Reason not Specified|2|||
164110910|NCT04158687|592767303|FG002|Overall Study|Reason not Specified|4|||
164110911|NCT04158687|592767304|FG003|Overall Study|Reason not Specified|4|||
164110912|NCT00585286|592767309|FG000|Overall Study|Lost to Follow-up|1|||
164110913|NCT03358147|592767314|FG000|Overall Study|Withdrawal by Subject|13|||
164110914|NCT03358147|592767315|FG001|Overall Study|Withdrawal by Subject|19|||
164110915|NCT03358147|592767316|FG002|Overall Study|Withdrawal by Subject|16|||
164110916|NCT03358147|592767317|FG003|Overall Study|Withdrawal by Subject|10|||
164110917|NCT03358147|592767318|FG004|Overall Study|Withdrawal by Subject|5|||
164110918|NCT03358147|592767314|FG000|Overall Study|Adverse Event|3|||
164110919|NCT03358147|592767315|FG001|Overall Study|Adverse Event|9|||
164110920|NCT03358147|592767316|FG002|Overall Study|Adverse Event|7|||
164110921|NCT03358147|592767317|FG003|Overall Study|Adverse Event|5|||
164110922|NCT03358147|592767318|FG004|Overall Study|Adverse Event|2|||
164110923|NCT03358147|592767314|FG000|Overall Study|Lost to Follow-up|4|||
164110924|NCT03358147|592767315|FG001|Overall Study|Lost to Follow-up|3|||
164110925|NCT03358147|592767316|FG002|Overall Study|Lost to Follow-up|7|||
164110926|NCT03358147|592767317|FG003|Overall Study|Lost to Follow-up|6|||
164110927|NCT03358147|592767318|FG004|Overall Study|Lost to Follow-up|4|||
164110928|NCT03358147|592767314|FG000|Overall Study|Major Protocol Deviation|11|||
164110929|NCT03358147|592767315|FG001|Overall Study|Major Protocol Deviation|3|||
164110930|NCT03358147|592767316|FG002|Overall Study|Major Protocol Deviation|2|||
164110931|NCT03358147|592767317|FG003|Overall Study|Major Protocol Deviation|3|||
164110932|NCT03358147|592767318|FG004|Overall Study|Major Protocol Deviation|1|||
164110933|NCT03358147|592767314|FG000|Overall Study|Protocol specified criteria|2|||
164110934|NCT03358147|592767315|FG001|Overall Study|Protocol specified criteria|3|||
164110935|NCT03358147|592767316|FG002|Overall Study|Protocol specified criteria|0|||
164110936|NCT03358147|592767317|FG003|Overall Study|Protocol specified criteria|3|||
164110937|NCT03358147|592767318|FG004|Overall Study|Protocol specified criteria|1|||
164110938|NCT03358147|592767314|FG000|Overall Study|Physician Decision|1|||
164110939|NCT03358147|592767315|FG001|Overall Study|Physician Decision|0|||
164110940|NCT03358147|592767316|FG002|Overall Study|Physician Decision|1|||
164110941|NCT03358147|592767317|FG003|Overall Study|Physician Decision|6|||
164110942|NCT03358147|592767318|FG004|Overall Study|Physician Decision|1|||
164110943|NCT03358147|592767314|FG000|Overall Study|Administrative reasons|0|||
164110944|NCT03358147|592767315|FG001|Overall Study|Administrative reasons|1|||
164110945|NCT03358147|592767316|FG002|Overall Study|Administrative reasons|0|||
164110946|NCT03358147|592767317|FG003|Overall Study|Administrative reasons|3|||
164110947|NCT03358147|592767318|FG004|Overall Study|Administrative reasons|0|||
164110948|NCT03358147|592767314|FG000|Overall Study|Lack of Efficacy|0|||
164110949|NCT03358147|592767315|FG001|Overall Study|Lack of Efficacy|1|||
164110950|NCT03358147|592767316|FG002|Overall Study|Lack of Efficacy|1|||
164110951|NCT03358147|592767317|FG003|Overall Study|Lack of Efficacy|0|||
164110952|NCT03358147|592767318|FG004|Overall Study|Lack of Efficacy|0|||
164110953|NCT02072096|592767321|FG000|Overall Study|Lack of Efficacy|18|||
164110954|NCT02072096|592767322|FG001|Overall Study|Lack of Efficacy|29|||
164110955|NCT02072096|592767321|FG000|Overall Study|Protocol Violation|7|||
164110956|NCT02072096|592767322|FG001|Overall Study|Protocol Violation|7|||
164110957|NCT02072096|592767321|FG000|Overall Study|Withdrawal by Subject|5|||
164110958|NCT02072096|592767322|FG001|Overall Study|Withdrawal by Subject|7|||
164110959|NCT02072096|592767321|FG000|Overall Study|Adverse Event|5|||
164110960|NCT02072096|592767322|FG001|Overall Study|Adverse Event|2|||
164110961|NCT02072096|592767321|FG000|Overall Study|No Reason Provided|4|||
164110962|NCT02072096|592767322|FG001|Overall Study|No Reason Provided|2|||
164110963|NCT02072096|592767321|FG000|Overall Study|Death|2|||
164110964|NCT02072096|592767322|FG001|Overall Study|Death|0|||
164110965|NCT02072096|592767321|FG000|Overall Study|Physician Decision|0|||
164110966|NCT02072096|592767322|FG001|Overall Study|Physician Decision|1|||
164110967|NCT02072096|592767321|FG000|Overall Study|Study Terminated by Sponsor|43|||
164110968|NCT02072096|592767322|FG001|Overall Study|Study Terminated by Sponsor|30|||
164110969|NCT02072096|592767321|FG000|Overall Study|Lost to Follow-up|1|||
164110970|NCT02072096|592767322|FG001|Overall Study|Lost to Follow-up|0|||
164110971|NCT03236311|592767323|FG000|Overall Study|Study terminated by sponsor|0|||
164110972|NCT03236311|592767324|FG001|Overall Study|Study terminated by sponsor|2|||
164110973|NCT03236311|592767323|FG000|Overall Study|Adverse Event|0|||
164110974|NCT03236311|592767324|FG001|Overall Study|Adverse Event|1|||
164110975|NCT00669162|592767325|FG000|Overall Study|Withdrawal by Subject|1|||
164110976|NCT02704091|592767326|FG000|Overall Study|Adverse Event|4|||
164110977|NCT02704091|592767327|FG001|Overall Study|Adverse Event|3|||
164110978|NCT02704091|592767326|FG000|Overall Study|Protocol Violation|5|||
164110979|NCT02704091|592767327|FG001|Overall Study|Protocol Violation|3|||
164110980|NCT02704091|592767326|FG000|Overall Study|Consent withdrawn|4|||
164110981|NCT02704091|592767327|FG001|Overall Study|Consent withdrawn|4|||
164110982|NCT02704091|592767326|FG000|Overall Study|Lost to Follow-up|13|||
164110983|NCT02704091|592767327|FG001|Overall Study|Lost to Follow-up|5|||
164110984|NCT02704091|592767326|FG000|Overall Study|Other|2|||
164110985|NCT02704091|592767327|FG001|Overall Study|Other|8|||
164110986|NCT02412852|592767328|FG000|Overall Study|Withdrawal by Subject|0|||
164110987|NCT02412852|592767329|FG001|Overall Study|Withdrawal by Subject|1|||
164110988|NCT02412852|592767330|FG002|Overall Study|Withdrawal by Subject|0|||
164110989|NCT02412852|592767331|FG003|Overall Study|Withdrawal by Subject|0|||
164110990|NCT02412852|592767328|FG000|Overall Study|Physician Decision|0|||
164110991|NCT02412852|592767329|FG001|Overall Study|Physician Decision|0|||
164110992|NCT02412852|592767330|FG002|Overall Study|Physician Decision|0|||
164110993|NCT02412852|592767331|FG003|Overall Study|Physician Decision|1|||
164110994|NCT01051349|592767332|FG000|Overall Study|Adverse Event|88|||
164110995|NCT01051349|592767332|FG000|Overall Study|Consent Withdrawn|54|||
164110996|NCT01051349|592767332|FG000|Overall Study|Investigator Decision|6|||
164110997|NCT01051349|592767332|FG000|Overall Study|Lost to Follow-up|6|||
164110998|NCT01051349|592767332|FG000|Overall Study|Subject non-compliance|7|||
164110999|NCT01051349|592767332|FG000|Overall Study|Reason not Specified|12|||
164111000|NCT02336074|592767341|FG000|Overall Study|Adverse Event|0|||
164111001|NCT02336074|592767342|FG001|Overall Study|Adverse Event|2|||
164111002|NCT05604014|592767345|FG000|Overall Study|Lost to Follow-up|13|||
164111003|NCT01266902|592767364|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
164111004|NCT01266902|592767365|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
164111005|NCT01266902|592767366|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
164111006|NCT01266902|592767364|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
164111007|NCT01266902|592767365|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
164111008|NCT01266902|592767366|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
164111009|NCT01266902|592767364|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
164111010|NCT01266902|592767365|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
164111011|NCT01266902|592767366|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
164111012|NCT01266902|592767364|FG000|Period 1 (Main Study)|Adverse Event|3|||
164111013|NCT01266902|592767365|FG001|Period 1 (Main Study)|Adverse Event|11|||
164111014|NCT01266902|592767366|FG002|Period 1 (Main Study)|Adverse Event|0|||
164111015|NCT01266902|592767364|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
164111016|NCT01266902|592767365|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
164111017|NCT01266902|592767366|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
164111018|NCT01266902|592767364|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
164111019|NCT01266902|592767365|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
164111020|NCT01266902|592767366|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
164111021|NCT01266902|592767364|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
164111022|NCT01266902|592767365|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
164111023|NCT01266902|592767366|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
164111024|NCT01266902|592767364|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
164111025|NCT01266902|592767365|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
164111026|NCT01266902|592767366|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
164111027|NCT01266902|592767364|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
164111028|NCT01266902|592767365|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
164111029|NCT01266902|592767366|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
164111030|NCT01266902|592767364|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
164111031|NCT01266902|592767365|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
164111032|NCT01266902|592767366|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
164111033|NCT00840203|592767370|FG000|First Intervention|Protocol Violation|1|||
164111034|NCT00840203|592767371|FG001|First Intervention|Protocol Violation|1|||
164111035|NCT00840203|592767370|FG000|Washout|Protocol Violation|1|||
164111036|NCT00840203|592767371|FG001|Washout|Protocol Violation|0|||
164111037|NCT02121184|592767372|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
164111038|NCT02121184|592767373|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
164111039|NCT02121184|592767372|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
164111040|NCT02121184|592767373|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
164111041|NCT02121184|592767372|FG000|Overall Study|Emergency cesarean section required|0|||
164111042|NCT02121184|592767373|FG001|Overall Study|Emergency cesarean section required|2|||
164111043|NCT02121184|592767372|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
164111044|NCT02121184|592767373|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
164111045|NCT04567329|592767376|FG000|Overall Study|Withdrawal by Subject|5|||
164111046|NCT04567329|592767377|FG001|Overall Study|Withdrawal by Subject|6|||
164111047|NCT04567329|592767376|FG000|Overall Study|Protocol Violation|2|||
164111048|NCT04567329|592767377|FG001|Overall Study|Protocol Violation|3|||
164111049|NCT04567329|592767376|FG000|Overall Study|Discontinued|2|||
164111050|NCT04567329|592767377|FG001|Overall Study|Discontinued|2|||
164111051|NCT04567329|592767376|FG000|Overall Study|Lost to Follow-up|0|||
164111052|NCT04567329|592767377|FG001|Overall Study|Lost to Follow-up|1|||
164111053|NCT04567329|592767376|FG000|Overall Study|Lack of Efficacy|0|||
164111054|NCT04567329|592767377|FG001|Overall Study|Lack of Efficacy|1|||
164111055|NCT00875524|592767380|FG000|Overall Study|Serious adverse event|0|||
164111056|NCT00875524|592767381|FG001|Overall Study|Serious adverse event|1|||
164111057|NCT00875524|592767380|FG000|Overall Study|Protocol Violation|4|||
164111058|NCT00875524|592767381|FG001|Overall Study|Protocol Violation|0|||
164111059|NCT00875524|592767380|FG000|Overall Study|Lost to Follow-up|1|||
164111060|NCT00875524|592767381|FG001|Overall Study|Lost to Follow-up|0|||
164111061|NCT00875524|592767380|FG000|Overall Study|Withdrawal by Subject|3|||
164111062|NCT00875524|592767381|FG001|Overall Study|Withdrawal by Subject|5|||
164111063|NCT00574847|592767391|FG000|Overall Study|Adverse Event|2|||
164111064|NCT00574847|592767392|FG001|Overall Study|Adverse Event|0|||
164111065|NCT00574847|592767391|FG000|Overall Study|Death|1|||
164111066|NCT00574847|592767392|FG001|Overall Study|Death|0|||
164111067|NCT00574847|592767391|FG000|Overall Study|Withdrawal by Subject|2|||
164111068|NCT00574847|592767392|FG001|Overall Study|Withdrawal by Subject|2|||
164111069|NCT00574847|592767391|FG000|Overall Study|Physician Decision|1|||
164111070|NCT00574847|592767392|FG001|Overall Study|Physician Decision|0|||
164111071|NCT00574847|592767391|FG000|Overall Study|Did not receive medication (declined)|2|||
164111072|NCT00574847|592767392|FG001|Overall Study|Did not receive medication (declined)|5|||
164111073|NCT00957021|592767393|FG000|Overall Study|Death|5|||
164111074|NCT00957021|592767393|FG000|Overall Study|Lost to Follow-up|8|||
164111075|NCT00957021|592767393|FG000|Overall Study|Withdrawal by Subject|34|||
164111076|NCT00957021|592767393|FG000|Overall Study|No 2 yr ROM data|35|||
164111077|NCT00957021|592767393|FG000|Overall Study|Revised study component by 2 yr visit|8|||
164111078|NCT00957021|592767393|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
164111079|NCT00957021|592767393|FG000|Overall Study|Surgery Cancelled|9|||
164111080|NCT00957021|592767393|FG000|Overall Study|Termination due to language issue|2|||
164111081|NCT00819169|592767397|FG000|Overall Study|Withdrawal by Subject|2|||
164111082|NCT00819169|592767398|FG001|Overall Study|Withdrawal by Subject|0|||
164111083|NCT00819169|592767399|FG002|Overall Study|Withdrawal by Subject|0|||
164111084|NCT00819169|592767400|FG003|Overall Study|Withdrawal by Subject|1|||
164111085|NCT00819169|592767401|FG004|Overall Study|Withdrawal by Subject|1|||
164111086|NCT00819169|592767402|FG005|Overall Study|Withdrawal by Subject|1|||
164111087|NCT00819169|592767403|FG006|Overall Study|Withdrawal by Subject|5|||
164111088|NCT00819169|592767404|FG007|Overall Study|Withdrawal by Subject|1|||
164111089|NCT00819169|592767405|FG008|Overall Study|Withdrawal by Subject|4|||
164111090|NCT00819169|592767397|FG000|Overall Study|Lost to Follow-up|0|||
164111091|NCT00819169|592767398|FG001|Overall Study|Lost to Follow-up|2|||
164111092|NCT00819169|592767399|FG002|Overall Study|Lost to Follow-up|0|||
164111093|NCT00819169|592767400|FG003|Overall Study|Lost to Follow-up|1|||
164111094|NCT00819169|592767401|FG004|Overall Study|Lost to Follow-up|0|||
164111095|NCT00819169|592767402|FG005|Overall Study|Lost to Follow-up|6|||
164111096|NCT00819169|592767403|FG006|Overall Study|Lost to Follow-up|2|||
164111097|NCT00819169|592767404|FG007|Overall Study|Lost to Follow-up|2|||
164111098|NCT00819169|592767405|FG008|Overall Study|Lost to Follow-up|1|||
164111099|NCT00819169|592767397|FG000|Overall Study|Death|1|||
164111100|NCT00819169|592767398|FG001|Overall Study|Death|1|||
164111101|NCT00819169|592767399|FG002|Overall Study|Death|3|||
164111102|NCT00819169|592767400|FG003|Overall Study|Death|8|||
164111103|NCT00819169|592767401|FG004|Overall Study|Death|5|||
164111104|NCT00819169|592767402|FG005|Overall Study|Death|7|||
164111105|NCT00819169|592767403|FG006|Overall Study|Death|9|||
164111106|NCT00819169|592767404|FG007|Overall Study|Death|4|||
164111107|NCT00819169|592767405|FG008|Overall Study|Death|7|||
164111108|NCT00819169|592767397|FG000|Overall Study|Ineligibility determined|0|||
164111109|NCT00819169|592767398|FG001|Overall Study|Ineligibility determined|0|||
164111110|NCT00819169|592767399|FG002|Overall Study|Ineligibility determined|0|||
164111111|NCT00819169|592767400|FG003|Overall Study|Ineligibility determined|2|||
164111112|NCT00819169|592767401|FG004|Overall Study|Ineligibility determined|0|||
164111113|NCT00819169|592767402|FG005|Overall Study|Ineligibility determined|0|||
164111114|NCT00819169|592767403|FG006|Overall Study|Ineligibility determined|0|||
164111115|NCT00819169|592767404|FG007|Overall Study|Ineligibility determined|0|||
164111116|NCT00819169|592767405|FG008|Overall Study|Ineligibility determined|1|||
164111117|NCT00819169|592767397|FG000|Overall Study|Adverse Event|0|||
164111118|NCT00819169|592767398|FG001|Overall Study|Adverse Event|0|||
164111119|NCT00819169|592767399|FG002|Overall Study|Adverse Event|0|||
164111120|NCT00819169|592767400|FG003|Overall Study|Adverse Event|0|||
164111121|NCT00819169|592767401|FG004|Overall Study|Adverse Event|1|||
164111122|NCT00819169|592767402|FG005|Overall Study|Adverse Event|0|||
164111123|NCT00819169|592767403|FG006|Overall Study|Adverse Event|0|||
164111124|NCT00819169|592767404|FG007|Overall Study|Adverse Event|0|||
164111125|NCT00819169|592767405|FG008|Overall Study|Adverse Event|0|||
164111126|NCT00819169|592767397|FG000|Overall Study|Administrative Decision|0|||
164111127|NCT00819169|592767398|FG001|Overall Study|Administrative Decision|0|||
164111128|NCT00819169|592767399|FG002|Overall Study|Administrative Decision|0|||
164111129|NCT00819169|592767400|FG003|Overall Study|Administrative Decision|0|||
164111130|NCT00819169|592767401|FG004|Overall Study|Administrative Decision|1|||
164111131|NCT00819169|592767402|FG005|Overall Study|Administrative Decision|2|||
164111132|NCT00819169|592767403|FG006|Overall Study|Administrative Decision|0|||
164111133|NCT00819169|592767404|FG007|Overall Study|Administrative Decision|2|||
164111134|NCT00819169|592767405|FG008|Overall Study|Administrative Decision|0|||
164111135|NCT02637141|592767409|FG000|Overall Study|Adverse Event|1|||
164111136|NCT02637141|592767410|FG001|Overall Study|Adverse Event|1|||
164111137|NCT02637141|592767411|FG002|Overall Study|Adverse Event|0|||
164111138|NCT02637141|592767409|FG000|Overall Study|Withdrawal by Subject|1|||
164111139|NCT02637141|592767410|FG001|Overall Study|Withdrawal by Subject|1|||
164111140|NCT02637141|592767411|FG002|Overall Study|Withdrawal by Subject|1|||
164111141|NCT01155531|592767415|FG000|Overall Study|Adverse Event|0|||
164111142|NCT01155531|592767416|FG001|Overall Study|Adverse Event|0|||
164111143|NCT01155531|592767417|FG002|Overall Study|Adverse Event|1|||
164111144|NCT01155531|592767418|FG003|Overall Study|Adverse Event|0|||
164111145|NCT01155531|592767415|FG000|Overall Study|Lost to Follow-up|0|||
164111146|NCT01155531|592767416|FG001|Overall Study|Lost to Follow-up|0|||
164111147|NCT01155531|592767417|FG002|Overall Study|Lost to Follow-up|0|||
164111148|NCT01155531|592767418|FG003|Overall Study|Lost to Follow-up|1|||
164111149|NCT01155531|592767415|FG000|Overall Study|Withdrawal by Subject|1|||
164111150|NCT01155531|592767416|FG001|Overall Study|Withdrawal by Subject|0|||
164111151|NCT01155531|592767417|FG002|Overall Study|Withdrawal by Subject|1|||
164111152|NCT01155531|592767418|FG003|Overall Study|Withdrawal by Subject|0|||
164111153|NCT02705716|592767419|FG000|Overall Study|Adverse Event|0|||
164111154|NCT02705716|592767420|FG001|Overall Study|Adverse Event|1|||
164111155|NCT02705716|592767419|FG000|Overall Study|Protocol Violation|3|||
164111156|NCT02705716|592767420|FG001|Overall Study|Protocol Violation|0|||
164111157|NCT02705716|592767419|FG000|Overall Study|Withdrawal of Consent|1|||
164111158|NCT02705716|592767420|FG001|Overall Study|Withdrawal of Consent|1|||
164111159|NCT00562718|592767421|FG000|Overall Study|Death|1|||
164111160|NCT00562718|592767421|FG000|Overall Study|Withdrawal by Subject|3|||
164111161|NCT00562718|592767421|FG000|Overall Study|Adverse Event|4|||
164111162|NCT00562718|592767421|FG000|Overall Study|Lack of Efficacy|2|||
164111163|NCT00562718|592767421|FG000|Overall Study|not stated|1|||
164111164|NCT04025021|592767422|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
164111165|NCT04025021|592767423|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
164111166|NCT00840879|592767424|FG000|Second Intervention|Withdrawal by Subject|1|||
164111167|NCT00840879|592767425|FG001|Second Intervention|Withdrawal by Subject|0|||
164111168|NCT00477594|592767426|FG000|Year 1 and Year 2|Adverse Event|4|||
164111169|NCT00477594|592767427|FG001|Year 1 and Year 2|Adverse Event|2|||
164111170|NCT00477594|592767426|FG000|Year 1 and Year 2|Physician Decision|2|||
164111171|NCT00477594|592767427|FG001|Year 1 and Year 2|Physician Decision|1|||
164111172|NCT00477594|592767426|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
164111173|NCT00477594|592767427|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
164111174|NCT00477594|592767426|FG000|Year 1 and Year 2|Other|1|||
164111175|NCT00477594|592767427|FG001|Year 1 and Year 2|Other|0|||
164111176|NCT00477594|592767426|FG000|Year 3|Adverse Event|1|||
164111177|NCT00477594|592767427|FG001|Year 3|Adverse Event|0|||
164111178|NCT00477594|592767426|FG000|Year 3|Withdrawal by Subject|1|||
164111179|NCT00477594|592767427|FG001|Year 3|Withdrawal by Subject|0|||
164111180|NCT00477594|592767426|FG000|Follow-up Period|Withdrawal by Subject|2|||
164111181|NCT00477594|592767427|FG001|Follow-up Period|Withdrawal by Subject|1|||
164111182|NCT00477594|592767426|FG000|Follow-up Period|Other|1|||
164111183|NCT00477594|592767427|FG001|Follow-up Period|Other|0|||
164111184|NCT02998541|592769239|FG000|Overall Study|Adverse Event|4|||
164111185|NCT02998541|592769240|FG001|Overall Study|Adverse Event|5|||
164111186|NCT02998541|592769241|FG002|Overall Study|Adverse Event|1|||
164111187|NCT02998541|592769239|FG000|Overall Study|Protocol Violation|1|||
164111188|NCT02998541|592769240|FG001|Overall Study|Protocol Violation|0|||
164111189|NCT02998541|592769241|FG002|Overall Study|Protocol Violation|0|||
164111190|NCT02998541|592769239|FG000|Overall Study|Withdrawal by Subject|3|||
164111191|NCT02998541|592769240|FG001|Overall Study|Withdrawal by Subject|1|||
164111192|NCT02998541|592769241|FG002|Overall Study|Withdrawal by Subject|0|||
164111193|NCT02998541|592769239|FG000|Overall Study|Lost to Follow-up|0|||
164111194|NCT02998541|592769240|FG001|Overall Study|Lost to Follow-up|3|||
164111195|NCT02998541|592769241|FG002|Overall Study|Lost to Follow-up|1|||
164111196|NCT02998541|592769239|FG000|Overall Study|Physician Decision|0|||
164111197|NCT02998541|592769240|FG001|Overall Study|Physician Decision|0|||
164111198|NCT02998541|592769241|FG002|Overall Study|Physician Decision|3|||
164111199|NCT02998541|592769239|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164111200|NCT02998541|592769240|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164111201|NCT02998541|592769241|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
164111202|NCT03540160|592769242|FG000|Overall Study|Protocol Violation|1|||
164111203|NCT03540160|592769242|FG000|Overall Study|Physician Decision|8|||
164111204|NCT03540160|592769242|FG000|Overall Study|Lack of Efficacy|60|||
164111205|NCT03540160|592769242|FG000|Overall Study|Pregnancy|1|||
164111206|NCT03540160|592769242|FG000|Overall Study|Adverse Event|20|||
164111207|NCT03540160|592769242|FG000|Overall Study|Withdrawal by Subject|68|||
164111208|NCT03540160|592769242|FG000|Overall Study|COVID-19|2|||
164111209|NCT03540160|592769242|FG000|Overall Study|Study Closure|10|||
164111210|NCT03540160|592769242|FG000|Overall Study|Lost to Follow-up|18|||
164111211|NCT03540160|592769242|FG000|Overall Study|Sponsor decision|191|||
164111212|NCT01944722|592769243|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
164111213|NCT01944722|592769243|FG000|Overall Study|Specimen Shipping Issues|34|||
164111214|NCT01944722|592769243|FG000|Overall Study|Improper Storage/Transport|5|||
164111215|NCT01944722|592769243|FG000|Overall Study|Insufficient Volume for Test|1|||
164111216|NCT01944722|592769243|FG000|Overall Study|Missing Specimens|3|||
164111217|NCT01944722|592769243|FG000|Overall Study|Specimens Mislabeled|2|||
164111218|NCT01944722|592769243|FG000|Overall Study|Withdrawal by Subject|8|||
164111219|NCT01944722|592769243|FG000|Overall Study|NILM Subjects <30 years old|8106|||
164111220|NCT01944722|592769243|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
164111221|NCT01944722|592769243|FG000|Overall Study|>ASCUS Cytology|1122|||
164111222|NCT01923740|592769244|FG000|Overall Study|Lost to Follow-up|4|||
164111223|NCT01923740|592769245|FG001|Overall Study|Lost to Follow-up|9|||
164111224|NCT01923740|592769244|FG000|Overall Study|Withdrawal by Subject|2|||
164111225|NCT01923740|592769245|FG001|Overall Study|Withdrawal by Subject|0|||
164111226|NCT03345420|592769247|FG000|Overall Study|Withdrawal by Subject|1|||
164111227|NCT02890992|592769248|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111228|NCT02890992|592769249|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
164111229|NCT02890992|592769250|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111230|NCT02890992|592769251|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111231|NCT02890992|592769252|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111232|NCT02890992|592769253|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111233|NCT02890992|592769254|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111234|NCT02890992|592769255|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
164111235|NCT02890992|592769248|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164111236|NCT02890992|592769249|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164111237|NCT02890992|592769250|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164111238|NCT02890992|592769251|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164111239|NCT02890992|592769252|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164111240|NCT02890992|592769253|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
164111241|NCT02890992|592769254|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
164111242|NCT02890992|592769255|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
164111243|NCT02890992|592769248|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111244|NCT02890992|592769249|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
164111245|NCT02890992|592769250|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111246|NCT02890992|592769251|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111247|NCT02890992|592769252|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111248|NCT02890992|592769253|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111249|NCT02890992|592769254|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111250|NCT02890992|592769255|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
164111251|NCT02933060|592769260|FG000|Overall Study|Withdrawal by Subject|0|||
164111252|NCT02933060|592769261|FG001|Overall Study|Withdrawal by Subject|1|||
164111253|NCT01945580|592769262|FG000|Overall Study|Withdrawal by Subject|13|||
164111254|NCT01945580|592769263|FG001|Overall Study|Withdrawal by Subject|35|||
164111255|NCT01945580|592769262|FG000|Overall Study|Physician Decision|3|||
164111256|NCT01945580|592769263|FG001|Overall Study|Physician Decision|2|||
164111257|NCT01945580|592769262|FG000|Overall Study|Lost to Follow-up|26|||
164111258|NCT01945580|592769263|FG001|Overall Study|Lost to Follow-up|39|||
164111259|NCT01945580|592769262|FG000|Overall Study|Death|7|||
164111260|NCT01945580|592769263|FG001|Overall Study|Death|2|||
164111261|NCT01945580|592769262|FG000|Overall Study|Patient moved out of state|0|||
164111262|NCT01945580|592769263|FG001|Overall Study|Patient moved out of state|1|||
164111263|NCT01945580|592769262|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
164111264|NCT01945580|592769263|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
164111265|NCT01945580|592769262|FG000|Overall Study|Family illness - unable to return|0|||
164111266|NCT01945580|592769263|FG001|Overall Study|Family illness - unable to return|1|||
164111267|NCT01945580|592769262|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
164111268|NCT01945580|592769263|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
164111269|NCT01945580|592769262|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
164148738|NCT03207867|592904943|FG007|Overall Study|Progressive Disease|8|||
164111270|NCT01945580|592769263|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
164111271|NCT01945580|592769262|FG000|Overall Study|Noncompliance with 36 month visit|1|||
164111272|NCT01945580|592769263|FG001|Overall Study|Noncompliance with 36 month visit|0|||
164111273|NCT01945580|592769262|FG000|Overall Study|The patient moved.|1|||
164111274|NCT01945580|592769263|FG001|Overall Study|The patient moved.|0|||
164111275|NCT01945580|592769262|FG000|Overall Study|No data available|0|||
164111276|NCT01945580|592769263|FG001|Overall Study|No data available|2|||
164111277|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
164111278|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
164111279|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
164111280|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
164111281|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
164111282|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
164111283|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
164111284|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
164111285|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
164111286|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
164111287|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
164111288|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
164111289|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
164111290|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
164111291|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
164111292|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
164111293|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
164111294|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
164111295|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
164111296|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
164111297|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
164111298|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
164111299|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
164111300|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
164111301|NCT00073307|592769268|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
164111302|NCT00073307|592769269|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
164111303|NCT00073307|592769270|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
164111304|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
164111305|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
164111306|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
164111307|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
164111308|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
164111309|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
164111310|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
164111311|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
164111312|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
164111313|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
164111314|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
164111315|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
164111316|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
164111317|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
164111318|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
164111319|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
164111320|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
164111321|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
164111322|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
164111323|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
164111324|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
164111325|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
164111326|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
164111327|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
164111328|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
164111329|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
164111330|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
164111331|NCT00073307|592769268|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
164111332|NCT00073307|592769269|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
164111333|NCT00073307|592769270|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
164111334|NCT00858780|592769271|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
164111335|NCT00858780|592769272|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164111336|NCT00858780|592769273|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164111337|NCT00858780|592769274|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164111338|NCT00858780|592769275|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
164111339|NCT00858780|592769271|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164111340|NCT00858780|592769272|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164111341|NCT00858780|592769273|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
164111342|NCT00858780|592769274|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164111343|NCT00858780|592769275|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
164111344|NCT00858780|592769271|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
164111345|NCT00858780|592769272|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
164111346|NCT00858780|592769273|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
164111347|NCT00858780|592769274|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
164111348|NCT00858780|592769275|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
164111349|NCT00858780|592769271|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164111350|NCT00858780|592769272|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
164111351|NCT00858780|592769273|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164111352|NCT00858780|592769274|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164111353|NCT00858780|592769275|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
164111354|NCT00858780|592769271|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164111355|NCT00858780|592769272|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164111356|NCT00858780|592769273|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164111357|NCT00858780|592769274|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
164111358|NCT00858780|592769275|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
164111359|NCT00858780|592769271|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
164111360|NCT00858780|592769272|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
164111361|NCT00858780|592769273|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
164111362|NCT00858780|592769274|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
164111363|NCT00858780|592769275|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
164111364|NCT01024855|592769278|FG000|Overall Study|Inclusion/exclusion criteria|1|||
164111365|NCT00577655|592769279|FG000|Overall Study|Patient Request|0|||
164111366|NCT00577655|592769280|FG001|Overall Study|Patient Request|2|||
164111367|NCT00577655|592769279|FG000|Overall Study|Protocol Violation|0|||
164111368|NCT00577655|592769280|FG001|Overall Study|Protocol Violation|1|||
164111369|NCT00577655|592769279|FG000|Overall Study|Lost to Follow-up|1|||
164111370|NCT00577655|592769280|FG001|Overall Study|Lost to Follow-up|1|||
164111371|NCT03306277|592769284|FG000|Overall Study|Death|1|||
164111372|NCT03306277|592769284|FG000|Overall Study|Adverse Event|1|||
164111373|NCT03306277|592769284|FG000|Overall Study|Withdrawal by Subject|1|||
164111374|NCT01370863|592769288|FG000|Overall Study|Adverse Event|1|||
164111375|NCT01370863|592769289|FG001|Overall Study|Adverse Event|1|||
164111376|NCT01370863|592769288|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
164111377|NCT01370863|592769289|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
164111378|NCT01370863|592769288|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
164111379|NCT01370863|592769289|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
164111380|NCT05004649|592769292|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
164111381|NCT05004649|592769292|FG000|Overall Study|Lost to Follow-up|1|||
164111382|NCT05004649|592769292|FG000|Overall Study|Withdrawal by Subject|2|||
164111383|NCT05004649|592769292|FG000|Overall Study|COVID-19|1|||
164111384|NCT01926119|592769294|FG000|Overall Study|Withdrawal by Subject|1|||
164111385|NCT00645853|592769295|FG000|Overall Study|Adverse Event|18|||
164111386|NCT00645853|592769296|FG001|Overall Study|Adverse Event|7|||
164111387|NCT00645853|592769295|FG000|Overall Study|AZ study closure in Hungary|60|||
164111388|NCT00645853|592769296|FG001|Overall Study|AZ study closure in Hungary|40|||
164111389|NCT00645853|592769295|FG000|Overall Study|Withdrawal by Subject|5|||
164111390|NCT00645853|592769296|FG001|Overall Study|Withdrawal by Subject|2|||
164111391|NCT00645853|592769295|FG000|Overall Study|Protocol Violation|0|||
164111392|NCT00645853|592769296|FG001|Overall Study|Protocol Violation|2|||
164111393|NCT00645853|592769295|FG000|Overall Study|Discontinuation criteria|2|||
164111394|NCT00645853|592769296|FG001|Overall Study|Discontinuation criteria|2|||
164111395|NCT00645853|592769295|FG000|Overall Study|recall of ICF, planned operation, death|7|||
164111396|NCT00645853|592769296|FG001|Overall Study|recall of ICF, planned operation, death|4|||
164111397|NCT00406393|592769297|FG000|Overall Study|Did not undergo transplantation|2|||
164111398|NCT00406393|592769298|FG001|Overall Study|Did not undergo transplantation|1|||
164111399|NCT03885934|592769299|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
164111400|NCT03885934|592769300|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
164111401|NCT03885934|592769301|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
164111402|NCT03885934|592769302|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
164111403|NCT03885934|592769303|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
164111404|NCT03885934|592769304|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
164111405|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
164111406|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
164111407|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
164111408|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
164111409|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
164111410|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
164111411|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
164111412|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
164111413|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
164111414|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
164111415|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
164111416|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
164111417|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
164111418|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
164111419|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
164111420|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
164111421|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
164111422|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
164111423|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
164111424|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
164111425|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
164111426|NCT02227238|592769305|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
164111427|NCT02227238|592769306|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
164111428|NCT02227238|592769307|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
164111429|NCT02227238|592769305|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
164111430|NCT02227238|592769306|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
164111431|NCT02227238|592769307|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
164111432|NCT02227238|592769305|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
164111433|NCT02227238|592769306|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
164111434|NCT02227238|592769307|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
164111435|NCT02227238|592769305|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
164111436|NCT02227238|592769306|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
164111437|NCT02227238|592769307|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
164111438|NCT02227238|592769305|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
164111439|NCT02227238|592769306|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
164111440|NCT02227238|592769307|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
164111441|NCT02227238|592769305|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
164111442|NCT02227238|592769306|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
164111443|NCT02227238|592769307|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
164111444|NCT02227238|592769305|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
164111445|NCT02227238|592769306|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
164111446|NCT02227238|592769307|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
164111447|NCT00380588|592769308|FG000|Overall Study|Unequivocal Disease Progression|25|||
164111448|NCT00380588|592769309|FG001|Overall Study|Unequivocal Disease Progression|34|||
164111449|NCT00380588|592769308|FG000|Overall Study|Next Cycle Not Started|4|||
164111450|NCT00380588|592769309|FG001|Overall Study|Next Cycle Not Started|0|||
164111451|NCT00380588|592769308|FG000|Overall Study|Adverse Event|7|||
164111452|NCT00380588|592769309|FG001|Overall Study|Adverse Event|3|||
164111453|NCT00380588|592769308|FG000|Overall Study|Withdrawal by Subject|1|||
164111454|NCT00380588|592769309|FG001|Overall Study|Withdrawal by Subject|3|||
164111455|NCT00380588|592769308|FG000|Overall Study|Physician Decision|2|||
164111456|NCT00380588|592769309|FG001|Overall Study|Physician Decision|0|||
164111457|NCT02096705|592769310|FG000|Treatment|Adverse Event|6|||
164111458|NCT02096705|592769311|FG001|Treatment|Adverse Event|3|||
164111459|NCT02096705|592769310|FG000|Treatment|Subject request to discontinue treatment|1|||
164111460|NCT02096705|592769311|FG001|Treatment|Subject request to discontinue treatment|1|||
164111461|NCT02096705|592769310|FG000|Treatment|Withdrawal by Subject|1|||
164111462|NCT02096705|592769311|FG001|Treatment|Withdrawal by Subject|0|||
164111463|NCT02096705|592769310|FG000|Treatment|Other|1|||
164111464|NCT02096705|592769311|FG001|Treatment|Other|1|||
164111465|NCT02096705|592769310|FG000|Follow-up|Withdrawal by Subject|1|||
164111466|NCT02096705|592769311|FG001|Follow-up|Withdrawal by Subject|0|||
164111467|NCT02096705|592769310|FG000|Follow-up|Adverse Event|2|||
164111468|NCT02096705|592769311|FG001|Follow-up|Adverse Event|2|||
164148739|NCT03207867|592904944|FG008|Overall Study|Progressive Disease|19|||
164111469|NCT02096705|592769310|FG000|Follow-up|Subjects not reporting status|1|||
164111470|NCT02096705|592769311|FG001|Follow-up|Subjects not reporting status|2|||
164111471|NCT02905435|592769312|FG000|Overall Study|Death|2|||
164111472|NCT02905435|592769312|FG000|Overall Study|Physician Decision|1|||
164111473|NCT02905435|592769312|FG000|Overall Study|Lost to Follow-up|4|||
164111474|NCT02377349|592769316|FG000|Overall Study|Serious Adverse Event|1|||
164111475|NCT02377349|592769317|FG001|Overall Study|Serious Adverse Event|0|||
164111476|NCT02377349|592769316|FG000|Overall Study|Protocol Violation|3|||
164111477|NCT02377349|592769317|FG001|Overall Study|Protocol Violation|2|||
164111478|NCT02377349|592769316|FG000|Overall Study|Withdrawal by Subject|5|||
164111479|NCT02377349|592769317|FG001|Overall Study|Withdrawal by Subject|3|||
164111480|NCT02377349|592769316|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
164111481|NCT02377349|592769317|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
164111482|NCT02377349|592769316|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
164111483|NCT02377349|592769317|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
164111484|NCT02377349|592769316|FG000|Overall Study|Other|0|||
164111485|NCT02377349|592769317|FG001|Overall Study|Other|1|||
164111486|NCT01507662|592769326|FG000|Overall Study|Death|26|||
164111487|NCT01507662|592769327|FG001|Overall Study|Death|18|||
164111488|NCT01507662|592769326|FG000|Overall Study|Withdrawal by Subject|290|||
164111489|NCT01507662|592769327|FG001|Overall Study|Withdrawal by Subject|287|||
164111490|NCT01507662|592769326|FG000|Overall Study|Lost to Follow-up|498|||
164111491|NCT01507662|592769327|FG001|Overall Study|Lost to Follow-up|523|||
164111492|NCT01507662|592769326|FG000|Overall Study|Proxy interview done|2|||
164111493|NCT01507662|592769327|FG001|Overall Study|Proxy interview done|3|||
164111494|NCT01395017|592769332|FG000|Overall Study|Lost to Follow-up|1|||
164111495|NCT01395017|592769333|FG001|Overall Study|Lost to Follow-up|0|||
164111496|NCT01395017|592769332|FG000|Overall Study|Adverse Event|26|||
164111497|NCT01395017|592769333|FG001|Overall Study|Adverse Event|12|||
164111498|NCT01395017|592769332|FG000|Overall Study|Physician Decision|11|||
164111499|NCT01395017|592769333|FG001|Overall Study|Physician Decision|15|||
164111500|NCT01395017|592769332|FG000|Overall Study|Withdrawal by Subject|14|||
164111501|NCT01395017|592769333|FG001|Overall Study|Withdrawal by Subject|8|||
164111502|NCT01395017|592769332|FG000|Overall Study|Protocol deviation|1|||
164111503|NCT01395017|592769333|FG001|Overall Study|Protocol deviation|2|||
164111504|NCT01395017|592769332|FG000|Overall Study|Death|4|||
164111505|NCT01395017|592769333|FG001|Overall Study|Death|3|||
164111506|NCT01395017|592769332|FG000|Overall Study|Disease progression|42|||
164111507|NCT01395017|592769333|FG001|Overall Study|Disease progression|58|||
164111508|NCT01395017|592769332|FG000|Overall Study|Sponsor discontinued study|1|||
164111509|NCT01395017|592769333|FG001|Overall Study|Sponsor discontinued study|4|||
164111510|NCT03366428|592769337|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
164111511|NCT03366428|592769337|FG000|Overall Study|Adverse Event|12|||
164111512|NCT03366428|592769337|FG000|Overall Study|Clinical progression|2|||
164111513|NCT03366428|592769337|FG000|Overall Study|Withdrawal by Subject|4|||
164111514|NCT01046084|592769341|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
164111515|NCT01046084|592769342|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
164111516|NCT00999687|592769343|FG000|First Intervention|Withdrawal by Subject|1|||
164111517|NCT00999687|592769343|FG000|Second Intervention|Withdrawal by Subject|2|||
164111518|NCT00999687|592769343|FG000|Second Intervention|Lack of Efficacy|1|||
164111519|NCT03614728|592769346|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
164111520|NCT03614728|592769347|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
164111521|NCT03614728|592769348|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
164111522|NCT03614728|592769349|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
164111523|NCT03614728|592769346|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
164111524|NCT03614728|592769347|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
164111525|NCT03614728|592769348|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
164111526|NCT03614728|592769349|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
164111527|NCT01971645|592769354|FG000|Overall Study|Adverse Event|1|||
164111528|NCT01971645|592769355|FG001|Overall Study|Adverse Event|0|||
164111529|NCT01971645|592769356|FG002|Overall Study|Adverse Event|0|||
164111530|NCT01971645|592769354|FG000|Overall Study|Lost to Follow-up|1|||
164111531|NCT01971645|592769355|FG001|Overall Study|Lost to Follow-up|0|||
164111532|NCT01971645|592769356|FG002|Overall Study|Lost to Follow-up|1|||
164111533|NCT01971645|592769354|FG000|Overall Study|Protocol Violation|0|||
164111534|NCT01971645|592769355|FG001|Overall Study|Protocol Violation|0|||
164111535|NCT01971645|592769356|FG002|Overall Study|Protocol Violation|1|||
164111536|NCT02943096|592769359|FG000|Overall Study|Lack of Efficacy|0|||
164111537|NCT02943096|592769360|FG001|Overall Study|Lack of Efficacy|1|||
164111538|NCT01401062|592769364|FG000|Overall Study|Death|9|||
164111539|NCT01401062|592769365|FG001|Overall Study|Death|7|||
164111540|NCT01401062|592769364|FG000|Overall Study|Physician Decision|1|||
164111541|NCT01401062|592769365|FG001|Overall Study|Physician Decision|0|||
164111542|NCT01401062|592769364|FG000|Overall Study|Withdrawal by Subject|1|||
164111543|NCT01401062|592769365|FG001|Overall Study|Withdrawal by Subject|1|||
164111544|NCT01717040|592769369|FG000|Overall Study|Lost to Follow-up|2|||
164111545|NCT01717040|592769370|FG001|Overall Study|Lost to Follow-up|3|||
164111546|NCT01717040|592769369|FG000|Overall Study|Lack of Efficacy|1|||
164111547|NCT01717040|592769370|FG001|Overall Study|Lack of Efficacy|1|||
164111548|NCT01717040|592769369|FG000|Overall Study|Adverse Event|1|||
164111549|NCT01717040|592769370|FG001|Overall Study|Adverse Event|0|||
164111550|NCT01717040|592769369|FG000|Overall Study|Required Medication Change|0|||
164111551|NCT01717040|592769370|FG001|Overall Study|Required Medication Change|1|||
164111552|NCT01717040|592769369|FG000|Overall Study|New Substance Use Disorder|1|||
164111553|NCT01717040|592769370|FG001|Overall Study|New Substance Use Disorder|0|||
164111554|NCT04203823|592769371|FG000|Overall Study|Withdrawal by Subject|2|||
164111555|NCT04203823|592769372|FG001|Overall Study|Withdrawal by Subject|2|||
164111556|NCT04203823|592769371|FG000|Overall Study|Adverse Event|1|||
164111557|NCT04203823|592769372|FG001|Overall Study|Adverse Event|1|||
164111558|NCT04203823|592769371|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
164111559|NCT04203823|592769372|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
164111560|NCT03684928|592769373|FG000|First Intervention|Lost to Follow-up|0|||
164111561|NCT03684928|592769374|FG001|First Intervention|Lost to Follow-up|1|||
164111562|NCT03684928|592769373|FG000|First Intervention|Withdrawal by Subject|0|||
164111563|NCT03684928|592769374|FG001|First Intervention|Withdrawal by Subject|2|||
164111564|NCT03684928|592769373|FG000|Second Intervention|Soft Tissue Injury|1|||
164111565|NCT03684928|592769374|FG001|Second Intervention|Soft Tissue Injury|0|||
164111566|NCT03193021|592769375|FG000|Overall Study|Lost to Follow-up|1|||
164111567|NCT03193021|592769376|FG001|Overall Study|Lost to Follow-up|1|||
164111568|NCT02286466|592769377|FG000|Overall Study|Death|1|||
164111569|NCT02286466|592769378|FG001|Overall Study|Death|3|||
164111570|NCT02286466|592769377|FG000|Overall Study|Withdrawal by Subject|5|||
164111571|NCT02286466|592769378|FG001|Overall Study|Withdrawal by Subject|2|||
164111572|NCT02286466|592769377|FG000|Overall Study|Lost to Follow-up|1|||
164111573|NCT02286466|592769378|FG001|Overall Study|Lost to Follow-up|4|||
164111574|NCT02286466|592769377|FG000|Overall Study|Declined Clinician Assessment|0|||
164111575|NCT02286466|592769378|FG001|Overall Study|Declined Clinician Assessment|1|||
164111576|NCT00835081|592769379|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
164111577|NCT00835081|592769380|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
164111578|NCT00874276|592769381|FG000|Overall Study|Withdrawal by Subject|1|||
164111579|NCT00874276|592769382|FG001|Overall Study|Withdrawal by Subject|1|||
164111580|NCT02300987|592770400|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
164111581|NCT02300987|592770401|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
164111582|NCT02300987|592770400|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
164111583|NCT02300987|592770401|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
164111584|NCT02300987|592770400|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
164111585|NCT02300987|592770401|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
164111586|NCT02300987|592770400|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
164111587|NCT02300987|592770401|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
164111588|NCT02300987|592770400|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
164111589|NCT02300987|592770401|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
164111590|NCT04211766|592770402|FG000|Overall Study|Withdrawal by Subject|5|||
164111591|NCT04211766|592770403|FG001|Overall Study|Withdrawal by Subject|1|||
164111592|NCT02308241|592770406|FG000|Overall Study|Withdrawal by Subject|3|||
164111593|NCT03609944|592770407|FG000|Overall Study|Lost to Follow-up|1|||
164111594|NCT03609944|592770408|FG001|Overall Study|Lost to Follow-up|5|||
164111595|NCT03609944|592770407|FG000|Overall Study|Withdrawal by Subject|1|||
164111596|NCT03609944|592770408|FG001|Overall Study|Withdrawal by Subject|1|||
164111597|NCT00659815|592770409|FG000|Overall Study|Study related symptoms and complaints|2|||
164111598|NCT00659815|592770410|FG001|Overall Study|Study related symptoms and complaints|1|||
164111599|NCT00659815|592770409|FG000|Overall Study|Inability to maintain wearing schedule|1|||
164111600|NCT00659815|592770410|FG001|Overall Study|Inability to maintain wearing schedule|2|||
164111601|NCT00659815|592770409|FG000|Overall Study|Withdrawal by Subject|1|||
164111602|NCT00659815|592770410|FG001|Overall Study|Withdrawal by Subject|1|||
164111603|NCT02578641|592770411|FG000|Overall Study|Adverse Event|5|||
164111604|NCT02578641|592770412|FG001|Overall Study|Adverse Event|15|||
164111605|NCT02578641|592770411|FG000|Overall Study|Death|16|||
164111606|NCT02578641|592770412|FG001|Overall Study|Death|8|||
164111607|NCT02578641|592770411|FG000|Overall Study|Lost to Follow-up|0|||
164111608|NCT02578641|592770412|FG001|Overall Study|Lost to Follow-up|1|||
164111609|NCT02578641|592770411|FG000|Overall Study|Withdrawal by Subject|14|||
164111610|NCT02578641|592770412|FG001|Overall Study|Withdrawal by Subject|7|||
164111611|NCT02578641|592770411|FG000|Overall Study|Progressive Disease|69|||
164111612|NCT02578641|592770412|FG001|Overall Study|Progressive Disease|21|||
164111613|NCT02578641|592770411|FG000|Overall Study|No Study Drug|2|||
164111614|NCT02578641|592770412|FG001|Overall Study|No Study Drug|0|||
164111615|NCT02578641|592770411|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
164111616|NCT02578641|592770412|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
164111617|NCT02578641|592770411|FG000|Overall Study|Non-compliance with Study Schedule|1|||
164111618|NCT02578641|592770412|FG001|Overall Study|Non-compliance with Study Schedule|0|||
164111619|NCT02578641|592770411|FG000|Overall Study|Other|1|||
164111620|NCT02578641|592770412|FG001|Overall Study|Other|10|||
164111621|NCT02578641|592770411|FG000|Overall Study|Not treated|1|||
164111622|NCT02578641|592770412|FG001|Overall Study|Not treated|4|||
164111623|NCT05330975|592770413|FG000|Primary|Lost to Follow-up|12|||
164111624|NCT05330975|592770414|FG001|Primary|Lost to Follow-up|21|||
164111625|NCT05330975|592770415|FG002|Primary|Lost to Follow-up|38|||
164111626|NCT05330975|592770416|FG003|Primary|Lost to Follow-up|30|||
164111627|NCT05330975|592770417|FG004|Primary|Lost to Follow-up|25|||
164111628|NCT05330975|592770418|FG005|Primary|Lost to Follow-up|28|||
164111629|NCT05330975|592770419|FG006|Primary|Lost to Follow-up|0|||
164111630|NCT05330975|592770413|FG000|Primary|Withdrawal by Subject|4|||
164111631|NCT05330975|592770414|FG001|Primary|Withdrawal by Subject|11|||
164111632|NCT05330975|592770415|FG002|Primary|Withdrawal by Subject|8|||
164111633|NCT05330975|592770416|FG003|Primary|Withdrawal by Subject|23|||
164111634|NCT05330975|592770417|FG004|Primary|Withdrawal by Subject|20|||
164111635|NCT05330975|592770418|FG005|Primary|Withdrawal by Subject|19|||
164111636|NCT05330975|592770419|FG006|Primary|Withdrawal by Subject|0|||
164111637|NCT05330975|592770413|FG000|Primary|Protocol Violation|0|||
164111638|NCT05330975|592770414|FG001|Primary|Protocol Violation|2|||
164111639|NCT05330975|592770415|FG002|Primary|Protocol Violation|0|||
164111640|NCT05330975|592770416|FG003|Primary|Protocol Violation|4|||
164111641|NCT05330975|592770417|FG004|Primary|Protocol Violation|0|||
164111642|NCT05330975|592770418|FG005|Primary|Protocol Violation|3|||
164111643|NCT05330975|592770419|FG006|Primary|Protocol Violation|0|||
164111644|NCT05330975|592770413|FG000|Primary|Death|0|||
164111645|NCT05330975|592770414|FG001|Primary|Death|3|||
164111646|NCT05330975|592770415|FG002|Primary|Death|1|||
164111647|NCT05330975|592770416|FG003|Primary|Death|1|||
164111648|NCT05330975|592770417|FG004|Primary|Death|0|||
164111649|NCT05330975|592770418|FG005|Primary|Death|0|||
164111650|NCT05330975|592770419|FG006|Primary|Death|0|||
164111651|NCT05330975|592770413|FG000|Primary|Other Than Specified|0|||
164111652|NCT05330975|592770414|FG001|Primary|Other Than Specified|1|||
164111653|NCT05330975|592770415|FG002|Primary|Other Than Specified|2|||
164111654|NCT05330975|592770416|FG003|Primary|Other Than Specified|1|||
164111655|NCT05330975|592770417|FG004|Primary|Other Than Specified|2|||
164111656|NCT05330975|592770418|FG005|Primary|Other Than Specified|2|||
164111657|NCT05330975|592770419|FG006|Primary|Other Than Specified|0|||
164111658|NCT05330975|592770413|FG000|Primary|Adverse Event|0|||
164111659|NCT05330975|592770414|FG001|Primary|Adverse Event|0|||
164111660|NCT05330975|592770415|FG002|Primary|Adverse Event|0|||
164111661|NCT05330975|592770416|FG003|Primary|Adverse Event|1|||
164111662|NCT05330975|592770417|FG004|Primary|Adverse Event|0|||
164111663|NCT05330975|592770418|FG005|Primary|Adverse Event|0|||
164111664|NCT05330975|592770419|FG006|Primary|Adverse Event|0|||
164111665|NCT05330975|592770413|FG000|Primary|Physician Decision|0|||
164111666|NCT05330975|592770414|FG001|Primary|Physician Decision|0|||
164111667|NCT05330975|592770415|FG002|Primary|Physician Decision|0|||
164111668|NCT05330975|592770416|FG003|Primary|Physician Decision|0|||
164111669|NCT05330975|592770417|FG004|Primary|Physician Decision|1|||
164111670|NCT05330975|592770418|FG005|Primary|Physician Decision|0|||
164111671|NCT05330975|592770419|FG006|Primary|Physician Decision|0|||
164111672|NCT05330975|592770413|FG000|Revaccination|Adverse Event|0|||
164111673|NCT05330975|592770414|FG001|Revaccination|Adverse Event|0|||
164111674|NCT05330975|592770415|FG002|Revaccination|Adverse Event|0|||
164111675|NCT05330975|592770416|FG003|Revaccination|Adverse Event|0|||
164111676|NCT05330975|592770417|FG004|Revaccination|Adverse Event|0|||
164111677|NCT05330975|592770418|FG005|Revaccination|Adverse Event|0|||
164111678|NCT05330975|592770419|FG006|Revaccination|Adverse Event|3|||
164111679|NCT05330975|592770413|FG000|Revaccination|Lost to Follow-up|0|||
164111680|NCT05330975|592770414|FG001|Revaccination|Lost to Follow-up|0|||
164111681|NCT05330975|592770415|FG002|Revaccination|Lost to Follow-up|0|||
164111682|NCT05330975|592770416|FG003|Revaccination|Lost to Follow-up|0|||
164111683|NCT05330975|592770417|FG004|Revaccination|Lost to Follow-up|0|||
164111684|NCT05330975|592770418|FG005|Revaccination|Lost to Follow-up|0|||
164111685|NCT05330975|592770419|FG006|Revaccination|Lost to Follow-up|10|||
164111686|NCT05330975|592770413|FG000|Revaccination|Withdrawal by Subject|0|||
164111687|NCT05330975|592770414|FG001|Revaccination|Withdrawal by Subject|0|||
164111688|NCT05330975|592770415|FG002|Revaccination|Withdrawal by Subject|0|||
164111689|NCT05330975|592770416|FG003|Revaccination|Withdrawal by Subject|0|||
164111690|NCT05330975|592770417|FG004|Revaccination|Withdrawal by Subject|0|||
164111691|NCT05330975|592770418|FG005|Revaccination|Withdrawal by Subject|0|||
164111692|NCT05330975|592770419|FG006|Revaccination|Withdrawal by Subject|2|||
164111693|NCT05330975|592770413|FG000|Revaccination|Death|0|||
164111694|NCT05330975|592770414|FG001|Revaccination|Death|0|||
164111695|NCT05330975|592770415|FG002|Revaccination|Death|0|||
164111696|NCT05330975|592770416|FG003|Revaccination|Death|0|||
164111697|NCT05330975|592770417|FG004|Revaccination|Death|0|||
164111698|NCT05330975|592770418|FG005|Revaccination|Death|0|||
164111699|NCT05330975|592770419|FG006|Revaccination|Death|3|||
164111700|NCT05267106|592770423|FG000|Overall Study|Death|50|||
164111701|NCT05267106|592770424|FG001|Overall Study|Death|2|||
164111702|NCT05267106|592770423|FG000|Overall Study|Study terminated by Sponsor|24|||
164111703|NCT05267106|592770424|FG001|Overall Study|Study terminated by Sponsor|6|||
164111704|NCT05267106|592770423|FG000|Overall Study|Withdrawal by Subject|0|||
164111705|NCT05267106|592770424|FG001|Overall Study|Withdrawal by Subject|1|||
164111706|NCT04165824|592770425|FG000|Overall Study|Adverse Event|23|||
164111707|NCT04165824|592770425|FG000|Overall Study|Physician Decision|1|||
164111708|NCT04165824|592770425|FG000|Overall Study|Withdrawal by Subject|17|||
164111709|NCT04165824|592770425|FG000|Overall Study|Other|5|||
164111710|NCT03292458|592770430|FG000|Period 1|Adverse Event|2|||
164111711|NCT03292458|592770431|FG001|Period 1|Adverse Event|0|||
164111712|NCT01513239|592770432|FG000|Period 1: Main Phase|Adverse Event|1|||
164111713|NCT01513239|592770433|FG001|Period 1: Main Phase|Adverse Event|1|||
164111714|NCT01513239|592770434|FG002|Period 1: Main Phase|Adverse Event|2|||
164111715|NCT01513239|592770435|FG003|Period 1: Main Phase|Adverse Event|0|||
164111716|NCT01513239|592770436|FG004|Period 1: Main Phase|Adverse Event|0|||
164111717|NCT01513239|592770437|FG005|Period 1: Main Phase|Adverse Event|0|||
164111718|NCT01513239|592770432|FG000|Period 1: Main Phase|Death|29|||
164111719|NCT01513239|592770433|FG001|Period 1: Main Phase|Death|22|||
164111720|NCT01513239|592770434|FG002|Period 1: Main Phase|Death|32|||
164111721|NCT01513239|592770435|FG003|Period 1: Main Phase|Death|0|||
164111722|NCT01513239|592770436|FG004|Period 1: Main Phase|Death|0|||
164111723|NCT01513239|592770437|FG005|Period 1: Main Phase|Death|0|||
164111724|NCT01513239|592770432|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
164111725|NCT01513239|592770433|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
164111726|NCT01513239|592770434|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
164111727|NCT01513239|592770435|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
164111728|NCT01513239|592770436|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
164111729|NCT01513239|592770437|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
164111730|NCT01513239|592770432|FG000|Period 1: Main Phase|Physician Decision|4|||
164111731|NCT01513239|592770433|FG001|Period 1: Main Phase|Physician Decision|4|||
164111732|NCT01513239|592770434|FG002|Period 1: Main Phase|Physician Decision|4|||
164111733|NCT01513239|592770435|FG003|Period 1: Main Phase|Physician Decision|0|||
164111734|NCT01513239|592770436|FG004|Period 1: Main Phase|Physician Decision|0|||
164111735|NCT01513239|592770437|FG005|Period 1: Main Phase|Physician Decision|0|||
164111736|NCT01513239|592770432|FG000|Period 1: Main Phase|Protocol Violation|2|||
164111737|NCT01513239|592770433|FG001|Period 1: Main Phase|Protocol Violation|2|||
164111738|NCT01513239|592770434|FG002|Period 1: Main Phase|Protocol Violation|2|||
164111739|NCT01513239|592770435|FG003|Period 1: Main Phase|Protocol Violation|0|||
164111740|NCT01513239|592770436|FG004|Period 1: Main Phase|Protocol Violation|0|||
164111741|NCT01513239|592770437|FG005|Period 1: Main Phase|Protocol Violation|0|||
164111742|NCT01513239|592770432|FG000|Period 1: Main Phase|Technical Problems|1|||
164111743|NCT01513239|592770433|FG001|Period 1: Main Phase|Technical Problems|2|||
164111744|NCT01513239|592770434|FG002|Period 1: Main Phase|Technical Problems|0|||
164111745|NCT01513239|592770435|FG003|Period 1: Main Phase|Technical Problems|0|||
164111746|NCT01513239|592770436|FG004|Period 1: Main Phase|Technical Problems|0|||
164111747|NCT01513239|592770437|FG005|Period 1: Main Phase|Technical Problems|0|||
164111748|NCT01513239|592770432|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
164111749|NCT01513239|592770433|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
164111750|NCT01513239|592770434|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
164111751|NCT01513239|592770435|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
164111752|NCT01513239|592770436|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
164111753|NCT01513239|592770437|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
164111754|NCT01513239|592770432|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
164111755|NCT01513239|592770433|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
164111756|NCT01513239|592770434|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
164111757|NCT01513239|592770435|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
164111758|NCT01513239|592770436|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
164111759|NCT01513239|592770437|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
164111760|NCT01513239|592770432|FG000|Period 2: 9 Month Extension Phase|Death|0|||
164111761|NCT01513239|592770433|FG001|Period 2: 9 Month Extension Phase|Death|0|||
164111762|NCT01513239|592770434|FG002|Period 2: 9 Month Extension Phase|Death|0|||
164111763|NCT01513239|592770435|FG003|Period 2: 9 Month Extension Phase|Death|2|||
164111764|NCT01513239|592770436|FG004|Period 2: 9 Month Extension Phase|Death|5|||
164111765|NCT01513239|592770437|FG005|Period 2: 9 Month Extension Phase|Death|2|||
164111766|NCT01513239|592770432|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164111767|NCT01513239|592770433|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164111768|NCT01513239|592770434|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164111769|NCT01513239|592770435|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
164111770|NCT01513239|592770436|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
164111771|NCT01513239|592770437|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
164111772|NCT01513239|592770432|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164111773|NCT01513239|592770433|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164111774|NCT01513239|592770434|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164111775|NCT01513239|592770435|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
164111776|NCT01513239|592770436|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164111777|NCT01513239|592770437|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
164111778|NCT01513239|592770432|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164111779|NCT01513239|592770433|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164111780|NCT01513239|592770434|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164111781|NCT01513239|592770435|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
164111782|NCT01513239|592770436|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
164111783|NCT01513239|592770437|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
164111784|NCT02276885|592770438|FG000|Overall Study|Withdrawal by Subject|2|||
164111785|NCT02276885|592770439|FG001|Overall Study|Withdrawal by Subject|0|||
164111786|NCT02276885|592770438|FG000|Overall Study|Lost to Follow-up|5|||
164111787|NCT02276885|592770439|FG001|Overall Study|Lost to Follow-up|2|||
164111788|NCT04569032|592770440|FG000|Overall Study|Death|10|||
164111789|NCT04569032|592770441|FG001|Overall Study|Death|13|||
164111790|NCT04569032|592770440|FG000|Overall Study|Withdrawal by Subject|2|||
164111791|NCT04569032|592770441|FG001|Overall Study|Withdrawal by Subject|0|||
164111792|NCT04569032|592770440|FG000|Overall Study|Lost to Follow-up|0|||
164111793|NCT04569032|592770441|FG001|Overall Study|Lost to Follow-up|1|||
164111794|NCT04569032|592770440|FG000|Overall Study|In long term follow up|22|||
164111795|NCT04569032|592770441|FG001|Overall Study|In long term follow up|34|||
164111796|NCT03837626|592770442|FG000|Overall Study|Adverse Event|3|||
164111797|NCT03837626|592770443|FG001|Overall Study|Adverse Event|3|||
164111798|NCT03837626|592770442|FG000|Overall Study|Withdrawal by Subject|2|||
164111799|NCT03837626|592770443|FG001|Overall Study|Withdrawal by Subject|4|||
164111800|NCT03837626|592770442|FG000|Overall Study|Physician Decision|2|||
164111801|NCT03837626|592770443|FG001|Overall Study|Physician Decision|3|||
164111802|NCT03837626|592770442|FG000|Overall Study|Lost to Follow-up|3|||
164111803|NCT03837626|592770443|FG001|Overall Study|Lost to Follow-up|1|||
164111804|NCT03599362|592770444|FG000|Overall Study|Screen Failure|3|||
164111805|NCT03707587|592770445|FG000|Overall Study|Death|0|||
164111806|NCT03707587|592770446|FG001|Overall Study|Death|1|||
164111807|NCT00834444|592770448|FG000|First Intervention|Adverse Event|1|||
164111808|NCT00834444|592770449|FG001|First Intervention|Adverse Event|0|||
164111809|NCT00834444|592770448|FG000|First Intervention|Intolerance to Venopuncture|0|||
164111810|NCT00834444|592770449|FG001|First Intervention|Intolerance to Venopuncture|1|||
164111811|NCT00834444|592770448|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
164111812|NCT00834444|592770449|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
164111813|NCT00834444|592770448|FG000|Second Intervention|Adverse Event|1|||
164111814|NCT00834444|592770449|FG001|Second Intervention|Adverse Event|0|||
164111815|NCT01496118|592770459|FG000|Overall Study|Disease progression|3|||
164111816|NCT01496118|592770460|FG001|Overall Study|Disease progression|2|||
164111817|NCT01496118|592770461|FG002|Overall Study|Disease progression|3|||
164111818|NCT01496118|592770462|FG003|Overall Study|Disease progression|1|||
164111819|NCT01496118|592770463|FG004|Overall Study|Disease progression|2|||
164111820|NCT01496118|592770464|FG005|Overall Study|Disease progression|2|||
164111821|NCT01496118|592770465|FG006|Overall Study|Disease progression|14|||
164111822|NCT01496118|592770466|FG007|Overall Study|Disease progression|10|||
164111823|NCT01496118|592770459|FG000|Overall Study|Physician Decision|0|||
164111824|NCT01496118|592770460|FG001|Overall Study|Physician Decision|0|||
164111825|NCT01496118|592770461|FG002|Overall Study|Physician Decision|0|||
164111826|NCT01496118|592770462|FG003|Overall Study|Physician Decision|0|||
164111827|NCT01496118|592770463|FG004|Overall Study|Physician Decision|1|||
164111828|NCT01496118|592770464|FG005|Overall Study|Physician Decision|0|||
164111829|NCT01496118|592770465|FG006|Overall Study|Physician Decision|3|||
164111830|NCT01496118|592770466|FG007|Overall Study|Physician Decision|6|||
164111831|NCT01496118|592770459|FG000|Overall Study|Adverse Event|1|||
164111832|NCT01496118|592770460|FG001|Overall Study|Adverse Event|1|||
164111833|NCT01496118|592770461|FG002|Overall Study|Adverse Event|0|||
164111834|NCT01496118|592770462|FG003|Overall Study|Adverse Event|0|||
164111835|NCT01496118|592770463|FG004|Overall Study|Adverse Event|0|||
164111836|NCT01496118|592770464|FG005|Overall Study|Adverse Event|0|||
164111837|NCT01496118|592770465|FG006|Overall Study|Adverse Event|6|||
164111838|NCT01496118|592770466|FG007|Overall Study|Adverse Event|10|||
164111839|NCT01496118|592770459|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111840|NCT01496118|592770460|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111841|NCT01496118|592770461|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111842|NCT01496118|592770462|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111843|NCT01496118|592770463|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111844|NCT01496118|592770464|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111845|NCT01496118|592770465|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
164111846|NCT01496118|592770466|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
164111847|NCT01496118|592770459|FG000|Overall Study|Death|0|||
164111848|NCT01496118|592770460|FG001|Overall Study|Death|0|||
164111849|NCT01496118|592770461|FG002|Overall Study|Death|0|||
164111850|NCT01496118|592770462|FG003|Overall Study|Death|0|||
164111851|NCT01496118|592770463|FG004|Overall Study|Death|0|||
164111852|NCT01496118|592770464|FG005|Overall Study|Death|0|||
164111853|NCT01496118|592770465|FG006|Overall Study|Death|1|||
164111854|NCT01496118|592770466|FG007|Overall Study|Death|1|||
164111855|NCT01496118|592770459|FG000|Overall Study|Withdrawal by Subject|0|||
164111856|NCT01496118|592770460|FG001|Overall Study|Withdrawal by Subject|0|||
164111857|NCT01496118|592770461|FG002|Overall Study|Withdrawal by Subject|0|||
164111858|NCT01496118|592770462|FG003|Overall Study|Withdrawal by Subject|2|||
164111859|NCT01496118|592770463|FG004|Overall Study|Withdrawal by Subject|0|||
164111860|NCT01496118|592770464|FG005|Overall Study|Withdrawal by Subject|1|||
164111861|NCT01496118|592770465|FG006|Overall Study|Withdrawal by Subject|6|||
164111862|NCT01496118|592770466|FG007|Overall Study|Withdrawal by Subject|3|||
164111863|NCT00841659|592770467|FG000|Washout: 2 Weeks|Protocol Violation|1|||
164111864|NCT00841659|592770468|FG001|Washout: 2 Weeks|Protocol Violation|0|||
164111865|NCT03499873|592770472|FG000|Overall Study|Withdrawal by Subject|4|||
164111866|NCT03499873|592770473|FG001|Overall Study|Withdrawal by Subject|6|||
164111867|NCT03499873|592770474|FG002|Overall Study|Withdrawal by Subject|1|||
164111868|NCT03499873|592770472|FG000|Overall Study|Subjects condition worsened|0|||
164111869|NCT03499873|592770473|FG001|Overall Study|Subjects condition worsened|3|||
164111870|NCT03499873|592770474|FG002|Overall Study|Subjects condition worsened|11|||
164111871|NCT03499873|592770472|FG000|Overall Study|Adverse Event|8|||
164111872|NCT03499873|592770473|FG001|Overall Study|Adverse Event|3|||
164111873|NCT03499873|592770474|FG002|Overall Study|Adverse Event|6|||
164111874|NCT03499873|592770472|FG000|Overall Study|Physician Decision|1|||
164111875|NCT03499873|592770473|FG001|Overall Study|Physician Decision|0|||
164111876|NCT03499873|592770474|FG002|Overall Study|Physician Decision|0|||
164111877|NCT03499873|592770472|FG000|Overall Study|Administrative reasons|0|||
164111878|NCT03499873|592770473|FG001|Overall Study|Administrative reasons|1|||
164111879|NCT03499873|592770474|FG002|Overall Study|Administrative reasons|0|||
164111880|NCT03499873|592770472|FG000|Overall Study|Concomitant therapy|5|||
164111881|NCT03499873|592770473|FG001|Overall Study|Concomitant therapy|4|||
164111882|NCT03499873|592770474|FG002|Overall Study|Concomitant therapy|7|||
164111883|NCT03499873|592770472|FG000|Overall Study|Miscellaneous|1|||
164111884|NCT03499873|592770473|FG001|Overall Study|Miscellaneous|2|||
164111885|NCT03499873|592770474|FG002|Overall Study|Miscellaneous|2|||
164111886|NCT03499873|592770472|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
164111887|NCT03499873|592770473|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
164111888|NCT03499873|592770474|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
164111889|NCT04608448|592770475|FG000|Overall Study|Withdrawal by Subject|1|||
164111890|NCT04608448|592770475|FG000|Overall Study|Adverse Event|1|||
164111891|NCT01297504|592770476|FG000|Overall Study|Invalid Consent|1|||
164111892|NCT01297504|592770476|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
164111893|NCT01297504|592770476|FG000|Overall Study|No Study Visits|4|||
164111894|NCT01297504|592770476|FG000|Overall Study|Death|3|||
164111895|NCT01297504|592770476|FG000|Overall Study|Lost to Follow-up|43|||
164111896|NCT01297504|592770476|FG000|Overall Study|Withdrawal by Subject|9|||
164111897|NCT01297504|592770476|FG000|Overall Study|Site Closure|3|||
164111898|NCT01297504|592770476|FG000|Overall Study|Protocol Violation|3|||
164111899|NCT00654186|592770477|FG000|Overall Study|Withdrawal by Subject|5|||
164111900|NCT00881751|592770478|FG000|Overall Study|Physician Decision|0|||
164111901|NCT00881751|592770479|FG001|Overall Study|Physician Decision|1|||
164111902|NCT00881751|592770478|FG000|Overall Study|Adverse Event|0|||
164111903|NCT00881751|592770479|FG001|Overall Study|Adverse Event|2|||
164111904|NCT00881751|592770478|FG000|Overall Study|Withdrawal by Subject|0|||
164111905|NCT00881751|592770479|FG001|Overall Study|Withdrawal by Subject|2|||
164111906|NCT00301964|592770480|FG000|Overall Study|Second primary|2|||
164111907|NCT00301964|592770480|FG000|Overall Study|Wrong primary|1|||
164111908|NCT00301964|592770480|FG000|Overall Study|Inadequate pathology|1|||
164111909|NCT02385708|592770481|FG000|Overall Study|Withdrawal by Subject|0|||
164111910|NCT02385708|592770482|FG001|Overall Study|Withdrawal by Subject|2|||
164111911|NCT02385708|592770481|FG000|Overall Study|Withdrawn - surgery canceled|2|||
164111912|NCT02385708|592770482|FG001|Overall Study|Withdrawn - surgery canceled|5|||
164111913|NCT02385708|592770481|FG000|Overall Study|Investigator decision|5|||
164111914|NCT02385708|592770482|FG001|Overall Study|Investigator decision|7|||
164111915|NCT02385708|592770481|FG000|Overall Study|Protocol Violation|1|||
164111916|NCT02385708|592770482|FG001|Overall Study|Protocol Violation|1|||
164111917|NCT02761915|592770483|FG000|Overall Study|Death|3|||
164111918|NCT02761915|592770484|FG001|Overall Study|Death|1|||
164111919|NCT02761915|592770485|FG002|Overall Study|Death|1|||
164111920|NCT02761915|592770486|FG003|Overall Study|Death|1|||
164111921|NCT02761915|592770487|FG004|Overall Study|Death|0|||
164111922|NCT02761915|592770488|FG005|Overall Study|Death|1|||
164111923|NCT02761915|592770483|FG000|Overall Study|Withdrawal by Subject|1|||
164111924|NCT02761915|592770484|FG001|Overall Study|Withdrawal by Subject|0|||
164111925|NCT02761915|592770485|FG002|Overall Study|Withdrawal by Subject|0|||
164111926|NCT02761915|592770486|FG003|Overall Study|Withdrawal by Subject|0|||
164111927|NCT02761915|592770487|FG004|Overall Study|Withdrawal by Subject|1|||
164111928|NCT02761915|592770488|FG005|Overall Study|Withdrawal by Subject|2|||
164111929|NCT02761915|592770483|FG000|Overall Study|Disease Progression|0|||
164111930|NCT02761915|592770484|FG001|Overall Study|Disease Progression|0|||
164111931|NCT02761915|592770485|FG002|Overall Study|Disease Progression|0|||
164111932|NCT02761915|592770486|FG003|Overall Study|Disease Progression|2|||
164111933|NCT02761915|592770487|FG004|Overall Study|Disease Progression|2|||
164111934|NCT02761915|592770488|FG005|Overall Study|Disease Progression|2|||
164111935|NCT02436200|592770489|FG000|Overall Study|Significant outlier|1|||
164111936|NCT02654145|592770496|FG000|Overall Study|Lack of Efficacy|1|||
164111937|NCT02654145|592770496|FG000|Overall Study|Protocol Violation|1|||
164111938|NCT02654145|592770496|FG000|Overall Study|Withdrawal by Subject|5|||
164111939|NCT00354835|592770497|FG000|Overall Study|Death|1|||
164111940|NCT00354835|592770498|FG001|Overall Study|Death|1|||
164111941|NCT00354835|592770497|FG000|Overall Study|Physician Decision|8|||
164111942|NCT00354835|592770498|FG001|Overall Study|Physician Decision|13|||
164111943|NCT00354835|592770497|FG000|Overall Study|Withdrawal by Subject|2|||
164111944|NCT00354835|592770498|FG001|Overall Study|Withdrawal by Subject|1|||
164111945|NCT00354835|592770497|FG000|Overall Study|Ineligible|17|||
164111946|NCT00354835|592770498|FG001|Overall Study|Ineligible|16|||
164111947|NCT00354835|592770497|FG000|Overall Study|Disease progression or relapse|15|||
164111948|NCT00354835|592770498|FG001|Overall Study|Disease progression or relapse|22|||
164111949|NCT00354835|592770497|FG000|Overall Study|Adverse Event|6|||
164111950|NCT00354835|592770498|FG001|Overall Study|Adverse Event|0|||
164111951|NCT00354835|592770497|FG000|Overall Study|Refusal of further therapy|3|||
164111952|NCT00354835|592770498|FG001|Overall Study|Refusal of further therapy|8|||
164111953|NCT01968551|592770499|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
164111954|NCT01968551|592770500|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
164111955|NCT01968551|592770501|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
164111956|NCT01968551|592770499|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
164111957|NCT01968551|592770500|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
164111958|NCT01968551|592770501|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
164111959|NCT01968551|592770499|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
164111960|NCT01968551|592770500|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
164111961|NCT01968551|592770501|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
164111962|NCT01968551|592770499|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
164111963|NCT01968551|592770500|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
164111964|NCT01968551|592770501|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
164111965|NCT01968551|592770499|FG000|Extension Phase|Adverse Event|0|||
164111966|NCT01968551|592770500|FG001|Extension Phase|Adverse Event|0|||
164111967|NCT01968551|592770501|FG002|Extension Phase|Adverse Event|2|||
164111968|NCT01968551|592770499|FG000|Extension Phase|Death|0|||
164111969|NCT01968551|592770500|FG001|Extension Phase|Death|1|||
164111970|NCT01968551|592770501|FG002|Extension Phase|Death|0|||
164111971|NCT01968551|592770499|FG000|Extension Phase|Withdrew Consent|0|||
164111972|NCT01968551|592770500|FG001|Extension Phase|Withdrew Consent|0|||
164111973|NCT01968551|592770501|FG002|Extension Phase|Withdrew Consent|1|||
164111974|NCT01968551|592770499|FG000|Extension Phase|Lost to Follow-up|1|||
164111975|NCT01968551|592770500|FG001|Extension Phase|Lost to Follow-up|0|||
164111976|NCT01968551|592770501|FG002|Extension Phase|Lost to Follow-up|1|||
164111977|NCT06475729|592770502|FG000|Overall Study|Withdrawal by Subject|2|||
164111978|NCT06475729|592770503|FG001|Overall Study|Withdrawal by Subject|1|||
164111979|NCT06475729|592770502|FG000|Overall Study|Randomized but did not receive any dose|3|||
164111980|NCT06475729|592770503|FG001|Overall Study|Randomized but did not receive any dose|2|||
164111981|NCT06475729|592770502|FG000|Overall Study|Lost to Follow-up|1|||
164111982|NCT06475729|592770503|FG001|Overall Study|Lost to Follow-up|2|||
164111983|NCT06475729|592770502|FG000|Overall Study|Physician Decision|5|||
164111984|NCT06475729|592770503|FG001|Overall Study|Physician Decision|2|||
164111985|NCT06475729|592770502|FG000|Overall Study|Adverse Event|1|||
164111986|NCT06475729|592770503|FG001|Overall Study|Adverse Event|1|||
164111987|NCT03922750|592770510|FG000|Overall Study|Unclassified|0|||
164111988|NCT03922750|592770511|FG001|Overall Study|Unclassified|0|||
164111989|NCT03922750|592770512|FG002|Overall Study|Unclassified|1|||
164111990|NCT03922750|592770510|FG000|Overall Study|Adverse Event|0|||
164111991|NCT03922750|592770511|FG001|Overall Study|Adverse Event|1|||
164111992|NCT03922750|592770512|FG002|Overall Study|Adverse Event|0|||
164111993|NCT02166606|592770513|FG000|Overall Study|Adverse Event|3|||
164111994|NCT02166606|592770513|FG000|Overall Study|Death|31|||
164111995|NCT02166606|592770513|FG000|Overall Study|Protocol Violation|7|||
164111996|NCT02166606|592770513|FG000|Overall Study|Lost to Follow-up|30|||
164111997|NCT02166606|592770513|FG000|Overall Study|Withdrawal by Subject|1|||
164111998|NCT02166606|592770513|FG000|Overall Study|Physician Decision|1|||
164111999|NCT02166606|592770513|FG000|Overall Study|Device upgrade|1|||
164112000|NCT02166606|592770513|FG000|Overall Study|Enrolled after End of Enrollment|4|||
164112001|NCT01958476|592770514|FG000|Overall Study|Parent requested exclusion from analysis|1|||
164112002|NCT01958476|592770515|FG001|Overall Study|Parent requested exclusion from analysis|0|||
164112003|NCT03868631|592770517|FG000|Baseline to Week 6|Adverse Event|0|||
164112004|NCT03868631|592770518|FG001|Baseline to Week 6|Adverse Event|3|||
164112005|NCT03868631|592770517|FG000|Baseline to Week 6|Protocol Violation|1|||
164112006|NCT03868631|592770518|FG001|Baseline to Week 6|Protocol Violation|1|||
164112007|NCT03868631|592770517|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
164112008|NCT03868631|592770518|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
164112009|NCT03868631|592770517|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
164112010|NCT03868631|592770518|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
164112011|NCT03868631|592770517|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
164112012|NCT03868631|592770518|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
164112013|NCT03868631|592770517|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
164112014|NCT03868631|592770518|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
164112015|NCT03867760|592770521|FG000|Overall Study|Lost to Follow-up|2|||
164112016|NCT03867760|592770522|FG001|Overall Study|Lost to Follow-up|3|||
164112017|NCT03867760|592770521|FG000|Overall Study|Withdrawal by Subject|1|||
164112018|NCT03867760|592770522|FG001|Overall Study|Withdrawal by Subject|2|||
164112019|NCT03867760|592770521|FG000|Overall Study|subject could not meet study logistics|3|||
164112020|NCT03867760|592770522|FG001|Overall Study|subject could not meet study logistics|3|||
164112021|NCT04236596|592770523|FG000|Overall Study|Withdrawal by Subject|1|||
164112022|NCT04236596|592770523|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
164112023|NCT04236596|592770523|FG000|Overall Study|Participants did not receive implant at all|4|||
164112024|NCT02588339|592770525|FG000|Overall Study|Withdrawal by Subject|1|||
164112025|NCT02588339|592770525|FG000|Overall Study|GVHD Progression prior to treatment|2|||
164112026|NCT02966340|592771860|FG000|Overall Study|Adverse Event|0|||
164112027|NCT02966340|592771861|FG001|Overall Study|Adverse Event|1|||
164112028|NCT02966340|592771860|FG000|Overall Study|Lost to Follow-up|0|||
164112029|NCT02966340|592771861|FG001|Overall Study|Lost to Follow-up|1|||
164112030|NCT02966340|592771860|FG000|Overall Study|Withdrawal by Subject|1|||
164112031|NCT02966340|592771861|FG001|Overall Study|Withdrawal by Subject|0|||
164112032|NCT02966340|592771860|FG000|Overall Study|data acquisition error|1|||
164112033|NCT02966340|592771861|FG001|Overall Study|data acquisition error|0|||
164112034|NCT02966340|592771860|FG000|Overall Study|startle non-responder|1|||
164112035|NCT02966340|592771861|FG001|Overall Study|startle non-responder|1|||
164112036|NCT04768296|592771862|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
164112037|NCT04768296|592771863|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
164112038|NCT00255346|592771870|FG000|Overall Study|Adverse Event|1|||
164112039|NCT00255346|592771871|FG001|Overall Study|Adverse Event|0|||
164112040|NCT00255346|592771872|FG002|Overall Study|Adverse Event|0|||
164112041|NCT00255346|592771873|FG003|Overall Study|Adverse Event|0|||
164112042|NCT00255346|592771874|FG004|Overall Study|Adverse Event|0|||
164112043|NCT04402489|592771876|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164112044|NCT04402489|592771877|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
164112045|NCT04402489|592771878|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164112046|NCT04402489|592771879|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164112047|NCT04402489|592771880|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
164112048|NCT04402489|592771876|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
164112049|NCT04402489|592771877|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164112050|NCT04402489|592771878|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164112051|NCT04402489|592771879|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164112052|NCT04402489|592771880|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
164112053|NCT04402489|592771876|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
164112054|NCT04402489|592771877|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
164112055|NCT04402489|592771878|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
164112056|NCT04402489|592771879|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
164112057|NCT04402489|592771880|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
164112058|NCT04402489|592771876|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164112059|NCT04402489|592771877|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164112060|NCT04402489|592771878|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
164112061|NCT04402489|592771879|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164112062|NCT04402489|592771880|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
164112063|NCT04402489|592771876|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164112064|NCT04402489|592771877|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164112065|NCT04402489|592771878|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164112066|NCT04402489|592771879|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
164112067|NCT04402489|592771880|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
164112068|NCT04402489|592771876|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
164112069|NCT04402489|592771877|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
164112070|NCT04402489|592771878|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
164112071|NCT04402489|592771879|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
164112072|NCT04402489|592771880|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
164112073|NCT03192891|592771881|FG000|Overall Study|Lost to Follow-up|55|||
164112074|NCT05223868|592771882|FG000|Overall Study|Lost to Follow-up|1|||
164112075|NCT05223868|592771883|FG001|Overall Study|Lost to Follow-up|3|||
164112076|NCT05223868|592771884|FG002|Overall Study|Lost to Follow-up|0|||
164112077|NCT05223868|592771885|FG003|Overall Study|Lost to Follow-up|0|||
164112078|NCT05223868|592771886|FG004|Overall Study|Lost to Follow-up|0|||
164112079|NCT05223868|592771887|FG005|Overall Study|Lost to Follow-up|1|||
164112080|NCT05223868|592771882|FG000|Overall Study|Withdrawal by Subject|6|||
164112081|NCT05223868|592771883|FG001|Overall Study|Withdrawal by Subject|2|||
164112082|NCT05223868|592771884|FG002|Overall Study|Withdrawal by Subject|3|||
164112083|NCT05223868|592771885|FG003|Overall Study|Withdrawal by Subject|1|||
164112084|NCT05223868|592771886|FG004|Overall Study|Withdrawal by Subject|1|||
164112085|NCT05223868|592771887|FG005|Overall Study|Withdrawal by Subject|2|||
164112086|NCT05223868|592771882|FG000|Overall Study|Other|0|||
164112087|NCT05223868|592771883|FG001|Overall Study|Other|2|||
164112088|NCT05223868|592771884|FG002|Overall Study|Other|0|||
164112089|NCT05223868|592771885|FG003|Overall Study|Other|0|||
164112090|NCT05223868|592771886|FG004|Overall Study|Other|1|||
164112091|NCT05223868|592771887|FG005|Overall Study|Other|1|||
164112092|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164112093|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164112094|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164112095|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
164112096|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164112097|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
164112098|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164112099|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164112100|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
164112101|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
164112102|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164112103|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
164112104|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164112105|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164112106|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
164112107|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164112108|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164112109|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
164112110|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164112111|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164112112|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
164112113|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
164112114|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164112115|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
164112116|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164112117|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164112118|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
164112119|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
164112120|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164112121|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
164112122|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
164112123|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
164112124|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
164112125|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
164112126|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
164112127|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
164112128|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
164112129|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
164112130|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
164112131|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
164112132|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
164112133|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
164112134|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
164112135|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
164112136|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
164112137|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
164112138|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
164112139|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
164112140|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
164112141|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
164112678|NCT02372006|592774100|FG002|Overall Study|Dose limiting toxicity|0|||
164112142|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
164112143|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
164112144|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
164112145|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
164112146|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
164112147|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
164112148|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
164112149|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
164112150|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
164112151|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
164112152|NCT03395197|592771888|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
164112153|NCT03395197|592771889|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
164112154|NCT03395197|592771890|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
164112155|NCT03395197|592771891|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
164112156|NCT03395197|592771892|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
164112157|NCT03395197|592771893|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
164112158|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Death|0|||
164112159|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Death|0|||
164112160|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Death|0|||
164112161|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Death|0|||
164112162|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Death|1|||
164112163|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Death|4|||
164112164|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164112165|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164112166|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164112167|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
164112168|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
164112169|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
164112170|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164112171|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164112172|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164112173|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164112174|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
164112175|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
164112176|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164112177|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164112178|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164112179|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
164112180|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
164112181|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
164112182|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164112183|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164112184|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164112185|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
164112186|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
164112187|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
164112188|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164112189|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164112190|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164112191|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
164112192|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
164112193|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
164112194|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164112195|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164112196|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164112197|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
164112198|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
164112199|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
164112200|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Other|0|||
164112201|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Other|0|||
164112202|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Other|0|||
164112203|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Other|0|||
164112204|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Other|3|||
164112205|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Other|3|||
164112206|NCT03395197|592771888|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
164112207|NCT03395197|592771889|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
164112208|NCT03395197|592771890|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
164112209|NCT03395197|592771891|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
164112210|NCT03395197|592771892|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
164112211|NCT03395197|592771893|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
164112212|NCT02655224|592771899|FG000|Overall Study|Adverse Event|1|||
164112213|NCT02655224|592771900|FG001|Overall Study|Adverse Event|1|||
164112214|NCT03036930|592771901|FG000|Overall Study|Lost to Follow-up|7|||
164112215|NCT03036930|592771901|FG000|Overall Study|Withdrawal by Subject|3|||
164112216|NCT03036930|592771901|FG000|Overall Study|Not eligible to receive transplant within 12 months|15|||
164112217|NCT04227899|592771908|FG000|Overall Study|Withdrawal by Subject|6|||
164112218|NCT04227899|592771909|FG001|Overall Study|Withdrawal by Subject|3|||
164112219|NCT04227899|592771908|FG000|Overall Study|Death|12|||
164112220|NCT04227899|592771909|FG001|Overall Study|Death|6|||
164112221|NCT04227899|592771908|FG000|Overall Study|Lost to Follow-up|2|||
164112222|NCT04227899|592771909|FG001|Overall Study|Lost to Follow-up|1|||
164112223|NCT05151471|592771910|FG000|Overall Study|Adverse Event|21|||
164112224|NCT05151471|592771911|FG001|Overall Study|Adverse Event|16|||
164112225|NCT05151471|592771910|FG000|Overall Study|Death|1|||
164112226|NCT05151471|592771911|FG001|Overall Study|Death|0|||
164112227|NCT05151471|592771910|FG000|Overall Study|Lost to Follow-up|0|||
164112228|NCT05151471|592771911|FG001|Overall Study|Lost to Follow-up|1|||
164112229|NCT05151471|592771910|FG000|Overall Study|Withdrawal by Subject|7|||
164112230|NCT05151471|592771911|FG001|Overall Study|Withdrawal by Subject|9|||
164112231|NCT05151471|592771910|FG000|Overall Study|Study terminated by sponsor|49|||
164112232|NCT05151471|592771911|FG001|Overall Study|Study terminated by sponsor|47|||
164112233|NCT05151471|592771910|FG000|Overall Study|Other|2|||
164112234|NCT05151471|592771911|FG001|Overall Study|Other|1|||
164112235|NCT00396162|592771916|FG000|Overall Study|Withdrawal by Subject|2|||
164112236|NCT00396162|592771917|FG001|Overall Study|Withdrawal by Subject|3|||
164112237|NCT02694536|592771918|FG000|Overall Study|Progressive Disease|40|||
164112238|NCT02694536|592771918|FG000|Overall Study|Lost to Follow-up|1|||
164112239|NCT02694536|592771918|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
164112240|NCT02694536|592771918|FG000|Overall Study|Withdrawal by Subject|8|||
164112241|NCT02694536|592771918|FG000|Overall Study|Death|8|||
164112242|NCT02694536|592771918|FG000|Overall Study|Other|22|||
164112243|NCT01741545|592771919|FG000|Treatment Period|Lack of Efficacy|0|||
164112244|NCT01741545|592771920|FG001|Treatment Period|Lack of Efficacy|1|||
164112245|NCT01741545|592771919|FG000|Treatment Period|Adverse event, non-fatal|1|||
164112246|NCT01741545|592771920|FG001|Treatment Period|Adverse event, non-fatal|3|||
164112247|NCT01741545|592771919|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
164112248|NCT01741545|592771920|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
164112249|NCT01741545|592771919|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
164112250|NCT01741545|592771920|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
164112251|NCT01911429|592771921|FG000|Overall Study|Adverse Event|5|||
164112252|NCT01911429|592771922|FG001|Overall Study|Adverse Event|3|||
164112253|NCT01911429|592771923|FG002|Overall Study|Adverse Event|9|||
164112254|NCT01911429|592771921|FG000|Overall Study|Lack of Efficacy|1|||
164112255|NCT01911429|592771922|FG001|Overall Study|Lack of Efficacy|2|||
164112256|NCT01911429|592771923|FG002|Overall Study|Lack of Efficacy|4|||
164112257|NCT01911429|592771921|FG000|Overall Study|Lost to Follow-up|0|||
164112258|NCT01911429|592771922|FG001|Overall Study|Lost to Follow-up|0|||
164112259|NCT01911429|592771923|FG002|Overall Study|Lost to Follow-up|1|||
164112260|NCT01911429|592771921|FG000|Overall Study|Protocol Violation|0|||
164112261|NCT01911429|592771922|FG001|Overall Study|Protocol Violation|0|||
164112262|NCT01911429|592771923|FG002|Overall Study|Protocol Violation|1|||
164112263|NCT01911429|592771921|FG000|Overall Study|Withdrawal by Subject|5|||
164112264|NCT01911429|592771922|FG001|Overall Study|Withdrawal by Subject|5|||
164112265|NCT01911429|592771923|FG002|Overall Study|Withdrawal by Subject|4|||
164112266|NCT01911429|592771921|FG000|Overall Study|Accidental randomization|0|||
164112267|NCT01911429|592771922|FG001|Overall Study|Accidental randomization|0|||
164112268|NCT01911429|592771923|FG002|Overall Study|Accidental randomization|1|||
164112269|NCT01911429|592771921|FG000|Overall Study|subject left study|1|||
164112270|NCT01911429|592771922|FG001|Overall Study|subject left study|0|||
164112271|NCT01911429|592771923|FG002|Overall Study|subject left study|0|||
164112272|NCT01664039|592771927|FG000|Overall Study|Adverse Event|3|||
164112273|NCT01664039|592771928|FG001|Overall Study|Adverse Event|4|||
164112274|NCT01664039|592771927|FG000|Overall Study|Lost to Follow-up|1|||
164112275|NCT01664039|592771928|FG001|Overall Study|Lost to Follow-up|1|||
164112276|NCT01664039|592771927|FG000|Overall Study|Withdrawal by Subject|1|||
164112277|NCT01664039|592771928|FG001|Overall Study|Withdrawal by Subject|3|||
164112278|NCT01664039|592771927|FG000|Overall Study|Noncompliance|1|||
164112279|NCT01664039|592771928|FG001|Overall Study|Noncompliance|1|||
164112280|NCT01853176|592771929|FG000|Overall Study|Study terminated|4|||
164112281|NCT01853176|592771930|FG001|Overall Study|Study terminated|0|||
164112282|NCT05029687|592771936|FG000|Overall Study|Withdrawal by Subject|4|||
164112283|NCT05029687|592771937|FG001|Overall Study|Withdrawal by Subject|0|||
164112284|NCT05029687|592771938|FG002|Overall Study|Withdrawal by Subject|2|||
164112285|NCT05029687|592771936|FG000|Overall Study|Lost to Follow-up|4|||
164112286|NCT05029687|592771937|FG001|Overall Study|Lost to Follow-up|0|||
164112287|NCT05029687|592771938|FG002|Overall Study|Lost to Follow-up|2|||
164112288|NCT00958724|592771939|FG000|Overall Study|Disease Progression|6|||
164112289|NCT04442503|592771940|FG000|Overall Study|Adverse Event|1|||
164112290|NCT04442503|592771941|FG001|Overall Study|Adverse Event|1|||
164112291|NCT04442503|592771940|FG000|Overall Study|Lost to Follow-up|8|||
164112292|NCT04442503|592771941|FG001|Overall Study|Lost to Follow-up|6|||
164112293|NCT04442503|592771940|FG000|Overall Study|Physician Decision|0|||
164112294|NCT04442503|592771941|FG001|Overall Study|Physician Decision|2|||
164112295|NCT04442503|592771940|FG000|Overall Study|Withdrawal by Subject|3|||
164112296|NCT04442503|592771941|FG001|Overall Study|Withdrawal by Subject|4|||
164112297|NCT04442503|592771940|FG000|Overall Study|Reason not Specified|0|||
164112298|NCT04442503|592771941|FG001|Overall Study|Reason not Specified|1|||
164112299|NCT04442503|592771940|FG000|Overall Study|Randomized but not Treated|3|||
164112300|NCT04442503|592771941|FG001|Overall Study|Randomized but not Treated|1|||
164112301|NCT05034874|592771948|FG000|Overall Study|Withdrawal by Subject|6|||
164112302|NCT05034874|592771949|FG001|Overall Study|Withdrawal by Subject|6|||
164112303|NCT05034874|592771948|FG000|Overall Study|Lost to Follow-up|18|||
164112304|NCT05034874|592771949|FG001|Overall Study|Lost to Follow-up|8|||
164112305|NCT05034874|592771948|FG000|Overall Study|Physician Decision|0|||
164112306|NCT05034874|592771949|FG001|Overall Study|Physician Decision|1|||
164112307|NCT05034874|592771948|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
164112308|NCT05034874|592771949|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
164112309|NCT01867658|592771950|FG000|Overall Study|Withdrawal by Subject|6|||
164112310|NCT01867658|592771950|FG000|Overall Study|Death|2|||
164112311|NCT01867658|592771950|FG000|Overall Study|Subject could not be contacted|1|||
164112312|NCT05278858|592771951|FG000|Overall Study|Withdrawal by Subject|1|||
164112313|NCT00474058|592771952|FG000|Overall Study|Adverse Event|11|||
164112314|NCT00474058|592771953|FG001|Overall Study|Adverse Event|6|||
164112315|NCT00474058|592771952|FG000|Overall Study|Lack of Efficacy|0|||
164112316|NCT00474058|592771953|FG001|Overall Study|Lack of Efficacy|4|||
164112317|NCT00474058|592771952|FG000|Overall Study|Withdrawal by Subject|11|||
164112318|NCT00474058|592771953|FG001|Overall Study|Withdrawal by Subject|7|||
164112319|NCT00474058|592771952|FG000|Overall Study|Other|2|||
164112320|NCT00474058|592771953|FG001|Overall Study|Other|0|||
164112321|NCT03101358|592771954|FG000|Overall Study|Non-compliance with study schedule|1|||
164112322|NCT03101358|592771955|FG001|Overall Study|Non-compliance with study schedule|0|||
164112323|NCT03101358|592771956|FG002|Overall Study|Non-compliance with study schedule|0|||
164112324|NCT03101358|592771957|FG003|Overall Study|Non-compliance with study schedule|1|||
164112325|NCT03101358|592771954|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
164112326|NCT03101358|592771955|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
164112327|NCT03101358|592771956|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
164112328|NCT03101358|592771957|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
164112329|NCT03101358|592771954|FG000|Overall Study|Physician Decision|1|||
164112330|NCT03101358|592771955|FG001|Overall Study|Physician Decision|0|||
164112331|NCT03101358|592771956|FG002|Overall Study|Physician Decision|0|||
164112332|NCT03101358|592771957|FG003|Overall Study|Physician Decision|3|||
164112333|NCT03101358|592771954|FG000|Overall Study|Adverse Event|0|||
164112334|NCT03101358|592771955|FG001|Overall Study|Adverse Event|0|||
164112335|NCT03101358|592771956|FG002|Overall Study|Adverse Event|1|||
164112336|NCT03101358|592771957|FG003|Overall Study|Adverse Event|0|||
164112337|NCT03101358|592771954|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
164112338|NCT03101358|592771955|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
164112339|NCT03101358|592771956|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
164112340|NCT03101358|592771957|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
164112341|NCT03101358|592771954|FG000|Overall Study|Lost to Follow-up|1|||
164112342|NCT03101358|592771955|FG001|Overall Study|Lost to Follow-up|0|||
164112343|NCT03101358|592771956|FG002|Overall Study|Lost to Follow-up|0|||
164112344|NCT03101358|592771957|FG003|Overall Study|Lost to Follow-up|1|||
164112345|NCT02640235|592771958|FG000|Overall Study|Withdrawal by Subject|7|||
164112346|NCT02640235|592771959|FG001|Overall Study|Withdrawal by Subject|6|||
164112347|NCT02640235|592771958|FG000|Overall Study|Lost to Follow-up|4|||
164112348|NCT02640235|592771959|FG001|Overall Study|Lost to Follow-up|3|||
164112349|NCT02640235|592771958|FG000|Overall Study|Death|2|||
164112350|NCT02640235|592771959|FG001|Overall Study|Death|3|||
164112351|NCT02640235|592771958|FG000|Overall Study|Other|1|||
164112352|NCT02640235|592771959|FG001|Overall Study|Other|2|||
164112353|NCT02426918|592771960|FG000|Overall Study|Adverse Event|2|||
164112354|NCT02426918|592771961|FG001|Overall Study|Adverse Event|2|||
164112355|NCT02426918|592771962|FG002|Overall Study|Adverse Event|0|||
164112356|NCT02426918|592771960|FG000|Overall Study|Physician Decision|1|||
164112357|NCT02426918|592771961|FG001|Overall Study|Physician Decision|1|||
164112358|NCT02426918|592771962|FG002|Overall Study|Physician Decision|1|||
164112359|NCT02426918|592771960|FG000|Overall Study|Withdrawal by Subject|5|||
164112360|NCT02426918|592771961|FG001|Overall Study|Withdrawal by Subject|5|||
164112361|NCT02426918|592771962|FG002|Overall Study|Withdrawal by Subject|4|||
164112362|NCT02426918|592771960|FG000|Overall Study|Other|9|||
164112363|NCT02426918|592771961|FG001|Overall Study|Other|11|||
164112364|NCT02426918|592771962|FG002|Overall Study|Other|9|||
164112365|NCT02420353|592771965|FG000|Overall Study|Withdrawal by Subject|0|||
164112366|NCT02420353|592771966|FG001|Overall Study|Withdrawal by Subject|1|||
164112367|NCT00503867|592771967|FG000|Overall Study|Lost to Follow-up|1|||
164112368|NCT00503867|592771967|FG000|Overall Study|Adverse Event|1|||
164112369|NCT01149057|592771968|FG000|Overall Study|Lack of Efficacy|16|||
164112370|NCT01149057|592771968|FG000|Overall Study|Adverse Event|13|||
164112371|NCT01149057|592771968|FG000|Overall Study|Withdrawal by Subject|9|||
164112372|NCT01149057|592771968|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
164112373|NCT01149057|592771968|FG000|Overall Study|B Cell Depletion|4|||
164112374|NCT01149057|592771968|FG000|Overall Study|Participant Non-Compliance|2|||
164112375|NCT01149057|592771968|FG000|Overall Study|Lost to Follow-up|1|||
164112376|NCT01149057|592771968|FG000|Overall Study|High Parathyroid Hormone Value|1|||
164112377|NCT01149057|592771968|FG000|Overall Study|Other|6|||
164112378|NCT05616728|592771969|FG000|Overall Study|Lost to Follow-up|0|||
164112379|NCT05616728|592771970|FG001|Overall Study|Lost to Follow-up|0|||
164112380|NCT05616728|592771971|FG002|Overall Study|Lost to Follow-up|1|||
164112381|NCT05616728|592771969|FG000|Overall Study|Withdrawal by Subject|1|||
164112382|NCT05616728|592771970|FG001|Overall Study|Withdrawal by Subject|1|||
164112383|NCT05616728|592771971|FG002|Overall Study|Withdrawal by Subject|0|||
164112384|NCT05616728|592771969|FG000|Overall Study|Physician Decision|1|||
164112385|NCT05616728|592771970|FG001|Overall Study|Physician Decision|1|||
164112386|NCT05616728|592771971|FG002|Overall Study|Physician Decision|1|||
164112387|NCT05616728|592771969|FG000|Overall Study|Other|0|||
164112388|NCT05616728|592771970|FG001|Overall Study|Other|2|||
164112389|NCT05616728|592771971|FG002|Overall Study|Other|0|||
164112390|NCT03504085|592771977|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
164112391|NCT03504085|592771978|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
164112392|NCT03504085|592771977|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
164112393|NCT03504085|592771978|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
164112394|NCT04133311|592771979|FG000|Period 1 Double Masked Treatment Period|Death|1|||
164112395|NCT04133311|592771980|FG001|Period 1 Double Masked Treatment Period|Death|0|||
164112396|NCT04133311|592771981|FG002|Period 1 Double Masked Treatment Period|Death|0|||
164112397|NCT04133311|592771982|FG003|Period 1 Double Masked Treatment Period|Death|0|||
164112398|NCT04133311|592771979|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
164112399|NCT04133311|592771980|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
164112400|NCT04133311|592771981|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
164112401|NCT04133311|592771982|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
164112402|NCT04133311|592771979|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
164112403|NCT04133311|592771980|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
164112404|NCT04133311|592771981|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
164112405|NCT04133311|592771982|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
164112406|NCT04133311|592771979|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
164112407|NCT04133311|592771980|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
164112408|NCT04133311|592771981|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
164112409|NCT04133311|592771982|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
164112410|NCT04133311|592771979|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
164112411|NCT04133311|592771980|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
164112412|NCT04133311|592771981|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
164112413|NCT04133311|592771982|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
164112414|NCT04133311|592771979|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
164112415|NCT04133311|592771980|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
164112416|NCT04133311|592771981|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
164112417|NCT04133311|592771982|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
164112418|NCT04133311|592771979|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
164112419|NCT04133311|592771980|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
164112420|NCT04133311|592771981|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
164112421|NCT04133311|592771982|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
164112422|NCT04133311|592771979|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
164112423|NCT04133311|592771980|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
164112424|NCT04133311|592771981|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
164112425|NCT04133311|592771982|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
164112426|NCT00728754|592771987|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
164112427|NCT00728754|592771988|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
164112428|NCT00728754|592771987|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
164112429|NCT00728754|592771988|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
164112430|NCT00728754|592771987|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
164112431|NCT00728754|592771988|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
164112432|NCT00295490|592771995|FG000|Overall Study|Protocol Violation|0|||
164112433|NCT00295490|592771996|FG001|Overall Study|Protocol Violation|0|||
164112434|NCT00295490|592771997|FG002|Overall Study|Protocol Violation|3|||
164112435|NCT00295490|592771998|FG003|Overall Study|Protocol Violation|3|||
164112436|NCT00295490|592771995|FG000|Overall Study|Withdrawal by Subject|0|||
164112437|NCT00295490|592771996|FG001|Overall Study|Withdrawal by Subject|2|||
164112438|NCT00295490|592771997|FG002|Overall Study|Withdrawal by Subject|0|||
164112439|NCT00295490|592771998|FG003|Overall Study|Withdrawal by Subject|1|||
164112440|NCT00295490|592771995|FG000|Overall Study|Lost to Follow-up|0|||
164112441|NCT00295490|592771996|FG001|Overall Study|Lost to Follow-up|0|||
164112442|NCT00295490|592771997|FG002|Overall Study|Lost to Follow-up|1|||
164112443|NCT00295490|592771998|FG003|Overall Study|Lost to Follow-up|0|||
164112444|NCT00295490|592771995|FG000|Overall Study|Adverse Event|1|||
164112445|NCT00295490|592771996|FG001|Overall Study|Adverse Event|0|||
164112446|NCT00295490|592771997|FG002|Overall Study|Adverse Event|0|||
164112447|NCT00295490|592771998|FG003|Overall Study|Adverse Event|0|||
164112448|NCT00295490|592771995|FG000|Overall Study|Other|0|||
164112449|NCT00295490|592771996|FG001|Overall Study|Other|2|||
164112450|NCT00295490|592771997|FG002|Overall Study|Other|0|||
164112451|NCT00295490|592771998|FG003|Overall Study|Other|1|||
164112452|NCT03255980|592771999|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
164112453|NCT03255980|592772000|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
164112454|NCT03255980|592772001|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
164112455|NCT03255980|592772002|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
164112456|NCT03255980|592771999|FG000|Overall Study|Adverse Event|1|||
164112457|NCT03255980|592772000|FG001|Overall Study|Adverse Event|1|||
164112458|NCT03255980|592772001|FG002|Overall Study|Adverse Event|0|||
164112459|NCT03255980|592772002|FG003|Overall Study|Adverse Event|1|||
164112460|NCT03255980|592771999|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
164112461|NCT03255980|592772000|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
164112462|NCT03255980|592772001|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
164112463|NCT03255980|592772002|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
164112464|NCT03255980|592771999|FG000|Overall Study|Lost to Follow-up|1|||
164112465|NCT03255980|592772000|FG001|Overall Study|Lost to Follow-up|1|||
164112466|NCT03255980|592772001|FG002|Overall Study|Lost to Follow-up|0|||
164112467|NCT03255980|592772002|FG003|Overall Study|Lost to Follow-up|3|||
164112468|NCT03255980|592771999|FG000|Overall Study|Withdrawal by Subject|0|||
164112469|NCT03255980|592772000|FG001|Overall Study|Withdrawal by Subject|1|||
164112470|NCT03255980|592772001|FG002|Overall Study|Withdrawal by Subject|0|||
164112471|NCT03255980|592772002|FG003|Overall Study|Withdrawal by Subject|3|||
164112472|NCT01597791|592772003|FG000|Overall Study|Physician Decision|2|||
164112473|NCT01597791|592772004|FG001|Overall Study|Physician Decision|1|||
164112474|NCT01597791|592772003|FG000|Overall Study|Cesarean Section|6|||
164112475|NCT01597791|592772004|FG001|Overall Study|Cesarean Section|7|||
164112476|NCT01597791|592772003|FG000|Overall Study|Subject withdrawal|0|||
164112477|NCT01597791|592772004|FG001|Overall Study|Subject withdrawal|1|||
164112478|NCT01597791|592772003|FG000|Overall Study|Protocol Violation|0|||
164112479|NCT01597791|592772004|FG001|Overall Study|Protocol Violation|1|||
164112480|NCT05468320|592772005|FG000|Overall Study|Other|1|||
164112481|NCT05468320|592772005|FG000|Overall Study|Adverse Event|1|||
164112482|NCT03921554|592772006|FG000|Overall Study|Adverse Event|2|||
164112483|NCT03921554|592772006|FG000|Overall Study|Withdrawal by Subject|1|||
164112484|NCT03921554|592772006|FG000|Overall Study|Death|3|||
164112485|NCT04440592|592772007|FG000|Overall Study|Adverse Event|8|||
164112486|NCT04440592|592772008|FG001|Overall Study|Adverse Event|0|||
164112487|NCT04440592|592772007|FG000|Overall Study|Lost to Follow-up|1|||
164112488|NCT04440592|592772008|FG001|Overall Study|Lost to Follow-up|0|||
164112489|NCT04440592|592772007|FG000|Overall Study|Withdrawal by Subject|1|||
164112490|NCT04440592|592772008|FG001|Overall Study|Withdrawal by Subject|1|||
164112491|NCT04440592|592772007|FG000|Overall Study|Other therapy needed|0|||
164112492|NCT04440592|592772008|FG001|Overall Study|Other therapy needed|1|||
164112493|NCT02957331|592772011|FG000|Overall Study|Protocol Violation|1|||
164112494|NCT02957331|592772012|FG001|Overall Study|Protocol Violation|0|||
164112495|NCT05568615|592773985|FG000|Overall Study|Death|1|||
164112496|NCT05568615|592773985|FG000|Overall Study|Physician Decision|1|||
164112497|NCT00565851|592773986|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
164112498|NCT00565851|592773987|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
164112499|NCT00565851|592773988|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
164112500|NCT00565851|592773989|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
164112501|NCT00565851|592773990|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
164112502|NCT00565851|592773991|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
164112503|NCT00565851|592773992|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
164112504|NCT00565851|592773993|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
164112505|NCT00565851|592773986|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
164112506|NCT00565851|592773987|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
164112507|NCT00565851|592773988|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
164112508|NCT00565851|592773989|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
164112509|NCT00565851|592773990|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
164112510|NCT00565851|592773991|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
164112511|NCT00565851|592773992|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
164112512|NCT00565851|592773993|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
164112513|NCT01520987|592774003|FG000|Overall Study|Withdrawal by Subject|1|||
164112514|NCT01520987|592774004|FG001|Overall Study|Withdrawal by Subject|0|||
164112515|NCT01520987|592774005|FG002|Overall Study|Withdrawal by Subject|0|||
164112516|NCT01520987|592774006|FG003|Overall Study|Withdrawal by Subject|0|||
164112517|NCT01520987|592774007|FG004|Overall Study|Withdrawal by Subject|0|||
164112518|NCT01520987|592774008|FG005|Overall Study|Withdrawal by Subject|1|||
164112519|NCT01520987|592774009|FG006|Overall Study|Withdrawal by Subject|0|||
164112520|NCT01520987|592774010|FG007|Overall Study|Withdrawal by Subject|0|||
164112521|NCT02005562|592774011|FG000|Overall Study|Death|2|||
164112522|NCT02005562|592774012|FG001|Overall Study|Death|2|||
164112523|NCT02005562|592774011|FG000|Overall Study|Graft loss|7|||
164112524|NCT02005562|592774012|FG001|Overall Study|Graft loss|6|||
164112525|NCT02005562|592774011|FG000|Overall Study|Withdrawal by Subject|2|||
164112526|NCT02005562|592774012|FG001|Overall Study|Withdrawal by Subject|2|||
164112527|NCT02005562|592774011|FG000|Overall Study|No transplant|1|||
164112528|NCT02005562|592774012|FG001|Overall Study|No transplant|4|||
164112529|NCT02005562|592774011|FG000|Overall Study|Physician Decision|0|||
164112530|NCT02005562|592774012|FG001|Overall Study|Physician Decision|1|||
164112531|NCT00660387|592774013|FG000|Overall Study|Adverse Event|1|||
164112532|NCT00660387|592774014|FG001|Overall Study|Adverse Event|2|||
164112533|NCT00660387|592774013|FG000|Overall Study|Lack of Efficacy|0|||
164112534|NCT00660387|592774014|FG001|Overall Study|Lack of Efficacy|1|||
164112535|NCT00660387|592774013|FG000|Overall Study|Protocol Violation|1|||
164112536|NCT00660387|592774014|FG001|Overall Study|Protocol Violation|0|||
164112537|NCT03086135|592774015|FG000|Overall Study|Adverse Event|1|||
164112538|NCT03086135|592774015|FG000|Overall Study|Lost to Follow-up|2|||
164112539|NCT01023061|592774016|FG000|Overall Study|Withdrawal prior to treatment|2|||
164112540|NCT02710214|592774017|FG000|Overall Study|Lost to Follow-up|1|||
164112541|NCT02710214|592774018|FG001|Overall Study|Lost to Follow-up|0|||
164112542|NCT02710214|592774017|FG000|Overall Study|Lack of Efficacy|0|||
164112543|NCT02710214|592774018|FG001|Overall Study|Lack of Efficacy|1|||
164112544|NCT02710214|592774017|FG000|Overall Study|Death|0|||
164112545|NCT02710214|592774018|FG001|Overall Study|Death|1|||
164112546|NCT02832167|592774020|FG000|Treatment Period 1|Disease progression|90|||
164112547|NCT02832167|592774020|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
164112548|NCT02832167|592774020|FG000|Treatment Period 1|Death|2|||
164112549|NCT02832167|592774020|FG000|Treatment Period 1|Study Drug Toxicity|6|||
164112550|NCT02832167|592774020|FG000|Treatment Period 1|Participant request to discontinue|9|||
164112551|NCT02832167|592774020|FG000|Treatment Period 1|No longer meet study criteria|1|||
164112552|NCT02832167|592774020|FG000|Treatment Period 1|Participant withdrew consent|3|||
164112553|NCT02832167|592774020|FG000|Treatment Period 1|Other reasons|6|||
164112554|NCT02832167|592774020|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
164112555|NCT02832167|592774020|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
164112556|NCT02832167|592774020|FG000|Transition From Period 1 to Period 2|Death|2|||
164112557|NCT02832167|592774020|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
164112558|NCT02832167|592774020|FG000|Treatment Period 2|Disease progression|69|||
164112559|NCT02832167|592774020|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
164112560|NCT02832167|592774020|FG000|Treatment Period 2|Maximum clinical benefit|1|||
164112561|NCT02832167|592774020|FG000|Treatment Period 2|Study Drug Toxicity|5|||
164112562|NCT02832167|592774020|FG000|Treatment Period 2|Participant request to discontinue|2|||
164112563|NCT02832167|592774020|FG000|Treatment Period 2|Participant withdrew consent|3|||
164112564|NCT02832167|592774020|FG000|Treatment Period 2|Other reasons|3|||
164112565|NCT01754376|592774021|FG000|Overall Study|Adverse Event|1|||
164112566|NCT01754376|592774021|FG000|Overall Study|Lack of Efficacy|2|||
164112567|NCT04590781|592774022|FG000|Overall Study|Death|0|||
164112568|NCT04590781|592774023|FG001|Overall Study|Death|2|||
164112569|NCT04590781|592774022|FG000|Overall Study|Withdrawal by Subject|2|||
164112570|NCT04590781|592774023|FG001|Overall Study|Withdrawal by Subject|0|||
164112571|NCT00820599|592774025|FG000|Overall Study|Death|129|||
164112572|NCT00820599|592774025|FG000|Overall Study|Withdrawal by Subject|2|||
164112573|NCT03686215|592774026|FG000|Overall Study|Adverse Event|0|||
164112574|NCT03686215|592774027|FG001|Overall Study|Adverse Event|0|||
164112575|NCT03686215|592774028|FG002|Overall Study|Adverse Event|7|||
164112576|NCT03686215|592774026|FG000|Overall Study|Physician Decision|0|||
164112577|NCT03686215|592774027|FG001|Overall Study|Physician Decision|0|||
164112578|NCT03686215|592774028|FG002|Overall Study|Physician Decision|1|||
164112579|NCT03686215|592774026|FG000|Overall Study|Protocol Violation|0|||
164112580|NCT03686215|592774027|FG001|Overall Study|Protocol Violation|0|||
164112581|NCT03686215|592774028|FG002|Overall Study|Protocol Violation|4|||
164112582|NCT03686215|592774026|FG000|Overall Study|Device issue|1|||
164112682|NCT02372006|592774098|FG000|Overall Study|Withdrawal by Subject|0|||
164112683|NCT02372006|592774099|FG001|Overall Study|Withdrawal by Subject|1|||
164112684|NCT02372006|592774100|FG002|Overall Study|Withdrawal by Subject|1|||
164112685|NCT02372006|592774098|FG000|Overall Study|Other reason for not completing|0|||
164112686|NCT02372006|592774099|FG001|Overall Study|Other reason for not completing|0|||
164112687|NCT02372006|592774100|FG002|Overall Study|Other reason for not completing|1|||
164112688|NCT01859598|592774101|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
164112689|NCT00009945|592774102|FG000|Overall Study|no follow up data|7|||
164112690|NCT00009945|592774103|FG001|Overall Study|no follow up data|5|||
164112691|NCT00672984|592774104|FG000|First Intervention|Adverse Event|5|||
164112692|NCT00672984|592774105|FG001|First Intervention|Adverse Event|0|||
164112693|NCT00672984|592774106|FG002|First Intervention|Adverse Event|0|||
164112694|NCT00672984|592774104|FG000|First Intervention|Withdrawal by Subject|1|||
164112695|NCT00672984|592774105|FG001|First Intervention|Withdrawal by Subject|2|||
164112696|NCT00672984|592774106|FG002|First Intervention|Withdrawal by Subject|2|||
164112697|NCT00672984|592774104|FG000|First Intervention|Sponsor decision|3|||
164112698|NCT00672984|592774105|FG001|First Intervention|Sponsor decision|0|||
164112699|NCT00672984|592774106|FG002|First Intervention|Sponsor decision|0|||
164112700|NCT00672984|592774104|FG000|Second Intervention|Non-compliance with facility policies|0|||
164112701|NCT00672984|592774105|FG001|Second Intervention|Non-compliance with facility policies|2|||
164112702|NCT00672984|592774106|FG002|Second Intervention|Non-compliance with facility policies|0|||
164112703|NCT00672984|592774104|FG000|Second Intervention|Withdrawal by Subject|0|||
164112704|NCT00672984|592774105|FG001|Second Intervention|Withdrawal by Subject|3|||
164112705|NCT00672984|592774106|FG002|Second Intervention|Withdrawal by Subject|0|||
164112706|NCT00672984|592774104|FG000|Second Intervention|Protocol Violation|0|||
164112707|NCT00672984|592774105|FG001|Second Intervention|Protocol Violation|1|||
164112708|NCT00672984|592774106|FG002|Second Intervention|Protocol Violation|1|||
164112709|NCT00672984|592774104|FG000|Third Intervention|Adverse Event|1|||
164112710|NCT00672984|592774105|FG001|Third Intervention|Adverse Event|0|||
164112711|NCT00672984|592774106|FG002|Third Intervention|Adverse Event|1|||
164112712|NCT00573313|592774107|FG000|Overall Study|Protocol Violation|5|||
164112713|NCT00573313|592774108|FG001|Overall Study|Protocol Violation|0|||
164112714|NCT00573313|592774109|FG002|Overall Study|Protocol Violation|6|||
164112715|NCT00573313|592774110|FG003|Overall Study|Protocol Violation|0|||
164112716|NCT02611362|592774111|FG000|Overall Study|Withdrawal by Subject|7|||
164112717|NCT02611362|592774112|FG001|Overall Study|Withdrawal by Subject|2|||
164112718|NCT02611362|592774111|FG000|Overall Study|Lost to Follow-up|2|||
164112719|NCT02611362|592774112|FG001|Overall Study|Lost to Follow-up|4|||
164112720|NCT00354159|592774113|FG000|Randomized Study Period|Withdrawal by Subject|5|||
164112721|NCT00354159|592774114|FG001|Randomized Study Period|Withdrawal by Subject|3|||
164112722|NCT00354159|592774113|FG000|Randomized Study Period|Physician Decision|6|||
164112723|NCT00354159|592774114|FG001|Randomized Study Period|Physician Decision|10|||
164112724|NCT00354159|592774113|FG000|Randomized Study Period|Lost to Follow-up|4|||
164112725|NCT00354159|592774114|FG001|Randomized Study Period|Lost to Follow-up|0|||
164112726|NCT00354159|592774113|FG000|Randomized Study Period|Death|7|||
164112727|NCT00354159|592774114|FG001|Randomized Study Period|Death|9|||
164112728|NCT00354159|592774113|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
164112729|NCT00354159|592774114|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
164112730|NCT00354159|592774113|FG000|Long-term Follow-up|Physician Decision|127|||
164112731|NCT00354159|592774114|FG001|Long-term Follow-up|Physician Decision|122|||
164112732|NCT00354159|592774113|FG000|Long-term Follow-up|Lost to Follow-up|1|||
164112733|NCT00354159|592774114|FG001|Long-term Follow-up|Lost to Follow-up|0|||
164112734|NCT00354159|592774113|FG000|Long-term Follow-up|Death|14|||
164112735|NCT00354159|592774114|FG001|Long-term Follow-up|Death|11|||
164112736|NCT00354159|592774113|FG000|Long-term Follow-up|Study Closed|29|||
164112737|NCT00354159|592774114|FG001|Long-term Follow-up|Study Closed|34|||
164112738|NCT02229084|592774116|FG000|Overall Study|Adverse Event|1|||
164112739|NCT02229084|592774117|FG001|Overall Study|Adverse Event|0|||
164112740|NCT02229084|592774118|FG002|Overall Study|Adverse Event|0|||
164112741|NCT02229084|592774119|FG003|Overall Study|Adverse Event|0|||
164112742|NCT02229084|592774120|FG004|Overall Study|Adverse Event|0|||
164112743|NCT02229084|592774121|FG005|Overall Study|Adverse Event|0|||
164112744|NCT02229084|592774122|FG006|Overall Study|Adverse Event|0|||
164112745|NCT02229084|592774116|FG000|Overall Study|Lost to Follow-up|0|||
164112746|NCT02229084|592774117|FG001|Overall Study|Lost to Follow-up|0|||
164112747|NCT02229084|592774118|FG002|Overall Study|Lost to Follow-up|1|||
164112748|NCT02229084|592774119|FG003|Overall Study|Lost to Follow-up|1|||
164112749|NCT02229084|592774120|FG004|Overall Study|Lost to Follow-up|0|||
164112750|NCT02229084|592774121|FG005|Overall Study|Lost to Follow-up|0|||
164112751|NCT02229084|592774122|FG006|Overall Study|Lost to Follow-up|1|||
164112752|NCT02229084|592774116|FG000|Overall Study|Physician Decision|0|||
164112753|NCT02229084|592774117|FG001|Overall Study|Physician Decision|0|||
164112754|NCT02229084|592774118|FG002|Overall Study|Physician Decision|0|||
164112755|NCT02229084|592774119|FG003|Overall Study|Physician Decision|1|||
164112756|NCT02229084|592774120|FG004|Overall Study|Physician Decision|3|||
164112757|NCT02229084|592774121|FG005|Overall Study|Physician Decision|0|||
164112758|NCT02229084|592774122|FG006|Overall Study|Physician Decision|1|||
164112759|NCT02229084|592774116|FG000|Overall Study|Withdrawal by Subject|0|||
164112760|NCT02229084|592774117|FG001|Overall Study|Withdrawal by Subject|0|||
164112761|NCT02229084|592774118|FG002|Overall Study|Withdrawal by Subject|1|||
164112762|NCT02229084|592774119|FG003|Overall Study|Withdrawal by Subject|0|||
164112763|NCT02229084|592774120|FG004|Overall Study|Withdrawal by Subject|1|||
164112764|NCT02229084|592774121|FG005|Overall Study|Withdrawal by Subject|1|||
164112765|NCT02229084|592774122|FG006|Overall Study|Withdrawal by Subject|1|||
164112766|NCT02229084|592774116|FG000|Overall Study|Death|0|||
164112767|NCT02229084|592774117|FG001|Overall Study|Death|0|||
164112768|NCT02229084|592774118|FG002|Overall Study|Death|0|||
164112769|NCT02229084|592774119|FG003|Overall Study|Death|0|||
164112770|NCT02229084|592774120|FG004|Overall Study|Death|0|||
164112771|NCT02229084|592774121|FG005|Overall Study|Death|0|||
164112772|NCT02229084|592774122|FG006|Overall Study|Death|1|||
164112773|NCT01728116|592774123|FG000|Overall Study|Sponsor Terminated Study|106|||
164112774|NCT01728116|592774124|FG001|Overall Study|Sponsor Terminated Study|35|||
164112775|NCT01728116|592774123|FG000|Overall Study|Withdrawal by Subject|16|||
164112776|NCT01728116|592774124|FG001|Overall Study|Withdrawal by Subject|9|||
164112777|NCT01728116|592774123|FG000|Overall Study|Adverse Event|13|||
164112778|NCT01728116|592774124|FG001|Overall Study|Adverse Event|0|||
164112779|NCT01728116|592774123|FG000|Overall Study|Procedure/device failure|7|||
164112780|NCT01728116|592774124|FG001|Overall Study|Procedure/device failure|0|||
164112781|NCT01728116|592774123|FG000|Overall Study|Lost to Follow-up|9|||
164112782|NCT01728116|592774124|FG001|Overall Study|Lost to Follow-up|2|||
164112783|NCT01728116|592774123|FG000|Overall Study|Physician Decision|2|||
164112784|NCT01728116|592774124|FG001|Overall Study|Physician Decision|0|||
164112785|NCT01728116|592774123|FG000|Overall Study|Subject Non-Compliance|2|||
164112786|NCT01728116|592774124|FG001|Overall Study|Subject Non-Compliance|0|||
164112787|NCT01728116|592774123|FG000|Overall Study|Inter-current finding at procedure|1|||
164112788|NCT01728116|592774124|FG001|Overall Study|Inter-current finding at procedure|0|||
164112789|NCT01728116|592774123|FG000|Overall Study|Incorrectly enrolled in Study|0|||
164112790|NCT01728116|592774124|FG001|Overall Study|Incorrectly enrolled in Study|1|||
164112791|NCT01728116|592774123|FG000|Overall Study|various not noted previously|5|||
164112792|NCT01728116|592774124|FG001|Overall Study|various not noted previously|0|||
164112793|NCT01559116|592774134|FG000|Overall Study|Adverse Event|10|||
164112794|NCT01559116|592774134|FG000|Overall Study|Lack of Efficacy|1|||
164112795|NCT01559116|592774134|FG000|Overall Study|Lost to Follow-up|1|||
164112796|NCT01559116|592774134|FG000|Overall Study|Protocol Violation|1|||
164112797|NCT01559116|592774134|FG000|Overall Study|Withdrawal by Subject|4|||
164112798|NCT01559116|592774134|FG000|Overall Study|other than stated above|9|||
164112799|NCT01868243|592774135|FG000|Overall Study|Death|0|||
164112800|NCT01868243|592774136|FG001|Overall Study|Death|1|||
164112801|NCT01745094|592774137|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
164112802|NCT01745094|592774138|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
164112803|NCT01745094|592774139|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
164112804|NCT01745094|592774140|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
164112805|NCT01745094|592774137|FG000|Overall Study|Adverse Event|0|||
164112806|NCT01745094|592774138|FG001|Overall Study|Adverse Event|0|||
164112807|NCT01745094|592774139|FG002|Overall Study|Adverse Event|3|||
164112808|NCT01745094|592774140|FG003|Overall Study|Adverse Event|0|||
164112809|NCT01745094|592774137|FG000|Overall Study|Withdrawal by Subject|2|||
164112810|NCT01745094|592774138|FG001|Overall Study|Withdrawal by Subject|0|||
164112811|NCT01745094|592774139|FG002|Overall Study|Withdrawal by Subject|1|||
164112812|NCT01745094|592774140|FG003|Overall Study|Withdrawal by Subject|2|||
164112813|NCT01745094|592774137|FG000|Overall Study|Protocol Violation|1|||
164112814|NCT01745094|592774138|FG001|Overall Study|Protocol Violation|0|||
164112815|NCT01745094|592774139|FG002|Overall Study|Protocol Violation|3|||
164112816|NCT01745094|592774140|FG003|Overall Study|Protocol Violation|1|||
164112817|NCT01745094|592774137|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
164112818|NCT01745094|592774138|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
164112819|NCT01745094|592774139|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
164112820|NCT01745094|592774140|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
164112821|NCT01745094|592774137|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
164112822|NCT01745094|592774138|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
164112823|NCT01745094|592774139|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
164112824|NCT01745094|592774140|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
164112825|NCT01745094|592774137|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
164112826|NCT01745094|592774138|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
164112827|NCT01745094|592774139|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
164112828|NCT01745094|592774140|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
164112829|NCT04610580|592774141|FG000|Two-way Crossover Period|Adverse Event|1|||
164112830|NCT04610580|592774142|FG001|Two-way Crossover Period|Adverse Event|0|||
164112831|NCT04610580|592774143|FG002|Two-way Crossover Period|Adverse Event|0|||
164112832|NCT04610580|592774144|FG003|Two-way Crossover Period|Adverse Event|0|||
164112833|NCT04610580|592774145|FG004|Two-way Crossover Period|Adverse Event|0|||
164112834|NCT04610580|592774146|FG005|Two-way Crossover Period|Adverse Event|0|||
164112835|NCT04610580|592774141|FG000|Two-way Crossover Period|Physician Decision|1|||
164112836|NCT04610580|592774142|FG001|Two-way Crossover Period|Physician Decision|0|||
164112837|NCT04610580|592774143|FG002|Two-way Crossover Period|Physician Decision|0|||
164112838|NCT04610580|592774144|FG003|Two-way Crossover Period|Physician Decision|0|||
164112839|NCT04610580|592774145|FG004|Two-way Crossover Period|Physician Decision|0|||
164112840|NCT04610580|592774146|FG005|Two-way Crossover Period|Physician Decision|0|||
164112841|NCT04610580|592774141|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
164112842|NCT04610580|592774142|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
164112843|NCT04610580|592774143|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
164112844|NCT04610580|592774144|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
164112845|NCT04610580|592774145|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
164112846|NCT04610580|592774146|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
164112847|NCT04610580|592774141|FG000|Two-way Crossover Period|Other than specified|0|||
164112848|NCT04610580|592774142|FG001|Two-way Crossover Period|Other than specified|1|||
164112849|NCT04610580|592774143|FG002|Two-way Crossover Period|Other than specified|0|||
164112850|NCT04610580|592774144|FG003|Two-way Crossover Period|Other than specified|0|||
164112851|NCT04610580|592774145|FG004|Two-way Crossover Period|Other than specified|0|||
164112852|NCT04610580|592774146|FG005|Two-way Crossover Period|Other than specified|0|||
164112853|NCT04610580|592774141|FG000|Washout Before Extension Period|Other than specified|0|||
164112854|NCT04610580|592774142|FG001|Washout Before Extension Period|Other than specified|1|||
164112855|NCT04610580|592774143|FG002|Washout Before Extension Period|Other than specified|0|||
164112856|NCT04610580|592774144|FG003|Washout Before Extension Period|Other than specified|0|||
164112857|NCT04610580|592774145|FG004|Washout Before Extension Period|Other than specified|0|||
164112858|NCT04610580|592774146|FG005|Washout Before Extension Period|Other than specified|0|||
164112859|NCT04610580|592774141|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
164112860|NCT04610580|592774142|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
164112861|NCT04610580|592774143|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
164112862|NCT04610580|592774144|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
164112863|NCT04610580|592774145|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
164112864|NCT04610580|592774146|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
164112865|NCT04610580|592774141|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164112866|NCT04610580|592774142|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164112867|NCT04610580|592774143|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164112868|NCT04610580|592774144|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164112869|NCT04610580|592774145|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
164112870|NCT04610580|592774146|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
164112871|NCT01451541|592774148|FG000|Overall Study|Adverse Event|4|||
164112872|NCT01451541|592774149|FG001|Overall Study|Adverse Event|3|||
164112873|NCT01451541|592774150|FG002|Overall Study|Adverse Event|6|||
164112874|NCT01451541|592774148|FG000|Overall Study|Lack of Efficacy|2|||
164112875|NCT01451541|592774149|FG001|Overall Study|Lack of Efficacy|0|||
164112876|NCT01451541|592774150|FG002|Overall Study|Lack of Efficacy|0|||
164112877|NCT01451541|592774148|FG000|Overall Study|Lost to Follow-up|4|||
164112878|NCT01451541|592774149|FG001|Overall Study|Lost to Follow-up|4|||
164112879|NCT01451541|592774150|FG002|Overall Study|Lost to Follow-up|7|||
164112880|NCT01451541|592774148|FG000|Overall Study|Withdrawal by Subject|15|||
164112881|NCT01451541|592774149|FG001|Overall Study|Withdrawal by Subject|8|||
164112882|NCT01451541|592774150|FG002|Overall Study|Withdrawal by Subject|6|||
164112883|NCT01451541|592774148|FG000|Overall Study|randomization error, noncompliance|11|||
164112884|NCT01451541|592774149|FG001|Overall Study|randomization error, noncompliance|10|||
164112885|NCT01451541|592774150|FG002|Overall Study|randomization error, noncompliance|8|||
164112886|NCT05665387|592774153|FG000|Overall Study|Withdrawal by Subject|1|||
164112887|NCT05665387|592774154|FG001|Overall Study|Withdrawal by Subject|0|||
164112888|NCT05665387|592774155|FG002|Overall Study|Withdrawal by Subject|1|||
164112889|NCT01824498|592774156|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
164112890|NCT01824498|592774157|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
164112891|NCT01824498|592774158|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
164112892|NCT01824498|592774159|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
164112893|NCT01824498|592774160|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
164112894|NCT01824498|592774161|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
164112895|NCT00006436|592774162|FG000|Overall Study|Refused further treatment|2|||
164112896|NCT00006436|592774162|FG000|Overall Study|Declined to participate (before treatment started)|1|||
164112897|NCT00939523|592774163|FG000|Overall Study|Lack of Efficacy|1|||
164112898|NCT00939523|592774163|FG000|Overall Study|Physician Decision|2|||
164112899|NCT00757172|592774168|FG000|Overall Study|Withdrawal by Subject|4|||
164112900|NCT00757172|592774168|FG000|Overall Study|Physician Decision|3|||
164112901|NCT00757172|592774168|FG000|Overall Study|Progression|4|||
164112902|NCT03196284|592774169|FG000|Main Part|Withdrawal by Subject|0|||
164112903|NCT03196284|592774170|FG001|Main Part|Withdrawal by Subject|1|||
164112904|NCT03196284|592774171|FG002|Main Part|Withdrawal by Subject|0|||
164112905|NCT03196284|592774169|FG000|Extension Part|Lack of Efficacy|0|||
164112906|NCT03196284|592774170|FG001|Extension Part|Lack of Efficacy|0|||
164112907|NCT03196284|592774171|FG002|Extension Part|Lack of Efficacy|1|||
164112908|NCT03196284|592774169|FG000|Extension Part|Withdrawal by Subject|0|||
164112909|NCT03196284|592774170|FG001|Extension Part|Withdrawal by Subject|0|||
164112910|NCT03196284|592774171|FG002|Extension Part|Withdrawal by Subject|1|||
164112911|NCT03196284|592774169|FG000|Extension Part|Physician Decision|0|||
164112912|NCT03196284|592774170|FG001|Extension Part|Physician Decision|0|||
164112913|NCT03196284|592774171|FG002|Extension Part|Physician Decision|1|||
164112914|NCT00685334|592774177|FG000|Overall Study|Withdrawal by Subject|5|||
164112915|NCT00685334|592774178|FG001|Overall Study|Withdrawal by Subject|6|||
164112916|NCT00685334|592774177|FG000|Overall Study|Lost to Follow-up|4|||
164112917|NCT00685334|592774178|FG001|Overall Study|Lost to Follow-up|0|||
164112918|NCT00685334|592774177|FG000|Overall Study|Chose to enter hospital|1|||
164112919|NCT00685334|592774178|FG001|Overall Study|Chose to enter hospital|1|||
164112920|NCT04577404|592774179|FG000|Overall Study|Adverse Event|31|||
164112921|NCT04577404|592774179|FG000|Overall Study|Death|1|||
164112922|NCT04577404|592774179|FG000|Overall Study|Lack of Efficacy|3|||
164112923|NCT04577404|592774179|FG000|Overall Study|Physician Decision|7|||
164112924|NCT04577404|592774179|FG000|Overall Study|Withdrawal by Subject|21|||
164112925|NCT04577404|592774179|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
164112926|NCT04556734|592775197|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
164112927|NCT04556734|592775198|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164112928|NCT04556734|592775199|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
164112929|NCT04556734|592775200|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164112930|NCT04556734|592775201|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164112931|NCT04556734|592775202|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164112932|NCT04556734|592775203|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164112933|NCT04556734|592775204|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164112934|NCT04556734|592775197|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
164112935|NCT04556734|592775198|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112936|NCT04556734|592775199|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112937|NCT04556734|592775200|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112938|NCT04556734|592775201|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112939|NCT04556734|592775202|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112940|NCT04556734|592775203|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112941|NCT04556734|592775204|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
164112942|NCT04556734|592775197|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164112943|NCT04556734|592775198|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164112944|NCT04556734|592775199|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
164112945|NCT04556734|592775200|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164112946|NCT04556734|592775201|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164112947|NCT04556734|592775202|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164112948|NCT04556734|592775203|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164112949|NCT04556734|592775204|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
164112950|NCT04556734|592775197|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
164112951|NCT04556734|592775198|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112952|NCT04556734|592775199|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112953|NCT04556734|592775200|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112954|NCT04556734|592775201|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112955|NCT04556734|592775202|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112956|NCT04556734|592775203|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112957|NCT04556734|592775204|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
164112958|NCT04556734|592775197|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112959|NCT04556734|592775198|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112960|NCT04556734|592775199|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
164112961|NCT04556734|592775200|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112962|NCT04556734|592775201|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112963|NCT04556734|592775202|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112964|NCT04556734|592775203|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112965|NCT04556734|592775204|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
164112966|NCT04556734|592775197|FG000|OLE Period (28 Weeks)|Not reported|0|||
164112967|NCT04556734|592775198|FG001|OLE Period (28 Weeks)|Not reported|0|||
164112968|NCT04556734|592775199|FG002|OLE Period (28 Weeks)|Not reported|0|||
164112969|NCT04556734|592775200|FG003|OLE Period (28 Weeks)|Not reported|0|||
164112970|NCT04556734|592775201|FG004|OLE Period (28 Weeks)|Not reported|0|||
164112971|NCT04556734|592775202|FG005|OLE Period (28 Weeks)|Not reported|1|||
164112972|NCT04556734|592775203|FG006|OLE Period (28 Weeks)|Not reported|0|||
164112973|NCT04556734|592775204|FG007|OLE Period (28 Weeks)|Not reported|0|||
164112974|NCT04556734|592775197|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112975|NCT04556734|592775198|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112976|NCT04556734|592775199|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112977|NCT04556734|592775200|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112978|NCT04556734|592775201|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112979|NCT04556734|592775202|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112980|NCT04556734|592775203|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
164112981|NCT04556734|592775204|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
164112982|NCT04556734|592775197|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
164112983|NCT04556734|592775198|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
164112984|NCT04556734|592775199|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
164112985|NCT04556734|592775200|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
164112986|NCT04556734|592775201|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
164112987|NCT04556734|592775202|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
164112988|NCT04556734|592775203|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
164112989|NCT04556734|592775204|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
164112990|NCT04556734|592775197|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164112991|NCT04556734|592775198|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164112992|NCT04556734|592775199|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164112993|NCT04556734|592775200|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
164112994|NCT04556734|592775201|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
164112995|NCT04556734|592775202|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
164112996|NCT04556734|592775203|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
164112997|NCT04556734|592775204|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
164112998|NCT00202839|592775205|FG000|Overall Study|Adverse Event|1|||
164112999|NCT00202839|592775206|FG001|Overall Study|Adverse Event|5|||
164113000|NCT00202839|592775205|FG000|Overall Study|Physician Decision|12|||
164113001|NCT00202839|592775206|FG001|Overall Study|Physician Decision|0|||
164113002|NCT00202839|592775205|FG000|Overall Study|Withdrawal by Subject|6|||
164113003|NCT00202839|592775206|FG001|Overall Study|Withdrawal by Subject|2|||
164113004|NCT00202839|592775205|FG000|Overall Study|Protocol Violation|2|||
164113005|NCT00202839|592775206|FG001|Overall Study|Protocol Violation|1|||
164113006|NCT00202839|592775205|FG000|Overall Study|Lost to Follow-up|3|||
164113007|NCT00202839|592775206|FG001|Overall Study|Lost to Follow-up|2|||
164113008|NCT01662024|592775209|FG000|Overall Study|Pregnancy|2|||
164113009|NCT01662024|592775209|FG000|Overall Study|Withdrawal by Subject|3|||
164113010|NCT01490190|592775213|FG000|Overall Study|Withdrawal by Subject|9|||
164113011|NCT01490190|592775213|FG000|Overall Study|Adverse Event|17|||
164113012|NCT01490190|592775213|FG000|Overall Study|Protocol Violation|5|||
164113013|NCT01490190|592775213|FG000|Overall Study|Lost to Follow-up|13|||
164113014|NCT01490190|592775213|FG000|Overall Study|Relocation|1|||
164113015|NCT01490190|592775213|FG000|Overall Study|Inconvenience|1|||
164113016|NCT01490190|592775213|FG000|Overall Study|Ring expulsion|2|||
164113017|NCT00063258|592775228|FG000|Overall Study|Physician Decision|2|||
164113018|NCT00063258|592775229|FG001|Overall Study|Physician Decision|0|||
164113019|NCT00063258|592775228|FG000|Overall Study|Lack of Efficacy|2|||
164113020|NCT00063258|592775229|FG001|Overall Study|Lack of Efficacy|0|||
164113021|NCT03988608|592775230|FG000|Overall Study|Adverse Event|1|||
164113022|NCT03988608|592775230|FG000|Overall Study|Lost to Follow-up|1|||
164113023|NCT03988608|592775230|FG000|Overall Study|Withdrawal by Subject|3|||
164113024|NCT03988608|592775230|FG000|Overall Study|Death|1|||
164113025|NCT00969124|592775242|FG000|Overall Study|Protocol Violation|2|||
164113026|NCT00969124|592775242|FG000|Overall Study|Inadequate bowel preparation|15|||
164113027|NCT00969124|592775242|FG000|Overall Study|Inability to reach cecum|9|||
164113028|NCT00969124|592775242|FG000|Overall Study|Previously unrecognized disease|3|||
164113029|NCT00969124|592775242|FG000|Overall Study|Technical error|1|||
164113030|NCT02786953|592775249|FG000|Overall Study|Withdrawal by Subject|3|||
164113031|NCT02786953|592775250|FG001|Overall Study|Withdrawal by Subject|0|||
164113032|NCT02786953|592775249|FG000|Overall Study|Physician Decision|0|||
164113033|NCT02786953|592775250|FG001|Overall Study|Physician Decision|1|||
164113034|NCT01186458|592775254|FG000|Overall Study|Adverse Event|1|||
164113035|NCT04281472|592775255|FG000|Stage A|Lack of Efficacy|8|||
164113036|NCT04281472|592775256|FG001|Stage A|Lack of Efficacy|0|||
164113037|NCT04281472|592775257|FG002|Stage A|Lack of Efficacy|0|||
164113038|NCT04281472|592775255|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
164113039|NCT04281472|592775256|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
164113040|NCT04281472|592775257|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
164113041|NCT04281472|592775255|FG000|Stage A|Adverse Event|20|||
164113042|NCT04281472|592775256|FG001|Stage A|Adverse Event|0|||
164113043|NCT04281472|592775257|FG002|Stage A|Adverse Event|0|||
164113044|NCT04281472|592775255|FG000|Stage A|Death|1|||
164113045|NCT04281472|592775256|FG001|Stage A|Death|0|||
164113046|NCT04281472|592775257|FG002|Stage A|Death|0|||
164113047|NCT04281472|592775255|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
164113048|NCT04281472|592775256|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
164113049|NCT04281472|592775257|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
164113050|NCT04281472|592775255|FG000|Stage A|Lost to Follow-up|2|||
164113051|NCT04281472|592775256|FG001|Stage A|Lost to Follow-up|0|||
164113052|NCT04281472|592775257|FG002|Stage A|Lost to Follow-up|0|||
164113053|NCT04281472|592775255|FG000|Stage A|Non-compliance with study drug|1|||
164113054|NCT04281472|592775256|FG001|Stage A|Non-compliance with study drug|0|||
164113055|NCT04281472|592775257|FG002|Stage A|Non-compliance with study drug|0|||
164113056|NCT04281472|592775255|FG000|Stage A|Physician Decision|1|||
164113057|NCT04281472|592775256|FG001|Stage A|Physician Decision|0|||
164113058|NCT04281472|592775257|FG002|Stage A|Physician Decision|0|||
164113059|NCT04281472|592775255|FG000|Stage A|Prohibited medications|2|||
164113060|NCT04281472|592775256|FG001|Stage A|Prohibited medications|0|||
164113061|NCT04281472|592775257|FG002|Stage A|Prohibited medications|0|||
164113062|NCT04281472|592775255|FG000|Stage A|Withdrawal by Subject|11|||
164113063|NCT04281472|592775256|FG001|Stage A|Withdrawal by Subject|0|||
164113064|NCT04281472|592775257|FG002|Stage A|Withdrawal by Subject|0|||
164113065|NCT04281472|592775255|FG000|Stage A|Other|5|||
164113066|NCT04281472|592775256|FG001|Stage A|Other|0|||
164113067|NCT04281472|592775257|FG002|Stage A|Other|0|||
164113068|NCT04281472|592775255|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
164113069|NCT04281472|592775256|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
164113070|NCT04281472|592775257|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
164113071|NCT04281472|592775255|FG000|Stage B|Adverse Event|0|||
164113072|NCT04281472|592775256|FG001|Stage B|Adverse Event|3|||
164113073|NCT04281472|592775257|FG002|Stage B|Adverse Event|0|||
164113074|NCT04281472|592775255|FG000|Stage B|Death|0|||
164113075|NCT04281472|592775256|FG001|Stage B|Death|0|||
164113076|NCT04281472|592775257|FG002|Stage B|Death|1|||
164113077|NCT04281472|592775255|FG000|Stage B|Lack of Efficacy|0|||
164113078|NCT04281472|592775256|FG001|Stage B|Lack of Efficacy|0|||
164113079|NCT04281472|592775257|FG002|Stage B|Lack of Efficacy|1|||
164113080|NCT04281472|592775255|FG000|Stage B|Lost to Follow-up|0|||
164113081|NCT04281472|592775256|FG001|Stage B|Lost to Follow-up|0|||
164113082|NCT04281472|592775257|FG002|Stage B|Lost to Follow-up|2|||
164113083|NCT04281472|592775255|FG000|Stage B|Prohibited medications|0|||
164113084|NCT04281472|592775256|FG001|Stage B|Prohibited medications|2|||
164113085|NCT04281472|592775257|FG002|Stage B|Prohibited medications|1|||
164113086|NCT04281472|592775255|FG000|Stage B|Protocol Violation|0|||
164113087|NCT04281472|592775256|FG001|Stage B|Protocol Violation|1|||
164113088|NCT04281472|592775257|FG002|Stage B|Protocol Violation|1|||
164113089|NCT04281472|592775255|FG000|Stage B|Sponsor decision|0|||
164113090|NCT04281472|592775256|FG001|Stage B|Sponsor decision|0|||
164113091|NCT04281472|592775257|FG002|Stage B|Sponsor decision|1|||
164113092|NCT04281472|592775255|FG000|Stage B|Withdrawal by Subject|0|||
164113093|NCT04281472|592775256|FG001|Stage B|Withdrawal by Subject|3|||
164113094|NCT04281472|592775257|FG002|Stage B|Withdrawal by Subject|3|||
164113095|NCT04281472|592775255|FG000|Stage B|Other|0|||
164113096|NCT04281472|592775256|FG001|Stage B|Other|3|||
164113097|NCT04281472|592775257|FG002|Stage B|Other|0|||
164113098|NCT01528735|592775266|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
164113099|NCT01528735|592775267|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
164113100|NCT01528735|592775266|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
164113101|NCT01528735|592775267|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
164113102|NCT03555695|592775268|FG000|Overall Study|Withdrawal by Subject|1|||
164113103|NCT03555695|592775268|FG000|Overall Study|Lost to Follow-up|1|||
164113104|NCT03555695|592775268|FG000|Overall Study|appendicitis (unrelated)|1|||
164113105|NCT03555695|592775268|FG000|Overall Study|pre-existing sciatica|1|||
164113106|NCT01426854|592775269|FG000|Overall Study|Adverse Event|1|||
164113107|NCT01426854|592775270|FG001|Overall Study|Adverse Event|5|||
164113108|NCT01426854|592775269|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
164113109|NCT01426854|592775270|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
164113110|NCT01426854|592775269|FG000|Overall Study|Lost to Follow-up|3|||
164113111|NCT01426854|592775270|FG001|Overall Study|Lost to Follow-up|0|||
164113112|NCT01426854|592775269|FG000|Overall Study|Noncompliance|0|||
164113113|NCT01426854|592775270|FG001|Overall Study|Noncompliance|1|||
164113114|NCT01426854|592775269|FG000|Overall Study|Treatment Failure|0|||
164113115|NCT01426854|592775270|FG001|Overall Study|Treatment Failure|16|||
164113116|NCT01426854|592775269|FG000|Overall Study|Protocol Deviation|0|||
164113117|NCT01426854|592775270|FG001|Overall Study|Protocol Deviation|1|||
164113118|NCT01426854|592775269|FG000|Overall Study|Other|3|||
164113119|NCT01426854|592775270|FG001|Overall Study|Other|2|||
164113120|NCT01942135|592775275|FG000|Overall Study|Adverse Event|21|||
164113121|NCT01942135|592775276|FG001|Overall Study|Adverse Event|7|||
164113122|NCT01942135|592775275|FG000|Overall Study|Global Deterioration of Health Status|9|||
164113123|NCT01942135|592775276|FG001|Overall Study|Global Deterioration of Health Status|6|||
164113124|NCT01942135|592775275|FG000|Overall Study|Randomized Not Treated|2|||
164113125|NCT01942135|592775276|FG001|Overall Study|Randomized Not Treated|2|||
164113126|NCT01942135|592775275|FG000|Overall Study|Death|2|||
164113127|NCT01942135|592775276|FG001|Overall Study|Death|1|||
164113128|NCT01942135|592775275|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
164113129|NCT01942135|592775276|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
164113130|NCT01942135|592775275|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
164113131|NCT01942135|592775276|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
164113132|NCT01942135|592775275|FG000|Overall Study|Withdrawal by Subject|4|||
164113133|NCT01942135|592775276|FG001|Overall Study|Withdrawal by Subject|3|||
164113134|NCT01942135|592775275|FG000|Overall Study|Protocol Violation|1|||
164113135|NCT01942135|592775276|FG001|Overall Study|Protocol Violation|0|||
164113136|NCT01942135|592775275|FG000|Overall Study|Other|19|||
164113137|NCT01942135|592775276|FG001|Overall Study|Other|4|||
164113138|NCT01499043|592775277|FG000|Overall Study|Progressive disease (radiographic)|2|||
164113139|NCT01499043|592775277|FG000|Overall Study|Progressive disease (clinical)|1|||
164113140|NCT01499043|592775277|FG000|Overall Study|Withdrawal by Subject|2|||
164113141|NCT01499043|592775277|FG000|Overall Study|Adverse Event|1|||
164113142|NCT01596127|592775281|FG000|Overall Study|Patient Ineligible|1|||
164113143|NCT01566435|592775282|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
164113144|NCT00438633|592775283|FG000|Overall Study|Withdrawal by Subject|1|||
164113145|NCT00438633|592775284|FG001|Overall Study|Withdrawal by Subject|0|||
164113146|NCT00438633|592775283|FG000|Overall Study|Lost to Follow-up|15|||
164113147|NCT00438633|592775284|FG001|Overall Study|Lost to Follow-up|17|||
164113148|NCT04569084|592775285|FG000|Overall Study|Adverse Event|10|||
164113149|NCT04569084|592775286|FG001|Overall Study|Adverse Event|14|||
164113150|NCT04569084|592775285|FG000|Overall Study|Death|2|||
164113151|NCT04569084|592775286|FG001|Overall Study|Death|3|||
164113152|NCT04569084|592775285|FG000|Overall Study|Lost to Follow-up|1|||
164113153|NCT04569084|592775286|FG001|Overall Study|Lost to Follow-up|1|||
164113154|NCT04569084|592775285|FG000|Overall Study|Physician Decision|3|||
164113155|NCT04569084|592775286|FG001|Overall Study|Physician Decision|3|||
164113156|NCT04569084|592775285|FG000|Overall Study|Protocol Violation|2|||
164113157|NCT04569084|592775286|FG001|Overall Study|Protocol Violation|1|||
164113158|NCT04569084|592775285|FG000|Overall Study|Withdrawal by Subject|20|||
164113159|NCT04569084|592775286|FG001|Overall Study|Withdrawal by Subject|21|||
164113160|NCT04569084|592775285|FG000|Overall Study|Study terminated by sponsor|26|||
164113161|NCT04569084|592775286|FG001|Overall Study|Study terminated by sponsor|23|||
164113162|NCT04569084|592775285|FG000|Overall Study|Other|3|||
164113163|NCT04569084|592775286|FG001|Overall Study|Other|5|||
164113164|NCT04729101|592777033|FG000|Overall Study|Adverse Event|1|||
164113165|NCT04729101|592777034|FG001|Overall Study|Adverse Event|0|||
164113166|NCT04729101|592777033|FG000|Overall Study|Physician Decision|1|||
164113167|NCT04729101|592777034|FG001|Overall Study|Physician Decision|0|||
164113168|NCT04729101|592777033|FG000|Overall Study|Withdrawal by Subject|1|||
164113169|NCT04729101|592777034|FG001|Overall Study|Withdrawal by Subject|0|||
164113170|NCT00274625|592777035|FG000|Overall Study|Lost to Follow-up|46|||
164113171|NCT00274625|592777036|FG001|Overall Study|Lost to Follow-up|54|||
164113172|NCT00274625|592777035|FG000|Overall Study|Excluded from analysis|14|||
164113173|NCT00274625|592777036|FG001|Overall Study|Excluded from analysis|8|||
164113174|NCT02940522|592777037|FG000|Overall Study|Lost to Follow-up|1|||
164113175|NCT02940522|592777038|FG001|Overall Study|Lost to Follow-up|2|||
164113176|NCT02940522|592777037|FG000|Overall Study|Withdrawal by Subject|1|||
164113177|NCT02940522|592777038|FG001|Overall Study|Withdrawal by Subject|0|||
164113178|NCT00762411|592777039|FG000|Initial Treatment|Death|7|||
164113179|NCT00762411|592777040|FG001|Initial Treatment|Death|6|||
164113180|NCT00762411|592777039|FG000|Initial Treatment|Adverse Event|132|||
164113181|NCT00762411|592777040|FG001|Initial Treatment|Adverse Event|40|||
164113182|NCT00762411|592777039|FG000|Initial Treatment|Protocol Violation|4|||
164113183|NCT00762411|592777040|FG001|Initial Treatment|Protocol Violation|1|||
164113184|NCT00762411|592777039|FG000|Initial Treatment|Withdrawal by Subject|65|||
164113185|NCT00762411|592777040|FG001|Initial Treatment|Withdrawal by Subject|52|||
164113186|NCT00762411|592777039|FG000|Initial Treatment|Physician Decision|1|||
164113187|NCT00762411|592777040|FG001|Initial Treatment|Physician Decision|0|||
164113188|NCT00762411|592777039|FG000|Initial Treatment|Sponsor Decision|293|||
164113189|NCT00762411|592777040|FG001|Initial Treatment|Sponsor Decision|401|||
164113190|NCT00762411|592777039|FG000|Initial Treatment|Lost to Follow-up|5|||
164113191|NCT00762411|592777040|FG001|Initial Treatment|Lost to Follow-up|0|||
164113192|NCT00762411|592777039|FG000|Initial Treatment|Caregiver Decision|21|||
164113193|NCT00762411|592777040|FG001|Initial Treatment|Caregiver Decision|16|||
164113194|NCT00762411|592777039|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
164113195|NCT00762411|592777040|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
164113196|NCT00762411|592777039|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
164113197|NCT00762411|592777040|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
164113198|NCT00762411|592777039|FG000|Delayed Start|Adverse Event|0|||
164113199|NCT00762411|592777040|FG001|Delayed Start|Adverse Event|4|||
164113200|NCT00762411|592777039|FG000|Delayed Start|Protocol Violation|0|||
164113201|NCT00762411|592777040|FG001|Delayed Start|Protocol Violation|1|||
164113202|NCT00762411|592777039|FG000|Delayed Start|Sponsor Decision|16|||
164113203|NCT00762411|592777040|FG001|Delayed Start|Sponsor Decision|20|||
164113204|NCT00762411|592777039|FG000|Delayed Start|Caregiver Decision|1|||
164113205|NCT00762411|592777040|FG001|Delayed Start|Caregiver Decision|1|||
164113206|NCT00762411|592777039|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
164113207|NCT00762411|592777040|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
164113208|NCT00762411|592777039|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
164113209|NCT00762411|592777040|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
164113210|NCT00762411|592777039|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
164113211|NCT00762411|592777040|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
164113212|NCT00762411|592777039|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
164113213|NCT00762411|592777040|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
164113214|NCT00762411|592777039|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
164113215|NCT00762411|592777040|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
164113216|NCT00762411|592777039|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
164113217|NCT00762411|592777040|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
164113218|NCT01813435|592777048|FG000|Overall Study|did not finish experimental regimen|1902|||
164113219|NCT01813435|592777049|FG001|Overall Study|did not finish experimental regimen|770|||
164113220|NCT01813435|592777048|FG000|Overall Study|Lost to Follow-up|268|||
164113221|NCT01813435|592777049|FG001|Overall Study|Lost to Follow-up|237|||
164113222|NCT01765751|592777056|FG000|Overall Study|Lost to Follow-up|0|||
164113223|NCT01765751|592777057|FG001|Overall Study|Lost to Follow-up|2|||
164113224|NCT01765751|592777058|FG002|Overall Study|Lost to Follow-up|1|||
164113225|NCT01120899|592777059|FG000|Overall Study|Withdrawal by Subject|3|||
164113226|NCT00452348|592777060|FG000|Overall Study|Adverse Event|6|||
164113227|NCT00452348|592777061|FG001|Overall Study|Adverse Event|9|||
164113228|NCT00452348|592777060|FG000|Overall Study|Lack of Efficacy|10|||
164113229|NCT00452348|592777061|FG001|Overall Study|Lack of Efficacy|9|||
164113230|NCT00452348|592777060|FG000|Overall Study|Lost to Follow-up|14|||
164113231|NCT00452348|592777061|FG001|Overall Study|Lost to Follow-up|8|||
164113232|NCT00452348|592777060|FG000|Overall Study|Protocol Violation|22|||
164113233|NCT00452348|592777061|FG001|Overall Study|Protocol Violation|28|||
164113234|NCT00452348|592777060|FG000|Overall Study|Withdrawal by Subject|18|||
164113235|NCT00452348|592777061|FG001|Overall Study|Withdrawal by Subject|21|||
164113236|NCT00452348|592777060|FG000|Overall Study|Other|9|||
164113237|NCT00452348|592777061|FG001|Overall Study|Other|9|||
164113238|NCT01243151|592777064|FG000|Overall Study|Adverse Event|0|||
164113239|NCT01243151|592777065|FG001|Overall Study|Adverse Event|1|||
164113240|NCT01243151|592777066|FG002|Overall Study|Adverse Event|0|||
164113241|NCT01243151|592777067|FG003|Overall Study|Adverse Event|0|||
164113242|NCT01243151|592777068|FG004|Overall Study|Adverse Event|0|||
164113243|NCT01243151|592777064|FG000|Overall Study|Protocol Violation|0|||
164113244|NCT01243151|592777065|FG001|Overall Study|Protocol Violation|0|||
164113245|NCT01243151|592777066|FG002|Overall Study|Protocol Violation|1|||
164113246|NCT01243151|592777067|FG003|Overall Study|Protocol Violation|0|||
164113247|NCT01243151|592777068|FG004|Overall Study|Protocol Violation|0|||
164113248|NCT01243151|592777064|FG000|Overall Study|Other|0|||
164113249|NCT01243151|592777065|FG001|Overall Study|Other|0|||
164113250|NCT01243151|592777066|FG002|Overall Study|Other|0|||
164113251|NCT01243151|592777067|FG003|Overall Study|Other|1|||
164113252|NCT01243151|592777068|FG004|Overall Study|Other|0|||
164113253|NCT01243151|592777064|FG000|Overall Study|Randomized but not treated|0|||
164113254|NCT01243151|592777065|FG001|Overall Study|Randomized but not treated|0|||
164113255|NCT01243151|592777066|FG002|Overall Study|Randomized but not treated|0|||
164113256|NCT01243151|592777067|FG003|Overall Study|Randomized but not treated|1|||
164113257|NCT01243151|592777068|FG004|Overall Study|Randomized but not treated|0|||
164113258|NCT03119662|592777069|FG000|Overall Study|Withdrawal by Subject|0|||
164113259|NCT03119662|592777070|FG001|Overall Study|Withdrawal by Subject|1|||
164113260|NCT00544167|592777072|FG000|Overall Study|Adverse Event|21|||
164113261|NCT00544167|592777072|FG000|Overall Study|Physician Decision|8|||
164113262|NCT00874549|592777073|FG000|Overall Study|Adverse Event|0|||
164113263|NCT00874549|592777074|FG001|Overall Study|Adverse Event|0|||
164113264|NCT00874549|592777075|FG002|Overall Study|Adverse Event|1|||
164113265|NCT00874549|592777076|FG003|Overall Study|Adverse Event|0|||
164113266|NCT00874549|592777073|FG000|Overall Study|Protocol Violation|1|||
164113267|NCT00874549|592777074|FG001|Overall Study|Protocol Violation|0|||
164113268|NCT00874549|592777075|FG002|Overall Study|Protocol Violation|2|||
164113269|NCT00874549|592777076|FG003|Overall Study|Protocol Violation|1|||
164113270|NCT00874549|592777073|FG000|Overall Study|Lost to Follow-up|0|||
164113271|NCT00874549|592777074|FG001|Overall Study|Lost to Follow-up|0|||
164113272|NCT00874549|592777075|FG002|Overall Study|Lost to Follow-up|1|||
164113273|NCT00874549|592777076|FG003|Overall Study|Lost to Follow-up|0|||
164113274|NCT00874549|592777073|FG000|Overall Study|Withdrawal by Subject|0|||
164113275|NCT00874549|592777074|FG001|Overall Study|Withdrawal by Subject|1|||
164113276|NCT00874549|592777075|FG002|Overall Study|Withdrawal by Subject|0|||
164113277|NCT00874549|592777076|FG003|Overall Study|Withdrawal by Subject|1|||
164113278|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
164113279|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
164113280|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
164113281|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
164113282|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
164113283|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
164113284|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
164113285|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
164113286|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
164113287|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
164132665|NCT01986010|592850661|FG006|Overall Study|Adverse Event|0|||
164113288|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
164113289|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
164113290|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
164113291|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
164113292|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
164113293|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
164113294|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
164113295|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
164113296|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
164113297|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
164113298|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
164113299|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
164113300|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
164113301|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
164113302|NCT01710358|592777079|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
164113303|NCT01710358|592777080|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
164113304|NCT01710358|592777081|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
164113305|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
164113306|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
164113307|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
164113308|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
164113309|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
164113310|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
164113311|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
164113312|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
164113313|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
164113314|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
164113315|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
164113316|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
164113317|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
164113318|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
164113319|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
164113320|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
164113321|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
164113322|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
164113323|NCT01710358|592777079|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
164113324|NCT01710358|592777080|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
164113325|NCT01710358|592777081|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
164113326|NCT01710358|592777079|FG000|Rescue Period|Adverse Event|0|||
164113327|NCT01710358|592777080|FG001|Rescue Period|Adverse Event|15|||
164113328|NCT01710358|592777081|FG002|Rescue Period|Adverse Event|0|||
164113329|NCT01710358|592777079|FG000|Rescue Period|Death|0|||
164113330|NCT01710358|592777080|FG001|Rescue Period|Death|1|||
164113331|NCT01710358|592777081|FG002|Rescue Period|Death|0|||
164113332|NCT01710358|592777079|FG000|Rescue Period|Lack of Efficacy|0|||
164113333|NCT01710358|592777080|FG001|Rescue Period|Lack of Efficacy|7|||
164113334|NCT01710358|592777081|FG002|Rescue Period|Lack of Efficacy|0|||
164113335|NCT01710358|592777079|FG000|Rescue Period|Withdrawal by Subject|0|||
164113336|NCT01710358|592777080|FG001|Rescue Period|Withdrawal by Subject|8|||
164113337|NCT01710358|592777081|FG002|Rescue Period|Withdrawal by Subject|0|||
164113338|NCT00880334|592777082|FG000|Randomized Phase|Physician Decision|1|||
164113339|NCT00880334|592777083|FG001|Randomized Phase|Physician Decision|0|||
164113340|NCT00880334|592777082|FG000|Randomized Phase|Withdrawal by Subject|2|||
164113341|NCT00880334|592777083|FG001|Randomized Phase|Withdrawal by Subject|1|||
164113342|NCT00880334|592777082|FG000|Randomized Phase|Inadequate Labs|1|||
164113343|NCT00880334|592777083|FG001|Randomized Phase|Inadequate Labs|1|||
164113344|NCT00880334|592777082|FG000|Randomized Phase|Brain Metastasis|0|||
164113345|NCT00880334|592777083|FG001|Randomized Phase|Brain Metastasis|1|||
164113346|NCT00880334|592777082|FG000|Randomized Phase|Crossover Participants|0|||
164113347|NCT00880334|592777083|FG001|Randomized Phase|Crossover Participants|37|||
164113348|NCT00084864|592777088|FG000|Overall Study|Adverse Event|1|||
164113349|NCT00084864|592777089|FG001|Overall Study|Adverse Event|0|||
164113350|NCT00084864|592777090|FG002|Overall Study|Adverse Event|0|||
164113351|NCT00084864|592777091|FG003|Overall Study|Adverse Event|0|||
164113352|NCT02460835|592777096|FG000|Overall Study|Disease progression prior to treatment|3|||
164113353|NCT02460835|592777096|FG000|Overall Study|Unable to complete planning scans|2|||
164113354|NCT02460835|592777096|FG000|Overall Study|Decrease in performance status|1|||
164113355|NCT02460835|592777096|FG000|Overall Study|Withdrawal by Subject|3|||
164113356|NCT02460835|592777096|FG000|Overall Study|Underwent fractionated RT|10|||
164113357|NCT02460835|592777096|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
164113358|NCT04697173|592777105|FG000|Overall Study|Withdrawal by Subject|34|||
164113359|NCT04697173|592777106|FG001|Overall Study|Withdrawal by Subject|38|||
164113360|NCT01632306|592777119|FG000|Overall Study|Protocol Violation|1|||
164113361|NCT01632306|592777120|FG001|Overall Study|Protocol Violation|0|||
164113362|NCT01632306|592777121|FG002|Overall Study|Protocol Violation|0|||
164113363|NCT03141151|592777126|FG000|Overall Study|Lost to Follow-up|3|||
164113364|NCT03141151|592777127|FG001|Overall Study|Lost to Follow-up|2|||
164113365|NCT03141151|592777126|FG000|Overall Study|Withdrawal by Subject|3|||
164113366|NCT03141151|592777127|FG001|Overall Study|Withdrawal by Subject|2|||
164113367|NCT03277248|592777134|FG000|Overall Study|Adverse Event|3|||
164113368|NCT03277248|592777135|FG001|Overall Study|Adverse Event|1|||
164113369|NCT03277248|592777134|FG000|Overall Study|Subject Withdrawal of Consent|6|||
164113370|NCT03277248|592777135|FG001|Overall Study|Subject Withdrawal of Consent|23|||
164113371|NCT03277248|592777134|FG000|Overall Study|Investigator/Sponsor Decision|2|||
164113372|NCT03277248|592777135|FG001|Overall Study|Investigator/Sponsor Decision|2|||
164113373|NCT03277248|592777134|FG000|Overall Study|Pregnancy|4|||
164113374|NCT03277248|592777135|FG001|Overall Study|Pregnancy|1|||
164113375|NCT03277248|592777134|FG000|Overall Study|Lost to Follow-up|0|||
164113376|NCT03277248|592777135|FG001|Overall Study|Lost to Follow-up|2|||
164113377|NCT03277248|592777134|FG000|Overall Study|Lack of Efficacy|0|||
164113378|NCT03277248|592777135|FG001|Overall Study|Lack of Efficacy|2|||
164113379|NCT03277248|592777134|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
164113380|NCT03277248|592777135|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
164113381|NCT01993940|592777136|FG000|Overall Study|Adverse Event|16|||
164113382|NCT01993940|592777137|FG001|Overall Study|Adverse Event|11|||
164113383|NCT01993940|592777136|FG000|Overall Study|Withdrawal by Subject|15|||
164113384|NCT01993940|592777137|FG001|Overall Study|Withdrawal by Subject|19|||
164113385|NCT01993940|592777136|FG000|Overall Study|Lost to Follow-up|2|||
164113386|NCT01993940|592777137|FG001|Overall Study|Lost to Follow-up|5|||
164113387|NCT01993940|592777136|FG000|Overall Study|Protocol Violation|5|||
164113388|NCT01993940|592777137|FG001|Overall Study|Protocol Violation|8|||
164113389|NCT01993940|592777136|FG000|Overall Study|Death|1|||
164113390|NCT01993940|592777137|FG001|Overall Study|Death|0|||
164113391|NCT01993940|592777136|FG000|Overall Study|Other - Miscellaneous|1|||
164113392|NCT01993940|592777137|FG001|Overall Study|Other - Miscellaneous|1|||
164113393|NCT01949532|592777138|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
164113394|NCT01949532|592777139|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
164113395|NCT00379353|592777140|FG000|Overall Study|Hospitalization|3|||
164113396|NCT00379353|592777141|FG001|Overall Study|Hospitalization|3|||
164113397|NCT00379353|592777140|FG000|Overall Study|Withdrawal by Subject|5|||
164113398|NCT00379353|592777141|FG001|Overall Study|Withdrawal by Subject|2|||
164113399|NCT00379353|592777140|FG000|Overall Study|Death|1|||
164113400|NCT00379353|592777141|FG001|Overall Study|Death|0|||
164113401|NCT00379353|592777140|FG000|Overall Study|Cardiac Tamponade|1|||
164113402|NCT00379353|592777141|FG001|Overall Study|Cardiac Tamponade|0|||
164113403|NCT00379353|592777140|FG000|Overall Study|Non-compliance|1|||
164113404|NCT00379353|592777141|FG001|Overall Study|Non-compliance|0|||
164113405|NCT00379353|592777140|FG000|Overall Study|Conflicting drug treatment|0|||
164113406|NCT00379353|592777141|FG001|Overall Study|Conflicting drug treatment|1|||
164113407|NCT01211262|592777142|FG000|Overall Study|Progressive Disease|18|||
164113408|NCT01211262|592777143|FG001|Overall Study|Progressive Disease|9|||
164113409|NCT01211262|592777142|FG000|Overall Study|Adverse Event|4|||
164113410|NCT01211262|592777143|FG001|Overall Study|Adverse Event|0|||
164113411|NCT01211262|592777142|FG000|Overall Study|Withdrawal of Consent|1|||
164113412|NCT01211262|592777143|FG001|Overall Study|Withdrawal of Consent|0|||
164113413|NCT01211262|592777142|FG000|Overall Study|Other|0|||
164113414|NCT01211262|592777143|FG001|Overall Study|Other|1|||
164113415|NCT01277510|592777146|FG000|Double-blind Phase|Non-compliance|0|||
164113416|NCT01277510|592777147|FG001|Double-blind Phase|Non-compliance|1|||
164113417|NCT01277510|592777146|FG000|Double-blind Phase|Adverse Event|1|||
164113418|NCT01277510|592777147|FG001|Double-blind Phase|Adverse Event|0|||
164113419|NCT01277510|592777146|FG000|Double-blind Phase|Withdrawal by Subject|2|||
164113420|NCT01277510|592777147|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164113421|NCT01277510|592777146|FG000|Double-blind Phase|Administrative decision|7|||
164113422|NCT01277510|592777147|FG001|Double-blind Phase|Administrative decision|9|||
164113423|NCT01277510|592777146|FG000|Double-blind Phase|Death|0|||
164113424|NCT01277510|592777147|FG001|Double-blind Phase|Death|1|||
164113425|NCT01277510|592777146|FG000|Double-blind Phase|Protocol-specified criteria|2|||
164113426|NCT01277510|592777147|FG001|Double-blind Phase|Protocol-specified criteria|6|||
164113427|NCT01277510|592777146|FG000|Double-blind Phase|Other|1|||
164113428|NCT01277510|592777147|FG001|Double-blind Phase|Other|1|||
164113429|NCT01277510|592777146|FG000|Open-label Phase|Administrative decision|4|||
164113430|NCT01277510|592777147|FG001|Open-label Phase|Administrative decision|3|||
164113431|NCT01277510|592777146|FG000|Open-label Phase|Protocol-specified criteria|1|||
164113432|NCT01277510|592777147|FG001|Open-label Phase|Protocol-specified criteria|0|||
164113433|NCT01277510|592777146|FG000|Open-label Phase|Never received investigational product|2|||
164113434|NCT01277510|592777147|FG001|Open-label Phase|Never received investigational product|0|||
164113435|NCT04049097|592777148|FG000|Overall Study|Adverse Event|18|||
164113436|NCT04049097|592777148|FG000|Overall Study|Death|2|||
164113437|NCT04049097|592777148|FG000|Overall Study|Lost to Follow-up|1|||
164113438|NCT04049097|592777148|FG000|Overall Study|Physician Decision|2|||
164113439|NCT04049097|592777148|FG000|Overall Study|Withdrawal by Subject|9|||
164113440|NCT04049097|592777148|FG000|Overall Study|Protocol Violation|2|||
164113441|NCT04049097|592777148|FG000|Overall Study|Other|1|||
164113442|NCT04049097|592777148|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
164113443|NCT00533507|592777149|FG000|Overall Study|Withdrawal by Subject|1|||
164113444|NCT01874535|592777150|FG000|Overall Study|Lost to Follow-up|10|||
164113445|NCT01874535|592777151|FG001|Overall Study|Lost to Follow-up|9|||
164113446|NCT01874535|592777150|FG000|Overall Study|incomplete symptom resolution|45|||
164113447|NCT01874535|592777151|FG001|Overall Study|incomplete symptom resolution|35|||
164113448|NCT02616380|592777156|FG000|Overall Study|Lost to Follow-up|1|||
164113449|NCT02616380|592777156|FG000|Overall Study|Other|2|||
164113450|NCT05065619|592777157|FG000|Up to Day 42|Lost to Follow-up|1|||
164113451|NCT05065619|592777158|FG001|Up to Day 42|Lost to Follow-up|0|||
164113452|NCT05065619|592777157|FG000|Up to Day 42|Withdrawal by Subject|1|||
164113453|NCT05065619|592777158|FG001|Up to Day 42|Withdrawal by Subject|0|||
164113454|NCT05065619|592777157|FG000|After Day 43|Lost to Follow-up|1|||
164113455|NCT05065619|592777158|FG001|After Day 43|Lost to Follow-up|0|||
164113456|NCT05065619|592777157|FG000|After Day 43|Physician Decision|3|||
164113457|NCT05065619|592777158|FG001|After Day 43|Physician Decision|0|||
164113458|NCT05065619|592777157|FG000|After Day 43|Withdrawal by Subject|1|||
164113459|NCT05065619|592777158|FG001|After Day 43|Withdrawal by Subject|2|||
164113460|NCT05065619|592777157|FG000|After Day 43|Public vaccination|6|||
164113461|NCT05065619|592777158|FG001|After Day 43|Public vaccination|8|||
164113462|NCT05065619|592777157|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
164113463|NCT05065619|592777158|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
164113464|NCT05065619|592777157|FG000|After Day 43|Study Terminated by Sponsor|88|||
164113465|NCT05065619|592777158|FG001|After Day 43|Study Terminated by Sponsor|16|||
164113466|NCT02119936|592777167|FG000|Overall Study|Lost to Follow-up|10|||
164113467|NCT00570128|592777168|FG000|Overall Study|Adverse Event|1|||
164113468|NCT00570128|592777169|FG001|Overall Study|Adverse Event|0|||
164113469|NCT00570128|592777168|FG000|Overall Study|Lost to Follow-up|1|||
164113470|NCT00570128|592777169|FG001|Overall Study|Lost to Follow-up|0|||
164113471|NCT00570128|592777168|FG000|Overall Study|Withdrawal by Subject|2|||
164113472|NCT00570128|592777169|FG001|Overall Study|Withdrawal by Subject|0|||
164113473|NCT05315713|592777170|FG000|Overall Study|Death|5|||
164113474|NCT05315713|592777170|FG000|Overall Study|Progressive disease|1|||
164113475|NCT05315713|592777170|FG000|Overall Study|Withdrawal by Subject|1|||
164113476|NCT05315713|592777170|FG000|Overall Study|Study terminated by sponsor|1|||
164113477|NCT00421304|592777171|FG000|Overall Study|Lost to Follow-up|5|||
164113478|NCT00421304|592777172|FG001|Overall Study|Lost to Follow-up|2|||
164113479|NCT00421304|592777173|FG002|Overall Study|Lost to Follow-up|5|||
164113480|NCT00421304|592777171|FG000|Overall Study|Withdrawal by Subject|2|||
164113481|NCT00421304|592777172|FG001|Overall Study|Withdrawal by Subject|2|||
164113482|NCT00421304|592777173|FG002|Overall Study|Withdrawal by Subject|2|||
164113483|NCT00421304|592777171|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
164113484|NCT00421304|592777172|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
164113485|NCT00421304|592777173|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
164113486|NCT00421304|592777171|FG000|Overall Study|Did not attend Day 360 visit|0|||
164113487|NCT00421304|592777172|FG001|Overall Study|Did not attend Day 360 visit|0|||
164113488|NCT00421304|592777173|FG002|Overall Study|Did not attend Day 360 visit|1|||
164113489|NCT00919711|592777174|FG000|Overall Study|Withdrawal by Subject|15|||
164113490|NCT00919711|592777175|FG001|Overall Study|Withdrawal by Subject|7|||
164113491|NCT00919711|592777174|FG000|Overall Study|Adverse Event|13|||
164113492|NCT00919711|592777175|FG001|Overall Study|Adverse Event|3|||
164113493|NCT00919711|592777174|FG000|Overall Study|Other|1|||
164113494|NCT00919711|592777175|FG001|Overall Study|Other|2|||
164113495|NCT00919711|592777174|FG000|Overall Study|Administrative Decision|0|||
164113496|NCT00919711|592777175|FG001|Overall Study|Administrative Decision|1|||
164113497|NCT00919711|592777174|FG000|Overall Study|Lost to Follow-up|2|||
164113498|NCT00919711|592777175|FG001|Overall Study|Lost to Follow-up|0|||
164113499|NCT00919711|592777174|FG000|Overall Study|Death|1|||
164113500|NCT00919711|592777175|FG001|Overall Study|Death|0|||
164113501|NCT00919711|592777174|FG000|Overall Study|Noncompliance|1|||
164113502|NCT00919711|592777175|FG001|Overall Study|Noncompliance|0|||
164113503|NCT00903877|592777176|FG000|Overall Study|Did not meet study criteria|33|||
164113504|NCT00903877|592777176|FG000|Overall Study|Withdrawal by Subject|3|||
164113505|NCT00903877|592777176|FG000|Overall Study|Adverse Event|2|||
164113506|NCT00903877|592777176|FG000|Overall Study|Lost to Follow-up|1|||
164113507|NCT00903877|592777176|FG000|Overall Study|Participation put on hold|4|||
164113508|NCT03694197|592777177|FG000|Overall Study|Adverse Event|9|||
164113509|NCT03694197|592777177|FG000|Overall Study|Protocol became inconvenient to participate|1|||
164113510|NCT03694197|592777177|FG000|Overall Study|Physician Decision|4|||
164113511|NCT03694197|592777177|FG000|Overall Study|Study terminated by sponsor|1350|||
164113512|NCT03694197|592777177|FG000|Overall Study|Participant moved|5|||
164113513|NCT03694197|592777177|FG000|Overall Study|Participant withdrew consent|10|||
164113514|NCT03694197|592777177|FG000|Overall Study|Related to IMP administration|1|||
164113515|NCT03694197|592777177|FG000|Overall Study|Not disclosed|5|||
164113516|NCT03820947|592777178|FG000|Overall Study|Physician Decision|0|||
164113517|NCT03820947|592777179|FG001|Overall Study|Physician Decision|1|||
164113518|NCT03820947|592777180|FG002|Overall Study|Physician Decision|1|||
164113519|NCT03820947|592777181|FG003|Overall Study|Physician Decision|0|||
164113520|NCT03820947|592777182|FG004|Overall Study|Physician Decision|3|||
164113521|NCT03820947|592777178|FG000|Overall Study|Withdrawal by Subject|6|||
164113522|NCT03820947|592777179|FG001|Overall Study|Withdrawal by Subject|10|||
164113523|NCT03820947|592777180|FG002|Overall Study|Withdrawal by Subject|3|||
164113524|NCT03820947|592777181|FG003|Overall Study|Withdrawal by Subject|8|||
164113525|NCT03820947|592777182|FG004|Overall Study|Withdrawal by Subject|5|||
164113526|NCT03820947|592777178|FG000|Overall Study|Procedure Not Attempted|0|||
164113527|NCT03820947|592777179|FG001|Overall Study|Procedure Not Attempted|2|||
164113528|NCT03820947|592777180|FG002|Overall Study|Procedure Not Attempted|1|||
164113529|NCT03820947|592777181|FG003|Overall Study|Procedure Not Attempted|0|||
164113530|NCT03820947|592777182|FG004|Overall Study|Procedure Not Attempted|0|||
164113531|NCT03820947|592777178|FG000|Overall Study|Other Exit|1|||
164113532|NCT03820947|592777179|FG001|Overall Study|Other Exit|3|||
164113533|NCT03820947|592777180|FG002|Overall Study|Other Exit|3|||
164113534|NCT03820947|592777181|FG003|Overall Study|Other Exit|3|||
164113535|NCT03820947|592777182|FG004|Overall Study|Other Exit|0|||
164113536|NCT03820947|592777178|FG000|Overall Study|Follow-up Not Done|10|||
164113537|NCT03820947|592777179|FG001|Overall Study|Follow-up Not Done|13|||
164113538|NCT03820947|592777180|FG002|Overall Study|Follow-up Not Done|2|||
164113539|NCT03820947|592777181|FG003|Overall Study|Follow-up Not Done|3|||
164113540|NCT03820947|592777182|FG004|Overall Study|Follow-up Not Done|12|||
164113541|NCT03820947|592777178|FG000|Overall Study|Death|0|||
164113542|NCT03820947|592777179|FG001|Overall Study|Death|0|||
164113543|NCT03820947|592777180|FG002|Overall Study|Death|0|||
164113544|NCT03820947|592777181|FG003|Overall Study|Death|0|||
164113545|NCT03820947|592777182|FG004|Overall Study|Death|9|||
164113546|NCT03820947|592777178|FG000|Overall Study|Lost to Follow-up|4|||
164113547|NCT03820947|592777179|FG001|Overall Study|Lost to Follow-up|6|||
164113548|NCT03820947|592777180|FG002|Overall Study|Lost to Follow-up|0|||
164113549|NCT03820947|592777181|FG003|Overall Study|Lost to Follow-up|0|||
164113550|NCT03820947|592777182|FG004|Overall Study|Lost to Follow-up|9|||
164113551|NCT05135273|592778611|FG000|Overall Study|Recruited into the army|0|||
164113552|NCT05135273|592778612|FG001|Overall Study|Recruited into the army|0|||
164113553|NCT05135273|592778613|FG002|Overall Study|Recruited into the army|0|||
164113554|NCT05135273|592778614|FG003|Overall Study|Recruited into the army|0|||
164113555|NCT05135273|592778615|FG004|Overall Study|Recruited into the army|1|||
164113556|NCT05135273|592778616|FG005|Overall Study|Recruited into the army|0|||
164113557|NCT05135273|592778617|FG006|Overall Study|Recruited into the army|0|||
164113558|NCT05135273|592778618|FG007|Overall Study|Recruited into the army|0|||
164113559|NCT05135273|592778611|FG000|Overall Study|Moved away from study site|0|||
164113560|NCT05135273|592778612|FG001|Overall Study|Moved away from study site|0|||
164113561|NCT05135273|592778613|FG002|Overall Study|Moved away from study site|0|||
164113562|NCT05135273|592778614|FG003|Overall Study|Moved away from study site|0|||
164113563|NCT05135273|592778615|FG004|Overall Study|Moved away from study site|0|||
164113564|NCT05135273|592778616|FG005|Overall Study|Moved away from study site|1|||
164113565|NCT05135273|592778617|FG006|Overall Study|Moved away from study site|1|||
164113566|NCT05135273|592778618|FG007|Overall Study|Moved away from study site|0|||
164113567|NCT05135273|592778611|FG000|Overall Study|Travel|0|||
164113568|NCT05135273|592778612|FG001|Overall Study|Travel|0|||
164113569|NCT05135273|592778613|FG002|Overall Study|Travel|0|||
164113570|NCT05135273|592778614|FG003|Overall Study|Travel|0|||
164113571|NCT05135273|592778615|FG004|Overall Study|Travel|0|||
164113572|NCT05135273|592778616|FG005|Overall Study|Travel|0|||
164113573|NCT05135273|592778617|FG006|Overall Study|Travel|0|||
164113574|NCT05135273|592778618|FG007|Overall Study|Travel|1|||
164113575|NCT04264819|592778624|FG000|Overall Study|Physician Decision|19|||
164113576|NCT04264819|592778624|FG000|Overall Study|Adverse Event|12|||
164113577|NCT04264819|592778624|FG000|Overall Study|Withdrawal by Subject|11|||
164113578|NCT04264819|592778624|FG000|Overall Study|Lost to Follow-up|2|||
164113579|NCT04264819|592778624|FG000|Overall Study|Death|2|||
164113580|NCT01680016|592778626|FG000|Overall Study|Adverse Event|0|||
164113581|NCT01680016|592778627|FG001|Overall Study|Adverse Event|0|||
164113582|NCT01680016|592778628|FG002|Overall Study|Adverse Event|1|||
164113583|NCT01680016|592778629|FG003|Overall Study|Adverse Event|4|||
164113584|NCT01680016|592778626|FG000|Overall Study|The Subject went out of The Trial|1|||
164113585|NCT01680016|592778627|FG001|Overall Study|The Subject went out of The Trial|0|||
164113586|NCT01680016|592778628|FG002|Overall Study|The Subject went out of The Trial|3|||
164113587|NCT01680016|592778629|FG003|Overall Study|The Subject went out of The Trial|0|||
164113588|NCT01680016|592778626|FG000|Overall Study|Protocol Violation|0|||
164113589|NCT01680016|592778627|FG001|Overall Study|Protocol Violation|1|||
164113590|NCT01680016|592778628|FG002|Overall Study|Protocol Violation|0|||
164113591|NCT01680016|592778629|FG003|Overall Study|Protocol Violation|0|||
164113592|NCT01680016|592778626|FG000|Overall Study|Withdrawal by Subject|5|||
164113593|NCT01680016|592778627|FG001|Overall Study|Withdrawal by Subject|7|||
164113594|NCT01680016|592778628|FG002|Overall Study|Withdrawal by Subject|1|||
164113595|NCT01680016|592778629|FG003|Overall Study|Withdrawal by Subject|1|||
164113596|NCT01958060|592778633|FG000|Overall Study|Not treated|2|||
164113597|NCT01958060|592778634|FG001|Overall Study|Not treated|0|||
164113598|NCT01958060|592778635|FG002|Overall Study|Not treated|0|||
164113599|NCT01958060|592778636|FG003|Overall Study|Not treated|0|||
164113600|NCT01958060|592778637|FG004|Overall Study|Not treated|1|||
164113601|NCT01958060|592778638|FG005|Overall Study|Not treated|0|||
164113602|NCT02846883|592778642|FG000|Overall Study|Death|0|||
164113603|NCT02846883|592778643|FG001|Overall Study|Death|1|||
164113604|NCT02846883|592778644|FG002|Overall Study|Death|1|||
164113605|NCT02846883|592778642|FG000|Overall Study|Lost to Follow-up|0|||
164113606|NCT02846883|592778643|FG001|Overall Study|Lost to Follow-up|0|||
164113607|NCT02846883|592778644|FG002|Overall Study|Lost to Follow-up|1|||
164113608|NCT02846883|592778642|FG000|Overall Study|Withdrawal by Subject|1|||
164113609|NCT02846883|592778643|FG001|Overall Study|Withdrawal by Subject|0|||
164113610|NCT02846883|592778644|FG002|Overall Study|Withdrawal by Subject|0|||
164113611|NCT02846883|592778642|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
164113612|NCT02846883|592778643|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
164113613|NCT02846883|592778644|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
164113614|NCT02846883|592778642|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
164113615|NCT02846883|592778643|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
164113616|NCT02846883|592778644|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
164113617|NCT00927251|592778645|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
164113618|NCT00442351|592778649|FG000|Overall Study|Administrative|6|||
164113619|NCT00442351|592778650|FG001|Overall Study|Administrative|5|||
164113620|NCT00442351|592778649|FG000|Overall Study|Did not meet protocol eligibility|1|||
164113621|NCT00442351|592778650|FG001|Overall Study|Did not meet protocol eligibility|0|||
164113622|NCT00442351|592778649|FG000|Overall Study|Other|0|||
164113623|NCT00442351|592778650|FG001|Overall Study|Other|1|||
164113624|NCT00500318|592778652|FG000|Overall Study|Adverse Event|3|||
164113625|NCT00500318|592778653|FG001|Overall Study|Adverse Event|8|||
164113626|NCT00500318|592778652|FG000|Overall Study|Protocol Violation|1|||
164113627|NCT00500318|592778653|FG001|Overall Study|Protocol Violation|3|||
164113628|NCT00500318|592778652|FG000|Overall Study|Withdrawal by Subject|1|||
164113629|NCT00500318|592778653|FG001|Overall Study|Withdrawal by Subject|2|||
164113630|NCT00500318|592778652|FG000|Overall Study|Lack of Efficacy|0|||
164113631|NCT00500318|592778653|FG001|Overall Study|Lack of Efficacy|3|||
164113632|NCT00500318|592778652|FG000|Overall Study|Other Reason|0|||
164113633|NCT00500318|592778653|FG001|Overall Study|Other Reason|1|||
164113634|NCT01350934|592778676|FG000|Base Study|Adverse Event|6|||
164113635|NCT01350934|592778677|FG001|Base Study|Adverse Event|0|||
164113636|NCT01350934|592778676|FG000|Base Study|Lost to Follow-up|1|||
164113637|NCT01350934|592778677|FG001|Base Study|Lost to Follow-up|0|||
164113638|NCT01350934|592778676|FG000|Base Study|Protocol Violation|1|||
164113639|NCT01350934|592778677|FG001|Base Study|Protocol Violation|1|||
164113640|NCT01350934|592778676|FG000|Base Study|Withdrawal by Subject|1|||
164113641|NCT01350934|592778677|FG001|Base Study|Withdrawal by Subject|2|||
164113642|NCT01350934|592778676|FG000|Base Study|Non-Compliance With Study Drug|2|||
164113643|NCT01350934|592778677|FG001|Base Study|Non-Compliance With Study Drug|0|||
164113644|NCT01350934|592778676|FG000|Extension Study|Adverse Event|2|||
164113645|NCT01350934|592778677|FG001|Extension Study|Adverse Event|1|||
164113646|NCT01350934|592778676|FG000|Extension Study|Lost to Follow-up|2|||
164113647|NCT01350934|592778677|FG001|Extension Study|Lost to Follow-up|0|||
164113648|NCT01350934|592778676|FG000|Extension Study|Protocol Violation|1|||
164113649|NCT01350934|592778677|FG001|Extension Study|Protocol Violation|1|||
164113650|NCT01350934|592778676|FG000|Extension Study|Lack of Efficacy|0|||
164113651|NCT01350934|592778677|FG001|Extension Study|Lack of Efficacy|1|||
164113652|NCT01350934|592778676|FG000|Extension Study|Withdrawal by Subject|0|||
164113653|NCT01350934|592778677|FG001|Extension Study|Withdrawal by Subject|1|||
164113654|NCT01011335|592778678|FG000|Overall Study|Lost to Follow-up|0|||
164113655|NCT01011335|592778679|FG001|Overall Study|Lost to Follow-up|0|||
164113656|NCT01011335|592778680|FG002|Overall Study|Lost to Follow-up|1|||
164113657|NCT01011335|592778681|FG003|Overall Study|Lost to Follow-up|1|||
164113658|NCT01011335|592778682|FG004|Overall Study|Lost to Follow-up|1|||
164113659|NCT01011335|592778683|FG005|Overall Study|Lost to Follow-up|1|||
164113660|NCT01011335|592778684|FG006|Overall Study|Lost to Follow-up|2|||
164113661|NCT01011335|592778685|FG007|Overall Study|Lost to Follow-up|2|||
164113662|NCT01011335|592778686|FG008|Overall Study|Lost to Follow-up|1|||
164113663|NCT01011335|592778687|FG009|Overall Study|Lost to Follow-up|0|||
164113664|NCT01011335|592778688|FG010|Overall Study|Lost to Follow-up|0|||
164113665|NCT01011335|592778689|FG011|Overall Study|Lost to Follow-up|1|||
164113666|NCT01011335|592778690|FG012|Overall Study|Lost to Follow-up|2|||
164113667|NCT01011335|592778678|FG000|Overall Study|Protocol Violation|0|||
164113668|NCT01011335|592778679|FG001|Overall Study|Protocol Violation|1|||
164113669|NCT01011335|592778680|FG002|Overall Study|Protocol Violation|0|||
164113670|NCT01011335|592778681|FG003|Overall Study|Protocol Violation|0|||
164113671|NCT01011335|592778682|FG004|Overall Study|Protocol Violation|0|||
164113672|NCT01011335|592778683|FG005|Overall Study|Protocol Violation|0|||
164113673|NCT01011335|592778684|FG006|Overall Study|Protocol Violation|0|||
164113674|NCT01011335|592778685|FG007|Overall Study|Protocol Violation|0|||
164113675|NCT01011335|592778686|FG008|Overall Study|Protocol Violation|0|||
164113676|NCT01011335|592778687|FG009|Overall Study|Protocol Violation|0|||
164113677|NCT01011335|592778688|FG010|Overall Study|Protocol Violation|0|||
164113678|NCT01011335|592778689|FG011|Overall Study|Protocol Violation|0|||
164113679|NCT01011335|592778690|FG012|Overall Study|Protocol Violation|0|||
164113680|NCT01011335|592778678|FG000|Overall Study|Moved/deployed or no booster|1|||
164113681|NCT01011335|592778679|FG001|Overall Study|Moved/deployed or no booster|0|||
164113682|NCT01011335|592778680|FG002|Overall Study|Moved/deployed or no booster|0|||
164113683|NCT01011335|592778681|FG003|Overall Study|Moved/deployed or no booster|1|||
164113684|NCT01011335|592778682|FG004|Overall Study|Moved/deployed or no booster|0|||
164113685|NCT01011335|592778683|FG005|Overall Study|Moved/deployed or no booster|0|||
164113686|NCT01011335|592778684|FG006|Overall Study|Moved/deployed or no booster|1|||
164113687|NCT01011335|592778685|FG007|Overall Study|Moved/deployed or no booster|0|||
164113688|NCT01011335|592778686|FG008|Overall Study|Moved/deployed or no booster|1|||
164113689|NCT01011335|592778687|FG009|Overall Study|Moved/deployed or no booster|0|||
164113690|NCT01011335|592778688|FG010|Overall Study|Moved/deployed or no booster|2|||
164113691|NCT01011335|592778689|FG011|Overall Study|Moved/deployed or no booster|0|||
164113692|NCT01011335|592778690|FG012|Overall Study|Moved/deployed or no booster|0|||
164113693|NCT01011335|592778678|FG000|Overall Study|Adverse Event|0|||
164113694|NCT01011335|592778679|FG001|Overall Study|Adverse Event|0|||
164113695|NCT01011335|592778680|FG002|Overall Study|Adverse Event|0|||
164113696|NCT01011335|592778681|FG003|Overall Study|Adverse Event|0|||
164113697|NCT01011335|592778682|FG004|Overall Study|Adverse Event|0|||
164113698|NCT01011335|592778683|FG005|Overall Study|Adverse Event|0|||
164113699|NCT01011335|592778684|FG006|Overall Study|Adverse Event|0|||
164113700|NCT01011335|592778685|FG007|Overall Study|Adverse Event|0|||
164113701|NCT01011335|592778686|FG008|Overall Study|Adverse Event|0|||
164113702|NCT01011335|592778687|FG009|Overall Study|Adverse Event|0|||
164113703|NCT01011335|592778688|FG010|Overall Study|Adverse Event|4|||
164113704|NCT01011335|592778689|FG011|Overall Study|Adverse Event|0|||
164113705|NCT01011335|592778690|FG012|Overall Study|Adverse Event|1|||
164113706|NCT02435433|592778691|FG000|Overall Study|Withdrawal by Subject|2|||
164113707|NCT02435433|592778692|FG001|Overall Study|Withdrawal by Subject|3|||
164113708|NCT02435433|592778693|FG002|Overall Study|Withdrawal by Subject|1|||
164113709|NCT02435433|592778694|FG003|Overall Study|Withdrawal by Subject|0|||
164113710|NCT02435433|592778695|FG004|Overall Study|Withdrawal by Subject|0|||
164113711|NCT02435433|592778691|FG000|Overall Study|Lost to Follow-up|2|||
164113712|NCT02435433|592778692|FG001|Overall Study|Lost to Follow-up|2|||
164113713|NCT02435433|592778693|FG002|Overall Study|Lost to Follow-up|4|||
164113714|NCT02435433|592778694|FG003|Overall Study|Lost to Follow-up|1|||
164113715|NCT02435433|592778695|FG004|Overall Study|Lost to Follow-up|0|||
164113716|NCT02817828|592778696|FG000|Overall Study|Lost to Follow-up|41|||
164113717|NCT02817828|592778696|FG000|Overall Study|Adverse event not related to bleeding|104|||
164113718|NCT02817828|592778696|FG000|Overall Study|Adverse event related to bleeding|53|||
164113719|NCT02817828|592778696|FG000|Overall Study|Protocol Violation|11|||
164113720|NCT02817828|592778696|FG000|Overall Study|Pregnancy|7|||
164113721|NCT02817828|592778696|FG000|Overall Study|Pregnancy wish|15|||
164113722|NCT02817828|592778696|FG000|Overall Study|Withdrawal by Subject|78|||
164113723|NCT02817828|592778696|FG000|Overall Study|Other|26|||
164113724|NCT00522041|592778698|FG000|Overall Study|Adverse Event|9|||
164113725|NCT00522041|592778699|FG001|Overall Study|Adverse Event|3|||
164113726|NCT00522041|592778698|FG000|Overall Study|Protocol Violation|2|||
164113727|NCT00522041|592778699|FG001|Overall Study|Protocol Violation|0|||
164113728|NCT00522041|592778698|FG000|Overall Study|Lost to Follow-up|1|||
164113729|NCT00522041|592778699|FG001|Overall Study|Lost to Follow-up|4|||
164113730|NCT00522041|592778698|FG000|Overall Study|Voluntary withdrawal|5|||
164113731|NCT00522041|592778699|FG001|Overall Study|Voluntary withdrawal|4|||
164113732|NCT00522041|592778698|FG000|Overall Study|Did not receive treatment|0|||
164113733|NCT00522041|592778699|FG001|Overall Study|Did not receive treatment|1|||
164113734|NCT01579006|592778700|FG000|Overall Study|Lack of Efficacy|10|||
164113735|NCT01579006|592778700|FG000|Overall Study|Adverse Event|13|||
164113736|NCT01579006|592778700|FG000|Overall Study|Withdrawal by Subject|5|||
164113737|NCT01579006|592778700|FG000|Overall Study|Non-compliance|3|||
164113738|NCT01579006|592778700|FG000|Overall Study|Due to participant's health fund|1|||
164113739|NCT01579006|592778700|FG000|Overall Study|Scheduled surgery|1|||
164113740|NCT00799708|592778704|FG000|Overall Study|non-compliance|1|||
164113741|NCT00799708|592778705|FG001|Overall Study|non-compliance|0|||
164113742|NCT00799708|592778706|FG002|Overall Study|non-compliance|0|||
164113743|NCT03343639|592778707|FG000|Overall Study|Withdrawal by Subject|10|||
164113744|NCT03343639|592778708|FG001|Overall Study|Withdrawal by Subject|6|||
164113745|NCT03343639|592778707|FG000|Overall Study|Lost to Follow-up|4|||
164113746|NCT03343639|592778708|FG001|Overall Study|Lost to Follow-up|5|||
164113747|NCT03343639|592778707|FG000|Overall Study|Protocol Violation|0|||
164113748|NCT03343639|592778708|FG001|Overall Study|Protocol Violation|1|||
164113749|NCT00735696|592778711|FG000|Overall Study|Withdrawal by Subject|1|||
164113750|NCT00735696|592778711|FG000|Overall Study|Enrolled but never Treated|1|||
164113751|NCT01708954|592778712|FG000|Step 1|Disease progression|26|||
164113752|NCT01708954|592778713|FG001|Step 1|Disease progression|17|||
164113753|NCT01708954|592778714|FG002|Step 1|Disease progression|14|||
164113754|NCT01708954|592778712|FG000|Step 1|Adverse Event|3|||
164113755|NCT01708954|592778713|FG001|Step 1|Adverse Event|11|||
164113756|NCT01708954|592778714|FG002|Step 1|Adverse Event|13|||
164113757|NCT01708954|592778712|FG000|Step 1|Death|3|||
164113758|NCT01708954|592778713|FG001|Step 1|Death|2|||
164113759|NCT01708954|592778714|FG002|Step 1|Death|3|||
164113760|NCT01708954|592778712|FG000|Step 1|Withdrawal by Subject|2|||
164113761|NCT01708954|592778713|FG001|Step 1|Withdrawal by Subject|5|||
164113762|NCT01708954|592778714|FG002|Step 1|Withdrawal by Subject|3|||
164113763|NCT01708954|592778712|FG000|Step 1|Other complicating disease|0|||
164113764|NCT01708954|592778713|FG001|Step 1|Other complicating disease|2|||
164113765|NCT01708954|592778714|FG002|Step 1|Other complicating disease|0|||
164113766|NCT01708954|592778712|FG000|Step 1|Crossed over to Step 2|2|||
164113767|NCT01708954|592778713|FG001|Step 1|Crossed over to Step 2|0|||
164113768|NCT01708954|592778714|FG002|Step 1|Crossed over to Step 2|0|||
164113769|NCT01708954|592778712|FG000|Step 1|Symptomatic deterioration|1|||
164113770|NCT01708954|592778713|FG001|Step 1|Symptomatic deterioration|0|||
164113771|NCT01708954|592778714|FG002|Step 1|Symptomatic deterioration|1|||
164113772|NCT01708954|592778712|FG000|Step 1|Off-treatment reason not submitted|1|||
164113773|NCT01708954|592778713|FG001|Step 1|Off-treatment reason not submitted|1|||
164113774|NCT01708954|592778714|FG002|Step 1|Off-treatment reason not submitted|1|||
164113775|NCT01708954|592778712|FG000|Step 1|Ineligible or never received treatment|4|||
164113776|NCT01708954|592778713|FG001|Step 1|Ineligible or never received treatment|2|||
164113777|NCT01708954|592778714|FG002|Step 1|Ineligible or never received treatment|8|||
164113778|NCT01708954|592778712|FG000|Step 2|Disease progression|9|||
164113779|NCT01708954|592778713|FG001|Step 2|Disease progression|4|||
164113780|NCT01708954|592778714|FG002|Step 2|Disease progression|0|||
164113781|NCT01708954|592778712|FG000|Step 2|Adverse Event|3|||
164113782|NCT01708954|592778713|FG001|Step 2|Adverse Event|2|||
164113783|NCT01708954|592778714|FG002|Step 2|Adverse Event|0|||
164113784|NCT01708954|592778712|FG000|Step 2|Withdrawal by Subject|1|||
164113785|NCT01708954|592778713|FG001|Step 2|Withdrawal by Subject|1|||
164113786|NCT01708954|592778714|FG002|Step 2|Withdrawal by Subject|0|||
164113787|NCT01192776|592778715|FG000|Overall Study|Death|8|||
164113788|NCT01192776|592778716|FG001|Overall Study|Death|15|||
164113789|NCT01192776|592778717|FG002|Overall Study|Death|18|||
164113790|NCT01192776|592778718|FG003|Overall Study|Death|15|||
164113791|NCT01192776|592778715|FG000|Overall Study|Lost to Follow-up|3|||
164113792|NCT01192776|592778716|FG001|Overall Study|Lost to Follow-up|6|||
164113793|NCT01192776|592778717|FG002|Overall Study|Lost to Follow-up|3|||
164113794|NCT01192776|592778718|FG003|Overall Study|Lost to Follow-up|5|||
164113795|NCT02587143|592778719|FG000|Overall Study|Adverse Event|1|||
164113796|NCT02587143|592778720|FG001|Overall Study|Adverse Event|0|||
164113797|NCT01119625|592778721|FG000|Overall Study|Lost to Follow-up|1|||
164113798|NCT01119625|592778722|FG001|Overall Study|Lost to Follow-up|2|||
164113799|NCT01119625|592778721|FG000|Overall Study|Withdrawal by Subject|2|||
164113800|NCT01119625|592778722|FG001|Overall Study|Withdrawal by Subject|1|||
164113801|NCT01119625|592778721|FG000|Overall Study|Other|0|||
164113802|NCT01119625|592778722|FG001|Overall Study|Other|1|||
164113803|NCT01721772|592778727|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
164113804|NCT01721772|592778728|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
164113805|NCT01721772|592778727|FG000|Pre-Treatment|Poor/non-compliance|0|||
164113806|NCT01721772|592778728|FG001|Pre-Treatment|Poor/non-compliance|1|||
164113807|NCT01721772|592778727|FG000|Pre-Treatment|Participant withdrew consent|0|||
164113808|NCT01721772|592778728|FG001|Pre-Treatment|Participant withdrew consent|1|||
164113809|NCT01721772|592778727|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
164113810|NCT01721772|592778728|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
164113811|NCT01721772|592778727|FG000|Treatment|Disease progression|119|||
164113812|NCT01721772|592778728|FG001|Treatment|Disease progression|168|||
164113813|NCT01721772|592778727|FG000|Treatment|Study drug toxicity|19|||
164113814|NCT01721772|592778728|FG001|Treatment|Study drug toxicity|10|||
164113815|NCT01721772|592778727|FG000|Treatment|Adverse event unrelated to study drug|7|||
164113816|NCT01721772|592778728|FG001|Treatment|Adverse event unrelated to study drug|7|||
164113817|NCT01721772|592778727|FG000|Treatment|Maximum clinical benefit|16|||
164113818|NCT01721772|592778728|FG001|Treatment|Maximum clinical benefit|4|||
164113819|NCT01721772|592778727|FG000|Treatment|Other|19|||
164113820|NCT01721772|592778728|FG001|Treatment|Other|2|||
164113821|NCT01721772|592778727|FG000|Treatment|Participant withdrew consent|2|||
164113822|NCT01721772|592778728|FG001|Treatment|Participant withdrew consent|5|||
164113823|NCT01721772|592778727|FG000|Treatment|Participant request to discontinue study treatment|21|||
164113824|NCT01721772|592778728|FG001|Treatment|Participant request to discontinue study treatment|8|||
164113825|NCT01721772|592778727|FG000|Treatment|Death|1|||
164113826|NCT01721772|592778728|FG001|Treatment|Death|0|||
164113827|NCT01721772|592778727|FG000|Treatment|Not reported|1|||
164113828|NCT01721772|592778728|FG001|Treatment|Not reported|0|||
164113829|NCT01721772|592778727|FG000|Treatment|Poor/non-compliance|1|||
164113830|NCT01721772|592778728|FG001|Treatment|Poor/non-compliance|0|||
164113831|NCT01721772|592778727|FG000|Treatment|Lost to Follow-up|0|||
164113832|NCT01721772|592778728|FG001|Treatment|Lost to Follow-up|1|||
164113833|NCT04542694|592778729|FG000|Overall Study|The need for prohibited therapy|2|||
164113834|NCT04542694|592778730|FG001|Overall Study|The need for prohibited therapy|0|||
164113835|NCT04542694|592778729|FG000|Overall Study|Adverse Event|1|||
164113836|NCT04542694|592778730|FG001|Overall Study|Adverse Event|0|||
164113837|NCT04542694|592778729|FG000|Overall Study|Protocol Violation|1|||
164113838|NCT04542694|592778730|FG001|Overall Study|Protocol Violation|0|||
164113839|NCT04633642|592778733|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
164113840|NCT04633642|592778734|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
164113841|NCT00611884|592778735|FG000|Overall Study|Adverse Event|1|||
164113842|NCT00611884|592778736|FG001|Overall Study|Adverse Event|0|||
164113843|NCT00611884|592778737|FG002|Overall Study|Adverse Event|0|||
164113844|NCT00611884|592778738|FG003|Overall Study|Adverse Event|1|||
164113845|NCT00611884|592778735|FG000|Overall Study|Non-Compliance|1|||
164113846|NCT00611884|592778736|FG001|Overall Study|Non-Compliance|4|||
164113847|NCT00611884|592778737|FG002|Overall Study|Non-Compliance|2|||
164113848|NCT00611884|592778738|FG003|Overall Study|Non-Compliance|2|||
164113849|NCT00611884|592778735|FG000|Overall Study|Lack of Efficacy|0|||
164113850|NCT00611884|592778736|FG001|Overall Study|Lack of Efficacy|1|||
164113851|NCT00611884|592778737|FG002|Overall Study|Lack of Efficacy|0|||
164113852|NCT00611884|592778738|FG003|Overall Study|Lack of Efficacy|0|||
164113853|NCT00611884|592778735|FG000|Overall Study|Unclassified|7|||
164113854|NCT00611884|592778736|FG001|Overall Study|Unclassified|4|||
164113855|NCT00611884|592778737|FG002|Overall Study|Unclassified|2|||
164113856|NCT00611884|592778738|FG003|Overall Study|Unclassified|3|||
164113857|NCT00981799|592778739|FG000|Overall Study|Adverse Event|1|||
164113858|NCT00981799|592778740|FG001|Overall Study|Adverse Event|1|||
164113859|NCT00981799|592778741|FG002|Overall Study|Adverse Event|0|||
164113860|NCT00981799|592778742|FG003|Overall Study|Adverse Event|0|||
164113861|NCT05387408|592778743|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
164113862|NCT01055834|592778747|FG000|Treatment Period I|Adverse Event|1|||
164113863|NCT01055834|592778748|FG001|Treatment Period I|Adverse Event|0|||
164113864|NCT01943435|592778749|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
164113865|NCT01943435|592778750|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
164113866|NCT01943435|592778751|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
164113867|NCT01943435|592778749|FG000|Intervention Period|Withdrawal by Subject|3|||
164113868|NCT01943435|592778750|FG001|Intervention Period|Withdrawal by Subject|3|||
164113869|NCT01943435|592778751|FG002|Intervention Period|Withdrawal by Subject|4|||
164113870|NCT01943435|592778749|FG000|2 Month Follow up|Lost to Follow-up|2|||
164113871|NCT01943435|592778750|FG001|2 Month Follow up|Lost to Follow-up|3|||
164113872|NCT01943435|592778751|FG002|2 Month Follow up|Lost to Follow-up|0|||
164113873|NCT01943435|592778749|FG000|6 Month Follow up|Lost to Follow-up|12|||
164113874|NCT01943435|592778750|FG001|6 Month Follow up|Lost to Follow-up|7|||
164113875|NCT01943435|592778751|FG002|6 Month Follow up|Lost to Follow-up|15|||
164113876|NCT04535986|592778752|FG000|Overall Study|Death|4|||
164113877|NCT04535986|592778753|FG001|Overall Study|Death|5|||
164113878|NCT04535986|592778752|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
164113879|NCT04535986|592778753|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
164113880|NCT04535986|592778752|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
164113881|NCT04535986|592778753|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
164113882|NCT04535986|592778752|FG000|Overall Study|Adverse Event|10|||
164113883|NCT04535986|592778753|FG001|Overall Study|Adverse Event|1|||
164113884|NCT04535986|592778752|FG000|Overall Study|Lack of Efficacy|3|||
164113885|NCT04535986|592778753|FG001|Overall Study|Lack of Efficacy|2|||
164113886|NCT04535986|592778752|FG000|Overall Study|Investigator discretion|3|||
164113887|NCT04535986|592778753|FG001|Overall Study|Investigator discretion|0|||
164113888|NCT04535986|592778752|FG000|Overall Study|Withdrawal by Subject|32|||
164113889|NCT04535986|592778753|FG001|Overall Study|Withdrawal by Subject|14|||
164113890|NCT04535986|592778752|FG000|Overall Study|Lost to Follow-up|5|||
164113891|NCT04535986|592778753|FG001|Overall Study|Lost to Follow-up|3|||
164113892|NCT04535986|592778752|FG000|Overall Study|Other|7|||
164113893|NCT04535986|592778753|FG001|Overall Study|Other|3|||
164113894|NCT00467597|592778754|FG000|Overall Study|Withdrawal by Subject|2|||
164113895|NCT00467597|592778755|FG001|Overall Study|Withdrawal by Subject|0|||
164113896|NCT04561115|592778756|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
164113897|NCT04561115|592778757|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
164113898|NCT04561115|592778756|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
164113899|NCT04561115|592778757|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
164113900|NCT04561115|592778756|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
164113901|NCT04561115|592778757|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
164113902|NCT00743145|592778758|FG000|Overall Study|Withdrawal by Subject|1|||
164113903|NCT00743145|592778758|FG000|Overall Study|Adverse Event|2|||
164113904|NCT00743145|592778758|FG000|Overall Study|Pregnancy|1|||
164113905|NCT02179190|592778759|FG000|Enrollment|Exit Prior to Device Attempt|11|||
164113906|NCT02179190|592778759|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
164113907|NCT02179190|592778759|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
164113908|NCT02179190|592778759|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
164113909|NCT02179190|592778759|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
164113910|NCT02179190|592778759|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
164113911|NCT01670097|592778760|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
164113912|NCT01670097|592778761|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
164113913|NCT01670097|592778760|FG000|Overall Study|Study burden|1|||
164113914|NCT01670097|592778761|FG001|Overall Study|Study burden|0|||
164113915|NCT01670097|592778760|FG000|Overall Study|COPD exacerbation|0|||
164113916|NCT01670097|592778761|FG001|Overall Study|COPD exacerbation|1|||
164113917|NCT01670097|592778760|FG000|Overall Study|Neutropenia|0|||
164113918|NCT01670097|592778761|FG001|Overall Study|Neutropenia|1|||
164113919|NCT01670097|592778760|FG000|Overall Study|Clinical deterioration|0|||
164113920|NCT01670097|592778761|FG001|Overall Study|Clinical deterioration|1|||
164113921|NCT01670097|592778760|FG000|Overall Study|Disease progression|0|||
164113922|NCT01670097|592778761|FG001|Overall Study|Disease progression|1|||
164113923|NCT02311894|592778762|FG000|Overall Study|Discontinued in error|1|||
164113924|NCT02311894|592778762|FG000|Overall Study|Lost to Follow-up|1|||
164113925|NCT02311894|592778762|FG000|Overall Study|Adverse Event|1|||
164113926|NCT02311894|592778762|FG000|Overall Study|Withdrawal by Subject|1|||
164113927|NCT00884390|592778763|FG000|Overall Study|Adverse Event|0|||
164113928|NCT00884390|592778764|FG001|Overall Study|Adverse Event|1|||
164113929|NCT00884390|592778763|FG000|Overall Study|Lost to Follow-up|0|||
164113930|NCT00884390|592778764|FG001|Overall Study|Lost to Follow-up|1|||
164113931|NCT00884390|592778763|FG000|Overall Study|Physician Decision|2|||
164113932|NCT00884390|592778764|FG001|Overall Study|Physician Decision|1|||
164113933|NCT00884390|592778763|FG000|Overall Study|Protocol Violation|4|||
164113934|NCT00884390|592778764|FG001|Overall Study|Protocol Violation|1|||
164113935|NCT00884390|592778763|FG000|Overall Study|Withdrawal by Subject|4|||
164113936|NCT00884390|592778764|FG001|Overall Study|Withdrawal by Subject|1|||
164113937|NCT00884390|592778763|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
164113938|NCT00884390|592778764|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
164113939|NCT00884390|592778763|FG000|Overall Study|Other|11|||
164113940|NCT00884390|592778764|FG001|Overall Study|Other|1|||
164113941|NCT01691612|592778765|FG000|Overall Study|deemed ineligible after 1st visit|6|||
164113942|NCT01691612|592778765|FG000|Overall Study|Adverse Event|1|||
164113943|NCT02623218|592778768|FG000|Overall Study|Lost to Follow-up|0|||
164113944|NCT02623218|592778769|FG001|Overall Study|Lost to Follow-up|1|||
164113945|NCT02623218|592778770|FG002|Overall Study|Lost to Follow-up|0|||
164113946|NCT02623218|592778771|FG003|Overall Study|Lost to Follow-up|0|||
164113947|NCT02623218|592778772|FG004|Overall Study|Lost to Follow-up|0|||
164113948|NCT00537095|592778777|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
164113949|NCT00537095|592778778|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
164113950|NCT00537095|592778777|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
164113951|NCT00537095|592778778|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
164113952|NCT00537095|592778777|FG000|Randomized Treatment Period (433 Days)|Death|3|||
164113953|NCT00537095|592778778|FG001|Randomized Treatment Period (433 Days)|Death|1|||
164113954|NCT00537095|592778777|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
164113955|NCT00537095|592778778|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
164113956|NCT00537095|592778777|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
164113957|NCT00537095|592778778|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
164113958|NCT00537095|592778777|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
164113959|NCT00537095|592778778|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
164113960|NCT00537095|592778777|FG000|Open-label Period (590 Days)|Adverse Event|2|||
164113961|NCT00537095|592778778|FG001|Open-label Period (590 Days)|Adverse Event|11|||
164113962|NCT00537095|592778777|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
164113963|NCT00537095|592778778|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
164113964|NCT00537095|592778777|FG000|Open-label Period (590 Days)|Death|2|||
164113965|NCT00537095|592778778|FG001|Open-label Period (590 Days)|Death|2|||
164113966|NCT00537095|592778777|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
164113967|NCT00537095|592778778|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
164113968|NCT00537095|592778777|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
164113969|NCT00537095|592778778|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
164113970|NCT00021541|592778779|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
164132666|NCT01986010|592850662|FG007|Overall Study|Adverse Event|0|||
164113971|NCT00021541|592778780|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
164113972|NCT00021541|592778779|FG000|Period 1-First Treatment|Adverse Event|2|||
164113973|NCT00021541|592778780|FG001|Period 1-First Treatment|Adverse Event|1|||
164113974|NCT00021541|592778779|FG000|Period 1-First Treatment|non-adherence|3|||
164113975|NCT00021541|592778780|FG001|Period 1-First Treatment|non-adherence|0|||
164113976|NCT00021541|592778779|FG000|Period 1-First Treatment|Death|1|||
164113977|NCT00021541|592778780|FG001|Period 1-First Treatment|Death|0|||
164113978|NCT00021541|592778779|FG000|Period 1-First Treatment|Pts that did not progress|2|||
164113979|NCT00021541|592778780|FG001|Period 1-First Treatment|Pts that did not progress|2|||
164113980|NCT00021541|592778779|FG000|Period 1-First Treatment|Ineligible|0|||
164113981|NCT00021541|592778780|FG001|Period 1-First Treatment|Ineligible|2|||
164113982|NCT00021541|592778779|FG000|Period 2-crossover|refused phase B|2|||
164113983|NCT00021541|592778780|FG001|Period 2-crossover|refused phase B|2|||
164113984|NCT00021541|592778779|FG000|Period 2-crossover|Withdrawal by Subject|3|||
164113985|NCT00021541|592778780|FG001|Period 2-crossover|Withdrawal by Subject|4|||
164113986|NCT00021541|592778779|FG000|Period 2-crossover|Adverse Event|2|||
164113987|NCT00021541|592778780|FG001|Period 2-crossover|Adverse Event|2|||
164113988|NCT00021541|592778779|FG000|Period 2-crossover|non-adherence|1|||
164113989|NCT00021541|592778780|FG001|Period 2-crossover|non-adherence|0|||
164113990|NCT00021541|592778779|FG000|Period 2-crossover|Pts that did not progress|2|||
164113991|NCT00021541|592778780|FG001|Period 2-crossover|Pts that did not progress|3|||
164113992|NCT01929681|592778781|FG000|Overall Study|Withdrawal by Subject|1|||
164113993|NCT01929681|592778782|FG001|Overall Study|Withdrawal by Subject|0|||
164113994|NCT01929681|592778781|FG000|Overall Study|Physician Decision|1|||
164113995|NCT01929681|592778782|FG001|Overall Study|Physician Decision|1|||
164113996|NCT00124618|592778784|FG000|Overall Study|Ineligible|1|||
164113997|NCT04194151|592778785|FG000|Overall Study|Physician Decision|1|||
164113998|NCT04194151|592778786|FG001|Overall Study|Physician Decision|1|||
164113999|NCT04194151|592778787|FG002|Overall Study|Physician Decision|1|||
164114000|NCT04194151|592778788|FG003|Overall Study|Physician Decision|1|||
164114001|NCT04194151|592778789|FG004|Overall Study|Physician Decision|0|||
164114002|NCT04194151|592778790|FG005|Overall Study|Physician Decision|1|||
164114003|NCT04194151|592778785|FG000|Overall Study|Monitorization problem|0|||
164114004|NCT04194151|592778786|FG001|Overall Study|Monitorization problem|1|||
164114005|NCT04194151|592778787|FG002|Overall Study|Monitorization problem|0|||
164114006|NCT04194151|592778788|FG003|Overall Study|Monitorization problem|0|||
164114007|NCT04194151|592778789|FG004|Overall Study|Monitorization problem|0|||
164114008|NCT04194151|592778790|FG005|Overall Study|Monitorization problem|0|||
164114009|NCT00087529|592778791|FG000|Overall Study|Death|1|||
164114010|NCT00087529|592778792|FG001|Overall Study|Death|0|||
164114011|NCT00087529|592778791|FG000|Overall Study|Adverse Event|0|||
164114012|NCT00087529|592778792|FG001|Overall Study|Adverse Event|8|||
164114013|NCT00087529|592778791|FG000|Overall Study|Pregnancy|0|||
164114014|NCT00087529|592778792|FG001|Overall Study|Pregnancy|1|||
164114015|NCT00087529|592778791|FG000|Overall Study|Lost to Follow-up|2|||
164114016|NCT00087529|592778792|FG001|Overall Study|Lost to Follow-up|3|||
164114017|NCT00087529|592778791|FG000|Overall Study|Participant Decision|14|||
164114018|NCT00087529|592778792|FG001|Overall Study|Participant Decision|37|||
164114019|NCT00087529|592778791|FG000|Overall Study|Physician Decision|4|||
164114020|NCT00087529|592778792|FG001|Overall Study|Physician Decision|8|||
164114021|NCT00087529|592778791|FG000|Overall Study|Initiation of Excluded Therapy|0|||
164114022|NCT00087529|592778792|FG001|Overall Study|Initiation of Excluded Therapy|1|||
164114023|NCT00087529|592778791|FG000|Overall Study|Participant Noncompliance|0|||
164114024|NCT00087529|592778792|FG001|Overall Study|Participant Noncompliance|1|||
164114025|NCT00087529|592778791|FG000|Overall Study|Disease Progression|5|||
164114026|NCT00087529|592778792|FG001|Overall Study|Disease Progression|4|||
164114027|NCT00087529|592778791|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
164114028|NCT00087529|592778792|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
164114029|NCT02535923|592778793|FG000|Overall Study|Lost to Follow-up|5|||
164114030|NCT02535923|592778794|FG001|Overall Study|Lost to Follow-up|5|||
164114031|NCT02535923|592778793|FG000|Overall Study|Withdrawal by Subject|4|||
164114032|NCT02535923|592778794|FG001|Overall Study|Withdrawal by Subject|3|||
164114033|NCT02722616|592780310|FG000|Overall Study|Sponsor closed study after one month|2|||
164114034|NCT02722616|592780311|FG001|Overall Study|Sponsor closed study after one month|0|||
164114035|NCT02722616|592780312|FG002|Overall Study|Sponsor closed study after one month|0|||
164114036|NCT01188226|592780315|FG000|Overall Study|Withdrawal by Subject|4|||
164114037|NCT04980456|592780316|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
164114038|NCT04980456|592780317|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
164114039|NCT04980456|592780316|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
164114040|NCT04980456|592780317|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
164114041|NCT04980456|592780316|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
164114042|NCT04980456|592780317|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
164114043|NCT04980456|592780316|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
164114044|NCT04980456|592780317|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
164114045|NCT02415387|592780325|FG000|Overall Study|Withdrawal by Subject|6|||
164132667|NCT01986010|592850663|FG008|Overall Study|Adverse Event|0|||
164073202|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
164073203|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
164073204|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
164073205|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
164073206|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
164073207|NCT03747939|592632838|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
164073208|NCT03747939|592632839|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
164073209|NCT03747939|592632840|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
164073210|NCT03747939|592632841|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
164073211|NCT03747939|592632838|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
164073212|NCT03747939|592632839|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
164073213|NCT03747939|592632840|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
164073214|NCT03747939|592632841|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
164073215|NCT03747939|592632838|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
164073216|NCT03747939|592632839|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
164073217|NCT03747939|592632840|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
164073218|NCT03747939|592632841|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
164073219|NCT03747939|592632838|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
164073220|NCT03747939|592632839|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
164073221|NCT03747939|592632840|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
164073222|NCT03747939|592632841|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
164073223|NCT03747939|592632838|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
164073224|NCT03747939|592632839|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
164073225|NCT03747939|592632840|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
164073226|NCT03747939|592632841|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
164073227|NCT03747939|592632838|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
164073228|NCT03747939|592632839|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
164073229|NCT03747939|592632840|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
164073230|NCT03747939|592632841|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
164073231|NCT03273712|592632842|FG000|Overall Study|Death|5|||
164073232|NCT03273712|592632842|FG000|Overall Study|Adverse Event|1|||
164073233|NCT03273712|592632842|FG000|Overall Study|Disease Progression|1|||
164073234|NCT03959137|592632845|FG000|Overall Study|Protocol Violation|6|||
164073235|NCT01542736|592632847|FG000|Overall Study|Death|1|||
164073236|NCT03674827|592632848|FG000|Treatment Phase|Adverse Event|0|||
164073237|NCT03674827|592632849|FG001|Treatment Phase|Adverse Event|0|||
164073238|NCT03674827|592632850|FG002|Treatment Phase|Adverse Event|0|||
164073239|NCT03674827|592632851|FG003|Treatment Phase|Adverse Event|0|||
164073240|NCT03674827|592632852|FG004|Treatment Phase|Adverse Event|0|||
164073241|NCT03674827|592632853|FG005|Treatment Phase|Adverse Event|2|||
164073242|NCT03674827|592632848|FG000|Treatment Phase|Death|2|||
164073243|NCT03674827|592632849|FG001|Treatment Phase|Death|0|||
164073244|NCT03674827|592632850|FG002|Treatment Phase|Death|0|||
164073245|NCT03674827|592632851|FG003|Treatment Phase|Death|0|||
164073246|NCT03674827|592632852|FG004|Treatment Phase|Death|1|||
164073247|NCT03674827|592632853|FG005|Treatment Phase|Death|0|||
164073248|NCT03674827|592632848|FG000|Treatment Phase|Progressive Disease|0|||
164073249|NCT03674827|592632849|FG001|Treatment Phase|Progressive Disease|4|||
164073250|NCT03674827|592632850|FG002|Treatment Phase|Progressive Disease|3|||
164073251|NCT03674827|592632851|FG003|Treatment Phase|Progressive Disease|4|||
164073252|NCT03674827|592632852|FG004|Treatment Phase|Progressive Disease|4|||
164073253|NCT03674827|592632853|FG005|Treatment Phase|Progressive Disease|9|||
164073254|NCT03674827|592632848|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
164073255|NCT03674827|592632849|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
164073256|NCT03674827|592632850|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
164073257|NCT03674827|592632851|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
164073258|NCT03674827|592632852|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
164073259|NCT03674827|592632853|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
164073260|NCT03674827|592632848|FG000|Treatment Phase|Withdrawal by Subject|0|||
164073261|NCT03674827|592632849|FG001|Treatment Phase|Withdrawal by Subject|0|||
164073262|NCT03674827|592632850|FG002|Treatment Phase|Withdrawal by Subject|0|||
164073263|NCT03674827|592632851|FG003|Treatment Phase|Withdrawal by Subject|0|||
164073264|NCT03674827|592632852|FG004|Treatment Phase|Withdrawal by Subject|0|||
164073265|NCT03674827|592632853|FG005|Treatment Phase|Withdrawal by Subject|1|||
164073266|NCT03674827|592632848|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
164073267|NCT03674827|592632849|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
164073268|NCT03674827|592632850|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
164073269|NCT03674827|592632851|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
164114046|NCT02415387|592780326|FG001|Overall Study|Withdrawal by Subject|1|||
164114047|NCT02415387|592780325|FG000|Overall Study|blood draw problem|0|||
164114048|NCT02415387|592780326|FG001|Overall Study|blood draw problem|1|||
164114049|NCT02415387|592780325|FG000|Overall Study|Protocol Violation|1|||
164114050|NCT02415387|592780326|FG001|Overall Study|Protocol Violation|0|||
164114051|NCT03687242|592780327|FG000|Overall Study|Adverse Event|1|||
164114052|NCT01151280|592780328|FG000|Overall Study|Adverse Event|1|||
164114053|NCT01151280|592780328|FG000|Overall Study|Lack of Efficacy|3|||
164114054|NCT02733627|592780330|FG000|Overall Study|Adverse Event|0|||
164114055|NCT02733627|592780331|FG001|Overall Study|Adverse Event|1|||
164114056|NCT02733627|592780332|FG002|Overall Study|Adverse Event|1|||
164114057|NCT02733627|592780333|FG003|Overall Study|Adverse Event|0|||
164114058|NCT02733627|592780330|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
164114059|NCT02733627|592780331|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
164114060|NCT02733627|592780332|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
164114061|NCT02733627|592780333|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
164114062|NCT02246764|592780334|FG000|Overall Study|Adverse Event|15|||
164114063|NCT02246764|592780335|FG001|Overall Study|Adverse Event|29|||
164114064|NCT02246764|592780336|FG002|Overall Study|Adverse Event|1|||
164114065|NCT02246764|592780334|FG000|Overall Study|Withdrawal by Subject|0|||
164114066|NCT02246764|592780335|FG001|Overall Study|Withdrawal by Subject|0|||
164114067|NCT02246764|592780336|FG002|Overall Study|Withdrawal by Subject|1|||
164114068|NCT02246764|592780334|FG000|Overall Study|Disallowed Concomitant Medication|1|||
164114069|NCT02246764|592780335|FG001|Overall Study|Disallowed Concomitant Medication|0|||
164114070|NCT02246764|592780336|FG002|Overall Study|Disallowed Concomitant Medication|0|||
164114071|NCT02246764|592780334|FG000|Overall Study|Physician Decision|0|||
164114072|NCT02246764|592780335|FG001|Overall Study|Physician Decision|2|||
164114073|NCT02246764|592780336|FG002|Overall Study|Physician Decision|1|||
164114074|NCT02246764|592780334|FG000|Overall Study|Protocol Violation|2|||
164114075|NCT02246764|592780335|FG001|Overall Study|Protocol Violation|1|||
164114076|NCT02246764|592780336|FG002|Overall Study|Protocol Violation|1|||
164114077|NCT05393271|592780337|FG000|Overall Study|Physician Decision|0|||
164114078|NCT05393271|592780338|FG001|Overall Study|Physician Decision|0|||
164114079|NCT05393271|592780339|FG002|Overall Study|Physician Decision|0|||
164114080|NCT05393271|592780340|FG003|Overall Study|Physician Decision|0|||
164114081|NCT05393271|592780341|FG004|Overall Study|Physician Decision|0|||
164114082|NCT05393271|592780342|FG005|Overall Study|Physician Decision|0|||
164114083|NCT05393271|592780343|FG006|Overall Study|Physician Decision|1|||
164114084|NCT05393271|592780344|FG007|Overall Study|Physician Decision|0|||
164114085|NCT05393271|592780345|FG008|Overall Study|Physician Decision|0|||
164114086|NCT05393271|592780346|FG009|Overall Study|Physician Decision|0|||
164114087|NCT05393271|592780347|FG010|Overall Study|Physician Decision|0|||
164114088|NCT02048813|592780348|FG000|Overall Study|Still on treatment|279|||
164114089|NCT02048813|592780349|FG001|Overall Study|Still on treatment|0|||
164114090|NCT02048813|592780348|FG000|Overall Study|Adverse Event|40|||
164114091|NCT02048813|592780349|FG001|Overall Study|Adverse Event|38|||
164114092|NCT02048813|592780348|FG000|Overall Study|Disease progression|13|||
164114093|NCT02048813|592780349|FG001|Overall Study|Disease progression|3|||
164114094|NCT02048813|592780348|FG000|Overall Study|Withdrawal by Subject|7|||
164114095|NCT02048813|592780349|FG001|Overall Study|Withdrawal by Subject|8|||
164114096|NCT02048813|592780348|FG000|Overall Study|Death|2|||
164114097|NCT02048813|592780349|FG001|Overall Study|Death|1|||
164114098|NCT02048813|592780348|FG000|Overall Study|Complication|2|||
164114099|NCT02048813|592780349|FG001|Overall Study|Complication|2|||
164114100|NCT02048813|592780348|FG000|Overall Study|Non-protocol therapy|0|||
164114101|NCT02048813|592780349|FG001|Overall Study|Non-protocol therapy|1|||
164114102|NCT02048813|592780348|FG000|Overall Study|Second primary cancer|2|||
164114103|NCT02048813|592780349|FG001|Overall Study|Second primary cancer|0|||
164114104|NCT02048813|592780348|FG000|Overall Study|Insurance|2|||
164114105|NCT02048813|592780349|FG001|Overall Study|Insurance|0|||
164114106|NCT02048813|592780348|FG000|Overall Study|Wound infection/healing|2|||
164114107|NCT02048813|592780349|FG001|Overall Study|Wound infection/healing|0|||
164114108|NCT02048813|592780348|FG000|Overall Study|Missed appointment|3|||
164114109|NCT02048813|592780349|FG001|Overall Study|Missed appointment|0|||
164114110|NCT02048813|592780348|FG000|Overall Study|Never started treatment|2|||
164114111|NCT02048813|592780349|FG001|Overall Study|Never started treatment|17|||
164114112|NCT03314857|592780353|FG000|Overall Study|Death|4|||
164114113|NCT03314857|592780353|FG000|Overall Study|Physician Decision|1|||
164114114|NCT02754492|592780354|FG000|Overall Study|Protocol Violation|2|||
164114115|NCT02754492|592780355|FG001|Overall Study|Protocol Violation|2|||
164114116|NCT02754492|592780356|FG002|Overall Study|Protocol Violation|0|||
164114117|NCT02754492|592780357|FG003|Overall Study|Protocol Violation|1|||
164114118|NCT02754492|592780354|FG000|Overall Study|Withdrawal by Subject|2|||
164114119|NCT02754492|592780355|FG001|Overall Study|Withdrawal by Subject|0|||
164114120|NCT02754492|592780356|FG002|Overall Study|Withdrawal by Subject|0|||
164114121|NCT02754492|592780357|FG003|Overall Study|Withdrawal by Subject|0|||
164114122|NCT02754492|592780354|FG000|Overall Study|Equipment malfuntion|0|||
164114123|NCT02754492|592780355|FG001|Overall Study|Equipment malfuntion|0|||
164114124|NCT02754492|592780356|FG002|Overall Study|Equipment malfuntion|2|||
164114125|NCT02754492|592780357|FG003|Overall Study|Equipment malfuntion|5|||
164114126|NCT02754492|592780354|FG000|Overall Study|Adverse Event|0|||
164114127|NCT02754492|592780355|FG001|Overall Study|Adverse Event|0|||
164114128|NCT02754492|592780356|FG002|Overall Study|Adverse Event|0|||
164114129|NCT02754492|592780357|FG003|Overall Study|Adverse Event|13|||
164114130|NCT02754492|592780354|FG000|Overall Study|Venous access issues not resulting in AE|0|||
164114131|NCT02754492|592780355|FG001|Overall Study|Venous access issues not resulting in AE|0|||
164114132|NCT02754492|592780356|FG002|Overall Study|Venous access issues not resulting in AE|0|||
164114133|NCT02754492|592780357|FG003|Overall Study|Venous access issues not resulting in AE|4|||
164114134|NCT01408888|592780358|FG000|First Intervention|Adverse Event|0|||
164114135|NCT01408888|592780359|FG001|First Intervention|Adverse Event|1|||
164114136|NCT01408888|592780358|FG000|First Intervention|Withdrawal by Subject|0|||
164114137|NCT01408888|592780359|FG001|First Intervention|Withdrawal by Subject|2|||
164114138|NCT01408888|592780358|FG000|Second Intervention|Withdrawal by Subject|1|||
164114139|NCT01408888|592780359|FG001|Second Intervention|Withdrawal by Subject|0|||
164114140|NCT01408888|592780358|FG000|Second Intervention|Adverse Event|1|||
164114141|NCT01408888|592780359|FG001|Second Intervention|Adverse Event|0|||
164114142|NCT01717313|592780360|FG000|Phase A (Weeks 0 to 24)|Death|0|||
164114143|NCT01717313|592780361|FG001|Phase A (Weeks 0 to 24)|Death|1|||
164114144|NCT01717313|592780360|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
164114145|NCT01717313|592780361|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
164114146|NCT01717313|592780360|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
164114147|NCT01717313|592780361|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
164114148|NCT01717313|592780360|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
164114149|NCT01717313|592780361|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
164114150|NCT01717313|592780360|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
164114151|NCT01717313|592780361|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
164114152|NCT01717313|592780360|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
164114153|NCT01717313|592780361|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
164114154|NCT01717313|592780360|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
164114155|NCT01717313|592780361|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
164114156|NCT01717313|592780360|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
164114157|NCT01717313|592780361|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
164114158|NCT01717313|592780360|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
164114159|NCT01717313|592780361|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
164114160|NCT01617096|592780366|FG000|Overall Study|Withdrawal by Subject|96|||
164114161|NCT01617096|592780367|FG001|Overall Study|Withdrawal by Subject|81|||
164114162|NCT01617096|592780366|FG000|Overall Study|Lost to Follow-up|37|||
164114163|NCT01617096|592780367|FG001|Overall Study|Lost to Follow-up|32|||
164114164|NCT01617096|592780366|FG000|Overall Study|Physician Decision|10|||
164114165|NCT01617096|592780367|FG001|Overall Study|Physician Decision|18|||
164114166|NCT01617096|592780366|FG000|Overall Study|Death|4|||
164114167|NCT01617096|592780367|FG001|Overall Study|Death|3|||
164114168|NCT01617096|592780366|FG000|Overall Study|Other|1|||
164114169|NCT01617096|592780367|FG001|Overall Study|Other|3|||
164114170|NCT01196390|592780370|FG000|Overall Study|Protocol Violation|4|||
164114171|NCT01196390|592780371|FG001|Overall Study|Protocol Violation|5|||
164114172|NCT01532908|592780372|FG000|Overall Study|Not Transplanted|1|||
164114173|NCT01532908|592780373|FG001|Overall Study|Not Transplanted|0|||
164114174|NCT00252564|592780374|FG000|Overall Study|Adverse Event|17|||
164114175|NCT00252564|592780375|FG001|Overall Study|Adverse Event|13|||
164114176|NCT00252564|592780374|FG000|Overall Study|Unrelated Complication|2|||
164114177|NCT00252564|592780375|FG001|Overall Study|Unrelated Complication|1|||
164114178|NCT00252564|592780374|FG000|Overall Study|Disease Progression|14|||
164114179|NCT00252564|592780375|FG001|Overall Study|Disease Progression|20|||
164114180|NCT00252564|592780374|FG000|Overall Study|Death|0|||
164114181|NCT00252564|592780375|FG001|Overall Study|Death|3|||
164114182|NCT00252564|592780374|FG000|Overall Study|Physician Decision|1|||
164114183|NCT00252564|592780375|FG001|Overall Study|Physician Decision|0|||
164114184|NCT00252564|592780374|FG000|Overall Study|Lost to Follow-up|1|||
164114185|NCT00252564|592780375|FG001|Overall Study|Lost to Follow-up|0|||
164114186|NCT00252564|592780374|FG000|Overall Study|Patient Request|4|||
164114187|NCT00252564|592780375|FG001|Overall Study|Patient Request|5|||
164114188|NCT00252564|592780374|FG000|Overall Study|Withdrawal by Subject|0|||
164114189|NCT00252564|592780375|FG001|Overall Study|Withdrawal by Subject|2|||
164114190|NCT03480022|592780376|FG000|Overall Study|Pregnancy|2|||
164114191|NCT03480022|592780377|FG001|Overall Study|Pregnancy|0|||
164114192|NCT03480022|592780376|FG000|Overall Study|Adverse Event|6|||
164114193|NCT03480022|592780377|FG001|Overall Study|Adverse Event|0|||
164114194|NCT03480022|592780376|FG000|Overall Study|Lack of Efficacy|0|||
164114195|NCT03480022|592780377|FG001|Overall Study|Lack of Efficacy|2|||
164114196|NCT03480022|592780376|FG000|Overall Study|Physician Decision|0|||
164114197|NCT03480022|592780377|FG001|Overall Study|Physician Decision|1|||
164114198|NCT03480022|592780376|FG000|Overall Study|Withdrawal by Subject|2|||
164114199|NCT03480022|592780377|FG001|Overall Study|Withdrawal by Subject|0|||
164114200|NCT03480022|592780376|FG000|Overall Study|Medication concerns|1|||
164114201|NCT03480022|592780377|FG001|Overall Study|Medication concerns|0|||
164114202|NCT03480022|592780376|FG000|Overall Study|Family member COVID exposure|0|||
164114203|NCT03480022|592780377|FG001|Overall Study|Family member COVID exposure|1|||
164114204|NCT00881569|592780378|FG000|Overall Study|Disease progression|1|||
164114205|NCT00881569|592780379|FG001|Overall Study|Disease progression|1|||
164114206|NCT04164758|592780380|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
164114207|NCT04164758|592780381|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
164114208|NCT04164758|592780382|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
164114209|NCT04164758|592780380|FG000|Overall Study|Adverse Event|0|||
164114210|NCT04164758|592780381|FG001|Overall Study|Adverse Event|1|||
164114211|NCT04164758|592780382|FG002|Overall Study|Adverse Event|0|||
164114212|NCT00697827|592780387|FG000|Overall Study|enrolled but not treated|2|||
164114213|NCT00697827|592780388|FG001|Overall Study|enrolled but not treated|1|||
164114214|NCT03259165|592780389|FG000|Overall Study|COVID 19 pandemic|1|||
164114215|NCT03259165|592780390|FG001|Overall Study|COVID 19 pandemic|1|||
164114216|NCT03732833|592780391|FG000|Overall Study|Adverse Event|0|||
164114217|NCT03732833|592780392|FG001|Overall Study|Adverse Event|3|||
164114218|NCT03732833|592780393|FG002|Overall Study|Adverse Event|1|||
164114219|NCT03732833|592780391|FG000|Overall Study|Withdrawal by Subject|11|||
164114220|NCT03732833|592780392|FG001|Overall Study|Withdrawal by Subject|13|||
164114221|NCT03732833|592780393|FG002|Overall Study|Withdrawal by Subject|8|||
164114222|NCT03732833|592780391|FG000|Overall Study|Lost to Follow-up|3|||
164114223|NCT03732833|592780392|FG001|Overall Study|Lost to Follow-up|5|||
164114224|NCT03732833|592780393|FG002|Overall Study|Lost to Follow-up|4|||
164114225|NCT03732833|592780391|FG000|Overall Study|Pregnancy|0|||
164114226|NCT03732833|592780392|FG001|Overall Study|Pregnancy|2|||
164114227|NCT03732833|592780393|FG002|Overall Study|Pregnancy|0|||
164114228|NCT03732833|592780391|FG000|Overall Study|Physician Decision|2|||
164114229|NCT03732833|592780392|FG001|Overall Study|Physician Decision|3|||
164114230|NCT03732833|592780393|FG002|Overall Study|Physician Decision|1|||
164114231|NCT03732833|592780391|FG000|Overall Study|Covid-19 related and other reasons|2|||
164114232|NCT03732833|592780392|FG001|Overall Study|Covid-19 related and other reasons|7|||
164114233|NCT03732833|592780393|FG002|Overall Study|Covid-19 related and other reasons|3|||
164114234|NCT01567527|592780396|FG000|Conversion Phase.|Protocol deviation|3|||
164114235|NCT01567527|592780397|FG001|Conversion Phase.|Protocol deviation|0|||
164114236|NCT01567527|592780398|FG002|Conversion Phase.|Protocol deviation|0|||
164114237|NCT01567527|592780399|FG003|Conversion Phase.|Protocol deviation|0|||
164114238|NCT01567527|592780400|FG004|Conversion Phase.|Protocol deviation|0|||
164114239|NCT01567527|592780396|FG000|Conversion Phase.|Met withdrawal criteria|10|||
164114240|NCT01567527|592780397|FG001|Conversion Phase.|Met withdrawal criteria|0|||
164114241|NCT01567527|592780398|FG002|Conversion Phase.|Met withdrawal criteria|0|||
164114242|NCT01567527|592780399|FG003|Conversion Phase.|Met withdrawal criteria|0|||
164114243|NCT01567527|592780400|FG004|Conversion Phase.|Met withdrawal criteria|0|||
164114244|NCT01567527|592780396|FG000|Conversion Phase.|Withdrawal by Subject|32|||
164114245|NCT01567527|592780397|FG001|Conversion Phase.|Withdrawal by Subject|0|||
164114246|NCT01567527|592780398|FG002|Conversion Phase.|Withdrawal by Subject|0|||
164114247|NCT01567527|592780399|FG003|Conversion Phase.|Withdrawal by Subject|0|||
164114248|NCT01567527|592780400|FG004|Conversion Phase.|Withdrawal by Subject|0|||
164114249|NCT01567527|592780396|FG000|Conversion Phase.|Lost to Follow-up|16|||
164114250|NCT01567527|592780397|FG001|Conversion Phase.|Lost to Follow-up|0|||
164114251|NCT01567527|592780398|FG002|Conversion Phase.|Lost to Follow-up|0|||
164114252|NCT01567527|592780399|FG003|Conversion Phase.|Lost to Follow-up|0|||
164114253|NCT01567527|592780400|FG004|Conversion Phase.|Lost to Follow-up|0|||
164114254|NCT01567527|592780396|FG000|Conversion Phase.|Lack of Efficacy|2|||
164114255|NCT01567527|592780397|FG001|Conversion Phase.|Lack of Efficacy|0|||
164114256|NCT01567527|592780398|FG002|Conversion Phase.|Lack of Efficacy|0|||
164114257|NCT01567527|592780399|FG003|Conversion Phase.|Lack of Efficacy|0|||
164114258|NCT01567527|592780400|FG004|Conversion Phase.|Lack of Efficacy|0|||
164114259|NCT01567527|592780396|FG000|Conversion Phase.|Adverse Event|33|||
164114260|NCT01567527|592780397|FG001|Conversion Phase.|Adverse Event|0|||
164114261|NCT01567527|592780398|FG002|Conversion Phase.|Adverse Event|0|||
164114262|NCT01567527|592780399|FG003|Conversion Phase.|Adverse Event|0|||
164114263|NCT01567527|592780400|FG004|Conversion Phase.|Adverse Event|0|||
164114264|NCT01567527|592780396|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
164114265|NCT01567527|592780397|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
164114266|NCT01567527|592780398|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
164114267|NCT01567527|592780399|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
164114268|NCT01567527|592780400|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
164114269|NCT01567527|592780396|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164114270|NCT01567527|592780397|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
164114271|NCT01567527|592780398|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164114272|NCT01567527|592780399|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164114273|NCT01567527|592780400|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
164114274|NCT01567527|592780396|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164114275|NCT01567527|592780397|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
164114276|NCT01567527|592780398|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164114277|NCT01567527|592780399|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164114278|NCT01567527|592780400|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
164114279|NCT01567527|592780396|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164114280|NCT01567527|592780397|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
164114281|NCT01567527|592780398|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164114282|NCT01567527|592780399|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164114283|NCT01567527|592780400|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
164114284|NCT01567527|592780396|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164114285|NCT01567527|592780397|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
164114286|NCT01567527|592780398|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164114287|NCT01567527|592780399|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164114288|NCT01567527|592780400|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
164114289|NCT01567527|592780396|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164114290|NCT01567527|592780397|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
164114291|NCT01567527|592780398|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164114292|NCT01567527|592780399|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164114293|NCT01567527|592780400|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
164114294|NCT01567527|592780396|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164114295|NCT01567527|592780397|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
164114296|NCT01567527|592780398|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164114297|NCT01567527|592780399|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164114298|NCT01567527|592780400|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
164114299|NCT01567527|592780396|FG000|IM Depot Stabilization.|Protocol deviation|0|||
164114300|NCT01567527|592780397|FG001|IM Depot Stabilization.|Protocol deviation|0|||
164114301|NCT01567527|592780398|FG002|IM Depot Stabilization.|Protocol deviation|5|||
164114302|NCT01567527|592780399|FG003|IM Depot Stabilization.|Protocol deviation|0|||
164114303|NCT01567527|592780400|FG004|IM Depot Stabilization.|Protocol deviation|0|||
164114304|NCT01567527|592780396|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
164114305|NCT01567527|592780397|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
164114306|NCT01567527|592780398|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
164114307|NCT01567527|592780399|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
164114308|NCT01567527|592780400|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
164114309|NCT01567527|592780396|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
164114310|NCT01567527|592780397|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
164114311|NCT01567527|592780398|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
164114312|NCT01567527|592780399|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
164114313|NCT01567527|592780400|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
164114314|NCT01567527|592780396|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
164114315|NCT01567527|592780397|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
164114316|NCT01567527|592780398|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
164114317|NCT01567527|592780399|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
164114318|NCT01567527|592780400|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
164114319|NCT01567527|592780396|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
164114320|NCT01567527|592780397|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
164114321|NCT01567527|592780398|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
164114322|NCT01567527|592780399|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
164114323|NCT01567527|592780400|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
164114324|NCT01567527|592780396|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
164114325|NCT01567527|592780397|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
164114326|NCT01567527|592780398|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
164114327|NCT01567527|592780399|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
164114328|NCT01567527|592780400|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
164114329|NCT01567527|592780396|FG000|IM Depot Stabilization.|Adverse Event|0|||
164114330|NCT01567527|592780397|FG001|IM Depot Stabilization.|Adverse Event|0|||
164114331|NCT01567527|592780398|FG002|IM Depot Stabilization.|Adverse Event|37|||
164114332|NCT01567527|592780399|FG003|IM Depot Stabilization.|Adverse Event|0|||
164114333|NCT01567527|592780400|FG004|IM Depot Stabilization.|Adverse Event|0|||
164114334|NCT01567527|592780396|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164114335|NCT01567527|592780397|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164114336|NCT01567527|592780398|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
164114337|NCT01567527|592780399|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164114338|NCT01567527|592780400|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
164114339|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
164114340|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
164114341|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
164132668|NCT01986010|592850664|FG009|Overall Study|Adverse Event|0|||
164114342|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
164114343|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
164114344|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
164114345|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
164114346|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
164114347|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
164114348|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
164114349|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
164114350|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
164114351|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
164114352|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
164114353|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
164114354|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
164114355|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
164114356|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
164114357|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
164114358|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
164114359|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164114360|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164114361|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
164114362|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
164114363|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
164114364|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
164114365|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
164114366|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
164114367|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
164114368|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
164114369|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
164114370|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
164114371|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
164114372|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
164114373|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
164114374|NCT01567527|592780396|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164114375|NCT01567527|592780397|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164114376|NCT01567527|592780398|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
164114377|NCT01567527|592780399|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
164114378|NCT01567527|592780400|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
164114379|NCT02004691|592780401|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
164114380|NCT02004691|592780402|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
164114381|NCT02004691|592780401|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
164114382|NCT02004691|592780402|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
164114383|NCT02004691|592780401|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
164114384|NCT02004691|592780402|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
164114385|NCT02004691|592780401|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
164114386|NCT02004691|592780402|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
164114387|NCT02004691|592780401|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
164114388|NCT02004691|592780402|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
164114389|NCT02004691|592780401|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
164114390|NCT02004691|592780402|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
164114391|NCT01726803|592780403|FG000|Overall Study|Lost to Follow-up|6|||
164114392|NCT01726803|592780404|FG001|Overall Study|Lost to Follow-up|1|||
164114393|NCT01726803|592780403|FG000|Overall Study|Withdrawal by Subject|1|||
164114394|NCT01726803|592780404|FG001|Overall Study|Withdrawal by Subject|0|||
164114395|NCT01970592|592780406|FG000|Overall Study|Withdrawal by Subject|4|||
164114396|NCT01970592|592780406|FG000|Overall Study|Physician Decision|1|||
164114397|NCT01970592|592780406|FG000|Overall Study|Adverse Event|1|||
164114398|NCT03980522|592780409|FG000|Treatment Period|Adverse Event|1|||
164114399|NCT03980522|592780410|FG001|Treatment Period|Adverse Event|0|||
164114400|NCT03980522|592780411|FG002|Treatment Period|Adverse Event|0|||
164114401|NCT03980522|592780412|FG003|Treatment Period|Adverse Event|0|||
164114402|NCT03980522|592780413|FG004|Treatment Period|Adverse Event|0|||
164114403|NCT01320722|592780414|FG000|Overall Study|Did not Receive Intervention|3|||
164114404|NCT01320722|592780415|FG001|Overall Study|Did not Receive Intervention|2|||
164114405|NCT01320722|592780416|FG002|Overall Study|Did not Receive Intervention|1|||
164114406|NCT01320722|592780417|FG003|Overall Study|Did not Receive Intervention|1|||
164114407|NCT01320722|592780418|FG004|Overall Study|Did not Receive Intervention|2|||
164114408|NCT01320722|592780414|FG000|Overall Study|Lost to Follow-up|0|||
164114409|NCT01320722|592780415|FG001|Overall Study|Lost to Follow-up|1|||
164114410|NCT01320722|592780416|FG002|Overall Study|Lost to Follow-up|0|||
164114411|NCT01320722|592780417|FG003|Overall Study|Lost to Follow-up|1|||
164114412|NCT01320722|592780418|FG004|Overall Study|Lost to Follow-up|3|||
164114413|NCT01320722|592780414|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
164114414|NCT01320722|592780415|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
164114415|NCT01320722|592780416|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
164114416|NCT01320722|592780417|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
164114417|NCT01320722|592780418|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
164114418|NCT01320722|592780414|FG000|Overall Study|Participant Developed a Rash|0|||
164114419|NCT01320722|592780415|FG001|Overall Study|Participant Developed a Rash|0|||
164114420|NCT01320722|592780416|FG002|Overall Study|Participant Developed a Rash|2|||
164114421|NCT01320722|592780417|FG003|Overall Study|Participant Developed a Rash|1|||
164114422|NCT01320722|592780418|FG004|Overall Study|Participant Developed a Rash|1|||
164114423|NCT01320722|592780414|FG000|Overall Study|Non-compliant with Medication|0|||
164114424|NCT01320722|592780415|FG001|Overall Study|Non-compliant with Medication|0|||
164114425|NCT01320722|592780416|FG002|Overall Study|Non-compliant with Medication|1|||
164114426|NCT01320722|592780417|FG003|Overall Study|Non-compliant with Medication|0|||
164114427|NCT01320722|592780418|FG004|Overall Study|Non-compliant with Medication|0|||
164114428|NCT01320722|592780414|FG000|Overall Study|Adverse Event|0|||
164114429|NCT01320722|592780415|FG001|Overall Study|Adverse Event|0|||
164114430|NCT01320722|592780416|FG002|Overall Study|Adverse Event|3|||
164114431|NCT01320722|592780417|FG003|Overall Study|Adverse Event|6|||
164114432|NCT01320722|592780418|FG004|Overall Study|Adverse Event|0|||
164114433|NCT01320722|592780414|FG000|Overall Study|Not Compliant with Study Procedures|0|||
164114434|NCT01320722|592780415|FG001|Overall Study|Not Compliant with Study Procedures|0|||
164114435|NCT01320722|592780416|FG002|Overall Study|Not Compliant with Study Procedures|0|||
164114436|NCT01320722|592780417|FG003|Overall Study|Not Compliant with Study Procedures|4|||
164114437|NCT01320722|592780418|FG004|Overall Study|Not Compliant with Study Procedures|0|||
164114438|NCT01320722|592780414|FG000|Overall Study|Pregnancy|0|||
164114439|NCT01320722|592780415|FG001|Overall Study|Pregnancy|0|||
164114440|NCT01320722|592780416|FG002|Overall Study|Pregnancy|0|||
164114441|NCT01320722|592780417|FG003|Overall Study|Pregnancy|1|||
164114442|NCT01320722|592780418|FG004|Overall Study|Pregnancy|0|||
164114443|NCT01320722|592780414|FG000|Overall Study|Started an Exclusionary Medication|0|||
164114444|NCT01320722|592780415|FG001|Overall Study|Started an Exclusionary Medication|0|||
164114445|NCT01320722|592780416|FG002|Overall Study|Started an Exclusionary Medication|0|||
164114446|NCT01320722|592780417|FG003|Overall Study|Started an Exclusionary Medication|0|||
164114447|NCT01320722|592780418|FG004|Overall Study|Started an Exclusionary Medication|1|||
164114448|NCT01320722|592780414|FG000|Overall Study|Withdrew due to Health Condition|0|||
164114449|NCT01320722|592780415|FG001|Overall Study|Withdrew due to Health Condition|0|||
164114450|NCT01320722|592780416|FG002|Overall Study|Withdrew due to Health Condition|0|||
164114451|NCT01320722|592780417|FG003|Overall Study|Withdrew due to Health Condition|0|||
164114452|NCT01320722|592780418|FG004|Overall Study|Withdrew due to Health Condition|1|||
164114453|NCT01091363|592780419|FG000|Overall Study|Withdrawal by Subject|11|||
164114454|NCT01091363|592780420|FG001|Overall Study|Withdrawal by Subject|15|||
164114455|NCT01091363|592780419|FG000|Overall Study|Lost to Follow-up|2|||
164114456|NCT01091363|592780420|FG001|Overall Study|Lost to Follow-up|2|||
164114457|NCT00160524|592780421|FG000|Overall Study|Adverse Event|119|||
164114458|NCT00160524|592780421|FG000|Overall Study|Adverse Event and Other|94|||
164114459|NCT00160524|592780421|FG000|Overall Study|Protocol Violation|16|||
164114460|NCT00160524|592780421|FG000|Overall Study|Protocol Violation and Other|2|||
164114461|NCT00160524|592780421|FG000|Overall Study|Withdrawal by Subject|141|||
164114462|NCT00160524|592780421|FG000|Overall Study|Withdrawal by Subject and Other|17|||
164114463|NCT00160524|592780421|FG000|Overall Study|Physician Decision|27|||
164114464|NCT00160524|592780421|FG000|Overall Study|Physician Decision and Other|6|||
164114465|NCT00160524|592780421|FG000|Overall Study|Lost to Follow-up|13|||
164114466|NCT00160524|592780421|FG000|Overall Study|Lost to Follow-up and Other|1|||
164114467|NCT00160524|592780421|FG000|Overall Study|Lack of Efficacy|21|||
164114468|NCT00160524|592780421|FG000|Overall Study|Lack of Efficacy and Other|1|||
164114469|NCT00160524|592780421|FG000|Overall Study|Other|20|||
164114470|NCT04892147|592780422|FG000|Overall Study|Withdrawal by Subject|2|||
164114471|NCT04892147|592780423|FG001|Overall Study|Withdrawal by Subject|0|||
164114472|NCT01215721|592780425|FG000|Overall Study|Adverse Event|2|||
164114473|NCT00045162|592780426|FG000|Overall Study|Ineligible|12|||
164114474|NCT00045162|592780427|FG001|Overall Study|Ineligible|8|||
164114475|NCT00045162|592780426|FG000|Overall Study|Not treated|7|||
164114476|NCT00045162|592780427|FG001|Overall Study|Not treated|2|||
164114477|NCT00045162|592780426|FG000|Overall Study|Adverse Event|55|||
164114478|NCT00045162|592780427|FG001|Overall Study|Adverse Event|50|||
164114479|NCT00045162|592780426|FG000|Overall Study|Lack of Efficacy|32|||
164114480|NCT00045162|592780427|FG001|Overall Study|Lack of Efficacy|29|||
164114481|NCT00045162|592780426|FG000|Overall Study|Death|10|||
164114482|NCT00045162|592780427|FG001|Overall Study|Death|10|||
164114483|NCT00045162|592780426|FG000|Overall Study|Withdrawal by Subject|5|||
164114484|NCT00045162|592780427|FG001|Overall Study|Withdrawal by Subject|3|||
164114485|NCT00045162|592780426|FG000|Overall Study|Other|21|||
164114486|NCT00045162|592780427|FG001|Overall Study|Other|16|||
164114487|NCT01044433|592780428|FG000|Overall Study|Lost to Follow-up|3|||
164114488|NCT01044433|592780428|FG000|Overall Study|Withdrawal by Subject|3|||
164114489|NCT05263505|592780429|FG000|Overall Study|Adverse Event|0|||
164114490|NCT05263505|592780430|FG001|Overall Study|Adverse Event|1|||
164114491|NCT00826241|592780431|FG000|Overall Study|Withdrawal from Follow-up|1|||
164114492|NCT00826241|592780431|FG000|Overall Study|Withdrew consent|2|||
164114493|NCT00826241|592780431|FG000|Overall Study|Death|4|||
164114494|NCT00826241|592780431|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
164114495|NCT00826241|592780431|FG000|Overall Study|Non-compliance|1|||
164114496|NCT00826241|592780431|FG000|Overall Study|Progression of disease|1|||
164114497|NCT00826241|592780431|FG000|Overall Study|Patient refused follow-up|3|||
164114498|NCT00826241|592780431|FG000|Overall Study|Lost to Follow-up|9|||
164114499|NCT00826241|592780431|FG000|Overall Study|Could not obtain records|1|||
164114500|NCT00826241|592780431|FG000|Overall Study|Screen failure|2|||
164114501|NCT00826241|592780431|FG000|Overall Study|Pt unable to proceed to registration|1|||
164114502|NCT00826241|592780431|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
164114503|NCT03407729|592780432|FG000|Overall Study|Lost to Follow-up|2|||
164114504|NCT03407729|592780433|FG001|Overall Study|Lost to Follow-up|0|||
164114505|NCT03407729|592780432|FG000|Overall Study|Unable to schedule|0|||
164114506|NCT03407729|592780433|FG001|Overall Study|Unable to schedule|3|||
164114507|NCT01849458|592780434|FG000|Overall Study|Lost to Follow-up|4|||
164114508|NCT01050764|592780437|FG000|Overall Study|Death, before HSCT|1|||
164114509|NCT01050764|592780437|FG000|Overall Study|Donor mobilization failure, death|1|||
164114510|NCT01050764|592780437|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
164114511|NCT00360490|592780442|FG000|Overall Study|Adverse Event|4|||
164114512|NCT00360490|592780443|FG001|Overall Study|Adverse Event|2|||
164114513|NCT00360490|592780442|FG000|Overall Study|Lost to Follow-up|2|||
164114514|NCT00360490|592780443|FG001|Overall Study|Lost to Follow-up|1|||
164114515|NCT00360490|592780442|FG000|Overall Study|Physician Decision|2|||
164114516|NCT00360490|592780443|FG001|Overall Study|Physician Decision|1|||
164114517|NCT00360490|592780442|FG000|Overall Study|Protocol Violation|0|||
164114518|NCT00360490|592780443|FG001|Overall Study|Protocol Violation|4|||
164114519|NCT00360490|592780442|FG000|Overall Study|Withdrawal by Subject|1|||
164114520|NCT00360490|592780443|FG001|Overall Study|Withdrawal by Subject|3|||
164114521|NCT02289820|592780444|FG000|Overall Study|Withdrawal by Subject|2|||
164114522|NCT02289820|592780445|FG001|Overall Study|Withdrawal by Subject|1|||
164114523|NCT02289820|592780446|FG002|Overall Study|Withdrawal by Subject|2|||
164114524|NCT02289820|592780447|FG003|Overall Study|Withdrawal by Subject|1|||
164114525|NCT02289820|592780448|FG004|Overall Study|Withdrawal by Subject|0|||
164114526|NCT02289820|592780449|FG005|Overall Study|Withdrawal by Subject|0|||
164114527|NCT02289820|592780450|FG006|Overall Study|Withdrawal by Subject|1|||
164114528|NCT02289820|592780444|FG000|Overall Study|Death|0|||
164114529|NCT02289820|592780445|FG001|Overall Study|Death|0|||
164114530|NCT02289820|592780446|FG002|Overall Study|Death|1|||
164114531|NCT02289820|592780447|FG003|Overall Study|Death|0|||
164114532|NCT02289820|592780448|FG004|Overall Study|Death|0|||
164114533|NCT02289820|592780449|FG005|Overall Study|Death|0|||
164114534|NCT02289820|592780450|FG006|Overall Study|Death|0|||
164114535|NCT02289820|592780444|FG000|Overall Study|Lost to Follow-up|0|||
164114536|NCT02289820|592780445|FG001|Overall Study|Lost to Follow-up|0|||
164114537|NCT02289820|592780446|FG002|Overall Study|Lost to Follow-up|3|||
164114538|NCT02289820|592780447|FG003|Overall Study|Lost to Follow-up|1|||
164114539|NCT02289820|592780448|FG004|Overall Study|Lost to Follow-up|0|||
164114540|NCT02289820|592780449|FG005|Overall Study|Lost to Follow-up|1|||
164114541|NCT02289820|592780450|FG006|Overall Study|Lost to Follow-up|1|||
164114542|NCT02289820|592780444|FG000|Overall Study|withdrawal of consent|0|||
164114543|NCT02289820|592780445|FG001|Overall Study|withdrawal of consent|1|||
164114544|NCT02289820|592780446|FG002|Overall Study|withdrawal of consent|0|||
164114545|NCT02289820|592780447|FG003|Overall Study|withdrawal of consent|0|||
164114546|NCT02289820|592780448|FG004|Overall Study|withdrawal of consent|0|||
164114547|NCT02289820|592780449|FG005|Overall Study|withdrawal of consent|0|||
164114548|NCT02289820|592780450|FG006|Overall Study|withdrawal of consent|0|||
164114549|NCT02005276|592780451|FG000|Overall Study|No longer interested|5|||
164114550|NCT02005276|592780452|FG001|Overall Study|No longer interested|2|||
164114551|NCT02005276|592780453|FG002|Overall Study|No longer interested|3|||
164114552|NCT02005276|592780454|FG003|Overall Study|No longer interested|3|||
164114553|NCT01688882|592780461|FG000|Overall Study|Adverse Event|1|||
164114554|NCT01688882|592780462|FG001|Overall Study|Adverse Event|0|||
164114555|NCT01688882|592780461|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164114556|NCT01688882|592780462|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164114557|NCT01688882|592780461|FG000|Overall Study|Administrative problems|1|||
164114558|NCT01688882|592780462|FG001|Overall Study|Administrative problems|0|||
164114559|NCT00556673|592780464|FG000|Overall Study|Protocol deviation|3|||
164114560|NCT00556673|592780465|FG001|Overall Study|Protocol deviation|2|||
164114561|NCT01971554|592780466|FG000|Overall Study|Lost to Follow-up|1|||
164114562|NCT01971554|592780467|FG001|Overall Study|Lost to Follow-up|0|||
164114563|NCT01971554|592780468|FG002|Overall Study|Lost to Follow-up|0|||
164114564|NCT01971554|592780469|FG003|Overall Study|Lost to Follow-up|0|||
164114565|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
164114566|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
164114567|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
164114568|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
164114569|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
164114570|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
164114571|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
164114572|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
164114573|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
164114574|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
164114575|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
164114576|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
164114577|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
164114578|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
164114579|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
164114580|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
164114581|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
164114582|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
164114583|NCT00950300|592780470|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
164114584|NCT00950300|592780471|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
164114585|NCT00950300|592780470|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
164114586|NCT00950300|592780471|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
164114587|NCT00950300|592780470|FG000|TFFU Period|Death|4|||
164114588|NCT00950300|592780471|FG001|TFFU Period|Death|1|||
164114589|NCT00950300|592780470|FG000|TFFU Period|Refused Treatment|10|||
164114590|NCT00950300|592780471|FG001|TFFU Period|Refused Treatment|11|||
164114591|NCT00950300|592780470|FG000|TFFU Period|Failure to Return|16|||
164114592|NCT00950300|592780471|FG001|TFFU Period|Failure to Return|16|||
164114593|NCT00950300|592780470|FG000|TFFU Period|Recurrence of Disease|63|||
164114594|NCT00950300|592780471|FG001|TFFU Period|Recurrence of Disease|72|||
164114595|NCT00950300|592780470|FG000|TFFU Period|Other|4|||
164114596|NCT00950300|592780471|FG001|TFFU Period|Other|3|||
164114597|NCT00950300|592780470|FG000|SFU Period|Death|44|||
164114598|NCT00950300|592780471|FG001|SFU Period|Death|42|||
164114599|NCT00950300|592780470|FG000|SFU Period|Lost to Follow-up|30|||
164114600|NCT00950300|592780471|FG001|SFU Period|Lost to Follow-up|28|||
164114601|NCT00950300|592780470|FG000|SFU Period|Withdrawal by Subject|4|||
164114602|NCT00950300|592780471|FG001|SFU Period|Withdrawal by Subject|8|||
164114603|NCT04388787|592780473|FG000|Blinded Period|Patient could not follow instructions|1|||
164114604|NCT04388787|592780473|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
164114605|NCT02129062|592782136|FG000|Overall Study|Death|1|||
164114606|NCT02129062|592782136|FG000|Overall Study|Disease Progression|2|||
164114607|NCT04662710|592782137|FG000|Overall Study|Death|14|||
164114608|NCT04662710|592782138|FG001|Overall Study|Death|331|||
164114609|NCT04662710|592782139|FG002|Overall Study|Death|367|||
164114610|NCT04662710|592782137|FG000|Overall Study|Ongoing|1|||
164114611|NCT04662710|592782138|FG001|Overall Study|Ongoing|109|||
164114612|NCT04662710|592782139|FG002|Overall Study|Ongoing|56|||
164114613|NCT04662710|592782137|FG000|Overall Study|Withdrawal by Subject|0|||
164114614|NCT04662710|592782138|FG001|Overall Study|Withdrawal by Subject|3|||
164114615|NCT04662710|592782139|FG002|Overall Study|Withdrawal by Subject|14|||
164132669|NCT01986010|592850665|FG010|Overall Study|Adverse Event|0|||
164073270|NCT03674827|592632852|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
164073271|NCT03674827|592632853|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
164073272|NCT03674827|592632848|FG000|Treatment Phase|Other|0|||
164073273|NCT03674827|592632849|FG001|Treatment Phase|Other|1|||
164073274|NCT03674827|592632850|FG002|Treatment Phase|Other|0|||
164073275|NCT03674827|592632851|FG003|Treatment Phase|Other|0|||
164073276|NCT03674827|592632852|FG004|Treatment Phase|Other|0|||
164073277|NCT03674827|592632853|FG005|Treatment Phase|Other|1|||
164073278|NCT03674827|592632848|FG000|Long-Term Follow-up Phase|Death|2|||
164073279|NCT03674827|592632849|FG001|Long-Term Follow-up Phase|Death|4|||
164073280|NCT03674827|592632850|FG002|Long-Term Follow-up Phase|Death|2|||
164073281|NCT03674827|592632851|FG003|Long-Term Follow-up Phase|Death|3|||
164073282|NCT03674827|592632852|FG004|Long-Term Follow-up Phase|Death|2|||
164073283|NCT03674827|592632853|FG005|Long-Term Follow-up Phase|Death|6|||
164073284|NCT03674827|592632848|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
164073285|NCT03674827|592632849|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
164073286|NCT03674827|592632850|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
164114616|NCT00224484|592782141|FG000|Overall Study|Serious Adverse Event|1|||
164114617|NCT00224484|592782142|FG001|Overall Study|Serious Adverse Event|1|||
164114618|NCT00224484|592782143|FG002|Overall Study|Serious Adverse Event|0|||
164114619|NCT00224484|592782141|FG000|Overall Study|Non-Serious Adverse Event|5|||
164114620|NCT00224484|592782142|FG001|Overall Study|Non-Serious Adverse Event|7|||
164114621|NCT00224484|592782143|FG002|Overall Study|Non-Serious Adverse Event|3|||
164114622|NCT00224484|592782141|FG000|Overall Study|Protocol Violation|2|||
164114623|NCT00224484|592782142|FG001|Overall Study|Protocol Violation|2|||
164114624|NCT00224484|592782143|FG002|Overall Study|Protocol Violation|0|||
164114625|NCT00224484|592782141|FG000|Overall Study|Withdrawal by Subject|49|||
164114626|NCT00224484|592782142|FG001|Overall Study|Withdrawal by Subject|18|||
164114627|NCT00224484|592782143|FG002|Overall Study|Withdrawal by Subject|16|||
164114628|NCT00224484|592782141|FG000|Overall Study|Migrated/moved from study area|18|||
164114629|NCT00224484|592782142|FG001|Overall Study|Migrated/moved from study area|5|||
164114630|NCT00224484|592782143|FG002|Overall Study|Migrated/moved from study area|5|||
164114631|NCT00224484|592782141|FG000|Overall Study|Lost to Follow-up|66|||
164114632|NCT00224484|592782142|FG001|Overall Study|Lost to Follow-up|28|||
164114633|NCT00224484|592782143|FG002|Overall Study|Lost to Follow-up|36|||
164114634|NCT00224484|592782141|FG000|Overall Study|Reason not specified|5|||
164114635|NCT00224484|592782142|FG001|Overall Study|Reason not specified|4|||
164114636|NCT00224484|592782143|FG002|Overall Study|Reason not specified|2|||
164114637|NCT00108628|592782146|FG000|Overall Study|Withdrawal by Subject|17|||
164114638|NCT00108628|592782147|FG001|Overall Study|Withdrawal by Subject|9|||
164114639|NCT00108628|592782146|FG000|Overall Study|Lack of Efficacy|2|||
164114640|NCT00108628|592782147|FG001|Overall Study|Lack of Efficacy|1|||
164114641|NCT00108628|592782146|FG000|Overall Study|Death|1|||
164114642|NCT00108628|592782147|FG001|Overall Study|Death|0|||
164114643|NCT01453153|592782148|FG000|Overall Study|Physician Decision|0|||
164114644|NCT01453153|592782149|FG001|Overall Study|Physician Decision|0|||
164114645|NCT01453153|592782150|FG002|Overall Study|Physician Decision|1|||
164114646|NCT01453153|592782148|FG000|Overall Study|Progressive Disease|3|||
164114647|NCT01453153|592782149|FG001|Overall Study|Progressive Disease|2|||
164114648|NCT01453153|592782150|FG002|Overall Study|Progressive Disease|16|||
164114649|NCT01453153|592782148|FG000|Overall Study|Withdrawal by Subject|0|||
164114650|NCT01453153|592782149|FG001|Overall Study|Withdrawal by Subject|1|||
164114651|NCT01453153|592782150|FG002|Overall Study|Withdrawal by Subject|2|||
164114652|NCT01453153|592782148|FG000|Overall Study|Adverse Event|1|||
164114653|NCT01453153|592782149|FG001|Overall Study|Adverse Event|1|||
164114654|NCT01453153|592782150|FG002|Overall Study|Adverse Event|1|||
164114655|NCT03547635|592782153|FG000|Overall Study|Adverse Event|5|||
164114656|NCT03547635|592782154|FG001|Overall Study|Adverse Event|2|||
164114657|NCT03547635|592782155|FG002|Overall Study|Adverse Event|3|||
164114658|NCT03547635|592782153|FG000|Overall Study|Lost to Follow-up|1|||
164114659|NCT03547635|592782154|FG001|Overall Study|Lost to Follow-up|3|||
164114660|NCT03547635|592782155|FG002|Overall Study|Lost to Follow-up|4|||
164114661|NCT03547635|592782153|FG000|Overall Study|Withdrawal by Subject|1|||
164114662|NCT03547635|592782154|FG001|Overall Study|Withdrawal by Subject|0|||
164114663|NCT03547635|592782155|FG002|Overall Study|Withdrawal by Subject|0|||
164114664|NCT03547635|592782153|FG000|Overall Study|Withdrawal By PI|0|||
164114665|NCT03547635|592782154|FG001|Overall Study|Withdrawal By PI|1|||
164114666|NCT03547635|592782155|FG002|Overall Study|Withdrawal By PI|0|||
164114667|NCT03547635|592782153|FG000|Overall Study|Withdrawal by Sponsor|0|||
164114668|NCT03547635|592782154|FG001|Overall Study|Withdrawal by Sponsor|0|||
164114669|NCT03547635|592782155|FG002|Overall Study|Withdrawal by Sponsor|1|||
164114670|NCT03547635|592782153|FG000|Overall Study|Errant Randomization before Treatment|0|||
164114671|NCT03547635|592782154|FG001|Overall Study|Errant Randomization before Treatment|1|||
164114672|NCT03547635|592782155|FG002|Overall Study|Errant Randomization before Treatment|0|||
164114673|NCT03547635|592782153|FG000|Overall Study|Withdrawal by Subject|1|||
164114674|NCT03547635|592782154|FG001|Overall Study|Withdrawal by Subject|0|||
164114675|NCT03547635|592782155|FG002|Overall Study|Withdrawal by Subject|0|||
164114676|NCT03243396|592782156|FG000|Overall Study|Lost to Follow-up|2|||
164114677|NCT03243396|592782157|FG001|Overall Study|Lost to Follow-up|3|||
164114678|NCT03243396|592782158|FG002|Overall Study|Lost to Follow-up|15|||
164114679|NCT03243396|592782159|FG003|Overall Study|Lost to Follow-up|8|||
164114680|NCT03243396|592782160|FG004|Overall Study|Lost to Follow-up|1|||
164114681|NCT03243396|592782161|FG005|Overall Study|Lost to Follow-up|4|||
164114682|NCT03243396|592782162|FG006|Overall Study|Lost to Follow-up|9|||
164114683|NCT02473393|592782163|FG000|Overall Study|Adverse Event|0|||
164114684|NCT02473393|592782164|FG001|Overall Study|Adverse Event|0|||
164114685|NCT02473393|592782165|FG002|Overall Study|Adverse Event|1|||
164114686|NCT02473393|592782166|FG003|Overall Study|Adverse Event|0|||
164114687|NCT02473393|592782163|FG000|Overall Study|Withdrawal by Subject|0|||
164114688|NCT02473393|592782164|FG001|Overall Study|Withdrawal by Subject|0|||
164114689|NCT02473393|592782165|FG002|Overall Study|Withdrawal by Subject|1|||
164114690|NCT02473393|592782166|FG003|Overall Study|Withdrawal by Subject|1|||
164114691|NCT02274558|592782170|FG000|Overall Study|Adverse Event|2|||
164114692|NCT02274558|592782171|FG001|Overall Study|Adverse Event|4|||
164114693|NCT02274558|592782172|FG002|Overall Study|Adverse Event|2|||
164114694|NCT02274558|592782170|FG000|Overall Study|Non-compliance|2|||
164114695|NCT02274558|592782171|FG001|Overall Study|Non-compliance|1|||
164114696|NCT02274558|592782172|FG002|Overall Study|Non-compliance|0|||
164114697|NCT02274558|592782170|FG000|Overall Study|Withdrawal by Subject|1|||
164114698|NCT02274558|592782171|FG001|Overall Study|Withdrawal by Subject|5|||
164114699|NCT02274558|592782172|FG002|Overall Study|Withdrawal by Subject|4|||
164114700|NCT02274558|592782170|FG000|Overall Study|Death|0|||
164114701|NCT02274558|592782171|FG001|Overall Study|Death|0|||
164114702|NCT02274558|592782172|FG002|Overall Study|Death|1|||
164114703|NCT02274558|592782170|FG000|Overall Study|Lost to Follow-up|2|||
164114704|NCT02274558|592782171|FG001|Overall Study|Lost to Follow-up|1|||
164114705|NCT02274558|592782172|FG002|Overall Study|Lost to Follow-up|1|||
164114706|NCT02274558|592782170|FG000|Overall Study|Physician Decision|0|||
164114707|NCT02274558|592782171|FG001|Overall Study|Physician Decision|2|||
164114708|NCT02274558|592782172|FG002|Overall Study|Physician Decision|1|||
164114709|NCT05996198|592782177|FG000|Overall Study|Withdrawal by Subject|1|||
164114710|NCT05996198|592782178|FG001|Overall Study|Withdrawal by Subject|0|||
164114711|NCT00059332|592782182|FG000|Overall Study|Withdrawal by Subject|2|||
164114712|NCT00059332|592782183|FG001|Overall Study|Withdrawal by Subject|1|||
164114713|NCT00059332|592782182|FG000|Overall Study|Lost to Follow-up|1|||
164114714|NCT00059332|592782183|FG001|Overall Study|Lost to Follow-up|1|||
164114715|NCT00487695|592782186|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
164114716|NCT00487695|592782187|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
164114717|NCT00487695|592782186|FG000|First Procedure|active wheezing (did not have procedure)|1|||
164114718|NCT00487695|592782187|FG001|First Procedure|active wheezing (did not have procedure)|0|||
164114719|NCT00487695|592782186|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
164114720|NCT00487695|592782187|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
164114721|NCT00487695|592782186|FG000|Second Procedure|active wheezing|0|||
164114722|NCT00487695|592782187|FG001|Second Procedure|active wheezing|1|||
164114723|NCT00487695|592782186|FG000|Second Procedure|Withdrawal by Subject|1|||
164114724|NCT00487695|592782187|FG001|Second Procedure|Withdrawal by Subject|2|||
164114725|NCT01358877|592782188|FG000|Overall Study|Withdrawal by Subject|475|||
164114726|NCT01358877|592782189|FG001|Overall Study|Withdrawal by Subject|466|||
164114727|NCT01358877|592782188|FG000|Overall Study|Recurrence of disease|181|||
164114728|NCT01358877|592782189|FG001|Overall Study|Recurrence of disease|269|||
164114729|NCT01358877|592782188|FG000|Overall Study|Lost to Follow-up|181|||
164114730|NCT01358877|592782189|FG001|Overall Study|Lost to Follow-up|176|||
164114731|NCT01358877|592782188|FG000|Overall Study|Death|41|||
164114732|NCT01358877|592782189|FG001|Overall Study|Death|46|||
164114733|NCT01358877|592782188|FG000|Overall Study|Adverse Event|39|||
164114734|NCT01358877|592782189|FG001|Overall Study|Adverse Event|42|||
164114735|NCT01358877|592782188|FG000|Overall Study|Physician Decision|43|||
164114736|NCT01358877|592782189|FG001|Overall Study|Physician Decision|32|||
164114737|NCT01358877|592782188|FG000|Overall Study|Contralateral breast cancer|42|||
164114738|NCT01358877|592782189|FG001|Overall Study|Contralateral breast cancer|28|||
164114739|NCT01358877|592782188|FG000|Overall Study|Reason not specified|37|||
164114740|NCT01358877|592782189|FG001|Overall Study|Reason not specified|29|||
164114741|NCT00397254|592782190|FG000|Overall Study|Lost to Follow-up|2|||
164114742|NCT00397254|592782191|FG001|Overall Study|Lost to Follow-up|2|||
164114743|NCT00152451|592782194|FG000|Overall Study|Adverse Event|4|||
164114744|NCT00323258|592782197|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
164114745|NCT00323258|592782198|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
164114746|NCT00323258|592782197|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
164114747|NCT00323258|592782198|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
164114748|NCT00323258|592782197|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
164114749|NCT00323258|592782198|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
164114750|NCT00323258|592782197|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
164114751|NCT00323258|592782198|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
164114752|NCT00323258|592782197|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
164114753|NCT00323258|592782198|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
164114754|NCT00323258|592782197|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
164114755|NCT00323258|592782198|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
164114756|NCT00323258|592782197|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
164114757|NCT00323258|592782198|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
164114758|NCT04473326|592782203|FG000|Overall Study|Death|0|||
164114759|NCT04473326|592782204|FG001|Overall Study|Death|1|||
164114760|NCT04473326|592782203|FG000|Overall Study|Withdrawal by Subject|1|||
164114761|NCT04473326|592782204|FG001|Overall Study|Withdrawal by Subject|2|||
164114762|NCT02046122|592782205|FG000|Overall Study|Physician Decision|8|||
164114763|NCT02046122|592782205|FG000|Overall Study|Withdrawal by Subject|1|||
164114764|NCT01097694|592782210|FG000|Overall Study|Adverse Event|5|||
164114765|NCT01097694|592782211|FG001|Overall Study|Adverse Event|0|||
164114766|NCT01097694|592782210|FG000|Overall Study|Lost to Follow-up|0|||
164114767|NCT01097694|592782211|FG001|Overall Study|Lost to Follow-up|3|||
164132670|NCT01986010|592850666|FG011|Overall Study|Adverse Event|0|||
164114768|NCT01097694|592782210|FG000|Overall Study|Withdrawal by Subject|3|||
164114769|NCT01097694|592782211|FG001|Overall Study|Withdrawal by Subject|1|||
164114770|NCT00668395|592782213|FG000|Overall Study|Withdrawal by Subject|4|||
164114771|NCT00668395|592782214|FG001|Overall Study|Withdrawal by Subject|4|||
164114772|NCT00668395|592782215|FG002|Overall Study|Withdrawal by Subject|1|||
164114773|NCT00668395|592782213|FG000|Overall Study|Adverse Event|1|||
164114774|NCT00668395|592782214|FG001|Overall Study|Adverse Event|1|||
164114775|NCT00668395|592782215|FG002|Overall Study|Adverse Event|0|||
164114776|NCT00668395|592782213|FG000|Overall Study|Physician Decision|1|||
164114777|NCT00668395|592782214|FG001|Overall Study|Physician Decision|1|||
164114778|NCT00668395|592782215|FG002|Overall Study|Physician Decision|0|||
164114779|NCT00766493|592782216|FG000|30 Days Post-Procedure|Discontinued|7|||
164114780|NCT00766493|592782216|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
164114781|NCT00766493|592782216|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
164114782|NCT00024258|592782217|FG000|Overall Study|Withdrawal by Subject|1|||
164114783|NCT00024258|592782217|FG000|Overall Study|Disease Progression|8|||
164114784|NCT01863433|592782218|FG000|Overall Study|Protocol Violation|1|||
164114785|NCT03950674|592782219|FG000|Overall Study|Death|16|||
164114786|NCT03950674|592782220|FG001|Overall Study|Death|15|||
164114787|NCT03950674|592782219|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
164114788|NCT03950674|592782220|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
164114789|NCT00830167|592782223|FG000|Overall Study|Lack of Efficacy|26|||
164114790|NCT00830167|592782224|FG001|Overall Study|Lack of Efficacy|10|||
164114791|NCT00830167|592782223|FG000|Overall Study|Adverse Event|8|||
164114792|NCT00830167|592782224|FG001|Overall Study|Adverse Event|24|||
164114793|NCT00830167|592782223|FG000|Overall Study|Not meeting entrance criteria|2|||
164114794|NCT00830167|592782224|FG001|Overall Study|Not meeting entrance criteria|5|||
164114795|NCT00830167|592782223|FG000|Overall Study|Withdrawal by Subject|2|||
164114796|NCT00830167|592782224|FG001|Overall Study|Withdrawal by Subject|0|||
164114797|NCT00830167|592782223|FG000|Overall Study|Lost to Follow-up|0|||
164114798|NCT00830167|592782224|FG001|Overall Study|Lost to Follow-up|1|||
164114799|NCT00830167|592782223|FG000|Overall Study|Protocol Violation|0|||
164114800|NCT00830167|592782224|FG001|Overall Study|Protocol Violation|1|||
164114801|NCT00830167|592782223|FG000|Overall Study|Other|2|||
164114802|NCT00830167|592782224|FG001|Overall Study|Other|2|||
164114803|NCT03428945|592782225|FG000|Overall Study|Lost to Follow-up|5|||
164114804|NCT03428945|592782226|FG001|Overall Study|Lost to Follow-up|3|||
164114805|NCT03428945|592782225|FG000|Overall Study|Withdrawal by Subject|10|||
164114806|NCT03428945|592782226|FG001|Overall Study|Withdrawal by Subject|10|||
164114807|NCT00982228|592782227|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
164114808|NCT00982228|592782228|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
164114809|NCT00982228|592782227|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
164114810|NCT00982228|592782228|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
164114811|NCT00982228|592782227|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
164114812|NCT00982228|592782228|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
164114813|NCT00982228|592782227|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
164114814|NCT00982228|592782228|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
164114815|NCT00982228|592782227|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
164114816|NCT00982228|592782228|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
164114817|NCT00982228|592782227|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
164114818|NCT00982228|592782228|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
164114819|NCT00982228|592782227|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
164114820|NCT00982228|592782228|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
164114821|NCT00982228|592782227|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
164114822|NCT00982228|592782228|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
164114823|NCT00982228|592782227|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
164114824|NCT00982228|592782228|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
164114825|NCT00982228|592782227|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
164114826|NCT00982228|592782228|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
164114827|NCT01801917|592782232|FG000|Period 1 - Randomized|Adverse Event|1|||
164114828|NCT01801917|592782233|FG001|Period 1 - Randomized|Adverse Event|0|||
164114829|NCT01801917|592782234|FG002|Period 1 - Randomized|Adverse Event|1|||
164114830|NCT01801917|592782235|FG003|Period 1 - Randomized|Adverse Event|0|||
164114831|NCT01924364|592782236|FG000|Overall Study|Physician Decision|3|||
164114832|NCT00265785|592782237|FG000|Overall Study|Adverse Event|4|||
164114833|NCT00265785|592782237|FG000|Overall Study|Withdrawal by Subject|3|||
164114834|NCT00265785|592782237|FG000|Overall Study|Progression/Relapse|15|||
164114835|NCT00265785|592782237|FG000|Overall Study|Not protocol specified|2|||
164114836|NCT00265785|592782237|FG000|Overall Study|Ineligible|1|||
164114837|NCT00265785|592782237|FG000|Overall Study|Did not receive protocol treatment|2|||
164114838|NCT03919695|592782238|FG000|3-month Follow-up|Death|1|||
164114839|NCT03919695|592782239|FG001|3-month Follow-up|Death|1|||
164114840|NCT03919695|592782238|FG000|3-month Follow-up|unable to contact|0|||
164114841|NCT03919695|592782239|FG001|3-month Follow-up|unable to contact|3|||
164114842|NCT03919695|592782238|FG000|3-month Follow-up|in prison|0|||
164114843|NCT03919695|592782239|FG001|3-month Follow-up|in prison|1|||
164114844|NCT03919695|592782238|FG000|6-month Follow-up|Death|0|||
164114845|NCT03919695|592782239|FG001|6-month Follow-up|Death|1|||
164114846|NCT03919695|592782238|FG000|6-month Follow-up|Lost to Follow-up|1|||
164114847|NCT03919695|592782239|FG001|6-month Follow-up|Lost to Follow-up|2|||
164114848|NCT03919695|592782238|FG000|6-month Follow-up|in prison|0|||
164114849|NCT03919695|592782239|FG001|6-month Follow-up|in prison|2|||
164114850|NCT03919695|592782238|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
164114851|NCT03919695|592782239|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
164114852|NCT03919695|592782238|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
164114853|NCT03919695|592782239|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
164114854|NCT04750239|592782240|FG000|Overall Study|Withdrawal by Subject|2|||
164114855|NCT04750239|592782240|FG000|Overall Study|Trial terminated by sponsor|1|||
164114856|NCT01912807|592782241|FG000|Overall Study|Did not meet elegibility criteria|6|||
164114857|NCT01912807|592782242|FG001|Overall Study|Did not meet elegibility criteria|4|||
164114858|NCT01912807|592782241|FG000|Overall Study|Lost to Follow-up|36|||
164114859|NCT01912807|592782242|FG001|Overall Study|Lost to Follow-up|37|||
164114860|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Adverse Event|8|||
164114861|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Adverse Event|5|||
164114862|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Adverse Event|9|||
164114863|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Adverse Event|0|||
164114864|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Adverse Event|0|||
164114865|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Adverse Event|0|||
164114866|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
164114867|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
164114868|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
164114869|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
164114870|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
164114871|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
164114872|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
164114873|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
164114874|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
164114875|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
164114876|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
164114877|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
164114878|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Physician Decision|4|||
164114879|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Physician Decision|0|||
164114880|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Physician Decision|2|||
164114881|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Physician Decision|0|||
164114882|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Physician Decision|0|||
164114883|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Physician Decision|0|||
164114884|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Pregnancy|1|||
164114885|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Pregnancy|2|||
164114886|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Pregnancy|0|||
164114887|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Pregnancy|0|||
164114888|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Pregnancy|0|||
164114889|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Pregnancy|0|||
164114890|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
164114891|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
164114892|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
164114893|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
164114894|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
164114895|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
164114896|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
164114897|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
164114898|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
164114899|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
164114900|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
164114901|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
164114902|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
164114903|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
164114904|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
164114905|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
164114906|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164114907|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
164114908|NCT02614196|592782243|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
164114909|NCT02614196|592782244|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
164114910|NCT02614196|592782245|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
164114911|NCT02614196|592782246|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
164114912|NCT02614196|592782247|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
164114913|NCT02614196|592782248|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
164114914|NCT02614196|592782243|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
164114915|NCT02614196|592782244|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
164114916|NCT02614196|592782245|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
164114917|NCT02614196|592782246|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
164114918|NCT02614196|592782247|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
164114919|NCT02614196|592782248|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
164114920|NCT02614196|592782243|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
164114921|NCT02614196|592782244|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
164114922|NCT02614196|592782245|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
164114923|NCT02614196|592782246|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
164114924|NCT02614196|592782247|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
164114925|NCT02614196|592782248|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
164114926|NCT02614196|592782243|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
164114927|NCT02614196|592782244|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
164114928|NCT02614196|592782245|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
164114929|NCT02614196|592782246|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
164114930|NCT02614196|592782247|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
164114931|NCT02614196|592782248|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
164114932|NCT02614196|592782243|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
164114933|NCT02614196|592782244|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
164114934|NCT02614196|592782245|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
164114935|NCT02614196|592782246|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
164114936|NCT02614196|592782247|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
164114937|NCT02614196|592782248|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
164114938|NCT01539239|592782249|FG000|Overall Study|Death|5|||
164114939|NCT01539239|592782250|FG001|Overall Study|Death|5|||
164114940|NCT01539239|592782249|FG000|Overall Study|Lost to Follow-up|7|||
164114941|NCT01539239|592782250|FG001|Overall Study|Lost to Follow-up|12|||
164114942|NCT00633022|592782253|FG000|Overall Study|Adverse Event|1|||
164114943|NCT00633022|592782254|FG001|Overall Study|Adverse Event|0|||
164114944|NCT00633022|592782255|FG002|Overall Study|Adverse Event|5|||
164114945|NCT00633022|592782253|FG000|Overall Study|Physician Decision|0|||
164114946|NCT00633022|592782254|FG001|Overall Study|Physician Decision|1|||
164114947|NCT00633022|592782255|FG002|Overall Study|Physician Decision|0|||
164114948|NCT03382041|592782256|FG000|Overall Study|Consent Form Lost|2|||
164114949|NCT03382041|592782257|FG001|Overall Study|Consent Form Lost|1|||
164114950|NCT03382041|592782256|FG000|Overall Study|Withdrawal by Subject|1|||
164114951|NCT03382041|592782257|FG001|Overall Study|Withdrawal by Subject|4|||
164114952|NCT03382041|592782256|FG000|Overall Study|Lost to Follow-up|1|||
164114953|NCT03382041|592782257|FG001|Overall Study|Lost to Follow-up|4|||
164114954|NCT01374451|592782258|FG000|Overall Study|Administrative problems|1|||
164114955|NCT01374451|592782259|FG001|Overall Study|Administrative problems|0|||
164114956|NCT04640194|592782260|FG000|Overall Study|Adverse Event|3|||
164114957|NCT04640194|592782261|FG001|Overall Study|Adverse Event|7|||
164114958|NCT04640194|592782262|FG002|Overall Study|Adverse Event|0|||
164114959|NCT04640194|592782263|FG003|Overall Study|Adverse Event|5|||
164114960|NCT04640194|592782264|FG004|Overall Study|Adverse Event|0|||
164114961|NCT04640194|592782265|FG005|Overall Study|Adverse Event|4|||
164114962|NCT04640194|592782266|FG006|Overall Study|Adverse Event|0|||
164114963|NCT04640194|592782260|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
164114964|NCT04640194|592782261|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
164114965|NCT04640194|592782262|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
164114966|NCT04640194|592782263|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
164114967|NCT04640194|592782264|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
164114968|NCT04640194|592782265|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
164114969|NCT04640194|592782266|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
164114970|NCT04640194|592782260|FG000|Overall Study|fibrinogen level too low|0|||
164114971|NCT04640194|592782261|FG001|Overall Study|fibrinogen level too low|0|||
164114972|NCT04640194|592782262|FG002|Overall Study|fibrinogen level too low|0|||
164114973|NCT04640194|592782263|FG003|Overall Study|fibrinogen level too low|1|||
164114974|NCT04640194|592782264|FG004|Overall Study|fibrinogen level too low|0|||
164114975|NCT04640194|592782265|FG005|Overall Study|fibrinogen level too low|0|||
164114976|NCT04640194|592782266|FG006|Overall Study|fibrinogen level too low|0|||
164114977|NCT04640194|592782260|FG000|Overall Study|mild bleeding|0|||
164114978|NCT04640194|592782261|FG001|Overall Study|mild bleeding|0|||
164114979|NCT04640194|592782262|FG002|Overall Study|mild bleeding|0|||
164114980|NCT04640194|592782263|FG003|Overall Study|mild bleeding|1|||
164114981|NCT04640194|592782264|FG004|Overall Study|mild bleeding|0|||
164114982|NCT04640194|592782265|FG005|Overall Study|mild bleeding|0|||
164114983|NCT04640194|592782266|FG006|Overall Study|mild bleeding|0|||
164114984|NCT04640194|592782260|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164114985|NCT04640194|592782261|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
164114986|NCT04640194|592782262|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164132671|NCT01986010|592850667|FG012|Overall Study|Adverse Event|0|||
164114987|NCT04640194|592782263|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164114988|NCT04640194|592782264|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164114989|NCT04640194|592782265|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164114990|NCT04640194|592782266|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
164114991|NCT03201003|592782267|FG000|Overall Study|Adverse Event|14|||
164114992|NCT03201003|592782268|FG001|Overall Study|Adverse Event|1|||
164114993|NCT03201003|592782267|FG000|Overall Study|Other reasons|5|||
164114994|NCT03201003|592782268|FG001|Overall Study|Other reasons|1|||
164114995|NCT03201003|592782267|FG000|Overall Study|Withdrawal by Subject|4|||
164114996|NCT03201003|592782268|FG001|Overall Study|Withdrawal by Subject|1|||
164114997|NCT03201003|592782267|FG000|Overall Study|Lost to Follow-up|2|||
164114998|NCT03201003|592782268|FG001|Overall Study|Lost to Follow-up|0|||
164114999|NCT03201003|592782267|FG000|Overall Study|Protocol Violation|1|||
164115000|NCT03201003|592782268|FG001|Overall Study|Protocol Violation|0|||
164115001|NCT00834613|592782269|FG000|First Intervention|Protocol Violation|1|||
164115002|NCT00834613|592782270|FG001|First Intervention|Protocol Violation|0|||
164115003|NCT00663234|592782271|FG000|Overall Study|Not willing to adhere to requirements|1|||
164115004|NCT01253564|592782277|FG000|Overall Study|Disease Progression|22|||
164115005|NCT01253564|592782277|FG000|Overall Study|Withdrawal by Subject|1|||
164115006|NCT01253564|592782277|FG000|Overall Study|Serious Adverse Event|1|||
164115007|NCT04584983|592782279|FG000|Overall Study|Parental request for withdraw|2|||
164115008|NCT04584983|592782280|FG001|Overall Study|Parental request for withdraw|0|||
164115009|NCT05377489|592782281|FG000|Overall Study|Withdrawal by Subject|122|||
164115010|NCT05377489|592782281|FG000|Overall Study|Lost to Follow-up|21|||
164115011|NCT05377489|592782281|FG000|Overall Study|Lack of Efficacy|10|||
164115012|NCT05377489|592782281|FG000|Overall Study|Adverse Event|5|||
164115013|NCT05377489|592782281|FG000|Overall Study|Death|4|||
164115014|NCT05377489|592782281|FG000|Overall Study|Physician Decision|3|||
164115015|NCT05377489|592782281|FG000|Overall Study|Protocol Violation|1|||
164115016|NCT05377489|592782281|FG000|Overall Study|Other|9|||
164115017|NCT00697619|592782291|FG000|Overall Study|Lack of Efficacy|2|||
164115018|NCT00697619|592782292|FG001|Overall Study|Lack of Efficacy|2|||
164115019|NCT00697619|592782291|FG000|Overall Study|Adverse Event|4|||
164115020|NCT00697619|592782292|FG001|Overall Study|Adverse Event|6|||
164115021|NCT00559637|592783681|FG000|Overall Study|Adverse Event|22|||
164115022|NCT00559637|592783681|FG000|Overall Study|Withdrawal by Subject|4|||
164115023|NCT00559637|592783681|FG000|Overall Study|Protocol Violation|6|||
164115024|NCT00559637|592783681|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
164115025|NCT00559637|592783681|FG000|Overall Study|Failure to return|6|||
164115026|NCT00559637|592783681|FG000|Overall Study|Insufficient response|3|||
164115027|NCT00559637|592783681|FG000|Overall Study|Started requiring dialysis after month 7|2|||
164115028|NCT00559637|592783681|FG000|Overall Study|Suspected lung cancer|1|||
164115029|NCT00559637|592783681|FG000|Overall Study|Participation in another study|1|||
164115030|NCT00559637|592783681|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
164115031|NCT00559637|592783681|FG000|Overall Study|Change of center|1|||
164115032|NCT00559637|592783681|FG000|Overall Study|Change of home|1|||
164115033|NCT00559637|592783681|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
164115034|NCT01705717|592783683|FG000|Overall Study|Adverse Event|2|||
164115035|NCT01705717|592783684|FG001|Overall Study|Adverse Event|2|||
164115036|NCT01705717|592783683|FG000|Overall Study|Lack of Efficacy|0|||
164115037|NCT01705717|592783684|FG001|Overall Study|Lack of Efficacy|1|||
164115038|NCT01705717|592783683|FG000|Overall Study|Other|0|||
164115039|NCT01705717|592783684|FG001|Overall Study|Other|2|||
164115040|NCT02031237|592783685|FG000|Overall Study|Death|1|||
164115041|NCT02031237|592783686|FG001|Overall Study|Death|5|||
164115042|NCT02031237|592783687|FG002|Overall Study|Death|0|||
164115043|NCT02031237|592783685|FG000|Overall Study|Physician Decision|0|||
164115044|NCT02031237|592783686|FG001|Overall Study|Physician Decision|1|||
164115045|NCT02031237|592783687|FG002|Overall Study|Physician Decision|0|||
164115046|NCT02031237|592783685|FG000|Overall Study|Withdrawal by Subject|2|||
164115047|NCT02031237|592783686|FG001|Overall Study|Withdrawal by Subject|2|||
164115048|NCT02031237|592783687|FG002|Overall Study|Withdrawal by Subject|0|||
164115049|NCT02031237|592783685|FG000|Overall Study|Protocol Violation|2|||
164115050|NCT02031237|592783686|FG001|Overall Study|Protocol Violation|6|||
164115051|NCT02031237|592783687|FG002|Overall Study|Protocol Violation|0|||
164115052|NCT02031237|592783685|FG000|Overall Study|Alternate Treatment Given|0|||
164115053|NCT02031237|592783686|FG001|Overall Study|Alternate Treatment Given|0|||
164115054|NCT02031237|592783687|FG002|Overall Study|Alternate Treatment Given|3|||
164115055|NCT02293460|592783688|FG000|Overall Study|Protocol Violation|1|||
164115056|NCT02293460|592783688|FG000|Overall Study|Lack of Efficacy|2|||
164115057|NCT02293460|592783688|FG000|Overall Study|Adverse Event|2|||
164115058|NCT02293460|592783688|FG000|Overall Study|Withdrawal by Subject|1|||
164115059|NCT01074008|592783693|FG000|Overall Study|Adverse Event|0|||
164115060|NCT01074008|592783694|FG001|Overall Study|Adverse Event|1|||
164115061|NCT01074008|592783695|FG002|Overall Study|Adverse Event|0|||
164115062|NCT01074008|592783696|FG003|Overall Study|Adverse Event|0|||
164115063|NCT01074008|592783697|FG004|Overall Study|Adverse Event|0|||
164115064|NCT01074008|592783698|FG005|Overall Study|Adverse Event|0|||
164115065|NCT01074008|592783699|FG006|Overall Study|Adverse Event|0|||
164115066|NCT01074008|592783700|FG007|Overall Study|Adverse Event|0|||
164115067|NCT01074008|592783701|FG008|Overall Study|Adverse Event|0|||
164115068|NCT01074008|592783693|FG000|Overall Study|Withdrawal by Subject|1|||
164115069|NCT01074008|592783694|FG001|Overall Study|Withdrawal by Subject|1|||
164115070|NCT01074008|592783695|FG002|Overall Study|Withdrawal by Subject|1|||
164115071|NCT01074008|592783696|FG003|Overall Study|Withdrawal by Subject|0|||
164115072|NCT01074008|592783697|FG004|Overall Study|Withdrawal by Subject|1|||
164115073|NCT01074008|592783698|FG005|Overall Study|Withdrawal by Subject|0|||
164115074|NCT01074008|592783699|FG006|Overall Study|Withdrawal by Subject|0|||
164115075|NCT01074008|592783700|FG007|Overall Study|Withdrawal by Subject|0|||
164115076|NCT01074008|592783701|FG008|Overall Study|Withdrawal by Subject|0|||
164115077|NCT01074008|592783693|FG000|Overall Study|Lost to Follow-up|0|||
164115078|NCT01074008|592783694|FG001|Overall Study|Lost to Follow-up|1|||
164115079|NCT01074008|592783695|FG002|Overall Study|Lost to Follow-up|1|||
164115080|NCT01074008|592783696|FG003|Overall Study|Lost to Follow-up|1|||
164115081|NCT01074008|592783697|FG004|Overall Study|Lost to Follow-up|1|||
164115082|NCT01074008|592783698|FG005|Overall Study|Lost to Follow-up|0|||
164115083|NCT01074008|592783699|FG006|Overall Study|Lost to Follow-up|1|||
164115084|NCT01074008|592783700|FG007|Overall Study|Lost to Follow-up|0|||
164115085|NCT01074008|592783701|FG008|Overall Study|Lost to Follow-up|4|||
164115086|NCT02805309|592783704|FG000|Overall Study|Lost to Follow-up|2|||
164115087|NCT02805309|592783705|FG001|Overall Study|Lost to Follow-up|2|||
164115088|NCT02805309|592783706|FG002|Overall Study|Lost to Follow-up|2|||
164115089|NCT02805309|592783704|FG000|Overall Study|Post-Randomization Exclusion|0|||
164115090|NCT02805309|592783705|FG001|Overall Study|Post-Randomization Exclusion|2|||
164115091|NCT02805309|592783706|FG002|Overall Study|Post-Randomization Exclusion|1|||
164115092|NCT01636934|592783707|FG000|Overall Study|Withdrawal by Subject|3|||
164115093|NCT01636934|592783708|FG001|Overall Study|Withdrawal by Subject|2|||
164115094|NCT01636934|592783707|FG000|Overall Study|Chemo cancel|1|||
164115095|NCT01636934|592783708|FG001|Overall Study|Chemo cancel|0|||
164115096|NCT01636934|592783707|FG000|Overall Study|Too ill to continue|1|||
164115097|NCT01636934|592783708|FG001|Overall Study|Too ill to continue|0|||
164115098|NCT01636934|592783707|FG000|Overall Study|Never started study medication|1|||
164115099|NCT01636934|592783708|FG001|Overall Study|Never started study medication|1|||
164115100|NCT03035890|592783722|FG000|Overall Study|Death|1|||
164115101|NCT05480800|592783726|FG000|Overall Study|Withdrawal by Subject|0|||
164115102|NCT05480800|592783727|FG001|Overall Study|Withdrawal by Subject|0|||
164115103|NCT05480800|592783728|FG002|Overall Study|Withdrawal by Subject|2|||
164115104|NCT05480800|592783729|FG003|Overall Study|Withdrawal by Subject|1|||
164115105|NCT05480800|592783730|FG004|Overall Study|Withdrawal by Subject|0|||
164115106|NCT05480800|592783731|FG005|Overall Study|Withdrawal by Subject|0|||
164115107|NCT05480800|592783732|FG006|Overall Study|Withdrawal by Subject|1|||
164115108|NCT05480800|592783733|FG007|Overall Study|Withdrawal by Subject|0|||
164115109|NCT05480800|592783726|FG000|Overall Study|Other|0|||
164115110|NCT05480800|592783727|FG001|Overall Study|Other|0|||
164115111|NCT05480800|592783728|FG002|Overall Study|Other|0|||
164115112|NCT05480800|592783729|FG003|Overall Study|Other|0|||
164115113|NCT05480800|592783730|FG004|Overall Study|Other|0|||
164115114|NCT05480800|592783731|FG005|Overall Study|Other|0|||
164115115|NCT05480800|592783732|FG006|Overall Study|Other|1|||
164115116|NCT05480800|592783733|FG007|Overall Study|Other|0|||
164115117|NCT00377156|592783738|FG000|Overall Study|Death|23|||
164115118|NCT00377156|592783739|FG001|Overall Study|Death|19|||
164115119|NCT00377156|592783738|FG000|Overall Study|Withdrawal by Subject|16|||
164115120|NCT00377156|592783739|FG001|Overall Study|Withdrawal by Subject|24|||
164115121|NCT00377156|592783738|FG000|Overall Study|Had follow-up <90 d|3|||
164115122|NCT00377156|592783739|FG001|Overall Study|Had follow-up <90 d|6|||
164115123|NCT00377156|592783738|FG000|Overall Study|Cancellation|1|||
164115124|NCT00377156|592783739|FG001|Overall Study|Cancellation|0|||
164115125|NCT00377156|592783738|FG000|Overall Study|Refused testing|0|||
164115126|NCT00377156|592783739|FG001|Overall Study|Refused testing|1|||
164115127|NCT00377156|592783738|FG000|Overall Study|Ineligible|0|||
164115128|NCT00377156|592783739|FG001|Overall Study|Ineligible|1|||
164115129|NCT00377156|592783738|FG000|Overall Study|Disability or language problem|0|||
164115130|NCT00377156|592783739|FG001|Overall Study|Disability or language problem|1|||
164115131|NCT00377156|592783738|FG000|Overall Study|Other|5|||
164115132|NCT00377156|592783739|FG001|Overall Study|Other|2|||
164115133|NCT00288704|592783740|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
164115134|NCT00288704|592783741|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
164115135|NCT00288704|592783742|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
164115136|NCT00288704|592783740|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
164115137|NCT00288704|592783741|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
164115138|NCT00288704|592783742|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
164115139|NCT00288704|592783740|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
164115140|NCT00288704|592783741|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
164132672|NCT01986010|592850668|FG013|Overall Study|Adverse Event|0|||
164115141|NCT00288704|592783742|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
164115142|NCT00288704|592783740|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
164115143|NCT00288704|592783741|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
164115144|NCT00288704|592783742|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
164115145|NCT00288704|592783740|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
164115146|NCT00288704|592783741|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
164115147|NCT00288704|592783742|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
164115148|NCT00288704|592783740|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
164115149|NCT00288704|592783741|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
164115150|NCT00288704|592783742|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
164115151|NCT00288704|592783740|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
164115152|NCT00288704|592783741|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
164115153|NCT00288704|592783742|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
164115154|NCT00676650|592783745|FG000|Overall Study|Death|45|||
164115155|NCT00676650|592783746|FG001|Overall Study|Death|14|||
164115156|NCT00676650|592783745|FG000|Overall Study|Adverse Event|159|||
164115157|NCT00676650|592783746|FG001|Overall Study|Adverse Event|21|||
164115158|NCT00676650|592783745|FG000|Overall Study|Global deterioration of health status|66|||
164115159|NCT00676650|592783746|FG001|Overall Study|Global deterioration of health status|31|||
164115160|NCT00676650|592783745|FG000|Overall Study|Lost to Follow-up|0|||
164115161|NCT00676650|592783746|FG001|Overall Study|Lost to Follow-up|1|||
164115162|NCT00676650|592783745|FG000|Overall Study|Objective progression or relapse|189|||
164115163|NCT00676650|592783746|FG001|Overall Study|Objective progression or relapse|140|||
164115164|NCT00676650|592783745|FG000|Overall Study|Other|14|||
164115165|NCT00676650|592783746|FG001|Overall Study|Other|10|||
164115166|NCT00676650|592783745|FG000|Overall Study|Protocol Violation|3|||
164115167|NCT00676650|592783746|FG001|Overall Study|Protocol Violation|1|||
164115168|NCT00676650|592783745|FG000|Overall Study|Study terminated by sponsor|57|||
164115169|NCT00676650|592783746|FG001|Overall Study|Study terminated by sponsor|43|||
164115170|NCT00676650|592783745|FG000|Overall Study|Withdrawal by Subject|48|||
164115171|NCT00676650|592783746|FG001|Overall Study|Withdrawal by Subject|24|||
164115172|NCT00676650|592783745|FG000|Overall Study|Randomized but not treated|3|||
164115173|NCT00676650|592783746|FG001|Overall Study|Randomized but not treated|4|||
164115174|NCT01802216|592783747|FG000|4 Month Visit|Participant did not show to visit|3|||
164115175|NCT01802216|592783748|FG001|4 Month Visit|Participant did not show to visit|4|||
164115176|NCT01802216|592783747|FG000|8 Month Visit|Participant did not show to visit|3|||
164115177|NCT01802216|592783748|FG001|8 Month Visit|Participant did not show to visit|5|||
164115178|NCT01802216|592783747|FG000|12 Month Visit|Participant did not show to visit|3|||
164115179|NCT01802216|592783748|FG001|12 Month Visit|Participant did not show to visit|4|||
164115180|NCT02297841|592783752|FG000|Overall Study|Withdrawal by Subject|1|||
164115181|NCT02297841|592783752|FG000|Overall Study|Protocol Violation|7|||
164115182|NCT05061992|592783753|FG000|Overall Study|Excess bowel movements|1|||
164115183|NCT05061992|592783754|FG001|Overall Study|Excess bowel movements|0|||
164115184|NCT05061992|592783753|FG000|Overall Study|Complications of Medical Care|1|||
164115185|NCT05061992|592783754|FG001|Overall Study|Complications of Medical Care|0|||
164115186|NCT05061992|592783753|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
164115187|NCT05061992|592783754|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
164115188|NCT05061992|592783753|FG000|Overall Study|Withdrawal by Subject|0|||
164115189|NCT05061992|592783754|FG001|Overall Study|Withdrawal by Subject|1|||
164115190|NCT01257581|592783758|FG000|Overall Study|Early Termination|3|||
164115191|NCT01257581|592783759|FG001|Overall Study|Early Termination|1|||
164115192|NCT01257581|592783760|FG002|Overall Study|Early Termination|2|||
164115193|NCT01257581|592783758|FG000|Overall Study|Death|2|||
164115194|NCT01257581|592783759|FG001|Overall Study|Death|2|||
164115195|NCT01257581|592783760|FG002|Overall Study|Death|4|||
164115196|NCT01157234|592783761|FG000|Overall Study|Withdrawal by Subject|1|||
164115197|NCT01157234|592783762|FG001|Overall Study|Withdrawal by Subject|0|||
164115198|NCT01698554|592783776|FG000|Overall Study|Adverse Event|2|||
164115199|NCT01698554|592783777|FG001|Overall Study|Adverse Event|5|||
164115200|NCT01698554|592783778|FG002|Overall Study|Adverse Event|0|||
164115201|NCT01698554|592783779|FG003|Overall Study|Adverse Event|1|||
164115202|NCT01698554|592783776|FG000|Overall Study|Lost to Follow-up|1|||
164115203|NCT01698554|592783777|FG001|Overall Study|Lost to Follow-up|0|||
164115204|NCT01698554|592783778|FG002|Overall Study|Lost to Follow-up|0|||
164115205|NCT01698554|592783779|FG003|Overall Study|Lost to Follow-up|0|||
164115206|NCT01698554|592783776|FG000|Overall Study|Personal Reasons|0|||
164115207|NCT01698554|592783777|FG001|Overall Study|Personal Reasons|5|||
164115208|NCT01698554|592783778|FG002|Overall Study|Personal Reasons|1|||
164115209|NCT01698554|592783779|FG003|Overall Study|Personal Reasons|1|||
164115210|NCT01698554|592783776|FG000|Overall Study|Protocol Violation|2|||
164115211|NCT01698554|592783777|FG001|Overall Study|Protocol Violation|0|||
164115212|NCT01698554|592783778|FG002|Overall Study|Protocol Violation|1|||
164115213|NCT01698554|592783779|FG003|Overall Study|Protocol Violation|0|||
164115214|NCT01698554|592783776|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164115215|NCT01698554|592783777|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164115216|NCT01698554|592783778|FG002|Overall Study|Other Miscellaneous Reasons|0|||
164115217|NCT01698554|592783779|FG003|Overall Study|Other Miscellaneous Reasons|0|||
164115218|NCT00751023|592783782|FG000|Overall Study|Lost to Follow-up|11|||
164115219|NCT00751023|592783783|FG001|Overall Study|Lost to Follow-up|7|||
164115220|NCT01547728|592783787|FG000|Overall Study|Change in procedure and equipment|1|||
164115221|NCT01547728|592783787|FG000|Overall Study|Drug not ready for subject|1|||
164115222|NCT01547728|592783787|FG000|Overall Study|Screen failure|39|||
164115223|NCT03448692|592783792|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
164115224|NCT03448692|592783793|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
164115225|NCT03448692|592783792|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
164115226|NCT03448692|592783793|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
164115227|NCT03448692|592783792|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
164115228|NCT03448692|592783793|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
164115229|NCT03448692|592783792|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
164115230|NCT03448692|592783793|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
164115231|NCT03448692|592783792|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
164115232|NCT03448692|592783793|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
164115233|NCT02786927|592783796|FG000|Overall Study|Adverse Event|1|||
164115234|NCT02786927|592783796|FG000|Overall Study|Protocol Violation|4|||
164115235|NCT02416934|592783798|FG000|Overall Study|given steroids|1|||
164115236|NCT02416934|592783799|FG001|Overall Study|given steroids|2|||
164115237|NCT02416934|592783798|FG000|Overall Study|Lost to Follow-up|0|||
164115238|NCT02416934|592783799|FG001|Overall Study|Lost to Follow-up|2|||
164115239|NCT02416934|592783798|FG000|Overall Study|Withdrawal by Subject|1|||
164115240|NCT02416934|592783799|FG001|Overall Study|Withdrawal by Subject|0|||
164115241|NCT02416934|592783798|FG000|Overall Study|recruited during continuing renewal proc|0|||
164115242|NCT02416934|592783799|FG001|Overall Study|recruited during continuing renewal proc|1|||
164115243|NCT02416934|592783798|FG000|Overall Study|Protocol Violation|0|||
164115244|NCT02416934|592783799|FG001|Overall Study|Protocol Violation|1|||
164115245|NCT02416934|592783798|FG000|Overall Study|surgery started late|0|||
164115246|NCT02416934|592783799|FG001|Overall Study|surgery started late|1|||
164115247|NCT02416934|592783798|FG000|Overall Study|re-operation|1|||
164115248|NCT02416934|592783799|FG001|Overall Study|re-operation|0|||
164115249|NCT00494013|592783800|FG000|Overall Study|Adverse Event|0|||
164115250|NCT00494013|592783801|FG001|Overall Study|Adverse Event|1|||
164115251|NCT00494013|592783800|FG000|Overall Study|Entry Criteria Not Met|1|||
164115252|NCT00494013|592783801|FG001|Overall Study|Entry Criteria Not Met|4|||
164115253|NCT00494013|592783800|FG000|Overall Study|Lost to Follow-up|5|||
164115254|NCT00494013|592783801|FG001|Overall Study|Lost to Follow-up|6|||
164115255|NCT00494013|592783800|FG000|Overall Study|Physician Decision|3|||
164115256|NCT00494013|592783801|FG001|Overall Study|Physician Decision|5|||
164115257|NCT00494013|592783800|FG000|Overall Study|Protocol Violation|8|||
164115258|NCT00494013|592783801|FG001|Overall Study|Protocol Violation|5|||
164115259|NCT00494013|592783800|FG000|Overall Study|Withdrawal by Subject|13|||
164115260|NCT00494013|592783801|FG001|Overall Study|Withdrawal by Subject|14|||
164115261|NCT00494013|592783800|FG000|Overall Study|Sponsor Decision|0|||
164115262|NCT00494013|592783801|FG001|Overall Study|Sponsor Decision|1|||
164115263|NCT01562613|592783805|FG000|Overall Study|Lost to Follow-up|2|||
164115264|NCT01562613|592783805|FG000|Overall Study|Withdrawal by Subject|2|||
164115265|NCT01337596|592783811|FG000|Overall Study|Withdrawal by Subject|0|||
164115266|NCT01337596|592783812|FG001|Overall Study|Withdrawal by Subject|0|||
164115267|NCT01337596|592783813|FG002|Overall Study|Withdrawal by Subject|0|||
164115268|NCT01337596|592783814|FG003|Overall Study|Withdrawal by Subject|0|||
164115269|NCT01337596|592783815|FG004|Overall Study|Withdrawal by Subject|2|||
164115270|NCT01337596|592783816|FG005|Overall Study|Withdrawal by Subject|0|||
164115271|NCT01337596|592783817|FG006|Overall Study|Withdrawal by Subject|0|||
164115272|NCT01337596|592783818|FG007|Overall Study|Withdrawal by Subject|0|||
164115273|NCT01337596|592783819|FG008|Overall Study|Withdrawal by Subject|0|||
164115274|NCT01709903|592783825|FG000|Overall Study|administrative problems|2|||
164115275|NCT01709903|592783826|FG001|Overall Study|administrative problems|6|||
164115276|NCT01709903|592783825|FG000|Overall Study|Abnormal test procedure results|1|||
164115277|NCT01709903|592783826|FG001|Overall Study|Abnormal test procedure results|0|||
164115278|NCT01709903|592783825|FG000|Overall Study|In ability to use device|1|||
164115279|NCT01709903|592783826|FG001|Overall Study|In ability to use device|1|||
164115280|NCT01709903|592783825|FG000|Overall Study|no longer needed study drug|0|||
164115281|NCT01709903|592783826|FG001|Overall Study|no longer needed study drug|1|||
164115282|NCT01709903|592783825|FG000|Overall Study|Lost to Follow-up|0|||
164115283|NCT01709903|592783826|FG001|Overall Study|Lost to Follow-up|2|||
164115284|NCT01709903|592783825|FG000|Overall Study|Death|2|||
164115285|NCT01709903|592783826|FG001|Overall Study|Death|0|||
164115286|NCT01709903|592783825|FG000|Overall Study|Protocol Violation|3|||
164115287|NCT01709903|592783826|FG001|Overall Study|Protocol Violation|2|||
164115288|NCT01709903|592783825|FG000|Overall Study|Lack of Efficacy|3|||
164115289|NCT01709903|592783826|FG001|Overall Study|Lack of Efficacy|3|||
164115290|NCT01709903|592783825|FG000|Overall Study|Withdrawal by Subject|6|||
164115291|NCT01709903|592783826|FG001|Overall Study|Withdrawal by Subject|6|||
164115292|NCT01709903|592783825|FG000|Overall Study|Adverse Event|11|||
164115293|NCT01709903|592783826|FG001|Overall Study|Adverse Event|18|||
164115294|NCT01751087|592783830|FG000|Overall Study|Withdrawal by Subject|1|||
164115295|NCT01751087|592783831|FG001|Overall Study|Withdrawal by Subject|0|||
164115296|NCT01751087|592783832|FG002|Overall Study|Withdrawal by Subject|0|||
164115297|NCT01751087|592783830|FG000|Overall Study|Physician Decision|0|||
164115298|NCT01751087|592783831|FG001|Overall Study|Physician Decision|0|||
164115299|NCT01751087|592783832|FG002|Overall Study|Physician Decision|1|||
164115300|NCT00724958|592783833|FG000|Overall Study|Adverse Event|28|||
164115301|NCT00724958|592783833|FG000|Overall Study|Loss of Response|40|||
164115302|NCT00724958|592783833|FG000|Overall Study|No Response|18|||
164115303|NCT00724958|592783833|FG000|Overall Study|Remission|7|||
164115304|NCT00724958|592783833|FG000|Overall Study|Other Reason|76|||
164115305|NCT00724958|592783833|FG000|Overall Study|No documentation for end of therapy|13|||
164115306|NCT02459418|592785201|FG000|Overall Study|Exclusion Criteria|4|||
164115307|NCT02459418|592785202|FG001|Overall Study|Exclusion Criteria|0|||
164115308|NCT02459418|592785201|FG000|Overall Study|Protocol Violation|0|||
164115309|NCT02459418|592785202|FG001|Overall Study|Protocol Violation|2|||
164115310|NCT02459418|592785201|FG000|Overall Study|Physician Decision|0|||
164115311|NCT02459418|592785202|FG001|Overall Study|Physician Decision|2|||
164115312|NCT02459418|592785201|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
164115313|NCT02459418|592785202|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
164115314|NCT02459418|592785201|FG000|Overall Study|Adverse Event|0|||
164115315|NCT02459418|592785202|FG001|Overall Study|Adverse Event|1|||
164115316|NCT02459418|592785201|FG000|Overall Study|Withdrawal by Subject|1|||
164115317|NCT02459418|592785202|FG001|Overall Study|Withdrawal by Subject|1|||
164115318|NCT02459418|592785201|FG000|Overall Study|Elevated Creatine Kinase|1|||
164115319|NCT02459418|592785202|FG001|Overall Study|Elevated Creatine Kinase|0|||
164115320|NCT02459418|592785201|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
164115321|NCT02459418|592785202|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
164115322|NCT00653159|592785203|FG000|Overall Study|Adverse Event|4|||
164115323|NCT00653159|592785204|FG001|Overall Study|Adverse Event|1|||
164115324|NCT00653159|592785203|FG000|Overall Study|Lost to Follow-up|1|||
164115325|NCT00653159|592785204|FG001|Overall Study|Lost to Follow-up|2|||
164115326|NCT01872715|592785205|FG000|Overall Study|Adverse Event|1|||
164115327|NCT01872715|592785205|FG000|Overall Study|Protocol Violation|1|||
164115328|NCT01872715|592785205|FG000|Overall Study|Withdrawal by Subject|2|||
164115329|NCT00683592|592785208|FG000|Overall Study|Adverse Event|12|||
164115330|NCT00683592|592785209|FG001|Overall Study|Adverse Event|4|||
164115331|NCT00683592|592785208|FG000|Overall Study|Withdrawal by Subject|11|||
164115332|NCT00683592|592785209|FG001|Overall Study|Withdrawal by Subject|11|||
164115333|NCT00683592|592785208|FG000|Overall Study|Lost to Follow-up|17|||
164115334|NCT00683592|592785209|FG001|Overall Study|Lost to Follow-up|17|||
164115335|NCT00683592|592785208|FG000|Overall Study|Lack of Efficacy|3|||
164115336|NCT00683592|592785209|FG001|Overall Study|Lack of Efficacy|7|||
164115337|NCT00683592|592785208|FG000|Overall Study|Physician Decision|0|||
164115338|NCT00683592|592785209|FG001|Overall Study|Physician Decision|1|||
164115339|NCT00683592|592785208|FG000|Overall Study|Non-compliance|3|||
164115340|NCT00683592|592785209|FG001|Overall Study|Non-compliance|5|||
164115341|NCT00683592|592785208|FG000|Overall Study|Other|1|||
164115342|NCT00683592|592785209|FG001|Overall Study|Other|1|||
164115343|NCT03303417|592785217|FG000|Overall Study|Withdrawal by Subject|1|||
164115344|NCT03303417|592785218|FG001|Overall Study|Withdrawal by Subject|1|||
164115345|NCT02697617|592785219|FG000|Overall Study|Withdrawal by Subject|0|||
164115346|NCT02697617|592785220|FG001|Overall Study|Withdrawal by Subject|2|||
164115347|NCT02697617|592785219|FG000|Overall Study|Pregnancy|1|||
164115348|NCT02697617|592785220|FG001|Overall Study|Pregnancy|0|||
164115349|NCT01848210|592785224|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
164115350|NCT01848210|592785225|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
164115351|NCT01848210|592785224|FG000|Overall Study|Lost to Follow-up|24|||
164115352|NCT01848210|592785225|FG001|Overall Study|Lost to Follow-up|12|||
164115353|NCT01848210|592785224|FG000|Overall Study|Protocol Violation|3|||
164115354|NCT01848210|592785225|FG001|Overall Study|Protocol Violation|5|||
164115355|NCT01848210|592785224|FG000|Overall Study|Use of Forbidden Drugs|9|||
164115356|NCT01848210|592785225|FG001|Overall Study|Use of Forbidden Drugs|10|||
164115357|NCT01848210|592785224|FG000|Overall Study|Impedition Condition|5|||
164115358|NCT01848210|592785225|FG001|Overall Study|Impedition Condition|9|||
164115359|NCT01848210|592785224|FG000|Overall Study|Adverse Event|7|||
164115360|NCT01848210|592785225|FG001|Overall Study|Adverse Event|9|||
164115361|NCT01848210|592785224|FG000|Overall Study|Discontinuation Criterion|5|||
164115362|NCT01848210|592785225|FG001|Overall Study|Discontinuation Criterion|7|||
164115363|NCT01848210|592785224|FG000|Overall Study|Hypesensitivity|1|||
164115364|NCT01848210|592785225|FG001|Overall Study|Hypesensitivity|0|||
164115365|NCT01848210|592785224|FG000|Overall Study|Hepatic Function Alteration|4|||
164115366|NCT01848210|592785225|FG001|Overall Study|Hepatic Function Alteration|0|||
164115367|NCT01848210|592785224|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
164115368|NCT01848210|592785225|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
164115369|NCT01848210|592785224|FG000|Overall Study|Administrative|1|||
164115370|NCT01848210|592785225|FG001|Overall Study|Administrative|0|||
164115371|NCT00381849|592785226|FG000|Wash Out|Withdrawal by Subject|0|||
164115372|NCT00381849|592785227|FG001|Wash Out|Withdrawal by Subject|1|||
164115373|NCT01765270|592785231|FG000|Overall Study|Physician Decision|1|||
164115374|NCT01765270|592785232|FG001|Overall Study|Physician Decision|0|||
164115375|NCT01765270|592785231|FG000|Overall Study|Withdrawal by Subject|0|||
164115376|NCT01765270|592785232|FG001|Overall Study|Withdrawal by Subject|1|||
164115377|NCT00517192|592785233|FG000|Overall Study|Adverse Event|1|||
164115378|NCT00517192|592785234|FG001|Overall Study|Adverse Event|1|||
164115379|NCT00517192|592785233|FG000|Overall Study|Lost to Follow-up|1|||
164115380|NCT00517192|592785234|FG001|Overall Study|Lost to Follow-up|1|||
164115381|NCT00517192|592785233|FG000|Overall Study|Withdrawal by Subject|1|||
164115382|NCT00517192|592785234|FG001|Overall Study|Withdrawal by Subject|0|||
164115383|NCT00517192|592785233|FG000|Overall Study|Early termination of the trial|16|||
164115384|NCT00517192|592785234|FG001|Overall Study|Early termination of the trial|18|||
164115385|NCT00329160|592785236|FG000|Overall Study|Adverse Event|27|||
164115386|NCT00329160|592785236|FG000|Overall Study|Withdrawal by Subject|13|||
164115387|NCT00329160|592785236|FG000|Overall Study|Protocol Violation|2|||
164115388|NCT00329160|592785236|FG000|Overall Study|Did not Receive Study Drug|1|||
164115389|NCT00329160|592785236|FG000|Overall Study|Incomplete IVUS|45|||
164115390|NCT04501094|592785237|FG000|Overall Study|Death (unrelated to research)|1|||
164115391|NCT04501094|592785238|FG001|Overall Study|Death (unrelated to research)|0|||
164115392|NCT05212948|592785243|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
164115393|NCT05212948|592785244|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
164115394|NCT05212948|592785243|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
164115395|NCT05212948|592785244|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
164115396|NCT05212948|592785243|FG000|Initial Vaccination Period|Pregnancy|20|||
164115397|NCT05212948|592785244|FG001|Initial Vaccination Period|Pregnancy|14|||
164115398|NCT05212948|592785243|FG000|Initial Vaccination Period|Physician Decision|686|||
164115399|NCT05212948|592785244|FG001|Initial Vaccination Period|Physician Decision|401|||
164115400|NCT05212948|592785243|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
164115401|NCT05212948|592785244|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
164115402|NCT05212948|592785243|FG000|Initial Vaccination Period|Death|23|||
164115403|NCT05212948|592785244|FG001|Initial Vaccination Period|Death|18|||
164115404|NCT05212948|592785243|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
164115405|NCT05212948|592785244|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
164115406|NCT05212948|592785243|FG000|Initial Vaccination Period|Adverse Event|36|||
164115407|NCT05212948|592785244|FG001|Initial Vaccination Period|Adverse Event|23|||
164115408|NCT05212948|592785243|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
164115409|NCT05212948|592785244|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
164115410|NCT05212948|592785243|FG000|Crossover Vaccination Period|Pregnancy|6|||
164115411|NCT05212948|592785244|FG001|Crossover Vaccination Period|Pregnancy|1|||
164115412|NCT05212948|592785243|FG000|Crossover Vaccination Period|Physician Decision|49|||
164115413|NCT05212948|592785244|FG001|Crossover Vaccination Period|Physician Decision|24|||
164115414|NCT05212948|592785243|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
164115415|NCT05212948|592785244|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
164115416|NCT05212948|592785243|FG000|Crossover Vaccination Period|Death|10|||
164115417|NCT05212948|592785244|FG001|Crossover Vaccination Period|Death|5|||
164115418|NCT05212948|592785243|FG000|Crossover Vaccination Period|Adverse Event|9|||
164115419|NCT05212948|592785244|FG001|Crossover Vaccination Period|Adverse Event|4|||
164115420|NCT05347693|592785245|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
164115421|NCT05347693|592785246|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
164115422|NCT05347693|592785247|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
164115423|NCT05347693|592785245|FG000|Inpatient Period|Withdrawal of consent|10|||
164115424|NCT05347693|592785246|FG001|Inpatient Period|Withdrawal of consent|0|||
164115425|NCT05347693|592785247|FG002|Inpatient Period|Withdrawal of consent|0|||
164115426|NCT05347693|592785245|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
164115427|NCT05347693|592785246|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
164115428|NCT05347693|592785247|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
164115429|NCT05347693|592785245|FG000|Inpatient Period|Screening Failure|8|||
164115430|NCT05347693|592785246|FG001|Inpatient Period|Screening Failure|0|||
164115431|NCT05347693|592785247|FG002|Inpatient Period|Screening Failure|0|||
164115432|NCT05347693|592785245|FG000|Inpatient Period|Death|2|||
164115433|NCT05347693|592785246|FG001|Inpatient Period|Death|0|||
164115434|NCT05347693|592785247|FG002|Inpatient Period|Death|0|||
164115435|NCT05347693|592785245|FG000|Inpatient Period|Physician Decision|5|||
164115436|NCT05347693|592785246|FG001|Inpatient Period|Physician Decision|0|||
164115437|NCT05347693|592785247|FG002|Inpatient Period|Physician Decision|0|||
164115438|NCT05347693|592785245|FG000|Inpatient Period|Adverse Event|3|||
164115439|NCT05347693|592785246|FG001|Inpatient Period|Adverse Event|0|||
164115440|NCT05347693|592785247|FG002|Inpatient Period|Adverse Event|0|||
164132431|NCT00123474|592850616|FG001|As Treated at Study Closure|Adverse Event|4|||
164115441|NCT05347693|592785245|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
164115442|NCT05347693|592785246|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
164115443|NCT05347693|592785247|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
164115444|NCT05347693|592785245|FG000|Outpatient Period|Adverse Event|0|||
164115445|NCT05347693|592785246|FG001|Outpatient Period|Adverse Event|9|||
164115446|NCT05347693|592785247|FG002|Outpatient Period|Adverse Event|0|||
164115447|NCT05347693|592785245|FG000|Outpatient Period|Death|0|||
164115448|NCT05347693|592785246|FG001|Outpatient Period|Death|6|||
164115449|NCT05347693|592785247|FG002|Outpatient Period|Death|2|||
164115450|NCT05347693|592785245|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
164115451|NCT05347693|592785246|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
164115452|NCT05347693|592785247|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
164115453|NCT05347693|592785245|FG000|Outpatient Period|Lost to Follow-up|0|||
164115454|NCT05347693|592785246|FG001|Outpatient Period|Lost to Follow-up|0|||
164115455|NCT05347693|592785247|FG002|Outpatient Period|Lost to Follow-up|1|||
164115456|NCT05347693|592785245|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
164115457|NCT05347693|592785246|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
164115458|NCT05347693|592785247|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
164115459|NCT05347693|592785245|FG000|Outpatient Period|Scheduled hemodialysis|0|||
164115460|NCT05347693|592785246|FG001|Outpatient Period|Scheduled hemodialysis|1|||
164115461|NCT05347693|592785247|FG002|Outpatient Period|Scheduled hemodialysis|0|||
164115462|NCT05347693|592785245|FG000|Outpatient Period|Severe HK|0|||
164115463|NCT05347693|592785246|FG001|Outpatient Period|Severe HK|0|||
164115464|NCT05347693|592785247|FG002|Outpatient Period|Severe HK|1|||
164115465|NCT05347693|592785245|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
164115466|NCT05347693|592785246|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
164115467|NCT05347693|592785247|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
164115468|NCT05347693|592785245|FG000|Outpatient Period|Start of dialysis|0|||
164115469|NCT05347693|592785246|FG001|Outpatient Period|Start of dialysis|0|||
164115470|NCT05347693|592785247|FG002|Outpatient Period|Start of dialysis|1|||
164115471|NCT05347693|592785245|FG000|Outpatient Period|The participant entered hemodialysis|0|||
164115472|NCT05347693|592785246|FG001|Outpatient Period|The participant entered hemodialysis|0|||
164115473|NCT05347693|592785247|FG002|Outpatient Period|The participant entered hemodialysis|1|||
164115474|NCT05347693|592785245|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
164115475|NCT05347693|592785246|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
164115476|NCT05347693|592785247|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
164115477|NCT05347693|592785245|FG000|Outpatient Period|Withdrawal by Subject|0|||
164115478|NCT05347693|592785246|FG001|Outpatient Period|Withdrawal by Subject|8|||
164115479|NCT05347693|592785247|FG002|Outpatient Period|Withdrawal by Subject|5|||
164115480|NCT03167606|592785248|FG000|Overall Study|Lost to Follow-up|73|||
164115481|NCT03167606|592785249|FG001|Overall Study|Lost to Follow-up|64|||
164115482|NCT03167606|592785248|FG000|Overall Study|Withdrawal by Subject|6|||
164115483|NCT03167606|592785249|FG001|Overall Study|Withdrawal by Subject|5|||
164115484|NCT03167606|592785248|FG000|Overall Study|Withdrawal by Investigator|0|||
164115485|NCT03167606|592785249|FG001|Overall Study|Withdrawal by Investigator|2|||
164115486|NCT00413049|592785250|FG000|Overall Study|Adverse Event|10|||
164115487|NCT00413049|592785251|FG001|Overall Study|Adverse Event|8|||
164115488|NCT00413049|592785250|FG000|Overall Study|Withdrawal by Subject|7|||
164115489|NCT00413049|592785251|FG001|Overall Study|Withdrawal by Subject|5|||
164115490|NCT00413049|592785250|FG000|Overall Study|Lost to Follow-up|2|||
164115491|NCT00413049|592785251|FG001|Overall Study|Lost to Follow-up|3|||
164115492|NCT00413049|592785250|FG000|Overall Study|Protocol Violation|3|||
164115493|NCT00413049|592785251|FG001|Overall Study|Protocol Violation|1|||
164115494|NCT00413049|592785250|FG000|Overall Study|Subject no longer requires study drug|0|||
164115495|NCT00413049|592785251|FG001|Overall Study|Subject no longer requires study drug|1|||
164115496|NCT00413049|592785250|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164115497|NCT00413049|592785251|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164115498|NCT00413049|592785250|FG000|Overall Study|Lack of Efficacy|1|||
164115499|NCT00413049|592785251|FG001|Overall Study|Lack of Efficacy|0|||
164115500|NCT01755975|592785258|FG000|Overall Study|Adverse Event|0|||
164115501|NCT01755975|592785259|FG001|Overall Study|Adverse Event|0|||
164115502|NCT01755975|592785260|FG002|Overall Study|Adverse Event|1|||
164115503|NCT01755975|592785261|FG003|Overall Study|Adverse Event|0|||
164115504|NCT01755975|592785262|FG004|Overall Study|Adverse Event|2|||
164115505|NCT03653026|592785263|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
164115506|NCT03653026|592785264|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
164115507|NCT03653026|592785265|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
164115508|NCT03653026|592785266|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
164115509|NCT03653026|592785263|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
164115510|NCT03653026|592785264|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
164115511|NCT03653026|592785265|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164115512|NCT03653026|592785266|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
164115513|NCT03653026|592785263|FG000|Part 1: Placebo-controlled Period|Other|0|||
164115514|NCT03653026|592785264|FG001|Part 1: Placebo-controlled Period|Other|3|||
164115515|NCT03653026|592785265|FG002|Part 1: Placebo-controlled Period|Other|0|||
164115516|NCT03653026|592785266|FG003|Part 1: Placebo-controlled Period|Other|0|||
164115517|NCT03653026|592785263|FG000|Part 2: Open-label Extension|Adverse Event|0|||
164115518|NCT03653026|592785264|FG001|Part 2: Open-label Extension|Adverse Event|0|||
164115519|NCT03653026|592785265|FG002|Part 2: Open-label Extension|Adverse Event|1|||
164115520|NCT03653026|592785266|FG003|Part 2: Open-label Extension|Adverse Event|1|||
164115521|NCT03653026|592785263|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164115522|NCT03653026|592785264|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
164115523|NCT03653026|592785265|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
164115524|NCT03653026|592785266|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
164115525|NCT03653026|592785263|FG000|Part 2: Open-label Extension|Other|0|||
164115526|NCT03653026|592785264|FG001|Part 2: Open-label Extension|Other|0|||
164115527|NCT03653026|592785265|FG002|Part 2: Open-label Extension|Other|1|||
164115528|NCT03653026|592785266|FG003|Part 2: Open-label Extension|Other|2|||
164115529|NCT02104817|592785269|FG000|Overall Study|Death|363|||
164115530|NCT02104817|592785270|FG001|Overall Study|Death|330|||
164115531|NCT02104817|592785269|FG000|Overall Study|Lost to Follow-up|3|||
164115532|NCT02104817|592785270|FG001|Overall Study|Lost to Follow-up|2|||
164115533|NCT02104817|592785269|FG000|Overall Study|Protocol Violation|0|||
164115534|NCT02104817|592785270|FG001|Overall Study|Protocol Violation|1|||
164115535|NCT02104817|592785269|FG000|Overall Study|Study terminated by sponsor|5854|||
164115536|NCT02104817|592785270|FG001|Overall Study|Study terminated by sponsor|5901|||
164115537|NCT02104817|592785269|FG000|Overall Study|Withdrawal by Subject|111|||
164115538|NCT02104817|592785270|FG001|Overall Study|Withdrawal by Subject|78|||
164115539|NCT02104817|592785269|FG000|Overall Study|Other reasons|128|||
164115540|NCT02104817|592785270|FG001|Overall Study|Other reasons|135|||
164115541|NCT00852917|592785271|FG000|Overall Study|Adverse Event|13|||
164115542|NCT00852917|592785272|FG001|Overall Study|Adverse Event|20|||
164115543|NCT00852917|592785273|FG002|Overall Study|Adverse Event|35|||
164115544|NCT00852917|592785274|FG003|Overall Study|Adverse Event|17|||
164115545|NCT00852917|592785271|FG000|Overall Study|Lack of Efficacy|21|||
164115546|NCT00852917|592785272|FG001|Overall Study|Lack of Efficacy|11|||
164115547|NCT00852917|592785273|FG002|Overall Study|Lack of Efficacy|11|||
164115548|NCT00852917|592785274|FG003|Overall Study|Lack of Efficacy|47|||
164115549|NCT00852917|592785271|FG000|Overall Study|Withdrawal by Subject|4|||
164115550|NCT00852917|592785272|FG001|Overall Study|Withdrawal by Subject|8|||
164115551|NCT00852917|592785273|FG002|Overall Study|Withdrawal by Subject|10|||
164115552|NCT00852917|592785274|FG003|Overall Study|Withdrawal by Subject|9|||
164115553|NCT00852917|592785271|FG000|Overall Study|Physician Decision|6|||
164115554|NCT00852917|592785272|FG001|Overall Study|Physician Decision|7|||
164115555|NCT00852917|592785273|FG002|Overall Study|Physician Decision|2|||
164115556|NCT00852917|592785274|FG003|Overall Study|Physician Decision|19|||
164115557|NCT00852917|592785271|FG000|Overall Study|Death|0|||
164115558|NCT00852917|592785272|FG001|Overall Study|Death|0|||
164115559|NCT00852917|592785273|FG002|Overall Study|Death|0|||
164115560|NCT00852917|592785274|FG003|Overall Study|Death|1|||
164115561|NCT01597479|592785278|FG000|Overall Study|Protocol Violation|1|||
164115562|NCT01597479|592785279|FG001|Overall Study|Protocol Violation|0|||
164115563|NCT01597479|592785278|FG000|Overall Study|Lost to Follow-up|1|||
164115564|NCT01597479|592785279|FG001|Overall Study|Lost to Follow-up|0|||
164115565|NCT02167594|592785280|FG000|Overall Study|Withdrawal by Subject|2|||
164115566|NCT02167594|592785281|FG001|Overall Study|Withdrawal by Subject|0|||
164115567|NCT02167594|592785282|FG002|Overall Study|Withdrawal by Subject|0|||
164115568|NCT02167594|592785280|FG000|Overall Study|Death|0|||
164115569|NCT02167594|592785281|FG001|Overall Study|Death|1|||
164115570|NCT02167594|592785282|FG002|Overall Study|Death|0|||
164115571|NCT02340780|592785283|FG000|Overall Study|Ineligible|1|||
164115572|NCT03433703|592785284|FG000|Overall Study|Study terminated by Sponsor|2|||
164115573|NCT03422068|592785287|FG000|Overall Study|Adverse Event|0|||
164115574|NCT03422068|592785288|FG001|Overall Study|Adverse Event|1|||
164115575|NCT03422068|592785287|FG000|Overall Study|Inconvenience to frequent study visits|0|||
164115576|NCT03422068|592785288|FG001|Overall Study|Inconvenience to frequent study visits|1|||
164115577|NCT01583530|592785290|FG000|Overall Study|Adverse Event|0|||
164115578|NCT01583530|592785291|FG001|Overall Study|Adverse Event|0|||
164115579|NCT01583530|592785292|FG002|Overall Study|Adverse Event|0|||
164115580|NCT01583530|592785293|FG003|Overall Study|Adverse Event|0|||
164115581|NCT01583530|592785294|FG004|Overall Study|Adverse Event|0|||
164115582|NCT01583530|592785295|FG005|Overall Study|Adverse Event|1|||
164115583|NCT01583530|592785290|FG000|Overall Study|Withdrawal by Subject|0|||
164115584|NCT01583530|592785291|FG001|Overall Study|Withdrawal by Subject|3|||
164115585|NCT01583530|592785292|FG002|Overall Study|Withdrawal by Subject|0|||
164115586|NCT01583530|592785293|FG003|Overall Study|Withdrawal by Subject|1|||
164115587|NCT01583530|592785294|FG004|Overall Study|Withdrawal by Subject|1|||
164115588|NCT01583530|592785295|FG005|Overall Study|Withdrawal by Subject|2|||
164115589|NCT01583530|592785290|FG000|Overall Study|Lost to Follow-up|0|||
164115590|NCT01583530|592785291|FG001|Overall Study|Lost to Follow-up|0|||
164115591|NCT01583530|592785292|FG002|Overall Study|Lost to Follow-up|0|||
164115592|NCT01583530|592785293|FG003|Overall Study|Lost to Follow-up|0|||
164115593|NCT01583530|592785294|FG004|Overall Study|Lost to Follow-up|3|||
164115594|NCT01583530|592785295|FG005|Overall Study|Lost to Follow-up|0|||
164115595|NCT01583530|592785290|FG000|Overall Study|Lack of compliance|0|||
164115596|NCT01583530|592785291|FG001|Overall Study|Lack of compliance|0|||
164115597|NCT01583530|592785292|FG002|Overall Study|Lack of compliance|0|||
164115598|NCT01583530|592785293|FG003|Overall Study|Lack of compliance|0|||
164115599|NCT01583530|592785294|FG004|Overall Study|Lack of compliance|1|||
164115600|NCT01583530|592785295|FG005|Overall Study|Lack of compliance|0|||
164115601|NCT02416180|592785296|FG000|Overall Study|Withdrawal by Subject|1|||
164115602|NCT00640926|592785297|FG000|Overall Study|Adverse Event|2|||
164115603|NCT00640926|592785298|FG001|Overall Study|Adverse Event|3|||
164115604|NCT00640926|592785299|FG002|Overall Study|Adverse Event|2|||
164115605|NCT00640926|592785297|FG000|Overall Study|Lack of Efficacy|0|||
164115606|NCT00640926|592785298|FG001|Overall Study|Lack of Efficacy|2|||
164115607|NCT00640926|592785299|FG002|Overall Study|Lack of Efficacy|1|||
164115608|NCT00640926|592785297|FG000|Overall Study|Protocol Violation|2|||
164115609|NCT00640926|592785298|FG001|Overall Study|Protocol Violation|0|||
164115610|NCT00640926|592785299|FG002|Overall Study|Protocol Violation|2|||
164115611|NCT00640926|592785297|FG000|Overall Study|Lost to Follow-up|3|||
164115612|NCT00640926|592785298|FG001|Overall Study|Lost to Follow-up|1|||
164115613|NCT00640926|592785299|FG002|Overall Study|Lost to Follow-up|2|||
164115614|NCT00640926|592785297|FG000|Overall Study|Withdrawal by Subject|1|||
164115615|NCT00640926|592785298|FG001|Overall Study|Withdrawal by Subject|0|||
164115616|NCT00640926|592785299|FG002|Overall Study|Withdrawal by Subject|1|||
164115617|NCT02985398|592785300|FG000|Overall Study|Adverse Event|1|||
164115618|NCT02985398|592785300|FG000|Overall Study|Lost to Follow-up|4|||
164115619|NCT02985398|592785300|FG000|Overall Study|Withdrawal by Subject|8|||
164115620|NCT02985398|592785300|FG000|Overall Study|Study Burden|9|||
164115621|NCT01841073|592785301|FG000|Overall Study|Adverse Event|1|||
164115622|NCT01841073|592785302|FG001|Overall Study|Adverse Event|1|||
164115623|NCT01841073|592785301|FG000|Overall Study|Physician Decision|1|||
164115624|NCT01841073|592785302|FG001|Overall Study|Physician Decision|0|||
164115625|NCT01841073|592785301|FG000|Overall Study|Lost to Follow-up|0|||
164115626|NCT01841073|592785302|FG001|Overall Study|Lost to Follow-up|2|||
164115627|NCT02858037|592785305|FG000|Overall Study|Death|1|||
164115628|NCT02858037|592785305|FG000|Overall Study|Withdrawal by Subject|18|||
164115629|NCT02858037|592785305|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
164115630|NCT02858037|592785305|FG000|Overall Study|Lost to Follow-up|3|||
164115631|NCT02858037|592785305|FG000|Overall Study|Other|4|||
164115632|NCT00283842|592785312|FG000|Overall Study|Adverse Event|8|||
164115633|NCT00283842|592785313|FG001|Overall Study|Adverse Event|7|||
164115634|NCT00283842|592785314|FG002|Overall Study|Adverse Event|21|||
164115635|NCT00283842|592785315|FG003|Overall Study|Adverse Event|21|||
164115636|NCT00283842|592785316|FG004|Overall Study|Adverse Event|5|||
164115637|NCT00283842|592785312|FG000|Overall Study|Protocol Violation|1|||
164115638|NCT00283842|592785313|FG001|Overall Study|Protocol Violation|5|||
164115639|NCT00283842|592785314|FG002|Overall Study|Protocol Violation|4|||
164115640|NCT00283842|592785315|FG003|Overall Study|Protocol Violation|0|||
164115641|NCT00283842|592785316|FG004|Overall Study|Protocol Violation|0|||
164115642|NCT00283842|592785312|FG000|Overall Study|Protocol deviation|0|||
164115643|NCT00283842|592785313|FG001|Overall Study|Protocol deviation|0|||
164115644|NCT00283842|592785314|FG002|Overall Study|Protocol deviation|0|||
164115645|NCT00283842|592785315|FG003|Overall Study|Protocol deviation|0|||
164115646|NCT00283842|592785316|FG004|Overall Study|Protocol deviation|2|||
164115647|NCT00283842|592785312|FG000|Overall Study|Withdrawal by Subject|2|||
164115648|NCT00283842|592785313|FG001|Overall Study|Withdrawal by Subject|1|||
164115649|NCT00283842|592785314|FG002|Overall Study|Withdrawal by Subject|1|||
164115650|NCT00283842|592785315|FG003|Overall Study|Withdrawal by Subject|5|||
164115651|NCT00283842|592785316|FG004|Overall Study|Withdrawal by Subject|4|||
164115652|NCT00283842|592785312|FG000|Overall Study|Lack of Efficacy|1|||
164115653|NCT00283842|592785313|FG001|Overall Study|Lack of Efficacy|3|||
164115654|NCT00283842|592785314|FG002|Overall Study|Lack of Efficacy|1|||
164115655|NCT00283842|592785315|FG003|Overall Study|Lack of Efficacy|0|||
164115656|NCT00283842|592785316|FG004|Overall Study|Lack of Efficacy|3|||
164115657|NCT00283842|592785312|FG000|Overall Study|Lost to Follow-up|0|||
164115658|NCT00283842|592785313|FG001|Overall Study|Lost to Follow-up|2|||
164115659|NCT00283842|592785314|FG002|Overall Study|Lost to Follow-up|4|||
164115660|NCT00283842|592785315|FG003|Overall Study|Lost to Follow-up|1|||
164115661|NCT00283842|592785316|FG004|Overall Study|Lost to Follow-up|1|||
164115662|NCT00550147|592785317|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
164115663|NCT00550147|592785317|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
164115664|NCT00550147|592785317|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
164115665|NCT00550147|592785317|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
164115666|NCT00550147|592785317|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
164115667|NCT04320745|592785318|FG000|Overall Study|Adverse Event|26|||
164115668|NCT04320745|592785318|FG000|Overall Study|Withdrawal by Subject|4|||
164115669|NCT04320745|592785318|FG000|Overall Study|Lost to Follow-up|12|||
164115670|NCT04320745|592785318|FG000|Overall Study|Protocol Deviation|2|||
164115671|NCT04320745|592785318|FG000|Overall Study|Non-compliance With Study Drug|2|||
164115672|NCT04320745|592785318|FG000|Overall Study|Reason Not Specified|1|||
164115673|NCT02472639|592785320|FG000|Overall Study|Physician Decision|4|||
164115674|NCT02472639|592785321|FG001|Overall Study|Physician Decision|3|||
164115675|NCT00046839|592785322|FG000|Overall Study|Ineligible / No protocol treatment|0|||
164115676|NCT00046839|592785323|FG001|Overall Study|Ineligible / No protocol treatment|2|||
164115677|NCT00046839|592785322|FG000|Overall Study|Withdrawal of consent|1|||
164115678|NCT00046839|592785323|FG001|Overall Study|Withdrawal of consent|0|||
164115679|NCT02050321|592785325|FG000|Overall Study|Withdrawal by Subject|1|||
164115680|NCT02050321|592785325|FG000|Overall Study|Adverse Event|1|||
164115681|NCT04768114|592785327|FG000|Overall Study|Lost to Follow-up|5|||
164115682|NCT04768114|592785328|FG001|Overall Study|Lost to Follow-up|10|||
164115683|NCT04768114|592785327|FG000|Overall Study|Withdrawal by Subject|0|||
164115684|NCT04768114|592785328|FG001|Overall Study|Withdrawal by Subject|1|||
164115685|NCT00715676|592785334|FG000|Overall Study|Adverse Event|3|||
164115686|NCT00715676|592785335|FG001|Overall Study|Adverse Event|5|||
164115687|NCT00715676|592785336|FG002|Overall Study|Adverse Event|21|||
164115688|NCT00715676|592785334|FG000|Overall Study|Withdrawal by Subject|1|||
164115689|NCT00715676|592785335|FG001|Overall Study|Withdrawal by Subject|3|||
164115690|NCT00715676|592785336|FG002|Overall Study|Withdrawal by Subject|8|||
164115691|NCT00715676|592785334|FG000|Overall Study|Lost to Follow-up|1|||
164115692|NCT00715676|592785335|FG001|Overall Study|Lost to Follow-up|2|||
164115693|NCT00715676|592785336|FG002|Overall Study|Lost to Follow-up|1|||
164115694|NCT00715676|592785334|FG000|Overall Study|Terminated by Sponsor|1|||
164115695|NCT00715676|592785335|FG001|Overall Study|Terminated by Sponsor|0|||
164115696|NCT00715676|592785336|FG002|Overall Study|Terminated by Sponsor|0|||
164115697|NCT00715676|592785334|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
164115698|NCT00715676|592785335|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
164115699|NCT00715676|592785336|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
164115700|NCT00715676|592785334|FG000|Overall Study|Use of Exclusionary Medication|0|||
164115701|NCT00715676|592785335|FG001|Overall Study|Use of Exclusionary Medication|0|||
164115702|NCT00715676|592785336|FG002|Overall Study|Use of Exclusionary Medication|1|||
164115703|NCT00715676|592785334|FG000|Overall Study|Elevated Blood Glucose|0|||
164115704|NCT00715676|592785335|FG001|Overall Study|Elevated Blood Glucose|1|||
164115705|NCT00715676|592785336|FG002|Overall Study|Elevated Blood Glucose|0|||
164115706|NCT03828539|592785337|FG000|Overall Study|Adverse Event|3|||
164115707|NCT03828539|592785338|FG001|Overall Study|Adverse Event|12|||
164115708|NCT03828539|592785337|FG000|Overall Study|Patient's/guardian's decision|3|||
164115709|NCT03828539|592785338|FG001|Overall Study|Patient's/guardian's decision|5|||
164115710|NCT03828539|592785337|FG000|Overall Study|Lost to Follow-up|4|||
164115711|NCT03828539|592785338|FG001|Overall Study|Lost to Follow-up|2|||
164115712|NCT03828539|592785337|FG000|Overall Study|Protocol Violation|3|||
164115713|NCT03828539|592785338|FG001|Overall Study|Protocol Violation|2|||
164115714|NCT03828539|592785337|FG000|Overall Study|Withdrawal of informed consent|2|||
164115715|NCT03828539|592785338|FG001|Overall Study|Withdrawal of informed consent|1|||
164115716|NCT03828539|592785337|FG000|Overall Study|New therapy for study indication|1|||
164115717|NCT03828539|592785338|FG001|Overall Study|New therapy for study indication|0|||
164115718|NCT02224053|592785339|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
164115719|NCT02224053|592785339|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
164115720|NCT02224053|592785339|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
164115721|NCT02224053|592785339|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
164115722|NCT02224053|592785339|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
164115723|NCT01898598|592785343|FG000|Overall Study|Adverse Event|1|||
164115724|NCT01898598|592785344|FG001|Overall Study|Adverse Event|0|||
164115725|NCT01898598|592785343|FG000|Overall Study|Withdrawal by Subject|3|||
164115726|NCT01898598|592785344|FG001|Overall Study|Withdrawal by Subject|0|||
164115727|NCT01898598|592785343|FG000|Overall Study|Lost to Follow-up|0|||
164115728|NCT01898598|592785344|FG001|Overall Study|Lost to Follow-up|1|||
164115729|NCT01898598|592785343|FG000|Overall Study|Other|0|||
164115730|NCT01898598|592785344|FG001|Overall Study|Other|1|||
164115731|NCT03833427|592785345|FG000|Overall Study|Death|4|||
164115732|NCT03833427|592785346|FG001|Overall Study|Death|2|||
164115733|NCT03833427|592785347|FG002|Overall Study|Death|9|||
164115734|NCT03833427|592785348|FG003|Overall Study|Death|11|||
164115735|NCT03833427|592785349|FG004|Overall Study|Death|0|||
164115736|NCT03833427|592785350|FG005|Overall Study|Death|0|||
164115737|NCT03833427|592785351|FG006|Overall Study|Death|0|||
164115738|NCT03833427|592785345|FG000|Overall Study|Withdrawal by Subject|0|||
164115739|NCT03833427|592785346|FG001|Overall Study|Withdrawal by Subject|1|||
164115740|NCT03833427|592785347|FG002|Overall Study|Withdrawal by Subject|1|||
164115741|NCT03833427|592785348|FG003|Overall Study|Withdrawal by Subject|0|||
164115742|NCT03833427|592785349|FG004|Overall Study|Withdrawal by Subject|0|||
164115743|NCT03833427|592785350|FG005|Overall Study|Withdrawal by Subject|0|||
164115744|NCT03833427|592785351|FG006|Overall Study|Withdrawal by Subject|0|||
164115745|NCT03833427|592785345|FG000|Overall Study|Sponsor Decision|0|||
164115746|NCT03833427|592785346|FG001|Overall Study|Sponsor Decision|0|||
164115747|NCT03833427|592785347|FG002|Overall Study|Sponsor Decision|1|||
164115748|NCT03833427|592785348|FG003|Overall Study|Sponsor Decision|3|||
164115749|NCT03833427|592785349|FG004|Overall Study|Sponsor Decision|0|||
164115750|NCT03833427|592785350|FG005|Overall Study|Sponsor Decision|0|||
164115751|NCT03833427|592785351|FG006|Overall Study|Sponsor Decision|0|||
164115752|NCT03294317|592785357|FG000|Overall Study|Physician Decision|1|||
164115753|NCT03294317|592785357|FG000|Overall Study|Withdrawal by Subject|6|||
164115754|NCT03294317|592785357|FG000|Overall Study|Lost to Follow-up|1|||
164115755|NCT03294317|592785357|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
164115756|NCT03294317|592785357|FG000|Overall Study|Failed HB lead implant|8|||
164115757|NCT03294317|592785357|FG000|Overall Study|Received CRT instead|1|||
164115758|NCT03294317|592785357|FG000|Overall Study|Exited after lead revision|2|||
164115759|NCT03847974|592785358|FG000|Overall Study|relocated out of region|3|||
164115760|NCT03847974|592785358|FG000|Overall Study|Withdrawal by Subject|2|||
164115761|NCT03847974|592785358|FG000|Overall Study|Adverse Event|1|||
164115762|NCT00593827|592785364|FG000|Overall Study|On Active Treatment/Pending|0|||
164115763|NCT00593827|592785365|FG001|Overall Study|On Active Treatment/Pending|2|||
164115764|NCT01833169|592785369|FG000|Overall Study|Disease Progression|99|||
164115765|NCT01833169|592785369|FG000|Overall Study|Adverse Event|33|||
164115766|NCT01833169|592785369|FG000|Overall Study|Withdrawal by Subject|9|||
164115767|NCT01833169|592785369|FG000|Overall Study|Death|3|||
164115768|NCT01833169|592785369|FG000|Overall Study|Physician Decision|2|||
164115769|NCT05467540|592785370|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
164115770|NCT05467540|592785370|FG000|3-Month Follow-up|Lost to Follow-up|4|||
164115771|NCT05467540|592785370|FG000|3-Month Follow-up|Death|5|||
164115772|NCT05467540|592785370|FG000|12-Month Follow-up|Lost to Follow-up|6|||
164115773|NCT05467540|592785370|FG000|12-Month Follow-up|Death|8|||
164115774|NCT05467540|592785370|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
164115775|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
164115776|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
164115777|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
164115778|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
164115779|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
164115780|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
164115781|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
164115782|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
164115783|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
164115784|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
164115785|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
164115786|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
164115787|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
164115788|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
164115789|NCT04592419|592787704|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
164115790|NCT04592419|592787705|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
164115791|NCT04592419|592787704|FG000|Open-Label Extension Period|Adverse Event|1|||
164115792|NCT04592419|592787705|FG001|Open-Label Extension Period|Adverse Event|2|||
164115793|NCT04592419|592787704|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
164115794|NCT04592419|592787705|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
164115795|NCT04592419|592787704|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
164115796|NCT04592419|592787705|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
164115797|NCT04592419|592787704|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
164115798|NCT04592419|592787705|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
164115799|NCT04592419|592787704|FG000|Open-Label Extension Period|Sponsor Request|73|||
164115800|NCT04592419|592787705|FG001|Open-Label Extension Period|Sponsor Request|84|||
164115801|NCT05693805|592787710|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
164115802|NCT05693805|592787711|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
164115803|NCT02943993|592787712|FG000|Overall Study|Withdrawal by Subject|52|||
164115804|NCT02943993|592787712|FG000|Overall Study|Transfer to another institution|6|||
164115805|NCT02943993|592787712|FG000|Overall Study|Lost to Follow-up|135|||
164115806|NCT02943993|592787712|FG000|Overall Study|Death|98|||
164115807|NCT02943993|592787712|FG000|Overall Study|Other reason for premature termination|32|||
164115808|NCT02943993|592787712|FG000|Overall Study|Missing reason for termination|7|||
164115809|NCT02152982|592787715|FG000|Overall Study|Withdrawal by Subject|17|||
164115810|NCT02152982|592787716|FG001|Overall Study|Withdrawal by Subject|16|||
164115811|NCT02152982|592787715|FG000|Overall Study|Did not start treatment|11|||
164115812|NCT02152982|592787716|FG001|Overall Study|Did not start treatment|5|||
164115813|NCT02152982|592787715|FG000|Overall Study|Disease progression|41|||
164115814|NCT02152982|592787716|FG001|Overall Study|Disease progression|52|||
164115815|NCT02152982|592787715|FG000|Overall Study|Adverse Event|7|||
164115816|NCT02152982|592787716|FG001|Overall Study|Adverse Event|12|||
164115817|NCT02152982|592787715|FG000|Overall Study|Complicating disease|1|||
164115818|NCT02152982|592787716|FG001|Overall Study|Complicating disease|1|||
164115819|NCT02152982|592787715|FG000|Overall Study|Death|0|||
164115820|NCT02152982|592787716|FG001|Overall Study|Death|3|||
164115821|NCT02152982|592787715|FG000|Overall Study|Physician Decision|3|||
164115822|NCT02152982|592787716|FG001|Overall Study|Physician Decision|0|||
164115823|NCT04968925|592787717|FG000|Phase I- Period 1|COVID-19 related|0|||
164115824|NCT04968925|592787718|FG001|Phase I- Period 1|COVID-19 related|1|||
164115825|NCT04968925|592787719|FG002|Phase I- Period 1|COVID-19 related|0|||
164115826|NCT04968925|592787720|FG003|Phase I- Period 1|COVID-19 related|0|||
164115827|NCT04968925|592787717|FG000|Phase I- Period 1|Subject enrolled in error|1|||
164115828|NCT04968925|592787718|FG001|Phase I- Period 1|Subject enrolled in error|1|||
164115829|NCT04968925|592787719|FG002|Phase I- Period 1|Subject enrolled in error|0|||
164115830|NCT04968925|592787720|FG003|Phase I- Period 1|Subject enrolled in error|0|||
164115831|NCT04968925|592787717|FG000|Phase II- Period 1|COVID-19 Related|0|||
164115832|NCT04968925|592787718|FG001|Phase II- Period 1|COVID-19 Related|0|||
164115833|NCT04968925|592787719|FG002|Phase II- Period 1|COVID-19 Related|6|||
164115834|NCT04968925|592787720|FG003|Phase II- Period 1|COVID-19 Related|6|||
164115835|NCT04968925|592787717|FG000|Phase II- Period 1|Subject enrolled in error|0|||
164115836|NCT04968925|592787718|FG001|Phase II- Period 1|Subject enrolled in error|0|||
164115837|NCT04968925|592787719|FG002|Phase II- Period 1|Subject enrolled in error|1|||
164115838|NCT04968925|592787720|FG003|Phase II- Period 1|Subject enrolled in error|0|||
164115839|NCT04968925|592787717|FG000|Phase II -Period 2|COVID-19 related|0|||
164115840|NCT04968925|592787718|FG001|Phase II -Period 2|COVID-19 related|0|||
164115841|NCT04968925|592787719|FG002|Phase II -Period 2|COVID-19 related|4|||
164115842|NCT04968925|592787720|FG003|Phase II -Period 2|COVID-19 related|3|||
164115843|NCT04968925|592787717|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
164115844|NCT04968925|592787718|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
164115845|NCT04968925|592787719|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
164115846|NCT04968925|592787720|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
164115847|NCT00835796|592787721|FG000|First Intervention|Withdrawal by Subject|0|||
164115848|NCT00835796|592787722|FG001|First Intervention|Withdrawal by Subject|1|||
164115849|NCT00876265|592787723|FG000|Overall Study|Miscellaneous reasons|4|||
164115850|NCT00876265|592787723|FG000|Overall Study|Lost to Follow-up|6|||
164115851|NCT00876265|592787723|FG000|Overall Study|Withdrawal by Subject|2|||
164115852|NCT00695110|592787726|FG000|Treatment Period 1|Adverse Event|1|||
164115853|NCT00695110|592787726|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164115854|NCT00695110|592787726|FG000|Treatment Period 3|Withdrawal by Subject|1|||
164115855|NCT00695110|592787726|FG000|Treatment Period 4|Adverse Event|1|||
164115856|NCT02510261|592787730|FG000|Overall Study|Adverse Event|5|||
164115857|NCT02510261|592787731|FG001|Overall Study|Adverse Event|8|||
164115858|NCT02510261|592787732|FG002|Overall Study|Adverse Event|0|||
164115859|NCT02510261|592787730|FG000|Overall Study|Physician Decision|1|||
164115860|NCT02510261|592787731|FG001|Overall Study|Physician Decision|5|||
164115861|NCT02510261|592787732|FG002|Overall Study|Physician Decision|0|||
164115862|NCT02510261|592787730|FG000|Overall Study|Death|19|||
164115863|NCT02510261|592787731|FG001|Overall Study|Death|19|||
164115864|NCT02510261|592787732|FG002|Overall Study|Death|0|||
164115865|NCT02510261|592787730|FG000|Overall Study|Withdrawal by Subject|3|||
164115866|NCT02510261|592787731|FG001|Overall Study|Withdrawal by Subject|10|||
164115867|NCT02510261|592787732|FG002|Overall Study|Withdrawal by Subject|3|||
164115868|NCT02780167|592787734|FG000|Overall Study|Adverse Event|9|||
164115869|NCT02780167|592787735|FG001|Overall Study|Adverse Event|8|||
164115870|NCT02780167|592787736|FG002|Overall Study|Adverse Event|8|||
164115871|NCT02780167|592787737|FG003|Overall Study|Adverse Event|12|||
164115872|NCT02780167|592787738|FG004|Overall Study|Adverse Event|8|||
164115873|NCT02780167|592787734|FG000|Overall Study|Lack of Efficacy|6|||
164115874|NCT02780167|592787735|FG001|Overall Study|Lack of Efficacy|5|||
164115875|NCT02780167|592787736|FG002|Overall Study|Lack of Efficacy|6|||
164115876|NCT02780167|592787737|FG003|Overall Study|Lack of Efficacy|1|||
164115877|NCT02780167|592787738|FG004|Overall Study|Lack of Efficacy|0|||
164115878|NCT02780167|592787734|FG000|Overall Study|Lost to Follow-up|2|||
164115879|NCT02780167|592787735|FG001|Overall Study|Lost to Follow-up|0|||
164115880|NCT02780167|592787736|FG002|Overall Study|Lost to Follow-up|1|||
164115881|NCT02780167|592787737|FG003|Overall Study|Lost to Follow-up|0|||
164115882|NCT02780167|592787738|FG004|Overall Study|Lost to Follow-up|0|||
164115883|NCT02780167|592787734|FG000|Overall Study|Does not meet entrance criteria|0|||
164115884|NCT02780167|592787735|FG001|Overall Study|Does not meet entrance criteria|0|||
164115885|NCT02780167|592787736|FG002|Overall Study|Does not meet entrance criteria|1|||
164115886|NCT02780167|592787737|FG003|Overall Study|Does not meet entrance criteria|0|||
164115887|NCT02780167|592787738|FG004|Overall Study|Does not meet entrance criteria|0|||
164115888|NCT02780167|592787734|FG000|Overall Study|No longer meets eligibility criteria|0|||
164115889|NCT02780167|592787735|FG001|Overall Study|No longer meets eligibility criteria|0|||
164115890|NCT02780167|592787736|FG002|Overall Study|No longer meets eligibility criteria|0|||
164115891|NCT02780167|592787737|FG003|Overall Study|No longer meets eligibility criteria|1|||
164115892|NCT02780167|592787738|FG004|Overall Study|No longer meets eligibility criteria|1|||
164115893|NCT02780167|592787734|FG000|Overall Study|Protocol Violation|5|||
164115894|NCT02780167|592787735|FG001|Overall Study|Protocol Violation|5|||
164115895|NCT02780167|592787736|FG002|Overall Study|Protocol Violation|1|||
164115896|NCT02780167|592787737|FG003|Overall Study|Protocol Violation|1|||
164115897|NCT02780167|592787738|FG004|Overall Study|Protocol Violation|2|||
164115898|NCT02780167|592787734|FG000|Overall Study|Withdrawal by Subject|6|||
164115899|NCT02780167|592787735|FG001|Overall Study|Withdrawal by Subject|4|||
164115900|NCT02780167|592787736|FG002|Overall Study|Withdrawal by Subject|4|||
164115901|NCT02780167|592787737|FG003|Overall Study|Withdrawal by Subject|3|||
164115902|NCT02780167|592787738|FG004|Overall Study|Withdrawal by Subject|4|||
164115903|NCT02780167|592787734|FG000|Overall Study|Other|0|||
164115904|NCT02780167|592787735|FG001|Overall Study|Other|0|||
164115905|NCT02780167|592787736|FG002|Overall Study|Other|3|||
164115906|NCT02780167|592787737|FG003|Overall Study|Other|1|||
164115907|NCT02780167|592787738|FG004|Overall Study|Other|2|||
164115908|NCT02315066|592787740|FG000|Overall Study|Lost to Follow-up|0|||
164115909|NCT02315066|592787741|FG001|Overall Study|Lost to Follow-up|1|||
164115910|NCT02315066|592787742|FG002|Overall Study|Lost to Follow-up|1|||
164115911|NCT02315066|592787743|FG003|Overall Study|Lost to Follow-up|0|||
164115912|NCT02315066|592787744|FG004|Overall Study|Lost to Follow-up|1|||
164115913|NCT02315066|592787745|FG005|Overall Study|Lost to Follow-up|0|||
164115914|NCT02315066|592787746|FG006|Overall Study|Lost to Follow-up|2|||
164115915|NCT02315066|592787747|FG007|Overall Study|Lost to Follow-up|1|||
164115916|NCT02315066|592787748|FG008|Overall Study|Lost to Follow-up|0|||
164115917|NCT02315066|592787749|FG009|Overall Study|Lost to Follow-up|0|||
164115918|NCT02315066|592787750|FG010|Overall Study|Lost to Follow-up|1|||
164115919|NCT02315066|592787751|FG011|Overall Study|Lost to Follow-up|2|||
164115920|NCT02315066|592787752|FG012|Overall Study|Lost to Follow-up|0|||
164115921|NCT02315066|592787753|FG013|Overall Study|Lost to Follow-up|4|||
164115922|NCT02315066|592787740|FG000|Overall Study|Death|2|||
164115923|NCT02315066|592787741|FG001|Overall Study|Death|7|||
164115924|NCT02315066|592787742|FG002|Overall Study|Death|6|||
164115925|NCT02315066|592787743|FG003|Overall Study|Death|11|||
164115926|NCT02315066|592787744|FG004|Overall Study|Death|10|||
164115927|NCT02315066|592787745|FG005|Overall Study|Death|3|||
164115928|NCT02315066|592787746|FG006|Overall Study|Death|9|||
164115929|NCT02315066|592787747|FG007|Overall Study|Death|9|||
164115930|NCT02315066|592787748|FG008|Overall Study|Death|10|||
164115931|NCT02315066|592787749|FG009|Overall Study|Death|8|||
164115932|NCT02315066|592787750|FG010|Overall Study|Death|10|||
164115933|NCT02315066|592787751|FG011|Overall Study|Death|7|||
164115934|NCT02315066|592787752|FG012|Overall Study|Death|8|||
164115935|NCT02315066|592787753|FG013|Overall Study|Death|21|||
164115936|NCT02315066|592787740|FG000|Overall Study|Other|0|||
164115937|NCT02315066|592787741|FG001|Overall Study|Other|0|||
164115938|NCT02315066|592787742|FG002|Overall Study|Other|0|||
164115939|NCT02315066|592787743|FG003|Overall Study|Other|0|||
164115940|NCT02315066|592787744|FG004|Overall Study|Other|0|||
164115941|NCT02315066|592787745|FG005|Overall Study|Other|0|||
164115942|NCT02315066|592787746|FG006|Overall Study|Other|0|||
164115943|NCT02315066|592787747|FG007|Overall Study|Other|1|||
164115944|NCT02315066|592787748|FG008|Overall Study|Other|1|||
164115945|NCT02315066|592787749|FG009|Overall Study|Other|2|||
164115946|NCT02315066|592787750|FG010|Overall Study|Other|0|||
164115947|NCT02315066|592787751|FG011|Overall Study|Other|0|||
164115948|NCT02315066|592787752|FG012|Overall Study|Other|0|||
164115949|NCT02315066|592787753|FG013|Overall Study|Other|0|||
164115950|NCT02315066|592787740|FG000|Overall Study|Subject refused further follow-up|0|||
164115951|NCT02315066|592787741|FG001|Overall Study|Subject refused further follow-up|2|||
164115952|NCT02315066|592787742|FG002|Overall Study|Subject refused further follow-up|2|||
164115953|NCT02315066|592787743|FG003|Overall Study|Subject refused further follow-up|0|||
164115954|NCT02315066|592787744|FG004|Overall Study|Subject refused further follow-up|0|||
164115955|NCT02315066|592787745|FG005|Overall Study|Subject refused further follow-up|0|||
164115956|NCT02315066|592787746|FG006|Overall Study|Subject refused further follow-up|2|||
164115957|NCT02315066|592787747|FG007|Overall Study|Subject refused further follow-up|3|||
164115958|NCT02315066|592787748|FG008|Overall Study|Subject refused further follow-up|0|||
164115959|NCT02315066|592787749|FG009|Overall Study|Subject refused further follow-up|1|||
164115960|NCT02315066|592787750|FG010|Overall Study|Subject refused further follow-up|1|||
164115961|NCT02315066|592787751|FG011|Overall Study|Subject refused further follow-up|2|||
164115962|NCT02315066|592787752|FG012|Overall Study|Subject refused further follow-up|2|||
164115963|NCT02315066|592787753|FG013|Overall Study|Subject refused further follow-up|4|||
164115964|NCT02315066|592787740|FG000|Overall Study|Study ongoing at date of cut-off|0|||
164115965|NCT02315066|592787741|FG001|Overall Study|Study ongoing at date of cut-off|0|||
164115966|NCT02315066|592787742|FG002|Overall Study|Study ongoing at date of cut-off|0|||
164115967|NCT02315066|592787743|FG003|Overall Study|Study ongoing at date of cut-off|0|||
164115968|NCT02315066|592787744|FG004|Overall Study|Study ongoing at date of cut-off|0|||
164115969|NCT02315066|592787745|FG005|Overall Study|Study ongoing at date of cut-off|0|||
164115970|NCT02315066|592787746|FG006|Overall Study|Study ongoing at date of cut-off|0|||
164115971|NCT02315066|592787747|FG007|Overall Study|Study ongoing at date of cut-off|0|||
164115972|NCT02315066|592787748|FG008|Overall Study|Study ongoing at date of cut-off|0|||
164115973|NCT02315066|592787749|FG009|Overall Study|Study ongoing at date of cut-off|0|||
164115974|NCT02315066|592787750|FG010|Overall Study|Study ongoing at date of cut-off|0|||
164115975|NCT02315066|592787751|FG011|Overall Study|Study ongoing at date of cut-off|0|||
164115976|NCT02315066|592787752|FG012|Overall Study|Study ongoing at date of cut-off|0|||
164115977|NCT02315066|592787753|FG013|Overall Study|Study ongoing at date of cut-off|1|||
164115978|NCT02003222|592787754|FG000|Induction|Never started treatment|0|||
164115979|NCT02003222|592787755|FG001|Induction|Never started treatment|0|||
164115980|NCT02003222|592787756|FG002|Induction|Never started treatment|0|||
164115981|NCT02003222|592787757|FG003|Induction|Never started treatment|0|||
164115982|NCT02003222|592787758|FG004|Induction|Never started treatment|8|||
164115983|NCT02003222|592787754|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
164115984|NCT02003222|592787755|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
164115985|NCT02003222|592787756|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
164115986|NCT02003222|592787757|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
164115987|NCT02003222|592787758|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
164115988|NCT02003222|592787754|FG000|Induction|Adverse Event|0|||
164115989|NCT02003222|592787755|FG001|Induction|Adverse Event|0|||
164115990|NCT02003222|592787756|FG002|Induction|Adverse Event|0|||
164115991|NCT02003222|592787757|FG003|Induction|Adverse Event|0|||
164115992|NCT02003222|592787758|FG004|Induction|Adverse Event|13|||
164115993|NCT02003222|592787754|FG000|Induction|Alternative therapy|0|||
164115994|NCT02003222|592787755|FG001|Induction|Alternative therapy|0|||
164115995|NCT02003222|592787756|FG002|Induction|Alternative therapy|0|||
164115996|NCT02003222|592787757|FG003|Induction|Alternative therapy|0|||
164115997|NCT02003222|592787758|FG004|Induction|Alternative therapy|12|||
164115998|NCT02003222|592787754|FG000|Induction|Disease progression|0|||
164115999|NCT02003222|592787755|FG001|Induction|Disease progression|0|||
164116000|NCT02003222|592787756|FG002|Induction|Disease progression|0|||
164116001|NCT02003222|592787757|FG003|Induction|Disease progression|0|||
164116002|NCT02003222|592787758|FG004|Induction|Disease progression|22|||
164116003|NCT02003222|592787754|FG000|Induction|Death|0|||
164116004|NCT02003222|592787755|FG001|Induction|Death|0|||
164116005|NCT02003222|592787756|FG002|Induction|Death|0|||
164116006|NCT02003222|592787757|FG003|Induction|Death|0|||
164116007|NCT02003222|592787758|FG004|Induction|Death|3|||
164116008|NCT02003222|592787754|FG000|Induction|Withdrawal by Subject|0|||
164116009|NCT02003222|592787755|FG001|Induction|Withdrawal by Subject|0|||
164116010|NCT02003222|592787756|FG002|Induction|Withdrawal by Subject|0|||
164116011|NCT02003222|592787757|FG003|Induction|Withdrawal by Subject|0|||
164116012|NCT02003222|592787758|FG004|Induction|Withdrawal by Subject|8|||
164116013|NCT02003222|592787754|FG000|Induction|Other reasons|0|||
164116014|NCT02003222|592787755|FG001|Induction|Other reasons|0|||
164116015|NCT02003222|592787756|FG002|Induction|Other reasons|0|||
164116016|NCT02003222|592787757|FG003|Induction|Other reasons|0|||
164116017|NCT02003222|592787758|FG004|Induction|Other reasons|22|||
164116018|NCT02003222|592787754|FG000|Intensification|Never started treatment|0|||
164116019|NCT02003222|592787755|FG001|Intensification|Never started treatment|0|||
164116020|NCT02003222|592787756|FG002|Intensification|Never started treatment|0|||
164116021|NCT02003222|592787757|FG003|Intensification|Never started treatment|0|||
164116022|NCT02003222|592787758|FG004|Intensification|Never started treatment|2|||
164116023|NCT02003222|592787754|FG000|Intensification|Adverse Event|0|||
164116024|NCT02003222|592787755|FG001|Intensification|Adverse Event|0|||
164116025|NCT02003222|592787756|FG002|Intensification|Adverse Event|0|||
164116026|NCT02003222|592787757|FG003|Intensification|Adverse Event|0|||
164116027|NCT02003222|592787758|FG004|Intensification|Adverse Event|6|||
164116028|NCT02003222|592787754|FG000|Intensification|Alternative therapy|0|||
164116029|NCT02003222|592787755|FG001|Intensification|Alternative therapy|0|||
164116030|NCT02003222|592787756|FG002|Intensification|Alternative therapy|0|||
164116031|NCT02003222|592787757|FG003|Intensification|Alternative therapy|0|||
164116032|NCT02003222|592787758|FG004|Intensification|Alternative therapy|8|||
164116033|NCT02003222|592787754|FG000|Intensification|Disease progression|0|||
164116034|NCT02003222|592787755|FG001|Intensification|Disease progression|0|||
164116035|NCT02003222|592787756|FG002|Intensification|Disease progression|0|||
164116036|NCT02003222|592787757|FG003|Intensification|Disease progression|0|||
164116037|NCT02003222|592787758|FG004|Intensification|Disease progression|18|||
164116038|NCT02003222|592787754|FG000|Intensification|Withdrawal by Subject|0|||
164116039|NCT02003222|592787755|FG001|Intensification|Withdrawal by Subject|0|||
164116040|NCT02003222|592787756|FG002|Intensification|Withdrawal by Subject|0|||
164116041|NCT02003222|592787757|FG003|Intensification|Withdrawal by Subject|0|||
164116042|NCT02003222|592787758|FG004|Intensification|Withdrawal by Subject|5|||
164116043|NCT02003222|592787754|FG000|Intensification|Other reasons|0|||
164116044|NCT02003222|592787755|FG001|Intensification|Other reasons|0|||
164116045|NCT02003222|592787756|FG002|Intensification|Other reasons|0|||
164116046|NCT02003222|592787757|FG003|Intensification|Other reasons|0|||
164116047|NCT02003222|592787758|FG004|Intensification|Other reasons|8|||
164116048|NCT04941768|592787763|FG000|Overall Study|Lost to Follow-up|10|||
164116049|NCT04941768|592787763|FG000|Overall Study|Death|24|||
164116050|NCT04941768|592787763|FG000|Overall Study|Progressive Disease|4|||
164116051|NCT04941768|592787763|FG000|Overall Study|Withdrawal by Subject|4|||
164116052|NCT04941768|592787763|FG000|Overall Study|Other|3|||
164116053|NCT04941768|592787763|FG000|Overall Study|Treatment ongoing|21|||
164116054|NCT04941768|592787763|FG000|Overall Study|Off treatment and in follow-up|21|||
164116055|NCT03302078|592787765|FG000|Washout Period|Adverse Event|0|||
164116056|NCT03302078|592787766|FG001|Washout Period|Adverse Event|1|||
164116057|NCT01886872|592787767|FG000|Overall Study|Ineligible|7|||
164116058|NCT01886872|592787768|FG001|Overall Study|Ineligible|4|||
164116059|NCT01886872|592787769|FG002|Overall Study|Ineligible|12|||
164116060|NCT05148299|592787770|FG000|Treatment Period|Adverse Event|1|||
164116061|NCT05148299|592787770|FG000|Treatment Period|Physician Decision|1|||
164116062|NCT05148299|592787770|FG000|Treatment Period|Death|1|||
164116063|NCT05148299|592787770|FG000|Follow-up Period|Death|3|||
164116064|NCT02161549|592787771|FG000|Overall Study|Physician Decision|6|||
164116065|NCT02161549|592787772|FG001|Overall Study|Physician Decision|2|||
164116066|NCT01957150|592787773|FG000|Overall Study|Adverse Event|23|||
164116067|NCT01957150|592787774|FG001|Overall Study|Adverse Event|20|||
164116068|NCT01957150|592787773|FG000|Overall Study|Withdrawal by Subject|13|||
164116069|NCT01957150|592787774|FG001|Overall Study|Withdrawal by Subject|17|||
164116070|NCT01957150|592787773|FG000|Overall Study|Physician Decision|3|||
164116071|NCT01957150|592787774|FG001|Overall Study|Physician Decision|6|||
164116072|NCT01957150|592787773|FG000|Overall Study|Lost to Follow-up|4|||
164116073|NCT01957150|592787774|FG001|Overall Study|Lost to Follow-up|4|||
164116074|NCT01957150|592787773|FG000|Overall Study|Protocol Violation|1|||
164116075|NCT01957150|592787774|FG001|Overall Study|Protocol Violation|0|||
164116076|NCT01957150|592787773|FG000|Overall Study|Lack of Efficacy|11|||
164116077|NCT01957150|592787774|FG001|Overall Study|Lack of Efficacy|11|||
164116078|NCT01856192|592787775|FG000|Overall Study|Adverse Event|12|||
164116079|NCT01856192|592787776|FG001|Overall Study|Adverse Event|4|||
164116080|NCT01856192|592787775|FG000|Overall Study|Alternative therapy|0|||
164116081|NCT01856192|592787776|FG001|Overall Study|Alternative therapy|3|||
164116082|NCT01856192|592787775|FG000|Overall Study|Death|3|||
164116083|NCT01856192|592787776|FG001|Overall Study|Death|5|||
164116084|NCT01856192|592787775|FG000|Overall Study|Lack of Efficacy|0|||
164116085|NCT01856192|592787776|FG001|Overall Study|Lack of Efficacy|5|||
164116086|NCT01856192|592787775|FG000|Overall Study|Withdrawal by Subject|1|||
164116087|NCT01856192|592787776|FG001|Overall Study|Withdrawal by Subject|1|||
164116088|NCT01856192|592787775|FG000|Overall Study|Other diseases|1|||
164116089|NCT01856192|592787776|FG001|Overall Study|Other diseases|0|||
164116090|NCT01856192|592787775|FG000|Overall Study|Never started treatment|7|||
164116091|NCT01856192|592787776|FG001|Overall Study|Never started treatment|5|||
164116092|NCT01856192|592787775|FG000|Overall Study|Path ineligible|20|||
164116093|NCT01856192|592787776|FG001|Overall Study|Path ineligible|34|||
164116094|NCT01856192|592787775|FG000|Overall Study|Non-path ineligible|2|||
164116095|NCT01856192|592787776|FG001|Overall Study|Non-path ineligible|2|||
164116096|NCT01856192|592787775|FG000|Overall Study|Physician Decision|1|||
164116097|NCT01856192|592787776|FG001|Overall Study|Physician Decision|1|||
164116098|NCT01856192|592787775|FG000|Overall Study|Suspicion of progressive disease|1|||
164116099|NCT01856192|592787776|FG001|Overall Study|Suspicion of progressive disease|0|||
164116100|NCT01856192|592787775|FG000|Overall Study|Non-compliance|1|||
164116101|NCT01856192|592787776|FG001|Overall Study|Non-compliance|0|||
164116102|NCT00098475|592787777|FG000|Step 1|Progressive disease|33|||
164116103|NCT00098475|592787778|FG001|Step 1|Progressive disease|35|||
164116104|NCT00098475|592787779|FG002|Step 1|Progressive disease|2|||
164116105|NCT00098475|592787780|FG003|Step 1|Progressive disease|1|||
164116106|NCT00098475|592787777|FG000|Step 1|Adverse Event|56|||
164116107|NCT00098475|592787778|FG001|Step 1|Adverse Event|37|||
164116108|NCT00098475|592787779|FG002|Step 1|Adverse Event|0|||
164116109|NCT00098475|592787780|FG003|Step 1|Adverse Event|1|||
164116110|NCT00098475|592787777|FG000|Step 1|Death|8|||
164116111|NCT00098475|592787778|FG001|Step 1|Death|5|||
164116112|NCT00098475|592787779|FG002|Step 1|Death|0|||
164116113|NCT00098475|592787780|FG003|Step 1|Death|1|||
164116114|NCT00098475|592787777|FG000|Step 1|Withdrawal by Subject|14|||
164116115|NCT00098475|592787778|FG001|Step 1|Withdrawal by Subject|11|||
164116116|NCT00098475|592787779|FG002|Step 1|Withdrawal by Subject|0|||
164116117|NCT00098475|592787780|FG003|Step 1|Withdrawal by Subject|0|||
164116118|NCT00098475|592787777|FG000|Step 1|Physician Decision|5|||
164116119|NCT00098475|592787778|FG001|Step 1|Physician Decision|2|||
164116120|NCT00098475|592787779|FG002|Step 1|Physician Decision|0|||
164116121|NCT00098475|592787780|FG003|Step 1|Physician Decision|0|||
164116122|NCT00098475|592787777|FG000|Step 1|Alternative therapy|31|||
164116123|NCT00098475|592787778|FG001|Step 1|Alternative therapy|43|||
164116124|NCT00098475|592787779|FG002|Step 1|Alternative therapy|1|||
164116125|NCT00098475|592787780|FG003|Step 1|Alternative therapy|0|||
164116126|NCT00098475|592787777|FG000|Step 1|Other disease|2|||
164116127|NCT00098475|592787778|FG001|Step 1|Other disease|1|||
164116128|NCT00098475|592787779|FG002|Step 1|Other disease|1|||
164116129|NCT00098475|592787780|FG003|Step 1|Other disease|0|||
164116130|NCT00098475|592787777|FG000|Step 1|Never started treatment|0|||
164116131|NCT00098475|592787778|FG001|Step 1|Never started treatment|2|||
164116132|NCT00098475|592787779|FG002|Step 1|Never started treatment|0|||
164116133|NCT00098475|592787780|FG003|Step 1|Never started treatment|0|||
164116134|NCT00098475|592787777|FG000|Step 1|Still on treatment as of this analysis|14|||
164116135|NCT00098475|592787778|FG001|Step 1|Still on treatment as of this analysis|27|||
164116136|NCT00098475|592787779|FG002|Step 1|Still on treatment as of this analysis|0|||
164116137|NCT00098475|592787780|FG003|Step 1|Still on treatment as of this analysis|0|||
164116138|NCT00098475|592787777|FG000|Step 1|Knee surgery|1|||
164116139|NCT00098475|592787778|FG001|Step 1|Knee surgery|0|||
164116140|NCT00098475|592787779|FG002|Step 1|Knee surgery|0|||
164116141|NCT00098475|592787780|FG003|Step 1|Knee surgery|0|||
164116142|NCT00098475|592787777|FG000|Step 1|Complications|1|||
164116143|NCT00098475|592787778|FG001|Step 1|Complications|0|||
164116144|NCT00098475|592787779|FG002|Step 1|Complications|0|||
164116145|NCT00098475|592787780|FG003|Step 1|Complications|0|||
164116146|NCT00098475|592787777|FG000|Step 1|Cannot comply due to other tx|0|||
164116147|NCT00098475|592787778|FG001|Step 1|Cannot comply due to other tx|1|||
164116148|NCT00098475|592787779|FG002|Step 1|Cannot comply due to other tx|0|||
164116149|NCT00098475|592787780|FG003|Step 1|Cannot comply due to other tx|0|||
164116150|NCT00098475|592787777|FG000|Step 1|Both patient and physician's decision|2|||
164116151|NCT00098475|592787778|FG001|Step 1|Both patient and physician's decision|1|||
164116152|NCT00098475|592787779|FG002|Step 1|Both patient and physician's decision|0|||
164116153|NCT00098475|592787780|FG003|Step 1|Both patient and physician's decision|0|||
164116154|NCT00098475|592787777|FG000|Step 1|Incorrect disease assessment|2|||
164116155|NCT00098475|592787778|FG001|Step 1|Incorrect disease assessment|0|||
164116156|NCT00098475|592787779|FG002|Step 1|Incorrect disease assessment|0|||
164116157|NCT00098475|592787780|FG003|Step 1|Incorrect disease assessment|0|||
164116158|NCT00098475|592787777|FG000|Step 1|Off treatment for > specified timeframe|1|||
164116159|NCT00098475|592787778|FG001|Step 1|Off treatment for > specified timeframe|1|||
164116160|NCT00098475|592787779|FG002|Step 1|Off treatment for > specified timeframe|0|||
164116161|NCT00098475|592787780|FG003|Step 1|Off treatment for > specified timeframe|0|||
164116162|NCT00098475|592787777|FG000|Step 1|Declining performance status|0|||
164116163|NCT00098475|592787778|FG001|Step 1|Declining performance status|1|||
164116164|NCT00098475|592787779|FG002|Step 1|Declining performance status|0|||
164116165|NCT00098475|592787780|FG003|Step 1|Declining performance status|0|||
164116166|NCT00098475|592787777|FG000|Step 1|Insurance issue|0|||
164116167|NCT00098475|592787778|FG001|Step 1|Insurance issue|1|||
164116168|NCT00098475|592787779|FG002|Step 1|Insurance issue|0|||
164116169|NCT00098475|592787780|FG003|Step 1|Insurance issue|0|||
164116170|NCT00098475|592787777|FG000|Step 1|Rising paraprotein|0|||
164116171|NCT00098475|592787778|FG001|Step 1|Rising paraprotein|1|||
164116172|NCT00098475|592787779|FG002|Step 1|Rising paraprotein|0|||
164116173|NCT00098475|592787780|FG003|Step 1|Rising paraprotein|0|||
164116174|NCT00098475|592787777|FG000|Step 1|Referred to other physicians|0|||
164116175|NCT00098475|592787778|FG001|Step 1|Referred to other physicians|1|||
164116176|NCT00098475|592787779|FG002|Step 1|Referred to other physicians|0|||
164116177|NCT00098475|592787780|FG003|Step 1|Referred to other physicians|0|||
164116178|NCT00098475|592787777|FG000|Step 1|Criteria to continue treatment not met|0|||
164116179|NCT00098475|592787778|FG001|Step 1|Criteria to continue treatment not met|1|||
164116180|NCT00098475|592787779|FG002|Step 1|Criteria to continue treatment not met|0|||
164116181|NCT00098475|592787780|FG003|Step 1|Criteria to continue treatment not met|0|||
164116182|NCT00098475|592787777|FG000|Step 1|Misinterpretation of lab data|0|||
164116183|NCT00098475|592787778|FG001|Step 1|Misinterpretation of lab data|1|||
164116184|NCT00098475|592787779|FG002|Step 1|Misinterpretation of lab data|0|||
164116185|NCT00098475|592787780|FG003|Step 1|Misinterpretation of lab data|0|||
164116186|NCT00098475|592787777|FG000|Step 1|Patient fell with fracture|1|||
164116187|NCT00098475|592787778|FG001|Step 1|Patient fell with fracture|0|||
164116188|NCT00098475|592787779|FG002|Step 1|Patient fell with fracture|0|||
164116189|NCT00098475|592787780|FG003|Step 1|Patient fell with fracture|0|||
164116190|NCT00098475|592787777|FG000|Step 1|Not documented|0|||
164116191|NCT00098475|592787778|FG001|Step 1|Not documented|1|||
164116192|NCT00098475|592787779|FG002|Step 1|Not documented|0|||
164116193|NCT00098475|592787780|FG003|Step 1|Not documented|0|||
164116194|NCT00098475|592787777|FG000|Step 2|Disease progression|1|||
164116195|NCT00098475|592787778|FG001|Step 2|Disease progression|4|||
164116196|NCT00098475|592787779|FG002|Step 2|Disease progression|0|||
164116197|NCT00098475|592787780|FG003|Step 2|Disease progression|0|||
164116198|NCT00098475|592787777|FG000|Step 2|Adverse Event|2|||
164116199|NCT00098475|592787778|FG001|Step 2|Adverse Event|0|||
164116200|NCT00098475|592787779|FG002|Step 2|Adverse Event|0|||
164116201|NCT00098475|592787780|FG003|Step 2|Adverse Event|0|||
164116202|NCT00098475|592787777|FG000|Step 2|Withdrawal by Subject|0|||
164116203|NCT00098475|592787778|FG001|Step 2|Withdrawal by Subject|2|||
164116204|NCT00098475|592787779|FG002|Step 2|Withdrawal by Subject|0|||
164116205|NCT00098475|592787780|FG003|Step 2|Withdrawal by Subject|0|||
164116206|NCT00098475|592787777|FG000|Step 2|Physician Decision|0|||
164116207|NCT00098475|592787778|FG001|Step 2|Physician Decision|1|||
164116208|NCT00098475|592787779|FG002|Step 2|Physician Decision|0|||
164116209|NCT00098475|592787780|FG003|Step 2|Physician Decision|0|||
164116210|NCT00098475|592787777|FG000|Step 2|Alternative therapy|1|||
164116211|NCT00098475|592787778|FG001|Step 2|Alternative therapy|2|||
164116212|NCT00098475|592787779|FG002|Step 2|Alternative therapy|0|||
164116213|NCT00098475|592787780|FG003|Step 2|Alternative therapy|0|||
164116214|NCT00098475|592787777|FG000|Step 2|Never started treatment|1|||
164116215|NCT00098475|592787778|FG001|Step 2|Never started treatment|1|||
164116216|NCT00098475|592787779|FG002|Step 2|Never started treatment|0|||
164116217|NCT00098475|592787780|FG003|Step 2|Never started treatment|0|||
164116218|NCT01685008|592787782|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
164116219|NCT01685008|592787783|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
164116220|NCT01685008|592787784|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
164116221|NCT01685008|592787785|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
164116222|NCT01685008|592787782|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
164116223|NCT01685008|592787783|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
164116224|NCT01685008|592787784|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
164116225|NCT01685008|592787785|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
164116226|NCT01685008|592787782|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
164116227|NCT01685008|592787783|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
164116228|NCT01685008|592787784|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
164116229|NCT01685008|592787785|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
164116230|NCT01685008|592787782|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
164116231|NCT01685008|592787783|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
164116232|NCT01685008|592787784|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
164116233|NCT01685008|592787785|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
164116234|NCT01685008|592787782|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
164116235|NCT01685008|592787783|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
164116236|NCT01685008|592787784|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
164116237|NCT01685008|592787785|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
164116238|NCT01963260|592787789|FG000|Overall Study|Withdrawal by Subject|2|||
164116239|NCT01963260|592787790|FG001|Overall Study|Withdrawal by Subject|0|||
164116240|NCT01963260|592787791|FG002|Overall Study|Withdrawal by Subject|0|||
164116241|NCT01963260|592787792|FG003|Overall Study|Withdrawal by Subject|1|||
164116242|NCT01963260|592787793|FG004|Overall Study|Withdrawal by Subject|2|||
164116243|NCT01963260|592787794|FG005|Overall Study|Withdrawal by Subject|0|||
164116244|NCT01963260|592787795|FG006|Overall Study|Withdrawal by Subject|0|||
164116245|NCT01963260|592787796|FG007|Overall Study|Withdrawal by Subject|0|||
164116246|NCT01963260|592787797|FG008|Overall Study|Withdrawal by Subject|0|||
164116247|NCT01963260|592787798|FG009|Overall Study|Withdrawal by Subject|0|||
164116248|NCT02340962|592787799|FG000|Overall Study|Lost to Follow-up|1|||
164116249|NCT02340962|592787800|FG001|Overall Study|Lost to Follow-up|0|||
164116250|NCT04994431|592787801|FG000|Overall Study|Adverse Event|1|||
164116251|NCT04994431|592787802|FG001|Overall Study|Adverse Event|0|||
164116252|NCT01341405|592787807|FG000|Overall Study|Adverse Event|0|||
164116253|NCT01341405|592787808|FG001|Overall Study|Adverse Event|1|||
164116254|NCT01341405|592787809|FG002|Overall Study|Adverse Event|1|||
164116255|NCT01341405|592787807|FG000|Overall Study|Withdrawal by Subject|3|||
164116256|NCT01341405|592787808|FG001|Overall Study|Withdrawal by Subject|2|||
164116257|NCT01341405|592787809|FG002|Overall Study|Withdrawal by Subject|1|||
164116258|NCT02760433|592787810|FG000|Overall Study|Lost to Follow-up|1|||
164116259|NCT02760433|592787811|FG001|Overall Study|Lost to Follow-up|0|||
164116260|NCT02760433|592787812|FG002|Overall Study|Lost to Follow-up|1|||
164116261|NCT02760433|592787813|FG003|Overall Study|Lost to Follow-up|0|||
164116262|NCT02760433|592787814|FG004|Overall Study|Lost to Follow-up|0|||
164116263|NCT02760433|592787810|FG000|Overall Study|Withdrawal by Subject|23|||
164116264|NCT02760433|592787811|FG001|Overall Study|Withdrawal by Subject|9|||
164116265|NCT02760433|592787812|FG002|Overall Study|Withdrawal by Subject|0|||
164116266|NCT02760433|592787813|FG003|Overall Study|Withdrawal by Subject|2|||
164116267|NCT02760433|592787814|FG004|Overall Study|Withdrawal by Subject|9|||
164116268|NCT02760433|592787810|FG000|Overall Study|Lack of Response At Week 14|0|||
164116269|NCT02760433|592787811|FG001|Overall Study|Lack of Response At Week 14|0|||
164116270|NCT02760433|592787812|FG002|Overall Study|Lack of Response At Week 14|0|||
164116271|NCT02760433|592787813|FG003|Overall Study|Lack of Response At Week 14|0|||
164116272|NCT02760433|592787814|FG004|Overall Study|Lack of Response At Week 14|1|||
164116273|NCT02760433|592787810|FG000|Overall Study|Subject refused to continue the study|1|||
164116274|NCT02760433|592787811|FG001|Overall Study|Subject refused to continue the study|0|||
164116275|NCT02760433|592787812|FG002|Overall Study|Subject refused to continue the study|0|||
164116276|NCT02760433|592787813|FG003|Overall Study|Subject refused to continue the study|0|||
164116277|NCT02760433|592787814|FG004|Overall Study|Subject refused to continue the study|0|||
164116278|NCT02760433|592787810|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
164116279|NCT02760433|592787811|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164116280|NCT02760433|592787812|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164116281|NCT02760433|592787813|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164116282|NCT02760433|592787814|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
164116283|NCT02760433|592787810|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164116284|NCT02760433|592787811|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
164116285|NCT02760433|592787812|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164116286|NCT02760433|592787813|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164116287|NCT02760433|592787814|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
164116288|NCT02151149|592787815|FG000|Treatment Period|Death|2|||
164116289|NCT02151149|592787816|FG001|Treatment Period|Death|3|||
164116290|NCT02151149|592787815|FG000|Treatment Period|Adverse Event|17|||
164116291|NCT02151149|592787816|FG001|Treatment Period|Adverse Event|14|||
164116292|NCT02151149|592787815|FG000|Treatment Period|Progressive Disease|25|||
164116293|NCT02151149|592787816|FG001|Treatment Period|Progressive Disease|24|||
164116294|NCT02151149|592787815|FG000|Treatment Period|Symptomatic Deterioration|2|||
164116295|NCT02151149|592787816|FG001|Treatment Period|Symptomatic Deterioration|10|||
164116296|NCT02151149|592787815|FG000|Treatment Period|Withdrawal by Subject|13|||
164116297|NCT02151149|592787816|FG001|Treatment Period|Withdrawal by Subject|11|||
164116298|NCT02151149|592787815|FG000|Treatment Period|Miscellaneous|8|||
164116299|NCT02151149|592787816|FG001|Treatment Period|Miscellaneous|7|||
164116300|NCT02151149|592787815|FG000|Treatment Period|Participants randomized but not treated|3|||
164116301|NCT02151149|592787816|FG001|Treatment Period|Participants randomized but not treated|2|||
164116302|NCT02151149|592787815|FG000|Follow-Up Period|Lost to Follow-up|2|||
164116303|NCT02151149|592787816|FG001|Follow-Up Period|Lost to Follow-up|3|||
164116304|NCT02151149|592787815|FG000|Follow-Up Period|Death|37|||
164116305|NCT02151149|592787816|FG001|Follow-Up Period|Death|34|||
164116306|NCT00057941|592787817|FG000|Overall Study|Death|1|||
164116307|NCT00057941|592787818|FG001|Overall Study|Death|2|||
164116308|NCT00057941|592787817|FG000|Overall Study|Adverse Event|7|||
164116309|NCT00057941|592787818|FG001|Overall Study|Adverse Event|9|||
164116310|NCT00057941|592787817|FG000|Overall Study|Lack of Efficacy|54|||
164116311|NCT00057941|592787818|FG001|Overall Study|Lack of Efficacy|53|||
164116312|NCT00057941|592787817|FG000|Overall Study|Withdrawal by Subject|6|||
164116313|NCT00057941|592787818|FG001|Overall Study|Withdrawal by Subject|1|||
164116314|NCT00057941|592787817|FG000|Overall Study|still on treatment|3|||
164116315|NCT00057941|592787818|FG001|Overall Study|still on treatment|1|||
164116316|NCT00057941|592787817|FG000|Overall Study|insurance, symptomatic deterioration|1|||
164116317|NCT00057941|592787818|FG001|Overall Study|insurance, symptomatic deterioration|3|||
164116318|NCT00057941|592787817|FG000|Overall Study|Ineligible|2|||
164116319|NCT00057941|592787818|FG001|Overall Study|Ineligible|5|||
164116320|NCT03419962|592787820|FG000|Overall Study|Change to other medication|1|||
164116321|NCT03419962|592787820|FG000|Overall Study|Refusal of continuing with trial drug|1|||
164116322|NCT03419962|592787820|FG000|Overall Study|Lost to Follow-up|3|||
164116323|NCT03419962|592787820|FG000|Overall Study|Difficulty in inhaling the doses|1|||
164116324|NCT03419962|592787820|FG000|Overall Study|Missing completion data|31|||
164116325|NCT03439085|592787823|FG000|Overall Study|Death|2|||
164116326|NCT03439085|592787823|FG000|Overall Study|Screen Failure|20|||
164116327|NCT01499160|592787824|FG000|Overall Study|Adverse Event|1|||
164116328|NCT01499160|592787824|FG000|Overall Study|Withdrawal by Subject|1|||
164116329|NCT01438476|592787827|FG000|Overall Study|Protocol Violation|1|||
164116330|NCT01438476|592787828|FG001|Overall Study|Protocol Violation|0|||
164116331|NCT01438476|592787827|FG000|Overall Study|Withdrawal by Subject|1|||
164116332|NCT01438476|592787828|FG001|Overall Study|Withdrawal by Subject|0|||
164116333|NCT01438476|592787827|FG000|Overall Study|No Surgery- Disease|8|||
164116334|NCT01438476|592787828|FG001|Overall Study|No Surgery- Disease|10|||
164116335|NCT01438476|592787827|FG000|Overall Study|Communication barrier|0|||
164116336|NCT01438476|592787828|FG001|Overall Study|Communication barrier|1|||
164116337|NCT02911935|592787829|FG000|Overall Study|Lost to Follow-up|5|||
164116338|NCT02911935|592787830|FG001|Overall Study|Lost to Follow-up|7|||
164116339|NCT00603512|592787831|FG000|Overall Study|Adverse Event|0|||
164116340|NCT00603512|592787832|FG001|Overall Study|Adverse Event|2|||
164116341|NCT00603512|592787833|FG002|Overall Study|Adverse Event|4|||
164116342|NCT00603512|592787834|FG003|Overall Study|Adverse Event|4|||
164116343|NCT00603512|592787835|FG004|Overall Study|Adverse Event|2|||
164116344|NCT00603512|592787831|FG000|Overall Study|Lack of Efficacy|0|||
164116345|NCT00603512|592787832|FG001|Overall Study|Lack of Efficacy|1|||
164116346|NCT00603512|592787833|FG002|Overall Study|Lack of Efficacy|0|||
164116347|NCT00603512|592787834|FG003|Overall Study|Lack of Efficacy|0|||
164116348|NCT00603512|592787835|FG004|Overall Study|Lack of Efficacy|1|||
164116349|NCT00603512|592787831|FG000|Overall Study|Other|2|||
164116350|NCT00603512|592787832|FG001|Overall Study|Other|1|||
164116351|NCT00603512|592787833|FG002|Overall Study|Other|0|||
164116352|NCT00603512|592787834|FG003|Overall Study|Other|1|||
164116353|NCT00603512|592787835|FG004|Overall Study|Other|1|||
164116354|NCT00603512|592787831|FG000|Overall Study|Withdrawal by Subject|0|||
164116355|NCT00603512|592787832|FG001|Overall Study|Withdrawal by Subject|0|||
164116356|NCT00603512|592787833|FG002|Overall Study|Withdrawal by Subject|0|||
164116357|NCT00603512|592787834|FG003|Overall Study|Withdrawal by Subject|0|||
164116358|NCT00603512|592787835|FG004|Overall Study|Withdrawal by Subject|1|||
164116359|NCT00603512|592787831|FG000|Overall Study|Randomized but not treated|0|||
164116360|NCT00603512|592787832|FG001|Overall Study|Randomized but not treated|1|||
164116361|NCT00603512|592787833|FG002|Overall Study|Randomized but not treated|1|||
164116362|NCT00603512|592787834|FG003|Overall Study|Randomized but not treated|2|||
164116363|NCT00603512|592787835|FG004|Overall Study|Randomized but not treated|0|||
164116364|NCT04979858|592787836|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
164116365|NCT04979858|592787837|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
164116366|NCT04253236|592787838|FG000|Overall Study|Adverse Event|1|||
164116367|NCT04253236|592787839|FG001|Overall Study|Adverse Event|0|||
164116368|NCT04253236|592787838|FG000|Overall Study|Safety Concerns|1|||
164116369|NCT04253236|592787839|FG001|Overall Study|Safety Concerns|0|||
164116370|NCT04253236|592787838|FG000|Overall Study|Study Terminated by Sponsor|1|||
164116371|NCT04253236|592787839|FG001|Overall Study|Study Terminated by Sponsor|0|||
164116372|NCT01896505|592787840|FG000|Overall Study|Adverse Event|1|||
164116373|NCT01896505|592787841|FG001|Overall Study|Adverse Event|0|||
164116374|NCT01896505|592787842|FG002|Overall Study|Adverse Event|2|||
164116375|NCT01896505|592787843|FG003|Overall Study|Adverse Event|1|||
164116376|NCT01896505|592787844|FG004|Overall Study|Adverse Event|1|||
164116377|NCT01896505|592787845|FG005|Overall Study|Adverse Event|0|||
164116378|NCT01896505|592787840|FG000|Overall Study|Physician Decision|1|||
164116379|NCT01896505|592787841|FG001|Overall Study|Physician Decision|3|||
164116380|NCT01896505|592787842|FG002|Overall Study|Physician Decision|2|||
164116381|NCT01896505|592787843|FG003|Overall Study|Physician Decision|0|||
164116382|NCT01896505|592787844|FG004|Overall Study|Physician Decision|0|||
164116383|NCT01896505|592787845|FG005|Overall Study|Physician Decision|1|||
164116384|NCT01896505|592787840|FG000|Overall Study|Withdrawal by Subject|1|||
164116385|NCT01896505|592787841|FG001|Overall Study|Withdrawal by Subject|0|||
164116386|NCT01896505|592787842|FG002|Overall Study|Withdrawal by Subject|3|||
164116387|NCT01896505|592787843|FG003|Overall Study|Withdrawal by Subject|1|||
164116388|NCT01896505|592787844|FG004|Overall Study|Withdrawal by Subject|0|||
164116389|NCT01896505|592787845|FG005|Overall Study|Withdrawal by Subject|0|||
164116390|NCT01896505|592787840|FG000|Overall Study|Disease Progression|7|||
164116391|NCT01896505|592787841|FG001|Overall Study|Disease Progression|5|||
164116392|NCT01896505|592787842|FG002|Overall Study|Disease Progression|8|||
164116393|NCT01896505|592787843|FG003|Overall Study|Disease Progression|4|||
164116394|NCT01896505|592787844|FG004|Overall Study|Disease Progression|4|||
164116395|NCT01896505|592787845|FG005|Overall Study|Disease Progression|4|||
164116396|NCT01896505|592787840|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
164116397|NCT01896505|592787841|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
164116398|NCT01896505|592787842|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
164116399|NCT01896505|592787843|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
164116400|NCT01896505|592787844|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
164116401|NCT01896505|592787845|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
164116402|NCT01896505|592787840|FG000|Overall Study|Intercurrent illness|0|||
164116403|NCT01896505|592787841|FG001|Overall Study|Intercurrent illness|1|||
164116404|NCT01896505|592787842|FG002|Overall Study|Intercurrent illness|0|||
164116405|NCT01896505|592787843|FG003|Overall Study|Intercurrent illness|0|||
164116406|NCT01896505|592787844|FG004|Overall Study|Intercurrent illness|0|||
164116407|NCT01896505|592787845|FG005|Overall Study|Intercurrent illness|0|||
164116408|NCT01896505|592787840|FG000|Overall Study|Death|0|||
164116409|NCT01896505|592787841|FG001|Overall Study|Death|0|||
164116410|NCT01896505|592787842|FG002|Overall Study|Death|1|||
164116411|NCT01896505|592787843|FG003|Overall Study|Death|1|||
164116412|NCT01896505|592787844|FG004|Overall Study|Death|0|||
164116413|NCT01896505|592787845|FG005|Overall Study|Death|1|||
164116414|NCT03259789|592787846|FG000|Overall Study|Adverse Event|3|||
164116415|NCT03259789|592787847|FG001|Overall Study|Adverse Event|2|||
164116416|NCT03259789|592787848|FG002|Overall Study|Adverse Event|1|||
164116417|NCT03259789|592787846|FG000|Overall Study|Withdrawal by Subject|9|||
164116418|NCT03259789|592787847|FG001|Overall Study|Withdrawal by Subject|5|||
164116419|NCT03259789|592787848|FG002|Overall Study|Withdrawal by Subject|1|||
164116420|NCT03259789|592787846|FG000|Overall Study|Lost to Follow-up|5|||
164116421|NCT03259789|592787847|FG001|Overall Study|Lost to Follow-up|9|||
164116422|NCT03259789|592787848|FG002|Overall Study|Lost to Follow-up|4|||
164116423|NCT03259789|592787846|FG000|Overall Study|Physician Decision|0|||
164116424|NCT03259789|592787847|FG001|Overall Study|Physician Decision|1|||
164116425|NCT03259789|592787848|FG002|Overall Study|Physician Decision|0|||
164116426|NCT02063217|592787849|FG000|Overall Study|Withdrawal by Subject|1|||
164116427|NCT02063217|592787850|FG001|Overall Study|Withdrawal by Subject|0|||
164116428|NCT02063217|592787851|FG002|Overall Study|Withdrawal by Subject|0|||
164116429|NCT00889252|592787852|FG000|Overall Study|Adverse Event|2|||
164116430|NCT00889252|592787853|FG001|Overall Study|Adverse Event|4|||
164116431|NCT00889252|592787852|FG000|Overall Study|Withdrawal by Subject|3|||
164116432|NCT00889252|592787853|FG001|Overall Study|Withdrawal by Subject|0|||
164116433|NCT00889252|592787852|FG000|Overall Study|Protocol Violation|2|||
164116434|NCT00889252|592787853|FG001|Overall Study|Protocol Violation|0|||
164116435|NCT04291508|592787854|FG000|Overall Study|Withdrawal by Subject|1|||
164116436|NCT04291508|592787855|FG001|Overall Study|Withdrawal by Subject|0|||
164116437|NCT04291508|592787856|FG002|Overall Study|Withdrawal by Subject|1|||
164116438|NCT04291508|592787857|FG003|Overall Study|Withdrawal by Subject|0|||
164116439|NCT04291508|592787854|FG000|Overall Study|lost to follow up|4|||
164116440|NCT04291508|592787855|FG001|Overall Study|lost to follow up|0|||
164116441|NCT04291508|592787856|FG002|Overall Study|lost to follow up|1|||
164116442|NCT04291508|592787857|FG003|Overall Study|lost to follow up|0|||
164116443|NCT03566238|592787858|FG000|Overall Study|Adverse Event|0|||
164116444|NCT03566238|592787859|FG001|Overall Study|Adverse Event|0|||
164116445|NCT03566238|592787860|FG002|Overall Study|Adverse Event|1|||
164116446|NCT03566238|592787858|FG000|Overall Study|Lack of Efficacy|5|||
164116447|NCT03566238|592787859|FG001|Overall Study|Lack of Efficacy|4|||
164116448|NCT03566238|592787860|FG002|Overall Study|Lack of Efficacy|2|||
164116449|NCT03566238|592787858|FG000|Overall Study|Other|0|||
164116450|NCT03566238|592787859|FG001|Overall Study|Other|1|||
164116451|NCT03566238|592787860|FG002|Overall Study|Other|0|||
164116452|NCT01120691|592787867|FG000|Overall Study|Adverse Event|59|||
164116453|NCT01120691|592787868|FG001|Overall Study|Adverse Event|67|||
164116454|NCT01120691|592787869|FG002|Overall Study|Adverse Event|47|||
164116455|NCT01120691|592787867|FG000|Overall Study|Subject withdrew consent|33|||
164116456|NCT01120691|592787868|FG001|Overall Study|Subject withdrew consent|50|||
164116457|NCT01120691|592787869|FG002|Overall Study|Subject withdrew consent|44|||
164116458|NCT01120691|592787867|FG000|Overall Study|Death|21|||
164116459|NCT01120691|592787868|FG001|Overall Study|Death|22|||
164116460|NCT01120691|592787869|FG002|Overall Study|Death|24|||
164116461|NCT01120691|592787867|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
164116462|NCT01120691|592787868|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
164116463|NCT01120691|592787869|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
164116464|NCT01120691|592787867|FG000|Overall Study|Administrative problems|15|||
164116465|NCT01120691|592787868|FG001|Overall Study|Administrative problems|8|||
164116466|NCT01120691|592787869|FG002|Overall Study|Administrative problems|9|||
164116467|NCT01120691|592787867|FG000|Overall Study|Protocol deviation|13|||
164116468|NCT01120691|592787868|FG001|Overall Study|Protocol deviation|12|||
164116469|NCT01120691|592787869|FG002|Overall Study|Protocol deviation|12|||
164116470|NCT01120691|592787867|FG000|Overall Study|Lost to Follow-up|5|||
164116471|NCT01120691|592787868|FG001|Overall Study|Lost to Follow-up|6|||
164116472|NCT01120691|592787869|FG002|Overall Study|Lost to Follow-up|4|||
164116473|NCT01120691|592787867|FG000|Overall Study|Abnormal test procedure result(s)|3|||
164116474|NCT01120691|592787868|FG001|Overall Study|Abnormal test procedure result(s)|2|||
164116475|NCT01120691|592787869|FG002|Overall Study|Abnormal test procedure result(s)|1|||
164116476|NCT01120691|592787867|FG000|Overall Study|Patient's inability to use the device|3|||
164116477|NCT01120691|592787868|FG001|Overall Study|Patient's inability to use the device|1|||
164116478|NCT01120691|592787869|FG002|Overall Study|Patient's inability to use the device|0|||
164116479|NCT01120691|592787867|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164116480|NCT01120691|592787868|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164116481|NCT01120691|592787869|FG002|Overall Study|Abnormal laboratory value(s)|4|||
164116482|NCT00089973|592787871|FG000|Overall Study|Adverse Event|3|||
164116483|NCT00089973|592787871|FG000|Overall Study|Withdrawal by Subject|1|||
164116484|NCT00089973|592787871|FG000|Overall Study|Disease progression|45|||
164116485|NCT00089973|592787871|FG000|Overall Study|Death|1|||
164116486|NCT01321697|592787877|FG000|Overall Study|Study Terminated|7|||
164116487|NCT01049581|592787878|FG000|Overall Study|Lost to Follow-up|2|||
164116488|NCT01049581|592787879|FG001|Overall Study|Lost to Follow-up|1|||
164116489|NCT00493792|592789279|FG000|Overall Study|Death|55|||
164116490|NCT00493792|592789280|FG001|Overall Study|Death|50|||
164116491|NCT00493792|592789279|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
164116492|NCT00493792|592789280|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
164116493|NCT00685035|592789281|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
164116494|NCT00685035|592789282|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
164116495|NCT02426541|592789286|FG000|Overall Study|Protocol Violation|1|||
164116496|NCT02426541|592789287|FG001|Overall Study|Protocol Violation|0|||
164116497|NCT00784979|592789290|FG000|Overall Study|incomplete data|6|||
164116498|NCT00894933|592789294|FG000|Overall Study|Lost to Follow-up|2|||
164116499|NCT00894933|592789294|FG000|Overall Study|Cancelled Procedure|1|||
164116500|NCT00894933|592789294|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
164116501|NCT04241133|592789295|FG000|Overall Study|COVID19 Precautions|14|||
164116502|NCT04241133|592789296|FG001|Overall Study|COVID19 Precautions|34|||
164116503|NCT00631007|592789300|FG000|Overall Study|Adverse Event|0|||
164116504|NCT00631007|592789301|FG001|Overall Study|Adverse Event|2|||
164116505|NCT00631007|592789302|FG002|Overall Study|Adverse Event|0|||
164116506|NCT00631007|592789303|FG003|Overall Study|Adverse Event|2|||
164116507|NCT00631007|592789304|FG004|Overall Study|Adverse Event|3|||
164116508|NCT00631007|592789305|FG005|Overall Study|Adverse Event|2|||
164116509|NCT00631007|592789300|FG000|Overall Study|Lost to Follow-up|2|||
164116510|NCT00631007|592789301|FG001|Overall Study|Lost to Follow-up|1|||
164116511|NCT00631007|592789302|FG002|Overall Study|Lost to Follow-up|2|||
164116512|NCT00631007|592789303|FG003|Overall Study|Lost to Follow-up|4|||
164116513|NCT00631007|592789304|FG004|Overall Study|Lost to Follow-up|5|||
164116514|NCT00631007|592789305|FG005|Overall Study|Lost to Follow-up|3|||
164116515|NCT00631007|592789300|FG000|Overall Study|Physician Decision|1|||
164116516|NCT00631007|592789301|FG001|Overall Study|Physician Decision|0|||
164116517|NCT00631007|592789302|FG002|Overall Study|Physician Decision|1|||
164116518|NCT00631007|592789303|FG003|Overall Study|Physician Decision|0|||
164116519|NCT00631007|592789304|FG004|Overall Study|Physician Decision|0|||
164116520|NCT00631007|592789305|FG005|Overall Study|Physician Decision|2|||
164116521|NCT00631007|592789300|FG000|Overall Study|Persistent Hyperglycemia|2|||
164116522|NCT00631007|592789301|FG001|Overall Study|Persistent Hyperglycemia|2|||
164116523|NCT00631007|592789302|FG002|Overall Study|Persistent Hyperglycemia|5|||
164116524|NCT00631007|592789303|FG003|Overall Study|Persistent Hyperglycemia|1|||
164116525|NCT00631007|592789304|FG004|Overall Study|Persistent Hyperglycemia|2|||
164116526|NCT00631007|592789305|FG005|Overall Study|Persistent Hyperglycemia|5|||
164116527|NCT00631007|592789300|FG000|Overall Study|Withdrawal by Subject|4|||
164116528|NCT00631007|592789301|FG001|Overall Study|Withdrawal by Subject|5|||
164116529|NCT00631007|592789302|FG002|Overall Study|Withdrawal by Subject|2|||
164116530|NCT00631007|592789303|FG003|Overall Study|Withdrawal by Subject|2|||
164116531|NCT00631007|592789304|FG004|Overall Study|Withdrawal by Subject|1|||
164116532|NCT00631007|592789305|FG005|Overall Study|Withdrawal by Subject|3|||
164116533|NCT00631007|592789300|FG000|Overall Study|Other|2|||
164116534|NCT00631007|592789301|FG001|Overall Study|Other|1|||
164116535|NCT00631007|592789302|FG002|Overall Study|Other|0|||
164116536|NCT00631007|592789303|FG003|Overall Study|Other|0|||
164116537|NCT00631007|592789304|FG004|Overall Study|Other|1|||
164116538|NCT00631007|592789305|FG005|Overall Study|Other|0|||
164116539|NCT02674633|592789306|FG000|Overall Study|Lost to Follow-up|3|||
164116540|NCT02674633|592789307|FG001|Overall Study|Lost to Follow-up|2|||
164116541|NCT02674633|592789306|FG000|Overall Study|Physician Decision|1|||
164116542|NCT02674633|592789307|FG001|Overall Study|Physician Decision|0|||
164116543|NCT02674633|592789306|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164116544|NCT02674633|592789307|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
164116545|NCT00683787|592789308|FG000|Overall Study|Progression|3|||
164116546|NCT00683787|592789309|FG001|Overall Study|Progression|3|||
164116547|NCT00683787|592789310|FG002|Overall Study|Progression|0|||
164116548|NCT00683787|592789308|FG000|Overall Study|Adverse Event|0|||
164116549|NCT00683787|592789309|FG001|Overall Study|Adverse Event|0|||
164116550|NCT00683787|592789310|FG002|Overall Study|Adverse Event|2|||
164116551|NCT01235715|592789311|FG000|Overall Study|Physician Decision|0|||
164116552|NCT01235715|592789312|FG001|Overall Study|Physician Decision|2|||
164116553|NCT00396630|592789322|FG000|Overall Study|Lost to Follow-up|1|||
164116554|NCT00396630|592789323|FG001|Overall Study|Lost to Follow-up|1|||
164116555|NCT00396630|592789322|FG000|Overall Study|Withdrawal by Subject|1|||
164116556|NCT00396630|592789323|FG001|Overall Study|Withdrawal by Subject|1|||
164116557|NCT00396630|592789322|FG000|Overall Study|Not vaccinated at Visit 3|3|||
164116558|NCT00396630|592789323|FG001|Overall Study|Not vaccinated at Visit 3|3|||
164116559|NCT02327325|592789324|FG000|Overall Study|Withdrawal by Subject|1|||
164116560|NCT02327325|592789325|FG001|Overall Study|Withdrawal by Subject|4|||
164116561|NCT02327325|592789326|FG002|Overall Study|Withdrawal by Subject|4|||
164116562|NCT02327325|592789324|FG000|Overall Study|Excluded by Study Team|0|||
164116563|NCT02327325|592789325|FG001|Overall Study|Excluded by Study Team|0|||
164116564|NCT02327325|592789326|FG002|Overall Study|Excluded by Study Team|1|||
164116565|NCT00651183|592789331|FG000|Overall Study|Lack of Efficacy|1|||
164116566|NCT00651183|592789332|FG001|Overall Study|Lack of Efficacy|0|||
164116567|NCT00651183|592789331|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
164116568|NCT00651183|592789332|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
164116569|NCT00651183|592789331|FG000|Overall Study|Tolerability insufficient|5|||
164116570|NCT00651183|592789332|FG001|Overall Study|Tolerability insufficient|2|||
164116571|NCT00651183|592789331|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
164116572|NCT00651183|592789332|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
164116573|NCT00651183|592789331|FG000|Overall Study|Withdrawal by Subject|6|||
164116574|NCT00651183|592789332|FG001|Overall Study|Withdrawal by Subject|3|||
164116575|NCT00651183|592789331|FG000|Overall Study|Lost to Follow-up|3|||
164116576|NCT00651183|592789332|FG001|Overall Study|Lost to Follow-up|1|||
164116577|NCT00651183|592789331|FG000|Overall Study|Other reasons|4|||
164116578|NCT00651183|592789332|FG001|Overall Study|Other reasons|2|||
164116579|NCT00651183|592789331|FG000|Overall Study|missing|1|||
164116580|NCT00651183|592789332|FG001|Overall Study|missing|0|||
164116581|NCT02575339|592789336|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
164116582|NCT02575339|592789337|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
164116583|NCT02575339|592789338|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
164116584|NCT02575339|592789336|FG000|Study Treatment|Disease Progression|5|||
164116585|NCT02575339|592789337|FG001|Study Treatment|Disease Progression|2|||
164116586|NCT02575339|592789338|FG002|Study Treatment|Disease Progression|0|||
164116587|NCT02575339|592789336|FG000|Study Treatment|Adverse Event|1|||
164116588|NCT02575339|592789337|FG001|Study Treatment|Adverse Event|2|||
164116589|NCT02575339|592789338|FG002|Study Treatment|Adverse Event|0|||
164116590|NCT02575339|592789336|FG000|Follow up|Death|6|||
164116591|NCT02575339|592789337|FG001|Follow up|Death|2|||
164116592|NCT02575339|592789338|FG002|Follow up|Death|0|||
164116593|NCT02575339|592789336|FG000|Follow up|Study Terminated|0|||
164116594|NCT02575339|592789337|FG001|Follow up|Study Terminated|2|||
164116595|NCT02575339|592789338|FG002|Follow up|Study Terminated|0|||
164116596|NCT02575339|592789336|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
164116597|NCT02575339|592789337|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
164116598|NCT02575339|592789338|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
164116599|NCT04675775|592789339|FG000|Overall Study|Withdrawal by Subject|7|||
164116600|NCT00108082|592789342|FG000|Overall Study|Adverse Event|14|||
164116601|NCT00108082|592789343|FG001|Overall Study|Adverse Event|12|||
164116602|NCT00108082|592789344|FG002|Overall Study|Adverse Event|17|||
164116603|NCT00108082|592789342|FG000|Overall Study|Lost to Follow-up|6|||
164116604|NCT00108082|592789343|FG001|Overall Study|Lost to Follow-up|3|||
164116605|NCT00108082|592789344|FG002|Overall Study|Lost to Follow-up|7|||
164116606|NCT00108082|592789342|FG000|Overall Study|Consent Withdrawn|3|||
164116607|NCT00108082|592789343|FG001|Overall Study|Consent Withdrawn|3|||
164116608|NCT00108082|592789344|FG002|Overall Study|Consent Withdrawn|5|||
164116609|NCT00108082|592789342|FG000|Overall Study|Protocol Violation|1|||
164116610|NCT00108082|592789343|FG001|Overall Study|Protocol Violation|2|||
164116611|NCT00108082|592789344|FG002|Overall Study|Protocol Violation|0|||
164116612|NCT00108082|592789342|FG000|Overall Study|Lack of Efficacy|3|||
164116613|NCT00108082|592789343|FG001|Overall Study|Lack of Efficacy|1|||
164116614|NCT00108082|592789344|FG002|Overall Study|Lack of Efficacy|2|||
164116615|NCT00108082|592789342|FG000|Overall Study|Amendment 4: > Month 12|5|||
164116616|NCT00108082|592789343|FG001|Overall Study|Amendment 4: > Month 12|7|||
164116617|NCT00108082|592789344|FG002|Overall Study|Amendment 4: > Month 12|5|||
164116618|NCT00108082|592789342|FG000|Overall Study|Woman of Child-bearing Potential|2|||
164116619|NCT00108082|592789343|FG001|Overall Study|Woman of Child-bearing Potential|0|||
164116620|NCT00108082|592789344|FG002|Overall Study|Woman of Child-bearing Potential|2|||
164116621|NCT00108082|592789342|FG000|Overall Study|Incorrectly Randomized|0|||
164116622|NCT00108082|592789343|FG001|Overall Study|Incorrectly Randomized|0|||
164116623|NCT00108082|592789344|FG002|Overall Study|Incorrectly Randomized|2|||
164116624|NCT00108082|592789342|FG000|Overall Study|Non-compliance|1|||
164116625|NCT00108082|592789343|FG001|Overall Study|Non-compliance|0|||
164116626|NCT00108082|592789344|FG002|Overall Study|Non-compliance|2|||
164116627|NCT00108082|592789342|FG000|Overall Study|Stopped Study Medication|0|||
164116628|NCT00108082|592789343|FG001|Overall Study|Stopped Study Medication|0|||
164116629|NCT00108082|592789344|FG002|Overall Study|Stopped Study Medication|1|||
164116630|NCT00108082|592789342|FG000|Overall Study|Site Closed Study|0|||
164116631|NCT00108082|592789343|FG001|Overall Study|Site Closed Study|2|||
164116632|NCT00108082|592789344|FG002|Overall Study|Site Closed Study|0|||
164116633|NCT00108082|592789342|FG000|Overall Study|Protocol Amendment|0|||
164116634|NCT00108082|592789343|FG001|Overall Study|Protocol Amendment|1|||
164116635|NCT00108082|592789344|FG002|Overall Study|Protocol Amendment|0|||
164116636|NCT00108082|592789342|FG000|Overall Study|Study Medication Not Tapered|0|||
164116637|NCT00108082|592789343|FG001|Overall Study|Study Medication Not Tapered|1|||
164116638|NCT00108082|592789344|FG002|Overall Study|Study Medication Not Tapered|0|||
164116639|NCT00108082|592789342|FG000|Overall Study|Subject Left Site Location|1|||
164116640|NCT00108082|592789343|FG001|Overall Study|Subject Left Site Location|0|||
164116641|NCT00108082|592789344|FG002|Overall Study|Subject Left Site Location|0|||
164116642|NCT00108082|592789342|FG000|Overall Study|Investigator Not at Site|1|||
164116643|NCT00108082|592789343|FG001|Overall Study|Investigator Not at Site|0|||
164116644|NCT00108082|592789344|FG002|Overall Study|Investigator Not at Site|0|||
164116645|NCT00108082|592789342|FG000|Overall Study|Blood Pressure Not Controlled|1|||
164116646|NCT00108082|592789343|FG001|Overall Study|Blood Pressure Not Controlled|0|||
164116647|NCT00108082|592789344|FG002|Overall Study|Blood Pressure Not Controlled|0|||
164116648|NCT01091103|592789348|FG000|Overall Study|Adverse Event|1|||
164116649|NCT01091103|592789348|FG000|Overall Study|Progressive Disease|3|||
164116650|NCT01270620|592789349|FG000|Overall Study|Withdrawal by Subject|1|||
164116651|NCT01270620|592789350|FG001|Overall Study|Withdrawal by Subject|3|||
164116652|NCT01045707|592789351|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
164116653|NCT01045707|592789352|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
164116654|NCT01045707|592789351|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
164116655|NCT01045707|592789352|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
164116656|NCT01045707|592789351|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
164116657|NCT01045707|592789352|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
164116658|NCT01045707|592789351|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
164116659|NCT01045707|592789352|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
164116660|NCT01045707|592789351|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
164116661|NCT01045707|592789352|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
164116662|NCT01045707|592789351|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
164116663|NCT01045707|592789352|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
164116664|NCT01045707|592789351|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
164116665|NCT01045707|592789352|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
164116666|NCT01045707|592789351|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
164116667|NCT01045707|592789352|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
164116668|NCT01045707|592789351|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
164116669|NCT01045707|592789352|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
164116670|NCT00348816|592789353|FG000|Overall Study|Noncompliance with radiation treatment|1|||
164116671|NCT04886063|592789356|FG000|Overall Study|Adverse Event|50|||
164116672|NCT04886063|592789356|FG000|Overall Study|Lack of Efficacy|31|||
164116673|NCT04886063|592789356|FG000|Overall Study|Withdrawal by Subject|45|||
164116674|NCT04886063|592789356|FG000|Overall Study|Physician Decision|3|||
164116675|NCT04886063|592789356|FG000|Overall Study|Protocol Violation|3|||
164116676|NCT04886063|592789356|FG000|Overall Study|Site closure|4|||
164116677|NCT04886063|592789356|FG000|Overall Study|Nursing home replacement|3|||
164116678|NCT04886063|592789356|FG000|Overall Study|Lost to Follow-up|5|||
164116679|NCT04886063|592789356|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
164116680|NCT04886063|592789356|FG000|Overall Study|>1 reason|20|||
164116681|NCT02451358|592789357|FG000|Overall Study|Withdrawal by Subject|1|||
164116682|NCT02451358|592789358|FG001|Overall Study|Withdrawal by Subject|1|||
164116683|NCT02451358|592789359|FG002|Overall Study|Withdrawal by Subject|0|||
164116684|NCT02451358|592789360|FG003|Overall Study|Withdrawal by Subject|0|||
164116685|NCT02451358|592789357|FG000|Overall Study|Protocol Violation|0|||
164116686|NCT02451358|592789358|FG001|Overall Study|Protocol Violation|1|||
164116687|NCT02451358|592789359|FG002|Overall Study|Protocol Violation|1|||
164116688|NCT02451358|592789360|FG003|Overall Study|Protocol Violation|0|||
164116689|NCT06128525|592789361|FG000|Overall Study|Patient withdrew consent|1|||
164116690|NCT03414034|592789366|FG000|Overall Study|Adverse Event|6|||
164116691|NCT03414034|592789367|FG001|Overall Study|Adverse Event|1|||
164116692|NCT03414034|592789368|FG002|Overall Study|Adverse Event|1|||
164116693|NCT03414034|592789366|FG000|Overall Study|Death|0|||
164116694|NCT03414034|592789367|FG001|Overall Study|Death|0|||
164116695|NCT03414034|592789368|FG002|Overall Study|Death|1|||
164116696|NCT03414034|592789366|FG000|Overall Study|Non-compliance With Study Drug|0|||
164116697|NCT03414034|592789367|FG001|Overall Study|Non-compliance With Study Drug|0|||
164116698|NCT03414034|592789368|FG002|Overall Study|Non-compliance With Study Drug|1|||
164116699|NCT03414034|592789366|FG000|Overall Study|Physician Decision|1|||
164116700|NCT03414034|592789367|FG001|Overall Study|Physician Decision|3|||
164116701|NCT03414034|592789368|FG002|Overall Study|Physician Decision|2|||
164116702|NCT03414034|592789366|FG000|Overall Study|Withdrawal of Informed Consent|2|||
164116703|NCT03414034|592789367|FG001|Overall Study|Withdrawal of Informed Consent|1|||
164116704|NCT03414034|592789368|FG002|Overall Study|Withdrawal of Informed Consent|4|||
164116705|NCT03414034|592789366|FG000|Overall Study|Progressive Disease|15|||
164116706|NCT03414034|592789367|FG001|Overall Study|Progressive Disease|15|||
164116707|NCT03414034|592789368|FG002|Overall Study|Progressive Disease|17|||
164116708|NCT03414034|592789366|FG000|Overall Study|Miscellaneous|0|||
164116709|NCT03414034|592789367|FG001|Overall Study|Miscellaneous|0|||
164116710|NCT03414034|592789368|FG002|Overall Study|Miscellaneous|2|||
164116711|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
164116712|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
164116713|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
164116714|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
164116715|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
164116716|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
164116717|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
164116718|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
164116719|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
164116720|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
164116721|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
164116722|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
164116723|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
164116724|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
164116725|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
164116726|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
164116727|NCT01067521|592789369|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
164116728|NCT01067521|592789370|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
164116729|NCT01067521|592789369|FG000|Open-Label Period|Death|3|||
164116730|NCT01067521|592789370|FG001|Open-Label Period|Death|1|||
164116731|NCT01067521|592789369|FG000|Open-Label Period|Adverse Event|30|||
164116732|NCT01067521|592789370|FG001|Open-Label Period|Adverse Event|28|||
164116733|NCT01067521|592789369|FG000|Open-Label Period|Withdrawal by Subject|160|||
164116734|NCT01067521|592789370|FG001|Open-Label Period|Withdrawal by Subject|88|||
164116735|NCT01067521|592789369|FG000|Open-Label Period|Physician Decision|13|||
164116736|NCT01067521|592789370|FG001|Open-Label Period|Physician Decision|11|||
164116737|NCT01067521|592789369|FG000|Open-Label Period|Non-compliance with study drug|5|||
164116738|NCT01067521|592789370|FG001|Open-Label Period|Non-compliance with study drug|0|||
164116739|NCT01067521|592789369|FG000|Open-Label Period|Protocol Violation|3|||
164116740|NCT01067521|592789370|FG001|Open-Label Period|Protocol Violation|0|||
164116741|NCT01067521|592789369|FG000|Open-Label Period|Pregnancy|14|||
164116742|NCT01067521|592789370|FG001|Open-Label Period|Pregnancy|8|||
164116743|NCT01067521|592789369|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
164116744|NCT01067521|592789370|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
164116745|NCT01067521|592789369|FG000|Open-Label Period|Lost to Follow-up|21|||
164116746|NCT01067521|592789370|FG001|Open-Label Period|Lost to Follow-up|20|||
164116747|NCT04142658|592789373|FG000|Overall Study|Death|2|||
164116748|NCT04142658|592789374|FG001|Overall Study|Death|1|||
164116749|NCT04142658|592789373|FG000|Overall Study|Lost to Follow-up|4|||
164116750|NCT04142658|592789374|FG001|Overall Study|Lost to Follow-up|13|||
164116751|NCT04142658|592789373|FG000|Overall Study|Withdrawal by Subject|9|||
164116752|NCT04142658|592789374|FG001|Overall Study|Withdrawal by Subject|16|||
164116753|NCT01781234|592789375|FG000|Overall Study|Adverse Event|2|||
164116754|NCT01781234|592789376|FG001|Overall Study|Adverse Event|0|||
164116755|NCT01781234|592789375|FG000|Overall Study|Protocol Violation|3|||
164116756|NCT01781234|592789376|FG001|Overall Study|Protocol Violation|0|||
164116757|NCT01781234|592789375|FG000|Overall Study|Withdrawal by Subject|4|||
164116758|NCT01781234|592789376|FG001|Overall Study|Withdrawal by Subject|3|||
164116759|NCT01294449|592789381|FG000|Overall Study|Death|11|||
164116760|NCT01294449|592789382|FG001|Overall Study|Death|12|||
164116761|NCT01294449|592789381|FG000|Overall Study|Withdrawal by Subject|1|||
164116762|NCT01294449|592789382|FG001|Overall Study|Withdrawal by Subject|3|||
164116763|NCT01685216|592789383|FG000|Overall Study|Did not receive study drug|1|||
164116764|NCT02466386|592789384|FG000|Overall Study|Adverse Event|5|||
164116765|NCT02466386|592789384|FG000|Overall Study|Protocol Violation|2|||
164116766|NCT02466386|592789384|FG000|Overall Study|Withdrawal by Subject|14|||
164116767|NCT02466386|592789384|FG000|Overall Study|Lost to Follow-up|5|||
164116768|NCT02466386|592789384|FG000|Overall Study|Lack of Efficacy|8|||
164116769|NCT02466386|592789384|FG000|Overall Study|Other|10|||
164116770|NCT05317195|592789385|FG000|Randomization|Withdrawal by Subject|1|||
164116771|NCT05317195|592789385|FG000|Randomization|Discontinued|6|||
164116772|NCT05317195|592789385|FG000|Admission|Withdrawal by Subject|2|||
164116773|NCT04718129|592789390|FG000|Overall Study|Lost to Follow-up|6|||
164116774|NCT04718129|592789391|FG001|Overall Study|Lost to Follow-up|7|||
164116775|NCT02212457|592789392|FG000|Overall Study|Adverse Event|1|||
164116776|NCT02212457|592789393|FG001|Overall Study|Adverse Event|2|||
164116777|NCT02212457|592789394|FG002|Overall Study|Adverse Event|2|||
164116778|NCT02212457|592789395|FG003|Overall Study|Adverse Event|2|||
164116779|NCT02212457|592789396|FG004|Overall Study|Adverse Event|0|||
164116780|NCT02212457|592789397|FG005|Overall Study|Adverse Event|1|||
164116781|NCT02212457|592789392|FG000|Overall Study|Withdrawal by Subject|8|||
164116782|NCT02212457|592789393|FG001|Overall Study|Withdrawal by Subject|10|||
164116783|NCT02212457|592789394|FG002|Overall Study|Withdrawal by Subject|8|||
164116784|NCT02212457|592789395|FG003|Overall Study|Withdrawal by Subject|6|||
164116785|NCT02212457|592789396|FG004|Overall Study|Withdrawal by Subject|5|||
164116786|NCT02212457|592789397|FG005|Overall Study|Withdrawal by Subject|4|||
164116787|NCT02212457|592789392|FG000|Overall Study|Lost to Follow-up|6|||
164116788|NCT02212457|592789393|FG001|Overall Study|Lost to Follow-up|7|||
164116789|NCT02212457|592789394|FG002|Overall Study|Lost to Follow-up|4|||
164116790|NCT02212457|592789395|FG003|Overall Study|Lost to Follow-up|1|||
164116791|NCT02212457|592789396|FG004|Overall Study|Lost to Follow-up|8|||
164116792|NCT02212457|592789397|FG005|Overall Study|Lost to Follow-up|4|||
164116793|NCT02212457|592789392|FG000|Overall Study|Protocol Violation|2|||
164116794|NCT02212457|592789393|FG001|Overall Study|Protocol Violation|1|||
164116795|NCT02212457|592789394|FG002|Overall Study|Protocol Violation|0|||
164116796|NCT02212457|592789395|FG003|Overall Study|Protocol Violation|1|||
164116797|NCT02212457|592789396|FG004|Overall Study|Protocol Violation|2|||
164116798|NCT02212457|592789397|FG005|Overall Study|Protocol Violation|3|||
164116799|NCT02212457|592789392|FG000|Overall Study|Other|2|||
164116800|NCT02212457|592789393|FG001|Overall Study|Other|1|||
164116801|NCT02212457|592789394|FG002|Overall Study|Other|2|||
164116802|NCT02212457|592789395|FG003|Overall Study|Other|1|||
164116803|NCT02212457|592789396|FG004|Overall Study|Other|0|||
164116804|NCT02212457|592789397|FG005|Overall Study|Other|1|||
164116805|NCT00772148|592789400|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
164116806|NCT00772148|592789401|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
164116807|NCT00772148|592789400|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
164116808|NCT00772148|592789401|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
164116809|NCT00772148|592789400|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
164116810|NCT00772148|592789401|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
164116811|NCT00772148|592789400|FG000|Maintenance Phase (Week 52)|Death|2|||
164116812|NCT00772148|592789401|FG001|Maintenance Phase (Week 52)|Death|2|||
164116813|NCT00772148|592789400|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
164116814|NCT00772148|592789401|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
164116815|NCT00772148|592789400|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
164116816|NCT00772148|592789401|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
164116817|NCT00772148|592789400|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
164116818|NCT00772148|592789401|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
164116819|NCT00688844|592789402|FG000|Overall Study|Lost to Follow-up|10|||
164116820|NCT00857818|592789403|FG000|Overall Study|Lack of Efficacy|1|||
164116821|NCT00857818|592789404|FG001|Overall Study|Lack of Efficacy|0|||
164116822|NCT00857818|592789403|FG000|Overall Study|Adverse Event|3|||
164116823|NCT00857818|592789404|FG001|Overall Study|Adverse Event|0|||
164116824|NCT00857818|592789403|FG000|Overall Study|Withdrawal by Subject|0|||
164116825|NCT00857818|592789404|FG001|Overall Study|Withdrawal by Subject|4|||
164116826|NCT00857818|592789403|FG000|Overall Study|Sponsor terminated study|6|||
164116827|NCT00857818|592789404|FG001|Overall Study|Sponsor terminated study|4|||
164116828|NCT00857818|592789403|FG000|Overall Study|Investigator decision|1|||
164116829|NCT00857818|592789404|FG001|Overall Study|Investigator decision|0|||
164116830|NCT02061280|592789408|FG000|Overall Study|Protocol Violation|12|||
164116831|NCT02061280|592789409|FG001|Overall Study|Protocol Violation|8|||
164116832|NCT02061280|592789408|FG000|Overall Study|moved out of state|0|||
164116833|NCT02061280|592789409|FG001|Overall Study|moved out of state|1|||
164116834|NCT02061280|592789408|FG000|Overall Study|Withdrawal by Subject|1|||
164116835|NCT02061280|592789409|FG001|Overall Study|Withdrawal by Subject|2|||
164116836|NCT02061280|592789408|FG000|Overall Study|Lost to Follow-up|5|||
164116837|NCT02061280|592789409|FG001|Overall Study|Lost to Follow-up|1|||
164116838|NCT01977456|592789410|FG000|Overall Study|Death|5|||
164116839|NCT01841060|592791640|FG000|Overall Study|Protocol Violation|10|||
164116840|NCT05258630|592791641|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
164116841|NCT05258630|592791642|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
164116842|NCT05258630|592791641|FG000|Overall Study|Lost to Follow-up|0|||
164116843|NCT05258630|592791642|FG001|Overall Study|Lost to Follow-up|2|||
164116844|NCT03431337|592791643|FG000|Overall Study|Lost to Follow-up|21|||
164116845|NCT03431337|592791644|FG001|Overall Study|Lost to Follow-up|19|||
164116846|NCT03431337|592791643|FG000|Overall Study|Withdrawal by Subject|8|||
164116847|NCT03431337|592791644|FG001|Overall Study|Withdrawal by Subject|3|||
164116848|NCT02419573|592791645|FG000|Overall Study|Lost to Follow-up|3|||
164116849|NCT02419573|592791646|FG001|Overall Study|Lost to Follow-up|0|||
164116850|NCT02419573|592791645|FG000|Overall Study|Withdrawal by Subject|1|||
164116851|NCT02419573|592791646|FG001|Overall Study|Withdrawal by Subject|0|||
164116852|NCT00401245|592791651|FG000|Double Blind Titration Phase|Adverse Event|3|||
164116853|NCT00401245|592791652|FG001|Double Blind Titration Phase|Adverse Event|2|||
164116854|NCT00401245|592791653|FG002|Double Blind Titration Phase|Adverse Event|5|||
164116855|NCT00401245|592791654|FG003|Double Blind Titration Phase|Adverse Event|12|||
164116856|NCT00401245|592791655|FG004|Double Blind Titration Phase|Adverse Event|0|||
164116857|NCT00401245|592791656|FG005|Double Blind Titration Phase|Adverse Event|0|||
164116858|NCT00401245|592791657|FG006|Double Blind Titration Phase|Adverse Event|0|||
164116859|NCT00401245|592791658|FG007|Double Blind Titration Phase|Adverse Event|0|||
164116860|NCT00401245|592791651|FG000|Double Blind Titration Phase|Other|0|||
164116861|NCT00401245|592791652|FG001|Double Blind Titration Phase|Other|0|||
164116862|NCT00401245|592791653|FG002|Double Blind Titration Phase|Other|1|||
164116863|NCT00401245|592791654|FG003|Double Blind Titration Phase|Other|0|||
164116864|NCT00401245|592791655|FG004|Double Blind Titration Phase|Other|0|||
164116865|NCT00401245|592791656|FG005|Double Blind Titration Phase|Other|0|||
164116866|NCT00401245|592791657|FG006|Double Blind Titration Phase|Other|0|||
164116867|NCT00401245|592791658|FG007|Double Blind Titration Phase|Other|0|||
164116868|NCT00401245|592791651|FG000|Double Blind Titration Phase|Protocol Violation|0|||
164116869|NCT00401245|592791652|FG001|Double Blind Titration Phase|Protocol Violation|0|||
164116870|NCT00401245|592791653|FG002|Double Blind Titration Phase|Protocol Violation|0|||
164116871|NCT00401245|592791654|FG003|Double Blind Titration Phase|Protocol Violation|1|||
164116872|NCT00401245|592791655|FG004|Double Blind Titration Phase|Protocol Violation|0|||
164116873|NCT00401245|592791656|FG005|Double Blind Titration Phase|Protocol Violation|0|||
164116874|NCT00401245|592791657|FG006|Double Blind Titration Phase|Protocol Violation|0|||
164116875|NCT00401245|592791658|FG007|Double Blind Titration Phase|Protocol Violation|0|||
164116876|NCT00401245|592791651|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
164116877|NCT00401245|592791652|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
164116878|NCT00401245|592791653|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
164116879|NCT00401245|592791654|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
164116880|NCT00401245|592791655|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
164116881|NCT00401245|592791656|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
164116882|NCT00401245|592791657|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
164116883|NCT00401245|592791658|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
164116884|NCT00401245|592791651|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164116885|NCT00401245|592791652|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
164116886|NCT00401245|592791653|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164132432|NCT00123474|592850617|FG002|As Treated at Study Closure|Adverse Event|10|||
164116887|NCT00401245|592791654|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
164116888|NCT00401245|592791655|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164116889|NCT00401245|592791656|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164116890|NCT00401245|592791657|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164116891|NCT00401245|592791658|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
164116892|NCT00401245|592791651|FG000|Open Label Phase|Adverse Event|5|||
164116893|NCT00401245|592791652|FG001|Open Label Phase|Adverse Event|14|||
164116894|NCT00401245|592791653|FG002|Open Label Phase|Adverse Event|6|||
164116895|NCT00401245|592791654|FG003|Open Label Phase|Adverse Event|7|||
164116896|NCT00401245|592791655|FG004|Open Label Phase|Adverse Event|0|||
164116897|NCT00401245|592791656|FG005|Open Label Phase|Adverse Event|0|||
164116898|NCT00401245|592791657|FG006|Open Label Phase|Adverse Event|0|||
164116899|NCT00401245|592791658|FG007|Open Label Phase|Adverse Event|0|||
164116900|NCT00401245|592791651|FG000|Open Label Phase|Lost to Follow-up|5|||
164116901|NCT00401245|592791652|FG001|Open Label Phase|Lost to Follow-up|7|||
164116902|NCT00401245|592791653|FG002|Open Label Phase|Lost to Follow-up|5|||
164116903|NCT00401245|592791654|FG003|Open Label Phase|Lost to Follow-up|4|||
164116904|NCT00401245|592791655|FG004|Open Label Phase|Lost to Follow-up|0|||
164116905|NCT00401245|592791656|FG005|Open Label Phase|Lost to Follow-up|0|||
164116906|NCT00401245|592791657|FG006|Open Label Phase|Lost to Follow-up|0|||
164116907|NCT00401245|592791658|FG007|Open Label Phase|Lost to Follow-up|0|||
164116908|NCT00401245|592791651|FG000|Open Label Phase|Other|4|||
164116909|NCT00401245|592791652|FG001|Open Label Phase|Other|8|||
164116910|NCT00401245|592791653|FG002|Open Label Phase|Other|7|||
164116911|NCT00401245|592791654|FG003|Open Label Phase|Other|8|||
164116912|NCT00401245|592791655|FG004|Open Label Phase|Other|0|||
164116913|NCT00401245|592791656|FG005|Open Label Phase|Other|0|||
164116914|NCT00401245|592791657|FG006|Open Label Phase|Other|0|||
164116915|NCT00401245|592791658|FG007|Open Label Phase|Other|0|||
164116916|NCT00401245|592791651|FG000|Open Label Phase|Protocol Violation|0|||
164116917|NCT00401245|592791652|FG001|Open Label Phase|Protocol Violation|1|||
164116918|NCT00401245|592791653|FG002|Open Label Phase|Protocol Violation|0|||
164116919|NCT00401245|592791654|FG003|Open Label Phase|Protocol Violation|1|||
164116920|NCT00401245|592791655|FG004|Open Label Phase|Protocol Violation|0|||
164116921|NCT00401245|592791656|FG005|Open Label Phase|Protocol Violation|0|||
164116922|NCT00401245|592791657|FG006|Open Label Phase|Protocol Violation|0|||
164116923|NCT00401245|592791658|FG007|Open Label Phase|Protocol Violation|0|||
164116924|NCT00401245|592791651|FG000|Open Label Phase|Withdrawal by Subject|3|||
164116925|NCT00401245|592791652|FG001|Open Label Phase|Withdrawal by Subject|3|||
164116926|NCT00401245|592791653|FG002|Open Label Phase|Withdrawal by Subject|2|||
164116927|NCT00401245|592791654|FG003|Open Label Phase|Withdrawal by Subject|1|||
164116928|NCT00401245|592791655|FG004|Open Label Phase|Withdrawal by Subject|0|||
164116929|NCT00401245|592791656|FG005|Open Label Phase|Withdrawal by Subject|0|||
164116930|NCT00401245|592791657|FG006|Open Label Phase|Withdrawal by Subject|0|||
164116931|NCT00401245|592791658|FG007|Open Label Phase|Withdrawal by Subject|0|||
164116932|NCT00401245|592791651|FG000|Open Label Phase|Lack of Efficacy|4|||
164116933|NCT00401245|592791652|FG001|Open Label Phase|Lack of Efficacy|2|||
164116934|NCT00401245|592791653|FG002|Open Label Phase|Lack of Efficacy|3|||
164116935|NCT00401245|592791654|FG003|Open Label Phase|Lack of Efficacy|0|||
164116936|NCT00401245|592791655|FG004|Open Label Phase|Lack of Efficacy|0|||
164116937|NCT00401245|592791656|FG005|Open Label Phase|Lack of Efficacy|0|||
164116938|NCT00401245|592791657|FG006|Open Label Phase|Lack of Efficacy|0|||
164116939|NCT00401245|592791658|FG007|Open Label Phase|Lack of Efficacy|0|||
164116940|NCT00401245|592791651|FG000|Double Blind Tapering Phase|Adverse Event|0|||
164116941|NCT00401245|592791652|FG001|Double Blind Tapering Phase|Adverse Event|0|||
164116942|NCT00401245|592791653|FG002|Double Blind Tapering Phase|Adverse Event|0|||
164116943|NCT00401245|592791654|FG003|Double Blind Tapering Phase|Adverse Event|0|||
164116944|NCT00401245|592791655|FG004|Double Blind Tapering Phase|Adverse Event|1|||
164116945|NCT00401245|592791656|FG005|Double Blind Tapering Phase|Adverse Event|1|||
164116946|NCT00401245|592791657|FG006|Double Blind Tapering Phase|Adverse Event|2|||
164116947|NCT00401245|592791658|FG007|Double Blind Tapering Phase|Adverse Event|4|||
164116948|NCT00401245|592791651|FG000|Double Blind Tapering Phase|Investigator request|0|||
164116949|NCT00401245|592791652|FG001|Double Blind Tapering Phase|Investigator request|0|||
164116950|NCT00401245|592791653|FG002|Double Blind Tapering Phase|Investigator request|0|||
164116951|NCT00401245|592791654|FG003|Double Blind Tapering Phase|Investigator request|0|||
164116952|NCT00401245|592791655|FG004|Double Blind Tapering Phase|Investigator request|0|||
164116953|NCT00401245|592791656|FG005|Double Blind Tapering Phase|Investigator request|0|||
164116954|NCT00401245|592791657|FG006|Double Blind Tapering Phase|Investigator request|0|||
164116955|NCT00401245|592791658|FG007|Double Blind Tapering Phase|Investigator request|1|||
164116956|NCT00401245|592791651|FG000|Double Blind Tapering Phase|Other|0|||
164116957|NCT00401245|592791652|FG001|Double Blind Tapering Phase|Other|0|||
164116958|NCT00401245|592791653|FG002|Double Blind Tapering Phase|Other|0|||
164116959|NCT00401245|592791654|FG003|Double Blind Tapering Phase|Other|0|||
164116960|NCT00401245|592791655|FG004|Double Blind Tapering Phase|Other|1|||
164116961|NCT00401245|592791656|FG005|Double Blind Tapering Phase|Other|0|||
164116962|NCT00401245|592791657|FG006|Double Blind Tapering Phase|Other|2|||
164116963|NCT00401245|592791658|FG007|Double Blind Tapering Phase|Other|2|||
164116964|NCT00401245|592791651|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164116965|NCT00401245|592791652|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164116966|NCT00401245|592791653|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164116967|NCT00401245|592791654|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164116968|NCT00401245|592791655|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
164116969|NCT00401245|592791656|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
164116970|NCT00401245|592791657|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
164116971|NCT00401245|592791658|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
164116972|NCT00401245|592791651|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116973|NCT00401245|592791652|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116974|NCT00401245|592791653|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116975|NCT00401245|592791654|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116976|NCT00401245|592791655|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116977|NCT00401245|592791656|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
164116978|NCT00401245|592791657|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116979|NCT00401245|592791658|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
164116980|NCT02344745|592791659|FG000|Overall Study|Data collection sheets were lost|2|||
164116981|NCT02344745|592791660|FG001|Overall Study|Data collection sheets were lost|0|||
164116982|NCT02788513|592791661|FG000|Overall Study|Withdrawal by Subject|3|||
164116983|NCT02788513|592791662|FG001|Overall Study|Withdrawal by Subject|0|||
164116984|NCT02788513|592791663|FG002|Overall Study|Withdrawal by Subject|2|||
164116985|NCT02788513|592791664|FG003|Overall Study|Withdrawal by Subject|3|||
164116986|NCT02788513|592791665|FG004|Overall Study|Withdrawal by Subject|1|||
164116987|NCT02788513|592791661|FG000|Overall Study|Lost to Follow-up|1|||
164116988|NCT02788513|592791662|FG001|Overall Study|Lost to Follow-up|0|||
164116989|NCT02788513|592791663|FG002|Overall Study|Lost to Follow-up|0|||
164116990|NCT02788513|592791664|FG003|Overall Study|Lost to Follow-up|0|||
164116991|NCT02788513|592791665|FG004|Overall Study|Lost to Follow-up|1|||
164116992|NCT02788513|592791661|FG000|Overall Study|Adverse Event|5|||
164116993|NCT02788513|592791662|FG001|Overall Study|Adverse Event|8|||
164116994|NCT02788513|592791663|FG002|Overall Study|Adverse Event|4|||
164116995|NCT02788513|592791664|FG003|Overall Study|Adverse Event|2|||
164116996|NCT02788513|592791665|FG004|Overall Study|Adverse Event|2|||
164116997|NCT02788513|592791661|FG000|Overall Study|Protocol Violation|0|||
164116998|NCT02788513|592791662|FG001|Overall Study|Protocol Violation|0|||
164116999|NCT02788513|592791663|FG002|Overall Study|Protocol Violation|1|||
164117000|NCT02788513|592791664|FG003|Overall Study|Protocol Violation|1|||
164117001|NCT02788513|592791665|FG004|Overall Study|Protocol Violation|0|||
164117002|NCT02788513|592791661|FG000|Overall Study|Subject decided to stop taking treatment|0|||
164117003|NCT02788513|592791662|FG001|Overall Study|Subject decided to stop taking treatment|0|||
164117004|NCT02788513|592791663|FG002|Overall Study|Subject decided to stop taking treatment|1|||
164117005|NCT02788513|592791664|FG003|Overall Study|Subject decided to stop taking treatment|0|||
164117006|NCT02788513|592791665|FG004|Overall Study|Subject decided to stop taking treatment|0|||
164117007|NCT02788513|592791661|FG000|Overall Study|Decision by the study team|0|||
164117008|NCT02788513|592791662|FG001|Overall Study|Decision by the study team|0|||
164117009|NCT02788513|592791663|FG002|Overall Study|Decision by the study team|0|||
164117010|NCT02788513|592791664|FG003|Overall Study|Decision by the study team|0|||
164117011|NCT02788513|592791665|FG004|Overall Study|Decision by the study team|1|||
164117012|NCT03230487|592791669|FG000|Overall Study|Adverse Event|0|||
164117013|NCT03230487|592791670|FG001|Overall Study|Adverse Event|0|||
164117014|NCT03230487|592791671|FG002|Overall Study|Adverse Event|0|||
164117015|NCT03230487|592791672|FG003|Overall Study|Adverse Event|1|||
164117016|NCT03230487|592791673|FG004|Overall Study|Adverse Event|0|||
164117017|NCT03230487|592791674|FG005|Overall Study|Adverse Event|0|||
164117018|NCT01933919|592791680|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
164117019|NCT01933919|592791681|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
164117020|NCT01933919|592791680|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
164117021|NCT01933919|592791681|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
164117022|NCT01933919|592791680|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
164117023|NCT01933919|592791681|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
164117024|NCT01933919|592791680|FG000|Open-label Long-term Phase|Adverse Event|2|||
164117025|NCT01933919|592791681|FG001|Open-label Long-term Phase|Adverse Event|0|||
164117026|NCT01933919|592791680|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
164117027|NCT01933919|592791681|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
164117028|NCT01933919|592791680|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
164117029|NCT01933919|592791681|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
164117030|NCT01933919|592791680|FG000|Open-label Long-term Phase|Other|1|||
164117031|NCT01933919|592791681|FG001|Open-label Long-term Phase|Other|2|||
164117032|NCT01961882|592791682|FG000|Overall Study|Adverse Event|3|||
164117033|NCT01961882|592791683|FG001|Overall Study|Adverse Event|2|||
164117034|NCT01961882|592791682|FG000|Overall Study|Physician Decision|1|||
164117035|NCT01961882|592791683|FG001|Overall Study|Physician Decision|0|||
164117036|NCT01961882|592791682|FG000|Overall Study|Withdrawal by Subject|4|||
164117037|NCT01961882|592791683|FG001|Overall Study|Withdrawal by Subject|1|||
164117038|NCT01961882|592791682|FG000|Overall Study|Relapse of AML|39|||
164117039|NCT01961882|592791683|FG001|Overall Study|Relapse of AML|37|||
164117040|NCT01961882|592791682|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
164117041|NCT01961882|592791683|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
164117042|NCT01961882|592791682|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
164117043|NCT01961882|592791683|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
164117044|NCT01901848|592791684|FG000|Randomized and Treated|Lost to Follow-up|3|||
164117045|NCT01901848|592791685|FG001|Randomized and Treated|Lost to Follow-up|6|||
164117046|NCT01901848|592791684|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
164117047|NCT01901848|592791685|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
164117048|NCT00684567|592791686|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
164117049|NCT00684567|592791686|FG000|Monotherapy Period|Adverse Event|2|||
164117050|NCT00684567|592791686|FG000|Monotherapy Period|Death|1|||
164117051|NCT00684567|592791686|FG000|Monotherapy Period|Progression of primary disease|11|||
164117052|NCT00809965|592791687|FG000|Overall Study|Death|194|||
164117053|NCT00809965|592791688|FG001|Overall Study|Death|147|||
164117054|NCT00809965|592791689|FG002|Overall Study|Death|196|||
164117055|NCT00809965|592791687|FG000|Overall Study|Lost to Follow-up|17|||
164117056|NCT00809965|592791688|FG001|Overall Study|Lost to Follow-up|10|||
164117057|NCT00809965|592791689|FG002|Overall Study|Lost to Follow-up|18|||
164117058|NCT00809965|592791687|FG000|Overall Study|Withdrawal by Subject|405|||
164117059|NCT00809965|592791688|FG001|Overall Study|Withdrawal by Subject|448|||
164117060|NCT00809965|592791689|FG002|Overall Study|Withdrawal by Subject|441|||
164117061|NCT00809965|592791687|FG000|Overall Study|Other Reason|167|||
164117062|NCT00809965|592791688|FG001|Overall Study|Other Reason|170|||
164117063|NCT00809965|592791689|FG002|Overall Study|Other Reason|189|||
164117064|NCT05552261|592791690|FG000|Overall Study|Withdrawal by Subject|1|||
164117065|NCT05552261|592791690|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
164117066|NCT00337428|592791691|FG000|Overall Study|Withdrawal by Subject|1|||
164117067|NCT00337428|592791692|FG001|Overall Study|Withdrawal by Subject|2|||
164117068|NCT00337428|592791691|FG000|Overall Study|Lack of Time|1|||
164117069|NCT00337428|592791692|FG001|Overall Study|Lack of Time|1|||
164117070|NCT00337428|592791691|FG000|Overall Study|Unwilling to Continue|1|||
164117071|NCT00337428|592791692|FG001|Overall Study|Unwilling to Continue|0|||
164117072|NCT00337428|592791691|FG000|Overall Study|Anorexia|1|||
164117073|NCT00337428|592791692|FG001|Overall Study|Anorexia|0|||
164117074|NCT02618382|592791693|FG000|Overall Study|Physician Decision|1|||
164117075|NCT02618382|592791693|FG000|Overall Study|Withdrawal by Subject|1|||
164117076|NCT02618382|592791693|FG000|Overall Study|Protocol Violation|1|||
164117077|NCT01628549|592791694|FG000|Overall Study|Adverse Event|1|||
164117078|NCT01628549|592791695|FG001|Overall Study|Adverse Event|1|||
164117079|NCT01628549|592791696|FG002|Overall Study|Adverse Event|0|||
164117080|NCT01628549|592791697|FG003|Overall Study|Adverse Event|4|||
164117081|NCT01628549|592791694|FG000|Overall Study|Lost to Follow-up|3|||
164117082|NCT01628549|592791695|FG001|Overall Study|Lost to Follow-up|4|||
164117083|NCT01628549|592791696|FG002|Overall Study|Lost to Follow-up|3|||
164117084|NCT01628549|592791697|FG003|Overall Study|Lost to Follow-up|3|||
164117085|NCT01628549|592791694|FG000|Overall Study|Withdrawal by Subject|3|||
164117086|NCT01628549|592791695|FG001|Overall Study|Withdrawal by Subject|4|||
164117087|NCT01628549|592791696|FG002|Overall Study|Withdrawal by Subject|4|||
164117088|NCT01628549|592791697|FG003|Overall Study|Withdrawal by Subject|1|||
164117089|NCT01628549|592791694|FG000|Overall Study|Protocol Violation|2|||
164117090|NCT01628549|592791695|FG001|Overall Study|Protocol Violation|1|||
164117091|NCT01628549|592791696|FG002|Overall Study|Protocol Violation|1|||
164117092|NCT01628549|592791697|FG003|Overall Study|Protocol Violation|0|||
164117093|NCT01628549|592791694|FG000|Overall Study|withdrawn for noncompliance|0|||
164117094|NCT01628549|592791695|FG001|Overall Study|withdrawn for noncompliance|2|||
164117095|NCT01628549|592791696|FG002|Overall Study|withdrawn for noncompliance|1|||
164117096|NCT01628549|592791697|FG003|Overall Study|withdrawn for noncompliance|0|||
164117097|NCT01628549|592791694|FG000|Overall Study|abnormal laboratory test results|0|||
164117098|NCT01628549|592791695|FG001|Overall Study|abnormal laboratory test results|0|||
164117099|NCT01628549|592791696|FG002|Overall Study|abnormal laboratory test results|1|||
164117100|NCT01628549|592791697|FG003|Overall Study|abnormal laboratory test results|0|||
164117101|NCT01628549|592791694|FG000|Overall Study|positive pregnancy test|0|||
164117102|NCT01628549|592791695|FG001|Overall Study|positive pregnancy test|0|||
164117103|NCT01628549|592791696|FG002|Overall Study|positive pregnancy test|0|||
164117104|NCT01628549|592791697|FG003|Overall Study|positive pregnancy test|1|||
164117105|NCT00177164|592791703|FG000|Overall Study|Protocol Violation|0|||
164117106|NCT00177164|592791704|FG001|Overall Study|Protocol Violation|7|||
164117107|NCT00177164|592791703|FG000|Overall Study|Lost to Follow-up|4|||
164117108|NCT00177164|592791704|FG001|Overall Study|Lost to Follow-up|5|||
164117109|NCT00177164|592791703|FG000|Overall Study|increase in alcohol and drug use|1|||
164117110|NCT00177164|592791704|FG001|Overall Study|increase in alcohol and drug use|2|||
164117111|NCT00177164|592791703|FG000|Overall Study|Adverse Event|1|||
164117112|NCT00177164|592791704|FG001|Overall Study|Adverse Event|0|||
164117113|NCT00177164|592791703|FG000|Overall Study|discharge from hospital|1|||
164117114|NCT00177164|592791704|FG001|Overall Study|discharge from hospital|0|||
164117115|NCT00177164|592791703|FG000|Overall Study|Lack of Efficacy|2|||
164117116|NCT00177164|592791704|FG001|Overall Study|Lack of Efficacy|1|||
164117117|NCT00177164|592791703|FG000|Overall Study|Pregnancy|0|||
164117118|NCT00177164|592791704|FG001|Overall Study|Pregnancy|1|||
164117119|NCT00965757|592791707|FG000|Double-blind Phase|Progression of concomitant disease|1|||
164117120|NCT00965757|592791708|FG001|Double-blind Phase|Progression of concomitant disease|2|||
164117121|NCT00965757|592791709|FG002|Double-blind Phase|Progression of concomitant disease|0|||
164117122|NCT00965757|592791710|FG003|Double-blind Phase|Progression of concomitant disease|0|||
164117123|NCT00965757|592791707|FG000|Double-blind Phase|Adverse drug reaction|2|||
164117124|NCT00965757|592791708|FG001|Double-blind Phase|Adverse drug reaction|1|||
164117125|NCT00965757|592791709|FG002|Double-blind Phase|Adverse drug reaction|0|||
164117126|NCT00965757|592791710|FG003|Double-blind Phase|Adverse drug reaction|0|||
164117127|NCT00965757|592791707|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
164117128|NCT00965757|592791708|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
164117129|NCT00965757|592791709|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
164117130|NCT00965757|592791710|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
164117131|NCT00965757|592791707|FG000|Double-blind Phase|Lack of Efficacy|7|||
164117132|NCT00965757|592791708|FG001|Double-blind Phase|Lack of Efficacy|11|||
164117133|NCT00965757|592791709|FG002|Double-blind Phase|Lack of Efficacy|0|||
164117134|NCT00965757|592791710|FG003|Double-blind Phase|Lack of Efficacy|0|||
164117135|NCT00965757|592791707|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
164117136|NCT00965757|592791708|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
164117137|NCT00965757|592791709|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
164117138|NCT00965757|592791710|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
164117139|NCT00965757|592791707|FG000|Double-blind Phase|Lost to Follow-up|0|||
164117140|NCT00965757|592791708|FG001|Double-blind Phase|Lost to Follow-up|1|||
164117141|NCT00965757|592791709|FG002|Double-blind Phase|Lost to Follow-up|0|||
164117142|NCT00965757|592791710|FG003|Double-blind Phase|Lost to Follow-up|0|||
164117143|NCT00965757|592791707|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
164117144|NCT00965757|592791708|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
164117145|NCT00965757|592791709|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
164117146|NCT00965757|592791710|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
164117147|NCT00965757|592791707|FG000|Double-blind Phase|Other|1|||
164117148|NCT00965757|592791708|FG001|Double-blind Phase|Other|0|||
164117149|NCT00965757|592791709|FG002|Double-blind Phase|Other|0|||
164117150|NCT00965757|592791710|FG003|Double-blind Phase|Other|0|||
164117151|NCT00965757|592791707|FG000|Extension Phase|Progression of concomitant disease|0|||
164117152|NCT00965757|592791708|FG001|Extension Phase|Progression of concomitant disease|0|||
164117153|NCT00965757|592791709|FG002|Extension Phase|Progression of concomitant disease|4|||
164117154|NCT00965757|592791710|FG003|Extension Phase|Progression of concomitant disease|2|||
164117155|NCT00965757|592791707|FG000|Extension Phase|Adverse drug reaction|0|||
164117156|NCT00965757|592791708|FG001|Extension Phase|Adverse drug reaction|0|||
164117157|NCT00965757|592791709|FG002|Extension Phase|Adverse drug reaction|6|||
164117158|NCT00965757|592791710|FG003|Extension Phase|Adverse drug reaction|3|||
164117159|NCT00965757|592791707|FG000|Extension Phase|Abnormal Laboratory Value|0|||
164117160|NCT00965757|592791708|FG001|Extension Phase|Abnormal Laboratory Value|0|||
164117161|NCT00965757|592791709|FG002|Extension Phase|Abnormal Laboratory Value|6|||
164117162|NCT00965757|592791710|FG003|Extension Phase|Abnormal Laboratory Value|1|||
164117163|NCT00965757|592791707|FG000|Extension Phase|Lack of Efficacy|0|||
164117164|NCT00965757|592791708|FG001|Extension Phase|Lack of Efficacy|0|||
164117165|NCT00965757|592791709|FG002|Extension Phase|Lack of Efficacy|8|||
164117166|NCT00965757|592791710|FG003|Extension Phase|Lack of Efficacy|12|||
164117167|NCT00965757|592791707|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
164117168|NCT00965757|592791708|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
164117169|NCT00965757|592791709|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
164117170|NCT00965757|592791710|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
164117171|NCT00965757|592791707|FG000|Extension Phase|Lost to Follow-up|0|||
164117172|NCT00965757|592791708|FG001|Extension Phase|Lost to Follow-up|0|||
164117173|NCT00965757|592791709|FG002|Extension Phase|Lost to Follow-up|0|||
164117174|NCT00965757|592791710|FG003|Extension Phase|Lost to Follow-up|1|||
164117175|NCT00965757|592791707|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
164117176|NCT00965757|592791708|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
164117177|NCT00965757|592791709|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
164117178|NCT00965757|592791710|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
164117179|NCT00965757|592791707|FG000|Extension Phase|Protocol Violation|0|||
164117180|NCT00965757|592791708|FG001|Extension Phase|Protocol Violation|0|||
164117181|NCT00965757|592791709|FG002|Extension Phase|Protocol Violation|0|||
164117182|NCT00965757|592791710|FG003|Extension Phase|Protocol Violation|1|||
164117183|NCT00965757|592791707|FG000|Extension Phase|Other|0|||
164117184|NCT00965757|592791708|FG001|Extension Phase|Other|0|||
164117185|NCT00965757|592791709|FG002|Extension Phase|Other|2|||
164117186|NCT00965757|592791710|FG003|Extension Phase|Other|1|||
164117187|NCT03807440|592791711|FG000|Overall Study|No documentation of index date 2|320|||
164117188|NCT03807440|592791711|FG000|Overall Study|No informed consent for index date 2|117|||
164117189|NCT01344018|592791712|FG000|Overall Study|Death|22|||
164117190|NCT01344018|592791713|FG001|Overall Study|Death|25|||
164117191|NCT01344018|592791712|FG000|Overall Study|Lost to Follow-up|4|||
164117192|NCT01344018|592791713|FG001|Overall Study|Lost to Follow-up|7|||
164117193|NCT04010227|592791715|FG000|Overall Study|Death|1|||
164117194|NCT04010227|592791716|FG001|Overall Study|Death|2|||
164117195|NCT04010227|592791715|FG000|Overall Study|Medical Reasons|4|||
164117196|NCT04010227|592791716|FG001|Overall Study|Medical Reasons|3|||
164117197|NCT04010227|592791715|FG000|Overall Study|Withdrawal by Subject|2|||
164117198|NCT04010227|592791716|FG001|Overall Study|Withdrawal by Subject|0|||
164117199|NCT04010227|592791715|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
164117200|NCT04010227|592791716|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
164117201|NCT01332968|592791717|FG000|Induction Period|Adverse Event|23|||
164117202|NCT01332968|592791718|FG001|Induction Period|Adverse Event|26|||
164117203|NCT01332968|592791719|FG002|Induction Period|Adverse Event|0|||
164117204|NCT01332968|592791720|FG003|Induction Period|Adverse Event|0|||
164117205|NCT01332968|592791721|FG004|Induction Period|Adverse Event|0|||
164117206|NCT01332968|592791722|FG005|Induction Period|Adverse Event|0|||
164117207|NCT01332968|592791723|FG006|Induction Period|Adverse Event|0|||
164117208|NCT01332968|592791724|FG007|Induction Period|Adverse Event|0|||
164117209|NCT01332968|592791717|FG000|Induction Period|Death|1|||
164117210|NCT01332968|592791718|FG001|Induction Period|Death|4|||
164117211|NCT01332968|592791719|FG002|Induction Period|Death|0|||
164117212|NCT01332968|592791720|FG003|Induction Period|Death|0|||
164117213|NCT01332968|592791721|FG004|Induction Period|Death|0|||
164117214|NCT01332968|592791722|FG005|Induction Period|Death|0|||
164117215|NCT01332968|592791723|FG006|Induction Period|Death|0|||
164117216|NCT01332968|592791724|FG007|Induction Period|Death|0|||
164117217|NCT01332968|592791717|FG000|Induction Period|Non-compliance|1|||
164117218|NCT01332968|592791718|FG001|Induction Period|Non-compliance|0|||
164117219|NCT01332968|592791719|FG002|Induction Period|Non-compliance|0|||
164117220|NCT01332968|592791720|FG003|Induction Period|Non-compliance|0|||
164117221|NCT01332968|592791721|FG004|Induction Period|Non-compliance|0|||
164117222|NCT01332968|592791722|FG005|Induction Period|Non-compliance|0|||
164117223|NCT01332968|592791723|FG006|Induction Period|Non-compliance|0|||
164117224|NCT01332968|592791724|FG007|Induction Period|Non-compliance|0|||
164117225|NCT01332968|592791717|FG000|Induction Period|Other|2|||
164117226|NCT01332968|592791718|FG001|Induction Period|Other|2|||
164117227|NCT01332968|592791719|FG002|Induction Period|Other|0|||
164117228|NCT01332968|592791720|FG003|Induction Period|Other|0|||
164117229|NCT01332968|592791721|FG004|Induction Period|Other|0|||
164117230|NCT01332968|592791722|FG005|Induction Period|Other|0|||
164117231|NCT01332968|592791723|FG006|Induction Period|Other|0|||
164117232|NCT01332968|592791724|FG007|Induction Period|Other|0|||
164117233|NCT01332968|592791717|FG000|Induction Period|Physician Decision|6|||
164117234|NCT01332968|592791718|FG001|Induction Period|Physician Decision|1|||
164117235|NCT01332968|592791719|FG002|Induction Period|Physician Decision|0|||
164117236|NCT01332968|592791720|FG003|Induction Period|Physician Decision|0|||
164117237|NCT01332968|592791721|FG004|Induction Period|Physician Decision|0|||
164117238|NCT01332968|592791722|FG005|Induction Period|Physician Decision|0|||
164117239|NCT01332968|592791723|FG006|Induction Period|Physician Decision|0|||
164117240|NCT01332968|592791724|FG007|Induction Period|Physician Decision|0|||
164117241|NCT01332968|592791717|FG000|Induction Period|Progressive Disease|15|||
164117242|NCT01332968|592791718|FG001|Induction Period|Progressive Disease|7|||
164117243|NCT01332968|592791719|FG002|Induction Period|Progressive Disease|0|||
164117244|NCT01332968|592791720|FG003|Induction Period|Progressive Disease|0|||
164117245|NCT01332968|592791721|FG004|Induction Period|Progressive Disease|0|||
164117246|NCT01332968|592791722|FG005|Induction Period|Progressive Disease|0|||
164117247|NCT01332968|592791723|FG006|Induction Period|Progressive Disease|0|||
164117248|NCT01332968|592791724|FG007|Induction Period|Progressive Disease|0|||
164117249|NCT01332968|592791717|FG000|Induction Period|Protocol Violation|3|||
164117250|NCT01332968|592791718|FG001|Induction Period|Protocol Violation|4|||
164117251|NCT01332968|592791719|FG002|Induction Period|Protocol Violation|0|||
164117252|NCT01332968|592791720|FG003|Induction Period|Protocol Violation|0|||
164117253|NCT01332968|592791721|FG004|Induction Period|Protocol Violation|0|||
164117254|NCT01332968|592791722|FG005|Induction Period|Protocol Violation|0|||
164117255|NCT01332968|592791723|FG006|Induction Period|Protocol Violation|0|||
164117256|NCT01332968|592791724|FG007|Induction Period|Protocol Violation|0|||
164117257|NCT01332968|592791717|FG000|Induction Period|Withdrawal by Subject|3|||
164117258|NCT01332968|592791718|FG001|Induction Period|Withdrawal by Subject|5|||
164117259|NCT01332968|592791719|FG002|Induction Period|Withdrawal by Subject|0|||
164117260|NCT01332968|592791720|FG003|Induction Period|Withdrawal by Subject|0|||
164117261|NCT01332968|592791721|FG004|Induction Period|Withdrawal by Subject|0|||
164117262|NCT01332968|592791722|FG005|Induction Period|Withdrawal by Subject|0|||
164117263|NCT01332968|592791723|FG006|Induction Period|Withdrawal by Subject|0|||
164117264|NCT01332968|592791724|FG007|Induction Period|Withdrawal by Subject|0|||
164117265|NCT01332968|592791717|FG000|Induction Period|Randomised but not treated|4|||
164117266|NCT01332968|592791718|FG001|Induction Period|Randomised but not treated|7|||
164117267|NCT01332968|592791719|FG002|Induction Period|Randomised but not treated|0|||
164117268|NCT01332968|592791720|FG003|Induction Period|Randomised but not treated|0|||
164117269|NCT01332968|592791721|FG004|Induction Period|Randomised but not treated|0|||
164117270|NCT01332968|592791722|FG005|Induction Period|Randomised but not treated|0|||
164117271|NCT01332968|592791723|FG006|Induction Period|Randomised but not treated|0|||
164117272|NCT01332968|592791724|FG007|Induction Period|Randomised but not treated|0|||
164117273|NCT01332968|592791717|FG000|Maintenance/Observation Period|Adverse Event|0|||
164117274|NCT01332968|592791718|FG001|Maintenance/Observation Period|Adverse Event|0|||
164117275|NCT01332968|592791719|FG002|Maintenance/Observation Period|Adverse Event|53|||
164117276|NCT01332968|592791720|FG003|Maintenance/Observation Period|Adverse Event|66|||
164117277|NCT01332968|592791721|FG004|Maintenance/Observation Period|Adverse Event|0|||
164117278|NCT01332968|592791722|FG005|Maintenance/Observation Period|Adverse Event|0|||
164117279|NCT01332968|592791723|FG006|Maintenance/Observation Period|Adverse Event|0|||
164117280|NCT01332968|592791724|FG007|Maintenance/Observation Period|Adverse Event|0|||
164117281|NCT01332968|592791717|FG000|Maintenance/Observation Period|Death|0|||
164117282|NCT01332968|592791718|FG001|Maintenance/Observation Period|Death|0|||
164117283|NCT01332968|592791719|FG002|Maintenance/Observation Period|Death|5|||
164117284|NCT01332968|592791720|FG003|Maintenance/Observation Period|Death|6|||
164117285|NCT01332968|592791721|FG004|Maintenance/Observation Period|Death|0|||
164117286|NCT01332968|592791722|FG005|Maintenance/Observation Period|Death|0|||
164117287|NCT01332968|592791723|FG006|Maintenance/Observation Period|Death|0|||
164117288|NCT01332968|592791724|FG007|Maintenance/Observation Period|Death|0|||
164117289|NCT01332968|592791717|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
164117290|NCT01332968|592791718|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
164117291|NCT01332968|592791719|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
164117292|NCT01332968|592791720|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
164117293|NCT01332968|592791721|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
164117294|NCT01332968|592791722|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
164117295|NCT01332968|592791723|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
164117296|NCT01332968|592791724|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
164117297|NCT01332968|592791717|FG000|Maintenance/Observation Period|Non-compliance|0|||
164117298|NCT01332968|592791718|FG001|Maintenance/Observation Period|Non-compliance|0|||
164117299|NCT01332968|592791719|FG002|Maintenance/Observation Period|Non-compliance|4|||
164117300|NCT01332968|592791720|FG003|Maintenance/Observation Period|Non-compliance|3|||
164117301|NCT01332968|592791721|FG004|Maintenance/Observation Period|Non-compliance|0|||
164117302|NCT01332968|592791722|FG005|Maintenance/Observation Period|Non-compliance|0|||
164117303|NCT01332968|592791723|FG006|Maintenance/Observation Period|Non-compliance|0|||
164117304|NCT01332968|592791724|FG007|Maintenance/Observation Period|Non-compliance|0|||
164117305|NCT01332968|592791717|FG000|Maintenance/Observation Period|Other|0|||
164117306|NCT01332968|592791718|FG001|Maintenance/Observation Period|Other|0|||
164117307|NCT01332968|592791719|FG002|Maintenance/Observation Period|Other|4|||
164117308|NCT01332968|592791720|FG003|Maintenance/Observation Period|Other|7|||
164117309|NCT01332968|592791721|FG004|Maintenance/Observation Period|Other|0|||
164117310|NCT01332968|592791722|FG005|Maintenance/Observation Period|Other|0|||
164117311|NCT01332968|592791723|FG006|Maintenance/Observation Period|Other|0|||
164117312|NCT01332968|592791724|FG007|Maintenance/Observation Period|Other|0|||
164117313|NCT01332968|592791717|FG000|Maintenance/Observation Period|Physician Decision|0|||
164117314|NCT01332968|592791718|FG001|Maintenance/Observation Period|Physician Decision|0|||
164117315|NCT01332968|592791719|FG002|Maintenance/Observation Period|Physician Decision|14|||
164117316|NCT01332968|592791720|FG003|Maintenance/Observation Period|Physician Decision|19|||
164117317|NCT01332968|592791721|FG004|Maintenance/Observation Period|Physician Decision|0|||
164117318|NCT01332968|592791722|FG005|Maintenance/Observation Period|Physician Decision|1|||
164117319|NCT01332968|592791723|FG006|Maintenance/Observation Period|Physician Decision|0|||
164117320|NCT01332968|592791724|FG007|Maintenance/Observation Period|Physician Decision|0|||
164117321|NCT01332968|592791717|FG000|Maintenance/Observation Period|Progressive Disease|0|||
164117322|NCT01332968|592791718|FG001|Maintenance/Observation Period|Progressive Disease|0|||
164117323|NCT01332968|592791719|FG002|Maintenance/Observation Period|Progressive Disease|72|||
164117324|NCT01332968|592791720|FG003|Maintenance/Observation Period|Progressive Disease|40|||
164117325|NCT01332968|592791721|FG004|Maintenance/Observation Period|Progressive Disease|0|||
164117326|NCT01332968|592791722|FG005|Maintenance/Observation Period|Progressive Disease|0|||
164117327|NCT01332968|592791723|FG006|Maintenance/Observation Period|Progressive Disease|0|||
164117328|NCT01332968|592791724|FG007|Maintenance/Observation Period|Progressive Disease|0|||
164117329|NCT01332968|592791717|FG000|Maintenance/Observation Period|Protocol Violation|0|||
164117330|NCT01332968|592791718|FG001|Maintenance/Observation Period|Protocol Violation|0|||
164117331|NCT01332968|592791719|FG002|Maintenance/Observation Period|Protocol Violation|1|||
164117332|NCT01332968|592791720|FG003|Maintenance/Observation Period|Protocol Violation|1|||
164117333|NCT01332968|592791721|FG004|Maintenance/Observation Period|Protocol Violation|0|||
164117334|NCT01332968|592791722|FG005|Maintenance/Observation Period|Protocol Violation|0|||
164132673|NCT01986010|592850669|FG014|Overall Study|Adverse Event|0|||
164117335|NCT01332968|592791723|FG006|Maintenance/Observation Period|Protocol Violation|0|||
164117336|NCT01332968|592791724|FG007|Maintenance/Observation Period|Protocol Violation|0|||
164117337|NCT01332968|592791717|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
164117338|NCT01332968|592791718|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
164117339|NCT01332968|592791719|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
164117340|NCT01332968|592791720|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
164117341|NCT01332968|592791721|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
164117342|NCT01332968|592791722|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
164117343|NCT01332968|592791723|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
164117344|NCT01332968|592791724|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
164117345|NCT01332968|592791717|FG000|Follow-Up Period|Adverse Event|0|||
164117346|NCT01332968|592791718|FG001|Follow-Up Period|Adverse Event|0|||
164117347|NCT01332968|592791719|FG002|Follow-Up Period|Adverse Event|0|||
164117348|NCT01332968|592791720|FG003|Follow-Up Period|Adverse Event|0|||
164117349|NCT01332968|592791721|FG004|Follow-Up Period|Adverse Event|0|||
164117350|NCT01332968|592791722|FG005|Follow-Up Period|Adverse Event|0|||
164117351|NCT01332968|592791723|FG006|Follow-Up Period|Adverse Event|0|||
164117352|NCT01332968|592791724|FG007|Follow-Up Period|Adverse Event|4|||
164117353|NCT01332968|592791717|FG000|Follow-Up Period|Death|0|||
164117354|NCT01332968|592791718|FG001|Follow-Up Period|Death|0|||
164117355|NCT01332968|592791719|FG002|Follow-Up Period|Death|0|||
164117356|NCT01332968|592791720|FG003|Follow-Up Period|Death|0|||
164117357|NCT01332968|592791721|FG004|Follow-Up Period|Death|0|||
164117358|NCT01332968|592791722|FG005|Follow-Up Period|Death|0|||
164117359|NCT01332968|592791723|FG006|Follow-Up Period|Death|27|||
164117360|NCT01332968|592791724|FG007|Follow-Up Period|Death|30|||
164117361|NCT01332968|592791717|FG000|Follow-Up Period|Lost to Follow-up|0|||
164117362|NCT01332968|592791718|FG001|Follow-Up Period|Lost to Follow-up|0|||
164117363|NCT01332968|592791719|FG002|Follow-Up Period|Lost to Follow-up|0|||
164117364|NCT01332968|592791720|FG003|Follow-Up Period|Lost to Follow-up|0|||
164117365|NCT01332968|592791721|FG004|Follow-Up Period|Lost to Follow-up|0|||
164117366|NCT01332968|592791722|FG005|Follow-Up Period|Lost to Follow-up|0|||
164117367|NCT01332968|592791723|FG006|Follow-Up Period|Lost to Follow-up|11|||
164117368|NCT01332968|592791724|FG007|Follow-Up Period|Lost to Follow-up|15|||
164117369|NCT01332968|592791717|FG000|Follow-Up Period|Non-compliance|0|||
164117370|NCT01332968|592791718|FG001|Follow-Up Period|Non-compliance|0|||
164117371|NCT01332968|592791719|FG002|Follow-Up Period|Non-compliance|0|||
164117372|NCT01332968|592791720|FG003|Follow-Up Period|Non-compliance|0|||
164117373|NCT01332968|592791721|FG004|Follow-Up Period|Non-compliance|0|||
164117374|NCT01332968|592791722|FG005|Follow-Up Period|Non-compliance|0|||
164117375|NCT01332968|592791723|FG006|Follow-Up Period|Non-compliance|4|||
164117376|NCT01332968|592791724|FG007|Follow-Up Period|Non-compliance|9|||
164117377|NCT01332968|592791717|FG000|Follow-Up Period|Other|0|||
164117378|NCT01332968|592791718|FG001|Follow-Up Period|Other|0|||
164117379|NCT01332968|592791719|FG002|Follow-Up Period|Other|0|||
164117380|NCT01332968|592791720|FG003|Follow-Up Period|Other|0|||
164117381|NCT01332968|592791721|FG004|Follow-Up Period|Other|0|||
164117382|NCT01332968|592791722|FG005|Follow-Up Period|Other|0|||
164117383|NCT01332968|592791723|FG006|Follow-Up Period|Other|18|||
164117384|NCT01332968|592791724|FG007|Follow-Up Period|Other|21|||
164117385|NCT01332968|592791717|FG000|Follow-Up Period|Physician Decision|0|||
164117386|NCT01332968|592791718|FG001|Follow-Up Period|Physician Decision|0|||
164117387|NCT01332968|592791719|FG002|Follow-Up Period|Physician Decision|0|||
164117388|NCT01332968|592791720|FG003|Follow-Up Period|Physician Decision|0|||
164117389|NCT01332968|592791721|FG004|Follow-Up Period|Physician Decision|0|||
164117390|NCT01332968|592791722|FG005|Follow-Up Period|Physician Decision|0|||
164117391|NCT01332968|592791723|FG006|Follow-Up Period|Physician Decision|12|||
164117392|NCT01332968|592791724|FG007|Follow-Up Period|Physician Decision|15|||
164117393|NCT01332968|592791717|FG000|Follow-Up Period|Progressive Disease|0|||
164117394|NCT01332968|592791718|FG001|Follow-Up Period|Progressive Disease|0|||
164117395|NCT01332968|592791719|FG002|Follow-Up Period|Progressive Disease|0|||
164117396|NCT01332968|592791720|FG003|Follow-Up Period|Progressive Disease|0|||
164117397|NCT01332968|592791721|FG004|Follow-Up Period|Progressive Disease|0|||
164117398|NCT01332968|592791722|FG005|Follow-Up Period|Progressive Disease|0|||
164117399|NCT01332968|592791723|FG006|Follow-Up Period|Progressive Disease|126|||
164117400|NCT01332968|592791724|FG007|Follow-Up Period|Progressive Disease|106|||
164117401|NCT01332968|592791717|FG000|Follow-Up Period|Protocol Violation|0|||
164117402|NCT01332968|592791718|FG001|Follow-Up Period|Protocol Violation|0|||
164117403|NCT01332968|592791719|FG002|Follow-Up Period|Protocol Violation|0|||
164117404|NCT01332968|592791720|FG003|Follow-Up Period|Protocol Violation|0|||
164117405|NCT01332968|592791721|FG004|Follow-Up Period|Protocol Violation|0|||
164117406|NCT01332968|592791722|FG005|Follow-Up Period|Protocol Violation|0|||
164117407|NCT01332968|592791723|FG006|Follow-Up Period|Protocol Violation|1|||
164117408|NCT01332968|592791724|FG007|Follow-Up Period|Protocol Violation|0|||
164117409|NCT01332968|592791717|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164117410|NCT01332968|592791718|FG001|Follow-Up Period|Withdrawal by Subject|0|||
164117411|NCT01332968|592791719|FG002|Follow-Up Period|Withdrawal by Subject|0|||
164117412|NCT01332968|592791720|FG003|Follow-Up Period|Withdrawal by Subject|0|||
164117413|NCT01332968|592791721|FG004|Follow-Up Period|Withdrawal by Subject|0|||
164117414|NCT01332968|592791722|FG005|Follow-Up Period|Withdrawal by Subject|0|||
164117415|NCT01332968|592791723|FG006|Follow-Up Period|Withdrawal by Subject|29|||
164117416|NCT01332968|592791724|FG007|Follow-Up Period|Withdrawal by Subject|32|||
164117417|NCT01332968|592791717|FG000|Follow-Up Period|No reason provided|0|||
164117418|NCT01332968|592791718|FG001|Follow-Up Period|No reason provided|0|||
164117419|NCT01332968|592791719|FG002|Follow-Up Period|No reason provided|0|||
164117420|NCT01332968|592791720|FG003|Follow-Up Period|No reason provided|0|||
164117421|NCT01332968|592791721|FG004|Follow-Up Period|No reason provided|0|||
164117422|NCT01332968|592791722|FG005|Follow-Up Period|No reason provided|0|||
164117423|NCT01332968|592791723|FG006|Follow-Up Period|No reason provided|2|||
164117424|NCT01332968|592791724|FG007|Follow-Up Period|No reason provided|3|||
164117425|NCT00721955|592791729|FG000|Overall Study|Adverse Event|0|||
164117426|NCT00721955|592791730|FG001|Overall Study|Adverse Event|0|||
164117427|NCT00721955|592791731|FG002|Overall Study|Adverse Event|2|||
164117428|NCT04194008|592791736|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
164117429|NCT04194008|592791736|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
164117430|NCT04194008|592791736|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
164117431|NCT04194008|592791736|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
164117432|NCT04194008|592791736|FG000|Treatment Phase With Nerivio|Missing data|4|||
164117433|NCT04194008|592791736|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
164117434|NCT01785615|592791737|FG000|Dietary Phase|Lost to Follow-up|0|||
164117435|NCT01785615|592791738|FG001|Dietary Phase|Lost to Follow-up|0|||
164117436|NCT01785615|592791739|FG002|Dietary Phase|Lost to Follow-up|0|||
164117437|NCT01785615|592791740|FG003|Dietary Phase|Lost to Follow-up|24|||
164117438|NCT02522780|592791741|FG000|Overall Study|Consent withdrawn by subject|5|||
164117439|NCT02522780|592791742|FG001|Overall Study|Consent withdrawn by subject|7|||
164117440|NCT02522780|592791741|FG000|Overall Study|Protocol deviation|1|||
164117441|NCT02522780|592791742|FG001|Overall Study|Protocol deviation|3|||
164117442|NCT02522780|592791741|FG000|Overall Study|Subject refused endoscopic procedure|0|||
164117443|NCT02522780|592791742|FG001|Overall Study|Subject refused endoscopic procedure|1|||
164117444|NCT02522780|592791741|FG000|Overall Study|Adverse event, non-fatal|11|||
164117445|NCT02522780|592791742|FG001|Overall Study|Adverse event, non-fatal|16|||
164117446|NCT00926367|592791743|FG000|Overall Study|Withdrawal by Subject|0|||
164117447|NCT00926367|592791744|FG001|Overall Study|Withdrawal by Subject|1|||
164117448|NCT00926367|592791743|FG000|Overall Study|Lost to Follow-up|1|||
164117449|NCT00926367|592791744|FG001|Overall Study|Lost to Follow-up|0|||
164117450|NCT00926367|592791743|FG000|Overall Study|Skin Irritation|1|||
164117451|NCT00926367|592791744|FG001|Overall Study|Skin Irritation|2|||
164117452|NCT01517867|592791745|FG000|Overall Study|never started treatment|29|||
164117453|NCT01517867|592791746|FG001|Overall Study|never started treatment|32|||
164117454|NCT01517867|592791745|FG000|Overall Study|Withdrawal by Subject|34|||
164117455|NCT01517867|592791746|FG001|Overall Study|Withdrawal by Subject|30|||
164117456|NCT01517867|592791745|FG000|Overall Study|Still in treatment at study end|0|||
164117457|NCT01517867|592791746|FG001|Overall Study|Still in treatment at study end|3|||
164117458|NCT01266603|592791747|FG000|Overall Study|Adverse Event|1|||
164117459|NCT01266603|592791747|FG000|Overall Study|Lack of Efficacy|14|||
164117460|NCT01266603|592791747|FG000|Overall Study|Withdrawal by Subject|1|||
164117461|NCT01266603|592791747|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
164117462|NCT02725411|592791750|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
164117463|NCT02725411|592791751|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
164117464|NCT02725411|592791752|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
164117465|NCT02725411|592791750|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
164117466|NCT02725411|592791751|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
164117467|NCT02725411|592791752|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
164117468|NCT02725411|592791750|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
164117469|NCT02725411|592791751|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
164117470|NCT02725411|592791752|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
164117471|NCT02725411|592791750|FG000|Treatment Period (56 Weeks)|Other|1|||
164117472|NCT02725411|592791751|FG001|Treatment Period (56 Weeks)|Other|4|||
164117473|NCT02725411|592791752|FG002|Treatment Period (56 Weeks)|Other|5|||
164117474|NCT02725411|592791750|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
164117475|NCT02725411|592791751|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
164117476|NCT02725411|592791752|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
164117477|NCT02725411|592791750|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
164117478|NCT02725411|592791751|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
164117479|NCT02725411|592791752|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
164117480|NCT02725411|592791750|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
164117481|NCT02725411|592791751|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
164117482|NCT02725411|592791752|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
164117483|NCT02725411|592791750|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
164117484|NCT02725411|592791751|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
164117485|NCT02725411|592791752|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
164117486|NCT02725411|592791750|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
164117487|NCT02725411|592791751|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
164117488|NCT02725411|592791752|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
164117489|NCT02725411|592791750|FG000|Follow-up Period (24 Weeks)|Other|1|||
164117490|NCT02725411|592791751|FG001|Follow-up Period (24 Weeks)|Other|4|||
164117491|NCT02725411|592791752|FG002|Follow-up Period (24 Weeks)|Other|2|||
164117492|NCT02725411|592791750|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
164117493|NCT02725411|592791751|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
164117494|NCT02725411|592791752|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
164117495|NCT04307849|592791753|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
164117496|NCT04307849|592791754|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
164117497|NCT04307849|592791755|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
164117498|NCT04307849|592791756|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
164117499|NCT04307849|592791757|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
164117500|NCT04307849|592791758|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
164117501|NCT04307849|592791753|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164117502|NCT04307849|592791754|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164117503|NCT04307849|592791755|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
164117504|NCT04307849|592791756|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164117505|NCT04307849|592791757|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164117506|NCT04307849|592791758|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
164117507|NCT04307849|592791753|FG000|Overall Study|Family member did not want them to continue|0|||
164117508|NCT04307849|592791754|FG001|Overall Study|Family member did not want them to continue|0|||
164117509|NCT04307849|592791755|FG002|Overall Study|Family member did not want them to continue|1|||
164117510|NCT04307849|592791756|FG003|Overall Study|Family member did not want them to continue|0|||
164117511|NCT04307849|592791757|FG004|Overall Study|Family member did not want them to continue|0|||
164117512|NCT04307849|592791758|FG005|Overall Study|Family member did not want them to continue|0|||
164117513|NCT04307849|592791753|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
164117514|NCT04307849|592791754|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
164117515|NCT04307849|592791755|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
164117516|NCT04307849|592791756|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
164117517|NCT04307849|592791757|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
164117518|NCT04307849|592791758|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
164117519|NCT02654015|592791761|FG000|Overall Study|Death|12|||
164117520|NCT02654015|592791761|FG000|Overall Study|Lost to Follow-up|3|||
164117521|NCT02418754|592791762|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164117522|NCT02418754|592791763|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
164117523|NCT02418754|592791764|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164117524|NCT02418754|592791765|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164117525|NCT02418754|592791766|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
164117526|NCT02418754|592791762|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
164117527|NCT02418754|592791763|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
164117528|NCT02418754|592791764|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
164117529|NCT02418754|592791765|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
164117530|NCT02418754|592791766|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
164117531|NCT02418754|592791762|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
164117532|NCT02418754|592791763|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164117533|NCT02418754|592791764|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164117534|NCT02418754|592791765|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164117535|NCT02418754|592791766|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
164117536|NCT02418754|592791762|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
164117537|NCT02418754|592791763|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
164117538|NCT02418754|592791764|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
164117539|NCT02418754|592791765|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
164117540|NCT02418754|592791766|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
164117541|NCT02418754|592791762|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164117542|NCT02418754|592791763|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164117543|NCT02418754|592791764|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
164117544|NCT02418754|592791765|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164117545|NCT02418754|592791766|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
164117546|NCT02418754|592791762|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
164117547|NCT02418754|592791763|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
164117548|NCT02418754|592791764|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
164117549|NCT02418754|592791765|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
164117550|NCT02418754|592791766|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
164117551|NCT02418754|592791762|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
164117552|NCT02418754|592791763|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164117553|NCT02418754|592791764|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164117554|NCT02418754|592791765|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164117555|NCT02418754|592791766|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
164117556|NCT02418754|592791762|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
164117557|NCT02418754|592791763|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
164117558|NCT02418754|592791764|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
164117559|NCT02418754|592791765|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
164117560|NCT02418754|592791766|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
164117561|NCT02418754|592791762|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
164117562|NCT02418754|592791763|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
164117563|NCT02418754|592791764|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
164117564|NCT02418754|592791765|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
164117565|NCT02418754|592791766|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
164117566|NCT02418754|592791762|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
164117567|NCT02418754|592791763|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
164117568|NCT02418754|592791764|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
164117569|NCT02418754|592791765|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
164117570|NCT02418754|592791766|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
164117571|NCT02418754|592791762|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
164117572|NCT02418754|592791763|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
164117573|NCT02418754|592791764|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
164117574|NCT02418754|592791765|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
164117575|NCT02418754|592791766|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
164117576|NCT00761176|592791771|FG000|Overall Study|Death|1|||
164117577|NCT00761176|592791772|FG001|Overall Study|Death|0|||
164117578|NCT00761176|592791771|FG000|Overall Study|Withdrawal by Subject|1|||
164117579|NCT00761176|592791772|FG001|Overall Study|Withdrawal by Subject|1|||
164117580|NCT02762994|592791775|FG000|Overall Study|Withdrawal by Subject|0|||
164117581|NCT02762994|592791776|FG001|Overall Study|Withdrawal by Subject|1|||
164117582|NCT02762994|592791777|FG002|Overall Study|Withdrawal by Subject|2|||
164117583|NCT02762994|592791778|FG003|Overall Study|Withdrawal by Subject|0|||
164117584|NCT02762994|592791775|FG000|Overall Study|Protocol Violation|1|||
164117585|NCT02762994|592791776|FG001|Overall Study|Protocol Violation|0|||
164117586|NCT02762994|592791777|FG002|Overall Study|Protocol Violation|0|||
164117587|NCT02762994|592791778|FG003|Overall Study|Protocol Violation|2|||
164117588|NCT05103657|592791779|FG000|Overall Study|Other reasons than listed|9|||
164117589|NCT05103657|592791780|FG001|Overall Study|Other reasons than listed|8|||
164117590|NCT05103657|592791779|FG000|Overall Study|Protocol deviation|2|||
164117591|NCT05103657|592791780|FG001|Overall Study|Protocol deviation|2|||
164117592|NCT05103657|592791779|FG000|Overall Study|No reason available|5|||
164117593|NCT05103657|592791780|FG001|Overall Study|No reason available|4|||
164117594|NCT05103657|592791779|FG000|Overall Study|Burden of study procedures|3|||
164117595|NCT05103657|592791780|FG001|Overall Study|Burden of study procedures|1|||
164117596|NCT05103657|592791779|FG000|Overall Study|Perceived lack of efficacy|1|||
164117597|NCT05103657|592791780|FG001|Overall Study|Perceived lack of efficacy|1|||
164117598|NCT05103657|592791779|FG000|Overall Study|Adverse Event|6|||
164117599|NCT05103657|592791780|FG001|Overall Study|Adverse Event|14|||
164117600|NCT05103657|592791779|FG000|Overall Study|Not Treated|1|||
164117601|NCT05103657|592791780|FG001|Overall Study|Not Treated|1|||
164117602|NCT02020967|592791781|FG000|Overall Study|Withdrawal by Subject|51|||
164117603|NCT00860262|592791785|FG000|Overall Study|Adverse Event|9|||
164117604|NCT00860262|592791786|FG001|Overall Study|Adverse Event|6|||
164117605|NCT00860262|592791787|FG002|Overall Study|Adverse Event|7|||
164117606|NCT00860262|592791785|FG000|Overall Study|Protocol Violation|0|||
164117607|NCT00860262|592791786|FG001|Overall Study|Protocol Violation|1|||
164117608|NCT00860262|592791787|FG002|Overall Study|Protocol Violation|0|||
164117609|NCT00860262|592791785|FG000|Overall Study|Lost to Follow-up|2|||
164117610|NCT00860262|592791786|FG001|Overall Study|Lost to Follow-up|0|||
164117611|NCT00860262|592791787|FG002|Overall Study|Lost to Follow-up|1|||
164117612|NCT00860262|592791785|FG000|Overall Study|Withdrawal by Subject|4|||
164117613|NCT00860262|592791786|FG001|Overall Study|Withdrawal by Subject|8|||
164117614|NCT00860262|592791787|FG002|Overall Study|Withdrawal by Subject|6|||
164117615|NCT00860262|592791785|FG000|Overall Study|Lack of Efficacy|0|||
164117616|NCT00860262|592791786|FG001|Overall Study|Lack of Efficacy|4|||
164117617|NCT00860262|592791787|FG002|Overall Study|Lack of Efficacy|3|||
164117618|NCT00860262|592791785|FG000|Overall Study|Other|5|||
164117619|NCT00860262|592791786|FG001|Overall Study|Other|3|||
164117620|NCT00860262|592791787|FG002|Overall Study|Other|1|||
164117621|NCT01183884|592791788|FG000|Overall Study|Progressive Disease|26|||
164117622|NCT01183884|592791788|FG000|Overall Study|Adverse Event|3|||
164117623|NCT01183884|592791788|FG000|Overall Study|Withdrawal by Subject|1|||
164117624|NCT01183884|592791788|FG000|Overall Study|Other Complicating Disease|3|||
164117625|NCT01183884|592791788|FG000|Overall Study|Not Treated|1|||
164117626|NCT01183884|592791788|FG000|Overall Study|Other|4|||
164117627|NCT02169336|592791789|FG000|Overall Study|Lack of Efficacy|1|||
164117628|NCT02169336|592791790|FG001|Overall Study|Lack of Efficacy|1|||
164117629|NCT02169336|592791791|FG002|Overall Study|Lack of Efficacy|0|||
164117630|NCT02169336|592791789|FG000|Overall Study|Adverse Event|2|||
164117631|NCT02169336|592791790|FG001|Overall Study|Adverse Event|3|||
164117632|NCT02169336|592791791|FG002|Overall Study|Adverse Event|1|||
164117633|NCT02169336|592791789|FG000|Overall Study|Withdrawal by Subject|1|||
164117634|NCT02169336|592791790|FG001|Overall Study|Withdrawal by Subject|0|||
164117635|NCT02169336|592791791|FG002|Overall Study|Withdrawal by Subject|0|||
164117636|NCT02169336|592791789|FG000|Overall Study|Physician Decision|0|||
164117637|NCT02169336|592791790|FG001|Overall Study|Physician Decision|0|||
164117638|NCT02169336|592791791|FG002|Overall Study|Physician Decision|1|||
164117639|NCT02169336|592791789|FG000|Overall Study|Subject declined to continue dosing|0|||
164117640|NCT02169336|592791790|FG001|Overall Study|Subject declined to continue dosing|0|||
164117641|NCT02169336|592791791|FG002|Overall Study|Subject declined to continue dosing|1|||
164117642|NCT01598896|592791792|FG000|Overall Study|Withdrawal by Subject|0|||
164117643|NCT01598896|592791793|FG001|Overall Study|Withdrawal by Subject|1|||
164117644|NCT01598896|592791792|FG000|Overall Study|Lack of Efficacy|0|||
164117645|NCT01598896|592791793|FG001|Overall Study|Lack of Efficacy|1|||
164117646|NCT00420095|592791794|FG000|Overall Study|Adverse Event|1|||
164117647|NCT00420095|592791795|FG001|Overall Study|Adverse Event|0|||
164117648|NCT00420095|592791794|FG000|Overall Study|Protocol Violation|1|||
164117649|NCT00420095|592791795|FG001|Overall Study|Protocol Violation|1|||
164117650|NCT00420095|592791794|FG000|Overall Study|Lost to Follow-up|1|||
164117651|NCT00420095|592791795|FG001|Overall Study|Lost to Follow-up|0|||
164117652|NCT00393705|592791796|FG000|Overall Study|Adverse Event|0|||
164117653|NCT00393705|592791797|FG001|Overall Study|Adverse Event|2|||
164117654|NCT00393705|592791796|FG000|Overall Study|Death|0|||
164117655|NCT00393705|592791797|FG001|Overall Study|Death|1|||
164117656|NCT00393705|592791796|FG000|Overall Study|Lost to Follow-up|2|||
164117657|NCT00393705|592791797|FG001|Overall Study|Lost to Follow-up|2|||
164117658|NCT00393705|592791796|FG000|Overall Study|Entry Criteria Not Met|10|||
164117659|NCT00393705|592791797|FG001|Overall Study|Entry Criteria Not Met|10|||
164117660|NCT00393705|592791796|FG000|Overall Study|Protocol Violation|4|||
164117661|NCT00393705|592791797|FG001|Overall Study|Protocol Violation|3|||
164117662|NCT00393705|592791796|FG000|Overall Study|Withdrawal by Subject|5|||
164117663|NCT00393705|592791797|FG001|Overall Study|Withdrawal by Subject|3|||
164117664|NCT00393705|592791796|FG000|Overall Study|Physician Decision|2|||
164117665|NCT00393705|592791797|FG001|Overall Study|Physician Decision|2|||
164117666|NCT00642811|592791798|FG000|Overall Study|Adverse Event|2|||
164117667|NCT00642811|592791799|FG001|Overall Study|Adverse Event|3|||
164117668|NCT00642811|592791800|FG002|Overall Study|Adverse Event|0|||
164117669|NCT00642811|592791801|FG003|Overall Study|Adverse Event|0|||
164117670|NCT00642811|592791802|FG004|Overall Study|Adverse Event|0|||
164117671|NCT00642811|592791803|FG005|Overall Study|Adverse Event|1|||
164117672|NCT00642811|592791798|FG000|Overall Study|Developement of discontinuation criteria|0|||
164117673|NCT00642811|592791799|FG001|Overall Study|Developement of discontinuation criteria|0|||
164117674|NCT00642811|592791800|FG002|Overall Study|Developement of discontinuation criteria|0|||
164117675|NCT00642811|592791801|FG003|Overall Study|Developement of discontinuation criteria|0|||
164117676|NCT00642811|592791802|FG004|Overall Study|Developement of discontinuation criteria|1|||
164117677|NCT00642811|592791803|FG005|Overall Study|Developement of discontinuation criteria|0|||
164117678|NCT00642811|592791798|FG000|Overall Study|Severe Non-compliance to protocol|1|||
164117679|NCT00642811|592791799|FG001|Overall Study|Severe Non-compliance to protocol|0|||
164117680|NCT00642811|592791800|FG002|Overall Study|Severe Non-compliance to protocol|0|||
164117681|NCT00642811|592791801|FG003|Overall Study|Severe Non-compliance to protocol|0|||
164117682|NCT00642811|592791802|FG004|Overall Study|Severe Non-compliance to protocol|0|||
164117683|NCT00642811|592791803|FG005|Overall Study|Severe Non-compliance to protocol|0|||
164117684|NCT00642811|592791798|FG000|Overall Study|Other|0|||
164117685|NCT00642811|592791799|FG001|Overall Study|Other|1|||
164117686|NCT00642811|592791800|FG002|Overall Study|Other|0|||
164117687|NCT00642811|592791801|FG003|Overall Study|Other|1|||
164117688|NCT00642811|592791802|FG004|Overall Study|Other|0|||
164117689|NCT00642811|592791803|FG005|Overall Study|Other|0|||
164117690|NCT04553406|592791806|FG000|Overall Study|Study Discontinuation|0|||
164117691|NCT04553406|592791807|FG001|Overall Study|Study Discontinuation|1|||
164117692|NCT03370510|592791808|FG000|Overall Study|COVID-19|2|||
164117693|NCT03370510|592791809|FG001|Overall Study|COVID-19|0|||
164117694|NCT01525628|592791810|FG000|Overall Study|Adverse Event|1|||
164117695|NCT01525628|592791811|FG001|Overall Study|Adverse Event|1|||
164117696|NCT01525628|592791812|FG002|Overall Study|Adverse Event|2|||
164117697|NCT01525628|592791813|FG003|Overall Study|Adverse Event|0|||
164117698|NCT01525628|592791814|FG004|Overall Study|Adverse Event|1|||
164117699|NCT01525628|592791810|FG000|Overall Study|Lack of Efficacy|0|||
164117700|NCT01525628|592791811|FG001|Overall Study|Lack of Efficacy|2|||
164117701|NCT01525628|592791812|FG002|Overall Study|Lack of Efficacy|2|||
164117702|NCT01525628|592791813|FG003|Overall Study|Lack of Efficacy|1|||
164117703|NCT01525628|592791814|FG004|Overall Study|Lack of Efficacy|2|||
164117704|NCT01525628|592791810|FG000|Overall Study|Protocol Violation|0|||
164117705|NCT01525628|592791811|FG001|Overall Study|Protocol Violation|0|||
164117706|NCT01525628|592791812|FG002|Overall Study|Protocol Violation|1|||
164117707|NCT01525628|592791813|FG003|Overall Study|Protocol Violation|0|||
164117708|NCT01525628|592791814|FG004|Overall Study|Protocol Violation|0|||
164117709|NCT01525628|592791810|FG000|Overall Study|Lost to Follow-up|1|||
164117710|NCT01525628|592791811|FG001|Overall Study|Lost to Follow-up|1|||
164117711|NCT01525628|592791812|FG002|Overall Study|Lost to Follow-up|0|||
164117712|NCT01525628|592791813|FG003|Overall Study|Lost to Follow-up|0|||
164117713|NCT01525628|592791814|FG004|Overall Study|Lost to Follow-up|0|||
164117714|NCT01525628|592791810|FG000|Overall Study|Withdrawal by Subject|0|||
164117715|NCT01525628|592791811|FG001|Overall Study|Withdrawal by Subject|1|||
164117716|NCT01525628|592791812|FG002|Overall Study|Withdrawal by Subject|0|||
164117717|NCT01525628|592791813|FG003|Overall Study|Withdrawal by Subject|0|||
164117718|NCT01525628|592791814|FG004|Overall Study|Withdrawal by Subject|0|||
164117719|NCT01525628|592791810|FG000|Overall Study|Other reason not defined above|0|||
164117720|NCT01525628|592791811|FG001|Overall Study|Other reason not defined above|0|||
164117721|NCT01525628|592791812|FG002|Overall Study|Other reason not defined above|0|||
164117722|NCT01525628|592791813|FG003|Overall Study|Other reason not defined above|3|||
164117723|NCT01525628|592791814|FG004|Overall Study|Other reason not defined above|0|||
164117724|NCT02614898|592791815|FG000|Overall Study|Participated until study termination|10|||
164117725|NCT02614898|592791816|FG001|Overall Study|Participated until study termination|26|||
164117726|NCT02614898|592791815|FG000|Overall Study|Lost to Follow-up|0|||
164117727|NCT02614898|592791816|FG001|Overall Study|Lost to Follow-up|2|||
164117728|NCT02614898|592791815|FG000|Overall Study|Physician Decision|1|||
164117729|NCT02614898|592791816|FG001|Overall Study|Physician Decision|8|||
164117730|NCT02614898|592791815|FG000|Overall Study|Study Terminated by Sponsor|3|||
164117731|NCT02614898|592791816|FG001|Overall Study|Study Terminated by Sponsor|0|||
164117732|NCT02614898|592791815|FG000|Overall Study|Withdrawal by Subject|0|||
164117733|NCT02614898|592791816|FG001|Overall Study|Withdrawal by Subject|2|||
164117734|NCT02614898|592791815|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
164117735|NCT02614898|592791816|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
164117736|NCT02614898|592791815|FG000|Overall Study|Other-Additional Information Unavailable|0|||
164117737|NCT02614898|592791816|FG001|Overall Study|Other-Additional Information Unavailable|11|||
164117738|NCT02614898|592791815|FG000|Overall Study|Missing|0|||
164117739|NCT02614898|592791816|FG001|Overall Study|Missing|1|||
164117740|NCT00787605|592791817|FG000|Overall Study|Administrative Problems|3|||
164117741|NCT00787605|592791818|FG001|Overall Study|Administrative Problems|0|||
164117742|NCT00787605|592791817|FG000|Overall Study|Adverse Event|14|||
164117743|NCT00787605|592791818|FG001|Overall Study|Adverse Event|25|||
164117744|NCT00787605|592791817|FG000|Overall Study|Lost to Follow-up|3|||
164117745|NCT00787605|592791818|FG001|Overall Study|Lost to Follow-up|6|||
164117746|NCT00787605|592791817|FG000|Overall Study|Protocol Violation|7|||
164117747|NCT00787605|592791818|FG001|Overall Study|Protocol Violation|3|||
164117748|NCT00787605|592791817|FG000|Overall Study|Withdrawal by Subject|6|||
164117749|NCT00787605|592791818|FG001|Overall Study|Withdrawal by Subject|13|||
164117750|NCT00787605|592791817|FG000|Overall Study|Lack of Efficacy|13|||
164117751|NCT00787605|592791818|FG001|Overall Study|Lack of Efficacy|9|||
164117752|NCT01223027|592791821|FG000|Overall Study|Adverse Event|20|||
164117753|NCT01223027|592791822|FG001|Overall Study|Adverse Event|10|||
164117754|NCT01223027|592791821|FG000|Overall Study|Death|42|||
164117755|NCT01223027|592791822|FG001|Overall Study|Death|42|||
164117756|NCT01223027|592791821|FG000|Overall Study|Lost to Follow-up|2|||
164117757|NCT01223027|592791822|FG001|Overall Study|Lost to Follow-up|1|||
164117758|NCT01223027|592791821|FG000|Overall Study|Physician Decision|4|||
164117759|NCT01223027|592791822|FG001|Overall Study|Physician Decision|8|||
164117760|NCT01223027|592791821|FG000|Overall Study|Progressive Disease|167|||
164117761|NCT01223027|592791822|FG001|Overall Study|Progressive Disease|183|||
164117762|NCT01223027|592791821|FG000|Overall Study|Protocol Violation|2|||
164117763|NCT01223027|592791822|FG001|Overall Study|Protocol Violation|1|||
164117764|NCT01223027|592791821|FG000|Overall Study|Subject/guardian decicion|18|||
164117765|NCT01223027|592791822|FG001|Overall Study|Subject/guardian decicion|16|||
164117766|NCT01223027|592791821|FG000|Overall Study|New therapy for study indication|17|||
164117767|NCT01223027|592791822|FG001|Overall Study|New therapy for study indication|8|||
164117768|NCT01223027|592791821|FG000|Overall Study|Study terminated by sponsor|2|||
164117769|NCT01223027|592791822|FG001|Overall Study|Study terminated by sponsor|8|||
164117770|NCT03493919|592791823|FG000|Overall Study|Other|2|||
164117771|NCT03493919|592791824|FG001|Overall Study|Other|0|||
164117772|NCT03493919|592791825|FG002|Overall Study|Other|1|||
164117773|NCT03493919|592791826|FG003|Overall Study|Other|0|||
164117774|NCT03493919|592791823|FG000|Overall Study|Withdrawal by Subject|9|||
164117775|NCT03493919|592791824|FG001|Overall Study|Withdrawal by Subject|3|||
164117776|NCT03493919|592791825|FG002|Overall Study|Withdrawal by Subject|1|||
164117777|NCT03493919|592791826|FG003|Overall Study|Withdrawal by Subject|1|||
164117778|NCT03493919|592791823|FG000|Overall Study|Lost to Follow-up|5|||
164117779|NCT03493919|592791824|FG001|Overall Study|Lost to Follow-up|0|||
164117780|NCT03493919|592791825|FG002|Overall Study|Lost to Follow-up|0|||
164117781|NCT03493919|592791826|FG003|Overall Study|Lost to Follow-up|3|||
164117782|NCT03493919|592791823|FG000|Overall Study|Adverse Event|0|||
164117783|NCT03493919|592791824|FG001|Overall Study|Adverse Event|1|||
164117784|NCT03493919|592791825|FG002|Overall Study|Adverse Event|0|||
164117785|NCT03493919|592791826|FG003|Overall Study|Adverse Event|0|||
164117786|NCT00460109|592793388|FG000|Overall Study|Death|1|||
164117787|NCT04167618|592793389|FG000|Overall Study|Trial terminated by sponsor|1|||
164117788|NCT04167618|592793390|FG001|Overall Study|Trial terminated by sponsor|1|||
164117789|NCT02994394|592793391|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
164117790|NCT02994394|592793392|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
164117791|NCT02994394|592793393|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
164117792|NCT02994394|592793394|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
164117793|NCT02994394|592793395|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
164117794|NCT02994394|592793396|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
164117795|NCT02994394|592793391|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
164117796|NCT02994394|592793392|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
164117797|NCT02994394|592793393|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
164117798|NCT02994394|592793394|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
164117799|NCT02994394|592793395|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
164117800|NCT02994394|592793396|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
164117801|NCT03619876|592793397|FG000|Overall Study|Withdrawal by Subject|1|||
164117802|NCT03619876|592793398|FG001|Overall Study|Withdrawal by Subject|2|||
164117803|NCT03619876|592793397|FG000|Overall Study|Withdrawal due to incidental finding|0|||
164117804|NCT03619876|592793398|FG001|Overall Study|Withdrawal due to incidental finding|2|||
164117805|NCT04982445|592793400|FG000|Overall Study|Protocol Violation|1|||
164117806|NCT04982445|592793400|FG000|Overall Study|Withdrawal by Subject|4|||
164117807|NCT04982445|592793400|FG000|Overall Study|Lost to Follow-up|1|||
164117808|NCT02014441|592793401|FG000|Overall Study|Withdrawal by Subject|12|||
164117809|NCT00114231|592793402|FG000|Overall Study|No consent|2|||
164117810|NCT00114231|592793403|FG001|Overall Study|No consent|0|||
164117811|NCT00114231|592793402|FG000|Overall Study|QARC requirement not met|1|||
164117812|NCT00114231|592793403|FG001|Overall Study|QARC requirement not met|0|||
164117813|NCT00114231|592793402|FG000|Overall Study|Suspected metastatic disease|1|||
164117814|NCT00114231|592793403|FG001|Overall Study|Suspected metastatic disease|0|||
164117815|NCT00114231|592793402|FG000|Overall Study|No adenocarcinoma|1|||
164117816|NCT00114231|592793403|FG001|Overall Study|No adenocarcinoma|0|||
164117817|NCT00114231|592793402|FG000|Overall Study|Low creatinine clearance|0|||
164117818|NCT00114231|592793403|FG001|Overall Study|Low creatinine clearance|1|||
164117819|NCT00114231|592793402|FG000|Overall Study|Tumor size > 4cm|1|||
164117820|NCT00114231|592793403|FG001|Overall Study|Tumor size > 4cm|0|||
164117821|NCT00114231|592793402|FG000|Overall Study|Tumor fixed on digital exam|0|||
164117822|NCT00114231|592793403|FG001|Overall Study|Tumor fixed on digital exam|1|||
164117823|NCT00114231|592793402|FG000|Overall Study|No Absolute Neutrophil Count|2|||
164117824|NCT00114231|592793403|FG001|Overall Study|No Absolute Neutrophil Count|0|||
164117825|NCT00114231|592793402|FG000|Overall Study|Biopsy done after registration|1|||
164117826|NCT00114231|592793403|FG001|Overall Study|Biopsy done after registration|0|||
164117827|NCT03330236|592793408|FG000|Overall Study|Death|2|||
164117828|NCT03330236|592793409|FG001|Overall Study|Death|1|||
164117829|NCT03330236|592793408|FG000|Overall Study|Withdrawal by Subject|2|||
164117830|NCT03330236|592793409|FG001|Overall Study|Withdrawal by Subject|4|||
164117831|NCT03330236|592793408|FG000|Overall Study|Lost to Follow-up|0|||
164117832|NCT03330236|592793409|FG001|Overall Study|Lost to Follow-up|2|||
164117833|NCT03330236|592793408|FG000|Overall Study|Physician Decision|2|||
164117834|NCT03330236|592793409|FG001|Overall Study|Physician Decision|0|||
164117835|NCT03330236|592793408|FG000|Overall Study|Protocol Violation|4|||
164117836|NCT03330236|592793409|FG001|Overall Study|Protocol Violation|3|||
164117837|NCT03330236|592793408|FG000|Overall Study|SedLine malfunction/blinding|19|||
164117838|NCT03330236|592793409|FG001|Overall Study|SedLine malfunction/blinding|14|||
164117839|NCT03330236|592793408|FG000|Overall Study|Volatile anesthetics used|11|||
164117840|NCT03330236|592793409|FG001|Overall Study|Volatile anesthetics used|8|||
164117841|NCT03330236|592793408|FG000|Overall Study|Surgery aborted/converted to open|60|||
164117842|NCT03330236|592793409|FG001|Overall Study|Surgery aborted/converted to open|52|||
164117843|NCT00763555|592793415|FG000|Overall Study|Adverse Event|2|||
164117844|NCT00763555|592793416|FG001|Overall Study|Adverse Event|1|||
164117845|NCT00763555|592793415|FG000|Overall Study|Withdrawal by Subject|2|||
164117846|NCT00763555|592793416|FG001|Overall Study|Withdrawal by Subject|6|||
164117847|NCT00763555|592793415|FG000|Overall Study|Lost to Follow-up|0|||
164117848|NCT00763555|592793416|FG001|Overall Study|Lost to Follow-up|3|||
164117849|NCT01729026|592793417|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
164117850|NCT01729026|592793418|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
164117851|NCT01729026|592793417|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
164117852|NCT01729026|592793418|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
164117853|NCT02940730|592793428|FG000|Intervention 2|Physician Decision|7|||
164117854|NCT02940730|592793429|FG001|Intervention 2|Physician Decision|0|||
164117855|NCT01522950|592793430|FG000|Overall Study|Withdrawal by Subject|3|||
164117856|NCT01522950|592793431|FG001|Overall Study|Withdrawal by Subject|2|||
164117857|NCT01522950|592793432|FG002|Overall Study|Withdrawal by Subject|1|||
164117858|NCT01522950|592793430|FG000|Overall Study|Adverse Event|3|||
164117859|NCT01522950|592793431|FG001|Overall Study|Adverse Event|1|||
164117860|NCT01522950|592793432|FG002|Overall Study|Adverse Event|1|||
164117861|NCT01522950|592793430|FG000|Overall Study|Protocol Violation|0|||
164117862|NCT01522950|592793431|FG001|Overall Study|Protocol Violation|0|||
164117863|NCT01522950|592793432|FG002|Overall Study|Protocol Violation|2|||
164117864|NCT01522950|592793430|FG000|Overall Study|Death|0|||
164117865|NCT01522950|592793431|FG001|Overall Study|Death|1|||
164117866|NCT01522950|592793432|FG002|Overall Study|Death|1|||
164117867|NCT01522950|592793430|FG000|Overall Study|Study Medication Sensitivity|0|||
164117868|NCT01522950|592793431|FG001|Overall Study|Study Medication Sensitivity|1|||
164117869|NCT01522950|592793432|FG002|Overall Study|Study Medication Sensitivity|0|||
164117870|NCT00483548|592793434|FG000|Overall Study|Randomized; not treated with study drug|1|||
164117871|NCT00483548|592793435|FG001|Overall Study|Randomized; not treated with study drug|3|||
164117872|NCT00483548|592793434|FG000|Overall Study|Adverse Event|25|||
164117873|NCT00483548|592793435|FG001|Overall Study|Adverse Event|14|||
164117874|NCT00483548|592793434|FG000|Overall Study|Laboratory abnormality|1|||
164117875|NCT00483548|592793435|FG001|Overall Study|Laboratory abnormality|2|||
164117876|NCT00483548|592793434|FG000|Overall Study|Lack of Efficacy|4|||
164117877|NCT00483548|592793435|FG001|Overall Study|Lack of Efficacy|8|||
164117878|NCT00483548|592793434|FG000|Overall Study|Protocol Violation|11|||
164117879|NCT00483548|592793435|FG001|Overall Study|Protocol Violation|7|||
164117880|NCT00483548|592793434|FG000|Overall Study|Pregnancy|1|||
164117881|NCT00483548|592793435|FG001|Overall Study|Pregnancy|0|||
164117882|NCT00483548|592793434|FG000|Overall Study|Protocol required discontinuation|6|||
164117883|NCT00483548|592793435|FG001|Overall Study|Protocol required discontinuation|6|||
164117884|NCT00483548|592793434|FG000|Overall Study|Unable to comply with protocol schedule|1|||
164117885|NCT00483548|592793435|FG001|Overall Study|Unable to comply with protocol schedule|0|||
164117886|NCT00483548|592793434|FG000|Overall Study|Non-compliance with medication|2|||
164117887|NCT00483548|592793435|FG001|Overall Study|Non-compliance with medication|0|||
164117888|NCT00483548|592793434|FG000|Overall Study|Lost to Follow-up|3|||
164117889|NCT00483548|592793435|FG001|Overall Study|Lost to Follow-up|4|||
164117890|NCT00483548|592793434|FG000|Overall Study|Withdrawal by Subject|5|||
164117891|NCT00483548|592793435|FG001|Overall Study|Withdrawal by Subject|2|||
164117892|NCT02916693|592793438|FG000|Overall Study|Lost to Follow-up|7|||
164117893|NCT00979212|592793442|FG000|Overall Study|Protocol Violation|1|||
164117894|NCT00979212|592793443|FG001|Overall Study|Protocol Violation|8|||
164117895|NCT00979212|592793442|FG000|Overall Study|No protocol therapy received|1|||
164117896|NCT00979212|592793443|FG001|Overall Study|No protocol therapy received|0|||
164117897|NCT00035555|592793444|FG000|Overall Study|Adverse Event|5|||
164117898|NCT00035555|592793445|FG001|Overall Study|Adverse Event|8|||
164117899|NCT00035555|592793446|FG002|Overall Study|Adverse Event|9|||
164117900|NCT00035555|592793444|FG000|Overall Study|Allograft loss|1|||
164117901|NCT00035555|592793445|FG001|Overall Study|Allograft loss|1|||
164117902|NCT00035555|592793446|FG002|Overall Study|Allograft loss|2|||
164117903|NCT00035555|592793444|FG000|Overall Study|Death|0|||
164117904|NCT00035555|592793445|FG001|Overall Study|Death|0|||
164117905|NCT00035555|592793446|FG002|Overall Study|Death|2|||
164117906|NCT00035555|592793444|FG000|Overall Study|Lost to Follow-up|0|||
164117907|NCT00035555|592793445|FG001|Overall Study|Lost to Follow-up|0|||
164117908|NCT00035555|592793446|FG002|Overall Study|Lost to Follow-up|1|||
164117909|NCT00035555|592793444|FG000|Overall Study|Noncompliance|0|||
164117910|NCT00035555|592793445|FG001|Overall Study|Noncompliance|1|||
164117911|NCT00035555|592793446|FG002|Overall Study|Noncompliance|1|||
164117912|NCT00035555|592793444|FG000|Overall Study|Prohibited medication|1|||
164117913|NCT00035555|592793445|FG001|Overall Study|Prohibited medication|1|||
164117914|NCT00035555|592793446|FG002|Overall Study|Prohibited medication|0|||
164117915|NCT00035555|592793444|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
164117916|NCT00035555|592793445|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
164117917|NCT00035555|592793446|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
164117918|NCT00035555|592793444|FG000|Overall Study|Withdrawal by Subject|2|||
164117919|NCT00035555|592793445|FG001|Overall Study|Withdrawal by Subject|0|||
164117920|NCT00035555|592793446|FG002|Overall Study|Withdrawal by Subject|2|||
164117921|NCT00035555|592793444|FG000|Overall Study|Investigator deemed not a good candidate|0|||
164117922|NCT00035555|592793445|FG001|Overall Study|Investigator deemed not a good candidate|0|||
164117923|NCT00035555|592793446|FG002|Overall Study|Investigator deemed not a good candidate|1|||
164117924|NCT00035555|592793444|FG000|Overall Study|Received cyclosporin in error|0|||
164117925|NCT00035555|592793445|FG001|Overall Study|Received cyclosporin in error|0|||
164117926|NCT00035555|592793446|FG002|Overall Study|Received cyclosporin in error|1|||
164117927|NCT03223909|592793447|FG000|Overall Study|Protocol Violation|48|||
164117928|NCT03223909|592793448|FG001|Overall Study|Protocol Violation|45|||
164117929|NCT03223909|592793449|FG002|Overall Study|Protocol Violation|16|||
164117930|NCT05070754|592793459|FG000|Overall Study|Withdrawal by Subject|0|||
164117931|NCT05070754|592793460|FG001|Overall Study|Withdrawal by Subject|0|||
164117932|NCT05070754|592793461|FG002|Overall Study|Withdrawal by Subject|0|||
164117933|NCT05070754|592793462|FG003|Overall Study|Withdrawal by Subject|1|||
164117934|NCT05070754|592793459|FG000|Overall Study|Protocol Violation|0|||
164117935|NCT05070754|592793460|FG001|Overall Study|Protocol Violation|0|||
164117936|NCT05070754|592793461|FG002|Overall Study|Protocol Violation|0|||
164117937|NCT05070754|592793462|FG003|Overall Study|Protocol Violation|1|||
164117938|NCT01398787|592793463|FG000|Overall Study|Adverse Event|1|||
164117939|NCT02351167|592793464|FG000|Overall Study|Withdrawal by Subject|19|||
164117940|NCT02351167|592793465|FG001|Overall Study|Withdrawal by Subject|18|||
164117941|NCT02351167|592793466|FG002|Overall Study|Withdrawal by Subject|21|||
164117942|NCT00529217|592793467|FG000|Overall Study|Lack of Efficacy|2|||
164117943|NCT00529217|592793467|FG000|Overall Study|Unable to adhere to study schedule|2|||
164117944|NCT00194792|592793470|FG000|Overall Study|Withdrawal by Subject|1|||
164117945|NCT02448563|592793471|FG000|Overall Study|Lost to Follow-up|16|||
164117946|NCT02448563|592793472|FG001|Overall Study|Lost to Follow-up|10|||
164117947|NCT02448563|592793471|FG000|Overall Study|Withdrawal by Subject|0|||
164117948|NCT02448563|592793472|FG001|Overall Study|Withdrawal by Subject|1|||
164117949|NCT00702507|592793474|FG000|Initial Treatment Phase|Adverse Event|2|||
164117950|NCT00702507|592793474|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
164117951|NCT00702507|592793474|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
164117952|NCT00702507|592793474|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
164117953|NCT00702507|592793474|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
164117954|NCT00702507|592793474|FG000|Follow-up Phase|Protocol Violation|2|||
164117955|NCT00702507|592793474|FG000|Follow-up Phase|Lost to Follow-up|23|||
164117956|NCT00702507|592793474|FG000|Follow-up Phase|Late Enrollment|1|||
164117957|NCT02308696|592793475|FG000|Overall Study|Lost to Follow-up|28|||
164117958|NCT02308696|592793476|FG001|Overall Study|Lost to Follow-up|21|||
164117959|NCT02308696|592793475|FG000|Overall Study|Death|8|||
164117960|NCT02308696|592793476|FG001|Overall Study|Death|4|||
164117961|NCT02308696|592793475|FG000|Overall Study|Moved to a Higher Level of Care|17|||
164117962|NCT02308696|592793476|FG001|Overall Study|Moved to a Higher Level of Care|6|||
164117963|NCT00113919|592793477|FG000|Overall Study|Physician Decision|8|||
164117964|NCT00113919|592793477|FG000|Overall Study|Death|6|||
164117965|NCT00372996|592793478|FG000|Overall Study|Death|11|||
164117966|NCT00372996|592793479|FG001|Overall Study|Death|4|||
164117967|NCT00372996|592793480|FG002|Overall Study|Death|8|||
164117968|NCT00372996|592793481|FG003|Overall Study|Death|7|||
164117969|NCT00372996|592793478|FG000|Overall Study|Lost to Follow-up|0|||
164117970|NCT00372996|592793479|FG001|Overall Study|Lost to Follow-up|2|||
164117971|NCT00372996|592793480|FG002|Overall Study|Lost to Follow-up|0|||
164117972|NCT00372996|592793481|FG003|Overall Study|Lost to Follow-up|1|||
164117973|NCT00372996|592793478|FG000|Overall Study|Withdrawal by Subject|12|||
164117974|NCT00372996|592793479|FG001|Overall Study|Withdrawal by Subject|6|||
164117975|NCT00372996|592793480|FG002|Overall Study|Withdrawal by Subject|9|||
164117976|NCT00372996|592793481|FG003|Overall Study|Withdrawal by Subject|5|||
164117977|NCT00372996|592793478|FG000|Overall Study|Study Terminated by Sponsor|4|||
164117978|NCT00372996|592793479|FG001|Overall Study|Study Terminated by Sponsor|0|||
164117979|NCT00372996|592793480|FG002|Overall Study|Study Terminated by Sponsor|4|||
164117980|NCT00372996|592793481|FG003|Overall Study|Study Terminated by Sponsor|0|||
164117981|NCT00372996|592793478|FG000|Overall Study|Other|10|||
164117982|NCT00372996|592793479|FG001|Overall Study|Other|2|||
164117983|NCT00372996|592793480|FG002|Overall Study|Other|7|||
164117984|NCT00372996|592793481|FG003|Overall Study|Other|7|||
164117985|NCT02914457|592793482|FG000|Overall Study|Withdrawal by Subject|1|||
164117986|NCT02914457|592793482|FG000|Overall Study|Physician Decision|1|||
164117987|NCT02914457|592793482|FG000|Overall Study|No veins available for lead placement|1|||
164117988|NCT02914457|592793482|FG000|Overall Study|Electrical instability of patient|1|||
164117989|NCT02914457|592793482|FG000|Overall Study|ECG acquisition error due to sweating|1|||
164117990|NCT02914457|592793482|FG000|Overall Study|Protocol Violation|1|||
164117991|NCT01055886|592793486|FG000|Overall Study|Withdrawal by Subject|4|||
164117992|NCT01055886|592793487|FG001|Overall Study|Withdrawal by Subject|9|||
164117993|NCT01055886|592793486|FG000|Overall Study|Lost to Follow-up|1|||
164117994|NCT01055886|592793487|FG001|Overall Study|Lost to Follow-up|1|||
164117995|NCT01055886|592793486|FG000|Overall Study|Withdrawal by PI|0|||
164117996|NCT01055886|592793487|FG001|Overall Study|Withdrawal by PI|1|||
164117997|NCT04254809|592793490|FG000|Overall Study|Lost to Follow-up|5|||
164117998|NCT04254809|592793491|FG001|Overall Study|Lost to Follow-up|10|||
164117999|NCT02972515|592793492|FG000|Overall Study|Lost to Follow-up|78|||
164118000|NCT01928615|592793493|FG000|Overall Study|Study Terminated by Sponsor|2|||
164118001|NCT04531527|592793494|FG000|Overall Study|Found to be Ineligible|3|||
164118002|NCT02608476|592793499|FG000|Overall Study|Withdrawal by Subject|30|||
164118003|NCT02608476|592793500|FG001|Overall Study|Withdrawal by Subject|37|||
164118004|NCT02608476|592793499|FG000|Overall Study|Lost to Follow-up|24|||
164118005|NCT02608476|592793500|FG001|Overall Study|Lost to Follow-up|24|||
164118006|NCT02608476|592793499|FG000|Overall Study|Adverse Event|2|||
164118007|NCT02608476|592793500|FG001|Overall Study|Adverse Event|8|||
164118008|NCT02608476|592793499|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
164118009|NCT02608476|592793500|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
164118010|NCT02608476|592793499|FG000|Overall Study|Noncompliance with treatment|1|||
164118011|NCT02608476|592793500|FG001|Overall Study|Noncompliance with treatment|5|||
164118012|NCT02608476|592793499|FG000|Overall Study|Lack of Efficacy|3|||
164118013|NCT02608476|592793500|FG001|Overall Study|Lack of Efficacy|1|||
164118014|NCT02608476|592793499|FG000|Overall Study|Other|0|||
164118015|NCT02608476|592793500|FG001|Overall Study|Other|1|||
164118016|NCT02608476|592793499|FG000|Overall Study|Physician Decision|1|||
164118017|NCT02608476|592793500|FG001|Overall Study|Physician Decision|0|||
164118018|NCT02608476|592793499|FG000|Overall Study|Pregnancy|0|||
164118019|NCT02608476|592793500|FG001|Overall Study|Pregnancy|1|||
164118020|NCT02608476|592793499|FG000|Overall Study|Progressive disease|1|||
164118021|NCT02608476|592793500|FG001|Overall Study|Progressive disease|0|||
164118022|NCT00676494|592793501|FG000|Overall Study|Missed Visit|8|||
164118023|NCT00676494|592793501|FG000|Overall Study|Withdrawal by Subject|6|||
164118024|NCT01203917|592793503|FG000|Overall Study|Death|29|||
164118025|NCT01203917|592793503|FG000|Overall Study|Lost to Follow-up|2|||
164118026|NCT01203917|592793503|FG000|Overall Study|Withdrawal by Subject|3|||
164118027|NCT01203917|592793503|FG000|Overall Study|Due to objective disease progression|1|||
164118028|NCT01203917|592793503|FG000|Overall Study|Due to EGFR M+I patient|1|||
164118029|NCT03310619|592793504|FG000|Pre-Treatment Period|Death|1|||
164118030|NCT03310619|592793505|FG001|Pre-Treatment Period|Death|0|||
164118031|NCT03310619|592793506|FG002|Pre-Treatment Period|Death|0|||
164118032|NCT03310619|592793507|FG003|Pre-Treatment Period|Death|0|||
164118033|NCT03310619|592793508|FG004|Pre-Treatment Period|Death|1|||
164118034|NCT03310619|592793509|FG005|Pre-Treatment Period|Death|0|||
164118035|NCT03310619|592793510|FG006|Pre-Treatment Period|Death|0|||
164118036|NCT03310619|592793511|FG007|Pre-Treatment Period|Death|0|||
164118037|NCT03310619|592793504|FG000|Pre-Treatment Period|Other reasons|2|||
164118038|NCT03310619|592793505|FG001|Pre-Treatment Period|Other reasons|1|||
164118039|NCT03310619|592793506|FG002|Pre-Treatment Period|Other reasons|2|||
164118040|NCT03310619|592793507|FG003|Pre-Treatment Period|Other reasons|0|||
164118041|NCT03310619|592793508|FG004|Pre-Treatment Period|Other reasons|0|||
164118042|NCT03310619|592793509|FG005|Pre-Treatment Period|Other reasons|0|||
164118043|NCT03310619|592793510|FG006|Pre-Treatment Period|Other reasons|2|||
164118044|NCT03310619|592793511|FG007|Pre-Treatment Period|Other reasons|0|||
164118045|NCT03310619|592793504|FG000|Treatment Period|Death|1|||
164118046|NCT03310619|592793505|FG001|Treatment Period|Death|2|||
164118047|NCT03310619|592793506|FG002|Treatment Period|Death|0|||
164118048|NCT03310619|592793507|FG003|Treatment Period|Death|0|||
164118049|NCT03310619|592793508|FG004|Treatment Period|Death|1|||
164118050|NCT03310619|592793509|FG005|Treatment Period|Death|0|||
164118051|NCT03310619|592793510|FG006|Treatment Period|Death|2|||
164118052|NCT03310619|592793511|FG007|Treatment Period|Death|0|||
164118053|NCT03310619|592793504|FG000|Treatment Period|Adverse Event|0|||
164118054|NCT03310619|592793505|FG001|Treatment Period|Adverse Event|1|||
164118055|NCT03310619|592793506|FG002|Treatment Period|Adverse Event|4|||
164118056|NCT03310619|592793507|FG003|Treatment Period|Adverse Event|1|||
164118057|NCT03310619|592793508|FG004|Treatment Period|Adverse Event|0|||
164118058|NCT03310619|592793509|FG005|Treatment Period|Adverse Event|0|||
164118059|NCT03310619|592793510|FG006|Treatment Period|Adverse Event|0|||
164118060|NCT03310619|592793511|FG007|Treatment Period|Adverse Event|0|||
164118061|NCT03310619|592793504|FG000|Treatment Period|Withdrawal by participant|0|||
164118062|NCT03310619|592793505|FG001|Treatment Period|Withdrawal by participant|0|||
164118063|NCT03310619|592793506|FG002|Treatment Period|Withdrawal by participant|1|||
164118064|NCT03310619|592793507|FG003|Treatment Period|Withdrawal by participant|0|||
164118065|NCT03310619|592793508|FG004|Treatment Period|Withdrawal by participant|0|||
164118066|NCT03310619|592793509|FG005|Treatment Period|Withdrawal by participant|0|||
164118067|NCT03310619|592793510|FG006|Treatment Period|Withdrawal by participant|0|||
164118068|NCT03310619|592793511|FG007|Treatment Period|Withdrawal by participant|0|||
164118069|NCT03310619|592793504|FG000|Treatment Period|Lost to Follow-up|0|||
164118070|NCT03310619|592793505|FG001|Treatment Period|Lost to Follow-up|0|||
164118071|NCT03310619|592793506|FG002|Treatment Period|Lost to Follow-up|0|||
164118072|NCT03310619|592793507|FG003|Treatment Period|Lost to Follow-up|0|||
164118073|NCT03310619|592793508|FG004|Treatment Period|Lost to Follow-up|0|||
164118074|NCT03310619|592793509|FG005|Treatment Period|Lost to Follow-up|0|||
164118075|NCT03310619|592793510|FG006|Treatment Period|Lost to Follow-up|0|||
164118076|NCT03310619|592793511|FG007|Treatment Period|Lost to Follow-up|1|||
164118077|NCT03310619|592793504|FG000|Treatment Period|Study terminated by sponsor|0|||
164118078|NCT03310619|592793505|FG001|Treatment Period|Study terminated by sponsor|0|||
164118079|NCT03310619|592793506|FG002|Treatment Period|Study terminated by sponsor|0|||
164118080|NCT03310619|592793507|FG003|Treatment Period|Study terminated by sponsor|0|||
164118081|NCT03310619|592793508|FG004|Treatment Period|Study terminated by sponsor|0|||
164118082|NCT03310619|592793509|FG005|Treatment Period|Study terminated by sponsor|0|||
164118083|NCT03310619|592793510|FG006|Treatment Period|Study terminated by sponsor|0|||
164118084|NCT03310619|592793511|FG007|Treatment Period|Study terminated by sponsor|1|||
164118085|NCT03310619|592793504|FG000|Treatment Period|Physician Decision|0|||
164118086|NCT03310619|592793505|FG001|Treatment Period|Physician Decision|0|||
164118087|NCT03310619|592793506|FG002|Treatment Period|Physician Decision|0|||
164118088|NCT03310619|592793507|FG003|Treatment Period|Physician Decision|0|||
164118089|NCT03310619|592793508|FG004|Treatment Period|Physician Decision|3|||
164118090|NCT03310619|592793509|FG005|Treatment Period|Physician Decision|0|||
164118091|NCT03310619|592793510|FG006|Treatment Period|Physician Decision|0|||
164118092|NCT03310619|592793511|FG007|Treatment Period|Physician Decision|0|||
164118093|NCT03310619|592793504|FG000|Treatment Period|Other reasons|1|||
164118094|NCT03310619|592793505|FG001|Treatment Period|Other reasons|0|||
164118095|NCT03310619|592793506|FG002|Treatment Period|Other reasons|2|||
164118096|NCT03310619|592793507|FG003|Treatment Period|Other reasons|0|||
164118097|NCT03310619|592793508|FG004|Treatment Period|Other reasons|0|||
164118098|NCT03310619|592793509|FG005|Treatment Period|Other reasons|0|||
164118099|NCT03310619|592793510|FG006|Treatment Period|Other reasons|0|||
164118100|NCT03310619|592793511|FG007|Treatment Period|Other reasons|0|||
164118101|NCT00152516|592793516|FG000|Overall Study|Adverse Event|18|||
164118102|NCT00152516|592793516|FG000|Overall Study|Lack and Loss of Efficacy|30|||
164118103|NCT00152516|592793516|FG000|Overall Study|Lost to Follow-up|5|||
164118104|NCT00152516|592793516|FG000|Overall Study|Withdrawal by Subject|8|||
164118105|NCT00152516|592793516|FG000|Overall Study|Protocol Violation|3|||
164118106|NCT00152516|592793516|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
164118107|NCT00152516|592793516|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
164118108|NCT00152516|592793516|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
164118109|NCT00152516|592793516|FG000|Overall Study|Other: Non-Compliance|2|||
164118110|NCT00152516|592793516|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
164118111|NCT00152516|592793516|FG000|Overall Study|Other: Moved Out Of State|1|||
164118112|NCT00152516|592793516|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
164118113|NCT00152516|592793516|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
164118114|NCT02387762|592793523|FG000|Overall Study|Withdrawal by Subject|1|||
164118115|NCT02387762|592793524|FG001|Overall Study|Withdrawal by Subject|0|||
164118116|NCT04203667|592793525|FG000|Overall Study|Withdrawal by Subject|1|||
164118117|NCT04203667|592793525|FG000|Overall Study|Lost to Follow-up|1|||
164118118|NCT04203667|592793525|FG000|Overall Study|Death|1|||
164118119|NCT04203667|592793525|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
164118120|NCT01160640|592793526|FG000|Overall Study|Physician Decision|3|||
164118121|NCT01160640|592793527|FG001|Overall Study|Physician Decision|3|||
164118122|NCT01160640|592793526|FG000|Overall Study|Incarceration|1|||
164118123|NCT01160640|592793527|FG001|Overall Study|Incarceration|0|||
164118124|NCT01160640|592793526|FG000|Overall Study|Withdrawal by Subject|0|||
164118125|NCT01160640|592793527|FG001|Overall Study|Withdrawal by Subject|3|||
164118126|NCT04428645|592793530|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
164118127|NCT03168906|592793533|FG000|Overall Study|Lack of Efficacy|6|||
164118128|NCT03168906|592793534|FG001|Overall Study|Lack of Efficacy|6|||
164118129|NCT03840382|592793537|FG000|Overall Study|Lost to Follow-up|11|||
164118130|NCT00434590|592793538|FG000|Overall Study|Administrative problems|5|||
164118131|NCT00434590|592793539|FG001|Overall Study|Administrative problems|5|||
164118132|NCT02839798|592795386|FG000|Overall Study|Withdrawal by Subject|2|||
164118133|NCT04129944|592795388|FG000|Overall Study|Death|0|||
164118134|NCT04129944|592795389|FG001|Overall Study|Death|0|||
164118135|NCT04129944|592795390|FG002|Overall Study|Death|0|||
164118136|NCT04129944|592795391|FG003|Overall Study|Death|1|||
164118137|NCT04129944|592795388|FG000|Overall Study|Lost to Follow-up|1|||
164118138|NCT04129944|592795389|FG001|Overall Study|Lost to Follow-up|0|||
164118139|NCT04129944|592795390|FG002|Overall Study|Lost to Follow-up|0|||
164118140|NCT04129944|592795391|FG003|Overall Study|Lost to Follow-up|0|||
164118141|NCT04129944|592795388|FG000|Overall Study|Withdrawal by Subject|1|||
164118142|NCT04129944|592795389|FG001|Overall Study|Withdrawal by Subject|0|||
164118143|NCT04129944|592795390|FG002|Overall Study|Withdrawal by Subject|1|||
164118144|NCT04129944|592795391|FG003|Overall Study|Withdrawal by Subject|2|||
164118145|NCT01560819|592795392|FG000|Overall Study|Physician Decision|1|||
164118146|NCT01560819|592795393|FG001|Overall Study|Physician Decision|0|||
164118147|NCT00996437|592795395|FG000|Overall Study|Death|1|||
164118148|NCT00996437|592795396|FG001|Overall Study|Death|0|||
164118149|NCT00996437|592795395|FG000|Overall Study|Dropped|2|||
164118150|NCT00996437|592795396|FG001|Overall Study|Dropped|2|||
164118151|NCT00996437|592795395|FG000|Overall Study|Missed|2|||
164118152|NCT00996437|592795396|FG001|Overall Study|Missed|5|||
164118153|NCT02576717|592795397|FG000|Overall Study|Other Reasons|16|||
164118154|NCT02576717|592795398|FG001|Overall Study|Other Reasons|18|||
164118155|NCT02576717|592795399|FG002|Overall Study|Other Reasons|15|||
164118156|NCT02576717|592795397|FG000|Overall Study|Covid-19 Pandemic|0|||
164118157|NCT02576717|592795398|FG001|Overall Study|Covid-19 Pandemic|1|||
164118158|NCT02576717|592795399|FG002|Overall Study|Covid-19 Pandemic|1|||
164118159|NCT02576717|592795397|FG000|Overall Study|Sponsor Decision|0|||
164118160|NCT02576717|592795398|FG001|Overall Study|Sponsor Decision|0|||
164118161|NCT02576717|592795399|FG002|Overall Study|Sponsor Decision|1|||
164118162|NCT02576717|592795397|FG000|Overall Study|Physician Decision|3|||
164118163|NCT02576717|592795398|FG001|Overall Study|Physician Decision|8|||
164118164|NCT02576717|592795399|FG002|Overall Study|Physician Decision|9|||
164118165|NCT02576717|592795397|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
164118166|NCT02576717|592795398|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
164118167|NCT02576717|592795399|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
164118168|NCT02576717|592795397|FG000|Overall Study|Death|3|||
164118169|NCT02576717|592795398|FG001|Overall Study|Death|5|||
164118170|NCT02576717|592795399|FG002|Overall Study|Death|3|||
164118171|NCT02576717|592795397|FG000|Overall Study|Lost to Follow-up|9|||
164118172|NCT02576717|592795398|FG001|Overall Study|Lost to Follow-up|10|||
164118173|NCT02576717|592795399|FG002|Overall Study|Lost to Follow-up|19|||
164118174|NCT02576717|592795397|FG000|Overall Study|Protocol Violation|4|||
164118175|NCT02576717|592795398|FG001|Overall Study|Protocol Violation|0|||
164118176|NCT02576717|592795399|FG002|Overall Study|Protocol Violation|5|||
164118177|NCT02576717|592795397|FG000|Overall Study|Lack of Efficacy|24|||
164118178|NCT02576717|592795398|FG001|Overall Study|Lack of Efficacy|28|||
164118179|NCT02576717|592795399|FG002|Overall Study|Lack of Efficacy|20|||
164118180|NCT02576717|592795397|FG000|Overall Study|Adverse Event|26|||
164118181|NCT02576717|592795398|FG001|Overall Study|Adverse Event|32|||
164118182|NCT02576717|592795399|FG002|Overall Study|Adverse Event|26|||
164118183|NCT01363011|592795400|FG000|Main Study|Adverse Event|2|||
164118184|NCT01363011|592795401|FG001|Main Study|Adverse Event|3|||
164118185|NCT01363011|592795400|FG000|Main Study|Investigator's Discretion|1|||
164118186|NCT01363011|592795401|FG001|Main Study|Investigator's Discretion|1|||
164118187|NCT01363011|592795400|FG000|Main Study|Withdrew Consent|1|||
164118188|NCT01363011|592795401|FG001|Main Study|Withdrew Consent|4|||
164118189|NCT01363011|592795400|FG000|Main Study|Protocol Violation|0|||
164118190|NCT01363011|592795401|FG001|Main Study|Protocol Violation|1|||
164118191|NCT01363011|592795400|FG000|Extension Phase|Adverse Event|1|||
164118192|NCT01363011|592795401|FG001|Extension Phase|Adverse Event|1|||
164118193|NCT01363011|592795400|FG000|Extension Phase|Lack of Efficacy|0|||
164118194|NCT01363011|592795401|FG001|Extension Phase|Lack of Efficacy|1|||
164118195|NCT01363011|592795400|FG000|Extension Phase|Investigator's Discretion|2|||
164118196|NCT01363011|592795401|FG001|Extension Phase|Investigator's Discretion|2|||
164118197|NCT01363011|592795400|FG000|Extension Phase|Withdrew Consent|0|||
164118198|NCT01363011|592795401|FG001|Extension Phase|Withdrew Consent|1|||
164118199|NCT01363011|592795400|FG000|Extension Phase|Lost to Follow-up|0|||
164118200|NCT01363011|592795401|FG001|Extension Phase|Lost to Follow-up|2|||
164118201|NCT01363011|592795400|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
164118202|NCT01363011|592795401|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
164118203|NCT00407745|592795402|FG000|Overall Study|Lack of Efficacy|1|||
164118204|NCT00407745|592795403|FG001|Overall Study|Lack of Efficacy|2|||
164118205|NCT00407745|592795402|FG000|Overall Study|Withdrawal by Subject|3|||
164118206|NCT00407745|592795403|FG001|Overall Study|Withdrawal by Subject|3|||
164118207|NCT00407745|592795402|FG000|Overall Study|Protocol Violation|5|||
164118208|NCT00407745|592795403|FG001|Overall Study|Protocol Violation|3|||
164118209|NCT00407745|592795402|FG000|Overall Study|Adverse Event|8|||
164118210|NCT00407745|592795403|FG001|Overall Study|Adverse Event|8|||
164118211|NCT00407745|592795402|FG000|Overall Study|Other|2|||
164118212|NCT00407745|592795403|FG001|Overall Study|Other|0|||
164118213|NCT00407745|592795402|FG000|Overall Study|Randomized, unknown if treated|0|||
164118214|NCT00407745|592795403|FG001|Overall Study|Randomized, unknown if treated|1|||
164118215|NCT02960438|592795404|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
164118216|NCT02960438|592795405|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
164118217|NCT02960438|592795406|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
164118218|NCT02960438|592795407|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
164118219|NCT02960438|592795404|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
164118220|NCT02960438|592795405|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
164118221|NCT02960438|592795406|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
164118222|NCT02960438|592795407|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
164118223|NCT02960438|592795404|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
164118224|NCT02960438|592795405|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
164118225|NCT02960438|592795406|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
164118226|NCT02960438|592795407|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
164118227|NCT02960438|592795404|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
164118228|NCT02960438|592795405|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
164118229|NCT02960438|592795406|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
164118230|NCT02960438|592795407|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
164118231|NCT02960438|592795404|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
164118232|NCT02960438|592795405|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
164118233|NCT02960438|592795406|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
164118234|NCT02960438|592795407|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
164118235|NCT02960438|592795404|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
164118236|NCT02960438|592795405|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
164118237|NCT02960438|592795406|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
164118238|NCT02960438|592795407|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
164118239|NCT02960438|592795404|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
164118240|NCT02960438|592795405|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
164118241|NCT02960438|592795406|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
164118242|NCT02960438|592795407|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
164118243|NCT02960438|592795404|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
164118244|NCT02960438|592795405|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
164118245|NCT02960438|592795406|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
164118246|NCT02960438|592795407|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
164118247|NCT02960438|592795404|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
164118248|NCT02960438|592795405|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
164118249|NCT02960438|592795406|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
164118250|NCT02960438|592795407|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
164118251|NCT02960438|592795404|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
164118252|NCT02960438|592795405|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
164118253|NCT02960438|592795406|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
164118254|NCT02960438|592795407|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
164118255|NCT02960438|592795404|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
164118256|NCT02960438|592795405|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
164118257|NCT02960438|592795406|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
164118258|NCT02960438|592795407|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
164118259|NCT02960438|592795404|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
164118260|NCT02960438|592795405|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
164118261|NCT02960438|592795406|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
164118262|NCT02960438|592795407|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
164118263|NCT00298740|592795412|FG000|Overall Study|Lack of Efficacy|6|||
164118264|NCT00298740|592795412|FG000|Overall Study|Withdrawal by Subject|3|||
164118265|NCT03449199|592795413|FG000|Overall Study|Lost to Follow-up|1|||
164118266|NCT03449199|592795414|FG001|Overall Study|Lost to Follow-up|1|||
164118267|NCT03449199|592795415|FG002|Overall Study|Lost to Follow-up|0|||
164118268|NCT03449199|592795413|FG000|Overall Study|Protocol Deviation|0|||
164118269|NCT03449199|592795414|FG001|Overall Study|Protocol Deviation|0|||
164118270|NCT03449199|592795415|FG002|Overall Study|Protocol Deviation|1|||
164118271|NCT03449199|592795413|FG000|Overall Study|Withdrawal by Subject|0|||
164118272|NCT03449199|592795414|FG001|Overall Study|Withdrawal by Subject|0|||
164118273|NCT03449199|592795415|FG002|Overall Study|Withdrawal by Subject|1|||
164118274|NCT03136406|592795416|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
164118275|NCT01201759|592795417|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
164118276|NCT01201759|592795418|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
164118277|NCT01201759|592795417|FG000|Visit 3 - Washout|Adverse Event|0|||
164118278|NCT01201759|592795418|FG001|Visit 3 - Washout|Adverse Event|3|||
164118279|NCT01201759|592795417|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
164118280|NCT01201759|592795418|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
164118281|NCT01201759|592795417|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
164118282|NCT01201759|592795418|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
164118283|NCT00906373|592795419|FG000|Overall Study|Withdrawal by Subject|0|||
164118284|NCT00906373|592795420|FG001|Overall Study|Withdrawal by Subject|5|||
164118285|NCT00906373|592795419|FG000|Overall Study|Other|0|||
164118286|NCT00906373|592795420|FG001|Overall Study|Other|1|||
164118287|NCT00906373|592795419|FG000|Overall Study|Still on treatment at cutoff date|0|||
164118288|NCT00906373|592795420|FG001|Overall Study|Still on treatment at cutoff date|2|||
164118289|NCT00848042|592795421|FG000|Overall Study|Death|1|||
164118290|NCT00848042|592795422|FG001|Overall Study|Death|2|||
164118291|NCT00848042|592795423|FG002|Overall Study|Death|0|||
164118292|NCT00848042|592795421|FG000|Overall Study|Other Therapy|3|||
164118293|NCT00848042|592795422|FG001|Overall Study|Other Therapy|0|||
164118294|NCT00848042|592795423|FG002|Overall Study|Other Therapy|0|||
164118295|NCT02744755|592795424|FG000|Study Period 1|Protocol Violation|2|||
164118296|NCT02744755|592795425|FG001|Study Period 1|Protocol Violation|1|||
164118297|NCT02744755|592795424|FG000|Study Period 1|not defined|0|||
164118298|NCT02744755|592795425|FG001|Study Period 1|not defined|1|||
164118299|NCT02744755|592795424|FG000|Study Period 1|Pregnancy|1|||
164118300|NCT02744755|592795425|FG001|Study Period 1|Pregnancy|0|||
164118301|NCT02744755|592795424|FG000|Study Period 1|Adverse Event|1|||
164118302|NCT02744755|592795425|FG001|Study Period 1|Adverse Event|1|||
164118303|NCT02744755|592795424|FG000|Study Period 1|Lost to Follow-up|1|||
164118304|NCT02744755|592795425|FG001|Study Period 1|Lost to Follow-up|1|||
164118305|NCT02744755|592795424|FG000|Study Period 1|Lack of Efficacy|1|||
164118306|NCT02744755|592795425|FG001|Study Period 1|Lack of Efficacy|0|||
164118307|NCT02744755|592795424|FG000|Study Period 1|Withdrawal by Subject|8|||
164118308|NCT02744755|592795425|FG001|Study Period 1|Withdrawal by Subject|4|||
164118309|NCT02744755|592795424|FG000|Study Period 2|Adverse Event|5|||
164118310|NCT02744755|592795425|FG001|Study Period 2|Adverse Event|0|||
164118311|NCT02744755|592795424|FG000|Study Period 2|Protocol Violation|1|||
164118312|NCT02744755|592795425|FG001|Study Period 2|Protocol Violation|0|||
164118313|NCT02744755|592795424|FG000|Study Period 2|not defined|3|||
164118314|NCT02744755|592795425|FG001|Study Period 2|not defined|2|||
164118315|NCT02744755|592795424|FG000|Study Period 2|Lost to Follow-up|0|||
164118316|NCT02744755|592795425|FG001|Study Period 2|Lost to Follow-up|2|||
164118317|NCT02744755|592795424|FG000|Study Period 2|Withdrawal by Subject|2|||
164118318|NCT02744755|592795425|FG001|Study Period 2|Withdrawal by Subject|2|||
164118319|NCT02744755|592795424|FG000|Study Period 2|Lack of Efficacy|3|||
164118320|NCT02744755|592795425|FG001|Study Period 2|Lack of Efficacy|2|||
164118321|NCT01652729|592795426|FG000|Overall Study|Withdrawal by Subject|14|||
164118322|NCT01652729|592795427|FG001|Overall Study|Withdrawal by Subject|7|||
164118323|NCT01652729|592795428|FG002|Overall Study|Withdrawal by Subject|7|||
164118324|NCT01652729|592795426|FG000|Overall Study|Adverse Event|4|||
164118325|NCT01652729|592795427|FG001|Overall Study|Adverse Event|0|||
164118326|NCT01652729|592795428|FG002|Overall Study|Adverse Event|3|||
164118327|NCT01652729|592795426|FG000|Overall Study|Physician Decision|1|||
164118328|NCT01652729|592795427|FG001|Overall Study|Physician Decision|0|||
164118329|NCT01652729|592795428|FG002|Overall Study|Physician Decision|1|||
164118330|NCT01652729|592795426|FG000|Overall Study|Protocol Violation|1|||
164118331|NCT01652729|592795427|FG001|Overall Study|Protocol Violation|0|||
164118332|NCT01652729|592795428|FG002|Overall Study|Protocol Violation|0|||
164118333|NCT01652729|592795426|FG000|Overall Study|Lost to Follow-up|6|||
164118334|NCT01652729|592795427|FG001|Overall Study|Lost to Follow-up|6|||
164118335|NCT01652729|592795428|FG002|Overall Study|Lost to Follow-up|3|||
164118336|NCT01652729|592795426|FG000|Overall Study|Administrative|1|||
164118337|NCT01652729|592795427|FG001|Overall Study|Administrative|0|||
164118338|NCT01652729|592795428|FG002|Overall Study|Administrative|0|||
164118339|NCT04364737|592795430|FG000|Overall Study|Withdrawal by Subject|4|||
164118340|NCT04364737|592795431|FG001|Overall Study|Withdrawal by Subject|9|||
164118341|NCT04364737|592795430|FG000|Overall Study|Lost to Follow-up|1|||
164118342|NCT04364737|592795431|FG001|Overall Study|Lost to Follow-up|1|||
164118343|NCT01220609|592795432|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
164118344|NCT01220609|592795432|FG000|Overall Study|Ineligible- Wrong cell type|1|||
164118345|NCT01220609|592795432|FG000|Overall Study|Ineligible-Never treated|1|||
164118346|NCT00112294|592795433|FG000|Overall Study|Still on study|5|||
164118347|NCT00112294|592795434|FG001|Overall Study|Still on study|0|||
164118348|NCT01190930|592795438|FG000|Induction|Adverse Event|17|||
164118349|NCT01190930|592795439|FG001|Induction|Adverse Event|0|||
164118350|NCT01190930|592795440|FG002|Induction|Adverse Event|0|||
164118351|NCT01190930|592795441|FG003|Induction|Adverse Event|0|||
164118352|NCT01190930|592795442|FG004|Induction|Adverse Event|0|||
164118353|NCT01190930|592795443|FG005|Induction|Adverse Event|0|||
164118354|NCT01190930|592795444|FG006|Induction|Adverse Event|0|||
164118355|NCT01190930|592795445|FG007|Induction|Adverse Event|0|||
164118356|NCT01190930|592795446|FG008|Induction|Adverse Event|0|||
164118357|NCT01190930|592795447|FG009|Induction|Adverse Event|0|||
164118358|NCT01190930|592795438|FG000|Induction|Death|34|||
164118359|NCT01190930|592795439|FG001|Induction|Death|0|||
164118360|NCT01190930|592795440|FG002|Induction|Death|0|||
164118361|NCT01190930|592795441|FG003|Induction|Death|0|||
164118362|NCT01190930|592795442|FG004|Induction|Death|0|||
164118363|NCT01190930|592795443|FG005|Induction|Death|0|||
164118364|NCT01190930|592795444|FG006|Induction|Death|0|||
164118365|NCT01190930|592795445|FG007|Induction|Death|0|||
164118366|NCT01190930|592795446|FG008|Induction|Death|0|||
164118367|NCT01190930|592795447|FG009|Induction|Death|0|||
164118368|NCT01190930|592795438|FG000|Induction|Lost to Follow-up|1|||
164118369|NCT01190930|592795439|FG001|Induction|Lost to Follow-up|0|||
164118370|NCT01190930|592795440|FG002|Induction|Lost to Follow-up|0|||
164118371|NCT01190930|592795441|FG003|Induction|Lost to Follow-up|0|||
164118372|NCT01190930|592795442|FG004|Induction|Lost to Follow-up|0|||
164118373|NCT01190930|592795443|FG005|Induction|Lost to Follow-up|0|||
164118374|NCT01190930|592795444|FG006|Induction|Lost to Follow-up|0|||
164118375|NCT01190930|592795445|FG007|Induction|Lost to Follow-up|0|||
164118376|NCT01190930|592795446|FG008|Induction|Lost to Follow-up|0|||
164118377|NCT01190930|592795447|FG009|Induction|Lost to Follow-up|0|||
164118378|NCT01190930|592795438|FG000|Induction|Physician Decision|125|||
164118379|NCT01190930|592795439|FG001|Induction|Physician Decision|3|||
164118380|NCT01190930|592795440|FG002|Induction|Physician Decision|0|||
164118381|NCT01190930|592795441|FG003|Induction|Physician Decision|0|||
164118382|NCT01190930|592795442|FG004|Induction|Physician Decision|0|||
164118383|NCT01190930|592795443|FG005|Induction|Physician Decision|0|||
164118384|NCT01190930|592795444|FG006|Induction|Physician Decision|0|||
164118385|NCT01190930|592795445|FG007|Induction|Physician Decision|0|||
164118386|NCT01190930|592795446|FG008|Induction|Physician Decision|0|||
164118387|NCT01190930|592795447|FG009|Induction|Physician Decision|0|||
164118388|NCT01190930|592795438|FG000|Induction|Withdrawal by Subject|9|||
164118389|NCT01190930|592795439|FG001|Induction|Withdrawal by Subject|0|||
164118390|NCT01190930|592795440|FG002|Induction|Withdrawal by Subject|0|||
164118391|NCT01190930|592795441|FG003|Induction|Withdrawal by Subject|0|||
164118392|NCT01190930|592795442|FG004|Induction|Withdrawal by Subject|0|||
164118393|NCT01190930|592795443|FG005|Induction|Withdrawal by Subject|0|||
164118394|NCT01190930|592795444|FG006|Induction|Withdrawal by Subject|0|||
164118395|NCT01190930|592795445|FG007|Induction|Withdrawal by Subject|0|||
164118396|NCT01190930|592795446|FG008|Induction|Withdrawal by Subject|0|||
164118397|NCT01190930|592795447|FG009|Induction|Withdrawal by Subject|0|||
164118398|NCT01190930|592795438|FG000|Induction|Refusal|235|||
164118399|NCT01190930|592795439|FG001|Induction|Refusal|0|||
164118400|NCT01190930|592795440|FG002|Induction|Refusal|0|||
164118401|NCT01190930|592795441|FG003|Induction|Refusal|0|||
164118402|NCT01190930|592795442|FG004|Induction|Refusal|0|||
164118403|NCT01190930|592795443|FG005|Induction|Refusal|0|||
164118404|NCT01190930|592795444|FG006|Induction|Refusal|0|||
164118405|NCT01190930|592795445|FG007|Induction|Refusal|0|||
164118406|NCT01190930|592795446|FG008|Induction|Refusal|0|||
164118407|NCT01190930|592795447|FG009|Induction|Refusal|0|||
164118408|NCT01190930|592795438|FG000|Induction|Inevaluable|23|||
164118409|NCT01190930|592795439|FG001|Induction|Inevaluable|1|||
164118410|NCT01190930|592795440|FG002|Induction|Inevaluable|0|||
164118411|NCT01190930|592795441|FG003|Induction|Inevaluable|0|||
164118412|NCT01190930|592795442|FG004|Induction|Inevaluable|0|||
164118413|NCT01190930|592795443|FG005|Induction|Inevaluable|0|||
164118414|NCT01190930|592795444|FG006|Induction|Inevaluable|0|||
164118415|NCT01190930|592795445|FG007|Induction|Inevaluable|0|||
164118416|NCT01190930|592795446|FG008|Induction|Inevaluable|0|||
164118417|NCT01190930|592795447|FG009|Induction|Inevaluable|0|||
164118418|NCT01190930|592795438|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
164118419|NCT01190930|592795439|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118420|NCT01190930|592795440|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118421|NCT01190930|592795441|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118422|NCT01190930|592795442|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118423|NCT01190930|592795443|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118424|NCT01190930|592795444|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118425|NCT01190930|592795445|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118426|NCT01190930|592795446|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118427|NCT01190930|592795447|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
164118428|NCT01190930|592795438|FG000|Induction|High Risk Downs|80|||
164118429|NCT01190930|592795439|FG001|Induction|High Risk Downs|0|||
164118430|NCT01190930|592795440|FG002|Induction|High Risk Downs|0|||
164118431|NCT01190930|592795441|FG003|Induction|High Risk Downs|0|||
164118432|NCT01190930|592795442|FG004|Induction|High Risk Downs|0|||
164118433|NCT01190930|592795443|FG005|Induction|High Risk Downs|0|||
164118434|NCT01190930|592795444|FG006|Induction|High Risk Downs|0|||
164118435|NCT01190930|592795445|FG007|Induction|High Risk Downs|0|||
164118436|NCT01190930|592795446|FG008|Induction|High Risk Downs|0|||
164118437|NCT01190930|592795447|FG009|Induction|High Risk Downs|0|||
164118438|NCT01190930|592795438|FG000|Induction|Enrollment onto another COG Protocol|1|||
164118439|NCT01190930|592795439|FG001|Induction|Enrollment onto another COG Protocol|0|||
164118440|NCT01190930|592795440|FG002|Induction|Enrollment onto another COG Protocol|0|||
164118441|NCT01190930|592795441|FG003|Induction|Enrollment onto another COG Protocol|0|||
164118442|NCT01190930|592795442|FG004|Induction|Enrollment onto another COG Protocol|0|||
164118443|NCT01190930|592795443|FG005|Induction|Enrollment onto another COG Protocol|0|||
164118444|NCT01190930|592795444|FG006|Induction|Enrollment onto another COG Protocol|0|||
164118445|NCT01190930|592795445|FG007|Induction|Enrollment onto another COG Protocol|0|||
164118446|NCT01190930|592795446|FG008|Induction|Enrollment onto another COG Protocol|0|||
164118447|NCT01190930|592795447|FG009|Induction|Enrollment onto another COG Protocol|0|||
164118448|NCT01190930|592795438|FG000|Induction|Average Risk|1847|||
164118449|NCT01190930|592795439|FG001|Induction|Average Risk|0|||
164118450|NCT01190930|592795440|FG002|Induction|Average Risk|0|||
164118451|NCT01190930|592795441|FG003|Induction|Average Risk|0|||
164118452|NCT01190930|592795442|FG004|Induction|Average Risk|0|||
164118453|NCT01190930|592795443|FG005|Induction|Average Risk|0|||
164118454|NCT01190930|592795444|FG006|Induction|Average Risk|0|||
164118455|NCT01190930|592795445|FG007|Induction|Average Risk|0|||
164118456|NCT01190930|592795446|FG008|Induction|Average Risk|0|||
164118457|NCT01190930|592795447|FG009|Induction|Average Risk|0|||
164118458|NCT01190930|592795438|FG000|Induction|High Risk|1227|||
164118459|NCT01190930|592795439|FG001|Induction|High Risk|0|||
164118460|NCT01190930|592795440|FG002|Induction|High Risk|0|||
164118461|NCT01190930|592795441|FG003|Induction|High Risk|0|||
164118462|NCT01190930|592795442|FG004|Induction|High Risk|0|||
164118463|NCT01190930|592795443|FG005|Induction|High Risk|0|||
164118464|NCT01190930|592795444|FG006|Induction|High Risk|0|||
164118465|NCT01190930|592795445|FG007|Induction|High Risk|0|||
164118466|NCT01190930|592795446|FG008|Induction|High Risk|0|||
164118467|NCT01190930|592795447|FG009|Induction|High Risk|0|||
164118468|NCT01190930|592795438|FG000|Induction|Low Risk|443|||
164118469|NCT01190930|592795439|FG001|Induction|Low Risk|0|||
164118470|NCT01190930|592795440|FG002|Induction|Low Risk|0|||
164118471|NCT01190930|592795441|FG003|Induction|Low Risk|0|||
164118472|NCT01190930|592795442|FG004|Induction|Low Risk|0|||
164118473|NCT01190930|592795443|FG005|Induction|Low Risk|0|||
164118474|NCT01190930|592795444|FG006|Induction|Low Risk|0|||
164118475|NCT01190930|592795445|FG007|Induction|Low Risk|0|||
164118476|NCT01190930|592795446|FG008|Induction|Low Risk|0|||
164118477|NCT01190930|592795447|FG009|Induction|Low Risk|0|||
164118478|NCT01190930|592795438|FG000|Induction|Very High Risk|1012|||
164118479|NCT01190930|592795439|FG001|Induction|Very High Risk|0|||
164118480|NCT01190930|592795440|FG002|Induction|Very High Risk|0|||
164118481|NCT01190930|592795441|FG003|Induction|Very High Risk|0|||
164118482|NCT01190930|592795442|FG004|Induction|Very High Risk|0|||
164118483|NCT01190930|592795443|FG005|Induction|Very High Risk|0|||
164118484|NCT01190930|592795444|FG006|Induction|Very High Risk|0|||
164118485|NCT01190930|592795445|FG007|Induction|Very High Risk|0|||
164118486|NCT01190930|592795446|FG008|Induction|Very High Risk|0|||
164118487|NCT01190930|592795447|FG009|Induction|Very High Risk|0|||
164118488|NCT01190930|592795438|FG000|Induction|Philadelphia chromosome-positive|99|||
164118489|NCT01190930|592795439|FG001|Induction|Philadelphia chromosome-positive|0|||
164118490|NCT01190930|592795440|FG002|Induction|Philadelphia chromosome-positive|0|||
164118491|NCT01190930|592795441|FG003|Induction|Philadelphia chromosome-positive|0|||
164118492|NCT01190930|592795442|FG004|Induction|Philadelphia chromosome-positive|0|||
164118493|NCT01190930|592795443|FG005|Induction|Philadelphia chromosome-positive|0|||
164118494|NCT01190930|592795444|FG006|Induction|Philadelphia chromosome-positive|0|||
164118495|NCT01190930|592795445|FG007|Induction|Philadelphia chromosome-positive|0|||
164118496|NCT01190930|592795446|FG008|Induction|Philadelphia chromosome-positive|0|||
164118497|NCT01190930|592795447|FG009|Induction|Philadelphia chromosome-positive|0|||
164118498|NCT01190930|592795438|FG000|Induction|Incomplete Induction data|63|||
164118499|NCT01190930|592795439|FG001|Induction|Incomplete Induction data|0|||
164118500|NCT01190930|592795440|FG002|Induction|Incomplete Induction data|0|||
164118501|NCT01190930|592795441|FG003|Induction|Incomplete Induction data|0|||
164118502|NCT01190930|592795442|FG004|Induction|Incomplete Induction data|0|||
164118503|NCT01190930|592795443|FG005|Induction|Incomplete Induction data|0|||
164118504|NCT01190930|592795444|FG006|Induction|Incomplete Induction data|0|||
164118505|NCT01190930|592795445|FG007|Induction|Incomplete Induction data|0|||
164118506|NCT01190930|592795446|FG008|Induction|Incomplete Induction data|0|||
164118507|NCT01190930|592795447|FG009|Induction|Incomplete Induction data|0|||
164118508|NCT01190930|592795438|FG000|Induction|Progressive disease|0|||
164118509|NCT01190930|592795439|FG001|Induction|Progressive disease|1|||
164118510|NCT01190930|592795440|FG002|Induction|Progressive disease|0|||
164118511|NCT01190930|592795441|FG003|Induction|Progressive disease|0|||
164118512|NCT01190930|592795442|FG004|Induction|Progressive disease|0|||
164118513|NCT01190930|592795443|FG005|Induction|Progressive disease|0|||
164118514|NCT01190930|592795444|FG006|Induction|Progressive disease|0|||
164118515|NCT01190930|592795445|FG007|Induction|Progressive disease|0|||
164118516|NCT01190930|592795446|FG008|Induction|Progressive disease|0|||
164118517|NCT01190930|592795447|FG009|Induction|Progressive disease|0|||
164118518|NCT01190930|592795438|FG000|Induction|No treatment|3|||
164118519|NCT01190930|592795439|FG001|Induction|No treatment|0|||
164118520|NCT01190930|592795440|FG002|Induction|No treatment|0|||
164118521|NCT01190930|592795441|FG003|Induction|No treatment|0|||
164118522|NCT01190930|592795442|FG004|Induction|No treatment|0|||
164118523|NCT01190930|592795443|FG005|Induction|No treatment|0|||
164118524|NCT01190930|592795444|FG006|Induction|No treatment|0|||
164118525|NCT01190930|592795445|FG007|Induction|No treatment|0|||
164118526|NCT01190930|592795446|FG008|Induction|No treatment|0|||
164118527|NCT01190930|592795447|FG009|Induction|No treatment|0|||
164118528|NCT01190930|592795438|FG000|Induction|Ineligible|69|||
164118529|NCT01190930|592795439|FG001|Induction|Ineligible|4|||
164118530|NCT01190930|592795440|FG002|Induction|Ineligible|0|||
164118531|NCT01190930|592795441|FG003|Induction|Ineligible|0|||
164118532|NCT01190930|592795442|FG004|Induction|Ineligible|0|||
164118533|NCT01190930|592795443|FG005|Induction|Ineligible|0|||
164118534|NCT01190930|592795444|FG006|Induction|Ineligible|0|||
164118535|NCT01190930|592795445|FG007|Induction|Ineligible|0|||
164118536|NCT01190930|592795446|FG008|Induction|Ineligible|0|||
164118537|NCT01190930|592795447|FG009|Induction|Ineligible|0|||
164118538|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
164118539|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
164118540|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
164118541|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
164118542|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
164118543|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
164118544|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
164118545|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
164118546|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
164118547|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
164118548|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Death|0|||
164118549|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Death|0|||
164118550|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Death|8|||
164118551|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Death|4|||
164118552|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Death|0|||
164118553|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Death|0|||
164118554|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Death|0|||
164118555|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Death|0|||
164118556|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Death|0|||
164118557|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Death|0|||
164118558|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
164118559|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
164118560|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
164118561|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
164118562|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
164118563|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
164118564|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
164118565|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
164118566|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
164118567|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
164118568|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118569|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
164118570|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
164118571|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
164118572|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118573|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118574|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118575|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118576|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118577|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
164118578|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Refusal|0|||
164118579|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Refusal|2|||
164118580|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Refusal|694|||
164118581|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Refusal|4|||
164118582|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Refusal|0|||
164118583|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Refusal|3|||
164118584|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Refusal|0|||
164118585|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Refusal|0|||
164118586|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Refusal|0|||
164118587|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Refusal|0|||
164118588|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
164118589|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
164118590|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
164118591|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
164118592|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
164118593|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
164118594|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
164118595|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
164118596|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
164118597|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
164118598|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118599|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
164118600|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118601|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118602|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118603|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118604|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118605|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118606|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118607|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
164118608|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
164118609|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
164118610|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
164118611|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
164118612|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
164118613|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
164118614|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
164118615|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
164118616|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
164118617|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
164073287|NCT03674827|592632851|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
164073288|NCT03674827|592632852|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
164073289|NCT03674827|592632853|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
164073290|NCT03674827|592632848|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
164073291|NCT03674827|592632849|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
164073292|NCT03674827|592632850|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
164073293|NCT03674827|592632851|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
164073294|NCT03674827|592632852|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
164073295|NCT03674827|592632853|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
164073296|NCT01289990|592632854|FG000|Overall Study|Death|0|||
164073297|NCT01289990|592632855|FG001|Overall Study|Death|0|||
164073298|NCT01289990|592632856|FG002|Overall Study|Death|0|||
164118618|NCT01190930|592795438|FG000|Post Induction Pre-Maintenance|Relapse|0|||
164118619|NCT01190930|592795439|FG001|Post Induction Pre-Maintenance|Relapse|0|||
164118620|NCT01190930|592795440|FG002|Post Induction Pre-Maintenance|Relapse|1|||
164118621|NCT01190930|592795441|FG003|Post Induction Pre-Maintenance|Relapse|0|||
164118622|NCT01190930|592795442|FG004|Post Induction Pre-Maintenance|Relapse|0|||
164118623|NCT01190930|592795443|FG005|Post Induction Pre-Maintenance|Relapse|0|||
164118624|NCT01190930|592795444|FG006|Post Induction Pre-Maintenance|Relapse|0|||
164118625|NCT01190930|592795445|FG007|Post Induction Pre-Maintenance|Relapse|0|||
164118626|NCT01190930|592795446|FG008|Post Induction Pre-Maintenance|Relapse|0|||
164118627|NCT01190930|592795447|FG009|Post Induction Pre-Maintenance|Relapse|0|||
164118628|NCT01190930|592795438|FG000|Maintenance|Adverse Event|0|||
164118629|NCT01190930|592795439|FG001|Maintenance|Adverse Event|0|||
164118630|NCT01190930|592795440|FG002|Maintenance|Adverse Event|0|||
164118631|NCT01190930|592795441|FG003|Maintenance|Adverse Event|0|||
164118632|NCT01190930|592795442|FG004|Maintenance|Adverse Event|0|||
164118633|NCT01190930|592795443|FG005|Maintenance|Adverse Event|1|||
164118634|NCT01190930|592795444|FG006|Maintenance|Adverse Event|1|||
164118635|NCT01190930|592795445|FG007|Maintenance|Adverse Event|3|||
164118636|NCT01190930|592795446|FG008|Maintenance|Adverse Event|3|||
164118637|NCT01190930|592795447|FG009|Maintenance|Adverse Event|0|||
164118638|NCT01190930|592795438|FG000|Maintenance|Death|0|||
164118639|NCT01190930|592795439|FG001|Maintenance|Death|0|||
164118640|NCT01190930|592795440|FG002|Maintenance|Death|0|||
164118641|NCT01190930|592795441|FG003|Maintenance|Death|1|||
164118642|NCT01190930|592795442|FG004|Maintenance|Death|0|||
164118643|NCT01190930|592795443|FG005|Maintenance|Death|0|||
164118644|NCT01190930|592795444|FG006|Maintenance|Death|2|||
164118645|NCT01190930|592795445|FG007|Maintenance|Death|2|||
164118646|NCT01190930|592795446|FG008|Maintenance|Death|2|||
164118647|NCT01190930|592795447|FG009|Maintenance|Death|2|||
164118648|NCT01190930|592795438|FG000|Maintenance|Lost to Follow-up|0|||
164118649|NCT01190930|592795439|FG001|Maintenance|Lost to Follow-up|0|||
164118650|NCT01190930|592795440|FG002|Maintenance|Lost to Follow-up|0|||
164118651|NCT01190930|592795441|FG003|Maintenance|Lost to Follow-up|0|||
164118652|NCT01190930|592795442|FG004|Maintenance|Lost to Follow-up|0|||
164118653|NCT01190930|592795443|FG005|Maintenance|Lost to Follow-up|0|||
164118654|NCT01190930|592795444|FG006|Maintenance|Lost to Follow-up|1|||
164118655|NCT01190930|592795445|FG007|Maintenance|Lost to Follow-up|1|||
164118656|NCT01190930|592795446|FG008|Maintenance|Lost to Follow-up|1|||
164118657|NCT01190930|592795447|FG009|Maintenance|Lost to Follow-up|0|||
164118658|NCT01190930|592795438|FG000|Maintenance|Physician Decision|0|||
164118659|NCT01190930|592795439|FG001|Maintenance|Physician Decision|1|||
164118660|NCT01190930|592795440|FG002|Maintenance|Physician Decision|0|||
164118661|NCT01190930|592795441|FG003|Maintenance|Physician Decision|5|||
164118662|NCT01190930|592795442|FG004|Maintenance|Physician Decision|9|||
164118663|NCT01190930|592795443|FG005|Maintenance|Physician Decision|4|||
164118664|NCT01190930|592795444|FG006|Maintenance|Physician Decision|8|||
164118665|NCT01190930|592795445|FG007|Maintenance|Physician Decision|8|||
164118666|NCT01190930|592795446|FG008|Maintenance|Physician Decision|10|||
164118667|NCT01190930|592795447|FG009|Maintenance|Physician Decision|17|||
164118668|NCT01190930|592795438|FG000|Maintenance|Withdrawal by Subject|0|||
164118669|NCT01190930|592795439|FG001|Maintenance|Withdrawal by Subject|0|||
164118670|NCT01190930|592795440|FG002|Maintenance|Withdrawal by Subject|0|||
164118671|NCT01190930|592795441|FG003|Maintenance|Withdrawal by Subject|0|||
164118672|NCT01190930|592795442|FG004|Maintenance|Withdrawal by Subject|0|||
164118673|NCT01190930|592795443|FG005|Maintenance|Withdrawal by Subject|0|||
164118674|NCT01190930|592795444|FG006|Maintenance|Withdrawal by Subject|2|||
164118675|NCT01190930|592795445|FG007|Maintenance|Withdrawal by Subject|1|||
164118676|NCT01190930|592795446|FG008|Maintenance|Withdrawal by Subject|4|||
164118677|NCT01190930|592795447|FG009|Maintenance|Withdrawal by Subject|1|||
164118678|NCT01190930|592795438|FG000|Maintenance|Refusal|0|||
164118679|NCT01190930|592795439|FG001|Maintenance|Refusal|1|||
164118680|NCT01190930|592795440|FG002|Maintenance|Refusal|0|||
164118681|NCT01190930|592795441|FG003|Maintenance|Refusal|2|||
164118682|NCT01190930|592795442|FG004|Maintenance|Refusal|0|||
164118683|NCT01190930|592795443|FG005|Maintenance|Refusal|4|||
164118684|NCT01190930|592795444|FG006|Maintenance|Refusal|5|||
164118685|NCT01190930|592795445|FG007|Maintenance|Refusal|17|||
164118686|NCT01190930|592795446|FG008|Maintenance|Refusal|13|||
164118687|NCT01190930|592795447|FG009|Maintenance|Refusal|6|||
164118688|NCT01190930|592795438|FG000|Maintenance|second malignant neoplasm|0|||
164118689|NCT01190930|592795439|FG001|Maintenance|second malignant neoplasm|0|||
164118690|NCT01190930|592795440|FG002|Maintenance|second malignant neoplasm|0|||
164118691|NCT01190930|592795441|FG003|Maintenance|second malignant neoplasm|1|||
164118692|NCT01190930|592795442|FG004|Maintenance|second malignant neoplasm|0|||
164118693|NCT01190930|592795443|FG005|Maintenance|second malignant neoplasm|1|||
164118694|NCT01190930|592795444|FG006|Maintenance|second malignant neoplasm|0|||
164118695|NCT01190930|592795445|FG007|Maintenance|second malignant neoplasm|0|||
164118696|NCT01190930|592795446|FG008|Maintenance|second malignant neoplasm|1|||
164118697|NCT01190930|592795447|FG009|Maintenance|second malignant neoplasm|0|||
164118698|NCT01190930|592795438|FG000|Maintenance|Inevaluable|0|||
164118699|NCT01190930|592795439|FG001|Maintenance|Inevaluable|0|||
164118700|NCT01190930|592795440|FG002|Maintenance|Inevaluable|0|||
164118701|NCT01190930|592795441|FG003|Maintenance|Inevaluable|0|||
164118702|NCT01190930|592795442|FG004|Maintenance|Inevaluable|0|||
164118703|NCT01190930|592795443|FG005|Maintenance|Inevaluable|1|||
164118704|NCT01190930|592795444|FG006|Maintenance|Inevaluable|1|||
164118705|NCT01190930|592795445|FG007|Maintenance|Inevaluable|1|||
164118706|NCT01190930|592795446|FG008|Maintenance|Inevaluable|0|||
164118707|NCT01190930|592795447|FG009|Maintenance|Inevaluable|0|||
164118708|NCT01190930|592795438|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
164118709|NCT01190930|592795439|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
164118710|NCT01190930|592795440|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
164118711|NCT01190930|592795441|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
164118712|NCT01190930|592795442|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
164118713|NCT01190930|592795443|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
164118714|NCT01190930|592795444|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
164118715|NCT01190930|592795445|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
164118716|NCT01190930|592795446|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
164118717|NCT01190930|592795447|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
164118718|NCT01190930|592795438|FG000|Maintenance|Relapse|0|||
164118719|NCT01190930|592795439|FG001|Maintenance|Relapse|0|||
164118720|NCT01190930|592795440|FG002|Maintenance|Relapse|0|||
164118721|NCT01190930|592795441|FG003|Maintenance|Relapse|2|||
164118722|NCT01190930|592795442|FG004|Maintenance|Relapse|0|||
164118723|NCT01190930|592795443|FG005|Maintenance|Relapse|1|||
164118724|NCT01190930|592795444|FG006|Maintenance|Relapse|6|||
164118725|NCT01190930|592795445|FG007|Maintenance|Relapse|13|||
164118726|NCT01190930|592795446|FG008|Maintenance|Relapse|11|||
164118727|NCT01190930|592795447|FG009|Maintenance|Relapse|11|||
164118728|NCT01190930|592795438|FG000|Maintenance|Still on therapy|0|||
164118729|NCT01190930|592795439|FG001|Maintenance|Still on therapy|8|||
164118730|NCT01190930|592795440|FG002|Maintenance|Still on therapy|0|||
164118731|NCT01190930|592795441|FG003|Maintenance|Still on therapy|29|||
164118732|NCT01190930|592795442|FG004|Maintenance|Still on therapy|0|||
164118733|NCT01190930|592795443|FG005|Maintenance|Still on therapy|0|||
164118734|NCT01190930|592795444|FG006|Maintenance|Still on therapy|0|||
164118735|NCT01190930|592795445|FG007|Maintenance|Still on therapy|0|||
164118736|NCT01190930|592795446|FG008|Maintenance|Still on therapy|0|||
164118737|NCT01190930|592795447|FG009|Maintenance|Still on therapy|0|||
164118738|NCT02418455|592795448|FG000|48-Week Treatment Period|Other- Not Specified|1|||
164118739|NCT02418455|592795448|FG000|Continuation Period|Sponsor Decision|7|||
164118740|NCT02001051|592795451|FG000|Overall Study|Deemed not eligible following enrollment|0|||
164118741|NCT02001051|592795452|FG001|Overall Study|Deemed not eligible following enrollment|1|||
164118742|NCT04205162|592795470|FG000|Overall Study|Lost to Follow-up|1|||
164118743|NCT04205162|592795471|FG001|Overall Study|Lost to Follow-up|0|||
164118744|NCT04205162|592795470|FG000|Overall Study|Withdrawal by Subject|2|||
164118745|NCT04205162|592795471|FG001|Overall Study|Withdrawal by Subject|0|||
164118746|NCT04205162|592795470|FG000|Overall Study|University closure due to COVID-19|1|||
164118747|NCT04205162|592795471|FG001|Overall Study|University closure due to COVID-19|0|||
164118748|NCT01999894|592795472|FG000|Overall Study|Adverse Event|9|||
164118749|NCT01999894|592795472|FG000|Overall Study|Lack of Efficacy|5|||
164118750|NCT01999894|592795472|FG000|Overall Study|Protocol Violation|1|||
164118751|NCT01999894|592795472|FG000|Overall Study|Withdrawal by Subject|7|||
164118752|NCT01999894|592795472|FG000|Overall Study|Lost to Follow-up|10|||
164118753|NCT01999894|592795472|FG000|Overall Study|Other Reason|3|||
164118754|NCT01999894|592795472|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
164118755|NCT01546519|592795474|FG000|Overall Study|Adverse Event|0|||
164118756|NCT01546519|592795475|FG001|Overall Study|Adverse Event|0|||
164118757|NCT01546519|592795476|FG002|Overall Study|Adverse Event|1|||
164118758|NCT01546519|592795477|FG003|Overall Study|Adverse Event|1|||
164118759|NCT01546519|592795474|FG000|Overall Study|Death|0|||
164118760|NCT01546519|592795475|FG001|Overall Study|Death|1|||
164118761|NCT01546519|592795476|FG002|Overall Study|Death|3|||
164118762|NCT01546519|592795477|FG003|Overall Study|Death|1|||
164118763|NCT01546519|592795474|FG000|Overall Study|related to disease progression|2|||
164118764|NCT01546519|592795475|FG001|Overall Study|related to disease progression|2|||
164118765|NCT01546519|592795476|FG002|Overall Study|related to disease progression|2|||
164118766|NCT01546519|592795477|FG003|Overall Study|related to disease progression|1|||
164118767|NCT01546519|592795474|FG000|Overall Study|Physician Decision|6|||
164118768|NCT01546519|592795475|FG001|Overall Study|Physician Decision|5|||
164118769|NCT01546519|592795476|FG002|Overall Study|Physician Decision|2|||
164118770|NCT01546519|592795477|FG003|Overall Study|Physician Decision|3|||
164118771|NCT01546519|592795474|FG000|Overall Study|Withdrawal by Subject|1|||
164118772|NCT01546519|592795475|FG001|Overall Study|Withdrawal by Subject|0|||
164118773|NCT01546519|592795476|FG002|Overall Study|Withdrawal by Subject|0|||
164118774|NCT01546519|592795477|FG003|Overall Study|Withdrawal by Subject|0|||
164118775|NCT01077258|592795483|FG000|Overall Study|Lost to Follow-up|1390|||
164118776|NCT01077258|592795483|FG000|Overall Study|Adverse drug reaction|218|||
164118777|NCT01077258|592795483|FG000|Overall Study|Lack of Efficacy|663|||
164118778|NCT01077258|592795483|FG000|Overall Study|Clinical remission|37|||
164118779|NCT01077258|592795483|FG000|Overall Study|Other reasons|260|||
164118780|NCT00434837|592795484|FG000|Overall Study|Lost to Follow-up|20|||
164118781|NCT00434837|592795485|FG001|Overall Study|Lost to Follow-up|23|||
164118782|NCT00434837|592795486|FG002|Overall Study|Lost to Follow-up|30|||
164118783|NCT00726895|592795488|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164118784|NCT00726895|592795489|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164118785|NCT01881737|592795493|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
164118786|NCT01881737|592795493|FG000|Overall Study|Withdrawal by Subject|1|||
164118787|NCT01881737|592795493|FG000|Overall Study|Worsening of baseline behavior|1|||
164118788|NCT01450800|592795502|FG000|Overall Study|Protocol Violation|1|||
164118789|NCT01450800|592795503|FG001|Overall Study|Protocol Violation|3|||
164118790|NCT03023137|592795504|FG000|Overall Study|Multiple pregnancy|2|||
164118791|NCT03023137|592795505|FG001|Overall Study|Multiple pregnancy|4|||
164118792|NCT03023137|592795504|FG000|Overall Study|Lost to Follow-up|1|||
164118793|NCT03023137|592795505|FG001|Overall Study|Lost to Follow-up|1|||
164118794|NCT03023137|592795504|FG000|Overall Study|Protocol Violation|0|||
164118795|NCT03023137|592795505|FG001|Overall Study|Protocol Violation|4|||
164118796|NCT03023137|592795504|FG000|Overall Study|Lost the baby in a car accident|1|||
164118797|NCT03023137|592795505|FG001|Overall Study|Lost the baby in a car accident|0|||
164118798|NCT03496298|592795506|FG000|Overall Study|Adverse Event|49|||
164118799|NCT03496298|592795507|FG001|Overall Study|Adverse Event|68|||
164118800|NCT03496298|592795508|FG002|Overall Study|Adverse Event|79|||
164118801|NCT03496298|592795506|FG000|Overall Study|Study terminated by Sponsor|1050|||
164118802|NCT03496298|592795507|FG001|Overall Study|Study terminated by Sponsor|1063|||
164118803|NCT03496298|592795508|FG002|Overall Study|Study terminated by Sponsor|1071|||
164118804|NCT03496298|592795506|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
164118805|NCT03496298|592795507|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
164118806|NCT03496298|592795508|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
164118807|NCT03496298|592795506|FG000|Overall Study|Withdrawal by Subject|176|||
164118808|NCT03496298|592795507|FG001|Overall Study|Withdrawal by Subject|154|||
164118809|NCT03496298|592795508|FG002|Overall Study|Withdrawal by Subject|151|||
164118810|NCT03496298|592795506|FG000|Overall Study|Other|29|||
164118811|NCT03496298|592795507|FG001|Overall Study|Other|20|||
164118812|NCT03496298|592795508|FG002|Overall Study|Other|23|||
164118813|NCT03496298|592795506|FG000|Overall Study|Randomized and not treated|1|||
164118814|NCT03496298|592795507|FG001|Overall Study|Randomized and not treated|1|||
164118815|NCT03496298|592795508|FG002|Overall Study|Randomized and not treated|1|||
164118816|NCT02058160|592795511|FG000|Overall Study|Randomized but not treated|2|||
164118817|NCT02058160|592795512|FG001|Overall Study|Randomized but not treated|4|||
164118818|NCT02058160|592795511|FG000|Overall Study|Poor compliance to protocol|4|||
164118819|NCT02058160|592795512|FG001|Overall Study|Poor compliance to protocol|1|||
164118820|NCT02058160|592795511|FG000|Overall Study|Adverse Event|12|||
164118821|NCT02058160|592795512|FG001|Overall Study|Adverse Event|3|||
164118822|NCT02058160|592795511|FG000|Overall Study|Lost to Follow-up|1|||
164118823|NCT02058160|592795512|FG001|Overall Study|Lost to Follow-up|0|||
164118824|NCT02058160|592795511|FG000|Overall Study|Other than specified above|12|||
164118825|NCT02058160|592795512|FG001|Overall Study|Other than specified above|6|||
164118826|NCT02260635|592795513|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
164118827|NCT02260635|592795514|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
164118828|NCT02260635|592795513|FG000|Open-Label Extension|Study Termination|25|||
164118829|NCT02260635|592795514|FG001|Open-Label Extension|Study Termination|25|||
164118830|NCT02260635|592795513|FG000|Open-Label Extension|Withdrawal by Subject|1|||
164118831|NCT02260635|592795514|FG001|Open-Label Extension|Withdrawal by Subject|0|||
164118832|NCT04106817|592795515|FG000|Overall Study|Lost to Follow-up|1|||
164118833|NCT04106817|592795516|FG001|Overall Study|Lost to Follow-up|0|||
164118834|NCT04106817|592795517|FG002|Overall Study|Lost to Follow-up|0|||
164118835|NCT04660032|592795518|FG000|Overall Study|Protocol Violation|1|||
164118836|NCT04660032|592795519|FG001|Overall Study|Protocol Violation|1|||
164118837|NCT00090753|592795520|FG000|First Treatment Period|Adverse Event|20|||
164118838|NCT00090753|592795521|FG001|First Treatment Period|Adverse Event|8|||
164118839|NCT00090753|592795520|FG000|First Treatment Period|Death|88|||
164118840|NCT00090753|592795521|FG001|First Treatment Period|Death|62|||
164118841|NCT00090753|592795520|FG000|First Treatment Period|Lack of Efficacy|2|||
164118842|NCT00090753|592795521|FG001|First Treatment Period|Lack of Efficacy|1|||
164118843|NCT00090753|592795520|FG000|First Treatment Period|Refused Treatment|32|||
164118844|NCT00090753|592795521|FG001|First Treatment Period|Refused Treatment|25|||
164118845|NCT00090753|592795520|FG000|First Treatment Period|Lost to Follow-up|4|||
164118846|NCT00090753|592795521|FG001|First Treatment Period|Lost to Follow-up|4|||
164118847|NCT00090753|592795520|FG000|First Treatment Period|Renal Transplant|70|||
164118848|NCT00090753|592795521|FG001|First Treatment Period|Renal Transplant|50|||
164118849|NCT00090753|592795520|FG000|First Treatment Period|Mircera Commercialization|1|||
164118850|NCT00090753|592795521|FG001|First Treatment Period|Mircera Commercialization|0|||
164118851|NCT00090753|592795520|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
164118852|NCT00090753|592795521|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
164118853|NCT00090753|592795520|FG000|Extended Treatment Period|Adverse Event|11|||
164118854|NCT00090753|592795521|FG001|Extended Treatment Period|Adverse Event|0|||
164118855|NCT00090753|592795520|FG000|Extended Treatment Period|Death|58|||
164118856|NCT00090753|592795521|FG001|Extended Treatment Period|Death|30|||
164118857|NCT00090753|592795520|FG000|Extended Treatment Period|Lack of Efficacy|1|||
164118858|NCT00090753|592795521|FG001|Extended Treatment Period|Lack of Efficacy|0|||
164118859|NCT00090753|592795520|FG000|Extended Treatment Period|Refused Treatment|18|||
164118860|NCT00090753|592795521|FG001|Extended Treatment Period|Refused Treatment|12|||
164118861|NCT00090753|592795520|FG000|Extended Treatment Period|Lost to Follow-up|3|||
164118862|NCT00090753|592795521|FG001|Extended Treatment Period|Lost to Follow-up|1|||
164118863|NCT00090753|592795520|FG000|Extended Treatment Period|Renal Transplant|15|||
164118864|NCT00090753|592795521|FG001|Extended Treatment Period|Renal Transplant|12|||
164118865|NCT00090753|592795520|FG000|Extended Treatment Period|Mircera Commercialization|188|||
164118866|NCT00090753|592795521|FG001|Extended Treatment Period|Mircera Commercialization|93|||
164118867|NCT00090753|592795520|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
164118868|NCT00090753|592795521|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
164118869|NCT00756717|592795530|FG000|Overall Study|Withdrawal by Subject|2|||
164118870|NCT00250705|592795531|FG000|Overall Study|Lack of Efficacy|2|||
164118871|NCT00587431|592795532|FG000|Overall Study|Adverse Event|1|||
164118872|NCT00587431|592795533|FG001|Overall Study|Adverse Event|0|||
164118873|NCT00587431|592795532|FG000|Overall Study|Withdrawal by Subject|0|||
164118874|NCT00587431|592795533|FG001|Overall Study|Withdrawal by Subject|1|||
164118875|NCT05467982|592795534|FG000|Overall Study|Death|0|||
164118876|NCT05467982|592795535|FG001|Overall Study|Death|1|||
164118877|NCT05467982|592795534|FG000|Overall Study|Lost to Follow-up|3|||
164118878|NCT05467982|592795535|FG001|Overall Study|Lost to Follow-up|1|||
164118879|NCT03185741|592795536|FG000|Baseline|Withdrawal by Subject|1|||
164118880|NCT03185741|592795537|FG001|Baseline|Withdrawal by Subject|3|||
164118881|NCT03185741|592795538|FG002|Baseline|Withdrawal by Subject|2|||
164118882|NCT03185741|592795536|FG000|Baseline|Lost to Follow-up|1|||
164118883|NCT03185741|592795537|FG001|Baseline|Lost to Follow-up|2|||
164118884|NCT03185741|592795538|FG002|Baseline|Lost to Follow-up|3|||
164118885|NCT03185741|592795536|FG000|3Month|Death|1|||
164118886|NCT03185741|592795537|FG001|3Month|Death|1|||
164118887|NCT03185741|592795538|FG002|3Month|Death|2|||
164118888|NCT03185741|592795536|FG000|3Month|Withdrawal by Subject|1|||
164118889|NCT03185741|592795537|FG001|3Month|Withdrawal by Subject|5|||
164118890|NCT03185741|592795538|FG002|3Month|Withdrawal by Subject|1|||
164118891|NCT03185741|592795536|FG000|3Month|Lost to Follow-up|7|||
164118892|NCT03185741|592795537|FG001|3Month|Lost to Follow-up|9|||
164118893|NCT03185741|592795538|FG002|3Month|Lost to Follow-up|8|||
164118894|NCT03185741|592795536|FG000|3Month|Unavailable for 3Month|11|||
164118895|NCT03185741|592795537|FG001|3Month|Unavailable for 3Month|10|||
164118896|NCT03185741|592795538|FG002|3Month|Unavailable for 3Month|11|||
164118897|NCT03185741|592795536|FG000|3Month|Protocol Violation|0|||
164118898|NCT03185741|592795537|FG001|3Month|Protocol Violation|0|||
164118899|NCT03185741|592795538|FG002|3Month|Protocol Violation|3|||
164118900|NCT03185741|592795536|FG000|6Month|Death|1|||
164118901|NCT03185741|592795537|FG001|6Month|Death|1|||
164118902|NCT03185741|592795538|FG002|6Month|Death|2|||
164118903|NCT03185741|592795536|FG000|6Month|Withdrawal by Subject|2|||
164118904|NCT03185741|592795537|FG001|6Month|Withdrawal by Subject|3|||
164118905|NCT03185741|592795538|FG002|6Month|Withdrawal by Subject|1|||
164118906|NCT03185741|592795536|FG000|6Month|Lost to Follow-up|16|||
164118907|NCT03185741|592795537|FG001|6Month|Lost to Follow-up|15|||
164118908|NCT03185741|592795538|FG002|6Month|Lost to Follow-up|16|||
164118909|NCT03573336|592795541|FG000|Overall Study|Study terminated|2|||
164118910|NCT03573336|592795542|FG001|Overall Study|Study terminated|4|||
164118911|NCT03573336|592795543|FG002|Overall Study|Study terminated|2|||
164118912|NCT03108820|592795544|FG000|Overall Study|Lost to Follow-up|30|||
164118913|NCT03108820|592795545|FG001|Overall Study|Lost to Follow-up|28|||
164118914|NCT03108820|592795544|FG000|Overall Study|Withdrawal by Subject|32|||
164118915|NCT03108820|592795545|FG001|Overall Study|Withdrawal by Subject|24|||
164118916|NCT03108820|592795544|FG000|Overall Study|Death|6|||
164118917|NCT03108820|592795545|FG001|Overall Study|Death|11|||
164118918|NCT01488448|592795551|FG000|Overall Study|Withdrawal by Subject|3|||
164118919|NCT01488448|592795552|FG001|Overall Study|Withdrawal by Subject|1|||
164118920|NCT01488448|592795551|FG000|Overall Study|Adverse Event|9|||
164118921|NCT01488448|592795552|FG001|Overall Study|Adverse Event|4|||
164118922|NCT01488448|592795551|FG000|Overall Study|Physician Decision|4|||
164073299|NCT01289990|592632857|FG003|Overall Study|Death|1|||
164073300|NCT01289990|592632858|FG004|Overall Study|Death|2|||
164073301|NCT01289990|592632859|FG005|Overall Study|Death|1|||
164073302|NCT01289990|592632860|FG006|Overall Study|Death|0|||
164073303|NCT01289990|592632861|FG007|Overall Study|Death|0|||
164073304|NCT01289990|592632862|FG008|Overall Study|Death|0|||
164073305|NCT01289990|592632863|FG009|Overall Study|Death|0|||
164073306|NCT01289990|592632864|FG010|Overall Study|Death|0|||
164073307|NCT01289990|592632865|FG011|Overall Study|Death|1|||
164073308|NCT01289990|592632866|FG012|Overall Study|Death|0|||
164118923|NCT01488448|592795552|FG001|Overall Study|Physician Decision|9|||
164118924|NCT01488448|592795551|FG000|Overall Study|Protocol Violation|4|||
164118925|NCT01488448|592795552|FG001|Overall Study|Protocol Violation|3|||
164073309|NCT01289990|592632854|FG000|Overall Study|Lost to Follow-up|3|||
164073310|NCT01289990|592632855|FG001|Overall Study|Lost to Follow-up|2|||
164073311|NCT01289990|592632856|FG002|Overall Study|Lost to Follow-up|5|||
164118926|NCT00654641|592795553|FG000|Overall Study|Lost to Follow-up|2|||
164118927|NCT00654641|592795554|FG001|Overall Study|Lost to Follow-up|3|||
164118928|NCT01475487|592795555|FG000|Overall Study|had to leave early for personal reasons|2|||
164118929|NCT01475487|592795556|FG001|Overall Study|had to leave early for personal reasons|1|||
164118930|NCT01992094|592795557|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
164118931|NCT01992094|592795558|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
164118932|NCT01992094|592795559|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
164118933|NCT01992094|592795557|FG000|Overall Study|Adverse Event|1|||
164118934|NCT01992094|592795558|FG001|Overall Study|Adverse Event|0|||
164118935|NCT01992094|592795559|FG002|Overall Study|Adverse Event|0|||
164118936|NCT01992094|592795557|FG000|Overall Study|Death|5|||
164118937|NCT01992094|592795558|FG001|Overall Study|Death|5|||
164118938|NCT01992094|592795559|FG002|Overall Study|Death|2|||
164118939|NCT01992094|592795557|FG000|Overall Study|Lost to Follow-up|26|||
164118940|NCT01992094|592795558|FG001|Overall Study|Lost to Follow-up|9|||
164118941|NCT01992094|592795559|FG002|Overall Study|Lost to Follow-up|13|||
164118942|NCT01992094|592795557|FG000|Overall Study|OTHER|4|||
164118943|NCT01992094|592795558|FG001|Overall Study|OTHER|0|||
164073312|NCT01289990|592632857|FG003|Overall Study|Lost to Follow-up|5|||
164073313|NCT01289990|592632858|FG004|Overall Study|Lost to Follow-up|3|||
164073314|NCT01289990|592632859|FG005|Overall Study|Lost to Follow-up|4|||
164073315|NCT01289990|592632860|FG006|Overall Study|Lost to Follow-up|2|||
164073316|NCT01289990|592632861|FG007|Overall Study|Lost to Follow-up|2|||
164073317|NCT01289990|592632862|FG008|Overall Study|Lost to Follow-up|1|||
164073318|NCT01289990|592632863|FG009|Overall Study|Lost to Follow-up|4|||
164073319|NCT01289990|592632864|FG010|Overall Study|Lost to Follow-up|2|||
164073320|NCT01289990|592632865|FG011|Overall Study|Lost to Follow-up|1|||
164073321|NCT01289990|592632866|FG012|Overall Study|Lost to Follow-up|2|||
164073322|NCT01289990|592632854|FG000|Overall Study|Withdrawal by Subject|15|||
164073323|NCT01289990|592632855|FG001|Overall Study|Withdrawal by Subject|14|||
164073324|NCT01289990|592632856|FG002|Overall Study|Withdrawal by Subject|12|||
164073325|NCT01289990|592632857|FG003|Overall Study|Withdrawal by Subject|13|||
164073326|NCT01289990|592632858|FG004|Overall Study|Withdrawal by Subject|8|||
164073327|NCT01289990|592632859|FG005|Overall Study|Withdrawal by Subject|7|||
164073328|NCT01289990|592632860|FG006|Overall Study|Withdrawal by Subject|13|||
164073329|NCT01289990|592632861|FG007|Overall Study|Withdrawal by Subject|9|||
164073330|NCT01289990|592632862|FG008|Overall Study|Withdrawal by Subject|12|||
164073331|NCT01289990|592632863|FG009|Overall Study|Withdrawal by Subject|13|||
164073332|NCT01289990|592632864|FG010|Overall Study|Withdrawal by Subject|11|||
164073333|NCT01289990|592632865|FG011|Overall Study|Withdrawal by Subject|13|||
164073334|NCT01289990|592632866|FG012|Overall Study|Withdrawal by Subject|16|||
164073335|NCT01289990|592632854|FG000|Overall Study|discontinued in preceding trial|18|||
164073336|NCT01289990|592632855|FG001|Overall Study|discontinued in preceding trial|20|||
164073337|NCT01289990|592632856|FG002|Overall Study|discontinued in preceding trial|41|||
164073338|NCT01289990|592632857|FG003|Overall Study|discontinued in preceding trial|17|||
164073339|NCT01289990|592632858|FG004|Overall Study|discontinued in preceding trial|11|||
164073340|NCT01289990|592632859|FG005|Overall Study|discontinued in preceding trial|12|||
164073341|NCT01289990|592632860|FG006|Overall Study|discontinued in preceding trial|18|||
164073342|NCT01289990|592632861|FG007|Overall Study|discontinued in preceding trial|8|||
164073343|NCT01289990|592632862|FG008|Overall Study|discontinued in preceding trial|17|||
164073344|NCT01289990|592632863|FG009|Overall Study|discontinued in preceding trial|21|||
164073345|NCT01289990|592632864|FG010|Overall Study|discontinued in preceding trial|17|||
164073346|NCT01289990|592632865|FG011|Overall Study|discontinued in preceding trial|17|||
164073347|NCT01289990|592632866|FG012|Overall Study|discontinued in preceding trial|24|||
164073348|NCT01289990|592632854|FG000|Overall Study|did not continue in extension|41|||
164073349|NCT01289990|592632855|FG001|Overall Study|did not continue in extension|45|||
164073350|NCT01289990|592632856|FG002|Overall Study|did not continue in extension|51|||
164073351|NCT01289990|592632857|FG003|Overall Study|did not continue in extension|51|||
164073352|NCT01289990|592632858|FG004|Overall Study|did not continue in extension|48|||
164073353|NCT01289990|592632859|FG005|Overall Study|did not continue in extension|50|||
164073354|NCT01289990|592632860|FG006|Overall Study|did not continue in extension|54|||
164073355|NCT01289990|592632861|FG007|Overall Study|did not continue in extension|36|||
164073356|NCT01289990|592632862|FG008|Overall Study|did not continue in extension|44|||
164073357|NCT01289990|592632863|FG009|Overall Study|did not continue in extension|48|||
164073358|NCT01289990|592632864|FG010|Overall Study|did not continue in extension|45|||
164073359|NCT01289990|592632865|FG011|Overall Study|did not continue in extension|34|||
164073360|NCT01289990|592632866|FG012|Overall Study|did not continue in extension|56|||
164073361|NCT01289990|592632854|FG000|Overall Study|Not treated|0|||
164073362|NCT01289990|592632855|FG001|Overall Study|Not treated|0|||
164073363|NCT01289990|592632856|FG002|Overall Study|Not treated|0|||
164073364|NCT01289990|592632857|FG003|Overall Study|Not treated|0|||
164118944|NCT01992094|592795559|FG002|Overall Study|OTHER|0|||
164118945|NCT01992094|592795557|FG000|Overall Study|Protocol Violation|1|||
164118946|NCT01992094|592795558|FG001|Overall Study|Protocol Violation|0|||
164118947|NCT01992094|592795559|FG002|Overall Study|Protocol Violation|1|||
164118948|NCT01992094|592795557|FG000|Overall Study|Withdrawal by Subject|7|||
164118949|NCT01992094|592795558|FG001|Overall Study|Withdrawal by Subject|3|||
164118950|NCT01992094|592795559|FG002|Overall Study|Withdrawal by Subject|4|||
164118951|NCT01214239|592795560|FG000|Overall Study|Adverse Event|3|||
164118952|NCT01214239|592795561|FG001|Overall Study|Adverse Event|4|||
164118953|NCT01214239|592795560|FG000|Overall Study|Protocol Violation|2|||
164118954|NCT01214239|592795561|FG001|Overall Study|Protocol Violation|1|||
164118955|NCT01214239|592795560|FG000|Overall Study|Lost to Follow-up|1|||
164118956|NCT01214239|592795561|FG001|Overall Study|Lost to Follow-up|1|||
164118957|NCT01214239|592795560|FG000|Overall Study|Withdrawal by Subject|4|||
164118958|NCT01214239|592795561|FG001|Overall Study|Withdrawal by Subject|9|||
164118959|NCT01214239|592795560|FG000|Overall Study|Lack of Efficacy|1|||
164118960|NCT01214239|592795561|FG001|Overall Study|Lack of Efficacy|2|||
164118961|NCT01214239|592795560|FG000|Overall Study|patient's private reason|1|||
164118962|NCT01214239|592795561|FG001|Overall Study|patient's private reason|1|||
164118963|NCT00810602|592795562|FG000|Overall Study|Withdrawal by Subject|8|||
164118964|NCT00810602|592795563|FG001|Overall Study|Withdrawal by Subject|3|||
164118965|NCT01142661|592795564|FG000|Overall Study|Adverse Event|2|||
164118966|NCT01142661|592795564|FG000|Overall Study|Withdrawal by Subject|1|||
164118967|NCT01142661|592795564|FG000|Overall Study|Physician Decision|1|||
164118968|NCT03180528|592797288|FG000|Overall Study|Adverse Event|1|||
164118969|NCT03180528|592797288|FG000|Overall Study|Withdrawal by Subject|1|||
164118970|NCT03180528|592797288|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
164118971|NCT02447887|592797289|FG000|Overall Study|Study was terminated|3|||
164118972|NCT03429049|592797290|FG000|Overall Study|Adverse Event|2|||
164118973|NCT03429049|592797291|FG001|Overall Study|Adverse Event|3|||
164118974|NCT03429049|592797290|FG000|Overall Study|Death|0|||
164118975|NCT03429049|592797291|FG001|Overall Study|Death|1|||
164118976|NCT03429049|592797290|FG000|Overall Study|Lack of Efficacy|4|||
164118977|NCT03429049|592797291|FG001|Overall Study|Lack of Efficacy|2|||
164118978|NCT03429049|592797290|FG000|Overall Study|Lost to Follow-up|9|||
164118979|NCT03429049|592797291|FG001|Overall Study|Lost to Follow-up|8|||
164118980|NCT03429049|592797290|FG000|Overall Study|Physician Decision|1|||
164118981|NCT03429049|592797291|FG001|Overall Study|Physician Decision|0|||
164118982|NCT03429049|592797290|FG000|Overall Study|Protocol Violation|3|||
164118983|NCT03429049|592797291|FG001|Overall Study|Protocol Violation|0|||
164118984|NCT03429049|592797290|FG000|Overall Study|Sponsor Decision|2|||
164118985|NCT03429049|592797291|FG001|Overall Study|Sponsor Decision|0|||
164118986|NCT03429049|592797290|FG000|Overall Study|Withdrawal by Subject|4|||
164118987|NCT03429049|592797291|FG001|Overall Study|Withdrawal by Subject|20|||
164118988|NCT03429049|592797290|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
164118989|NCT03429049|592797291|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
164118990|NCT04703855|592797292|FG000|Overall Study|Heart Transplant|1|||
164118991|NCT02012452|592797295|FG000|Overall Study|Lost to Follow-up|2|||
164118992|NCT02012452|592797296|FG001|Overall Study|Lost to Follow-up|1|||
164118993|NCT02012452|592797295|FG000|Overall Study|Withdrawal by Subject|4|||
164118994|NCT02012452|592797296|FG001|Overall Study|Withdrawal by Subject|0|||
164118995|NCT04403399|592797297|FG000|Period 2|Physician Decision|0|||
164118996|NCT04403399|592797298|FG001|Period 2|Physician Decision|1|||
164118997|NCT00399893|592797299|FG000|Overall Study|Withdrawal by Subject|1|||
164118998|NCT00399893|592797300|FG001|Overall Study|Withdrawal by Subject|0|||
164118999|NCT04412057|592797301|FG000|Overall Study|Death|3|||
164119000|NCT04412057|592797302|FG001|Overall Study|Death|7|||
164119001|NCT04412057|592797301|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
164119002|NCT04412057|592797302|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
164119003|NCT00831233|592797305|FG000|Overall Study|Adverse Event|0|||
164119004|NCT00831233|592797306|FG001|Overall Study|Adverse Event|1|||
164119005|NCT00831233|592797305|FG000|Overall Study|Protocol Violation|1|||
164119006|NCT00831233|592797306|FG001|Overall Study|Protocol Violation|0|||
164119007|NCT00831233|592797305|FG000|Overall Study|Selection Criteria Not Met|2|||
164119008|NCT00831233|592797306|FG001|Overall Study|Selection Criteria Not Met|0|||
164119009|NCT02457819|592797307|FG000|Overall Study|reason not given|8|||
164119010|NCT02457819|592797307|FG000|Overall Study|Withdrawal by Subject|24|||
164119011|NCT02457819|592797307|FG000|Overall Study|Protocol Violation|1|||
164119012|NCT02457819|592797307|FG000|Overall Study|non compliance with study drug|4|||
164119013|NCT02457819|592797307|FG000|Overall Study|Lost to Follow-up|10|||
164119014|NCT02457819|592797307|FG000|Overall Study|Lack of Efficacy|19|||
164119015|NCT02457819|592797307|FG000|Overall Study|Adverse Event|33|||
164119016|NCT01064531|592797309|FG000|Overall Study|Lost to Follow-up|0|||
164119017|NCT01064531|592797310|FG001|Overall Study|Lost to Follow-up|2|||
164119018|NCT01064531|592797309|FG000|Overall Study|Physician Decision|0|||
164119019|NCT01064531|592797310|FG001|Overall Study|Physician Decision|1|||
164119020|NCT01064531|592797309|FG000|Overall Study|Withdrawal by Subject|2|||
164119021|NCT01064531|592797310|FG001|Overall Study|Withdrawal by Subject|2|||
164119022|NCT01064531|592797309|FG000|Overall Study|Revision due to femoral stem loosening|1|||
164119023|NCT01064531|592797310|FG001|Overall Study|Revision due to femoral stem loosening|0|||
164119024|NCT01064531|592797309|FG000|Overall Study|Revision due to dislocation|0|||
164119025|NCT01064531|592797310|FG001|Overall Study|Revision due to dislocation|1|||
164119026|NCT01064531|592797309|FG000|Overall Study|Death|0|||
164119027|NCT01064531|592797310|FG001|Overall Study|Death|1|||
164119028|NCT00573170|592797315|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
164119029|NCT00573170|592797316|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
164119030|NCT00573170|592797317|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
164119031|NCT00573170|592797318|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
164119032|NCT00573170|592797319|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
164119033|NCT00573170|592797320|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
164119034|NCT00573170|592797315|FG000|First Washout Period|Adverse Event|1|||
164119035|NCT00573170|592797316|FG001|First Washout Period|Adverse Event|1|||
164119036|NCT00573170|592797317|FG002|First Washout Period|Adverse Event|0|||
164119037|NCT00573170|592797318|FG003|First Washout Period|Adverse Event|0|||
164119038|NCT00573170|592797319|FG004|First Washout Period|Adverse Event|0|||
164119039|NCT00573170|592797320|FG005|First Washout Period|Adverse Event|1|||
164119040|NCT00573170|592797315|FG000|First Washout Period|Lack of Efficacy|0|||
164119041|NCT00573170|592797316|FG001|First Washout Period|Lack of Efficacy|0|||
164119042|NCT00573170|592797317|FG002|First Washout Period|Lack of Efficacy|0|||
164119043|NCT00573170|592797318|FG003|First Washout Period|Lack of Efficacy|0|||
164119044|NCT00573170|592797319|FG004|First Washout Period|Lack of Efficacy|0|||
164119045|NCT00573170|592797320|FG005|First Washout Period|Lack of Efficacy|1|||
164119046|NCT00573170|592797315|FG000|First Washout Period|Lost to Follow-up|1|||
164119047|NCT00573170|592797316|FG001|First Washout Period|Lost to Follow-up|1|||
164119048|NCT00573170|592797317|FG002|First Washout Period|Lost to Follow-up|0|||
164119049|NCT00573170|592797318|FG003|First Washout Period|Lost to Follow-up|2|||
164119050|NCT00573170|592797319|FG004|First Washout Period|Lost to Follow-up|0|||
164119051|NCT00573170|592797320|FG005|First Washout Period|Lost to Follow-up|2|||
164119052|NCT00573170|592797315|FG000|First Washout Period|Withdrawal by Subject|2|||
164119053|NCT00573170|592797316|FG001|First Washout Period|Withdrawal by Subject|0|||
164119054|NCT00573170|592797317|FG002|First Washout Period|Withdrawal by Subject|0|||
164119055|NCT00573170|592797318|FG003|First Washout Period|Withdrawal by Subject|2|||
164119056|NCT00573170|592797319|FG004|First Washout Period|Withdrawal by Subject|3|||
164119057|NCT00573170|592797320|FG005|First Washout Period|Withdrawal by Subject|3|||
164119058|NCT00573170|592797315|FG000|First Washout Period|Other|4|||
164119059|NCT00573170|592797316|FG001|First Washout Period|Other|0|||
164119060|NCT00573170|592797317|FG002|First Washout Period|Other|1|||
164119061|NCT00573170|592797318|FG003|First Washout Period|Other|1|||
164119062|NCT00573170|592797319|FG004|First Washout Period|Other|0|||
164119063|NCT00573170|592797320|FG005|First Washout Period|Other|0|||
164119064|NCT00573170|592797315|FG000|Second Washout Period|Adverse Event|1|||
164119065|NCT00573170|592797316|FG001|Second Washout Period|Adverse Event|0|||
164119066|NCT00573170|592797317|FG002|Second Washout Period|Adverse Event|0|||
164119067|NCT00573170|592797318|FG003|Second Washout Period|Adverse Event|0|||
164119068|NCT00573170|592797319|FG004|Second Washout Period|Adverse Event|1|||
164119069|NCT00573170|592797320|FG005|Second Washout Period|Adverse Event|0|||
164119070|NCT00573170|592797315|FG000|Second Washout Period|Protocol Violation|2|||
164119071|NCT00573170|592797316|FG001|Second Washout Period|Protocol Violation|1|||
164119072|NCT00573170|592797317|FG002|Second Washout Period|Protocol Violation|1|||
164119073|NCT00573170|592797318|FG003|Second Washout Period|Protocol Violation|0|||
164119074|NCT00573170|592797319|FG004|Second Washout Period|Protocol Violation|0|||
164119075|NCT00573170|592797320|FG005|Second Washout Period|Protocol Violation|0|||
164119076|NCT00573170|592797315|FG000|Second Washout Period|Withdrawal by Subject|1|||
164119077|NCT00573170|592797316|FG001|Second Washout Period|Withdrawal by Subject|1|||
164119078|NCT00573170|592797317|FG002|Second Washout Period|Withdrawal by Subject|2|||
164119079|NCT00573170|592797318|FG003|Second Washout Period|Withdrawal by Subject|0|||
164119080|NCT00573170|592797319|FG004|Second Washout Period|Withdrawal by Subject|1|||
164119081|NCT00573170|592797320|FG005|Second Washout Period|Withdrawal by Subject|0|||
164119082|NCT00573170|592797315|FG000|Second Washout Period|Lost to Follow-up|0|||
164119083|NCT00573170|592797316|FG001|Second Washout Period|Lost to Follow-up|0|||
164119084|NCT00573170|592797317|FG002|Second Washout Period|Lost to Follow-up|0|||
164119085|NCT00573170|592797318|FG003|Second Washout Period|Lost to Follow-up|1|||
164119086|NCT00573170|592797319|FG004|Second Washout Period|Lost to Follow-up|0|||
164119087|NCT00573170|592797320|FG005|Second Washout Period|Lost to Follow-up|0|||
164119088|NCT00573170|592797315|FG000|Second Washout Period|Other|1|||
164119089|NCT00573170|592797316|FG001|Second Washout Period|Other|2|||
164119090|NCT00573170|592797317|FG002|Second Washout Period|Other|1|||
164119091|NCT00573170|592797318|FG003|Second Washout Period|Other|4|||
164119092|NCT00573170|592797319|FG004|Second Washout Period|Other|6|||
164119093|NCT00573170|592797320|FG005|Second Washout Period|Other|2|||
164119094|NCT00573170|592797315|FG000|Third Treatment Period|Withdrawal by Subject|1|||
164119095|NCT00573170|592797316|FG001|Third Treatment Period|Withdrawal by Subject|0|||
164132674|NCT01986010|592850670|FG015|Overall Study|Adverse Event|1|||
164119096|NCT00573170|592797317|FG002|Third Treatment Period|Withdrawal by Subject|0|||
164119097|NCT00573170|592797318|FG003|Third Treatment Period|Withdrawal by Subject|0|||
164119098|NCT00573170|592797319|FG004|Third Treatment Period|Withdrawal by Subject|0|||
164119099|NCT00573170|592797320|FG005|Third Treatment Period|Withdrawal by Subject|0|||
164119100|NCT00573170|592797315|FG000|Third Treatment Period|Lost to Follow-up|0|||
164119101|NCT00573170|592797316|FG001|Third Treatment Period|Lost to Follow-up|0|||
164119102|NCT00573170|592797317|FG002|Third Treatment Period|Lost to Follow-up|0|||
164119103|NCT00573170|592797318|FG003|Third Treatment Period|Lost to Follow-up|0|||
164119104|NCT00573170|592797319|FG004|Third Treatment Period|Lost to Follow-up|0|||
164119105|NCT00573170|592797320|FG005|Third Treatment Period|Lost to Follow-up|2|||
164119106|NCT00779402|592797323|FG000|Treatment Phase 1|Disease Progression|1|||
164119107|NCT00779402|592797324|FG001|Treatment Phase 1|Disease Progression|0|||
164119108|NCT00779402|592797323|FG000|Treatment Phase 1|Adverse Event|2|||
164119109|NCT00779402|592797324|FG001|Treatment Phase 1|Adverse Event|0|||
164119110|NCT00779402|592797323|FG000|Treatment Phase 1|Protocol Violation|1|||
164119111|NCT00779402|592797324|FG001|Treatment Phase 1|Protocol Violation|0|||
164119112|NCT00779402|592797323|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
164119113|NCT00779402|592797324|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
164119114|NCT00779402|592797323|FG000|Treatment Phase 1|Lost to Follow-up|0|||
164119115|NCT00779402|592797324|FG001|Treatment Phase 1|Lost to Follow-up|1|||
164119116|NCT00779402|592797323|FG000|Treatment Phase 1|Death|0|||
164119117|NCT00779402|592797324|FG001|Treatment Phase 1|Death|1|||
164119118|NCT00779402|592797323|FG000|Treatment Phase 1|Intercurrent Illness|1|||
164119119|NCT00779402|592797324|FG001|Treatment Phase 1|Intercurrent Illness|1|||
164119120|NCT00779402|592797323|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
164119121|NCT00779402|592797324|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
164119122|NCT00779402|592797323|FG000|Treatment Phase 1|Other|4|||
164119123|NCT00779402|592797324|FG001|Treatment Phase 1|Other|2|||
164119124|NCT00779402|592797323|FG000|Treatment Phase 1|Closure of Study|3|||
164119125|NCT00779402|592797324|FG001|Treatment Phase 1|Closure of Study|2|||
164119126|NCT00779402|592797323|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
164119127|NCT00779402|592797324|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
164119128|NCT00779402|592797323|FG000|Surveillance Phase|Protocol Violation|0|||
164119129|NCT00779402|592797324|FG001|Surveillance Phase|Protocol Violation|1|||
164119130|NCT00779402|592797323|FG000|Surveillance Phase|Patient refused to continue|22|||
164119131|NCT00779402|592797324|FG001|Surveillance Phase|Patient refused to continue|14|||
164119132|NCT00779402|592797323|FG000|Surveillance Phase|Lost to Follow-up|2|||
164119133|NCT00779402|592797324|FG001|Surveillance Phase|Lost to Follow-up|1|||
164119134|NCT00779402|592797323|FG000|Surveillance Phase|Death|0|||
164119135|NCT00779402|592797324|FG001|Surveillance Phase|Death|1|||
164119136|NCT00779402|592797323|FG000|Surveillance Phase|Intercurrent Illness|2|||
164119137|NCT00779402|592797324|FG001|Surveillance Phase|Intercurrent Illness|0|||
164119138|NCT00779402|592797323|FG000|Surveillance Phase|Other|5|||
164119139|NCT00779402|592797324|FG001|Surveillance Phase|Other|5|||
164119140|NCT00779402|592797323|FG000|Surveillance Phase|Withdrawal by Subject|4|||
164119141|NCT00779402|592797324|FG001|Surveillance Phase|Withdrawal by Subject|1|||
164119142|NCT00779402|592797323|FG000|Surveillance Phase|Closure of study|5|||
164119143|NCT00779402|592797324|FG001|Surveillance Phase|Closure of study|6|||
164119144|NCT00779402|592797323|FG000|Surveillance Phase|Completed Protocol Visits|3|||
164119145|NCT00779402|592797324|FG001|Surveillance Phase|Completed Protocol Visits|2|||
164119146|NCT00779402|592797323|FG000|Long-term Follow-up|Patient refused to continue|2|||
164119147|NCT00779402|592797324|FG001|Long-term Follow-up|Patient refused to continue|0|||
164119148|NCT00779402|592797323|FG000|Long-term Follow-up|Other|5|||
164119149|NCT00779402|592797324|FG001|Long-term Follow-up|Other|0|||
164119150|NCT00779402|592797323|FG000|Long-term Follow-up|Closure of Study|8|||
164119151|NCT00779402|592797324|FG001|Long-term Follow-up|Closure of Study|4|||
164119152|NCT00779402|592797323|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
164119153|NCT00779402|592797324|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
164119154|NCT01519947|592797325|FG000|Overall Study|Death|0|||
164119155|NCT01519947|592797326|FG001|Overall Study|Death|0|||
164119156|NCT01519947|592797327|FG002|Overall Study|Death|0|||
164119157|NCT01519947|592797328|FG003|Overall Study|Death|1|||
164119158|NCT01519947|592797325|FG000|Overall Study|Protocol Violation|0|||
164119159|NCT01519947|592797326|FG001|Overall Study|Protocol Violation|0|||
164119160|NCT01519947|592797327|FG002|Overall Study|Protocol Violation|2|||
164119161|NCT01519947|592797328|FG003|Overall Study|Protocol Violation|1|||
164119162|NCT01519947|592797325|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
164119163|NCT01519947|592797326|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
164119164|NCT01519947|592797327|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
164119165|NCT01519947|592797328|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
164119166|NCT01519947|592797325|FG000|Overall Study|Development of Anemia|0|||
164119167|NCT01519947|592797326|FG001|Overall Study|Development of Anemia|1|||
164119168|NCT01519947|592797327|FG002|Overall Study|Development of Anemia|0|||
164119169|NCT01519947|592797328|FG003|Overall Study|Development of Anemia|1|||
164119170|NCT01519947|592797325|FG000|Overall Study|Blood Transfusion|0|||
164119171|NCT01519947|592797326|FG001|Overall Study|Blood Transfusion|1|||
164119172|NCT01519947|592797327|FG002|Overall Study|Blood Transfusion|1|||
164119173|NCT01519947|592797328|FG003|Overall Study|Blood Transfusion|0|||
164119174|NCT01519947|592797325|FG000|Overall Study|Withdrawal by Subject|0|||
164119175|NCT01519947|592797326|FG001|Overall Study|Withdrawal by Subject|1|||
164119176|NCT01519947|592797327|FG002|Overall Study|Withdrawal by Subject|0|||
164119177|NCT01519947|592797328|FG003|Overall Study|Withdrawal by Subject|1|||
164119178|NCT01519947|592797325|FG000|Overall Study|Lost to Follow-up|0|||
164119179|NCT01519947|592797326|FG001|Overall Study|Lost to Follow-up|0|||
164119180|NCT01519947|592797327|FG002|Overall Study|Lost to Follow-up|3|||
164119181|NCT01519947|592797328|FG003|Overall Study|Lost to Follow-up|2|||
164119182|NCT01519947|592797325|FG000|Overall Study|Poor Response|1|||
164119183|NCT01519947|592797326|FG001|Overall Study|Poor Response|0|||
164119184|NCT01519947|592797327|FG002|Overall Study|Poor Response|0|||
164119185|NCT01519947|592797328|FG003|Overall Study|Poor Response|1|||
164119186|NCT01519947|592797325|FG000|Overall Study|Adverse Event|1|||
164119187|NCT01519947|592797326|FG001|Overall Study|Adverse Event|0|||
164119188|NCT01519947|592797327|FG002|Overall Study|Adverse Event|1|||
164119189|NCT01519947|592797328|FG003|Overall Study|Adverse Event|1|||
164119190|NCT00693225|592797329|FG000|Overall Study|Lost to Follow-up|1|||
164119191|NCT00693225|592797330|FG001|Overall Study|Lost to Follow-up|2|||
164119192|NCT00693225|592797329|FG000|Overall Study|Adverse Event|1|||
164119193|NCT00693225|592797330|FG001|Overall Study|Adverse Event|3|||
164119194|NCT01186016|592797333|FG000|Overall Study|Withdrawal by Subject|46|||
164119195|NCT01186016|592797334|FG001|Overall Study|Withdrawal by Subject|29|||
164119196|NCT03750695|592797336|FG000|Overall Study|Lost to Follow-up|0|||
164119197|NCT03750695|592797337|FG001|Overall Study|Lost to Follow-up|1|||
164119198|NCT03173560|592797338|FG000|Overall Study|Death|70|||
164119199|NCT03173560|592797339|FG001|Overall Study|Death|60|||
164119200|NCT03173560|592797338|FG000|Overall Study|Lost to Follow-up|1|||
164119201|NCT03173560|592797339|FG001|Overall Study|Lost to Follow-up|4|||
164119202|NCT03173560|592797338|FG000|Overall Study|Withdrawal by Subject|10|||
164119203|NCT03173560|592797339|FG001|Overall Study|Withdrawal by Subject|5|||
164119204|NCT03173560|592797338|FG000|Overall Study|Other|0|||
164119205|NCT03173560|592797339|FG001|Overall Study|Other|1|||
164119206|NCT02174276|592797342|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
164119207|NCT02174276|592797343|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
164119208|NCT02174276|592797344|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
164119209|NCT02174276|592797345|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
164119210|NCT02174276|592797342|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
164119211|NCT02174276|592797343|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
164119212|NCT02174276|592797344|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
164119213|NCT02174276|592797345|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
164119214|NCT02174276|592797342|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
164119215|NCT02174276|592797343|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
164119216|NCT02174276|592797344|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
164119217|NCT02174276|592797345|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
164119218|NCT02174276|592797342|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
164119219|NCT02174276|592797343|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
164119220|NCT02174276|592797344|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
164119221|NCT02174276|592797345|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
164119222|NCT02174276|592797342|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
164119223|NCT02174276|592797343|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
164119224|NCT02174276|592797344|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
164119225|NCT02174276|592797345|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
164119226|NCT02174276|592797342|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
164119227|NCT02174276|592797343|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
164119228|NCT02174276|592797344|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
164119229|NCT02174276|592797345|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
164119230|NCT02661022|592797346|FG000|Overall Study|Withdrawal by Subject|3|||
164119231|NCT02661022|592797347|FG001|Overall Study|Withdrawal by Subject|0|||
164119232|NCT02661022|592797346|FG000|Overall Study|Adverse Event|1|||
164119233|NCT02661022|592797347|FG001|Overall Study|Adverse Event|1|||
164119234|NCT02661022|592797346|FG000|Overall Study|Physician Decision|1|||
164119235|NCT02661022|592797347|FG001|Overall Study|Physician Decision|0|||
164119236|NCT02661022|592797346|FG000|Overall Study|Progressive Disease|2|||
164119237|NCT02661022|592797347|FG001|Overall Study|Progressive Disease|1|||
164119238|NCT00725764|592797349|FG000|Overall Study|Withdrawal by Subject|2|||
164119239|NCT00725764|592797349|FG000|Overall Study|Physician Decision|1|||
164119240|NCT00725764|592797349|FG000|Overall Study|Progressive Disease|7|||
164119241|NCT00725764|592797349|FG000|Overall Study|Lost to Follow-up|1|||
164119242|NCT00725764|592797349|FG000|Overall Study|Death|1|||
164119243|NCT00725764|592797349|FG000|Overall Study|Participant non compliant with protocol|1|||
164119244|NCT00725764|592797349|FG000|Overall Study|Decline in performance status|1|||
164119245|NCT04480307|592797350|FG000|Overall Study|Withdrawal by Subject|0|||
164119246|NCT04480307|592797351|FG001|Overall Study|Withdrawal by Subject|1|||
164119247|NCT04480307|592797352|FG002|Overall Study|Withdrawal by Subject|0|||
164119248|NCT04480307|592797353|FG003|Overall Study|Withdrawal by Subject|0|||
164119249|NCT04480307|592797350|FG000|Overall Study|Adverse Event|0|||
164119250|NCT04480307|592797351|FG001|Overall Study|Adverse Event|0|||
164119251|NCT04480307|592797352|FG002|Overall Study|Adverse Event|0|||
164119252|NCT04480307|592797353|FG003|Overall Study|Adverse Event|1|||
164119253|NCT00609154|592797354|FG000|Overall Study|Protocol Violation|1|||
164119254|NCT00609154|592797355|FG001|Overall Study|Protocol Violation|2|||
164119255|NCT00609154|592797354|FG000|Overall Study|Unable to establish IV access|0|||
164119256|NCT00609154|592797355|FG001|Overall Study|Unable to establish IV access|4|||
164119257|NCT00609154|592797354|FG000|Overall Study|Adverse Event|0|||
164119258|NCT00609154|592797355|FG001|Overall Study|Adverse Event|2|||
164119259|NCT00732160|592797363|FG000|Overall Study|Adverse Event|1|||
164119260|NCT00732160|592797364|FG001|Overall Study|Adverse Event|0|||
164119261|NCT00732160|592797365|FG002|Overall Study|Adverse Event|1|||
164119262|NCT00732160|592797366|FG003|Overall Study|Adverse Event|1|||
164119263|NCT00732160|592797363|FG000|Overall Study|scheduling|4|||
164119264|NCT00732160|592797364|FG001|Overall Study|scheduling|4|||
164119265|NCT00732160|592797365|FG002|Overall Study|scheduling|2|||
164119266|NCT00732160|592797366|FG003|Overall Study|scheduling|1|||
164119267|NCT02427399|592797369|FG000|Overall Study|Protocol Violation|14|||
164119268|NCT02427399|592797370|FG001|Overall Study|Protocol Violation|16|||
164119269|NCT02427399|592797371|FG002|Overall Study|Protocol Violation|12|||
164119270|NCT02427399|592797372|FG003|Overall Study|Protocol Violation|18|||
164119271|NCT02427399|592797373|FG004|Overall Study|Protocol Violation|15|||
164119272|NCT03507686|592797382|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
164119273|NCT03507686|592797383|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
164119274|NCT03507686|592797382|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
164119275|NCT03507686|592797383|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
164119276|NCT03507686|592797382|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
164119277|NCT03507686|592797383|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
164119278|NCT03507686|592797382|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
164119279|NCT03507686|592797383|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
164119280|NCT03507686|592797382|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
164119281|NCT03507686|592797383|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
164119282|NCT03507686|592797382|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
164119283|NCT03507686|592797383|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
164119284|NCT00585312|592797384|FG000|Overall Study|Adverse Event|3|||
164119285|NCT00585312|592797385|FG001|Overall Study|Adverse Event|0|||
164119286|NCT00585312|592797384|FG000|Overall Study|Lack of Efficacy|6|||
164119287|NCT00585312|592797385|FG001|Overall Study|Lack of Efficacy|11|||
164119288|NCT00585312|592797384|FG000|Overall Study|Lost to Follow-up|1|||
164119289|NCT00585312|592797385|FG001|Overall Study|Lost to Follow-up|1|||
164119290|NCT00585312|592797384|FG000|Overall Study|Reason not specified|2|||
164119291|NCT00585312|592797385|FG001|Overall Study|Reason not specified|0|||
164119292|NCT00585312|592797384|FG000|Overall Study|Withdrawal by Subject|5|||
164119293|NCT00585312|592797385|FG001|Overall Study|Withdrawal by Subject|1|||
164119294|NCT00585312|592797384|FG000|Overall Study|Study terminated by the sponsor|34|||
164119295|NCT00585312|592797385|FG001|Overall Study|Study terminated by the sponsor|31|||
164119296|NCT00129116|592797386|FG000|Primary Phase|Lost to Follow-up|1|||
164119297|NCT00129116|592797387|FG001|Primary Phase|Lost to Follow-up|1|||
164119298|NCT00129116|592797388|FG002|Primary Phase|Lost to Follow-up|0|||
164119299|NCT00129116|592797389|FG003|Primary Phase|Lost to Follow-up|1|||
164119300|NCT00129116|592797390|FG004|Primary Phase|Lost to Follow-up|1|||
164119301|NCT00129116|592797386|FG000|Primary Phase|Protocol Violation|0|||
164119302|NCT00129116|592797387|FG001|Primary Phase|Protocol Violation|1|||
164119303|NCT00129116|592797388|FG002|Primary Phase|Protocol Violation|0|||
164119304|NCT00129116|592797389|FG003|Primary Phase|Protocol Violation|0|||
164119305|NCT00129116|592797390|FG004|Primary Phase|Protocol Violation|0|||
164119306|NCT00129116|592797386|FG000|Primary Phase|Adverse Event|1|||
164119307|NCT00129116|592797387|FG001|Primary Phase|Adverse Event|1|||
164119308|NCT00129116|592797388|FG002|Primary Phase|Adverse Event|0|||
164119309|NCT00129116|592797389|FG003|Primary Phase|Adverse Event|0|||
164119310|NCT00129116|592797390|FG004|Primary Phase|Adverse Event|0|||
164119311|NCT00129116|592797386|FG000|Primary Phase|Withdrawal by Subject|0|||
164119312|NCT00129116|592797387|FG001|Primary Phase|Withdrawal by Subject|1|||
164119313|NCT00129116|592797388|FG002|Primary Phase|Withdrawal by Subject|0|||
164119314|NCT00129116|592797389|FG003|Primary Phase|Withdrawal by Subject|0|||
164119315|NCT00129116|592797390|FG004|Primary Phase|Withdrawal by Subject|0|||
164119316|NCT00129116|592797386|FG000|Primary Phase|Other|0|||
164119317|NCT00129116|592797387|FG001|Primary Phase|Other|0|||
164119318|NCT00129116|592797388|FG002|Primary Phase|Other|1|||
164119319|NCT00129116|592797389|FG003|Primary Phase|Other|0|||
164119320|NCT00129116|592797390|FG004|Primary Phase|Other|0|||
164119321|NCT00129116|592797386|FG000|Booster Phase|Lost to Follow-up|2|||
164119322|NCT00129116|592797387|FG001|Booster Phase|Lost to Follow-up|0|||
164119323|NCT00129116|592797388|FG002|Booster Phase|Lost to Follow-up|0|||
164119324|NCT00129116|592797389|FG003|Booster Phase|Lost to Follow-up|0|||
164119325|NCT00129116|592797390|FG004|Booster Phase|Lost to Follow-up|1|||
164119326|NCT02539368|592797392|FG000|Overall Study|Death|4|||
164119327|NCT02539368|592797393|FG001|Overall Study|Death|2|||
164119328|NCT02539368|592797394|FG002|Overall Study|Death|1|||
164119329|NCT02539368|592797395|FG003|Overall Study|Death|0|||
164119330|NCT02539368|592797396|FG004|Overall Study|Death|0|||
164119331|NCT02539368|592797392|FG000|Overall Study|Withdrawal by Subject|44|||
164119332|NCT02539368|592797393|FG001|Overall Study|Withdrawal by Subject|35|||
164119333|NCT02539368|592797394|FG002|Overall Study|Withdrawal by Subject|9|||
164119334|NCT02539368|592797395|FG003|Overall Study|Withdrawal by Subject|1|||
164119335|NCT02539368|592797396|FG004|Overall Study|Withdrawal by Subject|3|||
164119336|NCT02539368|592797392|FG000|Overall Study|Physician Decision|49|||
164119337|NCT02539368|592797393|FG001|Overall Study|Physician Decision|15|||
164119338|NCT02539368|592797394|FG002|Overall Study|Physician Decision|7|||
164119339|NCT02539368|592797395|FG003|Overall Study|Physician Decision|0|||
164119340|NCT02539368|592797396|FG004|Overall Study|Physician Decision|2|||
164119341|NCT02539368|592797392|FG000|Overall Study|Lost to Follow-up|96|||
164119342|NCT02539368|592797393|FG001|Overall Study|Lost to Follow-up|21|||
164119343|NCT02539368|592797394|FG002|Overall Study|Lost to Follow-up|16|||
164119344|NCT02539368|592797395|FG003|Overall Study|Lost to Follow-up|4|||
164119345|NCT02539368|592797396|FG004|Overall Study|Lost to Follow-up|3|||
164119346|NCT02539368|592797392|FG000|Overall Study|Adverse Event|44|||
164119347|NCT02539368|592797393|FG001|Overall Study|Adverse Event|5|||
164119348|NCT02539368|592797394|FG002|Overall Study|Adverse Event|9|||
164119349|NCT02539368|592797395|FG003|Overall Study|Adverse Event|0|||
164119350|NCT02539368|592797396|FG004|Overall Study|Adverse Event|3|||
164119351|NCT02539368|592797392|FG000|Overall Study|Participant Non-compliant|13|||
164119352|NCT02539368|592797393|FG001|Overall Study|Participant Non-compliant|2|||
164119353|NCT02539368|592797394|FG002|Overall Study|Participant Non-compliant|1|||
164119354|NCT02539368|592797395|FG003|Overall Study|Participant Non-compliant|1|||
164119355|NCT02539368|592797396|FG004|Overall Study|Participant Non-compliant|0|||
164119356|NCT02539368|592797392|FG000|Overall Study|Other|145|||
164119357|NCT02539368|592797393|FG001|Overall Study|Other|18|||
164119358|NCT02539368|592797394|FG002|Overall Study|Other|24|||
164119359|NCT02539368|592797395|FG003|Overall Study|Other|1|||
164119360|NCT02539368|592797396|FG004|Overall Study|Other|3|||
164119361|NCT02539368|592797392|FG000|Overall Study|Missing|10|||
164119362|NCT02539368|592797393|FG001|Overall Study|Missing|3|||
164119363|NCT02539368|592797394|FG002|Overall Study|Missing|0|||
164119364|NCT02539368|592797395|FG003|Overall Study|Missing|0|||
164119365|NCT02539368|592797396|FG004|Overall Study|Missing|0|||
164119366|NCT03558139|592797398|FG000|Overall Study|Consent Withdrawn|1|||
164119367|NCT03558139|592797399|FG001|Overall Study|Consent Withdrawn|1|||
164119368|NCT03558139|592797400|FG002|Overall Study|Consent Withdrawn|4|||
164119369|NCT03558139|592797398|FG000|Overall Study|Death|5|||
164119370|NCT03558139|592797399|FG001|Overall Study|Death|3|||
164119371|NCT03558139|592797400|FG002|Overall Study|Death|8|||
164119372|NCT03558139|592797398|FG000|Overall Study|Lost to Follow-up|0|||
164119373|NCT03558139|592797399|FG001|Overall Study|Lost to Follow-up|0|||
164119374|NCT03558139|592797400|FG002|Overall Study|Lost to Follow-up|3|||
164119375|NCT03558139|592797398|FG000|Overall Study|Study Ended Per Protocol|0|||
164119376|NCT03558139|592797399|FG001|Overall Study|Study Ended Per Protocol|3|||
164119377|NCT03558139|592797400|FG002|Overall Study|Study Ended Per Protocol|6|||
164119378|NCT02752802|592797401|FG000|Overall Study|Contrast Volume Not Collected|1|||
164119379|NCT02752802|592797402|FG001|Overall Study|Contrast Volume Not Collected|0|||
164119380|NCT00251316|592797403|FG000|Overall Study|Physician Decision|2|||
164119381|NCT00251316|592797404|FG001|Overall Study|Physician Decision|3|||
164119382|NCT00398073|592797405|FG000|Overall Study|Withdrawal by Subject|1|||
164119383|NCT00398073|592797406|FG001|Overall Study|Withdrawal by Subject|0|||
164119384|NCT01263561|592797407|FG000|Overall Study|Death|1|||
164119385|NCT01263561|592797408|FG001|Overall Study|Death|2|||
164119386|NCT00879684|592797409|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
164119387|NCT00879684|592797410|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
164119388|NCT00879684|592797411|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
164119389|NCT00879684|592797412|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
164119390|NCT00879684|592797413|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
164119391|NCT00879684|592797414|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
164119392|NCT00879684|592797415|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
164119393|NCT00879684|592797409|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
164119394|NCT00879684|592797410|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
164119395|NCT00879684|592797411|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
164119396|NCT00879684|592797412|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
164119397|NCT00879684|592797413|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
164119398|NCT00879684|592797414|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
164119399|NCT00879684|592797415|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
164119400|NCT00879684|592797409|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
164119401|NCT00879684|592797410|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
164119402|NCT00879684|592797411|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
164119403|NCT00879684|592797412|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
164119404|NCT00879684|592797413|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
164119405|NCT00879684|592797414|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
164119406|NCT00879684|592797415|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
164119407|NCT00879684|592797409|FG000|Stage 1: Dose Escalation|Death|0|||
164119408|NCT00879684|592797410|FG001|Stage 1: Dose Escalation|Death|0|||
164119409|NCT00879684|592797411|FG002|Stage 1: Dose Escalation|Death|1|||
164119410|NCT00879684|592797412|FG003|Stage 1: Dose Escalation|Death|0|||
164119411|NCT00879684|592797413|FG004|Stage 1: Dose Escalation|Death|0|||
164119412|NCT00879684|592797414|FG005|Stage 1: Dose Escalation|Death|0|||
164119413|NCT00879684|592797415|FG006|Stage 1: Dose Escalation|Death|0|||
164119414|NCT00879684|592797409|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164119415|NCT00879684|592797410|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164119416|NCT00879684|592797411|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164119417|NCT00879684|592797412|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164119418|NCT00879684|592797413|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164119419|NCT00879684|592797414|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
164119420|NCT00879684|592797415|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
164119421|NCT00879684|592797409|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
164119422|NCT00879684|592797410|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
164119423|NCT00879684|592797411|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
164119424|NCT00879684|592797412|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
164119425|NCT00879684|592797413|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
164119426|NCT00879684|592797414|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
164119427|NCT00879684|592797415|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
164119428|NCT00879684|592797409|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164119429|NCT00879684|592797410|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164119430|NCT00879684|592797411|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164119431|NCT00879684|592797412|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164119432|NCT00879684|592797413|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164119433|NCT00879684|592797414|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
164119434|NCT00879684|592797415|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
164119435|NCT00708682|592797416|FG000|Infant Series|Adverse Event|1|||
164119436|NCT00708682|592797416|FG000|Infant Series|Lost to Follow-up|4|||
164119437|NCT00708682|592797416|FG000|Infant Series|Protocol Violation|1|||
164119438|NCT00708682|592797416|FG000|Infant Series|Parent/legal guardian request|6|||
164119439|NCT00708682|592797416|FG000|Infant Series|Failed to return|2|||
164119440|NCT00708682|592797416|FG000|Infant Series|Other|19|||
164119441|NCT00708682|592797416|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
164119442|NCT00708682|592797416|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
164119443|NCT00708682|592797416|FG000|Toddler Dose|Lost to Follow-up|3|||
164119444|NCT00708682|592797416|FG000|Toddler Dose|Failed to Return|4|||
164119445|NCT03689894|592797418|FG000|Overall Study|Adverse Event|1|||
164119446|NCT00569777|592797419|FG000|Overall Study|Withdrawal by Subject|4|||
164119447|NCT00569777|592797420|FG001|Overall Study|Withdrawal by Subject|0|||
164119448|NCT00569777|592797419|FG000|Overall Study|Adverse Event|3|||
164119449|NCT00569777|592797420|FG001|Overall Study|Adverse Event|0|||
164119450|NCT00569777|592797419|FG000|Overall Study|Lost to Follow-up|1|||
164119451|NCT00569777|592797420|FG001|Overall Study|Lost to Follow-up|0|||
164119452|NCT00569777|592797419|FG000|Overall Study|scheduled eye surgery|0|||
164119453|NCT00569777|592797420|FG001|Overall Study|scheduled eye surgery|1|||
164119454|NCT00569777|592797419|FG000|Overall Study|did not meet exclusion criteria|1|||
164119455|NCT00569777|592797420|FG001|Overall Study|did not meet exclusion criteria|2|||
164119456|NCT00569777|592797419|FG000|Overall Study|pregnant|1|||
164119457|NCT00569777|592797420|FG001|Overall Study|pregnant|0|||
164119458|NCT02056652|592797425|FG000|Overall Study|Withdrawal by Subject|1|||
164119459|NCT02056652|592797426|FG001|Overall Study|Withdrawal by Subject|0|||
164119460|NCT02056652|592797425|FG000|Overall Study|Lost to Follow-up|0|||
164119461|NCT02056652|592797426|FG001|Overall Study|Lost to Follow-up|3|||
164119462|NCT00965731|592797433|FG000|Overall Study|Death|0|||
164119463|NCT00965731|592797434|FG001|Overall Study|Death|4|||
164119464|NCT00965731|592797433|FG000|Overall Study|Withdrawal by Subject|0|||
164119465|NCT00965731|592797434|FG001|Overall Study|Withdrawal by Subject|1|||
164119466|NCT00965731|592797433|FG000|Overall Study|Other|7|||
164119467|NCT00965731|592797434|FG001|Overall Study|Other|15|||
164119468|NCT04773600|592797435|FG000|Overall Study|Withdrawal by Subject|15|||
164119469|NCT04773600|592797436|FG001|Overall Study|Withdrawal by Subject|9|||
164119470|NCT04773600|592797435|FG000|Overall Study|Lost to Follow-up|10|||
164119471|NCT04773600|592797436|FG001|Overall Study|Lost to Follow-up|6|||
164119472|NCT04773600|592797435|FG000|Overall Study|Adverse Event|8|||
164119473|NCT04773600|592797436|FG001|Overall Study|Adverse Event|2|||
164119474|NCT04773600|592797435|FG000|Overall Study|Lack of Efficacy|2|||
164119475|NCT04773600|592797436|FG001|Overall Study|Lack of Efficacy|3|||
164119476|NCT04773600|592797435|FG000|Overall Study|Noncompliance|2|||
164119477|NCT04773600|592797436|FG001|Overall Study|Noncompliance|0|||
164119478|NCT04773600|592797435|FG000|Overall Study|Protocol Violation|2|||
164119479|NCT04773600|592797436|FG001|Overall Study|Protocol Violation|0|||
164119480|NCT04773600|592797435|FG000|Overall Study|Physician Decision|0|||
164119481|NCT04773600|592797436|FG001|Overall Study|Physician Decision|1|||
164119482|NCT04773600|592797435|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
164119483|NCT04773600|592797436|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
164119484|NCT04773600|592797435|FG000|Overall Study|Emergency Travel Out of Country|1|||
164119485|NCT04773600|592797436|FG001|Overall Study|Emergency Travel Out of Country|0|||
164119486|NCT03581188|592799087|FG000|Overall Study|Inclusion criteria not met|3|||
164119487|NCT03581188|592799088|FG001|Overall Study|Inclusion criteria not met|2|||
164119488|NCT03581188|592799087|FG000|Overall Study|Lost to Follow-up|5|||
164119489|NCT03581188|592799088|FG001|Overall Study|Lost to Follow-up|5|||
164119490|NCT03581188|592799087|FG000|Overall Study|Discontinued intervention|11|||
164119491|NCT03581188|592799088|FG001|Overall Study|Discontinued intervention|8|||
164119492|NCT01923311|592799091|FG000|Overall Study|Pregnancy|1|||
164119493|NCT01923311|592799092|FG001|Overall Study|Pregnancy|0|||
164119494|NCT01923311|592799091|FG000|Overall Study|Investigator's Discretion|1|||
164119495|NCT01923311|592799092|FG001|Overall Study|Investigator's Discretion|0|||
164119496|NCT01923311|592799091|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164119497|NCT01923311|592799092|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164119498|NCT01923311|592799091|FG000|Overall Study|Withdrew Consent|1|||
164119499|NCT01923311|592799092|FG001|Overall Study|Withdrew Consent|0|||
164119500|NCT01923311|592799091|FG000|Overall Study|Study Terminated by Sponsor|12|||
164119501|NCT01923311|592799092|FG001|Overall Study|Study Terminated by Sponsor|0|||
164119502|NCT00991510|592799094|FG000|Period I (Days 1-14)|Adverse Event|1|||
164119503|NCT00991510|592799095|FG001|Period I (Days 1-14)|Adverse Event|0|||
164119504|NCT00991510|592799094|FG000|Period III (Days 29-112)|Adverse Event|1|||
164119505|NCT00991510|592799095|FG001|Period III (Days 29-112)|Adverse Event|1|||
164119506|NCT03710590|592799096|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
164119507|NCT03710590|592799097|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
164119508|NCT02488824|592799098|FG000|Overall Study|Adverse Event|1|||
164119509|NCT02488824|592799099|FG001|Overall Study|Adverse Event|1|||
164119510|NCT01976728|592799100|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
164119511|NCT01976728|592799101|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
164119512|NCT01976728|592799102|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
164119513|NCT01976728|592799103|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
164119514|NCT02356211|592799104|FG000|Overall Study|Withdrawal by Subject|2|||
164119515|NCT02356211|592799105|FG001|Overall Study|Withdrawal by Subject|2|||
164119516|NCT02356211|592799104|FG000|Overall Study|ineligible|1|||
164119517|NCT02356211|592799105|FG001|Overall Study|ineligible|8|||
164119518|NCT01563237|592799107|FG000|Overall Study|Lost to Follow-up|6|||
164119519|NCT01563237|592799108|FG001|Overall Study|Lost to Follow-up|0|||
164119520|NCT01563237|592799107|FG000|Overall Study|Withdrawal by Subject|1|||
164119521|NCT01563237|592799108|FG001|Overall Study|Withdrawal by Subject|0|||
164119522|NCT01563237|592799107|FG000|Overall Study|Adverse Event|1|||
164119523|NCT01563237|592799108|FG001|Overall Study|Adverse Event|0|||
164119524|NCT01563237|592799107|FG000|Overall Study|Medical Reasons|1|||
164119525|NCT01563237|592799108|FG001|Overall Study|Medical Reasons|0|||
164119526|NCT01563237|592799107|FG000|Overall Study|Death|1|||
164119527|NCT01563237|592799108|FG001|Overall Study|Death|0|||
164119528|NCT02211014|592799109|FG000|Overall Study|Adverse Event|0|||
164119529|NCT02211014|592799110|FG001|Overall Study|Adverse Event|2|||
164119530|NCT02211014|592799109|FG000|Overall Study|Physician Decision|1|||
164119531|NCT02211014|592799110|FG001|Overall Study|Physician Decision|2|||
164119532|NCT02211014|592799109|FG000|Overall Study|Started another cancer therapy|1|||
164119533|NCT02211014|592799110|FG001|Overall Study|Started another cancer therapy|0|||
164119534|NCT02211014|592799109|FG000|Overall Study|Withdrawal by Subject|0|||
164119535|NCT02211014|592799110|FG001|Overall Study|Withdrawal by Subject|1|||
164119536|NCT02211014|592799109|FG000|Overall Study|In agreement with patient, no benefit|0|||
164119537|NCT02211014|592799110|FG001|Overall Study|In agreement with patient, no benefit|1|||
164119538|NCT03036839|592799111|FG000|Overall Study|Adverse Event|0|||
164119539|NCT03036839|592799112|FG001|Overall Study|Adverse Event|0|||
164119540|NCT03036839|592799113|FG002|Overall Study|Adverse Event|1|||
164119541|NCT03036839|592799111|FG000|Overall Study|Death|3|||
164119542|NCT03036839|592799112|FG001|Overall Study|Death|0|||
164119543|NCT03036839|592799113|FG002|Overall Study|Death|3|||
164119544|NCT03036839|592799111|FG000|Overall Study|Withdrew Consent|0|||
164119545|NCT03036839|592799112|FG001|Overall Study|Withdrew Consent|0|||
164119546|NCT03036839|592799113|FG002|Overall Study|Withdrew Consent|1|||
164119547|NCT01316419|592799114|FG000|Overall Study|Not treated|103|||
164119548|NCT01316419|592799114|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
164119549|NCT01316419|592799114|FG000|Overall Study|Lost to Follow-up|19|||
164119550|NCT00412737|592799115|FG000|Overall Study|Death|1|||
164119551|NCT00412737|592799116|FG001|Overall Study|Death|0|||
164119552|NCT00412737|592799115|FG000|Overall Study|Adverse Event|3|||
164119553|NCT00412737|592799116|FG001|Overall Study|Adverse Event|2|||
164119554|NCT00412737|592799115|FG000|Overall Study|Refused Treatment|6|||
164119555|NCT00412737|592799116|FG001|Overall Study|Refused Treatment|2|||
164119556|NCT00412737|592799115|FG000|Overall Study|Failure to Return|6|||
164119557|NCT00412737|592799116|FG001|Overall Study|Failure to Return|2|||
164119558|NCT00983918|592799119|FG000|Overall Study|conversion to open cholecystectomy|0|||
164119559|NCT00983918|592799120|FG001|Overall Study|conversion to open cholecystectomy|2|||
164119560|NCT00983918|592799121|FG002|Overall Study|conversion to open cholecystectomy|2|||
164119561|NCT00983918|592799122|FG003|Overall Study|conversion to open cholecystectomy|2|||
164119562|NCT01345318|592799146|FG000|Overall Study|Adverse Event|16|||
164119563|NCT01345318|592799146|FG000|Overall Study|Lack of Efficacy|17|||
164119564|NCT01345318|592799146|FG000|Overall Study|Lost to Follow-up|2|||
164119565|NCT01345318|592799146|FG000|Overall Study|Protocol Violation|1|||
164119566|NCT01345318|592799146|FG000|Overall Study|Withdrawal by Subject|41|||
164119567|NCT01345318|592799146|FG000|Overall Study|Other|3|||
164119568|NCT01685073|592799147|FG000|Overall Study|Lost to Follow-up|6|||
164119569|NCT01685073|592799148|FG001|Overall Study|Lost to Follow-up|8|||
164119570|NCT01685073|592799147|FG000|Overall Study|Withdrawal by Subject|24|||
164119571|NCT01685073|592799148|FG001|Overall Study|Withdrawal by Subject|24|||
164119572|NCT03180801|592799151|FG000|Overall Study|Physician Decision|3|||
164119573|NCT03180801|592799152|FG001|Overall Study|Physician Decision|3|||
164119574|NCT03180801|592799153|FG002|Overall Study|Physician Decision|1|||
164119575|NCT03180801|592799151|FG000|Overall Study|Non-compliance|1|||
164119576|NCT03180801|592799152|FG001|Overall Study|Non-compliance|4|||
164119577|NCT03180801|592799153|FG002|Overall Study|Non-compliance|0|||
164119578|NCT03180801|592799151|FG000|Overall Study|Inoculation Target Reached|1|||
164119579|NCT03180801|592799152|FG001|Overall Study|Inoculation Target Reached|1|||
164119580|NCT03180801|592799153|FG002|Overall Study|Inoculation Target Reached|3|||
164119581|NCT03180801|592799151|FG000|Overall Study|Adverse Event|1|||
164119582|NCT03180801|592799152|FG001|Overall Study|Adverse Event|0|||
164119583|NCT03180801|592799153|FG002|Overall Study|Adverse Event|2|||
164119584|NCT03180801|592799151|FG000|Overall Study|Withdrawal by Subject|2|||
164119585|NCT03180801|592799152|FG001|Overall Study|Withdrawal by Subject|2|||
164119586|NCT03180801|592799153|FG002|Overall Study|Withdrawal by Subject|1|||
164119587|NCT03180801|592799151|FG000|Overall Study|Lost to Follow-up|0|||
164119588|NCT03180801|592799152|FG001|Overall Study|Lost to Follow-up|2|||
164119589|NCT03180801|592799153|FG002|Overall Study|Lost to Follow-up|3|||
164119590|NCT01049412|592799154|FG000|Period I|Withdrawal by Subject|4|||
164119591|NCT01049412|592799155|FG001|Period I|Withdrawal by Subject|6|||
164119592|NCT01049412|592799154|FG000|Period I|Lost to Follow-up|2|||
164119593|NCT01049412|592799155|FG001|Period I|Lost to Follow-up|2|||
164119594|NCT01049412|592799154|FG000|Period I|Physician Decision|0|||
164119595|NCT01049412|592799155|FG001|Period I|Physician Decision|3|||
164119596|NCT01049412|592799154|FG000|Period I|Protocol Violation|1|||
164119597|NCT01049412|592799155|FG001|Period I|Protocol Violation|2|||
164119598|NCT01049412|592799154|FG000|Period I|Adverse Event|1|||
164119599|NCT01049412|592799155|FG001|Period I|Adverse Event|0|||
164119600|NCT01049412|592799154|FG000|Period II|Withdrawal by Subject|2|||
164119601|NCT01049412|592799155|FG001|Period II|Withdrawal by Subject|3|||
164119602|NCT01049412|592799154|FG000|Period II|Adverse Event|1|||
164119603|NCT01049412|592799155|FG001|Period II|Adverse Event|0|||
164119604|NCT01049412|592799154|FG000|Period II|Lost to Follow-up|1|||
164119605|NCT01049412|592799155|FG001|Period II|Lost to Follow-up|0|||
164119606|NCT05966090|592799158|FG000|Overall Study|Lost to Follow-up|6|||
164119607|NCT05966090|592799159|FG001|Overall Study|Lost to Follow-up|6|||
164119608|NCT05966090|592799158|FG000|Overall Study|Adverse Event|1|||
164119609|NCT05966090|592799159|FG001|Overall Study|Adverse Event|1|||
164119610|NCT05966090|592799158|FG000|Overall Study|Withdrawal by Subject|1|||
164119611|NCT05966090|592799159|FG001|Overall Study|Withdrawal by Subject|1|||
164119612|NCT05966090|592799158|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164119613|NCT05966090|592799159|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164119614|NCT05966090|592799158|FG000|Overall Study|Other|1|||
164119615|NCT05966090|592799159|FG001|Overall Study|Other|1|||
164119616|NCT00804141|592799160|FG000|Overall Study|Adverse Event|157|||
164119617|NCT00804141|592799160|FG000|Overall Study|Death|4|||
164119618|NCT00804141|592799160|FG000|Overall Study|Failed to return|96|||
164119619|NCT00804141|592799160|FG000|Overall Study|Investigator request|8|||
164119620|NCT00804141|592799160|FG000|Overall Study|Protocol Violation|85|||
164119621|NCT00804141|592799160|FG000|Overall Study|Withdrawal by Subject|131|||
164119622|NCT00804141|592799160|FG000|Overall Study|Lack of Efficacy|46|||
164119623|NCT00804141|592799160|FG000|Overall Study|Other than specified|30|||
164119624|NCT00804141|592799160|FG000|Overall Study|Enrolled but not treated|6|||
164119625|NCT01142908|592799161|FG000|Overall Study|Lost to Follow-up|19|||
164119626|NCT01142908|592799162|FG001|Overall Study|Lost to Follow-up|13|||
164119627|NCT01142908|592799161|FG000|Overall Study|Death|1|||
164119628|NCT01142908|592799162|FG001|Overall Study|Death|4|||
164119629|NCT01142908|592799161|FG000|Overall Study|Excluded - did not meet criteria|9|||
164119630|NCT01142908|592799162|FG001|Overall Study|Excluded - did not meet criteria|5|||
164119631|NCT01142908|592799161|FG000|Overall Study|Withdrawal by Subject|3|||
164119632|NCT01142908|592799162|FG001|Overall Study|Withdrawal by Subject|0|||
164119633|NCT03235479|592799164|FG000|Overall Study|Lost to Follow-up|8|||
164119634|NCT03235479|592799165|FG001|Overall Study|Lost to Follow-up|11|||
164119635|NCT03235479|592799164|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
164119636|NCT03235479|592799165|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
164119637|NCT03235479|592799164|FG000|Overall Study|Pregnancy|1|||
164119638|NCT03235479|592799165|FG001|Overall Study|Pregnancy|0|||
164119639|NCT03235479|592799164|FG000|Overall Study|Protocol Deviation|1|||
164119640|NCT03235479|592799165|FG001|Overall Study|Protocol Deviation|3|||
164119641|NCT03235479|592799164|FG000|Overall Study|Technical Problems|3|||
164119642|NCT03235479|592799165|FG001|Overall Study|Technical Problems|2|||
164119643|NCT03235479|592799164|FG000|Overall Study|Withdrawal by Subject|2|||
164119644|NCT03235479|592799165|FG001|Overall Study|Withdrawal by Subject|2|||
164119645|NCT03235479|592799164|FG000|Overall Study|Other Reasons|3|||
164119646|NCT03235479|592799165|FG001|Overall Study|Other Reasons|5|||
164119647|NCT03585959|592799177|FG000|Overall Study|Physician Decision|1|||
164119648|NCT03585959|592799177|FG000|Overall Study|Unsuccessful Procedure|2|||
164119649|NCT01098539|592799179|FG000|Overall Study|Adverse Event|26|||
164119650|NCT01098539|592799180|FG001|Overall Study|Adverse Event|26|||
164119651|NCT01098539|592799179|FG000|Overall Study|Protocol Violation|1|||
164119652|NCT01098539|592799180|FG001|Overall Study|Protocol Violation|4|||
164119653|NCT01098539|592799179|FG000|Overall Study|Noncompliance|3|||
164119654|NCT01098539|592799180|FG001|Overall Study|Noncompliance|5|||
164119655|NCT01098539|592799179|FG000|Overall Study|Lost to Follow-up|4|||
164119656|NCT01098539|592799180|FG001|Overall Study|Lost to Follow-up|4|||
164119657|NCT01098539|592799179|FG000|Overall Study|Withdrawal by Subject|12|||
164119658|NCT01098539|592799180|FG001|Overall Study|Withdrawal by Subject|26|||
164119659|NCT01098539|592799179|FG000|Overall Study|Physician Decision|5|||
164119660|NCT01098539|592799180|FG001|Overall Study|Physician Decision|3|||
164119661|NCT03843125|592799181|FG000|Overall Study|Adverse Event|17|||
164119662|NCT03843125|592799182|FG001|Overall Study|Adverse Event|13|||
164119663|NCT03843125|592799183|FG002|Overall Study|Adverse Event|5|||
164119664|NCT03843125|592799184|FG003|Overall Study|Adverse Event|9|||
164119665|NCT03843125|592799181|FG000|Overall Study|Death|0|||
164119666|NCT03843125|592799182|FG001|Overall Study|Death|6|||
164119667|NCT03843125|592799183|FG002|Overall Study|Death|2|||
164119668|NCT03843125|592799184|FG003|Overall Study|Death|0|||
164119669|NCT03843125|592799181|FG000|Overall Study|Lack of Efficacy|14|||
164119670|NCT03843125|592799182|FG001|Overall Study|Lack of Efficacy|11|||
164119671|NCT03843125|592799183|FG002|Overall Study|Lack of Efficacy|9|||
164119672|NCT03843125|592799184|FG003|Overall Study|Lack of Efficacy|4|||
164119673|NCT03843125|592799181|FG000|Overall Study|Lost to Follow-up|3|||
164119674|NCT03843125|592799182|FG001|Overall Study|Lost to Follow-up|4|||
164119675|NCT03843125|592799183|FG002|Overall Study|Lost to Follow-up|0|||
164119676|NCT03843125|592799184|FG003|Overall Study|Lost to Follow-up|2|||
164119677|NCT03843125|592799181|FG000|Overall Study|Other|12|||
164119678|NCT03843125|592799182|FG001|Overall Study|Other|14|||
164119679|NCT03843125|592799183|FG002|Overall Study|Other|3|||
164119680|NCT03843125|592799184|FG003|Overall Study|Other|4|||
164119681|NCT03843125|592799181|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
164119682|NCT03843125|592799182|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
164119683|NCT03843125|592799183|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
164119684|NCT03843125|592799184|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
164119685|NCT03843125|592799181|FG000|Overall Study|Study Terminated by Sponsor|318|||
164119686|NCT03843125|592799182|FG001|Overall Study|Study Terminated by Sponsor|318|||
164119687|NCT03843125|592799183|FG002|Overall Study|Study Terminated by Sponsor|163|||
164119688|NCT03843125|592799184|FG003|Overall Study|Study Terminated by Sponsor|163|||
164119689|NCT03843125|592799181|FG000|Overall Study|Withdrawal by Subject|23|||
164119690|NCT03843125|592799182|FG001|Overall Study|Withdrawal by Subject|12|||
164119691|NCT03843125|592799183|FG002|Overall Study|Withdrawal by Subject|6|||
164119692|NCT03843125|592799184|FG003|Overall Study|Withdrawal by Subject|9|||
164119693|NCT03843125|592799181|FG000|Overall Study|Missing data|0|||
164119694|NCT03843125|592799182|FG001|Overall Study|Missing data|1|||
164119695|NCT03843125|592799183|FG002|Overall Study|Missing data|1|||
164119696|NCT03843125|592799184|FG003|Overall Study|Missing data|0|||
164119697|NCT01386125|592799185|FG000|Overall Study|Lost to Follow-up|3|||
164119698|NCT01386125|592799186|FG001|Overall Study|Lost to Follow-up|9|||
164119699|NCT01386125|592799185|FG000|Overall Study|Physician Decision|0|||
164119700|NCT01386125|592799186|FG001|Overall Study|Physician Decision|1|||
164119701|NCT01386125|592799185|FG000|Overall Study|Protocol Violation|5|||
164119702|NCT01386125|592799186|FG001|Overall Study|Protocol Violation|7|||
164119703|NCT01386125|592799185|FG000|Overall Study|Disease Progress|1|||
164119704|NCT01386125|592799186|FG001|Overall Study|Disease Progress|2|||
164119705|NCT01386125|592799185|FG000|Overall Study|Withdrawal by Subject|13|||
164119706|NCT01386125|592799186|FG001|Overall Study|Withdrawal by Subject|12|||
164119707|NCT01386125|592799185|FG000|Overall Study|Adverse Event|2|||
164119708|NCT01386125|592799186|FG001|Overall Study|Adverse Event|5|||
164119709|NCT01386125|592799185|FG000|Overall Study|Lack of Efficacy|0|||
164119710|NCT01386125|592799186|FG001|Overall Study|Lack of Efficacy|1|||
164119711|NCT01386125|592799185|FG000|Overall Study|Participant Leaving Country|1|||
164119712|NCT01386125|592799186|FG001|Overall Study|Participant Leaving Country|0|||
164119713|NCT01292837|592799187|FG000|Overall Study|Adverse Event|1|||
164119714|NCT01292837|592799187|FG000|Overall Study|Further treatment determined|1|||
164119715|NCT02359864|592799188|FG000|Overall Study|Withdrawal by Subject|1|||
164119716|NCT02359864|592799189|FG001|Overall Study|Withdrawal by Subject|0|||
164119717|NCT00515216|592799193|FG000|Overall Study|Withdrawal by Subject|1|||
164119718|NCT00605176|592799198|FG000|Overall Study|Adverse Event|2|||
164119719|NCT00605176|592799199|FG001|Overall Study|Adverse Event|1|||
164119720|NCT00605176|592799200|FG002|Overall Study|Adverse Event|3|||
164119721|NCT00605176|592799198|FG000|Overall Study|Withdrawal by Subject|4|||
164119722|NCT00605176|592799199|FG001|Overall Study|Withdrawal by Subject|2|||
164119723|NCT00605176|592799200|FG002|Overall Study|Withdrawal by Subject|4|||
164119724|NCT00605176|592799198|FG000|Overall Study|Lost to Follow-up|2|||
164119725|NCT00605176|592799199|FG001|Overall Study|Lost to Follow-up|2|||
164119726|NCT00605176|592799200|FG002|Overall Study|Lost to Follow-up|1|||
164119727|NCT00605176|592799198|FG000|Overall Study|Non-complicance with study procedures|1|||
164119728|NCT00605176|592799199|FG001|Overall Study|Non-complicance with study procedures|0|||
164119729|NCT00605176|592799200|FG002|Overall Study|Non-complicance with study procedures|0|||
164119730|NCT00605176|592799198|FG000|Overall Study|Use of concomitant therapy|1|||
164119731|NCT00605176|592799199|FG001|Overall Study|Use of concomitant therapy|0|||
164119732|NCT00605176|592799200|FG002|Overall Study|Use of concomitant therapy|1|||
164119733|NCT00605176|592799198|FG000|Overall Study|Other (not due to AE)|1|||
164119734|NCT00605176|592799199|FG001|Overall Study|Other (not due to AE)|1|||
164119735|NCT00605176|592799200|FG002|Overall Study|Other (not due to AE)|0|||
164119736|NCT01086969|592799201|FG000|Overall Study|Withdrawal by Subject|1|||
164119737|NCT01086969|592799202|FG001|Overall Study|Withdrawal by Subject|2|||
164119738|NCT01086969|592799203|FG002|Overall Study|Withdrawal by Subject|0|||
164119739|NCT01609582|592799208|FG000|Overall Study|Adverse Event|20|||
164119740|NCT01609582|592799209|FG001|Overall Study|Adverse Event|18|||
164119741|NCT01609582|592799208|FG000|Overall Study|Lost to Follow-up|10|||
164119742|NCT01609582|592799209|FG001|Overall Study|Lost to Follow-up|10|||
164119743|NCT01609582|592799208|FG000|Overall Study|Withdrawal by Subject|21|||
164119744|NCT01609582|592799209|FG001|Overall Study|Withdrawal by Subject|15|||
164119745|NCT01609582|592799208|FG000|Overall Study|Study Terminated by Sponsor|1543|||
164119746|NCT01609582|592799209|FG001|Overall Study|Study Terminated by Sponsor|1548|||
164119747|NCT01609582|592799208|FG000|Overall Study|Other|9|||
164119748|NCT01609582|592799209|FG001|Overall Study|Other|10|||
164119749|NCT01609582|592799208|FG000|Overall Study|Randomized, but not treated|0|||
164119750|NCT01609582|592799209|FG001|Overall Study|Randomized, but not treated|3|||
164119751|NCT00685750|592799210|FG000|Overall Study|Tumor sampling failure|0|||
164119752|NCT00685750|592799211|FG001|Overall Study|Tumor sampling failure|0|||
164119753|NCT00685750|592799212|FG002|Overall Study|Tumor sampling failure|1|||
164119754|NCT00685750|592799213|FG003|Overall Study|Tumor sampling failure|0|||
164119755|NCT00685750|592799214|FG004|Overall Study|Tumor sampling failure|0|||
164119756|NCT00685750|592799215|FG005|Overall Study|Tumor sampling failure|0|||
164119757|NCT00685750|592799216|FG006|Overall Study|Tumor sampling failure|0|||
164119758|NCT00685750|592799210|FG000|Overall Study|Patient didn't receive the treatment|0|||
164119759|NCT00685750|592799211|FG001|Overall Study|Patient didn't receive the treatment|0|||
164119760|NCT00685750|592799212|FG002|Overall Study|Patient didn't receive the treatment|0|||
164119761|NCT00685750|592799213|FG003|Overall Study|Patient didn't receive the treatment|0|||
164119762|NCT00685750|592799214|FG004|Overall Study|Patient didn't receive the treatment|0|||
164119763|NCT00685750|592799215|FG005|Overall Study|Patient didn't receive the treatment|0|||
164119764|NCT00685750|592799216|FG006|Overall Study|Patient didn't receive the treatment|1|||
164119765|NCT00685750|592799210|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164119766|NCT00685750|592799211|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164119767|NCT00685750|592799212|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164119768|NCT00685750|592799213|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
164119769|NCT00685750|592799214|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
164119770|NCT00685750|592799215|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
164119771|NCT00685750|592799216|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
164119772|NCT04974580|592799219|FG000|Overall Study|Lost to Follow-up|33|||
164119773|NCT04974580|592799220|FG001|Overall Study|Lost to Follow-up|39|||
164119774|NCT04974580|592799221|FG002|Overall Study|Lost to Follow-up|30|||
164119775|NCT04974580|592799222|FG003|Overall Study|Lost to Follow-up|29|||
164119776|NCT00220727|592799235|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
164119777|NCT00220727|592799236|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
164119778|NCT02508116|592799237|FG000|Overall Study|Lost to Follow-up|2|||
164119779|NCT02508116|592799238|FG001|Overall Study|Lost to Follow-up|3|||
164119780|NCT02508116|592799237|FG000|Overall Study|Withdrawal by Subject|3|||
164119781|NCT02508116|592799238|FG001|Overall Study|Withdrawal by Subject|2|||
164119782|NCT02508116|592799237|FG000|Overall Study|Protocol Violation|1|||
164119783|NCT02508116|592799238|FG001|Overall Study|Protocol Violation|2|||
164119784|NCT02508116|592799237|FG000|Overall Study|Physician Decision|2|||
164119785|NCT02508116|592799238|FG001|Overall Study|Physician Decision|0|||
164119786|NCT00109850|592799239|FG000|Overall Study|Adverse Event|1|||
164119787|NCT00109850|592799239|FG000|Overall Study|Death|2|||
164119788|NCT00109850|592799239|FG000|Overall Study|Ineligible|1|||
164119789|NCT00239005|592799246|FG000|Overall Study|Adverse Event|6|||
164119790|NCT00239005|592799247|FG001|Overall Study|Adverse Event|6|||
164119791|NCT00239005|592799246|FG000|Overall Study|Withdrawal by Subject|3|||
164119792|NCT00239005|592799247|FG001|Overall Study|Withdrawal by Subject|4|||
164119793|NCT00239005|592799246|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
164119794|NCT00239005|592799247|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
164119795|NCT00239005|592799246|FG000|Overall Study|Protocol Violation|1|||
164119796|NCT00239005|592799247|FG001|Overall Study|Protocol Violation|0|||
164119797|NCT00239005|592799246|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
164119798|NCT00239005|592799247|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
164119799|NCT00239005|592799246|FG000|Overall Study|Lost to Follow-up|0|||
164119800|NCT00239005|592799247|FG001|Overall Study|Lost to Follow-up|1|||
164119801|NCT00987831|592799249|FG000|Overall Study|Never flared in 12 months|1|||
164119802|NCT00987831|592799250|FG001|Overall Study|Never flared in 12 months|0|||
164119803|NCT00987831|592799251|FG002|Overall Study|Never flared in 12 months|0|||
164119804|NCT00987831|592799249|FG000|Overall Study|Lost to Follow-up|0|||
164119805|NCT00987831|592799250|FG001|Overall Study|Lost to Follow-up|3|||
164119806|NCT00987831|592799251|FG002|Overall Study|Lost to Follow-up|0|||
164119807|NCT03253094|592799252|FG000|Overall Study|Adverse Event|2|||
164119808|NCT03253094|592799253|FG001|Overall Study|Adverse Event|0|||
164119809|NCT03253094|592799254|FG002|Overall Study|Adverse Event|0|||
164119810|NCT03253094|592799255|FG003|Overall Study|Adverse Event|0|||
164119811|NCT03253094|592799256|FG004|Overall Study|Adverse Event|0|||
164119812|NCT03253094|592799257|FG005|Overall Study|Adverse Event|0|||
164119813|NCT03253094|592799252|FG000|Overall Study|Lack of Efficacy|0|||
164119814|NCT03253094|592799253|FG001|Overall Study|Lack of Efficacy|0|||
164119815|NCT03253094|592799254|FG002|Overall Study|Lack of Efficacy|2|||
164119816|NCT03253094|592799255|FG003|Overall Study|Lack of Efficacy|1|||
164119817|NCT03253094|592799256|FG004|Overall Study|Lack of Efficacy|2|||
164119818|NCT03253094|592799257|FG005|Overall Study|Lack of Efficacy|1|||
164119819|NCT03253094|592799252|FG000|Overall Study|Lost to Follow-up|0|||
164119820|NCT03253094|592799253|FG001|Overall Study|Lost to Follow-up|0|||
164119821|NCT03253094|592799254|FG002|Overall Study|Lost to Follow-up|1|||
164119822|NCT03253094|592799255|FG003|Overall Study|Lost to Follow-up|1|||
164119823|NCT03253094|592799256|FG004|Overall Study|Lost to Follow-up|0|||
164119824|NCT03253094|592799257|FG005|Overall Study|Lost to Follow-up|1|||
164119825|NCT03253094|592799252|FG000|Overall Study|Physician Decision|1|||
164119826|NCT03253094|592799253|FG001|Overall Study|Physician Decision|0|||
164119827|NCT03253094|592799254|FG002|Overall Study|Physician Decision|0|||
164119828|NCT03253094|592799255|FG003|Overall Study|Physician Decision|1|||
164119829|NCT03253094|592799256|FG004|Overall Study|Physician Decision|0|||
164119830|NCT03253094|592799257|FG005|Overall Study|Physician Decision|2|||
164119831|NCT03253094|592799252|FG000|Overall Study|Withdrawal by Subject|1|||
164119832|NCT03253094|592799253|FG001|Overall Study|Withdrawal by Subject|2|||
164119833|NCT03253094|592799254|FG002|Overall Study|Withdrawal by Subject|1|||
164119834|NCT03253094|592799255|FG003|Overall Study|Withdrawal by Subject|0|||
164119835|NCT03253094|592799256|FG004|Overall Study|Withdrawal by Subject|3|||
164119836|NCT03253094|592799257|FG005|Overall Study|Withdrawal by Subject|0|||
164119837|NCT03253094|592799252|FG000|Overall Study|Other|0|||
164119838|NCT03253094|592799253|FG001|Overall Study|Other|1|||
164119839|NCT03253094|592799254|FG002|Overall Study|Other|2|||
164119840|NCT03253094|592799255|FG003|Overall Study|Other|1|||
164119841|NCT03253094|592799256|FG004|Overall Study|Other|0|||
164119842|NCT03253094|592799257|FG005|Overall Study|Other|0|||
164119843|NCT00824369|592799258|FG000|Overall Study|Nolonger willing to participate in study|1|||
164119844|NCT00824369|592799259|FG001|Overall Study|Nolonger willing to participate in study|0|||
164119845|NCT00824369|592799260|FG002|Overall Study|Nolonger willing to participate in study|1|||
164119846|NCT00824369|592799261|FG003|Overall Study|Nolonger willing to participate in study|2|||
164119847|NCT00824369|592799262|FG004|Overall Study|Nolonger willing to participate in study|0|||
164119848|NCT00824369|592799263|FG005|Overall Study|Nolonger willing to participate in study|1|||
164119849|NCT00824369|592799258|FG000|Overall Study|Lost to Follow-up|0|||
164119850|NCT00824369|592799259|FG001|Overall Study|Lost to Follow-up|0|||
164119851|NCT00824369|592799260|FG002|Overall Study|Lost to Follow-up|0|||
164119852|NCT00824369|592799261|FG003|Overall Study|Lost to Follow-up|0|||
164119853|NCT00824369|592799262|FG004|Overall Study|Lost to Follow-up|1|||
164119854|NCT00824369|592799263|FG005|Overall Study|Lost to Follow-up|0|||
164119855|NCT02413294|592799264|FG000|Overall Study|Withdrawal by Subject|1|||
164119856|NCT02625974|592799265|FG000|Part 1|Lost to Follow-up|9|||
164119857|NCT02625974|592799266|FG001|Part 1|Lost to Follow-up|3|||
164119858|NCT02625974|592799265|FG000|Part 2|Lost to Follow-up|4|||
164119859|NCT02625974|592799266|FG001|Part 2|Lost to Follow-up|6|||
164119860|NCT02625974|592799265|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
164119861|NCT02625974|592799266|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
164119862|NCT03941834|592800696|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
164119863|NCT03941834|592800697|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
164119864|NCT03941834|592800698|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
164119865|NCT03941834|592800696|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
164119866|NCT03941834|592800697|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
164119867|NCT03941834|592800698|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
164119868|NCT03941834|592800696|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
164119869|NCT03941834|592800697|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
164119870|NCT03941834|592800698|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
164119871|NCT03941834|592800696|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
164119872|NCT03941834|592800697|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
164119873|NCT03941834|592800698|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
164119874|NCT03941834|592800696|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
164119875|NCT03941834|592800697|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
164119876|NCT03941834|592800698|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
164119877|NCT03941834|592800696|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
164119878|NCT03941834|592800697|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
164119879|NCT03941834|592800698|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
164119880|NCT00802178|592800701|FG000|Overall Study|Lack of Efficacy|36|||
164119881|NCT00802178|592800701|FG000|Overall Study|Insufficient tolerability (IT)|17|||
164119882|NCT00802178|592800701|FG000|Overall Study|Withdrawal by Subject|18|||
164119883|NCT00802178|592800701|FG000|Overall Study|Other|32|||
164119884|NCT00802178|592800701|FG000|Overall Study|Lack of efficacy and patient wish|1|||
164119885|NCT00802178|592800701|FG000|Overall Study|IT and patient wish|8|||
164119886|NCT00802178|592800701|FG000|Overall Study|Patients wish and other reason|1|||
164119887|NCT01606228|592800702|FG000|Overall Study|Lost to Follow-up|20|||
164119888|NCT01606228|592800702|FG000|Overall Study|Withdrawal by Subject|3|||
164119889|NCT01606228|592800702|FG000|Overall Study|Non-compliant|3|||
164119890|NCT01606228|592800702|FG000|Overall Study|Lack of Efficacy|2|||
164119891|NCT01606228|592800702|FG000|Overall Study|Adverse Event|1|||
164119892|NCT01115855|592800703|FG000|Overall Study|Adverse Event|16|||
164119893|NCT01115855|592800704|FG001|Overall Study|Adverse Event|18|||
164119894|NCT01115855|592800703|FG000|Overall Study|Death|6|||
164119895|NCT01115855|592800704|FG001|Overall Study|Death|5|||
164119896|NCT01115855|592800703|FG000|Overall Study|Lab Abnormality|1|||
164119897|NCT01115855|592800704|FG001|Overall Study|Lab Abnormality|1|||
164119898|NCT01115855|592800703|FG000|Overall Study|Protocol Violation|0|||
164119899|NCT01115855|592800704|FG001|Overall Study|Protocol Violation|1|||
164119900|NCT01115855|592800703|FG000|Overall Study|Withdrawal by Subject|5|||
164119901|NCT01115855|592800704|FG001|Overall Study|Withdrawal by Subject|5|||
164119902|NCT01115855|592800703|FG000|Overall Study|Other|8|||
164119903|NCT01115855|592800704|FG001|Overall Study|Other|6|||
164119904|NCT04100096|592800705|FG000|Overall Study|Adverse Event|19|||
164119905|NCT04100096|592800706|FG001|Overall Study|Adverse Event|7|||
164119906|NCT04100096|592800705|FG000|Overall Study|Lack of Efficacy|0|||
164119907|NCT04100096|592800706|FG001|Overall Study|Lack of Efficacy|1|||
164119908|NCT04100096|592800705|FG000|Overall Study|Lost to Follow-up|13|||
164119909|NCT04100096|592800706|FG001|Overall Study|Lost to Follow-up|11|||
164119910|NCT04100096|592800705|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164119911|NCT04100096|592800706|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164119912|NCT04100096|592800705|FG000|Overall Study|Protocol Deviation|1|||
164119913|NCT04100096|592800706|FG001|Overall Study|Protocol Deviation|1|||
164119914|NCT04100096|592800705|FG000|Overall Study|Withdrawal by Participant|13|||
164119915|NCT04100096|592800706|FG001|Overall Study|Withdrawal by Participant|15|||
164119916|NCT01684215|592800707|FG000|Phase 1, Part 1|Adverse Event|1|||
164119917|NCT01684215|592800708|FG001|Phase 1, Part 1|Adverse Event|0|||
164119918|NCT01684215|592800709|FG002|Phase 1, Part 1|Adverse Event|0|||
164119919|NCT01684215|592800710|FG003|Phase 1, Part 1|Adverse Event|0|||
164119920|NCT01684215|592800707|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
164119921|NCT01684215|592800708|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
164119922|NCT01684215|592800709|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
164119923|NCT01684215|592800710|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
164119924|NCT01684215|592800707|FG000|Phase 1, Part 2|Adverse Event|0|||
164119925|NCT01684215|592800708|FG001|Phase 1, Part 2|Adverse Event|0|||
164119926|NCT01684215|592800709|FG002|Phase 1, Part 2|Adverse Event|1|||
164119927|NCT01684215|592800710|FG003|Phase 1, Part 2|Adverse Event|0|||
164119928|NCT01684215|592800707|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
164119929|NCT01684215|592800708|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
164119930|NCT01684215|592800709|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
164119931|NCT01684215|592800710|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
164119932|NCT01684215|592800707|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
164119933|NCT01684215|592800708|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
164119934|NCT01684215|592800709|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
164119935|NCT01684215|592800710|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
164119936|NCT01684215|592800707|FG000|Phase 2|Death|0|||
164119937|NCT01684215|592800708|FG001|Phase 2|Death|0|||
164119938|NCT01684215|592800709|FG002|Phase 2|Death|0|||
164119939|NCT01684215|592800710|FG003|Phase 2|Death|8|||
164119940|NCT01684215|592800707|FG000|Phase 2|Study terminated by sponsor|0|||
164119941|NCT01684215|592800708|FG001|Phase 2|Study terminated by sponsor|0|||
164119942|NCT01684215|592800709|FG002|Phase 2|Study terminated by sponsor|0|||
164119943|NCT01684215|592800710|FG003|Phase 2|Study terminated by sponsor|30|||
164119944|NCT01684215|592800707|FG000|Phase 2|Enrolled but not treated|0|||
164119945|NCT01684215|592800708|FG001|Phase 2|Enrolled but not treated|0|||
164119946|NCT01684215|592800709|FG002|Phase 2|Enrolled but not treated|0|||
164119947|NCT01684215|592800710|FG003|Phase 2|Enrolled but not treated|1|||
164119948|NCT01684215|592800707|FG000|Phase 2|Lost to Follow-up|0|||
164119949|NCT01684215|592800708|FG001|Phase 2|Lost to Follow-up|0|||
164119950|NCT01684215|592800709|FG002|Phase 2|Lost to Follow-up|0|||
164119951|NCT01684215|592800710|FG003|Phase 2|Lost to Follow-up|4|||
164119952|NCT00784134|592800711|FG000|Overall Study|Lost to Follow-up|3|||
164119953|NCT00784134|592800712|FG001|Overall Study|Lost to Follow-up|6|||
164119954|NCT03785145|592800713|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
164119955|NCT03785145|592800714|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
164119956|NCT03785145|592800713|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
164119957|NCT03785145|592800714|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
164119958|NCT03785145|592800713|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
164119959|NCT03785145|592800714|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
164119960|NCT03785145|592800713|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
164119961|NCT03785145|592800714|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
164119962|NCT03785145|592800713|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
164119963|NCT03785145|592800714|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
164119964|NCT03785145|592800713|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
164119965|NCT03785145|592800714|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
164119966|NCT03785145|592800713|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
164119967|NCT03785145|592800714|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
164119968|NCT03785145|592800713|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
164119969|NCT03785145|592800714|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
164119970|NCT03785145|592800713|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
164119971|NCT03785145|592800714|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
164119972|NCT03785145|592800713|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
164119973|NCT03785145|592800714|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
164119974|NCT03785145|592800713|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
164119975|NCT03785145|592800714|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
164119976|NCT01124695|592800718|FG000|Overall Study|Disease progression|77|||
164119977|NCT01124695|592800718|FG000|Overall Study|Adverse Event|11|||
164119978|NCT01124695|592800718|FG000|Overall Study|Death|1|||
164119979|NCT01124695|592800718|FG000|Overall Study|Withdrawal by Subject|7|||
164119980|NCT01124695|592800718|FG000|Overall Study|Physician Decision|3|||
164119981|NCT01124695|592800718|FG000|Overall Study|Alternative therapy|9|||
164119982|NCT01124695|592800718|FG000|Overall Study|No documentation that patient went off treatment|4|||
164119983|NCT01124695|592800718|FG000|Overall Study|Ineligible|9|||
164119984|NCT01124695|592800718|FG000|Overall Study|Ineligible and never start treatment|2|||
164119985|NCT00097786|592800719|FG000|Overall Study|lost to follow-up for all-cause death|296|||
164119986|NCT00097786|592800720|FG001|Overall Study|lost to follow-up for all-cause death|292|||
164119987|NCT00097786|592800721|FG002|Overall Study|lost to follow-up for all-cause death|313|||
164119988|NCT00097786|592800722|FG003|Overall Study|lost to follow-up for all-cause death|310|||
164119989|NCT02668822|592800723|FG000|Overall Study|Protocol Violation|2|||
164119990|NCT02668822|592800724|FG001|Overall Study|Protocol Violation|0|||
164119991|NCT02668822|592800723|FG000|Overall Study|Study Terminated by Sponsor|7|||
164119992|NCT02668822|592800724|FG001|Overall Study|Study Terminated by Sponsor|9|||
164119993|NCT01647711|592800727|FG000|Overall Study|Progressive disease|6|||
164119994|NCT01647711|592800728|FG001|Overall Study|Progressive disease|2|||
164119995|NCT01647711|592800729|FG002|Overall Study|Progressive disease|6|||
164119996|NCT01647711|592800730|FG003|Overall Study|Progressive disease|8|||
164119997|NCT01647711|592800731|FG004|Overall Study|Progressive disease|2|||
164119998|NCT01647711|592800727|FG000|Overall Study|Other adverse event|0|||
164119999|NCT01647711|592800728|FG001|Overall Study|Other adverse event|0|||
164120000|NCT01647711|592800729|FG002|Overall Study|Other adverse event|2|||
164120001|NCT01647711|592800730|FG003|Overall Study|Other adverse event|0|||
164120002|NCT01647711|592800731|FG004|Overall Study|Other adverse event|2|||
164120003|NCT01647711|592800727|FG000|Overall Study|Protocol Violation|0|||
164120004|NCT01647711|592800728|FG001|Overall Study|Protocol Violation|0|||
164120005|NCT01647711|592800729|FG002|Overall Study|Protocol Violation|0|||
164120006|NCT01647711|592800730|FG003|Overall Study|Protocol Violation|0|||
164120007|NCT01647711|592800731|FG004|Overall Study|Protocol Violation|1|||
164120008|NCT01647711|592800727|FG000|Overall Study|Refused to continue taking medication|0|||
164120009|NCT01647711|592800728|FG001|Overall Study|Refused to continue taking medication|0|||
164120010|NCT01647711|592800729|FG002|Overall Study|Refused to continue taking medication|0|||
164120011|NCT01647711|592800730|FG003|Overall Study|Refused to continue taking medication|2|||
164120012|NCT01647711|592800731|FG004|Overall Study|Refused to continue taking medication|1|||
164120013|NCT01647711|592800727|FG000|Overall Study|Other reason not defined|0|||
164120014|NCT01647711|592800728|FG001|Overall Study|Other reason not defined|1|||
164132675|NCT01986010|592850671|FG016|Overall Study|Adverse Event|0|||
164120015|NCT01647711|592800729|FG002|Overall Study|Other reason not defined|1|||
164120016|NCT01647711|592800730|FG003|Overall Study|Other reason not defined|1|||
164120017|NCT01647711|592800731|FG004|Overall Study|Other reason not defined|0|||
164120018|NCT01796964|592800734|FG000|Overall Study|Adverse Event|1|||
164120019|NCT01796964|592800735|FG001|Overall Study|Adverse Event|1|||
164120020|NCT01796964|592800734|FG000|Overall Study|Death|1|||
164120021|NCT01796964|592800735|FG001|Overall Study|Death|0|||
164120022|NCT01796964|592800734|FG000|Overall Study|Protocol Violation|0|||
164120023|NCT01796964|592800735|FG001|Overall Study|Protocol Violation|1|||
164120024|NCT01796964|592800734|FG000|Overall Study|Withdrawal by Subject|1|||
164120025|NCT01796964|592800735|FG001|Overall Study|Withdrawal by Subject|1|||
164120026|NCT04025684|592800736|FG000|Overall Study|Withdrawal by Subject|1|||
164120027|NCT04025684|592800737|FG001|Overall Study|Withdrawal by Subject|1|||
164120028|NCT04025684|592800738|FG002|Overall Study|Withdrawal by Subject|0|||
164120029|NCT04025684|592800739|FG003|Overall Study|Withdrawal by Subject|0|||
164120030|NCT04025684|592800736|FG000|Overall Study|Multiple reasons|1|||
164120031|NCT04025684|592800737|FG001|Overall Study|Multiple reasons|3|||
164120032|NCT04025684|592800738|FG002|Overall Study|Multiple reasons|0|||
164120033|NCT04025684|592800739|FG003|Overall Study|Multiple reasons|1|||
164120034|NCT00868296|592800740|FG000|Overall Study|Adverse Event|0|||
164120035|NCT00868296|592800741|FG001|Overall Study|Adverse Event|2|||
164120036|NCT00868296|592800740|FG000|Overall Study|Withdrawal by Subject|0|||
164120037|NCT00868296|592800741|FG001|Overall Study|Withdrawal by Subject|1|||
164120038|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
164120039|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
164120040|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
164120041|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
164120042|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
164120043|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
164120044|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164120045|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
164120046|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
164120047|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
164120048|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164120049|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164120050|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
164120051|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
164120052|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164120053|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164120054|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Death|2|||
164120055|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Death|1|||
164120056|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Death|0|||
164120057|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Death|0|||
164120058|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
164120059|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
164120060|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
164120061|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
164120062|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
164120063|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164120064|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164120065|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
164120066|NCT03110380|592800742|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
164120067|NCT03110380|592800743|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
164120068|NCT03110380|592800744|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
164120069|NCT03110380|592800745|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
164120070|NCT03110380|592800742|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164120071|NCT03110380|592800743|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
164120072|NCT03110380|592800744|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
164120073|NCT03110380|592800745|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
164120074|NCT03110380|592800742|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
164120075|NCT03110380|592800743|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
164120076|NCT03110380|592800744|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
164120077|NCT03110380|592800745|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
164120078|NCT03110380|592800742|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
164120079|NCT03110380|592800743|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
164120080|NCT03110380|592800744|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
164120081|NCT03110380|592800745|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
164120082|NCT01206439|592800748|FG000|Overall Study|subject did not meet inclusion criteria|1|||
164120083|NCT05889039|592800750|FG000|Overall Study|error in completing survey|0|||
164120084|NCT05889039|592800751|FG001|Overall Study|error in completing survey|2|||
164120085|NCT05889039|592800752|FG002|Overall Study|error in completing survey|0|||
164120086|NCT05889039|592800753|FG003|Overall Study|error in completing survey|0|||
164120087|NCT05889039|592800750|FG000|Overall Study|Lost to Follow-up|4|||
164120088|NCT05889039|592800751|FG001|Overall Study|Lost to Follow-up|0|||
164120089|NCT05889039|592800752|FG002|Overall Study|Lost to Follow-up|0|||
164120090|NCT05889039|592800753|FG003|Overall Study|Lost to Follow-up|0|||
164120091|NCT02795676|592800754|FG000|Overall Study|Adverse Event|2|||
164120092|NCT02795676|592800755|FG001|Overall Study|Adverse Event|0|||
164120093|NCT02795676|592800754|FG000|Overall Study|Withdrawal by Subject|3|||
164120094|NCT02795676|592800755|FG001|Overall Study|Withdrawal by Subject|1|||
164120095|NCT01115933|592800758|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
164120096|NCT00819767|592800759|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164120097|NCT00819767|592800760|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
164120098|NCT04234464|592800781|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
164120099|NCT04234464|592800782|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
164120100|NCT00476593|592800783|FG000|Overall Study|Lost to Follow-up|10|||
164120101|NCT00476593|592800784|FG001|Overall Study|Lost to Follow-up|2|||
164120102|NCT00476593|592800785|FG002|Overall Study|Lost to Follow-up|8|||
164120103|NCT00476593|592800786|FG003|Overall Study|Lost to Follow-up|22|||
164120104|NCT03430011|592800787|FG000|Pre-Treatment|Death|1|||
164120105|NCT03430011|592800788|FG001|Pre-Treatment|Death|0|||
164120106|NCT03430011|592800789|FG002|Pre-Treatment|Death|0|||
164120107|NCT03430011|592800790|FG003|Pre-Treatment|Death|0|||
164120108|NCT03430011|592800791|FG004|Pre-Treatment|Death|1|||
164120109|NCT03430011|592800792|FG005|Pre-Treatment|Death|0|||
164120110|NCT03430011|592800793|FG006|Pre-Treatment|Death|1|||
164120111|NCT03430011|592800794|FG007|Pre-Treatment|Death|0|||
164120112|NCT03430011|592800787|FG000|Pre-Treatment|Screen Fail|0|||
164120113|NCT03430011|592800788|FG001|Pre-Treatment|Screen Fail|0|||
164120114|NCT03430011|592800789|FG002|Pre-Treatment|Screen Fail|0|||
164120115|NCT03430011|592800790|FG003|Pre-Treatment|Screen Fail|0|||
164120116|NCT03430011|592800791|FG004|Pre-Treatment|Screen Fail|1|||
164120117|NCT03430011|592800792|FG005|Pre-Treatment|Screen Fail|0|||
164120118|NCT03430011|592800793|FG006|Pre-Treatment|Screen Fail|0|||
164120119|NCT03430011|592800794|FG007|Pre-Treatment|Screen Fail|0|||
164120120|NCT03430011|592800787|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120121|NCT03430011|592800788|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120122|NCT03430011|592800789|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
164120123|NCT03430011|592800790|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120124|NCT03430011|592800791|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120125|NCT03430011|592800792|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120126|NCT03430011|592800793|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120127|NCT03430011|592800794|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
164120128|NCT03430011|592800787|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
164120129|NCT03430011|592800788|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
164120130|NCT03430011|592800789|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
164120131|NCT03430011|592800790|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
164120132|NCT03430011|592800791|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
164120133|NCT03430011|592800792|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
164120134|NCT03430011|592800793|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
164120135|NCT03430011|592800794|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
164120136|NCT03430011|592800787|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
164120137|NCT03430011|592800788|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
164120138|NCT03430011|592800789|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
164120139|NCT03430011|592800790|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
164120140|NCT03430011|592800791|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
164120141|NCT03430011|592800792|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
164120142|NCT03430011|592800793|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
164120143|NCT03430011|592800794|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
164120144|NCT03430011|592800787|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
164120145|NCT03430011|592800788|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
164120146|NCT03430011|592800789|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
164120147|NCT03430011|592800790|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
164120148|NCT03430011|592800791|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
164120149|NCT03430011|592800792|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
164120150|NCT03430011|592800793|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
164120151|NCT03430011|592800794|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
164120152|NCT03430011|592800787|FG000|JCARH125 Treatment|Death|4|||
164120153|NCT03430011|592800788|FG001|JCARH125 Treatment|Death|19|||
164120154|NCT03430011|592800789|FG002|JCARH125 Treatment|Death|10|||
164120155|NCT03430011|592800790|FG003|JCARH125 Treatment|Death|8|||
164120156|NCT03430011|592800791|FG004|JCARH125 Treatment|Death|5|||
164120157|NCT03430011|592800792|FG005|JCARH125 Treatment|Death|3|||
164120158|NCT03430011|592800793|FG006|JCARH125 Treatment|Death|4|||
164120159|NCT03430011|592800794|FG007|JCARH125 Treatment|Death|2|||
164120160|NCT03430011|592800787|FG000|JCARH125 Treatment|Other reasons|1|||
164120161|NCT03430011|592800788|FG001|JCARH125 Treatment|Other reasons|0|||
164120162|NCT03430011|592800789|FG002|JCARH125 Treatment|Other reasons|4|||
164120163|NCT03430011|592800790|FG003|JCARH125 Treatment|Other reasons|2|||
164120164|NCT03430011|592800791|FG004|JCARH125 Treatment|Other reasons|2|||
164120165|NCT03430011|592800792|FG005|JCARH125 Treatment|Other reasons|1|||
164120166|NCT03430011|592800793|FG006|JCARH125 Treatment|Other reasons|3|||
164120167|NCT03430011|592800794|FG007|JCARH125 Treatment|Other reasons|2|||
164120168|NCT00559364|592800796|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
164120169|NCT00559364|592800797|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
164120170|NCT04126343|592800798|FG000|Overall Study|Adverse Event|0|||
164120171|NCT04126343|592800799|FG001|Overall Study|Adverse Event|0|||
164120172|NCT04126343|592800800|FG002|Overall Study|Adverse Event|0|||
164120173|NCT04126343|592800801|FG003|Overall Study|Adverse Event|0|||
164120174|NCT04126343|592800802|FG004|Overall Study|Adverse Event|0|||
164120175|NCT04126343|592800803|FG005|Overall Study|Adverse Event|1|||
164120176|NCT04126343|592800798|FG000|Overall Study|Withdrawal by Subject|0|||
164120177|NCT04126343|592800799|FG001|Overall Study|Withdrawal by Subject|0|||
164120178|NCT04126343|592800800|FG002|Overall Study|Withdrawal by Subject|0|||
164120179|NCT04126343|592800801|FG003|Overall Study|Withdrawal by Subject|1|||
164120180|NCT04126343|592800802|FG004|Overall Study|Withdrawal by Subject|0|||
164120181|NCT04126343|592800803|FG005|Overall Study|Withdrawal by Subject|0|||
164120182|NCT04126343|592800798|FG000|Overall Study|Related to COVID-19 pandemic|3|||
164120183|NCT04126343|592800799|FG001|Overall Study|Related to COVID-19 pandemic|4|||
164120184|NCT04126343|592800800|FG002|Overall Study|Related to COVID-19 pandemic|3|||
164120185|NCT04126343|592800801|FG003|Overall Study|Related to COVID-19 pandemic|3|||
164120186|NCT04126343|592800802|FG004|Overall Study|Related to COVID-19 pandemic|3|||
164120187|NCT04126343|592800803|FG005|Overall Study|Related to COVID-19 pandemic|3|||
164120188|NCT01235442|592800804|FG000|Overall Study|Lost to Follow-up|12|||
164120189|NCT01235442|592800805|FG001|Overall Study|Lost to Follow-up|10|||
164120190|NCT01235442|592800804|FG000|Overall Study|Death|0|||
164120191|NCT01235442|592800805|FG001|Overall Study|Death|2|||
164120192|NCT01235442|592800804|FG000|Overall Study|Pregnancy|1|||
164120193|NCT01235442|592800805|FG001|Overall Study|Pregnancy|1|||
164120194|NCT01235442|592800804|FG000|Overall Study|Ineligibility determined|5|||
164120195|NCT01235442|592800805|FG001|Overall Study|Ineligibility determined|4|||
164120196|NCT01235442|592800804|FG000|Overall Study|Protocol Violation|3|||
164120197|NCT01235442|592800805|FG001|Overall Study|Protocol Violation|3|||
164120198|NCT01235442|592800804|FG000|Overall Study|Adverse Event|4|||
164120199|NCT01235442|592800805|FG001|Overall Study|Adverse Event|6|||
164120200|NCT01235442|592800804|FG000|Overall Study|Withdrawal by Subject|15|||
164120201|NCT01235442|592800805|FG001|Overall Study|Withdrawal by Subject|9|||
164120202|NCT01235442|592800804|FG000|Overall Study|Lack of Efficacy|1|||
164120203|NCT01235442|592800805|FG001|Overall Study|Lack of Efficacy|3|||
164120204|NCT01235442|592800804|FG000|Overall Study|Noncompliance|1|||
164120205|NCT01235442|592800805|FG001|Overall Study|Noncompliance|2|||
164120206|NCT01235442|592800804|FG000|Overall Study|Administrative decision|1|||
164120207|NCT01235442|592800805|FG001|Overall Study|Administrative decision|2|||
164120208|NCT01235442|592800804|FG000|Overall Study|Other unspecified|1|||
164120209|NCT01235442|592800805|FG001|Overall Study|Other unspecified|2|||
164120210|NCT01857973|592800810|FG000|Overall Study|Subject did not meet required BG range|3|||
164120211|NCT01857973|592800810|FG000|Overall Study|drop out after 3 failed attempts|1|||
164120212|NCT01857973|592800810|FG000|Overall Study|Physician Decision|1|||
164120213|NCT01701973|592800813|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120214|NCT01701973|592800814|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
164120215|NCT01701973|592800815|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120216|NCT01701973|592800816|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120217|NCT01701973|592800817|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120218|NCT01701973|592800818|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120219|NCT01701973|592800819|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120220|NCT01701973|592800820|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
164120221|NCT02663882|592800821|FG000|Overall Study|Lost to Follow-up|4|||
164120222|NCT02663882|592800822|FG001|Overall Study|Lost to Follow-up|2|||
164120223|NCT03712124|592800823|FG000|Overall Study|Protocol Violation|1|||
164120224|NCT03712124|592800824|FG001|Overall Study|Protocol Violation|0|||
164120225|NCT00602537|592800826|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
164120226|NCT00602537|592800827|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
164120227|NCT00602537|592800826|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
164120228|NCT00602537|592800827|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
164120229|NCT00602537|592800826|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
164120230|NCT00602537|592800827|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
164120231|NCT00602537|592800826|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
164120232|NCT00602537|592800827|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
164120233|NCT00602537|592800826|FG000|Follow Up Study Comparison|Adverse Event|1|||
164120234|NCT00602537|592800827|FG001|Follow Up Study Comparison|Adverse Event|0|||
164120235|NCT00602537|592800826|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
164120236|NCT00602537|592800827|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
164120237|NCT00602537|592800826|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
164120238|NCT00602537|592800827|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
164120239|NCT00388037|592800830|FG000|Overall Study|Protocol Violation|1|||
164120240|NCT02941523|592800831|FG000|Monotherapy|Withdrawal by Subject|0|||
164120241|NCT02941523|592800832|FG001|Monotherapy|Withdrawal by Subject|1|||
164120242|NCT02941523|592800831|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
164120243|NCT02941523|592800832|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
164120244|NCT02941523|592800831|FG000|Carboplatin Combination Therapy|Death|1|||
164120245|NCT02941523|592800832|FG001|Carboplatin Combination Therapy|Death|2|||
164120246|NCT02941523|592800831|FG000|Carboplatin Combination Therapy|Disease progression|2|||
164120247|NCT02941523|592800832|FG001|Carboplatin Combination Therapy|Disease progression|0|||
164120248|NCT02941523|592800831|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
164120249|NCT02941523|592800832|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
164120250|NCT04330157|592800833|FG000|Overall Study|Protocol Violation|4|||
164120251|NCT04330157|592800833|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
164120252|NCT04314843|592800834|FG000|Overall Study|Death|2|||
164120253|NCT04314843|592800835|FG001|Overall Study|Death|2|||
164120254|NCT04314843|592800834|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
164120255|NCT04314843|592800835|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
164120256|NCT00869440|592800836|FG000|Overall Study|Withdrawal by Subject|1|||
164120257|NCT00869440|592800837|FG001|Overall Study|Withdrawal by Subject|0|||
164120258|NCT00869440|592800838|FG002|Overall Study|Withdrawal by Subject|0|||
164120259|NCT00869440|592800839|FG003|Overall Study|Withdrawal by Subject|0|||
164120260|NCT00869440|592800836|FG000|Overall Study|Physician Decision|1|||
164120261|NCT00869440|592800837|FG001|Overall Study|Physician Decision|1|||
164120262|NCT00869440|592800838|FG002|Overall Study|Physician Decision|0|||
164120263|NCT00869440|592800839|FG003|Overall Study|Physician Decision|0|||
164120264|NCT01899326|592800841|FG000|Overall Study|Withdrawal by Subject|1|||
164120265|NCT01899326|592800841|FG000|Overall Study|Adverse Event|2|||
164120266|NCT01899326|592800841|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
164120267|NCT00104247|592800842|FG000|Overall Study|Withdrawal by Subject|1|||
164120268|NCT00104247|592800843|FG001|Overall Study|Withdrawal by Subject|0|||
164120269|NCT00104247|592800842|FG000|Overall Study|Noncompliant with dosing|0|||
164120270|NCT00104247|592800843|FG001|Overall Study|Noncompliant with dosing|1|||
164120271|NCT01378962|592800844|FG000|Overall Study|Death|14|||
164120272|NCT01378962|592800844|FG000|Overall Study|Lost to Follow-up|1|||
164120273|NCT01378962|592800844|FG000|Overall Study|Other|2|||
164120274|NCT01588548|592800845|FG000|Overall Study|Withdrawal by Subject|0|||
164120275|NCT01588548|592800846|FG001|Overall Study|Withdrawal by Subject|1|||
164120276|NCT01588548|592800847|FG002|Overall Study|Withdrawal by Subject|1|||
164120277|NCT01588548|592800848|FG003|Overall Study|Withdrawal by Subject|1|||
164120278|NCT01588548|592800849|FG004|Overall Study|Withdrawal by Subject|2|||
164120279|NCT01588548|592800850|FG005|Overall Study|Withdrawal by Subject|3|||
164120280|NCT01588548|592800845|FG000|Overall Study|Adverse Event|0|||
164120281|NCT01588548|592800846|FG001|Overall Study|Adverse Event|0|||
164120282|NCT01588548|592800847|FG002|Overall Study|Adverse Event|1|||
164120283|NCT01588548|592800848|FG003|Overall Study|Adverse Event|2|||
164120284|NCT01588548|592800849|FG004|Overall Study|Adverse Event|1|||
164120285|NCT01588548|592800850|FG005|Overall Study|Adverse Event|0|||
164120286|NCT01588548|592800845|FG000|Overall Study|Condition Under Investigation Worsened|3|||
164120287|NCT01588548|592800846|FG001|Overall Study|Condition Under Investigation Worsened|6|||
164120288|NCT01588548|592800847|FG002|Overall Study|Condition Under Investigation Worsened|4|||
164120289|NCT01588548|592800848|FG003|Overall Study|Condition Under Investigation Worsened|4|||
164120290|NCT01588548|592800849|FG004|Overall Study|Condition Under Investigation Worsened|3|||
164120291|NCT01588548|592800850|FG005|Overall Study|Condition Under Investigation Worsened|3|||
164120292|NCT03257254|592800851|FG000|Overall Study|Withdrawal by Subject|7|||
164120293|NCT03257254|592800851|FG000|Overall Study|Lost to Follow-up|9|||
164120294|NCT03257254|592800851|FG000|Overall Study|Study discontinued by sponsor|5|||
164120295|NCT04149535|592800855|FG000|Overall Study|Death|11|||
164120296|NCT04149535|592800856|FG001|Overall Study|Death|7|||
164120297|NCT04149535|592800855|FG000|Overall Study|Physician Decision|10|||
164120298|NCT04149535|592800856|FG001|Overall Study|Physician Decision|4|||
164120299|NCT04149535|592800855|FG000|Overall Study|Withdrawal by Subject|6|||
164120300|NCT04149535|592800856|FG001|Overall Study|Withdrawal by Subject|7|||
164120301|NCT04149535|592800855|FG000|Overall Study|Not described|2|||
164120302|NCT04149535|592800856|FG001|Overall Study|Not described|0|||
164120303|NCT00109837|592803230|FG000|Overall Study|Adverse Event|2|||
164120304|NCT00109837|592803230|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
164120305|NCT00109837|592803230|FG000|Overall Study|Death|1|||
164120306|NCT00109837|592803230|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
164120307|NCT00109837|592803230|FG000|Overall Study|Not treated|1|||
164120308|NCT00109837|592803230|FG000|Overall Study|Ineligible|1|||
164120309|NCT01989676|592803231|FG000|Overall Study|Death|52|||
164120310|NCT01989676|592803232|FG001|Overall Study|Death|60|||
164120311|NCT01989676|592803231|FG000|Overall Study|Protocol Violation|2|||
164120312|NCT01989676|592803232|FG001|Overall Study|Protocol Violation|1|||
164120313|NCT01989676|592803231|FG000|Overall Study|Lost to Follow-up|8|||
164120314|NCT01989676|592803232|FG001|Overall Study|Lost to Follow-up|18|||
164120315|NCT01989676|592803231|FG000|Overall Study|No longer willing to participate in study|26|||
164120316|NCT01989676|592803232|FG001|Overall Study|No longer willing to participate in study|26|||
164120317|NCT01989676|592803231|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
164120318|NCT01989676|592803232|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
164120319|NCT01989676|592803231|FG000|Overall Study|Other|4|||
164120320|NCT01989676|592803232|FG001|Overall Study|Other|3|||
164120321|NCT01619579|592803233|FG000|Overall Study|Withdrawal by Subject|0|||
164120322|NCT01619579|592803234|FG001|Overall Study|Withdrawal by Subject|3|||
164120323|NCT02688387|592803236|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120324|NCT02688387|592803237|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120325|NCT02688387|592803238|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
164120326|NCT02688387|592803239|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120327|NCT02688387|592803240|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120328|NCT02688387|592803241|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120329|NCT02688387|592803242|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120330|NCT02688387|592803243|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120331|NCT02688387|592803244|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120332|NCT02688387|592803245|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120333|NCT02688387|592803246|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120334|NCT02688387|592803247|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120335|NCT02688387|592803248|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120336|NCT02688387|592803249|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120337|NCT02688387|592803250|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120338|NCT02688387|592803251|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120339|NCT02688387|592803252|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120340|NCT02688387|592803253|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120341|NCT02688387|592803254|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120342|NCT02688387|592803255|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120343|NCT02688387|592803256|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120344|NCT02688387|592803257|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
164120345|NCT02688387|592803236|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120346|NCT02688387|592803237|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120347|NCT02688387|592803238|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120348|NCT02688387|592803239|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
164120349|NCT02688387|592803240|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120350|NCT02688387|592803241|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120351|NCT02688387|592803242|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120352|NCT02688387|592803243|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120353|NCT02688387|592803244|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120354|NCT02688387|592803245|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120355|NCT02688387|592803246|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120356|NCT02688387|592803247|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120357|NCT02688387|592803248|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120358|NCT02688387|592803249|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120359|NCT02688387|592803250|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120360|NCT02688387|592803251|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120361|NCT02688387|592803252|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120362|NCT02688387|592803253|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120363|NCT02688387|592803254|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120364|NCT02688387|592803255|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120365|NCT02688387|592803256|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120366|NCT02688387|592803257|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120367|NCT02688387|592803236|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120368|NCT02688387|592803237|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
164120369|NCT02688387|592803238|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120370|NCT02688387|592803239|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120371|NCT02688387|592803240|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120372|NCT02688387|592803241|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120373|NCT02688387|592803242|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120374|NCT02688387|592803243|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120375|NCT02688387|592803244|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120376|NCT02688387|592803245|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120377|NCT02688387|592803246|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164132433|NCT00123474|592850618|FG003|As Treated at Study Closure|Adverse Event|8|||
164120378|NCT02688387|592803247|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120379|NCT02688387|592803248|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120380|NCT02688387|592803249|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120381|NCT02688387|592803250|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120382|NCT02688387|592803251|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120383|NCT02688387|592803252|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120384|NCT02688387|592803253|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120385|NCT02688387|592803254|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120386|NCT02688387|592803255|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120387|NCT02688387|592803256|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120388|NCT02688387|592803257|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
164120389|NCT02688387|592803236|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120390|NCT02688387|592803237|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120391|NCT02688387|592803238|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
164120392|NCT02688387|592803239|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120393|NCT02688387|592803240|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
164120394|NCT02688387|592803241|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120395|NCT02688387|592803242|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120396|NCT02688387|592803243|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120397|NCT02688387|592803244|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120398|NCT02688387|592803245|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120399|NCT02688387|592803246|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120400|NCT02688387|592803247|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120401|NCT02688387|592803248|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120402|NCT02688387|592803249|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120403|NCT02688387|592803250|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120404|NCT02688387|592803251|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120405|NCT02688387|592803252|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120406|NCT02688387|592803253|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120407|NCT02688387|592803254|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120408|NCT02688387|592803255|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120409|NCT02688387|592803256|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120410|NCT02688387|592803257|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
164120411|NCT02688387|592803236|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
164120412|NCT02688387|592803237|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120413|NCT02688387|592803238|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120414|NCT02688387|592803239|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120415|NCT02688387|592803240|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120416|NCT02688387|592803241|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120417|NCT02688387|592803242|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120418|NCT02688387|592803243|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120419|NCT02688387|592803244|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120420|NCT02688387|592803245|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120421|NCT02688387|592803246|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120422|NCT02688387|592803247|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120423|NCT02688387|592803248|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120424|NCT02688387|592803249|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120425|NCT02688387|592803250|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120426|NCT02688387|592803251|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120427|NCT02688387|592803252|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120428|NCT02688387|592803253|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120429|NCT02688387|592803254|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120430|NCT02688387|592803255|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120431|NCT02688387|592803256|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120432|NCT02688387|592803257|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
164120433|NCT02688387|592803236|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120434|NCT02688387|592803237|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120435|NCT02688387|592803238|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120436|NCT02688387|592803239|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120437|NCT02688387|592803240|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120438|NCT02688387|592803241|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120439|NCT02688387|592803242|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120440|NCT02688387|592803243|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120441|NCT02688387|592803244|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120442|NCT02688387|592803245|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120443|NCT02688387|592803246|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
164120444|NCT02688387|592803247|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120445|NCT02688387|592803248|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120446|NCT02688387|592803249|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120447|NCT02688387|592803250|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120448|NCT02688387|592803251|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120449|NCT02688387|592803252|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120450|NCT02688387|592803253|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120451|NCT02688387|592803254|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120452|NCT02688387|592803255|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120453|NCT02688387|592803256|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120454|NCT02688387|592803257|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
164120455|NCT02688387|592803236|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120456|NCT02688387|592803237|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120457|NCT02688387|592803238|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120458|NCT02688387|592803239|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120459|NCT02688387|592803240|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120460|NCT02688387|592803241|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120461|NCT02688387|592803242|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120462|NCT02688387|592803243|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120463|NCT02688387|592803244|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120464|NCT02688387|592803245|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120465|NCT02688387|592803246|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120466|NCT02688387|592803247|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120467|NCT02688387|592803248|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120468|NCT02688387|592803249|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120469|NCT02688387|592803250|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
164120470|NCT02688387|592803251|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120471|NCT02688387|592803252|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120472|NCT02688387|592803253|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120473|NCT02688387|592803254|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120474|NCT02688387|592803255|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120475|NCT02688387|592803256|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120476|NCT02688387|592803257|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
164120477|NCT02688387|592803236|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120478|NCT02688387|592803237|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120479|NCT02688387|592803238|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120480|NCT02688387|592803239|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120481|NCT02688387|592803240|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120482|NCT02688387|592803241|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120483|NCT02688387|592803242|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120484|NCT02688387|592803243|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120485|NCT02688387|592803244|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120486|NCT02688387|592803245|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120487|NCT02688387|592803246|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120488|NCT02688387|592803247|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120489|NCT02688387|592803248|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120490|NCT02688387|592803249|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120491|NCT02688387|592803250|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120492|NCT02688387|592803251|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120493|NCT02688387|592803252|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120494|NCT02688387|592803253|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120495|NCT02688387|592803254|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120496|NCT02688387|592803255|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120497|NCT02688387|592803256|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
164120498|NCT02688387|592803257|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
164120499|NCT02688387|592803236|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120500|NCT02688387|592803237|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120501|NCT02688387|592803238|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120502|NCT02688387|592803239|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120503|NCT02688387|592803240|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120504|NCT02688387|592803241|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120505|NCT02688387|592803242|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120506|NCT02688387|592803243|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120507|NCT02688387|592803244|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120508|NCT02688387|592803245|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120509|NCT02688387|592803246|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120510|NCT02688387|592803247|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120511|NCT02688387|592803248|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120512|NCT02688387|592803249|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120513|NCT02688387|592803250|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120514|NCT02688387|592803251|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120515|NCT02688387|592803252|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120516|NCT02688387|592803253|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120517|NCT02688387|592803254|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
164120518|NCT02688387|592803255|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120519|NCT02688387|592803256|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
164120520|NCT02688387|592803257|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
164120521|NCT02688387|592803236|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120522|NCT02688387|592803237|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120523|NCT02688387|592803238|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120524|NCT02688387|592803239|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120525|NCT02688387|592803240|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120526|NCT02688387|592803241|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120527|NCT02688387|592803242|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120528|NCT02688387|592803243|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120529|NCT02688387|592803244|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120530|NCT02688387|592803245|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120531|NCT02688387|592803246|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120532|NCT02688387|592803247|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120533|NCT02688387|592803248|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120534|NCT02688387|592803249|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120535|NCT02688387|592803250|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120536|NCT02688387|592803251|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120537|NCT02688387|592803252|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120538|NCT02688387|592803253|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120539|NCT02688387|592803254|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120540|NCT02688387|592803255|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
164120541|NCT02688387|592803256|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120542|NCT02688387|592803257|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
164120543|NCT02190279|592803258|FG000|Overall Study|Withdrawal consent|1|||
164120544|NCT02190279|592803259|FG001|Overall Study|Withdrawal consent|0|||
164120545|NCT02190279|592803260|FG002|Overall Study|Withdrawal consent|1|||
164120546|NCT02190279|592803258|FG000|Overall Study|Lost to Follow-up|2|||
164120547|NCT02190279|592803259|FG001|Overall Study|Lost to Follow-up|0|||
164120548|NCT02190279|592803260|FG002|Overall Study|Lost to Follow-up|0|||
164120549|NCT02190279|592803258|FG000|Overall Study|Refused further treatment|0|||
164120550|NCT02190279|592803259|FG001|Overall Study|Refused further treatment|0|||
164120551|NCT02190279|592803260|FG002|Overall Study|Refused further treatment|1|||
164120552|NCT02190279|592803258|FG000|Overall Study|Screening failure|0|||
164120553|NCT02190279|592803259|FG001|Overall Study|Screening failure|0|||
164120554|NCT02190279|592803260|FG002|Overall Study|Screening failure|1|||
164120555|NCT02938442|592803261|FG000|Overall Study|Death|0|||
164120556|NCT02938442|592803262|FG001|Overall Study|Death|1|||
164120557|NCT02938442|592803261|FG000|Overall Study|Lost to Follow-up|0|||
164120558|NCT02938442|592803262|FG001|Overall Study|Lost to Follow-up|1|||
164120559|NCT02938442|592803261|FG000|Overall Study|Physician Decision|0|||
164120560|NCT02938442|592803262|FG001|Overall Study|Physician Decision|1|||
164120561|NCT02938442|592803261|FG000|Overall Study|Withdrawal by Subject|2|||
164120562|NCT02938442|592803262|FG001|Overall Study|Withdrawal by Subject|0|||
164120563|NCT00480324|592803263|FG000|Overall Study|Adverse Event|1|||
164120564|NCT00480324|592803264|FG001|Overall Study|Adverse Event|1|||
164120565|NCT00480324|592803263|FG000|Overall Study|Protocol Violation|0|||
164120566|NCT00480324|592803264|FG001|Overall Study|Protocol Violation|1|||
164120567|NCT00480324|592803263|FG000|Overall Study|Withdrawal by Subject|14|||
164120568|NCT00480324|592803264|FG001|Overall Study|Withdrawal by Subject|5|||
164120569|NCT00480324|592803263|FG000|Overall Study|Lost to Follow-up|17|||
164120570|NCT00480324|592803264|FG001|Overall Study|Lost to Follow-up|8|||
164120571|NCT00480324|592803263|FG000|Overall Study|Subject's mother pregnant|0|||
164120572|NCT00480324|592803264|FG001|Overall Study|Subject's mother pregnant|1|||
164120573|NCT00966381|592803265|FG000|Overall Study|Withdrawal by Subject|2|||
164120574|NCT00966381|592803266|FG001|Overall Study|Withdrawal by Subject|2|||
164120575|NCT01915940|592803267|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
164120576|NCT01915940|592803268|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
164120577|NCT01915940|592803269|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
164120578|NCT01915940|592803267|FG000|Treatment Period|Decision of Participant|0|||
164120579|NCT01915940|592803268|FG001|Treatment Period|Decision of Participant|1|||
164120580|NCT01915940|592803269|FG002|Treatment Period|Decision of Participant|3|||
164120581|NCT01915940|592803267|FG000|Treatment Period|Adverse Event|0|||
164120582|NCT01915940|592803268|FG001|Treatment Period|Adverse Event|9|||
164120583|NCT01915940|592803269|FG002|Treatment Period|Adverse Event|1|||
164120584|NCT01915940|592803267|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
164120585|NCT01915940|592803268|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
164120586|NCT01915940|592803269|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
164120587|NCT03686150|592803270|FG000|Overall Study|Withdrawal by Subject|1|||
164120588|NCT03686150|592803271|FG001|Overall Study|Withdrawal by Subject|1|||
164120589|NCT03686150|592803272|FG002|Overall Study|Withdrawal by Subject|1|||
164120590|NCT03686150|592803273|FG003|Overall Study|Withdrawal by Subject|0|||
164120591|NCT03686150|592803274|FG004|Overall Study|Withdrawal by Subject|1|||
164120592|NCT03686150|592803275|FG005|Overall Study|Withdrawal by Subject|2|||
164120593|NCT03686150|592803270|FG000|Overall Study|Physician Decision|1|||
164120594|NCT03686150|592803271|FG001|Overall Study|Physician Decision|0|||
164120595|NCT03686150|592803272|FG002|Overall Study|Physician Decision|0|||
164120596|NCT03686150|592803273|FG003|Overall Study|Physician Decision|0|||
164120597|NCT03686150|592803274|FG004|Overall Study|Physician Decision|0|||
164120598|NCT03686150|592803275|FG005|Overall Study|Physician Decision|1|||
164120599|NCT03686150|592803270|FG000|Overall Study|Lost to Follow-up|0|||
164120600|NCT03686150|592803271|FG001|Overall Study|Lost to Follow-up|1|||
164120601|NCT03686150|592803272|FG002|Overall Study|Lost to Follow-up|0|||
164120602|NCT03686150|592803273|FG003|Overall Study|Lost to Follow-up|0|||
164120603|NCT03686150|592803274|FG004|Overall Study|Lost to Follow-up|0|||
164120604|NCT03686150|592803275|FG005|Overall Study|Lost to Follow-up|0|||
164120605|NCT02443324|592803276|FG000|Overall Study|Death|4|||
164120606|NCT02443324|592803277|FG001|Overall Study|Death|1|||
164120607|NCT02443324|592803278|FG002|Overall Study|Death|0|||
164120608|NCT02443324|592803279|FG003|Overall Study|Death|3|||
164120609|NCT02443324|592803280|FG004|Overall Study|Death|1|||
164120610|NCT02443324|592803281|FG005|Overall Study|Death|3|||
164120611|NCT02443324|592803282|FG006|Overall Study|Death|2|||
164120612|NCT02443324|592803276|FG000|Overall Study|Lost to Follow-up|0|||
164120613|NCT02443324|592803277|FG001|Overall Study|Lost to Follow-up|0|||
164120614|NCT02443324|592803278|FG002|Overall Study|Lost to Follow-up|0|||
164120615|NCT02443324|592803279|FG003|Overall Study|Lost to Follow-up|1|||
164120616|NCT02443324|592803280|FG004|Overall Study|Lost to Follow-up|0|||
164120617|NCT02443324|592803281|FG005|Overall Study|Lost to Follow-up|1|||
164120618|NCT02443324|592803282|FG006|Overall Study|Lost to Follow-up|0|||
164120619|NCT02443324|592803276|FG000|Overall Study|Physician Decision|0|||
164120620|NCT02443324|592803277|FG001|Overall Study|Physician Decision|3|||
164120621|NCT02443324|592803278|FG002|Overall Study|Physician Decision|5|||
164120622|NCT02443324|592803279|FG003|Overall Study|Physician Decision|1|||
164120623|NCT02443324|592803280|FG004|Overall Study|Physician Decision|1|||
164120624|NCT02443324|592803281|FG005|Overall Study|Physician Decision|0|||
164120625|NCT02443324|592803282|FG006|Overall Study|Physician Decision|2|||
164120626|NCT02443324|592803276|FG000|Overall Study|Progressive Disease|20|||
164120627|NCT02443324|592803277|FG001|Overall Study|Progressive Disease|20|||
164120628|NCT02443324|592803278|FG002|Overall Study|Progressive Disease|13|||
164120629|NCT02443324|592803279|FG003|Overall Study|Progressive Disease|10|||
164120630|NCT02443324|592803280|FG004|Overall Study|Progressive Disease|13|||
164120631|NCT02443324|592803281|FG005|Overall Study|Progressive Disease|17|||
164120632|NCT02443324|592803282|FG006|Overall Study|Progressive Disease|10|||
164120633|NCT02443324|592803276|FG000|Overall Study|Withdrawal by Subject|0|||
164120634|NCT02443324|592803277|FG001|Overall Study|Withdrawal by Subject|0|||
164120635|NCT02443324|592803278|FG002|Overall Study|Withdrawal by Subject|3|||
164120636|NCT02443324|592803279|FG003|Overall Study|Withdrawal by Subject|1|||
164120637|NCT02443324|592803280|FG004|Overall Study|Withdrawal by Subject|1|||
164120638|NCT02443324|592803281|FG005|Overall Study|Withdrawal by Subject|0|||
164120639|NCT02443324|592803282|FG006|Overall Study|Withdrawal by Subject|1|||
164120640|NCT02443324|592803276|FG000|Overall Study|Adverse Event|0|||
164120641|NCT02443324|592803277|FG001|Overall Study|Adverse Event|1|||
164120642|NCT02443324|592803278|FG002|Overall Study|Adverse Event|3|||
164120643|NCT02443324|592803279|FG003|Overall Study|Adverse Event|0|||
164120644|NCT02443324|592803280|FG004|Overall Study|Adverse Event|4|||
164120645|NCT02443324|592803281|FG005|Overall Study|Adverse Event|3|||
164120646|NCT02443324|592803282|FG006|Overall Study|Adverse Event|3|||
164120647|NCT02443324|592803276|FG000|Overall Study|Enrolled but Never Treated|0|||
164120648|NCT02443324|592803277|FG001|Overall Study|Enrolled but Never Treated|0|||
164120649|NCT02443324|592803278|FG002|Overall Study|Enrolled but Never Treated|1|||
164120650|NCT02443324|592803279|FG003|Overall Study|Enrolled but Never Treated|0|||
164120651|NCT02443324|592803280|FG004|Overall Study|Enrolled but Never Treated|1|||
164120652|NCT02443324|592803281|FG005|Overall Study|Enrolled but Never Treated|0|||
164120653|NCT02443324|592803282|FG006|Overall Study|Enrolled but Never Treated|1|||
164120654|NCT03346070|592803285|FG000|Overall Study|Death|0|||
164120655|NCT03346070|592803286|FG001|Overall Study|Death|0|||
164120656|NCT03346070|592803287|FG002|Overall Study|Death|0|||
164120657|NCT03346070|592803288|FG003|Overall Study|Death|0|||
164120658|NCT03346070|592803289|FG004|Overall Study|Death|1|||
164120659|NCT03346070|592803285|FG000|Overall Study|Lost to Follow-up|0|||
164120660|NCT03346070|592803286|FG001|Overall Study|Lost to Follow-up|1|||
164120661|NCT03346070|592803287|FG002|Overall Study|Lost to Follow-up|2|||
164120662|NCT03346070|592803288|FG003|Overall Study|Lost to Follow-up|0|||
164120663|NCT03346070|592803289|FG004|Overall Study|Lost to Follow-up|0|||
164120664|NCT03346070|592803285|FG000|Overall Study|Physician Decision|0|||
164120665|NCT03346070|592803286|FG001|Overall Study|Physician Decision|0|||
164120666|NCT03346070|592803287|FG002|Overall Study|Physician Decision|0|||
164120667|NCT03346070|592803288|FG003|Overall Study|Physician Decision|1|||
164120668|NCT03346070|592803289|FG004|Overall Study|Physician Decision|1|||
164120669|NCT03346070|592803285|FG000|Overall Study|Withdrawal by Subject|1|||
164120670|NCT03346070|592803286|FG001|Overall Study|Withdrawal by Subject|0|||
164120671|NCT03346070|592803287|FG002|Overall Study|Withdrawal by Subject|0|||
164120672|NCT03346070|592803288|FG003|Overall Study|Withdrawal by Subject|1|||
164120673|NCT03346070|592803289|FG004|Overall Study|Withdrawal by Subject|0|||
164120674|NCT03346070|592803285|FG000|Overall Study|Study medication not received as planned|2|||
164120675|NCT03346070|592803286|FG001|Overall Study|Study medication not received as planned|3|||
164120676|NCT03346070|592803287|FG002|Overall Study|Study medication not received as planned|2|||
164120677|NCT03346070|592803288|FG003|Overall Study|Study medication not received as planned|3|||
164120678|NCT03346070|592803289|FG004|Overall Study|Study medication not received as planned|2|||
164120679|NCT03346070|592803285|FG000|Overall Study|Screen Failure|0|||
164120680|NCT03346070|592803286|FG001|Overall Study|Screen Failure|0|||
164120681|NCT03346070|592803287|FG002|Overall Study|Screen Failure|0|||
164120682|NCT03346070|592803288|FG003|Overall Study|Screen Failure|1|||
164120683|NCT03346070|592803289|FG004|Overall Study|Screen Failure|1|||
164120684|NCT00988208|592803293|FG000|Overall Study|Adverse Event|71|||
164120685|NCT00988208|592803294|FG001|Overall Study|Adverse Event|122|||
164120686|NCT00988208|592803293|FG000|Overall Study|Disease Progression|103|||
164120687|NCT00988208|592803294|FG001|Overall Study|Disease Progression|89|||
164120688|NCT00988208|592803293|FG000|Overall Study|Withdrawal by Subject|50|||
164120689|NCT00988208|592803294|FG001|Overall Study|Withdrawal by Subject|57|||
164120690|NCT00988208|592803293|FG000|Overall Study|Death|9|||
164120691|NCT00988208|592803294|FG001|Overall Study|Death|15|||
164120692|NCT00988208|592803293|FG000|Overall Study|Lost to Follow-up|2|||
164120693|NCT00988208|592803294|FG001|Overall Study|Lost to Follow-up|3|||
164120694|NCT00988208|592803293|FG000|Overall Study|Protocol Violation|9|||
164120695|NCT00988208|592803294|FG001|Overall Study|Protocol Violation|2|||
164120696|NCT00988208|592803293|FG000|Overall Study|Sponsor Decision|102|||
164120697|NCT00988208|592803294|FG001|Overall Study|Sponsor Decision|78|||
164120698|NCT00988208|592803293|FG000|Overall Study|Clinical Progression|17|||
164120699|NCT00988208|592803294|FG001|Overall Study|Clinical Progression|16|||
164120700|NCT00988208|592803293|FG000|Overall Study|Biochemical Progression|21|||
164120701|NCT00988208|592803294|FG001|Overall Study|Biochemical Progression|7|||
164120702|NCT00988208|592803293|FG000|Overall Study|Clinical Deterioration|7|||
164120703|NCT00988208|592803294|FG001|Overall Study|Clinical Deterioration|14|||
164120704|NCT00988208|592803293|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
164120705|NCT00988208|592803294|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
164120706|NCT00988208|592803293|FG000|Overall Study|Other|8|||
164120707|NCT00988208|592803294|FG001|Overall Study|Other|3|||
164120708|NCT01613378|592803301|FG000|Overall Study|Lack of Efficacy|13|||
164120709|NCT01613378|592803301|FG000|Overall Study|Adverse Event|11|||
164120710|NCT01613378|592803301|FG000|Overall Study|Withdrawal by Subject|8|||
164120711|NCT01613378|592803301|FG000|Overall Study|Death|2|||
164120712|NCT01613378|592803301|FG000|Overall Study|Lost to Follow-up|1|||
164120713|NCT01613378|592803301|FG000|Overall Study|Other Reason|4|||
164120714|NCT00317642|592803302|FG000|Overall Study|Not Received Either Study Drug|1|||
164120715|NCT00317642|592803303|FG001|Overall Study|Not Received Either Study Drug|3|||
164120716|NCT00317642|592803302|FG000|Overall Study|Physician Decision|15|||
164120717|NCT00317642|592803303|FG001|Overall Study|Physician Decision|7|||
164120718|NCT00317642|592803302|FG000|Overall Study|Participant declined treatment|14|||
164120719|NCT00317642|592803303|FG001|Overall Study|Participant declined treatment|3|||
164120720|NCT00317642|592803302|FG000|Overall Study|Adverse Event|17|||
164120721|NCT00317642|592803303|FG001|Overall Study|Adverse Event|5|||
164120722|NCT00317642|592803302|FG000|Overall Study|Treatment Failure|56|||
164120723|NCT00317642|592803303|FG001|Overall Study|Treatment Failure|102|||
164120724|NCT00317642|592803302|FG000|Overall Study|Disease Recurrence|1|||
164120725|NCT00317642|592803303|FG001|Overall Study|Disease Recurrence|2|||
164120726|NCT00317642|592803302|FG000|Overall Study|Death|14|||
164120727|NCT00317642|592803303|FG001|Overall Study|Death|7|||
164120728|NCT00317642|592803302|FG000|Overall Study|Not Continue to Consolidation|2|||
164120729|NCT00317642|592803303|FG001|Overall Study|Not Continue to Consolidation|0|||
164120730|NCT00317642|592803302|FG000|Overall Study|Withdrawal by Subject|0|||
164120731|NCT00317642|592803303|FG001|Overall Study|Withdrawal by Subject|1|||
164120732|NCT00317642|592803302|FG000|Overall Study|Referred For Transplantation|1|||
164120733|NCT00317642|592803303|FG001|Overall Study|Referred For Transplantation|0|||
164120734|NCT00317642|592803302|FG000|Overall Study|AML Not Centrally Confirmed|1|||
164120735|NCT00317642|592803303|FG001|Overall Study|AML Not Centrally Confirmed|5|||
164120736|NCT00880087|592803304|FG000|Overall Study|Lost to Follow-up|0|||
164120737|NCT00880087|592803305|FG001|Overall Study|Lost to Follow-up|2|||
164120738|NCT01239472|592803308|FG000|Overall Study|Withdrawal by Subject|5|||
164120739|NCT01239472|592803309|FG001|Overall Study|Withdrawal by Subject|1|||
164120740|NCT01239472|592803308|FG000|Overall Study|Adverse Event|0|||
164120741|NCT01239472|592803309|FG001|Overall Study|Adverse Event|1|||
164120742|NCT01239472|592803308|FG000|Overall Study|Lack of Efficacy|0|||
164120743|NCT01239472|592803309|FG001|Overall Study|Lack of Efficacy|1|||
164120744|NCT00418522|592803313|FG000|Overall Study|Adverse Event|7|||
164120745|NCT00418522|592803314|FG001|Overall Study|Adverse Event|1|||
164120746|NCT00418522|592803313|FG000|Overall Study|Lack of Efficacy|1|||
164120747|NCT00418522|592803314|FG001|Overall Study|Lack of Efficacy|3|||
164120748|NCT00418522|592803313|FG000|Overall Study|Lost to Follow-up|10|||
164120749|NCT00418522|592803314|FG001|Overall Study|Lost to Follow-up|4|||
164120750|NCT00418522|592803313|FG000|Overall Study|Withdrawal by Subject|31|||
164120751|NCT00418522|592803314|FG001|Overall Study|Withdrawal by Subject|7|||
164120752|NCT00418522|592803313|FG000|Overall Study|Other|27|||
164120753|NCT00418522|592803314|FG001|Overall Study|Other|23|||
164120754|NCT00418522|592803313|FG000|Overall Study|Randomized but did not receive treatment|7|||
164120755|NCT00418522|592803314|FG001|Overall Study|Randomized but did not receive treatment|4|||
164120756|NCT02695719|592803315|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
164120757|NCT02695719|592803316|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
164120758|NCT02695719|592803315|FG000|Overall Study|Significant Protocol Deviation|0|||
164120759|NCT02695719|592803316|FG001|Overall Study|Significant Protocol Deviation|1|||
164120760|NCT02695719|592803315|FG000|Overall Study|Voluntary Withdrawal|1|||
164120761|NCT02695719|592803316|FG001|Overall Study|Voluntary Withdrawal|0|||
164120762|NCT01005329|592803319|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
164120763|NCT01714739|592803320|FG000|Overall Study|Disease progression|3|||
164120764|NCT01714739|592803321|FG001|Overall Study|Disease progression|5|||
164120765|NCT01714739|592803322|FG002|Overall Study|Disease progression|5|||
164120766|NCT01714739|592803323|FG003|Overall Study|Disease progression|204|||
164120767|NCT01714739|592803324|FG004|Overall Study|Disease progression|1|||
164120768|NCT01714739|592803325|FG005|Overall Study|Disease progression|3|||
164120769|NCT01714739|592803326|FG006|Overall Study|Disease progression|5|||
164120770|NCT01714739|592803320|FG000|Overall Study|Study drug toxicity|1|||
164120771|NCT01714739|592803321|FG001|Overall Study|Study drug toxicity|1|||
164120772|NCT01714739|592803322|FG002|Overall Study|Study drug toxicity|1|||
164120773|NCT01714739|592803323|FG003|Overall Study|Study drug toxicity|15|||
164120774|NCT01714739|592803324|FG004|Overall Study|Study drug toxicity|0|||
164120775|NCT01714739|592803325|FG005|Overall Study|Study drug toxicity|0|||
164120776|NCT01714739|592803326|FG006|Overall Study|Study drug toxicity|5|||
164120777|NCT01714739|592803320|FG000|Overall Study|Death|0|||
164120778|NCT01714739|592803321|FG001|Overall Study|Death|0|||
164120779|NCT01714739|592803322|FG002|Overall Study|Death|0|||
164120780|NCT01714739|592803323|FG003|Overall Study|Death|1|||
164120781|NCT01714739|592803324|FG004|Overall Study|Death|0|||
164120782|NCT01714739|592803325|FG005|Overall Study|Death|0|||
164120783|NCT01714739|592803326|FG006|Overall Study|Death|0|||
164120784|NCT01714739|592803320|FG000|Overall Study|Adverse Event unrelated to drug|0|||
164120785|NCT01714739|592803321|FG001|Overall Study|Adverse Event unrelated to drug|0|||
164120786|NCT01714739|592803322|FG002|Overall Study|Adverse Event unrelated to drug|3|||
164120787|NCT01714739|592803323|FG003|Overall Study|Adverse Event unrelated to drug|21|||
164120788|NCT01714739|592803324|FG004|Overall Study|Adverse Event unrelated to drug|0|||
164120789|NCT01714739|592803325|FG005|Overall Study|Adverse Event unrelated to drug|0|||
164120790|NCT01714739|592803326|FG006|Overall Study|Adverse Event unrelated to drug|0|||
164120791|NCT01714739|592803320|FG000|Overall Study|Participant request to stop therapy|0|||
164120792|NCT01714739|592803321|FG001|Overall Study|Participant request to stop therapy|1|||
164120793|NCT01714739|592803322|FG002|Overall Study|Participant request to stop therapy|0|||
164120794|NCT01714739|592803323|FG003|Overall Study|Participant request to stop therapy|6|||
164120795|NCT01714739|592803324|FG004|Overall Study|Participant request to stop therapy|0|||
164120796|NCT01714739|592803325|FG005|Overall Study|Participant request to stop therapy|0|||
164120797|NCT01714739|592803326|FG006|Overall Study|Participant request to stop therapy|0|||
164120798|NCT01714739|592803320|FG000|Overall Study|Participant withdrew consent|0|||
164120799|NCT01714739|592803321|FG001|Overall Study|Participant withdrew consent|1|||
164120800|NCT01714739|592803322|FG002|Overall Study|Participant withdrew consent|0|||
164120801|NCT01714739|592803323|FG003|Overall Study|Participant withdrew consent|8|||
164120802|NCT01714739|592803324|FG004|Overall Study|Participant withdrew consent|0|||
164120803|NCT01714739|592803325|FG005|Overall Study|Participant withdrew consent|0|||
164120804|NCT01714739|592803326|FG006|Overall Study|Participant withdrew consent|0|||
164120805|NCT01714739|592803320|FG000|Overall Study|Lost to Follow-up|0|||
164120806|NCT01714739|592803321|FG001|Overall Study|Lost to Follow-up|0|||
164120807|NCT01714739|592803322|FG002|Overall Study|Lost to Follow-up|0|||
164120808|NCT01714739|592803323|FG003|Overall Study|Lost to Follow-up|1|||
164120809|NCT01714739|592803324|FG004|Overall Study|Lost to Follow-up|0|||
164120810|NCT01714739|592803325|FG005|Overall Study|Lost to Follow-up|0|||
164120811|NCT01714739|592803326|FG006|Overall Study|Lost to Follow-up|0|||
164120812|NCT01714739|592803320|FG000|Overall Study|Maximum clinical benefit|0|||
164120813|NCT01714739|592803321|FG001|Overall Study|Maximum clinical benefit|1|||
164120814|NCT01714739|592803322|FG002|Overall Study|Maximum clinical benefit|1|||
164120815|NCT01714739|592803323|FG003|Overall Study|Maximum clinical benefit|3|||
164120816|NCT01714739|592803324|FG004|Overall Study|Maximum clinical benefit|0|||
164120817|NCT01714739|592803325|FG005|Overall Study|Maximum clinical benefit|0|||
164120818|NCT01714739|592803326|FG006|Overall Study|Maximum clinical benefit|0|||
164120819|NCT01714739|592803320|FG000|Overall Study|Poor/non-comliance|0|||
164120820|NCT01714739|592803321|FG001|Overall Study|Poor/non-comliance|1|||
164120821|NCT01714739|592803322|FG002|Overall Study|Poor/non-comliance|0|||
164120822|NCT01714739|592803323|FG003|Overall Study|Poor/non-comliance|1|||
164120823|NCT01714739|592803324|FG004|Overall Study|Poor/non-comliance|0|||
164120824|NCT01714739|592803325|FG005|Overall Study|Poor/non-comliance|0|||
164120825|NCT01714739|592803326|FG006|Overall Study|Poor/non-comliance|0|||
164120826|NCT01714739|592803320|FG000|Overall Study|No longer meets study criteria|0|||
164120827|NCT01714739|592803321|FG001|Overall Study|No longer meets study criteria|0|||
164120828|NCT01714739|592803322|FG002|Overall Study|No longer meets study criteria|0|||
164120829|NCT01714739|592803323|FG003|Overall Study|No longer meets study criteria|1|||
164120830|NCT01714739|592803324|FG004|Overall Study|No longer meets study criteria|0|||
164120831|NCT01714739|592803325|FG005|Overall Study|No longer meets study criteria|0|||
164120832|NCT01714739|592803326|FG006|Overall Study|No longer meets study criteria|0|||
164120833|NCT01714739|592803320|FG000|Overall Study|Other reason|0|||
164120834|NCT01714739|592803321|FG001|Overall Study|Other reason|0|||
164120835|NCT01714739|592803322|FG002|Overall Study|Other reason|0|||
164120836|NCT01714739|592803323|FG003|Overall Study|Other reason|3|||
164120837|NCT01714739|592803324|FG004|Overall Study|Other reason|1|||
164120838|NCT01714739|592803325|FG005|Overall Study|Other reason|0|||
164120839|NCT01714739|592803326|FG006|Overall Study|Other reason|0|||
164120840|NCT02250651|592803327|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
164120841|NCT02250651|592803328|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
164120842|NCT02250651|592803329|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
164120843|NCT02250651|592803327|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
164120844|NCT02250651|592803328|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
164120845|NCT02250651|592803329|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
164120846|NCT02250651|592803327|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
164120847|NCT02250651|592803328|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
164120848|NCT02250651|592803329|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
164120849|NCT02250651|592803327|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
164120850|NCT02250651|592803328|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
164120851|NCT02250651|592803329|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
164120852|NCT02250651|592803327|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
164120853|NCT02250651|592803328|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
164120854|NCT02250651|592803329|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
164120855|NCT02250651|592803327|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
164120856|NCT02250651|592803328|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
164120857|NCT02250651|592803329|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
164120858|NCT02250651|592803327|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
164120859|NCT02250651|592803328|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
164120860|NCT02250651|592803329|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
164120861|NCT02250651|592803327|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
164120862|NCT02250651|592803328|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
164120863|NCT02250651|592803329|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
164120864|NCT02250651|592803327|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
164120865|NCT02250651|592803328|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
164120866|NCT02250651|592803329|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
164120867|NCT02250651|592803327|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
164120868|NCT02250651|592803328|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
164120869|NCT02250651|592803329|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
164120870|NCT02250651|592803327|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
164120871|NCT02250651|592803328|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
164120872|NCT02250651|592803329|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
164120873|NCT02250651|592803327|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
164120874|NCT02250651|592803328|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
164120875|NCT02250651|592803329|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
164120876|NCT02250651|592803327|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
164120877|NCT02250651|592803328|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
164120878|NCT02250651|592803329|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
164120879|NCT02250651|592803327|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
164120880|NCT02250651|592803328|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
164120881|NCT02250651|592803329|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
164120882|NCT02250651|592803327|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
164120883|NCT02250651|592803328|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
164120884|NCT02250651|592803329|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
164120885|NCT01557920|592803332|FG000|Overall Study|Withdrawal by Subject|2|||
164120886|NCT01557920|592803333|FG001|Overall Study|Withdrawal by Subject|3|||
164120887|NCT01557920|592803332|FG000|Overall Study|Lack of Efficacy|1|||
164120888|NCT01557920|592803333|FG001|Overall Study|Lack of Efficacy|0|||
164120889|NCT01466036|592803336|FG000|Overall Study|Death|1|||
164120890|NCT01466036|592803337|FG001|Overall Study|Death|1|||
164120891|NCT01466036|592803336|FG000|Overall Study|Physician Decision|0|||
164120892|NCT01466036|592803337|FG001|Overall Study|Physician Decision|4|||
164120893|NCT01466036|592803336|FG000|Overall Study|Adverse Event|2|||
164120894|NCT01466036|592803337|FG001|Overall Study|Adverse Event|6|||
164120895|NCT01466036|592803336|FG000|Overall Study|Withdrawal by Subject|2|||
164120896|NCT01466036|592803337|FG001|Overall Study|Withdrawal by Subject|8|||
164120897|NCT01466036|592803336|FG000|Overall Study|progression/relapse|14|||
164120898|NCT01466036|592803337|FG001|Overall Study|progression/relapse|21|||
164120899|NCT01466036|592803336|FG000|Overall Study|prolonged treatment delay|1|||
164120900|NCT01466036|592803337|FG001|Overall Study|prolonged treatment delay|1|||
164120901|NCT01808248|592803344|FG000|Overall Study|Lack of Efficacy|3|||
164120902|NCT01808248|592803344|FG000|Overall Study|Withdrawal by Subject|1|||
164120903|NCT01808248|592803344|FG000|Overall Study|Lost to Follow-up|1|||
164120904|NCT01175473|592803347|FG000|Overall Study|Adverse Event|2|||
164120905|NCT01175473|592803348|FG001|Overall Study|Adverse Event|2|||
164120906|NCT03635983|592803354|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
164120907|NCT03635983|592803355|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
164120908|NCT03635983|592803354|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164120909|NCT03635983|592803355|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164120910|NCT03635983|592803354|FG000|Pre-Treatment Period|Other reasons|0|||
164120911|NCT03635983|592803355|FG001|Pre-Treatment Period|Other reasons|1|||
164120912|NCT03635983|592803354|FG000|Pre-Treatment Period|Disease Progression|0|||
164120913|NCT03635983|592803355|FG001|Pre-Treatment Period|Disease Progression|1|||
164120914|NCT03635983|592803354|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
164120915|NCT03635983|592803355|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
164120916|NCT03635983|592803354|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
164120917|NCT03635983|592803355|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
164120918|NCT03635983|592803354|FG000|Treatment Period|Withdrawal by Subject|3|||
164120919|NCT03635983|592803355|FG001|Treatment Period|Withdrawal by Subject|5|||
164120920|NCT03635983|592803354|FG000|Treatment Period|Death|3|||
164120921|NCT03635983|592803355|FG001|Treatment Period|Death|5|||
164120922|NCT03635983|592803354|FG000|Treatment Period|Poor/Non-compliance|2|||
164120923|NCT03635983|592803355|FG001|Treatment Period|Poor/Non-compliance|1|||
164120924|NCT03635983|592803354|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
164120925|NCT03635983|592803355|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
164120926|NCT03635983|592803354|FG000|Treatment Period|Other reasons|7|||
164120927|NCT03635983|592803355|FG001|Treatment Period|Other reasons|4|||
164120928|NCT03635983|592803354|FG000|Treatment Period|Disease progression|230|||
164120929|NCT03635983|592803355|FG001|Treatment Period|Disease progression|201|||
164120930|NCT03635983|592803354|FG000|Treatment Period|Study drug toxicity|35|||
164120931|NCT03635983|592803355|FG001|Treatment Period|Study drug toxicity|36|||
164120932|NCT03635983|592803354|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
164120933|NCT03635983|592803355|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
164120934|NCT03635983|592803354|FG000|Treatment Period|Maximum clinical benefit|3|||
164120935|NCT03635983|592803355|FG001|Treatment Period|Maximum clinical benefit|5|||
164120936|NCT03635983|592803354|FG000|Treatment Period|Administrative reason by the sponsor|1|||
164120937|NCT03635983|592803355|FG001|Treatment Period|Administrative reason by the sponsor|2|||
164120938|NCT03635983|592803354|FG000|Treatment Period|Lost to Follow-up|0|||
164120939|NCT03635983|592803355|FG001|Treatment Period|Lost to Follow-up|1|||
164120940|NCT00330460|592803360|FG000|Overall Study|Physician Decision|1|||
164120941|NCT00330460|592803361|FG001|Overall Study|Physician Decision|0|||
164120942|NCT00330460|592803360|FG000|Overall Study|Adverse Event|10|||
164120943|NCT00330460|592803361|FG001|Overall Study|Adverse Event|8|||
164120944|NCT00330460|592803360|FG000|Overall Study|Withdrawal by Subject|18|||
164120945|NCT00330460|592803361|FG001|Overall Study|Withdrawal by Subject|17|||
164120946|NCT00330460|592803360|FG000|Overall Study|Death|1|||
164120947|NCT00330460|592803361|FG001|Overall Study|Death|1|||
164120948|NCT00330460|592803360|FG000|Overall Study|Ineligibility determined|1|||
164120949|NCT00330460|592803361|FG001|Overall Study|Ineligibility determined|3|||
164120950|NCT00330460|592803360|FG000|Overall Study|Lost to Follow-up|8|||
164120951|NCT00330460|592803361|FG001|Overall Study|Lost to Follow-up|3|||
164120952|NCT00330460|592803360|FG000|Overall Study|Noncompliance|2|||
164120953|NCT00330460|592803361|FG001|Overall Study|Noncompliance|1|||
164120954|NCT00330460|592803360|FG000|Overall Study|Other|1|||
164120955|NCT00330460|592803361|FG001|Overall Study|Other|0|||
164120956|NCT02808819|592803364|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
164120957|NCT02808819|592803365|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
164120958|NCT02808819|592803364|FG000|Overall Study|Withdrawal by Subject|10|||
164120959|NCT02808819|592803365|FG001|Overall Study|Withdrawal by Subject|13|||
164120960|NCT02808819|592803364|FG000|Overall Study|Site terminated by sponsor|2|||
164120961|NCT02808819|592803365|FG001|Overall Study|Site terminated by sponsor|0|||
164120962|NCT02808819|592803364|FG000|Overall Study|Pregnancy|1|||
164120963|NCT02808819|592803365|FG001|Overall Study|Pregnancy|0|||
164120964|NCT02808819|592803364|FG000|Overall Study|Lost to Follow-up|1|||
164120965|NCT02808819|592803365|FG001|Overall Study|Lost to Follow-up|6|||
164120966|NCT02808819|592803364|FG000|Overall Study|Protocol Violation|0|||
164120967|NCT02808819|592803365|FG001|Overall Study|Protocol Violation|1|||
164120968|NCT02808819|592803364|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
164120969|NCT02808819|592803365|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
164120970|NCT02808819|592803364|FG000|Overall Study|Death|1|||
164120971|NCT02808819|592803365|FG001|Overall Study|Death|0|||
164120972|NCT02808819|592803364|FG000|Overall Study|Adverse Event|3|||
164120973|NCT02808819|592803365|FG001|Overall Study|Adverse Event|4|||
164120974|NCT03297294|592803366|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
164120975|NCT03297294|592803367|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
164120976|NCT03297294|592803368|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164120977|NCT03297294|592803369|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164120978|NCT03297294|592803370|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
164120979|NCT03297294|592803366|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
164120980|NCT03297294|592803367|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
164120981|NCT03297294|592803368|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164120982|NCT03297294|592803369|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164120983|NCT03297294|592803370|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
164120984|NCT03297294|592803366|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
164120985|NCT03297294|592803367|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
164120986|NCT03297294|592803368|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164120987|NCT03297294|592803369|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164120988|NCT03297294|592803370|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
164120989|NCT03297294|592803366|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
164120990|NCT03297294|592803367|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
164120991|NCT03297294|592803368|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164120992|NCT03297294|592803369|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164120993|NCT03297294|592803370|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
164120994|NCT03297294|592803366|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164120995|NCT03297294|592803367|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164120996|NCT03297294|592803368|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164120997|NCT03297294|592803369|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
164120998|NCT03297294|592803370|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
164120999|NCT01435031|592803371|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
164121000|NCT01435031|592803371|FG000|ITT at 1 Month|Death|1|||
164121001|NCT01435031|592803371|FG000|ITT at 1 Month|Lost to Follow-up|4|||
164121002|NCT01435031|592803371|FG000|ITT at 6 Months|Death|2|||
164121003|NCT01435031|592803371|FG000|ITT at 6 Months|Lost to Follow-up|3|||
164121004|NCT01435031|592803371|FG000|ITT at 1 Year|Death|1|||
164121005|NCT01435031|592803371|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
164121006|NCT01435031|592803371|FG000|ITT at 1 Year|Lost to Follow-up|6|||
164121007|NCT01435031|592803371|FG000|ITT at 2 Years|Death|7|||
164121008|NCT01435031|592803371|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
164121009|NCT01435031|592803371|FG000|ITT at 2 Years|Lost to Follow-up|4|||
164121010|NCT01435031|592803371|FG000|ITT at 3 Years|Death|5|||
164121011|NCT01435031|592803371|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
164121012|NCT01435031|592803371|FG000|ITT at 3 Years|Lost to Follow-up|4|||
164121013|NCT01435031|592803371|FG000|ITT at 4 Years|Death|4|||
164121014|NCT01435031|592803371|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
164121015|NCT01435031|592803371|FG000|ITT at 4 Years|Lost to Follow-up|1|||
164121016|NCT03718117|592803375|FG000|Overall Study|Death|12|||
164121017|NCT03718117|592803376|FG001|Overall Study|Death|11|||
164121018|NCT03718117|592803377|FG002|Overall Study|Death|0|||
164121019|NCT03718117|592803375|FG000|Overall Study|Other|0|||
164121020|NCT03718117|592803376|FG001|Overall Study|Other|1|||
164121021|NCT03718117|592803377|FG002|Overall Study|Other|0|||
164121022|NCT03718117|592803375|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
164121023|NCT03718117|592803376|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
164121024|NCT03718117|592803377|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
164121025|NCT03718117|592803375|FG000|Overall Study|Participant not met eligibility criteria|0|||
164121026|NCT03718117|592803376|FG001|Overall Study|Participant not met eligibility criteria|0|||
164121027|NCT03718117|592803377|FG002|Overall Study|Participant not met eligibility criteria|2|||
164121028|NCT01917968|592803378|FG000|Overall Study|Death|3|||
164121029|NCT01917968|592803379|FG001|Overall Study|Death|2|||
164121030|NCT01917968|592803378|FG000|Overall Study|Lost to Follow-up|21|||
164121031|NCT01917968|592803379|FG001|Overall Study|Lost to Follow-up|39|||
164121032|NCT01917968|592803378|FG000|Overall Study|Physician Decision|1|||
164121033|NCT01917968|592803379|FG001|Overall Study|Physician Decision|2|||
164121034|NCT01917968|592803378|FG000|Overall Study|Withdrawal by Subject|20|||
164121035|NCT01917968|592803379|FG001|Overall Study|Withdrawal by Subject|35|||
164121036|NCT01917968|592803378|FG000|Overall Study|Subject Relocation|5|||
164121037|NCT01917968|592803379|FG001|Overall Study|Subject Relocation|1|||
164121038|NCT01917968|592803378|FG000|Overall Study|36M Missed Visit|3|||
164121039|NCT01917968|592803379|FG001|Overall Study|36M Missed Visit|2|||
164121040|NCT01917968|592803378|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
164121041|NCT01917968|592803379|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
164121042|NCT01917968|592803378|FG000|Overall Study|Change in Family Circumstances|0|||
164121043|NCT01917968|592803379|FG001|Overall Study|Change in Family Circumstances|1|||
164121044|NCT01917968|592803378|FG000|Overall Study|No Data Available|0|||
164121045|NCT01917968|592803379|FG001|Overall Study|No Data Available|2|||
164121046|NCT02030535|592803381|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
164121047|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
164121048|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
164121049|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
164121050|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
164121051|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
164121052|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
164121053|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
164121054|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
164121055|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
164121056|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
164121057|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
164121058|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
164121059|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
164121060|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
164121061|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
164121062|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
164121063|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
164121064|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
164121065|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
164121066|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
164121067|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
164121068|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
164121069|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
164121070|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
164121071|NCT01435928|592803382|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
164121072|NCT01435928|592803383|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
164121073|NCT01435928|592803384|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
164121074|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
164121075|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
164121076|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
164121077|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
164121078|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
164121079|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
164121080|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
164121081|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
164121082|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
164121083|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
164121084|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
164121085|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
164121086|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
164121087|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
164121088|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
164121089|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
164121090|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
164121091|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
164121092|NCT01435928|592803382|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
164121093|NCT01435928|592803383|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
164121094|NCT01435928|592803384|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
164121095|NCT01634854|592803385|FG000|Overall Study|Cesarean delivery|2|||
164121096|NCT01634854|592803386|FG001|Overall Study|Cesarean delivery|7|||
164121097|NCT03365791|592803387|FG000|Overall Study|Adverse Event|5|||
164121098|NCT03365791|592803387|FG000|Overall Study|Death|1|||
164121099|NCT03365791|592803387|FG000|Overall Study|Lost to Follow-up|1|||
164121100|NCT03365791|592803387|FG000|Overall Study|Physician Decision|9|||
164121101|NCT03365791|592803387|FG000|Overall Study|Progressive disease|51|||
164121102|NCT03365791|592803387|FG000|Overall Study|Subject/guardian decision|5|||
164121103|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
164121104|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121105|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121106|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121107|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121108|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121109|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121110|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121111|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
164121112|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
164121113|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121114|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121115|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121116|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121117|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121118|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121119|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121120|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
164121121|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
164121122|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121123|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121124|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121125|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121126|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121127|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121128|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121129|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
164121130|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
164121131|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121132|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121133|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121134|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121135|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121136|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121137|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121138|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
164121139|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
164121140|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121141|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121142|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121143|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121144|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121145|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121146|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121147|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
164121148|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
164121149|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121150|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121151|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121152|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121153|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121154|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121155|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121156|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
164121157|NCT00739973|592803388|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
164121158|NCT00739973|592803389|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121159|NCT00739973|592803390|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121160|NCT00739973|592803391|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121161|NCT00739973|592803392|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121162|NCT00739973|592803393|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121163|NCT00739973|592803394|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121164|NCT00739973|592803395|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121165|NCT00739973|592803396|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
164121166|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
164121167|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
164121168|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
164121169|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
164121170|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
164121171|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
164121172|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
164121173|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
164121174|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
164121175|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121176|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121177|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121178|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121179|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
164121180|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121181|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121182|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
164121183|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
164121184|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
164121185|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
164121186|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121187|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121188|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121189|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121190|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121191|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121192|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
164121193|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
164121194|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
164121195|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
164121196|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
164121197|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
164121198|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
164121199|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
164121200|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
164121201|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
164121202|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121203|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121204|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
164121205|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121206|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121207|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121208|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121209|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121210|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
164121211|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164121212|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
164121213|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164121214|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
164121215|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164121216|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164121217|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
164121218|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
164121219|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
164121220|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
164121221|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
164121222|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
164121223|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
164121224|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
164121225|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
164121226|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
164121227|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
164121228|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
164121229|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121230|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121231|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121232|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121233|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121234|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121235|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
164121236|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121237|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
164121238|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
164121239|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
164121240|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
164121241|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
164121242|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
164121243|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
164121244|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
164121245|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
164121246|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
164121247|NCT00739973|592803388|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121248|NCT00739973|592803389|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
164121249|NCT00739973|592803390|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121250|NCT00739973|592803391|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121251|NCT00739973|592803392|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121252|NCT00739973|592803393|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121253|NCT00739973|592803394|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
164121254|NCT00739973|592803395|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121255|NCT00739973|592803396|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
164121256|NCT02219308|592803397|FG000|Overall Study|Withdrawal by Subject|1|||
164121257|NCT02219308|592803398|FG001|Overall Study|Withdrawal by Subject|2|||
164121258|NCT02175368|592803399|FG000|Overall Study|Lost to Follow-up|1|||
164121259|NCT02875028|592803400|FG000|Washout Period|Withdrawal by Subject|0|||
164121260|NCT02875028|592803401|FG001|Washout Period|Withdrawal by Subject|1|||
164121261|NCT05068284|592803402|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
164121262|NCT05068284|592803403|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
164121263|NCT05068284|592803404|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164121264|NCT05068284|592803405|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164121265|NCT05068284|592803406|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164121266|NCT05068284|592803407|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164121267|NCT05068284|592803408|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164121268|NCT05068284|592803409|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
164121269|NCT05068284|592803402|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121270|NCT05068284|592803403|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121271|NCT05068284|592803404|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
164121272|NCT05068284|592803405|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121273|NCT05068284|592803406|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121274|NCT05068284|592803407|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121275|NCT05068284|592803408|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121276|NCT05068284|592803409|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
164121277|NCT05068284|592803402|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
164121278|NCT05068284|592803403|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
164121279|NCT05068284|592803404|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
164121280|NCT05068284|592803405|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
164121281|NCT05068284|592803406|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
164121282|NCT05068284|592803407|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
164121283|NCT05068284|592803408|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
164121284|NCT05068284|592803409|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
164121285|NCT05068284|592803402|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164121286|NCT05068284|592803403|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164121287|NCT05068284|592803404|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
164121288|NCT05068284|592803405|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164121289|NCT05068284|592803406|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
164121290|NCT05068284|592803407|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164121291|NCT05068284|592803408|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164121292|NCT05068284|592803409|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
164121293|NCT05068284|592803402|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121294|NCT05068284|592803403|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121295|NCT05068284|592803404|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121296|NCT05068284|592803405|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
164121297|NCT05068284|592803406|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121298|NCT05068284|592803407|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121299|NCT05068284|592803408|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121300|NCT05068284|592803409|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
164121301|NCT05068284|592803402|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164121302|NCT05068284|592803403|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164121303|NCT05068284|592803404|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
164121304|NCT05068284|592803405|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
164121305|NCT05068284|592803406|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164121306|NCT05068284|592803407|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164121307|NCT05068284|592803408|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164121308|NCT05068284|592803409|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
164121309|NCT05068284|592803402|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121310|NCT05068284|592803403|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121311|NCT05068284|592803404|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
164121312|NCT05068284|592803405|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121313|NCT05068284|592803406|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121314|NCT05068284|592803407|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121315|NCT05068284|592803408|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121316|NCT05068284|592803409|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
164121317|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
164121318|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121319|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121320|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121321|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121322|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121323|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121324|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
164121325|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
164121326|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164121327|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164121328|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164121329|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164121330|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
164121331|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
164121332|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
164121333|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
164121334|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164121335|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164121336|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164121337|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164121338|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164121339|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
164121340|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
164121341|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
164121342|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164121343|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164121344|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164132676|NCT01986010|592850655|FG000|Overall Study|Lost to Follow-up|2|||
164121345|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164121346|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164121347|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164121348|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
164121349|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
164121350|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121351|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121352|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121353|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121354|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121355|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121356|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
164121357|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
164121358|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164121359|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164121360|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164121361|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
164121362|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
164121363|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
164121364|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
164121365|NCT05068284|592803402|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121366|NCT05068284|592803403|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121367|NCT05068284|592803404|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121368|NCT05068284|592803405|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121369|NCT05068284|592803406|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121370|NCT05068284|592803407|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121371|NCT05068284|592803408|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
164121372|NCT05068284|592803409|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
164121373|NCT01844531|592804988|FG000|Overall Study|Withdrawal by Subject|0|||
164121374|NCT01844531|592804989|FG001|Overall Study|Withdrawal by Subject|1|||
164121375|NCT01844531|592804990|FG002|Overall Study|Withdrawal by Subject|0|||
164121376|NCT01844531|592804991|FG003|Overall Study|Withdrawal by Subject|0|||
164121377|NCT01546922|592804992|FG000|First Period of 10 Weeks|Protocol Violation|3|||
164121378|NCT01546922|592804993|FG001|First Period of 10 Weeks|Protocol Violation|1|||
164121379|NCT01546922|592804992|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
164121380|NCT01546922|592804993|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
164121381|NCT01546922|592804992|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
164121382|NCT01546922|592804993|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
164121383|NCT01546922|592804992|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
164121384|NCT01546922|592804993|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
164121385|NCT01546922|592804992|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
164121386|NCT01546922|592804993|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
164121387|NCT02000531|592804999|FG000|Overall Study|Lost to Follow-up|1|||
164121388|NCT02000531|592805000|FG001|Overall Study|Lost to Follow-up|0|||
164121389|NCT02000531|592804999|FG000|Overall Study|Discontinued due to data cut-off|3|||
164121390|NCT02000531|592805000|FG001|Overall Study|Discontinued due to data cut-off|8|||
164121391|NCT00792623|592805001|FG000|Overall Study|Adverse Event|2|||
164121392|NCT00792623|592805001|FG000|Overall Study|Withdrawal by Subject|5|||
164121393|NCT00892281|592805005|FG000|Overall Study|Adverse Event|65|||
164121394|NCT00892281|592805006|FG001|Overall Study|Adverse Event|8|||
164121395|NCT00892281|592805005|FG000|Overall Study|Lost to Follow-up|81|||
164121396|NCT00892281|592805006|FG001|Overall Study|Lost to Follow-up|8|||
164121397|NCT00892281|592805005|FG000|Overall Study|Pregnancy|1|||
164121398|NCT00892281|592805006|FG001|Overall Study|Pregnancy|0|||
164121399|NCT00892281|592805005|FG000|Overall Study|Protocol Violation|7|||
164121400|NCT00892281|592805006|FG001|Overall Study|Protocol Violation|2|||
164121401|NCT00892281|592805005|FG000|Overall Study|Withdrawal by Subject|86|||
164121402|NCT00892281|592805006|FG001|Overall Study|Withdrawal by Subject|14|||
164121403|NCT00892281|592805005|FG000|Overall Study|Subject failed to return for final visit|2|||
164121404|NCT00892281|592805006|FG001|Overall Study|Subject failed to return for final visit|0|||
164121405|NCT00892281|592805005|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
164121406|NCT00892281|592805006|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
164121407|NCT00892281|592805005|FG000|Overall Study|Final visit completed 4 weeks late|0|||
164121408|NCT00892281|592805006|FG001|Overall Study|Final visit completed 4 weeks late|1|||
164121409|NCT00892281|592805005|FG000|Overall Study|Subject completed day after study closed|1|||
164121410|NCT00892281|592805006|FG001|Overall Study|Subject completed day after study closed|0|||
164121411|NCT00892281|592805005|FG000|Overall Study|Family emergency|1|||
164121412|NCT00892281|592805006|FG001|Overall Study|Family emergency|0|||
164121413|NCT00892281|592805005|FG000|Overall Study|Last visit not done - death in family|1|||
164121414|NCT00892281|592805006|FG001|Overall Study|Last visit not done - death in family|0|||
164121415|NCT00892281|592805005|FG000|Overall Study|Did not meet incl/excl criteria|1|||
164121416|NCT00892281|592805006|FG001|Overall Study|Did not meet incl/excl criteria|0|||
164121417|NCT00892281|592805005|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
164121418|NCT00892281|592805006|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
164121419|NCT00892281|592805005|FG000|Overall Study|Unable to redeem the drug voucher|1|||
164121420|NCT00892281|592805006|FG001|Overall Study|Unable to redeem the drug voucher|0|||
164121421|NCT00892281|592805005|FG000|Overall Study|Subject not good candidate for study|1|||
164121422|NCT00892281|592805006|FG001|Overall Study|Subject not good candidate for study|0|||
164121423|NCT00892281|592805005|FG000|Overall Study|Subject did not return for any visits|1|||
164121424|NCT00892281|592805006|FG001|Overall Study|Subject did not return for any visits|0|||
164121425|NCT00892281|592805005|FG000|Overall Study|Subject missed several visits/lost meds|1|||
164121426|NCT00892281|592805006|FG001|Overall Study|Subject missed several visits/lost meds|0|||
164121427|NCT00892281|592805005|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
164121428|NCT00892281|592805006|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
164121429|NCT00892281|592805005|FG000|Overall Study|Scheduled for knee replacement|0|||
164121430|NCT00892281|592805006|FG001|Overall Study|Scheduled for knee replacement|1|||
164121431|NCT00892281|592805005|FG000|Overall Study|PI complained of inadequate compensation|3|||
164121432|NCT00892281|592805006|FG001|Overall Study|PI complained of inadequate compensation|0|||
164121433|NCT00892281|592805005|FG000|Overall Study|Subject lost interest in program|0|||
164121434|NCT00892281|592805006|FG001|Overall Study|Subject lost interest in program|1|||
164121435|NCT00892281|592805005|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
164121436|NCT00892281|592805006|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
164121437|NCT00892281|592805005|FG000|Overall Study|Death in family|1|||
164121438|NCT00892281|592805006|FG001|Overall Study|Death in family|0|||
164121439|NCT00892281|592805005|FG000|Overall Study|Lack of efficacy of study product|2|||
164121440|NCT00892281|592805006|FG001|Overall Study|Lack of efficacy of study product|0|||
164121441|NCT00892281|592805005|FG000|Overall Study|Subject not seen by PI at final visit|1|||
164121442|NCT00892281|592805006|FG001|Overall Study|Subject not seen by PI at final visit|0|||
164121443|NCT00892281|592805005|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
164121444|NCT00892281|592805006|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
164121445|NCT00892281|592805005|FG000|Overall Study|Missed multiple visits|1|||
164121446|NCT00892281|592805006|FG001|Overall Study|Missed multiple visits|0|||
164121447|NCT00892281|592805005|FG000|Overall Study|Missed visits rescheduled out of window|1|||
164121448|NCT00892281|592805006|FG001|Overall Study|Missed visits rescheduled out of window|0|||
164121449|NCT00892281|592805005|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
164121450|NCT00892281|592805006|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
164121451|NCT00892281|592805005|FG000|Overall Study|Subject had history of drug abuse|1|||
164121452|NCT00892281|592805006|FG001|Overall Study|Subject had history of drug abuse|0|||
164121453|NCT00892281|592805005|FG000|Overall Study|Rash on hand|1|||
164121454|NCT00892281|592805006|FG001|Overall Study|Rash on hand|0|||
164121455|NCT00892281|592805005|FG000|Overall Study|Visit 4 date out of window|1|||
164121456|NCT00892281|592805006|FG001|Overall Study|Visit 4 date out of window|0|||
164121457|NCT01280617|592805007|FG000|Overall Study|Adverse Event|0|||
164121458|NCT01280617|592805008|FG001|Overall Study|Adverse Event|1|||
164121459|NCT00986570|592805009|FG000|Overall Study|Lost to Follow-up|6|||
164121460|NCT00986570|592805009|FG000|Overall Study|Potential bias for objective assessment|1|||
164121461|NCT02225665|592805010|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
164121462|NCT02225665|592805011|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
164121463|NCT02225665|592805010|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
164121464|NCT02225665|592805011|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
164121465|NCT01311557|592805012|FG000|Overall Study|Serious adverse event|0|||
164121466|NCT01311557|592805013|FG001|Overall Study|Serious adverse event|1|||
164121467|NCT01311557|592805012|FG000|Overall Study|Protocol Violation|4|||
164121468|NCT01311557|592805013|FG001|Overall Study|Protocol Violation|2|||
164121469|NCT01311557|592805012|FG000|Overall Study|Lost to Follow-up|0|||
164121470|NCT01311557|592805013|FG001|Overall Study|Lost to Follow-up|1|||
164121471|NCT01311557|592805012|FG000|Overall Study|Withdrawal by Subject|1|||
164121472|NCT01311557|592805013|FG001|Overall Study|Withdrawal by Subject|2|||
164121473|NCT00608517|592805014|FG000|Overall Study|Death|1|||
164121474|NCT00608517|592805015|FG001|Overall Study|Death|0|||
164121475|NCT00608517|592805016|FG002|Overall Study|Death|0|||
164121476|NCT00572039|592805017|FG000|Overall Study|Withdrawal by Subject|9|||
164121477|NCT00572039|592805018|FG001|Overall Study|Withdrawal by Subject|6|||
164121478|NCT00572039|592805017|FG000|Overall Study|Death|2|||
164121479|NCT00572039|592805018|FG001|Overall Study|Death|3|||
164121480|NCT00572039|592805017|FG000|Overall Study|Ill|5|||
164121481|NCT00572039|592805018|FG001|Overall Study|Ill|1|||
164121482|NCT01098110|592805024|FG000|Overall Study|Withdrawal by Subject|14|||
164121483|NCT01098110|592805025|FG001|Overall Study|Withdrawal by Subject|24|||
164121484|NCT01098110|592805026|FG002|Overall Study|Withdrawal by Subject|19|||
164121485|NCT01098110|592805024|FG000|Overall Study|Adverse Event|30|||
164121486|NCT01098110|592805025|FG001|Overall Study|Adverse Event|32|||
164121487|NCT01098110|592805026|FG002|Overall Study|Adverse Event|43|||
164121488|NCT01098110|592805024|FG000|Overall Study|Lack of Efficacy|13|||
164121489|NCT01098110|592805025|FG001|Overall Study|Lack of Efficacy|9|||
164121490|NCT01098110|592805026|FG002|Overall Study|Lack of Efficacy|27|||
164121491|NCT01098110|592805024|FG000|Overall Study|Other|4|||
164121492|NCT01098110|592805025|FG001|Overall Study|Other|7|||
164121493|NCT01098110|592805026|FG002|Overall Study|Other|5|||
164121494|NCT01098110|592805024|FG000|Overall Study|Untreated|1|||
164121495|NCT01098110|592805025|FG001|Overall Study|Untreated|1|||
164121496|NCT01098110|592805026|FG002|Overall Study|Untreated|0|||
164121497|NCT02147587|592805027|FG000|Overall Study|Adverse Event|9|||
164121498|NCT02147587|592805028|FG001|Overall Study|Adverse Event|4|||
164121499|NCT02147587|592805027|FG000|Overall Study|Lack of Efficacy|2|||
164121500|NCT02147587|592805028|FG001|Overall Study|Lack of Efficacy|1|||
164121501|NCT01355302|592805029|FG000|Phase 1b|Death|4|||
164121502|NCT01355302|592805030|FG001|Phase 1b|Death|0|||
164121503|NCT01355302|592805031|FG002|Phase 1b|Death|0|||
164121504|NCT01355302|592805029|FG000|Phase 1b|Study terminated by sponsor|2|||
164121505|NCT01355302|592805030|FG001|Phase 1b|Study terminated by sponsor|0|||
164121506|NCT01355302|592805031|FG002|Phase 1b|Study terminated by sponsor|0|||
164073365|NCT01289990|592632858|FG004|Overall Study|Not treated|0|||
164073366|NCT01289990|592632859|FG005|Overall Study|Not treated|0|||
164073367|NCT01289990|592632860|FG006|Overall Study|Not treated|1|||
164073368|NCT01289990|592632861|FG007|Overall Study|Not treated|0|||
164073369|NCT01289990|592632862|FG008|Overall Study|Not treated|1|||
164073370|NCT01289990|592632863|FG009|Overall Study|Not treated|0|||
164073371|NCT01289990|592632864|FG010|Overall Study|Not treated|1|||
164073372|NCT01289990|592632865|FG011|Overall Study|Not treated|2|||
164073373|NCT01289990|592632866|FG012|Overall Study|Not treated|0|||
164073374|NCT00363129|592632867|FG000|Overall Study|Withdrawal by Subject|11|||
164073375|NCT00363129|592632868|FG001|Overall Study|Withdrawal by Subject|18|||
164073376|NCT00363129|592632867|FG000|Overall Study|Adverse Event|8|||
164073377|NCT00363129|592632868|FG001|Overall Study|Adverse Event|3|||
164073378|NCT00363129|592632867|FG000|Overall Study|Alternate Treatment|2|||
164073379|NCT00363129|592632868|FG001|Overall Study|Alternate Treatment|4|||
164073380|NCT00363129|592632867|FG000|Overall Study|Other Medical Problems|2|||
164073381|NCT00363129|592632868|FG001|Overall Study|Other Medical Problems|4|||
164073382|NCT00363129|592632867|FG000|Overall Study|Death|0|||
164073383|NCT00363129|592632868|FG001|Overall Study|Death|1|||
164073384|NCT00363129|592632867|FG000|Overall Study|Other Reasons|6|||
164073385|NCT00363129|592632868|FG001|Overall Study|Other Reasons|3|||
164073386|NCT03454672|592632869|FG000|Overall Study|Adverse Event|1|||
164073387|NCT03454672|592632870|FG001|Overall Study|Adverse Event|1|||
164073388|NCT03454672|592632869|FG000|Overall Study|Lost to Follow-up|1|||
164073389|NCT03454672|592632870|FG001|Overall Study|Lost to Follow-up|3|||
164073390|NCT03454672|592632869|FG000|Overall Study|painful|1|||
164073391|NCT03454672|592632870|FG001|Overall Study|painful|2|||
164073392|NCT03454672|592632869|FG000|Overall Study|Non-compliance|2|||
164073393|NCT03454672|592632870|FG001|Overall Study|Non-compliance|4|||
164073394|NCT03454672|592632869|FG000|Overall Study|personal reasons|3|||
164073395|NCT03454672|592632870|FG001|Overall Study|personal reasons|2|||
164073396|NCT03454672|592632869|FG000|Overall Study|Withdrawal by Subject|1|||
164073397|NCT03454672|592632870|FG001|Overall Study|Withdrawal by Subject|0|||
164073398|NCT05166512|592632871|FG000|Randomized|Lost to Follow-up|2|||
164073399|NCT05166512|592632872|FG001|Randomized|Lost to Follow-up|0|||
164073400|NCT05166512|592632871|FG000|Randomized|Withdrawal by Subject|1|||
164073401|NCT05166512|592632872|FG001|Randomized|Withdrawal by Subject|0|||
164073402|NCT05166512|592632871|FG000|Baseline Data Collection|Lost to Follow-up|0|||
164073403|NCT05166512|592632872|FG001|Baseline Data Collection|Lost to Follow-up|3|||
164073404|NCT05166512|592632871|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
164073405|NCT05166512|592632872|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
164073406|NCT05166512|592632871|FG000|Baseline Data Collection|Protocol Violation|2|||
164073407|NCT05166512|592632872|FG001|Baseline Data Collection|Protocol Violation|0|||
164073408|NCT05166512|592632871|FG000|4 Month Data Collection|Lost to Follow-up|1|||
164073409|NCT05166512|592632872|FG001|4 Month Data Collection|Lost to Follow-up|0|||
164073410|NCT05166512|592632871|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
164073411|NCT05166512|592632872|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
164073412|NCT05166512|592632871|FG000|12 Month Data Collection|Lost to Follow-up|3|||
164073413|NCT05166512|592632872|FG001|12 Month Data Collection|Lost to Follow-up|1|||
164073414|NCT05166512|592632871|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
164073415|NCT05166512|592632872|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
164073416|NCT00420849|592632873|FG000|Overall Study|Lack of Efficacy|154|||
164073417|NCT00420849|592632873|FG000|Overall Study|Adverse Event|107|||
164121507|NCT01315028|592805036|FG000|Overall Study|Lost to Follow-up|1|||
164121508|NCT01315028|592805037|FG001|Overall Study|Lost to Follow-up|0|||
164121509|NCT01315028|592805036|FG000|Overall Study|Death|0|||
164121510|NCT01315028|592805037|FG001|Overall Study|Death|1|||
164121511|NCT02531594|592805038|FG000|Overall Study|Withdrawal by Subject|7|||
164121512|NCT02531594|592805039|FG001|Overall Study|Withdrawal by Subject|8|||
164121513|NCT03649412|592805050|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
164121514|NCT03649412|592805051|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
164121515|NCT03649412|592805050|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
164121516|NCT03649412|592805051|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
164121517|NCT03649412|592805050|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
164121518|NCT03649412|592805051|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
164121519|NCT03649412|592805050|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
164121520|NCT03649412|592805051|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
164121521|NCT03649412|592805050|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
164121522|NCT03649412|592805051|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
164121523|NCT03649412|592805050|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
164121524|NCT03649412|592805051|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
164121525|NCT00865514|592805052|FG000|Overall Study|Infusion cost exceeded funding|2|||
164121526|NCT02865395|592805053|FG000|Overall Study|Physician Decision|6|||
164121527|NCT02865395|592805054|FG001|Overall Study|Physician Decision|10|||
164121528|NCT02865395|592805055|FG002|Overall Study|Physician Decision|7|||
164121529|NCT04364763|592805056|FG000|Overall Study|Death|1|||
164121530|NCT04364763|592805057|FG001|Overall Study|Death|2|||
164121531|NCT04364763|592805056|FG000|Overall Study|Lost to Follow-up|1|||
164121532|NCT04364763|592805057|FG001|Overall Study|Lost to Follow-up|0|||
164121533|NCT01264835|592805060|FG000|Overall Study|Lost to Follow-up|1|||
164121534|NCT01256060|592805061|FG000|Overall Study|Lost to Follow-up|0|||
164121535|NCT01256060|592805062|FG001|Overall Study|Lost to Follow-up|1|||
164121536|NCT01256060|592805063|FG002|Overall Study|Lost to Follow-up|0|||
164121537|NCT01256060|592805064|FG003|Overall Study|Lost to Follow-up|0|||
164121538|NCT00436917|592805071|FG000|Overall Study|Withdrawal by Subject|13|||
164121539|NCT00436917|592805071|FG000|Overall Study|Adverse Event|2|||
164121540|NCT00436917|592805071|FG000|Overall Study|Physician Decision|1|||
164121541|NCT00436917|592805071|FG000|Overall Study|Death|1|||
164121542|NCT00436917|592805071|FG000|Overall Study|Lost to Follow-up|1|||
164121543|NCT00436917|592805071|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
164121544|NCT00436917|592805071|FG000|Overall Study|Increased creatinine|1|||
164121545|NCT00436917|592805071|FG000|Overall Study|Personal conflicts of patient|1|||
164121546|NCT03170869|592805072|FG000|Overall Study|Protocol Violation|5|||
164121547|NCT03170869|592805072|FG000|Overall Study|Early study termination|3|||
164121548|NCT00983528|592805075|FG000|Overall Study|Death|4|||
164121549|NCT00983528|592805075|FG000|Overall Study|Lost to Follow-up|1|||
164121550|NCT00983528|592805075|FG000|Overall Study|Study Terminated|1|||
164121551|NCT00373425|592805077|FG000|Overall Study|Relapse of NSCLC|116|||
164121552|NCT00373425|592805078|FG001|Overall Study|Relapse of NSCLC|104|||
164121553|NCT00373425|592805079|FG002|Overall Study|Relapse of NSCLC|19|||
164121554|NCT00373425|592805080|FG003|Overall Study|Relapse of NSCLC|2|||
164121555|NCT00373425|592805081|FG004|Overall Study|Relapse of NSCLC|26|||
164121556|NCT00373425|592805077|FG000|Overall Study|Adverse Event|191|||
164121557|NCT00373425|592805078|FG001|Overall Study|Adverse Event|22|||
164121558|NCT00373425|592805079|FG002|Overall Study|Adverse Event|59|||
164121559|NCT00373425|592805080|FG003|Overall Study|Adverse Event|0|||
164121560|NCT00373425|592805081|FG004|Overall Study|Adverse Event|34|||
164121561|NCT00373425|592805077|FG000|Overall Study|Patient request|35|||
164121562|NCT00373425|592805078|FG001|Overall Study|Patient request|18|||
164121563|NCT00373425|592805079|FG002|Overall Study|Patient request|43|||
164121564|NCT00373425|592805080|FG003|Overall Study|Patient request|6|||
164121565|NCT00373425|592805081|FG004|Overall Study|Patient request|7|||
164121566|NCT00373425|592805077|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
164121567|NCT00373425|592805078|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
164121568|NCT00373425|592805079|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
164121569|NCT00373425|592805080|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
164121570|NCT00373425|592805081|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
164121571|NCT00373425|592805077|FG000|Overall Study|Death|7|||
164121572|NCT00373425|592805078|FG001|Overall Study|Death|0|||
164121573|NCT00373425|592805079|FG002|Overall Study|Death|3|||
164121574|NCT00373425|592805080|FG003|Overall Study|Death|1|||
164121575|NCT00373425|592805081|FG004|Overall Study|Death|0|||
164121576|NCT00551616|592805084|FG000|Overall Study|Lost to Follow-up|48|||
164121577|NCT00551616|592805085|FG001|Overall Study|Lost to Follow-up|40|||
164121578|NCT02692482|592805086|FG000|Overall Study|Death|2|||
164121579|NCT02692482|592805087|FG001|Overall Study|Death|2|||
164121580|NCT02692482|592805086|FG000|Overall Study|Withdrawal by Subject|1|||
164121581|NCT02692482|592805087|FG001|Overall Study|Withdrawal by Subject|2|||
164121582|NCT00105157|592805090|FG000|Double-Blind (DB)|Never Treated|1|||
164121583|NCT00105157|592805091|FG001|Double-Blind (DB)|Never Treated|0|||
164121584|NCT00105157|592805092|FG002|Double-Blind (DB)|Never Treated|0|||
164121585|NCT00105157|592805093|FG003|Double-Blind (DB)|Never Treated|0|||
164121586|NCT00105157|592805090|FG000|Double-Blind (DB)|Adverse Event|2|||
164121587|NCT00105157|592805091|FG001|Double-Blind (DB)|Adverse Event|0|||
164121588|NCT00105157|592805092|FG002|Double-Blind (DB)|Adverse Event|1|||
164121589|NCT00105157|592805093|FG003|Double-Blind (DB)|Adverse Event|1|||
164121590|NCT00105157|592805090|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
164121591|NCT00105157|592805091|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
164121592|NCT00105157|592805092|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
164121593|NCT00105157|592805093|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
164121594|NCT00105157|592805090|FG000|Open-Label Continuation of DB|Adverse Event|3|||
164121595|NCT00105157|592805091|FG001|Open-Label Continuation of DB|Adverse Event|1|||
164121596|NCT00105157|592805092|FG002|Open-Label Continuation of DB|Adverse Event|0|||
164121597|NCT00105157|592805093|FG003|Open-Label Continuation of DB|Adverse Event|0|||
164121598|NCT00105157|592805090|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
164121599|NCT00105157|592805091|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
164121600|NCT00105157|592805092|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
164121601|NCT00105157|592805093|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
164121602|NCT00105157|592805090|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
164121603|NCT00105157|592805091|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
164121604|NCT00105157|592805092|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
164121605|NCT00105157|592805093|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
164121606|NCT00105157|592805090|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
164121607|NCT00105157|592805091|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
164121608|NCT00105157|592805092|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
164121609|NCT00105157|592805093|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
164121610|NCT00105157|592805090|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
164121611|NCT00105157|592805091|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
164121612|NCT00105157|592805092|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
164121613|NCT00105157|592805093|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
164121614|NCT00105157|592805090|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
164121615|NCT00105157|592805091|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
164121616|NCT00105157|592805092|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
164121617|NCT00105157|592805093|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
164121618|NCT00105157|592805090|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
164121619|NCT00105157|592805091|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
164121620|NCT00105157|592805092|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
164121621|NCT00105157|592805093|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
164121622|NCT00105157|592805090|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
164121623|NCT00105157|592805091|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
164121624|NCT00105157|592805092|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
164121625|NCT00105157|592805093|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
164121626|NCT00105157|592805090|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
164121627|NCT00105157|592805091|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
164121628|NCT00105157|592805092|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
164121629|NCT00105157|592805093|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
164121630|NCT00105157|592805090|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
164121631|NCT00105157|592805091|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
164121632|NCT00105157|592805092|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
164121633|NCT00105157|592805093|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
164121634|NCT00105157|592805090|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
164121635|NCT00105157|592805091|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
164121636|NCT00105157|592805092|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
164121637|NCT00105157|592805093|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
164121638|NCT03314662|592805094|FG000|Overall Study|Withdrawal by Subject|1|||
164121639|NCT03314662|592805095|FG001|Overall Study|Withdrawal by Subject|1|||
164121640|NCT03314662|592805096|FG002|Overall Study|Withdrawal by Subject|1|||
164121641|NCT03314662|592805094|FG000|Overall Study|Lost to Follow-up|5|||
164121642|NCT03314662|592805095|FG001|Overall Study|Lost to Follow-up|4|||
164121643|NCT03314662|592805096|FG002|Overall Study|Lost to Follow-up|4|||
164121644|NCT03314662|592805094|FG000|Overall Study|Death|2|||
164121645|NCT03314662|592805095|FG001|Overall Study|Death|0|||
164121646|NCT03314662|592805096|FG002|Overall Study|Death|0|||
164121647|NCT01117766|592805101|FG000|First Intervention|Adverse Event|0|||
164121648|NCT01117766|592805102|FG001|First Intervention|Adverse Event|1|||
164121649|NCT01117766|592805101|FG000|First Intervention|Protocol Violation|1|||
164121650|NCT01117766|592805102|FG001|First Intervention|Protocol Violation|0|||
164121651|NCT01117766|592805101|FG000|Washout Period|Protocol Violation|0|||
164121652|NCT01117766|592805102|FG001|Washout Period|Protocol Violation|2|||
164121653|NCT01117766|592805101|FG000|Second Intervention|Lost to Follow-up|1|||
164121654|NCT01117766|592805102|FG001|Second Intervention|Lost to Follow-up|0|||
164121655|NCT01117766|592805101|FG000|Second Intervention|Other|1|||
164121656|NCT01117766|592805102|FG001|Second Intervention|Other|2|||
164121657|NCT01117766|592805101|FG000|Second Intervention|Adverse Event|0|||
164121658|NCT01117766|592805102|FG001|Second Intervention|Adverse Event|2|||
164121659|NCT01117766|592805101|FG000|Second Intervention|Withdrawal by Subject|0|||
164121660|NCT01117766|592805102|FG001|Second Intervention|Withdrawal by Subject|1|||
164121661|NCT04405739|592805103|FG000|Overall Study|Adverse Event|0|||
164121662|NCT04405739|592805104|FG001|Overall Study|Adverse Event|1|||
164121663|NCT04405739|592805105|FG002|Overall Study|Adverse Event|0|||
164121664|NCT04405739|592805106|FG003|Overall Study|Adverse Event|0|||
164121665|NCT04405739|592805103|FG000|Overall Study|Lost to Follow-up|0|||
164121666|NCT04405739|592805104|FG001|Overall Study|Lost to Follow-up|2|||
164121667|NCT04405739|592805105|FG002|Overall Study|Lost to Follow-up|1|||
164121668|NCT04405739|592805106|FG003|Overall Study|Lost to Follow-up|3|||
164121669|NCT04405739|592805103|FG000|Overall Study|Withdrawal by Subject|0|||
164121670|NCT04405739|592805104|FG001|Overall Study|Withdrawal by Subject|2|||
164121671|NCT04405739|592805105|FG002|Overall Study|Withdrawal by Subject|1|||
164121672|NCT04405739|592805106|FG003|Overall Study|Withdrawal by Subject|1|||
164121673|NCT04405739|592805103|FG000|Overall Study|Death|0|||
164121674|NCT04405739|592805104|FG001|Overall Study|Death|0|||
164121675|NCT04405739|592805105|FG002|Overall Study|Death|1|||
164121676|NCT04405739|592805106|FG003|Overall Study|Death|0|||
164121677|NCT04405739|592805103|FG000|Overall Study|Transferred to rehab|0|||
164121678|NCT04405739|592805104|FG001|Overall Study|Transferred to rehab|0|||
164121679|NCT04405739|592805105|FG002|Overall Study|Transferred to rehab|0|||
164121680|NCT04405739|592805106|FG003|Overall Study|Transferred to rehab|1|||
164121681|NCT04405739|592805103|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
164121682|NCT04405739|592805104|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
164121683|NCT04405739|592805105|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
164121684|NCT04405739|592805106|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
164121685|NCT05766787|592805107|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
164121686|NCT05766787|592805108|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
164121687|NCT05766787|592805107|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
164121688|NCT05766787|592805108|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
164121689|NCT05766787|592805107|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
164121690|NCT05766787|592805108|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
164121691|NCT00438659|592805109|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
164121692|NCT00438659|592805110|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
164121693|NCT00438659|592805109|FG000|Overall Study|Cancel|5|||
164121694|NCT00438659|592805110|FG001|Overall Study|Cancel|2|||
164121695|NCT01867606|592805111|FG000|Overall Study|Withdrawal by Subject|10|||
164121696|NCT01867606|592805112|FG001|Overall Study|Withdrawal by Subject|14|||
164121697|NCT01867606|592805111|FG000|Overall Study|Protocol Violation|0|||
164121698|NCT01867606|592805112|FG001|Overall Study|Protocol Violation|1|||
164121699|NCT00206102|592805113|FG000|Overall Study|Adverse Event|119|||
164121700|NCT00206102|592805114|FG001|Overall Study|Adverse Event|82|||
164121701|NCT00206102|592805113|FG000|Overall Study|Protocol Violation|0|||
164121702|NCT00206102|592805114|FG001|Overall Study|Protocol Violation|2|||
164121703|NCT00206102|592805113|FG000|Overall Study|Lack of therapeutic response|16|||
164121704|NCT00206102|592805114|FG001|Overall Study|Lack of therapeutic response|11|||
164121705|NCT00206102|592805113|FG000|Overall Study|Lost to Follow-up|95|||
164121706|NCT00206102|592805114|FG001|Overall Study|Lost to Follow-up|66|||
164121707|NCT00206102|592805113|FG000|Overall Study|Withdrawal by Subject|118|||
164121708|NCT00206102|592805114|FG001|Overall Study|Withdrawal by Subject|101|||
164121709|NCT00206102|592805113|FG000|Overall Study|Study-specific discontinuation criteria|18|||
164121710|NCT00206102|592805114|FG001|Overall Study|Study-specific discontinuation criteria|17|||
164121711|NCT00206102|592805113|FG000|Overall Study|None of those categories|42|||
164121712|NCT00206102|592805114|FG001|Overall Study|None of those categories|36|||
164121713|NCT01835548|592805120|FG000|Dose Optimization Period|Adverse Event|0|||
164121714|NCT01835548|592805121|FG001|Dose Optimization Period|Adverse Event|0|||
164121715|NCT01835548|592805122|FG002|Dose Optimization Period|Adverse Event|1|||
164121716|NCT01835548|592805120|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
164121717|NCT01835548|592805121|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
164121718|NCT01835548|592805122|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
164121719|NCT01835548|592805120|FG000|Double-Blind Treatment Period|Adverse Event|0|||
164121720|NCT01835548|592805121|FG001|Double-Blind Treatment Period|Adverse Event|1|||
164121721|NCT01835548|592805122|FG002|Double-Blind Treatment Period|Adverse Event|0|||
164121722|NCT01835548|592805120|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164121723|NCT01835548|592805121|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
164121724|NCT01835548|592805122|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
164121725|NCT02490800|592805123|FG000|Overall Study|Adverse Event|0|||
164121726|NCT02490800|592805124|FG001|Overall Study|Adverse Event|0|||
164121727|NCT02490800|592805125|FG002|Overall Study|Adverse Event|0|||
164121728|NCT02490800|592805126|FG003|Overall Study|Adverse Event|2|||
164121729|NCT02490800|592805127|FG004|Overall Study|Adverse Event|3|||
164121730|NCT02490800|592805128|FG005|Overall Study|Adverse Event|2|||
164121731|NCT02490800|592805129|FG006|Overall Study|Adverse Event|0|||
164121732|NCT02490800|592805130|FG007|Overall Study|Adverse Event|0|||
164121733|NCT02490800|592805131|FG008|Overall Study|Adverse Event|0|||
164121734|NCT02490800|592805132|FG009|Overall Study|Adverse Event|0|||
164121735|NCT02490800|592805133|FG010|Overall Study|Adverse Event|0|||
164121736|NCT02490800|592805134|FG011|Overall Study|Adverse Event|2|||
164121737|NCT02490800|592805135|FG012|Overall Study|Adverse Event|2|||
164121738|NCT02490800|592805123|FG000|Overall Study|Withdrawal by Subject|0|||
164121739|NCT02490800|592805124|FG001|Overall Study|Withdrawal by Subject|0|||
164121740|NCT02490800|592805125|FG002|Overall Study|Withdrawal by Subject|0|||
164121741|NCT02490800|592805126|FG003|Overall Study|Withdrawal by Subject|1|||
164121742|NCT02490800|592805127|FG004|Overall Study|Withdrawal by Subject|0|||
164121743|NCT02490800|592805128|FG005|Overall Study|Withdrawal by Subject|0|||
164121744|NCT02490800|592805129|FG006|Overall Study|Withdrawal by Subject|0|||
164121745|NCT02490800|592805130|FG007|Overall Study|Withdrawal by Subject|0|||
164121746|NCT02490800|592805131|FG008|Overall Study|Withdrawal by Subject|1|||
164121747|NCT02490800|592805132|FG009|Overall Study|Withdrawal by Subject|0|||
164121748|NCT02490800|592805133|FG010|Overall Study|Withdrawal by Subject|0|||
164121749|NCT02490800|592805134|FG011|Overall Study|Withdrawal by Subject|0|||
164121750|NCT02490800|592805135|FG012|Overall Study|Withdrawal by Subject|0|||
164121751|NCT02490800|592805123|FG000|Overall Study|Progressive disease|3|||
164121752|NCT02490800|592805124|FG001|Overall Study|Progressive disease|3|||
164121753|NCT02490800|592805125|FG002|Overall Study|Progressive disease|3|||
164121754|NCT02490800|592805126|FG003|Overall Study|Progressive disease|4|||
164121755|NCT02490800|592805127|FG004|Overall Study|Progressive disease|4|||
164121756|NCT02490800|592805128|FG005|Overall Study|Progressive disease|1|||
164121757|NCT02490800|592805129|FG006|Overall Study|Progressive disease|4|||
164121758|NCT02490800|592805130|FG007|Overall Study|Progressive disease|3|||
164121759|NCT02490800|592805131|FG008|Overall Study|Progressive disease|6|||
164121760|NCT02490800|592805132|FG009|Overall Study|Progressive disease|2|||
164121761|NCT02490800|592805133|FG010|Overall Study|Progressive disease|7|||
164121762|NCT02490800|592805134|FG011|Overall Study|Progressive disease|1|||
164121763|NCT02490800|592805135|FG012|Overall Study|Progressive disease|10|||
164121764|NCT02490800|592805123|FG000|Overall Study|Patient enrolled in post-trial access|0|||
164121765|NCT02490800|592805124|FG001|Overall Study|Patient enrolled in post-trial access|0|||
164121766|NCT02490800|592805125|FG002|Overall Study|Patient enrolled in post-trial access|0|||
164121767|NCT02490800|592805126|FG003|Overall Study|Patient enrolled in post-trial access|0|||
164121768|NCT02490800|592805127|FG004|Overall Study|Patient enrolled in post-trial access|0|||
164121769|NCT02490800|592805128|FG005|Overall Study|Patient enrolled in post-trial access|0|||
164121770|NCT02490800|592805129|FG006|Overall Study|Patient enrolled in post-trial access|0|||
164121771|NCT02490800|592805130|FG007|Overall Study|Patient enrolled in post-trial access|0|||
164121772|NCT02490800|592805131|FG008|Overall Study|Patient enrolled in post-trial access|0|||
164121773|NCT02490800|592805132|FG009|Overall Study|Patient enrolled in post-trial access|1|||
164121774|NCT02490800|592805133|FG010|Overall Study|Patient enrolled in post-trial access|1|||
164121775|NCT02490800|592805134|FG011|Overall Study|Patient enrolled in post-trial access|0|||
164121776|NCT02490800|592805135|FG012|Overall Study|Patient enrolled in post-trial access|6|||
164121777|NCT01169038|592805136|FG000|Overall Study|Death|1|||
164121778|NCT01169038|592805136|FG000|Overall Study|Adverse Event|5|||
164121779|NCT01169038|592805136|FG000|Overall Study|Required antibiotic administration|1|||
164121780|NCT00576303|592805137|FG000|Dose Titration Period|Early withdrawal|17|||
164121781|NCT00576303|592805137|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
164121782|NCT00576303|592805137|FG000|Long Term Safety Period|Early withdrawal|16|||
164121783|NCT02843659|592805141|FG000|Overall Study|Subject Withdrew Consent|0|||
164121784|NCT02843659|592805142|FG001|Overall Study|Subject Withdrew Consent|0|||
164121785|NCT02843659|592805143|FG002|Overall Study|Subject Withdrew Consent|1|||
164121786|NCT02843659|592805141|FG000|Overall Study|Administrative Reason by Sponsor|4|||
164121787|NCT02843659|592805142|FG001|Overall Study|Administrative Reason by Sponsor|5|||
164121788|NCT02843659|592805143|FG002|Overall Study|Administrative Reason by Sponsor|4|||
164121789|NCT02843659|592805141|FG000|Overall Study|Adverse Event|0|||
164121790|NCT02843659|592805142|FG001|Overall Study|Adverse Event|1|||
164121791|NCT02843659|592805143|FG002|Overall Study|Adverse Event|0|||
164121792|NCT03203642|592805144|FG000|Overall Study|Adverse Event|3|||
164121793|NCT03203642|592805145|FG001|Overall Study|Adverse Event|1|||
164121794|NCT03203642|592805144|FG000|Overall Study|Withdrawal by Subject|6|||
164121795|NCT03203642|592805145|FG001|Overall Study|Withdrawal by Subject|6|||
164121796|NCT03203642|592805144|FG000|Overall Study|Lost to Follow-up|2|||
164121797|NCT03203642|592805145|FG001|Overall Study|Lost to Follow-up|1|||
164121798|NCT03203642|592805144|FG000|Overall Study|Termination of the study by sponsor|1|||
164121799|NCT03203642|592805145|FG001|Overall Study|Termination of the study by sponsor|1|||
164121800|NCT03203642|592805144|FG000|Overall Study|Participant moved|0|||
164121801|NCT03203642|592805145|FG001|Overall Study|Participant moved|1|||
164121802|NCT03203642|592805144|FG000|Overall Study|Investigator's decision|3|||
164121803|NCT03203642|592805145|FG001|Overall Study|Investigator's decision|0|||
164121804|NCT03203642|592805144|FG000|Overall Study|Other than above specified|0|||
164121805|NCT03203642|592805145|FG001|Overall Study|Other than above specified|1|||
164121806|NCT03250299|592806814|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
164121807|NCT03250299|592806815|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
164121808|NCT03250299|592806816|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
164121809|NCT03250299|592806817|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
164121810|NCT03250299|592806818|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
164121811|NCT03250299|592806814|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
164121812|NCT03250299|592806815|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
164121813|NCT03250299|592806816|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
164121814|NCT03250299|592806817|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
164121815|NCT03250299|592806818|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
164121816|NCT03250299|592806814|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164121817|NCT03250299|592806815|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164121818|NCT03250299|592806816|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
164121819|NCT03250299|592806817|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164121820|NCT03250299|592806818|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
164121821|NCT03250299|592806814|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
164121822|NCT03250299|592806815|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
164121823|NCT03250299|592806816|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
164121824|NCT03250299|592806817|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
164121825|NCT03250299|592806818|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
164121826|NCT00977548|592806819|FG000|Overall Study|Ineligible|4|||
164121827|NCT00977548|592806819|FG000|Overall Study|Adverse Event|8|||
164121828|NCT00977548|592806819|FG000|Overall Study|Withdrawal by Subject|1|||
164121829|NCT00794417|592806820|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
164121830|NCT00794417|592806821|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
164121831|NCT00794417|592806822|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
164121832|NCT00794417|592806823|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
164121833|NCT00794417|592806820|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
164121834|NCT00794417|592806821|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
164121835|NCT00794417|592806822|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
164121836|NCT00794417|592806823|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
164121837|NCT00794417|592806820|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
164121838|NCT00794417|592806821|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
164121839|NCT00794417|592806822|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
164121840|NCT00794417|592806823|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
164121841|NCT00794417|592806820|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
164121842|NCT00794417|592806821|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
164121843|NCT00794417|592806822|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
164121844|NCT00794417|592806823|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
164121845|NCT00794417|592806820|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
164121846|NCT00794417|592806821|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
164121847|NCT00794417|592806822|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
164121848|NCT00794417|592806823|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
164121849|NCT00794417|592806820|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
164121850|NCT00794417|592806821|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
164121851|NCT00794417|592806822|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
164121852|NCT00794417|592806823|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
164121853|NCT01546142|592806826|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
164121854|NCT01546142|592806827|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
164121855|NCT01546142|592806826|FG000|Overall Study|Subject Noncompliance|1|||
164121856|NCT01546142|592806827|FG001|Overall Study|Subject Noncompliance|1|||
164121857|NCT01546142|592806826|FG000|Overall Study|Adverse Event|6|||
164121858|NCT01546142|592806827|FG001|Overall Study|Adverse Event|3|||
164121859|NCT01546142|592806826|FG000|Overall Study|Lost to Follow-up|20|||
164121860|NCT01546142|592806827|FG001|Overall Study|Lost to Follow-up|15|||
164121861|NCT01546142|592806826|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
164121862|NCT01546142|592806827|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
164121863|NCT01546142|592806826|FG000|Overall Study|Subject Randomized but Not Treated|1|||
164121864|NCT01546142|592806827|FG001|Overall Study|Subject Randomized but Not Treated|0|||
164121865|NCT01213836|592806828|FG000|Period 1, First Intervention|Adverse Event|2|||
164121866|NCT01213836|592806829|FG001|Period 1, First Intervention|Adverse Event|1|||
164121867|NCT01213836|592806828|FG000|Period 1, First Intervention|Protocol Violation|0|||
164121868|NCT01213836|592806829|FG001|Period 1, First Intervention|Protocol Violation|1|||
164121869|NCT01213836|592806828|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
164121870|NCT01213836|592806829|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
164121871|NCT00255151|592806831|FG000|Overall Study|Adverse Event|10|||
164121872|NCT00255151|592806832|FG001|Overall Study|Adverse Event|6|||
164121873|NCT00255151|592806833|FG002|Overall Study|Adverse Event|9|||
164121874|NCT00255151|592806831|FG000|Overall Study|Lost to Follow-up|4|||
164121875|NCT00255151|592806832|FG001|Overall Study|Lost to Follow-up|3|||
164121876|NCT00255151|592806833|FG002|Overall Study|Lost to Follow-up|4|||
164121877|NCT00255151|592806831|FG000|Overall Study|Withdrawal by Subject|18|||
164121878|NCT00255151|592806832|FG001|Overall Study|Withdrawal by Subject|17|||
164121879|NCT00255151|592806833|FG002|Overall Study|Withdrawal by Subject|8|||
164121880|NCT00255151|592806831|FG000|Overall Study|Noncompliance|0|||
164121881|NCT00255151|592806832|FG001|Overall Study|Noncompliance|1|||
164121882|NCT00255151|592806833|FG002|Overall Study|Noncompliance|2|||
164121883|NCT00255151|592806831|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
164121884|NCT00255151|592806832|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
164121885|NCT00255151|592806833|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
164121886|NCT00255151|592806831|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
164121887|NCT00255151|592806832|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
164121888|NCT00255151|592806833|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
164121889|NCT00255151|592806831|FG000|Overall Study|Possible Barrett's Esophagus|1|||
164121890|NCT00255151|592806832|FG001|Overall Study|Possible Barrett's Esophagus|3|||
164121891|NCT00255151|592806833|FG002|Overall Study|Possible Barrett's Esophagus|8|||
164121892|NCT00255151|592806831|FG000|Overall Study|Esophageal Stricture|0|||
164121893|NCT00255151|592806832|FG001|Overall Study|Esophageal Stricture|0|||
164121894|NCT00255151|592806833|FG002|Overall Study|Esophageal Stricture|1|||
164121895|NCT00255151|592806831|FG000|Overall Study|Therapeutic Failure|11|||
164121896|NCT00255151|592806832|FG001|Overall Study|Therapeutic Failure|2|||
164121897|NCT00255151|592806833|FG002|Overall Study|Therapeutic Failure|3|||
164121898|NCT00743509|592806841|FG000|Overall Study|Withdrawal by Subject|2|||
164121899|NCT01534078|592806842|FG000|Overall Study|Death|1|||
164121900|NCT01534078|592806842|FG000|Overall Study|Withdrawal by Subject|1|||
164121901|NCT01470417|592806846|FG000|Overall Study|Disease progression|0|||
164121902|NCT01470417|592806847|FG001|Overall Study|Disease progression|2|||
164121903|NCT02973321|592806850|FG000|Overall Study|Other than specified|0|||
164121904|NCT02973321|592806851|FG001|Overall Study|Other than specified|5|||
164121905|NCT02973321|592806852|FG002|Overall Study|Other than specified|3|||
164121906|NCT02973321|592806853|FG003|Overall Study|Other than specified|3|||
164121907|NCT02973321|592806854|FG004|Overall Study|Other than specified|1|||
164121908|NCT02973321|592806850|FG000|Overall Study|Lack of Efficacy|0|||
164121909|NCT02973321|592806851|FG001|Overall Study|Lack of Efficacy|0|||
164121910|NCT02973321|592806852|FG002|Overall Study|Lack of Efficacy|0|||
164121911|NCT02973321|592806853|FG003|Overall Study|Lack of Efficacy|0|||
164121912|NCT02973321|592806854|FG004|Overall Study|Lack of Efficacy|1|||
164121913|NCT02973321|592806850|FG000|Overall Study|Adverse Event|1|||
164121914|NCT02973321|592806851|FG001|Overall Study|Adverse Event|10|||
164121915|NCT02973321|592806852|FG002|Overall Study|Adverse Event|11|||
164121916|NCT02973321|592806853|FG003|Overall Study|Adverse Event|13|||
164121917|NCT02973321|592806854|FG004|Overall Study|Adverse Event|3|||
164121918|NCT00263887|592806855|FG000|Overall Study|Withdrawal by Subject|1|||
164121919|NCT00263887|592806856|FG001|Overall Study|Withdrawal by Subject|1|||
164121920|NCT00263887|592806855|FG000|Overall Study|Lung transplantation|1|||
164121921|NCT00263887|592806856|FG001|Overall Study|Lung transplantation|2|||
164121922|NCT00263887|592806855|FG000|Overall Study|Too ill to attend visit|1|||
164121923|NCT00263887|592806856|FG001|Overall Study|Too ill to attend visit|0|||
164121924|NCT00263887|592806855|FG000|Overall Study|Adverse Event|0|||
164121925|NCT00263887|592806856|FG001|Overall Study|Adverse Event|2|||
164121926|NCT00263887|592806855|FG000|Overall Study|Disease progression|0|||
164121927|NCT00263887|592806856|FG001|Overall Study|Disease progression|1|||
164121928|NCT00263887|592806855|FG000|Overall Study|Lack of Efficacy|0|||
164121929|NCT00263887|592806856|FG001|Overall Study|Lack of Efficacy|1|||
164121930|NCT00493454|592806857|FG000|Overall Study|Withdrawal by Subject|1|||
164121931|NCT02274948|592806860|FG000|Overall Study|Lost to Follow-up|28|||
164121932|NCT02274948|592806861|FG001|Overall Study|Lost to Follow-up|25|||
164121933|NCT02274948|592806860|FG000|Overall Study|Withdrawal by Subject|64|||
164121934|NCT02274948|592806861|FG001|Overall Study|Withdrawal by Subject|58|||
164121935|NCT02274948|592806860|FG000|Overall Study|Stopped on family Practitioner advice|2|||
164121936|NCT02274948|592806861|FG001|Overall Study|Stopped on family Practitioner advice|5|||
164121937|NCT02274948|592806860|FG000|Overall Study|Left the area|4|||
164121938|NCT02274948|592806861|FG001|Overall Study|Left the area|3|||
164121939|NCT00707434|592806862|FG000|Overall Study|Adverse Event|1|||
164121940|NCT05212883|592806863|FG000|Overall Study|Invalid test result|125|||
164121941|NCT02502734|592806864|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
164121942|NCT02502734|592806865|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
164121943|NCT02502734|592806864|FG000|Washout Period|Adverse Event|1|||
164121944|NCT02502734|592806865|FG001|Washout Period|Adverse Event|0|||
164121945|NCT00614822|592806866|FG000|Overall Study|Adverse Event|3|||
164121946|NCT03095118|592806867|FG000|Overall Study|Adverse Event|1|||
164121947|NCT03095118|592806867|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
164121948|NCT00530348|592806868|FG000|Overall Study|Adverse Event|5|||
164121949|NCT00530348|592806869|FG001|Overall Study|Adverse Event|1|||
164121950|NCT00530348|592806868|FG000|Overall Study|Death|0|||
164121951|NCT00530348|592806869|FG001|Overall Study|Death|1|||
164121952|NCT00530348|592806868|FG000|Overall Study|Lack of Efficacy|2|||
164121953|NCT00530348|592806869|FG001|Overall Study|Lack of Efficacy|0|||
164121954|NCT00530348|592806868|FG000|Overall Study|Lost to Follow-up|0|||
164121955|NCT00530348|592806869|FG001|Overall Study|Lost to Follow-up|2|||
164121956|NCT00530348|592806868|FG000|Overall Study|Physician Decision|1|||
164121957|NCT00530348|592806869|FG001|Overall Study|Physician Decision|2|||
164121958|NCT00530348|592806868|FG000|Overall Study|Pregnancy|1|||
164121959|NCT00530348|592806869|FG001|Overall Study|Pregnancy|0|||
164121960|NCT00530348|592806868|FG000|Overall Study|Withdrawal by Subject|12|||
164121961|NCT00530348|592806869|FG001|Overall Study|Withdrawal by Subject|12|||
164121962|NCT00530348|592806868|FG000|Overall Study|Randomised in error|1|||
164121963|NCT00530348|592806869|FG001|Overall Study|Randomised in error|0|||
164121964|NCT00530348|592806868|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
164121965|NCT00530348|592806869|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
164121966|NCT00985231|592806873|FG000|Overall Study|ineligible|1|||
164121967|NCT00985231|592806874|FG001|Overall Study|ineligible|0|||
164121968|NCT00985231|592806873|FG000|Overall Study|Protocol Violation|1|||
164121969|NCT00985231|592806874|FG001|Overall Study|Protocol Violation|0|||
164121970|NCT00985231|592806873|FG000|Overall Study|Withdrawal by Subject|1|||
164121971|NCT00985231|592806874|FG001|Overall Study|Withdrawal by Subject|0|||
164121972|NCT00985231|592806873|FG000|Overall Study|Lost to Follow-up|0|||
164121973|NCT00985231|592806874|FG001|Overall Study|Lost to Follow-up|1|||
164121974|NCT00985231|592806873|FG000|Overall Study|Study related symptoms & complaints|0|||
164121975|NCT00985231|592806874|FG001|Overall Study|Study related symptoms & complaints|2|||
164121976|NCT00089076|592806875|FG000|Overall Study|Alternate Therapy|1|||
164121977|NCT00089076|592806875|FG000|Overall Study|Withdrawal by Subject|2|||
164121978|NCT00089076|592806875|FG000|Overall Study|Progression|7|||
164121979|NCT00808509|592806876|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
164121980|NCT00808509|592806877|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
164121981|NCT00808509|592806876|FG000|Randomized Phase|Reduced methotrexate dose|1|||
164121982|NCT00808509|592806877|FG001|Randomized Phase|Reduced methotrexate dose|2|||
164121983|NCT00808509|592806876|FG000|Randomized Phase|Patient refused rescue therapy|0|||
164121984|NCT00808509|592806877|FG001|Randomized Phase|Patient refused rescue therapy|3|||
164121985|NCT00931463|592806878|FG000|Overall Study|Death|8|||
164121986|NCT00931463|592806879|FG001|Overall Study|Death|4|||
164121987|NCT00931463|592806878|FG000|Overall Study|Withdrawal by Subject|5|||
164121988|NCT00931463|592806879|FG001|Overall Study|Withdrawal by Subject|0|||
164121989|NCT00931463|592806878|FG000|Overall Study|Lost to Follow-up|4|||
164121990|NCT00931463|592806879|FG001|Overall Study|Lost to Follow-up|1|||
164121991|NCT02169791|592806882|FG000|Overall Study|Death|6|||
164121992|NCT02169791|592806882|FG000|Overall Study|patient withdrew consent|1|||
164121993|NCT01501110|592806885|FG000|Overall Study|Death|0|||
164121994|NCT01501110|592806886|FG001|Overall Study|Death|1|||
164121995|NCT00575380|592806893|FG000|Overall Study|Withdrawal by Subject|1|||
164121996|NCT00575380|592806894|FG001|Overall Study|Withdrawal by Subject|0|||
164121997|NCT00575380|592806893|FG000|Overall Study|Adverse Event|0|||
164121998|NCT00575380|592806894|FG001|Overall Study|Adverse Event|1|||
164121999|NCT00575380|592806893|FG000|Overall Study|Various|0|||
164122000|NCT00575380|592806894|FG001|Overall Study|Various|2|||
164122001|NCT00003531|592806897|FG000|Overall Study|Not evaluable|10|||
164122002|NCT00346164|592806898|FG000|Overall Study|Adverse Event|0|||
164122003|NCT00346164|592806899|FG001|Overall Study|Adverse Event|0|||
164122004|NCT00346164|592806900|FG002|Overall Study|Adverse Event|0|||
164122005|NCT00346164|592806901|FG003|Overall Study|Adverse Event|1|||
164122006|NCT00346164|592806898|FG000|Overall Study|Lack of Efficacy|0|||
164122007|NCT00346164|592806899|FG001|Overall Study|Lack of Efficacy|1|||
164122008|NCT00346164|592806900|FG002|Overall Study|Lack of Efficacy|7|||
164122009|NCT00346164|592806901|FG003|Overall Study|Lack of Efficacy|25|||
164122010|NCT00346164|592806898|FG000|Overall Study|Physician Decision|0|||
164122011|NCT00346164|592806899|FG001|Overall Study|Physician Decision|1|||
164122012|NCT00346164|592806900|FG002|Overall Study|Physician Decision|2|||
164122013|NCT00346164|592806901|FG003|Overall Study|Physician Decision|27|||
164122014|NCT00346164|592806898|FG000|Overall Study|Protocol Violation|6|||
164122015|NCT00346164|592806899|FG001|Overall Study|Protocol Violation|2|||
164122016|NCT00346164|592806900|FG002|Overall Study|Protocol Violation|10|||
164122017|NCT00346164|592806901|FG003|Overall Study|Protocol Violation|4|||
164122018|NCT00346164|592806898|FG000|Overall Study|Withdrawal by Subject|0|||
164122019|NCT00346164|592806899|FG001|Overall Study|Withdrawal by Subject|0|||
164122020|NCT00346164|592806900|FG002|Overall Study|Withdrawal by Subject|2|||
164122021|NCT00346164|592806901|FG003|Overall Study|Withdrawal by Subject|0|||
164122022|NCT00346164|592806898|FG000|Overall Study|Ineligible|11|||
164122023|NCT00346164|592806899|FG001|Overall Study|Ineligible|2|||
164122024|NCT00346164|592806900|FG002|Overall Study|Ineligible|2|||
164122025|NCT00346164|592806901|FG003|Overall Study|Ineligible|23|||
164122026|NCT00346164|592806898|FG000|Overall Study|Refusal of further protocol therapy|0|||
164122027|NCT00346164|592806899|FG001|Overall Study|Refusal of further protocol therapy|1|||
164122028|NCT00346164|592806900|FG002|Overall Study|Refusal of further protocol therapy|3|||
164122029|NCT00346164|592806901|FG003|Overall Study|Refusal of further protocol therapy|15|||
164122030|NCT00346164|592806898|FG000|Overall Study|Inability to start week 16 tx on time|0|||
164132677|NCT01986010|592850656|FG001|Overall Study|Lost to Follow-up|1|||
164122031|NCT00346164|592806899|FG001|Overall Study|Inability to start week 16 tx on time|0|||
164122032|NCT00346164|592806900|FG002|Overall Study|Inability to start week 16 tx on time|0|||
164122033|NCT00346164|592806901|FG003|Overall Study|Inability to start week 16 tx on time|11|||
164122034|NCT02927834|592806902|FG000|Overall Study|Lost to Follow-up|1|||
164122035|NCT02927834|592806903|FG001|Overall Study|Lost to Follow-up|2|||
164122036|NCT02927834|592806904|FG002|Overall Study|Lost to Follow-up|2|||
164122037|NCT03812991|592806906|FG000|Overall Study|Lost to Follow-up|3|||
164122038|NCT03812991|592806907|FG001|Overall Study|Lost to Follow-up|1|||
164122039|NCT00127166|592806908|FG000|Period I|Protocol Violation|0|||
164122040|NCT00127166|592806909|FG001|Period I|Protocol Violation|2|||
164122041|NCT00127166|592806908|FG000|Period I|Withdrawal by Subject|2|||
164122042|NCT00127166|592806909|FG001|Period I|Withdrawal by Subject|0|||
164122043|NCT00127166|592806908|FG000|Period I|Patient did not meet inclusion criteria|1|||
164122044|NCT00127166|592806909|FG001|Period I|Patient did not meet inclusion criteria|0|||
164122045|NCT00127166|592806908|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
164122046|NCT00127166|592806909|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
164122047|NCT00127166|592806908|FG000|Period II|Withdrawal by Subject|2|||
164122048|NCT00127166|592806909|FG001|Period II|Withdrawal by Subject|0|||
164122049|NCT00127166|592806908|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
164122050|NCT00127166|592806909|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
164122051|NCT01396421|592806910|FG000|Overall Study|Lost to Follow-up|0|||
164122052|NCT01396421|592806911|FG001|Overall Study|Lost to Follow-up|0|||
164122053|NCT01396421|592806912|FG002|Overall Study|Lost to Follow-up|0|||
164122054|NCT01396421|592806913|FG003|Overall Study|Lost to Follow-up|1|||
164122055|NCT01396421|592806910|FG000|Overall Study|Adverse Event|17|||
164122056|NCT01396421|592806911|FG001|Overall Study|Adverse Event|15|||
164122057|NCT01396421|592806912|FG002|Overall Study|Adverse Event|12|||
164122058|NCT01396421|592806913|FG003|Overall Study|Adverse Event|32|||
164122059|NCT01396421|592806910|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
164122060|NCT01396421|592806911|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
164122061|NCT01396421|592806912|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
164122062|NCT01396421|592806913|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
164122063|NCT01396421|592806910|FG000|Overall Study|Physician Decision|1|||
164122064|NCT01396421|592806911|FG001|Overall Study|Physician Decision|1|||
164122065|NCT01396421|592806912|FG002|Overall Study|Physician Decision|0|||
164122066|NCT01396421|592806913|FG003|Overall Study|Physician Decision|3|||
164122067|NCT01396421|592806910|FG000|Overall Study|Withdrawal by Subject|31|||
164122068|NCT01396421|592806911|FG001|Overall Study|Withdrawal by Subject|24|||
164122069|NCT01396421|592806912|FG002|Overall Study|Withdrawal by Subject|13|||
164122070|NCT01396421|592806913|FG003|Overall Study|Withdrawal by Subject|21|||
164122071|NCT01396421|592806910|FG000|Overall Study|Protocol Deviation|2|||
164122072|NCT01396421|592806911|FG001|Overall Study|Protocol Deviation|1|||
164122073|NCT01396421|592806912|FG002|Overall Study|Protocol Deviation|1|||
164122074|NCT01396421|592806913|FG003|Overall Study|Protocol Deviation|0|||
164122075|NCT01396421|592806910|FG000|Overall Study|Lack of Efficacy|7|||
164122076|NCT01396421|592806911|FG001|Overall Study|Lack of Efficacy|17|||
164122077|NCT01396421|592806912|FG002|Overall Study|Lack of Efficacy|7|||
164122078|NCT01396421|592806913|FG003|Overall Study|Lack of Efficacy|18|||
164122079|NCT01148225|592806914|FG000|Overall Study|Other|185|||
164122080|NCT04798482|592806919|FG000|Overall Study|Physician Decision|1|||
164122081|NCT04798482|592806919|FG000|Overall Study|Lost eligibility|1|||
164122082|NCT01506908|592806920|FG000|Overall Study|Adverse Event|1|||
164122083|NCT01506908|592806921|FG001|Overall Study|Adverse Event|0|||
164122084|NCT01610063|592806922|FG000|Overall Study|Lost to Follow-up|42|||
164122085|NCT01610063|592806923|FG001|Overall Study|Lost to Follow-up|20|||
164122086|NCT04232540|592806932|FG000|Overall Study|Lost to Follow-up|1|||
164122087|NCT04232540|592806933|FG001|Overall Study|Lost to Follow-up|0|||
164122088|NCT00537017|592806934|FG000|Treatment Phase|Adverse Event|19|||
164122089|NCT00537017|592806934|FG000|Treatment Phase|Withdrawal by Subject|13|||
164122090|NCT00537017|592806934|FG000|Treatment Phase|Protocol Violation|2|||
164122091|NCT00537017|592806934|FG000|Follow-up Phase|Withdrawal by Subject|9|||
164122092|NCT01662362|592806936|FG000|Overall Study|Lost to Follow-up|38|||
164122093|NCT02339090|592806937|FG000|Overall Study|Adverse Event|1|||
164073418|NCT00420849|592632873|FG000|Overall Study|Withdrawal by Subject|28|||
164073419|NCT00420849|592632873|FG000|Overall Study|Death|18|||
164073420|NCT00420849|592632873|FG000|Overall Study|Other|14|||
164073421|NCT00420849|592632873|FG000|Overall Study|Transplant|8|||
164073422|NCT00420849|592632873|FG000|Overall Study|Protocol Violation|1|||
164073423|NCT00420849|592632873|FG000|Overall Study|Lost to Follow-up|1|||
164073424|NCT00659581|592632874|FG000|Overall Study|Adverse Event|1006|||
164073425|NCT00659581|592632874|FG000|Overall Study|Lack of Efficacy|1183|||
164073426|NCT00659581|592632874|FG000|Overall Study|Other|6393|||
164073427|NCT01345058|592632875|FG000|Overall Study|Withdrawal by Subject|1|||
164073428|NCT01345058|592632876|FG001|Overall Study|Withdrawal by Subject|0|||
164073429|NCT01345058|592632875|FG000|Overall Study|Participant Reported Increase in Events|1|||
164073430|NCT01345058|592632876|FG001|Overall Study|Participant Reported Increase in Events|0|||
164073431|NCT01345058|592632875|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
164122094|NCT02339090|592806938|FG001|Overall Study|Adverse Event|0|||
164122095|NCT02339090|592806937|FG000|Overall Study|Lost to Follow-up|0|||
164122096|NCT02339090|592806938|FG001|Overall Study|Lost to Follow-up|1|||
164122097|NCT02339090|592806937|FG000|Overall Study|Non-compliance With Study Drug|0|||
164122098|NCT02339090|592806938|FG001|Overall Study|Non-compliance With Study Drug|1|||
164122099|NCT02339090|592806937|FG000|Overall Study|Withdrawal by Subject|2|||
164122100|NCT02339090|592806938|FG001|Overall Study|Withdrawal by Subject|1|||
164122101|NCT02339090|592806937|FG000|Overall Study|Poor Growth|3|||
164122102|NCT02339090|592806938|FG001|Overall Study|Poor Growth|0|||
164122103|NCT02339090|592806937|FG000|Overall Study|Randomized but not treated|0|||
164122104|NCT02339090|592806938|FG001|Overall Study|Randomized but not treated|2|||
164122105|NCT00442546|592806939|FG000|Overall Study|Adverse Event|11|||
164122106|NCT00442546|592806940|FG001|Overall Study|Adverse Event|17|||
164122107|NCT00442546|592806941|FG002|Overall Study|Adverse Event|13|||
164122108|NCT00442546|592806939|FG000|Overall Study|Lost to Follow-up|1|||
164122109|NCT00442546|592806940|FG001|Overall Study|Lost to Follow-up|2|||
164122110|NCT00442546|592806941|FG002|Overall Study|Lost to Follow-up|1|||
164122111|NCT00442546|592806939|FG000|Overall Study|Other|4|||
164122112|NCT00442546|592806940|FG001|Overall Study|Other|9|||
164122113|NCT00442546|592806941|FG002|Overall Study|Other|6|||
164122114|NCT00442546|592806939|FG000|Overall Study|Withdrawal by Subject|5|||
164122115|NCT00442546|592806940|FG001|Overall Study|Withdrawal by Subject|5|||
164122116|NCT00442546|592806941|FG002|Overall Study|Withdrawal by Subject|7|||
164122117|NCT00442546|592806939|FG000|Overall Study|Randomized But Not Treated|5|||
164122118|NCT00442546|592806940|FG001|Overall Study|Randomized But Not Treated|4|||
164122119|NCT00442546|592806941|FG002|Overall Study|Randomized But Not Treated|6|||
164122120|NCT01253317|592806943|FG000|Overall Study|Adverse Event|2|||
164122121|NCT03183141|592806944|FG000|Overall Study|Withdrawal by Subject|2|||
164122122|NCT03183141|592806945|FG001|Overall Study|Withdrawal by Subject|4|||
164122123|NCT03183141|592806944|FG000|Overall Study|Death|0|||
164122124|NCT03183141|592806945|FG001|Overall Study|Death|8|||
164122125|NCT01507090|592806949|FG000|Overall Study|incomplete dataset|18|||
164122126|NCT00546910|592809161|FG000|Overall Study|Adverse Event|2|||
164122127|NCT00546910|592809162|FG001|Overall Study|Adverse Event|3|||
164122128|NCT00546910|592809161|FG000|Overall Study|Lack of Efficacy|5|||
164122129|NCT00546910|592809162|FG001|Overall Study|Lack of Efficacy|7|||
164122130|NCT00546910|592809161|FG000|Overall Study|Physician Decision|0|||
164122131|NCT00546910|592809162|FG001|Overall Study|Physician Decision|1|||
164122132|NCT00546910|592809161|FG000|Overall Study|Withdrawal by Subject|2|||
164122133|NCT00546910|592809162|FG001|Overall Study|Withdrawal by Subject|0|||
164122134|NCT01301482|592809163|FG000|Overall Study|Withdrawal by Subject|1|||
164122135|NCT04039919|592809169|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164122136|NCT04039919|592809170|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164122137|NCT04039919|592809171|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164122138|NCT04039919|592809172|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164122139|NCT04039919|592809173|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164122140|NCT04039919|592809169|FG000|Treatment Period 1|Sponsor's decision|0|||
164122141|NCT04039919|592809170|FG001|Treatment Period 1|Sponsor's decision|0|||
164122142|NCT04039919|592809171|FG002|Treatment Period 1|Sponsor's decision|0|||
164122143|NCT04039919|592809172|FG003|Treatment Period 1|Sponsor's decision|0|||
164122144|NCT04039919|592809173|FG004|Treatment Period 1|Sponsor's decision|16|||
164122145|NCT04039919|592809169|FG000|Treatment Period 5|Withdrawal by Subject|1|||
164122146|NCT04039919|592809170|FG001|Treatment Period 5|Withdrawal by Subject|0|||
164122147|NCT04039919|592809171|FG002|Treatment Period 5|Withdrawal by Subject|0|||
164122148|NCT04039919|592809172|FG003|Treatment Period 5|Withdrawal by Subject|0|||
164122149|NCT04039919|592809173|FG004|Treatment Period 5|Withdrawal by Subject|0|||
164122150|NCT00706095|592809174|FG000|Overall Study|Progressive Disease|4|||
164122151|NCT00706095|592809175|FG001|Overall Study|Progressive Disease|5|||
164122152|NCT00706095|592809176|FG002|Overall Study|Progressive Disease|3|||
164122153|NCT00706095|592809174|FG000|Overall Study|Clinical Progression|1|||
164122154|NCT00706095|592809175|FG001|Overall Study|Clinical Progression|2|||
164122155|NCT00706095|592809176|FG002|Overall Study|Clinical Progression|2|||
164122156|NCT00706095|592809174|FG000|Overall Study|Withdrawal by Subject|1|||
164122157|NCT00706095|592809175|FG001|Overall Study|Withdrawal by Subject|0|||
164122158|NCT00706095|592809176|FG002|Overall Study|Withdrawal by Subject|0|||
164122159|NCT01011556|592809178|FG000|Overall Study|Adverse Event|1|||
164122160|NCT01011556|592809179|FG001|Overall Study|Adverse Event|3|||
164122161|NCT01011556|592809180|FG002|Overall Study|Adverse Event|2|||
164122162|NCT01011556|592809181|FG003|Overall Study|Adverse Event|1|||
164122163|NCT01011556|592809178|FG000|Overall Study|Lost to Follow-up|1|||
164122164|NCT01011556|592809179|FG001|Overall Study|Lost to Follow-up|0|||
164122165|NCT01011556|592809180|FG002|Overall Study|Lost to Follow-up|0|||
164122166|NCT01011556|592809181|FG003|Overall Study|Lost to Follow-up|0|||
164122167|NCT01011556|592809178|FG000|Overall Study|Physician Decision|1|||
164122168|NCT01011556|592809179|FG001|Overall Study|Physician Decision|0|||
164122169|NCT01011556|592809180|FG002|Overall Study|Physician Decision|0|||
164122170|NCT01011556|592809181|FG003|Overall Study|Physician Decision|1|||
164122171|NCT01011556|592809178|FG000|Overall Study|Protocol Violation|0|||
164122172|NCT01011556|592809179|FG001|Overall Study|Protocol Violation|1|||
164122173|NCT01011556|592809180|FG002|Overall Study|Protocol Violation|0|||
164122174|NCT01011556|592809181|FG003|Overall Study|Protocol Violation|0|||
164122175|NCT01011556|592809178|FG000|Overall Study|Withdrawal by Subject|1|||
164122176|NCT01011556|592809179|FG001|Overall Study|Withdrawal by Subject|2|||
164122177|NCT01011556|592809180|FG002|Overall Study|Withdrawal by Subject|4|||
164122178|NCT01011556|592809181|FG003|Overall Study|Withdrawal by Subject|4|||
164122179|NCT01011556|592809178|FG000|Overall Study|Sponsor decision|0|||
164122180|NCT01011556|592809179|FG001|Overall Study|Sponsor decision|1|||
164122181|NCT01011556|592809180|FG002|Overall Study|Sponsor decision|1|||
164122182|NCT01011556|592809181|FG003|Overall Study|Sponsor decision|2|||
164122183|NCT01011556|592809178|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
164122184|NCT01011556|592809179|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
164122185|NCT01011556|592809180|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
164122186|NCT01011556|592809181|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
164122187|NCT03920280|592809182|FG000|Overall Study|Adverse Event|2|||
164122188|NCT03920280|592809183|FG001|Overall Study|Adverse Event|3|||
164122189|NCT03920280|592809182|FG000|Overall Study|Lost to Follow-up|0|||
164122190|NCT03920280|592809183|FG001|Overall Study|Lost to Follow-up|1|||
164122191|NCT03920280|592809182|FG000|Overall Study|Withdrawal by Subject|1|||
164122192|NCT03920280|592809183|FG001|Overall Study|Withdrawal by Subject|1|||
164122193|NCT03920280|592809182|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
164122194|NCT03920280|592809183|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
164122195|NCT01009515|592809184|FG000|Overall Study|Withdrawal by Subject|3|||
164122196|NCT02075606|592809186|FG000|Overall Study|Adverse Event|5|||
164122197|NCT02075606|592809186|FG000|Overall Study|Withdrawal by Subject|1|||
164122198|NCT02075606|592809186|FG000|Overall Study|Death|1|||
164122199|NCT02075606|592809186|FG000|Overall Study|Investigator's decision|1|||
164122200|NCT02075606|592809186|FG000|Overall Study|Symptom management|1|||
164122201|NCT02075606|592809186|FG000|Overall Study|Increasing Symptoms|1|||
164122202|NCT00983476|592809190|FG000|Overall Study|Did not receive intervention|17|||
164122203|NCT00983476|592809191|FG001|Overall Study|Did not receive intervention|22|||
164122204|NCT00983476|592809192|FG002|Overall Study|Did not receive intervention|0|||
164122205|NCT01439724|592809194|FG000|Overall Study|missing consultation|9|||
164122206|NCT01439724|592809195|FG001|Overall Study|missing consultation|8|||
164122207|NCT01857206|592809197|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
164122208|NCT01857206|592809198|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
164122209|NCT01857206|592809197|FG000|Overall Study|Lost to Follow-up|9|||
164122210|NCT01857206|592809198|FG001|Overall Study|Lost to Follow-up|6|||
164122211|NCT01857206|592809197|FG000|Overall Study|Unclassified|3|||
164122212|NCT01857206|592809198|FG001|Overall Study|Unclassified|3|||
164122213|NCT01857206|592809197|FG000|Overall Study|Withdrawal by Subject|1|||
164122214|NCT01857206|592809198|FG001|Overall Study|Withdrawal by Subject|0|||
164122215|NCT01483625|592809199|FG000|Overall Study|Adverse Event|1|||
164122216|NCT01483625|592809200|FG001|Overall Study|Adverse Event|1|||
164122217|NCT01483625|592809199|FG000|Overall Study|Refused to continue medication|2|||
164122218|NCT01483625|592809200|FG001|Overall Study|Refused to continue medication|1|||
164122219|NCT01483625|592809199|FG000|Overall Study|Due to other reason|1|||
164122220|NCT01483625|592809200|FG001|Overall Study|Due to other reason|0|||
164122221|NCT00084799|592809201|FG000|Overall Study|Disease Progression|1|||
164122222|NCT00084799|592809202|FG001|Overall Study|Disease Progression|0|||
164122223|NCT04019054|592809203|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
164122224|NCT04019054|592809204|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
164122225|NCT04019054|592809203|FG000|Overall Study|Withdrawal by Subject|3|||
164122226|NCT04019054|592809204|FG001|Overall Study|Withdrawal by Subject|1|||
164122227|NCT01261624|592809209|FG000|Week 0 to Week 12|Disease Progression|1|||
164122228|NCT01261624|592809210|FG001|Week 0 to Week 12|Disease Progression|1|||
164122229|NCT01261624|592809209|FG000|Week 0 to Week 12|Insufficient Response|0|||
164122230|NCT01261624|592809210|FG001|Week 0 to Week 12|Insufficient Response|2|||
164122231|NCT01261624|592809209|FG000|Week 13 to Week 24|Insufficient Response|0|||
164122232|NCT01261624|592809210|FG001|Week 13 to Week 24|Insufficient Response|1|||
164122233|NCT01040793|592809211|FG000|Overall Study|Adverse Event|5|||
164122234|NCT01040793|592809212|FG001|Overall Study|Adverse Event|3|||
164122235|NCT01040793|592809213|FG002|Overall Study|Adverse Event|0|||
164122236|NCT01040793|592809214|FG003|Overall Study|Adverse Event|2|||
164122237|NCT01040793|592809215|FG004|Overall Study|Adverse Event|2|||
164122238|NCT01040793|592809216|FG005|Overall Study|Adverse Event|1|||
164122239|NCT01040793|592809211|FG000|Overall Study|Protocol Violation|1|||
164122240|NCT01040793|592809212|FG001|Overall Study|Protocol Violation|1|||
164122241|NCT01040793|592809213|FG002|Overall Study|Protocol Violation|1|||
164122242|NCT01040793|592809214|FG003|Overall Study|Protocol Violation|0|||
164122243|NCT01040793|592809215|FG004|Overall Study|Protocol Violation|1|||
164122244|NCT01040793|592809216|FG005|Overall Study|Protocol Violation|0|||
164122245|NCT01040793|592809211|FG000|Overall Study|Lost to Follow-up|0|||
164122246|NCT01040793|592809212|FG001|Overall Study|Lost to Follow-up|1|||
164122247|NCT01040793|592809213|FG002|Overall Study|Lost to Follow-up|1|||
164122248|NCT01040793|592809214|FG003|Overall Study|Lost to Follow-up|0|||
164122249|NCT01040793|592809215|FG004|Overall Study|Lost to Follow-up|0|||
164122250|NCT01040793|592809216|FG005|Overall Study|Lost to Follow-up|0|||
164122251|NCT01040793|592809211|FG000|Overall Study|Withdrawal by Subject|0|||
164122252|NCT01040793|592809212|FG001|Overall Study|Withdrawal by Subject|0|||
164122253|NCT01040793|592809213|FG002|Overall Study|Withdrawal by Subject|0|||
164122254|NCT01040793|592809214|FG003|Overall Study|Withdrawal by Subject|2|||
164122255|NCT01040793|592809215|FG004|Overall Study|Withdrawal by Subject|0|||
164122256|NCT01040793|592809216|FG005|Overall Study|Withdrawal by Subject|0|||
164122257|NCT01040793|592809211|FG000|Overall Study|Other reasons not listed above|0|||
164122258|NCT01040793|592809212|FG001|Overall Study|Other reasons not listed above|0|||
164122259|NCT01040793|592809213|FG002|Overall Study|Other reasons not listed above|1|||
164122260|NCT01040793|592809214|FG003|Overall Study|Other reasons not listed above|0|||
164122261|NCT01040793|592809215|FG004|Overall Study|Other reasons not listed above|1|||
164122262|NCT01040793|592809216|FG005|Overall Study|Other reasons not listed above|0|||
164122263|NCT02094261|592809217|FG000|Overall Study|Death|24|||
164122264|NCT02094261|592809217|FG000|Overall Study|Lost to Follow-up|1|||
164122265|NCT02094261|592809217|FG000|Overall Study|Withdrawal by Subject|4|||
164122266|NCT02094261|592809217|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
164122267|NCT02412722|592809220|FG000|Overall Study|Adverse Event|0|||
164122268|NCT02412722|592809221|FG001|Overall Study|Adverse Event|2|||
164122269|NCT02412722|592809222|FG002|Overall Study|Adverse Event|0|||
164122270|NCT02412722|592809223|FG003|Overall Study|Adverse Event|3|||
164122271|NCT02412722|592809224|FG004|Overall Study|Adverse Event|0|||
164122272|NCT02412722|592809225|FG005|Overall Study|Adverse Event|3|||
164122273|NCT02412722|592809220|FG000|Overall Study|Progressive Disease|6|||
164122274|NCT02412722|592809221|FG001|Overall Study|Progressive Disease|4|||
164122275|NCT02412722|592809222|FG002|Overall Study|Progressive Disease|4|||
164122276|NCT02412722|592809223|FG003|Overall Study|Progressive Disease|9|||
164122277|NCT02412722|592809224|FG004|Overall Study|Progressive Disease|3|||
164122278|NCT02412722|592809225|FG005|Overall Study|Progressive Disease|3|||
164122279|NCT02412722|592809220|FG000|Overall Study|Withdrawal by Subject|2|||
164122280|NCT02412722|592809221|FG001|Overall Study|Withdrawal by Subject|0|||
164122281|NCT02412722|592809222|FG002|Overall Study|Withdrawal by Subject|1|||
164122282|NCT02412722|592809223|FG003|Overall Study|Withdrawal by Subject|2|||
164122283|NCT02412722|592809224|FG004|Overall Study|Withdrawal by Subject|1|||
164122284|NCT02412722|592809225|FG005|Overall Study|Withdrawal by Subject|1|||
164122285|NCT02412722|592809220|FG000|Overall Study|Lost to Follow-up|0|||
164122286|NCT02412722|592809221|FG001|Overall Study|Lost to Follow-up|0|||
164122287|NCT02412722|592809222|FG002|Overall Study|Lost to Follow-up|0|||
164122288|NCT02412722|592809223|FG003|Overall Study|Lost to Follow-up|0|||
164122289|NCT02412722|592809224|FG004|Overall Study|Lost to Follow-up|1|||
164122290|NCT02412722|592809225|FG005|Overall Study|Lost to Follow-up|0|||
164122291|NCT02412722|592809220|FG000|Overall Study|Received drug in run-in and discontinued|0|||
164122292|NCT02412722|592809221|FG001|Overall Study|Received drug in run-in and discontinued|2|||
164122293|NCT02412722|592809222|FG002|Overall Study|Received drug in run-in and discontinued|0|||
164122294|NCT02412722|592809223|FG003|Overall Study|Received drug in run-in and discontinued|0|||
164122295|NCT02412722|592809224|FG004|Overall Study|Received drug in run-in and discontinued|0|||
164122296|NCT02412722|592809225|FG005|Overall Study|Received drug in run-in and discontinued|0|||
164122297|NCT02412722|592809220|FG000|Overall Study|Reason not Specified|3|||
164122298|NCT02412722|592809221|FG001|Overall Study|Reason not Specified|0|||
164122299|NCT02412722|592809222|FG002|Overall Study|Reason not Specified|2|||
164122300|NCT02412722|592809223|FG003|Overall Study|Reason not Specified|1|||
164122301|NCT02412722|592809224|FG004|Overall Study|Reason not Specified|2|||
164122302|NCT02412722|592809225|FG005|Overall Study|Reason not Specified|6|||
164122303|NCT01083680|592809226|FG000|Overall Study|Lost to Follow-up|2758|||
164122304|NCT01083680|592809226|FG000|Overall Study|Withdrawal by Subject|1086|||
164122305|NCT03877926|592809227|FG000|Overall Study|Adverse Event|1|||
164122306|NCT03877926|592809228|FG001|Overall Study|Adverse Event|0|||
164122307|NCT03877926|592809229|FG002|Overall Study|Adverse Event|0|||
164122308|NCT03877926|592809230|FG003|Overall Study|Adverse Event|0|||
164122309|NCT03877926|592809227|FG000|Overall Study|Death|2|||
164122310|NCT03877926|592809228|FG001|Overall Study|Death|2|||
164122311|NCT03877926|592809229|FG002|Overall Study|Death|2|||
164122312|NCT03877926|592809230|FG003|Overall Study|Death|0|||
164122313|NCT03877926|592809227|FG000|Overall Study|Lost to Follow-up|41|||
164122314|NCT03877926|592809228|FG001|Overall Study|Lost to Follow-up|52|||
164122315|NCT03877926|592809229|FG002|Overall Study|Lost to Follow-up|45|||
164122316|NCT03877926|592809230|FG003|Overall Study|Lost to Follow-up|17|||
164122317|NCT03877926|592809227|FG000|Overall Study|Physician Decision|2|||
164122318|NCT03877926|592809228|FG001|Overall Study|Physician Decision|0|||
164122319|NCT03877926|592809229|FG002|Overall Study|Physician Decision|2|||
164122320|NCT03877926|592809230|FG003|Overall Study|Physician Decision|0|||
164122321|NCT03877926|592809227|FG000|Overall Study|Withdrawal by Subject|18|||
164122322|NCT03877926|592809228|FG001|Overall Study|Withdrawal by Subject|21|||
164122323|NCT03877926|592809229|FG002|Overall Study|Withdrawal by Subject|12|||
164122324|NCT03877926|592809230|FG003|Overall Study|Withdrawal by Subject|4|||
164122325|NCT03877926|592809227|FG000|Overall Study|Other - Various|4|||
164122326|NCT03877926|592809228|FG001|Overall Study|Other - Various|1|||
164122327|NCT03877926|592809229|FG002|Overall Study|Other - Various|1|||
164122328|NCT03877926|592809230|FG003|Overall Study|Other - Various|0|||
164122329|NCT03877926|592809227|FG000|Overall Study|Not Treated|3|||
164122330|NCT03877926|592809228|FG001|Overall Study|Not Treated|1|||
164122331|NCT03877926|592809229|FG002|Overall Study|Not Treated|1|||
164122332|NCT03877926|592809230|FG003|Overall Study|Not Treated|0|||
164122333|NCT03554317|592809232|FG000|Overall Study|Withdrawal by Subject|1|||
164122334|NCT03554317|592809232|FG000|Overall Study|PSA Progression|3|||
164122335|NCT03554317|592809232|FG000|Overall Study|Radiographic Progression|4|||
164122336|NCT03546647|592809233|FG000|Overall Study|Adverse Event|1|||
164122337|NCT03546647|592809234|FG001|Overall Study|Adverse Event|0|||
164122338|NCT02400476|592809237|FG000|Overall Study|Adverse Event|57|||
164122339|NCT02400476|592809238|FG001|Overall Study|Adverse Event|10|||
164122340|NCT02400476|592809239|FG002|Overall Study|Adverse Event|22|||
164122341|NCT02400476|592809240|FG003|Overall Study|Adverse Event|19|||
164122342|NCT02400476|592809241|FG004|Overall Study|Adverse Event|5|||
164122343|NCT02400476|592809242|FG005|Overall Study|Adverse Event|8|||
164122344|NCT02400476|592809237|FG000|Overall Study|Withdrawal by Subject|4|||
164122345|NCT02400476|592809238|FG001|Overall Study|Withdrawal by Subject|1|||
164122346|NCT02400476|592809239|FG002|Overall Study|Withdrawal by Subject|12|||
164122347|NCT02400476|592809240|FG003|Overall Study|Withdrawal by Subject|7|||
164122348|NCT02400476|592809241|FG004|Overall Study|Withdrawal by Subject|5|||
164122349|NCT02400476|592809242|FG005|Overall Study|Withdrawal by Subject|5|||
164122350|NCT02400476|592809237|FG000|Overall Study|Lost to Follow-up|0|||
164122351|NCT02400476|592809238|FG001|Overall Study|Lost to Follow-up|0|||
164122352|NCT02400476|592809239|FG002|Overall Study|Lost to Follow-up|0|||
164122353|NCT02400476|592809240|FG003|Overall Study|Lost to Follow-up|1|||
164122354|NCT02400476|592809241|FG004|Overall Study|Lost to Follow-up|3|||
164122355|NCT02400476|592809242|FG005|Overall Study|Lost to Follow-up|1|||
164122356|NCT02400476|592809237|FG000|Overall Study|Physician Decision|0|||
164122357|NCT02400476|592809238|FG001|Overall Study|Physician Decision|0|||
164122358|NCT02400476|592809239|FG002|Overall Study|Physician Decision|1|||
164122359|NCT02400476|592809240|FG003|Overall Study|Physician Decision|1|||
164122360|NCT02400476|592809241|FG004|Overall Study|Physician Decision|0|||
164122361|NCT02400476|592809242|FG005|Overall Study|Physician Decision|1|||
164122362|NCT02400476|592809237|FG000|Overall Study|Other, Disease Progression|0|||
164122363|NCT02400476|592809238|FG001|Overall Study|Other, Disease Progression|1|||
164122364|NCT02400476|592809239|FG002|Overall Study|Other, Disease Progression|2|||
164122365|NCT02400476|592809240|FG003|Overall Study|Other, Disease Progression|1|||
164122366|NCT02400476|592809241|FG004|Overall Study|Other, Disease Progression|2|||
164122367|NCT02400476|592809242|FG005|Overall Study|Other, Disease Progression|1|||
164122368|NCT02400476|592809237|FG000|Overall Study|Other, Decreased Quality of Life|0|||
164122369|NCT02400476|592809238|FG001|Overall Study|Other, Decreased Quality of Life|0|||
164122370|NCT02400476|592809239|FG002|Overall Study|Other, Decreased Quality of Life|2|||
164122371|NCT02400476|592809240|FG003|Overall Study|Other, Decreased Quality of Life|0|||
164122372|NCT02400476|592809241|FG004|Overall Study|Other, Decreased Quality of Life|0|||
164122373|NCT02400476|592809242|FG005|Overall Study|Other, Decreased Quality of Life|0|||
164122374|NCT02400476|592809237|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164122375|NCT02400476|592809238|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164122376|NCT02400476|592809239|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
164122377|NCT02400476|592809240|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
164122378|NCT02400476|592809241|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164122379|NCT02400476|592809242|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
164122380|NCT00124462|592809243|FG000|Overall Study|Lost to Follow-up|3|||
164122381|NCT00124462|592809244|FG001|Overall Study|Lost to Follow-up|3|||
164122382|NCT00124462|592809243|FG000|Overall Study|Physician Decision|3|||
164122383|NCT00124462|592809244|FG001|Overall Study|Physician Decision|4|||
164122384|NCT00124462|592809243|FG000|Overall Study|Withdrawal by Subject|4|||
164122385|NCT00124462|592809244|FG001|Overall Study|Withdrawal by Subject|5|||
164122386|NCT00124462|592809243|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
164122387|NCT00124462|592809244|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
164122388|NCT02487082|592809245|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
164122389|NCT02487082|592809246|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
164122390|NCT02487082|592809245|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
164122391|NCT02487082|592809246|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
164122392|NCT00588731|592809247|FG000|Overall Study|Withdrawal by Subject|3|||
164122393|NCT00588731|592809248|FG001|Overall Study|Withdrawal by Subject|2|||
164122394|NCT00268892|592809253|FG000|Overall Study|Adverse Event|14|||
164122395|NCT00268892|592809254|FG001|Overall Study|Adverse Event|17|||
164122396|NCT00268892|592809255|FG002|Overall Study|Adverse Event|20|||
164122397|NCT00268892|592809253|FG000|Overall Study|Lack of Efficacy|1|||
164122398|NCT00268892|592809254|FG001|Overall Study|Lack of Efficacy|3|||
164122399|NCT00268892|592809255|FG002|Overall Study|Lack of Efficacy|0|||
164122400|NCT00268892|592809253|FG000|Overall Study|Withdrawal by Subject|14|||
164122401|NCT00268892|592809254|FG001|Overall Study|Withdrawal by Subject|15|||
164122402|NCT00268892|592809255|FG002|Overall Study|Withdrawal by Subject|13|||
164122403|NCT00268892|592809253|FG000|Overall Study|Physician Decision|0|||
164122404|NCT00268892|592809254|FG001|Overall Study|Physician Decision|1|||
164122405|NCT00268892|592809255|FG002|Overall Study|Physician Decision|0|||
164122406|NCT00268892|592809253|FG000|Overall Study|Lost to Follow-up|5|||
164122407|NCT00268892|592809254|FG001|Overall Study|Lost to Follow-up|2|||
164122408|NCT00268892|592809255|FG002|Overall Study|Lost to Follow-up|4|||
164122409|NCT00268892|592809253|FG000|Overall Study|Protocol Violation|0|||
164122410|NCT00268892|592809254|FG001|Overall Study|Protocol Violation|1|||
164122411|NCT00268892|592809255|FG002|Overall Study|Protocol Violation|0|||
164122412|NCT00268892|592809253|FG000|Overall Study|Disease Progression|1|||
164122413|NCT00268892|592809254|FG001|Overall Study|Disease Progression|1|||
164122414|NCT00268892|592809255|FG002|Overall Study|Disease Progression|0|||
164122415|NCT00268892|592809253|FG000|Overall Study|Trial Site Closed|4|||
164122416|NCT00268892|592809254|FG001|Overall Study|Trial Site Closed|2|||
164122417|NCT00268892|592809255|FG002|Overall Study|Trial Site Closed|2|||
164122418|NCT00680186|592809256|FG000|Overall Study|Adverse Event|47|||
164122419|NCT00680186|592809257|FG001|Overall Study|Adverse Event|44|||
164122420|NCT00680186|592809256|FG000|Overall Study|Protocol Violation|31|||
164122421|NCT00680186|592809257|FG001|Overall Study|Protocol Violation|26|||
164122422|NCT00680186|592809256|FG000|Overall Study|Lost to Follow-up|11|||
164122423|NCT00680186|592809257|FG001|Overall Study|Lost to Follow-up|6|||
164122424|NCT00680186|592809256|FG000|Overall Study|Withdrawal by Subject|32|||
164122425|NCT00680186|592809257|FG001|Overall Study|Withdrawal by Subject|39|||
164122426|NCT00680186|592809256|FG000|Overall Study|Other|4|||
164122427|NCT00680186|592809257|FG001|Overall Study|Other|1|||
164122428|NCT01684878|592809260|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
164122429|NCT01684878|592809261|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
164122430|NCT01684878|592809262|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
164122431|NCT01684878|592809263|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
164122432|NCT01684878|592809260|FG000|Part 1: Safety Run in Phase|Death|15|||
164122433|NCT01684878|592809261|FG001|Part 1: Safety Run in Phase|Death|20|||
164122434|NCT01684878|592809262|FG002|Part 1: Safety Run in Phase|Death|0|||
164122435|NCT01684878|592809263|FG003|Part 1: Safety Run in Phase|Death|0|||
164122436|NCT01684878|592809260|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
164122437|NCT01684878|592809261|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
164122438|NCT01684878|592809262|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
164122439|NCT01684878|592809263|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
164122440|NCT01684878|592809260|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
164122441|NCT01684878|592809261|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
164122442|NCT01684878|592809262|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
164122443|NCT01684878|592809263|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
164122444|NCT01684878|592809260|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
164122445|NCT01684878|592809261|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
164122446|NCT01684878|592809262|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
164122447|NCT01684878|592809263|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
164122448|NCT01684878|592809260|FG000|Part 2: Randomized Phase|Death|0|||
164122449|NCT01684878|592809261|FG001|Part 2: Randomized Phase|Death|0|||
164122450|NCT01684878|592809262|FG002|Part 2: Randomized Phase|Death|62|||
164122451|NCT01684878|592809263|FG003|Part 2: Randomized Phase|Death|68|||
164122452|NCT01684878|592809260|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
164122453|NCT01684878|592809261|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
164122454|NCT01684878|592809262|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
164122455|NCT01684878|592809263|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
164122456|NCT01684878|592809260|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
164122457|NCT01684878|592809261|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
164122458|NCT01684878|592809262|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
164122459|NCT01684878|592809263|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
164122460|NCT04647383|592809267|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
164122461|NCT04647383|592809268|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
164122462|NCT04647383|592809269|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
164122463|NCT04647383|592809270|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
164122464|NCT02087176|592809271|FG000|Overall Study|Withdrawal by Subject|1|||
164122465|NCT02087176|592809271|FG000|Overall Study|Death|10|||
164122466|NCT02087176|592809271|FG000|Overall Study|Censored|19|||
164122467|NCT02087176|592809271|FG000|Overall Study|Study Terminated by Sponsor|2|||
164122468|NCT00479388|592809276|FG000|Overall Study|Adverse Event|90|||
164122469|NCT00479388|592809277|FG001|Overall Study|Adverse Event|45|||
164122470|NCT00479388|592809276|FG000|Overall Study|Lost to Follow-up|0|||
164122471|NCT00479388|592809277|FG001|Overall Study|Lost to Follow-up|2|||
164122472|NCT00479388|592809276|FG000|Overall Study|Protocol Violation|10|||
164122473|NCT00479388|592809277|FG001|Overall Study|Protocol Violation|9|||
164122474|NCT00479388|592809276|FG000|Overall Study|Withdrawal by Subject|32|||
164122475|NCT00479388|592809277|FG001|Overall Study|Withdrawal by Subject|17|||
164122476|NCT03942211|592809278|FG000|Overall Study|Death|1|||
164122477|NCT03942211|592809279|FG001|Overall Study|Death|0|||
164122478|NCT03942211|592809278|FG000|Overall Study|Study terminated by sponsor|5|||
164122479|NCT03942211|592809279|FG001|Overall Study|Study terminated by sponsor|3|||
164122480|NCT03942211|592809278|FG000|Overall Study|Adverse Event|0|||
164122481|NCT03942211|592809279|FG001|Overall Study|Adverse Event|1|||
164122482|NCT01876368|592809285|FG000|Overall Study|Adverse Event|2|||
164122483|NCT01876368|592809286|FG001|Overall Study|Adverse Event|5|||
164122484|NCT01876368|592809285|FG000|Overall Study|Lack of Efficacy|1|||
164122485|NCT01876368|592809286|FG001|Overall Study|Lack of Efficacy|0|||
164122486|NCT01876368|592809285|FG000|Overall Study|Lost to Follow-up|0|||
164122487|NCT01876368|592809286|FG001|Overall Study|Lost to Follow-up|1|||
164122488|NCT01876368|592809285|FG000|Overall Study|Non-compliance with study treatment|0|||
164122489|NCT01876368|592809286|FG001|Overall Study|Non-compliance with study treatment|1|||
164122490|NCT01876368|592809285|FG000|Overall Study|Physician Decision|0|||
164122491|NCT01876368|592809286|FG001|Overall Study|Physician Decision|2|||
164122492|NCT01876368|592809285|FG000|Overall Study|Protocol deviation|3|||
164122493|NCT01876368|592809286|FG001|Overall Study|Protocol deviation|3|||
164122494|NCT01876368|592809285|FG000|Overall Study|Subject/guardian decision|3|||
164122495|NCT01876368|592809286|FG001|Overall Study|Subject/guardian decision|1|||
164122496|NCT01955044|592809287|FG000|Overall Study|Death|1|||
164122497|NCT01955044|592809288|FG001|Overall Study|Death|1|||
164122498|NCT01955044|592809289|FG002|Overall Study|Death|0|||
164122499|NCT01644149|592809290|FG000|Overall Study|Withdrawal by Subject|1|||
164122500|NCT01644149|592809291|FG001|Overall Study|Withdrawal by Subject|0|||
164122501|NCT01644149|592809290|FG000|Overall Study|Lost to Follow-up|3|||
164122502|NCT01644149|592809291|FG001|Overall Study|Lost to Follow-up|1|||
164122503|NCT00690482|592809292|FG000|Overall Study|Adverse Event|2|||
164122504|NCT00690482|592809293|FG001|Overall Study|Adverse Event|1|||
164122505|NCT00690482|592809292|FG000|Overall Study|Incorrect enrolment|0|||
164122506|NCT00690482|592809293|FG001|Overall Study|Incorrect enrolment|1|||
164122507|NCT00690482|592809292|FG000|Overall Study|Study-specific discontinuation criteria|1|||
164122508|NCT00690482|592809293|FG001|Overall Study|Study-specific discontinuation criteria|0|||
164122509|NCT00690482|592809292|FG000|Overall Study|Intake of prohibited medicine|1|||
164122510|NCT00690482|592809293|FG001|Overall Study|Intake of prohibited medicine|0|||
164122511|NCT00690482|592809292|FG000|Overall Study|withdrew consent at rand.day|0|||
164122512|NCT00690482|592809293|FG001|Overall Study|withdrew consent at rand.day|1|||
164122513|NCT00605917|592809296|FG000|Overall Study|Protocol Violation|79|||
164122514|NCT00925301|592809297|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
164122515|NCT00925301|592809298|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
164122516|NCT00925301|592809299|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
164122517|NCT00925301|592809300|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
164122518|NCT00925301|592809297|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
164122519|NCT00925301|592809298|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
164122520|NCT00925301|592809299|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
164122521|NCT00925301|592809300|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
164122522|NCT00925301|592809297|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
164122523|NCT00925301|592809298|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
164122524|NCT00925301|592809299|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
164122525|NCT00925301|592809300|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
164122526|NCT00925301|592809297|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
164122527|NCT00925301|592809298|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
164122528|NCT00925301|592809299|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
164122529|NCT00925301|592809300|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
164122530|NCT00925301|592809297|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
164122531|NCT00925301|592809298|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
164122532|NCT00925301|592809299|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
164122533|NCT00925301|592809300|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
164122534|NCT00925301|592809297|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
164122535|NCT00925301|592809298|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
164122536|NCT00925301|592809299|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
164122537|NCT00925301|592809300|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
164122538|NCT00925301|592809297|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
164122539|NCT00925301|592809298|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
164122540|NCT00925301|592809299|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
164122541|NCT00925301|592809300|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
164122542|NCT03043560|592809301|FG000|Overall Study|Discontinued Intervention|1|||
164122543|NCT03043560|592809302|FG001|Overall Study|Discontinued Intervention|2|||
164122544|NCT03043560|592809301|FG000|Overall Study|Lost to Follow-up|0|||
164122545|NCT03043560|592809302|FG001|Overall Study|Lost to Follow-up|1|||
164122546|NCT00292227|592809303|FG000|Patch Period|Adverse Event|1|||
164122547|NCT00292227|592809304|FG001|Patch Period|Adverse Event|0|||
164122548|NCT00292227|592809305|FG002|Patch Period|Adverse Event|2|||
164122549|NCT00292227|592809303|FG000|Patch Period|Withdrawal by Subject|0|||
164122550|NCT00292227|592809304|FG001|Patch Period|Withdrawal by Subject|0|||
164122551|NCT00292227|592809305|FG002|Patch Period|Withdrawal by Subject|1|||
164122552|NCT03234608|592809309|FG000|Overall Study|Lost to Follow-up|23|||
164122553|NCT03234608|592809310|FG001|Overall Study|Lost to Follow-up|21|||
164122554|NCT02329431|592809311|FG000|Overall Study|Lost to Follow-up|20|||
164122555|NCT02329431|592809312|FG001|Overall Study|Lost to Follow-up|13|||
164122556|NCT02105701|592809313|FG000|Overall Study|Lost to Follow-up|1|||
164122557|NCT02105701|592809314|FG001|Overall Study|Lost to Follow-up|0|||
164122558|NCT02105701|592809315|FG002|Overall Study|Lost to Follow-up|2|||
164122559|NCT02105701|592809316|FG003|Overall Study|Lost to Follow-up|1|||
164122560|NCT02105701|592809313|FG000|Overall Study|Protocol Violation|0|||
164122561|NCT02105701|592809314|FG001|Overall Study|Protocol Violation|0|||
164122562|NCT02105701|592809315|FG002|Overall Study|Protocol Violation|1|||
164122563|NCT02105701|592809316|FG003|Overall Study|Protocol Violation|0|||
164122564|NCT02105701|592809313|FG000|Overall Study|Withdrawal by Subject|2|||
164122565|NCT02105701|592809314|FG001|Overall Study|Withdrawal by Subject|1|||
164122566|NCT02105701|592809315|FG002|Overall Study|Withdrawal by Subject|0|||
164122567|NCT02105701|592809316|FG003|Overall Study|Withdrawal by Subject|1|||
164122568|NCT02105701|592809313|FG000|Overall Study|Death|1|||
164122569|NCT02105701|592809314|FG001|Overall Study|Death|0|||
164122570|NCT02105701|592809315|FG002|Overall Study|Death|0|||
164122571|NCT02105701|592809316|FG003|Overall Study|Death|0|||
164122572|NCT01362296|592809317|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
164122573|NCT01362296|592809318|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
164122574|NCT01362296|592809319|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
164122575|NCT01362296|592809320|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
164122576|NCT01362296|592809317|FG000|Randomized Phase (RP)|Physician Decision|1|||
164122577|NCT01362296|592809318|FG001|Randomized Phase (RP)|Physician Decision|9|||
164122578|NCT01362296|592809319|FG002|Randomized Phase (RP)|Physician Decision|0|||
164122579|NCT01362296|592809320|FG003|Randomized Phase (RP)|Physician Decision|0|||
164122580|NCT01362296|592809317|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
164122581|NCT01362296|592809318|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
164122582|NCT01362296|592809319|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
164122583|NCT01362296|592809320|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
164122584|NCT01362296|592809317|FG000|Randomized Phase (RP)|Adverse Event|20|||
164122585|NCT01362296|592809318|FG001|Randomized Phase (RP)|Adverse Event|4|||
164122586|NCT01362296|592809319|FG002|Randomized Phase (RP)|Adverse Event|0|||
164122587|NCT01362296|592809320|FG003|Randomized Phase (RP)|Adverse Event|0|||
164122588|NCT01362296|592809317|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
164122589|NCT01362296|592809318|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
164122590|NCT01362296|592809319|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
164122591|NCT01362296|592809320|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
164122592|NCT01362296|592809317|FG000|Crossover Phase|PD including Death due to PD|0|||
164122593|NCT01362296|592809318|FG001|Crossover Phase|PD including Death due to PD|0|||
164122594|NCT01362296|592809319|FG002|Crossover Phase|PD including Death due to PD|16|||
164122595|NCT01362296|592809320|FG003|Crossover Phase|PD including Death due to PD|1|||
164122596|NCT01362296|592809317|FG000|Crossover Phase|Withdrawal by Subject|0|||
164122597|NCT01362296|592809318|FG001|Crossover Phase|Withdrawal by Subject|0|||
164122598|NCT01362296|592809319|FG002|Crossover Phase|Withdrawal by Subject|2|||
164122599|NCT01362296|592809320|FG003|Crossover Phase|Withdrawal by Subject|1|||
164122600|NCT01362296|592809317|FG000|Crossover Phase|Adverse Event|0|||
164122601|NCT01362296|592809318|FG001|Crossover Phase|Adverse Event|0|||
164122602|NCT01362296|592809319|FG002|Crossover Phase|Adverse Event|4|||
164122603|NCT01362296|592809320|FG003|Crossover Phase|Adverse Event|0|||
164122604|NCT01362296|592809317|FG000|Crossover Phase|Study Closed/Terminated|0|||
164122605|NCT01362296|592809318|FG001|Crossover Phase|Study Closed/Terminated|0|||
164122606|NCT01362296|592809319|FG002|Crossover Phase|Study Closed/Terminated|1|||
164122607|NCT01362296|592809320|FG003|Crossover Phase|Study Closed/Terminated|0|||
164122608|NCT00248170|592809322|FG000|Overall Study|Withdrawal by Subject|71|||
164122609|NCT00248170|592809323|FG001|Overall Study|Withdrawal by Subject|79|||
164122610|NCT00248170|592809322|FG000|Overall Study|Protocol Violation|35|||
164122611|NCT00248170|592809323|FG001|Overall Study|Protocol Violation|30|||
164122612|NCT00248170|592809322|FG000|Overall Study|Lost to Follow-up|28|||
164122613|NCT00248170|592809323|FG001|Overall Study|Lost to Follow-up|35|||
164122614|NCT00248170|592809322|FG000|Overall Study|Disease progression|196|||
164122615|NCT00248170|592809323|FG001|Overall Study|Disease progression|216|||
164122616|NCT00248170|592809322|FG000|Overall Study|Death|28|||
164122617|NCT00248170|592809323|FG001|Overall Study|Death|47|||
164122618|NCT00248170|592809322|FG000|Overall Study|Adverse Event|311|||
164122619|NCT00248170|592809323|FG001|Overall Study|Adverse Event|296|||
164122620|NCT00248170|592809322|FG000|Overall Study|Administrative problems|22|||
164122621|NCT00248170|592809323|FG001|Overall Study|Administrative problems|25|||
164122622|NCT00248170|592809322|FG000|Overall Study|Abnormal test procedure(s) result|49|||
164122623|NCT00248170|592809323|FG001|Overall Study|Abnormal test procedure(s) result|61|||
164122624|NCT00248170|592809322|FG000|Overall Study|Abnormal laboratory values|4|||
164122625|NCT00248170|592809323|FG001|Overall Study|Abnormal laboratory values|0|||
164122626|NCT00248170|592809322|FG000|Overall Study|Protocol deviation|17|||
164122627|NCT00248170|592809323|FG001|Overall Study|Protocol deviation|19|||
164122628|NCT01557582|592809324|FG000|Overall Study|Protocol Violation|4|||
164122629|NCT01557582|592809324|FG000|Overall Study|Operator error|2|||
164122630|NCT02953678|592809349|FG000|Overall Study|Adverse Event|20|||
164122631|NCT02953678|592809349|FG000|Overall Study|Death|7|||
164122632|NCT02953678|592809349|FG000|Overall Study|Physician Decision|23|||
164122633|NCT02953678|592809349|FG000|Overall Study|Progressive Disease of GVHD|7|||
164122634|NCT02953678|592809349|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
164122635|NCT02953678|592809349|FG000|Overall Study|Withdrawal by participant|3|||
164122636|NCT02953678|592809349|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
164122637|NCT02953678|592809349|FG000|Overall Study|Participants were transferred to commercial product.|3|||
164122638|NCT04034355|592809352|FG000|Overall Study|Study terminated by Sponsor|10|||
164122639|NCT04034355|592809353|FG001|Overall Study|Study terminated by Sponsor|17|||
164122640|NCT04034355|592809352|FG000|Overall Study|Withdrawal by Subject|12|||
164122641|NCT04034355|592809353|FG001|Overall Study|Withdrawal by Subject|11|||
164122642|NCT04034355|592809352|FG000|Overall Study|Site terminated by Sponsor|4|||
164122643|NCT04034355|592809353|FG001|Overall Study|Site terminated by Sponsor|5|||
164122644|NCT04034355|592809352|FG000|Overall Study|Adverse Event|2|||
164122645|NCT04034355|592809353|FG001|Overall Study|Adverse Event|0|||
164122646|NCT04034355|592809352|FG000|Overall Study|Death|1|||
164122647|NCT04034355|592809353|FG001|Overall Study|Death|1|||
164122648|NCT04034355|592809352|FG000|Overall Study|Not reported|2|||
164122649|NCT04034355|592809353|FG001|Overall Study|Not reported|0|||
164122650|NCT04034355|592809352|FG000|Overall Study|Lost to Follow-up|1|||
164122651|NCT04034355|592809353|FG001|Overall Study|Lost to Follow-up|0|||
164122652|NCT04034355|592809352|FG000|Overall Study|Physician Decision|1|||
164122653|NCT04034355|592809353|FG001|Overall Study|Physician Decision|0|||
164122654|NCT04034355|592809352|FG000|Overall Study|Protocol Violation|0|||
164122655|NCT04034355|592809353|FG001|Overall Study|Protocol Violation|1|||
164122656|NCT04034355|592809352|FG000|Overall Study|Progressive disease|1|||
164122657|NCT04034355|592809353|FG001|Overall Study|Progressive disease|0|||
164122658|NCT03064438|592811426|FG000|Overall Study|Lost to Follow-up|1|||
164122659|NCT03064438|592811427|FG001|Overall Study|Lost to Follow-up|0|||
164122660|NCT03064438|592811426|FG000|Overall Study|Withdrawal by Subject|0|||
164122661|NCT03064438|592811427|FG001|Overall Study|Withdrawal by Subject|1|||
164122662|NCT01937351|592811428|FG000|Overall Study|Withdrawal by Subject|4|||
164122663|NCT01937351|592811429|FG001|Overall Study|Withdrawal by Subject|2|||
164122664|NCT01937351|592811428|FG000|Overall Study|Death|1|||
164122665|NCT01937351|592811429|FG001|Overall Study|Death|0|||
164122666|NCT01937351|592811428|FG000|Overall Study|Not treated w device, per protocol fail|4|||
164122667|NCT01937351|592811429|FG001|Overall Study|Not treated w device, per protocol fail|0|||
164122668|NCT04373551|592811430|FG000|Overall Study|Lost to Follow-up|15|||
164122669|NCT04373551|592811430|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
164122670|NCT02070757|592811431|FG000|Overall Study|Adverse Event|107|||
164122671|NCT02070757|592811432|FG001|Overall Study|Adverse Event|99|||
164122672|NCT02070757|592811431|FG000|Overall Study|Lost to Follow-up|7|||
164122673|NCT02070757|592811432|FG001|Overall Study|Lost to Follow-up|4|||
164122674|NCT02070757|592811431|FG000|Overall Study|Protocol Violation|0|||
164122675|NCT02070757|592811432|FG001|Overall Study|Protocol Violation|4|||
164122676|NCT02070757|592811431|FG000|Overall Study|Withdrawal by Subject|1|||
164122677|NCT02070757|592811432|FG001|Overall Study|Withdrawal by Subject|3|||
164122678|NCT02070757|592811431|FG000|Overall Study|Investigator Decision|0|||
164122679|NCT02070757|592811432|FG001|Overall Study|Investigator Decision|2|||
164122680|NCT02070757|592811431|FG000|Overall Study|Discharged from Study Hospital|2|||
164122681|NCT02070757|592811432|FG001|Overall Study|Discharged from Study Hospital|2|||
164122682|NCT04086641|592811433|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
164122683|NCT04086641|592811434|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
164122684|NCT00126126|592811444|FG000|Overall Study|Lost to Follow-up|0|||
164122685|NCT00126126|592811445|FG001|Overall Study|Lost to Follow-up|2|||
164122686|NCT01048502|592811446|FG000|Overall Study|Lost to Follow-up|2|||
164122687|NCT01048502|592811447|FG001|Overall Study|Lost to Follow-up|0|||
164122688|NCT01048502|592811448|FG002|Overall Study|Lost to Follow-up|0|||
164122689|NCT01048502|592811449|FG003|Overall Study|Lost to Follow-up|0|||
164122690|NCT01048502|592811446|FG000|Overall Study|Adverse Event|1|||
164122691|NCT01048502|592811447|FG001|Overall Study|Adverse Event|0|||
164122692|NCT01048502|592811448|FG002|Overall Study|Adverse Event|0|||
164122693|NCT01048502|592811449|FG003|Overall Study|Adverse Event|0|||
164122694|NCT01048502|592811446|FG000|Overall Study|Withdrawal by Subject|1|||
164122695|NCT01048502|592811447|FG001|Overall Study|Withdrawal by Subject|4|||
164122696|NCT01048502|592811448|FG002|Overall Study|Withdrawal by Subject|5|||
164122697|NCT01048502|592811449|FG003|Overall Study|Withdrawal by Subject|3|||
164122698|NCT01048502|592811446|FG000|Overall Study|Physician Decision|0|||
164122699|NCT01048502|592811447|FG001|Overall Study|Physician Decision|3|||
164122700|NCT01048502|592811448|FG002|Overall Study|Physician Decision|0|||
164122701|NCT01048502|592811449|FG003|Overall Study|Physician Decision|1|||
164122702|NCT01333072|592811451|FG000|Overall Study|Lost to Follow-up|3|||
164122703|NCT01333072|592811452|FG001|Overall Study|Lost to Follow-up|0|||
164122704|NCT01333072|592811451|FG000|Overall Study|Adverse Event|2|||
164122705|NCT01333072|592811452|FG001|Overall Study|Adverse Event|4|||
164122706|NCT01333072|592811451|FG000|Overall Study|Physician Decision|1|||
164122707|NCT01333072|592811452|FG001|Overall Study|Physician Decision|0|||
164122708|NCT02457611|592811453|FG000|Overall Study|Lost to Follow-up|3|||
164122709|NCT01463982|592811454|FG000|Overall Study|Withdrawal by Subject|0|||
164122710|NCT01463982|592811455|FG001|Overall Study|Withdrawal by Subject|1|||
164122711|NCT01463982|592811456|FG002|Overall Study|Withdrawal by Subject|1|||
164122712|NCT01463982|592811457|FG003|Overall Study|Withdrawal by Subject|0|||
164122713|NCT01463982|592811454|FG000|Overall Study|Treatment delay over 5 week|0|||
164122714|NCT01463982|592811455|FG001|Overall Study|Treatment delay over 5 week|0|||
164122715|NCT01463982|592811456|FG002|Overall Study|Treatment delay over 5 week|1|||
164122716|NCT01463982|592811457|FG003|Overall Study|Treatment delay over 5 week|0|||
164122717|NCT04220775|592811464|FG000|Overall Study|Adverse Event|1|||
164122718|NCT04220775|592811465|FG001|Overall Study|Adverse Event|0|||
164122719|NCT04220775|592811464|FG000|Overall Study|Disease Progression|1|||
164122720|NCT04220775|592811465|FG001|Overall Study|Disease Progression|0|||
164122721|NCT00271024|592811468|FG000|Overall Study|Lost Interest|3|||
164122722|NCT00271024|592811469|FG001|Overall Study|Lost Interest|4|||
164122723|NCT00271024|592811470|FG002|Overall Study|Lost Interest|2|||
164122724|NCT00271024|592811471|FG003|Overall Study|Lost Interest|3|||
164122725|NCT00271024|592811468|FG000|Overall Study|Unknown/Unspecified|11|||
164122726|NCT00271024|592811469|FG001|Overall Study|Unknown/Unspecified|11|||
164122727|NCT00271024|592811470|FG002|Overall Study|Unknown/Unspecified|8|||
164122728|NCT00271024|592811471|FG003|Overall Study|Unknown/Unspecified|4|||
164122729|NCT00271024|592811468|FG000|Overall Study|Protocol Violation|1|||
164122730|NCT00271024|592811469|FG001|Overall Study|Protocol Violation|6|||
164122731|NCT00271024|592811470|FG002|Overall Study|Protocol Violation|5|||
164122732|NCT00271024|592811471|FG003|Overall Study|Protocol Violation|11|||
164122733|NCT00271024|592811468|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
164122734|NCT00271024|592811469|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
164122735|NCT00271024|592811470|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
164122736|NCT00271024|592811471|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
164122737|NCT00271024|592811468|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
164122738|NCT00271024|592811469|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
164122739|NCT00271024|592811470|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
164122740|NCT00271024|592811471|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
164122741|NCT04668274|592811475|FG000|Part 1 Study Period 1|Adverse Event|3|||
164122742|NCT04668274|592811476|FG001|Part 1 Study Period 1|Adverse Event|0|||
164122743|NCT04668274|592811477|FG002|Part 1 Study Period 1|Adverse Event|0|||
164122744|NCT04668274|592811478|FG003|Part 1 Study Period 1|Adverse Event|0|||
164122745|NCT04668274|592811475|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
164122746|NCT04668274|592811476|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
164122747|NCT04668274|592811477|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
164122748|NCT04668274|592811478|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
164122749|NCT04668274|592811475|FG000|Part 1 Study Period 2|Other|0|||
164122750|NCT04668274|592811476|FG001|Part 1 Study Period 2|Other|1|||
164122751|NCT04668274|592811477|FG002|Part 1 Study Period 2|Other|0|||
164122752|NCT04668274|592811478|FG003|Part 1 Study Period 2|Other|0|||
164122753|NCT04668274|592811475|FG000|Part 1 Study Period 3|Adverse Event|0|||
164122754|NCT04668274|592811476|FG001|Part 1 Study Period 3|Adverse Event|0|||
164122755|NCT04668274|592811477|FG002|Part 1 Study Period 3|Adverse Event|1|||
164122756|NCT04668274|592811478|FG003|Part 1 Study Period 3|Adverse Event|0|||
164122757|NCT04668274|592811475|FG000|Part 1 Study Period 3|Other|0|||
164122758|NCT04668274|592811476|FG001|Part 1 Study Period 3|Other|0|||
164122759|NCT04668274|592811477|FG002|Part 1 Study Period 3|Other|2|||
164122760|NCT04668274|592811478|FG003|Part 1 Study Period 3|Other|0|||
164122761|NCT04668274|592811475|FG000|Part 2 Study Period 4|Other|0|||
164122762|NCT04668274|592811476|FG001|Part 2 Study Period 4|Other|0|||
164122763|NCT04668274|592811477|FG002|Part 2 Study Period 4|Other|0|||
164122764|NCT04668274|592811478|FG003|Part 2 Study Period 4|Other|1|||
164122765|NCT04449341|592811481|FG000|Overall Study|Protocol Violation|1|||
164122766|NCT04449341|592811482|FG001|Overall Study|Protocol Violation|0|||
164122767|NCT04499482|592811483|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
164122768|NCT01020526|592811485|FG000|Overall Study|Withdrawal by Subject|5|||
164122769|NCT01020526|592811485|FG000|Overall Study|Other reasons|3|||
164122770|NCT01020526|592811485|FG000|Overall Study|Insufficient clinical response|3|||
164122771|NCT01020526|592811485|FG000|Overall Study|Lost to Follow-up|1|||
164122772|NCT01020526|592811485|FG000|Overall Study|Adverse Event|2|||
164122773|NCT02363439|592811486|FG000|Overall Study|Lack of Efficacy|4|||
164122774|NCT03573817|592811491|FG000|Overall Study|Adverse Event|0|||
164122775|NCT03573817|592811492|FG001|Overall Study|Adverse Event|2|||
164122776|NCT03573817|592811491|FG000|Overall Study|Protocol Violation|0|||
164122777|NCT03573817|592811492|FG001|Overall Study|Protocol Violation|1|||
164122778|NCT03573817|592811491|FG000|Overall Study|Withdrawal by Subject|1|||
164122779|NCT03573817|592811492|FG001|Overall Study|Withdrawal by Subject|1|||
164122780|NCT02010255|592811493|FG000|Overall Study|Death|0|||
164122781|NCT02010255|592811494|FG001|Overall Study|Death|1|||
164122782|NCT02010255|592811495|FG002|Overall Study|Death|4|||
164122783|NCT02010255|592811496|FG003|Overall Study|Death|4|||
164122784|NCT02010255|592811497|FG004|Overall Study|Death|2|||
164122785|NCT02010255|592811498|FG005|Overall Study|Death|0|||
164122786|NCT02010255|592811499|FG006|Overall Study|Death|1|||
164122787|NCT02010255|592811500|FG007|Overall Study|Death|1|||
164122788|NCT02010255|592811501|FG008|Overall Study|Death|1|||
164122789|NCT02010255|592811502|FG009|Overall Study|Death|0|||
164122790|NCT02010255|592811503|FG010|Overall Study|Death|1|||
164122791|NCT02010255|592811504|FG011|Overall Study|Death|1|||
164122792|NCT02010255|592811505|FG012|Overall Study|Death|0|||
164122793|NCT02010255|592811506|FG013|Overall Study|Death|0|||
164122794|NCT02010255|592811493|FG000|Overall Study|Lack of Efficacy|4|||
164122795|NCT02010255|592811494|FG001|Overall Study|Lack of Efficacy|1|||
164122796|NCT02010255|592811495|FG002|Overall Study|Lack of Efficacy|2|||
164122797|NCT02010255|592811496|FG003|Overall Study|Lack of Efficacy|1|||
164122798|NCT02010255|592811497|FG004|Overall Study|Lack of Efficacy|1|||
164122799|NCT02010255|592811498|FG005|Overall Study|Lack of Efficacy|0|||
164122800|NCT02010255|592811499|FG006|Overall Study|Lack of Efficacy|0|||
164122801|NCT02010255|592811500|FG007|Overall Study|Lack of Efficacy|0|||
164122802|NCT02010255|592811501|FG008|Overall Study|Lack of Efficacy|0|||
164122803|NCT02010255|592811502|FG009|Overall Study|Lack of Efficacy|0|||
164122804|NCT02010255|592811503|FG010|Overall Study|Lack of Efficacy|1|||
164122805|NCT02010255|592811504|FG011|Overall Study|Lack of Efficacy|0|||
164122806|NCT02010255|592811505|FG012|Overall Study|Lack of Efficacy|0|||
164122807|NCT02010255|592811506|FG013|Overall Study|Lack of Efficacy|0|||
164122808|NCT02010255|592811493|FG000|Overall Study|Withdrew Consent|1|||
164122809|NCT02010255|592811494|FG001|Overall Study|Withdrew Consent|0|||
164122810|NCT02010255|592811495|FG002|Overall Study|Withdrew Consent|0|||
164122811|NCT02010255|592811496|FG003|Overall Study|Withdrew Consent|1|||
164122812|NCT02010255|592811497|FG004|Overall Study|Withdrew Consent|0|||
164122813|NCT02010255|592811498|FG005|Overall Study|Withdrew Consent|0|||
164122814|NCT02010255|592811499|FG006|Overall Study|Withdrew Consent|0|||
164122815|NCT02010255|592811500|FG007|Overall Study|Withdrew Consent|0|||
164122816|NCT02010255|592811501|FG008|Overall Study|Withdrew Consent|0|||
164122817|NCT02010255|592811502|FG009|Overall Study|Withdrew Consent|0|||
164122818|NCT02010255|592811503|FG010|Overall Study|Withdrew Consent|0|||
164122819|NCT02010255|592811504|FG011|Overall Study|Withdrew Consent|0|||
164122820|NCT02010255|592811505|FG012|Overall Study|Withdrew Consent|0|||
164122821|NCT02010255|592811506|FG013|Overall Study|Withdrew Consent|0|||
164122822|NCT02010255|592811493|FG000|Overall Study|Adverse Event|1|||
164122823|NCT02010255|592811494|FG001|Overall Study|Adverse Event|0|||
164122824|NCT02010255|592811495|FG002|Overall Study|Adverse Event|0|||
164122825|NCT02010255|592811496|FG003|Overall Study|Adverse Event|0|||
164122826|NCT02010255|592811497|FG004|Overall Study|Adverse Event|0|||
164122827|NCT02010255|592811498|FG005|Overall Study|Adverse Event|0|||
164122828|NCT02010255|592811499|FG006|Overall Study|Adverse Event|0|||
164122829|NCT02010255|592811500|FG007|Overall Study|Adverse Event|0|||
164122830|NCT02010255|592811501|FG008|Overall Study|Adverse Event|0|||
164122831|NCT02010255|592811502|FG009|Overall Study|Adverse Event|0|||
164122832|NCT02010255|592811503|FG010|Overall Study|Adverse Event|0|||
164122833|NCT02010255|592811504|FG011|Overall Study|Adverse Event|0|||
164122834|NCT02010255|592811505|FG012|Overall Study|Adverse Event|0|||
164122835|NCT02010255|592811506|FG013|Overall Study|Adverse Event|0|||
164122836|NCT02010255|592811493|FG000|Overall Study|Lost to Follow-up|0|||
164122837|NCT02010255|592811494|FG001|Overall Study|Lost to Follow-up|0|||
164122838|NCT02010255|592811495|FG002|Overall Study|Lost to Follow-up|1|||
164122839|NCT02010255|592811496|FG003|Overall Study|Lost to Follow-up|0|||
164122840|NCT02010255|592811497|FG004|Overall Study|Lost to Follow-up|1|||
164122841|NCT02010255|592811498|FG005|Overall Study|Lost to Follow-up|0|||
164122842|NCT02010255|592811499|FG006|Overall Study|Lost to Follow-up|0|||
164122843|NCT02010255|592811500|FG007|Overall Study|Lost to Follow-up|0|||
164122844|NCT02010255|592811501|FG008|Overall Study|Lost to Follow-up|0|||
164122845|NCT02010255|592811502|FG009|Overall Study|Lost to Follow-up|0|||
164122846|NCT02010255|592811503|FG010|Overall Study|Lost to Follow-up|0|||
164122847|NCT02010255|592811504|FG011|Overall Study|Lost to Follow-up|0|||
164122848|NCT02010255|592811505|FG012|Overall Study|Lost to Follow-up|0|||
164122849|NCT02010255|592811506|FG013|Overall Study|Lost to Follow-up|0|||
164122850|NCT02010255|592811493|FG000|Overall Study|Randomized but Not Treated|0|||
164122851|NCT02010255|592811494|FG001|Overall Study|Randomized but Not Treated|0|||
164122852|NCT02010255|592811495|FG002|Overall Study|Randomized but Not Treated|0|||
164122853|NCT02010255|592811496|FG003|Overall Study|Randomized but Not Treated|0|||
164122854|NCT02010255|592811497|FG004|Overall Study|Randomized but Not Treated|0|||
164122855|NCT02010255|592811498|FG005|Overall Study|Randomized but Not Treated|0|||
164122856|NCT02010255|592811499|FG006|Overall Study|Randomized but Not Treated|0|||
164122857|NCT02010255|592811500|FG007|Overall Study|Randomized but Not Treated|0|||
164122858|NCT02010255|592811501|FG008|Overall Study|Randomized but Not Treated|0|||
164122859|NCT02010255|592811502|FG009|Overall Study|Randomized but Not Treated|0|||
164122860|NCT02010255|592811503|FG010|Overall Study|Randomized but Not Treated|0|||
164122861|NCT02010255|592811504|FG011|Overall Study|Randomized but Not Treated|0|||
164122862|NCT02010255|592811505|FG012|Overall Study|Randomized but Not Treated|0|||
164122863|NCT02010255|592811506|FG013|Overall Study|Randomized but Not Treated|1|||
164122864|NCT00508027|592811515|FG000|Dose Level 1|Lost to Follow-up|4|||
164122865|NCT00508027|592811515|FG000|Dose Level 1|Withdrawal by Subject|2|||
164122866|NCT00508027|592811515|FG000|Dose Level 1|Physician Decision|2|||
164122867|NCT00508027|592811515|FG000|Dose Level 2|Lost to Follow-up|2|||
164122868|NCT00508027|592811515|FG000|Dose Level 2|Withdrawal by Subject|2|||
164122869|NCT01719562|592811516|FG000|Overall Study|Lost to Follow-up|1|||
164122870|NCT01719562|592811517|FG001|Overall Study|Lost to Follow-up|0|||
164122871|NCT01719562|592811516|FG000|Overall Study|Death|1|||
164122872|NCT01719562|592811517|FG001|Overall Study|Death|0|||
164122873|NCT01719562|592811516|FG000|Overall Study|New cancer diagnosis|1|||
164122874|NCT01719562|592811517|FG001|Overall Study|New cancer diagnosis|0|||
164122875|NCT02013531|592811518|FG000|Overall Study|Lost to Follow-up|3|||
164122876|NCT02013531|592811518|FG000|Overall Study|Met Withdrawal Criteria|1|||
164122877|NCT02013531|592811518|FG000|Overall Study|Withdrawal by Subject|1|||
164122878|NCT00537199|592811523|FG000|Overall Study|Study Terminated|1|||
164122879|NCT00467831|592811524|FG000|Overall Study|Death|2|||
164122880|NCT00467831|592811524|FG000|Overall Study|Withdrawal by Subject|1|||
164122881|NCT00612677|592811525|FG000|Overall Study|study closed before treatment started|1|||
164122882|NCT03139240|592811526|FG000|Overall Study|Lost to Follow-up|0|||
164122883|NCT03139240|592811527|FG001|Overall Study|Lost to Follow-up|1|||
164122884|NCT03139240|592811528|FG002|Overall Study|Lost to Follow-up|1|||
164122885|NCT03139240|592811529|FG003|Overall Study|Lost to Follow-up|0|||
164122886|NCT00860743|592811531|FG000|Overall Study|Withdrawal by Subject|3|||
164122887|NCT00860743|592811532|FG001|Overall Study|Withdrawal by Subject|0|||
164122888|NCT00823199|592811536|FG000|Overall Study|Withdrawal by Subject|2|||
164122889|NCT02776553|592811537|FG000|Overall Study|Lost to Follow-up|1|||
164122890|NCT02776553|592811538|FG001|Overall Study|Lost to Follow-up|0|||
164122891|NCT02776553|592811537|FG000|Overall Study|got liver transplant|1|||
164122892|NCT02776553|592811538|FG001|Overall Study|got liver transplant|2|||
164122893|NCT02776553|592811537|FG000|Overall Study|had other surgery|1|||
164122894|NCT02776553|592811538|FG001|Overall Study|had other surgery|0|||
164122895|NCT02776553|592811537|FG000|Overall Study|Protocol Violation|0|||
164122896|NCT02776553|592811538|FG001|Overall Study|Protocol Violation|1|||
164122897|NCT00941720|592811539|FG000|Overall Study|Withdrawal by Subject|1|||
164122898|NCT00941720|592811539|FG000|Overall Study|Insurance denied participation|11|||
164122899|NCT00941720|592811539|FG000|Overall Study|ineligible|2|||
164122900|NCT00171340|592811540|FG000|Overall Study|Adverse Event|46|||
164122901|NCT00171340|592811541|FG001|Overall Study|Adverse Event|42|||
164122902|NCT00171340|592811540|FG000|Overall Study|Lack of Efficacy|29|||
164122903|NCT00171340|592811541|FG001|Overall Study|Lack of Efficacy|41|||
164122904|NCT00171340|592811540|FG000|Overall Study|Protocol Violation|7|||
164122905|NCT00171340|592811541|FG001|Overall Study|Protocol Violation|8|||
164122906|NCT00171340|592811540|FG000|Overall Study|Withdrawal by Subject|22|||
164122907|NCT00171340|592811541|FG001|Overall Study|Withdrawal by Subject|19|||
164122908|NCT00171340|592811540|FG000|Overall Study|Lost to Follow-up|0|||
164122909|NCT00171340|592811541|FG001|Overall Study|Lost to Follow-up|5|||
164122910|NCT00171340|592811540|FG000|Overall Study|Abnormal Laboratory Results|2|||
164122911|NCT00171340|592811541|FG001|Overall Study|Abnormal Laboratory Results|0|||
164122912|NCT00171340|592811540|FG000|Overall Study|Abnormal Test Procedure Results|6|||
164122913|NCT00171340|592811541|FG001|Overall Study|Abnormal Test Procedure Results|11|||
164122914|NCT00171340|592811540|FG000|Overall Study|No Longer Required Study Drug|1|||
164122915|NCT00171340|592811541|FG001|Overall Study|No Longer Required Study Drug|1|||
164122916|NCT00171340|592811540|FG000|Overall Study|Administrative Problems|5|||
164122917|NCT00171340|592811541|FG001|Overall Study|Administrative Problems|2|||
164122918|NCT00171340|592811540|FG000|Overall Study|Death|6|||
164122919|NCT00171340|592811541|FG001|Overall Study|Death|6|||
164122920|NCT03827018|592811542|FG000|Overall Study|Adverse Event|1|||
164122921|NCT03827018|592811543|FG001|Overall Study|Adverse Event|0|||
164122922|NCT03827018|592811542|FG000|Overall Study|Withdrawal by Subject|2|||
164122923|NCT03827018|592811543|FG001|Overall Study|Withdrawal by Subject|2|||
164122924|NCT03827018|592811542|FG000|Overall Study|Lack of Efficacy|0|||
164122925|NCT03827018|592811543|FG001|Overall Study|Lack of Efficacy|1|||
164122926|NCT01998243|592811544|FG000|Overall Study|Pregnancy|0|||
164122927|NCT01998243|592811545|FG001|Overall Study|Pregnancy|1|||
164122928|NCT01998243|592811544|FG000|Overall Study|Protocol Violation|5|||
164122929|NCT01998243|592811545|FG001|Overall Study|Protocol Violation|2|||
164122930|NCT01998243|592811544|FG000|Overall Study|Withdrawal by Subject|3|||
164122931|NCT01998243|592811545|FG001|Overall Study|Withdrawal by Subject|4|||
164122932|NCT04569786|592811559|FG000|Overall Study|Lost to Follow-up|1|||
164122933|NCT04569786|592811560|FG001|Overall Study|Lost to Follow-up|0|||
164122934|NCT04569786|592811561|FG002|Overall Study|Lost to Follow-up|4|||
164122935|NCT04569786|592811562|FG003|Overall Study|Lost to Follow-up|1|||
164122936|NCT04569786|592811563|FG004|Overall Study|Lost to Follow-up|0|||
164122937|NCT04569786|592811559|FG000|Overall Study|Withdrawal by Subject|0|||
164122938|NCT04569786|592811560|FG001|Overall Study|Withdrawal by Subject|0|||
164132678|NCT01986010|592850657|FG002|Overall Study|Lost to Follow-up|2|||
164122939|NCT04569786|592811561|FG002|Overall Study|Withdrawal by Subject|0|||
164122940|NCT04569786|592811562|FG003|Overall Study|Withdrawal by Subject|5|||
164122941|NCT04569786|592811563|FG004|Overall Study|Withdrawal by Subject|1|||
164122942|NCT04569786|592811559|FG000|Overall Study|Physician Decision|0|||
164122943|NCT04569786|592811560|FG001|Overall Study|Physician Decision|0|||
164122944|NCT04569786|592811561|FG002|Overall Study|Physician Decision|0|||
164122945|NCT04569786|592811562|FG003|Overall Study|Physician Decision|1|||
164122946|NCT04569786|592811563|FG004|Overall Study|Physician Decision|0|||
164122947|NCT01640184|592811564|FG000|Overall Study|Death|1|||
164122948|NCT01640184|592811565|FG001|Overall Study|Death|0|||
164122949|NCT01640184|592811566|FG002|Overall Study|Death|0|||
164122950|NCT01640184|592811564|FG000|Overall Study|Lost to Follow-up|4|||
164122951|NCT01640184|592811565|FG001|Overall Study|Lost to Follow-up|1|||
164122952|NCT01640184|592811566|FG002|Overall Study|Lost to Follow-up|0|||
164122953|NCT01640184|592811564|FG000|Overall Study|Physician Decision|3|||
164122954|NCT01640184|592811565|FG001|Overall Study|Physician Decision|0|||
164122955|NCT01640184|592811566|FG002|Overall Study|Physician Decision|0|||
164122956|NCT01640184|592811564|FG000|Overall Study|Withdrawal by Subject|0|||
164122957|NCT01640184|592811565|FG001|Overall Study|Withdrawal by Subject|1|||
164122958|NCT01640184|592811566|FG002|Overall Study|Withdrawal by Subject|1|||
164122959|NCT01640184|592811564|FG000|Overall Study|Protocol Violation|0|||
164122960|NCT01640184|592811565|FG001|Overall Study|Protocol Violation|0|||
164122961|NCT01640184|592811566|FG002|Overall Study|Protocol Violation|1|||
164122962|NCT01351350|592811567|FG000|Overall Study|Disease Progression|5|||
164122963|NCT01351350|592811568|FG001|Overall Study|Disease Progression|13|||
164122964|NCT01351350|592811569|FG002|Overall Study|Disease Progression|6|||
164122965|NCT01351350|592811570|FG003|Overall Study|Disease Progression|8|||
164122966|NCT01351350|592811571|FG004|Overall Study|Disease Progression|5|||
164122967|NCT01351350|592811567|FG000|Overall Study|Adverse Event|1|||
164122968|NCT01351350|592811568|FG001|Overall Study|Adverse Event|10|||
164122969|NCT01351350|592811569|FG002|Overall Study|Adverse Event|1|||
164122970|NCT01351350|592811570|FG003|Overall Study|Adverse Event|2|||
164122971|NCT01351350|592811571|FG004|Overall Study|Adverse Event|0|||
164122972|NCT01351350|592811567|FG000|Overall Study|Participant Decision|2|||
164122973|NCT01351350|592811568|FG001|Overall Study|Participant Decision|6|||
164122974|NCT01351350|592811569|FG002|Overall Study|Participant Decision|3|||
164122975|NCT01351350|592811570|FG003|Overall Study|Participant Decision|3|||
164122976|NCT01351350|592811571|FG004|Overall Study|Participant Decision|2|||
164122977|NCT01351350|592811567|FG000|Overall Study|Enrolled but not Treated|0|||
164122978|NCT01351350|592811568|FG001|Overall Study|Enrolled but not Treated|0|||
164122979|NCT01351350|592811569|FG002|Overall Study|Enrolled but not Treated|1|||
164122980|NCT01351350|592811570|FG003|Overall Study|Enrolled but not Treated|0|||
164122981|NCT01351350|592811571|FG004|Overall Study|Enrolled but not Treated|0|||
164122982|NCT02260258|592811575|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
164122983|NCT02260258|592811576|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
164122984|NCT01930175|592811577|FG000|Core Study|Lost to Follow-up|0|||
164122985|NCT01930175|592811578|FG001|Core Study|Lost to Follow-up|1|||
164122986|NCT01930175|592811579|FG002|Core Study|Lost to Follow-up|0|||
164122987|NCT01930175|592811577|FG000|Core Study|Adverse Event|0|||
164122988|NCT01930175|592811578|FG001|Core Study|Adverse Event|0|||
164122989|NCT01930175|592811579|FG002|Core Study|Adverse Event|1|||
164122990|NCT02820740|592811580|FG000|Overall Study|Did not have procedure|2|||
164122991|NCT00890552|592811581|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
164122992|NCT00890552|592811581|FG000|On-treatment|Early prog disease/ death|10|||
164122993|NCT04965389|592811582|FG000|Overall Study|Other reasons|1|||
164122994|NCT04965389|592811583|FG001|Overall Study|Other reasons|0|||
164122995|NCT04965389|592811584|FG002|Overall Study|Other reasons|0|||
164122996|NCT04965389|592811585|FG003|Overall Study|Other reasons|0|||
164122997|NCT04965389|592811582|FG000|Overall Study|Participant withdrew consent|0|||
164122998|NCT04965389|592811583|FG001|Overall Study|Participant withdrew consent|1|||
164122999|NCT04965389|592811584|FG002|Overall Study|Participant withdrew consent|0|||
164123000|NCT04965389|592811585|FG003|Overall Study|Participant withdrew consent|0|||
164123001|NCT04965389|592811582|FG000|Overall Study|Poor/Non-compliance|0|||
164123002|NCT04965389|592811583|FG001|Overall Study|Poor/Non-compliance|1|||
164123003|NCT04965389|592811584|FG002|Overall Study|Poor/Non-compliance|0|||
164123004|NCT04965389|592811585|FG003|Overall Study|Poor/Non-compliance|0|||
164123005|NCT01436643|592811586|FG000|2-week Pre-treatment|Abnormal test result|0|||
164123006|NCT01436643|592811587|FG001|2-week Pre-treatment|Abnormal test result|0|||
164123007|NCT01436643|592811588|FG002|2-week Pre-treatment|Abnormal test result|0|||
164123008|NCT01436643|592811589|FG003|2-week Pre-treatment|Abnormal test result|1|||
164123009|NCT01436643|592811586|FG000|2-week Pre-treatment|Adverse Event|0|||
164123010|NCT01436643|592811587|FG001|2-week Pre-treatment|Adverse Event|0|||
164123011|NCT01436643|592811588|FG002|2-week Pre-treatment|Adverse Event|0|||
164123012|NCT01436643|592811589|FG003|2-week Pre-treatment|Adverse Event|5|||
164123013|NCT01436643|592811586|FG000|2-week Pre-treatment|Protocol Violation|0|||
164123014|NCT01436643|592811587|FG001|2-week Pre-treatment|Protocol Violation|0|||
164123015|NCT01436643|592811588|FG002|2-week Pre-treatment|Protocol Violation|0|||
164123016|NCT01436643|592811589|FG003|2-week Pre-treatment|Protocol Violation|4|||
164123017|NCT01436643|592811586|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
164123018|NCT01436643|592811587|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
164123019|NCT01436643|592811588|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
164123020|NCT01436643|592811589|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
164123021|NCT01436643|592811586|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
164123022|NCT01436643|592811587|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
164123023|NCT01436643|592811588|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
164123024|NCT01436643|592811589|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
164123025|NCT01436643|592811586|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
164123026|NCT01436643|592811587|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
164123027|NCT01436643|592811588|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
164123028|NCT01436643|592811589|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
164123029|NCT03693950|592811590|FG000|Overall Study|Withdrawal by Subject|1|||
164123030|NCT03693950|592811591|FG001|Overall Study|Withdrawal by Subject|0|||
164123031|NCT04230876|592811592|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
164123032|NCT04230876|592811593|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
164123033|NCT01181531|592811594|FG000|Overall Study|Other|17|||
164123034|NCT01181531|592811595|FG001|Overall Study|Other|12|||
164123035|NCT01181531|592811594|FG000|Overall Study|Partial consent by subject withdrawn|0|||
164123036|NCT01181531|592811595|FG001|Overall Study|Partial consent by subject withdrawn|1|||
164123037|NCT01181531|592811594|FG000|Overall Study|Physician Decision|3|||
164123038|NCT01181531|592811595|FG001|Overall Study|Physician Decision|1|||
164123039|NCT01181531|592811594|FG000|Overall Study|Noncompliance|2|||
164123040|NCT01181531|592811595|FG001|Overall Study|Noncompliance|2|||
164123041|NCT01181531|592811594|FG000|Overall Study|Ineligibility determined|1|||
164123042|NCT01181531|592811595|FG001|Overall Study|Ineligibility determined|2|||
164123043|NCT01181531|592811594|FG000|Overall Study|Protocol Specified Criteria|15|||
164123044|NCT01181531|592811595|FG001|Overall Study|Protocol Specified Criteria|8|||
164123045|NCT01181531|592811594|FG000|Overall Study|Pregnancy|0|||
164123046|NCT01181531|592811595|FG001|Overall Study|Pregnancy|1|||
164123047|NCT01181531|592811594|FG000|Overall Study|Withdrawal by Subject|8|||
164123048|NCT01181531|592811595|FG001|Overall Study|Withdrawal by Subject|7|||
164123049|NCT01181531|592811594|FG000|Overall Study|Protocol Violation|6|||
164123050|NCT01181531|592811595|FG001|Overall Study|Protocol Violation|6|||
164123051|NCT01181531|592811594|FG000|Overall Study|Death|9|||
164123052|NCT01181531|592811595|FG001|Overall Study|Death|12|||
164123053|NCT01181531|592811594|FG000|Overall Study|Adverse Event|0|||
164123054|NCT01181531|592811595|FG001|Overall Study|Adverse Event|1|||
164123055|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
164123056|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
164123057|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
164123058|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
164123059|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
164123060|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
164123061|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
164123062|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
164123063|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
164123064|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
164123065|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
164123066|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
164123067|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Death|0|||
164123068|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Death|1|||
164123069|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Death|0|||
164123070|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Death|0|||
164123071|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
164123072|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
164123073|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
164123074|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
164123075|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
164123076|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
164123077|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
164123078|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
164123079|NCT00545688|592811597|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
164123080|NCT00545688|592811598|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
164123081|NCT00545688|592811599|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
164123082|NCT00545688|592811600|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
164123083|NCT00545688|592811597|FG000|Adjuvant Treatment Period|Disease Progression|3|||
164123084|NCT00545688|592811598|FG001|Adjuvant Treatment Period|Disease Progression|3|||
164123085|NCT00545688|592811599|FG002|Adjuvant Treatment Period|Disease Progression|0|||
164123086|NCT00545688|592811600|FG003|Adjuvant Treatment Period|Disease Progression|7|||
164123087|NCT00545688|592811597|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
164123088|NCT00545688|592811598|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
164123089|NCT00545688|592811599|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
164123090|NCT00545688|592811600|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
164123091|NCT00545688|592811597|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
164123092|NCT00545688|592811598|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
164123093|NCT00545688|592811599|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
164123094|NCT00545688|592811600|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
164123095|NCT00545688|592811597|FG000|Adjuvant Treatment Period|Adverse Event|0|||
164123096|NCT00545688|592811598|FG001|Adjuvant Treatment Period|Adverse Event|3|||
164123097|NCT00545688|592811599|FG002|Adjuvant Treatment Period|Adverse Event|2|||
164123098|NCT00545688|592811600|FG003|Adjuvant Treatment Period|Adverse Event|2|||
164123099|NCT00545688|592811597|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
164123100|NCT00545688|592811598|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
164123101|NCT00545688|592811599|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
164123102|NCT00545688|592811600|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
164123103|NCT00545688|592811597|FG000|Follow-Up Period|Death|4|||
164123104|NCT00545688|592811598|FG001|Follow-Up Period|Death|2|||
164123105|NCT00545688|592811599|FG002|Follow-Up Period|Death|2|||
164123106|NCT00545688|592811600|FG003|Follow-Up Period|Death|6|||
164123107|NCT00545688|592811597|FG000|Follow-Up Period|Disease Progression|6|||
164123108|NCT00545688|592811598|FG001|Follow-Up Period|Disease Progression|5|||
164123109|NCT00545688|592811599|FG002|Follow-Up Period|Disease Progression|9|||
164123110|NCT00545688|592811600|FG003|Follow-Up Period|Disease Progression|9|||
164123111|NCT00545688|592811597|FG000|Follow-Up Period|Refused Treatment|6|||
164123112|NCT00545688|592811598|FG001|Follow-Up Period|Refused Treatment|2|||
164123113|NCT00545688|592811599|FG002|Follow-Up Period|Refused Treatment|0|||
164123114|NCT00545688|592811600|FG003|Follow-Up Period|Refused Treatment|2|||
164123115|NCT00545688|592811597|FG000|Follow-Up Period|Lost to Follow-up|3|||
164123116|NCT00545688|592811598|FG001|Follow-Up Period|Lost to Follow-up|3|||
164123117|NCT00545688|592811599|FG002|Follow-Up Period|Lost to Follow-up|3|||
164123118|NCT00545688|592811600|FG003|Follow-Up Period|Lost to Follow-up|1|||
164123119|NCT00545688|592811597|FG000|Follow-Up Period|Unspecified Reason|2|||
164123120|NCT00545688|592811598|FG001|Follow-Up Period|Unspecified Reason|5|||
164123121|NCT00545688|592811599|FG002|Follow-Up Period|Unspecified Reason|6|||
164123122|NCT00545688|592811600|FG003|Follow-Up Period|Unspecified Reason|8|||
164123123|NCT00545688|592811597|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
164123124|NCT00545688|592811598|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
164123125|NCT00545688|592811599|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
164123126|NCT00545688|592811600|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
164123127|NCT02737592|592811603|FG000|Overall Study|Withdrawal by Subject|1|||
164123128|NCT02792218|592811605|FG000|Overall Study|Patient/guardian decision|15|||
164123129|NCT02792218|592811606|FG001|Overall Study|Patient/guardian decision|42|||
164123130|NCT02792218|592811605|FG000|Overall Study|Adverse Event|15|||
164123131|NCT02792218|592811606|FG001|Overall Study|Adverse Event|14|||
164123132|NCT02792218|592811605|FG000|Overall Study|Lost to Follow-up|10|||
164123133|NCT02792218|592811606|FG001|Overall Study|Lost to Follow-up|5|||
164123134|NCT02792218|592811605|FG000|Overall Study|Lack of Efficacy|1|||
164123135|NCT02792218|592811606|FG001|Overall Study|Lack of Efficacy|12|||
164123136|NCT02792218|592811605|FG000|Overall Study|Physician Decision|4|||
164123137|NCT02792218|592811606|FG001|Overall Study|Physician Decision|4|||
164123138|NCT02792218|592811605|FG000|Overall Study|Protocol deviation|3|||
164123139|NCT02792218|592811606|FG001|Overall Study|Protocol deviation|2|||
164123140|NCT02792218|592811605|FG000|Overall Study|New therapy for study indication|0|||
164123141|NCT02792218|592811606|FG001|Overall Study|New therapy for study indication|1|||
164123142|NCT02792218|592811605|FG000|Overall Study|Non-compliance with study treatment|0|||
164123143|NCT02792218|592811606|FG001|Overall Study|Non-compliance with study treatment|1|||
164123144|NCT02792218|592811605|FG000|Overall Study|Pregnancy|1|||
164123145|NCT02792218|592811606|FG001|Overall Study|Pregnancy|0|||
164123146|NCT03123783|592811607|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164123147|NCT03123783|592811608|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
164123148|NCT03123783|592811609|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164123149|NCT03123783|592811610|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164123150|NCT03123783|592811611|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164123151|NCT03123783|592811612|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164123152|NCT03123783|592811613|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
164123153|NCT03123783|592811607|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
164123154|NCT03123783|592811608|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
164123155|NCT03123783|592811609|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
164123156|NCT03123783|592811610|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
164123157|NCT03123783|592811611|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
164123158|NCT03123783|592811612|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
164123159|NCT03123783|592811613|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
164123160|NCT03123783|592811607|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
164123161|NCT03123783|592811608|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
164123162|NCT03123783|592811609|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
164123163|NCT03123783|592811610|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
164123164|NCT03123783|592811611|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
164123165|NCT03123783|592811612|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
164123166|NCT03123783|592811613|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
164123167|NCT03123783|592811607|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164123168|NCT03123783|592811608|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164123169|NCT03123783|592811609|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164123170|NCT03123783|592811610|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164123171|NCT03123783|592811611|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
164123172|NCT03123783|592811612|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164123173|NCT03123783|592811613|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
164123174|NCT00749411|592811619|FG000|Overall Study|Adverse Event|0|||
164123175|NCT00749411|592811620|FG001|Overall Study|Adverse Event|2|||
164123176|NCT00749411|592811619|FG000|Overall Study|Lack of Efficacy|0|||
164123177|NCT00749411|592811620|FG001|Overall Study|Lack of Efficacy|1|||
164123178|NCT00749411|592811619|FG000|Overall Study|Protocol Violation|1|||
164123179|NCT00749411|592811620|FG001|Overall Study|Protocol Violation|1|||
164123180|NCT00749411|592811619|FG000|Overall Study|Protocol-defined stopping criteria|0|||
164123181|NCT00749411|592811620|FG001|Overall Study|Protocol-defined stopping criteria|1|||
164123182|NCT00614926|592812714|FG000|Overall Study|Burden of travel|1|||
164123183|NCT00614926|592812715|FG001|Overall Study|Burden of travel|0|||
164123184|NCT00614926|592812714|FG000|Overall Study|Adverse Event|3|||
164123185|NCT00614926|592812715|FG001|Overall Study|Adverse Event|0|||
164123186|NCT01432574|592812722|FG000|Overall Study|Moved|2|||
164123187|NCT01432574|592812722|FG000|Overall Study|Not interested|1|||
164123188|NCT03135899|592812723|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123189|NCT03135899|592812724|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123190|NCT03135899|592812725|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123191|NCT03135899|592812726|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123192|NCT03135899|592812727|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123193|NCT03135899|592812728|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123194|NCT03135899|592812729|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
164123195|NCT03135899|592812730|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
164123196|NCT03135899|592812723|FG000|Overall Study|Withdrawal by Subject|0|||
164123197|NCT03135899|592812724|FG001|Overall Study|Withdrawal by Subject|0|||
164123198|NCT03135899|592812725|FG002|Overall Study|Withdrawal by Subject|0|||
164123199|NCT03135899|592812726|FG003|Overall Study|Withdrawal by Subject|0|||
164123200|NCT03135899|592812727|FG004|Overall Study|Withdrawal by Subject|0|||
164123201|NCT03135899|592812728|FG005|Overall Study|Withdrawal by Subject|2|||
164123202|NCT03135899|592812729|FG006|Overall Study|Withdrawal by Subject|0|||
164123203|NCT03135899|592812730|FG007|Overall Study|Withdrawal by Subject|0|||
164123204|NCT01042535|592812731|FG000|Overall Study|disease progression prior to treatment|3|||
164123205|NCT01042535|592812731|FG000|Overall Study|disease progression during treatment|3|||
164123206|NCT01042535|592812731|FG000|Overall Study|complications from other disease|2|||
164123207|NCT02129647|592812737|FG000|Overall Study|Adverse Event|2|||
164123208|NCT02129647|592812737|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
164123209|NCT00918463|592812738|FG000|Overall Study|Death|1|||
164123210|NCT00918463|592812738|FG000|Overall Study|Lack of Efficacy|1|||
164123211|NCT01045993|592812740|FG000|Overall Study|Treated-later found eligibility not met|0|||
164123212|NCT01045993|592812741|FG001|Overall Study|Treated-later found eligibility not met|1|||
164123213|NCT01045993|592812742|FG002|Overall Study|Treated-later found eligibility not met|0|||
164123214|NCT01045993|592812743|FG003|Overall Study|Treated-later found eligibility not met|0|||
164123215|NCT01659736|592812744|FG000|Treatment Period|Adverse Event|1|||
164123216|NCT01659736|592812745|FG001|Treatment Period|Adverse Event|1|||
164123217|NCT01659736|592812744|FG000|Treatment Period|Protocol Violation|3|||
164123218|NCT01659736|592812745|FG001|Treatment Period|Protocol Violation|1|||
164123219|NCT01659736|592812744|FG000|Treatment Period|Withdrawal by Subject|1|||
164123220|NCT01659736|592812745|FG001|Treatment Period|Withdrawal by Subject|0|||
164123221|NCT01659736|592812744|FG000|3-month Follow-up|Lost to Follow-up|0|||
164123222|NCT01659736|592812745|FG001|3-month Follow-up|Lost to Follow-up|1|||
164123223|NCT01570283|592812751|FG000|Cohort 1: Dose Level 1|Death|0|||
164123224|NCT01570283|592812752|FG001|Cohort 1: Dose Level 1|Death|1|||
164123225|NCT01570283|592812753|FG002|Cohort 1: Dose Level 1|Death|0|||
164123226|NCT01570283|592812754|FG003|Cohort 1: Dose Level 1|Death|0|||
164123227|NCT01570283|592812755|FG004|Cohort 1: Dose Level 1|Death|0|||
164123228|NCT01570283|592812756|FG005|Cohort 1: Dose Level 1|Death|0|||
164123229|NCT01570283|592812751|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164123230|NCT01570283|592812752|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
164123231|NCT01570283|592812753|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164123232|NCT01570283|592812754|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164123233|NCT01570283|592812755|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164123234|NCT01570283|592812756|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
164123235|NCT01570283|592812751|FG000|Cohort 2: Dose Level 2|Death|0|||
164123236|NCT01570283|592812752|FG001|Cohort 2: Dose Level 2|Death|0|||
164123237|NCT01570283|592812753|FG002|Cohort 2: Dose Level 2|Death|1|||
164123238|NCT01570283|592812754|FG003|Cohort 2: Dose Level 2|Death|0|||
164123239|NCT01570283|592812755|FG004|Cohort 2: Dose Level 2|Death|0|||
164123240|NCT01570283|592812756|FG005|Cohort 2: Dose Level 2|Death|0|||
164123241|NCT01570283|592812751|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164123242|NCT01570283|592812752|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164123243|NCT01570283|592812753|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164123244|NCT01570283|592812754|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
164123245|NCT01570283|592812755|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164123246|NCT01570283|592812756|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
164123247|NCT01570283|592812751|FG000|Cohort 3: Dose Level 3|Death|0|||
164123248|NCT01570283|592812752|FG001|Cohort 3: Dose Level 3|Death|0|||
164123249|NCT01570283|592812753|FG002|Cohort 3: Dose Level 3|Death|0|||
164123250|NCT01570283|592812754|FG003|Cohort 3: Dose Level 3|Death|0|||
164123251|NCT01570283|592812755|FG004|Cohort 3: Dose Level 3|Death|0|||
164123252|NCT01570283|592812756|FG005|Cohort 3: Dose Level 3|Death|1|||
164123253|NCT01570283|592812751|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164123254|NCT01570283|592812752|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164123255|NCT01570283|592812753|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164123256|NCT01570283|592812754|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164123257|NCT01570283|592812755|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
164123258|NCT01570283|592812756|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
164123259|NCT01833533|592812757|FG000|Overall Study|Adverse Event|0|||
164123260|NCT01833533|592812758|FG001|Overall Study|Adverse Event|1|||
164123261|NCT01833533|592812757|FG000|Overall Study|Lost to Follow-up|4|||
164123262|NCT01833533|592812758|FG001|Overall Study|Lost to Follow-up|9|||
164123263|NCT01833533|592812757|FG000|Overall Study|To Enter an Extension Study|0|||
164123264|NCT01833533|592812758|FG001|Overall Study|To Enter an Extension Study|4|||
164123265|NCT01833533|592812757|FG000|Overall Study|Other|2|||
164123266|NCT01833533|592812758|FG001|Overall Study|Other|7|||
164123267|NCT02017860|592812759|FG000|Overall Study|Adverse Event|1|||
164123268|NCT02017860|592812759|FG000|Overall Study|Withdrawal by Subject|1|||
164123269|NCT02772562|592812760|FG000|Overall Study|Withdrawal by Subject|1|||
164123270|NCT02772562|592812760|FG000|Overall Study|Protocol Violation|1|||
164123271|NCT00754442|592812765|FG000|Overall Study|Withdrawal by Subject|5|||
164123272|NCT00754442|592812766|FG001|Overall Study|Withdrawal by Subject|3|||
164123273|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
164123274|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
164123275|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
164123276|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
164123277|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
164123278|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
164123279|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
164123280|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
164123281|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
164123282|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
164123283|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
164123284|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
164123285|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
164123286|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
164123287|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
164123288|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
164123289|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
164123290|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
164123291|NCT00384293|592812767|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
164123292|NCT00384293|592812768|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
164123293|NCT00384293|592812769|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
164123294|NCT00384293|592812767|FG000|Post-randomization Period|Adverse Event|0|||
164123295|NCT00384293|592812768|FG001|Post-randomization Period|Adverse Event|23|||
164123296|NCT00384293|592812769|FG002|Post-randomization Period|Adverse Event|7|||
164123297|NCT00384293|592812767|FG000|Post-randomization Period|Lost to Follow-up|0|||
164123298|NCT00384293|592812768|FG001|Post-randomization Period|Lost to Follow-up|2|||
164123299|NCT00384293|592812769|FG002|Post-randomization Period|Lost to Follow-up|1|||
164123300|NCT00384293|592812767|FG000|Post-randomization Period|Protocol Violation|0|||
164123301|NCT00384293|592812768|FG001|Post-randomization Period|Protocol Violation|1|||
164123302|NCT00384293|592812769|FG002|Post-randomization Period|Protocol Violation|0|||
164123303|NCT00384293|592812767|FG000|Post-randomization Period|Withdrawal by Subject|0|||
164123304|NCT00384293|592812768|FG001|Post-randomization Period|Withdrawal by Subject|8|||
164123305|NCT00384293|592812769|FG002|Post-randomization Period|Withdrawal by Subject|6|||
164123306|NCT00384293|592812767|FG000|Post-randomization Period|Trial Termination|0|||
164123307|NCT00384293|592812768|FG001|Post-randomization Period|Trial Termination|180|||
164123308|NCT00384293|592812769|FG002|Post-randomization Period|Trial Termination|204|||
164123309|NCT00384293|592812767|FG000|Post-randomization Period|Patient Randomized in Error|0|||
164123310|NCT00384293|592812768|FG001|Post-randomization Period|Patient Randomized in Error|0|||
164123311|NCT00384293|592812769|FG002|Post-randomization Period|Patient Randomized in Error|1|||
164123312|NCT01832402|592812778|FG000|Overall Study|Lost to Follow-up|2|||
164123313|NCT01832402|592812779|FG001|Overall Study|Lost to Follow-up|0|||
164123314|NCT01832402|592812778|FG000|Overall Study|Withdrawal by Subject|3|||
164123315|NCT01832402|592812779|FG001|Overall Study|Withdrawal by Subject|3|||
164123316|NCT01832402|592812778|FG000|Overall Study|Declining Performance status|2|||
164123317|NCT01832402|592812779|FG001|Overall Study|Declining Performance status|1|||
164123318|NCT01198873|592812780|FG000|Overall Study|Adverse Event|4|||
164123319|NCT01198873|592812781|FG001|Overall Study|Adverse Event|7|||
164123320|NCT01198873|592812780|FG000|Overall Study|Study closure|29|||
164123321|NCT01198873|592812781|FG001|Overall Study|Study closure|23|||
164123322|NCT01198873|592812780|FG000|Overall Study|Other than above|4|||
164123323|NCT01198873|592812781|FG001|Overall Study|Other than above|2|||
164123324|NCT00775528|592812787|FG000|Overall Study|Protocol Violation|1|||
164123325|NCT02492841|592812788|FG000|Overall Study|Lost to Follow-up|34|||
164123326|NCT02492841|592812789|FG001|Overall Study|Lost to Follow-up|31|||
164123327|NCT02492841|592812790|FG002|Overall Study|Lost to Follow-up|35|||
164123328|NCT00613730|592812793|FG000|Overall Study|Disease progression|2|||
164123329|NCT00613730|592812793|FG000|Overall Study|Administrative decision|1|||
164123330|NCT00895037|592812798|FG000|Overall Study|Death|0|||
164123331|NCT00895037|592812799|FG001|Overall Study|Death|2|||
164123332|NCT00895037|592812800|FG002|Overall Study|Death|1|||
164123333|NCT03903159|592812810|FG000|Overall Study|Discharged with Staff Approval|2|||
164123334|NCT03903159|592812810|FG000|Overall Study|Discharged at Staff Request|2|||
164123335|NCT03903159|592812810|FG000|Overall Study|Discharged Against Staff Advice|1|||
164123336|NCT01382251|592812813|FG000|Overall Study|Surgeries cancelled or delayed|16|||
164123337|NCT01382251|592812814|FG001|Overall Study|Surgeries cancelled or delayed|16|||
164123338|NCT01382251|592812813|FG000|Overall Study|Lost to Follow-up|4|||
164123339|NCT01382251|592812814|FG001|Overall Study|Lost to Follow-up|4|||
164123340|NCT01382251|592812813|FG000|Overall Study|Contacted after study closed|1|||
164123341|NCT01382251|592812814|FG001|Overall Study|Contacted after study closed|1|||
164123342|NCT01117987|592812815|FG000|Overall Study|Protocol deviation|0|||
164123343|NCT01117987|592812816|FG001|Overall Study|Protocol deviation|1|||
164123344|NCT01117987|592812815|FG000|Overall Study|Subject no longer requires study drug|1|||
164123345|NCT01117987|592812816|FG001|Overall Study|Subject no longer requires study drug|0|||
164123346|NCT01117987|592812815|FG000|Overall Study|Lost to Follow-up|1|||
164123347|NCT01117987|592812816|FG001|Overall Study|Lost to Follow-up|1|||
164123348|NCT01117987|592812815|FG000|Overall Study|Abnormal test procedure result|2|||
164123349|NCT01117987|592812816|FG001|Overall Study|Abnormal test procedure result|0|||
164123350|NCT01117987|592812815|FG000|Overall Study|Lack of Efficacy|3|||
164123351|NCT01117987|592812816|FG001|Overall Study|Lack of Efficacy|4|||
164123352|NCT01117987|592812815|FG000|Overall Study|Death|5|||
164123353|NCT01117987|592812816|FG001|Overall Study|Death|10|||
164123354|NCT01117987|592812815|FG000|Overall Study|Withdrawal by Subject|5|||
164123355|NCT01117987|592812816|FG001|Overall Study|Withdrawal by Subject|10|||
164123356|NCT01117987|592812815|FG000|Overall Study|Adverse Event|19|||
164123357|NCT01117987|592812816|FG001|Overall Study|Adverse Event|26|||
164123358|NCT01117987|592812815|FG000|Overall Study|Administrative problems|25|||
164123359|NCT01117987|592812816|FG001|Overall Study|Administrative problems|22|||
164123360|NCT00702208|592812822|FG000|Overall Study|Lost to Follow-up|28|||
164123361|NCT00702208|592812822|FG000|Overall Study|Did not self-lavage|1|||
164123362|NCT00702208|592812822|FG000|Overall Study|Unsatisfactory colposcopy|2|||
164123363|NCT00562120|592812823|FG000|First Intervention Period|Adverse Event|1|||
164123364|NCT00562120|592812824|FG001|First Intervention Period|Adverse Event|0|||
164123365|NCT00562120|592812825|FG002|First Intervention Period|Adverse Event|0|||
164123366|NCT00562120|592812826|FG003|First Intervention Period|Adverse Event|0|||
164123367|NCT00562120|592812823|FG000|First Intervention Period|Randomized but not Treated|1|||
164123368|NCT00562120|592812824|FG001|First Intervention Period|Randomized but not Treated|0|||
164123369|NCT00562120|592812825|FG002|First Intervention Period|Randomized but not Treated|0|||
164123370|NCT00562120|592812826|FG003|First Intervention Period|Randomized but not Treated|0|||
164123371|NCT02148445|592812827|FG000|Overall Study|Death|1|||
164123372|NCT02148445|592812828|FG001|Overall Study|Death|3|||
164123373|NCT03450629|592812829|FG000|Overall Study|Adverse Event|15|||
164123374|NCT03450629|592812830|FG001|Overall Study|Adverse Event|14|||
164123375|NCT03450629|592812829|FG000|Overall Study|Physician Decision|2|||
164123376|NCT03450629|592812830|FG001|Overall Study|Physician Decision|2|||
164123377|NCT03450629|592812829|FG000|Overall Study|Lack of Efficacy|2|||
164123378|NCT03450629|592812830|FG001|Overall Study|Lack of Efficacy|0|||
164123379|NCT03450629|592812829|FG000|Overall Study|Lost to Follow-up|4|||
164123380|NCT03450629|592812830|FG001|Overall Study|Lost to Follow-up|2|||
164123381|NCT03450629|592812829|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
164123382|NCT03450629|592812830|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
164123383|NCT03450629|592812829|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164123384|NCT03450629|592812830|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164123385|NCT03450629|592812829|FG000|Overall Study|Protocol Violation|11|||
164123386|NCT03450629|592812830|FG001|Overall Study|Protocol Violation|8|||
164123387|NCT03450629|592812829|FG000|Overall Study|Withdrawal by Subject|12|||
164123388|NCT03450629|592812830|FG001|Overall Study|Withdrawal by Subject|6|||
164123389|NCT03366194|592812831|FG000|Overall Study|Lost to Follow-up|2|||
164123390|NCT02093923|592812832|FG000|Overall Study|Lost to Follow-up|0|||
164123391|NCT02093923|592812833|FG001|Overall Study|Lost to Follow-up|0|||
164123392|NCT02093923|592812834|FG002|Overall Study|Lost to Follow-up|0|||
164123393|NCT02093923|592812835|FG003|Overall Study|Lost to Follow-up|1|||
164123394|NCT02093923|592812836|FG004|Overall Study|Lost to Follow-up|0|||
164123395|NCT02093923|592812832|FG000|Overall Study|Screen failure after randomization|0|||
164123396|NCT02093923|592812833|FG001|Overall Study|Screen failure after randomization|0|||
164123397|NCT02093923|592812834|FG002|Overall Study|Screen failure after randomization|0|||
164123398|NCT02093923|592812835|FG003|Overall Study|Screen failure after randomization|1|||
164123399|NCT02093923|592812836|FG004|Overall Study|Screen failure after randomization|0|||
164123400|NCT03438006|592812837|FG000|Overall Study|Adverse Event|1|||
164123401|NCT03438006|592812837|FG000|Overall Study|Lost to Follow-up|67|||
164123402|NCT03438006|592812837|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
164123403|NCT03438006|592812837|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
164123404|NCT00955721|592812838|FG000|Overall Study|Physician Decision|1|||
164123405|NCT00955721|592812839|FG001|Overall Study|Physician Decision|0|||
164123406|NCT00955721|592812838|FG000|Overall Study|Death|1|||
164123407|NCT00955721|592812839|FG001|Overall Study|Death|0|||
164123408|NCT00955721|592812838|FG000|Overall Study|Withdrawal by Subject|1|||
164123409|NCT00955721|592812839|FG001|Overall Study|Withdrawal by Subject|0|||
164123410|NCT04678817|592814292|FG000|Overall Study|Lost to Follow-up|28|||
164123411|NCT04678817|592814293|FG001|Overall Study|Lost to Follow-up|0|||
164123412|NCT04678817|592814294|FG002|Overall Study|Lost to Follow-up|0|||
164123413|NCT01961687|592814297|FG000|Overall Study|Lost to Follow-up|19|||
164123414|NCT01961687|592814297|FG000|Overall Study|Re-operation|17|||
164123415|NCT01961687|592814297|FG000|Overall Study|Death|7|||
164123416|NCT01961687|592814297|FG000|Overall Study|Withdrawal by Subject|6|||
164123417|NCT01961687|592814297|FG000|Overall Study|Adverse Event|6|||
164123418|NCT01961687|592814297|FG000|Overall Study|Moved to area without study site|2|||
164123419|NCT01961687|592814297|FG000|Overall Study|Sponsor decision|2|||
164123420|NCT01961687|592814297|FG000|Overall Study|Physician Decision|1|||
164123421|NCT01961687|592814297|FG000|Overall Study|Unable to meet follow-up requirements|1|||
164123422|NCT01552369|592814299|FG000|Overall Study|Did not consent to extended follow up|8|||
164123423|NCT01552369|592814300|FG001|Overall Study|Did not consent to extended follow up|9|||
164123424|NCT02999984|592814307|FG000|Overall Study|Treatment Failure|1|||
164123425|NCT00754013|592814311|FG000|Overall Study|Lost to Follow-up|1|||
164123426|NCT00754013|592814312|FG001|Overall Study|Lost to Follow-up|1|||
164123427|NCT00754013|592814311|FG000|Overall Study|didn't return after study termed|3|||
164123428|NCT00754013|592814312|FG001|Overall Study|didn't return after study termed|4|||
164123429|NCT02310789|592814313|FG000|Overall Study|Adverse Event|1|||
164123430|NCT01197417|592814317|FG000|Overall Study|Physician Decision|3|||
164123431|NCT01197417|592814318|FG001|Overall Study|Physician Decision|2|||
164123432|NCT01197417|592814317|FG000|Overall Study|Withdrawal by Subject|2|||
164123433|NCT01197417|592814318|FG001|Overall Study|Withdrawal by Subject|4|||
164123434|NCT01197417|592814317|FG000|Overall Study|Site miscommunication|0|||
164123435|NCT01197417|592814318|FG001|Overall Study|Site miscommunication|1|||
164123436|NCT01197417|592814317|FG000|Overall Study|Subject transferred to intensive care|0|||
164123437|NCT01197417|592814318|FG001|Overall Study|Subject transferred to intensive care|1|||
164123438|NCT01197417|592814317|FG000|Overall Study|Not consented in time to receive drug|0|||
164123439|NCT01197417|592814318|FG001|Overall Study|Not consented in time to receive drug|1|||
164123440|NCT01197417|592814317|FG000|Overall Study|Hypotension|1|||
164123441|NCT01197417|592814318|FG001|Overall Study|Hypotension|2|||
164123442|NCT01197417|592814317|FG000|Overall Study|Found to be ineligible|2|||
164123443|NCT01197417|592814318|FG001|Overall Study|Found to be ineligible|5|||
164123444|NCT01197417|592814317|FG000|Overall Study|No 25-hour magnesium level|0|||
164123445|NCT01197417|592814318|FG001|Overall Study|No 25-hour magnesium level|2|||
164123446|NCT02813421|592814325|FG000|Overall Study|Withdrawal by Subject|1|||
164123447|NCT02813421|592814326|FG001|Overall Study|Withdrawal by Subject|2|||
164123448|NCT02813421|592814325|FG000|Overall Study|Lost to Follow-up|1|||
164123449|NCT02813421|592814326|FG001|Overall Study|Lost to Follow-up|1|||
164123450|NCT02914236|592814327|FG000|Overall Study|Lost to Follow-up|1|||
164123451|NCT01221090|592814334|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
164123452|NCT01221090|592814335|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
164123453|NCT01221090|592814336|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
164123454|NCT01221090|592814337|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
164123455|NCT01221090|592814334|FG000|Overall Study|Withdrawal by Subject|0|||
164123456|NCT01221090|592814335|FG001|Overall Study|Withdrawal by Subject|22|||
164123457|NCT01221090|592814336|FG002|Overall Study|Withdrawal by Subject|27|||
164123458|NCT01221090|592814337|FG003|Overall Study|Withdrawal by Subject|2|||
164123459|NCT03438539|592814338|FG000|Overall Study|Lost to Follow-up|8|||
164123460|NCT03438539|592814339|FG001|Overall Study|Lost to Follow-up|4|||
164123461|NCT03438539|592814340|FG002|Overall Study|Lost to Follow-up|10|||
164123462|NCT03438539|592814341|FG003|Overall Study|Lost to Follow-up|9|||
164123463|NCT03438539|592814342|FG004|Overall Study|Lost to Follow-up|3|||
164123464|NCT03438539|592814343|FG005|Overall Study|Lost to Follow-up|8|||
164123465|NCT00440466|592814345|FG000|Overall Study|Death|3|||
164123466|NCT00440466|592814346|FG001|Overall Study|Death|2|||
164123467|NCT00440466|592814347|FG002|Overall Study|Death|9|||
164123468|NCT00440466|592814345|FG000|Overall Study|Adverse Event|3|||
164123469|NCT00440466|592814346|FG001|Overall Study|Adverse Event|4|||
164123470|NCT00440466|592814347|FG002|Overall Study|Adverse Event|11|||
164123471|NCT00440466|592814345|FG000|Overall Study|Lost to Follow-up|1|||
164123472|NCT00440466|592814346|FG001|Overall Study|Lost to Follow-up|0|||
164123473|NCT00440466|592814347|FG002|Overall Study|Lost to Follow-up|2|||
164123474|NCT00440466|592814345|FG000|Overall Study|Physician Decision|2|||
164123475|NCT00440466|592814346|FG001|Overall Study|Physician Decision|0|||
164123476|NCT00440466|592814347|FG002|Overall Study|Physician Decision|1|||
164123477|NCT00440466|592814345|FG000|Overall Study|Protocol Violation|2|||
164123478|NCT00440466|592814346|FG001|Overall Study|Protocol Violation|0|||
164123479|NCT00440466|592814347|FG002|Overall Study|Protocol Violation|4|||
164123480|NCT00440466|592814345|FG000|Overall Study|Withdrawal by Subject|2|||
164123481|NCT00440466|592814346|FG001|Overall Study|Withdrawal by Subject|5|||
164123482|NCT00440466|592814347|FG002|Overall Study|Withdrawal by Subject|9|||
164123483|NCT00440466|592814345|FG000|Overall Study|Began Dialysis|0|||
164123484|NCT00440466|592814346|FG001|Overall Study|Began Dialysis|0|||
164123485|NCT00440466|592814347|FG002|Overall Study|Began Dialysis|1|||
164123486|NCT00440466|592814345|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
164123487|NCT00440466|592814346|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
164123488|NCT00440466|592814347|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
164123489|NCT00655850|592814354|FG000|Overall Study|Death|2|||
164123490|NCT00655850|592814354|FG000|Overall Study|Withdrawal by Subject|1|||
164123491|NCT01223235|592814355|FG000|Overall Study|Withdrawal by Subject|1|||
164123492|NCT01715896|592814358|FG000|Overall Study|Lost to Follow-up|0|||
164123493|NCT01715896|592814359|FG001|Overall Study|Lost to Follow-up|2|||
164123494|NCT01715896|592814358|FG000|Overall Study|Withdrawal by Subject|1|||
164123495|NCT01715896|592814359|FG001|Overall Study|Withdrawal by Subject|4|||
164123496|NCT01715896|592814358|FG000|Overall Study|Other|2|||
164123497|NCT01715896|592814359|FG001|Overall Study|Other|5|||
164123498|NCT03756883|592814360|FG000|Overall Study|Adverse Event|2|||
164123499|NCT03756883|592814361|FG001|Overall Study|Adverse Event|2|||
164123500|NCT03756883|592814362|FG002|Overall Study|Adverse Event|2|||
164123501|NCT03756883|592814360|FG000|Overall Study|Lack of Efficacy|0|||
164123502|NCT03756883|592814361|FG001|Overall Study|Lack of Efficacy|1|||
164123503|NCT03756883|592814362|FG002|Overall Study|Lack of Efficacy|2|||
164123504|NCT03756883|592814360|FG000|Overall Study|Lost to Follow-up|3|||
164123505|NCT03756883|592814361|FG001|Overall Study|Lost to Follow-up|3|||
164123506|NCT03756883|592814362|FG002|Overall Study|Lost to Follow-up|0|||
164123507|NCT03756883|592814360|FG000|Overall Study|Protocol Violation|2|||
164123508|NCT03756883|592814361|FG001|Overall Study|Protocol Violation|0|||
164123509|NCT03756883|592814362|FG002|Overall Study|Protocol Violation|1|||
164123510|NCT03756883|592814360|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
164123511|NCT03756883|592814361|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
164123512|NCT03756883|592814362|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
164123513|NCT03756883|592814360|FG000|Overall Study|Withdrawal by Subject|4|||
164123514|NCT03756883|592814361|FG001|Overall Study|Withdrawal by Subject|1|||
164123515|NCT03756883|592814362|FG002|Overall Study|Withdrawal by Subject|0|||
164123516|NCT03756883|592814360|FG000|Overall Study|Other Reasons|2|||
164123517|NCT03756883|592814361|FG001|Overall Study|Other Reasons|4|||
164123518|NCT03756883|592814362|FG002|Overall Study|Other Reasons|0|||
164123519|NCT00685802|592814363|FG000|Washout Period of 7 Days|Protocol Violation|2|||
164123520|NCT00685802|592814364|FG001|Washout Period of 7 Days|Protocol Violation|0|||
164123521|NCT00685802|592814363|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
164123522|NCT00685802|592814364|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
164123523|NCT03336242|592814365|FG000|Overall Study|Adverse Event|0|||
164123524|NCT03336242|592814366|FG001|Overall Study|Adverse Event|1|||
164123525|NCT03005067|592814367|FG000|Overall Study|Withdrawal by Subject|3|||
164123526|NCT03005067|592814368|FG001|Overall Study|Withdrawal by Subject|2|||
164123527|NCT03005067|592814367|FG000|Overall Study|Adverse Event|4|||
164123528|NCT03005067|592814368|FG001|Overall Study|Adverse Event|3|||
164132679|NCT01986010|592850658|FG003|Overall Study|Lost to Follow-up|2|||
164123529|NCT03005067|592814367|FG000|Overall Study|Other (reason not specified)|3|||
164123530|NCT03005067|592814368|FG001|Overall Study|Other (reason not specified)|1|||
164123531|NCT03005067|592814367|FG000|Overall Study|Protocol Violation|0|||
164123532|NCT03005067|592814368|FG001|Overall Study|Protocol Violation|1|||
164123533|NCT00103038|592814373|FG000|Overall Study|Withdrawal by Subject|8|||
164123534|NCT00103038|592814373|FG000|Overall Study|Screen failure|3|||
164123535|NCT00103038|592814373|FG000|Overall Study|Death|1|||
164123536|NCT00103038|592814373|FG000|Overall Study|Physician Decision|1|||
164123537|NCT05445843|592814376|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
164123538|NCT05445843|592814377|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
164123539|NCT05445843|592814376|FG000|Overall Study|Progressive disease|17|||
164123540|NCT05445843|592814377|FG001|Overall Study|Progressive disease|9|||
164123541|NCT05445843|592814376|FG000|Overall Study|Physician Decision|16|||
164123542|NCT05445843|592814377|FG001|Overall Study|Physician Decision|4|||
164123543|NCT05445843|592814376|FG000|Overall Study|Death|6|||
164123544|NCT05445843|592814377|FG001|Overall Study|Death|3|||
164123545|NCT05445843|592814376|FG000|Overall Study|Subject decision|6|||
164123546|NCT05445843|592814377|FG001|Overall Study|Subject decision|2|||
164123547|NCT05445843|592814376|FG000|Overall Study|Adverse Event|2|||
164123548|NCT05445843|592814377|FG001|Overall Study|Adverse Event|0|||
164123549|NCT05307679|592814382|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
164123550|NCT05307679|592814383|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
164123551|NCT01740791|592814386|FG000|Overall Study|Randomized but never treated|5|||
164123552|NCT01740791|592814387|FG001|Overall Study|Randomized but never treated|3|||
164123553|NCT01740791|592814388|FG002|Overall Study|Randomized but never treated|2|||
164123554|NCT01740791|592814389|FG003|Overall Study|Randomized but never treated|2|||
164123555|NCT01740791|592814390|FG004|Overall Study|Randomized but never treated|1|||
164123556|NCT01740791|592814391|FG005|Overall Study|Randomized but never treated|3|||
164123557|NCT01740791|592814386|FG000|Overall Study|Lost to Follow-up|2|||
164123558|NCT01740791|592814387|FG001|Overall Study|Lost to Follow-up|0|||
164123559|NCT01740791|592814388|FG002|Overall Study|Lost to Follow-up|2|||
164123560|NCT01740791|592814389|FG003|Overall Study|Lost to Follow-up|3|||
164123561|NCT01740791|592814390|FG004|Overall Study|Lost to Follow-up|2|||
164123562|NCT01740791|592814391|FG005|Overall Study|Lost to Follow-up|3|||
164123563|NCT01740791|592814386|FG000|Overall Study|Withdrew Consent|4|||
164123564|NCT01740791|592814387|FG001|Overall Study|Withdrew Consent|0|||
164123565|NCT01740791|592814388|FG002|Overall Study|Withdrew Consent|1|||
164123566|NCT01740791|592814389|FG003|Overall Study|Withdrew Consent|2|||
164123567|NCT01740791|592814390|FG004|Overall Study|Withdrew Consent|0|||
164123568|NCT01740791|592814391|FG005|Overall Study|Withdrew Consent|3|||
164123569|NCT01740791|592814386|FG000|Overall Study|Investigator's discretion|1|||
164123570|NCT01740791|592814387|FG001|Overall Study|Investigator's discretion|0|||
164123571|NCT01740791|592814388|FG002|Overall Study|Investigator's discretion|1|||
164123572|NCT01740791|592814389|FG003|Overall Study|Investigator's discretion|0|||
164123573|NCT01740791|592814390|FG004|Overall Study|Investigator's discretion|0|||
164123574|NCT01740791|592814391|FG005|Overall Study|Investigator's discretion|1|||
164123575|NCT01740791|592814386|FG000|Overall Study|Adverse Event|0|||
164123576|NCT01740791|592814387|FG001|Overall Study|Adverse Event|0|||
164123577|NCT01740791|592814388|FG002|Overall Study|Adverse Event|0|||
164123578|NCT01740791|592814389|FG003|Overall Study|Adverse Event|0|||
164123579|NCT01740791|592814390|FG004|Overall Study|Adverse Event|0|||
164123580|NCT01740791|592814391|FG005|Overall Study|Adverse Event|1|||
164123581|NCT02674386|592814392|FG000|Overall Study|Lost to Follow-up|0|||
164123582|NCT02674386|592814393|FG001|Overall Study|Lost to Follow-up|1|||
164123583|NCT02674386|592814394|FG002|Overall Study|Lost to Follow-up|1|||
164123584|NCT02674386|592814392|FG000|Overall Study|Withdrawal by Subject|0|||
164123585|NCT02674386|592814393|FG001|Overall Study|Withdrawal by Subject|4|||
164123586|NCT02674386|592814394|FG002|Overall Study|Withdrawal by Subject|0|||
164123587|NCT02674386|592814392|FG000|Overall Study|Other|0|||
164123588|NCT02674386|592814393|FG001|Overall Study|Other|1|||
164123589|NCT02674386|592814394|FG002|Overall Study|Other|0|||
164123590|NCT02674386|592814392|FG000|Overall Study|Enrolled but not evaluated|0|||
164123591|NCT02674386|592814393|FG001|Overall Study|Enrolled but not evaluated|4|||
164123592|NCT02674386|592814394|FG002|Overall Study|Enrolled but not evaluated|0|||
164123593|NCT02462486|592814395|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
164123594|NCT02462486|592814396|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
164123595|NCT02462486|592814397|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
164123596|NCT02462486|592814395|FG000|Overall Study|Adverse Event|53|||
164123597|NCT02462486|592814396|FG001|Overall Study|Adverse Event|48|||
164123598|NCT02462486|592814397|FG002|Overall Study|Adverse Event|21|||
164123599|NCT02462486|592814395|FG000|Overall Study|Lack of Efficacy|6|||
164123600|NCT02462486|592814396|FG001|Overall Study|Lack of Efficacy|12|||
164123601|NCT02462486|592814397|FG002|Overall Study|Lack of Efficacy|3|||
164123602|NCT02462486|592814395|FG000|Overall Study|Lost to Follow-up|3|||
164123603|NCT02462486|592814396|FG001|Overall Study|Lost to Follow-up|4|||
164123604|NCT02462486|592814397|FG002|Overall Study|Lost to Follow-up|2|||
164123605|NCT02462486|592814395|FG000|Overall Study|Withdrawal by Subject|25|||
164123606|NCT02462486|592814396|FG001|Overall Study|Withdrawal by Subject|22|||
164123607|NCT02462486|592814397|FG002|Overall Study|Withdrawal by Subject|19|||
164123608|NCT02462486|592814395|FG000|Overall Study|Protocol Violation|3|||
164123609|NCT02462486|592814396|FG001|Overall Study|Protocol Violation|1|||
164123610|NCT02462486|592814397|FG002|Overall Study|Protocol Violation|1|||
164123611|NCT02462486|592814395|FG000|Overall Study|Reason not Specified|3|||
164123612|NCT02462486|592814396|FG001|Overall Study|Reason not Specified|4|||
164123613|NCT02462486|592814397|FG002|Overall Study|Reason not Specified|3|||
164123614|NCT02039063|592814398|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
164123615|NCT02039063|592814399|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
164123616|NCT02039063|592814400|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
164123617|NCT02039063|592814401|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
164123618|NCT02039063|592814398|FG000|Treatment Phase|Progression of disease|0|||
164123619|NCT02039063|592814399|FG001|Treatment Phase|Progression of disease|0|||
164123620|NCT02039063|592814400|FG002|Treatment Phase|Progression of disease|1|||
164123621|NCT02039063|592814401|FG003|Treatment Phase|Progression of disease|1|||
164123622|NCT02039063|592814398|FG000|Extension Phase|Inadequate therapeutic effect|0|||
164123623|NCT02039063|592814399|FG001|Extension Phase|Inadequate therapeutic effect|1|||
164123624|NCT02039063|592814400|FG002|Extension Phase|Inadequate therapeutic effect|2|||
164123625|NCT02039063|592814401|FG003|Extension Phase|Inadequate therapeutic effect|0|||
164123626|NCT02039063|592814398|FG000|Extension Phase|Progression of disease|0|||
164123627|NCT02039063|592814399|FG001|Extension Phase|Progression of disease|0|||
164123628|NCT02039063|592814400|FG002|Extension Phase|Progression of disease|0|||
164123629|NCT02039063|592814401|FG003|Extension Phase|Progression of disease|1|||
164123630|NCT02039063|592814398|FG000|Extension Phase|Adverse Event|0|||
164123631|NCT02039063|592814399|FG001|Extension Phase|Adverse Event|0|||
164123632|NCT02039063|592814400|FG002|Extension Phase|Adverse Event|1|||
164123633|NCT02039063|592814401|FG003|Extension Phase|Adverse Event|0|||
164123634|NCT01192399|592814404|FG000|Overall Study|Lack of Efficacy|2|||
164123635|NCT00384176|592814408|FG000|Overall Study|Death|239|||
164123636|NCT00384176|592814409|FG001|Overall Study|Death|247|||
164123637|NCT00384176|592814410|FG002|Overall Study|Death|105|||
164123638|NCT00384176|592814408|FG000|Overall Study|Withdrawal by Subject|52|||
164123639|NCT00384176|592814409|FG001|Overall Study|Withdrawal by Subject|48|||
164123640|NCT00384176|592814410|FG002|Overall Study|Withdrawal by Subject|22|||
164123641|NCT00384176|592814408|FG000|Overall Study|Lost to Follow-up|16|||
164123642|NCT00384176|592814409|FG001|Overall Study|Lost to Follow-up|18|||
164123643|NCT00384176|592814410|FG002|Overall Study|Lost to Follow-up|4|||
164123644|NCT00384176|592814408|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
164123645|NCT00384176|592814409|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
164123646|NCT00384176|592814410|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
164123647|NCT00384176|592814408|FG000|Overall Study|Longer QTC as Visit 1|1|||
164123648|NCT00384176|592814409|FG001|Overall Study|Longer QTC as Visit 1|0|||
164123649|NCT00384176|592814410|FG002|Overall Study|Longer QTC as Visit 1|0|||
164123650|NCT00384176|592814408|FG000|Overall Study|Toxicity of treatment|1|||
164123651|NCT00384176|592814409|FG001|Overall Study|Toxicity of treatment|0|||
164123652|NCT00384176|592814410|FG002|Overall Study|Toxicity of treatment|0|||
164123653|NCT00384176|592814408|FG000|Overall Study|Did not receive study treatment|0|||
164123654|NCT00384176|592814409|FG001|Overall Study|Did not receive study treatment|1|||
164123655|NCT00384176|592814410|FG002|Overall Study|Did not receive study treatment|1|||
164123656|NCT00384176|592814408|FG000|Overall Study|Physician Decision|0|||
164123657|NCT00384176|592814409|FG001|Overall Study|Physician Decision|2|||
164123658|NCT00384176|592814410|FG002|Overall Study|Physician Decision|0|||
164123659|NCT00384176|592814408|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
164123660|NCT00384176|592814409|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
164123661|NCT00384176|592814410|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
164123662|NCT01425528|592814411|FG000|Overall Study|Withdrawal by Subject|1|||
164123663|NCT01425528|592814412|FG001|Overall Study|Withdrawal by Subject|1|||
164123664|NCT02697773|592814413|FG000|Overall Study|Adverse Event|2|||
164123665|NCT02697773|592814414|FG001|Overall Study|Adverse Event|1|||
164123666|NCT02697773|592814415|FG002|Overall Study|Adverse Event|2|||
164123667|NCT02697773|592814413|FG000|Overall Study|Death|0|||
164123668|NCT02697773|592814414|FG001|Overall Study|Death|0|||
164123669|NCT02697773|592814415|FG002|Overall Study|Death|2|||
164123670|NCT02697773|592814413|FG000|Overall Study|Lack of Efficacy|4|||
164123671|NCT02697773|592814414|FG001|Overall Study|Lack of Efficacy|6|||
164123672|NCT02697773|592814415|FG002|Overall Study|Lack of Efficacy|6|||
164123673|NCT02697773|592814413|FG000|Overall Study|Lost to Follow-up|5|||
164123674|NCT02697773|592814414|FG001|Overall Study|Lost to Follow-up|5|||
164123675|NCT02697773|592814415|FG002|Overall Study|Lost to Follow-up|7|||
164123676|NCT02697773|592814413|FG000|Overall Study|Other|15|||
164123677|NCT02697773|592814414|FG001|Overall Study|Other|11|||
164123678|NCT02697773|592814415|FG002|Overall Study|Other|10|||
164123679|NCT02697773|592814413|FG000|Overall Study|Protocol Violation|1|||
164123680|NCT02697773|592814414|FG001|Overall Study|Protocol Violation|1|||
164123681|NCT02697773|592814415|FG002|Overall Study|Protocol Violation|0|||
164123682|NCT02697773|592814413|FG000|Overall Study|Withdrawal by Subject|10|||
164123683|NCT02697773|592814414|FG001|Overall Study|Withdrawal by Subject|13|||
164123684|NCT02697773|592814415|FG002|Overall Study|Withdrawal by Subject|13|||
164123685|NCT02697773|592814413|FG000|Overall Study|Randomized but not treated|1|||
164123686|NCT02697773|592814414|FG001|Overall Study|Randomized but not treated|1|||
164123687|NCT02697773|592814415|FG002|Overall Study|Randomized but not treated|0|||
164123688|NCT00613834|592814416|FG000|Overall Study|Withdrawal by Subject|0|||
164123689|NCT00613834|592814417|FG001|Overall Study|Withdrawal by Subject|3|||
164123690|NCT00842530|592814418|FG000|Overall Study|Serious adverse event|0|||
164123691|NCT00842530|592814419|FG001|Overall Study|Serious adverse event|6|||
164123692|NCT00842530|592814418|FG000|Overall Study|Other adverse event|6|||
164123693|NCT00842530|592814419|FG001|Overall Study|Other adverse event|1|||
164123694|NCT00842530|592814418|FG000|Overall Study|Protocol Violation|32|||
164123695|NCT00842530|592814419|FG001|Overall Study|Protocol Violation|14|||
164123696|NCT00842530|592814418|FG000|Overall Study|Lost to Follow-up|6|||
164123697|NCT00842530|592814419|FG001|Overall Study|Lost to Follow-up|8|||
164123698|NCT00842530|592814418|FG000|Overall Study|Withdrawal by Subject|73|||
164123699|NCT00842530|592814419|FG001|Overall Study|Withdrawal by Subject|28|||
164123700|NCT02939950|592814420|FG000|Overall Study|Lost to Follow-up|13|||
164123701|NCT02939950|592814421|FG001|Overall Study|Lost to Follow-up|16|||
164123702|NCT02939950|592814420|FG000|Overall Study|Positive slit lamp findings|0|||
164123703|NCT02939950|592814421|FG001|Overall Study|Positive slit lamp findings|1|||
164123704|NCT02939950|592814420|FG000|Overall Study|Chalazion upper lid|0|||
164123705|NCT02939950|592814421|FG001|Overall Study|Chalazion upper lid|1|||
164123706|NCT02939950|592814420|FG000|Overall Study|Lack of motivation|0|||
164123707|NCT02939950|592814421|FG001|Overall Study|Lack of motivation|2|||
164123708|NCT02939950|592814420|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
164123709|NCT02939950|592814421|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
164123710|NCT02939950|592814420|FG000|Overall Study|Military orders|1|||
164123711|NCT02939950|592814421|FG001|Overall Study|Military orders|0|||
164123712|NCT02939950|592814420|FG000|Overall Study|Participant Relocated|5|||
164123713|NCT02939950|592814421|FG001|Overall Study|Participant Relocated|3|||
164123714|NCT02939950|592814420|FG000|Overall Study|Study related symptoms|8|||
164123715|NCT02939950|592814421|FG001|Overall Study|Study related symptoms|8|||
164123716|NCT02939950|592814420|FG000|Overall Study|Unacceptable lens movement|2|||
164123717|NCT02939950|592814421|FG001|Overall Study|Unacceptable lens movement|0|||
164123718|NCT02939950|592814420|FG000|Overall Study|Protocol Violation|6|||
164123719|NCT02939950|592814421|FG001|Overall Study|Protocol Violation|3|||
164123720|NCT02939950|592814420|FG000|Overall Study|Physician Decision|2|||
164123721|NCT02939950|592814421|FG001|Overall Study|Physician Decision|0|||
164123722|NCT02939950|592814420|FG000|Overall Study|Pregnancy|6|||
164123723|NCT02939950|592814421|FG001|Overall Study|Pregnancy|7|||
164123724|NCT02939950|592814420|FG000|Overall Study|Withdrawal by Subject|12|||
164123725|NCT02939950|592814421|FG001|Overall Study|Withdrawal by Subject|28|||
164123726|NCT02939950|592814420|FG000|Overall Study|Adverse Event|7|||
164123727|NCT02939950|592814421|FG001|Overall Study|Adverse Event|3|||
164123728|NCT02939950|592814420|FG000|Overall Study|Randomized, not dispensed|1|||
164123729|NCT02939950|592814421|FG001|Overall Study|Randomized, not dispensed|0|||
164123730|NCT02939950|592814420|FG000|Overall Study|Ineligible at Baseline|2|||
164123731|NCT02939950|592814421|FG001|Overall Study|Ineligible at Baseline|8|||
164123732|NCT02243293|592814422|FG000|Overall Study|Adverse Event|1|||
164123733|NCT02243293|592814423|FG001|Overall Study|Adverse Event|0|||
164123734|NCT02243293|592814424|FG002|Overall Study|Adverse Event|0|||
164123735|NCT02243293|592814425|FG003|Overall Study|Adverse Event|0|||
164123736|NCT02243293|592814426|FG004|Overall Study|Adverse Event|0|||
164123737|NCT02243293|592814427|FG005|Overall Study|Adverse Event|0|||
164123738|NCT02243293|592814428|FG006|Overall Study|Adverse Event|0|||
164123739|NCT02243293|592814429|FG007|Overall Study|Adverse Event|0|||
164123740|NCT02243293|592814430|FG008|Overall Study|Adverse Event|0|||
164123741|NCT02243293|592814431|FG009|Overall Study|Adverse Event|0|||
164123742|NCT02243293|592814432|FG010|Overall Study|Adverse Event|0|||
164123743|NCT02243293|592814433|FG011|Overall Study|Adverse Event|0|||
164123744|NCT02243293|592814434|FG012|Overall Study|Adverse Event|0|||
164123745|NCT02243293|592814435|FG013|Overall Study|Adverse Event|0|||
164123746|NCT02243293|592814436|FG014|Overall Study|Adverse Event|0|||
164123747|NCT02243293|592814437|FG015|Overall Study|Adverse Event|1|||
164123748|NCT02243293|592814438|FG016|Overall Study|Adverse Event|0|||
164123749|NCT02243293|592814439|FG017|Overall Study|Adverse Event|0|||
164123750|NCT02243293|592814440|FG018|Overall Study|Adverse Event|0|||
164123751|NCT02243293|592814441|FG019|Overall Study|Adverse Event|0|||
164123752|NCT02243293|592814442|FG020|Overall Study|Adverse Event|1|||
164123753|NCT02243293|592814443|FG021|Overall Study|Adverse Event|0|||
164123754|NCT02243293|592814422|FG000|Overall Study|Withdrawal by Subject|1|||
164123755|NCT02243293|592814423|FG001|Overall Study|Withdrawal by Subject|0|||
164123756|NCT02243293|592814424|FG002|Overall Study|Withdrawal by Subject|0|||
164123757|NCT02243293|592814425|FG003|Overall Study|Withdrawal by Subject|0|||
164123758|NCT02243293|592814426|FG004|Overall Study|Withdrawal by Subject|0|||
164123759|NCT02243293|592814427|FG005|Overall Study|Withdrawal by Subject|0|||
164123760|NCT02243293|592814428|FG006|Overall Study|Withdrawal by Subject|0|||
164123761|NCT02243293|592814429|FG007|Overall Study|Withdrawal by Subject|0|||
164123762|NCT02243293|592814430|FG008|Overall Study|Withdrawal by Subject|0|||
164123763|NCT02243293|592814431|FG009|Overall Study|Withdrawal by Subject|1|||
164123764|NCT02243293|592814432|FG010|Overall Study|Withdrawal by Subject|0|||
164123765|NCT02243293|592814433|FG011|Overall Study|Withdrawal by Subject|1|||
164123766|NCT02243293|592814434|FG012|Overall Study|Withdrawal by Subject|0|||
164123767|NCT02243293|592814435|FG013|Overall Study|Withdrawal by Subject|0|||
164123768|NCT02243293|592814436|FG014|Overall Study|Withdrawal by Subject|0|||
164123769|NCT02243293|592814437|FG015|Overall Study|Withdrawal by Subject|0|||
164123770|NCT02243293|592814438|FG016|Overall Study|Withdrawal by Subject|0|||
164123771|NCT02243293|592814439|FG017|Overall Study|Withdrawal by Subject|0|||
164123772|NCT02243293|592814440|FG018|Overall Study|Withdrawal by Subject|0|||
164123773|NCT02243293|592814441|FG019|Overall Study|Withdrawal by Subject|0|||
164123774|NCT02243293|592814442|FG020|Overall Study|Withdrawal by Subject|0|||
164123775|NCT02243293|592814443|FG021|Overall Study|Withdrawal by Subject|1|||
164123776|NCT02243293|592814422|FG000|Overall Study|Lost to Follow-up|0|||
164123777|NCT02243293|592814423|FG001|Overall Study|Lost to Follow-up|1|||
164123778|NCT02243293|592814424|FG002|Overall Study|Lost to Follow-up|1|||
164123779|NCT02243293|592814425|FG003|Overall Study|Lost to Follow-up|1|||
164123780|NCT02243293|592814426|FG004|Overall Study|Lost to Follow-up|0|||
164123781|NCT02243293|592814427|FG005|Overall Study|Lost to Follow-up|0|||
164123782|NCT02243293|592814428|FG006|Overall Study|Lost to Follow-up|3|||
164123783|NCT02243293|592814429|FG007|Overall Study|Lost to Follow-up|0|||
164123784|NCT02243293|592814430|FG008|Overall Study|Lost to Follow-up|0|||
164123785|NCT02243293|592814431|FG009|Overall Study|Lost to Follow-up|0|||
164123786|NCT02243293|592814432|FG010|Overall Study|Lost to Follow-up|0|||
164123787|NCT02243293|592814433|FG011|Overall Study|Lost to Follow-up|2|||
164123788|NCT02243293|592814434|FG012|Overall Study|Lost to Follow-up|0|||
164123789|NCT02243293|592814435|FG013|Overall Study|Lost to Follow-up|0|||
164123790|NCT02243293|592814436|FG014|Overall Study|Lost to Follow-up|0|||
164123791|NCT02243293|592814437|FG015|Overall Study|Lost to Follow-up|0|||
164123792|NCT02243293|592814438|FG016|Overall Study|Lost to Follow-up|3|||
164123793|NCT02243293|592814439|FG017|Overall Study|Lost to Follow-up|1|||
164123794|NCT02243293|592814440|FG018|Overall Study|Lost to Follow-up|0|||
164123795|NCT02243293|592814441|FG019|Overall Study|Lost to Follow-up|0|||
164123796|NCT02243293|592814442|FG020|Overall Study|Lost to Follow-up|1|||
164123797|NCT02243293|592814443|FG021|Overall Study|Lost to Follow-up|2|||
164123798|NCT02243293|592814422|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
164123799|NCT02243293|592814423|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
164123800|NCT02243293|592814424|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
164123801|NCT02243293|592814425|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
164123802|NCT02243293|592814426|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
164123803|NCT02243293|592814427|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
164123804|NCT02243293|592814428|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
164123805|NCT02243293|592814429|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
164123806|NCT02243293|592814430|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
164123807|NCT02243293|592814431|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
164123808|NCT02243293|592814432|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
164123809|NCT02243293|592814433|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
164123810|NCT02243293|592814434|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
164123811|NCT02243293|592814435|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
164123812|NCT02243293|592814436|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
164123813|NCT02243293|592814437|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
164123814|NCT02243293|592814438|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
164123815|NCT02243293|592814439|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
164123816|NCT02243293|592814440|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
164123817|NCT02243293|592814441|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
164123818|NCT02243293|592814442|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
164123819|NCT02243293|592814443|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
164123820|NCT02243293|592814422|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
164123821|NCT02243293|592814423|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
164123822|NCT02243293|592814424|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
164123823|NCT02243293|592814425|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
164123824|NCT02243293|592814426|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
164123825|NCT02243293|592814427|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
164123826|NCT02243293|592814428|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
164123827|NCT02243293|592814429|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
164123828|NCT02243293|592814430|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
164123829|NCT02243293|592814431|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
164123830|NCT02243293|592814432|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
164123831|NCT02243293|592814433|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
164123832|NCT02243293|592814434|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
164123833|NCT02243293|592814435|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
164123834|NCT02243293|592814436|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
164123835|NCT02243293|592814437|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
164123836|NCT02243293|592814438|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
164123837|NCT02243293|592814439|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
164123838|NCT02243293|592814440|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
164123839|NCT02243293|592814441|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
164123840|NCT02243293|592814442|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
164123841|NCT02243293|592814443|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
164123842|NCT02244424|592814444|FG000|Overall Study|Lost to Follow-up|20|||
164123843|NCT02244424|592814445|FG001|Overall Study|Lost to Follow-up|10|||
164123844|NCT02377063|592814446|FG000|Overall Study|Non-compliance|5|||
164123845|NCT01524913|592814447|FG000|Overall Study|Lost to Follow-up|4|||
164123846|NCT01524913|592814448|FG001|Overall Study|Lost to Follow-up|0|||
164123847|NCT01524913|592814449|FG002|Overall Study|Lost to Follow-up|0|||
164123848|NCT02723773|592816453|FG000|Overall Study|Adverse Event|934|||
164123849|NCT02723773|592816454|FG001|Overall Study|Adverse Event|3|||
164123850|NCT02723773|592816455|FG002|Overall Study|Adverse Event|1|||
164123851|NCT02723773|592816456|FG003|Overall Study|Adverse Event|9|||
164123852|NCT02723773|592816453|FG000|Overall Study|Protocol Violation|1|||
164123853|NCT02723773|592816454|FG001|Overall Study|Protocol Violation|0|||
164123854|NCT02723773|592816455|FG002|Overall Study|Protocol Violation|0|||
164123855|NCT02723773|592816456|FG003|Overall Study|Protocol Violation|0|||
164123856|NCT02723773|592816453|FG000|Overall Study|Withdrawal by Subject|360|||
164123857|NCT02723773|592816454|FG001|Overall Study|Withdrawal by Subject|5|||
164123858|NCT02723773|592816455|FG002|Overall Study|Withdrawal by Subject|6|||
164123859|NCT02723773|592816456|FG003|Overall Study|Withdrawal by Subject|10|||
164123860|NCT02723773|592816453|FG000|Overall Study|Migrated/moved from study area|37|||
164123861|NCT02723773|592816454|FG001|Overall Study|Migrated/moved from study area|0|||
164123862|NCT02723773|592816455|FG002|Overall Study|Migrated/moved from study area|0|||
164123863|NCT02723773|592816456|FG003|Overall Study|Migrated/moved from study area|1|||
164123864|NCT02723773|592816453|FG000|Overall Study|Lost to Follow-up|198|||
164123865|NCT02723773|592816454|FG001|Overall Study|Lost to Follow-up|0|||
164123866|NCT02723773|592816455|FG002|Overall Study|Lost to Follow-up|0|||
164123867|NCT02723773|592816456|FG003|Overall Study|Lost to Follow-up|0|||
164123868|NCT02723773|592816453|FG000|Overall Study|Other|189|||
164123869|NCT02723773|592816454|FG001|Overall Study|Other|1|||
164123870|NCT02723773|592816455|FG002|Overall Study|Other|2|||
164123871|NCT02723773|592816456|FG003|Overall Study|Other|2|||
164123872|NCT05168774|592816457|FG000|Overall Study|Lack of Efficacy|1|||
164123873|NCT05168774|592816458|FG001|Overall Study|Lack of Efficacy|2|||
164123874|NCT05168774|592816457|FG000|Overall Study|Withdrawal by Subject|1|||
164123875|NCT05168774|592816458|FG001|Overall Study|Withdrawal by Subject|2|||
164123876|NCT05168774|592816457|FG000|Overall Study|Adverse Event|2|||
164123877|NCT05168774|592816458|FG001|Overall Study|Adverse Event|0|||
164123878|NCT02124902|592816460|FG000|Overall Study|Adverse Event|7|||
164123879|NCT02124902|592816461|FG001|Overall Study|Adverse Event|2|||
164123880|NCT02124902|592816460|FG000|Overall Study|Went to alternative treatment|4|||
164123881|NCT02124902|592816461|FG001|Overall Study|Went to alternative treatment|0|||
164123882|NCT02124902|592816460|FG000|Overall Study|Withdrawal by Subject|2|||
164123883|NCT02124902|592816461|FG001|Overall Study|Withdrawal by Subject|1|||
164123884|NCT02124902|592816460|FG000|Overall Study|Physician Decision|2|||
164123885|NCT02124902|592816461|FG001|Overall Study|Physician Decision|0|||
164123886|NCT02124902|592816460|FG000|Overall Study|Not eligible|1|||
164123887|NCT02124902|592816461|FG001|Overall Study|Not eligible|0|||
164123888|NCT02124902|592816460|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
164123889|NCT02124902|592816461|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
164123890|NCT01314118|592816462|FG000|Overall Study|Adverse Event|10|||
164123891|NCT01314118|592816462|FG000|Overall Study|Progressive disease|3|||
164123892|NCT01314118|592816462|FG000|Overall Study|Death|8|||
164123893|NCT01314118|592816462|FG000|Overall Study|Physician Decision|13|||
164123894|NCT01314118|592816462|FG000|Overall Study|Sponsor Decision|1|||
164123895|NCT01314118|592816462|FG000|Overall Study|Protocol Violation|2|||
164123896|NCT01314118|592816462|FG000|Overall Study|Withdrawal by Subject|26|||
164123897|NCT01314118|592816462|FG000|Overall Study|Other|21|||
164123898|NCT02658487|592816468|FG000|Overall Study|Death|2|||
164123899|NCT02658487|592816468|FG000|Overall Study|Disease progression|10|||
164123900|NCT02658487|592816468|FG000|Overall Study|Alternative therapy|1|||
164123901|NCT02658487|592816468|FG000|Overall Study|Adverse Event|1|||
164123902|NCT02658487|592816468|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
164123903|NCT02658487|592816468|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
164123904|NCT01467479|592816469|FG000|Overall Study|No Study Medication|1|||
164123905|NCT01467479|592816470|FG001|Overall Study|No Study Medication|0|||
164123906|NCT01467479|592816471|FG002|Overall Study|No Study Medication|2|||
164123907|NCT01467479|592816469|FG000|Overall Study|Adverse Event|1|||
164123908|NCT01467479|592816470|FG001|Overall Study|Adverse Event|2|||
164123909|NCT01467479|592816471|FG002|Overall Study|Adverse Event|0|||
164123910|NCT01467479|592816469|FG000|Overall Study|Death|0|||
164123911|NCT01467479|592816470|FG001|Overall Study|Death|0|||
164123912|NCT01467479|592816471|FG002|Overall Study|Death|1|||
164123913|NCT01467479|592816469|FG000|Overall Study|Lost to Follow-up|2|||
164123914|NCT01467479|592816470|FG001|Overall Study|Lost to Follow-up|5|||
164123915|NCT01467479|592816471|FG002|Overall Study|Lost to Follow-up|3|||
164123916|NCT01467479|592816469|FG000|Overall Study|Withdrawal of Consent|3|||
164123917|NCT01467479|592816470|FG001|Overall Study|Withdrawal of Consent|7|||
164123918|NCT01467479|592816471|FG002|Overall Study|Withdrawal of Consent|7|||
164123919|NCT01467479|592816469|FG000|Overall Study|Study Terminated by Sponsor|1|||
164123920|NCT01467479|592816470|FG001|Overall Study|Study Terminated by Sponsor|3|||
164123921|NCT01467479|592816471|FG002|Overall Study|Study Terminated by Sponsor|3|||
164123922|NCT01467479|592816469|FG000|Overall Study|Other|1|||
164123923|NCT01467479|592816470|FG001|Overall Study|Other|0|||
164123924|NCT01467479|592816471|FG002|Overall Study|Other|0|||
164123925|NCT02284347|592816481|FG000|Overall Study|Lost to Follow-up|2|||
164123926|NCT02284347|592816481|FG000|Overall Study|Withdrawn prior to treatment|1|||
164123927|NCT01730040|592816482|FG000|Overall Study|Randomized but not treated|0|||
164123928|NCT01730040|592816483|FG001|Overall Study|Randomized but not treated|0|||
164123929|NCT01730040|592816484|FG002|Overall Study|Randomized but not treated|0|||
164123930|NCT01730040|592816485|FG003|Overall Study|Randomized but not treated|0|||
164123931|NCT01730040|592816486|FG004|Overall Study|Randomized but not treated|0|||
164123932|NCT01730040|592816487|FG005|Overall Study|Randomized but not treated|1|||
164123933|NCT01730040|592816488|FG006|Overall Study|Randomized but not treated|0|||
164123934|NCT01730040|592816482|FG000|Overall Study|Subject moved|0|||
164123935|NCT01730040|592816483|FG001|Overall Study|Subject moved|0|||
164123936|NCT01730040|592816484|FG002|Overall Study|Subject moved|1|||
164123937|NCT01730040|592816485|FG003|Overall Study|Subject moved|0|||
164123938|NCT01730040|592816486|FG004|Overall Study|Subject moved|0|||
164123939|NCT01730040|592816487|FG005|Overall Study|Subject moved|0|||
164123940|NCT01730040|592816488|FG006|Overall Study|Subject moved|1|||
164123941|NCT01730040|592816482|FG000|Overall Study|Physician Decision|0|||
164123942|NCT01730040|592816483|FG001|Overall Study|Physician Decision|0|||
164123943|NCT01730040|592816484|FG002|Overall Study|Physician Decision|0|||
164123944|NCT01730040|592816485|FG003|Overall Study|Physician Decision|0|||
164123945|NCT01730040|592816486|FG004|Overall Study|Physician Decision|0|||
164123946|NCT01730040|592816487|FG005|Overall Study|Physician Decision|1|||
164123947|NCT01730040|592816488|FG006|Overall Study|Physician Decision|1|||
164123948|NCT01730040|592816482|FG000|Overall Study|Other than specified|7|||
164123949|NCT01730040|592816483|FG001|Overall Study|Other than specified|8|||
164123950|NCT01730040|592816484|FG002|Overall Study|Other than specified|5|||
164123951|NCT01730040|592816485|FG003|Overall Study|Other than specified|5|||
164123952|NCT01730040|592816486|FG004|Overall Study|Other than specified|5|||
164123953|NCT01730040|592816487|FG005|Overall Study|Other than specified|4|||
164123954|NCT01730040|592816488|FG006|Overall Study|Other than specified|4|||
164123955|NCT01730040|592816482|FG000|Overall Study|Adverse Event|4|||
164123956|NCT01730040|592816483|FG001|Overall Study|Adverse Event|3|||
164123957|NCT01730040|592816484|FG002|Overall Study|Adverse Event|5|||
164123958|NCT01730040|592816485|FG003|Overall Study|Adverse Event|3|||
164123959|NCT01730040|592816486|FG004|Overall Study|Adverse Event|1|||
164123960|NCT01730040|592816487|FG005|Overall Study|Adverse Event|1|||
164123961|NCT01730040|592816488|FG006|Overall Study|Adverse Event|2|||
164123962|NCT01730040|592816482|FG000|Overall Study|Poor compliance to protocol|2|||
164123963|NCT01730040|592816483|FG001|Overall Study|Poor compliance to protocol|4|||
164123964|NCT01730040|592816484|FG002|Overall Study|Poor compliance to protocol|0|||
164123965|NCT01730040|592816485|FG003|Overall Study|Poor compliance to protocol|0|||
164123966|NCT01730040|592816486|FG004|Overall Study|Poor compliance to protocol|0|||
164123967|NCT01730040|592816487|FG005|Overall Study|Poor compliance to protocol|0|||
164123968|NCT01730040|592816488|FG006|Overall Study|Poor compliance to protocol|1|||
164123969|NCT00544817|592816492|FG000|Combined Modality|Lack of Efficacy|2|||
164123970|NCT00544817|592816492|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
164123971|NCT00544817|592816492|FG000|Combined Modality|Adverse Event|2|||
164123972|NCT00544817|592816492|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
164123973|NCT00544817|592816492|FG000|No Treatment Interval|Lack of Efficacy|8|||
164123974|NCT00544817|592816492|FG000|No Treatment Interval|Physician Decision|3|||
164123975|NCT00544817|592816492|FG000|No Treatment Interval|Adverse Event|1|||
164123976|NCT00544817|592816492|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
164123977|NCT00544817|592816492|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
164123978|NCT00544817|592816492|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
164123979|NCT01885182|592816493|FG000|Overall Study|Adverse Event|11|||
164123980|NCT01885182|592816494|FG001|Overall Study|Adverse Event|13|||
164123981|NCT01885182|592816493|FG000|Overall Study|Withdrawal by Subject|13|||
164123982|NCT01885182|592816494|FG001|Overall Study|Withdrawal by Subject|6|||
164123983|NCT01885182|592816493|FG000|Overall Study|Lost to Follow-up|2|||
164123984|NCT01885182|592816494|FG001|Overall Study|Lost to Follow-up|2|||
164123985|NCT01885182|592816493|FG000|Overall Study|Lack of Efficacy|8|||
164123986|NCT01885182|592816494|FG001|Overall Study|Lack of Efficacy|1|||
164123987|NCT00380692|592816497|FG000|Study Period II - Double Blind|Adverse Event|1|||
164132680|NCT01986010|592850659|FG004|Overall Study|Lost to Follow-up|2|||
164123988|NCT00380692|592816498|FG001|Study Period II - Double Blind|Adverse Event|0|||
164123989|NCT00380692|592816497|FG000|Study Period II - Double Blind|Protocol Violation|2|||
164123990|NCT00380692|592816498|FG001|Study Period II - Double Blind|Protocol Violation|2|||
164123991|NCT00380692|592816497|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
164123992|NCT00380692|592816498|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
164123993|NCT00380692|592816497|FG000|Study Period II - Double Blind|Physician Decision|0|||
164123994|NCT00380692|592816498|FG001|Study Period II - Double Blind|Physician Decision|1|||
164123995|NCT00380692|592816497|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
164123996|NCT00380692|592816498|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
164123997|NCT00380692|592816497|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
164123998|NCT00380692|592816498|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
164123999|NCT00380692|592816497|FG000|Study Period III - Open Label|Adverse Event|5|||
164124000|NCT00380692|592816498|FG001|Study Period III - Open Label|Adverse Event|3|||
164124001|NCT00380692|592816497|FG000|Study Period III - Open Label|Protocol Violation|0|||
164124002|NCT00380692|592816498|FG001|Study Period III - Open Label|Protocol Violation|0|||
164124003|NCT00380692|592816497|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
164124004|NCT00380692|592816498|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
164124005|NCT00380692|592816497|FG000|Study Period III - Open Label|Physician Decision|0|||
164124006|NCT00380692|592816498|FG001|Study Period III - Open Label|Physician Decision|3|||
164124007|NCT00380692|592816497|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
164124008|NCT00380692|592816498|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
164124009|NCT00380692|592816497|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
164124010|NCT00380692|592816498|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
164124011|NCT00708708|592816500|FG000|Overall Study|Another therapy instead of Enbrel|141|||
164124012|NCT00708708|592816500|FG000|Overall Study|Lost to Follow-up|52|||
164124013|NCT00708708|592816500|FG000|Overall Study|Withdrawal by Subject|51|||
164124014|NCT00708708|592816500|FG000|Overall Study|Intolerance|42|||
164124015|NCT00708708|592816500|FG000|Overall Study|Another therapy along with Enbrel|15|||
164124016|NCT00708708|592816500|FG000|Overall Study|Other unspecified|11|||
164124017|NCT00708708|592816500|FG000|Overall Study|Good effectiveness|9|||
164124018|NCT00708708|592816500|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
164124019|NCT00708708|592816500|FG000|Overall Study|Administrative reasons|7|||
164124020|NCT00708708|592816500|FG000|Overall Study|Lack of effectiveness|4|||
164124021|NCT00708708|592816500|FG000|Overall Study|Lack of compliance|3|||
164124022|NCT00708708|592816500|FG000|Overall Study|Pregnancy|3|||
164124023|NCT00708708|592816500|FG000|Overall Study|Adverse Event|3|||
164124024|NCT00708708|592816500|FG000|Overall Study|Missing values|392|||
164124025|NCT04213209|592816501|FG000|Overall Study|Protocol Violation|1|||
164124026|NCT04213209|592816502|FG001|Overall Study|Protocol Violation|0|||
164124027|NCT04213209|592816503|FG002|Overall Study|Protocol Violation|0|||
164124028|NCT04213209|592816504|FG003|Overall Study|Protocol Violation|0|||
164124029|NCT04213209|592816505|FG004|Overall Study|Protocol Violation|0|||
164124030|NCT04213209|592816506|FG005|Overall Study|Protocol Violation|0|||
164124031|NCT02065713|592816507|FG000|Overall Study|Adverse Event|0|||
164124032|NCT02065713|592816508|FG001|Overall Study|Adverse Event|1|||
164124033|NCT02065713|592816507|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164124034|NCT02065713|592816508|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
164124035|NCT00140413|592816509|FG000|Overall Study|Lost to Follow-up|1|||
164124036|NCT00140413|592816510|FG001|Overall Study|Lost to Follow-up|0|||
164124037|NCT00140413|592816509|FG000|Overall Study|Withdrawal by Subject|2|||
164124038|NCT00140413|592816510|FG001|Overall Study|Withdrawal by Subject|0|||
164124039|NCT02459665|592816511|FG000|Overall Study|Withdrawal by Subject|0|||
164124040|NCT02459665|592816512|FG001|Overall Study|Withdrawal by Subject|1|||
164124041|NCT02459665|592816513|FG002|Overall Study|Withdrawal by Subject|1|||
164124042|NCT02459665|592816514|FG003|Overall Study|Withdrawal by Subject|2|||
164124043|NCT00296491|592816519|FG000|Overall Study|Low Pollen Counts|18|||
164124044|NCT00296491|592816520|FG001|Overall Study|Low Pollen Counts|26|||
164124045|NCT00296491|592816521|FG002|Overall Study|Low Pollen Counts|25|||
164124046|NCT00296491|592816522|FG003|Overall Study|Low Pollen Counts|16|||
164124047|NCT00296491|592816519|FG000|Overall Study|Protocol Violation|4|||
164124048|NCT00296491|592816520|FG001|Overall Study|Protocol Violation|6|||
164124049|NCT00296491|592816521|FG002|Overall Study|Protocol Violation|2|||
164124050|NCT00296491|592816522|FG003|Overall Study|Protocol Violation|3|||
164124051|NCT00296491|592816519|FG000|Overall Study|Adverse Event|1|||
164124052|NCT00296491|592816520|FG001|Overall Study|Adverse Event|3|||
164124053|NCT00296491|592816521|FG002|Overall Study|Adverse Event|1|||
164124054|NCT00296491|592816522|FG003|Overall Study|Adverse Event|4|||
164124055|NCT00296491|592816519|FG000|Overall Study|Withdrawn due to Asthma|0|||
164124056|NCT00296491|592816520|FG001|Overall Study|Withdrawn due to Asthma|0|||
164124057|NCT00296491|592816521|FG002|Overall Study|Withdrawn due to Asthma|0|||
164124058|NCT00296491|592816522|FG003|Overall Study|Withdrawn due to Asthma|4|||
164124059|NCT00296491|592816519|FG000|Overall Study|Withdrawal by Subject|7|||
164124060|NCT00296491|592816520|FG001|Overall Study|Withdrawal by Subject|3|||
164124061|NCT00296491|592816521|FG002|Overall Study|Withdrawal by Subject|3|||
164124062|NCT00296491|592816522|FG003|Overall Study|Withdrawal by Subject|2|||
164124063|NCT00296491|592816519|FG000|Overall Study|Non-Compliance|12|||
164124064|NCT00296491|592816520|FG001|Overall Study|Non-Compliance|13|||
164124065|NCT00296491|592816521|FG002|Overall Study|Non-Compliance|10|||
164124066|NCT00296491|592816522|FG003|Overall Study|Non-Compliance|14|||
164124067|NCT00296491|592816519|FG000|Overall Study|Lost to Follow-up|0|||
164124068|NCT00296491|592816520|FG001|Overall Study|Lost to Follow-up|2|||
164124069|NCT00296491|592816521|FG002|Overall Study|Lost to Follow-up|2|||
164124070|NCT00296491|592816522|FG003|Overall Study|Lost to Follow-up|0|||
164124071|NCT01929395|592816527|FG000|Overall Study|Did not complete - non-related toxicity|1|||
164124072|NCT01929395|592816528|FG001|Overall Study|Did not complete - non-related toxicity|0|||
164124073|NCT01929395|592816529|FG002|Overall Study|Did not complete - non-related toxicity|0|||
164124074|NCT01929395|592816527|FG000|Overall Study|Withdrawal by Subject|0|||
164124075|NCT01929395|592816528|FG001|Overall Study|Withdrawal by Subject|1|||
164124076|NCT01929395|592816529|FG002|Overall Study|Withdrawal by Subject|0|||
164124077|NCT01929395|592816527|FG000|Overall Study|Screen Fail|0|||
164124078|NCT01929395|592816528|FG001|Overall Study|Screen Fail|0|||
164124079|NCT01929395|592816529|FG002|Overall Study|Screen Fail|1|||
164124080|NCT03604341|592816531|FG000|Overall Study|Withdrawal by Subject|1|||
164124081|NCT03604341|592816532|FG001|Overall Study|Withdrawal by Subject|1|||
164124082|NCT03604341|592816531|FG000|Overall Study|Adverse Event|1|||
164124083|NCT03604341|592816532|FG001|Overall Study|Adverse Event|0|||
164124084|NCT03604341|592816531|FG000|Overall Study|Protocol Violation|0|||
164124085|NCT03604341|592816532|FG001|Overall Study|Protocol Violation|1|||
164124086|NCT00355472|592816533|FG000|Overall Study|Physician Decision|1|||
164124087|NCT04706507|592816540|FG000|Overall Study|Death|45|||
164124088|NCT04706507|592816541|FG001|Overall Study|Death|22|||
164124089|NCT04706507|592816540|FG000|Overall Study|Unable to adhere|0|||
164124090|NCT04706507|592816541|FG001|Overall Study|Unable to adhere|2|||
164124091|NCT04706507|592816540|FG000|Overall Study|Lost to Follow-up|13|||
164124092|NCT04706507|592816541|FG001|Overall Study|Lost to Follow-up|12|||
164124093|NCT04706507|592816540|FG000|Overall Study|Withdrawal of consent|1|||
164124094|NCT04706507|592816541|FG001|Overall Study|Withdrawal of consent|1|||
164124095|NCT04706507|592816540|FG000|Overall Study|Patient or LAR refuses further participation|0|||
164124096|NCT04706507|592816541|FG001|Overall Study|Patient or LAR refuses further participation|3|||
164124097|NCT02310763|592816545|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
164124098|NCT02310763|592816546|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
164124099|NCT02310763|592816547|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
164124100|NCT02310763|592816545|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
164124101|NCT02310763|592816546|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
164124102|NCT02310763|592816547|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
164124103|NCT02310763|592816545|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
164124104|NCT02310763|592816546|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
164124105|NCT02310763|592816547|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
164124106|NCT02310763|592816545|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
164124107|NCT02310763|592816546|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
164124108|NCT02310763|592816547|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
164124109|NCT02310763|592816545|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
164124110|NCT02310763|592816546|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
164124111|NCT02310763|592816547|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
164124112|NCT01731886|592816549|FG000|Overall Study|Death|1|||
164124113|NCT01731886|592816550|FG001|Overall Study|Death|0|||
164124114|NCT01731886|592816549|FG000|Overall Study|Never started treatment|0|||
164124115|NCT01731886|592816550|FG001|Overall Study|Never started treatment|1|||
164124116|NCT01731886|592816549|FG000|Overall Study|Non-compliant|1|||
164124117|NCT01731886|592816550|FG001|Overall Study|Non-compliant|0|||
164124118|NCT02280187|592816551|FG000|Overall Study|Lost to Follow-up|218|||
164124119|NCT00939627|592816552|FG000|Overall Study|Disease Progression|16|||
164124120|NCT00939627|592816553|FG001|Overall Study|Disease Progression|12|||
164124121|NCT00939627|592816554|FG002|Overall Study|Disease Progression|0|||
164124122|NCT00939627|592816552|FG000|Overall Study|Adverse Event|6|||
164124123|NCT00939627|592816553|FG001|Overall Study|Adverse Event|7|||
164124124|NCT00939627|592816554|FG002|Overall Study|Adverse Event|0|||
164124125|NCT00939627|592816552|FG000|Overall Study|Death|0|||
164124126|NCT00939627|592816553|FG001|Overall Study|Death|2|||
164124127|NCT00939627|592816554|FG002|Overall Study|Death|0|||
164124128|NCT00939627|592816552|FG000|Overall Study|Withdrawal by Subject|2|||
164124129|NCT00939627|592816553|FG001|Overall Study|Withdrawal by Subject|4|||
164124130|NCT00939627|592816554|FG002|Overall Study|Withdrawal by Subject|0|||
164124131|NCT00939627|592816552|FG000|Overall Study|Other complicating disease|1|||
164124132|NCT00939627|592816553|FG001|Overall Study|Other complicating disease|1|||
164124133|NCT00939627|592816554|FG002|Overall Study|Other complicating disease|0|||
164124134|NCT00939627|592816552|FG000|Overall Study|Not compliant|2|||
164124135|NCT00939627|592816553|FG001|Overall Study|Not compliant|0|||
164124136|NCT00939627|592816554|FG002|Overall Study|Not compliant|0|||
164124137|NCT00939627|592816552|FG000|Overall Study|No off-tx reason given|0|||
164124138|NCT00939627|592816553|FG001|Overall Study|No off-tx reason given|2|||
164124139|NCT00939627|592816554|FG002|Overall Study|No off-tx reason given|0|||
164124140|NCT03417830|592816557|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
164124141|NCT03417830|592816558|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
164124142|NCT02563769|592816559|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
164124143|NCT02563769|592816560|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
164124144|NCT02563769|592816561|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
164124145|NCT00303667|592816573|FG000|Overall Study|Death|0|||
164124146|NCT00303667|592816574|FG001|Overall Study|Death|4|||
164124147|NCT01523587|592816575|FG000|Overall Study|Other than listed|5|||
164124148|NCT01523587|592816576|FG001|Overall Study|Other than listed|5|||
164124149|NCT01523587|592816575|FG000|Overall Study|Worsening of underlying cancer disease|19|||
164124150|NCT01523587|592816576|FG001|Overall Study|Worsening of underlying cancer disease|34|||
164124151|NCT01523587|592816575|FG000|Overall Study|Adverse Event|68|||
164124152|NCT01523587|592816576|FG001|Overall Study|Adverse Event|52|||
164124153|NCT01523587|592816575|FG000|Overall Study|Protocol Violation|5|||
164124154|NCT01523587|592816576|FG001|Overall Study|Protocol Violation|3|||
164124155|NCT01523587|592816575|FG000|Overall Study|Lost to Follow-up|2|||
164124156|NCT01523587|592816576|FG001|Overall Study|Lost to Follow-up|2|||
164124157|NCT01523587|592816575|FG000|Overall Study|Withdrawal by Subject|28|||
164124158|NCT01523587|592816576|FG001|Overall Study|Withdrawal by Subject|20|||
164124159|NCT01523587|592816575|FG000|Overall Study|Withdrew due to Progressive disease|265|||
164124160|NCT01523587|592816576|FG001|Overall Study|Withdrew due to Progressive disease|279|||
164124161|NCT01523587|592816575|FG000|Overall Study|Randomised but bot treated|6|||
164124162|NCT01523587|592816576|FG001|Overall Study|Randomised but bot treated|2|||
164124163|NCT00724373|592816577|FG000|Overall Study|Adverse Event|41|||
164124164|NCT00724373|592816577|FG000|Overall Study|Lack of Efficacy|82|||
164124165|NCT00724373|592816577|FG000|Overall Study|Lost to Follow-up|7|||
164124166|NCT00724373|592816577|FG000|Overall Study|Non-compliance|2|||
164124167|NCT00724373|592816577|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
164124168|NCT00724373|592816577|FG000|Overall Study|Participant moved away|1|||
164124169|NCT00724373|592816577|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
164124170|NCT00724373|592816577|FG000|Overall Study|Only to have 24 week regimen|1|||
164124171|NCT00724373|592816577|FG000|Overall Study|Viral Relapse|1|||
164124172|NCT00724373|592816577|FG000|Overall Study|Acute HCV infection|1|||
164124173|NCT00724373|592816577|FG000|Overall Study|Drug Relapse|1|||
164124174|NCT00724373|592816577|FG000|Overall Study|Tolerability|23|||
164124175|NCT02083926|592816580|FG000|Overall Study|Withdrawal by Subject|1|||
164124176|NCT02083926|592816581|FG001|Overall Study|Withdrawal by Subject|0|||
164124177|NCT03465436|592816584|FG000|Period 1|Protocol Violation|0|||
164124178|NCT03465436|592816585|FG001|Period 1|Protocol Violation|0|||
164124179|NCT03465436|592816586|FG002|Period 1|Protocol Violation|1|||
164124180|NCT03465436|592816587|FG003|Period 1|Protocol Violation|0|||
164124181|NCT03465436|592816584|FG000|Period 2|Protocol Violation|0|||
164124182|NCT03465436|592816585|FG001|Period 2|Protocol Violation|1|||
164124183|NCT03465436|592816586|FG002|Period 2|Protocol Violation|0|||
164124184|NCT03465436|592816587|FG003|Period 2|Protocol Violation|0|||
164124185|NCT03465436|592816584|FG000|Period 3|Protocol Violation|1|||
164124186|NCT03465436|592816585|FG001|Period 3|Protocol Violation|1|||
164124187|NCT03465436|592816586|FG002|Period 3|Protocol Violation|0|||
164124188|NCT03465436|592816587|FG003|Period 3|Protocol Violation|0|||
164124189|NCT03465436|592816584|FG000|Period 4|Protocol Violation|0|||
164124190|NCT03465436|592816585|FG001|Period 4|Protocol Violation|0|||
164124191|NCT03465436|592816586|FG002|Period 4|Protocol Violation|1|||
164124192|NCT03465436|592816587|FG003|Period 4|Protocol Violation|0|||
164124193|NCT04117945|592816588|FG000|Overall Study|Death|1|||
164124194|NCT04117945|592816589|FG001|Overall Study|Death|0|||
164124195|NCT04117945|592816588|FG000|Overall Study|Withdrawal by Subject|3|||
164124196|NCT04117945|592816589|FG001|Overall Study|Withdrawal by Subject|1|||
164124197|NCT04117945|592816588|FG000|Overall Study|Disease Progression|0|||
164124198|NCT04117945|592816589|FG001|Overall Study|Disease Progression|2|||
164124199|NCT04117945|592816588|FG000|Overall Study|Ineligible|8|||
164124200|NCT04117945|592816589|FG001|Overall Study|Ineligible|7|||
164124201|NCT00402025|592816593|FG000|Overall Study|Adverse Event|0|||
164124202|NCT00402025|592816594|FG001|Overall Study|Adverse Event|0|||
164124203|NCT00402025|592816595|FG002|Overall Study|Adverse Event|2|||
164124204|NCT00402025|592816593|FG000|Overall Study|Death|0|||
164124205|NCT00402025|592816594|FG001|Overall Study|Death|1|||
164124206|NCT00402025|592816595|FG002|Overall Study|Death|5|||
164124207|NCT00402025|592816593|FG000|Overall Study|Disease Progression|1|||
164124208|NCT00402025|592816594|FG001|Overall Study|Disease Progression|1|||
164124209|NCT00402025|592816595|FG002|Overall Study|Disease Progression|2|||
164124210|NCT00402025|592816593|FG000|Overall Study|Physician Decision|1|||
164124211|NCT00402025|592816594|FG001|Overall Study|Physician Decision|1|||
164124212|NCT00402025|592816595|FG002|Overall Study|Physician Decision|0|||
164124213|NCT00402025|592816593|FG000|Overall Study|Participant Decision|0|||
164124214|NCT00402025|592816594|FG001|Overall Study|Participant Decision|0|||
164124215|NCT00402025|592816595|FG002|Overall Study|Participant Decision|1|||
164124216|NCT01172821|592816630|FG000|Overall Study|Adverse Event|5|||
164124217|NCT01172821|592816631|FG001|Overall Study|Adverse Event|2|||
164124218|NCT01172821|592816632|FG002|Overall Study|Adverse Event|2|||
164124219|NCT01172821|592816633|FG003|Overall Study|Adverse Event|7|||
164124220|NCT01172821|592816630|FG000|Overall Study|Protocol Violation|0|||
164124221|NCT01172821|592816631|FG001|Overall Study|Protocol Violation|2|||
164124222|NCT01172821|592816632|FG002|Overall Study|Protocol Violation|1|||
164124223|NCT01172821|592816633|FG003|Overall Study|Protocol Violation|2|||
164124224|NCT01172821|592816630|FG000|Overall Study|Lost to Follow-up|4|||
164124225|NCT01172821|592816631|FG001|Overall Study|Lost to Follow-up|1|||
164124226|NCT01172821|592816632|FG002|Overall Study|Lost to Follow-up|2|||
164124227|NCT01172821|592816633|FG003|Overall Study|Lost to Follow-up|2|||
164124228|NCT01172821|592816630|FG000|Overall Study|Withdrawal by Subject|2|||
164124229|NCT01172821|592816631|FG001|Overall Study|Withdrawal by Subject|3|||
164124230|NCT01172821|592816632|FG002|Overall Study|Withdrawal by Subject|3|||
164124231|NCT01172821|592816633|FG003|Overall Study|Withdrawal by Subject|3|||
164124232|NCT01172821|592816630|FG000|Overall Study|Other|3|||
164124233|NCT01172821|592816631|FG001|Overall Study|Other|4|||
164124234|NCT01172821|592816632|FG002|Overall Study|Other|5|||
164124235|NCT01172821|592816633|FG003|Overall Study|Other|3|||
164124236|NCT02756637|592816634|FG000|Overall Study|Not eligible for initial SWOG study|10|||
164124237|NCT02756637|592816635|FG001|Overall Study|Not eligible for initial SWOG study|10|||
164124238|NCT02756637|592816634|FG000|Overall Study|No available NLR value|44|||
164124239|NCT02756637|592816635|FG001|Overall Study|No available NLR value|44|||
164124240|NCT02756637|592816634|FG000|Overall Study|Did not complete curative therapy|33|||
164124241|NCT02756637|592816635|FG001|Overall Study|Did not complete curative therapy|0|||
164124242|NCT02985879|592816636|FG000|Overall Study|Adverse Event|7|||
164124243|NCT02985879|592816637|FG001|Overall Study|Adverse Event|9|||
164124244|NCT02985879|592816638|FG002|Overall Study|Adverse Event|7|||
164124245|NCT02985879|592816636|FG000|Overall Study|Withdrew consent|6|||
164124246|NCT02985879|592816637|FG001|Overall Study|Withdrew consent|8|||
164124247|NCT02985879|592816638|FG002|Overall Study|Withdrew consent|10|||
164124248|NCT02985879|592816636|FG000|Overall Study|Lost to Follow-up|1|||
164124249|NCT02985879|592816637|FG001|Overall Study|Lost to Follow-up|0|||
164124250|NCT02985879|592816638|FG002|Overall Study|Lost to Follow-up|2|||
164124251|NCT02985879|592816636|FG000|Overall Study|Other, not specified|62|||
164124252|NCT02985879|592816637|FG001|Overall Study|Other, not specified|58|||
164124253|NCT02985879|592816638|FG002|Overall Study|Other, not specified|58|||
164124254|NCT03940703|592817846|FG000|Overall Study|Still under treatment|31|||
164124255|NCT03940703|592817847|FG001|Overall Study|Still under treatment|0|||
164124256|NCT04079712|592817848|FG000|Overall Study|Disease progression before starting treatment|1|||
164124257|NCT01475253|592817849|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
164124258|NCT01475253|592817850|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
164124259|NCT01475253|592817851|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
164124260|NCT01475253|592817852|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
164124261|NCT01475253|592817849|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
164124262|NCT01475253|592817850|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
164124263|NCT01475253|592817851|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
164124264|NCT01475253|592817852|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
164124265|NCT02676284|592817857|FG000|Overall Study|Withdrawal by Subject|1|||
164124266|NCT03919448|592817859|FG000|Overall Study|Withdrawal by Subject|1|||
164124267|NCT03919448|592817860|FG001|Overall Study|Withdrawal by Subject|0|||
164124268|NCT03919448|592817861|FG002|Overall Study|Withdrawal by Subject|0|||
164124269|NCT04507126|592817862|FG000|Overall Study|Withdrawal by Subject|3|||
164124270|NCT04507126|592817862|FG000|Overall Study|Protocol Violation|4|||
164124271|NCT01567826|592817870|FG000|Overall Study|Lost to Follow-up|3|||
164124272|NCT01567826|592817871|FG001|Overall Study|Lost to Follow-up|2|||
164124273|NCT00865098|592817875|FG000|Overall Study|Progressive disease|1|||
164124274|NCT01014624|592817876|FG000|Overall Study|Adverse Event|0|||
164124275|NCT01014624|592817877|FG001|Overall Study|Adverse Event|1|||
164124276|NCT01014624|592817876|FG000|Overall Study|Protocol Violation|1|||
164124277|NCT01014624|592817877|FG001|Overall Study|Protocol Violation|0|||
164124278|NCT01014624|592817876|FG000|Overall Study|Withdrawal by Subject|1|||
164124279|NCT01014624|592817877|FG001|Overall Study|Withdrawal by Subject|0|||
164124280|NCT01557842|592817888|FG000|Overall Study|Lost to Follow-up|0|||
164124281|NCT01557842|592817889|FG001|Overall Study|Lost to Follow-up|1|||
164124282|NCT01557842|592817888|FG000|Overall Study|Death|1|||
164124283|NCT01557842|592817889|FG001|Overall Study|Death|0|||
164124284|NCT01557842|592817888|FG000|Overall Study|Lack of Efficacy|0|||
164124285|NCT01557842|592817889|FG001|Overall Study|Lack of Efficacy|1|||
164124286|NCT01557842|592817888|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
164124287|NCT01557842|592817889|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
164124288|NCT01557842|592817888|FG000|Overall Study|Study Terminated by Sponsor|3|||
164124289|NCT01557842|592817889|FG001|Overall Study|Study Terminated by Sponsor|4|||
164124290|NCT01557842|592817888|FG000|Overall Study|Not Ablated|2|||
164124291|NCT01557842|592817889|FG001|Overall Study|Not Ablated|0|||
164124292|NCT05611996|592817890|FG000|Overall Study|Ineligible|1|||
164124293|NCT05611996|592817890|FG000|Overall Study|Withdrawal by Subject|9|||
164132681|NCT01986010|592850660|FG005|Overall Study|Lost to Follow-up|2|||
164124294|NCT04479475|592817898|FG000|Overall Study|Withdrawal by Subject|7|||
164124295|NCT05560763|592817901|FG000|Overall Study|Withdrawal by Subject|4|||
164124296|NCT00619359|592817904|FG000|Overall Study|Adverse Event|32|||
164124297|NCT00619359|592817905|FG001|Overall Study|Adverse Event|36|||
164124298|NCT00619359|592817904|FG000|Overall Study|Lost to Follow-up|12|||
164124299|NCT00619359|592817905|FG001|Overall Study|Lost to Follow-up|16|||
164124300|NCT00619359|592817904|FG000|Overall Study|Physician Decision|0|||
164124301|NCT00619359|592817905|FG001|Overall Study|Physician Decision|7|||
164124302|NCT00619359|592817904|FG000|Overall Study|Protocol Violation|1|||
164124303|NCT00619359|592817905|FG001|Overall Study|Protocol Violation|1|||
164124304|NCT00619359|592817904|FG000|Overall Study|Withdrawal by Subject|19|||
164124305|NCT00619359|592817905|FG001|Overall Study|Withdrawal by Subject|20|||
164124306|NCT00619359|592817904|FG000|Overall Study|Progressive Disease|3|||
164124307|NCT00619359|592817905|FG001|Overall Study|Progressive Disease|1|||
164124308|NCT06972251|592817906|FG000|Overall Study|Withdrawal by Subject|1|||
164124309|NCT06972251|592817907|FG001|Overall Study|Withdrawal by Subject|0|||
164124310|NCT06972251|592817906|FG000|Overall Study|Lost to Follow-up|10|||
164124311|NCT06972251|592817907|FG001|Overall Study|Lost to Follow-up|2|||
164124312|NCT05575063|592817908|FG000|Overall Study|Withdrawal by Subject|1|||
164124313|NCT00484419|592817909|FG000|Overall Study|Adverse Event|3|||
164124314|NCT00484419|592817910|FG001|Overall Study|Adverse Event|0|||
164124315|NCT00484419|592817911|FG002|Overall Study|Adverse Event|0|||
164124316|NCT00484419|592817909|FG000|Overall Study|Lost to Follow-up|1|||
164124317|NCT00484419|592817910|FG001|Overall Study|Lost to Follow-up|0|||
164124318|NCT00484419|592817911|FG002|Overall Study|Lost to Follow-up|2|||
164124319|NCT00484419|592817909|FG000|Overall Study|Withdrawal by Subject|3|||
164124320|NCT00484419|592817910|FG001|Overall Study|Withdrawal by Subject|1|||
164124321|NCT00484419|592817911|FG002|Overall Study|Withdrawal by Subject|1|||
164124322|NCT00484419|592817909|FG000|Overall Study|subject met discontinuation criteria|2|||
164124323|NCT00484419|592817910|FG001|Overall Study|subject met discontinuation criteria|2|||
164124324|NCT00484419|592817911|FG002|Overall Study|subject met discontinuation criteria|4|||
164124325|NCT00484419|592817909|FG000|Overall Study|required restricted medication|1|||
164124326|NCT00484419|592817910|FG001|Overall Study|required restricted medication|0|||
164124327|NCT00484419|592817911|FG002|Overall Study|required restricted medication|1|||
164124328|NCT00484419|592817909|FG000|Overall Study|Physician Decision|1|||
164124329|NCT00484419|592817910|FG001|Overall Study|Physician Decision|1|||
164124330|NCT00484419|592817911|FG002|Overall Study|Physician Decision|1|||
164124331|NCT00484419|592817909|FG000|Overall Study|subject unable to receive medication|1|||
164124332|NCT00484419|592817910|FG001|Overall Study|subject unable to receive medication|0|||
164124333|NCT00484419|592817911|FG002|Overall Study|subject unable to receive medication|0|||
164124334|NCT00484419|592817909|FG000|Overall Study|subject relocated|0|||
164124335|NCT00484419|592817910|FG001|Overall Study|subject relocated|1|||
164124336|NCT00484419|592817911|FG002|Overall Study|subject relocated|0|||
164124337|NCT00484419|592817909|FG000|Overall Study|sponsor decision, randomized in error|0|||
164124338|NCT00484419|592817910|FG001|Overall Study|sponsor decision, randomized in error|0|||
164124339|NCT00484419|592817911|FG002|Overall Study|sponsor decision, randomized in error|2|||
164124340|NCT01829113|592817912|FG000|Overall Study|Disease Progression|37|||
164124341|NCT01829113|592817913|FG001|Overall Study|Disease Progression|48|||
164124342|NCT01829113|592817912|FG000|Overall Study|Adverse Event|14|||
164124343|NCT01829113|592817913|FG001|Overall Study|Adverse Event|10|||
164124344|NCT01829113|592817912|FG000|Overall Study|Withdrawal by Subject|17|||
164124345|NCT01829113|592817913|FG001|Overall Study|Withdrawal by Subject|10|||
164124346|NCT01829113|592817912|FG000|Overall Study|Death|4|||
164124347|NCT01829113|592817913|FG001|Overall Study|Death|6|||
164124348|NCT01829113|592817912|FG000|Overall Study|Sponsor Decision|1|||
164124349|NCT01829113|592817913|FG001|Overall Study|Sponsor Decision|1|||
164124350|NCT01829113|592817912|FG000|Overall Study|No Study Treatment Received|3|||
164124351|NCT01829113|592817913|FG001|Overall Study|No Study Treatment Received|2|||
164124352|NCT01829113|592817912|FG000|Overall Study|Physician Decision|1|||
164124353|NCT01829113|592817913|FG001|Overall Study|Physician Decision|1|||
164124354|NCT00873119|592817915|FG000|Overall Study|Patient request|4|||
164124355|NCT00873119|592817916|FG001|Overall Study|Patient request|2|||
164124356|NCT00873119|592817915|FG000|Overall Study|Adverse Event|8|||
164124357|NCT00873119|592817916|FG001|Overall Study|Adverse Event|0|||
164124358|NCT00873119|592817915|FG000|Overall Study|Progressive disease|26|||
164124359|NCT00873119|592817916|FG001|Overall Study|Progressive disease|18|||
164124360|NCT00873119|592817915|FG000|Overall Study|Death|2|||
164124361|NCT00873119|592817916|FG001|Overall Study|Death|1|||
164124362|NCT00873119|592817915|FG000|Overall Study|Other|2|||
164124363|NCT00873119|592817916|FG001|Overall Study|Other|5|||
164124364|NCT00873119|592817915|FG000|Overall Study|Not treated|2|||
164124365|NCT00873119|592817916|FG001|Overall Study|Not treated|0|||
164124366|NCT03648879|592817917|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
164124367|NCT00285584|592817918|FG000|Month 3|Lost to Follow-up|3|||
164124368|NCT00285584|592817919|FG001|Month 3|Lost to Follow-up|3|||
164124369|NCT00285584|592817918|FG000|Month 3|Withdrawal by Subject|1|||
164124370|NCT00285584|592817919|FG001|Month 3|Withdrawal by Subject|0|||
164124371|NCT00285584|592817918|FG000|Month 6|Lost to Follow-up|0|||
164124372|NCT00285584|592817919|FG001|Month 6|Lost to Follow-up|1|||
164124373|NCT01884688|592817920|FG000|Overall Study|Screen Failure|2|||
164124374|NCT04099641|592817921|FG000|Overall Study|Death|46|||
164124375|NCT04099641|592817922|FG001|Overall Study|Death|12|||
164124376|NCT04099641|592817921|FG000|Overall Study|Lost to Follow-up|1|||
164124377|NCT04099641|592817922|FG001|Overall Study|Lost to Follow-up|0|||
164124378|NCT04099641|592817921|FG000|Overall Study|Withdrawal by Subject|2|||
164124379|NCT04099641|592817922|FG001|Overall Study|Withdrawal by Subject|0|||
164124380|NCT02470091|592817924|FG000|Overall Study|Withdrawal by Subject|1|||
164124381|NCT02470091|592817925|FG001|Overall Study|Withdrawal by Subject|0|||
164124382|NCT02470091|592817924|FG000|Overall Study|Ineligible|0|||
164124383|NCT02470091|592817925|FG001|Overall Study|Ineligible|2|||
164124384|NCT02709486|592817926|FG000|Overall Study|Adverse Event|2|||
164124385|NCT02709486|592817927|FG001|Overall Study|Adverse Event|5|||
164124386|NCT02709486|592817928|FG002|Overall Study|Adverse Event|3|||
164124387|NCT02709486|592817926|FG000|Overall Study|Death|0|||
164124388|NCT02709486|592817927|FG001|Overall Study|Death|0|||
164124389|NCT02709486|592817928|FG002|Overall Study|Death|2|||
164124390|NCT02709486|592817926|FG000|Overall Study|Insufficient clinical response|7|||
164124391|NCT02709486|592817927|FG001|Overall Study|Insufficient clinical response|3|||
164124392|NCT02709486|592817928|FG002|Overall Study|Insufficient clinical response|3|||
164124393|NCT02709486|592817926|FG000|Overall Study|Lost to Follow-up|3|||
164124394|NCT02709486|592817927|FG001|Overall Study|Lost to Follow-up|2|||
164124395|NCT02709486|592817928|FG002|Overall Study|Lost to Follow-up|2|||
164124396|NCT02709486|592817926|FG000|Overall Study|Other|0|||
164124397|NCT02709486|592817927|FG001|Overall Study|Other|2|||
164124398|NCT02709486|592817928|FG002|Overall Study|Other|3|||
164124399|NCT02709486|592817926|FG000|Overall Study|Withdrawal by Subject|32|||
164124400|NCT02709486|592817927|FG001|Overall Study|Withdrawal by Subject|22|||
164124401|NCT02709486|592817928|FG002|Overall Study|Withdrawal by Subject|32|||
164124402|NCT00536484|592817933|FG000|Overall Study|Adverse Event|21|||
164124403|NCT00536484|592817934|FG001|Overall Study|Adverse Event|34|||
164124404|NCT00536484|592817933|FG000|Overall Study|Withdrawal by Subject|11|||
164124405|NCT00536484|592817934|FG001|Overall Study|Withdrawal by Subject|11|||
164124406|NCT00536484|592817933|FG000|Overall Study|Lost to Follow-up|8|||
164124407|NCT00536484|592817934|FG001|Overall Study|Lost to Follow-up|6|||
164124408|NCT00536484|592817933|FG000|Overall Study|Lack of Efficacy|16|||
164124409|NCT00536484|592817934|FG001|Overall Study|Lack of Efficacy|5|||
164124410|NCT00536484|592817933|FG000|Overall Study|Other|4|||
164124411|NCT00536484|592817934|FG001|Overall Study|Other|0|||
164124412|NCT00706355|592817935|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
164124413|NCT00706355|592817936|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
164124414|NCT00706355|592817937|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
164124415|NCT00706355|592817938|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
164124416|NCT00706355|592817935|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
164124417|NCT00706355|592817936|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
164124418|NCT00706355|592817937|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
164124419|NCT00706355|592817938|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
164124420|NCT00706355|592817935|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
164124421|NCT00706355|592817936|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
164124422|NCT00706355|592817937|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
164124423|NCT00706355|592817938|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
164124424|NCT00706355|592817935|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
164124425|NCT00706355|592817936|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
164124426|NCT00706355|592817937|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
164124427|NCT00706355|592817938|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
164124428|NCT00706355|592817935|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
164124429|NCT00706355|592817936|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
164124430|NCT00706355|592817937|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
164124431|NCT00706355|592817938|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
164124432|NCT00706355|592817935|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
164124433|NCT00706355|592817936|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
164124434|NCT00706355|592817937|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
164124435|NCT00706355|592817938|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
164124436|NCT00706355|592817935|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
164124437|NCT00706355|592817936|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
164124438|NCT00706355|592817937|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
164124439|NCT00706355|592817938|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
164124440|NCT00706355|592817935|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
164124441|NCT00706355|592817936|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
164124442|NCT00706355|592817937|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
164124443|NCT00706355|592817938|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
164124444|NCT00706355|592817935|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
164124445|NCT00706355|592817936|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
164124446|NCT00706355|592817937|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
164124447|NCT00706355|592817938|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
164124448|NCT02549573|592817941|FG000|Overall Study|Withdrawal by Subject|0|||
164124449|NCT02549573|592817942|FG001|Overall Study|Withdrawal by Subject|2|||
164124450|NCT02549573|592817941|FG000|Overall Study|Protocol Violation|0|||
164124451|NCT02549573|592817942|FG001|Overall Study|Protocol Violation|1|||
164124452|NCT02610816|592817943|FG000|Phase 1|Withdrawal by Subject|2|||
164124453|NCT02610816|592817944|FG001|Phase 1|Withdrawal by Subject|6|||
164124454|NCT02610816|592817945|FG002|Phase 1|Withdrawal by Subject|0|||
164124455|NCT02610816|592817946|FG003|Phase 1|Withdrawal by Subject|0|||
164124456|NCT02610816|592817943|FG000|Phase 1|Lost to Follow-up|2|||
164124457|NCT02610816|592817944|FG001|Phase 1|Lost to Follow-up|1|||
164124458|NCT02610816|592817945|FG002|Phase 1|Lost to Follow-up|0|||
164124459|NCT02610816|592817946|FG003|Phase 1|Lost to Follow-up|0|||
164124460|NCT02610816|592817943|FG000|Phase 1|Physician Decision|0|||
164124461|NCT02610816|592817944|FG001|Phase 1|Physician Decision|1|||
164124462|NCT02610816|592817945|FG002|Phase 1|Physician Decision|0|||
164124463|NCT02610816|592817946|FG003|Phase 1|Physician Decision|0|||
164124464|NCT02610816|592817943|FG000|Phase 2|Withdrawal by Subject|0|||
164124465|NCT02610816|592817944|FG001|Phase 2|Withdrawal by Subject|0|||
164124466|NCT02610816|592817945|FG002|Phase 2|Withdrawal by Subject|9|||
164124467|NCT02610816|592817946|FG003|Phase 2|Withdrawal by Subject|3|||
164124468|NCT02610816|592817943|FG000|Phase 2|Lost to Follow-up|0|||
164124469|NCT02610816|592817944|FG001|Phase 2|Lost to Follow-up|0|||
164124470|NCT02610816|592817945|FG002|Phase 2|Lost to Follow-up|2|||
164124471|NCT02610816|592817946|FG003|Phase 2|Lost to Follow-up|0|||
164124472|NCT02610816|592817943|FG000|Phase 2|Physician Decision|0|||
164124473|NCT02610816|592817944|FG001|Phase 2|Physician Decision|0|||
164124474|NCT02610816|592817945|FG002|Phase 2|Physician Decision|0|||
164124475|NCT02610816|592817946|FG003|Phase 2|Physician Decision|2|||
164124476|NCT02610816|592817943|FG000|Phase 2|Pregnancy|0|||
164124477|NCT02610816|592817944|FG001|Phase 2|Pregnancy|0|||
164124478|NCT02610816|592817945|FG002|Phase 2|Pregnancy|0|||
164124479|NCT02610816|592817946|FG003|Phase 2|Pregnancy|1|||
164124480|NCT02691741|592817947|FG000|Overall Study|Adverse Event|0|||
164124481|NCT02691741|592817948|FG001|Overall Study|Adverse Event|2|||
164124482|NCT02691741|592817947|FG000|Overall Study|Lost to Follow-up|1|||
164124483|NCT02691741|592817948|FG001|Overall Study|Lost to Follow-up|0|||
164124484|NCT02691741|592817947|FG000|Overall Study|Physician Decision|0|||
164124485|NCT02691741|592817948|FG001|Overall Study|Physician Decision|1|||
164124486|NCT02691741|592817947|FG000|Overall Study|Withdrawal by Subject|0|||
164124487|NCT02691741|592817948|FG001|Overall Study|Withdrawal by Subject|4|||
164124488|NCT05626803|592819393|FG000|Overall Study|Lost to Follow-up|0|||
164124489|NCT05626803|592819394|FG001|Overall Study|Lost to Follow-up|1|||
164124490|NCT05626803|592819395|FG002|Overall Study|Lost to Follow-up|0|||
164124491|NCT05626803|592819396|FG003|Overall Study|Lost to Follow-up|0|||
164124492|NCT04974619|592819397|FG000|Overall Study|Lost to Follow-up|0|||
164124493|NCT04974619|592819398|FG001|Overall Study|Lost to Follow-up|0|||
164124494|NCT04974619|592819399|FG002|Overall Study|Lost to Follow-up|1|||
164124495|NCT04974619|592819397|FG000|Overall Study|Withdrawal by Subject|0|||
164124496|NCT04974619|592819398|FG001|Overall Study|Withdrawal by Subject|0|||
164124497|NCT04974619|592819399|FG002|Overall Study|Withdrawal by Subject|1|||
164124498|NCT04974619|592819397|FG000|Overall Study|Protocol Violation|0|||
164124499|NCT04974619|592819398|FG001|Overall Study|Protocol Violation|1|||
164124500|NCT04974619|592819399|FG002|Overall Study|Protocol Violation|0|||
164124501|NCT01688466|592819400|FG000|Overall Study|Withdrawal by Subject|2|||
164124502|NCT01688466|592819401|FG001|Overall Study|Withdrawal by Subject|1|||
164124503|NCT01688466|592819400|FG000|Overall Study|Death|0|||
164124504|NCT01688466|592819401|FG001|Overall Study|Death|1|||
164124505|NCT01688466|592819400|FG000|Overall Study|Adverse Event|0|||
164124506|NCT01688466|592819401|FG001|Overall Study|Adverse Event|4|||
164124507|NCT01688466|592819400|FG000|Overall Study|Not evaluable|0|||
164124508|NCT01688466|592819401|FG001|Overall Study|Not evaluable|1|||
164124509|NCT03310957|592819402|FG000|Overall Study|Withdrawal by Subject|1|||
164124510|NCT03310957|592819403|FG001|Overall Study|Withdrawal by Subject|1|||
164124511|NCT03310957|592819404|FG002|Overall Study|Withdrawal by Subject|1|||
164124512|NCT03310957|592819405|FG003|Overall Study|Withdrawal by Subject|5|||
164124513|NCT03310957|592819406|FG004|Overall Study|Withdrawal by Subject|0|||
164124514|NCT03310957|592819407|FG005|Overall Study|Withdrawal by Subject|4|||
164124515|NCT03310957|592819408|FG006|Overall Study|Withdrawal by Subject|3|||
164124516|NCT03310957|592819402|FG000|Overall Study|Site Terminated|0|||
164124517|NCT03310957|592819403|FG001|Overall Study|Site Terminated|1|||
164124518|NCT03310957|592819404|FG002|Overall Study|Site Terminated|1|||
164124519|NCT03310957|592819405|FG003|Overall Study|Site Terminated|1|||
164124520|NCT03310957|592819406|FG004|Overall Study|Site Terminated|0|||
164124521|NCT03310957|592819407|FG005|Overall Study|Site Terminated|2|||
164124522|NCT03310957|592819408|FG006|Overall Study|Site Terminated|8|||
164124523|NCT03310957|592819402|FG000|Overall Study|Lost to Follow-up|1|||
164124524|NCT03310957|592819403|FG001|Overall Study|Lost to Follow-up|1|||
164124525|NCT03310957|592819404|FG002|Overall Study|Lost to Follow-up|1|||
164124526|NCT03310957|592819405|FG003|Overall Study|Lost to Follow-up|4|||
164124527|NCT03310957|592819406|FG004|Overall Study|Lost to Follow-up|0|||
164124528|NCT03310957|592819407|FG005|Overall Study|Lost to Follow-up|4|||
164124529|NCT03310957|592819408|FG006|Overall Study|Lost to Follow-up|2|||
164124530|NCT03310957|592819402|FG000|Overall Study|Death|5|||
164124531|NCT03310957|592819403|FG001|Overall Study|Death|8|||
164124532|NCT03310957|592819404|FG002|Overall Study|Death|18|||
164124533|NCT03310957|592819405|FG003|Overall Study|Death|31|||
164124534|NCT03310957|592819406|FG004|Overall Study|Death|1|||
164124535|NCT03310957|592819407|FG005|Overall Study|Death|29|||
164124536|NCT03310957|592819408|FG006|Overall Study|Death|7|||
164124537|NCT03310957|592819402|FG000|Overall Study|Discontinuation per sponsor|0|||
164124538|NCT03310957|592819403|FG001|Overall Study|Discontinuation per sponsor|1|||
164124539|NCT03310957|592819404|FG002|Overall Study|Discontinuation per sponsor|2|||
164124540|NCT03310957|592819405|FG003|Overall Study|Discontinuation per sponsor|4|||
164124541|NCT03310957|592819406|FG004|Overall Study|Discontinuation per sponsor|1|||
164124542|NCT03310957|592819407|FG005|Overall Study|Discontinuation per sponsor|9|||
164124543|NCT03310957|592819408|FG006|Overall Study|Discontinuation per sponsor|12|||
164124544|NCT03310957|592819402|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
164124545|NCT03310957|592819403|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
164124546|NCT03310957|592819404|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
164124547|NCT03310957|592819405|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
164124548|NCT03310957|592819406|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
164124549|NCT03310957|592819407|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
164124550|NCT03310957|592819408|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
164124551|NCT03310957|592819402|FG000|Overall Study|Treatment landscape|0|||
164124552|NCT03310957|592819403|FG001|Overall Study|Treatment landscape|0|||
164124553|NCT03310957|592819404|FG002|Overall Study|Treatment landscape|1|||
164124554|NCT03310957|592819405|FG003|Overall Study|Treatment landscape|1|||
164124555|NCT03310957|592819406|FG004|Overall Study|Treatment landscape|0|||
164124556|NCT03310957|592819407|FG005|Overall Study|Treatment landscape|1|||
164124557|NCT03310957|592819408|FG006|Overall Study|Treatment landscape|0|||
164124558|NCT03310957|592819402|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164124559|NCT03310957|592819403|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164124560|NCT03310957|592819404|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164124561|NCT03310957|592819405|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164124562|NCT03310957|592819406|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
164124563|NCT03310957|592819407|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164124564|NCT03310957|592819408|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
164124565|NCT03310957|592819402|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164124566|NCT03310957|592819403|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164124567|NCT03310957|592819404|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
164124568|NCT03310957|592819405|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164124569|NCT03310957|592819406|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164124570|NCT03310957|592819407|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164124571|NCT03310957|592819408|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
164124572|NCT03310957|592819402|FG000|Overall Study|Hospice|0|||
164124573|NCT03310957|592819403|FG001|Overall Study|Hospice|0|||
164124574|NCT03310957|592819404|FG002|Overall Study|Hospice|0|||
164124575|NCT03310957|592819405|FG003|Overall Study|Hospice|0|||
164124576|NCT03310957|592819406|FG004|Overall Study|Hospice|0|||
164124577|NCT03310957|592819407|FG005|Overall Study|Hospice|1|||
164124578|NCT03310957|592819408|FG006|Overall Study|Hospice|0|||
164124579|NCT03310957|592819402|FG000|Overall Study|Progressive|0|||
164124580|NCT03310957|592819403|FG001|Overall Study|Progressive|0|||
164124581|NCT03310957|592819404|FG002|Overall Study|Progressive|1|||
164124582|NCT03310957|592819405|FG003|Overall Study|Progressive|0|||
164124583|NCT03310957|592819406|FG004|Overall Study|Progressive|0|||
164124584|NCT03310957|592819407|FG005|Overall Study|Progressive|0|||
164124585|NCT03310957|592819408|FG006|Overall Study|Progressive|0|||
164124586|NCT04146363|592819415|FG000|Induction Period|Adverse Event|1|||
164124587|NCT04146363|592819416|FG001|Induction Period|Adverse Event|2|||
164124588|NCT04146363|592819417|FG002|Induction Period|Adverse Event|0|||
164124589|NCT04146363|592819418|FG003|Induction Period|Adverse Event|0|||
164124590|NCT04146363|592819419|FG004|Induction Period|Adverse Event|0|||
164124591|NCT04146363|592819420|FG005|Induction Period|Adverse Event|0|||
164124592|NCT04146363|592819421|FG006|Induction Period|Adverse Event|0|||
164124593|NCT04146363|592819422|FG007|Induction Period|Adverse Event|0|||
164124594|NCT04146363|592819423|FG008|Induction Period|Adverse Event|0|||
164124595|NCT04146363|592819424|FG009|Induction Period|Adverse Event|0|||
164124596|NCT04146363|592819425|FG010|Induction Period|Adverse Event|0|||
164124597|NCT04146363|592819415|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
164124598|NCT04146363|592819416|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
164124599|NCT04146363|592819417|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
164124600|NCT04146363|592819418|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
164124601|NCT04146363|592819419|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
164124602|NCT04146363|592819420|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
164124603|NCT04146363|592819421|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
164124604|NCT04146363|592819422|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
164124605|NCT04146363|592819423|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
164124606|NCT04146363|592819424|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
164124607|NCT04146363|592819425|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
164124608|NCT04146363|592819415|FG000|Induction Period|Lack of Efficacy|7|||
164124609|NCT04146363|592819416|FG001|Induction Period|Lack of Efficacy|2|||
164124610|NCT04146363|592819417|FG002|Induction Period|Lack of Efficacy|0|||
164124611|NCT04146363|592819418|FG003|Induction Period|Lack of Efficacy|0|||
164124612|NCT04146363|592819419|FG004|Induction Period|Lack of Efficacy|0|||
164124613|NCT04146363|592819420|FG005|Induction Period|Lack of Efficacy|0|||
164124614|NCT04146363|592819421|FG006|Induction Period|Lack of Efficacy|0|||
164124615|NCT04146363|592819422|FG007|Induction Period|Lack of Efficacy|0|||
164124616|NCT04146363|592819423|FG008|Induction Period|Lack of Efficacy|0|||
164124617|NCT04146363|592819424|FG009|Induction Period|Lack of Efficacy|0|||
164124618|NCT04146363|592819425|FG010|Induction Period|Lack of Efficacy|0|||
164124619|NCT04146363|592819415|FG000|Induction Period|Lost to Follow-up|1|||
164124620|NCT04146363|592819416|FG001|Induction Period|Lost to Follow-up|4|||
164124621|NCT04146363|592819417|FG002|Induction Period|Lost to Follow-up|0|||
164124622|NCT04146363|592819418|FG003|Induction Period|Lost to Follow-up|0|||
164124623|NCT04146363|592819419|FG004|Induction Period|Lost to Follow-up|0|||
164124624|NCT04146363|592819420|FG005|Induction Period|Lost to Follow-up|0|||
164124625|NCT04146363|592819421|FG006|Induction Period|Lost to Follow-up|0|||
164124626|NCT04146363|592819422|FG007|Induction Period|Lost to Follow-up|0|||
164124627|NCT04146363|592819423|FG008|Induction Period|Lost to Follow-up|0|||
164124628|NCT04146363|592819424|FG009|Induction Period|Lost to Follow-up|0|||
164124629|NCT04146363|592819425|FG010|Induction Period|Lost to Follow-up|0|||
164124630|NCT04146363|592819415|FG000|Induction Period|Positive quantiferon test|0|||
164124631|NCT04146363|592819416|FG001|Induction Period|Positive quantiferon test|1|||
164124632|NCT04146363|592819417|FG002|Induction Period|Positive quantiferon test|0|||
164124633|NCT04146363|592819418|FG003|Induction Period|Positive quantiferon test|0|||
164124634|NCT04146363|592819419|FG004|Induction Period|Positive quantiferon test|0|||
164124635|NCT04146363|592819420|FG005|Induction Period|Positive quantiferon test|0|||
164124636|NCT04146363|592819421|FG006|Induction Period|Positive quantiferon test|0|||
164124637|NCT04146363|592819422|FG007|Induction Period|Positive quantiferon test|0|||
164124638|NCT04146363|592819423|FG008|Induction Period|Positive quantiferon test|0|||
164124639|NCT04146363|592819424|FG009|Induction Period|Positive quantiferon test|0|||
164124640|NCT04146363|592819425|FG010|Induction Period|Positive quantiferon test|0|||
164124641|NCT04146363|592819415|FG000|Induction Period|Protocol Deviation|5|||
164124642|NCT04146363|592819416|FG001|Induction Period|Protocol Deviation|6|||
164124643|NCT04146363|592819417|FG002|Induction Period|Protocol Deviation|0|||
164124644|NCT04146363|592819418|FG003|Induction Period|Protocol Deviation|0|||
164124645|NCT04146363|592819419|FG004|Induction Period|Protocol Deviation|0|||
164124646|NCT04146363|592819420|FG005|Induction Period|Protocol Deviation|0|||
164124647|NCT04146363|592819421|FG006|Induction Period|Protocol Deviation|0|||
164124648|NCT04146363|592819422|FG007|Induction Period|Protocol Deviation|0|||
164124649|NCT04146363|592819423|FG008|Induction Period|Protocol Deviation|0|||
164124650|NCT04146363|592819424|FG009|Induction Period|Protocol Deviation|0|||
164124651|NCT04146363|592819425|FG010|Induction Period|Protocol Deviation|0|||
164124652|NCT04146363|592819415|FG000|Induction Period|Withdrawal by Subject|6|||
164124653|NCT04146363|592819416|FG001|Induction Period|Withdrawal by Subject|3|||
164124654|NCT04146363|592819417|FG002|Induction Period|Withdrawal by Subject|0|||
164124655|NCT04146363|592819418|FG003|Induction Period|Withdrawal by Subject|0|||
164124656|NCT04146363|592819419|FG004|Induction Period|Withdrawal by Subject|0|||
164124657|NCT04146363|592819420|FG005|Induction Period|Withdrawal by Subject|0|||
164124658|NCT04146363|592819421|FG006|Induction Period|Withdrawal by Subject|0|||
164124659|NCT04146363|592819422|FG007|Induction Period|Withdrawal by Subject|0|||
164124660|NCT04146363|592819423|FG008|Induction Period|Withdrawal by Subject|0|||
164124661|NCT04146363|592819424|FG009|Induction Period|Withdrawal by Subject|0|||
164124662|NCT04146363|592819425|FG010|Induction Period|Withdrawal by Subject|0|||
164124663|NCT04146363|592819415|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124664|NCT04146363|592819416|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124665|NCT04146363|592819417|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124666|NCT04146363|592819418|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124667|NCT04146363|592819419|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124668|NCT04146363|592819420|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124669|NCT04146363|592819421|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
164124670|NCT04146363|592819422|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
164124671|NCT04146363|592819423|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124672|NCT04146363|592819424|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124673|NCT04146363|592819425|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
164124674|NCT04146363|592819415|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124675|NCT04146363|592819416|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124676|NCT04146363|592819417|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124677|NCT04146363|592819418|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124678|NCT04146363|592819419|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164073432|NCT01345058|592632876|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
164073433|NCT01345058|592632875|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
164073434|NCT01345058|592632876|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
164073435|NCT01345058|592632875|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
164073436|NCT01345058|592632876|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
164073437|NCT01892020|592632878|FG000|Period 1|Adverse Event|1|||
164073438|NCT01892020|592632879|FG001|Period 1|Adverse Event|1|||
164073439|NCT01892020|592632878|FG000|Period 1|Protocol Violation|2|||
164073440|NCT01892020|592632879|FG001|Period 1|Protocol Violation|4|||
164073441|NCT01892020|592632878|FG000|Period 1|Unclassified|0|||
164073442|NCT01892020|592632879|FG001|Period 1|Unclassified|1|||
164073443|NCT01892020|592632878|FG000|Period 2|Protocol Violation|1|||
164073444|NCT01892020|592632879|FG001|Period 2|Protocol Violation|0|||
164073445|NCT02149199|592632884|FG000|Overall Study|Study specific withdrawal criteria|4|||
164073446|NCT02149199|592632885|FG001|Overall Study|Study specific withdrawal criteria|21|||
164073447|NCT02149199|592632886|FG002|Overall Study|Study specific withdrawal criteria|6|||
164073448|NCT02149199|592632884|FG000|Overall Study|Other|20|||
164073449|NCT02149199|592632885|FG001|Overall Study|Other|25|||
164073450|NCT02149199|592632886|FG002|Overall Study|Other|20|||
164073451|NCT02149199|592632884|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
164073452|NCT02149199|592632885|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
164073453|NCT02149199|592632886|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
164073454|NCT02149199|592632884|FG000|Overall Study|Withdrawal by Subject|75|||
164073455|NCT02149199|592632885|FG001|Overall Study|Withdrawal by Subject|93|||
164073456|NCT02149199|592632886|FG002|Overall Study|Withdrawal by Subject|77|||
164073457|NCT02149199|592632884|FG000|Overall Study|Protocol Violation|16|||
164073458|NCT02149199|592632885|FG001|Overall Study|Protocol Violation|13|||
164073459|NCT02149199|592632886|FG002|Overall Study|Protocol Violation|15|||
164073460|NCT02149199|592632884|FG000|Overall Study|Lost to Follow-up|3|||
164073461|NCT02149199|592632885|FG001|Overall Study|Lost to Follow-up|12|||
164073462|NCT02149199|592632886|FG002|Overall Study|Lost to Follow-up|11|||
164073463|NCT02149199|592632884|FG000|Overall Study|Death|0|||
164073464|NCT02149199|592632885|FG001|Overall Study|Death|0|||
164073465|NCT02149199|592632886|FG002|Overall Study|Death|1|||
164073466|NCT02149199|592632884|FG000|Overall Study|Adverse Event|6|||
164073467|NCT02149199|592632885|FG001|Overall Study|Adverse Event|15|||
164073468|NCT02149199|592632886|FG002|Overall Study|Adverse Event|9|||
164073469|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073470|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073471|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073472|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164073473|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164073474|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073475|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073476|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073477|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073478|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164073479|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073480|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073481|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164073482|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
164073483|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
164073484|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
164073485|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
164073486|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
164073487|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
164073488|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073489|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073490|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073491|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073492|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073493|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
164073494|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073495|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164124679|NCT04146363|592819420|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124680|NCT04146363|592819421|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124681|NCT04146363|592819422|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
164124682|NCT04146363|592819423|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124683|NCT04146363|592819424|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124684|NCT04146363|592819425|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
164124685|NCT04146363|592819415|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124686|NCT04146363|592819416|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124687|NCT04146363|592819417|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124688|NCT04146363|592819418|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124689|NCT04146363|592819419|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124690|NCT04146363|592819420|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124691|NCT04146363|592819421|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
164124692|NCT04146363|592819422|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
164124693|NCT04146363|592819423|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124694|NCT04146363|592819424|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124695|NCT04146363|592819425|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
164124696|NCT04146363|592819415|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124697|NCT04146363|592819416|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124698|NCT04146363|592819417|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
164124699|NCT04146363|592819418|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124700|NCT04146363|592819419|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124701|NCT04146363|592819420|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
164124702|NCT04146363|592819421|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124703|NCT04146363|592819422|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124704|NCT04146363|592819423|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124705|NCT04146363|592819424|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124706|NCT04146363|592819425|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
164124707|NCT04146363|592819415|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124708|NCT04146363|592819416|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124709|NCT04146363|592819417|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124710|NCT04146363|592819418|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124711|NCT04146363|592819419|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
164124712|NCT04146363|592819420|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
164124713|NCT04146363|592819421|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
164124714|NCT04146363|592819422|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
164124715|NCT04146363|592819423|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124716|NCT04146363|592819424|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124717|NCT04146363|592819425|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
164124718|NCT04146363|592819415|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124719|NCT04146363|592819416|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124720|NCT04146363|592819417|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
164124721|NCT04146363|592819418|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124722|NCT04146363|592819419|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124723|NCT04146363|592819420|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
164124724|NCT04146363|592819421|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
164124725|NCT04146363|592819422|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
164124726|NCT04146363|592819423|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124727|NCT04146363|592819424|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124728|NCT04146363|592819425|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
164124729|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124730|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124731|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124732|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124733|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124734|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124735|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124736|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124737|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
164124738|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
164124739|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
164124740|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124741|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124742|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124743|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164132682|NCT01986010|592850661|FG006|Overall Study|Lost to Follow-up|0|||
164124744|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124745|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124746|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124747|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
164124748|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
164124749|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
164124750|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
164124751|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124752|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124753|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124754|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124755|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124756|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124757|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124758|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124759|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
164124760|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
164124761|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
164124762|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124763|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124764|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124765|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124766|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124767|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124768|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124769|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124770|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
164124771|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
164124772|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
164124773|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124774|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124775|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124776|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124777|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124778|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124779|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124780|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
164124781|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
164124782|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
164124783|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
164124784|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124785|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124786|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124787|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124788|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124789|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124790|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124791|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124792|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124793|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
164124794|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
164124795|NCT04146363|592819415|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124796|NCT04146363|592819416|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124797|NCT04146363|592819417|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124798|NCT04146363|592819418|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124799|NCT04146363|592819419|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124800|NCT04146363|592819420|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124801|NCT04146363|592819421|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124802|NCT04146363|592819422|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124803|NCT04146363|592819423|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124804|NCT04146363|592819424|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
164124805|NCT04146363|592819425|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
164124806|NCT00107042|592819426|FG000|Overall Study|Lost to Follow-up|9|||
164124807|NCT00107042|592819427|FG001|Overall Study|Lost to Follow-up|7|||
164124808|NCT00107042|592819426|FG000|Overall Study|Withdrawal by Subject|6|||
164124809|NCT00107042|592819427|FG001|Overall Study|Withdrawal by Subject|1|||
164124810|NCT00107042|592819426|FG000|Overall Study|Moved out of area|5|||
164124811|NCT00107042|592819427|FG001|Overall Study|Moved out of area|3|||
164124812|NCT00107042|592819426|FG000|Overall Study|Pregnancy|1|||
164124813|NCT00107042|592819427|FG001|Overall Study|Pregnancy|1|||
164124814|NCT00107042|592819426|FG000|Overall Study|Inadvertent enrollment|0|||
164124815|NCT00107042|592819427|FG001|Overall Study|Inadvertent enrollment|1|||
164124816|NCT00107042|592819426|FG000|Overall Study|vaccinated outside window|1|||
164124817|NCT00107042|592819427|FG001|Overall Study|vaccinated outside window|1|||
164124818|NCT00107042|592819426|FG000|Overall Study|Disallowed medications|0|||
164124819|NCT00107042|592819427|FG001|Overall Study|Disallowed medications|2|||
164124820|NCT04776746|592819428|FG000|Overall Study|Study terminated by sponsor|61|||
164124821|NCT04776746|592819428|FG000|Overall Study|Adverse Event|5|||
164124822|NCT04776746|592819428|FG000|Overall Study|Death|4|||
164124823|NCT04776746|592819428|FG000|Overall Study|Lack of Efficacy|3|||
164124824|NCT04776746|592819428|FG000|Overall Study|Noncompliance with study drug|2|||
164124825|NCT04776746|592819428|FG000|Overall Study|Not related to COVID-19|2|||
164124826|NCT03265288|592819431|FG000|Overall Study|Adverse Event|0|||
164124827|NCT03265288|592819432|FG001|Overall Study|Adverse Event|1|||
164124828|NCT03265288|592819431|FG000|Overall Study|Withdrawal by Subject|13|||
164124829|NCT03265288|592819432|FG001|Overall Study|Withdrawal by Subject|5|||
164124830|NCT03265288|592819431|FG000|Overall Study|Drug Withdrawn|3|||
164124831|NCT03265288|592819432|FG001|Overall Study|Drug Withdrawn|3|||
164124832|NCT03265288|592819431|FG000|Overall Study|Any Other Reason|7|||
164124833|NCT03265288|592819432|FG001|Overall Study|Any Other Reason|3|||
164124834|NCT03575871|592819441|FG000|Overall Study|Adverse Event|5|||
164124835|NCT03575871|592819442|FG001|Overall Study|Adverse Event|5|||
164124836|NCT03575871|592819443|FG002|Overall Study|Adverse Event|8|||
164124837|NCT03575871|592819441|FG000|Overall Study|Death|1|||
164124838|NCT03575871|592819442|FG001|Overall Study|Death|0|||
164124839|NCT03575871|592819443|FG002|Overall Study|Death|0|||
164124840|NCT03575871|592819441|FG000|Overall Study|Lack of Efficacy|5|||
164124841|NCT03575871|592819442|FG001|Overall Study|Lack of Efficacy|4|||
164124842|NCT03575871|592819443|FG002|Overall Study|Lack of Efficacy|7|||
164124843|NCT03575871|592819441|FG000|Overall Study|Lost to Follow-up|1|||
164124844|NCT03575871|592819442|FG001|Overall Study|Lost to Follow-up|1|||
164124845|NCT03575871|592819443|FG002|Overall Study|Lost to Follow-up|1|||
164124846|NCT03575871|592819441|FG000|Overall Study|Protocol Deviation|1|||
164124847|NCT03575871|592819442|FG001|Overall Study|Protocol Deviation|1|||
164124848|NCT03575871|592819443|FG002|Overall Study|Protocol Deviation|1|||
164124849|NCT03575871|592819441|FG000|Overall Study|Withdrawal by Subject|6|||
164124850|NCT03575871|592819442|FG001|Overall Study|Withdrawal by Subject|1|||
164124851|NCT03575871|592819443|FG002|Overall Study|Withdrawal by Subject|9|||
164124852|NCT03575871|592819441|FG000|Overall Study|Other than specified|2|||
164124853|NCT03575871|592819442|FG001|Overall Study|Other than specified|2|||
164124854|NCT03575871|592819443|FG002|Overall Study|Other than specified|0|||
164124855|NCT05444556|592819444|FG000|Overall Study|Withdrawal by Subject|0|||
164124856|NCT05444556|592819445|FG001|Overall Study|Withdrawal by Subject|0|||
164124857|NCT05444556|592819446|FG002|Overall Study|Withdrawal by Subject|2|||
164124858|NCT05444556|592819447|FG003|Overall Study|Withdrawal by Subject|1|||
164124859|NCT02791893|592819448|FG000|Blinded Phase|Lost to Follow-up|2|||
164124860|NCT02791893|592819449|FG001|Blinded Phase|Lost to Follow-up|2|||
164124861|NCT02791893|592819448|FG000|Blinded Phase|Withdrawal by Subject|1|||
164124862|NCT02791893|592819449|FG001|Blinded Phase|Withdrawal by Subject|2|||
164124863|NCT02791893|592819448|FG000|Open Label Phase|Lost to Follow-up|3|||
164124864|NCT02791893|592819449|FG001|Open Label Phase|Lost to Follow-up|0|||
164124865|NCT02791893|592819448|FG000|Open Label Phase|Withdrawal by Subject|0|||
164124866|NCT02791893|592819449|FG001|Open Label Phase|Withdrawal by Subject|2|||
164124867|NCT04319159|592819454|FG000|Overall Study|Screening failure|13|||
164124868|NCT04319159|592819454|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
164124869|NCT04319159|592819454|FG000|Overall Study|Withdrawal by Subject|1|||
164124870|NCT02100319|592819464|FG000|Overall Study|Case Report Forms Uncollected|11|||
164124871|NCT02100319|592819464|FG000|Overall Study|Protocol Deviation|5|||
164124872|NCT04976621|592819465|FG000|Overall Study|Lost to Follow-up|2|||
164124873|NCT04976621|592819466|FG001|Overall Study|Lost to Follow-up|2|||
164124874|NCT04976621|592819465|FG000|Overall Study|Withdrawal by Subject|1|||
164124875|NCT04976621|592819466|FG001|Overall Study|Withdrawal by Subject|1|||
164124876|NCT02589522|592819468|FG000|Overall Study|Physician Decision|1|||
164124877|NCT02589522|592819469|FG001|Overall Study|Physician Decision|2|||
164124878|NCT02589522|592819470|FG002|Overall Study|Physician Decision|0|||
164124879|NCT02589522|592819468|FG000|Overall Study|Did not start treatment|1|||
164124880|NCT02589522|592819469|FG001|Overall Study|Did not start treatment|0|||
164124881|NCT02589522|592819470|FG002|Overall Study|Did not start treatment|0|||
164124882|NCT01478828|592819471|FG000|Overall Study|Adverse Event|1|||
164124883|NCT00949988|592819474|FG000|Overall Study|Withdrawal by Subject|3|||
164124884|NCT00351351|592819476|FG000|Overall Study|surgical access pbs; device issues|9|||
164124885|NCT00351351|592819477|FG001|Overall Study|surgical access pbs; device issues|4|||
164124886|NCT03891329|592819480|FG000|Overall Study|Death|5|||
164124887|NCT03891329|592819480|FG000|Overall Study|Lost to Follow-up|4|||
164124888|NCT03891329|592819480|FG000|Overall Study|Physician Decision|4|||
164124889|NCT03891329|592819480|FG000|Overall Study|Device explanted|3|||
164124890|NCT03891329|592819480|FG000|Overall Study|No study device implanted|3|||
164124891|NCT03176784|592819481|FG000|Overall Study|Lost to Follow-up|77|||
164124892|NCT03176784|592819482|FG001|Overall Study|Lost to Follow-up|79|||
164124893|NCT03176784|592819483|FG002|Overall Study|Lost to Follow-up|79|||
164124894|NCT03176784|592819484|FG003|Overall Study|Lost to Follow-up|49|||
164124895|NCT03176784|592819481|FG000|Overall Study|Withdrawal by Subject|28|||
164124896|NCT03176784|592819482|FG001|Overall Study|Withdrawal by Subject|34|||
164124897|NCT03176784|592819483|FG002|Overall Study|Withdrawal by Subject|34|||
164124898|NCT03176784|592819484|FG003|Overall Study|Withdrawal by Subject|21|||
164124899|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
164124900|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
164124901|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
164124902|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
164124903|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
164124904|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
164124905|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
164124906|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
164124907|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
164124908|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
164124909|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
164124910|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
164124911|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164124912|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164124913|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164124914|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164124915|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
164124916|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
164124917|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
164124918|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
164124919|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
164124920|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
164124921|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
164124922|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
164124923|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
164124924|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
164124925|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
164124926|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
164124927|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Death|0|||
164124928|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Death|1|||
164124929|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Death|0|||
164124930|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Death|0|||
164124931|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
164124932|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
164124933|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
164124934|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
164124935|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
164124936|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
164124937|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
164124938|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
164124939|NCT02990806|592819485|FG000|Stage 1 (22 Weeks)|Other|1|||
164124940|NCT02990806|592819486|FG001|Stage 1 (22 Weeks)|Other|3|||
164124941|NCT02990806|592819487|FG002|Stage 1 (22 Weeks)|Other|0|||
164124942|NCT02990806|592819488|FG003|Stage 1 (22 Weeks)|Other|0|||
164124943|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
164124944|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
164124945|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
164124946|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
164124947|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Death|1|||
164124948|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Death|0|||
164124949|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Death|0|||
164124950|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Death|0|||
164124951|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
164124952|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
164124953|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
164124954|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
164124955|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
164124956|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
164124957|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
164124958|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
164124959|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
164124960|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
164124961|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
164124962|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
164124963|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
164124964|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
164124965|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
164124966|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
164124967|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164124968|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164124969|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
164124970|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
164124971|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
164124972|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
164124973|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
164124974|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
164124975|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
164124976|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
164124977|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
164124978|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
164124979|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
164124980|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
164124981|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
164124982|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
164124983|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
164124984|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
164124985|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
164124986|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
164124987|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Other|3|||
164124988|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Other|0|||
164124989|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Other|4|||
164124990|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Other|1|||
164124991|NCT02990806|592819485|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
164124992|NCT02990806|592819486|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
164124993|NCT02990806|592819487|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
164124994|NCT02990806|592819488|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
164124995|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
164124996|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
164124997|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
164124998|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
164124999|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
164125000|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
164125001|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
164125002|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
164125003|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164125004|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
164125005|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164125006|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
164125007|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
164125008|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
164125009|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
164125010|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
164125011|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
164125012|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
164125013|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
164125014|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
164125015|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
164125016|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
164125017|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
164125018|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
164125019|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
164125020|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
164125021|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
164125022|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
164125023|NCT02990806|592819485|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
164125024|NCT02990806|592819486|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
164125025|NCT02990806|592819487|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
164125026|NCT02990806|592819488|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
164125027|NCT02654587|592819491|FG000|Overall Study|patient alive at end of study|22|||
164125028|NCT02654587|592819492|FG001|Overall Study|patient alive at end of study|8|||
164125029|NCT02654587|592819491|FG000|Overall Study|Withdrawal by Subject|1|||
164125030|NCT02654587|592819492|FG001|Overall Study|Withdrawal by Subject|7|||
164125031|NCT01825837|592819493|FG000|PART I|Withdrawal by Subject|0|||
164125032|NCT01825837|592819494|FG001|PART I|Withdrawal by Subject|0|||
164125033|NCT01825837|592819495|FG002|PART I|Withdrawal by Subject|0|||
164125034|NCT01825837|592819496|FG003|PART I|Withdrawal by Subject|6|||
164125035|NCT01825837|592819493|FG000|PART I|Patient non-compliance|0|||
164125036|NCT01825837|592819494|FG001|PART I|Patient non-compliance|0|||
164125037|NCT01825837|592819495|FG002|PART I|Patient non-compliance|0|||
164125038|NCT01825837|592819496|FG003|PART I|Patient non-compliance|1|||
164125039|NCT01825837|592819493|FG000|PART I|Treatment failure|0|||
164125040|NCT01825837|592819494|FG001|PART I|Treatment failure|0|||
164125041|NCT01825837|592819495|FG002|PART I|Treatment failure|0|||
164125042|NCT01825837|592819496|FG003|PART I|Treatment failure|7|||
164125043|NCT01825837|592819493|FG000|PART I|reason unspecified|0|||
164125044|NCT01825837|592819494|FG001|PART I|reason unspecified|0|||
164125045|NCT01825837|592819495|FG002|PART I|reason unspecified|0|||
164125046|NCT01825837|592819496|FG003|PART I|reason unspecified|3|||
164125047|NCT01825837|592819493|FG000|PART II|Withdrawal by Subject|3|||
164125048|NCT01825837|592819494|FG001|PART II|Withdrawal by Subject|3|||
164125049|NCT01825837|592819495|FG002|PART II|Withdrawal by Subject|7|||
164125050|NCT01825837|592819496|FG003|PART II|Withdrawal by Subject|0|||
164125051|NCT01825837|592819493|FG000|PART II|Patient non-compliance|5|||
164125052|NCT01825837|592819494|FG001|PART II|Patient non-compliance|2|||
164125053|NCT01825837|592819495|FG002|PART II|Patient non-compliance|4|||
164125054|NCT01825837|592819496|FG003|PART II|Patient non-compliance|0|||
164125055|NCT01825837|592819493|FG000|PART II|Adverse Event|3|||
164125056|NCT01825837|592819494|FG001|PART II|Adverse Event|3|||
164125057|NCT01825837|592819495|FG002|PART II|Adverse Event|1|||
164125058|NCT01825837|592819496|FG003|PART II|Adverse Event|0|||
164125059|NCT01825837|592819493|FG000|PART II|Treatment failure|6|||
164125060|NCT01825837|592819494|FG001|PART II|Treatment failure|4|||
164125061|NCT01825837|592819495|FG002|PART II|Treatment failure|5|||
164125062|NCT01825837|592819496|FG003|PART II|Treatment failure|0|||
164125063|NCT01825837|592819493|FG000|PART II|reason unspecified|2|||
164125064|NCT01825837|592819494|FG001|PART II|reason unspecified|2|||
164125065|NCT01825837|592819495|FG002|PART II|reason unspecified|2|||
164125066|NCT01825837|592819496|FG003|PART II|reason unspecified|0|||
164125067|NCT00904748|592819499|FG000|Overall Study|Withdrawal by Subject|1|||
164125068|NCT00904748|592819500|FG001|Overall Study|Withdrawal by Subject|1|||
164125069|NCT00904748|592819501|FG002|Overall Study|Withdrawal by Subject|1|||
164125070|NCT00904748|592819502|FG003|Overall Study|Withdrawal by Subject|2|||
164125071|NCT00904748|592819503|FG004|Overall Study|Withdrawal by Subject|0|||
164125072|NCT00904748|592819504|FG005|Overall Study|Withdrawal by Subject|0|||
164125073|NCT00904748|592819499|FG000|Overall Study|Adverse Event|0|||
164125074|NCT00904748|592819500|FG001|Overall Study|Adverse Event|0|||
164125075|NCT00904748|592819501|FG002|Overall Study|Adverse Event|0|||
164125076|NCT00904748|592819502|FG003|Overall Study|Adverse Event|0|||
164125077|NCT00904748|592819503|FG004|Overall Study|Adverse Event|1|||
164125078|NCT00904748|592819504|FG005|Overall Study|Adverse Event|0|||
164125079|NCT01682148|592819505|FG000|Overall Study|Withdrawal by Subject|2|||
164125080|NCT01682148|592819506|FG001|Overall Study|Withdrawal by Subject|0|||
164125081|NCT01682148|592819505|FG000|Overall Study|Lost to Follow-up|1|||
164125082|NCT01682148|592819506|FG001|Overall Study|Lost to Follow-up|2|||
164125083|NCT01682148|592819505|FG000|Overall Study|Protocol Violation|1|||
164125084|NCT01682148|592819506|FG001|Overall Study|Protocol Violation|1|||
164125085|NCT01202877|592819507|FG000|Overall Study|Disease Progression|0|||
164125086|NCT01202877|592819508|FG001|Overall Study|Disease Progression|1|||
164125087|NCT01202877|592819509|FG002|Overall Study|Disease Progression|2|||
164125088|NCT01202877|592819507|FG000|Overall Study|Adverse Event|0|||
164125089|NCT01202877|592819508|FG001|Overall Study|Adverse Event|0|||
164125090|NCT01202877|592819509|FG002|Overall Study|Adverse Event|2|||
164125091|NCT01202877|592819507|FG000|Overall Study|Withdrawal by Subject|0|||
164125092|NCT01202877|592819508|FG001|Overall Study|Withdrawal by Subject|0|||
164125093|NCT01202877|592819509|FG002|Overall Study|Withdrawal by Subject|1|||
164125094|NCT01202877|592819507|FG000|Overall Study|Death|0|||
164125095|NCT01202877|592819508|FG001|Overall Study|Death|0|||
164125096|NCT01202877|592819509|FG002|Overall Study|Death|1|||
164125097|NCT00396331|592819510|FG000|Overall Study|Failed to mobilize - no transplant|8|||
164125098|NCT00396331|592819510|FG000|Overall Study|Did not go on to transplant|5|||
164125099|NCT00396331|592819510|FG000|Overall Study|Lost to Follow-up|3|||
164125100|NCT00396331|592819510|FG000|Overall Study|Death|16|||
164125101|NCT01029392|592819520|FG000|Overall Study|Withdrawal by Subject|18|||
164125102|NCT01029392|592819521|FG001|Overall Study|Withdrawal by Subject|11|||
164125103|NCT01029392|592819520|FG000|Overall Study|Physician Decision|2|||
164125104|NCT01029392|592819521|FG001|Overall Study|Physician Decision|0|||
164125105|NCT01103479|592819522|FG000|Overall Study|Up to date with CRC screening|1|||
164125106|NCT01103479|592819523|FG001|Overall Study|Up to date with CRC screening|9|||
164125107|NCT01103479|592819524|FG002|Overall Study|Up to date with CRC screening|12|||
164125108|NCT01103479|592819522|FG000|Overall Study|Family history of CRC|1|||
164125109|NCT01103479|592819523|FG001|Overall Study|Family history of CRC|0|||
164125110|NCT01103479|592819524|FG002|Overall Study|Family history of CRC|2|||
164125111|NCT01103479|592819522|FG000|Overall Study|Active cancer|1|||
164125112|NCT01103479|592819523|FG001|Overall Study|Active cancer|0|||
164125113|NCT01103479|592819524|FG002|Overall Study|Active cancer|0|||
164125114|NCT01103479|592819522|FG000|Overall Study|Saw non-study physician|2|||
164125115|NCT01103479|592819523|FG001|Overall Study|Saw non-study physician|0|||
164125116|NCT01103479|592819524|FG002|Overall Study|Saw non-study physician|0|||
164125117|NCT00834899|592819525|FG000|Overall Study|Withdrawal by Subject|1|||
164125118|NCT00834899|592819526|FG001|Overall Study|Withdrawal by Subject|1|||
164125119|NCT01298778|592819527|FG000|Overall Study|Lost to Follow-up|2|||
164125120|NCT01298778|592819528|FG001|Overall Study|Lost to Follow-up|3|||
164125121|NCT01298778|592819527|FG000|Overall Study|Incorrect use of VAS|1|||
164125122|NCT01298778|592819528|FG001|Overall Study|Incorrect use of VAS|0|||
164125123|NCT01298778|592819527|FG000|Overall Study|Withdrawal by Subject|0|||
164125124|NCT01298778|592819528|FG001|Overall Study|Withdrawal by Subject|1|||
164125125|NCT01298778|592819527|FG000|Overall Study|Protocol Violation|0|||
164125126|NCT01298778|592819528|FG001|Overall Study|Protocol Violation|1|||
164125127|NCT01298778|592819527|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
164125128|NCT01298778|592819528|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
164125129|NCT02377921|592819529|FG000|Overall Study|Subject non-compliance|1|||
164125130|NCT02377921|592819530|FG001|Overall Study|Subject non-compliance|1|||
164125131|NCT02443545|592819533|FG000|Overall Study|Adverse Event|1|||
164125132|NCT02443545|592819534|FG001|Overall Study|Adverse Event|1|||
164125133|NCT02443545|592819533|FG000|Overall Study|Lost to Follow-up|0|||
164125134|NCT02443545|592819534|FG001|Overall Study|Lost to Follow-up|2|||
164125135|NCT02443545|592819533|FG000|Overall Study|Physician Decision|3|||
164125136|NCT02443545|592819534|FG001|Overall Study|Physician Decision|0|||
164125137|NCT02443545|592819533|FG000|Overall Study|Protocol Violation|8|||
164125138|NCT02443545|592819534|FG001|Overall Study|Protocol Violation|1|||
164125139|NCT02443545|592819533|FG000|Overall Study|Pregnancy|1|||
164125140|NCT02443545|592819534|FG001|Overall Study|Pregnancy|1|||
164125141|NCT02443545|592819533|FG000|Overall Study|Withdrawal by Subject|6|||
164125142|NCT02443545|592819534|FG001|Overall Study|Withdrawal by Subject|3|||
164125143|NCT02443545|592819533|FG000|Overall Study|Termination of study|20|||
164125144|NCT02443545|592819534|FG001|Overall Study|Termination of study|11|||
164125145|NCT02139124|592819537|FG000|Overall Study|Adverse Event|2|||
164125146|NCT02139124|592819538|FG001|Overall Study|Adverse Event|0|||
164125147|NCT02139124|592819539|FG002|Overall Study|Adverse Event|1|||
164125148|NCT02139124|592819540|FG003|Overall Study|Adverse Event|2|||
164125149|NCT02139124|592819541|FG004|Overall Study|Adverse Event|5|||
164125150|NCT02139124|592819537|FG000|Overall Study|Withdrawal by Subject|2|||
164125151|NCT02139124|592819538|FG001|Overall Study|Withdrawal by Subject|2|||
164125152|NCT02139124|592819539|FG002|Overall Study|Withdrawal by Subject|2|||
164125153|NCT02139124|592819540|FG003|Overall Study|Withdrawal by Subject|2|||
164125154|NCT02139124|592819541|FG004|Overall Study|Withdrawal by Subject|3|||
164125155|NCT02139124|592819537|FG000|Overall Study|Protocol Violation|0|||
164125156|NCT02139124|592819538|FG001|Overall Study|Protocol Violation|0|||
164125157|NCT02139124|592819539|FG002|Overall Study|Protocol Violation|0|||
164125158|NCT02139124|592819540|FG003|Overall Study|Protocol Violation|1|||
164125159|NCT02139124|592819541|FG004|Overall Study|Protocol Violation|1|||
164125160|NCT02139124|592819537|FG000|Overall Study|non-compliant|1|||
164125161|NCT02139124|592819538|FG001|Overall Study|non-compliant|0|||
164125162|NCT02139124|592819539|FG002|Overall Study|non-compliant|0|||
164125163|NCT02139124|592819540|FG003|Overall Study|non-compliant|2|||
164125164|NCT02139124|592819541|FG004|Overall Study|non-compliant|0|||
164125165|NCT02139124|592819537|FG000|Overall Study|incarceration|0|||
164125166|NCT02139124|592819538|FG001|Overall Study|incarceration|0|||
164125167|NCT02139124|592819539|FG002|Overall Study|incarceration|1|||
164125168|NCT02139124|592819540|FG003|Overall Study|incarceration|0|||
164125169|NCT02139124|592819541|FG004|Overall Study|incarceration|0|||
164125170|NCT02139124|592819537|FG000|Overall Study|subject moved|1|||
164125171|NCT02139124|592819538|FG001|Overall Study|subject moved|0|||
164125172|NCT02139124|592819539|FG002|Overall Study|subject moved|0|||
164125173|NCT02139124|592819540|FG003|Overall Study|subject moved|0|||
164125174|NCT02139124|592819541|FG004|Overall Study|subject moved|0|||
164125175|NCT02139124|592819537|FG000|Overall Study|Lost to Follow-up|3|||
164125176|NCT02139124|592819538|FG001|Overall Study|Lost to Follow-up|2|||
164125177|NCT02139124|592819539|FG002|Overall Study|Lost to Follow-up|0|||
164125178|NCT02139124|592819540|FG003|Overall Study|Lost to Follow-up|5|||
164125179|NCT02139124|592819541|FG004|Overall Study|Lost to Follow-up|4|||
164125180|NCT00560937|592819543|FG000|Overall Study|Withdrawal by Subject|0|||
164125181|NCT00560937|592819544|FG001|Overall Study|Withdrawal by Subject|1|||
164125182|NCT00560937|592819543|FG000|Overall Study|Physician Decision|1|||
164125183|NCT00560937|592819544|FG001|Overall Study|Physician Decision|1|||
164125184|NCT03078478|592819545|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
164125185|NCT03078478|592819546|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
164125186|NCT03078478|592819545|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
164125187|NCT03078478|592819546|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
164125188|NCT03078478|592819545|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
164125189|NCT03078478|592819546|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
164125190|NCT03078478|592819545|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
164125191|NCT03078478|592819546|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
164125192|NCT03078478|592819545|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
164125193|NCT03078478|592819546|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
164125194|NCT03078478|592819545|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
164125195|NCT03078478|592819546|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
164125196|NCT03078478|592819545|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
164125197|NCT03078478|592819546|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
164125198|NCT03078478|592819545|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
164125199|NCT03078478|592819546|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
164125200|NCT03821272|592820697|FG000|Overall Study|Death|1|||
164125201|NCT03821272|592820698|FG001|Overall Study|Death|0|||
164125202|NCT03821272|592820697|FG000|Overall Study|Physician Decision|1|||
164125203|NCT03821272|592820698|FG001|Overall Study|Physician Decision|0|||
164125204|NCT03821272|592820697|FG000|Overall Study|Withdrawal by Subject|1|||
164125205|NCT03821272|592820698|FG001|Overall Study|Withdrawal by Subject|0|||
164125206|NCT05904769|592820699|FG000|Overall Study|Physician Decision|0|||
164125207|NCT05904769|592820700|FG001|Overall Study|Physician Decision|6|||
164125208|NCT02516410|592820706|FG000|Overall Study|Adverse Event|0|||
164125209|NCT02516410|592820707|FG001|Overall Study|Adverse Event|1|||
164125210|NCT02516410|592820706|FG000|Overall Study|Withdrawal by Subject|0|||
164125211|NCT02516410|592820707|FG001|Overall Study|Withdrawal by Subject|1|||
164125212|NCT01286558|592820708|FG000|Overall Study|Adverse Event|1|||
164125213|NCT01286558|592820709|FG001|Overall Study|Adverse Event|1|||
164125214|NCT01286558|592820708|FG000|Overall Study|Withdrawal by Subject|0|||
164125215|NCT01286558|592820709|FG001|Overall Study|Withdrawal by Subject|1|||
164125216|NCT01220297|592820710|FG000|Overall Study|Death|2|||
164125217|NCT01220297|592820710|FG000|Overall Study|Lost to Follow-up|1|||
164125218|NCT01287039|592820712|FG000|Overall Study|Noncompliance with study procedures|0|||
164125219|NCT01287039|592820713|FG001|Overall Study|Noncompliance with study procedures|1|||
164125220|NCT01287039|592820712|FG000|Overall Study|Change of location/residence|0|||
164125221|NCT01287039|592820713|FG001|Overall Study|Change of location/residence|3|||
164125222|NCT01287039|592820712|FG000|Overall Study|Elective surgery|0|||
164125223|NCT01287039|592820713|FG001|Overall Study|Elective surgery|1|||
164125224|NCT01287039|592820712|FG000|Overall Study|Protocol Violation|2|||
164125225|NCT01287039|592820713|FG001|Overall Study|Protocol Violation|3|||
164125226|NCT01287039|592820712|FG000|Overall Study|Excluded medication taken|1|||
164125227|NCT01287039|592820713|FG001|Overall Study|Excluded medication taken|0|||
164125228|NCT01287039|592820712|FG000|Overall Study|Noncompliance with study medication|0|||
164125229|NCT01287039|592820713|FG001|Overall Study|Noncompliance with study medication|1|||
164125230|NCT01287039|592820712|FG000|Overall Study|Problem with travel|0|||
164125231|NCT01287039|592820713|FG001|Overall Study|Problem with travel|1|||
164125232|NCT01287039|592820712|FG000|Overall Study|Death|1|||
164125233|NCT01287039|592820713|FG001|Overall Study|Death|0|||
164125234|NCT01287039|592820712|FG000|Overall Study|Change of residence|1|||
164125235|NCT01287039|592820713|FG001|Overall Study|Change of residence|0|||
164125236|NCT01287039|592820712|FG000|Overall Study|Adverse Event|7|||
164125237|NCT01287039|592820713|FG001|Overall Study|Adverse Event|4|||
164125238|NCT01287039|592820712|FG000|Overall Study|Withdrawal by Subject|14|||
164125239|NCT01287039|592820713|FG001|Overall Study|Withdrawal by Subject|11|||
164125240|NCT01287039|592820712|FG000|Overall Study|Lost to Follow-up|3|||
164125241|NCT01287039|592820713|FG001|Overall Study|Lost to Follow-up|2|||
164125242|NCT01360866|592820714|FG000|Overall Study|Lost to Follow-up|11|||
164125243|NCT01360866|592820715|FG001|Overall Study|Lost to Follow-up|28|||
164125244|NCT01360866|592820716|FG002|Overall Study|Lost to Follow-up|41|||
164125245|NCT01360866|592820717|FG003|Overall Study|Lost to Follow-up|0|||
164125246|NCT01360866|592820714|FG000|Overall Study|Adverse Event|56|||
164125247|NCT01360866|592820715|FG001|Overall Study|Adverse Event|61|||
164125248|NCT01360866|592820716|FG002|Overall Study|Adverse Event|134|||
164125249|NCT01360866|592820717|FG003|Overall Study|Adverse Event|6|||
164125250|NCT01360866|592820714|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
164125251|NCT01360866|592820715|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
164125252|NCT01360866|592820716|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
164125253|NCT01360866|592820717|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
164125254|NCT01360866|592820714|FG000|Overall Study|Withdrawn by Investigator|9|||
164125255|NCT01360866|592820715|FG001|Overall Study|Withdrawn by Investigator|8|||
164125256|NCT01360866|592820716|FG002|Overall Study|Withdrawn by Investigator|31|||
164125257|NCT01360866|592820717|FG003|Overall Study|Withdrawn by Investigator|2|||
164125258|NCT01360866|592820714|FG000|Overall Study|Withdrawal by participant|79|||
164125259|NCT01360866|592820715|FG001|Overall Study|Withdrawal by participant|89|||
164125260|NCT01360866|592820716|FG002|Overall Study|Withdrawal by participant|168|||
164125261|NCT01360866|592820717|FG003|Overall Study|Withdrawal by participant|8|||
164125262|NCT01360866|592820714|FG000|Overall Study|Protocol Deviation|25|||
164125263|NCT01360866|592820715|FG001|Overall Study|Protocol Deviation|33|||
164125264|NCT01360866|592820716|FG002|Overall Study|Protocol Deviation|61|||
164125265|NCT01360866|592820717|FG003|Overall Study|Protocol Deviation|2|||
164125266|NCT01360866|592820714|FG000|Overall Study|Lack of Efficacy|30|||
164125267|NCT01360866|592820715|FG001|Overall Study|Lack of Efficacy|40|||
164125268|NCT01360866|592820716|FG002|Overall Study|Lack of Efficacy|30|||
164125269|NCT01360866|592820717|FG003|Overall Study|Lack of Efficacy|4|||
164125270|NCT05016622|592820718|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
164125271|NCT05016622|592820718|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
164125272|NCT01117337|592820727|FG000|Overall Study|Lost to Follow-up|4|||
164125273|NCT01117337|592820728|FG001|Overall Study|Lost to Follow-up|0|||
164125274|NCT00584844|592820730|FG000|Overall Study|Withdrawal by Subject|59|||
164125275|NCT00584844|592820730|FG000|Overall Study|Screen Failure|20|||
164125276|NCT00171301|592820733|FG000|Overall Study|Death|1|||
164125277|NCT00171301|592820734|FG001|Overall Study|Death|2|||
164125278|NCT00171301|592820733|FG000|Overall Study|Adverse Event|1|||
164125279|NCT00171301|592820734|FG001|Overall Study|Adverse Event|2|||
164125280|NCT00171301|592820733|FG000|Overall Study|Lost to Follow-up|6|||
164125281|NCT00171301|592820734|FG001|Overall Study|Lost to Follow-up|2|||
164125282|NCT00171301|592820733|FG000|Overall Study|Protocol Violation|0|||
164125283|NCT00171301|592820734|FG001|Overall Study|Protocol Violation|2|||
164125284|NCT00171301|592820733|FG000|Overall Study|Withdrawal by Subject|0|||
164125285|NCT00171301|592820734|FG001|Overall Study|Withdrawal by Subject|1|||
164125286|NCT02370914|592820739|FG000|Overall Study|Protocol Violation|2|||
164125287|NCT03451006|592820740|FG000|Overall Study|Withdrawal by Subject|2|||
164125288|NCT03451006|592820741|FG001|Overall Study|Withdrawal by Subject|2|||
164125289|NCT05224544|592820742|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
164125290|NCT05224544|592820743|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
164125291|NCT03847194|592820744|FG000|Overall Study|Lost to Follow-up|2|||
164125292|NCT03847194|592820745|FG001|Overall Study|Lost to Follow-up|5|||
164125293|NCT03847194|592820744|FG000|Overall Study|Withdrawal by Subject|1|||
164125294|NCT03847194|592820745|FG001|Overall Study|Withdrawal by Subject|2|||
164125295|NCT03847194|592820744|FG000|Overall Study|Death|0|||
164125296|NCT03847194|592820745|FG001|Overall Study|Death|1|||
164125297|NCT01341587|592820746|FG000|Overall Study|Lost to Follow-up|2|||
164125298|NCT01341587|592820747|FG001|Overall Study|Lost to Follow-up|0|||
164125299|NCT01341587|592820746|FG000|Overall Study|stopped using the meters|2|||
164125300|NCT01341587|592820747|FG001|Overall Study|stopped using the meters|10|||
164125301|NCT04403763|592820748|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
164125302|NCT04403763|592820749|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
164125303|NCT04403763|592820750|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
164125304|NCT04403763|592820751|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
164125305|NCT04403763|592820752|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
164125306|NCT04403763|592820753|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
164125307|NCT04403763|592820754|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
164125308|NCT04403763|592820748|FG000|Stage 1|Early termination due to PK tube failure|0|||
164125309|NCT04403763|592820749|FG001|Stage 1|Early termination due to PK tube failure|0|||
164125310|NCT04403763|592820750|FG002|Stage 1|Early termination due to PK tube failure|1|||
164125311|NCT04403763|592820751|FG003|Stage 1|Early termination due to PK tube failure|0|||
164125312|NCT04403763|592820752|FG004|Stage 1|Early termination due to PK tube failure|0|||
164125313|NCT04403763|592820753|FG005|Stage 1|Early termination due to PK tube failure|0|||
164125314|NCT04403763|592820754|FG006|Stage 1|Early termination due to PK tube failure|0|||
164125315|NCT04403763|592820748|FG000|Stage 2A|Adverse Event|0|||
164125316|NCT04403763|592820749|FG001|Stage 2A|Adverse Event|0|||
164125317|NCT04403763|592820750|FG002|Stage 2A|Adverse Event|0|||
164125318|NCT04403763|592820751|FG003|Stage 2A|Adverse Event|0|||
164125319|NCT04403763|592820752|FG004|Stage 2A|Adverse Event|0|||
164125320|NCT04403763|592820753|FG005|Stage 2A|Adverse Event|0|||
164125321|NCT04403763|592820754|FG006|Stage 2A|Adverse Event|1|||
164125322|NCT00350402|592820755|FG000|Overall Study|Lost to Follow-up|1|||
164125323|NCT00350402|592820756|FG001|Overall Study|Lost to Follow-up|1|||
164125324|NCT01376310|592820757|FG000|Overall Study|Study closed/terminated|1|||
164125325|NCT01376310|592820758|FG001|Overall Study|Study closed/terminated|2|||
164125326|NCT01376310|592820757|FG000|Overall Study|Withdrawal by Subject|8|||
164125327|NCT01376310|592820758|FG001|Overall Study|Withdrawal by Subject|2|||
164125328|NCT01376310|592820757|FG000|Overall Study|Physician Decision|26|||
164125329|NCT01376310|592820758|FG001|Overall Study|Physician Decision|7|||
164125330|NCT01376310|592820757|FG000|Overall Study|Lost to Follow-up|1|||
164125331|NCT01376310|592820758|FG001|Overall Study|Lost to Follow-up|0|||
164125332|NCT00645944|592820759|FG000|Randomized|Withdrawal by Subject|1|||
164125333|NCT00645944|592820760|FG001|Randomized|Withdrawal by Subject|2|||
164125334|NCT00645944|592820759|FG000|Received Medication|Adverse Event|2|||
164125335|NCT00645944|592820760|FG001|Received Medication|Adverse Event|1|||
164125336|NCT00645944|592820759|FG000|Received Medication|Withdrawal by Subject|1|||
164125337|NCT00645944|592820760|FG001|Received Medication|Withdrawal by Subject|1|||
164125338|NCT00645944|592820759|FG000|Received Medication|Lost to Follow-up|1|||
164125339|NCT00645944|592820760|FG001|Received Medication|Lost to Follow-up|0|||
164125340|NCT00645944|592820759|FG000|Received Medication|Protocol Violation|2|||
164125341|NCT00645944|592820760|FG001|Received Medication|Protocol Violation|1|||
164125342|NCT01807117|592820762|FG000|Overall Study|Physician Decision|2|||
164125343|NCT01807117|592820762|FG000|Overall Study|Disease diagnosis not a study disease|1|||
164125344|NCT01534637|592820763|FG000|Overall Study|Physician Decision|3|||
164125345|NCT01534637|592820763|FG000|Overall Study|Lack of Efficacy|3|||
164125346|NCT01534637|592820763|FG000|Overall Study|Withdrawal by Subject|1|||
164125347|NCT01534637|592820763|FG000|Overall Study|Adverse Event|1|||
164125348|NCT01534637|592820763|FG000|Overall Study|Liver Mets before treatment|1|||
164125349|NCT00606502|592820769|FG000|Randomization|Randomized but not treated|3|||
164125350|NCT00606502|592820770|FG001|Randomization|Randomized but not treated|0|||
164125351|NCT00606502|592820769|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
164125352|NCT00606502|592820770|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
164125353|NCT02080832|592820780|FG000|Overall Study|Excluded from analysis by MRI|9|||
164125354|NCT02080832|592820781|FG001|Overall Study|Excluded from analysis by MRI|10|||
164125355|NCT02080832|592820782|FG002|Overall Study|Excluded from analysis by MRI|14|||
164125356|NCT02080832|592820780|FG000|Overall Study|Lost to Follow-up|0|||
164125357|NCT02080832|592820781|FG001|Overall Study|Lost to Follow-up|2|||
164125358|NCT02080832|592820782|FG002|Overall Study|Lost to Follow-up|2|||
164125359|NCT01560507|592820783|FG000|Overall Study|Lost to Follow-up|3|||
164125360|NCT01560507|592820784|FG001|Overall Study|Lost to Follow-up|1|||
164125361|NCT01560507|592820785|FG002|Overall Study|Lost to Follow-up|2|||
164125362|NCT01560507|592820783|FG000|Overall Study|Withdrawal by Subject|1|||
164125363|NCT01560507|592820784|FG001|Overall Study|Withdrawal by Subject|1|||
164125364|NCT01560507|592820785|FG002|Overall Study|Withdrawal by Subject|0|||
164125365|NCT03069417|592820786|FG000|Overall Study|Lost to Follow-up|2|||
164125366|NCT03069417|592820787|FG001|Overall Study|Lost to Follow-up|0|||
164125367|NCT03069417|592820786|FG000|Overall Study|Reason Unknown|4|||
164125368|NCT03069417|592820787|FG001|Overall Study|Reason Unknown|7|||
164125369|NCT00440115|592820788|FG000|Overall Study|Death|7|||
164125370|NCT00440115|592820789|FG001|Overall Study|Death|9|||
164125371|NCT00440115|592820790|FG002|Overall Study|Death|5|||
164125372|NCT00440115|592820788|FG000|Overall Study|Incarceration|0|||
164125373|NCT00440115|592820789|FG001|Overall Study|Incarceration|2|||
164125374|NCT00440115|592820790|FG002|Overall Study|Incarceration|1|||
164125375|NCT01660022|592820792|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
164125376|NCT01660022|592820793|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
164125377|NCT01660022|592820794|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
164125378|NCT01660022|592820795|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
164125379|NCT01660022|592820796|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
164125380|NCT01660022|592820797|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
164125381|NCT01660022|592820792|FG000|First Sequence (7 Days)|Adverse Event|0|||
164125382|NCT01660022|592820793|FG001|First Sequence (7 Days)|Adverse Event|0|||
164125383|NCT01660022|592820794|FG002|First Sequence (7 Days)|Adverse Event|0|||
164125384|NCT01660022|592820795|FG003|First Sequence (7 Days)|Adverse Event|0|||
164125385|NCT01660022|592820796|FG004|First Sequence (7 Days)|Adverse Event|1|||
164125386|NCT01660022|592820797|FG005|First Sequence (7 Days)|Adverse Event|3|||
164125387|NCT01660022|592820792|FG000|First Sequence (7 Days)|Protocol Violation|0|||
164125388|NCT01660022|592820793|FG001|First Sequence (7 Days)|Protocol Violation|0|||
164125389|NCT01660022|592820794|FG002|First Sequence (7 Days)|Protocol Violation|0|||
164125390|NCT01660022|592820795|FG003|First Sequence (7 Days)|Protocol Violation|0|||
164125391|NCT01660022|592820796|FG004|First Sequence (7 Days)|Protocol Violation|0|||
164125392|NCT01660022|592820797|FG005|First Sequence (7 Days)|Protocol Violation|1|||
164125393|NCT03545191|592820800|FG000|Overall Study|Death|1|||
164125394|NCT03545191|592820801|FG001|Overall Study|Death|0|||
164125395|NCT03545191|592820802|FG002|Overall Study|Death|0|||
164125396|NCT03545191|592820800|FG000|Overall Study|Adverse Event|4|||
164125397|NCT03545191|592820801|FG001|Overall Study|Adverse Event|2|||
164125398|NCT03545191|592820802|FG002|Overall Study|Adverse Event|7|||
164125399|NCT03545191|592820800|FG000|Overall Study|Other reasons|3|||
164125400|NCT03545191|592820801|FG001|Overall Study|Other reasons|11|||
164125401|NCT03545191|592820802|FG002|Overall Study|Other reasons|8|||
164125402|NCT03545191|592820800|FG000|Overall Study|Withdrawal by Subject|13|||
164125403|NCT03545191|592820801|FG001|Overall Study|Withdrawal by Subject|10|||
164125404|NCT03545191|592820802|FG002|Overall Study|Withdrawal by Subject|12|||
164125405|NCT03545191|592820800|FG000|Overall Study|Lost to Follow-up|1|||
164125406|NCT03545191|592820801|FG001|Overall Study|Lost to Follow-up|2|||
164125407|NCT03545191|592820802|FG002|Overall Study|Lost to Follow-up|3|||
164125408|NCT01277718|592820806|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
164125409|NCT01277718|592820807|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
164125410|NCT01277718|592820806|FG000|Period 2 - Second Intervention|Physician Decision|0|||
164125411|NCT01277718|592820807|FG001|Period 2 - Second Intervention|Physician Decision|2|||
164125412|NCT03919162|592820810|FG000|Overall Study|Adverse Event|3|||
164125413|NCT03919162|592820811|FG001|Overall Study|Adverse Event|2|||
164125414|NCT03919162|592820810|FG000|Overall Study|Death|2|||
164125415|NCT03919162|592820811|FG001|Overall Study|Death|0|||
164125416|NCT03919162|592820810|FG000|Overall Study|Lost to Follow-up|1|||
164125417|NCT03919162|592820811|FG001|Overall Study|Lost to Follow-up|0|||
164125418|NCT03919162|592820810|FG000|Overall Study|Withdrawal by Subject|12|||
164125419|NCT03919162|592820811|FG001|Overall Study|Withdrawal by Subject|12|||
164125420|NCT03919162|592820810|FG000|Overall Study|Study terminated by Sponsor|20|||
164125421|NCT03919162|592820811|FG001|Overall Study|Study terminated by Sponsor|24|||
164125422|NCT03919162|592820810|FG000|Overall Study|Screen failure|1|||
164125423|NCT03919162|592820811|FG001|Overall Study|Screen failure|0|||
164125424|NCT03919162|592820810|FG000|Overall Study|Missing|1|||
164125425|NCT03919162|592820811|FG001|Overall Study|Missing|1|||
164125426|NCT02746627|592820813|FG000|Overall Study|Withdrawal by Subject|1|||
164125427|NCT02746627|592820814|FG001|Overall Study|Withdrawal by Subject|1|||
164125428|NCT02746627|592820815|FG002|Overall Study|Withdrawal by Subject|1|||
164125429|NCT02858726|592820816|FG000|Overall Study|Adverse Event|4|||
164125430|NCT02858726|592820817|FG001|Overall Study|Adverse Event|4|||
164125431|NCT02858726|592820818|FG002|Overall Study|Adverse Event|9|||
164125432|NCT02858726|592820819|FG003|Overall Study|Adverse Event|1|||
164125433|NCT02858726|592820816|FG000|Overall Study|Physician Decision|0|||
164125434|NCT02858726|592820817|FG001|Overall Study|Physician Decision|0|||
164125435|NCT02858726|592820818|FG002|Overall Study|Physician Decision|1|||
164125436|NCT02858726|592820819|FG003|Overall Study|Physician Decision|0|||
164125437|NCT02858726|592820816|FG000|Overall Study|Protocol Violation|0|||
164125438|NCT02858726|592820817|FG001|Overall Study|Protocol Violation|0|||
164125439|NCT02858726|592820818|FG002|Overall Study|Protocol Violation|0|||
164125440|NCT02858726|592820819|FG003|Overall Study|Protocol Violation|1|||
164125441|NCT02858726|592820816|FG000|Overall Study|Study Terminated by Sponsor|0|||
164125442|NCT02858726|592820817|FG001|Overall Study|Study Terminated by Sponsor|0|||
164125443|NCT02858726|592820818|FG002|Overall Study|Study Terminated by Sponsor|0|||
164125444|NCT02858726|592820819|FG003|Overall Study|Study Terminated by Sponsor|1|||
164125445|NCT02858726|592820816|FG000|Overall Study|Withdrawal by Subject|1|||
164125446|NCT02858726|592820817|FG001|Overall Study|Withdrawal by Subject|2|||
164125447|NCT02858726|592820818|FG002|Overall Study|Withdrawal by Subject|1|||
164125448|NCT02858726|592820819|FG003|Overall Study|Withdrawal by Subject|0|||
164125449|NCT02858726|592820816|FG000|Overall Study|Noncompliance|0|||
164125450|NCT02858726|592820817|FG001|Overall Study|Noncompliance|1|||
164125451|NCT02858726|592820818|FG002|Overall Study|Noncompliance|0|||
164125452|NCT02858726|592820819|FG003|Overall Study|Noncompliance|0|||
164125453|NCT01688726|592820822|FG000|Overall Study|Adverse Event|1|||
164125454|NCT01688726|592820823|FG001|Overall Study|Adverse Event|0|||
164125455|NCT01688726|592820822|FG000|Overall Study|Relocated abroad|0|||
164125456|NCT01688726|592820823|FG001|Overall Study|Relocated abroad|1|||
164125457|NCT00710749|592820825|FG000|First Intervention|Withdrawal by Subject|1|||
164125458|NCT00710749|592820826|FG001|First Intervention|Withdrawal by Subject|0|||
164125459|NCT05478252|592820827|FG000|Overall Study|Withdrawal by Subject|2|||
164125460|NCT05478252|592820828|FG001|Overall Study|Withdrawal by Subject|3|||
164125461|NCT05478252|592820827|FG000|Overall Study|Lost to Follow-up|4|||
164125462|NCT05478252|592820828|FG001|Overall Study|Lost to Follow-up|2|||
164125463|NCT05478252|592820827|FG000|Overall Study|Physician Decision|1|||
164125464|NCT05478252|592820828|FG001|Overall Study|Physician Decision|1|||
164125465|NCT05478252|592820827|FG000|Overall Study|Death|1|||
164125466|NCT05478252|592820828|FG001|Overall Study|Death|0|||
164125467|NCT04718194|592822544|FG000|Overall Study|Withdrawal by Subject|3|||
164125468|NCT04718194|592822545|FG001|Overall Study|Withdrawal by Subject|0|||
164125469|NCT04718194|592822544|FG000|Overall Study|Lost to Follow-up|3|||
164125470|NCT04718194|592822545|FG001|Overall Study|Lost to Follow-up|0|||
164125471|NCT01215513|592822546|FG000|Overall Study|Not completed CS42|9|||
164125472|NCT01215513|592822546|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
164125473|NCT01215513|592822546|FG000|Overall Study|Adverse event (CS42A)|2|||
164125474|NCT01215513|592822546|FG000|Overall Study|Physician decision (CS42A)|6|||
164125475|NCT01215513|592822546|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
164125476|NCT01215513|592822546|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
164125477|NCT00821873|592822547|FG000|Overall Study|Lost to Follow-up|4|||
164125478|NCT03861481|592822553|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
164125479|NCT03861481|592822554|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
164125480|NCT03861481|592822553|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
164125481|NCT03861481|592822554|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
164125482|NCT03861481|592822553|FG000|Overall Study|Relapse|1|||
164125483|NCT03861481|592822554|FG001|Overall Study|Relapse|0|||
164125484|NCT03861481|592822553|FG000|Overall Study|Withdrawal by Subject|0|||
164125485|NCT03861481|592822554|FG001|Overall Study|Withdrawal by Subject|1|||
164125486|NCT03861481|592822553|FG000|Overall Study|Lack of Efficacy|4|||
164125487|NCT03861481|592822554|FG001|Overall Study|Lack of Efficacy|5|||
164125488|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
164125489|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
164125490|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
164125491|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
164125492|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
164125493|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
164125494|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
164125495|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
164125496|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
164125497|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
164125498|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
164125499|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
164125500|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
164125501|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
164125502|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
164125503|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
164125504|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164125505|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
164125506|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
164125507|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164125508|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164125509|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164125510|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164125511|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
164125512|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
164125513|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164125514|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164125515|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
164125516|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164125517|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
164125518|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
164125519|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
164125520|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
164125521|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
164125522|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
164125523|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
164125524|NCT00773734|592822555|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164125525|NCT00773734|592822556|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164125526|NCT00773734|592822557|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164125527|NCT00773734|592822558|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
164125528|NCT00773734|592822559|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
164125529|NCT00773734|592822560|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
164125530|NCT00773734|592822555|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
164125531|NCT00773734|592822556|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
164125532|NCT00773734|592822557|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
164125533|NCT00773734|592822558|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
164125534|NCT00773734|592822559|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
164125535|NCT00773734|592822560|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
164125536|NCT00773734|592822555|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
164125537|NCT00773734|592822556|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
164125538|NCT00773734|592822557|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
164125539|NCT00773734|592822558|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
164125540|NCT00773734|592822559|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
164125541|NCT00773734|592822560|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
164125542|NCT00773734|592822555|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
164125543|NCT00773734|592822556|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
164125544|NCT00773734|592822557|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
164125545|NCT00773734|592822558|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
164125546|NCT00773734|592822559|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
164125547|NCT00773734|592822560|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
164125548|NCT00773734|592822555|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164125549|NCT00773734|592822556|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
164125550|NCT00773734|592822557|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
164125551|NCT00773734|592822558|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164125552|NCT00773734|592822559|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164125553|NCT00773734|592822560|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
164125554|NCT00773734|592822555|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
164125555|NCT00773734|592822556|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164125556|NCT00773734|592822557|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164132683|NCT01986010|592850662|FG007|Overall Study|Lost to Follow-up|0|||
164125557|NCT00773734|592822558|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164125558|NCT00773734|592822559|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
164125559|NCT00773734|592822560|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
164125560|NCT00773734|592822555|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
164125561|NCT00773734|592822556|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
164125562|NCT00773734|592822557|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
164125563|NCT00773734|592822558|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
164125564|NCT00773734|592822559|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
164125565|NCT00773734|592822560|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
164125566|NCT00773734|592822555|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164125567|NCT00773734|592822556|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164125568|NCT00773734|592822557|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164125569|NCT00773734|592822558|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
164125570|NCT00773734|592822559|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
164125571|NCT00773734|592822560|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
164125572|NCT00773734|592822555|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
164125573|NCT00773734|592822556|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
164125574|NCT00773734|592822557|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
164125575|NCT00773734|592822558|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
164125576|NCT00773734|592822559|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
164125577|NCT00773734|592822560|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
164125578|NCT00773734|592822555|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
164125579|NCT00773734|592822556|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
164125580|NCT00773734|592822557|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
164125581|NCT00773734|592822558|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
164125582|NCT00773734|592822559|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
164125583|NCT00773734|592822560|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
164125584|NCT00773734|592822555|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
164125585|NCT00773734|592822556|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
164125586|NCT00773734|592822557|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
164125587|NCT00773734|592822558|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
164125588|NCT00773734|592822559|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
164125589|NCT00773734|592822560|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
164125590|NCT00773734|592822555|FG000|Extension: Active Treatment Week 24-52|Other|0|||
164125591|NCT00773734|592822556|FG001|Extension: Active Treatment Week 24-52|Other|0|||
164125592|NCT00773734|592822557|FG002|Extension: Active Treatment Week 24-52|Other|1|||
164125593|NCT00773734|592822558|FG003|Extension: Active Treatment Week 24-52|Other|2|||
164125594|NCT00773734|592822559|FG004|Extension: Active Treatment Week 24-52|Other|0|||
164125595|NCT00773734|592822560|FG005|Extension: Active Treatment Week 24-52|Other|1|||
164125596|NCT00773734|592822555|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164125597|NCT00773734|592822556|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164125598|NCT00773734|592822557|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164125599|NCT00773734|592822558|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
164125600|NCT00773734|592822559|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164125601|NCT00773734|592822560|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
164125602|NCT00773734|592822555|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164125603|NCT00773734|592822556|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164125604|NCT00773734|592822557|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
164125605|NCT00773734|592822558|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
164125606|NCT00773734|592822559|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164125607|NCT00773734|592822560|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
164125608|NCT00773734|592822555|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164125609|NCT00773734|592822556|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164125610|NCT00773734|592822557|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
164125611|NCT00773734|592822558|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
164125612|NCT00773734|592822559|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164125613|NCT00773734|592822560|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
164125614|NCT00773734|592822555|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164125615|NCT00773734|592822556|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164125616|NCT00773734|592822557|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
164125617|NCT00773734|592822558|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
164125618|NCT00773734|592822559|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164125619|NCT00773734|592822560|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
164125620|NCT00856830|592822564|FG000|Irinotecan & Bendamustine|Death|0|||
164125621|NCT00856830|592822565|FG001|Irinotecan & Bendamustine|Death|0|||
164125622|NCT00856830|592822566|FG002|Irinotecan & Bendamustine|Death|0|||
164125623|NCT00856830|592822567|FG003|Irinotecan & Bendamustine|Death|2|||
164125624|NCT00856830|592822564|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
164125625|NCT00856830|592822565|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
164125626|NCT00856830|592822566|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
164125627|NCT00856830|592822567|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
164125628|NCT03768726|592822568|FG000|Treatment Phase|Adverse Event|2|||
164125629|NCT03768726|592822569|FG001|Treatment Phase|Adverse Event|2|||
164125630|NCT03768726|592822568|FG000|Treatment Phase|Lost to Follow-up|1|||
164125631|NCT03768726|592822569|FG001|Treatment Phase|Lost to Follow-up|0|||
164125632|NCT03768726|592822568|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
164125633|NCT03768726|592822569|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
164125634|NCT03768726|592822568|FG000|Treatment Phase|Withdrawal by Subject|3|||
164125635|NCT03768726|592822569|FG001|Treatment Phase|Withdrawal by Subject|1|||
164125636|NCT03768726|592822568|FG000|Follow-Up|Adverse Event|2|||
164125637|NCT03768726|592822569|FG001|Follow-Up|Adverse Event|2|||
164125638|NCT03768726|592822568|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
164125639|NCT03768726|592822569|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
164125640|NCT03768726|592822568|FG000|Follow-Up|Withdrawal by Subject|2|||
164125641|NCT03768726|592822569|FG001|Follow-Up|Withdrawal by Subject|0|||
164125642|NCT03768726|592822568|FG000|Follow-Up|Other|1|||
164125643|NCT03768726|592822569|FG001|Follow-Up|Other|0|||
164125644|NCT01787279|592822570|FG000|Overall Study|Lost to Follow-up|2|||
164125645|NCT01787279|592822570|FG000|Overall Study|Lack of Efficacy|1|||
164125646|NCT02148913|592822571|FG000|Overall Study|Death|0|||
164125647|NCT02148913|592822572|FG001|Overall Study|Death|1|||
164125648|NCT02148913|592822573|FG002|Overall Study|Death|0|||
164125649|NCT02148913|592822574|FG003|Overall Study|Death|0|||
164125650|NCT02954159|592822576|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
164125651|NCT02954159|592822577|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
164125652|NCT02954159|592822576|FG000|Overall Study|Withdrawal by Subject|0|||
164125653|NCT02954159|592822577|FG001|Overall Study|Withdrawal by Subject|1|||
164125654|NCT05506358|592822578|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
164125655|NCT05506358|592822579|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164125656|NCT05506358|592822580|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164125657|NCT05506358|592822581|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164125658|NCT05506358|592822582|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
164125659|NCT05506358|592822578|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
164125660|NCT05506358|592822579|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164125661|NCT05506358|592822580|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164125662|NCT05506358|592822581|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164125663|NCT05506358|592822582|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
164125664|NCT05506358|592822578|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164125665|NCT05506358|592822579|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164125666|NCT05506358|592822580|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164125667|NCT05506358|592822581|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
164125668|NCT05506358|592822582|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
164125669|NCT05506358|592822578|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
164125670|NCT05506358|592822579|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
164125671|NCT05506358|592822580|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
164125672|NCT05506358|592822581|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
164125673|NCT05506358|592822582|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
164125674|NCT05506358|592822578|FG000|Overall Study|HbE trait|0|||
164125675|NCT05506358|592822579|FG001|Overall Study|HbE trait|0|||
164125676|NCT05506358|592822580|FG002|Overall Study|HbE trait|0|||
164125677|NCT05506358|592822581|FG003|Overall Study|HbE trait|1|||
164125678|NCT05506358|592822582|FG004|Overall Study|HbE trait|0|||
164125679|NCT03438396|592822589|FG000|Overall Study|Reason Not Specified|9|||
164125680|NCT03438396|592822589|FG000|Overall Study|Withdrawal by Subject|5|||
164125681|NCT03438396|592822589|FG000|Overall Study|Lost to Follow-up|2|||
164125682|NCT03438396|592822589|FG000|Overall Study|Death|85|||
164125683|NCT03438396|592822589|FG000|Overall Study|Not treated|1|||
164125684|NCT01744093|592822590|FG000|Overall Study|Withdrawal by Subject|6|||
164125685|NCT01744093|592822591|FG001|Overall Study|Withdrawal by Subject|1|||
164125686|NCT02006628|592822592|FG000|Overall Study|Adverse Event|1|||
164125687|NCT02006628|592822593|FG001|Overall Study|Adverse Event|1|||
164125688|NCT02006628|592822592|FG000|Overall Study|Withdrawal by Subject|2|||
164125689|NCT02006628|592822593|FG001|Overall Study|Withdrawal by Subject|1|||
164125690|NCT00262041|592822594|FG000|Overall Study|Withdrawal by Subject|0|||
164125691|NCT00262041|592822595|FG001|Overall Study|Withdrawal by Subject|3|||
164125692|NCT00262041|592822596|FG002|Overall Study|Withdrawal by Subject|1|||
164125693|NCT00262041|592822594|FG000|Overall Study|Lost to Follow-up|1|||
164125694|NCT00262041|592822595|FG001|Overall Study|Lost to Follow-up|1|||
164125695|NCT00262041|592822596|FG002|Overall Study|Lost to Follow-up|5|||
164125696|NCT00262041|592822594|FG000|Overall Study|Unable to classify|1|||
164125697|NCT00262041|592822595|FG001|Overall Study|Unable to classify|0|||
164125698|NCT00262041|592822596|FG002|Overall Study|Unable to classify|0|||
164125699|NCT03578237|592822599|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
164125700|NCT03578237|592822600|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
164125701|NCT01173471|592822601|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164125702|NCT01173471|592822602|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164125703|NCT01173471|592822603|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164125704|NCT01173471|592822604|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
164125705|NCT01173471|592822601|FG000|Overall Study|Condition under investigation worsened|2|||
164125706|NCT01173471|592822602|FG001|Overall Study|Condition under investigation worsened|0|||
164125707|NCT01173471|592822603|FG002|Overall Study|Condition under investigation worsened|0|||
164125708|NCT01173471|592822604|FG003|Overall Study|Condition under investigation worsened|0|||
164125709|NCT01173471|592822601|FG000|Overall Study|Lost to Follow-up|0|||
164125710|NCT01173471|592822602|FG001|Overall Study|Lost to Follow-up|0|||
164125711|NCT01173471|592822603|FG002|Overall Study|Lost to Follow-up|1|||
164125712|NCT01173471|592822604|FG003|Overall Study|Lost to Follow-up|0|||
164125713|NCT01173471|592822601|FG000|Overall Study|Reason given as Other|0|||
164125714|NCT01173471|592822602|FG001|Overall Study|Reason given as Other|0|||
164125715|NCT01173471|592822603|FG002|Overall Study|Reason given as Other|1|||
164125716|NCT01173471|592822604|FG003|Overall Study|Reason given as Other|0|||
164125717|NCT03028740|592822606|FG000|Overall Study|Did not Receive Study Drug|4|||
164125718|NCT03028740|592822607|FG001|Overall Study|Did not Receive Study Drug|5|||
164125719|NCT03028740|592822606|FG000|Overall Study|Adverse Event|8|||
164125720|NCT03028740|592822607|FG001|Overall Study|Adverse Event|26|||
164125721|NCT03028740|592822606|FG000|Overall Study|Lack of Efficacy|0|||
164125722|NCT03028740|592822607|FG001|Overall Study|Lack of Efficacy|1|||
164125723|NCT03028740|592822606|FG000|Overall Study|Withdrawal by Subject|48|||
164125724|NCT03028740|592822607|FG001|Overall Study|Withdrawal by Subject|101|||
164125725|NCT03028740|592822606|FG000|Overall Study|Lost to Follow-up|30|||
164125726|NCT03028740|592822607|FG001|Overall Study|Lost to Follow-up|54|||
164125727|NCT03028740|592822606|FG000|Overall Study|Physician Decision|4|||
164125728|NCT03028740|592822607|FG001|Overall Study|Physician Decision|11|||
164125729|NCT03028740|592822606|FG000|Overall Study|Protocol Violation|4|||
164125730|NCT03028740|592822607|FG001|Overall Study|Protocol Violation|8|||
164125731|NCT03028740|592822606|FG000|Overall Study|Non-compliance with Study Drug|0|||
164125732|NCT03028740|592822607|FG001|Overall Study|Non-compliance with Study Drug|2|||
164125733|NCT03028740|592822606|FG000|Overall Study|Study Terminated by Sponsor|467|||
164125734|NCT03028740|592822607|FG001|Overall Study|Study Terminated by Sponsor|917|||
164125735|NCT03028740|592822606|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
164125736|NCT03028740|592822607|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
164125737|NCT03028740|592822606|FG000|Overall Study|Reason not Specified|1|||
164125738|NCT03028740|592822607|FG001|Overall Study|Reason not Specified|5|||
164125739|NCT00252174|592822608|FG000|Overall Study|Withdrawal by Subject|0|||
164125740|NCT00252174|592822609|FG001|Overall Study|Withdrawal by Subject|1|||
164125741|NCT00252174|592822610|FG002|Overall Study|Withdrawal by Subject|0|||
164125742|NCT01138826|592822611|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
164125743|NCT01138826|592822612|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
164125744|NCT01138826|592822613|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
164125745|NCT01138826|592822614|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
164125746|NCT01138826|592822615|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
164125747|NCT01138826|592822616|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
164125748|NCT02566993|592822617|FG000|Overall Study|Randomized but not treated|5|||
164125749|NCT02566993|592822618|FG001|Overall Study|Randomized but not treated|16|||
164125750|NCT02566993|592822617|FG000|Overall Study|Progressive disease|213|||
164125751|NCT02566993|592822618|FG001|Overall Study|Progressive disease|152|||
164125752|NCT02566993|592822617|FG000|Overall Study|Withdrawal by Subject|12|||
164125753|NCT02566993|592822618|FG001|Overall Study|Withdrawal by Subject|28|||
164125754|NCT02566993|592822617|FG000|Overall Study|Death|17|||
164125755|NCT02566993|592822618|FG001|Overall Study|Death|23|||
164125756|NCT02566993|592822617|FG000|Overall Study|Physician Decision|10|||
164125757|NCT02566993|592822618|FG001|Overall Study|Physician Decision|17|||
164125758|NCT02566993|592822617|FG000|Overall Study|Study drug-related adverse event|20|||
164125759|NCT02566993|592822618|FG001|Overall Study|Study drug-related adverse event|41|||
164125760|NCT02566993|592822617|FG000|Overall Study|Non study drug-related adverse event|9|||
164125761|NCT02566993|592822618|FG001|Overall Study|Non study drug-related adverse event|9|||
164125762|NCT02566993|592822617|FG000|Overall Study|Symptomatic deterioration|9|||
164125763|NCT02566993|592822618|FG001|Overall Study|Symptomatic deterioration|16|||
164125764|NCT02566993|592822617|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
164125765|NCT02566993|592822618|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
164125766|NCT02566993|592822617|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
164125767|NCT02566993|592822618|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
164125768|NCT02566993|592822617|FG000|Overall Study|Screening failure|2|||
164125769|NCT02566993|592822618|FG001|Overall Study|Screening failure|0|||
164125770|NCT02566993|592822617|FG000|Overall Study|Lost to Follow-up|0|||
164125771|NCT02566993|592822618|FG001|Overall Study|Lost to Follow-up|1|||
164125772|NCT02566993|592822617|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
164125773|NCT02566993|592822618|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
164125774|NCT05206448|592822619|FG000|Overall Study|Lost to Follow-up|2|||
164125775|NCT05206448|592822620|FG001|Overall Study|Lost to Follow-up|2|||
164125776|NCT05206448|592822619|FG000|Overall Study|Withdrawal by Subject|2|||
164125777|NCT05206448|592822620|FG001|Overall Study|Withdrawal by Subject|0|||
164125778|NCT05206448|592822619|FG000|Overall Study|found ineligible after randomization|1|||
164125779|NCT05206448|592822620|FG001|Overall Study|found ineligible after randomization|1|||
164125780|NCT05206448|592822619|FG000|Overall Study|unable to complete study due to personal constraints|1|||
164125781|NCT05206448|592822620|FG001|Overall Study|unable to complete study due to personal constraints|0|||
164125782|NCT05206448|592822619|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
164125783|NCT05206448|592822620|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
164125784|NCT04572243|592822622|FG000|Core Study: 14 Weeks|Adverse Event|1|||
164125785|NCT04572243|592822623|FG001|Core Study: 14 Weeks|Adverse Event|2|||
164125786|NCT04572243|592822624|FG002|Core Study: 14 Weeks|Adverse Event|0|||
164125787|NCT04572243|592822625|FG003|Core Study: 14 Weeks|Adverse Event|0|||
164125788|NCT04572243|592822622|FG000|Core Study: 14 Weeks|Subject choice|0|||
164125789|NCT04572243|592822623|FG001|Core Study: 14 Weeks|Subject choice|2|||
164125790|NCT04572243|592822624|FG002|Core Study: 14 Weeks|Subject choice|0|||
164125791|NCT04572243|592822625|FG003|Core Study: 14 Weeks|Subject choice|0|||
164125792|NCT04572243|592822622|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
164125793|NCT04572243|592822623|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
164125794|NCT04572243|592822624|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
164125795|NCT04572243|592822625|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
164125796|NCT04572243|592822622|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
164125797|NCT04572243|592822623|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
164125798|NCT04572243|592822624|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
164125799|NCT04572243|592822625|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
164125800|NCT01661881|592822626|FG000|Overall Study|Disease Progression|1|||
164125801|NCT01790113|592822627|FG000|Overall Study|Adverse Event|2|||
164125802|NCT01790113|592822628|FG001|Overall Study|Adverse Event|7|||
164125803|NCT01790113|592822627|FG000|Overall Study|Study ended due to FDA clearance|1|||
164125804|NCT01790113|592822628|FG001|Overall Study|Study ended due to FDA clearance|68|||
164125805|NCT00775606|592822629|FG000|Overall Study|Study sponsor terminated funding|3|||
164125806|NCT00775606|592822630|FG001|Overall Study|Study sponsor terminated funding|0|||
164125807|NCT02278718|592822631|FG000|Overall Study|Adverse Event|1|||
164125808|NCT02278718|592822632|FG001|Overall Study|Adverse Event|0|||
164125809|NCT02278718|592822631|FG000|Overall Study|Lost to Follow-up|2|||
164125810|NCT02278718|592822632|FG001|Overall Study|Lost to Follow-up|4|||
164125811|NCT02278718|592822631|FG000|Overall Study|Withdrawal by Subject|1|||
164125812|NCT02278718|592822632|FG001|Overall Study|Withdrawal by Subject|4|||
164125813|NCT02278718|592822631|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
164125814|NCT02278718|592822632|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
164125815|NCT02278718|592822631|FG000|Overall Study|Missing|0|||
164125816|NCT02278718|592822632|FG001|Overall Study|Missing|1|||
164125817|NCT04440449|592822633|FG000|Overall Study|Lost to Follow-up|2|||
164125818|NCT04440449|592822634|FG001|Overall Study|Lost to Follow-up|0|||
164125819|NCT02547766|592822635|FG000|Overall Study|Withdrawal by Subject|1|||
164125820|NCT03212794|592822636|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
164125821|NCT03212794|592822637|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
164125822|NCT03212794|592822636|FG000|Overall Study|Lost to Follow-up|5|||
164125823|NCT03212794|592822637|FG001|Overall Study|Lost to Follow-up|6|||
164125824|NCT03212794|592822636|FG000|Overall Study|Incarcerated; unable to participate|2|||
164125825|NCT03212794|592822637|FG001|Overall Study|Incarcerated; unable to participate|0|||
164125826|NCT03212794|592822636|FG000|Overall Study|Withdrawal by Subject|1|||
164125827|NCT03212794|592822637|FG001|Overall Study|Withdrawal by Subject|0|||
164125828|NCT03212794|592822636|FG000|Overall Study|Death|0|||
164125829|NCT03212794|592822637|FG001|Overall Study|Death|1|||
164125830|NCT03212794|592822636|FG000|Overall Study|Found to be ineligible after allocation|0|||
164125831|NCT03212794|592822637|FG001|Overall Study|Found to be ineligible after allocation|1|||
164125832|NCT03212794|592822636|FG000|Overall Study|Relocated out of area|2|||
164125833|NCT03212794|592822637|FG001|Overall Study|Relocated out of area|0|||
164125834|NCT01144403|592822643|FG000|Overall Study|Lost to Follow-up|3|||
164125835|NCT01144403|592822643|FG000|Overall Study|Death|1|||
164125836|NCT01144403|592822643|FG000|Overall Study|Adverse Event|1|||
164125837|NCT02903238|592822647|FG000|Overall Study|Lost to Follow-up|4|||
164125838|NCT02777918|592822648|FG000|Overall Study|Medical reasons|1|||
164125839|NCT02777918|592822649|FG001|Overall Study|Medical reasons|2|||
164125840|NCT02777918|592822648|FG000|Overall Study|Too busy / stressed|1|||
164125841|NCT02777918|592822649|FG001|Overall Study|Too busy / stressed|1|||
164125842|NCT02777918|592822648|FG000|Overall Study|Withdrawal by Subject|1|||
164125843|NCT02777918|592822649|FG001|Overall Study|Withdrawal by Subject|1|||
164125844|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
164125845|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
164125846|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
164125847|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
164125848|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
164125849|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
164125850|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
164125851|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
164125852|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
164125853|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
164125854|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
164125855|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
164125856|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
164125857|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
164125858|NCT02510014|592822655|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
164125859|NCT02510014|592822656|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
164125860|NCT02510014|592822655|FG000|Treatment Period|Adverse Event|11|||
164125861|NCT02510014|592822656|FG001|Treatment Period|Adverse Event|4|||
164125862|NCT02510014|592822655|FG000|Treatment Period|Withdrawal symptoms|3|||
164125863|NCT02510014|592822656|FG001|Treatment Period|Withdrawal symptoms|0|||
164125864|NCT02510014|592822655|FG000|Treatment Period|Lost to Follow-up|80|||
164125865|NCT02510014|592822656|FG001|Treatment Period|Lost to Follow-up|19|||
164125866|NCT02510014|592822655|FG000|Treatment Period|Physician Decision|5|||
164125867|NCT02510014|592822656|FG001|Treatment Period|Physician Decision|0|||
164125868|NCT02510014|592822655|FG000|Treatment Period|Withdrawal by Subject|67|||
164125869|NCT02510014|592822656|FG001|Treatment Period|Withdrawal by Subject|24|||
164125870|NCT02510014|592822655|FG000|Treatment Period|Withdrawn by the investigator|7|||
164125871|NCT02510014|592822656|FG001|Treatment Period|Withdrawn by the investigator|1|||
164125872|NCT02510014|592822655|FG000|Treatment Period|Protocol Violation|4|||
164125873|NCT02510014|592822656|FG001|Treatment Period|Protocol Violation|4|||
164125874|NCT02510014|592822655|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
164125875|NCT02510014|592822656|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
164125876|NCT04179019|592822658|FG000|Overall Study|Lost to Follow-up|2|||
164125877|NCT04179019|592822658|FG000|Overall Study|Physician Decision|2|||
164125878|NCT04179019|592822658|FG000|Overall Study|Withdrawal by Subject|5|||
164125879|NCT04179019|592822658|FG000|Overall Study|Adverse Event|4|||
164125880|NCT01949116|592822659|FG000|Overall Study|Death|2|||
164125881|NCT01949116|592822660|FG001|Overall Study|Death|0|||
164125882|NCT01949116|592822659|FG000|Overall Study|Lost to Follow-up|1|||
164125883|NCT01949116|592822660|FG001|Overall Study|Lost to Follow-up|3|||
164125884|NCT01949116|592822659|FG000|Overall Study|Withdrawal by Subject|5|||
164125885|NCT01949116|592822660|FG001|Overall Study|Withdrawal by Subject|3|||
164125886|NCT00307931|592822671|FG000|Overall Study|Adverse Event|1|||
164125887|NCT00233987|592822676|FG000|Overall Study|Withdrawal by Subject|1|||
164125888|NCT00233987|592822676|FG000|Overall Study|Lack of Efficacy|2|||
164125889|NCT00233987|592822676|FG000|Overall Study|Reason Under Review|1|||
164125890|NCT00233987|592822676|FG000|Overall Study|Other - Not Protocol Specified|5|||
164125891|NCT00233987|592822676|FG000|Overall Study|Eligible but No Treatment Received|2|||
164125892|NCT00233987|592822676|FG000|Overall Study|Ineligible|4|||
164125893|NCT04553913|592822679|FG000|Overall Study|patient's block resolved prior to PACU|1|||
164125894|NCT04553913|592822679|FG000|Overall Study|did not use the device properly|5|||
164125895|NCT01481324|592822680|FG000|Overall Study|Missing Data|0|||
164125896|NCT01481324|592822681|FG001|Overall Study|Missing Data|2|||
164125897|NCT01481324|592822682|FG002|Overall Study|Missing Data|2|||
164125898|NCT04846881|592822685|FG000|Overall Study|Adverse Event|14|||
164125899|NCT04846881|592822686|FG001|Overall Study|Adverse Event|15|||
164125900|NCT04846881|592822685|FG000|Overall Study|Burden of study procedures|7|||
164125901|NCT04846881|592822686|FG001|Overall Study|Burden of study procedures|3|||
164125902|NCT04846881|592822685|FG000|Overall Study|Protocol deviation|6|||
164125903|NCT04846881|592822686|FG001|Overall Study|Protocol deviation|4|||
164125904|NCT04846881|592822685|FG000|Overall Study|Perceived lack of efficacy|5|||
164125905|NCT04846881|592822686|FG001|Overall Study|Perceived lack of efficacy|2|||
164125906|NCT04846881|592822685|FG000|Overall Study|Change of residence|2|||
164125907|NCT04846881|592822686|FG001|Overall Study|Change of residence|0|||
164125908|NCT04846881|592822685|FG000|Overall Study|Technical problems|0|||
164125909|NCT04846881|592822686|FG001|Overall Study|Technical problems|1|||
164125910|NCT04846881|592822685|FG000|Overall Study|Other than listed|3|||
164125911|NCT04846881|592822686|FG001|Overall Study|Other than listed|10|||
164125912|NCT04846881|592822685|FG000|Overall Study|No reason available|1|||
164125913|NCT04846881|592822686|FG001|Overall Study|No reason available|3|||
164125914|NCT04846881|592822685|FG000|Overall Study|Patient randomised in error|1|||
164125915|NCT04846881|592822686|FG001|Overall Study|Patient randomised in error|0|||
164125916|NCT04560998|592822687|FG000|Overall Study|Withdrawal by Subject|18|||
164125917|NCT04560998|592822688|FG001|Overall Study|Withdrawal by Subject|12|||
164125918|NCT04560998|592822687|FG000|Overall Study|Lost to Follow-up|8|||
164125919|NCT04560998|592822688|FG001|Overall Study|Lost to Follow-up|5|||
164125920|NCT04560998|592822687|FG000|Overall Study|Physician Decision|4|||
164125921|NCT04560998|592822688|FG001|Overall Study|Physician Decision|0|||
164125922|NCT01000610|592824492|FG000|Overall Study|Adverse Event|1|||
164125923|NCT01000610|592824492|FG000|Overall Study|Lost to Follow-up|4|||
164125924|NCT01000610|592824492|FG000|Overall Study|Treatment failure|1|||
164125925|NCT01010126|592824493|FG000|Overall Study|Withdrawal by Subject|1|||
164125926|NCT01010126|592824494|FG001|Overall Study|Withdrawal by Subject|0|||
164125927|NCT01010126|592824495|FG002|Overall Study|Withdrawal by Subject|1|||
164125928|NCT01010126|592824496|FG003|Overall Study|Withdrawal by Subject|0|||
164125929|NCT01010126|592824497|FG004|Overall Study|Withdrawal by Subject|3|||
164125930|NCT01010126|592824498|FG005|Overall Study|Withdrawal by Subject|0|||
164125931|NCT04495283|592824501|FG000|Overall Study|Physician Decision|0|||
164125932|NCT04495283|592824502|FG001|Overall Study|Physician Decision|0|||
164125933|NCT04495283|592824503|FG002|Overall Study|Physician Decision|1|||
164125934|NCT04495283|592824501|FG000|Overall Study|Withdrawal by Subject|0|||
164125935|NCT04495283|592824502|FG001|Overall Study|Withdrawal by Subject|1|||
164125936|NCT04495283|592824503|FG002|Overall Study|Withdrawal by Subject|1|||
164125937|NCT04495283|592824501|FG000|Overall Study|Other|1|||
164125938|NCT04495283|592824502|FG001|Overall Study|Other|0|||
164125939|NCT04495283|592824503|FG002|Overall Study|Other|1|||
164125940|NCT03341000|592824517|FG000|Overall Study|Adverse Event|1|||
164125941|NCT02698865|592824519|FG000|Overall Study|Other|11|||
164125942|NCT02698865|592824520|FG001|Overall Study|Other|11|||
164125943|NCT02698865|592824519|FG000|Overall Study|Withdrawal by Subject|20|||
164125944|NCT02698865|592824520|FG001|Overall Study|Withdrawal by Subject|16|||
164125945|NCT02698865|592824519|FG000|Overall Study|Physician Decision|0|||
164125946|NCT02698865|592824520|FG001|Overall Study|Physician Decision|4|||
164125947|NCT02698865|592824519|FG000|Overall Study|Lost to Follow-up|4|||
164125948|NCT02698865|592824520|FG001|Overall Study|Lost to Follow-up|2|||
164125949|NCT02177136|592824524|FG000|DB Phase|Withdrawal by Subject|2|||
164125950|NCT02177136|592824525|FG001|DB Phase|Withdrawal by Subject|0|||
164125951|NCT02177136|592824526|FG002|DB Phase|Withdrawal by Subject|0|||
164125952|NCT02177136|592824527|FG003|DB Phase|Withdrawal by Subject|0|||
164125953|NCT02177136|592824524|FG000|DB Phase|Discontinued Due to Pruritus|1|||
164125954|NCT02177136|592824525|FG001|DB Phase|Discontinued Due to Pruritus|3|||
164125955|NCT02177136|592824526|FG002|DB Phase|Discontinued Due to Pruritus|0|||
164125956|NCT02177136|592824527|FG003|DB Phase|Discontinued Due to Pruritus|0|||
164125957|NCT02177136|592824524|FG000|DB Phase|Adverse Event|3|||
164125958|NCT02177136|592824525|FG001|DB Phase|Adverse Event|2|||
164125959|NCT02177136|592824526|FG002|DB Phase|Adverse Event|3|||
164125960|NCT02177136|592824527|FG003|DB Phase|Adverse Event|0|||
164125961|NCT02177136|592824524|FG000|DB Phase|Protocol Violation|0|||
164125962|NCT02177136|592824525|FG001|DB Phase|Protocol Violation|0|||
164125963|NCT02177136|592824526|FG002|DB Phase|Protocol Violation|1|||
164125964|NCT02177136|592824527|FG003|DB Phase|Protocol Violation|0|||
164125965|NCT02177136|592824524|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
164125966|NCT02177136|592824525|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
164125967|NCT02177136|592824526|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
164125968|NCT02177136|592824527|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
164125969|NCT02177136|592824524|FG000|LTSE Phase|Withdrawal by Subject|0|||
164125970|NCT02177136|592824525|FG001|LTSE Phase|Withdrawal by Subject|0|||
164125971|NCT02177136|592824526|FG002|LTSE Phase|Withdrawal by Subject|0|||
164125972|NCT02177136|592824527|FG003|LTSE Phase|Withdrawal by Subject|6|||
164125973|NCT02177136|592824524|FG000|LTSE Phase|Adverse Event|0|||
164125974|NCT02177136|592824525|FG001|LTSE Phase|Adverse Event|0|||
164125975|NCT02177136|592824526|FG002|LTSE Phase|Adverse Event|0|||
164125976|NCT02177136|592824527|FG003|LTSE Phase|Adverse Event|10|||
164125977|NCT02177136|592824524|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
164125978|NCT02177136|592824525|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
164125979|NCT02177136|592824526|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
164125980|NCT02177136|592824527|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
164125981|NCT02177136|592824524|FG000|LTSE Phase|Physician Decision|0|||
164125982|NCT02177136|592824525|FG001|LTSE Phase|Physician Decision|0|||
164125983|NCT02177136|592824526|FG002|LTSE Phase|Physician Decision|0|||
164125984|NCT02177136|592824527|FG003|LTSE Phase|Physician Decision|2|||
164125985|NCT02177136|592824524|FG000|LTSE Phase|Lost to Follow-up|0|||
164125986|NCT02177136|592824525|FG001|LTSE Phase|Lost to Follow-up|0|||
164125987|NCT02177136|592824526|FG002|LTSE Phase|Lost to Follow-up|0|||
164125988|NCT02177136|592824527|FG003|LTSE Phase|Lost to Follow-up|1|||
164125989|NCT02177136|592824524|FG000|LTSE Phase|Participant Moved|0|||
164125990|NCT02177136|592824525|FG001|LTSE Phase|Participant Moved|0|||
164125991|NCT02177136|592824526|FG002|LTSE Phase|Participant Moved|0|||
164125992|NCT02177136|592824527|FG003|LTSE Phase|Participant Moved|1|||
164125993|NCT01386684|592824528|FG000|Overall Study|Lost to Follow-up|51|||
164125994|NCT01386684|592824528|FG000|Overall Study|Other|51|||
164125995|NCT01386684|592824528|FG000|Overall Study|Death|47|||
164125996|NCT01386684|592824528|FG000|Overall Study|Withdrawal of Consent|44|||
164125997|NCT01386684|592824528|FG000|Overall Study|Alternative Therapy Required|37|||
164125998|NCT01386684|592824528|FG000|Overall Study|Disease Progression|28|||
164125999|NCT01386684|592824528|FG000|Overall Study|Adverse Event|20|||
164126000|NCT01386684|592824528|FG000|Overall Study|Noncompliance|8|||
164126001|NCT01386684|592824528|FG000|Overall Study|Protocol Violation|4|||
164126002|NCT01386684|592824528|FG000|Overall Study|Missing|3|||
164126003|NCT02119286|592824534|FG000|Overall Study|Adverse Event|9|||
164126004|NCT02119286|592824535|FG001|Overall Study|Adverse Event|7|||
164126005|NCT02119286|592824536|FG002|Overall Study|Adverse Event|2|||
164126006|NCT02119286|592824534|FG000|Overall Study|Lack of Efficacy|11|||
164126007|NCT02119286|592824535|FG001|Overall Study|Lack of Efficacy|3|||
164126008|NCT02119286|592824536|FG002|Overall Study|Lack of Efficacy|4|||
164126009|NCT02119286|592824534|FG000|Overall Study|Lost to Follow-up|2|||
164126010|NCT02119286|592824535|FG001|Overall Study|Lost to Follow-up|0|||
164126011|NCT02119286|592824536|FG002|Overall Study|Lost to Follow-up|1|||
164126012|NCT02119286|592824534|FG000|Overall Study|Withdrawal by Subject|4|||
164126013|NCT02119286|592824535|FG001|Overall Study|Withdrawal by Subject|1|||
164126014|NCT02119286|592824536|FG002|Overall Study|Withdrawal by Subject|0|||
164126015|NCT04109313|592824537|FG000|Overall Study|Pregnancy|1|||
164126016|NCT04109313|592824537|FG000|Overall Study|Adverse Event|11|||
164126017|NCT04109313|592824537|FG000|Overall Study|Lack of Efficacy|11|||
164126018|NCT04109313|592824537|FG000|Overall Study|Lost to Follow-up|1|||
164126019|NCT04109313|592824537|FG000|Overall Study|Physician Decision|2|||
164126020|NCT04109313|592824537|FG000|Overall Study|Subject Decision|13|||
164126021|NCT04109313|592824537|FG000|Overall Study|Covid-19 situation|2|||
164126022|NCT02694549|592824538|FG000|Overall Study|screen failures|2|||
164126023|NCT01996332|592824541|FG000|Overall Study|Adverse Event|117|||
164126024|NCT01996332|592824541|FG000|Overall Study|Lack of Efficacy|1245|||
164126025|NCT01996332|592824541|FG000|Overall Study|Death|264|||
164126026|NCT01996332|592824541|FG000|Overall Study|Protocol Violation|9|||
164126027|NCT01996332|592824541|FG000|Overall Study|Withdrawal by Subject|71|||
164126028|NCT01996332|592824541|FG000|Overall Study|Other|20|||
164126029|NCT01996332|592824541|FG000|Overall Study|Clinical Deterioration|28|||
164126030|NCT01996332|592824541|FG000|Overall Study|Physician Decision|17|||
164126031|NCT01996332|592824541|FG000|Overall Study|Lost to Follow-up|34|||
164126032|NCT02113189|592824542|FG000|Overall Study|Lost to follow up|2|||
164126033|NCT02113189|592824543|FG001|Overall Study|Lost to follow up|1|||
164126034|NCT02113189|592824544|FG002|Overall Study|Lost to follow up|3|||
164126035|NCT00099268|592824547|FG000|Overall Study|Withdrawal by Subject|46|||
164126036|NCT00099268|592824548|FG001|Overall Study|Withdrawal by Subject|28|||
164126037|NCT00099268|592824547|FG000|Overall Study|Adverse Event|19|||
164126038|NCT00099268|592824548|FG001|Overall Study|Adverse Event|19|||
164126039|NCT00099268|592824547|FG000|Overall Study|Protocol Violation|9|||
164126040|NCT00099268|592824548|FG001|Overall Study|Protocol Violation|8|||
164126041|NCT00099268|592824547|FG000|Overall Study|Lost to Follow-up|6|||
164126042|NCT00099268|592824548|FG001|Overall Study|Lost to Follow-up|4|||
164126043|NCT00099268|592824547|FG000|Overall Study|Lack of Efficacy|5|||
164126044|NCT00099268|592824548|FG001|Overall Study|Lack of Efficacy|18|||
164126045|NCT00099268|592824547|FG000|Overall Study|Administrative problems|4|||
164126046|NCT00099268|592824548|FG001|Overall Study|Administrative problems|4|||
164126047|NCT00099268|592824547|FG000|Overall Study|Death|3|||
164126048|NCT00099268|592824548|FG001|Overall Study|Death|1|||
164126049|NCT03702049|592824549|FG000|Overall Study|Lost to Follow-up|4|||
164126050|NCT03702049|592824549|FG000|Overall Study|Physician Decision|1|||
164126051|NCT01763918|592824550|FG000|Overall Study|Withdrawal by Subject|2|||
164126052|NCT01763918|592824551|FG001|Overall Study|Withdrawal by Subject|1|||
164126053|NCT01763918|592824552|FG002|Overall Study|Withdrawal by Subject|1|||
164126054|NCT01763918|592824553|FG003|Overall Study|Withdrawal by Subject|2|||
164126055|NCT01763918|592824550|FG000|Overall Study|Sponsor Decision|4|||
164126056|NCT01763918|592824551|FG001|Overall Study|Sponsor Decision|0|||
164126057|NCT01763918|592824552|FG002|Overall Study|Sponsor Decision|9|||
164126058|NCT01763918|592824553|FG003|Overall Study|Sponsor Decision|0|||
164126059|NCT00897949|592824554|FG000|Overall Study|Adverse Event|1|||
164126060|NCT00897949|592824555|FG001|Overall Study|Adverse Event|1|||
164126061|NCT00897949|592824556|FG002|Overall Study|Adverse Event|0|||
164126062|NCT00897949|592824554|FG000|Overall Study|Lost to Follow-up|0|||
164126063|NCT00897949|592824555|FG001|Overall Study|Lost to Follow-up|2|||
164126064|NCT00897949|592824556|FG002|Overall Study|Lost to Follow-up|1|||
164126065|NCT00897949|592824554|FG000|Overall Study|Protocol Violation|6|||
164126066|NCT00897949|592824555|FG001|Overall Study|Protocol Violation|3|||
164126067|NCT00897949|592824556|FG002|Overall Study|Protocol Violation|1|||
164126068|NCT00897949|592824554|FG000|Overall Study|Withdrawal by Subject|1|||
164126069|NCT00897949|592824555|FG001|Overall Study|Withdrawal by Subject|2|||
164126070|NCT00897949|592824556|FG002|Overall Study|Withdrawal by Subject|0|||
164126071|NCT00897949|592824554|FG000|Overall Study|Patient Uncoorperative|0|||
164126072|NCT00897949|592824555|FG001|Overall Study|Patient Uncoorperative|2|||
164126073|NCT00897949|592824556|FG002|Overall Study|Patient Uncoorperative|1|||
164126074|NCT00897949|592824554|FG000|Overall Study|Lost to Follow-up|30|||
164073496|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073497|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164073498|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073499|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073500|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073501|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
164073502|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164073503|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
164073504|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164073505|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
164073506|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
164073507|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
164073508|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073509|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073510|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073511|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073512|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
164073513|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073514|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073515|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073516|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073517|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073518|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073519|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073520|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073521|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
164073522|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073523|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073524|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
164073525|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
164073526|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073527|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073528|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073529|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073530|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073531|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073532|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073533|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073534|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073535|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073536|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164073537|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073538|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073539|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164073540|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073541|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073542|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164073543|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
164073544|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
164073545|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164073546|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
164073547|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073548|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164073549|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073550|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073551|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164073552|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073553|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164126075|NCT00897949|592824555|FG001|Overall Study|Lost to Follow-up|23|||
164126076|NCT00897949|592824556|FG002|Overall Study|Lost to Follow-up|17|||
164126077|NCT00897949|592824554|FG000|Overall Study|Withdrawal by Subject|24|||
164126078|NCT00897949|592824555|FG001|Overall Study|Withdrawal by Subject|31|||
164126079|NCT00897949|592824556|FG002|Overall Study|Withdrawal by Subject|17|||
164126080|NCT00897949|592824554|FG000|Overall Study|Abnormal Prestudy Labs|2|||
164126081|NCT00897949|592824555|FG001|Overall Study|Abnormal Prestudy Labs|3|||
164126082|NCT00897949|592824556|FG002|Overall Study|Abnormal Prestudy Labs|4|||
164126083|NCT00897949|592824554|FG000|Overall Study|Abnormal Baseline ECG|2|||
164126084|NCT00897949|592824555|FG001|Overall Study|Abnormal Baseline ECG|2|||
164126085|NCT00897949|592824556|FG002|Overall Study|Abnormal Baseline ECG|4|||
164126086|NCT00897949|592824554|FG000|Overall Study|Need for Concom. Med.|0|||
164126087|NCT00897949|592824555|FG001|Overall Study|Need for Concom. Med.|1|||
164126088|NCT00897949|592824556|FG002|Overall Study|Need for Concom. Med.|1|||
164126089|NCT00897949|592824554|FG000|Overall Study|Lack of Migraine Attack|29|||
164126090|NCT00897949|592824555|FG001|Overall Study|Lack of Migraine Attack|30|||
164126091|NCT00897949|592824556|FG002|Overall Study|Lack of Migraine Attack|19|||
164126092|NCT00897949|592824554|FG000|Overall Study|Did not take study drug|9|||
164126093|NCT00897949|592824555|FG001|Overall Study|Did not take study drug|3|||
164126094|NCT00897949|592824556|FG002|Overall Study|Did not take study drug|4|||
164126095|NCT01553747|592824557|FG000|Overall Study|Protocol Violation|0|||
164126096|NCT01553747|592824558|FG001|Overall Study|Protocol Violation|2|||
164126097|NCT01553747|592824559|FG002|Overall Study|Protocol Violation|0|||
164126098|NCT01553747|592824557|FG000|Overall Study|Voluntarily withdrew|70|||
164126099|NCT01553747|592824558|FG001|Overall Study|Voluntarily withdrew|66|||
164126100|NCT01553747|592824559|FG002|Overall Study|Voluntarily withdrew|74|||
164126101|NCT01553747|592824557|FG000|Overall Study|Adverse event or SAE|32|||
164126102|NCT01553747|592824558|FG001|Overall Study|Adverse event or SAE|28|||
164126103|NCT01553747|592824559|FG002|Overall Study|Adverse event or SAE|19|||
164126104|NCT01553747|592824557|FG000|Overall Study|Physician decision: other|10|||
164126105|NCT01553747|592824558|FG001|Overall Study|Physician decision: other|8|||
164126106|NCT01553747|592824559|FG002|Overall Study|Physician decision: other|7|||
164126107|NCT01553747|592824557|FG000|Overall Study|Lost to Follow-up|11|||
164126108|NCT01553747|592824558|FG001|Overall Study|Lost to Follow-up|5|||
164126109|NCT01553747|592824559|FG002|Overall Study|Lost to Follow-up|6|||
164126110|NCT01553747|592824557|FG000|Overall Study|Sponsor decision, specify|7|||
164126111|NCT01553747|592824558|FG001|Overall Study|Sponsor decision, specify|5|||
164126112|NCT01553747|592824559|FG002|Overall Study|Sponsor decision, specify|0|||
164126113|NCT01553747|592824557|FG000|Overall Study|Physician decision: lack of efficacy|1|||
164126114|NCT01553747|592824558|FG001|Overall Study|Physician decision: lack of efficacy|5|||
164126115|NCT01553747|592824559|FG002|Overall Study|Physician decision: lack of efficacy|3|||
164126116|NCT00102687|592824560|FG000|Initial Period|Withdrawal by Subject|6|||
164126117|NCT00102687|592824561|FG001|Initial Period|Withdrawal by Subject|3|||
164126118|NCT00102687|592824562|FG002|Initial Period|Withdrawal by Subject|5|||
164126119|NCT00102687|592824563|FG003|Initial Period|Withdrawal by Subject|0|||
164126120|NCT00102687|592824564|FG004|Initial Period|Withdrawal by Subject|0|||
164126121|NCT00102687|592824560|FG000|Initial Period|Adverse Event|4|||
164126122|NCT00102687|592824561|FG001|Initial Period|Adverse Event|7|||
164126123|NCT00102687|592824562|FG002|Initial Period|Adverse Event|9|||
164126124|NCT00102687|592824563|FG003|Initial Period|Adverse Event|0|||
164126125|NCT00102687|592824564|FG004|Initial Period|Adverse Event|0|||
164126126|NCT00102687|592824560|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
164126127|NCT00102687|592824561|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
164126128|NCT00102687|592824562|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
164126129|NCT00102687|592824563|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
164126130|NCT00102687|592824564|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
164126131|NCT00102687|592824560|FG000|Initial Period|Protocol Violation|0|||
164126132|NCT00102687|592824561|FG001|Initial Period|Protocol Violation|0|||
164126133|NCT00102687|592824562|FG002|Initial Period|Protocol Violation|2|||
164126134|NCT00102687|592824563|FG003|Initial Period|Protocol Violation|0|||
164126135|NCT00102687|592824564|FG004|Initial Period|Protocol Violation|0|||
164126136|NCT00102687|592824560|FG000|Initial Period|Physician Decision|2|||
164126137|NCT00102687|592824561|FG001|Initial Period|Physician Decision|9|||
164126138|NCT00102687|592824562|FG002|Initial Period|Physician Decision|6|||
164126139|NCT00102687|592824563|FG003|Initial Period|Physician Decision|0|||
164126140|NCT00102687|592824564|FG004|Initial Period|Physician Decision|0|||
164126141|NCT00102687|592824560|FG000|Initial Period|Sponsor's decision|0|||
164126142|NCT00102687|592824561|FG001|Initial Period|Sponsor's decision|1|||
164126143|NCT00102687|592824562|FG002|Initial Period|Sponsor's decision|1|||
164126144|NCT00102687|592824563|FG003|Initial Period|Sponsor's decision|0|||
164126145|NCT00102687|592824564|FG004|Initial Period|Sponsor's decision|0|||
164126146|NCT00102687|592824560|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
164126147|NCT00102687|592824561|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
164126148|NCT00102687|592824562|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
164126149|NCT00102687|592824563|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
164132684|NCT01986010|592850663|FG008|Overall Study|Lost to Follow-up|4|||
164126150|NCT00102687|592824564|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
164126151|NCT00102687|592824560|FG000|Initial Period|Death|1|||
164126152|NCT00102687|592824561|FG001|Initial Period|Death|1|||
164126153|NCT00102687|592824562|FG002|Initial Period|Death|1|||
164126154|NCT00102687|592824563|FG003|Initial Period|Death|0|||
164126155|NCT00102687|592824564|FG004|Initial Period|Death|0|||
164126156|NCT00102687|592824560|FG000|Maintenance Period|Withdrawal by Subject|4|||
164126157|NCT00102687|592824561|FG001|Maintenance Period|Withdrawal by Subject|0|||
164126158|NCT00102687|592824562|FG002|Maintenance Period|Withdrawal by Subject|2|||
164126159|NCT00102687|592824563|FG003|Maintenance Period|Withdrawal by Subject|3|||
164126160|NCT00102687|592824564|FG004|Maintenance Period|Withdrawal by Subject|1|||
164126161|NCT00102687|592824560|FG000|Maintenance Period|Adverse Event|1|||
164126162|NCT00102687|592824561|FG001|Maintenance Period|Adverse Event|0|||
164126163|NCT00102687|592824562|FG002|Maintenance Period|Adverse Event|0|||
164126164|NCT00102687|592824563|FG003|Maintenance Period|Adverse Event|1|||
164126165|NCT00102687|592824564|FG004|Maintenance Period|Adverse Event|3|||
164126166|NCT00102687|592824560|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
164126167|NCT00102687|592824561|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
164126168|NCT00102687|592824562|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
164126169|NCT00102687|592824563|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
164126170|NCT00102687|592824564|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
164126171|NCT00102687|592824560|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
164126172|NCT00102687|592824561|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
164126173|NCT00102687|592824562|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
164126174|NCT00102687|592824563|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
164126175|NCT00102687|592824564|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
164126176|NCT00102687|592824560|FG000|Maintenance Period|Death|0|||
164126177|NCT00102687|592824561|FG001|Maintenance Period|Death|0|||
164126178|NCT00102687|592824562|FG002|Maintenance Period|Death|0|||
164126179|NCT00102687|592824563|FG003|Maintenance Period|Death|1|||
164126180|NCT00102687|592824564|FG004|Maintenance Period|Death|1|||
164126181|NCT00102687|592824560|FG000|Maintenance Period|Physician Decision|1|||
164126182|NCT00102687|592824561|FG001|Maintenance Period|Physician Decision|2|||
164126183|NCT00102687|592824562|FG002|Maintenance Period|Physician Decision|3|||
164126184|NCT00102687|592824563|FG003|Maintenance Period|Physician Decision|0|||
164126185|NCT00102687|592824564|FG004|Maintenance Period|Physician Decision|4|||
164126186|NCT03253744|592824570|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
164126187|NCT03253744|592824571|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
164126188|NCT03253744|592824572|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
164126189|NCT03253744|592824573|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
164126190|NCT06279871|592824574|FG000|Overall Study|Death|0|||
164126191|NCT06279871|592824575|FG001|Overall Study|Death|0|||
164126192|NCT06279871|592824576|FG002|Overall Study|Death|0|||
164126193|NCT06279871|592824577|FG003|Overall Study|Death|0|||
164126194|NCT06279871|592824578|FG004|Overall Study|Death|0|||
164126195|NCT06279871|592824579|FG005|Overall Study|Death|1|||
164126196|NCT06279871|592824580|FG006|Overall Study|Death|0|||
164126197|NCT06279871|592824574|FG000|Overall Study|Other than Specified|1|||
164126198|NCT06279871|592824575|FG001|Overall Study|Other than Specified|0|||
164126199|NCT06279871|592824576|FG002|Overall Study|Other than Specified|4|||
164126200|NCT06279871|592824577|FG003|Overall Study|Other than Specified|0|||
164126201|NCT06279871|592824578|FG004|Overall Study|Other than Specified|0|||
164126202|NCT06279871|592824579|FG005|Overall Study|Other than Specified|0|||
164126203|NCT06279871|592824580|FG006|Overall Study|Other than Specified|0|||
164126204|NCT06279871|592824574|FG000|Overall Study|Withdrawal by Subject|4|||
164126205|NCT06279871|592824575|FG001|Overall Study|Withdrawal by Subject|8|||
164126206|NCT06279871|592824576|FG002|Overall Study|Withdrawal by Subject|4|||
164126207|NCT06279871|592824577|FG003|Overall Study|Withdrawal by Subject|2|||
164126208|NCT06279871|592824578|FG004|Overall Study|Withdrawal by Subject|0|||
164126209|NCT06279871|592824579|FG005|Overall Study|Withdrawal by Subject|0|||
164126210|NCT06279871|592824580|FG006|Overall Study|Withdrawal by Subject|0|||
164126211|NCT06279871|592824574|FG000|Overall Study|Lost to Follow-up|11|||
164126212|NCT06279871|592824575|FG001|Overall Study|Lost to Follow-up|10|||
164126213|NCT06279871|592824576|FG002|Overall Study|Lost to Follow-up|8|||
164126214|NCT06279871|592824577|FG003|Overall Study|Lost to Follow-up|0|||
164126215|NCT06279871|592824578|FG004|Overall Study|Lost to Follow-up|0|||
164126216|NCT06279871|592824579|FG005|Overall Study|Lost to Follow-up|0|||
164126217|NCT06279871|592824580|FG006|Overall Study|Lost to Follow-up|0|||
164126218|NCT06279871|592824574|FG000|Overall Study|Adverse Event|0|||
164126219|NCT06279871|592824575|FG001|Overall Study|Adverse Event|1|||
164126220|NCT06279871|592824576|FG002|Overall Study|Adverse Event|0|||
164126221|NCT06279871|592824577|FG003|Overall Study|Adverse Event|0|||
164126222|NCT06279871|592824578|FG004|Overall Study|Adverse Event|0|||
164126223|NCT06279871|592824579|FG005|Overall Study|Adverse Event|0|||
164126224|NCT06279871|592824580|FG006|Overall Study|Adverse Event|0|||
164126225|NCT03739138|592824589|FG000|Overall Study|Death|0|||
164126226|NCT03739138|592824590|FG001|Overall Study|Death|7|||
164126227|NCT03739138|592824591|FG002|Overall Study|Death|4|||
164126228|NCT03739138|592824592|FG003|Overall Study|Death|13|||
164126229|NCT03739138|592824593|FG004|Overall Study|Death|0|||
164126230|NCT03739138|592824589|FG000|Overall Study|Lost to Follow-up|0|||
164126231|NCT03739138|592824590|FG001|Overall Study|Lost to Follow-up|0|||
164126232|NCT03739138|592824591|FG002|Overall Study|Lost to Follow-up|1|||
164126233|NCT03739138|592824592|FG003|Overall Study|Lost to Follow-up|0|||
164126234|NCT03739138|592824593|FG004|Overall Study|Lost to Follow-up|0|||
164126235|NCT03739138|592824589|FG000|Overall Study|Study Terminated By Sponsor|0|||
164126236|NCT03739138|592824590|FG001|Overall Study|Study Terminated By Sponsor|0|||
164126237|NCT03739138|592824591|FG002|Overall Study|Study Terminated By Sponsor|0|||
164126238|NCT03739138|592824592|FG003|Overall Study|Study Terminated By Sponsor|4|||
164126239|NCT03739138|592824593|FG004|Overall Study|Study Terminated By Sponsor|0|||
164126240|NCT03739138|592824589|FG000|Overall Study|Withdrawal by Subject|0|||
164126241|NCT03739138|592824590|FG001|Overall Study|Withdrawal by Subject|0|||
164126242|NCT03739138|592824591|FG002|Overall Study|Withdrawal by Subject|0|||
164126243|NCT03739138|592824592|FG003|Overall Study|Withdrawal by Subject|1|||
164126244|NCT03739138|592824593|FG004|Overall Study|Withdrawal by Subject|0|||
164126245|NCT01056640|592824594|FG000|Overall Study|Withdrawal by Subject|11|||
164126246|NCT01056640|592824595|FG001|Overall Study|Withdrawal by Subject|8|||
164126247|NCT01056640|592824594|FG000|Overall Study|Death|15|||
164126248|NCT01056640|592824595|FG001|Overall Study|Death|4|||
164126249|NCT01803269|592824596|FG000|Overall Study|Withdrawal by Subject|3|||
164126250|NCT01803269|592824597|FG001|Overall Study|Withdrawal by Subject|0|||
164126251|NCT01803269|592824598|FG002|Overall Study|Withdrawal by Subject|0|||
164126252|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
164126253|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
164126254|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
164126255|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
164126256|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
164126257|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
164126258|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
164126259|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
164126260|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
164126261|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
164126262|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Subject decision|1|||
164126263|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Subject decision|1|||
164126264|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
164126265|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
164126266|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
164126267|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
164126268|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
164126269|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
164126270|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
164126271|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
164126272|NCT00518882|592824601|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
164126273|NCT00518882|592824602|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
164126274|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
164126275|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
164126276|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
164126277|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
164126278|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
164126279|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
164126280|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
164126281|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
164126282|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
164126283|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
164126284|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
164126285|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
164126286|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
164126287|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
164126288|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
164126289|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
164126290|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
164126291|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
164126292|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
164126293|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
164126294|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
164126295|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
164126296|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
164126297|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
164126298|NCT00518882|592824601|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
164126299|NCT00518882|592824602|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
164126300|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
164126301|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
164126302|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
164126303|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
164126304|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
164126305|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
164126306|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
164126307|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
164126308|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
164126309|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
164126310|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
164126311|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
164126312|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
164126313|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
164126314|NCT04740931|592824605|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
164126315|NCT04740931|592824606|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
164126316|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
164126317|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
164126318|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
164126319|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
164126320|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
164126321|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
164126322|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
164126323|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
164126324|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
164126325|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
164126326|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
164126327|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
164126328|NCT04740931|592824605|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
164126329|NCT04740931|592824606|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
164126330|NCT02696031|592824608|FG000|Up to Week 24|Adverse Event|2|||
164126331|NCT02696031|592824609|FG001|Up to Week 24|Adverse Event|4|||
164126332|NCT02696031|592824610|FG002|Up to Week 24|Adverse Event|2|||
164126333|NCT02696031|592824611|FG003|Up to Week 24|Adverse Event|0|||
164126334|NCT02696031|592824612|FG004|Up to Week 24|Adverse Event|0|||
164126335|NCT02696031|592824613|FG005|Up to Week 24|Adverse Event|0|||
164126336|NCT02696031|592824608|FG000|Up to Week 24|Lack of Efficacy|2|||
164126337|NCT02696031|592824609|FG001|Up to Week 24|Lack of Efficacy|1|||
164126338|NCT02696031|592824610|FG002|Up to Week 24|Lack of Efficacy|2|||
164126339|NCT02696031|592824611|FG003|Up to Week 24|Lack of Efficacy|0|||
164126340|NCT02696031|592824612|FG004|Up to Week 24|Lack of Efficacy|0|||
164126341|NCT02696031|592824613|FG005|Up to Week 24|Lack of Efficacy|0|||
164126342|NCT02696031|592824608|FG000|Up to Week 24|Lost to Follow-up|0|||
164126343|NCT02696031|592824609|FG001|Up to Week 24|Lost to Follow-up|1|||
164126344|NCT02696031|592824610|FG002|Up to Week 24|Lost to Follow-up|1|||
164126345|NCT02696031|592824611|FG003|Up to Week 24|Lost to Follow-up|0|||
164126346|NCT02696031|592824612|FG004|Up to Week 24|Lost to Follow-up|0|||
164126347|NCT02696031|592824613|FG005|Up to Week 24|Lost to Follow-up|0|||
164126348|NCT02696031|592824608|FG000|Up to Week 24|Physician Decision|1|||
164126349|NCT02696031|592824609|FG001|Up to Week 24|Physician Decision|0|||
164126350|NCT02696031|592824610|FG002|Up to Week 24|Physician Decision|1|||
164126351|NCT02696031|592824611|FG003|Up to Week 24|Physician Decision|0|||
164126352|NCT02696031|592824612|FG004|Up to Week 24|Physician Decision|0|||
164126353|NCT02696031|592824613|FG005|Up to Week 24|Physician Decision|0|||
164126354|NCT02696031|592824608|FG000|Up to Week 24|Protocol Violation|1|||
164126355|NCT02696031|592824609|FG001|Up to Week 24|Protocol Violation|0|||
164126356|NCT02696031|592824610|FG002|Up to Week 24|Protocol Violation|0|||
164126357|NCT02696031|592824611|FG003|Up to Week 24|Protocol Violation|0|||
164126358|NCT02696031|592824612|FG004|Up to Week 24|Protocol Violation|0|||
164126359|NCT02696031|592824613|FG005|Up to Week 24|Protocol Violation|0|||
164126360|NCT02696031|592824608|FG000|Up to Week 24|Withdrawal by Subject|4|||
164126361|NCT02696031|592824609|FG001|Up to Week 24|Withdrawal by Subject|1|||
164126362|NCT02696031|592824610|FG002|Up to Week 24|Withdrawal by Subject|5|||
164126363|NCT02696031|592824611|FG003|Up to Week 24|Withdrawal by Subject|0|||
164126364|NCT02696031|592824612|FG004|Up to Week 24|Withdrawal by Subject|0|||
164126365|NCT02696031|592824613|FG005|Up to Week 24|Withdrawal by Subject|0|||
164126366|NCT02696031|592824608|FG000|Up to Week 52|Adverse Event|4|||
164126367|NCT02696031|592824609|FG001|Up to Week 52|Adverse Event|5|||
164126368|NCT02696031|592824610|FG002|Up to Week 52|Adverse Event|3|||
164126369|NCT02696031|592824611|FG003|Up to Week 52|Adverse Event|0|||
164126370|NCT02696031|592824612|FG004|Up to Week 52|Adverse Event|0|||
164126371|NCT02696031|592824613|FG005|Up to Week 52|Adverse Event|0|||
164126372|NCT02696031|592824608|FG000|Up to Week 52|Lack of Efficacy|10|||
164126373|NCT02696031|592824609|FG001|Up to Week 52|Lack of Efficacy|7|||
164126374|NCT02696031|592824610|FG002|Up to Week 52|Lack of Efficacy|11|||
164126375|NCT02696031|592824611|FG003|Up to Week 52|Lack of Efficacy|0|||
164126376|NCT02696031|592824612|FG004|Up to Week 52|Lack of Efficacy|0|||
164126377|NCT02696031|592824613|FG005|Up to Week 52|Lack of Efficacy|0|||
164126378|NCT02696031|592824608|FG000|Up to Week 52|Lost to Follow-up|1|||
164126379|NCT02696031|592824609|FG001|Up to Week 52|Lost to Follow-up|1|||
164126380|NCT02696031|592824610|FG002|Up to Week 52|Lost to Follow-up|1|||
164126381|NCT02696031|592824611|FG003|Up to Week 52|Lost to Follow-up|0|||
164126382|NCT02696031|592824612|FG004|Up to Week 52|Lost to Follow-up|0|||
164126383|NCT02696031|592824613|FG005|Up to Week 52|Lost to Follow-up|0|||
164126384|NCT02696031|592824608|FG000|Up to Week 52|Physician Decision|1|||
164126385|NCT02696031|592824609|FG001|Up to Week 52|Physician Decision|1|||
164126386|NCT02696031|592824610|FG002|Up to Week 52|Physician Decision|2|||
164126387|NCT02696031|592824611|FG003|Up to Week 52|Physician Decision|0|||
164126388|NCT02696031|592824612|FG004|Up to Week 52|Physician Decision|0|||
164126389|NCT02696031|592824613|FG005|Up to Week 52|Physician Decision|0|||
164126390|NCT02696031|592824608|FG000|Up to Week 52|Pregnancy|0|||
164126391|NCT02696031|592824609|FG001|Up to Week 52|Pregnancy|2|||
164126392|NCT02696031|592824610|FG002|Up to Week 52|Pregnancy|0|||
164126393|NCT02696031|592824611|FG003|Up to Week 52|Pregnancy|0|||
164126394|NCT02696031|592824612|FG004|Up to Week 52|Pregnancy|0|||
164126395|NCT02696031|592824613|FG005|Up to Week 52|Pregnancy|0|||
164126396|NCT02696031|592824608|FG000|Up to Week 52|Protocol Violation|1|||
164126397|NCT02696031|592824609|FG001|Up to Week 52|Protocol Violation|0|||
164126398|NCT02696031|592824610|FG002|Up to Week 52|Protocol Violation|0|||
164126399|NCT02696031|592824611|FG003|Up to Week 52|Protocol Violation|0|||
164126400|NCT02696031|592824612|FG004|Up to Week 52|Protocol Violation|0|||
164126401|NCT02696031|592824613|FG005|Up to Week 52|Protocol Violation|0|||
164126402|NCT02696031|592824608|FG000|Up to Week 52|Withdrawal by Subject|12|||
164126403|NCT02696031|592824609|FG001|Up to Week 52|Withdrawal by Subject|3|||
164126404|NCT02696031|592824610|FG002|Up to Week 52|Withdrawal by Subject|9|||
164126405|NCT02696031|592824611|FG003|Up to Week 52|Withdrawal by Subject|0|||
164126406|NCT02696031|592824612|FG004|Up to Week 52|Withdrawal by Subject|0|||
164126407|NCT02696031|592824613|FG005|Up to Week 52|Withdrawal by Subject|0|||
164126408|NCT02696031|592824608|FG000|Up to Week 104|Pregnancy|0|||
164126409|NCT02696031|592824609|FG001|Up to Week 104|Pregnancy|2|||
164126410|NCT02696031|592824610|FG002|Up to Week 104|Pregnancy|1|||
164126411|NCT02696031|592824611|FG003|Up to Week 104|Pregnancy|0|||
164126412|NCT02696031|592824612|FG004|Up to Week 104|Pregnancy|0|||
164126413|NCT02696031|592824613|FG005|Up to Week 104|Pregnancy|0|||
164126414|NCT02696031|592824608|FG000|Up to Week 104|Withdrawal by Subject|15|||
164126415|NCT02696031|592824609|FG001|Up to Week 104|Withdrawal by Subject|10|||
164126416|NCT02696031|592824610|FG002|Up to Week 104|Withdrawal by Subject|16|||
164126417|NCT02696031|592824611|FG003|Up to Week 104|Withdrawal by Subject|0|||
164126418|NCT02696031|592824612|FG004|Up to Week 104|Withdrawal by Subject|0|||
164126419|NCT02696031|592824613|FG005|Up to Week 104|Withdrawal by Subject|0|||
164126420|NCT02696031|592824608|FG000|Up to Week 104|Protocol Violation|1|||
164126421|NCT02696031|592824609|FG001|Up to Week 104|Protocol Violation|0|||
164126422|NCT02696031|592824610|FG002|Up to Week 104|Protocol Violation|0|||
164126423|NCT02696031|592824611|FG003|Up to Week 104|Protocol Violation|0|||
164126424|NCT02696031|592824612|FG004|Up to Week 104|Protocol Violation|0|||
164126425|NCT02696031|592824613|FG005|Up to Week 104|Protocol Violation|0|||
164126426|NCT02696031|592824608|FG000|Up to Week 104|Physician Decision|1|||
164126427|NCT02696031|592824609|FG001|Up to Week 104|Physician Decision|2|||
164126428|NCT02696031|592824610|FG002|Up to Week 104|Physician Decision|3|||
164126429|NCT02696031|592824611|FG003|Up to Week 104|Physician Decision|0|||
164126430|NCT02696031|592824612|FG004|Up to Week 104|Physician Decision|0|||
164126431|NCT02696031|592824613|FG005|Up to Week 104|Physician Decision|0|||
164126432|NCT02696031|592824608|FG000|Up to Week 104|Lost to Follow-up|2|||
164126433|NCT02696031|592824609|FG001|Up to Week 104|Lost to Follow-up|3|||
164126434|NCT02696031|592824610|FG002|Up to Week 104|Lost to Follow-up|1|||
164126435|NCT02696031|592824611|FG003|Up to Week 104|Lost to Follow-up|0|||
164126436|NCT02696031|592824612|FG004|Up to Week 104|Lost to Follow-up|0|||
164126437|NCT02696031|592824613|FG005|Up to Week 104|Lost to Follow-up|0|||
164126438|NCT02696031|592824608|FG000|Up to Week 104|Lack of Efficacy|13|||
164126439|NCT02696031|592824609|FG001|Up to Week 104|Lack of Efficacy|12|||
164126440|NCT02696031|592824610|FG002|Up to Week 104|Lack of Efficacy|11|||
164126441|NCT02696031|592824611|FG003|Up to Week 104|Lack of Efficacy|0|||
164126442|NCT02696031|592824612|FG004|Up to Week 104|Lack of Efficacy|0|||
164126443|NCT02696031|592824613|FG005|Up to Week 104|Lack of Efficacy|0|||
164126444|NCT02696031|592824608|FG000|Up to Week 104|Adverse Event|7|||
164126445|NCT02696031|592824609|FG001|Up to Week 104|Adverse Event|11|||
164126446|NCT02696031|592824610|FG002|Up to Week 104|Adverse Event|5|||
164126447|NCT02696031|592824611|FG003|Up to Week 104|Adverse Event|0|||
164126448|NCT02696031|592824612|FG004|Up to Week 104|Adverse Event|0|||
164126449|NCT02696031|592824613|FG005|Up to Week 104|Adverse Event|0|||
164126450|NCT02696031|592824608|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164126451|NCT02696031|592824609|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
164126452|NCT02696031|592824610|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164126453|NCT02696031|592824611|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164126454|NCT02696031|592824612|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164126455|NCT02696031|592824613|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
164126456|NCT02696031|592824608|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
164126457|NCT02696031|592824609|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
164126458|NCT02696031|592824610|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
164126459|NCT02696031|592824611|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
164126460|NCT02696031|592824612|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
164126461|NCT02696031|592824613|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
164126462|NCT02696031|592824608|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164126463|NCT02696031|592824609|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164126464|NCT02696031|592824610|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164126465|NCT02696031|592824611|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
164126466|NCT02696031|592824612|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
164126467|NCT02696031|592824613|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
164126468|NCT02696031|592824608|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164126469|NCT02696031|592824609|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164126470|NCT02696031|592824610|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164126471|NCT02696031|592824611|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
164126472|NCT02696031|592824612|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164126473|NCT02696031|592824613|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
164126474|NCT02696031|592824608|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164126475|NCT02696031|592824609|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164126476|NCT02696031|592824610|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164126477|NCT02696031|592824611|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164126478|NCT02696031|592824612|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
164126479|NCT02696031|592824613|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
164126480|NCT02696031|592824608|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
164126481|NCT02696031|592824609|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
164126482|NCT02696031|592824610|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
164126483|NCT02696031|592824611|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
164126484|NCT02696031|592824612|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
164126485|NCT02696031|592824613|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
164126486|NCT02696031|592824608|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
164126487|NCT02696031|592824609|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
164126488|NCT02696031|592824610|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
164126489|NCT02696031|592824611|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
164126490|NCT02696031|592824612|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
164126491|NCT02696031|592824613|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
164126492|NCT02339740|592824614|FG000|Overall Study|Death|1|||
164126493|NCT02339740|592824615|FG001|Overall Study|Death|0|||
164126494|NCT02339740|592824614|FG000|Overall Study|Physician Decision|0|||
164126495|NCT02339740|592824615|FG001|Overall Study|Physician Decision|2|||
164126496|NCT02339740|592824614|FG000|Overall Study|Withdrawal by Subject|5|||
164126497|NCT02339740|592824615|FG001|Overall Study|Withdrawal by Subject|1|||
164126498|NCT02339740|592824614|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
164126499|NCT02339740|592824615|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
164126500|NCT00063882|592824616|FG000|Overall Study|Protocol Violation|3|||
164126501|NCT00063882|592824617|FG001|Overall Study|Protocol Violation|3|||
164126502|NCT00063882|592824616|FG000|Overall Study|Withdrawal by Subject|2|||
164126503|NCT00063882|592824617|FG001|Overall Study|Withdrawal by Subject|1|||
164126504|NCT01855048|592824619|FG000|Overall Study|Withdrawal by Subject|0|||
164126505|NCT01855048|592824620|FG001|Overall Study|Withdrawal by Subject|1|||
164126506|NCT01855048|592824621|FG002|Overall Study|Withdrawal by Subject|0|||
164126507|NCT01855048|592824622|FG003|Overall Study|Withdrawal by Subject|0|||
164126508|NCT01855048|592824623|FG004|Overall Study|Withdrawal by Subject|1|||
164126509|NCT01855048|592824624|FG005|Overall Study|Withdrawal by Subject|0|||
164126510|NCT02972502|592824629|FG000|Overall Study|Lost to Follow-up|3|||
164126511|NCT02972502|592824630|FG001|Overall Study|Lost to Follow-up|1|||
164126512|NCT02972502|592824629|FG000|Overall Study|Withdrawal by Subject|1|||
164126513|NCT02972502|592824630|FG001|Overall Study|Withdrawal by Subject|1|||
164126514|NCT03832738|592824631|FG000|Overall Study|Withdrawal by Subject|6|||
164126515|NCT03832738|592824632|FG001|Overall Study|Withdrawal by Subject|7|||
164126516|NCT03832738|592824633|FG002|Overall Study|Withdrawal by Subject|16|||
164126517|NCT03832738|592824631|FG000|Overall Study|Physician Decision|0|||
164126518|NCT03832738|592824632|FG001|Overall Study|Physician Decision|1|||
164126519|NCT03832738|592824633|FG002|Overall Study|Physician Decision|2|||
164126520|NCT03832738|592824631|FG000|Overall Study|Adverse Event|2|||
164126521|NCT03832738|592824632|FG001|Overall Study|Adverse Event|3|||
164126522|NCT03832738|592824633|FG002|Overall Study|Adverse Event|1|||
164126523|NCT03832738|592824631|FG000|Overall Study|Pregnancy|0|||
164126524|NCT03832738|592824632|FG001|Overall Study|Pregnancy|1|||
164126525|NCT03832738|592824633|FG002|Overall Study|Pregnancy|0|||
164126526|NCT03852459|592824634|FG000|Overall Study|Adverse Event|2|||
164126527|NCT03852459|592824635|FG001|Overall Study|Adverse Event|2|||
164126528|NCT03852459|592824634|FG000|Overall Study|Withdrawal by Subject|1|||
164126529|NCT03852459|592824635|FG001|Overall Study|Withdrawal by Subject|1|||
164126530|NCT00049842|592824636|FG000|Treatment Phase|Adverse Event|47|||
164126531|NCT00049842|592824637|FG001|Treatment Phase|Adverse Event|12|||
164126532|NCT00049842|592824636|FG000|Treatment Phase|Withdrawal by Subject|35|||
164126533|NCT00049842|592824637|FG001|Treatment Phase|Withdrawal by Subject|46|||
164126534|NCT00049842|592824636|FG000|Treatment Phase|Non-compliance with protocol|7|||
164126535|NCT00049842|592824637|FG001|Treatment Phase|Non-compliance with protocol|8|||
164126536|NCT00049842|592824636|FG000|Treatment Phase|Lost to Follow-up|4|||
164126537|NCT00049842|592824637|FG001|Treatment Phase|Lost to Follow-up|8|||
164126538|NCT00049842|592824636|FG000|Treatment Phase|Administrative|0|||
164126539|NCT00049842|592824637|FG001|Treatment Phase|Administrative|3|||
164126540|NCT00049842|592824636|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
164126541|NCT00049842|592824637|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
164126542|NCT00049842|592824636|FG000|Follow-up Phase|Adverse Event|6|||
164126543|NCT00049842|592824637|FG001|Follow-up Phase|Adverse Event|1|||
164126544|NCT00049842|592824636|FG000|Follow-up Phase|Other|1|||
164126545|NCT00049842|592824637|FG001|Follow-up Phase|Other|4|||
164126546|NCT05486065|592824639|FG000|Overall Study|Withdrawal by Subject|1|||
164126547|NCT05486065|592824640|FG001|Overall Study|Withdrawal by Subject|5|||
164126548|NCT05486065|592824641|FG002|Overall Study|Withdrawal by Subject|4|||
164126549|NCT05486065|592824642|FG003|Overall Study|Withdrawal by Subject|3|||
164126550|NCT05486065|592824639|FG000|Overall Study|Lost to Follow-up|4|||
164126551|NCT05486065|592824640|FG001|Overall Study|Lost to Follow-up|2|||
164126552|NCT05486065|592824641|FG002|Overall Study|Lost to Follow-up|2|||
164126553|NCT05486065|592824642|FG003|Overall Study|Lost to Follow-up|2|||
164126554|NCT05486065|592824639|FG000|Overall Study|Physician Decision|0|||
164126555|NCT05486065|592824640|FG001|Overall Study|Physician Decision|1|||
164126556|NCT05486065|592824641|FG002|Overall Study|Physician Decision|1|||
164126557|NCT05486065|592824642|FG003|Overall Study|Physician Decision|0|||
164126558|NCT05486065|592824639|FG000|Overall Study|Failure to meet randomization criteria|0|||
164126559|NCT05486065|592824640|FG001|Overall Study|Failure to meet randomization criteria|0|||
164126560|NCT05486065|592824641|FG002|Overall Study|Failure to meet randomization criteria|0|||
164126561|NCT05486065|592824642|FG003|Overall Study|Failure to meet randomization criteria|1|||
164126562|NCT02442271|592824647|FG000|Overall Study|Adverse Event|1|||
164126563|NCT02442271|592824647|FG000|Overall Study|Withdrew Consent|1|||
164126564|NCT02442271|592824647|FG000|Overall Study|Lost to Follow-up|1|||
164126565|NCT02442271|592824647|FG000|Overall Study|Other|1|||
164126566|NCT00831623|592824652|FG000|Overall Study|Withdrawal by Subject|9|||
164126567|NCT00831623|592824652|FG000|Overall Study|Lost to Follow-up|1|||
164126568|NCT00831623|592824652|FG000|Overall Study|Not 2 years post-treatment|12|||
164126569|NCT01138111|592824656|FG000|Overall Study|Withdrawal by Subject|5|||
164126570|NCT01138111|592824656|FG000|Overall Study|Adverse Event|1|||
164126571|NCT01138111|592824656|FG000|Overall Study|Death|1|||
164126572|NCT01138111|592824656|FG000|Overall Study|Lost to Follow-up|2|||
164126573|NCT01118117|592824657|FG000|Overall Study|Death|8|||
164126574|NCT01118117|592824658|FG001|Overall Study|Death|0|||
164126575|NCT01118117|592824657|FG000|Overall Study|Lost to Follow-up|6|||
164126576|NCT01118117|592824658|FG001|Overall Study|Lost to Follow-up|0|||
164126577|NCT01118117|592824657|FG000|Overall Study|Missed 12 Month Visit|7|||
164126578|NCT01118117|592824658|FG001|Overall Study|Missed 12 Month Visit|0|||
164126579|NCT02149121|592824659|FG000|Main Study Period|Lack of Efficacy|2|||
164126580|NCT02149121|592824660|FG001|Main Study Period|Lack of Efficacy|2|||
164126581|NCT02149121|592824661|FG002|Main Study Period|Lack of Efficacy|1|||
164126582|NCT02149121|592824662|FG003|Main Study Period|Lack of Efficacy|0|||
164126583|NCT02149121|592824663|FG004|Main Study Period|Lack of Efficacy|0|||
164126584|NCT02149121|592824664|FG005|Main Study Period|Lack of Efficacy|0|||
164126585|NCT02149121|592824665|FG006|Main Study Period|Lack of Efficacy|0|||
164126586|NCT02149121|592824659|FG000|Main Study Period|Withdrawal by Subject|9|||
164126587|NCT02149121|592824660|FG001|Main Study Period|Withdrawal by Subject|5|||
164126588|NCT02149121|592824661|FG002|Main Study Period|Withdrawal by Subject|1|||
164126589|NCT02149121|592824662|FG003|Main Study Period|Withdrawal by Subject|0|||
164126590|NCT02149121|592824663|FG004|Main Study Period|Withdrawal by Subject|0|||
164126591|NCT02149121|592824664|FG005|Main Study Period|Withdrawal by Subject|0|||
164126592|NCT02149121|592824665|FG006|Main Study Period|Withdrawal by Subject|0|||
164126593|NCT02149121|592824659|FG000|Main Study Period|Adverse Event|2|||
164126594|NCT02149121|592824660|FG001|Main Study Period|Adverse Event|5|||
164126595|NCT02149121|592824661|FG002|Main Study Period|Adverse Event|1|||
164126596|NCT02149121|592824662|FG003|Main Study Period|Adverse Event|0|||
164126597|NCT02149121|592824663|FG004|Main Study Period|Adverse Event|0|||
164126598|NCT02149121|592824664|FG005|Main Study Period|Adverse Event|0|||
164126599|NCT02149121|592824665|FG006|Main Study Period|Adverse Event|0|||
164126600|NCT02149121|592824659|FG000|Main Study Period|Protocol Violation|2|||
164126601|NCT02149121|592824660|FG001|Main Study Period|Protocol Violation|0|||
164126602|NCT02149121|592824661|FG002|Main Study Period|Protocol Violation|0|||
164126603|NCT02149121|592824662|FG003|Main Study Period|Protocol Violation|0|||
164126604|NCT02149121|592824663|FG004|Main Study Period|Protocol Violation|0|||
164126605|NCT02149121|592824664|FG005|Main Study Period|Protocol Violation|0|||
164126606|NCT02149121|592824665|FG006|Main Study Period|Protocol Violation|0|||
164126607|NCT02149121|592824659|FG000|Main Study Period|Lost to Follow-up|2|||
164126608|NCT02149121|592824660|FG001|Main Study Period|Lost to Follow-up|1|||
164126609|NCT02149121|592824661|FG002|Main Study Period|Lost to Follow-up|0|||
164126610|NCT02149121|592824662|FG003|Main Study Period|Lost to Follow-up|0|||
164126611|NCT02149121|592824663|FG004|Main Study Period|Lost to Follow-up|0|||
164126612|NCT02149121|592824664|FG005|Main Study Period|Lost to Follow-up|0|||
164126613|NCT02149121|592824665|FG006|Main Study Period|Lost to Follow-up|0|||
164126614|NCT02149121|592824659|FG000|Main Study Period|Death|1|||
164126615|NCT02149121|592824660|FG001|Main Study Period|Death|0|||
164126616|NCT02149121|592824661|FG002|Main Study Period|Death|0|||
164126617|NCT02149121|592824662|FG003|Main Study Period|Death|0|||
164126618|NCT02149121|592824663|FG004|Main Study Period|Death|0|||
164126619|NCT02149121|592824664|FG005|Main Study Period|Death|0|||
164126620|NCT02149121|592824665|FG006|Main Study Period|Death|0|||
164126621|NCT02149121|592824659|FG000|Main Study Period|Physician Decision|1|||
164126622|NCT02149121|592824660|FG001|Main Study Period|Physician Decision|0|||
164126623|NCT02149121|592824661|FG002|Main Study Period|Physician Decision|0|||
164126624|NCT02149121|592824662|FG003|Main Study Period|Physician Decision|0|||
164126625|NCT02149121|592824663|FG004|Main Study Period|Physician Decision|0|||
164126626|NCT02149121|592824664|FG005|Main Study Period|Physician Decision|0|||
164126627|NCT02149121|592824665|FG006|Main Study Period|Physician Decision|0|||
164126628|NCT02149121|592824659|FG000|Main Study Period|Developed any malignancy|0|||
164126629|NCT02149121|592824660|FG001|Main Study Period|Developed any malignancy|1|||
164126630|NCT02149121|592824661|FG002|Main Study Period|Developed any malignancy|1|||
164126631|NCT02149121|592824662|FG003|Main Study Period|Developed any malignancy|0|||
164126632|NCT02149121|592824663|FG004|Main Study Period|Developed any malignancy|0|||
164126633|NCT02149121|592824664|FG005|Main Study Period|Developed any malignancy|0|||
164126634|NCT02149121|592824665|FG006|Main Study Period|Developed any malignancy|0|||
164126635|NCT02149121|592824659|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
164126636|NCT02149121|592824660|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
164126637|NCT02149121|592824661|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
164126638|NCT02149121|592824662|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
164126639|NCT02149121|592824663|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
164126640|NCT02149121|592824664|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
164126641|NCT02149121|592824665|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
164126642|NCT02149121|592824659|FG000|Main Study Period|Disease progression|0|||
164126643|NCT02149121|592824660|FG001|Main Study Period|Disease progression|1|||
164126644|NCT02149121|592824661|FG002|Main Study Period|Disease progression|0|||
164126645|NCT02149121|592824662|FG003|Main Study Period|Disease progression|0|||
164126646|NCT02149121|592824663|FG004|Main Study Period|Disease progression|0|||
164126647|NCT02149121|592824664|FG005|Main Study Period|Disease progression|0|||
164126648|NCT02149121|592824665|FG006|Main Study Period|Disease progression|0|||
164126649|NCT02149121|592824659|FG000|Extension Study Period|Withdrawal by Subject|0|||
164126650|NCT02149121|592824660|FG001|Extension Study Period|Withdrawal by Subject|0|||
164126651|NCT02149121|592824661|FG002|Extension Study Period|Withdrawal by Subject|0|||
164126652|NCT02149121|592824662|FG003|Extension Study Period|Withdrawal by Subject|1|||
164126653|NCT02149121|592824663|FG004|Extension Study Period|Withdrawal by Subject|0|||
164126654|NCT02149121|592824664|FG005|Extension Study Period|Withdrawal by Subject|2|||
164126655|NCT02149121|592824665|FG006|Extension Study Period|Withdrawal by Subject|0|||
164126656|NCT00493246|592827023|FG000|Overall Study|Withdrawal by Subject|0|||
164126657|NCT00493246|592827024|FG001|Overall Study|Withdrawal by Subject|0|||
164126658|NCT00493246|592827025|FG002|Overall Study|Withdrawal by Subject|0|||
164126659|NCT00493246|592827026|FG003|Overall Study|Withdrawal by Subject|0|||
164126660|NCT00493246|592827027|FG004|Overall Study|Withdrawal by Subject|1|||
164126661|NCT00493246|592827028|FG005|Overall Study|Withdrawal by Subject|0|||
164126662|NCT00493246|592827029|FG006|Overall Study|Withdrawal by Subject|0|||
164126663|NCT00493246|592827030|FG007|Overall Study|Withdrawal by Subject|0|||
164126664|NCT00493246|592827023|FG000|Overall Study|No access to draw blood|0|||
164126665|NCT00493246|592827024|FG001|Overall Study|No access to draw blood|0|||
164126666|NCT00493246|592827025|FG002|Overall Study|No access to draw blood|0|||
164126667|NCT00493246|592827026|FG003|Overall Study|No access to draw blood|0|||
164126668|NCT00493246|592827027|FG004|Overall Study|No access to draw blood|0|||
164126669|NCT00493246|592827028|FG005|Overall Study|No access to draw blood|1|||
164126670|NCT00493246|592827029|FG006|Overall Study|No access to draw blood|0|||
164126671|NCT00493246|592827030|FG007|Overall Study|No access to draw blood|0|||
164126672|NCT00493246|592827023|FG000|Overall Study|Lost to Follow-up|0|||
164126673|NCT00493246|592827024|FG001|Overall Study|Lost to Follow-up|0|||
164126674|NCT00493246|592827025|FG002|Overall Study|Lost to Follow-up|0|||
164126675|NCT00493246|592827026|FG003|Overall Study|Lost to Follow-up|0|||
164126676|NCT00493246|592827027|FG004|Overall Study|Lost to Follow-up|0|||
164126677|NCT00493246|592827028|FG005|Overall Study|Lost to Follow-up|0|||
164126678|NCT00493246|592827029|FG006|Overall Study|Lost to Follow-up|1|||
164126679|NCT00493246|592827030|FG007|Overall Study|Lost to Follow-up|0|||
164126680|NCT00595335|592827032|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
164126681|NCT00595335|592827033|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
164126682|NCT00595335|592827032|FG000|Baseline to Six Months|Disease Progression|1|||
164126683|NCT00595335|592827033|FG001|Baseline to Six Months|Disease Progression|1|||
164126684|NCT00595335|592827032|FG000|Baseline to Six Months|Adverse Event|1|||
164126685|NCT00595335|592827033|FG001|Baseline to Six Months|Adverse Event|0|||
164126686|NCT00595335|592827032|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
164126687|NCT00595335|592827033|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
164126688|NCT00595335|592827032|FG000|Six Months to Twelve Months|Disease Progression|1|||
164126689|NCT00595335|592827033|FG001|Six Months to Twelve Months|Disease Progression|0|||
164126690|NCT01013649|592827038|FG000|First Step|Withdrawal by Subject|36|||
164126691|NCT01013649|592827039|FG001|First Step|Withdrawal by Subject|19|||
164126692|NCT01013649|592827040|FG002|First Step|Withdrawal by Subject|0|||
164126693|NCT01013649|592827041|FG003|First Step|Withdrawal by Subject|0|||
164126694|NCT01013649|592827038|FG000|First Step|Progression|58|||
164126695|NCT01013649|592827039|FG001|First Step|Progression|23|||
164126696|NCT01013649|592827040|FG002|First Step|Progression|0|||
164126697|NCT01013649|592827041|FG003|First Step|Progression|0|||
164126698|NCT01013649|592827038|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
164126699|NCT01013649|592827039|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
164126700|NCT01013649|592827040|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
164126701|NCT01013649|592827041|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
164126702|NCT01013649|592827038|FG000|First Step|Death|3|||
164126703|NCT01013649|592827039|FG001|First Step|Death|4|||
164126704|NCT01013649|592827040|FG002|First Step|Death|0|||
164126705|NCT01013649|592827041|FG003|First Step|Death|0|||
164126706|NCT01013649|592827038|FG000|First Step|Adverse Event|9|||
164126707|NCT01013649|592827039|FG001|First Step|Adverse Event|5|||
164126708|NCT01013649|592827040|FG002|First Step|Adverse Event|0|||
164126709|NCT01013649|592827041|FG003|First Step|Adverse Event|0|||
164126710|NCT01013649|592827038|FG000|First Step|Other|4|||
164126711|NCT01013649|592827039|FG001|First Step|Other|6|||
164126712|NCT01013649|592827040|FG002|First Step|Other|0|||
164126713|NCT01013649|592827041|FG003|First Step|Other|0|||
164126714|NCT00493779|592827042|FG000|Overall Study|Logistical issue at site|1|||
164126715|NCT01647958|592827043|FG000|Initial Study|Lost to Follow-up|2|||
164126716|NCT01647958|592827044|FG001|Initial Study|Lost to Follow-up|3|||
164126717|NCT01647958|592827043|FG000|Continuation Phase|treatment received during Overall Study|39|||
164126718|NCT01647958|592827044|FG001|Continuation Phase|treatment received during Overall Study|0|||
164126719|NCT01647958|592827043|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
164126720|NCT01647958|592827044|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
164126721|NCT01131299|592827045|FG000|Overall Study|Withdrawal by Subject|4|||
164126722|NCT01131299|592827046|FG001|Overall Study|Withdrawal by Subject|7|||
164126723|NCT01207440|592827054|FG000|Overall Study|Adverse Event|46|||
164126724|NCT01207440|592827055|FG001|Overall Study|Adverse Event|11|||
164126725|NCT01207440|592827056|FG002|Overall Study|Adverse Event|7|||
164126726|NCT01207440|592827057|FG003|Overall Study|Adverse Event|2|||
164126727|NCT01207440|592827058|FG004|Overall Study|Adverse Event|6|||
164126728|NCT01207440|592827059|FG005|Overall Study|Adverse Event|6|||
164126729|NCT01207440|592827060|FG006|Overall Study|Adverse Event|2|||
164126730|NCT01207440|592827054|FG000|Overall Study|Death|6|||
164126731|NCT01207440|592827055|FG001|Overall Study|Death|3|||
164126732|NCT01207440|592827056|FG002|Overall Study|Death|2|||
164126733|NCT01207440|592827057|FG003|Overall Study|Death|2|||
164126734|NCT01207440|592827058|FG004|Overall Study|Death|7|||
164126735|NCT01207440|592827059|FG005|Overall Study|Death|5|||
164126736|NCT01207440|592827060|FG006|Overall Study|Death|1|||
164126737|NCT01207440|592827054|FG000|Overall Study|Lack of Efficacy|13|||
164126738|NCT01207440|592827055|FG001|Overall Study|Lack of Efficacy|2|||
164126739|NCT01207440|592827056|FG002|Overall Study|Lack of Efficacy|5|||
164126740|NCT01207440|592827057|FG003|Overall Study|Lack of Efficacy|1|||
164126741|NCT01207440|592827058|FG004|Overall Study|Lack of Efficacy|2|||
164126742|NCT01207440|592827059|FG005|Overall Study|Lack of Efficacy|3|||
164126743|NCT01207440|592827060|FG006|Overall Study|Lack of Efficacy|0|||
164126744|NCT01207440|592827054|FG000|Overall Study|Lost to Follow-up|0|||
164126745|NCT01207440|592827055|FG001|Overall Study|Lost to Follow-up|0|||
164126746|NCT01207440|592827056|FG002|Overall Study|Lost to Follow-up|2|||
164126747|NCT01207440|592827057|FG003|Overall Study|Lost to Follow-up|1|||
164126748|NCT01207440|592827058|FG004|Overall Study|Lost to Follow-up|0|||
164126749|NCT01207440|592827059|FG005|Overall Study|Lost to Follow-up|0|||
164126750|NCT01207440|592827060|FG006|Overall Study|Lost to Follow-up|0|||
164126751|NCT01207440|592827054|FG000|Overall Study|Non-compliance with Study Drug|3|||
164126752|NCT01207440|592827055|FG001|Overall Study|Non-compliance with Study Drug|0|||
164126753|NCT01207440|592827056|FG002|Overall Study|Non-compliance with Study Drug|1|||
164126754|NCT01207440|592827057|FG003|Overall Study|Non-compliance with Study Drug|0|||
164126755|NCT01207440|592827058|FG004|Overall Study|Non-compliance with Study Drug|0|||
164126756|NCT01207440|592827059|FG005|Overall Study|Non-compliance with Study Drug|0|||
164126757|NCT01207440|592827060|FG006|Overall Study|Non-compliance with Study Drug|0|||
164126758|NCT01207440|592827054|FG000|Overall Study|Physician Decision|6|||
164126759|NCT01207440|592827055|FG001|Overall Study|Physician Decision|5|||
164126760|NCT01207440|592827056|FG002|Overall Study|Physician Decision|5|||
164126761|NCT01207440|592827057|FG003|Overall Study|Physician Decision|0|||
164126762|NCT01207440|592827058|FG004|Overall Study|Physician Decision|1|||
164126763|NCT01207440|592827059|FG005|Overall Study|Physician Decision|0|||
164126764|NCT01207440|592827060|FG006|Overall Study|Physician Decision|0|||
164126765|NCT01207440|592827054|FG000|Overall Study|Progressive Disease|19|||
164126766|NCT01207440|592827055|FG001|Overall Study|Progressive Disease|10|||
164126767|NCT01207440|592827056|FG002|Overall Study|Progressive Disease|19|||
164126768|NCT01207440|592827057|FG003|Overall Study|Progressive Disease|7|||
164126769|NCT01207440|592827058|FG004|Overall Study|Progressive Disease|23|||
164126770|NCT01207440|592827059|FG005|Overall Study|Progressive Disease|27|||
164126771|NCT01207440|592827060|FG006|Overall Study|Progressive Disease|0|||
164126772|NCT01207440|592827054|FG000|Overall Study|Protocol Violation|2|||
164126773|NCT01207440|592827055|FG001|Overall Study|Protocol Violation|0|||
164126774|NCT01207440|592827056|FG002|Overall Study|Protocol Violation|0|||
164126775|NCT01207440|592827057|FG003|Overall Study|Protocol Violation|0|||
164126776|NCT01207440|592827058|FG004|Overall Study|Protocol Violation|0|||
164126777|NCT01207440|592827059|FG005|Overall Study|Protocol Violation|0|||
164126778|NCT01207440|592827060|FG006|Overall Study|Protocol Violation|0|||
164126779|NCT01207440|592827054|FG000|Overall Study|Site Terminated by Sponsor|69|||
164126780|NCT01207440|592827055|FG001|Overall Study|Site Terminated by Sponsor|19|||
164126781|NCT01207440|592827056|FG002|Overall Study|Site Terminated by Sponsor|12|||
164126782|NCT01207440|592827057|FG003|Overall Study|Site Terminated by Sponsor|2|||
164126783|NCT01207440|592827058|FG004|Overall Study|Site Terminated by Sponsor|3|||
164126784|NCT01207440|592827059|FG005|Overall Study|Site Terminated by Sponsor|0|||
164126785|NCT01207440|592827060|FG006|Overall Study|Site Terminated by Sponsor|2|||
164126786|NCT01207440|592827054|FG000|Overall Study|Withdrawal by Subject|29|||
164126787|NCT01207440|592827055|FG001|Overall Study|Withdrawal by Subject|4|||
164126788|NCT01207440|592827056|FG002|Overall Study|Withdrawal by Subject|5|||
164126789|NCT01207440|592827057|FG003|Overall Study|Withdrawal by Subject|3|||
164126790|NCT01207440|592827058|FG004|Overall Study|Withdrawal by Subject|2|||
164126791|NCT01207440|592827059|FG005|Overall Study|Withdrawal by Subject|2|||
164126792|NCT01207440|592827060|FG006|Overall Study|Withdrawal by Subject|0|||
164126793|NCT01207440|592827054|FG000|Overall Study|Reason Not Specified|10|||
164126794|NCT01207440|592827055|FG001|Overall Study|Reason Not Specified|10|||
164126795|NCT01207440|592827056|FG002|Overall Study|Reason Not Specified|7|||
164126796|NCT01207440|592827057|FG003|Overall Study|Reason Not Specified|0|||
164126797|NCT01207440|592827058|FG004|Overall Study|Reason Not Specified|4|||
164126798|NCT01207440|592827059|FG005|Overall Study|Reason Not Specified|3|||
164126799|NCT01207440|592827060|FG006|Overall Study|Reason Not Specified|0|||
164126800|NCT01592721|592827061|FG000|Long-term Follow-up|Death|1|||
164126801|NCT01408563|592827064|FG000|Overall Study|Ineligible after consent/ registration|2|||
164126802|NCT02091141|592827067|FG000|Overall Study|Death|280|||
164126803|NCT02091141|592827068|FG001|Overall Study|Death|118|||
164126804|NCT02091141|592827069|FG002|Overall Study|Death|46|||
164126805|NCT02091141|592827070|FG003|Overall Study|Death|13|||
164126806|NCT02091141|592827071|FG004|Overall Study|Death|31|||
164126807|NCT02091141|592827072|FG005|Overall Study|Death|16|||
164126808|NCT02091141|592827073|FG006|Overall Study|Death|12|||
164126809|NCT02091141|592827067|FG000|Overall Study|Withdrawal by Subject|21|||
164126810|NCT02091141|592827068|FG001|Overall Study|Withdrawal by Subject|13|||
164126811|NCT02091141|592827069|FG002|Overall Study|Withdrawal by Subject|3|||
164126812|NCT02091141|592827070|FG003|Overall Study|Withdrawal by Subject|2|||
164126813|NCT02091141|592827071|FG004|Overall Study|Withdrawal by Subject|2|||
164126814|NCT02091141|592827072|FG005|Overall Study|Withdrawal by Subject|3|||
164126815|NCT02091141|592827073|FG006|Overall Study|Withdrawal by Subject|0|||
164126816|NCT02091141|592827067|FG000|Overall Study|Lost to Follow-up|21|||
164126817|NCT02091141|592827068|FG001|Overall Study|Lost to Follow-up|5|||
164126818|NCT02091141|592827069|FG002|Overall Study|Lost to Follow-up|1|||
164126819|NCT02091141|592827070|FG003|Overall Study|Lost to Follow-up|0|||
164126820|NCT02091141|592827071|FG004|Overall Study|Lost to Follow-up|1|||
164126821|NCT02091141|592827072|FG005|Overall Study|Lost to Follow-up|2|||
164126822|NCT02091141|592827073|FG006|Overall Study|Lost to Follow-up|0|||
164126823|NCT02091141|592827067|FG000|Overall Study|Reason Not Specified|6|||
164126824|NCT02091141|592827068|FG001|Overall Study|Reason Not Specified|5|||
164126825|NCT02091141|592827069|FG002|Overall Study|Reason Not Specified|2|||
164126826|NCT02091141|592827070|FG003|Overall Study|Reason Not Specified|0|||
164126827|NCT02091141|592827071|FG004|Overall Study|Reason Not Specified|0|||
164126828|NCT02091141|592827072|FG005|Overall Study|Reason Not Specified|0|||
164126829|NCT02091141|592827073|FG006|Overall Study|Reason Not Specified|1|||
164126830|NCT02091141|592827067|FG000|Overall Study|Study Ended by Sponsor|1|||
164126831|NCT02091141|592827068|FG001|Overall Study|Study Ended by Sponsor|9|||
164126832|NCT02091141|592827069|FG002|Overall Study|Study Ended by Sponsor|0|||
164126833|NCT02091141|592827070|FG003|Overall Study|Study Ended by Sponsor|0|||
164126834|NCT02091141|592827071|FG004|Overall Study|Study Ended by Sponsor|0|||
164126835|NCT02091141|592827072|FG005|Overall Study|Study Ended by Sponsor|0|||
164126836|NCT02091141|592827073|FG006|Overall Study|Study Ended by Sponsor|0|||
164126837|NCT02091141|592827067|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
164126838|NCT02091141|592827068|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
164126839|NCT02091141|592827069|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
164126840|NCT02091141|592827070|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
164126841|NCT02091141|592827071|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
164126842|NCT02091141|592827072|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
164126843|NCT02091141|592827073|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
164126844|NCT02246439|592827074|FG000|Overall Study|Adverse Event|3|||
164126845|NCT02246439|592827075|FG001|Overall Study|Adverse Event|0|||
164126846|NCT02246439|592827074|FG000|Overall Study|Lost to Follow-up|7|||
164126847|NCT02246439|592827075|FG001|Overall Study|Lost to Follow-up|5|||
164126848|NCT02246439|592827074|FG000|Overall Study|Protocol Violation|0|||
164126849|NCT02246439|592827075|FG001|Overall Study|Protocol Violation|2|||
164126850|NCT02246439|592827074|FG000|Overall Study|Physician Decision|0|||
164126851|NCT02246439|592827075|FG001|Overall Study|Physician Decision|1|||
164126852|NCT02246439|592827074|FG000|Overall Study|Unkonwn|1|||
164126853|NCT02246439|592827075|FG001|Overall Study|Unkonwn|3|||
164126854|NCT02246439|592827074|FG000|Overall Study|Withdrawal by Subject|1|||
164126855|NCT02246439|592827075|FG001|Overall Study|Withdrawal by Subject|0|||
164126856|NCT03439852|592827076|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
164126857|NCT03439852|592827077|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
164126858|NCT03439852|592827076|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
164126859|NCT03439852|592827077|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
164126860|NCT03439852|592827076|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
164126861|NCT03439852|592827077|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
164126862|NCT04551911|592827080|FG000|Overall Study|Lost to Follow-up|2|||
164126863|NCT04551911|592827081|FG001|Overall Study|Lost to Follow-up|1|||
164126864|NCT04551911|592827080|FG000|Overall Study|Withdrawal by Subject|10|||
164126865|NCT04551911|592827081|FG001|Overall Study|Withdrawal by Subject|10|||
164126866|NCT04551911|592827080|FG000|Overall Study|Did not receive the study drug|3|||
164126867|NCT04551911|592827081|FG001|Overall Study|Did not receive the study drug|4|||
164126868|NCT01272921|592827086|FG000|Overall Study|Protocol Violation|2|||
164126869|NCT01272921|592827087|FG001|Overall Study|Protocol Violation|1|||
164126870|NCT01132664|592827088|FG000|Phase lb|Adverse Event|0|||
164126871|NCT01132664|592827089|FG001|Phase lb|Adverse Event|1|||
164126872|NCT01132664|592827090|FG002|Phase lb|Adverse Event|0|||
164126873|NCT01132664|592827091|FG003|Phase lb|Adverse Event|0|||
164126874|NCT01132664|592827092|FG004|Phase lb|Adverse Event|0|||
164126875|NCT01132664|592827088|FG000|Phase lb|Withdrawal by Subject|1|||
164126876|NCT01132664|592827089|FG001|Phase lb|Withdrawal by Subject|2|||
164126877|NCT01132664|592827090|FG002|Phase lb|Withdrawal by Subject|0|||
164126878|NCT01132664|592827091|FG003|Phase lb|Withdrawal by Subject|0|||
164126879|NCT01132664|592827092|FG004|Phase lb|Withdrawal by Subject|0|||
164126880|NCT01132664|592827088|FG000|Phase lb|Disease Progression|4|||
164126881|NCT01132664|592827089|FG001|Phase lb|Disease Progression|9|||
164126882|NCT01132664|592827090|FG002|Phase lb|Disease Progression|0|||
164126883|NCT01132664|592827091|FG003|Phase lb|Disease Progression|0|||
164126884|NCT01132664|592827092|FG004|Phase lb|Disease Progression|0|||
164126885|NCT01132664|592827088|FG000|Phase ll|Death|0|||
164126886|NCT01132664|592827089|FG001|Phase ll|Death|0|||
164126887|NCT01132664|592827090|FG002|Phase ll|Death|2|||
164126888|NCT01132664|592827091|FG003|Phase ll|Death|0|||
164126889|NCT01132664|592827092|FG004|Phase ll|Death|0|||
164126890|NCT01132664|592827088|FG000|Phase ll|Adverse Event|0|||
164126891|NCT01132664|592827089|FG001|Phase ll|Adverse Event|0|||
164126892|NCT01132664|592827090|FG002|Phase ll|Adverse Event|10|||
164126893|NCT01132664|592827091|FG003|Phase ll|Adverse Event|0|||
164126894|NCT01132664|592827092|FG004|Phase ll|Adverse Event|0|||
164126895|NCT01132664|592827088|FG000|Phase ll|Withdrawal by Subject|0|||
164126896|NCT01132664|592827089|FG001|Phase ll|Withdrawal by Subject|0|||
164126897|NCT01132664|592827090|FG002|Phase ll|Withdrawal by Subject|3|||
164126898|NCT01132664|592827091|FG003|Phase ll|Withdrawal by Subject|0|||
164126899|NCT01132664|592827092|FG004|Phase ll|Withdrawal by Subject|0|||
164126900|NCT01132664|592827088|FG000|Phase ll|Disease progression|0|||
164126901|NCT01132664|592827089|FG001|Phase ll|Disease progression|0|||
164126902|NCT01132664|592827090|FG002|Phase ll|Disease progression|35|||
164126903|NCT01132664|592827091|FG003|Phase ll|Disease progression|0|||
164126904|NCT01132664|592827092|FG004|Phase ll|Disease progression|0|||
164126905|NCT01132664|592827088|FG000|BM Cohort|Disease progression|0|||
164126906|NCT01132664|592827089|FG001|BM Cohort|Disease progression|0|||
164126907|NCT01132664|592827090|FG002|BM Cohort|Disease progression|0|||
164126908|NCT01132664|592827091|FG003|BM Cohort|Disease progression|3|||
164126909|NCT01132664|592827092|FG004|BM Cohort|Disease progression|4|||
164126910|NCT01132664|592827088|FG000|BM Cohort|Adverse Event|0|||
164126911|NCT01132664|592827089|FG001|BM Cohort|Adverse Event|0|||
164126912|NCT01132664|592827090|FG002|BM Cohort|Adverse Event|0|||
164126913|NCT01132664|592827091|FG003|BM Cohort|Adverse Event|0|||
164126914|NCT01132664|592827092|FG004|BM Cohort|Adverse Event|1|||
164126915|NCT01132664|592827088|FG000|BM Cohort|Withdrawal by Subject|0|||
164126916|NCT01132664|592827089|FG001|BM Cohort|Withdrawal by Subject|0|||
164126917|NCT01132664|592827090|FG002|BM Cohort|Withdrawal by Subject|0|||
164126918|NCT01132664|592827091|FG003|BM Cohort|Withdrawal by Subject|0|||
164126919|NCT01132664|592827092|FG004|BM Cohort|Withdrawal by Subject|1|||
164126920|NCT04271735|592827094|FG000|Overall Study|Physician Decision|2|||
164126921|NCT04271735|592827095|FG001|Overall Study|Physician Decision|0|||
164126922|NCT04268316|592827096|FG000|Overall Study|Withdrawal by Subject|2|||
164126923|NCT04268316|592827097|FG001|Overall Study|Withdrawal by Subject|1|||
164126924|NCT04268316|592827098|FG002|Overall Study|Withdrawal by Subject|0|||
164126925|NCT02040779|592827100|FG000|Overall Study|Adverse Event|1|||
164126926|NCT02040779|592827101|FG001|Overall Study|Adverse Event|0|||
164126927|NCT02040779|592827102|FG002|Overall Study|Adverse Event|0|||
164126928|NCT02040779|592827100|FG000|Overall Study|Withdrawal by Subject|4|||
164126929|NCT02040779|592827101|FG001|Overall Study|Withdrawal by Subject|1|||
164126930|NCT02040779|592827102|FG002|Overall Study|Withdrawal by Subject|3|||
164126931|NCT02040779|592827100|FG000|Overall Study|Non-compliance|0|||
164126932|NCT02040779|592827101|FG001|Overall Study|Non-compliance|1|||
164126933|NCT02040779|592827102|FG002|Overall Study|Non-compliance|0|||
164126934|NCT02040779|592827100|FG000|Overall Study|Protocol Violation|2|||
164126935|NCT02040779|592827101|FG001|Overall Study|Protocol Violation|1|||
164126936|NCT02040779|592827102|FG002|Overall Study|Protocol Violation|0|||
164126937|NCT02040779|592827100|FG000|Overall Study|Lost to Follow-up|1|||
164126938|NCT02040779|592827101|FG001|Overall Study|Lost to Follow-up|2|||
164126939|NCT02040779|592827102|FG002|Overall Study|Lost to Follow-up|1|||
164126940|NCT02040779|592827100|FG000|Overall Study|Lack of Efficacy|4|||
164126941|NCT02040779|592827101|FG001|Overall Study|Lack of Efficacy|2|||
164126942|NCT02040779|592827102|FG002|Overall Study|Lack of Efficacy|0|||
164126943|NCT02132637|592827103|FG000|Study Period 1|Withdrawal by Subject|0|||
164126944|NCT02132637|592827104|FG001|Study Period 1|Withdrawal by Subject|4|||
164126945|NCT02132637|592827103|FG000|Study Period 1|Physician Decision|1|||
164126946|NCT02132637|592827104|FG001|Study Period 1|Physician Decision|0|||
164126947|NCT02132637|592827103|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
164126948|NCT02132637|592827104|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
164126949|NCT02132637|592827103|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
164126950|NCT02132637|592827104|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
164126951|NCT00922272|592827107|FG000|Open-label Phase|Adverse Event|5|||
164126952|NCT00922272|592827108|FG001|Open-label Phase|Adverse Event|0|||
164126953|NCT00922272|592827107|FG000|Open-label Phase|Protocol Violation|1|||
164126954|NCT00922272|592827108|FG001|Open-label Phase|Protocol Violation|0|||
164126955|NCT00922272|592827107|FG000|Open-label Phase|Withdrawal by Subject|11|||
164126956|NCT00922272|592827108|FG001|Open-label Phase|Withdrawal by Subject|0|||
164126957|NCT00922272|592827107|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
164126958|NCT00922272|592827108|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
164126959|NCT00922272|592827107|FG000|Open-label Phase|Withdrawal criteria met|5|||
164126960|NCT00922272|592827108|FG001|Open-label Phase|Withdrawal criteria met|0|||
164126961|NCT00922272|592827107|FG000|Double-blind Phase|Adverse Event|1|||
164126962|NCT00922272|592827108|FG001|Double-blind Phase|Adverse Event|1|||
164126963|NCT00922272|592827107|FG000|Double-blind Phase|Withdrawal by Subject|1|||
164126964|NCT00922272|592827108|FG001|Double-blind Phase|Withdrawal by Subject|1|||
164126965|NCT00922272|592827107|FG000|Double-blind Phase|Lost to Follow-up|2|||
164126966|NCT00922272|592827108|FG001|Double-blind Phase|Lost to Follow-up|1|||
164126967|NCT00922272|592827107|FG000|Double-blind Phase|Withdrawal criteria met|1|||
164126968|NCT00922272|592827108|FG001|Double-blind Phase|Withdrawal criteria met|1|||
164126969|NCT00922272|592827107|FG000|Double-blind Phase|Noncompliance|1|||
164126970|NCT00922272|592827108|FG001|Double-blind Phase|Noncompliance|1|||
164126971|NCT00922272|592827107|FG000|Double-blind Phase|Positive urine drug screen|1|||
164126972|NCT00922272|592827108|FG001|Double-blind Phase|Positive urine drug screen|1|||
164126973|NCT03197558|592827109|FG000|Overall Study|Tubes not placed|1|||
164126974|NCT02581163|592827111|FG000|Overall Study|Failure to return|15|||
164126975|NCT02581163|592827111|FG000|Overall Study|Insufficient virological response|3|||
164126976|NCT02581163|592827111|FG000|Overall Study|Withdrew consent|1|||
164126977|NCT02581163|592827111|FG000|Overall Study|Death|1|||
164126978|NCT02581163|592827111|FG000|Overall Study|Other, not specified|9|||
164126979|NCT02384941|592827121|FG000|Overall Study|Adverse Event|11|||
164126980|NCT02384941|592827122|FG001|Overall Study|Adverse Event|13|||
164126981|NCT02384941|592827123|FG002|Overall Study|Adverse Event|17|||
164126982|NCT02384941|592827121|FG000|Overall Study|Lost to Follow-up|3|||
164126983|NCT02384941|592827122|FG001|Overall Study|Lost to Follow-up|2|||
164126984|NCT02384941|592827123|FG002|Overall Study|Lost to Follow-up|1|||
164126985|NCT02384941|592827121|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164126986|NCT02384941|592827122|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164126987|NCT02384941|592827123|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164126988|NCT02384941|592827121|FG000|Overall Study|Physician Decision|1|||
164126989|NCT02384941|592827122|FG001|Overall Study|Physician Decision|1|||
164126990|NCT02384941|592827123|FG002|Overall Study|Physician Decision|0|||
164126991|NCT02384941|592827121|FG000|Overall Study|Protocol Violation|3|||
164126992|NCT02384941|592827122|FG001|Overall Study|Protocol Violation|0|||
164126993|NCT02384941|592827123|FG002|Overall Study|Protocol Violation|0|||
164126994|NCT02384941|592827121|FG000|Overall Study|Withdrawal by Subject|26|||
164126995|NCT02384941|592827122|FG001|Overall Study|Withdrawal by Subject|19|||
164126996|NCT02384941|592827123|FG002|Overall Study|Withdrawal by Subject|20|||
164126997|NCT02384941|592827121|FG000|Overall Study|Pregnancy|0|||
164126998|NCT02384941|592827122|FG001|Overall Study|Pregnancy|0|||
164126999|NCT02384941|592827123|FG002|Overall Study|Pregnancy|1|||
164127000|NCT02384941|592827121|FG000|Overall Study|Other than specified above|4|||
164127001|NCT02384941|592827122|FG001|Overall Study|Other than specified above|0|||
164127002|NCT02384941|592827123|FG002|Overall Study|Other than specified above|1|||
164127003|NCT02493777|592827124|FG000|Overall Study|Lost to Follow-up|0|||
164127004|NCT02493777|592827125|FG001|Overall Study|Lost to Follow-up|1|||
164127005|NCT00468728|592827126|FG000|Treatment|criteria for mITT population|4|||
164127006|NCT00468728|592827127|FG001|Treatment|criteria for mITT population|11|||
164127007|NCT00468728|592827126|FG000|Follow-up|mITT failure|34|||
164127008|NCT00468728|592827127|FG001|Follow-up|mITT failure|31|||
164127009|NCT01705236|592827128|FG000|Overall Study|Lost to Follow-up|1|||
164127010|NCT01705236|592827128|FG000|Overall Study|Administrative problems|2|||
164127011|NCT01705236|592827128|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
164127012|NCT01705236|592827128|FG000|Overall Study|Protocol Violation|3|||
164127013|NCT01705236|592827128|FG000|Overall Study|Abnormal test procedure result(s)|4|||
164127014|NCT01705236|592827128|FG000|Overall Study|Abnormal laboratory value(s)|4|||
164127015|NCT01705236|592827128|FG000|Overall Study|Withdrawal by Subject|5|||
164127016|NCT01705236|592827128|FG000|Overall Study|Adverse Event|5|||
164127017|NCT06005597|592827129|FG000|Overall Study|Lost to Follow-up|1|||
164127018|NCT06005597|592827130|FG001|Overall Study|Lost to Follow-up|2|||
164127019|NCT06005597|592827131|FG002|Overall Study|Lost to Follow-up|1|||
164127020|NCT06005597|592827132|FG003|Overall Study|Lost to Follow-up|2|||
164127021|NCT06005597|592827129|FG000|Overall Study|Death|1|||
164127022|NCT06005597|592827130|FG001|Overall Study|Death|1|||
164127023|NCT06005597|592827131|FG002|Overall Study|Death|1|||
164127024|NCT06005597|592827132|FG003|Overall Study|Death|0|||
164127025|NCT02224573|592827133|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
164127026|NCT02224573|592827134|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
164127027|NCT02224573|592827133|FG000|Treatment Phase|Started on Other IMP|1|||
164127028|NCT02224573|592827134|FG001|Treatment Phase|Started on Other IMP|0|||
164127029|NCT02224573|592827133|FG000|Treatment Phase|Participant Discontinued IMP|0|||
164127030|NCT02224573|592827134|FG001|Treatment Phase|Participant Discontinued IMP|1|||
164127031|NCT02224573|592827133|FG000|Treatment Phase|Lack of Efficacy|15|||
164127032|NCT02224573|592827134|FG001|Treatment Phase|Lack of Efficacy|8|||
164127033|NCT02224573|592827133|FG000|Treatment Phase|Began Commercial Product|1|||
164127034|NCT02224573|592827134|FG001|Treatment Phase|Began Commercial Product|0|||
164127035|NCT02224573|592827133|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
164127036|NCT02224573|592827134|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
164127037|NCT02224573|592827133|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
164127038|NCT02224573|592827134|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
164127039|NCT02224573|592827133|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
164127040|NCT02224573|592827134|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
164127041|NCT02224573|592827133|FG000|Treatment Phase|Continued Compassionate Use|1|||
164127042|NCT02224573|592827134|FG001|Treatment Phase|Continued Compassionate Use|0|||
164127043|NCT02224573|592827133|FG000|Treatment Phase|Lack of Efficiency|2|||
164127044|NCT02224573|592827134|FG001|Treatment Phase|Lack of Efficiency|1|||
164127045|NCT02224573|592827133|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
164127046|NCT02224573|592827134|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
164127047|NCT02224573|592827133|FG000|Treatment Phase|Participant Moved|2|||
164127048|NCT02224573|592827134|FG001|Treatment Phase|Participant Moved|0|||
164127049|NCT02224573|592827133|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
164127050|NCT02224573|592827134|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
164127051|NCT02224573|592827133|FG000|Treatment Phase|Refused Medication|1|||
164127052|NCT02224573|592827134|FG001|Treatment Phase|Refused Medication|1|||
164127053|NCT02224573|592827133|FG000|Treatment Phase|Adverse Event|26|||
164127054|NCT02224573|592827134|FG001|Treatment Phase|Adverse Event|38|||
164127055|NCT02224573|592827133|FG000|Treatment Phase|Placed in Group Home|0|||
164127056|NCT02224573|592827134|FG001|Treatment Phase|Placed in Group Home|1|||
164127057|NCT02224573|592827133|FG000|Treatment Phase|Pursued Other Trials|1|||
164127058|NCT02224573|592827134|FG001|Treatment Phase|Pursued Other Trials|0|||
164127059|NCT02224573|592827133|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
164127060|NCT02224573|592827134|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
164127061|NCT02224573|592827133|FG000|Treatment Phase|Lost to Follow-up|2|||
164127062|NCT02224573|592827134|FG001|Treatment Phase|Lost to Follow-up|1|||
164127063|NCT02224573|592827133|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
164127064|NCT02224573|592827134|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
164127065|NCT02224573|592827133|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
164127066|NCT02224573|592827134|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
164127067|NCT02224573|592827133|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
164127068|NCT02224573|592827134|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
164127069|NCT02224573|592827133|FG000|Taper Phase|Adverse Event|1|||
164127070|NCT02224573|592827134|FG001|Taper Phase|Adverse Event|1|||
164127071|NCT02546362|592827135|FG000|4-week Treatment Period|Lost to Follow-up|1|||
164127072|NCT02546362|592827135|FG000|4-week Treatment Period|Change in medication|2|||
164127073|NCT02546362|592827135|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
164127074|NCT02546362|592827135|FG000|12-week Treatment Period|Lost to Follow-up|2|||
164127075|NCT02546362|592827135|FG000|12-week Treatment Period|Change in medication|1|||
164127076|NCT02025010|592827136|FG000|Overall Study|Symptomatic or radiographic progression|36|||
164127077|NCT02025010|592827136|FG000|Overall Study|Adverse Event|6|||
164127078|NCT02025010|592827136|FG000|Overall Study|Physician Decision|7|||
164127079|NCT02025010|592827136|FG000|Overall Study|Withdrawal by Subject|3|||
164127080|NCT02025010|592827136|FG000|Overall Study|Intercurrent illness|3|||
164127081|NCT02025010|592827136|FG000|Overall Study|Patients still on treatment|3|||
164127082|NCT02025010|592827136|FG000|Overall Study|Never initiate the treatment|2|||
164127083|NCT05444543|592827146|FG000|Overall Study|Withdrawal by Subject|1|||
164127084|NCT05444543|592827147|FG001|Overall Study|Withdrawal by Subject|0|||
164127085|NCT05444543|592827146|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
164127086|NCT05444543|592827147|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
164127087|NCT05444543|592827146|FG000|Overall Study|Adverse Event|0|||
164127088|NCT05444543|592827147|FG001|Overall Study|Adverse Event|1|||
164127089|NCT05444543|592827146|FG000|Overall Study|Family relocating at a distance from study site|0|||
164127090|NCT05444543|592827147|FG001|Overall Study|Family relocating at a distance from study site|1|||
164127091|NCT01134627|592827150|FG000|Overall Study|Adverse Event|47|||
164127092|NCT01134627|592827151|FG001|Overall Study|Adverse Event|31|||
164127093|NCT01134627|592827150|FG000|Overall Study|Lost to Follow-up|1|||
164127094|NCT01134627|592827151|FG001|Overall Study|Lost to Follow-up|2|||
164127095|NCT01134627|592827150|FG000|Overall Study|Protocol Violation|3|||
164127096|NCT01134627|592827151|FG001|Overall Study|Protocol Violation|5|||
164127097|NCT01134627|592827150|FG000|Overall Study|Lack of Efficacy|2|||
164127098|NCT01134627|592827151|FG001|Overall Study|Lack of Efficacy|12|||
164127099|NCT01134627|592827150|FG000|Overall Study|Withdrawal by Subject|4|||
164127100|NCT01134627|592827151|FG001|Overall Study|Withdrawal by Subject|3|||
164127101|NCT01134627|592827150|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
164127102|NCT01134627|592827151|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
164127103|NCT01134627|592827150|FG000|Overall Study|Other|11|||
164127104|NCT01134627|592827151|FG001|Overall Study|Other|14|||
164127105|NCT00977431|592827152|FG000|Overall Study|Other than listed|1|||
164127106|NCT00977431|592827153|FG001|Overall Study|Other than listed|0|||
164127107|NCT00977431|592827154|FG002|Overall Study|Other than listed|0|||
164127108|NCT00977431|592827155|FG003|Overall Study|Other than listed|0|||
164127109|NCT00977431|592827156|FG004|Overall Study|Other than listed|2|||
164127110|NCT00977431|592827152|FG000|Overall Study|Protocol Violation|0|||
164127111|NCT00977431|592827153|FG001|Overall Study|Protocol Violation|0|||
164127112|NCT00977431|592827154|FG002|Overall Study|Protocol Violation|1|||
164127113|NCT00977431|592827155|FG003|Overall Study|Protocol Violation|0|||
164127114|NCT00977431|592827156|FG004|Overall Study|Protocol Violation|0|||
164127115|NCT00977431|592827152|FG000|Overall Study|Adverse Event|3|||
164127116|NCT00977431|592827153|FG001|Overall Study|Adverse Event|0|||
164127117|NCT00977431|592827154|FG002|Overall Study|Adverse Event|4|||
164127118|NCT00977431|592827155|FG003|Overall Study|Adverse Event|0|||
164127119|NCT00977431|592827156|FG004|Overall Study|Adverse Event|6|||
164127120|NCT00977431|592827152|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
164127121|NCT00977431|592827153|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
164127122|NCT00977431|592827154|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
164127123|NCT00977431|592827155|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
164127124|NCT00977431|592827156|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
164127125|NCT00977431|592827152|FG000|Overall Study|Progressive disease|2|||
164127126|NCT00977431|592827153|FG001|Overall Study|Progressive disease|6|||
164127127|NCT00977431|592827154|FG002|Overall Study|Progressive disease|1|||
164127128|NCT00977431|592827155|FG003|Overall Study|Progressive disease|3|||
164127129|NCT00977431|592827156|FG004|Overall Study|Progressive disease|5|||
164127130|NCT00597116|592827157|FG000|Overall Study|Adverse Event|2|||
164127131|NCT00597116|592827158|FG001|Overall Study|Adverse Event|1|||
164127132|NCT00597116|592827157|FG000|Overall Study|Withdrawal by Subject|0|||
164127133|NCT00597116|592827158|FG001|Overall Study|Withdrawal by Subject|2|||
164127134|NCT00597116|592827157|FG000|Overall Study|Physician Decision|0|||
164127135|NCT00597116|592827158|FG001|Overall Study|Physician Decision|1|||
164127136|NCT00597116|592827157|FG000|Overall Study|Death|0|||
164127137|NCT00597116|592827158|FG001|Overall Study|Death|1|||
164127138|NCT00597116|592827157|FG000|Overall Study|Lost to Follow-up|1|||
164127139|NCT00597116|592827158|FG001|Overall Study|Lost to Follow-up|0|||
164127140|NCT00597116|592827157|FG000|Overall Study|Progressive disease|11|||
164127141|NCT00597116|592827158|FG001|Overall Study|Progressive disease|6|||
164127142|NCT00958126|592827164|FG000|Overall Study|Serious Adverse Event|0|||
164127143|NCT00958126|592827165|FG001|Overall Study|Serious Adverse Event|2|||
164127144|NCT00958126|592827166|FG002|Overall Study|Serious Adverse Event|0|||
164127145|NCT00958126|592827167|FG003|Overall Study|Serious Adverse Event|0|||
164127146|NCT00958126|592827168|FG004|Overall Study|Serious Adverse Event|0|||
164127147|NCT00958126|592827169|FG005|Overall Study|Serious Adverse Event|0|||
164127148|NCT00958126|592827170|FG006|Overall Study|Serious Adverse Event|1|||
164127149|NCT00958126|592827171|FG007|Overall Study|Serious Adverse Event|0|||
164127150|NCT00958126|592827164|FG000|Overall Study|Withdrawal by Subject|0|||
164127151|NCT00958126|592827165|FG001|Overall Study|Withdrawal by Subject|2|||
164127152|NCT00958126|592827166|FG002|Overall Study|Withdrawal by Subject|0|||
164127153|NCT00958126|592827167|FG003|Overall Study|Withdrawal by Subject|0|||
164127154|NCT00958126|592827168|FG004|Overall Study|Withdrawal by Subject|0|||
164127155|NCT00958126|592827169|FG005|Overall Study|Withdrawal by Subject|0|||
164127156|NCT00958126|592827170|FG006|Overall Study|Withdrawal by Subject|0|||
164127157|NCT00958126|592827171|FG007|Overall Study|Withdrawal by Subject|0|||
164127158|NCT00958126|592827164|FG000|Overall Study|Moved away from study area|0|||
164127159|NCT00958126|592827165|FG001|Overall Study|Moved away from study area|0|||
164127160|NCT00958126|592827166|FG002|Overall Study|Moved away from study area|1|||
164127161|NCT00958126|592827167|FG003|Overall Study|Moved away from study area|1|||
164127162|NCT00958126|592827168|FG004|Overall Study|Moved away from study area|0|||
164127163|NCT00958126|592827169|FG005|Overall Study|Moved away from study area|0|||
164127164|NCT00958126|592827170|FG006|Overall Study|Moved away from study area|0|||
164127165|NCT00958126|592827171|FG007|Overall Study|Moved away from study area|0|||
164127166|NCT00958126|592827164|FG000|Overall Study|Lost to Follow-up|1|||
164127167|NCT00958126|592827165|FG001|Overall Study|Lost to Follow-up|5|||
164127168|NCT00958126|592827166|FG002|Overall Study|Lost to Follow-up|9|||
164127169|NCT00958126|592827167|FG003|Overall Study|Lost to Follow-up|8|||
164127170|NCT00958126|592827168|FG004|Overall Study|Lost to Follow-up|0|||
164127171|NCT00958126|592827169|FG005|Overall Study|Lost to Follow-up|0|||
164127172|NCT00958126|592827170|FG006|Overall Study|Lost to Follow-up|0|||
164127173|NCT00958126|592827171|FG007|Overall Study|Lost to Follow-up|0|||
164127174|NCT00958126|592827164|FG000|Overall Study|Sponsor/Investigator decision|0|||
164127175|NCT00958126|592827165|FG001|Overall Study|Sponsor/Investigator decision|0|||
164127176|NCT00958126|592827166|FG002|Overall Study|Sponsor/Investigator decision|0|||
164127177|NCT00958126|592827167|FG003|Overall Study|Sponsor/Investigator decision|1|||
164127178|NCT00958126|592827168|FG004|Overall Study|Sponsor/Investigator decision|0|||
164127179|NCT00958126|592827169|FG005|Overall Study|Sponsor/Investigator decision|0|||
164127180|NCT00958126|592827170|FG006|Overall Study|Sponsor/Investigator decision|0|||
164127181|NCT00958126|592827171|FG007|Overall Study|Sponsor/Investigator decision|0|||
164127182|NCT00958126|592827164|FG000|Overall Study|Other Reason|0|||
164127183|NCT00958126|592827165|FG001|Overall Study|Other Reason|0|||
164127184|NCT00958126|592827166|FG002|Overall Study|Other Reason|0|||
164127185|NCT00958126|592827167|FG003|Overall Study|Other Reason|1|||
164127186|NCT00958126|592827168|FG004|Overall Study|Other Reason|0|||
164127187|NCT00958126|592827169|FG005|Overall Study|Other Reason|1|||
164127188|NCT00958126|592827170|FG006|Overall Study|Other Reason|0|||
164127189|NCT00958126|592827171|FG007|Overall Study|Other Reason|0|||
164127190|NCT00720226|592827172|FG000|Overall Study|Withdrawal by Subject|7|||
164127191|NCT00720226|592827173|FG001|Overall Study|Withdrawal by Subject|4|||
164127192|NCT03401073|592827176|FG000|Overall Study|Lost to Follow-up|1|||
164127193|NCT03401073|592827177|FG001|Overall Study|Lost to Follow-up|2|||
164127194|NCT00733369|592827178|FG000|Overall Study|Lost to Follow-up|2|||
164127195|NCT00733369|592827179|FG001|Overall Study|Lost to Follow-up|1|||
164127196|NCT00733369|592827178|FG000|Overall Study|Adverse Event|4|||
164127197|NCT00733369|592827179|FG001|Overall Study|Adverse Event|4|||
164127198|NCT00733369|592827178|FG000|Overall Study|Protocol Violation|4|||
164127199|NCT00733369|592827179|FG001|Overall Study|Protocol Violation|4|||
164127200|NCT01470612|592827180|FG000|Overall Study|Adverse Event|20|||
164127201|NCT01470612|592827181|FG001|Overall Study|Adverse Event|80|||
164127202|NCT01470612|592827180|FG000|Overall Study|Death|0|||
164127203|NCT01470612|592827181|FG001|Overall Study|Death|1|||
164127204|NCT01470612|592827180|FG000|Overall Study|Lack of Efficacy|20|||
164127205|NCT01470612|592827181|FG001|Overall Study|Lack of Efficacy|326|||
164127206|NCT01470612|592827180|FG000|Overall Study|Lost to Follow-up|2|||
164127207|NCT01470612|592827181|FG001|Overall Study|Lost to Follow-up|5|||
164127208|NCT01470612|592827180|FG000|Overall Study|Did not meet entrance criteria|0|||
164127209|NCT01470612|592827181|FG001|Overall Study|Did not meet entrance criteria|1|||
164127210|NCT01470612|592827180|FG000|Overall Study|Pregnancy|2|||
164127211|NCT01470612|592827181|FG001|Overall Study|Pregnancy|10|||
164127212|NCT01470612|592827180|FG000|Overall Study|Protocol Violation|2|||
164127213|NCT01470612|592827181|FG001|Overall Study|Protocol Violation|7|||
164127214|NCT01470612|592827180|FG000|Overall Study|Withdrawal by Subject|24|||
164127215|NCT01470612|592827181|FG001|Overall Study|Withdrawal by Subject|79|||
164127216|NCT01470612|592827180|FG000|Overall Study|Other|14|||
164127217|NCT01470612|592827181|FG001|Overall Study|Other|156|||
164127218|NCT01813071|592827182|FG000|Overall Study|Protocol Violation|0|||
164127219|NCT01813071|592827183|FG001|Overall Study|Protocol Violation|0|||
164127220|NCT01813071|592827184|FG002|Overall Study|Protocol Violation|0|||
164127221|NCT01813071|592827185|FG003|Overall Study|Protocol Violation|0|||
164127222|NCT01813071|592827186|FG004|Overall Study|Protocol Violation|1|||
164127223|NCT01813071|592827187|FG005|Overall Study|Protocol Violation|4|||
164127224|NCT01813071|592827188|FG006|Overall Study|Protocol Violation|2|||
164127225|NCT01813071|592827189|FG007|Overall Study|Protocol Violation|4|||
164127226|NCT01813071|592827190|FG008|Overall Study|Protocol Violation|2|||
164127227|NCT01813071|592827182|FG000|Overall Study|Withdrawal by Subject|0|||
164127228|NCT01813071|592827183|FG001|Overall Study|Withdrawal by Subject|0|||
164127229|NCT01813071|592827184|FG002|Overall Study|Withdrawal by Subject|0|||
164127230|NCT01813071|592827185|FG003|Overall Study|Withdrawal by Subject|0|||
164127231|NCT01813071|592827186|FG004|Overall Study|Withdrawal by Subject|0|||
164127232|NCT01813071|592827187|FG005|Overall Study|Withdrawal by Subject|1|||
164127233|NCT01813071|592827188|FG006|Overall Study|Withdrawal by Subject|0|||
164127234|NCT01813071|592827189|FG007|Overall Study|Withdrawal by Subject|0|||
164127235|NCT01813071|592827190|FG008|Overall Study|Withdrawal by Subject|0|||
164127236|NCT01813071|592827182|FG000|Overall Study|Adverse Event|0|||
164127237|NCT01813071|592827183|FG001|Overall Study|Adverse Event|0|||
164127238|NCT01813071|592827184|FG002|Overall Study|Adverse Event|0|||
164127239|NCT01813071|592827185|FG003|Overall Study|Adverse Event|0|||
164127240|NCT01813071|592827186|FG004|Overall Study|Adverse Event|0|||
164127241|NCT01813071|592827187|FG005|Overall Study|Adverse Event|1|||
164127242|NCT01813071|592827188|FG006|Overall Study|Adverse Event|0|||
164127243|NCT01813071|592827189|FG007|Overall Study|Adverse Event|0|||
164127244|NCT01813071|592827190|FG008|Overall Study|Adverse Event|0|||
164127245|NCT01813071|592827182|FG000|Overall Study|Physician Decision|0|||
164127246|NCT01813071|592827183|FG001|Overall Study|Physician Decision|0|||
164127247|NCT01813071|592827184|FG002|Overall Study|Physician Decision|0|||
164127248|NCT01813071|592827185|FG003|Overall Study|Physician Decision|0|||
164127249|NCT01813071|592827186|FG004|Overall Study|Physician Decision|0|||
164127250|NCT01813071|592827187|FG005|Overall Study|Physician Decision|0|||
164127251|NCT01813071|592827188|FG006|Overall Study|Physician Decision|1|||
164127252|NCT01813071|592827189|FG007|Overall Study|Physician Decision|0|||
164127253|NCT01813071|592827190|FG008|Overall Study|Physician Decision|0|||
164127254|NCT01813071|592827182|FG000|Overall Study|Met inc/exc criteria|0|||
164127255|NCT01813071|592827183|FG001|Overall Study|Met inc/exc criteria|0|||
164127256|NCT01813071|592827184|FG002|Overall Study|Met inc/exc criteria|0|||
164127257|NCT01813071|592827185|FG003|Overall Study|Met inc/exc criteria|0|||
164127258|NCT01813071|592827186|FG004|Overall Study|Met inc/exc criteria|0|||
164127259|NCT01813071|592827187|FG005|Overall Study|Met inc/exc criteria|1|||
164127260|NCT01813071|592827188|FG006|Overall Study|Met inc/exc criteria|0|||
164127261|NCT01813071|592827189|FG007|Overall Study|Met inc/exc criteria|1|||
164127262|NCT01813071|592827190|FG008|Overall Study|Met inc/exc criteria|1|||
164127263|NCT00123955|592827193|FG000|Overall Study|Adverse Event|1|||
164127264|NCT00123955|592827194|FG001|Overall Study|Adverse Event|0|||
164127265|NCT00123955|592827193|FG000|Overall Study|Withdrawal by Subject|4|||
164127266|NCT00123955|592827194|FG001|Overall Study|Withdrawal by Subject|3|||
164127267|NCT00123955|592827193|FG000|Overall Study|Death|0|||
164127268|NCT00123955|592827194|FG001|Overall Study|Death|1|||
164127269|NCT04459715|592827197|FG000|Overall Study|Adverse Event|3|||
164127270|NCT04459715|592827198|FG001|Overall Study|Adverse Event|3|||
164127271|NCT04459715|592827197|FG000|Overall Study|Death|111|||
164127272|NCT04459715|592827198|FG001|Overall Study|Death|93|||
164127273|NCT04459715|592827197|FG000|Overall Study|Lost to Follow-up|10|||
164127274|NCT04459715|592827198|FG001|Overall Study|Lost to Follow-up|9|||
164127275|NCT04459715|592827197|FG000|Overall Study|Other Reasons|4|||
164127276|NCT04459715|592827198|FG001|Overall Study|Other Reasons|5|||
164127277|NCT04459715|592827197|FG000|Overall Study|PROTOCOL DEVIATION|0|||
164127278|NCT04459715|592827198|FG001|Overall Study|PROTOCOL DEVIATION|1|||
164127279|NCT04459715|592827197|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
164127280|NCT04459715|592827198|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
164127281|NCT04459715|592827197|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
164127282|NCT04459715|592827198|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
164127283|NCT04459715|592827197|FG000|Overall Study|Withdrawal by Subject|22|||
164127284|NCT04459715|592827198|FG001|Overall Study|Withdrawal by Subject|22|||
164127285|NCT02427984|592827199|FG000|Overall Study|Lost to Follow-up|13|||
164127286|NCT02427984|592827200|FG001|Overall Study|Lost to Follow-up|5|||
164127287|NCT02427984|592827201|FG002|Overall Study|Lost to Follow-up|18|||
164127288|NCT02054130|592828790|FG000|Overall Study|Withdrawal by Subject|4|||
164127289|NCT02054130|592828791|FG001|Overall Study|Withdrawal by Subject|4|||
164127290|NCT02054130|592828792|FG002|Overall Study|Withdrawal by Subject|7|||
164127291|NCT02054130|592828793|FG003|Overall Study|Withdrawal by Subject|10|||
164127292|NCT02054130|592828790|FG000|Overall Study|Death|0|||
164127293|NCT02054130|592828791|FG001|Overall Study|Death|1|||
164127294|NCT02054130|592828792|FG002|Overall Study|Death|0|||
164127295|NCT02054130|592828793|FG003|Overall Study|Death|0|||
164127296|NCT02054130|592828790|FG000|Overall Study|Lost to Follow-up|0|||
164127297|NCT02054130|592828791|FG001|Overall Study|Lost to Follow-up|0|||
164127298|NCT02054130|592828792|FG002|Overall Study|Lost to Follow-up|1|||
164127299|NCT02054130|592828793|FG003|Overall Study|Lost to Follow-up|2|||
164127300|NCT02054130|592828790|FG000|Overall Study|Missed dose|4|||
164127301|NCT02054130|592828791|FG001|Overall Study|Missed dose|6|||
164127302|NCT02054130|592828792|FG002|Overall Study|Missed dose|7|||
164127303|NCT02054130|592828793|FG003|Overall Study|Missed dose|10|||
164127304|NCT00866658|592828806|FG000|Overall Study|Adverse Event|5|||
164127305|NCT00866658|592828807|FG001|Overall Study|Adverse Event|14|||
164127306|NCT00866658|592828806|FG000|Overall Study|Lack of Efficacy|2|||
164127307|NCT00866658|592828807|FG001|Overall Study|Lack of Efficacy|1|||
164127308|NCT00866658|592828806|FG000|Overall Study|Withdrawal by Subject|1|||
164127309|NCT00866658|592828807|FG001|Overall Study|Withdrawal by Subject|0|||
164127310|NCT00866658|592828806|FG000|Overall Study|Protocol Violation|1|||
164127311|NCT00866658|592828807|FG001|Overall Study|Protocol Violation|1|||
164127312|NCT00866658|592828806|FG000|Overall Study|Familial and Personal Reasons|4|||
164127313|NCT00866658|592828807|FG001|Overall Study|Familial and Personal Reasons|5|||
164127314|NCT01304693|592828816|FG000|Overall Study|Adverse Event|0|||
164127315|NCT01304693|592828817|FG001|Overall Study|Adverse Event|0|||
164127316|NCT01304693|592828818|FG002|Overall Study|Adverse Event|0|||
164127317|NCT01304693|592828819|FG003|Overall Study|Adverse Event|0|||
164127318|NCT01304693|592828820|FG004|Overall Study|Adverse Event|1|||
164127319|NCT01304693|592828816|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
164127320|NCT01304693|592828817|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
164127321|NCT01304693|592828818|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
164127322|NCT01304693|592828819|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
164127323|NCT01304693|592828820|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
164127324|NCT00931268|592828821|FG000|Overall Study|Lost to Follow-up|6|||
164127325|NCT02072148|592828823|FG000|Overall Study|withdrew prior to surgery|23|||
164127326|NCT02072148|592828824|FG001|Overall Study|withdrew prior to surgery|0|||
164127327|NCT02072148|592828825|FG002|Overall Study|withdrew prior to surgery|0|||
164127328|NCT02072148|592828823|FG000|Overall Study|Death|0|||
164127329|NCT02072148|592828824|FG001|Overall Study|Death|0|||
164127330|NCT02072148|592828825|FG002|Overall Study|Death|1|||
164127331|NCT02072148|592828823|FG000|Overall Study|Withdrawal by Subject|0|||
164127332|NCT02072148|592828824|FG001|Overall Study|Withdrawal by Subject|13|||
164127333|NCT02072148|592828825|FG002|Overall Study|Withdrawal by Subject|12|||
164127334|NCT00430495|592828826|FG000|Overall Study|Adverse Event|2|||
164127335|NCT00430495|592828827|FG001|Overall Study|Adverse Event|3|||
164127336|NCT00430495|592828828|FG002|Overall Study|Adverse Event|2|||
164127337|NCT00430495|592828829|FG003|Overall Study|Adverse Event|0|||
164127338|NCT00430495|592828826|FG000|Overall Study|Death|0|||
164127339|NCT00430495|592828827|FG001|Overall Study|Death|0|||
164127340|NCT00430495|592828828|FG002|Overall Study|Death|1|||
164127341|NCT00430495|592828829|FG003|Overall Study|Death|0|||
164127342|NCT00430495|592828826|FG000|Overall Study|Lost to Follow-up|0|||
164127343|NCT00430495|592828827|FG001|Overall Study|Lost to Follow-up|1|||
164127344|NCT00430495|592828828|FG002|Overall Study|Lost to Follow-up|4|||
164127345|NCT00430495|592828829|FG003|Overall Study|Lost to Follow-up|0|||
164127346|NCT00430495|592828826|FG000|Overall Study|Protocol Violation|1|||
164127347|NCT00430495|592828827|FG001|Overall Study|Protocol Violation|0|||
164127348|NCT00430495|592828828|FG002|Overall Study|Protocol Violation|1|||
164127349|NCT00430495|592828829|FG003|Overall Study|Protocol Violation|0|||
164127350|NCT00430495|592828826|FG000|Overall Study|Disease Progression|1|||
164127351|NCT00430495|592828827|FG001|Overall Study|Disease Progression|1|||
164127352|NCT00430495|592828828|FG002|Overall Study|Disease Progression|0|||
164127353|NCT00430495|592828829|FG003|Overall Study|Disease Progression|0|||
164127354|NCT00430495|592828826|FG000|Overall Study|Other|8|||
164127355|NCT00430495|592828827|FG001|Overall Study|Other|2|||
164127356|NCT00430495|592828828|FG002|Overall Study|Other|5|||
164127357|NCT00430495|592828829|FG003|Overall Study|Other|4|||
164127358|NCT00430495|592828826|FG000|Overall Study|Randomized but not Treated|2|||
164127359|NCT00430495|592828827|FG001|Overall Study|Randomized but not Treated|0|||
164127360|NCT00430495|592828828|FG002|Overall Study|Randomized but not Treated|0|||
164127361|NCT00430495|592828829|FG003|Overall Study|Randomized but not Treated|0|||
164127362|NCT04132336|592828830|FG000|Overall Study|Investigator Decision|0|||
164127363|NCT04132336|592828831|FG001|Overall Study|Investigator Decision|1|||
164127364|NCT04132336|592828832|FG002|Overall Study|Investigator Decision|0|||
164127365|NCT04132336|592828833|FG003|Overall Study|Investigator Decision|0|||
164127366|NCT04132336|592828834|FG004|Overall Study|Investigator Decision|0|||
164127367|NCT04132336|592828835|FG005|Overall Study|Investigator Decision|0|||
164127368|NCT04132336|592828836|FG006|Overall Study|Investigator Decision|0|||
164127369|NCT02488330|592828837|FG000|Overall Study|Adverse Event|1|||
164127370|NCT02488330|592828837|FG000|Overall Study|Physician Decision|2|||
164127371|NCT02488330|592828837|FG000|Overall Study|Death|2|||
164127372|NCT02488330|592828837|FG000|Overall Study|Disease Progression|3|||
164127373|NCT02488330|592828837|FG000|Overall Study|Study Termination by Sponsor|4|||
164127374|NCT01621191|592828839|FG000|Overall Study|Adverse Event|9|||
164127375|NCT01621191|592828839|FG000|Overall Study|Withdrawal by Subject|8|||
164127376|NCT01621191|592828839|FG000|Overall Study|Lack of Efficacy|6|||
164127377|NCT01621191|592828839|FG000|Overall Study|Lost to Follow-up|1|||
164127378|NCT01621191|592828839|FG000|Overall Study|Site Removed From Study|1|||
164127379|NCT04355663|592828841|FG000|Overall Study|Physician Decision|2|||
164127380|NCT04355663|592828842|FG001|Overall Study|Physician Decision|7|||
164127381|NCT04355663|592828843|FG002|Overall Study|Physician Decision|0|||
164127382|NCT04355663|592828841|FG000|Overall Study|Adverse Event|0|||
164127383|NCT04355663|592828842|FG001|Overall Study|Adverse Event|0|||
164127384|NCT04355663|592828843|FG002|Overall Study|Adverse Event|1|||
164127385|NCT04355663|592828841|FG000|Overall Study|Withdrawal by Subject|0|||
164127386|NCT04355663|592828842|FG001|Overall Study|Withdrawal by Subject|8|||
164127387|NCT04355663|592828843|FG002|Overall Study|Withdrawal by Subject|3|||
164127388|NCT02787408|592828849|FG000|Overall Study|Death|16|||
164127389|NCT02787408|592828849|FG000|Overall Study|Withdrawal by Subject|1|||
164127390|NCT02787408|592828849|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
164127391|NCT01782482|592828850|FG000|Overall Study|Adverse Event|2|||
164127392|NCT01782482|592828851|FG001|Overall Study|Adverse Event|1|||
164127393|NCT01782482|592828850|FG000|Overall Study|Lost to Follow-up|2|||
164127394|NCT01782482|592828851|FG001|Overall Study|Lost to Follow-up|3|||
164127395|NCT01782482|592828850|FG000|Overall Study|Physician Decision|1|||
164127396|NCT01782482|592828851|FG001|Overall Study|Physician Decision|0|||
164127397|NCT01782482|592828850|FG000|Overall Study|Protocol Violation|1|||
164127398|NCT01782482|592828851|FG001|Overall Study|Protocol Violation|0|||
164127399|NCT01782482|592828850|FG000|Overall Study|Withdrawal by Subject|2|||
164127400|NCT01782482|592828851|FG001|Overall Study|Withdrawal by Subject|3|||
164127401|NCT01782482|592828850|FG000|Overall Study|Randomized in Error|2|||
164127402|NCT01782482|592828851|FG001|Overall Study|Randomized in Error|2|||
164127403|NCT01782482|592828850|FG000|Overall Study|Habitually wearing toric lens OS|0|||
164127404|NCT01782482|592828851|FG001|Overall Study|Habitually wearing toric lens OS|1|||
164127405|NCT02408120|592828852|FG000|Overall Study|Withdrawal by Subject|0|||
164127406|NCT02408120|592828853|FG001|Overall Study|Withdrawal by Subject|1|||
164127407|NCT02408120|592828852|FG000|Overall Study|Treatment Refusal|1|||
164127408|NCT02408120|592828853|FG001|Overall Study|Treatment Refusal|0|||
164127409|NCT02408120|592828852|FG000|Overall Study|Received Steroids|1|||
164127410|NCT02408120|592828853|FG001|Overall Study|Received Steroids|1|||
164127411|NCT02408120|592828852|FG000|Overall Study|Discharged same day|1|||
164127412|NCT02408120|592828853|FG001|Overall Study|Discharged same day|1|||
164127413|NCT02408120|592828852|FG000|Overall Study|Did not receive insulin|1|||
164127414|NCT02408120|592828853|FG001|Overall Study|Did not receive insulin|2|||
164127415|NCT01010750|592828854|FG000|Second Intervention|Adverse Event|0|||
164127416|NCT01010750|592828855|FG001|Second Intervention|Adverse Event|1|||
164127417|NCT01010750|592828856|FG002|Second Intervention|Adverse Event|0|||
164127418|NCT01010750|592828857|FG003|Second Intervention|Adverse Event|0|||
164127419|NCT01010750|592828858|FG004|Second Intervention|Adverse Event|0|||
164127420|NCT01010750|592828859|FG005|Second Intervention|Adverse Event|0|||
164127421|NCT00466726|592828860|FG000|Overall Study|Not evaluable for response|14|||
164127422|NCT02096588|592828861|FG000|Overall Study|Lack of Efficacy|2|||
164127423|NCT02096588|592828862|FG001|Overall Study|Lack of Efficacy|0|||
164127424|NCT02096588|592828861|FG000|Overall Study|Withdrawal by Subject|0|||
164127425|NCT02096588|592828862|FG001|Overall Study|Withdrawal by Subject|1|||
164127426|NCT01258101|592828863|FG000|Overall Study|Adverse Event|5|||
164127427|NCT01258101|592828864|FG001|Overall Study|Adverse Event|6|||
164127428|NCT01258101|592828865|FG002|Overall Study|Adverse Event|0|||
164127429|NCT01258101|592828866|FG003|Overall Study|Adverse Event|0|||
164127430|NCT01258101|592828863|FG000|Overall Study|Extra exclusion criterion amended|2|||
164127431|NCT01258101|592828864|FG001|Overall Study|Extra exclusion criterion amended|1|||
164127432|NCT01258101|592828865|FG002|Overall Study|Extra exclusion criterion amended|1|||
164127433|NCT01258101|592828866|FG003|Overall Study|Extra exclusion criterion amended|1|||
164127434|NCT01258101|592828863|FG000|Overall Study|Informed consent has been withdrawn|2|||
164127435|NCT01258101|592828864|FG001|Overall Study|Informed consent has been withdrawn|2|||
164127436|NCT01258101|592828865|FG002|Overall Study|Informed consent has been withdrawn|1|||
164127437|NCT01258101|592828866|FG003|Overall Study|Informed consent has been withdrawn|1|||
164127438|NCT01258101|592828863|FG000|Overall Study|Patient is not able to attend visits|8|||
164127439|NCT01258101|592828864|FG001|Overall Study|Patient is not able to attend visits|9|||
164127440|NCT01258101|592828865|FG002|Overall Study|Patient is not able to attend visits|7|||
164127441|NCT01258101|592828866|FG003|Overall Study|Patient is not able to attend visits|6|||
164127442|NCT01258101|592828863|FG000|Overall Study|Patient´s compliance|4|||
164127443|NCT01258101|592828864|FG001|Overall Study|Patient´s compliance|3|||
164127444|NCT01258101|592828865|FG002|Overall Study|Patient´s compliance|1|||
164127445|NCT01258101|592828866|FG003|Overall Study|Patient´s compliance|2|||
164127446|NCT01258101|592828863|FG000|Overall Study|Lost to Follow-up|5|||
164127447|NCT01258101|592828864|FG001|Overall Study|Lost to Follow-up|5|||
164127448|NCT01258101|592828865|FG002|Overall Study|Lost to Follow-up|0|||
164127449|NCT01258101|592828866|FG003|Overall Study|Lost to Follow-up|6|||
164127450|NCT01258101|592828863|FG000|Overall Study|PCR positive at week 24|0|||
164127451|NCT01258101|592828864|FG001|Overall Study|PCR positive at week 24|0|||
164132685|NCT01986010|592850664|FG009|Overall Study|Lost to Follow-up|2|||
164127452|NCT01258101|592828865|FG002|Overall Study|PCR positive at week 24|0|||
164127453|NCT01258101|592828866|FG003|Overall Study|PCR positive at week 24|1|||
164127454|NCT01258101|592828863|FG000|Overall Study|Other reason|7|||
164127455|NCT01258101|592828864|FG001|Overall Study|Other reason|8|||
164127456|NCT01258101|592828865|FG002|Overall Study|Other reason|1|||
164127457|NCT01258101|592828866|FG003|Overall Study|Other reason|8|||
164127458|NCT00757848|592828867|FG000|Overall Study|Voluntary discontinuation|1|||
164127459|NCT00757848|592828868|FG001|Overall Study|Voluntary discontinuation|0|||
164127460|NCT00757848|592828867|FG000|Overall Study|Adverse Event|1|||
164127461|NCT00757848|592828868|FG001|Overall Study|Adverse Event|2|||
164127462|NCT00757848|592828867|FG000|Overall Study|Incorrect enrolment|1|||
164127463|NCT00757848|592828868|FG001|Overall Study|Incorrect enrolment|0|||
164127464|NCT01020799|592828871|FG000|Overall Study|Adverse Event|4|||
164127465|NCT01020799|592828872|FG001|Overall Study|Adverse Event|3|||
164127466|NCT01020799|592828873|FG002|Overall Study|Adverse Event|2|||
164127467|NCT01020799|592828871|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
164127468|NCT01020799|592828872|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
164127469|NCT01020799|592828873|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
164127470|NCT01020799|592828871|FG000|Overall Study|Protocol Violation|3|||
164127471|NCT01020799|592828872|FG001|Overall Study|Protocol Violation|2|||
164127472|NCT01020799|592828873|FG002|Overall Study|Protocol Violation|0|||
164127473|NCT01020799|592828871|FG000|Overall Study|Withdrawal by Subject|2|||
164127474|NCT01020799|592828872|FG001|Overall Study|Withdrawal by Subject|2|||
164127475|NCT01020799|592828873|FG002|Overall Study|Withdrawal by Subject|3|||
164127476|NCT01020799|592828871|FG000|Overall Study|Lost to Follow-up|6|||
164127477|NCT01020799|592828872|FG001|Overall Study|Lost to Follow-up|4|||
164127478|NCT01020799|592828873|FG002|Overall Study|Lost to Follow-up|2|||
164127479|NCT02556307|592828876|FG000|Overall Study|Premature treatment interruption|11|||
164127480|NCT02556307|592828876|FG000|Overall Study|Lost to Follow-up|36|||
164127481|NCT02556307|592828876|FG000|Overall Study|Change to triple therapy|4|||
164127482|NCT02556307|592828876|FG000|Overall Study|Enrolled but not treated|2|||
164127483|NCT03438227|592828877|FG000|Overall Study|Withdrawal by Subject|10|||
164127484|NCT03438227|592828878|FG001|Overall Study|Withdrawal by Subject|5|||
164127485|NCT03977701|592828879|FG000|Overall Study|COVID-19 pandemic|0|||
164127486|NCT03977701|592828880|FG001|Overall Study|COVID-19 pandemic|0|||
164127487|NCT03977701|592828881|FG002|Overall Study|COVID-19 pandemic|0|||
164127488|NCT03977701|592828882|FG003|Overall Study|COVID-19 pandemic|0|||
164127489|NCT03977701|592828883|FG004|Overall Study|COVID-19 pandemic|0|||
164127490|NCT03977701|592828884|FG005|Overall Study|COVID-19 pandemic|1|||
164127491|NCT03977701|592828885|FG006|Overall Study|COVID-19 pandemic|0|||
164127492|NCT03977701|592828886|FG007|Overall Study|COVID-19 pandemic|1|||
164127493|NCT03977701|592828887|FG008|Overall Study|COVID-19 pandemic|0|||
164127494|NCT03977701|592828888|FG009|Overall Study|COVID-19 pandemic|0|||
164127495|NCT00430950|592828889|FG000|Overall Study|Adverse Event|7|||
164127496|NCT00430950|592828890|FG001|Overall Study|Adverse Event|6|||
164127497|NCT00430950|592828889|FG000|Overall Study|Withdrawal by Subject|1|||
164127498|NCT00430950|592828890|FG001|Overall Study|Withdrawal by Subject|0|||
164127499|NCT00430950|592828889|FG000|Overall Study|concomitant medication,etc.|5|||
164127500|NCT00430950|592828890|FG001|Overall Study|concomitant medication,etc.|7|||
164127501|NCT02429934|592828891|FG000|Overall Study|Withdrawal by Subject|0|||
164127502|NCT02429934|592828892|FG001|Overall Study|Withdrawal by Subject|2|||
164127503|NCT02429934|592828891|FG000|Overall Study|Adverse Event|2|||
164127504|NCT02429934|592828892|FG001|Overall Study|Adverse Event|0|||
164127505|NCT02429934|592828891|FG000|Overall Study|Lost to Follow-up|1|||
164127506|NCT02429934|592828892|FG001|Overall Study|Lost to Follow-up|1|||
164127507|NCT02429934|592828891|FG000|Overall Study|Physician Decision|1|||
164127508|NCT02429934|592828892|FG001|Overall Study|Physician Decision|0|||
164127509|NCT00869024|592828893|FG000|Overall Study|Death|2|||
164127510|NCT00869024|592828894|FG001|Overall Study|Death|3|||
164127511|NCT00869024|592828893|FG000|Overall Study|Lost to Follow-up|0|||
164127512|NCT00869024|592828894|FG001|Overall Study|Lost to Follow-up|1|||
164127513|NCT00869024|592828893|FG000|Overall Study|Protocol Violation|0|||
164127514|NCT00869024|592828894|FG001|Overall Study|Protocol Violation|1|||
164127515|NCT00293202|592828895|FG000|Overall Study|Withdrawal by Subject|1|||
164127516|NCT00293202|592828896|FG001|Overall Study|Withdrawal by Subject|2|||
164127517|NCT00293202|592828895|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
164127518|NCT00293202|592828896|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
164127519|NCT00293202|592828895|FG000|Overall Study|on-hold due to fistula maturation time|1|||
164127520|NCT00293202|592828896|FG001|Overall Study|on-hold due to fistula maturation time|0|||
164127521|NCT01564459|592828897|FG000|Run-In|Adverse Event|7|||
164127522|NCT01564459|592828898|FG001|Run-In|Adverse Event|0|||
164127523|NCT01564459|592828899|FG002|Run-In|Adverse Event|0|||
164127524|NCT01564459|592828897|FG000|Run-In|Lost to Follow-up|1|||
164127525|NCT01564459|592828898|FG001|Run-In|Lost to Follow-up|0|||
164127526|NCT01564459|592828899|FG002|Run-In|Lost to Follow-up|0|||
164127527|NCT01564459|592828897|FG000|Run-In|Non-compliance with study drug|2|||
164127528|NCT01564459|592828898|FG001|Run-In|Non-compliance with study drug|0|||
164127529|NCT01564459|592828899|FG002|Run-In|Non-compliance with study drug|0|||
164127530|NCT01564459|592828897|FG000|Run-In|Protocol Violation|1|||
164127531|NCT01564459|592828898|FG001|Run-In|Protocol Violation|0|||
164127532|NCT01564459|592828899|FG002|Run-In|Protocol Violation|0|||
164127533|NCT01564459|592828897|FG000|Run-In|Withdrawal by Subject|1|||
164127534|NCT01564459|592828898|FG001|Run-In|Withdrawal by Subject|0|||
164127535|NCT01564459|592828899|FG002|Run-In|Withdrawal by Subject|0|||
164127536|NCT01564459|592828897|FG000|Double-blind Treatment|Adverse Event|0|||
164127537|NCT01564459|592828898|FG001|Double-blind Treatment|Adverse Event|0|||
164127538|NCT01564459|592828899|FG002|Double-blind Treatment|Adverse Event|1|||
164127539|NCT03864042|592828902|FG000|DDI Phase|Adverse Event|2|||
164127540|NCT03864042|592828903|FG001|DDI Phase|Adverse Event|0|||
164127541|NCT03864042|592828904|FG002|DDI Phase|Adverse Event|0|||
164127542|NCT03864042|592828902|FG000|DDI Phase|Physician Decision|1|||
164127543|NCT03864042|592828903|FG001|DDI Phase|Physician Decision|0|||
164127544|NCT03864042|592828904|FG002|DDI Phase|Physician Decision|0|||
164127545|NCT03864042|592828902|FG000|DDI Phase|Progressive Disease|1|||
164127546|NCT03864042|592828903|FG001|DDI Phase|Progressive Disease|0|||
164127547|NCT03864042|592828904|FG002|DDI Phase|Progressive Disease|0|||
164127548|NCT03864042|592828902|FG000|Post-DDI Phase|Adverse Event|5|||
164127549|NCT03864042|592828903|FG001|Post-DDI Phase|Adverse Event|3|||
164127550|NCT03864042|592828904|FG002|Post-DDI Phase|Adverse Event|2|||
164127551|NCT03864042|592828902|FG000|Post-DDI Phase|Progressive Disease|11|||
164127552|NCT03864042|592828903|FG001|Post-DDI Phase|Progressive Disease|6|||
164127553|NCT03864042|592828904|FG002|Post-DDI Phase|Progressive Disease|13|||
164127554|NCT03864042|592828902|FG000|Post-DDI Phase|Discretion of investigator|1|||
164127555|NCT03864042|592828903|FG001|Post-DDI Phase|Discretion of investigator|1|||
164127556|NCT03864042|592828904|FG002|Post-DDI Phase|Discretion of investigator|0|||
164127557|NCT03864042|592828902|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
164127558|NCT03864042|592828903|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
164127559|NCT03864042|592828904|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
164127560|NCT03864042|592828902|FG000|Post-DDI Phase|Withdrawal of consent|1|||
164127561|NCT03864042|592828903|FG001|Post-DDI Phase|Withdrawal of consent|2|||
164127562|NCT03864042|592828904|FG002|Post-DDI Phase|Withdrawal of consent|0|||
164127563|NCT01698775|592828905|FG000|Phase A|Adverse Event|2|||
164127564|NCT01698775|592828906|FG001|Phase A|Adverse Event|1|||
164127565|NCT01698775|592828905|FG000|Phase A|Death|1|||
164127566|NCT01698775|592828906|FG001|Phase A|Death|1|||
164127567|NCT01698775|592828905|FG000|Phase A|Lack of Efficacy|1|||
164127568|NCT01698775|592828906|FG001|Phase A|Lack of Efficacy|0|||
164127569|NCT01698775|592828905|FG000|Phase A|Lost to Follow-up|1|||
164127570|NCT01698775|592828906|FG001|Phase A|Lost to Follow-up|2|||
164127571|NCT01698775|592828905|FG000|Phase A|Protocol Violation|1|||
164127572|NCT01698775|592828906|FG001|Phase A|Protocol Violation|0|||
164127573|NCT01698775|592828905|FG000|Phase A|Withdrawal by Subject|3|||
164127574|NCT01698775|592828906|FG001|Phase A|Withdrawal by Subject|4|||
164127575|NCT01698775|592828905|FG000|Phase A|Kidney [transplant]|0|||
164127576|NCT01698775|592828906|FG001|Phase A|Kidney [transplant]|1|||
164127577|NCT01698775|592828905|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
164127578|NCT01698775|592828906|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
164127579|NCT01698775|592828905|FG000|Phase B|Adverse Event|6|||
164127580|NCT01698775|592828906|FG001|Phase B|Adverse Event|3|||
164127581|NCT01698775|592828905|FG000|Phase B|Death|0|||
164127582|NCT01698775|592828906|FG001|Phase B|Death|1|||
164127583|NCT01698775|592828905|FG000|Phase B|Lack of Efficacy|0|||
164127584|NCT01698775|592828906|FG001|Phase B|Lack of Efficacy|1|||
164127585|NCT01698775|592828905|FG000|Phase B|Lost to Follow-up|0|||
164127586|NCT01698775|592828906|FG001|Phase B|Lost to Follow-up|1|||
164127587|NCT01698775|592828905|FG000|Phase B|Physician Decision|1|||
164127588|NCT01698775|592828906|FG001|Phase B|Physician Decision|1|||
164127589|NCT01698775|592828905|FG000|Phase B|Protocol Violation|1|||
164127590|NCT01698775|592828906|FG001|Phase B|Protocol Violation|1|||
164127591|NCT01698775|592828905|FG000|Phase B|Withdrawal by Subject|6|||
164127592|NCT01698775|592828906|FG001|Phase B|Withdrawal by Subject|2|||
164127593|NCT01244061|592828911|FG000|Overall Study|Death|1|||
164127594|NCT01244061|592828912|FG001|Overall Study|Death|0|||
164127595|NCT01244061|592828911|FG000|Overall Study|Did not meet entrance criteria|1|||
164127596|NCT01244061|592828912|FG001|Overall Study|Did not meet entrance criteria|0|||
164127597|NCT01244061|592828911|FG000|Overall Study|Lack of Efficacy|1|||
164127598|NCT01244061|592828912|FG001|Overall Study|Lack of Efficacy|3|||
164127599|NCT01244061|592828911|FG000|Overall Study|Lost to Follow-up|34|||
164127600|NCT01244061|592828912|FG001|Overall Study|Lost to Follow-up|30|||
164127601|NCT01244061|592828911|FG000|Overall Study|Withdrawal by Subject|29|||
164127602|NCT01244061|592828912|FG001|Overall Study|Withdrawal by Subject|46|||
164127603|NCT01244061|592828911|FG000|Overall Study|Other|8|||
164127604|NCT01244061|592828912|FG001|Overall Study|Other|19|||
164127605|NCT01244061|592828911|FG000|Overall Study|Protocol Violation|1|||
164127606|NCT01244061|592828912|FG001|Overall Study|Protocol Violation|1|||
164127607|NCT01244061|592828911|FG000|Overall Study|Adverse Event|5|||
164127608|NCT01244061|592828912|FG001|Overall Study|Adverse Event|2|||
164127609|NCT01244061|592828911|FG000|Overall Study|Randomized but not treated|2|||
164127610|NCT01244061|592828912|FG001|Overall Study|Randomized but not treated|2|||
164127611|NCT03166124|592828913|FG000|Treatment Period 1|Adverse Event|0|||
164127612|NCT03166124|592828914|FG001|Treatment Period 1|Adverse Event|0|||
164127613|NCT03166124|592828915|FG002|Treatment Period 1|Adverse Event|1|||
164127614|NCT03166124|592828916|FG003|Treatment Period 1|Adverse Event|0|||
164127615|NCT03166124|592828913|FG000|Wash-out Period|Withdrawal by Subject|0|||
164127616|NCT03166124|592828914|FG001|Wash-out Period|Withdrawal by Subject|1|||
164127617|NCT03166124|592828915|FG002|Wash-out Period|Withdrawal by Subject|0|||
164127618|NCT03166124|592828916|FG003|Wash-out Period|Withdrawal by Subject|1|||
164127619|NCT03166124|592828913|FG000|Wash-out Period|Adverse Event|0|||
164127620|NCT03166124|592828914|FG001|Wash-out Period|Adverse Event|1|||
164127621|NCT03166124|592828915|FG002|Wash-out Period|Adverse Event|1|||
164127622|NCT03166124|592828916|FG003|Wash-out Period|Adverse Event|0|||
164127623|NCT00766831|592828917|FG000|Overall Study|Withdrawal by Subject|4|||
164127624|NCT00766831|592828917|FG000|Overall Study|Lost to Follow-up|3|||
164127625|NCT00766831|592828917|FG000|Overall Study|Adverse Event|20|||
164127626|NCT00766831|592828917|FG000|Overall Study|Protocol Violation|15|||
164127627|NCT00766831|592828917|FG000|Overall Study|Physician Decision|5|||
164127628|NCT00766831|592828917|FG000|Overall Study|Withdrawal of consent|26|||
164127629|NCT00766831|592828917|FG000|Overall Study|Non cooperation by participants|14|||
164127630|NCT00766831|592828917|FG000|Overall Study|Other|28|||
164127631|NCT00788593|592828920|FG000|Placebo Run-in Phase|Adverse Event|2|||
164127632|NCT00788593|592828921|FG001|Placebo Run-in Phase|Adverse Event|0|||
164127633|NCT00788593|592828922|FG002|Placebo Run-in Phase|Adverse Event|0|||
164127634|NCT00788593|592828920|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
164127635|NCT00788593|592828921|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
164127636|NCT00788593|592828922|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
164127637|NCT00788593|592828920|FG000|Placebo Run-in Phase|Protocol Violation|2|||
164127638|NCT00788593|592828921|FG001|Placebo Run-in Phase|Protocol Violation|0|||
164127639|NCT00788593|592828922|FG002|Placebo Run-in Phase|Protocol Violation|0|||
164127640|NCT00788593|592828920|FG000|First Intervention Period|Adverse Event|0|||
164127641|NCT00788593|592828921|FG001|First Intervention Period|Adverse Event|1|||
164127642|NCT00788593|592828922|FG002|First Intervention Period|Adverse Event|0|||
164127643|NCT00788593|592828920|FG000|Second Intervention Period|Lost to Follow-up|0|||
164127644|NCT00788593|592828921|FG001|Second Intervention Period|Lost to Follow-up|1|||
164127645|NCT00788593|592828922|FG002|Second Intervention Period|Lost to Follow-up|0|||
164127646|NCT00788593|592828920|FG000|Second Intervention Period|Other|0|||
164127647|NCT00788593|592828921|FG001|Second Intervention Period|Other|0|||
164127648|NCT00788593|592828922|FG002|Second Intervention Period|Other|1|||
164127649|NCT00515034|592828923|FG000|Overall Study|Adverse Event|2|||
164127650|NCT00515034|592828924|FG001|Overall Study|Adverse Event|0|||
164127651|NCT00515034|592828925|FG002|Overall Study|Adverse Event|1|||
164127652|NCT00515034|592828926|FG003|Overall Study|Adverse Event|0|||
164127653|NCT00515034|592828923|FG000|Overall Study|Death|4|||
164127654|NCT00515034|592828924|FG001|Overall Study|Death|2|||
164127655|NCT00515034|592828925|FG002|Overall Study|Death|1|||
164127656|NCT00515034|592828926|FG003|Overall Study|Death|3|||
164127657|NCT00515034|592828923|FG000|Overall Study|Withdrawal by Subject|1|||
164127658|NCT00515034|592828924|FG001|Overall Study|Withdrawal by Subject|0|||
164127659|NCT00515034|592828925|FG002|Overall Study|Withdrawal by Subject|3|||
164127660|NCT00515034|592828926|FG003|Overall Study|Withdrawal by Subject|0|||
164127661|NCT00515034|592828923|FG000|Overall Study|Physician Decision|0|||
164127662|NCT00515034|592828924|FG001|Overall Study|Physician Decision|0|||
164127663|NCT00515034|592828925|FG002|Overall Study|Physician Decision|1|||
164127664|NCT00515034|592828926|FG003|Overall Study|Physician Decision|1|||
164127665|NCT00515034|592828923|FG000|Overall Study|Other|1|||
164127666|NCT00515034|592828924|FG001|Overall Study|Other|0|||
164127667|NCT00515034|592828925|FG002|Overall Study|Other|2|||
164127668|NCT00515034|592828926|FG003|Overall Study|Other|1|||
164127669|NCT01392326|592828927|FG000|Overall Study|Death|2|||
164127670|NCT01392326|592828928|FG001|Overall Study|Death|0|||
164127671|NCT01392326|592828929|FG002|Overall Study|Death|0|||
164127672|NCT01392326|592828927|FG000|Overall Study|Withdrawal by Subject|12|||
164127673|NCT01392326|592828928|FG001|Overall Study|Withdrawal by Subject|11|||
164127674|NCT01392326|592828929|FG002|Overall Study|Withdrawal by Subject|15|||
164127675|NCT01392326|592828927|FG000|Overall Study|Protocol Violation|2|||
164127676|NCT01392326|592828928|FG001|Overall Study|Protocol Violation|0|||
164127677|NCT01392326|592828929|FG002|Overall Study|Protocol Violation|0|||
164127678|NCT01392326|592828927|FG000|Overall Study|Pregnancy|0|||
164127679|NCT01392326|592828928|FG001|Overall Study|Pregnancy|0|||
164127680|NCT01392326|592828929|FG002|Overall Study|Pregnancy|1|||
164127681|NCT01392326|592828927|FG000|Overall Study|Physician Decision|7|||
164127682|NCT01392326|592828928|FG001|Overall Study|Physician Decision|5|||
164127683|NCT01392326|592828929|FG002|Overall Study|Physician Decision|2|||
164127684|NCT01392326|592828927|FG000|Overall Study|Lost to Follow-up|1|||
164127685|NCT01392326|592828928|FG001|Overall Study|Lost to Follow-up|3|||
164127686|NCT01392326|592828929|FG002|Overall Study|Lost to Follow-up|4|||
164127687|NCT01392326|592828927|FG000|Overall Study|Lack of Efficacy|14|||
164127688|NCT01392326|592828928|FG001|Overall Study|Lack of Efficacy|10|||
164127689|NCT01392326|592828929|FG002|Overall Study|Lack of Efficacy|15|||
164127690|NCT01392326|592828927|FG000|Overall Study|Adverse Event|9|||
164127691|NCT01392326|592828928|FG001|Overall Study|Adverse Event|6|||
164127692|NCT01392326|592828929|FG002|Overall Study|Adverse Event|11|||
164127693|NCT03487848|592828932|FG000|Overall Study|Lost to Follow-up|1|||
164127694|NCT01558297|592828933|FG000|Overall Study|Withdrawal by Subject|2|||
164127695|NCT01558297|592828934|FG001|Overall Study|Withdrawal by Subject|2|||
164127696|NCT01558297|592828935|FG002|Overall Study|Withdrawal by Subject|1|||
164127697|NCT00094094|592828936|FG000|Overall Study|Death|2|||
164127698|NCT00094094|592828936|FG000|Overall Study|Lack of Efficacy|23|||
164127699|NCT00094094|592828936|FG000|Overall Study|Adverse Event|7|||
164127700|NCT02655016|592828939|FG000|Overall Study|Disease progression|6|||
164127701|NCT02655016|592828940|FG001|Overall Study|Disease progression|4|||
164127702|NCT02655016|592828939|FG000|Overall Study|Site closed|0|||
164127703|NCT02655016|592828940|FG001|Overall Study|Site closed|1|||
164127704|NCT02655016|592828939|FG000|Overall Study|Death|30|||
164127705|NCT02655016|592828940|FG001|Overall Study|Death|48|||
164127706|NCT02655016|592828939|FG000|Overall Study|Lost to Follow-up|1|||
164127707|NCT02655016|592828940|FG001|Overall Study|Lost to Follow-up|1|||
164127708|NCT02655016|592828939|FG000|Overall Study|Withdrawal by Subject|18|||
164127709|NCT02655016|592828940|FG001|Overall Study|Withdrawal by Subject|36|||
164127710|NCT00952276|592828945|FG000|Overall Study|Withdrawal by Subject|1|||
164127711|NCT00952276|592828946|FG001|Overall Study|Withdrawal by Subject|0|||
164127712|NCT00952276|592828947|FG002|Overall Study|Withdrawal by Subject|0|||
164127713|NCT00952276|592828948|FG003|Overall Study|Withdrawal by Subject|1|||
164127714|NCT00952276|592828949|FG004|Overall Study|Withdrawal by Subject|0|||
164127715|NCT03959527|592830612|FG000|Overall Study|Withdrawal by Subject|8|||
164127716|NCT03959527|592830613|FG001|Overall Study|Withdrawal by Subject|3|||
164127717|NCT03959527|592830612|FG000|Overall Study|Lost to Follow-up|31|||
164127718|NCT03959527|592830613|FG001|Overall Study|Lost to Follow-up|15|||
164127719|NCT03959527|592830612|FG000|Overall Study|Did not meet eligibility criteria|1|||
164127720|NCT03959527|592830613|FG001|Overall Study|Did not meet eligibility criteria|1|||
164127721|NCT03959527|592830612|FG000|Overall Study|Protocol Violation|10|||
164127722|NCT03959527|592830613|FG001|Overall Study|Protocol Violation|5|||
164127723|NCT06029959|592830614|FG000|Overall Study|Physician Decision|6|||
164127724|NCT02960893|592830619|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
164127725|NCT02960893|592830620|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
164127726|NCT02960893|592830621|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
164127727|NCT02960893|592830622|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
164127728|NCT02960893|592830619|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
164127729|NCT02960893|592830620|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
164127730|NCT02960893|592830621|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
164127731|NCT02960893|592830622|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
164127732|NCT02960893|592830619|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
164127733|NCT02960893|592830620|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
164127734|NCT02960893|592830621|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
164127735|NCT02960893|592830622|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
164127736|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
164127737|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
164127738|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
164127739|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
164127740|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
164127741|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
164127742|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
164127743|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
164127744|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
164127745|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
164127746|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
164127747|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
164127748|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
164127749|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
164127750|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
164127751|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
164127752|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
164127753|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
164127754|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
164127755|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
164127756|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
164127757|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
164127758|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
164127759|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
164127760|NCT02960893|592830619|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
164127761|NCT02960893|592830620|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
164132686|NCT01986010|592850665|FG010|Overall Study|Lost to Follow-up|0|||
164127762|NCT02960893|592830621|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
164127763|NCT02960893|592830622|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
164127764|NCT02631876|592830627|FG000|Overall Study|Death|96|||
164127765|NCT02631876|592830628|FG001|Overall Study|Death|50|||
164127766|NCT02631876|592830627|FG000|Overall Study|Investigator's discretion|1|||
164127767|NCT02631876|592830628|FG001|Overall Study|Investigator's discretion|0|||
164127768|NCT02631876|592830627|FG000|Overall Study|Lost to Follow-up|2|||
164127769|NCT02631876|592830628|FG001|Overall Study|Lost to Follow-up|0|||
164127770|NCT02631876|592830627|FG000|Overall Study|Withdrawal by Subject|16|||
164127771|NCT02631876|592830628|FG001|Overall Study|Withdrawal by Subject|9|||
164127772|NCT02631876|592830627|FG000|Overall Study|Other than specified|4|||
164127773|NCT02631876|592830628|FG001|Overall Study|Other than specified|4|||
164127774|NCT04285567|592830629|FG000|Overall Study|Death|3|||
164127775|NCT04285567|592830630|FG001|Overall Study|Death|3|||
164127776|NCT04285567|592830629|FG000|Overall Study|Lost to Follow-up|1|||
164127777|NCT04285567|592830630|FG001|Overall Study|Lost to Follow-up|1|||
164127778|NCT04285567|592830629|FG000|Overall Study|Reason Not Specified|1|||
164127779|NCT04285567|592830630|FG001|Overall Study|Reason Not Specified|1|||
164127780|NCT04285567|592830629|FG000|Overall Study|Physician Decision|2|||
164127781|NCT04285567|592830630|FG001|Overall Study|Physician Decision|1|||
164127782|NCT04285567|592830629|FG000|Overall Study|Withdrawal by Subject|2|||
164127783|NCT04285567|592830630|FG001|Overall Study|Withdrawal by Subject|6|||
164127784|NCT04285567|592830629|FG000|Overall Study|Adverse Event|1|||
164127785|NCT04285567|592830630|FG001|Overall Study|Adverse Event|0|||
164127786|NCT04285567|592830629|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
164127787|NCT04285567|592830630|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
164127788|NCT04556552|592830631|FG000|Overall Study|Lost to Follow-up|1|||
164127789|NCT04556552|592830632|FG001|Overall Study|Lost to Follow-up|0|||
164127790|NCT04556552|592830631|FG000|Overall Study|Claustrophobia|0|||
164127791|NCT04556552|592830632|FG001|Overall Study|Claustrophobia|1|||
164127792|NCT04556552|592830631|FG000|Overall Study|Inability to continue|0|||
164127793|NCT04556552|592830632|FG001|Overall Study|Inability to continue|1|||
164127794|NCT00605865|592830633|FG000|Overall Study|Protocol Violation|115|||
164127795|NCT02856880|592830639|FG000|Overall Study|Withdrawal of consent|1|||
164127796|NCT00094458|592830640|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
164127797|NCT00094458|592830641|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
164127798|NCT00094458|592830642|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
164127799|NCT00094458|592830643|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
164127800|NCT00094458|592830644|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
164127801|NCT00094458|592830645|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
164127802|NCT00094458|592830640|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
164127803|NCT00094458|592830641|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
164127804|NCT00094458|592830642|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
164127805|NCT00094458|592830643|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
164127806|NCT00094458|592830644|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
164127807|NCT00094458|592830645|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
164127808|NCT00094458|592830640|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
164127809|NCT00094458|592830641|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
164127810|NCT00094458|592830642|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
164127811|NCT00094458|592830643|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
164127812|NCT00094458|592830644|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
164127813|NCT00094458|592830645|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
164127814|NCT00094458|592830640|FG000|Main Study: Through Week 30|Adverse Event|38|||
164127815|NCT00094458|592830641|FG001|Main Study: Through Week 30|Adverse Event|20|||
164127816|NCT00094458|592830642|FG002|Main Study: Through Week 30|Adverse Event|28|||
164127817|NCT00094458|592830643|FG003|Main Study: Through Week 30|Adverse Event|0|||
164127818|NCT00094458|592830644|FG004|Main Study: Through Week 30|Adverse Event|0|||
164127819|NCT00094458|592830645|FG005|Main Study: Through Week 30|Adverse Event|0|||
164127820|NCT00094458|592830640|FG000|Main Study: Through Week 30|Death|1|||
164127821|NCT00094458|592830641|FG001|Main Study: Through Week 30|Death|0|||
164127822|NCT00094458|592830642|FG002|Main Study: Through Week 30|Death|0|||
164127823|NCT00094458|592830643|FG003|Main Study: Through Week 30|Death|0|||
164127824|NCT00094458|592830644|FG004|Main Study: Through Week 30|Death|0|||
164127825|NCT00094458|592830645|FG005|Main Study: Through Week 30|Death|0|||
164127826|NCT00094458|592830640|FG000|Main Study: Through Week 30|Other|19|||
164127827|NCT00094458|592830641|FG001|Main Study: Through Week 30|Other|16|||
164127828|NCT00094458|592830642|FG002|Main Study: Through Week 30|Other|9|||
164127829|NCT00094458|592830643|FG003|Main Study: Through Week 30|Other|0|||
164127830|NCT00094458|592830644|FG004|Main Study: Through Week 30|Other|0|||
164127831|NCT00094458|592830645|FG005|Main Study: Through Week 30|Other|0|||
164127832|NCT00094458|592830640|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
164127833|NCT00094458|592830641|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
164127834|NCT00094458|592830642|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
164127835|NCT00094458|592830643|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
164132687|NCT01986010|592850666|FG011|Overall Study|Lost to Follow-up|1|||
164127836|NCT00094458|592830644|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
164127837|NCT00094458|592830645|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
164127838|NCT00094458|592830640|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
164127839|NCT00094458|592830641|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164127840|NCT00094458|592830642|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
164127841|NCT00094458|592830643|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164127842|NCT00094458|592830644|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164127843|NCT00094458|592830645|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
164127844|NCT00094458|592830640|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
164127845|NCT00094458|592830641|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
164127846|NCT00094458|592830642|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
164127847|NCT00094458|592830643|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
164127848|NCT00094458|592830644|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
164127849|NCT00094458|592830645|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
164127850|NCT00094458|592830640|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
164127851|NCT00094458|592830641|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
164127852|NCT00094458|592830642|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
164127853|NCT00094458|592830643|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
164127854|NCT00094458|592830644|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
164127855|NCT00094458|592830645|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
164127856|NCT00094458|592830640|FG000|OLE: Open-Label Extension|Adverse Event|0|||
164127857|NCT00094458|592830641|FG001|OLE: Open-Label Extension|Adverse Event|0|||
164127858|NCT00094458|592830642|FG002|OLE: Open-Label Extension|Adverse Event|0|||
164127859|NCT00094458|592830643|FG003|OLE: Open-Label Extension|Adverse Event|0|||
164127860|NCT00094458|592830644|FG004|OLE: Open-Label Extension|Adverse Event|3|||
164127861|NCT00094458|592830645|FG005|OLE: Open-Label Extension|Adverse Event|4|||
164127862|NCT00094458|592830640|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164127863|NCT00094458|592830641|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164127864|NCT00094458|592830642|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164127865|NCT00094458|592830643|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
164127866|NCT00094458|592830644|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
164127867|NCT00094458|592830645|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
164127868|NCT00094458|592830640|FG000|OLE: Open-Label Extension|Patient decision|0|||
164127869|NCT00094458|592830641|FG001|OLE: Open-Label Extension|Patient decision|0|||
164127870|NCT00094458|592830642|FG002|OLE: Open-Label Extension|Patient decision|0|||
164127871|NCT00094458|592830643|FG003|OLE: Open-Label Extension|Patient decision|0|||
164127872|NCT00094458|592830644|FG004|OLE: Open-Label Extension|Patient decision|1|||
164127873|NCT00094458|592830645|FG005|OLE: Open-Label Extension|Patient decision|0|||
164127874|NCT03247517|592830646|FG000|Overall Study|Adverse Event|0|||
164127875|NCT03247517|592830647|FG001|Overall Study|Adverse Event|4|||
164127876|NCT03247517|592830648|FG002|Overall Study|Adverse Event|2|||
164127877|NCT03247517|592830646|FG000|Overall Study|Lost to Follow-up|2|||
164127878|NCT03247517|592830647|FG001|Overall Study|Lost to Follow-up|6|||
164127879|NCT03247517|592830648|FG002|Overall Study|Lost to Follow-up|4|||
164127880|NCT03247517|592830646|FG000|Overall Study|Consent withdrawn by caregiver|1|||
164127881|NCT03247517|592830647|FG001|Overall Study|Consent withdrawn by caregiver|4|||
164127882|NCT03247517|592830648|FG002|Overall Study|Consent withdrawn by caregiver|7|||
164127883|NCT03247517|592830646|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
164127884|NCT03247517|592830647|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
164127885|NCT03247517|592830648|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
164127886|NCT03247517|592830646|FG000|Overall Study|Protocol Violation|0|||
164127887|NCT03247517|592830647|FG001|Overall Study|Protocol Violation|2|||
164127888|NCT03247517|592830648|FG002|Overall Study|Protocol Violation|0|||
164127889|NCT03247517|592830646|FG000|Overall Study|Multiple reasons|3|||
164127890|NCT03247517|592830647|FG001|Overall Study|Multiple reasons|1|||
164127891|NCT03247517|592830648|FG002|Overall Study|Multiple reasons|0|||
164127892|NCT03310411|592830649|FG000|Period 1|Adverse Event|0|||
164127893|NCT03310411|592830650|FG001|Period 1|Adverse Event|0|||
164127894|NCT03310411|592830651|FG002|Period 1|Adverse Event|0|||
164127895|NCT03310411|592830652|FG003|Period 1|Adverse Event|1|||
164127896|NCT03573505|592830653|FG000|Overall Study|Adverse Event|1|||
164127897|NCT03573505|592830654|FG001|Overall Study|Adverse Event|1|||
164127898|NCT03573505|592830653|FG000|Overall Study|Consent withdrawn|0|||
164127899|NCT03573505|592830654|FG001|Overall Study|Consent withdrawn|1|||
164127900|NCT03573505|592830653|FG000|Overall Study|Disease progression|0|||
164127901|NCT03573505|592830654|FG001|Overall Study|Disease progression|1|||
164127902|NCT03573505|592830653|FG000|Overall Study|Site Terminated by Sponsor|1|||
164127903|NCT03573505|592830654|FG001|Overall Study|Site Terminated by Sponsor|1|||
164127904|NCT03573505|592830653|FG000|Overall Study|Study terminated by sponsor|50|||
164127905|NCT03573505|592830654|FG001|Overall Study|Study terminated by sponsor|45|||
164127906|NCT03573505|592830653|FG000|Overall Study|Reason not specified|0|||
164127907|NCT03573505|592830654|FG001|Overall Study|Reason not specified|1|||
164127908|NCT03573505|592830653|FG000|Overall Study|Death|0|||
164127909|NCT03573505|592830654|FG001|Overall Study|Death|4|||
164127910|NCT00515541|592830655|FG000|Overall Study|Physician Decision|0|||
164127911|NCT00515541|592830656|FG001|Overall Study|Physician Decision|2|||
164127912|NCT00515541|592830657|FG002|Overall Study|Physician Decision|0|||
164127913|NCT00515541|592830658|FG003|Overall Study|Physician Decision|1|||
164127914|NCT00515541|592830655|FG000|Overall Study|No show for appointments|0|||
164127915|NCT00515541|592830656|FG001|Overall Study|No show for appointments|1|||
164127916|NCT00515541|592830657|FG002|Overall Study|No show for appointments|0|||
164127917|NCT00515541|592830658|FG003|Overall Study|No show for appointments|2|||
164127918|NCT00515541|592830655|FG000|Overall Study|Withdrawal by Subject|0|||
164127919|NCT00515541|592830656|FG001|Overall Study|Withdrawal by Subject|2|||
164127920|NCT00515541|592830657|FG002|Overall Study|Withdrawal by Subject|0|||
164127921|NCT00515541|592830658|FG003|Overall Study|Withdrawal by Subject|2|||
164127922|NCT00158756|592830660|FG000|Overall Study|Withdrawal by Subject|5|||
164127923|NCT00158756|592830661|FG001|Overall Study|Withdrawal by Subject|0|||
164127924|NCT00158756|592830662|FG002|Overall Study|Withdrawal by Subject|6|||
164127925|NCT00158756|592830663|FG003|Overall Study|Withdrawal by Subject|1|||
164127926|NCT00158756|592830664|FG004|Overall Study|Withdrawal by Subject|3|||
164127927|NCT00158756|592830660|FG000|Overall Study|Adverse Event|0|||
164127928|NCT00158756|592830661|FG001|Overall Study|Adverse Event|0|||
164127929|NCT00158756|592830662|FG002|Overall Study|Adverse Event|1|||
164127930|NCT00158756|592830663|FG003|Overall Study|Adverse Event|0|||
164127931|NCT00158756|592830664|FG004|Overall Study|Adverse Event|0|||
164127932|NCT00158756|592830660|FG000|Overall Study|Serious adverse event|0|||
164127933|NCT00158756|592830661|FG001|Overall Study|Serious adverse event|0|||
164127934|NCT00158756|592830662|FG002|Overall Study|Serious adverse event|1|||
164127935|NCT00158756|592830663|FG003|Overall Study|Serious adverse event|0|||
164127936|NCT00158756|592830664|FG004|Overall Study|Serious adverse event|0|||
164127937|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
164127938|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
164127939|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
164127940|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
164127941|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
164127942|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
164127943|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
164127944|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
164127945|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
164127946|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
164127947|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
164127948|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
164127949|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
164127950|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
164127951|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
164127952|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
164127953|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
164127954|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
164127955|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
164127956|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
164127957|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
164127958|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
164127959|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
164127960|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
164127961|NCT01421342|592830665|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
164127962|NCT01421342|592830666|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
164127963|NCT01421342|592830667|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
164127964|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
164127965|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
164127966|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
164127967|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
164127968|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
164127969|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
164127970|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
164127971|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
164127972|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
164127973|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
164127974|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
164127975|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
164127976|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
164127977|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
164127978|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
164127979|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
164127980|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
164127981|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
164127982|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
164127983|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
164127984|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
164127985|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
164127986|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
164127987|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
164127988|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
164127989|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
164127990|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
164127991|NCT01421342|592830665|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
164127992|NCT01421342|592830666|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
164127993|NCT01421342|592830667|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
164127994|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
164127995|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
164127996|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
164127997|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
164127998|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
164127999|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
164128000|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
164128001|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
164128002|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
164128003|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
164128004|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
164128005|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
164128006|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
164128007|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
164128008|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
164128009|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
164128010|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
164128011|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
164128012|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
164128013|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
164128014|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
164128015|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
164128016|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
164128017|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
164128018|NCT01421342|592830665|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
164128019|NCT01421342|592830666|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
164128020|NCT01421342|592830667|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
164128021|NCT03656874|592830668|FG000|Overall Study|Lost to Follow-up|3|||
164128022|NCT03656874|592830669|FG001|Overall Study|Lost to Follow-up|17|||
164128023|NCT01206816|592830670|FG000|Overall Study|Protocol Violation|0|||
164128024|NCT01206816|592830671|FG001|Overall Study|Protocol Violation|0|||
164128025|NCT01206816|592830672|FG002|Overall Study|Protocol Violation|1|||
164128026|NCT01206816|592830673|FG003|Overall Study|Protocol Violation|0|||
164128027|NCT01206816|592830674|FG004|Overall Study|Protocol Violation|0|||
164128028|NCT01206816|592830675|FG005|Overall Study|Protocol Violation|0|||
164128029|NCT01206816|592830676|FG006|Overall Study|Protocol Violation|0|||
164128030|NCT01206816|592830670|FG000|Overall Study|Withdrawal by Subject|0|||
164128031|NCT01206816|592830671|FG001|Overall Study|Withdrawal by Subject|0|||
164128032|NCT01206816|592830672|FG002|Overall Study|Withdrawal by Subject|1|||
164128033|NCT01206816|592830673|FG003|Overall Study|Withdrawal by Subject|0|||
164128034|NCT01206816|592830674|FG004|Overall Study|Withdrawal by Subject|0|||
164128035|NCT01206816|592830675|FG005|Overall Study|Withdrawal by Subject|0|||
164128036|NCT01206816|592830676|FG006|Overall Study|Withdrawal by Subject|0|||
164128037|NCT01206816|592830670|FG000|Overall Study|Progressive disease|3|||
164128038|NCT01206816|592830671|FG001|Overall Study|Progressive disease|3|||
164128039|NCT01206816|592830672|FG002|Overall Study|Progressive disease|13|||
164128040|NCT01206816|592830673|FG003|Overall Study|Progressive disease|3|||
164128041|NCT01206816|592830674|FG004|Overall Study|Progressive disease|3|||
164128042|NCT01206816|592830675|FG005|Overall Study|Progressive disease|16|||
164128043|NCT01206816|592830676|FG006|Overall Study|Progressive disease|3|||
164128044|NCT01206816|592830670|FG000|Overall Study|Other AE|0|||
164128045|NCT01206816|592830671|FG001|Overall Study|Other AE|0|||
164128046|NCT01206816|592830672|FG002|Overall Study|Other AE|4|||
164128047|NCT01206816|592830673|FG003|Overall Study|Other AE|0|||
164128048|NCT01206816|592830674|FG004|Overall Study|Other AE|0|||
164128049|NCT01206816|592830675|FG005|Overall Study|Other AE|3|||
164128050|NCT01206816|592830676|FG006|Overall Study|Other AE|2|||
164128051|NCT01206816|592830670|FG000|Overall Study|other than stated above|0|||
164128052|NCT01206816|592830671|FG001|Overall Study|other than stated above|0|||
164128053|NCT01206816|592830672|FG002|Overall Study|other than stated above|1|||
164128054|NCT01206816|592830673|FG003|Overall Study|other than stated above|0|||
164128055|NCT01206816|592830674|FG004|Overall Study|other than stated above|0|||
164128056|NCT01206816|592830675|FG005|Overall Study|other than stated above|0|||
164128057|NCT01206816|592830676|FG006|Overall Study|other than stated above|1|||
164128058|NCT02528123|592830678|FG000|Overall Study|Lost to Follow-up|1|||
164128059|NCT01939496|592830679|FG000|Overall Study|Adverse Event|2|||
164128060|NCT01939496|592830680|FG001|Overall Study|Adverse Event|0|||
164128061|NCT01939496|592830681|FG002|Overall Study|Adverse Event|0|||
164128062|NCT01939496|592830679|FG000|Overall Study|Lost to Follow-up|1|||
164128063|NCT01939496|592830680|FG001|Overall Study|Lost to Follow-up|1|||
164128064|NCT01939496|592830681|FG002|Overall Study|Lost to Follow-up|0|||
164128065|NCT01939496|592830679|FG000|Overall Study|Physician Decision|1|||
164128066|NCT01939496|592830680|FG001|Overall Study|Physician Decision|0|||
164128067|NCT01939496|592830681|FG002|Overall Study|Physician Decision|0|||
164128068|NCT01939496|592830679|FG000|Overall Study|Protocol Violation|3|||
164128069|NCT01939496|592830680|FG001|Overall Study|Protocol Violation|0|||
164128070|NCT01939496|592830681|FG002|Overall Study|Protocol Violation|0|||
164128071|NCT01939496|592830679|FG000|Overall Study|Withdrawal by Subject|0|||
164128072|NCT01939496|592830680|FG001|Overall Study|Withdrawal by Subject|1|||
164128073|NCT01939496|592830681|FG002|Overall Study|Withdrawal by Subject|1|||
164128074|NCT01939496|592830679|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
164128075|NCT01939496|592830680|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
164128076|NCT01939496|592830681|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
164128077|NCT01939496|592830679|FG000|Overall Study|Other|2|||
164128078|NCT01939496|592830680|FG001|Overall Study|Other|0|||
164128079|NCT01939496|592830681|FG002|Overall Study|Other|1|||
164128080|NCT03052322|592830682|FG000|Overall Study|Other un-specified|1|||
164128081|NCT03052322|592830683|FG001|Overall Study|Other un-specified|2|||
164128082|NCT03052322|592830682|FG000|Overall Study|Withdrawal by Subject|10|||
164128083|NCT03052322|592830683|FG001|Overall Study|Withdrawal by Subject|9|||
164128084|NCT03052322|592830682|FG000|Overall Study|Death|0|||
164128085|NCT03052322|592830683|FG001|Overall Study|Death|2|||
164128086|NCT03052322|592830682|FG000|Overall Study|Lack of Efficacy|1|||
164128087|NCT03052322|592830683|FG001|Overall Study|Lack of Efficacy|2|||
164128088|NCT03052322|592830682|FG000|Overall Study|Protocol Violation|1|||
164128089|NCT03052322|592830683|FG001|Overall Study|Protocol Violation|0|||
164128090|NCT03052322|592830682|FG000|Overall Study|Lost to Follow-up|2|||
164128091|NCT03052322|592830683|FG001|Overall Study|Lost to Follow-up|4|||
164128092|NCT03052322|592830682|FG000|Overall Study|Adverse Event|6|||
164128093|NCT03052322|592830683|FG001|Overall Study|Adverse Event|13|||
164128094|NCT05065983|592830686|FG000|Overall Study|Lost to Follow-up|2|||
164128095|NCT00506129|592830687|FG000|Overall Study|Disease Progression/Relapse|15|||
164128096|NCT00506129|592830687|FG000|Overall Study|Death|7|||
164128097|NCT01642914|592830688|FG000|Overall Study|Adverse Event|11|||
164128098|NCT01642914|592830689|FG001|Overall Study|Adverse Event|7|||
164128099|NCT01642914|592830690|FG002|Overall Study|Adverse Event|15|||
164128100|NCT01642914|592830688|FG000|Overall Study|Lack of Efficacy|9|||
164128101|NCT01642914|592830689|FG001|Overall Study|Lack of Efficacy|4|||
164128102|NCT01642914|592830690|FG002|Overall Study|Lack of Efficacy|2|||
164128103|NCT01642914|592830688|FG000|Overall Study|Protocol Violation|15|||
164128104|NCT01642914|592830689|FG001|Overall Study|Protocol Violation|13|||
164128105|NCT01642914|592830690|FG002|Overall Study|Protocol Violation|6|||
164128106|NCT01642914|592830688|FG000|Overall Study|Withdrawal by Subject|5|||
164128107|NCT01642914|592830689|FG001|Overall Study|Withdrawal by Subject|5|||
164128108|NCT01642914|592830690|FG002|Overall Study|Withdrawal by Subject|10|||
164128109|NCT01642914|592830688|FG000|Overall Study|Lost to Follow-up|5|||
164128110|NCT01642914|592830689|FG001|Overall Study|Lost to Follow-up|3|||
164128111|NCT01642914|592830690|FG002|Overall Study|Lost to Follow-up|7|||
164128112|NCT01642914|592830688|FG000|Overall Study|Other Reason|1|||
164128113|NCT01642914|592830689|FG001|Overall Study|Other Reason|0|||
164128114|NCT01642914|592830690|FG002|Overall Study|Other Reason|0|||
164128115|NCT04295135|592830691|FG000|Overall Study|Withdrawal by Subject|2|||
164128116|NCT04295135|592830692|FG001|Overall Study|Withdrawal by Subject|1|||
164128117|NCT04295135|592830691|FG000|Overall Study|Subject left organization|8|||
164128118|NCT04295135|592830692|FG001|Overall Study|Subject left organization|4|||
164128119|NCT02923674|592830693|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
164128120|NCT02923674|592830694|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
164128121|NCT02923674|592830695|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
164128122|NCT02923674|592830693|FG000|Overall Study|Lost to Follow-up|7|||
164128123|NCT02923674|592830694|FG001|Overall Study|Lost to Follow-up|12|||
164128124|NCT02923674|592830695|FG002|Overall Study|Lost to Follow-up|7|||
164128125|NCT02923674|592830693|FG000|Overall Study|Problem with intervention|2|||
164128126|NCT02923674|592830694|FG001|Overall Study|Problem with intervention|2|||
164128127|NCT02923674|592830695|FG002|Overall Study|Problem with intervention|1|||
164128128|NCT02923674|592830693|FG000|Overall Study|Adverse Event|3|||
164128129|NCT02923674|592830694|FG001|Overall Study|Adverse Event|1|||
164128130|NCT02923674|592830695|FG002|Overall Study|Adverse Event|1|||
164128131|NCT02923674|592830693|FG000|Overall Study|Withdrawal by Subject|2|||
164128132|NCT02923674|592830694|FG001|Overall Study|Withdrawal by Subject|2|||
164128133|NCT02923674|592830695|FG002|Overall Study|Withdrawal by Subject|2|||
164128134|NCT02712333|592830699|FG000|First Period|Withdrawal by Subject|3|||
164128135|NCT02712333|592830700|FG001|First Period|Withdrawal by Subject|2|||
164128136|NCT03463993|592830701|FG000|Overall Study|Lost to Follow-up|7|||
164128137|NCT03463993|592830702|FG001|Overall Study|Lost to Follow-up|8|||
164128138|NCT03463993|592830701|FG000|Overall Study|Withdrawal by Subject|2|||
164128139|NCT03463993|592830702|FG001|Overall Study|Withdrawal by Subject|0|||
164128140|NCT03463993|592830701|FG000|Overall Study|Protocol Violation|4|||
164128141|NCT03463993|592830702|FG001|Overall Study|Protocol Violation|1|||
164128142|NCT03463993|592830701|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
164128143|NCT03463993|592830702|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
164128144|NCT03463993|592830701|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
164128145|NCT03463993|592830702|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
164128146|NCT01231373|592830709|FG000|Overall Study|Withdrew consent prior to randomization|2|||
164128147|NCT01231373|592830710|FG001|Overall Study|Withdrew consent prior to randomization|1|||
164128148|NCT01231373|592830711|FG002|Overall Study|Withdrew consent prior to randomization|0|||
164128149|NCT01231373|592830712|FG003|Overall Study|Withdrew consent prior to randomization|0|||
164128150|NCT01231373|592830709|FG000|Overall Study|Lost to Follow-up|0|||
164128151|NCT01231373|592830710|FG001|Overall Study|Lost to Follow-up|0|||
164128152|NCT01231373|592830711|FG002|Overall Study|Lost to Follow-up|0|||
164128153|NCT01231373|592830712|FG003|Overall Study|Lost to Follow-up|1|||
164128154|NCT01231373|592830709|FG000|Overall Study|Withdrew Consent|1|||
164128155|NCT01231373|592830710|FG001|Overall Study|Withdrew Consent|0|||
164128156|NCT01231373|592830711|FG002|Overall Study|Withdrew Consent|0|||
164128157|NCT01231373|592830712|FG003|Overall Study|Withdrew Consent|0|||
164128158|NCT01901874|592830713|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
164128159|NCT01901874|592830713|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
164128160|NCT01901874|592830713|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
164128161|NCT01901874|592830713|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
164128162|NCT01901874|592830713|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
164128163|NCT01901874|592830713|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
164128164|NCT03078582|592830714|FG000|Overall Study|Adverse Event|0|||
164128165|NCT03078582|592830715|FG001|Overall Study|Adverse Event|8|||
164128166|NCT02039414|592830716|FG000|Overall Study|Delivered|1|||
164128167|NCT02039414|592830717|FG001|Overall Study|Delivered|1|||
164128168|NCT02039414|592830716|FG000|Overall Study|Lost to Follow-up|2|||
164128169|NCT02039414|592830717|FG001|Overall Study|Lost to Follow-up|0|||
164128170|NCT02039414|592830716|FG000|Overall Study|Protocol Violation|3|||
164128171|NCT02039414|592830717|FG001|Overall Study|Protocol Violation|1|||
164128172|NCT00706992|592830726|FG000|Overall Study|Study termination|5|||
164128173|NCT00706992|592830727|FG001|Overall Study|Study termination|5|||
164128174|NCT00706992|592830728|FG002|Overall Study|Study termination|6|||
164128175|NCT00706992|592830729|FG003|Overall Study|Study termination|2|||
164128176|NCT00706992|592830730|FG004|Overall Study|Study termination|3|||
164128177|NCT00706992|592830731|FG005|Overall Study|Study termination|2|||
164128178|NCT00706992|592830732|FG006|Overall Study|Study termination|3|||
164128179|NCT00706992|592830726|FG000|Overall Study|Disease progression before treatment|0|||
164128180|NCT00706992|592830727|FG001|Overall Study|Disease progression before treatment|0|||
164128181|NCT00706992|592830728|FG002|Overall Study|Disease progression before treatment|0|||
164128182|NCT00706992|592830729|FG003|Overall Study|Disease progression before treatment|0|||
164128183|NCT00706992|592830730|FG004|Overall Study|Disease progression before treatment|1|||
164128184|NCT00706992|592830731|FG005|Overall Study|Disease progression before treatment|0|||
164128185|NCT00706992|592830732|FG006|Overall Study|Disease progression before treatment|0|||
164128186|NCT01491035|592830737|FG000|Overall Study|Lost to Follow-up|0|||
164128187|NCT01491035|592830738|FG001|Overall Study|Lost to Follow-up|0|||
164128188|NCT01491035|592830739|FG002|Overall Study|Lost to Follow-up|0|||
164128189|NCT01491035|592830740|FG003|Overall Study|Lost to Follow-up|0|||
164128190|NCT01491035|592830741|FG004|Overall Study|Lost to Follow-up|1|||
164128191|NCT01491035|592830742|FG005|Overall Study|Lost to Follow-up|0|||
164128192|NCT01491035|592830743|FG006|Overall Study|Lost to Follow-up|0|||
164128193|NCT01491035|592830744|FG007|Overall Study|Lost to Follow-up|0|||
164128194|NCT02025751|592830750|FG000|Overall Study|Lost to Follow-up|1|||
164128195|NCT02025751|592830751|FG001|Overall Study|Lost to Follow-up|0|||
164128196|NCT02025751|592830750|FG000|Overall Study|Adverse Event|0|||
164128197|NCT02025751|592830751|FG001|Overall Study|Adverse Event|1|||
164128198|NCT02025751|592830750|FG000|Overall Study|Physician Decision|0|||
164128199|NCT02025751|592830751|FG001|Overall Study|Physician Decision|1|||
164128200|NCT02025751|592830750|FG000|Overall Study|Withdrawal by Subject|0|||
164128201|NCT02025751|592830751|FG001|Overall Study|Withdrawal by Subject|1|||
164128202|NCT02687360|592830754|FG000|Overall Study|Withdrawal by Subject|3|||
164128203|NCT02687360|592830755|FG001|Overall Study|Withdrawal by Subject|0|||
164128204|NCT00653991|592830757|FG000|3 Month Follow-up|Participant would not respond|150|||
164128205|NCT00653991|592830758|FG001|3 Month Follow-up|Participant would not respond|157|||
164128206|NCT00653991|592830757|FG000|6 Month Follow-up|Participant would not respond|133|||
164128207|NCT00653991|592830758|FG001|6 Month Follow-up|Participant would not respond|141|||
164128208|NCT02181296|592830759|FG000|Overall Study|Lost to Follow-up|7|||
164128209|NCT02181296|592830760|FG001|Overall Study|Lost to Follow-up|6|||
164128210|NCT01568866|592830761|FG000|Overall Study|Disease Progression|208|||
164128211|NCT01568866|592830762|FG001|Overall Study|Disease Progression|183|||
164128212|NCT01568866|592830761|FG000|Overall Study|Adverse Event|94|||
164128213|NCT01568866|592830762|FG001|Overall Study|Adverse Event|96|||
164128214|NCT01568866|592830761|FG000|Overall Study|Patient Request|55|||
164128215|NCT01568866|592830762|FG001|Overall Study|Patient Request|71|||
164128216|NCT01568866|592830761|FG000|Overall Study|Physician Decision|40|||
164128217|NCT01568866|592830762|FG001|Overall Study|Physician Decision|32|||
164128218|NCT01568866|592830761|FG000|Overall Study|Withdrawal by Subject|19|||
164128219|NCT01568866|592830762|FG001|Overall Study|Withdrawal by Subject|11|||
164128220|NCT01568866|592830761|FG000|Overall Study|Death|10|||
164128221|NCT01568866|592830762|FG001|Overall Study|Death|18|||
164128222|NCT01568866|592830761|FG000|Overall Study|Protocol Non-compliance|2|||
164128223|NCT01568866|592830762|FG001|Overall Study|Protocol Non-compliance|4|||
164128224|NCT01568866|592830761|FG000|Overall Study|Lost to Follow-up|1|||
164128225|NCT01568866|592830762|FG001|Overall Study|Lost to Follow-up|0|||
164128226|NCT01568866|592830761|FG000|Overall Study|Randomized but Not Dosed|9|||
164128227|NCT01568866|592830762|FG001|Overall Study|Randomized but Not Dosed|1|||
164128228|NCT03499119|592830763|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
164128229|NCT03499119|592830764|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
164128230|NCT03499119|592830765|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
164128231|NCT03499119|592830766|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
164128232|NCT03499119|592830763|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
164128233|NCT03499119|592830764|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
164128234|NCT03499119|592830765|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
164128235|NCT03499119|592830766|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
164128236|NCT03499119|592830763|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
164128237|NCT03499119|592830764|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
164128238|NCT03499119|592830765|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
164128239|NCT03499119|592830766|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
164128240|NCT03499119|592830763|FG000|Optional Extension Phase|Lost to Follow-up|0|||
164128241|NCT03499119|592830764|FG001|Optional Extension Phase|Lost to Follow-up|0|||
164128242|NCT03499119|592830765|FG002|Optional Extension Phase|Lost to Follow-up|0|||
164128243|NCT03499119|592830766|FG003|Optional Extension Phase|Lost to Follow-up|1|||
164128244|NCT03499119|592830763|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
164128245|NCT03499119|592830764|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
164128246|NCT03499119|592830765|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
164128247|NCT03499119|592830766|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
164128248|NCT03499119|592830763|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
164128249|NCT03499119|592830764|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
164128250|NCT03499119|592830765|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
164128251|NCT03499119|592830766|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
164128252|NCT04189445|592831701|FG000|Overall Study|Withdrawal of consent|8|||
164128253|NCT04189445|592831702|FG001|Overall Study|Withdrawal of consent|1|||
164128254|NCT04189445|592831703|FG002|Overall Study|Withdrawal of consent|0|||
164128255|NCT04189445|592831701|FG000|Overall Study|Study Terminated by Sponsor|25|||
164128256|NCT04189445|592831702|FG001|Overall Study|Study Terminated by Sponsor|3|||
164128257|NCT04189445|592831703|FG002|Overall Study|Study Terminated by Sponsor|0|||
164128258|NCT04189445|592831701|FG000|Overall Study|Death|54|||
164128259|NCT04189445|592831702|FG001|Overall Study|Death|24|||
164128260|NCT04189445|592831703|FG002|Overall Study|Death|0|||
164128261|NCT00003138|592831704|FG000|Step 1|Reasons off treatment not documented|60|||
164128262|NCT00003138|592831705|FG001|Step 1|Reasons off treatment not documented|57|||
164128263|NCT00003138|592831704|FG000|Step 1|Never started treatment|1|||
164128264|NCT00003138|592831705|FG001|Step 1|Never started treatment|0|||
164128265|NCT00003138|592831704|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
164128266|NCT00003138|592831705|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
164128267|NCT00003138|592831704|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
164128268|NCT00003138|592831705|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
164128269|NCT00003138|592831704|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
164128270|NCT00003138|592831705|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
164128271|NCT00003138|592831704|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
164128272|NCT00003138|592831705|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
164128273|NCT05142566|592831706|FG000|Overall Study|Protocol Violation|1|||
164128274|NCT01859130|592831707|FG000|Overall Study|Death|4|||
164128275|NCT01859130|592831707|FG000|Overall Study|Lost to Follow-up|16|||
164128276|NCT01859130|592831707|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
164128277|NCT01859130|592831707|FG000|Overall Study|Physician Decision|6|||
164128278|NCT01859130|592831707|FG000|Overall Study|Withdrawal by Subject|17|||
164128279|NCT01859130|592831707|FG000|Overall Study|Adverse Event|11|||
164128280|NCT02145026|592831711|FG000|Overall Study|Adverse Event|2|||
164128281|NCT02145026|592831711|FG000|Overall Study|Death|4|||
164128282|NCT02145026|592831711|FG000|Overall Study|Withdrawal by Subject|2|||
164128283|NCT02145026|592831711|FG000|Overall Study|Physician Decision|4|||
164128284|NCT04505293|592831714|FG000|Overall Study|Lost to Follow-up|2|||
164128285|NCT04505293|592831714|FG000|Overall Study|Withdrawal by Subject|6|||
164128286|NCT04505293|592831714|FG000|Overall Study|CT scan unreadable|277|||
164128287|NCT01249365|592831715|FG000|Overall Study|Lost to Follow-up|1|||
164128288|NCT00003875|592831716|FG000|Overall Study|Screen Failed|1|||
164128289|NCT01300052|592831719|FG000|Overall Study|Adverse Event|3|||
164128290|NCT01300052|592831720|FG001|Overall Study|Adverse Event|0|||
164128291|NCT01300052|592831719|FG000|Overall Study|Withdrawal by Subject|2|||
164128292|NCT01300052|592831720|FG001|Overall Study|Withdrawal by Subject|2|||
164128293|NCT01300052|592831719|FG000|Overall Study|Protocol Violation|1|||
164128294|NCT01300052|592831720|FG001|Overall Study|Protocol Violation|1|||
164128295|NCT03835325|592831721|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
164128296|NCT03835325|592831721|FG000|Overall Study|Selection failure|1|||
164128297|NCT01546649|592831724|FG000|Overall Study|Adverse Event|4|||
164128298|NCT01546649|592831725|FG001|Overall Study|Adverse Event|5|||
164128299|NCT01546649|592831724|FG000|Overall Study|Protocol Violation|1|||
164128300|NCT01546649|592831725|FG001|Overall Study|Protocol Violation|0|||
164128301|NCT01546649|592831724|FG000|Overall Study|Lack of Efficacy|1|||
164128302|NCT01546649|592831725|FG001|Overall Study|Lack of Efficacy|0|||
164128303|NCT01546649|592831724|FG000|Overall Study|Recurrence|1|||
164128304|NCT01546649|592831725|FG001|Overall Study|Recurrence|1|||
164128305|NCT01546649|592831724|FG000|Overall Study|Discovery of secondary cancer|0|||
164128306|NCT01546649|592831725|FG001|Overall Study|Discovery of secondary cancer|1|||
164128307|NCT01546649|592831724|FG000|Overall Study|Withdrawal by Subject|1|||
164128308|NCT01546649|592831725|FG001|Overall Study|Withdrawal by Subject|2|||
164128309|NCT01370213|592831726|FG000|Overall Study|Early Death|1|||
164128310|NCT01370213|592831727|FG001|Overall Study|Early Death|0|||
164128311|NCT01370213|592831728|FG002|Overall Study|Early Death|0|||
164128312|NCT01370213|592831726|FG000|Overall Study|Not evaluable|0|||
164128313|NCT01370213|592831727|FG001|Overall Study|Not evaluable|2|||
164128314|NCT01370213|592831728|FG002|Overall Study|Not evaluable|0|||
164128315|NCT01550744|592831732|FG000|Open-Label|Lost to Follow-up|7|||
164128316|NCT01550744|592831733|FG001|Open-Label|Lost to Follow-up|0|||
164128317|NCT01550744|592831734|FG002|Open-Label|Lost to Follow-up|0|||
164128318|NCT01550744|592831732|FG000|Open-Label|Withdrawal by Subject|13|||
164128319|NCT01550744|592831733|FG001|Open-Label|Withdrawal by Subject|0|||
164128320|NCT01550744|592831734|FG002|Open-Label|Withdrawal by Subject|0|||
164128321|NCT01550744|592831732|FG000|Open-Label|Adverse Event|11|||
164128322|NCT01550744|592831733|FG001|Open-Label|Adverse Event|0|||
164128323|NCT01550744|592831734|FG002|Open-Label|Adverse Event|0|||
164128324|NCT01550744|592831732|FG000|Open-Label|Lack of Efficacy|4|||
164128325|NCT01550744|592831733|FG001|Open-Label|Lack of Efficacy|0|||
164128326|NCT01550744|592831734|FG002|Open-Label|Lack of Efficacy|0|||
164128327|NCT01550744|592831732|FG000|Open-Label|Protocol Violation|4|||
164128328|NCT01550744|592831733|FG001|Open-Label|Protocol Violation|0|||
164128329|NCT01550744|592831734|FG002|Open-Label|Protocol Violation|0|||
164128330|NCT01550744|592831732|FG000|Open-Label|Not all 3 study drug injections received|2|||
164128331|NCT01550744|592831733|FG001|Open-Label|Not all 3 study drug injections received|0|||
164128332|NCT01550744|592831734|FG002|Open-Label|Not all 3 study drug injections received|0|||
164128333|NCT01550744|592831732|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
164128334|NCT01550744|592831733|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
164128335|NCT01550744|592831734|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
164128336|NCT01550744|592831732|FG000|Open-Label|Other|1|||
164128337|NCT01550744|592831733|FG001|Open-Label|Other|0|||
164128338|NCT01550744|592831734|FG002|Open-Label|Other|0|||
164128339|NCT01550744|592831732|FG000|Double-Blind|Lost to Follow-up|0|||
164128340|NCT01550744|592831733|FG001|Double-Blind|Lost to Follow-up|6|||
164128341|NCT01550744|592831734|FG002|Double-Blind|Lost to Follow-up|12|||
164128342|NCT01550744|592831732|FG000|Double-Blind|Withdrawal by Subject|0|||
164128343|NCT01550744|592831733|FG001|Double-Blind|Withdrawal by Subject|2|||
164128344|NCT01550744|592831734|FG002|Double-Blind|Withdrawal by Subject|15|||
164128345|NCT01550744|592831732|FG000|Double-Blind|Adverse Event|0|||
164128346|NCT01550744|592831733|FG001|Double-Blind|Adverse Event|4|||
164128347|NCT01550744|592831734|FG002|Double-Blind|Adverse Event|15|||
164128348|NCT01550744|592831732|FG000|Double-Blind|Death|0|||
164128349|NCT01550744|592831733|FG001|Double-Blind|Death|1|||
164128350|NCT01550744|592831734|FG002|Double-Blind|Death|0|||
164128351|NCT01550744|592831732|FG000|Double-Blind|Lack of Efficacy|0|||
164128352|NCT01550744|592831733|FG001|Double-Blind|Lack of Efficacy|2|||
164128353|NCT01550744|592831734|FG002|Double-Blind|Lack of Efficacy|8|||
164128354|NCT01550744|592831732|FG000|Double-Blind|Protocol Violation|0|||
164128355|NCT01550744|592831733|FG001|Double-Blind|Protocol Violation|0|||
164128356|NCT01550744|592831734|FG002|Double-Blind|Protocol Violation|4|||
164128357|NCT01550744|592831732|FG000|Double-Blind|Pregnancy|0|||
164128358|NCT01550744|592831733|FG001|Double-Blind|Pregnancy|0|||
164128359|NCT01550744|592831734|FG002|Double-Blind|Pregnancy|3|||
164128360|NCT01550744|592831732|FG000|Double-Blind|Other|0|||
164128361|NCT01550744|592831733|FG001|Double-Blind|Other|2|||
164128362|NCT01550744|592831734|FG002|Double-Blind|Other|10|||
164128363|NCT00706381|592831737|FG000|Overall Study|Lost to Follow-up|0|||
164128364|NCT00706381|592831738|FG001|Overall Study|Lost to Follow-up|1|||
164128365|NCT00706381|592831739|FG002|Overall Study|Lost to Follow-up|1|||
164128366|NCT00706381|592831740|FG003|Overall Study|Lost to Follow-up|0|||
164128367|NCT05420012|592831741|FG000|Overall Study|Lost to Follow-up|0|||
164128368|NCT05420012|592831742|FG001|Overall Study|Lost to Follow-up|1|||
164128369|NCT00038649|592831746|FG000|Overall Study|Adverse Event|9|||
164128370|NCT03395639|592831747|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
164128371|NCT03395639|592831748|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
164128372|NCT03395639|592831749|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
164128373|NCT03395639|592831747|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
164128374|NCT03395639|592831748|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
164128375|NCT03395639|592831749|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
164128376|NCT03395639|592831747|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
164128377|NCT03395639|592831748|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
164128378|NCT03395639|592831749|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
164128379|NCT03395639|592831747|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
164128380|NCT03395639|592831748|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
164128381|NCT03395639|592831749|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
164128382|NCT03395639|592831747|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
164128383|NCT03395639|592831748|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
164128384|NCT03395639|592831749|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
164128385|NCT00567476|592831754|FG000|Overall Study|Adverse Event|2|||
164128386|NCT00567476|592831755|FG001|Overall Study|Adverse Event|0|||
164128387|NCT00567476|592831754|FG000|Overall Study|Pregnancy|1|||
164128388|NCT00567476|592831755|FG001|Overall Study|Pregnancy|0|||
164128389|NCT00567476|592831754|FG000|Overall Study|Protocol Violation|4|||
164128390|NCT00567476|592831755|FG001|Overall Study|Protocol Violation|1|||
164128391|NCT00567476|592831754|FG000|Overall Study|Lost to Follow-up|0|||
164128392|NCT00567476|592831755|FG001|Overall Study|Lost to Follow-up|1|||
164128393|NCT00567476|592831754|FG000|Overall Study|Administrative issues|1|||
164128394|NCT00567476|592831755|FG001|Overall Study|Administrative issues|0|||
164128395|NCT00567476|592831754|FG000|Overall Study|Medical Decision|0|||
164128396|NCT00567476|592831755|FG001|Overall Study|Medical Decision|1|||
164128397|NCT00567476|592831754|FG000|Overall Study|Non-adherence to protocol|0|||
164128398|NCT00567476|592831755|FG001|Overall Study|Non-adherence to protocol|1|||
164128399|NCT00995085|592831756|FG000|Overall Study|Withdrawal by Subject|5|||
164128400|NCT01194973|592831758|FG000|Screening Period|Screen Failure|3|||
164128401|NCT01194973|592831758|FG000|26 Week Treatment Period|Adverse Event|1|||
164128402|NCT01194973|592831758|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
164128403|NCT01194973|592831758|FG000|26 Week Treatment Period|Pregnancy|1|||
164128404|NCT00767520|592831761|FG000|Overall Study|Participants still on treatment|11|||
164128405|NCT00767520|592831762|FG001|Overall Study|Participants still on treatment|15|||
164128406|NCT00767520|592831761|FG000|Overall Study|Randomized in error and Never treated|0|||
164128407|NCT00767520|592831762|FG001|Overall Study|Randomized in error and Never treated|2|||
164128408|NCT01338987|592831763|FG000|Overall Study|enrolled on new protocol|0|||
164128409|NCT01338987|592831764|FG001|Overall Study|enrolled on new protocol|0|||
164128410|NCT01338987|592831765|FG002|Overall Study|enrolled on new protocol|1|||
164128411|NCT01338987|592831766|FG003|Overall Study|enrolled on new protocol|0|||
164128412|NCT01338987|592831767|FG004|Overall Study|enrolled on new protocol|0|||
164128413|NCT01338987|592831763|FG000|Overall Study|Disease progression on study|2|||
164128414|NCT01338987|592831764|FG001|Overall Study|Disease progression on study|1|||
164128415|NCT01338987|592831765|FG002|Overall Study|Disease progression on study|1|||
164128416|NCT01338987|592831766|FG003|Overall Study|Disease progression on study|0|||
164128417|NCT01338987|592831767|FG004|Overall Study|Disease progression on study|0|||
164128418|NCT00851643|592831779|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
164128419|NCT00851643|592831780|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164128420|NCT00851643|592831781|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164128421|NCT00851643|592831782|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164128422|NCT00851643|592831783|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164128423|NCT00851643|592831784|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
164128424|NCT00851643|592831779|FG000|Base Study (Up to 12 Months)|Other|0|||
164128425|NCT00851643|592831780|FG001|Base Study (Up to 12 Months)|Other|0|||
164128426|NCT00851643|592831781|FG002|Base Study (Up to 12 Months)|Other|0|||
164128427|NCT00851643|592831782|FG003|Base Study (Up to 12 Months)|Other|0|||
164128428|NCT00851643|592831783|FG004|Base Study (Up to 12 Months)|Other|0|||
164128429|NCT00851643|592831784|FG005|Base Study (Up to 12 Months)|Other|1|||
164128430|NCT00851643|592831779|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
164128431|NCT00851643|592831780|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
164128432|NCT00851643|592831781|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
164128433|NCT00851643|592831782|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
164128434|NCT00851643|592831783|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
164128435|NCT00851643|592831784|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
164128436|NCT00851643|592831779|FG000|Extension Study (Up to 36 Months)|Moved|0|||
164128437|NCT00851643|592831780|FG001|Extension Study (Up to 36 Months)|Moved|2|||
164128438|NCT00851643|592831781|FG002|Extension Study (Up to 36 Months)|Moved|1|||
164128439|NCT00851643|592831782|FG003|Extension Study (Up to 36 Months)|Moved|1|||
164128440|NCT00851643|592831783|FG004|Extension Study (Up to 36 Months)|Moved|0|||
164128441|NCT00851643|592831784|FG005|Extension Study (Up to 36 Months)|Moved|1|||
164128442|NCT01641133|592831785|FG000|Overall Study|Protocol Violation|0|||
164128443|NCT01641133|592831786|FG001|Overall Study|Protocol Violation|1|||
164128444|NCT01641133|592831787|FG002|Overall Study|Protocol Violation|1|||
164128445|NCT01641133|592831785|FG000|Overall Study|Migrated/moved from study area|5|||
164128446|NCT01641133|592831786|FG001|Overall Study|Migrated/moved from study area|3|||
164128447|NCT01641133|592831787|FG002|Overall Study|Migrated/moved from study area|1|||
164128448|NCT01641133|592831785|FG000|Overall Study|Adverse Event|0|||
164128449|NCT01641133|592831786|FG001|Overall Study|Adverse Event|0|||
164128450|NCT01641133|592831787|FG002|Overall Study|Adverse Event|1|||
164128451|NCT01641133|592831785|FG000|Overall Study|Withdrawal by Subject|5|||
164128452|NCT01641133|592831786|FG001|Overall Study|Withdrawal by Subject|3|||
164128453|NCT01641133|592831787|FG002|Overall Study|Withdrawal by Subject|3|||
164128454|NCT01641133|592831785|FG000|Overall Study|Lost to Follow-up|0|||
164128455|NCT01641133|592831786|FG001|Overall Study|Lost to Follow-up|2|||
164128456|NCT01641133|592831787|FG002|Overall Study|Lost to Follow-up|2|||
164128457|NCT03351231|592831788|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
164128458|NCT03351231|592831788|FG000|Combination Therapy Period|Disease progression|2|||
164128459|NCT03351231|592831788|FG000|Combination Therapy Period|Study drug toxicity|1|||
164128460|NCT03351231|592831788|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
164128461|NCT03351231|592831788|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
164128462|NCT03351231|592831788|FG000|Safety Follow-Up Period|Other reason|2|||
164128463|NCT02340221|592831795|FG000|Overall Study|Death|100|||
164128464|NCT02340221|592831796|FG001|Overall Study|Death|197|||
164128465|NCT02340221|592831795|FG000|Overall Study|Withdrawal by Participant|24|||
164128466|NCT02340221|592831796|FG001|Overall Study|Withdrawal by Participant|37|||
164128467|NCT02340221|592831795|FG000|Overall Study|Lost to Follow-up|4|||
164128468|NCT02340221|592831796|FG001|Overall Study|Lost to Follow-up|15|||
164128469|NCT02340221|592831795|FG000|Overall Study|Reason Not Specified|85|||
164128470|NCT02340221|592831796|FG001|Overall Study|Reason Not Specified|165|||
164128471|NCT02340221|592831795|FG000|Overall Study|Study Terminated by Sponsor|1|||
164128472|NCT02340221|592831796|FG001|Overall Study|Study Terminated by Sponsor|3|||
164128473|NCT00518622|592831797|FG000|Overall Study|Lost to Follow-up|0|||
164128474|NCT00518622|592831798|FG001|Overall Study|Lost to Follow-up|0|||
164128475|NCT00518622|592831799|FG002|Overall Study|Lost to Follow-up|1|||
164128476|NCT00518622|592831800|FG003|Overall Study|Lost to Follow-up|0|||
164128477|NCT00518622|592831801|FG004|Overall Study|Lost to Follow-up|0|||
164128478|NCT00518622|592831802|FG005|Overall Study|Lost to Follow-up|0|||
164128479|NCT00518622|592831803|FG006|Overall Study|Lost to Follow-up|0|||
164128480|NCT00518622|592831804|FG007|Overall Study|Lost to Follow-up|0|||
164128481|NCT00518622|592831797|FG000|Overall Study|Study medication taken incorrectly|0|||
164128482|NCT00518622|592831798|FG001|Overall Study|Study medication taken incorrectly|1|||
164128483|NCT00518622|592831799|FG002|Overall Study|Study medication taken incorrectly|0|||
164128484|NCT00518622|592831800|FG003|Overall Study|Study medication taken incorrectly|0|||
164128485|NCT00518622|592831801|FG004|Overall Study|Study medication taken incorrectly|0|||
164128486|NCT00518622|592831802|FG005|Overall Study|Study medication taken incorrectly|0|||
164128487|NCT00518622|592831803|FG006|Overall Study|Study medication taken incorrectly|0|||
164128488|NCT00518622|592831804|FG007|Overall Study|Study medication taken incorrectly|0|||
164128489|NCT00103402|592831805|FG000|Overall Study|Adverse Event|3|||
164128490|NCT00103402|592831806|FG001|Overall Study|Adverse Event|4|||
164128491|NCT00103402|592831805|FG000|Overall Study|Lost to Follow-up|8|||
164128492|NCT00103402|592831806|FG001|Overall Study|Lost to Follow-up|7|||
164128493|NCT00103402|592831805|FG000|Overall Study|Dissatisfied/No longer interested|6|||
164128494|NCT00103402|592831806|FG001|Overall Study|Dissatisfied/No longer interested|6|||
164128495|NCT00103402|592831805|FG000|Overall Study|Personal constraints/Other|5|||
164128496|NCT00103402|592831806|FG001|Overall Study|Personal constraints/Other|0|||
164128497|NCT02013375|592831809|FG000|Overall Study|Did not engraft|1|||
164128498|NCT02013375|592831809|FG000|Overall Study|Did not engraft|1|||
164128499|NCT00712985|592831810|FG000|Overall Study|1 withdrew prior to start of drug|1|||
164128500|NCT00712985|592831810|FG000|Overall Study|1 patient moved out of state|1|||
164128501|NCT00712985|592831810|FG000|Overall Study|Lack of Efficacy|3|||
164128502|NCT01663727|592831811|FG000|Overall Study|Death|161|||
164128503|NCT01663727|592831812|FG001|Overall Study|Death|155|||
164128504|NCT01663727|592831811|FG000|Overall Study|Lost to Follow-up|10|||
164128505|NCT01663727|592831812|FG001|Overall Study|Lost to Follow-up|8|||
164128506|NCT01663727|592831811|FG000|Overall Study|Withdrawal by Subject|18|||
164128507|NCT01663727|592831812|FG001|Overall Study|Withdrawal by Subject|25|||
164128508|NCT01663727|592831811|FG000|Overall Study|Study Terminated|51|||
164128509|NCT01663727|592831812|FG001|Overall Study|Study Terminated|50|||
164128510|NCT01663727|592831811|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
164128511|NCT01663727|592831812|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
164128512|NCT01663727|592831811|FG000|Overall Study|Withdrawal prior to dosing.|1|||
164128513|NCT01663727|592831812|FG001|Overall Study|Withdrawal prior to dosing.|0|||
164128514|NCT01902628|592831813|FG000|Overall Study|Withdrawal of participant's consent|7|||
164128515|NCT01902628|592831813|FG000|Overall Study|Adverse Event|41|||
164128516|NCT01902628|592831813|FG000|Overall Study|Lost to Follow-up|35|||
164128517|NCT02522403|592833867|FG000|Overall Study|Lost to Follow-up|2|||
164128518|NCT02522403|592833868|FG001|Overall Study|Lost to Follow-up|2|||
164128519|NCT02522403|592833867|FG000|Overall Study|Withdrawal by Subject|2|||
164128520|NCT02522403|592833868|FG001|Overall Study|Withdrawal by Subject|4|||
164128521|NCT01553279|592833869|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
164128522|NCT01553279|592833870|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
164128523|NCT01553279|592833869|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
164128524|NCT01553279|592833870|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
164128525|NCT01553279|592833869|FG000|Interim Period|Withdrawal by Subject|2|||
164128526|NCT01553279|592833870|FG001|Interim Period|Withdrawal by Subject|2|||
164128527|NCT01553279|592833869|FG000|Interim Period|Lost to Follow-up|1|||
164128528|NCT01553279|592833870|FG001|Interim Period|Lost to Follow-up|0|||
164128529|NCT01553279|592833869|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
164128530|NCT01553279|592833870|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
164128531|NCT01553279|592833869|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
164128532|NCT01553279|592833870|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
164128533|NCT00619112|592833871|FG000|Overall Study|Adverse Event|1|||
164128534|NCT00619112|592833872|FG001|Overall Study|Adverse Event|2|||
164128535|NCT00729248|592833873|FG000|Overall Study|Physician Decision|2|||
164128536|NCT02588950|592833874|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
164128537|NCT02588950|592833875|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
164128538|NCT02588950|592833876|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
164128539|NCT02588950|592833877|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
164128540|NCT02588950|592833874|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
164128541|NCT02588950|592833875|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
164128542|NCT02588950|592833876|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
164128543|NCT02588950|592833877|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
164128544|NCT05855616|592833878|FG000|Overall Study|Lost to Follow-up|1|||
164128545|NCT05855616|592833879|FG001|Overall Study|Lost to Follow-up|2|||
164128546|NCT00652028|592833882|FG000|Overall Study|Adverse Event|1|||
164128547|NCT00652028|592833883|FG001|Overall Study|Adverse Event|0|||
164128548|NCT00652028|592833884|FG002|Overall Study|Adverse Event|0|||
164128549|NCT00652028|592833885|FG003|Overall Study|Adverse Event|0|||
164128550|NCT00652028|592833882|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
164128551|NCT00652028|592833883|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
164128552|NCT00652028|592833884|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
164128553|NCT00652028|592833885|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
164128554|NCT00652028|592833882|FG000|Overall Study|Physician Decision|0|||
164128555|NCT00652028|592833883|FG001|Overall Study|Physician Decision|0|||
164128556|NCT00652028|592833884|FG002|Overall Study|Physician Decision|1|||
164128557|NCT00652028|592833885|FG003|Overall Study|Physician Decision|0|||
164128558|NCT02072824|592833886|FG000|Overall Study|Insufficient clinical response|1|||
164128559|NCT02072824|592833887|FG001|Overall Study|Insufficient clinical response|0|||
164128560|NCT02072824|592833888|FG002|Overall Study|Insufficient clinical response|1|||
164128561|NCT02072824|592833886|FG000|Overall Study|No longer willing to participate|1|||
164128562|NCT02072824|592833887|FG001|Overall Study|No longer willing to participate|0|||
164128563|NCT02072824|592833888|FG002|Overall Study|No longer willing to participate|1|||
164128564|NCT02072824|592833886|FG000|Overall Study|Medication error|0|||
164128565|NCT02072824|592833887|FG001|Overall Study|Medication error|1|||
164128566|NCT02072824|592833888|FG002|Overall Study|Medication error|0|||
164128567|NCT02072824|592833886|FG000|Overall Study|Adverse Event|0|||
164128568|NCT02072824|592833887|FG001|Overall Study|Adverse Event|0|||
164128569|NCT02072824|592833888|FG002|Overall Study|Adverse Event|1|||
164128570|NCT01388166|592833889|FG000|Overall Study|Adverse Event|16|||
164128571|NCT01388166|592833889|FG000|Overall Study|Lost to Follow-up|30|||
164128572|NCT01388166|592833889|FG000|Overall Study|Others than specified above|13|||
164128573|NCT00127036|592833891|FG000|Overall Study|Insufficient Data for Analysis|6|||
164128574|NCT00127036|592833892|FG001|Overall Study|Insufficient Data for Analysis|11|||
164128575|NCT00127036|592833891|FG000|Overall Study|Screen Failure|2|||
164128576|NCT00127036|592833892|FG001|Overall Study|Screen Failure|0|||
164128577|NCT01429051|592833895|FG000|Titration Phase|Death|1|||
164128578|NCT01429051|592833895|FG000|Titration Phase|Withdrawal by Subject|7|||
164128579|NCT01429051|592833895|FG000|Titration Phase|Physician Decision|1|||
164128580|NCT01429051|592833895|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
164128581|NCT01429051|592833895|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
164128582|NCT01429051|592833895|FG000|Efficacy Phase|Adverse Event|1|||
164128583|NCT01429051|592833895|FG000|Efficacy Phase|Death|1|||
164128584|NCT01429051|592833895|FG000|Tolerability Phase|Death|5|||
164128585|NCT01429051|592833895|FG000|Tolerability Phase|Adverse Event|2|||
164128586|NCT01429051|592833895|FG000|Tolerability Phase|Withdrawal by Subject|5|||
164128587|NCT01429051|592833895|FG000|Tolerability Phase|Physician Decision|1|||
164128588|NCT01429051|592833895|FG000|Tolerability Phase|Other|2|||
164128589|NCT01797835|592833903|FG000|Overall Study|Lost to Follow-up|31|||
164128590|NCT01797835|592833904|FG001|Overall Study|Lost to Follow-up|27|||
164128591|NCT03001219|592833905|FG000|Proof of Concept|Study Termination by Sponsor|0|||
164128592|NCT03001219|592833906|FG001|Proof of Concept|Study Termination by Sponsor|1|||
164128593|NCT03001219|592833905|FG000|Proof of Concept|Withdrawal by Subject|0|||
164128594|NCT03001219|592833906|FG001|Proof of Concept|Withdrawal by Subject|4|||
164128595|NCT03001219|592833905|FG000|Proof of Concept|Protocol Deviation|0|||
164128596|NCT03001219|592833906|FG001|Proof of Concept|Protocol Deviation|1|||
164128597|NCT03001219|592833905|FG000|Proof of Concept|Adverse Event|1|||
164128598|NCT03001219|592833906|FG001|Proof of Concept|Adverse Event|1|||
164128599|NCT03001219|592833905|FG000|Proof of Concept|Physician Decision|1|||
164128600|NCT03001219|592833906|FG001|Proof of Concept|Physician Decision|0|||
164128601|NCT03001219|592833905|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
164128602|NCT03001219|592833906|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
164128603|NCT03001219|592833905|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
164128604|NCT03001219|592833906|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
164128605|NCT03001219|592833905|FG000|Extension Period Analysis|Physician Decision|0|||
164128606|NCT03001219|592833906|FG001|Extension Period Analysis|Physician Decision|1|||
164128607|NCT03001219|592833905|FG000|Extension Period Analysis|Adverse Event|1|||
164128608|NCT03001219|592833906|FG001|Extension Period Analysis|Adverse Event|1|||
164128609|NCT03001219|592833905|FG000|Extension Period Analysis|Protocol Deviation|0|||
164128610|NCT03001219|592833906|FG001|Extension Period Analysis|Protocol Deviation|1|||
164128611|NCT03001219|592833905|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
164128612|NCT03001219|592833906|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
164128613|NCT01403064|592833907|FG000|Overall Study|Death|0|||
164128614|NCT01403064|592833908|FG001|Overall Study|Death|0|||
164128615|NCT01403064|592833909|FG002|Overall Study|Death|1|||
164128616|NCT01403064|592833910|FG003|Overall Study|Death|1|||
164128617|NCT01403064|592833907|FG000|Overall Study|Withdrawal by Subject|0|||
164128618|NCT01403064|592833908|FG001|Overall Study|Withdrawal by Subject|0|||
164128619|NCT01403064|592833909|FG002|Overall Study|Withdrawal by Subject|1|||
164128620|NCT01403064|592833910|FG003|Overall Study|Withdrawal by Subject|1|||
164128621|NCT01403064|592833907|FG000|Overall Study|Other|1|||
164128622|NCT01403064|592833908|FG001|Overall Study|Other|0|||
164128623|NCT01403064|592833909|FG002|Overall Study|Other|2|||
164128624|NCT01403064|592833910|FG003|Overall Study|Other|1|||
164128625|NCT00973765|592833911|FG000|Overall Study|Lost to Follow-up|8|||
164128626|NCT00973765|592833912|FG001|Overall Study|Lost to Follow-up|14|||
164128627|NCT02669940|592833913|FG000|Overall Study|Failure to return|0|||
164128628|NCT02669940|592833914|FG001|Overall Study|Failure to return|3|||
164128629|NCT02669940|592833913|FG000|Overall Study|Insufficient follow-up data|1|||
164128630|NCT02669940|592833914|FG001|Overall Study|Insufficient follow-up data|0|||
164128631|NCT01892657|592833915|FG000|Overall Study|Withdrawal by Subject|6|||
164128632|NCT01892657|592833915|FG000|Overall Study|Protocol Violation|12|||
164128633|NCT00986180|592833916|FG000|Overall Study|Adverse Event|21|||
164128634|NCT00986180|592833917|FG001|Overall Study|Adverse Event|23|||
164128635|NCT00986180|592833916|FG000|Overall Study|Lack of Efficacy|4|||
164128636|NCT00986180|592833917|FG001|Overall Study|Lack of Efficacy|3|||
164128637|NCT00986180|592833916|FG000|Overall Study|Lost to Follow-up|5|||
164128638|NCT00986180|592833917|FG001|Overall Study|Lost to Follow-up|7|||
164128639|NCT00986180|592833916|FG000|Overall Study|Physician Decision|1|||
164128640|NCT00986180|592833917|FG001|Overall Study|Physician Decision|3|||
164128641|NCT00986180|592833916|FG000|Overall Study|Protocol Violation|2|||
164128642|NCT00986180|592833917|FG001|Overall Study|Protocol Violation|0|||
164128643|NCT00986180|592833916|FG000|Overall Study|Withdrawal by Subject|1|||
164128644|NCT00986180|592833917|FG001|Overall Study|Withdrawal by Subject|9|||
164128645|NCT00986180|592833916|FG000|Overall Study|Miscellanies|10|||
164128646|NCT00986180|592833917|FG001|Overall Study|Miscellanies|11|||
164128647|NCT03579966|592833927|FG000|Overall Study|Adverse Event|6|||
164128648|NCT03579966|592833927|FG000|Overall Study|Lost to Follow-up|4|||
164128649|NCT03579966|592833927|FG000|Overall Study|Physician Decision|10|||
164128650|NCT03579966|592833927|FG000|Overall Study|Pregnancy|1|||
164128651|NCT03579966|592833927|FG000|Overall Study|Withdrawal by Subject|16|||
164128652|NCT03579966|592833927|FG000|Overall Study|Study terminated by Sponsor|22|||
164128653|NCT03579966|592833927|FG000|Overall Study|Protocol Violation|1|||
164128654|NCT02408068|592833928|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
164128655|NCT02408068|592833929|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
164128656|NCT02408068|592833930|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
164128657|NCT02408068|592833931|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
164128658|NCT02408068|592833932|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
164128659|NCT02408068|592833933|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
164128660|NCT03484117|592833937|FG000|Overall Study|Lost to Follow-up|1|||
164128661|NCT03484117|592833938|FG001|Overall Study|Lost to Follow-up|3|||
164128662|NCT03484117|592833937|FG000|Overall Study|Declined participation in exit assess|1|||
164128663|NCT03484117|592833938|FG001|Overall Study|Declined participation in exit assess|1|||
164128664|NCT03551496|592833939|FG000|Overall Study|Death|11|||
164128665|NCT03551496|592833940|FG001|Overall Study|Death|7|||
164128666|NCT03551496|592833939|FG000|Overall Study|Withdrawal by Subject|4|||
164128667|NCT03551496|592833940|FG001|Overall Study|Withdrawal by Subject|3|||
164128668|NCT03551496|592833939|FG000|Overall Study|Other Reasons|1|||
164128669|NCT03551496|592833940|FG001|Overall Study|Other Reasons|0|||
164128670|NCT00942331|592833941|FG000|Overall Study|Did not start treatment|15|||
164128671|NCT00942331|592833942|FG001|Overall Study|Did not start treatment|22|||
164128672|NCT03856593|592833945|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
164128673|NCT03856593|592833946|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
164128674|NCT02595008|592833947|FG000|Overall Study|Enrolled In Error|1|||
164128675|NCT02595008|592833948|FG001|Overall Study|Enrolled In Error|0|||
164128676|NCT03407118|592833949|FG000|Period 2|Withdrawal by Subject|1|||
164128677|NCT03407118|592833950|FG001|Period 2|Withdrawal by Subject|0|||
164128678|NCT01347866|592833967|FG000|Overall Study|Death|0|||
164128679|NCT01347866|592833968|FG001|Overall Study|Death|0|||
164128680|NCT01347866|592833969|FG002|Overall Study|Death|0|||
164128681|NCT01347866|592833970|FG003|Overall Study|Death|1|||
164128682|NCT01347866|592833971|FG004|Overall Study|Death|2|||
164128683|NCT01347866|592833972|FG005|Overall Study|Death|2|||
164128684|NCT01347866|592833973|FG006|Overall Study|Death|1|||
164128685|NCT01347866|592833974|FG007|Overall Study|Death|0|||
164128686|NCT01347866|592833975|FG008|Overall Study|Death|4|||
164128687|NCT01347866|592833976|FG009|Overall Study|Death|1|||
164128688|NCT01347866|592833977|FG010|Overall Study|Death|3|||
164128689|NCT01347866|592833978|FG011|Overall Study|Death|1|||
164128690|NCT01347866|592833979|FG012|Overall Study|Death|2|||
164128691|NCT01347866|592833980|FG013|Overall Study|Death|0|||
164128692|NCT01347866|592833981|FG014|Overall Study|Death|0|||
164128693|NCT01347866|592833982|FG015|Overall Study|Death|1|||
164128694|NCT01347866|592833983|FG016|Overall Study|Death|0|||
164128695|NCT01347866|592833967|FG000|Overall Study|Lost to Follow-up|0|||
164128696|NCT01347866|592833968|FG001|Overall Study|Lost to Follow-up|0|||
164128697|NCT01347866|592833969|FG002|Overall Study|Lost to Follow-up|0|||
164128698|NCT01347866|592833970|FG003|Overall Study|Lost to Follow-up|0|||
164128699|NCT01347866|592833971|FG004|Overall Study|Lost to Follow-up|0|||
164128700|NCT01347866|592833972|FG005|Overall Study|Lost to Follow-up|0|||
164128701|NCT01347866|592833973|FG006|Overall Study|Lost to Follow-up|0|||
164128702|NCT01347866|592833974|FG007|Overall Study|Lost to Follow-up|1|||
164128703|NCT01347866|592833975|FG008|Overall Study|Lost to Follow-up|1|||
164128704|NCT01347866|592833976|FG009|Overall Study|Lost to Follow-up|0|||
164128705|NCT01347866|592833977|FG010|Overall Study|Lost to Follow-up|0|||
164128706|NCT01347866|592833978|FG011|Overall Study|Lost to Follow-up|0|||
164128707|NCT01347866|592833979|FG012|Overall Study|Lost to Follow-up|0|||
164128708|NCT01347866|592833980|FG013|Overall Study|Lost to Follow-up|0|||
164128709|NCT01347866|592833981|FG014|Overall Study|Lost to Follow-up|0|||
164128710|NCT01347866|592833982|FG015|Overall Study|Lost to Follow-up|0|||
164128711|NCT01347866|592833983|FG016|Overall Study|Lost to Follow-up|0|||
164128712|NCT01347866|592833967|FG000|Overall Study|Other|3|||
164128713|NCT01347866|592833968|FG001|Overall Study|Other|1|||
164128714|NCT01347866|592833969|FG002|Overall Study|Other|1|||
164128715|NCT01347866|592833970|FG003|Overall Study|Other|4|||
164128716|NCT01347866|592833971|FG004|Overall Study|Other|5|||
164128717|NCT01347866|592833972|FG005|Overall Study|Other|0|||
164128718|NCT01347866|592833973|FG006|Overall Study|Other|5|||
164128719|NCT01347866|592833974|FG007|Overall Study|Other|3|||
164128720|NCT01347866|592833975|FG008|Overall Study|Other|22|||
164128721|NCT01347866|592833976|FG009|Overall Study|Other|5|||
164128722|NCT01347866|592833977|FG010|Overall Study|Other|0|||
164128723|NCT01347866|592833978|FG011|Overall Study|Other|3|||
164128724|NCT01347866|592833979|FG012|Overall Study|Other|4|||
164128725|NCT01347866|592833980|FG013|Overall Study|Other|4|||
164128726|NCT01347866|592833981|FG014|Overall Study|Other|2|||
164128727|NCT01347866|592833982|FG015|Overall Study|Other|3|||
164128728|NCT01347866|592833983|FG016|Overall Study|Other|0|||
164128729|NCT01347866|592833967|FG000|Overall Study|Subject refused further follow-up|2|||
164128730|NCT01347866|592833968|FG001|Overall Study|Subject refused further follow-up|0|||
164128731|NCT01347866|592833969|FG002|Overall Study|Subject refused further follow-up|0|||
164128732|NCT01347866|592833970|FG003|Overall Study|Subject refused further follow-up|2|||
164128733|NCT01347866|592833971|FG004|Overall Study|Subject refused further follow-up|0|||
164128734|NCT01347866|592833972|FG005|Overall Study|Subject refused further follow-up|1|||
164128735|NCT01347866|592833973|FG006|Overall Study|Subject refused further follow-up|0|||
164128736|NCT01347866|592833974|FG007|Overall Study|Subject refused further follow-up|0|||
164128737|NCT01347866|592833975|FG008|Overall Study|Subject refused further follow-up|4|||
164128738|NCT01347866|592833976|FG009|Overall Study|Subject refused further follow-up|1|||
164128739|NCT01347866|592833977|FG010|Overall Study|Subject refused further follow-up|0|||
164128740|NCT01347866|592833978|FG011|Overall Study|Subject refused further follow-up|0|||
164128741|NCT01347866|592833979|FG012|Overall Study|Subject refused further follow-up|1|||
164128742|NCT01347866|592833980|FG013|Overall Study|Subject refused further follow-up|3|||
164128743|NCT01347866|592833981|FG014|Overall Study|Subject refused further follow-up|1|||
164128744|NCT01347866|592833982|FG015|Overall Study|Subject refused further follow-up|0|||
164128745|NCT01347866|592833983|FG016|Overall Study|Subject refused further follow-up|2|||
164128746|NCT02999477|592833986|FG000|Overall Study|found ineligible after first dose|0|||
164128747|NCT02999477|592833987|FG001|Overall Study|found ineligible after first dose|1|||
164128748|NCT02999477|592833986|FG000|Overall Study|Withdrawal by Subject|1|||
164128749|NCT02999477|592833987|FG001|Overall Study|Withdrawal by Subject|1|||
164128750|NCT01846273|592833988|FG000|Overall Study|Adverse Event|9|||
164128751|NCT01846273|592833989|FG001|Overall Study|Adverse Event|7|||
164128752|NCT01846273|592833990|FG002|Overall Study|Adverse Event|0|||
164128753|NCT01846273|592833988|FG000|Overall Study|Subject withdrew consent|5|||
164128754|NCT01846273|592833989|FG001|Overall Study|Subject withdrew consent|8|||
164128755|NCT01846273|592833990|FG002|Overall Study|Subject withdrew consent|0|||
164128756|NCT01846273|592833988|FG000|Overall Study|Lost to Follow-up|2|||
164128757|NCT01846273|592833989|FG001|Overall Study|Lost to Follow-up|1|||
164128758|NCT01846273|592833990|FG002|Overall Study|Lost to Follow-up|0|||
164128759|NCT01846273|592833988|FG000|Overall Study|Administrative problems|1|||
164128760|NCT01846273|592833989|FG001|Overall Study|Administrative problems|0|||
164128761|NCT01846273|592833990|FG002|Overall Study|Administrative problems|0|||
164128762|NCT01846273|592833988|FG000|Overall Study|Death|2|||
164128763|NCT01846273|592833989|FG001|Overall Study|Death|1|||
164128764|NCT01846273|592833990|FG002|Overall Study|Death|0|||
164128765|NCT01846273|592833988|FG000|Overall Study|Disease Progression|0|||
164128766|NCT01846273|592833989|FG001|Overall Study|Disease Progression|4|||
164128767|NCT01846273|592833990|FG002|Overall Study|Disease Progression|0|||
164128768|NCT01846273|592833988|FG000|Overall Study|Protocol Deviation|2|||
164128769|NCT01846273|592833989|FG001|Overall Study|Protocol Deviation|3|||
164128770|NCT01846273|592833990|FG002|Overall Study|Protocol Deviation|0|||
164128771|NCT01846273|592833988|FG000|Overall Study|Physician Decision|1|||
164128772|NCT01846273|592833989|FG001|Overall Study|Physician Decision|2|||
164128773|NCT01846273|592833990|FG002|Overall Study|Physician Decision|0|||
164128774|NCT02939014|592833991|FG000|Overall Study|Lost to Follow-up|1|||
164128775|NCT02939014|592833992|FG001|Overall Study|Lost to Follow-up|0|||
164128776|NCT02939014|592833991|FG000|Overall Study|Death|4|||
164128777|NCT02939014|592833992|FG001|Overall Study|Death|3|||
164128778|NCT00359788|592833993|FG000|Overall Study|Adverse Event|11|||
164128779|NCT00359788|592833994|FG001|Overall Study|Adverse Event|10|||
164128780|NCT00359788|592833993|FG000|Overall Study|Lack of Efficacy|1|||
164128781|NCT00359788|592833994|FG001|Overall Study|Lack of Efficacy|2|||
164128782|NCT00359788|592833993|FG000|Overall Study|Lost to Follow-up|3|||
164128783|NCT00359788|592833994|FG001|Overall Study|Lost to Follow-up|2|||
164128784|NCT00359788|592833993|FG000|Overall Study|Withdrawal by Subject|4|||
164128785|NCT00359788|592833994|FG001|Overall Study|Withdrawal by Subject|1|||
164128786|NCT00359788|592833993|FG000|Overall Study|Protocol Violation|4|||
164128787|NCT00359788|592833994|FG001|Overall Study|Protocol Violation|2|||
164128788|NCT02143583|592833997|FG000|Overall Study|Withdrawal by Subject|1|||
164128789|NCT02143583|592833998|FG001|Overall Study|Withdrawal by Subject|0|||
164128790|NCT02143583|592833999|FG002|Overall Study|Withdrawal by Subject|1|||
164128791|NCT02143583|592833997|FG000|Overall Study|husband illness|0|||
164128792|NCT02143583|592833998|FG001|Overall Study|husband illness|0|||
164128793|NCT02143583|592833999|FG002|Overall Study|husband illness|1|||
164128794|NCT02220725|592834000|FG000|Overall Study|Lost to Follow-up|0|||
164128795|NCT02220725|592834001|FG001|Overall Study|Lost to Follow-up|0|||
164128796|NCT02220725|592834002|FG002|Overall Study|Lost to Follow-up|0|||
164128797|NCT02220725|592834003|FG003|Overall Study|Lost to Follow-up|1|||
164128798|NCT02220725|592834000|FG000|Overall Study|Withdrawal by Subject|0|||
164128799|NCT02220725|592834001|FG001|Overall Study|Withdrawal by Subject|0|||
164128800|NCT02220725|592834002|FG002|Overall Study|Withdrawal by Subject|0|||
164128801|NCT02220725|592834003|FG003|Overall Study|Withdrawal by Subject|1|||
164128802|NCT01673698|592834004|FG000|Overall Study|Lost to Follow-up|51|||
164128803|NCT01673698|592834005|FG001|Overall Study|Lost to Follow-up|13|||
164128804|NCT02333487|592834006|FG000|Overall Study|Adverse Event|0|||
164128805|NCT02333487|592834007|FG001|Overall Study|Adverse Event|2|||
164128806|NCT02333487|592834008|FG002|Overall Study|Adverse Event|0|||
164128807|NCT01297322|592834009|FG000|Overall Study|Lost to Follow-up|1|||
164128808|NCT01297322|592834010|FG001|Overall Study|Lost to Follow-up|0|||
164128809|NCT01297322|592834009|FG000|Overall Study|Withdrawal by Subject|0|||
164128810|NCT01297322|592834010|FG001|Overall Study|Withdrawal by Subject|1|||
164128811|NCT01297322|592834009|FG000|Overall Study|Protocol Violation|0|||
164128812|NCT01297322|592834010|FG001|Overall Study|Protocol Violation|3|||
164128813|NCT01111019|592834011|FG000|Overall Study|Withdrew Prematurely|2|||
164128814|NCT01111019|592834011|FG000|Overall Study|Other|1|||
164128815|NCT01583218|592834012|FG000|Overall Study|Withdrawal by Subject|43|||
164128816|NCT01583218|592834013|FG001|Overall Study|Withdrawal by Subject|29|||
164128817|NCT01583218|592834012|FG000|Overall Study|Death|206|||
164128818|NCT01583218|592834013|FG001|Overall Study|Death|211|||
164128819|NCT01583218|592834012|FG000|Overall Study|Lost to Follow-up|11|||
164128820|NCT01583218|592834013|FG001|Overall Study|Lost to Follow-up|17|||
164128821|NCT01583218|592834012|FG000|Overall Study|Adverse event or serious adverse event|3|||
164128822|NCT01583218|592834013|FG001|Overall Study|Adverse event or serious adverse event|3|||
164128823|NCT01583218|592834012|FG000|Overall Study|Patient /Family decision|3|||
164128824|NCT01583218|592834013|FG001|Overall Study|Patient /Family decision|0|||
164128825|NCT01583218|592834012|FG000|Overall Study|Cannot contact patient directly|1|||
164128826|NCT01583218|592834013|FG001|Overall Study|Cannot contact patient directly|2|||
164128827|NCT01583218|592834012|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
164128828|NCT01583218|592834013|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
164128829|NCT01583218|592834012|FG000|Overall Study|Patient did not wish to attend visits|0|||
164128830|NCT01583218|592834013|FG001|Overall Study|Patient did not wish to attend visits|1|||
164128831|NCT01583218|592834012|FG000|Overall Study|Patient randomized but not dosed|17|||
164128832|NCT01583218|592834013|FG001|Overall Study|Patient randomized but not dosed|16|||
164128833|NCT01583218|592834012|FG000|Overall Study|Patient was assessed via phone in person|1|||
164128834|NCT01583218|592834013|FG001|Overall Study|Patient was assessed via phone in person|0|||
164128835|NCT01583218|592834012|FG000|Overall Study|Patient deemed ineligible after random|2|||
164128836|NCT01583218|592834013|FG001|Overall Study|Patient deemed ineligible after random|0|||
164128837|NCT01583218|592834012|FG000|Overall Study|Patient was early terminated from study|0|||
164128838|NCT01583218|592834013|FG001|Overall Study|Patient was early terminated from study|1|||
164128839|NCT01583218|592834012|FG000|Overall Study|Patient was randomized due to mistake|1|||
164128840|NCT01583218|592834013|FG001|Overall Study|Patient was randomized due to mistake|0|||
164128841|NCT01583218|592834012|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
164128842|NCT01583218|592834013|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
164128843|NCT01583218|592834012|FG000|Overall Study|Withdraw of consent on day of random|1|||
164128844|NCT01583218|592834013|FG001|Overall Study|Withdraw of consent on day of random|0|||
164128845|NCT01232491|592834017|FG000|Overall Study|Adverse Event|13|||
164128846|NCT01232491|592834018|FG001|Overall Study|Adverse Event|8|||
164128847|NCT01232491|592834017|FG000|Overall Study|Lack of Efficacy|1|||
164128848|NCT01232491|592834018|FG001|Overall Study|Lack of Efficacy|5|||
164128849|NCT01232491|592834017|FG000|Overall Study|Protocol Violation|13|||
164128850|NCT01232491|592834018|FG001|Overall Study|Protocol Violation|11|||
164128851|NCT01232491|592834017|FG000|Overall Study|Withdrawal Criteria|12|||
164128852|NCT01232491|592834018|FG001|Overall Study|Withdrawal Criteria|21|||
164128853|NCT01232491|592834017|FG000|Overall Study|Other|21|||
164128854|NCT01232491|592834018|FG001|Overall Study|Other|18|||
164128855|NCT02932228|592834019|FG000|Overall Study|Death|8|||
164128856|NCT02932228|592834020|FG001|Overall Study|Death|23|||
164128857|NCT02932228|592834019|FG000|Overall Study|not eligible upon chart review|2|||
164128858|NCT02932228|592834020|FG001|Overall Study|not eligible upon chart review|5|||
164128859|NCT04385277|592836458|FG000|Overall Study|Physician Decision|2|||
164128860|NCT04385277|592836458|FG000|Overall Study|Ineligible|1|||
164128861|NCT04385277|592836458|FG000|Overall Study|Patient/Parent Refusal|2|||
164128862|NCT04905290|592836459|FG000|Overall Study|Adverse Event|4|||
164128863|NCT04905290|592836459|FG000|Overall Study|Death|2|||
164128864|NCT04905290|592836459|FG000|Overall Study|Withdrawal by Subject|4|||
164128865|NCT04905290|592836459|FG000|Overall Study|Physician Decision|2|||
164128866|NCT04905290|592836459|FG000|Overall Study|Lost to Follow-up|2|||
164128867|NCT04905290|592836459|FG000|Overall Study|Screen Failure|2|||
164128868|NCT04905290|592836459|FG000|Overall Study|Unsuccessful Procedure|2|||
164128869|NCT03303625|592836460|FG000|Overall Study|Withdrawal by Subject|2|||
164128870|NCT03303625|592836461|FG001|Overall Study|Withdrawal by Subject|0|||
164128871|NCT03303625|592836462|FG002|Overall Study|Withdrawal by Subject|0|||
164128872|NCT03303625|592836463|FG003|Overall Study|Withdrawal by Subject|0|||
164128873|NCT01045421|592836468|FG000|Phase 1|Progressive Disease|0|||
164128874|NCT01045421|592836469|FG001|Phase 1|Progressive Disease|0|||
164128875|NCT01045421|592836470|FG002|Phase 1|Progressive Disease|0|||
164128876|NCT01045421|592836471|FG003|Phase 1|Progressive Disease|0|||
164128877|NCT01045421|592836472|FG004|Phase 1|Progressive Disease|1|||
164128878|NCT01045421|592836473|FG005|Phase 1|Progressive Disease|0|||
164128879|NCT01045421|592836474|FG006|Phase 1|Progressive Disease|0|||
164128880|NCT01045421|592836475|FG007|Phase 1|Progressive Disease|0|||
164128881|NCT01045421|592836476|FG008|Phase 1|Progressive Disease|0|||
164128882|NCT01045421|592836477|FG009|Phase 1|Progressive Disease|0|||
164128883|NCT01045421|592836478|FG010|Phase 1|Progressive Disease|0|||
164128884|NCT01045421|592836468|FG000|Phase 1|Withdrawal by Subject|0|||
164128885|NCT01045421|592836469|FG001|Phase 1|Withdrawal by Subject|0|||
164128886|NCT01045421|592836470|FG002|Phase 1|Withdrawal by Subject|0|||
164128887|NCT01045421|592836471|FG003|Phase 1|Withdrawal by Subject|1|||
164128888|NCT01045421|592836472|FG004|Phase 1|Withdrawal by Subject|0|||
164128889|NCT01045421|592836473|FG005|Phase 1|Withdrawal by Subject|0|||
164128890|NCT01045421|592836474|FG006|Phase 1|Withdrawal by Subject|0|||
164128891|NCT01045421|592836475|FG007|Phase 1|Withdrawal by Subject|0|||
164128892|NCT01045421|592836476|FG008|Phase 1|Withdrawal by Subject|0|||
164128893|NCT01045421|592836477|FG009|Phase 1|Withdrawal by Subject|0|||
164128894|NCT01045421|592836478|FG010|Phase 1|Withdrawal by Subject|0|||
164128895|NCT01045421|592836468|FG000|Phase 2|Progressive Disease|0|||
164128896|NCT01045421|592836469|FG001|Phase 2|Progressive Disease|0|||
164128897|NCT01045421|592836470|FG002|Phase 2|Progressive Disease|0|||
164128898|NCT01045421|592836471|FG003|Phase 2|Progressive Disease|0|||
164128899|NCT01045421|592836472|FG004|Phase 2|Progressive Disease|0|||
164128900|NCT01045421|592836473|FG005|Phase 2|Progressive Disease|0|||
164128901|NCT01045421|592836474|FG006|Phase 2|Progressive Disease|0|||
164128902|NCT01045421|592836475|FG007|Phase 2|Progressive Disease|1|||
164128903|NCT01045421|592836476|FG008|Phase 2|Progressive Disease|1|||
164128904|NCT01045421|592836477|FG009|Phase 2|Progressive Disease|1|||
164128905|NCT01045421|592836478|FG010|Phase 2|Progressive Disease|1|||
164128906|NCT01045421|592836468|FG000|Phase 2|Death|0|||
164128907|NCT01045421|592836469|FG001|Phase 2|Death|0|||
164128908|NCT01045421|592836470|FG002|Phase 2|Death|0|||
164128909|NCT01045421|592836471|FG003|Phase 2|Death|0|||
164128910|NCT01045421|592836472|FG004|Phase 2|Death|0|||
164128911|NCT01045421|592836473|FG005|Phase 2|Death|0|||
164128912|NCT01045421|592836474|FG006|Phase 2|Death|0|||
164128913|NCT01045421|592836475|FG007|Phase 2|Death|1|||
164128914|NCT01045421|592836476|FG008|Phase 2|Death|1|||
164128915|NCT01045421|592836477|FG009|Phase 2|Death|2|||
164128916|NCT01045421|592836478|FG010|Phase 2|Death|0|||
164128917|NCT01045421|592836468|FG000|Phase 2|Other|0|||
164128918|NCT01045421|592836469|FG001|Phase 2|Other|0|||
164128919|NCT01045421|592836470|FG002|Phase 2|Other|0|||
164128920|NCT01045421|592836471|FG003|Phase 2|Other|0|||
164128921|NCT01045421|592836472|FG004|Phase 2|Other|0|||
164128922|NCT01045421|592836473|FG005|Phase 2|Other|0|||
164128923|NCT01045421|592836474|FG006|Phase 2|Other|0|||
164128924|NCT01045421|592836475|FG007|Phase 2|Other|3|||
164128925|NCT01045421|592836476|FG008|Phase 2|Other|0|||
164128926|NCT01045421|592836477|FG009|Phase 2|Other|0|||
164128927|NCT01045421|592836478|FG010|Phase 2|Other|1|||
164128928|NCT03340064|592836479|FG000|First Period|Adverse Event, non-fatal|2|||
164128929|NCT03340064|592836480|FG001|First Period|Adverse Event, non-fatal|0|||
164128930|NCT03340064|592836479|FG000|First Period|Lack of Efficacy|3|||
164128931|NCT03340064|592836480|FG001|First Period|Lack of Efficacy|0|||
164128932|NCT03340064|592836479|FG000|Second Period|Adverse Event, non-fatal|1|||
164128933|NCT03340064|592836480|FG001|Second Period|Adverse Event, non-fatal|1|||
164128934|NCT03340064|592836479|FG000|Second Period|Lack of Efficacy|11|||
164128935|NCT03340064|592836480|FG001|Second Period|Lack of Efficacy|0|||
164128936|NCT03340064|592836479|FG000|Second Period|Physician Decision|3|||
164128937|NCT03340064|592836480|FG001|Second Period|Physician Decision|0|||
164128938|NCT03340064|592836479|FG000|Second Period|Withdrawal by Subject|2|||
164128939|NCT03340064|592836480|FG001|Second Period|Withdrawal by Subject|1|||
164128940|NCT03340064|592836479|FG000|Second Period|Approved Drug Available For Indication|1|||
164128941|NCT03340064|592836480|FG001|Second Period|Approved Drug Available For Indication|0|||
164128942|NCT03340064|592836479|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
164128943|NCT03340064|592836480|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
164128944|NCT00856973|592836481|FG000|Overall Study|Adverse Event|5|||
164128945|NCT00856973|592836482|FG001|Overall Study|Adverse Event|5|||
164128946|NCT00856973|592836483|FG002|Overall Study|Adverse Event|3|||
164128947|NCT00856973|592836481|FG000|Overall Study|Lost to Follow-up|6|||
164128948|NCT00856973|592836482|FG001|Overall Study|Lost to Follow-up|3|||
164128949|NCT00856973|592836483|FG002|Overall Study|Lost to Follow-up|5|||
164128950|NCT00856973|592836481|FG000|Overall Study|Physician Decision|0|||
164128951|NCT00856973|592836482|FG001|Overall Study|Physician Decision|3|||
164128952|NCT00856973|592836483|FG002|Overall Study|Physician Decision|1|||
164128953|NCT00856973|592836481|FG000|Overall Study|Protocol Violation|1|||
164128954|NCT00856973|592836482|FG001|Overall Study|Protocol Violation|2|||
164128955|NCT00856973|592836483|FG002|Overall Study|Protocol Violation|1|||
164128956|NCT00856973|592836481|FG000|Overall Study|Withdrawal by Subject|13|||
164128957|NCT00856973|592836482|FG001|Overall Study|Withdrawal by Subject|16|||
164128958|NCT00856973|592836483|FG002|Overall Study|Withdrawal by Subject|15|||
164128959|NCT00856973|592836481|FG000|Overall Study|Other|11|||
164128960|NCT00856973|592836482|FG001|Overall Study|Other|12|||
164128961|NCT00856973|592836483|FG002|Overall Study|Other|13|||
164128962|NCT01884311|592836485|FG000|Overall Study|Withdrawal by Subject|3|||
164128963|NCT01884311|592836485|FG000|Overall Study|withdrew consent due to AEs|1|||
164128964|NCT01884311|592836485|FG000|Overall Study|Precautionary measure|1|||
164128965|NCT02858492|592836486|FG000|Overall Study|Withdrawal by Subject|0|||
164128966|NCT02858492|592836487|FG001|Overall Study|Withdrawal by Subject|1|||
164128967|NCT02858492|592836488|FG002|Overall Study|Withdrawal by Subject|0|||
164128968|NCT02858492|592836489|FG003|Overall Study|Withdrawal by Subject|1|||
164128969|NCT02858492|592836486|FG000|Overall Study|Adverse Event|0|||
164128970|NCT02858492|592836487|FG001|Overall Study|Adverse Event|0|||
164128971|NCT02858492|592836488|FG002|Overall Study|Adverse Event|0|||
164128972|NCT02858492|592836489|FG003|Overall Study|Adverse Event|3|||
164128973|NCT02858492|592836486|FG000|Overall Study|Lack of Efficacy|0|||
164128974|NCT02858492|592836487|FG001|Overall Study|Lack of Efficacy|0|||
164128975|NCT02858492|592836488|FG002|Overall Study|Lack of Efficacy|0|||
164128976|NCT02858492|592836489|FG003|Overall Study|Lack of Efficacy|1|||
164128977|NCT02858492|592836486|FG000|Overall Study|Protocol defined stopping criteria|0|||
164128978|NCT02858492|592836487|FG001|Overall Study|Protocol defined stopping criteria|0|||
164128979|NCT02858492|592836488|FG002|Overall Study|Protocol defined stopping criteria|0|||
164128980|NCT02858492|592836489|FG003|Overall Study|Protocol defined stopping criteria|1|||
164128981|NCT02944383|592836490|FG000|Overall Study|Lost to Follow-up|0|||
164128982|NCT02944383|592836491|FG001|Overall Study|Lost to Follow-up|0|||
164128983|NCT02944383|592836492|FG002|Overall Study|Lost to Follow-up|1|||
164128984|NCT02944383|592836490|FG000|Overall Study|Withdrawal by Subject|1|||
164128985|NCT02944383|592836491|FG001|Overall Study|Withdrawal by Subject|0|||
164128986|NCT02944383|592836492|FG002|Overall Study|Withdrawal by Subject|0|||
164128987|NCT01995266|592836494|FG000|Overall Study|Death|1|||
164128988|NCT01995266|592836494|FG000|Overall Study|Lack of Efficacy|6|||
164128989|NCT01995266|592836494|FG000|Overall Study|Adverse Event|2|||
164128990|NCT03853148|592836495|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
164128991|NCT03853148|592836496|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
164128992|NCT03853148|592836497|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
164128993|NCT03853148|592836498|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
164128994|NCT00090610|592836499|FG000|Overall Study|Withdrawal by Subject|1|||
164128995|NCT00090610|592836500|FG001|Overall Study|Withdrawal by Subject|1|||
164128996|NCT03623386|592836503|FG000|Overall Study|Protocol Violation|3|||
164128997|NCT03623386|592836504|FG001|Overall Study|Protocol Violation|2|||
164128998|NCT03623386|592836505|FG002|Overall Study|Protocol Violation|0|||
164128999|NCT03623386|592836503|FG000|Overall Study|Physician Decision|1|||
164129000|NCT03623386|592836504|FG001|Overall Study|Physician Decision|1|||
164129001|NCT03623386|592836505|FG002|Overall Study|Physician Decision|0|||
164129002|NCT03623386|592836503|FG000|Overall Study|Lost to Follow-up|0|||
164129003|NCT03623386|592836504|FG001|Overall Study|Lost to Follow-up|2|||
164129004|NCT03623386|592836505|FG002|Overall Study|Lost to Follow-up|0|||
164129005|NCT03623386|592836503|FG000|Overall Study|COVID-19|0|||
164129006|NCT03623386|592836504|FG001|Overall Study|COVID-19|1|||
164129007|NCT03623386|592836505|FG002|Overall Study|COVID-19|0|||
164129008|NCT00599521|592836510|FG000|Overall Study|Lack of Efficacy|4|||
164129009|NCT00599521|592836511|FG001|Overall Study|Lack of Efficacy|8|||
164129010|NCT00599521|592836510|FG000|Overall Study|Adverse Event|4|||
164129011|NCT00599521|592836511|FG001|Overall Study|Adverse Event|1|||
164129012|NCT00599521|592836510|FG000|Overall Study|Withdrawal by Subject|28|||
164129013|NCT00599521|592836511|FG001|Overall Study|Withdrawal by Subject|34|||
164129014|NCT00599521|592836510|FG000|Overall Study|Protocol Violation|1|||
164129015|NCT00599521|592836511|FG001|Overall Study|Protocol Violation|1|||
164129016|NCT00599521|592836510|FG000|Overall Study|Lost to Follow-up|23|||
164129017|NCT00599521|592836511|FG001|Overall Study|Lost to Follow-up|23|||
164129018|NCT00599521|592836510|FG000|Overall Study|Pregnancy|0|||
164129019|NCT00599521|592836511|FG001|Overall Study|Pregnancy|2|||
164129020|NCT02751359|592836516|FG000|Overall Study|Lost to Follow-up|1|||
164129021|NCT02667288|592836517|FG000|Overall Study|Protocol Violation|5|||
164129022|NCT02667288|592836517|FG000|Overall Study|Lost to Follow-up|3|||
164129023|NCT02667288|592836517|FG000|Overall Study|Withdrawal by Subject|5|||
164129024|NCT01196078|592836518|FG000|Overall Study|Withdrawal by Subject|3|||
164129025|NCT01196078|592836519|FG001|Overall Study|Withdrawal by Subject|5|||
164129026|NCT01196078|592836518|FG000|Overall Study|Adverse Event|4|||
164129027|NCT01196078|592836519|FG001|Overall Study|Adverse Event|4|||
164129028|NCT01196078|592836518|FG000|Overall Study|Protocol Violation|2|||
164129029|NCT01196078|592836519|FG001|Overall Study|Protocol Violation|1|||
164129030|NCT01196078|592836518|FG000|Overall Study|Lack of Efficacy|17|||
164129031|NCT01196078|592836519|FG001|Overall Study|Lack of Efficacy|23|||
164129032|NCT01196078|592836518|FG000|Overall Study|Lost to Follow-up|1|||
164129033|NCT01196078|592836519|FG001|Overall Study|Lost to Follow-up|0|||
164129034|NCT01196078|592836518|FG000|Overall Study|Death|6|||
164129035|NCT01196078|592836519|FG001|Overall Study|Death|4|||
164129036|NCT02400671|592836520|FG000|Overall Study|Death|5|||
164129037|NCT02400671|592836521|FG001|Overall Study|Death|3|||
164129038|NCT02400671|592836522|FG002|Overall Study|Death|4|||
164129039|NCT02400671|592836520|FG000|Overall Study|Lost to Follow-up|20|||
164129040|NCT02400671|592836521|FG001|Overall Study|Lost to Follow-up|27|||
164129041|NCT02400671|592836522|FG002|Overall Study|Lost to Follow-up|24|||
164129042|NCT02400671|592836520|FG000|Overall Study|Withdrawal by Subject|2|||
164129043|NCT02400671|592836521|FG001|Overall Study|Withdrawal by Subject|2|||
164129044|NCT02400671|592836522|FG002|Overall Study|Withdrawal by Subject|0|||
164129045|NCT04397445|592836525|FG000|Overall Study|Withdrawal by Subject|1|||
164129046|NCT04397445|592836526|FG001|Overall Study|Withdrawal by Subject|0|||
164129047|NCT04397445|592836527|FG002|Overall Study|Withdrawal by Subject|0|||
164129048|NCT04397445|592836528|FG003|Overall Study|Withdrawal by Subject|0|||
164129049|NCT03921151|592836529|FG000|Overall Study|Withdrawal by Subject|11|||
164129050|NCT03921151|592836530|FG001|Overall Study|Withdrawal by Subject|16|||
164129051|NCT00857792|592836532|FG000|Overall Study|inadequate image quality for analysis|12|||
164129052|NCT03760250|592836535|FG000|Overall Study|Withdrawal by Subject|1|||
164129053|NCT03760250|592836535|FG000|Overall Study|Physician Decision|1|||
164129054|NCT03733210|592836536|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
164129055|NCT03733210|592836537|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
164129056|NCT00307034|592836544|FG000|Overall Study|Adverse Event|1|||
164129057|NCT00307034|592836545|FG001|Overall Study|Adverse Event|2|||
164129058|NCT00307034|592836544|FG000|Overall Study|Withdrawal by Subject|1|||
164129059|NCT00307034|592836545|FG001|Overall Study|Withdrawal by Subject|2|||
164129060|NCT00307034|592836544|FG000|Overall Study|Lost to Follow-up|0|||
164129061|NCT00307034|592836545|FG001|Overall Study|Lost to Follow-up|3|||
164129062|NCT04920916|592836548|FG000|Phase IIa 60 Day Study|Death|2|||
164129063|NCT04920916|592836549|FG001|Phase IIa 60 Day Study|Death|5|||
164129064|NCT04920916|592836548|FG000|1 Year Follow up (Phone Call)|Death|1|||
164129065|NCT04920916|592836549|FG001|1 Year Follow up (Phone Call)|Death|3|||
164129066|NCT04920916|592836548|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
164129067|NCT04920916|592836549|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
164129068|NCT02011113|592836550|FG000|Overall Study|Adverse Event|4|||
164129069|NCT02011113|592836550|FG000|Overall Study|Disease Progression (DP)|16|||
164129070|NCT02011113|592836550|FG000|Overall Study|Death|1|||
164129071|NCT02011113|592836550|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
164129072|NCT02011113|592836550|FG000|Overall Study|Investigator's judgement- DP|3|||
164129073|NCT02011113|592836550|FG000|Overall Study|Study terminated by sponsor|11|||
164129074|NCT04688931|592836553|FG000|Overall Study|Adverse Event|4|||
164129075|NCT04688931|592836554|FG001|Overall Study|Adverse Event|1|||
164129076|NCT04688931|592836553|FG000|Overall Study|Withdrawal by Subject|5|||
164129077|NCT04688931|592836554|FG001|Overall Study|Withdrawal by Subject|16|||
164129078|NCT04688931|592836553|FG000|Overall Study|Physician Decision|3|||
164129079|NCT04688931|592836554|FG001|Overall Study|Physician Decision|5|||
164129080|NCT04688931|592836553|FG000|Overall Study|Noncompliance|0|||
164129081|NCT04688931|592836554|FG001|Overall Study|Noncompliance|1|||
164129082|NCT04688931|592836553|FG000|Overall Study|Lost to Follow-up|1|||
164129083|NCT04688931|592836554|FG001|Overall Study|Lost to Follow-up|3|||
164129084|NCT04688931|592836553|FG000|Overall Study|Randomization Error|3|||
164129085|NCT04688931|592836554|FG001|Overall Study|Randomization Error|0|||
164129086|NCT04688931|592836553|FG000|Overall Study|Not Eligible|1|||
164129087|NCT04688931|592836554|FG001|Overall Study|Not Eligible|3|||
164129088|NCT04688931|592836553|FG000|Overall Study|Disease Progression|0|||
164129089|NCT04688931|592836554|FG001|Overall Study|Disease Progression|2|||
164129090|NCT04688931|592836553|FG000|Overall Study|Sponsor Requirement|1|||
164129091|NCT04688931|592836554|FG001|Overall Study|Sponsor Requirement|1|||
164129092|NCT04688931|592836553|FG000|Overall Study|Other Reason|1|||
164129093|NCT04688931|592836554|FG001|Overall Study|Other Reason|2|||
164129094|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Adverse Event|9|||
164129095|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Adverse Event|4|||
164129096|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Adverse Event|5|||
164129097|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Adverse Event|9|||
164129098|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Adverse Event|8|||
164129099|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Adverse Event|0|||
164129100|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Adverse Event|0|||
164129101|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
164129102|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
164129103|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
164129104|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
164129105|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
164129106|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
164129107|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
164129108|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Death|1|||
164129109|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Death|1|||
164129110|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Death|1|||
164129111|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Death|1|||
164129112|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Death|0|||
164129113|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Death|0|||
164129114|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Death|0|||
164129115|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
164129116|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
164129117|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
164129118|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
164129119|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
164129120|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
164129121|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
164129122|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164132688|NCT01986010|592850667|FG012|Overall Study|Lost to Follow-up|1|||
164129123|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164129124|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
164129125|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164129126|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164129127|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164129128|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
164129129|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
164129130|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
164129131|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
164129132|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
164129133|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
164129134|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
164129135|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
164129136|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Other|2|||
164129137|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Other|9|||
164129138|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Other|9|||
164129139|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Other|3|||
164129140|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Other|2|||
164129141|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Other|0|||
164129142|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Other|0|||
164129143|NCT00361335|592836557|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
164129144|NCT00361335|592836558|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
164129145|NCT00361335|592836559|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
164129146|NCT00361335|592836560|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
164129147|NCT00361335|592836561|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
164129148|NCT00361335|592836562|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
164129149|NCT00361335|592836563|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
164129150|NCT00361335|592836557|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
164129151|NCT00361335|592836558|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
164129152|NCT00361335|592836559|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
164129153|NCT00361335|592836560|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
164129154|NCT00361335|592836561|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
164129155|NCT00361335|592836562|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
164129156|NCT00361335|592836563|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
164129157|NCT00361335|592836557|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
164129158|NCT00361335|592836558|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164129159|NCT00361335|592836559|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
164129160|NCT00361335|592836560|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164129161|NCT00361335|592836561|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164129162|NCT00361335|592836562|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
164129163|NCT00361335|592836563|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
164129164|NCT00361335|592836557|FG000|SC Period: Week E0 to Week E24|Death|0|||
164129165|NCT00361335|592836558|FG001|SC Period: Week E0 to Week E24|Death|0|||
164129166|NCT00361335|592836559|FG002|SC Period: Week E0 to Week E24|Death|0|||
164129167|NCT00361335|592836560|FG003|SC Period: Week E0 to Week E24|Death|0|||
164129168|NCT00361335|592836561|FG004|SC Period: Week E0 to Week E24|Death|0|||
164129169|NCT00361335|592836562|FG005|SC Period: Week E0 to Week E24|Death|0|||
164129170|NCT00361335|592836563|FG006|SC Period: Week E0 to Week E24|Death|1|||
164129171|NCT00361335|592836557|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164129172|NCT00361335|592836558|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
164129173|NCT00361335|592836559|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
164129174|NCT00361335|592836560|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
164129175|NCT00361335|592836561|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164129176|NCT00361335|592836562|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164129177|NCT00361335|592836563|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
164129178|NCT00361335|592836557|FG000|SC Period: Week E0 to Week E24|Other|1|||
164129179|NCT00361335|592836558|FG001|SC Period: Week E0 to Week E24|Other|0|||
164129180|NCT00361335|592836559|FG002|SC Period: Week E0 to Week E24|Other|0|||
164129181|NCT00361335|592836560|FG003|SC Period: Week E0 to Week E24|Other|1|||
164129182|NCT00361335|592836561|FG004|SC Period: Week E0 to Week E24|Other|0|||
164129183|NCT00361335|592836562|FG005|SC Period: Week E0 to Week E24|Other|1|||
164129184|NCT00361335|592836563|FG006|SC Period: Week E0 to Week E24|Other|2|||
164129185|NCT00361335|592836557|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164129186|NCT00361335|592836558|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164129187|NCT00361335|592836559|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
164129188|NCT00361335|592836560|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164129189|NCT00361335|592836561|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164129190|NCT00361335|592836562|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
164129191|NCT00361335|592836563|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
164129192|NCT02034058|592836566|FG000|Overall Study|Death|3|||
164129193|NCT01765582|592836573|FG000|Overall Study|Other|3|||
164129194|NCT01765582|592836574|FG001|Overall Study|Other|6|||
164129195|NCT01765582|592836575|FG002|Overall Study|Other|9|||
164129196|NCT01765582|592836573|FG000|Overall Study|Lost to Follow-up|2|||
164129197|NCT01765582|592836574|FG001|Overall Study|Lost to Follow-up|2|||
164129198|NCT01765582|592836575|FG002|Overall Study|Lost to Follow-up|1|||
164129199|NCT01765582|592836573|FG000|Overall Study|Death|31|||
164129200|NCT01765582|592836574|FG001|Overall Study|Death|36|||
164129201|NCT01765582|592836575|FG002|Overall Study|Death|33|||
164129202|NCT01765582|592836573|FG000|Overall Study|Sponsor Decision|46|||
164129203|NCT01765582|592836574|FG001|Overall Study|Sponsor Decision|42|||
164129204|NCT01765582|592836575|FG002|Overall Study|Sponsor Decision|42|||
164129205|NCT01765582|592836573|FG000|Overall Study|Withdrawal of Consent|11|||
164129206|NCT01765582|592836574|FG001|Overall Study|Withdrawal of Consent|6|||
164129207|NCT01765582|592836575|FG002|Overall Study|Withdrawal of Consent|10|||
164129208|NCT03251963|592836578|FG000|Overall Study|inappropriate Xa level timing|6|||
164129209|NCT03251963|592836579|FG001|Overall Study|inappropriate Xa level timing|3|||
164129210|NCT03251963|592836578|FG000|Overall Study|no peak Xa level drawn|2|||
164129211|NCT03251963|592836579|FG001|Overall Study|no peak Xa level drawn|0|||
164129212|NCT03251963|592836578|FG000|Overall Study|bled prior to Xa level|1|||
164129213|NCT03251963|592836579|FG001|Overall Study|bled prior to Xa level|2|||
164129214|NCT00616941|592836580|FG000|Overall Study|Progressive Disease|1|||
164129215|NCT00616941|592836581|FG001|Overall Study|Progressive Disease|2|||
164129216|NCT00616941|592836582|FG002|Overall Study|Progressive Disease|1|||
164129217|NCT00616941|592836580|FG000|Overall Study|Adverse Event|0|||
164129218|NCT00616941|592836581|FG001|Overall Study|Adverse Event|1|||
164129219|NCT00616941|592836582|FG002|Overall Study|Adverse Event|1|||
164129220|NCT00616941|592836580|FG000|Overall Study|Subject Non-compliance|0|||
164129221|NCT00616941|592836581|FG001|Overall Study|Subject Non-compliance|0|||
164129222|NCT00616941|592836582|FG002|Overall Study|Subject Non-compliance|1|||
164129223|NCT00616941|592836580|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
164129224|NCT00616941|592836581|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
164129225|NCT00616941|592836582|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
164129226|NCT00616941|592836580|FG000|Overall Study|Vaccination Suspended|0|||
164129227|NCT00616941|592836581|FG001|Overall Study|Vaccination Suspended|0|||
164129228|NCT00616941|592836582|FG002|Overall Study|Vaccination Suspended|3|||
164129229|NCT00714493|592836593|FG000|Overall Study|Adverse Event|11|||
164129230|NCT00714493|592836593|FG000|Overall Study|Death|3|||
164129231|NCT00714493|592836593|FG000|Overall Study|Lack of Efficacy|10|||
164129232|NCT00714493|592836593|FG000|Overall Study|Lost to Follow-up|3|||
164129233|NCT00714493|592836593|FG000|Overall Study|Protocol Violation|12|||
164129234|NCT00714493|592836593|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
164129235|NCT00714493|592836593|FG000|Overall Study|OTHER|2|||
164129236|NCT00076804|592836594|FG000|Overall Study|Death|9|||
164129237|NCT00076804|592836595|FG001|Overall Study|Death|20|||
164073554|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073555|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164073556|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073557|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
164073558|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
164073559|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
164073560|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
164073561|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
164073562|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
164073563|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
164073564|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073565|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164073566|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
164073567|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073568|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073569|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073570|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073571|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164073572|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164073573|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164073574|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073575|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164073576|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073577|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164073578|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073579|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
164129238|NCT00076804|592836594|FG000|Overall Study|Lost to Follow-up|9|||
164129239|NCT00076804|592836595|FG001|Overall Study|Lost to Follow-up|9|||
164129240|NCT00076804|592836594|FG000|Overall Study|Withdrawal by Subject|10|||
164132689|NCT01986010|592850668|FG013|Overall Study|Lost to Follow-up|1|||
164129241|NCT00076804|592836595|FG001|Overall Study|Withdrawal by Subject|8|||
164129242|NCT00076804|592836594|FG000|Overall Study|Early study Closure|32|||
164129243|NCT00076804|592836595|FG001|Overall Study|Early study Closure|32|||
164129244|NCT00354341|592836596|FG000|Overall Study|Adverse Event|1|||
164129245|NCT00354341|592836597|FG001|Overall Study|Adverse Event|0|||
164129246|NCT00354341|592836596|FG000|Overall Study|Death|0|||
164129247|NCT00354341|592836597|FG001|Overall Study|Death|2|||
164129248|NCT00354341|592836596|FG000|Overall Study|Refused treatment|1|||
164129249|NCT00354341|592836597|FG001|Overall Study|Refused treatment|2|||
164129250|NCT00354341|592836596|FG000|Overall Study|Failure to return|0|||
164129251|NCT00354341|592836597|FG001|Overall Study|Failure to return|1|||
164129252|NCT00354341|592836596|FG000|Overall Study|Other|1|||
164129253|NCT00354341|592836597|FG001|Overall Study|Other|2|||
164129254|NCT00251719|592836598|FG000|Overall Study|Adverse Event|14|||
164129255|NCT00251719|592836599|FG001|Overall Study|Adverse Event|8|||
164129256|NCT00251719|592836600|FG002|Overall Study|Adverse Event|7|||
164129257|NCT00251719|592836598|FG000|Overall Study|Protocol Violation|1|||
164129258|NCT00251719|592836599|FG001|Overall Study|Protocol Violation|1|||
164129259|NCT00251719|592836600|FG002|Overall Study|Protocol Violation|1|||
164129260|NCT00251719|592836598|FG000|Overall Study|Lost to Follow-up|5|||
164129261|NCT00251719|592836599|FG001|Overall Study|Lost to Follow-up|11|||
164129262|NCT00251719|592836600|FG002|Overall Study|Lost to Follow-up|8|||
164129263|NCT00251719|592836598|FG000|Overall Study|Withdrawal by Subject|14|||
164129264|NCT00251719|592836599|FG001|Overall Study|Withdrawal by Subject|12|||
164129265|NCT00251719|592836600|FG002|Overall Study|Withdrawal by Subject|11|||
164129266|NCT00251719|592836598|FG000|Overall Study|Lack of Efficacy|2|||
164129267|NCT00251719|592836599|FG001|Overall Study|Lack of Efficacy|1|||
164129268|NCT00251719|592836600|FG002|Overall Study|Lack of Efficacy|0|||
164129269|NCT00251719|592836598|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
164129270|NCT00251719|592836599|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
164129271|NCT00251719|592836600|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
164129272|NCT00251719|592836598|FG000|Overall Study|Investigator decision|1|||
164129273|NCT00251719|592836599|FG001|Overall Study|Investigator decision|1|||
164129274|NCT00251719|592836600|FG002|Overall Study|Investigator decision|0|||
164129275|NCT00251719|592836598|FG000|Overall Study|Noncompliance|2|||
164129276|NCT00251719|592836599|FG001|Overall Study|Noncompliance|3|||
164129277|NCT00251719|592836600|FG002|Overall Study|Noncompliance|1|||
164129278|NCT00251719|592836598|FG000|Overall Study|Barrett's esophagus|2|||
164129279|NCT00251719|592836599|FG001|Overall Study|Barrett's esophagus|2|||
164129280|NCT00251719|592836600|FG002|Overall Study|Barrett's esophagus|0|||
164129281|NCT01732874|592836602|FG000|Overall Study|Withdrawal by Subject|5|||
164129282|NCT01732874|592836603|FG001|Overall Study|Withdrawal by Subject|1|||
164129283|NCT01732874|592836602|FG000|Overall Study|Death of Infant|3|||
164129284|NCT01732874|592836603|FG001|Overall Study|Death of Infant|2|||
164129285|NCT03709823|592836604|FG000|Overall Study|Adverse Event|0|||
164129286|NCT03709823|592836605|FG001|Overall Study|Adverse Event|0|||
164129287|NCT03709823|592836606|FG002|Overall Study|Adverse Event|1|||
164129288|NCT03709823|592836607|FG003|Overall Study|Adverse Event|0|||
164129289|NCT03709823|592836608|FG004|Overall Study|Adverse Event|0|||
164129290|NCT03709823|592836609|FG005|Overall Study|Adverse Event|0|||
164129291|NCT03709823|592836604|FG000|Overall Study|Lost to Follow-up|2|||
164129292|NCT03709823|592836605|FG001|Overall Study|Lost to Follow-up|2|||
164129293|NCT03709823|592836606|FG002|Overall Study|Lost to Follow-up|2|||
164129294|NCT03709823|592836607|FG003|Overall Study|Lost to Follow-up|1|||
164129295|NCT03709823|592836608|FG004|Overall Study|Lost to Follow-up|1|||
164129296|NCT03709823|592836609|FG005|Overall Study|Lost to Follow-up|0|||
164129297|NCT03709823|592836604|FG000|Overall Study|Withdrawal by Subject|1|||
164129298|NCT03709823|592836605|FG001|Overall Study|Withdrawal by Subject|3|||
164129299|NCT03709823|592836606|FG002|Overall Study|Withdrawal by Subject|0|||
164129300|NCT03709823|592836607|FG003|Overall Study|Withdrawal by Subject|0|||
164129301|NCT03709823|592836608|FG004|Overall Study|Withdrawal by Subject|0|||
164129302|NCT03709823|592836609|FG005|Overall Study|Withdrawal by Subject|0|||
164129303|NCT03709823|592836604|FG000|Overall Study|Other, Not Specified|0|||
164129304|NCT03709823|592836605|FG001|Overall Study|Other, Not Specified|0|||
164129305|NCT03709823|592836606|FG002|Overall Study|Other, Not Specified|0|||
164129306|NCT03709823|592836607|FG003|Overall Study|Other, Not Specified|1|||
164129307|NCT03709823|592836608|FG004|Overall Study|Other, Not Specified|0|||
164129308|NCT03709823|592836609|FG005|Overall Study|Other, Not Specified|0|||
164129309|NCT00557076|592836612|FG000|Overall Study|Unblinding|0|||
164129310|NCT00557076|592836613|FG001|Overall Study|Unblinding|1|||
164129311|NCT00688376|592836614|FG000|Double-Blind Phase|Adverse Event|4|||
164129312|NCT00688376|592836615|FG001|Double-Blind Phase|Adverse Event|4|||
164129313|NCT00688376|592836614|FG000|Double-Blind Phase|Protocol Violation|1|||
164129314|NCT00688376|592836615|FG001|Double-Blind Phase|Protocol Violation|2|||
164129315|NCT00688376|592836614|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
164129316|NCT00688376|592836615|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
164129317|NCT00688376|592836614|FG000|Double-Blind Phase|Not treated|0|||
164129318|NCT00688376|592836615|FG001|Double-Blind Phase|Not treated|1|||
164129319|NCT00688376|592836614|FG000|Blinded Extension Phase|Adverse Event|3|||
164129320|NCT00688376|592836615|FG001|Blinded Extension Phase|Adverse Event|4|||
164129321|NCT00688376|592836614|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
164129322|NCT00688376|592836615|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
164129323|NCT00688376|592836614|FG000|Blinded Extension Phase|Physician Decision|1|||
164129324|NCT00688376|592836615|FG001|Blinded Extension Phase|Physician Decision|0|||
164129325|NCT00688376|592836614|FG000|Blinded Extension Phase|Other|1|||
164129326|NCT00688376|592836615|FG001|Blinded Extension Phase|Other|0|||
164129327|NCT02303041|592836616|FG000|Overall Study|Adverse Event|1|||
164129328|NCT02303041|592836617|FG001|Overall Study|Adverse Event|2|||
164129329|NCT00886288|592836618|FG000|Overall Study|no respect of the 12 weeks period|657|||
164129330|NCT00886288|592836619|FG001|Overall Study|no respect of the 12 weeks period|227|||
164129331|NCT00886288|592836618|FG000|Overall Study|Lost to Follow-up|86|||
164129332|NCT00886288|592836619|FG001|Overall Study|Lost to Follow-up|0|||
164129333|NCT01070771|592836620|FG000|Overall Study|Adverse Event|2|||
164129334|NCT01070771|592836620|FG000|Overall Study|Protocol Violation|1|||
164129335|NCT00700817|592836625|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
164129336|NCT00700817|592836626|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
164129337|NCT00700817|592836627|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
164129338|NCT00700817|592836628|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
164129339|NCT00700817|592836629|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
164129340|NCT00700817|592836625|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
164073580|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
164073581|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
164073582|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
164073583|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073584|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073585|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073586|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073587|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
164073588|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073589|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073590|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073591|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073592|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
164073593|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073594|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073595|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073596|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073597|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073598|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073599|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073600|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073601|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
164073602|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
164073603|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164073604|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164073605|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164073606|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164073607|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
164073608|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164073609|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164073610|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164073611|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164073612|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
164073613|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164073614|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164073615|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
164073616|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
164073617|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
164073618|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
164073619|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
164073620|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
164073621|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073622|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073623|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073624|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073625|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073626|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164129341|NCT00700817|592836626|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
164129342|NCT00700817|592836627|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
164129343|NCT00700817|592836628|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
164129344|NCT00700817|592836629|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
164129345|NCT00700817|592836625|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
164129346|NCT00700817|592836626|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
164129347|NCT00700817|592836627|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
164129348|NCT00700817|592836628|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
164129349|NCT00700817|592836629|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
164129350|NCT00700817|592836625|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
164129351|NCT00700817|592836626|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
164129352|NCT00700817|592836627|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
164129353|NCT00700817|592836628|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
164129354|NCT00700817|592836629|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
164129355|NCT00700817|592836625|FG000|Week 0-26 (Main Period)|Unclassified|14|||
164129356|NCT00700817|592836626|FG001|Week 0-26 (Main Period)|Unclassified|4|||
164129357|NCT00700817|592836627|FG002|Week 0-26 (Main Period)|Unclassified|8|||
164129358|NCT00700817|592836628|FG003|Week 0-26 (Main Period)|Unclassified|0|||
164129359|NCT00700817|592836629|FG004|Week 0-26 (Main Period)|Unclassified|0|||
164129360|NCT00700817|592836625|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
164129361|NCT00700817|592836626|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
164129362|NCT00700817|592836627|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
164129363|NCT00700817|592836628|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
164129364|NCT00700817|592836629|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
164129365|NCT00700817|592836625|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
164129366|NCT00700817|592836626|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
164129367|NCT00700817|592836627|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
164129368|NCT00700817|592836628|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
164129369|NCT00700817|592836629|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
164129370|NCT00700817|592836625|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
164129371|NCT00700817|592836626|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
164129372|NCT00700817|592836627|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
164129373|NCT00700817|592836628|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
164129374|NCT00700817|592836629|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
164129375|NCT00700817|592836625|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
164129376|NCT00700817|592836626|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
164129377|NCT00700817|592836627|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
164129378|NCT00700817|592836628|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
164129379|NCT00700817|592836629|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
164129380|NCT00700817|592836625|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
164129381|NCT00700817|592836626|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
164129382|NCT00700817|592836627|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
164129383|NCT00700817|592836628|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
164129384|NCT00700817|592836629|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
164129385|NCT00700817|592836625|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
164129386|NCT00700817|592836626|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
164129387|NCT00700817|592836627|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
164129388|NCT00700817|592836628|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
164129389|NCT00700817|592836629|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
164129390|NCT00700817|592836625|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
164129391|NCT00700817|592836626|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
164129392|NCT00700817|592836627|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
164129393|NCT00700817|592836628|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
164129394|NCT00700817|592836629|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
164129395|NCT00700817|592836625|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
164129396|NCT00700817|592836626|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
164129397|NCT00700817|592836627|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
164129398|NCT00700817|592836628|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
164129399|NCT00700817|592836629|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
164129400|NCT00700817|592836625|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
164129401|NCT00700817|592836626|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
164129402|NCT00700817|592836627|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
164129403|NCT00700817|592836628|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
164129404|NCT00700817|592836629|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
164129405|NCT00700817|592836625|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
164129406|NCT00700817|592836626|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
164129407|NCT00700817|592836627|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
164129408|NCT00700817|592836628|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
164129409|NCT00700817|592836629|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
164129410|NCT00058214|592836630|FG000|Overall Study|Adverse Event|1|||
164129411|NCT03097588|592836631|FG000|Overall Study|Adverse Event|1|||
164129412|NCT01144364|592836632|FG000|Induction Phase|Disease progression|14|||
164129413|NCT01144364|592836633|FG001|Induction Phase|Disease progression|0|||
164129414|NCT01144364|592836634|FG002|Induction Phase|Disease progression|0|||
164129415|NCT01144364|592836632|FG000|Induction Phase|Adverse Event|9|||
164129416|NCT01144364|592836633|FG001|Induction Phase|Adverse Event|0|||
164129417|NCT01144364|592836634|FG002|Induction Phase|Adverse Event|0|||
164129418|NCT01144364|592836632|FG000|Induction Phase|Death|1|||
164129419|NCT01144364|592836633|FG001|Induction Phase|Death|0|||
164129420|NCT01144364|592836634|FG002|Induction Phase|Death|0|||
164129421|NCT01144364|592836632|FG000|Induction Phase|Withdrawal by Subject|1|||
164129422|NCT01144364|592836633|FG001|Induction Phase|Withdrawal by Subject|0|||
164129423|NCT01144364|592836634|FG002|Induction Phase|Withdrawal by Subject|0|||
164129424|NCT01144364|592836632|FG000|Induction Phase|Lost to Follow-up|2|||
164129425|NCT01144364|592836633|FG001|Induction Phase|Lost to Follow-up|0|||
164129426|NCT01144364|592836634|FG002|Induction Phase|Lost to Follow-up|0|||
164129427|NCT01144364|592836632|FG000|Induction Phase|Physician Decision|1|||
164129428|NCT01144364|592836633|FG001|Induction Phase|Physician Decision|0|||
164129429|NCT01144364|592836634|FG002|Induction Phase|Physician Decision|0|||
164129430|NCT01144364|592836632|FG000|Induction Phase|Stable disease|2|||
164129431|NCT01144364|592836633|FG001|Induction Phase|Stable disease|0|||
164129432|NCT01144364|592836634|FG002|Induction Phase|Stable disease|0|||
164129433|NCT01144364|592836632|FG000|Induction Phase|Secondary neoplasia|1|||
164129434|NCT01144364|592836633|FG001|Induction Phase|Secondary neoplasia|0|||
164129435|NCT01144364|592836634|FG002|Induction Phase|Secondary neoplasia|0|||
164129436|NCT01144364|592836632|FG000|Induction Phase|Protocol Violation|1|||
164129437|NCT01144364|592836633|FG001|Induction Phase|Protocol Violation|0|||
164129438|NCT01144364|592836634|FG002|Induction Phase|Protocol Violation|0|||
164129439|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
164129440|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
164129441|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
164129442|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
164129443|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
164129444|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
164129445|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Death|0|||
164129446|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Death|2|||
164129447|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Death|0|||
164129448|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
164129449|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
164129450|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
164129451|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
164129452|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
164129453|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
164129454|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
164129455|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
164129456|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
164129457|NCT01144364|592836632|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
164129458|NCT01144364|592836633|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
164129459|NCT01144364|592836634|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
164129460|NCT00891839|592836635|FG000|Overall Study|Adverse Event|2|||
164129461|NCT00891839|592836635|FG000|Overall Study|Withdrawal by Subject|2|||
164129462|NCT00891839|592836635|FG000|Overall Study|Disease progression|3|||
164129463|NCT02037165|592836636|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164129464|NCT02037165|592836637|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164129465|NCT02037165|592836638|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164129466|NCT02037165|592836639|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
164129467|NCT02037165|592836640|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
164129468|NCT02674061|592836641|FG000|Overall Study|Death|229|||
164129469|NCT02674061|592836642|FG001|Overall Study|Death|77|||
164129470|NCT02674061|592836641|FG000|Overall Study|Lost to Follow-up|3|||
164129471|NCT02674061|592836642|FG001|Overall Study|Lost to Follow-up|3|||
164129472|NCT02674061|592836641|FG000|Overall Study|Withdrawal by Subject|9|||
164129473|NCT02674061|592836642|FG001|Overall Study|Withdrawal by Subject|1|||
164129474|NCT02674061|592836641|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
164129475|NCT02674061|592836642|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
164129476|NCT03334721|592836643|FG000|Overall Study|Withdrawal by Subject|1|||
164129477|NCT03334721|592836644|FG001|Overall Study|Withdrawal by Subject|0|||
164129478|NCT03334721|592836643|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
164129479|NCT03334721|592836644|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
164129480|NCT04062448|592838352|FG000|Overall Study|Lost to Follow-up|1|||
164129481|NCT04062448|592838352|FG000|Overall Study|Withdrawal by Subject|2|||
164129482|NCT00573157|592838353|FG000|Overall Study|Adverse Event|3|||
164129483|NCT00573157|592838354|FG001|Overall Study|Adverse Event|1|||
164129484|NCT00573157|592838353|FG000|Overall Study|Other|1|||
164129485|NCT00573157|592838354|FG001|Overall Study|Other|1|||
164129486|NCT00609518|592838355|FG000|Overall Study|Death from Study Disease|32|||
164129487|NCT00609518|592838356|FG001|Overall Study|Death from Study Disease|32|||
164129488|NCT00609518|592838355|FG000|Overall Study|Withdrawal by Subject|5|||
164129489|NCT00609518|592838356|FG001|Overall Study|Withdrawal by Subject|3|||
164129490|NCT00609518|592838355|FG000|Overall Study|Lost to Follow-up|3|||
164129491|NCT00609518|592838356|FG001|Overall Study|Lost to Follow-up|0|||
164129492|NCT00609518|592838355|FG000|Overall Study|Physician Decision|1|||
164129493|NCT00609518|592838356|FG001|Overall Study|Physician Decision|3|||
164129494|NCT00609518|592838355|FG000|Overall Study|Death from Adverse Event|2|||
164129495|NCT00609518|592838356|FG001|Overall Study|Death from Adverse Event|2|||
164129496|NCT01400919|592838361|FG000|Overall Study|Withdrawal by Subject|4|||
164129497|NCT01400919|592838361|FG000|Overall Study|Lost to Follow-up|2|||
164129498|NCT01400919|592838361|FG000|Overall Study|Missed visit|2|||
164129499|NCT01449279|592838362|FG000|Overall Study|Lack of Efficacy|5|||
164129500|NCT01449279|592838362|FG000|Overall Study|Toxicity|2|||
164129501|NCT00846521|592838363|FG000|Overall Study|Withdrawal by Subject|5|||
164129502|NCT00846521|592838363|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
164129503|NCT00846521|592838363|FG000|Overall Study|Protocol Violation|1|||
164129504|NCT02792959|592838365|FG000|Overall Study|Protocol Violation|1|||
164129505|NCT04392583|592838366|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
164129506|NCT03201250|592838367|FG000|Overall Study|screen failures|3|||
164129507|NCT03201250|592838368|FG001|Overall Study|screen failures|0|||
164129508|NCT03201250|592838369|FG002|Overall Study|screen failures|0|||
164129509|NCT02575911|592838372|FG000|Overall Study|Lost to Follow-up|1|||
164129510|NCT01340768|592838373|FG000|Overall Study|Lost to Follow-up|10|||
164129511|NCT01340768|592838374|FG001|Overall Study|Lost to Follow-up|4|||
164129512|NCT01340768|592838373|FG000|Overall Study|Withdrawal by Subject|5|||
164129513|NCT01340768|592838374|FG001|Overall Study|Withdrawal by Subject|1|||
164129514|NCT01340768|592838373|FG000|Overall Study|Other|2|||
164129515|NCT01340768|592838374|FG001|Overall Study|Other|0|||
164129516|NCT03052959|592838379|FG000|Overall Study|Lost to Follow-up|4|||
164129517|NCT03052959|592838380|FG001|Overall Study|Lost to Follow-up|5|||
164129518|NCT02397408|592838381|FG000|Overall Study|Physician Decision|4|||
164129519|NCT02397408|592838381|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
164129520|NCT02335983|592838382|FG000|Overall Study|Sponsor Decision|0|||
164129521|NCT02335983|592838383|FG001|Overall Study|Sponsor Decision|0|||
164129522|NCT02335983|592838384|FG002|Overall Study|Sponsor Decision|1|||
164129523|NCT02335983|592838385|FG003|Overall Study|Sponsor Decision|1|||
164129524|NCT02335983|592838386|FG004|Overall Study|Sponsor Decision|0|||
164129525|NCT02335983|592838387|FG005|Overall Study|Sponsor Decision|1|||
164129526|NCT02335983|592838382|FG000|Overall Study|Withdrawal by Subject|3|||
164129527|NCT02335983|592838383|FG001|Overall Study|Withdrawal by Subject|2|||
164129528|NCT02335983|592838384|FG002|Overall Study|Withdrawal by Subject|2|||
164129529|NCT02335983|592838385|FG003|Overall Study|Withdrawal by Subject|1|||
164129530|NCT02335983|592838386|FG004|Overall Study|Withdrawal by Subject|3|||
164129531|NCT02335983|592838387|FG005|Overall Study|Withdrawal by Subject|9|||
164129532|NCT02335983|592838382|FG000|Overall Study|Death|0|||
164129533|NCT02335983|592838383|FG001|Overall Study|Death|0|||
164129534|NCT02335983|592838384|FG002|Overall Study|Death|2|||
164129535|NCT02335983|592838385|FG003|Overall Study|Death|0|||
164129536|NCT02335983|592838386|FG004|Overall Study|Death|0|||
164129537|NCT02335983|592838387|FG005|Overall Study|Death|0|||
164129538|NCT02335983|592838382|FG000|Overall Study|Lost to Follow-up|0|||
164129539|NCT02335983|592838383|FG001|Overall Study|Lost to Follow-up|0|||
164129540|NCT02335983|592838384|FG002|Overall Study|Lost to Follow-up|0|||
164129541|NCT02335983|592838385|FG003|Overall Study|Lost to Follow-up|0|||
164129542|NCT02335983|592838386|FG004|Overall Study|Lost to Follow-up|0|||
164129543|NCT02335983|592838387|FG005|Overall Study|Lost to Follow-up|1|||
164129544|NCT02335983|592838382|FG000|Overall Study|Protocol Specified Criteria|5|||
164129545|NCT02335983|592838383|FG001|Overall Study|Protocol Specified Criteria|7|||
164129546|NCT02335983|592838384|FG002|Overall Study|Protocol Specified Criteria|27|||
164129547|NCT02335983|592838385|FG003|Overall Study|Protocol Specified Criteria|7|||
164129548|NCT02335983|592838386|FG004|Overall Study|Protocol Specified Criteria|5|||
164129549|NCT02335983|592838387|FG005|Overall Study|Protocol Specified Criteria|21|||
164129550|NCT00629265|592838392|FG000|Overall Study|Lost to Follow-up|4|||
164129551|NCT00629265|592838393|FG001|Overall Study|Lost to Follow-up|5|||
164129552|NCT00629265|592838392|FG000|Overall Study|Withdrawal by Subject|11|||
164129553|NCT00629265|592838393|FG001|Overall Study|Withdrawal by Subject|8|||
164129554|NCT00629265|592838392|FG000|Overall Study|Death|1|||
164129555|NCT00629265|592838393|FG001|Overall Study|Death|0|||
164129556|NCT00629265|592838392|FG000|Overall Study|Adverse Event|2|||
164129557|NCT00629265|592838393|FG001|Overall Study|Adverse Event|0|||
164129558|NCT00629265|592838392|FG000|Overall Study|HNC Recurrence|4|||
164129559|NCT00629265|592838393|FG001|Overall Study|HNC Recurrence|0|||
164129560|NCT00629265|592838392|FG000|Overall Study|Other CA Requiring Treatment|1|||
164129561|NCT00629265|592838393|FG001|Overall Study|Other CA Requiring Treatment|3|||
164129562|NCT00629265|592838392|FG000|Overall Study|Needed Esophageal Dilation|4|||
164129563|NCT00629265|592838393|FG001|Overall Study|Needed Esophageal Dilation|1|||
164129564|NCT00629265|592838392|FG000|Overall Study|Unrelated Medical Complications|3|||
164129565|NCT00629265|592838393|FG001|Overall Study|Unrelated Medical Complications|1|||
164129566|NCT00629265|592838392|FG000|Overall Study|Unknown Reason|2|||
164129567|NCT00629265|592838393|FG001|Overall Study|Unknown Reason|2|||
164129568|NCT04465630|592838394|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
164129569|NCT04465630|592838394|FG000|Overall Study|Screen failure|8|||
164129570|NCT04465630|592838394|FG000|Overall Study|Baseline failure|16|||
164129571|NCT01732484|592838398|FG000|Overall Study|Death|7|||
164129572|NCT01732484|592838398|FG000|Overall Study|Lost to Follow-up|14|||
164129573|NCT01732484|592838398|FG000|Overall Study|chronical illness|5|||
164129574|NCT00289874|592838399|FG000|Overall Study|Adverse Event|1|||
164129575|NCT00289874|592838400|FG001|Overall Study|Adverse Event|5|||
164129576|NCT00289874|592838399|FG000|Overall Study|Lost to Follow-up|1|||
164129577|NCT00289874|592838400|FG001|Overall Study|Lost to Follow-up|1|||
164129578|NCT00289874|592838399|FG000|Overall Study|Protocol Violation|3|||
164129579|NCT00289874|592838400|FG001|Overall Study|Protocol Violation|2|||
164129580|NCT00289874|592838399|FG000|Overall Study|Did not meet eligibility|1|||
164129581|NCT00289874|592838400|FG001|Overall Study|Did not meet eligibility|0|||
164129582|NCT01087489|592838401|FG000|Overall Study|enrolled in another VA study|0|||
164129583|NCT01087489|592838402|FG001|Overall Study|enrolled in another VA study|1|||
164129584|NCT01087489|592838401|FG000|Overall Study|Death|0|||
164129585|NCT01087489|592838402|FG001|Overall Study|Death|1|||
164129586|NCT01087489|592838401|FG000|Overall Study|unable to survey by telephone|0|||
164129587|NCT01087489|592838402|FG001|Overall Study|unable to survey by telephone|1|||
164129588|NCT05070546|592838410|FG000|Overall Study|Death|0|||
164129589|NCT05070546|592838411|FG001|Overall Study|Death|0|||
164129590|NCT05070546|592838412|FG002|Overall Study|Death|0|||
164129591|NCT05070546|592838413|FG003|Overall Study|Death|0|||
164129592|NCT05070546|592838414|FG004|Overall Study|Death|0|||
164129593|NCT05070546|592838415|FG005|Overall Study|Death|1|||
164129594|NCT05070546|592838410|FG000|Overall Study|Lost to Follow-up|8|||
164129595|NCT05070546|592838411|FG001|Overall Study|Lost to Follow-up|2|||
164129596|NCT05070546|592838412|FG002|Overall Study|Lost to Follow-up|7|||
164129597|NCT05070546|592838413|FG003|Overall Study|Lost to Follow-up|1|||
164129598|NCT05070546|592838414|FG004|Overall Study|Lost to Follow-up|2|||
164129599|NCT05070546|592838415|FG005|Overall Study|Lost to Follow-up|0|||
164129600|NCT05070546|592838410|FG000|Overall Study|Withdrawal by Subject|1|||
164129601|NCT05070546|592838411|FG001|Overall Study|Withdrawal by Subject|1|||
164129602|NCT05070546|592838412|FG002|Overall Study|Withdrawal by Subject|3|||
164129603|NCT05070546|592838413|FG003|Overall Study|Withdrawal by Subject|0|||
164129604|NCT05070546|592838414|FG004|Overall Study|Withdrawal by Subject|0|||
164129605|NCT05070546|592838415|FG005|Overall Study|Withdrawal by Subject|0|||
164129606|NCT05070546|592838410|FG000|Overall Study|Other|0|||
164129607|NCT05070546|592838411|FG001|Overall Study|Other|0|||
164129608|NCT05070546|592838412|FG002|Overall Study|Other|0|||
164129609|NCT05070546|592838413|FG003|Overall Study|Other|0|||
164129610|NCT05070546|592838414|FG004|Overall Study|Other|3|||
164129611|NCT05070546|592838415|FG005|Overall Study|Other|0|||
164129612|NCT05070546|592838410|FG000|Overall Study|Randomized but not vaccinated|1|||
164129613|NCT05070546|592838411|FG001|Overall Study|Randomized but not vaccinated|0|||
164129614|NCT05070546|592838412|FG002|Overall Study|Randomized but not vaccinated|1|||
164129615|NCT05070546|592838413|FG003|Overall Study|Randomized but not vaccinated|1|||
164129616|NCT05070546|592838414|FG004|Overall Study|Randomized but not vaccinated|3|||
164129617|NCT05070546|592838415|FG005|Overall Study|Randomized but not vaccinated|0|||
164129618|NCT02643355|592838416|FG000|Overall Study|Withdrawal by Subject|1|||
164129619|NCT02643355|592838417|FG001|Overall Study|Withdrawal by Subject|3|||
164129620|NCT02643355|592838416|FG000|Overall Study|Protocol Violation|0|||
164129621|NCT02643355|592838417|FG001|Overall Study|Protocol Violation|2|||
164129622|NCT01974440|592838421|FG000|Overall Study|Lost to Follow-up|7|||
164129623|NCT01974440|592838422|FG001|Overall Study|Lost to Follow-up|7|||
164129624|NCT01974440|592838421|FG000|Overall Study|Withdrawal by Subject|24|||
164129625|NCT01974440|592838422|FG001|Overall Study|Withdrawal by Subject|20|||
164129626|NCT01974440|592838421|FG000|Overall Study|Sponsor decision|109|||
164129627|NCT01974440|592838422|FG001|Overall Study|Sponsor decision|110|||
164129628|NCT01615263|592838431|FG000|Overall Study|Post-randomization exclusion|0|||
164129629|NCT01615263|592838432|FG001|Overall Study|Post-randomization exclusion|2|||
164129630|NCT00988065|592838437|FG000|Overall Study|Adverse Event|4|||
164129631|NCT00988065|592838438|FG001|Overall Study|Adverse Event|10|||
164129632|NCT00988065|592838439|FG002|Overall Study|Adverse Event|2|||
164129633|NCT00988065|592838437|FG000|Overall Study|Lost to Follow-up|1|||
164129634|NCT00988065|592838438|FG001|Overall Study|Lost to Follow-up|2|||
164129635|NCT00988065|592838439|FG002|Overall Study|Lost to Follow-up|2|||
164129636|NCT00988065|592838437|FG000|Overall Study|Subject withdrew consent|3|||
164129637|NCT00988065|592838438|FG001|Overall Study|Subject withdrew consent|5|||
164129638|NCT00988065|592838439|FG002|Overall Study|Subject withdrew consent|2|||
164129639|NCT00988065|592838437|FG000|Overall Study|Noncompliance with protocol|5|||
164129640|NCT00988065|592838438|FG001|Overall Study|Noncompliance with protocol|6|||
164129641|NCT00988065|592838439|FG002|Overall Study|Noncompliance with protocol|9|||
164129642|NCT00985712|592838440|FG000|Overall Study|Adverse Event|0|||
164129643|NCT00985712|592838441|FG001|Overall Study|Adverse Event|1|||
164129644|NCT00985712|592838440|FG000|Overall Study|Lost to Follow-up|2|||
164129645|NCT00985712|592838441|FG001|Overall Study|Lost to Follow-up|2|||
164129646|NCT00985712|592838440|FG000|Overall Study|Protocol Violation|0|||
164129647|NCT00985712|592838441|FG001|Overall Study|Protocol Violation|1|||
164129648|NCT00985712|592838440|FG000|Overall Study|Withdrawal by Subject|4|||
164129649|NCT00985712|592838441|FG001|Overall Study|Withdrawal by Subject|1|||
164129650|NCT00985712|592838440|FG000|Overall Study|Sponsor decision|0|||
164129651|NCT00985712|592838441|FG001|Overall Study|Sponsor decision|2|||
164129652|NCT03096847|592838447|FG000|Overall Study|Other|2|||
164129653|NCT03096847|592838448|FG001|Overall Study|Other|1|||
164129654|NCT03096847|592838449|FG002|Overall Study|Other|2|||
164129655|NCT03096847|592838447|FG000|Overall Study|Lost to Follow-up|1|||
164129656|NCT03096847|592838448|FG001|Overall Study|Lost to Follow-up|0|||
164129657|NCT03096847|592838449|FG002|Overall Study|Lost to Follow-up|1|||
164129658|NCT03096847|592838447|FG000|Overall Study|Death|6|||
164129659|NCT03096847|592838448|FG001|Overall Study|Death|0|||
164129660|NCT03096847|592838449|FG002|Overall Study|Death|2|||
164129661|NCT03096847|592838447|FG000|Overall Study|Protocol Violation|3|||
164129662|NCT03096847|592838448|FG001|Overall Study|Protocol Violation|0|||
164129663|NCT03096847|592838449|FG002|Overall Study|Protocol Violation|6|||
164129664|NCT03096847|592838447|FG000|Overall Study|Physician Decision|12|||
164129665|NCT03096847|592838448|FG001|Overall Study|Physician Decision|2|||
164129666|NCT03096847|592838449|FG002|Overall Study|Physician Decision|8|||
164129667|NCT03096847|592838447|FG000|Overall Study|Withdrawal by Subject|24|||
164129668|NCT03096847|592838448|FG001|Overall Study|Withdrawal by Subject|1|||
164129669|NCT03096847|592838449|FG002|Overall Study|Withdrawal by Subject|12|||
164129670|NCT03096847|592838447|FG000|Overall Study|Adverse Event|72|||
164129671|NCT03096847|592838448|FG001|Overall Study|Adverse Event|6|||
164129672|NCT03096847|592838449|FG002|Overall Study|Adverse Event|28|||
164129673|NCT03096847|592838447|FG000|Overall Study|Progressive disease|97|||
164129674|NCT03096847|592838448|FG001|Overall Study|Progressive disease|10|||
164129675|NCT03096847|592838449|FG002|Overall Study|Progressive disease|78|||
164129676|NCT03096847|592838447|FG000|Overall Study|Non-compliance with study medication|1|||
164129677|NCT03096847|592838448|FG001|Overall Study|Non-compliance with study medication|0|||
164129678|NCT03096847|592838449|FG002|Overall Study|Non-compliance with study medication|0|||
164129679|NCT03096847|592838447|FG000|Overall Study|New therapy for study indication|1|||
164129680|NCT03096847|592838448|FG001|Overall Study|New therapy for study indication|0|||
164129681|NCT03096847|592838449|FG002|Overall Study|New therapy for study indication|1|||
164129682|NCT00359632|592838453|FG000|Overall Study|Death|2|||
164129683|NCT00359632|592838454|FG001|Overall Study|Death|0|||
164129684|NCT00359632|592838453|FG000|Overall Study|Adverse Event|1|||
164129685|NCT00359632|592838454|FG001|Overall Study|Adverse Event|0|||
164129686|NCT00359632|592838453|FG000|Overall Study|Non-compliance with visit schedule|1|||
164129687|NCT00359632|592838454|FG001|Overall Study|Non-compliance with visit schedule|0|||
164129688|NCT03978091|592838457|FG000|Overall Study|Lost to Follow-up|0|||
164129689|NCT03978091|592838458|FG001|Overall Study|Lost to Follow-up|0|||
164129690|NCT03978091|592838459|FG002|Overall Study|Lost to Follow-up|1|||
164129691|NCT03978091|592838460|FG003|Overall Study|Lost to Follow-up|0|||
164129692|NCT03978091|592838461|FG004|Overall Study|Lost to Follow-up|0|||
164129693|NCT03978091|592838462|FG005|Overall Study|Lost to Follow-up|0|||
164129694|NCT03978091|592838457|FG000|Overall Study|Withdrawal by Subject|0|||
164129695|NCT03978091|592838458|FG001|Overall Study|Withdrawal by Subject|0|||
164129696|NCT03978091|592838459|FG002|Overall Study|Withdrawal by Subject|0|||
164129697|NCT03978091|592838460|FG003|Overall Study|Withdrawal by Subject|1|||
164129698|NCT03978091|592838461|FG004|Overall Study|Withdrawal by Subject|1|||
164129699|NCT03978091|592838462|FG005|Overall Study|Withdrawal by Subject|0|||
164129700|NCT04700280|592838470|FG000|Overall Study|Adverse Event|4|||
164129701|NCT04700280|592838471|FG001|Overall Study|Adverse Event|0|||
164129702|NCT04700280|592838470|FG000|Overall Study|Lack of Efficacy|1|||
164129703|NCT04700280|592838471|FG001|Overall Study|Lack of Efficacy|0|||
164129704|NCT04700280|592838470|FG000|Overall Study|Study terminated by sponsor|5|||
164129705|NCT04700280|592838471|FG001|Overall Study|Study terminated by sponsor|3|||
164129706|NCT04700280|592838470|FG000|Overall Study|Other than specified|1|||
164129707|NCT04700280|592838471|FG001|Overall Study|Other than specified|0|||
164129708|NCT01843348|592838472|FG000|Overall Study|Withdrawal by Subject|4|||
164129709|NCT01843348|592838473|FG001|Overall Study|Withdrawal by Subject|16|||
164129710|NCT01843348|592838474|FG002|Overall Study|Withdrawal by Subject|18|||
164129711|NCT01843348|592838472|FG000|Overall Study|Lost to Follow-up|5|||
164129712|NCT01843348|592838473|FG001|Overall Study|Lost to Follow-up|4|||
164129713|NCT01843348|592838474|FG002|Overall Study|Lost to Follow-up|2|||
164129714|NCT01843348|592838472|FG000|Overall Study|Death|5|||
164129715|NCT01843348|592838473|FG001|Overall Study|Death|3|||
164129716|NCT01843348|592838474|FG002|Overall Study|Death|4|||
164129717|NCT01843348|592838472|FG000|Overall Study|Graft loss/retransplantation|5|||
164129718|NCT01843348|592838473|FG001|Overall Study|Graft loss/retransplantation|8|||
164129719|NCT01843348|592838474|FG002|Overall Study|Graft loss/retransplantation|11|||
164129720|NCT01843348|592838472|FG000|Overall Study|Various reasons|4|||
164129721|NCT01843348|592838473|FG001|Overall Study|Various reasons|9|||
164129722|NCT01843348|592838474|FG002|Overall Study|Various reasons|6|||
164129723|NCT02093221|592838475|FG000|Overall Study|Adverse Event|1|||
164129724|NCT02093221|592838476|FG001|Overall Study|Adverse Event|0|||
164129725|NCT02093221|592838477|FG002|Overall Study|Adverse Event|0|||
164129726|NCT02093221|592838478|FG003|Overall Study|Adverse Event|0|||
164129727|NCT02093221|592838479|FG004|Overall Study|Adverse Event|0|||
164129728|NCT02093221|592838475|FG000|Overall Study|Withdrawal by Subject|1|||
164129729|NCT02093221|592838476|FG001|Overall Study|Withdrawal by Subject|1|||
164129730|NCT02093221|592838477|FG002|Overall Study|Withdrawal by Subject|4|||
164129731|NCT02093221|592838478|FG003|Overall Study|Withdrawal by Subject|1|||
164129732|NCT02093221|592838479|FG004|Overall Study|Withdrawal by Subject|1|||
164129733|NCT02093221|592838475|FG000|Overall Study|Lost to Follow-up|2|||
164129734|NCT02093221|592838476|FG001|Overall Study|Lost to Follow-up|0|||
164129735|NCT02093221|592838477|FG002|Overall Study|Lost to Follow-up|1|||
164129736|NCT02093221|592838478|FG003|Overall Study|Lost to Follow-up|1|||
164129737|NCT02093221|592838479|FG004|Overall Study|Lost to Follow-up|0|||
164129738|NCT02093221|592838475|FG000|Overall Study|Death|0|||
164129739|NCT02093221|592838476|FG001|Overall Study|Death|1|||
164129740|NCT02093221|592838477|FG002|Overall Study|Death|0|||
164129741|NCT02093221|592838478|FG003|Overall Study|Death|0|||
164129742|NCT02093221|592838479|FG004|Overall Study|Death|0|||
164129743|NCT02093221|592838475|FG000|Overall Study|Protocol Violation|0|||
164129744|NCT02093221|592838476|FG001|Overall Study|Protocol Violation|1|||
164129745|NCT02093221|592838477|FG002|Overall Study|Protocol Violation|0|||
164129746|NCT02093221|592838478|FG003|Overall Study|Protocol Violation|0|||
164129747|NCT02093221|592838479|FG004|Overall Study|Protocol Violation|0|||
164129748|NCT02093221|592838475|FG000|Overall Study|Study termination|6|||
164129749|NCT02093221|592838476|FG001|Overall Study|Study termination|5|||
164129750|NCT02093221|592838477|FG002|Overall Study|Study termination|4|||
164129751|NCT02093221|592838478|FG003|Overall Study|Study termination|6|||
164129752|NCT02093221|592838479|FG004|Overall Study|Study termination|7|||
164129753|NCT00257920|592838480|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
164129754|NCT00257920|592838481|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
164129755|NCT00257920|592838480|FG000|Period: Second Intervention|Other|2|||
164129756|NCT00257920|592838481|FG001|Period: Second Intervention|Other|1|||
164129757|NCT00770692|592838482|FG000|Overall Study|Withdrawal by Subject|7|||
164129758|NCT00770692|592838483|FG001|Overall Study|Withdrawal by Subject|9|||
164129759|NCT00770692|592838484|FG002|Overall Study|Withdrawal by Subject|9|||
164129760|NCT00770692|592838485|FG003|Overall Study|Withdrawal by Subject|6|||
164129761|NCT00770692|592838482|FG000|Overall Study|Adverse Event|3|||
164129762|NCT00770692|592838483|FG001|Overall Study|Adverse Event|0|||
164129763|NCT00770692|592838484|FG002|Overall Study|Adverse Event|4|||
164129764|NCT00770692|592838485|FG003|Overall Study|Adverse Event|4|||
164129765|NCT00770692|592838482|FG000|Overall Study|Investigator judgment|2|||
164129766|NCT00770692|592838483|FG001|Overall Study|Investigator judgment|0|||
164129767|NCT00770692|592838484|FG002|Overall Study|Investigator judgment|1|||
164129768|NCT00770692|592838485|FG003|Overall Study|Investigator judgment|1|||
164129769|NCT01230892|592838486|FG000|Overall Study|Withdrawal by Subject|1|||
164129770|NCT01230892|592838487|FG001|Overall Study|Withdrawal by Subject|1|||
164129771|NCT01230892|592838486|FG000|Overall Study|Lost to Follow-up|2|||
164129772|NCT01230892|592838487|FG001|Overall Study|Lost to Follow-up|0|||
164129773|NCT00725621|592838488|FG000|Overall Study|Adverse Event|25|||
164129774|NCT00725621|592838488|FG000|Overall Study|Lack of Efficacy|46|||
164129775|NCT00725621|592838488|FG000|Overall Study|Withdrawal by Subject|57|||
164129776|NCT00725621|592838488|FG000|Overall Study|Physician Decision|19|||
164129777|NCT00725621|592838488|FG000|Overall Study|Lost to Follow-up|52|||
164129778|NCT00725621|592838488|FG000|Overall Study|Non-compliance|8|||
164129779|NCT00725621|592838488|FG000|Overall Study|Continued treatment by other physician|6|||
164129780|NCT00725621|592838488|FG000|Overall Study|Switched to other study|1|||
164129781|NCT00725621|592838488|FG000|Overall Study|Switched to other drug|1|||
164129782|NCT00725621|592838488|FG000|Overall Study|Prepared for elective surgery|1|||
164129783|NCT00725621|592838488|FG000|Overall Study|Reason not specified|55|||
164129784|NCT01189500|592838489|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
164129785|NCT01189500|592838489|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
164129786|NCT00062751|592838490|FG000|Overall Study|Disease progression|24|||
164129787|NCT00062751|592838491|FG001|Overall Study|Disease progression|17|||
164129788|NCT00062751|592838492|FG002|Overall Study|Disease progression|24|||
164129789|NCT00062751|592838493|FG003|Overall Study|Disease progression|2|||
164129790|NCT00062751|592838494|FG004|Overall Study|Disease progression|2|||
164129791|NCT00062751|592838490|FG000|Overall Study|Adverse Event|4|||
164129792|NCT00062751|592838491|FG001|Overall Study|Adverse Event|7|||
164129793|NCT00062751|592838492|FG002|Overall Study|Adverse Event|2|||
164129794|NCT00062751|592838493|FG003|Overall Study|Adverse Event|2|||
164129795|NCT00062751|592838494|FG004|Overall Study|Adverse Event|2|||
164129796|NCT00062751|592838490|FG000|Overall Study|Other|2|||
164129797|NCT00062751|592838491|FG001|Overall Study|Other|3|||
164129798|NCT00062751|592838492|FG002|Overall Study|Other|1|||
164129799|NCT00062751|592838493|FG003|Overall Study|Other|0|||
164129800|NCT00062751|592838494|FG004|Overall Study|Other|1|||
164129801|NCT00062751|592838490|FG000|Overall Study|Withdrawal by Subject|1|||
164129802|NCT00062751|592838491|FG001|Overall Study|Withdrawal by Subject|2|||
164129803|NCT00062751|592838492|FG002|Overall Study|Withdrawal by Subject|2|||
164129804|NCT00062751|592838493|FG003|Overall Study|Withdrawal by Subject|1|||
164129805|NCT00062751|592838494|FG004|Overall Study|Withdrawal by Subject|0|||
164129806|NCT00062751|592838490|FG000|Overall Study|Symptomatic deterioration|1|||
164129807|NCT00062751|592838491|FG001|Overall Study|Symptomatic deterioration|1|||
164129808|NCT00062751|592838492|FG002|Overall Study|Symptomatic deterioration|0|||
164129809|NCT00062751|592838493|FG003|Overall Study|Symptomatic deterioration|0|||
164129810|NCT00062751|592838494|FG004|Overall Study|Symptomatic deterioration|1|||
164129811|NCT00062751|592838490|FG000|Overall Study|Death|1|||
164129812|NCT00062751|592838491|FG001|Overall Study|Death|0|||
164129813|NCT00062751|592838492|FG002|Overall Study|Death|1|||
164129814|NCT00062751|592838493|FG003|Overall Study|Death|0|||
164129815|NCT00062751|592838494|FG004|Overall Study|Death|0|||
164129816|NCT01000493|592838495|FG000|Overall Study|Adverse Event|3|||
164129817|NCT01000493|592838496|FG001|Overall Study|Adverse Event|6|||
164129818|NCT01000493|592838495|FG000|Overall Study|Lack of Efficacy|1|||
164129819|NCT01000493|592838496|FG001|Overall Study|Lack of Efficacy|1|||
164129820|NCT01000493|592838495|FG000|Overall Study|Protocol Violation|1|||
164129821|NCT01000493|592838496|FG001|Overall Study|Protocol Violation|8|||
164129822|NCT01000493|592838495|FG000|Overall Study|Study closed/terminated|25|||
164129823|NCT01000493|592838496|FG001|Overall Study|Study closed/terminated|23|||
164129824|NCT01000493|592838495|FG000|Overall Study|Lost to Follow-up|5|||
164129825|NCT01000493|592838496|FG001|Overall Study|Lost to Follow-up|9|||
164129826|NCT01000493|592838495|FG000|Overall Study|Physician Decision|1|||
164129827|NCT01000493|592838496|FG001|Overall Study|Physician Decision|1|||
164129828|NCT01000493|592838495|FG000|Overall Study|Withdrawal by Subject|3|||
164129829|NCT01000493|592838496|FG001|Overall Study|Withdrawal by Subject|7|||
164129830|NCT00673933|592838504|FG000|Overall Study|Withdrawal by Subject|2|||
164129831|NCT00673933|592838504|FG000|Overall Study|Lost to Follow-up|1|||
164129832|NCT02206620|592838505|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164129833|NCT02206620|592838506|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
164129834|NCT02206620|592838505|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
164129835|NCT02206620|592838506|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
164129836|NCT05816200|592838507|FG000|Overall Study|Lost to Follow-up|2|||
164129837|NCT05816200|592838508|FG001|Overall Study|Lost to Follow-up|1|||
164129838|NCT02394730|592838509|FG000|Overall Study|Lost to Follow-up|1|||
164129839|NCT02394730|592838510|FG001|Overall Study|Lost to Follow-up|0|||
164129840|NCT02394730|592838509|FG000|Overall Study|Withdrawal by Subject|0|||
164129841|NCT02394730|592838510|FG001|Overall Study|Withdrawal by Subject|1|||
164129842|NCT03295318|592839750|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
164129843|NCT03295318|592839751|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
164129844|NCT03295318|592839752|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
164129845|NCT03295318|592839750|FG000|Overall Study|Death|1|||
164129846|NCT03295318|592839751|FG001|Overall Study|Death|1|||
164129847|NCT03295318|592839752|FG002|Overall Study|Death|1|||
164129848|NCT03295318|592839750|FG000|Overall Study|Protocol Violation|4|||
164129849|NCT03295318|592839751|FG001|Overall Study|Protocol Violation|3|||
164129850|NCT03295318|592839752|FG002|Overall Study|Protocol Violation|3|||
164129851|NCT03295318|592839750|FG000|Overall Study|Withdrawal by Subject|0|||
164129852|NCT03295318|592839751|FG001|Overall Study|Withdrawal by Subject|0|||
164129853|NCT03295318|592839752|FG002|Overall Study|Withdrawal by Subject|1|||
164129854|NCT03295318|592839750|FG000|Overall Study|Subject discontinued due to travel|0|||
164129855|NCT03295318|592839751|FG001|Overall Study|Subject discontinued due to travel|1|||
164129856|NCT03295318|592839752|FG002|Overall Study|Subject discontinued due to travel|0|||
164129857|NCT03747601|592839753|FG000|Overall Study|COVID halt to visits|4|||
164129858|NCT04319718|592839754|FG000|Overall Study|Adverse Event|0|||
164129859|NCT04319718|592839755|FG001|Overall Study|Adverse Event|2|||
164129860|NCT04319718|592839754|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
164129861|NCT04319718|592839755|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
164129862|NCT02221037|592839756|FG000|Overall Study|Physician Decision|0|||
164129863|NCT02221037|592839757|FG001|Overall Study|Physician Decision|0|||
164129864|NCT02221037|592839758|FG002|Overall Study|Physician Decision|1|||
164129865|NCT02221037|592839759|FG003|Overall Study|Physician Decision|0|||
164129866|NCT03955471|592839761|FG000|Overall Study|Death|22|||
164129867|NCT03955471|592839761|FG000|Overall Study|Lost to Follow-up|1|||
164129868|NCT03955471|592839761|FG000|Overall Study|Withdrawal by Subject|6|||
164129869|NCT03955471|592839761|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
164129870|NCT01030341|592839762|FG000|Overall Study|Withdrawal by Subject|1|||
164129871|NCT01030341|592839762|FG000|Overall Study|Lost to Follow-up|2|||
164129872|NCT02307266|592839765|FG000|Overall Study|Adverse Event|3|||
164129873|NCT02307266|592839766|FG001|Overall Study|Adverse Event|1|||
164129874|NCT02307266|592839767|FG002|Overall Study|Adverse Event|5|||
164129875|NCT02307266|592839765|FG000|Overall Study|Withdrawal by Subject|2|||
164129876|NCT02307266|592839766|FG001|Overall Study|Withdrawal by Subject|0|||
164129877|NCT02307266|592839767|FG002|Overall Study|Withdrawal by Subject|1|||
164129878|NCT02307266|592839765|FG000|Overall Study|Lost to Follow-up|3|||
164129879|NCT02307266|592839766|FG001|Overall Study|Lost to Follow-up|0|||
164129880|NCT02307266|592839767|FG002|Overall Study|Lost to Follow-up|0|||
164129881|NCT00793780|592839768|FG000|Overall Study|Withdrawal by Subject|2|||
164129882|NCT00793780|592839769|FG001|Overall Study|Withdrawal by Subject|1|||
164129883|NCT01032018|592839770|FG000|Overall Study|Lost to Follow-up|6|||
164129884|NCT01032018|592839771|FG001|Overall Study|Lost to Follow-up|5|||
164129885|NCT01032018|592839770|FG000|Overall Study|Death|0|||
164129886|NCT01032018|592839771|FG001|Overall Study|Death|1|||
164129887|NCT00858143|592839773|FG000|Overall Study|Adverse Event|16|||
164129888|NCT00858143|592839773|FG000|Overall Study|Lack of Efficacy|4|||
164129889|NCT00858143|592839773|FG000|Overall Study|Death|7|||
164129890|NCT00858143|592839773|FG000|Overall Study|Other|23|||
164129891|NCT01293539|592839775|FG000|Overall Study|Physician Decision|1|||
164129892|NCT04032158|592839777|FG000|Overall Study|Study Termination|2|||
164129893|NCT04032158|592839778|FG001|Overall Study|Study Termination|1|||
164129894|NCT00059787|592839779|FG000|Overall Study|Adverse Event|13|||
164129895|NCT00059787|592839779|FG000|Overall Study|disease progression|2|||
164129896|NCT00059787|592839779|FG000|Overall Study|ineligible|1|||
164129897|NCT00059787|592839779|FG000|Overall Study|Other|4|||
164129898|NCT01248013|592839782|FG000|Overall Study|Withdrawal by Subject|14|||
164129899|NCT04325204|592839785|FG000|Overall Study|Death|0|||
164129900|NCT04325204|592839786|FG001|Overall Study|Death|1|||
164129901|NCT04325204|592839785|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
164129902|NCT04325204|592839786|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
164129903|NCT04325204|592839785|FG000|Overall Study|Lost to Follow-up|8|||
164129904|NCT04325204|592839786|FG001|Overall Study|Lost to Follow-up|8|||
164129905|NCT04325204|592839785|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
164129906|NCT04325204|592839786|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
164129907|NCT00841906|592839787|FG000|Overall Study|Withdrawal by Subject|2|||
164129908|NCT00841906|592839788|FG001|Overall Study|Withdrawal by Subject|0|||
164129909|NCT04710979|592839789|FG000|Overall Study|Lost to Follow-up|2|||
164129910|NCT04710979|592839790|FG001|Overall Study|Lost to Follow-up|4|||
164129911|NCT04710979|592839789|FG000|Overall Study|Withdrawal by Subject|1|||
164129912|NCT04710979|592839790|FG001|Overall Study|Withdrawal by Subject|0|||
164129913|NCT00394524|592839794|FG000|Overall Study|Protocol Violation|2|||
164129914|NCT00394524|592839795|FG001|Overall Study|Protocol Violation|3|||
164129915|NCT00394524|592839794|FG000|Overall Study|Death|1|||
164129916|NCT00394524|592839795|FG001|Overall Study|Death|0|||
164129917|NCT00394524|592839794|FG000|Overall Study|Withdrawal by Subject|0|||
164129918|NCT00394524|592839795|FG001|Overall Study|Withdrawal by Subject|1|||
164129919|NCT03827564|592839796|FG000|Overall Study|Discontinued due to Study Termination|1|||
164129920|NCT03827564|592839797|FG001|Overall Study|Discontinued due to Study Termination|0|||
164129921|NCT00891371|592839800|FG000|Pre-assignment|Inclusion/exclusion|5|||
164129922|NCT00891371|592839800|FG000|Pre-assignment|Consent withdrawal|1|||
164129923|NCT00891371|592839800|FG000|Treatment|Lack of Efficacy|5|||
164129924|NCT00891371|592839800|FG000|Treatment|Adverse Event|2|||
164129925|NCT00891371|592839800|FG000|Treatment|Death|1|||
164129926|NCT00891371|592839800|FG000|Treatment|Lost to Follow-up|1|||
164129927|NCT02238626|592839801|FG000|Overall Study|Adverse Event|3|||
164129928|NCT02238626|592839802|FG001|Overall Study|Adverse Event|5|||
164129929|NCT02238626|592839803|FG002|Overall Study|Adverse Event|0|||
164129930|NCT02238626|592839804|FG003|Overall Study|Adverse Event|3|||
164129931|NCT02238626|592839801|FG000|Overall Study|Lost to Follow-up|2|||
164129932|NCT02238626|592839802|FG001|Overall Study|Lost to Follow-up|4|||
164129933|NCT02238626|592839803|FG002|Overall Study|Lost to Follow-up|2|||
164129934|NCT02238626|592839804|FG003|Overall Study|Lost to Follow-up|2|||
164129935|NCT02238626|592839801|FG000|Overall Study|Withdrawal by Subject|0|||
164129936|NCT02238626|592839802|FG001|Overall Study|Withdrawal by Subject|3|||
164129937|NCT02238626|592839803|FG002|Overall Study|Withdrawal by Subject|0|||
164129938|NCT02238626|592839804|FG003|Overall Study|Withdrawal by Subject|1|||
164129939|NCT02238626|592839801|FG000|Overall Study|Death|0|||
164129940|NCT02238626|592839802|FG001|Overall Study|Death|0|||
164129941|NCT02238626|592839803|FG002|Overall Study|Death|1|||
164129942|NCT02238626|592839804|FG003|Overall Study|Death|1|||
164129943|NCT02238626|592839801|FG000|Overall Study|Other|0|||
164129944|NCT02238626|592839802|FG001|Overall Study|Other|2|||
164129945|NCT02238626|592839803|FG002|Overall Study|Other|0|||
164129946|NCT02238626|592839804|FG003|Overall Study|Other|0|||
164129947|NCT02621034|592839805|FG000|Overall Study|Lost to Follow-up|3|||
164129948|NCT02621034|592839806|FG001|Overall Study|Lost to Follow-up|2|||
164129949|NCT02621034|592839807|FG002|Overall Study|Lost to Follow-up|5|||
164129950|NCT04421586|592839816|FG000|Overall Study|Death|0|||
164129951|NCT04421586|592839817|FG001|Overall Study|Death|1|||
164129952|NCT04421586|592839816|FG000|Overall Study|Lost to Follow-up|2|||
164129953|NCT04421586|592839817|FG001|Overall Study|Lost to Follow-up|2|||
164129954|NCT04421586|592839816|FG000|Overall Study|Withdrawn by PI|1|||
164129955|NCT04421586|592839817|FG001|Overall Study|Withdrawn by PI|0|||
164129956|NCT04421586|592839816|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
164129957|NCT04421586|592839817|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
164129958|NCT02963441|592839818|FG000|Overall Study|Protocol violation or withdrawn|8|||
164129959|NCT02963441|592839818|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
164129960|NCT02963441|592839818|FG000|Overall Study|IDx-DR insufficient quality|33|||
164129961|NCT00974974|592839820|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
164129962|NCT00974974|592839821|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
164129963|NCT00974974|592839820|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
164129964|NCT00974974|592839821|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
164129965|NCT00974974|592839820|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
164129966|NCT00974974|592839821|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
164129967|NCT00974974|592839820|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
164129968|NCT00974974|592839821|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
164129969|NCT00974974|592839820|FG000|IR CD-LD Dose Adjustment|Various|0|||
164129970|NCT00974974|592839821|FG001|IR CD-LD Dose Adjustment|Various|9|||
164129971|NCT00974974|592839820|FG000|IPX066 Dose Conversion|Adverse Event|23|||
164129972|NCT00974974|592839821|FG001|IPX066 Dose Conversion|Adverse Event|0|||
164129973|NCT00974974|592839820|FG000|IPX066 Dose Conversion|Death|2|||
164129974|NCT00974974|592839821|FG001|IPX066 Dose Conversion|Death|0|||
164129975|NCT00974974|592839820|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
164129976|NCT00974974|592839821|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
164129977|NCT00974974|592839820|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
164129978|NCT00974974|592839821|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
164129979|NCT00974974|592839820|FG000|IPX066 Dose Conversion|Various|3|||
164129980|NCT00974974|592839821|FG001|IPX066 Dose Conversion|Various|0|||
164129981|NCT00974974|592839820|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
164129982|NCT00974974|592839821|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
164129983|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
164129984|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
164129985|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
164129986|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
164129987|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
164129988|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
164129989|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
164129990|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
164129991|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
164129992|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
164129993|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
164129994|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
164129995|NCT00974974|592839820|FG000|Maintenance - Double Blind Treatment|Various|4|||
164129996|NCT00974974|592839821|FG001|Maintenance - Double Blind Treatment|Various|0|||
164129997|NCT01297465|592839822|FG000|Overall Study|Lack of Ovarian Response|1|||
164129998|NCT01297465|592839823|FG001|Overall Study|Lack of Ovarian Response|1|||
164129999|NCT01297465|592839822|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
164130000|NCT01297465|592839823|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
164130001|NCT01297465|592839822|FG000|Overall Study|No Oocytes Retrieved|1|||
164130002|NCT01297465|592839823|FG001|Overall Study|No Oocytes Retrieved|1|||
164130003|NCT01297465|592839822|FG000|Overall Study|Poor oocyte quality|0|||
164130004|NCT01297465|592839823|FG001|Overall Study|Poor oocyte quality|1|||
164130005|NCT01297465|592839822|FG000|Overall Study|No Fertilization|6|||
164130006|NCT01297465|592839823|FG001|Overall Study|No Fertilization|4|||
164130007|NCT01297465|592839822|FG000|Overall Study|All Embryos Discarded|0|||
164130008|NCT01297465|592839823|FG001|Overall Study|All Embryos Discarded|1|||
164130009|NCT01297465|592839822|FG000|Overall Study|Intention to Freeze all Embryos|0|||
164130010|NCT01297465|592839823|FG001|Overall Study|Intention to Freeze all Embryos|1|||
164130011|NCT00969540|592839824|FG000|Overall Study|Lost to Follow-up|1|||
164130012|NCT00969540|592839825|FG001|Overall Study|Lost to Follow-up|1|||
164130013|NCT00801099|592839826|FG000|Overall Study|Lost to Follow-up|101|||
164130014|NCT00950963|592839827|FG000|Overall Study|Lost to Follow-up|29|||
164130015|NCT00950963|592839828|FG001|Overall Study|Lost to Follow-up|24|||
164130016|NCT04647721|592839829|FG000|Overall Study|Withdrawal by Subject|0|||
164130017|NCT04647721|592839830|FG001|Overall Study|Withdrawal by Subject|2|||
164130018|NCT04647721|592839829|FG000|Overall Study|Lost to Follow-up|2|||
164130019|NCT04647721|592839830|FG001|Overall Study|Lost to Follow-up|0|||
164130020|NCT00136318|592839833|FG000|Overall Study|Adverse Event|5|||
164130021|NCT00136318|592839834|FG001|Overall Study|Adverse Event|5|||
164130022|NCT00136318|592839833|FG000|Overall Study|Withdrawal by Subject|2|||
164130023|NCT00136318|592839834|FG001|Overall Study|Withdrawal by Subject|2|||
164130024|NCT02005887|592839835|FG000|Overall Study|Protocol Violation|0|||
164130025|NCT02005887|592839836|FG001|Overall Study|Protocol Violation|2|||
164130026|NCT02749292|592839838|FG000|Overall Study|Physician Decision|1|||
164130027|NCT02749292|592839839|FG001|Overall Study|Physician Decision|0|||
164130028|NCT02749292|592839838|FG000|Overall Study|Withdrawal by Subject|5|||
164130029|NCT02749292|592839839|FG001|Overall Study|Withdrawal by Subject|7|||
164130030|NCT02749292|592839838|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
164130031|NCT02749292|592839839|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
164130032|NCT02749292|592839838|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
164130033|NCT02749292|592839839|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
164130034|NCT02749292|592839838|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
164130035|NCT02749292|592839839|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
164130036|NCT02749292|592839838|FG000|Overall Study|Adverse Event|4|||
164130037|NCT02749292|592839839|FG001|Overall Study|Adverse Event|1|||
164130038|NCT02749292|592839838|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
164130039|NCT02749292|592839839|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
164130040|NCT02749292|592839838|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
164130041|NCT02749292|592839839|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
164130042|NCT02749292|592839838|FG000|Overall Study|Requiring glucocorticoids|0|||
164130043|NCT02749292|592839839|FG001|Overall Study|Requiring glucocorticoids|3|||
164130044|NCT02749292|592839838|FG000|Overall Study|Cancer|1|||
164130045|NCT02749292|592839839|FG001|Overall Study|Cancer|0|||
164130046|NCT00251641|592839840|FG000|Overall Study|Adverse Event|80|||
164130047|NCT00251641|592839841|FG001|Overall Study|Adverse Event|8|||
164130048|NCT00251641|592839840|FG000|Overall Study|Lack of Efficacy|2|||
164130049|NCT00251641|592839841|FG001|Overall Study|Lack of Efficacy|1|||
164130050|NCT00251641|592839840|FG000|Overall Study|Progression of Disease|0|||
164130051|NCT00251641|592839841|FG001|Overall Study|Progression of Disease|2|||
164130052|NCT00251641|592839840|FG000|Overall Study|Lost to Follow-up|3|||
164130053|NCT00251641|592839841|FG001|Overall Study|Lost to Follow-up|3|||
164130054|NCT00251641|592839840|FG000|Overall Study|Withdrawal by Subject|6|||
164130055|NCT00251641|592839841|FG001|Overall Study|Withdrawal by Subject|8|||
164130056|NCT00251641|592839840|FG000|Overall Study|Protocol Violation|10|||
164130057|NCT00251641|592839841|FG001|Overall Study|Protocol Violation|2|||
164130058|NCT00251641|592839840|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
164130059|NCT00251641|592839841|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
164130060|NCT00251641|592839840|FG000|Overall Study|Switched Treatment|9|||
164130061|NCT00251641|592839841|FG001|Overall Study|Switched Treatment|63|||
164130062|NCT00876018|592839842|FG000|Overall Study|Lost to Follow-up|0|||
164130063|NCT00876018|592839843|FG001|Overall Study|Lost to Follow-up|1|||
164130064|NCT00876018|592839844|FG002|Overall Study|Lost to Follow-up|1|||
164130065|NCT00876018|592839842|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
164130066|NCT00876018|592839843|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
164130067|NCT00876018|592839844|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
164130068|NCT03629028|592839847|FG000|Overall Study|Lost to Follow-up|26|||
164130069|NCT03629028|592839848|FG001|Overall Study|Lost to Follow-up|23|||
164130070|NCT03629028|592839847|FG000|Overall Study|Pregnancy|4|||
164130071|NCT03629028|592839848|FG001|Overall Study|Pregnancy|2|||
164130072|NCT03629028|592839847|FG000|Overall Study|intolerance to examination|2|||
164130073|NCT03629028|592839848|FG001|Overall Study|intolerance to examination|0|||
164130074|NCT03828448|592839849|FG000|Overall Study|Sponsor's Discretion|34|||
164130075|NCT02192164|592839853|FG000|Overall Study|Other|8|||
164130076|NCT02192164|592839853|FG000|Overall Study|Withdrawal by Subject|1|||
164130077|NCT02192164|592839853|FG000|Overall Study|Physician Decision|4|||
164130078|NCT02192164|592839853|FG000|Overall Study|Did not meet the exclusion criteria|1|||
164130079|NCT03123861|592839854|FG000|Overall Study|Protocol Violation|1|||
164130080|NCT03123861|592839855|FG001|Overall Study|Protocol Violation|1|||
164130081|NCT03123861|592839854|FG000|Overall Study|Withdrawal by Subject|2|||
164130082|NCT03123861|592839855|FG001|Overall Study|Withdrawal by Subject|2|||
164130083|NCT04932941|592839856|FG000|Overall Study|Lost to Follow-up|3|||
164130084|NCT04932941|592839857|FG001|Overall Study|Lost to Follow-up|1|||
164130085|NCT04932941|592839856|FG000|Overall Study|Withdrawal by Subject|7|||
164130086|NCT04932941|592839857|FG001|Overall Study|Withdrawal by Subject|4|||
164130087|NCT04932941|592839856|FG000|Overall Study|Other|4|||
164130088|NCT04932941|592839857|FG001|Overall Study|Other|2|||
164130089|NCT00588640|592839858|FG000|Overall Study|Physician Decision|1|||
164130090|NCT00588640|592839858|FG000|Overall Study|Ineligible Patient|1|||
164130091|NCT01393730|592839859|FG000|Overall Study|Withdrawal by Subject|3|||
164130092|NCT01393730|592839859|FG000|Overall Study|Other|2|||
164130093|NCT01393730|592839859|FG000|Overall Study|Adverse Event|1|||
164130094|NCT00448136|592839863|FG000|Overall Study|Death|3|||
164130095|NCT00448136|592839864|FG001|Overall Study|Death|8|||
164130096|NCT00448136|592839863|FG000|Overall Study|Investigator's decision (progression)|1|||
164130097|NCT00448136|592839864|FG001|Overall Study|Investigator's decision (progression)|0|||
164130098|NCT03407430|592839867|FG000|Washout|Protocol Violation|1|||
164130099|NCT03407430|592839868|FG001|Washout|Protocol Violation|0|||
164130100|NCT00922987|592839870|FG000|Overall Study|Insufficient clinical response|1|||
164130101|NCT00922987|592839870|FG000|Overall Study|Protocol Violation|2|||
164130102|NCT00922987|592839870|FG000|Overall Study|Adverse Event|1|||
164130103|NCT03510182|592839871|FG000|Overall Study|Withdrawal by Subject|2|||
164130104|NCT00375492|592839877|FG000|Overall Study|Adverse Event|4|||
164130105|NCT00375492|592839878|FG001|Overall Study|Adverse Event|5|||
164130106|NCT00375492|592839877|FG000|Overall Study|Entry Criteria Not Met|0|||
164130107|NCT00375492|592839878|FG001|Overall Study|Entry Criteria Not Met|1|||
164130108|NCT00375492|592839877|FG000|Overall Study|Loss of Glucose Control|0|||
164130109|NCT00375492|592839878|FG001|Overall Study|Loss of Glucose Control|1|||
164130110|NCT00375492|592839877|FG000|Overall Study|Lost to Follow-up|10|||
164130111|NCT00375492|592839878|FG001|Overall Study|Lost to Follow-up|5|||
164130112|NCT00375492|592839877|FG000|Overall Study|Physician Decision|0|||
164130113|NCT00375492|592839878|FG001|Overall Study|Physician Decision|4|||
164130114|NCT00375492|592839877|FG000|Overall Study|Protocol Violation|6|||
164130115|NCT00375492|592839878|FG001|Overall Study|Protocol Violation|3|||
164130116|NCT00375492|592839877|FG000|Overall Study|Sponsor Decision|0|||
164130117|NCT00375492|592839878|FG001|Overall Study|Sponsor Decision|1|||
164130118|NCT00375492|592839877|FG000|Overall Study|Withdrawal by Subject|6|||
164130119|NCT00375492|592839878|FG001|Overall Study|Withdrawal by Subject|6|||
164130120|NCT05011123|592841434|FG000|Overall Study|Withdrawal by Subject|4|||
164130121|NCT05011123|592841435|FG001|Overall Study|Withdrawal by Subject|2|||
164130122|NCT05011123|592841434|FG000|Overall Study|Lost to Follow-up|7|||
164130123|NCT05011123|592841435|FG001|Overall Study|Lost to Follow-up|6|||
164130124|NCT05011123|592841434|FG000|Overall Study|Ongoing at the time of DBL date|36|||
164130125|NCT05011123|592841435|FG001|Overall Study|Ongoing at the time of DBL date|10|||
164130126|NCT05011123|592841434|FG000|Overall Study|Randomized but did not receive vaccination|1|||
164130127|NCT05011123|592841435|FG001|Overall Study|Randomized but did not receive vaccination|0|||
164130128|NCT00461253|592841436|FG000|Overall Study|Death|985|||
164130129|NCT00461253|592841437|FG001|Overall Study|Death|0|||
164130130|NCT00461253|592841436|FG000|Overall Study|Protocol Violation|613|||
164130131|NCT00461253|592841437|FG001|Overall Study|Protocol Violation|236|||
164130132|NCT00461253|592841436|FG000|Overall Study|no response|2609|||
164130133|NCT00461253|592841437|FG001|Overall Study|no response|11789|||
164130134|NCT00461253|592841436|FG000|Overall Study|administrative|773|||
164130135|NCT00461253|592841437|FG001|Overall Study|administrative|7773|||
164130136|NCT01933113|592841438|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
164130137|NCT02297438|592841439|FG000|Overall Study|Death|79|||
164130138|NCT02297438|592841440|FG001|Overall Study|Death|86|||
164130139|NCT02297438|592841439|FG000|Overall Study|Lost to Follow-up|9|||
164130140|NCT02297438|592841440|FG001|Overall Study|Lost to Follow-up|7|||
164130141|NCT02297438|592841439|FG000|Overall Study|Withdrawal by Subject|7|||
164130142|NCT02297438|592841440|FG001|Overall Study|Withdrawal by Subject|0|||
164130143|NCT02297438|592841439|FG000|Overall Study|Other|9|||
164130144|NCT02297438|592841440|FG001|Overall Study|Other|5|||
164130145|NCT02297438|592841439|FG000|Overall Study|Ongoing|65|||
164130146|NCT02297438|592841440|FG001|Overall Study|Ongoing|73|||
164130147|NCT00792935|592841450|FG000|Overall Study|Adverse Event|2|||
164130148|NCT00792935|592841451|FG001|Overall Study|Adverse Event|1|||
164130149|NCT00792935|592841450|FG000|Overall Study|Lost to Follow-up|0|||
164130150|NCT00792935|592841451|FG001|Overall Study|Lost to Follow-up|1|||
164130151|NCT00792935|592841450|FG000|Overall Study|Protocol Violation|2|||
164130152|NCT00792935|592841451|FG001|Overall Study|Protocol Violation|0|||
164130153|NCT00792935|592841450|FG000|Overall Study|Withdrawal by Subject|0|||
164130154|NCT00792935|592841451|FG001|Overall Study|Withdrawal by Subject|1|||
164130155|NCT01959035|592841460|FG000|Overall Study|Adverse Event|5|||
164130156|NCT01959035|592841460|FG000|Overall Study|Withdrawal by Subject|4|||
164130157|NCT01959035|592841460|FG000|Overall Study|Lost to Follow-up|1|||
164130158|NCT01959035|592841460|FG000|Overall Study|Other (no primary reason given)|1|||
164130159|NCT00450619|592841461|FG000|Overall Study|refused treatment after randomization|2|||
164130160|NCT00450619|592841462|FG001|Overall Study|refused treatment after randomization|0|||
164130161|NCT00450619|592841461|FG000|Overall Study|did not progress; refused further trmt|1|||
164130162|NCT00450619|592841462|FG001|Overall Study|did not progress; refused further trmt|1|||
164130163|NCT00450619|592841461|FG000|Overall Study|Adverse Event|1|||
164130164|NCT00450619|592841462|FG001|Overall Study|Adverse Event|0|||
164130165|NCT03254602|592841463|FG000|Overall Study|Lost to Follow-up|4|||
164130166|NCT02963311|592841466|FG000|Overall Study|Withdrawal by Subject|1|||
164130167|NCT02963311|592841466|FG000|Overall Study|Screen Failure|4|||
164130168|NCT01691820|592841467|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
164130169|NCT01691820|592841468|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
164130170|NCT01691820|592841467|FG000|Overall Study|Migrated/moved from study area|7|||
164130171|NCT01691820|592841468|FG001|Overall Study|Migrated/moved from study area|4|||
164130172|NCT01691820|592841467|FG000|Overall Study|Lost to Follow-up|6|||
164130173|NCT01691820|592841468|FG001|Overall Study|Lost to Follow-up|17|||
164130174|NCT01691820|592841467|FG000|Overall Study|Other (unspecified)|4|||
164130175|NCT01691820|592841468|FG001|Overall Study|Other (unspecified)|1|||
164130176|NCT04442490|592841471|FG000|Overall Study|Withdrawal by Subject|18|||
164130177|NCT04442490|592841472|FG001|Overall Study|Withdrawal by Subject|10|||
164130178|NCT04442490|592841471|FG000|Overall Study|Lost to Follow-up|7|||
164130179|NCT04442490|592841472|FG001|Overall Study|Lost to Follow-up|7|||
164130180|NCT04442490|592841471|FG000|Overall Study|Adverse Event|2|||
164130181|NCT04442490|592841472|FG001|Overall Study|Adverse Event|6|||
164130182|NCT04442490|592841471|FG000|Overall Study|Noncompliance|3|||
164130183|NCT04442490|592841472|FG001|Overall Study|Noncompliance|1|||
164130184|NCT04442490|592841471|FG000|Overall Study|Physician Decision|2|||
164130185|NCT04442490|592841472|FG001|Overall Study|Physician Decision|1|||
164130186|NCT04442490|592841471|FG000|Overall Study|Reason not Specified|2|||
164130187|NCT04442490|592841472|FG001|Overall Study|Reason not Specified|1|||
164130188|NCT04442490|592841471|FG000|Overall Study|Randomized but not Treated|3|||
164130189|NCT04442490|592841472|FG001|Overall Study|Randomized but not Treated|3|||
164130190|NCT01968694|592841474|FG000|Washout (1 Month)|Lost to Follow-up|0|||
164130191|NCT01968694|592841475|FG001|Washout (1 Month)|Lost to Follow-up|1|||
164130192|NCT02836496|592841476|FG000|Overall Study|Adverse Event|2|||
164130193|NCT02836496|592841477|FG001|Overall Study|Adverse Event|1|||
164130194|NCT02836496|592841476|FG000|Overall Study|Withdrawal by Subject|0|||
164130195|NCT02836496|592841477|FG001|Overall Study|Withdrawal by Subject|1|||
164130196|NCT01246011|592841478|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
164130197|NCT01246011|592841479|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
164130198|NCT01246011|592841480|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
164130199|NCT01246011|592841478|FG000|Overall Study|Withdrawal by Subject|0|||
164130200|NCT01246011|592841479|FG001|Overall Study|Withdrawal by Subject|0|||
164130201|NCT01246011|592841480|FG002|Overall Study|Withdrawal by Subject|1|||
164130202|NCT00415194|592841484|FG000|Overall Study|Adverse Event|37|||
164130203|NCT00415194|592841485|FG001|Overall Study|Adverse Event|32|||
164130204|NCT00415194|592841484|FG000|Overall Study|Entry Criteria Not Met|4|||
164130205|NCT00415194|592841485|FG001|Overall Study|Entry Criteria Not Met|8|||
164130206|NCT00415194|592841484|FG000|Overall Study|Lost to Follow-up|1|||
164130207|NCT00415194|592841485|FG001|Overall Study|Lost to Follow-up|0|||
164130208|NCT00415194|592841484|FG000|Overall Study|Physician Decision|10|||
164130209|NCT00415194|592841485|FG001|Overall Study|Physician Decision|16|||
164130210|NCT00415194|592841484|FG000|Overall Study|Progressive Disease|180|||
164130211|NCT00415194|592841485|FG001|Overall Study|Progressive Disease|217|||
164130212|NCT00415194|592841484|FG000|Overall Study|Protocol Violation|4|||
164130213|NCT00415194|592841485|FG001|Overall Study|Protocol Violation|2|||
164130214|NCT00415194|592841484|FG000|Overall Study|Withdrawal by Subject|28|||
164130215|NCT00415194|592841485|FG001|Overall Study|Withdrawal by Subject|21|||
164130216|NCT00415194|592841484|FG000|Overall Study|Death Due to Study Disease|26|||
164130217|NCT00415194|592841485|FG001|Overall Study|Death Due to Study Disease|29|||
164130218|NCT00415194|592841484|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
164130219|NCT00415194|592841485|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
164130220|NCT00415194|592841484|FG000|Overall Study|Death Due to Procedural Related AE|0|||
164130221|NCT00415194|592841485|FG001|Overall Study|Death Due to Procedural Related AE|1|||
164130222|NCT00415194|592841484|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
164130223|NCT00415194|592841485|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
164130224|NCT01646138|592841486|FG000|Overall Study|Lost to Follow-up|0|||
164130225|NCT01646138|592841487|FG001|Overall Study|Lost to Follow-up|0|||
164130226|NCT01646138|592841488|FG002|Overall Study|Lost to Follow-up|0|||
164130227|NCT01646138|592841489|FG003|Overall Study|Lost to Follow-up|0|||
164130228|NCT01646138|592841490|FG004|Overall Study|Lost to Follow-up|2|||
164130229|NCT01683838|592841491|FG000|Overall Study|Adverse Event|12|||
164130230|NCT01683838|592841492|FG001|Overall Study|Adverse Event|2|||
164130231|NCT01683838|592841491|FG000|Overall Study|Protocol Violation|3|||
164130232|NCT01683838|592841492|FG001|Overall Study|Protocol Violation|1|||
164130233|NCT01683838|592841491|FG000|Overall Study|Withdrawal by Subject|6|||
164130234|NCT01683838|592841492|FG001|Overall Study|Withdrawal by Subject|5|||
164130235|NCT01683838|592841491|FG000|Overall Study|Lost to Follow-up|1|||
164130236|NCT01683838|592841492|FG001|Overall Study|Lost to Follow-up|1|||
164130237|NCT01683838|592841491|FG000|Overall Study|Other|4|||
164130238|NCT01683838|592841492|FG001|Overall Study|Other|3|||
164130239|NCT01524679|592841493|FG000|Overall Study|Lost to Follow-up|1|||
164130240|NCT01524679|592841494|FG001|Overall Study|Lost to Follow-up|4|||
164130241|NCT01524679|592841493|FG000|Overall Study|Withdrawal by Subject|4|||
164130242|NCT01524679|592841494|FG001|Overall Study|Withdrawal by Subject|4|||
164130243|NCT01524679|592841493|FG000|Overall Study|Adverse Event|9|||
164130244|NCT01524679|592841494|FG001|Overall Study|Adverse Event|0|||
164130245|NCT01524679|592841493|FG000|Overall Study|Protocol Violation|1|||
164130246|NCT01524679|592841494|FG001|Overall Study|Protocol Violation|0|||
164130247|NCT01524679|592841493|FG000|Overall Study|Lack of Efficacy|2|||
164130248|NCT01524679|592841494|FG001|Overall Study|Lack of Efficacy|0|||
164130249|NCT01524679|592841493|FG000|Overall Study|e.g.wish for children, relocation|6|||
164130250|NCT01524679|592841494|FG001|Overall Study|e.g.wish for children, relocation|1|||
164130251|NCT04078126|592841497|FG000|Washout|Study put on hold due to COVID-19|0|||
164130252|NCT04078126|592841498|FG001|Washout|Study put on hold due to COVID-19|2|||
164130253|NCT04078126|592841497|FG000|Period 2|Study put on hold due to COVID-19|1|||
164130254|NCT04078126|592841498|FG001|Period 2|Study put on hold due to COVID-19|1|||
164130255|NCT03321630|592841501|FG000|Overall Study|Adverse Event|1|||
164130256|NCT03321630|592841501|FG000|Overall Study|Investigator Discretion|2|||
164130257|NCT03321630|592841501|FG000|Overall Study|Withdrawal by Subject|1|||
164130258|NCT00140426|592841502|FG000|Overall Study|Withdrawal by Subject|0|||
164130259|NCT00140426|592841503|FG001|Overall Study|Withdrawal by Subject|3|||
164130260|NCT02149108|592841504|FG000|Overall Study|Not treated|1|||
164130261|NCT02149108|592841505|FG001|Overall Study|Not treated|2|||
164130262|NCT02149108|592841504|FG000|Overall Study|Progressive Disease (PD)|324|||
164130263|NCT02149108|592841505|FG001|Overall Study|Progressive Disease (PD)|318|||
164130264|NCT02149108|592841504|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
164130265|NCT02149108|592841505|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
164130266|NCT02149108|592841504|FG000|Overall Study|Other Adverse Event (AE)|8|||
164130267|NCT02149108|592841505|FG001|Overall Study|Other Adverse Event (AE)|18|||
164130268|NCT02149108|592841504|FG000|Overall Study|Other not defined above|0|||
164130269|NCT02149108|592841505|FG001|Overall Study|Other not defined above|2|||
164130270|NCT02149108|592841504|FG000|Overall Study|Refusal to continue trial medication|15|||
164130271|NCT02149108|592841505|FG001|Overall Study|Refusal to continue trial medication|11|||
164130272|NCT02149108|592841504|FG000|Overall Study|Lost to Follow-up|1|||
164130273|NCT02149108|592841505|FG001|Overall Study|Lost to Follow-up|0|||
164130274|NCT04168190|592841506|FG000|Overall Study|Lost to Follow-up|0|||
164130275|NCT04168190|592841507|FG001|Overall Study|Lost to Follow-up|1|||
164130276|NCT04168190|592841508|FG002|Overall Study|Lost to Follow-up|0|||
164073627|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073628|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073629|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073630|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073631|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
164073632|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073633|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073634|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073635|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073636|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073637|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073638|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073639|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
164073640|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164073641|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164073642|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073643|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073644|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164073645|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164073646|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073647|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
164073648|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073649|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164073650|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073651|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073652|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164073653|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
164073654|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
164073655|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
164073656|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
164073657|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
164073658|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
164073659|NCT01915498|592632889|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
164073660|NCT01915498|592632890|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164073661|NCT01915498|592632891|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164073662|NCT01915498|592632892|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
164073663|NCT01915498|592632893|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
164073664|NCT01915498|592632894|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
164073665|NCT01915498|592632895|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
164073666|NCT01915498|592632896|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
164073667|NCT01915498|592632897|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
164073668|NCT01915498|592632898|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
164073669|NCT01915498|592632899|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164073670|NCT01915498|592632900|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
164073671|NCT01915498|592632901|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
164073672|NCT01915498|592632902|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
164073673|NCT01915498|592632903|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
164073674|NCT01915498|592632904|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
164073675|NCT01915498|592632905|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
164130277|NCT04168190|592841509|FG003|Overall Study|Lost to Follow-up|7|||
164130278|NCT04168190|592841510|FG004|Overall Study|Lost to Follow-up|5|||
164130279|NCT04168190|592841506|FG000|Overall Study|Withdrawal by Subject|1|||
164130280|NCT04168190|592841507|FG001|Overall Study|Withdrawal by Subject|0|||
164130281|NCT04168190|592841508|FG002|Overall Study|Withdrawal by Subject|0|||
164130282|NCT04168190|592841509|FG003|Overall Study|Withdrawal by Subject|2|||
164130283|NCT04168190|592841510|FG004|Overall Study|Withdrawal by Subject|4|||
164130284|NCT04168190|592841506|FG000|Overall Study|Death|0|||
164130285|NCT04168190|592841507|FG001|Overall Study|Death|0|||
164130286|NCT04168190|592841508|FG002|Overall Study|Death|0|||
164130287|NCT04168190|592841509|FG003|Overall Study|Death|1|||
164130288|NCT04168190|592841510|FG004|Overall Study|Death|0|||
164130289|NCT02325518|592841511|FG000|Overall Study|Adverse Event|4|||
164130290|NCT02325518|592841512|FG001|Overall Study|Adverse Event|1|||
164130291|NCT02325518|592841511|FG000|Overall Study|Physician Decision|0|||
164130292|NCT02325518|592841512|FG001|Overall Study|Physician Decision|1|||
164130293|NCT02325518|592841511|FG000|Overall Study|Withdrawal by Subject|0|||
164130294|NCT02325518|592841512|FG001|Overall Study|Withdrawal by Subject|1|||
164130295|NCT01675661|592841513|FG000|Overall Study|Lost to Follow-up|22|||
164130296|NCT01675661|592841514|FG001|Overall Study|Lost to Follow-up|23|||
164130297|NCT01675661|592841513|FG000|Overall Study|Practical problems|9|||
164130298|NCT01675661|592841514|FG001|Overall Study|Practical problems|5|||
164130299|NCT01675661|592841513|FG000|Overall Study|Moved away|5|||
164130300|NCT01675661|592841514|FG001|Overall Study|Moved away|6|||
164130301|NCT01675661|592841513|FG000|Overall Study|Withdrawal by Subject|3|||
164130302|NCT01675661|592841514|FG001|Overall Study|Withdrawal by Subject|7|||
164130303|NCT01675661|592841513|FG000|Overall Study|Physician Decision|0|||
164130304|NCT01675661|592841514|FG001|Overall Study|Physician Decision|2|||
164130305|NCT01675661|592841513|FG000|Overall Study|Death|0|||
164130306|NCT01675661|592841514|FG001|Overall Study|Death|1|||
164130307|NCT01675661|592841513|FG000|Overall Study|Other reason|1|||
164130308|NCT01675661|592841514|FG001|Overall Study|Other reason|2|||
164130309|NCT04765384|592841515|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
164130310|NCT04765384|592841516|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
164130311|NCT04765384|592841517|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
164130312|NCT04765384|592841518|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
164130313|NCT04765384|592841519|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
164130314|NCT04765384|592841520|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
164130315|NCT04765384|592841515|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
164130316|NCT04765384|592841516|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
164130317|NCT04765384|592841517|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
164130318|NCT04765384|592841518|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
164130319|NCT04765384|592841519|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
164130320|NCT04765384|592841520|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
164130321|NCT04765384|592841515|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164130322|NCT04765384|592841516|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164130323|NCT04765384|592841517|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164130324|NCT04765384|592841518|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164130325|NCT04765384|592841519|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
164130326|NCT04765384|592841520|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
164130327|NCT04765384|592841515|FG000|Post-natal: Neonates and Infants|Death|0|||
164130328|NCT04765384|592841516|FG001|Post-natal: Neonates and Infants|Death|0|||
164130329|NCT04765384|592841517|FG002|Post-natal: Neonates and Infants|Death|0|||
164130330|NCT04765384|592841518|FG003|Post-natal: Neonates and Infants|Death|1|||
164130331|NCT04765384|592841519|FG004|Post-natal: Neonates and Infants|Death|0|||
164130332|NCT04765384|592841520|FG005|Post-natal: Neonates and Infants|Death|0|||
164130333|NCT04765384|592841515|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164130334|NCT04765384|592841516|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164130335|NCT04765384|592841517|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164130336|NCT04765384|592841518|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164130337|NCT04765384|592841519|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
164130338|NCT04765384|592841520|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
164130339|NCT00987389|592841521|FG000|Overall Study|Ineligible|0|||
164130340|NCT00987389|592841522|FG001|Overall Study|Ineligible|3|||
164130341|NCT00987389|592841523|FG002|Overall Study|Ineligible|0|||
164130342|NCT00987389|592841524|FG003|Overall Study|Ineligible|0|||
164130343|NCT00987389|592841521|FG000|Overall Study|Lost to Follow-up|4|||
164130344|NCT00987389|592841522|FG001|Overall Study|Lost to Follow-up|1|||
164130345|NCT00987389|592841523|FG002|Overall Study|Lost to Follow-up|3|||
164130346|NCT00987389|592841524|FG003|Overall Study|Lost to Follow-up|1|||
164130347|NCT00987389|592841521|FG000|Overall Study|Withdrawal by Subject|4|||
164130348|NCT00987389|592841522|FG001|Overall Study|Withdrawal by Subject|3|||
164130349|NCT00987389|592841523|FG002|Overall Study|Withdrawal by Subject|2|||
164130350|NCT00987389|592841524|FG003|Overall Study|Withdrawal by Subject|1|||
164130351|NCT00987389|592841521|FG000|Overall Study|Withdrawn from Treatment|0|||
164130352|NCT00987389|592841522|FG001|Overall Study|Withdrawn from Treatment|1|||
164130353|NCT00987389|592841523|FG002|Overall Study|Withdrawn from Treatment|0|||
164130354|NCT00987389|592841524|FG003|Overall Study|Withdrawn from Treatment|0|||
164130355|NCT00987389|592841521|FG000|Overall Study|Multiple different reasons|1|||
164130356|NCT00987389|592841522|FG001|Overall Study|Multiple different reasons|0|||
164130357|NCT00987389|592841523|FG002|Overall Study|Multiple different reasons|3|||
164130358|NCT00987389|592841524|FG003|Overall Study|Multiple different reasons|1|||
164130359|NCT02992418|592841527|FG000|Overall Study|Withdrawal by Subject|11|||
164130360|NCT02992418|592841528|FG001|Overall Study|Withdrawal by Subject|12|||
164130361|NCT02992418|592841527|FG000|Overall Study|Non-compliance with the protocol|308|||
164130362|NCT02992418|592841528|FG001|Overall Study|Non-compliance with the protocol|308|||
164130363|NCT02992418|592841527|FG000|Overall Study|Lost to Follow-up|27|||
164130364|NCT02992418|592841528|FG001|Overall Study|Lost to Follow-up|22|||
164130365|NCT00289536|592841529|FG000|Period 3|Lost to Follow-up|0|||
164130366|NCT00289536|592841530|FG001|Period 3|Lost to Follow-up|0|||
164130367|NCT00289536|592841531|FG002|Period 3|Lost to Follow-up|1|||
164130368|NCT03246126|592841532|FG000|Overall Study|Withdrawal by Subject|0|||
164130369|NCT03246126|592841533|FG001|Overall Study|Withdrawal by Subject|1|||
164130370|NCT01006135|592841536|FG000|Overall Study|Adverse Event|22|||
164130371|NCT01006135|592841536|FG000|Overall Study|Protocol Violation|14|||
164130372|NCT01006135|592841536|FG000|Overall Study|Lost to Follow-up|32|||
164130373|NCT01006135|592841536|FG000|Overall Study|Other|72|||
164130374|NCT05297578|592841537|FG000|Overall Study|Lost to Follow-up|1|||
164130375|NCT05297578|592841538|FG001|Overall Study|Lost to Follow-up|1|||
164130376|NCT05297578|592841539|FG002|Overall Study|Lost to Follow-up|2|||
164130377|NCT05297578|592841540|FG003|Overall Study|Lost to Follow-up|1|||
164130378|NCT05297578|592841537|FG000|Overall Study|Death|0|||
164130379|NCT05297578|592841538|FG001|Overall Study|Death|1|||
164130380|NCT05297578|592841539|FG002|Overall Study|Death|0|||
164130381|NCT05297578|592841540|FG003|Overall Study|Death|0|||
164130382|NCT05297578|592841537|FG000|Overall Study|Withdrawal by Subject|0|||
164130383|NCT05297578|592841538|FG001|Overall Study|Withdrawal by Subject|0|||
164130384|NCT05297578|592841539|FG002|Overall Study|Withdrawal by Subject|1|||
164130385|NCT05297578|592841540|FG003|Overall Study|Withdrawal by Subject|0|||
164130386|NCT03127644|592841541|FG000|Overall Study|Study-specific withdrawal criteria|0|||
164130387|NCT03127644|592841542|FG001|Overall Study|Study-specific withdrawal criteria|0|||
164130388|NCT03127644|592841543|FG002|Overall Study|Study-specific withdrawal criteria|2|||
164130389|NCT02032706|592841546|FG000|Overall Study|Did not qualify|5|||
164130390|NCT02032706|592841546|FG000|Overall Study|Protocol Violation|1|||
164130391|NCT00893737|592841547|FG000|Overall Study|Adverse Event|4|||
164130392|NCT00893737|592841547|FG000|Overall Study|Withdrawal by Subject|2|||
164130393|NCT00893737|592841547|FG000|Overall Study|Lost to Follow-up|6|||
164130394|NCT01156142|592841548|FG000|Overall Study|Withdrawal by Subject|8|||
164130395|NCT01156142|592841549|FG001|Overall Study|Withdrawal by Subject|6|||
164130396|NCT01156142|592841548|FG000|Overall Study|Ineligible|0|||
164130397|NCT01156142|592841549|FG001|Overall Study|Ineligible|1|||
164130398|NCT00928707|592841550|FG000|Overall Study|Protocol Violation|1|||
164130399|NCT00928707|592841551|FG001|Overall Study|Protocol Violation|0|||
164130400|NCT00132028|592841552|FG000|Overall Study|Adverse Event|7|||
164130401|NCT00132028|592841552|FG000|Overall Study|Death|2|||
164130402|NCT00132028|592841552|FG000|Overall Study|Lack of Efficacy|11|||
164130403|NCT00132028|592841552|FG000|Overall Study|Withdrawal by Subject|2|||
164130404|NCT00132028|592841552|FG000|Overall Study|not eligible|2|||
164130405|NCT00132028|592841552|FG000|Overall Study|Physician Decision|3|||
164130406|NCT02140411|592841553|FG000|Overall Study|Adverse Event|1|||
164130407|NCT03981419|592841556|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
164130408|NCT03981419|592841557|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
164130409|NCT01330459|592841558|FG000|Overall Study|Physician Decision|0|||
164130410|NCT01330459|592841559|FG001|Overall Study|Physician Decision|2|||
164130411|NCT02272634|592841567|FG000|Overall Study|Adverse Event|1|||
164130412|NCT02272634|592841568|FG001|Overall Study|Adverse Event|0|||
164130413|NCT02272634|592841569|FG002|Overall Study|Adverse Event|0|||
164130414|NCT02272634|592841567|FG000|Overall Study|Protocol Violation|0|||
164130415|NCT02272634|592841568|FG001|Overall Study|Protocol Violation|0|||
164130416|NCT02272634|592841569|FG002|Overall Study|Protocol Violation|1|||
164130417|NCT02272634|592841567|FG000|Overall Study|Withdrawal by Subject|0|||
164130418|NCT02272634|592841568|FG001|Overall Study|Withdrawal by Subject|1|||
164130419|NCT02272634|592841569|FG002|Overall Study|Withdrawal by Subject|0|||
164130420|NCT01437943|592841570|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
164130421|NCT01437943|592841571|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
164130422|NCT01437943|592841570|FG000|Overall Study|Subject expressed pregnancy plans|1|||
164130423|NCT01437943|592841571|FG001|Overall Study|Subject expressed pregnancy plans|0|||
164130424|NCT01437943|592841570|FG000|Overall Study|Adverse Event|2|||
164130425|NCT01437943|592841571|FG001|Overall Study|Adverse Event|0|||
164130426|NCT01660334|592841572|FG000|Overall Study|Lost to Follow-up|1|||
164130427|NCT00536263|592841573|FG000|Overall Study|Adverse Event|5|||
164130428|NCT00536263|592841574|FG001|Overall Study|Adverse Event|5|||
164130429|NCT00536263|592841575|FG002|Overall Study|Adverse Event|7|||
164130430|NCT00536263|592841573|FG000|Overall Study|Lost to Follow-up|3|||
164130431|NCT00536263|592841574|FG001|Overall Study|Lost to Follow-up|4|||
164130432|NCT00536263|592841575|FG002|Overall Study|Lost to Follow-up|4|||
164130433|NCT00536263|592841573|FG000|Overall Study|Subject withdrew - not treatment related|2|||
164130434|NCT00536263|592841574|FG001|Overall Study|Subject withdrew - not treatment related|0|||
164130435|NCT00536263|592841575|FG002|Overall Study|Subject withdrew - not treatment related|5|||
164130436|NCT00536263|592841573|FG000|Overall Study|Subject withdrew - treatment related|0|||
164130437|NCT00536263|592841574|FG001|Overall Study|Subject withdrew - treatment related|3|||
164130438|NCT00536263|592841575|FG002|Overall Study|Subject withdrew - treatment related|2|||
164130439|NCT00536263|592841573|FG000|Overall Study|Noncompliance with protocol|0|||
164130440|NCT00536263|592841574|FG001|Overall Study|Noncompliance with protocol|0|||
164130441|NCT00536263|592841575|FG002|Overall Study|Noncompliance with protocol|1|||
164130442|NCT00536263|592841573|FG000|Overall Study|Did not meet protocol eligibility|1|||
164130443|NCT00536263|592841574|FG001|Overall Study|Did not meet protocol eligibility|2|||
164130444|NCT00536263|592841575|FG002|Overall Study|Did not meet protocol eligibility|2|||
164130445|NCT01640873|592841582|FG000|Overall Study|Protocol Violation|2|||
164130446|NCT01640873|592841583|FG001|Overall Study|Protocol Violation|1|||
164130447|NCT01321008|592841584|FG000|Overall Study|Early Study Termination|1|||
164130448|NCT02458092|592841585|FG000|Overall Study|Withdrawal by Subject|1|||
164130449|NCT02458092|592841586|FG001|Overall Study|Withdrawal by Subject|0|||
164130450|NCT00679913|592841587|FG000|Overall Study|Protocol Violation|18|||
164130451|NCT00679913|592841588|FG001|Overall Study|Protocol Violation|13|||
164130452|NCT00456495|592841593|FG000|Overall Study|Physician Decision|2|||
164130453|NCT01301508|592841594|FG000|Overall Study|Withdrawal by Subject|1|||
164130454|NCT01301508|592841595|FG001|Overall Study|Withdrawal by Subject|2|||
164130455|NCT01301508|592841594|FG000|Overall Study|Lost to Follow-up|0|||
164130456|NCT01301508|592841595|FG001|Overall Study|Lost to Follow-up|1|||
164130457|NCT05069155|592841600|FG000|Overall Study|Withdrawal by Subject|1|||
164130458|NCT05069155|592841601|FG001|Overall Study|Withdrawal by Subject|3|||
164130459|NCT01346774|592841602|FG000|Overall Study|Did not take a single dose|6|||
164130460|NCT01346774|592841603|FG001|Overall Study|Did not take a single dose|4|||
164130461|NCT01346774|592841602|FG000|Overall Study|Lost to Follow-up|3|||
164130462|NCT01346774|592841603|FG001|Overall Study|Lost to Follow-up|4|||
164130463|NCT01346774|592841602|FG000|Overall Study|Withdrawal by Subject|1|||
164130464|NCT01346774|592841603|FG001|Overall Study|Withdrawal by Subject|4|||
164130465|NCT01346774|592841602|FG000|Overall Study|Protocol Violation|2|||
164130466|NCT01346774|592841603|FG001|Overall Study|Protocol Violation|3|||
164130467|NCT01346774|592841602|FG000|Overall Study|Adverse Event|1|||
164130468|NCT01346774|592841603|FG001|Overall Study|Adverse Event|2|||
164130469|NCT01929031|592841604|FG000|Overall Study|Adverse Event|3|||
164130470|NCT01929031|592841605|FG001|Overall Study|Adverse Event|1|||
164130471|NCT01929031|592841606|FG002|Overall Study|Adverse Event|1|||
164130472|NCT01929031|592841607|FG003|Overall Study|Adverse Event|0|||
164130473|NCT01929031|592841608|FG004|Overall Study|Adverse Event|0|||
164130474|NCT01929031|592841609|FG005|Overall Study|Adverse Event|0|||
164130475|NCT01929031|592841604|FG000|Overall Study|Protocol Violation|1|||
164130476|NCT01929031|592841605|FG001|Overall Study|Protocol Violation|0|||
164130477|NCT01929031|592841606|FG002|Overall Study|Protocol Violation|0|||
164130478|NCT01929031|592841607|FG003|Overall Study|Protocol Violation|0|||
164130479|NCT01929031|592841608|FG004|Overall Study|Protocol Violation|0|||
164130480|NCT01929031|592841609|FG005|Overall Study|Protocol Violation|1|||
164130481|NCT01929031|592841604|FG000|Overall Study|Reason other than specified above|0|||
164130482|NCT01929031|592841605|FG001|Overall Study|Reason other than specified above|1|||
164130483|NCT01929031|592841606|FG002|Overall Study|Reason other than specified above|0|||
164130484|NCT01929031|592841607|FG003|Overall Study|Reason other than specified above|0|||
164130485|NCT01929031|592841608|FG004|Overall Study|Reason other than specified above|1|||
164130486|NCT01929031|592841609|FG005|Overall Study|Reason other than specified above|0|||
164130487|NCT01366443|592841610|FG000|Overall Study|Lost to Follow-up|2|||
164130488|NCT01366443|592841610|FG000|Overall Study|Under 18 yo|1|||
164130489|NCT00369382|592841616|FG000|Overall Study|Death|0|||
164130490|NCT00369382|592841617|FG001|Overall Study|Death|2|||
164130491|NCT00369382|592841616|FG000|Overall Study|Physician Decision|2|||
164130492|NCT00369382|592841617|FG001|Overall Study|Physician Decision|1|||
164130493|NCT00369382|592841616|FG000|Overall Study|Withdrawal by Subject|5|||
164130494|NCT00369382|592841617|FG001|Overall Study|Withdrawal by Subject|0|||
164130495|NCT00369382|592841616|FG000|Overall Study|Randomized, not treated|2|||
164130496|NCT00369382|592841617|FG001|Overall Study|Randomized, not treated|0|||
164130497|NCT00369382|592841616|FG000|Overall Study|Other|1|||
164130498|NCT00369382|592841617|FG001|Overall Study|Other|0|||
164130499|NCT01334710|592841619|FG000|Overall Study|Trial was terminated|3|||
164130500|NCT00321828|592842910|FG000|Overall Study|Ineligible|3|||
164130501|NCT00321828|592842910|FG000|Overall Study|No follow up data|1|||
164130502|NCT00678041|592842913|FG000|Overall Study|Physician Decision|5|||
164130503|NCT00678041|592842914|FG001|Overall Study|Physician Decision|5|||
164130504|NCT02358343|592842915|FG000|Screening Intervention|Death|0|||
164130505|NCT02358343|592842916|FG001|Screening Intervention|Death|2|||
164130506|NCT02358343|592842917|FG002|Screening Intervention|Death|0|||
164130507|NCT02358343|592842918|FG003|Screening Intervention|Death|0|||
164130508|NCT02358343|592842919|FG004|Screening Intervention|Death|0|||
164130509|NCT02358343|592842915|FG000|Screening Intervention|Withdrawal by Subject|1|||
164130510|NCT02358343|592842916|FG001|Screening Intervention|Withdrawal by Subject|0|||
164130511|NCT02358343|592842917|FG002|Screening Intervention|Withdrawal by Subject|0|||
164130512|NCT02358343|592842918|FG003|Screening Intervention|Withdrawal by Subject|0|||
164130513|NCT02358343|592842919|FG004|Screening Intervention|Withdrawal by Subject|0|||
164130514|NCT02358343|592842915|FG000|Screening Intervention|Determined Ineligible|5|||
164130515|NCT02358343|592842916|FG001|Screening Intervention|Determined Ineligible|6|||
164130516|NCT02358343|592842917|FG002|Screening Intervention|Determined Ineligible|0|||
164130517|NCT02358343|592842918|FG003|Screening Intervention|Determined Ineligible|0|||
164130518|NCT02358343|592842919|FG004|Screening Intervention|Determined Ineligible|0|||
164130519|NCT02358343|592842915|FG000|Comparative Efficacy Trial / Observation|Death|0|||
164130520|NCT02358343|592842916|FG001|Comparative Efficacy Trial / Observation|Death|0|||
164130521|NCT02358343|592842917|FG002|Comparative Efficacy Trial / Observation|Death|2|||
164130522|NCT02358343|592842918|FG003|Comparative Efficacy Trial / Observation|Death|0|||
164130523|NCT02358343|592842919|FG004|Comparative Efficacy Trial / Observation|Death|0|||
164130524|NCT02358343|592842915|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
164130525|NCT02358343|592842916|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
164130526|NCT02358343|592842917|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
164130527|NCT02358343|592842918|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
164130528|NCT02358343|592842919|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
164130529|NCT02358343|592842915|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164130530|NCT02358343|592842916|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164130531|NCT02358343|592842917|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
164130532|NCT02358343|592842918|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164130533|NCT02358343|592842919|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
164130534|NCT00577395|592842925|FG000|Overall Study|Study was terminated early by Sponsor|7|||
164130535|NCT00577395|592842926|FG001|Overall Study|Study was terminated early by Sponsor|6|||
164130536|NCT04322149|592842927|FG000|Overall Study|Adverse Event|1|||
164130537|NCT04322149|592842928|FG001|Overall Study|Adverse Event|1|||
164130538|NCT04322149|592842929|FG002|Overall Study|Adverse Event|0|||
164130539|NCT04322149|592842930|FG003|Overall Study|Adverse Event|0|||
164130540|NCT04322149|592842927|FG000|Overall Study|Withdrawal by Subject|0|||
164130541|NCT04322149|592842928|FG001|Overall Study|Withdrawal by Subject|0|||
164130542|NCT04322149|592842929|FG002|Overall Study|Withdrawal by Subject|0|||
164130543|NCT04322149|592842930|FG003|Overall Study|Withdrawal by Subject|2|||
164130544|NCT04322149|592842927|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
164130545|NCT04322149|592842928|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
164130546|NCT04322149|592842929|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
164130547|NCT04322149|592842930|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
164130548|NCT01700049|592842935|FG000|Overall Study|Withdrawal by Subject|1|||
164130549|NCT03084367|592842936|FG000|Overall Study|Lost to Follow-up|32|||
164130550|NCT03084367|592842936|FG000|Overall Study|Withdrawal by Subject|4|||
164130551|NCT03084367|592842936|FG000|Overall Study|Other|1|||
164130552|NCT01206101|592842937|FG000|Overall Study|Adverse Event|1|||
164130553|NCT01206101|592842938|FG001|Overall Study|Adverse Event|0|||
164130554|NCT01206101|592842937|FG000|Overall Study|Physician Decision|0|||
164130555|NCT01206101|592842938|FG001|Overall Study|Physician Decision|1|||
164130556|NCT01206101|592842937|FG000|Overall Study|Unclassified|1|||
164130557|NCT01206101|592842938|FG001|Overall Study|Unclassified|0|||
164130558|NCT00368979|592842944|FG000|Overall Study|Adverse Event|9|||
164130559|NCT00368979|592842945|FG001|Overall Study|Adverse Event|16|||
164130560|NCT00368979|592842944|FG000|Overall Study|Lack of Efficacy|5|||
164130561|NCT00368979|592842945|FG001|Overall Study|Lack of Efficacy|3|||
164130562|NCT00368979|592842944|FG000|Overall Study|Other|3|||
164130563|NCT00368979|592842945|FG001|Overall Study|Other|1|||
164130564|NCT00368979|592842944|FG000|Overall Study|Lost to Follow-up|1|||
164130565|NCT00368979|592842945|FG001|Overall Study|Lost to Follow-up|0|||
164130566|NCT00368979|592842944|FG000|Overall Study|Protocol Violation|2|||
164130567|NCT00368979|592842945|FG001|Overall Study|Protocol Violation|1|||
164130568|NCT00368979|592842944|FG000|Overall Study|Withdrawal by Subject|5|||
164130569|NCT00368979|592842945|FG001|Overall Study|Withdrawal by Subject|9|||
164130570|NCT00912093|592842946|FG000|The Controlled Phase|Death|0|||
164130571|NCT00912093|592842947|FG001|The Controlled Phase|Death|1|||
164130572|NCT00912093|592842948|FG002|The Controlled Phase|Death|0|||
164130573|NCT00912093|592842949|FG003|The Controlled Phase|Death|0|||
164130574|NCT00912093|592842950|FG004|The Controlled Phase|Death|0|||
164130575|NCT00912093|592842946|FG000|The Controlled Phase|Medical Condition|0|||
164130576|NCT00912093|592842947|FG001|The Controlled Phase|Medical Condition|1|||
164130577|NCT00912093|592842948|FG002|The Controlled Phase|Medical Condition|0|||
164130578|NCT00912093|592842949|FG003|The Controlled Phase|Medical Condition|0|||
164130579|NCT00912093|592842950|FG004|The Controlled Phase|Medical Condition|0|||
164130580|NCT00912093|592842946|FG000|The Controlled Phase|Lost to Follow-up|0|||
164130581|NCT00912093|592842947|FG001|The Controlled Phase|Lost to Follow-up|0|||
164130582|NCT00912093|592842948|FG002|The Controlled Phase|Lost to Follow-up|0|||
164130583|NCT00912093|592842949|FG003|The Controlled Phase|Lost to Follow-up|0|||
164130584|NCT00912093|592842950|FG004|The Controlled Phase|Lost to Follow-up|1|||
164130585|NCT00103311|592842951|FG000|Overall Study|Lost to Follow-up|1|||
164130586|NCT00103311|592842952|FG001|Overall Study|Lost to Follow-up|0|||
164130587|NCT00103311|592842951|FG000|Overall Study|Withdrawal by Subject|2|||
164130588|NCT00103311|592842952|FG001|Overall Study|Withdrawal by Subject|1|||
164130589|NCT00103311|592842951|FG000|Overall Study|Adverse Event|1|||
164130590|NCT00103311|592842952|FG001|Overall Study|Adverse Event|0|||
164130591|NCT01462318|592842955|FG000|Main Study / TP-DI Study|Other|2|||
164130592|NCT01462318|592842956|FG001|Main Study / TP-DI Study|Other|0|||
164130593|NCT01462318|592842957|FG002|Main Study / TP-DI Study|Other|0|||
164130594|NCT01462318|592842955|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
164130595|NCT01462318|592842956|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
164130596|NCT01462318|592842957|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
164130597|NCT01462318|592842955|FG000|Main Study / TP-DI Study|Adverse Event|4|||
164130598|NCT01462318|592842956|FG001|Main Study / TP-DI Study|Adverse Event|0|||
164130599|NCT01462318|592842957|FG002|Main Study / TP-DI Study|Adverse Event|0|||
164130600|NCT01462318|592842955|FG000|Extension Phase|Lost to Follow-up|0|||
164130601|NCT01462318|592842956|FG001|Extension Phase|Lost to Follow-up|0|||
164130602|NCT01462318|592842957|FG002|Extension Phase|Lost to Follow-up|1|||
164073676|NCT01915498|592632906|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
164073677|NCT01915498|592632907|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
164073678|NCT01915498|592632889|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073679|NCT01915498|592632890|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073680|NCT01915498|592632891|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073681|NCT01915498|592632892|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073682|NCT01915498|592632893|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073683|NCT01915498|592632894|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073684|NCT01915498|592632895|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073685|NCT01915498|592632896|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073686|NCT01915498|592632897|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073687|NCT01915498|592632898|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164130603|NCT01462318|592842955|FG000|Extension Phase|Other|0|||
164130604|NCT01462318|592842956|FG001|Extension Phase|Other|0|||
164130605|NCT01462318|592842957|FG002|Extension Phase|Other|1|||
164130606|NCT01462318|592842955|FG000|Extension Phase|Disease Progression|0|||
164130607|NCT01462318|592842956|FG001|Extension Phase|Disease Progression|0|||
164130608|NCT01462318|592842957|FG002|Extension Phase|Disease Progression|1|||
164130609|NCT01462318|592842955|FG000|Extension Phase|Withdrawal by Subject|0|||
164130610|NCT01462318|592842956|FG001|Extension Phase|Withdrawal by Subject|0|||
164130611|NCT01462318|592842957|FG002|Extension Phase|Withdrawal by Subject|15|||
164130612|NCT01462318|592842955|FG000|Extension Phase|Investigator Decision|0|||
164130613|NCT01462318|592842956|FG001|Extension Phase|Investigator Decision|0|||
164130614|NCT01462318|592842957|FG002|Extension Phase|Investigator Decision|5|||
164130615|NCT01462318|592842955|FG000|Extension Phase|Adverse Event|0|||
164130616|NCT01462318|592842956|FG001|Extension Phase|Adverse Event|0|||
164130617|NCT01462318|592842957|FG002|Extension Phase|Adverse Event|22|||
164130618|NCT00270257|592842960|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
164130619|NCT00270257|592842961|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
164130620|NCT01195103|592842962|FG000|Overall Study|Withdrawal by Subject|1|||
164130621|NCT01195103|592842963|FG001|Overall Study|Withdrawal by Subject|0|||
164130622|NCT01195103|592842964|FG002|Overall Study|Withdrawal by Subject|0|||
164130623|NCT01155024|592842971|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
164130624|NCT01155024|592842972|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
164130625|NCT01155024|592842971|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
164130626|NCT01155024|592842972|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
164130627|NCT01155024|592842971|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
164130628|NCT01155024|592842972|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
164130629|NCT01593696|592842973|FG000|Dose Escalation|Progressive Disease|2|||
164130630|NCT01593696|592842974|FG001|Dose Escalation|Progressive Disease|0|||
164130631|NCT01593696|592842975|FG002|Dose Escalation|Progressive Disease|0|||
164130632|NCT01593696|592842976|FG003|Dose Escalation|Progressive Disease|0|||
164130633|NCT01593696|592842973|FG000|Dose Expansion|Fungal infection|0|||
164130634|NCT01593696|592842974|FG001|Dose Expansion|Fungal infection|0|||
164130635|NCT01593696|592842975|FG002|Dose Expansion|Fungal infection|1|||
164130636|NCT01593696|592842976|FG003|Dose Expansion|Fungal infection|0|||
164130637|NCT00369655|592842977|FG000|Overall Study|Refusal of further treatment|2|||
164130638|NCT04049617|592842978|FG000|Overall Study|Adverse Event|0|||
164130639|NCT04049617|592842979|FG001|Overall Study|Adverse Event|0|||
164130640|NCT04049617|592842980|FG002|Overall Study|Adverse Event|0|||
164130641|NCT04049617|592842981|FG003|Overall Study|Adverse Event|1|||
164130642|NCT04049617|592842982|FG004|Overall Study|Adverse Event|0|||
164130643|NCT04049617|592842983|FG005|Overall Study|Adverse Event|0|||
164130644|NCT04049617|592842978|FG000|Overall Study|Death|0|||
164130645|NCT04049617|592842979|FG001|Overall Study|Death|0|||
164130646|NCT04049617|592842980|FG002|Overall Study|Death|0|||
164130647|NCT04049617|592842981|FG003|Overall Study|Death|0|||
164130648|NCT04049617|592842982|FG004|Overall Study|Death|0|||
164130649|NCT04049617|592842983|FG005|Overall Study|Death|1|||
164130650|NCT04049617|592842978|FG000|Overall Study|Lost to Follow-up|0|||
164130651|NCT04049617|592842979|FG001|Overall Study|Lost to Follow-up|0|||
164130652|NCT04049617|592842980|FG002|Overall Study|Lost to Follow-up|0|||
164130653|NCT04049617|592842981|FG003|Overall Study|Lost to Follow-up|1|||
164130654|NCT04049617|592842982|FG004|Overall Study|Lost to Follow-up|0|||
164130655|NCT04049617|592842983|FG005|Overall Study|Lost to Follow-up|0|||
164130656|NCT04049617|592842978|FG000|Overall Study|Withdrew consent|0|||
164130657|NCT04049617|592842979|FG001|Overall Study|Withdrew consent|0|||
164130658|NCT04049617|592842980|FG002|Overall Study|Withdrew consent|1|||
164130659|NCT04049617|592842981|FG003|Overall Study|Withdrew consent|0|||
164130660|NCT04049617|592842982|FG004|Overall Study|Withdrew consent|0|||
164130661|NCT04049617|592842983|FG005|Overall Study|Withdrew consent|0|||
164130662|NCT01780987|592842984|FG000|Overall Study|Adverse Event|0|||
164130663|NCT01780987|592842985|FG001|Overall Study|Adverse Event|4|||
164130664|NCT01780987|592842984|FG000|Overall Study|Withdrawal by Subject|2|||
164130665|NCT01780987|592842985|FG001|Overall Study|Withdrawal by Subject|0|||
164130666|NCT01780987|592842984|FG000|Overall Study|Request of Changing Hospital|0|||
164130667|NCT01780987|592842985|FG001|Overall Study|Request of Changing Hospital|1|||
164130668|NCT01780987|592842984|FG000|Overall Study|Changing Residence|1|||
164130669|NCT01780987|592842985|FG001|Overall Study|Changing Residence|0|||
164130670|NCT01780987|592842984|FG000|Overall Study|Not Receiving any Study Medication|0|||
164130671|NCT01780987|592842985|FG001|Overall Study|Not Receiving any Study Medication|1|||
164130672|NCT03402750|592842986|FG000|Overall Study|Lost to Follow-up|2|||
164130673|NCT03402750|592842987|FG001|Overall Study|Lost to Follow-up|1|||
164130674|NCT02981303|592842988|FG000|Overall Study|Progressive Disease|17|||
164130675|NCT02981303|592842989|FG001|Overall Study|Progressive Disease|37|||
164130676|NCT02981303|592842988|FG000|Overall Study|Adverse Event|1|||
164130677|NCT02981303|592842989|FG001|Overall Study|Adverse Event|4|||
164130678|NCT02981303|592842988|FG000|Overall Study|Withdrawal by Subject|0|||
164130679|NCT02981303|592842989|FG001|Overall Study|Withdrawal by Subject|1|||
164130680|NCT02534844|592842990|FG000|Part B|Withdrawal by Subject|0|||
164130681|NCT02534844|592842991|FG001|Part B|Withdrawal by Subject|0|||
164130682|NCT02534844|592842992|FG002|Part B|Withdrawal by Subject|0|||
164130683|NCT02534844|592842993|FG003|Part B|Withdrawal by Subject|0|||
164130684|NCT02534844|592842994|FG004|Part B|Withdrawal by Subject|2|||
164130685|NCT02534844|592842995|FG005|Part B|Withdrawal by Subject|1|||
164130686|NCT01971970|592842996|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
164130687|NCT01971970|592842997|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
164130688|NCT01971970|592842996|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
164130689|NCT01971970|592842997|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
164130690|NCT01971970|592842996|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
164130691|NCT01971970|592842997|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
164130692|NCT01971970|592842996|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
164130693|NCT01971970|592842997|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
164130694|NCT01971970|592842996|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
164130695|NCT01971970|592842997|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
164130696|NCT01971970|592842996|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
164130697|NCT01971970|592842997|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
164130698|NCT01971970|592842996|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
164130699|NCT01971970|592842997|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
164130700|NCT00848107|592842998|FG000|Overall Study|Lost to Follow-up|2|||
164130701|NCT00848107|592842998|FG000|Overall Study|Withdrawal by Subject|8|||
164130702|NCT00848107|592842998|FG000|Overall Study|Adverse Event|9|||
164130703|NCT00848107|592842998|FG000|Overall Study|Death|1|||
164130704|NCT00848107|592842998|FG000|Overall Study|Pregnancy|1|||
164130705|NCT01831765|592842999|FG000|Overall Study|Lack of Efficacy|1|||
164130706|NCT01831765|592843000|FG001|Overall Study|Lack of Efficacy|0|||
164130707|NCT01831765|592843001|FG002|Overall Study|Lack of Efficacy|0|||
164130708|NCT01831765|592842999|FG000|Overall Study|Other, sponsor withdrew subject|0|||
164130709|NCT01831765|592843000|FG001|Overall Study|Other, sponsor withdrew subject|1|||
164130710|NCT01831765|592843001|FG002|Overall Study|Other, sponsor withdrew subject|0|||
164130711|NCT01831765|592842999|FG000|Overall Study|Pregnancy|1|||
164130712|NCT01831765|592843000|FG001|Overall Study|Pregnancy|1|||
164130713|NCT01831765|592843001|FG002|Overall Study|Pregnancy|2|||
164130714|NCT01831765|592842999|FG000|Overall Study|Death|0|||
164130715|NCT01831765|592843000|FG001|Overall Study|Death|1|||
164130716|NCT01831765|592843001|FG002|Overall Study|Death|1|||
164130717|NCT01831765|592842999|FG000|Overall Study|Other, site closed|1|||
164130718|NCT01831765|592843000|FG001|Overall Study|Other, site closed|1|||
164130719|NCT01831765|592843001|FG002|Overall Study|Other, site closed|0|||
164130720|NCT01831765|592842999|FG000|Overall Study|Adverse Event|5|||
164130721|NCT01831765|592843000|FG001|Overall Study|Adverse Event|3|||
164130722|NCT01831765|592843001|FG002|Overall Study|Adverse Event|3|||
164130723|NCT01831765|592842999|FG000|Overall Study|Withdrawal by Subject|22|||
164130724|NCT01831765|592843000|FG001|Overall Study|Withdrawal by Subject|7|||
164130725|NCT01831765|592843001|FG002|Overall Study|Withdrawal by Subject|17|||
164130726|NCT01831765|592842999|FG000|Overall Study|Withdrawal criteria|12|||
164130727|NCT01831765|592843000|FG001|Overall Study|Withdrawal criteria|10|||
164130728|NCT01831765|592843001|FG002|Overall Study|Withdrawal criteria|16|||
164130729|NCT01831765|592842999|FG000|Overall Study|Lost to Follow-up|2|||
164130730|NCT01831765|592843000|FG001|Overall Study|Lost to Follow-up|3|||
164130731|NCT01831765|592843001|FG002|Overall Study|Lost to Follow-up|3|||
164130732|NCT00859586|592843002|FG000|Overall Study|Donors|4|||
164130733|NCT00080938|592843003|FG000|Overall Study|Adverse Event|3|||
164130734|NCT00080938|592843003|FG000|Overall Study|Withdrawal by Subject|6|||
164130735|NCT00080938|592843003|FG000|Overall Study|Death|2|||
164130736|NCT00080938|592843003|FG000|Overall Study|Lack of Efficacy|7|||
164130737|NCT00080938|592843003|FG000|Overall Study|other disease|1|||
164130738|NCT00080938|592843003|FG000|Overall Study|Not started protocol therapy|1|||
164130739|NCT00080938|592843003|FG000|Overall Study|Ineligible|4|||
164130740|NCT00706511|592843006|FG000|Overall Study|Withdrawal by Subject|1|||
164130741|NCT00706511|592843007|FG001|Overall Study|Withdrawal by Subject|0|||
164130742|NCT00706511|592843008|FG002|Overall Study|Withdrawal by Subject|0|||
164130743|NCT00706511|592843009|FG003|Overall Study|Withdrawal by Subject|0|||
164130744|NCT02116608|592843012|FG000|Overall Study|Lost to Follow-up|0|||
164130745|NCT02116608|592843013|FG001|Overall Study|Lost to Follow-up|0|||
164130746|NCT02116608|592843014|FG002|Overall Study|Lost to Follow-up|1|||
164130747|NCT02116608|592843012|FG000|Overall Study|Physician Decision|0|||
164130748|NCT02116608|592843013|FG001|Overall Study|Physician Decision|1|||
164130749|NCT02116608|592843014|FG002|Overall Study|Physician Decision|0|||
164130750|NCT02116608|592843012|FG000|Overall Study|Death|0|||
164130751|NCT02116608|592843013|FG001|Overall Study|Death|1|||
164130752|NCT02116608|592843014|FG002|Overall Study|Death|0|||
164130753|NCT01169532|592843016|FG000|Overall Study|Withdrawal by Subject|1|||
164130754|NCT00117325|592843020|FG000|Overall Study|Adverse Event|3|||
164130755|NCT00117325|592843021|FG001|Overall Study|Adverse Event|3|||
164130756|NCT00117325|592843020|FG000|Overall Study|Lost to Follow-up|1|||
164130757|NCT00117325|592843021|FG001|Overall Study|Lost to Follow-up|1|||
164130758|NCT00117325|592843020|FG000|Overall Study|Protocol Violation|2|||
164130759|NCT00117325|592843021|FG001|Overall Study|Protocol Violation|3|||
164130760|NCT00117325|592843020|FG000|Overall Study|Withdrawal by Subject|3|||
164130761|NCT00117325|592843021|FG001|Overall Study|Withdrawal by Subject|2|||
164130762|NCT00117325|592843020|FG000|Overall Study|Lack of Efficacy|1|||
164130763|NCT00117325|592843021|FG001|Overall Study|Lack of Efficacy|0|||
164130764|NCT00117325|592843020|FG000|Overall Study|Use of prohibited medicine|1|||
164130765|NCT00117325|592843021|FG001|Overall Study|Use of prohibited medicine|2|||
164130766|NCT00117325|592843020|FG000|Overall Study|Early termination|1|||
164130767|NCT00117325|592843021|FG001|Overall Study|Early termination|1|||
164130768|NCT00117325|592843020|FG000|Overall Study|Admisnitrative|1|||
164130769|NCT00117325|592843021|FG001|Overall Study|Admisnitrative|0|||
164130770|NCT01468818|592843025|FG000|Overall Study|Death during treatment|2|||
164130771|NCT02266134|592843026|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
164130772|NCT02266134|592843027|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
164130773|NCT02266134|592843028|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
164130774|NCT02266134|592843029|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
164130775|NCT02266134|592843026|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
164130776|NCT02266134|592843027|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
164130777|NCT02266134|592843028|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
164130778|NCT02266134|592843029|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
164130779|NCT02266134|592843026|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
164130780|NCT02266134|592843027|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
164130781|NCT02266134|592843028|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
164130782|NCT02266134|592843029|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
164130783|NCT02266134|592843026|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
164130784|NCT02266134|592843027|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
164130785|NCT02266134|592843028|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
164130786|NCT02266134|592843029|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
164130787|NCT02266134|592843026|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
164130788|NCT02266134|592843027|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
164130789|NCT02266134|592843028|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
164130790|NCT02266134|592843029|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
164132690|NCT01986010|592850669|FG014|Overall Study|Lost to Follow-up|2|||
164130791|NCT02266134|592843026|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
164130792|NCT02266134|592843027|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
164130793|NCT02266134|592843028|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
164130794|NCT02266134|592843029|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
164130795|NCT00302081|592843030|FG000|Overall Study|Adverse Event|6|||
164130796|NCT00302081|592843031|FG001|Overall Study|Adverse Event|5|||
164130797|NCT00302081|592843032|FG002|Overall Study|Adverse Event|4|||
164130798|NCT00302081|592843030|FG000|Overall Study|Lost to Follow-up|21|||
164130799|NCT00302081|592843031|FG001|Overall Study|Lost to Follow-up|18|||
164130800|NCT00302081|592843032|FG002|Overall Study|Lost to Follow-up|28|||
164130801|NCT00302081|592843030|FG000|Overall Study|Withdrawal by Subject|8|||
164130802|NCT00302081|592843031|FG001|Overall Study|Withdrawal by Subject|12|||
164130803|NCT00302081|592843032|FG002|Overall Study|Withdrawal by Subject|8|||
164130804|NCT00302081|592843030|FG000|Overall Study|Protocol Violation|5|||
164130805|NCT00302081|592843031|FG001|Overall Study|Protocol Violation|1|||
164130806|NCT00302081|592843032|FG002|Overall Study|Protocol Violation|2|||
164130807|NCT00302081|592843030|FG000|Overall Study|Lack of Efficacy|1|||
164130808|NCT00302081|592843031|FG001|Overall Study|Lack of Efficacy|0|||
164130809|NCT00302081|592843032|FG002|Overall Study|Lack of Efficacy|5|||
164130810|NCT00302081|592843030|FG000|Overall Study|Death|2|||
164130811|NCT00302081|592843031|FG001|Overall Study|Death|1|||
164130812|NCT00302081|592843032|FG002|Overall Study|Death|0|||
164130813|NCT00302081|592843030|FG000|Overall Study|Other|13|||
164130814|NCT00302081|592843031|FG001|Overall Study|Other|6|||
164130815|NCT00302081|592843032|FG002|Overall Study|Other|5|||
164130816|NCT02701413|592843033|FG000|Overall Study|Withdrawal by Subject|7|||
164130817|NCT02701413|592843034|FG001|Overall Study|Withdrawal by Subject|11|||
164130818|NCT02138136|592843035|FG000|Overall Study|Protocol Violation|4|||
164130819|NCT02138136|592843035|FG000|Overall Study|Physician Decision|7|||
164130820|NCT02138136|592843035|FG000|Overall Study|Lack of Efficacy|35|||
164130821|NCT02138136|592843035|FG000|Overall Study|Pregnancy|2|||
164130822|NCT02138136|592843035|FG000|Overall Study|Adverse Event|18|||
164130823|NCT02138136|592843035|FG000|Overall Study|Withdrawal by Subject|36|||
164130824|NCT02138136|592843035|FG000|Overall Study|Lost to Follow-up|32|||
164130825|NCT02138136|592843035|FG000|Overall Study|Withdrawn by Sponsor|5|||
164130826|NCT01359644|592843040|FG000|Treatment Period|Lack of Efficacy|0|||
164130827|NCT01359644|592843041|FG001|Treatment Period|Lack of Efficacy|1|||
164130828|NCT01359644|592843042|FG002|Treatment Period|Lack of Efficacy|0|||
164130829|NCT01359644|592843043|FG003|Treatment Period|Lack of Efficacy|0|||
164130830|NCT01359644|592843044|FG004|Treatment Period|Lack of Efficacy|0|||
164130831|NCT01359644|592843045|FG005|Treatment Period|Lack of Efficacy|0|||
164130832|NCT01359644|592843046|FG006|Treatment Period|Lack of Efficacy|0|||
164130833|NCT01359644|592843047|FG007|Treatment Period|Lack of Efficacy|0|||
164130834|NCT01359644|592843048|FG008|Treatment Period|Lack of Efficacy|0|||
164130835|NCT01359644|592843049|FG009|Treatment Period|Lack of Efficacy|0|||
164130836|NCT01359644|592843040|FG000|Treatment Period|Adverse Event|0|||
164130837|NCT01359644|592843041|FG001|Treatment Period|Adverse Event|0|||
164130838|NCT01359644|592843042|FG002|Treatment Period|Adverse Event|1|||
164130839|NCT01359644|592843043|FG003|Treatment Period|Adverse Event|0|||
164130840|NCT01359644|592843044|FG004|Treatment Period|Adverse Event|0|||
164130841|NCT01359644|592843045|FG005|Treatment Period|Adverse Event|1|||
164130842|NCT01359644|592843046|FG006|Treatment Period|Adverse Event|0|||
164130843|NCT01359644|592843047|FG007|Treatment Period|Adverse Event|0|||
164130844|NCT01359644|592843048|FG008|Treatment Period|Adverse Event|0|||
164130845|NCT01359644|592843049|FG009|Treatment Period|Adverse Event|0|||
164130846|NCT01359644|592843040|FG000|Treatment Period|Lost to Follow-up|0|||
164130847|NCT01359644|592843041|FG001|Treatment Period|Lost to Follow-up|0|||
164130848|NCT01359644|592843042|FG002|Treatment Period|Lost to Follow-up|0|||
164130849|NCT01359644|592843043|FG003|Treatment Period|Lost to Follow-up|0|||
164130850|NCT01359644|592843044|FG004|Treatment Period|Lost to Follow-up|0|||
164130851|NCT01359644|592843045|FG005|Treatment Period|Lost to Follow-up|1|||
164130852|NCT01359644|592843046|FG006|Treatment Period|Lost to Follow-up|0|||
164130853|NCT01359644|592843047|FG007|Treatment Period|Lost to Follow-up|0|||
164130854|NCT01359644|592843048|FG008|Treatment Period|Lost to Follow-up|0|||
164130855|NCT01359644|592843049|FG009|Treatment Period|Lost to Follow-up|0|||
164130856|NCT01359644|592843040|FG000|Follow-up Period|Withdrawal by Subject|0|||
164130857|NCT01359644|592843041|FG001|Follow-up Period|Withdrawal by Subject|0|||
164130858|NCT01359644|592843042|FG002|Follow-up Period|Withdrawal by Subject|0|||
164130859|NCT01359644|592843043|FG003|Follow-up Period|Withdrawal by Subject|0|||
164130860|NCT01359644|592843044|FG004|Follow-up Period|Withdrawal by Subject|0|||
164130861|NCT01359644|592843045|FG005|Follow-up Period|Withdrawal by Subject|1|||
164130862|NCT01359644|592843046|FG006|Follow-up Period|Withdrawal by Subject|0|||
164130863|NCT01359644|592843047|FG007|Follow-up Period|Withdrawal by Subject|0|||
164130864|NCT01359644|592843048|FG008|Follow-up Period|Withdrawal by Subject|0|||
164130865|NCT01359644|592843049|FG009|Follow-up Period|Withdrawal by Subject|0|||
164130866|NCT01359644|592843040|FG000|Follow-up Period|Lost to Follow-up|0|||
164130867|NCT01359644|592843041|FG001|Follow-up Period|Lost to Follow-up|0|||
164130868|NCT01359644|592843042|FG002|Follow-up Period|Lost to Follow-up|0|||
164130869|NCT01359644|592843043|FG003|Follow-up Period|Lost to Follow-up|0|||
164130870|NCT01359644|592843044|FG004|Follow-up Period|Lost to Follow-up|0|||
164130871|NCT01359644|592843045|FG005|Follow-up Period|Lost to Follow-up|0|||
164130872|NCT01359644|592843046|FG006|Follow-up Period|Lost to Follow-up|1|||
164130873|NCT01359644|592843047|FG007|Follow-up Period|Lost to Follow-up|2|||
164130874|NCT01359644|592843048|FG008|Follow-up Period|Lost to Follow-up|0|||
164130875|NCT01359644|592843049|FG009|Follow-up Period|Lost to Follow-up|0|||
164130876|NCT00311311|592843051|FG000|Overall Study|Adverse Event|3|||
164130877|NCT00311311|592843052|FG001|Overall Study|Adverse Event|2|||
164130878|NCT00311311|592843051|FG000|Overall Study|Withdrawal by Subject|1|||
164130879|NCT00311311|592843052|FG001|Overall Study|Withdrawal by Subject|1|||
164130880|NCT00311311|592843051|FG000|Overall Study|Noncompliance|0|||
164130881|NCT00311311|592843052|FG001|Overall Study|Noncompliance|1|||
164130882|NCT00311311|592843051|FG000|Overall Study|Study Termination by Sponsor|3|||
164130883|NCT00311311|592843052|FG001|Overall Study|Study Termination by Sponsor|4|||
164130884|NCT00311311|592843051|FG000|Overall Study|Death|1|||
164130885|NCT00311311|592843052|FG001|Overall Study|Death|0|||
164130886|NCT00311311|592843051|FG000|Overall Study|Lack of ancillary assistance|0|||
164130887|NCT00311311|592843052|FG001|Overall Study|Lack of ancillary assistance|1|||
164130888|NCT00826449|592843055|FG000|Overall Study|Disease Progression|4|||
164130889|NCT00826449|592843055|FG000|Overall Study|Withdrawal by Subject|1|||
164130890|NCT00160641|592843070|FG000|Overall Study|Adverse Event|102|||
164130891|NCT00160641|592843070|FG000|Overall Study|Withdrawal by Subject|87|||
164130892|NCT00160641|592843070|FG000|Overall Study|Lost to Follow-up|8|||
164130893|NCT00160641|592843070|FG000|Overall Study|Lack of Efficacy|12|||
164130894|NCT00160641|592843070|FG000|Overall Study|Protocol Violation|3|||
164130895|NCT00160641|592843070|FG000|Overall Study|Other|9|||
164130896|NCT01875471|592843071|FG000|Overall Study|Adverse Event|0|||
164130897|NCT01875471|592843072|FG001|Overall Study|Adverse Event|1|||
164130898|NCT01875471|592843071|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
164130899|NCT01875471|592843072|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
164130900|NCT00975286|592843076|FG000|Overall Study|Adverse Event|9|||
164130901|NCT00975286|592843077|FG001|Overall Study|Adverse Event|19|||
164130902|NCT00975286|592843076|FG000|Overall Study|Protocol Violation|1|||
164130903|NCT00975286|592843077|FG001|Overall Study|Protocol Violation|2|||
164130904|NCT00975286|592843076|FG000|Overall Study|Withdrawal by Subject|0|||
164130905|NCT00975286|592843077|FG001|Overall Study|Withdrawal by Subject|2|||
164130906|NCT00975286|592843076|FG000|Overall Study|Familial and Personal Reasons|2|||
164130907|NCT00975286|592843077|FG001|Overall Study|Familial and Personal Reasons|2|||
164130908|NCT00975286|592843076|FG000|Overall Study|Poor Compliance to Protocol|0|||
164130909|NCT00975286|592843077|FG001|Overall Study|Poor Compliance to Protocol|2|||
164130910|NCT00975286|592843076|FG000|Overall Study|Sponsor Decision|0|||
164130911|NCT00975286|592843077|FG001|Overall Study|Sponsor Decision|2|||
164130912|NCT03512262|592843081|FG000|Overall Study|Adverse Event|8|||
164130913|NCT03512262|592843082|FG001|Overall Study|Adverse Event|3|||
164130914|NCT03512262|592843081|FG000|Overall Study|Death (non-treatment emergent)|1|||
164130915|NCT03512262|592843082|FG001|Overall Study|Death (non-treatment emergent)|0|||
164130916|NCT03512262|592843081|FG000|Overall Study|Withdrawal by Subject|17|||
164130917|NCT03512262|592843082|FG001|Overall Study|Withdrawal by Subject|9|||
164130918|NCT03512262|592843081|FG000|Overall Study|Lost to Follow-up|7|||
164130919|NCT03512262|592843082|FG001|Overall Study|Lost to Follow-up|1|||
164130920|NCT03512262|592843081|FG000|Overall Study|Other than Specified|2|||
164130921|NCT03512262|592843082|FG001|Overall Study|Other than Specified|2|||
164130922|NCT04221789|592845668|FG000|Overall Study|deviation from protoco|22|||
164130923|NCT04221789|592845669|FG001|Overall Study|deviation from protoco|8|||
164130924|NCT04394351|592845680|FG000|Part A (16 Weeks)|Adverse Event|1|||
164130925|NCT04394351|592845681|FG001|Part A (16 Weeks)|Adverse Event|0|||
164130926|NCT04394351|592845682|FG002|Part A (16 Weeks)|Adverse Event|0|||
164130927|NCT04394351|592845683|FG003|Part A (16 Weeks)|Adverse Event|0|||
164130928|NCT04394351|592845684|FG004|Part A (16 Weeks)|Adverse Event|0|||
164130929|NCT04394351|592845685|FG005|Part A (16 Weeks)|Adverse Event|0|||
164130930|NCT04394351|592845686|FG006|Part A (16 Weeks)|Adverse Event|0|||
164130931|NCT04394351|592845687|FG007|Part A (16 Weeks)|Adverse Event|0|||
164130932|NCT04394351|592845680|FG000|Part A (16 Weeks)|Physician Decision|0|||
164130933|NCT04394351|592845681|FG001|Part A (16 Weeks)|Physician Decision|1|||
164130934|NCT04394351|592845682|FG002|Part A (16 Weeks)|Physician Decision|0|||
164130935|NCT04394351|592845683|FG003|Part A (16 Weeks)|Physician Decision|0|||
164130936|NCT04394351|592845684|FG004|Part A (16 Weeks)|Physician Decision|0|||
164130937|NCT04394351|592845685|FG005|Part A (16 Weeks)|Physician Decision|0|||
164130938|NCT04394351|592845686|FG006|Part A (16 Weeks)|Physician Decision|0|||
164130939|NCT04394351|592845687|FG007|Part A (16 Weeks)|Physician Decision|0|||
164130940|NCT04394351|592845680|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130941|NCT04394351|592845681|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
164130942|NCT04394351|592845682|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130943|NCT04394351|592845683|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130944|NCT04394351|592845684|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130945|NCT04394351|592845685|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130946|NCT04394351|592845686|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130947|NCT04394351|592845687|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
164130948|NCT04394351|592845680|FG000|Part B (36 Weeks)|Adverse Event|0|||
164130949|NCT04394351|592845681|FG001|Part B (36 Weeks)|Adverse Event|0|||
164130950|NCT04394351|592845682|FG002|Part B (36 Weeks)|Adverse Event|0|||
164130951|NCT04394351|592845683|FG003|Part B (36 Weeks)|Adverse Event|0|||
164130952|NCT04394351|592845684|FG004|Part B (36 Weeks)|Adverse Event|0|||
164130953|NCT04394351|592845685|FG005|Part B (36 Weeks)|Adverse Event|0|||
164130954|NCT04394351|592845686|FG006|Part B (36 Weeks)|Adverse Event|1|||
164130955|NCT04394351|592845687|FG007|Part B (36 Weeks)|Adverse Event|0|||
164130956|NCT04394351|592845680|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130957|NCT04394351|592845681|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130958|NCT04394351|592845682|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130959|NCT04394351|592845683|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130960|NCT04394351|592845684|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130961|NCT04394351|592845685|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130962|NCT04394351|592845686|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
164130963|NCT04394351|592845687|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
164130964|NCT04394351|592845680|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130965|NCT04394351|592845681|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130966|NCT04394351|592845682|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130967|NCT04394351|592845683|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130968|NCT04394351|592845684|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130969|NCT04394351|592845685|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130970|NCT04394351|592845686|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
164130971|NCT04394351|592845687|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
164130972|NCT04394351|592845680|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130973|NCT04394351|592845681|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130974|NCT04394351|592845682|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130975|NCT04394351|592845683|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130976|NCT04394351|592845684|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130977|NCT04394351|592845685|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130978|NCT04394351|592845686|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
164130979|NCT04394351|592845687|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
164130980|NCT04394351|592845680|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130981|NCT04394351|592845681|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130982|NCT04394351|592845682|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130983|NCT04394351|592845683|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130984|NCT04394351|592845684|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130985|NCT04394351|592845685|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130986|NCT04394351|592845686|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
164130987|NCT04394351|592845687|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
164130988|NCT03653507|592845688|FG000|Overall Study|Miscellaneous|28|||
164130989|NCT03653507|592845689|FG001|Overall Study|Miscellaneous|19|||
164130990|NCT03653507|592845688|FG000|Overall Study|Withdrawal by Subject|37|||
164130991|NCT03653507|592845689|FG001|Overall Study|Withdrawal by Subject|22|||
164130992|NCT03653507|592845688|FG000|Overall Study|Protocol Deviation|2|||
164130993|NCT03653507|592845689|FG001|Overall Study|Protocol Deviation|1|||
164130994|NCT03653507|592845688|FG000|Overall Study|Progressive disease|117|||
164130995|NCT03653507|592845689|FG001|Overall Study|Progressive disease|168|||
164130996|NCT03653507|592845688|FG000|Overall Study|Lost to Follow-up|1|||
164130997|NCT03653507|592845689|FG001|Overall Study|Lost to Follow-up|1|||
164130998|NCT03653507|592845688|FG000|Overall Study|Death|25|||
164130999|NCT03653507|592845689|FG001|Overall Study|Death|22|||
164131000|NCT03653507|592845688|FG000|Overall Study|Adverse Event|35|||
164131001|NCT03653507|592845689|FG001|Overall Study|Adverse Event|14|||
164131002|NCT01288053|592845696|FG000|Overall Study|Death|1|||
164131003|NCT03188666|592845697|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
164131004|NCT03188666|592845698|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
164131005|NCT03188666|592845699|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
164131006|NCT03188666|592845700|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
164131007|NCT03188666|592845697|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
164131008|NCT03188666|592845698|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
164131009|NCT03188666|592845699|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
164131010|NCT03188666|592845700|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
164131011|NCT03188666|592845697|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
164131012|NCT03188666|592845698|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
164131013|NCT03188666|592845699|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
164131014|NCT03188666|592845700|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
164131015|NCT03188666|592845697|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
164131016|NCT03188666|592845698|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
164131017|NCT03188666|592845699|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
164131018|NCT03188666|592845700|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
164131019|NCT00144781|592845701|FG000|Overall Study|Adverse Event|0|||
164131020|NCT00144781|592845702|FG001|Overall Study|Adverse Event|1|||
164131021|NCT00144781|592845703|FG002|Overall Study|Adverse Event|0|||
164131022|NCT00144781|592845704|FG003|Overall Study|Adverse Event|0|||
164131023|NCT00144781|592845701|FG000|Overall Study|Non-compliant|0|||
164131024|NCT00144781|592845702|FG001|Overall Study|Non-compliant|1|||
164131025|NCT00144781|592845703|FG002|Overall Study|Non-compliant|0|||
164131026|NCT00144781|592845704|FG003|Overall Study|Non-compliant|0|||
164131027|NCT02068092|592845705|FG000|Overall Study|Physician Decision|2|||
164131028|NCT02068092|592845705|FG000|Overall Study|Adverse Event|2|||
164131029|NCT02068092|592845705|FG000|Overall Study|Lost to Follow-up|4|||
164131030|NCT02068092|592845705|FG000|Overall Study|Withdrawal by Subject|2|||
164131031|NCT03696953|592845706|FG000|Overall Study|Withdrawal by Subject|6|||
164131032|NCT03696953|592845707|FG001|Overall Study|Withdrawal by Subject|1|||
164131033|NCT03696953|592845706|FG000|Overall Study|missed GBS swabs|2|||
164131034|NCT03696953|592845707|FG001|Overall Study|missed GBS swabs|2|||
164131035|NCT03696953|592845706|FG000|Overall Study|lost study bottle containing capsules|2|||
164131036|NCT03696953|592845707|FG001|Overall Study|lost study bottle containing capsules|0|||
164131037|NCT03696953|592845706|FG000|Overall Study|Premature birth|1|||
164131038|NCT03696953|592845707|FG001|Overall Study|Premature birth|4|||
164131039|NCT03696953|592845706|FG000|Overall Study|Gestational hypertension|1|||
164131040|NCT03696953|592845707|FG001|Overall Study|Gestational hypertension|1|||
164131041|NCT03696953|592845706|FG000|Overall Study|Gestational diabetes|2|||
164131042|NCT03696953|592845707|FG001|Overall Study|Gestational diabetes|1|||
164131043|NCT03696953|592845706|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
164131044|NCT03696953|592845707|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
164131045|NCT03696953|592845706|FG000|Overall Study|Changed prenatal provider|1|||
164131046|NCT03696953|592845707|FG001|Overall Study|Changed prenatal provider|1|||
164131047|NCT03502707|592845708|FG000|Overall Study|Adverse Event|0|||
164131048|NCT03502707|592845709|FG001|Overall Study|Adverse Event|0|||
164131049|NCT03502707|592845710|FG002|Overall Study|Adverse Event|0|||
164131050|NCT03502707|592845711|FG003|Overall Study|Adverse Event|0|||
164131051|NCT03502707|592845712|FG004|Overall Study|Adverse Event|0|||
164131052|NCT03502707|592845713|FG005|Overall Study|Adverse Event|0|||
164131053|NCT03502707|592845714|FG006|Overall Study|Adverse Event|0|||
164131054|NCT03502707|592845715|FG007|Overall Study|Adverse Event|0|||
164131055|NCT03502707|592845716|FG008|Overall Study|Adverse Event|0|||
164131056|NCT03502707|592845717|FG009|Overall Study|Adverse Event|0|||
164131057|NCT03502707|592845718|FG010|Overall Study|Adverse Event|0|||
164131058|NCT03502707|592845719|FG011|Overall Study|Adverse Event|0|||
164131059|NCT03502707|592845720|FG012|Overall Study|Adverse Event|0|||
164131060|NCT03502707|592845721|FG013|Overall Study|Adverse Event|0|||
164131061|NCT03502707|592845722|FG014|Overall Study|Adverse Event|0|||
164131062|NCT03502707|592845723|FG015|Overall Study|Adverse Event|1|||
164131063|NCT03502707|592845724|FG016|Overall Study|Adverse Event|5|||
164131064|NCT03502707|592845725|FG017|Overall Study|Adverse Event|0|||
164131065|NCT03502707|592845708|FG000|Overall Study|Death|0|||
164131066|NCT03502707|592845709|FG001|Overall Study|Death|0|||
164131067|NCT03502707|592845710|FG002|Overall Study|Death|0|||
164131068|NCT03502707|592845711|FG003|Overall Study|Death|1|||
164131069|NCT03502707|592845712|FG004|Overall Study|Death|0|||
164131070|NCT03502707|592845713|FG005|Overall Study|Death|0|||
164131071|NCT03502707|592845714|FG006|Overall Study|Death|0|||
164131072|NCT03502707|592845715|FG007|Overall Study|Death|0|||
164131073|NCT03502707|592845716|FG008|Overall Study|Death|1|||
164131074|NCT03502707|592845717|FG009|Overall Study|Death|1|||
164131075|NCT03502707|592845718|FG010|Overall Study|Death|0|||
164131076|NCT03502707|592845719|FG011|Overall Study|Death|0|||
164131077|NCT03502707|592845720|FG012|Overall Study|Death|1|||
164131078|NCT03502707|592845721|FG013|Overall Study|Death|0|||
164131079|NCT03502707|592845722|FG014|Overall Study|Death|0|||
164131080|NCT03502707|592845723|FG015|Overall Study|Death|1|||
164131081|NCT03502707|592845724|FG016|Overall Study|Death|0|||
164131082|NCT03502707|592845725|FG017|Overall Study|Death|0|||
164131083|NCT03502707|592845708|FG000|Overall Study|Lost to Follow-up|0|||
164131084|NCT03502707|592845709|FG001|Overall Study|Lost to Follow-up|0|||
164131085|NCT03502707|592845710|FG002|Overall Study|Lost to Follow-up|0|||
164131086|NCT03502707|592845711|FG003|Overall Study|Lost to Follow-up|0|||
164131087|NCT03502707|592845712|FG004|Overall Study|Lost to Follow-up|0|||
164131088|NCT03502707|592845713|FG005|Overall Study|Lost to Follow-up|0|||
164131089|NCT03502707|592845714|FG006|Overall Study|Lost to Follow-up|0|||
164131090|NCT03502707|592845715|FG007|Overall Study|Lost to Follow-up|5|||
164131091|NCT03502707|592845716|FG008|Overall Study|Lost to Follow-up|0|||
164131092|NCT03502707|592845717|FG009|Overall Study|Lost to Follow-up|2|||
164131093|NCT03502707|592845718|FG010|Overall Study|Lost to Follow-up|1|||
164131094|NCT03502707|592845719|FG011|Overall Study|Lost to Follow-up|2|||
164131095|NCT03502707|592845720|FG012|Overall Study|Lost to Follow-up|1|||
164131096|NCT03502707|592845721|FG013|Overall Study|Lost to Follow-up|1|||
164131097|NCT03502707|592845722|FG014|Overall Study|Lost to Follow-up|0|||
164131098|NCT03502707|592845723|FG015|Overall Study|Lost to Follow-up|4|||
164131099|NCT03502707|592845724|FG016|Overall Study|Lost to Follow-up|9|||
164131100|NCT03502707|592845725|FG017|Overall Study|Lost to Follow-up|2|||
164131101|NCT03502707|592845708|FG000|Overall Study|Physician Decision|0|||
164131102|NCT03502707|592845709|FG001|Overall Study|Physician Decision|0|||
164131103|NCT03502707|592845710|FG002|Overall Study|Physician Decision|0|||
164131104|NCT03502707|592845711|FG003|Overall Study|Physician Decision|0|||
164131105|NCT03502707|592845712|FG004|Overall Study|Physician Decision|0|||
164131106|NCT03502707|592845713|FG005|Overall Study|Physician Decision|0|||
164131107|NCT03502707|592845714|FG006|Overall Study|Physician Decision|0|||
164131108|NCT03502707|592845715|FG007|Overall Study|Physician Decision|0|||
164131109|NCT03502707|592845716|FG008|Overall Study|Physician Decision|2|||
164131110|NCT03502707|592845717|FG009|Overall Study|Physician Decision|1|||
164131111|NCT03502707|592845718|FG010|Overall Study|Physician Decision|0|||
164131112|NCT03502707|592845719|FG011|Overall Study|Physician Decision|0|||
164131113|NCT03502707|592845720|FG012|Overall Study|Physician Decision|0|||
164131114|NCT03502707|592845721|FG013|Overall Study|Physician Decision|0|||
164131115|NCT03502707|592845722|FG014|Overall Study|Physician Decision|1|||
164131116|NCT03502707|592845723|FG015|Overall Study|Physician Decision|3|||
164131117|NCT03502707|592845724|FG016|Overall Study|Physician Decision|0|||
164131118|NCT03502707|592845725|FG017|Overall Study|Physician Decision|0|||
164131119|NCT03502707|592845708|FG000|Overall Study|Protocol Violation|0|||
164131120|NCT03502707|592845709|FG001|Overall Study|Protocol Violation|0|||
164131121|NCT03502707|592845710|FG002|Overall Study|Protocol Violation|0|||
164131122|NCT03502707|592845711|FG003|Overall Study|Protocol Violation|0|||
164131123|NCT03502707|592845712|FG004|Overall Study|Protocol Violation|0|||
164131124|NCT03502707|592845713|FG005|Overall Study|Protocol Violation|0|||
164131125|NCT03502707|592845714|FG006|Overall Study|Protocol Violation|0|||
164131126|NCT03502707|592845715|FG007|Overall Study|Protocol Violation|0|||
164131127|NCT03502707|592845716|FG008|Overall Study|Protocol Violation|0|||
164131128|NCT03502707|592845717|FG009|Overall Study|Protocol Violation|0|||
164131129|NCT03502707|592845718|FG010|Overall Study|Protocol Violation|0|||
164131130|NCT03502707|592845719|FG011|Overall Study|Protocol Violation|0|||
164131131|NCT03502707|592845720|FG012|Overall Study|Protocol Violation|0|||
164131132|NCT03502707|592845721|FG013|Overall Study|Protocol Violation|0|||
164131133|NCT03502707|592845722|FG014|Overall Study|Protocol Violation|0|||
164131134|NCT03502707|592845723|FG015|Overall Study|Protocol Violation|1|||
164131135|NCT03502707|592845724|FG016|Overall Study|Protocol Violation|0|||
164131136|NCT03502707|592845725|FG017|Overall Study|Protocol Violation|0|||
164131137|NCT03502707|592845708|FG000|Overall Study|Withdrawal by Subject|1|||
164131138|NCT03502707|592845709|FG001|Overall Study|Withdrawal by Subject|1|||
164131139|NCT03502707|592845710|FG002|Overall Study|Withdrawal by Subject|0|||
164131140|NCT03502707|592845711|FG003|Overall Study|Withdrawal by Subject|0|||
164131141|NCT03502707|592845712|FG004|Overall Study|Withdrawal by Subject|0|||
164131142|NCT03502707|592845713|FG005|Overall Study|Withdrawal by Subject|2|||
164131143|NCT03502707|592845714|FG006|Overall Study|Withdrawal by Subject|0|||
164131144|NCT03502707|592845715|FG007|Overall Study|Withdrawal by Subject|3|||
164131145|NCT03502707|592845716|FG008|Overall Study|Withdrawal by Subject|1|||
164131146|NCT03502707|592845717|FG009|Overall Study|Withdrawal by Subject|2|||
164131147|NCT03502707|592845718|FG010|Overall Study|Withdrawal by Subject|12|||
164131148|NCT03502707|592845719|FG011|Overall Study|Withdrawal by Subject|23|||
164131149|NCT03502707|592845720|FG012|Overall Study|Withdrawal by Subject|5|||
164131150|NCT03502707|592845721|FG013|Overall Study|Withdrawal by Subject|3|||
164131151|NCT03502707|592845722|FG014|Overall Study|Withdrawal by Subject|3|||
164131152|NCT03502707|592845723|FG015|Overall Study|Withdrawal by Subject|43|||
164131153|NCT03502707|592845724|FG016|Overall Study|Withdrawal by Subject|44|||
164131154|NCT03502707|592845725|FG017|Overall Study|Withdrawal by Subject|18|||
164131155|NCT03502707|592845708|FG000|Overall Study|Sponsor's Decision|1|||
164131156|NCT03502707|592845709|FG001|Overall Study|Sponsor's Decision|0|||
164131157|NCT03502707|592845710|FG002|Overall Study|Sponsor's Decision|0|||
164131158|NCT03502707|592845711|FG003|Overall Study|Sponsor's Decision|0|||
164131159|NCT03502707|592845712|FG004|Overall Study|Sponsor's Decision|0|||
164131160|NCT03502707|592845713|FG005|Overall Study|Sponsor's Decision|0|||
164131161|NCT03502707|592845714|FG006|Overall Study|Sponsor's Decision|0|||
164131162|NCT03502707|592845715|FG007|Overall Study|Sponsor's Decision|0|||
164131163|NCT03502707|592845716|FG008|Overall Study|Sponsor's Decision|0|||
164131164|NCT03502707|592845717|FG009|Overall Study|Sponsor's Decision|1|||
164131165|NCT03502707|592845718|FG010|Overall Study|Sponsor's Decision|0|||
164131166|NCT03502707|592845719|FG011|Overall Study|Sponsor's Decision|0|||
164131167|NCT03502707|592845720|FG012|Overall Study|Sponsor's Decision|0|||
164131168|NCT03502707|592845721|FG013|Overall Study|Sponsor's Decision|0|||
164131169|NCT03502707|592845722|FG014|Overall Study|Sponsor's Decision|0|||
164131170|NCT03502707|592845723|FG015|Overall Study|Sponsor's Decision|2|||
164131171|NCT03502707|592845724|FG016|Overall Study|Sponsor's Decision|1|||
164131172|NCT03502707|592845725|FG017|Overall Study|Sponsor's Decision|0|||
164131173|NCT03502707|592845708|FG000|Overall Study|Initiated Prohibited Medication|0|||
164131174|NCT03502707|592845709|FG001|Overall Study|Initiated Prohibited Medication|0|||
164131175|NCT03502707|592845710|FG002|Overall Study|Initiated Prohibited Medication|0|||
164131176|NCT03502707|592845711|FG003|Overall Study|Initiated Prohibited Medication|0|||
164131177|NCT03502707|592845712|FG004|Overall Study|Initiated Prohibited Medication|0|||
164131178|NCT03502707|592845713|FG005|Overall Study|Initiated Prohibited Medication|0|||
164131179|NCT03502707|592845714|FG006|Overall Study|Initiated Prohibited Medication|0|||
164131180|NCT03502707|592845715|FG007|Overall Study|Initiated Prohibited Medication|0|||
164131181|NCT03502707|592845716|FG008|Overall Study|Initiated Prohibited Medication|0|||
164131182|NCT03502707|592845717|FG009|Overall Study|Initiated Prohibited Medication|0|||
164131183|NCT03502707|592845718|FG010|Overall Study|Initiated Prohibited Medication|0|||
164131184|NCT03502707|592845719|FG011|Overall Study|Initiated Prohibited Medication|0|||
164131185|NCT03502707|592845720|FG012|Overall Study|Initiated Prohibited Medication|0|||
164131186|NCT03502707|592845721|FG013|Overall Study|Initiated Prohibited Medication|0|||
164131187|NCT03502707|592845722|FG014|Overall Study|Initiated Prohibited Medication|0|||
164131188|NCT03502707|592845723|FG015|Overall Study|Initiated Prohibited Medication|0|||
164131189|NCT03502707|592845724|FG016|Overall Study|Initiated Prohibited Medication|1|||
164131190|NCT03502707|592845725|FG017|Overall Study|Initiated Prohibited Medication|0|||
164131191|NCT03502707|592845708|FG000|Overall Study|Other|0|||
164131192|NCT03502707|592845709|FG001|Overall Study|Other|0|||
164131193|NCT03502707|592845710|FG002|Overall Study|Other|0|||
164131194|NCT03502707|592845711|FG003|Overall Study|Other|0|||
164131195|NCT03502707|592845712|FG004|Overall Study|Other|0|||
164131196|NCT03502707|592845713|FG005|Overall Study|Other|0|||
164131197|NCT03502707|592845714|FG006|Overall Study|Other|0|||
164131198|NCT03502707|592845715|FG007|Overall Study|Other|0|||
164131199|NCT03502707|592845716|FG008|Overall Study|Other|1|||
164131200|NCT03502707|592845717|FG009|Overall Study|Other|1|||
164131201|NCT03502707|592845718|FG010|Overall Study|Other|2|||
164131202|NCT03502707|592845719|FG011|Overall Study|Other|0|||
164131203|NCT03502707|592845720|FG012|Overall Study|Other|0|||
164131204|NCT03502707|592845721|FG013|Overall Study|Other|0|||
164131205|NCT03502707|592845722|FG014|Overall Study|Other|0|||
164131206|NCT03502707|592845723|FG015|Overall Study|Other|4|||
164131207|NCT03502707|592845724|FG016|Overall Study|Other|1|||
164131208|NCT03502707|592845725|FG017|Overall Study|Other|0|||
164131209|NCT03502707|592845708|FG000|Overall Study|Randomized but not vaccinated|0|||
164131210|NCT03502707|592845709|FG001|Overall Study|Randomized but not vaccinated|0|||
164131211|NCT03502707|592845710|FG002|Overall Study|Randomized but not vaccinated|0|||
164131212|NCT03502707|592845711|FG003|Overall Study|Randomized but not vaccinated|0|||
164131213|NCT03502707|592845712|FG004|Overall Study|Randomized but not vaccinated|0|||
164131214|NCT03502707|592845713|FG005|Overall Study|Randomized but not vaccinated|0|||
164131215|NCT03502707|592845714|FG006|Overall Study|Randomized but not vaccinated|0|||
164131216|NCT03502707|592845715|FG007|Overall Study|Randomized but not vaccinated|0|||
164131217|NCT03502707|592845716|FG008|Overall Study|Randomized but not vaccinated|0|||
164131218|NCT03502707|592845717|FG009|Overall Study|Randomized but not vaccinated|0|||
164131219|NCT03502707|592845718|FG010|Overall Study|Randomized but not vaccinated|0|||
164131220|NCT03502707|592845719|FG011|Overall Study|Randomized but not vaccinated|1|||
164131221|NCT03502707|592845720|FG012|Overall Study|Randomized but not vaccinated|0|||
164131222|NCT03502707|592845721|FG013|Overall Study|Randomized but not vaccinated|0|||
164131223|NCT03502707|592845722|FG014|Overall Study|Randomized but not vaccinated|0|||
164131224|NCT03502707|592845723|FG015|Overall Study|Randomized but not vaccinated|0|||
164131225|NCT03502707|592845724|FG016|Overall Study|Randomized but not vaccinated|0|||
164131226|NCT03502707|592845725|FG017|Overall Study|Randomized but not vaccinated|1|||
164131227|NCT04092894|592845726|FG000|Overall Study|Withdrawal by Subject|2|||
164131228|NCT04092894|592845727|FG001|Overall Study|Withdrawal by Subject|4|||
164131229|NCT04092894|592845726|FG000|Overall Study|Discontinued EEG after randomization|10|||
164131230|NCT04092894|592845727|FG001|Overall Study|Discontinued EEG after randomization|6|||
164131231|NCT01106014|592845732|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
164131232|NCT01106014|592845733|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
164131233|NCT01106014|592845732|FG000|Overall Study|Adverse Event|78|||
164131234|NCT01106014|592845733|FG001|Overall Study|Adverse Event|42|||
164131235|NCT01106014|592845732|FG000|Overall Study|Withdrawal by Subject|43|||
164131236|NCT01106014|592845733|FG001|Overall Study|Withdrawal by Subject|37|||
164131237|NCT01106014|592845732|FG000|Overall Study|Administrative reason|7|||
164131238|NCT01106014|592845733|FG001|Overall Study|Administrative reason|6|||
164131239|NCT01106014|592845732|FG000|Overall Study|Lost to Follow-up|2|||
164131240|NCT01106014|592845733|FG001|Overall Study|Lost to Follow-up|3|||
164131241|NCT02935686|592845734|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
164131242|NCT02935686|592845735|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164131243|NCT02935686|592845736|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164131244|NCT02935686|592845737|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164131245|NCT02935686|592845738|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
164131246|NCT02935686|592845734|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
164131247|NCT02935686|592845735|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
164131248|NCT02935686|592845736|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
164131249|NCT02935686|592845737|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
164131250|NCT02935686|592845738|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
164131251|NCT02935686|592845734|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164131252|NCT02935686|592845735|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
164131253|NCT02935686|592845736|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164131254|NCT02935686|592845737|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164131255|NCT02935686|592845738|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
164131256|NCT02935686|592845734|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
164131257|NCT02935686|592845735|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
164131258|NCT02935686|592845736|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
164131259|NCT02935686|592845737|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
164131260|NCT02935686|592845738|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
164131261|NCT02935686|592845734|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
164131262|NCT02935686|592845735|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
164131263|NCT02935686|592845736|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
164131264|NCT02935686|592845737|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
164131265|NCT02935686|592845738|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
164131266|NCT02935686|592845734|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164131267|NCT02935686|592845735|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
164131268|NCT02935686|592845736|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164131269|NCT02935686|592845737|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164131270|NCT02935686|592845738|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
164131271|NCT02935686|592845734|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
164131272|NCT02935686|592845735|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
164131273|NCT02935686|592845736|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
164131274|NCT02935686|592845737|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
164131275|NCT02935686|592845738|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
164131276|NCT02935686|592845734|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164131277|NCT02935686|592845735|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
164131278|NCT02935686|592845736|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164131279|NCT02935686|592845737|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164131280|NCT02935686|592845738|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
164131281|NCT02935686|592845734|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164131282|NCT02935686|592845735|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
164131283|NCT02935686|592845736|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164131284|NCT02935686|592845737|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164131285|NCT02935686|592845738|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
164131286|NCT02935686|592845734|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164131287|NCT02935686|592845735|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164131288|NCT02935686|592845736|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164131289|NCT02935686|592845737|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
164131290|NCT02935686|592845738|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
164131291|NCT02935686|592845734|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
164131292|NCT02935686|592845735|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
164131293|NCT02935686|592845736|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
164131294|NCT02935686|592845737|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
164131295|NCT02935686|592845738|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
164131296|NCT02128217|592845743|FG000|Overall Study|Lost to Follow-up|0|||
164131297|NCT02128217|592845744|FG001|Overall Study|Lost to Follow-up|1|||
164131298|NCT05071313|592845745|FG000|Overall Study|Lost to Follow-up|17|||
164131299|NCT05071313|592845746|FG001|Overall Study|Lost to Follow-up|10|||
164131300|NCT05071313|592845745|FG000|Overall Study|Physician Decision|1|||
164131301|NCT05071313|592845746|FG001|Overall Study|Physician Decision|6|||
164131302|NCT05071313|592845745|FG000|Overall Study|Death|1|||
164131303|NCT05071313|592845746|FG001|Overall Study|Death|0|||
164131304|NCT05071313|592845745|FG000|Overall Study|Withdrawal by Subject|10|||
164131305|NCT05071313|592845746|FG001|Overall Study|Withdrawal by Subject|15|||
164131306|NCT05071313|592845745|FG000|Overall Study|Other|1|||
164131307|NCT05071313|592845746|FG001|Overall Study|Other|0|||
164131308|NCT05071313|592845745|FG000|Overall Study|Randomized but not vaccinated|4|||
164131309|NCT05071313|592845746|FG001|Overall Study|Randomized but not vaccinated|2|||
164131310|NCT00541970|592845747|FG000|Month 7|Protocol Violation|9|||
164131311|NCT00541970|592845748|FG001|Month 7|Protocol Violation|13|||
164131312|NCT00541970|592845749|FG002|Month 7|Protocol Violation|11|||
164131313|NCT00541970|592845750|FG003|Month 7|Protocol Violation|5|||
164131314|NCT00541970|592845747|FG000|Month 12|Adverse Event|0|||
164131315|NCT00541970|592845748|FG001|Month 12|Adverse Event|1|||
164131316|NCT00541970|592845749|FG002|Month 12|Adverse Event|1|||
164131317|NCT00541970|592845750|FG003|Month 12|Adverse Event|1|||
164131318|NCT00541970|592845747|FG000|Month 12|Protocol Violation|12|||
164131319|NCT00541970|592845748|FG001|Month 12|Protocol Violation|21|||
164131320|NCT00541970|592845749|FG002|Month 12|Protocol Violation|20|||
164131321|NCT00541970|592845750|FG003|Month 12|Protocol Violation|15|||
164131322|NCT00541970|592845747|FG000|Month 18|Adverse Event|0|||
164131323|NCT00541970|592845748|FG001|Month 18|Adverse Event|1|||
164131324|NCT00541970|592845749|FG002|Month 18|Adverse Event|1|||
164131325|NCT00541970|592845750|FG003|Month 18|Adverse Event|1|||
164131326|NCT00541970|592845747|FG000|Month 18|Protocol Violation|14|||
164131327|NCT00541970|592845748|FG001|Month 18|Protocol Violation|23|||
164131328|NCT00541970|592845749|FG002|Month 18|Protocol Violation|24|||
164131329|NCT00541970|592845750|FG003|Month 18|Protocol Violation|16|||
164131330|NCT00541970|592845747|FG000|Month 24|Adverse Event|0|||
164131331|NCT00541970|592845748|FG001|Month 24|Adverse Event|1|||
164131332|NCT00541970|592845749|FG002|Month 24|Adverse Event|1|||
164131333|NCT00541970|592845750|FG003|Month 24|Adverse Event|1|||
164131334|NCT00541970|592845747|FG000|Month 24|Protocol Violation|29|||
164131335|NCT00541970|592845748|FG001|Month 24|Protocol Violation|31|||
164131336|NCT00541970|592845749|FG002|Month 24|Protocol Violation|31|||
164131337|NCT00541970|592845750|FG003|Month 24|Protocol Violation|21|||
164131338|NCT00541970|592845747|FG000|Month 36|Protocol Violation|61|||
164131339|NCT00541970|592845748|FG001|Month 36|Protocol Violation|66|||
164131340|NCT00541970|592845749|FG002|Month 36|Protocol Violation|66|||
164131341|NCT00541970|592845750|FG003|Month 36|Protocol Violation|60|||
164131342|NCT00541970|592845747|FG000|Month 48|Withdrawal by Subject|2|||
164131343|NCT00541970|592845748|FG001|Month 48|Withdrawal by Subject|4|||
164131344|NCT00541970|592845749|FG002|Month 48|Withdrawal by Subject|4|||
164131345|NCT00541970|592845750|FG003|Month 48|Withdrawal by Subject|2|||
164131346|NCT00541970|592845747|FG000|Month 48|Other|3|||
164131347|NCT00541970|592845748|FG001|Month 48|Other|1|||
164131348|NCT00541970|592845749|FG002|Month 48|Other|1|||
164131349|NCT00541970|592845750|FG003|Month 48|Other|0|||
164131350|NCT00541970|592845747|FG000|Month 48|Lost to Follow-up|66|||
164131351|NCT00541970|592845748|FG001|Month 48|Lost to Follow-up|68|||
164131352|NCT00541970|592845749|FG002|Month 48|Lost to Follow-up|68|||
164131353|NCT00541970|592845750|FG003|Month 48|Lost to Follow-up|73|||
164131354|NCT00541970|592845747|FG000|Month 60|Protocol Violation|78|||
164131355|NCT00541970|592845748|FG001|Month 60|Protocol Violation|77|||
164131356|NCT00541970|592845749|FG002|Month 60|Protocol Violation|82|||
164131357|NCT00541970|592845750|FG003|Month 60|Protocol Violation|72|||
164131358|NCT03107026|592845751|FG000|Overall Study|Adverse Event|2|||
164131359|NCT03107026|592845752|FG001|Overall Study|Adverse Event|14|||
164131360|NCT03107026|592845753|FG002|Overall Study|Adverse Event|23|||
164131361|NCT03107026|592845751|FG000|Overall Study|Lost to Follow-up|12|||
164131362|NCT03107026|592845752|FG001|Overall Study|Lost to Follow-up|12|||
164131363|NCT03107026|592845753|FG002|Overall Study|Lost to Follow-up|13|||
164131364|NCT03107026|592845751|FG000|Overall Study|Protocol Violation|1|||
164131365|NCT03107026|592845752|FG001|Overall Study|Protocol Violation|2|||
164131366|NCT03107026|592845753|FG002|Overall Study|Protocol Violation|0|||
164131367|NCT03107026|592845751|FG000|Overall Study|Pregnancy|1|||
164131368|NCT03107026|592845752|FG001|Overall Study|Pregnancy|0|||
164131369|NCT03107026|592845753|FG002|Overall Study|Pregnancy|0|||
164131370|NCT03107026|592845751|FG000|Overall Study|Withdrawal by Subject|13|||
164131371|NCT03107026|592845752|FG001|Overall Study|Withdrawal by Subject|5|||
164131372|NCT03107026|592845753|FG002|Overall Study|Withdrawal by Subject|17|||
164131373|NCT03107026|592845751|FG000|Overall Study|non compliance with study visits|1|||
164131374|NCT03107026|592845752|FG001|Overall Study|non compliance with study visits|2|||
164131375|NCT03107026|592845753|FG002|Overall Study|non compliance with study visits|0|||
164131376|NCT03107026|592845751|FG000|Overall Study|non-compliance with study drug|2|||
164131377|NCT03107026|592845752|FG001|Overall Study|non-compliance with study drug|2|||
164131378|NCT03107026|592845753|FG002|Overall Study|non-compliance with study drug|3|||
164131379|NCT03107026|592845751|FG000|Overall Study|Physician Decision|0|||
164131380|NCT03107026|592845752|FG001|Overall Study|Physician Decision|1|||
164131381|NCT03107026|592845753|FG002|Overall Study|Physician Decision|0|||
164131382|NCT00062010|592845754|FG000|Overall Study|Ineligible|3|||
164131383|NCT01183221|592845755|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
164131384|NCT01183221|592845756|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
164131385|NCT00852969|592845763|FG000|Overall Study|Adverse Event|0|||
164131386|NCT00852969|592845764|FG001|Overall Study|Adverse Event|1|||
164131387|NCT00852969|592845763|FG000|Overall Study|Lost to Follow-up|0|||
164131388|NCT00852969|592845764|FG001|Overall Study|Lost to Follow-up|1|||
164131389|NCT03596151|592845765|FG000|Overall Study|Withdrawal by Subject|1|||
164131390|NCT00807248|592845767|FG000|Overall Study|Adverse Event|1|||
164131391|NCT00807248|592845768|FG001|Overall Study|Adverse Event|2|||
164131392|NCT00807248|592845769|FG002|Overall Study|Adverse Event|2|||
164131393|NCT00807248|592845770|FG003|Overall Study|Adverse Event|6|||
164131394|NCT00807248|592845767|FG000|Overall Study|Lack of Efficacy|14|||
164131395|NCT00807248|592845768|FG001|Overall Study|Lack of Efficacy|4|||
164131396|NCT00807248|592845769|FG002|Overall Study|Lack of Efficacy|8|||
164131397|NCT00807248|592845770|FG003|Overall Study|Lack of Efficacy|3|||
164131398|NCT00807248|592845767|FG000|Overall Study|Protocol Violation|0|||
164131399|NCT00807248|592845768|FG001|Overall Study|Protocol Violation|1|||
164131400|NCT00807248|592845769|FG002|Overall Study|Protocol Violation|1|||
164131401|NCT00807248|592845770|FG003|Overall Study|Protocol Violation|0|||
164131402|NCT00807248|592845767|FG000|Overall Study|Withdrawal of Consent|5|||
164131403|NCT00807248|592845768|FG001|Overall Study|Withdrawal of Consent|5|||
164131404|NCT00807248|592845769|FG002|Overall Study|Withdrawal of Consent|5|||
164131405|NCT00807248|592845770|FG003|Overall Study|Withdrawal of Consent|5|||
164131406|NCT00807248|592845767|FG000|Overall Study|Lost to Follow-up|1|||
164131407|NCT00807248|592845768|FG001|Overall Study|Lost to Follow-up|0|||
164131408|NCT00807248|592845769|FG002|Overall Study|Lost to Follow-up|0|||
164131409|NCT00807248|592845770|FG003|Overall Study|Lost to Follow-up|0|||
164131410|NCT00807248|592845767|FG000|Overall Study|Other Reason|0|||
164131411|NCT00807248|592845768|FG001|Overall Study|Other Reason|0|||
164131412|NCT00807248|592845769|FG002|Overall Study|Other Reason|2|||
164131413|NCT00807248|592845770|FG003|Overall Study|Other Reason|0|||
164131414|NCT02444793|592845771|FG000|Overall Study|Lost to Follow-up|2|||
164131415|NCT02444793|592845772|FG001|Overall Study|Lost to Follow-up|2|||
164131416|NCT02444793|592845773|FG002|Overall Study|Lost to Follow-up|0|||
164131417|NCT02444793|592845774|FG003|Overall Study|Lost to Follow-up|0|||
164131418|NCT02444793|592845771|FG000|Overall Study|Death|0|||
164131419|NCT02444793|592845772|FG001|Overall Study|Death|3|||
164131420|NCT02444793|592845773|FG002|Overall Study|Death|0|||
164131421|NCT02444793|592845774|FG003|Overall Study|Death|0|||
164131422|NCT02444793|592845771|FG000|Overall Study|Other|0|||
164131423|NCT02444793|592845772|FG001|Overall Study|Other|0|||
164131424|NCT02444793|592845773|FG002|Overall Study|Other|2|||
164131425|NCT02444793|592845774|FG003|Overall Study|Other|0|||
164131426|NCT02444793|592845771|FG000|Overall Study|Objective progression or relapse|9|||
164131427|NCT02444793|592845772|FG001|Overall Study|Objective progression or relapse|1|||
164131428|NCT02444793|592845773|FG002|Overall Study|Objective progression or relapse|2|||
164131429|NCT02444793|592845774|FG003|Overall Study|Objective progression or relapse|3|||
164131430|NCT02504671|592845777|FG000|Overall Study|Withdrawal by Subject|1|||
164131431|NCT02504671|592845778|FG001|Overall Study|Withdrawal by Subject|5|||
164131432|NCT02504671|592845779|FG002|Overall Study|Withdrawal by Subject|4|||
164131433|NCT02504671|592845780|FG003|Overall Study|Withdrawal by Subject|4|||
164131434|NCT02504671|592845781|FG004|Overall Study|Withdrawal by Subject|5|||
164131435|NCT02504671|592845782|FG005|Overall Study|Withdrawal by Subject|3|||
164131436|NCT02504671|592845777|FG000|Overall Study|Lack of Efficacy|1|||
164131437|NCT02504671|592845778|FG001|Overall Study|Lack of Efficacy|3|||
164131438|NCT02504671|592845779|FG002|Overall Study|Lack of Efficacy|1|||
164131439|NCT02504671|592845780|FG003|Overall Study|Lack of Efficacy|0|||
164131440|NCT02504671|592845781|FG004|Overall Study|Lack of Efficacy|4|||
164131441|NCT02504671|592845782|FG005|Overall Study|Lack of Efficacy|4|||
164131442|NCT02504671|592845777|FG000|Overall Study|Adverse Event|1|||
164131443|NCT02504671|592845778|FG001|Overall Study|Adverse Event|1|||
164131444|NCT02504671|592845779|FG002|Overall Study|Adverse Event|0|||
164131445|NCT02504671|592845780|FG003|Overall Study|Adverse Event|1|||
164131446|NCT02504671|592845781|FG004|Overall Study|Adverse Event|0|||
164131447|NCT02504671|592845782|FG005|Overall Study|Adverse Event|2|||
164131448|NCT02504671|592845777|FG000|Overall Study|Protocol Violation|2|||
164131449|NCT02504671|592845778|FG001|Overall Study|Protocol Violation|1|||
164131450|NCT02504671|592845779|FG002|Overall Study|Protocol Violation|0|||
164131451|NCT02504671|592845780|FG003|Overall Study|Protocol Violation|0|||
164131452|NCT02504671|592845781|FG004|Overall Study|Protocol Violation|0|||
164131453|NCT02504671|592845782|FG005|Overall Study|Protocol Violation|1|||
164131454|NCT02504671|592845777|FG000|Overall Study|Lost to Follow-up|0|||
164131455|NCT02504671|592845778|FG001|Overall Study|Lost to Follow-up|0|||
164131456|NCT02504671|592845779|FG002|Overall Study|Lost to Follow-up|2|||
164131457|NCT02504671|592845780|FG003|Overall Study|Lost to Follow-up|0|||
164131458|NCT02504671|592845781|FG004|Overall Study|Lost to Follow-up|0|||
164131459|NCT02504671|592845782|FG005|Overall Study|Lost to Follow-up|1|||
164131460|NCT02504671|592845777|FG000|Overall Study|Protocol defined stopping criteria|7|||
164131461|NCT02504671|592845778|FG001|Overall Study|Protocol defined stopping criteria|4|||
164131462|NCT02504671|592845779|FG002|Overall Study|Protocol defined stopping criteria|3|||
164131463|NCT02504671|592845780|FG003|Overall Study|Protocol defined stopping criteria|5|||
164131464|NCT02504671|592845781|FG004|Overall Study|Protocol defined stopping criteria|3|||
164131465|NCT02504671|592845782|FG005|Overall Study|Protocol defined stopping criteria|3|||
164131466|NCT00210249|592845783|FG000|Overall Study|Lost to Follow-up|5|||
164131467|NCT00210249|592845783|FG000|Overall Study|Protocol Violation|11|||
164131468|NCT03222583|592845784|FG000|Overall Study|Withdrawal by Subject|3|||
164131469|NCT03222583|592845785|FG001|Overall Study|Withdrawal by Subject|3|||
164131470|NCT03222583|592845784|FG000|Overall Study|Lost to Follow-up|1|||
164131471|NCT03222583|592845785|FG001|Overall Study|Lost to Follow-up|0|||
164131472|NCT03222583|592845784|FG000|Overall Study|Other|1|||
164131473|NCT03222583|592845785|FG001|Overall Study|Other|3|||
164131474|NCT04280705|592845788|FG000|Overall Study|Enrolled but not treated|4|||
164131475|NCT04280705|592845789|FG001|Overall Study|Enrolled but not treated|10|||
164131476|NCT04280705|592845788|FG000|Overall Study|Physician Decision|1|||
164131477|NCT04280705|592845789|FG001|Overall Study|Physician Decision|0|||
164131478|NCT04280705|592845788|FG000|Overall Study|Withdrawal by Subject|7|||
164131479|NCT04280705|592845789|FG001|Overall Study|Withdrawal by Subject|9|||
164131480|NCT04280705|592845788|FG000|Overall Study|Adverse Event|0|||
164131481|NCT04280705|592845789|FG001|Overall Study|Adverse Event|4|||
164131482|NCT04280705|592845788|FG000|Overall Study|Transferred to another hospital|1|||
164131483|NCT04280705|592845789|FG001|Overall Study|Transferred to another hospital|1|||
164131484|NCT01951885|592845790|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
164131485|NCT01951885|592845791|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
164131486|NCT01951885|592845790|FG000|Overall Study|Adverse Event|1|||
164131487|NCT01951885|592845791|FG001|Overall Study|Adverse Event|0|||
164131488|NCT01951885|592845790|FG000|Overall Study|Withdrawal by Subject|0|||
164131489|NCT01951885|592845791|FG001|Overall Study|Withdrawal by Subject|1|||
164131490|NCT01951885|592845790|FG000|Overall Study|ineligible due to a change in donor|0|||
164131491|NCT01951885|592845791|FG001|Overall Study|ineligible due to a change in donor|1|||
164131492|NCT01951885|592845790|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
164131493|NCT01951885|592845791|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
164131494|NCT01687478|592845792|FG000|Overall Study|Adverse Event|3|||
164131495|NCT01687478|592845793|FG001|Overall Study|Adverse Event|10|||
164131496|NCT01687478|592845792|FG000|Overall Study|Lost to Follow-up|1|||
164131497|NCT01687478|592845793|FG001|Overall Study|Lost to Follow-up|3|||
164131498|NCT01687478|592845792|FG000|Overall Study|Protocol Violation|0|||
164131499|NCT01687478|592845793|FG001|Overall Study|Protocol Violation|2|||
164131500|NCT01687478|592845792|FG000|Overall Study|Withdrawal by Subject|21|||
164131501|NCT01687478|592845793|FG001|Overall Study|Withdrawal by Subject|19|||
164131502|NCT01687478|592845792|FG000|Overall Study|Physician Decision|1|||
164131503|NCT01687478|592845793|FG001|Overall Study|Physician Decision|3|||
164131504|NCT01687478|592845792|FG000|Overall Study|Entry Criteria Not Met|6|||
164131505|NCT01687478|592845793|FG001|Overall Study|Entry Criteria Not Met|2|||
164131506|NCT03188718|592845794|FG000|Overall Study|Participant noncompliance|4|||
164131507|NCT03188718|592845794|FG000|Overall Study|Withdrawal by Subject|1|||
164131508|NCT03188718|592845794|FG000|Overall Study|Device failure|3|||
164131509|NCT01936623|592845809|FG000|Overall Study|Lost to Follow-up|0|||
164131510|NCT01936623|592845810|FG001|Overall Study|Lost to Follow-up|5|||
164131511|NCT01383135|592845811|FG000|Overall Study|Not Scanned / Imaged|1|||
164131512|NCT01383135|592845812|FG001|Overall Study|Not Scanned / Imaged|0|||
164131513|NCT01383135|592845813|FG002|Overall Study|Not Scanned / Imaged|1|||
164131514|NCT01383135|592845814|FG003|Overall Study|Not Scanned / Imaged|0|||
164131515|NCT02455050|592845817|FG000|Treatment Period 1|Lost to Follow-up|1|||
164131516|NCT02455050|592845818|FG001|Treatment Period 1|Lost to Follow-up|1|||
164131517|NCT02455050|592845819|FG002|Treatment Period 1|Lost to Follow-up|1|||
164131518|NCT02455050|592845820|FG003|Treatment Period 1|Lost to Follow-up|2|||
164131519|NCT02455050|592845817|FG000|Treatment Period 2|Lost to Follow-up|1|||
164131520|NCT02455050|592845818|FG001|Treatment Period 2|Lost to Follow-up|0|||
164131521|NCT02455050|592845819|FG002|Treatment Period 2|Lost to Follow-up|2|||
164131522|NCT02455050|592845820|FG003|Treatment Period 2|Lost to Follow-up|1|||
164131523|NCT02605993|592845821|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
164131524|NCT02605993|592845822|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
164131525|NCT02605993|592845823|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
164131526|NCT02605993|592845824|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
164131527|NCT03493386|592845827|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164131528|NCT03493386|592845828|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
164131529|NCT03493386|592845829|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164131530|NCT03493386|592845830|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
164131531|NCT00988442|592845836|FG000|Overall Study|Death|1|||
164131532|NCT00988442|592845837|FG001|Overall Study|Death|2|||
164131533|NCT00988442|592845836|FG000|Overall Study|Lost to Follow-up|0|||
164131534|NCT00988442|592845837|FG001|Overall Study|Lost to Follow-up|1|||
164131535|NCT00988442|592845836|FG000|Overall Study|Early Study Closure|29|||
164131536|NCT00988442|592845837|FG001|Overall Study|Early Study Closure|25|||
164131537|NCT04620135|592845840|FG000|Study Completion|Adverse Event|2|||
164131538|NCT04620135|592845841|FG001|Study Completion|Adverse Event|3|||
164131539|NCT04620135|592845840|FG000|Study Completion|Withdrawal by Subject|2|||
164131540|NCT04620135|592845841|FG001|Study Completion|Withdrawal by Subject|0|||
164131541|NCT01442688|592845843|FG000|First Intervention|Withdrawal by Subject|1|||
164131542|NCT01442688|592845844|FG001|First Intervention|Withdrawal by Subject|0|||
164131543|NCT01442688|592845843|FG000|First Intervention|subject incarcerated|1|||
164131544|NCT01442688|592845844|FG001|First Intervention|subject incarcerated|0|||
164131545|NCT01442688|592845843|FG000|Second Intervention|Adverse Event|1|||
164131546|NCT01442688|592845844|FG001|Second Intervention|Adverse Event|0|||
164131547|NCT00762437|592845845|FG000|Overall Study|Lost to Follow-up|7|||
164131548|NCT00762437|592845845|FG000|Overall Study|Missed final study visit|11|||
164131549|NCT00762437|592845845|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
164131550|NCT04771403|592845849|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
164131551|NCT04771403|592845850|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
164131552|NCT04771403|592845849|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
164131553|NCT04771403|592845850|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
164131554|NCT04771403|592845849|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
164131555|NCT04771403|592845850|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
164131556|NCT04771403|592845849|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
164131557|NCT04771403|592845850|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
164131558|NCT04771403|592845849|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
164131559|NCT04771403|592845850|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
164131560|NCT04771403|592845849|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
164131561|NCT04771403|592845850|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
164131562|NCT04771403|592845849|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
164131563|NCT04771403|592845850|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
164131564|NCT04771403|592845849|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
164131565|NCT04771403|592845850|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
164131566|NCT04480021|592845851|FG000|Overall Study|Lost to Follow-up|3|||
164131567|NCT04480021|592845852|FG001|Overall Study|Lost to Follow-up|4|||
164131568|NCT00857259|592845853|FG000|Overall Study|Protocol Violation|1|||
164131569|NCT00857259|592845854|FG001|Overall Study|Protocol Violation|0|||
164131570|NCT00857259|592845855|FG002|Overall Study|Protocol Violation|1|||
164131571|NCT00546572|592845856|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
164131572|NCT00546572|592845857|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
164131573|NCT00546572|592845856|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
164131574|NCT00546572|592845857|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
164131575|NCT00546572|592845856|FG000|Vax 1 / Year 0|Protocol Violation|3|||
164131576|NCT00546572|592845857|FG001|Vax 1 / Year 0|Protocol Violation|4|||
164131577|NCT00546572|592845856|FG000|Vax 1 / Year 0|Death|2|||
164131578|NCT00546572|592845857|FG001|Vax 1 / Year 0|Death|2|||
164131579|NCT00546572|592845856|FG000|Vax 1 / Year 0|Adverse Event|0|||
164131580|NCT00546572|592845857|FG001|Vax 1 / Year 0|Adverse Event|1|||
164131581|NCT00546572|592845856|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
164131582|NCT00546572|592845857|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
164131583|NCT00546572|592845856|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
164131584|NCT00546572|592845857|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
164131585|NCT00546572|592845856|FG000|Vax 2 / Year 1|Other|1|||
164131586|NCT00546572|592845857|FG001|Vax 2 / Year 1|Other|1|||
164131587|NCT00546572|592845856|FG000|Vax 2 / Year 1|Adverse Event|1|||
164131588|NCT00546572|592845857|FG001|Vax 2 / Year 1|Adverse Event|0|||
164131589|NCT00546572|592845856|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
164131590|NCT00546572|592845857|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
164131591|NCT03979820|592845858|FG000|Overall Study|Protocol Violation|1|||
164131592|NCT03979820|592845859|FG001|Overall Study|Protocol Violation|0|||
164131593|NCT03979820|592845860|FG002|Overall Study|Protocol Violation|0|||
164131594|NCT03979820|592845861|FG003|Overall Study|Protocol Violation|0|||
164131595|NCT03979820|592845858|FG000|Overall Study|Withdrawal by Subject|0|||
164131596|NCT03979820|592845859|FG001|Overall Study|Withdrawal by Subject|0|||
164131597|NCT03979820|592845860|FG002|Overall Study|Withdrawal by Subject|1|||
164131598|NCT03979820|592845861|FG003|Overall Study|Withdrawal by Subject|0|||
164131599|NCT03979820|592845858|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
164131600|NCT03979820|592845859|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
164131601|NCT03979820|592845860|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
164131602|NCT03979820|592845861|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
164131603|NCT01229735|592845862|FG000|Overall Study|Lack of Efficacy|8|||
164131604|NCT01229735|592845863|FG001|Overall Study|Lack of Efficacy|8|||
164131605|NCT01229735|592845862|FG000|Overall Study|Protocol Violation|13|||
164131606|NCT01229735|592845863|FG001|Overall Study|Protocol Violation|8|||
164131607|NCT01229735|592845862|FG000|Overall Study|Lost to Follow-up|0|||
164131608|NCT01229735|592845863|FG001|Overall Study|Lost to Follow-up|2|||
164131609|NCT01229735|592845862|FG000|Overall Study|Withdrawal by Subject|18|||
164131610|NCT01229735|592845863|FG001|Overall Study|Withdrawal by Subject|17|||
164131611|NCT01229735|592845862|FG000|Overall Study|Other Reason|13|||
164131612|NCT01229735|592845863|FG001|Overall Study|Other Reason|10|||
164131613|NCT01229735|592845862|FG000|Overall Study|SAE, non-fatal|0|||
164131614|NCT01229735|592845863|FG001|Overall Study|SAE, non-fatal|4|||
164131615|NCT01229735|592845862|FG000|Overall Study|AE, non-serious non-fatal|13|||
164131616|NCT01229735|592845863|FG001|Overall Study|AE, non-serious non-fatal|17|||
164131617|NCT01229735|592845862|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
164131618|NCT01229735|592845863|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
164131619|NCT02685202|592845864|FG000|Overall Study|Lost to Follow-up|9|||
164131620|NCT02130882|592845865|FG000|Overall Study|Withdrawal by Subject|0|||
164131621|NCT02130882|592845866|FG001|Overall Study|Withdrawal by Subject|1|||
164131622|NCT01300923|592845869|FG000|Overall Study|Physician Decision|0|||
164131623|NCT01300923|592845870|FG001|Overall Study|Physician Decision|2|||
164131624|NCT02707861|592845871|FG000|Overall Study|Went onto commercial drug|30|||
164131625|NCT02707861|592845872|FG001|Overall Study|Went onto commercial drug|23|||
164131626|NCT02707861|592845871|FG000|Overall Study|Adverse Event|2|||
164131627|NCT02707861|592845872|FG001|Overall Study|Adverse Event|3|||
164131628|NCT02707861|592845871|FG000|Overall Study|Death|5|||
164131629|NCT02707861|592845872|FG001|Overall Study|Death|2|||
164131630|NCT02707861|592845871|FG000|Overall Study|Lack of Efficacy|0|||
164131631|NCT02707861|592845872|FG001|Overall Study|Lack of Efficacy|2|||
164131632|NCT02707861|592845871|FG000|Overall Study|Physician Decision|1|||
164131633|NCT02707861|592845872|FG001|Overall Study|Physician Decision|4|||
164131634|NCT02707861|592845871|FG000|Overall Study|Withdrawal by Subject|2|||
164131635|NCT02707861|592845872|FG001|Overall Study|Withdrawal by Subject|1|||
164131636|NCT02707861|592845871|FG000|Overall Study|Lost to Follow-up|1|||
164131637|NCT02707861|592845872|FG001|Overall Study|Lost to Follow-up|3|||
164131638|NCT00731549|592845875|FG000|Overall Study|Lost to Follow-up|19|||
164131639|NCT00731549|592845875|FG000|Overall Study|Met withdrawal criteria|24|||
164131640|NCT00731549|592845875|FG000|Overall Study|Physician Decision|16|||
164131641|NCT00731549|592845875|FG000|Overall Study|Withdrawal by Subject|89|||
164131642|NCT00731549|592845875|FG000|Overall Study|Protocol deviation|1|||
164131643|NCT00731549|592845875|FG000|Overall Study|Adverse Event|31|||
164131644|NCT00731549|592845875|FG000|Overall Study|Lack of efficacy with AE|37|||
164131645|NCT00731549|592845875|FG000|Overall Study|Lack of efficacy without AE|6|||
164131646|NCT00507546|592845876|FG000|Overall Study|Withdrawal by Subject|1|||
164131647|NCT00507546|592845877|FG001|Overall Study|Withdrawal by Subject|0|||
164131648|NCT00507546|592845876|FG000|Overall Study|Protocol Violation|1|||
164131649|NCT00507546|592845877|FG001|Overall Study|Protocol Violation|0|||
164131650|NCT00507546|592845876|FG000|Overall Study|Physician Decision|0|||
164131651|NCT00507546|592845877|FG001|Overall Study|Physician Decision|1|||
164131652|NCT00609466|592845881|FG000|Overall Study|Withdrawal by Subject|0|||
164131653|NCT00609466|592845882|FG001|Overall Study|Withdrawal by Subject|1|||
164131654|NCT00609466|592845883|FG002|Overall Study|Withdrawal by Subject|1|||
164131655|NCT00609466|592845881|FG000|Overall Study|Adverse Event|2|||
164131656|NCT00609466|592845882|FG001|Overall Study|Adverse Event|3|||
164131657|NCT00609466|592845883|FG002|Overall Study|Adverse Event|1|||
164131658|NCT00609466|592845881|FG000|Overall Study|Lack of Efficacy|0|||
164131659|NCT00609466|592845882|FG001|Overall Study|Lack of Efficacy|2|||
164131660|NCT00609466|592845883|FG002|Overall Study|Lack of Efficacy|2|||
164131661|NCT01299805|592845886|FG000|Overall Study|Adverse Event|2|||
164131662|NCT01299805|592845887|FG001|Overall Study|Adverse Event|0|||
164132434|NCT00123474|592850615|FG000|As Treated at Study Closure|Disease Progression|35|||
164132435|NCT00123474|592850616|FG001|As Treated at Study Closure|Disease Progression|42|||
164132436|NCT00123474|592850617|FG002|As Treated at Study Closure|Disease Progression|29|||
164132437|NCT00123474|592850618|FG003|As Treated at Study Closure|Disease Progression|27|||
164132438|NCT00123474|592850615|FG000|As Treated at Study Closure|Investigator Request|12|||
164132439|NCT00123474|592850616|FG001|As Treated at Study Closure|Investigator Request|6|||
164132440|NCT00123474|592850617|FG002|As Treated at Study Closure|Investigator Request|7|||
164132441|NCT00123474|592850618|FG003|As Treated at Study Closure|Investigator Request|5|||
164132442|NCT00123474|592850615|FG000|As Treated at Study Closure|non-specified|54|||
164132443|NCT00123474|592850616|FG001|As Treated at Study Closure|non-specified|47|||
164132444|NCT00123474|592850617|FG002|As Treated at Study Closure|non-specified|57|||
164132445|NCT00123474|592850618|FG003|As Treated at Study Closure|non-specified|60|||
164132446|NCT00123474|592850615|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
164132447|NCT00123474|592850616|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
164132448|NCT00123474|592850617|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
164132449|NCT00123474|592850618|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
164132450|NCT00123474|592850615|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
164132451|NCT00123474|592850616|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
164132452|NCT00123474|592850617|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
164132453|NCT00123474|592850618|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
164132454|NCT01059344|592850619|FG000|Overall Study|Adverse Event|12|||
164132455|NCT01059344|592850620|FG001|Overall Study|Adverse Event|30|||
164132456|NCT01059344|592850619|FG000|Overall Study|Withdrawal by Subject|6|||
164132457|NCT01059344|592850620|FG001|Overall Study|Withdrawal by Subject|9|||
164132458|NCT01059344|592850619|FG000|Overall Study|Lost to Follow-up|1|||
164132459|NCT01059344|592850620|FG001|Overall Study|Lost to Follow-up|1|||
164132460|NCT01059344|592850619|FG000|Overall Study|Other|3|||
164132461|NCT01059344|592850620|FG001|Overall Study|Other|6|||
164132462|NCT02731326|592850625|FG000|Overall Study|Withdrawal by Subject|4|||
164132463|NCT02731326|592850626|FG001|Overall Study|Withdrawal by Subject|1|||
164132464|NCT02731326|592850625|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
164132465|NCT02731326|592850626|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
164132466|NCT02731326|592850625|FG000|Overall Study|Discharged without AliveCor|10|||
164131663|NCT02518919|592848336|FG000|Overall Study|Protocol Violation|1|||
164131664|NCT02518919|592848337|FG001|Overall Study|Protocol Violation|1|||
164131665|NCT02518919|592848338|FG002|Overall Study|Protocol Violation|2|||
164131666|NCT04498403|592848339|FG000|Overall Study|Adverse Event|1|||
164131667|NCT04498403|592848340|FG001|Overall Study|Adverse Event|0|||
164131668|NCT04498403|592848339|FG000|Overall Study|Study Terminated By Sponsor|29|||
164131669|NCT04498403|592848340|FG001|Overall Study|Study Terminated By Sponsor|10|||
164131670|NCT03986138|592848341|FG000|First MRI Examination|Physician Decision|0|||
164131671|NCT03986138|592848342|FG001|First MRI Examination|Physician Decision|1|||
164131672|NCT03986138|592848341|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
164131673|NCT03986138|592848342|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
164131674|NCT03986138|592848341|FG000|Washout|Withdrawal by Subject|4|||
164131675|NCT03986138|592848342|FG001|Washout|Withdrawal by Subject|5|||
164131676|NCT03986138|592848341|FG000|Washout|Lost to Follow-up|0|||
164131677|NCT03986138|592848342|FG001|Washout|Lost to Follow-up|2|||
164131678|NCT03986138|592848341|FG000|Washout|Adverse Event|1|||
164131679|NCT03986138|592848342|FG001|Washout|Adverse Event|1|||
164131680|NCT03986138|592848341|FG000|Washout|Other reason|5|||
164131681|NCT03986138|592848342|FG001|Washout|Other reason|5|||
164131682|NCT03986138|592848341|FG000|Second MRI Examination|Withdrawal by Subject|0|||
164131683|NCT03986138|592848342|FG001|Second MRI Examination|Withdrawal by Subject|2|||
164131684|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Death|89|||
164131685|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Death|193|||
164131686|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Death|198|||
164131687|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
164131688|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
164131689|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
164131690|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
164131691|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
164131692|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
164131693|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
164131694|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
164131695|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
164131696|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
164131697|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
164131698|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
164131699|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
164131700|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
164131701|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
164131702|NCT02031458|592848344|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
164131703|NCT02031458|592848345|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
164131704|NCT02031458|592848346|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
164131705|NCT02031458|592848344|FG000|Baseline to May 8, 2015|Death|36|||
164131706|NCT02031458|592848345|FG001|Baseline to May 8, 2015|Death|87|||
164131707|NCT02031458|592848346|FG002|Baseline to May 8, 2015|Death|100|||
164131708|NCT02031458|592848344|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
164131709|NCT02031458|592848345|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
164131710|NCT02031458|592848346|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
164131711|NCT02031458|592848344|FG000|Baseline to May 8, 2015|Physician Decision|0|||
164131712|NCT02031458|592848345|FG001|Baseline to May 8, 2015|Physician Decision|1|||
164131713|NCT02031458|592848346|FG002|Baseline to May 8, 2015|Physician Decision|0|||
164131714|NCT02031458|592848344|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
164131715|NCT02031458|592848345|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
164131716|NCT02031458|592848346|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
164131717|NCT02031458|592848344|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
164131718|NCT02031458|592848345|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
164131719|NCT02031458|592848346|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
164131720|NCT02031458|592848344|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
164131721|NCT02031458|592848345|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
164131722|NCT02031458|592848346|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
164131723|NCT02031458|592848344|FG000|Baseline to May 8, 2015|On Treatment|43|||
164131724|NCT02031458|592848345|FG001|Baseline to May 8, 2015|On Treatment|81|||
164131725|NCT02031458|592848346|FG002|Baseline to May 8, 2015|On Treatment|73|||
164131726|NCT02031458|592848344|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
164131727|NCT02031458|592848345|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
164131728|NCT02031458|592848346|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
164131729|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
164131730|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
164131731|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
164131732|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
164131733|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
164131734|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
164131735|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
164131736|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
164131737|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
164131738|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
164131739|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
164131740|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
164131741|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
164131742|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
164131743|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
164131744|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
164131745|NCT03182244|592848349|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
164131746|NCT03182244|592848350|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
164131747|NCT03182244|592848349|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
164131748|NCT03182244|592848350|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
164131749|NCT03182244|592848349|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
164131750|NCT03182244|592848350|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
164131751|NCT03182244|592848349|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
164131752|NCT03182244|592848350|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
164131753|NCT03182244|592848349|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
164131754|NCT03182244|592848350|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
164131755|NCT02049450|592848351|FG000|Overall Study|Adverse Event|2|||
164131756|NCT02049450|592848351|FG000|Overall Study|Withdrawal by Subject|1|||
164131757|NCT02049450|592848351|FG000|Overall Study|Patients/guardian decision|1|||
164131758|NCT02492880|592848352|FG000|Overall Study|Lost to Follow-up|1|||
164131759|NCT02492880|592848352|FG000|Overall Study|Protocol Violation|1|||
164131760|NCT00292188|592848356|FG000|Single-Blind|Adverse Event|14|||
164131761|NCT00292188|592848357|FG001|Single-Blind|Adverse Event|0|||
164131762|NCT00292188|592848358|FG002|Single-Blind|Adverse Event|0|||
164131763|NCT00292188|592848356|FG000|Single-Blind|Lack of Efficacy|2|||
164131764|NCT00292188|592848357|FG001|Single-Blind|Lack of Efficacy|0|||
164131765|NCT00292188|592848358|FG002|Single-Blind|Lack of Efficacy|0|||
164131766|NCT00292188|592848356|FG000|Single-Blind|Laboratory Abnormality|5|||
164131767|NCT00292188|592848357|FG001|Single-Blind|Laboratory Abnormality|0|||
164131768|NCT00292188|592848358|FG002|Single-Blind|Laboratory Abnormality|0|||
164131769|NCT00292188|592848356|FG000|Single-Blind|Lost to Follow-up|3|||
164131770|NCT00292188|592848357|FG001|Single-Blind|Lost to Follow-up|0|||
164131771|NCT00292188|592848358|FG002|Single-Blind|Lost to Follow-up|0|||
164131772|NCT00292188|592848356|FG000|Single-Blind|Other|77|||
164131773|NCT00292188|592848357|FG001|Single-Blind|Other|0|||
164131774|NCT00292188|592848358|FG002|Single-Blind|Other|0|||
164131775|NCT00292188|592848356|FG000|Single-Blind|Withdrawal by Subject|12|||
164131776|NCT00292188|592848357|FG001|Single-Blind|Withdrawal by Subject|0|||
164131777|NCT00292188|592848358|FG002|Single-Blind|Withdrawal by Subject|0|||
164131778|NCT00292188|592848356|FG000|Single-Blind|Did not receive treatment|1|||
164131779|NCT00292188|592848357|FG001|Single-Blind|Did not receive treatment|0|||
164131780|NCT00292188|592848358|FG002|Single-Blind|Did not receive treatment|0|||
164131781|NCT00292188|592848356|FG000|Double-Blind|Adverse Event|0|||
164131782|NCT00292188|592848357|FG001|Double-Blind|Adverse Event|25|||
164131783|NCT00292188|592848358|FG002|Double-Blind|Adverse Event|9|||
164131784|NCT00292188|592848356|FG000|Double-Blind|Lack of Efficacy|0|||
164131785|NCT00292188|592848357|FG001|Double-Blind|Lack of Efficacy|2|||
164131786|NCT00292188|592848358|FG002|Double-Blind|Lack of Efficacy|12|||
164131787|NCT00292188|592848356|FG000|Double-Blind|Lost to Follow-up|0|||
164131788|NCT00292188|592848357|FG001|Double-Blind|Lost to Follow-up|1|||
164131789|NCT00292188|592848358|FG002|Double-Blind|Lost to Follow-up|0|||
164131790|NCT00292188|592848356|FG000|Double-Blind|Other|0|||
164131791|NCT00292188|592848357|FG001|Double-Blind|Other|3|||
164131792|NCT00292188|592848358|FG002|Double-Blind|Other|4|||
164131793|NCT00292188|592848356|FG000|Double-Blind|Withdrawal by Subject|0|||
164131794|NCT00292188|592848357|FG001|Double-Blind|Withdrawal by Subject|0|||
164131795|NCT00292188|592848358|FG002|Double-Blind|Withdrawal by Subject|3|||
164131796|NCT00292188|592848356|FG000|Double-Blind|Laboratory Abnormality|0|||
164131797|NCT00292188|592848357|FG001|Double-Blind|Laboratory Abnormality|0|||
164131798|NCT00292188|592848358|FG002|Double-Blind|Laboratory Abnormality|1|||
164131799|NCT03186781|592848359|FG000|Overall Study|Lost to Follow-up|0|||
164131800|NCT03186781|592848360|FG001|Overall Study|Lost to Follow-up|0|||
164131801|NCT03186781|592848361|FG002|Overall Study|Lost to Follow-up|1|||
164131802|NCT03186781|592848362|FG003|Overall Study|Lost to Follow-up|0|||
164131803|NCT03186781|592848363|FG004|Overall Study|Lost to Follow-up|1|||
164131804|NCT03186781|592848364|FG005|Overall Study|Lost to Follow-up|0|||
164131805|NCT03186781|592848359|FG000|Overall Study|Moved from Area|0|||
164131806|NCT03186781|592848360|FG001|Overall Study|Moved from Area|0|||
164131807|NCT03186781|592848361|FG002|Overall Study|Moved from Area|0|||
164131808|NCT03186781|592848362|FG003|Overall Study|Moved from Area|0|||
164131809|NCT03186781|592848363|FG004|Overall Study|Moved from Area|1|||
164131810|NCT03186781|592848364|FG005|Overall Study|Moved from Area|0|||
164131811|NCT03186781|592848359|FG000|Overall Study|Withdrawal by Subject|0|||
164131812|NCT03186781|592848360|FG001|Overall Study|Withdrawal by Subject|0|||
164131813|NCT03186781|592848361|FG002|Overall Study|Withdrawal by Subject|0|||
164131814|NCT03186781|592848362|FG003|Overall Study|Withdrawal by Subject|0|||
164131815|NCT03186781|592848363|FG004|Overall Study|Withdrawal by Subject|1|||
164131816|NCT03186781|592848364|FG005|Overall Study|Withdrawal by Subject|0|||
164131817|NCT04709835|592848365|FG000|Overall Study|Withdrawal by Subject|0|||
164131818|NCT04709835|592848366|FG001|Overall Study|Withdrawal by Subject|1|||
164131819|NCT04709835|592848367|FG002|Overall Study|Withdrawal by Subject|0|||
164131820|NCT03786718|592848368|FG000|Overall Study|Lost to Follow-up|3|||
164131821|NCT03786718|592848368|FG000|Overall Study|Withdrawal by Subject|1|||
164131822|NCT03786718|592848368|FG000|Overall Study|Did not use the intervention|2|||
164131823|NCT03786718|592848368|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
164131824|NCT00372411|592848371|FG000|Overall Study|Withdrawal by Subject|3|||
164131825|NCT00372411|592848372|FG001|Overall Study|Withdrawal by Subject|4|||
164131826|NCT00372411|592848373|FG002|Overall Study|Withdrawal by Subject|1|||
164131827|NCT00372411|592848371|FG000|Overall Study|Death|0|||
164131828|NCT00372411|592848372|FG001|Overall Study|Death|2|||
164131829|NCT00372411|592848373|FG002|Overall Study|Death|1|||
164131830|NCT00372411|592848371|FG000|Overall Study|Lost to Follow-up|1|||
164131831|NCT00372411|592848372|FG001|Overall Study|Lost to Follow-up|1|||
164131832|NCT00372411|592848373|FG002|Overall Study|Lost to Follow-up|1|||
164131833|NCT00372411|592848371|FG000|Overall Study|Adverse Event|1|||
164131834|NCT00372411|592848372|FG001|Overall Study|Adverse Event|1|||
164131835|NCT00372411|592848373|FG002|Overall Study|Adverse Event|0|||
164131836|NCT00667810|592848376|FG000|Overall Study|Adverse Event|13|||
164131837|NCT00667810|592848377|FG001|Overall Study|Adverse Event|14|||
164131838|NCT00667810|592848378|FG002|Overall Study|Adverse Event|19|||
164131839|NCT00667810|592848379|FG003|Overall Study|Adverse Event|1|||
164131840|NCT00667810|592848376|FG000|Overall Study|Death|1|||
164131841|NCT00667810|592848377|FG001|Overall Study|Death|1|||
164131842|NCT00667810|592848378|FG002|Overall Study|Death|3|||
164131843|NCT00667810|592848379|FG003|Overall Study|Death|0|||
164131844|NCT00667810|592848376|FG000|Overall Study|Lack of Efficacy|1|||
164131845|NCT00667810|592848377|FG001|Overall Study|Lack of Efficacy|0|||
164131846|NCT00667810|592848378|FG002|Overall Study|Lack of Efficacy|2|||
164131847|NCT00667810|592848379|FG003|Overall Study|Lack of Efficacy|0|||
164131848|NCT00667810|592848376|FG000|Overall Study|Lost to Follow-up|1|||
164131849|NCT00667810|592848377|FG001|Overall Study|Lost to Follow-up|4|||
164131850|NCT00667810|592848378|FG002|Overall Study|Lost to Follow-up|2|||
164131851|NCT00667810|592848379|FG003|Overall Study|Lost to Follow-up|0|||
164131852|NCT00667810|592848376|FG000|Overall Study|Physician Decision|1|||
164131853|NCT00667810|592848377|FG001|Overall Study|Physician Decision|1|||
164131854|NCT00667810|592848378|FG002|Overall Study|Physician Decision|2|||
164131855|NCT00667810|592848379|FG003|Overall Study|Physician Decision|0|||
164131856|NCT00667810|592848376|FG000|Overall Study|Protocol Violation|0|||
164131857|NCT00667810|592848377|FG001|Overall Study|Protocol Violation|2|||
164131858|NCT00667810|592848378|FG002|Overall Study|Protocol Violation|0|||
164131859|NCT00667810|592848379|FG003|Overall Study|Protocol Violation|0|||
164131860|NCT00667810|592848376|FG000|Overall Study|Withdrawal by Subject|14|||
164131861|NCT00667810|592848377|FG001|Overall Study|Withdrawal by Subject|20|||
164131862|NCT00667810|592848378|FG002|Overall Study|Withdrawal by Subject|29|||
164131863|NCT00667810|592848379|FG003|Overall Study|Withdrawal by Subject|1|||
164131864|NCT00667810|592848376|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
164131865|NCT00667810|592848377|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
164131866|NCT00667810|592848378|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
164131867|NCT00667810|592848379|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
164131868|NCT00667810|592848376|FG000|Overall Study|Failed to Return|0|||
164131869|NCT00667810|592848377|FG001|Overall Study|Failed to Return|0|||
164131870|NCT00667810|592848378|FG002|Overall Study|Failed to Return|2|||
164131871|NCT00667810|592848379|FG003|Overall Study|Failed to Return|0|||
164131872|NCT00667810|592848376|FG000|Overall Study|Loss of Caregiver|0|||
164131873|NCT00667810|592848377|FG001|Overall Study|Loss of Caregiver|1|||
164131874|NCT00667810|592848378|FG002|Overall Study|Loss of Caregiver|3|||
164131875|NCT00667810|592848379|FG003|Overall Study|Loss of Caregiver|0|||
164131876|NCT00667810|592848376|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
164131877|NCT00667810|592848377|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
164131878|NCT00667810|592848378|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
164131879|NCT00667810|592848379|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
164131880|NCT00667810|592848376|FG000|Overall Study|Other|6|||
164131881|NCT00667810|592848377|FG001|Overall Study|Other|6|||
164131882|NCT00667810|592848378|FG002|Overall Study|Other|5|||
164131883|NCT00667810|592848379|FG003|Overall Study|Other|0|||
164131884|NCT01570686|592848382|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164131885|NCT01570686|592848383|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164131886|NCT01570686|592848382|FG000|Overall Study|Administrative problems|0|||
164131887|NCT01570686|592848383|FG001|Overall Study|Administrative problems|1|||
164131888|NCT01570686|592848382|FG000|Overall Study|Adverse Event|8|||
164131889|NCT01570686|592848383|FG001|Overall Study|Adverse Event|6|||
164131890|NCT01570686|592848382|FG000|Overall Study|Lost to Follow-up|4|||
164131891|NCT01570686|592848383|FG001|Overall Study|Lost to Follow-up|3|||
164131892|NCT01570686|592848382|FG000|Overall Study|Protocol Deviation|3|||
164131893|NCT01570686|592848383|FG001|Overall Study|Protocol Deviation|0|||
164131894|NCT01570686|592848382|FG000|Overall Study|Withdrawal by Subject|4|||
164131895|NCT01570686|592848383|FG001|Overall Study|Withdrawal by Subject|4|||
164131896|NCT01570686|592848382|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164131897|NCT01570686|592848383|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164131898|NCT02372071|592848386|FG000|Overall Study|Protocol Violation|18|||
164131899|NCT02227147|592848387|FG000|Controlled Treatment Period|Adverse Event|4|||
164131900|NCT02227147|592848388|FG001|Controlled Treatment Period|Adverse Event|3|||
164131901|NCT02227147|592848387|FG000|Controlled Treatment Period|Other|2|||
164131902|NCT02227147|592848388|FG001|Controlled Treatment Period|Other|0|||
164131903|NCT02227147|592848387|FG000|Follow-up Period|Other|3|||
164131904|NCT02227147|592848388|FG001|Follow-up Period|Other|5|||
164131905|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
164131906|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
164131907|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
164131908|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
164131909|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
164131910|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
164131911|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
164131912|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
164131913|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
164131914|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
164131915|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
164131916|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
164131917|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
164131918|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
164131919|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
164131920|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
164131921|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
164131922|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
164131923|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
164131924|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
164131925|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
164131926|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
164131927|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
164131928|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
164131929|NCT03514641|592848393|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
164131930|NCT03514641|592848394|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
164131931|NCT03514641|592848395|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
164131932|NCT03514641|592848396|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
164131933|NCT03514641|592848393|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
164131934|NCT03514641|592848394|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
164131935|NCT03514641|592848395|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
164131936|NCT03514641|592848396|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
164131937|NCT03514641|592848393|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
164131938|NCT03514641|592848394|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
164131939|NCT03514641|592848395|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
164131940|NCT03514641|592848396|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
164131941|NCT03514641|592848393|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
164131942|NCT03514641|592848394|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
164131943|NCT03514641|592848395|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
164131944|NCT03514641|592848396|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
164131945|NCT03514641|592848393|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
164131946|NCT03514641|592848394|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
164131947|NCT03514641|592848395|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
164131948|NCT03514641|592848396|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
164131949|NCT03514641|592848393|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
164131950|NCT03514641|592848394|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
164131951|NCT03514641|592848395|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
164131952|NCT03514641|592848396|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
164131953|NCT01345175|592848397|FG000|Overall Study|Physician Decision|0|||
164131954|NCT01345175|592848398|FG001|Overall Study|Physician Decision|1|||
164131955|NCT01345175|592848397|FG000|Overall Study|Withdrawal by Subject|1|||
164131956|NCT01345175|592848398|FG001|Overall Study|Withdrawal by Subject|1|||
164131957|NCT01345175|592848397|FG000|Overall Study|Failed to complete BFI|3|||
164131958|NCT01345175|592848398|FG001|Overall Study|Failed to complete BFI|2|||
164131959|NCT01345175|592848397|FG000|Overall Study|Stopped taking medication|2|||
164131960|NCT01345175|592848398|FG001|Overall Study|Stopped taking medication|2|||
164131961|NCT01561430|592848402|FG000|Overall Study|Adverse Event|0|||
164131962|NCT01561430|592848403|FG001|Overall Study|Adverse Event|0|||
164131963|NCT01561430|592848404|FG002|Overall Study|Adverse Event|3|||
164131964|NCT01561430|592848405|FG003|Overall Study|Adverse Event|1|||
164131965|NCT01561430|592848402|FG000|Overall Study|Withdrawal by Subject|0|||
164131966|NCT01561430|592848403|FG001|Overall Study|Withdrawal by Subject|0|||
164131967|NCT01561430|592848404|FG002|Overall Study|Withdrawal by Subject|1|||
164131968|NCT01561430|592848405|FG003|Overall Study|Withdrawal by Subject|0|||
164131969|NCT01561430|592848402|FG000|Overall Study|Physician Decision|0|||
164131970|NCT01561430|592848403|FG001|Overall Study|Physician Decision|1|||
164131971|NCT01561430|592848404|FG002|Overall Study|Physician Decision|0|||
164131972|NCT01561430|592848405|FG003|Overall Study|Physician Decision|0|||
164131973|NCT01561430|592848402|FG000|Overall Study|Sponsor Decision|1|||
164131974|NCT01561430|592848403|FG001|Overall Study|Sponsor Decision|14|||
164131975|NCT01561430|592848404|FG002|Overall Study|Sponsor Decision|13|||
164131976|NCT01561430|592848405|FG003|Overall Study|Sponsor Decision|12|||
164131977|NCT04112173|592848406|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
164131978|NCT03347422|592848407|FG000|Part A (26 Weeks)|Adverse Event|3|||
164131979|NCT03347422|592848408|FG001|Part A (26 Weeks)|Adverse Event|0|||
164131980|NCT03347422|592848407|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
164131981|NCT03347422|592848408|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
164131982|NCT03347422|592848407|FG000|Part B (149 Weeks)|Adverse Event|0|||
164131983|NCT03347422|592848408|FG001|Part B (149 Weeks)|Adverse Event|1|||
164131984|NCT03347422|592848407|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
164131985|NCT03347422|592848408|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
164131986|NCT03347422|592848407|FG000|Part B (149 Weeks)|Other|1|||
164131987|NCT03347422|592848408|FG001|Part B (149 Weeks)|Other|0|||
164131988|NCT04234984|592848420|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
164131989|NCT04234984|592848420|FG000|Follow-up at the Second Time Point|Death|1|||
164131990|NCT04234984|592848420|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
164131991|NCT01055132|592848421|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
164131992|NCT01055132|592848422|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
164131993|NCT01055132|592848421|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
164131994|NCT01055132|592848422|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
164131995|NCT00158600|592848423|FG000|Overall Study|unable to commit time to study|0|||
164131996|NCT00158600|592848424|FG001|Overall Study|unable to commit time to study|1|||
164131997|NCT00158600|592848423|FG000|Overall Study|Adverse Event|2|||
164131998|NCT00158600|592848424|FG001|Overall Study|Adverse Event|1|||
164131999|NCT00158600|592848423|FG000|Overall Study|Death|1|||
164132000|NCT00158600|592848424|FG001|Overall Study|Death|0|||
164132001|NCT00158600|592848423|FG000|Overall Study|Withdrawal by Subject|2|||
164132002|NCT00158600|592848424|FG001|Overall Study|Withdrawal by Subject|2|||
164132003|NCT02570113|592848425|FG000|Overall Study|Withdrawal by Subject|3|||
164132004|NCT02038907|592848426|FG000|Overall Study|Protocol Violation|0|||
164132005|NCT02038907|592848427|FG001|Overall Study|Protocol Violation|0|||
164132006|NCT02038907|592848428|FG002|Overall Study|Protocol Violation|0|||
164132007|NCT02038907|592848429|FG003|Overall Study|Protocol Violation|0|||
164132008|NCT02038907|592848430|FG004|Overall Study|Protocol Violation|0|||
164132009|NCT02038907|592848431|FG005|Overall Study|Protocol Violation|0|||
164132010|NCT02038907|592848432|FG006|Overall Study|Protocol Violation|0|||
164132011|NCT02038907|592848433|FG007|Overall Study|Protocol Violation|0|||
164132012|NCT02038907|592848434|FG008|Overall Study|Protocol Violation|0|||
164132013|NCT02038907|592848435|FG009|Overall Study|Protocol Violation|0|||
164132014|NCT02038907|592848436|FG010|Overall Study|Protocol Violation|1|||
164132015|NCT02038907|592848437|FG011|Overall Study|Protocol Violation|0|||
164132016|NCT02038907|592848438|FG012|Overall Study|Protocol Violation|0|||
164132017|NCT02038907|592848439|FG013|Overall Study|Protocol Violation|0|||
164132018|NCT02038907|592848426|FG000|Overall Study|Withdrawal by Subject|0|||
164132019|NCT02038907|592848427|FG001|Overall Study|Withdrawal by Subject|0|||
164132020|NCT02038907|592848428|FG002|Overall Study|Withdrawal by Subject|0|||
164132021|NCT02038907|592848429|FG003|Overall Study|Withdrawal by Subject|0|||
164132022|NCT02038907|592848430|FG004|Overall Study|Withdrawal by Subject|0|||
164132023|NCT02038907|592848431|FG005|Overall Study|Withdrawal by Subject|0|||
164132024|NCT02038907|592848432|FG006|Overall Study|Withdrawal by Subject|0|||
164132025|NCT02038907|592848433|FG007|Overall Study|Withdrawal by Subject|0|||
164132026|NCT02038907|592848434|FG008|Overall Study|Withdrawal by Subject|0|||
164132027|NCT02038907|592848435|FG009|Overall Study|Withdrawal by Subject|0|||
164132028|NCT02038907|592848436|FG010|Overall Study|Withdrawal by Subject|1|||
164132029|NCT02038907|592848437|FG011|Overall Study|Withdrawal by Subject|0|||
164132030|NCT02038907|592848438|FG012|Overall Study|Withdrawal by Subject|0|||
164132031|NCT02038907|592848439|FG013|Overall Study|Withdrawal by Subject|0|||
164132032|NCT02746471|592848440|FG000|Overall Study|Death|43|||
164132033|NCT02746471|592848440|FG000|Overall Study|Exited before 36 months|1119|||
164132034|NCT02564211|592848441|FG000|Overall Study|Adverse Event|4|||
164132035|NCT00910091|592848443|FG000|Pre-assignment|Withdrawal by Subject|0|||
164132036|NCT00910091|592848444|FG001|Pre-assignment|Withdrawal by Subject|2|||
164132037|NCT00910091|592848443|FG000|Treatment and Survival|Withdrawal by Subject|3|||
164132038|NCT00910091|592848444|FG001|Treatment and Survival|Withdrawal by Subject|4|||
164132039|NCT00910091|592848443|FG000|Treatment and Survival|Adverse Event|1|||
164132040|NCT00910091|592848444|FG001|Treatment and Survival|Adverse Event|0|||
164132041|NCT00622466|592848449|FG000|Overall Study|Death|1|||
164132042|NCT00622466|592848449|FG000|Overall Study|Adverse Event|1|||
164132043|NCT00622466|592848449|FG000|Overall Study|Withdrawal by Subject|2|||
164132044|NCT01908816|592848452|FG000|Overall Study|Subject's no longer requires study drug|0|||
164132045|NCT01908816|592848453|FG001|Overall Study|Subject's no longer requires study drug|0|||
164132046|NCT01908816|592848454|FG002|Overall Study|Subject's no longer requires study drug|0|||
164132047|NCT01908816|592848455|FG003|Overall Study|Subject's no longer requires study drug|1|||
164132048|NCT01908816|592848452|FG000|Overall Study|Protocol deviation|1|||
164132049|NCT01908816|592848453|FG001|Overall Study|Protocol deviation|2|||
164132050|NCT01908816|592848454|FG002|Overall Study|Protocol deviation|1|||
164132051|NCT01908816|592848455|FG003|Overall Study|Protocol deviation|1|||
164132052|NCT01908816|592848452|FG000|Overall Study|Withdrawal by Subject|0|||
164132053|NCT01908816|592848453|FG001|Overall Study|Withdrawal by Subject|4|||
164132054|NCT01908816|592848454|FG002|Overall Study|Withdrawal by Subject|2|||
164132055|NCT01908816|592848455|FG003|Overall Study|Withdrawal by Subject|2|||
164132056|NCT01908816|592848452|FG000|Overall Study|Lost to Follow-up|3|||
164132057|NCT01908816|592848453|FG001|Overall Study|Lost to Follow-up|5|||
164132058|NCT01908816|592848454|FG002|Overall Study|Lost to Follow-up|4|||
164132059|NCT01908816|592848455|FG003|Overall Study|Lost to Follow-up|2|||
164132060|NCT01908816|592848452|FG000|Overall Study|Death|1|||
164132061|NCT01908816|592848453|FG001|Overall Study|Death|0|||
164132062|NCT01908816|592848454|FG002|Overall Study|Death|7|||
164132063|NCT01908816|592848455|FG003|Overall Study|Death|1|||
164132064|NCT01908816|592848452|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
164132065|NCT01908816|592848453|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
164132066|NCT01908816|592848454|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
164132067|NCT01908816|592848455|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
164132068|NCT01908816|592848452|FG000|Overall Study|Early termination|87|||
164132069|NCT01908816|592848453|FG001|Overall Study|Early termination|60|||
164132070|NCT01908816|592848454|FG002|Overall Study|Early termination|43|||
164132071|NCT01908816|592848455|FG003|Overall Study|Early termination|28|||
164132072|NCT02618408|592848457|FG000|Overall Study|Withdrawal by Subject|1|||
164132073|NCT02618408|592848458|FG001|Overall Study|Withdrawal by Subject|0|||
164132074|NCT02618408|592848459|FG002|Overall Study|Withdrawal by Subject|4|||
164132075|NCT02618408|592848457|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
164132076|NCT02618408|592848458|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
164132077|NCT02618408|592848459|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
164132078|NCT02618408|592848457|FG000|Overall Study|Lost to Follow-up|4|||
164132079|NCT02618408|592848458|FG001|Overall Study|Lost to Follow-up|2|||
164132080|NCT02618408|592848459|FG002|Overall Study|Lost to Follow-up|6|||
164132081|NCT02618408|592848457|FG000|Overall Study|Adverse Event|4|||
164132082|NCT02618408|592848458|FG001|Overall Study|Adverse Event|0|||
164132083|NCT02618408|592848459|FG002|Overall Study|Adverse Event|10|||
164132084|NCT02618408|592848457|FG000|Overall Study|Physician Decision|1|||
164132085|NCT02618408|592848458|FG001|Overall Study|Physician Decision|1|||
164132086|NCT02618408|592848459|FG002|Overall Study|Physician Decision|2|||
164132087|NCT02618408|592848457|FG000|Overall Study|Protocol Violation|1|||
164132088|NCT02618408|592848458|FG001|Overall Study|Protocol Violation|1|||
164132089|NCT02618408|592848459|FG002|Overall Study|Protocol Violation|2|||
164132090|NCT02618408|592848457|FG000|Overall Study|Other, Multiple Categories|0|||
164132091|NCT02618408|592848458|FG001|Overall Study|Other, Multiple Categories|0|||
164132092|NCT02618408|592848459|FG002|Overall Study|Other, Multiple Categories|4|||
164132093|NCT05183217|592848463|FG000|Overall Study|Withdrawal by Subject|1|||
164132094|NCT05183217|592848464|FG001|Overall Study|Withdrawal by Subject|1|||
164132095|NCT03914950|592848466|FG000|Overall Study|Physician Decision|54|||
164132096|NCT03397771|592848469|FG000|Overall Study|2 erroneously randomized, never treated|3|||
164132097|NCT03397771|592848470|FG001|Overall Study|2 erroneously randomized, never treated|1|||
164132098|NCT03397771|592848469|FG000|Overall Study|Withdrawal by Subject|1|||
164132099|NCT03397771|592848470|FG001|Overall Study|Withdrawal by Subject|3|||
164132100|NCT03397771|592848469|FG000|Overall Study|Protocol Violation|2|||
164132101|NCT03397771|592848470|FG001|Overall Study|Protocol Violation|2|||
164132102|NCT03397771|592848469|FG000|Overall Study|Adverse Event|2|||
164132103|NCT03397771|592848470|FG001|Overall Study|Adverse Event|1|||
164132104|NCT02669758|592848471|FG000|Overall Study|Withdrawal by Subject|43|||
164132105|NCT02669758|592848471|FG000|Overall Study|Lost to Follow-up|19|||
164132106|NCT02669758|592848471|FG000|Overall Study|Adverse Event|16|||
164132107|NCT02669758|592848471|FG000|Overall Study|Non-Compliance with Study Drug|8|||
164132108|NCT02669758|592848471|FG000|Overall Study|Lack of Efficacy|5|||
164132109|NCT02669758|592848471|FG000|Overall Study|Pregnancy|1|||
164132110|NCT02669758|592848471|FG000|Overall Study|Study noncompliance|1|||
164132111|NCT02669758|592848471|FG000|Overall Study|Protocol Violation|1|||
164132112|NCT03393806|592848474|FG000|Overall Study|Physician Decision|1|||
164132113|NCT03393806|592848475|FG001|Overall Study|Physician Decision|0|||
164132114|NCT01259115|592848476|FG000|Period 1|Adverse Event|1|||
164132115|NCT01259115|592848477|FG001|Period 1|Adverse Event|0|||
164132116|NCT01259115|592848476|FG000|Period 1|Protocol Violation|2|||
164132117|NCT01259115|592848477|FG001|Period 1|Protocol Violation|0|||
164132118|NCT01259115|592848476|FG000|Period 1|Lost to Follow-up|0|||
164132119|NCT01259115|592848477|FG001|Period 1|Lost to Follow-up|1|||
164132120|NCT01259115|592848476|FG000|Period 2|Adverse Event|1|||
164132121|NCT01259115|592848477|FG001|Period 2|Adverse Event|0|||
164132122|NCT02987959|592848482|FG000|Overall Study|Grantor stopped supply of drugs|6|||
164132123|NCT04453202|592848483|FG000|Overall Study|Adverse Event|0|||
164132124|NCT04453202|592848484|FG001|Overall Study|Adverse Event|0|||
164132125|NCT04453202|592848485|FG002|Overall Study|Adverse Event|0|||
164132126|NCT04453202|592848486|FG003|Overall Study|Adverse Event|0|||
164132127|NCT04453202|592848487|FG004|Overall Study|Adverse Event|0|||
164132128|NCT04453202|592848488|FG005|Overall Study|Adverse Event|0|||
164132129|NCT04453202|592848489|FG006|Overall Study|Adverse Event|1|||
164132130|NCT04453202|592848490|FG007|Overall Study|Adverse Event|0|||
164132131|NCT04453202|592848491|FG008|Overall Study|Adverse Event|0|||
164132132|NCT04453202|592848492|FG009|Overall Study|Adverse Event|0|||
164132133|NCT04453202|592848493|FG010|Overall Study|Adverse Event|0|||
164132134|NCT04453202|592848483|FG000|Overall Study|Death|0|||
164132135|NCT04453202|592848484|FG001|Overall Study|Death|0|||
164132136|NCT04453202|592848485|FG002|Overall Study|Death|0|||
164132137|NCT04453202|592848486|FG003|Overall Study|Death|0|||
164132138|NCT04453202|592848487|FG004|Overall Study|Death|0|||
164132139|NCT04453202|592848488|FG005|Overall Study|Death|0|||
164132140|NCT04453202|592848489|FG006|Overall Study|Death|0|||
164132141|NCT04453202|592848490|FG007|Overall Study|Death|0|||
164132142|NCT04453202|592848491|FG008|Overall Study|Death|0|||
164132143|NCT04453202|592848492|FG009|Overall Study|Death|1|||
164132144|NCT04453202|592848493|FG010|Overall Study|Death|0|||
164132145|NCT04453202|592848483|FG000|Overall Study|Lost to Follow-up|0|||
164132146|NCT04453202|592848484|FG001|Overall Study|Lost to Follow-up|1|||
164132147|NCT04453202|592848485|FG002|Overall Study|Lost to Follow-up|0|||
164132148|NCT04453202|592848486|FG003|Overall Study|Lost to Follow-up|1|||
164132149|NCT04453202|592848487|FG004|Overall Study|Lost to Follow-up|0|||
164132150|NCT04453202|592848488|FG005|Overall Study|Lost to Follow-up|0|||
164132151|NCT04453202|592848489|FG006|Overall Study|Lost to Follow-up|0|||
164132152|NCT04453202|592848490|FG007|Overall Study|Lost to Follow-up|0|||
164132153|NCT04453202|592848491|FG008|Overall Study|Lost to Follow-up|0|||
164132154|NCT04453202|592848492|FG009|Overall Study|Lost to Follow-up|1|||
164132155|NCT04453202|592848493|FG010|Overall Study|Lost to Follow-up|1|||
164132156|NCT04453202|592848483|FG000|Overall Study|Withdrawal by Subject|1|||
164132157|NCT04453202|592848484|FG001|Overall Study|Withdrawal by Subject|2|||
164132158|NCT04453202|592848485|FG002|Overall Study|Withdrawal by Subject|1|||
164132159|NCT04453202|592848486|FG003|Overall Study|Withdrawal by Subject|2|||
164132160|NCT04453202|592848487|FG004|Overall Study|Withdrawal by Subject|1|||
164132161|NCT04453202|592848488|FG005|Overall Study|Withdrawal by Subject|1|||
164132162|NCT04453202|592848489|FG006|Overall Study|Withdrawal by Subject|0|||
164132163|NCT04453202|592848490|FG007|Overall Study|Withdrawal by Subject|0|||
164132164|NCT04453202|592848491|FG008|Overall Study|Withdrawal by Subject|0|||
164132165|NCT04453202|592848492|FG009|Overall Study|Withdrawal by Subject|1|||
164132166|NCT04453202|592848493|FG010|Overall Study|Withdrawal by Subject|0|||
164132167|NCT04453202|592848483|FG000|Overall Study|Adverse Event|0|||
164132168|NCT04453202|592848484|FG001|Overall Study|Adverse Event|0|||
164132169|NCT04453202|592848485|FG002|Overall Study|Adverse Event|0|||
164132170|NCT04453202|592848486|FG003|Overall Study|Adverse Event|0|||
164132171|NCT04453202|592848487|FG004|Overall Study|Adverse Event|0|||
164132172|NCT04453202|592848488|FG005|Overall Study|Adverse Event|1|||
164132173|NCT04453202|592848489|FG006|Overall Study|Adverse Event|0|||
164132174|NCT04453202|592848490|FG007|Overall Study|Adverse Event|0|||
164132175|NCT04453202|592848491|FG008|Overall Study|Adverse Event|0|||
164132176|NCT04453202|592848492|FG009|Overall Study|Adverse Event|0|||
164132177|NCT04453202|592848493|FG010|Overall Study|Adverse Event|0|||
164132178|NCT01355159|592848498|FG000|Overall Study|Withdrew consent|39|||
164132179|NCT01355159|592848499|FG001|Overall Study|Withdrew consent|47|||
164132180|NCT01355159|592848498|FG000|Overall Study|No primary outcome data|17|||
164132181|NCT01355159|592848499|FG001|Overall Study|No primary outcome data|11|||
164132182|NCT01355159|592848498|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
164132183|NCT01355159|592848499|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
164132184|NCT01355159|592848498|FG000|Overall Study|Early intrauterine fetal death|6|||
164132185|NCT01355159|592848499|FG001|Overall Study|Early intrauterine fetal death|6|||
164132186|NCT03276221|592848500|FG000|Overall Study|Lost to Follow-up|6|||
164132187|NCT03276221|592848501|FG001|Overall Study|Lost to Follow-up|2|||
164132188|NCT03276221|592848502|FG002|Overall Study|Lost to Follow-up|0|||
164132189|NCT03276221|592848500|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
164132190|NCT03276221|592848501|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
164132191|NCT03276221|592848502|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
164132192|NCT00424775|592848503|FG000|Overall Study|Adverse Event|2|||
164132193|NCT00424775|592848504|FG001|Overall Study|Adverse Event|0|||
164132194|NCT00424775|592848503|FG000|Overall Study|Lack of Efficacy|1|||
164132195|NCT00424775|592848504|FG001|Overall Study|Lack of Efficacy|0|||
164132196|NCT02615171|592848505|FG000|Overall Study|Lost to Follow-up|2|||
164132197|NCT02615171|592848506|FG001|Overall Study|Lost to Follow-up|1|||
164132198|NCT02384850|592848510|FG000|Overall Study|Withdrawal by Subject|2|||
164132199|NCT02384850|592848511|FG001|Overall Study|Withdrawal by Subject|2|||
164132200|NCT00446199|592848512|FG000|Overall Study|Adverse Event|7|||
164132201|NCT00446199|592848513|FG001|Overall Study|Adverse Event|4|||
164132202|NCT00446199|592848514|FG002|Overall Study|Adverse Event|6|||
164132203|NCT00446199|592848515|FG003|Overall Study|Adverse Event|4|||
164132204|NCT00446199|592848512|FG000|Overall Study|Lost to Follow-up|4|||
164132205|NCT00446199|592848513|FG001|Overall Study|Lost to Follow-up|5|||
164132206|NCT00446199|592848514|FG002|Overall Study|Lost to Follow-up|2|||
164132207|NCT00446199|592848515|FG003|Overall Study|Lost to Follow-up|6|||
164132208|NCT00446199|592848512|FG000|Overall Study|Protocol Violation|1|||
164073688|NCT01915498|592632899|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073689|NCT01915498|592632900|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073690|NCT01915498|592632901|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073691|NCT01915498|592632902|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073692|NCT01915498|592632903|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073693|NCT01915498|592632904|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073694|NCT01915498|592632905|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073695|NCT01915498|592632906|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
164073696|NCT01915498|592632907|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
164073697|NCT01915498|592632889|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073698|NCT01915498|592632890|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073699|NCT01915498|592632891|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073700|NCT01915498|592632892|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073701|NCT01915498|592632893|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073702|NCT01915498|592632894|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073703|NCT01915498|592632895|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073704|NCT01915498|592632896|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073705|NCT01915498|592632897|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073706|NCT01915498|592632898|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073707|NCT01915498|592632899|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073708|NCT01915498|592632900|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073709|NCT01915498|592632901|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073710|NCT01915498|592632902|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073711|NCT01915498|592632903|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073712|NCT01915498|592632904|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073713|NCT01915498|592632905|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073714|NCT01915498|592632906|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
164073715|NCT01915498|592632907|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
164073716|NCT01915498|592632889|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073717|NCT01915498|592632890|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073718|NCT01915498|592632891|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073719|NCT01915498|592632892|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073720|NCT01915498|592632893|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073721|NCT01915498|592632894|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073722|NCT01915498|592632895|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073723|NCT01915498|592632896|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073724|NCT01915498|592632897|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073725|NCT01915498|592632898|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073726|NCT01915498|592632899|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073727|NCT01915498|592632900|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073728|NCT01915498|592632901|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073729|NCT01915498|592632902|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073730|NCT01915498|592632903|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073731|NCT01915498|592632904|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073732|NCT01915498|592632905|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073733|NCT01915498|592632906|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
164073734|NCT01915498|592632907|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
164073735|NCT00314262|592632913|FG000|Overall Study|Adverse Event|2|||
164073736|NCT00314262|592632913|FG000|Overall Study|Withdrawal by Subject|2|||
164073737|NCT00314262|592632913|FG000|Overall Study|Physician Decision|1|||
164073738|NCT01185639|592632914|FG000|Overall Study|Progressed and didn't receive therapy|2|||
164132209|NCT00446199|592848513|FG001|Overall Study|Protocol Violation|2|||
164132210|NCT00446199|592848514|FG002|Overall Study|Protocol Violation|1|||
164132211|NCT00446199|592848515|FG003|Overall Study|Protocol Violation|3|||
164132212|NCT00446199|592848512|FG000|Overall Study|Withdrawal by Subject|2|||
164132213|NCT00446199|592848513|FG001|Overall Study|Withdrawal by Subject|5|||
164132214|NCT00446199|592848514|FG002|Overall Study|Withdrawal by Subject|9|||
164132215|NCT00446199|592848515|FG003|Overall Study|Withdrawal by Subject|10|||
164132216|NCT00446199|592848512|FG000|Overall Study|Site termination|2|||
164132217|NCT00446199|592848513|FG001|Overall Study|Site termination|0|||
164132218|NCT00446199|592848514|FG002|Overall Study|Site termination|0|||
164132219|NCT00446199|592848515|FG003|Overall Study|Site termination|1|||
164132220|NCT00446199|592848512|FG000|Overall Study|Randomization in Error|2|||
164132221|NCT00446199|592848513|FG001|Overall Study|Randomization in Error|0|||
164132222|NCT00446199|592848514|FG002|Overall Study|Randomization in Error|1|||
164132223|NCT00446199|592848515|FG003|Overall Study|Randomization in Error|1|||
164132224|NCT00446199|592848512|FG000|Overall Study|Lack of Efficacy|1|||
164132225|NCT00446199|592848513|FG001|Overall Study|Lack of Efficacy|0|||
164132226|NCT00446199|592848514|FG002|Overall Study|Lack of Efficacy|0|||
164132227|NCT00446199|592848515|FG003|Overall Study|Lack of Efficacy|1|||
164132228|NCT00446199|592848512|FG000|Overall Study|Non-compliant with study drug|1|||
164132229|NCT00446199|592848513|FG001|Overall Study|Non-compliant with study drug|0|||
164132230|NCT00446199|592848514|FG002|Overall Study|Non-compliant with study drug|5|||
164132231|NCT00446199|592848515|FG003|Overall Study|Non-compliant with study drug|0|||
164132232|NCT00446199|592848512|FG000|Overall Study|Non-compliant with visit schedule|1|||
164132233|NCT00446199|592848513|FG001|Overall Study|Non-compliant with visit schedule|1|||
164132234|NCT00446199|592848514|FG002|Overall Study|Non-compliant with visit schedule|1|||
164132235|NCT00446199|592848515|FG003|Overall Study|Non-compliant with visit schedule|2|||
164132236|NCT00446199|592848512|FG000|Overall Study|Hormone fear|0|||
164132237|NCT00446199|592848513|FG001|Overall Study|Hormone fear|0|||
164132238|NCT00446199|592848514|FG002|Overall Study|Hormone fear|0|||
164132239|NCT00446199|592848515|FG003|Overall Study|Hormone fear|1|||
164132240|NCT00446199|592848512|FG000|Overall Study|Lost interest in study participation|0|||
164132241|NCT00446199|592848513|FG001|Overall Study|Lost interest in study participation|1|||
164132242|NCT00446199|592848514|FG002|Overall Study|Lost interest in study participation|0|||
164132243|NCT00446199|592848515|FG003|Overall Study|Lost interest in study participation|0|||
164132244|NCT00446199|592848512|FG000|Overall Study|In-/Exclusion criterion violated|2|||
164132245|NCT00446199|592848513|FG001|Overall Study|In-/Exclusion criterion violated|1|||
164132246|NCT00446199|592848514|FG002|Overall Study|In-/Exclusion criterion violated|2|||
164132247|NCT00446199|592848515|FG003|Overall Study|In-/Exclusion criterion violated|1|||
164132248|NCT00446199|592848512|FG000|Overall Study|Move|0|||
164132249|NCT00446199|592848513|FG001|Overall Study|Move|1|||
164132250|NCT00446199|592848514|FG002|Overall Study|Move|0|||
164132251|NCT00446199|592848515|FG003|Overall Study|Move|0|||
164132252|NCT02312063|592848516|FG000|Overall Study|Withdrawal by Subject|0|||
164132253|NCT02312063|592848517|FG001|Overall Study|Withdrawal by Subject|1|||
164132254|NCT01079832|592848520|FG000|Overall Study|Withdrawal by Subject|1|||
164132255|NCT01195272|592848523|FG000|Overall Study|Adverse Event|1|||
164132256|NCT01195272|592848523|FG000|Overall Study|Lack of Efficacy|3|||
164132257|NCT01769339|592848524|FG000|Overall Study|Lost to Follow-up|42|||
164132258|NCT01769339|592848524|FG000|Overall Study|Adverse Event|1|||
164132259|NCT04969861|592848525|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
164132260|NCT04969861|592848526|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
164132261|NCT00290251|592848527|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164132262|NCT00290251|592848528|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164132263|NCT00290251|592848529|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164132264|NCT00290251|592848530|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164132265|NCT00290251|592848531|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
164132266|NCT00290251|592848532|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
164132267|NCT00290251|592848527|FG000|Treatment 1 (Months 2-4)|headache|0|||
164132268|NCT00290251|592848528|FG001|Treatment 1 (Months 2-4)|headache|0|||
164132269|NCT00290251|592848529|FG002|Treatment 1 (Months 2-4)|headache|0|||
164132270|NCT00290251|592848530|FG003|Treatment 1 (Months 2-4)|headache|0|||
164132271|NCT00290251|592848531|FG004|Treatment 1 (Months 2-4)|headache|1|||
164132272|NCT00290251|592848532|FG005|Treatment 1 (Months 2-4)|headache|0|||
164132273|NCT00290251|592848527|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
164132274|NCT00290251|592848528|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
164132275|NCT00290251|592848529|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
164132276|NCT00290251|592848530|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
164132277|NCT00290251|592848531|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
164132278|NCT00290251|592848532|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
164132279|NCT03548064|592850548|FG000|Overall Study|Withdrawal by Subject|0|||
164132280|NCT03548064|592850549|FG001|Overall Study|Withdrawal by Subject|0|||
164132281|NCT03548064|592850550|FG002|Overall Study|Withdrawal by Subject|0|||
164132282|NCT03548064|592850551|FG003|Overall Study|Withdrawal by Subject|1|||
164132283|NCT03548064|592850552|FG004|Overall Study|Withdrawal by Subject|0|||
164132284|NCT03548064|592850553|FG005|Overall Study|Withdrawal by Subject|0|||
164132285|NCT03548064|592850554|FG006|Overall Study|Withdrawal by Subject|0|||
164132286|NCT03548064|592850555|FG007|Overall Study|Withdrawal by Subject|0|||
164132287|NCT03548064|592850548|FG000|Overall Study|Lost to Follow-up|0|||
164132288|NCT03548064|592850549|FG001|Overall Study|Lost to Follow-up|0|||
164132289|NCT03548064|592850550|FG002|Overall Study|Lost to Follow-up|0|||
164132290|NCT03548064|592850551|FG003|Overall Study|Lost to Follow-up|0|||
164132291|NCT03548064|592850552|FG004|Overall Study|Lost to Follow-up|2|||
164132292|NCT03548064|592850553|FG005|Overall Study|Lost to Follow-up|0|||
164132293|NCT03548064|592850554|FG006|Overall Study|Lost to Follow-up|0|||
164132294|NCT03548064|592850555|FG007|Overall Study|Lost to Follow-up|0|||
164132295|NCT03548064|592850548|FG000|Overall Study|Covid-19 Pandemic|0|||
164132296|NCT03548064|592850549|FG001|Overall Study|Covid-19 Pandemic|0|||
164132297|NCT03548064|592850550|FG002|Overall Study|Covid-19 Pandemic|0|||
164132298|NCT03548064|592850551|FG003|Overall Study|Covid-19 Pandemic|0|||
164132299|NCT03548064|592850552|FG004|Overall Study|Covid-19 Pandemic|10|||
164132300|NCT03548064|592850553|FG005|Overall Study|Covid-19 Pandemic|3|||
164132301|NCT03548064|592850554|FG006|Overall Study|Covid-19 Pandemic|0|||
164132302|NCT03548064|592850555|FG007|Overall Study|Covid-19 Pandemic|0|||
164132303|NCT06218823|592850558|FG000|Overall Study|Death|3|||
164132304|NCT06218823|592850559|FG001|Overall Study|Death|0|||
164132305|NCT06218823|592850558|FG000|Overall Study|Lost to Follow-up|0|||
164132306|NCT06218823|592850559|FG001|Overall Study|Lost to Follow-up|2|||
164132307|NCT03611543|592850560|FG000|Overall Study|Withdrawal by Subject|4|||
164132308|NCT03611543|592850561|FG001|Overall Study|Withdrawal by Subject|4|||
164132309|NCT03611543|592850560|FG000|Overall Study|Physician Decision|1|||
164132310|NCT03611543|592850561|FG001|Overall Study|Physician Decision|1|||
164132311|NCT03611543|592850560|FG000|Overall Study|Protocol Violation|2|||
164132312|NCT03611543|592850561|FG001|Overall Study|Protocol Violation|2|||
164132313|NCT03611543|592850560|FG000|Overall Study|Device failure|2|||
164132314|NCT03611543|592850561|FG001|Overall Study|Device failure|2|||
164132315|NCT03611543|592850560|FG000|Overall Study|Missing information|5|||
164132316|NCT03611543|592850561|FG001|Overall Study|Missing information|5|||
164132317|NCT06077487|592850562|FG000|Overall Study|Withdrawal by Subject|0|||
164132318|NCT06077487|592850563|FG001|Overall Study|Withdrawal by Subject|1|||
164132319|NCT05101486|592850564|FG000|Overall Study|Death|1|||
164132320|NCT05101486|592850565|FG001|Overall Study|Death|0|||
164132321|NCT05101486|592850566|FG002|Overall Study|Death|1|||
164132322|NCT05101486|592850564|FG000|Overall Study|Lost to Follow-up|12|||
164132323|NCT05101486|592850565|FG001|Overall Study|Lost to Follow-up|8|||
164132324|NCT05101486|592850566|FG002|Overall Study|Lost to Follow-up|17|||
164132325|NCT05101486|592850564|FG000|Overall Study|Physician Decision|1|||
164132326|NCT05101486|592850565|FG001|Overall Study|Physician Decision|0|||
164132327|NCT05101486|592850566|FG002|Overall Study|Physician Decision|0|||
164132328|NCT05101486|592850564|FG000|Overall Study|Protocol Violation|0|||
164132329|NCT05101486|592850565|FG001|Overall Study|Protocol Violation|0|||
164132330|NCT05101486|592850566|FG002|Overall Study|Protocol Violation|1|||
164132331|NCT05101486|592850564|FG000|Overall Study|Withdrawal by Subject|5|||
164132332|NCT05101486|592850565|FG001|Overall Study|Withdrawal by Subject|2|||
164132333|NCT05101486|592850566|FG002|Overall Study|Withdrawal by Subject|4|||
164132334|NCT05101486|592850564|FG000|Overall Study|Randomized but not vaccinated|1|||
164132335|NCT05101486|592850565|FG001|Overall Study|Randomized but not vaccinated|1|||
164132336|NCT05101486|592850566|FG002|Overall Study|Randomized but not vaccinated|1|||
164132337|NCT02788045|592850567|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
164132338|NCT02788045|592850568|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
164132339|NCT02788045|592850569|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
164132340|NCT02788045|592850567|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
164132341|NCT02788045|592850568|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
164132342|NCT02788045|592850569|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
164132343|NCT02788045|592850567|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
164132344|NCT02788045|592850568|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
164132345|NCT02788045|592850569|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
164132346|NCT02788045|592850567|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
164132347|NCT02788045|592850568|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
164132348|NCT02788045|592850569|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
164132349|NCT02788045|592850567|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
164132350|NCT02788045|592850568|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
164132351|NCT02788045|592850569|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
164132352|NCT02788045|592850567|FG000|Main Study (Up to Week 72)|Other|3|||
164132353|NCT02788045|592850568|FG001|Main Study (Up to Week 72)|Other|0|||
164132354|NCT02788045|592850569|FG002|Main Study (Up to Week 72)|Other|0|||
164132355|NCT02788045|592850567|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
164132356|NCT02788045|592850568|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
164132357|NCT02788045|592850569|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
164132358|NCT02788045|592850567|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
164132359|NCT02788045|592850568|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
164132360|NCT02788045|592850569|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
164132361|NCT02788045|592850567|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
164132362|NCT02788045|592850568|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
164132363|NCT02788045|592850569|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
164132364|NCT03047473|592850573|FG000|Overall Study|Lost to Follow-up|2|||
164132365|NCT00721630|592850574|FG000|Overall Study|Participant found to be ineligible|1|||
164132366|NCT04711902|592850577|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
164132367|NCT04711902|592850578|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
164132368|NCT04711902|592850579|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
164132369|NCT04711902|592850580|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
164132370|NCT04711902|592850581|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
164132371|NCT04711902|592850582|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
164132372|NCT01398514|592850585|FG000|Overall Study|Adverse Event|1|||
164132373|NCT01398514|592850586|FG001|Overall Study|Adverse Event|0|||
164132374|NCT01398514|592850585|FG000|Overall Study|Non-compliance with study procedures|2|||
164132375|NCT01398514|592850586|FG001|Overall Study|Non-compliance with study procedures|0|||
164132376|NCT01398514|592850585|FG000|Overall Study|Physiologic non-responsiveness|1|||
164132377|NCT01398514|592850586|FG001|Overall Study|Physiologic non-responsiveness|3|||
164132378|NCT01398514|592850585|FG000|Overall Study|Failure to show a conditioned response|4|||
164132379|NCT01398514|592850586|FG001|Overall Study|Failure to show a conditioned response|3|||
164132380|NCT00754650|592850588|FG000|Overall Study|Disease Progression|2|||
164132381|NCT03167723|592850592|FG000|Overall Study|Protocol Violation|4|||
164132382|NCT03167723|592850593|FG001|Overall Study|Protocol Violation|6|||
164132383|NCT00507130|592850596|FG000|Overall Study|Lost to Follow-up|0|||
164132384|NCT00507130|592850597|FG001|Overall Study|Lost to Follow-up|0|||
164132385|NCT00507130|592850598|FG002|Overall Study|Lost to Follow-up|1|||
164132386|NCT00507130|592850599|FG003|Overall Study|Lost to Follow-up|1|||
164132387|NCT00507130|592850596|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
164132388|NCT00507130|592850597|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
164132389|NCT00507130|592850598|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
164132390|NCT00507130|592850599|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
164132391|NCT02524730|592850600|FG000|Overall Study|Lost to Follow-up|5|||
164132392|NCT02524730|592850600|FG000|Overall Study|Withdrawal by Subject|18|||
164132393|NCT02524730|592850600|FG000|Overall Study|Death|10|||
164132394|NCT02524730|592850600|FG000|Overall Study|Adverse Event|8|||
164132395|NCT02524730|592850600|FG000|Overall Study|Protocol Violation|1|||
164132396|NCT02524730|592850600|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
164132397|NCT00699374|592850608|FG000|Overall Study|Death|93|||
164132398|NCT00699374|592850609|FG001|Overall Study|Death|83|||
164132399|NCT00699374|592850608|FG000|Overall Study|Adverse Event|70|||
164132400|NCT00699374|592850609|FG001|Overall Study|Adverse Event|67|||
164132401|NCT00699374|592850608|FG000|Overall Study|Global deterioration of health status|7|||
164132402|NCT00699374|592850609|FG001|Overall Study|Global deterioration of health status|8|||
164132403|NCT00699374|592850608|FG000|Overall Study|Lost to Follow-up|3|||
164132404|NCT00699374|592850609|FG001|Overall Study|Lost to Follow-up|5|||
164132405|NCT00699374|592850608|FG000|Overall Study|Withdrawal by Subject|34|||
164132406|NCT00699374|592850609|FG001|Overall Study|Withdrawal by Subject|44|||
164132407|NCT00699374|592850608|FG000|Overall Study|Objective progression or relapse|281|||
164132408|NCT00699374|592850609|FG001|Overall Study|Objective progression or relapse|277|||
164132409|NCT00699374|592850608|FG000|Overall Study|Other|18|||
164132410|NCT00699374|592850609|FG001|Overall Study|Other|15|||
164132411|NCT00699374|592850608|FG000|Overall Study|Protocol Violation|2|||
164132412|NCT00699374|592850609|FG001|Overall Study|Protocol Violation|6|||
164132413|NCT00699374|592850608|FG000|Overall Study|Study terminated by sponsor|13|||
164132414|NCT00699374|592850609|FG001|Overall Study|Study terminated by sponsor|28|||
164132415|NCT00699374|592850608|FG000|Overall Study|Randomized but not treated|4|||
164132416|NCT00699374|592850609|FG001|Overall Study|Randomized but not treated|2|||
164132417|NCT00699374|592850608|FG000|Overall Study|Died 28 days after last dose|5|||
164132418|NCT00699374|592850609|FG001|Overall Study|Died 28 days after last dose|9|||
164132419|NCT03678285|592850614|FG000|Overall Study|Adverse Event|2|||
164073739|NCT02662556|592632915|FG000|Overall Study|Adverse Event|4|||
164073740|NCT02662556|592632915|FG000|Overall Study|Lack of Efficacy|4|||
164132420|NCT03678285|592850614|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
164132421|NCT03678285|592850614|FG000|Overall Study|Dehydrated prior to start of workout|1|||
164132422|NCT00123474|592850615|FG000|Randomized to Treatment|Randomized, never treated|1|||
164132423|NCT00123474|592850616|FG001|Randomized to Treatment|Randomized, never treated|4|||
164132424|NCT00123474|592850617|FG002|Randomized to Treatment|Randomized, never treated|2|||
164132425|NCT00123474|592850618|FG003|Randomized to Treatment|Randomized, never treated|1|||
164132426|NCT00123474|592850615|FG000|As Treated at Study Closure|not reported when site closed|1|||
164132427|NCT00123474|592850616|FG001|As Treated at Study Closure|not reported when site closed|0|||
164132428|NCT00123474|592850617|FG002|As Treated at Study Closure|not reported when site closed|1|||
164132429|NCT00123474|592850618|FG003|As Treated at Study Closure|not reported when site closed|0|||
164132430|NCT00123474|592850615|FG000|As Treated at Study Closure|Adverse Event|10|||
164132467|NCT02731326|592850626|FG001|Overall Study|Discharged without AliveCor|0|||
164132468|NCT02731326|592850625|FG000|Overall Study|Duplicate Participant|1|||
164132469|NCT02731326|592850626|FG001|Overall Study|Duplicate Participant|1|||
164132470|NCT01085201|592850627|FG000|Overall Study|Scheduling conflict|1|||
164132471|NCT01085201|592850628|FG001|Overall Study|Scheduling conflict|0|||
164132472|NCT01085201|592850629|FG002|Overall Study|Scheduling conflict|1|||
164132473|NCT01085201|592850630|FG003|Overall Study|Scheduling conflict|0|||
164132474|NCT01085201|592850631|FG004|Overall Study|Scheduling conflict|0|||
164132475|NCT01085201|592850627|FG000|Overall Study|Unknown- no study drug|2|||
164132476|NCT01085201|592850628|FG001|Overall Study|Unknown- no study drug|0|||
164132477|NCT01085201|592850629|FG002|Overall Study|Unknown- no study drug|0|||
164132478|NCT01085201|592850630|FG003|Overall Study|Unknown- no study drug|0|||
164132479|NCT01085201|592850631|FG004|Overall Study|Unknown- no study drug|0|||
164132480|NCT01085201|592850627|FG000|Overall Study|Fond ineligible after consent|0|||
164132481|NCT01085201|592850628|FG001|Overall Study|Fond ineligible after consent|1|||
164132482|NCT01085201|592850629|FG002|Overall Study|Fond ineligible after consent|1|||
164132483|NCT01085201|592850630|FG003|Overall Study|Fond ineligible after consent|0|||
164132484|NCT01085201|592850631|FG004|Overall Study|Fond ineligible after consent|0|||
164132485|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
164132486|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
164132487|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
164132488|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
164132489|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
164132490|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
164132491|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
164132492|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
164132493|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
164132494|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132495|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
164132496|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132497|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132498|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132499|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132500|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132501|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132502|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
164132503|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132504|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
164132505|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132506|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
164132507|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132508|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132509|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132510|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132511|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132512|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132513|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
164132514|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132515|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
164132516|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132517|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132518|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132519|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132520|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
164132521|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
164132522|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
164132523|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
164132524|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132525|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
164132526|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132527|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132528|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132529|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132530|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132531|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
164132664|NCT01986010|592850660|FG005|Overall Study|Adverse Event|0|||
164132532|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132533|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132534|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132535|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132536|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132537|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132538|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
164132539|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132540|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132541|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132542|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
164132543|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132544|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132545|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132546|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132547|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132548|NCT03893565|592850632|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164132549|NCT03893565|592850633|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
164132550|NCT03893565|592850634|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
164132551|NCT03893565|592850635|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
164132552|NCT03893565|592850636|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164132553|NCT03893565|592850637|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164132554|NCT03893565|592850638|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164132555|NCT03893565|592850639|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164132556|NCT03893565|592850640|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
164132557|NCT03893565|592850632|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
164132558|NCT03893565|592850633|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
164132559|NCT03893565|592850634|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
164132560|NCT03893565|592850635|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
164132561|NCT03893565|592850636|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
164132562|NCT03893565|592850637|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
164132563|NCT03893565|592850638|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
164132564|NCT03893565|592850639|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
164132565|NCT03893565|592850640|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
164132566|NCT03893565|592850632|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132567|NCT03893565|592850633|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132568|NCT03893565|592850634|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132569|NCT03893565|592850635|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132570|NCT03893565|592850636|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132571|NCT03893565|592850637|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132572|NCT03893565|592850638|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
164132573|NCT03893565|592850639|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132574|NCT03893565|592850640|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
164132575|NCT03893565|592850632|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132576|NCT03893565|592850633|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132577|NCT03893565|592850634|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132578|NCT03893565|592850635|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132579|NCT03893565|592850636|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132580|NCT03893565|592850637|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
164132581|NCT03893565|592850638|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
164132582|NCT03893565|592850639|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132583|NCT03893565|592850640|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
164132584|NCT03893565|592850632|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
164132585|NCT03893565|592850633|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
164132586|NCT03893565|592850634|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
164132587|NCT03893565|592850635|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
164132588|NCT03893565|592850636|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
164132589|NCT03893565|592850637|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
164132590|NCT03893565|592850638|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
164132591|NCT03893565|592850639|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
164132592|NCT03893565|592850640|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
164132593|NCT03893565|592850632|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132594|NCT03893565|592850633|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132595|NCT03893565|592850634|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132596|NCT03893565|592850635|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132597|NCT03893565|592850636|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132598|NCT03893565|592850637|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132599|NCT03893565|592850638|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132600|NCT03893565|592850639|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
164132601|NCT03893565|592850640|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
164132602|NCT03893565|592850632|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132603|NCT03893565|592850633|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132604|NCT03893565|592850634|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132605|NCT03893565|592850635|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132606|NCT03893565|592850636|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132607|NCT03893565|592850637|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132608|NCT03893565|592850638|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132609|NCT03893565|592850639|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
164132610|NCT03893565|592850640|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
164132611|NCT03893565|592850632|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132612|NCT03893565|592850633|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132613|NCT03893565|592850634|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132614|NCT03893565|592850635|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132615|NCT03893565|592850636|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132616|NCT03893565|592850637|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132617|NCT03893565|592850638|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132618|NCT03893565|592850639|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
164132619|NCT03893565|592850640|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
164132620|NCT03893565|592850632|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132621|NCT03893565|592850633|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132622|NCT03893565|592850634|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132623|NCT03893565|592850635|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132624|NCT03893565|592850636|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132625|NCT03893565|592850637|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132626|NCT03893565|592850638|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132627|NCT03893565|592850639|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
164132628|NCT03893565|592850640|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
164132629|NCT03870477|592850645|FG000|Overall Study|Early Study Termination|1|||
164132630|NCT02256436|592850648|FG000|Overall Study|Adverse Event|9|||
164132631|NCT02256436|592850649|FG001|Overall Study|Adverse Event|14|||
164132632|NCT02256436|592850648|FG000|Overall Study|Death|216|||
164132633|NCT02256436|592850649|FG001|Overall Study|Death|208|||
164132634|NCT02256436|592850648|FG000|Overall Study|Lost to Follow-up|1|||
164132635|NCT02256436|592850649|FG001|Overall Study|Lost to Follow-up|2|||
164132636|NCT02256436|592850648|FG000|Overall Study|Physician Decision|1|||
164132637|NCT02256436|592850649|FG001|Overall Study|Physician Decision|0|||
164132638|NCT02256436|592850648|FG000|Overall Study|Protocol Violation|0|||
164132639|NCT02256436|592850649|FG001|Overall Study|Protocol Violation|1|||
164132640|NCT02256436|592850648|FG000|Overall Study|Withdrawal by Subject|26|||
164132641|NCT02256436|592850649|FG001|Overall Study|Withdrawal by Subject|10|||
164132642|NCT02256436|592850648|FG000|Overall Study|Transferred to Extension Study|11|||
164132643|NCT02256436|592850649|FG001|Overall Study|Transferred to Extension Study|23|||
164132644|NCT02256436|592850648|FG000|Overall Study|Did Not Continue on Extension Study|8|||
164132645|NCT02256436|592850649|FG001|Overall Study|Did Not Continue on Extension Study|12|||
164132646|NCT05961215|592850650|FG000|Overall Study|Withdrawal by Subject|1|||
164132647|NCT04480710|592850651|FG000|Overall Study|Adverse Event|0|||
164132648|NCT04480710|592850652|FG001|Overall Study|Adverse Event|2|||
164132649|NCT04480710|592850653|FG002|Overall Study|Adverse Event|0|||
164132650|NCT04480710|592850654|FG003|Overall Study|Adverse Event|0|||
164132651|NCT04480710|592850651|FG000|Overall Study|Withdrawal by Subject|0|||
164132652|NCT04480710|592850652|FG001|Overall Study|Withdrawal by Subject|1|||
164132653|NCT04480710|592850653|FG002|Overall Study|Withdrawal by Subject|0|||
164132654|NCT04480710|592850654|FG003|Overall Study|Withdrawal by Subject|0|||
164132655|NCT04480710|592850651|FG000|Overall Study|Physician Decision|0|||
164132656|NCT04480710|592850652|FG001|Overall Study|Physician Decision|0|||
164132657|NCT04480710|592850653|FG002|Overall Study|Physician Decision|1|||
164132658|NCT04480710|592850654|FG003|Overall Study|Physician Decision|0|||
164132659|NCT01986010|592850655|FG000|Overall Study|Adverse Event|0|||
164132660|NCT01986010|592850656|FG001|Overall Study|Adverse Event|1|||
164132661|NCT01986010|592850657|FG002|Overall Study|Adverse Event|0|||
164132662|NCT01986010|592850658|FG003|Overall Study|Adverse Event|0|||
164132663|NCT01986010|592850659|FG004|Overall Study|Adverse Event|0|||
164132710|NCT01986010|592850655|FG000|Overall Study|Withdrawal by Subject|2|||
164132711|NCT01986010|592850656|FG001|Overall Study|Withdrawal by Subject|2|||
164132712|NCT01986010|592850657|FG002|Overall Study|Withdrawal by Subject|3|||
164132713|NCT01986010|592850658|FG003|Overall Study|Withdrawal by Subject|0|||
164132714|NCT01986010|592850659|FG004|Overall Study|Withdrawal by Subject|2|||
164132715|NCT01986010|592850660|FG005|Overall Study|Withdrawal by Subject|4|||
164132716|NCT01986010|592850661|FG006|Overall Study|Withdrawal by Subject|0|||
164132717|NCT01986010|592850662|FG007|Overall Study|Withdrawal by Subject|0|||
164132718|NCT01986010|592850663|FG008|Overall Study|Withdrawal by Subject|0|||
164132719|NCT01986010|592850664|FG009|Overall Study|Withdrawal by Subject|0|||
164132720|NCT01986010|592850665|FG010|Overall Study|Withdrawal by Subject|0|||
164132721|NCT01986010|592850666|FG011|Overall Study|Withdrawal by Subject|2|||
164132722|NCT01986010|592850667|FG012|Overall Study|Withdrawal by Subject|0|||
164132723|NCT01986010|592850668|FG013|Overall Study|Withdrawal by Subject|1|||
164132724|NCT01986010|592850669|FG014|Overall Study|Withdrawal by Subject|2|||
164132725|NCT01986010|592850670|FG015|Overall Study|Withdrawal by Subject|0|||
164132726|NCT01986010|592850671|FG016|Overall Study|Withdrawal by Subject|0|||
164132727|NCT01986010|592850655|FG000|Overall Study|Status Not Recorded|2|||
164132728|NCT01986010|592850656|FG001|Overall Study|Status Not Recorded|4|||
164132729|NCT01986010|592850657|FG002|Overall Study|Status Not Recorded|2|||
164132730|NCT01986010|592850658|FG003|Overall Study|Status Not Recorded|0|||
164132731|NCT01986010|592850659|FG004|Overall Study|Status Not Recorded|1|||
164132732|NCT01986010|592850660|FG005|Overall Study|Status Not Recorded|2|||
164132733|NCT01986010|592850661|FG006|Overall Study|Status Not Recorded|0|||
164132734|NCT01986010|592850662|FG007|Overall Study|Status Not Recorded|0|||
164132735|NCT01986010|592850663|FG008|Overall Study|Status Not Recorded|2|||
164132736|NCT01986010|592850664|FG009|Overall Study|Status Not Recorded|1|||
164132737|NCT01986010|592850665|FG010|Overall Study|Status Not Recorded|7|||
164132738|NCT01986010|592850666|FG011|Overall Study|Status Not Recorded|7|||
164132739|NCT01986010|592850667|FG012|Overall Study|Status Not Recorded|9|||
164132740|NCT01986010|592850668|FG013|Overall Study|Status Not Recorded|9|||
164132741|NCT01986010|592850669|FG014|Overall Study|Status Not Recorded|5|||
164132742|NCT01986010|592850670|FG015|Overall Study|Status Not Recorded|10|||
164132743|NCT01986010|592850671|FG016|Overall Study|Status Not Recorded|4|||
164132744|NCT01394952|592850672|FG000|Overall Study|Lost to Follow-up|0|||
164132745|NCT01394952|592850673|FG001|Overall Study|Lost to Follow-up|5|||
164132746|NCT01394952|592850672|FG000|Overall Study|Withdrawal by Subject|10|||
164132747|NCT01394952|592850673|FG001|Overall Study|Withdrawal by Subject|5|||
164132748|NCT01394952|592850672|FG000|Overall Study|Physician Decision|2|||
164132749|NCT01394952|592850673|FG001|Overall Study|Physician Decision|0|||
164132750|NCT01394952|592850672|FG000|Overall Study|Sponsor Decision|5|||
164132751|NCT01394952|592850673|FG001|Overall Study|Sponsor Decision|7|||
164132752|NCT01335997|592850674|FG000|Period I and II|Adverse Event|63|||
164132753|NCT01335997|592850675|FG001|Period I and II|Adverse Event|43|||
164132754|NCT01335997|592850674|FG000|Period I and II|Noncompliance with Study Drug|1|||
164132755|NCT01335997|592850675|FG001|Period I and II|Noncompliance with Study Drug|1|||
164132756|NCT01335997|592850674|FG000|Period I and II|Lost to Follow-up|3|||
164132757|NCT01335997|592850675|FG001|Period I and II|Lost to Follow-up|5|||
164132758|NCT01335997|592850674|FG000|Period I and II|Withdrawal by Subject|9|||
164132759|NCT01335997|592850675|FG001|Period I and II|Withdrawal by Subject|4|||
164132760|NCT01335997|592850674|FG000|Period I and II|Study Terminated by Sponsor|406|||
164132761|NCT01335997|592850675|FG001|Period I and II|Study Terminated by Sponsor|415|||
164132762|NCT01335997|592850674|FG000|Period I and II|Protocol Violation|9|||
164132763|NCT01335997|592850675|FG001|Period I and II|Protocol Violation|10|||
164132764|NCT01335997|592850674|FG000|Period I and II|Physician Decision|2|||
164132765|NCT01335997|592850675|FG001|Period I and II|Physician Decision|1|||
164132766|NCT01335997|592850674|FG000|Period III|Adverse Event|0|||
164132767|NCT01335997|592850675|FG001|Period III|Adverse Event|2|||
164132768|NCT01335997|592850674|FG000|Period III|Study Terminated by Sponsor|77|||
164132769|NCT01335997|592850675|FG001|Period III|Study Terminated by Sponsor|76|||
164132770|NCT01335997|592850674|FG000|Period III|Protocol Violation|0|||
164132771|NCT01335997|592850675|FG001|Period III|Protocol Violation|1|||
164132772|NCT01335997|592850674|FG000|Period III|Lost to Follow-up|1|||
164132773|NCT01335997|592850675|FG001|Period III|Lost to Follow-up|0|||
164132774|NCT00085423|592850678|FG000|Overall Study|Withdrawal by Subject|1|||
164132775|NCT00085423|592850678|FG000|Overall Study|screen failure|1|||
164132776|NCT04740814|592850679|FG000|Overall Study|Adverse Event|3|||
164132777|NCT04740814|592850679|FG000|Overall Study|Protocol Violation|2|||
164132778|NCT04740814|592850679|FG000|Overall Study|Lost to Follow-up|2|||
164132779|NCT04740814|592850679|FG000|Overall Study|Withdrawal by Subject|3|||
164132780|NCT01103466|592850680|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
164132781|NCT01103466|592850681|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
164132782|NCT01103466|592850682|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
164132783|NCT01103466|592850680|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
164132784|NCT01103466|592850681|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
164132785|NCT01103466|592850682|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
164132786|NCT01103466|592850680|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
164132787|NCT01103466|592850681|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
164132788|NCT01103466|592850682|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
164132789|NCT01103466|592850680|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
164132790|NCT01103466|592850681|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
164132791|NCT01103466|592850682|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
164132792|NCT01103466|592850680|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
164132793|NCT01103466|592850681|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
164132794|NCT01103466|592850682|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
164132795|NCT01103466|592850680|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
164132796|NCT01103466|592850681|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
164132797|NCT01103466|592850682|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
164132798|NCT02994940|592850685|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
164132799|NCT02994940|592850686|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
164132800|NCT02994940|592850685|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
164132801|NCT02994940|592850686|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
164132802|NCT02994940|592850685|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
164132803|NCT02994940|592850686|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
164132804|NCT02331368|592850691|FG000|Overall Study|Withdrawal by Subject|3|||
164132805|NCT02302859|592850692|FG000|Overall Study|Lost Phone|1|||
164132806|NCT02302859|592850693|FG001|Overall Study|Lost Phone|1|||
164132807|NCT02302859|592850692|FG000|Overall Study|Withdrawal by Subject|0|||
164132808|NCT02302859|592850693|FG001|Overall Study|Withdrawal by Subject|1|||
164132809|NCT02989168|592850706|FG000|Overall Study|Withdrawal by Subject|2|||
164132810|NCT02989168|592850707|FG001|Overall Study|Withdrawal by Subject|0|||
164132811|NCT02989168|592850706|FG000|Overall Study|Physician Decision|0|||
164132812|NCT02989168|592850707|FG001|Overall Study|Physician Decision|1|||
164132813|NCT02989168|592850706|FG000|Overall Study|Adverse Event|1|||
164132814|NCT02989168|592850707|FG001|Overall Study|Adverse Event|2|||
164132815|NCT02989168|592850706|FG000|Overall Study|Sponsor stopped study.|1|||
164132816|NCT02989168|592850707|FG001|Overall Study|Sponsor stopped study.|0|||
164132817|NCT03456960|592850708|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164132818|NCT03456960|592850709|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164132819|NCT03456960|592850710|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
164132820|NCT03456960|592850711|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
164132821|NCT03456960|592850712|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164132822|NCT03456960|592850713|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
164132823|NCT03456960|592850708|FG000|Period 2 (1 Day)|Adverse Event|1|||
164132824|NCT03456960|592850709|FG001|Period 2 (1 Day)|Adverse Event|0|||
164132825|NCT03456960|592850710|FG002|Period 2 (1 Day)|Adverse Event|0|||
164132826|NCT03456960|592850711|FG003|Period 2 (1 Day)|Adverse Event|1|||
164132827|NCT03456960|592850712|FG004|Period 2 (1 Day)|Adverse Event|0|||
164132828|NCT03456960|592850713|FG005|Period 2 (1 Day)|Adverse Event|0|||
164132829|NCT00532935|592850714|FG000|Overall Study|Adverse Event|11|||
164132830|NCT00532935|592850715|FG001|Overall Study|Adverse Event|12|||
164132831|NCT00532935|592850714|FG000|Overall Study|Lack of Efficacy|0|||
164132832|NCT00532935|592850715|FG001|Overall Study|Lack of Efficacy|3|||
164132833|NCT00532935|592850714|FG000|Overall Study|Lost to Follow-up|10|||
164132834|NCT00532935|592850715|FG001|Overall Study|Lost to Follow-up|6|||
164132835|NCT00532935|592850714|FG000|Overall Study|Physician Decision|4|||
164132836|NCT00532935|592850715|FG001|Overall Study|Physician Decision|5|||
164132837|NCT00532935|592850714|FG000|Overall Study|Pregnancy|1|||
164132838|NCT00532935|592850715|FG001|Overall Study|Pregnancy|0|||
164132839|NCT00532935|592850714|FG000|Overall Study|Protocol Violation|4|||
164132840|NCT00532935|592850715|FG001|Overall Study|Protocol Violation|2|||
164132841|NCT00532935|592850714|FG000|Overall Study|Withdrawal by Subject|10|||
164132842|NCT00532935|592850715|FG001|Overall Study|Withdrawal by Subject|9|||
164132843|NCT00532935|592850714|FG000|Overall Study|Protocol Specific Criteria|11|||
164132844|NCT00532935|592850715|FG001|Overall Study|Protocol Specific Criteria|15|||
164132845|NCT01940497|592850716|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
164132846|NCT01940497|592850717|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
164132847|NCT01940497|592850716|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
164132848|NCT01940497|592850717|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
164132849|NCT01940497|592850716|FG000|Overall Study|Violation of Entry Criteria|1|||
164132850|NCT01940497|592850717|FG001|Overall Study|Violation of Entry Criteria|1|||
164132851|NCT01940497|592850716|FG000|Overall Study|Refused Treatment|1|||
164132852|NCT01940497|592850717|FG001|Overall Study|Refused Treatment|3|||
164132853|NCT01940497|592850716|FG000|Overall Study|Withdrew Consent|6|||
164132854|NCT01940497|592850717|FG001|Overall Study|Withdrew Consent|2|||
164132855|NCT01940497|592850716|FG000|Overall Study|Administrative/Other|1|||
164132856|NCT01940497|592850717|FG001|Overall Study|Administrative/Other|1|||
164132857|NCT00502801|592850718|FG000|Treatment Period|Withdrawal by Subject|3|||
164132858|NCT00502801|592850718|FG000|Treatment Period|Adverse Event|7|||
164132859|NCT00502801|592850718|FG000|Treatment Period|Death|14|||
164132861|NCT00502801|592850718|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
164132862|NCT00502801|592850718|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
164132863|NCT00502801|592850718|FG000|End of Therapy to Test of Cure|Death|3|||
164132864|NCT00502801|592850718|FG000|End of Therapy to Test of Cure|OTHER|2|||
164132865|NCT04135196|592850719|FG000|Overall Study|Lost to Follow-up|8|||
164132866|NCT04135196|592850720|FG001|Overall Study|Lost to Follow-up|7|||
164132867|NCT04135196|592850721|FG002|Overall Study|Lost to Follow-up|8|||
164132868|NCT04135196|592850722|FG003|Overall Study|Lost to Follow-up|9|||
164132869|NCT04135196|592850723|FG004|Overall Study|Lost to Follow-up|1|||
164132870|NCT04135196|592850719|FG000|Overall Study|Pregnancy|0|||
164132871|NCT04135196|592850720|FG001|Overall Study|Pregnancy|0|||
164132872|NCT04135196|592850721|FG002|Overall Study|Pregnancy|1|||
164132873|NCT04135196|592850722|FG003|Overall Study|Pregnancy|0|||
164132874|NCT04135196|592850723|FG004|Overall Study|Pregnancy|0|||
164132875|NCT04135196|592850719|FG000|Overall Study|Withdrawal by Subject|0|||
164132876|NCT04135196|592850720|FG001|Overall Study|Withdrawal by Subject|0|||
164132877|NCT04135196|592850721|FG002|Overall Study|Withdrawal by Subject|0|||
164132878|NCT04135196|592850722|FG003|Overall Study|Withdrawal by Subject|0|||
164132879|NCT04135196|592850723|FG004|Overall Study|Withdrawal by Subject|1|||
164132880|NCT02435836|592850727|FG000|Overall Study|Lost to Follow-up|21|||
164132881|NCT02435836|592850727|FG000|Overall Study|Lack of Efficacy|1|||
164132882|NCT02435836|592850727|FG000|Overall Study|Withdrawal by Subject|236|||
164132883|NCT02435836|592850727|FG000|Overall Study|Insufficient Clinical Response|26|||
164132884|NCT02435836|592850727|FG000|Overall Study|Adverse Event|44|||
164132885|NCT02435836|592850727|FG000|Overall Study|Sponsor discontinued trial|167|||
164132886|NCT02435836|592850727|FG000|Overall Study|Noncompliance|27|||
164132887|NCT02435836|592850727|FG000|Overall Study|Protocol Violation|6|||
164132888|NCT02435836|592850727|FG000|Overall Study|Met Withdrawal Criteria|7|||
164132889|NCT02435836|592850727|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
164132890|NCT01661179|592850730|FG000|Overall Study|Death|1|||
164132891|NCT01661179|592850730|FG000|Overall Study|Withdrawal by Subject|1|||
164132892|NCT01661179|592850730|FG000|Overall Study|Other Eligibility criteria|4|||
164132893|NCT01946191|592850731|FG000|Allocation|Did not complete orientation|1|||
164132894|NCT01946191|592850732|FG001|Allocation|Did not complete orientation|1|||
164132895|NCT01946191|592850731|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
164132896|NCT01946191|592850732|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
164132897|NCT01946191|592850731|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
164132898|NCT01946191|592850732|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
164132899|NCT01946191|592850731|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
164132900|NCT01946191|592850732|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
164132901|NCT03071094|592850739|FG000|Overall Study|Death|1|||
164132902|NCT03071094|592850740|FG001|Overall Study|Death|1|||
164132903|NCT03071094|592850739|FG000|Overall Study|Adverse Event|1|||
164132904|NCT03071094|592850740|FG001|Overall Study|Adverse Event|0|||
164132905|NCT04732221|592852589|FG000|Base Period|Death|2|||
164132906|NCT04732221|592852590|FG001|Base Period|Death|0|||
164132907|NCT04732221|592852591|FG002|Base Period|Death|0|||
164132908|NCT04732221|592852592|FG003|Base Period|Death|0|||
164132909|NCT04732221|592852593|FG004|Base Period|Death|0|||
164132910|NCT04732221|592852594|FG005|Base Period|Death|0|||
164132911|NCT04732221|592852595|FG006|Base Period|Death|0|||
164132912|NCT04732221|592852589|FG000|Base Period|Withdrawal by Subject|0|||
164132913|NCT04732221|592852590|FG001|Base Period|Withdrawal by Subject|1|||
164132914|NCT04732221|592852591|FG002|Base Period|Withdrawal by Subject|1|||
164132915|NCT04732221|592852592|FG003|Base Period|Withdrawal by Subject|0|||
164132916|NCT04732221|592852593|FG004|Base Period|Withdrawal by Subject|0|||
164132917|NCT04732221|592852594|FG005|Base Period|Withdrawal by Subject|0|||
164132918|NCT04732221|592852595|FG006|Base Period|Withdrawal by Subject|0|||
164132919|NCT04732221|592852589|FG000|Extension Period|Adverse Event|0|||
164132920|NCT04732221|592852590|FG001|Extension Period|Adverse Event|0|||
164132921|NCT04732221|592852591|FG002|Extension Period|Adverse Event|0|||
164132922|NCT04732221|592852592|FG003|Extension Period|Adverse Event|0|||
164132923|NCT04732221|592852593|FG004|Extension Period|Adverse Event|0|||
164132924|NCT04732221|592852594|FG005|Extension Period|Adverse Event|1|||
164132925|NCT04732221|592852595|FG006|Extension Period|Adverse Event|0|||
164132926|NCT04732221|592852589|FG000|Extension Period|Death|0|||
164132927|NCT04732221|592852590|FG001|Extension Period|Death|0|||
164132928|NCT04732221|592852591|FG002|Extension Period|Death|0|||
164132929|NCT04732221|592852592|FG003|Extension Period|Death|0|||
164132930|NCT04732221|592852593|FG004|Extension Period|Death|1|||
164132931|NCT04732221|592852594|FG005|Extension Period|Death|0|||
164132932|NCT04732221|592852595|FG006|Extension Period|Death|2|||
164132933|NCT04732221|592852589|FG000|Extension Period|Pregnancy|0|||
164132934|NCT04732221|592852590|FG001|Extension Period|Pregnancy|0|||
164132935|NCT04732221|592852591|FG002|Extension Period|Pregnancy|0|||
164132936|NCT04732221|592852592|FG003|Extension Period|Pregnancy|0|||
164132937|NCT04732221|592852593|FG004|Extension Period|Pregnancy|1|||
164132938|NCT04732221|592852594|FG005|Extension Period|Pregnancy|0|||
164132939|NCT04732221|592852595|FG006|Extension Period|Pregnancy|0|||
164132940|NCT04732221|592852589|FG000|Extension Period|Sponsors Decision|0|||
164132941|NCT04732221|592852590|FG001|Extension Period|Sponsors Decision|0|||
164132942|NCT04732221|592852591|FG002|Extension Period|Sponsors Decision|0|||
164132943|NCT04732221|592852592|FG003|Extension Period|Sponsors Decision|0|||
164132944|NCT04732221|592852593|FG004|Extension Period|Sponsors Decision|41|||
164132945|NCT04732221|592852594|FG005|Extension Period|Sponsors Decision|40|||
164132946|NCT04732221|592852595|FG006|Extension Period|Sponsors Decision|40|||
164132947|NCT04732221|592852589|FG000|Extension Period|Withdrawal by Subject|0|||
164132948|NCT04732221|592852590|FG001|Extension Period|Withdrawal by Subject|0|||
164132949|NCT04732221|592852591|FG002|Extension Period|Withdrawal by Subject|0|||
164132950|NCT04732221|592852592|FG003|Extension Period|Withdrawal by Subject|0|||
164132951|NCT04732221|592852593|FG004|Extension Period|Withdrawal by Subject|1|||
164132952|NCT04732221|592852594|FG005|Extension Period|Withdrawal by Subject|5|||
164132953|NCT04732221|592852595|FG006|Extension Period|Withdrawal by Subject|2|||
164132954|NCT04305587|592852598|FG000|Overall Study|Withdrawal by Subject|0|||
164132955|NCT04305587|592852599|FG001|Overall Study|Withdrawal by Subject|0|||
164132956|NCT04305587|592852600|FG002|Overall Study|Withdrawal by Subject|0|||
164132957|NCT04305587|592852601|FG003|Overall Study|Withdrawal by Subject|1|||
164132958|NCT04305587|592852602|FG004|Overall Study|Withdrawal by Subject|0|||
164132959|NCT04305587|592852603|FG005|Overall Study|Withdrawal by Subject|0|||
164132960|NCT04305587|592852604|FG006|Overall Study|Withdrawal by Subject|0|||
164132961|NCT04305587|592852605|FG007|Overall Study|Withdrawal by Subject|0|||
164132962|NCT04305587|592852606|FG008|Overall Study|Withdrawal by Subject|0|||
164132963|NCT00824616|592852607|FG000|Overall Study|Adverse Event|2|||
164132964|NCT00824616|592852608|FG001|Overall Study|Adverse Event|1|||
164132965|NCT00824616|592852607|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
164132966|NCT00824616|592852608|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
164132967|NCT00824616|592852607|FG000|Overall Study|Hyperglycemia|1|||
164132968|NCT00824616|592852608|FG001|Overall Study|Hyperglycemia|1|||
164132969|NCT00824616|592852607|FG000|Overall Study|Lack of Efficacy|2|||
164132970|NCT00824616|592852608|FG001|Overall Study|Lack of Efficacy|1|||
164132971|NCT00824616|592852607|FG000|Overall Study|Lost to Follow-up|0|||
164132972|NCT00824616|592852608|FG001|Overall Study|Lost to Follow-up|1|||
164132973|NCT00824616|592852607|FG000|Overall Study|Withdrawal by Subject|1|||
164132974|NCT00824616|592852608|FG001|Overall Study|Withdrawal by Subject|1|||
164132975|NCT01200992|592852609|FG000|Overall Study|Study terminated early|35|||
164132976|NCT01200992|592852610|FG001|Overall Study|Study terminated early|41|||
164132977|NCT01200992|592852609|FG000|Overall Study|Randomized but not treated|2|||
164132978|NCT01200992|592852610|FG001|Overall Study|Randomized but not treated|0|||
164132979|NCT01783548|592852618|FG000|Overall Study|Adverse Event|8|||
164132980|NCT01783548|592852619|FG001|Overall Study|Adverse Event|4|||
164132981|NCT01783548|592852618|FG000|Overall Study|Withdrawal by Subject|11|||
164132982|NCT01783548|592852619|FG001|Overall Study|Withdrawal by Subject|8|||
164132983|NCT01783548|592852618|FG000|Overall Study|Non-compliance|4|||
164132984|NCT01783548|592852619|FG001|Overall Study|Non-compliance|0|||
164132985|NCT01783548|592852618|FG000|Overall Study|Protocol Violation|2|||
164132986|NCT01783548|592852619|FG001|Overall Study|Protocol Violation|2|||
164132987|NCT01783548|592852618|FG000|Overall Study|Lost to Follow-up|8|||
164132988|NCT01783548|592852619|FG001|Overall Study|Lost to Follow-up|3|||
164132989|NCT01783548|592852618|FG000|Overall Study|Lack of Efficacy|1|||
164132990|NCT01783548|592852619|FG001|Overall Study|Lack of Efficacy|1|||
164132991|NCT04645966|592852620|FG000|Vaccination Phase|Adverse Event|1|||
164132992|NCT04645966|592852621|FG001|Vaccination Phase|Adverse Event|0|||
164132993|NCT04645966|592852622|FG002|Vaccination Phase|Adverse Event|0|||
164132994|NCT04645966|592852623|FG003|Vaccination Phase|Adverse Event|0|||
164132995|NCT04645966|592852624|FG004|Vaccination Phase|Adverse Event|0|||
164132996|NCT04645966|592852625|FG005|Vaccination Phase|Adverse Event|0|||
164132997|NCT04645966|592852626|FG006|Vaccination Phase|Adverse Event|1|||
164132998|NCT04645966|592852627|FG007|Vaccination Phase|Adverse Event|0|||
164132999|NCT04645966|592852628|FG008|Vaccination Phase|Adverse Event|0|||
164133000|NCT04645966|592852620|FG000|Vaccination Phase|Death|0|||
164133001|NCT04645966|592852621|FG001|Vaccination Phase|Death|0|||
164133002|NCT04645966|592852622|FG002|Vaccination Phase|Death|0|||
164133003|NCT04645966|592852623|FG003|Vaccination Phase|Death|0|||
164133004|NCT04645966|592852624|FG004|Vaccination Phase|Death|0|||
164133005|NCT04645966|592852625|FG005|Vaccination Phase|Death|1|||
164133006|NCT04645966|592852626|FG006|Vaccination Phase|Death|0|||
164133007|NCT04645966|592852627|FG007|Vaccination Phase|Death|0|||
164133008|NCT04645966|592852628|FG008|Vaccination Phase|Death|0|||
164133009|NCT04645966|592852620|FG000|Vaccination Phase|Protocol Violation|0|||
164133010|NCT04645966|592852621|FG001|Vaccination Phase|Protocol Violation|0|||
164133011|NCT04645966|592852622|FG002|Vaccination Phase|Protocol Violation|0|||
164133012|NCT04645966|592852623|FG003|Vaccination Phase|Protocol Violation|0|||
164133013|NCT04645966|592852624|FG004|Vaccination Phase|Protocol Violation|1|||
164133014|NCT04645966|592852625|FG005|Vaccination Phase|Protocol Violation|0|||
164133015|NCT04645966|592852626|FG006|Vaccination Phase|Protocol Violation|0|||
164133016|NCT04645966|592852627|FG007|Vaccination Phase|Protocol Violation|0|||
164133017|NCT04645966|592852628|FG008|Vaccination Phase|Protocol Violation|0|||
164133018|NCT04645966|592852620|FG000|Vaccination Phase|Study terminated by sponsor|0|||
164133019|NCT04645966|592852621|FG001|Vaccination Phase|Study terminated by sponsor|0|||
164133020|NCT04645966|592852622|FG002|Vaccination Phase|Study terminated by sponsor|14|||
164133021|NCT04645966|592852623|FG003|Vaccination Phase|Study terminated by sponsor|15|||
164133022|NCT04645966|592852624|FG004|Vaccination Phase|Study terminated by sponsor|47|||
164133023|NCT04645966|592852625|FG005|Vaccination Phase|Study terminated by sponsor|43|||
164133024|NCT04645966|592852626|FG006|Vaccination Phase|Study terminated by sponsor|29|||
164133025|NCT04645966|592852627|FG007|Vaccination Phase|Study terminated by sponsor|29|||
164133026|NCT04645966|592852628|FG008|Vaccination Phase|Study terminated by sponsor|12|||
164133027|NCT04645966|592852620|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
164133028|NCT04645966|592852621|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
164133029|NCT04645966|592852622|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
164133030|NCT04645966|592852623|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
164133031|NCT04645966|592852624|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
164133032|NCT04645966|592852625|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
164133033|NCT04645966|592852626|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
164133034|NCT04645966|592852627|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
164133035|NCT04645966|592852628|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
164133036|NCT04645966|592852620|FG000|Vaccination Phase|Other|0|||
164133037|NCT04645966|592852621|FG001|Vaccination Phase|Other|0|||
164133038|NCT04645966|592852622|FG002|Vaccination Phase|Other|0|||
164133039|NCT04645966|592852623|FG003|Vaccination Phase|Other|0|||
164133040|NCT04645966|592852624|FG004|Vaccination Phase|Other|0|||
164133041|NCT04645966|592852625|FG005|Vaccination Phase|Other|2|||
164133042|NCT04645966|592852626|FG006|Vaccination Phase|Other|0|||
164133043|NCT04645966|592852627|FG007|Vaccination Phase|Other|0|||
164133044|NCT04645966|592852628|FG008|Vaccination Phase|Other|0|||
164133045|NCT04645966|592852620|FG000|Vaccination Phase|Lost to Follow-up|0|||
164133046|NCT04645966|592852621|FG001|Vaccination Phase|Lost to Follow-up|0|||
164133047|NCT04645966|592852622|FG002|Vaccination Phase|Lost to Follow-up|0|||
164133048|NCT04645966|592852623|FG003|Vaccination Phase|Lost to Follow-up|0|||
164133049|NCT04645966|592852624|FG004|Vaccination Phase|Lost to Follow-up|0|||
164133050|NCT04645966|592852625|FG005|Vaccination Phase|Lost to Follow-up|0|||
164133051|NCT04645966|592852626|FG006|Vaccination Phase|Lost to Follow-up|0|||
164133052|NCT04645966|592852627|FG007|Vaccination Phase|Lost to Follow-up|1|||
164133053|NCT04645966|592852628|FG008|Vaccination Phase|Lost to Follow-up|0|||
164133054|NCT04645966|592852620|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
164133055|NCT04645966|592852621|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
164133056|NCT04645966|592852622|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
164133057|NCT04645966|592852623|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
164133058|NCT04645966|592852624|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
164133059|NCT04645966|592852625|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
164133060|NCT04645966|592852626|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
164133061|NCT04645966|592852627|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
164133062|NCT04645966|592852628|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
164133063|NCT04645966|592852620|FG000|Follow-up Phase|Lost to Follow-up|0|||
164133064|NCT04645966|592852621|FG001|Follow-up Phase|Lost to Follow-up|0|||
164133065|NCT04645966|592852622|FG002|Follow-up Phase|Lost to Follow-up|0|||
164133066|NCT04645966|592852623|FG003|Follow-up Phase|Lost to Follow-up|0|||
164133067|NCT04645966|592852624|FG004|Follow-up Phase|Lost to Follow-up|0|||
164133068|NCT04645966|592852625|FG005|Follow-up Phase|Lost to Follow-up|0|||
164133069|NCT04645966|592852626|FG006|Follow-up Phase|Lost to Follow-up|0|||
164133070|NCT04645966|592852627|FG007|Follow-up Phase|Lost to Follow-up|1|||
164133071|NCT04645966|592852628|FG008|Follow-up Phase|Lost to Follow-up|0|||
164133072|NCT00552578|592852632|FG000|Overall Study|Lost to Follow-up|1|||
164133073|NCT00552578|592852633|FG001|Overall Study|Lost to Follow-up|1|||
164133074|NCT04729309|592852636|FG000|Period 1|Subject unable to return for Period 2|3|||
164133075|NCT04729309|592852637|FG001|Period 1|Subject unable to return for Period 2|0|||
164133076|NCT04729309|592852636|FG000|Period 1|Lost to Follow-up|1|||
164133077|NCT04729309|592852637|FG001|Period 1|Lost to Follow-up|0|||
164133078|NCT01059539|592852638|FG000|Overall Study|Adverse Event|66|||
164133079|NCT01059539|592852638|FG000|Overall Study|Insufficient Therapeutic Response|26|||
164133080|NCT01059539|592852638|FG000|Overall Study|Protocol Violation|55|||
164133081|NCT01059539|592852638|FG000|Overall Study|Withdrawal of Consent|80|||
164133082|NCT01059539|592852638|FG000|Overall Study|Lost to Follow-up|42|||
164133083|NCT01059539|592852638|FG000|Overall Study|Reason Not Specified|2|||
164133084|NCT04091659|592852642|FG000|Overall Study|Protocol Violation|3|||
164133085|NCT04091659|592852643|FG001|Overall Study|Protocol Violation|0|||
164133086|NCT04091659|592852642|FG000|Overall Study|Lost to Follow-up|0|||
164133087|NCT04091659|592852643|FG001|Overall Study|Lost to Follow-up|1|||
164133088|NCT00616629|592852650|FG000|Overall Study|Protocol Violation|1|||
164133089|NCT00616629|592852651|FG001|Overall Study|Protocol Violation|2|||
164133090|NCT00616629|592852652|FG002|Overall Study|Protocol Violation|1|||
164133091|NCT00616629|592852653|FG003|Overall Study|Protocol Violation|0|||
164133092|NCT00616629|592852654|FG004|Overall Study|Protocol Violation|0|||
164133093|NCT00616629|592852650|FG000|Overall Study|AV-block|1|||
164133094|NCT00616629|592852651|FG001|Overall Study|AV-block|0|||
164133095|NCT00616629|592852652|FG002|Overall Study|AV-block|0|||
164133104|NCT01447420|592852655|FG000|Overall Study|Withdrawal by Subject|4|||
164133105|NCT01447420|592852656|FG001|Overall Study|Withdrawal by Subject|1|||
164133106|NCT01447420|592852657|FG002|Overall Study|Withdrawal by Subject|0|||
164133107|NCT01447420|592852655|FG000|Overall Study|Lack of Efficacy|1|||
164133108|NCT01447420|592852656|FG001|Overall Study|Lack of Efficacy|19|||
164133109|NCT01447420|592852657|FG002|Overall Study|Lack of Efficacy|8|||
164133110|NCT04015908|592852661|FG000|Overall Study|Lost to Follow-up|0|||
164133111|NCT04015908|592852662|FG001|Overall Study|Lost to Follow-up|1|||
164133112|NCT01715571|592852663|FG000|Overall Study|Lost to Follow-up|8|||
164133113|NCT03569228|592852669|FG000|Overall Study|Withdrawal by PI|0|||
164133114|NCT03569228|592852670|FG001|Overall Study|Withdrawal by PI|0|||
164133115|NCT03569228|592852671|FG002|Overall Study|Withdrawal by PI|2|||
164133116|NCT03569228|592852672|FG003|Overall Study|Withdrawal by PI|2|||
164133117|NCT03569228|592852673|FG004|Overall Study|Withdrawal by PI|1|||
164133118|NCT03569228|592852674|FG005|Overall Study|Withdrawal by PI|0|||
164133119|NCT03569228|592852675|FG006|Overall Study|Withdrawal by PI|0|||
164133120|NCT03569228|592852676|FG007|Overall Study|Withdrawal by PI|0|||
164133121|NCT03569228|592852677|FG008|Overall Study|Withdrawal by PI|0|||
164133122|NCT03569228|592852669|FG000|Overall Study|Lost to Follow-up|0|||
164133123|NCT03569228|592852670|FG001|Overall Study|Lost to Follow-up|0|||
164133124|NCT03569228|592852671|FG002|Overall Study|Lost to Follow-up|0|||
164133125|NCT03569228|592852672|FG003|Overall Study|Lost to Follow-up|0|||
164133126|NCT03569228|592852673|FG004|Overall Study|Lost to Follow-up|0|||
164133127|NCT03569228|592852674|FG005|Overall Study|Lost to Follow-up|0|||
164133128|NCT03569228|592852675|FG006|Overall Study|Lost to Follow-up|0|||
164133129|NCT03569228|592852676|FG007|Overall Study|Lost to Follow-up|0|||
164133130|NCT03569228|592852677|FG008|Overall Study|Lost to Follow-up|1|||
164133131|NCT03569228|592852669|FG000|Overall Study|Screen Fail|2|||
164133132|NCT03569228|592852670|FG001|Overall Study|Screen Fail|2|||
164133133|NCT03569228|592852671|FG002|Overall Study|Screen Fail|1|||
164133134|NCT03569228|592852672|FG003|Overall Study|Screen Fail|1|||
164133135|NCT03569228|592852673|FG004|Overall Study|Screen Fail|1|||
164133136|NCT03569228|592852674|FG005|Overall Study|Screen Fail|3|||
164133137|NCT03569228|592852675|FG006|Overall Study|Screen Fail|1|||
164133138|NCT03569228|592852676|FG007|Overall Study|Screen Fail|5|||
164133139|NCT03569228|592852677|FG008|Overall Study|Screen Fail|2|||
164133140|NCT05442866|592852678|FG000|Overall Study|Death|1|||
164133141|NCT05442866|592852678|FG000|Overall Study|Lost to Follow-up|9|||
164133142|NCT05442866|592852678|FG000|Overall Study|Protocol Violation|1|||
164133143|NCT01584843|592852691|FG000|First Treatment Period|Adverse Event|0|||
164133144|NCT01584843|592852692|FG001|First Treatment Period|Adverse Event|0|||
164133145|NCT01584843|592852693|FG002|First Treatment Period|Adverse Event|1|||
164133146|NCT01584843|592852694|FG003|First Treatment Period|Adverse Event|0|||
164133147|NCT01584843|592852695|FG004|First Treatment Period|Adverse Event|0|||
164133148|NCT01584843|592852696|FG005|First Treatment Period|Adverse Event|0|||
164133149|NCT01584843|592852691|FG000|First Treatment Period|Protocol Violation|0|||
164133150|NCT01584843|592852692|FG001|First Treatment Period|Protocol Violation|0|||
164133151|NCT01584843|592852693|FG002|First Treatment Period|Protocol Violation|0|||
164133152|NCT01584843|592852694|FG003|First Treatment Period|Protocol Violation|0|||
164133153|NCT01584843|592852695|FG004|First Treatment Period|Protocol Violation|0|||
164133154|NCT01584843|592852696|FG005|First Treatment Period|Protocol Violation|1|||
164133155|NCT01584843|592852691|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164133156|NCT01584843|592852692|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164133157|NCT01584843|592852693|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164133158|NCT01584843|592852694|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164133159|NCT01584843|592852695|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
164133160|NCT01584843|592852696|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
164133161|NCT01584843|592852691|FG000|Second Treatment Period|Withdrawal by Subject|0|||
164133162|NCT01584843|592852692|FG001|Second Treatment Period|Withdrawal by Subject|0|||
164133163|NCT01584843|592852693|FG002|Second Treatment Period|Withdrawal by Subject|0|||
164133164|NCT01584843|592852694|FG003|Second Treatment Period|Withdrawal by Subject|0|||
164133165|NCT01584843|592852695|FG004|Second Treatment Period|Withdrawal by Subject|0|||
164133166|NCT01584843|592852696|FG005|Second Treatment Period|Withdrawal by Subject|1|||
164133167|NCT04126213|592852699|FG000|Overall Study|Lost to Follow-up|9|||
164133168|NCT04126213|592852700|FG001|Overall Study|Lost to Follow-up|1|||
164133169|NCT04126213|592852701|FG002|Overall Study|Lost to Follow-up|5|||
164133170|NCT04126213|592852702|FG003|Overall Study|Lost to Follow-up|10|||
164133171|NCT04126213|592852703|FG004|Overall Study|Lost to Follow-up|4|||
164133172|NCT04126213|592852704|FG005|Overall Study|Lost to Follow-up|7|||
164133173|NCT04126213|592852699|FG000|Overall Study|Withdrawal by Subject|3|||
164133174|NCT04126213|592852700|FG001|Overall Study|Withdrawal by Subject|2|||
164133175|NCT04126213|592852701|FG002|Overall Study|Withdrawal by Subject|1|||
164133176|NCT04126213|592852702|FG003|Overall Study|Withdrawal by Subject|1|||
164133177|NCT04126213|592852703|FG004|Overall Study|Withdrawal by Subject|1|||
164133178|NCT04126213|592852704|FG005|Overall Study|Withdrawal by Subject|1|||
164133179|NCT04126213|592852699|FG000|Overall Study|Other|0|||
164133180|NCT04126213|592852700|FG001|Overall Study|Other|0|||
164133181|NCT04126213|592852701|FG002|Overall Study|Other|2|||
164133185|NCT04126213|592852699|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164133186|NCT04126213|592852700|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164133187|NCT04126213|592852701|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164133188|NCT04126213|592852702|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164133189|NCT04126213|592852703|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164133190|NCT04126213|592852704|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164133191|NCT02853370|592852706|FG000|Overall Study|Physician Decision|1|||
164133192|NCT02853370|592852706|FG000|Overall Study|Lack of Efficacy|2|||
164133193|NCT02853370|592852706|FG000|Overall Study|Death|1|||
164133194|NCT02853370|592852706|FG000|Overall Study|Adverse Event|4|||
164133195|NCT02853370|592852706|FG000|Overall Study|Withdrawal by Subject|3|||
164133196|NCT00643565|592852708|FG000|Overall Study|Death|12|||
164133197|NCT00643565|592852709|FG001|Overall Study|Death|11|||
164133198|NCT00643565|592852708|FG000|Overall Study|Withdrawal by Subject|4|||
164133199|NCT00643565|592852709|FG001|Overall Study|Withdrawal by Subject|1|||
164133200|NCT00643565|592852708|FG000|Overall Study|Lost to Follow-up|0|||
164133201|NCT00643565|592852709|FG001|Overall Study|Lost to Follow-up|6|||
164133202|NCT00643565|592852708|FG000|Overall Study|Other|7|||
164133203|NCT00643565|592852709|FG001|Overall Study|Other|8|||
164133204|NCT00643565|592852708|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
164133205|NCT00643565|592852709|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
164133206|NCT00643565|592852708|FG000|Overall Study|Recurrence of Disease|2|||
164133207|NCT00643565|592852709|FG001|Overall Study|Recurrence of Disease|1|||
164133208|NCT00643565|592852708|FG000|Overall Study|Progression of Disease|18|||
164133209|NCT00643565|592852709|FG001|Overall Study|Progression of Disease|14|||
164133210|NCT00643565|592852708|FG000|Overall Study|Protocol Violation|3|||
164133211|NCT00643565|592852709|FG001|Overall Study|Protocol Violation|0|||
164133212|NCT00643565|592852708|FG000|Overall Study|Did Not Cooperate|0|||
164133213|NCT00643565|592852709|FG001|Overall Study|Did Not Cooperate|1|||
164133214|NCT00643565|592852708|FG000|Overall Study|Administrative|22|||
164133215|NCT00643565|592852709|FG001|Overall Study|Administrative|16|||
164133216|NCT00643565|592852708|FG000|Overall Study|Adverse Event|5|||
164133217|NCT00643565|592852709|FG001|Overall Study|Adverse Event|8|||
164133218|NCT02317614|592852710|FG000|Overall Study|Lost to Follow-up|1|||
164133219|NCT02317614|592852711|FG001|Overall Study|Lost to Follow-up|1|||
164133220|NCT02317614|592852710|FG000|Overall Study|Withdrawal by Subject|1|||
164133221|NCT02317614|592852711|FG001|Overall Study|Withdrawal by Subject|0|||
164133222|NCT02317614|592852710|FG000|Overall Study|Death|1|||
164133223|NCT02317614|592852711|FG001|Overall Study|Death|1|||
164133224|NCT03285308|592852714|FG000|Overall Study|Adverse Event|3|||
164133225|NCT03285308|592852715|FG001|Overall Study|Adverse Event|7|||
164133226|NCT03285308|592852714|FG000|Overall Study|Withdrawal by Subject|8|||
164133227|NCT03285308|592852715|FG001|Overall Study|Withdrawal by Subject|9|||
164133228|NCT03285308|592852714|FG000|Overall Study|Lost to Follow-up|3|||
164133229|NCT03285308|592852715|FG001|Overall Study|Lost to Follow-up|1|||
164133230|NCT03285308|592852714|FG000|Overall Study|Protocol Deviation|6|||
164133231|NCT03285308|592852715|FG001|Overall Study|Protocol Deviation|5|||
164133232|NCT03285308|592852714|FG000|Overall Study|Reason not Specified|0|||
164133233|NCT03285308|592852715|FG001|Overall Study|Reason not Specified|1|||
164133234|NCT03283761|592852716|FG000|Study Treatment|Patient Non-Compliance|1|||
164133235|NCT03283761|592852716|FG000|Study Treatment|Alternative Cancer Therapy|7|||
164133236|NCT03283761|592852716|FG000|Study Treatment|Disease progression|21|||
164133237|NCT03283761|592852716|FG000|Study Treatment|Adverse Event|3|||
164133238|NCT03283761|592852716|FG000|Study Treatment|Withdrawal by Subject|4|||
164133239|NCT03283761|592852716|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
164133240|NCT03283761|592852716|FG000|Study Treatment|Symptomatic Deterioration|1|||
164133241|NCT03283761|592852716|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
164133242|NCT03283761|592852716|FG000|Follow up|Lost to Follow-up|1|||
164133243|NCT03283761|592852716|FG000|Follow up|Symptomatic Deterioration|1|||
164133244|NCT03283761|592852716|FG000|Follow up|Death|29|||
164133245|NCT03283761|592852716|FG000|Follow up|study terminated|4|||
164133246|NCT03283761|592852716|FG000|Follow up|Primary Investigator Withdrawal|1|||
164133247|NCT03283761|592852716|FG000|Follow up|Switched to alternative therapy|1|||
164133248|NCT03283761|592852716|FG000|Follow up|Subject is now in Hospice|1|||
164133249|NCT02283983|592852717|FG000|Overall Study|Inclusion criteria not met|0|||
164133250|NCT02283983|592852718|FG001|Overall Study|Inclusion criteria not met|1|||
164133251|NCT02283983|592852717|FG000|Overall Study|Withdrawal by Subject|4|||
164133252|NCT02283983|592852718|FG001|Overall Study|Withdrawal by Subject|2|||
164133253|NCT02283983|592852717|FG000|Overall Study|Protocol Violation|0|||
164133254|NCT02283983|592852718|FG001|Overall Study|Protocol Violation|4|||
164133255|NCT02283983|592852717|FG000|Overall Study|Physician Decision|2|||
164133256|NCT02283983|592852718|FG001|Overall Study|Physician Decision|4|||
164133257|NCT02283983|592852717|FG000|Overall Study|Death|1|||
164133258|NCT02283983|592852718|FG001|Overall Study|Death|0|||
164133259|NCT02283983|592852717|FG000|Overall Study|Adverse Event|1|||
164133260|NCT02283983|592852718|FG001|Overall Study|Adverse Event|0|||
164133261|NCT02283983|592852717|FG000|Overall Study|Lost to Follow-up|9|||
164133265|NCT03275064|592852719|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164133266|NCT03275064|592852720|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164133267|NCT03275064|592852721|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164133268|NCT03275064|592852722|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
164133269|NCT03275064|592852723|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
164133270|NCT03275064|592852719|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
164133271|NCT03275064|592852720|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164133272|NCT03275064|592852721|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164133273|NCT03275064|592852722|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164133274|NCT03275064|592852723|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
164133275|NCT03275064|592852719|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
164133276|NCT03275064|592852720|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
164133277|NCT03275064|592852721|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
164133278|NCT03275064|592852722|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
164133279|NCT03275064|592852723|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
164133280|NCT03275064|592852719|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164133281|NCT03275064|592852720|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164133282|NCT03275064|592852721|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164133283|NCT03275064|592852722|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
164133284|NCT03275064|592852723|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
164133285|NCT03275064|592852719|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
164133286|NCT03275064|592852720|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
164133287|NCT03275064|592852721|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
164133288|NCT03275064|592852722|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
164133289|NCT03275064|592852723|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
164133290|NCT00620555|592852726|FG000|Overall Study|Adverse Event|4|||
164133291|NCT00620555|592852726|FG000|Overall Study|Protocol Violation|2|||
164133292|NCT00620555|592852726|FG000|Overall Study|Lack of Efficacy|12|||
164133293|NCT00620555|592852726|FG000|Overall Study|Withdrawal by Subject|1|||
164133294|NCT00620555|592852726|FG000|Overall Study|Choice of other treatment|1|||
164133295|NCT00620555|592852726|FG000|Overall Study|Visit failure against planned|1|||
164133296|NCT00669071|592852728|FG000|Overall Study|Lost to Follow-up|3|||
164133297|NCT00669071|592852728|FG000|Overall Study|Final visit 40 days out of window|1|||
164133298|NCT04305496|592852729|FG000|Global Cohort|Withdrawal by Subject|13|||
164133299|NCT04305496|592852730|FG001|Global Cohort|Withdrawal by Subject|6|||
164133300|NCT04305496|592852729|FG000|Global Cohort|Physician Decision|1|||
164133301|NCT04305496|592852730|FG001|Global Cohort|Physician Decision|1|||
164133302|NCT04305496|592852729|FG000|Global Cohort|Subjective disease progression|16|||
164133303|NCT04305496|592852730|FG001|Global Cohort|Subjective disease progression|17|||
164133304|NCT04305496|592852729|FG000|Global Cohort|Condition under investigation worsened|209|||
164133305|NCT04305496|592852730|FG001|Global Cohort|Condition under investigation worsened|273|||
164133306|NCT04305496|592852729|FG000|Global Cohort|Protocol Violation|2|||
164133307|NCT04305496|592852730|FG001|Global Cohort|Protocol Violation|0|||
164133308|NCT04305496|592852729|FG000|Global Cohort|Adverse Event|44|||
164133309|NCT04305496|592852730|FG001|Global Cohort|Adverse Event|6|||
164133310|NCT04305496|592852729|FG000|Global Cohort|Death|3|||
164133311|NCT04305496|592852730|FG001|Global Cohort|Death|2|||
164133312|NCT04305496|592852729|FG000|Global Cohort|Any reason not specifically recorded|4|||
164133313|NCT04305496|592852730|FG001|Global Cohort|Any reason not specifically recorded|5|||
164133314|NCT04305496|592852729|FG000|China Cohort|Any reason not specifically recorded|1|||
164133315|NCT04305496|592852730|FG001|China Cohort|Any reason not specifically recorded|1|||
164133316|NCT04305496|592852729|FG000|China Cohort|Adverse Event|8|||
164133317|NCT04305496|592852730|FG001|China Cohort|Adverse Event|2|||
164133318|NCT04305496|592852729|FG000|China Cohort|Condition under investigation worsened|40|||
164133319|NCT04305496|592852730|FG001|China Cohort|Condition under investigation worsened|47|||
164133320|NCT04305496|592852729|FG000|China Cohort|Subjective disease progression|2|||
164133321|NCT04305496|592852730|FG001|China Cohort|Subjective disease progression|2|||
164133322|NCT04305496|592852729|FG000|China Cohort|Withdrawal by Subject|2|||
164133323|NCT04305496|592852730|FG001|China Cohort|Withdrawal by Subject|1|||
164133324|NCT01910389|592852732|FG000|Overall Study|Withdrawal by Subject|2|||
164133325|NCT01910389|592852733|FG001|Overall Study|Withdrawal by Subject|0|||
164133326|NCT01910389|592852732|FG000|Overall Study|Study Closed|13|||
164133327|NCT01910389|592852733|FG001|Overall Study|Study Closed|8|||
164133328|NCT02912650|592852735|FG000|Overall Study|Withdrawal by Subject|1|||
164133329|NCT02912650|592852736|FG001|Overall Study|Withdrawal by Subject|0|||
164133330|NCT02912650|592852737|FG002|Overall Study|Withdrawal by Subject|1|||
164133331|NCT02912650|592852738|FG003|Overall Study|Withdrawal by Subject|5|||
164133336|NCT01898650|592852739|FG000|Overall Study|the subject would not lie still for imaging|1|||
164133337|NCT05896202|592852742|FG000|Overall Study|Lost to Follow-up|2|||
164133338|NCT05896202|592852743|FG001|Overall Study|Lost to Follow-up|2|||
164133339|NCT02357342|592852744|FG000|First 6 Months|Death|2|||
164133340|NCT02357342|592852745|FG001|First 6 Months|Death|0|||
164133341|NCT01674647|592852746|FG000|Treatment Period|Death|4|||
164133342|NCT01674647|592852747|FG001|Treatment Period|Death|1|||
164133343|NCT01674647|592852746|FG000|Treatment Period|Efficacy outcome reached|0|||
164133344|NCT01674647|592852747|FG001|Treatment Period|Efficacy outcome reached|1|||
164133345|NCT01674647|592852746|FG000|Treatment Period|Physician Decision|3|||
164133346|NCT01674647|592852747|FG001|Treatment Period|Physician Decision|1|||
164133347|NCT01674647|592852746|FG000|Treatment Period|Adverse Event|60|||
164133348|NCT01674647|592852747|FG001|Treatment Period|Adverse Event|22|||
164133349|NCT01674647|592852746|FG000|Treatment Period|Non-compliance with study drug|3|||
164133350|NCT01674647|592852747|FG001|Treatment Period|Non-compliance with study drug|0|||
164133351|NCT01674647|592852746|FG000|Treatment Period|Lost to Follow-up|1|||
164133352|NCT01674647|592852747|FG001|Treatment Period|Lost to Follow-up|1|||
164133353|NCT01674647|592852746|FG000|Treatment Period|Withdrawal by Subject|19|||
164133354|NCT01674647|592852747|FG001|Treatment Period|Withdrawal by Subject|16|||
164133355|NCT01674647|592852746|FG000|Treatment Period|Switching to other therapy|5|||
164133356|NCT01674647|592852747|FG001|Treatment Period|Switching to other therapy|2|||
164133357|NCT01674647|592852746|FG000|Treatment Period|Logistical difficulties|5|||
164133358|NCT01674647|592852747|FG001|Treatment Period|Logistical difficulties|8|||
164133359|NCT01674647|592852746|FG000|Treatment Period|Treatment failure|0|||
164133360|NCT01674647|592852747|FG001|Treatment Period|Treatment failure|14|||
164133361|NCT01674647|592852746|FG000|Treatment Period|Protocol Violation|56|||
164133362|NCT01674647|592852747|FG001|Treatment Period|Protocol Violation|36|||
164133363|NCT01674647|592852746|FG000|30-day Safety Follow-up Period|Death|3|||
164133364|NCT01674647|592852747|FG001|30-day Safety Follow-up Period|Death|2|||
164133365|NCT01674647|592852746|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
164133366|NCT01674647|592852747|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
164133367|NCT01674647|592852746|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
164133368|NCT01674647|592852747|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
164133369|NCT01674647|592852746|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
164133370|NCT01674647|592852747|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
164133371|NCT01674647|592852746|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
164133372|NCT01674647|592852747|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
164133373|NCT01674647|592852746|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
164133374|NCT01674647|592852747|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
164133375|NCT01490866|592852750|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
164133376|NCT01490866|592852750|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
164133377|NCT01490866|592852750|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
164133378|NCT01490866|592852750|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
164133379|NCT01490866|592852750|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
164133380|NCT01490866|592852750|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
164133381|NCT01490866|592852750|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
164133382|NCT01490866|592852750|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
164133383|NCT01490866|592852750|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
164133384|NCT01490866|592852750|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
164133385|NCT01490866|592852750|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
164133386|NCT03923530|592852751|FG000|Overall Study|Withdrawal by Subject|1|||
164133387|NCT03923530|592852751|FG000|Overall Study|screen failure|3|||
164133388|NCT00741936|592852752|FG000|Overall Study|Lost to Follow-up|1|||
164133389|NCT00741936|592852753|FG001|Overall Study|Lost to Follow-up|1|||
164133390|NCT00741936|592852752|FG000|Overall Study|Adverse Event|3|||
164133391|NCT00741936|592852753|FG001|Overall Study|Adverse Event|4|||
164133392|NCT00741936|592852752|FG000|Overall Study|Pregnancy|0|||
164133393|NCT00741936|592852753|FG001|Overall Study|Pregnancy|1|||
164133394|NCT00741936|592852752|FG000|Overall Study|Protocol Violation|2|||
164133395|NCT00741936|592852753|FG001|Overall Study|Protocol Violation|0|||
164133396|NCT00741936|592852752|FG000|Overall Study|Lack of Efficacy|0|||
164133397|NCT00741936|592852753|FG001|Overall Study|Lack of Efficacy|2|||
164133398|NCT00741936|592852752|FG000|Overall Study|Low compliance|3|||
164133399|NCT00741936|592852753|FG001|Overall Study|Low compliance|0|||
164133400|NCT01941940|592852754|FG000|Overall Study|Adverse Event|11|||
164133401|NCT01941940|592852754|FG000|Overall Study|Lost to Follow-up|2|||
164133402|NCT01941940|592852754|FG000|Overall Study|Physician Decision|2|||
164133403|NCT01941940|592852754|FG000|Overall Study|Withdrawal by Subject|15|||
164133404|NCT01941940|592852754|FG000|Overall Study|Death|1|||
164133405|NCT01941940|592852754|FG000|Overall Study|Other|1|||
164133406|NCT01941940|592852754|FG000|Overall Study|Other|1|||
164133407|NCT03212521|592852755|FG000|Overall Study|Adverse Event|1|||
164133408|NCT03212521|592852755|FG000|Overall Study|Lost to Follow-up|4|||
164133409|NCT03212521|592852755|FG000|Overall Study|Withdrawal by Subject|1|||
164133410|NCT03212521|592852755|FG000|Overall Study|Other|1|||
164133413|NCT00914459|592852756|FG000|Overall Study|Parent/Legal guardian request|1|||
164133414|NCT00914459|592852757|FG001|Overall Study|Parent/Legal guardian request|0|||
164133415|NCT03176459|592852758|FG000|Overall Study|Lost to Follow-up|5|||
164133416|NCT03176459|592852759|FG001|Overall Study|Lost to Follow-up|7|||
164133417|NCT01083810|592852760|FG000|Overall Study|Lost to Follow-up|23|||
164133418|NCT01083810|592852761|FG001|Overall Study|Lost to Follow-up|11|||
164133419|NCT01083810|592852762|FG002|Overall Study|Lost to Follow-up|4|||
164133420|NCT01083810|592852760|FG000|Overall Study|Adverse Event|15|||
164133421|NCT01083810|592852761|FG001|Overall Study|Adverse Event|11|||
164133422|NCT01083810|592852762|FG002|Overall Study|Adverse Event|4|||
164133423|NCT01083810|592852760|FG000|Overall Study|Withdrawal by Subject|7|||
164133424|NCT01083810|592852761|FG001|Overall Study|Withdrawal by Subject|2|||
164133425|NCT01083810|592852762|FG002|Overall Study|Withdrawal by Subject|4|||
164133426|NCT01083810|592852760|FG000|Overall Study|Reason not reported|6|||
164133427|NCT01083810|592852761|FG001|Overall Study|Reason not reported|1|||
164133428|NCT01083810|592852762|FG002|Overall Study|Reason not reported|1|||
164133429|NCT01083810|592852760|FG000|Overall Study|Non-compliance|4|||
164133430|NCT01083810|592852761|FG001|Overall Study|Non-compliance|7|||
164133431|NCT01083810|592852762|FG002|Overall Study|Non-compliance|2|||
164133432|NCT01083810|592852760|FG000|Overall Study|Simplification|4|||
164133433|NCT01083810|592852761|FG001|Overall Study|Simplification|1|||
164133434|NCT01083810|592852762|FG002|Overall Study|Simplification|0|||
164133435|NCT01083810|592852760|FG000|Overall Study|Death|2|||
164133436|NCT01083810|592852761|FG001|Overall Study|Death|2|||
164133437|NCT01083810|592852762|FG002|Overall Study|Death|3|||
164133438|NCT01083810|592852760|FG000|Overall Study|Co-morbidities|1|||
164133439|NCT01083810|592852761|FG001|Overall Study|Co-morbidities|0|||
164133440|NCT01083810|592852762|FG002|Overall Study|Co-morbidities|0|||
164133441|NCT01083810|592852760|FG000|Overall Study|Participation in study|1|||
164133442|NCT01083810|592852761|FG001|Overall Study|Participation in study|0|||
164133443|NCT01083810|592852762|FG002|Overall Study|Participation in study|0|||
164133444|NCT01083810|592852760|FG000|Overall Study|Therapy break|1|||
164133445|NCT01083810|592852761|FG001|Overall Study|Therapy break|2|||
164133446|NCT01083810|592852762|FG002|Overall Study|Therapy break|2|||
164133447|NCT01083810|592852760|FG000|Overall Study|Virologic failure|1|||
164133448|NCT01083810|592852761|FG001|Overall Study|Virologic failure|8|||
164133449|NCT01083810|592852762|FG002|Overall Study|Virologic failure|0|||
164133450|NCT01602965|592852763|FG000|Overall Study|Lost to Follow-up|4|||
164133451|NCT01602965|592852764|FG001|Overall Study|Lost to Follow-up|2|||
164133452|NCT04941729|592857139|FG000|Overall Study|Death|0|||
164133453|NCT04941729|592857140|FG001|Overall Study|Death|1|||
164133454|NCT04941729|592857139|FG000|Overall Study|Study terminated by sponsor|11|||
164133455|NCT04941729|592857140|FG001|Overall Study|Study terminated by sponsor|10|||
164133456|NCT00006721|592857141|FG000|Overall Study|Adverse Event|0|||
164133457|NCT00006721|592857142|FG001|Overall Study|Adverse Event|4|||
164133458|NCT00006721|592857143|FG002|Overall Study|Adverse Event|4|||
164133459|NCT00006721|592857141|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
164133460|NCT00006721|592857142|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
164133461|NCT00006721|592857143|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
164133462|NCT00006721|592857141|FG000|Overall Study|Progression/Relapse|0|||
164133463|NCT00006721|592857142|FG001|Overall Study|Progression/Relapse|1|||
164133464|NCT00006721|592857143|FG002|Overall Study|Progression/Relapse|2|||
164133465|NCT00006721|592857141|FG000|Overall Study|Death|0|||
164133466|NCT00006721|592857142|FG001|Overall Study|Death|1|||
164133467|NCT00006721|592857143|FG002|Overall Study|Death|2|||
164133468|NCT00006721|592857141|FG000|Overall Study|Other - Not Protocol Specified|0|||
164133469|NCT00006721|592857142|FG001|Overall Study|Other - Not Protocol Specified|7|||
164133470|NCT00006721|592857143|FG002|Overall Study|Other - Not Protocol Specified|7|||
164133471|NCT00006721|592857141|FG000|Overall Study|Ineligible|2|||
164133472|NCT00006721|592857142|FG001|Overall Study|Ineligible|12|||
164133473|NCT00006721|592857143|FG002|Overall Study|Ineligible|10|||
164133474|NCT00006721|592857141|FG000|Overall Study|Eligible but no Treatment Received|1|||
164133475|NCT00006721|592857142|FG001|Overall Study|Eligible but no Treatment Received|0|||
164133476|NCT00006721|592857143|FG002|Overall Study|Eligible but no Treatment Received|0|||
164133477|NCT03845296|592857144|FG000|Overall Study|On Treatment|2|||
164133478|NCT03845296|592857145|FG001|Overall Study|On Treatment|1|||
164133479|NCT03845296|592857144|FG000|Overall Study|Adverse Event|4|||
164133480|NCT03845296|592857145|FG001|Overall Study|Adverse Event|11|||
164133481|NCT03845296|592857144|FG000|Overall Study|Refusal unrelated to adverse event|0|||
164133482|NCT03845296|592857145|FG001|Overall Study|Refusal unrelated to adverse event|1|||
164133483|NCT03845296|592857144|FG000|Overall Study|Progression/relapse|14|||
164133484|NCT03845296|592857145|FG001|Overall Study|Progression/relapse|18|||
164133485|NCT03845296|592857144|FG000|Overall Study|Death|4|||
164133486|NCT03845296|592857145|FG001|Overall Study|Death|0|||
164133487|NCT03845296|592857144|FG000|Overall Study|Other - not protocol specified|1|||
164133488|NCT03845296|592857145|FG001|Overall Study|Other - not protocol specified|3|||
164133489|NCT05424042|592857146|FG000|Overall Study|Withdrawal by Subject|2|||
164133490|NCT05424042|592857147|FG001|Overall Study|Withdrawal by Subject|0|||
164133491|NCT05424042|592857148|FG002|Overall Study|Withdrawal by Subject|4|||
164133598|NCT05327816|592857170|FG010|Overall Study|Study Terminated by Sponsor|12|||
164133599|NCT05327816|592857160|FG000|Overall Study|Randomized but not treated|0|||
164133600|NCT05327816|592857161|FG001|Overall Study|Randomized but not treated|0|||
164133601|NCT05327816|592857162|FG002|Overall Study|Randomized but not treated|0|||
164133602|NCT05327816|592857163|FG003|Overall Study|Randomized but not treated|0|||
164133603|NCT05327816|592857164|FG004|Overall Study|Randomized but not treated|0|||
164133604|NCT05327816|592857165|FG005|Overall Study|Randomized but not treated|0|||
164133605|NCT05327816|592857166|FG006|Overall Study|Randomized but not treated|1|||
164133606|NCT05327816|592857167|FG007|Overall Study|Randomized but not treated|1|||
164133607|NCT05327816|592857168|FG008|Overall Study|Randomized but not treated|1|||
164133608|NCT05327816|592857169|FG009|Overall Study|Randomized but not treated|0|||
164133609|NCT05327816|592857170|FG010|Overall Study|Randomized but not treated|0|||
164133610|NCT01167257|592857171|FG000|Overall Study|Lost to Follow-up|2|||
164133611|NCT01167257|592857172|FG001|Overall Study|Lost to Follow-up|2|||
164133612|NCT01167257|592857171|FG000|Overall Study|Withdrew consent|1|||
164133613|NCT01167257|592857172|FG001|Overall Study|Withdrew consent|1|||
164133614|NCT01367665|592857173|FG000|Overall Study|Death|102|||
164133615|NCT01367665|592857174|FG001|Overall Study|Death|19|||
164133616|NCT01367665|592857173|FG000|Overall Study|Lost to Follow-up|222|||
164133617|NCT01367665|592857174|FG001|Overall Study|Lost to Follow-up|22|||
164133618|NCT01367665|592857173|FG000|Overall Study|Not Done|118|||
164133619|NCT01367665|592857174|FG001|Overall Study|Not Done|14|||
164133620|NCT02752906|592857175|FG000|Overall Study|Protocol Violation|2|||
164133621|NCT02752906|592857176|FG001|Overall Study|Protocol Violation|1|||
164133622|NCT02752906|592857175|FG000|Overall Study|Withdrawal by Subject|2|||
164133623|NCT02752906|592857176|FG001|Overall Study|Withdrawal by Subject|2|||
164133624|NCT02752906|592857175|FG000|Overall Study|Lost to Follow-up|3|||
164133625|NCT02752906|592857176|FG001|Overall Study|Lost to Follow-up|2|||
164133626|NCT03283319|592857178|FG000|Overall Study|Lost to Follow-up|5|||
164133627|NCT03283319|592857179|FG001|Overall Study|Lost to Follow-up|4|||
164133628|NCT03283319|592857180|FG002|Overall Study|Lost to Follow-up|5|||
164133629|NCT03283319|592857181|FG003|Overall Study|Lost to Follow-up|5|||
164133630|NCT03283319|592857182|FG004|Overall Study|Lost to Follow-up|4|||
164133631|NCT03283319|592857183|FG005|Overall Study|Lost to Follow-up|3|||
164133632|NCT03283319|592857178|FG000|Overall Study|Withdrawal by Subject|2|||
164133633|NCT03283319|592857179|FG001|Overall Study|Withdrawal by Subject|2|||
164133634|NCT03283319|592857180|FG002|Overall Study|Withdrawal by Subject|2|||
164133635|NCT03283319|592857181|FG003|Overall Study|Withdrawal by Subject|1|||
164133636|NCT03283319|592857182|FG004|Overall Study|Withdrawal by Subject|0|||
164133637|NCT03283319|592857183|FG005|Overall Study|Withdrawal by Subject|1|||
164133638|NCT03283319|592857178|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
164133639|NCT03283319|592857179|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
164133640|NCT03283319|592857180|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
164133641|NCT03283319|592857181|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
164133642|NCT03283319|592857182|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
164133643|NCT03283319|592857183|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
164133644|NCT04663295|592857184|FG000|Run-in Period|Withdrawal by Subject|3|||
164133645|NCT04663295|592857184|FG000|Overall Study Period|Pregnancy|1|||
164133646|NCT04663295|592857184|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
164133647|NCT00554190|592857185|FG000|Overall Study|Termination forms not completed|10|||
164133648|NCT01502410|592857187|FG000|Overall Study|Adverse Event|1|||
164133649|NCT01502410|592857188|FG001|Overall Study|Adverse Event|2|||
164133650|NCT01502410|592857189|FG002|Overall Study|Adverse Event|0|||
164133651|NCT01502410|592857190|FG003|Overall Study|Adverse Event|0|||
164133652|NCT01502410|592857187|FG000|Overall Study|Lack of Efficacy|7|||
164133653|NCT01502410|592857188|FG001|Overall Study|Lack of Efficacy|7|||
164133654|NCT01502410|592857189|FG002|Overall Study|Lack of Efficacy|0|||
164133655|NCT01502410|592857190|FG003|Overall Study|Lack of Efficacy|0|||
164133656|NCT01502410|592857187|FG000|Overall Study|Physician Decision|0|||
164133657|NCT01502410|592857188|FG001|Overall Study|Physician Decision|1|||
164133658|NCT01502410|592857189|FG002|Overall Study|Physician Decision|0|||
164133659|NCT01502410|592857190|FG003|Overall Study|Physician Decision|0|||
164133660|NCT01502410|592857187|FG000|Overall Study|Withdrawal by Subject|2|||
164133661|NCT01502410|592857188|FG001|Overall Study|Withdrawal by Subject|0|||
164133662|NCT01502410|592857189|FG002|Overall Study|Withdrawal by Subject|0|||
164133663|NCT01502410|592857190|FG003|Overall Study|Withdrawal by Subject|0|||
164133664|NCT01007942|592857202|FG000|Overall Study|Adverse Event|29|||
164133665|NCT01007942|592857203|FG001|Overall Study|Adverse Event|14|||
164133666|NCT01007942|592857202|FG000|Overall Study|Abnormal test procedure|0|||
164133667|NCT01007942|592857203|FG001|Overall Study|Abnormal test procedure|1|||
164133668|NCT01007942|592857202|FG000|Overall Study|Disease progression|217|||
164133669|NCT01007942|592857203|FG001|Overall Study|Disease progression|242|||
164133670|NCT01007942|592857202|FG000|Overall Study|New cancer therapy|5|||
164133671|NCT01007942|592857203|FG001|Overall Study|New cancer therapy|1|||
164133672|NCT01007942|592857202|FG000|Overall Study|Protocol Violation|1|||
164133673|NCT01007942|592857203|FG001|Overall Study|Protocol Violation|1|||
164133674|NCT01007942|592857202|FG000|Overall Study|Withdrawal by Subject|19|||
164133749|NCT01175811|592857218|FG000|Overall Study|Adverse Event|1|||
164133675|NCT01007942|592857203|FG001|Overall Study|Withdrawal by Subject|14|||
164133676|NCT01007942|592857202|FG000|Overall Study|Lost to Follow-up|1|||
164133677|NCT01007942|592857203|FG001|Overall Study|Lost to Follow-up|0|||
164133678|NCT01007942|592857202|FG000|Overall Study|Administrative problems|2|||
164133679|NCT01007942|592857203|FG001|Overall Study|Administrative problems|0|||
164133680|NCT01007942|592857202|FG000|Overall Study|Death|3|||
164133681|NCT01007942|592857203|FG001|Overall Study|Death|2|||
164133682|NCT01007942|592857202|FG000|Overall Study|Patients untreated|4|||
164133683|NCT01007942|592857203|FG001|Overall Study|Patients untreated|3|||
164133684|NCT04492020|592857204|FG000|Overall Study|Adverse Event|1|||
164133685|NCT04492020|592857205|FG001|Overall Study|Adverse Event|3|||
164133686|NCT04492020|592857204|FG000|Overall Study|Withdrawal by Subject|4|||
164133687|NCT04492020|592857205|FG001|Overall Study|Withdrawal by Subject|3|||
164133688|NCT04492020|592857204|FG000|Overall Study|Lost to Follow-up|4|||
164133689|NCT04492020|592857205|FG001|Overall Study|Lost to Follow-up|3|||
164133690|NCT04492020|592857204|FG000|Overall Study|Protocol Violation|5|||
164133691|NCT04492020|592857205|FG001|Overall Study|Protocol Violation|2|||
164133692|NCT04492020|592857204|FG000|Overall Study|Lack of Qualifying Event|25|||
164133693|NCT04492020|592857205|FG001|Overall Study|Lack of Qualifying Event|27|||
164133694|NCT04492020|592857204|FG000|Overall Study|Non-compliance with Study Drug|2|||
164133695|NCT04492020|592857205|FG001|Overall Study|Non-compliance with Study Drug|1|||
164133696|NCT00325195|592857206|FG000|Randomized|Not dosed|5|||
164133697|NCT00325195|592857207|FG001|Randomized|Not dosed|5|||
164133698|NCT00325195|592857208|FG002|Randomized|Not dosed|3|||
164133699|NCT00325195|592857206|FG000|Received Intervention: ITT Population|Adverse Event|15|||
164133700|NCT00325195|592857207|FG001|Received Intervention: ITT Population|Adverse Event|17|||
164133701|NCT00325195|592857208|FG002|Received Intervention: ITT Population|Adverse Event|1|||
164133702|NCT00325195|592857206|FG000|Received Intervention: ITT Population|Death|3|||
164133703|NCT00325195|592857207|FG001|Received Intervention: ITT Population|Death|1|||
164133704|NCT00325195|592857208|FG002|Received Intervention: ITT Population|Death|0|||
164133705|NCT00325195|592857206|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
164133706|NCT00325195|592857207|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
164133707|NCT00325195|592857208|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
164133708|NCT00325195|592857206|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
164133709|NCT00325195|592857207|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
164133710|NCT00325195|592857208|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
164133711|NCT00325195|592857206|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
164133712|NCT00325195|592857207|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
164133713|NCT00325195|592857208|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
164133714|NCT04594707|592857209|FG000|Overall Study|Adverse Event|0|||
164133715|NCT04594707|592857210|FG001|Overall Study|Adverse Event|0|||
164133716|NCT04594707|592857211|FG002|Overall Study|Adverse Event|1|||
164133717|NCT04594707|592857209|FG000|Overall Study|Death|0|||
164133718|NCT04594707|592857210|FG001|Overall Study|Death|2|||
164133719|NCT04594707|592857211|FG002|Overall Study|Death|2|||
164133720|NCT04594707|592857209|FG000|Overall Study|Lung Transplant|0|||
164133721|NCT04594707|592857210|FG001|Overall Study|Lung Transplant|0|||
164133722|NCT04594707|592857211|FG002|Overall Study|Lung Transplant|1|||
164133723|NCT04594707|592857209|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
164133724|NCT04594707|592857210|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
164133725|NCT04594707|592857211|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
164133726|NCT04594707|592857209|FG000|Overall Study|Study Terminated By Sponsor|19|||
164133727|NCT04594707|592857210|FG001|Overall Study|Study Terminated By Sponsor|47|||
164133728|NCT04594707|592857211|FG002|Overall Study|Study Terminated By Sponsor|41|||
164133729|NCT04594707|592857209|FG000|Overall Study|Withdrawal by Subject|1|||
164133730|NCT04594707|592857210|FG001|Overall Study|Withdrawal by Subject|0|||
164133731|NCT04594707|592857211|FG002|Overall Study|Withdrawal by Subject|2|||
164133732|NCT04585789|592857212|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
164133733|NCT04585789|592857213|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
164133734|NCT04585789|592857214|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
164133735|NCT04585789|592857212|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
164133736|NCT04585789|592857213|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
164133737|NCT04585789|592857214|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
164133738|NCT03412396|592857215|FG000|Overall Study|Withdrawal by Subject|2|||
164133739|NCT03412396|592857215|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
164133740|NCT03412396|592857215|FG000|Overall Study|Did not undergo RP|2|||
164133741|NCT05083585|592857216|FG000|Overall Study|Death|1|||
164133742|NCT05083585|592857217|FG001|Overall Study|Death|1|||
164133743|NCT05083585|592857216|FG000|Overall Study|Lost to Follow-up|1|||
164133744|NCT05083585|592857217|FG001|Overall Study|Lost to Follow-up|1|||
164133745|NCT05083585|592857216|FG000|Overall Study|Withdrawal by Subject|2|||
164133746|NCT05083585|592857217|FG001|Overall Study|Withdrawal by Subject|0|||
164133747|NCT05083585|592857216|FG000|Overall Study|Randomized but not vaccinated|2|||
164133748|NCT05083585|592857217|FG001|Overall Study|Randomized but not vaccinated|0|||
164133817|NCT02393248|592857246|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133818|NCT02393248|592857247|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133819|NCT02393248|592857248|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133820|NCT02393248|592857249|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133821|NCT02393248|592857250|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133822|NCT02393248|592857251|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133823|NCT02393248|592857252|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
164133824|NCT02393248|592857228|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
164133825|NCT02393248|592857229|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
164133826|NCT02393248|592857230|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
164133827|NCT02393248|592857231|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
164133828|NCT02393248|592857232|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
164133829|NCT02393248|592857233|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
164133830|NCT02393248|592857234|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
164133831|NCT02393248|592857235|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
164133832|NCT02393248|592857236|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
164133833|NCT02393248|592857237|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
164133834|NCT02393248|592857238|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
164133835|NCT02393248|592857239|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
164133836|NCT02393248|592857240|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
164133837|NCT02393248|592857241|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
164133838|NCT02393248|592857242|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
164133839|NCT02393248|592857243|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
164133840|NCT02393248|592857244|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
164133841|NCT02393248|592857245|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
164133842|NCT02393248|592857246|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
164133843|NCT02393248|592857247|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
164133844|NCT02393248|592857248|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
164133845|NCT02393248|592857249|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
164133846|NCT02393248|592857250|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
164133847|NCT02393248|592857251|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
164133848|NCT02393248|592857252|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
164133849|NCT02393248|592857228|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
164133850|NCT02393248|592857229|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133851|NCT02393248|592857230|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133852|NCT02393248|592857231|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133853|NCT02393248|592857232|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133854|NCT02393248|592857233|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133855|NCT02393248|592857234|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133856|NCT02393248|592857235|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133857|NCT02393248|592857236|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133858|NCT02393248|592857237|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133859|NCT02393248|592857238|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133860|NCT02393248|592857239|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133861|NCT02393248|592857240|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133862|NCT02393248|592857241|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133863|NCT02393248|592857242|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133864|NCT02393248|592857243|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133865|NCT02393248|592857244|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133866|NCT02393248|592857245|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133867|NCT02393248|592857246|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133868|NCT02393248|592857247|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133869|NCT02393248|592857248|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133870|NCT02393248|592857249|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133871|NCT02393248|592857250|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133872|NCT02393248|592857251|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133873|NCT02393248|592857252|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
164133874|NCT02393248|592857228|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133875|NCT02393248|592857229|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133876|NCT02393248|592857230|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133877|NCT02393248|592857231|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133878|NCT02393248|592857232|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133879|NCT02393248|592857233|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
164133880|NCT02393248|592857234|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
164133881|NCT02393248|592857235|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133882|NCT02393248|592857236|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133883|NCT02393248|592857237|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
164133884|NCT02393248|592857238|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133885|NCT02393248|592857239|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133886|NCT02393248|592857240|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133887|NCT02393248|592857241|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133888|NCT02393248|592857242|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133889|NCT02393248|592857243|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133890|NCT02393248|592857244|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133891|NCT02393248|592857245|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133892|NCT02393248|592857246|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133893|NCT02393248|592857247|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133894|NCT02393248|592857248|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133895|NCT02393248|592857249|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133896|NCT02393248|592857250|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133897|NCT02393248|592857251|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133898|NCT02393248|592857252|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
164133899|NCT02393248|592857228|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133900|NCT02393248|592857229|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133901|NCT02393248|592857230|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133902|NCT02393248|592857231|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133903|NCT02393248|592857232|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133904|NCT02393248|592857233|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133905|NCT02393248|592857234|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
164133906|NCT02393248|592857235|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133907|NCT02393248|592857236|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133908|NCT02393248|592857237|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133909|NCT02393248|592857238|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133910|NCT02393248|592857239|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133911|NCT02393248|592857240|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133912|NCT02393248|592857241|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133913|NCT02393248|592857242|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133914|NCT02393248|592857243|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133915|NCT02393248|592857244|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133916|NCT02393248|592857245|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133917|NCT02393248|592857246|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133918|NCT02393248|592857247|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133919|NCT02393248|592857248|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133920|NCT02393248|592857249|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133921|NCT02393248|592857250|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133922|NCT02393248|592857251|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133923|NCT02393248|592857252|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
164133924|NCT02393248|592857228|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133925|NCT02393248|592857229|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133926|NCT02393248|592857230|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133927|NCT02393248|592857231|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133928|NCT02393248|592857232|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133929|NCT02393248|592857233|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133930|NCT02393248|592857234|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133931|NCT02393248|592857235|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133932|NCT02393248|592857236|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133933|NCT02393248|592857237|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133934|NCT02393248|592857238|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133935|NCT02393248|592857239|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
164133936|NCT02393248|592857240|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
164133937|NCT02393248|592857241|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
164133938|NCT02393248|592857242|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
164133939|NCT02393248|592857243|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133940|NCT02393248|592857244|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133941|NCT02393248|592857245|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133942|NCT02393248|592857246|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133943|NCT02393248|592857247|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133944|NCT02393248|592857248|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133945|NCT02393248|592857249|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133946|NCT02393248|592857250|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133947|NCT02393248|592857251|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133948|NCT02393248|592857252|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
164133949|NCT02393248|592857228|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133950|NCT02393248|592857229|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133951|NCT02393248|592857230|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133952|NCT02393248|592857231|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133953|NCT02393248|592857232|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133954|NCT02393248|592857233|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133955|NCT02393248|592857234|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133956|NCT02393248|592857235|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133957|NCT02393248|592857236|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133958|NCT02393248|592857237|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133959|NCT02393248|592857238|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
164133960|NCT02393248|592857239|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
164133961|NCT02393248|592857240|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133962|NCT02393248|592857241|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133963|NCT02393248|592857242|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133964|NCT02393248|592857243|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133965|NCT02393248|592857244|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133966|NCT02393248|592857245|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133967|NCT02393248|592857246|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133968|NCT02393248|592857247|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133969|NCT02393248|592857248|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133970|NCT02393248|592857249|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133971|NCT02393248|592857250|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133972|NCT02393248|592857251|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133973|NCT02393248|592857252|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
164133974|NCT02393248|592857228|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
164133975|NCT02393248|592857229|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
164133976|NCT02393248|592857230|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
164133977|NCT02393248|592857231|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
164133978|NCT02393248|592857232|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
164133979|NCT02393248|592857233|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
164133980|NCT02393248|592857234|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
164133981|NCT02393248|592857235|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
164133982|NCT02393248|592857236|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
164133983|NCT02393248|592857237|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
164133984|NCT02393248|592857238|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
164133985|NCT02393248|592857239|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
164133986|NCT02393248|592857240|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
164133987|NCT02393248|592857241|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
164133988|NCT02393248|592857242|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
164133989|NCT02393248|592857243|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
164133990|NCT02393248|592857244|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
164133991|NCT02393248|592857245|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
164133992|NCT02393248|592857246|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
164133993|NCT02393248|592857247|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
164133994|NCT02393248|592857248|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
164133995|NCT02393248|592857249|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
164133996|NCT02393248|592857250|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
164133997|NCT02393248|592857251|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
164133998|NCT02393248|592857252|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
164133999|NCT02393248|592857228|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134000|NCT02393248|592857229|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134001|NCT02393248|592857230|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134002|NCT02393248|592857231|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134003|NCT02393248|592857232|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134004|NCT02393248|592857233|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134005|NCT02393248|592857234|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134006|NCT02393248|592857235|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134007|NCT02393248|592857236|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134008|NCT02393248|592857237|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134009|NCT02393248|592857238|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134010|NCT02393248|592857239|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
164134011|NCT02393248|592857240|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134012|NCT02393248|592857241|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
164134013|NCT02393248|592857242|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134014|NCT02393248|592857243|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134015|NCT02393248|592857244|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134016|NCT02393248|592857245|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134017|NCT02393248|592857246|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134018|NCT02393248|592857247|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134019|NCT02393248|592857248|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134020|NCT02393248|592857249|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134021|NCT02393248|592857250|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134022|NCT02393248|592857251|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134023|NCT02393248|592857252|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
164134024|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134025|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134026|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134027|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134028|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134029|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134030|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134031|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134032|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134033|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134034|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134035|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134036|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134037|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134038|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134039|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134040|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134041|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134042|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
164134043|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134044|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
164134045|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
164134046|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134047|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
164134048|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
164134049|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Death|0|||
164134050|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Death|0|||
164134051|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Death|0|||
164134052|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Death|0|||
164134053|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Death|0|||
164134054|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Death|0|||
164134055|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Death|0|||
164134056|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Death|0|||
164134057|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Death|0|||
164134058|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Death|0|||
164134059|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Death|0|||
164134060|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Death|0|||
164134061|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Death|0|||
164134062|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Death|0|||
164134063|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Death|0|||
164134064|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Death|1|||
164134065|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Death|7|||
164134066|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Death|5|||
164134067|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Death|5|||
164134068|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Death|3|||
164134069|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Death|7|||
164134070|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Death|5|||
164134071|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Death|6|||
164134072|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Death|3|||
164134073|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Death|0|||
164134074|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134075|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134076|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134077|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134078|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134079|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134080|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134081|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134082|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134083|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134084|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134085|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134086|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134087|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134088|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134089|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134090|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134091|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164134092|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164134093|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
164134094|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164134095|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164134096|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164134097|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
164134098|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
164134099|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Disease Progression|0|||
164134100|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Disease Progression|0|||
164134101|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Disease Progression|0|||
164134102|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Disease Progression|0|||
164134103|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Disease Progression|0|||
164134104|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Disease Progression|0|||
164134105|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Disease Progression|0|||
164134106|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Disease Progression|0|||
164134107|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Disease Progression|0|||
164134108|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Disease Progression|0|||
164134109|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Disease Progression|0|||
164134110|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Disease Progression|0|||
164134111|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Disease Progression|0|||
164134112|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Disease Progression|0|||
164134113|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Disease Progression|0|||
164134114|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Disease Progression|0|||
164134115|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Disease Progression|0|||
164134116|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Disease Progression|0|||
164134117|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Disease Progression|0|||
164134118|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Disease Progression|0|||
164134119|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Disease Progression|2|||
164134120|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Disease Progression|1|||
164134121|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Disease Progression|0|||
164134122|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Disease Progression|0|||
164134123|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Disease Progression|0|||
164134124|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134125|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134126|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134127|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134128|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134129|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134130|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134131|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134132|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134133|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134134|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134135|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134136|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134137|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134138|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134139|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134140|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134141|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134142|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134143|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134144|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
164134145|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
164134146|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134147|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134148|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
164134149|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134150|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134151|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134152|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134153|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134154|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134155|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134156|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134157|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134158|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134159|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134160|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134161|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134162|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134163|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134164|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134165|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134166|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134167|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134168|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134169|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
164134170|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134171|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134172|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134173|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
164134174|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Adverse Event|0|||
164134175|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Adverse Event|0|||
164134176|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Adverse Event|0|||
164134177|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Adverse Event|0|||
164134178|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Adverse Event|0|||
164134179|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Adverse Event|0|||
164134180|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Adverse Event|0|||
164134181|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Adverse Event|0|||
164134182|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Adverse Event|0|||
164134183|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Adverse Event|0|||
164134184|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Adverse Event|0|||
164134185|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Adverse Event|0|||
164134186|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Adverse Event|0|||
164134187|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Adverse Event|0|||
164134188|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Adverse Event|0|||
164134189|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Adverse Event|0|||
164134190|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Adverse Event|0|||
164134191|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Adverse Event|0|||
164134192|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Adverse Event|0|||
164134193|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Adverse Event|0|||
164134194|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Adverse Event|0|||
164134195|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Adverse Event|0|||
164134196|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Adverse Event|0|||
164134197|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Adverse Event|1|||
164134198|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Adverse Event|0|||
164134199|NCT02393248|592857228|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134200|NCT02393248|592857229|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134201|NCT02393248|592857230|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134202|NCT02393248|592857231|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134203|NCT02393248|592857232|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134204|NCT02393248|592857233|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134205|NCT02393248|592857234|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134206|NCT02393248|592857235|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134207|NCT02393248|592857236|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134208|NCT02393248|592857237|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134209|NCT02393248|592857238|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134210|NCT02393248|592857239|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134211|NCT02393248|592857240|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134212|NCT02393248|592857241|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134213|NCT02393248|592857242|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134214|NCT02393248|592857243|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134215|NCT02393248|592857244|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134216|NCT02393248|592857245|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134217|NCT02393248|592857246|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134218|NCT02393248|592857247|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134219|NCT02393248|592857248|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134220|NCT02393248|592857249|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134221|NCT02393248|592857250|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134222|NCT02393248|592857251|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
164134223|NCT02393248|592857252|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
164134224|NCT03560986|592857253|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
164134225|NCT03560986|592857254|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
164134226|NCT03560986|592857253|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
164134227|NCT03560986|592857254|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
164134228|NCT03560986|592857253|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
164134229|NCT03560986|592857254|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
164134230|NCT03560986|592857253|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
164134231|NCT03560986|592857254|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
164134232|NCT03560986|592857253|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
164134233|NCT03560986|592857254|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
164134234|NCT03560986|592857253|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
164134235|NCT03560986|592857254|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
164134236|NCT03560986|592857253|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
164134237|NCT03560986|592857254|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
164134238|NCT02585934|592857255|FG000|Overall Study|Lost to Follow-up|2|||
164134239|NCT02585934|592857256|FG001|Overall Study|Lost to Follow-up|2|||
164134240|NCT02585934|592857255|FG000|Overall Study|Protocol Violation|14|||
164134241|NCT02585934|592857256|FG001|Overall Study|Protocol Violation|11|||
164134242|NCT02585934|592857255|FG000|Overall Study|Adverse Event|21|||
164134243|NCT02585934|592857256|FG001|Overall Study|Adverse Event|22|||
164134244|NCT02585934|592857255|FG000|Overall Study|Physician Decision|3|||
164134245|NCT02585934|592857256|FG001|Overall Study|Physician Decision|2|||
164134246|NCT02585934|592857255|FG000|Overall Study|Withdrawal by Subject|7|||
164134247|NCT02585934|592857256|FG001|Overall Study|Withdrawal by Subject|21|||
164134248|NCT02585934|592857255|FG000|Overall Study|Lack of Efficacy|2|||
164134249|NCT02585934|592857256|FG001|Overall Study|Lack of Efficacy|1|||
164134250|NCT02585934|592857255|FG000|Overall Study|Death|2|||
164134251|NCT02585934|592857256|FG001|Overall Study|Death|0|||
164134252|NCT02585934|592857255|FG000|Overall Study|Caregiver Withdrew Consent|7|||
164134253|NCT02585934|592857256|FG001|Overall Study|Caregiver Withdrew Consent|7|||
164134254|NCT02585934|592857255|FG000|Overall Study|Sponsor Termination|1|||
164134255|NCT02585934|592857256|FG001|Overall Study|Sponsor Termination|2|||
164134256|NCT02585934|592857255|FG000|Overall Study|Another Reason|10|||
164134257|NCT02585934|592857256|FG001|Overall Study|Another Reason|5|||
164134258|NCT00655876|592857268|FG000|Overall Study|Protocol Violation|9|||
164134259|NCT00655876|592857269|FG001|Overall Study|Protocol Violation|7|||
164134260|NCT00326963|592857270|FG000|Overall Study|Adverse Event|2|||
164134261|NCT00326963|592857270|FG000|Overall Study|Injection site reaction|1|||
164134262|NCT00326963|592857270|FG000|Overall Study|Death|1|||
164134263|NCT00326963|592857270|FG000|Overall Study|Failure to return|10|||
164134264|NCT00326963|592857270|FG000|Overall Study|Withdrawal by Subject|10|||
164134265|NCT00326963|592857270|FG000|Overall Study|Refused treatment / did not cooperate|5|||
164134266|NCT00326963|592857270|FG000|Overall Study|Violation of selection criteria at entry|2|||
164134267|NCT00326963|592857270|FG000|Overall Study|Other protocol violation|1|||
164134268|NCT00326963|592857270|FG000|Overall Study|Administrative / other|1|||
164134269|NCT00895947|592857274|FG000|Overall Study|Adverse Event|3|||
164134270|NCT00895947|592857275|FG001|Overall Study|Adverse Event|4|||
164134271|NCT00895947|592857274|FG000|Overall Study|Lost to Follow-up|3|||
164134272|NCT00895947|592857275|FG001|Overall Study|Lost to Follow-up|4|||
164134273|NCT00895947|592857274|FG000|Overall Study|Protocol Violation|4|||
164134274|NCT00895947|592857275|FG001|Overall Study|Protocol Violation|2|||
164134275|NCT00895947|592857274|FG000|Overall Study|Withdrawal by Subject|2|||
164134276|NCT00895947|592857275|FG001|Overall Study|Withdrawal by Subject|0|||
164134277|NCT01739348|592857278|FG000|Part I (Base Study)|Adverse Event|41|||
164134278|NCT01739348|592857279|FG001|Part I (Base Study)|Adverse Event|52|||
164134279|NCT01739348|592857280|FG002|Part I (Base Study)|Adverse Event|8|||
164134280|NCT01739348|592857281|FG003|Part I (Base Study)|Adverse Event|33|||
164134281|NCT01739348|592857278|FG000|Part I (Base Study)|Death|10|||
164134282|NCT01739348|592857279|FG001|Part I (Base Study)|Death|7|||
164134305|NCT01739348|592857278|FG000|Part I (Base Study)|Screen Failure|2|||
164134306|NCT01739348|592857279|FG001|Part I (Base Study)|Screen Failure|0|||
164134307|NCT01739348|592857280|FG002|Part I (Base Study)|Screen Failure|0|||
164134308|NCT01739348|592857281|FG003|Part I (Base Study)|Screen Failure|0|||
164134309|NCT01739348|592857278|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
164134310|NCT01739348|592857279|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
164134311|NCT01739348|592857280|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
164134312|NCT01739348|592857281|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
164134313|NCT01739348|592857278|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
164134314|NCT01739348|592857279|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
164134315|NCT01739348|592857280|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
164134316|NCT01739348|592857281|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
164134317|NCT01739348|592857278|FG000|Part I (Base Study)|Participant Moved|4|||
164134318|NCT01739348|592857279|FG001|Part I (Base Study)|Participant Moved|3|||
164134319|NCT01739348|592857280|FG002|Part I (Base Study)|Participant Moved|1|||
164134320|NCT01739348|592857281|FG003|Part I (Base Study)|Participant Moved|7|||
164134321|NCT01739348|592857278|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
164134322|NCT01739348|592857279|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
164134323|NCT01739348|592857280|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
164134324|NCT01739348|592857281|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
164134325|NCT01739348|592857278|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
164134326|NCT01739348|592857279|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
164134327|NCT01739348|592857280|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
164134328|NCT01739348|592857281|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
164134329|NCT01739348|592857278|FG000|Part II (Extension Study)|Adverse Event|10|||
164134330|NCT01739348|592857279|FG001|Part II (Extension Study)|Adverse Event|11|||
164134331|NCT01739348|592857280|FG002|Part II (Extension Study)|Adverse Event|7|||
164134332|NCT01739348|592857281|FG003|Part II (Extension Study)|Adverse Event|26|||
164134333|NCT01739348|592857278|FG000|Part II (Extension Study)|Death|3|||
164134334|NCT01739348|592857279|FG001|Part II (Extension Study)|Death|3|||
164134335|NCT01739348|592857280|FG002|Part II (Extension Study)|Death|2|||
164134336|NCT01739348|592857281|FG003|Part II (Extension Study)|Death|6|||
164134337|NCT01739348|592857278|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
164134338|NCT01739348|592857279|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
164134339|NCT01739348|592857280|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
164134340|NCT01739348|592857281|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
164134341|NCT01739348|592857278|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
164134342|NCT01739348|592857279|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
164134343|NCT01739348|592857280|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
164134344|NCT01739348|592857281|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
164134345|NCT01739348|592857278|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
164134346|NCT01739348|592857279|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
164134347|NCT01739348|592857280|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
164134348|NCT01739348|592857281|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
164134349|NCT01739348|592857278|FG000|Part II (Extension Study)|Physician Decision|7|||
164134350|NCT01739348|592857279|FG001|Part II (Extension Study)|Physician Decision|11|||
164134351|NCT01739348|592857280|FG002|Part II (Extension Study)|Physician Decision|6|||
164134352|NCT01739348|592857281|FG003|Part II (Extension Study)|Physician Decision|12|||
164134353|NCT01739348|592857278|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
164134354|NCT01739348|592857279|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
164134355|NCT01739348|592857280|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
164134356|NCT01739348|592857281|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
164134357|NCT01739348|592857278|FG000|Part II (Extension Study)|Participant Moved|3|||
164134358|NCT01739348|592857279|FG001|Part II (Extension Study)|Participant Moved|3|||
164134359|NCT01739348|592857280|FG002|Part II (Extension Study)|Participant Moved|0|||
164134360|NCT01739348|592857281|FG003|Part II (Extension Study)|Participant Moved|3|||
164134361|NCT01739348|592857278|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
164134362|NCT01739348|592857279|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
164134363|NCT01739348|592857280|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
164134364|NCT01739348|592857281|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
164134365|NCT01739348|592857278|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
164134366|NCT01739348|592857279|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
164134367|NCT01739348|592857280|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
164134368|NCT01739348|592857281|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
164134369|NCT00528411|592857287|FG000|Overall Study|Adverse Event|4|||
164134370|NCT00528411|592857288|FG001|Overall Study|Adverse Event|0|||
164134371|NCT00528411|592857289|FG002|Overall Study|Adverse Event|1|||
164134372|NCT00528411|592857287|FG000|Overall Study|Incorrect Enrolment|1|||
164134373|NCT00528411|592857288|FG001|Overall Study|Incorrect Enrolment|1|||
164134374|NCT00528411|592857289|FG002|Overall Study|Incorrect Enrolment|0|||
164134375|NCT00528411|592857287|FG000|Overall Study|Severe non-compliance to protocol|0|||
164134376|NCT00528411|592857288|FG001|Overall Study|Severe non-compliance to protocol|1|||
164134377|NCT00528411|592857289|FG002|Overall Study|Severe non-compliance to protocol|0|||
164134378|NCT00528411|592857287|FG000|Overall Study|Prior commitment medication|0|||
164134379|NCT00528411|592857288|FG001|Overall Study|Prior commitment medication|1|||
164134380|NCT00528411|592857289|FG002|Overall Study|Prior commitment medication|0|||
164134381|NCT02695537|592857299|FG000|Overall Study|Adverse Event|3|||
164134382|NCT02695537|592857299|FG000|Overall Study|Lack of Efficacy|28|||
164134383|NCT02695537|592857299|FG000|Overall Study|Withdrawal by Subject|4|||
164134384|NCT02695537|592857299|FG000|Overall Study|Protocol Violation|3|||
164134385|NCT02792699|592857300|FG000|Overall Study|Adverse Event|1|||
164134386|NCT02792699|592857301|FG001|Overall Study|Adverse Event|2|||
164134387|NCT02792699|592857302|FG002|Overall Study|Adverse Event|4|||
164134388|NCT02792699|592857300|FG000|Overall Study|Withdrawal by Subject|4|||
164134389|NCT02792699|592857301|FG001|Overall Study|Withdrawal by Subject|4|||
164134390|NCT02792699|592857302|FG002|Overall Study|Withdrawal by Subject|3|||
164134391|NCT02792699|592857300|FG000|Overall Study|Lost to Follow-up|0|||
164134392|NCT02792699|592857301|FG001|Overall Study|Lost to Follow-up|1|||
164134393|NCT02792699|592857302|FG002|Overall Study|Lost to Follow-up|2|||
164134394|NCT02792699|592857300|FG000|Overall Study|Physician Decision|2|||
164134395|NCT02792699|592857301|FG001|Overall Study|Physician Decision|0|||
164134396|NCT02792699|592857302|FG002|Overall Study|Physician Decision|0|||
164134397|NCT02792699|592857300|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
164134398|NCT02792699|592857301|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
164134399|NCT02792699|592857302|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
164134400|NCT02792699|592857300|FG000|Overall Study|Other|1|||
164134401|NCT02792699|592857301|FG001|Overall Study|Other|0|||
164134402|NCT02792699|592857302|FG002|Overall Study|Other|0|||
164134403|NCT00077857|592857305|FG000|Overall Study|Adverse Event|30|||
164134404|NCT00077857|592857306|FG001|Overall Study|Adverse Event|32|||
164134405|NCT00077857|592857305|FG000|Overall Study|Death|7|||
164134406|NCT00077857|592857306|FG001|Overall Study|Death|3|||
164134407|NCT00077857|592857305|FG000|Overall Study|Insufficient therapeutic response|112|||
164134408|NCT00077857|592857306|FG001|Overall Study|Insufficient therapeutic response|128|||
164134409|NCT00077857|592857305|FG000|Overall Study|Violation of selection criteria at entry|3|||
164134410|NCT00077857|592857306|FG001|Overall Study|Violation of selection criteria at entry|1|||
164134411|NCT00077857|592857305|FG000|Overall Study|Other protocol violation|0|||
164134412|NCT00077857|592857306|FG001|Overall Study|Other protocol violation|1|||
164134413|NCT00077857|592857305|FG000|Overall Study|Refused treatment|29|||
164134414|NCT00077857|592857306|FG001|Overall Study|Refused treatment|21|||
164134415|NCT00077857|592857305|FG000|Overall Study|Failure to return|5|||
164134416|NCT00077857|592857306|FG001|Overall Study|Failure to return|5|||
164134417|NCT00077857|592857305|FG000|Overall Study|Other|15|||
164134418|NCT00077857|592857306|FG001|Overall Study|Other|13|||
164134419|NCT05084963|592857309|FG000|Overall Study|Withdrawal by Subject|0|||
164134420|NCT05084963|592857310|FG001|Overall Study|Withdrawal by Subject|0|||
164134421|NCT05084963|592857311|FG002|Overall Study|Withdrawal by Subject|1|||
164134422|NCT06354998|592857312|FG000|Overall Study|Withdrawal by Subject|3|||
164134423|NCT06354998|592857313|FG001|Overall Study|Withdrawal by Subject|0|||
164134424|NCT03819049|592857314|FG000|Overall Study|Lost to Follow-up|1|||
164134425|NCT03819049|592857315|FG001|Overall Study|Lost to Follow-up|2|||
164134426|NCT03819049|592857316|FG002|Overall Study|Lost to Follow-up|9|||
164134427|NCT03819049|592857317|FG003|Overall Study|Lost to Follow-up|0|||
164134428|NCT03819049|592857318|FG004|Overall Study|Lost to Follow-up|3|||
164134429|NCT03819049|592857319|FG005|Overall Study|Lost to Follow-up|1|||
164134430|NCT03819049|592857320|FG006|Overall Study|Lost to Follow-up|0|||
164134431|NCT03819049|592857314|FG000|Overall Study|Withdrawal by Subject|0|||
164134432|NCT03819049|592857315|FG001|Overall Study|Withdrawal by Subject|0|||
164134433|NCT03819049|592857316|FG002|Overall Study|Withdrawal by Subject|18|||
164134434|NCT03819049|592857317|FG003|Overall Study|Withdrawal by Subject|0|||
164134435|NCT03819049|592857318|FG004|Overall Study|Withdrawal by Subject|10|||
164134436|NCT03819049|592857319|FG005|Overall Study|Withdrawal by Subject|9|||
164134437|NCT03819049|592857320|FG006|Overall Study|Withdrawal by Subject|1|||
164134438|NCT03819049|592857314|FG000|Overall Study|Ongoing|0|||
164134439|NCT03819049|592857315|FG001|Overall Study|Ongoing|0|||
164134440|NCT03819049|592857316|FG002|Overall Study|Ongoing|75|||
164134441|NCT03819049|592857317|FG003|Overall Study|Ongoing|0|||
164134442|NCT03819049|592857318|FG004|Overall Study|Ongoing|41|||
164134443|NCT03819049|592857319|FG005|Overall Study|Ongoing|0|||
164134444|NCT03819049|592857320|FG006|Overall Study|Ongoing|0|||
164134445|NCT03819049|592857314|FG000|Overall Study|Other|0|||
164134446|NCT03819049|592857315|FG001|Overall Study|Other|0|||
164134447|NCT03819049|592857316|FG002|Overall Study|Other|2|||
164134448|NCT03819049|592857317|FG003|Overall Study|Other|0|||
164134449|NCT03819049|592857318|FG004|Overall Study|Other|0|||
164134450|NCT03819049|592857319|FG005|Overall Study|Other|0|||
164134451|NCT03819049|592857320|FG006|Overall Study|Other|0|||
164134452|NCT03819049|592857314|FG000|Overall Study|Randomized but not vaccinated|0|||
164134453|NCT03819049|592857315|FG001|Overall Study|Randomized but not vaccinated|0|||
164134454|NCT03819049|592857316|FG002|Overall Study|Randomized but not vaccinated|0|||
164134455|NCT03819049|592857317|FG003|Overall Study|Randomized but not vaccinated|1|||
164134456|NCT03819049|592857318|FG004|Overall Study|Randomized but not vaccinated|0|||
164134457|NCT03819049|592857319|FG005|Overall Study|Randomized but not vaccinated|2|||
164134458|NCT03819049|592857320|FG006|Overall Study|Randomized but not vaccinated|1|||
164134459|NCT03819049|592857314|FG000|Overall Study|Physician Decision|0|||
164134460|NCT03819049|592857315|FG001|Overall Study|Physician Decision|0|||
164134461|NCT03819049|592857316|FG002|Overall Study|Physician Decision|0|||
164134462|NCT03819049|592857317|FG003|Overall Study|Physician Decision|0|||
164134463|NCT03819049|592857318|FG004|Overall Study|Physician Decision|0|||
164134464|NCT03819049|592857319|FG005|Overall Study|Physician Decision|0|||
164134465|NCT03819049|592857320|FG006|Overall Study|Physician Decision|1|||
164134466|NCT00816361|592857321|FG000|Overall Study|Withdrawal by Subject|0|||
164134467|NCT00816361|592857322|FG001|Overall Study|Withdrawal by Subject|0|||
164134468|NCT00816361|592857323|FG002|Overall Study|Withdrawal by Subject|0|||
164134469|NCT00816361|592857324|FG003|Overall Study|Withdrawal by Subject|0|||
164134470|NCT00816361|592857325|FG004|Overall Study|Withdrawal by Subject|1|||
164134471|NCT00816361|592857326|FG005|Overall Study|Withdrawal by Subject|2|||
164134472|NCT00816361|592857327|FG006|Overall Study|Withdrawal by Subject|0|||
164134473|NCT00816361|592857328|FG007|Overall Study|Withdrawal by Subject|2|||
164134474|NCT00816361|592857329|FG008|Overall Study|Withdrawal by Subject|1|||
164134475|NCT00816361|592857321|FG000|Overall Study|Death|4|||
164134476|NCT00816361|592857322|FG001|Overall Study|Death|3|||
164134477|NCT00816361|592857323|FG002|Overall Study|Death|3|||
164134478|NCT00816361|592857324|FG003|Overall Study|Death|3|||
164134479|NCT00816361|592857325|FG004|Overall Study|Death|1|||
164134480|NCT00816361|592857326|FG005|Overall Study|Death|1|||
164134481|NCT00816361|592857327|FG006|Overall Study|Death|3|||
164134482|NCT00816361|592857328|FG007|Overall Study|Death|7|||
164134483|NCT00816361|592857329|FG008|Overall Study|Death|8|||
164134484|NCT00816361|592857321|FG000|Overall Study|Other|0|||
164134485|NCT00816361|592857322|FG001|Overall Study|Other|0|||
164134486|NCT00816361|592857323|FG002|Overall Study|Other|0|||
164134487|NCT00816361|592857324|FG003|Overall Study|Other|0|||
164134488|NCT00816361|592857325|FG004|Overall Study|Other|0|||
164134489|NCT00816361|592857326|FG005|Overall Study|Other|0|||
164134490|NCT00816361|592857327|FG006|Overall Study|Other|0|||
164134491|NCT00816361|592857328|FG007|Overall Study|Other|0|||
164134492|NCT00816361|592857329|FG008|Overall Study|Other|1|||
164134493|NCT02500641|592857330|FG000|Overall Study|Adverse Event|0|||
164134494|NCT02500641|592857331|FG001|Overall Study|Adverse Event|2|||
164134495|NCT02500641|592857330|FG000|Overall Study|Withdrawal by Subject|4|||
164134496|NCT02500641|592857331|FG001|Overall Study|Withdrawal by Subject|5|||
164134497|NCT02500641|592857330|FG000|Overall Study|Unable to follow study procedures|3|||
164134498|NCT02500641|592857331|FG001|Overall Study|Unable to follow study procedures|2|||
164134499|NCT02500641|592857330|FG000|Overall Study|Protocol Violation|1|||
164134500|NCT02500641|592857331|FG001|Overall Study|Protocol Violation|2|||
164134501|NCT02500641|592857330|FG000|Overall Study|Lost to Follow-up|1|||
164134502|NCT02500641|592857331|FG001|Overall Study|Lost to Follow-up|0|||
164134503|NCT02500641|592857330|FG000|Overall Study|Sponsor decision|1|||
164134504|NCT02500641|592857331|FG001|Overall Study|Sponsor decision|0|||
164134505|NCT02500641|592857330|FG000|Overall Study|Non compliance to study drug|0|||
164134506|NCT02500641|592857331|FG001|Overall Study|Non compliance to study drug|1|||
164134507|NCT02440568|592857332|FG000|Overall Study|Death|1|||
164134508|NCT02440568|592857333|FG001|Overall Study|Death|3|||
164134509|NCT02440568|592857334|FG002|Overall Study|Death|4|||
164134510|NCT02440568|592857335|FG003|Overall Study|Death|2|||
164134511|NCT02440568|592857332|FG000|Overall Study|Lack of Efficacy|2|||
164134512|NCT02440568|592857333|FG001|Overall Study|Lack of Efficacy|0|||
164134513|NCT02440568|592857334|FG002|Overall Study|Lack of Efficacy|1|||
164134514|NCT02440568|592857335|FG003|Overall Study|Lack of Efficacy|0|||
164134515|NCT02440568|592857332|FG000|Overall Study|Lost to Follow-up|1|||
164134516|NCT02440568|592857333|FG001|Overall Study|Lost to Follow-up|0|||
164134517|NCT02440568|592857334|FG002|Overall Study|Lost to Follow-up|0|||
164134518|NCT02440568|592857335|FG003|Overall Study|Lost to Follow-up|0|||
164134519|NCT01763684|592857336|FG000|Overall Study|Study terminated early due to low enrollment|126|||
164134520|NCT01763684|592857337|FG001|Overall Study|Study terminated early due to low enrollment|127|||
164134521|NCT01763684|592857336|FG000|Overall Study|Study surgery not performed|7|||
164134522|NCT01763684|592857337|FG001|Overall Study|Study surgery not performed|6|||
164134523|NCT01181271|592857340|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
164134524|NCT01181271|592857340|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
164134525|NCT01181271|592857340|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
164134526|NCT01181271|592857340|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
164134527|NCT00444457|592857341|FG000|Infant Series|Other|0|||
164134528|NCT00444457|592857342|FG001|Infant Series|Other|1|||
164134529|NCT00444457|592857343|FG002|Infant Series|Other|0|||
164134530|NCT00444457|592857344|FG003|Infant Series|Other|0|||
164134531|NCT00444457|592857341|FG000|Infant Series|Parent or legal guardian request|18|||
164134532|NCT00444457|592857342|FG001|Infant Series|Parent or legal guardian request|29|||
164134533|NCT00444457|592857343|FG002|Infant Series|Parent or legal guardian request|34|||
164134534|NCT00444457|592857344|FG003|Infant Series|Parent or legal guardian request|14|||
164134535|NCT00444457|592857341|FG000|Infant Series|Lost to Follow-up|10|||
164134536|NCT00444457|592857342|FG001|Infant Series|Lost to Follow-up|11|||
164134537|NCT00444457|592857343|FG002|Infant Series|Lost to Follow-up|7|||
164134538|NCT00444457|592857344|FG003|Infant Series|Lost to Follow-up|6|||
164134539|NCT00444457|592857341|FG000|Infant Series|Protocol Violation|16|||
164134540|NCT00444457|592857342|FG001|Infant Series|Protocol Violation|8|||
164134541|NCT00444457|592857343|FG002|Infant Series|Protocol Violation|6|||
164134542|NCT00444457|592857344|FG003|Infant Series|Protocol Violation|3|||
164134543|NCT00444457|592857341|FG000|Infant Series|Failed to return|5|||
164134544|NCT00444457|592857342|FG001|Infant Series|Failed to return|4|||
164134545|NCT00444457|592857343|FG002|Infant Series|Failed to return|4|||
164134546|NCT00444457|592857344|FG003|Infant Series|Failed to return|2|||
164134547|NCT00444457|592857341|FG000|Infant Series|Investigator request|4|||
164134548|NCT00444457|592857342|FG001|Infant Series|Investigator request|3|||
164134549|NCT00444457|592857343|FG002|Infant Series|Investigator request|3|||
164134550|NCT00444457|592857344|FG003|Infant Series|Investigator request|2|||
164134551|NCT00444457|592857341|FG000|Infant Series|Other|0|||
164134552|NCT00444457|592857342|FG001|Infant Series|Other|2|||
164134553|NCT00444457|592857343|FG002|Infant Series|Other|4|||
164134554|NCT00444457|592857344|FG003|Infant Series|Other|0|||
164134555|NCT00444457|592857341|FG000|Infant Series|Adverse Event|1|||
164134556|NCT00444457|592857342|FG001|Infant Series|Adverse Event|2|||
164134557|NCT00444457|592857343|FG002|Infant Series|Adverse Event|2|||
164134558|NCT00444457|592857344|FG003|Infant Series|Adverse Event|0|||
164134559|NCT00444457|592857341|FG000|Infant Series|Death|0|||
164134560|NCT00444457|592857342|FG001|Infant Series|Death|1|||
164134561|NCT00444457|592857343|FG002|Infant Series|Death|1|||
164134562|NCT00444457|592857344|FG003|Infant Series|Death|1|||
164134563|NCT00444457|592857341|FG000|After Infant Series|Other|0|||
164134564|NCT00444457|592857342|FG001|After Infant Series|Other|1|||
164134565|NCT00444457|592857343|FG002|After Infant Series|Other|1|||
164134566|NCT00444457|592857344|FG003|After Infant Series|Other|1|||
164134567|NCT00444457|592857341|FG000|After Infant Series|Parent or legal guardian request|4|||
164134568|NCT00444457|592857342|FG001|After Infant Series|Parent or legal guardian request|11|||
164134569|NCT00444457|592857343|FG002|After Infant Series|Parent or legal guardian request|6|||
164134570|NCT00444457|592857344|FG003|After Infant Series|Parent or legal guardian request|3|||
164134571|NCT00444457|592857341|FG000|After Infant Series|Failed to return|7|||
164134572|NCT00444457|592857342|FG001|After Infant Series|Failed to return|6|||
164134573|NCT00444457|592857343|FG002|After Infant Series|Failed to return|5|||
164134574|NCT00444457|592857344|FG003|After Infant Series|Failed to return|1|||
164134575|NCT00444457|592857341|FG000|After Infant Series|Lost to Follow-up|5|||
164134576|NCT00444457|592857342|FG001|After Infant Series|Lost to Follow-up|5|||
164134577|NCT00444457|592857343|FG002|After Infant Series|Lost to Follow-up|5|||
164134578|NCT00444457|592857344|FG003|After Infant Series|Lost to Follow-up|2|||
164134579|NCT00444457|592857341|FG000|After Infant Series|Protocol Violation|2|||
164134580|NCT00444457|592857342|FG001|After Infant Series|Protocol Violation|4|||
164134581|NCT00444457|592857343|FG002|After Infant Series|Protocol Violation|2|||
164134582|NCT00444457|592857344|FG003|After Infant Series|Protocol Violation|2|||
164134583|NCT00444457|592857341|FG000|After Infant Series|Adverse Event|2|||
164134584|NCT00444457|592857342|FG001|After Infant Series|Adverse Event|2|||
164134585|NCT00444457|592857343|FG002|After Infant Series|Adverse Event|0|||
164134586|NCT00444457|592857344|FG003|After Infant Series|Adverse Event|0|||
164134587|NCT00444457|592857341|FG000|After Infant Series|Investigator request|0|||
164134588|NCT00444457|592857342|FG001|After Infant Series|Investigator request|0|||
164134589|NCT00444457|592857343|FG002|After Infant Series|Investigator request|0|||
164134590|NCT00444457|592857344|FG003|After Infant Series|Investigator request|1|||
164134591|NCT00444457|592857341|FG000|After Infant Series|Other|0|||
164134592|NCT00444457|592857342|FG001|After Infant Series|Other|1|||
164134593|NCT00444457|592857343|FG002|After Infant Series|Other|0|||
164134594|NCT00444457|592857344|FG003|After Infant Series|Other|0|||
164134595|NCT00444457|592857341|FG000|Toddler Dose|Lost to Follow-up|4|||
164134596|NCT00444457|592857342|FG001|Toddler Dose|Lost to Follow-up|1|||
164134597|NCT00444457|592857343|FG002|Toddler Dose|Lost to Follow-up|1|||
164134598|NCT00444457|592857344|FG003|Toddler Dose|Lost to Follow-up|3|||
164134599|NCT00444457|592857341|FG000|Toddler Dose|Failed to return|2|||
164134600|NCT00444457|592857342|FG001|Toddler Dose|Failed to return|2|||
164134601|NCT00444457|592857343|FG002|Toddler Dose|Failed to return|1|||
164134602|NCT00444457|592857344|FG003|Toddler Dose|Failed to return|3|||
164134603|NCT00444457|592857341|FG000|Toddler Dose|Parent or legal guardian request|0|||
164134604|NCT00444457|592857342|FG001|Toddler Dose|Parent or legal guardian request|3|||
164134605|NCT00444457|592857343|FG002|Toddler Dose|Parent or legal guardian request|2|||
164134606|NCT00444457|592857344|FG003|Toddler Dose|Parent or legal guardian request|1|||
164134607|NCT00444457|592857341|FG000|Toddler Dose|Protocol Violation|1|||
164134608|NCT00444457|592857342|FG001|Toddler Dose|Protocol Violation|0|||
164134609|NCT00444457|592857343|FG002|Toddler Dose|Protocol Violation|0|||
164134610|NCT00444457|592857344|FG003|Toddler Dose|Protocol Violation|1|||
164134611|NCT01121666|592857345|FG000|Overall Study|Protocol Violation|29|||
164134724|NCT03970837|592857365|FG010|Overall Study|Withdrawal by Subject|0|||
164134725|NCT03970837|592857366|FG011|Overall Study|Withdrawal by Subject|1|||
164134726|NCT03970837|592857355|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
164134727|NCT03970837|592857356|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
164134728|NCT03970837|592857357|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
164134729|NCT03970837|592857358|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164134730|NCT03970837|592857359|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
164134731|NCT03970837|592857360|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164134732|NCT03970837|592857361|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164134733|NCT03970837|592857362|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164134734|NCT03970837|592857363|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
164134735|NCT03970837|592857364|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164134736|NCT03970837|592857365|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164134737|NCT03970837|592857366|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
164134738|NCT03970837|592857355|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164134739|NCT03970837|592857356|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164134740|NCT03970837|592857357|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164134741|NCT03970837|592857358|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164134742|NCT03970837|592857359|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164134743|NCT03970837|592857360|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164134744|NCT03970837|592857361|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
164134745|NCT03970837|592857362|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
164134746|NCT03970837|592857363|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
164134747|NCT03970837|592857364|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
164134748|NCT03970837|592857365|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
164134749|NCT03970837|592857366|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
164134750|NCT02132754|592857367|FG000|Overall Study|Adverse Event|0|||
164134751|NCT02132754|592857368|FG001|Overall Study|Adverse Event|0|||
164134752|NCT02132754|592857369|FG002|Overall Study|Adverse Event|0|||
164134753|NCT02132754|592857370|FG003|Overall Study|Adverse Event|0|||
164134754|NCT02132754|592857371|FG004|Overall Study|Adverse Event|0|||
164134755|NCT02132754|592857372|FG005|Overall Study|Adverse Event|0|||
164134756|NCT02132754|592857373|FG006|Overall Study|Adverse Event|0|||
164134757|NCT02132754|592857374|FG007|Overall Study|Adverse Event|0|||
164134758|NCT02132754|592857375|FG008|Overall Study|Adverse Event|0|||
164134759|NCT02132754|592857376|FG009|Overall Study|Adverse Event|0|||
164134760|NCT02132754|592857377|FG010|Overall Study|Adverse Event|0|||
164134761|NCT02132754|592857378|FG011|Overall Study|Adverse Event|0|||
164134762|NCT02132754|592857379|FG012|Overall Study|Adverse Event|0|||
164134763|NCT02132754|592857380|FG013|Overall Study|Adverse Event|0|||
164134764|NCT02132754|592857381|FG014|Overall Study|Adverse Event|0|||
164134765|NCT02132754|592857382|FG015|Overall Study|Adverse Event|0|||
164134766|NCT02132754|592857383|FG016|Overall Study|Adverse Event|0|||
164134767|NCT02132754|592857384|FG017|Overall Study|Adverse Event|1|||
164134768|NCT02132754|592857385|FG018|Overall Study|Adverse Event|0|||
164134769|NCT02132754|592857386|FG019|Overall Study|Adverse Event|0|||
164134770|NCT02132754|592857387|FG020|Overall Study|Adverse Event|0|||
164134771|NCT02132754|592857388|FG021|Overall Study|Adverse Event|0|||
164134772|NCT02132754|592857389|FG022|Overall Study|Adverse Event|0|||
164134773|NCT02132754|592857390|FG023|Overall Study|Adverse Event|0|||
164134774|NCT02132754|592857391|FG024|Overall Study|Adverse Event|0|||
164134775|NCT02132754|592857392|FG025|Overall Study|Adverse Event|1|||
164134776|NCT02132754|592857393|FG026|Overall Study|Adverse Event|1|||
164134777|NCT02132754|592857394|FG027|Overall Study|Adverse Event|0|||
164134778|NCT02132754|592857395|FG028|Overall Study|Adverse Event|0|||
164134779|NCT02132754|592857396|FG029|Overall Study|Adverse Event|0|||
164134780|NCT02132754|592857397|FG030|Overall Study|Adverse Event|1|||
164134781|NCT02132754|592857398|FG031|Overall Study|Adverse Event|0|||
164134782|NCT02132754|592857399|FG032|Overall Study|Adverse Event|1|||
164134783|NCT02132754|592857400|FG033|Overall Study|Adverse Event|1|||
164134784|NCT02132754|592857367|FG000|Overall Study|Clinical Progression|0|||
164134785|NCT02132754|592857368|FG001|Overall Study|Clinical Progression|0|||
164134786|NCT02132754|592857369|FG002|Overall Study|Clinical Progression|0|||
164134787|NCT02132754|592857370|FG003|Overall Study|Clinical Progression|0|||
164134788|NCT02132754|592857371|FG004|Overall Study|Clinical Progression|0|||
164134789|NCT02132754|592857372|FG005|Overall Study|Clinical Progression|0|||
164134790|NCT02132754|592857373|FG006|Overall Study|Clinical Progression|0|||
164134791|NCT02132754|592857374|FG007|Overall Study|Clinical Progression|0|||
164134792|NCT02132754|592857375|FG008|Overall Study|Clinical Progression|0|||
164134793|NCT02132754|592857376|FG009|Overall Study|Clinical Progression|1|||
164134794|NCT02132754|592857377|FG010|Overall Study|Clinical Progression|0|||
164134795|NCT02132754|592857378|FG011|Overall Study|Clinical Progression|0|||
164134796|NCT02132754|592857379|FG012|Overall Study|Clinical Progression|0|||
164134797|NCT02132754|592857380|FG013|Overall Study|Clinical Progression|0|||
164134798|NCT02132754|592857381|FG014|Overall Study|Clinical Progression|0|||
164134799|NCT02132754|592857382|FG015|Overall Study|Clinical Progression|0|||
164134800|NCT02132754|592857383|FG016|Overall Study|Clinical Progression|1|||
164134801|NCT02132754|592857384|FG017|Overall Study|Clinical Progression|1|||
164134802|NCT02132754|592857385|FG018|Overall Study|Clinical Progression|0|||
164134803|NCT02132754|592857386|FG019|Overall Study|Clinical Progression|1|||
164134804|NCT02132754|592857387|FG020|Overall Study|Clinical Progression|0|||
164134805|NCT02132754|592857388|FG021|Overall Study|Clinical Progression|0|||
164134806|NCT02132754|592857389|FG022|Overall Study|Clinical Progression|1|||
164134807|NCT02132754|592857390|FG023|Overall Study|Clinical Progression|0|||
164134808|NCT02132754|592857391|FG024|Overall Study|Clinical Progression|1|||
164134809|NCT02132754|592857392|FG025|Overall Study|Clinical Progression|1|||
164134810|NCT02132754|592857393|FG026|Overall Study|Clinical Progression|0|||
164134811|NCT02132754|592857394|FG027|Overall Study|Clinical Progression|1|||
164134812|NCT02132754|592857395|FG028|Overall Study|Clinical Progression|1|||
164134813|NCT02132754|592857396|FG029|Overall Study|Clinical Progression|0|||
164134814|NCT02132754|592857397|FG030|Overall Study|Clinical Progression|1|||
164134815|NCT02132754|592857398|FG031|Overall Study|Clinical Progression|0|||
164134816|NCT02132754|592857399|FG032|Overall Study|Clinical Progression|0|||
164134817|NCT02132754|592857400|FG033|Overall Study|Clinical Progression|2|||
164134818|NCT02132754|592857367|FG000|Overall Study|Death|0|||
164134819|NCT02132754|592857368|FG001|Overall Study|Death|0|||
164134820|NCT02132754|592857369|FG002|Overall Study|Death|0|||
164134821|NCT02132754|592857370|FG003|Overall Study|Death|0|||
164134822|NCT02132754|592857371|FG004|Overall Study|Death|0|||
164134823|NCT02132754|592857372|FG005|Overall Study|Death|0|||
164134824|NCT02132754|592857373|FG006|Overall Study|Death|0|||
164134825|NCT02132754|592857374|FG007|Overall Study|Death|0|||
164134826|NCT02132754|592857375|FG008|Overall Study|Death|0|||
164134827|NCT02132754|592857376|FG009|Overall Study|Death|0|||
164134828|NCT02132754|592857377|FG010|Overall Study|Death|0|||
164134829|NCT02132754|592857378|FG011|Overall Study|Death|0|||
164134830|NCT02132754|592857379|FG012|Overall Study|Death|0|||
164134831|NCT02132754|592857380|FG013|Overall Study|Death|0|||
164134832|NCT02132754|592857381|FG014|Overall Study|Death|0|||
164134833|NCT02132754|592857382|FG015|Overall Study|Death|1|||
164134834|NCT02132754|592857383|FG016|Overall Study|Death|0|||
164134835|NCT02132754|592857384|FG017|Overall Study|Death|0|||
164134836|NCT02132754|592857385|FG018|Overall Study|Death|0|||
164134837|NCT02132754|592857386|FG019|Overall Study|Death|1|||
164134838|NCT02132754|592857387|FG020|Overall Study|Death|0|||
164134839|NCT02132754|592857388|FG021|Overall Study|Death|1|||
164134840|NCT02132754|592857389|FG022|Overall Study|Death|0|||
164134841|NCT02132754|592857390|FG023|Overall Study|Death|0|||
164134842|NCT02132754|592857391|FG024|Overall Study|Death|0|||
164134843|NCT02132754|592857392|FG025|Overall Study|Death|0|||
164134844|NCT02132754|592857393|FG026|Overall Study|Death|1|||
164134845|NCT02132754|592857394|FG027|Overall Study|Death|0|||
164134846|NCT02132754|592857395|FG028|Overall Study|Death|0|||
164134847|NCT02132754|592857396|FG029|Overall Study|Death|0|||
164134848|NCT02132754|592857397|FG030|Overall Study|Death|0|||
164134849|NCT02132754|592857398|FG031|Overall Study|Death|0|||
164134850|NCT02132754|592857399|FG032|Overall Study|Death|0|||
164134851|NCT02132754|592857400|FG033|Overall Study|Death|2|||
164134852|NCT02132754|592857367|FG000|Overall Study|Excluded Medication|0|||
164134853|NCT02132754|592857368|FG001|Overall Study|Excluded Medication|0|||
164134854|NCT02132754|592857369|FG002|Overall Study|Excluded Medication|0|||
164134855|NCT02132754|592857370|FG003|Overall Study|Excluded Medication|0|||
164134856|NCT02132754|592857371|FG004|Overall Study|Excluded Medication|0|||
164134857|NCT02132754|592857372|FG005|Overall Study|Excluded Medication|0|||
164134858|NCT02132754|592857373|FG006|Overall Study|Excluded Medication|0|||
164134859|NCT02132754|592857374|FG007|Overall Study|Excluded Medication|0|||
164134860|NCT02132754|592857375|FG008|Overall Study|Excluded Medication|0|||
164134861|NCT02132754|592857376|FG009|Overall Study|Excluded Medication|0|||
164134862|NCT02132754|592857377|FG010|Overall Study|Excluded Medication|0|||
164134863|NCT02132754|592857378|FG011|Overall Study|Excluded Medication|0|||
164134864|NCT02132754|592857379|FG012|Overall Study|Excluded Medication|0|||
164134865|NCT02132754|592857380|FG013|Overall Study|Excluded Medication|0|||
164134866|NCT02132754|592857381|FG014|Overall Study|Excluded Medication|0|||
164134867|NCT02132754|592857382|FG015|Overall Study|Excluded Medication|0|||
164134868|NCT02132754|592857383|FG016|Overall Study|Excluded Medication|0|||
164134869|NCT02132754|592857384|FG017|Overall Study|Excluded Medication|0|||
164134870|NCT02132754|592857385|FG018|Overall Study|Excluded Medication|0|||
164134871|NCT02132754|592857386|FG019|Overall Study|Excluded Medication|0|||
164134872|NCT02132754|592857387|FG020|Overall Study|Excluded Medication|1|||
164134873|NCT02132754|592857388|FG021|Overall Study|Excluded Medication|0|||
164134874|NCT02132754|592857389|FG022|Overall Study|Excluded Medication|0|||
164134875|NCT02132754|592857390|FG023|Overall Study|Excluded Medication|0|||
164134876|NCT02132754|592857391|FG024|Overall Study|Excluded Medication|0|||
164134877|NCT02132754|592857392|FG025|Overall Study|Excluded Medication|0|||
164134878|NCT02132754|592857393|FG026|Overall Study|Excluded Medication|0|||
164134879|NCT02132754|592857394|FG027|Overall Study|Excluded Medication|0|||
164134880|NCT02132754|592857395|FG028|Overall Study|Excluded Medication|0|||
164134881|NCT02132754|592857396|FG029|Overall Study|Excluded Medication|0|||
164134990|NCT02132754|592857369|FG002|Overall Study|Transferred to Extension Study|0|||
164134991|NCT02132754|592857370|FG003|Overall Study|Transferred to Extension Study|0|||
164134992|NCT02132754|592857371|FG004|Overall Study|Transferred to Extension Study|0|||
164134993|NCT02132754|592857372|FG005|Overall Study|Transferred to Extension Study|0|||
164134994|NCT02132754|592857373|FG006|Overall Study|Transferred to Extension Study|0|||
164134995|NCT02132754|592857374|FG007|Overall Study|Transferred to Extension Study|0|||
164134996|NCT02132754|592857375|FG008|Overall Study|Transferred to Extension Study|0|||
164134997|NCT02132754|592857376|FG009|Overall Study|Transferred to Extension Study|0|||
164134998|NCT02132754|592857377|FG010|Overall Study|Transferred to Extension Study|0|||
164134999|NCT02132754|592857378|FG011|Overall Study|Transferred to Extension Study|0|||
164135000|NCT02132754|592857379|FG012|Overall Study|Transferred to Extension Study|0|||
164135001|NCT02132754|592857380|FG013|Overall Study|Transferred to Extension Study|0|||
164135002|NCT02132754|592857381|FG014|Overall Study|Transferred to Extension Study|0|||
164135003|NCT02132754|592857382|FG015|Overall Study|Transferred to Extension Study|0|||
164135004|NCT02132754|592857383|FG016|Overall Study|Transferred to Extension Study|0|||
164135005|NCT02132754|592857384|FG017|Overall Study|Transferred to Extension Study|0|||
164135006|NCT02132754|592857385|FG018|Overall Study|Transferred to Extension Study|0|||
164135007|NCT02132754|592857386|FG019|Overall Study|Transferred to Extension Study|0|||
164135008|NCT02132754|592857387|FG020|Overall Study|Transferred to Extension Study|0|||
164135009|NCT02132754|592857388|FG021|Overall Study|Transferred to Extension Study|0|||
164135010|NCT02132754|592857389|FG022|Overall Study|Transferred to Extension Study|0|||
164135011|NCT02132754|592857390|FG023|Overall Study|Transferred to Extension Study|0|||
164135012|NCT02132754|592857391|FG024|Overall Study|Transferred to Extension Study|0|||
164135013|NCT02132754|592857392|FG025|Overall Study|Transferred to Extension Study|0|||
164135014|NCT02132754|592857393|FG026|Overall Study|Transferred to Extension Study|0|||
164135015|NCT02132754|592857394|FG027|Overall Study|Transferred to Extension Study|0|||
164135016|NCT02132754|592857395|FG028|Overall Study|Transferred to Extension Study|0|||
164135017|NCT02132754|592857396|FG029|Overall Study|Transferred to Extension Study|0|||
164135018|NCT02132754|592857397|FG030|Overall Study|Transferred to Extension Study|0|||
164135019|NCT02132754|592857398|FG031|Overall Study|Transferred to Extension Study|0|||
164135020|NCT02132754|592857399|FG032|Overall Study|Transferred to Extension Study|0|||
164135021|NCT02132754|592857400|FG033|Overall Study|Transferred to Extension Study|6|||
164135022|NCT02132754|592857367|FG000|Overall Study|Withdrawal by Subject|0|||
164135023|NCT02132754|592857368|FG001|Overall Study|Withdrawal by Subject|0|||
164135024|NCT02132754|592857369|FG002|Overall Study|Withdrawal by Subject|0|||
164135025|NCT02132754|592857370|FG003|Overall Study|Withdrawal by Subject|0|||
164135026|NCT02132754|592857371|FG004|Overall Study|Withdrawal by Subject|0|||
164135027|NCT02132754|592857372|FG005|Overall Study|Withdrawal by Subject|0|||
164135028|NCT02132754|592857373|FG006|Overall Study|Withdrawal by Subject|0|||
164135029|NCT02132754|592857374|FG007|Overall Study|Withdrawal by Subject|0|||
164135030|NCT02132754|592857375|FG008|Overall Study|Withdrawal by Subject|0|||
164135031|NCT02132754|592857376|FG009|Overall Study|Withdrawal by Subject|1|||
164135032|NCT02132754|592857377|FG010|Overall Study|Withdrawal by Subject|0|||
164135033|NCT02132754|592857378|FG011|Overall Study|Withdrawal by Subject|0|||
164135034|NCT02132754|592857379|FG012|Overall Study|Withdrawal by Subject|1|||
164135035|NCT02132754|592857380|FG013|Overall Study|Withdrawal by Subject|0|||
164135036|NCT02132754|592857381|FG014|Overall Study|Withdrawal by Subject|1|||
164135037|NCT02132754|592857382|FG015|Overall Study|Withdrawal by Subject|2|||
164135038|NCT02132754|592857383|FG016|Overall Study|Withdrawal by Subject|1|||
164135039|NCT02132754|592857384|FG017|Overall Study|Withdrawal by Subject|0|||
164135040|NCT02132754|592857385|FG018|Overall Study|Withdrawal by Subject|0|||
164135041|NCT02132754|592857386|FG019|Overall Study|Withdrawal by Subject|0|||
164135042|NCT02132754|592857387|FG020|Overall Study|Withdrawal by Subject|1|||
164135043|NCT02132754|592857388|FG021|Overall Study|Withdrawal by Subject|0|||
164135044|NCT02132754|592857389|FG022|Overall Study|Withdrawal by Subject|0|||
164135045|NCT02132754|592857390|FG023|Overall Study|Withdrawal by Subject|0|||
164135046|NCT02132754|592857391|FG024|Overall Study|Withdrawal by Subject|1|||
164135047|NCT02132754|592857392|FG025|Overall Study|Withdrawal by Subject|0|||
164135048|NCT02132754|592857393|FG026|Overall Study|Withdrawal by Subject|0|||
164135049|NCT02132754|592857394|FG027|Overall Study|Withdrawal by Subject|1|||
164135050|NCT02132754|592857395|FG028|Overall Study|Withdrawal by Subject|0|||
164135051|NCT02132754|592857396|FG029|Overall Study|Withdrawal by Subject|0|||
164135052|NCT02132754|592857397|FG030|Overall Study|Withdrawal by Subject|0|||
164135053|NCT02132754|592857398|FG031|Overall Study|Withdrawal by Subject|1|||
164135054|NCT02132754|592857399|FG032|Overall Study|Withdrawal by Subject|0|||
164135055|NCT02132754|592857400|FG033|Overall Study|Withdrawal by Subject|2|||
164135056|NCT01193127|592857409|FG000|Randomized|Surgery Cancelled|0|||
164135057|NCT01193127|592857410|FG001|Randomized|Surgery Cancelled|0|||
164135058|NCT01193127|592857411|FG002|Randomized|Surgery Cancelled|0|||
164135059|NCT01193127|592857412|FG003|Randomized|Surgery Cancelled|1|||
164135060|NCT01193127|592857409|FG000|Treated|Withdrawal by Subject|0|||
164135061|NCT01193127|592857410|FG001|Treated|Withdrawal by Subject|0|||
164135062|NCT01193127|592857411|FG002|Treated|Withdrawal by Subject|0|||
164135173|NCT00593736|592859097|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
164135174|NCT00593736|592859098|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
164135175|NCT00593736|592859099|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
164135176|NCT00593736|592859100|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
164135177|NCT00593736|592859097|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
164135178|NCT00593736|592859098|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
164135179|NCT00593736|592859099|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
164135180|NCT00593736|592859100|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
164135181|NCT00593736|592859097|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
164135182|NCT00593736|592859098|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
164135183|NCT00593736|592859099|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
164135184|NCT00593736|592859100|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
164135185|NCT00593736|592859097|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
164135186|NCT00593736|592859098|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
164135187|NCT00593736|592859099|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
164135188|NCT00593736|592859100|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
164135189|NCT00593736|592859097|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
164135190|NCT00593736|592859098|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
164135191|NCT00593736|592859099|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
164135192|NCT00593736|592859100|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
164135193|NCT00593736|592859097|FG000|Screening Period and Placebo Run-in|Various|0|||
164135194|NCT00593736|592859098|FG001|Screening Period and Placebo Run-in|Various|0|||
164135195|NCT00593736|592859099|FG002|Screening Period and Placebo Run-in|Various|0|||
164135196|NCT00593736|592859100|FG003|Screening Period and Placebo Run-in|Various|25|||
164135197|NCT00593736|592859097|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
164135198|NCT00593736|592859098|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
164135199|NCT00593736|592859099|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
164135200|NCT00593736|592859100|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
164135201|NCT00593736|592859097|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
164135202|NCT00593736|592859098|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
164135203|NCT00593736|592859099|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
164135204|NCT00593736|592859100|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
164135205|NCT00593736|592859097|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
164135206|NCT00593736|592859098|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
164135207|NCT00593736|592859099|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
164135208|NCT00593736|592859100|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
164135209|NCT00593736|592859097|FG000|Treatment Period and Placebo Run-out|Various|1|||
164135210|NCT00593736|592859098|FG001|Treatment Period and Placebo Run-out|Various|1|||
164135211|NCT00593736|592859099|FG002|Treatment Period and Placebo Run-out|Various|1|||
164135212|NCT00593736|592859100|FG003|Treatment Period and Placebo Run-out|Various|0|||
164135213|NCT01868893|592859101|FG000|Overall Study|Adverse Event|2|||
164135214|NCT01868893|592859101|FG000|Overall Study|Commercial availability of study drug|17|||
164135215|NCT01868893|592859101|FG000|Overall Study|Neutropenia|1|||
164135216|NCT01857271|592859102|FG000|Overall Study|Lost to Follow-up|1|||
164135217|NCT03825341|592859105|FG000|Overall Study|Withdrawal by Subject|0|||
164135218|NCT03825341|592859106|FG001|Overall Study|Withdrawal by Subject|1|||
164135219|NCT04283500|592859109|FG000|Overall Study|Lost to Follow-up|8|||
164135220|NCT04283500|592859109|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
164135221|NCT00470067|592859116|FG000|Overall Study|Death|1|||
164135222|NCT00470067|592859116|FG000|Overall Study|Disease Progression|6|||
164135223|NCT01460901|592859117|FG000|Overall Study|Withdrawal by Subject|2|||
164135224|NCT00338455|592859118|FG000|Overall Study|Death|2|||
164135225|NCT00338455|592859119|FG001|Overall Study|Death|1|||
164135226|NCT00338455|592859118|FG000|Overall Study|Physician Decision|1|||
164135227|NCT00338455|592859119|FG001|Overall Study|Physician Decision|0|||
164135228|NCT01517373|592859120|FG000|Run-in Period|Death|1|||
164135229|NCT01517373|592859121|FG001|Run-in Period|Death|0|||
164135230|NCT01517373|592859122|FG002|Run-in Period|Death|0|||
164135231|NCT01517373|592859123|FG003|Run-in Period|Death|0|||
164135232|NCT01517373|592859124|FG004|Run-in Period|Death|0|||
164135233|NCT01517373|592859125|FG005|Run-in Period|Death|0|||
164135234|NCT01517373|592859120|FG000|Run-in Period|Adverse Event|5|||
164135235|NCT01517373|592859121|FG001|Run-in Period|Adverse Event|0|||
164135236|NCT01517373|592859122|FG002|Run-in Period|Adverse Event|0|||
164135237|NCT01517373|592859123|FG003|Run-in Period|Adverse Event|0|||
164135238|NCT01517373|592859124|FG004|Run-in Period|Adverse Event|0|||
164135239|NCT01517373|592859125|FG005|Run-in Period|Adverse Event|0|||
164135240|NCT01517373|592859120|FG000|Run-in Period|Did not meet eligibility criteria|34|||
164135241|NCT01517373|592859121|FG001|Run-in Period|Did not meet eligibility criteria|0|||
164135242|NCT01517373|592859122|FG002|Run-in Period|Did not meet eligibility criteria|0|||
164135243|NCT01517373|592859123|FG003|Run-in Period|Did not meet eligibility criteria|0|||
164135244|NCT01517373|592859124|FG004|Run-in Period|Did not meet eligibility criteria|0|||
164135245|NCT01517373|592859125|FG005|Run-in Period|Did not meet eligibility criteria|0|||
164135246|NCT01517373|592859120|FG000|Run-in Period|Lost to Follow-up|1|||
164135247|NCT01517373|592859121|FG001|Run-in Period|Lost to Follow-up|0|||
164135248|NCT01517373|592859122|FG002|Run-in Period|Lost to Follow-up|0|||
164135249|NCT01517373|592859123|FG003|Run-in Period|Lost to Follow-up|0|||
164135250|NCT01517373|592859124|FG004|Run-in Period|Lost to Follow-up|0|||
164135251|NCT01517373|592859125|FG005|Run-in Period|Lost to Follow-up|0|||
164135252|NCT01517373|592859120|FG000|Run-in Period|Withdrawal by Subject|12|||
164135253|NCT01517373|592859121|FG001|Run-in Period|Withdrawal by Subject|0|||
164135254|NCT01517373|592859122|FG002|Run-in Period|Withdrawal by Subject|0|||
164135255|NCT01517373|592859123|FG003|Run-in Period|Withdrawal by Subject|0|||
164135256|NCT01517373|592859124|FG004|Run-in Period|Withdrawal by Subject|0|||
164135257|NCT01517373|592859125|FG005|Run-in Period|Withdrawal by Subject|0|||
164135258|NCT01517373|592859120|FG000|Run-in Period|Sponsor Decision|3|||
164135259|NCT01517373|592859121|FG001|Run-in Period|Sponsor Decision|0|||
164135260|NCT01517373|592859122|FG002|Run-in Period|Sponsor Decision|0|||
164135261|NCT01517373|592859123|FG003|Run-in Period|Sponsor Decision|0|||
164135262|NCT01517373|592859124|FG004|Run-in Period|Sponsor Decision|0|||
164135263|NCT01517373|592859125|FG005|Run-in Period|Sponsor Decision|0|||
164135264|NCT01517373|592859120|FG000|Run-in Period|Other|1|||
164135265|NCT01517373|592859121|FG001|Run-in Period|Other|0|||
164135266|NCT01517373|592859122|FG002|Run-in Period|Other|0|||
164135267|NCT01517373|592859123|FG003|Run-in Period|Other|0|||
164135268|NCT01517373|592859124|FG004|Run-in Period|Other|0|||
164135269|NCT01517373|592859125|FG005|Run-in Period|Other|0|||
164135270|NCT01517373|592859120|FG000|Treatment Period|Adverse Event|0|||
164135271|NCT01517373|592859121|FG001|Treatment Period|Adverse Event|0|||
164135272|NCT01517373|592859122|FG002|Treatment Period|Adverse Event|0|||
164135273|NCT01517373|592859123|FG003|Treatment Period|Adverse Event|0|||
164135274|NCT01517373|592859124|FG004|Treatment Period|Adverse Event|0|||
164135275|NCT01517373|592859125|FG005|Treatment Period|Adverse Event|2|||
164135276|NCT01517373|592859120|FG000|Treatment Period|Lost to Follow-up|0|||
164135277|NCT01517373|592859121|FG001|Treatment Period|Lost to Follow-up|0|||
164135278|NCT01517373|592859122|FG002|Treatment Period|Lost to Follow-up|1|||
164135279|NCT01517373|592859123|FG003|Treatment Period|Lost to Follow-up|1|||
164135280|NCT01517373|592859124|FG004|Treatment Period|Lost to Follow-up|0|||
164135281|NCT01517373|592859125|FG005|Treatment Period|Lost to Follow-up|0|||
164135282|NCT01517373|592859120|FG000|Treatment Period|Withdrawal by Subject|0|||
164135283|NCT01517373|592859121|FG001|Treatment Period|Withdrawal by Subject|3|||
164135284|NCT01517373|592859122|FG002|Treatment Period|Withdrawal by Subject|2|||
164135285|NCT01517373|592859123|FG003|Treatment Period|Withdrawal by Subject|2|||
164135286|NCT01517373|592859124|FG004|Treatment Period|Withdrawal by Subject|2|||
164135287|NCT01517373|592859125|FG005|Treatment Period|Withdrawal by Subject|3|||
164135288|NCT01517373|592859120|FG000|Treatment Period|Other|0|||
164135289|NCT01517373|592859121|FG001|Treatment Period|Other|0|||
164135290|NCT01517373|592859122|FG002|Treatment Period|Other|0|||
164135291|NCT01517373|592859123|FG003|Treatment Period|Other|0|||
164135292|NCT01517373|592859124|FG004|Treatment Period|Other|1|||
164135293|NCT01517373|592859125|FG005|Treatment Period|Other|0|||
164135294|NCT01517373|592859120|FG000|Treatment Period|Protocol Violation|0|||
164135295|NCT01517373|592859121|FG001|Treatment Period|Protocol Violation|0|||
164135296|NCT01517373|592859122|FG002|Treatment Period|Protocol Violation|0|||
164135297|NCT01517373|592859123|FG003|Treatment Period|Protocol Violation|0|||
164135298|NCT01517373|592859124|FG004|Treatment Period|Protocol Violation|1|||
164135299|NCT01517373|592859125|FG005|Treatment Period|Protocol Violation|0|||
164135300|NCT01517373|592859120|FG000|Treatment Period|Lack of Efficacy|0|||
164135301|NCT01517373|592859121|FG001|Treatment Period|Lack of Efficacy|1|||
164135302|NCT01517373|592859122|FG002|Treatment Period|Lack of Efficacy|1|||
164135303|NCT01517373|592859123|FG003|Treatment Period|Lack of Efficacy|3|||
164135304|NCT01517373|592859124|FG004|Treatment Period|Lack of Efficacy|2|||
164135305|NCT01517373|592859125|FG005|Treatment Period|Lack of Efficacy|0|||
164135306|NCT01517373|592859120|FG000|Treatment Period|Medication error without AEs|0|||
164135307|NCT01517373|592859121|FG001|Treatment Period|Medication error without AEs|0|||
164135308|NCT01517373|592859122|FG002|Treatment Period|Medication error without AEs|2|||
164135309|NCT01517373|592859123|FG003|Treatment Period|Medication error without AEs|1|||
164135310|NCT01517373|592859124|FG004|Treatment Period|Medication error without AEs|0|||
164135311|NCT01517373|592859125|FG005|Treatment Period|Medication error without AEs|2|||
164135312|NCT00851318|592859129|FG000|Overall Study|Withdrawal by Subject|7|||
164135313|NCT00851318|592859130|FG001|Overall Study|Withdrawal by Subject|1|||
164135314|NCT00851318|592859131|FG002|Overall Study|Withdrawal by Subject|5|||
164135315|NCT00851318|592859132|FG003|Overall Study|Withdrawal by Subject|3|||
164135316|NCT00851318|592859129|FG000|Overall Study|Adverse Event|13|||
164135317|NCT00851318|592859130|FG001|Overall Study|Adverse Event|2|||
164135318|NCT00851318|592859131|FG002|Overall Study|Adverse Event|9|||
164135319|NCT00851318|592859132|FG003|Overall Study|Adverse Event|12|||
164135320|NCT00851318|592859129|FG000|Overall Study|Pregnancy|0|||
164135321|NCT00851318|592859130|FG001|Overall Study|Pregnancy|0|||
164135322|NCT00851318|592859131|FG002|Overall Study|Pregnancy|1|||
164135328|NCT00851318|592859129|FG000|Overall Study|Non-compliance with Study Procedures|2|||
164135329|NCT00851318|592859130|FG001|Overall Study|Non-compliance with Study Procedures|0|||
164135330|NCT00851318|592859131|FG002|Overall Study|Non-compliance with Study Procedures|1|||
164135331|NCT00851318|592859132|FG003|Overall Study|Non-compliance with Study Procedures|0|||
164135332|NCT00851318|592859129|FG000|Overall Study|Physician Decision|0|||
164135333|NCT00851318|592859130|FG001|Overall Study|Physician Decision|0|||
164135334|NCT00851318|592859131|FG002|Overall Study|Physician Decision|1|||
164135335|NCT00851318|592859132|FG003|Overall Study|Physician Decision|1|||
164135336|NCT03597529|592859137|FG000|Overall Study|Lost to Follow-up|10|||
164135337|NCT03597529|592859138|FG001|Overall Study|Lost to Follow-up|12|||
164135338|NCT03597529|592859137|FG000|Overall Study|Physician Decision|3|||
164135339|NCT03597529|592859138|FG001|Overall Study|Physician Decision|1|||
164135340|NCT03597529|592859137|FG000|Overall Study|Withdrawal by Subject|6|||
164135341|NCT03597529|592859138|FG001|Overall Study|Withdrawal by Subject|3|||
164135342|NCT03597529|592859137|FG000|Overall Study|Non-compliant with study activities|1|||
164135343|NCT03597529|592859138|FG001|Overall Study|Non-compliant with study activities|2|||
164135344|NCT01755767|592859143|FG000|Overall Study|Progressive Disease|8|||
164135345|NCT01755767|592859144|FG001|Overall Study|Progressive Disease|7|||
164135346|NCT01755767|592859145|FG002|Overall Study|Progressive Disease|91|||
164135347|NCT01755767|592859146|FG003|Overall Study|Progressive Disease|43|||
164135348|NCT01755767|592859143|FG000|Overall Study|Clinical Disease Progression|4|||
164135349|NCT01755767|592859144|FG001|Overall Study|Clinical Disease Progression|2|||
164135350|NCT01755767|592859145|FG002|Overall Study|Clinical Disease Progression|29|||
164135351|NCT01755767|592859146|FG003|Overall Study|Clinical Disease Progression|20|||
164135352|NCT01755767|592859143|FG000|Overall Study|Radiographic Disease Progression|9|||
164135353|NCT01755767|592859144|FG001|Overall Study|Radiographic Disease Progression|4|||
164135354|NCT01755767|592859145|FG002|Overall Study|Radiographic Disease Progression|44|||
164135355|NCT01755767|592859146|FG003|Overall Study|Radiographic Disease Progression|27|||
164135356|NCT01755767|592859143|FG000|Overall Study|Adverse Event|6|||
164135357|NCT01755767|592859144|FG001|Overall Study|Adverse Event|0|||
164135358|NCT01755767|592859145|FG002|Overall Study|Adverse Event|28|||
164135359|NCT01755767|592859146|FG003|Overall Study|Adverse Event|11|||
164135360|NCT01755767|592859143|FG000|Overall Study|Death|1|||
164135361|NCT01755767|592859144|FG001|Overall Study|Death|2|||
164135362|NCT01755767|592859145|FG002|Overall Study|Death|15|||
164135363|NCT01755767|592859146|FG003|Overall Study|Death|4|||
164135364|NCT01755767|592859143|FG000|Overall Study|Subject Decision|0|||
164135365|NCT01755767|592859144|FG001|Overall Study|Subject Decision|0|||
164135366|NCT01755767|592859145|FG002|Overall Study|Subject Decision|10|||
164135367|NCT01755767|592859146|FG003|Overall Study|Subject Decision|3|||
164135368|NCT01755767|592859143|FG000|Overall Study|Withdrawal by Subject|0|||
164135369|NCT01755767|592859144|FG001|Overall Study|Withdrawal by Subject|0|||
164135370|NCT01755767|592859145|FG002|Overall Study|Withdrawal by Subject|2|||
164135371|NCT01755767|592859146|FG003|Overall Study|Withdrawal by Subject|1|||
164135372|NCT01755767|592859143|FG000|Overall Study|Other|0|||
164135373|NCT01755767|592859144|FG001|Overall Study|Other|0|||
164135374|NCT01755767|592859145|FG002|Overall Study|Other|2|||
164135375|NCT01755767|592859146|FG003|Overall Study|Other|3|||
164135376|NCT01755767|592859143|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
164135377|NCT01755767|592859144|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
164135378|NCT01755767|592859145|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
164135379|NCT01755767|592859146|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
164135380|NCT02196701|592859148|FG000|Overall Study|Adverse Event|1|||
164135381|NCT02196701|592859148|FG000|Overall Study|Lost to Follow-up|1|||
164135382|NCT02196701|592859148|FG000|Overall Study|Non-adherence to Protocol|1|||
164135383|NCT01341782|592859151|FG000|Overall Study|Adverse Event|1|||
164135384|NCT01341782|592859152|FG001|Overall Study|Adverse Event|1|||
164135385|NCT01341782|592859151|FG000|Overall Study|Withdrawal by Subject|6|||
164135386|NCT01341782|592859152|FG001|Overall Study|Withdrawal by Subject|5|||
164135387|NCT01341782|592859151|FG000|Overall Study|Missed 3 consecutive doses|0|||
164135388|NCT01341782|592859152|FG001|Overall Study|Missed 3 consecutive doses|4|||
164135389|NCT01341782|592859151|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
164135390|NCT01341782|592859152|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
164135391|NCT01341782|592859151|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
164135392|NCT01341782|592859152|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
164135393|NCT01341782|592859151|FG000|Overall Study|Other|5|||
164135394|NCT01341782|592859152|FG001|Overall Study|Other|0|||
164135395|NCT03796039|592859153|FG000|Overall Study|Death|2|||
164135396|NCT03796039|592859154|FG001|Overall Study|Death|1|||
164135397|NCT03796039|592859153|FG000|Overall Study|Withdrawal by Subject|7|||
164135398|NCT03796039|592859154|FG001|Overall Study|Withdrawal by Subject|4|||
164135399|NCT01140503|592859155|FG000|Overall Study|Withdrawal by Subject|1|||
164135400|NCT01157897|592859157|FG000|Overall Study|Lost to Follow-up|2|||
164135401|NCT01157897|592859158|FG001|Overall Study|Lost to Follow-up|0|||
164135402|NCT01157897|592859159|FG002|Overall Study|Lost to Follow-up|0|||
164135403|NCT01157897|592859160|FG003|Overall Study|Lost to Follow-up|1|||
164135404|NCT01157897|592859157|FG000|Overall Study|Relocated|0|||
164135408|NCT00681590|592859161|FG000|Overall Study|Withdrawal by Subject|2|||
164135409|NCT00681590|592859162|FG001|Overall Study|Withdrawal by Subject|12|||
164135410|NCT01791153|592859165|FG000|Part 1: Blinded Period|Adverse Event|7|||
164135411|NCT01791153|592859166|FG001|Part 1: Blinded Period|Adverse Event|3|||
164135412|NCT01791153|592859167|FG002|Part 1: Blinded Period|Adverse Event|2|||
164135413|NCT01791153|592859168|FG003|Part 1: Blinded Period|Adverse Event|0|||
164135414|NCT01791153|592859169|FG004|Part 1: Blinded Period|Adverse Event|0|||
164135415|NCT01791153|592859170|FG005|Part 1: Blinded Period|Adverse Event|0|||
164135416|NCT01791153|592859171|FG006|Part 1: Blinded Period|Adverse Event|0|||
164135417|NCT01791153|592859172|FG007|Part 1: Blinded Period|Adverse Event|0|||
164135418|NCT01791153|592859165|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
164135419|NCT01791153|592859166|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
164135420|NCT01791153|592859167|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
164135421|NCT01791153|592859168|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
164135422|NCT01791153|592859169|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
164135423|NCT01791153|592859170|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
164135424|NCT01791153|592859171|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
164135425|NCT01791153|592859172|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
164135426|NCT01791153|592859165|FG000|Part 1: Blinded Period|Non-Compliance|1|||
164135427|NCT01791153|592859166|FG001|Part 1: Blinded Period|Non-Compliance|0|||
164135428|NCT01791153|592859167|FG002|Part 1: Blinded Period|Non-Compliance|0|||
164135429|NCT01791153|592859168|FG003|Part 1: Blinded Period|Non-Compliance|0|||
164135430|NCT01791153|592859169|FG004|Part 1: Blinded Period|Non-Compliance|0|||
164135431|NCT01791153|592859170|FG005|Part 1: Blinded Period|Non-Compliance|0|||
164135432|NCT01791153|592859171|FG006|Part 1: Blinded Period|Non-Compliance|0|||
164135433|NCT01791153|592859172|FG007|Part 1: Blinded Period|Non-Compliance|0|||
164135434|NCT01791153|592859165|FG000|Part 1: Blinded Period|Physician Decision|0|||
164135435|NCT01791153|592859166|FG001|Part 1: Blinded Period|Physician Decision|0|||
164135436|NCT01791153|592859167|FG002|Part 1: Blinded Period|Physician Decision|0|||
164135437|NCT01791153|592859168|FG003|Part 1: Blinded Period|Physician Decision|1|||
164135438|NCT01791153|592859169|FG004|Part 1: Blinded Period|Physician Decision|0|||
164135439|NCT01791153|592859170|FG005|Part 1: Blinded Period|Physician Decision|0|||
164135440|NCT01791153|592859171|FG006|Part 1: Blinded Period|Physician Decision|0|||
164135441|NCT01791153|592859172|FG007|Part 1: Blinded Period|Physician Decision|0|||
164135442|NCT01791153|592859165|FG000|Part 1: Blinded Period|Protocol Violation|0|||
164135443|NCT01791153|592859166|FG001|Part 1: Blinded Period|Protocol Violation|0|||
164135444|NCT01791153|592859167|FG002|Part 1: Blinded Period|Protocol Violation|0|||
164135445|NCT01791153|592859168|FG003|Part 1: Blinded Period|Protocol Violation|1|||
164135446|NCT01791153|592859169|FG004|Part 1: Blinded Period|Protocol Violation|0|||
164135447|NCT01791153|592859170|FG005|Part 1: Blinded Period|Protocol Violation|0|||
164135448|NCT01791153|592859171|FG006|Part 1: Blinded Period|Protocol Violation|0|||
164135449|NCT01791153|592859172|FG007|Part 1: Blinded Period|Protocol Violation|0|||
164135450|NCT01791153|592859165|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
164135451|NCT01791153|592859166|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
164135452|NCT01791153|592859167|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
164135453|NCT01791153|592859168|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
164135454|NCT01791153|592859169|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
164135455|NCT01791153|592859170|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
164135456|NCT01791153|592859171|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
164135457|NCT01791153|592859172|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
164135458|NCT01791153|592859165|FG000|Part 2: Open-label Period|Adverse Event|0|||
164135459|NCT01791153|592859166|FG001|Part 2: Open-label Period|Adverse Event|0|||
164135460|NCT01791153|592859167|FG002|Part 2: Open-label Period|Adverse Event|0|||
164135461|NCT01791153|592859168|FG003|Part 2: Open-label Period|Adverse Event|0|||
164135462|NCT01791153|592859169|FG004|Part 2: Open-label Period|Adverse Event|0|||
164135463|NCT01791153|592859170|FG005|Part 2: Open-label Period|Adverse Event|1|||
164135464|NCT01791153|592859171|FG006|Part 2: Open-label Period|Adverse Event|1|||
164135465|NCT01791153|592859172|FG007|Part 2: Open-label Period|Adverse Event|2|||
164135466|NCT01791153|592859165|FG000|Part 2: Open-label Period|Death|0|||
164135467|NCT01791153|592859166|FG001|Part 2: Open-label Period|Death|0|||
164135468|NCT01791153|592859167|FG002|Part 2: Open-label Period|Death|0|||
164135469|NCT01791153|592859168|FG003|Part 2: Open-label Period|Death|0|||
164135470|NCT01791153|592859169|FG004|Part 2: Open-label Period|Death|0|||
164135471|NCT01791153|592859170|FG005|Part 2: Open-label Period|Death|1|||
164135472|NCT01791153|592859171|FG006|Part 2: Open-label Period|Death|1|||
164135473|NCT01791153|592859172|FG007|Part 2: Open-label Period|Death|1|||
164135474|NCT01791153|592859165|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
164135475|NCT01791153|592859166|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
164135476|NCT01791153|592859167|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
164135477|NCT01791153|592859168|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
164135478|NCT01791153|592859169|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
164135479|NCT01791153|592859170|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
164135480|NCT01791153|592859171|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
164135481|NCT01791153|592859172|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
164135634|NCT02799095|592861962|FG007|Part A|Adverse Event|0|||
164135482|NCT01791153|592859165|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
164135483|NCT01791153|592859166|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
164135484|NCT01791153|592859167|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
164135485|NCT01791153|592859168|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
164135486|NCT01791153|592859169|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
164135487|NCT01791153|592859170|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
164135488|NCT01791153|592859171|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
164135489|NCT01791153|592859172|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
164135490|NCT01791153|592859165|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
164135491|NCT01791153|592859166|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
164135492|NCT01791153|592859167|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
164135493|NCT01791153|592859168|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
164135494|NCT01791153|592859169|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
164135495|NCT01791153|592859170|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
164135496|NCT01791153|592859171|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
164135497|NCT01791153|592859172|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
164135498|NCT01791153|592859165|FG000|Part 2: Open-label Period|Physician Decision|0|||
164135499|NCT01791153|592859166|FG001|Part 2: Open-label Period|Physician Decision|0|||
164135500|NCT01791153|592859167|FG002|Part 2: Open-label Period|Physician Decision|0|||
164135501|NCT01791153|592859168|FG003|Part 2: Open-label Period|Physician Decision|0|||
164135502|NCT01791153|592859169|FG004|Part 2: Open-label Period|Physician Decision|1|||
164135503|NCT01791153|592859170|FG005|Part 2: Open-label Period|Physician Decision|1|||
164135504|NCT01791153|592859171|FG006|Part 2: Open-label Period|Physician Decision|0|||
164135505|NCT01791153|592859172|FG007|Part 2: Open-label Period|Physician Decision|0|||
164135506|NCT02562482|592859176|FG000|Overall Study|Enrolled, but did not receive product|4|||
164135507|NCT02562482|592859177|FG001|Overall Study|Enrolled, but did not receive product|0|||
164135508|NCT02562482|592859176|FG000|Overall Study|Lost to Follow-up|9|||
164135509|NCT02562482|592859177|FG001|Overall Study|Lost to Follow-up|6|||
164135510|NCT02562482|592859176|FG000|Overall Study|Moved from area|2|||
164135511|NCT02562482|592859177|FG001|Overall Study|Moved from area|3|||
164135512|NCT02562482|592859176|FG000|Overall Study|Withdrawal by Subject|5|||
164135513|NCT02562482|592859177|FG001|Overall Study|Withdrawal by Subject|3|||
164135514|NCT02562482|592859176|FG000|Overall Study|Physician Decision|1|||
164135515|NCT02562482|592859177|FG001|Overall Study|Physician Decision|3|||
164135516|NCT02562482|592859176|FG000|Overall Study|Illness/Injury unrelated to product|0|||
164135517|NCT02562482|592859177|FG001|Overall Study|Illness/Injury unrelated to product|1|||
164135518|NCT04669691|592859178|FG000|Overall Study|Death|0|||
164135519|NCT04669691|592859179|FG001|Overall Study|Death|1|||
164135520|NCT04669691|592859180|FG002|Overall Study|Death|0|||
164135521|NCT04669691|592859181|FG003|Overall Study|Death|0|||
164135522|NCT04669691|592859182|FG004|Overall Study|Death|0|||
164135523|NCT04669691|592859183|FG005|Overall Study|Death|0|||
164135524|NCT04156620|592859184|FG000|Overall Study|Adverse event - TP 1|5|||
164135525|NCT04156620|592859185|FG001|Overall Study|Adverse event - TP 1|2|||
164135526|NCT04156620|592859184|FG000|Overall Study|Lost to follow-up TP 1|1|||
164135527|NCT04156620|592859185|FG001|Overall Study|Lost to follow-up TP 1|1|||
164135528|NCT04156620|592859184|FG000|Overall Study|Progressive disease - TP 1|0|||
164135529|NCT04156620|592859185|FG001|Overall Study|Progressive disease - TP 1|1|||
164135530|NCT04156620|592859184|FG000|Overall Study|Subject decision - TP 1|3|||
164135531|NCT04156620|592859185|FG001|Overall Study|Subject decision - TP 1|5|||
164135532|NCT04156620|592859184|FG000|Overall Study|Adverse event - TP 2|5|||
164135533|NCT04156620|592859185|FG001|Overall Study|Adverse event - TP 2|6|||
164135534|NCT04156620|592859184|FG000|Overall Study|Death - TP 2|1|||
164135535|NCT04156620|592859185|FG001|Overall Study|Death - TP 2|0|||
164135536|NCT04156620|592859184|FG000|Overall Study|Lost to follow-up - TP 2|5|||
164135537|NCT04156620|592859185|FG001|Overall Study|Lost to follow-up - TP 2|2|||
164135538|NCT04156620|592859184|FG000|Overall Study|Physician decision - TP 2|4|||
164135539|NCT04156620|592859185|FG001|Overall Study|Physician decision - TP 2|2|||
164135540|NCT04156620|592859184|FG000|Overall Study|Pregnancy - TP 2|1|||
164135541|NCT04156620|592859185|FG001|Overall Study|Pregnancy - TP 2|1|||
164135542|NCT04156620|592859184|FG000|Overall Study|Subject decision - TP 2|11|||
164135543|NCT04156620|592859185|FG001|Overall Study|Subject decision - TP 2|9|||
164135544|NCT04156620|592859184|FG000|Overall Study|New therapy for study indication - TP 2|1|||
164135545|NCT04156620|592859185|FG001|Overall Study|New therapy for study indication - TP 2|0|||
164135546|NCT00390221|592859191|FG000|Overall Study|Lost to Follow-up|0|||
164135547|NCT00390221|592859192|FG001|Overall Study|Lost to Follow-up|3|||
164135548|NCT00390221|592859193|FG002|Overall Study|Lost to Follow-up|0|||
164135549|NCT00390221|592859191|FG000|Overall Study|Adverse Event|1|||
164135550|NCT00390221|592859192|FG001|Overall Study|Adverse Event|4|||
164135551|NCT00390221|592859193|FG002|Overall Study|Adverse Event|3|||
164135552|NCT00390221|592859191|FG000|Overall Study|Investigator Decision|0|||
164135553|NCT00390221|592859192|FG001|Overall Study|Investigator Decision|0|||
164135554|NCT00390221|592859193|FG002|Overall Study|Investigator Decision|1|||
164135555|NCT00390221|592859191|FG000|Overall Study|Withdrawal by Subject|13|||
164135556|NCT00390221|592859192|FG001|Overall Study|Withdrawal by Subject|9|||
164135557|NCT00390221|592859193|FG002|Overall Study|Withdrawal by Subject|7|||
164135558|NCT00390221|592859191|FG000|Overall Study|Subject Non-compliance|1|||
164135559|NCT00390221|592859192|FG001|Overall Study|Subject Non-compliance|0|||
164135560|NCT00390221|592859193|FG002|Overall Study|Subject Non-compliance|2|||
164135561|NCT00390221|592859191|FG000|Overall Study|Other|3|||
164135562|NCT00390221|592859192|FG001|Overall Study|Other|4|||
164135563|NCT00390221|592859193|FG002|Overall Study|Other|2|||
164135564|NCT02011386|592859198|FG000|Overall Study|Non-compliance|2|||
164135565|NCT02011386|592859198|FG000|Overall Study|Lack of Efficacy|3|||
164135566|NCT04555720|592859199|FG000|Overall Study|Lost to Follow-up|2|||
164135567|NCT04555720|592859200|FG001|Overall Study|Lost to Follow-up|0|||
164135568|NCT04555720|592859201|FG002|Overall Study|Lost to Follow-up|0|||
164135569|NCT04555720|592859202|FG003|Overall Study|Lost to Follow-up|0|||
164135570|NCT04555720|592859199|FG000|Overall Study|Withdrawal by Subject|4|||
164135571|NCT04555720|592859200|FG001|Overall Study|Withdrawal by Subject|6|||
164135572|NCT04555720|592859201|FG002|Overall Study|Withdrawal by Subject|0|||
164135573|NCT04555720|592859202|FG003|Overall Study|Withdrawal by Subject|0|||
164135574|NCT00321737|592859203|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
164135575|NCT00321737|592859204|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
164135576|NCT00321737|592859205|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
164135577|NCT00321737|592859203|FG000|Overall Study|Adverse Event|11|||
164135578|NCT00321737|592859204|FG001|Overall Study|Adverse Event|3|||
164135579|NCT00321737|592859205|FG002|Overall Study|Adverse Event|6|||
164135580|NCT00321737|592859203|FG000|Overall Study|Lost to Follow-up|5|||
164135581|NCT00321737|592859204|FG001|Overall Study|Lost to Follow-up|5|||
164135582|NCT00321737|592859205|FG002|Overall Study|Lost to Follow-up|6|||
164135583|NCT00321737|592859203|FG000|Overall Study|Withdrawal by Subject|19|||
164135584|NCT00321737|592859204|FG001|Overall Study|Withdrawal by Subject|12|||
164135585|NCT00321737|592859205|FG002|Overall Study|Withdrawal by Subject|17|||
164135586|NCT00321737|592859203|FG000|Overall Study|Protocol Violation|0|||
164135587|NCT00321737|592859204|FG001|Overall Study|Protocol Violation|0|||
164135588|NCT00321737|592859205|FG002|Overall Study|Protocol Violation|1|||
164135589|NCT00321737|592859203|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
164135590|NCT00321737|592859204|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164135591|NCT00321737|592859205|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
164135592|NCT00321737|592859203|FG000|Overall Study|Possible Barrett's Esophagus|2|||
164135593|NCT00321737|592859204|FG001|Overall Study|Possible Barrett's Esophagus|1|||
164135594|NCT00321737|592859205|FG002|Overall Study|Possible Barrett's Esophagus|1|||
164135595|NCT00321737|592859203|FG000|Overall Study|Therapeutic Failure|6|||
164135596|NCT00321737|592859204|FG001|Overall Study|Therapeutic Failure|0|||
164135597|NCT00321737|592859205|FG002|Overall Study|Therapeutic Failure|2|||
164135598|NCT00321737|592859203|FG000|Overall Study|Pregnancy|0|||
164135599|NCT00321737|592859204|FG001|Overall Study|Pregnancy|2|||
164135600|NCT00321737|592859205|FG002|Overall Study|Pregnancy|0|||
164135601|NCT00321737|592859203|FG000|Overall Study|Noncompliance|2|||
164135602|NCT00321737|592859204|FG001|Overall Study|Noncompliance|0|||
164135603|NCT00321737|592859205|FG002|Overall Study|Noncompliance|0|||
164135604|NCT00321737|592859203|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
164135605|NCT00321737|592859204|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
164135606|NCT00321737|592859205|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
164135607|NCT02283294|592859206|FG000|Overall Study|Lost to Follow-up|1|||
164135608|NCT02283294|592859207|FG001|Overall Study|Lost to Follow-up|1|||
164135609|NCT02283294|592859206|FG000|Overall Study|Withdrawal by Subject|1|||
164135610|NCT02283294|592859207|FG001|Overall Study|Withdrawal by Subject|6|||
164135611|NCT02283294|592859206|FG000|Overall Study|Protocol Violation|1|||
164135612|NCT02283294|592859207|FG001|Overall Study|Protocol Violation|0|||
164135613|NCT02283294|592859206|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
164135614|NCT02283294|592859207|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
164135615|NCT00633243|592861953|FG000|Overall Study|Withdrawal by Subject|0|||
164135616|NCT00633243|592861954|FG001|Overall Study|Withdrawal by Subject|1|||
164135617|NCT00633243|592861953|FG000|Overall Study|incarceration|0|||
164135618|NCT00633243|592861954|FG001|Overall Study|incarceration|2|||
164135619|NCT00633243|592861953|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
164135620|NCT00633243|592861954|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
164135621|NCT00633243|592861953|FG000|Overall Study|Not comfortable with self-injecting|0|||
164135622|NCT00633243|592861954|FG001|Overall Study|Not comfortable with self-injecting|1|||
164135623|NCT00633243|592861953|FG000|Overall Study|Mental Health--Depression|0|||
164135624|NCT00633243|592861954|FG001|Overall Study|Mental Health--Depression|1|||
164135625|NCT00633243|592861953|FG000|Overall Study|Couldn't tolerate side-effects|1|||
164135626|NCT00633243|592861954|FG001|Overall Study|Couldn't tolerate side-effects|1|||
164135627|NCT02799095|592861955|FG000|Part A|Adverse Event|1|||
164135628|NCT02799095|592861956|FG001|Part A|Adverse Event|0|||
164135629|NCT02799095|592861957|FG002|Part A|Adverse Event|1|||
164135630|NCT02799095|592861958|FG003|Part A|Adverse Event|4|||
164135631|NCT02799095|592861959|FG004|Part A|Adverse Event|1|||
164135632|NCT02799095|592861960|FG005|Part A|Adverse Event|0|||
164135633|NCT02799095|592861961|FG006|Part A|Adverse Event|0|||
164135747|NCT02799095|592861956|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
164135748|NCT02799095|592861957|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
164135749|NCT02799095|592861958|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
164135750|NCT02799095|592861959|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
164135751|NCT02799095|592861960|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
164135752|NCT02799095|592861961|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
164135753|NCT02799095|592861962|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
164135754|NCT02799095|592861963|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
164135755|NCT02799095|592861964|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
164135756|NCT02799095|592861965|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
164135757|NCT02799095|592861966|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
164135758|NCT02799095|592861967|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
164135759|NCT02799095|592861968|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
164135760|NCT02799095|592861969|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
164135761|NCT02799095|592861970|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
164135762|NCT02799095|592861971|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
164135763|NCT02799095|592861955|FG000|Part B|Death|0|||
164135764|NCT02799095|592861956|FG001|Part B|Death|0|||
164135765|NCT02799095|592861957|FG002|Part B|Death|0|||
164135766|NCT02799095|592861958|FG003|Part B|Death|0|||
164135767|NCT02799095|592861959|FG004|Part B|Death|0|||
164135768|NCT02799095|592861960|FG005|Part B|Death|0|||
164135769|NCT02799095|592861961|FG006|Part B|Death|0|||
164135770|NCT02799095|592861962|FG007|Part B|Death|7|||
164135771|NCT02799095|592861963|FG008|Part B|Death|7|||
164135772|NCT02799095|592861964|FG009|Part B|Death|0|||
164135773|NCT02799095|592861965|FG010|Part B|Death|0|||
164135774|NCT02799095|592861966|FG011|Part B|Death|0|||
164135775|NCT02799095|592861967|FG012|Part B|Death|0|||
164135776|NCT02799095|592861968|FG013|Part B|Death|0|||
164135777|NCT02799095|592861969|FG014|Part B|Death|0|||
164135778|NCT02799095|592861970|FG015|Part B|Death|0|||
164135779|NCT02799095|592861971|FG016|Part B|Death|0|||
164135780|NCT02799095|592861955|FG000|Part B|Progressive Disease|0|||
164135781|NCT02799095|592861956|FG001|Part B|Progressive Disease|0|||
164135782|NCT02799095|592861957|FG002|Part B|Progressive Disease|0|||
164135783|NCT02799095|592861958|FG003|Part B|Progressive Disease|0|||
164135784|NCT02799095|592861959|FG004|Part B|Progressive Disease|0|||
164135785|NCT02799095|592861960|FG005|Part B|Progressive Disease|0|||
164135786|NCT02799095|592861961|FG006|Part B|Progressive Disease|0|||
164135787|NCT02799095|592861962|FG007|Part B|Progressive Disease|1|||
164135788|NCT02799095|592861963|FG008|Part B|Progressive Disease|0|||
164135789|NCT02799095|592861964|FG009|Part B|Progressive Disease|0|||
164135790|NCT02799095|592861965|FG010|Part B|Progressive Disease|0|||
164135791|NCT02799095|592861966|FG011|Part B|Progressive Disease|0|||
164135792|NCT02799095|592861967|FG012|Part B|Progressive Disease|0|||
164135793|NCT02799095|592861968|FG013|Part B|Progressive Disease|0|||
164135794|NCT02799095|592861969|FG014|Part B|Progressive Disease|0|||
164135795|NCT02799095|592861970|FG015|Part B|Progressive Disease|0|||
164135796|NCT02799095|592861971|FG016|Part B|Progressive Disease|0|||
164135797|NCT02799095|592861955|FG000|Part B|Withdrawal by Subject|0|||
164135798|NCT02799095|592861956|FG001|Part B|Withdrawal by Subject|0|||
164135799|NCT02799095|592861957|FG002|Part B|Withdrawal by Subject|0|||
164135800|NCT02799095|592861958|FG003|Part B|Withdrawal by Subject|0|||
164135801|NCT02799095|592861959|FG004|Part B|Withdrawal by Subject|0|||
164135802|NCT02799095|592861960|FG005|Part B|Withdrawal by Subject|0|||
164135803|NCT02799095|592861961|FG006|Part B|Withdrawal by Subject|0|||
164135804|NCT02799095|592861962|FG007|Part B|Withdrawal by Subject|10|||
164135805|NCT02799095|592861963|FG008|Part B|Withdrawal by Subject|7|||
164135806|NCT02799095|592861964|FG009|Part B|Withdrawal by Subject|0|||
164135807|NCT02799095|592861965|FG010|Part B|Withdrawal by Subject|0|||
164135808|NCT02799095|592861966|FG011|Part B|Withdrawal by Subject|0|||
164135809|NCT02799095|592861967|FG012|Part B|Withdrawal by Subject|0|||
164135810|NCT02799095|592861968|FG013|Part B|Withdrawal by Subject|0|||
164135811|NCT02799095|592861969|FG014|Part B|Withdrawal by Subject|0|||
164135812|NCT02799095|592861970|FG015|Part B|Withdrawal by Subject|0|||
164135813|NCT02799095|592861971|FG016|Part B|Withdrawal by Subject|0|||
164135814|NCT02799095|592861955|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
164135815|NCT02799095|592861956|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
164135816|NCT02799095|592861957|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
164135817|NCT02799095|592861958|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
164135818|NCT02799095|592861959|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
164135819|NCT02799095|592861960|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
164135820|NCT02799095|592861961|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
164135821|NCT02799095|592861962|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
164135822|NCT02799095|592861963|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
164135823|NCT02799095|592861964|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
164135824|NCT02799095|592861965|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
164135825|NCT02799095|592861966|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
164135826|NCT02799095|592861967|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
164135827|NCT02799095|592861968|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
164135914|NCT02799095|592861970|FG015|Part C|Clinical Progression|0|||
164135828|NCT02799095|592861969|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
164135829|NCT02799095|592861970|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
164135830|NCT02799095|592861971|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
164135831|NCT02799095|592861955|FG000|Part C|Adverse Event|0|||
164135832|NCT02799095|592861956|FG001|Part C|Adverse Event|0|||
164135833|NCT02799095|592861957|FG002|Part C|Adverse Event|0|||
164135834|NCT02799095|592861958|FG003|Part C|Adverse Event|0|||
164135835|NCT02799095|592861959|FG004|Part C|Adverse Event|0|||
164135836|NCT02799095|592861960|FG005|Part C|Adverse Event|0|||
164135837|NCT02799095|592861961|FG006|Part C|Adverse Event|0|||
164135838|NCT02799095|592861962|FG007|Part C|Adverse Event|0|||
164135839|NCT02799095|592861963|FG008|Part C|Adverse Event|0|||
164135840|NCT02799095|592861964|FG009|Part C|Adverse Event|0|||
164135841|NCT02799095|592861965|FG010|Part C|Adverse Event|3|||
164135842|NCT02799095|592861966|FG011|Part C|Adverse Event|1|||
164135843|NCT02799095|592861967|FG012|Part C|Adverse Event|0|||
164135844|NCT02799095|592861968|FG013|Part C|Adverse Event|1|||
164135845|NCT02799095|592861969|FG014|Part C|Adverse Event|0|||
164135846|NCT02799095|592861970|FG015|Part C|Adverse Event|0|||
164135847|NCT02799095|592861971|FG016|Part C|Adverse Event|0|||
164135848|NCT02799095|592861955|FG000|Part C|Death|0|||
164135849|NCT02799095|592861956|FG001|Part C|Death|0|||
164135850|NCT02799095|592861957|FG002|Part C|Death|0|||
164135851|NCT02799095|592861958|FG003|Part C|Death|0|||
164135852|NCT02799095|592861959|FG004|Part C|Death|0|||
164135853|NCT02799095|592861960|FG005|Part C|Death|0|||
164135854|NCT02799095|592861961|FG006|Part C|Death|0|||
164135855|NCT02799095|592861962|FG007|Part C|Death|0|||
164135856|NCT02799095|592861963|FG008|Part C|Death|0|||
164135857|NCT02799095|592861964|FG009|Part C|Death|0|||
164135858|NCT02799095|592861965|FG010|Part C|Death|7|||
164135859|NCT02799095|592861966|FG011|Part C|Death|5|||
164135860|NCT02799095|592861967|FG012|Part C|Death|6|||
164135861|NCT02799095|592861968|FG013|Part C|Death|8|||
164135862|NCT02799095|592861969|FG014|Part C|Death|1|||
164135863|NCT02799095|592861970|FG015|Part C|Death|8|||
164135864|NCT02799095|592861971|FG016|Part C|Death|1|||
164135865|NCT02799095|592861955|FG000|Part C|Lost to Follow-up|0|||
164135866|NCT02799095|592861956|FG001|Part C|Lost to Follow-up|0|||
164135867|NCT02799095|592861957|FG002|Part C|Lost to Follow-up|0|||
164135868|NCT02799095|592861958|FG003|Part C|Lost to Follow-up|0|||
164135869|NCT02799095|592861959|FG004|Part C|Lost to Follow-up|0|||
164135870|NCT02799095|592861960|FG005|Part C|Lost to Follow-up|0|||
164135871|NCT02799095|592861961|FG006|Part C|Lost to Follow-up|0|||
164135872|NCT02799095|592861962|FG007|Part C|Lost to Follow-up|0|||
164135873|NCT02799095|592861963|FG008|Part C|Lost to Follow-up|0|||
164135874|NCT02799095|592861964|FG009|Part C|Lost to Follow-up|0|||
164135875|NCT02799095|592861965|FG010|Part C|Lost to Follow-up|1|||
164135876|NCT02799095|592861966|FG011|Part C|Lost to Follow-up|1|||
164135877|NCT02799095|592861967|FG012|Part C|Lost to Follow-up|1|||
164135878|NCT02799095|592861968|FG013|Part C|Lost to Follow-up|3|||
164135879|NCT02799095|592861969|FG014|Part C|Lost to Follow-up|0|||
164135880|NCT02799095|592861970|FG015|Part C|Lost to Follow-up|0|||
164135881|NCT02799095|592861971|FG016|Part C|Lost to Follow-up|0|||
164135882|NCT02799095|592861955|FG000|Part C|Progressive Disease|0|||
164135883|NCT02799095|592861956|FG001|Part C|Progressive Disease|0|||
164135884|NCT02799095|592861957|FG002|Part C|Progressive Disease|0|||
164135885|NCT02799095|592861958|FG003|Part C|Progressive Disease|0|||
164135886|NCT02799095|592861959|FG004|Part C|Progressive Disease|0|||
164135887|NCT02799095|592861960|FG005|Part C|Progressive Disease|0|||
164135888|NCT02799095|592861961|FG006|Part C|Progressive Disease|0|||
164135889|NCT02799095|592861962|FG007|Part C|Progressive Disease|0|||
164135890|NCT02799095|592861963|FG008|Part C|Progressive Disease|0|||
164135891|NCT02799095|592861964|FG009|Part C|Progressive Disease|2|||
164135892|NCT02799095|592861965|FG010|Part C|Progressive Disease|13|||
164135893|NCT02799095|592861966|FG011|Part C|Progressive Disease|2|||
164135894|NCT02799095|592861967|FG012|Part C|Progressive Disease|0|||
164135895|NCT02799095|592861968|FG013|Part C|Progressive Disease|1|||
164135896|NCT02799095|592861969|FG014|Part C|Progressive Disease|0|||
164135897|NCT02799095|592861970|FG015|Part C|Progressive Disease|0|||
164135898|NCT02799095|592861971|FG016|Part C|Progressive Disease|0|||
164135899|NCT02799095|592861955|FG000|Part C|Clinical Progression|0|||
164135900|NCT02799095|592861956|FG001|Part C|Clinical Progression|0|||
164135901|NCT02799095|592861957|FG002|Part C|Clinical Progression|0|||
164135902|NCT02799095|592861958|FG003|Part C|Clinical Progression|0|||
164135903|NCT02799095|592861959|FG004|Part C|Clinical Progression|0|||
164135904|NCT02799095|592861960|FG005|Part C|Clinical Progression|0|||
164135905|NCT02799095|592861961|FG006|Part C|Clinical Progression|0|||
164135906|NCT02799095|592861962|FG007|Part C|Clinical Progression|0|||
164135907|NCT02799095|592861963|FG008|Part C|Clinical Progression|0|||
164135908|NCT02799095|592861964|FG009|Part C|Clinical Progression|1|||
164135909|NCT02799095|592861965|FG010|Part C|Clinical Progression|3|||
164135910|NCT02799095|592861966|FG011|Part C|Clinical Progression|0|||
164135911|NCT02799095|592861967|FG012|Part C|Clinical Progression|0|||
164135912|NCT02799095|592861968|FG013|Part C|Clinical Progression|1|||
164135913|NCT02799095|592861969|FG014|Part C|Clinical Progression|0|||
164135975|NCT04994483|592861972|FG000|Overall Study|Withdrawal by Subject|41|||
164135976|NCT04994483|592861973|FG001|Overall Study|Withdrawal by Subject|38|||
164135977|NCT04994483|592861972|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
164135978|NCT04994483|592861973|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
164135979|NCT04994483|592861972|FG000|Overall Study|Met stopping criteria|1|||
164135980|NCT04994483|592861973|FG001|Overall Study|Met stopping criteria|0|||
164135981|NCT04994483|592861972|FG000|Overall Study|Randomized in error, not treated|4|||
164135982|NCT04994483|592861973|FG001|Overall Study|Randomized in error, not treated|3|||
164135983|NCT04994483|592861972|FG000|Overall Study|Lack of a reliable study partner|0|||
164135984|NCT04994483|592861973|FG001|Overall Study|Lack of a reliable study partner|1|||
164135985|NCT04994483|592861972|FG000|Overall Study|Met MRI exclusion criteria|0|||
164135986|NCT04994483|592861973|FG001|Overall Study|Met MRI exclusion criteria|1|||
164135987|NCT00759902|592861974|FG000|Overall Study|Adverse Event|0|||
164135988|NCT00759902|592861975|FG001|Overall Study|Adverse Event|1|||
164135989|NCT02903030|592861976|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
164135990|NCT02903030|592861977|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
164135991|NCT03700385|592861984|FG000|Overall Study|Lost to Follow-up|1|||
164135992|NCT00699283|592861985|FG000|Overall Study|Lack of Efficacy|15|||
164135993|NCT00699283|592861986|FG001|Overall Study|Lack of Efficacy|5|||
164135994|NCT00699283|592861985|FG000|Overall Study|Lost to Follow-up|2|||
164135995|NCT00699283|592861986|FG001|Overall Study|Lost to Follow-up|0|||
164135996|NCT00699283|592861985|FG000|Overall Study|Withdrawal by Subject|1|||
164135997|NCT00699283|592861986|FG001|Overall Study|Withdrawal by Subject|0|||
164135998|NCT00699283|592861985|FG000|Overall Study|Other Reason|5|||
164135999|NCT00699283|592861986|FG001|Overall Study|Other Reason|1|||
164136000|NCT00699283|592861985|FG000|Overall Study|SAE, non-fatal|1|||
164136001|NCT00699283|592861986|FG001|Overall Study|SAE, non-fatal|1|||
164136002|NCT00699283|592861985|FG000|Overall Study|AE, non-serious non-fatal|8|||
164136003|NCT00699283|592861986|FG001|Overall Study|AE, non-serious non-fatal|1|||
164136004|NCT00699283|592861985|FG000|Overall Study|AE of unknown type|1|||
164136005|NCT00699283|592861986|FG001|Overall Study|AE of unknown type|0|||
164136006|NCT04590040|592861992|FG000|Treatment Period|Lost to Follow-up|2|||
164136007|NCT04590040|592861993|FG001|Treatment Period|Lost to Follow-up|5|||
164136008|NCT04590040|592861994|FG002|Treatment Period|Lost to Follow-up|0|||
164136009|NCT04590040|592861992|FG000|Treatment Period|Physician Decision|0|||
164136010|NCT04590040|592861993|FG001|Treatment Period|Physician Decision|0|||
164136011|NCT04590040|592861994|FG002|Treatment Period|Physician Decision|2|||
164136012|NCT00000378|592861997|FG000|Overall Study|Lack of Efficacy|16|||
164136013|NCT00000378|592861998|FG001|Overall Study|Lack of Efficacy|14|||
164136014|NCT01284361|592862003|FG000|Overall Study|Withdrawal by Subject|1|||
164136015|NCT01284361|592862003|FG000|Overall Study|Protocol Violation|5|||
164136016|NCT01284361|592862003|FG000|Overall Study|Adverse Event|1|||
164136017|NCT01284361|592862003|FG000|Overall Study|Lost to Follow-up|2|||
164136018|NCT00805675|592862006|FG000|Overall Study|Adverse Event|0|||
164136019|NCT00805675|592862007|FG001|Overall Study|Adverse Event|0|||
164136020|NCT00805675|592862008|FG002|Overall Study|Adverse Event|1|||
164136021|NCT02771795|592862010|FG000|Overall Study|Withdrawal by Subject|47|||
164136022|NCT02771795|592862011|FG001|Overall Study|Withdrawal by Subject|37|||
164136023|NCT02771795|592862010|FG000|Overall Study|Termination by premature discontinuation of study|168|||
164136024|NCT02771795|592862011|FG001|Overall Study|Termination by premature discontinuation of study|185|||
164136025|NCT01957397|592862013|FG000|Test Period 1|sudden leakage/small bag|1|||
164136026|NCT01957397|592862014|FG001|Test Period 1|sudden leakage/small bag|1|||
164136027|NCT01957397|592862013|FG000|Test Period 1|Withdrawal by Subject|1|||
164136028|NCT01957397|592862014|FG001|Test Period 1|Withdrawal by Subject|0|||
164136029|NCT01957397|592862013|FG000|Test Period 2|Adverse Event|0|||
164136030|NCT01957397|592862014|FG001|Test Period 2|Adverse Event|1|||
164136031|NCT01957397|592862013|FG000|Test Period 3|Adverse Event|1|||
164136032|NCT01957397|592862014|FG001|Test Period 3|Adverse Event|2|||
164136033|NCT01957397|592862013|FG000|Test Period 3|the adhesive did not work|1|||
164136034|NCT01957397|592862014|FG001|Test Period 3|the adhesive did not work|0|||
164136035|NCT00505375|592862015|FG000|Overall Study|Death|1|||
164136036|NCT00505375|592862016|FG001|Overall Study|Death|0|||
164136037|NCT00505375|592862015|FG000|Overall Study|Withdrawal by Subject|2|||
164136038|NCT00505375|592862016|FG001|Overall Study|Withdrawal by Subject|2|||
164136039|NCT00505375|592862015|FG000|Overall Study|Lost to Follow-up|0|||
164136040|NCT00505375|592862016|FG001|Overall Study|Lost to Follow-up|2|||
164136041|NCT00505375|592862015|FG000|Overall Study|Pregnancy|1|||
164136042|NCT00505375|592862016|FG001|Overall Study|Pregnancy|0|||
164136043|NCT00505375|592862015|FG000|Overall Study|Travel issues|0|||
164136044|NCT00505375|592862016|FG001|Overall Study|Travel issues|1|||
164136045|NCT02906930|592862017|FG000|Overall Study|Withdrawal by Subject|0|||
164136046|NCT02906930|592862018|FG001|Overall Study|Withdrawal by Subject|5|||
164136047|NCT02906930|592862019|FG002|Overall Study|Withdrawal by Subject|5|||
164136048|NCT02906930|592862020|FG003|Overall Study|Withdrawal by Subject|4|||
164136049|NCT02906930|592862017|FG000|Overall Study|Lost to Follow-up|5|||
164136050|NCT02906930|592862018|FG001|Overall Study|Lost to Follow-up|7|||
164136051|NCT02906930|592862019|FG002|Overall Study|Lost to Follow-up|5|||
164136182|NCT00742924|592862059|FG000|Overall Study|Withdrawal by Subject|0|||
164136183|NCT00742924|592862060|FG001|Overall Study|Withdrawal by Subject|1|||
164136184|NCT00742924|592862061|FG002|Overall Study|Withdrawal by Subject|1|||
164136185|NCT00742924|592862062|FG003|Overall Study|Withdrawal by Subject|0|||
164136186|NCT05005312|592862078|FG000|Overall Study|Enrolled, but not treated|0|||
164136187|NCT05005312|592862079|FG001|Overall Study|Enrolled, but not treated|1|||
164136188|NCT01283035|592862080|FG000|Overall Study|Subject later found ineligible|1|||
164136189|NCT06077149|592862081|FG000|Overall Study|Death|1|||
164136190|NCT06077149|592862082|FG001|Overall Study|Death|0|||
164136191|NCT06077149|592862081|FG000|Overall Study|Withdrawal by Subject|2|||
164136192|NCT06077149|592862082|FG001|Overall Study|Withdrawal by Subject|0|||
164136193|NCT06077149|592862081|FG000|Overall Study|RSV infection before vaccination|3|||
164136194|NCT06077149|592862082|FG001|Overall Study|RSV infection before vaccination|0|||
164136195|NCT04658095|592862083|FG000|Overall Study|Study terminated|5|||
164136196|NCT04658095|592862084|FG001|Overall Study|Study terminated|1|||
164136197|NCT04658095|592862085|FG002|Overall Study|Study terminated|4|||
164136198|NCT01441947|592862086|FG000|Overall Study|Withdrawal by Subject|3|||
164136199|NCT01441947|592862087|FG001|Overall Study|Withdrawal by Subject|0|||
164136200|NCT02970318|592862089|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
164136201|NCT02970318|592862090|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
164136202|NCT02970318|592862091|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
164136203|NCT02970318|592862092|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
164136204|NCT02970318|592862089|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
164136205|NCT02970318|592862090|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
164136206|NCT02970318|592862091|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
164136207|NCT02970318|592862092|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
164136208|NCT02970318|592862089|FG000|Overall for Arm A & Main for Arm B|Death|41|||
164136209|NCT02970318|592862090|FG001|Overall for Arm A & Main for Arm B|Death|33|||
164136210|NCT02970318|592862091|FG002|Overall for Arm A & Main for Arm B|Death|0|||
164136211|NCT02970318|592862092|FG003|Overall for Arm A & Main for Arm B|Death|0|||
164136212|NCT02970318|592862089|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
164136213|NCT02970318|592862090|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
164136214|NCT02970318|592862091|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
164136215|NCT02970318|592862092|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
164136216|NCT02970318|592862089|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
164136217|NCT02970318|592862090|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
164136218|NCT02970318|592862091|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
164136219|NCT02970318|592862092|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
164136220|NCT02970318|592862089|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
164136221|NCT02970318|592862090|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
164136222|NCT02970318|592862091|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
164136223|NCT02970318|592862092|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
164136224|NCT02970318|592862089|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
164136225|NCT02970318|592862090|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
164136226|NCT02970318|592862091|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
164136227|NCT02970318|592862092|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
164136228|NCT03384654|592862093|FG000|Overall Study|Withdrawal by Subject|0|||
164136229|NCT03384654|592862094|FG001|Overall Study|Withdrawal by Subject|0|||
164136230|NCT03384654|592862095|FG002|Overall Study|Withdrawal by Subject|1|||
164136231|NCT03384654|592862096|FG003|Overall Study|Withdrawal by Subject|0|||
164136232|NCT01616953|592862097|FG000|Overall Study|Lost to Follow-up|1|||
164136233|NCT01616953|592862098|FG001|Overall Study|Lost to Follow-up|0|||
164136234|NCT01616953|592862097|FG000|Overall Study|lack of bone and soft tissue|1|||
164136235|NCT01616953|592862098|FG001|Overall Study|lack of bone and soft tissue|0|||
164136236|NCT02036775|592862099|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164136237|NCT02036775|592862100|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164136238|NCT02036775|592862101|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164136239|NCT02036775|592862102|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164136240|NCT02036775|592862103|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
164136241|NCT02036775|592862104|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
164136242|NCT03496610|592862108|FG000|Overall Study|Lost to Follow-up|3|||
164136243|NCT03496610|592862109|FG001|Overall Study|Lost to Follow-up|2|||
164136244|NCT03496610|592862108|FG000|Overall Study|Physician Decision|1|||
164136245|NCT03496610|592862109|FG001|Overall Study|Physician Decision|0|||
164136246|NCT03496610|592862108|FG000|Overall Study|Withdrawal by Subject|1|||
164136247|NCT03496610|592862109|FG001|Overall Study|Withdrawal by Subject|0|||
164136248|NCT00426361|592862110|FG000|Overall Study|Lost to Follow-up|3|||
164136249|NCT00426361|592862111|FG001|Overall Study|Lost to Follow-up|2|||
164136250|NCT00426361|592862112|FG002|Overall Study|Lost to Follow-up|5|||
164136251|NCT00426361|592862110|FG000|Overall Study|Withdrawal by Subject|1|||
164136252|NCT00426361|592862111|FG001|Overall Study|Withdrawal by Subject|3|||
164136253|NCT00426361|592862112|FG002|Overall Study|Withdrawal by Subject|0|||
164136254|NCT01408628|592862113|FG000|Consented|Withdrawal by Subject|12|||
164136255|NCT01408628|592862113|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
164136256|NCT01408628|592862113|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
164136257|NCT01408628|592862113|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
164136258|NCT01970865|592862114|FG000|Overall Study|Death|3|||
164136259|NCT01970865|592862115|FG001|Overall Study|Death|2|||
164136260|NCT01970865|592862116|FG002|Overall Study|Death|3|||
164136261|NCT01970865|592862117|FG003|Overall Study|Death|6|||
164136262|NCT01970865|592862118|FG004|Overall Study|Death|9|||
164136263|NCT01970865|592862119|FG005|Overall Study|Death|3|||
164136264|NCT01970865|592862120|FG006|Overall Study|Death|2|||
164136265|NCT01970865|592862121|FG007|Overall Study|Death|3|||
164136266|NCT01970865|592862122|FG008|Overall Study|Death|2|||
164136267|NCT01970865|592862123|FG009|Overall Study|Death|2|||
164136268|NCT01970865|592862124|FG010|Overall Study|Death|8|||
164136269|NCT01970865|592862125|FG011|Overall Study|Death|13|||
164136270|NCT01970865|592862126|FG012|Overall Study|Death|25|||
164136271|NCT01970865|592862127|FG013|Overall Study|Death|46|||
164136272|NCT01970865|592862128|FG014|Overall Study|Death|37|||
164136273|NCT01970865|592862129|FG015|Overall Study|Death|22|||
164136274|NCT01970865|592862130|FG016|Overall Study|Death|1|||
164136275|NCT01970865|592862131|FG017|Overall Study|Death|17|||
164136276|NCT01970865|592862114|FG000|Overall Study|Lost to Follow-up|0|||
164136277|NCT01970865|592862115|FG001|Overall Study|Lost to Follow-up|0|||
164136278|NCT01970865|592862116|FG002|Overall Study|Lost to Follow-up|0|||
164136279|NCT01970865|592862117|FG003|Overall Study|Lost to Follow-up|1|||
164136280|NCT01970865|592862118|FG004|Overall Study|Lost to Follow-up|1|||
164136281|NCT01970865|592862119|FG005|Overall Study|Lost to Follow-up|0|||
164136282|NCT01970865|592862120|FG006|Overall Study|Lost to Follow-up|0|||
164136283|NCT01970865|592862121|FG007|Overall Study|Lost to Follow-up|0|||
164136284|NCT01970865|592862122|FG008|Overall Study|Lost to Follow-up|0|||
164136285|NCT01970865|592862123|FG009|Overall Study|Lost to Follow-up|0|||
164136286|NCT01970865|592862124|FG010|Overall Study|Lost to Follow-up|1|||
164136287|NCT01970865|592862125|FG011|Overall Study|Lost to Follow-up|0|||
164136288|NCT01970865|592862126|FG012|Overall Study|Lost to Follow-up|2|||
164136289|NCT01970865|592862127|FG013|Overall Study|Lost to Follow-up|0|||
164136290|NCT01970865|592862128|FG014|Overall Study|Lost to Follow-up|1|||
164136291|NCT01970865|592862129|FG015|Overall Study|Lost to Follow-up|4|||
164136292|NCT01970865|592862130|FG016|Overall Study|Lost to Follow-up|0|||
164136293|NCT01970865|592862131|FG017|Overall Study|Lost to Follow-up|1|||
164136294|NCT01970865|592862114|FG000|Overall Study|Other|0|||
164136295|NCT01970865|592862115|FG001|Overall Study|Other|1|||
164136296|NCT01970865|592862116|FG002|Overall Study|Other|0|||
164136297|NCT01970865|592862117|FG003|Overall Study|Other|1|||
164136298|NCT01970865|592862118|FG004|Overall Study|Other|1|||
164136299|NCT01970865|592862119|FG005|Overall Study|Other|0|||
164136300|NCT01970865|592862120|FG006|Overall Study|Other|1|||
164136301|NCT01970865|592862121|FG007|Overall Study|Other|0|||
164136302|NCT01970865|592862122|FG008|Overall Study|Other|0|||
164136303|NCT01970865|592862123|FG009|Overall Study|Other|0|||
164136304|NCT01970865|592862124|FG010|Overall Study|Other|2|||
164136305|NCT01970865|592862125|FG011|Overall Study|Other|3|||
164136306|NCT01970865|592862126|FG012|Overall Study|Other|8|||
164136307|NCT01970865|592862127|FG013|Overall Study|Other|3|||
164136308|NCT01970865|592862128|FG014|Overall Study|Other|2|||
164136309|NCT01970865|592862129|FG015|Overall Study|Other|3|||
164136310|NCT01970865|592862130|FG016|Overall Study|Other|0|||
164136311|NCT01970865|592862131|FG017|Overall Study|Other|2|||
164136312|NCT01970865|592862114|FG000|Overall Study|Participant refused further follow-up|0|||
164136313|NCT01970865|592862115|FG001|Overall Study|Participant refused further follow-up|0|||
164136314|NCT01970865|592862116|FG002|Overall Study|Participant refused further follow-up|0|||
164136315|NCT01970865|592862117|FG003|Overall Study|Participant refused further follow-up|2|||
164136316|NCT01970865|592862118|FG004|Overall Study|Participant refused further follow-up|3|||
164136317|NCT01970865|592862119|FG005|Overall Study|Participant refused further follow-up|0|||
164136318|NCT01970865|592862120|FG006|Overall Study|Participant refused further follow-up|0|||
164136319|NCT01970865|592862121|FG007|Overall Study|Participant refused further follow-up|0|||
164136320|NCT01970865|592862122|FG008|Overall Study|Participant refused further follow-up|0|||
164136321|NCT01970865|592862123|FG009|Overall Study|Participant refused further follow-up|0|||
164136322|NCT01970865|592862124|FG010|Overall Study|Participant refused further follow-up|1|||
164136323|NCT01970865|592862125|FG011|Overall Study|Participant refused further follow-up|4|||
164136324|NCT01970865|592862126|FG012|Overall Study|Participant refused further follow-up|7|||
164136325|NCT01970865|592862127|FG013|Overall Study|Participant refused further follow-up|8|||
164136326|NCT01970865|592862128|FG014|Overall Study|Participant refused further follow-up|3|||
164136327|NCT01970865|592862129|FG015|Overall Study|Participant refused further follow-up|11|||
164136328|NCT01970865|592862130|FG016|Overall Study|Participant refused further follow-up|0|||
164136329|NCT01970865|592862131|FG017|Overall Study|Participant refused further follow-up|6|||
164136330|NCT01629966|592862132|FG000|Overall Study|Pregnancy|0|||
164136331|NCT01629966|592862133|FG001|Overall Study|Pregnancy|1|||
164136392|NCT03118570|592862140|FG001|Overall Study|Other, Not Specified|3|||
164136393|NCT03118570|592862141|FG002|Overall Study|Other, Not Specified|0|||
164136394|NCT03118570|592862142|FG003|Overall Study|Other, Not Specified|0|||
164136395|NCT03118570|592862143|FG004|Overall Study|Other, Not Specified|0|||
164136396|NCT01672970|592862144|FG000|Overall Study|Lack of Efficacy|12|||
164136397|NCT01672970|592862144|FG000|Overall Study|Adverse Event|18|||
164136398|NCT01672970|592862144|FG000|Overall Study|Withdrawal by Subject|2|||
164136399|NCT01672970|592862144|FG000|Overall Study|Lost to Follow-up|5|||
164136400|NCT01672970|592862144|FG000|Overall Study|Other|9|||
164136401|NCT01672970|592862144|FG000|Overall Study|Enrolled but not treated|1|||
164136402|NCT04568031|592862147|FG000|Overall Study|Lost to Follow-up|1|||
164136403|NCT04568031|592862148|FG001|Overall Study|Lost to Follow-up|0|||
164136404|NCT04568031|592862149|FG002|Overall Study|Lost to Follow-up|0|||
164136405|NCT04568031|592862150|FG003|Overall Study|Lost to Follow-up|0|||
164136406|NCT04568031|592862147|FG000|Overall Study|Physician Decision|1|||
164136407|NCT04568031|592862148|FG001|Overall Study|Physician Decision|0|||
164136408|NCT04568031|592862149|FG002|Overall Study|Physician Decision|1|||
164136409|NCT04568031|592862150|FG003|Overall Study|Physician Decision|0|||
164136410|NCT04568031|592862147|FG000|Overall Study|Withdrawal by Subject|1|||
164136411|NCT04568031|592862148|FG001|Overall Study|Withdrawal by Subject|0|||
164136412|NCT04568031|592862149|FG002|Overall Study|Withdrawal by Subject|4|||
164136413|NCT04568031|592862150|FG003|Overall Study|Withdrawal by Subject|1|||
164136414|NCT04430855|592862151|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
164136415|NCT04430855|592862152|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
164136416|NCT04430855|592862151|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
164136417|NCT04430855|592862152|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
164136418|NCT04430855|592862151|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
164136419|NCT04430855|592862152|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
164136420|NCT04430855|592862151|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
164136421|NCT04430855|592862152|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
164136422|NCT04430855|592862151|FG000|Period 1 (Weeks 1-12)|Other|0|||
164136423|NCT04430855|592862152|FG001|Period 1 (Weeks 1-12)|Other|1|||
164136424|NCT04430855|592862151|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
164136425|NCT04430855|592862152|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
164136426|NCT04430855|592862151|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
164136427|NCT04430855|592862152|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
164136428|NCT04430855|592862151|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
164136429|NCT04430855|592862152|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
164136430|NCT00186043|592862153|FG000|Overall Study|Lack of Efficacy|1|||
164136431|NCT00186043|592862154|FG001|Overall Study|Lack of Efficacy|3|||
164136432|NCT00186043|592862153|FG000|Overall Study|Lost to Follow-up|4|||
164136433|NCT00186043|592862154|FG001|Overall Study|Lost to Follow-up|6|||
164136434|NCT00186043|592862153|FG000|Overall Study|Withdrawal by Subject|1|||
164136435|NCT00186043|592862154|FG001|Overall Study|Withdrawal by Subject|0|||
164136436|NCT00186043|592862153|FG000|Overall Study|Adverse Event|7|||
164136437|NCT00186043|592862154|FG001|Overall Study|Adverse Event|3|||
164136438|NCT00186043|592862153|FG000|Overall Study|Protocol Violation|2|||
164136439|NCT00186043|592862154|FG001|Overall Study|Protocol Violation|1|||
164136440|NCT04874636|592862155|FG000|Overall Study|Adverse Event|17|||
164136441|NCT04874636|592862156|FG001|Overall Study|Adverse Event|7|||
164136442|NCT04874636|592862155|FG000|Overall Study|Lost to Follow-up|1|||
164136443|NCT04874636|592862156|FG001|Overall Study|Lost to Follow-up|0|||
164136444|NCT04874636|592862155|FG000|Overall Study|Non-Compliance with Study Drug|2|||
164136445|NCT04874636|592862156|FG001|Overall Study|Non-Compliance with Study Drug|0|||
164136446|NCT04874636|592862155|FG000|Overall Study|Physician Decision|1|||
164136447|NCT04874636|592862156|FG001|Overall Study|Physician Decision|0|||
164136448|NCT04874636|592862155|FG000|Overall Study|Withdrawal by Subject|6|||
164136449|NCT04874636|592862156|FG001|Overall Study|Withdrawal by Subject|5|||
164136450|NCT00620659|592862165|FG000|Treatment Period 1|Adverse Event|1|||
164136451|NCT00620659|592862166|FG001|Treatment Period 1|Adverse Event|0|||
164136452|NCT00620659|592862167|FG002|Treatment Period 1|Adverse Event|0|||
164136453|NCT00620659|592862168|FG003|Treatment Period 1|Adverse Event|3|||
164136454|NCT00620659|592862169|FG004|Treatment Period 1|Adverse Event|0|||
164136455|NCT00620659|592862170|FG005|Treatment Period 1|Adverse Event|0|||
164136456|NCT00620659|592862165|FG000|Treatment Period 1|Protocol Violation|1|||
164136457|NCT00620659|592862166|FG001|Treatment Period 1|Protocol Violation|0|||
164136458|NCT00620659|592862167|FG002|Treatment Period 1|Protocol Violation|0|||
164136459|NCT00620659|592862168|FG003|Treatment Period 1|Protocol Violation|0|||
164136460|NCT00620659|592862169|FG004|Treatment Period 1|Protocol Violation|0|||
164136461|NCT00620659|592862170|FG005|Treatment Period 1|Protocol Violation|0|||
164136462|NCT00620659|592862165|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164136463|NCT00620659|592862166|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164136464|NCT00620659|592862167|FG002|Treatment Period 1|Withdrawal by Subject|1|||
164136465|NCT00620659|592862168|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164136466|NCT00620659|592862169|FG004|Treatment Period 1|Withdrawal by Subject|1|||
164136467|NCT00620659|592862170|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164136468|NCT00620659|592862165|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
164136469|NCT00620659|592862166|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
164136470|NCT00620659|592862167|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
164136471|NCT00620659|592862168|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
164136472|NCT00620659|592862169|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
164136473|NCT00620659|592862170|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
164136474|NCT00620659|592862165|FG000|Treatment Period 2|Adverse Event|0|||
164136475|NCT00620659|592862166|FG001|Treatment Period 2|Adverse Event|3|||
164136476|NCT00620659|592862167|FG002|Treatment Period 2|Adverse Event|0|||
164136477|NCT00620659|592862168|FG003|Treatment Period 2|Adverse Event|0|||
164136478|NCT00620659|592862169|FG004|Treatment Period 2|Adverse Event|2|||
164136479|NCT00620659|592862170|FG005|Treatment Period 2|Adverse Event|0|||
164136480|NCT00620659|592862165|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164136481|NCT00620659|592862166|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164136482|NCT00620659|592862167|FG002|Treatment Period 2|Withdrawal by Subject|1|||
164136483|NCT00620659|592862168|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164136484|NCT00620659|592862169|FG004|Treatment Period 2|Withdrawal by Subject|3|||
164136485|NCT00620659|592862170|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164136486|NCT00620659|592862165|FG000|Placebo Washout Period 2|Adverse Event|2|||
164136487|NCT00620659|592862166|FG001|Placebo Washout Period 2|Adverse Event|0|||
164136488|NCT00620659|592862167|FG002|Placebo Washout Period 2|Adverse Event|0|||
164136489|NCT00620659|592862168|FG003|Placebo Washout Period 2|Adverse Event|0|||
164136490|NCT00620659|592862169|FG004|Placebo Washout Period 2|Adverse Event|0|||
164136491|NCT00620659|592862170|FG005|Placebo Washout Period 2|Adverse Event|0|||
164136492|NCT00620659|592862165|FG000|Treatment Period 3|Adverse Event|0|||
164136493|NCT00620659|592862166|FG001|Treatment Period 3|Adverse Event|2|||
164136494|NCT00620659|592862167|FG002|Treatment Period 3|Adverse Event|0|||
164136495|NCT00620659|592862168|FG003|Treatment Period 3|Adverse Event|0|||
164136496|NCT00620659|592862169|FG004|Treatment Period 3|Adverse Event|0|||
164136497|NCT00620659|592862170|FG005|Treatment Period 3|Adverse Event|0|||
164136498|NCT00620659|592862165|FG000|Treatment Period 3|Withdrawal by Subject|0|||
164136499|NCT00620659|592862166|FG001|Treatment Period 3|Withdrawal by Subject|0|||
164136500|NCT00620659|592862167|FG002|Treatment Period 3|Withdrawal by Subject|0|||
164136501|NCT00620659|592862168|FG003|Treatment Period 3|Withdrawal by Subject|1|||
164136502|NCT00620659|592862169|FG004|Treatment Period 3|Withdrawal by Subject|0|||
164136503|NCT00620659|592862170|FG005|Treatment Period 3|Withdrawal by Subject|0|||
164136504|NCT01709838|592862171|FG000|Overall Study|Withdrawal by Subject|21|||
164136505|NCT01709838|592862171|FG000|Overall Study|Lost to Follow-up|16|||
164136506|NCT01709838|592862171|FG000|Overall Study|Pregnancy|10|||
164136507|NCT01709838|592862171|FG000|Overall Study|Subject/guardian decision|8|||
164136508|NCT01709838|592862171|FG000|Overall Study|Adverse Event|4|||
164136509|NCT01709838|592862171|FG000|Overall Study|Physician Decision|4|||
164136510|NCT01709838|592862171|FG000|Overall Study|Death|3|||
164136511|NCT01709838|592862171|FG000|Overall Study|Protocol Violation|1|||
164136512|NCT02352779|592862172|FG000|Overall Study|Personal Issues|1|||
164136513|NCT02352779|592862173|FG001|Overall Study|Personal Issues|1|||
164136514|NCT02352779|592862174|FG002|Overall Study|Personal Issues|0|||
164136515|NCT02352779|592862172|FG000|Overall Study|Too Many Forms|2|||
164136516|NCT02352779|592862173|FG001|Overall Study|Too Many Forms|0|||
164136517|NCT02352779|592862174|FG002|Overall Study|Too Many Forms|0|||
164136518|NCT02352779|592862172|FG000|Overall Study|Feeling Overwhelmed|1|||
164136519|NCT02352779|592862173|FG001|Overall Study|Feeling Overwhelmed|0|||
164136520|NCT02352779|592862174|FG002|Overall Study|Feeling Overwhelmed|0|||
164136521|NCT02352779|592862172|FG000|Overall Study|Disliked Intervention|1|||
164136522|NCT02352779|592862173|FG001|Overall Study|Disliked Intervention|0|||
164136523|NCT02352779|592862174|FG002|Overall Study|Disliked Intervention|0|||
164136524|NCT02352779|592862172|FG000|Overall Study|Changed Mind|1|||
164136525|NCT02352779|592862173|FG001|Overall Study|Changed Mind|0|||
164136526|NCT02352779|592862174|FG002|Overall Study|Changed Mind|0|||
164136527|NCT02352779|592862172|FG000|Overall Study|Study Related Symptoms|1|||
164136528|NCT02352779|592862173|FG001|Overall Study|Study Related Symptoms|0|||
164136529|NCT02352779|592862174|FG002|Overall Study|Study Related Symptoms|0|||
164136530|NCT02352779|592862172|FG000|Overall Study|Absence of Symptoms|1|||
164136531|NCT02352779|592862173|FG001|Overall Study|Absence of Symptoms|0|||
164136532|NCT02352779|592862174|FG002|Overall Study|Absence of Symptoms|0|||
164136533|NCT02352779|592862172|FG000|Overall Study|Other Medical Reason|0|||
164136534|NCT02352779|592862173|FG001|Overall Study|Other Medical Reason|0|||
164136535|NCT02352779|592862174|FG002|Overall Study|Other Medical Reason|1|||
164136536|NCT02352779|592862172|FG000|Overall Study|No Reason|0|||
164136537|NCT02352779|592862173|FG001|Overall Study|No Reason|0|||
164136538|NCT02352779|592862174|FG002|Overall Study|No Reason|1|||
164136539|NCT00968799|592862177|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
164136540|NCT00719849|592862180|FG000|Overall Study|Death|0|||
164136541|NCT00719849|592862181|FG001|Overall Study|Death|1|||
164136542|NCT00389831|592862185|FG000|Overall Study|Lack of Efficacy|0|||
164136543|NCT00389831|592862186|FG001|Overall Study|Lack of Efficacy|2|||
164136544|NCT00389831|592862185|FG000|Overall Study|Did not receive treatment.|0|||
164136545|NCT00389831|592862186|FG001|Overall Study|Did not receive treatment.|2|||
164136546|NCT00389831|592862185|FG000|Overall Study|Other reasons|0|||
164136550|NCT00594646|592862191|FG000|Overall Study|Withdrawal by Subject|1|||
164136551|NCT00594646|592862191|FG000|Overall Study|Lost to Follow-up|15|||
164136552|NCT03907462|592862192|FG000|Overall Study|Physician Decision|1|||
164136553|NCT03907462|592862193|FG001|Overall Study|Physician Decision|3|||
164136554|NCT03907462|592862194|FG002|Overall Study|Physician Decision|1|||
164136555|NCT03907462|592862192|FG000|Overall Study|Withdrawal by Subject|6|||
164136556|NCT03907462|592862193|FG001|Overall Study|Withdrawal by Subject|3|||
164136557|NCT03907462|592862194|FG002|Overall Study|Withdrawal by Subject|3|||
164136558|NCT03907462|592862192|FG000|Overall Study|Pregnancy|4|||
164136559|NCT03907462|592862193|FG001|Overall Study|Pregnancy|2|||
164136560|NCT03907462|592862194|FG002|Overall Study|Pregnancy|6|||
164136561|NCT03907462|592862192|FG000|Overall Study|Lost to Follow-up|16|||
164136562|NCT03907462|592862193|FG001|Overall Study|Lost to Follow-up|18|||
164136563|NCT03907462|592862194|FG002|Overall Study|Lost to Follow-up|22|||
164136564|NCT00663026|592864972|FG000|Overall Study|Lost to Follow-up|1|||
164136565|NCT00663026|592864973|FG001|Overall Study|Lost to Follow-up|0|||
164136566|NCT00663026|592864974|FG002|Overall Study|Lost to Follow-up|0|||
164136567|NCT00663026|592864972|FG000|Overall Study|Other|1|||
164136568|NCT00663026|592864973|FG001|Overall Study|Other|2|||
164136569|NCT00663026|592864974|FG002|Overall Study|Other|0|||
164136570|NCT00663026|592864972|FG000|Overall Study|Adverse Event|0|||
164136571|NCT00663026|592864973|FG001|Overall Study|Adverse Event|2|||
164136572|NCT00663026|592864974|FG002|Overall Study|Adverse Event|3|||
164136573|NCT00663026|592864972|FG000|Overall Study|Caregiver Request|0|||
164136574|NCT00663026|592864973|FG001|Overall Study|Caregiver Request|2|||
164136575|NCT00663026|592864974|FG002|Overall Study|Caregiver Request|0|||
164136576|NCT00663026|592864972|FG000|Overall Study|Withdrawal by Subject|0|||
164136577|NCT00663026|592864973|FG001|Overall Study|Withdrawal by Subject|0|||
164136578|NCT00663026|592864974|FG002|Overall Study|Withdrawal by Subject|1|||
164136579|NCT04003896|592864975|FG000|Overall Study|Withdrawal by Subject|3|||
164136580|NCT04003896|592864975|FG000|Overall Study|Physician Decision|1|||
164136581|NCT00806286|592864978|FG000|Overall Study|Adverse Event|5|||
164136582|NCT00806286|592864979|FG001|Overall Study|Adverse Event|2|||
164136583|NCT00806286|592864980|FG002|Overall Study|Adverse Event|0|||
164136584|NCT00806286|592864978|FG000|Overall Study|Disease progression|31|||
164136585|NCT00806286|592864979|FG001|Overall Study|Disease progression|38|||
164136586|NCT00806286|592864980|FG002|Overall Study|Disease progression|1|||
164136587|NCT00806286|592864978|FG000|Overall Study|Death|1|||
164136588|NCT00806286|592864979|FG001|Overall Study|Death|6|||
164136589|NCT00806286|592864980|FG002|Overall Study|Death|0|||
164136590|NCT00806286|592864978|FG000|Overall Study|Lost to Follow-up|0|||
164136591|NCT00806286|592864979|FG001|Overall Study|Lost to Follow-up|1|||
164136592|NCT00806286|592864980|FG002|Overall Study|Lost to Follow-up|0|||
164136593|NCT00806286|592864978|FG000|Overall Study|Withdrawal by Subject|8|||
164136594|NCT00806286|592864979|FG001|Overall Study|Withdrawal by Subject|3|||
164136595|NCT00806286|592864980|FG002|Overall Study|Withdrawal by Subject|1|||
164136596|NCT00806286|592864978|FG000|Overall Study|Physician Decision|2|||
164136597|NCT00806286|592864979|FG001|Overall Study|Physician Decision|2|||
164136598|NCT00806286|592864980|FG002|Overall Study|Physician Decision|0|||
164136599|NCT00806286|592864978|FG000|Overall Study|Due to a variety of reasons|7|||
164136600|NCT00806286|592864979|FG001|Overall Study|Due to a variety of reasons|2|||
164136601|NCT00806286|592864980|FG002|Overall Study|Due to a variety of reasons|1|||
164136602|NCT02006693|592864981|FG000|Overall Study|No Reason Specified|6|||
164136603|NCT02006693|592864982|FG001|Overall Study|No Reason Specified|8|||
164136604|NCT02006693|592864981|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
164136605|NCT02006693|592864982|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
164136606|NCT02006693|592864981|FG000|Overall Study|XEN Implant Explantation|0|||
164136607|NCT02006693|592864982|FG001|Overall Study|XEN Implant Explantation|1|||
164136608|NCT02006693|592864981|FG000|Overall Study|Death|2|||
164136609|NCT02006693|592864982|FG001|Overall Study|Death|2|||
164136610|NCT02006693|592864981|FG000|Overall Study|Lost to Follow-up|4|||
164136611|NCT02006693|592864982|FG001|Overall Study|Lost to Follow-up|1|||
164136612|NCT02006693|592864981|FG000|Overall Study|Patient Decision|4|||
164136613|NCT02006693|592864982|FG001|Overall Study|Patient Decision|0|||
164136614|NCT03151408|592864983|FG000|Overall Study|Adverse Event|24|||
164136615|NCT03151408|592864984|FG001|Overall Study|Adverse Event|23|||
164136616|NCT03151408|592864983|FG000|Overall Study|Death|46|||
164136617|NCT03151408|592864984|FG001|Overall Study|Death|26|||
164136618|NCT03151408|592864983|FG000|Overall Study|Physician Decision|13|||
164136619|NCT03151408|592864984|FG001|Overall Study|Physician Decision|19|||
164136620|NCT03151408|592864983|FG000|Overall Study|Withdrawal by Subject|16|||
164136621|NCT03151408|592864984|FG001|Overall Study|Withdrawal by Subject|20|||
164136622|NCT03151408|592864983|FG000|Overall Study|Progressive disease|45|||
164136623|NCT03151408|592864984|FG001|Overall Study|Progressive disease|61|||
164136624|NCT03151408|592864983|FG000|Overall Study|non-compliance by patient|1|||
164136625|NCT03151408|592864984|FG001|Overall Study|non-compliance by patient|0|||
164136626|NCT03151408|592864983|FG000|Overall Study|other reasons|56|||
164136627|NCT03151408|592864984|FG001|Overall Study|other reasons|52|||
164136628|NCT03151408|592864983|FG000|Overall Study|randomized and not treated|2|||
164136629|NCT03151408|592864984|FG001|Overall Study|randomized and not treated|2|||
164136666|NCT03400943|592864987|FG000|Post-treatment Period 1|Adverse Event|2|||
164136667|NCT03400943|592864988|FG001|Post-treatment Period 1|Adverse Event|0|||
164136668|NCT03400943|592864989|FG002|Post-treatment Period 1|Adverse Event|0|||
164136669|NCT03400943|592864990|FG003|Post-treatment Period 1|Adverse Event|0|||
164136670|NCT03400943|592864987|FG000|Post-treatment Period 1|Protocol Violation|1|||
164136671|NCT03400943|592864988|FG001|Post-treatment Period 1|Protocol Violation|0|||
164136672|NCT03400943|592864989|FG002|Post-treatment Period 1|Protocol Violation|0|||
164136673|NCT03400943|592864990|FG003|Post-treatment Period 1|Protocol Violation|0|||
164136674|NCT03400943|592864987|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
164136675|NCT03400943|592864988|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
164136676|NCT03400943|592864989|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
164136677|NCT03400943|592864990|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
164136678|NCT03400943|592864987|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
164136679|NCT03400943|592864988|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
164136680|NCT03400943|592864989|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
164136681|NCT03400943|592864990|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
164136682|NCT03400943|592864987|FG000|Post-treatment Period 1|Other|2|||
164136683|NCT03400943|592864988|FG001|Post-treatment Period 1|Other|0|||
164136684|NCT03400943|592864989|FG002|Post-treatment Period 1|Other|4|||
164136685|NCT03400943|592864990|FG003|Post-treatment Period 1|Other|5|||
164136686|NCT03400943|592864987|FG000|Treatment Period 2|Study terminated by sponsor|0|||
164136687|NCT03400943|592864988|FG001|Treatment Period 2|Study terminated by sponsor|1|||
164136688|NCT03400943|592864989|FG002|Treatment Period 2|Study terminated by sponsor|0|||
164136689|NCT03400943|592864990|FG003|Treatment Period 2|Study terminated by sponsor|0|||
164136690|NCT03400943|592864987|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164136691|NCT03400943|592864988|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164136692|NCT03400943|592864989|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164136693|NCT03400943|592864990|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164136694|NCT03400943|592864987|FG000|Treatment Period 2|Other|1|||
164136695|NCT03400943|592864988|FG001|Treatment Period 2|Other|6|||
164136696|NCT03400943|592864989|FG002|Treatment Period 2|Other|0|||
164136697|NCT03400943|592864990|FG003|Treatment Period 2|Other|0|||
164136698|NCT03400943|592864987|FG000|Follow-up Period|Withdrawal by Subject|1|||
164136699|NCT03400943|592864988|FG001|Follow-up Period|Withdrawal by Subject|0|||
164136700|NCT03400943|592864989|FG002|Follow-up Period|Withdrawal by Subject|0|||
164136701|NCT03400943|592864990|FG003|Follow-up Period|Withdrawal by Subject|0|||
164136702|NCT03317834|592864991|FG000|Overall Study|Death|2|||
164136703|NCT03317834|592864991|FG000|Overall Study|Device Revision|5|||
164136704|NCT03317834|592864991|FG000|Overall Study|Withdrawal by Subject|13|||
164136705|NCT03317834|592864991|FG000|Overall Study|Lost to Follow-up|13|||
164136706|NCT03839823|592864995|FG000|Overall Study|Adverse Event|8|||
164136707|NCT03839823|592864996|FG001|Overall Study|Adverse Event|4|||
164136708|NCT03839823|592864995|FG000|Overall Study|Death|1|||
164136709|NCT03839823|592864996|FG001|Overall Study|Death|0|||
164136710|NCT03839823|592864995|FG000|Overall Study|Physician Decision|1|||
164136711|NCT03839823|592864996|FG001|Overall Study|Physician Decision|5|||
164136712|NCT03839823|592864995|FG000|Overall Study|Progressive Disease (PD)|65|||
164136713|NCT03839823|592864996|FG001|Overall Study|Progressive Disease (PD)|65|||
164136714|NCT03839823|592864995|FG000|Overall Study|Subject Decision|2|||
164136715|NCT03839823|592864996|FG001|Overall Study|Subject Decision|9|||
164136716|NCT03839823|592864995|FG000|Overall Study|Not Treated|0|||
164136717|NCT03839823|592864996|FG001|Overall Study|Not Treated|10|||
164136718|NCT01716715|592864997|FG000|Overall Study|Never Treated|2|||
164136719|NCT01716715|592864998|FG001|Overall Study|Never Treated|4|||
164136720|NCT00660400|592864999|FG000|Overall Study|Lack of insurance approval|1|||
164136721|NCT00660400|592864999|FG000|Overall Study|Suboptimal organ function|1|||
164136722|NCT00660400|592864999|FG000|Overall Study|Intracranial hemorrhage|1|||
164136723|NCT00660400|592864999|FG000|Overall Study|Withdrawal by Subject|1|||
164136724|NCT01161407|592865000|FG000|Overall Study|Protocol Violation|3|||
164136725|NCT01161407|592865001|FG001|Overall Study|Protocol Violation|1|||
164136726|NCT01777620|592865002|FG000|Overall Study|Subject Withdrawal|1|||
164136727|NCT01777620|592865003|FG001|Overall Study|Subject Withdrawal|0|||
164136728|NCT04562155|592865004|FG000|Overall Study|COVID-19 pandemic|0|||
164136729|NCT04562155|592865005|FG001|Overall Study|COVID-19 pandemic|0|||
164136730|NCT04562155|592865006|FG002|Overall Study|COVID-19 pandemic|0|||
164136731|NCT04562155|592865007|FG003|Overall Study|COVID-19 pandemic|1|||
164136732|NCT04562155|592865004|FG000|Overall Study|Adverse Event|7|||
164136733|NCT04562155|592865005|FG001|Overall Study|Adverse Event|3|||
164136734|NCT04562155|592865006|FG002|Overall Study|Adverse Event|8|||
164136735|NCT04562155|592865007|FG003|Overall Study|Adverse Event|1|||
164136736|NCT04562155|592865004|FG000|Overall Study|Withdrawal by Subject|3|||
164136737|NCT04562155|592865005|FG001|Overall Study|Withdrawal by Subject|6|||
164136738|NCT04562155|592865006|FG002|Overall Study|Withdrawal by Subject|3|||
164136739|NCT04562155|592865007|FG003|Overall Study|Withdrawal by Subject|3|||
164136740|NCT04562155|592865004|FG000|Overall Study|Participant personal reason|1|||
164136741|NCT04562155|592865005|FG001|Overall Study|Participant personal reason|0|||
164136742|NCT04562155|592865006|FG002|Overall Study|Participant personal reason|2|||
164136743|NCT04562155|592865007|FG003|Overall Study|Participant personal reason|1|||
164136744|NCT04005352|592865016|FG000|Overall Study|Adverse Event|4|||
164136745|NCT04005352|592865017|FG001|Overall Study|Adverse Event|5|||
164136746|NCT04005352|592865016|FG000|Overall Study|Death|4|||
164136747|NCT04005352|592865017|FG001|Overall Study|Death|2|||
164136748|NCT04005352|592865016|FG000|Overall Study|Lost to Follow-up|6|||
164136749|NCT04005352|592865017|FG001|Overall Study|Lost to Follow-up|2|||
164136750|NCT04005352|592865016|FG000|Overall Study|Physician Decision|7|||
164136751|NCT04005352|592865017|FG001|Overall Study|Physician Decision|13|||
164136752|NCT04005352|592865016|FG000|Overall Study|Protocol Violation|0|||
164136753|NCT04005352|592865017|FG001|Overall Study|Protocol Violation|1|||
164136754|NCT04005352|592865016|FG000|Overall Study|Withdrawal by Subject|28|||
164136755|NCT04005352|592865017|FG001|Overall Study|Withdrawal by Subject|38|||
164136756|NCT00849186|592865018|FG000|Overall Study|Adverse Event|2|||
164136757|NCT00849186|592865018|FG000|Overall Study|Withdrawal by Subject|1|||
164136758|NCT00849186|592865018|FG000|Overall Study|not treated|6|||
164136759|NCT00849186|592865018|FG000|Overall Study|Other|1|||
164136760|NCT00936897|592865021|FG000|Overall Study|Withdrawal by Subject|9|||
164136761|NCT00936897|592865022|FG001|Overall Study|Withdrawal by Subject|19|||
164136762|NCT00936897|592865021|FG000|Overall Study|Adverse Event|4|||
164136763|NCT00936897|592865022|FG001|Overall Study|Adverse Event|13|||
164136764|NCT00936897|592865021|FG000|Overall Study|Other|3|||
164136765|NCT00936897|592865022|FG001|Overall Study|Other|9|||
164136766|NCT00936897|592865021|FG000|Overall Study|Lost to Follow-up|1|||
164136767|NCT00936897|592865022|FG001|Overall Study|Lost to Follow-up|10|||
164136768|NCT00936897|592865021|FG000|Overall Study|Administrative Decision|1|||
164136769|NCT00936897|592865022|FG001|Overall Study|Administrative Decision|2|||
164136770|NCT00936897|592865021|FG000|Overall Study|Protocol Violation|1|||
164136771|NCT00936897|592865022|FG001|Overall Study|Protocol Violation|1|||
164136772|NCT00936897|592865021|FG000|Overall Study|Ineligibility Determined|0|||
164136773|NCT00936897|592865022|FG001|Overall Study|Ineligibility Determined|3|||
164136774|NCT00936897|592865021|FG000|Overall Study|Noncompliance|0|||
164136775|NCT00936897|592865022|FG001|Overall Study|Noncompliance|2|||
164136776|NCT00936897|592865021|FG000|Overall Study|Death|0|||
164136777|NCT00936897|592865022|FG001|Overall Study|Death|1|||
164136778|NCT04058067|592865023|FG000|Overall Study|Adverse Event|2|||
164136779|NCT04058067|592865024|FG001|Overall Study|Adverse Event|0|||
164136780|NCT04058067|592865023|FG000|Overall Study|Death|0|||
164136781|NCT04058067|592865024|FG001|Overall Study|Death|1|||
164136782|NCT04058067|592865023|FG000|Overall Study|Physician Decision|3|||
164136783|NCT04058067|592865024|FG001|Overall Study|Physician Decision|1|||
164136784|NCT04058067|592865023|FG000|Overall Study|Protocol Violation|0|||
164136785|NCT04058067|592865024|FG001|Overall Study|Protocol Violation|1|||
164136786|NCT04058067|592865023|FG000|Overall Study|Withdrawal by Subject|7|||
164136787|NCT04058067|592865024|FG001|Overall Study|Withdrawal by Subject|8|||
164136788|NCT00417170|592865025|FG000|Overall Study|Adverse Event|1|||
164136789|NCT00417170|592865026|FG001|Overall Study|Adverse Event|1|||
164136790|NCT00417170|592865025|FG000|Overall Study|Withdrawal by Subject|1|||
164136791|NCT00417170|592865026|FG001|Overall Study|Withdrawal by Subject|1|||
164136792|NCT00417170|592865025|FG000|Overall Study|Lost to Follow-up|0|||
164136793|NCT00417170|592865026|FG001|Overall Study|Lost to Follow-up|1|||
164136794|NCT01001988|592865029|FG000|Overall Study|Protocol Violation|84|||
164136795|NCT01001988|592865029|FG000|Overall Study|Withdrawal by Subject|18|||
164136796|NCT01001988|592865029|FG000|Overall Study|Lost to Follow-up|15|||
164136797|NCT04628793|592865030|FG000|Overall Study|Study terminated by sponsor|0|||
164136798|NCT04628793|592865031|FG001|Overall Study|Study terminated by sponsor|0|||
164136799|NCT04628793|592865032|FG002|Overall Study|Study terminated by sponsor|8|||
164136800|NCT04628793|592865030|FG000|Overall Study|Withdrawal by Subject|2|||
164136801|NCT04628793|592865031|FG001|Overall Study|Withdrawal by Subject|3|||
164136802|NCT04628793|592865032|FG002|Overall Study|Withdrawal by Subject|0|||
164136803|NCT04628793|592865030|FG000|Overall Study|Lost to Follow-up|0|||
164136804|NCT04628793|592865031|FG001|Overall Study|Lost to Follow-up|1|||
164136805|NCT04628793|592865032|FG002|Overall Study|Lost to Follow-up|0|||
164136806|NCT01329549|592865039|FG000|Overall Study|Withdrawal by Subject|1|||
164136807|NCT01329549|592865039|FG000|Overall Study|Adverse Event|1|||
164136808|NCT00191165|592865040|FG000|Overall Study|Adverse Event|2|||
164136809|NCT00191165|592865041|FG001|Overall Study|Adverse Event|0|||
164136810|NCT00191165|592865040|FG000|Overall Study|Protocol Violation|0|||
164136811|NCT00191165|592865041|FG001|Overall Study|Protocol Violation|1|||
164136812|NCT00191165|592865040|FG000|Overall Study|Participant Moved Away|0|||
164136813|NCT00191165|592865041|FG001|Overall Study|Participant Moved Away|1|||
164136814|NCT03200912|592865042|FG000|Overall Study|Adverse Event|3|||
164136815|NCT03200912|592865043|FG001|Overall Study|Adverse Event|0|||
164136816|NCT03200912|592865044|FG002|Overall Study|Adverse Event|0|||
164136817|NCT03200912|592865042|FG000|Overall Study|Withdrawal by Subject|1|||
164136818|NCT03200912|592865043|FG001|Overall Study|Withdrawal by Subject|2|||
164136819|NCT03200912|592865044|FG002|Overall Study|Withdrawal by Subject|4|||
164136820|NCT03200912|592865042|FG000|Overall Study|Non-compliance with study drug|0|||
164136821|NCT03200912|592865043|FG001|Overall Study|Non-compliance with study drug|1|||
164137039|NCT03334617|592865129|FG009|Overall Study|Adverse Event|0|||
164136822|NCT03200912|592865044|FG002|Overall Study|Non-compliance with study drug|0|||
164136823|NCT03196635|592865045|FG000|Overall Study|Withdrawal by Subject|1|||
164136824|NCT00998309|592865048|FG000|Overall Study|Protocol Violation|4|||
164136825|NCT03421730|592865049|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136826|NCT03421730|592865050|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
164136827|NCT03421730|592865051|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136828|NCT03421730|592865052|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136829|NCT03421730|592865053|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136830|NCT03421730|592865054|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136831|NCT03421730|592865055|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136832|NCT03421730|592865056|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136833|NCT03421730|592865057|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136834|NCT03421730|592865058|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136835|NCT03421730|592865059|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136836|NCT03421730|592865060|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
164136837|NCT03421730|592865049|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136838|NCT03421730|592865050|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136839|NCT03421730|592865051|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136840|NCT03421730|592865052|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136841|NCT03421730|592865053|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
164136842|NCT03421730|592865054|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136843|NCT03421730|592865055|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136844|NCT03421730|592865056|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136845|NCT03421730|592865057|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136846|NCT03421730|592865058|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136847|NCT03421730|592865059|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136848|NCT03421730|592865060|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
164136849|NCT02865460|592865061|FG000|Overall Study|Adverse Event|1|||
164136850|NCT02865460|592865062|FG001|Overall Study|Adverse Event|0|||
164136851|NCT02865460|592865061|FG000|Overall Study|Withdrawal by Subject|1|||
164136852|NCT02865460|592865062|FG001|Overall Study|Withdrawal by Subject|1|||
164136853|NCT02865460|592865061|FG000|Overall Study|Lost to Follow-up|7|||
164136854|NCT02865460|592865062|FG001|Overall Study|Lost to Follow-up|4|||
164136855|NCT02865460|592865061|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
164136856|NCT02865460|592865062|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
164136857|NCT00901576|592865069|FG000|Second Intervention|Withdrawal by Subject|0|||
164136858|NCT00901576|592865070|FG001|Second Intervention|Withdrawal by Subject|0|||
164136859|NCT00901576|592865071|FG002|Second Intervention|Withdrawal by Subject|0|||
164136860|NCT00901576|592865072|FG003|Second Intervention|Withdrawal by Subject|1|||
164136861|NCT00901576|592865073|FG004|Second Intervention|Withdrawal by Subject|0|||
164136862|NCT00901576|592865074|FG005|Second Intervention|Withdrawal by Subject|1|||
164136863|NCT00901576|592865069|FG000|Second Intervention|Physician Decision|1|||
164136864|NCT00901576|592865070|FG001|Second Intervention|Physician Decision|0|||
164136865|NCT00901576|592865071|FG002|Second Intervention|Physician Decision|0|||
164136866|NCT00901576|592865072|FG003|Second Intervention|Physician Decision|0|||
164136867|NCT00901576|592865073|FG004|Second Intervention|Physician Decision|0|||
164136868|NCT00901576|592865074|FG005|Second Intervention|Physician Decision|0|||
164136869|NCT01696279|592865075|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
164136870|NCT01696279|592865076|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
164136871|NCT01696279|592865077|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
164136872|NCT01696279|592865078|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
164136873|NCT01696279|592865075|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
164136874|NCT01696279|592865076|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
164136875|NCT01696279|592865077|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
164136876|NCT01696279|592865078|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
164136877|NCT01696279|592865075|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
164136878|NCT01696279|592865076|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
164136879|NCT01696279|592865077|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
164136880|NCT01696279|592865078|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
164136881|NCT01696279|592865075|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
164136882|NCT01696279|592865076|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
164136883|NCT01696279|592865077|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
164136884|NCT01696279|592865078|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
164136885|NCT01696279|592865075|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
164137040|NCT03334617|592865130|FG010|Overall Study|Adverse Event|0|||
164136886|NCT01696279|592865076|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
164136887|NCT01696279|592865077|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
164136888|NCT01696279|592865078|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
164136889|NCT01696279|592865075|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
164136890|NCT01696279|592865076|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
164136891|NCT01696279|592865077|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
164136892|NCT01696279|592865078|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
164136893|NCT01696279|592865075|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
164136894|NCT01696279|592865076|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
164136895|NCT01696279|592865077|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
164136896|NCT01696279|592865078|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
164136897|NCT01696279|592865075|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
164136898|NCT01696279|592865076|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
164136899|NCT01696279|592865077|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
164136900|NCT01696279|592865078|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
164136901|NCT01696279|592865075|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
164136902|NCT01696279|592865076|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
164136903|NCT01696279|592865077|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
164136904|NCT01696279|592865078|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
164136905|NCT01696279|592865075|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
164136906|NCT01696279|592865076|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
164136907|NCT01696279|592865077|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
164136908|NCT01696279|592865078|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
164136909|NCT01696279|592865075|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
164136910|NCT01696279|592865076|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
164136911|NCT01696279|592865077|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
164136912|NCT01696279|592865078|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
164136913|NCT00171951|592865079|FG000|Overall Study|Adverse Event|1|||
164136914|NCT00171951|592865079|FG000|Overall Study|Abnormal Laboratory Values|2|||
164136915|NCT00171951|592865079|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164136916|NCT00171951|592865079|FG000|Overall Study|Participants Withdrew Consent|3|||
164136917|NCT00171951|592865079|FG000|Overall Study|New Cancer Therapy|5|||
164136918|NCT00171951|592865079|FG000|Overall Study|Reason not Specified|2|||
164136919|NCT01661062|592865080|FG000|Overall Study|Completed Treatment Off Study|3|||
164136920|NCT01661062|592865080|FG000|Overall Study|Withdrawal by Subject|2|||
164136921|NCT05788289|592865081|FG000|Overall Study|Death|3|||
164136922|NCT04154631|592865083|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
164136923|NCT04154631|592865084|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
164136924|NCT02238795|592865085|FG000|Overall Study|Patient without purpura fulminans|1|||
164136925|NCT05187013|592865087|FG000|Overall Study|Withdrawal by Subject|1|||
164136926|NCT05187013|592865088|FG001|Overall Study|Withdrawal by Subject|1|||
164136927|NCT05187013|592865089|FG002|Overall Study|Withdrawal by Subject|0|||
164136928|NCT05187013|592865087|FG000|Overall Study|Death|0|||
164136929|NCT05187013|592865088|FG001|Overall Study|Death|1|||
164136930|NCT05187013|592865089|FG002|Overall Study|Death|0|||
164136931|NCT05187013|592865087|FG000|Overall Study|Lost to Follow-up|20|||
164136932|NCT05187013|592865088|FG001|Overall Study|Lost to Follow-up|17|||
164136933|NCT05187013|592865089|FG002|Overall Study|Lost to Follow-up|0|||
164136934|NCT05187013|592865087|FG000|Overall Study|Ongoing Participants|3|||
164136935|NCT05187013|592865088|FG001|Overall Study|Ongoing Participants|5|||
164136936|NCT05187013|592865089|FG002|Overall Study|Ongoing Participants|0|||
164136937|NCT01096368|592865091|FG000|Overall Study|Death|0|||
164136938|NCT01096368|592865092|FG001|Overall Study|Death|1|||
164136939|NCT01096368|592865093|FG002|Overall Study|Death|0|||
164136940|NCT01096368|592865094|FG003|Overall Study|Death|0|||
164136941|NCT01096368|592865095|FG004|Overall Study|Death|0|||
164136942|NCT01096368|592865091|FG000|Overall Study|Physician Decision|0|||
164136943|NCT01096368|592865092|FG001|Overall Study|Physician Decision|13|||
164136944|NCT01096368|592865093|FG002|Overall Study|Physician Decision|2|||
164136945|NCT01096368|592865094|FG003|Overall Study|Physician Decision|4|||
164136946|NCT01096368|592865095|FG004|Overall Study|Physician Decision|6|||
164136947|NCT01096368|592865091|FG000|Overall Study|Withdrawal by Subject|0|||
164136948|NCT01096368|592865092|FG001|Overall Study|Withdrawal by Subject|52|||
164136949|NCT01096368|592865093|FG002|Overall Study|Withdrawal by Subject|0|||
164136950|NCT01096368|592865094|FG003|Overall Study|Withdrawal by Subject|10|||
164136951|NCT01096368|592865095|FG004|Overall Study|Withdrawal by Subject|14|||
164136952|NCT01096368|592865091|FG000|Overall Study|Ineligible|0|||
164136953|NCT01096368|592865092|FG001|Overall Study|Ineligible|3|||
164136954|NCT01096368|592865093|FG002|Overall Study|Ineligible|2|||
164136955|NCT01096368|592865094|FG003|Overall Study|Ineligible|0|||
164136956|NCT01096368|592865095|FG004|Overall Study|Ineligible|25|||
164136957|NCT01096368|592865091|FG000|Overall Study|Did not start treatment|0|||
164136958|NCT01096368|592865092|FG001|Overall Study|Did not start treatment|4|||
164136959|NCT01096368|592865093|FG002|Overall Study|Did not start treatment|4|||
164136960|NCT01096368|592865094|FG003|Overall Study|Did not start treatment|0|||
164136961|NCT01096368|592865095|FG004|Overall Study|Did not start treatment|0|||
164136962|NCT01096368|592865091|FG000|Overall Study|Progressive disease|0|||
164136963|NCT01096368|592865092|FG001|Overall Study|Progressive disease|6|||
164136964|NCT01096368|592865093|FG002|Overall Study|Progressive disease|0|||
164136965|NCT01096368|592865094|FG003|Overall Study|Progressive disease|10|||
164136966|NCT01096368|592865095|FG004|Overall Study|Progressive disease|3|||
164136967|NCT01096368|592865091|FG000|Overall Study|Other|0|||
164136968|NCT01096368|592865092|FG001|Overall Study|Other|0|||
164136969|NCT01096368|592865093|FG002|Overall Study|Other|1|||
164136970|NCT01096368|592865094|FG003|Overall Study|Other|0|||
164136971|NCT01096368|592865095|FG004|Overall Study|Other|0|||
164136972|NCT01096368|592865091|FG000|Overall Study|Treated with institutional review|0|||
164136973|NCT01096368|592865092|FG001|Overall Study|Treated with institutional review|0|||
164136974|NCT01096368|592865093|FG002|Overall Study|Treated with institutional review|0|||
164136975|NCT01096368|592865094|FG003|Overall Study|Treated with institutional review|0|||
164136976|NCT01096368|592865095|FG004|Overall Study|Treated with institutional review|1|||
164136977|NCT01568320|592865097|FG000|Overall Study|Death|20|||
164136978|NCT01568320|592865097|FG000|Overall Study|Lost to Follow-up|9|||
164136979|NCT01568320|592865097|FG000|Overall Study|Withdrawal by Subject|10|||
164136980|NCT01568320|592865097|FG000|Overall Study|Conversion to open repair|1|||
164136981|NCT01568320|592865097|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
164136982|NCT03233230|592865098|FG000|Overall Study|Adverse Event|6|||
164136983|NCT03233230|592865099|FG001|Overall Study|Adverse Event|3|||
164136984|NCT03233230|592865100|FG002|Overall Study|Adverse Event|6|||
164136985|NCT03233230|592865101|FG003|Overall Study|Adverse Event|3|||
164136986|NCT03233230|592865098|FG000|Overall Study|Protocol Violation|1|||
164136987|NCT03233230|592865099|FG001|Overall Study|Protocol Violation|2|||
164136988|NCT03233230|592865100|FG002|Overall Study|Protocol Violation|1|||
164136989|NCT03233230|592865101|FG003|Overall Study|Protocol Violation|1|||
164136990|NCT03233230|592865098|FG000|Overall Study|Lack of Efficacy|1|||
164136991|NCT03233230|592865099|FG001|Overall Study|Lack of Efficacy|0|||
164136992|NCT03233230|592865100|FG002|Overall Study|Lack of Efficacy|0|||
164136993|NCT03233230|592865101|FG003|Overall Study|Lack of Efficacy|0|||
164136994|NCT03233230|592865098|FG000|Overall Study|Other|5|||
164136995|NCT03233230|592865099|FG001|Overall Study|Other|5|||
164136996|NCT03233230|592865100|FG002|Overall Study|Other|5|||
164136997|NCT03233230|592865101|FG003|Overall Study|Other|3|||
164136998|NCT03233230|592865098|FG000|Overall Study|Withdrawal by Subject|2|||
164136999|NCT03233230|592865099|FG001|Overall Study|Withdrawal by Subject|2|||
164137000|NCT03233230|592865100|FG002|Overall Study|Withdrawal by Subject|0|||
164137001|NCT03233230|592865101|FG003|Overall Study|Withdrawal by Subject|1|||
164137002|NCT03233230|592865098|FG000|Overall Study|Lost to Follow-up|0|||
164137003|NCT03233230|592865099|FG001|Overall Study|Lost to Follow-up|3|||
164137004|NCT03233230|592865100|FG002|Overall Study|Lost to Follow-up|0|||
164137005|NCT03233230|592865101|FG003|Overall Study|Lost to Follow-up|0|||
164137006|NCT04159935|592865102|FG000|Overall Study|Study terminated due to COVID-19|1|||
164137007|NCT04159935|592865103|FG001|Overall Study|Study terminated due to COVID-19|3|||
164137008|NCT02927366|592865104|FG000|Overall Study|Adverse Event|1|||
164137009|NCT02927366|592865105|FG001|Overall Study|Adverse Event|0|||
164137010|NCT02927366|592865104|FG000|Overall Study|Patient schedule|1|||
164137011|NCT02927366|592865105|FG001|Overall Study|Patient schedule|0|||
164137012|NCT00587990|592865110|FG000|Overall Study|Death|0|||
164137013|NCT00587990|592865111|FG001|Overall Study|Death|0|||
164137014|NCT00587990|592865112|FG002|Overall Study|Death|1|||
164137015|NCT00206323|592865113|FG000|Overall Study|Lack of Efficacy|4|||
164137016|NCT00206323|592865114|FG001|Overall Study|Lack of Efficacy|1|||
164137017|NCT00206323|592865113|FG000|Overall Study|Adverse Event|1|||
164137018|NCT00206323|592865114|FG001|Overall Study|Adverse Event|1|||
164137019|NCT00206323|592865113|FG000|Overall Study|Lost to Follow-up|1|||
164137020|NCT00206323|592865114|FG001|Overall Study|Lost to Follow-up|1|||
164137021|NCT02910063|592865115|FG000|Phase 2|Withdrawal by Subject|3|||
164137022|NCT02910063|592865116|FG001|Phase 2|Withdrawal by Subject|0|||
164137023|NCT02910063|592865117|FG002|Phase 2|Withdrawal by Subject|0|||
164137024|NCT02910063|592865115|FG000|Phase 2|Lost to Follow-up|1|||
164137025|NCT02910063|592865116|FG001|Phase 2|Lost to Follow-up|0|||
164137026|NCT02910063|592865117|FG002|Phase 2|Lost to Follow-up|0|||
164137027|NCT02910063|592865115|FG000|Phase 2|Death|24|||
164137028|NCT02910063|592865116|FG001|Phase 2|Death|0|||
164137029|NCT02910063|592865117|FG002|Phase 2|Death|0|||
164137030|NCT03334617|592865120|FG000|Overall Study|Adverse Event|0|||
164137031|NCT03334617|592865121|FG001|Overall Study|Adverse Event|0|||
164137032|NCT03334617|592865122|FG002|Overall Study|Adverse Event|0|||
164137033|NCT03334617|592865123|FG003|Overall Study|Adverse Event|0|||
164137034|NCT03334617|592865124|FG004|Overall Study|Adverse Event|0|||
164137035|NCT03334617|592865125|FG005|Overall Study|Adverse Event|0|||
164137036|NCT03334617|592865126|FG006|Overall Study|Adverse Event|0|||
164137037|NCT03334617|592865127|FG007|Overall Study|Adverse Event|0|||
164137038|NCT03334617|592865128|FG008|Overall Study|Adverse Event|1|||
164137184|NCT00911807|592865162|FG001|Overall Study|Withdrawal by Subject|10|||
164137185|NCT00911807|592865163|FG002|Overall Study|Withdrawal by Subject|7|||
164137186|NCT00911807|592865161|FG000|Overall Study|Organizational reasons|1|||
164137187|NCT00911807|592865162|FG001|Overall Study|Organizational reasons|3|||
164137188|NCT00911807|592865163|FG002|Overall Study|Organizational reasons|1|||
164137189|NCT01753336|592865165|FG000|Overall Study|Patient decision|12|||
164137190|NCT01753336|592865165|FG000|Overall Study|Lost to Follow-up|3|||
164137191|NCT01753336|592865165|FG000|Overall Study|Physician Decision|2|||
164137192|NCT01753336|592865165|FG000|Overall Study|Sponsor's decision|2|||
164137193|NCT01753336|592865165|FG000|Overall Study|Withdrawal by Subject|1|||
164137194|NCT00855803|592865166|FG000|Overall Study|Death|2|||
164137195|NCT00855803|592865166|FG000|Overall Study|Lost to Follow-up|2|||
164137196|NCT00855803|592865166|FG000|Overall Study|Technical inability to undergo procedure|2|||
164137197|NCT00855803|592865166|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
164137198|NCT00855803|592865166|FG000|Overall Study|Withdrawal by Subject|3|||
164137199|NCT00855803|592865166|FG000|Overall Study|Physician Decision|3|||
164137200|NCT00809159|592865167|FG000|Part 1|Adverse Event|1|||
164137201|NCT00809159|592865168|FG001|Part 1|Adverse Event|1|||
164137202|NCT00809159|592865169|FG002|Part 1|Adverse Event|0|||
164137203|NCT00809159|592865170|FG003|Part 1|Adverse Event|0|||
164137204|NCT00809159|592865171|FG004|Part 1|Adverse Event|0|||
164137205|NCT00809159|592865172|FG005|Part 1|Adverse Event|0|||
164137206|NCT00809159|592865167|FG000|Part 1|Lost to Follow-up|1|||
164137207|NCT00809159|592865168|FG001|Part 1|Lost to Follow-up|0|||
164137208|NCT00809159|592865169|FG002|Part 1|Lost to Follow-up|0|||
164137209|NCT00809159|592865170|FG003|Part 1|Lost to Follow-up|0|||
164137210|NCT00809159|592865171|FG004|Part 1|Lost to Follow-up|0|||
164137211|NCT00809159|592865172|FG005|Part 1|Lost to Follow-up|0|||
164137212|NCT00809159|592865167|FG000|Part 1|Withdrawal by Subject|3|||
164137213|NCT00809159|592865168|FG001|Part 1|Withdrawal by Subject|1|||
164137214|NCT00809159|592865169|FG002|Part 1|Withdrawal by Subject|0|||
164137215|NCT00809159|592865170|FG003|Part 1|Withdrawal by Subject|0|||
164137216|NCT00809159|592865171|FG004|Part 1|Withdrawal by Subject|0|||
164137217|NCT00809159|592865172|FG005|Part 1|Withdrawal by Subject|0|||
164137218|NCT00809159|592865167|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
164137219|NCT00809159|592865168|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
164137220|NCT00809159|592865169|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
164137221|NCT00809159|592865170|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
164137222|NCT00809159|592865171|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
164137223|NCT00809159|592865172|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
164137224|NCT00809159|592865167|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
164137225|NCT00809159|592865168|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
164137226|NCT00809159|592865169|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
164137227|NCT00809159|592865170|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
164137228|NCT00809159|592865171|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
164137229|NCT00809159|592865172|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
164137230|NCT00809159|592865167|FG000|Part 1 and 2|Administrative problems|0|||
164137231|NCT00809159|592865168|FG001|Part 1 and 2|Administrative problems|0|||
164137232|NCT00809159|592865169|FG002|Part 1 and 2|Administrative problems|0|||
164137233|NCT00809159|592865170|FG003|Part 1 and 2|Administrative problems|1|||
164137234|NCT00809159|592865171|FG004|Part 1 and 2|Administrative problems|0|||
164137235|NCT00809159|592865172|FG005|Part 1 and 2|Administrative problems|0|||
164137236|NCT00809159|592865167|FG000|Part 1 and 2|Adverse Event|0|||
164137237|NCT00809159|592865168|FG001|Part 1 and 2|Adverse Event|0|||
164137238|NCT00809159|592865169|FG002|Part 1 and 2|Adverse Event|1|||
164137239|NCT00809159|592865170|FG003|Part 1 and 2|Adverse Event|0|||
164137240|NCT00809159|592865171|FG004|Part 1 and 2|Adverse Event|1|||
164137241|NCT00809159|592865172|FG005|Part 1 and 2|Adverse Event|1|||
164137242|NCT00809159|592865167|FG000|Part 1 and 2|Lost to Follow-up|0|||
164137243|NCT00809159|592865168|FG001|Part 1 and 2|Lost to Follow-up|0|||
164137244|NCT00809159|592865169|FG002|Part 1 and 2|Lost to Follow-up|1|||
164137245|NCT00809159|592865170|FG003|Part 1 and 2|Lost to Follow-up|1|||
164137246|NCT00809159|592865171|FG004|Part 1 and 2|Lost to Follow-up|0|||
164137247|NCT00809159|592865172|FG005|Part 1 and 2|Lost to Follow-up|0|||
164137248|NCT00809159|592865167|FG000|Part 1 and 2|Withdrawal by Subject|0|||
164137249|NCT00809159|592865168|FG001|Part 1 and 2|Withdrawal by Subject|0|||
164137250|NCT00809159|592865169|FG002|Part 1 and 2|Withdrawal by Subject|4|||
164137251|NCT00809159|592865170|FG003|Part 1 and 2|Withdrawal by Subject|0|||
164137252|NCT00809159|592865171|FG004|Part 1 and 2|Withdrawal by Subject|0|||
164137253|NCT00809159|592865172|FG005|Part 1 and 2|Withdrawal by Subject|1|||
164137254|NCT03201211|592865173|FG000|Overall Study|Adverse Event|1|||
164137255|NCT03201211|592865174|FG001|Overall Study|Adverse Event|0|||
164137256|NCT03201211|592865175|FG002|Overall Study|Adverse Event|0|||
164137257|NCT03201211|592865173|FG000|Overall Study|Protocol Violation|1|||
164137258|NCT03201211|592865174|FG001|Overall Study|Protocol Violation|0|||
164137259|NCT03201211|592865175|FG002|Overall Study|Protocol Violation|0|||
164137260|NCT03201211|592865173|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164137261|NCT03201211|592865174|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164137262|NCT03201211|592865175|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164137263|NCT03201211|592865173|FG000|Overall Study|OTHER unknown reasons|0|||
164137264|NCT03201211|592865174|FG001|Overall Study|OTHER unknown reasons|1|||
164137265|NCT03201211|592865175|FG002|Overall Study|OTHER unknown reasons|0|||
164137266|NCT03918109|592865180|FG000|Overall Study|Withdrawal by Subject|0|||
164137267|NCT03918109|592865181|FG001|Overall Study|Withdrawal by Subject|0|||
164137268|NCT03918109|592865182|FG002|Overall Study|Withdrawal by Subject|2|||
164137269|NCT03918109|592865183|FG003|Overall Study|Withdrawal by Subject|1|||
164137270|NCT03918109|592865180|FG000|Overall Study|Lost to Follow-up|0|||
164137271|NCT03918109|592865181|FG001|Overall Study|Lost to Follow-up|0|||
164137272|NCT03918109|592865182|FG002|Overall Study|Lost to Follow-up|0|||
164137273|NCT03918109|592865183|FG003|Overall Study|Lost to Follow-up|1|||
164137274|NCT03050060|592865186|FG000|Overall Study|Adverse Event|7|||
164137275|NCT03050060|592865186|FG000|Overall Study|Withdrawal by Subject|1|||
164137276|NCT03050060|592865186|FG000|Overall Study|Progression|7|||
164137277|NCT02304458|592865187|FG000|Overall Study|Adverse Event|0|||
164137278|NCT02304458|592865188|FG001|Overall Study|Adverse Event|0|||
164137279|NCT02304458|592865189|FG002|Overall Study|Adverse Event|7|||
164137280|NCT02304458|592865190|FG003|Overall Study|Adverse Event|0|||
164137281|NCT02304458|592865191|FG004|Overall Study|Adverse Event|0|||
164137282|NCT02304458|592865192|FG005|Overall Study|Adverse Event|0|||
164137283|NCT02304458|592865193|FG006|Overall Study|Adverse Event|3|||
164137284|NCT02304458|592865194|FG007|Overall Study|Adverse Event|4|||
164137285|NCT02304458|592865187|FG000|Overall Study|Death|0|||
164137286|NCT02304458|592865188|FG001|Overall Study|Death|0|||
164137287|NCT02304458|592865189|FG002|Overall Study|Death|2|||
164137288|NCT02304458|592865190|FG003|Overall Study|Death|0|||
164137289|NCT02304458|592865191|FG004|Overall Study|Death|0|||
164137290|NCT02304458|592865192|FG005|Overall Study|Death|0|||
164137291|NCT02304458|592865193|FG006|Overall Study|Death|1|||
164137292|NCT02304458|592865194|FG007|Overall Study|Death|0|||
164137293|NCT02304458|592865187|FG000|Overall Study|Lack of Efficacy|4|||
164137294|NCT02304458|592865188|FG001|Overall Study|Lack of Efficacy|6|||
164137295|NCT02304458|592865189|FG002|Overall Study|Lack of Efficacy|38|||
164137296|NCT02304458|592865190|FG003|Overall Study|Lack of Efficacy|5|||
164137297|NCT02304458|592865191|FG004|Overall Study|Lack of Efficacy|6|||
164137298|NCT02304458|592865192|FG005|Overall Study|Lack of Efficacy|6|||
164137299|NCT02304458|592865193|FG006|Overall Study|Lack of Efficacy|21|||
164137300|NCT02304458|592865194|FG007|Overall Study|Lack of Efficacy|4|||
164137301|NCT02304458|592865187|FG000|Overall Study|Physician Decision|2|||
164137302|NCT02304458|592865188|FG001|Overall Study|Physician Decision|0|||
164137303|NCT02304458|592865189|FG002|Overall Study|Physician Decision|16|||
164137304|NCT02304458|592865190|FG003|Overall Study|Physician Decision|1|||
164137305|NCT02304458|592865191|FG004|Overall Study|Physician Decision|0|||
164137306|NCT02304458|592865192|FG005|Overall Study|Physician Decision|0|||
164137307|NCT02304458|592865193|FG006|Overall Study|Physician Decision|3|||
164137308|NCT02304458|592865194|FG007|Overall Study|Physician Decision|0|||
164137309|NCT02304458|592865187|FG000|Overall Study|Protocol Violation|0|||
164137310|NCT02304458|592865188|FG001|Overall Study|Protocol Violation|0|||
164137311|NCT02304458|592865189|FG002|Overall Study|Protocol Violation|1|||
164137312|NCT02304458|592865190|FG003|Overall Study|Protocol Violation|0|||
164137313|NCT02304458|592865191|FG004|Overall Study|Protocol Violation|0|||
164137314|NCT02304458|592865192|FG005|Overall Study|Protocol Violation|0|||
164137315|NCT02304458|592865193|FG006|Overall Study|Protocol Violation|0|||
164137316|NCT02304458|592865194|FG007|Overall Study|Protocol Violation|0|||
164137317|NCT02304458|592865187|FG000|Overall Study|Withdrawal by Subject|1|||
164137318|NCT02304458|592865188|FG001|Overall Study|Withdrawal by Subject|0|||
164137319|NCT02304458|592865189|FG002|Overall Study|Withdrawal by Subject|7|||
164137320|NCT02304458|592865190|FG003|Overall Study|Withdrawal by Subject|0|||
164137321|NCT02304458|592865191|FG004|Overall Study|Withdrawal by Subject|0|||
164137322|NCT02304458|592865192|FG005|Overall Study|Withdrawal by Subject|0|||
164137323|NCT02304458|592865193|FG006|Overall Study|Withdrawal by Subject|1|||
164137324|NCT02304458|592865194|FG007|Overall Study|Withdrawal by Subject|0|||
164137325|NCT04188301|592865195|FG000|Month 3|Lost to Follow-up|0|||
164137326|NCT04188301|592865196|FG001|Month 3|Lost to Follow-up|0|||
164137327|NCT04188301|592865197|FG002|Month 3|Lost to Follow-up|1|||
164137328|NCT04188301|592865195|FG000|Month 12|Lost to Follow-up|0|||
164137329|NCT04188301|592865196|FG001|Month 12|Lost to Follow-up|0|||
164137330|NCT04188301|592865197|FG002|Month 12|Lost to Follow-up|2|||
164137331|NCT04188301|592865195|FG000|Month 12|Death|1|||
164137332|NCT04188301|592865196|FG001|Month 12|Death|1|||
164137333|NCT04188301|592865197|FG002|Month 12|Death|0|||
164137334|NCT04188301|592865195|FG000|Month 18|Lost to Follow-up|6|||
164137335|NCT04188301|592865196|FG001|Month 18|Lost to Follow-up|0|||
164137336|NCT04188301|592865197|FG002|Month 18|Lost to Follow-up|0|||
164137337|NCT01770392|592865198|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
164137338|NCT03401450|592865199|FG000|Overall Study|Lost to Follow-up|4|||
164137339|NCT03401450|592865200|FG001|Overall Study|Lost to Follow-up|6|||
164137340|NCT03401450|592865199|FG000|Overall Study|Anesthesia plan changed|2|||
164137341|NCT03401450|592865200|FG001|Overall Study|Anesthesia plan changed|2|||
164137342|NCT03401450|592865199|FG000|Overall Study|Did not complete medication diary|4|||
164137343|NCT03401450|592865200|FG001|Overall Study|Did not complete medication diary|2|||
164137344|NCT03401450|592865199|FG000|Overall Study|post surgery medication change|2|||
164137345|NCT03401450|592865200|FG001|Overall Study|post surgery medication change|1|||
164137346|NCT03401450|592865199|FG000|Overall Study|Cancelled surgery|0|||
164137347|NCT03401450|592865200|FG001|Overall Study|Cancelled surgery|2|||
164137348|NCT00228423|592865201|FG000|Overall Study|Adverse Event|2|||
164137349|NCT00228423|592865202|FG001|Overall Study|Adverse Event|5|||
164137350|NCT00228423|592865201|FG000|Overall Study|Withdrawal by Subject|7|||
164137351|NCT00228423|592865202|FG001|Overall Study|Withdrawal by Subject|3|||
164137352|NCT00228423|592865201|FG000|Overall Study|Protocol Violation|1|||
164137353|NCT00228423|592865202|FG001|Overall Study|Protocol Violation|3|||
164137354|NCT00228423|592865201|FG000|Overall Study|Physician Decision|0|||
164137355|NCT00228423|592865202|FG001|Overall Study|Physician Decision|1|||
164137356|NCT04639713|592865212|FG000|Overall Study|Protocol Noncompliance|2|||
164137357|NCT04639713|592865212|FG000|Overall Study|Withdrawal by Subject|1|||
164137358|NCT00191113|592866828|FG000|Core Study|Withdrawal by Subject|25|||
164137359|NCT00191113|592866829|FG001|Core Study|Withdrawal by Subject|9|||
164137360|NCT00191113|592866828|FG000|Core Study|Protocol Violation|6|||
164137361|NCT00191113|592866829|FG001|Core Study|Protocol Violation|2|||
164137362|NCT00191113|592866828|FG000|Core Study|Lost to Follow-up|3|||
164137363|NCT00191113|592866829|FG001|Core Study|Lost to Follow-up|0|||
164137364|NCT00191113|592866828|FG000|Core Study|Adverse Event|0|||
164137365|NCT00191113|592866829|FG001|Core Study|Adverse Event|2|||
164137366|NCT00191113|592866828|FG000|Core Study|Lack of Efficacy|0|||
164137367|NCT00191113|592866829|FG001|Core Study|Lack of Efficacy|2|||
164137368|NCT00191113|592866828|FG000|Core Study|Death|1|||
164137369|NCT00191113|592866829|FG001|Core Study|Death|0|||
164137370|NCT01555671|592866832|FG000|Overall Study|Physician Decision|20|||
164137371|NCT01555671|592866833|FG001|Overall Study|Physician Decision|25|||
164137372|NCT00631657|592866834|FG000|6-Month Treatment Period|Adverse Event|47|||
164137373|NCT00631657|592866835|FG001|6-Month Treatment Period|Adverse Event|0|||
164137374|NCT00631657|592866836|FG002|6-Month Treatment Period|Adverse Event|7|||
164137375|NCT00631657|592866834|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
164137376|NCT00631657|592866835|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
164137377|NCT00631657|592866836|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
164137378|NCT00631657|592866834|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
164137379|NCT00631657|592866835|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
164137380|NCT00631657|592866836|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
164137381|NCT00631657|592866834|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
164137382|NCT00631657|592866835|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
164137383|NCT00631657|592866836|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
164137384|NCT00631657|592866834|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
164137385|NCT00631657|592866835|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
164137386|NCT00631657|592866836|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
164137387|NCT00631657|592866834|FG000|6-Month Treatment Period|Other|16|||
164137388|NCT00631657|592866835|FG001|6-Month Treatment Period|Other|0|||
164137389|NCT00631657|592866836|FG002|6-Month Treatment Period|Other|4|||
164137390|NCT00631657|592866834|FG000|6-Month Treatment Period|Not Treated|2|||
164137391|NCT00631657|592866835|FG001|6-Month Treatment Period|Not Treated|0|||
164137392|NCT00631657|592866836|FG002|6-Month Treatment Period|Not Treated|1|||
164137393|NCT00631657|592866834|FG000|7-Day Discontinuation Period|Not Treated|1|||
164137394|NCT00631657|592866835|FG001|7-Day Discontinuation Period|Not Treated|1|||
164137395|NCT00631657|592866836|FG002|7-Day Discontinuation Period|Not Treated|1|||
164137396|NCT00631657|592866834|FG000|7-Day Discontinuation Period|Other|1|||
164137397|NCT00631657|592866835|FG001|7-Day Discontinuation Period|Other|0|||
164137398|NCT00631657|592866836|FG002|7-Day Discontinuation Period|Other|0|||
164137399|NCT03929757|592866837|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
164137400|NCT03929757|592866838|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
164137401|NCT03929757|592866839|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
164137402|NCT03929757|592866837|FG000|Main Study: Up to Day 365|Other|1|||
164137403|NCT03929757|592866838|FG001|Main Study: Up to Day 365|Other|0|||
164137404|NCT03929757|592866839|FG002|Main Study: Up to Day 365|Other|0|||
164137405|NCT03929757|592866837|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
164137406|NCT03929757|592866838|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
164137407|NCT03929757|592866839|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
164137408|NCT01154816|592866840|FG000|Overall Study|Withdrawal by Subject|1|||
164137409|NCT01154816|592866841|FG001|Overall Study|Withdrawal by Subject|0|||
164137410|NCT01154816|592866842|FG002|Overall Study|Withdrawal by Subject|0|||
164137411|NCT01154816|592866843|FG003|Overall Study|Withdrawal by Subject|1|||
164137412|NCT01154816|592866844|FG004|Overall Study|Withdrawal by Subject|0|||
164137413|NCT01154816|592866845|FG005|Overall Study|Withdrawal by Subject|0|||
164137414|NCT01154816|592866846|FG006|Overall Study|Withdrawal by Subject|0|||
164137415|NCT01154816|592866847|FG007|Overall Study|Withdrawal by Subject|0|||
164137416|NCT01154816|592866848|FG008|Overall Study|Withdrawal by Subject|1|||
164137417|NCT01154816|592866849|FG009|Overall Study|Withdrawal by Subject|3|||
164137498|NCT02563106|592866864|FG001|Overall Study|Lost to Follow-up|2|||
164137418|NCT01154816|592866850|FG010|Overall Study|Withdrawal by Subject|0|||
164137419|NCT01154816|592866851|FG011|Overall Study|Withdrawal by Subject|0|||
164137420|NCT01154816|592866840|FG000|Overall Study|Progressive Disease|13|||
164137421|NCT01154816|592866841|FG001|Overall Study|Progressive Disease|8|||
164137422|NCT01154816|592866842|FG002|Overall Study|Progressive Disease|9|||
164137423|NCT01154816|592866843|FG003|Overall Study|Progressive Disease|9|||
164137424|NCT01154816|592866844|FG004|Overall Study|Progressive Disease|8|||
164137425|NCT01154816|592866845|FG005|Overall Study|Progressive Disease|8|||
164137426|NCT01154816|592866846|FG006|Overall Study|Progressive Disease|5|||
164137427|NCT01154816|592866847|FG007|Overall Study|Progressive Disease|6|||
164137428|NCT01154816|592866848|FG008|Overall Study|Progressive Disease|8|||
164137429|NCT01154816|592866849|FG009|Overall Study|Progressive Disease|6|||
164137430|NCT01154816|592866850|FG010|Overall Study|Progressive Disease|10|||
164137431|NCT01154816|592866851|FG011|Overall Study|Progressive Disease|3|||
164137432|NCT01154816|592866840|FG000|Overall Study|Physician Decision|1|||
164137433|NCT01154816|592866841|FG001|Overall Study|Physician Decision|0|||
164137434|NCT01154816|592866842|FG002|Overall Study|Physician Decision|1|||
164137435|NCT01154816|592866843|FG003|Overall Study|Physician Decision|0|||
164137436|NCT01154816|592866844|FG004|Overall Study|Physician Decision|2|||
164137437|NCT01154816|592866845|FG005|Overall Study|Physician Decision|0|||
164137438|NCT01154816|592866846|FG006|Overall Study|Physician Decision|0|||
164137439|NCT01154816|592866847|FG007|Overall Study|Physician Decision|0|||
164137440|NCT01154816|592866848|FG008|Overall Study|Physician Decision|0|||
164137441|NCT01154816|592866849|FG009|Overall Study|Physician Decision|1|||
164137442|NCT01154816|592866850|FG010|Overall Study|Physician Decision|1|||
164137443|NCT01154816|592866851|FG011|Overall Study|Physician Decision|1|||
164137444|NCT01154816|592866840|FG000|Overall Study|Adverse Event|5|||
164137445|NCT01154816|592866841|FG001|Overall Study|Adverse Event|2|||
164137446|NCT01154816|592866842|FG002|Overall Study|Adverse Event|0|||
164137447|NCT01154816|592866843|FG003|Overall Study|Adverse Event|0|||
164137448|NCT01154816|592866844|FG004|Overall Study|Adverse Event|0|||
164137449|NCT01154816|592866845|FG005|Overall Study|Adverse Event|0|||
164137450|NCT01154816|592866846|FG006|Overall Study|Adverse Event|1|||
164137451|NCT01154816|592866847|FG007|Overall Study|Adverse Event|1|||
164137452|NCT01154816|592866848|FG008|Overall Study|Adverse Event|0|||
164137453|NCT01154816|592866849|FG009|Overall Study|Adverse Event|0|||
164137454|NCT01154816|592866850|FG010|Overall Study|Adverse Event|0|||
164137455|NCT01154816|592866851|FG011|Overall Study|Adverse Event|0|||
164137456|NCT00686075|592866852|FG000|Overall Study|Withdrawal by Subject|4|||
164137457|NCT00686075|592866853|FG001|Overall Study|Withdrawal by Subject|3|||
164137458|NCT00686075|592866854|FG002|Overall Study|Withdrawal by Subject|3|||
164137459|NCT00686075|592866855|FG003|Overall Study|Withdrawal by Subject|7|||
164137460|NCT00686075|592866856|FG004|Overall Study|Withdrawal by Subject|1|||
164137461|NCT00686075|592866857|FG005|Overall Study|Withdrawal by Subject|0|||
164137462|NCT00686075|592866858|FG006|Overall Study|Withdrawal by Subject|0|||
164137463|NCT00686075|592866859|FG007|Overall Study|Withdrawal by Subject|2|||
164137464|NCT00686075|592866860|FG008|Overall Study|Withdrawal by Subject|4|||
164137465|NCT00686075|592866861|FG009|Overall Study|Withdrawal by Subject|6|||
164137466|NCT00686075|592866852|FG000|Overall Study|Lost to Follow-up|3|||
164137467|NCT00686075|592866853|FG001|Overall Study|Lost to Follow-up|6|||
164137468|NCT00686075|592866854|FG002|Overall Study|Lost to Follow-up|3|||
164137469|NCT00686075|592866855|FG003|Overall Study|Lost to Follow-up|2|||
164137470|NCT00686075|592866856|FG004|Overall Study|Lost to Follow-up|3|||
164137471|NCT00686075|592866857|FG005|Overall Study|Lost to Follow-up|3|||
164137472|NCT00686075|592866858|FG006|Overall Study|Lost to Follow-up|0|||
164137473|NCT00686075|592866859|FG007|Overall Study|Lost to Follow-up|0|||
164137474|NCT00686075|592866860|FG008|Overall Study|Lost to Follow-up|2|||
164137475|NCT00686075|592866861|FG009|Overall Study|Lost to Follow-up|3|||
164137476|NCT00686075|592866852|FG000|Overall Study|Other|1|||
164137477|NCT00686075|592866853|FG001|Overall Study|Other|1|||
164137478|NCT00686075|592866854|FG002|Overall Study|Other|0|||
164137479|NCT00686075|592866855|FG003|Overall Study|Other|0|||
164137480|NCT00686075|592866856|FG004|Overall Study|Other|0|||
164137481|NCT00686075|592866857|FG005|Overall Study|Other|0|||
164137482|NCT00686075|592866858|FG006|Overall Study|Other|0|||
164137483|NCT00686075|592866859|FG007|Overall Study|Other|0|||
164137484|NCT00686075|592866860|FG008|Overall Study|Other|0|||
164137485|NCT00686075|592866861|FG009|Overall Study|Other|1|||
164137486|NCT01119508|592866862|FG000|Overall Study|Adverse Event|56|||
164137487|NCT01119508|592866862|FG000|Overall Study|Withdrawal by Subject|2|||
164137488|NCT01119508|592866862|FG000|Overall Study|Died before tumor response evaluation|1|||
164137489|NCT02563106|592866863|FG000|Overall Study|Withdrawal by Subject|7|||
164137490|NCT02563106|592866864|FG001|Overall Study|Withdrawal by Subject|8|||
164137491|NCT02563106|592866863|FG000|Overall Study|Adverse Event|17|||
164137492|NCT02563106|592866864|FG001|Overall Study|Adverse Event|15|||
164137493|NCT02563106|592866863|FG000|Overall Study|Protocol Violation|1|||
164137494|NCT02563106|592866864|FG001|Overall Study|Protocol Violation|0|||
164137495|NCT02563106|592866863|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
164137496|NCT02563106|592866864|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
164137497|NCT02563106|592866863|FG000|Overall Study|Lost to Follow-up|3|||
164137518|NCT01136967|592866870|FG001|Overall Study|Investigator's Choice|1|||
164137519|NCT01136967|592866869|FG000|Overall Study|Increase in Lesion Size|0|||
164137520|NCT01136967|592866870|FG001|Overall Study|Increase in Lesion Size|2|||
164137521|NCT01136967|592866869|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
164137522|NCT01136967|592866870|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
164137523|NCT01735955|592866871|FG000|Overall Study|Administrative problems|1|||
164137524|NCT01735955|592866871|FG000|Overall Study|Patient/guardian decision|1|||
164137525|NCT01735955|592866871|FG000|Overall Study|Patient withdrew consent|2|||
164137526|NCT01735955|592866871|FG000|Overall Study|Physician Decision|4|||
164137527|NCT01735955|592866871|FG000|Overall Study|Disease progression|24|||
164137528|NCT01735955|592866871|FG000|Overall Study|Adverse Event|5|||
164137529|NCT04228783|592866872|FG000|Overall Study|Adverse Event|1|||
164137530|NCT04228783|592866873|FG001|Overall Study|Adverse Event|0|||
164137531|NCT04228783|592866874|FG002|Overall Study|Adverse Event|2|||
164137532|NCT04228783|592866875|FG003|Overall Study|Adverse Event|0|||
164137533|NCT04228783|592866876|FG004|Overall Study|Adverse Event|0|||
164137534|NCT04228783|592866877|FG005|Overall Study|Adverse Event|1|||
164137535|NCT04228783|592866872|FG000|Overall Study|Death|0|||
164137536|NCT04228783|592866873|FG001|Overall Study|Death|0|||
164137537|NCT04228783|592866874|FG002|Overall Study|Death|0|||
164137538|NCT04228783|592866875|FG003|Overall Study|Death|0|||
164137539|NCT04228783|592866876|FG004|Overall Study|Death|1|||
164137540|NCT04228783|592866877|FG005|Overall Study|Death|0|||
164137541|NCT04228783|592866872|FG000|Overall Study|Lost to Follow-up|36|||
164137542|NCT04228783|592866873|FG001|Overall Study|Lost to Follow-up|36|||
164137543|NCT04228783|592866874|FG002|Overall Study|Lost to Follow-up|28|||
164137544|NCT04228783|592866875|FG003|Overall Study|Lost to Follow-up|6|||
164137545|NCT04228783|592866876|FG004|Overall Study|Lost to Follow-up|14|||
164137546|NCT04228783|592866877|FG005|Overall Study|Lost to Follow-up|3|||
164137547|NCT04228783|592866872|FG000|Overall Study|Physician Decision|1|||
164137548|NCT04228783|592866873|FG001|Overall Study|Physician Decision|2|||
164137549|NCT04228783|592866874|FG002|Overall Study|Physician Decision|0|||
164137550|NCT04228783|592866875|FG003|Overall Study|Physician Decision|0|||
164137551|NCT04228783|592866876|FG004|Overall Study|Physician Decision|0|||
164137552|NCT04228783|592866877|FG005|Overall Study|Physician Decision|0|||
164137553|NCT04228783|592866872|FG000|Overall Study|Protocol Violation|0|||
164137554|NCT04228783|592866873|FG001|Overall Study|Protocol Violation|0|||
164137555|NCT04228783|592866874|FG002|Overall Study|Protocol Violation|0|||
164137556|NCT04228783|592866875|FG003|Overall Study|Protocol Violation|1|||
164137557|NCT04228783|592866876|FG004|Overall Study|Protocol Violation|0|||
164137558|NCT04228783|592866877|FG005|Overall Study|Protocol Violation|0|||
164137559|NCT04228783|592866872|FG000|Overall Study|Withdrawal by Subject|6|||
164137560|NCT04228783|592866873|FG001|Overall Study|Withdrawal by Subject|10|||
164137561|NCT04228783|592866874|FG002|Overall Study|Withdrawal by Subject|19|||
164137562|NCT04228783|592866875|FG003|Overall Study|Withdrawal by Subject|1|||
164137563|NCT04228783|592866876|FG004|Overall Study|Withdrawal by Subject|2|||
164137564|NCT04228783|592866877|FG005|Overall Study|Withdrawal by Subject|0|||
164137565|NCT04228783|592866872|FG000|Overall Study|Other|4|||
164137566|NCT04228783|592866873|FG001|Overall Study|Other|3|||
164137567|NCT04228783|592866874|FG002|Overall Study|Other|2|||
164137568|NCT04228783|592866875|FG003|Overall Study|Other|1|||
164137569|NCT04228783|592866876|FG004|Overall Study|Other|0|||
164137570|NCT04228783|592866877|FG005|Overall Study|Other|0|||
164137571|NCT03327792|592866878|FG000|Overall Study|Adverse Event|4|||
164137572|NCT03327792|592866879|FG001|Overall Study|Adverse Event|0|||
164137573|NCT03327792|592866878|FG000|Overall Study|Family/Personal issues|3|||
164137574|NCT03327792|592866879|FG001|Overall Study|Family/Personal issues|2|||
164137575|NCT03327792|592866878|FG000|Overall Study|Lost to Follow-up|0|||
164137576|NCT03327792|592866879|FG001|Overall Study|Lost to Follow-up|1|||
164137577|NCT00626392|592866880|FG000|Run-in Period|Adverse Event|0|||
164137578|NCT00626392|592866881|FG001|Run-in Period|Adverse Event|0|||
164137579|NCT00626392|592866882|FG002|Run-in Period|Adverse Event|1|||
164137580|NCT00626392|592866883|FG003|Run-in Period|Adverse Event|0|||
164137581|NCT00626392|592866884|FG004|Run-in Period|Adverse Event|1|||
164137582|NCT00626392|592866885|FG005|Run-in Period|Adverse Event|0|||
164137583|NCT00626392|592866880|FG000|Run-in Period|Withdrawal by Subject|0|||
164137584|NCT00626392|592866881|FG001|Run-in Period|Withdrawal by Subject|1|||
164137585|NCT00626392|592866882|FG002|Run-in Period|Withdrawal by Subject|1|||
164137586|NCT00626392|592866883|FG003|Run-in Period|Withdrawal by Subject|1|||
164137587|NCT00626392|592866884|FG004|Run-in Period|Withdrawal by Subject|3|||
164137588|NCT00626392|592866885|FG005|Run-in Period|Withdrawal by Subject|1|||
164137589|NCT00626392|592866880|FG000|Run-in Period|Noncompliance|1|||
164137590|NCT00626392|592866881|FG001|Run-in Period|Noncompliance|0|||
164137591|NCT00626392|592866882|FG002|Run-in Period|Noncompliance|1|||
164137592|NCT00626392|592866883|FG003|Run-in Period|Noncompliance|0|||
164137593|NCT00626392|592866884|FG004|Run-in Period|Noncompliance|0|||
164137594|NCT00626392|592866885|FG005|Run-in Period|Noncompliance|0|||
164137595|NCT00626392|592866880|FG000|Coadministration Period|Adverse Event|3|||
164137596|NCT00626392|592866881|FG001|Coadministration Period|Adverse Event|1|||
164137597|NCT00626392|592866882|FG002|Coadministration Period|Adverse Event|7|||
164137598|NCT00626392|592866883|FG003|Coadministration Period|Adverse Event|4|||
164137599|NCT00626392|592866884|FG004|Coadministration Period|Adverse Event|3|||
164137600|NCT00626392|592866885|FG005|Coadministration Period|Adverse Event|4|||
164137601|NCT00626392|592866880|FG000|Coadministration Period|Withdrawal by Subject|1|||
164137602|NCT00626392|592866881|FG001|Coadministration Period|Withdrawal by Subject|1|||
164137603|NCT00626392|592866882|FG002|Coadministration Period|Withdrawal by Subject|0|||
164137604|NCT00626392|592866883|FG003|Coadministration Period|Withdrawal by Subject|1|||
164137605|NCT00626392|592866884|FG004|Coadministration Period|Withdrawal by Subject|0|||
164137606|NCT00626392|592866885|FG005|Coadministration Period|Withdrawal by Subject|1|||
164137607|NCT00626392|592866880|FG000|Coadministration Period|Protocol Violation|0|||
164137608|NCT00626392|592866881|FG001|Coadministration Period|Protocol Violation|1|||
164137609|NCT00626392|592866882|FG002|Coadministration Period|Protocol Violation|0|||
164137610|NCT00626392|592866883|FG003|Coadministration Period|Protocol Violation|1|||
164137611|NCT00626392|592866884|FG004|Coadministration Period|Protocol Violation|1|||
164137612|NCT00626392|592866885|FG005|Coadministration Period|Protocol Violation|0|||
164137613|NCT00626392|592866880|FG000|Coadministration Period|Other|0|||
164137614|NCT00626392|592866881|FG001|Coadministration Period|Other|2|||
164137615|NCT00626392|592866882|FG002|Coadministration Period|Other|3|||
164137616|NCT00626392|592866883|FG003|Coadministration Period|Other|1|||
164137617|NCT00626392|592866884|FG004|Coadministration Period|Other|1|||
164137618|NCT00626392|592866885|FG005|Coadministration Period|Other|1|||
164137619|NCT04576923|592866886|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
164137620|NCT03151811|592866892|FG000|Overall Study|Randomized But Not Treated|18|||
164137621|NCT03151811|592866893|FG001|Overall Study|Randomized But Not Treated|3|||
164137622|NCT03151811|592866892|FG000|Overall Study|Progressive Disease|130|||
164137623|NCT03151811|592866893|FG001|Overall Study|Progressive Disease|170|||
164137624|NCT03151811|592866892|FG000|Overall Study|Adverse Event|49|||
164137625|NCT03151811|592866893|FG001|Overall Study|Adverse Event|40|||
164137626|NCT03151811|592866892|FG000|Overall Study|Lack of Efficacy|6|||
164137627|NCT03151811|592866893|FG001|Overall Study|Lack of Efficacy|8|||
164137628|NCT03151811|592866892|FG000|Overall Study|Physician Decision|21|||
164137629|NCT03151811|592866893|FG001|Overall Study|Physician Decision|9|||
164137630|NCT03151811|592866892|FG000|Overall Study|Withdrawal by Subject|17|||
164137631|NCT03151811|592866893|FG001|Overall Study|Withdrawal by Subject|7|||
164137632|NCT03151811|592866892|FG000|Overall Study|Lost to Follow-up|0|||
164137633|NCT03151811|592866893|FG001|Overall Study|Lost to Follow-up|1|||
164137634|NCT03151811|592866892|FG000|Overall Study|Study Terminated by Sponsor|5|||
164137635|NCT03151811|592866893|FG001|Overall Study|Study Terminated by Sponsor|11|||
164137636|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
164137637|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
164137638|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
164137639|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
164137640|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
164137641|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
164137642|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
164137643|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
164137644|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
164137645|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
164137646|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Death|1|||
164137647|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Death|0|||
164137648|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Death|0|||
164137649|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Death|0|||
164137650|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Death|0|||
164137651|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
164137652|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
164137653|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
164137654|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
164137655|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
164137656|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
164137657|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
164137658|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
164137659|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
164137660|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
164137661|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
164137662|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
164137663|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
164137664|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
164137665|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
164137666|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
164137667|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
164137668|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
164137669|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
164137670|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164137671|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
164137672|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164137673|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164137674|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164137675|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
164137676|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Other|4|||
164137677|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Other|4|||
164137678|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Other|3|||
164137679|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Other|1|||
164137680|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Other|0|||
164137681|NCT01081834|592866896|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
164137682|NCT01081834|592866897|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
164137683|NCT01081834|592866898|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164137684|NCT01081834|592866899|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164137685|NCT01081834|592866900|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
164137686|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164137687|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164137688|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164137689|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164137690|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
164137691|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Death|1|||
164137692|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Death|0|||
164137693|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Death|0|||
164137694|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Death|0|||
164137695|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Death|0|||
164137696|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
164137697|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
164137698|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164137699|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164137700|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164137701|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164137702|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164137703|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164137704|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164137705|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164137706|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164137707|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
164137708|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164137709|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164137710|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
164137711|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164137712|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164137713|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164137714|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164137715|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164137716|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
164137717|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
164137718|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
164137719|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
164137720|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
164137721|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Other|4|||
164137722|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Other|5|||
164137723|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Other|4|||
164137724|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Other|0|||
164137725|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Other|0|||
164137726|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
164137727|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
164137728|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
164137729|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
164137730|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
164137731|NCT01081834|592866896|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164137732|NCT01081834|592866897|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
164137733|NCT01081834|592866898|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164137734|NCT01081834|592866899|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164137735|NCT01081834|592866900|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
164137736|NCT01085734|592866901|FG000|Overall Study|Adverse Event|0|||
164137737|NCT01085734|592866902|FG001|Overall Study|Adverse Event|2|||
164137738|NCT01085734|592866901|FG000|Overall Study|Death|1|||
164137739|NCT01085734|592866902|FG001|Overall Study|Death|0|||
164137740|NCT01085734|592866901|FG000|Overall Study|Lost to Follow-up|0|||
164137741|NCT01085734|592866902|FG001|Overall Study|Lost to Follow-up|1|||
164137742|NCT01085734|592866901|FG000|Overall Study|Withdrawal by Subject|0|||
164137743|NCT01085734|592866902|FG001|Overall Study|Withdrawal by Subject|1|||
164137744|NCT02045147|592866905|FG000|Overall Study|Withdrawal by Subject|2|||
164137745|NCT02045147|592866906|FG001|Overall Study|Withdrawal by Subject|0|||
164137746|NCT02045147|592866907|FG002|Overall Study|Withdrawal by Subject|0|||
164137747|NCT02045147|592866908|FG003|Overall Study|Withdrawal by Subject|0|||
164137748|NCT02045147|592866909|FG004|Overall Study|Withdrawal by Subject|0|||
164137749|NCT02045147|592866910|FG005|Overall Study|Withdrawal by Subject|0|||
164137750|NCT02045147|592866911|FG006|Overall Study|Withdrawal by Subject|0|||
164137751|NCT02045147|592866912|FG007|Overall Study|Withdrawal by Subject|1|||
164137752|NCT02045147|592866905|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
164137753|NCT02045147|592866906|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
164137754|NCT02045147|592866907|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
164137755|NCT02045147|592866908|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
164137756|NCT02045147|592866909|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
164137757|NCT02045147|592866910|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
164137758|NCT02045147|592866911|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
164137759|NCT02045147|592866912|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
164137760|NCT01475097|592866913|FG000|Overall Study|Protocol Violation|1|||
164137761|NCT01475097|592866914|FG001|Overall Study|Protocol Violation|1|||
164137762|NCT04839692|592866915|FG000|Overall Study|Withdrawal by Subject|0|||
164137763|NCT04839692|592866916|FG001|Overall Study|Withdrawal by Subject|3|||
164137764|NCT04839692|592866915|FG000|Overall Study|Physician Decision|1|||
164137765|NCT04839692|592866916|FG001|Overall Study|Physician Decision|0|||
164137766|NCT00049530|592866917|FG000|Overall Study|Lack of Efficacy|25|||
164137767|NCT00049530|592866917|FG000|Overall Study|Adverse Event|2|||
164137768|NCT00049530|592866917|FG000|Overall Study|Death|1|||
164137769|NCT00049530|592866917|FG000|Overall Study|symptomatic deterioration|1|||
164137770|NCT00049530|592866917|FG000|Overall Study|ineligible|3|||
164137771|NCT03511326|592866919|FG000|Overall Study|Withdrawal by Subject|1|||
164137772|NCT01305044|592866922|FG000|Overall Study|Withdrawal by Subject|3|||
164137773|NCT01305044|592866923|FG001|Overall Study|Withdrawal by Subject|6|||
164137774|NCT00492024|592866928|FG000|Treatment|Adverse Event|3|||
164137775|NCT00492024|592866929|FG001|Treatment|Adverse Event|1|||
164137776|NCT00492024|592866928|FG000|Treatment|Lack of Efficacy|21|||
164137777|NCT00492024|592866929|FG001|Treatment|Lack of Efficacy|20|||
164137778|NCT00492024|592866928|FG000|Treatment|Lost to Follow-up|3|||
164137779|NCT00492024|592866929|FG001|Treatment|Lost to Follow-up|1|||
164137780|NCT00492024|592866928|FG000|Treatment|Withdrawal by Subject|2|||
164137781|NCT00492024|592866929|FG001|Treatment|Withdrawal by Subject|0|||
164137782|NCT00492024|592866928|FG000|Follow up|Lack of Efficacy|0|||
164137783|NCT00492024|592866929|FG001|Follow up|Lack of Efficacy|1|||
164137784|NCT00492024|592866928|FG000|Follow up|Lost to Follow-up|1|||
164137785|NCT00492024|592866929|FG001|Follow up|Lost to Follow-up|1|||
164137786|NCT03247816|592866930|FG000|Overall Study|Adverse Event|12|||
164137787|NCT03247816|592866930|FG000|Overall Study|Physician Decision|3|||
164137788|NCT03247816|592866930|FG000|Overall Study|Lack of Efficacy|1|||
164137789|NCT03247816|592866930|FG000|Overall Study|Lost to Follow-up|10|||
164137790|NCT03247816|592866930|FG000|Overall Study|Missing Feraccru stop date|3|||
164137791|NCT01439009|592866933|FG000|Overall Study|Physician Decision|5|||
164137792|NCT01439009|592866934|FG001|Overall Study|Physician Decision|3|||
164137793|NCT01439009|592866933|FG000|Overall Study|Protocol Violation|2|||
164137794|NCT01439009|592866934|FG001|Overall Study|Protocol Violation|0|||
164137795|NCT01439009|592866933|FG000|Overall Study|Deviation of exclusion criteria|1|||
164137796|NCT01439009|592866934|FG001|Overall Study|Deviation of exclusion criteria|0|||
164137797|NCT00926783|592866935|FG000|Overall Study|Incomplete CFAE Procedures|3|||
164137798|NCT00926783|592866936|FG001|Overall Study|Incomplete CFAE Procedures|3|||
164137799|NCT00696787|592866937|FG000|Overall Study|Adverse Event|1|||
164137800|NCT00696787|592866938|FG001|Overall Study|Adverse Event|0|||
164137801|NCT00696787|592866939|FG002|Overall Study|Adverse Event|6|||
164137802|NCT00696787|592866937|FG000|Overall Study|Discontinuation by Sponsor|9|||
164137803|NCT00696787|592866938|FG001|Overall Study|Discontinuation by Sponsor|13|||
164137804|NCT00696787|592866939|FG002|Overall Study|Discontinuation by Sponsor|14|||
164137805|NCT00696787|592866937|FG000|Overall Study|Lack of Efficacy|0|||
164137806|NCT00696787|592866938|FG001|Overall Study|Lack of Efficacy|1|||
164137925|NCT00750308|592866983|FG010|Second Treatment|Withdrawal by Subject|0|||
164137926|NCT00750308|592866984|FG011|Second Treatment|Withdrawal by Subject|0|||
164137927|NCT00750308|592866973|FG000|Third Treatment|Withdrawal by Subject|0|||
164137928|NCT00750308|592866974|FG001|Third Treatment|Withdrawal by Subject|1|||
164137929|NCT00750308|592866975|FG002|Third Treatment|Withdrawal by Subject|0|||
164137930|NCT00750308|592866976|FG003|Third Treatment|Withdrawal by Subject|0|||
164137931|NCT00750308|592866977|FG004|Third Treatment|Withdrawal by Subject|0|||
164137932|NCT00750308|592866978|FG005|Third Treatment|Withdrawal by Subject|0|||
164137933|NCT00750308|592866979|FG006|Third Treatment|Withdrawal by Subject|0|||
164137934|NCT00750308|592866980|FG007|Third Treatment|Withdrawal by Subject|0|||
164137935|NCT00750308|592866981|FG008|Third Treatment|Withdrawal by Subject|0|||
164137936|NCT00750308|592866982|FG009|Third Treatment|Withdrawal by Subject|0|||
164137937|NCT00750308|592866983|FG010|Third Treatment|Withdrawal by Subject|0|||
164137938|NCT00750308|592866984|FG011|Third Treatment|Withdrawal by Subject|0|||
164137939|NCT01822275|592866985|FG000|Overall Study|Withdrawal by Subject|3|||
164137940|NCT01822275|592866985|FG000|Overall Study|Adverse Event|3|||
164137941|NCT01822275|592866985|FG000|Overall Study|Progression|14|||
164137942|NCT01822275|592866985|FG000|Overall Study|Physician Decision|2|||
164137943|NCT02980874|592866986|FG000|Overall Study|Adverse Event|2|||
164137944|NCT02980874|592866987|FG001|Overall Study|Adverse Event|7|||
164137945|NCT02980874|592866986|FG000|Overall Study|Withdrawal by Subject|7|||
164137946|NCT02980874|592866987|FG001|Overall Study|Withdrawal by Subject|2|||
164137947|NCT02980874|592866986|FG000|Overall Study|Lost to Follow-up|5|||
164137948|NCT02980874|592866987|FG001|Overall Study|Lost to Follow-up|5|||
164137949|NCT02980874|592866986|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
164137950|NCT02980874|592866987|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
164137951|NCT02980874|592866986|FG000|Overall Study|Unknown study completion status|1|||
164137952|NCT02980874|592866987|FG001|Overall Study|Unknown study completion status|0|||
164137953|NCT00513682|592866988|FG000|Washout Phase|Adverse Event|2|||
164137954|NCT02450526|592866989|FG000|DB Period (Cycle 1)|Adverse Event|0|||
164137955|NCT02450526|592866990|FG001|DB Period (Cycle 1)|Adverse Event|0|||
164137956|NCT02450526|592866991|FG002|DB Period (Cycle 1)|Adverse Event|2|||
164137957|NCT02450526|592866992|FG003|DB Period (Cycle 1)|Adverse Event|0|||
164137958|NCT02450526|592866993|FG004|DB Period (Cycle 1)|Adverse Event|0|||
164137959|NCT02450526|592866989|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
164137960|NCT02450526|592866990|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
164137961|NCT02450526|592866991|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
164137962|NCT02450526|592866992|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
164137963|NCT02450526|592866993|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
164137964|NCT02450526|592866989|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
164137965|NCT02450526|592866990|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
164137966|NCT02450526|592866991|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
164137967|NCT02450526|592866992|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
164137968|NCT02450526|592866993|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
164137969|NCT02450526|592866989|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
164137970|NCT02450526|592866990|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
164137971|NCT02450526|592866991|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
164137972|NCT02450526|592866992|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
164137973|NCT02450526|592866993|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
164137974|NCT02450526|592866989|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
164137975|NCT02450526|592866990|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
164137976|NCT02450526|592866991|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
164137977|NCT02450526|592866992|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
164137978|NCT02450526|592866993|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
164137979|NCT02450526|592866989|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164137980|NCT02450526|592866990|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164137981|NCT02450526|592866991|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164137982|NCT02450526|592866992|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
164137983|NCT02450526|592866993|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
164137984|NCT02450526|592866989|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164137985|NCT02450526|592866990|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164137986|NCT02450526|592866991|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164137987|NCT02450526|592866992|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
164137988|NCT02450526|592866993|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
164137989|NCT02450526|592866989|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
164137990|NCT02450526|592866990|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
164137991|NCT02450526|592866991|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
164137992|NCT02450526|592866992|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
164137993|NCT02450526|592866993|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
164137994|NCT02582866|592866996|FG000|Overall Study|Death|1|||
164137995|NCT02582866|592866996|FG000|Overall Study|Lack of Efficacy|2|||
164137996|NCT02582866|592866996|FG000|Overall Study|Lost to Follow-up|2|||
164137997|NCT02582866|592866996|FG000|Overall Study|Withdrawal by Subject|7|||
164137998|NCT02582866|592866996|FG000|Overall Study|Investigator decision|5|||
164137999|NCT02582866|592866996|FG000|Overall Study|Participant wants to get pregnant|1|||
164138044|NCT00758680|592867016|FG007|Overall Study|Withdrawal by Subject|0|||
164138045|NCT00758680|592867017|FG008|Overall Study|Withdrawal by Subject|1|||
164138046|NCT00758680|592867018|FG009|Overall Study|Withdrawal by Subject|0|||
164138047|NCT00319982|592867019|FG000|Overall Study|Withdrawal by Subject|1|||
164138048|NCT00319982|592867020|FG001|Overall Study|Withdrawal by Subject|0|||
164138049|NCT03480386|592867021|FG000|Overall Study|Did not complete measures at 3-months|17|||
164138050|NCT03480386|592867022|FG001|Overall Study|Did not complete measures at 3-months|14|||
164138051|NCT03480386|592867021|FG000|Overall Study|No baseline measures|11|||
164138052|NCT03480386|592867022|FG001|Overall Study|No baseline measures|14|||
164138053|NCT03480386|592867021|FG000|Overall Study|Death|0|||
164138054|NCT03480386|592867022|FG001|Overall Study|Death|5|||
164138055|NCT03480386|592867021|FG000|Overall Study|Withdrawal by Subject|12|||
164138056|NCT03480386|592867022|FG001|Overall Study|Withdrawal by Subject|8|||
164138057|NCT03480386|592867021|FG000|Overall Study|Lost to Follow-up|2|||
164138058|NCT03480386|592867022|FG001|Overall Study|Lost to Follow-up|1|||
164138059|NCT03480386|592867021|FG000|Overall Study|Complicating disease|0|||
164138060|NCT03480386|592867022|FG001|Overall Study|Complicating disease|1|||
164138061|NCT03480386|592867021|FG000|Overall Study|Disease progression|3|||
164138062|NCT03480386|592867022|FG001|Overall Study|Disease progression|0|||
164138063|NCT03480386|592867021|FG000|Overall Study|Became ineligible|0|||
164138064|NCT03480386|592867022|FG001|Overall Study|Became ineligible|2|||
164138065|NCT02201290|592867023|FG000|Overall Study|Withdrawal by Subject|2|||
164138066|NCT02201290|592867023|FG000|Overall Study|Lack of Efficacy|2|||
164138067|NCT02201290|592867023|FG000|Overall Study|Adverse Event|1|||
164138068|NCT00070499|592868368|FG000|Overall Study|Adverse Event|6|||
164138069|NCT00070499|592868369|FG001|Overall Study|Adverse Event|6|||
164138070|NCT00070499|592868370|FG002|Overall Study|Adverse Event|19|||
164138071|NCT00070499|592868371|FG003|Overall Study|Adverse Event|15|||
164138072|NCT00070499|592868368|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
164138073|NCT00070499|592868369|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
164138074|NCT00070499|592868370|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
164138075|NCT00070499|592868371|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
164138076|NCT00070499|592868368|FG000|Overall Study|Progression/relapse|4|||
164138077|NCT00070499|592868369|FG001|Overall Study|Progression/relapse|2|||
164138078|NCT00070499|592868370|FG002|Overall Study|Progression/relapse|1|||
164138079|NCT00070499|592868371|FG003|Overall Study|Progression/relapse|4|||
164138080|NCT00070499|592868368|FG000|Overall Study|Death|1|||
164138081|NCT00070499|592868369|FG001|Overall Study|Death|1|||
164138082|NCT00070499|592868370|FG002|Overall Study|Death|1|||
164138083|NCT00070499|592868371|FG003|Overall Study|Death|2|||
164138084|NCT00070499|592868368|FG000|Overall Study|Other - not protocol specified|7|||
164138085|NCT00070499|592868369|FG001|Overall Study|Other - not protocol specified|3|||
164138086|NCT00070499|592868370|FG002|Overall Study|Other - not protocol specified|12|||
164138087|NCT00070499|592868371|FG003|Overall Study|Other - not protocol specified|20|||
164138088|NCT00070499|592868368|FG000|Overall Study|Still on protocol treatment|10|||
164138089|NCT00070499|592868369|FG001|Overall Study|Still on protocol treatment|4|||
164138090|NCT00070499|592868370|FG002|Overall Study|Still on protocol treatment|79|||
164138091|NCT00070499|592868371|FG003|Overall Study|Still on protocol treatment|57|||
164138092|NCT00070499|592868368|FG000|Overall Study|Did not start treatment|1|||
164138093|NCT00070499|592868369|FG001|Overall Study|Did not start treatment|0|||
164138094|NCT00070499|592868370|FG002|Overall Study|Did not start treatment|0|||
164138095|NCT00070499|592868371|FG003|Overall Study|Did not start treatment|2|||
164138096|NCT00070499|592868368|FG000|Overall Study|Not eligible|2|||
164138097|NCT00070499|592868369|FG001|Overall Study|Not eligible|5|||
164138098|NCT00070499|592868370|FG002|Overall Study|Not eligible|3|||
164138099|NCT00070499|592868371|FG003|Overall Study|Not eligible|2|||
164138100|NCT00805467|592868372|FG000|Overall Study|Lack of Efficacy|0|||
164138101|NCT00805467|592868373|FG001|Overall Study|Lack of Efficacy|8|||
164138102|NCT00805467|592868374|FG002|Overall Study|Lack of Efficacy|13|||
164138103|NCT00805467|592868375|FG003|Overall Study|Lack of Efficacy|86|||
164138104|NCT00805467|592868372|FG000|Overall Study|Lost to Follow-up|0|||
164138105|NCT00805467|592868373|FG001|Overall Study|Lost to Follow-up|1|||
164138106|NCT00805467|592868374|FG002|Overall Study|Lost to Follow-up|7|||
164138107|NCT00805467|592868375|FG003|Overall Study|Lost to Follow-up|21|||
164138108|NCT00805467|592868372|FG000|Overall Study|Withdrawal by Subject|0|||
164138109|NCT00805467|592868373|FG001|Overall Study|Withdrawal by Subject|6|||
164138110|NCT00805467|592868374|FG002|Overall Study|Withdrawal by Subject|45|||
164138111|NCT00805467|592868375|FG003|Overall Study|Withdrawal by Subject|50|||
164138112|NCT00805467|592868372|FG000|Overall Study|Protocol Violation|0|||
164138113|NCT00805467|592868373|FG001|Overall Study|Protocol Violation|3|||
164138114|NCT00805467|592868374|FG002|Overall Study|Protocol Violation|0|||
164138115|NCT00805467|592868375|FG003|Overall Study|Protocol Violation|5|||
164138116|NCT00805467|592868372|FG000|Overall Study|Adverse Event|0|||
164138117|NCT00805467|592868373|FG001|Overall Study|Adverse Event|13|||
164138118|NCT00805467|592868374|FG002|Overall Study|Adverse Event|26|||
164138119|NCT00805467|592868375|FG003|Overall Study|Adverse Event|57|||
164138120|NCT00805467|592868372|FG000|Overall Study|Death|0|||
164138121|NCT00805467|592868373|FG001|Overall Study|Death|2|||
164138132|NCT04240392|592868377|FG000|Overall Study|Withdrawal by Subject|13|||
164138133|NCT04240392|592868378|FG001|Overall Study|Withdrawal by Subject|4|||
164138134|NCT04240392|592868377|FG000|Overall Study|Lost to Follow-up|11|||
164138135|NCT04240392|592868378|FG001|Overall Study|Lost to Follow-up|12|||
164138136|NCT03589768|592868379|FG000|Overall Study|Death|1|||
164138137|NCT03589768|592868380|FG001|Overall Study|Death|0|||
164138138|NCT03589768|592868381|FG002|Overall Study|Death|8|||
164138139|NCT03589768|592868382|FG003|Overall Study|Death|3|||
164138140|NCT03589768|592868379|FG000|Overall Study|Withdrawal by Subject|2|||
164138141|NCT03589768|592868380|FG001|Overall Study|Withdrawal by Subject|0|||
164138142|NCT03589768|592868381|FG002|Overall Study|Withdrawal by Subject|0|||
164138143|NCT03589768|592868382|FG003|Overall Study|Withdrawal by Subject|0|||
164138144|NCT03589768|592868379|FG000|Overall Study|Protocol Violation|1|||
164138145|NCT03589768|592868380|FG001|Overall Study|Protocol Violation|0|||
164138146|NCT03589768|592868381|FG002|Overall Study|Protocol Violation|0|||
164138147|NCT03589768|592868382|FG003|Overall Study|Protocol Violation|0|||
164138148|NCT05307510|592868394|FG000|Overall Study|Lost to Follow-up|3|||
164138149|NCT05307510|592868395|FG001|Overall Study|Lost to Follow-up|6|||
164138150|NCT05307510|592868394|FG000|Overall Study|Withdrawal by Subject|0|||
164138151|NCT05307510|592868395|FG001|Overall Study|Withdrawal by Subject|1|||
164138152|NCT04345601|592868397|FG000|Overall Study|Death|0|||
164138153|NCT04345601|592868398|FG001|Overall Study|Death|3|||
164138154|NCT04345601|592868399|FG002|Overall Study|Death|2|||
164138155|NCT04345601|592868397|FG000|Overall Study|Lost to Follow-up|0|||
164138156|NCT04345601|592868398|FG001|Overall Study|Lost to Follow-up|0|||
164138157|NCT04345601|592868399|FG002|Overall Study|Lost to Follow-up|2|||
164138158|NCT04241315|592868404|FG000|Overall Study|Withdrawal by Subject|0|||
164138159|NCT04241315|592868405|FG001|Overall Study|Withdrawal by Subject|1|||
164138160|NCT03047330|592868406|FG000|Sleep Block 1|Withdrawal by Subject|3|||
164138161|NCT01908907|592868407|FG000|Overall Study|Physician Decision|1|||
164138162|NCT01908907|592868408|FG001|Overall Study|Physician Decision|0|||
164138163|NCT01908907|592868407|FG000|Overall Study|Protocol Violation|1|||
164138164|NCT01908907|592868408|FG001|Overall Study|Protocol Violation|0|||
164138165|NCT01392963|592868418|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
164138166|NCT01392963|592868419|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
164138167|NCT01392963|592868418|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
164138168|NCT01392963|592868419|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
164138169|NCT01392963|592868418|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
164138170|NCT01392963|592868419|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
164138171|NCT03783039|592868420|FG000|Overall Study|Death|2|||
164138172|NCT03783039|592868421|FG001|Overall Study|Death|1|||
164138173|NCT00837473|592868424|FG000|Overall Study|Lost to Follow-up|1|||
164138174|NCT00837473|592868424|FG000|Overall Study|Withdrawal by Subject|2|||
164138175|NCT02338193|592868425|FG000|Overall Study|Withdrawal by Subject|0|||
164138176|NCT02338193|592868426|FG001|Overall Study|Withdrawal by Subject|0|||
164138177|NCT02338193|592868427|FG002|Overall Study|Withdrawal by Subject|2|||
164138178|NCT02338193|592868425|FG000|Overall Study|Pregnancy|0|||
164138179|NCT02338193|592868426|FG001|Overall Study|Pregnancy|1|||
164138180|NCT02338193|592868427|FG002|Overall Study|Pregnancy|1|||
164138181|NCT02338193|592868425|FG000|Overall Study|Noncompliant with visits|2|||
164138182|NCT02338193|592868426|FG001|Overall Study|Noncompliant with visits|2|||
164138183|NCT02338193|592868427|FG002|Overall Study|Noncompliant with visits|7|||
164138184|NCT02338193|592868425|FG000|Overall Study|moved out of state|0|||
164138185|NCT02338193|592868426|FG001|Overall Study|moved out of state|1|||
164138186|NCT02338193|592868427|FG002|Overall Study|moved out of state|0|||
164138187|NCT02338193|592868425|FG000|Overall Study|intolerant of side effects|1|||
164138188|NCT02338193|592868426|FG001|Overall Study|intolerant of side effects|0|||
164138189|NCT02338193|592868427|FG002|Overall Study|intolerant of side effects|0|||
164138190|NCT01724489|592868428|FG000|Overall Study|Adverse Event|8|||
164138191|NCT01724489|592868429|FG001|Overall Study|Adverse Event|3|||
164138192|NCT01724489|592868428|FG000|Overall Study|Surgery, medication|1|||
164138193|NCT01724489|592868429|FG001|Overall Study|Surgery, medication|1|||
164138194|NCT01724489|592868428|FG000|Overall Study|Lost to Follow-up|1|||
164138195|NCT01724489|592868429|FG001|Overall Study|Lost to Follow-up|2|||
164138196|NCT01724489|592868428|FG000|Overall Study|Withdrawal by Subject|6|||
164138197|NCT01724489|592868429|FG001|Overall Study|Withdrawal by Subject|6|||
164138198|NCT02861014|592868430|FG000|Primary Analysis|Adverse Event|7|||
164138199|NCT02861014|592868430|FG000|Primary Analysis|Death|1|||
164138200|NCT02861014|592868430|FG000|Primary Analysis|Lack of Efficacy|3|||
164138201|NCT02861014|592868430|FG000|Primary Analysis|Physician Decision|2|||
164138202|NCT02861014|592868430|FG000|Primary Analysis|Pregnancy|4|||
164138203|NCT02861014|592868430|FG000|Primary Analysis|Protocol Violation|2|||
164138204|NCT02861014|592868430|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
164138205|NCT02861014|592868430|FG000|Primary Analysis|Withdrawal by Subject|14|||
164138206|NCT02861014|592868430|FG000|Primary Analysis|Commercial ocrelizumab|3|||
164138207|NCT02861014|592868430|FG000|Safety Follow-up|Adverse Event|1|||
164138208|NCT02861014|592868430|FG000|Safety Follow-up|Pregnancy|1|||
164138209|NCT02861014|592868430|FG000|Safety Follow-up|Withdrawal by Subject|9|||
164138210|NCT02861014|592868430|FG000|Safety Follow-up|Study terminated by sponsor|1|||
164138211|NCT02861014|592868430|FG000|Safety Follow-up|Physician Decision|1|||
164138212|NCT02861014|592868430|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
164138213|NCT02861014|592868430|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
164138214|NCT00867503|592868433|FG000|Overall Study|Withdrawal by Subject|1|||
164138215|NCT02704403|592868434|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
164138216|NCT02704403|592868435|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
164138217|NCT02704403|592868434|FG000|Overall Study|Administrative reasons by sponsor|1251|||
164138218|NCT02704403|592868435|FG001|Overall Study|Administrative reasons by sponsor|616|||
164138219|NCT02704403|592868434|FG000|Overall Study|Death|4|||
164138220|NCT02704403|592868435|FG001|Overall Study|Death|3|||
164138221|NCT02704403|592868434|FG000|Overall Study|Endpoint event|52|||
164138222|NCT02704403|592868435|FG001|Overall Study|Endpoint event|24|||
164138223|NCT02704403|592868434|FG000|Overall Study|Lost to Follow-up|22|||
164138224|NCT02704403|592868435|FG001|Overall Study|Lost to Follow-up|11|||
164138225|NCT02704403|592868434|FG000|Overall Study|Protocol Violation|15|||
164138226|NCT02704403|592868435|FG001|Overall Study|Protocol Violation|15|||
164138227|NCT02704403|592868434|FG000|Overall Study|Adverse Event|2|||
164138228|NCT02704403|592868435|FG001|Overall Study|Adverse Event|0|||
164138229|NCT02704403|592868434|FG000|Overall Study|Withdrawal by Subject|85|||
164138230|NCT02704403|592868435|FG001|Overall Study|Withdrawal by Subject|45|||
164138231|NCT02704403|592868434|FG000|Overall Study|Investigator decision|1|||
164138232|NCT02704403|592868435|FG001|Overall Study|Investigator decision|1|||
164138233|NCT02704403|592868434|FG000|Overall Study|Follow-up not possible|1|||
164138234|NCT02704403|592868435|FG001|Overall Study|Follow-up not possible|2|||
164138235|NCT01844856|592868442|FG000|Overall Study|Lost to Follow-up|15|||
164138236|NCT01844856|592868443|FG001|Overall Study|Lost to Follow-up|3|||
164138237|NCT01844856|592868442|FG000|Overall Study|Adverse Event|3|||
164138238|NCT01844856|592868443|FG001|Overall Study|Adverse Event|6|||
164138239|NCT01844856|592868442|FG000|Overall Study|Withdrawal by Subject|3|||
164138240|NCT01844856|592868443|FG001|Overall Study|Withdrawal by Subject|2|||
164138241|NCT01844856|592868442|FG000|Overall Study|Noncompliance|2|||
164138242|NCT01844856|592868443|FG001|Overall Study|Noncompliance|3|||
164138243|NCT01844856|592868442|FG000|Overall Study|Enterococcus Resistant|0|||
164138244|NCT01844856|592868443|FG001|Overall Study|Enterococcus Resistant|1|||
164138245|NCT01844856|592868442|FG000|Overall Study|Inadvertently Not Scheduled|1|||
164138246|NCT01844856|592868443|FG001|Overall Study|Inadvertently Not Scheduled|0|||
164138247|NCT01844856|592868442|FG000|Overall Study|Randomized but was a Screen Failure|0|||
164138248|NCT01844856|592868443|FG001|Overall Study|Randomized but was a Screen Failure|1|||
164138249|NCT00927394|592868446|FG000|Overall Study|Adverse Event|14|||
164138250|NCT00927394|592868447|FG001|Overall Study|Adverse Event|9|||
164138251|NCT00927394|592868446|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
164138252|NCT00927394|592868447|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
164138253|NCT00927394|592868446|FG000|Overall Study|Withdrawal by Subject|20|||
164138254|NCT00927394|592868447|FG001|Overall Study|Withdrawal by Subject|24|||
164138255|NCT00927394|592868446|FG000|Overall Study|Lost to Follow-up|8|||
164138256|NCT00927394|592868447|FG001|Overall Study|Lost to Follow-up|14|||
164138257|NCT00927394|592868446|FG000|Overall Study|Administrative Problem|1|||
164138258|NCT00927394|592868447|FG001|Overall Study|Administrative Problem|0|||
164138259|NCT00927394|592868446|FG000|Overall Study|Death|1|||
164138260|NCT00927394|592868447|FG001|Overall Study|Death|1|||
164138261|NCT00927394|592868446|FG000|Overall Study|Protocol deviation|16|||
164138262|NCT00927394|592868447|FG001|Overall Study|Protocol deviation|13|||
164138263|NCT00927394|592868446|FG000|Overall Study|Randomized in error|0|||
164138264|NCT00927394|592868447|FG001|Overall Study|Randomized in error|1|||
164138265|NCT01221363|592868448|FG000|Overall Study|Pregnancy|1|||
164138266|NCT01221363|592868449|FG001|Overall Study|Pregnancy|0|||
164138267|NCT01221363|592868448|FG000|Overall Study|Withdrawal by Subject|11|||
164138268|NCT01221363|592868449|FG001|Overall Study|Withdrawal by Subject|5|||
164138269|NCT01756079|592868450|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
164138270|NCT01756079|592868450|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
164138271|NCT01756079|592868450|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
164138272|NCT01756079|592868450|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
164138273|NCT01756079|592868450|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
164138274|NCT04623086|592868451|FG000|Overall Study|Withdrawal by Subject|0|||
164138275|NCT04623086|592868452|FG001|Overall Study|Withdrawal by Subject|0|||
164138276|NCT04623086|592868453|FG002|Overall Study|Withdrawal by Subject|10|||
164138277|NCT03464630|592868454|FG000|Overall Study|Lost to Follow-up|62|||
164138278|NCT03464630|592868455|FG001|Overall Study|Lost to Follow-up|52|||
164138279|NCT03464630|592868454|FG000|Overall Study|Withdrawal by Subject|16|||
164138280|NCT03464630|592868455|FG001|Overall Study|Withdrawal by Subject|10|||
164138281|NCT03464630|592868454|FG000|Overall Study|Passive Disengagement|8|||
164138282|NCT03464630|592868455|FG001|Overall Study|Passive Disengagement|4|||
164138283|NCT00715624|592868456|FG000|Overall Study|Adverse Event|12|||
164138284|NCT00715624|592868457|FG001|Overall Study|Adverse Event|37|||
164138285|NCT00715624|592868456|FG000|Overall Study|Lack of Efficacy|11|||
164138286|NCT00715624|592868457|FG001|Overall Study|Lack of Efficacy|11|||
164138291|NCT00715624|592868456|FG000|Overall Study|Withdrawal by Subject|11|||
164138292|NCT00715624|592868457|FG001|Overall Study|Withdrawal by Subject|25|||
164138293|NCT00715624|592868456|FG000|Overall Study|Familial and personal reasons|10|||
164138294|NCT00715624|592868457|FG001|Overall Study|Familial and personal reasons|22|||
164138295|NCT00715624|592868456|FG000|Overall Study|Poor compliance|6|||
164138296|NCT00715624|592868457|FG001|Overall Study|Poor compliance|13|||
164138297|NCT00715624|592868456|FG000|Overall Study|Sponsor decision|0|||
164138298|NCT00715624|592868457|FG001|Overall Study|Sponsor decision|4|||
164138299|NCT00715624|592868456|FG000|Overall Study|Incorrect randomization (not treated)|0|||
164138300|NCT00715624|592868457|FG001|Overall Study|Incorrect randomization (not treated)|1|||
164138301|NCT00715624|592868456|FG000|Overall Study|Other|0|||
164138302|NCT00715624|592868457|FG001|Overall Study|Other|1|||
164138303|NCT04524364|592868460|FG000|Overall Study|Physician Decision|3|||
164138304|NCT04524364|592868461|FG001|Overall Study|Physician Decision|6|||
164138305|NCT04524364|592868460|FG000|Overall Study|Adverse Event|0|||
164138306|NCT04524364|592868461|FG001|Overall Study|Adverse Event|1|||
164138307|NCT04524364|592868460|FG000|Overall Study|Investigational device deficiency|0|||
164138308|NCT04524364|592868461|FG001|Overall Study|Investigational device deficiency|1|||
164138309|NCT04524364|592868460|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
164138310|NCT04524364|592868461|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
164138311|NCT04524364|592868460|FG000|Overall Study|Device unavailability|0|||
164138312|NCT04524364|592868461|FG001|Overall Study|Device unavailability|2|||
164138313|NCT04524364|592868460|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
164138314|NCT04524364|592868461|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
164138315|NCT04524364|592868460|FG000|Overall Study|Low International normalized ratio (INR)|1|||
164138316|NCT04524364|592868461|FG001|Overall Study|Low International normalized ratio (INR)|0|||
164138317|NCT02309138|592868462|FG000|Overall Study|Withdrawal by Subject|44|||
164138318|NCT02309138|592868463|FG001|Overall Study|Withdrawal by Subject|15|||
164138319|NCT02309138|592868462|FG000|Overall Study|Protocol Violation|4|||
164138320|NCT02309138|592868463|FG001|Overall Study|Protocol Violation|2|||
164138321|NCT02309138|592868462|FG000|Overall Study|delivered before visit 2|0|||
164138322|NCT02309138|592868463|FG001|Overall Study|delivered before visit 2|1|||
164138323|NCT00735397|592868468|FG000|Overall Study|Adverse Event|194|||
164138324|NCT00735397|592868468|FG000|Overall Study|Lost to Follow-up|33|||
164138325|NCT00735397|592868468|FG000|Overall Study|Participant choice|252|||
164138326|NCT00735397|592868468|FG000|Overall Study|Inadequate therapeutic effect|202|||
164138327|NCT00735397|592868468|FG000|Overall Study|Administrative/Other|502|||
164138328|NCT02677714|592868469|FG000|Overall Study|Withdrawal by Subject|2|||
164138329|NCT02677714|592868470|FG001|Overall Study|Withdrawal by Subject|0|||
164138330|NCT00380744|592868471|FG000|Overall Study|Death|0|||
164138331|NCT00380744|592868472|FG001|Overall Study|Death|0|||
164138332|NCT00380744|592868473|FG002|Overall Study|Death|0|||
164138333|NCT00380744|592868474|FG003|Overall Study|Death|0|||
164138334|NCT00380744|592868475|FG004|Overall Study|Death|0|||
164138335|NCT00380744|592868476|FG005|Overall Study|Death|0|||
164138336|NCT00380744|592868477|FG006|Overall Study|Death|1|||
164138337|NCT00380744|592868471|FG000|Overall Study|Withdrawal by Subject|1|||
164138338|NCT00380744|592868472|FG001|Overall Study|Withdrawal by Subject|0|||
164138339|NCT00380744|592868473|FG002|Overall Study|Withdrawal by Subject|0|||
164138340|NCT00380744|592868474|FG003|Overall Study|Withdrawal by Subject|0|||
164138341|NCT00380744|592868475|FG004|Overall Study|Withdrawal by Subject|0|||
164138342|NCT00380744|592868476|FG005|Overall Study|Withdrawal by Subject|0|||
164138343|NCT00380744|592868477|FG006|Overall Study|Withdrawal by Subject|0|||
164138344|NCT01955083|592868487|FG000|Overall Study|Lost to Follow-up|1|||
164138345|NCT01955083|592868488|FG001|Overall Study|Lost to Follow-up|1|||
164138346|NCT01559389|592868497|FG000|Overall Study|Withdrawal by Subject|20|||
164138347|NCT01559389|592868498|FG001|Overall Study|Withdrawal by Subject|20|||
164138348|NCT02871492|592868499|FG000|Overall Study|Lost to Follow-up|6|||
164138349|NCT02871492|592868500|FG001|Overall Study|Lost to Follow-up|3|||
164138350|NCT02871492|592868501|FG002|Overall Study|Lost to Follow-up|5|||
164138351|NCT02871492|592868499|FG000|Overall Study|Withdrawal by Subject|0|||
164138352|NCT02871492|592868500|FG001|Overall Study|Withdrawal by Subject|0|||
164138353|NCT02871492|592868501|FG002|Overall Study|Withdrawal by Subject|1|||
164138354|NCT04546724|592868502|FG000|Overall Study|Withdrawal by Subject|145|||
164138355|NCT04546724|592868503|FG001|Overall Study|Withdrawal by Subject|41|||
164138356|NCT04546724|592868502|FG000|Overall Study|Adverse Event|1|||
164138357|NCT04546724|592868503|FG001|Overall Study|Adverse Event|1|||
164138358|NCT04546724|592868502|FG000|Overall Study|Lost to Follow-up|186|||
164138359|NCT04546724|592868503|FG001|Overall Study|Lost to Follow-up|63|||
164138360|NCT04546724|592868502|FG000|Overall Study|Physician Decision|8|||
164138361|NCT04546724|592868503|FG001|Overall Study|Physician Decision|2|||
164138362|NCT04546724|592868502|FG000|Overall Study|Death|2|||
164138363|NCT04546724|592868503|FG001|Overall Study|Death|1|||
164138364|NCT04546724|592868502|FG000|Overall Study|subject has been out of town|1|||
164138365|NCT04546724|592868503|FG001|Overall Study|subject has been out of town|0|||
164138366|NCT04546724|592868502|FG000|Overall Study|subject is incarcerated|2|||
164138367|NCT04546724|592868503|FG001|Overall Study|subject is incarcerated|0|||
164138368|NCT04546724|592868502|FG000|Overall Study|subject is relocating|12|||
164138369|NCT04546724|592868503|FG001|Overall Study|subject is relocating|4|||
164138370|NCT04546724|592868502|FG000|Overall Study|Subject in another study|1|||
164138371|NCT04546724|592868503|FG001|Overall Study|Subject in another study|1|||
164138372|NCT03583086|592868506|FG000|Overall Study|Death|2|||
164138373|NCT03583086|592868507|FG001|Overall Study|Death|6|||
164138374|NCT03583086|592868508|FG002|Overall Study|Death|12|||
164138375|NCT03583086|592868509|FG003|Overall Study|Death|10|||
164138376|NCT03583086|592868510|FG004|Overall Study|Death|14|||
164138377|NCT03583086|592868511|FG005|Overall Study|Death|14|||
164138378|NCT03583086|592868512|FG006|Overall Study|Death|4|||
164138379|NCT03583086|592868506|FG000|Overall Study|Withdrawal by Subject|0|||
164138380|NCT03583086|592868507|FG001|Overall Study|Withdrawal by Subject|0|||
164138381|NCT03583086|592868508|FG002|Overall Study|Withdrawal by Subject|1|||
164138382|NCT03583086|592868509|FG003|Overall Study|Withdrawal by Subject|0|||
164138383|NCT03583086|592868510|FG004|Overall Study|Withdrawal by Subject|0|||
164138384|NCT03583086|592868511|FG005|Overall Study|Withdrawal by Subject|0|||
164138385|NCT03583086|592868512|FG006|Overall Study|Withdrawal by Subject|1|||
164138386|NCT03583086|592868506|FG000|Overall Study|Refused follow-up|0|||
164138387|NCT03583086|592868507|FG001|Overall Study|Refused follow-up|0|||
164138388|NCT03583086|592868508|FG002|Overall Study|Refused follow-up|1|||
164138389|NCT03583086|592868509|FG003|Overall Study|Refused follow-up|0|||
164138390|NCT03583086|592868510|FG004|Overall Study|Refused follow-up|1|||
164138391|NCT03583086|592868511|FG005|Overall Study|Refused follow-up|0|||
164138392|NCT03583086|592868512|FG006|Overall Study|Refused follow-up|0|||
164138393|NCT03583086|592868506|FG000|Overall Study|Declining Performance Status|0|||
164138394|NCT03583086|592868507|FG001|Overall Study|Declining Performance Status|0|||
164138395|NCT03583086|592868508|FG002|Overall Study|Declining Performance Status|1|||
164138396|NCT03583086|592868509|FG003|Overall Study|Declining Performance Status|0|||
164138397|NCT03583086|592868510|FG004|Overall Study|Declining Performance Status|0|||
164138398|NCT03583086|592868511|FG005|Overall Study|Declining Performance Status|0|||
164138399|NCT03583086|592868512|FG006|Overall Study|Declining Performance Status|0|||
164138400|NCT03583086|592868506|FG000|Overall Study|Still on study|0|||
164138401|NCT03583086|592868507|FG001|Overall Study|Still on study|0|||
164138402|NCT03583086|592868508|FG002|Overall Study|Still on study|0|||
164138403|NCT03583086|592868509|FG003|Overall Study|Still on study|1|||
164138404|NCT03583086|592868510|FG004|Overall Study|Still on study|0|||
164138405|NCT03583086|592868511|FG005|Overall Study|Still on study|0|||
164138406|NCT03583086|592868512|FG006|Overall Study|Still on study|1|||
164138407|NCT03583086|592868506|FG000|Overall Study|Disease progression|0|||
164138408|NCT03583086|592868507|FG001|Overall Study|Disease progression|0|||
164138409|NCT03583086|592868508|FG002|Overall Study|Disease progression|0|||
164138410|NCT03583086|592868509|FG003|Overall Study|Disease progression|0|||
164138411|NCT03583086|592868510|FG004|Overall Study|Disease progression|0|||
164138412|NCT03583086|592868511|FG005|Overall Study|Disease progression|0|||
164138413|NCT03583086|592868512|FG006|Overall Study|Disease progression|1|||
164138414|NCT03583086|592868506|FG000|Overall Study|Undergoing radiation therapy|0|||
164138415|NCT03583086|592868507|FG001|Overall Study|Undergoing radiation therapy|0|||
164138416|NCT03583086|592868508|FG002|Overall Study|Undergoing radiation therapy|0|||
164138417|NCT03583086|592868509|FG003|Overall Study|Undergoing radiation therapy|0|||
164138418|NCT03583086|592868510|FG004|Overall Study|Undergoing radiation therapy|0|||
164138419|NCT03583086|592868511|FG005|Overall Study|Undergoing radiation therapy|0|||
164138420|NCT03583086|592868512|FG006|Overall Study|Undergoing radiation therapy|1|||
164138421|NCT03583086|592868506|FG000|Overall Study|Lost to Follow-up|0|||
164138422|NCT03583086|592868507|FG001|Overall Study|Lost to Follow-up|0|||
164138423|NCT03583086|592868508|FG002|Overall Study|Lost to Follow-up|0|||
164138424|NCT03583086|592868509|FG003|Overall Study|Lost to Follow-up|0|||
164138425|NCT03583086|592868510|FG004|Overall Study|Lost to Follow-up|0|||
164138426|NCT03583086|592868511|FG005|Overall Study|Lost to Follow-up|1|||
164138427|NCT03583086|592868512|FG006|Overall Study|Lost to Follow-up|0|||
164138428|NCT03583086|592868506|FG000|Overall Study|Adverse Event|0|||
164138429|NCT03583086|592868507|FG001|Overall Study|Adverse Event|0|||
164138430|NCT03583086|592868508|FG002|Overall Study|Adverse Event|0|||
164138431|NCT03583086|592868509|FG003|Overall Study|Adverse Event|0|||
164138432|NCT03583086|592868510|FG004|Overall Study|Adverse Event|0|||
164138433|NCT03583086|592868511|FG005|Overall Study|Adverse Event|1|||
164138434|NCT03583086|592868512|FG006|Overall Study|Adverse Event|0|||
164138435|NCT00396812|592868514|FG000|Overall Study|Physician Decision|1|||
164138436|NCT02387983|592868519|FG000|Overall Study|Adverse Event|4|||
164138437|NCT02387983|592868519|FG000|Overall Study|Protocol Violation|1|||
164138438|NCT02387983|592868519|FG000|Overall Study|Withdrawal by Subject|2|||
164138439|NCT00724048|592868523|FG000|Overall Study|Adverse Event|1|||
164138440|NCT00724048|592868524|FG001|Overall Study|Adverse Event|1|||
164138441|NCT00724048|592868525|FG002|Overall Study|Adverse Event|1|||
164138442|NCT00724048|592868526|FG003|Overall Study|Adverse Event|0|||
164138443|NCT00724048|592868523|FG000|Overall Study|Lost to Follow-up|0|||
164138444|NCT00724048|592868524|FG001|Overall Study|Lost to Follow-up|1|||
164138648|NCT00229723|592870149|FG003|Concomitant Phase|Clinical progression|0|||
164138649|NCT00229723|592870150|FG004|Concomitant Phase|Clinical progression|0|||
164138650|NCT00229723|592870151|FG005|Concomitant Phase|Clinical progression|0|||
164138651|NCT00229723|592870152|FG006|Concomitant Phase|Clinical progression|1|||
164138652|NCT00229723|592870146|FG000|Concomitant Phase|Lost to Follow-up|0|||
164138653|NCT00229723|592870147|FG001|Concomitant Phase|Lost to Follow-up|0|||
164138654|NCT00229723|592870148|FG002|Concomitant Phase|Lost to Follow-up|0|||
164138655|NCT00229723|592870149|FG003|Concomitant Phase|Lost to Follow-up|0|||
164138656|NCT00229723|592870150|FG004|Concomitant Phase|Lost to Follow-up|1|||
164138657|NCT00229723|592870151|FG005|Concomitant Phase|Lost to Follow-up|0|||
164138658|NCT00229723|592870152|FG006|Concomitant Phase|Lost to Follow-up|0|||
164138659|NCT00229723|592870146|FG000|Concomitant Phase|Informed consent withdrawn|3|||
164138660|NCT00229723|592870147|FG001|Concomitant Phase|Informed consent withdrawn|2|||
164138661|NCT00229723|592870148|FG002|Concomitant Phase|Informed consent withdrawn|0|||
164138662|NCT00229723|592870149|FG003|Concomitant Phase|Informed consent withdrawn|2|||
164138663|NCT00229723|592870150|FG004|Concomitant Phase|Informed consent withdrawn|0|||
164138664|NCT00229723|592870151|FG005|Concomitant Phase|Informed consent withdrawn|0|||
164138665|NCT00229723|592870152|FG006|Concomitant Phase|Informed consent withdrawn|0|||
164138666|NCT00229723|592870146|FG000|Concomitant Phase|Severe non-compliance|0|||
164138667|NCT00229723|592870147|FG001|Concomitant Phase|Severe non-compliance|1|||
164138668|NCT00229723|592870148|FG002|Concomitant Phase|Severe non-compliance|0|||
164138669|NCT00229723|592870149|FG003|Concomitant Phase|Severe non-compliance|0|||
164138670|NCT00229723|592870150|FG004|Concomitant Phase|Severe non-compliance|1|||
164138671|NCT00229723|592870151|FG005|Concomitant Phase|Severe non-compliance|0|||
164138672|NCT00229723|592870152|FG006|Concomitant Phase|Severe non-compliance|0|||
164138673|NCT00229723|592870146|FG000|Concomitant Phase|Other|3|||
164138674|NCT00229723|592870147|FG001|Concomitant Phase|Other|0|||
164138675|NCT00229723|592870148|FG002|Concomitant Phase|Other|1|||
164138676|NCT00229723|592870149|FG003|Concomitant Phase|Other|1|||
164138677|NCT00229723|592870150|FG004|Concomitant Phase|Other|0|||
164138678|NCT00229723|592870151|FG005|Concomitant Phase|Other|2|||
164138679|NCT00229723|592870152|FG006|Concomitant Phase|Other|0|||
164138680|NCT00229723|592870146|FG000|Maintenance Phase|Adverse Event|7|||
164138681|NCT00229723|592870147|FG001|Maintenance Phase|Adverse Event|2|||
164138682|NCT00229723|592870148|FG002|Maintenance Phase|Adverse Event|1|||
164138683|NCT00229723|592870149|FG003|Maintenance Phase|Adverse Event|4|||
164138684|NCT00229723|592870150|FG004|Maintenance Phase|Adverse Event|7|||
164138685|NCT00229723|592870151|FG005|Maintenance Phase|Adverse Event|5|||
164138686|NCT00229723|592870152|FG006|Maintenance Phase|Adverse Event|2|||
164138687|NCT00229723|592870146|FG000|Maintenance Phase|Objective disease progression|5|||
164138688|NCT00229723|592870147|FG001|Maintenance Phase|Objective disease progression|5|||
164138689|NCT00229723|592870148|FG002|Maintenance Phase|Objective disease progression|3|||
164138690|NCT00229723|592870149|FG003|Maintenance Phase|Objective disease progression|6|||
164138691|NCT00229723|592870150|FG004|Maintenance Phase|Objective disease progression|2|||
164138692|NCT00229723|592870151|FG005|Maintenance Phase|Objective disease progression|9|||
164138693|NCT00229723|592870152|FG006|Maintenance Phase|Objective disease progression|5|||
164138694|NCT00229723|592870146|FG000|Maintenance Phase|Clinical progression|4|||
164138695|NCT00229723|592870147|FG001|Maintenance Phase|Clinical progression|1|||
164138696|NCT00229723|592870148|FG002|Maintenance Phase|Clinical progression|2|||
164138697|NCT00229723|592870149|FG003|Maintenance Phase|Clinical progression|2|||
164138698|NCT00229723|592870150|FG004|Maintenance Phase|Clinical progression|1|||
164138699|NCT00229723|592870151|FG005|Maintenance Phase|Clinical progression|1|||
164138700|NCT00229723|592870152|FG006|Maintenance Phase|Clinical progression|1|||
164138701|NCT00229723|592870146|FG000|Maintenance Phase|Lost to Follow-up|0|||
164138702|NCT00229723|592870147|FG001|Maintenance Phase|Lost to Follow-up|1|||
164138703|NCT00229723|592870148|FG002|Maintenance Phase|Lost to Follow-up|2|||
164138704|NCT00229723|592870149|FG003|Maintenance Phase|Lost to Follow-up|2|||
164138705|NCT00229723|592870150|FG004|Maintenance Phase|Lost to Follow-up|0|||
164138706|NCT00229723|592870151|FG005|Maintenance Phase|Lost to Follow-up|0|||
164138707|NCT00229723|592870152|FG006|Maintenance Phase|Lost to Follow-up|1|||
164138708|NCT00229723|592870146|FG000|Maintenance Phase|Informed consent withdrawn|1|||
164138709|NCT00229723|592870147|FG001|Maintenance Phase|Informed consent withdrawn|0|||
164138710|NCT00229723|592870148|FG002|Maintenance Phase|Informed consent withdrawn|0|||
164138711|NCT00229723|592870149|FG003|Maintenance Phase|Informed consent withdrawn|1|||
164138712|NCT00229723|592870150|FG004|Maintenance Phase|Informed consent withdrawn|1|||
164138713|NCT00229723|592870151|FG005|Maintenance Phase|Informed consent withdrawn|1|||
164138714|NCT00229723|592870152|FG006|Maintenance Phase|Informed consent withdrawn|0|||
164138715|NCT00229723|592870146|FG000|Maintenance Phase|Severe non-compliance|3|||
164138716|NCT00229723|592870147|FG001|Maintenance Phase|Severe non-compliance|1|||
164138717|NCT00229723|592870148|FG002|Maintenance Phase|Severe non-compliance|0|||
164138718|NCT00229723|592870149|FG003|Maintenance Phase|Severe non-compliance|0|||
164138719|NCT00229723|592870150|FG004|Maintenance Phase|Severe non-compliance|1|||
164138720|NCT00229723|592870151|FG005|Maintenance Phase|Severe non-compliance|0|||
164138721|NCT00229723|592870152|FG006|Maintenance Phase|Severe non-compliance|0|||
164138722|NCT00229723|592870146|FG000|Maintenance Phase|Other|5|||
164138938|NCT01197755|592870217|FG002|Overall Study|Severe non-compliance to the protocol|2|||
164138939|NCT01197755|592870215|FG000|Overall Study|Withdrawal by Subject|1|||
164138940|NCT01197755|592870216|FG001|Overall Study|Withdrawal by Subject|0|||
164138941|NCT01197755|592870217|FG002|Overall Study|Withdrawal by Subject|0|||
164138942|NCT01197755|592870215|FG000|Overall Study|Lost to Follow-up|0|||
164138943|NCT01197755|592870216|FG001|Overall Study|Lost to Follow-up|0|||
164138944|NCT01197755|592870217|FG002|Overall Study|Lost to Follow-up|1|||
164138945|NCT01197755|592870215|FG000|Overall Study|eg, change in circumstances|7|||
164138946|NCT01197755|592870216|FG001|Overall Study|eg, change in circumstances|3|||
164138947|NCT01197755|592870217|FG002|Overall Study|eg, change in circumstances|2|||
164138948|NCT03365011|592870218|FG000|Overall Study|Withdrawal by Subject|1|||
164138949|NCT03365011|592870219|FG001|Overall Study|Withdrawal by Subject|2|||
164138950|NCT00499174|592870220|FG000|Overall Study|Physician Decision|78|||
164138951|NCT00499174|592870221|FG001|Overall Study|Physician Decision|9|||
164138952|NCT03582826|592870222|FG000|Overall Study|Lost to Follow-up|39|||
164138953|NCT03582826|592870223|FG001|Overall Study|Lost to Follow-up|0|||
164138954|NCT03582826|592870222|FG000|Overall Study|Withdrawal by Subject|2|||
164138955|NCT03582826|592870223|FG001|Overall Study|Withdrawal by Subject|0|||
164138956|NCT01214915|592870227|FG000|Overall Study|Adverse Event|8|||
164138957|NCT01214915|592870227|FG000|Overall Study|Lack of Efficacy|3|||
164138958|NCT00574912|592870228|FG000|Overall Study|Could not place IV lines.|3|||
164138959|NCT00574912|592870228|FG000|Overall Study|scheduling conflicts|3|||
164138960|NCT00574912|592870228|FG000|Overall Study|Physician Decision|2|||
164138961|NCT02342639|592870242|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
164138962|NCT02342639|592870243|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
164138963|NCT02342639|592870242|FG000|Overall Study|Protocol Violation|0|||
164138964|NCT02342639|592870243|FG001|Overall Study|Protocol Violation|2|||
164138965|NCT01200069|592871931|FG000|Overall Study|Withdrawal by Subject|0|||
164138966|NCT01200069|592871932|FG001|Overall Study|Withdrawal by Subject|1|||
164138967|NCT00761657|592871933|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
164138968|NCT00761657|592871934|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
164138969|NCT00761657|592871935|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
164138970|NCT00761657|592871936|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
164138971|NCT00761657|592871937|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
164138972|NCT00761657|592871938|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
164138973|NCT00761657|592871939|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
164138974|NCT00761657|592871940|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
164138975|NCT00761657|592871941|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
164138976|NCT00761657|592871933|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138977|NCT00761657|592871934|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138978|NCT00761657|592871935|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
164138979|NCT00761657|592871936|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
164138980|NCT00761657|592871937|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138981|NCT00761657|592871938|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138982|NCT00761657|592871939|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138983|NCT00761657|592871940|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138984|NCT00761657|592871941|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
164138985|NCT00761657|592871933|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
164138986|NCT00761657|592871934|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
164138987|NCT00761657|592871935|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
164138988|NCT00761657|592871936|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
164138989|NCT00761657|592871937|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
164138990|NCT00761657|592871938|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
164138991|NCT00761657|592871939|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
164138992|NCT00761657|592871940|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
164138993|NCT00761657|592871941|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
164138994|NCT00761657|592871933|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
164138995|NCT00761657|592871934|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
164138996|NCT00761657|592871935|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
164138997|NCT00761657|592871936|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
164138998|NCT00761657|592871937|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
164138999|NCT00761657|592871938|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
164139000|NCT00761657|592871939|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
164139001|NCT00761657|592871940|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
164139002|NCT00761657|592871941|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
164139003|NCT01564537|592871947|FG000|Overall Study|Site Terminated by Sponsor|1|||
164139004|NCT01564537|592871948|FG001|Overall Study|Site Terminated by Sponsor|0|||
164139005|NCT01564537|592871947|FG000|Overall Study|Withdrawal by Subject|12|||
164139006|NCT01564537|592871948|FG001|Overall Study|Withdrawal by Subject|14|||
164139007|NCT01564537|592871947|FG000|Overall Study|Lost to Follow-up|7|||
164139008|NCT01564537|592871948|FG001|Overall Study|Lost to Follow-up|3|||
164139009|NCT01564537|592871947|FG000|Overall Study|Reason not specified|81|||
164139010|NCT01564537|592871948|FG001|Overall Study|Reason not specified|82|||
164139011|NCT02932306|592871956|FG000|Overall Study|Withdrawal by Subject|16|||
164139012|NCT02932306|592871957|FG001|Overall Study|Withdrawal by Subject|25|||
164139037|NCT02065700|592871970|FG000|Overall Study|Withdrawal by Subject|90|||
164139038|NCT02065700|592871971|FG001|Overall Study|Withdrawal by Subject|29|||
164139039|NCT02065700|592871970|FG000|Overall Study|Lost to Follow-up|12|||
164139040|NCT02065700|592871971|FG001|Overall Study|Lost to Follow-up|9|||
164139041|NCT02065700|592871970|FG000|Overall Study|Physician Decision|2|||
164139042|NCT02065700|592871971|FG001|Overall Study|Physician Decision|0|||
164139043|NCT02065700|592871970|FG000|Overall Study|Sponsor Request|38|||
164139044|NCT02065700|592871971|FG001|Overall Study|Sponsor Request|15|||
164139045|NCT02065700|592871970|FG000|Overall Study|Treatment Failure|3|||
164139046|NCT02065700|592871971|FG001|Overall Study|Treatment Failure|2|||
164139047|NCT02065700|592871970|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
164139048|NCT02065700|592871971|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
164139049|NCT02065700|592871970|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
164139050|NCT02065700|592871971|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
164139051|NCT02065700|592871970|FG000|Overall Study|Non-compliance with Study Procedures|2|||
164139052|NCT02065700|592871971|FG001|Overall Study|Non-compliance with Study Procedures|0|||
164139053|NCT02065700|592871970|FG000|Overall Study|Not Defined|21|||
164139054|NCT02065700|592871971|FG001|Overall Study|Not Defined|3|||
164139055|NCT02315196|592871972|FG000|Overall Study|Withdrew consent|9|||
164139056|NCT03559400|592871973|FG000|Overall Study|Lost to Follow-up|9|||
164139057|NCT03559400|592871974|FG001|Overall Study|Lost to Follow-up|7|||
164139058|NCT03559400|592871973|FG000|Overall Study|Death|0|||
164139059|NCT03559400|592871974|FG001|Overall Study|Death|2|||
164139060|NCT04933968|592871979|FG000|Overall Study|Adverse Event|0|||
164139061|NCT04933968|592871980|FG001|Overall Study|Adverse Event|0|||
164139062|NCT04933968|592871981|FG002|Overall Study|Adverse Event|1|||
164139063|NCT04933968|592871982|FG003|Overall Study|Adverse Event|1|||
164139064|NCT04933968|592871983|FG004|Overall Study|Adverse Event|0|||
164139065|NCT04933968|592871984|FG005|Overall Study|Adverse Event|0|||
164139066|NCT04933968|592871979|FG000|Overall Study|Lost to Follow-up|1|||
164139067|NCT04933968|592871980|FG001|Overall Study|Lost to Follow-up|0|||
164139068|NCT04933968|592871981|FG002|Overall Study|Lost to Follow-up|1|||
164139069|NCT04933968|592871982|FG003|Overall Study|Lost to Follow-up|0|||
164139070|NCT04933968|592871983|FG004|Overall Study|Lost to Follow-up|0|||
164139071|NCT04933968|592871984|FG005|Overall Study|Lost to Follow-up|0|||
164139072|NCT04933968|592871979|FG000|Overall Study|Randomized not treated|1|||
164139073|NCT04933968|592871980|FG001|Overall Study|Randomized not treated|0|||
164139074|NCT04933968|592871981|FG002|Overall Study|Randomized not treated|0|||
164139075|NCT04933968|592871982|FG003|Overall Study|Randomized not treated|0|||
164139076|NCT04933968|592871983|FG004|Overall Study|Randomized not treated|0|||
164139077|NCT04933968|592871984|FG005|Overall Study|Randomized not treated|0|||
164139078|NCT04933968|592871979|FG000|Overall Study|Sponsor terminated study|0|||
164139079|NCT04933968|592871980|FG001|Overall Study|Sponsor terminated study|0|||
164139080|NCT04933968|592871981|FG002|Overall Study|Sponsor terminated study|0|||
164139081|NCT04933968|592871982|FG003|Overall Study|Sponsor terminated study|1|||
164139082|NCT04933968|592871983|FG004|Overall Study|Sponsor terminated study|2|||
164139083|NCT04933968|592871984|FG005|Overall Study|Sponsor terminated study|0|||
164139084|NCT04933968|592871979|FG000|Overall Study|Other|0|||
164139085|NCT04933968|592871980|FG001|Overall Study|Other|0|||
164139086|NCT04933968|592871981|FG002|Overall Study|Other|0|||
164139087|NCT04933968|592871982|FG003|Overall Study|Other|1|||
164139088|NCT04933968|592871983|FG004|Overall Study|Other|0|||
164139089|NCT04933968|592871984|FG005|Overall Study|Other|0|||
164139090|NCT04933968|592871979|FG000|Overall Study|Missing|1|||
164139091|NCT04933968|592871980|FG001|Overall Study|Missing|3|||
164139092|NCT04933968|592871981|FG002|Overall Study|Missing|2|||
164139093|NCT04933968|592871982|FG003|Overall Study|Missing|1|||
164139094|NCT04933968|592871983|FG004|Overall Study|Missing|1|||
164139095|NCT04933968|592871984|FG005|Overall Study|Missing|0|||
164139096|NCT01664130|592871987|FG000|Overall Study|competing secondary disease|2|||
164139097|NCT02679235|592871990|FG000|Overall Study|Withdrawal by Subject|3|||
164139098|NCT02679235|592871990|FG000|Overall Study|Adverse Event|1|||
164139099|NCT00923273|592871991|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164139100|NCT00923273|592871992|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164139101|NCT00923273|592871993|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164139102|NCT00923273|592871994|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
164139103|NCT00923273|592871995|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
164139104|NCT00923273|592871991|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164139105|NCT00923273|592871992|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164139106|NCT00923273|592871993|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164139107|NCT00923273|592871994|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
164139108|NCT00923273|592871995|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
164139109|NCT03146962|592872000|FG000|Overall Study|Lost to Follow-up|1|||
164139110|NCT03146962|592872001|FG001|Overall Study|Lost to Follow-up|1|||
164139111|NCT03146962|592872002|FG002|Overall Study|Lost to Follow-up|0|||
164139112|NCT03146962|592872003|FG003|Overall Study|Lost to Follow-up|0|||
164139266|NCT03016975|592872039|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
164139267|NCT03016975|592872040|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
164139268|NCT03016975|592872041|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
164139269|NCT03016975|592872039|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
164139270|NCT03016975|592872040|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
164139271|NCT03016975|592872041|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
164139272|NCT00811928|592872042|FG000|Overall Study|AEs and SAEs Including Death|7|||
164139273|NCT00811928|592872043|FG001|Overall Study|AEs and SAEs Including Death|11|||
164139274|NCT00811928|592872042|FG000|Overall Study|Withdrawal by Subject|18|||
164139275|NCT00811928|592872043|FG001|Overall Study|Withdrawal by Subject|12|||
164139276|NCT00811928|592872042|FG000|Overall Study|Did Not Take Study Drug|3|||
164139277|NCT00811928|592872043|FG001|Overall Study|Did Not Take Study Drug|0|||
164139278|NCT00811928|592872042|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
164139279|NCT00811928|592872043|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
164139280|NCT00811928|592872042|FG000|Overall Study|Investigator Decision|2|||
164139281|NCT00811928|592872043|FG001|Overall Study|Investigator Decision|1|||
164139282|NCT00811928|592872042|FG000|Overall Study|Poor Compliance|2|||
164139283|NCT00811928|592872043|FG001|Overall Study|Poor Compliance|5|||
164139284|NCT01085357|592872044|FG000|Overall Study|Adverse Event|1|||
164139285|NCT01085357|592872045|FG001|Overall Study|Adverse Event|1|||
164139286|NCT01085357|592872044|FG000|Overall Study|Subject Decision|4|||
164139287|NCT01085357|592872045|FG001|Overall Study|Subject Decision|3|||
164139288|NCT01085357|592872044|FG000|Overall Study|Investigator Decision|1|||
164139289|NCT01085357|592872045|FG001|Overall Study|Investigator Decision|1|||
164139290|NCT01085357|592872044|FG000|Overall Study|Death|11|||
164139291|NCT01085357|592872045|FG001|Overall Study|Death|1|||
164139292|NCT01085357|592872044|FG000|Overall Study|Lost to Follow-up|2|||
164139293|NCT01085357|592872045|FG001|Overall Study|Lost to Follow-up|0|||
164139294|NCT02910011|592872046|FG000|Overall Study|Physician Decision|2|||
164139295|NCT00838435|592872047|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
164139296|NCT00838435|592872047|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
164139297|NCT00838435|592872047|FG000|Part 2 (7 Years)|Adverse Event|2|||
164139298|NCT00838435|592872047|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
164139299|NCT00838435|592872047|FG000|Part 2 (7 Years)|Physician Decision|1|||
164139300|NCT00838435|592872047|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
164139301|NCT00838435|592872047|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
164139302|NCT02348723|592872048|FG000|Overall Study|No ablation|21|||
164139303|NCT02348723|592872049|FG001|Overall Study|No ablation|20|||
164139304|NCT02348723|592872048|FG000|Overall Study|Non-compliant with Protocol|1|||
164139305|NCT02348723|592872049|FG001|Overall Study|Non-compliant with Protocol|0|||
164139306|NCT02348723|592872048|FG000|Overall Study|Lost to Follow-up|1|||
164139307|NCT02348723|592872049|FG001|Overall Study|Lost to Follow-up|1|||
164139308|NCT02348723|592872048|FG000|Overall Study|Consent withdrawn|1|||
164139309|NCT02348723|592872049|FG001|Overall Study|Consent withdrawn|3|||
164139310|NCT02348723|592872048|FG000|Overall Study|Reason other than specified|1|||
164139311|NCT02348723|592872049|FG001|Overall Study|Reason other than specified|1|||
164139312|NCT02348723|592872048|FG000|Overall Study|Adverse Event|3|||
164139313|NCT02348723|592872049|FG001|Overall Study|Adverse Event|1|||
164139314|NCT00678886|592872050|FG000|Overall Study|Withdrawal by Subject|0|||
164139315|NCT00678886|592872051|FG001|Overall Study|Withdrawal by Subject|0|||
164139316|NCT00678886|592872052|FG002|Overall Study|Withdrawal by Subject|4|||
164139317|NCT00678886|592872053|FG003|Overall Study|Withdrawal by Subject|6|||
164139318|NCT00678886|592872050|FG000|Overall Study|Physician Decision|0|||
164139319|NCT00678886|592872051|FG001|Overall Study|Physician Decision|0|||
164139320|NCT00678886|592872052|FG002|Overall Study|Physician Decision|1|||
164139321|NCT00678886|592872053|FG003|Overall Study|Physician Decision|1|||
164139322|NCT00678886|592872050|FG000|Overall Study|Lost to Follow-up|0|||
164139323|NCT00678886|592872051|FG001|Overall Study|Lost to Follow-up|0|||
164139324|NCT00678886|592872052|FG002|Overall Study|Lost to Follow-up|3|||
164139325|NCT00678886|592872053|FG003|Overall Study|Lost to Follow-up|2|||
164139326|NCT00678886|592872050|FG000|Overall Study|Other|0|||
164139327|NCT00678886|592872051|FG001|Overall Study|Other|0|||
164139328|NCT00678886|592872052|FG002|Overall Study|Other|1|||
164139329|NCT00678886|592872053|FG003|Overall Study|Other|0|||
164139330|NCT01147107|592872054|FG000|Overall Study|Lack of Efficacy|5|||
164139331|NCT01147107|592872055|FG001|Overall Study|Lack of Efficacy|0|||
164139332|NCT01147107|592872054|FG000|Overall Study|Withdrawal by Subject|1|||
164139333|NCT01147107|592872055|FG001|Overall Study|Withdrawal by Subject|1|||
164139334|NCT04435184|592872056|FG000|Overall Study|follow-up blood draws missing|3|||
164139335|NCT04435184|592872057|FG001|Overall Study|follow-up blood draws missing|5|||
164139336|NCT04693416|592872058|FG000|Overall Study|Lost to Follow-up|13|||
164139337|NCT04693416|592872059|FG001|Overall Study|Lost to Follow-up|0|||
164139338|NCT02290223|592872060|FG000|6 Months|Lost to Follow-up|9|||
164139339|NCT02290223|592872061|FG001|6 Months|Lost to Follow-up|6|||
164139340|NCT02290223|592872060|FG000|6 Months|Withdrawal by Subject|5|||
164139341|NCT02290223|592872061|FG001|6 Months|Withdrawal by Subject|0|||
164139342|NCT02290223|592872060|FG000|6 Months|deceased (not related to study)|2|||
164139343|NCT02290223|592872061|FG001|6 Months|deceased (not related to study)|0|||
164139381|NCT03753763|592872093|FG001|Overall Study|clinical deterioration|0|||
164139382|NCT01104779|592872094|FG000|Overall Study|Protocol Violation|1|||
164139383|NCT01104779|592872095|FG001|Overall Study|Protocol Violation|2|||
164139384|NCT01104779|592872096|FG002|Overall Study|Protocol Violation|2|||
164139385|NCT01104779|592872094|FG000|Overall Study|Lack of Efficacy|26|||
164139386|NCT01104779|592872095|FG001|Overall Study|Lack of Efficacy|12|||
164139387|NCT01104779|592872096|FG002|Overall Study|Lack of Efficacy|13|||
164139388|NCT01104779|592872094|FG000|Overall Study|Adverse Event|13|||
164139389|NCT01104779|592872095|FG001|Overall Study|Adverse Event|14|||
164139390|NCT01104779|592872096|FG002|Overall Study|Adverse Event|13|||
164139391|NCT01104779|592872094|FG000|Overall Study|Did not meet inc/exc criteria|1|||
164139392|NCT01104779|592872095|FG001|Overall Study|Did not meet inc/exc criteria|1|||
164139393|NCT01104779|592872096|FG002|Overall Study|Did not meet inc/exc criteria|1|||
164139394|NCT01104779|592872094|FG000|Overall Study|Other reasons|0|||
164139395|NCT01104779|592872095|FG001|Overall Study|Other reasons|1|||
164139396|NCT01104779|592872096|FG002|Overall Study|Other reasons|0|||
164139397|NCT01104779|592872094|FG000|Overall Study|Lost to Follow-up|2|||
164139398|NCT01104779|592872095|FG001|Overall Study|Lost to Follow-up|0|||
164139399|NCT01104779|592872096|FG002|Overall Study|Lost to Follow-up|1|||
164139400|NCT01104779|592872094|FG000|Overall Study|Withdrawal by Subject|16|||
164139401|NCT01104779|592872095|FG001|Overall Study|Withdrawal by Subject|25|||
164139402|NCT01104779|592872096|FG002|Overall Study|Withdrawal by Subject|32|||
164139403|NCT01372774|592872098|FG000|Overall Study|Withdrawal prior to treatment|4|||
164139404|NCT01372774|592872099|FG001|Overall Study|Withdrawal prior to treatment|5|||
164139405|NCT00871741|592872100|FG000|Overall Study|Premature study termination|9|||
164139406|NCT00871741|592872101|FG001|Overall Study|Premature study termination|7|||
164139407|NCT01565850|592872102|FG000|Overall Study|Adverse Event|0|||
164139408|NCT01565850|592872103|FG001|Overall Study|Adverse Event|1|||
164139409|NCT01565850|592872102|FG000|Overall Study|Lost to Follow-up|12|||
164139410|NCT01565850|592872103|FG001|Overall Study|Lost to Follow-up|4|||
164139411|NCT01565850|592872102|FG000|Overall Study|Investigator's Discretion|2|||
164139412|NCT01565850|592872103|FG001|Overall Study|Investigator's Discretion|1|||
164139413|NCT01565850|592872102|FG000|Overall Study|Participant noncompliance|2|||
164139414|NCT01565850|592872103|FG001|Overall Study|Participant noncompliance|0|||
164139415|NCT01565850|592872102|FG000|Overall Study|Withdrew Consent|4|||
164139416|NCT01565850|592872103|FG001|Overall Study|Withdrew Consent|2|||
164139417|NCT04324073|592874036|FG000|Overall Study|withdrew consent|0|||
164139418|NCT04324073|592874037|FG001|Overall Study|withdrew consent|4|||
164139419|NCT04324073|592874038|FG002|Overall Study|withdrew consent|2|||
164139420|NCT04324073|592874039|FG003|Overall Study|withdrew consent|8|||
164139421|NCT03665441|592874040|FG000|Overall Study|survival follow up ongoing|23|||
164139422|NCT03665441|592874041|FG001|Overall Study|survival follow up ongoing|0|||
164139423|NCT03665441|592874040|FG000|Overall Study|Patients ongoing on treatment|9|||
164139424|NCT03665441|592874041|FG001|Overall Study|Patients ongoing on treatment|6|||
164139425|NCT03665441|592874040|FG000|Overall Study|Randomized but not treated|7|||
164139426|NCT03665441|592874041|FG001|Overall Study|Randomized but not treated|11|||
164139427|NCT03610516|592874042|FG000|Treatment Epoch|Adverse Event|3|||
164139428|NCT03610516|592874043|FG001|Treatment Epoch|Adverse Event|1|||
164139429|NCT03610516|592874042|FG000|Treatment Epoch|Death|1|||
164139430|NCT03610516|592874043|FG001|Treatment Epoch|Death|0|||
164139431|NCT03610516|592874042|FG000|Treatment Epoch|Lack of Efficacy|0|||
164139432|NCT03610516|592874043|FG001|Treatment Epoch|Lack of Efficacy|1|||
164139433|NCT03610516|592874042|FG000|Treatment Epoch|No longer requires treatment|1|||
164139434|NCT03610516|592874043|FG001|Treatment Epoch|No longer requires treatment|0|||
164139435|NCT03610516|592874042|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
164139436|NCT03610516|592874043|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
164139437|NCT03610516|592874042|FG000|Treatment Epoch|Physician Decision|8|||
164139438|NCT03610516|592874043|FG001|Treatment Epoch|Physician Decision|5|||
164139439|NCT03610516|592874042|FG000|Treatment Epoch|Protocol Deviation|1|||
164139440|NCT03610516|592874043|FG001|Treatment Epoch|Protocol Deviation|0|||
164139441|NCT03610516|592874042|FG000|Treatment Epoch|Withdrawal by Subject|3|||
164139442|NCT03610516|592874043|FG001|Treatment Epoch|Withdrawal by Subject|1|||
164139443|NCT03610516|592874042|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
164139444|NCT03610516|592874043|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
164139445|NCT03610516|592874042|FG000|Post-Treatment Follow-up|Death|1|||
164139446|NCT03610516|592874043|FG001|Post-Treatment Follow-up|Death|0|||
164139447|NCT02886624|592874044|FG000|12-week Post Treatment Follow-up|Death|1|||
164139448|NCT02886624|592874044|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
164139449|NCT00359801|592874049|FG000|Overall Study|Lost to Follow-up|72|||
164139450|NCT00359801|592874050|FG001|Overall Study|Lost to Follow-up|58|||
164139451|NCT00359801|592874049|FG000|Overall Study|Withdrawal by Subject|143|||
164139452|NCT00359801|592874050|FG001|Overall Study|Withdrawal by Subject|96|||
164139453|NCT00359801|592874049|FG000|Overall Study|Other|66|||
164139454|NCT00359801|592874050|FG001|Overall Study|Other|46|||
164139455|NCT00359801|592874049|FG000|Overall Study|Final Status Unknown: missing data|7|||
164139456|NCT00359801|592874050|FG001|Overall Study|Final Status Unknown: missing data|4|||
164139457|NCT00359801|592874049|FG000|Overall Study|Sponsor Decision|17|||
164139507|NCT01056289|592874068|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
164139508|NCT01056289|592874069|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
164139509|NCT01056289|592874070|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
164139510|NCT01056289|592874067|FG000|Double-blind Phase|Adverse Event|0|||
164139511|NCT01056289|592874068|FG001|Double-blind Phase|Adverse Event|1|||
164139512|NCT01056289|592874069|FG002|Double-blind Phase|Adverse Event|2|||
164139513|NCT01056289|592874070|FG003|Double-blind Phase|Adverse Event|1|||
164139514|NCT01056289|592874067|FG000|Double-blind Phase|Lost to Follow-up|0|||
164139515|NCT01056289|592874068|FG001|Double-blind Phase|Lost to Follow-up|2|||
164139516|NCT01056289|592874069|FG002|Double-blind Phase|Lost to Follow-up|2|||
164139517|NCT01056289|592874070|FG003|Double-blind Phase|Lost to Follow-up|2|||
164139518|NCT01056289|592874067|FG000|Double-blind Phase|Other|0|||
164139519|NCT01056289|592874068|FG001|Double-blind Phase|Other|0|||
164139520|NCT01056289|592874069|FG002|Double-blind Phase|Other|1|||
164139521|NCT01056289|592874070|FG003|Double-blind Phase|Other|2|||
164139522|NCT01056289|592874067|FG000|Double-blind Phase|Protocol Violation|0|||
164139523|NCT01056289|592874068|FG001|Double-blind Phase|Protocol Violation|0|||
164139524|NCT01056289|592874069|FG002|Double-blind Phase|Protocol Violation|1|||
164139525|NCT01056289|592874070|FG003|Double-blind Phase|Protocol Violation|1|||
164139526|NCT01056289|592874067|FG000|Double-blind Phase|Withdrawal by Subject|0|||
164139527|NCT01056289|592874068|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164139528|NCT01056289|592874069|FG002|Double-blind Phase|Withdrawal by Subject|4|||
164139529|NCT01056289|592874070|FG003|Double-blind Phase|Withdrawal by Subject|2|||
164139530|NCT01056289|592874067|FG000|Double-blind Phase|Discontinuation symptom|0|||
164139531|NCT01056289|592874068|FG001|Double-blind Phase|Discontinuation symptom|1|||
164139532|NCT01056289|592874069|FG002|Double-blind Phase|Discontinuation symptom|2|||
164139533|NCT01056289|592874070|FG003|Double-blind Phase|Discontinuation symptom|2|||
164139534|NCT01056289|592874067|FG000|Double-blind Phase|Physician Decision|0|||
164139535|NCT01056289|592874068|FG001|Double-blind Phase|Physician Decision|0|||
164139536|NCT01056289|592874069|FG002|Double-blind Phase|Physician Decision|1|||
164139537|NCT01056289|592874070|FG003|Double-blind Phase|Physician Decision|0|||
164139538|NCT00459043|592874077|FG000|Overall Study|Withdrawal by Subject|1|||
164139539|NCT00459043|592874078|FG001|Overall Study|Withdrawal by Subject|0|||
164139540|NCT00270855|592874081|FG000|Overall Study|Withdrawal by Subject|8|||
164139541|NCT00270855|592874082|FG001|Overall Study|Withdrawal by Subject|8|||
164139542|NCT01396512|592874088|FG000|Overall Study|Withdrawal by Subject|0|||
164139543|NCT01396512|592874089|FG001|Overall Study|Withdrawal by Subject|1|||
164139544|NCT02500043|592874096|FG000|Overall Study|Randomized, but not Treated|2|||
164139545|NCT02500043|592874097|FG001|Overall Study|Randomized, but not Treated|2|||
164139546|NCT02500043|592874096|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
164139547|NCT02500043|592874097|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
164139548|NCT02500043|592874096|FG000|Overall Study|Adverse Event|33|||
164139549|NCT02500043|592874097|FG001|Overall Study|Adverse Event|11|||
164139550|NCT02500043|592874096|FG000|Overall Study|Clinical Progression|54|||
164139551|NCT02500043|592874097|FG001|Overall Study|Clinical Progression|35|||
164139552|NCT02500043|592874096|FG000|Overall Study|Radiological Progression|192|||
164139553|NCT02500043|592874097|FG001|Overall Study|Radiological Progression|110|||
164139554|NCT02500043|592874096|FG000|Overall Study|Physician's Decision|11|||
164139555|NCT02500043|592874097|FG001|Overall Study|Physician's Decision|3|||
164139556|NCT02500043|592874096|FG000|Overall Study|Withdrawal by Subject|14|||
164139557|NCT02500043|592874097|FG001|Overall Study|Withdrawal by Subject|4|||
164139558|NCT02500043|592874096|FG000|Overall Study|Death|11|||
164139559|NCT02500043|592874097|FG001|Overall Study|Death|2|||
164139560|NCT02500043|592874096|FG000|Overall Study|Protocol Deviation|1|||
164139561|NCT02500043|592874097|FG001|Overall Study|Protocol Deviation|0|||
164139562|NCT00580788|592874098|FG000|Overall Study|Adverse Event|0|||
164139563|NCT00580788|592874099|FG001|Overall Study|Adverse Event|0|||
164139564|NCT00580788|592874100|FG002|Overall Study|Adverse Event|0|||
164139565|NCT00580788|592874101|FG003|Overall Study|Adverse Event|1|||
164139566|NCT01403051|592874102|FG000|Overall Study|Protocol Violation|2|||
164139567|NCT01403051|592874103|FG001|Overall Study|Protocol Violation|0|||
164139568|NCT01403051|592874102|FG000|Overall Study|Death|1|||
164139569|NCT01403051|592874103|FG001|Overall Study|Death|0|||
164139570|NCT01403051|592874102|FG000|Overall Study|Withdrawal by Subject|2|||
164139571|NCT01403051|592874103|FG001|Overall Study|Withdrawal by Subject|1|||
164139572|NCT01403051|592874102|FG000|Overall Study|Lost to Follow-up|5|||
164139573|NCT01403051|592874103|FG001|Overall Study|Lost to Follow-up|5|||
164139574|NCT05776862|592874110|FG000|Overall Study|Adverse Event|0|||
164139575|NCT05776862|592874111|FG001|Overall Study|Adverse Event|1|||
164139576|NCT05776862|592874110|FG000|Overall Study|non-compliance|1|||
164139577|NCT05776862|592874111|FG001|Overall Study|non-compliance|0|||
164139578|NCT01635218|592874112|FG000|Overall Study|Lost to Follow-up|3|||
164139579|NCT01635218|592874113|FG001|Overall Study|Lost to Follow-up|7|||
164139580|NCT01635218|592874114|FG002|Overall Study|Lost to Follow-up|6|||
164139581|NCT03262038|592874115|FG000|Overall Study|Withdrawal by Subject|0|||
164139582|NCT03262038|592874116|FG001|Overall Study|Withdrawal by Subject|1|||
164139583|NCT03323437|592874117|FG000|Overall Study|Withdrawal by Subject|0|||
164139584|NCT03323437|592874118|FG001|Overall Study|Withdrawal by Subject|4|||
164139585|NCT00282919|592874119|FG000|Overall Study|Lack of Efficacy|4|||
164139586|NCT00282919|592874119|FG000|Overall Study|Withdrawal by Subject|1|||
164139587|NCT00282919|592874119|FG000|Overall Study|Asymptomatic Parasitemia|2|||
164139588|NCT00168818|592874124|FG000|Overall Study|Adverse Event|23|||
164139589|NCT00168818|592874125|FG001|Overall Study|Adverse Event|29|||
164139590|NCT00168818|592874126|FG002|Overall Study|Adverse Event|31|||
164139591|NCT00168818|592874124|FG000|Overall Study|Protocol Violation|16|||
164139592|NCT00168818|592874125|FG001|Overall Study|Protocol Violation|11|||
164139593|NCT00168818|592874126|FG002|Overall Study|Protocol Violation|11|||
164139594|NCT00168818|592874124|FG000|Overall Study|Lost to Follow-up|13|||
164139595|NCT00168818|592874125|FG001|Overall Study|Lost to Follow-up|4|||
164139596|NCT00168818|592874126|FG002|Overall Study|Lost to Follow-up|15|||
164139597|NCT00168818|592874124|FG000|Overall Study|Withdrawal by Subject|43|||
164139598|NCT00168818|592874125|FG001|Overall Study|Withdrawal by Subject|41|||
164139599|NCT00168818|592874126|FG002|Overall Study|Withdrawal by Subject|37|||
164139600|NCT00168818|592874124|FG000|Overall Study|Other|22|||
164139601|NCT00168818|592874125|FG001|Overall Study|Other|24|||
164139602|NCT00168818|592874126|FG002|Overall Study|Other|30|||
164139603|NCT00168818|592874124|FG000|Treatment|Adverse Event|77|||
164139604|NCT00168818|592874125|FG001|Treatment|Adverse Event|89|||
164139605|NCT00168818|592874126|FG002|Treatment|Adverse Event|68|||
164139606|NCT00168818|592874124|FG000|Treatment|Protocol Violation|8|||
164139607|NCT00168818|592874125|FG001|Treatment|Protocol Violation|11|||
164139608|NCT00168818|592874126|FG002|Treatment|Protocol Violation|11|||
164139609|NCT00168818|592874124|FG000|Treatment|Lost to Follow-up|0|||
164139610|NCT00168818|592874125|FG001|Treatment|Lost to Follow-up|2|||
164139611|NCT00168818|592874126|FG002|Treatment|Lost to Follow-up|1|||
164139612|NCT00168818|592874124|FG000|Treatment|Withdrawal by Subject|25|||
164139613|NCT00168818|592874125|FG001|Treatment|Withdrawal by Subject|20|||
164139614|NCT00168818|592874126|FG002|Treatment|Withdrawal by Subject|22|||
164139615|NCT00168818|592874124|FG000|Treatment|Other|23|||
164139616|NCT00168818|592874125|FG001|Treatment|Other|29|||
164139617|NCT00168818|592874126|FG002|Treatment|Other|31|||
164139618|NCT01994291|592874127|FG000|Overall Study|Adverse Event|4|||
164139619|NCT01994291|592874128|FG001|Overall Study|Adverse Event|1|||
164139620|NCT01994291|592874129|FG002|Overall Study|Adverse Event|3|||
164139621|NCT01994291|592874127|FG000|Overall Study|Lost to Follow-up|1|||
164139622|NCT01994291|592874128|FG001|Overall Study|Lost to Follow-up|1|||
164139623|NCT01994291|592874129|FG002|Overall Study|Lost to Follow-up|0|||
164139624|NCT01994291|592874127|FG000|Overall Study|Does not meet entrance criteria|1|||
164139625|NCT01994291|592874128|FG001|Overall Study|Does not meet entrance criteria|0|||
164139626|NCT01994291|592874129|FG002|Overall Study|Does not meet entrance criteria|0|||
164139627|NCT01994291|592874127|FG000|Overall Study|Medication error without associated AE|1|||
164139628|NCT01994291|592874128|FG001|Overall Study|Medication error without associated AE|0|||
164139629|NCT01994291|592874129|FG002|Overall Study|Medication error without associated AE|1|||
164139630|NCT01994291|592874127|FG000|Overall Study|Protocol Violation|1|||
164139631|NCT01994291|592874128|FG001|Overall Study|Protocol Violation|0|||
164139632|NCT01994291|592874129|FG002|Overall Study|Protocol Violation|0|||
164139633|NCT01994291|592874127|FG000|Overall Study|Withdrawal by Subject|6|||
164139634|NCT01994291|592874128|FG001|Overall Study|Withdrawal by Subject|3|||
164139635|NCT01994291|592874129|FG002|Overall Study|Withdrawal by Subject|5|||
164139636|NCT01994291|592874127|FG000|Overall Study|Other|1|||
164139637|NCT01994291|592874128|FG001|Overall Study|Other|2|||
164139638|NCT01994291|592874129|FG002|Overall Study|Other|0|||
164139639|NCT01775189|592874130|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164139640|NCT01775189|592874131|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
164139641|NCT01775189|592874132|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164139642|NCT01775189|592874133|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164139643|NCT01775189|592874134|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164139644|NCT01775189|592874135|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164139645|NCT01775189|592874136|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164139646|NCT01775189|592874130|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164139647|NCT01775189|592874131|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
164139648|NCT01775189|592874132|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164139649|NCT01775189|592874133|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164139650|NCT01775189|592874134|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164139651|NCT01775189|592874135|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164139652|NCT01775189|592874136|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164139653|NCT01775189|592874130|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164139654|NCT01775189|592874131|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
164139655|NCT01775189|592874132|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
164139656|NCT01775189|592874133|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164139657|NCT01775189|592874134|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164139658|NCT01775189|592874135|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164139733|NCT03155945|592874169|FG000|Overall Study|Other Reason|0|||
164139659|NCT01775189|592874136|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
164139660|NCT01775189|592874130|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164139661|NCT01775189|592874131|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164139662|NCT01775189|592874132|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164139663|NCT01775189|592874133|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164139664|NCT01775189|592874134|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164139665|NCT01775189|592874135|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
164139666|NCT01775189|592874136|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
164139667|NCT01775189|592874130|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164139668|NCT01775189|592874131|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164139669|NCT01775189|592874132|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164139670|NCT01775189|592874133|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
164139671|NCT01775189|592874134|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164139672|NCT01775189|592874135|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164139673|NCT01775189|592874136|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
164139674|NCT01775189|592874130|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164139675|NCT01775189|592874131|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164139676|NCT01775189|592874132|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164139677|NCT01775189|592874133|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
164139678|NCT01775189|592874134|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164139679|NCT01775189|592874135|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
164139680|NCT01775189|592874136|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
164139681|NCT02227446|592874137|FG000|Overall Study|not eligible post randomization|18|||
164139682|NCT02227446|592874138|FG001|Overall Study|not eligible post randomization|29|||
164139683|NCT02227446|592874137|FG000|Overall Study|Withdrawal by Subject|4|||
164139684|NCT02227446|592874138|FG001|Overall Study|Withdrawal by Subject|5|||
164139685|NCT02368314|592874145|FG000|Overall Study|Withdrawal by Subject|2|||
164139686|NCT02368314|592874146|FG001|Overall Study|Withdrawal by Subject|1|||
164139687|NCT02368314|592874145|FG000|Overall Study|Adverse Event|1|||
164139688|NCT02368314|592874146|FG001|Overall Study|Adverse Event|2|||
164139689|NCT00369317|592874147|FG000|Overall Study|Adverse Event|3|||
164139690|NCT00369317|592874147|FG000|Overall Study|Death|1|||
164139691|NCT00369317|592874147|FG000|Overall Study|Lack of Efficacy|5|||
164139692|NCT00369317|592874147|FG000|Overall Study|Physician Decision|2|||
164139693|NCT00369317|592874147|FG000|Overall Study|Withdrawal by Subject|8|||
164139694|NCT00369317|592874147|FG000|Overall Study|Ineligible|1|||
164139695|NCT02722148|592874153|FG000|Overall Study|Lost to Follow-up|2|||
164139696|NCT02722148|592874153|FG000|Overall Study|Non compliant with treatment regimen|3|||
164139697|NCT01458106|592874154|FG000|Overall Study|Withdrawal by Subject|2|||
164139698|NCT01458106|592874155|FG001|Overall Study|Withdrawal by Subject|0|||
164139699|NCT01458106|592874154|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
164139700|NCT01458106|592874155|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
164139701|NCT01458106|592874154|FG000|Overall Study|Withdrawn Per Protocol|0|||
164139702|NCT01458106|592874155|FG001|Overall Study|Withdrawn Per Protocol|1|||
164139703|NCT00073021|592874156|FG000|Overall Study|Protocol Violation|2|||
164139704|NCT00073021|592874157|FG001|Overall Study|Protocol Violation|1|||
164139705|NCT00073021|592874156|FG000|Overall Study|Adverse Event|4|||
164139706|NCT00073021|592874157|FG001|Overall Study|Adverse Event|4|||
164139707|NCT00073021|592874156|FG000|Overall Study|Withdrawal by Subject|6|||
164139708|NCT00073021|592874157|FG001|Overall Study|Withdrawal by Subject|5|||
164139709|NCT00073021|592874156|FG000|Overall Study|Physician Decision|3|||
164139710|NCT00073021|592874157|FG001|Overall Study|Physician Decision|1|||
164139711|NCT00073021|592874156|FG000|Overall Study|Lack of Efficacy|11|||
164139712|NCT00073021|592874157|FG001|Overall Study|Lack of Efficacy|5|||
164139713|NCT01425723|592874158|FG000|Overall Study|Lack of Efficacy|0|||
164139714|NCT01425723|592874159|FG001|Overall Study|Lack of Efficacy|1|||
164139715|NCT01425723|592874158|FG000|Overall Study|Withdrawal by Subject|1|||
164139716|NCT01425723|592874159|FG001|Overall Study|Withdrawal by Subject|4|||
164139717|NCT01425723|592874158|FG000|Overall Study|Lost to Follow-up|0|||
164139718|NCT01425723|592874159|FG001|Overall Study|Lost to Follow-up|3|||
164139719|NCT01425723|592874158|FG000|Overall Study|Physician Decision|2|||
164139720|NCT01425723|592874159|FG001|Overall Study|Physician Decision|0|||
164139721|NCT01425723|592874158|FG000|Overall Study|Other|1|||
164139722|NCT01425723|592874159|FG001|Overall Study|Other|10|||
164139723|NCT04428333|592874163|FG000|Overall Study|Physician Decision|5|||
164139724|NCT04428333|592874164|FG001|Overall Study|Physician Decision|6|||
164139725|NCT04428333|592874163|FG000|Overall Study|Withdrawal by Subject|1|||
164139726|NCT04428333|592874164|FG001|Overall Study|Withdrawal by Subject|3|||
164139727|NCT04428333|592874163|FG000|Overall Study|Study Terminated By Sponsor|14|||
164139728|NCT04428333|592874164|FG001|Overall Study|Study Terminated By Sponsor|16|||
164139729|NCT03155945|592874169|FG000|Overall Study|Lost to Follow-up|0|||
164139730|NCT03155945|592874170|FG001|Overall Study|Lost to Follow-up|1|||
164139731|NCT03155945|592874169|FG000|Overall Study|Withdrawal by Subject|0|||
164139732|NCT03155945|592874170|FG001|Overall Study|Withdrawal by Subject|1|||
164139753|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
164139754|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
164139755|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
164139756|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139757|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139758|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139759|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139760|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139761|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139762|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139763|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139764|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139765|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139766|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139767|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
164139768|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
164139769|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
164139770|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139771|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139772|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139773|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139774|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139775|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139776|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139777|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139778|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139779|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139780|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139781|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
164139782|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
164139783|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
164139784|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139785|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139786|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139787|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139788|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139789|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139790|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139791|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139792|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139793|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139794|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139795|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
164139796|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
164139797|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
164139798|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139799|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139800|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139801|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139802|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139803|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139804|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139805|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139806|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139807|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139808|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139809|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
164139810|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
164139811|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
164139812|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139813|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139814|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139815|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139816|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139817|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139818|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139819|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139820|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139821|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139822|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139823|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
164139824|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
164139825|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
164139826|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139827|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139828|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139829|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139830|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139831|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139832|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139833|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139834|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139835|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139836|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139837|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
164139838|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
164139839|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
164139840|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139841|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139842|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139843|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139844|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139845|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139846|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139847|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139848|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139849|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139850|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139851|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
164139852|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
164139853|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
164139854|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139855|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139856|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139857|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139858|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139859|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139860|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139861|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139862|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139863|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139864|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139865|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
164139866|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
164139867|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
164139868|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139869|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139870|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139871|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139872|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139873|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139874|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139875|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139876|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139877|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139878|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139879|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
164139880|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
164139881|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
164139882|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139883|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139884|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139885|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139886|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139887|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139888|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139889|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139890|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139891|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139892|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139893|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
164139894|NCT03982199|592874176|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
164139895|NCT03982199|592874177|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
164139896|NCT03982199|592874178|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139897|NCT03982199|592874179|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139898|NCT03982199|592874180|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139899|NCT03982199|592874181|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139900|NCT03982199|592874182|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139901|NCT03982199|592874183|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139902|NCT03982199|592874184|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139903|NCT03982199|592874185|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139904|NCT03982199|592874186|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139905|NCT03982199|592874187|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139906|NCT03982199|592874188|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139907|NCT03982199|592874189|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
164139908|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139909|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139910|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139911|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
164139912|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139913|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139914|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139915|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139916|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139917|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139918|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139919|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139920|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139921|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
164139922|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139923|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139924|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
164139925|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139926|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139927|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139928|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139929|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139930|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139931|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139932|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139933|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139934|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139935|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
164139936|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139937|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139938|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
164139939|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139940|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139941|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139942|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139943|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139944|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139945|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139946|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139947|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139948|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139949|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
164139950|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139951|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139952|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
164139953|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
164139954|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139955|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139956|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139957|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139958|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139959|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139960|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139961|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139962|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139963|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
164139964|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139965|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139966|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139967|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
164139968|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139969|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139970|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139971|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139972|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139973|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139974|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139975|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139976|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139977|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
164139978|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139979|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139980|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
164139981|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
164139982|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139983|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139984|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139985|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139986|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139987|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139988|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139989|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139990|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139991|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
164139992|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139993|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139994|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139995|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139996|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139997|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139998|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164139999|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164140000|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
164140001|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164140002|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164140003|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164140004|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164140005|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
164140006|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140007|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140008|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140009|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140010|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140011|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140012|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140076|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140013|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140014|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
164140015|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140016|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140017|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140018|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140019|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
164140020|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140021|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140022|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140023|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140024|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140025|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140026|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140027|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140028|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
164140029|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140030|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140031|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140032|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140033|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
164140034|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140035|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140036|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140037|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140038|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140039|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140040|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140041|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140042|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
164140043|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140044|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140045|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140046|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140047|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
164140048|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140049|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140050|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140051|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140052|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140053|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140054|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140055|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140056|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
164140057|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140058|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140059|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140060|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140061|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
164140062|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140063|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140064|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140065|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140066|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140067|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
164140068|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140069|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
164140070|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
164140071|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140072|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140073|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140074|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140075|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
164140077|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140078|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140079|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140080|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140081|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140082|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140083|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140084|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
164140085|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140086|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140087|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140088|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140089|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
164140090|NCT03982199|592874176|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140091|NCT03982199|592874177|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140092|NCT03982199|592874178|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140093|NCT03982199|592874179|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140094|NCT03982199|592874180|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140095|NCT03982199|592874181|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
164140096|NCT03982199|592874182|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140097|NCT03982199|592874183|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
164140098|NCT03982199|592874184|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
164140099|NCT03982199|592874185|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140100|NCT03982199|592874186|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140101|NCT03982199|592874187|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140102|NCT03982199|592874188|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140103|NCT03982199|592874189|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
164140104|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140105|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140106|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140107|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140108|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140109|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140110|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140111|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140112|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
164140113|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
164140114|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
164140115|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
164140116|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
164140117|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
164140118|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140119|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140120|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140121|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140122|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140123|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140124|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140125|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140126|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140127|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
164140128|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140129|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140130|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140131|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
164140132|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140133|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140134|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140135|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140136|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140279|NCT00402116|592876011|FG000|Overall Study|Adverse Event|0|||
164140137|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140138|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140139|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140140|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140141|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140142|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140143|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140144|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
164140145|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
164140146|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140147|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140148|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140149|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140150|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140151|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140152|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140153|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140154|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140155|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140156|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
164140157|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
164140158|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
164140159|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
164140160|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140161|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140162|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140163|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140164|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140165|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140166|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140167|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140168|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140169|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140170|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140171|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140172|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
164140173|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
164140174|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140175|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140176|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140177|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140178|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140179|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140180|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140181|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140182|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140183|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140184|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140185|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
164140186|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
164140187|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
164140188|NCT03982199|592874176|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140189|NCT03982199|592874177|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140190|NCT03982199|592874178|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140191|NCT03982199|592874179|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140192|NCT03982199|592874180|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140193|NCT03982199|592874181|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140194|NCT03982199|592874182|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140195|NCT03982199|592874183|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140196|NCT03982199|592874184|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140197|NCT03982199|592874185|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140198|NCT03982199|592874186|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140199|NCT03982199|592874187|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140200|NCT03982199|592874188|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
164140201|NCT03982199|592874189|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
164140202|NCT03433755|592874190|FG000|Overall Study|Lost to Follow-up|1|||
164140203|NCT03433755|592874191|FG001|Overall Study|Lost to Follow-up|0|||
164140204|NCT03433755|592874192|FG002|Overall Study|Lost to Follow-up|0|||
164140205|NCT03433755|592874193|FG003|Overall Study|Lost to Follow-up|0|||
164140206|NCT03433755|592874190|FG000|Overall Study|Decision by Sponsor|1|||
164140207|NCT03433755|592874191|FG001|Overall Study|Decision by Sponsor|0|||
164140208|NCT03433755|592874192|FG002|Overall Study|Decision by Sponsor|0|||
164140209|NCT03433755|592874193|FG003|Overall Study|Decision by Sponsor|0|||
164140210|NCT05065567|592874195|FG000|Overall Study|Lost to Follow-up|10|||
164140211|NCT05065567|592874196|FG001|Overall Study|Lost to Follow-up|9|||
164140212|NCT05065567|592874197|FG002|Overall Study|Lost to Follow-up|6|||
164140213|NCT05323123|592874198|FG000|Overall Study|Withdrawal by Subject|2|||
164140214|NCT05323123|592874199|FG001|Overall Study|Withdrawal by Subject|1|||
164140215|NCT05323123|592874198|FG000|Overall Study|Lost to Follow-up|4|||
164140216|NCT05323123|592874199|FG001|Overall Study|Lost to Follow-up|2|||
164140217|NCT05323123|592874198|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
164140218|NCT05323123|592874199|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
164140219|NCT05529472|592874200|FG000|Overall Study|Withdrawal by Subject|1|||
164140220|NCT05529472|592874201|FG001|Overall Study|Withdrawal by Subject|1|||
164140221|NCT03408639|592875982|FG000|Overall Study|Death|5|||
164140222|NCT03408639|592875983|FG001|Overall Study|Death|5|||
164140223|NCT03408639|592875982|FG000|Overall Study|Lost to Follow-up|1|||
164140224|NCT03408639|592875983|FG001|Overall Study|Lost to Follow-up|4|||
164140225|NCT03408639|592875982|FG000|Overall Study|Withdrawal by Subject|2|||
164140226|NCT03408639|592875983|FG001|Overall Study|Withdrawal by Subject|7|||
164140227|NCT03408639|592875982|FG000|Overall Study|Physician Decision|3|||
164140228|NCT03408639|592875983|FG001|Overall Study|Physician Decision|6|||
164140229|NCT00213135|592875993|FG000|Overall Study|Adverse Event|9|||
164140230|NCT00213135|592875994|FG001|Overall Study|Adverse Event|5|||
164140231|NCT00213135|592875995|FG002|Overall Study|Adverse Event|5|||
164140232|NCT00213135|592875993|FG000|Overall Study|Lost to Follow-up|11|||
164140233|NCT00213135|592875994|FG001|Overall Study|Lost to Follow-up|8|||
164140234|NCT00213135|592875995|FG002|Overall Study|Lost to Follow-up|4|||
164140235|NCT00213135|592875993|FG000|Overall Study|Protocol Violation|4|||
164140236|NCT00213135|592875994|FG001|Overall Study|Protocol Violation|4|||
164140237|NCT00213135|592875995|FG002|Overall Study|Protocol Violation|10|||
164140238|NCT00213135|592875993|FG000|Overall Study|Death|1|||
164140239|NCT00213135|592875994|FG001|Overall Study|Death|1|||
164140240|NCT00213135|592875995|FG002|Overall Study|Death|2|||
164140241|NCT00213135|592875993|FG000|Overall Study|Disease progression|4|||
164140242|NCT00213135|592875994|FG001|Overall Study|Disease progression|5|||
164140243|NCT00213135|592875995|FG002|Overall Study|Disease progression|21|||
164140244|NCT00213135|592875993|FG000|Overall Study|Other|21|||
164140245|NCT00213135|592875994|FG001|Overall Study|Other|12|||
164140246|NCT00213135|592875995|FG002|Overall Study|Other|15|||
164140247|NCT01924754|592876000|FG000|Overall Study|Lost to Follow-up|1|||
164140248|NCT01924754|592876001|FG001|Overall Study|Lost to Follow-up|2|||
164140249|NCT01924754|592876002|FG002|Overall Study|Lost to Follow-up|1|||
164140250|NCT01924754|592876000|FG000|Overall Study|Pregnancy|0|||
164140251|NCT01924754|592876001|FG001|Overall Study|Pregnancy|1|||
164140252|NCT01924754|592876002|FG002|Overall Study|Pregnancy|2|||
164140253|NCT03132155|592876003|FG000|Overall Study|Lack of Efficacy|6|||
164140254|NCT03132155|592876003|FG000|Overall Study|Lost to Follow-up|1|||
164140255|NCT03132155|592876003|FG000|Overall Study|Withdrawal by Subject|1|||
164140256|NCT02925403|592876009|FG000|Overall Study|Lost to Follow-up|0|||
164140257|NCT02925403|592876010|FG001|Overall Study|Lost to Follow-up|1|||
164140258|NCT00402116|592876011|FG000|Overall Study|Jaw infection after surgery-other|1|||
164140259|NCT00402116|592876012|FG001|Overall Study|Jaw infection after surgery-other|0|||
164140260|NCT00402116|592876013|FG002|Overall Study|Jaw infection after surgery-other|0|||
164140261|NCT00402116|592876011|FG000|Overall Study|Withdrawal by Subject|1|||
164140262|NCT00402116|592876012|FG001|Overall Study|Withdrawal by Subject|0|||
164140263|NCT00402116|592876013|FG002|Overall Study|Withdrawal by Subject|5|||
164140264|NCT00402116|592876011|FG000|Overall Study|Treatment completed per protocol|1|||
164140265|NCT00402116|592876012|FG001|Overall Study|Treatment completed per protocol|1|||
164140266|NCT00402116|592876013|FG002|Overall Study|Treatment completed per protocol|2|||
164140267|NCT00402116|592876011|FG000|Overall Study|other complicating disease|0|||
164140268|NCT00402116|592876012|FG001|Overall Study|other complicating disease|0|||
164140269|NCT00402116|592876013|FG002|Overall Study|other complicating disease|2|||
164140270|NCT00402116|592876011|FG000|Overall Study|Disease Progression|0|||
164140271|NCT00402116|592876012|FG001|Overall Study|Disease Progression|4|||
164140272|NCT00402116|592876013|FG002|Overall Study|Disease Progression|38|||
164140273|NCT00402116|592876011|FG000|Overall Study|mistaken thrombocytopenia|0|||
164140274|NCT00402116|592876012|FG001|Overall Study|mistaken thrombocytopenia|0|||
164140275|NCT00402116|592876013|FG002|Overall Study|mistaken thrombocytopenia|1|||
164140276|NCT00402116|592876011|FG000|Overall Study|decline related hyponatremia/tumor|0|||
164140277|NCT00402116|592876012|FG001|Overall Study|decline related hyponatremia/tumor|0|||
164140278|NCT00402116|592876013|FG002|Overall Study|decline related hyponatremia/tumor|1|||
164140290|NCT03156504|592876015|FG000|Overall Study|Withdrawal by Subject|1|||
164140291|NCT00450801|592876016|FG000|Overall Study|Death|1|||
164140292|NCT05048329|592876017|FG000|Overall Study|Withdrawal by Subject|1|||
164140293|NCT05048329|592876017|FG000|Overall Study|Screenfail|1|||
164140294|NCT00324649|592876018|FG000|Overall Study|Adverse Event|1|||
164140295|NCT00324649|592876019|FG001|Overall Study|Adverse Event|4|||
164140296|NCT00324649|592876018|FG000|Overall Study|Withdrawal by Subject|0|||
164140297|NCT00324649|592876019|FG001|Overall Study|Withdrawal by Subject|1|||
164140298|NCT00324649|592876018|FG000|Overall Study|Noncompliance|1|||
164140299|NCT00324649|592876019|FG001|Overall Study|Noncompliance|0|||
164140300|NCT02618759|592876020|FG000|Overall Study|Lost to Follow-up|0|||
164140301|NCT02618759|592876021|FG001|Overall Study|Lost to Follow-up|1|||
164140302|NCT02618759|592876020|FG000|Overall Study|Withdrawal by Subject|1|||
164140303|NCT02618759|592876021|FG001|Overall Study|Withdrawal by Subject|0|||
164140304|NCT02618759|592876020|FG000|Overall Study|Other Reasons|1|||
164140305|NCT02618759|592876021|FG001|Overall Study|Other Reasons|4|||
164140306|NCT03301649|592876022|FG000|Overall Study|Need alternate therapy due to live lice|17|||
164140307|NCT03301649|592876023|FG001|Overall Study|Need alternate therapy due to live lice|25|||
164140308|NCT03301649|592876024|FG002|Overall Study|Need alternate therapy due to live lice|81|||
164140309|NCT03301649|592876022|FG000|Overall Study|Lost to Follow-up|11|||
164140310|NCT03301649|592876023|FG001|Overall Study|Lost to Follow-up|11|||
164140311|NCT03301649|592876024|FG002|Overall Study|Lost to Follow-up|3|||
164140312|NCT03301649|592876022|FG000|Overall Study|Protocol Violation|0|||
164140313|NCT03301649|592876023|FG001|Overall Study|Protocol Violation|1|||
164140314|NCT03301649|592876024|FG002|Overall Study|Protocol Violation|1|||
164140315|NCT03301649|592876022|FG000|Overall Study|Withdrawal by Subject|10|||
164140316|NCT03301649|592876023|FG001|Overall Study|Withdrawal by Subject|4|||
164140317|NCT03301649|592876024|FG002|Overall Study|Withdrawal by Subject|0|||
164140318|NCT03301649|592876022|FG000|Overall Study|Other than specified|5|||
164140319|NCT03301649|592876023|FG001|Overall Study|Other than specified|3|||
164140320|NCT03301649|592876024|FG002|Overall Study|Other than specified|0|||
164140321|NCT03257865|592876026|FG000|Overall Study|Adverse Event|4|||
164140322|NCT03257865|592876027|FG001|Overall Study|Adverse Event|8|||
164140323|NCT03257865|592876026|FG000|Overall Study|Lack of Efficacy|1|||
164140324|NCT03257865|592876027|FG001|Overall Study|Lack of Efficacy|2|||
164140325|NCT03257865|592876026|FG000|Overall Study|Non-compliance with Study Drug|0|||
164140326|NCT03257865|592876027|FG001|Overall Study|Non-compliance with Study Drug|2|||
164140327|NCT03257865|592876026|FG000|Overall Study|Withdrawal by Subject|23|||
164140328|NCT03257865|592876027|FG001|Overall Study|Withdrawal by Subject|17|||
164140329|NCT03257865|592876026|FG000|Overall Study|Physician Decision|3|||
164140330|NCT03257865|592876027|FG001|Overall Study|Physician Decision|1|||
164140331|NCT03257865|592876026|FG000|Overall Study|Other|0|||
164140332|NCT03257865|592876027|FG001|Overall Study|Other|1|||
164140333|NCT03257865|592876026|FG000|Overall Study|Lost to Follow-up|4|||
164140334|NCT03257865|592876027|FG001|Overall Study|Lost to Follow-up|4|||
164140335|NCT01111825|592876028|FG000|Overall Study|Withdrawal by Subject|0|||
164140336|NCT01111825|592876029|FG001|Overall Study|Withdrawal by Subject|0|||
164140337|NCT01111825|592876030|FG002|Overall Study|Withdrawal by Subject|1|||
164140338|NCT01111825|592876031|FG003|Overall Study|Withdrawal by Subject|0|||
164140339|NCT01111825|592876028|FG000|Overall Study|Lost to Follow-up|0|||
164140340|NCT01111825|592876029|FG001|Overall Study|Lost to Follow-up|0|||
164140341|NCT01111825|592876030|FG002|Overall Study|Lost to Follow-up|3|||
164140342|NCT01111825|592876031|FG003|Overall Study|Lost to Follow-up|1|||
164140343|NCT01111825|592876028|FG000|Overall Study|Adverse Event|2|||
164140344|NCT01111825|592876029|FG001|Overall Study|Adverse Event|1|||
164140345|NCT01111825|592876030|FG002|Overall Study|Adverse Event|4|||
164140346|NCT01111825|592876031|FG003|Overall Study|Adverse Event|0|||
164140347|NCT01111825|592876028|FG000|Overall Study|Disease Progression|1|||
164140348|NCT01111825|592876029|FG001|Overall Study|Disease Progression|0|||
164140349|NCT01111825|592876030|FG002|Overall Study|Disease Progression|0|||
164140350|NCT01111825|592876031|FG003|Overall Study|Disease Progression|0|||
164140351|NCT01111825|592876028|FG000|Overall Study|Discontinuation by Sponsor|0|||
164140352|NCT01111825|592876029|FG001|Overall Study|Discontinuation by Sponsor|0|||
164140353|NCT01111825|592876030|FG002|Overall Study|Discontinuation by Sponsor|0|||
164140354|NCT01111825|592876031|FG003|Overall Study|Discontinuation by Sponsor|20|||
164140355|NCT01377987|592876032|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
164140356|NCT01377987|592876033|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
164140357|NCT00469144|592876034|FG000|Overall Study|Death|0|||
164140358|NCT00469144|592876035|FG001|Overall Study|Death|1|||
164140359|NCT00469144|592876034|FG000|Overall Study|No Response|5|||
164140360|NCT00469144|592876035|FG001|Overall Study|No Response|5|||
164140361|NCT00469144|592876034|FG000|Overall Study|Progressive Disease|1|||
164140362|NCT00469144|592876035|FG001|Overall Study|Progressive Disease|0|||
164140363|NCT02901548|592876038|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
164140364|NCT01266031|592876039|FG000|Overall Study|Not treated|0|||
164140365|NCT01266031|592876040|FG001|Overall Study|Not treated|3|||
164140366|NCT01266031|592876041|FG002|Overall Study|Not treated|2|||
164140367|NCT04893018|592876042|FG000|Overall Study|Lost to Follow-up|1|||
164140368|NCT04893018|592876043|FG001|Overall Study|Lost to Follow-up|0|||
164140369|NCT04893018|592876042|FG000|Overall Study|Withdrawal by Subject|2|||
164140370|NCT04893018|592876043|FG001|Overall Study|Withdrawal by Subject|0|||
164140371|NCT04893018|592876042|FG000|Overall Study|Study Terminated|1|||
164140372|NCT04893018|592876043|FG001|Overall Study|Study Terminated|2|||
164140373|NCT03336528|592876046|FG000|Overall Study|Protocol Violation|1|||
164140374|NCT03336528|592876047|FG001|Overall Study|Protocol Violation|1|||
164140375|NCT03336528|592876046|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
164140376|NCT03336528|592876047|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
164140377|NCT03336528|592876046|FG000|Overall Study|Did not receive study medication|1|||
164140378|NCT03336528|592876047|FG001|Overall Study|Did not receive study medication|2|||
164140379|NCT02842073|592876051|FG000|Overall Study|Withdrawal by Subject|1|||
164140380|NCT00195338|592876052|FG000|Overall Study|Lost to Follow-up|2|||
164140381|NCT00195338|592876052|FG000|Overall Study|Adverse Event|5|||
164140382|NCT00195338|592876052|FG000|Overall Study|Lack of Efficacy|1|||
164140383|NCT00195338|592876052|FG000|Overall Study|Early closure of the site|4|||
164140384|NCT02047734|592876055|FG000|Overall Study|Adverse Event|18|||
164140385|NCT02047734|592876056|FG001|Overall Study|Adverse Event|13|||
164140386|NCT02047734|592876057|FG002|Overall Study|Adverse Event|13|||
164140387|NCT02047734|592876055|FG000|Overall Study|Lack of Efficacy|4|||
164140388|NCT02047734|592876056|FG001|Overall Study|Lack of Efficacy|5|||
164140389|NCT02047734|592876057|FG002|Overall Study|Lack of Efficacy|1|||
164140390|NCT02047734|592876055|FG000|Overall Study|Protocol Violation|3|||
164140391|NCT02047734|592876056|FG001|Overall Study|Protocol Violation|1|||
164140392|NCT02047734|592876057|FG002|Overall Study|Protocol Violation|1|||
164140393|NCT02047734|592876055|FG000|Overall Study|Lost to Follow-up|1|||
164140394|NCT02047734|592876056|FG001|Overall Study|Lost to Follow-up|4|||
164140395|NCT02047734|592876057|FG002|Overall Study|Lost to Follow-up|0|||
164140396|NCT02047734|592876055|FG000|Overall Study|Death|0|||
164140397|NCT02047734|592876056|FG001|Overall Study|Death|1|||
164140398|NCT02047734|592876057|FG002|Overall Study|Death|0|||
164140399|NCT02047734|592876055|FG000|Overall Study|Withdrawal by Subject|30|||
164140400|NCT02047734|592876056|FG001|Overall Study|Withdrawal by Subject|31|||
164140401|NCT02047734|592876057|FG002|Overall Study|Withdrawal by Subject|19|||
164140402|NCT02047734|592876055|FG000|Overall Study|Physician Decision|7|||
164140403|NCT02047734|592876056|FG001|Overall Study|Physician Decision|6|||
164140404|NCT02047734|592876057|FG002|Overall Study|Physician Decision|5|||
164140405|NCT02047734|592876055|FG000|Overall Study|Miscellaneous|2|||
164140406|NCT02047734|592876056|FG001|Overall Study|Miscellaneous|4|||
164140407|NCT02047734|592876057|FG002|Overall Study|Miscellaneous|6|||
164140408|NCT02047734|592876055|FG000|Overall Study|Did Not Receive Study Drug|2|||
164140409|NCT02047734|592876056|FG001|Overall Study|Did Not Receive Study Drug|4|||
164140410|NCT02047734|592876057|FG002|Overall Study|Did Not Receive Study Drug|1|||
164140411|NCT01333397|592876058|FG000|Overall Study|Lost to Follow-up|1|||
164140412|NCT01333397|592876059|FG001|Overall Study|Lost to Follow-up|0|||
164140413|NCT01333397|592876060|FG002|Overall Study|Lost to Follow-up|0|||
164140414|NCT01333397|592876061|FG003|Overall Study|Lost to Follow-up|1|||
164140415|NCT01333397|592876062|FG004|Overall Study|Lost to Follow-up|0|||
164140416|NCT00314951|592876065|FG000|Treatment|Didn't meet criteria for mITT population|16|||
164140417|NCT00314951|592876066|FG001|Treatment|Didn't meet criteria for mITT population|11|||
164140418|NCT00314951|592876065|FG000|Follow-up|mITT failure|44|||
164140419|NCT00314951|592876066|FG001|Follow-up|mITT failure|34|||
164140420|NCT00920790|592876067|FG000|Overall Study|aggravation of general condition|14|||
164140421|NCT04411914|592876068|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
164140422|NCT04411914|592876069|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
164140423|NCT02639052|592876075|FG000|Overall Study|Lost to Follow-up|1|||
164140424|NCT02655666|592876077|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
164140425|NCT00895414|592876078|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
164140426|NCT00895414|592876079|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
164140427|NCT00895414|592876078|FG000|First Intervention (14 Days)|Physician Decision|0|||
164140428|NCT00895414|592876079|FG001|First Intervention (14 Days)|Physician Decision|1|||
164140429|NCT00789737|592876084|FG000|Overall Study|Withdrawal by Subject|13|||
164140430|NCT00789737|592876085|FG001|Overall Study|Withdrawal by Subject|22|||
164140431|NCT00789737|592876084|FG000|Overall Study|Lost to Follow-up|10|||
164140432|NCT00789737|592876085|FG001|Overall Study|Lost to Follow-up|14|||
164140433|NCT00789737|592876084|FG000|Overall Study|Adverse Event|8|||
164140434|NCT00789737|592876085|FG001|Overall Study|Adverse Event|8|||
164140435|NCT00789737|592876084|FG000|Overall Study|Protocol Violation|3|||
164140436|NCT00789737|592876085|FG001|Overall Study|Protocol Violation|0|||
164140437|NCT00789737|592876084|FG000|Overall Study|Lack of Efficacy|3|||
164140438|NCT00789737|592876085|FG001|Overall Study|Lack of Efficacy|0|||
164140439|NCT00789737|592876084|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
164140440|NCT00789737|592876085|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
164140441|NCT00789737|592876084|FG000|Overall Study|Other|11|||
164140442|NCT00789737|592876085|FG001|Overall Study|Other|7|||
164140443|NCT02458287|592876086|FG000|Overall Study|Adverse Event|0|||
164140444|NCT02458287|592876087|FG001|Overall Study|Adverse Event|0|||
164140445|NCT02458287|592876088|FG002|Overall Study|Adverse Event|0|||
164140446|NCT02458287|592876089|FG003|Overall Study|Adverse Event|1|||
164140506|NCT00642278|592876095|FG000|Overall Study|Withdrawal by Subject|1|||
164140507|NCT00642278|592876096|FG001|Overall Study|Withdrawal by Subject|1|||
164140508|NCT00642278|592876097|FG002|Overall Study|Withdrawal by Subject|1|||
164140509|NCT00642278|592876098|FG003|Overall Study|Withdrawal by Subject|3|||
164140510|NCT00642278|592876099|FG004|Overall Study|Withdrawal by Subject|6|||
164140511|NCT00642278|592876100|FG005|Overall Study|Withdrawal by Subject|2|||
164140512|NCT00642278|592876101|FG006|Overall Study|Withdrawal by Subject|2|||
164140513|NCT00642278|592876095|FG000|Overall Study|Noncompliance with study drug regimen|0|||
164140514|NCT00642278|592876096|FG001|Overall Study|Noncompliance with study drug regimen|0|||
164140515|NCT00642278|592876097|FG002|Overall Study|Noncompliance with study drug regimen|0|||
164140516|NCT00642278|592876098|FG003|Overall Study|Noncompliance with study drug regimen|1|||
164140517|NCT00642278|592876099|FG004|Overall Study|Noncompliance with study drug regimen|0|||
164140518|NCT00642278|592876100|FG005|Overall Study|Noncompliance with study drug regimen|0|||
164140519|NCT00642278|592876101|FG006|Overall Study|Noncompliance with study drug regimen|0|||
164140520|NCT00642278|592876095|FG000|Overall Study|Other|2|||
164140521|NCT00642278|592876096|FG001|Overall Study|Other|1|||
164140522|NCT00642278|592876097|FG002|Overall Study|Other|0|||
164140523|NCT00642278|592876098|FG003|Overall Study|Other|1|||
164140524|NCT00642278|592876099|FG004|Overall Study|Other|0|||
164140525|NCT00642278|592876100|FG005|Overall Study|Other|1|||
164140526|NCT00642278|592876101|FG006|Overall Study|Other|0|||
164140527|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
164140528|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164140529|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
164140530|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164140531|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164140532|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
164140533|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164140534|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164140535|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164140536|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164140537|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
164140538|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
164140539|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
164140540|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
164140541|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
164140542|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
164140543|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164140544|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164140545|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164140546|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164140547|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
164140548|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
164140549|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
164140550|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164140551|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164140552|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164140553|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164140554|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
164140555|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164140556|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
164140557|NCT03713619|592876102|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
164140558|NCT03713619|592876103|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
164140559|NCT03713619|592876104|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
164140560|NCT03713619|592876105|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
164140561|NCT03713619|592876106|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
164140562|NCT03713619|592876102|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
164140563|NCT03713619|592876103|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
164140564|NCT03713619|592876104|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
164140565|NCT03713619|592876105|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
164140566|NCT03713619|592876106|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
164140567|NCT03713619|592876102|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
164140568|NCT03713619|592876103|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164140569|NCT03713619|592876104|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164140570|NCT03713619|592876105|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
164140571|NCT03713619|592876106|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164140572|NCT03713619|592876102|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
164140573|NCT03713619|592876103|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
164140574|NCT03713619|592876104|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
164140709|NCT02092467|592876130|FG001|Overall Study|Death|66|||
164140575|NCT03713619|592876105|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
164140576|NCT03713619|592876106|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
164140577|NCT03713619|592876102|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
164140578|NCT03713619|592876103|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
164140579|NCT03713619|592876104|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
164140580|NCT03713619|592876105|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
164140581|NCT03713619|592876106|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
164140582|NCT03713619|592876102|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
164140583|NCT03713619|592876103|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
164140584|NCT03713619|592876104|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
164140585|NCT03713619|592876105|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
164140586|NCT03713619|592876106|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
164140587|NCT03713619|592876102|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164140588|NCT03713619|592876103|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
164140589|NCT03713619|592876104|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164140590|NCT03713619|592876105|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
164140591|NCT03713619|592876106|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
164140592|NCT03553576|592876107|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
164140593|NCT03553576|592876108|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
164140594|NCT03553576|592876107|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
164140595|NCT03553576|592876108|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
164140596|NCT03553576|592876107|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
164140597|NCT03553576|592876108|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
164140598|NCT03553576|592876107|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
164140599|NCT03553576|592876108|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
164140600|NCT03553576|592876107|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
164140601|NCT03553576|592876108|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
164140602|NCT03553576|592876107|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
164140603|NCT03553576|592876108|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
164140604|NCT03553576|592876107|FG000|Overall Study|Physician Decision|2|||
164140605|NCT03553576|592876108|FG001|Overall Study|Physician Decision|5|||
164140606|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
164140607|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
164140608|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
164140609|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
164140610|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
164140611|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
164140612|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
164140613|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
164140614|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
164140615|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
164140616|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
164140617|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
164140618|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
164140619|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
164140620|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
164140621|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
164140622|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
164140623|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
164140624|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
164140625|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
164140626|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
164140627|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
164140628|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
164140629|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
164140630|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
164140631|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
164140632|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
164140633|NCT02552212|592876109|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
164140634|NCT02552212|592876110|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
164140635|NCT02552212|592876111|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
164140636|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
164140637|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
164140638|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
164140639|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
164140640|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
164140641|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
164140642|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
164140643|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
164140644|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
164140645|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
164140646|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
164140647|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
164140648|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
164140649|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
164140650|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
164140651|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
164140652|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
164140653|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
164140654|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
164140655|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
164140656|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
164140657|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
164140658|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
164140659|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
164140660|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
164140661|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
164140662|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
164140663|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
164140664|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
164140665|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
164140666|NCT02552212|592876109|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
164140667|NCT02552212|592876110|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
164140668|NCT02552212|592876111|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
164140669|NCT00418821|592876115|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
164140670|NCT02823652|592876116|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
164140671|NCT02823652|592876117|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
164140672|NCT02823652|592876118|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
164140673|NCT02823652|592876116|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
164140674|NCT02823652|592876117|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
164140675|NCT02823652|592876118|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
164140676|NCT02823652|592876116|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
164140677|NCT02823652|592876117|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
164140678|NCT02823652|592876118|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
164140679|NCT02823652|592876116|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
164140680|NCT02823652|592876117|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
164140681|NCT02823652|592876118|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
164140682|NCT04853992|592876119|FG000|Treatment Period A|Adverse Event|0|||
164140683|NCT04853992|592876120|FG001|Treatment Period A|Adverse Event|1|||
164140684|NCT04853992|592876119|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
164140685|NCT04853992|592876120|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
164140686|NCT02269163|592876121|FG000|Overall Study|Lost to Follow-up|1|||
164140687|NCT02269163|592876122|FG001|Overall Study|Lost to Follow-up|0|||
164140688|NCT02269163|592876121|FG000|Overall Study|Major protocol violation|0|||
164140689|NCT02269163|592876122|FG001|Overall Study|Major protocol violation|1|||
164140690|NCT02269163|592876121|FG000|Overall Study|Other|2|||
164140691|NCT02269163|592876122|FG001|Overall Study|Other|2|||
164140692|NCT02269163|592876121|FG000|Overall Study|Withdrawal by Subject|0|||
164140693|NCT02269163|592876122|FG001|Overall Study|Withdrawal by Subject|3|||
164140694|NCT02269163|592876121|FG000|Overall Study|Physician Decision|0|||
164140695|NCT02269163|592876122|FG001|Overall Study|Physician Decision|1|||
164140696|NCT02351960|592876123|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
164140697|NCT02351960|592876124|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
164140698|NCT02351960|592876123|FG000|Overall Study|Voluntary Withdrawal|5|||
164140699|NCT02351960|592876124|FG001|Overall Study|Voluntary Withdrawal|4|||
164140700|NCT02351960|592876123|FG000|Overall Study|Significant Protocol Deviation|0|||
164140701|NCT02351960|592876124|FG001|Overall Study|Significant Protocol Deviation|5|||
164140702|NCT01094886|592876125|FG000|Overall Study|Adverse Event|2|||
164140703|NCT01094886|592876125|FG000|Overall Study|Withdrawal by Subject|5|||
164140704|NCT03866902|592876126|FG000|Overall Study|Lost to Follow-up|98|||
164140705|NCT03866902|592876127|FG001|Overall Study|Lost to Follow-up|82|||
164140706|NCT03866902|592876126|FG000|Overall Study|Pregnancy|18|||
164140707|NCT03866902|592876127|FG001|Overall Study|Pregnancy|24|||
164140708|NCT02092467|592876129|FG000|Overall Study|Death|49|||
164140751|NCT02377427|592876144|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
164140752|NCT02293863|592876145|FG000|Overall Study|Death|4|||
164140753|NCT02293863|592876146|FG001|Overall Study|Death|6|||
164140754|NCT02293863|592876147|FG002|Overall Study|Death|4|||
164140755|NCT02293863|592876145|FG000|Overall Study|Lost to Follow-up|2|||
164140756|NCT02293863|592876146|FG001|Overall Study|Lost to Follow-up|2|||
164140757|NCT02293863|592876147|FG002|Overall Study|Lost to Follow-up|2|||
164140758|NCT02293863|592876145|FG000|Overall Study|Withdrawal by Subject|3|||
164140759|NCT02293863|592876146|FG001|Overall Study|Withdrawal by Subject|3|||
164140760|NCT02293863|592876147|FG002|Overall Study|Withdrawal by Subject|1|||
164140761|NCT02293863|592876145|FG000|Overall Study|Reason Not Specified|0|||
164140762|NCT02293863|592876146|FG001|Overall Study|Reason Not Specified|2|||
164140763|NCT02293863|592876147|FG002|Overall Study|Reason Not Specified|2|||
164140764|NCT04778904|592878575|FG000|Overall Study|Protocol Violation|1|||
164140765|NCT04778904|592878576|FG001|Overall Study|Protocol Violation|0|||
164140766|NCT04778904|592878577|FG002|Overall Study|Protocol Violation|0|||
164140767|NCT04778904|592878578|FG003|Overall Study|Protocol Violation|0|||
164140768|NCT04778904|592878575|FG000|Overall Study|Withdrawal by Subject|0|||
164140769|NCT04778904|592878576|FG001|Overall Study|Withdrawal by Subject|0|||
164140770|NCT04778904|592878577|FG002|Overall Study|Withdrawal by Subject|1|||
164140771|NCT04778904|592878578|FG003|Overall Study|Withdrawal by Subject|0|||
164140772|NCT03452137|592878579|FG000|Overall Study|Death|67|||
164140773|NCT03452137|592878580|FG001|Overall Study|Death|70|||
164140774|NCT03452137|592878579|FG000|Overall Study|Lost to Follow-up|4|||
164140775|NCT03452137|592878580|FG001|Overall Study|Lost to Follow-up|2|||
164140776|NCT03452137|592878579|FG000|Overall Study|Physician Decision|0|||
164140777|NCT03452137|592878580|FG001|Overall Study|Physician Decision|1|||
164140778|NCT03452137|592878579|FG000|Overall Study|Study Terminated by Sponsor|120|||
164140779|NCT03452137|592878580|FG001|Overall Study|Study Terminated by Sponsor|121|||
164140780|NCT03452137|592878579|FG000|Overall Study|Withdrawal by Subject|12|||
164140781|NCT03452137|592878580|FG001|Overall Study|Withdrawal by Subject|9|||
164140782|NCT04138043|592878581|FG000|Overall Study|Withdrawal by Subject|0|||
164140783|NCT04138043|592878582|FG001|Overall Study|Withdrawal by Subject|1|||
164140784|NCT03772717|592878583|FG000|Overall Study|Withdrawal by Subject|2|||
164140785|NCT02856802|592878584|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
164140786|NCT02856802|592878585|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
164140787|NCT02856802|592878584|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
164140788|NCT02856802|592878585|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
164140789|NCT02856802|592878584|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
164140790|NCT02856802|592878585|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
164140791|NCT02856802|592878584|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
164140792|NCT02856802|592878585|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
164140793|NCT02856802|592878584|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
164140794|NCT02856802|592878585|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
164140795|NCT02856802|592878584|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
164140796|NCT02856802|592878585|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
164140797|NCT00587860|592878586|FG000|Overall Study|Lost to Follow-up|2|||
164140798|NCT00587860|592878587|FG001|Overall Study|Lost to Follow-up|2|||
164140799|NCT00587860|592878586|FG000|Overall Study|Withdrawal by Subject|3|||
164140800|NCT00587860|592878587|FG001|Overall Study|Withdrawal by Subject|3|||
164140801|NCT01659125|592878588|FG000|Overall Study|Withdrawal by Subject|2|||
164140802|NCT01659125|592878588|FG000|Overall Study|Lost to Follow-up|7|||
164140803|NCT01659125|592878588|FG000|Overall Study|Technical Problem|1|||
164140804|NCT01659125|592878588|FG000|Overall Study|Time Constraints|2|||
164140805|NCT01659125|592878588|FG000|Overall Study|Failed to Start Treatment|2|||
164140806|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
164140807|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
164140808|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
164140809|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
164140810|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
164140811|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
164140812|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
164140813|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
164140814|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
164140815|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
164140816|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
164140817|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
164140818|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
164140819|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
164140820|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
164140821|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
164140822|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
164140823|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
164140824|NCT00261443|592878589|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
164140825|NCT00261443|592878590|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
164140826|NCT00261443|592878591|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
164140827|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
164140828|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
164140829|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
164140830|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
164140831|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
164140832|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
164140833|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
164140834|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
164140835|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
164140836|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
164140837|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
164140838|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
164140839|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
164140840|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
164140841|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
164140842|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
164140843|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
164140844|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
164140845|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
164140846|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
164140847|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
164140848|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
164140849|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
164140850|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
164140851|NCT00261443|592878589|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
164140852|NCT00261443|592878590|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
164140853|NCT00261443|592878591|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
164140854|NCT00261443|592878589|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
164140855|NCT00261443|592878590|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
164140856|NCT00261443|592878591|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
164140857|NCT00261443|592878589|FG000|3: Assessment of Relapse|Adverse Event|0|||
164140858|NCT00261443|592878590|FG001|3: Assessment of Relapse|Adverse Event|15|||
164140859|NCT00261443|592878591|FG002|3: Assessment of Relapse|Adverse Event|19|||
164140860|NCT00261443|592878589|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
164140861|NCT00261443|592878590|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
164140862|NCT00261443|592878591|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
164140863|NCT00261443|592878589|FG000|3: Assessment of Relapse|Death|0|||
164140864|NCT00261443|592878590|FG001|3: Assessment of Relapse|Death|0|||
164140865|NCT00261443|592878591|FG002|3: Assessment of Relapse|Death|1|||
164140866|NCT00261443|592878589|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
164140867|NCT00261443|592878590|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
164140868|NCT00261443|592878591|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
164140869|NCT00261443|592878589|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
164140870|NCT00261443|592878590|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
164140871|NCT00261443|592878591|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
164140872|NCT00261443|592878589|FG000|3: Assessment of Relapse|Pregnancy|0|||
164140873|NCT00261443|592878590|FG001|3: Assessment of Relapse|Pregnancy|2|||
164140874|NCT00261443|592878591|FG002|3: Assessment of Relapse|Pregnancy|1|||
164140875|NCT00261443|592878589|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
164140876|NCT00261443|592878590|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
164140877|NCT00261443|592878591|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
164140878|NCT00261443|592878589|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
164140879|NCT00261443|592878590|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
164140880|NCT00261443|592878591|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
164140881|NCT00261443|592878589|FG000|3: Assessment of Relapse|Other Reasons|0|||
164140882|NCT00261443|592878590|FG001|3: Assessment of Relapse|Other Reasons|4|||
164140883|NCT00261443|592878591|FG002|3: Assessment of Relapse|Other Reasons|3|||
164140884|NCT00261443|592878589|FG000|4: Extension Phase|Adverse Event|0|||
164140885|NCT00261443|592878590|FG001|4: Extension Phase|Adverse Event|1|||
164140886|NCT00261443|592878591|FG002|4: Extension Phase|Adverse Event|0|||
164140887|NCT00261443|592878589|FG000|4: Extension Phase|Withdrawal by Subject|0|||
164140888|NCT00261443|592878590|FG001|4: Extension Phase|Withdrawal by Subject|1|||
164140889|NCT00261443|592878591|FG002|4: Extension Phase|Withdrawal by Subject|2|||
164140890|NCT00261443|592878589|FG000|4: Extension Phase|Lost to Follow-up|0|||
164140891|NCT00261443|592878590|FG001|4: Extension Phase|Lost to Follow-up|1|||
164140892|NCT00261443|592878591|FG002|4: Extension Phase|Lost to Follow-up|0|||
164140893|NCT02755649|592878592|FG000|Overall Study|Transitioned into OLE study|99|||
164140894|NCT02755649|592878593|FG001|Overall Study|Transitioned into OLE study|98|||
164140895|NCT02755649|592878594|FG002|Overall Study|Transitioned into OLE study|100|||
164140896|NCT02755649|592878592|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
164140897|NCT02755649|592878593|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
164140898|NCT02755649|592878594|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
164140899|NCT02755649|592878592|FG000|Overall Study|Physician Decision|0|||
164140900|NCT02755649|592878593|FG001|Overall Study|Physician Decision|0|||
164140901|NCT02755649|592878594|FG002|Overall Study|Physician Decision|2|||
164140902|NCT02755649|592878592|FG000|Overall Study|Withdrawal by Subject|0|||
164140903|NCT02755649|592878593|FG001|Overall Study|Withdrawal by Subject|1|||
164140904|NCT02755649|592878594|FG002|Overall Study|Withdrawal by Subject|0|||
164140905|NCT02755649|592878592|FG000|Overall Study|Undecided|1|||
164140906|NCT02755649|592878593|FG001|Overall Study|Undecided|0|||
164140907|NCT02755649|592878594|FG002|Overall Study|Undecided|0|||
164140908|NCT01286753|592878595|FG000|Overall Study|Adverse Event|7|||
164140909|NCT01286753|592878596|FG001|Overall Study|Adverse Event|6|||
164140910|NCT01286753|592878595|FG000|Overall Study|Progression|11|||
164140911|NCT01286753|592878596|FG001|Overall Study|Progression|13|||
164140912|NCT01286753|592878595|FG000|Overall Study|Refused Treatment|1|||
164140913|NCT01286753|592878596|FG001|Overall Study|Refused Treatment|0|||
164140914|NCT01286753|592878595|FG000|Overall Study|Withdrawal of Consent|0|||
164140915|NCT01286753|592878596|FG001|Overall Study|Withdrawal of Consent|2|||
164140916|NCT01286753|592878595|FG000|Overall Study|Discontinued to Join Extension Study|6|||
164140917|NCT01286753|592878596|FG001|Overall Study|Discontinued to Join Extension Study|4|||
164140918|NCT01286753|592878595|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
164140919|NCT01286753|592878596|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
164140920|NCT02126826|592878600|FG000|Overall Study|Withdrawal by Subject|0|||
164140921|NCT02126826|592878601|FG001|Overall Study|Withdrawal by Subject|0|||
164140922|NCT02126826|592878602|FG002|Overall Study|Withdrawal by Subject|0|||
164140923|NCT02126826|592878603|FG003|Overall Study|Withdrawal by Subject|1|||
164140924|NCT02126826|592878604|FG004|Overall Study|Withdrawal by Subject|0|||
164140925|NCT02126826|592878605|FG005|Overall Study|Withdrawal by Subject|0|||
164140926|NCT02126826|592878606|FG006|Overall Study|Withdrawal by Subject|0|||
164140927|NCT01371747|592878607|FG000|Overall Study|Adverse Event|4|||
164140928|NCT01371747|592878608|FG001|Overall Study|Adverse Event|2|||
164140929|NCT01371747|592878609|FG002|Overall Study|Adverse Event|7|||
164140930|NCT01371747|592878610|FG003|Overall Study|Adverse Event|2|||
164140931|NCT01371747|592878611|FG004|Overall Study|Adverse Event|2|||
164140932|NCT01371747|592878612|FG005|Overall Study|Adverse Event|2|||
164140933|NCT01371747|592878607|FG000|Overall Study|Death|1|||
164140934|NCT01371747|592878608|FG001|Overall Study|Death|0|||
164140935|NCT01371747|592878609|FG002|Overall Study|Death|4|||
164140936|NCT01371747|592878610|FG003|Overall Study|Death|1|||
164140937|NCT01371747|592878611|FG004|Overall Study|Death|2|||
164140938|NCT01371747|592878612|FG005|Overall Study|Death|0|||
164140939|NCT01371747|592878607|FG000|Overall Study|Abnormal Renal Function|0|||
164140940|NCT01371747|592878608|FG001|Overall Study|Abnormal Renal Function|2|||
164140941|NCT01371747|592878609|FG002|Overall Study|Abnormal Renal Function|0|||
164140942|NCT01371747|592878610|FG003|Overall Study|Abnormal Renal Function|1|||
164140943|NCT01371747|592878611|FG004|Overall Study|Abnormal Renal Function|0|||
164140944|NCT01371747|592878612|FG005|Overall Study|Abnormal Renal Function|1|||
164140945|NCT01371747|592878607|FG000|Overall Study|High Serum Potassium Results|1|||
164140946|NCT01371747|592878608|FG001|Overall Study|High Serum Potassium Results|1|||
164140947|NCT01371747|592878609|FG002|Overall Study|High Serum Potassium Results|1|||
164140948|NCT01371747|592878610|FG003|Overall Study|High Serum Potassium Results|2|||
164140949|NCT01371747|592878611|FG004|Overall Study|High Serum Potassium Results|0|||
164140950|NCT01371747|592878612|FG005|Overall Study|High Serum Potassium Results|2|||
164140951|NCT01371747|592878607|FG000|Overall Study|Low Serum Potassium Results|1|||
164140952|NCT01371747|592878608|FG001|Overall Study|Low Serum Potassium Results|1|||
164140953|NCT01371747|592878609|FG002|Overall Study|Low Serum Potassium Results|1|||
164140954|NCT01371747|592878610|FG003|Overall Study|Low Serum Potassium Results|1|||
164140955|NCT01371747|592878611|FG004|Overall Study|Low Serum Potassium Results|0|||
164140956|NCT01371747|592878612|FG005|Overall Study|Low Serum Potassium Results|3|||
164140957|NCT01371747|592878607|FG000|Overall Study|Protocol Violation|0|||
164140958|NCT01371747|592878608|FG001|Overall Study|Protocol Violation|0|||
164140959|NCT01371747|592878609|FG002|Overall Study|Protocol Violation|1|||
164140960|NCT01371747|592878610|FG003|Overall Study|Protocol Violation|0|||
164140961|NCT01371747|592878611|FG004|Overall Study|Protocol Violation|0|||
164140962|NCT01371747|592878612|FG005|Overall Study|Protocol Violation|0|||
164140963|NCT01371747|592878607|FG000|Overall Study|Non-Compliance|3|||
164140964|NCT01371747|592878608|FG001|Overall Study|Non-Compliance|4|||
164140965|NCT01371747|592878609|FG002|Overall Study|Non-Compliance|3|||
164140966|NCT01371747|592878610|FG003|Overall Study|Non-Compliance|0|||
164140967|NCT01371747|592878611|FG004|Overall Study|Non-Compliance|0|||
164140968|NCT01371747|592878612|FG005|Overall Study|Non-Compliance|1|||
164141067|NCT00509366|592878647|FG001|Overall Study|Not Treated (Screen Failure)|1|||
164141068|NCT00509366|592878648|FG002|Overall Study|Not Treated (Screen Failure)|1|||
164141069|NCT00509366|592878649|FG003|Overall Study|Not Treated (Screen Failure)|0|||
164141070|NCT00509366|592878650|FG004|Overall Study|Not Treated (Screen Failure)|0|||
164141071|NCT02119819|592878653|FG000|Overall Study|Adverse Event|3|||
164141072|NCT02119819|592878654|FG001|Overall Study|Adverse Event|1|||
164141073|NCT02119819|592878655|FG002|Overall Study|Adverse Event|2|||
164141074|NCT02119819|592878656|FG003|Overall Study|Adverse Event|3|||
164141075|NCT02119819|592878657|FG004|Overall Study|Adverse Event|0|||
164141076|NCT02119819|592878658|FG005|Overall Study|Adverse Event|1|||
164141077|NCT02119819|592878653|FG000|Overall Study|Lack of Efficacy|0|||
164141078|NCT02119819|592878654|FG001|Overall Study|Lack of Efficacy|0|||
164141079|NCT02119819|592878655|FG002|Overall Study|Lack of Efficacy|0|||
164141080|NCT02119819|592878656|FG003|Overall Study|Lack of Efficacy|0|||
164141081|NCT02119819|592878657|FG004|Overall Study|Lack of Efficacy|0|||
164141082|NCT02119819|592878658|FG005|Overall Study|Lack of Efficacy|1|||
164141083|NCT02119819|592878653|FG000|Overall Study|Lost to Follow-up|0|||
164141084|NCT02119819|592878654|FG001|Overall Study|Lost to Follow-up|0|||
164141085|NCT02119819|592878655|FG002|Overall Study|Lost to Follow-up|1|||
164141086|NCT02119819|592878656|FG003|Overall Study|Lost to Follow-up|2|||
164141087|NCT02119819|592878657|FG004|Overall Study|Lost to Follow-up|1|||
164141088|NCT02119819|592878658|FG005|Overall Study|Lost to Follow-up|2|||
164141089|NCT02119819|592878653|FG000|Overall Study|Physician Decision|1|||
164141090|NCT02119819|592878654|FG001|Overall Study|Physician Decision|1|||
164141091|NCT02119819|592878655|FG002|Overall Study|Physician Decision|0|||
164141092|NCT02119819|592878656|FG003|Overall Study|Physician Decision|0|||
164141093|NCT02119819|592878657|FG004|Overall Study|Physician Decision|0|||
164141094|NCT02119819|592878658|FG005|Overall Study|Physician Decision|1|||
164141095|NCT02119819|592878653|FG000|Overall Study|Withdrawal by Subject|5|||
164141096|NCT02119819|592878654|FG001|Overall Study|Withdrawal by Subject|3|||
164141097|NCT02119819|592878655|FG002|Overall Study|Withdrawal by Subject|0|||
164141098|NCT02119819|592878656|FG003|Overall Study|Withdrawal by Subject|0|||
164141099|NCT02119819|592878657|FG004|Overall Study|Withdrawal by Subject|6|||
164141100|NCT02119819|592878658|FG005|Overall Study|Withdrawal by Subject|10|||
164141101|NCT02119819|592878653|FG000|Overall Study|Jury Duty|0|||
164141102|NCT02119819|592878654|FG001|Overall Study|Jury Duty|0|||
164141103|NCT02119819|592878655|FG002|Overall Study|Jury Duty|1|||
164141104|NCT02119819|592878656|FG003|Overall Study|Jury Duty|0|||
164141105|NCT02119819|592878657|FG004|Overall Study|Jury Duty|0|||
164141106|NCT02119819|592878658|FG005|Overall Study|Jury Duty|0|||
164141107|NCT02119819|592878653|FG000|Overall Study|Protocol Violation|0|||
164141108|NCT02119819|592878654|FG001|Overall Study|Protocol Violation|0|||
164141109|NCT02119819|592878655|FG002|Overall Study|Protocol Violation|0|||
164141110|NCT02119819|592878656|FG003|Overall Study|Protocol Violation|1|||
164141111|NCT02119819|592878657|FG004|Overall Study|Protocol Violation|0|||
164141112|NCT02119819|592878658|FG005|Overall Study|Protocol Violation|0|||
164141113|NCT02119819|592878653|FG000|Overall Study|Left the city to get a job|0|||
164141114|NCT02119819|592878654|FG001|Overall Study|Left the city to get a job|0|||
164141115|NCT02119819|592878655|FG002|Overall Study|Left the city to get a job|0|||
164141116|NCT02119819|592878656|FG003|Overall Study|Left the city to get a job|1|||
164141117|NCT02119819|592878657|FG004|Overall Study|Left the city to get a job|0|||
164141118|NCT02119819|592878658|FG005|Overall Study|Left the city to get a job|0|||
164141119|NCT04497948|592878661|FG000|Overall Study|Death|2|||
164141120|NCT02242045|592878667|FG000|Overall Study|Investigator's Discretion|1|||
164141121|NCT02242045|592878667|FG000|Overall Study|Progressive Disease|2|||
164141122|NCT02242045|592878667|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
164141123|NCT02242045|592878667|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
164141124|NCT01421511|592878668|FG000|Overall Study|Lost to Follow-up|11|||
164141125|NCT01421511|592878669|FG001|Overall Study|Lost to Follow-up|14|||
164141126|NCT01421511|592878668|FG000|Overall Study|Randomized but didn't receive study drug|1|||
164141127|NCT01421511|592878669|FG001|Overall Study|Randomized but didn't receive study drug|7|||
164141128|NCT01421511|592878668|FG000|Overall Study|Physician Decision|0|||
164141129|NCT01421511|592878669|FG001|Overall Study|Physician Decision|1|||
164141130|NCT01421511|592878668|FG000|Overall Study|Withdrawal by Subject|6|||
164141131|NCT01421511|592878669|FG001|Overall Study|Withdrawal by Subject|5|||
164141132|NCT01421511|592878668|FG000|Overall Study|Death|1|||
164141133|NCT01421511|592878669|FG001|Overall Study|Death|1|||
164141134|NCT00749892|592878670|FG000|Overall Study|Withdrawal by Subject|3|||
164141135|NCT00106964|592878672|FG000|Overall Study|Lost to Follow-up|8|||
164141136|NCT00106964|592878673|FG001|Overall Study|Lost to Follow-up|6|||
164141137|NCT00106964|592878674|FG002|Overall Study|Lost to Follow-up|2|||
164141138|NCT00106964|592878672|FG000|Overall Study|Pregnancy|2|||
164141139|NCT00106964|592878673|FG001|Overall Study|Pregnancy|3|||
164141140|NCT00106964|592878674|FG002|Overall Study|Pregnancy|2|||
164141141|NCT00106964|592878672|FG000|Overall Study|Death|1|||
164141142|NCT00106964|592878673|FG001|Overall Study|Death|1|||
164141143|NCT00106964|592878674|FG002|Overall Study|Death|0|||
164141144|NCT00106964|592878672|FG000|Overall Study|Incarceration|0|||
164141145|NCT00106964|592878673|FG001|Overall Study|Incarceration|1|||
164141209|NCT04040192|592878677|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
164141210|NCT03207243|592878678|FG000|Overall Study|Adverse Event|2|||
164141211|NCT03207243|592878679|FG001|Overall Study|Adverse Event|2|||
164141212|NCT03207243|592878678|FG000|Overall Study|Loss of Asthma Control|47|||
164141213|NCT03207243|592878679|FG001|Overall Study|Loss of Asthma Control|31|||
164141214|NCT03207243|592878678|FG000|Overall Study|Withdrawal by Subject|2|||
164141215|NCT03207243|592878679|FG001|Overall Study|Withdrawal by Subject|4|||
164141216|NCT03207243|592878678|FG000|Overall Study|Physician Decision|1|||
164141217|NCT03207243|592878679|FG001|Overall Study|Physician Decision|1|||
164141218|NCT03207243|592878678|FG000|Overall Study|Lost to Follow-up|0|||
164141219|NCT03207243|592878679|FG001|Overall Study|Lost to Follow-up|1|||
164141220|NCT03207243|592878678|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
164141221|NCT03207243|592878679|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
164141222|NCT03207243|592878678|FG000|Overall Study|Protocol Violation|0|||
164141223|NCT03207243|592878679|FG001|Overall Study|Protocol Violation|3|||
164141224|NCT00603837|592878688|FG000|Overall Study|Physician Decision|3|||
164141225|NCT00603837|592878689|FG001|Overall Study|Physician Decision|0|||
164141226|NCT04611529|592878690|FG000|2-day Follow up|Lost to Follow-up|5|||
164141227|NCT04611529|592878691|FG001|2-day Follow up|Lost to Follow-up|6|||
164141228|NCT04611529|592878692|FG002|2-day Follow up|Lost to Follow-up|3|||
164141229|NCT02121392|592878693|FG000|Prior to Intervention|Protocol Violation|40|||
164141230|NCT02121392|592878694|FG001|Prior to Intervention|Protocol Violation|35|||
164141231|NCT02121392|592878693|FG000|Prior to Intervention|Withdrawal by Subject|8|||
164141232|NCT02121392|592878694|FG001|Prior to Intervention|Withdrawal by Subject|6|||
164141233|NCT02121392|592878693|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
164141234|NCT02121392|592878694|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
164141235|NCT02121392|592878693|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
164141236|NCT02121392|592878694|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
164141237|NCT01352416|592878695|FG000|Overall Study|Physician Decision|1|||
164141238|NCT01352416|592878696|FG001|Overall Study|Physician Decision|2|||
164141239|NCT01352416|592878697|FG002|Overall Study|Physician Decision|2|||
164141240|NCT01352416|592878698|FG003|Overall Study|Physician Decision|1|||
164141241|NCT00253448|592878699|FG000|Overall Study|Withdrawal by Subject|1|||
164141242|NCT02564887|592878700|FG000|Overall Study|Lost to Follow-up|6|||
164141243|NCT02564887|592878701|FG001|Overall Study|Lost to Follow-up|0|||
164141244|NCT01851330|592878702|FG000|Overall Study|Lack of Efficacy|10|||
164141245|NCT01851330|592878703|FG001|Overall Study|Lack of Efficacy|9|||
164141246|NCT01851330|592878704|FG002|Overall Study|Lack of Efficacy|2|||
164141247|NCT01851330|592878702|FG000|Overall Study|Lost to Follow-up|1|||
164141248|NCT01851330|592878703|FG001|Overall Study|Lost to Follow-up|6|||
164141249|NCT01851330|592878704|FG002|Overall Study|Lost to Follow-up|9|||
164141250|NCT01851330|592878702|FG000|Overall Study|Withdrew Consent|2|||
164141251|NCT01851330|592878703|FG001|Overall Study|Withdrew Consent|1|||
164141252|NCT01851330|592878704|FG002|Overall Study|Withdrew Consent|0|||
164141253|NCT01851330|592878702|FG000|Overall Study|Investigator's Discretion|0|||
164141254|NCT01851330|592878703|FG001|Overall Study|Investigator's Discretion|0|||
164141255|NCT01851330|592878704|FG002|Overall Study|Investigator's Discretion|1|||
164141256|NCT01199016|592878705|FG000|Overall Study|No longer meets eligibility criteria|4|||
164141257|NCT01199016|592878705|FG000|Overall Study|Entrance criteria|5|||
164141258|NCT01199016|592878705|FG000|Overall Study|Protocol Violation|9|||
164141259|NCT01199016|592878705|FG000|Overall Study|Other|13|||
164141260|NCT01199016|592878705|FG000|Overall Study|Withdrawal by Subject|21|||
164141261|NCT01199016|592878705|FG000|Overall Study|Lost to Follow-up|25|||
164141262|NCT02960490|592878714|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
164141263|NCT02960490|592878715|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
164141264|NCT02960490|592878716|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141265|NCT02960490|592878717|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141266|NCT02960490|592878718|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141267|NCT02960490|592878719|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141268|NCT02960490|592878720|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141269|NCT02960490|592878721|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141270|NCT02960490|592878722|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141271|NCT02960490|592878723|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
164141272|NCT02960490|592878714|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141273|NCT02960490|592878715|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
164141274|NCT02960490|592878716|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141275|NCT02960490|592878717|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141276|NCT02960490|592878718|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141277|NCT02960490|592878719|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141278|NCT02960490|592878720|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141279|NCT02960490|592878721|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141280|NCT02960490|592878722|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141281|NCT02960490|592878723|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
164141282|NCT02960490|592878714|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
164141283|NCT02960490|592878715|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
164141284|NCT02960490|592878716|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141285|NCT02960490|592878717|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141286|NCT02960490|592878718|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141287|NCT02960490|592878719|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141288|NCT02960490|592878720|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141289|NCT02960490|592878721|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141290|NCT02960490|592878722|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141291|NCT02960490|592878723|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
164141292|NCT02960490|592878714|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
164141293|NCT02960490|592878715|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
164141294|NCT02960490|592878716|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141295|NCT02960490|592878717|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141296|NCT02960490|592878718|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141297|NCT02960490|592878719|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141298|NCT02960490|592878720|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141299|NCT02960490|592878721|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141300|NCT02960490|592878722|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141301|NCT02960490|592878723|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
164141302|NCT02960490|592878714|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141303|NCT02960490|592878715|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141304|NCT02960490|592878716|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
164141305|NCT02960490|592878717|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
164141306|NCT02960490|592878718|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141307|NCT02960490|592878719|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
164141308|NCT02960490|592878720|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141309|NCT02960490|592878721|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141310|NCT02960490|592878722|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141311|NCT02960490|592878723|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
164141312|NCT02960490|592878714|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141313|NCT02960490|592878715|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141314|NCT02960490|592878716|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
164141315|NCT02960490|592878717|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141316|NCT02960490|592878718|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
164141317|NCT02960490|592878719|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141318|NCT02960490|592878720|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141319|NCT02960490|592878721|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141320|NCT02960490|592878722|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141321|NCT02960490|592878723|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
164141322|NCT02960490|592878714|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
164141323|NCT02960490|592878715|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
164141324|NCT02960490|592878716|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
164141325|NCT02960490|592878717|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
164141326|NCT02960490|592878718|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
164141327|NCT02960490|592878719|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
164141328|NCT02960490|592878720|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
164141329|NCT02960490|592878721|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
164141330|NCT02960490|592878722|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
164141331|NCT02960490|592878723|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
164141332|NCT02960490|592878714|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141333|NCT02960490|592878715|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141334|NCT02960490|592878716|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141335|NCT02960490|592878717|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141336|NCT02960490|592878718|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141337|NCT02960490|592878719|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141338|NCT02960490|592878720|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
164141339|NCT02960490|592878721|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
164141340|NCT02960490|592878722|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
164141341|NCT02960490|592878723|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
164141342|NCT02960490|592878714|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141343|NCT02960490|592878715|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141344|NCT02960490|592878716|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141345|NCT02960490|592878717|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141346|NCT02960490|592878718|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141347|NCT02960490|592878719|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141348|NCT02960490|592878720|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141349|NCT02960490|592878721|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
164141350|NCT02960490|592878722|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141351|NCT02960490|592878723|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
164141352|NCT02960490|592878714|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164141353|NCT02960490|592878715|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164141354|NCT02960490|592878716|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164141355|NCT02960490|592878717|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164141356|NCT02960490|592878718|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164141357|NCT02960490|592878719|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
164141358|NCT02960490|592878720|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
164141359|NCT02960490|592878721|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
164141360|NCT02960490|592878722|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
164141361|NCT02960490|592878723|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
164141362|NCT02960490|592878714|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141363|NCT02960490|592878715|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141364|NCT02960490|592878716|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141365|NCT02960490|592878717|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141366|NCT02960490|592878718|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141367|NCT02960490|592878719|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141368|NCT02960490|592878720|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
164141369|NCT02960490|592878721|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141370|NCT02960490|592878722|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141371|NCT02960490|592878723|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
164141372|NCT02960490|592878714|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141373|NCT02960490|592878715|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141374|NCT02960490|592878716|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141375|NCT02960490|592878717|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141376|NCT02960490|592878718|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141377|NCT02960490|592878719|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141378|NCT02960490|592878720|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141379|NCT02960490|592878721|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
164141380|NCT02960490|592878722|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141381|NCT02960490|592878723|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
164141382|NCT04106661|592878724|FG000|Overall Study|Protocol Violation|3|||
164141383|NCT04106661|592878725|FG001|Overall Study|Protocol Violation|0|||
164141384|NCT04106661|592878724|FG000|Overall Study|Scheduling difficulties|1|||
164141385|NCT04106661|592878725|FG001|Overall Study|Scheduling difficulties|1|||
164141386|NCT00233402|592878726|FG000|Overall Study|No pathology data|12|||
164141387|NCT00233402|592878727|FG001|Overall Study|No pathology data|9|||
164141388|NCT00233402|592878726|FG000|Overall Study|No Ta/T1|89|||
164141389|NCT00233402|592878727|FG001|Overall Study|No Ta/T1|94|||
164141390|NCT00233402|592878726|FG000|Overall Study|Lost to follow up etc|3|||
164141391|NCT00233402|592878727|FG001|Overall Study|Lost to follow up etc|21|||
164141392|NCT03280381|592878728|FG000|Overall Study|Physician Decision|0|||
164141393|NCT03280381|592878729|FG001|Overall Study|Physician Decision|2|||
164141394|NCT03503864|592878730|FG000|Overall Study|Protocol Violation|6|||
164141395|NCT03503864|592878730|FG000|Overall Study|Withdrawal by Subject|7|||
164141396|NCT00423319|592878731|FG000|Overall Study|Death|2|||
164141397|NCT00423319|592878732|FG001|Overall Study|Death|0|||
164141398|NCT00423319|592878731|FG000|Overall Study|Adverse Event|93|||
164141399|NCT00423319|592878732|FG001|Overall Study|Adverse Event|112|||
164141400|NCT00423319|592878731|FG000|Overall Study|Withdrawal by Subject|86|||
164141401|NCT00423319|592878732|FG001|Overall Study|Withdrawal by Subject|99|||
164141402|NCT00423319|592878731|FG000|Overall Study|Lost to Follow-up|4|||
164141403|NCT00423319|592878732|FG001|Overall Study|Lost to Follow-up|3|||
164141404|NCT00423319|592878731|FG000|Overall Study|Poor compliance or noncompliance|1|||
164141405|NCT00423319|592878732|FG001|Overall Study|Poor compliance or noncompliance|1|||
164141406|NCT00423319|592878731|FG000|Overall Study|No longer meets study criteria|15|||
164141407|NCT00423319|592878732|FG001|Overall Study|No longer meets study criteria|15|||
164141408|NCT00423319|592878731|FG000|Overall Study|Other|23|||
164141409|NCT00423319|592878732|FG001|Overall Study|Other|22|||
164141410|NCT02087189|592878734|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
164141411|NCT00478426|592878735|FG000|Overall Study|Withdrawal by Subject|1|||
164141412|NCT01189487|592878736|FG000|Overall Study|Lack of Efficacy|2|||
164141413|NCT01189487|592878736|FG000|Overall Study|Adverse Event|1|||
164141414|NCT04630158|592878737|FG000|Overall Study|Adverse Event|1|||
164141415|NCT04630158|592878738|FG001|Overall Study|Adverse Event|1|||
164141416|NCT04630158|592878739|FG002|Overall Study|Adverse Event|1|||
164141417|NCT04630158|592878737|FG000|Overall Study|Physician Decision|0|||
164141418|NCT04630158|592878738|FG001|Overall Study|Physician Decision|2|||
164141440|NCT02952898|592878760|FG000|Overall Study|Withdrawal by Subject|10|||
164141441|NCT02952898|592878761|FG001|Overall Study|Withdrawal by Subject|8|||
164141442|NCT02952898|592878762|FG002|Overall Study|Withdrawal by Subject|8|||
164141443|NCT02952898|592878760|FG000|Overall Study|Adverse Event|8|||
164141444|NCT02952898|592878761|FG001|Overall Study|Adverse Event|8|||
164141445|NCT02952898|592878762|FG002|Overall Study|Adverse Event|3|||
164141446|NCT02952898|592878760|FG000|Overall Study|Lost to Follow-up|3|||
164141447|NCT02952898|592878761|FG001|Overall Study|Lost to Follow-up|2|||
164141448|NCT02952898|592878762|FG002|Overall Study|Lost to Follow-up|2|||
164141449|NCT02952898|592878760|FG000|Overall Study|Non-compliance with study drug|1|||
164141450|NCT02952898|592878761|FG001|Overall Study|Non-compliance with study drug|1|||
164141451|NCT02952898|592878762|FG002|Overall Study|Non-compliance with study drug|2|||
164141452|NCT04844762|592878763|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141453|NCT04844762|592878764|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141454|NCT04844762|592878765|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
164141455|NCT04844762|592878766|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141456|NCT04844762|592878767|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141457|NCT04844762|592878768|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141458|NCT04844762|592878763|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
164141459|NCT04844762|592878764|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
164141460|NCT04844762|592878765|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
164141461|NCT04844762|592878766|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
164141462|NCT04844762|592878767|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
164141463|NCT04844762|592878768|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
164141464|NCT04844762|592878763|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141465|NCT04844762|592878764|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141466|NCT04844762|592878765|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164141467|NCT04844762|592878766|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
164141468|NCT04844762|592878767|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141469|NCT04844762|592878768|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164141470|NCT04844762|592878763|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141471|NCT04844762|592878764|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141472|NCT04844762|592878765|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
164141473|NCT04844762|592878766|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
164141474|NCT04844762|592878767|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
164141475|NCT04844762|592878768|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141476|NCT04844762|592878763|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
164141477|NCT04844762|592878764|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
164141478|NCT04844762|592878765|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141479|NCT04844762|592878766|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141480|NCT04844762|592878767|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141481|NCT04844762|592878768|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141482|NCT04844762|592878763|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164141483|NCT04844762|592878764|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141484|NCT04844762|592878765|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141485|NCT04844762|592878766|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141486|NCT04844762|592878767|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141487|NCT04844762|592878768|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141488|NCT04844762|592878763|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141489|NCT04844762|592878764|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141490|NCT04844762|592878765|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141491|NCT04844762|592878766|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141492|NCT04844762|592878767|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
164141493|NCT04844762|592878768|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
164141494|NCT04844762|592878763|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
164141495|NCT04844762|592878764|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141496|NCT04844762|592878765|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141497|NCT04844762|592878766|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141498|NCT04844762|592878767|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141499|NCT04844762|592878768|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
164141500|NCT04844762|592878763|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164141501|NCT04844762|592878764|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141502|NCT04844762|592878765|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141503|NCT04844762|592878766|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141504|NCT04844762|592878767|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
164141505|NCT04844762|592878768|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
164141506|NCT04844762|592878763|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164141507|NCT04844762|592878764|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
164141508|NCT04844762|592878765|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164141509|NCT04844762|592878766|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164141510|NCT04844762|592878767|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164141511|NCT04844762|592878768|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
164141512|NCT04844762|592878763|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164141513|NCT04844762|592878764|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164141514|NCT04844762|592878765|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164141515|NCT04844762|592878766|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
164141516|NCT04844762|592878767|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164141517|NCT04844762|592878768|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
164141518|NCT02802631|592878771|FG000|Overall Study|Withdrawal by Subject|1|||
164141519|NCT02802631|592878772|FG001|Overall Study|Withdrawal by Subject|0|||
164141520|NCT02802631|592878773|FG002|Overall Study|Withdrawal by Subject|0|||
164141521|NCT02802631|592878774|FG003|Overall Study|Withdrawal by Subject|0|||
164141522|NCT02802631|592878775|FG004|Overall Study|Withdrawal by Subject|0|||
164141523|NCT02802631|592878776|FG005|Overall Study|Withdrawal by Subject|0|||
164141524|NCT02802631|592878777|FG006|Overall Study|Withdrawal by Subject|0|||
164141525|NCT02802631|592878778|FG007|Overall Study|Withdrawal by Subject|0|||
164141526|NCT02802631|592878771|FG000|Overall Study|Physician Decision|1|||
164141527|NCT02802631|592878772|FG001|Overall Study|Physician Decision|0|||
164141528|NCT02802631|592878773|FG002|Overall Study|Physician Decision|0|||
164141529|NCT02802631|592878774|FG003|Overall Study|Physician Decision|0|||
164141530|NCT02802631|592878775|FG004|Overall Study|Physician Decision|0|||
164141531|NCT02802631|592878776|FG005|Overall Study|Physician Decision|0|||
164141532|NCT02802631|592878777|FG006|Overall Study|Physician Decision|1|||
164141533|NCT02802631|592878778|FG007|Overall Study|Physician Decision|0|||
164141534|NCT02802631|592878771|FG000|Overall Study|Adverse Event|0|||
164141535|NCT02802631|592878772|FG001|Overall Study|Adverse Event|2|||
164141536|NCT02802631|592878773|FG002|Overall Study|Adverse Event|0|||
164141537|NCT02802631|592878774|FG003|Overall Study|Adverse Event|1|||
164141538|NCT02802631|592878775|FG004|Overall Study|Adverse Event|6|||
164141539|NCT02802631|592878776|FG005|Overall Study|Adverse Event|1|||
164141540|NCT02802631|592878777|FG006|Overall Study|Adverse Event|4|||
164141541|NCT02802631|592878778|FG007|Overall Study|Adverse Event|0|||
164141542|NCT02802631|592878771|FG000|Overall Study|Sponsor Decision|0|||
164141543|NCT02802631|592878772|FG001|Overall Study|Sponsor Decision|0|||
164141544|NCT02802631|592878773|FG002|Overall Study|Sponsor Decision|6|||
164141545|NCT02802631|592878774|FG003|Overall Study|Sponsor Decision|0|||
164141546|NCT02802631|592878775|FG004|Overall Study|Sponsor Decision|2|||
164141547|NCT02802631|592878776|FG005|Overall Study|Sponsor Decision|0|||
164141548|NCT02802631|592878777|FG006|Overall Study|Sponsor Decision|0|||
164141549|NCT02802631|592878778|FG007|Overall Study|Sponsor Decision|4|||
164141550|NCT00477633|592878779|FG000|Overall Study|Did not receive treatment|23|||
164141551|NCT00477633|592878779|FG000|Overall Study|Adverse Event|143|||
164141552|NCT00477633|592878779|FG000|Overall Study|Pregnancy|23|||
164141553|NCT00477633|592878779|FG000|Overall Study|Lost to Follow-up|271|||
164141554|NCT00477633|592878779|FG000|Overall Study|Withdrawal by Subject|149|||
164141555|NCT00477633|592878779|FG000|Overall Study|Protocol Violation|25|||
164141556|NCT00477633|592878779|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
164141557|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #1|24|||
164141558|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #1|0|||
164141559|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
164141560|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
164141561|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141562|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141563|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
164141564|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
164141565|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
164141566|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
164141567|NCT03888066|592880691|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141568|NCT03888066|592880692|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141569|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141570|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141571|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
164141572|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
164141573|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141574|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141575|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
164141576|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141577|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #2|5|||
164141578|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #2|0|||
164141579|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
164141580|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
164141581|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
164141582|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
164141583|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
164141584|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
164141585|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #3|11|||
164141586|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #3|0|||
164141587|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
164141588|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
164141589|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
164141590|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164141591|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141592|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141593|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #4|3|||
164141594|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #4|0|||
164141595|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
164141596|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
164141597|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
164141598|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
164141599|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
164141600|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164141601|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
164141602|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
164141603|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
164141604|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141605|NCT03888066|592880691|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
164141606|NCT03888066|592880692|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164141607|NCT03888066|592880691|FG000|Run-in Phase|AE (Adverse Event)|17|||
164141608|NCT03888066|592880692|FG001|Run-in Phase|AE (Adverse Event)|0|||
164141609|NCT03888066|592880691|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
164141610|NCT03888066|592880692|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
164141611|NCT03888066|592880691|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141612|NCT03888066|592880692|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141613|NCT03888066|592880691|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
164141614|NCT03888066|592880692|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141615|NCT03888066|592880691|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
164141616|NCT03888066|592880692|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164141617|NCT03888066|592880691|FG000|Run-in Phase|Withdrawal by Subject|43|||
164141618|NCT03888066|592880692|FG001|Run-in Phase|Withdrawal by Subject|0|||
164141619|NCT03888066|592880691|FG000|Run-in Phase|AE; Physician Decision|1|||
164141620|NCT03888066|592880692|FG001|Run-in Phase|AE; Physician Decision|0|||
164141621|NCT03888066|592880691|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
164141622|NCT03888066|592880692|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
164141623|NCT03888066|592880691|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
164141624|NCT03888066|592880692|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
164141625|NCT03888066|592880691|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
164141626|NCT03888066|592880692|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
164141627|NCT03888066|592880691|FG000|Run-in Phase|Death|1|||
164141628|NCT03888066|592880692|FG001|Run-in Phase|Death|0|||
164141629|NCT03888066|592880691|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
164141630|NCT03888066|592880692|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
164141631|NCT03888066|592880691|FG000|Run-in Phase|Physician Decision|1|||
164141632|NCT03888066|592880692|FG001|Run-in Phase|Physician Decision|0|||
164141633|NCT03888066|592880691|FG000|Run-in Phase|Protocol Violation|13|||
164141634|NCT03888066|592880692|FG001|Run-in Phase|Protocol Violation|0|||
164141635|NCT03888066|592880691|FG000|Run-in Phase|Sponsor Request|34|||
164141636|NCT03888066|592880692|FG001|Run-in Phase|Sponsor Request|0|||
164141637|NCT03888066|592880691|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
164141638|NCT03888066|592880692|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
164141639|NCT03888066|592880691|FG000|Run-in Phase|Withdrawal Of Consent|1|||
164141640|NCT03888066|592880692|FG001|Run-in Phase|Withdrawal Of Consent|0|||
164141641|NCT03888066|592880691|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
164141642|NCT03888066|592880692|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
164141643|NCT03888066|592880691|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
164141644|NCT03888066|592880692|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
164141645|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
164141646|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
164141647|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
164141648|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
164141649|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
164141650|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
164141651|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
164141652|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
164141653|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
164141654|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
164141655|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
164141656|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
164141657|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
164141658|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
164141659|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
164141660|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
164141661|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
164141662|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
164141663|NCT03888066|592880691|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
164141664|NCT03888066|592880692|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
164141665|NCT03278626|592880693|FG000|Overall Study|Death|2|||
164141666|NCT03278626|592880693|FG000|Overall Study|Toxicity|1|||
164141667|NCT03278626|592880693|FG000|Overall Study|Disease Progression|2|||
164141668|NCT02856555|592880694|FG000|Overall Study|Adverse Event|1|||
164141669|NCT02856555|592880695|FG001|Overall Study|Adverse Event|0|||
164141670|NCT02856555|592880696|FG002|Overall Study|Adverse Event|0|||
164141671|NCT02856555|592880694|FG000|Overall Study|Lost to Follow-up|1|||
164141672|NCT02856555|592880695|FG001|Overall Study|Lost to Follow-up|3|||
164141673|NCT02856555|592880696|FG002|Overall Study|Lost to Follow-up|0|||
164141674|NCT02856555|592880694|FG000|Overall Study|Withdrawal by Subject|3|||
164141675|NCT02856555|592880695|FG001|Overall Study|Withdrawal by Subject|0|||
164141676|NCT02856555|592880696|FG002|Overall Study|Withdrawal by Subject|0|||
164141677|NCT02856555|592880694|FG000|Overall Study|Randomized but Never Treated|0|||
164141678|NCT02856555|592880695|FG001|Overall Study|Randomized but Never Treated|1|||
164141679|NCT02856555|592880696|FG002|Overall Study|Randomized but Never Treated|0|||
164141680|NCT03333941|592880697|FG000|Overall Study|Lost to Follow-up|10|||
164141681|NCT03333941|592880697|FG000|Overall Study|Death|2|||
164141682|NCT03333941|592880697|FG000|Overall Study|Adverse Event|1|||
164141683|NCT04971187|592880698|FG000|Overall Study|Screen failures|2|||
164141684|NCT04981717|592880704|FG000|Overall Study|Protocol Violation|0|||
164141685|NCT04981717|592880705|FG001|Overall Study|Protocol Violation|3|||
164141686|NCT04981717|592880704|FG000|Overall Study|Adverse Event|1|||
164141687|NCT04981717|592880705|FG001|Overall Study|Adverse Event|3|||
164141688|NCT04981717|592880704|FG000|Overall Study|Pregnancy|1|||
164141689|NCT04981717|592880705|FG001|Overall Study|Pregnancy|0|||
164141690|NCT04981717|592880704|FG000|Overall Study|Physician Decision|1|||
164141691|NCT04981717|592880705|FG001|Overall Study|Physician Decision|0|||
164141692|NCT04981717|592880704|FG000|Overall Study|Sponsor Request|157|||
164141693|NCT04981717|592880705|FG001|Overall Study|Sponsor Request|172|||
164141694|NCT04981717|592880704|FG000|Overall Study|Lost to Follow-up|4|||
164141695|NCT04981717|592880705|FG001|Overall Study|Lost to Follow-up|5|||
164141696|NCT04981717|592880704|FG000|Overall Study|Withdrawal by Subject|50|||
164141697|NCT04981717|592880705|FG001|Overall Study|Withdrawal by Subject|37|||
164141698|NCT02207634|592880706|FG000|Overall Study|Withdrawal by Subject|21|||
164141699|NCT02207634|592880707|FG001|Overall Study|Withdrawal by Subject|31|||
164141700|NCT02207634|592880706|FG000|Overall Study|Lost to Follow-up|1|||
164141701|NCT02207634|592880707|FG001|Overall Study|Lost to Follow-up|0|||
164141702|NCT02077140|592880708|FG000|Overall Study|Lost to Follow-up|4|||
164141703|NCT02077140|592880709|FG001|Overall Study|Lost to Follow-up|1|||
164141704|NCT02077140|592880710|FG002|Overall Study|Lost to Follow-up|2|||
164141705|NCT02077140|592880711|FG003|Overall Study|Lost to Follow-up|2|||
164141706|NCT02077140|592880712|FG004|Overall Study|Lost to Follow-up|3|||
164141707|NCT02077140|592880708|FG000|Overall Study|Withdrawal by Subject|0|||
164141708|NCT02077140|592880709|FG001|Overall Study|Withdrawal by Subject|1|||
164141709|NCT02077140|592880710|FG002|Overall Study|Withdrawal by Subject|0|||
164141710|NCT02077140|592880711|FG003|Overall Study|Withdrawal by Subject|2|||
164141711|NCT02077140|592880712|FG004|Overall Study|Withdrawal by Subject|2|||
164141712|NCT00974922|592880713|FG000|Overall Study|study terminated|24|||
164141713|NCT01762800|592880714|FG000|Overall Study|Adverse Event|8|||
164141714|NCT01762800|592880715|FG001|Overall Study|Adverse Event|13|||
164141739|NCT05384171|592880723|FG000|Overall Study|Withdrawal by Subject|3|||
164141740|NCT05384171|592880724|FG001|Overall Study|Withdrawal by Subject|0|||
164141741|NCT02052011|592880731|FG000|Overall Study|Lost to Follow-up|3|||
164141742|NCT02052011|592880732|FG001|Overall Study|Lost to Follow-up|0|||
164141743|NCT02052011|592880731|FG000|Overall Study|Withdrawal by Subject|1|||
164141744|NCT02052011|592880732|FG001|Overall Study|Withdrawal by Subject|2|||
164141745|NCT00000620|592880733|FG000|Overall Study|Death|86|||
164141746|NCT00000620|592880734|FG001|Overall Study|Death|67|||
164141747|NCT00000620|592880735|FG002|Overall Study|Death|112|||
164141748|NCT00000620|592880736|FG003|Overall Study|Death|126|||
164141749|NCT00000620|592880737|FG004|Overall Study|Death|64|||
164141750|NCT00000620|592880738|FG005|Overall Study|Death|77|||
164141751|NCT00000620|592880739|FG006|Overall Study|Death|91|||
164141752|NCT00000620|592880740|FG007|Overall Study|Death|95|||
164141753|NCT00000620|592880733|FG000|Overall Study|Lost to Follow-up|14|||
164141754|NCT00000620|592880734|FG001|Overall Study|Lost to Follow-up|14|||
164141755|NCT00000620|592880735|FG002|Overall Study|Lost to Follow-up|14|||
164141756|NCT00000620|592880736|FG003|Overall Study|Lost to Follow-up|14|||
164141757|NCT00000620|592880737|FG004|Overall Study|Lost to Follow-up|15|||
164141758|NCT00000620|592880738|FG005|Overall Study|Lost to Follow-up|15|||
164141759|NCT00000620|592880739|FG006|Overall Study|Lost to Follow-up|13|||
164141760|NCT00000620|592880740|FG007|Overall Study|Lost to Follow-up|14|||
164141761|NCT00000620|592880733|FG000|Overall Study|Withdrawal by Subject|40|||
164141762|NCT00000620|592880734|FG001|Overall Study|Withdrawal by Subject|27|||
164141763|NCT00000620|592880735|FG002|Overall Study|Withdrawal by Subject|28|||
164141764|NCT00000620|592880736|FG003|Overall Study|Withdrawal by Subject|27|||
164141765|NCT00000620|592880737|FG004|Overall Study|Withdrawal by Subject|30|||
164141766|NCT00000620|592880738|FG005|Overall Study|Withdrawal by Subject|32|||
164141767|NCT00000620|592880739|FG006|Overall Study|Withdrawal by Subject|32|||
164141768|NCT00000620|592880740|FG007|Overall Study|Withdrawal by Subject|21|||
164141769|NCT00000620|592880733|FG000|Overall Study|missed closeout visit|22|||
164141770|NCT00000620|592880734|FG001|Overall Study|missed closeout visit|28|||
164141771|NCT00000620|592880735|FG002|Overall Study|missed closeout visit|16|||
164141772|NCT00000620|592880736|FG003|Overall Study|missed closeout visit|11|||
164141773|NCT00000620|592880737|FG004|Overall Study|missed closeout visit|26|||
164141774|NCT00000620|592880738|FG005|Overall Study|missed closeout visit|28|||
164141775|NCT00000620|592880739|FG006|Overall Study|missed closeout visit|13|||
164141776|NCT00000620|592880740|FG007|Overall Study|missed closeout visit|16|||
164141777|NCT02648932|592880741|FG000|Overall Study|No transplant|3|||
164141778|NCT02648932|592880742|FG001|Overall Study|No transplant|1|||
164141779|NCT01590797|592880743|FG000|Overall Study|Adverse Event|4|||
164141780|NCT01590797|592880744|FG001|Overall Study|Adverse Event|3|||
164141781|NCT01590797|592880743|FG000|Overall Study|Lack of Efficacy|0|||
164141782|NCT01590797|592880744|FG001|Overall Study|Lack of Efficacy|2|||
164141783|NCT01590797|592880743|FG000|Overall Study|Lost to Follow-up|0|||
164141784|NCT01590797|592880744|FG001|Overall Study|Lost to Follow-up|1|||
164141785|NCT01590797|592880743|FG000|Overall Study|Protocol Violation|4|||
164141786|NCT01590797|592880744|FG001|Overall Study|Protocol Violation|1|||
164141787|NCT01590797|592880743|FG000|Overall Study|Withdrawal by Subject|7|||
164141788|NCT01590797|592880744|FG001|Overall Study|Withdrawal by Subject|5|||
164141789|NCT01590797|592880743|FG000|Overall Study|Other Protocol Specified Criteria|2|||
164141790|NCT01590797|592880744|FG001|Overall Study|Other Protocol Specified Criteria|4|||
164141791|NCT03106987|592880745|FG000|Overall Study|Death|37|||
164141792|NCT03106987|592880746|FG001|Overall Study|Death|22|||
164141793|NCT03106987|592880747|FG002|Overall Study|Death|12|||
164141794|NCT03106987|592880748|FG003|Overall Study|Death|8|||
164141795|NCT03106987|592880745|FG000|Overall Study|Lost to Follow-up|2|||
164141796|NCT03106987|592880746|FG001|Overall Study|Lost to Follow-up|0|||
164141797|NCT03106987|592880747|FG002|Overall Study|Lost to Follow-up|2|||
164141798|NCT03106987|592880748|FG003|Overall Study|Lost to Follow-up|2|||
164141799|NCT03106987|592880745|FG000|Overall Study|Withdrawal by Subject|5|||
164141800|NCT03106987|592880746|FG001|Overall Study|Withdrawal by Subject|1|||
164141801|NCT03106987|592880747|FG002|Overall Study|Withdrawal by Subject|4|||
164141802|NCT03106987|592880748|FG003|Overall Study|Withdrawal by Subject|1|||
164141803|NCT01307111|592880749|FG000|IUD Insertion|Lost to Follow-up|2|||
164141804|NCT01307111|592880750|FG001|IUD Insertion|Lost to Follow-up|0|||
164141805|NCT01307111|592880749|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
164141806|NCT01307111|592880750|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
164141807|NCT02114385|592880758|FG000|Overall Study|Withdrawal by Subject|3|||
164141808|NCT02114385|592880759|FG001|Overall Study|Withdrawal by Subject|2|||
164141809|NCT02114385|592880758|FG000|Overall Study|Lost to Follow-up|0|||
164141810|NCT02114385|592880759|FG001|Overall Study|Lost to Follow-up|6|||
164141811|NCT05320887|592880763|FG000|Overall Study|Lost to Follow-up|0|||
164141812|NCT05320887|592880764|FG001|Overall Study|Lost to Follow-up|3|||
164141813|NCT05320887|592880765|FG002|Overall Study|Lost to Follow-up|0|||
164141814|NCT05320887|592880766|FG003|Overall Study|Lost to Follow-up|0|||
164141815|NCT02460679|592880769|FG000|Overall Study|Investigator Decision|1|||
164141816|NCT02460679|592880769|FG000|Overall Study|Withdrawal by Subject|4|||
164141817|NCT03066258|592880782|FG000|Overall Study|Death|1|||
164141965|NCT01104792|592880867|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
164141966|NCT01102374|592880868|FG000|Overall Study|Death|9|||
164141967|NCT01102374|592880869|FG001|Overall Study|Death|13|||
164141968|NCT01102374|592880868|FG000|Overall Study|Lost to Follow-up|7|||
164141969|NCT01102374|592880869|FG001|Overall Study|Lost to Follow-up|6|||
164141970|NCT02071849|592880871|FG000|6-month Primary Endpoint|Did not receive device|4|||
164141971|NCT02071849|592880871|FG000|6-month Primary Endpoint|Adverse Event|1|||
164141972|NCT02071849|592880871|FG000|2-year Extended Follow-up|Adverse Event|1|||
164141973|NCT02056392|592880874|FG000|Overall Study|Lost to Follow-up|0|||
164141974|NCT02056392|592880875|FG001|Overall Study|Lost to Follow-up|1|||
164141975|NCT02056392|592880876|FG002|Overall Study|Lost to Follow-up|2|||
164141976|NCT02056392|592880877|FG003|Overall Study|Lost to Follow-up|0|||
164141977|NCT02056392|592880878|FG004|Overall Study|Lost to Follow-up|0|||
164141978|NCT02056392|592880879|FG005|Overall Study|Lost to Follow-up|0|||
164141979|NCT02056392|592880874|FG000|Overall Study|Protocol Violation|1|||
164141980|NCT02056392|592880875|FG001|Overall Study|Protocol Violation|0|||
164141981|NCT02056392|592880876|FG002|Overall Study|Protocol Violation|1|||
164141982|NCT02056392|592880877|FG003|Overall Study|Protocol Violation|0|||
164141983|NCT02056392|592880878|FG004|Overall Study|Protocol Violation|0|||
164141984|NCT02056392|592880879|FG005|Overall Study|Protocol Violation|0|||
164141985|NCT02056392|592880874|FG000|Overall Study|Withdrawal by Subject|1|||
164141986|NCT02056392|592880875|FG001|Overall Study|Withdrawal by Subject|0|||
164141987|NCT02056392|592880876|FG002|Overall Study|Withdrawal by Subject|0|||
164141988|NCT02056392|592880877|FG003|Overall Study|Withdrawal by Subject|0|||
164141989|NCT02056392|592880878|FG004|Overall Study|Withdrawal by Subject|1|||
164141990|NCT02056392|592880879|FG005|Overall Study|Withdrawal by Subject|0|||
164141991|NCT00103610|592880880|FG000|Overall Study|Entered Rescue Procedure|10|||
164141992|NCT00103610|592880881|FG001|Overall Study|Entered Rescue Procedure|52|||
164141993|NCT00103610|592880880|FG000|Overall Study|Death|16|||
164141994|NCT00103610|592880881|FG001|Overall Study|Death|12|||
164141995|NCT00103610|592880880|FG000|Overall Study|Elective Withdrawal|4|||
164141996|NCT00103610|592880881|FG001|Overall Study|Elective Withdrawal|0|||
164141997|NCT00103610|592880880|FG000|Overall Study|Lost to Follow-up|3|||
164141998|NCT00103610|592880881|FG001|Overall Study|Lost to Follow-up|1|||
164141999|NCT00103610|592880880|FG000|Overall Study|Adverse Event|2|||
164142000|NCT00103610|592880881|FG001|Overall Study|Adverse Event|2|||
164142001|NCT00103610|592880880|FG000|Overall Study|Other|2|||
164142002|NCT00103610|592880881|FG001|Overall Study|Other|7|||
164142003|NCT00103610|592880880|FG000|Overall Study|Failed mobilization|1|||
164142004|NCT00103610|592880881|FG001|Overall Study|Failed mobilization|5|||
164142005|NCT00103610|592880880|FG000|Overall Study|Noncompliance|0|||
164142006|NCT00103610|592880881|FG001|Overall Study|Noncompliance|1|||
164142007|NCT00658021|592880882|FG000|28-Week Treatment Period|Adverse Event|3|||
164142008|NCT00658021|592880883|FG001|28-Week Treatment Period|Adverse Event|1|||
164142009|NCT00658021|592880884|FG002|28-Week Treatment Period|Adverse Event|0|||
164142010|NCT00658021|592880882|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
164142011|NCT00658021|592880883|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
164142012|NCT00658021|592880884|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
164142013|NCT00658021|592880882|FG000|28-Week Treatment Period|Protocol Violation|0|||
164142014|NCT00658021|592880883|FG001|28-Week Treatment Period|Protocol Violation|2|||
164142015|NCT00658021|592880884|FG002|28-Week Treatment Period|Protocol Violation|1|||
164142016|NCT00658021|592880882|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
164142017|NCT00658021|592880883|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
164142018|NCT00658021|592880884|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
164142019|NCT00658021|592880882|FG000|28-Week Treatment Period|Physician Decision|1|||
164142020|NCT00658021|592880883|FG001|28-Week Treatment Period|Physician Decision|2|||
164142021|NCT00658021|592880884|FG002|28-Week Treatment Period|Physician Decision|1|||
164142022|NCT00658021|592880882|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
164142023|NCT00658021|592880883|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
164142024|NCT00658021|592880884|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
164142025|NCT00658021|592880882|FG000|28-Week Treatment Period|Loss of glucose control|1|||
164142026|NCT00658021|592880883|FG001|28-Week Treatment Period|Loss of glucose control|1|||
164142027|NCT00658021|592880884|FG002|28-Week Treatment Period|Loss of glucose control|10|||
164142028|NCT00658021|592880882|FG000|28-Week Treatment Period|Other|2|||
164142029|NCT00658021|592880883|FG001|28-Week Treatment Period|Other|3|||
164142030|NCT00658021|592880884|FG002|28-Week Treatment Period|Other|1|||
164142031|NCT00658021|592880882|FG000|28-Week Treatment Period|Did not receive treatment|2|||
164142032|NCT00658021|592880883|FG001|28-Week Treatment Period|Did not receive treatment|0|||
164142033|NCT00658021|592880884|FG002|28-Week Treatment Period|Did not receive treatment|0|||
164142034|NCT00658021|592880882|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
164142035|NCT00658021|592880883|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
164142036|NCT00658021|592880884|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
164142037|NCT00658021|592880882|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
164142038|NCT00658021|592880883|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
164142039|NCT00658021|592880884|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
164142079|NCT01277601|592882543|FG000|Overall Study|Noncompliance with Study Drug|1|||
164142080|NCT01277601|592882544|FG001|Overall Study|Noncompliance with Study Drug|3|||
164142081|NCT01277601|592882545|FG002|Overall Study|Noncompliance with Study Drug|2|||
164142082|NCT01277601|592882546|FG003|Overall Study|Noncompliance with Study Drug|0|||
164142083|NCT01277601|592882543|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
164142084|NCT01277601|592882544|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
164142085|NCT01277601|592882545|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
164142086|NCT01277601|592882546|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
164142087|NCT01277601|592882543|FG000|Overall Study|Protocol Violation|0|||
164142088|NCT01277601|592882544|FG001|Overall Study|Protocol Violation|2|||
164142089|NCT01277601|592882545|FG002|Overall Study|Protocol Violation|5|||
164142090|NCT01277601|592882546|FG003|Overall Study|Protocol Violation|0|||
164142091|NCT01277601|592882543|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
164142092|NCT01277601|592882544|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
164142093|NCT01277601|592882545|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
164142094|NCT01277601|592882546|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
164142095|NCT02260570|592882548|FG000|Overall Study|Withdrawal by Subject|2|||
164142096|NCT02260570|592882549|FG001|Overall Study|Withdrawal by Subject|1|||
164142097|NCT02260570|592882548|FG000|Overall Study|Physician Decision|1|||
164142098|NCT02260570|592882549|FG001|Overall Study|Physician Decision|1|||
164142099|NCT04034927|592882550|FG000|Overall Study|Adverse Event|4|||
164142100|NCT04034927|592882551|FG001|Overall Study|Adverse Event|9|||
164142101|NCT04034927|592882550|FG000|Overall Study|Death|0|||
164142102|NCT04034927|592882551|FG001|Overall Study|Death|1|||
164142103|NCT04034927|592882550|FG000|Overall Study|Withdrawal by Subject|0|||
164142104|NCT04034927|592882551|FG001|Overall Study|Withdrawal by Subject|3|||
164142105|NCT04034927|592882550|FG000|Overall Study|Still on Treatment|2|||
164142106|NCT04034927|592882551|FG001|Overall Study|Still on Treatment|1|||
164142107|NCT04034927|592882550|FG000|Overall Study|Other|1|||
164142108|NCT04034927|592882551|FG001|Overall Study|Other|1|||
164142109|NCT03996447|592882554|FG000|First MRI Examination|Adverse Event|2|||
164142110|NCT03996447|592882555|FG001|First MRI Examination|Adverse Event|0|||
164142111|NCT03996447|592882554|FG000|First MRI Examination|Withdrawal by Subject|1|||
164142112|NCT03996447|592882555|FG001|First MRI Examination|Withdrawal by Subject|2|||
164142113|NCT03996447|592882554|FG000|First MRI Examination|Protocol Violation|0|||
164142114|NCT03996447|592882555|FG001|First MRI Examination|Protocol Violation|1|||
164142115|NCT03996447|592882554|FG000|Washout|Adverse Event|2|||
164142116|NCT03996447|592882555|FG001|Washout|Adverse Event|0|||
164142117|NCT03996447|592882554|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
164142118|NCT03996447|592882555|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
164142119|NCT03996447|592882554|FG000|Washout|Withdrawal by Subject|0|||
164142120|NCT03996447|592882555|FG001|Washout|Withdrawal by Subject|1|||
164142121|NCT03996447|592882554|FG000|Washout|Other reason|1|||
164142122|NCT03996447|592882555|FG001|Washout|Other reason|1|||
164142123|NCT00369486|592882557|FG000|4-Week Visit|Missed visit|2|||
164142124|NCT00369486|592882558|FG001|4-Week Visit|Missed visit|2|||
164142125|NCT00369486|592882559|FG002|4-Week Visit|Missed visit|0|||
164142126|NCT00369486|592882560|FG003|4-Week Visit|Missed visit|2|||
164142127|NCT00369486|592882561|FG004|4-Week Visit|Missed visit|1|||
164142128|NCT00369486|592882557|FG000|4-Week Visit|Dropped|0|||
164142129|NCT00369486|592882558|FG001|4-Week Visit|Dropped|0|||
164142130|NCT00369486|592882559|FG002|4-Week Visit|Dropped|1|||
164142131|NCT00369486|592882560|FG003|4-Week Visit|Dropped|0|||
164142132|NCT00369486|592882561|FG004|4-Week Visit|Dropped|0|||
164142133|NCT00369486|592882557|FG000|8-Week Visit|Missed visit|0|||
164142134|NCT00369486|592882558|FG001|8-Week Visit|Missed visit|1|||
164142135|NCT00369486|592882559|FG002|8-Week Visit|Missed visit|0|||
164142136|NCT00369486|592882560|FG003|8-Week Visit|Missed visit|0|||
164142137|NCT00369486|592882561|FG004|8-Week Visit|Missed visit|1|||
164142138|NCT00369486|592882557|FG000|8-Week Visit|Dropped|0|||
164142139|NCT00369486|592882558|FG001|8-Week Visit|Dropped|0|||
164142140|NCT00369486|592882559|FG002|8-Week Visit|Dropped|0|||
164142141|NCT00369486|592882560|FG003|8-Week Visit|Dropped|1|||
164142142|NCT00369486|592882561|FG004|8-Week Visit|Dropped|0|||
164142143|NCT00369486|592882557|FG000|17-Week Visit|Missed visit|0|||
164142144|NCT00369486|592882558|FG001|17-Week Visit|Missed visit|0|||
164142145|NCT00369486|592882559|FG002|17-Week Visit|Missed visit|1|||
164142146|NCT00369486|592882560|FG003|17-Week Visit|Missed visit|1|||
164142147|NCT00369486|592882561|FG004|17-Week Visit|Missed visit|1|||
164142148|NCT00369486|592882557|FG000|34-Week Visit|Dropped|0|||
164142149|NCT00369486|592882558|FG001|34-Week Visit|Dropped|1|||
164142150|NCT00369486|592882559|FG002|34-Week Visit|Dropped|1|||
164142151|NCT00369486|592882560|FG003|34-Week Visit|Dropped|3|||
164142152|NCT00369486|592882561|FG004|34-Week Visit|Dropped|3|||
164142153|NCT01810302|592882562|FG000|Overall Study|Death|1|||
164142154|NCT01810302|592882563|FG001|Overall Study|Death|0|||
164142155|NCT01810302|592882562|FG000|Overall Study|Physician Decision|0|||
164142156|NCT01810302|592882563|FG001|Overall Study|Physician Decision|1|||
164142157|NCT00287586|592882564|FG000|Overall Study|Withdrew Consent|19|||
164142158|NCT00287586|592882565|FG001|Overall Study|Withdrew Consent|30|||
164142293|NCT02186834|592882587|FG000|Treatment at RP2D|Died prior to treatment|0|||
164142294|NCT02186834|592882588|FG001|Treatment at RP2D|Died prior to treatment|0|||
164142295|NCT02186834|592882589|FG002|Treatment at RP2D|Died prior to treatment|0|||
164142296|NCT02186834|592882590|FG003|Treatment at RP2D|Died prior to treatment|0|||
164142297|NCT02186834|592882591|FG004|Treatment at RP2D|Died prior to treatment|0|||
164142298|NCT02186834|592882592|FG005|Treatment at RP2D|Died prior to treatment|1|||
164142299|NCT04581369|592882593|FG000|Overall Study|Death|7|||
164142300|NCT04581369|592882594|FG001|Overall Study|Death|6|||
164142301|NCT04581369|592882595|FG002|Overall Study|Death|0|||
164142302|NCT04581369|592882593|FG000|Overall Study|Lost to Follow-up|7|||
164142303|NCT04581369|592882594|FG001|Overall Study|Lost to Follow-up|3|||
164142304|NCT04581369|592882595|FG002|Overall Study|Lost to Follow-up|0|||
164142305|NCT04581369|592882593|FG000|Overall Study|liver transplant|2|||
164142306|NCT04581369|592882594|FG001|Overall Study|liver transplant|2|||
164142307|NCT04581369|592882595|FG002|Overall Study|liver transplant|0|||
164142308|NCT04581369|592882593|FG000|Overall Study|transitioned to hospice care|0|||
164142309|NCT04581369|592882594|FG001|Overall Study|transitioned to hospice care|5|||
164142310|NCT04581369|592882595|FG002|Overall Study|transitioned to hospice care|0|||
164142311|NCT04746794|592882598|FG000|Overall Study|Did not complete any study assessment|50303|||
164142312|NCT04746794|592882599|FG001|Overall Study|Did not complete any study assessment|44997|||
164142313|NCT01422187|592882602|FG000|Overall Study|Personal reason|1|||
164142314|NCT01422187|592882603|FG001|Overall Study|Personal reason|0|||
164142315|NCT01422187|592882604|FG002|Overall Study|Personal reason|0|||
164142316|NCT01422187|592882602|FG000|Overall Study|Lost to Follow-up|0|||
164142317|NCT01422187|592882603|FG001|Overall Study|Lost to Follow-up|1|||
164142318|NCT01422187|592882604|FG002|Overall Study|Lost to Follow-up|0|||
164142319|NCT00856375|592882665|FG000|Overall Study|Other|0|||
164142320|NCT00856375|592882666|FG001|Overall Study|Other|1|||
164142321|NCT00856375|592882665|FG000|Overall Study|Death|32|||
164142322|NCT00856375|592882666|FG001|Overall Study|Death|30|||
164142323|NCT00856375|592882665|FG000|Overall Study|Sponsor Terminated Study|7|||
164142324|NCT00856375|592882666|FG001|Overall Study|Sponsor Terminated Study|7|||
164142325|NCT00856375|592882665|FG000|Overall Study|Withdrawal by Subject|2|||
164142326|NCT00856375|592882666|FG001|Overall Study|Withdrawal by Subject|1|||
164142327|NCT00856375|592882665|FG000|Overall Study|Lost to Follow-up|1|||
164142328|NCT00856375|592882666|FG001|Overall Study|Lost to Follow-up|2|||
164142329|NCT02538965|592882671|FG000|Treatment Period|Other = Death due to disease progression|1|||
164142330|NCT02538965|592882671|FG000|Treatment Period|Adverse Event|2|||
164142331|NCT02538965|592882671|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
164142332|NCT02538965|592882671|FG000|Treatment Period|Treatment Failure|9|||
164142333|NCT02538965|592882671|FG000|Treatment Period|Disease Progression|1|||
164142334|NCT02538965|592882671|FG000|Treatment Period|Physician Decision|2|||
164142335|NCT02538965|592882671|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
164142336|NCT02538965|592882671|FG000|Follow-Up Period|Withdrawal by Parent|4|||
164142337|NCT00875797|592882672|FG000|Overall Study|Protocol Violation|6|||
164142338|NCT00875797|592882673|FG001|Overall Study|Protocol Violation|3|||
164142339|NCT00741286|592882676|FG000|Overall Study|Lost to Follow-up|15|||
164142340|NCT00741286|592882677|FG001|Overall Study|Lost to Follow-up|10|||
164142341|NCT00741286|592882676|FG000|Overall Study|Adverse Event|1|||
164142342|NCT00741286|592882677|FG001|Overall Study|Adverse Event|6|||
164142343|NCT00741286|592882676|FG000|Overall Study|Protocol Violation|3|||
164142344|NCT00741286|592882677|FG001|Overall Study|Protocol Violation|2|||
164142345|NCT00741286|592882676|FG000|Overall Study|Primary Outcome|1|||
164142346|NCT00741286|592882677|FG001|Overall Study|Primary Outcome|1|||
164142347|NCT02892149|592882678|FG000|Overall Study|Death|262|||
164142348|NCT02892149|592882679|FG001|Overall Study|Death|278|||
164142349|NCT02892149|592882678|FG000|Overall Study|Withdrawal by Subject|53|||
164142350|NCT02892149|592882679|FG001|Overall Study|Withdrawal by Subject|47|||
164142351|NCT02892149|592882678|FG000|Overall Study|Lost to Follow-up|37|||
164142352|NCT02892149|592882679|FG001|Overall Study|Lost to Follow-up|31|||
164142353|NCT02165735|592882680|FG000|Overall Study|Lost to Follow-up|12|||
164142354|NCT02165735|592882681|FG001|Overall Study|Lost to Follow-up|10|||
164142355|NCT02165735|592882680|FG000|Overall Study|Withdrawal by Subject|3|||
164142356|NCT02165735|592882681|FG001|Overall Study|Withdrawal by Subject|0|||
164142357|NCT02165735|592882680|FG000|Overall Study|Participant indicated lack of time|1|||
164142358|NCT02165735|592882681|FG001|Overall Study|Participant indicated lack of time|3|||
164142359|NCT02165735|592882680|FG000|Overall Study|Protocol Violation|0|||
164142360|NCT02165735|592882681|FG001|Overall Study|Protocol Violation|1|||
164142361|NCT00101283|592882682|FG000|Overall Study|Withdrawal by Subject|0|||
164142362|NCT00101283|592882683|FG001|Overall Study|Withdrawal by Subject|1|||
164142363|NCT00101283|592882682|FG000|Overall Study|Insurance Refusal|0|||
164142364|NCT00101283|592882683|FG001|Overall Study|Insurance Refusal|1|||
164142365|NCT00101283|592882682|FG000|Overall Study|Prostate Cancer Recurrence|0|||
164142366|NCT00101283|592882683|FG001|Overall Study|Prostate Cancer Recurrence|1|||
164142367|NCT00595309|592882684|FG000|Overall Study|Lost to Follow-up|1|||
164142368|NCT00595309|592882684|FG000|Overall Study|planned vaccination against yellow fever|1|||
164142369|NCT00595309|592882684|FG000|Overall Study|acute infection after V0|1|||
164142370|NCT00595309|592882684|FG000|Overall Study|personal reason|1|||
164142375|NCT00182325|592882692|FG000|Overall Study|Did not complete survey|22|||
164142376|NCT00182325|592882693|FG001|Overall Study|Did not complete survey|43|||
164142377|NCT02015065|592882697|FG000|Overall Study|Death on study|1|||
164142378|NCT02015065|592882698|FG001|Overall Study|Death on study|2|||
164142379|NCT02015065|592882699|FG002|Overall Study|Death on study|1|||
164142380|NCT01420965|592882700|FG000|Overall Study|Withdrawal by Subject|1|||
164142381|NCT01420965|592882701|FG001|Overall Study|Withdrawal by Subject|0|||
164142382|NCT01420965|592882702|FG002|Overall Study|Withdrawal by Subject|0|||
164142383|NCT01420965|592882700|FG000|Overall Study|Adverse Event|0|||
164142384|NCT01420965|592882701|FG001|Overall Study|Adverse Event|1|||
164142385|NCT01420965|592882702|FG002|Overall Study|Adverse Event|0|||
164142386|NCT00252239|592882707|FG000|Overall Study|Withdrawal by Subject|1|||
164142387|NCT00252239|592882708|FG001|Overall Study|Withdrawal by Subject|0|||
164142388|NCT00252239|592882709|FG002|Overall Study|Withdrawal by Subject|0|||
164142389|NCT00252239|592882710|FG003|Overall Study|Withdrawal by Subject|1|||
164142390|NCT00252239|592882707|FG000|Overall Study|Lost to Follow-up|0|||
164142391|NCT00252239|592882708|FG001|Overall Study|Lost to Follow-up|0|||
164142392|NCT00252239|592882709|FG002|Overall Study|Lost to Follow-up|2|||
164142393|NCT00252239|592882710|FG003|Overall Study|Lost to Follow-up|0|||
164142394|NCT02613182|592882713|FG000|Overall Study|Death|6|||
164142395|NCT02613182|592882713|FG000|Overall Study|Physician Decision|1|||
164142396|NCT02613182|592882713|FG000|Overall Study|Study Terminated by Sponsor|21|||
164142397|NCT02613182|592882713|FG000|Overall Study|Withdrawal by Subject|6|||
164142398|NCT02785952|592882714|FG000|Overall Study|Adverse Event|31|||
164142399|NCT02785952|592882715|FG001|Overall Study|Adverse Event|19|||
164142400|NCT02785952|592882714|FG000|Overall Study|Refusal unrelated to adverse events|10|||
164142401|NCT02785952|592882715|FG001|Overall Study|Refusal unrelated to adverse events|5|||
164142402|NCT02785952|592882714|FG000|Overall Study|Disease progression/relapse|61|||
164142403|NCT02785952|592882715|FG001|Overall Study|Disease progression/relapse|89|||
164142404|NCT02785952|592882714|FG000|Overall Study|Death|11|||
164142405|NCT02785952|592882715|FG001|Overall Study|Death|7|||
164142406|NCT02785952|592882714|FG000|Overall Study|Other- not protocol specified|6|||
164142407|NCT02785952|592882715|FG001|Overall Study|Other- not protocol specified|4|||
164142408|NCT02785952|592882714|FG000|Overall Study|On protocol treatment|6|||
164142409|NCT02785952|592882715|FG001|Overall Study|On protocol treatment|3|||
164142410|NCT00090363|592882718|FG000|Overall Study|Lost to Follow-up|1|||
164142411|NCT00090363|592882719|FG001|Overall Study|Lost to Follow-up|2|||
164142412|NCT00090363|592882720|FG002|Overall Study|Lost to Follow-up|1|||
164142413|NCT00090363|592882718|FG000|Overall Study|Withdrawal by Subject|7|||
164142414|NCT00090363|592882719|FG001|Overall Study|Withdrawal by Subject|7|||
164142415|NCT00090363|592882720|FG002|Overall Study|Withdrawal by Subject|6|||
164142416|NCT00090363|592882718|FG000|Overall Study|Study-specific discontinuation criteria|75|||
164142417|NCT00090363|592882719|FG001|Overall Study|Study-specific discontinuation criteria|74|||
164142418|NCT00090363|592882720|FG002|Overall Study|Study-specific discontinuation criteria|62|||
164142419|NCT00090363|592882718|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164142420|NCT00090363|592882719|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
164142421|NCT00090363|592882720|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164142422|NCT00090363|592882718|FG000|Overall Study|Consent expired|7|||
164142423|NCT00090363|592882719|FG001|Overall Study|Consent expired|10|||
164142424|NCT00090363|592882720|FG002|Overall Study|Consent expired|9|||
164142425|NCT00090363|592882718|FG000|Overall Study|Reasons not specified|2|||
164142426|NCT00090363|592882719|FG001|Overall Study|Reasons not specified|1|||
164142427|NCT00090363|592882720|FG002|Overall Study|Reasons not specified|1|||
164142428|NCT00090363|592882718|FG000|Overall Study|Continuing on study off treatment|14|||
164142429|NCT00090363|592882719|FG001|Overall Study|Continuing on study off treatment|13|||
164142430|NCT00090363|592882720|FG002|Overall Study|Continuing on study off treatment|16|||
164142431|NCT04642365|592882722|FG000|Overall Study|Death|3|||
164142432|NCT04642365|592882723|FG001|Overall Study|Death|2|||
164142433|NCT04642365|592882724|FG002|Overall Study|Death|4|||
164142434|NCT04642365|592882725|FG003|Overall Study|Death|5|||
164142435|NCT04642365|592882726|FG004|Overall Study|Death|5|||
164142436|NCT04642365|592882727|FG005|Overall Study|Death|3|||
164142437|NCT04642365|592882728|FG006|Overall Study|Death|2|||
164142438|NCT04642365|592882729|FG007|Overall Study|Death|1|||
164142439|NCT04642365|592882722|FG000|Overall Study|Physician Decision|1|||
164142440|NCT04642365|592882723|FG001|Overall Study|Physician Decision|0|||
164142441|NCT04642365|592882724|FG002|Overall Study|Physician Decision|0|||
164142442|NCT04642365|592882725|FG003|Overall Study|Physician Decision|0|||
164142443|NCT04642365|592882726|FG004|Overall Study|Physician Decision|0|||
164142444|NCT04642365|592882727|FG005|Overall Study|Physician Decision|0|||
164142445|NCT04642365|592882728|FG006|Overall Study|Physician Decision|0|||
164142446|NCT04642365|592882729|FG007|Overall Study|Physician Decision|0|||
164142447|NCT04642365|592882722|FG000|Overall Study|Progressive Disease|1|||
164142448|NCT04642365|592882723|FG001|Overall Study|Progressive Disease|1|||
164142449|NCT04642365|592882724|FG002|Overall Study|Progressive Disease|1|||
164142450|NCT04642365|592882725|FG003|Overall Study|Progressive Disease|0|||
164142451|NCT04642365|592882726|FG004|Overall Study|Progressive Disease|0|||
164142452|NCT04642365|592882727|FG005|Overall Study|Progressive Disease|0|||
164142455|NCT04642365|592882722|FG000|Overall Study|Study Terminated By Sponsor|0|||
164142456|NCT04642365|592882723|FG001|Overall Study|Study Terminated By Sponsor|2|||
164142457|NCT04642365|592882724|FG002|Overall Study|Study Terminated By Sponsor|1|||
164142458|NCT04642365|592882725|FG003|Overall Study|Study Terminated By Sponsor|1|||
164142459|NCT04642365|592882726|FG004|Overall Study|Study Terminated By Sponsor|1|||
164142460|NCT04642365|592882727|FG005|Overall Study|Study Terminated By Sponsor|2|||
164142461|NCT04642365|592882728|FG006|Overall Study|Study Terminated By Sponsor|2|||
164142462|NCT04642365|592882729|FG007|Overall Study|Study Terminated By Sponsor|1|||
164142463|NCT04642365|592882722|FG000|Overall Study|Symptomatic Deterioration|1|||
164142464|NCT04642365|592882723|FG001|Overall Study|Symptomatic Deterioration|1|||
164142465|NCT04642365|592882724|FG002|Overall Study|Symptomatic Deterioration|0|||
164142466|NCT04642365|592882725|FG003|Overall Study|Symptomatic Deterioration|0|||
164142467|NCT04642365|592882726|FG004|Overall Study|Symptomatic Deterioration|0|||
164142468|NCT04642365|592882727|FG005|Overall Study|Symptomatic Deterioration|1|||
164142469|NCT04642365|592882728|FG006|Overall Study|Symptomatic Deterioration|0|||
164142470|NCT04642365|592882729|FG007|Overall Study|Symptomatic Deterioration|0|||
164142471|NCT04642365|592882722|FG000|Overall Study|Withdrawal by Subject|0|||
164142472|NCT04642365|592882723|FG001|Overall Study|Withdrawal by Subject|0|||
164142473|NCT04642365|592882724|FG002|Overall Study|Withdrawal by Subject|1|||
164142474|NCT04642365|592882725|FG003|Overall Study|Withdrawal by Subject|1|||
164142475|NCT04642365|592882726|FG004|Overall Study|Withdrawal by Subject|0|||
164142476|NCT04642365|592882727|FG005|Overall Study|Withdrawal by Subject|0|||
164142477|NCT04642365|592882728|FG006|Overall Study|Withdrawal by Subject|2|||
164142478|NCT04642365|592882729|FG007|Overall Study|Withdrawal by Subject|0|||
164142479|NCT04642365|592882722|FG000|Overall Study|Adverse Event|0|||
164142480|NCT04642365|592882723|FG001|Overall Study|Adverse Event|0|||
164142481|NCT04642365|592882724|FG002|Overall Study|Adverse Event|0|||
164142482|NCT04642365|592882725|FG003|Overall Study|Adverse Event|0|||
164142483|NCT04642365|592882726|FG004|Overall Study|Adverse Event|0|||
164142484|NCT04642365|592882727|FG005|Overall Study|Adverse Event|0|||
164142485|NCT04642365|592882728|FG006|Overall Study|Adverse Event|0|||
164142486|NCT04642365|592882729|FG007|Overall Study|Adverse Event|1|||
164142487|NCT02728843|592882730|FG000|Overall Study|Adverse Event|0|||
164142488|NCT02728843|592882731|FG001|Overall Study|Adverse Event|2|||
164142489|NCT02728843|592882732|FG002|Overall Study|Adverse Event|3|||
164142490|NCT02728843|592882733|FG003|Overall Study|Adverse Event|1|||
164142491|NCT02728843|592882734|FG004|Overall Study|Adverse Event|2|||
164142492|NCT02728843|592882730|FG000|Overall Study|Lack of Efficacy|0|||
164142493|NCT02728843|592882731|FG001|Overall Study|Lack of Efficacy|1|||
164142494|NCT02728843|592882732|FG002|Overall Study|Lack of Efficacy|1|||
164142495|NCT02728843|592882733|FG003|Overall Study|Lack of Efficacy|0|||
164142496|NCT02728843|592882734|FG004|Overall Study|Lack of Efficacy|0|||
164142497|NCT02728843|592882730|FG000|Overall Study|Protocol Violation|2|||
164142498|NCT02728843|592882731|FG001|Overall Study|Protocol Violation|0|||
164142499|NCT02728843|592882732|FG002|Overall Study|Protocol Violation|4|||
164142500|NCT02728843|592882733|FG003|Overall Study|Protocol Violation|2|||
164142501|NCT02728843|592882734|FG004|Overall Study|Protocol Violation|2|||
164142502|NCT02728843|592882730|FG000|Overall Study|Withdrawal by Subject|1|||
164142503|NCT02728843|592882731|FG001|Overall Study|Withdrawal by Subject|0|||
164142504|NCT02728843|592882732|FG002|Overall Study|Withdrawal by Subject|0|||
164142505|NCT02728843|592882733|FG003|Overall Study|Withdrawal by Subject|1|||
164142506|NCT02728843|592882734|FG004|Overall Study|Withdrawal by Subject|0|||
164142507|NCT02728843|592882730|FG000|Overall Study|Use of rescue medication|0|||
164142508|NCT02728843|592882731|FG001|Overall Study|Use of rescue medication|2|||
164142509|NCT02728843|592882732|FG002|Overall Study|Use of rescue medication|0|||
164142510|NCT02728843|592882733|FG003|Overall Study|Use of rescue medication|2|||
164142511|NCT02728843|592882734|FG004|Overall Study|Use of rescue medication|1|||
164142512|NCT03185013|592882735|FG000|Overall Study|Withdrawal by Subject|5|||
164142513|NCT03185013|592882736|FG001|Overall Study|Withdrawal by Subject|3|||
164142514|NCT03185013|592882735|FG000|Overall Study|Adverse Event|1|||
164142515|NCT03185013|592882736|FG001|Overall Study|Adverse Event|0|||
164142516|NCT03185013|592882735|FG000|Overall Study|Progressive Disease|1|||
164142517|NCT03185013|592882736|FG001|Overall Study|Progressive Disease|0|||
164142518|NCT03185013|592882735|FG000|Overall Study|Lost to Follow-up|8|||
164142519|NCT03185013|592882736|FG001|Overall Study|Lost to Follow-up|2|||
164142520|NCT03185013|592882735|FG000|Overall Study|Physician Decision|1|||
164142521|NCT03185013|592882736|FG001|Overall Study|Physician Decision|0|||
164142522|NCT03185013|592882735|FG000|Overall Study|Protocol Deviation|2|||
164142523|NCT03185013|592882736|FG001|Overall Study|Protocol Deviation|0|||
164142524|NCT03185013|592882735|FG000|Overall Study|Reason not Specified|3|||
164142525|NCT03185013|592882736|FG001|Overall Study|Reason not Specified|2|||
164142526|NCT03185013|592882735|FG000|Overall Study|Death|1|||
164142527|NCT03185013|592882736|FG001|Overall Study|Death|0|||
164142528|NCT00197496|592882740|FG000|Baseline to Discharge|not interested|1|||
164142529|NCT00197496|592882741|FG001|Baseline to Discharge|not interested|0|||
164142530|NCT00197496|592882740|FG000|Baseline to Discharge|MRSA|1|||
164142531|NCT00197496|592882741|FG001|Baseline to Discharge|MRSA|0|||
164142532|NCT00197496|592882740|FG000|Baseline to Discharge|Physician Decision|0|||
164142533|NCT00197496|592882741|FG001|Baseline to Discharge|Physician Decision|1|||
164142534|NCT00197496|592882740|FG000|Baseline to Discharge|Protocol Violation|0|||
164142535|NCT00197496|592882741|FG001|Baseline to Discharge|Protocol Violation|1|||
164142536|NCT00197496|592882740|FG000|Follow-up|Lost to Follow-up|2|||
164142537|NCT00197496|592882741|FG001|Follow-up|Lost to Follow-up|1|||
164142538|NCT03255655|592882742|FG000|Overall Study|Lost to Follow-up|7|||
164142539|NCT03255655|592882743|FG001|Overall Study|Lost to Follow-up|4|||
164142540|NCT01806506|592882747|FG000|Overall Study|Lost to Follow-up|2|||
164142541|NCT01806506|592882748|FG001|Overall Study|Lost to Follow-up|1|||
164142542|NCT02099682|592882751|FG000|Overall Study|Data Not Available|51|||
164142543|NCT02099682|592882751|FG000|Overall Study|Lost to Follow-up|31|||
164142544|NCT02099682|592882751|FG000|Overall Study|Other|29|||
164142545|NCT02203331|592882752|FG000|Overall Study|Pregnancy|1|||
164142546|NCT02203331|592882753|FG001|Overall Study|Pregnancy|0|||
164142547|NCT02203331|592882754|FG002|Overall Study|Pregnancy|0|||
164142548|NCT02203331|592882755|FG003|Overall Study|Pregnancy|0|||
164142549|NCT02203331|592882756|FG004|Overall Study|Pregnancy|2|||
164142550|NCT02203331|592882757|FG005|Overall Study|Pregnancy|0|||
164142551|NCT02203331|592882752|FG000|Overall Study|Withdrawal by Subject|1|||
164142552|NCT02203331|592882753|FG001|Overall Study|Withdrawal by Subject|0|||
164142553|NCT02203331|592882754|FG002|Overall Study|Withdrawal by Subject|1|||
164142554|NCT02203331|592882755|FG003|Overall Study|Withdrawal by Subject|0|||
164142555|NCT02203331|592882756|FG004|Overall Study|Withdrawal by Subject|0|||
164142556|NCT02203331|592882757|FG005|Overall Study|Withdrawal by Subject|3|||
164142557|NCT02203331|592882752|FG000|Overall Study|Adverse Event|4|||
164142558|NCT02203331|592882753|FG001|Overall Study|Adverse Event|8|||
164142559|NCT02203331|592882754|FG002|Overall Study|Adverse Event|3|||
164142560|NCT02203331|592882755|FG003|Overall Study|Adverse Event|4|||
164142561|NCT02203331|592882756|FG004|Overall Study|Adverse Event|3|||
164142562|NCT02203331|592882757|FG005|Overall Study|Adverse Event|3|||
164142563|NCT02203331|592882752|FG000|Overall Study|Other Reasons|1|||
164142564|NCT02203331|592882753|FG001|Overall Study|Other Reasons|2|||
164142565|NCT02203331|592882754|FG002|Overall Study|Other Reasons|0|||
164142566|NCT02203331|592882755|FG003|Overall Study|Other Reasons|2|||
164142567|NCT02203331|592882756|FG004|Overall Study|Other Reasons|0|||
164142568|NCT02203331|592882757|FG005|Overall Study|Other Reasons|0|||
164142569|NCT02203331|592882752|FG000|Overall Study|Lack of Efficacy|0|||
164142570|NCT02203331|592882753|FG001|Overall Study|Lack of Efficacy|2|||
164142571|NCT02203331|592882754|FG002|Overall Study|Lack of Efficacy|1|||
164142572|NCT02203331|592882755|FG003|Overall Study|Lack of Efficacy|0|||
164142573|NCT02203331|592882756|FG004|Overall Study|Lack of Efficacy|0|||
164142574|NCT02203331|592882757|FG005|Overall Study|Lack of Efficacy|1|||
164142575|NCT02203331|592882752|FG000|Overall Study|Protocol Violation|0|||
164142576|NCT02203331|592882753|FG001|Overall Study|Protocol Violation|2|||
164142577|NCT02203331|592882754|FG002|Overall Study|Protocol Violation|0|||
164142578|NCT02203331|592882755|FG003|Overall Study|Protocol Violation|1|||
164142579|NCT02203331|592882756|FG004|Overall Study|Protocol Violation|1|||
164142580|NCT02203331|592882757|FG005|Overall Study|Protocol Violation|0|||
164142581|NCT02203331|592882752|FG000|Overall Study|Lost to Follow-up|0|||
164142582|NCT02203331|592882753|FG001|Overall Study|Lost to Follow-up|0|||
164142583|NCT02203331|592882754|FG002|Overall Study|Lost to Follow-up|0|||
164142584|NCT02203331|592882755|FG003|Overall Study|Lost to Follow-up|0|||
164142585|NCT02203331|592882756|FG004|Overall Study|Lost to Follow-up|1|||
164142586|NCT02203331|592882757|FG005|Overall Study|Lost to Follow-up|0|||
164142587|NCT02542605|592882758|FG000|Part B: Challenge Phase|Sponsor decision|1|||
164142588|NCT02542605|592882759|FG001|Part B: Challenge Phase|Sponsor decision|0|||
164142589|NCT02542605|592882760|FG002|Part B: Challenge Phase|Sponsor decision|0|||
164142590|NCT02542605|592882758|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
164142591|NCT02542605|592882759|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
164142592|NCT02542605|592882760|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
164142593|NCT00278889|592882762|FG000|Overall Study|Withdrawal by Subject|0|||
164142594|NCT00278889|592882763|FG001|Overall Study|Withdrawal by Subject|5|||
164142595|NCT00278889|592882764|FG002|Overall Study|Withdrawal by Subject|3|||
164142596|NCT00278889|592882762|FG000|Overall Study|Lost to Follow-up|1|||
164142597|NCT00278889|592882763|FG001|Overall Study|Lost to Follow-up|1|||
164142598|NCT00278889|592882764|FG002|Overall Study|Lost to Follow-up|0|||
164142599|NCT00278889|592882762|FG000|Overall Study|Death|24|||
164142600|NCT00278889|592882763|FG001|Overall Study|Death|21|||
164142601|NCT00278889|592882764|FG002|Overall Study|Death|17|||
164142602|NCT00704730|592882765|FG000|Overall Study|Adverse Event|35|||
164142603|NCT00704730|592882766|FG001|Overall Study|Adverse Event|9|||
164142604|NCT00704730|592882765|FG000|Overall Study|Death|11|||
164142605|NCT00704730|592882766|FG001|Overall Study|Death|5|||
164142606|NCT00704730|592882765|FG000|Overall Study|Physician Decision|2|||
164142607|NCT00704730|592882766|FG001|Overall Study|Physician Decision|0|||
164142608|NCT00704730|592882765|FG000|Overall Study|Did not receive drug|5|||
164142609|NCT00704730|592882766|FG001|Overall Study|Did not receive drug|2|||
164142610|NCT00704730|592882765|FG000|Overall Study|Disease progression per PI|58|||
164142611|NCT00704730|592882766|FG001|Overall Study|Disease progression per PI|67|||
164142612|NCT00704730|592882765|FG000|Overall Study|data unavailable|1|||
164142614|NCT00704730|592882765|FG000|Overall Study|Withdrawal by Subject|9|||
164142615|NCT00704730|592882766|FG001|Overall Study|Withdrawal by Subject|13|||
164142616|NCT05833139|592884355|FG000|Study Period 2|Adverse Event|1|||
164142617|NCT02847260|592884358|FG000|Overall Study|Adverse Event|3|||
164142618|NCT02847260|592884358|FG000|Overall Study|Withdrawal by Subject|2|||
164142619|NCT02847260|592884358|FG000|Overall Study|Clinical Deterioration|1|||
164142620|NCT02847260|592884358|FG000|Overall Study|Physician Decision|1|||
164142621|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
164142622|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
164142623|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
164142624|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
164142625|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
164142626|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
164142627|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
164142628|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
164142629|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
164142630|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
164142631|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
164142632|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
164142633|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
164142634|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
164142635|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
164142636|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164142637|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164142638|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164142639|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164142640|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
164142641|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
164142642|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
164142643|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
164142644|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
164142645|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
164142646|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164142647|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164142648|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164142649|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164142650|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
164142651|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
164142652|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
164142653|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
164142654|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
164142655|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
164142656|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164142657|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164142658|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164142659|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164142660|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
164142661|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142662|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142663|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142664|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
164142665|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142666|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142667|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142668|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142669|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142670|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
164142671|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
164142672|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
164142673|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
164142674|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
164142675|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
164142676|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
164142677|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
164142678|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
164142679|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
164142680|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
164142681|NCT03104400|592884359|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142682|NCT03104400|592884360|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142683|NCT03104400|592884361|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142684|NCT03104400|592884362|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
164142685|NCT03104400|592884363|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142686|NCT03104400|592884364|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142687|NCT03104400|592884365|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142688|NCT03104400|592884366|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142689|NCT03104400|592884367|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142690|NCT03104400|592884368|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
164142691|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
164142692|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
164142693|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
164142694|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
164142695|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
164142696|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
164142697|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
164142698|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
164142699|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
164142700|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
164142701|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164142702|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164142703|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164142704|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164142705|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
164142706|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
164142707|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
164142708|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
164142709|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
164142710|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
164142711|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164142712|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164142713|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164142714|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164142715|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
164142716|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
164142717|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
164142718|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
164142719|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
164142720|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
164142721|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164142722|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164142723|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164142724|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164142725|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
164142726|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
164142727|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
164142728|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
164142729|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
164142730|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
164142731|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142732|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142733|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142734|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142735|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142736|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142737|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
164142738|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
164142739|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
164142740|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
164142741|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142742|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142743|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142744|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142745|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142746|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142747|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142748|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
164142749|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
164142750|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
164142751|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
164142752|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
164142753|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
164142754|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
164142755|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
164142756|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
164142757|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
164142758|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
164142759|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
164142760|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
164142761|NCT03104400|592884359|FG000|Period 2 Week 56 - 260)|Other|0|||
164142762|NCT03104400|592884360|FG001|Period 2 Week 56 - 260)|Other|0|||
164142763|NCT03104400|592884361|FG002|Period 2 Week 56 - 260)|Other|0|||
164142764|NCT03104400|592884362|FG003|Period 2 Week 56 - 260)|Other|0|||
164142765|NCT03104400|592884363|FG004|Period 2 Week 56 - 260)|Other|0|||
164142766|NCT03104400|592884364|FG005|Period 2 Week 56 - 260)|Other|0|||
164142767|NCT03104400|592884365|FG006|Period 2 Week 56 - 260)|Other|0|||
164142768|NCT03104400|592884366|FG007|Period 2 Week 56 - 260)|Other|0|||
164142769|NCT03104400|592884367|FG008|Period 2 Week 56 - 260)|Other|1|||
164142770|NCT03104400|592884368|FG009|Period 2 Week 56 - 260)|Other|1|||
164142771|NCT00264550|592884371|FG000|Overall Study|Death|0|||
164142772|NCT00264550|592884372|FG001|Overall Study|Death|3|||
164142773|NCT00264550|592884373|FG002|Overall Study|Death|0|||
164142774|NCT00264550|592884374|FG003|Overall Study|Death|0|||
164142775|NCT00264550|592884371|FG000|Overall Study|Lost to Follow-up|3|||
164142776|NCT00264550|592884372|FG001|Overall Study|Lost to Follow-up|1|||
164142777|NCT00264550|592884373|FG002|Overall Study|Lost to Follow-up|1|||
164142778|NCT00264550|592884374|FG003|Overall Study|Lost to Follow-up|1|||
164142779|NCT00264550|592884371|FG000|Overall Study|Adverse Event|23|||
164142780|NCT00264550|592884372|FG001|Overall Study|Adverse Event|18|||
164142781|NCT00264550|592884373|FG002|Overall Study|Adverse Event|9|||
164142782|NCT00264550|592884374|FG003|Overall Study|Adverse Event|14|||
164142783|NCT00264550|592884371|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
164142784|NCT00264550|592884372|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
164142785|NCT00264550|592884373|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
164142786|NCT00264550|592884374|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
164142787|NCT00264550|592884371|FG000|Overall Study|Discontinued oral study agent|0|||
164142788|NCT00264550|592884372|FG001|Overall Study|Discontinued oral study agent|1|||
164142789|NCT00264550|592884373|FG002|Overall Study|Discontinued oral study agent|0|||
164142790|NCT00264550|592884374|FG003|Overall Study|Discontinued oral study agent|0|||
164142791|NCT00264550|592884371|FG000|Overall Study|Other|13|||
164142792|NCT00264550|592884372|FG001|Overall Study|Other|7|||
164142793|NCT00264550|592884373|FG002|Overall Study|Other|3|||
164142794|NCT00264550|592884374|FG003|Overall Study|Other|9|||
164142795|NCT02129608|592884375|FG000|Overall Study|Lost to Follow-up|0|||
164142796|NCT02129608|592884376|FG001|Overall Study|Lost to Follow-up|1|||
164142797|NCT02129608|592884377|FG002|Overall Study|Lost to Follow-up|1|||
164142798|NCT02129608|592884375|FG000|Overall Study|Withdrawal by Subject|0|||
164142799|NCT02129608|592884376|FG001|Overall Study|Withdrawal by Subject|0|||
164142800|NCT02129608|592884377|FG002|Overall Study|Withdrawal by Subject|2|||
164142801|NCT00129389|592884378|FG000|Overall Study|Adverse Event|19|||
164142802|NCT00129389|592884379|FG001|Overall Study|Adverse Event|87|||
164142803|NCT00129389|592884378|FG000|Overall Study|Death|0|||
164142804|NCT00129389|592884379|FG001|Overall Study|Death|1|||
164142805|NCT00129389|592884378|FG000|Overall Study|Lost to Follow-up|2|||
164142806|NCT00129389|592884379|FG001|Overall Study|Lost to Follow-up|1|||
164142807|NCT00129389|592884378|FG000|Overall Study|Physician Decision|0|||
164142808|NCT00129389|592884379|FG001|Overall Study|Physician Decision|4|||
164142809|NCT00129389|592884378|FG000|Overall Study|Protocol Violation|0|||
164142810|NCT00129389|592884379|FG001|Overall Study|Protocol Violation|6|||
164142811|NCT00129389|592884378|FG000|Overall Study|Withdrawal by Subject|9|||
164142812|NCT00129389|592884379|FG001|Overall Study|Withdrawal by Subject|23|||
164142813|NCT00129389|592884378|FG000|Overall Study|Relapse|1|||
164142814|NCT00129389|592884379|FG001|Overall Study|Relapse|0|||
164142815|NCT00129389|592884378|FG000|Overall Study|Not eligible|1|||
164142816|NCT00129389|592884379|FG001|Overall Study|Not eligible|2|||
164142817|NCT00129389|592884378|FG000|Overall Study|Crossed to the other arm|1|||
164142818|NCT00129389|592884379|FG001|Overall Study|Crossed to the other arm|16|||
164142819|NCT01191944|592884384|FG000|Overall Study|Adverse Event|11|||
164142820|NCT01191944|592884385|FG001|Overall Study|Adverse Event|12|||
164142821|NCT01191944|592884384|FG000|Overall Study|Protocol Violation|1|||
164142822|NCT01191944|592884385|FG001|Overall Study|Protocol Violation|2|||
164142823|NCT01191944|592884384|FG000|Overall Study|Withdrawal by Subject|4|||
164142824|NCT01191944|592884385|FG001|Overall Study|Withdrawal by Subject|2|||
164142825|NCT01191944|592884384|FG000|Overall Study|Other|1|||
164142826|NCT01191944|592884385|FG001|Overall Study|Other|3|||
164142827|NCT02794246|592884390|FG000|Overall Study|Withdrawal by Subject|2|||
164142828|NCT02794246|592884390|FG000|Overall Study|Physician Decision|4|||
164142829|NCT04602546|592884391|FG000|Overall Study|Training|2|||
164142830|NCT04602546|592884392|FG001|Overall Study|Training|2|||
164142831|NCT04602546|592884393|FG002|Overall Study|Training|1|||
164142832|NCT04602546|592884394|FG003|Overall Study|Training|2|||
164142833|NCT04602546|592884395|FG004|Overall Study|Training|0|||
164142834|NCT04602546|592884391|FG000|Overall Study|Randomized with disqualified data|2|||
164142835|NCT04602546|592884392|FG001|Overall Study|Randomized with disqualified data|0|||
164142836|NCT04602546|592884393|FG002|Overall Study|Randomized with disqualified data|2|||
164142837|NCT04602546|592884394|FG003|Overall Study|Randomized with disqualified data|5|||
164142838|NCT04602546|592884395|FG004|Overall Study|Randomized with disqualified data|3|||
164142839|NCT00425373|592884405|FG000|Overall Study|Adverse Event|2|||
164142840|NCT00425373|592884406|FG001|Overall Study|Adverse Event|2|||
164142841|NCT00425373|592884407|FG002|Overall Study|Adverse Event|0|||
164142842|NCT00425373|592884408|FG003|Overall Study|Adverse Event|1|||
164142843|NCT00425373|592884409|FG004|Overall Study|Adverse Event|4|||
164142844|NCT00425373|592884410|FG005|Overall Study|Adverse Event|6|||
164142845|NCT00425373|592884411|FG006|Overall Study|Adverse Event|2|||
164142846|NCT00425373|592884412|FG007|Overall Study|Adverse Event|3|||
164142847|NCT00425373|592884413|FG008|Overall Study|Adverse Event|8|||
164142848|NCT00425373|592884405|FG000|Overall Study|Lost to Follow-up|0|||
164142849|NCT00425373|592884406|FG001|Overall Study|Lost to Follow-up|1|||
164142850|NCT00425373|592884407|FG002|Overall Study|Lost to Follow-up|0|||
164142851|NCT00425373|592884408|FG003|Overall Study|Lost to Follow-up|0|||
164142852|NCT00425373|592884409|FG004|Overall Study|Lost to Follow-up|1|||
164142853|NCT00425373|592884410|FG005|Overall Study|Lost to Follow-up|0|||
164142854|NCT00425373|592884411|FG006|Overall Study|Lost to Follow-up|0|||
164142855|NCT00425373|592884412|FG007|Overall Study|Lost to Follow-up|0|||
164142856|NCT00425373|592884413|FG008|Overall Study|Lost to Follow-up|0|||
164142857|NCT00425373|592884405|FG000|Overall Study|Protocol Violation|1|||
164142858|NCT00425373|592884406|FG001|Overall Study|Protocol Violation|0|||
164142859|NCT00425373|592884407|FG002|Overall Study|Protocol Violation|1|||
164142860|NCT00425373|592884408|FG003|Overall Study|Protocol Violation|0|||
164142861|NCT00425373|592884409|FG004|Overall Study|Protocol Violation|0|||
164142862|NCT00425373|592884410|FG005|Overall Study|Protocol Violation|0|||
164142863|NCT00425373|592884411|FG006|Overall Study|Protocol Violation|0|||
164142864|NCT00425373|592884412|FG007|Overall Study|Protocol Violation|5|||
164142865|NCT00425373|592884413|FG008|Overall Study|Protocol Violation|3|||
164142866|NCT00425373|592884405|FG000|Overall Study|Withdrawal by Subject|2|||
164142867|NCT00425373|592884406|FG001|Overall Study|Withdrawal by Subject|0|||
164142868|NCT00425373|592884407|FG002|Overall Study|Withdrawal by Subject|2|||
164142869|NCT00425373|592884408|FG003|Overall Study|Withdrawal by Subject|1|||
164142870|NCT00425373|592884409|FG004|Overall Study|Withdrawal by Subject|4|||
164142871|NCT00425373|592884410|FG005|Overall Study|Withdrawal by Subject|0|||
164142872|NCT00425373|592884411|FG006|Overall Study|Withdrawal by Subject|2|||
164142873|NCT00425373|592884412|FG007|Overall Study|Withdrawal by Subject|2|||
164142874|NCT00425373|592884413|FG008|Overall Study|Withdrawal by Subject|2|||
164142875|NCT00425373|592884405|FG000|Overall Study|Lack of Efficacy|0|||
164142876|NCT00425373|592884406|FG001|Overall Study|Lack of Efficacy|0|||
164142877|NCT00425373|592884407|FG002|Overall Study|Lack of Efficacy|0|||
164142878|NCT00425373|592884408|FG003|Overall Study|Lack of Efficacy|0|||
164142879|NCT00425373|592884409|FG004|Overall Study|Lack of Efficacy|1|||
164142880|NCT00425373|592884410|FG005|Overall Study|Lack of Efficacy|3|||
164142881|NCT00425373|592884411|FG006|Overall Study|Lack of Efficacy|3|||
164142882|NCT00425373|592884412|FG007|Overall Study|Lack of Efficacy|0|||
164142883|NCT00425373|592884413|FG008|Overall Study|Lack of Efficacy|5|||
164142884|NCT00582010|592884417|FG000|Overall Study|Death|0|||
164142885|NCT00582010|592884418|FG001|Overall Study|Death|1|||
164142886|NCT02463357|592884423|FG000|Overall Study|Withdrawal by Subject|1|||
164142887|NCT02463357|592884424|FG001|Overall Study|Withdrawal by Subject|0|||
164142888|NCT02463357|592884425|FG002|Overall Study|Withdrawal by Subject|0|||
164142889|NCT02463357|592884426|FG003|Overall Study|Withdrawal by Subject|0|||
164142890|NCT02463357|592884427|FG004|Overall Study|Withdrawal by Subject|0|||
164142891|NCT02463357|592884423|FG000|Overall Study|Withdrawal by Subject|0|||
164142892|NCT02463357|592884424|FG001|Overall Study|Withdrawal by Subject|0|||
164142893|NCT02463357|592884425|FG002|Overall Study|Withdrawal by Subject|0|||
164142894|NCT02463357|592884426|FG003|Overall Study|Withdrawal by Subject|0|||
164142895|NCT02463357|592884427|FG004|Overall Study|Withdrawal by Subject|1|||
164142896|NCT01371539|592884430|FG000|Period One: One Week|Lost to Follow-up|0|||
164142897|NCT01371539|592884431|FG001|Period One: One Week|Lost to Follow-up|1|||
164142898|NCT01371539|592884430|FG000|Period Two: One Week|Lost to Follow-up|0|||
164142899|NCT01371539|592884431|FG001|Period Two: One Week|Lost to Follow-up|1|||
164142900|NCT01371539|592884430|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
164142901|NCT01371539|592884431|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
164142902|NCT01371539|592884430|FG000|Period Two: One Week|Time/job conflict|0|||
164142903|NCT01371539|592884431|FG001|Period Two: One Week|Time/job conflict|1|||
164142904|NCT01399658|592884432|FG000|Overall Study|Ineligible|1|||
164142905|NCT01399658|592884432|FG000|Overall Study|Machine Technical Issue|3|||
164142906|NCT01399658|592884432|FG000|Overall Study|Alternative therapy|1|||
164142907|NCT01399658|592884432|FG000|Overall Study|No reason given|1|||
164142908|NCT02620579|592884435|FG000|Overall Study|Physician Decision|0|||
164142909|NCT02620579|592884436|FG001|Overall Study|Physician Decision|0|||
164142910|NCT02620579|592884437|FG002|Overall Study|Physician Decision|0|||
164142911|NCT02620579|592884438|FG003|Overall Study|Physician Decision|1|||
164142912|NCT02620579|592884435|FG000|Overall Study|Withdrawal by Subject|0|||
164142913|NCT02620579|592884436|FG001|Overall Study|Withdrawal by Subject|1|||
164142914|NCT02620579|592884437|FG002|Overall Study|Withdrawal by Subject|1|||
164142915|NCT02620579|592884438|FG003|Overall Study|Withdrawal by Subject|0|||
164142916|NCT04315506|592884440|FG000|Overall Study|Lost to Follow-up|74|||
164142917|NCT04315506|592884441|FG001|Overall Study|Lost to Follow-up|82|||
164142918|NCT04315506|592884440|FG000|Overall Study|Withdrawal by Subject|8|||
164142919|NCT04315506|592884441|FG001|Overall Study|Withdrawal by Subject|8|||
164142920|NCT04315506|592884440|FG000|Overall Study|Physician Decision|0|||
164142921|NCT04315506|592884441|FG001|Overall Study|Physician Decision|1|||
164142922|NCT01721317|592884442|FG000|Overall Study|Study Closed / Terminated|2|||
164142923|NCT01721317|592884443|FG001|Overall Study|Study Closed / Terminated|2|||
164142924|NCT01721317|592884442|FG000|Overall Study|Physician Decision|0|||
164142925|NCT01721317|592884443|FG001|Overall Study|Physician Decision|1|||
164142926|NCT01721317|592884442|FG000|Overall Study|Withdrawal by Subject|0|||
164142927|NCT01721317|592884443|FG001|Overall Study|Withdrawal by Subject|1|||
164142928|NCT02661217|592884444|FG000|Overall Study|Physician Decision|12|||
164142929|NCT02661217|592884445|FG001|Overall Study|Physician Decision|15|||
164142930|NCT02661217|592884444|FG000|Overall Study|Lost to Follow-up|1|||
164142931|NCT02661217|592884445|FG001|Overall Study|Lost to Follow-up|4|||
164142932|NCT02661217|592884444|FG000|Overall Study|Protocol Deviation|0|||
164142933|NCT02661217|592884445|FG001|Overall Study|Protocol Deviation|4|||
164142934|NCT02661217|592884444|FG000|Overall Study|Non-compliance with study treatment|5|||
164142935|NCT02661217|592884445|FG001|Overall Study|Non-compliance with study treatment|5|||
164142936|NCT02661217|592884444|FG000|Overall Study|Death|21|||
164142937|NCT02661217|592884445|FG001|Overall Study|Death|15|||
164142938|NCT02661217|592884444|FG000|Overall Study|Adverse Event|10|||
164142939|NCT02661217|592884445|FG001|Overall Study|Adverse Event|8|||
164142940|NCT02661217|592884444|FG000|Overall Study|Withdrawal by Subject|15|||
164142941|NCT02661217|592884445|FG001|Overall Study|Withdrawal by Subject|19|||
164142942|NCT02661217|592884444|FG000|Overall Study|Did not enter follow-up epoch|7|||
164142943|NCT02661217|592884445|FG001|Overall Study|Did not enter follow-up epoch|10|||
164142944|NCT02661217|592884444|FG000|Overall Study|Death - no study drug received|1|||
164142945|NCT02661217|592884445|FG001|Overall Study|Death - no study drug received|2|||
164142946|NCT02661217|592884444|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
164142947|NCT02661217|592884445|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
164142948|NCT00958893|592884451|FG000|Overall Study|Study prematurely terminated|4|||
164142949|NCT00378573|592884453|FG000|Treatment Period|Adverse Event|9|||
164142950|NCT00378573|592884453|FG000|Treatment Period|Physician Decision|1|||
164142951|NCT00378573|592884453|FG000|Treatment Period|Withdrawal by Subject|2|||
164142952|NCT00378573|592884453|FG000|Treatment Period|Disease Progression|4|||
164142953|NCT00378573|592884453|FG000|Treatment Period|Sponsor decision to close study|1|||
164142954|NCT00378573|592884453|FG000|Follow-up|Death|12|||
164142955|NCT00378573|592884453|FG000|Follow-up|Lost to Follow-up|1|||
164142956|NCT00378573|592884453|FG000|Follow-up|Withdrawal by Subject|1|||
164142957|NCT03485365|592884460|FG000|Overall Study|Protocol Violation|0|||
164142958|NCT03485365|592884461|FG001|Overall Study|Protocol Violation|0|||
164142959|NCT03485365|592884462|FG002|Overall Study|Protocol Violation|0|||
164142960|NCT03485365|592884463|FG003|Overall Study|Protocol Violation|1|||
164142961|NCT03485365|592884464|FG004|Overall Study|Protocol Violation|0|||
164142962|NCT03485365|592884465|FG005|Overall Study|Protocol Violation|0|||
164142963|NCT03485365|592884466|FG006|Overall Study|Protocol Violation|1|||
164142964|NCT03485365|592884467|FG007|Overall Study|Protocol Violation|0|||
164142965|NCT03485365|592884468|FG008|Overall Study|Protocol Violation|0|||
164142966|NCT02181790|592884469|FG000|Overall Study|study terminated|2|||
164142967|NCT02181790|592884470|FG001|Overall Study|study terminated|0|||
164142968|NCT03276078|592884471|FG000|Overall Study|Adverse Event|1|||
164142969|NCT01275430|592884477|FG000|Overall Study|Adverse Event|1|||
164142970|NCT01275430|592884477|FG000|Overall Study|No Contrast Injection|6|||
164142971|NCT01275430|592884477|FG000|Overall Study|Device Malfunction|1|||
164142972|NCT01275430|592884477|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
164142973|NCT04988087|592884478|FG000|Overall Study|Adverse Event|4|||
164142974|NCT04988087|592884479|FG001|Overall Study|Adverse Event|0|||
164142975|NCT04988087|592884480|FG002|Overall Study|Adverse Event|0|||
164142976|NCT04988087|592884481|FG003|Overall Study|Adverse Event|0|||
164142977|NCT04988087|592884478|FG000|Overall Study|Withdrawal by Subject|1|||
164142978|NCT04988087|592884479|FG001|Overall Study|Withdrawal by Subject|1|||
164142979|NCT04988087|592884480|FG002|Overall Study|Withdrawal by Subject|0|||
164142980|NCT04988087|592884481|FG003|Overall Study|Withdrawal by Subject|0|||
164142981|NCT04988087|592884478|FG000|Overall Study|Technical problems|7|||
164142982|NCT04988087|592884479|FG001|Overall Study|Technical problems|9|||
164142983|NCT04988087|592884480|FG002|Overall Study|Technical problems|1|||
164142984|NCT04988087|592884481|FG003|Overall Study|Technical problems|2|||
164142985|NCT03968978|592884482|FG000|Overall Study|Adverse Event|1|||
164142986|NCT03968978|592884483|FG001|Overall Study|Adverse Event|0|||
164142987|NCT00863772|592884484|FG000|Overall Study|Adverse Event|1|||
164142988|NCT00863772|592884485|FG001|Overall Study|Adverse Event|4|||
164142989|NCT00863772|592884486|FG002|Overall Study|Adverse Event|0|||
164142990|NCT00863772|592884484|FG000|Overall Study|Lack of Efficacy|4|||
164142991|NCT00863772|592884485|FG001|Overall Study|Lack of Efficacy|2|||
164142992|NCT00863772|592884486|FG002|Overall Study|Lack of Efficacy|4|||
164142999|NCT00863772|592884484|FG000|Overall Study|Withdrawal by Subject|4|||
164143000|NCT00863772|592884485|FG001|Overall Study|Withdrawal by Subject|7|||
164143001|NCT00863772|592884486|FG002|Overall Study|Withdrawal by Subject|5|||
164143002|NCT00863772|592884484|FG000|Overall Study|Study terminated by sponsor|44|||
164143003|NCT00863772|592884485|FG001|Overall Study|Study terminated by sponsor|45|||
164143004|NCT00863772|592884486|FG002|Overall Study|Study terminated by sponsor|36|||
164143005|NCT00863772|592884484|FG000|Overall Study|Entered extension study|6|||
164143006|NCT00863772|592884485|FG001|Overall Study|Entered extension study|4|||
164143007|NCT00863772|592884486|FG002|Overall Study|Entered extension study|9|||
164143008|NCT00863772|592884484|FG000|Overall Study|Other|1|||
164143009|NCT00863772|592884485|FG001|Overall Study|Other|2|||
164143010|NCT00863772|592884486|FG002|Overall Study|Other|4|||
164143011|NCT00863772|592884484|FG000|Overall Study|Randomized but not Treated|1|||
164143012|NCT00863772|592884485|FG001|Overall Study|Randomized but not Treated|0|||
164143013|NCT00863772|592884486|FG002|Overall Study|Randomized but not Treated|0|||
164143014|NCT00205803|592884491|FG000|Infant Series|Lost to Follow-up|10|||
164143015|NCT00205803|592884492|FG001|Infant Series|Lost to Follow-up|4|||
164143016|NCT00205803|592884491|FG000|Infant Series|Withdrawal by Subject|2|||
164143017|NCT00205803|592884492|FG001|Infant Series|Withdrawal by Subject|5|||
164143018|NCT00205803|592884491|FG000|Infant Series|Physician Decision|3|||
164143019|NCT00205803|592884492|FG001|Infant Series|Physician Decision|1|||
164143020|NCT00205803|592884491|FG000|Infant Series|Protocol Violation|1|||
164143021|NCT00205803|592884492|FG001|Infant Series|Protocol Violation|0|||
164143022|NCT00205803|592884491|FG000|Infant Series|Lost Kaiser coverage|0|||
164143023|NCT00205803|592884492|FG001|Infant Series|Lost Kaiser coverage|1|||
164143024|NCT00205803|592884491|FG000|Infant Series|Non-compliant|1|||
164143025|NCT00205803|592884492|FG001|Infant Series|Non-compliant|0|||
164143026|NCT00205803|592884491|FG000|Infant Series|Sponsor request|1|||
164143027|NCT00205803|592884492|FG001|Infant Series|Sponsor request|0|||
164143028|NCT00205803|592884491|FG000|After Infant Series|Adverse Event|1|||
164143029|NCT00205803|592884492|FG001|After Infant Series|Adverse Event|1|||
164143030|NCT00205803|592884491|FG000|After Infant Series|Protocol Violation|1|||
164143031|NCT00205803|592884492|FG001|After Infant Series|Protocol Violation|1|||
164143032|NCT00205803|592884491|FG000|After Infant Series|Lost to Follow-up|2|||
164143033|NCT00205803|592884492|FG001|After Infant Series|Lost to Follow-up|1|||
164143034|NCT00205803|592884491|FG000|After Infant Series|Physician Decision|3|||
164143035|NCT00205803|592884492|FG001|After Infant Series|Physician Decision|2|||
164143036|NCT00205803|592884491|FG000|After Infant Series|Withdrawal by Subject|1|||
164143037|NCT00205803|592884492|FG001|After Infant Series|Withdrawal by Subject|4|||
164143038|NCT00205803|592884491|FG000|After Infant Series|Other|10|||
164143039|NCT00205803|592884492|FG001|After Infant Series|Other|4|||
164143040|NCT00205803|592884491|FG000|Toddler Dose|Lost to Follow-up|2|||
164143041|NCT00205803|592884492|FG001|Toddler Dose|Lost to Follow-up|3|||
164143042|NCT05038800|592884494|FG000|Overall Study|Death|1|||
164143043|NCT05038800|592884495|FG001|Overall Study|Death|1|||
164143044|NCT05038800|592884496|FG002|Overall Study|Death|5|||
164143045|NCT05038800|592884497|FG003|Overall Study|Death|3|||
164143046|NCT05038800|592884498|FG004|Overall Study|Death|1|||
164143047|NCT05038800|592884494|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143048|NCT05038800|592884495|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143049|NCT05038800|592884496|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143050|NCT05038800|592884497|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
164143051|NCT05038800|592884498|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
164143052|NCT05038800|592884494|FG000|Overall Study|Lack of Efficacy|0|||
164143053|NCT05038800|592884495|FG001|Overall Study|Lack of Efficacy|0|||
164143054|NCT05038800|592884496|FG002|Overall Study|Lack of Efficacy|0|||
164143055|NCT05038800|592884497|FG003|Overall Study|Lack of Efficacy|0|||
164143056|NCT05038800|592884498|FG004|Overall Study|Lack of Efficacy|1|||
164143057|NCT00121134|592884499|FG000|Overall Study|Progression of Disease|5|||
164143058|NCT00121134|592884500|FG001|Overall Study|Progression of Disease|3|||
164143059|NCT00121134|592884501|FG002|Overall Study|Progression of Disease|4|||
164143060|NCT00121134|592884502|FG003|Overall Study|Progression of Disease|2|||
164143061|NCT00121134|592884499|FG000|Overall Study|Toxicity|4|||
164143062|NCT00121134|592884500|FG001|Overall Study|Toxicity|7|||
164143063|NCT00121134|592884501|FG002|Overall Study|Toxicity|13|||
164143064|NCT00121134|592884502|FG003|Overall Study|Toxicity|5|||
164143065|NCT00121134|592884499|FG000|Overall Study|Physician Decision|6|||
164143066|NCT00121134|592884500|FG001|Overall Study|Physician Decision|4|||
164143067|NCT00121134|592884501|FG002|Overall Study|Physician Decision|4|||
164143068|NCT00121134|592884502|FG003|Overall Study|Physician Decision|1|||
164143069|NCT00121134|592884499|FG000|Overall Study|Treatment Delay|1|||
164143070|NCT00121134|592884500|FG001|Overall Study|Treatment Delay|0|||
164143071|NCT00121134|592884501|FG002|Overall Study|Treatment Delay|0|||
164143072|NCT00121134|592884502|FG003|Overall Study|Treatment Delay|0|||
164143073|NCT00121134|592884499|FG000|Overall Study|Intercurrent Illness|0|||
164143074|NCT00121134|592884500|FG001|Overall Study|Intercurrent Illness|0|||
164143075|NCT00121134|592884501|FG002|Overall Study|Intercurrent Illness|0|||
164143076|NCT00121134|592884502|FG003|Overall Study|Intercurrent Illness|1|||
164143077|NCT00121134|592884499|FG000|Overall Study|Patient Personal Reasons|0|||
164143078|NCT00121134|592884500|FG001|Overall Study|Patient Personal Reasons|1|||
164143079|NCT00121134|592884501|FG002|Overall Study|Patient Personal Reasons|0|||
164143080|NCT00121134|592884502|FG003|Overall Study|Patient Personal Reasons|0|||
164143081|NCT02478320|592884508|FG000|Overall Study|Adverse Event|2|||
164143082|NCT02478320|592884509|FG001|Overall Study|Adverse Event|0|||
164143083|NCT02478320|592884508|FG000|Overall Study|Death|1|||
164143084|NCT02478320|592884509|FG001|Overall Study|Death|0|||
164143085|NCT02478320|592884508|FG000|Overall Study|Lack of Efficacy|4|||
164143086|NCT02478320|592884509|FG001|Overall Study|Lack of Efficacy|0|||
164143087|NCT02478320|592884508|FG000|Overall Study|Withdrawal by Subject|2|||
164143088|NCT02478320|592884509|FG001|Overall Study|Withdrawal by Subject|0|||
164143089|NCT02478320|592884508|FG000|Overall Study|Screen Failure|3|||
164143090|NCT02478320|592884509|FG001|Overall Study|Screen Failure|0|||
164143091|NCT04400682|592884512|FG000|Period 1|Withdrawal by Subject|1|||
164143092|NCT04400682|592884513|FG001|Period 1|Withdrawal by Subject|4|||
164143093|NCT03597464|592884514|FG000|Overall Study|Withdrawal by Subject|4|||
164143094|NCT03597464|592884515|FG001|Overall Study|Withdrawal by Subject|5|||
164143095|NCT03597464|592884514|FG000|Overall Study|Lost to Follow-up|3|||
164143096|NCT03597464|592884515|FG001|Overall Study|Lost to Follow-up|1|||
164143097|NCT03597464|592884514|FG000|Overall Study|Pregnancy|3|||
164143098|NCT03597464|592884515|FG001|Overall Study|Pregnancy|1|||
164143099|NCT03597464|592884514|FG000|Overall Study|Lack of Efficacy|2|||
164143100|NCT03597464|592884515|FG001|Overall Study|Lack of Efficacy|0|||
164143101|NCT03597464|592884514|FG000|Overall Study|Physician Decision|2|||
164143102|NCT03597464|592884515|FG001|Overall Study|Physician Decision|2|||
164143103|NCT03597464|592884514|FG000|Overall Study|Protocol Violation|1|||
164143104|NCT03597464|592884515|FG001|Overall Study|Protocol Violation|1|||
164143105|NCT03597464|592884514|FG000|Overall Study|Adverse Event|0|||
164143106|NCT03597464|592884515|FG001|Overall Study|Adverse Event|2|||
164143107|NCT03597464|592884514|FG000|Overall Study|Death|0|||
164143108|NCT03597464|592884515|FG001|Overall Study|Death|3|||
164143109|NCT03316547|592884523|FG000|Overall Study|Death|3|||
164143110|NCT03316547|592884524|FG001|Overall Study|Death|1|||
164143111|NCT03316547|592884523|FG000|Overall Study|Lost to Follow-up|6|||
164143112|NCT03316547|592884524|FG001|Overall Study|Lost to Follow-up|6|||
164143113|NCT03316547|592884523|FG000|Overall Study|Withdrawal by Subject|3|||
164143114|NCT03316547|592884524|FG001|Overall Study|Withdrawal by Subject|2|||
164143115|NCT03316547|592884523|FG000|Overall Study|Transfer to another hospital|6|||
164143116|NCT03316547|592884524|FG001|Overall Study|Transfer to another hospital|4|||
164143117|NCT01831258|592886500|FG000|Overall Study|Withdrawal by Subject|2|||
164143118|NCT01831258|592886501|FG001|Overall Study|Withdrawal by Subject|1|||
164143119|NCT01831258|592886500|FG000|Overall Study|Lost to Follow-up|3|||
164143120|NCT01831258|592886501|FG001|Overall Study|Lost to Follow-up|2|||
164143121|NCT01753297|592886506|FG000|Overall Study|Lost to Follow-up|7|||
164143122|NCT01753297|592886507|FG001|Overall Study|Lost to Follow-up|2|||
164143123|NCT01753297|592886506|FG000|Overall Study|Withdrawal by Subject|26|||
164143124|NCT01753297|592886507|FG001|Overall Study|Withdrawal by Subject|23|||
164143125|NCT01753297|592886506|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
164143126|NCT01753297|592886507|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
164143127|NCT01753297|592886506|FG000|Overall Study|Death|0|||
164143128|NCT01753297|592886507|FG001|Overall Study|Death|2|||
164143129|NCT01753297|592886506|FG000|Overall Study|Did not attend end of study visit|7|||
164143130|NCT01753297|592886507|FG001|Overall Study|Did not attend end of study visit|8|||
164143131|NCT02533180|592886508|FG000|Overall Study|Death|0|||
164143132|NCT02533180|592886509|FG001|Overall Study|Death|2|||
164143133|NCT02533180|592886508|FG000|Overall Study|Lost to Follow-up|0|||
164143134|NCT02533180|592886509|FG001|Overall Study|Lost to Follow-up|1|||
164143135|NCT02533180|592886508|FG000|Overall Study|Physician Decision|0|||
164143136|NCT02533180|592886509|FG001|Overall Study|Physician Decision|1|||
164143137|NCT02533180|592886508|FG000|Overall Study|Withdrawal by Subject|2|||
164143138|NCT02533180|592886509|FG001|Overall Study|Withdrawal by Subject|5|||
164143139|NCT02533180|592886508|FG000|Overall Study|Screen Failure|37|||
164143140|NCT02533180|592886509|FG001|Overall Study|Screen Failure|0|||
164143141|NCT02533180|592886508|FG000|Overall Study|Protocol Deviation|0|||
164143142|NCT02533180|592886509|FG001|Overall Study|Protocol Deviation|1|||
164143143|NCT02533180|592886508|FG000|Overall Study|Non-compliance|0|||
164143144|NCT02533180|592886509|FG001|Overall Study|Non-compliance|1|||
164143145|NCT01174043|592886510|FG000|Overall Study|Disease progression|5|||
164143146|NCT01174043|592886510|FG000|Overall Study|Adverse Event|3|||
164143147|NCT01174043|592886510|FG000|Overall Study|Death|1|||
164143148|NCT01174043|592886510|FG000|Overall Study|Withdrawal by Subject|2|||
164143149|NCT00794339|592886516|FG000|Overall Study|Withdrawal by Subject|3|||
164143150|NCT00794339|592886516|FG000|Overall Study|Ineligible|4|||
164143151|NCT00794339|592886516|FG000|Overall Study|Tx prior to ATSM|3|||
164143152|NCT00794339|592886516|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
164143153|NCT00794339|592886516|FG000|Overall Study|Tx not per protocol|1|||
164143154|NCT00492778|592886523|FG000|Overall Study|Ineligible by Pathology Review|8|||
164143155|NCT00492778|592886524|FG001|Overall Study|Ineligible by Pathology Review|1|||
164143156|NCT03717012|592886539|FG000|Overall Study|Due to trial termination|1|||
164143157|NCT03717012|592886540|FG001|Overall Study|Due to trial termination|2|||
164143158|NCT03717012|592886539|FG000|Overall Study|Protocol Violation|0|||
164143159|NCT03717012|592886540|FG001|Overall Study|Protocol Violation|2|||
164143160|NCT03717012|592886539|FG000|Overall Study|Adverse Event|0|||
164143161|NCT03717012|592886540|FG001|Overall Study|Adverse Event|1|||
164143162|NCT03717012|592886539|FG000|Overall Study|Lung transplant|0|||
164143163|NCT03717012|592886540|FG001|Overall Study|Lung transplant|1|||
164143164|NCT00789035|592886541|FG000|Overall Study|Adverse Event|0|||
164143165|NCT00789035|592886542|FG001|Overall Study|Adverse Event|2|||
164143166|NCT00789035|592886543|FG002|Overall Study|Adverse Event|0|||
164143167|NCT00789035|592886544|FG003|Overall Study|Adverse Event|1|||
164143168|NCT00789035|592886545|FG004|Overall Study|Adverse Event|3|||
164143169|NCT00789035|592886541|FG000|Overall Study|Lack of Efficacy|3|||
164143170|NCT00789035|592886542|FG001|Overall Study|Lack of Efficacy|0|||
164143171|NCT00789035|592886543|FG002|Overall Study|Lack of Efficacy|0|||
164143172|NCT00789035|592886544|FG003|Overall Study|Lack of Efficacy|0|||
164143173|NCT00789035|592886545|FG004|Overall Study|Lack of Efficacy|2|||
164143174|NCT00789035|592886541|FG000|Overall Study|Protocol Violation|1|||
164143175|NCT00789035|592886542|FG001|Overall Study|Protocol Violation|0|||
164143176|NCT00789035|592886543|FG002|Overall Study|Protocol Violation|0|||
164143177|NCT00789035|592886544|FG003|Overall Study|Protocol Violation|0|||
164143178|NCT00789035|592886545|FG004|Overall Study|Protocol Violation|0|||
164143179|NCT00789035|592886541|FG000|Overall Study|Withdrawal by Subject|0|||
164143180|NCT00789035|592886542|FG001|Overall Study|Withdrawal by Subject|2|||
164143181|NCT00789035|592886543|FG002|Overall Study|Withdrawal by Subject|0|||
164143182|NCT00789035|592886544|FG003|Overall Study|Withdrawal by Subject|0|||
164143183|NCT00789035|592886545|FG004|Overall Study|Withdrawal by Subject|0|||
164143184|NCT00789035|592886541|FG000|Overall Study|Other reason not defined above|2|||
164143185|NCT00789035|592886542|FG001|Overall Study|Other reason not defined above|3|||
164143186|NCT00789035|592886543|FG002|Overall Study|Other reason not defined above|1|||
164143187|NCT00789035|592886544|FG003|Overall Study|Other reason not defined above|0|||
164143188|NCT00789035|592886545|FG004|Overall Study|Other reason not defined above|1|||
164143189|NCT04414618|592886546|FG000|Overall Study|Death|3|||
164143190|NCT04414618|592886547|FG001|Overall Study|Death|3|||
164143191|NCT04414618|592886546|FG000|Overall Study|Withdrawal by Subject|2|||
164143192|NCT04414618|592886547|FG001|Overall Study|Withdrawal by Subject|1|||
164143193|NCT04414618|592886546|FG000|Overall Study|Lost to Follow-up|2|||
164143194|NCT04414618|592886547|FG001|Overall Study|Lost to Follow-up|3|||
164143195|NCT04414618|592886546|FG000|Overall Study|Physician Decision|1|||
164143196|NCT04414618|592886547|FG001|Overall Study|Physician Decision|0|||
164143197|NCT00658879|592886548|FG000|Overall Study|Protocol Violation|1|||
164143198|NCT02640690|592886549|FG000|Overall Study|Lost to Follow-up|7|||
164143199|NCT02640690|592886550|FG001|Overall Study|Lost to Follow-up|7|||
164143200|NCT02640690|592886549|FG000|Overall Study|Withdrawal by Subject|16|||
164143201|NCT02640690|592886550|FG001|Overall Study|Withdrawal by Subject|20|||
164143202|NCT02640690|592886549|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
164143203|NCT02640690|592886550|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
164143204|NCT01118975|592886551|FG000|Overall Study|Adverse Event|0|||
164143205|NCT01118975|592886552|FG001|Overall Study|Adverse Event|1|||
164143206|NCT01645787|592886553|FG000|Washout (2 Weeks)|Adverse Event|1|||
164143207|NCT01645787|592886554|FG001|Washout (2 Weeks)|Adverse Event|0|||
164143208|NCT02806024|592886557|FG000|Overall Study|Night Delivery|1|||
164143209|NCT02806024|592886558|FG001|Overall Study|Night Delivery|1|||
164143210|NCT02806024|592886557|FG000|Overall Study|DVT during antepartum admission|0|||
164143211|NCT02806024|592886558|FG001|Overall Study|DVT during antepartum admission|1|||
164143212|NCT01098474|592886559|FG000|Active Phase|Other|0|||
164143213|NCT01098474|592886560|FG001|Active Phase|Other|0|||
164143214|NCT01098474|592886561|FG002|Active Phase|Other|3|||
164143215|NCT01098474|592886562|FG003|Active Phase|Other|0|||
164143216|NCT01098474|592886563|FG004|Active Phase|Other|0|||
164143217|NCT01098474|592886564|FG005|Active Phase|Other|0|||
164143218|NCT01098474|592886559|FG000|Active Phase|Withdrawal by Subject|1|||
164143219|NCT01098474|592886560|FG001|Active Phase|Withdrawal by Subject|1|||
164143220|NCT01098474|592886561|FG002|Active Phase|Withdrawal by Subject|2|||
164143221|NCT01098474|592886562|FG003|Active Phase|Withdrawal by Subject|0|||
164143222|NCT01098474|592886563|FG004|Active Phase|Withdrawal by Subject|0|||
164143223|NCT01098474|592886564|FG005|Active Phase|Withdrawal by Subject|0|||
164143224|NCT01098474|592886559|FG000|Active Phase|Lost to Follow-up|1|||
164143225|NCT01098474|592886560|FG001|Active Phase|Lost to Follow-up|0|||
164143226|NCT01098474|592886561|FG002|Active Phase|Lost to Follow-up|0|||
164143227|NCT01098474|592886562|FG003|Active Phase|Lost to Follow-up|0|||
164143228|NCT01098474|592886563|FG004|Active Phase|Lost to Follow-up|0|||
164143229|NCT01098474|592886564|FG005|Active Phase|Lost to Follow-up|0|||
164143230|NCT01098474|592886559|FG000|Follow Up Phase|Travelled out of study area|0|||
164143231|NCT01098474|592886560|FG001|Follow Up Phase|Travelled out of study area|0|||
164143232|NCT01098474|592886561|FG002|Follow Up Phase|Travelled out of study area|0|||
164143233|NCT01098474|592886562|FG003|Follow Up Phase|Travelled out of study area|0|||
164143234|NCT01098474|592886563|FG004|Follow Up Phase|Travelled out of study area|1|||
164143235|NCT01098474|592886564|FG005|Follow Up Phase|Travelled out of study area|0|||
164143236|NCT01098474|592886559|FG000|Follow Up Phase|Other|0|||
164143237|NCT01098474|592886560|FG001|Follow Up Phase|Other|0|||
164143238|NCT01098474|592886561|FG002|Follow Up Phase|Other|0|||
164143239|NCT01098474|592886562|FG003|Follow Up Phase|Other|0|||
164143240|NCT01098474|592886563|FG004|Follow Up Phase|Other|0|||
164143241|NCT01098474|592886564|FG005|Follow Up Phase|Other|4|||
164143242|NCT01098474|592886559|FG000|Follow Up Phase|Withdrawal by Subject|0|||
164143243|NCT01098474|592886560|FG001|Follow Up Phase|Withdrawal by Subject|0|||
164143244|NCT01098474|592886561|FG002|Follow Up Phase|Withdrawal by Subject|0|||
164143245|NCT01098474|592886562|FG003|Follow Up Phase|Withdrawal by Subject|2|||
164143246|NCT01098474|592886563|FG004|Follow Up Phase|Withdrawal by Subject|0|||
164143247|NCT01098474|592886564|FG005|Follow Up Phase|Withdrawal by Subject|1|||
164143248|NCT01098474|592886559|FG000|Follow Up Phase|Lost to Follow-up|0|||
164143249|NCT01098474|592886560|FG001|Follow Up Phase|Lost to Follow-up|0|||
164143250|NCT01098474|592886561|FG002|Follow Up Phase|Lost to Follow-up|0|||
164143251|NCT01098474|592886562|FG003|Follow Up Phase|Lost to Follow-up|0|||
164143252|NCT01098474|592886563|FG004|Follow Up Phase|Lost to Follow-up|1|||
164143253|NCT01098474|592886564|FG005|Follow Up Phase|Lost to Follow-up|0|||
164143254|NCT00711880|592886569|FG000|Overall Study|Adverse Event|11|||
164143255|NCT00711880|592886570|FG001|Overall Study|Adverse Event|2|||
164143256|NCT00711880|592886569|FG000|Overall Study|Patient non-compliance|1|||
164143257|NCT00711880|592886570|FG001|Overall Study|Patient non-compliance|0|||
164143258|NCT00711880|592886569|FG000|Overall Study|Lack of Efficacy|1|||
164143259|NCT00711880|592886570|FG001|Overall Study|Lack of Efficacy|5|||
164143260|NCT00704132|592886571|FG000|Overall Study|Clinical Adverse Experience|1|||
164143261|NCT00704132|592886572|FG001|Overall Study|Clinical Adverse Experience|0|||
164143262|NCT00704132|592886571|FG000|Overall Study|Lack of Efficacy|0|||
164143263|NCT00704132|592886572|FG001|Overall Study|Lack of Efficacy|1|||
164143264|NCT00704132|592886571|FG000|Overall Study|Withdrawal by Subject|0|||
164143265|NCT00704132|592886572|FG001|Overall Study|Withdrawal by Subject|1|||
164143266|NCT00442962|592886573|FG000|Overall Study|Pregnancy|1|||
164143267|NCT00442962|592886573|FG000|Overall Study|Lost to Follow-up|7|||
164143268|NCT04238650|592886574|FG000|Overall Study|Withdrawal by Subject|0|||
164143269|NCT04238650|592886575|FG001|Overall Study|Withdrawal by Subject|1|||
164143270|NCT03348163|592886576|FG000|Overall Study|Withdrawal by Subject|2|||
164143271|NCT03348163|592886577|FG001|Overall Study|Withdrawal by Subject|0|||
164143272|NCT02756208|592886578|FG000|Overall Study|Withdrawal by Subject|1|||
164143273|NCT02756208|592886579|FG001|Overall Study|Withdrawal by Subject|0|||
164143274|NCT02756208|592886580|FG002|Overall Study|Withdrawal by Subject|1|||
164143275|NCT02756208|592886581|FG003|Overall Study|Withdrawal by Subject|3|||
164143276|NCT02756208|592886578|FG000|Overall Study|Lost to Follow-up|3|||
164143277|NCT02756208|592886579|FG001|Overall Study|Lost to Follow-up|1|||
164143278|NCT02756208|592886580|FG002|Overall Study|Lost to Follow-up|1|||
164143279|NCT02756208|592886581|FG003|Overall Study|Lost to Follow-up|1|||
164143280|NCT02756208|592886578|FG000|Overall Study|Physician Decision|1|||
164143281|NCT02756208|592886579|FG001|Overall Study|Physician Decision|0|||
164143282|NCT02756208|592886580|FG002|Overall Study|Physician Decision|0|||
164143283|NCT02756208|592886581|FG003|Overall Study|Physician Decision|0|||
164143284|NCT02756208|592886578|FG000|Overall Study|Protocol Violation|0|||
164143285|NCT02756208|592886579|FG001|Overall Study|Protocol Violation|1|||
164143286|NCT02756208|592886580|FG002|Overall Study|Protocol Violation|0|||
164143287|NCT02756208|592886581|FG003|Overall Study|Protocol Violation|0|||
164143288|NCT02585778|592886582|FG000|Overall Study|Adverse Event|17|||
164143289|NCT02585778|592886583|FG001|Overall Study|Adverse Event|4|||
164143290|NCT02585778|592886582|FG000|Overall Study|Participant did not wish to continue|9|||
164143291|NCT02585778|592886583|FG001|Overall Study|Participant did not wish to continue|4|||
164143292|NCT02585778|592886582|FG000|Overall Study|Poor compliance to study protocol|0|||
164143293|NCT02585778|592886583|FG001|Overall Study|Poor compliance to study protocol|2|||
164143294|NCT02585778|592886582|FG000|Overall Study|Death|0|||
164143295|NCT02585778|592886583|FG001|Overall Study|Death|1|||
164143296|NCT02585778|592886582|FG000|Overall Study|Randomized but not treated|1|||
164143297|NCT02585778|592886583|FG001|Overall Study|Randomized but not treated|2|||
164143298|NCT02585778|592886582|FG000|Overall Study|Other than specified above|6|||
164143299|NCT02585778|592886583|FG001|Overall Study|Other than specified above|2|||
164143300|NCT05246670|592886586|FG000|Overall Study|Withdrawal by Subject|2|||
164143301|NCT05246670|592886587|FG001|Overall Study|Withdrawal by Subject|3|||
164143302|NCT05246670|592886588|FG002|Overall Study|Withdrawal by Subject|0|||
164143303|NCT05246670|592886589|FG003|Overall Study|Withdrawal by Subject|1|||
164143304|NCT05246670|592886586|FG000|Overall Study|Adverse Event|0|||
164143305|NCT05246670|592886587|FG001|Overall Study|Adverse Event|0|||
164143306|NCT05246670|592886588|FG002|Overall Study|Adverse Event|1|||
164143307|NCT05246670|592886589|FG003|Overall Study|Adverse Event|0|||
164143308|NCT05246670|592886586|FG000|Overall Study|Physician Decision|1|||
164143309|NCT05246670|592886587|FG001|Overall Study|Physician Decision|0|||
164143310|NCT05246670|592886588|FG002|Overall Study|Physician Decision|0|||
164143311|NCT05246670|592886589|FG003|Overall Study|Physician Decision|0|||
164143312|NCT05246670|592886586|FG000|Overall Study|Protocol Violation|1|||
164143354|NCT00879411|592886603|FG000|Overall Study|lost to follow-up (non-AE)|162|||
164143355|NCT05124691|592886604|FG000|Phase II|Eligibility criteria|0|||
164143356|NCT05124691|592886605|FG001|Phase II|Eligibility criteria|1|||
164143357|NCT05124691|592886606|FG002|Phase II|Eligibility criteria|0|||
164143358|NCT05124691|592886604|FG000|Phase II|Withdrawal by Subject|6|||
164143359|NCT05124691|592886605|FG001|Phase II|Withdrawal by Subject|2|||
164143360|NCT05124691|592886606|FG002|Phase II|Withdrawal by Subject|3|||
164143361|NCT05124691|592886604|FG000|Phase III|Withdrawal by Subject|6|||
164143362|NCT05124691|592886605|FG001|Phase III|Withdrawal by Subject|4|||
164143363|NCT05124691|592886606|FG002|Phase III|Withdrawal by Subject|4|||
164143364|NCT05124691|592886604|FG000|Phase III|Lost to Follow-up|1|||
164143365|NCT05124691|592886605|FG001|Phase III|Lost to Follow-up|0|||
164143366|NCT05124691|592886606|FG002|Phase III|Lost to Follow-up|0|||
164143367|NCT05211726|592886607|FG000|Overall Study|Withdrawal by Subject|2|||
164143368|NCT05211726|592886608|FG001|Overall Study|Withdrawal by Subject|3|||
164143369|NCT05211726|592886607|FG000|Overall Study|Protocol Violation|0|||
164143370|NCT05211726|592886608|FG001|Overall Study|Protocol Violation|1|||
164143371|NCT02714426|592886618|FG000|Overall Study|Withdrawal by Subject|2|||
164143372|NCT02714426|592886619|FG001|Overall Study|Withdrawal by Subject|2|||
164143373|NCT03456453|592886623|FG000|Overall Study|Withdrawal by Subject|2|||
164143374|NCT03456453|592886624|FG001|Overall Study|Withdrawal by Subject|0|||
164143375|NCT03456453|592886623|FG000|Overall Study|Not released to community|1|||
164143376|NCT03456453|592886624|FG001|Overall Study|Not released to community|5|||
164143377|NCT03456453|592886623|FG000|Overall Study|Lost to Follow-up|0|||
164143378|NCT03456453|592886624|FG001|Overall Study|Lost to Follow-up|2|||
164143379|NCT00896480|592886625|FG000|Overall Study|Disease progression/recurrence|21|||
164143380|NCT00725205|592886630|FG000|Overall Study|Adverse Event|22|||
164143381|NCT00725205|592886630|FG000|Overall Study|Investigator Discontinued|1|||
164143382|NCT00725205|592886630|FG000|Overall Study|Non-compliance With Protocol|14|||
164143383|NCT00725205|592886630|FG000|Overall Study|Other|8|||
164143384|NCT00725205|592886630|FG000|Overall Study|Protocol Defined Clinical Event|1|||
164143385|NCT00725205|592886630|FG000|Overall Study|Treatment Failure|41|||
164143386|NCT03014180|592886631|FG000|Overall Study|Protocol Violation|2|||
164143387|NCT02212379|592886635|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
164143388|NCT02212379|592886635|FG000|From Baseline to Week 48|Adverse Event|7|||
164143389|NCT02212379|592886635|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
164143390|NCT02212379|592886635|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
164143391|NCT02212379|592886635|FG000|From Week 48 to Week 96|Adverse Event|1|||
164143392|NCT02212379|592886635|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
164143393|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
164143394|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
164143395|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143396|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143397|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143398|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143399|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143400|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143401|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143402|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
164143403|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
164143404|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
164143405|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143406|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143407|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143408|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143409|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143410|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143411|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143412|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
164143413|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143414|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
164143415|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143416|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143417|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143418|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143419|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143420|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143421|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143562|NCT03922529|592888460|FG001|Overall Study|Adverse Event|0|||
164143422|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
164143423|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
164143424|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143425|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143426|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143427|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143428|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143429|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143430|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143431|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143432|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
164143433|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
164143434|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
164143435|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143436|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143437|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143438|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143439|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143440|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143441|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143442|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
164143443|NCT04784533|592886636|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
164143444|NCT04784533|592886637|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
164143445|NCT04784533|592886638|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143446|NCT04784533|592886639|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143447|NCT04784533|592886640|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143448|NCT04784533|592886641|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143449|NCT04784533|592886642|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143450|NCT04784533|592886643|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143451|NCT04784533|592886644|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143452|NCT04784533|592886645|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
164143453|NCT04784533|592886636|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143454|NCT04784533|592886637|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143455|NCT04784533|592886638|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
164143456|NCT04784533|592886639|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143457|NCT04784533|592886640|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143458|NCT04784533|592886641|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143459|NCT04784533|592886642|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143460|NCT04784533|592886643|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143461|NCT04784533|592886644|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143462|NCT04784533|592886645|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
164143463|NCT04784533|592886636|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143464|NCT04784533|592886637|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143465|NCT04784533|592886638|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143466|NCT04784533|592886639|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143467|NCT04784533|592886640|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143468|NCT04784533|592886641|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143469|NCT04784533|592886642|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143470|NCT04784533|592886643|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143471|NCT04784533|592886644|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
164143472|NCT04784533|592886645|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
164143473|NCT04784533|592886636|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143474|NCT04784533|592886637|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143475|NCT04784533|592886638|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143476|NCT04784533|592886639|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143477|NCT04784533|592886640|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143478|NCT04784533|592886641|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143479|NCT04784533|592886642|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143480|NCT04784533|592886643|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
164143481|NCT04784533|592886644|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
164143482|NCT04784533|592886645|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
164143483|NCT02105974|592886646|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
164143484|NCT02105974|592886647|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
164143485|NCT02105974|592886648|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
164143486|NCT02105974|592886646|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
164143487|NCT02105974|592886647|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
164144024|NCT00086281|592888578|FG007|Phase 1|Serious Adverse Event|0|||
164143488|NCT02105974|592886648|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
164143489|NCT02105974|592886646|FG000|2 Week Run-in Period|Adverse Event|6|||
164143490|NCT02105974|592886647|FG001|2 Week Run-in Period|Adverse Event|0|||
164143491|NCT02105974|592886648|FG002|2 Week Run-in Period|Adverse Event|0|||
164143492|NCT02105974|592886646|FG000|2 Week Run-in Period|Study closed/terminated|1|||
164143493|NCT02105974|592886647|FG001|2 Week Run-in Period|Study closed/terminated|0|||
164143494|NCT02105974|592886648|FG002|2 Week Run-in Period|Study closed/terminated|0|||
164143495|NCT02105974|592886646|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
164143496|NCT02105974|592886647|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
164143497|NCT02105974|592886648|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
164143498|NCT02105974|592886646|FG000|2 Week Run-in Period|Withdrew consent|23|||
164143499|NCT02105974|592886647|FG001|2 Week Run-in Period|Withdrew consent|0|||
164143500|NCT02105974|592886648|FG002|2 Week Run-in Period|Withdrew consent|0|||
164143501|NCT02105974|592886646|FG000|2 Week Run-in Period|Investigator discretion|8|||
164143502|NCT02105974|592886647|FG001|2 Week Run-in Period|Investigator discretion|0|||
164143503|NCT02105974|592886648|FG002|2 Week Run-in Period|Investigator discretion|0|||
164143504|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
164143505|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
164143506|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
164143507|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
164143508|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
164143509|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
164143510|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
164143511|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
164143512|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
164143513|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
164143514|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
164143515|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
164143516|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
164143517|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
164143518|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
164143519|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
164143520|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
164143521|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
164143522|NCT02105974|592886646|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
164143523|NCT02105974|592886647|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
164143524|NCT02105974|592886648|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
164143525|NCT02682927|592886664|FG000|Overall Study|Adverse Event|0|||
164143526|NCT02682927|592886665|FG001|Overall Study|Adverse Event|0|||
164143527|NCT02682927|592886666|FG002|Overall Study|Adverse Event|5|||
164143528|NCT02682927|592886667|FG003|Overall Study|Adverse Event|1|||
164143529|NCT02682927|592886668|FG004|Overall Study|Adverse Event|0|||
164143530|NCT02682927|592886669|FG005|Overall Study|Adverse Event|2|||
164143531|NCT02682927|592886664|FG000|Overall Study|Death|0|||
164143532|NCT02682927|592886665|FG001|Overall Study|Death|0|||
164143533|NCT02682927|592886666|FG002|Overall Study|Death|0|||
164143534|NCT02682927|592886667|FG003|Overall Study|Death|1|||
164143535|NCT02682927|592886668|FG004|Overall Study|Death|0|||
164143536|NCT02682927|592886669|FG005|Overall Study|Death|0|||
164143537|NCT02682927|592886664|FG000|Overall Study|Lack of Efficacy|1|||
164143538|NCT02682927|592886665|FG001|Overall Study|Lack of Efficacy|0|||
164143539|NCT02682927|592886666|FG002|Overall Study|Lack of Efficacy|0|||
164143540|NCT02682927|592886667|FG003|Overall Study|Lack of Efficacy|1|||
164143541|NCT02682927|592886668|FG004|Overall Study|Lack of Efficacy|0|||
164143542|NCT02682927|592886669|FG005|Overall Study|Lack of Efficacy|0|||
164143543|NCT02682927|592886664|FG000|Overall Study|Other|0|||
164143544|NCT02682927|592886665|FG001|Overall Study|Other|0|||
164143545|NCT02682927|592886666|FG002|Overall Study|Other|0|||
164143546|NCT02682927|592886667|FG003|Overall Study|Other|2|||
164143547|NCT02682927|592886668|FG004|Overall Study|Other|0|||
164143548|NCT02682927|592886669|FG005|Overall Study|Other|0|||
164143549|NCT02682927|592886664|FG000|Overall Study|Withdrawal by Subject|2|||
164143550|NCT02682927|592886665|FG001|Overall Study|Withdrawal by Subject|0|||
164143551|NCT02682927|592886666|FG002|Overall Study|Withdrawal by Subject|1|||
164143552|NCT02682927|592886667|FG003|Overall Study|Withdrawal by Subject|0|||
164143553|NCT02682927|592886668|FG004|Overall Study|Withdrawal by Subject|1|||
164143554|NCT02682927|592886669|FG005|Overall Study|Withdrawal by Subject|1|||
164143555|NCT03922529|592888459|FG000|Overall Study|Withdrawal by Subject|13|||
164143556|NCT03922529|592888460|FG001|Overall Study|Withdrawal by Subject|12|||
164143557|NCT03922529|592888459|FG000|Overall Study|Death|7|||
164143558|NCT03922529|592888460|FG001|Overall Study|Death|12|||
164143559|NCT03922529|592888459|FG000|Overall Study|Lost to Follow-up|12|||
164143560|NCT03922529|592888460|FG001|Overall Study|Lost to Follow-up|19|||
164143561|NCT03922529|592888459|FG000|Overall Study|Adverse Event|1|||
164143563|NCT03922529|592888459|FG000|Overall Study|Death after withdrawal|1|||
164143564|NCT03922529|592888460|FG001|Overall Study|Death after withdrawal|0|||
164143565|NCT03922529|592888459|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
164143566|NCT03922529|592888460|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
164143567|NCT03922529|592888459|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
164143568|NCT03922529|592888460|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
164143569|NCT02465398|592888461|FG000|Overall Study|Death|7|||
164143570|NCT02465398|592888461|FG000|Overall Study|Revision|7|||
164143571|NCT02465398|592888461|FG000|Overall Study|did not receive study device|1|||
164143572|NCT02465398|592888461|FG000|Overall Study|Withdrawal by Subject|1|||
164143573|NCT02465398|592888461|FG000|Overall Study|Lost to Follow-up|14|||
164143574|NCT02540850|592888462|FG000|Overall Study|Lost to Follow-up|69|||
164143575|NCT02540850|592888463|FG001|Overall Study|Lost to Follow-up|66|||
164143576|NCT02540850|592888464|FG002|Overall Study|Lost to Follow-up|34|||
164143577|NCT03760185|592888467|FG000|Overall Study|Lost to Follow-up|1|||
164143578|NCT03760185|592888468|FG001|Overall Study|Lost to Follow-up|1|||
164143579|NCT00230178|592888469|FG000|Overall Study|Adverse Event|1|||
164143580|NCT00230178|592888470|FG001|Overall Study|Adverse Event|5|||
164143581|NCT00230178|592888471|FG002|Overall Study|Adverse Event|2|||
164143582|NCT00230178|592888469|FG000|Overall Study|Withdrawal by Subject|0|||
164143583|NCT00230178|592888470|FG001|Overall Study|Withdrawal by Subject|0|||
164143584|NCT00230178|592888471|FG002|Overall Study|Withdrawal by Subject|1|||
164143585|NCT00230178|592888469|FG000|Overall Study|Various other reasons|3|||
164143586|NCT00230178|592888470|FG001|Overall Study|Various other reasons|2|||
164143587|NCT00230178|592888471|FG002|Overall Study|Various other reasons|4|||
164143588|NCT01275729|592888474|FG000|Overall Study|Death|3|||
164143589|NCT01275729|592888474|FG000|Overall Study|Withdrawal by Subject|1|||
164143590|NCT02252406|592888479|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
164143591|NCT02252406|592888480|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
164143592|NCT02252406|592888479|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
164143593|NCT02252406|592888480|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
164143594|NCT02252406|592888479|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
164143595|NCT02252406|592888480|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
164143596|NCT02252406|592888479|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
164143597|NCT02252406|592888480|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
164143598|NCT02252406|592888479|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
164143599|NCT02252406|592888480|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
164143600|NCT00447876|592888481|FG000|Overall Study|Withdrawal by Subject|1|||
164143601|NCT00447876|592888482|FG001|Overall Study|Withdrawal by Subject|4|||
164143602|NCT00447876|592888481|FG000|Overall Study|Lost to Follow-up|1|||
164143603|NCT00447876|592888482|FG001|Overall Study|Lost to Follow-up|0|||
164143604|NCT00447876|592888481|FG000|Overall Study|Deterioration of symptomology|1|||
164143605|NCT00447876|592888482|FG001|Overall Study|Deterioration of symptomology|0|||
164143606|NCT00005957|592888483|FG000|Overall Study|No treated|3|||
164143607|NCT00005957|592888484|FG001|Overall Study|No treated|9|||
164143608|NCT00005957|592888483|FG000|Overall Study|Crossover to the other arm|5|||
164143609|NCT00005957|592888484|FG001|Overall Study|Crossover to the other arm|19|||
164143610|NCT01609023|592888485|FG000|Overall Study|Lack of Efficacy|3|||
164143611|NCT01609023|592888485|FG000|Overall Study|Withdrawal by Subject|4|||
164143612|NCT01609023|592888485|FG000|Overall Study|Lost to Follow-up|8|||
164143613|NCT01609023|592888485|FG000|Overall Study|Toxicity|3|||
164143614|NCT01609023|592888485|FG000|Overall Study|Disease progression|10|||
164143615|NCT01609023|592888485|FG000|Overall Study|Physician Decision|2|||
164143616|NCT01609023|592888485|FG000|Overall Study|Death|2|||
164143617|NCT01609023|592888485|FG000|Overall Study|Personal reasons|1|||
164143618|NCT04172597|592888486|FG000|Overall Study|Disease Progression|0|||
164143619|NCT04172597|592888487|FG001|Overall Study|Disease Progression|0|||
164143620|NCT04172597|592888488|FG002|Overall Study|Disease Progression|0|||
164143621|NCT04172597|592888489|FG003|Overall Study|Disease Progression|0|||
164143622|NCT04172597|592888490|FG004|Overall Study|Disease Progression|1|||
164143623|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|Death|0|||
164143624|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|Death|1|||
164143625|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
164143626|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
164143627|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
164143628|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
164143629|NCT02952586|592888494|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
164143630|NCT02952586|592888495|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
164143631|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
164143632|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
164143633|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
164143634|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
164143635|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
164143636|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
164143637|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
164143638|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
164143639|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
164143640|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
164143641|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
164143642|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
164143643|NCT02952586|592888494|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
164143644|NCT02952586|592888495|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
164143645|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Death|3|||
164143646|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Death|8|||
164143647|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
164143648|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
164143649|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
164143650|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
164143651|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
164143652|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
164143653|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
164143654|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
164143655|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
164143656|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
164143657|NCT02952586|592888494|FG000|CRT for Cisplatin (63 Days)|Other|1|||
164143658|NCT02952586|592888495|FG001|CRT for Cisplatin (63 Days)|Other|1|||
164143659|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Death|5|||
164143660|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Death|8|||
164143661|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
164143662|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
164143663|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
164143664|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
164143665|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
164143666|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
164143667|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
164143668|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
164143669|NCT02952586|592888494|FG000|CRT for IMRT (63 Days)|Other|1|||
164143670|NCT02952586|592888495|FG001|CRT for IMRT (63 Days)|Other|0|||
164143671|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Death|17|||
164143672|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Death|11|||
164143673|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
164143674|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
164143675|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
164143676|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
164143677|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
164143678|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
164143679|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
164143680|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
164143681|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
164143682|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
164143683|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
164143684|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
164143685|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
164143686|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
164143687|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Other|2|||
164143688|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Other|1|||
164143689|NCT02952586|592888494|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
164143690|NCT02952586|592888495|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
164143691|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Death|12|||
164143692|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Death|10|||
164143693|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
164143694|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
164143695|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
164143696|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
164143697|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Other|7|||
164143698|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Other|5|||
164143699|NCT02952586|592888494|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
164143700|NCT02952586|592888495|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
164143701|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Death|51|||
164143702|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Death|31|||
164143703|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
164143704|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
164143705|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
164143706|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
164143707|NCT02952586|592888494|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
164143708|NCT02952586|592888495|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
164143709|NCT04974749|592888496|FG000|Overall Study|Withdrawal by Subject|2|||
164143710|NCT04974749|592888496|FG000|Overall Study|Gestation|1|||
164143711|NCT01520870|592888497|FG000|Overall Study|Withdrawal by Subject|2|||
164143712|NCT00796107|592888503|FG000|Overall Study|Lack of Efficacy|1|||
164143713|NCT00796107|592888503|FG000|Overall Study|Progressive Disease|5|||
164143714|NCT02075515|592888508|FG000|Overall Study|Serious Adverse Event|1|||
164143715|NCT02075515|592888509|FG001|Overall Study|Serious Adverse Event|1|||
164143716|NCT02075515|592888510|FG002|Overall Study|Serious Adverse Event|1|||
164143717|NCT02075515|592888508|FG000|Overall Study|Non-Serious Adverse Event|0|||
164143718|NCT02075515|592888509|FG001|Overall Study|Non-Serious Adverse Event|1|||
164143719|NCT02075515|592888510|FG002|Overall Study|Non-Serious Adverse Event|0|||
164143720|NCT02075515|592888508|FG000|Overall Study|Withdrawal by Subject|2|||
164143721|NCT02075515|592888509|FG001|Overall Study|Withdrawal by Subject|0|||
164143722|NCT02075515|592888510|FG002|Overall Study|Withdrawal by Subject|1|||
164143723|NCT02075515|592888508|FG000|Overall Study|Lost to Follow-up|1|||
164143724|NCT02075515|592888509|FG001|Overall Study|Lost to Follow-up|3|||
164143725|NCT02075515|592888510|FG002|Overall Study|Lost to Follow-up|6|||
164143726|NCT00626561|592888511|FG000|Overall Study|Withdrawal by Subject|2|||
164143727|NCT00626561|592888511|FG000|Overall Study|Disease Progression|2|||
164143728|NCT02797171|592888512|FG000|Overall Study|Lost to Follow-up|2|||
164143729|NCT02797171|592888513|FG001|Overall Study|Lost to Follow-up|0|||
164143730|NCT02797171|592888514|FG002|Overall Study|Lost to Follow-up|2|||
164143731|NCT02797171|592888515|FG003|Overall Study|Lost to Follow-up|1|||
164143732|NCT02797171|592888516|FG004|Overall Study|Lost to Follow-up|2|||
164143733|NCT02797171|592888517|FG005|Overall Study|Lost to Follow-up|0|||
164143734|NCT02797171|592888512|FG000|Overall Study|Withdrawal by Subject|1|||
164143735|NCT02797171|592888513|FG001|Overall Study|Withdrawal by Subject|1|||
164143736|NCT02797171|592888514|FG002|Overall Study|Withdrawal by Subject|0|||
164143737|NCT02797171|592888515|FG003|Overall Study|Withdrawal by Subject|0|||
164143738|NCT02797171|592888516|FG004|Overall Study|Withdrawal by Subject|0|||
164143739|NCT02797171|592888517|FG005|Overall Study|Withdrawal by Subject|0|||
164143740|NCT02797171|592888512|FG000|Overall Study|Protocol Violation|1|||
164143741|NCT02797171|592888513|FG001|Overall Study|Protocol Violation|0|||
164143742|NCT02797171|592888514|FG002|Overall Study|Protocol Violation|0|||
164143743|NCT02797171|592888515|FG003|Overall Study|Protocol Violation|0|||
164143744|NCT02797171|592888516|FG004|Overall Study|Protocol Violation|0|||
164143745|NCT02797171|592888517|FG005|Overall Study|Protocol Violation|0|||
164143746|NCT02797171|592888512|FG000|Overall Study|Participant unable to adhere|0|||
164143747|NCT02797171|592888513|FG001|Overall Study|Participant unable to adhere|1|||
164143748|NCT02797171|592888514|FG002|Overall Study|Participant unable to adhere|0|||
164143749|NCT02797171|592888515|FG003|Overall Study|Participant unable to adhere|0|||
164143750|NCT02797171|592888516|FG004|Overall Study|Participant unable to adhere|0|||
164143751|NCT02797171|592888517|FG005|Overall Study|Participant unable to adhere|0|||
164143752|NCT02797171|592888512|FG000|Overall Study|Not Randomized|0|||
164143753|NCT02797171|592888513|FG001|Overall Study|Not Randomized|0|||
164143754|NCT02797171|592888514|FG002|Overall Study|Not Randomized|0|||
164143755|NCT02797171|592888515|FG003|Overall Study|Not Randomized|0|||
164143756|NCT02797171|592888516|FG004|Overall Study|Not Randomized|0|||
164143757|NCT02797171|592888517|FG005|Overall Study|Not Randomized|1|||
164143758|NCT01372748|592888518|FG000|Overall Study|Lost to Follow-up|16|||
164143759|NCT01372748|592888519|FG001|Overall Study|Lost to Follow-up|34|||
164143760|NCT01372748|592888518|FG000|Overall Study|Withdrawal by Subject|7|||
164143761|NCT01372748|592888519|FG001|Overall Study|Withdrawal by Subject|5|||
164143762|NCT00606632|592888520|FG000|Overall Study|Withdrawal by Subject|13|||
164143763|NCT00606632|592888520|FG000|Overall Study|Miscellaneous reasons|9|||
164143764|NCT03908437|592888521|FG000|Overall Study|Death|0|||
164143765|NCT03908437|592888522|FG001|Overall Study|Death|1|||
164143766|NCT03908437|592888521|FG000|Overall Study|Lost to Follow-up|31|||
164143767|NCT03908437|592888522|FG001|Overall Study|Lost to Follow-up|24|||
164143768|NCT03633825|592888523|FG000|Enrollment|Did not post on network|5066|||
164143769|NCT03633825|592888524|FG001|Enrollment|Did not post on network|5080|||
164143770|NCT03633825|592888523|FG000|Enrollment|Post not classified as crisis|13967|||
164143771|NCT03633825|592888524|FG001|Enrollment|Post not classified as crisis|13757|||
164143772|NCT03633825|592888523|FG000|Follow up|Lost to Follow-up|478|||
164143773|NCT03633825|592888524|FG001|Follow up|Lost to Follow-up|450|||
164143774|NCT03682107|592888525|FG000|Overall Study|Withdrawal by Subject|0|||
164143775|NCT03682107|592888526|FG001|Overall Study|Withdrawal by Subject|1|||
164143776|NCT03682107|592888527|FG002|Overall Study|Withdrawal by Subject|0|||
164143777|NCT03682107|592888528|FG003|Overall Study|Withdrawal by Subject|0|||
164143778|NCT03682107|592888529|FG004|Overall Study|Withdrawal by Subject|0|||
164143779|NCT00214383|592888532|FG000|Overall Study|Lost to Follow-up|16|||
164143780|NCT00214383|592888533|FG001|Overall Study|Lost to Follow-up|26|||
164143781|NCT01890434|592888534|FG000|Overall Study|Adverse Event|8|||
164143782|NCT01890434|592888534|FG000|Overall Study|PCI at external hospital|1|||
164143783|NCT01890434|592888534|FG000|Overall Study|Assessment discrepancy|1|||
164143784|NCT01890434|592888534|FG000|Overall Study|CRC didn't contact participant for FU|1|||
164143785|NCT01890434|592888534|FG000|Overall Study|Could not get whole set of images|1|||
164143786|NCT01890434|592888534|FG000|Overall Study|Decline to return for GSPECT|1|||
164143787|NCT01890434|592888534|FG000|Overall Study|GSPECT at rest was not done|1|||
164143788|NCT01890434|592888534|FG000|Overall Study|Participant didn't complete MRI|1|||
164143789|NCT01890434|592888534|FG000|Overall Study|Uncontactable by phone|1|||
164143790|NCT01890434|592888534|FG000|Overall Study|Moved out of position|1|||
164143791|NCT01890434|592888534|FG000|Overall Study|Unable to contact|1|||
164143792|NCT01890434|592888534|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
164143793|NCT00428116|592888535|FG000|Overall Study|Death|1|||
164143794|NCT00428116|592888536|FG001|Overall Study|Death|0|||
164143795|NCT00428116|592888535|FG000|Overall Study|Withdrawal by Subject|1|||
164143796|NCT00428116|592888536|FG001|Overall Study|Withdrawal by Subject|0|||
164143797|NCT00428116|592888535|FG000|Overall Study|Lost to Follow-up|1|||
164143798|NCT00428116|592888536|FG001|Overall Study|Lost to Follow-up|0|||
164143799|NCT01038297|592888537|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
164143800|NCT01038297|592888538|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
164143801|NCT01038297|592888539|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
164143802|NCT02257385|592888542|FG000|Overall Study|Adverse Event|12|||
164143803|NCT02257385|592888543|FG001|Overall Study|Adverse Event|8|||
164143804|NCT02257385|592888542|FG000|Overall Study|Lack of Efficacy|1|||
164143805|NCT02257385|592888543|FG001|Overall Study|Lack of Efficacy|2|||
164143806|NCT02257385|592888542|FG000|Overall Study|Protocol Violation|5|||
164143807|NCT02257385|592888543|FG001|Overall Study|Protocol Violation|7|||
164143808|NCT02257385|592888542|FG000|Overall Study|Lost to Follow-up|0|||
164143809|NCT02257385|592888543|FG001|Overall Study|Lost to Follow-up|1|||
164143810|NCT02257385|592888542|FG000|Overall Study|Withdrawal by Subject|4|||
164143811|NCT02257385|592888543|FG001|Overall Study|Withdrawal by Subject|4|||
164143812|NCT01449370|592888546|FG000|Overall Study|Disease Progression|5|||
164143813|NCT01449370|592888547|FG001|Overall Study|Disease Progression|4|||
164143814|NCT01449370|592888548|FG002|Overall Study|Disease Progression|8|||
164143815|NCT01449370|592888549|FG003|Overall Study|Disease Progression|3|||
164143816|NCT01449370|592888550|FG004|Overall Study|Disease Progression|3|||
164143817|NCT01449370|592888551|FG005|Overall Study|Disease Progression|3|||
164143818|NCT01449370|592888552|FG006|Overall Study|Disease Progression|3|||
164143819|NCT01449370|592888553|FG007|Overall Study|Disease Progression|2|||
164143820|NCT01449370|592888554|FG008|Overall Study|Disease Progression|9|||
164143821|NCT01449370|592888555|FG009|Overall Study|Disease Progression|1|||
164143822|NCT01449370|592888556|FG010|Overall Study|Disease Progression|3|||
164143823|NCT01449370|592888557|FG011|Overall Study|Disease Progression|3|||
164143824|NCT01449370|592888558|FG012|Overall Study|Disease Progression|2|||
164143825|NCT01449370|592888559|FG013|Overall Study|Disease Progression|8|||
164143826|NCT01449370|592888560|FG014|Overall Study|Disease Progression|3|||
164143827|NCT01449370|592888561|FG015|Overall Study|Disease Progression|1|||
164143828|NCT01449370|592888562|FG016|Overall Study|Disease Progression|4|||
164143829|NCT01449370|592888563|FG017|Overall Study|Disease Progression|3|||
164143830|NCT01449370|592888564|FG018|Overall Study|Disease Progression|1|||
164143831|NCT01449370|592888565|FG019|Overall Study|Disease Progression|2|||
164143832|NCT01449370|592888566|FG020|Overall Study|Disease Progression|5|||
164143833|NCT01449370|592888567|FG021|Overall Study|Disease Progression|2|||
164143834|NCT01449370|592888568|FG022|Overall Study|Disease Progression|3|||
164143835|NCT01449370|592888569|FG023|Overall Study|Disease Progression|7|||
164143836|NCT01449370|592888570|FG024|Overall Study|Disease Progression|3|||
164143837|NCT01449370|592888546|FG000|Overall Study|Adverse Event|1|||
164143838|NCT01449370|592888547|FG001|Overall Study|Adverse Event|2|||
164143839|NCT01449370|592888548|FG002|Overall Study|Adverse Event|0|||
164143840|NCT01449370|592888549|FG003|Overall Study|Adverse Event|1|||
164143841|NCT01449370|592888550|FG004|Overall Study|Adverse Event|0|||
164143842|NCT01449370|592888551|FG005|Overall Study|Adverse Event|0|||
164143843|NCT01449370|592888552|FG006|Overall Study|Adverse Event|0|||
164143844|NCT01449370|592888553|FG007|Overall Study|Adverse Event|0|||
164143845|NCT01449370|592888554|FG008|Overall Study|Adverse Event|1|||
164143846|NCT01449370|592888555|FG009|Overall Study|Adverse Event|1|||
164143847|NCT01449370|592888556|FG010|Overall Study|Adverse Event|0|||
164143848|NCT01449370|592888557|FG011|Overall Study|Adverse Event|0|||
164143849|NCT01449370|592888558|FG012|Overall Study|Adverse Event|0|||
164143850|NCT01449370|592888559|FG013|Overall Study|Adverse Event|2|||
164143851|NCT01449370|592888560|FG014|Overall Study|Adverse Event|0|||
164143852|NCT01449370|592888561|FG015|Overall Study|Adverse Event|1|||
164143853|NCT01449370|592888562|FG016|Overall Study|Adverse Event|0|||
164143854|NCT01449370|592888563|FG017|Overall Study|Adverse Event|0|||
164143855|NCT01449370|592888564|FG018|Overall Study|Adverse Event|1|||
164143856|NCT01449370|592888565|FG019|Overall Study|Adverse Event|1|||
164143857|NCT01449370|592888566|FG020|Overall Study|Adverse Event|0|||
164143858|NCT01449370|592888567|FG021|Overall Study|Adverse Event|1|||
164143859|NCT01449370|592888568|FG022|Overall Study|Adverse Event|0|||
164143860|NCT01449370|592888569|FG023|Overall Study|Adverse Event|1|||
164143861|NCT01449370|592888570|FG024|Overall Study|Adverse Event|3|||
164143862|NCT01449370|592888546|FG000|Overall Study|Participant Decision|0|||
164143863|NCT01449370|592888547|FG001|Overall Study|Participant Decision|0|||
164143864|NCT01449370|592888548|FG002|Overall Study|Participant Decision|0|||
164143865|NCT01449370|592888549|FG003|Overall Study|Participant Decision|0|||
164143866|NCT01449370|592888550|FG004|Overall Study|Participant Decision|0|||
164143867|NCT01449370|592888551|FG005|Overall Study|Participant Decision|0|||
164143868|NCT01449370|592888552|FG006|Overall Study|Participant Decision|0|||
164143869|NCT01449370|592888553|FG007|Overall Study|Participant Decision|1|||
164143870|NCT01449370|592888554|FG008|Overall Study|Participant Decision|1|||
164143871|NCT01449370|592888555|FG009|Overall Study|Participant Decision|0|||
164143872|NCT01449370|592888556|FG010|Overall Study|Participant Decision|0|||
164143873|NCT01449370|592888557|FG011|Overall Study|Participant Decision|0|||
164143874|NCT01449370|592888558|FG012|Overall Study|Participant Decision|1|||
164143875|NCT01449370|592888559|FG013|Overall Study|Participant Decision|1|||
164143876|NCT01449370|592888560|FG014|Overall Study|Participant Decision|0|||
164143877|NCT01449370|592888561|FG015|Overall Study|Participant Decision|1|||
164143878|NCT01449370|592888562|FG016|Overall Study|Participant Decision|3|||
164143879|NCT01449370|592888563|FG017|Overall Study|Participant Decision|0|||
164143880|NCT01449370|592888564|FG018|Overall Study|Participant Decision|1|||
164143881|NCT01449370|592888565|FG019|Overall Study|Participant Decision|0|||
164143882|NCT01449370|592888566|FG020|Overall Study|Participant Decision|0|||
164143883|NCT01449370|592888567|FG021|Overall Study|Participant Decision|1|||
164143884|NCT01449370|592888568|FG022|Overall Study|Participant Decision|0|||
164143885|NCT01449370|592888569|FG023|Overall Study|Participant Decision|0|||
164143886|NCT01449370|592888570|FG024|Overall Study|Participant Decision|1|||
164143887|NCT01449370|592888546|FG000|Overall Study|Lost to Follow-up|0|||
164143888|NCT01449370|592888547|FG001|Overall Study|Lost to Follow-up|0|||
164143889|NCT01449370|592888548|FG002|Overall Study|Lost to Follow-up|0|||
164143890|NCT01449370|592888549|FG003|Overall Study|Lost to Follow-up|0|||
164143891|NCT01449370|592888550|FG004|Overall Study|Lost to Follow-up|0|||
164143892|NCT01449370|592888551|FG005|Overall Study|Lost to Follow-up|0|||
164143893|NCT01449370|592888552|FG006|Overall Study|Lost to Follow-up|0|||
164143894|NCT01449370|592888553|FG007|Overall Study|Lost to Follow-up|0|||
164143895|NCT01449370|592888554|FG008|Overall Study|Lost to Follow-up|0|||
164143896|NCT01449370|592888555|FG009|Overall Study|Lost to Follow-up|0|||
164143897|NCT01449370|592888556|FG010|Overall Study|Lost to Follow-up|0|||
164143898|NCT01449370|592888557|FG011|Overall Study|Lost to Follow-up|0|||
164143899|NCT01449370|592888558|FG012|Overall Study|Lost to Follow-up|0|||
164143900|NCT01449370|592888559|FG013|Overall Study|Lost to Follow-up|0|||
164143901|NCT01449370|592888560|FG014|Overall Study|Lost to Follow-up|0|||
164143902|NCT01449370|592888561|FG015|Overall Study|Lost to Follow-up|0|||
164143903|NCT01449370|592888562|FG016|Overall Study|Lost to Follow-up|0|||
164143904|NCT01449370|592888563|FG017|Overall Study|Lost to Follow-up|0|||
164143905|NCT01449370|592888564|FG018|Overall Study|Lost to Follow-up|0|||
164143906|NCT01449370|592888565|FG019|Overall Study|Lost to Follow-up|0|||
164143907|NCT01449370|592888566|FG020|Overall Study|Lost to Follow-up|1|||
164143908|NCT01449370|592888567|FG021|Overall Study|Lost to Follow-up|0|||
164143909|NCT01449370|592888568|FG022|Overall Study|Lost to Follow-up|0|||
164143910|NCT01449370|592888569|FG023|Overall Study|Lost to Follow-up|0|||
164143911|NCT01449370|592888570|FG024|Overall Study|Lost to Follow-up|0|||
164143912|NCT01449370|592888546|FG000|Overall Study|Other|0|||
164143913|NCT01449370|592888547|FG001|Overall Study|Other|0|||
164143914|NCT01449370|592888548|FG002|Overall Study|Other|0|||
164143915|NCT01449370|592888549|FG003|Overall Study|Other|0|||
164143916|NCT01449370|592888550|FG004|Overall Study|Other|0|||
164143917|NCT01449370|592888551|FG005|Overall Study|Other|0|||
164143918|NCT01449370|592888552|FG006|Overall Study|Other|0|||
164143919|NCT01449370|592888553|FG007|Overall Study|Other|0|||
164143920|NCT01449370|592888554|FG008|Overall Study|Other|1|||
164143921|NCT01449370|592888555|FG009|Overall Study|Other|1|||
164143922|NCT01449370|592888556|FG010|Overall Study|Other|0|||
164143923|NCT01449370|592888557|FG011|Overall Study|Other|0|||
164143924|NCT01449370|592888558|FG012|Overall Study|Other|0|||
164143925|NCT01449370|592888559|FG013|Overall Study|Other|0|||
164143926|NCT01449370|592888560|FG014|Overall Study|Other|0|||
164143927|NCT01449370|592888561|FG015|Overall Study|Other|0|||
164143928|NCT01449370|592888562|FG016|Overall Study|Other|0|||
164143929|NCT01449370|592888563|FG017|Overall Study|Other|0|||
164143930|NCT01449370|592888564|FG018|Overall Study|Other|0|||
164143931|NCT01449370|592888565|FG019|Overall Study|Other|0|||
164143932|NCT01449370|592888566|FG020|Overall Study|Other|0|||
164143933|NCT01449370|592888567|FG021|Overall Study|Other|0|||
164143934|NCT01449370|592888568|FG022|Overall Study|Other|1|||
164143935|NCT01449370|592888569|FG023|Overall Study|Other|1|||
164143936|NCT01449370|592888570|FG024|Overall Study|Other|0|||
164143937|NCT01449370|592888546|FG000|Overall Study|Medication Prohibited by Protocol|0|||
164143938|NCT01449370|592888547|FG001|Overall Study|Medication Prohibited by Protocol|0|||
164143939|NCT01449370|592888548|FG002|Overall Study|Medication Prohibited by Protocol|0|||
164143940|NCT01449370|592888549|FG003|Overall Study|Medication Prohibited by Protocol|0|||
164143941|NCT01449370|592888550|FG004|Overall Study|Medication Prohibited by Protocol|0|||
164143942|NCT01449370|592888551|FG005|Overall Study|Medication Prohibited by Protocol|0|||
164143943|NCT01449370|592888552|FG006|Overall Study|Medication Prohibited by Protocol|0|||
164143944|NCT01449370|592888553|FG007|Overall Study|Medication Prohibited by Protocol|0|||
164143945|NCT01449370|592888554|FG008|Overall Study|Medication Prohibited by Protocol|0|||
164143946|NCT01449370|592888555|FG009|Overall Study|Medication Prohibited by Protocol|0|||
164143947|NCT01449370|592888556|FG010|Overall Study|Medication Prohibited by Protocol|0|||
164143948|NCT01449370|592888557|FG011|Overall Study|Medication Prohibited by Protocol|0|||
164143949|NCT01449370|592888558|FG012|Overall Study|Medication Prohibited by Protocol|0|||
164143950|NCT01449370|592888559|FG013|Overall Study|Medication Prohibited by Protocol|0|||
164143951|NCT01449370|592888560|FG014|Overall Study|Medication Prohibited by Protocol|0|||
164143952|NCT01449370|592888561|FG015|Overall Study|Medication Prohibited by Protocol|0|||
164143953|NCT01449370|592888562|FG016|Overall Study|Medication Prohibited by Protocol|0|||
164143954|NCT01449370|592888563|FG017|Overall Study|Medication Prohibited by Protocol|0|||
164143955|NCT01449370|592888564|FG018|Overall Study|Medication Prohibited by Protocol|0|||
164143956|NCT01449370|592888565|FG019|Overall Study|Medication Prohibited by Protocol|0|||
164143957|NCT01449370|592888566|FG020|Overall Study|Medication Prohibited by Protocol|0|||
164143958|NCT01449370|592888567|FG021|Overall Study|Medication Prohibited by Protocol|0|||
164143959|NCT01449370|592888568|FG022|Overall Study|Medication Prohibited by Protocol|0|||
164143960|NCT01449370|592888569|FG023|Overall Study|Medication Prohibited by Protocol|1|||
164143961|NCT01449370|592888570|FG024|Overall Study|Medication Prohibited by Protocol|0|||
164143962|NCT01449370|592888546|FG000|Overall Study|Death|0|||
164143963|NCT01449370|592888547|FG001|Overall Study|Death|0|||
164143964|NCT01449370|592888548|FG002|Overall Study|Death|0|||
164143965|NCT01449370|592888549|FG003|Overall Study|Death|0|||
164143966|NCT01449370|592888550|FG004|Overall Study|Death|0|||
164143967|NCT01449370|592888551|FG005|Overall Study|Death|0|||
164143968|NCT01449370|592888552|FG006|Overall Study|Death|0|||
164143969|NCT01449370|592888553|FG007|Overall Study|Death|0|||
164143970|NCT01449370|592888554|FG008|Overall Study|Death|0|||
164143971|NCT01449370|592888555|FG009|Overall Study|Death|0|||
164143972|NCT01449370|592888556|FG010|Overall Study|Death|0|||
164143973|NCT01449370|592888557|FG011|Overall Study|Death|0|||
164143974|NCT01449370|592888558|FG012|Overall Study|Death|0|||
164143975|NCT01449370|592888559|FG013|Overall Study|Death|0|||
164143976|NCT01449370|592888560|FG014|Overall Study|Death|0|||
164143977|NCT01449370|592888561|FG015|Overall Study|Death|0|||
164143978|NCT01449370|592888562|FG016|Overall Study|Death|0|||
164143979|NCT01449370|592888563|FG017|Overall Study|Death|0|||
164143980|NCT01449370|592888564|FG018|Overall Study|Death|0|||
164143981|NCT01449370|592888565|FG019|Overall Study|Death|0|||
164143982|NCT01449370|592888566|FG020|Overall Study|Death|0|||
164143983|NCT01449370|592888567|FG021|Overall Study|Death|0|||
164143984|NCT01449370|592888568|FG022|Overall Study|Death|0|||
164143985|NCT01449370|592888569|FG023|Overall Study|Death|0|||
164143986|NCT01449370|592888570|FG024|Overall Study|Death|1|||
164143987|NCT00086281|592888571|FG000|Phase 1|Adverse Event|0|||
164143988|NCT00086281|592888572|FG001|Phase 1|Adverse Event|0|||
164143989|NCT00086281|592888573|FG002|Phase 1|Adverse Event|0|||
164143990|NCT00086281|592888574|FG003|Phase 1|Adverse Event|0|||
164143991|NCT00086281|592888575|FG004|Phase 1|Adverse Event|0|||
164143992|NCT00086281|592888576|FG005|Phase 1|Adverse Event|0|||
164143993|NCT00086281|592888577|FG006|Phase 1|Adverse Event|0|||
164143994|NCT00086281|592888578|FG007|Phase 1|Adverse Event|0|||
164143995|NCT00086281|592888579|FG008|Phase 1|Adverse Event|0|||
164143996|NCT00086281|592888580|FG009|Phase 1|Adverse Event|1|||
164143997|NCT00086281|592888581|FG010|Phase 1|Adverse Event|2|||
164143998|NCT00086281|592888582|FG011|Phase 1|Adverse Event|1|||
164143999|NCT00086281|592888583|FG012|Phase 1|Adverse Event|1|||
164144000|NCT00086281|592888584|FG013|Phase 1|Adverse Event|1|||
164144001|NCT00086281|592888585|FG014|Phase 1|Adverse Event|2|||
164144002|NCT00086281|592888571|FG000|Phase 1|Protocol Violation|0|||
164144003|NCT00086281|592888572|FG001|Phase 1|Protocol Violation|0|||
164144004|NCT00086281|592888573|FG002|Phase 1|Protocol Violation|0|||
164144005|NCT00086281|592888574|FG003|Phase 1|Protocol Violation|0|||
164144006|NCT00086281|592888575|FG004|Phase 1|Protocol Violation|0|||
164144007|NCT00086281|592888576|FG005|Phase 1|Protocol Violation|0|||
164144008|NCT00086281|592888577|FG006|Phase 1|Protocol Violation|0|||
164144009|NCT00086281|592888578|FG007|Phase 1|Protocol Violation|0|||
164144010|NCT00086281|592888579|FG008|Phase 1|Protocol Violation|0|||
164144011|NCT00086281|592888580|FG009|Phase 1|Protocol Violation|0|||
164144012|NCT00086281|592888581|FG010|Phase 1|Protocol Violation|1|||
164144013|NCT00086281|592888582|FG011|Phase 1|Protocol Violation|0|||
164144014|NCT00086281|592888583|FG012|Phase 1|Protocol Violation|0|||
164144015|NCT00086281|592888584|FG013|Phase 1|Protocol Violation|0|||
164144016|NCT00086281|592888585|FG014|Phase 1|Protocol Violation|0|||
164144017|NCT00086281|592888571|FG000|Phase 1|Serious Adverse Event|0|||
164144018|NCT00086281|592888572|FG001|Phase 1|Serious Adverse Event|0|||
164144019|NCT00086281|592888573|FG002|Phase 1|Serious Adverse Event|0|||
164144020|NCT00086281|592888574|FG003|Phase 1|Serious Adverse Event|0|||
164144021|NCT00086281|592888575|FG004|Phase 1|Serious Adverse Event|0|||
164144022|NCT00086281|592888576|FG005|Phase 1|Serious Adverse Event|0|||
164144023|NCT00086281|592888577|FG006|Phase 1|Serious Adverse Event|0|||
164144048|NCT00908310|592888589|FG000|Overall Study|Withdrawal by Subject|7|||
164144049|NCT00908310|592888589|FG000|Overall Study|Lost to Follow-up|7|||
164144050|NCT00908310|592888589|FG000|Overall Study|Screening failure|5|||
164144051|NCT00908310|592888589|FG000|Overall Study|Other reasons|4|||
164144052|NCT00351533|592888592|FG000|Overall Study|Extubated before first BAL|1|||
164144053|NCT00351533|592888593|FG001|Overall Study|Extubated before first BAL|0|||
164144054|NCT00351533|592888592|FG000|Overall Study|Lost to Follow-up|1|||
164144055|NCT00351533|592888593|FG001|Overall Study|Lost to Follow-up|3|||
164144056|NCT00351533|592888592|FG000|Overall Study|Physician Decision|0|||
164144057|NCT00351533|592888593|FG001|Overall Study|Physician Decision|1|||
164144058|NCT00351533|592888592|FG000|Overall Study|Withdrawal by Subject|0|||
164144059|NCT00351533|592888593|FG001|Overall Study|Withdrawal by Subject|1|||
164144060|NCT01885195|592888594|FG000|Overall Study|Adverse Event|29|||
164144061|NCT01885195|592888594|FG000|Overall Study|Death|1|||
164144062|NCT01885195|592888594|FG000|Overall Study|Disease Progression|67|||
164144063|NCT01885195|592888594|FG000|Overall Study|Protocol Deviation|2|||
164144064|NCT01885195|592888594|FG000|Overall Study|Physician Decision|3|||
164144065|NCT01885195|592888594|FG000|Overall Study|Patient/guardian decision|8|||
164144066|NCT03390426|592888597|FG000|Overall Study|Protocol Violation|0|||
164144067|NCT03390426|592888598|FG001|Overall Study|Protocol Violation|1|||
164144068|NCT00259272|592888599|FG000|Overall Study|Adverse Event|2|||
164144069|NCT00259272|592888600|FG001|Overall Study|Adverse Event|1|||
164144070|NCT00259272|592888601|FG002|Overall Study|Adverse Event|0|||
164144071|NCT00259272|592888602|FG003|Overall Study|Adverse Event|3|||
164144072|NCT00259272|592888599|FG000|Overall Study|Lack of Efficacy|5|||
164144073|NCT00259272|592888600|FG001|Overall Study|Lack of Efficacy|1|||
164144074|NCT00259272|592888601|FG002|Overall Study|Lack of Efficacy|2|||
164144075|NCT00259272|592888602|FG003|Overall Study|Lack of Efficacy|6|||
164144076|NCT00259272|592888599|FG000|Overall Study|Physician Decision|1|||
164144077|NCT00259272|592888600|FG001|Overall Study|Physician Decision|2|||
164144078|NCT00259272|592888601|FG002|Overall Study|Physician Decision|1|||
164144079|NCT00259272|592888602|FG003|Overall Study|Physician Decision|3|||
164144080|NCT00259272|592888599|FG000|Overall Study|Protocol Violation|2|||
164144081|NCT00259272|592888600|FG001|Overall Study|Protocol Violation|0|||
164144082|NCT00259272|592888601|FG002|Overall Study|Protocol Violation|0|||
164144083|NCT00259272|592888602|FG003|Overall Study|Protocol Violation|1|||
164144084|NCT00259272|592888599|FG000|Overall Study|Sponsor Decision|0|||
164144085|NCT00259272|592888600|FG001|Overall Study|Sponsor Decision|1|||
164144086|NCT00259272|592888601|FG002|Overall Study|Sponsor Decision|0|||
164144087|NCT00259272|592888602|FG003|Overall Study|Sponsor Decision|0|||
164144088|NCT00259272|592888599|FG000|Overall Study|Withdrawal by Subject|4|||
164144089|NCT00259272|592888600|FG001|Overall Study|Withdrawal by Subject|2|||
164144090|NCT00259272|592888601|FG002|Overall Study|Withdrawal by Subject|2|||
164144091|NCT00259272|592888602|FG003|Overall Study|Withdrawal by Subject|7|||
164144092|NCT00259272|592888599|FG000|Overall Study|Lost to Follow-up|1|||
164144093|NCT00259272|592888600|FG001|Overall Study|Lost to Follow-up|0|||
164144094|NCT00259272|592888601|FG002|Overall Study|Lost to Follow-up|0|||
164144095|NCT00259272|592888602|FG003|Overall Study|Lost to Follow-up|1|||
164144096|NCT03301623|592888605|FG000|Overall Study|Death|3|||
164144097|NCT03301623|592888606|FG001|Overall Study|Death|1|||
164144098|NCT03301623|592888605|FG000|Overall Study|Withdrawal by Subject|11|||
164144099|NCT03301623|592888606|FG001|Overall Study|Withdrawal by Subject|13|||
164144100|NCT03301623|592888605|FG000|Overall Study|Lost to Follow-up|3|||
164144101|NCT03301623|592888606|FG001|Overall Study|Lost to Follow-up|1|||
164144102|NCT02516553|592888607|FG000|Overall Study|Progressive disease|2|||
164144103|NCT02516553|592888608|FG001|Overall Study|Progressive disease|2|||
164144104|NCT02516553|592888609|FG002|Overall Study|Progressive disease|3|||
164144105|NCT02516553|592888610|FG003|Overall Study|Progressive disease|5|||
164144106|NCT02516553|592888611|FG004|Overall Study|Progressive disease|3|||
164144107|NCT02516553|592888612|FG005|Overall Study|Progressive disease|0|||
164144108|NCT02516553|592888613|FG006|Overall Study|Progressive disease|5|||
164144109|NCT02516553|592888614|FG007|Overall Study|Progressive disease|5|||
164144110|NCT02516553|592888615|FG008|Overall Study|Progressive disease|11|||
164144111|NCT02516553|592888616|FG009|Overall Study|Progressive disease|3|||
164144112|NCT02516553|592888617|FG010|Overall Study|Progressive disease|10|||
164144113|NCT02516553|592888618|FG011|Overall Study|Progressive disease|8|||
164144114|NCT02516553|592888619|FG012|Overall Study|Progressive disease|8|||
164144115|NCT02516553|592888620|FG013|Overall Study|Progressive disease|2|||
164144116|NCT02516553|592888621|FG014|Overall Study|Progressive disease|2|||
164144117|NCT02516553|592888622|FG015|Overall Study|Progressive disease|2|||
164144118|NCT02516553|592888623|FG016|Overall Study|Progressive disease|1|||
164144119|NCT02516553|592888624|FG017|Overall Study|Progressive disease|9|||
164144120|NCT02516553|592888625|FG018|Overall Study|Progressive disease|12|||
164144121|NCT02516553|592888626|FG019|Overall Study|Progressive disease|7|||
164144122|NCT02516553|592888627|FG020|Overall Study|Progressive disease|16|||
164144123|NCT02516553|592888628|FG021|Overall Study|Progressive disease|18|||
164144124|NCT02516553|592888607|FG000|Overall Study|Dose limiting toxicity|0|||
164144125|NCT02516553|592888608|FG001|Overall Study|Dose limiting toxicity|0|||
164144126|NCT02516553|592888609|FG002|Overall Study|Dose limiting toxicity|0|||
164144127|NCT02516553|592888610|FG003|Overall Study|Dose limiting toxicity|0|||
164144128|NCT02516553|592888611|FG004|Overall Study|Dose limiting toxicity|3|||
164144129|NCT02516553|592888612|FG005|Overall Study|Dose limiting toxicity|1|||
164144130|NCT02516553|592888613|FG006|Overall Study|Dose limiting toxicity|1|||
164144131|NCT02516553|592888614|FG007|Overall Study|Dose limiting toxicity|0|||
164144132|NCT02516553|592888615|FG008|Overall Study|Dose limiting toxicity|1|||
164144133|NCT02516553|592888616|FG009|Overall Study|Dose limiting toxicity|0|||
164144134|NCT02516553|592888617|FG010|Overall Study|Dose limiting toxicity|0|||
164144135|NCT02516553|592888618|FG011|Overall Study|Dose limiting toxicity|1|||
164144136|NCT02516553|592888619|FG012|Overall Study|Dose limiting toxicity|0|||
164144137|NCT02516553|592888620|FG013|Overall Study|Dose limiting toxicity|1|||
164144138|NCT02516553|592888621|FG014|Overall Study|Dose limiting toxicity|0|||
164144139|NCT02516553|592888622|FG015|Overall Study|Dose limiting toxicity|0|||
164144140|NCT02516553|592888623|FG016|Overall Study|Dose limiting toxicity|1|||
164144141|NCT02516553|592888624|FG017|Overall Study|Dose limiting toxicity|1|||
164144142|NCT02516553|592888625|FG018|Overall Study|Dose limiting toxicity|0|||
164144143|NCT02516553|592888626|FG019|Overall Study|Dose limiting toxicity|2|||
164144144|NCT02516553|592888627|FG020|Overall Study|Dose limiting toxicity|0|||
164144145|NCT02516553|592888628|FG021|Overall Study|Dose limiting toxicity|0|||
164144146|NCT02516553|592888607|FG000|Overall Study|Other Adverse Events|0|||
164144147|NCT02516553|592888608|FG001|Overall Study|Other Adverse Events|0|||
164144148|NCT02516553|592888609|FG002|Overall Study|Other Adverse Events|0|||
164144149|NCT02516553|592888610|FG003|Overall Study|Other Adverse Events|1|||
164144150|NCT02516553|592888611|FG004|Overall Study|Other Adverse Events|0|||
164144151|NCT02516553|592888612|FG005|Overall Study|Other Adverse Events|1|||
164144152|NCT02516553|592888613|FG006|Overall Study|Other Adverse Events|0|||
164144153|NCT02516553|592888614|FG007|Overall Study|Other Adverse Events|0|||
164144154|NCT02516553|592888615|FG008|Overall Study|Other Adverse Events|0|||
164144155|NCT02516553|592888616|FG009|Overall Study|Other Adverse Events|1|||
164144156|NCT02516553|592888617|FG010|Overall Study|Other Adverse Events|3|||
164144157|NCT02516553|592888618|FG011|Overall Study|Other Adverse Events|2|||
164144158|NCT02516553|592888619|FG012|Overall Study|Other Adverse Events|0|||
164144159|NCT02516553|592888620|FG013|Overall Study|Other Adverse Events|1|||
164144160|NCT02516553|592888621|FG014|Overall Study|Other Adverse Events|0|||
164144161|NCT02516553|592888622|FG015|Overall Study|Other Adverse Events|0|||
164144162|NCT02516553|592888623|FG016|Overall Study|Other Adverse Events|0|||
164144163|NCT02516553|592888624|FG017|Overall Study|Other Adverse Events|2|||
164144164|NCT02516553|592888625|FG018|Overall Study|Other Adverse Events|1|||
164144165|NCT02516553|592888626|FG019|Overall Study|Other Adverse Events|2|||
164144166|NCT02516553|592888627|FG020|Overall Study|Other Adverse Events|2|||
164144167|NCT02516553|592888628|FG021|Overall Study|Other Adverse Events|1|||
164144168|NCT02516553|592888607|FG000|Overall Study|Refused to continue trial medication|0|||
164144169|NCT02516553|592888608|FG001|Overall Study|Refused to continue trial medication|0|||
164144170|NCT02516553|592888609|FG002|Overall Study|Refused to continue trial medication|0|||
164144171|NCT02516553|592888610|FG003|Overall Study|Refused to continue trial medication|0|||
164144172|NCT02516553|592888611|FG004|Overall Study|Refused to continue trial medication|0|||
164144173|NCT02516553|592888612|FG005|Overall Study|Refused to continue trial medication|0|||
164144174|NCT02516553|592888613|FG006|Overall Study|Refused to continue trial medication|0|||
164144175|NCT02516553|592888614|FG007|Overall Study|Refused to continue trial medication|0|||
164144176|NCT02516553|592888615|FG008|Overall Study|Refused to continue trial medication|0|||
164144177|NCT02516553|592888616|FG009|Overall Study|Refused to continue trial medication|0|||
164144178|NCT02516553|592888617|FG010|Overall Study|Refused to continue trial medication|1|||
164144179|NCT02516553|592888618|FG011|Overall Study|Refused to continue trial medication|0|||
164144180|NCT02516553|592888619|FG012|Overall Study|Refused to continue trial medication|0|||
164144181|NCT02516553|592888620|FG013|Overall Study|Refused to continue trial medication|0|||
164144182|NCT02516553|592888621|FG014|Overall Study|Refused to continue trial medication|0|||
164144183|NCT02516553|592888622|FG015|Overall Study|Refused to continue trial medication|0|||
164144184|NCT02516553|592888623|FG016|Overall Study|Refused to continue trial medication|0|||
164144185|NCT02516553|592888624|FG017|Overall Study|Refused to continue trial medication|0|||
164144186|NCT02516553|592888625|FG018|Overall Study|Refused to continue trial medication|1|||
164144187|NCT02516553|592888626|FG019|Overall Study|Refused to continue trial medication|0|||
164144188|NCT02516553|592888627|FG020|Overall Study|Refused to continue trial medication|0|||
164144189|NCT02516553|592888628|FG021|Overall Study|Refused to continue trial medication|1|||
164144190|NCT02516553|592888607|FG000|Overall Study|other reasons than listed|0|||
164144191|NCT02516553|592888608|FG001|Overall Study|other reasons than listed|0|||
164144192|NCT02516553|592888609|FG002|Overall Study|other reasons than listed|0|||
164144193|NCT02516553|592888610|FG003|Overall Study|other reasons than listed|0|||
164144194|NCT02516553|592888611|FG004|Overall Study|other reasons than listed|0|||
164144195|NCT02516553|592888612|FG005|Overall Study|other reasons than listed|0|||
164144196|NCT02516553|592888613|FG006|Overall Study|other reasons than listed|0|||
164144197|NCT02516553|592888614|FG007|Overall Study|other reasons than listed|1|||
164144198|NCT02516553|592888615|FG008|Overall Study|other reasons than listed|1|||
164144199|NCT02516553|592888616|FG009|Overall Study|other reasons than listed|0|||
164144200|NCT02516553|592888617|FG010|Overall Study|other reasons than listed|1|||
164144201|NCT02516553|592888618|FG011|Overall Study|other reasons than listed|1|||
164144202|NCT02516553|592888619|FG012|Overall Study|other reasons than listed|0|||
164144203|NCT02516553|592888620|FG013|Overall Study|other reasons than listed|0|||
164144204|NCT02516553|592888621|FG014|Overall Study|other reasons than listed|0|||
164144205|NCT02516553|592888622|FG015|Overall Study|other reasons than listed|0|||
164144206|NCT02516553|592888623|FG016|Overall Study|other reasons than listed|0|||
164144207|NCT02516553|592888624|FG017|Overall Study|other reasons than listed|0|||
164144208|NCT02516553|592888625|FG018|Overall Study|other reasons than listed|0|||
164144209|NCT02516553|592888626|FG019|Overall Study|other reasons than listed|0|||
164144210|NCT02516553|592888627|FG020|Overall Study|other reasons than listed|2|||
164144211|NCT02516553|592888628|FG021|Overall Study|other reasons than listed|2|||
164144212|NCT00315731|592888630|FG000|Overall Study|Lost to Follow-up|1|||
164144213|NCT00315731|592888630|FG000|Overall Study|Death|5|||
164144214|NCT01680497|592888632|FG000|Overall Study|Lost to Follow-up|2|||
164144215|NCT03462459|592888634|FG000|Overall Study|Death|1|||
164144216|NCT03462459|592888635|FG001|Overall Study|Death|0|||
164144217|NCT03462459|592888634|FG000|Overall Study|Lack of Efficacy|2|||
164144218|NCT03462459|592888635|FG001|Overall Study|Lack of Efficacy|4|||
164144219|NCT03462459|592888634|FG000|Overall Study|Lost to Follow-up|1|||
164144220|NCT03462459|592888635|FG001|Overall Study|Lost to Follow-up|3|||
164144221|NCT03462459|592888634|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
164144222|NCT03462459|592888635|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
164144223|NCT03462459|592888634|FG000|Overall Study|Withdrawal by Subject|3|||
164144224|NCT03462459|592888635|FG001|Overall Study|Withdrawal by Subject|2|||
164144225|NCT03462459|592888634|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
164144226|NCT03462459|592888635|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
164144227|NCT01177059|592888636|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
164144228|NCT01177059|592888636|FG000|Overall Study|Withdrew consent|2|||
164144229|NCT01177059|592888636|FG000|Overall Study|Lost to Follow-up|18|||
164144230|NCT01243775|592888637|FG000|Overall Study|Withdrawal by Subject|2|||
164144231|NCT04051619|592888638|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
164144232|NCT04051619|592888639|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
164144233|NCT04051619|592888638|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
164144234|NCT04051619|592888639|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
164144235|NCT05938621|592889795|FG000|Overall Study|Lost to Follow-up|1|||
164144236|NCT05938621|592889796|FG001|Overall Study|Lost to Follow-up|5|||
164144237|NCT05938621|592889797|FG002|Overall Study|Lost to Follow-up|2|||
164144238|NCT05938621|592889798|FG003|Overall Study|Lost to Follow-up|2|||
164144239|NCT02731638|592889799|FG000|Overall Study|Lost to Follow-up|6|||
164144240|NCT02731638|592889800|FG001|Overall Study|Lost to Follow-up|9|||
164144241|NCT04158245|592889801|FG000|Overall Study|Lost to Follow-up|1|||
164144242|NCT02454608|592889802|FG000|Double-Blind Period|Lack of Efficacy|0|||
164144243|NCT02454608|592889803|FG001|Double-Blind Period|Lack of Efficacy|2|||
164144244|NCT02454608|592889804|FG002|Double-Blind Period|Lack of Efficacy|0|||
164144245|NCT02454608|592889802|FG000|Open Label Period|Lost to Follow-up|0|||
164144246|NCT02454608|592889803|FG001|Open Label Period|Lost to Follow-up|0|||
164144247|NCT02454608|592889804|FG002|Open Label Period|Lost to Follow-up|11|||
164144248|NCT02454608|592889802|FG000|Open Label Period|Withdrawal by Subject|0|||
164144249|NCT02454608|592889803|FG001|Open Label Period|Withdrawal by Subject|0|||
164144250|NCT02454608|592889804|FG002|Open Label Period|Withdrawal by Subject|8|||
164144251|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
164144252|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
164144253|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
164144254|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
164144255|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
164144256|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
164144257|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
164144258|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
164144259|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
164144260|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
164144261|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
164144262|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
164144263|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
164144264|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
164144265|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
164144266|NCT04856930|592889805|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144267|NCT04856930|592889806|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
164144268|NCT04856930|592889807|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144269|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
164144270|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
164144271|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
164144272|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
164144273|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
164144274|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
164144275|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
164144276|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
164144277|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
164144278|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
164144279|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
164144280|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
164144281|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
164144282|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144283|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
164144284|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
164144285|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
164144286|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
164144287|NCT04856930|592889805|FG000|Extension Period (16 Weeks)|Other than specified|0|||
164144288|NCT04856930|592889806|FG001|Extension Period (16 Weeks)|Other than specified|0|||
164144289|NCT04856930|592889807|FG002|Extension Period (16 Weeks)|Other than specified|1|||
164144290|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
164144291|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
164144292|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
164144293|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
164144294|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
164144295|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
164144296|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
164144297|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
164144298|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
164144299|NCT04856930|592889805|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
164144300|NCT04856930|592889806|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
164144301|NCT04856930|592889807|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
164144302|NCT00678210|592889808|FG000|Overall Study|Adverse Event|1|||
164144303|NCT00678210|592889809|FG001|Overall Study|Adverse Event|2|||
164144304|NCT00678210|592889810|FG002|Overall Study|Adverse Event|3|||
164144305|NCT00678210|592889811|FG003|Overall Study|Adverse Event|3|||
164144306|NCT00678210|592889808|FG000|Overall Study|Lack of Efficacy|2|||
164144307|NCT00678210|592889809|FG001|Overall Study|Lack of Efficacy|3|||
164144308|NCT00678210|592889810|FG002|Overall Study|Lack of Efficacy|1|||
164144309|NCT00678210|592889811|FG003|Overall Study|Lack of Efficacy|9|||
164144310|NCT00678210|592889808|FG000|Overall Study|Lost to Follow-up|4|||
164144311|NCT00678210|592889809|FG001|Overall Study|Lost to Follow-up|2|||
164144312|NCT00678210|592889810|FG002|Overall Study|Lost to Follow-up|0|||
164144313|NCT00678210|592889811|FG003|Overall Study|Lost to Follow-up|1|||
164144314|NCT00678210|592889808|FG000|Overall Study|Withdrawal by Subject|3|||
164144315|NCT00678210|592889809|FG001|Overall Study|Withdrawal by Subject|4|||
164144316|NCT00678210|592889810|FG002|Overall Study|Withdrawal by Subject|1|||
164144317|NCT00678210|592889811|FG003|Overall Study|Withdrawal by Subject|7|||
164144318|NCT00678210|592889808|FG000|Overall Study|Other|1|||
164144319|NCT00678210|592889809|FG001|Overall Study|Other|0|||
164144320|NCT00678210|592889810|FG002|Overall Study|Other|1|||
164144321|NCT00678210|592889811|FG003|Overall Study|Other|0|||
164144322|NCT01383707|592889814|FG000|Overall Study|Consent withdrawal|6|||
164144323|NCT01383707|592889814|FG000|Overall Study|Death|19|||
164144324|NCT01383707|592889814|FG000|Overall Study|Other|8|||
164144325|NCT01383707|592889814|FG000|Overall Study|Sponsor's decision|2|||
164144326|NCT01383707|592889814|FG000|Overall Study|Adverse Event|14|||
164144327|NCT01383707|592889814|FG000|Overall Study|Progressive disease|23|||
164144328|NCT02473523|592889826|FG000|Overall Study|Death|1|||
164144329|NCT02473523|592889826|FG000|Overall Study|Lost to Follow-up|1|||
164144330|NCT02111603|592889829|FG000|Overall Study|Withdrawal by Subject|1|||
164144331|NCT00976911|592889830|FG000|Overall Study|Withdrawal by Subject|4|||
164144332|NCT00976911|592889831|FG001|Overall Study|Withdrawal by Subject|6|||
164144333|NCT00976911|592889830|FG000|Overall Study|Death|138|||
164144334|NCT00976911|592889831|FG001|Overall Study|Death|126|||
164144335|NCT00976911|592889830|FG000|Overall Study|Adverse Event|0|||
164144336|NCT00976911|592889831|FG001|Overall Study|Adverse Event|1|||
164144337|NCT00976911|592889830|FG000|Overall Study|Protocol Violation|2|||
164144338|NCT00976911|592889831|FG001|Overall Study|Protocol Violation|0|||
164144339|NCT00976911|592889830|FG000|Overall Study|Other|8|||
164144340|NCT00976911|592889831|FG001|Overall Study|Other|9|||
164144341|NCT00976911|592889830|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
164144342|NCT00976911|592889831|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
164144343|NCT02954991|592889832|FG000|Overall Study|Death|92|||
164144344|NCT02954991|592889833|FG001|Overall Study|Death|11|||
164144345|NCT02954991|592889834|FG002|Overall Study|Death|2|||
164144346|NCT02954991|592889832|FG000|Overall Study|Lost to Follow-up|3|||
164144349|NCT02954991|592889832|FG000|Overall Study|Withdrawal by Subject|9|||
164144350|NCT02954991|592889833|FG001|Overall Study|Withdrawal by Subject|8|||
164144351|NCT02954991|592889834|FG002|Overall Study|Withdrawal by Subject|1|||
164144352|NCT02954991|592889832|FG000|Overall Study|Study Terminated by Sponsor|18|||
164144353|NCT02954991|592889833|FG001|Overall Study|Study Terminated by Sponsor|10|||
164144354|NCT02954991|592889834|FG002|Overall Study|Study Terminated by Sponsor|1|||
164144355|NCT02954991|592889832|FG000|Overall Study|Miscellaneous|2|||
164144356|NCT02954991|592889833|FG001|Overall Study|Miscellaneous|1|||
164144357|NCT02954991|592889834|FG002|Overall Study|Miscellaneous|1|||
164144358|NCT00576316|592889835|FG000|Overall Study|Adverse Event|9|||
164144359|NCT00576316|592889835|FG000|Overall Study|Withdrawal by Subject|2|||
164144360|NCT00576316|592889835|FG000|Overall Study|Protocol Violation|9|||
164144361|NCT02552303|592889838|FG000|Allocation|Withdrawal by Subject|2|||
164144362|NCT02552303|592889839|FG001|Allocation|Withdrawal by Subject|1|||
164144363|NCT02552303|592889840|FG002|Allocation|Withdrawal by Subject|1|||
164144364|NCT02552303|592889841|FG003|Allocation|Withdrawal by Subject|1|||
164144365|NCT02552303|592889838|FG000|Allocation|ineligible|1|||
164144366|NCT02552303|592889839|FG001|Allocation|ineligible|1|||
164144367|NCT02552303|592889840|FG002|Allocation|ineligible|0|||
164144368|NCT02552303|592889841|FG003|Allocation|ineligible|0|||
164144369|NCT02552303|592889838|FG000|Follow-Up|Lost to Follow-up|0|||
164144370|NCT02552303|592889839|FG001|Follow-Up|Lost to Follow-up|0|||
164144371|NCT02552303|592889840|FG002|Follow-Up|Lost to Follow-up|1|||
164144372|NCT02552303|592889841|FG003|Follow-Up|Lost to Follow-up|0|||
164144373|NCT02552303|592889838|FG000|Follow-Up|ineligible|0|||
164144374|NCT02552303|592889839|FG001|Follow-Up|ineligible|2|||
164144375|NCT02552303|592889840|FG002|Follow-Up|ineligible|0|||
164144376|NCT02552303|592889841|FG003|Follow-Up|ineligible|0|||
164144377|NCT01582152|592889842|FG000|Overall Study|Disease Progression|4|||
164144378|NCT01582152|592889843|FG001|Overall Study|Disease Progression|5|||
164144379|NCT01582152|592889842|FG000|Overall Study|Adverse Event|2|||
164144380|NCT01582152|592889843|FG001|Overall Study|Adverse Event|1|||
164144381|NCT03055624|592889844|FG000|Overall Study|Study closed|9|||
164144382|NCT02437903|592889847|FG000|Overall Study|Adverse Event|1|||
164144383|NCT02437903|592889847|FG000|Overall Study|Withdrawal by Subject|1|||
164144384|NCT02437903|592889847|FG000|Overall Study|Lost to Follow-up|3|||
164144385|NCT00799825|592889851|FG000|Overall Study|Adverse Event|1|||
164144386|NCT00799825|592889851|FG000|Overall Study|Withdrawal by Subject|6|||
164144387|NCT00799825|592889851|FG000|Overall Study|Lost to Follow-up|38|||
164144388|NCT00799825|592889851|FG000|Overall Study|Pregnancy|3|||
164144389|NCT00362336|592889852|FG000|Overall Study|Serious Adverse Event|1|||
164144390|NCT00362336|592889853|FG001|Overall Study|Serious Adverse Event|0|||
164144391|NCT00362336|592889854|FG002|Overall Study|Serious Adverse Event|1|||
164144392|NCT00362336|592889852|FG000|Overall Study|Protocol Violation|0|||
164144393|NCT00362336|592889853|FG001|Overall Study|Protocol Violation|0|||
164144394|NCT00362336|592889854|FG002|Overall Study|Protocol Violation|1|||
164144395|NCT00362336|592889852|FG000|Overall Study|Lost to Follow-up|6|||
164144396|NCT00362336|592889853|FG001|Overall Study|Lost to Follow-up|4|||
164144397|NCT00362336|592889854|FG002|Overall Study|Lost to Follow-up|0|||
164144398|NCT00362336|592889852|FG000|Overall Study|Withdrawal by Subject|3|||
164144399|NCT00362336|592889853|FG001|Overall Study|Withdrawal by Subject|3|||
164144400|NCT00362336|592889854|FG002|Overall Study|Withdrawal by Subject|1|||
164144401|NCT02289456|592889855|FG000|Induction Period|Death|2|||
164144402|NCT02289456|592889855|FG000|Induction Period|Adverse Event|11|||
164144403|NCT02289456|592889855|FG000|Induction Period|Progressive Disease (PD)|4|||
164144404|NCT02289456|592889855|FG000|Induction Period|Symptomatic Deterioration|4|||
164144405|NCT02289456|592889855|FG000|Induction Period|Withdrawal by Subject|2|||
164144406|NCT02289456|592889855|FG000|Induction Period|Miscellaneous|1|||
164144407|NCT02289456|592889855|FG000|Monotherapy Period|Death|1|||
164144408|NCT02289456|592889855|FG000|Monotherapy Period|Adverse Event|1|||
164144409|NCT02289456|592889855|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
164144410|NCT02289456|592889855|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
164144411|NCT02289456|592889855|FG000|Monotherapy Period|Withdrawal by Subject|2|||
164144412|NCT02289456|592889855|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
164144413|NCT02289456|592889855|FG000|Monotherapy Period|Miscellaneous|1|||
164144414|NCT01625988|592889856|FG000|Overall Study|Lost to Follow-up|5|||
164144415|NCT01625988|592889857|FG001|Overall Study|Lost to Follow-up|6|||
164144416|NCT01625988|592889856|FG000|Overall Study|Withdrawal by Subject|8|||
164144417|NCT01625988|592889857|FG001|Overall Study|Withdrawal by Subject|3|||
164144418|NCT01625988|592889856|FG000|Overall Study|Adverse Event|0|||
164144419|NCT01625988|592889857|FG001|Overall Study|Adverse Event|1|||
164144420|NCT01625988|592889856|FG000|Overall Study|Lack of Efficacy|0|||
164144421|NCT01625988|592889857|FG001|Overall Study|Lack of Efficacy|1|||
164144422|NCT01625988|592889856|FG000|Overall Study|Randomized Inappropriately|1|||
164144423|NCT01625988|592889857|FG001|Overall Study|Randomized Inappropriately|0|||
164144424|NCT01625988|592889856|FG000|Overall Study|Protocol Violation|0|||
164144425|NCT01625988|592889857|FG001|Overall Study|Protocol Violation|2|||
164144426|NCT02681510|592889858|FG000|Overall Study|Withdrawal by Subject|1|||
164144427|NCT02681510|592889858|FG000|Overall Study|Lost to Follow-up|9|||
164144428|NCT00134901|592889868|FG000|Overall Study|Lost to Follow-up|5|||
164144430|NCT00134901|592889868|FG000|Overall Study|discontinued intervention|12|||
164144431|NCT00134901|592889869|FG001|Overall Study|discontinued intervention|10|||
164144432|NCT04841577|592889870|FG000|Overall Study|Adverse Event|5|||
164144433|NCT04841577|592889871|FG001|Overall Study|Adverse Event|10|||
164144434|NCT04841577|592889870|FG000|Overall Study|Lost to Follow-up|8|||
164144435|NCT04841577|592889871|FG001|Overall Study|Lost to Follow-up|7|||
164144436|NCT04841577|592889870|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
164144437|NCT04841577|592889871|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
164144438|NCT04841577|592889870|FG000|Overall Study|Other|0|||
164144439|NCT04841577|592889871|FG001|Overall Study|Other|1|||
164144440|NCT01004003|592889874|FG000|Overall Study|Progressive disease|2|||
164144441|NCT01004003|592889875|FG001|Overall Study|Progressive disease|1|||
164144442|NCT01004003|592889876|FG002|Overall Study|Progressive disease|1|||
164144443|NCT01004003|592889877|FG003|Overall Study|Progressive disease|0|||
164144444|NCT01004003|592889878|FG004|Overall Study|Progressive disease|2|||
164144445|NCT01004003|592889879|FG005|Overall Study|Progressive disease|1|||
164144446|NCT01004003|592889880|FG006|Overall Study|Progressive disease|1|||
164144447|NCT01004003|592889881|FG007|Overall Study|Progressive disease|39|||
164144448|NCT01004003|592889882|FG008|Overall Study|Progressive disease|22|||
164144449|NCT01004003|592889874|FG000|Overall Study|Adverse Event|4|||
164144450|NCT01004003|592889875|FG001|Overall Study|Adverse Event|2|||
164144451|NCT01004003|592889876|FG002|Overall Study|Adverse Event|3|||
164144452|NCT01004003|592889877|FG003|Overall Study|Adverse Event|3|||
164144453|NCT01004003|592889878|FG004|Overall Study|Adverse Event|2|||
164144454|NCT01004003|592889879|FG005|Overall Study|Adverse Event|2|||
164144455|NCT01004003|592889880|FG006|Overall Study|Adverse Event|7|||
164144456|NCT01004003|592889881|FG007|Overall Study|Adverse Event|21|||
164144457|NCT01004003|592889882|FG008|Overall Study|Adverse Event|6|||
164144458|NCT01004003|592889874|FG000|Overall Study|Refused to continue taking trial med.|0|||
164144459|NCT01004003|592889875|FG001|Overall Study|Refused to continue taking trial med.|0|||
164144460|NCT01004003|592889876|FG002|Overall Study|Refused to continue taking trial med.|0|||
164144461|NCT01004003|592889877|FG003|Overall Study|Refused to continue taking trial med.|0|||
164144462|NCT01004003|592889878|FG004|Overall Study|Refused to continue taking trial med.|0|||
164144463|NCT01004003|592889879|FG005|Overall Study|Refused to continue taking trial med.|0|||
164144464|NCT01004003|592889880|FG006|Overall Study|Refused to continue taking trial med.|0|||
164144465|NCT01004003|592889881|FG007|Overall Study|Refused to continue taking trial med.|0|||
164144466|NCT01004003|592889882|FG008|Overall Study|Refused to continue taking trial med.|2|||
164144467|NCT01004003|592889874|FG000|Overall Study|Other|0|||
164144468|NCT01004003|592889875|FG001|Overall Study|Other|0|||
164144469|NCT01004003|592889876|FG002|Overall Study|Other|0|||
164144470|NCT01004003|592889877|FG003|Overall Study|Other|0|||
164144471|NCT01004003|592889878|FG004|Overall Study|Other|0|||
164144472|NCT01004003|592889879|FG005|Overall Study|Other|1|||
164144473|NCT01004003|592889880|FG006|Overall Study|Other|0|||
164144474|NCT01004003|592889881|FG007|Overall Study|Other|0|||
164144475|NCT01004003|592889882|FG008|Overall Study|Other|0|||
164144476|NCT01589497|592889886|FG000|Overall Study|Withdrawal by Subject|0|||
164144477|NCT01589497|592889887|FG001|Overall Study|Withdrawal by Subject|1|||
164144478|NCT01589497|592889888|FG002|Overall Study|Withdrawal by Subject|0|||
164144479|NCT01589497|592889889|FG003|Overall Study|Withdrawal by Subject|1|||
164144480|NCT01589497|592889886|FG000|Overall Study|Death|1|||
164144481|NCT01589497|592889887|FG001|Overall Study|Death|0|||
164144482|NCT01589497|592889888|FG002|Overall Study|Death|0|||
164144483|NCT01589497|592889889|FG003|Overall Study|Death|0|||
164144484|NCT01589497|592889886|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
164144485|NCT01589497|592889887|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
164144486|NCT01589497|592889888|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
164144487|NCT01589497|592889889|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
164144488|NCT04123561|592889896|FG000|Overall Study|Lost to Follow-up|20|||
164144489|NCT04123561|592889897|FG001|Overall Study|Lost to Follow-up|12|||
164144490|NCT04123561|592889898|FG002|Overall Study|Lost to Follow-up|5|||
164144491|NCT04123561|592889896|FG000|Overall Study|Withdrawal by Subject|9|||
164144492|NCT04123561|592889897|FG001|Overall Study|Withdrawal by Subject|7|||
164144493|NCT04123561|592889898|FG002|Overall Study|Withdrawal by Subject|9|||
164144494|NCT04123561|592889896|FG000|Overall Study|Lack of Efficacy|7|||
164144495|NCT04123561|592889897|FG001|Overall Study|Lack of Efficacy|8|||
164144496|NCT04123561|592889898|FG002|Overall Study|Lack of Efficacy|6|||
164144497|NCT04123561|592889896|FG000|Overall Study|Adverse Event|5|||
164144498|NCT04123561|592889897|FG001|Overall Study|Adverse Event|2|||
164144499|NCT04123561|592889898|FG002|Overall Study|Adverse Event|3|||
164144500|NCT04123561|592889896|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
164144501|NCT04123561|592889897|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
164144502|NCT04123561|592889898|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
164144503|NCT04123561|592889896|FG000|Overall Study|Death|0|||
164144504|NCT04123561|592889897|FG001|Overall Study|Death|0|||
164144505|NCT04123561|592889898|FG002|Overall Study|Death|1|||
164144506|NCT04123561|592889896|FG000|Overall Study|Protocol Violation|0|||
164144509|NCT01653912|592889906|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144510|NCT01653912|592889907|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
164144511|NCT01653912|592889908|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144512|NCT01653912|592889909|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144513|NCT01653912|592889910|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144514|NCT01653912|592889911|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
164144515|NCT01653912|592889906|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144516|NCT01653912|592889907|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144517|NCT01653912|592889908|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
164144518|NCT01653912|592889909|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144519|NCT01653912|592889910|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144520|NCT01653912|592889911|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
164144521|NCT01653912|592889906|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144522|NCT01653912|592889907|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144523|NCT01653912|592889908|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144524|NCT01653912|592889909|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
164144525|NCT01653912|592889910|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144526|NCT01653912|592889911|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
164144527|NCT01653912|592889906|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144528|NCT01653912|592889907|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144529|NCT01653912|592889908|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144530|NCT01653912|592889909|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
164144531|NCT01653912|592889910|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144532|NCT01653912|592889911|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144533|NCT01653912|592889906|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144534|NCT01653912|592889907|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144535|NCT01653912|592889908|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144536|NCT01653912|592889909|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144537|NCT01653912|592889910|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
164144538|NCT01653912|592889911|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
164144539|NCT01653912|592889906|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144540|NCT01653912|592889907|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144541|NCT01653912|592889908|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144542|NCT01653912|592889909|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144543|NCT01653912|592889910|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
164144544|NCT01653912|592889911|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
164144545|NCT01653912|592889906|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144546|NCT01653912|592889907|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144547|NCT01653912|592889908|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144548|NCT01653912|592889909|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144549|NCT01653912|592889910|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
164144550|NCT01653912|592889911|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
164144551|NCT00708227|592889912|FG000|Overall Study|Physician Decision|0|||
164144552|NCT00708227|592889913|FG001|Overall Study|Physician Decision|3|||
164144553|NCT00708227|592889914|FG002|Overall Study|Physician Decision|1|||
164144554|NCT00708227|592889915|FG003|Overall Study|Physician Decision|2|||
164144555|NCT00708227|592889912|FG000|Overall Study|Withdrawal by Subject|1|||
164144556|NCT00708227|592889913|FG001|Overall Study|Withdrawal by Subject|2|||
164144557|NCT00708227|592889914|FG002|Overall Study|Withdrawal by Subject|0|||
164144558|NCT00708227|592889915|FG003|Overall Study|Withdrawal by Subject|1|||
164144559|NCT04007991|592889916|FG000|Overall Study|Withdrawal by Subject|1|||
164144560|NCT04007991|592889917|FG001|Overall Study|Withdrawal by Subject|1|||
164144561|NCT04007991|592889916|FG000|Overall Study|Physician Decision|1|||
164144562|NCT04007991|592889917|FG001|Overall Study|Physician Decision|1|||
164144563|NCT04007991|592889916|FG000|Overall Study|Non-compliance with Study Drug|0|||
164144564|NCT04007991|592889917|FG001|Overall Study|Non-compliance with Study Drug|1|||
164144565|NCT04007991|592889916|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
164144566|NCT04007991|592889917|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
164144567|NCT04007991|592889916|FG000|Overall Study|Adverse event, non-fatal|5|||
164144568|NCT04007991|592889917|FG001|Overall Study|Adverse event, non-fatal|0|||
164144569|NCT04007991|592889916|FG000|Overall Study|Lost to Follow-up|2|||
164144570|NCT04007991|592889917|FG001|Overall Study|Lost to Follow-up|1|||
164144571|NCT01987479|592889918|FG000|Overall Study|Protocol Violation|1|||
164144572|NCT01987479|592889918|FG000|Overall Study|Physician Decision|2|||
164144573|NCT01987479|592889918|FG000|Overall Study|Participant/legal guardian decision|1|||
164144574|NCT01987479|592889918|FG000|Overall Study|Other|5|||
164144575|NCT01987479|592889918|FG000|Overall Study|Lost to Follow-up|1|||
164144576|NCT01987479|592889918|FG000|Overall Study|Adverse Event|7|||
164144577|NCT03654599|592889921|FG000|Overall Study|Lost to Follow-up|14|||
164144578|NCT03654599|592889922|FG001|Overall Study|Lost to Follow-up|12|||
164144579|NCT03654599|592889921|FG000|Overall Study|Death|8|||
164144580|NCT03654599|592889922|FG001|Overall Study|Death|6|||
164144581|NCT03654599|592889921|FG000|Overall Study|Withdrawal by Subject|6|||
164144582|NCT03654599|592889922|FG001|Overall Study|Withdrawal by Subject|4|||
164144583|NCT01290302|592891703|FG000|Overall Study|Adverse Event|2|||
164144584|NCT01290302|592891704|FG001|Overall Study|Adverse Event|0|||
164144585|NCT01290302|592891703|FG000|Overall Study|Withdrawal by Subject|1|||
164144586|NCT01290302|592891704|FG001|Overall Study|Withdrawal by Subject|0|||
164144587|NCT01290302|592891703|FG000|Overall Study|Physician Decision|0|||
164144588|NCT01290302|592891704|FG001|Overall Study|Physician Decision|2|||
164144589|NCT01290302|592891703|FG000|Overall Study|Expiration of time for screening window|1|||
164144590|NCT01290302|592891704|FG001|Overall Study|Expiration of time for screening window|0|||
164144591|NCT03816878|592891707|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
164144592|NCT03816878|592891708|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
164144593|NCT03816878|592891707|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
164144594|NCT03816878|592891708|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
164144595|NCT03355469|592891709|FG000|Overall Study|COVID-19|3|||
164144596|NCT03355469|592891710|FG001|Overall Study|COVID-19|2|||
164144597|NCT03355469|592891711|FG002|Overall Study|COVID-19|3|||
164144598|NCT03355469|592891712|FG003|Overall Study|COVID-19|3|||
164144599|NCT03355469|592891709|FG000|Overall Study|Lost to Follow-up|1|||
164144600|NCT03355469|592891710|FG001|Overall Study|Lost to Follow-up|0|||
164144601|NCT03355469|592891711|FG002|Overall Study|Lost to Follow-up|1|||
164144602|NCT03355469|592891712|FG003|Overall Study|Lost to Follow-up|0|||
164144603|NCT03355469|592891709|FG000|Overall Study|Withdrawal by Subject|2|||
164144604|NCT03355469|592891710|FG001|Overall Study|Withdrawal by Subject|1|||
164144605|NCT03355469|592891711|FG002|Overall Study|Withdrawal by Subject|0|||
164144606|NCT03355469|592891712|FG003|Overall Study|Withdrawal by Subject|3|||
164144607|NCT02291510|592891713|FG000|Overall Study|Adverse Event|0|||
164144608|NCT02291510|592891714|FG001|Overall Study|Adverse Event|0|||
164144609|NCT02291510|592891715|FG002|Overall Study|Adverse Event|0|||
164144610|NCT02291510|592891716|FG003|Overall Study|Adverse Event|1|||
164144611|NCT04825912|592891722|FG000|Overall Study|Death|3|||
164144612|NCT04825912|592891722|FG000|Overall Study|Withdrawal by Subject|1|||
164144613|NCT01009814|592891725|FG000|Overall Study|No longer met study criteria|1|||
164144614|NCT01009814|592891726|FG001|Overall Study|No longer met study criteria|1|||
164144615|NCT01009814|592891727|FG002|Overall Study|No longer met study criteria|0|||
164144616|NCT01009814|592891728|FG003|Overall Study|No longer met study criteria|0|||
164144617|NCT01009814|592891729|FG004|Overall Study|No longer met study criteria|0|||
164144618|NCT01173120|592891730|FG000|Overall Study|Lack of Efficacy|2|||
164144619|NCT01173120|592891730|FG000|Overall Study|Lost to Follow-up|1|||
164144620|NCT01173120|592891730|FG000|Overall Study|Participant Decision|2|||
164144621|NCT01173120|592891730|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
164144622|NCT01173120|592891730|FG000|Overall Study|Switch-Participant Decision|12|||
164144623|NCT01173120|592891730|FG000|Overall Study|Switch-Difficulty With Device|12|||
164144624|NCT01977417|592891734|FG000|Overall Study|Adverse Event|1|||
164144625|NCT01977417|592891735|FG001|Overall Study|Adverse Event|0|||
164144626|NCT01977417|592891734|FG000|Overall Study|Withdrawal by Subject|2|||
164144627|NCT01977417|592891735|FG001|Overall Study|Withdrawal by Subject|4|||
164144628|NCT01977417|592891734|FG000|Overall Study|Female enrollment goal met|0|||
164144629|NCT01977417|592891735|FG001|Overall Study|Female enrollment goal met|2|||
164144630|NCT02906358|592891736|FG000|Overall Study|Withdrawal by Subject|10|||
164144631|NCT02906358|592891737|FG001|Overall Study|Withdrawal by Subject|7|||
164144632|NCT02906358|592891736|FG000|Overall Study|Lost to Follow-up|12|||
164144633|NCT02906358|592891737|FG001|Overall Study|Lost to Follow-up|15|||
164144634|NCT02699684|592891738|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
164144635|NCT02699684|592891739|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
164144636|NCT00616421|592891742|FG000|Overall Study|Withdrawal by Subject|9|||
164144637|NCT00616421|592891743|FG001|Overall Study|Withdrawal by Subject|11|||
164144638|NCT00616421|592891744|FG002|Overall Study|Withdrawal by Subject|8|||
164144639|NCT00616421|592891742|FG000|Overall Study|Lost to Follow-up|12|||
164144640|NCT00616421|592891743|FG001|Overall Study|Lost to Follow-up|26|||
164144641|NCT00616421|592891744|FG002|Overall Study|Lost to Follow-up|30|||
164144642|NCT00616421|592891742|FG000|Overall Study|Inappropriate enrollment|3|||
164144643|NCT00616421|592891743|FG001|Overall Study|Inappropriate enrollment|0|||
164144644|NCT00616421|592891744|FG002|Overall Study|Inappropriate enrollment|1|||
164144645|NCT00616421|592891742|FG000|Overall Study|Administrative reason|1|||
164144646|NCT00616421|592891743|FG001|Overall Study|Administrative reason|0|||
164144647|NCT00616421|592891744|FG002|Overall Study|Administrative reason|0|||
164144648|NCT00616421|592891742|FG000|Overall Study|Protocol Violation|0|||
164144649|NCT00616421|592891743|FG001|Overall Study|Protocol Violation|1|||
164144650|NCT00616421|592891744|FG002|Overall Study|Protocol Violation|2|||
164144651|NCT00616421|592891742|FG000|Overall Study|Unable to classify|1|||
164144652|NCT00616421|592891743|FG001|Overall Study|Unable to classify|0|||
164144653|NCT00616421|592891744|FG002|Overall Study|Unable to classify|0|||
164144654|NCT01495702|592891745|FG000|Randomized Phase|Randomized But Not Treated|1|||
164144655|NCT01495702|592891746|FG001|Randomized Phase|Randomized But Not Treated|4|||
164144662|NCT01495702|592891745|FG000|Randomized Phase|Investigators Discretion|2|||
164144663|NCT01495702|592891746|FG001|Randomized Phase|Investigators Discretion|0|||
164144664|NCT01495702|592891745|FG000|Randomized Phase|Withdrew Consent|10|||
164144665|NCT01495702|592891746|FG001|Randomized Phase|Withdrew Consent|18|||
164144666|NCT01495702|592891745|FG000|Randomized Phase|Lost to Follow-up|4|||
164144667|NCT01495702|592891746|FG001|Randomized Phase|Lost to Follow-up|3|||
164144668|NCT01495702|592891745|FG000|Randomized Phase|Participant Noncompliance|1|||
164144669|NCT01495702|592891746|FG001|Randomized Phase|Participant Noncompliance|0|||
164144670|NCT01495702|592891745|FG000|Randomized Phase|Protocol Violation|3|||
164144671|NCT01495702|592891746|FG001|Randomized Phase|Protocol Violation|1|||
164144672|NCT04152863|592891747|FG000|Overall Study|Death|13|||
164144673|NCT04152863|592891748|FG001|Overall Study|Death|12|||
164144674|NCT04152863|592891749|FG002|Overall Study|Death|7|||
164144675|NCT04152863|592891747|FG000|Overall Study|Physician Decision|1|||
164144676|NCT04152863|592891748|FG001|Overall Study|Physician Decision|1|||
164144677|NCT04152863|592891749|FG002|Overall Study|Physician Decision|1|||
164144678|NCT04152863|592891747|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
164144679|NCT04152863|592891748|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
164144680|NCT04152863|592891749|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
164144681|NCT04152863|592891747|FG000|Overall Study|Withdrawal by Subject|2|||
164144682|NCT04152863|592891748|FG001|Overall Study|Withdrawal by Subject|1|||
164144683|NCT04152863|592891749|FG002|Overall Study|Withdrawal by Subject|3|||
164144684|NCT01644617|592891753|FG000|Overall Study|Withdrawal by Subject|3|||
164144685|NCT01644617|592891754|FG001|Overall Study|Withdrawal by Subject|4|||
164144686|NCT01644617|592891755|FG002|Overall Study|Withdrawal by Subject|1|||
164144687|NCT01644617|592891753|FG000|Overall Study|Lost to Follow-up|0|||
164144688|NCT01644617|592891754|FG001|Overall Study|Lost to Follow-up|1|||
164144689|NCT01644617|592891755|FG002|Overall Study|Lost to Follow-up|0|||
164144690|NCT01644617|592891753|FG000|Overall Study|Adverse Event|3|||
164144691|NCT01644617|592891754|FG001|Overall Study|Adverse Event|0|||
164144692|NCT01644617|592891755|FG002|Overall Study|Adverse Event|6|||
164144693|NCT03593395|592891762|FG000|Overall Study|Lost to Follow-up|48|||
164144694|NCT03593395|592891763|FG001|Overall Study|Lost to Follow-up|3|||
164144695|NCT03593395|592891762|FG000|Overall Study|Withdrawal by Subject|5|||
164144696|NCT03593395|592891763|FG001|Overall Study|Withdrawal by Subject|24|||
164144697|NCT03593395|592891762|FG000|Overall Study|Death|2|||
164144698|NCT03593395|592891763|FG001|Overall Study|Death|3|||
164144699|NCT03593395|592891762|FG000|Overall Study|Physician Decision|0|||
164144700|NCT03593395|592891763|FG001|Overall Study|Physician Decision|6|||
164144701|NCT03593395|592891762|FG000|Overall Study|Participant Relocated|19|||
164144702|NCT03593395|592891763|FG001|Overall Study|Participant Relocated|3|||
164144703|NCT03593395|592891762|FG000|Overall Study|No Information|1|||
164144704|NCT03593395|592891763|FG001|Overall Study|No Information|7|||
164144705|NCT00741338|592891764|FG000|Overall Study|Adverse Event|0|||
164144706|NCT00741338|592891765|FG001|Overall Study|Adverse Event|1|||
164144707|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
164144708|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
164144709|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
164144710|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164144711|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
164144712|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
164144713|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
164144714|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
164144715|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164144716|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
164144717|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164144718|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164144719|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
164144720|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164144721|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
164144722|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
164144723|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
164144724|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
164144725|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
164144726|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
164144727|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
164144728|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164144729|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
164144730|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164144731|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
164144732|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144733|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144734|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
164144735|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144736|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
164144737|NCT03713632|592891766|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
164144738|NCT03713632|592891767|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144739|NCT03713632|592891768|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144740|NCT03713632|592891769|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144741|NCT03713632|592891770|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
164144742|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
164144743|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
164144744|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
164144745|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
164144746|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
164144747|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
164144748|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
164144749|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
164144750|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
164144751|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
164144752|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
164144753|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
164144754|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
164144755|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
164144756|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
164144757|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
164144758|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
164144759|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
164144760|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
164144761|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
164144762|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
164144763|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
164144764|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164144765|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
164144766|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
164144767|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
164144768|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144769|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144770|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144771|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
164144772|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Death|0|||
164144773|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Death|1|||
164144774|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Death|0|||
164144775|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Death|0|||
164144776|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Death|0|||
164144777|NCT03713632|592891766|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144778|NCT03713632|592891767|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
164144779|NCT03713632|592891768|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144780|NCT03713632|592891769|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144781|NCT03713632|592891770|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
164144782|NCT01524978|592891774|FG000|Overall Study|Other|16|||
164144783|NCT01524978|592891775|FG001|Overall Study|Other|2|||
164144784|NCT01524978|592891776|FG002|Overall Study|Other|1|||
164144785|NCT01524978|592891777|FG003|Overall Study|Other|2|||
164144786|NCT01524978|592891778|FG004|Overall Study|Other|1|||
164144787|NCT01524978|592891779|FG005|Overall Study|Other|3|||
164144788|NCT01524978|592891780|FG006|Overall Study|Other|17|||
164144789|NCT01524978|592891781|FG007|Overall Study|Other|1|||
164144790|NCT01524978|592891782|FG008|Overall Study|Other|2|||
164144791|NCT01524978|592891783|FG009|Overall Study|Other|2|||
164144792|NCT01524978|592891784|FG010|Overall Study|Other|5|||
164144793|NCT01524978|592891774|FG000|Overall Study|Withdrawal by Subject|12|||
164144794|NCT01524978|592891775|FG001|Overall Study|Withdrawal by Subject|0|||
164144795|NCT01524978|592891776|FG002|Overall Study|Withdrawal by Subject|1|||
164144796|NCT01524978|592891777|FG003|Overall Study|Withdrawal by Subject|1|||
164144797|NCT01524978|592891778|FG004|Overall Study|Withdrawal by Subject|3|||
164144798|NCT01524978|592891779|FG005|Overall Study|Withdrawal by Subject|1|||
164144799|NCT01524978|592891780|FG006|Overall Study|Withdrawal by Subject|6|||
164144800|NCT01524978|592891781|FG007|Overall Study|Withdrawal by Subject|2|||
164144801|NCT01524978|592891782|FG008|Overall Study|Withdrawal by Subject|4|||
164144802|NCT01524978|592891783|FG009|Overall Study|Withdrawal by Subject|0|||
164144803|NCT01524978|592891784|FG010|Overall Study|Withdrawal by Subject|5|||
164144804|NCT01524978|592891774|FG000|Overall Study|Lost to Follow-up|0|||
164144805|NCT01524978|592891775|FG001|Overall Study|Lost to Follow-up|0|||
164144806|NCT01524978|592891776|FG002|Overall Study|Lost to Follow-up|3|||
164144831|NCT03790657|592891794|FG000|Overall Study|Withdrawal by Subject|1|||
164144832|NCT03790657|592891795|FG001|Overall Study|Withdrawal by Subject|1|||
164144833|NCT03126435|592891796|FG000|Overall Study|Death|90|||
164144834|NCT03126435|592891797|FG001|Overall Study|Death|84|||
164144835|NCT03126435|592891796|FG000|Overall Study|Lost to Follow-up|4|||
164144836|NCT03126435|592891797|FG001|Overall Study|Lost to Follow-up|3|||
164144837|NCT03126435|592891796|FG000|Overall Study|Physician Decision|0|||
164144838|NCT03126435|592891797|FG001|Overall Study|Physician Decision|1|||
164144839|NCT03126435|592891796|FG000|Overall Study|Withdrawal by Subject|6|||
164144840|NCT03126435|592891797|FG001|Overall Study|Withdrawal by Subject|12|||
164144841|NCT03126435|592891796|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
164144842|NCT03126435|592891797|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
164144843|NCT02370238|592891804|FG000|Overall Study|Death|42|||
164144844|NCT02370238|592891805|FG001|Overall Study|Death|35|||
164144845|NCT02370238|592891804|FG000|Overall Study|Lost to Follow-up|1|||
164144846|NCT02370238|592891805|FG001|Overall Study|Lost to Follow-up|3|||
164144847|NCT02370238|592891804|FG000|Overall Study|Withdrawal by Subject|2|||
164144848|NCT02370238|592891805|FG001|Overall Study|Withdrawal by Subject|6|||
164144849|NCT02370238|592891804|FG000|Overall Study|Other|2|||
164144850|NCT02370238|592891805|FG001|Overall Study|Other|1|||
164144851|NCT01937871|592891806|FG000|Overall Study|Adverse Event|6|||
164144852|NCT01937871|592891807|FG001|Overall Study|Adverse Event|6|||
164144853|NCT01937871|592891808|FG002|Overall Study|Adverse Event|2|||
164144854|NCT01937871|592891806|FG000|Overall Study|Lost to Follow-up|8|||
164144855|NCT01937871|592891807|FG001|Overall Study|Lost to Follow-up|2|||
164144856|NCT01937871|592891808|FG002|Overall Study|Lost to Follow-up|4|||
164144857|NCT01937871|592891806|FG000|Overall Study|Withdrawal by Subject|9|||
164144858|NCT01937871|592891807|FG001|Overall Study|Withdrawal by Subject|6|||
164144859|NCT01937871|592891808|FG002|Overall Study|Withdrawal by Subject|4|||
164144860|NCT01937871|592891806|FG000|Overall Study|Physician Decision|0|||
164144861|NCT01937871|592891807|FG001|Overall Study|Physician Decision|1|||
164144862|NCT01937871|592891808|FG002|Overall Study|Physician Decision|0|||
164144863|NCT01937871|592891806|FG000|Overall Study|Entry Criteria Not Met|1|||
164144864|NCT01937871|592891807|FG001|Overall Study|Entry Criteria Not Met|2|||
164144865|NCT01937871|592891808|FG002|Overall Study|Entry Criteria Not Met|1|||
164144866|NCT02652949|592891809|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
164144867|NCT02652949|592891809|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
164144868|NCT02652949|592891809|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
164144869|NCT02652949|592891809|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
164144870|NCT02652949|592891809|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
164144871|NCT02652949|592891809|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
164144872|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
164144873|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
164144874|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
164144875|NCT02652949|592891809|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
164144876|NCT02652949|592891809|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
164144877|NCT02652949|592891809|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
164144878|NCT02652949|592891809|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
164144879|NCT02652949|592891809|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
164144880|NCT02652949|592891809|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164144881|NCT02652949|592891809|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
164144882|NCT02652949|592891809|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
164144883|NCT01973595|592891810|FG000|Washout|Withdrawal by Subject|1|||
164144884|NCT01973595|592891811|FG001|Washout|Withdrawal by Subject|0|||
164144885|NCT01973595|592891812|FG002|Washout|Withdrawal by Subject|1|||
164144886|NCT01973595|592891813|FG003|Washout|Withdrawal by Subject|0|||
164144887|NCT01141205|592891814|FG000|Overall Study|Physician Decision|1|||
164144888|NCT01141205|592891815|FG001|Overall Study|Physician Decision|1|||
164144889|NCT01141205|592891814|FG000|Overall Study|Lost to Follow-up|1|||
164144890|NCT01141205|592891815|FG001|Overall Study|Lost to Follow-up|0|||
164144891|NCT01141205|592891814|FG000|Overall Study|Withdrawal by Subject|1|||
164144892|NCT01141205|592891815|FG001|Overall Study|Withdrawal by Subject|1|||
164144893|NCT03837743|592891821|FG000|Overall Study|Adverse Event|1|||
164144894|NCT03837743|592891821|FG000|Overall Study|Withdrawal by Subject|2|||
164144895|NCT05199090|592891822|FG000|Overall Study|Adverse Event|1|||
164144896|NCT05199090|592891823|FG001|Overall Study|Adverse Event|4|||
164144897|NCT05199090|592891824|FG002|Overall Study|Adverse Event|0|||
164144898|NCT05199090|592891825|FG003|Overall Study|Adverse Event|0|||
164144899|NCT05199090|592891826|FG004|Overall Study|Adverse Event|0|||
164144900|NCT05199090|592891827|FG005|Overall Study|Adverse Event|0|||
164144901|NCT05199090|592891822|FG000|Overall Study|Lost to Follow-up|1|||
164144902|NCT05199090|592891823|FG001|Overall Study|Lost to Follow-up|0|||
164144903|NCT05199090|592891824|FG002|Overall Study|Lost to Follow-up|1|||
164144904|NCT05199090|592891825|FG003|Overall Study|Lost to Follow-up|4|||
164144905|NCT05199090|592891826|FG004|Overall Study|Lost to Follow-up|0|||
164144906|NCT05199090|592891827|FG005|Overall Study|Lost to Follow-up|5|||
164144913|NCT05199090|592891822|FG000|Overall Study|Study terminated by sponsor|0|||
164144914|NCT05199090|592891823|FG001|Overall Study|Study terminated by sponsor|6|||
164144915|NCT05199090|592891824|FG002|Overall Study|Study terminated by sponsor|0|||
164144916|NCT05199090|592891825|FG003|Overall Study|Study terminated by sponsor|0|||
164144917|NCT05199090|592891826|FG004|Overall Study|Study terminated by sponsor|0|||
164144918|NCT05199090|592891827|FG005|Overall Study|Study terminated by sponsor|5|||
164144919|NCT05199090|592891822|FG000|Overall Study|Subject decision|0|||
164144920|NCT05199090|592891823|FG001|Overall Study|Subject decision|4|||
164144921|NCT05199090|592891824|FG002|Overall Study|Subject decision|0|||
164144922|NCT05199090|592891825|FG003|Overall Study|Subject decision|2|||
164144923|NCT05199090|592891826|FG004|Overall Study|Subject decision|5|||
164144924|NCT05199090|592891827|FG005|Overall Study|Subject decision|2|||
164144925|NCT04868968|592891828|FG000|Overall Study|Lost to Follow-up|1|||
164144926|NCT00384930|592891831|FG000|Overall Study|Adverse Event|5|||
164144927|NCT00384930|592891832|FG001|Overall Study|Adverse Event|4|||
164144928|NCT00384930|592891833|FG002|Overall Study|Adverse Event|12|||
164144929|NCT00384930|592891834|FG003|Overall Study|Adverse Event|11|||
164144930|NCT00384930|592891835|FG004|Overall Study|Adverse Event|14|||
164144931|NCT00384930|592891831|FG000|Overall Study|Entry Criteria Not Met|2|||
164144932|NCT00384930|592891832|FG001|Overall Study|Entry Criteria Not Met|6|||
164144933|NCT00384930|592891833|FG002|Overall Study|Entry Criteria Not Met|7|||
164144934|NCT00384930|592891834|FG003|Overall Study|Entry Criteria Not Met|8|||
164144935|NCT00384930|592891835|FG004|Overall Study|Entry Criteria Not Met|4|||
164144936|NCT00384930|592891831|FG000|Overall Study|Lack of Efficacy|1|||
164144937|NCT00384930|592891832|FG001|Overall Study|Lack of Efficacy|1|||
164144938|NCT00384930|592891833|FG002|Overall Study|Lack of Efficacy|2|||
164144939|NCT00384930|592891834|FG003|Overall Study|Lack of Efficacy|1|||
164144940|NCT00384930|592891835|FG004|Overall Study|Lack of Efficacy|2|||
164144941|NCT00384930|592891831|FG000|Overall Study|Lost to Follow-up|5|||
164144942|NCT00384930|592891832|FG001|Overall Study|Lost to Follow-up|3|||
164144943|NCT00384930|592891833|FG002|Overall Study|Lost to Follow-up|0|||
164144944|NCT00384930|592891834|FG003|Overall Study|Lost to Follow-up|4|||
164144945|NCT00384930|592891835|FG004|Overall Study|Lost to Follow-up|6|||
164144946|NCT00384930|592891831|FG000|Overall Study|Physician Decision|0|||
164144947|NCT00384930|592891832|FG001|Overall Study|Physician Decision|1|||
164144948|NCT00384930|592891833|FG002|Overall Study|Physician Decision|1|||
164144949|NCT00384930|592891834|FG003|Overall Study|Physician Decision|0|||
164144950|NCT00384930|592891835|FG004|Overall Study|Physician Decision|1|||
164144951|NCT00384930|592891831|FG000|Overall Study|Protocol Violation|1|||
164144952|NCT00384930|592891832|FG001|Overall Study|Protocol Violation|0|||
164144953|NCT00384930|592891833|FG002|Overall Study|Protocol Violation|1|||
164144954|NCT00384930|592891834|FG003|Overall Study|Protocol Violation|6|||
164144955|NCT00384930|592891835|FG004|Overall Study|Protocol Violation|4|||
164144956|NCT00384930|592891831|FG000|Overall Study|Sponsor Decision|3|||
164144957|NCT00384930|592891832|FG001|Overall Study|Sponsor Decision|4|||
164144958|NCT00384930|592891833|FG002|Overall Study|Sponsor Decision|0|||
164144959|NCT00384930|592891834|FG003|Overall Study|Sponsor Decision|5|||
164144960|NCT00384930|592891835|FG004|Overall Study|Sponsor Decision|0|||
164144961|NCT00384930|592891831|FG000|Overall Study|Withdrawal by Subject|9|||
164144962|NCT00384930|592891832|FG001|Overall Study|Withdrawal by Subject|7|||
164144963|NCT00384930|592891833|FG002|Overall Study|Withdrawal by Subject|7|||
164144964|NCT00384930|592891834|FG003|Overall Study|Withdrawal by Subject|6|||
164144965|NCT00384930|592891835|FG004|Overall Study|Withdrawal by Subject|16|||
164144966|NCT00384930|592891831|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
164144967|NCT00384930|592891832|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
164144968|NCT00384930|592891833|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
164144969|NCT00384930|592891834|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
164144970|NCT00384930|592891835|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
164144971|NCT01547130|592891840|FG000|Overall Study|Lost to Follow-up|9|||
164144972|NCT01547130|592891841|FG001|Overall Study|Lost to Follow-up|5|||
164144973|NCT01685840|592891842|FG000|Overall Study|Death|77|||
164144974|NCT01685840|592891843|FG001|Overall Study|Death|66|||
164144975|NCT01685840|592891842|FG000|Overall Study|Lost to Follow-up|27|||
164144976|NCT01685840|592891843|FG001|Overall Study|Lost to Follow-up|25|||
164144977|NCT01685840|592891842|FG000|Overall Study|Physician Decision|3|||
164144978|NCT01685840|592891843|FG001|Overall Study|Physician Decision|7|||
164144979|NCT01685840|592891842|FG000|Overall Study|Withdrawal by Subject|14|||
164144980|NCT01685840|592891843|FG001|Overall Study|Withdrawal by Subject|17|||
164144981|NCT01685840|592891842|FG000|Overall Study|Futility|197|||
164144982|NCT01685840|592891843|FG001|Overall Study|Futility|200|||
164144983|NCT01685840|592891842|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
164144984|NCT01685840|592891843|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
164144985|NCT00710866|592891844|FG000|Overall Study|Protocol Violation|5|||
164144986|NCT00710866|592891845|FG001|Overall Study|Protocol Violation|4|||
164144987|NCT00710866|592891844|FG000|Overall Study|Withdrawal by Subject|2|||
164144988|NCT00710866|592891845|FG001|Overall Study|Withdrawal by Subject|1|||
164144989|NCT00710866|592891844|FG000|Overall Study|Lost to Follow-up|1|||
164144990|NCT00710866|592891845|FG001|Overall Study|Lost to Follow-up|0|||
164144991|NCT00710866|592891844|FG000|Overall Study|Failed to meet eligibility|1|||
164144992|NCT00710866|592891845|FG001|Overall Study|Failed to meet eligibility|1|||
164144993|NCT04487067|592891851|FG000|Overall Study|Adverse Event|3|||
164144994|NCT04487067|592891851|FG000|Overall Study|Death Other Than Progressive Disease|60|||
164144995|NCT04487067|592891851|FG000|Overall Study|Death Due To Progressive Disease|40|||
164144996|NCT04487067|592891851|FG000|Overall Study|Lost to Follow-up|3|||
164144997|NCT04487067|592891851|FG000|Overall Study|Progressive Disease|1|||
164144998|NCT04487067|592891851|FG000|Overall Study|Protocol Violation|3|||
164144999|NCT04487067|592891851|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
164145000|NCT04487067|592891851|FG000|Overall Study|Withdrawal by Subject|15|||
164145001|NCT04324021|592891852|FG000|Overall Study|Adverse Event|1|||
164145002|NCT04324021|592891853|FG001|Overall Study|Adverse Event|0|||
164145003|NCT04324021|592891854|FG002|Overall Study|Adverse Event|0|||
164145004|NCT04324021|592891852|FG000|Overall Study|Lack of Efficacy|0|||
164145005|NCT04324021|592891853|FG001|Overall Study|Lack of Efficacy|0|||
164145006|NCT04324021|592891854|FG002|Overall Study|Lack of Efficacy|1|||
164145007|NCT04324021|592891852|FG000|Overall Study|Death|1|||
164145008|NCT04324021|592891853|FG001|Overall Study|Death|1|||
164145009|NCT04324021|592891854|FG002|Overall Study|Death|0|||
164145010|NCT00246324|592891855|FG000|Overall Study|Withdrawal by Subject|1|||
164145011|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
164145012|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
164145013|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
164145014|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Death|1|||
164145015|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Death|3|||
164145016|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Death|1|||
164145017|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
164145018|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
164145019|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
164145020|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
164145021|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
164145022|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
164145023|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
164145024|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
164145025|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
164145026|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
164145027|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
164145028|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
164145029|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
164145030|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
164145031|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
164145032|NCT00299130|592891856|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
164145033|NCT00299130|592891857|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
164145034|NCT00299130|592891858|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
164145035|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
164145036|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
164145037|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
164145038|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
164145039|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
164145040|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
164145041|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
164145042|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
164145043|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
164145044|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
164145045|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
164145046|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
164145047|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
164145048|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
164145049|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
164145050|NCT00299130|592891856|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
164145051|NCT00299130|592891857|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
164145052|NCT00299130|592891858|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
164145053|NCT00299130|592891856|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
164145054|NCT00299130|592891857|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
164145055|NCT00299130|592891858|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
164145056|NCT00299130|592891856|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
164145057|NCT00299130|592891857|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
164145058|NCT00299130|592891858|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
164145059|NCT00299130|592891856|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
164145060|NCT00299130|592891857|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
164145061|NCT00299130|592891858|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
164145062|NCT01098487|592891860|FG000|Overall Study|Adverse Event|22|||
164145063|NCT01098487|592891860|FG000|Overall Study|Lack of Efficacy|11|||
164145064|NCT01098487|592891860|FG000|Overall Study|Withdrawal by Subject|7|||
164145065|NCT01098487|592891860|FG000|Overall Study|Lost to Follow-up|3|||
164145066|NCT01098487|592891860|FG000|Overall Study|Physician Decision|1|||
164145067|NCT00345631|592891861|FG000|Overall Study|Withdrawal by Subject|1|||
164145068|NCT00345631|592891862|FG001|Overall Study|Withdrawal by Subject|0|||
164145069|NCT00345631|592891863|FG002|Overall Study|Withdrawal by Subject|1|||
164145070|NCT00345631|592891861|FG000|Overall Study|Adverse Event|0|||
164145071|NCT00345631|592891862|FG001|Overall Study|Adverse Event|1|||
164145072|NCT00345631|592891863|FG002|Overall Study|Adverse Event|0|||
164145073|NCT00345631|592891861|FG000|Overall Study|Lost to Follow-up|3|||
164145074|NCT00345631|592891862|FG001|Overall Study|Lost to Follow-up|7|||
164145075|NCT00345631|592891863|FG002|Overall Study|Lost to Follow-up|4|||
164145076|NCT00345631|592891861|FG000|Overall Study|Other reasons|0|||
164145077|NCT00345631|592891862|FG001|Overall Study|Other reasons|0|||
164145078|NCT00345631|592891863|FG002|Overall Study|Other reasons|1|||
164145079|NCT03371459|592891868|FG000|Washout|Lost to Follow-up|0|||
164145080|NCT03371459|592891869|FG001|Washout|Lost to Follow-up|1|||
164145081|NCT01374269|592891872|FG000|Overall Study|Withdrawal by Subject|4|||
164145082|NCT01374269|592891873|FG001|Overall Study|Withdrawal by Subject|0|||
164145083|NCT01374269|592891872|FG000|Overall Study|Lost to Follow-up|1|||
164145084|NCT01374269|592891873|FG001|Overall Study|Lost to Follow-up|3|||
164145085|NCT01374269|592891872|FG000|Overall Study|closed research|1|||
164145086|NCT01374269|592891873|FG001|Overall Study|closed research|2|||
164145087|NCT04559347|592894179|FG000|Overall Study|Death|1|||
164145088|NCT04559347|592894180|FG001|Overall Study|Death|0|||
164145089|NCT04559347|592894179|FG000|Overall Study|Thoracotomy conversion|1|||
164145090|NCT04559347|592894180|FG001|Overall Study|Thoracotomy conversion|1|||
164145091|NCT04559347|592894179|FG000|Overall Study|Provider unavailable|2|||
164145092|NCT04559347|592894180|FG001|Overall Study|Provider unavailable|1|||
164145093|NCT04559347|592894179|FG000|Overall Study|Other|2|||
164145094|NCT04559347|592894180|FG001|Overall Study|Other|1|||
164145095|NCT00615199|592894181|FG000|Overall Study|Adverse Event|3|||
164145096|NCT00615199|592894182|FG001|Overall Study|Adverse Event|1|||
164145097|NCT00615199|592894183|FG002|Overall Study|Adverse Event|1|||
164145098|NCT00615199|592894184|FG003|Overall Study|Adverse Event|0|||
164145099|NCT00615199|592894181|FG000|Overall Study|Lack of Efficacy|2|||
164145100|NCT00615199|592894182|FG001|Overall Study|Lack of Efficacy|0|||
164145101|NCT00615199|592894183|FG002|Overall Study|Lack of Efficacy|0|||
164145102|NCT00615199|592894184|FG003|Overall Study|Lack of Efficacy|1|||
164145103|NCT00615199|592894181|FG000|Overall Study|Lost to Follow-up|1|||
164145104|NCT00615199|592894182|FG001|Overall Study|Lost to Follow-up|0|||
164145105|NCT00615199|592894183|FG002|Overall Study|Lost to Follow-up|0|||
164145106|NCT00615199|592894184|FG003|Overall Study|Lost to Follow-up|0|||
164145107|NCT00615199|592894181|FG000|Overall Study|Other|0|||
164145108|NCT00615199|592894182|FG001|Overall Study|Other|0|||
164145109|NCT00615199|592894183|FG002|Overall Study|Other|0|||
164145110|NCT00615199|592894184|FG003|Overall Study|Other|1|||
164145111|NCT00615199|592894181|FG000|Overall Study|Withdrawal by Subject|2|||
164145112|NCT00615199|592894182|FG001|Overall Study|Withdrawal by Subject|1|||
164145113|NCT00615199|592894183|FG002|Overall Study|Withdrawal by Subject|0|||
164145114|NCT00615199|592894184|FG003|Overall Study|Withdrawal by Subject|0|||
164145115|NCT00459355|592894185|FG000|Overall Study|Subject no longer met inc criteria|20|||
164145116|NCT00459355|592894186|FG001|Overall Study|Subject no longer met inc criteria|18|||
164145117|NCT00618371|592894189|FG000|Overall Study|Withdrawal by Subject|2|||
164145118|NCT02969382|592894190|FG000|Overall Study|Adverse Event|8|||
164145119|NCT02969382|592894191|FG001|Overall Study|Adverse Event|10|||
164145120|NCT02969382|592894190|FG000|Overall Study|Lack of Efficacy|4|||
164145121|NCT02969382|592894191|FG001|Overall Study|Lack of Efficacy|5|||
164145122|NCT02969382|592894190|FG000|Overall Study|Death|0|||
164145123|NCT02969382|592894191|FG001|Overall Study|Death|1|||
164145124|NCT02969382|592894190|FG000|Overall Study|PROTOCOL DEVIATION|0|||
164145125|NCT02969382|592894191|FG001|Overall Study|PROTOCOL DEVIATION|1|||
164145126|NCT02969382|592894190|FG000|Overall Study|Withdrawal by Subject|14|||
164145127|NCT02969382|592894191|FG001|Overall Study|Withdrawal by Subject|9|||
164145128|NCT00886015|592894199|FG000|Overall Study|Death|0|||
164145129|NCT00886015|592894200|FG001|Overall Study|Death|2|||
164145130|NCT02013817|592894201|FG000|Overall Study|Adverse Event|12|||
164145131|NCT02013817|592894201|FG000|Overall Study|Withdrawal by Subject|4|||
164145132|NCT02013817|592894201|FG000|Overall Study|Death|2|||
164145133|NCT02013817|592894201|FG000|Overall Study|Other|9|||
164145134|NCT01145508|592894202|FG000|Overall Study|Adverse Event|1|||
164145135|NCT01145508|592894203|FG001|Overall Study|Adverse Event|0|||
164145136|NCT01145508|592894202|FG000|Overall Study|Death|1|||
164145137|NCT01145508|592894203|FG001|Overall Study|Death|0|||
164145138|NCT01145508|592894202|FG000|Overall Study|Physician Decision|2|||
164145139|NCT01145508|592894203|FG001|Overall Study|Physician Decision|1|||
164145140|NCT01145508|592894202|FG000|Overall Study|Never started treatment|1|||
164145141|NCT01145508|592894203|FG001|Overall Study|Never started treatment|1|||
164145142|NCT01611857|592894204|FG000|Overall Study|Withdrawal by Subject|0|||
164145143|NCT01611857|592894205|FG001|Overall Study|Withdrawal by Subject|2|||
164145144|NCT03971474|592894206|FG000|Overall Study|Adverse Event|11|||
164145145|NCT03971474|592894207|FG001|Overall Study|Adverse Event|7|||
164145146|NCT03971474|592894206|FG000|Overall Study|Refusal unrelated to adverse event|5|||
164145147|NCT03971474|592894207|FG001|Overall Study|Refusal unrelated to adverse event|1|||
164145148|NCT03971474|592894206|FG000|Overall Study|Progression/relapse|40|||
164145149|NCT03971474|592894207|FG001|Overall Study|Progression/relapse|47|||
164145150|NCT03971474|592894206|FG000|Overall Study|Death|6|||
164145151|NCT03971474|592894207|FG001|Overall Study|Death|3|||
164145152|NCT03971474|592894206|FG000|Overall Study|Other - not protocol specified|5|||
164145153|NCT03971474|592894207|FG001|Overall Study|Other - not protocol specified|4|||
164145154|NCT03971474|592894206|FG000|Overall Study|On treatment|0|||
164145155|NCT03971474|592894207|FG001|Overall Study|On treatment|7|||
164145156|NCT01023035|592894209|FG000|Treatment Period|Adverse Event|27|||
164145157|NCT01023035|592894210|FG001|Treatment Period|Adverse Event|32|||
164145158|NCT01023035|592894211|FG002|Treatment Period|Adverse Event|50|||
164145159|NCT01023035|592894209|FG000|Treatment Period|Non-Medical Reasons|19|||
164145160|NCT01023035|592894210|FG001|Treatment Period|Non-Medical Reasons|22|||
164145161|NCT01023035|592894211|FG002|Treatment Period|Non-Medical Reasons|44|||
164145162|NCT01023035|592894209|FG000|Treatment Period|Treatment Failure|26|||
164145163|NCT01023035|592894210|FG001|Treatment Period|Treatment Failure|31|||
164145164|NCT01023035|592894211|FG002|Treatment Period|Treatment Failure|24|||
164145165|NCT01023035|592894209|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
164145166|NCT01023035|592894210|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
164145167|NCT01023035|592894211|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
164145168|NCT01023035|592894209|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
164145169|NCT01023035|592894210|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
164145170|NCT01023035|592894211|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
164145171|NCT01807065|592894212|FG000|Overall Study|Receive no sip-T due to IV access|1|||
164145172|NCT01807065|592894213|FG001|Overall Study|Receive no sip-T due to IV access|1|||
164145173|NCT01482312|592894215|FG000|Period 1, 90 Minutes of Wear|Other|1|||
164145174|NCT01482312|592894216|FG001|Period 1, 90 Minutes of Wear|Other|0|||
164145175|NCT01482312|592894217|FG002|Period 1, 90 Minutes of Wear|Other|0|||
164145176|NCT01482312|592894215|FG000|Period 2, 90 Minutes of Wear|Other|1|||
164145177|NCT01482312|592894216|FG001|Period 2, 90 Minutes of Wear|Other|0|||
164145178|NCT01482312|592894217|FG002|Period 2, 90 Minutes of Wear|Other|0|||
164145179|NCT01699815|592894218|FG000|Overall Study|Protocol Violation|4|||
164145180|NCT01699815|592894219|FG001|Overall Study|Protocol Violation|7|||
164145181|NCT01699815|592894218|FG000|Overall Study|record could not be located|1|||
164145182|NCT01699815|592894219|FG001|Overall Study|record could not be located|0|||
164145183|NCT01699815|592894218|FG000|Overall Study|Adverse Event|0|||
164145184|NCT01699815|592894219|FG001|Overall Study|Adverse Event|1|||
164145185|NCT01295320|592894220|FG000|Overall Study|Adverse Event|2|||
164145186|NCT01295320|592894220|FG000|Overall Study|Lost to Follow-up|4|||
164145187|NCT01295320|592894220|FG000|Overall Study|Withdrawal by Subject|2|||
164145188|NCT01295320|592894220|FG000|Overall Study|Subject was bedridden|1|||
164145189|NCT01295320|592894220|FG000|Overall Study|Unable to travel|1|||
164145190|NCT00462904|592894221|FG000|Overall Study|Lost to Follow-up|1|||
164145191|NCT00699816|592894224|FG000|Overall Study|Protocol Violation|1|||
164145192|NCT00699816|592894225|FG001|Overall Study|Protocol Violation|3|||
164145193|NCT00560391|592894226|FG000|Overall Study|Still on treatment|0|||
164145194|NCT00560391|592894227|FG001|Overall Study|Still on treatment|0|||
164145195|NCT00560391|592894228|FG002|Overall Study|Still on treatment|0|||
164145196|NCT00560391|592894229|FG003|Overall Study|Still on treatment|1|||
164145197|NCT00560391|592894230|FG004|Overall Study|Still on treatment|2|||
164145198|NCT03668808|592894231|FG000|First Intervention|Withdrawal by Subject|2|||
164145199|NCT03668808|592894232|FG001|First Intervention|Withdrawal by Subject|2|||
164145200|NCT00280735|592894233|FG000|Overall Study|Adverse Event|5|||
164145201|NCT00280735|592894233|FG000|Overall Study|Lack of Efficacy|3|||
164145202|NCT00280735|592894233|FG000|Overall Study|Withdrawal by Subject|8|||
164145203|NCT00280735|592894233|FG000|Overall Study|Intercurrent Illness|2|||
164145204|NCT01895777|592894234|FG000|Overall Study|Adverse Event|1|||
164145205|NCT01895777|592894235|FG001|Overall Study|Adverse Event|2|||
164145206|NCT01895777|592894234|FG000|Overall Study|Lost to Follow-up|2|||
164145207|NCT01895777|592894235|FG001|Overall Study|Lost to Follow-up|0|||
164145208|NCT01895777|592894234|FG000|Overall Study|Not treated|1|||
164145209|NCT01895777|592894235|FG001|Overall Study|Not treated|0|||
164145210|NCT01895777|592894234|FG000|Overall Study|Other reasons|3|||
164145211|NCT01895777|592894235|FG001|Overall Study|Other reasons|2|||
164145212|NCT01895777|592894234|FG000|Overall Study|Non-compliance with the CTP|2|||
164145213|NCT01895777|592894235|FG001|Overall Study|Non-compliance with the CTP|1|||
164145214|NCT02125877|592894245|FG000|Overall Study|Physician Decision|1|||
164145215|NCT02125877|592894246|FG001|Overall Study|Physician Decision|0|||
164145216|NCT02125877|592894245|FG000|Overall Study|Death|0|||
164145218|NCT02125877|592894245|FG000|Overall Study|Administrative problems|0|||
164145219|NCT02125877|592894246|FG001|Overall Study|Administrative problems|1|||
164145220|NCT02125877|592894245|FG000|Overall Study|Participant/guardian decision|0|||
164145221|NCT02125877|592894246|FG001|Overall Study|Participant/guardian decision|2|||
164145222|NCT02125877|592894245|FG000|Overall Study|Withdrawal by Subject|2|||
164145223|NCT02125877|592894246|FG001|Overall Study|Withdrawal by Subject|1|||
164145224|NCT02125877|592894245|FG000|Overall Study|Protocol deviation|4|||
164145225|NCT02125877|592894246|FG001|Overall Study|Protocol deviation|1|||
164145226|NCT02125877|592894245|FG000|Overall Study|Adverse Event|6|||
164145227|NCT02125877|592894246|FG001|Overall Study|Adverse Event|4|||
164145228|NCT04223752|592894247|FG000|Overall Study|Participant enrolled in error|0|||
164145229|NCT04223752|592894248|FG001|Overall Study|Participant enrolled in error|0|||
164145230|NCT04223752|592894249|FG002|Overall Study|Participant enrolled in error|0|||
164145231|NCT04223752|592894250|FG003|Overall Study|Participant enrolled in error|0|||
164145232|NCT04223752|592894251|FG004|Overall Study|Participant enrolled in error|1|||
164145233|NCT04223752|592894247|FG000|Overall Study|Death|0|||
164145234|NCT04223752|592894248|FG001|Overall Study|Death|0|||
164145235|NCT04223752|592894249|FG002|Overall Study|Death|0|||
164145236|NCT04223752|592894250|FG003|Overall Study|Death|2|||
164145237|NCT04223752|592894251|FG004|Overall Study|Death|1|||
164145238|NCT01822366|592894252|FG000|Overall Study|Lost to Follow-up|5|||
164145239|NCT01822366|592894253|FG001|Overall Study|Lost to Follow-up|1|||
164145240|NCT01822366|592894254|FG002|Overall Study|Lost to Follow-up|5|||
164145241|NCT01822366|592894255|FG003|Overall Study|Lost to Follow-up|1|||
164145242|NCT01822366|592894252|FG000|Overall Study|Withdrawal by Subject|0|||
164145243|NCT01822366|592894253|FG001|Overall Study|Withdrawal by Subject|6|||
164145244|NCT01822366|592894254|FG002|Overall Study|Withdrawal by Subject|0|||
164145245|NCT01822366|592894255|FG003|Overall Study|Withdrawal by Subject|6|||
164145246|NCT01822366|592894252|FG000|Overall Study|Partial Intervention Completion|0|||
164145247|NCT01822366|592894253|FG001|Overall Study|Partial Intervention Completion|15|||
164145248|NCT01822366|592894254|FG002|Overall Study|Partial Intervention Completion|0|||
164145249|NCT01822366|592894255|FG003|Overall Study|Partial Intervention Completion|15|||
164145250|NCT03489109|592894256|FG000|Overall Study|Lost to Follow-up|1|||
164145251|NCT03489109|592894257|FG001|Overall Study|Lost to Follow-up|2|||
164145252|NCT02552732|592894258|FG000|Overall Study|Lost to Follow-up|2|||
164145253|NCT02552732|592894258|FG000|Overall Study|Physician Decision|1|||
164145254|NCT02552732|592894258|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
164145255|NCT02552732|592894258|FG000|Overall Study|Withdrawal by Subject|6|||
164145256|NCT05061420|592894259|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
164145257|NCT05061420|592894260|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164145258|NCT05061420|592894261|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
164145259|NCT05061420|592894259|FG000|Overall Study|Progressive disease|11|||
164145260|NCT05061420|592894260|FG001|Overall Study|Progressive disease|15|||
164145261|NCT05061420|592894261|FG002|Overall Study|Progressive disease|14|||
164145262|NCT05061420|592894259|FG000|Overall Study|Withdrawal by Subject|2|||
164145263|NCT05061420|592894260|FG001|Overall Study|Withdrawal by Subject|0|||
164145264|NCT05061420|592894261|FG002|Overall Study|Withdrawal by Subject|1|||
164145265|NCT05061420|592894259|FG000|Overall Study|Not related to COVID-19|2|||
164145266|NCT05061420|592894260|FG001|Overall Study|Not related to COVID-19|0|||
164145267|NCT05061420|592894261|FG002|Overall Study|Not related to COVID-19|0|||
164145268|NCT00025259|592894263|FG000|Overall Study|Death|1|||
164145269|NCT00025259|592894264|FG001|Overall Study|Death|3|||
164145270|NCT00025259|592894265|FG002|Overall Study|Death|0|||
164145271|NCT00025259|592894266|FG003|Overall Study|Death|3|||
164145272|NCT00025259|592894267|FG004|Overall Study|Death|0|||
164145273|NCT00025259|592894268|FG005|Overall Study|Death|1|||
164145274|NCT00025259|592894269|FG006|Overall Study|Death|2|||
164145275|NCT00025259|592894263|FG000|Overall Study|Lack of Efficacy|2|||
164145276|NCT00025259|592894264|FG001|Overall Study|Lack of Efficacy|46|||
164145277|NCT00025259|592894265|FG002|Overall Study|Lack of Efficacy|60|||
164145278|NCT00025259|592894266|FG003|Overall Study|Lack of Efficacy|78|||
164145279|NCT00025259|592894267|FG004|Overall Study|Lack of Efficacy|11|||
164145280|NCT00025259|592894268|FG005|Overall Study|Lack of Efficacy|30|||
164145281|NCT00025259|592894269|FG006|Overall Study|Lack of Efficacy|38|||
164145282|NCT00025259|592894263|FG000|Overall Study|Lost to Follow-up|2|||
164145283|NCT00025259|592894264|FG001|Overall Study|Lost to Follow-up|9|||
164145284|NCT00025259|592894265|FG002|Overall Study|Lost to Follow-up|13|||
164145285|NCT00025259|592894266|FG003|Overall Study|Lost to Follow-up|13|||
164145286|NCT00025259|592894267|FG004|Overall Study|Lost to Follow-up|1|||
164145287|NCT00025259|592894268|FG005|Overall Study|Lost to Follow-up|3|||
164145288|NCT00025259|592894269|FG006|Overall Study|Lost to Follow-up|1|||
164145289|NCT00025259|592894263|FG000|Overall Study|Physician Decision|12|||
164145290|NCT00025259|592894264|FG001|Overall Study|Physician Decision|1|||
164145291|NCT00025259|592894265|FG002|Overall Study|Physician Decision|0|||
164145292|NCT00025259|592894266|FG003|Overall Study|Physician Decision|5|||
164145293|NCT00025259|592894267|FG004|Overall Study|Physician Decision|4|||
164145294|NCT00025259|592894268|FG005|Overall Study|Physician Decision|2|||
164145295|NCT00025259|592894269|FG006|Overall Study|Physician Decision|1|||
164145303|NCT00025259|592894263|FG000|Overall Study|Withdrawal by Subject|9|||
164145304|NCT00025259|592894264|FG001|Overall Study|Withdrawal by Subject|27|||
164145305|NCT00025259|592894265|FG002|Overall Study|Withdrawal by Subject|6|||
164145306|NCT00025259|592894266|FG003|Overall Study|Withdrawal by Subject|14|||
164145307|NCT00025259|592894267|FG004|Overall Study|Withdrawal by Subject|11|||
164145308|NCT00025259|592894268|FG005|Overall Study|Withdrawal by Subject|8|||
164145309|NCT00025259|592894269|FG006|Overall Study|Withdrawal by Subject|3|||
164145310|NCT00025259|592894263|FG000|Overall Study|Ineligible|14|||
164145311|NCT00025259|592894264|FG001|Overall Study|Ineligible|1|||
164145312|NCT00025259|592894265|FG002|Overall Study|Ineligible|0|||
164145313|NCT00025259|592894266|FG003|Overall Study|Ineligible|0|||
164145314|NCT00025259|592894267|FG004|Overall Study|Ineligible|6|||
164145315|NCT00025259|592894268|FG005|Overall Study|Ineligible|0|||
164145316|NCT00025259|592894269|FG006|Overall Study|Ineligible|1|||
164145317|NCT00025259|592894263|FG000|Overall Study|Randomization error|1|||
164145318|NCT00025259|592894264|FG001|Overall Study|Randomization error|0|||
164145319|NCT00025259|592894265|FG002|Overall Study|Randomization error|0|||
164145320|NCT00025259|592894266|FG003|Overall Study|Randomization error|0|||
164145321|NCT00025259|592894267|FG004|Overall Study|Randomization error|1|||
164145322|NCT00025259|592894268|FG005|Overall Study|Randomization error|7|||
164145323|NCT00025259|592894269|FG006|Overall Study|Randomization error|2|||
164145324|NCT00025259|592894263|FG000|Overall Study|Adverse Event|1|||
164145325|NCT00025259|592894264|FG001|Overall Study|Adverse Event|0|||
164145326|NCT00025259|592894265|FG002|Overall Study|Adverse Event|0|||
164145327|NCT00025259|592894266|FG003|Overall Study|Adverse Event|0|||
164145328|NCT00025259|592894267|FG004|Overall Study|Adverse Event|0|||
164145329|NCT00025259|592894268|FG005|Overall Study|Adverse Event|0|||
164145330|NCT00025259|592894269|FG006|Overall Study|Adverse Event|0|||
164145331|NCT03138655|592894274|FG000|Overall Study|Adverse Event|2|||
164145332|NCT03138655|592894275|FG001|Overall Study|Adverse Event|1|||
164145333|NCT03138655|592894276|FG002|Overall Study|Adverse Event|2|||
164145334|NCT03138655|592894277|FG003|Overall Study|Adverse Event|1|||
164145335|NCT03138655|592894278|FG004|Overall Study|Adverse Event|1|||
164145336|NCT03138655|592894279|FG005|Overall Study|Adverse Event|4|||
164145337|NCT03138655|592894280|FG006|Overall Study|Adverse Event|2|||
164145338|NCT03138655|592894281|FG007|Overall Study|Adverse Event|2|||
164145339|NCT03138655|592894274|FG000|Overall Study|Withdrawal by Subject|0|||
164145340|NCT03138655|592894275|FG001|Overall Study|Withdrawal by Subject|1|||
164145341|NCT03138655|592894276|FG002|Overall Study|Withdrawal by Subject|0|||
164145342|NCT03138655|592894277|FG003|Overall Study|Withdrawal by Subject|0|||
164145343|NCT03138655|592894278|FG004|Overall Study|Withdrawal by Subject|0|||
164145344|NCT03138655|592894279|FG005|Overall Study|Withdrawal by Subject|0|||
164145345|NCT03138655|592894280|FG006|Overall Study|Withdrawal by Subject|1|||
164145346|NCT03138655|592894281|FG007|Overall Study|Withdrawal by Subject|0|||
164145347|NCT03138655|592894274|FG000|Overall Study|Reason not Specified|1|||
164145348|NCT03138655|592894275|FG001|Overall Study|Reason not Specified|0|||
164145349|NCT03138655|592894276|FG002|Overall Study|Reason not Specified|0|||
164145350|NCT03138655|592894277|FG003|Overall Study|Reason not Specified|2|||
164145351|NCT03138655|592894278|FG004|Overall Study|Reason not Specified|1|||
164145352|NCT03138655|592894279|FG005|Overall Study|Reason not Specified|1|||
164145353|NCT03138655|592894280|FG006|Overall Study|Reason not Specified|0|||
164145354|NCT03138655|592894281|FG007|Overall Study|Reason not Specified|0|||
164145355|NCT02027428|592894282|FG000|Induction|Never treated|7|||
164145356|NCT02027428|592894283|FG001|Induction|Never treated|0|||
164145357|NCT02027428|592894284|FG002|Induction|Never treated|0|||
164145358|NCT02027428|592894282|FG000|Induction|Progressive disease|77|||
164145359|NCT02027428|592894283|FG001|Induction|Progressive disease|0|||
164145360|NCT02027428|592894284|FG002|Induction|Progressive disease|0|||
164145361|NCT02027428|592894282|FG000|Induction|Adverse Event|51|||
164145362|NCT02027428|592894283|FG001|Induction|Adverse Event|0|||
164145363|NCT02027428|592894284|FG002|Induction|Adverse Event|0|||
164145364|NCT02027428|592894282|FG000|Induction|Withdrawal by Subject|22|||
164145365|NCT02027428|592894283|FG001|Induction|Withdrawal by Subject|0|||
164145366|NCT02027428|592894284|FG002|Induction|Withdrawal by Subject|0|||
164145367|NCT02027428|592894282|FG000|Induction|Death|21|||
164145368|NCT02027428|592894283|FG001|Induction|Death|0|||
164145369|NCT02027428|592894284|FG002|Induction|Death|0|||
164145370|NCT02027428|592894282|FG000|Induction|Symptomatic deterioration|16|||
164145371|NCT02027428|592894283|FG001|Induction|Symptomatic deterioration|0|||
164145372|NCT02027428|592894284|FG002|Induction|Symptomatic deterioration|0|||
164145373|NCT02027428|592894282|FG000|Induction|Study terminated by sponsor|12|||
164145374|NCT02027428|592894283|FG001|Induction|Study terminated by sponsor|0|||
164145375|NCT02027428|592894284|FG002|Induction|Study terminated by sponsor|0|||
164145376|NCT02027428|592894282|FG000|Induction|Protocol Violation|1|||
164145377|NCT02027428|592894283|FG001|Induction|Protocol Violation|0|||
164145378|NCT02027428|592894284|FG002|Induction|Protocol Violation|0|||
164145379|NCT02027428|592894282|FG000|Induction|Miscellaneous|14|||
164145380|NCT02027428|592894283|FG001|Induction|Miscellaneous|0|||
164145381|NCT02027428|592894284|FG002|Induction|Miscellaneous|0|||
164145382|NCT02027428|592894282|FG000|Induction|Induction Treatment Ongoing|4|||
164145460|NCT01198132|592894311|FG000|Overall Study|Lack of Efficacy|2|||
164145383|NCT02027428|592894283|FG001|Induction|Induction Treatment Ongoing|0|||
164145384|NCT02027428|592894284|FG002|Induction|Induction Treatment Ongoing|0|||
164145385|NCT02027428|592894282|FG000|Maintenance|Death|0|||
164145386|NCT02027428|592894283|FG001|Maintenance|Death|3|||
164145387|NCT02027428|592894284|FG002|Maintenance|Death|2|||
164145388|NCT02027428|592894282|FG000|Maintenance|Adverse Event|0|||
164145389|NCT02027428|592894283|FG001|Maintenance|Adverse Event|21|||
164145390|NCT02027428|592894284|FG002|Maintenance|Adverse Event|1|||
164145391|NCT02027428|592894282|FG000|Maintenance|Progressive disease|0|||
164145392|NCT02027428|592894283|FG001|Maintenance|Progressive disease|84|||
164145393|NCT02027428|592894284|FG002|Maintenance|Progressive disease|47|||
164145394|NCT02027428|592894282|FG000|Maintenance|Symptomatic deterioration|0|||
164145395|NCT02027428|592894283|FG001|Maintenance|Symptomatic deterioration|4|||
164145396|NCT02027428|592894284|FG002|Maintenance|Symptomatic deterioration|1|||
164145397|NCT02027428|592894282|FG000|Maintenance|Withdrawal by Subject|0|||
164145398|NCT02027428|592894283|FG001|Maintenance|Withdrawal by Subject|6|||
164145399|NCT02027428|592894284|FG002|Maintenance|Withdrawal by Subject|5|||
164145400|NCT02027428|592894282|FG000|Maintenance|Protocol Violation|0|||
164145401|NCT02027428|592894283|FG001|Maintenance|Protocol Violation|0|||
164145402|NCT02027428|592894284|FG002|Maintenance|Protocol Violation|1|||
164145403|NCT02027428|592894282|FG000|Maintenance|Other|0|||
164145404|NCT02027428|592894283|FG001|Maintenance|Other|6|||
164145405|NCT02027428|592894284|FG002|Maintenance|Other|3|||
164145406|NCT02027428|592894282|FG000|Survival Follow-up|Death|0|||
164145407|NCT02027428|592894283|FG001|Survival Follow-up|Death|78|||
164145408|NCT02027428|592894284|FG002|Survival Follow-up|Death|45|||
164145409|NCT02027428|592894282|FG000|Survival Follow-up|Lost to Follow-up|0|||
164145410|NCT02027428|592894283|FG001|Survival Follow-up|Lost to Follow-up|1|||
164145411|NCT02027428|592894284|FG002|Survival Follow-up|Lost to Follow-up|1|||
164145412|NCT01128543|592894285|FG000|Overall Study|Withdrawal by Subject|3|||
164145413|NCT01128543|592894285|FG000|Overall Study|Protocol Violation|1|||
164145414|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Death|8|||
164145415|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Death|5|||
164145416|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Death|5|||
164145417|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Death|7|||
164145418|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
164145419|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
164145420|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
164145421|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
164145422|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
164145423|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
164145424|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
164145425|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
164145426|NCT03340974|592894289|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
164145427|NCT03340974|592894290|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
164145428|NCT03340974|592894291|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
164145429|NCT03340974|592894292|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
164145430|NCT00396565|592894304|FG000|Overall Study|Physician Decision|3|||
164145431|NCT00396565|592894305|FG001|Overall Study|Physician Decision|1|||
164145432|NCT00396565|592894306|FG002|Overall Study|Physician Decision|2|||
164145433|NCT00396565|592894304|FG000|Overall Study|Adverse Event|5|||
164145434|NCT00396565|592894305|FG001|Overall Study|Adverse Event|13|||
164145435|NCT00396565|592894306|FG002|Overall Study|Adverse Event|3|||
164145436|NCT00396565|592894304|FG000|Overall Study|Withdrawal by Subject|8|||
164145437|NCT00396565|592894305|FG001|Overall Study|Withdrawal by Subject|13|||
164145438|NCT00396565|592894306|FG002|Overall Study|Withdrawal by Subject|1|||
164145439|NCT00396565|592894304|FG000|Overall Study|Lack of Efficacy|32|||
164145440|NCT00396565|592894305|FG001|Overall Study|Lack of Efficacy|64|||
164145441|NCT00396565|592894306|FG002|Overall Study|Lack of Efficacy|11|||
164145442|NCT04877457|592894307|FG000|Overall Study|Early termination of study due to low enrollment|2|||
164145443|NCT04877457|592894308|FG001|Overall Study|Early termination of study due to low enrollment|1|||
164145444|NCT02211417|592894309|FG000|Overall Study|Withdrawal by Subject|11|||
164145445|NCT02211417|592894310|FG001|Overall Study|Withdrawal by Subject|8|||
164145446|NCT02211417|592894309|FG000|Overall Study|Protocol Violation|1|||
164145447|NCT02211417|592894310|FG001|Overall Study|Protocol Violation|0|||
164145448|NCT02211417|592894309|FG000|Overall Study|Pregnancy|0|||
164145449|NCT02211417|592894310|FG001|Overall Study|Pregnancy|1|||
164145450|NCT02211417|592894309|FG000|Overall Study|Lost to Follow-up|2|||
164145451|NCT02211417|592894310|FG001|Overall Study|Lost to Follow-up|3|||
164145452|NCT02211417|592894309|FG000|Overall Study|Adverse Event|1|||
164145453|NCT02211417|592894310|FG001|Overall Study|Adverse Event|4|||
164145454|NCT01198132|592894311|FG000|Overall Study|Withdrawal by Subject|4|||
164145455|NCT01198132|592894312|FG001|Overall Study|Withdrawal by Subject|5|||
164145456|NCT01198132|592894311|FG000|Overall Study|Physician Decision|5|||
164145457|NCT01198132|592894312|FG001|Overall Study|Physician Decision|4|||
164145458|NCT01198132|592894311|FG000|Overall Study|Other Unspecified|3|||
164145459|NCT01198132|592894312|FG001|Overall Study|Other Unspecified|6|||
164145462|NCT01198132|592894311|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
164145463|NCT01198132|592894312|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
164145464|NCT01198132|592894311|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
164145465|NCT01198132|592894312|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
164145466|NCT01198132|592894311|FG000|Overall Study|Adverse Event|0|||
164145467|NCT01198132|592894312|FG001|Overall Study|Adverse Event|1|||
164145468|NCT01198132|592894311|FG000|Overall Study|Protocol Violation|1|||
164145469|NCT01198132|592894312|FG001|Overall Study|Protocol Violation|0|||
164145470|NCT04697069|592894313|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
164145471|NCT04697069|592894314|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
164145472|NCT04697069|592894313|FG000|Overall Study|Study termination|2|||
164145473|NCT04697069|592894314|FG001|Overall Study|Study termination|1|||
164145474|NCT05180227|592894315|FG000|Overall Study|Hypertension at screening|1|||
164145475|NCT05180227|592894315|FG000|Overall Study|Lost to Follow-up|1|||
164145476|NCT02924727|592894316|FG000|Overall Study|Withdrawal by Subject|2|||
164145477|NCT02924727|592894317|FG001|Overall Study|Withdrawal by Subject|4|||
164145478|NCT02924727|592894316|FG000|Overall Study|Lost to Follow-up|2|||
164145479|NCT02924727|592894317|FG001|Overall Study|Lost to Follow-up|5|||
164145480|NCT02924727|592894316|FG000|Overall Study|Death|221|||
164145481|NCT02924727|592894317|FG001|Overall Study|Death|247|||
164145482|NCT02924727|592894316|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
164145483|NCT02924727|592894317|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
164145484|NCT02185053|592894318|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
164145485|NCT02185053|592894319|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
164145486|NCT02185053|592894320|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
164145487|NCT02185053|592894318|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
164145488|NCT02185053|592894319|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145489|NCT02185053|592894320|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145490|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
164145491|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
164145492|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
164145493|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
164145494|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
164145495|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
164145496|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145497|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
164145498|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
164145499|NCT02185053|592894318|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
164145500|NCT02185053|592894319|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
164145501|NCT02185053|592894320|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
164145502|NCT02185053|592894318|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
164145503|NCT02185053|592894319|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
164145504|NCT02185053|592894320|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
164145505|NCT02185053|592894318|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
164145506|NCT02185053|592894319|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
164145507|NCT02185053|592894320|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
164145508|NCT02521376|592894323|FG000|Overall Study|Enrolled, But Not Treated|1|||
164145509|NCT02521376|592894324|FG001|Overall Study|Enrolled, But Not Treated|0|||
164145510|NCT02521376|592894325|FG002|Overall Study|Enrolled, But Not Treated|0|||
164145511|NCT02521376|592894326|FG003|Overall Study|Enrolled, But Not Treated|0|||
164145512|NCT00338728|592894327|FG000|Overall Study|Screen Failure|14|||
164145513|NCT00340678|592894330|FG000|Overall Study|Lost to Follow-up|1|||
164145514|NCT00340678|592894331|FG001|Overall Study|Lost to Follow-up|0|||
164145515|NCT00340678|592894332|FG002|Overall Study|Lost to Follow-up|0|||
164145516|NCT00340678|592894333|FG003|Overall Study|Lost to Follow-up|0|||
164145517|NCT04803305|592894334|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
164145518|NCT04803305|592894335|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
164145519|NCT04803305|592894334|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
164145520|NCT04803305|592894335|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
164145521|NCT04803305|592894334|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
164145522|NCT04803305|592894335|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
164145523|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
164145524|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
164145525|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
164145526|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
164145527|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
164145528|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
164145529|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
164145530|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
164145531|NCT04803305|592894334|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
164145532|NCT04803305|592894335|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
164145533|NCT01862484|592894337|FG000|Overall Study|Lack of Efficacy|1|||
164145534|NCT01862484|592894338|FG001|Overall Study|Lack of Efficacy|1|||
164145535|NCT01862484|592894337|FG000|Overall Study|Lost to Follow-up|1|||
164145536|NCT01862484|592894338|FG001|Overall Study|Lost to Follow-up|2|||
164145537|NCT01862484|592894337|FG000|Overall Study|Protocol Violation|0|||
164145538|NCT01862484|592894338|FG001|Overall Study|Protocol Violation|2|||
164145539|NCT01862484|592894337|FG000|Overall Study|Withdrawal by Subject|0|||
164145540|NCT01862484|592894338|FG001|Overall Study|Withdrawal by Subject|3|||
164145541|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
164145542|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
164145543|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
164145544|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
164145545|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
164145546|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
164145547|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
164145548|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
164145549|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
164145550|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
164145551|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
164145552|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
164145553|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
164145554|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
164145555|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
164145556|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
164145557|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
164145558|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
164145559|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
164145560|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
164145561|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Death|1|||
164145562|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Death|0|||
164145563|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Death|0|||
164145564|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Death|0|||
164145565|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Death|0|||
164145566|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Death|1|||
164145567|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Death|0|||
164145568|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Death|0|||
164145569|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Death|0|||
164145570|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Death|0|||
164145571|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Death|0|||
164145572|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Death|0|||
164145573|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Death|0|||
164145574|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Death|0|||
164145575|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Death|0|||
164145576|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Death|0|||
164145577|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Death|0|||
164145578|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Death|0|||
164145579|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Death|0|||
164145580|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Death|0|||
164145581|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
164145582|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
164145583|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
164145584|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
164145585|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
164145586|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
164145587|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
164145588|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
164145589|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
164145590|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
164145591|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
164145592|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
164145593|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
164145594|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
164145595|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
164145596|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
164145597|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
164145598|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
164145599|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
164145600|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
164145601|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145602|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145603|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145604|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
164145605|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145606|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145607|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
164145608|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145609|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145610|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145611|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145612|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145613|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145614|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145615|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145616|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145617|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145618|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145619|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145620|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
164145621|NCT00996892|592894339|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
164145622|NCT00996892|592894340|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
164145623|NCT00996892|592894341|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
164145624|NCT00996892|592894342|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
164145625|NCT00996892|592894343|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
164145626|NCT00996892|592894344|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
164145627|NCT00996892|592894345|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
164145628|NCT00996892|592894346|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
164145629|NCT00996892|592894347|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
164145630|NCT00996892|592894348|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
164145631|NCT00996892|592894349|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
164145632|NCT00996892|592894350|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
164145633|NCT00996892|592894351|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
164145634|NCT00996892|592894352|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
164145635|NCT00996892|592894353|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
164145636|NCT00996892|592894354|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
164145637|NCT00996892|592894355|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
164145638|NCT00996892|592894356|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
164145639|NCT00996892|592894357|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
164145640|NCT00996892|592894358|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
164145641|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
164145642|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
164145643|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
164145644|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
164145645|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
164145646|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
164145647|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
164145648|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
164145649|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
164145650|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
164145651|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
164145652|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
164145653|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
164145654|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
164145655|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
164145656|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
164145657|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
164145658|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
164145659|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
164145660|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
164145661|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Death|0|||
164145662|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Death|0|||
164145663|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Death|0|||
164145664|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Death|0|||
164145665|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Death|0|||
164145666|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Death|0|||
164145667|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Death|0|||
164145668|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Death|0|||
164145669|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Death|0|||
164145670|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Death|2|||
164145671|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Death|0|||
164145672|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Death|1|||
164145673|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Death|1|||
164145674|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Death|0|||
164145675|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Death|0|||
164145676|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Death|0|||
164145677|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Death|0|||
164145678|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Death|0|||
164145679|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Death|0|||
164145681|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
164145682|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
164145683|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
164145684|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
164145685|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
164145686|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
164145687|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
164145688|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
164145689|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
164145690|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
164145691|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
164145692|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
164145693|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
164145694|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
164145695|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
164145696|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
164145697|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
164145698|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
164145699|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
164145700|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
164145701|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145702|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145703|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145704|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145705|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145706|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145707|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145708|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145709|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145710|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145711|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145712|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145713|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
164145714|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145715|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145716|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145717|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145718|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145719|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145720|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
164145721|NCT00996892|592894339|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
164145722|NCT00996892|592894340|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
164145723|NCT00996892|592894341|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
164145724|NCT00996892|592894342|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
164145725|NCT00996892|592894343|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
164145726|NCT00996892|592894344|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
164145727|NCT00996892|592894345|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
164145728|NCT00996892|592894346|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
164145729|NCT00996892|592894347|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
164145730|NCT00996892|592894348|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
164145731|NCT00996892|592894349|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
164145732|NCT00996892|592894350|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
164145733|NCT00996892|592894351|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
164145734|NCT00996892|592894352|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
164145735|NCT00996892|592894353|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
164145736|NCT00996892|592894354|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
164145737|NCT00996892|592894355|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
164145738|NCT00996892|592894356|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
164145739|NCT00996892|592894357|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
164145740|NCT00996892|592894358|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
164145741|NCT00996892|592894339|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
164145742|NCT00996892|592894340|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
164145743|NCT00996892|592894341|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
164145744|NCT00996892|592894342|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
164145745|NCT00996892|592894343|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
164145746|NCT00996892|592894344|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
164145747|NCT00996892|592894345|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
164145748|NCT00996892|592894346|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
164145749|NCT00996892|592894347|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
164145750|NCT00996892|592894348|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
164145751|NCT00996892|592894349|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
164145752|NCT00996892|592894350|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
164145753|NCT00996892|592894351|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
164145754|NCT00996892|592894352|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
164145755|NCT00996892|592894353|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
164145756|NCT00996892|592894354|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
164145757|NCT00996892|592894355|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
164145758|NCT00996892|592894356|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
164145759|NCT00996892|592894357|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
164145760|NCT00996892|592894358|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
164145761|NCT00996892|592894339|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
164145762|NCT00996892|592894340|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
164145763|NCT00996892|592894341|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
164145764|NCT00996892|592894342|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
164145765|NCT00996892|592894343|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
164145766|NCT00996892|592894344|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
164145767|NCT00996892|592894345|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
164145768|NCT00996892|592894346|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
164145769|NCT00996892|592894347|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
164145770|NCT00996892|592894348|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
164145771|NCT00996892|592894349|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
164145772|NCT00996892|592894350|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
164145773|NCT00996892|592894351|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
164145774|NCT00996892|592894352|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
164145775|NCT00996892|592894353|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
164145776|NCT00996892|592894354|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
164145777|NCT00996892|592894355|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
164145778|NCT00996892|592894356|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
164145779|NCT00996892|592894357|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
164145780|NCT00996892|592894358|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
164145781|NCT00996892|592894339|FG000|Expansion Stage 2|Adverse Event|0|||
164145782|NCT00996892|592894340|FG001|Expansion Stage 2|Adverse Event|0|||
164145783|NCT00996892|592894341|FG002|Expansion Stage 2|Adverse Event|0|||
164145784|NCT00996892|592894342|FG003|Expansion Stage 2|Adverse Event|0|||
164145785|NCT00996892|592894343|FG004|Expansion Stage 2|Adverse Event|0|||
164145786|NCT00996892|592894344|FG005|Expansion Stage 2|Adverse Event|0|||
164145787|NCT00996892|592894345|FG006|Expansion Stage 2|Adverse Event|0|||
164145788|NCT00996892|592894346|FG007|Expansion Stage 2|Adverse Event|0|||
164145789|NCT00996892|592894347|FG008|Expansion Stage 2|Adverse Event|0|||
164145790|NCT00996892|592894348|FG009|Expansion Stage 2|Adverse Event|0|||
164145791|NCT00996892|592894349|FG010|Expansion Stage 2|Adverse Event|0|||
164145792|NCT00996892|592894350|FG011|Expansion Stage 2|Adverse Event|0|||
164145793|NCT00996892|592894351|FG012|Expansion Stage 2|Adverse Event|0|||
164145794|NCT00996892|592894352|FG013|Expansion Stage 2|Adverse Event|0|||
164145795|NCT00996892|592894353|FG014|Expansion Stage 2|Adverse Event|0|||
164145796|NCT00996892|592894354|FG015|Expansion Stage 2|Adverse Event|0|||
164145797|NCT00996892|592894355|FG016|Expansion Stage 2|Adverse Event|0|||
164145798|NCT00996892|592894356|FG017|Expansion Stage 2|Adverse Event|0|||
164145799|NCT00996892|592894357|FG018|Expansion Stage 2|Adverse Event|3|||
164145800|NCT00996892|592894358|FG019|Expansion Stage 2|Adverse Event|0|||
164145801|NCT00996892|592894339|FG000|Expansion Stage 2|Death|0|||
164145802|NCT00996892|592894340|FG001|Expansion Stage 2|Death|0|||
164145803|NCT00996892|592894341|FG002|Expansion Stage 2|Death|0|||
164145804|NCT00996892|592894342|FG003|Expansion Stage 2|Death|0|||
164145805|NCT00996892|592894343|FG004|Expansion Stage 2|Death|0|||
164145806|NCT00996892|592894344|FG005|Expansion Stage 2|Death|0|||
164145807|NCT00996892|592894345|FG006|Expansion Stage 2|Death|0|||
164145808|NCT00996892|592894346|FG007|Expansion Stage 2|Death|0|||
164145809|NCT00996892|592894347|FG008|Expansion Stage 2|Death|0|||
164145810|NCT00996892|592894348|FG009|Expansion Stage 2|Death|0|||
164145811|NCT00996892|592894349|FG010|Expansion Stage 2|Death|0|||
164145812|NCT00996892|592894350|FG011|Expansion Stage 2|Death|0|||
164145813|NCT00996892|592894351|FG012|Expansion Stage 2|Death|0|||
164145814|NCT00996892|592894352|FG013|Expansion Stage 2|Death|0|||
164145815|NCT00996892|592894353|FG014|Expansion Stage 2|Death|0|||
164145816|NCT00996892|592894354|FG015|Expansion Stage 2|Death|0|||
164145817|NCT00996892|592894355|FG016|Expansion Stage 2|Death|0|||
164145818|NCT00996892|592894356|FG017|Expansion Stage 2|Death|0|||
164145819|NCT00996892|592894357|FG018|Expansion Stage 2|Death|2|||
164145820|NCT00996892|592894358|FG019|Expansion Stage 2|Death|0|||
164145821|NCT00996892|592894339|FG000|Expansion Stage 2|Physician Decision|0|||
164145822|NCT00996892|592894340|FG001|Expansion Stage 2|Physician Decision|0|||
164145823|NCT00996892|592894341|FG002|Expansion Stage 2|Physician Decision|0|||
164145824|NCT00996892|592894342|FG003|Expansion Stage 2|Physician Decision|0|||
164145825|NCT00996892|592894343|FG004|Expansion Stage 2|Physician Decision|0|||
164145826|NCT00996892|592894344|FG005|Expansion Stage 2|Physician Decision|0|||
164145827|NCT00996892|592894345|FG006|Expansion Stage 2|Physician Decision|0|||
164145828|NCT00996892|592894346|FG007|Expansion Stage 2|Physician Decision|0|||
164145829|NCT00996892|592894347|FG008|Expansion Stage 2|Physician Decision|0|||
164145830|NCT00996892|592894348|FG009|Expansion Stage 2|Physician Decision|0|||
164145831|NCT00996892|592894349|FG010|Expansion Stage 2|Physician Decision|0|||
164145832|NCT00996892|592894350|FG011|Expansion Stage 2|Physician Decision|0|||
164145833|NCT00996892|592894351|FG012|Expansion Stage 2|Physician Decision|0|||
164145834|NCT00996892|592894352|FG013|Expansion Stage 2|Physician Decision|0|||
164145835|NCT00996892|592894353|FG014|Expansion Stage 2|Physician Decision|0|||
164145836|NCT00996892|592894354|FG015|Expansion Stage 2|Physician Decision|0|||
164145837|NCT00996892|592894355|FG016|Expansion Stage 2|Physician Decision|0|||
164145838|NCT00996892|592894356|FG017|Expansion Stage 2|Physician Decision|0|||
164145839|NCT00996892|592894357|FG018|Expansion Stage 2|Physician Decision|1|||
164145840|NCT00996892|592894358|FG019|Expansion Stage 2|Physician Decision|0|||
164145841|NCT00996892|592894339|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
164145842|NCT00996892|592894340|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
164145843|NCT00996892|592894341|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
164145844|NCT00996892|592894342|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
164145845|NCT00996892|592894343|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
164145846|NCT00996892|592894344|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
164145847|NCT00996892|592894345|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
164145848|NCT00996892|592894346|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
164145849|NCT00996892|592894347|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
164145850|NCT00996892|592894348|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
164145851|NCT00996892|592894349|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
164145852|NCT00996892|592894350|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
164145853|NCT00996892|592894351|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
164145854|NCT00996892|592894352|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
164145855|NCT00996892|592894353|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
164145856|NCT00996892|592894354|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
164145857|NCT00996892|592894355|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
164145858|NCT00996892|592894356|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
164145859|NCT00996892|592894357|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
164145860|NCT00996892|592894358|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
164145861|NCT00996892|592894339|FG000|Expansion Stage 2|Disease Progression|0|||
164145862|NCT00996892|592894340|FG001|Expansion Stage 2|Disease Progression|0|||
164145863|NCT00996892|592894341|FG002|Expansion Stage 2|Disease Progression|0|||
164145864|NCT00996892|592894342|FG003|Expansion Stage 2|Disease Progression|0|||
164145865|NCT00996892|592894343|FG004|Expansion Stage 2|Disease Progression|0|||
164145866|NCT00996892|592894344|FG005|Expansion Stage 2|Disease Progression|0|||
164145867|NCT00996892|592894345|FG006|Expansion Stage 2|Disease Progression|0|||
164145868|NCT00996892|592894346|FG007|Expansion Stage 2|Disease Progression|0|||
164145869|NCT00996892|592894347|FG008|Expansion Stage 2|Disease Progression|0|||
164145870|NCT00996892|592894348|FG009|Expansion Stage 2|Disease Progression|0|||
164145871|NCT00996892|592894349|FG010|Expansion Stage 2|Disease Progression|0|||
164145872|NCT00996892|592894350|FG011|Expansion Stage 2|Disease Progression|0|||
164145873|NCT00996892|592894351|FG012|Expansion Stage 2|Disease Progression|0|||
164145874|NCT00996892|592894352|FG013|Expansion Stage 2|Disease Progression|0|||
164145875|NCT00996892|592894353|FG014|Expansion Stage 2|Disease Progression|0|||
164145876|NCT00996892|592894354|FG015|Expansion Stage 2|Disease Progression|0|||
164145877|NCT00996892|592894355|FG016|Expansion Stage 2|Disease Progression|0|||
164145878|NCT00996892|592894356|FG017|Expansion Stage 2|Disease Progression|0|||
164145879|NCT00996892|592894357|FG018|Expansion Stage 2|Disease Progression|28|||
164145880|NCT00996892|592894358|FG019|Expansion Stage 2|Disease Progression|0|||
164145881|NCT00996892|592894339|FG000|Expansion Stage 2A|Adverse Event|0|||
164145882|NCT00996892|592894340|FG001|Expansion Stage 2A|Adverse Event|0|||
164145883|NCT00996892|592894341|FG002|Expansion Stage 2A|Adverse Event|0|||
164145884|NCT00996892|592894342|FG003|Expansion Stage 2A|Adverse Event|0|||
164145885|NCT00996892|592894343|FG004|Expansion Stage 2A|Adverse Event|0|||
164145886|NCT00996892|592894344|FG005|Expansion Stage 2A|Adverse Event|0|||
164145887|NCT00996892|592894345|FG006|Expansion Stage 2A|Adverse Event|0|||
164145888|NCT00996892|592894346|FG007|Expansion Stage 2A|Adverse Event|0|||
164145889|NCT00996892|592894347|FG008|Expansion Stage 2A|Adverse Event|0|||
164145890|NCT00996892|592894348|FG009|Expansion Stage 2A|Adverse Event|0|||
164145891|NCT00996892|592894349|FG010|Expansion Stage 2A|Adverse Event|0|||
164145892|NCT00996892|592894350|FG011|Expansion Stage 2A|Adverse Event|0|||
164145893|NCT00996892|592894351|FG012|Expansion Stage 2A|Adverse Event|0|||
164145894|NCT00996892|592894352|FG013|Expansion Stage 2A|Adverse Event|0|||
164145895|NCT00996892|592894353|FG014|Expansion Stage 2A|Adverse Event|0|||
164145896|NCT00996892|592894354|FG015|Expansion Stage 2A|Adverse Event|0|||
164145897|NCT00996892|592894355|FG016|Expansion Stage 2A|Adverse Event|0|||
164145898|NCT00996892|592894356|FG017|Expansion Stage 2A|Adverse Event|0|||
164145899|NCT00996892|592894357|FG018|Expansion Stage 2A|Adverse Event|0|||
164145900|NCT00996892|592894358|FG019|Expansion Stage 2A|Adverse Event|8|||
164145901|NCT00996892|592894339|FG000|Expansion Stage 2A|Physician Decision|0|||
164145902|NCT00996892|592894340|FG001|Expansion Stage 2A|Physician Decision|0|||
164145903|NCT00996892|592894341|FG002|Expansion Stage 2A|Physician Decision|0|||
164145904|NCT00996892|592894342|FG003|Expansion Stage 2A|Physician Decision|0|||
164145905|NCT00996892|592894343|FG004|Expansion Stage 2A|Physician Decision|0|||
164145906|NCT00996892|592894344|FG005|Expansion Stage 2A|Physician Decision|0|||
164145907|NCT00996892|592894345|FG006|Expansion Stage 2A|Physician Decision|0|||
164145908|NCT00996892|592894346|FG007|Expansion Stage 2A|Physician Decision|0|||
164145909|NCT00996892|592894347|FG008|Expansion Stage 2A|Physician Decision|0|||
164145910|NCT00996892|592894348|FG009|Expansion Stage 2A|Physician Decision|0|||
164145911|NCT00996892|592894349|FG010|Expansion Stage 2A|Physician Decision|0|||
164145912|NCT00996892|592894350|FG011|Expansion Stage 2A|Physician Decision|0|||
164145913|NCT00996892|592894351|FG012|Expansion Stage 2A|Physician Decision|0|||
164145914|NCT00996892|592894352|FG013|Expansion Stage 2A|Physician Decision|0|||
164145915|NCT00996892|592894353|FG014|Expansion Stage 2A|Physician Decision|0|||
164145916|NCT00996892|592894354|FG015|Expansion Stage 2A|Physician Decision|0|||
164145917|NCT00996892|592894355|FG016|Expansion Stage 2A|Physician Decision|0|||
164145918|NCT00996892|592894356|FG017|Expansion Stage 2A|Physician Decision|0|||
164145919|NCT00996892|592894357|FG018|Expansion Stage 2A|Physician Decision|0|||
164145920|NCT00996892|592894358|FG019|Expansion Stage 2A|Physician Decision|2|||
164145921|NCT00996892|592894339|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
164145922|NCT00996892|592894340|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
164145923|NCT00996892|592894341|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
164145924|NCT00996892|592894342|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
164145925|NCT00996892|592894343|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
164145926|NCT00996892|592894344|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
164145927|NCT00996892|592894345|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
164145928|NCT00996892|592894346|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
164145929|NCT00996892|592894347|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
164145930|NCT00996892|592894348|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
164145931|NCT00996892|592894349|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
164145932|NCT00996892|592894350|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
164145933|NCT00996892|592894351|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
164145934|NCT00996892|592894352|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
164145935|NCT00996892|592894353|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
164145936|NCT00996892|592894354|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
164145937|NCT00996892|592894355|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
164145938|NCT00996892|592894356|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
164145939|NCT00996892|592894357|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
164145940|NCT00996892|592894358|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
164145941|NCT00996892|592894339|FG000|Expansion Stage 2A|Disease Progression|0|||
164145942|NCT00996892|592894340|FG001|Expansion Stage 2A|Disease Progression|0|||
164145943|NCT00996892|592894341|FG002|Expansion Stage 2A|Disease Progression|0|||
164145944|NCT00996892|592894342|FG003|Expansion Stage 2A|Disease Progression|0|||
164145945|NCT00996892|592894343|FG004|Expansion Stage 2A|Disease Progression|0|||
164145946|NCT00996892|592894344|FG005|Expansion Stage 2A|Disease Progression|0|||
164145947|NCT00996892|592894345|FG006|Expansion Stage 2A|Disease Progression|0|||
164145948|NCT00996892|592894346|FG007|Expansion Stage 2A|Disease Progression|0|||
164145949|NCT00996892|592894347|FG008|Expansion Stage 2A|Disease Progression|0|||
164145950|NCT00996892|592894348|FG009|Expansion Stage 2A|Disease Progression|0|||
164145951|NCT00996892|592894349|FG010|Expansion Stage 2A|Disease Progression|0|||
164145952|NCT00996892|592894350|FG011|Expansion Stage 2A|Disease Progression|0|||
164145953|NCT00996892|592894351|FG012|Expansion Stage 2A|Disease Progression|0|||
164145954|NCT00996892|592894352|FG013|Expansion Stage 2A|Disease Progression|0|||
164145955|NCT00996892|592894353|FG014|Expansion Stage 2A|Disease Progression|0|||
164145956|NCT00996892|592894354|FG015|Expansion Stage 2A|Disease Progression|0|||
164145957|NCT00996892|592894355|FG016|Expansion Stage 2A|Disease Progression|0|||
164145958|NCT00996892|592894356|FG017|Expansion Stage 2A|Disease Progression|0|||
164145959|NCT00996892|592894357|FG018|Expansion Stage 2A|Disease Progression|0|||
164145960|NCT00996892|592894358|FG019|Expansion Stage 2A|Disease Progression|31|||
164145961|NCT00993421|592894359|FG000|Overall Study|Adverse Event|2|||
164145962|NCT00993421|592894360|FG001|Overall Study|Adverse Event|7|||
164145963|NCT00993421|592894361|FG002|Overall Study|Adverse Event|6|||
164145964|NCT00993421|592894362|FG003|Overall Study|Adverse Event|9|||
164145965|NCT00993421|592894363|FG004|Overall Study|Adverse Event|5|||
164145966|NCT00993421|592894364|FG005|Overall Study|Adverse Event|7|||
164145967|NCT00993421|592894365|FG006|Overall Study|Adverse Event|1|||
164145968|NCT00993421|592894359|FG000|Overall Study|Sponsor Decision|36|||
164145969|NCT00993421|592894360|FG001|Overall Study|Sponsor Decision|31|||
164145970|NCT00993421|592894361|FG002|Overall Study|Sponsor Decision|28|||
164145971|NCT00993421|592894362|FG003|Overall Study|Sponsor Decision|30|||
164145972|NCT00993421|592894363|FG004|Overall Study|Sponsor Decision|38|||
164145973|NCT00993421|592894364|FG005|Overall Study|Sponsor Decision|30|||
164145974|NCT00993421|592894365|FG006|Overall Study|Sponsor Decision|29|||
164145975|NCT00993421|592894359|FG000|Overall Study|Lost to Follow-up|3|||
164145976|NCT00993421|592894360|FG001|Overall Study|Lost to Follow-up|5|||
164145977|NCT00993421|592894361|FG002|Overall Study|Lost to Follow-up|5|||
164145978|NCT00993421|592894362|FG003|Overall Study|Lost to Follow-up|0|||
164145979|NCT00993421|592894363|FG004|Overall Study|Lost to Follow-up|0|||
164145980|NCT00993421|592894364|FG005|Overall Study|Lost to Follow-up|0|||
164145981|NCT00993421|592894365|FG006|Overall Study|Lost to Follow-up|6|||
164145982|NCT00993421|592894359|FG000|Overall Study|Withdrawal by Subject|3|||
164145983|NCT00993421|592894360|FG001|Overall Study|Withdrawal by Subject|2|||
164145984|NCT00993421|592894361|FG002|Overall Study|Withdrawal by Subject|3|||
164145985|NCT00993421|592894362|FG003|Overall Study|Withdrawal by Subject|3|||
164145986|NCT00993421|592894363|FG004|Overall Study|Withdrawal by Subject|3|||
164145987|NCT00993421|592894364|FG005|Overall Study|Withdrawal by Subject|5|||
164145988|NCT00993421|592894365|FG006|Overall Study|Withdrawal by Subject|3|||
164145989|NCT00993421|592894359|FG000|Overall Study|Death|0|||
164145990|NCT00993421|592894360|FG001|Overall Study|Death|0|||
164145991|NCT00993421|592894361|FG002|Overall Study|Death|0|||
164145992|NCT00993421|592894362|FG003|Overall Study|Death|0|||
164145993|NCT00993421|592894363|FG004|Overall Study|Death|0|||
164145994|NCT00993421|592894364|FG005|Overall Study|Death|0|||
164145995|NCT00993421|592894365|FG006|Overall Study|Death|1|||
164145996|NCT00993421|592894359|FG000|Overall Study|Entry Criteria Exclusion|0|||
164145997|NCT00993421|592894360|FG001|Overall Study|Entry Criteria Exclusion|0|||
164145998|NCT00993421|592894361|FG002|Overall Study|Entry Criteria Exclusion|1|||
164145999|NCT00993421|592894362|FG003|Overall Study|Entry Criteria Exclusion|3|||
164146000|NCT00993421|592894363|FG004|Overall Study|Entry Criteria Exclusion|0|||
164146001|NCT00993421|592894364|FG005|Overall Study|Entry Criteria Exclusion|1|||
164146002|NCT00993421|592894365|FG006|Overall Study|Entry Criteria Exclusion|0|||
164146003|NCT00993421|592894359|FG000|Overall Study|Physician Decision|0|||
164146004|NCT00993421|592894360|FG001|Overall Study|Physician Decision|0|||
164146005|NCT00993421|592894361|FG002|Overall Study|Physician Decision|0|||
164146006|NCT00993421|592894362|FG003|Overall Study|Physician Decision|0|||
164146007|NCT00993421|592894363|FG004|Overall Study|Physician Decision|0|||
164146008|NCT00993421|592894364|FG005|Overall Study|Physician Decision|1|||
164146009|NCT00993421|592894365|FG006|Overall Study|Physician Decision|1|||
164146010|NCT00993421|592894359|FG000|Overall Study|Protocol Violation|0|||
164146011|NCT00993421|592894360|FG001|Overall Study|Protocol Violation|0|||
164146012|NCT00993421|592894361|FG002|Overall Study|Protocol Violation|0|||
164146013|NCT00993421|592894362|FG003|Overall Study|Protocol Violation|0|||
164146014|NCT00993421|592894363|FG004|Overall Study|Protocol Violation|0|||
164146015|NCT00993421|592894364|FG005|Overall Study|Protocol Violation|2|||
164146016|NCT00993421|592894365|FG006|Overall Study|Protocol Violation|1|||
164146017|NCT02759692|592894366|FG000|Period 1|Test article no longer available|1|||
164146018|NCT02759692|592894367|FG001|Period 1|Test article no longer available|1|||
164146019|NCT02759692|592894366|FG000|Period 1|No longer meets eligibility criteria.|1|||
164146020|NCT02759692|592894367|FG001|Period 1|No longer meets eligibility criteria.|0|||
164146021|NCT02759692|592894366|FG000|Period 1|Miss-Randomized|1|||
164146022|NCT02759692|592894367|FG001|Period 1|Miss-Randomized|1|||
164146023|NCT02759692|592894366|FG000|Period 2|Lost to Follow-up|1|||
164146024|NCT02759692|592894367|FG001|Period 2|Lost to Follow-up|0|||
164146025|NCT02759692|592894366|FG000|Period 2|Test article no longer available|0|||
164146026|NCT02759692|592894367|FG001|Period 2|Test article no longer available|1|||
164146027|NCT01954745|592894373|FG000|Overall Study|Radiological Progression|11|||
164146028|NCT01954745|592894373|FG000|Overall Study|Clinical Progression|5|||
164146029|NCT01954745|592894373|FG000|Overall Study|Adverse Event|2|||
164146030|NCT01954745|592894373|FG000|Overall Study|Death|1|||
164146031|NCT05314816|592894374|FG000|Overall Study|Lost to Follow-up|5|||
164146032|NCT05314816|592894375|FG001|Overall Study|Lost to Follow-up|0|||
164146033|NCT05314816|592894376|FG002|Overall Study|Lost to Follow-up|1|||
164146034|NCT05314816|592894374|FG000|Overall Study|Protocol Violation|13|||
164146035|NCT05314816|592894375|FG001|Overall Study|Protocol Violation|8|||
164146036|NCT05314816|592894376|FG002|Overall Study|Protocol Violation|0|||
164146037|NCT04042376|592894377|FG000|Overall Study|Withdrawal by Subject|1|||
164146038|NCT04042376|592894377|FG000|Overall Study|Death|3|||
164146039|NCT02551666|592894378|FG000|Overall Study|Withdrawal by Subject|1|||
164146040|NCT02551666|592894379|FG001|Overall Study|Withdrawal by Subject|3|||
164146041|NCT05422625|592894380|FG000|Overall Study|Withdrawal by Subject|1|||
164146042|NCT05422625|592894381|FG001|Overall Study|Withdrawal by Subject|0|||
164146043|NCT01433055|592895978|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
164146044|NCT01433055|592895979|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
164146045|NCT01433055|592895978|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
164146046|NCT01433055|592895979|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
164146047|NCT00733005|592895985|FG000|Overall Study|Adverse Event|0|||
164146048|NCT00733005|592895986|FG001|Overall Study|Adverse Event|1|||
164146049|NCT00733005|592895985|FG000|Overall Study|Treatment Failure|0|||
164146050|NCT00733005|592895986|FG001|Overall Study|Treatment Failure|1|||
164146051|NCT00733005|592895985|FG000|Overall Study|Withdrawal by Subject|0|||
164146052|NCT00733005|592895986|FG001|Overall Study|Withdrawal by Subject|1|||
164146053|NCT00733005|592895985|FG000|Overall Study|Protocol Violation|2|||
164146054|NCT00733005|592895986|FG001|Overall Study|Protocol Violation|0|||
164146055|NCT01769456|592895987|FG000|Overall Study|Lost to Follow-up|19|||
164146056|NCT01769456|592895987|FG000|Overall Study|Withdrawal by Subject|3|||
164146057|NCT01769456|592895987|FG000|Overall Study|Did not receive PCC intervention|6|||
164146058|NCT01769456|592895987|FG000|Overall Study|Moved out of the area|3|||
164146059|NCT01769456|592895987|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
164146060|NCT01769456|592895987|FG000|Overall Study|Parental request to youth to withdraw|1|||
164146061|NCT05244122|592895994|FG000|Overall Study|Withdrawal by Subject|318|||
164146062|NCT02653625|592895999|FG000|Overall Study|Adverse Event|1|||
164146063|NCT02653625|592895999|FG000|Overall Study|Non-compliance with Study Drug|1|||
164146064|NCT02653625|592895999|FG000|Overall Study|Protocol Violation|1|||
164146065|NCT02653625|592895999|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
164146066|NCT03965689|592896002|FG000|Overall Study|Too sick to get study intervention|2|||
164146067|NCT05377749|592896003|FG000|3 Weeks|Lost to Follow-up|2|||
164146068|NCT05377749|592896004|FG001|3 Weeks|Lost to Follow-up|4|||
164146069|NCT05377749|592896003|FG000|3 Weeks|Withdrawal by Subject|1|||
164146070|NCT05377749|592896004|FG001|3 Weeks|Withdrawal by Subject|1|||
164146071|NCT02090725|592896006|FG000|Overall Study|Withdrawal by Subject|1|||
164146072|NCT02090725|592896006|FG000|Overall Study|participants moved from area|3|||
164146073|NCT00764881|592896007|FG000|Overall Study|Adverse Event|5|||
164146074|NCT00764881|592896008|FG001|Overall Study|Adverse Event|1|||
164146075|NCT00764881|592896007|FG000|Overall Study|Withdrawal by Subject|1|||
164146076|NCT00764881|592896008|FG001|Overall Study|Withdrawal by Subject|3|||
164146077|NCT00764881|592896007|FG000|Overall Study|Protocol Violation|2|||
164146078|NCT00764881|592896008|FG001|Overall Study|Protocol Violation|2|||
164146079|NCT00764881|592896007|FG000|Overall Study|Lost to Follow-up|2|||
164146080|NCT00764881|592896008|FG001|Overall Study|Lost to Follow-up|0|||
164146081|NCT00764881|592896007|FG000|Overall Study|Noncompliant|1|||
164146082|NCT00764881|592896008|FG001|Overall Study|Noncompliant|0|||
164146083|NCT00764881|592896007|FG000|Overall Study|Accidentally discontinued study drug|1|||
164146084|NCT00764881|592896008|FG001|Overall Study|Accidentally discontinued study drug|0|||
164146085|NCT00764881|592896007|FG000|Overall Study|Wished to become pregnant|1|||
164146086|NCT00764881|592896008|FG001|Overall Study|Wished to become pregnant|0|||
164146087|NCT00764881|592896007|FG000|Overall Study|Carcinoma detected|1|||
164146088|NCT00764881|592896008|FG001|Overall Study|Carcinoma detected|0|||
164146089|NCT00764881|592896007|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
164146090|NCT00764881|592896008|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
164146091|NCT00764881|592896007|FG000|Overall Study|no treatment or no observation|2|||
164146092|NCT00764881|592896008|FG001|Overall Study|no treatment or no observation|2|||
164146093|NCT01214655|592896009|FG000|Part A|Progressive Disease|7|||
164146094|NCT01214655|592896010|FG001|Part A|Progressive Disease|0|||
164146095|NCT01214655|592896011|FG002|Part A|Progressive Disease|0|||
164146096|NCT01214655|592896009|FG000|Part A|Physician Decision|1|||
164146097|NCT01214655|592896010|FG001|Part A|Physician Decision|0|||
164146098|NCT01214655|592896011|FG002|Part A|Physician Decision|0|||
164146099|NCT01214655|592896009|FG000|Part B|Progressive disease|0|||
164146100|NCT01214655|592896010|FG001|Part B|Progressive disease|10|||
164146101|NCT01214655|592896011|FG002|Part B|Progressive disease|0|||
164146102|NCT01214655|592896009|FG000|Part B|Death|0|||
164146103|NCT01214655|592896010|FG001|Part B|Death|1|||
164146104|NCT01214655|592896011|FG002|Part B|Death|0|||
164146105|NCT01214655|592896009|FG000|Part B|Withdrawal by Subject|0|||
164146106|NCT01214655|592896010|FG001|Part B|Withdrawal by Subject|2|||
164146107|NCT01214655|592896011|FG002|Part B|Withdrawal by Subject|0|||
164146108|NCT01214655|592896009|FG000|Part C|Progressive Disease|0|||
164146109|NCT01214655|592896010|FG001|Part C|Progressive Disease|0|||
164146110|NCT01214655|592896011|FG002|Part C|Progressive Disease|5|||
164146111|NCT01214655|592896009|FG000|Part C|Death|0|||
164146112|NCT01214655|592896010|FG001|Part C|Death|0|||
164146113|NCT01214655|592896011|FG002|Part C|Death|1|||
164146114|NCT01214655|592896009|FG000|Part C|Physician Decision|0|||
164146115|NCT01214655|592896010|FG001|Part C|Physician Decision|0|||
164146116|NCT01214655|592896011|FG002|Part C|Physician Decision|1|||
164146117|NCT05256134|592896014|FG000|Overall Study|Study Terminated by Sponsor|11|||
164146118|NCT05256134|592896015|FG001|Overall Study|Study Terminated by Sponsor|10|||
164146119|NCT05256134|592896014|FG000|Overall Study|Withdrawal by Subject|1|||
164146120|NCT05256134|592896015|FG001|Overall Study|Withdrawal by Subject|3|||
164146121|NCT01692626|592896016|FG000|Overall Study|Death|0|||
164146122|NCT01692626|592896017|FG001|Overall Study|Death|1|||
164146123|NCT01692626|592896016|FG000|Overall Study|Adverse Event|2|||
164146124|NCT01692626|592896017|FG001|Overall Study|Adverse Event|3|||
164146125|NCT01692626|592896016|FG000|Overall Study|Protocol Violation|1|||
164146126|NCT01692626|592896017|FG001|Overall Study|Protocol Violation|2|||
164146127|NCT01692626|592896016|FG000|Overall Study|Withdrawal by Subject|1|||
164146128|NCT01692626|592896017|FG001|Overall Study|Withdrawal by Subject|0|||
164146129|NCT00855894|592896018|FG000|Overall Study|Death|31|||
164146130|NCT00855894|592896018|FG000|Overall Study|Patient's decision|1|||
164146131|NCT00855894|592896018|FG000|Overall Study|Disease progression|1|||
164146132|NCT01434810|592896033|FG000|Overall Study|Did not receive treatment|11|||
164146133|NCT01434810|592896034|FG001|Overall Study|Did not receive treatment|3|||
164146134|NCT01434810|592896033|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
164146135|NCT01434810|592896034|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
164146136|NCT02794870|592896036|FG000|Overall Study|Withdrawal by Subject|2|||
164146137|NCT02794870|592896037|FG001|Overall Study|Withdrawal by Subject|0|||
164146138|NCT02439970|592896042|FG000|Overall Study|Study Terminated|2|||
164146140|NCT01121562|592896044|FG000|Overall Study|Objective progression or relapse|8|||
164146141|NCT01121562|592896044|FG000|Overall Study|Withdrawal by Subject|1|||
164146142|NCT01121562|592896044|FG000|Overall Study|Adverse Event|1|||
164146143|NCT01121562|592896044|FG000|Overall Study|Sponsor Decision|1|||
164146144|NCT01121562|592896044|FG000|Overall Study|Met study discontinuation criteria|1|||
164146145|NCT02540083|592896047|FG000|Overall Study|Withdrawal by Subject|16|||
164146146|NCT00185588|592896048|FG000|Overall Study|Adverse Event|3|||
164146147|NCT00185588|592896049|FG001|Overall Study|Adverse Event|1|||
164146148|NCT00185588|592896050|FG002|Overall Study|Adverse Event|4|||
164146149|NCT00185588|592896051|FG003|Overall Study|Adverse Event|2|||
164146150|NCT00185588|592896048|FG000|Overall Study|Lost to Follow-up|0|||
164146151|NCT00185588|592896049|FG001|Overall Study|Lost to Follow-up|0|||
164146152|NCT00185588|592896050|FG002|Overall Study|Lost to Follow-up|1|||
164146153|NCT00185588|592896051|FG003|Overall Study|Lost to Follow-up|2|||
164146154|NCT00185588|592896048|FG000|Overall Study|Withdrawal by Subject|0|||
164146155|NCT00185588|592896049|FG001|Overall Study|Withdrawal by Subject|1|||
164146156|NCT00185588|592896050|FG002|Overall Study|Withdrawal by Subject|0|||
164146157|NCT00185588|592896051|FG003|Overall Study|Withdrawal by Subject|0|||
164146158|NCT00185588|592896048|FG000|Overall Study|Physician Decision|0|||
164146159|NCT00185588|592896049|FG001|Overall Study|Physician Decision|0|||
164146160|NCT00185588|592896050|FG002|Overall Study|Physician Decision|1|||
164146161|NCT00185588|592896051|FG003|Overall Study|Physician Decision|0|||
164146162|NCT00398866|592896052|FG000|Overall Study|Adverse Event|1|||
164146163|NCT00398866|592896053|FG001|Overall Study|Adverse Event|0|||
164146164|NCT00398866|592896054|FG002|Overall Study|Adverse Event|0|||
164146165|NCT00398866|592896052|FG000|Overall Study|Lack of Efficacy|0|||
164146166|NCT00398866|592896053|FG001|Overall Study|Lack of Efficacy|0|||
164146167|NCT00398866|592896054|FG002|Overall Study|Lack of Efficacy|1|||
164146168|NCT00398866|592896052|FG000|Overall Study|Lost to Follow-up|7|||
164146169|NCT00398866|592896053|FG001|Overall Study|Lost to Follow-up|6|||
164146170|NCT00398866|592896054|FG002|Overall Study|Lost to Follow-up|4|||
164146171|NCT00398866|592896052|FG000|Overall Study|Withdrawal by Subject|5|||
164146172|NCT00398866|592896053|FG001|Overall Study|Withdrawal by Subject|1|||
164146173|NCT00398866|592896054|FG002|Overall Study|Withdrawal by Subject|2|||
164146174|NCT00398866|592896052|FG000|Overall Study|Unable to complete requirements of study|1|||
164146175|NCT00398866|592896053|FG001|Overall Study|Unable to complete requirements of study|1|||
164146176|NCT00398866|592896054|FG002|Overall Study|Unable to complete requirements of study|1|||
164146177|NCT01569295|592896063|FG000|Overall Study|Progressive Disease|75|||
164146178|NCT01569295|592896064|FG001|Overall Study|Progressive Disease|139|||
164146179|NCT01569295|592896063|FG000|Overall Study|Adverse Event|39|||
164146180|NCT01569295|592896064|FG001|Overall Study|Adverse Event|14|||
164146181|NCT01569295|592896063|FG000|Overall Study|Withdrawal by Subject|25|||
164146182|NCT01569295|592896064|FG001|Overall Study|Withdrawal by Subject|12|||
164146183|NCT01569295|592896063|FG000|Overall Study|Death|19|||
164146184|NCT01569295|592896064|FG001|Overall Study|Death|15|||
164146185|NCT01569295|592896063|FG000|Overall Study|Physician Decision|13|||
164146186|NCT01569295|592896064|FG001|Overall Study|Physician Decision|18|||
164146187|NCT01569295|592896063|FG000|Overall Study|Study Terminated by Sponsor|24|||
164146188|NCT01569295|592896064|FG001|Overall Study|Study Terminated by Sponsor|2|||
164146189|NCT01569295|592896063|FG000|Overall Study|Other Reason not Specified|3|||
164146190|NCT01569295|592896064|FG001|Overall Study|Other Reason not Specified|5|||
164146191|NCT01569295|592896063|FG000|Overall Study|Non-Compliance with Study Drug|6|||
164146192|NCT01569295|592896064|FG001|Overall Study|Non-Compliance with Study Drug|1|||
164146193|NCT01569295|592896063|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
164146194|NCT01569295|592896064|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
164146195|NCT01569295|592896063|FG000|Overall Study|Lost to Follow-up|1|||
164146196|NCT01569295|592896064|FG001|Overall Study|Lost to Follow-up|1|||
164146197|NCT02064296|592896065|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
164146198|NCT02064296|592896066|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
164146199|NCT02064296|592896067|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
164146200|NCT02064296|592896065|FG000|Intervention|Withdrawal by Subject|0|||
164146201|NCT02064296|592896066|FG001|Intervention|Withdrawal by Subject|1|||
164146202|NCT02064296|592896067|FG002|Intervention|Withdrawal by Subject|2|||
164146203|NCT01814553|592896073|FG000|Overall Study|PD per clinical progression|6|||
164146204|NCT01814553|592896074|FG001|Overall Study|PD per clinical progression|8|||
164146205|NCT01814553|592896073|FG000|Overall Study|Other Adverse Event|4|||
164146206|NCT01814553|592896074|FG001|Overall Study|Other Adverse Event|5|||
164146207|NCT01814553|592896073|FG000|Overall Study|Withdrawal by Subject|1|||
164146208|NCT01814553|592896074|FG001|Overall Study|Withdrawal by Subject|1|||
164146209|NCT01814553|592896073|FG000|Overall Study|Other than stated|7|||
164146210|NCT01814553|592896074|FG001|Overall Study|Other than stated|8|||
164146211|NCT03151304|592896075|FG000|Overall Study|Termination of study by Sponsor|23|||
164146212|NCT03151304|592896075|FG000|Overall Study|missing|3|||
164146213|NCT03151304|592896075|FG000|Overall Study|Withdrawal by Subject|8|||
164146214|NCT03151304|592896075|FG000|Overall Study|multiple reasons|30|||
164146215|NCT04759768|592896081|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
164146441|NCT05026177|592898059|FG001|Overall Study|Adverse Event|33|||
164146216|NCT04759768|592896082|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
164146217|NCT04759768|592896081|FG000|Washout (7 Days)|Physician Decision|0|||
164146218|NCT04759768|592896082|FG001|Washout (7 Days)|Physician Decision|1|||
164146219|NCT02996487|592896083|FG000|Overall Study|Lost to Follow-up|1|||
164146220|NCT02996487|592896084|FG001|Overall Study|Lost to Follow-up|1|||
164146221|NCT02996487|592896085|FG002|Overall Study|Lost to Follow-up|0|||
164146222|NCT02996487|592896083|FG000|Overall Study|Death|0|||
164146223|NCT02996487|592896084|FG001|Overall Study|Death|1|||
164146224|NCT02996487|592896085|FG002|Overall Study|Death|0|||
164146225|NCT02996487|592896083|FG000|Overall Study|Withdrawal by Subject|2|||
164146226|NCT02996487|592896084|FG001|Overall Study|Withdrawal by Subject|3|||
164146227|NCT02996487|592896085|FG002|Overall Study|Withdrawal by Subject|0|||
164146228|NCT02800642|592896086|FG000|Overall Study|Death|3|||
164146229|NCT02800642|592896086|FG000|Overall Study|Other|10|||
164146230|NCT02800642|592896086|FG000|Overall Study|Physician Decision|2|||
164146231|NCT02800642|592896086|FG000|Overall Study|Adverse Event|6|||
164146232|NCT02800642|592896086|FG000|Overall Study|Withdrawal by Subject|3|||
164146233|NCT02800642|592896086|FG000|Overall Study|Lost to Follow-up|1|||
164146234|NCT02859142|592896087|FG000|Overall Study|Adverse Event|1|||
164146235|NCT02859142|592896088|FG001|Overall Study|Adverse Event|2|||
164146236|NCT02859142|592896087|FG000|Overall Study|Lost to Follow-up|1|||
164146237|NCT02859142|592896088|FG001|Overall Study|Lost to Follow-up|4|||
164146238|NCT02859142|592896087|FG000|Overall Study|Withdrawal by Subject|2|||
164146239|NCT02859142|592896088|FG001|Overall Study|Withdrawal by Subject|0|||
164146240|NCT02859142|592896087|FG000|Overall Study|Scheduling difficulties|0|||
164146241|NCT02859142|592896088|FG001|Overall Study|Scheduling difficulties|3|||
164146242|NCT02374346|592896089|FG000|Overall Study|operated or discharged during weekend|48|||
164146243|NCT05299528|592896090|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146244|NCT05299528|592896091|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
164146245|NCT05299528|592896092|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146246|NCT05299528|592896093|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146247|NCT05299528|592896094|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146248|NCT05299528|592896095|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146249|NCT05299528|592896096|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
164146250|NCT05299528|592896090|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146251|NCT05299528|592896091|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146252|NCT05299528|592896092|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146253|NCT05299528|592896093|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146254|NCT05299528|592896094|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146255|NCT05299528|592896095|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
164146256|NCT05299528|592896096|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
164146257|NCT05299528|592896090|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
164146258|NCT05299528|592896091|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
164146259|NCT05299528|592896092|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
164146260|NCT05299528|592896093|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
164146261|NCT05299528|592896094|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
164146262|NCT05299528|592896095|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
164146263|NCT05299528|592896096|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
164146264|NCT00490841|592896097|FG000|Overall Study|Death|5|||
164146265|NCT00490841|592896097|FG000|Overall Study|Withdrawal by Subject|4|||
164146266|NCT00490841|592896097|FG000|Overall Study|Lost to Follow-up|1|||
164146267|NCT00490841|592896097|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
164146268|NCT01277211|592896098|FG000|Overall Study|Adverse Event|60|||
164146269|NCT01277211|592896099|FG001|Overall Study|Adverse Event|22|||
164146270|NCT01277211|592896098|FG000|Overall Study|Pregnancy|9|||
164146271|NCT01277211|592896099|FG001|Overall Study|Pregnancy|4|||
164146272|NCT01277211|592896098|FG000|Overall Study|Lost to Follow-up|14|||
164146273|NCT01277211|592896099|FG001|Overall Study|Lost to Follow-up|9|||
164146274|NCT01277211|592896098|FG000|Overall Study|Did not wish to continue|17|||
164146275|NCT01277211|592896099|FG001|Overall Study|Did not wish to continue|0|||
164146276|NCT01277211|592896098|FG000|Overall Study|Withdrew Consent|9|||
164146277|NCT01277211|592896099|FG001|Overall Study|Withdrew Consent|9|||
164146278|NCT01277211|592896098|FG000|Overall Study|Non-compliance with protocol|13|||
164146279|NCT01277211|592896099|FG001|Overall Study|Non-compliance with protocol|4|||
164146280|NCT01277211|592896098|FG000|Overall Study|Did not meet protocol eligibility|1|||
164146281|NCT01277211|592896099|FG001|Overall Study|Did not meet protocol eligibility|0|||
164146282|NCT01277211|592896098|FG000|Overall Study|Administrative|3|||
164146283|NCT01277211|592896099|FG001|Overall Study|Administrative|0|||
164146284|NCT01277211|592896098|FG000|Overall Study|Pregnancy wish|0|||
164146285|NCT01277211|592896099|FG001|Overall Study|Pregnancy wish|2|||
164146286|NCT01277211|592896098|FG000|Overall Study|Discontinued prior to treatment|24|||
164146287|NCT01277211|592896099|FG001|Overall Study|Discontinued prior to treatment|13|||
164146288|NCT01107197|592896102|FG000|Overall Study|Death|12|||
164146289|NCT01107197|592896103|FG001|Overall Study|Death|10|||
164146290|NCT01107197|592896102|FG000|Overall Study|Lost to Follow-up|5|||
164146291|NCT01107197|592896103|FG001|Overall Study|Lost to Follow-up|8|||
164146292|NCT01107197|592896102|FG000|Overall Study|Withdrawal by Subject|3|||
164146293|NCT01107197|592896103|FG001|Overall Study|Withdrawal by Subject|5|||
164146294|NCT03516513|592896104|FG000|Overall Study|Withdrawal by Subject|2|||
164146295|NCT03516513|592896105|FG001|Overall Study|Withdrawal by Subject|2|||
164146296|NCT03516513|592896106|FG002|Overall Study|Withdrawal by Subject|0|||
164146297|NCT03516513|592896107|FG003|Overall Study|Withdrawal by Subject|0|||
164146298|NCT01301729|592896109|FG000|Overall Study|Withdrawal by Subject|2|||
164146299|NCT01301729|592896109|FG000|Overall Study|Participant did not Return for Treatment|1|||
164146300|NCT01301729|592896109|FG000|Overall Study|Violated Selection Criteria|1|||
164146301|NCT03071276|592896110|FG000|Overall Study|Adverse Event|1|||
164146302|NCT03071276|592896110|FG000|Overall Study|Lack of Efficacy|14|||
164146303|NCT00447993|592896111|FG000|Overall Study|Lost to Follow-up|0|||
164146304|NCT00447993|592896112|FG001|Overall Study|Lost to Follow-up|0|||
164146305|NCT00447993|592896113|FG002|Overall Study|Lost to Follow-up|2|||
164146306|NCT00447993|592896114|FG003|Overall Study|Lost to Follow-up|2|||
164146307|NCT00447993|592896111|FG000|Overall Study|Withdrawal by Subject|0|||
164146308|NCT00447993|592896112|FG001|Overall Study|Withdrawal by Subject|0|||
164146309|NCT00447993|592896113|FG002|Overall Study|Withdrawal by Subject|2|||
164146310|NCT00447993|592896114|FG003|Overall Study|Withdrawal by Subject|2|||
164146311|NCT04614246|592896115|FG000|Overall Study|Adverse Event|0|||
164146312|NCT04614246|592896116|FG001|Overall Study|Adverse Event|1|||
164146313|NCT04614246|592896117|FG002|Overall Study|Adverse Event|1|||
164146314|NCT04614246|592896118|FG003|Overall Study|Adverse Event|2|||
164146315|NCT04614246|592896119|FG004|Overall Study|Adverse Event|1|||
164146316|NCT04614246|592896115|FG000|Overall Study|Lost to Follow-up|0|||
164146317|NCT04614246|592896116|FG001|Overall Study|Lost to Follow-up|1|||
164146318|NCT04614246|592896117|FG002|Overall Study|Lost to Follow-up|0|||
164146319|NCT04614246|592896118|FG003|Overall Study|Lost to Follow-up|1|||
164146320|NCT04614246|592896119|FG004|Overall Study|Lost to Follow-up|3|||
164146321|NCT04614246|592896115|FG000|Overall Study|Other reason|0|||
164146322|NCT04614246|592896116|FG001|Overall Study|Other reason|1|||
164146323|NCT04614246|592896117|FG002|Overall Study|Other reason|2|||
164146324|NCT04614246|592896118|FG003|Overall Study|Other reason|0|||
164146325|NCT04614246|592896119|FG004|Overall Study|Other reason|0|||
164146326|NCT04614246|592896115|FG000|Overall Study|Withdrawal by Subject|4|||
164146327|NCT04614246|592896116|FG001|Overall Study|Withdrawal by Subject|2|||
164146328|NCT04614246|592896117|FG002|Overall Study|Withdrawal by Subject|4|||
164146329|NCT04614246|592896118|FG003|Overall Study|Withdrawal by Subject|3|||
164146330|NCT04614246|592896119|FG004|Overall Study|Withdrawal by Subject|4|||
164146331|NCT04614246|592896115|FG000|Overall Study|Physician Decision|0|||
164146332|NCT04614246|592896116|FG001|Overall Study|Physician Decision|2|||
164146333|NCT04614246|592896117|FG002|Overall Study|Physician Decision|1|||
164146334|NCT04614246|592896118|FG003|Overall Study|Physician Decision|0|||
164146335|NCT04614246|592896119|FG004|Overall Study|Physician Decision|0|||
164146336|NCT04614246|592896115|FG000|Overall Study|Study terminated by sponsor|10|||
164146337|NCT04614246|592896116|FG001|Overall Study|Study terminated by sponsor|15|||
164146338|NCT04614246|592896117|FG002|Overall Study|Study terminated by sponsor|12|||
164146339|NCT04614246|592896118|FG003|Overall Study|Study terminated by sponsor|13|||
164146340|NCT04614246|592896119|FG004|Overall Study|Study terminated by sponsor|9|||
164146341|NCT04614246|592896115|FG000|Overall Study|Pregnancy|2|||
164146342|NCT04614246|592896116|FG001|Overall Study|Pregnancy|0|||
164146343|NCT04614246|592896117|FG002|Overall Study|Pregnancy|1|||
164146344|NCT04614246|592896118|FG003|Overall Study|Pregnancy|0|||
164146345|NCT04614246|592896119|FG004|Overall Study|Pregnancy|0|||
164146346|NCT04380961|592896129|FG000|Overall Study|Lost to Follow-up|17|||
164146347|NCT04380961|592896130|FG001|Overall Study|Lost to Follow-up|11|||
164146348|NCT04380961|592896129|FG000|Overall Study|Withdrawal by Subject|3|||
164146349|NCT04380961|592896130|FG001|Overall Study|Withdrawal by Subject|0|||
164146350|NCT04380961|592896129|FG000|Overall Study|Death|22|||
164146351|NCT04380961|592896130|FG001|Overall Study|Death|16|||
164146352|NCT04380961|592896129|FG000|Overall Study|Other|1|||
164146353|NCT04380961|592896130|FG001|Overall Study|Other|0|||
164146354|NCT04380961|592896129|FG000|Overall Study|Randomized but Not Treated|1|||
164146355|NCT04380961|592896130|FG001|Overall Study|Randomized but Not Treated|2|||
164146356|NCT01059786|592898030|FG000|Overall Study|Did not receive 6 cycles.|0|||
164146357|NCT01059786|592898031|FG001|Overall Study|Did not receive 6 cycles.|0|||
164146358|NCT01059786|592898032|FG002|Overall Study|Did not receive 6 cycles.|4|||
164146359|NCT01059786|592898033|FG003|Overall Study|Did not receive 6 cycles.|1|||
164146360|NCT01059786|592898034|FG004|Overall Study|Did not receive 6 cycles.|0|||
164146361|NCT04205812|592898035|FG000|Randomized Treatment Period|Ongoing|28|||
164146362|NCT04205812|592898036|FG001|Randomized Treatment Period|Ongoing|138|||
164146363|NCT04205812|592898035|FG000|Randomized Treatment Period|Death|94|||
164146364|NCT04205812|592898036|FG001|Randomized Treatment Period|Death|226|||
164146365|NCT04205812|592898035|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
164146366|NCT04205812|592898036|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
164146367|NCT04205812|592898035|FG000|Randomized Treatment Period|Physician Decision|1|||
164146368|NCT04205812|592898036|FG001|Randomized Treatment Period|Physician Decision|4|||
164146369|NCT04205812|592898035|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
164146370|NCT04205812|592898036|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
164146371|NCT04205812|592898035|FG000|Randomized Treatment Period|Progressive Disease|0|||
164146372|NCT04205812|592898036|FG001|Randomized Treatment Period|Progressive Disease|1|||
164146373|NCT04205812|592898035|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
164146374|NCT04205812|592898036|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
164146375|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Ongoing|17|||
164146376|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Ongoing|0|||
164146377|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Death|39|||
164146378|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Death|0|||
164146379|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
164146380|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
164146381|NCT04205812|592898035|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
164146382|NCT04205812|592898036|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
164146383|NCT00371033|592898037|FG000|Overall Study|Lost to Follow-up|3|||
164146384|NCT00371033|592898038|FG001|Overall Study|Lost to Follow-up|2|||
164146385|NCT00371033|592898037|FG000|Overall Study|No longer interested|2|||
164146386|NCT00371033|592898038|FG001|Overall Study|No longer interested|0|||
164146387|NCT00371033|592898037|FG000|Overall Study|Uknown|3|||
164146388|NCT00371033|592898038|FG001|Overall Study|Uknown|1|||
164146389|NCT02514447|592898039|FG000|Overall Study|Withdrawal by Subject|3|||
164146390|NCT02514447|592898040|FG001|Overall Study|Withdrawal by Subject|1|||
164146391|NCT02514447|592898041|FG002|Overall Study|Withdrawal by Subject|1|||
164146392|NCT02514447|592898042|FG003|Overall Study|Withdrawal by Subject|0|||
164146393|NCT02514447|592898043|FG004|Overall Study|Withdrawal by Subject|0|||
164146394|NCT02514447|592898044|FG005|Overall Study|Withdrawal by Subject|0|||
164146395|NCT02514447|592898045|FG006|Overall Study|Withdrawal by Subject|0|||
164146396|NCT02514447|592898046|FG007|Overall Study|Withdrawal by Subject|1|||
164146397|NCT02514447|592898047|FG008|Overall Study|Withdrawal by Subject|1|||
164146398|NCT02514447|592898039|FG000|Overall Study|Death|24|||
164146399|NCT02514447|592898040|FG001|Overall Study|Death|28|||
164146400|NCT02514447|592898041|FG002|Overall Study|Death|29|||
164146401|NCT02514447|592898042|FG003|Overall Study|Death|0|||
164146402|NCT02514447|592898043|FG004|Overall Study|Death|3|||
164146403|NCT02514447|592898044|FG005|Overall Study|Death|4|||
164146404|NCT02514447|592898045|FG006|Overall Study|Death|8|||
164146405|NCT02514447|592898046|FG007|Overall Study|Death|6|||
164146406|NCT02514447|592898047|FG008|Overall Study|Death|5|||
164146407|NCT02514447|592898039|FG000|Overall Study|Lost to Follow-up|1|||
164146408|NCT02514447|592898040|FG001|Overall Study|Lost to Follow-up|0|||
164146409|NCT02514447|592898041|FG002|Overall Study|Lost to Follow-up|0|||
164146410|NCT02514447|592898042|FG003|Overall Study|Lost to Follow-up|0|||
164146411|NCT02514447|592898043|FG004|Overall Study|Lost to Follow-up|0|||
164146412|NCT02514447|592898044|FG005|Overall Study|Lost to Follow-up|0|||
164146413|NCT02514447|592898045|FG006|Overall Study|Lost to Follow-up|0|||
164146414|NCT02514447|592898046|FG007|Overall Study|Lost to Follow-up|0|||
164146415|NCT02514447|592898047|FG008|Overall Study|Lost to Follow-up|1|||
164146416|NCT02514447|592898039|FG000|Overall Study|Sponsor Termination of Study|0|||
164146417|NCT02514447|592898040|FG001|Overall Study|Sponsor Termination of Study|1|||
164146418|NCT02514447|592898041|FG002|Overall Study|Sponsor Termination of Study|1|||
164146419|NCT02514447|592898042|FG003|Overall Study|Sponsor Termination of Study|0|||
164146420|NCT02514447|592898043|FG004|Overall Study|Sponsor Termination of Study|0|||
164146421|NCT02514447|592898044|FG005|Overall Study|Sponsor Termination of Study|0|||
164146422|NCT02514447|592898045|FG006|Overall Study|Sponsor Termination of Study|0|||
164146423|NCT02514447|592898046|FG007|Overall Study|Sponsor Termination of Study|0|||
164146424|NCT02514447|592898047|FG008|Overall Study|Sponsor Termination of Study|0|||
164146425|NCT02514447|592898039|FG000|Overall Study|Study completion per Investigator|1|||
164146426|NCT02514447|592898040|FG001|Overall Study|Study completion per Investigator|0|||
164146427|NCT02514447|592898041|FG002|Overall Study|Study completion per Investigator|1|||
164146428|NCT02514447|592898042|FG003|Overall Study|Study completion per Investigator|2|||
164146429|NCT02514447|592898043|FG004|Overall Study|Study completion per Investigator|0|||
164146430|NCT02514447|592898044|FG005|Overall Study|Study completion per Investigator|0|||
164146431|NCT02514447|592898045|FG006|Overall Study|Study completion per Investigator|0|||
164146432|NCT02514447|592898046|FG007|Overall Study|Study completion per Investigator|0|||
164146433|NCT02514447|592898047|FG008|Overall Study|Study completion per Investigator|1|||
164146434|NCT03130777|592898052|FG000|Overall Study|Death|0|||
164146435|NCT03130777|592898053|FG001|Overall Study|Death|1|||
164146436|NCT03130777|592898052|FG000|Overall Study|Did not meet eligibility criteria|1|||
164146437|NCT03130777|592898053|FG001|Overall Study|Did not meet eligibility criteria|0|||
164146438|NCT05929651|592898057|FG000|Overall Study|Protocol Deviation|1|||
164146439|NCT05929651|592898057|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
164146440|NCT05026177|592898058|FG000|Overall Study|Adverse Event|33|||
164146446|NCT05026177|592898058|FG000|Overall Study|Noncompliance with study drug|6|||
164146447|NCT05026177|592898059|FG001|Overall Study|Noncompliance with study drug|2|||
164146448|NCT05026177|592898060|FG002|Overall Study|Noncompliance with study drug|1|||
164146449|NCT05026177|592898058|FG000|Overall Study|Physician Decision|4|||
164146450|NCT05026177|592898059|FG001|Overall Study|Physician Decision|1|||
164146451|NCT05026177|592898060|FG002|Overall Study|Physician Decision|0|||
164146452|NCT05026177|592898058|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
164146453|NCT05026177|592898059|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
164146454|NCT05026177|592898060|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
164146455|NCT05026177|592898058|FG000|Overall Study|Withdrawal by Subject|53|||
164146456|NCT05026177|592898059|FG001|Overall Study|Withdrawal by Subject|51|||
164146457|NCT05026177|592898060|FG002|Overall Study|Withdrawal by Subject|55|||
164146458|NCT05026177|592898058|FG000|Overall Study|Protocol Violation|0|||
164146459|NCT05026177|592898059|FG001|Overall Study|Protocol Violation|1|||
164146460|NCT05026177|592898060|FG002|Overall Study|Protocol Violation|0|||
164146461|NCT05026177|592898058|FG000|Overall Study|Study terminated by sponsor|70|||
164146462|NCT05026177|592898059|FG001|Overall Study|Study terminated by sponsor|74|||
164146463|NCT05026177|592898060|FG002|Overall Study|Study terminated by sponsor|67|||
164146464|NCT05026177|592898058|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
164146465|NCT05026177|592898059|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
164146466|NCT05026177|592898060|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
164146467|NCT05026177|592898058|FG000|Overall Study|Starting alternative treatment|0|||
164146468|NCT05026177|592898059|FG001|Overall Study|Starting alternative treatment|1|||
164146469|NCT05026177|592898060|FG002|Overall Study|Starting alternative treatment|1|||
164146470|NCT05026177|592898058|FG000|Overall Study|Noncompliance with study procedures|0|||
164146471|NCT05026177|592898059|FG001|Overall Study|Noncompliance with study procedures|1|||
164146472|NCT05026177|592898060|FG002|Overall Study|Noncompliance with study procedures|1|||
164146473|NCT05026177|592898058|FG000|Overall Study|Met stopping criteria|0|||
164146474|NCT05026177|592898059|FG001|Overall Study|Met stopping criteria|0|||
164146475|NCT05026177|592898060|FG002|Overall Study|Met stopping criteria|1|||
164146476|NCT05026177|592898058|FG000|Overall Study|Health issues preventing continuation|0|||
164146477|NCT05026177|592898059|FG001|Overall Study|Health issues preventing continuation|0|||
164146478|NCT05026177|592898060|FG002|Overall Study|Health issues preventing continuation|1|||
164146479|NCT05026177|592898058|FG000|Overall Study|Randomized in error, not treated|0|||
164146480|NCT05026177|592898059|FG001|Overall Study|Randomized in error, not treated|0|||
164146481|NCT05026177|592898060|FG002|Overall Study|Randomized in error, not treated|2|||
164146482|NCT05109611|592898063|FG000|Overall Study|Adverse Event|13|||
164146483|NCT05109611|592898064|FG001|Overall Study|Adverse Event|10|||
164146484|NCT05109611|592898063|FG000|Overall Study|Withdrawal by Subject|1|||
164146485|NCT05109611|592898064|FG001|Overall Study|Withdrawal by Subject|0|||
164146486|NCT05109611|592898063|FG000|Overall Study|Lost to Follow-up|1|||
164146487|NCT05109611|592898064|FG001|Overall Study|Lost to Follow-up|2|||
164146488|NCT05109611|592898063|FG000|Overall Study|Protocol Violation|0|||
164146489|NCT05109611|592898064|FG001|Overall Study|Protocol Violation|4|||
164146490|NCT05109611|592898063|FG000|Overall Study|Information unavailable|1|||
164146491|NCT05109611|592898064|FG001|Overall Study|Information unavailable|1|||
164146492|NCT03203850|592898068|FG000|Overall Study|Subject/guardian decision|4|||
164146493|NCT03203850|592898069|FG001|Overall Study|Subject/guardian decision|3|||
164146494|NCT03203850|592898068|FG000|Overall Study|Adverse Event|3|||
164146495|NCT03203850|592898069|FG001|Overall Study|Adverse Event|0|||
164146496|NCT03203850|592898068|FG000|Overall Study|Death|1|||
164146497|NCT03203850|592898069|FG001|Overall Study|Death|0|||
164146498|NCT02717455|592898070|FG000|Overall Study|Adverse Event|1|||
164146499|NCT02717455|592898071|FG001|Overall Study|Adverse Event|0|||
164146500|NCT02717455|592898072|FG002|Overall Study|Adverse Event|0|||
164146501|NCT02717455|592898073|FG003|Overall Study|Adverse Event|2|||
164146502|NCT02717455|592898074|FG004|Overall Study|Adverse Event|2|||
164146503|NCT02717455|592898075|FG005|Overall Study|Adverse Event|2|||
164146504|NCT02717455|592898070|FG000|Overall Study|Withdrawal by Subject|1|||
164146505|NCT02717455|592898071|FG001|Overall Study|Withdrawal by Subject|1|||
164146506|NCT02717455|592898072|FG002|Overall Study|Withdrawal by Subject|0|||
164146507|NCT02717455|592898073|FG003|Overall Study|Withdrawal by Subject|2|||
164146508|NCT02717455|592898074|FG004|Overall Study|Withdrawal by Subject|2|||
164146509|NCT02717455|592898075|FG005|Overall Study|Withdrawal by Subject|1|||
164146510|NCT02717455|592898070|FG000|Overall Study|Death|1|||
164146511|NCT02717455|592898071|FG001|Overall Study|Death|0|||
164146512|NCT02717455|592898072|FG002|Overall Study|Death|0|||
164146513|NCT02717455|592898073|FG003|Overall Study|Death|0|||
164146514|NCT02717455|592898074|FG004|Overall Study|Death|1|||
164146515|NCT02717455|592898075|FG005|Overall Study|Death|0|||
164146516|NCT02717455|592898070|FG000|Overall Study|Did not receive study drug|0|||
164146517|NCT02717455|592898071|FG001|Overall Study|Did not receive study drug|0|||
164146518|NCT02717455|592898072|FG002|Overall Study|Did not receive study drug|0|||
164146519|NCT02717455|592898073|FG003|Overall Study|Did not receive study drug|1|||
164146520|NCT02717455|592898074|FG004|Overall Study|Did not receive study drug|0|||
164146521|NCT02717455|592898075|FG005|Overall Study|Did not receive study drug|1|||
164146522|NCT02717455|592898070|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146523|NCT02717455|592898071|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146524|NCT02717455|592898072|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146525|NCT02717455|592898073|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146526|NCT02717455|592898074|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
164146527|NCT02717455|592898075|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
164146528|NCT02717455|592898070|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
164146529|NCT02717455|592898071|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
164146530|NCT02717455|592898072|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
164146531|NCT02717455|592898073|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
164146532|NCT02717455|592898074|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
164146533|NCT02717455|592898075|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
164146534|NCT02301390|592898078|FG000|Overall Study|Withdrawal by Subject|3|||
164146535|NCT02301390|592898079|FG001|Overall Study|Withdrawal by Subject|5|||
164146536|NCT02301390|592898078|FG000|Overall Study|Protocol Violation|1|||
164146537|NCT02301390|592898079|FG001|Overall Study|Protocol Violation|0|||
164146538|NCT02301390|592898078|FG000|Overall Study|Physician Decision|1|||
164146539|NCT02301390|592898079|FG001|Overall Study|Physician Decision|0|||
164146540|NCT02301390|592898078|FG000|Overall Study|Lost to Follow-up|0|||
164146541|NCT02301390|592898079|FG001|Overall Study|Lost to Follow-up|1|||
164146542|NCT02301390|592898078|FG000|Overall Study|Death|2|||
164146543|NCT02301390|592898079|FG001|Overall Study|Death|2|||
164146544|NCT02301390|592898078|FG000|Overall Study|Procedure not completed|0|||
164146545|NCT02301390|592898079|FG001|Overall Study|Procedure not completed|4|||
164146546|NCT02301390|592898078|FG000|Overall Study|Missed multiple visits|1|||
164146547|NCT02301390|592898079|FG001|Overall Study|Missed multiple visits|1|||
164146548|NCT02301390|592898078|FG000|Overall Study|study terminated|2|||
164146549|NCT02301390|592898079|FG001|Overall Study|study terminated|0|||
164146550|NCT02481869|592898082|FG000|Overall Study|Lost to Follow-up|3|||
164146551|NCT02481869|592898083|FG001|Overall Study|Lost to Follow-up|4|||
164146552|NCT02481869|592898082|FG000|Overall Study|Withdrawal by Subject|2|||
164146553|NCT02481869|592898083|FG001|Overall Study|Withdrawal by Subject|0|||
164146554|NCT01153425|592898086|FG000|Overall Study|Withdrawal by Subject|3|||
164146555|NCT01153425|592898087|FG001|Overall Study|Withdrawal by Subject|3|||
164146556|NCT03154125|592898088|FG000|Overall Study|Lost to Follow-up|11|||
164146557|NCT03154125|592898089|FG001|Overall Study|Lost to Follow-up|11|||
164146558|NCT03154125|592898090|FG002|Overall Study|Lost to Follow-up|0|||
164146559|NCT03154125|592898088|FG000|Overall Study|Withdrawal by Subject|49|||
164146560|NCT03154125|592898089|FG001|Overall Study|Withdrawal by Subject|55|||
164146561|NCT03154125|592898090|FG002|Overall Study|Withdrawal by Subject|8|||
164146562|NCT03154125|592898088|FG000|Overall Study|Physician Decision|13|||
164146563|NCT03154125|592898089|FG001|Overall Study|Physician Decision|6|||
164146564|NCT03154125|592898090|FG002|Overall Study|Physician Decision|0|||
164146565|NCT03154125|592898088|FG000|Overall Study|Protocol Violation|3|||
164146566|NCT03154125|592898089|FG001|Overall Study|Protocol Violation|5|||
164146567|NCT03154125|592898090|FG002|Overall Study|Protocol Violation|0|||
164146568|NCT00810511|592898091|FG000|Overall Study|Protocol Violation|0|||
164146569|NCT00810511|592898092|FG001|Overall Study|Protocol Violation|1|||
164146570|NCT00810511|592898091|FG000|Overall Study|Lack of Efficacy|9|||
164146571|NCT00810511|592898092|FG001|Overall Study|Lack of Efficacy|1|||
164146572|NCT00810511|592898091|FG000|Overall Study|death in the family|0|||
164146573|NCT00810511|592898092|FG001|Overall Study|death in the family|1|||
164146574|NCT00810511|592898091|FG000|Overall Study|Lost to Follow-up|1|||
164146575|NCT00810511|592898092|FG001|Overall Study|Lost to Follow-up|0|||
164146576|NCT00810511|592898091|FG000|Overall Study|deposits on contact lens|0|||
164146577|NCT00810511|592898092|FG001|Overall Study|deposits on contact lens|1|||
164146578|NCT00911300|592898094|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
164146579|NCT00911300|592898095|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
164146580|NCT00911300|592898094|FG000|Overall Study|Death|1|||
164146581|NCT00911300|592898095|FG001|Overall Study|Death|0|||
164146582|NCT00911300|592898094|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
164146583|NCT00911300|592898095|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
164146584|NCT00911300|592898094|FG000|Overall Study|Adverse Event|14|||
164146585|NCT00911300|592898095|FG001|Overall Study|Adverse Event|6|||
164146586|NCT00911300|592898094|FG000|Overall Study|Protocol Violation|3|||
164146587|NCT00911300|592898095|FG001|Overall Study|Protocol Violation|2|||
164146588|NCT00911300|592898094|FG000|Overall Study|Consent Withdrawn|4|||
164146589|NCT00911300|592898095|FG001|Overall Study|Consent Withdrawn|12|||
164146590|NCT00911300|592898094|FG000|Overall Study|Coronary Angiography Performed|1|||
164146591|NCT00911300|592898095|FG001|Overall Study|Coronary Angiography Performed|0|||
164146592|NCT00911300|592898094|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
164146593|NCT00911300|592898095|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
164146594|NCT00911300|592898094|FG000|Overall Study|Received Commercial Treatment|1|||
164146595|NCT00911300|592898095|FG001|Overall Study|Received Commercial Treatment|0|||
164146596|NCT00911300|592898094|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
164146597|NCT00911300|592898095|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
164146598|NCT00911300|592898094|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
164146599|NCT00911300|592898095|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
164146600|NCT00911300|592898094|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
164146601|NCT00911300|592898095|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
164146602|NCT00911300|592898094|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
164146603|NCT00911300|592898095|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
164146604|NCT00911300|592898094|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
164146605|NCT00911300|592898095|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
164146606|NCT00911300|592898094|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
164146607|NCT00911300|592898095|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
164146608|NCT00911300|592898094|FG000|Overall Study|International Normalized Ratio Too High|0|||
164146609|NCT00911300|592898095|FG001|Overall Study|International Normalized Ratio Too High|1|||
164146610|NCT00911300|592898094|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
164146611|NCT00911300|592898095|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
164146612|NCT00911300|592898094|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
164146613|NCT00911300|592898095|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
164146614|NCT00911300|592898094|FG000|Overall Study|Physician Decision|0|||
164146615|NCT00911300|592898095|FG001|Overall Study|Physician Decision|1|||
164146616|NCT00911300|592898094|FG000|Overall Study|Treatment Stopped by Mistake|0|||
164146617|NCT00911300|592898095|FG001|Overall Study|Treatment Stopped by Mistake|1|||
164146618|NCT00911300|592898094|FG000|Overall Study|Randomized; No Study Medication Received|0|||
164146619|NCT00911300|592898095|FG001|Overall Study|Randomized; No Study Medication Received|2|||
164146620|NCT03022370|592898096|FG000|Overall Study|Death|6|||
164146621|NCT03022370|592898097|FG001|Overall Study|Death|12|||
164146622|NCT03022370|592898096|FG000|Overall Study|Lost to Follow-up|174|||
164146623|NCT03022370|592898097|FG001|Overall Study|Lost to Follow-up|109|||
164146624|NCT01965860|592898101|FG000|Overall Study|Pregnancy|1|||
164146625|NCT01965860|592898102|FG001|Overall Study|Pregnancy|0|||
164146626|NCT01965860|592898103|FG002|Overall Study|Pregnancy|1|||
164146627|NCT01965860|592898101|FG000|Overall Study|Logistics|1|||
164146628|NCT01965860|592898102|FG001|Overall Study|Logistics|0|||
164146629|NCT01965860|592898103|FG002|Overall Study|Logistics|0|||
164146630|NCT03571828|592898110|FG000|Overall Study|Withdrawal by Subject|1|||
164146631|NCT03571828|592898111|FG001|Overall Study|Withdrawal by Subject|0|||
164146632|NCT03571828|592898110|FG000|Overall Study|Decision by sponsor|5|||
164146633|NCT03571828|592898111|FG001|Overall Study|Decision by sponsor|1|||
164146634|NCT03571828|592898110|FG000|Overall Study|Death|2|||
164146635|NCT03571828|592898111|FG001|Overall Study|Death|0|||
164146636|NCT00666328|592898112|FG000|Overall Study|Death|2|||
164146637|NCT00666328|592898112|FG000|Overall Study|Lost to Follow-up|2|||
164146638|NCT00666328|592898112|FG000|Overall Study|No longer met eligibility criteria|1|||
164146639|NCT02288325|592898113|FG000|Run-in Period|Adverse Event|48|||
164146640|NCT02288325|592898114|FG001|Run-in Period|Adverse Event|0|||
164146641|NCT02288325|592898115|FG002|Run-in Period|Adverse Event|0|||
164146642|NCT02288325|592898113|FG000|Run-in Period|Lack of Efficacy|16|||
164146643|NCT02288325|592898114|FG001|Run-in Period|Lack of Efficacy|0|||
164146644|NCT02288325|592898115|FG002|Run-in Period|Lack of Efficacy|0|||
164146645|NCT02288325|592898113|FG000|Run-in Period|Withdrawal of Consent|28|||
164146646|NCT02288325|592898114|FG001|Run-in Period|Withdrawal of Consent|0|||
164146647|NCT02288325|592898115|FG002|Run-in Period|Withdrawal of Consent|0|||
164146648|NCT02288325|592898113|FG000|Run-in Period|Lost to Follow-up|25|||
164146649|NCT02288325|592898114|FG001|Run-in Period|Lost to Follow-up|0|||
164146650|NCT02288325|592898115|FG002|Run-in Period|Lost to Follow-up|0|||
164146651|NCT02288325|592898113|FG000|Run-in Period|Protocol Violation|17|||
164146652|NCT02288325|592898114|FG001|Run-in Period|Protocol Violation|0|||
164146653|NCT02288325|592898115|FG002|Run-in Period|Protocol Violation|0|||
164146654|NCT02288325|592898113|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
164146655|NCT02288325|592898114|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
164146656|NCT02288325|592898115|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
164146657|NCT02288325|592898113|FG000|Run-in Period|Reason not Specified|8|||
164146658|NCT02288325|592898114|FG001|Run-in Period|Reason not Specified|0|||
164146659|NCT02288325|592898115|FG002|Run-in Period|Reason not Specified|0|||
164146660|NCT02288325|592898113|FG000|Stabilization Period|Adverse Event|13|||
164146661|NCT02288325|592898114|FG001|Stabilization Period|Adverse Event|0|||
164146662|NCT02288325|592898115|FG002|Stabilization Period|Adverse Event|0|||
164146663|NCT02288325|592898113|FG000|Stabilization Period|Lack of Efficacy|22|||
164146664|NCT02288325|592898114|FG001|Stabilization Period|Lack of Efficacy|0|||
164146665|NCT02288325|592898115|FG002|Stabilization Period|Lack of Efficacy|0|||
164146666|NCT02288325|592898113|FG000|Stabilization Period|Withdrawal of Consent|23|||
164146667|NCT02288325|592898114|FG001|Stabilization Period|Withdrawal of Consent|0|||
164146668|NCT02288325|592898115|FG002|Stabilization Period|Withdrawal of Consent|0|||
164146669|NCT02288325|592898113|FG000|Stabilization Period|Lost to Follow-up|12|||
164146670|NCT02288325|592898114|FG001|Stabilization Period|Lost to Follow-up|0|||
164146671|NCT02288325|592898115|FG002|Stabilization Period|Lost to Follow-up|0|||
164146672|NCT02288325|592898113|FG000|Stabilization Period|Protocol Violation|8|||
164146673|NCT02288325|592898114|FG001|Stabilization Period|Protocol Violation|0|||
164146674|NCT02288325|592898115|FG002|Stabilization Period|Protocol Violation|0|||
164146675|NCT02288325|592898113|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
164146676|NCT02288325|592898114|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
164146677|NCT02288325|592898115|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
164146678|NCT02288325|592898113|FG000|Stabilization Period|Reason not Specified|15|||
164146679|NCT02288325|592898114|FG001|Stabilization Period|Reason not Specified|0|||
164146680|NCT02288325|592898115|FG002|Stabilization Period|Reason not Specified|0|||
164146681|NCT02288325|592898113|FG000|Double-blind Treatment Period|Adverse Event|0|||
164146682|NCT02288325|592898114|FG001|Double-blind Treatment Period|Adverse Event|2|||
164146683|NCT02288325|592898115|FG002|Double-blind Treatment Period|Adverse Event|5|||
164146684|NCT02288325|592898113|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
164146685|NCT02288325|592898114|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
164146686|NCT02288325|592898115|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
164146687|NCT02288325|592898113|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164146688|NCT02288325|592898114|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
164146689|NCT02288325|592898115|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
164146690|NCT02288325|592898113|FG000|Double-blind Treatment Period|Protocol Violation|0|||
164146691|NCT02288325|592898114|FG001|Double-blind Treatment Period|Protocol Violation|1|||
164146692|NCT02288325|592898115|FG002|Double-blind Treatment Period|Protocol Violation|2|||
164146693|NCT02288325|592898113|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
164146694|NCT02288325|592898114|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
164146695|NCT02288325|592898115|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
164146696|NCT02288325|592898113|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
164146697|NCT02288325|592898114|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
164146698|NCT02288325|592898115|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
164146699|NCT00769379|592898119|FG000|Overall Study|No follow up data mapped to Other.|3|||
164146700|NCT00769379|592898120|FG001|Overall Study|No follow up data mapped to Other.|13|||
164146701|NCT03607487|592898121|FG000|Overall Study|Withdrawal by Subject|2|||
164146702|NCT03607487|592898122|FG001|Overall Study|Withdrawal by Subject|0|||
164146703|NCT03607487|592898123|FG002|Overall Study|Withdrawal by Subject|0|||
164146704|NCT03607487|592898124|FG003|Overall Study|Withdrawal by Subject|1|||
164146705|NCT04759703|592898126|FG000|Overall Study|Withdrawal by Subject|4|||
164146706|NCT04759703|592898127|FG001|Overall Study|Withdrawal by Subject|9|||
164146707|NCT04759703|592898126|FG000|Overall Study|Adverse Event|1|||
164146708|NCT04759703|592898127|FG001|Overall Study|Adverse Event|0|||
164146709|NCT04759703|592898126|FG000|Overall Study|Lost to Follow-up|2|||
164146710|NCT04759703|592898127|FG001|Overall Study|Lost to Follow-up|0|||
164146711|NCT04186845|592898135|FG000|Overall Study|Death|2|||
164146712|NCT04186845|592898135|FG000|Overall Study|Lost to Follow-up|1|||
164146713|NCT04186845|592898135|FG000|Overall Study|Physician Decision|1|||
164146714|NCT04186845|592898135|FG000|Overall Study|Protocol Violation|1|||
164146715|NCT04186845|592898135|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
164146716|NCT04186845|592898135|FG000|Overall Study|Biopsy ordered but not done|1|||
164146717|NCT04186845|592898135|FG000|Overall Study|It was previously confirmed|1|||
164146718|NCT04186845|592898135|FG000|Overall Study|Patient cancelled scheduled scans|2|||
164146719|NCT04186845|592898135|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
164146720|NCT04186845|592898135|FG000|Overall Study|Subject refused confirmatory imaging|1|||
164146721|NCT04186845|592898135|FG000|Overall Study|Too small to biopsy|1|||
164146722|NCT04036110|592898136|FG000|Overall Study|Lost to Follow-up|3|||
164146723|NCT04036110|592898137|FG001|Overall Study|Lost to Follow-up|2|||
164146724|NCT04036110|592898138|FG002|Overall Study|Lost to Follow-up|1|||
164146725|NCT04036110|592898136|FG000|Overall Study|Study Suspended|4|||
164146726|NCT04036110|592898137|FG001|Overall Study|Study Suspended|5|||
164146727|NCT04036110|592898138|FG002|Overall Study|Study Suspended|1|||
164146728|NCT00534404|592898141|FG000|Overall Study|Death|0|||
164146729|NCT00534404|592898142|FG001|Overall Study|Death|0|||
164146730|NCT00534404|592898143|FG002|Overall Study|Death|2|||
164146731|NCT00534404|592898141|FG000|Overall Study|Withdrawal by Subject|8|||
164146732|NCT00534404|592898142|FG001|Overall Study|Withdrawal by Subject|2|||
164146733|NCT00534404|592898143|FG002|Overall Study|Withdrawal by Subject|38|||
164146734|NCT00534404|592898141|FG000|Overall Study|Removed by study staff|2|||
164146735|NCT00534404|592898142|FG001|Overall Study|Removed by study staff|3|||
164146736|NCT00534404|592898143|FG002|Overall Study|Removed by study staff|1|||
164146737|NCT00534404|592898141|FG000|Overall Study|Lost to Follow-up|170|||
164146738|NCT00534404|592898142|FG001|Overall Study|Lost to Follow-up|138|||
164146739|NCT00534404|592898143|FG002|Overall Study|Lost to Follow-up|201|||
164146740|NCT02676765|592898144|FG000|Overall Study|Lost to Follow-up|0|||
164146741|NCT02676765|592898145|FG001|Overall Study|Lost to Follow-up|1|||
164146742|NCT02565511|592898146|FG000|Overall Study|Study terminated by Sponsor|35|||
164146743|NCT02565511|592898147|FG001|Overall Study|Study terminated by Sponsor|22|||
164146744|NCT02565511|592898148|FG002|Overall Study|Study terminated by Sponsor|235|||
164146745|NCT02565511|592898149|FG003|Overall Study|Study terminated by Sponsor|156|||
164146746|NCT02565511|592898146|FG000|Overall Study|Withdrawal by Subject|3|||
164146747|NCT02565511|592898147|FG001|Overall Study|Withdrawal by Subject|0|||
164146748|NCT02565511|592898148|FG002|Overall Study|Withdrawal by Subject|12|||
164146749|NCT02565511|592898149|FG003|Overall Study|Withdrawal by Subject|5|||
164146750|NCT02565511|592898146|FG000|Overall Study|Adverse Event|0|||
164146751|NCT02565511|592898147|FG001|Overall Study|Adverse Event|0|||
164146752|NCT02565511|592898148|FG002|Overall Study|Adverse Event|1|||
164146753|NCT02565511|592898149|FG003|Overall Study|Adverse Event|1|||
164146754|NCT02565511|592898146|FG000|Overall Study|Lost to Follow-up|4|||
164146755|NCT02565511|592898147|FG001|Overall Study|Lost to Follow-up|1|||
164146756|NCT02565511|592898148|FG002|Overall Study|Lost to Follow-up|0|||
164146757|NCT02565511|592898149|FG003|Overall Study|Lost to Follow-up|1|||
164146758|NCT02565511|592898146|FG000|Overall Study|Physician Decision|0|||
164146759|NCT02565511|592898147|FG001|Overall Study|Physician Decision|0|||
164146760|NCT02565511|592898148|FG002|Overall Study|Physician Decision|0|||
164146761|NCT02565511|592898149|FG003|Overall Study|Physician Decision|1|||
164146762|NCT02565511|592898146|FG000|Overall Study|Protocol deviation|0|||
164146763|NCT02565511|592898147|FG001|Overall Study|Protocol deviation|0|||
164146764|NCT02565511|592898148|FG002|Overall Study|Protocol deviation|3|||
164146765|NCT02565511|592898149|FG003|Overall Study|Protocol deviation|0|||
164146766|NCT01941498|592898150|FG000|Overall Study|Relocated out of state|1|||
164146767|NCT00104572|592898152|FG000|Overall Study|Withdrawal by Subject|3|||
164146768|NCT00104572|592898153|FG001|Overall Study|Withdrawal by Subject|3|||
164146769|NCT00104572|592898154|FG002|Overall Study|Withdrawal by Subject|0|||
164146770|NCT00098774|592898155|FG000|Overall Study|Adverse Event|2|||
164146771|NCT00098774|592898155|FG000|Overall Study|Disease Progression|9|||
164146772|NCT00098774|592898155|FG000|Overall Study|Withdrawal by Subject|1|||
164146773|NCT00098774|592898155|FG000|Overall Study|Failed (to respond) during induction|4|||
164146774|NCT00098774|592898155|FG000|Overall Study|Physician Decision|2|||
164146775|NCT03097991|592898156|FG000|Overall Study|Didn't meet study criteria|8|||
164146776|NCT03097991|592898157|FG001|Overall Study|Didn't meet study criteria|0|||
164146777|NCT03097991|592898156|FG000|Overall Study|Withdrawal by Subject|12|||
164146778|NCT03097991|592898157|FG001|Overall Study|Withdrawal by Subject|6|||
164146779|NCT03097991|592898156|FG000|Overall Study|Death of Baby|3|||
164146780|NCT03097991|592898157|FG001|Overall Study|Death of Baby|1|||
164146781|NCT03097991|592898156|FG000|Overall Study|Lost to Follow-up|24|||
164146782|NCT03097991|592898157|FG001|Overall Study|Lost to Follow-up|38|||
164146783|NCT03097991|592898156|FG000|Overall Study|Adverse Event|3|||
164146784|NCT03097991|592898157|FG001|Overall Study|Adverse Event|5|||
164146785|NCT01755091|592898158|FG000|Overall Study|Withdrawal by Subject|6|||
164146786|NCT01755091|592898159|FG001|Overall Study|Withdrawal by Subject|1|||
164146787|NCT01755091|592898160|FG002|Overall Study|Withdrawal by Subject|3|||
164146788|NCT01755091|592898158|FG000|Overall Study|Adverse Event|1|||
164146789|NCT01755091|592898159|FG001|Overall Study|Adverse Event|1|||
164146790|NCT01755091|592898160|FG002|Overall Study|Adverse Event|1|||
164146791|NCT01755091|592898158|FG000|Overall Study|Lost to Follow-up|1|||
164146792|NCT01755091|592898159|FG001|Overall Study|Lost to Follow-up|0|||
164146793|NCT01755091|592898160|FG002|Overall Study|Lost to Follow-up|1|||
164146794|NCT01755091|592898158|FG000|Overall Study|Physician Decision|1|||
164146795|NCT01755091|592898159|FG001|Overall Study|Physician Decision|1|||
164146796|NCT01755091|592898160|FG002|Overall Study|Physician Decision|2|||
164146797|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
164146798|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
164146799|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
164146800|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
164146801|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
164146802|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
164146803|NCT03452943|592898161|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
164146804|NCT03452943|592898162|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
164146805|NCT03452943|592898161|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
164146806|NCT03452943|592898162|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
164146807|NCT03452943|592898161|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
164146808|NCT03452943|592898162|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
164146809|NCT01330303|592898167|FG000|Period 1|Adverse Event|1|||
164146810|NCT01330303|592898168|FG001|Period 1|Adverse Event|0|||
164146811|NCT01330303|592898167|FG000|Period 1|Protocol Violation|0|||
164146812|NCT01330303|592898168|FG001|Period 1|Protocol Violation|1|||
164146813|NCT01330303|592898167|FG000|Period 1|Withdrawal by Subject|0|||
164146814|NCT01330303|592898168|FG001|Period 1|Withdrawal by Subject|1|||
164146815|NCT00796757|592898169|FG000|Overall Study|Withdrawal by Subject|14|||
164146816|NCT00796757|592898169|FG000|Overall Study|Death|61|||
164146817|NCT00796757|592898169|FG000|Overall Study|Protocol Violation|1|||
164146818|NCT00796757|592898169|FG000|Overall Study|Participant noncompliance|1|||
164146819|NCT00796757|592898169|FG000|Overall Study|Investigator's decision|2|||
164146820|NCT00796757|592898169|FG000|Overall Study|Other|7|||
164146825|NCT00352417|592898172|FG000|Overall Study|Withdrawal by Subject|1|||
164146826|NCT00352417|592898173|FG001|Overall Study|Withdrawal by Subject|2|||
164146827|NCT00352417|592898172|FG000|Overall Study|Lost to Follow-up|1|||
164146828|NCT00352417|592898173|FG001|Overall Study|Lost to Follow-up|0|||
164146829|NCT00352417|592898172|FG000|Overall Study|Schedule Change|2|||
164146830|NCT00352417|592898173|FG001|Overall Study|Schedule Change|1|||
164146831|NCT02447744|592898174|FG000|Overall Study|Withdrawal by Subject|3|||
164146832|NCT02447744|592898175|FG001|Overall Study|Withdrawal by Subject|1|||
164146833|NCT02447744|592898174|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
164146834|NCT02447744|592898175|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
164146835|NCT00912912|592898176|FG000|Overall Study|Withdrawal by Subject|1|||
164146836|NCT00912912|592898176|FG000|Overall Study|Disease Progression|3|||
164146837|NCT00306995|592898177|FG000|Study Part I|Withdrawal by Subject|0|||
164146838|NCT00306995|592898178|FG001|Study Part I|Withdrawal by Subject|0|||
164146839|NCT00306995|592898179|FG002|Study Part I|Withdrawal by Subject|0|||
164146840|NCT00306995|592898180|FG003|Study Part I|Withdrawal by Subject|0|||
164146841|NCT00306995|592898181|FG004|Study Part I|Withdrawal by Subject|0|||
164146842|NCT00306995|592898182|FG005|Study Part I|Withdrawal by Subject|0|||
164146843|NCT00306995|592898183|FG006|Study Part I|Withdrawal by Subject|1|||
164146844|NCT00306995|592898177|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
164146845|NCT00306995|592898178|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
164146846|NCT00306995|592898179|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
164146847|NCT00306995|592898180|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
164146848|NCT00306995|592898181|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
164146849|NCT00306995|592898182|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
164146850|NCT00306995|592898183|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
164146851|NCT06419907|592899884|FG000|Overall Study|Protocol Violation|0|||
164146852|NCT06419907|592899885|FG001|Overall Study|Protocol Violation|3|||
164146853|NCT06419907|592899886|FG002|Overall Study|Protocol Violation|0|||
164146854|NCT06419907|592899887|FG003|Overall Study|Protocol Violation|1|||
164146855|NCT06419907|592899884|FG000|Overall Study|Lost to Follow-up|0|||
164146856|NCT06419907|592899885|FG001|Overall Study|Lost to Follow-up|0|||
164146857|NCT06419907|592899886|FG002|Overall Study|Lost to Follow-up|2|||
164146858|NCT06419907|592899887|FG003|Overall Study|Lost to Follow-up|1|||
164146859|NCT03573830|592899888|FG000|Overall Study|Dropped without completing treatment|0|||
164146860|NCT03573830|592899889|FG001|Overall Study|Dropped without completing treatment|7|||
164146861|NCT03573830|592899888|FG000|Overall Study|Lost to Follow-up|4|||
164146862|NCT03573830|592899889|FG001|Overall Study|Lost to Follow-up|0|||
164146863|NCT00266630|592899890|FG000|Overall Study|Adverse Event|8|||
164146864|NCT00266630|592899891|FG001|Overall Study|Adverse Event|6|||
164146865|NCT00266630|592899890|FG000|Overall Study|Lack of Efficacy|1|||
164146866|NCT00266630|592899891|FG001|Overall Study|Lack of Efficacy|4|||
164146867|NCT00266630|592899890|FG000|Overall Study|Entry Criteria not met|1|||
164146868|NCT00266630|592899891|FG001|Overall Study|Entry Criteria not met|0|||
164146869|NCT00266630|592899890|FG000|Overall Study|Protocol Violation|1|||
164146870|NCT00266630|592899891|FG001|Overall Study|Protocol Violation|3|||
164146871|NCT00266630|592899890|FG000|Overall Study|Physician Decision|1|||
164146872|NCT00266630|592899891|FG001|Overall Study|Physician Decision|2|||
164146873|NCT00266630|592899890|FG000|Overall Study|Withdrawal by Subject|10|||
164146874|NCT00266630|592899891|FG001|Overall Study|Withdrawal by Subject|2|||
164146875|NCT00266630|592899890|FG000|Overall Study|Lost to Follow-up|1|||
164146876|NCT00266630|592899891|FG001|Overall Study|Lost to Follow-up|0|||
164146877|NCT00266630|592899890|FG000|Overall Study|Other|19|||
164146878|NCT00266630|592899891|FG001|Overall Study|Other|11|||
164146879|NCT03284723|592899896|FG000|Overall Study|Death|0|||
164146880|NCT03284723|592899897|FG001|Overall Study|Death|0|||
164146881|NCT03284723|592899898|FG002|Overall Study|Death|0|||
164146882|NCT03284723|592899899|FG003|Overall Study|Death|1|||
164146883|NCT03284723|592899900|FG004|Overall Study|Death|0|||
164146884|NCT03284723|592899901|FG005|Overall Study|Death|0|||
164146885|NCT03284723|592899902|FG006|Overall Study|Death|1|||
164146886|NCT03284723|592899903|FG007|Overall Study|Death|0|||
164146887|NCT03284723|592899904|FG008|Overall Study|Death|0|||
164146888|NCT03284723|592899905|FG009|Overall Study|Death|2|||
164146889|NCT03284723|592899906|FG010|Overall Study|Death|1|||
164146890|NCT03284723|592899907|FG011|Overall Study|Death|0|||
164146891|NCT03284723|592899896|FG000|Overall Study|Lost to Follow-up|0|||
164146892|NCT03284723|592899897|FG001|Overall Study|Lost to Follow-up|0|||
164146893|NCT03284723|592899898|FG002|Overall Study|Lost to Follow-up|0|||
164146894|NCT03284723|592899899|FG003|Overall Study|Lost to Follow-up|0|||
164146895|NCT03284723|592899900|FG004|Overall Study|Lost to Follow-up|0|||
164146896|NCT03284723|592899901|FG005|Overall Study|Lost to Follow-up|2|||
164146897|NCT03284723|592899902|FG006|Overall Study|Lost to Follow-up|1|||
164146898|NCT03284723|592899903|FG007|Overall Study|Lost to Follow-up|0|||
164146899|NCT03284723|592899904|FG008|Overall Study|Lost to Follow-up|0|||
164146900|NCT03284723|592899905|FG009|Overall Study|Lost to Follow-up|2|||
164146901|NCT03284723|592899906|FG010|Overall Study|Lost to Follow-up|0|||
164146902|NCT03284723|592899907|FG011|Overall Study|Lost to Follow-up|0|||
164146903|NCT03284723|592899896|FG000|Overall Study|Study Terminated By Sponsor|0|||
164146904|NCT03284723|592899897|FG001|Overall Study|Study Terminated By Sponsor|0|||
164146905|NCT03284723|592899898|FG002|Overall Study|Study Terminated By Sponsor|0|||
164146906|NCT03284723|592899899|FG003|Overall Study|Study Terminated By Sponsor|0|||
164146907|NCT03284723|592899900|FG004|Overall Study|Study Terminated By Sponsor|1|||
164146908|NCT03284723|592899901|FG005|Overall Study|Study Terminated By Sponsor|0|||
164146909|NCT03284723|592899902|FG006|Overall Study|Study Terminated By Sponsor|0|||
164146910|NCT03284723|592899903|FG007|Overall Study|Study Terminated By Sponsor|0|||
164146911|NCT03284723|592899904|FG008|Overall Study|Study Terminated By Sponsor|1|||
164146912|NCT03284723|592899905|FG009|Overall Study|Study Terminated By Sponsor|1|||
164146913|NCT03284723|592899906|FG010|Overall Study|Study Terminated By Sponsor|1|||
164146914|NCT03284723|592899907|FG011|Overall Study|Study Terminated By Sponsor|1|||
164146915|NCT03284723|592899896|FG000|Overall Study|Withdrawal by Subject|0|||
164146916|NCT03284723|592899897|FG001|Overall Study|Withdrawal by Subject|0|||
164146917|NCT03284723|592899898|FG002|Overall Study|Withdrawal by Subject|0|||
164146918|NCT03284723|592899899|FG003|Overall Study|Withdrawal by Subject|0|||
164146919|NCT03284723|592899900|FG004|Overall Study|Withdrawal by Subject|5|||
164146920|NCT03284723|592899901|FG005|Overall Study|Withdrawal by Subject|3|||
164146921|NCT03284723|592899902|FG006|Overall Study|Withdrawal by Subject|1|||
164146922|NCT03284723|592899903|FG007|Overall Study|Withdrawal by Subject|0|||
164146923|NCT03284723|592899904|FG008|Overall Study|Withdrawal by Subject|6|||
164146924|NCT03284723|592899905|FG009|Overall Study|Withdrawal by Subject|0|||
164146925|NCT03284723|592899906|FG010|Overall Study|Withdrawal by Subject|3|||
164146926|NCT03284723|592899907|FG011|Overall Study|Withdrawal by Subject|1|||
164146927|NCT03284723|592899896|FG000|Overall Study|Other|1|||
164146928|NCT03284723|592899897|FG001|Overall Study|Other|0|||
164146929|NCT03284723|592899898|FG002|Overall Study|Other|1|||
164146930|NCT03284723|592899899|FG003|Overall Study|Other|0|||
164146931|NCT03284723|592899900|FG004|Overall Study|Other|1|||
164146932|NCT03284723|592899901|FG005|Overall Study|Other|0|||
164146933|NCT03284723|592899902|FG006|Overall Study|Other|0|||
164146934|NCT03284723|592899903|FG007|Overall Study|Other|0|||
164146935|NCT03284723|592899904|FG008|Overall Study|Other|0|||
164146936|NCT03284723|592899905|FG009|Overall Study|Other|0|||
164146937|NCT03284723|592899906|FG010|Overall Study|Other|1|||
164146938|NCT03284723|592899907|FG011|Overall Study|Other|0|||
164146939|NCT03284723|592899896|FG000|Overall Study|Adverse Event|0|||
164146940|NCT03284723|592899897|FG001|Overall Study|Adverse Event|0|||
164146941|NCT03284723|592899898|FG002|Overall Study|Adverse Event|0|||
164146942|NCT03284723|592899899|FG003|Overall Study|Adverse Event|0|||
164146943|NCT03284723|592899900|FG004|Overall Study|Adverse Event|0|||
164146944|NCT03284723|592899901|FG005|Overall Study|Adverse Event|0|||
164146945|NCT03284723|592899902|FG006|Overall Study|Adverse Event|0|||
164146946|NCT03284723|592899903|FG007|Overall Study|Adverse Event|0|||
164146947|NCT03284723|592899904|FG008|Overall Study|Adverse Event|1|||
164146948|NCT03284723|592899905|FG009|Overall Study|Adverse Event|0|||
164146949|NCT03284723|592899906|FG010|Overall Study|Adverse Event|0|||
164146950|NCT03284723|592899907|FG011|Overall Study|Adverse Event|0|||
164146951|NCT00064987|592899912|FG000|Overall Study|Physician Decision|3|||
164146952|NCT00064987|592899913|FG001|Overall Study|Physician Decision|0|||
164146953|NCT01499095|592899914|FG000|Overall Study|Randomized But Not Treated|1|||
164146954|NCT01499095|592899915|FG001|Overall Study|Randomized But Not Treated|1|||
164146955|NCT01499095|592899914|FG000|Overall Study|Adverse Event|12|||
164146956|NCT01499095|592899915|FG001|Overall Study|Adverse Event|7|||
164146957|NCT01499095|592899914|FG000|Overall Study|Lack of Efficacy|2|||
164146958|NCT01499095|592899915|FG001|Overall Study|Lack of Efficacy|1|||
164146959|NCT01499095|592899914|FG000|Overall Study|Protocol Violation|6|||
164146960|NCT01499095|592899915|FG001|Overall Study|Protocol Violation|7|||
164146961|NCT01499095|592899914|FG000|Overall Study|Received Rescue Therapy|32|||
164146962|NCT01499095|592899915|FG001|Overall Study|Received Rescue Therapy|40|||
164146963|NCT01499095|592899914|FG000|Overall Study|Diverse Reasons|22|||
164146964|NCT01499095|592899915|FG001|Overall Study|Diverse Reasons|25|||
164146965|NCT01499095|592899914|FG000|Overall Study|Lost to Follow-up|6|||
164146966|NCT01499095|592899915|FG001|Overall Study|Lost to Follow-up|4|||
164146967|NCT01499095|592899914|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
164146968|NCT01499095|592899915|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
164146969|NCT01499095|592899914|FG000|Overall Study|Hypoglycemia|3|||
164146970|NCT01499095|592899915|FG001|Overall Study|Hypoglycemia|1|||
164146971|NCT01499095|592899914|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
164146972|NCT01499095|592899915|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
164146973|NCT01499095|592899914|FG000|Overall Study|Change in Injection Schedule|2|||
164146974|NCT01499095|592899915|FG001|Overall Study|Change in Injection Schedule|0|||
164146975|NCT01499095|592899914|FG000|Overall Study|Perceived Lack of Efficacy|1|||
164146976|NCT01499095|592899915|FG001|Overall Study|Perceived Lack of Efficacy|1|||
164146977|NCT01368497|592899916|FG000|Overall Study|Lost to Follow-up|2|||
164146978|NCT00443729|592899920|FG000|Overall Study|Never Treated|0|||
164146979|NCT00443729|592899921|FG001|Overall Study|Never Treated|1|||
164146980|NCT00443729|592899920|FG000|Overall Study|Lack of Efficacy|4|||
164146981|NCT00443729|592899921|FG001|Overall Study|Lack of Efficacy|2|||
164146982|NCT00443729|592899920|FG000|Overall Study|Lost to Follow-up|0|||
164146988|NCT00443729|592899920|FG000|Overall Study|Withdrawal by Subject|3|||
164146989|NCT00443729|592899921|FG001|Overall Study|Withdrawal by Subject|1|||
164146990|NCT00782626|592899925|FG000|Overall Study|Adverse Event|1|||
164146991|NCT00782626|592899925|FG000|Overall Study|Progressive Disease|5|||
164146992|NCT00782626|592899925|FG000|Overall Study|Other Complicating Disease|1|||
164146993|NCT00077207|592899928|FG000|Overall Study|Adverse Event|5|||
164146994|NCT00077207|592899928|FG000|Overall Study|Lack of Efficacy|12|||
164146995|NCT00077207|592899928|FG000|Overall Study|Physician Decision|6|||
164146996|NCT00077207|592899928|FG000|Overall Study|Withdrawal by Subject|6|||
164146997|NCT00077207|592899928|FG000|Overall Study|Ineligible|1|||
164146998|NCT03052751|592899931|FG000|Dosing Period 1|Adverse Event|0|||
164146999|NCT03052751|592899932|FG001|Dosing Period 1|Adverse Event|1|||
164147000|NCT03052751|592899933|FG002|Dosing Period 1|Adverse Event|0|||
164147001|NCT03052751|592899934|FG003|Dosing Period 1|Adverse Event|0|||
164147002|NCT03052751|592899935|FG004|Dosing Period 1|Adverse Event|0|||
164147003|NCT03052751|592899936|FG005|Dosing Period 1|Adverse Event|0|||
164147004|NCT03052751|592899931|FG000|Dosing Period 2|Adverse Event|0|||
164147005|NCT03052751|592899932|FG001|Dosing Period 2|Adverse Event|0|||
164147006|NCT03052751|592899933|FG002|Dosing Period 2|Adverse Event|3|||
164147007|NCT03052751|592899934|FG003|Dosing Period 2|Adverse Event|0|||
164147008|NCT03052751|592899935|FG004|Dosing Period 2|Adverse Event|0|||
164147009|NCT03052751|592899936|FG005|Dosing Period 2|Adverse Event|0|||
164147010|NCT03052751|592899931|FG000|Observation Period|Adverse Event|0|||
164147011|NCT03052751|592899932|FG001|Observation Period|Adverse Event|0|||
164147012|NCT03052751|592899933|FG002|Observation Period|Adverse Event|0|||
164147013|NCT03052751|592899934|FG003|Observation Period|Adverse Event|0|||
164147014|NCT03052751|592899935|FG004|Observation Period|Adverse Event|1|||
164147015|NCT03052751|592899936|FG005|Observation Period|Adverse Event|0|||
164147016|NCT01427608|592899941|FG000|Overall Study|Death|1|||
164147017|NCT01427608|592899942|FG001|Overall Study|Death|0|||
164147018|NCT01427608|592899941|FG000|Overall Study|Withdrawal by Subject|7|||
164147019|NCT01427608|592899942|FG001|Overall Study|Withdrawal by Subject|3|||
164147020|NCT01427608|592899941|FG000|Overall Study|Relapsed-all cause|13|||
164147021|NCT01427608|592899942|FG001|Overall Study|Relapsed-all cause|34|||
164147022|NCT01427608|592899941|FG000|Overall Study|Events not attributed to study meds|0|||
164147023|NCT01427608|592899942|FG001|Overall Study|Events not attributed to study meds|1|||
164147024|NCT01027702|592899945|FG000|Overall Study|Received subsequent therapy|1|||
164147025|NCT01027702|592899946|FG001|Overall Study|Received subsequent therapy|2|||
164147026|NCT01027702|592899947|FG002|Overall Study|Received subsequent therapy|0|||
164147027|NCT01027702|592899948|FG003|Overall Study|Received subsequent therapy|4|||
164147028|NCT01027702|592899949|FG004|Overall Study|Received subsequent therapy|1|||
164147029|NCT01027702|592899950|FG005|Overall Study|Received subsequent therapy|0|||
164147030|NCT01027702|592899951|FG006|Overall Study|Received subsequent therapy|1|||
164147031|NCT01027702|592899945|FG000|Overall Study|Death|0|||
164147032|NCT01027702|592899946|FG001|Overall Study|Death|0|||
164147033|NCT01027702|592899947|FG002|Overall Study|Death|1|||
164147034|NCT01027702|592899948|FG003|Overall Study|Death|0|||
164147035|NCT01027702|592899949|FG004|Overall Study|Death|0|||
164147036|NCT01027702|592899950|FG005|Overall Study|Death|0|||
164147037|NCT01027702|592899951|FG006|Overall Study|Death|0|||
164147038|NCT00403585|592899952|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
164147039|NCT00403585|592899952|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
164147040|NCT00403585|592899952|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
164147041|NCT02862730|592899955|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147042|NCT02862730|592899956|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147043|NCT02862730|592899957|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
164147044|NCT02862730|592899958|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147045|NCT02862730|592899959|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147046|NCT02862730|592899960|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147047|NCT02862730|592899961|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
164147048|NCT02862730|592899955|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
164147049|NCT02862730|592899956|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147050|NCT02862730|592899957|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147051|NCT02862730|592899958|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147052|NCT02862730|592899959|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147053|NCT02862730|592899960|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147054|NCT02862730|592899961|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
164147055|NCT02862730|592899955|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147056|NCT02862730|592899956|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147057|NCT02862730|592899957|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
164147058|NCT02862730|592899958|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147059|NCT02862730|592899959|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
164147060|NCT02862730|592899960|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147061|NCT02862730|592899961|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
164147062|NCT02862730|592899955|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147063|NCT02862730|592899956|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147064|NCT02862730|592899957|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147065|NCT02862730|592899958|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
164147066|NCT02862730|592899959|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147067|NCT02862730|592899960|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147068|NCT02862730|592899961|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
164147069|NCT02121652|592899962|FG000|Overall Study|Lost to Follow-up|2|||
164147070|NCT02121652|592899963|FG001|Overall Study|Lost to Follow-up|1|||
164147071|NCT02121652|592899962|FG000|Overall Study|Death|1|||
164147072|NCT02121652|592899963|FG001|Overall Study|Death|0|||
164147073|NCT02121652|592899962|FG000|Overall Study|Withdrawal by Subject|3|||
164147074|NCT02121652|592899963|FG001|Overall Study|Withdrawal by Subject|3|||
164147075|NCT01090414|592899964|FG000|Study 101-99|Progressive Disease|28|||
164147076|NCT01090414|592899965|FG001|Study 101-99|Progressive Disease|48|||
164147077|NCT01090414|592899966|FG002|Study 101-99|Progressive Disease|10|||
164147078|NCT01090414|592899967|FG003|Study 101-99|Progressive Disease|4|||
164147079|NCT01090414|592899964|FG000|Study 101-99|Adverse Event|10|||
164147080|NCT01090414|592899965|FG001|Study 101-99|Adverse Event|28|||
164147081|NCT01090414|592899966|FG002|Study 101-99|Adverse Event|18|||
164147082|NCT01090414|592899967|FG003|Study 101-99|Adverse Event|0|||
164147083|NCT01090414|592899964|FG000|Study 101-99|Investigator Request|1|||
164147084|NCT01090414|592899965|FG001|Study 101-99|Investigator Request|11|||
164147085|NCT01090414|592899966|FG002|Study 101-99|Investigator Request|4|||
164147086|NCT01090414|592899967|FG003|Study 101-99|Investigator Request|0|||
164147087|NCT01090414|592899964|FG000|Study 101-99|Death|3|||
164147088|NCT01090414|592899965|FG001|Study 101-99|Death|8|||
164147089|NCT01090414|592899966|FG002|Study 101-99|Death|1|||
164147090|NCT01090414|592899967|FG003|Study 101-99|Death|0|||
164147091|NCT01090414|592899964|FG000|Study 101-99|Sponsor Discontinued Study|0|||
164147092|NCT01090414|592899965|FG001|Study 101-99|Sponsor Discontinued Study|7|||
164147093|NCT01090414|592899966|FG002|Study 101-99|Sponsor Discontinued Study|5|||
164147094|NCT01090414|592899967|FG003|Study 101-99|Sponsor Discontinued Study|0|||
164147095|NCT01090414|592899964|FG000|Study 101-99|Other (Unknown Reasons)|3|||
164147096|NCT01090414|592899965|FG001|Study 101-99|Other (Unknown Reasons)|3|||
164147097|NCT01090414|592899966|FG002|Study 101-99|Other (Unknown Reasons)|0|||
164147098|NCT01090414|592899967|FG003|Study 101-99|Other (Unknown Reasons)|0|||
164147099|NCT01090414|592899964|FG000|Study 101-99|Withdrew Consent|0|||
164147100|NCT01090414|592899965|FG001|Study 101-99|Withdrew Consent|2|||
164147101|NCT01090414|592899966|FG002|Study 101-99|Withdrew Consent|3|||
164147102|NCT01090414|592899967|FG003|Study 101-99|Withdrew Consent|1|||
164147103|NCT01090414|592899964|FG000|Study 101-99|Participant Request|3|||
164147104|NCT01090414|592899965|FG001|Study 101-99|Participant Request|1|||
164147105|NCT01090414|592899966|FG002|Study 101-99|Participant Request|0|||
164147106|NCT01090414|592899967|FG003|Study 101-99|Participant Request|0|||
164147107|NCT04342819|592899968|FG000|Overall Study|Declined|4|||
164147108|NCT04342819|592899968|FG000|Overall Study|Not meeeting selection criteria|1|||
164147109|NCT00668317|592899969|FG000|Overall Study|Adverse Event|2|||
164147110|NCT01526655|592899970|FG000|Overall Study|Withdrawal by Subject|0|||
164147111|NCT01526655|592899971|FG001|Overall Study|Withdrawal by Subject|1|||
164147112|NCT04753216|592899972|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
164147113|NCT04753216|592899972|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
164147114|NCT04753216|592899972|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
164147115|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
164147116|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Death|1|||
164147117|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
164147118|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
164147119|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
164147120|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
164147121|NCT02001987|592899973|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
164147122|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
164147123|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
164147124|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
164147125|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
164147126|NCT02001987|592899973|FG000|LTE Period (52 Weeks)|Other|3|||
164147127|NCT04138823|592899981|FG000|Overall Study|Clinical disease progression|0|||
164147128|NCT04138823|592899982|FG001|Overall Study|Clinical disease progression|0|||
164147129|NCT04138823|592899983|FG002|Overall Study|Clinical disease progression|1|||
164147130|NCT04138823|592899981|FG000|Overall Study|Objective disease progression|3|||
164147131|NCT04138823|592899982|FG001|Overall Study|Objective disease progression|2|||
164147132|NCT04138823|592899983|FG002|Overall Study|Objective disease progression|5|||
164147133|NCT04868500|592899984|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
164147134|NCT04868500|592899985|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
164147135|NCT04868500|592899984|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
164147136|NCT04868500|592899985|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
164147141|NCT02466685|592899987|FG000|Overall Study|Withdrawal by Subject|1|||
164147142|NCT02466685|592899988|FG001|Overall Study|Withdrawal by Subject|0|||
164147143|NCT02466685|592899987|FG000|Overall Study|Physician Decision|1|||
164147144|NCT02466685|592899988|FG001|Overall Study|Physician Decision|1|||
164147145|NCT02593110|592899989|FG000|Overall Study|Withdrawal by Subject|0|||
164147146|NCT02593110|592899990|FG001|Overall Study|Withdrawal by Subject|3|||
164147147|NCT02593110|592899991|FG002|Overall Study|Withdrawal by Subject|3|||
164147148|NCT02593110|592899992|FG003|Overall Study|Withdrawal by Subject|2|||
164147149|NCT02593110|592899989|FG000|Overall Study|Death|0|||
164147150|NCT02593110|592899990|FG001|Overall Study|Death|0|||
164147151|NCT02593110|592899991|FG002|Overall Study|Death|1|||
164147152|NCT02593110|592899992|FG003|Overall Study|Death|0|||
164147153|NCT01130597|592899993|FG000|Overall Study|Protocol-specified (High K+)|1|||
164147154|NCT01130597|592899993|FG000|Overall Study|Adverse Event|4|||
164147155|NCT01130597|592899993|FG000|Overall Study|Death|1|||
164147156|NCT01130597|592899993|FG000|Overall Study|Protocol Violation|1|||
164147157|NCT05794503|592899998|FG000|Overall Study|Operation Cancelled|2|||
164147158|NCT05794503|592899999|FG001|Overall Study|Operation Cancelled|0|||
164147159|NCT05794503|592899998|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
164147160|NCT05794503|592899999|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
164147161|NCT05794503|592899998|FG000|Overall Study|Protocol Violation|1|||
164147162|NCT05794503|592899999|FG001|Overall Study|Protocol Violation|0|||
164147163|NCT03052127|592900000|FG000|Overall Study|Withdrawal by Subject|0|||
164147164|NCT03052127|592900001|FG001|Overall Study|Withdrawal by Subject|0|||
164147165|NCT03052127|592900002|FG002|Overall Study|Withdrawal by Subject|0|||
164147166|NCT03052127|592900003|FG003|Overall Study|Withdrawal by Subject|0|||
164147167|NCT03052127|592900004|FG004|Overall Study|Withdrawal by Subject|0|||
164147168|NCT03052127|592900005|FG005|Overall Study|Withdrawal by Subject|0|||
164147169|NCT03052127|592900006|FG006|Overall Study|Withdrawal by Subject|0|||
164147170|NCT03052127|592900007|FG007|Overall Study|Withdrawal by Subject|1|||
164147171|NCT03052127|592900008|FG008|Overall Study|Withdrawal by Subject|1|||
164147172|NCT03052127|592900009|FG009|Overall Study|Withdrawal by Subject|1|||
164147173|NCT03052127|592900010|FG010|Overall Study|Withdrawal by Subject|0|||
164147174|NCT03052127|592900011|FG011|Overall Study|Withdrawal by Subject|0|||
164147175|NCT03052127|592900000|FG000|Overall Study|Discontinuation by Sponsor|0|||
164147176|NCT03052127|592900001|FG001|Overall Study|Discontinuation by Sponsor|0|||
164147177|NCT03052127|592900002|FG002|Overall Study|Discontinuation by Sponsor|0|||
164147178|NCT03052127|592900003|FG003|Overall Study|Discontinuation by Sponsor|0|||
164147179|NCT03052127|592900004|FG004|Overall Study|Discontinuation by Sponsor|0|||
164147180|NCT03052127|592900005|FG005|Overall Study|Discontinuation by Sponsor|0|||
164147181|NCT03052127|592900006|FG006|Overall Study|Discontinuation by Sponsor|0|||
164147182|NCT03052127|592900007|FG007|Overall Study|Discontinuation by Sponsor|0|||
164147183|NCT03052127|592900008|FG008|Overall Study|Discontinuation by Sponsor|4|||
164147184|NCT03052127|592900009|FG009|Overall Study|Discontinuation by Sponsor|2|||
164147185|NCT03052127|592900010|FG010|Overall Study|Discontinuation by Sponsor|5|||
164147186|NCT03052127|592900011|FG011|Overall Study|Discontinuation by Sponsor|13|||
164147187|NCT03052127|592900000|FG000|Overall Study|Inability to comply with trial requirements|0|||
164147188|NCT03052127|592900001|FG001|Overall Study|Inability to comply with trial requirements|0|||
164147189|NCT03052127|592900002|FG002|Overall Study|Inability to comply with trial requirements|1|||
164147190|NCT03052127|592900003|FG003|Overall Study|Inability to comply with trial requirements|0|||
164147191|NCT03052127|592900004|FG004|Overall Study|Inability to comply with trial requirements|0|||
164147192|NCT03052127|592900005|FG005|Overall Study|Inability to comply with trial requirements|0|||
164147193|NCT03052127|592900006|FG006|Overall Study|Inability to comply with trial requirements|0|||
164147194|NCT03052127|592900007|FG007|Overall Study|Inability to comply with trial requirements|0|||
164147195|NCT03052127|592900008|FG008|Overall Study|Inability to comply with trial requirements|0|||
164147196|NCT03052127|592900009|FG009|Overall Study|Inability to comply with trial requirements|0|||
164147197|NCT03052127|592900010|FG010|Overall Study|Inability to comply with trial requirements|0|||
164147198|NCT03052127|592900011|FG011|Overall Study|Inability to comply with trial requirements|0|||
164147199|NCT03052127|592900000|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147200|NCT03052127|592900001|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147201|NCT03052127|592900002|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147202|NCT03052127|592900003|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147203|NCT03052127|592900004|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147204|NCT03052127|592900005|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147205|NCT03052127|592900006|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
164147206|NCT03052127|592900007|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147207|NCT03052127|592900008|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147208|NCT03052127|592900009|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147209|NCT03052127|592900010|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147210|NCT03052127|592900011|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
164147211|NCT03694327|592900012|FG000|Overall Study|Lost to Follow-up|13|||
164147212|NCT03694327|592900013|FG001|Overall Study|Lost to Follow-up|23|||
164147213|NCT01464931|592900016|FG000|Overall Study|Withdrawal by Subject|1|||
164147214|NCT01464931|592900017|FG001|Overall Study|Withdrawal by Subject|0|||
164147215|NCT01982812|592900018|FG000|Overall Study|Death|1|||
164147216|NCT01982812|592900019|FG001|Overall Study|Death|5|||
164147217|NCT01982812|592900018|FG000|Overall Study|Adverse Event|0|||
164147218|NCT01982812|592900019|FG001|Overall Study|Adverse Event|5|||
164147219|NCT00307437|592900021|FG000|Controlled Period|Adverse Event|7|||
164147220|NCT00307437|592900022|FG001|Controlled Period|Adverse Event|2|||
164147221|NCT00307437|592900023|FG002|Controlled Period|Adverse Event|5|||
164147222|NCT00307437|592900024|FG003|Controlled Period|Adverse Event|0|||
164147223|NCT00307437|592900025|FG004|Controlled Period|Adverse Event|0|||
164147224|NCT00307437|592900026|FG005|Controlled Period|Adverse Event|0|||
164147225|NCT00307437|592900027|FG006|Controlled Period|Adverse Event|0|||
164147226|NCT00307437|592900021|FG000|Controlled Period|Death|0|||
164147227|NCT00307437|592900022|FG001|Controlled Period|Death|0|||
164147228|NCT00307437|592900023|FG002|Controlled Period|Death|1|||
164147229|NCT00307437|592900024|FG003|Controlled Period|Death|0|||
164147230|NCT00307437|592900025|FG004|Controlled Period|Death|0|||
164147231|NCT00307437|592900026|FG005|Controlled Period|Death|0|||
164147232|NCT00307437|592900027|FG006|Controlled Period|Death|0|||
164147233|NCT00307437|592900021|FG000|Controlled Period|Lack of Efficacy|2|||
164147234|NCT00307437|592900022|FG001|Controlled Period|Lack of Efficacy|0|||
164147235|NCT00307437|592900023|FG002|Controlled Period|Lack of Efficacy|0|||
164147236|NCT00307437|592900024|FG003|Controlled Period|Lack of Efficacy|0|||
164147237|NCT00307437|592900025|FG004|Controlled Period|Lack of Efficacy|0|||
164147238|NCT00307437|592900026|FG005|Controlled Period|Lack of Efficacy|0|||
164147239|NCT00307437|592900027|FG006|Controlled Period|Lack of Efficacy|0|||
164147240|NCT00307437|592900021|FG000|Controlled Period|Lost to Follow-up|2|||
164147241|NCT00307437|592900022|FG001|Controlled Period|Lost to Follow-up|3|||
164147242|NCT00307437|592900023|FG002|Controlled Period|Lost to Follow-up|0|||
164147243|NCT00307437|592900024|FG003|Controlled Period|Lost to Follow-up|0|||
164147244|NCT00307437|592900025|FG004|Controlled Period|Lost to Follow-up|0|||
164147245|NCT00307437|592900026|FG005|Controlled Period|Lost to Follow-up|0|||
164147246|NCT00307437|592900027|FG006|Controlled Period|Lost to Follow-up|0|||
164147247|NCT00307437|592900021|FG000|Controlled Period|Other|5|||
164147248|NCT00307437|592900022|FG001|Controlled Period|Other|1|||
164147249|NCT00307437|592900023|FG002|Controlled Period|Other|3|||
164147250|NCT00307437|592900024|FG003|Controlled Period|Other|0|||
164147251|NCT00307437|592900025|FG004|Controlled Period|Other|0|||
164147252|NCT00307437|592900026|FG005|Controlled Period|Other|0|||
164147253|NCT00307437|592900027|FG006|Controlled Period|Other|0|||
164147254|NCT00307437|592900021|FG000|After Controlled Period|Adverse Event|0|||
164147255|NCT00307437|592900022|FG001|After Controlled Period|Adverse Event|0|||
164147256|NCT00307437|592900023|FG002|After Controlled Period|Adverse Event|0|||
164147257|NCT00307437|592900024|FG003|After Controlled Period|Adverse Event|18|||
164147258|NCT00307437|592900025|FG004|After Controlled Period|Adverse Event|16|||
164147259|NCT00307437|592900026|FG005|After Controlled Period|Adverse Event|31|||
164147260|NCT00307437|592900027|FG006|After Controlled Period|Adverse Event|40|||
164147261|NCT00307437|592900021|FG000|After Controlled Period|Death|0|||
164147262|NCT00307437|592900022|FG001|After Controlled Period|Death|0|||
164147263|NCT00307437|592900023|FG002|After Controlled Period|Death|0|||
164147264|NCT00307437|592900024|FG003|After Controlled Period|Death|3|||
164147265|NCT00307437|592900025|FG004|After Controlled Period|Death|1|||
164147266|NCT00307437|592900026|FG005|After Controlled Period|Death|1|||
164147267|NCT00307437|592900027|FG006|After Controlled Period|Death|3|||
164147268|NCT00307437|592900021|FG000|After Controlled Period|Lack of Efficacy|0|||
164147269|NCT00307437|592900022|FG001|After Controlled Period|Lack of Efficacy|0|||
164147270|NCT00307437|592900023|FG002|After Controlled Period|Lack of Efficacy|0|||
164147271|NCT00307437|592900024|FG003|After Controlled Period|Lack of Efficacy|15|||
164147272|NCT00307437|592900025|FG004|After Controlled Period|Lack of Efficacy|17|||
164147273|NCT00307437|592900026|FG005|After Controlled Period|Lack of Efficacy|37|||
164147274|NCT00307437|592900027|FG006|After Controlled Period|Lack of Efficacy|24|||
164147275|NCT00307437|592900021|FG000|After Controlled Period|Lost to Follow-up|0|||
164147276|NCT00307437|592900022|FG001|After Controlled Period|Lost to Follow-up|0|||
164147277|NCT00307437|592900023|FG002|After Controlled Period|Lost to Follow-up|0|||
164147278|NCT00307437|592900024|FG003|After Controlled Period|Lost to Follow-up|7|||
164147279|NCT00307437|592900025|FG004|After Controlled Period|Lost to Follow-up|12|||
164147280|NCT00307437|592900026|FG005|After Controlled Period|Lost to Follow-up|13|||
164147281|NCT00307437|592900027|FG006|After Controlled Period|Lost to Follow-up|18|||
164147282|NCT00307437|592900021|FG000|After Controlled Period|Other|0|||
164147283|NCT00307437|592900022|FG001|After Controlled Period|Other|0|||
164147284|NCT00307437|592900023|FG002|After Controlled Period|Other|0|||
164147285|NCT00307437|592900024|FG003|After Controlled Period|Other|15|||
164147286|NCT00307437|592900025|FG004|After Controlled Period|Other|9|||
164147287|NCT00307437|592900026|FG005|After Controlled Period|Other|40|||
164147288|NCT00307437|592900027|FG006|After Controlled Period|Other|28|||
164147289|NCT03017612|592900030|FG000|Overall Study|Adverse Event|2|||
164147290|NCT00985491|592900034|FG000|Overall Study|Adverse Event|8|||
164147291|NCT00985491|592900034|FG000|Overall Study|device migration|7|||
164147370|NCT05168202|592902025|FG001|Overall Study|Adverse Event|1|||
164147292|NCT00985491|592900034|FG000|Overall Study|Withdrawal by Subject|1|||
164147293|NCT00985491|592900034|FG000|Overall Study|implant failure|3|||
164147294|NCT01893346|592900035|FG000|Overall Study|Lost to Follow-up|0|||
164147295|NCT01893346|592900036|FG001|Overall Study|Lost to Follow-up|1|||
164147296|NCT01893346|592900037|FG002|Overall Study|Lost to Follow-up|0|||
164147297|NCT01893346|592900038|FG003|Overall Study|Lost to Follow-up|0|||
164147298|NCT01893346|592900035|FG000|Overall Study|Protocol Violation|1|||
164147299|NCT01893346|592900036|FG001|Overall Study|Protocol Violation|0|||
164147300|NCT01893346|592900037|FG002|Overall Study|Protocol Violation|0|||
164147301|NCT01893346|592900038|FG003|Overall Study|Protocol Violation|0|||
164147302|NCT01893346|592900035|FG000|Overall Study|Withdrawal by Subject|2|||
164147303|NCT01893346|592900036|FG001|Overall Study|Withdrawal by Subject|0|||
164147304|NCT01893346|592900037|FG002|Overall Study|Withdrawal by Subject|0|||
164147305|NCT01893346|592900038|FG003|Overall Study|Withdrawal by Subject|0|||
164147306|NCT02933255|592900044|FG000|Overall Study|Discontinued due to study closure.|1|||
164147307|NCT02933255|592900045|FG001|Overall Study|Discontinued due to study closure.|0|||
164147308|NCT00721227|592900046|FG000|Overall Study|Lost to Follow-up|3|||
164147309|NCT00721227|592900047|FG001|Overall Study|Lost to Follow-up|0|||
164147310|NCT00721227|592900046|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
164147311|NCT00721227|592900047|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
164147312|NCT01632280|592900061|FG000|Overall Study|Withdrawal by Subject|1|||
164147313|NCT01632280|592900062|FG001|Overall Study|Withdrawal by Subject|0|||
164147314|NCT05221320|592902011|FG000|Overall Study|Lack of Efficacy|3|||
164147315|NCT05221320|592902012|FG001|Overall Study|Lack of Efficacy|7|||
164147316|NCT05221320|592902013|FG002|Overall Study|Lack of Efficacy|10|||
164147317|NCT05221320|592902014|FG003|Overall Study|Lack of Efficacy|1|||
164147318|NCT05221320|592902015|FG004|Overall Study|Lack of Efficacy|0|||
164147319|NCT05221320|592902016|FG005|Overall Study|Lack of Efficacy|0|||
164147320|NCT05221320|592902011|FG000|Overall Study|Physician Decision|1|||
164147321|NCT05221320|592902012|FG001|Overall Study|Physician Decision|0|||
164147322|NCT05221320|592902013|FG002|Overall Study|Physician Decision|3|||
164147323|NCT05221320|592902014|FG003|Overall Study|Physician Decision|1|||
164147324|NCT05221320|592902015|FG004|Overall Study|Physician Decision|0|||
164147325|NCT05221320|592902016|FG005|Overall Study|Physician Decision|0|||
164147326|NCT05221320|592902011|FG000|Overall Study|Withdrawal by Subject|0|||
164147327|NCT05221320|592902012|FG001|Overall Study|Withdrawal by Subject|3|||
164147328|NCT05221320|592902013|FG002|Overall Study|Withdrawal by Subject|1|||
164147329|NCT05221320|592902014|FG003|Overall Study|Withdrawal by Subject|0|||
164147330|NCT05221320|592902015|FG004|Overall Study|Withdrawal by Subject|0|||
164147331|NCT05221320|592902016|FG005|Overall Study|Withdrawal by Subject|0|||
164147332|NCT05221320|592902011|FG000|Overall Study|Death|0|||
164147333|NCT05221320|592902012|FG001|Overall Study|Death|5|||
164147334|NCT05221320|592902013|FG002|Overall Study|Death|6|||
164147335|NCT05221320|592902014|FG003|Overall Study|Death|0|||
164147336|NCT05221320|592902015|FG004|Overall Study|Death|1|||
164147337|NCT05221320|592902016|FG005|Overall Study|Death|0|||
164147338|NCT06473519|592902017|FG000|Overall Study|Lost to Follow-up|2|||
164147339|NCT06473519|592902018|FG001|Overall Study|Lost to Follow-up|5|||
164147340|NCT06473519|592902017|FG000|Overall Study|Withdrawal by Subject|1|||
164147341|NCT06473519|592902018|FG001|Overall Study|Withdrawal by Subject|4|||
164147342|NCT06473519|592902017|FG000|Overall Study|Randomized but not vaccinated|1|||
164147343|NCT06473519|592902018|FG001|Overall Study|Randomized but not vaccinated|2|||
164147344|NCT02586688|592902019|FG000|Overall Study|Lost to Follow-up|2|||
164147345|NCT02586688|592902020|FG001|Overall Study|Lost to Follow-up|1|||
164147346|NCT02586688|592902019|FG000|Overall Study|Withdrawal by Subject|1|||
164147347|NCT02586688|592902020|FG001|Overall Study|Withdrawal by Subject|1|||
164147348|NCT02586688|592902019|FG000|Overall Study|Adverse Event|3|||
164147349|NCT02586688|592902020|FG001|Overall Study|Adverse Event|1|||
164147350|NCT04856917|592902021|FG000|Overall Study|Withdrawal by Subject|4|||
164147351|NCT04856917|592902022|FG001|Overall Study|Withdrawal by Subject|3|||
164147352|NCT04856917|592902023|FG002|Overall Study|Withdrawal by Subject|1|||
164147353|NCT04856917|592902021|FG000|Overall Study|Lost to Follow-up|3|||
164147354|NCT04856917|592902022|FG001|Overall Study|Lost to Follow-up|1|||
164147355|NCT04856917|592902023|FG002|Overall Study|Lost to Follow-up|1|||
164147356|NCT04856917|592902021|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
164147357|NCT04856917|592902022|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
164147358|NCT04856917|592902023|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
164147359|NCT04856917|592902021|FG000|Overall Study|Other|1|||
164147360|NCT04856917|592902022|FG001|Overall Study|Other|1|||
164147361|NCT04856917|592902023|FG002|Overall Study|Other|0|||
164147362|NCT05168202|592902024|FG000|Overall Study|Progressive Disease|4|||
164147363|NCT05168202|592902025|FG001|Overall Study|Progressive Disease|4|||
164147364|NCT05168202|592902026|FG002|Overall Study|Progressive Disease|2|||
164147365|NCT05168202|592902027|FG003|Overall Study|Progressive Disease|3|||
164147366|NCT05168202|592902028|FG004|Overall Study|Progressive Disease|2|||
164147367|NCT05168202|592902029|FG005|Overall Study|Progressive Disease|3|||
164147368|NCT05168202|592902030|FG006|Overall Study|Progressive Disease|2|||
164147369|NCT05168202|592902024|FG000|Overall Study|Adverse Event|2|||
164147383|NCT05168202|592902024|FG000|Overall Study|Withdrawal by Subject|0|||
164147384|NCT05168202|592902025|FG001|Overall Study|Withdrawal by Subject|0|||
164147385|NCT05168202|592902026|FG002|Overall Study|Withdrawal by Subject|1|||
164147386|NCT05168202|592902027|FG003|Overall Study|Withdrawal by Subject|1|||
164147387|NCT05168202|592902028|FG004|Overall Study|Withdrawal by Subject|1|||
164147388|NCT05168202|592902029|FG005|Overall Study|Withdrawal by Subject|1|||
164147389|NCT05168202|592902030|FG006|Overall Study|Withdrawal by Subject|0|||
164147390|NCT05168202|592902024|FG000|Overall Study|Disease Relapse|0|||
164147391|NCT05168202|592902025|FG001|Overall Study|Disease Relapse|1|||
164147392|NCT05168202|592902026|FG002|Overall Study|Disease Relapse|0|||
164147393|NCT05168202|592902027|FG003|Overall Study|Disease Relapse|1|||
164147394|NCT05168202|592902028|FG004|Overall Study|Disease Relapse|1|||
164147395|NCT05168202|592902029|FG005|Overall Study|Disease Relapse|0|||
164147396|NCT05168202|592902030|FG006|Overall Study|Disease Relapse|0|||
164147397|NCT05168202|592902024|FG000|Overall Study|Other Reasons|0|||
164147398|NCT05168202|592902025|FG001|Overall Study|Other Reasons|0|||
164147399|NCT05168202|592902026|FG002|Overall Study|Other Reasons|0|||
164147400|NCT05168202|592902027|FG003|Overall Study|Other Reasons|0|||
164147401|NCT05168202|592902028|FG004|Overall Study|Other Reasons|0|||
164147402|NCT05168202|592902029|FG005|Overall Study|Other Reasons|2|||
164147403|NCT05168202|592902030|FG006|Overall Study|Other Reasons|1|||
164147404|NCT05168202|592902024|FG000|Overall Study|Physician Decision|0|||
164147405|NCT05168202|592902025|FG001|Overall Study|Physician Decision|1|||
164147406|NCT05168202|592902026|FG002|Overall Study|Physician Decision|1|||
164147407|NCT05168202|592902027|FG003|Overall Study|Physician Decision|0|||
164147408|NCT05168202|592902028|FG004|Overall Study|Physician Decision|0|||
164147409|NCT05168202|592902029|FG005|Overall Study|Physician Decision|0|||
164147410|NCT05168202|592902030|FG006|Overall Study|Physician Decision|0|||
164147411|NCT05168202|592902024|FG000|Overall Study|Study Terminated by Sponsor|0|||
164147412|NCT05168202|592902025|FG001|Overall Study|Study Terminated by Sponsor|0|||
164147413|NCT05168202|592902026|FG002|Overall Study|Study Terminated by Sponsor|0|||
164147414|NCT05168202|592902027|FG003|Overall Study|Study Terminated by Sponsor|1|||
164147415|NCT05168202|592902028|FG004|Overall Study|Study Terminated by Sponsor|0|||
164147416|NCT05168202|592902029|FG005|Overall Study|Study Terminated by Sponsor|0|||
164147417|NCT05168202|592902030|FG006|Overall Study|Study Terminated by Sponsor|0|||
164147418|NCT04011722|592902034|FG000|30 Days|Death|5|||
164147419|NCT04011722|592902035|FG001|30 Days|Death|1|||
164147420|NCT04011722|592902034|FG000|1 Year|Death|13|||
164147421|NCT04011722|592902035|FG001|1 Year|Death|5|||
164147422|NCT04011722|592902034|FG000|1 Year|Withdrawal by Subject|8|||
164147423|NCT04011722|592902035|FG001|1 Year|Withdrawal by Subject|2|||
164147424|NCT04011722|592902034|FG000|1 Year|Missed Visit|6|||
164147425|NCT04011722|592902035|FG001|1 Year|Missed Visit|1|||
164147426|NCT04011722|592902034|FG000|1 Year|Pending Visit|0|||
164147427|NCT04011722|592902035|FG001|1 Year|Pending Visit|11|||
164147428|NCT04011722|592902034|FG000|1 Year|Not Yet Due|0|||
164147429|NCT04011722|592902035|FG001|1 Year|Not Yet Due|9|||
164147430|NCT04011722|592902034|FG000|2 Year|Death|16|||
164147431|NCT04011722|592902035|FG001|2 Year|Death|1|||
164147432|NCT04011722|592902034|FG000|2 Year|Withdrawal by Subject|10|||
164147433|NCT04011722|592902035|FG001|2 Year|Withdrawal by Subject|1|||
164147434|NCT04011722|592902034|FG000|2 Year|Missed Visit|9|||
164147435|NCT04011722|592902035|FG001|2 Year|Missed Visit|0|||
164147436|NCT04011722|592902034|FG000|2 Year|Visit Pending|1|||
164147437|NCT04011722|592902035|FG001|2 Year|Visit Pending|3|||
164147438|NCT04011722|592902034|FG000|2 Year|Not Yet Due|43|||
164147439|NCT04011722|592902035|FG001|2 Year|Not Yet Due|54|||
164147440|NCT04011722|592902034|FG000|3 Year|Death|10|||
164147441|NCT04011722|592902035|FG001|3 Year|Death|0|||
164147442|NCT04011722|592902034|FG000|3 Year|Withdrawal by Subject|2|||
164147443|NCT04011722|592902035|FG001|3 Year|Withdrawal by Subject|0|||
164147444|NCT04011722|592902034|FG000|3 Year|Missed Visit|2|||
164147445|NCT04011722|592902035|FG001|3 Year|Missed Visit|0|||
164147446|NCT04011722|592902034|FG000|3 Year|Pending Visit|34|||
164147447|NCT04011722|592902035|FG001|3 Year|Pending Visit|0|||
164147448|NCT04011722|592902034|FG000|3 Year|Not Yet Due|99|||
164147449|NCT04011722|592902035|FG001|3 Year|Not Yet Due|0|||
164147450|NCT05626231|592902038|FG000|Provider Enrollment|Worked part-time|4|||
164147451|NCT05626231|592902038|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
164147452|NCT05626231|592902038|FG000|Provider Enrollment|Non-clinical employee|1|||
164147453|NCT05626231|592902038|FG000|Provider Enrollment|Provider does not see clients|3|||
164147454|NCT05626231|592902038|FG000|Provider Enrollment|Other|5|||
164147455|NCT06195930|592902039|FG000|Overall Study|Adverse Event|4|||
164147456|NCT00233948|592902048|FG000|Overall Study|Adverse Event|1|||
164147457|NCT00233948|592902049|FG001|Overall Study|Adverse Event|0|||
164147458|NCT00233948|592902050|FG002|Overall Study|Adverse Event|0|||
164147459|NCT00233948|592902051|FG003|Overall Study|Adverse Event|0|||
164147460|NCT00233948|592902052|FG004|Overall Study|Adverse Event|0|||
164147461|NCT00233948|592902053|FG005|Overall Study|Adverse Event|0|||
164147462|NCT01567462|592902054|FG000|Overall Study|Withdrawal by Subject|4|||
164147463|NCT01567462|592902055|FG001|Overall Study|Withdrawal by Subject|7|||
164147464|NCT02548156|592902056|FG000|Washout Period 1|Lost to Follow-up|0|||
164147465|NCT02548156|592902057|FG001|Washout Period 1|Lost to Follow-up|0|||
164147466|NCT02548156|592902058|FG002|Washout Period 1|Lost to Follow-up|0|||
164147467|NCT02548156|592902059|FG003|Washout Period 1|Lost to Follow-up|0|||
164147468|NCT02548156|592902060|FG004|Washout Period 1|Lost to Follow-up|1|||
164147469|NCT02548156|592902061|FG005|Washout Period 1|Lost to Follow-up|0|||
164147470|NCT00444587|592902068|FG000|Overall Study|Death|2|||
164147471|NCT00444587|592902069|FG001|Overall Study|Death|1|||
164147472|NCT00444587|592902068|FG000|Overall Study|Progression of the disease|73|||
164147473|NCT00444587|592902069|FG001|Overall Study|Progression of the disease|8|||
164147474|NCT00444587|592902068|FG000|Overall Study|Refused treatment/did not cooperate|4|||
164147475|NCT00444587|592902069|FG001|Overall Study|Refused treatment/did not cooperate|1|||
164147476|NCT00444587|592902068|FG000|Overall Study|Investigator decision|3|||
164147477|NCT00444587|592902069|FG001|Overall Study|Investigator decision|0|||
164147478|NCT00444587|592902068|FG000|Overall Study|Protocol Violation|1|||
164147479|NCT00444587|592902069|FG001|Overall Study|Protocol Violation|0|||
164147480|NCT00444587|592902068|FG000|Overall Study|Missing|0|||
164147481|NCT00444587|592902069|FG001|Overall Study|Missing|5|||
164147482|NCT00196326|592902070|FG000|Overall Study|Did not meet protocol requirements|64|||
164147483|NCT00196326|592902070|FG000|Overall Study|Non-compliance with the protocol|81|||
164147484|NCT00196326|592902070|FG000|Overall Study|Physician Decision|3|||
164147485|NCT00196326|592902070|FG000|Overall Study|Withdrawal by Subject|225|||
164147486|NCT00196326|592902070|FG000|Overall Study|Adverse Event|253|||
164147487|NCT00196326|592902070|FG000|Overall Study|Pregnancy|34|||
164147488|NCT00196326|592902070|FG000|Overall Study|Lost to Follow-up|304|||
164147489|NCT00196326|592902070|FG000|Overall Study|Other|22|||
164147490|NCT01473407|592902073|FG000|Overall Study|Physician Decision|1|||
164147491|NCT01473407|592902074|FG001|Overall Study|Physician Decision|4|||
164147492|NCT01473407|592902073|FG000|Overall Study|Lost to Follow-up|10|||
164147493|NCT01473407|592902074|FG001|Overall Study|Lost to Follow-up|4|||
164147494|NCT01473407|592902073|FG000|Overall Study|Adverse Event|8|||
164147495|NCT01473407|592902074|FG001|Overall Study|Adverse Event|8|||
164147496|NCT01473407|592902073|FG000|Overall Study|Randomization Error|3|||
164147497|NCT01473407|592902074|FG001|Overall Study|Randomization Error|1|||
164147498|NCT01473407|592902073|FG000|Overall Study|Withdrawal by Subject|4|||
164147499|NCT01473407|592902074|FG001|Overall Study|Withdrawal by Subject|7|||
164147500|NCT01473407|592902073|FG000|Overall Study|Kidney Transplant|7|||
164147501|NCT01473407|592902074|FG001|Overall Study|Kidney Transplant|6|||
164147502|NCT01473407|592902073|FG000|Overall Study|Vacation/Travel|1|||
164147503|NCT01473407|592902074|FG001|Overall Study|Vacation/Travel|1|||
164147504|NCT01473407|592902073|FG000|Overall Study|Elevated Hemoglobin|1|||
164147505|NCT01473407|592902074|FG001|Overall Study|Elevated Hemoglobin|0|||
164147506|NCT01473407|592902073|FG000|Overall Study|Patient Received Aranesp|1|||
164147507|NCT01473407|592902074|FG001|Overall Study|Patient Received Aranesp|0|||
164147508|NCT01473407|592902073|FG000|Overall Study|Patient Lost Green Card Status|1|||
164147509|NCT01473407|592902074|FG001|Overall Study|Patient Lost Green Card Status|0|||
164147510|NCT01473407|592902073|FG000|Overall Study|Temperature Excursion|2|||
164147511|NCT01473407|592902074|FG001|Overall Study|Temperature Excursion|3|||
164147512|NCT01473407|592902073|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
164147513|NCT01473407|592902074|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
164147514|NCT01473407|592902073|FG000|Overall Study|Sponsor's Decision|10|||
164147515|NCT01473407|592902074|FG001|Overall Study|Sponsor's Decision|10|||
164147516|NCT01473407|592902073|FG000|Overall Study|Site Closure|1|||
164147517|NCT01473407|592902074|FG001|Overall Study|Site Closure|0|||
164147518|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
164147519|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
164147520|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
164147521|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
164147522|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
164147523|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
164147524|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
164147525|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
164147526|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
164147527|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
164147528|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
164147529|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
164147530|NCT02422797|592902075|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
164147531|NCT02422797|592902076|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
164147532|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
164147533|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
164147534|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
164147535|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
164147536|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
164147537|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
164147538|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
164147539|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
164147540|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
164147541|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
164147542|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
164147543|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
164147544|NCT02422797|592902075|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
164147545|NCT02422797|592902076|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
164147546|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
164147547|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
164147548|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
164147549|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
164147550|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
164147551|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
164147552|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
164147553|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
164147554|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
164147555|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
164147556|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
164147557|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
164147558|NCT02422797|592902075|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
164147559|NCT02422797|592902076|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
164147560|NCT05223920|592902077|FG000|Overall Study|Adverse Event|6|||
164147561|NCT05223920|592902078|FG001|Overall Study|Adverse Event|3|||
164147562|NCT05223920|592902077|FG000|Overall Study|Death|2|||
164147563|NCT05223920|592902078|FG001|Overall Study|Death|0|||
164147564|NCT05223920|592902077|FG000|Overall Study|Disease Progression|1|||
164147565|NCT05223920|592902078|FG001|Overall Study|Disease Progression|2|||
164147566|NCT05223920|592902077|FG000|Overall Study|Physician Decision|1|||
164147567|NCT05223920|592902078|FG001|Overall Study|Physician Decision|2|||
164147568|NCT05223920|592902077|FG000|Overall Study|Sponsor decision|11|||
164147569|NCT05223920|592902078|FG001|Overall Study|Sponsor decision|9|||
164147570|NCT05223920|592902077|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
164147571|NCT05223920|592902078|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
164147572|NCT05223920|592902077|FG000|Overall Study|Subject decision|1|||
164147573|NCT05223920|592902078|FG001|Overall Study|Subject decision|0|||
164147574|NCT05223920|592902077|FG000|Overall Study|Withdrawal by Subject|1|||
164147575|NCT05223920|592902078|FG001|Overall Study|Withdrawal by Subject|6|||
164147576|NCT04071405|592902079|FG000|Overall Study|Protocol Violation|3|||
164147577|NCT00369941|592902082|FG000|Overall Study|Never Treated|1|||
164147578|NCT00369941|592902083|FG001|Overall Study|Never Treated|2|||
164147579|NCT00369941|592902082|FG000|Overall Study|Adverse Event|14|||
164147580|NCT00369941|592902083|FG001|Overall Study|Adverse Event|28|||
164147581|NCT00369941|592902082|FG000|Overall Study|Lack of Efficacy|6|||
164147582|NCT00369941|592902083|FG001|Overall Study|Lack of Efficacy|10|||
164147583|NCT00369941|592902082|FG000|Overall Study|Lost to Follow-up|12|||
164147584|NCT00369941|592902083|FG001|Overall Study|Lost to Follow-up|22|||
164147585|NCT00369941|592902082|FG000|Overall Study|Protocol Violation|5|||
164147586|NCT00369941|592902083|FG001|Overall Study|Protocol Violation|3|||
164147587|NCT00369941|592902082|FG000|Overall Study|Withdrawal by Subject|5|||
164147588|NCT00369941|592902083|FG001|Overall Study|Withdrawal by Subject|18|||
164147589|NCT00369941|592902082|FG000|Overall Study|Pregnancy|4|||
164147590|NCT00369941|592902083|FG001|Overall Study|Pregnancy|2|||
164147591|NCT00369941|592902082|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
164147592|NCT00369941|592902083|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
164147593|NCT00369941|592902082|FG000|Overall Study|Moved|11|||
164147594|NCT00369941|592902083|FG001|Overall Study|Moved|5|||
164147595|NCT00369941|592902082|FG000|Overall Study|Treatment with Prohibited Medication|3|||
164147596|NCT00369941|592902083|FG001|Overall Study|Treatment with Prohibited Medication|1|||
164147597|NCT00369941|592902082|FG000|Overall Study|Employment Interfered with Study Visits|1|||
164147598|NCT00369941|592902083|FG001|Overall Study|Employment Interfered with Study Visits|0|||
164147599|NCT00369941|592902082|FG000|Overall Study|Study Site Terminated|2|||
164147600|NCT00369941|592902083|FG001|Overall Study|Study Site Terminated|0|||
164147601|NCT00369941|592902082|FG000|Overall Study|Miscellaneous|3|||
164147602|NCT00369941|592902083|FG001|Overall Study|Miscellaneous|3|||
164147603|NCT03685344|592902084|FG000|Overall Study|Withdrawal by Subject|1|||
164147604|NCT03685344|592902085|FG001|Overall Study|Withdrawal by Subject|1|||
164147605|NCT03685344|592902086|FG002|Overall Study|Withdrawal by Subject|2|||
164147606|NCT03685344|592902087|FG003|Overall Study|Withdrawal by Subject|0|||
164147607|NCT03685344|592902084|FG000|Overall Study|Physician Decision|1|||
164147608|NCT03685344|592902085|FG001|Overall Study|Physician Decision|1|||
164147609|NCT03685344|592902086|FG002|Overall Study|Physician Decision|5|||
164147610|NCT03685344|592902087|FG003|Overall Study|Physician Decision|0|||
164147615|NCT02276807|592902088|FG000|Overall Study|Withdrawal by Subject|8|||
164147616|NCT02276807|592902089|FG001|Overall Study|Withdrawal by Subject|7|||
164147617|NCT02276807|592902088|FG000|Overall Study|Lost to Follow-up|10|||
164147618|NCT02276807|592902089|FG001|Overall Study|Lost to Follow-up|10|||
164147619|NCT00261950|592902090|FG000|Overall Study|Lost to Follow-up|2|||
164147620|NCT00261950|592902090|FG000|Overall Study|Death|6|||
164147621|NCT00261950|592902090|FG000|Overall Study|Withdrawal by Subject|5|||
164147622|NCT00261950|592902090|FG000|Overall Study|Other|1|||
164147623|NCT00261950|592902090|FG000|Overall Study|Physician Decision|1|||
164147624|NCT00261950|592902090|FG000|Overall Study|Protocol specified Criteria|11|||
164147625|NCT03288714|592902091|FG000|Overall Study|Lost to Follow-up|2|||
164147626|NCT03288714|592902092|FG001|Overall Study|Lost to Follow-up|1|||
164147627|NCT03288714|592902091|FG000|Overall Study|Non-compliance with study schedule|2|||
164147628|NCT03288714|592902092|FG001|Overall Study|Non-compliance with study schedule|0|||
164147629|NCT03288714|592902091|FG000|Overall Study|Withdrawal by Subject|3|||
164147630|NCT03288714|592902092|FG001|Overall Study|Withdrawal by Subject|1|||
164147631|NCT03288714|592902091|FG000|Overall Study|Clinical Worsening|2|||
164147632|NCT03288714|592902092|FG001|Overall Study|Clinical Worsening|1|||
164147633|NCT03288714|592902091|FG000|Overall Study|Adverse Event|1|||
164147634|NCT03288714|592902092|FG001|Overall Study|Adverse Event|0|||
164147635|NCT02232984|592902097|FG000|Overall Study|Withdrawal by Subject|5|||
164147636|NCT02232984|592902097|FG000|Overall Study|Death|1|||
164147637|NCT02232984|592902097|FG000|Overall Study|Investigator withdrawal|10|||
164147638|NCT02232984|592902097|FG000|Overall Study|Device implant unsuccessful|53|||
164147639|NCT02232984|592902097|FG000|Overall Study|not disclosed by site|7|||
164147640|NCT02232984|592902097|FG000|Overall Study|Protocol Violation|1|||
164147641|NCT01884337|592902100|FG000|Treatment|Adverse Event|2|||
164147642|NCT01884337|592902101|FG001|Treatment|Adverse Event|2|||
164147643|NCT01884337|592902100|FG000|Treatment|Subj. request to discont. treatment|2|||
164147644|NCT01884337|592902101|FG001|Treatment|Subj. request to discont. treatment|0|||
164147645|NCT01884337|592902100|FG000|Follow-up Period|Lost to Follow-up|1|||
164147646|NCT01884337|592902101|FG001|Follow-up Period|Lost to Follow-up|1|||
164147647|NCT02455518|592902102|FG000|Overall Study|Protocol Violation|0|||
164147648|NCT02455518|592902103|FG001|Overall Study|Protocol Violation|1|||
164147649|NCT02455518|592902104|FG002|Overall Study|Protocol Violation|1|||
164147650|NCT02455518|592902105|FG003|Overall Study|Protocol Violation|3|||
164147651|NCT02508935|592902106|FG000|Overall Study|Withdrawal by Subject|1|||
164147652|NCT02508935|592902106|FG000|Overall Study|Withdrawal by Caregiver|8|||
164147653|NCT02508935|592902106|FG000|Overall Study|Pain Score <4|1|||
164147654|NCT02508935|592902106|FG000|Overall Study|Emesis|3|||
164147655|NCT02508935|592902106|FG000|Overall Study|Adverse Event|3|||
164147656|NCT02508935|592902106|FG000|Overall Study|Protocol Violation|1|||
164147657|NCT02508935|592902106|FG000|Overall Study|Physician Decision|1|||
164147658|NCT02508935|592902106|FG000|Overall Study|Trial terminated by sponsor|5|||
164147659|NCT00535405|592902114|FG000|Overall Study|Adverse Event|6|||
164147660|NCT00535405|592902115|FG001|Overall Study|Adverse Event|8|||
164147661|NCT00535405|592902116|FG002|Overall Study|Adverse Event|3|||
164147662|NCT00535405|592902117|FG003|Overall Study|Adverse Event|8|||
164147663|NCT00535405|592902118|FG004|Overall Study|Adverse Event|6|||
164147664|NCT00535405|592902114|FG000|Overall Study|Lost to Follow-up|1|||
164147665|NCT00535405|592902115|FG001|Overall Study|Lost to Follow-up|3|||
164147666|NCT00535405|592902116|FG002|Overall Study|Lost to Follow-up|3|||
164147667|NCT00535405|592902117|FG003|Overall Study|Lost to Follow-up|2|||
164147668|NCT00535405|592902118|FG004|Overall Study|Lost to Follow-up|1|||
164147669|NCT00535405|592902114|FG000|Overall Study|Physician Decision|3|||
164147670|NCT00535405|592902115|FG001|Overall Study|Physician Decision|2|||
164147671|NCT00535405|592902116|FG002|Overall Study|Physician Decision|0|||
164147672|NCT00535405|592902117|FG003|Overall Study|Physician Decision|1|||
164147673|NCT00535405|592902118|FG004|Overall Study|Physician Decision|1|||
164147674|NCT00535405|592902114|FG000|Overall Study|Protocol Violation|2|||
164147675|NCT00535405|592902115|FG001|Overall Study|Protocol Violation|2|||
164147676|NCT00535405|592902116|FG002|Overall Study|Protocol Violation|2|||
164147677|NCT00535405|592902117|FG003|Overall Study|Protocol Violation|1|||
164147678|NCT00535405|592902118|FG004|Overall Study|Protocol Violation|0|||
164147679|NCT00535405|592902114|FG000|Overall Study|Withdrawal by Subject|5|||
164147680|NCT00535405|592902115|FG001|Overall Study|Withdrawal by Subject|11|||
164147681|NCT00535405|592902116|FG002|Overall Study|Withdrawal by Subject|10|||
164147682|NCT00535405|592902117|FG003|Overall Study|Withdrawal by Subject|10|||
164147683|NCT00535405|592902118|FG004|Overall Study|Withdrawal by Subject|8|||
164147684|NCT01332292|592902121|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164147685|NCT01332292|592902122|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164147686|NCT01332292|592902121|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164147687|NCT01332292|592902122|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
164147688|NCT01332292|592902121|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
164147689|NCT01332292|592902122|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
164147690|NCT03910673|592902124|FG000|Overall Study|Adverse Event|0|||
164147691|NCT03910673|592902125|FG001|Overall Study|Adverse Event|0|||
164147692|NCT03910673|592902126|FG002|Overall Study|Adverse Event|0|||
164147711|NCT02006732|592902129|FG000|Overall Study|Withdrawal by Subject|3|||
164147712|NCT02006732|592902130|FG001|Overall Study|Withdrawal by Subject|0|||
164147713|NCT02006732|592902131|FG002|Overall Study|Withdrawal by Subject|4|||
164147714|NCT02006732|592902132|FG003|Overall Study|Withdrawal by Subject|1|||
164147715|NCT02969044|592902150|FG000|Overall Study|Withdrawal by Subject|2|||
164147716|NCT02969044|592902151|FG001|Overall Study|Withdrawal by Subject|6|||
164147717|NCT02969044|592902150|FG000|Overall Study|Adverse Event|3|||
164147718|NCT02969044|592902151|FG001|Overall Study|Adverse Event|0|||
164147719|NCT04650204|592902152|FG000|Overall Study|Study was Terminated|2|||
164147720|NCT04650204|592902153|FG001|Overall Study|Study was Terminated|1|||
164147721|NCT03164616|592902155|FG000|Overall Study|Death|250|||
164147722|NCT03164616|592902156|FG001|Overall Study|Death|264|||
164147723|NCT03164616|592902157|FG002|Overall Study|Death|279|||
164147724|NCT03164616|592902155|FG000|Overall Study|Lost to Follow-up|2|||
164147725|NCT03164616|592902156|FG001|Overall Study|Lost to Follow-up|2|||
164147726|NCT03164616|592902157|FG002|Overall Study|Lost to Follow-up|2|||
164147727|NCT03164616|592902155|FG000|Overall Study|Withdrawal by Subject|6|||
164147728|NCT03164616|592902156|FG001|Overall Study|Withdrawal by Subject|7|||
164147729|NCT03164616|592902157|FG002|Overall Study|Withdrawal by Subject|16|||
164147730|NCT03548337|592902158|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
164147731|NCT03548337|592902159|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
164147732|NCT03548337|592902158|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
164147733|NCT03548337|592902159|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
164147734|NCT03548337|592902158|FG000|Infant Series|Lost to Follow-up|2|||
164147735|NCT03548337|592902159|FG001|Infant Series|Lost to Follow-up|1|||
164147736|NCT03548337|592902158|FG000|Infant Series|Adverse Event|0|||
164147737|NCT03548337|592902159|FG001|Infant Series|Adverse Event|2|||
164147738|NCT03548337|592902158|FG000|Infant Series|Randomized but Not Vaccinated|1|||
164147739|NCT03548337|592902159|FG001|Infant Series|Randomized but Not Vaccinated|0|||
164147740|NCT03548337|592902158|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
164147741|NCT03548337|592902159|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
164147742|NCT04502212|592902161|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
164147743|NCT04502212|592902161|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
164147744|NCT01911273|592902163|FG000|Overall Study|Progression of Disease|1|||
164147745|NCT01911273|592902164|FG001|Overall Study|Progression of Disease|0|||
164147746|NCT01911273|592902163|FG000|Overall Study|Withdrawal by Subject|0|||
164147747|NCT01911273|592902164|FG001|Overall Study|Withdrawal by Subject|2|||
164147748|NCT02503787|592902169|FG000|Enrollment|Withdrawal by Subject|6|||
164147749|NCT02503787|592902169|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
164147750|NCT02503787|592902169|FG000|Enrollment|Physician Decision|2|||
164147751|NCT02503787|592902169|FG000|Enrollment|Insurance issue|2|||
164147752|NCT02503787|592902169|FG000|Enrollment|Lost to Follow-up|1|||
164147753|NCT02503787|592902169|FG000|Enrollment|Study closure|1|||
164147754|NCT02503787|592902169|FG000|Enrollment|Adverse Event|1|||
164147755|NCT02503787|592902169|FG000|Enrollment|Protocol Violation|1|||
164147756|NCT02503787|592902169|FG000|Enrollment|Inability to implant system|1|||
164147757|NCT02503787|592902169|FG000|Enrollment|Unable to be programmed|1|||
164147758|NCT02503787|592902169|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
164147759|NCT02503787|592902169|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
164147760|NCT02503787|592902169|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
164147761|NCT02503787|592902169|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
164147762|NCT02503787|592902169|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
164147763|NCT02503787|592902169|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
164147764|NCT04787627|592902170|FG000|Overall Study|Withdrawal by Subject|3|||
164147765|NCT04787627|592902171|FG001|Overall Study|Withdrawal by Subject|0|||
164147766|NCT04787627|592902170|FG000|Overall Study|Physician Decision|2|||
164147767|NCT04787627|592902171|FG001|Overall Study|Physician Decision|0|||
164147768|NCT04787627|592902170|FG000|Overall Study|Excluded|0|||
164147769|NCT04787627|592902171|FG001|Overall Study|Excluded|1|||
164147770|NCT00548093|592902172|FG000|Overall Study|Death|33|||
164147771|NCT00548093|592902173|FG001|Overall Study|Death|13|||
164147772|NCT00548093|592902172|FG000|Overall Study|Lost to Follow-up|3|||
164147773|NCT00548093|592902173|FG001|Overall Study|Lost to Follow-up|1|||
164147774|NCT00548093|592902172|FG000|Overall Study|Objective progression or relapse|1|||
164147775|NCT00548093|592902173|FG001|Overall Study|Objective progression or relapse|1|||
164147776|NCT00548093|592902172|FG000|Overall Study|Other|11|||
164147777|NCT00548093|592902173|FG001|Overall Study|Other|1|||
164147778|NCT00548093|592902172|FG000|Overall Study|Withdrawal by Subject|1|||
164147779|NCT00548093|592902173|FG001|Overall Study|Withdrawal by Subject|0|||
164147780|NCT00548093|592902172|FG000|Overall Study|Completed post-treatment follow-up|1|||
164147781|NCT00548093|592902173|FG001|Overall Study|Completed post-treatment follow-up|0|||
164147782|NCT02359994|592902175|FG000|Overall Population Study|Adverse Event|1|||
164147783|NCT02359994|592902176|FG001|Overall Population Study|Adverse Event|1|||
164147784|NCT02359994|592902175|FG000|Overall Population Study|Death|1|||
164147785|NCT02359994|592902176|FG001|Overall Population Study|Death|5|||
164147786|NCT02359994|592902175|FG000|Overall Population Study|Lost to Follow-up|1|||
164147787|NCT02359994|592902176|FG001|Overall Population Study|Lost to Follow-up|1|||
164147788|NCT02359994|592902175|FG000|Overall Population Study|Withdrawal by Subject|1|||
164147789|NCT02359994|592902176|FG001|Overall Population Study|Withdrawal by Subject|0|||
164147790|NCT02359994|592902175|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
164147791|NCT02359994|592902176|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
164147792|NCT02359994|592902175|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
164147793|NCT02359994|592902176|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
164147794|NCT02359994|592902175|FG000|Extended Oncology 24-Month Survival|Death|19|||
164147795|NCT02359994|592902176|FG001|Extended Oncology 24-Month Survival|Death|21|||
164147796|NCT02359994|592902175|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
164147797|NCT02359994|592902176|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
164147798|NCT01320150|592902177|FG000|Overall Study|Protocol Violation|15|||
164147799|NCT01320150|592902177|FG000|Overall Study|Withdrawal by Subject|5|||
164147800|NCT01320150|592902177|FG000|Overall Study|Death|2|||
164147801|NCT01320150|592902177|FG000|Overall Study|Lost to Follow-up|44|||
164147802|NCT00919854|592902178|FG000|Overall Study|Adverse Event|1|||
164147803|NCT00143247|592902184|FG000|Overall Study|Death|8|||
164147804|NCT00143247|592902184|FG000|Overall Study|Adverse Event|19|||
164147805|NCT00143247|592902184|FG000|Overall Study|Lack of Efficacy|3|||
164147806|NCT00143247|592902184|FG000|Overall Study|Withdrawal by Subject|55|||
164147807|NCT00143247|592902184|FG000|Overall Study|Study terminated by sponsor|31|||
164147808|NCT00143247|592902184|FG000|Overall Study|Protocol Violation|15|||
164147809|NCT00143247|592902184|FG000|Overall Study|Lost to Follow-up|12|||
164147810|NCT00143247|592902184|FG000|Overall Study|following inaccurate lab adverse event|1|||
164147811|NCT00143247|592902184|FG000|Overall Study|Other|12|||
164147812|NCT00489827|592902185|FG000|Overall Study|Intraoperative exclusion criteria|1|||
164147813|NCT00489827|592902186|FG001|Overall Study|Intraoperative exclusion criteria|1|||
164147814|NCT00489827|592902185|FG000|Overall Study|Intraoperative exclusion criteria|1|||
164147815|NCT00489827|592902186|FG001|Overall Study|Intraoperative exclusion criteria|1|||
164147816|NCT02766283|592902187|FG000|Overall Study|Lost to Follow-up|27|||
164147817|NCT03086551|592902188|FG000|First Intervention|Failure to meet inclusion criterion|1|||
164147818|NCT03086551|592902189|FG001|First Intervention|Failure to meet inclusion criterion|0|||
164147819|NCT03086551|592902188|FG000|First Intervention|Lost to Follow-up|0|||
164147820|NCT03086551|592902189|FG001|First Intervention|Lost to Follow-up|1|||
164147821|NCT03086551|592902188|FG000|Washout|Lost to Follow-up|1|||
164147822|NCT03086551|592902189|FG001|Washout|Lost to Follow-up|2|||
164147823|NCT03086551|592902188|FG000|Washout|Withdrawal by Subject|2|||
164147824|NCT03086551|592902189|FG001|Washout|Withdrawal by Subject|1|||
164147825|NCT03736031|592902191|FG000|Overall Study|Death|2|||
164147826|NCT03736031|592902192|FG001|Overall Study|Death|4|||
164147827|NCT03736031|592902191|FG000|Overall Study|Lost to Follow-up|21|||
164147828|NCT03736031|592902192|FG001|Overall Study|Lost to Follow-up|2|||
164147829|NCT03736031|592902191|FG000|Overall Study|Withdrawal by Subject|9|||
164147830|NCT03736031|592902192|FG001|Overall Study|Withdrawal by Subject|0|||
164147831|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
164147832|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
164147833|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
164147834|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
164147835|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
164147836|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
164147837|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
164147838|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
164147839|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
164147840|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
164147841|NCT00451178|592902193|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
164147842|NCT00451178|592902194|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
164147843|NCT00451178|592902193|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
164147844|NCT00451178|592902194|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
164147845|NCT00451178|592902193|FG000|Prior to Maintenance Therapy|PD|2|||
164147846|NCT00451178|592902194|FG001|Prior to Maintenance Therapy|PD|0|||
164147847|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
164147848|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
164147849|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
164147850|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
164147851|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
164147852|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
164147853|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
164147854|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
164147855|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
164147856|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
164147857|NCT00451178|592902193|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
164147858|NCT00451178|592902194|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
164147859|NCT00451178|592902193|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
164147860|NCT00451178|592902194|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
164147861|NCT02603146|592904753|FG000|Overall Study|Lost to Follow-up|5|||
164147862|NCT02603146|592904754|FG001|Overall Study|Lost to Follow-up|6|||
164147863|NCT02603146|592904753|FG000|Overall Study|Withdrawal by Subject|8|||
164147864|NCT02603146|592904754|FG001|Overall Study|Withdrawal by Subject|10|||
164147865|NCT02603146|592904753|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
164147866|NCT02603146|592904754|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
164147867|NCT02603146|592904753|FG000|Overall Study|Participant moved|2|||
164147868|NCT02603146|592904754|FG001|Overall Study|Participant moved|0|||
164147869|NCT02603146|592904753|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
164147870|NCT02603146|592904754|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
164147871|NCT03300817|592904763|FG000|Overall Study|Withdrawal by Subject|1|||
164147872|NCT03300817|592904763|FG000|Overall Study|Adverse Event|1|||
164147873|NCT03300817|592904763|FG000|Overall Study|Subject Found to be Ineligible|2|||
164147874|NCT03729596|592904766|FG000|Overall Study|Death|3|||
164147875|NCT03729596|592904767|FG001|Overall Study|Death|5|||
164147876|NCT03729596|592904768|FG002|Overall Study|Death|4|||
164147877|NCT03729596|592904769|FG003|Overall Study|Death|1|||
164147878|NCT03729596|592904770|FG004|Overall Study|Death|0|||
164147879|NCT03729596|592904771|FG005|Overall Study|Death|34|||
164147880|NCT03729596|592904772|FG006|Overall Study|Death|18|||
164147881|NCT03729596|592904773|FG007|Overall Study|Death|14|||
164147882|NCT03729596|592904774|FG008|Overall Study|Death|19|||
164147883|NCT03729596|592904775|FG009|Overall Study|Death|9|||
164147884|NCT03729596|592904766|FG000|Overall Study|Lost to Follow-up|0|||
164147885|NCT03729596|592904767|FG001|Overall Study|Lost to Follow-up|0|||
164147886|NCT03729596|592904768|FG002|Overall Study|Lost to Follow-up|0|||
164147887|NCT03729596|592904769|FG003|Overall Study|Lost to Follow-up|0|||
164147888|NCT03729596|592904770|FG004|Overall Study|Lost to Follow-up|0|||
164147889|NCT03729596|592904771|FG005|Overall Study|Lost to Follow-up|0|||
164147890|NCT03729596|592904772|FG006|Overall Study|Lost to Follow-up|1|||
164147891|NCT03729596|592904773|FG007|Overall Study|Lost to Follow-up|0|||
164147892|NCT03729596|592904774|FG008|Overall Study|Lost to Follow-up|0|||
164147893|NCT03729596|592904775|FG009|Overall Study|Lost to Follow-up|1|||
164147894|NCT03729596|592904766|FG000|Overall Study|protocol amendment|0|||
164147895|NCT03729596|592904767|FG001|Overall Study|protocol amendment|1|||
164147896|NCT03729596|592904768|FG002|Overall Study|protocol amendment|3|||
164147897|NCT03729596|592904769|FG003|Overall Study|protocol amendment|6|||
164147898|NCT03729596|592904770|FG004|Overall Study|protocol amendment|5|||
164147899|NCT03729596|592904771|FG005|Overall Study|protocol amendment|0|||
164147900|NCT03729596|592904772|FG006|Overall Study|protocol amendment|0|||
164147901|NCT03729596|592904773|FG007|Overall Study|protocol amendment|0|||
164147902|NCT03729596|592904774|FG008|Overall Study|protocol amendment|0|||
164147903|NCT03729596|592904775|FG009|Overall Study|protocol amendment|0|||
164147904|NCT03729596|592904766|FG000|Overall Study|Withdrawal by Subject|0|||
164147905|NCT03729596|592904767|FG001|Overall Study|Withdrawal by Subject|0|||
164147906|NCT03729596|592904768|FG002|Overall Study|Withdrawal by Subject|0|||
164147907|NCT03729596|592904769|FG003|Overall Study|Withdrawal by Subject|0|||
164147908|NCT03729596|592904770|FG004|Overall Study|Withdrawal by Subject|0|||
164147909|NCT03729596|592904771|FG005|Overall Study|Withdrawal by Subject|4|||
164147910|NCT03729596|592904772|FG006|Overall Study|Withdrawal by Subject|2|||
164147911|NCT03729596|592904773|FG007|Overall Study|Withdrawal by Subject|3|||
164147912|NCT03729596|592904774|FG008|Overall Study|Withdrawal by Subject|2|||
164147913|NCT03729596|592904775|FG009|Overall Study|Withdrawal by Subject|3|||
164147914|NCT03729596|592904766|FG000|Overall Study|study terminated by sponsor|0|||
164147915|NCT03729596|592904767|FG001|Overall Study|study terminated by sponsor|0|||
164147916|NCT03729596|592904768|FG002|Overall Study|study terminated by sponsor|0|||
164147917|NCT03729596|592904769|FG003|Overall Study|study terminated by sponsor|0|||
164147918|NCT03729596|592904770|FG004|Overall Study|study terminated by sponsor|1|||
164147919|NCT03729596|592904771|FG005|Overall Study|study terminated by sponsor|3|||
164147920|NCT03729596|592904772|FG006|Overall Study|study terminated by sponsor|0|||
164147921|NCT03729596|592904773|FG007|Overall Study|study terminated by sponsor|1|||
164147922|NCT03729596|592904774|FG008|Overall Study|study terminated by sponsor|0|||
164147923|NCT03729596|592904775|FG009|Overall Study|study terminated by sponsor|0|||
164147924|NCT03713593|592904776|FG000|Overall Study|Sponsor Decision|73|||
164147925|NCT03713593|592904777|FG001|Overall Study|Sponsor Decision|41|||
164147926|NCT03713593|592904776|FG000|Overall Study|Lost to Follow-up|2|||
164147927|NCT03713593|592904777|FG001|Overall Study|Lost to Follow-up|1|||
164147928|NCT03713593|592904776|FG000|Overall Study|Death|314|||
164147929|NCT03713593|592904777|FG001|Overall Study|Death|349|||
164147930|NCT03713593|592904776|FG000|Overall Study|Withdrawal by Subject|6|||
164147931|NCT03713593|592904777|FG001|Overall Study|Withdrawal by Subject|8|||
164147932|NCT02789137|592904787|FG000|Overall Study|Dropped out/Died|58|||
164147933|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
164147934|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
164147935|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
164147936|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
164147937|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
164147938|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
164147939|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
164147940|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
164147941|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
164147942|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
164147943|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
164147944|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
164147945|NCT00445432|592904788|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
164147946|NCT00445432|592904789|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
164147947|NCT00445432|592904790|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
164147948|NCT00445432|592904791|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
164147949|NCT00445432|592904788|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
164147950|NCT00445432|592904789|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
164147951|NCT00445432|592904790|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
164147952|NCT00445432|592904791|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
164147953|NCT00445432|592904788|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
164147954|NCT00445432|592904789|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
164147955|NCT00445432|592904790|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
164147956|NCT00445432|592904791|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
164147957|NCT00445432|592904788|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
164147958|NCT00445432|592904789|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
164147959|NCT00445432|592904790|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
164147960|NCT00445432|592904791|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
164147961|NCT00799058|592904798|FG000|Overall Study|Withdrawal by Subject|2|||
164147962|NCT00799058|592904799|FG001|Overall Study|Withdrawal by Subject|2|||
164147963|NCT00799058|592904800|FG002|Overall Study|Withdrawal by Subject|2|||
164147964|NCT00799058|592904798|FG000|Overall Study|Lost to Follow-up|1|||
164147965|NCT00799058|592904799|FG001|Overall Study|Lost to Follow-up|2|||
164147966|NCT00799058|592904800|FG002|Overall Study|Lost to Follow-up|1|||
164147967|NCT00799058|592904798|FG000|Overall Study|Adverse Event|0|||
164147968|NCT00799058|592904799|FG001|Overall Study|Adverse Event|2|||
164147969|NCT00799058|592904800|FG002|Overall Study|Adverse Event|0|||
164147970|NCT00799058|592904798|FG000|Overall Study|Pregnancy|1|||
164147971|NCT00799058|592904799|FG001|Overall Study|Pregnancy|0|||
164147972|NCT00799058|592904800|FG002|Overall Study|Pregnancy|0|||
164147973|NCT00799058|592904798|FG000|Overall Study|Not adherent|3|||
164147974|NCT00799058|592904799|FG001|Overall Study|Not adherent|2|||
164147975|NCT00799058|592904800|FG002|Overall Study|Not adherent|1|||
164147976|NCT00799058|592904798|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
164147977|NCT00799058|592904799|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
164147978|NCT00799058|592904800|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
164147979|NCT00799058|592904798|FG000|Overall Study|IP dispensing error|1|||
164147980|NCT00799058|592904799|FG001|Overall Study|IP dispensing error|0|||
164147981|NCT00799058|592904800|FG002|Overall Study|IP dispensing error|0|||
164147982|NCT00799058|592904798|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
164147983|NCT00799058|592904799|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
164147984|NCT00799058|592904800|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
164147985|NCT00799058|592904798|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
164147986|NCT00799058|592904799|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
164147987|NCT00799058|592904800|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
164147988|NCT00799058|592904798|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
164147989|NCT00799058|592904799|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
164147990|NCT00799058|592904800|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
164147991|NCT00799058|592904798|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
164147992|NCT00799058|592904799|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
164147993|NCT00799058|592904800|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
164147994|NCT02088697|592904807|FG000|Period I|Physician Decision|1|||
164147995|NCT02088697|592904808|FG001|Period I|Physician Decision|4|||
164147996|NCT02088697|592904807|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
164147997|NCT02088697|592904808|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
164147998|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Other|34|||
164147999|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Other|0|||
164148000|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Other|0|||
164148001|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Other|0|||
164148002|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Death|14|||
164148003|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Death|0|||
164148004|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Death|0|||
164148005|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Death|0|||
164148006|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
164148007|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
164148008|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
164148009|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
164148010|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
164148011|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
164148012|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
164148013|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
164148014|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
164148015|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
164148016|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
164148017|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
164148018|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
164148019|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
164148020|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
164148021|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
164148022|NCT01995513|592904809|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
164148023|NCT01995513|592904810|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
164148024|NCT01995513|592904811|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
164148025|NCT01995513|592904812|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
164148026|NCT01995513|592904809|FG000|Period 1: Second Open Label Treatment|Other|0|||
164148027|NCT01995513|592904810|FG001|Period 1: Second Open Label Treatment|Other|2|||
164148028|NCT01995513|592904811|FG002|Period 1: Second Open Label Treatment|Other|0|||
164148029|NCT01995513|592904812|FG003|Period 1: Second Open Label Treatment|Other|0|||
164148030|NCT01995513|592904809|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
164148031|NCT01995513|592904810|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
164148032|NCT01995513|592904811|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
164148033|NCT01995513|592904812|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
164148034|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Death|0|||
164148035|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Death|0|||
164148036|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Death|0|||
164148037|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Death|1|||
164148038|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Other|0|||
164148039|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Other|0|||
164148040|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Other|3|||
164148041|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Other|3|||
164148042|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
164148043|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
164148044|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
164148045|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
164148046|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
164148047|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
164148048|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
164148049|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
164148050|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
164148051|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
164148052|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
164148053|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
164148054|NCT01995513|592904809|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
164148055|NCT01995513|592904810|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
164148056|NCT01995513|592904811|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
164148057|NCT01995513|592904812|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
164148058|NCT01232452|592904813|FG000|Overall Study|Adverse Event|17|||
164148059|NCT01232452|592904814|FG001|Overall Study|Adverse Event|15|||
164148060|NCT01232452|592904813|FG000|Overall Study|Withdrawal by Subject|11|||
164148061|NCT01232452|592904814|FG001|Overall Study|Withdrawal by Subject|8|||
164148062|NCT01232452|592904813|FG000|Overall Study|Physician Decision|8|||
164148063|NCT01232452|592904814|FG001|Overall Study|Physician Decision|12|||
164148064|NCT01232452|592904813|FG000|Overall Study|Protocol entry criterion not met|0|||
164148065|NCT01232452|592904814|FG001|Overall Study|Protocol entry criterion not met|2|||
164148066|NCT01232452|592904813|FG000|Overall Study|Sponsor Decision|3|||
164148067|NCT01232452|592904814|FG001|Overall Study|Sponsor Decision|1|||
164148068|NCT01232452|592904813|FG000|Overall Study|Protocol Violation|0|||
164148069|NCT01232452|592904814|FG001|Overall Study|Protocol Violation|1|||
164148074|NCT00247676|592904819|FG000|Overall Study|Withdrawal by Subject|2|||
164148075|NCT03594071|592904820|FG000|Overall Study|Re-operation|3|||
164148076|NCT03594071|592904820|FG000|Overall Study|Missed visit|2|||
164148077|NCT05219448|592904821|FG000|Overall Study|Lost to Follow-up|9|||
164148078|NCT05219448|592904822|FG001|Overall Study|Lost to Follow-up|0|||
164148079|NCT01750190|592904823|FG000|Overall Study|Adverse Event|47|||
164148080|NCT01750190|592904824|FG001|Overall Study|Adverse Event|19|||
164148081|NCT01750190|592904823|FG000|Overall Study|Death|38|||
164148082|NCT01750190|592904824|FG001|Overall Study|Death|11|||
164148083|NCT01750190|592904823|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
164148084|NCT01750190|592904824|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
164148085|NCT01750190|592904823|FG000|Overall Study|Lost to Follow-up|28|||
164148086|NCT01750190|592904824|FG001|Overall Study|Lost to Follow-up|7|||
164148087|NCT01750190|592904823|FG000|Overall Study|Physician Decision|16|||
164148088|NCT01750190|592904824|FG001|Overall Study|Physician Decision|17|||
164148089|NCT01750190|592904823|FG000|Overall Study|Protocol Violation|6|||
164148090|NCT01750190|592904824|FG001|Overall Study|Protocol Violation|5|||
164148091|NCT01750190|592904823|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
164148092|NCT01750190|592904824|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
164148093|NCT01750190|592904823|FG000|Overall Study|Withdrawal by Subject|83|||
164148094|NCT01750190|592904824|FG001|Overall Study|Withdrawal by Subject|89|||
164148095|NCT01750190|592904823|FG000|Overall Study|Kidney Transplant|8|||
164148096|NCT01750190|592904824|FG001|Overall Study|Kidney Transplant|4|||
164148097|NCT01750190|592904823|FG000|Overall Study|Dialysis|22|||
164148098|NCT01750190|592904824|FG001|Overall Study|Dialysis|8|||
164148099|NCT01750190|592904823|FG000|Overall Study|Other than Specified|13|||
164148100|NCT01750190|592904824|FG001|Overall Study|Other than Specified|4|||
164148101|NCT02287922|592904825|FG000|Overall Study|Adverse Event|1|||
164148102|NCT02287922|592904826|FG001|Overall Study|Adverse Event|1|||
164148103|NCT02287922|592904827|FG002|Overall Study|Adverse Event|3|||
164148104|NCT02287922|592904828|FG003|Overall Study|Adverse Event|4|||
164148105|NCT02287922|592904825|FG000|Overall Study|Withdrawal by Subject|1|||
164148106|NCT02287922|592904826|FG001|Overall Study|Withdrawal by Subject|1|||
164148107|NCT02287922|592904827|FG002|Overall Study|Withdrawal by Subject|1|||
164148108|NCT02287922|592904828|FG003|Overall Study|Withdrawal by Subject|2|||
164148109|NCT02287922|592904825|FG000|Overall Study|Lost to Follow-up|0|||
164148110|NCT02287922|592904826|FG001|Overall Study|Lost to Follow-up|0|||
164148111|NCT02287922|592904827|FG002|Overall Study|Lost to Follow-up|1|||
164148112|NCT02287922|592904828|FG003|Overall Study|Lost to Follow-up|0|||
164148113|NCT02287922|592904825|FG000|Overall Study|Sponsor's decision|0|||
164148114|NCT02287922|592904826|FG001|Overall Study|Sponsor's decision|0|||
164148115|NCT02287922|592904827|FG002|Overall Study|Sponsor's decision|0|||
164148116|NCT02287922|592904828|FG003|Overall Study|Sponsor's decision|1|||
164148117|NCT02287922|592904825|FG000|Overall Study|Other|1|||
164148118|NCT02287922|592904826|FG001|Overall Study|Other|0|||
164148119|NCT02287922|592904827|FG002|Overall Study|Other|2|||
164148120|NCT02287922|592904828|FG003|Overall Study|Other|0|||
164148121|NCT02906670|592904831|FG000|Cohort 1, QW|Radiological Progression|1|||
164148122|NCT02906670|592904832|FG001|Cohort 1, QW|Radiological Progression|0|||
164148123|NCT02906670|592904833|FG002|Cohort 1, QW|Radiological Progression|0|||
164148124|NCT02906670|592904834|FG003|Cohort 1, QW|Radiological Progression|0|||
164148125|NCT02906670|592904835|FG004|Cohort 1, QW|Radiological Progression|0|||
164148126|NCT02906670|592904836|FG005|Cohort 1, QW|Radiological Progression|0|||
164148127|NCT02906670|592904837|FG006|Cohort 1, QW|Radiological Progression|0|||
164148128|NCT02906670|592904838|FG007|Cohort 1, QW|Radiological Progression|0|||
164148129|NCT02906670|592904839|FG008|Cohort 1, QW|Radiological Progression|0|||
164148130|NCT02906670|592904840|FG009|Cohort 1, QW|Radiological Progression|0|||
164148131|NCT02906670|592904831|FG000|Cohort 2, QW|Radiological Progression|0|||
164148132|NCT02906670|592904832|FG001|Cohort 2, QW|Radiological Progression|1|||
164148133|NCT02906670|592904833|FG002|Cohort 2, QW|Radiological Progression|0|||
164148134|NCT02906670|592904834|FG003|Cohort 2, QW|Radiological Progression|0|||
164148135|NCT02906670|592904835|FG004|Cohort 2, QW|Radiological Progression|0|||
164148136|NCT02906670|592904836|FG005|Cohort 2, QW|Radiological Progression|0|||
164148137|NCT02906670|592904837|FG006|Cohort 2, QW|Radiological Progression|0|||
164148138|NCT02906670|592904838|FG007|Cohort 2, QW|Radiological Progression|0|||
164148139|NCT02906670|592904839|FG008|Cohort 2, QW|Radiological Progression|0|||
164148140|NCT02906670|592904840|FG009|Cohort 2, QW|Radiological Progression|0|||
164148141|NCT02906670|592904831|FG000|Cohort 3, QW|Radiological Progression|0|||
164148142|NCT02906670|592904832|FG001|Cohort 3, QW|Radiological Progression|0|||
164148143|NCT02906670|592904833|FG002|Cohort 3, QW|Radiological Progression|2|||
164148144|NCT02906670|592904834|FG003|Cohort 3, QW|Radiological Progression|0|||
164148145|NCT02906670|592904835|FG004|Cohort 3, QW|Radiological Progression|0|||
164148146|NCT02906670|592904836|FG005|Cohort 3, QW|Radiological Progression|0|||
164148147|NCT02906670|592904837|FG006|Cohort 3, QW|Radiological Progression|0|||
164148148|NCT02906670|592904838|FG007|Cohort 3, QW|Radiological Progression|0|||
164148149|NCT02906670|592904839|FG008|Cohort 3, QW|Radiological Progression|0|||
164148150|NCT02906670|592904840|FG009|Cohort 3, QW|Radiological Progression|0|||
164148151|NCT02906670|592904831|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148152|NCT02906670|592904832|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148153|NCT02906670|592904833|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
164148154|NCT02906670|592904834|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148155|NCT02906670|592904835|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148156|NCT02906670|592904836|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148157|NCT02906670|592904837|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148158|NCT02906670|592904838|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148159|NCT02906670|592904839|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148160|NCT02906670|592904840|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
164148161|NCT02906670|592904831|FG000|Cohort 4, Q2W|Radiological Progression|0|||
164148162|NCT02906670|592904832|FG001|Cohort 4, Q2W|Radiological Progression|0|||
164148163|NCT02906670|592904833|FG002|Cohort 4, Q2W|Radiological Progression|0|||
164148164|NCT02906670|592904834|FG003|Cohort 4, Q2W|Radiological Progression|0|||
164148165|NCT02906670|592904835|FG004|Cohort 4, Q2W|Radiological Progression|0|||
164148166|NCT02906670|592904836|FG005|Cohort 4, Q2W|Radiological Progression|1|||
164148167|NCT02906670|592904837|FG006|Cohort 4, Q2W|Radiological Progression|0|||
164148168|NCT02906670|592904838|FG007|Cohort 4, Q2W|Radiological Progression|0|||
164148169|NCT02906670|592904839|FG008|Cohort 4, Q2W|Radiological Progression|0|||
164148170|NCT02906670|592904840|FG009|Cohort 4, Q2W|Radiological Progression|0|||
164148171|NCT02906670|592904831|FG000|Cohort 4, Q2W|Clinical Progression|0|||
164148172|NCT02906670|592904832|FG001|Cohort 4, Q2W|Clinical Progression|0|||
164148173|NCT02906670|592904833|FG002|Cohort 4, Q2W|Clinical Progression|0|||
164148174|NCT02906670|592904834|FG003|Cohort 4, Q2W|Clinical Progression|0|||
164148175|NCT02906670|592904835|FG004|Cohort 4, Q2W|Clinical Progression|0|||
164148176|NCT02906670|592904836|FG005|Cohort 4, Q2W|Clinical Progression|2|||
164148177|NCT02906670|592904837|FG006|Cohort 4, Q2W|Clinical Progression|0|||
164148178|NCT02906670|592904838|FG007|Cohort 4, Q2W|Clinical Progression|0|||
164148179|NCT02906670|592904839|FG008|Cohort 4, Q2W|Clinical Progression|0|||
164148180|NCT02906670|592904840|FG009|Cohort 4, Q2W|Clinical Progression|0|||
164148181|NCT02906670|592904831|FG000|Cohort 5, Q2W|Radiological Progression|0|||
164148182|NCT02906670|592904832|FG001|Cohort 5, Q2W|Radiological Progression|0|||
164148183|NCT02906670|592904833|FG002|Cohort 5, Q2W|Radiological Progression|0|||
164148184|NCT02906670|592904834|FG003|Cohort 5, Q2W|Radiological Progression|0|||
164148185|NCT02906670|592904835|FG004|Cohort 5, Q2W|Radiological Progression|0|||
164148186|NCT02906670|592904836|FG005|Cohort 5, Q2W|Radiological Progression|0|||
164148187|NCT02906670|592904837|FG006|Cohort 5, Q2W|Radiological Progression|4|||
164148188|NCT02906670|592904838|FG007|Cohort 5, Q2W|Radiological Progression|0|||
164148189|NCT02906670|592904839|FG008|Cohort 5, Q2W|Radiological Progression|0|||
164148190|NCT02906670|592904840|FG009|Cohort 5, Q2W|Radiological Progression|0|||
164148191|NCT02906670|592904831|FG000|Cohort 5, Q2W|Clinical Progression|0|||
164148192|NCT02906670|592904832|FG001|Cohort 5, Q2W|Clinical Progression|0|||
164148193|NCT02906670|592904833|FG002|Cohort 5, Q2W|Clinical Progression|0|||
164148194|NCT02906670|592904834|FG003|Cohort 5, Q2W|Clinical Progression|0|||
164148195|NCT02906670|592904835|FG004|Cohort 5, Q2W|Clinical Progression|0|||
164148196|NCT02906670|592904836|FG005|Cohort 5, Q2W|Clinical Progression|0|||
164148197|NCT02906670|592904837|FG006|Cohort 5, Q2W|Clinical Progression|1|||
164148198|NCT02906670|592904838|FG007|Cohort 5, Q2W|Clinical Progression|0|||
164148199|NCT02906670|592904839|FG008|Cohort 5, Q2W|Clinical Progression|0|||
164148200|NCT02906670|592904840|FG009|Cohort 5, Q2W|Clinical Progression|0|||
164148201|NCT02906670|592904831|FG000|Cohort 5, Q2W|Adverse Event|0|||
164148202|NCT02906670|592904832|FG001|Cohort 5, Q2W|Adverse Event|0|||
164148203|NCT02906670|592904833|FG002|Cohort 5, Q2W|Adverse Event|0|||
164148204|NCT02906670|592904834|FG003|Cohort 5, Q2W|Adverse Event|0|||
164148205|NCT02906670|592904835|FG004|Cohort 5, Q2W|Adverse Event|0|||
164148206|NCT02906670|592904836|FG005|Cohort 5, Q2W|Adverse Event|0|||
164148207|NCT02906670|592904837|FG006|Cohort 5, Q2W|Adverse Event|1|||
164148208|NCT02906670|592904838|FG007|Cohort 5, Q2W|Adverse Event|0|||
164148209|NCT02906670|592904839|FG008|Cohort 5, Q2W|Adverse Event|0|||
164148210|NCT02906670|592904840|FG009|Cohort 5, Q2W|Adverse Event|0|||
164148211|NCT02906670|592904831|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148212|NCT02906670|592904832|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148213|NCT02906670|592904833|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148214|NCT02906670|592904834|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148215|NCT02906670|592904835|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148216|NCT02906670|592904836|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148217|NCT02906670|592904837|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
164148218|NCT02906670|592904838|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148219|NCT02906670|592904839|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148220|NCT02906670|592904840|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
164148221|NCT02906670|592904831|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
164148222|NCT02906670|592904832|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
164148223|NCT02906670|592904833|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
164148224|NCT02906670|592904834|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
164148225|NCT02906670|592904835|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
164148226|NCT02906670|592904836|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
164148227|NCT02906670|592904837|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
164148228|NCT02906670|592904838|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
164148229|NCT02906670|592904839|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
164148230|NCT02906670|592904840|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
164148231|NCT02906670|592904831|FG000|Cohort 5P, Q2W|Adverse Event|0|||
164148232|NCT02906670|592904832|FG001|Cohort 5P, Q2W|Adverse Event|0|||
164148233|NCT02906670|592904833|FG002|Cohort 5P, Q2W|Adverse Event|0|||
164148234|NCT02906670|592904834|FG003|Cohort 5P, Q2W|Adverse Event|0|||
164148235|NCT02906670|592904835|FG004|Cohort 5P, Q2W|Adverse Event|0|||
164148236|NCT02906670|592904836|FG005|Cohort 5P, Q2W|Adverse Event|0|||
164148237|NCT02906670|592904837|FG006|Cohort 5P, Q2W|Adverse Event|0|||
164148238|NCT02906670|592904838|FG007|Cohort 5P, Q2W|Adverse Event|1|||
164148239|NCT02906670|592904839|FG008|Cohort 5P, Q2W|Adverse Event|0|||
164148240|NCT02906670|592904840|FG009|Cohort 5P, Q2W|Adverse Event|0|||
164148241|NCT02906670|592904831|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
164148242|NCT02906670|592904832|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
164148243|NCT02906670|592904833|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
164148244|NCT02906670|592904834|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
164148245|NCT02906670|592904835|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
164148246|NCT02906670|592904836|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
164148247|NCT02906670|592904837|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
164148248|NCT02906670|592904838|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
164148249|NCT02906670|592904839|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
164148250|NCT02906670|592904840|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
164148251|NCT02906670|592904831|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
164148252|NCT02906670|592904832|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
164148253|NCT02906670|592904833|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
164148254|NCT02906670|592904834|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
164148255|NCT02906670|592904835|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
164148256|NCT02906670|592904836|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
164148257|NCT02906670|592904837|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
164148258|NCT02906670|592904838|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
164148259|NCT02906670|592904839|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
164148260|NCT02906670|592904840|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
164148261|NCT02906670|592904831|FG000|Cohort 4P, QW|Radiological Progression|0|||
164148262|NCT02906670|592904832|FG001|Cohort 4P, QW|Radiological Progression|0|||
164148263|NCT02906670|592904833|FG002|Cohort 4P, QW|Radiological Progression|0|||
164148264|NCT02906670|592904834|FG003|Cohort 4P, QW|Radiological Progression|3|||
164148265|NCT02906670|592904835|FG004|Cohort 4P, QW|Radiological Progression|0|||
164148266|NCT02906670|592904836|FG005|Cohort 4P, QW|Radiological Progression|0|||
164148267|NCT02906670|592904837|FG006|Cohort 4P, QW|Radiological Progression|0|||
164148268|NCT02906670|592904838|FG007|Cohort 4P, QW|Radiological Progression|0|||
164148269|NCT02906670|592904839|FG008|Cohort 4P, QW|Radiological Progression|0|||
164148270|NCT02906670|592904840|FG009|Cohort 4P, QW|Radiological Progression|0|||
164148271|NCT02906670|592904831|FG000|Cohort 7P, Q2W|Adverse Event|0|||
164148272|NCT02906670|592904832|FG001|Cohort 7P, Q2W|Adverse Event|0|||
164148273|NCT02906670|592904833|FG002|Cohort 7P, Q2W|Adverse Event|0|||
164148274|NCT02906670|592904834|FG003|Cohort 7P, Q2W|Adverse Event|0|||
164148275|NCT02906670|592904835|FG004|Cohort 7P, Q2W|Adverse Event|0|||
164148276|NCT02906670|592904836|FG005|Cohort 7P, Q2W|Adverse Event|0|||
164148277|NCT02906670|592904837|FG006|Cohort 7P, Q2W|Adverse Event|0|||
164148278|NCT02906670|592904838|FG007|Cohort 7P, Q2W|Adverse Event|0|||
164148279|NCT02906670|592904839|FG008|Cohort 7P, Q2W|Adverse Event|0|||
164148280|NCT02906670|592904840|FG009|Cohort 7P, Q2W|Adverse Event|1|||
164148281|NCT02906670|592904831|FG000|Cohort 7P, Q2W|Physician Decision|0|||
164148282|NCT02906670|592904832|FG001|Cohort 7P, Q2W|Physician Decision|0|||
164148283|NCT02906670|592904833|FG002|Cohort 7P, Q2W|Physician Decision|0|||
164148284|NCT02906670|592904834|FG003|Cohort 7P, Q2W|Physician Decision|0|||
164148285|NCT02906670|592904835|FG004|Cohort 7P, Q2W|Physician Decision|0|||
164148286|NCT02906670|592904836|FG005|Cohort 7P, Q2W|Physician Decision|0|||
164148287|NCT02906670|592904837|FG006|Cohort 7P, Q2W|Physician Decision|0|||
164148288|NCT02906670|592904838|FG007|Cohort 7P, Q2W|Physician Decision|0|||
164148289|NCT02906670|592904839|FG008|Cohort 7P, Q2W|Physician Decision|0|||
164148290|NCT02906670|592904840|FG009|Cohort 7P, Q2W|Physician Decision|1|||
164148291|NCT02906670|592904831|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148292|NCT02906670|592904832|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148293|NCT02906670|592904833|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148294|NCT02906670|592904834|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148295|NCT02906670|592904835|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148296|NCT02906670|592904836|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148297|NCT02906670|592904837|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148298|NCT02906670|592904838|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148299|NCT02906670|592904839|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
164148300|NCT02906670|592904840|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
164148301|NCT02906670|592904831|FG000|Cohort 5P, QW|Radiological Progression|0|||
164148302|NCT02906670|592904832|FG001|Cohort 5P, QW|Radiological Progression|0|||
164148303|NCT02906670|592904833|FG002|Cohort 5P, QW|Radiological Progression|0|||
164148304|NCT02906670|592904834|FG003|Cohort 5P, QW|Radiological Progression|0|||
164148305|NCT02906670|592904835|FG004|Cohort 5P, QW|Radiological Progression|3|||
164148306|NCT02906670|592904836|FG005|Cohort 5P, QW|Radiological Progression|0|||
164148307|NCT02906670|592904837|FG006|Cohort 5P, QW|Radiological Progression|0|||
164148308|NCT02906670|592904838|FG007|Cohort 5P, QW|Radiological Progression|0|||
164148309|NCT02906670|592904839|FG008|Cohort 5P, QW|Radiological Progression|0|||
164148310|NCT02906670|592904840|FG009|Cohort 5P, QW|Radiological Progression|0|||
164148311|NCT00958828|592904841|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
164148312|NCT00958828|592904842|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
164148313|NCT00958828|592904841|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
164148314|NCT00958828|592904842|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
164148315|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
164148316|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
164148317|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
164148318|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
164148319|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
164148320|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
164148321|NCT02673775|592904855|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
164148322|NCT02673775|592904856|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
164148323|NCT03762239|592904857|FG000|Overall Study|Appointment to the doctor|1|||
164148324|NCT03762239|592904858|FG001|Overall Study|Appointment to the doctor|1|||
164148325|NCT02016183|592904859|FG000|Overall Study|Case Report Forms Uncollected|13|||
164148326|NCT02016183|592904859|FG000|Overall Study|Protocol Violation|52|||
164148327|NCT00770328|592904860|FG000|Overall Study|Adverse Event|11|||
164148328|NCT00770328|592904861|FG001|Overall Study|Adverse Event|2|||
164148329|NCT00770328|592904860|FG000|Overall Study|Lost to Follow-up|2|||
164148330|NCT00770328|592904861|FG001|Overall Study|Lost to Follow-up|2|||
164148331|NCT02286843|592904864|FG000|Overall Study|Not Treated|4|||
164148332|NCT02286843|592904864|FG000|Overall Study|Protocol Violation|1|||
164148333|NCT02286843|592904864|FG000|Overall Study|Withdrawal by Subject|1|||
164148334|NCT02536846|592904865|FG000|Overall Study|Withdrawal by Subject|1|||
164148335|NCT04388553|592904866|FG000|Overall Study|Protocol Violation|1|||
164148336|NCT04388553|592904867|FG001|Overall Study|Protocol Violation|0|||
164148337|NCT04604795|592904868|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
164148338|NCT04604795|592904869|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
164148339|NCT04604795|592904870|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148340|NCT04604795|592904871|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148341|NCT04604795|592904872|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148342|NCT04604795|592904873|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148343|NCT04604795|592904874|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148344|NCT04604795|592904875|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148345|NCT04604795|592904876|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148346|NCT04604795|592904877|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
164148347|NCT04604795|592904868|FG000|Part B: Up to Day 14|Adverse Event|0|||
164148348|NCT04604795|592904869|FG001|Part B: Up to Day 14|Adverse Event|0|||
164148349|NCT04604795|592904870|FG002|Part B: Up to Day 14|Adverse Event|0|||
164148350|NCT04604795|592904871|FG003|Part B: Up to Day 14|Adverse Event|0|||
164148351|NCT04604795|592904872|FG004|Part B: Up to Day 14|Adverse Event|2|||
164148352|NCT04604795|592904873|FG005|Part B: Up to Day 14|Adverse Event|1|||
164148353|NCT04604795|592904874|FG006|Part B: Up to Day 14|Adverse Event|0|||
164148354|NCT04604795|592904875|FG007|Part B: Up to Day 14|Adverse Event|0|||
164148355|NCT04604795|592904876|FG008|Part B: Up to Day 14|Adverse Event|0|||
164148356|NCT04604795|592904877|FG009|Part B: Up to Day 14|Adverse Event|0|||
164148357|NCT04604795|592904868|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148358|NCT04604795|592904869|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148359|NCT04604795|592904870|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148360|NCT04604795|592904871|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148361|NCT04604795|592904872|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148362|NCT04604795|592904873|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148363|NCT04604795|592904874|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148364|NCT04604795|592904875|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148365|NCT04604795|592904876|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
164148366|NCT04604795|592904877|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
164148367|NCT04604795|592904868|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148368|NCT04604795|592904869|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148369|NCT04604795|592904870|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148370|NCT04604795|592904871|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148371|NCT04604795|592904872|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148372|NCT04604795|592904873|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148373|NCT04604795|592904874|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148374|NCT04604795|592904875|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148375|NCT04604795|592904876|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
164148376|NCT04604795|592904877|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
164148377|NCT04604795|592904868|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148378|NCT04604795|592904869|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148379|NCT04604795|592904870|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148380|NCT04604795|592904871|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148381|NCT04604795|592904872|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148382|NCT04604795|592904873|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148383|NCT04604795|592904874|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148384|NCT04604795|592904875|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148385|NCT04604795|592904876|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
164148386|NCT04604795|592904877|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
164148387|NCT04604795|592904868|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148388|NCT04604795|592904869|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148389|NCT04604795|592904870|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148390|NCT04604795|592904871|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148391|NCT04604795|592904872|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148392|NCT04604795|592904873|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148393|NCT04604795|592904874|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148394|NCT04604795|592904875|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148395|NCT04604795|592904876|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
164148396|NCT04604795|592904877|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
164148397|NCT00174954|592904882|FG000|Overall Study|Adverse Event|2|||
164148398|NCT00174954|592904882|FG000|Overall Study|No tophi found in MRI|1|||
164148399|NCT00174954|592904882|FG000|Overall Study|Physician Decision|1|||
164148400|NCT00839254|592904883|FG000|Overall Study|Protocol Violation|0|||
164148401|NCT00839254|592904884|FG001|Overall Study|Protocol Violation|1|||
164148402|NCT00839254|592904885|FG002|Overall Study|Protocol Violation|1|||
164148403|NCT00839254|592904886|FG003|Overall Study|Protocol Violation|1|||
164148404|NCT00839254|592904887|FG004|Overall Study|Protocol Violation|0|||
164148405|NCT00839254|592904888|FG005|Overall Study|Protocol Violation|0|||
164148406|NCT00839254|592904889|FG006|Overall Study|Protocol Violation|1|||
164148407|NCT00839254|592904890|FG007|Overall Study|Protocol Violation|2|||
164148408|NCT00839254|592904883|FG000|Overall Study|Physician Decision|0|||
164148409|NCT00839254|592904884|FG001|Overall Study|Physician Decision|1|||
164148410|NCT00839254|592904885|FG002|Overall Study|Physician Decision|0|||
164148411|NCT00839254|592904886|FG003|Overall Study|Physician Decision|0|||
164148412|NCT00839254|592904887|FG004|Overall Study|Physician Decision|0|||
164148413|NCT00839254|592904888|FG005|Overall Study|Physician Decision|0|||
164148414|NCT00839254|592904889|FG006|Overall Study|Physician Decision|0|||
164148415|NCT00839254|592904890|FG007|Overall Study|Physician Decision|1|||
164148416|NCT00839254|592904883|FG000|Overall Study|Wrong treatment number allocation|0|||
164148417|NCT00839254|592904884|FG001|Overall Study|Wrong treatment number allocation|1|||
164148418|NCT00839254|592904885|FG002|Overall Study|Wrong treatment number allocation|0|||
164148419|NCT00839254|592904886|FG003|Overall Study|Wrong treatment number allocation|0|||
164148420|NCT00839254|592904887|FG004|Overall Study|Wrong treatment number allocation|0|||
164148421|NCT00839254|592904888|FG005|Overall Study|Wrong treatment number allocation|1|||
164148422|NCT00839254|592904889|FG006|Overall Study|Wrong treatment number allocation|0|||
164148423|NCT00839254|592904890|FG007|Overall Study|Wrong treatment number allocation|0|||
164148424|NCT00839254|592904883|FG000|Overall Study|Adverse Event|12|||
164148425|NCT00839254|592904884|FG001|Overall Study|Adverse Event|6|||
164148426|NCT00839254|592904885|FG002|Overall Study|Adverse Event|3|||
164148427|NCT00839254|592904886|FG003|Overall Study|Adverse Event|5|||
164148428|NCT00839254|592904887|FG004|Overall Study|Adverse Event|2|||
164148429|NCT00839254|592904888|FG005|Overall Study|Adverse Event|1|||
164148430|NCT00839254|592904889|FG006|Overall Study|Adverse Event|0|||
164148431|NCT00839254|592904890|FG007|Overall Study|Adverse Event|1|||
164148432|NCT00839254|592904883|FG000|Overall Study|Withdrawal by Subject|87|||
164148433|NCT00839254|592904884|FG001|Overall Study|Withdrawal by Subject|53|||
164148434|NCT00839254|592904885|FG002|Overall Study|Withdrawal by Subject|54|||
164148435|NCT00839254|592904886|FG003|Overall Study|Withdrawal by Subject|32|||
164148436|NCT00839254|592904887|FG004|Overall Study|Withdrawal by Subject|27|||
164148437|NCT00839254|592904888|FG005|Overall Study|Withdrawal by Subject|15|||
164148438|NCT00839254|592904889|FG006|Overall Study|Withdrawal by Subject|22|||
164148439|NCT00839254|592904890|FG007|Overall Study|Withdrawal by Subject|9|||
164148440|NCT00839254|592904883|FG000|Overall Study|Wrong group allocation|0|||
164148441|NCT00839254|592904884|FG001|Overall Study|Wrong group allocation|0|||
164148442|NCT00839254|592904885|FG002|Overall Study|Wrong group allocation|0|||
164148443|NCT00839254|592904886|FG003|Overall Study|Wrong group allocation|0|||
164148444|NCT00839254|592904887|FG004|Overall Study|Wrong group allocation|0|||
164148445|NCT00839254|592904888|FG005|Overall Study|Wrong group allocation|0|||
164148446|NCT00839254|592904889|FG006|Overall Study|Wrong group allocation|1|||
164148447|NCT00839254|592904890|FG007|Overall Study|Wrong group allocation|0|||
164148448|NCT00839254|592904883|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
164148449|NCT00839254|592904884|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148450|NCT00839254|592904885|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148451|NCT00839254|592904886|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148452|NCT00839254|592904887|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148453|NCT00839254|592904888|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
164148454|NCT00839254|592904889|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148455|NCT00839254|592904890|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
164148456|NCT00839254|592904883|FG000|Overall Study|Withdrawn due to non-compliance|2|||
164148457|NCT00839254|592904884|FG001|Overall Study|Withdrawn due to non-compliance|0|||
164148458|NCT00839254|592904885|FG002|Overall Study|Withdrawn due to non-compliance|0|||
164148459|NCT00839254|592904886|FG003|Overall Study|Withdrawn due to non-compliance|0|||
164148460|NCT00839254|592904887|FG004|Overall Study|Withdrawn due to non-compliance|0|||
164148461|NCT00839254|592904888|FG005|Overall Study|Withdrawn due to non-compliance|0|||
164148462|NCT00839254|592904889|FG006|Overall Study|Withdrawn due to non-compliance|0|||
164148463|NCT00839254|592904890|FG007|Overall Study|Withdrawn due to non-compliance|0|||
164148464|NCT00839254|592904883|FG000|Overall Study|Lost to Follow-up|51|||
164148465|NCT00839254|592904884|FG001|Overall Study|Lost to Follow-up|30|||
164148466|NCT00839254|592904885|FG002|Overall Study|Lost to Follow-up|32|||
164148467|NCT00839254|592904886|FG003|Overall Study|Lost to Follow-up|24|||
164148468|NCT00839254|592904887|FG004|Overall Study|Lost to Follow-up|8|||
164148469|NCT00839254|592904888|FG005|Overall Study|Lost to Follow-up|8|||
164148470|NCT00839254|592904889|FG006|Overall Study|Lost to Follow-up|4|||
164148471|NCT00839254|592904890|FG007|Overall Study|Lost to Follow-up|2|||
164148472|NCT04597632|592904891|FG000|Overall Study|Withdrawal by Subject|10|||
164148473|NCT04597632|592904891|FG000|Overall Study|Lost to Follow-up|1|||
164148474|NCT04597632|592904891|FG000|Overall Study|Death|1|||
164148475|NCT04597632|592904891|FG000|Overall Study|Adverse Event|5|||
164148476|NCT01823835|592904892|FG000|Overall Study|Adverse Event|0|||
164148477|NCT01823835|592904893|FG001|Overall Study|Adverse Event|0|||
164148478|NCT01823835|592904894|FG002|Overall Study|Adverse Event|0|||
164148479|NCT01823835|592904895|FG003|Overall Study|Adverse Event|0|||
164148480|NCT01823835|592904896|FG004|Overall Study|Adverse Event|1|||
164148481|NCT01823835|592904897|FG005|Overall Study|Adverse Event|0|||
164148482|NCT01823835|592904898|FG006|Overall Study|Adverse Event|1|||
164148483|NCT01823835|592904899|FG007|Overall Study|Adverse Event|0|||
164148484|NCT01823835|592904900|FG008|Overall Study|Adverse Event|0|||
164148485|NCT01823835|592904901|FG009|Overall Study|Adverse Event|0|||
164148486|NCT01823835|592904902|FG010|Overall Study|Adverse Event|1|||
164148487|NCT01823835|592904903|FG011|Overall Study|Adverse Event|2|||
164148488|NCT01823835|592904904|FG012|Overall Study|Adverse Event|0|||
164148489|NCT01823835|592904905|FG013|Overall Study|Adverse Event|0|||
164148490|NCT01823835|592904906|FG014|Overall Study|Adverse Event|0|||
164148491|NCT01823835|592904892|FG000|Overall Study|Physician Decision|0|||
164148492|NCT01823835|592904893|FG001|Overall Study|Physician Decision|0|||
164148493|NCT01823835|592904894|FG002|Overall Study|Physician Decision|0|||
164148494|NCT01823835|592904895|FG003|Overall Study|Physician Decision|0|||
164148495|NCT01823835|592904896|FG004|Overall Study|Physician Decision|0|||
164148496|NCT01823835|592904897|FG005|Overall Study|Physician Decision|0|||
164148497|NCT01823835|592904898|FG006|Overall Study|Physician Decision|0|||
164148498|NCT01823835|592904899|FG007|Overall Study|Physician Decision|0|||
164148499|NCT01823835|592904900|FG008|Overall Study|Physician Decision|0|||
164148500|NCT01823835|592904901|FG009|Overall Study|Physician Decision|0|||
164148501|NCT01823835|592904902|FG010|Overall Study|Physician Decision|0|||
164148502|NCT01823835|592904903|FG011|Overall Study|Physician Decision|2|||
164148503|NCT01823835|592904904|FG012|Overall Study|Physician Decision|0|||
164148504|NCT01823835|592904905|FG013|Overall Study|Physician Decision|0|||
164148505|NCT01823835|592904906|FG014|Overall Study|Physician Decision|0|||
164148506|NCT01823835|592904892|FG000|Overall Study|Progressive Disease|3|||
164148507|NCT01823835|592904893|FG001|Overall Study|Progressive Disease|4|||
164148508|NCT01823835|592904894|FG002|Overall Study|Progressive Disease|3|||
164148509|NCT01823835|592904895|FG003|Overall Study|Progressive Disease|6|||
164148510|NCT01823835|592904896|FG004|Overall Study|Progressive Disease|4|||
164148511|NCT01823835|592904897|FG005|Overall Study|Progressive Disease|6|||
164148512|NCT01823835|592904898|FG006|Overall Study|Progressive Disease|5|||
164148513|NCT01823835|592904899|FG007|Overall Study|Progressive Disease|3|||
164148514|NCT01823835|592904900|FG008|Overall Study|Progressive Disease|3|||
164148515|NCT01823835|592904901|FG009|Overall Study|Progressive Disease|18|||
164148516|NCT01823835|592904902|FG010|Overall Study|Progressive Disease|8|||
164148517|NCT01823835|592904903|FG011|Overall Study|Progressive Disease|46|||
164148518|NCT01823835|592904904|FG012|Overall Study|Progressive Disease|18|||
164148519|NCT01823835|592904905|FG013|Overall Study|Progressive Disease|4|||
164148520|NCT01823835|592904906|FG014|Overall Study|Progressive Disease|6|||
164148521|NCT01823835|592904892|FG000|Overall Study|Study Termination|0|||
164148522|NCT01823835|592904893|FG001|Overall Study|Study Termination|0|||
164148523|NCT01823835|592904894|FG002|Overall Study|Study Termination|0|||
164148536|NCT01823835|592904892|FG000|Overall Study|Withdrawal by Subject|0|||
164148537|NCT01823835|592904893|FG001|Overall Study|Withdrawal by Subject|0|||
164148538|NCT01823835|592904894|FG002|Overall Study|Withdrawal by Subject|1|||
164148539|NCT01823835|592904895|FG003|Overall Study|Withdrawal by Subject|0|||
164148540|NCT01823835|592904896|FG004|Overall Study|Withdrawal by Subject|0|||
164148541|NCT01823835|592904897|FG005|Overall Study|Withdrawal by Subject|0|||
164148542|NCT01823835|592904898|FG006|Overall Study|Withdrawal by Subject|0|||
164148543|NCT01823835|592904899|FG007|Overall Study|Withdrawal by Subject|0|||
164148544|NCT01823835|592904900|FG008|Overall Study|Withdrawal by Subject|0|||
164148545|NCT01823835|592904901|FG009|Overall Study|Withdrawal by Subject|1|||
164148546|NCT01823835|592904902|FG010|Overall Study|Withdrawal by Subject|1|||
164148547|NCT01823835|592904903|FG011|Overall Study|Withdrawal by Subject|2|||
164148548|NCT01823835|592904904|FG012|Overall Study|Withdrawal by Subject|1|||
164148549|NCT01823835|592904905|FG013|Overall Study|Withdrawal by Subject|0|||
164148550|NCT01823835|592904906|FG014|Overall Study|Withdrawal by Subject|0|||
164148551|NCT00509795|592904907|FG000|Overall Study|Adverse Event|4|||
164148552|NCT00509795|592904908|FG001|Overall Study|Adverse Event|3|||
164148553|NCT00509795|592904909|FG002|Overall Study|Adverse Event|5|||
164148554|NCT00509795|592904910|FG003|Overall Study|Adverse Event|4|||
164148555|NCT00509795|592904907|FG000|Overall Study|Death|3|||
164148556|NCT00509795|592904908|FG001|Overall Study|Death|1|||
164148557|NCT00509795|592904909|FG002|Overall Study|Death|2|||
164148558|NCT00509795|592904910|FG003|Overall Study|Death|7|||
164148559|NCT00509795|592904907|FG000|Overall Study|Lack of Efficacy|0|||
164148560|NCT00509795|592904908|FG001|Overall Study|Lack of Efficacy|0|||
164148561|NCT00509795|592904909|FG002|Overall Study|Lack of Efficacy|2|||
164148562|NCT00509795|592904910|FG003|Overall Study|Lack of Efficacy|2|||
164148563|NCT00509795|592904907|FG000|Overall Study|Lost to Follow-up|1|||
164148564|NCT00509795|592904908|FG001|Overall Study|Lost to Follow-up|2|||
164148565|NCT00509795|592904909|FG002|Overall Study|Lost to Follow-up|4|||
164148566|NCT00509795|592904910|FG003|Overall Study|Lost to Follow-up|4|||
164148567|NCT00509795|592904907|FG000|Overall Study|OTHER|1|||
164148568|NCT00509795|592904908|FG001|Overall Study|OTHER|0|||
164148569|NCT00509795|592904909|FG002|Overall Study|OTHER|4|||
164148570|NCT00509795|592904910|FG003|Overall Study|OTHER|1|||
164148571|NCT00509795|592904907|FG000|Overall Study|Protocol Violation|3|||
164148572|NCT00509795|592904908|FG001|Overall Study|Protocol Violation|0|||
164148573|NCT00509795|592904909|FG002|Overall Study|Protocol Violation|3|||
164148574|NCT00509795|592904910|FG003|Overall Study|Protocol Violation|1|||
164148575|NCT00509795|592904907|FG000|Overall Study|Withdrawal by Subject|10|||
164148576|NCT00509795|592904908|FG001|Overall Study|Withdrawal by Subject|5|||
164148577|NCT00509795|592904909|FG002|Overall Study|Withdrawal by Subject|7|||
164148578|NCT00509795|592904910|FG003|Overall Study|Withdrawal by Subject|8|||
164148579|NCT04895982|592904911|FG000|Overall Study|Withdrawal by Subject|0|||
164148580|NCT04895982|592904912|FG001|Overall Study|Withdrawal by Subject|0|||
164148581|NCT04895982|592904913|FG002|Overall Study|Withdrawal by Subject|0|||
164148582|NCT04895982|592904914|FG003|Overall Study|Withdrawal by Subject|0|||
164148583|NCT04895982|592904915|FG004|Overall Study|Withdrawal by Subject|0|||
164148584|NCT04895982|592904916|FG005|Overall Study|Withdrawal by Subject|1|||
164148585|NCT04895982|592904917|FG006|Overall Study|Withdrawal by Subject|1|||
164148586|NCT04895982|592904918|FG007|Overall Study|Withdrawal by Subject|0|||
164148587|NCT04895982|592904919|FG008|Overall Study|Withdrawal by Subject|0|||
164148588|NCT04895982|592904920|FG009|Overall Study|Withdrawal by Subject|1|||
164148589|NCT04895982|592904921|FG010|Overall Study|Withdrawal by Subject|0|||
164148590|NCT04895982|592904922|FG011|Overall Study|Withdrawal by Subject|1|||
164148591|NCT04895982|592904911|FG000|Overall Study|Withdrawal by parent/guardian|2|||
164148592|NCT04895982|592904912|FG001|Overall Study|Withdrawal by parent/guardian|3|||
164148593|NCT04895982|592904913|FG002|Overall Study|Withdrawal by parent/guardian|3|||
164148594|NCT04895982|592904914|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164148595|NCT04895982|592904915|FG004|Overall Study|Withdrawal by parent/guardian|3|||
164148596|NCT04895982|592904916|FG005|Overall Study|Withdrawal by parent/guardian|2|||
164148597|NCT04895982|592904917|FG006|Overall Study|Withdrawal by parent/guardian|1|||
164148598|NCT04895982|592904918|FG007|Overall Study|Withdrawal by parent/guardian|0|||
164148599|NCT04895982|592904919|FG008|Overall Study|Withdrawal by parent/guardian|3|||
164148600|NCT04895982|592904920|FG009|Overall Study|Withdrawal by parent/guardian|0|||
164148601|NCT04895982|592904921|FG010|Overall Study|Withdrawal by parent/guardian|0|||
164148602|NCT04895982|592904922|FG011|Overall Study|Withdrawal by parent/guardian|0|||
164148603|NCT04895982|592904911|FG000|Overall Study|Other|0|||
164148604|NCT04895982|592904912|FG001|Overall Study|Other|0|||
164148605|NCT04895982|592904913|FG002|Overall Study|Other|1|||
164148606|NCT04895982|592904914|FG003|Overall Study|Other|1|||
164148607|NCT04895982|592904915|FG004|Overall Study|Other|0|||
164148608|NCT04895982|592904916|FG005|Overall Study|Other|0|||
164148609|NCT04895982|592904917|FG006|Overall Study|Other|0|||
164148610|NCT04895982|592904918|FG007|Overall Study|Other|0|||
164148611|NCT04895982|592904919|FG008|Overall Study|Other|0|||
164148612|NCT04895982|592904920|FG009|Overall Study|Other|1|||
164148613|NCT04895982|592904921|FG010|Overall Study|Other|0|||
164148639|NCT04895982|592904911|FG000|Overall Study|Refused further study procedures|0|||
164148640|NCT04895982|592904912|FG001|Overall Study|Refused further study procedures|0|||
164148641|NCT04895982|592904913|FG002|Overall Study|Refused further study procedures|1|||
164148642|NCT04895982|592904914|FG003|Overall Study|Refused further study procedures|0|||
164148643|NCT04895982|592904915|FG004|Overall Study|Refused further study procedures|0|||
164148644|NCT04895982|592904916|FG005|Overall Study|Refused further study procedures|0|||
164148645|NCT04895982|592904917|FG006|Overall Study|Refused further study procedures|0|||
164148646|NCT04895982|592904918|FG007|Overall Study|Refused further study procedures|0|||
164148647|NCT04895982|592904919|FG008|Overall Study|Refused further study procedures|0|||
164148648|NCT04895982|592904920|FG009|Overall Study|Refused further study procedures|0|||
164148649|NCT04895982|592904921|FG010|Overall Study|Refused further study procedures|0|||
164148650|NCT04895982|592904922|FG011|Overall Study|Refused further study procedures|0|||
164148651|NCT02215967|592904932|FG000|Overall Study|Patient became ineligible for treatment|0|||
164148652|NCT02215967|592904933|FG001|Overall Study|Patient became ineligible for treatment|0|||
164148653|NCT02215967|592904934|FG002|Overall Study|Patient became ineligible for treatment|0|||
164148654|NCT02215967|592904935|FG003|Overall Study|Patient became ineligible for treatment|3|||
164148655|NCT02215967|592904932|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
164148656|NCT02215967|592904933|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
164148657|NCT02215967|592904934|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
164148658|NCT02215967|592904935|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
164148659|NCT03207867|592904936|FG000|Overall Study|Adverse Event|1|||
164148660|NCT03207867|592904937|FG001|Overall Study|Adverse Event|0|||
164148661|NCT03207867|592904938|FG002|Overall Study|Adverse Event|1|||
164148662|NCT03207867|592904939|FG003|Overall Study|Adverse Event|0|||
164148663|NCT03207867|592904940|FG004|Overall Study|Adverse Event|0|||
164148664|NCT03207867|592904941|FG005|Overall Study|Adverse Event|2|||
164148665|NCT03207867|592904942|FG006|Overall Study|Adverse Event|1|||
164148666|NCT03207867|592904943|FG007|Overall Study|Adverse Event|1|||
164148667|NCT03207867|592904944|FG008|Overall Study|Adverse Event|2|||
164148668|NCT03207867|592904945|FG009|Overall Study|Adverse Event|2|||
164148669|NCT03207867|592904946|FG010|Overall Study|Adverse Event|0|||
164148670|NCT03207867|592904947|FG011|Overall Study|Adverse Event|0|||
164148671|NCT03207867|592904948|FG012|Overall Study|Adverse Event|0|||
164148672|NCT03207867|592904949|FG013|Overall Study|Adverse Event|0|||
164148673|NCT03207867|592904950|FG014|Overall Study|Adverse Event|0|||
164148674|NCT03207867|592904951|FG015|Overall Study|Adverse Event|0|||
164148675|NCT03207867|592904952|FG016|Overall Study|Adverse Event|3|||
164148676|NCT03207867|592904953|FG017|Overall Study|Adverse Event|1|||
164148677|NCT03207867|592904954|FG018|Overall Study|Adverse Event|2|||
164148678|NCT03207867|592904955|FG019|Overall Study|Adverse Event|1|||
164148679|NCT03207867|592904956|FG020|Overall Study|Adverse Event|0|||
164148680|NCT03207867|592904957|FG021|Overall Study|Adverse Event|0|||
164148681|NCT03207867|592904958|FG022|Overall Study|Adverse Event|0|||
164148682|NCT03207867|592904959|FG023|Overall Study|Adverse Event|0|||
164148683|NCT03207867|592904936|FG000|Overall Study|Death|0|||
164148684|NCT03207867|592904937|FG001|Overall Study|Death|0|||
164148685|NCT03207867|592904938|FG002|Overall Study|Death|0|||
164148686|NCT03207867|592904939|FG003|Overall Study|Death|0|||
164148687|NCT03207867|592904940|FG004|Overall Study|Death|0|||
164148688|NCT03207867|592904941|FG005|Overall Study|Death|1|||
164148689|NCT03207867|592904942|FG006|Overall Study|Death|0|||
164148690|NCT03207867|592904943|FG007|Overall Study|Death|3|||
164148691|NCT03207867|592904944|FG008|Overall Study|Death|1|||
164148692|NCT03207867|592904945|FG009|Overall Study|Death|2|||
164148693|NCT03207867|592904946|FG010|Overall Study|Death|0|||
164148694|NCT03207867|592904947|FG011|Overall Study|Death|1|||
164148695|NCT03207867|592904948|FG012|Overall Study|Death|0|||
164148696|NCT03207867|592904949|FG013|Overall Study|Death|1|||
164148697|NCT03207867|592904950|FG014|Overall Study|Death|0|||
164148698|NCT03207867|592904951|FG015|Overall Study|Death|0|||
164148699|NCT03207867|592904952|FG016|Overall Study|Death|0|||
164148700|NCT03207867|592904953|FG017|Overall Study|Death|2|||
164148701|NCT03207867|592904954|FG018|Overall Study|Death|0|||
164148702|NCT03207867|592904955|FG019|Overall Study|Death|1|||
164148703|NCT03207867|592904956|FG020|Overall Study|Death|0|||
164148704|NCT03207867|592904957|FG021|Overall Study|Death|0|||
164148705|NCT03207867|592904958|FG022|Overall Study|Death|0|||
164148706|NCT03207867|592904959|FG023|Overall Study|Death|0|||
164148707|NCT03207867|592904936|FG000|Overall Study|Physician Decision|3|||
164148708|NCT03207867|592904937|FG001|Overall Study|Physician Decision|5|||
164148709|NCT03207867|592904938|FG002|Overall Study|Physician Decision|0|||
164148710|NCT03207867|592904939|FG003|Overall Study|Physician Decision|3|||
164148711|NCT03207867|592904940|FG004|Overall Study|Physician Decision|2|||
164148712|NCT03207867|592904941|FG005|Overall Study|Physician Decision|0|||
164148713|NCT03207867|592904942|FG006|Overall Study|Physician Decision|0|||
164148714|NCT03207867|592904943|FG007|Overall Study|Physician Decision|0|||
164148715|NCT03207867|592904944|FG008|Overall Study|Physician Decision|4|||
164148716|NCT03207867|592904945|FG009|Overall Study|Physician Decision|2|||
164148717|NCT03207867|592904946|FG010|Overall Study|Physician Decision|0|||
164148718|NCT03207867|592904947|FG011|Overall Study|Physician Decision|4|||
164148740|NCT03207867|592904945|FG009|Overall Study|Progressive Disease|23|||
164148741|NCT03207867|592904946|FG010|Overall Study|Progressive Disease|2|||
164148742|NCT03207867|592904947|FG011|Overall Study|Progressive Disease|24|||
164148743|NCT03207867|592904948|FG012|Overall Study|Progressive Disease|3|||
164148744|NCT03207867|592904949|FG013|Overall Study|Progressive Disease|11|||
164148745|NCT03207867|592904950|FG014|Overall Study|Progressive Disease|9|||
164148746|NCT03207867|592904951|FG015|Overall Study|Progressive Disease|5|||
164148747|NCT03207867|592904952|FG016|Overall Study|Progressive Disease|10|||
164148748|NCT03207867|592904953|FG017|Overall Study|Progressive Disease|14|||
164148749|NCT03207867|592904954|FG018|Overall Study|Progressive Disease|13|||
164148750|NCT03207867|592904955|FG019|Overall Study|Progressive Disease|14|||
164148751|NCT03207867|592904956|FG020|Overall Study|Progressive Disease|6|||
164148752|NCT03207867|592904957|FG021|Overall Study|Progressive Disease|3|||
164148753|NCT03207867|592904958|FG022|Overall Study|Progressive Disease|3|||
164148754|NCT03207867|592904959|FG023|Overall Study|Progressive Disease|3|||
164148755|NCT03207867|592904936|FG000|Overall Study|Patient/guardian Decision|0|||
164148756|NCT03207867|592904937|FG001|Overall Study|Patient/guardian Decision|0|||
164148757|NCT03207867|592904938|FG002|Overall Study|Patient/guardian Decision|1|||
164148758|NCT03207867|592904939|FG003|Overall Study|Patient/guardian Decision|1|||
164148759|NCT03207867|592904940|FG004|Overall Study|Patient/guardian Decision|1|||
164148760|NCT03207867|592904941|FG005|Overall Study|Patient/guardian Decision|2|||
164148761|NCT03207867|592904942|FG006|Overall Study|Patient/guardian Decision|1|||
164148762|NCT03207867|592904943|FG007|Overall Study|Patient/guardian Decision|0|||
164148763|NCT03207867|592904944|FG008|Overall Study|Patient/guardian Decision|1|||
164148764|NCT03207867|592904945|FG009|Overall Study|Patient/guardian Decision|0|||
164148765|NCT03207867|592904946|FG010|Overall Study|Patient/guardian Decision|0|||
164148766|NCT03207867|592904947|FG011|Overall Study|Patient/guardian Decision|1|||
164148767|NCT03207867|592904948|FG012|Overall Study|Patient/guardian Decision|0|||
164148768|NCT03207867|592904949|FG013|Overall Study|Patient/guardian Decision|1|||
164148769|NCT03207867|592904950|FG014|Overall Study|Patient/guardian Decision|2|||
164148770|NCT03207867|592904951|FG015|Overall Study|Patient/guardian Decision|0|||
164148771|NCT03207867|592904952|FG016|Overall Study|Patient/guardian Decision|1|||
164148772|NCT03207867|592904953|FG017|Overall Study|Patient/guardian Decision|3|||
164148773|NCT03207867|592904954|FG018|Overall Study|Patient/guardian Decision|4|||
164148774|NCT03207867|592904955|FG019|Overall Study|Patient/guardian Decision|1|||
164148775|NCT03207867|592904956|FG020|Overall Study|Patient/guardian Decision|0|||
164148776|NCT03207867|592904957|FG021|Overall Study|Patient/guardian Decision|0|||
164148777|NCT03207867|592904958|FG022|Overall Study|Patient/guardian Decision|0|||
164148778|NCT03207867|592904959|FG023|Overall Study|Patient/guardian Decision|0|||
164148779|NCT03560037|592907153|FG000|Overall Study|Protocol Violation|1|||
164148780|NCT03560037|592907154|FG001|Overall Study|Protocol Violation|0|||
164148781|NCT03560037|592907153|FG000|Overall Study|Physician Decision|0|||
164148782|NCT03560037|592907154|FG001|Overall Study|Physician Decision|1|||
164148783|NCT03620708|592907155|FG000|Overall Study|Lost to Follow-up|1|||
164148784|NCT03620708|592907156|FG001|Overall Study|Lost to Follow-up|1|||
164148785|NCT03620708|592907157|FG002|Overall Study|Lost to Follow-up|2|||
164148786|NCT03620708|592907155|FG000|Overall Study|Withdrawal by Subject|0|||
164148787|NCT03620708|592907156|FG001|Overall Study|Withdrawal by Subject|0|||
164148788|NCT03620708|592907157|FG002|Overall Study|Withdrawal by Subject|1|||
164148789|NCT02498613|592907158|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
164148790|NCT02498613|592907159|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
164148791|NCT02498613|592907160|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
164148792|NCT02498613|592907161|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
164148793|NCT02498613|592907158|FG000|Overall Study|Withdrawal by Subject|3|||
164148794|NCT02498613|592907159|FG001|Overall Study|Withdrawal by Subject|1|||
164148795|NCT02498613|592907160|FG002|Overall Study|Withdrawal by Subject|0|||
164148796|NCT02498613|592907161|FG003|Overall Study|Withdrawal by Subject|0|||
164148797|NCT05126693|592907162|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
164148798|NCT05126693|592907163|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
164148799|NCT05126693|592907162|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
164148800|NCT05126693|592907163|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
164148801|NCT05126693|592907162|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
164148802|NCT05126693|592907163|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
164148803|NCT05061134|592907165|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
164148804|NCT05061134|592907166|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
164148805|NCT05061134|592907167|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
164148806|NCT05061134|592907165|FG000|Overall Study|Subject not treated|0|||
164148807|NCT05061134|592907166|FG001|Overall Study|Subject not treated|0|||
164148808|NCT05061134|592907167|FG002|Overall Study|Subject not treated|2|||
164148809|NCT05061134|592907165|FG000|Overall Study|Other|0|||
164148810|NCT05061134|592907166|FG001|Overall Study|Other|0|||
164148811|NCT05061134|592907167|FG002|Overall Study|Other|9|||
164148812|NCT05061134|592907165|FG000|Overall Study|Withdrawal by Subject|9|||
164148813|NCT05061134|592907166|FG001|Overall Study|Withdrawal by Subject|8|||
164148814|NCT05061134|592907167|FG002|Overall Study|Withdrawal by Subject|5|||
164148815|NCT05061134|592907165|FG000|Overall Study|Study Terminated by Sponsor|22|||
164148816|NCT05061134|592907166|FG001|Overall Study|Study Terminated by Sponsor|14|||
164148817|NCT05061134|592907167|FG002|Overall Study|Study Terminated by Sponsor|7|||
164148818|NCT05061134|592907165|FG000|Overall Study|Progressive Disease|1|||
164148819|NCT05061134|592907166|FG001|Overall Study|Progressive Disease|2|||
164148820|NCT05061134|592907167|FG002|Overall Study|Progressive Disease|0|||
164148821|NCT05061134|592907165|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
164148822|NCT05061134|592907166|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
164148823|NCT05061134|592907167|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
164148824|NCT05061134|592907165|FG000|Overall Study|Lost to Follow-up|1|||
164148825|NCT05061134|592907166|FG001|Overall Study|Lost to Follow-up|0|||
164148826|NCT05061134|592907167|FG002|Overall Study|Lost to Follow-up|0|||
164148827|NCT05061134|592907165|FG000|Overall Study|Physician Decision|1|||
164148828|NCT05061134|592907166|FG001|Overall Study|Physician Decision|1|||
164148829|NCT05061134|592907167|FG002|Overall Study|Physician Decision|0|||
164148830|NCT05061134|592907165|FG000|Overall Study|Disease progression|1|||
164148831|NCT05061134|592907166|FG001|Overall Study|Disease progression|0|||
164148832|NCT05061134|592907167|FG002|Overall Study|Disease progression|0|||
164148833|NCT05061134|592907165|FG000|Overall Study|Death|43|||
164148834|NCT05061134|592907166|FG001|Overall Study|Death|23|||
164148835|NCT05061134|592907167|FG002|Overall Study|Death|14|||
164148836|NCT05061134|592907165|FG000|Overall Study|Database lock|2|||
164148837|NCT05061134|592907166|FG001|Overall Study|Database lock|0|||
164148838|NCT05061134|592907167|FG002|Overall Study|Database lock|0|||
164148839|NCT03631199|592907171|FG000|Overall Study|Progressive disease|9|||
164148840|NCT03631199|592907172|FG001|Overall Study|Progressive disease|5|||
164148841|NCT03631199|592907173|FG002|Overall Study|Progressive disease|5|||
164148842|NCT03631199|592907174|FG003|Overall Study|Progressive disease|149|||
164148843|NCT03631199|592907175|FG004|Overall Study|Progressive disease|148|||
164148844|NCT03631199|592907171|FG000|Overall Study|Physician Decision|0|||
164148845|NCT03631199|592907172|FG001|Overall Study|Physician Decision|2|||
164148846|NCT03631199|592907173|FG002|Overall Study|Physician Decision|3|||
164148847|NCT03631199|592907174|FG003|Overall Study|Physician Decision|19|||
164148848|NCT03631199|592907175|FG004|Overall Study|Physician Decision|13|||
164148849|NCT03631199|592907171|FG000|Overall Study|Adverse Event|1|||
164148850|NCT03631199|592907172|FG001|Overall Study|Adverse Event|1|||
164148851|NCT03631199|592907173|FG002|Overall Study|Adverse Event|0|||
164148852|NCT03631199|592907174|FG003|Overall Study|Adverse Event|28|||
164148853|NCT03631199|592907175|FG004|Overall Study|Adverse Event|29|||
164148854|NCT03631199|592907171|FG000|Overall Study|Death|0|||
164148855|NCT03631199|592907172|FG001|Overall Study|Death|1|||
164148856|NCT03631199|592907173|FG002|Overall Study|Death|0|||
164148857|NCT03631199|592907174|FG003|Overall Study|Death|35|||
164148858|NCT03631199|592907175|FG004|Overall Study|Death|48|||
164148859|NCT03631199|592907171|FG000|Overall Study|Subject decision|0|||
164148860|NCT03631199|592907172|FG001|Overall Study|Subject decision|1|||
164148861|NCT03631199|592907173|FG002|Overall Study|Subject decision|0|||
164148862|NCT03631199|592907174|FG003|Overall Study|Subject decision|12|||
164148863|NCT03631199|592907175|FG004|Overall Study|Subject decision|12|||
164148864|NCT03631199|592907171|FG000|Overall Study|No treated|0|||
164148865|NCT03631199|592907172|FG001|Overall Study|No treated|0|||
164148866|NCT03631199|592907173|FG002|Overall Study|No treated|0|||
164148867|NCT03631199|592907174|FG003|Overall Study|No treated|0|||
164148868|NCT03631199|592907175|FG004|Overall Study|No treated|1|||
164148869|NCT03631199|592907171|FG000|Overall Study|Treatment ongoing|0|||
164148870|NCT03631199|592907172|FG001|Overall Study|Treatment ongoing|1|||
164148871|NCT03631199|592907173|FG002|Overall Study|Treatment ongoing|1|||
164148872|NCT03631199|592907174|FG003|Overall Study|Treatment ongoing|76|||
164148873|NCT03631199|592907175|FG004|Overall Study|Treatment ongoing|71|||
164148874|NCT03631199|592907171|FG000|Overall Study|Guardian decision|0|||
164148875|NCT03631199|592907172|FG001|Overall Study|Guardian decision|0|||
164148876|NCT03631199|592907173|FG002|Overall Study|Guardian decision|0|||
164148877|NCT03631199|592907174|FG003|Overall Study|Guardian decision|1|||
164148878|NCT03631199|592907175|FG004|Overall Study|Guardian decision|1|||
164148879|NCT03999996|592907176|FG000|Prior to Booster|Adverse Event|2|||
164148880|NCT03999996|592907177|FG001|Prior to Booster|Adverse Event|0|||
164148881|NCT03999996|592907178|FG002|Prior to Booster|Adverse Event|0|||
164148882|NCT03999996|592907179|FG003|Prior to Booster|Adverse Event|0|||
164148883|NCT03999996|592907176|FG000|Prior to Booster|Lost to Follow-up|17|||
164148884|NCT03999996|592907177|FG001|Prior to Booster|Lost to Follow-up|22|||
164148885|NCT03999996|592907178|FG002|Prior to Booster|Lost to Follow-up|0|||
164148886|NCT03999996|592907179|FG003|Prior to Booster|Lost to Follow-up|0|||
164148887|NCT03999996|592907176|FG000|Prior to Booster|Withdrawal of Consent|51|||
164148888|NCT03999996|592907177|FG001|Prior to Booster|Withdrawal of Consent|8|||
164148889|NCT03999996|592907178|FG002|Prior to Booster|Withdrawal of Consent|0|||
164148890|NCT03999996|592907179|FG003|Prior to Booster|Withdrawal of Consent|0|||
164148891|NCT03999996|592907176|FG000|Prior to Booster|Death|0|||
164148892|NCT03999996|592907177|FG001|Prior to Booster|Death|1|||
164148893|NCT03999996|592907178|FG002|Prior to Booster|Death|0|||
164148894|NCT03999996|592907179|FG003|Prior to Booster|Death|0|||
164148895|NCT03999996|592907176|FG000|Prior to Booster|Reason Not Specified|27|||
164148896|NCT03999996|592907177|FG001|Prior to Booster|Reason Not Specified|4|||
164148897|NCT03999996|592907178|FG002|Prior to Booster|Reason Not Specified|0|||
164148898|NCT03999996|592907179|FG003|Prior to Booster|Reason Not Specified|0|||
164148899|NCT03999996|592907176|FG000|Booster Phase|Lost to Follow-up|0|||
164148900|NCT03999996|592907177|FG001|Booster Phase|Lost to Follow-up|0|||
164148901|NCT03999996|592907178|FG002|Booster Phase|Lost to Follow-up|3|||
164148902|NCT03999996|592907179|FG003|Booster Phase|Lost to Follow-up|3|||
164148903|NCT03999996|592907176|FG000|Booster Phase|Withdrawal of Consent|0|||
164148904|NCT03999996|592907177|FG001|Booster Phase|Withdrawal of Consent|0|||
164148905|NCT03999996|592907178|FG002|Booster Phase|Withdrawal of Consent|0|||
164148906|NCT03999996|592907179|FG003|Booster Phase|Withdrawal of Consent|1|||
164148907|NCT03999996|592907176|FG000|Booster Phase|Reason Not Specified|0|||
164148908|NCT03999996|592907177|FG001|Booster Phase|Reason Not Specified|0|||
164148909|NCT03999996|592907178|FG002|Booster Phase|Reason Not Specified|0|||
164148910|NCT03999996|592907179|FG003|Booster Phase|Reason Not Specified|1|||
164148911|NCT03690388|592907180|FG000|Overall Study|Adverse Event|8|||
164148912|NCT03690388|592907181|FG001|Overall Study|Adverse Event|1|||
164148913|NCT03690388|592907180|FG000|Overall Study|Radiographic Progression|14|||
164148914|NCT03690388|592907181|FG001|Overall Study|Radiographic Progression|29|||
164148915|NCT03690388|592907180|FG000|Overall Study|Clinical deterioration|10|||
164148916|NCT03690388|592907181|FG001|Overall Study|Clinical deterioration|6|||
164148917|NCT03690388|592907180|FG000|Overall Study|Withdrawal by Subject|2|||
164148918|NCT03690388|592907181|FG001|Overall Study|Withdrawal by Subject|0|||
164148919|NCT03690388|592907180|FG000|Overall Study|Lack of Efficacy|1|||
164148920|NCT03690388|592907181|FG001|Overall Study|Lack of Efficacy|0|||
164148921|NCT03690388|592907180|FG000|Overall Study|Lost to Follow-up|1|||
164148922|NCT03690388|592907181|FG001|Overall Study|Lost to Follow-up|0|||
164148923|NCT03765788|592907182|FG000|Overall Study|Subject decision|2|||
164148924|NCT03765788|592907183|FG001|Overall Study|Subject decision|3|||
164148925|NCT03765788|592907182|FG000|Overall Study|Physician Decision|2|||
164148926|NCT03765788|592907183|FG001|Overall Study|Physician Decision|4|||
164148927|NCT03765788|592907182|FG000|Overall Study|Death|0|||
164148928|NCT03765788|592907183|FG001|Overall Study|Death|1|||
164148929|NCT03765788|592907182|FG000|Overall Study|Lost to Follow-up|1|||
164148930|NCT03765788|592907183|FG001|Overall Study|Lost to Follow-up|0|||
164148931|NCT00001521|592907184|FG000|Overall Study|Withdrawal by Subject|3|||
164148932|NCT00001521|592907185|FG001|Overall Study|Withdrawal by Subject|3|||
164148933|NCT00001521|592907184|FG000|Overall Study|Physician Decision|1|||
164148934|NCT00001521|592907185|FG001|Overall Study|Physician Decision|1|||
164148935|NCT00001521|592907184|FG000|Overall Study|Noncompliant|6|||
164148936|NCT00001521|592907185|FG001|Overall Study|Noncompliant|3|||
164148937|NCT03176134|592907186|FG000|Overall Study|Lost to Follow-up|0|||
164148938|NCT03176134|592907187|FG001|Overall Study|Lost to Follow-up|2|||
164148939|NCT03176134|592907188|FG002|Overall Study|Lost to Follow-up|0|||
164148940|NCT03176134|592907189|FG003|Overall Study|Lost to Follow-up|0|||
164148941|NCT03176134|592907190|FG004|Overall Study|Lost to Follow-up|0|||
164148942|NCT03176134|592907191|FG005|Overall Study|Lost to Follow-up|0|||
164148943|NCT03176134|592907192|FG006|Overall Study|Lost to Follow-up|0|||
164148944|NCT03176134|592907193|FG007|Overall Study|Lost to Follow-up|0|||
164148945|NCT03176134|592907186|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
164148946|NCT03176134|592907187|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
164148947|NCT03176134|592907188|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164148948|NCT03176134|592907189|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164148949|NCT03176134|592907190|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
164148950|NCT03176134|592907191|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
164148951|NCT03176134|592907192|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
164148952|NCT03176134|592907193|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
164148953|NCT03410056|592907198|FG000|Overall Study|Decision by Sponsor|0|||
164148954|NCT03410056|592907199|FG001|Overall Study|Decision by Sponsor|0|||
164148955|NCT03410056|592907200|FG002|Overall Study|Decision by Sponsor|3|||
164148956|NCT03410056|592907201|FG003|Overall Study|Decision by Sponsor|0|||
164148957|NCT03410056|592907202|FG004|Overall Study|Decision by Sponsor|0|||
164148958|NCT03410056|592907203|FG005|Overall Study|Decision by Sponsor|0|||
164148959|NCT03410056|592907204|FG006|Overall Study|Decision by Sponsor|0|||
164148960|NCT03410056|592907198|FG000|Overall Study|Withdrawal by Subject|0|||
164148961|NCT03410056|592907199|FG001|Overall Study|Withdrawal by Subject|2|||
164148962|NCT03410056|592907200|FG002|Overall Study|Withdrawal by Subject|5|||
164148963|NCT03410056|592907201|FG003|Overall Study|Withdrawal by Subject|5|||
164148964|NCT03410056|592907202|FG004|Overall Study|Withdrawal by Subject|0|||
164148965|NCT03410056|592907203|FG005|Overall Study|Withdrawal by Subject|0|||
164148966|NCT03410056|592907204|FG006|Overall Study|Withdrawal by Subject|0|||
164148967|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
164148968|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
164148969|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
164148970|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
164148971|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
164148972|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
164148973|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
164148974|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
164148975|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
164148976|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
164148977|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
164148978|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
164148979|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
164148980|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
164148981|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
164148982|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
164148983|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
164148984|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
164148985|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
164148986|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
164148987|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
164148988|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
164148989|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
164148990|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
164148991|NCT01130532|592907208|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
164148992|NCT01130532|592907209|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
164148993|NCT01130532|592907210|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
164148994|NCT01130532|592907211|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
164148995|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
164148996|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
164148997|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
164148998|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
164148999|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
164149000|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
164149001|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
164149002|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
164149003|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
164149004|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
164149005|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
164149006|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
164149007|NCT01130532|592907208|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
164149008|NCT01130532|592907209|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
164149009|NCT01130532|592907210|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
164149010|NCT01130532|592907211|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
164149011|NCT02762929|592907212|FG000|Overall Study|Adverse Event|0|||
164149012|NCT02762929|592907213|FG001|Overall Study|Adverse Event|0|||
164149013|NCT02762929|592907214|FG002|Overall Study|Adverse Event|0|||
164149014|NCT02762929|592907215|FG003|Overall Study|Adverse Event|1|||
164149015|NCT02762929|592907216|FG004|Overall Study|Adverse Event|0|||
164149016|NCT02762929|592907217|FG005|Overall Study|Adverse Event|0|||
164149017|NCT02762929|592907212|FG000|Overall Study|Lost to Follow-up|1|||
164149018|NCT02762929|592907213|FG001|Overall Study|Lost to Follow-up|2|||
164149019|NCT02762929|592907214|FG002|Overall Study|Lost to Follow-up|0|||
164149020|NCT02762929|592907215|FG003|Overall Study|Lost to Follow-up|1|||
164149021|NCT02762929|592907216|FG004|Overall Study|Lost to Follow-up|0|||
164149022|NCT02762929|592907217|FG005|Overall Study|Lost to Follow-up|0|||
164149023|NCT02762929|592907212|FG000|Overall Study|Withdrawal by Subject|0|||
164149024|NCT02762929|592907213|FG001|Overall Study|Withdrawal by Subject|1|||
164149025|NCT02762929|592907214|FG002|Overall Study|Withdrawal by Subject|0|||
164149026|NCT02762929|592907215|FG003|Overall Study|Withdrawal by Subject|0|||
164149027|NCT02762929|592907216|FG004|Overall Study|Withdrawal by Subject|0|||
164149028|NCT02762929|592907217|FG005|Overall Study|Withdrawal by Subject|0|||
164149029|NCT02762929|592907212|FG000|Overall Study|exclusionary medication disclosed late|0|||
164149030|NCT02762929|592907213|FG001|Overall Study|exclusionary medication disclosed late|0|||
164149031|NCT02762929|592907214|FG002|Overall Study|exclusionary medication disclosed late|0|||
164149032|NCT02762929|592907215|FG003|Overall Study|exclusionary medication disclosed late|1|||
164149033|NCT02762929|592907216|FG004|Overall Study|exclusionary medication disclosed late|0|||
164149034|NCT02762929|592907217|FG005|Overall Study|exclusionary medication disclosed late|0|||
164149035|NCT02656303|592907218|FG000|Overall Study|Adverse Event|3|||
164149036|NCT02656303|592907219|FG001|Overall Study|Adverse Event|2|||
164149037|NCT02656303|592907220|FG002|Overall Study|Adverse Event|0|||
164149038|NCT02656303|592907218|FG000|Overall Study|Death|12|||
164149039|NCT02656303|592907219|FG001|Overall Study|Death|4|||
164149040|NCT02656303|592907220|FG002|Overall Study|Death|1|||
164149041|NCT02656303|592907218|FG000|Overall Study|Lack of Efficacy|1|||
164149042|NCT02656303|592907219|FG001|Overall Study|Lack of Efficacy|0|||
164149043|NCT02656303|592907220|FG002|Overall Study|Lack of Efficacy|0|||
164149044|NCT02656303|592907218|FG000|Overall Study|Non-Compliance with Study|1|||
164149045|NCT02656303|592907219|FG001|Overall Study|Non-Compliance with Study|1|||
164149046|NCT02656303|592907220|FG002|Overall Study|Non-Compliance with Study|0|||
164149047|NCT02656303|592907218|FG000|Overall Study|Investigator Decision|2|||
164149048|NCT02656303|592907219|FG001|Overall Study|Investigator Decision|1|||
164149049|NCT02656303|592907220|FG002|Overall Study|Investigator Decision|0|||
164149050|NCT02656303|592907218|FG000|Overall Study|Progressive Disease|25|||
164149051|NCT02656303|592907219|FG001|Overall Study|Progressive Disease|14|||
164149052|NCT02656303|592907220|FG002|Overall Study|Progressive Disease|10|||
164149053|NCT02656303|592907218|FG000|Overall Study|Study Terminated by Sponsor|20|||
164149054|NCT02656303|592907219|FG001|Overall Study|Study Terminated by Sponsor|7|||
164149055|NCT02656303|592907220|FG002|Overall Study|Study Terminated by Sponsor|5|||
164149056|NCT02656303|592907218|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
164149057|NCT02656303|592907219|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
164149058|NCT02656303|592907220|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
164149059|NCT02656303|592907218|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
164149060|NCT02656303|592907219|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
164149061|NCT02656303|592907220|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
164149062|NCT02656303|592907218|FG000|Overall Study|Reason not Specified|1|||
164149063|NCT02656303|592907219|FG001|Overall Study|Reason not Specified|1|||
164149064|NCT02656303|592907220|FG002|Overall Study|Reason not Specified|2|||
164149065|NCT03041311|592907223|FG000|Overall Study|Death|39|||
164149066|NCT03041311|592907224|FG001|Overall Study|Death|42|||
164149067|NCT03041311|592907223|FG000|Overall Study|Lost to Follow-up|0|||
164149068|NCT03041311|592907224|FG001|Overall Study|Lost to Follow-up|1|||
164149069|NCT03041311|592907223|FG000|Overall Study|Withdrawal by Subject|8|||
164149070|NCT03041311|592907224|FG001|Overall Study|Withdrawal by Subject|5|||
164149071|NCT03041311|592907223|FG000|Overall Study|Sponsor Terminated Study|2|||
164149072|NCT03041311|592907224|FG001|Overall Study|Sponsor Terminated Study|4|||
164149073|NCT03041311|592907223|FG000|Overall Study|Disease Progression|3|||
164149074|NCT03041311|592907224|FG001|Overall Study|Disease Progression|1|||
164149075|NCT03041311|592907223|FG000|Overall Study|Randomized in error, did not receive drug|2|||
164149076|NCT03041311|592907224|FG001|Overall Study|Randomized in error, did not receive drug|0|||
164149077|NCT01842438|592907225|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
164149078|NCT01842438|592907226|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
164149079|NCT01842438|592907225|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
164149080|NCT01842438|592907226|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
164149081|NCT01842438|592907225|FG000|T2: 6month Follow-up|Death|0|||
164149082|NCT01842438|592907226|FG001|T2: 6month Follow-up|Death|1|||
164149083|NCT04909853|592907227|FG000|Part 1|Assigned but not treated|0|||
164149084|NCT04909853|592907228|FG001|Part 1|Assigned but not treated|0|||
164149085|NCT04909853|592907229|FG002|Part 1|Assigned but not treated|1|||
164149086|NCT04909853|592907230|FG003|Part 1|Assigned but not treated|0|||
164149087|NCT04909853|592907227|FG000|Part 2|Adverse Event|0|||
164149088|NCT04909853|592907228|FG001|Part 2|Adverse Event|0|||
164149089|NCT04909853|592907229|FG002|Part 2|Adverse Event|0|||
164149090|NCT04909853|592907230|FG003|Part 2|Adverse Event|1|||
164149091|NCT02366689|592907240|FG000|Overall Study|Withdrawal by Subject|1|||
164149092|NCT02366689|592907241|FG001|Overall Study|Withdrawal by Subject|0|||
164149093|NCT02366689|592907242|FG002|Overall Study|Withdrawal by Subject|1|||
164149094|NCT02366689|592907240|FG000|Overall Study|Lost to Follow-up|3|||
164149095|NCT02366689|592907241|FG001|Overall Study|Lost to Follow-up|2|||
164149096|NCT02366689|592907242|FG002|Overall Study|Lost to Follow-up|0|||
164149097|NCT02366689|592907240|FG000|Overall Study|Pregnancy|0|||
164149098|NCT02366689|592907241|FG001|Overall Study|Pregnancy|1|||
164149099|NCT02366689|592907242|FG002|Overall Study|Pregnancy|1|||
164149100|NCT03718832|592907243|FG000|Analysis Sample|Withdrawal by Subject|18|||
164149101|NCT03718832|592907244|FG001|Analysis Sample|Withdrawal by Subject|15|||
164149102|NCT03718832|592907243|FG000|Analysis Sample|Legal hold on data|1|||
164149103|NCT03718832|592907244|FG001|Analysis Sample|Legal hold on data|0|||
164149104|NCT03718832|592907243|FG000|Analysis Sample|Participant from treated household|0|||
164149105|NCT03718832|592907244|FG001|Analysis Sample|Participant from treated household|1|||
164149106|NCT03718832|592907243|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
164149107|NCT03718832|592907244|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
164149108|NCT01996241|592907245|FG000|Overall Study|Lost to Follow-up|252|||
164149109|NCT01996241|592907246|FG001|Overall Study|Lost to Follow-up|235|||
164149110|NCT01720225|592907250|FG000|Overall Study|Withdrawal by Subject|0|||
164149111|NCT01720225|592907251|FG001|Overall Study|Withdrawal by Subject|1|||
164149112|NCT01720225|592907250|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
164149113|NCT01720225|592907251|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
164149114|NCT02604407|592907252|FG000|Overall Study|Adverse Event|0|||
164149115|NCT02604407|592907253|FG001|Overall Study|Adverse Event|7|||
164149116|NCT02604407|592907254|FG002|Overall Study|Adverse Event|5|||
164149117|NCT02604407|592907252|FG000|Overall Study|Protocol Violation|2|||
164149118|NCT02604407|592907253|FG001|Overall Study|Protocol Violation|0|||
164149119|NCT02604407|592907254|FG002|Overall Study|Protocol Violation|0|||
164149120|NCT02604407|592907252|FG000|Overall Study|Withdrawal by Subject|3|||
164149121|NCT02604407|592907253|FG001|Overall Study|Withdrawal by Subject|3|||
164149122|NCT02604407|592907254|FG002|Overall Study|Withdrawal by Subject|5|||
164149123|NCT02604407|592907252|FG000|Overall Study|Lost to Follow-up|2|||
164149124|NCT02604407|592907253|FG001|Overall Study|Lost to Follow-up|1|||
164149125|NCT02604407|592907254|FG002|Overall Study|Lost to Follow-up|2|||
164149126|NCT02604407|592907252|FG000|Overall Study|Lack of Efficacy|1|||
164149127|NCT02604407|592907253|FG001|Overall Study|Lack of Efficacy|0|||
164149128|NCT02604407|592907254|FG002|Overall Study|Lack of Efficacy|0|||
164149129|NCT02604407|592907252|FG000|Overall Study|Other|3|||
164149130|NCT02604407|592907253|FG001|Overall Study|Other|1|||
164149131|NCT02604407|592907254|FG002|Overall Study|Other|4|||
164149132|NCT00661193|592907255|FG000|Overall Study|Adverse Event|2|||
164149133|NCT00661193|592907256|FG001|Overall Study|Adverse Event|1|||
164149134|NCT00661193|592907255|FG000|Overall Study|Withdrawal by Subject|3|||
164149135|NCT00661193|592907256|FG001|Overall Study|Withdrawal by Subject|1|||
164149136|NCT00661193|592907255|FG000|Overall Study|Progression|27|||
164149137|NCT00661193|592907256|FG001|Overall Study|Progression|24|||
164149138|NCT00661193|592907255|FG000|Overall Study|Not protocol specified|1|||
164149139|NCT00661193|592907256|FG001|Overall Study|Not protocol specified|0|||
164149140|NCT02964312|592907263|FG000|Overall Study|Lost to Follow-up|28|||
164149141|NCT02964312|592907263|FG000|Overall Study|Withdrawal by Subject|11|||
164149142|NCT02964312|592907263|FG000|Overall Study|Lack of Efficacy|10|||
164149143|NCT02964312|592907263|FG000|Overall Study|Did not consent to long-term FU|14|||
164149144|NCT02964312|592907263|FG000|Overall Study|Death|1|||
164149145|NCT00191191|592907266|FG000|Overall Study|Entry Criteria Exclusion|2|||
164149146|NCT00191191|592907267|FG001|Overall Study|Entry Criteria Exclusion|0|||
164149147|NCT00191191|592907266|FG000|Overall Study|Treated with Another Systemic Agent|1|||
164149148|NCT00191191|592907267|FG001|Overall Study|Treated with Another Systemic Agent|1|||
164149149|NCT00191191|592907266|FG000|Overall Study|Adverse Event|11|||
164149150|NCT00191191|592907267|FG001|Overall Study|Adverse Event|21|||
164149151|NCT00191191|592907266|FG000|Overall Study|Progressive Disease|84|||
164149152|NCT00191191|592907267|FG001|Overall Study|Progressive Disease|72|||
164149153|NCT00191191|592907266|FG000|Overall Study|Toxicity After Dose Reduction|7|||
164149154|NCT00191191|592907267|FG001|Overall Study|Toxicity After Dose Reduction|8|||
164149155|NCT00191191|592907266|FG000|Overall Study|Family/Caregiver Decision|5|||
164149156|NCT00191191|592907267|FG001|Overall Study|Family/Caregiver Decision|7|||
164149157|NCT00191191|592907266|FG000|Overall Study|Lost to Follow-up|1|||
164149158|NCT00191191|592907267|FG001|Overall Study|Lost to Follow-up|0|||
164149159|NCT00191191|592907266|FG000|Overall Study|Physician Decision|3|||
164149160|NCT00191191|592907267|FG001|Overall Study|Physician Decision|2|||
164149161|NCT00191191|592907266|FG000|Overall Study|Good Clinical Practice Violation|0|||
164149162|NCT00191191|592907267|FG001|Overall Study|Good Clinical Practice Violation|1|||
164149163|NCT03280264|592907275|FG000|Overall Study|Adverse Event|1|||
164149164|NCT03280264|592907275|FG000|Overall Study|Physician Decision|1|||
164149165|NCT03280264|592907275|FG000|Overall Study|Withdrawal by Subject|1|||
164149166|NCT04882241|592907276|FG000|Overall Study|Ongoing in study|46|||
164149167|NCT04882241|592907277|FG001|Overall Study|Ongoing in study|48|||
164149168|NCT04882241|592907278|FG002|Overall Study|Ongoing in study|0|||
164149169|NCT04882241|592907279|FG003|Overall Study|Ongoing in study|0|||
164149170|NCT04882241|592907276|FG000|Overall Study|Death|13|||
164149171|NCT04882241|592907277|FG001|Overall Study|Death|13|||
164149172|NCT04882241|592907278|FG002|Overall Study|Death|0|||
164149173|NCT04882241|592907279|FG003|Overall Study|Death|0|||
164149174|NCT00524420|592907286|FG000|Overall Study|Lack of Efficacy|1|||
164149175|NCT00524420|592907287|FG001|Overall Study|Lack of Efficacy|0|||
164149176|NCT00577863|592907288|FG000|Overall Study|Adverse Event|4|||
164149177|NCT00577863|592907289|FG001|Overall Study|Adverse Event|2|||
164149178|NCT00577863|592907288|FG000|Overall Study|Death|1|||
164149179|NCT00577863|592907289|FG001|Overall Study|Death|0|||
164149180|NCT00577863|592907288|FG000|Overall Study|Lost to Follow-up|2|||
164149181|NCT00577863|592907289|FG001|Overall Study|Lost to Follow-up|2|||
164149182|NCT00577863|592907288|FG000|Overall Study|Entry Criteria Exclusion|1|||
164149183|NCT00577863|592907289|FG001|Overall Study|Entry Criteria Exclusion|0|||
164149184|NCT00577863|592907288|FG000|Overall Study|Withdrawal by Subject|0|||
164149185|NCT00577863|592907289|FG001|Overall Study|Withdrawal by Subject|2|||
164149186|NCT00577863|592907288|FG000|Overall Study|Sponsor Decision|2|||
164149187|NCT00577863|592907289|FG001|Overall Study|Sponsor Decision|7|||
164149188|NCT00577863|592907288|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
164149189|NCT00577863|592907289|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
164149190|NCT02738138|592907293|FG000|Overall Study|Adverse Event|0|||
164149191|NCT02738138|592907294|FG001|Overall Study|Adverse Event|1|||
164149192|NCT02738138|592907293|FG000|Overall Study|Lost to Follow-up|2|||
164149193|NCT02738138|592907294|FG001|Overall Study|Lost to Follow-up|0|||
164149194|NCT02738138|592907293|FG000|Overall Study|Other - not further specified|1|||
164149195|NCT02738138|592907294|FG001|Overall Study|Other - not further specified|0|||
164149196|NCT03639779|592907303|FG000|Overall Study|Lost to Follow-up|1|||
164149197|NCT02413229|592907306|FG000|Overall Study|Adverse Event|0|||
164149198|NCT02413229|592907307|FG001|Overall Study|Adverse Event|0|||
164149199|NCT02413229|592907308|FG002|Overall Study|Adverse Event|0|||
164149200|NCT02413229|592907309|FG003|Overall Study|Adverse Event|1|||
164149201|NCT02413229|592907310|FG004|Overall Study|Adverse Event|0|||
164149202|NCT02413229|592907311|FG005|Overall Study|Adverse Event|0|||
164149203|NCT02413229|592907312|FG006|Overall Study|Adverse Event|0|||
164149204|NCT02413229|592907313|FG007|Overall Study|Adverse Event|1|||
164149205|NCT02413229|592907306|FG000|Overall Study|Lost to Follow-up|0|||
164149206|NCT02413229|592907307|FG001|Overall Study|Lost to Follow-up|0|||
164149207|NCT02413229|592907308|FG002|Overall Study|Lost to Follow-up|1|||
164149208|NCT02413229|592907309|FG003|Overall Study|Lost to Follow-up|0|||
164149209|NCT02413229|592907310|FG004|Overall Study|Lost to Follow-up|2|||
164149210|NCT02413229|592907311|FG005|Overall Study|Lost to Follow-up|0|||
164149211|NCT02413229|592907312|FG006|Overall Study|Lost to Follow-up|0|||
164149212|NCT02413229|592907313|FG007|Overall Study|Lost to Follow-up|0|||
164149213|NCT02413229|592907306|FG000|Overall Study|Withdrawal by Subject|1|||
164149214|NCT02413229|592907307|FG001|Overall Study|Withdrawal by Subject|1|||
164149215|NCT02413229|592907308|FG002|Overall Study|Withdrawal by Subject|0|||
164149216|NCT02413229|592907309|FG003|Overall Study|Withdrawal by Subject|0|||
164149217|NCT02413229|592907310|FG004|Overall Study|Withdrawal by Subject|1|||
164149218|NCT02413229|592907311|FG005|Overall Study|Withdrawal by Subject|0|||
164149219|NCT02413229|592907312|FG006|Overall Study|Withdrawal by Subject|0|||
164149220|NCT02413229|592907313|FG007|Overall Study|Withdrawal by Subject|2|||
164149221|NCT02413229|592907306|FG000|Overall Study|Progressive Disease|0|||
164149222|NCT02413229|592907307|FG001|Overall Study|Progressive Disease|0|||
164149223|NCT02413229|592907308|FG002|Overall Study|Progressive Disease|0|||
164149224|NCT02413229|592907309|FG003|Overall Study|Progressive Disease|0|||
164149225|NCT02413229|592907310|FG004|Overall Study|Progressive Disease|0|||
164149226|NCT02413229|592907311|FG005|Overall Study|Progressive Disease|0|||
164149227|NCT02413229|592907312|FG006|Overall Study|Progressive Disease|0|||
164149228|NCT02413229|592907313|FG007|Overall Study|Progressive Disease|1|||
164149229|NCT02932462|592907314|FG000|Overall Study|Adverse Event|1|||
164149230|NCT02932462|592907315|FG001|Overall Study|Adverse Event|2|||
164149231|NCT02932462|592907314|FG000|Overall Study|Lost to Follow-up|4|||
164149232|NCT02932462|592907315|FG001|Overall Study|Lost to Follow-up|1|||
164149233|NCT02932462|592907314|FG000|Overall Study|Protocol Violation|0|||
164149234|NCT02932462|592907315|FG001|Overall Study|Protocol Violation|5|||
164149235|NCT02932462|592907314|FG000|Overall Study|Withdrawal by Subject|1|||
164149236|NCT02932462|592907315|FG001|Overall Study|Withdrawal by Subject|4|||
164149237|NCT02932462|592907314|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164149238|NCT02932462|592907315|FG001|Overall Study|Non-Compliance With Study Drug|1|||
164149239|NCT02932462|592907314|FG000|Overall Study|Progressive Disease|1|||
164149240|NCT02932462|592907315|FG001|Overall Study|Progressive Disease|0|||
164149241|NCT05024747|592907319|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
164149242|NCT05024747|592907320|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
164149243|NCT05024747|592907319|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
164149244|NCT05024747|592907320|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
164149245|NCT05024747|592907319|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
164149246|NCT05024747|592907320|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
164149247|NCT00662649|592907321|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
164149248|NCT00662649|592907322|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
164149249|NCT00662649|592907323|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
164149250|NCT00662649|592907324|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
164149251|NCT00662649|592907325|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
164149252|NCT00662649|592907321|FG000|Core Study (24 Months)|Adverse Event|22|||
164149253|NCT00662649|592907322|FG001|Core Study (24 Months)|Adverse Event|13|||
164149254|NCT00662649|592907323|FG002|Core Study (24 Months)|Adverse Event|18|||
164149255|NCT00662649|592907324|FG003|Core Study (24 Months)|Adverse Event|0|||
164149256|NCT00662649|592907325|FG004|Core Study (24 Months)|Adverse Event|0|||
164149257|NCT00662649|592907321|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
164149258|NCT00662649|592907322|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
164149259|NCT00662649|592907323|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
164149260|NCT00662649|592907324|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
164149261|NCT00662649|592907325|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
164149262|NCT00662649|592907321|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
164149263|NCT00662649|592907322|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
164149264|NCT00662649|592907323|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
164149265|NCT00662649|592907324|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
164149266|NCT00662649|592907325|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
164149267|NCT00662649|592907321|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
164149268|NCT00662649|592907322|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
164149269|NCT00662649|592907323|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
164149270|NCT00662649|592907324|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
164149271|NCT00662649|592907325|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
164149272|NCT00662649|592907321|FG000|Core Study (24 Months)|Protocol Violation|5|||
164149273|NCT00662649|592907322|FG001|Core Study (24 Months)|Protocol Violation|5|||
164149274|NCT00662649|592907323|FG002|Core Study (24 Months)|Protocol Violation|4|||
164149275|NCT00662649|592907324|FG003|Core Study (24 Months)|Protocol Violation|0|||
164149276|NCT00662649|592907325|FG004|Core Study (24 Months)|Protocol Violation|0|||
164149277|NCT00662649|592907321|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
164149278|NCT00662649|592907322|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
164149279|NCT00662649|592907323|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
164149280|NCT00662649|592907324|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
164149281|NCT00662649|592907325|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
164149282|NCT00662649|592907321|FG000|Core Study (24 Months)|Death|1|||
164149283|NCT00662649|592907322|FG001|Core Study (24 Months)|Death|0|||
164149284|NCT00662649|592907323|FG002|Core Study (24 Months)|Death|2|||
164149285|NCT00662649|592907324|FG003|Core Study (24 Months)|Death|0|||
164149286|NCT00662649|592907325|FG004|Core Study (24 Months)|Death|0|||
164149287|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
164149288|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
164149289|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
164149290|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
164149291|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
164149292|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
164149293|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
164149294|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
164149295|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
164149296|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
164149297|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149298|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149299|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149300|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
164149301|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
164149302|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
164149303|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
164149304|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
164149305|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
164149306|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
164149307|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
164149308|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
164149309|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
164149310|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
164149311|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
164149312|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
164149313|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
164149314|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
164149315|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
164149316|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
164149317|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
164149318|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
164149319|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
164149320|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
164149321|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
164149322|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149323|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
164149324|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149325|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149326|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
164149327|NCT00662649|592907321|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
164149328|NCT00662649|592907322|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
164149329|NCT00662649|592907323|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
164149330|NCT00662649|592907324|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
164149331|NCT00662649|592907325|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
164149332|NCT04688671|592907330|FG000|Overall Study|Adverse Event|3|||
164149333|NCT04688671|592907331|FG001|Overall Study|Adverse Event|1|||
164149334|NCT04688671|592907330|FG000|Overall Study|Withdrawal by Subject|3|||
164149335|NCT04688671|592907331|FG001|Overall Study|Withdrawal by Subject|1|||
164149336|NCT04688671|592907330|FG000|Overall Study|Lack of Efficacy|1|||
164149337|NCT04688671|592907331|FG001|Overall Study|Lack of Efficacy|1|||
164149338|NCT04688671|592907330|FG000|Overall Study|Protocol Violation|1|||
164149339|NCT04688671|592907331|FG001|Overall Study|Protocol Violation|0|||
164149340|NCT04688671|592907330|FG000|Overall Study|Lost to Follow-up|0|||
164149341|NCT04688671|592907331|FG001|Overall Study|Lost to Follow-up|1|||
164149342|NCT01960257|592907332|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
164149343|NCT01960257|592907333|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
164149344|NCT01960257|592907334|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
164149345|NCT01960257|592907332|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
164149346|NCT01960257|592907333|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
164149347|NCT01960257|592907334|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
164149348|NCT01960257|592907332|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
164149349|NCT01960257|592907333|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
164149350|NCT01960257|592907334|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
164149351|NCT01942993|592907335|FG000|Overall Study|Lost to Follow-up|1|||
164149352|NCT01942993|592907335|FG000|Overall Study|Physician Decision|1|||
164149353|NCT01349192|592907339|FG000|Overall Study|Protocol Violation|0|||
164149354|NCT01349192|592907340|FG001|Overall Study|Protocol Violation|1|||
164149355|NCT01349192|592907339|FG000|Overall Study|Withdrawal by Subject|0|||
164149356|NCT01349192|592907340|FG001|Overall Study|Withdrawal by Subject|2|||
164149357|NCT01349192|592907339|FG000|Overall Study|Lost to Follow-up|1|||
164149358|NCT01349192|592907340|FG001|Overall Study|Lost to Follow-up|3|||
164149359|NCT01349192|592907339|FG000|Overall Study|Failure to adhere to Protocol|2|||
164149360|NCT01349192|592907340|FG001|Overall Study|Failure to adhere to Protocol|0|||
164149361|NCT03749330|592907341|FG000|Overall Study|Clinicians left work in the CICU|0|||
164149362|NCT03749330|592907342|FG001|Overall Study|Clinicians left work in the CICU|2|||
164149363|NCT03749330|592907343|FG002|Overall Study|Clinicians left work in the CICU|0|||
164149364|NCT03749330|592907344|FG003|Overall Study|Clinicians left work in the CICU|0|||
164149365|NCT03749330|592907345|FG004|Overall Study|Clinicians left work in the CICU|0|||
164149366|NCT03749330|592907346|FG005|Overall Study|Clinicians left work in the CICU|0|||
164149367|NCT02038010|592907350|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
164149368|NCT02038010|592907351|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
164149369|NCT02038010|592907352|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
164149370|NCT02038010|592907353|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
164149371|NCT02038010|592907350|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
164149372|NCT02038010|592907351|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
164149373|NCT02038010|592907352|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
164149374|NCT02038010|592907353|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
164149375|NCT02038010|592907350|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
164149376|NCT02038010|592907351|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
164149377|NCT02038010|592907352|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
164149378|NCT02038010|592907353|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
164149379|NCT02038010|592907350|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
164149380|NCT02038010|592907351|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
164149381|NCT02038010|592907352|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
164149382|NCT02038010|592907353|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
164149383|NCT02038010|592907350|FG000|Follow Up|Death|4|||
164149384|NCT02038010|592907351|FG001|Follow Up|Death|3|||
164149385|NCT02038010|592907352|FG002|Follow Up|Death|0|||
164149386|NCT02038010|592907353|FG003|Follow Up|Death|0|||
164149387|NCT02038010|592907350|FG000|Follow Up|Other|3|||
164149388|NCT02038010|592907351|FG001|Follow Up|Other|0|||
164149389|NCT02038010|592907352|FG002|Follow Up|Other|0|||
164149390|NCT02038010|592907353|FG003|Follow Up|Other|0|||
164149391|NCT02105467|592907357|FG000|Period 1|Lost to Follow-up|1|||
164149392|NCT02105467|592907358|FG001|Period 1|Lost to Follow-up|0|||
164149393|NCT02105467|592907357|FG000|Period 1|Death|1|||
164149394|NCT02105467|592907358|FG001|Period 1|Death|0|||
164149395|NCT02105467|592907357|FG000|Period 2|Lost to Follow-up|1|||
164149396|NCT02105467|592907358|FG001|Period 2|Lost to Follow-up|0|||
164149397|NCT02105467|592907357|FG000|Period 2|Death|1|||
164149398|NCT02105467|592907358|FG001|Period 2|Death|0|||
164149399|NCT02105467|592907357|FG000|Period 2|Withdrawal by Subject|0|||
164149400|NCT02105467|592907358|FG001|Period 2|Withdrawal by Subject|2|||
164149401|NCT02105467|592907357|FG000|Period 3|Lost to Follow-up|0|||
164149402|NCT02105467|592907358|FG001|Period 3|Lost to Follow-up|1|||
164149403|NCT03908125|592907359|FG000|Overall Study|Withdrawal by Subject|92|||
164149404|NCT03908125|592907359|FG000|Overall Study|Lost to Follow-up|8|||
164149405|NCT02262325|592907360|FG000|Overall Study|Death|16|||
164149406|NCT02262325|592907360|FG000|Overall Study|Lost to Follow-up|1|||
164149407|NCT02815995|592907361|FG000|Overall Study|Disease Progression|3|||
164149408|NCT02815995|592907362|FG001|Overall Study|Disease Progression|7|||
164149409|NCT02815995|592907363|FG002|Overall Study|Disease Progression|2|||
164149410|NCT02815995|592907364|FG003|Overall Study|Disease Progression|4|||
164149411|NCT02815995|592907365|FG004|Overall Study|Disease Progression|3|||
164149412|NCT02815995|592907366|FG005|Overall Study|Disease Progression|9|||
164149413|NCT02815995|592907367|FG006|Overall Study|Disease Progression|3|||
164149414|NCT02815995|592907368|FG007|Overall Study|Disease Progression|1|||
164149415|NCT02815995|592907361|FG000|Overall Study|Adverse Event|1|||
164149416|NCT02815995|592907362|FG001|Overall Study|Adverse Event|2|||
164149417|NCT02815995|592907363|FG002|Overall Study|Adverse Event|2|||
164149418|NCT02815995|592907364|FG003|Overall Study|Adverse Event|0|||
164149419|NCT02815995|592907365|FG004|Overall Study|Adverse Event|0|||
164149420|NCT02815995|592907366|FG005|Overall Study|Adverse Event|1|||
164149421|NCT02815995|592907367|FG006|Overall Study|Adverse Event|0|||
164149422|NCT02815995|592907368|FG007|Overall Study|Adverse Event|0|||
164149423|NCT02815995|592907361|FG000|Overall Study|Pregnancy|0|||
164149424|NCT02815995|592907362|FG001|Overall Study|Pregnancy|0|||
164149425|NCT02815995|592907363|FG002|Overall Study|Pregnancy|0|||
164149426|NCT02815995|592907364|FG003|Overall Study|Pregnancy|0|||
164149427|NCT02815995|592907365|FG004|Overall Study|Pregnancy|0|||
164149428|NCT02815995|592907366|FG005|Overall Study|Pregnancy|0|||
164149429|NCT02815995|592907367|FG006|Overall Study|Pregnancy|1|||
164149430|NCT02815995|592907368|FG007|Overall Study|Pregnancy|0|||
164149431|NCT01071915|592907372|FG000|Overall Study|Adverse Event|3|||
164149432|NCT01071915|592907372|FG000|Overall Study|Physician Decision|2|||
164149433|NCT01071915|592907372|FG000|Overall Study|Withdrawal by Subject|2|||
164149434|NCT01071915|592907372|FG000|Overall Study|Miscellaneous Reasons|2|||
164149435|NCT00344448|592907374|FG000|Screening|Withdrawal by Subject|0|||
164149436|NCT00344448|592907375|FG001|Screening|Withdrawal by Subject|1|||
164149437|NCT00344448|592907374|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
164149438|NCT00344448|592907375|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
164149439|NCT00344448|592907374|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
164149440|NCT00344448|592907375|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
164149441|NCT00344448|592907374|FG000|Open Label|Withdrawal by Subject|1|||
164149442|NCT00344448|592907375|FG001|Open Label|Withdrawal by Subject|1|||
164149443|NCT00344448|592907374|FG000|Open Label|Study terminated|1|||
164149444|NCT00344448|592907375|FG001|Open Label|Study terminated|0|||
164149445|NCT03519087|592907376|FG000|Clinic Evaluation|Physician Decision|15|||
164149446|NCT03519087|592907377|FG001|Clinic Evaluation|Physician Decision|18|||
164149447|NCT03519087|592907378|FG002|Clinic Evaluation|Physician Decision|0|||
164149448|NCT03519087|592907379|FG003|Clinic Evaluation|Physician Decision|0|||
164149449|NCT03519087|592907380|FG004|Clinic Evaluation|Physician Decision|0|||
164149450|NCT03519087|592907376|FG000|Clinic Evaluation|Protocol Violation|1|||
164149451|NCT03519087|592907377|FG001|Clinic Evaluation|Protocol Violation|0|||
164149452|NCT03519087|592907378|FG002|Clinic Evaluation|Protocol Violation|0|||
164149453|NCT03519087|592907379|FG003|Clinic Evaluation|Protocol Violation|0|||
164149454|NCT03519087|592907380|FG004|Clinic Evaluation|Protocol Violation|0|||
164149455|NCT03519087|592907376|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
164149456|NCT03519087|592907377|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
164149457|NCT03519087|592907378|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
164149458|NCT03519087|592907379|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
164149459|NCT03519087|592907380|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
164149460|NCT03519087|592907376|FG000|Re-randomization for Treatment|Not appropriate|2|||
164149461|NCT03519087|592907377|FG001|Re-randomization for Treatment|Not appropriate|3|||
164149462|NCT03519087|592907378|FG002|Re-randomization for Treatment|Not appropriate|0|||
164149463|NCT03519087|592907379|FG003|Re-randomization for Treatment|Not appropriate|0|||
164149464|NCT03519087|592907380|FG004|Re-randomization for Treatment|Not appropriate|0|||
164149465|NCT03519087|592907376|FG000|Laboratory Testing|Lost to Follow-up|0|||
164149466|NCT03519087|592907377|FG001|Laboratory Testing|Lost to Follow-up|0|||
164149467|NCT03519087|592907378|FG002|Laboratory Testing|Lost to Follow-up|2|||
164149468|NCT03519087|592907379|FG003|Laboratory Testing|Lost to Follow-up|3|||
164149469|NCT03519087|592907380|FG004|Laboratory Testing|Lost to Follow-up|6|||
164149470|NCT03519087|592907376|FG000|Laboratory Testing|Protocol Violation|0|||
164149471|NCT03519087|592907377|FG001|Laboratory Testing|Protocol Violation|0|||
164149472|NCT03519087|592907378|FG002|Laboratory Testing|Protocol Violation|0|||
164149473|NCT03519087|592907379|FG003|Laboratory Testing|Protocol Violation|1|||
164149474|NCT03519087|592907380|FG004|Laboratory Testing|Protocol Violation|0|||
164149475|NCT01137071|592907381|FG000|Overall Study|Disease Progression|11|||
164149476|NCT01137071|592907381|FG000|Overall Study|Withdrawal by Subject|2|||
164149477|NCT01137071|592907381|FG000|Overall Study|Wrongly Included|1|||
164149478|NCT04807400|592907382|FG000|Overall Study|Adverse Event|2|||
164149479|NCT04807400|592907383|FG001|Overall Study|Adverse Event|3|||
164149480|NCT04807400|592907384|FG002|Overall Study|Adverse Event|3|||
164149481|NCT04807400|592907382|FG000|Overall Study|Death|2|||
164149482|NCT04807400|592907383|FG001|Overall Study|Death|0|||
164149483|NCT04807400|592907384|FG002|Overall Study|Death|0|||
164149484|NCT04807400|592907382|FG000|Overall Study|Lost to Follow-up|8|||
164149485|NCT04807400|592907383|FG001|Overall Study|Lost to Follow-up|6|||
164149486|NCT04807400|592907384|FG002|Overall Study|Lost to Follow-up|6|||
164149487|NCT04807400|592907382|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164149488|NCT04807400|592907383|FG001|Overall Study|Non-Compliance With Study Drug|4|||
164149489|NCT04807400|592907384|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164149490|NCT04807400|592907382|FG000|Overall Study|Participant Decision|20|||
164149491|NCT04807400|592907383|FG001|Overall Study|Participant Decision|19|||
164149492|NCT04807400|592907384|FG002|Overall Study|Participant Decision|26|||
164149493|NCT04807400|592907382|FG000|Overall Study|Physician Decision|0|||
164149494|NCT04807400|592907383|FG001|Overall Study|Physician Decision|1|||
164149495|NCT04807400|592907384|FG002|Overall Study|Physician Decision|0|||
164149496|NCT04807400|592907382|FG000|Overall Study|Protocol Violation|4|||
164149497|NCT04807400|592907383|FG001|Overall Study|Protocol Violation|3|||
164149498|NCT04807400|592907384|FG002|Overall Study|Protocol Violation|7|||
164149499|NCT04807400|592907382|FG000|Overall Study|Withdrawal by Subject|13|||
164149500|NCT04807400|592907383|FG001|Overall Study|Withdrawal by Subject|9|||
164149501|NCT04807400|592907384|FG002|Overall Study|Withdrawal by Subject|20|||
164149502|NCT04807400|592907382|FG000|Overall Study|Mis-randomized|1|||
164149503|NCT04807400|592907383|FG001|Overall Study|Mis-randomized|0|||
164149504|NCT04807400|592907384|FG002|Overall Study|Mis-randomized|0|||
164149505|NCT04194645|592907387|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149506|NCT04194645|592907388|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149507|NCT04194645|592907389|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149508|NCT04194645|592907390|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149509|NCT04194645|592907391|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149510|NCT04194645|592907392|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149511|NCT04194645|592907393|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149512|NCT04194645|592907394|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149513|NCT04194645|592907395|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149514|NCT04194645|592907396|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
164149515|NCT04194645|592907397|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149516|NCT04194645|592907398|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149517|NCT04194645|592907399|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149518|NCT04194645|592907400|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149519|NCT04194645|592907401|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
164149520|NCT03076775|592907402|FG000|Overall Study|Lost to Follow-up|1|||
164149521|NCT03076775|592907403|FG001|Overall Study|Lost to Follow-up|0|||
164149522|NCT01783886|592907404|FG000|Overall Study|Lost to Follow-up|0|||
164149523|NCT01783886|592907405|FG001|Overall Study|Lost to Follow-up|3|||
164149524|NCT01783886|592907406|FG002|Overall Study|Lost to Follow-up|0|||
164149525|NCT01783886|592907404|FG000|Overall Study|Protocol deviation|0|||
164149526|NCT01783886|592907405|FG001|Overall Study|Protocol deviation|0|||
164149527|NCT01783886|592907406|FG002|Overall Study|Protocol deviation|2|||
164149528|NCT01783886|592907404|FG000|Overall Study|Withdrawal of consent by participant|1|||
164149529|NCT01783886|592907405|FG001|Overall Study|Withdrawal of consent by participant|3|||
164149530|NCT01783886|592907406|FG002|Overall Study|Withdrawal of consent by participant|4|||
164149531|NCT01783886|592907404|FG000|Overall Study|Adverse Event|4|||
164149532|NCT01783886|592907405|FG001|Overall Study|Adverse Event|5|||
164149533|NCT01783886|592907406|FG002|Overall Study|Adverse Event|4|||
164149534|NCT00940316|592907407|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
164149535|NCT00940316|592907408|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
164149536|NCT00940316|592907409|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
164149537|NCT00940316|592907407|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
164149538|NCT00940316|592907408|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
164149539|NCT00940316|592907409|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
164149540|NCT00940316|592907407|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
164149541|NCT00940316|592907408|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
164149542|NCT00940316|592907409|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
164149543|NCT00940316|592907407|FG000|Treated After Cycle 5|Adverse Event|0|||
164149544|NCT00940316|592907408|FG001|Treated After Cycle 5|Adverse Event|0|||
164149545|NCT00940316|592907409|FG002|Treated After Cycle 5|Adverse Event|1|||
164149546|NCT00940316|592907407|FG000|Treated After Cycle 5|Progressive disease|0|||
164149547|NCT00940316|592907408|FG001|Treated After Cycle 5|Progressive disease|1|||
164149548|NCT00940316|592907409|FG002|Treated After Cycle 5|Progressive disease|0|||
164149549|NCT02290405|592907410|FG000|Overall Study|Withdrawal by Subject|1|||
164149550|NCT02290405|592907411|FG001|Overall Study|Withdrawal by Subject|0|||
164149551|NCT01068262|592909448|FG000|Overall Study|Adverse Event|2|||
164149552|NCT01068262|592909449|FG001|Overall Study|Adverse Event|0|||
164149553|NCT01068262|592909450|FG002|Overall Study|Adverse Event|1|||
164149554|NCT01068262|592909451|FG003|Overall Study|Adverse Event|0|||
164149555|NCT01068262|592909448|FG000|Overall Study|Protocol Violation|1|||
164149556|NCT01068262|592909449|FG001|Overall Study|Protocol Violation|0|||
164149557|NCT01068262|592909450|FG002|Overall Study|Protocol Violation|0|||
164149558|NCT01068262|592909451|FG003|Overall Study|Protocol Violation|0|||
164149559|NCT01068262|592909448|FG000|Overall Study|Withdrawal by Subject|0|||
164149560|NCT01068262|592909449|FG001|Overall Study|Withdrawal by Subject|1|||
164149561|NCT01068262|592909450|FG002|Overall Study|Withdrawal by Subject|0|||
164149562|NCT01068262|592909451|FG003|Overall Study|Withdrawal by Subject|0|||
164149563|NCT04182490|592909452|FG000|Overall Study|Withdrawal by Subject|3|||
164149564|NCT04182490|592909453|FG001|Overall Study|Withdrawal by Subject|3|||
164149565|NCT04182490|592909452|FG000|Overall Study|Lost to Follow-up|0|||
164149566|NCT04182490|592909453|FG001|Overall Study|Lost to Follow-up|1|||
164149567|NCT04182490|592909452|FG000|Overall Study|Physician Decision|0|||
164149568|NCT04182490|592909453|FG001|Overall Study|Physician Decision|1|||
164149569|NCT01811472|592909459|FG000|Overall Study|Adverse Event|1|||
164149570|NCT01811472|592909460|FG001|Overall Study|Adverse Event|0|||
164149571|NCT01811472|592909461|FG002|Overall Study|Adverse Event|4|||
164149572|NCT01811472|592909459|FG000|Overall Study|Lost to Follow-up|0|||
164149573|NCT01811472|592909460|FG001|Overall Study|Lost to Follow-up|0|||
164149574|NCT01811472|592909461|FG002|Overall Study|Lost to Follow-up|1|||
164149575|NCT01811472|592909459|FG000|Overall Study|Subject/guardian decision|1|||
164149576|NCT01811472|592909460|FG001|Overall Study|Subject/guardian decision|0|||
164149577|NCT01811472|592909461|FG002|Overall Study|Subject/guardian decision|0|||
164149578|NCT04108299|592909470|FG000|Overall Study|Not interested in participating|2|||
164149579|NCT04108299|592909471|FG001|Overall Study|Not interested in participating|1|||
164149580|NCT04108299|592909472|FG002|Overall Study|Not interested in participating|2|||
164149581|NCT04108299|592909473|FG003|Overall Study|Not interested in participating|1|||
164149582|NCT02009722|592909480|FG000|Overall Study|Protocol Violation|1|||
164149583|NCT02009722|592909481|FG001|Overall Study|Protocol Violation|2|||
164149584|NCT02009722|592909480|FG000|Overall Study|Did not receive intervention|0|||
164149585|NCT02009722|592909481|FG001|Overall Study|Did not receive intervention|1|||
164149586|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
164149587|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
164149588|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
164149589|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
164149590|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
164149591|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
164149592|NCT02955212|592909482|FG000|Period 1: Double-blind Treatment Period|Other|3|||
164149593|NCT02955212|592909483|FG001|Period 1: Double-blind Treatment Period|Other|2|||
164149594|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Adverse Event|11|||
164149595|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Adverse Event|7|||
164149596|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
164149597|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
164149598|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
164149599|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
164149600|NCT02955212|592909482|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
164149601|NCT02955212|592909483|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
164149602|NCT02955212|592909482|FG000|Period 2: Open-label Extension|Other|2|||
164149603|NCT02955212|592909483|FG001|Period 2: Open-label Extension|Other|4|||
164149604|NCT02454933|592909492|FG000|Overall Study|Progressive disease|10|||
164149605|NCT02454933|592909493|FG001|Overall Study|Progressive disease|7|||
164149606|NCT02454933|592909492|FG000|Overall Study|Adverse Event|1|||
164149607|NCT02454933|592909493|FG001|Overall Study|Adverse Event|1|||
164149608|NCT02454933|592909492|FG000|Overall Study|Withdrawal by Subject|0|||
164149609|NCT02454933|592909493|FG001|Overall Study|Withdrawal by Subject|3|||
164149610|NCT02454933|592909492|FG000|Overall Study|Lost to Follow-up|1|||
164149611|NCT02454933|592909493|FG001|Overall Study|Lost to Follow-up|0|||
164149612|NCT02515331|592909505|FG000|Overall Study|Withdrawal by Subject|0|||
164149613|NCT02515331|592909506|FG001|Overall Study|Withdrawal by Subject|0|||
164149614|NCT02515331|592909507|FG002|Overall Study|Withdrawal by Subject|1|||
164149615|NCT02515331|592909505|FG000|Overall Study|Protocol deviation|0|||
164149616|NCT02515331|592909506|FG001|Overall Study|Protocol deviation|0|||
164149617|NCT02515331|592909507|FG002|Overall Study|Protocol deviation|3|||
164149618|NCT02515331|592909505|FG000|Overall Study|Adverse Event|2|||
164149619|NCT02515331|592909506|FG001|Overall Study|Adverse Event|0|||
164149620|NCT02515331|592909507|FG002|Overall Study|Adverse Event|0|||
164149621|NCT00124748|592909508|FG000|Overall Study|Adverse Event|8|||
164149622|NCT00124748|592909509|FG001|Overall Study|Adverse Event|39|||
164149623|NCT00124748|592909508|FG000|Overall Study|Abnormal laboratory Value|2|||
164149624|NCT00124748|592909509|FG001|Overall Study|Abnormal laboratory Value|2|||
164149625|NCT00124748|592909508|FG000|Overall Study|Abnormal Procedure|0|||
164149626|NCT00124748|592909509|FG001|Overall Study|Abnormal Procedure|1|||
164149627|NCT00124748|592909508|FG000|Overall Study|Lack of Efficacy|20|||
164149628|NCT00124748|592909509|FG001|Overall Study|Lack of Efficacy|41|||
164149629|NCT00124748|592909508|FG000|Overall Study|No longer requires study drug|1|||
164149630|NCT00124748|592909509|FG001|Overall Study|No longer requires study drug|1|||
164149631|NCT00124748|592909508|FG000|Overall Study|Protocol Violation|3|||
164149632|NCT00124748|592909509|FG001|Overall Study|Protocol Violation|1|||
164149633|NCT00124748|592909508|FG000|Overall Study|Withdrawal by Subject|5|||
164149634|NCT00124748|592909509|FG001|Overall Study|Withdrawal by Subject|15|||
164149635|NCT00124748|592909508|FG000|Overall Study|Lost to Follow-up|2|||
164149636|NCT00124748|592909509|FG001|Overall Study|Lost to Follow-up|7|||
164149637|NCT00124748|592909508|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
164149638|NCT00124748|592909509|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
164149639|NCT00124748|592909508|FG000|Overall Study|Death|1|||
164149640|NCT00124748|592909509|FG001|Overall Study|Death|3|||
164149641|NCT00322712|592909510|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
164149642|NCT02071225|592909511|FG000|Overall Study|Withdrawal of Consent|2|||
164149643|NCT02071225|592909511|FG000|Overall Study|Protocol Deviation|1|||
164149644|NCT02071225|592909511|FG000|Overall Study|Lost to Follow-up|2|||
164149645|NCT02071225|592909511|FG000|Overall Study|Death|25|||
164149646|NCT04176250|592909514|FG000|Overall Study|Adverse Event|0|||
164149647|NCT04176250|592909515|FG001|Overall Study|Adverse Event|1|||
164149648|NCT04176250|592909516|FG002|Overall Study|Adverse Event|0|||
164149649|NCT04176250|592909517|FG003|Overall Study|Adverse Event|1|||
164149650|NCT04176250|592909518|FG004|Overall Study|Adverse Event|0|||
164149651|NCT04176250|592909519|FG005|Overall Study|Adverse Event|1|||
164149652|NCT04176250|592909514|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149653|NCT04176250|592909515|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149654|NCT04176250|592909516|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
164149655|NCT04176250|592909517|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
164149656|NCT04176250|592909518|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149657|NCT04176250|592909519|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
164149658|NCT04176250|592909514|FG000|Overall Study|Withdrawal by Subject|0|||
164149659|NCT04176250|592909515|FG001|Overall Study|Withdrawal by Subject|0|||
164149660|NCT04176250|592909516|FG002|Overall Study|Withdrawal by Subject|0|||
164149661|NCT04176250|592909517|FG003|Overall Study|Withdrawal by Subject|0|||
164149662|NCT04176250|592909518|FG004|Overall Study|Withdrawal by Subject|0|||
164149663|NCT04176250|592909519|FG005|Overall Study|Withdrawal by Subject|1|||
164149664|NCT04176250|592909514|FG000|Overall Study|Randomized in error|0|||
164149665|NCT04176250|592909515|FG001|Overall Study|Randomized in error|0|||
164149666|NCT04176250|592909516|FG002|Overall Study|Randomized in error|0|||
164149667|NCT04176250|592909517|FG003|Overall Study|Randomized in error|0|||
164149668|NCT04176250|592909518|FG004|Overall Study|Randomized in error|1|||
164149669|NCT04176250|592909519|FG005|Overall Study|Randomized in error|0|||
164149670|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
164149671|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
164149672|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
164149673|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149674|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
164149675|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
164149676|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149677|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149678|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149679|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149680|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149681|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149682|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149683|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149684|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149685|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149686|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
164149687|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
164149688|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149689|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
164149690|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
164149691|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
164149692|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
164149693|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149694|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149695|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149696|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149697|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149698|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149699|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149700|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149701|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149702|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149703|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
164149704|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
164149705|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
164149706|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
164149707|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
164149708|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
164149709|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
164149710|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149711|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149712|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149713|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149714|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149715|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149716|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149717|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149718|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149719|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149720|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
164149721|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149722|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
164149723|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
164149724|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149725|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
164149726|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
164149727|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149728|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149729|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149730|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149731|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149732|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149733|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149734|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149735|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149736|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149737|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
164149738|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149739|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149740|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
164149741|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
164149742|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149743|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149744|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149745|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149746|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149747|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149748|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149749|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149750|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149751|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149752|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149753|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149754|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
164149755|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149756|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149757|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149758|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149759|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
164149760|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149761|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149762|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149763|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149764|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149765|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149766|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149767|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149768|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149769|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149770|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149771|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
164149772|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149773|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
164149774|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149775|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149776|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149777|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149778|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149779|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149843|NCT01342081|592909539|FG000|Overall Study|Adverse Event|1|||
164149780|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149781|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149782|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149783|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149784|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149785|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149786|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149787|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149788|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
164149789|NCT00758524|592909520|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149790|NCT00758524|592909521|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
164149791|NCT00758524|592909522|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149792|NCT00758524|592909523|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149793|NCT00758524|592909524|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149794|NCT00758524|592909525|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149795|NCT00758524|592909526|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149796|NCT00758524|592909527|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149797|NCT00758524|592909528|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149798|NCT00758524|592909529|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149799|NCT00758524|592909530|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149800|NCT00758524|592909531|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149801|NCT00758524|592909532|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149802|NCT00758524|592909533|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149803|NCT00758524|592909534|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149804|NCT00758524|592909535|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149805|NCT00758524|592909536|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
164149806|NCT00758524|592909520|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149807|NCT00758524|592909521|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149808|NCT00758524|592909522|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149809|NCT00758524|592909523|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149810|NCT00758524|592909524|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149811|NCT00758524|592909525|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149812|NCT00758524|592909526|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149813|NCT00758524|592909527|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149814|NCT00758524|592909528|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
164149815|NCT00758524|592909529|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149816|NCT00758524|592909530|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149817|NCT00758524|592909531|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149818|NCT00758524|592909532|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149819|NCT00758524|592909533|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149820|NCT00758524|592909534|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149821|NCT00758524|592909535|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149822|NCT00758524|592909536|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
164149823|NCT00758524|592909520|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149824|NCT00758524|592909521|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149825|NCT00758524|592909522|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149826|NCT00758524|592909523|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149827|NCT00758524|592909524|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149828|NCT00758524|592909525|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149829|NCT00758524|592909526|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
164149830|NCT00758524|592909527|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149831|NCT00758524|592909528|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149832|NCT00758524|592909529|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149833|NCT00758524|592909530|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149834|NCT00758524|592909531|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149835|NCT00758524|592909532|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149836|NCT00758524|592909533|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149837|NCT00758524|592909534|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149838|NCT00758524|592909535|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149839|NCT00758524|592909536|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
164149840|NCT01342081|592909539|FG000|Overall Study|Did not receive allocated intervention|0|||
164149841|NCT01342081|592909540|FG001|Overall Study|Did not receive allocated intervention|0|||
164149842|NCT01342081|592909541|FG002|Overall Study|Did not receive allocated intervention|1|||
164149844|NCT01342081|592909540|FG001|Overall Study|Adverse Event|0|||
164149845|NCT01342081|592909541|FG002|Overall Study|Adverse Event|0|||
164149846|NCT01342081|592909539|FG000|Overall Study|Physician Decision|0|||
164149847|NCT01342081|592909540|FG001|Overall Study|Physician Decision|1|||
164149848|NCT01342081|592909541|FG002|Overall Study|Physician Decision|0|||
164149849|NCT01342081|592909539|FG000|Overall Study|Withdrawal by Subject|1|||
164149850|NCT01342081|592909540|FG001|Overall Study|Withdrawal by Subject|1|||
164149851|NCT01342081|592909541|FG002|Overall Study|Withdrawal by Subject|0|||
164149852|NCT04720053|592909543|FG000|Overall Study|Lost to Follow-up|12|||
164149853|NCT01350271|592909544|FG000|Overall Study|Lost to Follow-up|21|||
164149854|NCT01350271|592909545|FG001|Overall Study|Lost to Follow-up|17|||
164149855|NCT01350271|592909546|FG002|Overall Study|Lost to Follow-up|26|||
164149856|NCT01973439|592909547|FG000|Overall Study|Lost samples from one PK Day|2|||
164149857|NCT01973439|592909547|FG000|Overall Study|Vomiting after commencing once daily|1|||
164149858|NCT01973439|592909547|FG000|Overall Study|PK curve incomplete|2|||
164149859|NCT02500589|592909552|FG000|Overall Study|Withdrawal by Subject|11|||
164149860|NCT02500589|592909553|FG001|Overall Study|Withdrawal by Subject|14|||
164149861|NCT02500589|592909552|FG000|Overall Study|Lost to Follow-up|10|||
164149862|NCT02500589|592909553|FG001|Overall Study|Lost to Follow-up|12|||
164149863|NCT02500589|592909552|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
164149864|NCT02500589|592909553|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
164149865|NCT02500589|592909552|FG000|Overall Study|Death|7|||
164149866|NCT02500589|592909553|FG001|Overall Study|Death|5|||
164149867|NCT03656744|592909558|FG000|Overall Study|Adverse Event|1|||
164149868|NCT03656744|592909559|FG001|Overall Study|Adverse Event|4|||
164149869|NCT03656744|592909560|FG002|Overall Study|Adverse Event|1|||
164149870|NCT03656744|592909558|FG000|Overall Study|Protocol Violation|1|||
164149871|NCT03656744|592909559|FG001|Overall Study|Protocol Violation|0|||
164149872|NCT03656744|592909560|FG002|Overall Study|Protocol Violation|0|||
164149873|NCT03656744|592909558|FG000|Overall Study|Lost to Follow-up|2|||
164149874|NCT03656744|592909559|FG001|Overall Study|Lost to Follow-up|2|||
164149875|NCT03656744|592909560|FG002|Overall Study|Lost to Follow-up|0|||
164149876|NCT03656744|592909558|FG000|Overall Study|Withdrawal by Subject|0|||
164149877|NCT03656744|592909559|FG001|Overall Study|Withdrawal by Subject|1|||
164149878|NCT03656744|592909560|FG002|Overall Study|Withdrawal by Subject|0|||
164149879|NCT03656744|592909558|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
164149880|NCT03656744|592909559|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
164149881|NCT03656744|592909560|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
164149882|NCT00996489|592909561|FG000|Overall Study|Device failure|45|||
164149883|NCT00996489|592909561|FG000|Overall Study|Discontinued|116|||
164149884|NCT03142191|592909562|FG000|Placebo Controlled Period|Death|0|||
164149885|NCT03142191|592909563|FG001|Placebo Controlled Period|Death|1|||
164149886|NCT03142191|592909564|FG002|Placebo Controlled Period|Death|1|||
164149887|NCT03142191|592909565|FG003|Placebo Controlled Period|Death|0|||
164149888|NCT03142191|592909566|FG004|Placebo Controlled Period|Death|0|||
164149889|NCT03142191|592909562|FG000|Placebo Controlled Period|Adverse Event|4|||
164149890|NCT03142191|592909563|FG001|Placebo Controlled Period|Adverse Event|5|||
164149891|NCT03142191|592909564|FG002|Placebo Controlled Period|Adverse Event|1|||
164149892|NCT03142191|592909565|FG003|Placebo Controlled Period|Adverse Event|0|||
164149893|NCT03142191|592909566|FG004|Placebo Controlled Period|Adverse Event|0|||
164149894|NCT03142191|592909562|FG000|Placebo Controlled Period|Progressive Disease|1|||
164149895|NCT03142191|592909563|FG001|Placebo Controlled Period|Progressive Disease|0|||
164149896|NCT03142191|592909564|FG002|Placebo Controlled Period|Progressive Disease|1|||
164149897|NCT03142191|592909565|FG003|Placebo Controlled Period|Progressive Disease|0|||
164149898|NCT03142191|592909566|FG004|Placebo Controlled Period|Progressive Disease|0|||
164149899|NCT03142191|592909562|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
164149900|NCT03142191|592909563|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
164149901|NCT03142191|592909564|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
164149902|NCT03142191|592909565|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
164149903|NCT03142191|592909566|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
164149904|NCT03142191|592909562|FG000|Placebo Controlled Period|Other Reasons|1|||
164149905|NCT03142191|592909563|FG001|Placebo Controlled Period|Other Reasons|0|||
164149906|NCT03142191|592909564|FG002|Placebo Controlled Period|Other Reasons|0|||
164149907|NCT03142191|592909565|FG003|Placebo Controlled Period|Other Reasons|0|||
164149908|NCT03142191|592909566|FG004|Placebo Controlled Period|Other Reasons|0|||
164149909|NCT03142191|592909562|FG000|Active Treatment Extension Period|Death|2|||
164149910|NCT03142191|592909563|FG001|Active Treatment Extension Period|Death|1|||
164149911|NCT03142191|592909564|FG002|Active Treatment Extension Period|Death|1|||
164149912|NCT03142191|592909565|FG003|Active Treatment Extension Period|Death|1|||
164149913|NCT03142191|592909566|FG004|Active Treatment Extension Period|Death|0|||
164149914|NCT03142191|592909562|FG000|Active Treatment Extension Period|Adverse Event|6|||
164149915|NCT03142191|592909563|FG001|Active Treatment Extension Period|Adverse Event|5|||
164149916|NCT03142191|592909564|FG002|Active Treatment Extension Period|Adverse Event|4|||
164149917|NCT03142191|592909565|FG003|Active Treatment Extension Period|Adverse Event|1|||
164149918|NCT03142191|592909566|FG004|Active Treatment Extension Period|Adverse Event|0|||
164149919|NCT03142191|592909562|FG000|Active Treatment Extension Period|Progressive Disease|10|||
164149920|NCT03142191|592909563|FG001|Active Treatment Extension Period|Progressive Disease|5|||
164149921|NCT03142191|592909564|FG002|Active Treatment Extension Period|Progressive Disease|4|||
164149922|NCT03142191|592909565|FG003|Active Treatment Extension Period|Progressive Disease|1|||
164149923|NCT03142191|592909566|FG004|Active Treatment Extension Period|Progressive Disease|2|||
164149924|NCT03142191|592909562|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
164149925|NCT03142191|592909563|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
164149926|NCT03142191|592909564|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
164149927|NCT03142191|592909565|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
164149928|NCT03142191|592909566|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
164149929|NCT03142191|592909562|FG000|Active Treatment Extension Period|Physician Decision|2|||
164149930|NCT03142191|592909563|FG001|Active Treatment Extension Period|Physician Decision|0|||
164149931|NCT03142191|592909564|FG002|Active Treatment Extension Period|Physician Decision|0|||
164149932|NCT03142191|592909565|FG003|Active Treatment Extension Period|Physician Decision|0|||
164149933|NCT03142191|592909566|FG004|Active Treatment Extension Period|Physician Decision|0|||
164149934|NCT03142191|592909562|FG000|Active Treatment Extension Period|Other Reasons|3|||
164149935|NCT03142191|592909563|FG001|Active Treatment Extension Period|Other Reasons|3|||
164149936|NCT03142191|592909564|FG002|Active Treatment Extension Period|Other Reasons|3|||
164149937|NCT03142191|592909565|FG003|Active Treatment Extension Period|Other Reasons|8|||
164149938|NCT03142191|592909566|FG004|Active Treatment Extension Period|Other Reasons|3|||
164149939|NCT03142191|592909562|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
164149940|NCT03142191|592909563|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
164149941|NCT03142191|592909564|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
164149942|NCT03142191|592909565|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
164149943|NCT03142191|592909566|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
164149944|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
164149945|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
164149946|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
164149947|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
164149948|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
164149949|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
164149950|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
164149951|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
164149952|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
164149953|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
164149954|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
164149955|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
164149956|NCT01130493|592909571|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
164149957|NCT01130493|592909572|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
164149958|NCT01130493|592909573|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
164149959|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
164149960|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
164149961|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
164149962|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
164149963|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
164149964|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
164149965|NCT01130493|592909571|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
164149966|NCT01130493|592909572|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
164149967|NCT01130493|592909573|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
164149968|NCT01130493|592909571|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
164149969|NCT01130493|592909572|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
164149970|NCT01130493|592909573|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
164149971|NCT01130493|592909571|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
164149972|NCT01130493|592909572|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
164149973|NCT01130493|592909573|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
164149974|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
164149975|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
164149976|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
164149977|NCT01130493|592909571|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
164149978|NCT01130493|592909572|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
164149979|NCT01130493|592909573|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
164149980|NCT01130493|592909571|FG000|Part 2: OLE|Adverse Event|0|||
164149981|NCT01130493|592909572|FG001|Part 2: OLE|Adverse Event|2|||
164149982|NCT01130493|592909573|FG002|Part 2: OLE|Adverse Event|1|||
164149983|NCT01130493|592909571|FG000|Part 2: OLE|Withdrawal by Subject|0|||
164149984|NCT01130493|592909572|FG001|Part 2: OLE|Withdrawal by Subject|1|||
164149985|NCT01130493|592909573|FG002|Part 2: OLE|Withdrawal by Subject|4|||
164149986|NCT03541317|592909574|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
164149987|NCT03541317|592909575|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149988|NCT03541317|592909576|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149989|NCT03541317|592909577|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149990|NCT03541317|592909578|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149991|NCT03541317|592909579|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
164149992|NCT00879086|592909582|FG000|Overall Study|Adverse Event|3|||
164149993|NCT00879086|592909583|FG001|Overall Study|Adverse Event|15|||
164149994|NCT00879086|592909582|FG000|Overall Study|Participant choice|2|||
164149995|NCT00879086|592909583|FG001|Overall Study|Participant choice|2|||
164149996|NCT00879086|592909582|FG000|Overall Study|Progression of disease|40|||
164149997|NCT00879086|592909583|FG001|Overall Study|Progression of disease|26|||
164149998|NCT00879086|592909582|FG000|Overall Study|Withdrawal of consent|2|||
164149999|NCT00879086|592909583|FG001|Overall Study|Withdrawal of consent|1|||
164150000|NCT00879086|592909582|FG000|Overall Study|Other|4|||
164150001|NCT00879086|592909583|FG001|Overall Study|Other|6|||
164150002|NCT00879086|592909582|FG000|Overall Study|Death|1|||
164150003|NCT00879086|592909583|FG001|Overall Study|Death|2|||
164150004|NCT04728802|592909584|FG000|Overall Study|Withdrawal by Subject|4|||
164150005|NCT04728802|592909585|FG001|Overall Study|Withdrawal by Subject|20|||
164150006|NCT04728802|592909584|FG000|Overall Study|Physician Decision|7|||
164150007|NCT04728802|592909585|FG001|Overall Study|Physician Decision|7|||
164150008|NCT04728802|592909584|FG000|Overall Study|Protocol Violation|10|||
164150009|NCT04728802|592909585|FG001|Overall Study|Protocol Violation|4|||
164150010|NCT04728802|592909584|FG000|Overall Study|Transfer|1|||
164150011|NCT04728802|592909585|FG001|Overall Study|Transfer|0|||
164150012|NCT04728802|592909584|FG000|Overall Study|Death|4|||
164150013|NCT04728802|592909585|FG001|Overall Study|Death|5|||
164150014|NCT04728802|592909584|FG000|Overall Study|Other|3|||
164150015|NCT04728802|592909585|FG001|Overall Study|Other|0|||
164150016|NCT02517463|592909590|FG000|Overall Study|Lost to Follow-up|5|||
164150017|NCT02517463|592909591|FG001|Overall Study|Lost to Follow-up|2|||
164150018|NCT02296931|592909594|FG000|Overall Study|Protocol Violation|0|||
164150019|NCT02296931|592909595|FG001|Overall Study|Protocol Violation|2|||
164150020|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|3|||
164150021|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|2|||
164150022|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|1|||
164150023|NCT01590277|592909596|FG000|Overall Study|Withdrawal by Subject|1|||
164150024|NCT04386616|592909597|FG000|Overall Study|Death|22|||
164150025|NCT04386616|592909598|FG001|Overall Study|Death|22|||
164150026|NCT04386616|592909599|FG002|Overall Study|Death|21|||
164150027|NCT04386616|592909597|FG000|Overall Study|Lost to Follow-up|5|||
164150028|NCT04386616|592909598|FG001|Overall Study|Lost to Follow-up|8|||
164150029|NCT04386616|592909599|FG002|Overall Study|Lost to Follow-up|6|||
164150030|NCT04386616|592909597|FG000|Overall Study|Withdrawal by Subject|2|||
164150031|NCT04386616|592909598|FG001|Overall Study|Withdrawal by Subject|4|||
164150032|NCT04386616|592909599|FG002|Overall Study|Withdrawal by Subject|1|||
164150033|NCT04386616|592909597|FG000|Overall Study|Adverse Event|1|||
164150034|NCT04386616|592909598|FG001|Overall Study|Adverse Event|1|||
164150035|NCT04386616|592909599|FG002|Overall Study|Adverse Event|0|||
164150036|NCT01377012|592909600|FG000|Core Study|Study terminated by Sponsor|47|||
164150037|NCT01377012|592909601|FG001|Core Study|Study terminated by Sponsor|54|||
164150038|NCT01377012|592909602|FG002|Core Study|Study terminated by Sponsor|46|||
164150039|NCT01377012|592909600|FG000|Core Study|Technical problems|1|||
164150040|NCT01377012|592909601|FG001|Core Study|Technical problems|0|||
164150041|NCT01377012|592909602|FG002|Core Study|Technical problems|0|||
164150042|NCT01377012|592909600|FG000|Core Study|Withdrawal by Subject|15|||
164150043|NCT01377012|592909601|FG001|Core Study|Withdrawal by Subject|23|||
164150044|NCT01377012|592909602|FG002|Core Study|Withdrawal by Subject|18|||
164150045|NCT01377012|592909600|FG000|Core Study|Protocol Violation|7|||
164150046|NCT01377012|592909601|FG001|Core Study|Protocol Violation|3|||
164150047|NCT01377012|592909602|FG002|Core Study|Protocol Violation|2|||
164150048|NCT01377012|592909600|FG000|Core Study|Pregnancy|0|||
164150049|NCT01377012|592909601|FG001|Core Study|Pregnancy|0|||
164150050|NCT01377012|592909602|FG002|Core Study|Pregnancy|1|||
164150051|NCT01377012|592909600|FG000|Core Study|Physician Decision|5|||
164150052|NCT01377012|592909601|FG001|Core Study|Physician Decision|4|||
164150053|NCT01377012|592909602|FG002|Core Study|Physician Decision|10|||
164150054|NCT01377012|592909600|FG000|Core Study|Non-Compliant with study treatment|0|||
164150055|NCT01377012|592909601|FG001|Core Study|Non-Compliant with study treatment|0|||
164150056|NCT01377012|592909602|FG002|Core Study|Non-Compliant with study treatment|1|||
164150057|NCT01377012|592909600|FG000|Core Study|No Longer require treatment|0|||
164150058|NCT01377012|592909601|FG001|Core Study|No Longer require treatment|0|||
164150059|NCT01377012|592909602|FG002|Core Study|No Longer require treatment|1|||
164150060|NCT01377012|592909600|FG000|Core Study|Lost to Follow-up|7|||
164150061|NCT01377012|592909601|FG001|Core Study|Lost to Follow-up|5|||
164150062|NCT01377012|592909602|FG002|Core Study|Lost to Follow-up|4|||
164150063|NCT01377012|592909600|FG000|Core Study|Lack of Efficacy|41|||
164150064|NCT01377012|592909601|FG001|Core Study|Lack of Efficacy|28|||
164150065|NCT01377012|592909602|FG002|Core Study|Lack of Efficacy|37|||
164150066|NCT01377012|592909600|FG000|Core Study|Death|1|||
164150067|NCT01377012|592909601|FG001|Core Study|Death|1|||
164150068|NCT01377012|592909602|FG002|Core Study|Death|1|||
164150069|NCT01377012|592909600|FG000|Core Study|Adverse Event|10|||
164150070|NCT01377012|592909601|FG001|Core Study|Adverse Event|14|||
164150071|NCT01377012|592909602|FG002|Core Study|Adverse Event|13|||
164150072|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
164150073|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
164150074|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
164150075|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
164150076|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
164150077|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
164150078|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
164150079|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
164150080|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
164150081|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
164150082|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
164150083|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
164150084|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
164150085|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
164150086|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
164150087|NCT01377012|592909600|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
164150088|NCT01377012|592909601|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
164150089|NCT01377012|592909602|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
164150090|NCT00805961|592909603|FG000|Modality Therapy|Withdrawal by Subject|1|||
164150091|NCT00805961|592909603|FG000|Modality Therapy|Adverse Event|1|||
164150092|NCT00805961|592909603|FG000|Modality Therapy|Disease Progression|2|||
164150093|NCT00805961|592909603|FG000|Treatment-Free Interval|Adverse Event|3|||
164150094|NCT00805961|592909603|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
164150095|NCT00805961|592909603|FG000|Treatment-Free Interval|Physician Decision|1|||
164150096|NCT00805961|592909603|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
164150097|NCT00805961|592909603|FG000|Maintenance Treatment|Lack of Efficacy|13|||
164150098|NCT00805961|592909603|FG000|Maintenance Treatment|Intercurrent Illness|7|||
164150099|NCT00805961|592909603|FG000|Maintenance Treatment|Adverse Event|6|||
164150100|NCT00805961|592909603|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
164150101|NCT00805961|592909603|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
164150102|NCT00805961|592909603|FG000|Maintenance Treatment|Withdrawn Consent|1|||
164150103|NCT05022212|592909611|FG000|Overall Study|Lost to Follow-up|0|||
164150104|NCT05022212|592909612|FG001|Overall Study|Lost to Follow-up|2|||
164150105|NCT02905032|592909613|FG000|Overall Study|Withdrawal by Subject|2|||
164150106|NCT02905032|592909614|FG001|Overall Study|Withdrawal by Subject|0|||
164150107|NCT02905032|592909615|FG002|Overall Study|Withdrawal by Subject|0|||
164150108|NCT02905032|592909613|FG000|Overall Study|Protocol Violation|6|||
164150109|NCT02905032|592909614|FG001|Overall Study|Protocol Violation|12|||
164150110|NCT02905032|592909615|FG002|Overall Study|Protocol Violation|0|||
164150111|NCT00739063|592909616|FG000|Overall Study|Screen failures|8|||
164150112|NCT04917861|592909618|FG000|Main Study (196 Days)|Adverse Event|0|||
164150113|NCT04917861|592909619|FG001|Main Study (196 Days)|Adverse Event|1|||
164150114|NCT04917861|592909620|FG002|Main Study (196 Days)|Adverse Event|0|||
164150115|NCT04917861|592909621|FG003|Main Study (196 Days)|Adverse Event|0|||
164150116|NCT04917861|592909618|FG000|Main Study (196 Days)|Death|0|||
164150117|NCT04917861|592909619|FG001|Main Study (196 Days)|Death|0|||
164150118|NCT04917861|592909620|FG002|Main Study (196 Days)|Death|0|||
164150119|NCT04917861|592909621|FG003|Main Study (196 Days)|Death|1|||
164150120|NCT04917861|592909618|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
164150121|NCT04917861|592909619|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
164150122|NCT04917861|592909620|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
164150123|NCT04917861|592909621|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
164150124|NCT04917861|592909618|FG000|Main Study (196 Days)|Physician Decision|0|||
164150125|NCT04917861|592909619|FG001|Main Study (196 Days)|Physician Decision|0|||
164150126|NCT04917861|592909620|FG002|Main Study (196 Days)|Physician Decision|0|||
164150127|NCT04917861|592909621|FG003|Main Study (196 Days)|Physician Decision|1|||
164150128|NCT04917861|592909618|FG000|Main Study (196 Days)|Pregnancy|1|||
164150129|NCT04917861|592909619|FG001|Main Study (196 Days)|Pregnancy|1|||
164150130|NCT04917861|592909620|FG002|Main Study (196 Days)|Pregnancy|0|||
164150131|NCT04917861|592909621|FG003|Main Study (196 Days)|Pregnancy|0|||
164150132|NCT04917861|592909618|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
164150133|NCT04917861|592909619|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
164150134|NCT04917861|592909620|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
164150135|NCT04917861|592909621|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
164150136|NCT04917861|592909618|FG000|Main Study (196 Days)|Other Than Specified|1|||
164150137|NCT04917861|592909619|FG001|Main Study (196 Days)|Other Than Specified|0|||
164150138|NCT04917861|592909620|FG002|Main Study (196 Days)|Other Than Specified|1|||
164150139|NCT04917861|592909621|FG003|Main Study (196 Days)|Other Than Specified|2|||
164150140|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
164150141|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
164150142|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
164150143|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
164150144|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
164150145|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
164150146|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
164150147|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
164150148|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
164150149|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
164150150|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
164150151|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
164150152|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
164150153|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
164150154|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
164150155|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
164150156|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
164150157|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
164150158|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
164150159|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
164150160|NCT04917861|592909618|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
164150161|NCT04917861|592909619|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
164150162|NCT04917861|592909620|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
164150163|NCT04917861|592909621|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
164150164|NCT01260701|592909622|FG000|Overall Study|Adverse Event|9|||
164150165|NCT01260701|592909622|FG000|Overall Study|Withdrawal by Subject|2|||
164150166|NCT01260701|592909622|FG000|Overall Study|Progression|53|||
164150167|NCT01260701|592909622|FG000|Overall Study|Death|2|||
164150168|NCT01260701|592909622|FG000|Overall Study|Not protocol specified|3|||
164150169|NCT01260701|592909622|FG000|Overall Study|Under review|1|||
164150170|NCT01260701|592909622|FG000|Overall Study|Ineligible|4|||
164150171|NCT01260701|592909622|FG000|Overall Study|Did not begin protocol therapy|1|||
164150172|NCT00720382|592909623|FG000|Overall Study|Adverse Event|54|||
164150173|NCT00720382|592909624|FG001|Overall Study|Adverse Event|17|||
164150174|NCT00720382|592909623|FG000|Overall Study|Lack of Efficacy|18|||
164150175|NCT00720382|592909624|FG001|Overall Study|Lack of Efficacy|7|||
164150176|NCT00720382|592909623|FG000|Overall Study|Non-Compliance|15|||
164150177|NCT00720382|592909624|FG001|Overall Study|Non-Compliance|5|||
164150178|NCT00720382|592909623|FG000|Overall Study|Withdrawal by Subject|47|||
164150179|NCT00720382|592909624|FG001|Overall Study|Withdrawal by Subject|11|||
164150180|NCT00720382|592909623|FG000|Overall Study|Lost to Follow-up|28|||
164150181|NCT00720382|592909624|FG001|Overall Study|Lost to Follow-up|14|||
164150182|NCT00720382|592909623|FG000|Overall Study|administrative|14|||
164150183|NCT00720382|592909624|FG001|Overall Study|administrative|5|||
164150184|NCT05192889|592909626|FG000|Block 1: All Eligible Patients|Death|2|||
164150185|NCT05192889|592909627|FG001|Block 1: All Eligible Patients|Death|0|||
164150186|NCT05192889|592909628|FG002|Block 1: All Eligible Patients|Death|0|||
164150187|NCT05192889|592909626|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
164150188|NCT05192889|592909627|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
164150189|NCT05192889|592909628|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
164150190|NCT05192889|592909626|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
164150191|NCT05192889|592909627|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
164150192|NCT05192889|592909628|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
164150193|NCT04467840|592910889|FG000|Overall Study|Death|35|||
164150194|NCT04467840|592910890|FG001|Overall Study|Death|39|||
164150195|NCT04467840|592910889|FG000|Overall Study|Withdrawal by Subject|8|||
164150196|NCT04467840|592910890|FG001|Overall Study|Withdrawal by Subject|4|||
164150197|NCT04467840|592910889|FG000|Overall Study|Adverse Event|2|||
164150198|NCT04467840|592910890|FG001|Overall Study|Adverse Event|0|||
164150199|NCT04467840|592910889|FG000|Overall Study|Lost to Follow-up|1|||
164150200|NCT04467840|592910890|FG001|Overall Study|Lost to Follow-up|3|||
164150201|NCT04467840|592910889|FG000|Overall Study|Physician Decision|1|||
164150202|NCT04467840|592910890|FG001|Overall Study|Physician Decision|0|||
164150203|NCT04467840|592910889|FG000|Overall Study|Other|1|||
164150204|NCT04467840|592910890|FG001|Overall Study|Other|5|||
164150205|NCT04467840|592910889|FG000|Overall Study|Missing study completion status|3|||
164150206|NCT04467840|592910890|FG001|Overall Study|Missing study completion status|1|||
164150207|NCT06082843|592910897|FG000|Overall Study|Withdrawal by Subject|0|||
164150208|NCT06082843|592910898|FG001|Overall Study|Withdrawal by Subject|2|||
164150209|NCT06082843|592910897|FG000|Overall Study|Study terminated by sponsor|12|||
164150210|NCT06082843|592910898|FG001|Overall Study|Study terminated by sponsor|8|||
164150211|NCT00696423|592910901|FG000|Overall Study|Lost to Follow-up|0|||
164150212|NCT00696423|592910902|FG001|Overall Study|Lost to Follow-up|5|||
164150213|NCT03989102|592910903|FG000|Year 1|Withdrawal by Subject|6|||
164150214|NCT03989102|592910904|FG001|Year 1|Withdrawal by Subject|2|||
164150215|NCT03989102|592910905|FG002|Year 1|Withdrawal by Subject|7|||
164150216|NCT03989102|592910903|FG000|Year 1|Lost to Follow-up|5|||
164150217|NCT03989102|592910904|FG001|Year 1|Lost to Follow-up|2|||
164150218|NCT03989102|592910905|FG002|Year 1|Lost to Follow-up|5|||
164150219|NCT03989102|592910903|FG000|Year 1|Subject met withdrawal criteria|1|||
164150220|NCT03989102|592910904|FG001|Year 1|Subject met withdrawal criteria|0|||
164150221|NCT03989102|592910905|FG002|Year 1|Subject met withdrawal criteria|1|||
164150222|NCT03989102|592910903|FG000|Year 2|Lost to Follow-up|7|||
164150223|NCT03989102|592910904|FG001|Year 2|Lost to Follow-up|3|||
164150224|NCT03989102|592910905|FG002|Year 2|Lost to Follow-up|4|||
164150225|NCT03989102|592910903|FG000|Year 2|Withdrawal by Subject|3|||
164150226|NCT03989102|592910904|FG001|Year 2|Withdrawal by Subject|1|||
164150227|NCT03989102|592910905|FG002|Year 2|Withdrawal by Subject|2|||
164150228|NCT03989102|592910903|FG000|Year 2|Subject non-compliant|3|||
164150229|NCT03989102|592910904|FG001|Year 2|Subject non-compliant|2|||
164150230|NCT03989102|592910905|FG002|Year 2|Subject non-compliant|0|||
164150231|NCT03989102|592910903|FG000|Year 2|Travel|1|||
164150232|NCT03989102|592910904|FG001|Year 2|Travel|0|||
164150233|NCT03989102|592910905|FG002|Year 2|Travel|1|||
164150234|NCT03989102|592910903|FG000|Year 2|P16 missing|4|||
164150235|NCT03989102|592910904|FG001|Year 2|P16 missing|2|||
164150236|NCT03989102|592910905|FG002|Year 2|P16 missing|1|||
164150237|NCT03989102|592910903|FG000|Year 2|P11 missing|1|||
164150238|NCT03989102|592910904|FG001|Year 2|P11 missing|3|||
164150239|NCT03989102|592910905|FG002|Year 2|P11 missing|7|||
164150240|NCT03989102|592910903|FG000|Year 2|Definitive displacement outside the study site|0|||
164150241|NCT03989102|592910904|FG001|Year 2|Definitive displacement outside the study site|1|||
164150242|NCT03989102|592910905|FG002|Year 2|Definitive displacement outside the study site|0|||
164150243|NCT03989102|592910903|FG000|Year 2|Subject missed last study visit|0|||
164150244|NCT03989102|592910904|FG001|Year 2|Subject missed last study visit|1|||
164150245|NCT03989102|592910905|FG002|Year 2|Subject missed last study visit|0|||
164150246|NCT03989102|592910903|FG000|Year 2|Death|0|||
164150247|NCT03989102|592910904|FG001|Year 2|Death|1|||
164150248|NCT03989102|592910905|FG002|Year 2|Death|0|||
164150249|NCT03989102|592910903|FG000|Year 2|Subject not reachable|0|||
164150250|NCT03989102|592910904|FG001|Year 2|Subject not reachable|0|||
164150251|NCT03989102|592910905|FG002|Year 2|Subject not reachable|1|||
164150252|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
164150253|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
164150254|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
164150255|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
164150256|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
164150257|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
164150258|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
164150259|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
164150260|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
164150261|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
164150262|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
164150263|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
164150264|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
164150265|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
164150266|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
164150267|NCT03989102|592910903|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
164150268|NCT03989102|592910904|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
164150269|NCT03989102|592910905|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
164150270|NCT04054765|592910906|FG000|Baseline|Withdrawal by Subject|5|||
164150271|NCT04054765|592910907|FG001|Baseline|Withdrawal by Subject|3|||
164150272|NCT04054765|592910906|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
164150273|NCT04054765|592910907|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
164150274|NCT04054765|592910906|FG000|3-month Follow up|Withdrawal by Subject|0|||
164150275|NCT04054765|592910907|FG001|3-month Follow up|Withdrawal by Subject|3|||
164150276|NCT04054765|592910906|FG000|6-month Follow up|Lost to Follow-up|32|||
164150277|NCT04054765|592910907|FG001|6-month Follow up|Lost to Follow-up|32|||
164150278|NCT01290068|592910908|FG000|Overall Study|Adverse Event|1|||
164150279|NCT01290068|592910909|FG001|Overall Study|Adverse Event|3|||
164150280|NCT01290068|592910908|FG000|Overall Study|Lost to Follow-up|3|||
164150281|NCT01290068|592910909|FG001|Overall Study|Lost to Follow-up|0|||
164150282|NCT01290068|592910908|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
164150283|NCT01290068|592910909|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
164150284|NCT01290068|592910908|FG000|Overall Study|Other|3|||
164150285|NCT01290068|592910909|FG001|Overall Study|Other|1|||
164150286|NCT02719184|592910912|FG000|Overall Study|Other than listed|1|||
164150287|NCT02719184|592910913|FG001|Overall Study|Other than listed|12|||
164150288|NCT02719184|592910914|FG002|Overall Study|Other than listed|13|||
164150289|NCT02719184|592910915|FG003|Overall Study|Other than listed|22|||
164150290|NCT02719184|592910916|FG004|Overall Study|Other than listed|9|||
164150291|NCT02719184|592910912|FG000|Overall Study|Withdrawal by Subject|5|||
164150292|NCT02719184|592910913|FG001|Overall Study|Withdrawal by Subject|3|||
164150293|NCT02719184|592910914|FG002|Overall Study|Withdrawal by Subject|6|||
164150294|NCT02719184|592910915|FG003|Overall Study|Withdrawal by Subject|6|||
164150295|NCT02719184|592910916|FG004|Overall Study|Withdrawal by Subject|0|||
164150296|NCT02719184|592910912|FG000|Overall Study|Lost to Follow-up|0|||
164150297|NCT02719184|592910913|FG001|Overall Study|Lost to Follow-up|4|||
164150298|NCT02719184|592910914|FG002|Overall Study|Lost to Follow-up|1|||
164150299|NCT02719184|592910915|FG003|Overall Study|Lost to Follow-up|3|||
164150300|NCT02719184|592910916|FG004|Overall Study|Lost to Follow-up|0|||
164150301|NCT02719184|592910912|FG000|Overall Study|Protocol Violation|0|||
164150302|NCT02719184|592910913|FG001|Overall Study|Protocol Violation|3|||
164150303|NCT02719184|592910914|FG002|Overall Study|Protocol Violation|0|||
164150304|NCT02719184|592910915|FG003|Overall Study|Protocol Violation|2|||
164150305|NCT02719184|592910916|FG004|Overall Study|Protocol Violation|0|||
164150306|NCT02719184|592910912|FG000|Overall Study|Adverse Event|0|||
164150307|NCT02719184|592910913|FG001|Overall Study|Adverse Event|0|||
164150308|NCT02719184|592910914|FG002|Overall Study|Adverse Event|0|||
164150309|NCT02719184|592910915|FG003|Overall Study|Adverse Event|3|||
164150310|NCT02719184|592910916|FG004|Overall Study|Adverse Event|0|||
164150311|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Physician Decision|3|||
164150312|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
164150313|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Disease Progression|1|||
164150314|NCT00545714|592910917|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
164150315|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
164150316|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
164150317|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
164150318|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
164150319|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
164150320|NCT00545714|592910917|FG000|Maintenance Phase (36 Months)|Death|2|||
164150321|NCT04428034|592910920|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
164150322|NCT02556801|592910923|FG000|Overall Study|Lost to Follow-up|1|||
164150323|NCT02556801|592910924|FG001|Overall Study|Lost to Follow-up|0|||
164150324|NCT02556801|592910925|FG002|Overall Study|Lost to Follow-up|2|||
164150325|NCT02556801|592910926|FG003|Overall Study|Lost to Follow-up|0|||
164150326|NCT02556801|592910923|FG000|Overall Study|Withdrawal by Subject|1|||
164150327|NCT02556801|592910924|FG001|Overall Study|Withdrawal by Subject|1|||
164150328|NCT02556801|592910925|FG002|Overall Study|Withdrawal by Subject|1|||
164150329|NCT02556801|592910926|FG003|Overall Study|Withdrawal by Subject|0|||
164150330|NCT02556801|592910923|FG000|Overall Study|Protocol Violation|0|||
164150331|NCT02556801|592910924|FG001|Overall Study|Protocol Violation|3|||
164150332|NCT02556801|592910925|FG002|Overall Study|Protocol Violation|1|||
164150333|NCT02556801|592910926|FG003|Overall Study|Protocol Violation|1|||
164150334|NCT02556801|592910923|FG000|Overall Study|Adverse Event|0|||
164150335|NCT02556801|592910924|FG001|Overall Study|Adverse Event|2|||
164150336|NCT02556801|592910925|FG002|Overall Study|Adverse Event|0|||
164150337|NCT02556801|592910926|FG003|Overall Study|Adverse Event|3|||
164150338|NCT02556801|592910923|FG000|Overall Study|Pregnancy|0|||
164150339|NCT02556801|592910924|FG001|Overall Study|Pregnancy|1|||
164150340|NCT02556801|592910925|FG002|Overall Study|Pregnancy|0|||
164150341|NCT02556801|592910926|FG003|Overall Study|Pregnancy|0|||
164150342|NCT02556801|592910923|FG000|Overall Study|Personal reasons patient|0|||
164150343|NCT02556801|592910924|FG001|Overall Study|Personal reasons patient|0|||
164150344|NCT02556801|592910925|FG002|Overall Study|Personal reasons patient|0|||
164150345|NCT02556801|592910926|FG003|Overall Study|Personal reasons patient|1|||
164150346|NCT01431079|592910929|FG000|Overall Study|Lost to Follow-up|35|||
164150347|NCT01431079|592910930|FG001|Overall Study|Lost to Follow-up|39|||
164150348|NCT01626690|592910931|FG000|Overall Study|Protocol Violation|1|||
164150349|NCT01626690|592910932|FG001|Overall Study|Protocol Violation|0|||
164150350|NCT01626690|592910931|FG000|Overall Study|Adverse Event|1|||
164150351|NCT01626690|592910932|FG001|Overall Study|Adverse Event|0|||
164150352|NCT02676882|592910933|FG000|Overall Study|Adverse Event|1|||
164150353|NCT02676882|592910934|FG001|Overall Study|Adverse Event|0|||
164150354|NCT02676882|592910933|FG000|Overall Study|Lost to Follow-up|1|||
164150355|NCT02676882|592910934|FG001|Overall Study|Lost to Follow-up|0|||
164150356|NCT02676882|592910933|FG000|Overall Study|Withdrawal by Subject|1|||
164150357|NCT02676882|592910934|FG001|Overall Study|Withdrawal by Subject|2|||
164150358|NCT00114140|592910935|FG000|Overall Study|Protocol Violation|7|||
164150359|NCT02414958|592910936|FG000|Overall Study|Adverse Event|6|||
164150360|NCT02414958|592910937|FG001|Overall Study|Adverse Event|6|||
164150361|NCT02414958|592910938|FG002|Overall Study|Adverse Event|3|||
164150362|NCT02414958|592910936|FG000|Overall Study|Protocol Violation|10|||
164150363|NCT02414958|592910937|FG001|Overall Study|Protocol Violation|3|||
164150364|NCT02414958|592910938|FG002|Overall Study|Protocol Violation|1|||
164150365|NCT02414958|592910936|FG000|Overall Study|Lost to Follow-up|7|||
164150366|NCT02414958|592910937|FG001|Overall Study|Lost to Follow-up|4|||
164150367|NCT02414958|592910938|FG002|Overall Study|Lost to Follow-up|0|||
164150368|NCT02414958|592910936|FG000|Overall Study|Withdrawal by Subject|5|||
164150369|NCT02414958|592910937|FG001|Overall Study|Withdrawal by Subject|3|||
164150370|NCT02414958|592910938|FG002|Overall Study|Withdrawal by Subject|5|||
164150371|NCT02414958|592910936|FG000|Overall Study|Other than specified|4|||
164150372|NCT02414958|592910937|FG001|Overall Study|Other than specified|4|||
164150373|NCT02414958|592910938|FG002|Overall Study|Other than specified|5|||
164150374|NCT00811733|592910940|FG000|Overall Study|Investigator Discretion|10|||
164150375|NCT00811733|592910941|FG001|Overall Study|Investigator Discretion|8|||
164150376|NCT00811733|592910940|FG000|Overall Study|Withdrawal by Subject|1|||
164150377|NCT00811733|592910941|FG001|Overall Study|Withdrawal by Subject|2|||
164150378|NCT00793871|592910942|FG000|Overall Study|Death|50|||
164150379|NCT00793871|592910942|FG000|Overall Study|Lost to Follow-up|3|||
164150380|NCT00793871|592910942|FG000|Overall Study|Study terminated by the Sponsor|7|||
164150381|NCT00111241|592910945|FG000|Overall Study|Lost to Follow-up|1|||
164150382|NCT00111241|592910946|FG001|Overall Study|Lost to Follow-up|0|||
164150383|NCT00111241|592910945|FG000|Overall Study|Withdrawal by Subject|4|||
164150384|NCT00111241|592910946|FG001|Overall Study|Withdrawal by Subject|0|||
164150385|NCT00111241|592910945|FG000|Overall Study|Protocol Violation|9|||
164150386|NCT00111241|592910946|FG001|Overall Study|Protocol Violation|8|||
164150387|NCT00111241|592910945|FG000|Overall Study|Adverse Event|1|||
164150388|NCT00111241|592910946|FG001|Overall Study|Adverse Event|0|||
164150389|NCT02096744|592910957|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
164150390|NCT02096744|592910958|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
164150391|NCT02096744|592910957|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
164150392|NCT02096744|592910958|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
164150393|NCT02096744|592910957|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
164150394|NCT02096744|592910958|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
164150395|NCT05724589|592910964|FG000|Overall Study|Lost to Follow-up|1|||
164150396|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
164150397|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Off-label use|283|||
164150398|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
164150399|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
164150400|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
164150401|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
164150402|NCT01070953|592910965|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
164150403|NCT01070953|592910965|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
164150404|NCT01070953|592910965|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
164150405|NCT01070953|592910965|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
164150406|NCT04700137|592910968|FG000|Overall Study|Lost to Follow-up|1|||
164150407|NCT04700137|592910969|FG001|Overall Study|Lost to Follow-up|6|||
164150408|NCT04700137|592910970|FG002|Overall Study|Lost to Follow-up|1|||
164150409|NCT04700137|592910971|FG003|Overall Study|Lost to Follow-up|1|||
164150410|NCT04700137|592910968|FG000|Overall Study|Withdrawal by Subject|0|||
164150411|NCT04700137|592910969|FG001|Overall Study|Withdrawal by Subject|0|||
164150412|NCT04700137|592910970|FG002|Overall Study|Withdrawal by Subject|1|||
164150413|NCT04700137|592910971|FG003|Overall Study|Withdrawal by Subject|0|||
164150414|NCT04700137|592910968|FG000|Overall Study|Death|0|||
164150415|NCT04700137|592910969|FG001|Overall Study|Death|0|||
164150416|NCT04700137|592910970|FG002|Overall Study|Death|1|||
164150417|NCT04700137|592910971|FG003|Overall Study|Death|0|||
164150418|NCT03449446|592910977|FG000|Overall Study|Randomized but Never Treated|0|||
164150419|NCT03449446|592910978|FG001|Overall Study|Randomized but Never Treated|0|||
164150420|NCT03449446|592910979|FG002|Overall Study|Randomized but Never Treated|1|||
164150421|NCT03449446|592910980|FG003|Overall Study|Randomized but Never Treated|1|||
164150422|NCT03449446|592910981|FG004|Overall Study|Randomized but Never Treated|1|||
164150423|NCT03449446|592910982|FG005|Overall Study|Randomized but Never Treated|0|||
164150424|NCT03449446|592910983|FG006|Overall Study|Randomized but Never Treated|0|||
164150425|NCT03449446|592910977|FG000|Overall Study|Unknown Reason|33|||
164150426|NCT03449446|592910978|FG001|Overall Study|Unknown Reason|1|||
164150427|NCT03449446|592910979|FG002|Overall Study|Unknown Reason|1|||
164150428|NCT03449446|592910980|FG003|Overall Study|Unknown Reason|1|||
164150429|NCT03449446|592910981|FG004|Overall Study|Unknown Reason|2|||
164150430|NCT03449446|592910982|FG005|Overall Study|Unknown Reason|2|||
164150431|NCT03449446|592910983|FG006|Overall Study|Unknown Reason|0|||
164150432|NCT03449446|592910977|FG000|Overall Study|Withdrew Consent|1|||
164150433|NCT03449446|592910978|FG001|Overall Study|Withdrew Consent|3|||
164150434|NCT03449446|592910979|FG002|Overall Study|Withdrew Consent|1|||
164150435|NCT03449446|592910980|FG003|Overall Study|Withdrew Consent|4|||
164150436|NCT03449446|592910981|FG004|Overall Study|Withdrew Consent|4|||
164150437|NCT03449446|592910982|FG005|Overall Study|Withdrew Consent|4|||
164150438|NCT03449446|592910983|FG006|Overall Study|Withdrew Consent|1|||
164150439|NCT03449446|592910977|FG000|Overall Study|Adverse Event|1|||
164150440|NCT03449446|592910978|FG001|Overall Study|Adverse Event|2|||
164150441|NCT03449446|592910979|FG002|Overall Study|Adverse Event|1|||
164150442|NCT03449446|592910980|FG003|Overall Study|Adverse Event|0|||
164150443|NCT03449446|592910981|FG004|Overall Study|Adverse Event|0|||
164150444|NCT03449446|592910982|FG005|Overall Study|Adverse Event|2|||
164150445|NCT03449446|592910983|FG006|Overall Study|Adverse Event|0|||
164150446|NCT03449446|592910977|FG000|Overall Study|Lost to Follow-up|0|||
164150447|NCT03449446|592910978|FG001|Overall Study|Lost to Follow-up|0|||
164150448|NCT03449446|592910979|FG002|Overall Study|Lost to Follow-up|2|||
164150449|NCT03449446|592910980|FG003|Overall Study|Lost to Follow-up|1|||
164150450|NCT03449446|592910981|FG004|Overall Study|Lost to Follow-up|3|||
164150451|NCT03449446|592910982|FG005|Overall Study|Lost to Follow-up|0|||
164150452|NCT03449446|592910983|FG006|Overall Study|Lost to Follow-up|0|||
164150453|NCT03449446|592910977|FG000|Overall Study|Investigator's Discretion|0|||
164150454|NCT03449446|592910978|FG001|Overall Study|Investigator's Discretion|1|||
164150455|NCT03449446|592910979|FG002|Overall Study|Investigator's Discretion|1|||
164150456|NCT03449446|592910980|FG003|Overall Study|Investigator's Discretion|2|||
164150457|NCT03449446|592910981|FG004|Overall Study|Investigator's Discretion|0|||
164150458|NCT03449446|592910982|FG005|Overall Study|Investigator's Discretion|0|||
164150459|NCT03449446|592910983|FG006|Overall Study|Investigator's Discretion|0|||
164150460|NCT03449446|592910977|FG000|Overall Study|Non Compliance with Study Drug|1|||
164150461|NCT03449446|592910978|FG001|Overall Study|Non Compliance with Study Drug|0|||
164150462|NCT03449446|592910979|FG002|Overall Study|Non Compliance with Study Drug|0|||
164150463|NCT03449446|592910980|FG003|Overall Study|Non Compliance with Study Drug|0|||
164150464|NCT03449446|592910981|FG004|Overall Study|Non Compliance with Study Drug|0|||
164150465|NCT03449446|592910982|FG005|Overall Study|Non Compliance with Study Drug|0|||
164150466|NCT03449446|592910983|FG006|Overall Study|Non Compliance with Study Drug|0|||
164150467|NCT03449446|592910977|FG000|Overall Study|Protocol Violation|0|||
164150468|NCT03449446|592910978|FG001|Overall Study|Protocol Violation|0|||
164150469|NCT03449446|592910979|FG002|Overall Study|Protocol Violation|0|||
164150470|NCT03449446|592910980|FG003|Overall Study|Protocol Violation|0|||
164150471|NCT03449446|592910981|FG004|Overall Study|Protocol Violation|1|||
164150472|NCT03449446|592910982|FG005|Overall Study|Protocol Violation|1|||
164150473|NCT03449446|592910983|FG006|Overall Study|Protocol Violation|0|||
164150474|NCT03449446|592910977|FG000|Overall Study|Death|0|||
164150475|NCT03449446|592910978|FG001|Overall Study|Death|0|||
164150476|NCT03449446|592910979|FG002|Overall Study|Death|0|||
164150477|NCT03449446|592910980|FG003|Overall Study|Death|0|||
164150478|NCT03449446|592910981|FG004|Overall Study|Death|1|||
164150479|NCT03449446|592910982|FG005|Overall Study|Death|0|||
164150480|NCT03449446|592910983|FG006|Overall Study|Death|0|||
164150481|NCT03180645|592910996|FG000|Overall Study|Adverse Event|0|||
164150482|NCT03180645|592910997|FG001|Overall Study|Adverse Event|1|||
164150483|NCT03180645|592910998|FG002|Overall Study|Adverse Event|2|||
164150484|NCT04208750|592910999|FG000|Overall Study|Lost to Follow-up|16|||
164150485|NCT04208750|592911000|FG001|Overall Study|Lost to Follow-up|15|||
164150486|NCT02201277|592911004|FG000|Overall Study|Death|3|||
164150487|NCT02201277|592911005|FG001|Overall Study|Death|4|||
164150488|NCT02201277|592911004|FG000|Overall Study|Lost to Follow-up|2|||
164150489|NCT02201277|592911005|FG001|Overall Study|Lost to Follow-up|1|||
164150490|NCT02201277|592911004|FG000|Overall Study|Failed retrieval|1|||
164150491|NCT02201277|592911005|FG001|Overall Study|Failed retrieval|0|||
164150492|NCT02201277|592911004|FG000|Overall Study|Physician Decision|1|||
164150493|NCT02201277|592911005|FG001|Overall Study|Physician Decision|0|||
164150494|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
164150495|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
164150496|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
164150497|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
164150498|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
164150499|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
164150500|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
164150501|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
164150502|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
164150503|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
164150504|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
164150505|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
164150506|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
164150507|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
164150508|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
164150509|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
164150510|NCT00866359|592911007|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
164150511|NCT00866359|592911008|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
164150512|NCT00866359|592911009|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
164150513|NCT00866359|592911010|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
164150514|NCT00866359|592911007|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
164150515|NCT00866359|592911008|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
164150516|NCT00866359|592911009|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
164150595|NCT04515147|592912234|FG001|Overall Study|Miscellaneous|0|||
164150517|NCT00866359|592911010|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
164150518|NCT01625091|592911011|FG000|Intervention|Death|1|||
164150519|NCT01625091|592911012|FG001|Intervention|Death|1|||
164150520|NCT01625091|592911011|FG000|Intervention|Withdrawal by Subject|4|||
164150521|NCT01625091|592911012|FG001|Intervention|Withdrawal by Subject|1|||
164150522|NCT01625091|592911011|FG000|Intervention|Adverse Event|0|||
164150523|NCT01625091|592911012|FG001|Intervention|Adverse Event|2|||
164150524|NCT01625091|592911011|FG000|Intervention|Lost to Follow-up|4|||
164150525|NCT01625091|592911012|FG001|Intervention|Lost to Follow-up|4|||
164150526|NCT01625091|592911011|FG000|Intervention|Study termination|2|||
164150527|NCT01625091|592911012|FG001|Intervention|Study termination|3|||
164150528|NCT01625091|592911011|FG000|Post-intervention|Death|0|||
164150529|NCT01625091|592911012|FG001|Post-intervention|Death|1|||
164150530|NCT01625091|592911011|FG000|Post-intervention|Lost to Follow-up|2|||
164150531|NCT01625091|592911012|FG001|Post-intervention|Lost to Follow-up|0|||
164150532|NCT01625091|592911011|FG000|Post-intervention|Study termination|2|||
164150533|NCT01625091|592911012|FG001|Post-intervention|Study termination|1|||
164150534|NCT02163057|592911013|FG000|Overall Study|Participant Refusal to Continue|2|||
164150535|NCT02163057|592911014|FG001|Overall Study|Participant Refusal to Continue|2|||
164150536|NCT02163057|592911013|FG000|Overall Study|Participant Significant Noncompliance|0|||
164150537|NCT02163057|592911014|FG001|Overall Study|Participant Significant Noncompliance|1|||
164150538|NCT02163057|592911013|FG000|Overall Study|Progression of Disease|1|||
164150539|NCT02163057|592911014|FG001|Overall Study|Progression of Disease|2|||
164150540|NCT01547390|592911021|FG000|Overall Study|Withdrawal by Subject|10|||
164150541|NCT01547390|592911022|FG001|Overall Study|Withdrawal by Subject|7|||
164150542|NCT01547390|592911021|FG000|Overall Study|termination of pregnancy|0|||
164150543|NCT01547390|592911022|FG001|Overall Study|termination of pregnancy|1|||
164150544|NCT01547390|592911021|FG000|Overall Study|Lost to Follow-up|0|||
164150545|NCT01547390|592911022|FG001|Overall Study|Lost to Follow-up|2|||
164150546|NCT01547390|592911021|FG000|Overall Study|Adverse Event|3|||
164150547|NCT01547390|592911022|FG001|Overall Study|Adverse Event|0|||
164150548|NCT00265759|592912223|FG000|Overall Study|Withdrawal by Subject|0|||
164150549|NCT00265759|592912224|FG001|Overall Study|Withdrawal by Subject|1|||
164150550|NCT00265759|592912225|FG002|Overall Study|Withdrawal by Subject|2|||
164150551|NCT00265759|592912226|FG003|Overall Study|Withdrawal by Subject|2|||
164150552|NCT00265759|592912223|FG000|Overall Study|Cancel|0|||
164150553|NCT00265759|592912224|FG001|Overall Study|Cancel|0|||
164150554|NCT00265759|592912225|FG002|Overall Study|Cancel|0|||
164150555|NCT00265759|592912226|FG003|Overall Study|Cancel|3|||
164150556|NCT00265759|592912223|FG000|Overall Study|Ineligible|0|||
164150557|NCT00265759|592912224|FG001|Overall Study|Ineligible|0|||
164150558|NCT00265759|592912225|FG002|Overall Study|Ineligible|0|||
164150559|NCT00265759|592912226|FG003|Overall Study|Ineligible|1|||
164150560|NCT00265759|592912223|FG000|Overall Study|Bilateral disease|0|||
164150561|NCT00265759|592912224|FG001|Overall Study|Bilateral disease|0|||
164150562|NCT00265759|592912225|FG002|Overall Study|Bilateral disease|0|||
164150563|NCT00265759|592912226|FG003|Overall Study|Bilateral disease|2|||
164150564|NCT00265759|592912223|FG000|Overall Study|Discontinued due to intolerability|0|||
164150565|NCT00265759|592912224|FG001|Overall Study|Discontinued due to intolerability|0|||
164150566|NCT00265759|592912225|FG002|Overall Study|Discontinued due to intolerability|0|||
164150567|NCT00265759|592912226|FG003|Overall Study|Discontinued due to intolerability|1|||
164150568|NCT04653454|592912227|FG000|Overall Study|Withdrawal by Subject|1|||
164150569|NCT04653454|592912227|FG000|Overall Study|Physician Decision|40|||
164150570|NCT05525520|592912229|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
164150571|NCT05525520|592912230|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
164150572|NCT05525520|592912229|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
164150573|NCT05525520|592912230|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
164150574|NCT05878093|592912231|FG000|Overall Study|Withdrawal by Subject|3|||
164150575|NCT05878093|592912232|FG001|Overall Study|Withdrawal by Subject|1|||
164150576|NCT04515147|592912233|FG000|Overall Study|Withdrawal by Subject|1|||
164150577|NCT04515147|592912234|FG001|Overall Study|Withdrawal by Subject|0|||
164150578|NCT04515147|592912235|FG002|Overall Study|Withdrawal by Subject|10|||
164150579|NCT04515147|592912236|FG003|Overall Study|Withdrawal by Subject|18|||
164150580|NCT04515147|592912237|FG004|Overall Study|Withdrawal by Subject|1|||
164150581|NCT04515147|592912238|FG005|Overall Study|Withdrawal by Subject|8|||
164150582|NCT04515147|592912233|FG000|Overall Study|Lost to Follow-up|0|||
164150583|NCT04515147|592912234|FG001|Overall Study|Lost to Follow-up|1|||
164150584|NCT04515147|592912235|FG002|Overall Study|Lost to Follow-up|5|||
164150585|NCT04515147|592912236|FG003|Overall Study|Lost to Follow-up|6|||
164150586|NCT04515147|592912237|FG004|Overall Study|Lost to Follow-up|2|||
164150587|NCT04515147|592912238|FG005|Overall Study|Lost to Follow-up|1|||
164150588|NCT04515147|592912233|FG000|Overall Study|Adverse Event|0|||
164150589|NCT04515147|592912234|FG001|Overall Study|Adverse Event|0|||
164150590|NCT04515147|592912235|FG002|Overall Study|Adverse Event|0|||
164150591|NCT04515147|592912236|FG003|Overall Study|Adverse Event|2|||
164150592|NCT04515147|592912237|FG004|Overall Study|Adverse Event|0|||
164150593|NCT04515147|592912238|FG005|Overall Study|Adverse Event|0|||
164150594|NCT04515147|592912233|FG000|Overall Study|Miscellaneous|0|||
164150596|NCT04515147|592912235|FG002|Overall Study|Miscellaneous|0|||
164150597|NCT04515147|592912236|FG003|Overall Study|Miscellaneous|1|||
164150598|NCT04515147|592912237|FG004|Overall Study|Miscellaneous|0|||
164150599|NCT04515147|592912238|FG005|Overall Study|Miscellaneous|1|||
164150600|NCT04123405|592912239|FG000|Overall Study|Adverse Event|1|||
164150601|NCT04123405|592912240|FG001|Overall Study|Adverse Event|2|||
164150602|NCT04123405|592912241|FG002|Overall Study|Adverse Event|3|||
164150603|NCT04123405|592912242|FG003|Overall Study|Adverse Event|3|||
164150604|NCT04123405|592912239|FG000|Overall Study|Exclusion criteria met|1|||
164150605|NCT04123405|592912240|FG001|Overall Study|Exclusion criteria met|2|||
164150606|NCT04123405|592912241|FG002|Overall Study|Exclusion criteria met|0|||
164150607|NCT04123405|592912242|FG003|Overall Study|Exclusion criteria met|2|||
164150608|NCT04123405|592912239|FG000|Overall Study|Withdrawal by Subject|1|||
164150609|NCT04123405|592912240|FG001|Overall Study|Withdrawal by Subject|3|||
164150610|NCT04123405|592912241|FG002|Overall Study|Withdrawal by Subject|0|||
164150611|NCT04123405|592912242|FG003|Overall Study|Withdrawal by Subject|2|||
164150612|NCT04123405|592912239|FG000|Overall Study|Contact to subject lost|0|||
164150613|NCT04123405|592912240|FG001|Overall Study|Contact to subject lost|0|||
164150614|NCT04123405|592912241|FG002|Overall Study|Contact to subject lost|0|||
164150615|NCT04123405|592912242|FG003|Overall Study|Contact to subject lost|1|||
164150616|NCT04123405|592912239|FG000|Overall Study|screening failure|1|||
164150617|NCT04123405|592912240|FG001|Overall Study|screening failure|0|||
164150618|NCT04123405|592912241|FG002|Overall Study|screening failure|0|||
164150619|NCT04123405|592912242|FG003|Overall Study|screening failure|0|||
164150620|NCT01050530|592912243|FG000|Overall Study|Adverse Event|6|||
164150621|NCT01050530|592912244|FG001|Overall Study|Adverse Event|3|||
164150622|NCT01050530|592912243|FG000|Overall Study|Lack of Efficacy|1|||
164150623|NCT01050530|592912244|FG001|Overall Study|Lack of Efficacy|4|||
164150624|NCT01050530|592912243|FG000|Overall Study|Withdrawal by Subject|0|||
164150625|NCT01050530|592912244|FG001|Overall Study|Withdrawal by Subject|3|||
164150626|NCT01050530|592912243|FG000|Overall Study|Protocol Violation|1|||
164150627|NCT01050530|592912244|FG001|Overall Study|Protocol Violation|0|||
164150628|NCT01202175|592912252|FG000|Overall Study|Lost to Follow-up|2|||
164150629|NCT01202175|592912252|FG000|Overall Study|Withdrawal by Subject|1|||
164150630|NCT01202175|592912252|FG000|Overall Study|Adverse Event|2|||
164150631|NCT02790437|592912253|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
164150632|NCT02790437|592912254|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
164150633|NCT02790437|592912253|FG000|Overall Study|Adverse Event|1|||
164150634|NCT02790437|592912254|FG001|Overall Study|Adverse Event|0|||
164150635|NCT02790437|592912253|FG000|Overall Study|Withdrawal by Subject|1|||
164150636|NCT02790437|592912254|FG001|Overall Study|Withdrawal by Subject|0|||
164150637|NCT04747470|592912255|FG000|Overall Study|Death|0|||
164150638|NCT04747470|592912256|FG001|Overall Study|Death|3|||
164150639|NCT04747470|592912257|FG002|Overall Study|Death|2|||
164150640|NCT04747470|592912258|FG003|Overall Study|Death|2|||
164150641|NCT04747470|592912259|FG004|Overall Study|Death|2|||
164150642|NCT04747470|592912260|FG005|Overall Study|Death|0|||
164150643|NCT04747470|592912261|FG006|Overall Study|Death|0|||
164150644|NCT04747470|592912262|FG007|Overall Study|Death|0|||
164150645|NCT04747470|592912263|FG008|Overall Study|Death|0|||
164150646|NCT04747470|592912264|FG009|Overall Study|Death|0|||
164150647|NCT04747470|592912265|FG010|Overall Study|Death|0|||
164150648|NCT04747470|592912255|FG000|Overall Study|Withdrew Consent|0|||
164150649|NCT04747470|592912256|FG001|Overall Study|Withdrew Consent|0|||
164150650|NCT04747470|592912257|FG002|Overall Study|Withdrew Consent|0|||
164150651|NCT04747470|592912258|FG003|Overall Study|Withdrew Consent|1|||
164150652|NCT04747470|592912259|FG004|Overall Study|Withdrew Consent|0|||
164150653|NCT04747470|592912260|FG005|Overall Study|Withdrew Consent|0|||
164150654|NCT04747470|592912261|FG006|Overall Study|Withdrew Consent|0|||
164150655|NCT04747470|592912262|FG007|Overall Study|Withdrew Consent|0|||
164150656|NCT04747470|592912263|FG008|Overall Study|Withdrew Consent|0|||
164150657|NCT04747470|592912264|FG009|Overall Study|Withdrew Consent|0|||
164150658|NCT04747470|592912265|FG010|Overall Study|Withdrew Consent|0|||
164150659|NCT04747470|592912255|FG000|Overall Study|Study Terminated by Sponsor|0|||
164150660|NCT04747470|592912256|FG001|Overall Study|Study Terminated by Sponsor|0|||
164150661|NCT04747470|592912257|FG002|Overall Study|Study Terminated by Sponsor|1|||
164150662|NCT04747470|592912258|FG003|Overall Study|Study Terminated by Sponsor|0|||
164150663|NCT04747470|592912259|FG004|Overall Study|Study Terminated by Sponsor|2|||
164150664|NCT04747470|592912260|FG005|Overall Study|Study Terminated by Sponsor|0|||
164150665|NCT04747470|592912261|FG006|Overall Study|Study Terminated by Sponsor|0|||
164150666|NCT04747470|592912262|FG007|Overall Study|Study Terminated by Sponsor|0|||
164150667|NCT04747470|592912263|FG008|Overall Study|Study Terminated by Sponsor|0|||
164150668|NCT04747470|592912264|FG009|Overall Study|Study Terminated by Sponsor|0|||
164150669|NCT04747470|592912265|FG010|Overall Study|Study Terminated by Sponsor|0|||
164150670|NCT01125189|592912272|FG000|Treatment Period|Lack of Efficacy|15|||
164150671|NCT01125189|592912273|FG001|Treatment Period|Lack of Efficacy|18|||
164150672|NCT01125189|592912274|FG002|Treatment Period|Lack of Efficacy|25|||
164150673|NCT01125189|592912272|FG000|Treatment Period|Adverse Event|7|||
164150674|NCT01125189|592912273|FG001|Treatment Period|Adverse Event|8|||
164150675|NCT01125189|592912274|FG002|Treatment Period|Adverse Event|8|||
164150676|NCT01125189|592912272|FG000|Treatment Period|Withdrawal by Subject|3|||
164150677|NCT01125189|592912273|FG001|Treatment Period|Withdrawal by Subject|1|||
164150678|NCT01125189|592912274|FG002|Treatment Period|Withdrawal by Subject|1|||
164150679|NCT01125189|592912272|FG000|Treatment Period|Death|1|||
164150680|NCT01125189|592912273|FG001|Treatment Period|Death|0|||
164150681|NCT01125189|592912274|FG002|Treatment Period|Death|0|||
164150682|NCT01125189|592912272|FG000|Treatment Period|Lost to Follow-up|1|||
164150683|NCT01125189|592912273|FG001|Treatment Period|Lost to Follow-up|2|||
164150684|NCT01125189|592912274|FG002|Treatment Period|Lost to Follow-up|1|||
164150685|NCT01125189|592912272|FG000|Treatment Period|Poor compliance/noncompliance|0|||
164150686|NCT01125189|592912273|FG001|Treatment Period|Poor compliance/noncompliance|1|||
164150687|NCT01125189|592912274|FG002|Treatment Period|Poor compliance/noncompliance|0|||
164150688|NCT01125189|592912272|FG000|Treatment Period|Participants requested to discontinue|1|||
164150689|NCT01125189|592912273|FG001|Treatment Period|Participants requested to discontinue|3|||
164150690|NCT01125189|592912274|FG002|Treatment Period|Participants requested to discontinue|4|||
164150691|NCT01125189|592912272|FG000|Treatment Period|Other reasons|1|||
164150692|NCT01125189|592912273|FG001|Treatment Period|Other reasons|1|||
164150693|NCT01125189|592912274|FG002|Treatment Period|Other reasons|0|||
164150694|NCT01125189|592912272|FG000|Treatment Period|Completed 24 week treatment period only|2|||
164150695|NCT01125189|592912273|FG001|Treatment Period|Completed 24 week treatment period only|1|||
164150696|NCT01125189|592912274|FG002|Treatment Period|Completed 24 week treatment period only|2|||
164150697|NCT01125189|592912272|FG000|Follow up Period|Withdrawal by Subject|3|||
164150698|NCT01125189|592912273|FG001|Follow up Period|Withdrawal by Subject|2|||
164150699|NCT01125189|592912274|FG002|Follow up Period|Withdrawal by Subject|5|||
164150700|NCT01125189|592912272|FG000|Follow up Period|Death|1|||
164150701|NCT01125189|592912273|FG001|Follow up Period|Death|0|||
164150702|NCT01125189|592912274|FG002|Follow up Period|Death|0|||
164150703|NCT01125189|592912272|FG000|Follow up Period|Lost to Follow-up|12|||
164150704|NCT01125189|592912273|FG001|Follow up Period|Lost to Follow-up|9|||
164150705|NCT01125189|592912274|FG002|Follow up Period|Lost to Follow-up|6|||
164150706|NCT01125189|592912272|FG000|Follow up Period|Other reasons|4|||
164150707|NCT01125189|592912273|FG001|Follow up Period|Other reasons|4|||
164150708|NCT01125189|592912274|FG002|Follow up Period|Other reasons|5|||
164150709|NCT00110396|592912275|FG000|Overall Study|Adverse Event|15|||
164150710|NCT00110396|592912275|FG000|Overall Study|Lost to Follow-up|1|||
164150711|NCT00110396|592912275|FG000|Overall Study|Administration of plasmapheresis|1|||
164150712|NCT00110396|592912275|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
164150713|NCT00110396|592912275|FG000|Overall Study|Lack of Efficacy|1|||
164150714|NCT00110396|592912275|FG000|Overall Study|Decided not to continue treatment|1|||
164150715|NCT00110396|592912275|FG000|Overall Study|Patient non-compliance|1|||
164150716|NCT00110396|592912275|FG000|Overall Study|Patient refused to continue|1|||
164150717|NCT00110396|592912275|FG000|Overall Study|Patient refused to participate|1|||
164150718|NCT00110396|592912275|FG000|Overall Study|Patient will|1|||
164150719|NCT00110396|592912275|FG000|Overall Study|Patient's decision|1|||
164150720|NCT00110396|592912275|FG000|Overall Study|Participation in MS vaccine study|1|||
164150721|NCT00110396|592912275|FG000|Overall Study|Pregnancy|1|||
164150722|NCT00110396|592912275|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
164150723|NCT00110396|592912275|FG000|Overall Study|Protocol Violation|2|||
164150724|NCT00110396|592912275|FG000|Overall Study|Patient refused to come back|1|||
164150725|NCT00110396|592912275|FG000|Overall Study|The patient has refused|2|||
164150726|NCT00110396|592912275|FG000|Overall Study|The patient has refused to visit site|1|||
164150727|NCT00110396|592912275|FG000|Overall Study|Patient is to be administered copaxone|1|||
164150728|NCT01269918|592912276|FG000|Overall Study|Did not receive study drug|0|||
164150729|NCT01269918|592912277|FG001|Overall Study|Did not receive study drug|3|||
164150730|NCT00245466|592912278|FG000|Overall Study|Adverse Event|2|||
164150731|NCT00245466|592912279|FG001|Overall Study|Adverse Event|8|||
164150732|NCT00245466|592912280|FG002|Overall Study|Adverse Event|4|||
164150733|NCT00245466|592912278|FG000|Overall Study|Low prostate specific antigen suppr|16|||
164150734|NCT00245466|592912279|FG001|Overall Study|Low prostate specific antigen suppr|14|||
164150735|NCT00245466|592912280|FG002|Overall Study|Low prostate specific antigen suppr|5|||
164150736|NCT00245466|592912278|FG000|Overall Study|Insufficient testosterone suppr|12|||
164150737|NCT00245466|592912279|FG001|Overall Study|Insufficient testosterone suppr|12|||
164150738|NCT00245466|592912280|FG002|Overall Study|Insufficient testosterone suppr|21|||
164150739|NCT00245466|592912278|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
164150740|NCT00245466|592912279|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
164150741|NCT00245466|592912280|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
164150742|NCT00245466|592912278|FG000|Overall Study|Withdrawal by Subject|2|||
164150743|NCT00245466|592912279|FG001|Overall Study|Withdrawal by Subject|2|||
164150744|NCT00245466|592912280|FG002|Overall Study|Withdrawal by Subject|1|||
164150745|NCT00245466|592912278|FG000|Overall Study|Lost to Follow-up|3|||
164150746|NCT00245466|592912279|FG001|Overall Study|Lost to Follow-up|0|||
164150747|NCT00245466|592912280|FG002|Overall Study|Lost to Follow-up|0|||
164150748|NCT00245466|592912278|FG000|Overall Study|Disease progression|0|||
164150749|NCT00245466|592912279|FG001|Overall Study|Disease progression|3|||
164150750|NCT00245466|592912280|FG002|Overall Study|Disease progression|1|||
164150751|NCT00245466|592912278|FG000|Overall Study|Protocol Violation|1|||
164150752|NCT00245466|592912279|FG001|Overall Study|Protocol Violation|2|||
164150753|NCT00245466|592912280|FG002|Overall Study|Protocol Violation|2|||
164150754|NCT00245466|592912278|FG000|Overall Study|Death|0|||
164150755|NCT00245466|592912279|FG001|Overall Study|Death|2|||
164150756|NCT00245466|592912280|FG002|Overall Study|Death|0|||
164150757|NCT00245466|592912278|FG000|Overall Study|Administrative reasons|0|||
164150758|NCT00245466|592912279|FG001|Overall Study|Administrative reasons|1|||
164150759|NCT00245466|592912280|FG002|Overall Study|Administrative reasons|0|||
164150760|NCT00856193|592912281|FG000|Period 2|Abnormal test procedure results|0|||
164150761|NCT00856193|592912282|FG001|Period 2|Abnormal test procedure results|1|||
164150762|NCT00856193|592912281|FG000|Period 2|Lost to Follow-up|0|||
164150763|NCT00856193|592912282|FG001|Period 2|Lost to Follow-up|1|||
164150764|NCT03885661|592912283|FG000|Overall Study|Withdrawal by Subject|0|||
164150765|NCT03885661|592912284|FG001|Overall Study|Withdrawal by Subject|1|||
164150766|NCT03885661|592912283|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
164150767|NCT03885661|592912284|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
164150768|NCT05064397|592912285|FG000|Overall Study|Adverse Event|4|||
164150769|NCT05064397|592912285|FG000|Overall Study|Lack of Efficacy|12|||
164150770|NCT05064397|592912285|FG000|Overall Study|Withdrawal by Subject|3|||
164150771|NCT05064397|592912285|FG000|Overall Study|Lost to Follow-up|1|||
164150772|NCT05064397|592912285|FG000|Overall Study|Other reasons|3|||
164150773|NCT04542057|592912286|FG000|Overall Study|Death|3|||
164150774|NCT04542057|592912287|FG001|Overall Study|Death|1|||
164150775|NCT04542057|592912286|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
164150776|NCT04542057|592912287|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
164150777|NCT04542057|592912286|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
164150778|NCT04542057|592912287|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
164150779|NCT04542057|592912286|FG000|Overall Study|Adverse Event|15|||
164150780|NCT04542057|592912287|FG001|Overall Study|Adverse Event|6|||
164150781|NCT04542057|592912286|FG000|Overall Study|COVID-19 adverse event|6|||
164150782|NCT04542057|592912287|FG001|Overall Study|COVID-19 adverse event|4|||
164150783|NCT04542057|592912286|FG000|Overall Study|Lack of Efficacy|2|||
164150784|NCT04542057|592912287|FG001|Overall Study|Lack of Efficacy|5|||
164150785|NCT04542057|592912286|FG000|Overall Study|Study terminated by sponsor|1|||
164150786|NCT04542057|592912287|FG001|Overall Study|Study terminated by sponsor|0|||
164150787|NCT04542057|592912286|FG000|Overall Study|Investigator discretion|2|||
164150788|NCT04542057|592912287|FG001|Overall Study|Investigator discretion|1|||
164150789|NCT04542057|592912286|FG000|Overall Study|Withdrawal by Subject|52|||
164150790|NCT04542057|592912287|FG001|Overall Study|Withdrawal by Subject|30|||
164150791|NCT04542057|592912286|FG000|Overall Study|Lost to Follow-up|8|||
164150792|NCT04542057|592912287|FG001|Overall Study|Lost to Follow-up|11|||
164150793|NCT04542057|592912286|FG000|Overall Study|Other|2|||
164150794|NCT04542057|592912287|FG001|Overall Study|Other|2|||
164150795|NCT02324582|592912288|FG000|Overall Study|Screen Failures|0|||
164150796|NCT02324582|592912289|FG001|Overall Study|Screen Failures|5|||
164150797|NCT00129545|592912293|FG000|Overall Study|Death|5|||
164150798|NCT00129545|592912294|FG001|Overall Study|Death|60|||
164150799|NCT00129545|592912295|FG002|Overall Study|Death|44|||
164150800|NCT00129545|592912293|FG000|Overall Study|Withdrawal by Subject|3|||
164150801|NCT00129545|592912294|FG001|Overall Study|Withdrawal by Subject|18|||
164150802|NCT00129545|592912295|FG002|Overall Study|Withdrawal by Subject|44|||
164150803|NCT00129545|592912293|FG000|Overall Study|Lost to Follow-up|2|||
164150804|NCT00129545|592912294|FG001|Overall Study|Lost to Follow-up|22|||
164150805|NCT00129545|592912295|FG002|Overall Study|Lost to Follow-up|13|||
164150806|NCT00129545|592912293|FG000|Overall Study|Physician Decision|0|||
164150807|NCT00129545|592912294|FG001|Overall Study|Physician Decision|3|||
164150808|NCT00129545|592912295|FG002|Overall Study|Physician Decision|10|||
164150809|NCT00129545|592912293|FG000|Overall Study|Device not implanted|16|||
164150810|NCT00129545|592912294|FG001|Overall Study|Device not implanted|61|||
164150811|NCT00129545|592912295|FG002|Overall Study|Device not implanted|0|||
164150812|NCT03624192|592912296|FG000|Overall Study|Lost to Follow-up|1|||
164150813|NCT03624192|592912297|FG001|Overall Study|Lost to Follow-up|1|||
164150814|NCT04660331|592912298|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
164150815|NCT04660331|592912299|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
164150816|NCT04660331|592912300|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
164150817|NCT01640249|592912302|FG000|Period 1|Withdrawal by Subject|1|||
164150818|NCT01640249|592912303|FG001|Period 1|Withdrawal by Subject|0|||
164150819|NCT01640249|592912304|FG002|Period 1|Withdrawal by Subject|0|||
164150820|NCT01640249|592912305|FG003|Period 1|Withdrawal by Subject|0|||
164150821|NCT01640249|592912306|FG004|Period 1|Withdrawal by Subject|0|||
164150822|NCT01640249|592912307|FG005|Period 1|Withdrawal by Subject|1|||
164150823|NCT01640249|592912308|FG006|Period 1|Withdrawal by Subject|0|||
164150824|NCT00065156|592912309|FG000|Overall Study|Adverse Event|37|||
164150825|NCT00065156|592912309|FG000|Overall Study|Lack of Efficacy|52|||
164150826|NCT00065156|592912309|FG000|Overall Study|Withdrawal by Subject|8|||
164150827|NCT00065156|592912309|FG000|Overall Study|Lost to Follow-up|1|||
164150828|NCT00065156|592912309|FG000|Overall Study|Death|11|||
164150829|NCT00065156|592912309|FG000|Overall Study|Study Closed by Sponsor|2|||
164150830|NCT00065156|592912309|FG000|Overall Study|Disease Progression|7|||
164150831|NCT00065156|592912309|FG000|Overall Study|Investigator Decision|2|||
164150832|NCT00065156|592912309|FG000|Overall Study|Non-Compliance|2|||
164150833|NCT00065156|592912309|FG000|Overall Study|Loss of Response|1|||
164150834|NCT00065156|592912309|FG000|Overall Study|Secondary Malign Disease|1|||
164150835|NCT00312338|592912310|FG000|Overall Study|Adverse Event|7|||
164150836|NCT00312338|592912311|FG001|Overall Study|Adverse Event|2|||
164150837|NCT00312338|592912310|FG000|Overall Study|Lost to Follow-up|9|||
164150838|NCT00312338|592912311|FG001|Overall Study|Lost to Follow-up|1|||
164150839|NCT00312338|592912310|FG000|Overall Study|Withdrawal by Subject|4|||
164150840|NCT00312338|592912311|FG001|Overall Study|Withdrawal by Subject|0|||
164150841|NCT00312338|592912310|FG000|Overall Study|Subsequent infection|2|||
164150842|NCT00312338|592912311|FG001|Overall Study|Subsequent infection|0|||
164150843|NCT00100828|592912312|FG000|Overall Study|Physician Decision|6|||
164150844|NCT04583735|592912313|FG000|Double-masked Treatment Period|Adverse Event|0|||
164150845|NCT04583735|592912314|FG001|Double-masked Treatment Period|Adverse Event|1|||
164150846|NCT04583735|592912313|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
164150847|NCT04583735|592912314|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
164150848|NCT04583735|592912313|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
164150849|NCT04583735|592912314|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
164150850|NCT04583735|592912313|FG000|Open-label Treatment Period|Adverse Event|1|||
164150851|NCT04583735|592912314|FG001|Open-label Treatment Period|Adverse Event|1|||
164150852|NCT04583735|592912313|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
164150853|NCT04583735|592912314|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164150854|NCT04583735|592912313|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164150855|NCT04583735|592912314|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
164150856|NCT01176513|592912315|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
164150857|NCT01215136|592912316|FG000|Overall Study|Adverse Event|2|||
164150858|NCT01215136|592912317|FG001|Overall Study|Adverse Event|9|||
164150859|NCT01215136|592912316|FG000|Overall Study|Disease Progression|3|||
164150860|NCT01215136|592912317|FG001|Overall Study|Disease Progression|14|||
164150861|NCT01215136|592912316|FG000|Overall Study|Symptomatic Deterioration|1|||
164150862|NCT01215136|592912317|FG001|Overall Study|Symptomatic Deterioration|1|||
164150863|NCT01215136|592912316|FG000|Overall Study|Death|0|||
164150864|NCT01215136|592912317|FG001|Overall Study|Death|2|||
164150865|NCT01215136|592912316|FG000|Overall Study|Withdrawal by Subject|0|||
164150866|NCT01215136|592912317|FG001|Overall Study|Withdrawal by Subject|1|||
164150867|NCT01125917|592912322|FG000|Overall Study|Adverse Event|43|||
164150868|NCT01125917|592912322|FG000|Overall Study|Lost to Follow-up|23|||
164150869|NCT01125917|592912322|FG000|Overall Study|Withdrawal by Subject|31|||
164150870|NCT01125917|592912322|FG000|Overall Study|Administrative|223|||
164150871|NCT01125917|592912322|FG000|Overall Study|Lack of Efficacy|19|||
164150872|NCT04421131|592912324|FG000|Overall Study|Lost to Follow-up|1|||
164150873|NCT04421131|592912324|FG000|Overall Study|Protocol Violation|2|||
164150874|NCT04421131|592912324|FG000|Overall Study|App crashed|5|||
164150875|NCT02308124|592912325|FG000|Overall Study|Lost to Follow-up|6|||
164150876|NCT02308124|592912326|FG001|Overall Study|Lost to Follow-up|6|||
164150877|NCT02308124|592912327|FG002|Overall Study|Lost to Follow-up|6|||
164150878|NCT02308124|592912325|FG000|Overall Study|Adverse Event|0|||
164150879|NCT02308124|592912326|FG001|Overall Study|Adverse Event|2|||
164150880|NCT02308124|592912327|FG002|Overall Study|Adverse Event|2|||
164150881|NCT01957176|592912329|FG000|Overall Study|Adverse Event|2|||
164150882|NCT01957176|592912330|FG001|Overall Study|Adverse Event|0|||
164150883|NCT01957176|592912329|FG000|Overall Study|Physician Decision|2|||
164150884|NCT01957176|592912330|FG001|Overall Study|Physician Decision|1|||
164150885|NCT01957176|592912329|FG000|Overall Study|Withdrawal by Subject|1|||
164150886|NCT01957176|592912330|FG001|Overall Study|Withdrawal by Subject|0|||
164150887|NCT00952731|592912331|FG000|Overall Study|Drug supply expired|1|||
164150888|NCT00952731|592912332|FG001|Overall Study|Drug supply expired|0|||
164150889|NCT01449812|592912333|FG000|Overall Study|Migrated/moved from study area|1|||
164150890|NCT01449812|592912334|FG001|Overall Study|Migrated/moved from study area|0|||
164150891|NCT01449812|592912335|FG002|Overall Study|Migrated/moved from study area|0|||
164150892|NCT01449812|592912333|FG000|Overall Study|Withdrawal by Subject|0|||
164150893|NCT01449812|592912334|FG001|Overall Study|Withdrawal by Subject|0|||
164150894|NCT01449812|592912335|FG002|Overall Study|Withdrawal by Subject|1|||
164150895|NCT01449812|592912333|FG000|Overall Study|Lost to Follow-up|1|||
164150896|NCT01449812|592912334|FG001|Overall Study|Lost to Follow-up|0|||
164150897|NCT01449812|592912335|FG002|Overall Study|Lost to Follow-up|0|||
164150898|NCT04075487|592915694|FG000|Overall Study|Withdrawal by Subject|1|||
164150899|NCT05655546|592915697|FG000|Overall Study|Withdrawal by Subject|2|||
164150900|NCT05655546|592915698|FG001|Overall Study|Withdrawal by Subject|4|||
164150901|NCT03493685|592915699|FG000|Overall Study|Death|4|||
164150902|NCT03493685|592915700|FG001|Overall Study|Death|3|||
164150903|NCT03493685|592915699|FG000|Overall Study|Lost to Follow-up|3|||
164150904|NCT03493685|592915700|FG001|Overall Study|Lost to Follow-up|2|||
164150905|NCT03493685|592915699|FG000|Overall Study|Physician Decision|2|||
164150906|NCT03493685|592915700|FG001|Overall Study|Physician Decision|0|||
164150907|NCT03493685|592915699|FG000|Overall Study|Withdrawal by Subject|7|||
164150908|NCT03493685|592915700|FG001|Overall Study|Withdrawal by Subject|11|||
164150909|NCT04452669|592915701|FG000|Overall Study|Death|1|||
164150910|NCT04452669|592915702|FG001|Overall Study|Death|4|||
164150911|NCT04576507|592915706|FG000|Overall Study|Adverse Event|4|||
164150912|NCT04576507|592915706|FG000|Overall Study|Withdrawal by Subject|1|||
164150913|NCT02721732|592915707|FG000|Overall Study|Adverse Event|2|||
164150914|NCT02721732|592915708|FG001|Overall Study|Adverse Event|0|||
164150915|NCT02721732|592915709|FG002|Overall Study|Adverse Event|2|||
164150916|NCT02721732|592915710|FG003|Overall Study|Adverse Event|0|||
164150917|NCT02721732|592915711|FG004|Overall Study|Adverse Event|1|||
164150918|NCT02721732|592915712|FG005|Overall Study|Adverse Event|0|||
164150919|NCT02721732|592915713|FG006|Overall Study|Adverse Event|1|||
164150920|NCT02721732|592915714|FG007|Overall Study|Adverse Event|0|||
164150921|NCT02721732|592915715|FG008|Overall Study|Adverse Event|1|||
164150922|NCT02721732|592915716|FG009|Overall Study|Adverse Event|1|||
164150923|NCT02721732|592915707|FG000|Overall Study|Death|0|||
164150924|NCT02721732|592915708|FG001|Overall Study|Death|0|||
164150925|NCT02721732|592915709|FG002|Overall Study|Death|0|||
164150926|NCT02721732|592915710|FG003|Overall Study|Death|0|||
164150927|NCT02721732|592915711|FG004|Overall Study|Death|1|||
164150928|NCT02721732|592915712|FG005|Overall Study|Death|0|||
164150929|NCT02721732|592915713|FG006|Overall Study|Death|1|||
164150930|NCT02721732|592915714|FG007|Overall Study|Death|0|||
164150931|NCT02721732|592915715|FG008|Overall Study|Death|0|||
164150932|NCT02721732|592915716|FG009|Overall Study|Death|1|||
164150933|NCT02721732|592915707|FG000|Overall Study|Lack of Efficacy|12|||
164150934|NCT02721732|592915708|FG001|Overall Study|Lack of Efficacy|11|||
164150935|NCT02721732|592915709|FG002|Overall Study|Lack of Efficacy|18|||
164150936|NCT02721732|592915710|FG003|Overall Study|Lack of Efficacy|5|||
164150937|NCT02721732|592915711|FG004|Overall Study|Lack of Efficacy|21|||
164150938|NCT02721732|592915712|FG005|Overall Study|Lack of Efficacy|2|||
164150939|NCT02721732|592915713|FG006|Overall Study|Lack of Efficacy|8|||
164150940|NCT02721732|592915714|FG007|Overall Study|Lack of Efficacy|11|||
164150941|NCT02721732|592915715|FG008|Overall Study|Lack of Efficacy|10|||
164150942|NCT02721732|592915716|FG009|Overall Study|Lack of Efficacy|20|||
164150943|NCT02721732|592915707|FG000|Overall Study|Physician Decision|0|||
164150944|NCT02721732|592915708|FG001|Overall Study|Physician Decision|0|||
164150945|NCT02721732|592915709|FG002|Overall Study|Physician Decision|1|||
164150946|NCT02721732|592915710|FG003|Overall Study|Physician Decision|0|||
164150947|NCT02721732|592915711|FG004|Overall Study|Physician Decision|0|||
164150948|NCT02721732|592915712|FG005|Overall Study|Physician Decision|0|||
164150949|NCT02721732|592915713|FG006|Overall Study|Physician Decision|0|||
164150950|NCT02721732|592915714|FG007|Overall Study|Physician Decision|0|||
164150951|NCT02721732|592915715|FG008|Overall Study|Physician Decision|0|||
164150952|NCT02721732|592915716|FG009|Overall Study|Physician Decision|0|||
164150953|NCT02721732|592915707|FG000|Overall Study|Withdrawal by Subject|1|||
164150954|NCT02721732|592915708|FG001|Overall Study|Withdrawal by Subject|0|||
164150955|NCT02721732|592915709|FG002|Overall Study|Withdrawal by Subject|0|||
164150956|NCT02721732|592915710|FG003|Overall Study|Withdrawal by Subject|0|||
164150957|NCT02721732|592915711|FG004|Overall Study|Withdrawal by Subject|3|||
164150958|NCT02721732|592915712|FG005|Overall Study|Withdrawal by Subject|0|||
164150959|NCT02721732|592915713|FG006|Overall Study|Withdrawal by Subject|1|||
164150960|NCT02721732|592915714|FG007|Overall Study|Withdrawal by Subject|1|||
164150961|NCT02721732|592915715|FG008|Overall Study|Withdrawal by Subject|0|||
164150962|NCT02721732|592915716|FG009|Overall Study|Withdrawal by Subject|1|||
164150963|NCT02721732|592915707|FG000|Overall Study|Participant Choice|1|||
164150964|NCT02721732|592915708|FG001|Overall Study|Participant Choice|0|||
164150965|NCT02721732|592915709|FG002|Overall Study|Participant Choice|0|||
164150966|NCT02721732|592915710|FG003|Overall Study|Participant Choice|0|||
164150967|NCT02721732|592915711|FG004|Overall Study|Participant Choice|0|||
164150968|NCT02721732|592915712|FG005|Overall Study|Participant Choice|0|||
164150969|NCT02721732|592915713|FG006|Overall Study|Participant Choice|0|||
164150970|NCT02721732|592915714|FG007|Overall Study|Participant Choice|0|||
164150971|NCT02721732|592915715|FG008|Overall Study|Participant Choice|0|||
164150972|NCT02721732|592915716|FG009|Overall Study|Participant Choice|1|||
164150973|NCT02721732|592915707|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150974|NCT02721732|592915708|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150975|NCT02721732|592915709|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
164150976|NCT02721732|592915710|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150977|NCT02721732|592915711|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150978|NCT02721732|592915712|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150979|NCT02721732|592915713|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150980|NCT02721732|592915714|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150981|NCT02721732|592915715|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164151053|NCT02848001|592915734|FG010|Overall Study|other reasons|0|||
164150982|NCT02721732|592915716|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
164150983|NCT02721732|592915707|FG000|Overall Study|Progression and withdrew consent|1|||
164150984|NCT02721732|592915708|FG001|Overall Study|Progression and withdrew consent|1|||
164150985|NCT02721732|592915709|FG002|Overall Study|Progression and withdrew consent|0|||
164150986|NCT02721732|592915710|FG003|Overall Study|Progression and withdrew consent|0|||
164150987|NCT02721732|592915711|FG004|Overall Study|Progression and withdrew consent|0|||
164150988|NCT02721732|592915712|FG005|Overall Study|Progression and withdrew consent|0|||
164150989|NCT02721732|592915713|FG006|Overall Study|Progression and withdrew consent|0|||
164150990|NCT02721732|592915714|FG007|Overall Study|Progression and withdrew consent|0|||
164150991|NCT02721732|592915715|FG008|Overall Study|Progression and withdrew consent|0|||
164150992|NCT02721732|592915716|FG009|Overall Study|Progression and withdrew consent|1|||
164150993|NCT02721732|592915707|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
164150994|NCT02721732|592915708|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
164150995|NCT02721732|592915709|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
164150996|NCT02721732|592915710|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
164150997|NCT02721732|592915711|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
164150998|NCT02721732|592915712|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
164150999|NCT02721732|592915713|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
164151000|NCT02721732|592915714|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
164151001|NCT02721732|592915715|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
164151002|NCT02721732|592915716|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
164151003|NCT04100018|592915722|FG000|Pre-Treatment Period|Not Reported|0|||
164151004|NCT04100018|592915723|FG001|Pre-Treatment Period|Not Reported|4|||
164151005|NCT04100018|592915722|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
164151006|NCT04100018|592915723|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
164151007|NCT04100018|592915722|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
164151008|NCT04100018|592915723|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
164151009|NCT04100018|592915722|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
164151010|NCT04100018|592915723|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
164151011|NCT04100018|592915722|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
164151012|NCT04100018|592915723|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
164151013|NCT04100018|592915722|FG000|Treatment Period|Ongoing Treatment|1|||
164151014|NCT04100018|592915723|FG001|Treatment Period|Ongoing Treatment|0|||
164151015|NCT04100018|592915722|FG000|Treatment Period|Other Reason|26|||
164151016|NCT04100018|592915723|FG001|Treatment Period|Other Reason|37|||
164151017|NCT04100018|592915722|FG000|Treatment Period|Completed treatment as per protocol|1|||
164151018|NCT04100018|592915723|FG001|Treatment Period|Completed treatment as per protocol|2|||
164151019|NCT04100018|592915722|FG000|Treatment Period|Maximum clinical benefit|3|||
164151020|NCT04100018|592915723|FG001|Treatment Period|Maximum clinical benefit|0|||
164151021|NCT04100018|592915722|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
164151022|NCT04100018|592915723|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
164151023|NCT04100018|592915722|FG000|Treatment Period|Study drug toxicity|67|||
164151024|NCT04100018|592915723|FG001|Treatment Period|Study drug toxicity|28|||
164151025|NCT04100018|592915722|FG000|Treatment Period|Disease Progression|284|||
164151026|NCT04100018|592915723|FG001|Treatment Period|Disease Progression|327|||
164151027|NCT04100018|592915722|FG000|Treatment Period|Administrative reasons by sponsor|16|||
164151028|NCT04100018|592915723|FG001|Treatment Period|Administrative reasons by sponsor|30|||
164151029|NCT04100018|592915722|FG000|Treatment Period|Poor/Non-Compliance|1|||
164151030|NCT04100018|592915723|FG001|Treatment Period|Poor/Non-Compliance|0|||
164151031|NCT04100018|592915722|FG000|Treatment Period|Lost to Follow-up|2|||
164151032|NCT04100018|592915723|FG001|Treatment Period|Lost to Follow-up|2|||
164151033|NCT04100018|592915722|FG000|Treatment Period|Death|16|||
164151034|NCT04100018|592915723|FG001|Treatment Period|Death|11|||
164151035|NCT04100018|592915722|FG000|Treatment Period|Participant withdrew consent|10|||
164151036|NCT04100018|592915723|FG001|Treatment Period|Participant withdrew consent|10|||
164151037|NCT04100018|592915722|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
164151038|NCT04100018|592915723|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
164151039|NCT04100018|592915722|FG000|Treatment Period|Adverse Event|14|||
164151040|NCT04100018|592915723|FG001|Treatment Period|Adverse Event|6|||
164151041|NCT04100018|592915722|FG000|Treatment Period|Lack of Efficacy|4|||
164151042|NCT04100018|592915723|FG001|Treatment Period|Lack of Efficacy|2|||
164151043|NCT02848001|592915724|FG000|Overall Study|other reasons|0|||
164151044|NCT02848001|592915725|FG001|Overall Study|other reasons|0|||
164151045|NCT02848001|592915726|FG002|Overall Study|other reasons|1|||
164151046|NCT02848001|592915727|FG003|Overall Study|other reasons|0|||
164151047|NCT02848001|592915728|FG004|Overall Study|other reasons|4|||
164151048|NCT02848001|592915729|FG005|Overall Study|other reasons|1|||
164151049|NCT02848001|592915730|FG006|Overall Study|other reasons|0|||
164151050|NCT02848001|592915731|FG007|Overall Study|other reasons|2|||
164151051|NCT02848001|592915732|FG008|Overall Study|other reasons|2|||
164151052|NCT02848001|592915733|FG009|Overall Study|other reasons|3|||
164151054|NCT02848001|592915735|FG011|Overall Study|other reasons|1|||
164151055|NCT02848001|592915736|FG012|Overall Study|other reasons|1|||
164151056|NCT02848001|592915737|FG013|Overall Study|other reasons|0|||
164151057|NCT02848001|592915738|FG014|Overall Study|other reasons|0|||
164151058|NCT02848001|592915739|FG015|Overall Study|other reasons|2|||
164151059|NCT02848001|592915740|FG016|Overall Study|other reasons|1|||
164151060|NCT02848001|592915724|FG000|Overall Study|Lack of Efficacy|0|||
164151061|NCT02848001|592915725|FG001|Overall Study|Lack of Efficacy|1|||
164151062|NCT02848001|592915726|FG002|Overall Study|Lack of Efficacy|1|||
164151063|NCT02848001|592915727|FG003|Overall Study|Lack of Efficacy|2|||
164151064|NCT02848001|592915728|FG004|Overall Study|Lack of Efficacy|3|||
164151065|NCT02848001|592915729|FG005|Overall Study|Lack of Efficacy|0|||
164151066|NCT02848001|592915730|FG006|Overall Study|Lack of Efficacy|1|||
164151067|NCT02848001|592915731|FG007|Overall Study|Lack of Efficacy|0|||
164151068|NCT02848001|592915732|FG008|Overall Study|Lack of Efficacy|0|||
164151069|NCT02848001|592915733|FG009|Overall Study|Lack of Efficacy|1|||
164151070|NCT02848001|592915734|FG010|Overall Study|Lack of Efficacy|0|||
164151071|NCT02848001|592915735|FG011|Overall Study|Lack of Efficacy|2|||
164151072|NCT02848001|592915736|FG012|Overall Study|Lack of Efficacy|0|||
164151073|NCT02848001|592915737|FG013|Overall Study|Lack of Efficacy|2|||
164151074|NCT02848001|592915738|FG014|Overall Study|Lack of Efficacy|2|||
164151075|NCT02848001|592915739|FG015|Overall Study|Lack of Efficacy|0|||
164151076|NCT02848001|592915740|FG016|Overall Study|Lack of Efficacy|0|||
164151077|NCT02848001|592915724|FG000|Overall Study|Progressive Disease|2|||
164151078|NCT02848001|592915725|FG001|Overall Study|Progressive Disease|1|||
164151079|NCT02848001|592915726|FG002|Overall Study|Progressive Disease|0|||
164151080|NCT02848001|592915727|FG003|Overall Study|Progressive Disease|4|||
164151081|NCT02848001|592915728|FG004|Overall Study|Progressive Disease|3|||
164151082|NCT02848001|592915729|FG005|Overall Study|Progressive Disease|0|||
164151083|NCT02848001|592915730|FG006|Overall Study|Progressive Disease|4|||
164151084|NCT02848001|592915731|FG007|Overall Study|Progressive Disease|1|||
164151085|NCT02848001|592915732|FG008|Overall Study|Progressive Disease|0|||
164151086|NCT02848001|592915733|FG009|Overall Study|Progressive Disease|2|||
164151087|NCT02848001|592915734|FG010|Overall Study|Progressive Disease|3|||
164151088|NCT02848001|592915735|FG011|Overall Study|Progressive Disease|2|||
164151089|NCT02848001|592915736|FG012|Overall Study|Progressive Disease|1|||
164151090|NCT02848001|592915737|FG013|Overall Study|Progressive Disease|0|||
164151091|NCT02848001|592915738|FG014|Overall Study|Progressive Disease|2|||
164151092|NCT02848001|592915739|FG015|Overall Study|Progressive Disease|4|||
164151093|NCT02848001|592915740|FG016|Overall Study|Progressive Disease|0|||
164151094|NCT02848001|592915724|FG000|Overall Study|Adverse Event|0|||
164151095|NCT02848001|592915725|FG001|Overall Study|Adverse Event|0|||
164151096|NCT02848001|592915726|FG002|Overall Study|Adverse Event|0|||
164151097|NCT02848001|592915727|FG003|Overall Study|Adverse Event|0|||
164151098|NCT02848001|592915728|FG004|Overall Study|Adverse Event|2|||
164151099|NCT02848001|592915729|FG005|Overall Study|Adverse Event|0|||
164151100|NCT02848001|592915730|FG006|Overall Study|Adverse Event|0|||
164151101|NCT02848001|592915731|FG007|Overall Study|Adverse Event|0|||
164151102|NCT02848001|592915732|FG008|Overall Study|Adverse Event|0|||
164151103|NCT02848001|592915733|FG009|Overall Study|Adverse Event|1|||
164151104|NCT02848001|592915734|FG010|Overall Study|Adverse Event|0|||
164151105|NCT02848001|592915735|FG011|Overall Study|Adverse Event|1|||
164151106|NCT02848001|592915736|FG012|Overall Study|Adverse Event|1|||
164151107|NCT02848001|592915737|FG013|Overall Study|Adverse Event|0|||
164151108|NCT02848001|592915738|FG014|Overall Study|Adverse Event|2|||
164151109|NCT02848001|592915739|FG015|Overall Study|Adverse Event|0|||
164151110|NCT02848001|592915740|FG016|Overall Study|Adverse Event|0|||
164151111|NCT02848001|592915724|FG000|Overall Study|Death|0|||
164151112|NCT02848001|592915725|FG001|Overall Study|Death|0|||
164151113|NCT02848001|592915726|FG002|Overall Study|Death|0|||
164151114|NCT02848001|592915727|FG003|Overall Study|Death|1|||
164151115|NCT02848001|592915728|FG004|Overall Study|Death|3|||
164151116|NCT02848001|592915729|FG005|Overall Study|Death|1|||
164151117|NCT02848001|592915730|FG006|Overall Study|Death|2|||
164151118|NCT02848001|592915731|FG007|Overall Study|Death|3|||
164151119|NCT02848001|592915732|FG008|Overall Study|Death|4|||
164151120|NCT02848001|592915733|FG009|Overall Study|Death|1|||
164151121|NCT02848001|592915734|FG010|Overall Study|Death|0|||
164151122|NCT02848001|592915735|FG011|Overall Study|Death|1|||
164151123|NCT02848001|592915736|FG012|Overall Study|Death|3|||
164151124|NCT02848001|592915737|FG013|Overall Study|Death|0|||
164151125|NCT02848001|592915738|FG014|Overall Study|Death|2|||
164151126|NCT02848001|592915739|FG015|Overall Study|Death|3|||
164151127|NCT02848001|592915740|FG016|Overall Study|Death|0|||
164151128|NCT02848001|592915724|FG000|Overall Study|Physician Decision|0|||
164151129|NCT02848001|592915725|FG001|Overall Study|Physician Decision|0|||
164151130|NCT02848001|592915726|FG002|Overall Study|Physician Decision|0|||
164151131|NCT02848001|592915727|FG003|Overall Study|Physician Decision|0|||
164151132|NCT02848001|592915728|FG004|Overall Study|Physician Decision|0|||
164151133|NCT02848001|592915729|FG005|Overall Study|Physician Decision|0|||
164151134|NCT02848001|592915730|FG006|Overall Study|Physician Decision|0|||
164151135|NCT02848001|592915731|FG007|Overall Study|Physician Decision|0|||
164151136|NCT02848001|592915732|FG008|Overall Study|Physician Decision|1|||
164151137|NCT02848001|592915733|FG009|Overall Study|Physician Decision|1|||
164151138|NCT02848001|592915734|FG010|Overall Study|Physician Decision|0|||
164151139|NCT02848001|592915735|FG011|Overall Study|Physician Decision|0|||
164151140|NCT02848001|592915736|FG012|Overall Study|Physician Decision|2|||
164151141|NCT02848001|592915737|FG013|Overall Study|Physician Decision|0|||
164151142|NCT02848001|592915738|FG014|Overall Study|Physician Decision|0|||
164151143|NCT02848001|592915739|FG015|Overall Study|Physician Decision|0|||
164151144|NCT02848001|592915740|FG016|Overall Study|Physician Decision|0|||
164151145|NCT02848001|592915724|FG000|Overall Study|Withdrawal by Subject|0|||
164151146|NCT02848001|592915725|FG001|Overall Study|Withdrawal by Subject|0|||
164151147|NCT02848001|592915726|FG002|Overall Study|Withdrawal by Subject|0|||
164151148|NCT02848001|592915727|FG003|Overall Study|Withdrawal by Subject|0|||
164151149|NCT02848001|592915728|FG004|Overall Study|Withdrawal by Subject|0|||
164151150|NCT02848001|592915729|FG005|Overall Study|Withdrawal by Subject|1|||
164151151|NCT02848001|592915730|FG006|Overall Study|Withdrawal by Subject|1|||
164151152|NCT02848001|592915731|FG007|Overall Study|Withdrawal by Subject|1|||
164151153|NCT02848001|592915732|FG008|Overall Study|Withdrawal by Subject|0|||
164151154|NCT02848001|592915733|FG009|Overall Study|Withdrawal by Subject|0|||
164151155|NCT02848001|592915734|FG010|Overall Study|Withdrawal by Subject|0|||
164151156|NCT02848001|592915735|FG011|Overall Study|Withdrawal by Subject|0|||
164151157|NCT02848001|592915736|FG012|Overall Study|Withdrawal by Subject|0|||
164151158|NCT02848001|592915737|FG013|Overall Study|Withdrawal by Subject|0|||
164151159|NCT02848001|592915738|FG014|Overall Study|Withdrawal by Subject|0|||
164151160|NCT02848001|592915739|FG015|Overall Study|Withdrawal by Subject|0|||
164151161|NCT02848001|592915740|FG016|Overall Study|Withdrawal by Subject|0|||
164151162|NCT04358081|592915741|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
164151163|NCT04358081|592915742|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
164151164|NCT04358081|592915743|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
164151165|NCT04358081|592915741|FG000|Treatment Phase of Study|Adverse Event|1|||
164151166|NCT04358081|592915742|FG001|Treatment Phase of Study|Adverse Event|0|||
164151167|NCT04358081|592915743|FG002|Treatment Phase of Study|Adverse Event|1|||
164151168|NCT04358081|592915741|FG000|Treatment Phase of Study|Physician Decision|2|||
164151169|NCT04358081|592915742|FG001|Treatment Phase of Study|Physician Decision|0|||
164151170|NCT04358081|592915743|FG002|Treatment Phase of Study|Physician Decision|1|||
164151171|NCT04358081|592915741|FG000|Treatment Phase of Study|Protocol Violation|1|||
164151172|NCT04358081|592915742|FG001|Treatment Phase of Study|Protocol Violation|0|||
164151173|NCT04358081|592915743|FG002|Treatment Phase of Study|Protocol Violation|0|||
164151174|NCT04358081|592915741|FG000|Study Completion Phase|Death|0|||
164151175|NCT04358081|592915742|FG001|Study Completion Phase|Death|0|||
164151176|NCT04358081|592915743|FG002|Study Completion Phase|Death|1|||
164151177|NCT04358081|592915741|FG000|Study Completion Phase|Lost to Follow-up|1|||
164151178|NCT04358081|592915742|FG001|Study Completion Phase|Lost to Follow-up|0|||
164151179|NCT04358081|592915743|FG002|Study Completion Phase|Lost to Follow-up|1|||
164151180|NCT00725283|592915747|FG000|Overall Study|Missing Code|3|||
164151181|NCT00725283|592915747|FG000|Overall Study|Death|5|||
164151182|NCT00725283|592915747|FG000|Overall Study|Other|6|||
164151183|NCT00725283|592915747|FG000|Overall Study|Withdrawal by Subject|10|||
164151184|NCT03103087|592915748|FG000|Overall Study|Did not receive any study drug|1|||
164151185|NCT03103087|592915749|FG001|Overall Study|Did not receive any study drug|0|||
164151186|NCT03103087|592915750|FG002|Overall Study|Did not receive any study drug|0|||
164151187|NCT03103087|592915748|FG000|Overall Study|Protocol Violation|1|||
164151188|NCT03103087|592915749|FG001|Overall Study|Protocol Violation|2|||
164151189|NCT03103087|592915750|FG002|Overall Study|Protocol Violation|1|||
164151190|NCT03103087|592915748|FG000|Overall Study|Lack of Efficacy|2|||
164151191|NCT03103087|592915749|FG001|Overall Study|Lack of Efficacy|1|||
164151192|NCT03103087|592915750|FG002|Overall Study|Lack of Efficacy|1|||
164151193|NCT03103087|592915748|FG000|Overall Study|Pregnancy|0|||
164151194|NCT03103087|592915749|FG001|Overall Study|Pregnancy|0|||
164151195|NCT03103087|592915750|FG002|Overall Study|Pregnancy|1|||
164151196|NCT03103087|592915748|FG000|Overall Study|Adverse Event|2|||
164151197|NCT03103087|592915749|FG001|Overall Study|Adverse Event|15|||
164151198|NCT03103087|592915750|FG002|Overall Study|Adverse Event|6|||
164151199|NCT03103087|592915748|FG000|Overall Study|Withdrawal by Subject|13|||
164151200|NCT03103087|592915749|FG001|Overall Study|Withdrawal by Subject|6|||
164151201|NCT03103087|592915750|FG002|Overall Study|Withdrawal by Subject|6|||
164151202|NCT03103087|592915748|FG000|Overall Study|Lost to Follow-up|4|||
164151203|NCT03103087|592915749|FG001|Overall Study|Lost to Follow-up|2|||
164151204|NCT03103087|592915750|FG002|Overall Study|Lost to Follow-up|7|||
164151205|NCT03103087|592915748|FG000|Overall Study|Other reason not reported|1|||
164151206|NCT03103087|592915749|FG001|Overall Study|Other reason not reported|3|||
164151207|NCT03103087|592915750|FG002|Overall Study|Other reason not reported|5|||
164151208|NCT00118157|592915751|FG000|Overall Study|Adverse Event|2|||
164151209|NCT00118157|592915751|FG000|Overall Study|Death|8|||
164151210|NCT00118157|592915751|FG000|Overall Study|Withdrawal by Subject|2|||
164151211|NCT00413699|592915752|FG000|Initial Period|Death|25|||
164151212|NCT00413699|592915753|FG001|Initial Period|Death|30|||
164151213|NCT00413699|592915754|FG002|Initial Period|Death|0|||
164151214|NCT00413699|592915752|FG000|Initial Period|Lack of Efficacy|59|||
164151215|NCT00413699|592915753|FG001|Initial Period|Lack of Efficacy|115|||
164151216|NCT00413699|592915754|FG002|Initial Period|Lack of Efficacy|0|||
164151217|NCT00413699|592915752|FG000|Initial Period|Lost to Follow-up|31|||
164151218|NCT00413699|592915753|FG001|Initial Period|Lost to Follow-up|101|||
164151219|NCT00413699|592915754|FG002|Initial Period|Lost to Follow-up|0|||
164151220|NCT00413699|592915752|FG000|Initial Period|Protocol Violation|38|||
164151221|NCT00413699|592915753|FG001|Initial Period|Protocol Violation|89|||
164151222|NCT00413699|592915754|FG002|Initial Period|Protocol Violation|0|||
164151223|NCT00413699|592915752|FG000|Initial Period|Pregnancy|10|||
164151224|NCT00413699|592915753|FG001|Initial Period|Pregnancy|8|||
164151225|NCT00413699|592915754|FG002|Initial Period|Pregnancy|0|||
164151226|NCT00413699|592915752|FG000|Initial Period|Did not meet entrance criteria|2|||
164151227|NCT00413699|592915753|FG001|Initial Period|Did not meet entrance criteria|2|||
164151228|NCT00413699|592915754|FG002|Initial Period|Did not meet entrance criteria|0|||
164151229|NCT00413699|592915752|FG000|Initial Period|Medication error without adverse event|0|||
164151230|NCT00413699|592915753|FG001|Initial Period|Medication error without adverse event|1|||
164151231|NCT00413699|592915754|FG002|Initial Period|Medication error without adverse event|0|||
164151232|NCT00413699|592915752|FG000|Initial Period|Study terminated by Sponsor|0|||
164151233|NCT00413699|592915753|FG001|Initial Period|Study terminated by Sponsor|1|||
164151234|NCT00413699|592915754|FG002|Initial Period|Study terminated by Sponsor|0|||
164151235|NCT00413699|592915752|FG000|Initial Period|Other|67|||
164151236|NCT00413699|592915753|FG001|Initial Period|Other|211|||
164151237|NCT00413699|592915754|FG002|Initial Period|Other|0|||
164151238|NCT00413699|592915752|FG000|Initial Period|Adverse event related to study drug|178|||
164151239|NCT00413699|592915753|FG001|Initial Period|Adverse event related to study drug|527|||
164151240|NCT00413699|592915754|FG002|Initial Period|Adverse event related to study drug|0|||
164151241|NCT00413699|592915752|FG000|Initial Period|Adverse event not related to study drug|113|||
164151242|NCT00413699|592915753|FG001|Initial Period|Adverse event not related to study drug|248|||
164151243|NCT00413699|592915754|FG002|Initial Period|Adverse event not related to study drug|0|||
164151244|NCT00413699|592915752|FG000|Initial Period|Missing end of study page|0|||
164151245|NCT00413699|592915753|FG001|Initial Period|Missing end of study page|4|||
164151246|NCT00413699|592915754|FG002|Initial Period|Missing end of study page|0|||
164151247|NCT00413699|592915752|FG000|Initial Period|No longer willing to participate|116|||
164151248|NCT00413699|592915753|FG001|Initial Period|No longer willing to participate|368|||
164151249|NCT00413699|592915754|FG002|Initial Period|No longer willing to participate|0|||
164151250|NCT00413699|592915752|FG000|Extension Period|No Longer Willing to Participate|0|||
164151251|NCT00413699|592915753|FG001|Extension Period|No Longer Willing to Participate|0|||
164151252|NCT00413699|592915754|FG002|Extension Period|No Longer Willing to Participate|2|||
164151253|NCT00413699|592915752|FG000|Extension Period|Protocol Violation|0|||
164151254|NCT00413699|592915753|FG001|Extension Period|Protocol Violation|0|||
164151255|NCT00413699|592915754|FG002|Extension Period|Protocol Violation|1|||
164151256|NCT00413699|592915752|FG000|Extension Period|Adverse Event|0|||
164151257|NCT00413699|592915753|FG001|Extension Period|Adverse Event|0|||
164151258|NCT00413699|592915754|FG002|Extension Period|Adverse Event|2|||
164151259|NCT02115269|592915756|FG000|Overall Study|Lost to Follow-up|43|||
164151260|NCT02115269|592915756|FG000|Overall Study|Did not complete patient diary|3|||
164151261|NCT02115269|592915756|FG000|Overall Study|Moved to another city|7|||
164151262|NCT02115269|592915756|FG000|Overall Study|Withdrawal by Subject|2|||
164151263|NCT02115269|592915756|FG000|Overall Study|Didn't take study drug|2|||
164151264|NCT05989672|592915757|FG000|Overall Study|Adverse Event|3|||
164151265|NCT05989672|592915758|FG001|Overall Study|Adverse Event|0|||
164151266|NCT05989672|592915759|FG002|Overall Study|Adverse Event|0|||
164151267|NCT03283566|592915760|FG000|Overall Study|Lost to Follow-up|1|||
164151268|NCT03283566|592915761|FG001|Overall Study|Lost to Follow-up|2|||
164151269|NCT02760004|592915762|FG000|Overall Study|Lost to Follow-up|13|||
164151270|NCT02760004|592915763|FG001|Overall Study|Lost to Follow-up|22|||
164151271|NCT01495000|592915764|FG000|Overall Study|Lost to Follow-up|2|||
164151272|NCT01495000|592915765|FG001|Overall Study|Lost to Follow-up|2|||
164151273|NCT01495000|592915764|FG000|Overall Study|Protocol Violation|1|||
164151274|NCT01495000|592915765|FG001|Overall Study|Protocol Violation|0|||
164151275|NCT01495000|592915764|FG000|Overall Study|Withdrawal by Subject|10|||
164151276|NCT01495000|592915765|FG001|Overall Study|Withdrawal by Subject|10|||
164151277|NCT02070965|592915766|FG000|Overall Study|Lost to Follow-up|0|||
164151278|NCT02070965|592915767|FG001|Overall Study|Lost to Follow-up|1|||
164151279|NCT02070965|592915768|FG002|Overall Study|Lost to Follow-up|0|||
164151280|NCT02070965|592915766|FG000|Overall Study|Withdrawal by Subject|1|||
164151281|NCT02070965|592915767|FG001|Overall Study|Withdrawal by Subject|1|||
164151282|NCT02070965|592915768|FG002|Overall Study|Withdrawal by Subject|1|||
164151283|NCT02070965|592915766|FG000|Overall Study|Subject moved|1|||
164151284|NCT02070965|592915767|FG001|Overall Study|Subject moved|0|||
164151285|NCT02070965|592915768|FG002|Overall Study|Subject moved|0|||
164151286|NCT03889886|592915769|FG000|Overall Study|Other|0|||
164151287|NCT03889886|592915770|FG001|Overall Study|Other|1|||
164151288|NCT03889886|592915771|FG002|Overall Study|Other|0|||
164151289|NCT03889886|592915772|FG003|Overall Study|Other|1|||
164151290|NCT03889886|592915769|FG000|Overall Study|Withdrawal by Subject|0|||
164151441|NCT03172494|592915839|FG001|Overall Study|Lack of Efficacy|0|||
164151291|NCT03889886|592915770|FG001|Overall Study|Withdrawal by Subject|0|||
164151292|NCT03889886|592915771|FG002|Overall Study|Withdrawal by Subject|1|||
164151293|NCT03889886|592915772|FG003|Overall Study|Withdrawal by Subject|0|||
164151294|NCT03889886|592915769|FG000|Overall Study|Adverse Event|0|||
164151295|NCT03889886|592915770|FG001|Overall Study|Adverse Event|0|||
164151296|NCT03889886|592915771|FG002|Overall Study|Adverse Event|0|||
164151297|NCT03889886|592915772|FG003|Overall Study|Adverse Event|6|||
164151298|NCT01308424|592915774|FG000|Baseline Eligibility|Screen Failures|71|||
164151299|NCT01308424|592915775|FG001|Baseline Eligibility|Screen Failures|0|||
164151300|NCT01308424|592915776|FG002|Baseline Eligibility|Screen Failures|0|||
164151301|NCT01308424|592915774|FG000|Randomization|Adverse Event|0|||
164151302|NCT01308424|592915775|FG001|Randomization|Adverse Event|1|||
164151303|NCT01308424|592915776|FG002|Randomization|Adverse Event|1|||
164151304|NCT01308424|592915774|FG000|Randomization|Lost to Follow-up|0|||
164151305|NCT01308424|592915775|FG001|Randomization|Lost to Follow-up|1|||
164151306|NCT01308424|592915776|FG002|Randomization|Lost to Follow-up|0|||
164151307|NCT01308424|592915774|FG000|Randomization|Physician Decision|0|||
164151308|NCT01308424|592915775|FG001|Randomization|Physician Decision|1|||
164151309|NCT01308424|592915776|FG002|Randomization|Physician Decision|1|||
164151310|NCT00948155|592915777|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
164151311|NCT00948155|592915778|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
164151312|NCT00948155|592915777|FG000|Washout 14 Days|Lost to Follow-up|1|||
164151313|NCT00948155|592915778|FG001|Washout 14 Days|Lost to Follow-up|2|||
164151314|NCT05767905|592915779|FG000|Overall Study|Adverse Event|0|||
164151315|NCT05767905|592915780|FG001|Overall Study|Adverse Event|0|||
164151316|NCT05767905|592915781|FG002|Overall Study|Adverse Event|1|||
164151317|NCT01841593|592915782|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
164151318|NCT01841593|592915783|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
164151319|NCT01841593|592915782|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
164151320|NCT01841593|592915783|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
164151321|NCT02635984|592915784|FG000|Overall Study|Lost to Follow-up|2|||
164151322|NCT02635984|592915785|FG001|Overall Study|Lost to Follow-up|4|||
164151323|NCT02635984|592915784|FG000|Overall Study|Study Arm Closed|1|||
164151324|NCT02635984|592915785|FG001|Overall Study|Study Arm Closed|0|||
164151325|NCT00307086|592915788|FG000|Overall Study|ineligible|5|||
164151326|NCT01487525|592915789|FG000|Overall Study|Withdrawal by Subject|0|||
164151327|NCT01487525|592915790|FG001|Overall Study|Withdrawal by Subject|1|||
164151328|NCT03518008|592915791|FG000|Period 2, Second Week of Wear|Family emergency|0|||
164151329|NCT03518008|592915792|FG001|Period 2, Second Week of Wear|Family emergency|1|||
164151330|NCT02501928|592915797|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164151331|NCT02501928|592915798|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164151332|NCT02501928|592915799|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
164151333|NCT02501928|592915800|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
164151334|NCT02501928|592915801|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
164151335|NCT02501928|592915802|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
164151336|NCT01197911|592915803|FG000|Overall Study|Adverse Event|0|||
164151337|NCT01197911|592915804|FG001|Overall Study|Adverse Event|0|||
164151338|NCT01197911|592915805|FG002|Overall Study|Adverse Event|1|||
164151339|NCT00838526|592915806|FG000|Overall Study|Adverse Event|3|||
164151340|NCT00838526|592915807|FG001|Overall Study|Adverse Event|12|||
164151341|NCT00838526|592915806|FG000|Overall Study|Lost to Follow-up|4|||
164151342|NCT00838526|592915807|FG001|Overall Study|Lost to Follow-up|12|||
164151343|NCT00838526|592915806|FG000|Overall Study|Withdrawal by Subject|4|||
164151344|NCT00838526|592915807|FG001|Overall Study|Withdrawal by Subject|5|||
164151345|NCT00838526|592915806|FG000|Overall Study|Lack of Efficacy|2|||
164151346|NCT00838526|592915807|FG001|Overall Study|Lack of Efficacy|3|||
164151347|NCT00838526|592915806|FG000|Overall Study|Other|11|||
164151348|NCT00838526|592915807|FG001|Overall Study|Other|7|||
164151349|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
164151350|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
164151351|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
164151352|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
164151353|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
164151354|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
164151355|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
164151356|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
164151357|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
164151358|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
164151359|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
164151360|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
164151361|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
164151362|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
164151363|NCT04338022|592915809|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
164151364|NCT04338022|592915810|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
164151365|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
164151366|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
164151367|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
164151368|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
164151369|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
164151370|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
164151371|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
164151372|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
164151373|NCT04338022|592915809|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
164151374|NCT04338022|592915810|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
164151375|NCT04338022|592915809|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
164151376|NCT04338022|592915810|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
164151377|NCT00786409|592915811|FG000|Overall Study|Withdrawal by Subject|2|||
164151378|NCT00786409|592915811|FG000|Overall Study|Adverse Event|2|||
164151379|NCT00786409|592915811|FG000|Overall Study|Pregnancy|2|||
164151380|NCT00786409|592915811|FG000|Overall Study|Lost to Follow-up|1|||
164151381|NCT00610129|592915812|FG000|Overall Study|Not treated since patients ineligible|3|||
164151382|NCT02273388|592915815|FG000|Overall Study|Adverse Event|0|||
164151383|NCT02273388|592915816|FG001|Overall Study|Adverse Event|0|||
164151384|NCT02273388|592915817|FG002|Overall Study|Adverse Event|0|||
164151385|NCT02273388|592915818|FG003|Overall Study|Adverse Event|0|||
164151386|NCT02273388|592915819|FG004|Overall Study|Adverse Event|0|||
164151387|NCT02273388|592915820|FG005|Overall Study|Adverse Event|0|||
164151388|NCT02273388|592915821|FG006|Overall Study|Adverse Event|1|||
164151389|NCT02273388|592915822|FG007|Overall Study|Adverse Event|2|||
164151390|NCT02273388|592915823|FG008|Overall Study|Adverse Event|0|||
164151391|NCT02273388|592915824|FG009|Overall Study|Adverse Event|0|||
164151392|NCT02273388|592915825|FG010|Overall Study|Adverse Event|0|||
164151393|NCT02273388|592915826|FG011|Overall Study|Adverse Event|0|||
164151394|NCT02273388|592915815|FG000|Overall Study|Adverse Event study disease worse|4|||
164151395|NCT02273388|592915816|FG001|Overall Study|Adverse Event study disease worse|3|||
164151396|NCT02273388|592915817|FG002|Overall Study|Adverse Event study disease worse|3|||
164151397|NCT02273388|592915818|FG003|Overall Study|Adverse Event study disease worse|2|||
164151398|NCT02273388|592915819|FG004|Overall Study|Adverse Event study disease worse|4|||
164151399|NCT02273388|592915820|FG005|Overall Study|Adverse Event study disease worse|3|||
164151400|NCT02273388|592915821|FG006|Overall Study|Adverse Event study disease worse|14|||
164151401|NCT02273388|592915822|FG007|Overall Study|Adverse Event study disease worse|6|||
164151402|NCT02273388|592915823|FG008|Overall Study|Adverse Event study disease worse|6|||
164151403|NCT02273388|592915824|FG009|Overall Study|Adverse Event study disease worse|5|||
164151404|NCT02273388|592915825|FG010|Overall Study|Adverse Event study disease worse|10|||
164151405|NCT02273388|592915826|FG011|Overall Study|Adverse Event study disease worse|1|||
164151406|NCT02273388|592915815|FG000|Overall Study|Sponsor decision|0|||
164151407|NCT02273388|592915816|FG001|Overall Study|Sponsor decision|0|||
164151408|NCT02273388|592915817|FG002|Overall Study|Sponsor decision|0|||
164151409|NCT02273388|592915818|FG003|Overall Study|Sponsor decision|0|||
164151410|NCT02273388|592915819|FG004|Overall Study|Sponsor decision|0|||
164151411|NCT02273388|592915820|FG005|Overall Study|Sponsor decision|0|||
164151412|NCT02273388|592915821|FG006|Overall Study|Sponsor decision|0|||
164151413|NCT02273388|592915822|FG007|Overall Study|Sponsor decision|0|||
164151414|NCT02273388|592915823|FG008|Overall Study|Sponsor decision|0|||
164151415|NCT02273388|592915824|FG009|Overall Study|Sponsor decision|0|||
164151416|NCT02273388|592915825|FG010|Overall Study|Sponsor decision|0|||
164151417|NCT02273388|592915826|FG011|Overall Study|Sponsor decision|1|||
164151418|NCT04331808|592915827|FG000|Overall Study|Withdrew consent|1|||
164151419|NCT04331808|592915828|FG001|Overall Study|Withdrew consent|0|||
164151420|NCT04331808|592915829|FG002|Overall Study|Withdrew consent|2|||
164151421|NCT04331808|592915830|FG003|Overall Study|Withdrew consent|3|||
164151422|NCT02445963|592915831|FG000|Overall Study|Lost to Follow-up|1|||
164151423|NCT02445963|592915832|FG001|Overall Study|Lost to Follow-up|0|||
164151424|NCT02445963|592915833|FG002|Overall Study|Lost to Follow-up|0|||
164151425|NCT02445963|592915834|FG003|Overall Study|Lost to Follow-up|0|||
164151426|NCT02445963|592915831|FG000|Overall Study|Change in employment|1|||
164151427|NCT02445963|592915832|FG001|Overall Study|Change in employment|0|||
164151428|NCT02445963|592915833|FG002|Overall Study|Change in employment|0|||
164151429|NCT02445963|592915834|FG003|Overall Study|Change in employment|0|||
164151430|NCT02445963|592915831|FG000|Overall Study|Symptoms post-vaccination|0|||
164151431|NCT02445963|592915832|FG001|Overall Study|Symptoms post-vaccination|0|||
164151432|NCT02445963|592915833|FG002|Overall Study|Symptoms post-vaccination|1|||
164151433|NCT02445963|592915834|FG003|Overall Study|Symptoms post-vaccination|0|||
164151434|NCT03172494|592915838|FG000|Overall Study|Adverse Event|5|||
164151435|NCT03172494|592915839|FG001|Overall Study|Adverse Event|1|||
164151436|NCT03172494|592915840|FG002|Overall Study|Adverse Event|15|||
164151437|NCT03172494|592915838|FG000|Overall Study|Protocol Violation|3|||
164151438|NCT03172494|592915839|FG001|Overall Study|Protocol Violation|2|||
164151439|NCT03172494|592915840|FG002|Overall Study|Protocol Violation|1|||
164151440|NCT03172494|592915838|FG000|Overall Study|Lack of Efficacy|0|||
164151442|NCT03172494|592915840|FG002|Overall Study|Lack of Efficacy|4|||
164151443|NCT03172494|592915838|FG000|Overall Study|Pregnancy|0|||
164151444|NCT03172494|592915839|FG001|Overall Study|Pregnancy|1|||
164151445|NCT03172494|592915840|FG002|Overall Study|Pregnancy|0|||
164151446|NCT03172494|592915838|FG000|Overall Study|Withdrawal by Subject|10|||
164151447|NCT03172494|592915839|FG001|Overall Study|Withdrawal by Subject|8|||
164151448|NCT03172494|592915840|FG002|Overall Study|Withdrawal by Subject|8|||
164151449|NCT03172494|592915838|FG000|Overall Study|Severe hypoglycaemic episode|0|||
164151450|NCT03172494|592915839|FG001|Overall Study|Severe hypoglycaemic episode|0|||
164151451|NCT03172494|592915840|FG002|Overall Study|Severe hypoglycaemic episode|1|||
164151452|NCT03172494|592915838|FG000|Overall Study|Non-compliance towards treatment|2|||
164151453|NCT03172494|592915839|FG001|Overall Study|Non-compliance towards treatment|0|||
164151454|NCT03172494|592915840|FG002|Overall Study|Non-compliance towards treatment|0|||
164151455|NCT04233073|592915841|FG000|Overall Study|Death|5|||
164151456|NCT00143390|592915842|FG000|Overall Study|Death|2|||
164151457|NCT00143390|592915843|FG001|Overall Study|Death|0|||
164151458|NCT00143390|592915842|FG000|Overall Study|Not meeting entry criteria|2|||
164151459|NCT00143390|592915843|FG001|Overall Study|Not meeting entry criteria|5|||
164151460|NCT00143390|592915842|FG000|Overall Study|Withdrawal by Subject|4|||
164151461|NCT00143390|592915843|FG001|Overall Study|Withdrawal by Subject|4|||
164151462|NCT00143390|592915842|FG000|Overall Study|Progressive disease|119|||
164151463|NCT00143390|592915843|FG001|Overall Study|Progressive disease|115|||
164151464|NCT00143390|592915842|FG000|Overall Study|Protocol Violation|2|||
164151465|NCT00143390|592915843|FG001|Overall Study|Protocol Violation|0|||
164151466|NCT00143390|592915842|FG000|Overall Study|Study termination|10|||
164151467|NCT00143390|592915843|FG001|Overall Study|Study termination|15|||
164151468|NCT00143390|592915842|FG000|Overall Study|Adverse Event|9|||
164151469|NCT00143390|592915843|FG001|Overall Study|Adverse Event|8|||
164151470|NCT00143390|592915842|FG000|Overall Study|Other|1|||
164151471|NCT00143390|592915843|FG001|Overall Study|Other|2|||
164151472|NCT00243412|592915845|FG000|Overall Study|Death|0|||
164151473|NCT00243412|592915846|FG001|Overall Study|Death|1|||
164151474|NCT00243412|592915845|FG000|Overall Study|Adverse Event|4|||
164151475|NCT00243412|592915846|FG001|Overall Study|Adverse Event|2|||
164151476|NCT00243412|592915845|FG000|Overall Study|Lost to Follow-up|0|||
164151477|NCT00243412|592915846|FG001|Overall Study|Lost to Follow-up|1|||
164151478|NCT00243412|592915845|FG000|Overall Study|Physician Decision|1|||
164151479|NCT00243412|592915846|FG001|Overall Study|Physician Decision|1|||
164151480|NCT00243412|592915845|FG000|Overall Study|Withdrawal by Subject|4|||
164151481|NCT00243412|592915846|FG001|Overall Study|Withdrawal by Subject|5|||
164151482|NCT00243412|592915845|FG000|Overall Study|Other|1|||
164151483|NCT00243412|592915846|FG001|Overall Study|Other|1|||
164151484|NCT00041132|592915847|FG000|Overall Study|Adverse Event|19|||
164151485|NCT00041132|592915847|FG000|Overall Study|Death|1|||
164151486|NCT00041132|592915847|FG000|Overall Study|Not Eligible|7|||
164151487|NCT00041132|592915847|FG000|Overall Study|Withdrawal by Subject|1|||
164151488|NCT00041132|592915847|FG000|Overall Study|Physician Decision|2|||
164151489|NCT02764151|592915848|FG000|Overall Study|Subject refused further follow-up|0|||
164151490|NCT02764151|592915849|FG001|Overall Study|Subject refused further follow-up|0|||
164151491|NCT02764151|592915850|FG002|Overall Study|Subject refused further follow-up|0|||
164151492|NCT02764151|592915851|FG003|Overall Study|Subject refused further follow-up|1|||
164151493|NCT02764151|592915848|FG000|Overall Study|Other|0|||
164151494|NCT02764151|592915849|FG001|Overall Study|Other|0|||
164151495|NCT02764151|592915850|FG002|Overall Study|Other|0|||
164151496|NCT02764151|592915851|FG003|Overall Study|Other|2|||
164151497|NCT01450683|592915855|FG000|Overall Study|Adverse Event|2|||
164151498|NCT00625872|592915857|FG000|Overall Study|Withdrawal by Subject|1|||
164151499|NCT00625872|592915858|FG001|Overall Study|Withdrawal by Subject|0|||
164151500|NCT00625872|592915857|FG000|Overall Study|Does not meet inclusion criteria|1|||
164151501|NCT00625872|592915858|FG001|Overall Study|Does not meet inclusion criteria|0|||
164151502|NCT00625872|592915857|FG000|Overall Study|Terminated by sponsor|2|||
164151503|NCT00625872|592915858|FG001|Overall Study|Terminated by sponsor|5|||
164151504|NCT00625872|592915857|FG000|Overall Study|Randomized but not treated|0|||
164151505|NCT00625872|592915858|FG001|Overall Study|Randomized but not treated|1|||
164151506|NCT01512160|592915859|FG000|Overall Study|Lost to Follow-up|1|||
164151507|NCT01512160|592915860|FG001|Overall Study|Lost to Follow-up|0|||
164151508|NCT01512160|592915861|FG002|Overall Study|Lost to Follow-up|0|||
164151509|NCT01512160|592915862|FG003|Overall Study|Lost to Follow-up|0|||
164151510|NCT01512160|592915859|FG000|Overall Study|Withdrawal by Subject|1|||
164151511|NCT01512160|592915860|FG001|Overall Study|Withdrawal by Subject|0|||
164151512|NCT01512160|592915861|FG002|Overall Study|Withdrawal by Subject|0|||
164151513|NCT01512160|592915862|FG003|Overall Study|Withdrawal by Subject|1|||
164151514|NCT02729909|592915863|FG000|Overall Study|Lost to Follow-up|0|||
164151515|NCT02729909|592915864|FG001|Overall Study|Lost to Follow-up|1|||
164151516|NCT02729909|592915863|FG000|Overall Study|Lack of Efficacy|0|||
164151517|NCT02729909|592915864|FG001|Overall Study|Lack of Efficacy|2|||
164151518|NCT02729909|592915863|FG000|Overall Study|Significant Protocol Deviation|0|||
164151519|NCT02729909|592915864|FG001|Overall Study|Significant Protocol Deviation|2|||
164151520|NCT02729909|592915863|FG000|Overall Study|Voluntary Withdrawal|1|||
164151521|NCT02729909|592915864|FG001|Overall Study|Voluntary Withdrawal|0|||
164151522|NCT04779879|592915868|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151523|NCT04779879|592915869|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151524|NCT04779879|592915870|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151525|NCT04779879|592915871|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
164151526|NCT04779879|592915872|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151527|NCT04779879|592915873|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
164151528|NCT04779879|592915868|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151529|NCT04779879|592915869|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151530|NCT04779879|592915870|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151531|NCT04779879|592915871|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
164151532|NCT04779879|592915872|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151533|NCT04779879|592915873|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
164151534|NCT04779879|592915868|FG000|Part C: Up to Week 36|Death|0|||
164151535|NCT04779879|592915869|FG001|Part C: Up to Week 36|Death|0|||
164151536|NCT04779879|592915870|FG002|Part C: Up to Week 36|Death|0|||
164151537|NCT04779879|592915871|FG003|Part C: Up to Week 36|Death|0|||
164151538|NCT04779879|592915872|FG004|Part C: Up to Week 36|Death|0|||
164151539|NCT04779879|592915873|FG005|Part C: Up to Week 36|Death|1|||
164151540|NCT04779879|592915868|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151541|NCT04779879|592915869|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151542|NCT04779879|592915870|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151543|NCT04779879|592915871|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
164151544|NCT04779879|592915872|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
164151545|NCT04779879|592915873|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
164151546|NCT05101343|592915874|FG000|Overall Study|Withdrawal by Subject|2|||
164151547|NCT05101343|592915875|FG001|Overall Study|Withdrawal by Subject|1|||
164151548|NCT02854527|592915876|FG000|Overall Study|Adverse Event|0|||
164151549|NCT02854527|592915877|FG001|Overall Study|Adverse Event|0|||
164151550|NCT02854527|592915878|FG002|Overall Study|Adverse Event|0|||
164151551|NCT02854527|592915879|FG003|Overall Study|Adverse Event|0|||
164151552|NCT02854527|592915880|FG004|Overall Study|Adverse Event|1|||
164151553|NCT02854527|592915881|FG005|Overall Study|Adverse Event|0|||
164151554|NCT02854527|592915882|FG006|Overall Study|Adverse Event|0|||
164151555|NCT02854527|592915883|FG007|Overall Study|Adverse Event|0|||
164151556|NCT02854527|592915884|FG008|Overall Study|Adverse Event|0|||
164151557|NCT02854527|592915885|FG009|Overall Study|Adverse Event|0|||
164151558|NCT02854527|592915876|FG000|Overall Study|Lost to Follow-up|0|||
164151559|NCT02854527|592915877|FG001|Overall Study|Lost to Follow-up|0|||
164151560|NCT02854527|592915878|FG002|Overall Study|Lost to Follow-up|0|||
164151561|NCT02854527|592915879|FG003|Overall Study|Lost to Follow-up|1|||
164151562|NCT02854527|592915880|FG004|Overall Study|Lost to Follow-up|0|||
164151563|NCT02854527|592915881|FG005|Overall Study|Lost to Follow-up|0|||
164151564|NCT02854527|592915882|FG006|Overall Study|Lost to Follow-up|0|||
164151565|NCT02854527|592915883|FG007|Overall Study|Lost to Follow-up|0|||
164151566|NCT02854527|592915884|FG008|Overall Study|Lost to Follow-up|0|||
164151567|NCT02854527|592915885|FG009|Overall Study|Lost to Follow-up|0|||
164151568|NCT01959295|592915886|FG000|Overall Study|Adverse Event|2|||
164151569|NCT01959295|592915887|FG001|Overall Study|Adverse Event|0|||
164151570|NCT01959295|592915886|FG000|Overall Study|Lost to Follow-up|0|||
164151571|NCT01959295|592915887|FG001|Overall Study|Lost to Follow-up|2|||
164151572|NCT01959295|592915886|FG000|Overall Study|Physician Decision|2|||
164151573|NCT01959295|592915887|FG001|Overall Study|Physician Decision|3|||
164151574|NCT01959295|592915886|FG000|Overall Study|Protocol Violation|16|||
164151575|NCT01959295|592915887|FG001|Overall Study|Protocol Violation|5|||
164151576|NCT01959295|592915886|FG000|Overall Study|Withdrawal by Subject|3|||
164151577|NCT01959295|592915887|FG001|Overall Study|Withdrawal by Subject|1|||
164151578|NCT01959295|592915886|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
164151579|NCT01959295|592915887|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
164151580|NCT01682811|592915890|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151581|NCT01682811|592915891|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151582|NCT01682811|592915892|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151583|NCT01682811|592915893|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151584|NCT01682811|592915894|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
164151585|NCT01682811|592915895|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151586|NCT01682811|592915896|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
164151587|NCT01682811|592915890|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
164151588|NCT01682811|592915891|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
164151589|NCT01682811|592915892|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
164151590|NCT01682811|592915893|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
164151591|NCT01682811|592915894|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
164151592|NCT01682811|592915895|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
164151593|NCT01682811|592915896|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
164151594|NCT01682811|592915890|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151595|NCT01682811|592915891|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151596|NCT01682811|592915892|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151597|NCT01682811|592915893|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151598|NCT01682811|592915894|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
164151599|NCT01682811|592915895|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151600|NCT01682811|592915896|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
164151601|NCT01682811|592915890|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151602|NCT01682811|592915891|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151603|NCT01682811|592915892|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151604|NCT01682811|592915893|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151605|NCT01682811|592915894|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151606|NCT01682811|592915895|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
164151607|NCT01682811|592915896|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
164151608|NCT01128179|592915897|FG000|Overall Study|Death|1|||
164151609|NCT01128179|592915898|FG001|Overall Study|Death|0|||
164151610|NCT01128179|592915897|FG000|Overall Study|Protocol Violation|1|||
164151611|NCT01128179|592915898|FG001|Overall Study|Protocol Violation|0|||
164151612|NCT02694328|592915902|FG000|Overall Study|Adverse Event|27|||
164151613|NCT02694328|592915903|FG001|Overall Study|Adverse Event|33|||
164151614|NCT02694328|592915902|FG000|Overall Study|Withdrawal by Subject|27|||
164151615|NCT02694328|592915903|FG001|Overall Study|Withdrawal by Subject|23|||
164151616|NCT02694328|592915902|FG000|Overall Study|Lost to Follow-up|26|||
164151617|NCT02694328|592915903|FG001|Overall Study|Lost to Follow-up|22|||
164151618|NCT02694328|592915902|FG000|Overall Study|Noncompliant with study drug|11|||
164151619|NCT02694328|592915903|FG001|Overall Study|Noncompliant with study drug|8|||
164151620|NCT02694328|592915902|FG000|Overall Study|Incarceration|1|||
164151621|NCT02694328|592915903|FG001|Overall Study|Incarceration|1|||
164151622|NCT02694328|592915902|FG000|Overall Study|Lack of Efficacy|1|||
164151623|NCT02694328|592915903|FG001|Overall Study|Lack of Efficacy|2|||
164151624|NCT02694328|592915902|FG000|Overall Study|Pregnancy|1|||
164151625|NCT02694328|592915903|FG001|Overall Study|Pregnancy|1|||
164151626|NCT02694328|592915902|FG000|Overall Study|Protocol Violation|6|||
164151627|NCT02694328|592915903|FG001|Overall Study|Protocol Violation|5|||
164151628|NCT02694328|592915902|FG000|Overall Study|Abnormal Laboratory Value|0|||
164151629|NCT02694328|592915903|FG001|Overall Study|Abnormal Laboratory Value|3|||
164151630|NCT03511105|592917876|FG000|Overall Study|Adverse Event|1|||
164151631|NCT03511105|592917877|FG001|Overall Study|Adverse Event|0|||
164151632|NCT03511105|592917876|FG000|Overall Study|Withdrew consent|1|||
164151633|NCT03511105|592917877|FG001|Overall Study|Withdrew consent|0|||
164151634|NCT02810457|592917878|FG000|Overall Study|Randomised but no treatment received|2|||
164151635|NCT02810457|592917879|FG001|Overall Study|Randomised but no treatment received|1|||
164151636|NCT02810457|592917878|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
164151637|NCT02810457|592917879|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
164151638|NCT02810457|592917878|FG000|Overall Study|Adverse Event|37|||
164151639|NCT02810457|592917879|FG001|Overall Study|Adverse Event|43|||
164151640|NCT02810457|592917878|FG000|Overall Study|Patient decision|31|||
164151641|NCT02810457|592917879|FG001|Overall Study|Patient decision|35|||
164151642|NCT02810457|592917878|FG000|Overall Study|Patient lost to follow-up|2|||
164151643|NCT02810457|592917879|FG001|Overall Study|Patient lost to follow-up|2|||
164151644|NCT02810457|592917878|FG000|Overall Study|Death|39|||
164151645|NCT02810457|592917879|FG001|Overall Study|Death|28|||
164151646|NCT02810457|592917878|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
164151647|NCT02810457|592917879|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
164151648|NCT02810457|592917878|FG000|Overall Study|Clinical progression|15|||
164151649|NCT02810457|592917879|FG001|Overall Study|Clinical progression|16|||
164151650|NCT02810457|592917878|FG000|Overall Study|Investigator decision|3|||
164151651|NCT02810457|592917879|FG001|Overall Study|Investigator decision|2|||
164151652|NCT02810457|592917878|FG000|Overall Study|Patient ineligibility|3|||
164151653|NCT02810457|592917879|FG001|Overall Study|Patient ineligibility|0|||
164151654|NCT02810457|592917878|FG000|Overall Study|Miscalculated PD|1|||
164151655|NCT02810457|592917879|FG001|Overall Study|Miscalculated PD|0|||
164151656|NCT02810457|592917878|FG000|Overall Study|Physician Decision|0|||
164151657|NCT02810457|592917879|FG001|Overall Study|Physician Decision|1|||
164151658|NCT01962103|592917880|FG000|Phase 1|Adverse Event|4|||
164151659|NCT01962103|592917881|FG001|Phase 1|Adverse Event|0|||
164151660|NCT01962103|592917882|FG002|Phase 1|Adverse Event|2|||
164151661|NCT01962103|592917883|FG003|Phase 1|Adverse Event|1|||
164151662|NCT01962103|592917884|FG004|Phase 1|Adverse Event|2|||
164151663|NCT01962103|592917885|FG005|Phase 1|Adverse Event|2|||
164151664|NCT01962103|592917886|FG006|Phase 1|Adverse Event|0|||
164151665|NCT01962103|592917887|FG007|Phase 1|Adverse Event|0|||
164151666|NCT01962103|592917888|FG008|Phase 1|Adverse Event|0|||
164151667|NCT01962103|592917880|FG000|Phase 1|Progressive Disease|8|||
164151668|NCT01962103|592917881|FG001|Phase 1|Progressive Disease|6|||
164151669|NCT01962103|592917882|FG002|Phase 1|Progressive Disease|8|||
164151670|NCT01962103|592917883|FG003|Phase 1|Progressive Disease|4|||
164151671|NCT01962103|592917884|FG004|Phase 1|Progressive Disease|5|||
164151672|NCT01962103|592917885|FG005|Phase 1|Progressive Disease|4|||
164151673|NCT01962103|592917886|FG006|Phase 1|Progressive Disease|0|||
164151674|NCT01962103|592917887|FG007|Phase 1|Progressive Disease|0|||
164151675|NCT01962103|592917888|FG008|Phase 1|Progressive Disease|0|||
164151676|NCT01962103|592917880|FG000|Phase 1|Withdrawal by Subject|0|||
164151677|NCT01962103|592917881|FG001|Phase 1|Withdrawal by Subject|0|||
164151678|NCT01962103|592917882|FG002|Phase 1|Withdrawal by Subject|0|||
164151679|NCT01962103|592917883|FG003|Phase 1|Withdrawal by Subject|2|||
164151680|NCT01962103|592917884|FG004|Phase 1|Withdrawal by Subject|0|||
164151681|NCT01962103|592917885|FG005|Phase 1|Withdrawal by Subject|0|||
164151682|NCT01962103|592917886|FG006|Phase 1|Withdrawal by Subject|0|||
164151683|NCT01962103|592917887|FG007|Phase 1|Withdrawal by Subject|0|||
164151684|NCT01962103|592917888|FG008|Phase 1|Withdrawal by Subject|0|||
164151685|NCT01962103|592917880|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
164151686|NCT01962103|592917881|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
164151687|NCT01962103|592917882|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
164151688|NCT01962103|592917883|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
164151689|NCT01962103|592917884|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
164151690|NCT01962103|592917885|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
164151691|NCT01962103|592917886|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
164151692|NCT01962103|592917887|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
164151693|NCT01962103|592917888|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
164151694|NCT01962103|592917880|FG000|Phase 1|Physician Decision|0|||
164151695|NCT01962103|592917881|FG001|Phase 1|Physician Decision|0|||
164151696|NCT01962103|592917882|FG002|Phase 1|Physician Decision|0|||
164151697|NCT01962103|592917883|FG003|Phase 1|Physician Decision|1|||
164151698|NCT01962103|592917884|FG004|Phase 1|Physician Decision|0|||
164151699|NCT01962103|592917885|FG005|Phase 1|Physician Decision|0|||
164151700|NCT01962103|592917886|FG006|Phase 1|Physician Decision|0|||
164151701|NCT01962103|592917887|FG007|Phase 1|Physician Decision|0|||
164151702|NCT01962103|592917888|FG008|Phase 1|Physician Decision|0|||
164151703|NCT01962103|592917880|FG000|Phase 1|Symptomatic Deterioration|3|||
164151704|NCT01962103|592917881|FG001|Phase 1|Symptomatic Deterioration|2|||
164151705|NCT01962103|592917882|FG002|Phase 1|Symptomatic Deterioration|2|||
164151706|NCT01962103|592917883|FG003|Phase 1|Symptomatic Deterioration|2|||
164151707|NCT01962103|592917884|FG004|Phase 1|Symptomatic Deterioration|1|||
164151708|NCT01962103|592917885|FG005|Phase 1|Symptomatic Deterioration|1|||
164151709|NCT01962103|592917886|FG006|Phase 1|Symptomatic Deterioration|0|||
164151710|NCT01962103|592917887|FG007|Phase 1|Symptomatic Deterioration|0|||
164151711|NCT01962103|592917888|FG008|Phase 1|Symptomatic Deterioration|0|||
164151712|NCT01962103|592917880|FG000|Phase 1|Miscellaneous|1|||
164151713|NCT01962103|592917881|FG001|Phase 1|Miscellaneous|0|||
164151714|NCT01962103|592917882|FG002|Phase 1|Miscellaneous|0|||
164151715|NCT01962103|592917883|FG003|Phase 1|Miscellaneous|0|||
164151716|NCT01962103|592917884|FG004|Phase 1|Miscellaneous|0|||
164151717|NCT01962103|592917885|FG005|Phase 1|Miscellaneous|0|||
164151718|NCT01962103|592917886|FG006|Phase 1|Miscellaneous|0|||
164151719|NCT01962103|592917887|FG007|Phase 1|Miscellaneous|0|||
164151720|NCT01962103|592917888|FG008|Phase 1|Miscellaneous|0|||
164151721|NCT01962103|592917880|FG000|Phase 2|Adverse Event|0|||
164151722|NCT01962103|592917881|FG001|Phase 2|Adverse Event|0|||
164151723|NCT01962103|592917882|FG002|Phase 2|Adverse Event|0|||
164151724|NCT01962103|592917883|FG003|Phase 2|Adverse Event|0|||
164151725|NCT01962103|592917884|FG004|Phase 2|Adverse Event|0|||
164151726|NCT01962103|592917885|FG005|Phase 2|Adverse Event|0|||
164151727|NCT01962103|592917886|FG006|Phase 2|Adverse Event|1|||
164151728|NCT01962103|592917887|FG007|Phase 2|Adverse Event|0|||
164151729|NCT01962103|592917888|FG008|Phase 2|Adverse Event|3|||
164151730|NCT01962103|592917880|FG000|Phase 2|Progressive Disease|0|||
164151731|NCT01962103|592917881|FG001|Phase 2|Progressive Disease|0|||
164151732|NCT01962103|592917882|FG002|Phase 2|Progressive Disease|0|||
164151733|NCT01962103|592917883|FG003|Phase 2|Progressive Disease|0|||
164151734|NCT01962103|592917884|FG004|Phase 2|Progressive Disease|0|||
164151735|NCT01962103|592917885|FG005|Phase 2|Progressive Disease|0|||
164151736|NCT01962103|592917886|FG006|Phase 2|Progressive Disease|11|||
164151737|NCT01962103|592917887|FG007|Phase 2|Progressive Disease|12|||
164151738|NCT01962103|592917888|FG008|Phase 2|Progressive Disease|11|||
164151739|NCT01962103|592917880|FG000|Phase 2|Symptomatic Deterioration|0|||
164151740|NCT01962103|592917881|FG001|Phase 2|Symptomatic Deterioration|0|||
164151741|NCT01962103|592917882|FG002|Phase 2|Symptomatic Deterioration|0|||
164151742|NCT01962103|592917883|FG003|Phase 2|Symptomatic Deterioration|0|||
164151743|NCT01962103|592917884|FG004|Phase 2|Symptomatic Deterioration|0|||
164151744|NCT01962103|592917885|FG005|Phase 2|Symptomatic Deterioration|0|||
164151745|NCT01962103|592917886|FG006|Phase 2|Symptomatic Deterioration|2|||
164151746|NCT01962103|592917887|FG007|Phase 2|Symptomatic Deterioration|2|||
164151747|NCT01962103|592917888|FG008|Phase 2|Symptomatic Deterioration|0|||
164151748|NCT02750618|592917889|FG000|Overall Study|Withdrawal by Subject|1|||
164151749|NCT02094300|592917896|FG000|Overall Study|Death|7|||
164151750|NCT02094300|592917896|FG000|Overall Study|Lost to Follow-up|10|||
164151751|NCT02094300|592917896|FG000|Overall Study|Still be eligible for follow-up|3|||
164151752|NCT00276484|592917897|FG000|Overall Study|Adverse Event|4|||
164151753|NCT00276484|592917898|FG001|Overall Study|Adverse Event|7|||
164151754|NCT00276484|592917897|FG000|Overall Study|Lost to Follow-up|1|||
164151755|NCT00276484|592917898|FG001|Overall Study|Lost to Follow-up|1|||
164151756|NCT00276484|592917897|FG000|Overall Study|Protocol Violation|0|||
164151757|NCT00276484|592917898|FG001|Overall Study|Protocol Violation|1|||
164151758|NCT00276484|592917897|FG000|Overall Study|Withdrawal by Subject|4|||
164151759|NCT00276484|592917898|FG001|Overall Study|Withdrawal by Subject|3|||
164151760|NCT00276484|592917897|FG000|Overall Study|Could not take time off work|0|||
164151761|NCT00276484|592917898|FG001|Overall Study|Could not take time off work|1|||
164151762|NCT03347110|592917912|FG000|Overall Study|Other (Participant is incarcerated)|1|||
164151763|NCT03347110|592917912|FG000|Overall Study|Withdrawal by Subject|9|||
164151764|NCT03347110|592917912|FG000|Overall Study|Lost to Follow-up|1|||
164151765|NCT03347110|592917912|FG000|Overall Study|Lack of Efficacy|2|||
164151766|NCT03347110|592917912|FG000|Overall Study|Adverse Event, non-fatal|9|||
164151767|NCT00116779|592917913|FG000|Overall Study|Adverse Event|4|||
164151768|NCT00116779|592917914|FG001|Overall Study|Adverse Event|2|||
164151769|NCT00116779|592917913|FG000|Overall Study|Protocol Violation|1|||
164151770|NCT00116779|592917914|FG001|Overall Study|Protocol Violation|4|||
164151771|NCT00116779|592917913|FG000|Overall Study|Withdrawal by Subject|4|||
164151772|NCT00116779|592917914|FG001|Overall Study|Withdrawal by Subject|1|||
164151773|NCT00116779|592917913|FG000|Overall Study|Inadequate testosterone suppression|7|||
164151774|NCT00116779|592917914|FG001|Overall Study|Inadequate testosterone suppression|9|||
164151775|NCT00116779|592917913|FG000|Overall Study|Physician Decision|3|||
164151776|NCT00116779|592917914|FG001|Overall Study|Physician Decision|1|||
164151777|NCT00116779|592917913|FG000|Overall Study|Elevated PSA levels|2|||
164151778|NCT00116779|592917914|FG001|Overall Study|Elevated PSA levels|2|||
164151779|NCT01321879|592917918|FG000|Overall Study|Lack of Efficacy|5|||
164151780|NCT01321879|592917918|FG000|Overall Study|Adverse Event|5|||
164151781|NCT01321879|592917918|FG000|Overall Study|Death|3|||
164151782|NCT01321879|592917918|FG000|Overall Study|Withdrawal by Subject|1|||
164151783|NCT02687451|592917919|FG000|Overall Study|Withdrawal by Subject|1|||
164151784|NCT02687451|592917920|FG001|Overall Study|Withdrawal by Subject|0|||
164151785|NCT02687451|592917921|FG002|Overall Study|Withdrawal by Subject|0|||
164151786|NCT02687451|592917922|FG003|Overall Study|Withdrawal by Subject|0|||
164151787|NCT02687451|592917923|FG004|Overall Study|Withdrawal by Subject|0|||
164151788|NCT02687451|592917924|FG005|Overall Study|Withdrawal by Subject|1|||
164151789|NCT01518322|592917931|FG000|Overall Study|FeNO measurement was missing|13|||
164151790|NCT00707239|592917932|FG000|Overall Study|Adverse Event|5|||
164151791|NCT00707239|592917933|FG001|Overall Study|Adverse Event|3|||
164151792|NCT00707239|592917934|FG002|Overall Study|Adverse Event|2|||
164151793|NCT00707239|592917932|FG000|Overall Study|Death|3|||
164151794|NCT00707239|592917933|FG001|Overall Study|Death|1|||
164151795|NCT00707239|592917934|FG002|Overall Study|Death|3|||
164151796|NCT00707239|592917932|FG000|Overall Study|Physician Decision|1|||
164151797|NCT00707239|592917933|FG001|Overall Study|Physician Decision|1|||
164151798|NCT00707239|592917934|FG002|Overall Study|Physician Decision|2|||
164151799|NCT00707239|592917932|FG000|Overall Study|Protocol Violation|0|||
164151800|NCT00707239|592917933|FG001|Overall Study|Protocol Violation|0|||
164151801|NCT00707239|592917934|FG002|Overall Study|Protocol Violation|1|||
164151802|NCT00707239|592917932|FG000|Overall Study|Lack of Efficacy|1|||
164151803|NCT00707239|592917933|FG001|Overall Study|Lack of Efficacy|2|||
164151804|NCT00707239|592917934|FG002|Overall Study|Lack of Efficacy|0|||
164151805|NCT00707239|592917932|FG000|Overall Study|Randomized, but not treated|1|||
164151806|NCT00707239|592917933|FG001|Overall Study|Randomized, but not treated|1|||
164151807|NCT00707239|592917934|FG002|Overall Study|Randomized, but not treated|1|||
164151808|NCT00707239|592917932|FG000|Overall Study|Other|8|||
164151809|NCT00707239|592917933|FG001|Overall Study|Other|3|||
164151810|NCT00707239|592917934|FG002|Overall Study|Other|5|||
164151811|NCT03472014|592917935|FG000|Overall Study|Lost to Follow-up|4|||
164151812|NCT03652051|592917941|FG000|Stage 1|Adverse Event|0|||
164151813|NCT03652051|592917942|FG001|Stage 1|Adverse Event|5|||
164151814|NCT03652051|592917943|FG002|Stage 1|Adverse Event|7|||
164151815|NCT03652051|592917944|FG003|Stage 1|Adverse Event|1|||
164151816|NCT03652051|592917941|FG000|Stage 1|Withdrawal by Subject|0|||
164151817|NCT03652051|592917942|FG001|Stage 1|Withdrawal by Subject|0|||
164151818|NCT03652051|592917943|FG002|Stage 1|Withdrawal by Subject|1|||
164151819|NCT03652051|592917944|FG003|Stage 1|Withdrawal by Subject|0|||
164151820|NCT03652051|592917941|FG000|Stage 2|Adverse Event|0|||
164151821|NCT03652051|592917942|FG001|Stage 2|Adverse Event|2|||
164151822|NCT03652051|592917943|FG002|Stage 2|Adverse Event|1|||
164151823|NCT03652051|592917944|FG003|Stage 2|Adverse Event|0|||
164151824|NCT03652051|592917941|FG000|Stage 2|Protocol Violation|0|||
164151825|NCT03652051|592917942|FG001|Stage 2|Protocol Violation|1|||
164151826|NCT03652051|592917943|FG002|Stage 2|Protocol Violation|6|||
164151827|NCT03652051|592917944|FG003|Stage 2|Protocol Violation|0|||
164151828|NCT03652051|592917941|FG000|Stage 2|Lost to Follow-up|0|||
164151829|NCT03652051|592917942|FG001|Stage 2|Lost to Follow-up|2|||
164151830|NCT03652051|592917943|FG002|Stage 2|Lost to Follow-up|0|||
164151831|NCT03652051|592917944|FG003|Stage 2|Lost to Follow-up|3|||
164151832|NCT03652051|592917941|FG000|Stage 2|Withdrawal by Subject|0|||
164151833|NCT03652051|592917942|FG001|Stage 2|Withdrawal by Subject|11|||
164151834|NCT03652051|592917943|FG002|Stage 2|Withdrawal by Subject|9|||
164151835|NCT03652051|592917944|FG003|Stage 2|Withdrawal by Subject|3|||
164151836|NCT01930162|592917945|FG000|Overall Study|Abnormal test procedure result(s)|4|||
164151837|NCT01930162|592917945|FG000|Overall Study|Death|1|||
164151838|NCT02394600|592917948|FG000|Overall Study|Adverse Event|3|||
164151839|NCT02394600|592917949|FG001|Overall Study|Adverse Event|0|||
164151840|NCT02394600|592917948|FG000|Overall Study|Lost to Follow-up|0|||
164151841|NCT02394600|592917949|FG001|Overall Study|Lost to Follow-up|1|||
164151842|NCT02394600|592917948|FG000|Overall Study|Withdrawal by Subject|0|||
164151843|NCT02394600|592917949|FG001|Overall Study|Withdrawal by Subject|1|||
164151844|NCT02394600|592917948|FG000|Overall Study|Protocol Violation|1|||
164151845|NCT02394600|592917949|FG001|Overall Study|Protocol Violation|0|||
164151846|NCT02569801|592917950|FG000|Overall Study|Withdrawal by Subject|9|||
164151847|NCT02569801|592917951|FG001|Overall Study|Withdrawal by Subject|9|||
164151848|NCT02569801|592917950|FG000|Overall Study|Sponsor Decision|13|||
164151849|NCT02569801|592917951|FG001|Overall Study|Sponsor Decision|14|||
164151850|NCT02569801|592917950|FG000|Overall Study|Progressive Disease|2|||
164151851|NCT02569801|592917951|FG001|Overall Study|Progressive Disease|7|||
164151852|NCT02569801|592917950|FG000|Overall Study|Lost to Follow-up|0|||
164151853|NCT02569801|592917951|FG001|Overall Study|Lost to Follow-up|1|||
164151854|NCT02569801|592917950|FG000|Overall Study|Death|12|||
164151855|NCT02569801|592917951|FG001|Overall Study|Death|4|||
164151856|NCT03442751|592917954|FG000|Overall Study|Withdrawal by Subject|3|||
164151857|NCT03442751|592917955|FG001|Overall Study|Withdrawal by Subject|1|||
164151858|NCT03442751|592917954|FG000|Overall Study|Lost to Follow-up|3|||
164151859|NCT03442751|592917955|FG001|Overall Study|Lost to Follow-up|0|||
164151860|NCT03934541|592917956|FG000|Overall Study|Study Terminated by Sponsor|0|||
164151861|NCT03934541|592917957|FG001|Overall Study|Study Terminated by Sponsor|1|||
164151862|NCT03934541|592917958|FG002|Overall Study|Study Terminated by Sponsor|0|||
164151863|NCT03934541|592917959|FG003|Overall Study|Study Terminated by Sponsor|0|||
164151864|NCT01928472|592917962|FG000|Overall Study|Death|0|||
164151865|NCT01928472|592917963|FG001|Overall Study|Death|0|||
164151866|NCT01928472|592917964|FG002|Overall Study|Death|1|||
164151867|NCT01928472|592917965|FG003|Overall Study|Death|0|||
164151868|NCT01928472|592917962|FG000|Overall Study|Withdrawal by Subject|4|||
164151869|NCT01928472|592917963|FG001|Overall Study|Withdrawal by Subject|4|||
164151870|NCT01928472|592917964|FG002|Overall Study|Withdrawal by Subject|1|||
164151871|NCT01928472|592917965|FG003|Overall Study|Withdrawal by Subject|2|||
164151872|NCT01928472|592917962|FG000|Overall Study|Lost to Follow-up|2|||
164151873|NCT01928472|592917963|FG001|Overall Study|Lost to Follow-up|3|||
164151874|NCT01928472|592917964|FG002|Overall Study|Lost to Follow-up|4|||
164151875|NCT01928472|592917965|FG003|Overall Study|Lost to Follow-up|0|||
164151876|NCT01928472|592917962|FG000|Overall Study|Administrative Reason|2|||
164151877|NCT01928472|592917963|FG001|Overall Study|Administrative Reason|1|||
164151878|NCT01928472|592917964|FG002|Overall Study|Administrative Reason|0|||
164151879|NCT01928472|592917965|FG003|Overall Study|Administrative Reason|0|||
164151880|NCT01928472|592917962|FG000|Overall Study|Unclassified|0|||
164151881|NCT01928472|592917963|FG001|Overall Study|Unclassified|0|||
164151882|NCT01928472|592917964|FG002|Overall Study|Unclassified|1|||
164151883|NCT01928472|592917965|FG003|Overall Study|Unclassified|0|||
164151884|NCT04620746|592917966|FG000|Overall Study|Adverse Event|2|||
164151885|NCT04620746|592917967|FG001|Overall Study|Adverse Event|0|||
164151886|NCT04620746|592917966|FG000|Overall Study|Uniterpretable skin test|1|||
164151887|NCT04620746|592917967|FG001|Overall Study|Uniterpretable skin test|0|||
164151888|NCT04620746|592917966|FG000|Overall Study|Withdrawal by Subject|0|||
164151889|NCT04620746|592917967|FG001|Overall Study|Withdrawal by Subject|1|||
164151890|NCT03404674|592917977|FG000|Overall Study|Inability to Attend Future Visits|0|||
164151891|NCT03404674|592917978|FG001|Overall Study|Inability to Attend Future Visits|1|||
164151892|NCT03404674|592917979|FG002|Overall Study|Inability to Attend Future Visits|1|||
164151893|NCT03404674|592917980|FG003|Overall Study|Inability to Attend Future Visits|0|||
164151894|NCT03404674|592917981|FG004|Overall Study|Inability to Attend Future Visits|0|||
164151895|NCT03404674|592917982|FG005|Overall Study|Inability to Attend Future Visits|0|||
164151896|NCT03404674|592917977|FG000|Overall Study|Behavioral Problems|0|||
164151897|NCT03404674|592917978|FG001|Overall Study|Behavioral Problems|0|||
164151898|NCT03404674|592917979|FG002|Overall Study|Behavioral Problems|1|||
164151899|NCT03404674|592917980|FG003|Overall Study|Behavioral Problems|0|||
164151900|NCT03404674|592917981|FG004|Overall Study|Behavioral Problems|0|||
164151901|NCT03404674|592917982|FG005|Overall Study|Behavioral Problems|0|||
164151902|NCT03404674|592917977|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151903|NCT03404674|592917978|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151904|NCT03404674|592917979|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151905|NCT03404674|592917980|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
164151906|NCT03404674|592917981|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
164151907|NCT03404674|592917982|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
164151908|NCT01526057|592917991|FG000|Overall Study|Withdrawal by Subject|3|||
164151909|NCT01526057|592917992|FG001|Overall Study|Withdrawal by Subject|2|||
164151910|NCT01526057|592917993|FG002|Overall Study|Withdrawal by Subject|2|||
164151911|NCT01526057|592917991|FG000|Overall Study|Adverse Event|3|||
164151912|NCT01526057|592917992|FG001|Overall Study|Adverse Event|1|||
164151913|NCT01526057|592917993|FG002|Overall Study|Adverse Event|1|||
164151914|NCT01526057|592917991|FG000|Overall Study|Death|1|||
164151915|NCT01526057|592917992|FG001|Overall Study|Death|0|||
164151916|NCT01526057|592917993|FG002|Overall Study|Death|0|||
164151917|NCT01526057|592917991|FG000|Overall Study|Lost to Follow-up|1|||
164151918|NCT01526057|592917992|FG001|Overall Study|Lost to Follow-up|0|||
164151919|NCT01526057|592917993|FG002|Overall Study|Lost to Follow-up|1|||
164151920|NCT01526057|592917991|FG000|Overall Study|Other|1|||
164151921|NCT01526057|592917992|FG001|Overall Study|Other|0|||
164151922|NCT01526057|592917993|FG002|Overall Study|Other|1|||
164151923|NCT01526057|592917991|FG000|Overall Study|Protocol Violation|0|||
164151924|NCT01526057|592917992|FG001|Overall Study|Protocol Violation|0|||
164151925|NCT01526057|592917993|FG002|Overall Study|Protocol Violation|1|||
164151926|NCT02123446|592917994|FG000|Washout Period (1 Day)|Physician Decision|1|||
164151927|NCT02123446|592917995|FG001|Washout Period (1 Day)|Physician Decision|0|||
164151928|NCT02553772|592917997|FG000|Overall Study|Adverse Event|2|||
164151929|NCT02553772|592917998|FG001|Overall Study|Adverse Event|3|||
164151930|NCT02553772|592917997|FG000|Overall Study|Lost to Follow-up|2|||
164151931|NCT02553772|592917998|FG001|Overall Study|Lost to Follow-up|1|||
164151932|NCT02553772|592917997|FG000|Overall Study|Withdrawal of Consent|1|||
164151933|NCT02553772|592917998|FG001|Overall Study|Withdrawal of Consent|1|||
164151934|NCT02553772|592917997|FG000|Overall Study|Lack of Efficacy|1|||
164151935|NCT02553772|592917998|FG001|Overall Study|Lack of Efficacy|0|||
164151936|NCT02553772|592917997|FG000|Overall Study|Other Miscellaneous Reasons|0|||
164151937|NCT02553772|592917998|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164151938|NCT02860546|592917999|FG000|Overall Study|Clinical Progression|6|||
164151939|NCT02860546|592917999|FG000|Overall Study|Radiological Progression|12|||
164151940|NCT02466321|592918000|FG000|Overall Study|Death|26|||
164151941|NCT02466321|592918000|FG000|Overall Study|Revision|6|||
164151942|NCT02466321|592918000|FG000|Overall Study|Lost to Follow-up|60|||
164151943|NCT02466321|592918000|FG000|Overall Study|Did not receive study device|1|||
164151944|NCT01855828|592918001|FG000|Overall Study|Adverse Event|1|||
164151945|NCT01855828|592918001|FG000|Overall Study|Withdrawal by Subject|1|||
164151946|NCT00489255|592918010|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
164151947|NCT00489255|592918011|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
164151948|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
164151949|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
164151950|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
164151951|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
164151952|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
164151953|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
164151954|NCT00489255|592918010|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
164151955|NCT00489255|592918011|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
164151956|NCT00489255|592918010|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
164151957|NCT00489255|592918011|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
164151958|NCT00489255|592918010|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
164151959|NCT00489255|592918011|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
164151960|NCT00489255|592918010|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
164151961|NCT00489255|592918011|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
164151962|NCT00489255|592918010|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
164151963|NCT00489255|592918011|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
164151964|NCT00489255|592918010|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
164151965|NCT00489255|592918011|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
164151966|NCT03953612|592918012|FG000|Overall Study|Randomized but did not start|1|||
164151967|NCT03953612|592918013|FG001|Overall Study|Randomized but did not start|1|||
164151968|NCT03953612|592918014|FG002|Overall Study|Randomized but did not start|1|||
164151969|NCT03953612|592918012|FG000|Overall Study|Withdrawal by Subject|2|||
164151970|NCT03953612|592918013|FG001|Overall Study|Withdrawal by Subject|1|||
164151971|NCT03953612|592918014|FG002|Overall Study|Withdrawal by Subject|0|||
164151972|NCT03485352|592918015|FG000|Overall Study|Lost to Follow-up|9|||
164151973|NCT00852202|592918026|FG000|Overall Study|Adverse Event|2|||
164151974|NCT00852202|592918027|FG001|Overall Study|Adverse Event|3|||
164151975|NCT00852202|592918028|FG002|Overall Study|Adverse Event|7|||
164151976|NCT00852202|592918026|FG000|Overall Study|Lack of Efficacy|4|||
164151977|NCT00852202|592918027|FG001|Overall Study|Lack of Efficacy|1|||
164151978|NCT00852202|592918028|FG002|Overall Study|Lack of Efficacy|2|||
164151979|NCT00852202|592918026|FG000|Overall Study|Protocol Violation|2|||
164151980|NCT00852202|592918027|FG001|Overall Study|Protocol Violation|2|||
164151981|NCT00852202|592918028|FG002|Overall Study|Protocol Violation|7|||
164151982|NCT00852202|592918026|FG000|Overall Study|Withdrawal by Subject|3|||
164151983|NCT00852202|592918027|FG001|Overall Study|Withdrawal by Subject|1|||
164151984|NCT00852202|592918028|FG002|Overall Study|Withdrawal by Subject|2|||
164151985|NCT00852202|592918026|FG000|Overall Study|Lost to Follow-up|5|||
164151986|NCT00852202|592918027|FG001|Overall Study|Lost to Follow-up|5|||
164151987|NCT00852202|592918028|FG002|Overall Study|Lost to Follow-up|6|||
164151988|NCT00852202|592918026|FG000|Overall Study|pregnancy,moving away and surgery|1|||
164151989|NCT00852202|592918027|FG001|Overall Study|pregnancy,moving away and surgery|0|||
164151990|NCT00852202|592918028|FG002|Overall Study|pregnancy,moving away and surgery|2|||
164151991|NCT02552121|592918031|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
164151992|NCT02552121|592918032|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151993|NCT02552121|592918033|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151994|NCT02552121|592918034|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151995|NCT02552121|592918035|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151996|NCT02552121|592918036|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151997|NCT02552121|592918037|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151998|NCT02552121|592918038|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
164151999|NCT02552121|592918031|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
164152000|NCT02552121|592918032|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152001|NCT02552121|592918033|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152002|NCT02552121|592918034|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152003|NCT02552121|592918035|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152004|NCT02552121|592918036|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152005|NCT02552121|592918037|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152006|NCT02552121|592918038|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
164152007|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152008|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
164152009|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152010|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152011|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152012|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152013|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152014|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
164152015|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152016|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
164152017|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152018|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152019|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152020|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152021|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152022|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
164152023|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152024|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
164152025|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152026|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152027|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152028|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152029|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152030|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
164152031|NCT02552121|592918031|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152032|NCT02552121|592918032|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
164152033|NCT02552121|592918033|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152034|NCT02552121|592918034|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152035|NCT02552121|592918035|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152036|NCT02552121|592918036|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152037|NCT02552121|592918037|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152038|NCT02552121|592918038|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
164152039|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
164152040|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
164152041|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
164152042|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
164152043|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
164152044|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
164152045|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
164152046|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
164152047|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
164152048|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
164152049|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
164152050|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
164152051|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
164152052|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
164152053|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
164152054|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
164152055|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
164152056|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
164152057|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
164152058|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
164152059|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
164152060|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
164152061|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
164152062|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
164152063|NCT02552121|592918031|FG000|Part 2: Cohort Expansion|Death|0|||
164152064|NCT02552121|592918032|FG001|Part 2: Cohort Expansion|Death|0|||
164152065|NCT02552121|592918033|FG002|Part 2: Cohort Expansion|Death|1|||
164152066|NCT02552121|592918034|FG003|Part 2: Cohort Expansion|Death|0|||
164152067|NCT02552121|592918035|FG004|Part 2: Cohort Expansion|Death|0|||
164152068|NCT02552121|592918036|FG005|Part 2: Cohort Expansion|Death|0|||
164152069|NCT02552121|592918037|FG006|Part 2: Cohort Expansion|Death|0|||
164152070|NCT02552121|592918038|FG007|Part 2: Cohort Expansion|Death|0|||
164152071|NCT03629184|592918039|FG000|Overall Study|Withdrawal by Subject|2|||
164152072|NCT03629184|592918040|FG001|Overall Study|Withdrawal by Subject|1|||
164152073|NCT03629184|592918039|FG000|Overall Study|Physician Decision|1|||
164152074|NCT03629184|592918040|FG001|Overall Study|Physician Decision|0|||
164152075|NCT00853099|592919408|FG000|Double-blind Period|Adverse Event|7|||
164152076|NCT00853099|592919409|FG001|Double-blind Period|Adverse Event|9|||
164152077|NCT00853099|592919410|FG002|Double-blind Period|Adverse Event|13|||
164152078|NCT00853099|592919411|FG003|Double-blind Period|Adverse Event|0|||
164152079|NCT00853099|592919408|FG000|Double-blind Period|Withdrawal by Subject|2|||
164152080|NCT00853099|592919409|FG001|Double-blind Period|Withdrawal by Subject|3|||
164152081|NCT00853099|592919410|FG002|Double-blind Period|Withdrawal by Subject|0|||
164152082|NCT00853099|592919411|FG003|Double-blind Period|Withdrawal by Subject|0|||
164152083|NCT00853099|592919408|FG000|Double-blind Period|Lack of Efficacy|14|||
164152084|NCT00853099|592919409|FG001|Double-blind Period|Lack of Efficacy|17|||
164152085|NCT00853099|592919410|FG002|Double-blind Period|Lack of Efficacy|16|||
164152086|NCT00853099|592919411|FG003|Double-blind Period|Lack of Efficacy|0|||
164152087|NCT00853099|592919408|FG000|Double-blind Period|Other|0|||
164152088|NCT00853099|592919409|FG001|Double-blind Period|Other|0|||
164152089|NCT00853099|592919410|FG002|Double-blind Period|Other|1|||
164152090|NCT00853099|592919411|FG003|Double-blind Period|Other|0|||
164152091|NCT00853099|592919408|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
164152092|NCT00853099|592919409|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
164152093|NCT00853099|592919410|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
164152094|NCT00853099|592919411|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
164152095|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
164152096|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
164152097|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
164152098|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
164152099|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
164152100|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
164152101|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
164152102|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
164152103|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
164152104|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
164152105|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
164152106|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
164152107|NCT00853099|592919408|FG000|Double-blind + Open-label Periods|Other|0|||
164152108|NCT00853099|592919409|FG001|Double-blind + Open-label Periods|Other|0|||
164152109|NCT00853099|592919410|FG002|Double-blind + Open-label Periods|Other|0|||
164152110|NCT00853099|592919411|FG003|Double-blind + Open-label Periods|Other|6|||
164152111|NCT02439216|592919415|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
164152112|NCT02439216|592919416|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152113|NCT02439216|592919417|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152114|NCT02439216|592919418|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152115|NCT02439216|592919419|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152116|NCT02439216|592919420|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152117|NCT02439216|592919421|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152118|NCT02439216|592919422|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152119|NCT02439216|592919423|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
164152120|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152121|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152122|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152123|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152124|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152125|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152126|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152127|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
164152128|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
164152129|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152130|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152131|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152132|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152133|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152134|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152135|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
164152136|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
164152137|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
164152138|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152139|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152140|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152141|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152142|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152143|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152144|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152145|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
164152146|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
164152147|NCT02439216|592919415|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152148|NCT02439216|592919416|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152149|NCT02439216|592919417|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152150|NCT02439216|592919418|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152151|NCT02439216|592919419|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152152|NCT02439216|592919420|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152153|NCT02439216|592919421|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
164152154|NCT02439216|592919422|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
164152155|NCT02439216|592919423|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
164152156|NCT00470535|592919431|FG000|Overall Study|Disease Progression|13|||
164152157|NCT00470535|592919431|FG000|Overall Study|Withdrawal by Subject|1|||
164152158|NCT00470535|592919431|FG000|Overall Study|Adverse Event|1|||
164152159|NCT00470535|592919431|FG000|Overall Study|Death|1|||
164152160|NCT00470535|592919431|FG000|Overall Study|Other|2|||
164152161|NCT00725491|592919434|FG000|Overall Study|Adverse Event|3|||
164152162|NCT00725491|592919435|FG001|Overall Study|Adverse Event|2|||
164152163|NCT00725491|592919434|FG000|Overall Study|Pregnancy|0|||
164152164|NCT00725491|592919435|FG001|Overall Study|Pregnancy|3|||
164152165|NCT00725491|592919434|FG000|Overall Study|Risk for hyperstimulation|2|||
164152166|NCT00725491|592919435|FG001|Overall Study|Risk for hyperstimulation|9|||
164152167|NCT00725491|592919434|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
164152168|NCT00725491|592919435|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
164152169|NCT00725491|592919434|FG000|Overall Study|Fertilization failure|0|||
164152170|NCT00725491|592919435|FG001|Overall Study|Fertilization failure|1|||
164152171|NCT00725491|592919434|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
164152172|NCT00725491|592919435|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
164152173|NCT00942357|592919438|FG000|Overall Study|Ineligible|37|||
164152174|NCT00942357|592919439|FG001|Overall Study|Ineligible|40|||
164152175|NCT00897715|592919440|FG000|Overall Study|Lost to Follow-up|0|||
164152176|NCT00897715|592919441|FG001|Overall Study|Lost to Follow-up|1|||
164152177|NCT00897715|592919440|FG000|Overall Study|Physician Decision|1|||
164152178|NCT00897715|592919441|FG001|Overall Study|Physician Decision|0|||
164152179|NCT00897715|592919440|FG000|Overall Study|increased risk of infection|1|||
164152180|NCT00897715|592919441|FG001|Overall Study|increased risk of infection|0|||
164152181|NCT01641640|592919442|FG000|Overall Study|Enrolled but not treated|1|||
164152182|NCT01641640|592919442|FG000|Overall Study|Efficacy failure|29|||
164152183|NCT01641640|592919442|FG000|Overall Study|Lost to Follow-up|3|||
164152184|NCT01641640|592919442|FG000|Overall Study|Withdrawal by Subject|2|||
164152185|NCT01641640|592919442|FG000|Overall Study|Adverse Event|1|||
164152186|NCT01199939|592919444|FG000|Overall Study|Adverse Event|4|||
164152187|NCT01199939|592919444|FG000|Overall Study|Protocol Violation|3|||
164152188|NCT01199939|592919444|FG000|Overall Study|Lost to Follow-up|2|||
164152189|NCT01199939|592919444|FG000|Overall Study|Reached a virologic endpoint|4|||
164152190|NCT03238651|592919445|FG000|Overall Study|Other|0|||
164152191|NCT03238651|592919446|FG001|Overall Study|Other|0|||
164152192|NCT03238651|592919447|FG002|Overall Study|Other|0|||
164152193|NCT03238651|592919448|FG003|Overall Study|Other|0|||
164152194|NCT03238651|592919449|FG004|Overall Study|Other|1|||
164152195|NCT03238651|592919445|FG000|Overall Study|Progressive Disease|2|||
164152196|NCT03238651|592919446|FG001|Overall Study|Progressive Disease|2|||
164152197|NCT03238651|592919447|FG002|Overall Study|Progressive Disease|2|||
164152198|NCT03238651|592919448|FG003|Overall Study|Progressive Disease|2|||
164152199|NCT03238651|592919449|FG004|Overall Study|Progressive Disease|0|||
164152200|NCT03238651|592919445|FG000|Overall Study|Withdrawal by Subject|0|||
164152201|NCT03238651|592919446|FG001|Overall Study|Withdrawal by Subject|1|||
164152202|NCT03238651|592919447|FG002|Overall Study|Withdrawal by Subject|0|||
164152203|NCT03238651|592919448|FG003|Overall Study|Withdrawal by Subject|1|||
164152204|NCT03238651|592919449|FG004|Overall Study|Withdrawal by Subject|0|||
164152205|NCT03238651|592919445|FG000|Overall Study|Adverse Event|1|||
164152206|NCT03238651|592919446|FG001|Overall Study|Adverse Event|3|||
164152207|NCT03238651|592919447|FG002|Overall Study|Adverse Event|2|||
164152208|NCT03238651|592919448|FG003|Overall Study|Adverse Event|0|||
164152209|NCT03238651|592919449|FG004|Overall Study|Adverse Event|0|||
164152210|NCT03875508|592919450|FG000|Overall Study|Adverse Event|1|||
164152211|NCT03875508|592919450|FG000|Overall Study|Lost to Follow-up|8|||
164152212|NCT03875508|592919450|FG000|Overall Study|Lack of Efficacy|1|||
164152213|NCT03875508|592919450|FG000|Overall Study|Other, not specified|2|||
164152214|NCT00711087|592919451|FG000|Overall Study|Lost to Follow-up|1|||
164152215|NCT00711087|592919452|FG001|Overall Study|Lost to Follow-up|0|||
164152216|NCT02137252|592919453|FG000|Overall Study|trial terminated early|2|||
164152217|NCT02137252|592919454|FG001|Overall Study|trial terminated early|1|||
164152218|NCT00428246|592919456|FG000|Overall Study|Withdrawal by Subject|0|||
164152219|NCT00428246|592919457|FG001|Overall Study|Withdrawal by Subject|0|||
164152220|NCT00428246|592919458|FG002|Overall Study|Withdrawal by Subject|1|||
164152221|NCT00428246|592919456|FG000|Overall Study|Adverse Event|1|||
164152222|NCT00428246|592919457|FG001|Overall Study|Adverse Event|0|||
164152223|NCT00428246|592919458|FG002|Overall Study|Adverse Event|0|||
164152224|NCT02603887|592919461|FG000|Stage 1|Adverse Event|4|||
164152225|NCT02603887|592919461|FG000|Stage 1|Disease progression|1|||
164152226|NCT02603887|592919461|FG000|Stage 2|FDA guidance|1|||
164152227|NCT03535740|592919464|FG000|Overall Study|Death|44|||
164152228|NCT03535740|592919464|FG000|Overall Study|Lost to Follow-up|1|||
164152229|NCT03535740|592919464|FG000|Overall Study|Withdrawal by Subject|13|||
164152230|NCT03535740|592919464|FG000|Overall Study|Site terminated by Sponsor|45|||
164152231|NCT05198518|592919467|FG000|Screening Visit|Deemed unable to participate|58|||
164152232|NCT05198518|592919468|FG001|Screening Visit|Deemed unable to participate|0|||
164152233|NCT05198518|592919469|FG002|Screening Visit|Deemed unable to participate|0|||
164152234|NCT01870778|592919476|FG000|Overall Study|Withdrawal by Subject|8|||
164152235|NCT01870778|592919477|FG001|Overall Study|Withdrawal by Subject|7|||
164152236|NCT01870778|592919476|FG000|Overall Study|Lost to Follow-up|0|||
164152237|NCT01870778|592919477|FG001|Overall Study|Lost to Follow-up|2|||
164152238|NCT05317312|592919478|FG000|Overall Study|Withdrawal by Subject|0|||
164152239|NCT05317312|592919479|FG001|Overall Study|Withdrawal by Subject|1|||
164152240|NCT05317312|592919480|FG002|Overall Study|Withdrawal by Subject|0|||
164152241|NCT05317312|592919481|FG003|Overall Study|Withdrawal by Subject|0|||
164152242|NCT05317312|592919478|FG000|Overall Study|Lost to Follow-up|0|||
164152243|NCT05317312|592919479|FG001|Overall Study|Lost to Follow-up|0|||
164152244|NCT05317312|592919480|FG002|Overall Study|Lost to Follow-up|0|||
164152245|NCT05317312|592919481|FG003|Overall Study|Lost to Follow-up|1|||
164152246|NCT05317312|592919478|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
164152247|NCT05317312|592919479|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
164152248|NCT05317312|592919480|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
164152249|NCT05317312|592919481|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
164152250|NCT00124917|592919482|FG000|Overall Study|Physician Decision|3|||
164152251|NCT00613171|592919485|FG000|Overall Study|Adverse Event|7|||
164152252|NCT00613171|592919485|FG000|Overall Study|Withdrawal by Subject|3|||
164152253|NCT00613171|592919485|FG000|Overall Study|Reason not Specified|4|||
164152254|NCT00951496|592919490|FG000|Overall Study|Did not initiate study treatment|10|||
164152255|NCT00951496|592919491|FG001|Overall Study|Did not initiate study treatment|8|||
164152256|NCT00951496|592919492|FG002|Overall Study|Did not initiate study treatment|13|||
164152257|NCT01169350|592919495|FG000|Overall Study|Physician Decision|3|||
164152258|NCT01169350|592919495|FG000|Overall Study|Lost to Follow-up|2|||
164152259|NCT04870710|592919497|FG000|Overall Study|Lost to Follow-up|3|||
164152260|NCT01042093|592919498|FG000|Overall Study|Protocol Violation|2|||
164152261|NCT01042093|592919499|FG001|Overall Study|Protocol Violation|2|||
164152262|NCT01042093|592919500|FG002|Overall Study|Protocol Violation|2|||
164152263|NCT01042093|592919501|FG003|Overall Study|Protocol Violation|3|||
164152264|NCT01042093|592919498|FG000|Overall Study|Withdrawal by Subject|0|||
164152265|NCT01042093|592919499|FG001|Overall Study|Withdrawal by Subject|0|||
164152266|NCT01042093|592919500|FG002|Overall Study|Withdrawal by Subject|0|||
164152267|NCT01042093|592919501|FG003|Overall Study|Withdrawal by Subject|1|||
164152268|NCT01329900|592919502|FG000|Overall Study|Elevated creatinine/renal function|1|||
164152269|NCT01866098|592919503|FG000|Overall Study|Lost to Follow-up|11|||
164152270|NCT01866098|592919504|FG001|Overall Study|Lost to Follow-up|18|||
164152271|NCT01866098|592919505|FG002|Overall Study|Lost to Follow-up|13|||
164152272|NCT01866098|592919503|FG000|Overall Study|Physician Decision|0|||
164152273|NCT01866098|592919504|FG001|Overall Study|Physician Decision|1|||
164152274|NCT01866098|592919505|FG002|Overall Study|Physician Decision|2|||
164152275|NCT01866098|592919503|FG000|Overall Study|Adverse Event|1|||
164152276|NCT01866098|592919504|FG001|Overall Study|Adverse Event|5|||
164152277|NCT01866098|592919505|FG002|Overall Study|Adverse Event|4|||
164152278|NCT01866098|592919503|FG000|Overall Study|Protocol Violation|1|||
164152279|NCT01866098|592919504|FG001|Overall Study|Protocol Violation|0|||
164152280|NCT01866098|592919505|FG002|Overall Study|Protocol Violation|0|||
164152281|NCT01866098|592919503|FG000|Overall Study|Withdrawal by Subject|1|||
164152282|NCT01866098|592919504|FG001|Overall Study|Withdrawal by Subject|2|||
164152283|NCT01866098|592919505|FG002|Overall Study|Withdrawal by Subject|0|||
164152284|NCT01866098|592919503|FG000|Overall Study|Unrelated Hospitalization|2|||
164152285|NCT01866098|592919504|FG001|Overall Study|Unrelated Hospitalization|0|||
164152286|NCT01866098|592919505|FG002|Overall Study|Unrelated Hospitalization|1|||
164152287|NCT01866098|592919503|FG000|Overall Study|Non-compliance|1|||
164152288|NCT01866098|592919504|FG001|Overall Study|Non-compliance|0|||
164152289|NCT01866098|592919505|FG002|Overall Study|Non-compliance|1|||
164152290|NCT01866098|592919503|FG000|Overall Study|Pregnancy|2|||
164152291|NCT01866098|592919504|FG001|Overall Study|Pregnancy|0|||
164152292|NCT01866098|592919505|FG002|Overall Study|Pregnancy|0|||
164152293|NCT01866098|592919503|FG000|Overall Study|Death|0|||
164152294|NCT01866098|592919504|FG001|Overall Study|Death|1|||
164152295|NCT01866098|592919505|FG002|Overall Study|Death|0|||
164152296|NCT04239027|592919506|FG000|Overall Study|Adverse Event|4|||
164152297|NCT04239027|592919506|FG000|Overall Study|Withdrawal by Subject|9|||
164152298|NCT04239027|592919506|FG000|Overall Study|Death|1|||
164152299|NCT04239027|592919506|FG000|Overall Study|Physician Decision|9|||
164152300|NCT04239027|592919506|FG000|Overall Study|Lost to Follow-up|2|||
164152301|NCT04239027|592919506|FG000|Overall Study|Lack of Efficacy|1|||
164152302|NCT01184079|592919513|FG000|Overall Study|Lost to Follow-up|14|||
164152303|NCT01184079|592919514|FG001|Overall Study|Lost to Follow-up|2|||
164152304|NCT01876446|592919517|FG000|Overall Study|Death|0|||
164152305|NCT01876446|592919518|FG001|Overall Study|Death|1|||
164152306|NCT01876446|592919517|FG000|Overall Study|Withdrawal by Subject|1|||
164152307|NCT01876446|592919518|FG001|Overall Study|Withdrawal by Subject|2|||
164152308|NCT01876446|592919517|FG000|Overall Study|Physician Decision|1|||
164152309|NCT01876446|592919518|FG001|Overall Study|Physician Decision|3|||
164152310|NCT02108912|592919519|FG000|Overall Study|Lost to Follow-up|1|||
164152311|NCT02108912|592919520|FG001|Overall Study|Lost to Follow-up|1|||
164152312|NCT02108912|592919519|FG000|Overall Study|lack of transportation|1|||
164152313|NCT02108912|592919520|FG001|Overall Study|lack of transportation|0|||
164152314|NCT02108912|592919519|FG000|Overall Study|high blood pressure|1|||
164152315|NCT02108912|592919520|FG001|Overall Study|high blood pressure|0|||
164152316|NCT01808573|592919526|FG000|Overall Study|Death|212|||
164152317|NCT01808573|592919527|FG001|Overall Study|Death|240|||
164152318|NCT01808573|592919526|FG000|Overall Study|Withdrawal by Subject|12|||
164152319|NCT01808573|592919527|FG001|Overall Study|Withdrawal by Subject|10|||
164152320|NCT01808573|592919526|FG000|Overall Study|Lost to Follow-up|3|||
164152321|NCT01808573|592919527|FG001|Overall Study|Lost to Follow-up|0|||
164152322|NCT01808573|592919526|FG000|Overall Study|Discontinuation of study by sponsor|79|||
164152323|NCT01808573|592919527|FG001|Overall Study|Discontinuation of study by sponsor|64|||
164152324|NCT01808573|592919526|FG000|Overall Study|Randomized in Error|1|||
164152325|NCT01808573|592919527|FG001|Overall Study|Randomized in Error|0|||
164152326|NCT00995774|592919530|FG000|Training Period 2|Withdrawal by Subject|2|||
164152327|NCT00995774|592919531|FG001|Training Period 2|Withdrawal by Subject|0|||
164152328|NCT01523002|592919532|FG000|Period 1|Withdrawal by Subject|1|||
164152329|NCT01523002|592919533|FG001|Period 1|Withdrawal by Subject|3|||
164152330|NCT01523002|592919532|FG000|Period 1|Lost to Follow-up|1|||
164152331|NCT01523002|592919533|FG001|Period 1|Lost to Follow-up|0|||
164152332|NCT01523002|592919532|FG000|Period 1|Adverse Event|0|||
164152333|NCT01523002|592919533|FG001|Period 1|Adverse Event|8|||
164152334|NCT01523002|592919532|FG000|Period 2|Withdrawal by Subject|4|||
164152335|NCT01523002|592919533|FG001|Period 2|Withdrawal by Subject|1|||
164152336|NCT01523002|592919532|FG000|Period 2|Adverse Event|2|||
164152337|NCT01523002|592919533|FG001|Period 2|Adverse Event|5|||
164152338|NCT01523002|592919532|FG000|Period 3|Withdrawal by Subject|1|||
164152339|NCT01523002|592919533|FG001|Period 3|Withdrawal by Subject|0|||
164152340|NCT01523002|592919532|FG000|Period 3|Adverse Event|3|||
164152341|NCT01523002|592919533|FG001|Period 3|Adverse Event|0|||
164152342|NCT01256502|592919534|FG000|Overall Study|Had scaffold removed|4|||
164152343|NCT01256502|592919534|FG000|Overall Study|Personal reasons|5|||
164152344|NCT01256502|592919534|FG000|Overall Study|Protocol deviation|1|||
164152345|NCT01245283|592919535|FG000|Overall Study|Lost to Follow-up|14|||
164152346|NCT01245283|592919536|FG001|Overall Study|Lost to Follow-up|11|||
164152347|NCT01245283|592919537|FG002|Overall Study|Lost to Follow-up|11|||
164152348|NCT01982955|592919542|FG000|Overall Study|Randomized but not treated|0|||
164152349|NCT01982955|592919543|FG001|Overall Study|Randomized but not treated|0|||
164152350|NCT01982955|592919544|FG002|Overall Study|Randomized but not treated|0|||
164152351|NCT01982955|592919545|FG003|Overall Study|Randomized but not treated|1|||
164152352|NCT01982955|592919546|FG004|Overall Study|Randomized but not treated|0|||
164152353|NCT02575833|592919547|FG000|Overall Study|Withdrawal by Subject|0|||
164152354|NCT02575833|592919548|FG001|Overall Study|Withdrawal by Subject|1|||
164152355|NCT02575833|592919547|FG000|Overall Study|Lost to Follow-up|1|||
164152356|NCT02575833|592919548|FG001|Overall Study|Lost to Follow-up|0|||
164152357|NCT03093259|592919549|FG000|Overall Study|Adverse Event|1|||
164152358|NCT03093259|592919550|FG001|Overall Study|Adverse Event|0|||
164152359|NCT03093259|592919549|FG000|Overall Study|Withdrawal by Subject|1|||
164152360|NCT03093259|592919550|FG001|Overall Study|Withdrawal by Subject|0|||
164152361|NCT02633787|592919551|FG000|Overall Study|Withdrawal by Subject|1|||
164152362|NCT00768248|592919552|FG000|Overall Study|Research coordinator didn't collect data|1|||
164152363|NCT00768248|592919553|FG001|Overall Study|Research coordinator didn't collect data|1|||
164152364|NCT02548143|592919558|FG000|Overall Study|Adverse Event|1|||
164152365|NCT02548143|592919559|FG001|Overall Study|Adverse Event|0|||
164152366|NCT02548143|592919558|FG000|Overall Study|Withdrawal by Subject|0|||
164152367|NCT02548143|592919559|FG001|Overall Study|Withdrawal by Subject|1|||
164152368|NCT05825404|592921258|FG000|First Intervention (Weeks 2-5)|Death|0|||
164152369|NCT05825404|592921259|FG001|First Intervention (Weeks 2-5)|Death|1|||
164152370|NCT05825404|592921258|FG000|Second Intervention (Weeks 8-11)|Death|0|||
164152371|NCT05825404|592921259|FG001|Second Intervention (Weeks 8-11)|Death|1|||
164152372|NCT02243605|592921260|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
164152373|NCT02243605|592921261|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
164152374|NCT02243605|592921260|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
164152375|NCT02243605|592921261|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
164152376|NCT02243605|592921260|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
164152377|NCT02243605|592921261|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
164152378|NCT02243605|592921260|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
164152379|NCT02243605|592921261|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
164152380|NCT02243605|592921260|FG000|Stage 2 - Final Analysis Population|Progression|0|||
164152381|NCT02243605|592921261|FG001|Stage 2 - Final Analysis Population|Progression|1|||
164152382|NCT01557504|592921264|FG000|Overall Study|Physician Decision|1|||
164152383|NCT01557504|592921265|FG001|Overall Study|Physician Decision|0|||
164152384|NCT01321749|592921271|FG000|Overall Study|Lost to Follow-up|4|||
164152385|NCT01321749|592921272|FG001|Overall Study|Lost to Follow-up|11|||
164152386|NCT01321749|592921271|FG000|Overall Study|Protocol Violation|4|||
164152387|NCT01321749|592921272|FG001|Overall Study|Protocol Violation|7|||
164152388|NCT01321749|592921271|FG000|Overall Study|Withdrawal by Subject|5|||
164152389|NCT01321749|592921272|FG001|Overall Study|Withdrawal by Subject|4|||
164152390|NCT04179838|592921276|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
164152391|NCT04179838|592921277|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
164152392|NCT04179838|592921276|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
164152393|NCT04179838|592921277|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
164152394|NCT02763046|592921278|FG000|Overall Study|Adverse Event|5|||
164152395|NCT02763046|592921279|FG001|Overall Study|Adverse Event|4|||
164152396|NCT02763046|592921280|FG002|Overall Study|Adverse Event|0|||
164152397|NCT02763046|592921278|FG000|Overall Study|Lack of Efficacy|1|||
164152398|NCT02763046|592921279|FG001|Overall Study|Lack of Efficacy|1|||
164152399|NCT02763046|592921280|FG002|Overall Study|Lack of Efficacy|3|||
164152400|NCT02763046|592921278|FG000|Overall Study|Physician Decision|1|||
164152401|NCT02763046|592921279|FG001|Overall Study|Physician Decision|0|||
164152402|NCT02763046|592921280|FG002|Overall Study|Physician Decision|1|||
164152403|NCT02763046|592921278|FG000|Overall Study|Subject/guardian decision|2|||
164152404|NCT02763046|592921279|FG001|Overall Study|Subject/guardian decision|0|||
164152405|NCT02763046|592921280|FG002|Overall Study|Subject/guardian decision|4|||
164152406|NCT00818766|592921285|FG000|Overall Study|Could not be Contacted on Day 28|11|||
164152407|NCT00818766|592921286|FG001|Overall Study|Could not be Contacted on Day 28|10|||
164152408|NCT00818766|592921285|FG000|Overall Study|Death|1|||
164152409|NCT00818766|592921286|FG001|Overall Study|Death|0|||
164152410|NCT00818766|592921285|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
164152411|NCT00818766|592921286|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
164152412|NCT00086684|592921287|FG000|Overall Study|Adverse Event|12|||
164152413|NCT00086684|592921288|FG001|Overall Study|Adverse Event|17|||
164152414|NCT00086684|592921289|FG002|Overall Study|Adverse Event|14|||
164152415|NCT00086684|592921287|FG000|Overall Study|Lack of Efficacy|6|||
164152416|NCT00086684|592921288|FG001|Overall Study|Lack of Efficacy|6|||
164152417|NCT00086684|592921289|FG002|Overall Study|Lack of Efficacy|5|||
164152418|NCT00086684|592921287|FG000|Overall Study|Lost to Follow-up|15|||
164152419|NCT00086684|592921288|FG001|Overall Study|Lost to Follow-up|8|||
164152420|NCT00086684|592921289|FG002|Overall Study|Lost to Follow-up|10|||
164152421|NCT00086684|592921287|FG000|Overall Study|Protocol Violation|8|||
164152422|NCT00086684|592921288|FG001|Overall Study|Protocol Violation|3|||
164152423|NCT00086684|592921289|FG002|Overall Study|Protocol Violation|0|||
164152424|NCT00086684|592921287|FG000|Overall Study|Withdrawal by Subject|0|||
164152425|NCT00086684|592921288|FG001|Overall Study|Withdrawal by Subject|4|||
164152426|NCT00086684|592921289|FG002|Overall Study|Withdrawal by Subject|10|||
164152427|NCT00086684|592921287|FG000|Overall Study|NONCOMPLIANCE|5|||
164152428|NCT00086684|592921288|FG001|Overall Study|NONCOMPLIANCE|7|||
164152429|NCT00086684|592921289|FG002|Overall Study|NONCOMPLIANCE|6|||
164152430|NCT00086684|592921287|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164152431|NCT00086684|592921288|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
164152432|NCT00086684|592921289|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
164152433|NCT00086684|592921287|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
164152434|NCT00086684|592921288|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
164152435|NCT00086684|592921289|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
164152436|NCT00086684|592921287|FG000|Overall Study|Other|4|||
164152437|NCT00086684|592921288|FG001|Overall Study|Other|2|||
164152438|NCT00086684|592921289|FG002|Overall Study|Other|3|||
164152439|NCT01103180|592921292|FG000|Overall Study|Withdrawal by Subject|8|||
164152440|NCT01103180|592921293|FG001|Overall Study|Withdrawal by Subject|13|||
164152441|NCT01103180|592921292|FG000|Overall Study|Lost to Follow-up|13|||
164152442|NCT01103180|592921293|FG001|Overall Study|Lost to Follow-up|7|||
164152443|NCT01103180|592921292|FG000|Overall Study|Physician Decision|1|||
164152444|NCT01103180|592921293|FG001|Overall Study|Physician Decision|0|||
164152445|NCT01103180|592921292|FG000|Overall Study|Protocol Violation|0|||
164152446|NCT01103180|592921293|FG001|Overall Study|Protocol Violation|1|||
164152447|NCT01173523|592921294|FG000|Overall Study|Clinical Progression|1|||
164152448|NCT01173523|592921295|FG001|Overall Study|Clinical Progression|1|||
164152449|NCT01173523|592921294|FG000|Overall Study|Progressive Disease|10|||
164152450|NCT01173523|592921295|FG001|Overall Study|Progressive Disease|8|||
164152451|NCT01173523|592921294|FG000|Overall Study|Other|2|||
164152452|NCT01173523|592921295|FG001|Overall Study|Other|3|||
164152453|NCT01067105|592921296|FG000|Overall Study|Adverse Event|14|||
164152454|NCT01067105|592921296|FG000|Overall Study|Protocol Violation|48|||
164152455|NCT01067105|592921296|FG000|Overall Study|Withdrawal by Subject|36|||
164152456|NCT01067105|592921296|FG000|Overall Study|Lost to Follow-up|6|||
164152457|NCT01067105|592921296|FG000|Overall Study|Physician Decision|6|||
164152458|NCT01067105|592921296|FG000|Overall Study|Other|31|||
164152459|NCT01866826|592921297|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
164152460|NCT01866826|592921298|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
164152461|NCT01866826|592921297|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
164152462|NCT01866826|592921298|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
164152463|NCT01866826|592921297|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
164152464|NCT01866826|592921298|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
164152465|NCT02493660|592921299|FG000|Overall Study|Physician Decision|0|||
164152466|NCT02493660|592921300|FG001|Overall Study|Physician Decision|1|||
164152467|NCT02493660|592921299|FG000|Overall Study|Adverse Event|4|||
164152468|NCT02493660|592921300|FG001|Overall Study|Adverse Event|2|||
164152469|NCT02493660|592921299|FG000|Overall Study|Withdrawal by Subject|2|||
164152470|NCT02493660|592921300|FG001|Overall Study|Withdrawal by Subject|3|||
164152471|NCT02493660|592921299|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
164152472|NCT02493660|592921300|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
164152473|NCT02493660|592921299|FG000|Overall Study|Protocol Violation|0|||
164152474|NCT02493660|592921300|FG001|Overall Study|Protocol Violation|1|||
164152475|NCT02493660|592921299|FG000|Overall Study|Death|0|||
164152476|NCT02493660|592921300|FG001|Overall Study|Death|1|||
164152477|NCT02493660|592921299|FG000|Overall Study|Lost to Follow-up|2|||
164152478|NCT02493660|592921300|FG001|Overall Study|Lost to Follow-up|4|||
164152479|NCT00709995|592921301|FG000|Overall Study|Adverse Event|4|||
164152480|NCT00709995|592921302|FG001|Overall Study|Adverse Event|2|||
164152481|NCT00709995|592921301|FG000|Overall Study|Withdrawal by Subject|1|||
164152482|NCT00709995|592921302|FG001|Overall Study|Withdrawal by Subject|3|||
164152483|NCT01276041|592921303|FG000|Overall Study|Adverse Event|2|||
164152484|NCT01276041|592921303|FG000|Overall Study|Protocol Violation|1|||
164152485|NCT00638508|592921304|FG000|Overall Study|Physician Decision|5|||
164152486|NCT00638508|592921305|FG001|Overall Study|Physician Decision|2|||
164152487|NCT03500198|592921306|FG000|Overall Study|Lost to Follow-up|0|||
164152488|NCT03500198|592921307|FG001|Overall Study|Lost to Follow-up|1|||
164152489|NCT00654095|592921308|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
164152490|NCT00654095|592921308|FG000|Overall Study|Elevated triglyceride level (2)|1|||
164152491|NCT00654095|592921308|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
164152492|NCT00654095|592921308|FG000|Overall Study|Adverse Event|11|||
164152493|NCT00654095|592921308|FG000|Overall Study|Withdrawal by Subject|5|||
164152494|NCT00654095|592921308|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
164152495|NCT00654095|592921308|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
164152496|NCT00654095|592921308|FG000|Overall Study|Did not meet inclusion criteria|1|||
164152497|NCT00595621|592921314|FG000|Open Label Run in|Adverse Event|1|||
164152498|NCT00595621|592921315|FG001|Open Label Run in|Adverse Event|0|||
164152499|NCT00595621|592921314|FG000|Open Label Run in|Physician Decision|1|||
164152500|NCT00595621|592921315|FG001|Open Label Run in|Physician Decision|0|||
164152501|NCT00595621|592921314|FG000|Open Label Run in|Withdrawal by Subject|1|||
164152502|NCT00595621|592921315|FG001|Open Label Run in|Withdrawal by Subject|0|||
164152503|NCT00595621|592921314|FG000|Randomization and Study|Adverse Event|2|||
164152504|NCT00595621|592921315|FG001|Randomization and Study|Adverse Event|0|||
164152505|NCT00595621|592921314|FG000|Randomization and Study|Withdrawal by Subject|0|||
164152506|NCT00595621|592921315|FG001|Randomization and Study|Withdrawal by Subject|1|||
164152507|NCT02440464|592921316|FG000|Overall Study|Withdrawal by Subject|3|||
164152508|NCT02440464|592921317|FG001|Overall Study|Withdrawal by Subject|2|||
164152509|NCT00324987|592921318|FG000|Overall Study|Adverse Event|2|||
164152510|NCT00324987|592921319|FG001|Overall Study|Adverse Event|1|||
164152511|NCT00324987|592921318|FG000|Overall Study|Withdrawal by Subject|1|||
164152512|NCT00324987|592921319|FG001|Overall Study|Withdrawal by Subject|1|||
164152513|NCT00324987|592921318|FG000|Overall Study|Progression|1|||
164152514|NCT00324987|592921319|FG001|Overall Study|Progression|1|||
164152515|NCT00324987|592921318|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
164152516|NCT00324987|592921319|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
164152517|NCT02968576|592921321|FG000|Overall Study|Pregnancy|0|||
164152518|NCT02968576|592921322|FG001|Overall Study|Pregnancy|1|||
164152519|NCT02058069|592921325|FG000|Overall Study|Exclusion due to implant size|5|||
164152520|NCT02058069|592921325|FG000|Overall Study|Withdrawal by Subject|6|||
164152521|NCT02222922|592921326|FG000|Overall Study|Death|0|||
164152522|NCT02222922|592921327|FG001|Overall Study|Death|0|||
164152523|NCT02222922|592921328|FG002|Overall Study|Death|0|||
164152524|NCT02222922|592921329|FG003|Overall Study|Death|0|||
164152525|NCT02222922|592921330|FG004|Overall Study|Death|13|||
164152526|NCT02222922|592921331|FG005|Overall Study|Death|0|||
164152527|NCT02222922|592921332|FG006|Overall Study|Death|0|||
164152528|NCT02222922|592921333|FG007|Overall Study|Death|0|||
164152529|NCT02222922|592921334|FG008|Overall Study|Death|2|||
164152530|NCT02222922|592921326|FG000|Overall Study|Lost to Follow-up|0|||
164152531|NCT02222922|592921327|FG001|Overall Study|Lost to Follow-up|0|||
164152532|NCT02222922|592921328|FG002|Overall Study|Lost to Follow-up|1|||
164152533|NCT02222922|592921329|FG003|Overall Study|Lost to Follow-up|0|||
164152534|NCT02222922|592921330|FG004|Overall Study|Lost to Follow-up|9|||
164152535|NCT02222922|592921331|FG005|Overall Study|Lost to Follow-up|1|||
164152536|NCT02222922|592921332|FG006|Overall Study|Lost to Follow-up|0|||
164152537|NCT02222922|592921333|FG007|Overall Study|Lost to Follow-up|0|||
164152538|NCT02222922|592921334|FG008|Overall Study|Lost to Follow-up|0|||
164152539|NCT02222922|592921326|FG000|Overall Study|Other|0|||
164152540|NCT02222922|592921327|FG001|Overall Study|Other|0|||
164152541|NCT02222922|592921328|FG002|Overall Study|Other|0|||
164152542|NCT02222922|592921329|FG003|Overall Study|Other|2|||
164152543|NCT02222922|592921330|FG004|Overall Study|Other|10|||
164152544|NCT02222922|592921331|FG005|Overall Study|Other|2|||
164152545|NCT02222922|592921332|FG006|Overall Study|Other|2|||
164152546|NCT02222922|592921333|FG007|Overall Study|Other|4|||
164152547|NCT02222922|592921334|FG008|Overall Study|Other|1|||
164152548|NCT02222922|592921326|FG000|Overall Study|Participant refused further follow-up|1|||
164152549|NCT02222922|592921327|FG001|Overall Study|Participant refused further follow-up|0|||
164152550|NCT02222922|592921328|FG002|Overall Study|Participant refused further follow-up|0|||
164152551|NCT02222922|592921329|FG003|Overall Study|Participant refused further follow-up|1|||
164152552|NCT02222922|592921330|FG004|Overall Study|Participant refused further follow-up|6|||
164152553|NCT02222922|592921331|FG005|Overall Study|Participant refused further follow-up|0|||
164152554|NCT02222922|592921332|FG006|Overall Study|Participant refused further follow-up|0|||
164152555|NCT02222922|592921333|FG007|Overall Study|Participant refused further follow-up|0|||
164152556|NCT02222922|592921334|FG008|Overall Study|Participant refused further follow-up|3|||
164152557|NCT01998919|592921335|FG000|Overall Study|Death|2|||
164152558|NCT01998919|592921336|FG001|Overall Study|Death|2|||
164152559|NCT01998919|592921335|FG000|Overall Study|Adverse Event|0|||
164152560|NCT01998919|592921336|FG001|Overall Study|Adverse Event|5|||
164152561|NCT01998919|592921335|FG000|Overall Study|Disease progression|31|||
164152562|NCT01998919|592921336|FG001|Overall Study|Disease progression|22|||
164152563|NCT01998919|592921335|FG000|Overall Study|Withdrawal by Subject|2|||
164152564|NCT01998919|592921336|FG001|Overall Study|Withdrawal by Subject|4|||
164152565|NCT01998919|592921335|FG000|Overall Study|Lost to Follow-up|2|||
164152566|NCT01998919|592921336|FG001|Overall Study|Lost to Follow-up|0|||
164152567|NCT01998919|592921335|FG000|Overall Study|Other|5|||
164152568|NCT01998919|592921336|FG001|Overall Study|Other|2|||
164152569|NCT00927589|592921338|FG000|Overall Study|Death|1|||
164152570|NCT00927589|592921338|FG000|Overall Study|Physician Decision|1|||
164152571|NCT00927589|592921338|FG000|Overall Study|Withdrawal by Subject|3|||
164152572|NCT00927589|592921338|FG000|Overall Study|Adverse Event|2|||
164152573|NCT00927589|592921338|FG000|Overall Study|Disease Progression|8|||
164152574|NCT00927589|592921338|FG000|Overall Study|Non-compliance|1|||
164152575|NCT01778530|592921341|FG000|Overall Study|Progression on study|1|||
164152576|NCT01778530|592921341|FG000|Overall Study|Adverse event/side effect|1|||
164152577|NCT02792517|592921349|FG000|Overall Study|Withdrawal by Subject|10|||
164152578|NCT02792517|592921349|FG000|Overall Study|Decision by Sponsor|7|||
164152579|NCT02792517|592921349|FG000|Overall Study|Lost to Follow-up|3|||
164152580|NCT00882518|592921350|FG000|Overall Study|Adverse Event|9|||
164152581|NCT00882518|592921351|FG001|Overall Study|Adverse Event|18|||
164152582|NCT00882518|592921350|FG000|Overall Study|Withdrawal by Subject|9|||
164152583|NCT00882518|592921351|FG001|Overall Study|Withdrawal by Subject|13|||
164152584|NCT00882518|592921350|FG000|Overall Study|Lack of Efficacy|12|||
164152585|NCT00882518|592921351|FG001|Overall Study|Lack of Efficacy|9|||
164152586|NCT00882518|592921350|FG000|Overall Study|Severe non-compliance to protocol|3|||
164152587|NCT00882518|592921351|FG001|Overall Study|Severe non-compliance to protocol|1|||
164152588|NCT00882518|592921350|FG000|Overall Study|Incorrect enrolment|4|||
164152589|NCT00882518|592921351|FG001|Overall Study|Incorrect enrolment|2|||
164152590|NCT00882518|592921350|FG000|Overall Study|Central lab closure for National day|1|||
164152591|NCT00882518|592921351|FG001|Overall Study|Central lab closure for National day|0|||
164152592|NCT00882518|592921350|FG000|Overall Study|Allocating random number by mistake|0|||
164152593|NCT00882518|592921351|FG001|Overall Study|Allocating random number by mistake|1|||
164152594|NCT01958437|592921352|FG000|Overall Study|Incidental MRI findings|0|||
164152595|NCT01958437|592921353|FG001|Overall Study|Incidental MRI findings|0|||
164152596|NCT01958437|592921354|FG002|Overall Study|Incidental MRI findings|1|||
164152597|NCT01958437|592921355|FG003|Overall Study|Incidental MRI findings|1|||
164152598|NCT01998841|592921367|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
164152599|NCT01998841|592921368|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
164152600|NCT01998841|592921369|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
164152601|NCT01998841|592921370|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152602|NCT01998841|592921371|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152603|NCT01998841|592921367|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152604|NCT01998841|592921368|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152605|NCT01998841|592921369|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
164152606|NCT01998841|592921370|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
164152607|NCT01998841|592921371|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
164152608|NCT00972595|592921372|FG000|Period 1|Adverse Event|1|||
164152609|NCT00972595|592921373|FG001|Period 1|Adverse Event|0|||
164152610|NCT01461538|592921374|FG000|Overall Study|Death|15|||
164152611|NCT01461538|592921375|FG001|Overall Study|Death|6|||
164152612|NCT01461538|592921376|FG002|Overall Study|Death|2|||
164152613|NCT01461538|592921374|FG000|Overall Study|Study Stopped by Sponsor|2|||
164152614|NCT01461538|592921375|FG001|Overall Study|Study Stopped by Sponsor|1|||
164152615|NCT01461538|592921376|FG002|Overall Study|Study Stopped by Sponsor|0|||
164152616|NCT01461538|592921374|FG000|Overall Study|Withdrawal by Subject|1|||
164152617|NCT01461538|592921375|FG001|Overall Study|Withdrawal by Subject|1|||
164152618|NCT01461538|592921376|FG002|Overall Study|Withdrawal by Subject|0|||
164152619|NCT00141778|592921377|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
164152620|NCT00141778|592921378|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
164152621|NCT00141778|592921379|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
164152622|NCT00141778|592921377|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
164152623|NCT00141778|592921378|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
164152624|NCT00141778|592921379|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
164152625|NCT00141778|592921377|FG000|Started Study Medication|Withdrawal by Subject|0|||
164152626|NCT00141778|592921378|FG001|Started Study Medication|Withdrawal by Subject|2|||
164152627|NCT00141778|592921379|FG002|Started Study Medication|Withdrawal by Subject|0|||
164152628|NCT00141778|592921377|FG000|Started Study Medication|Difficulty Swallowing|0|||
164152629|NCT00141778|592921378|FG001|Started Study Medication|Difficulty Swallowing|1|||
164152630|NCT00141778|592921379|FG002|Started Study Medication|Difficulty Swallowing|0|||
164152631|NCT00141778|592921377|FG000|Started Study Medication|Chest Discomfort|0|||
164152632|NCT00141778|592921378|FG001|Started Study Medication|Chest Discomfort|0|||
164152633|NCT00141778|592921379|FG002|Started Study Medication|Chest Discomfort|1|||
164152634|NCT01406574|592921381|FG000|Overall Study|Adverse Event|0|||
164152635|NCT01406574|592921382|FG001|Overall Study|Adverse Event|0|||
164152636|NCT01406574|592921383|FG002|Overall Study|Adverse Event|1|||
164152637|NCT01406574|592921384|FG003|Overall Study|Adverse Event|3|||
164152638|NCT01406574|592921381|FG000|Overall Study|Physician Decision|0|||
164152639|NCT01406574|592921382|FG001|Overall Study|Physician Decision|0|||
164152640|NCT01406574|592921383|FG002|Overall Study|Physician Decision|0|||
164152641|NCT01406574|592921384|FG003|Overall Study|Physician Decision|1|||
164152642|NCT01406574|592921381|FG000|Overall Study|Withdrawal by Subject|0|||
164152643|NCT01406574|592921382|FG001|Overall Study|Withdrawal by Subject|1|||
164152644|NCT01406574|592921383|FG002|Overall Study|Withdrawal by Subject|0|||
164152645|NCT01406574|592921384|FG003|Overall Study|Withdrawal by Subject|0|||
164152646|NCT01406574|592921381|FG000|Overall Study|Definite progression of primary disease|1|||
164152647|NCT01406574|592921382|FG001|Overall Study|Definite progression of primary disease|0|||
164152648|NCT01406574|592921383|FG002|Overall Study|Definite progression of primary disease|0|||
164152649|NCT01406574|592921384|FG003|Overall Study|Definite progression of primary disease|0|||
164152650|NCT04052620|592921385|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
164152651|NCT04052620|592921386|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
164152652|NCT04052620|592921385|FG000|Overall Study|Withdrawal by Subject|1|||
164152653|NCT04052620|592921386|FG001|Overall Study|Withdrawal by Subject|0|||
164152654|NCT04052620|592921385|FG000|Overall Study|Lost to Follow-up|1|||
164152655|NCT04052620|592921386|FG001|Overall Study|Lost to Follow-up|1|||
164152656|NCT04052620|592921385|FG000|Overall Study|Adverse Event|1|||
164152657|NCT04052620|592921386|FG001|Overall Study|Adverse Event|0|||
164152658|NCT04052620|592921385|FG000|Overall Study|Subject did not meet study Criteria|0|||
164152659|NCT04052620|592921386|FG001|Overall Study|Subject did not meet study Criteria|1|||
164152660|NCT04052620|592921385|FG000|Overall Study|Screened failure, randomized by mistake|0|||
164152661|NCT04052620|592921386|FG001|Overall Study|Screened failure, randomized by mistake|1|||
164152662|NCT04052620|592921385|FG000|Overall Study|Personal reasons|2|||
164152663|NCT04052620|592921386|FG001|Overall Study|Personal reasons|4|||
164152664|NCT04052620|592921385|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
164152665|NCT04052620|592921386|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
164152666|NCT03552380|592921388|FG000|Study Treatment|Disease Progression|3|||
164152667|NCT03552380|592921389|FG001|Study Treatment|Disease Progression|4|||
164152668|NCT03552380|592921388|FG000|Study Treatment|Adverse Event|2|||
164152669|NCT03552380|592921389|FG001|Study Treatment|Adverse Event|2|||
164152670|NCT03552380|592921388|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
164152671|NCT03552380|592921389|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
164152672|NCT03552380|592921388|FG000|Follow up|Death|3|||
164152673|NCT03552380|592921389|FG001|Follow up|Death|4|||
164152674|NCT03552380|592921388|FG000|Follow up|Site IRB terminated|0|||
164152675|NCT03552380|592921389|FG001|Follow up|Site IRB terminated|1|||
164152676|NCT03447743|592921390|FG000|Overall Study|Withdrawal by Subject|2|||
164152677|NCT03447743|592921390|FG000|Overall Study|Lost to Follow-up|3|||
164152678|NCT03447743|592921390|FG000|Overall Study|Adverse Event|1|||
164152679|NCT03447743|592921390|FG000|Overall Study|Did not meet criteria to continue|1|||
164152680|NCT01112059|592921391|FG000|Overall Study|Withdrawal by Subject|1|||
164152681|NCT01112059|592921392|FG001|Overall Study|Withdrawal by Subject|0|||
164152682|NCT03567980|592921399|FG000|Overall Study|Adverse Event|1|||
164152683|NCT01610492|592921400|FG000|Overall Study|Adverse Event|1|||
164152684|NCT01610492|592921400|FG000|Overall Study|Lack of Efficacy|3|||
164152685|NCT01610492|592921400|FG000|Overall Study|Other: Reached stopping criteria|1|||
164152686|NCT01610492|592921400|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
164152687|NCT01757275|592921402|FG000|Overall Study|Lost to Follow-up|1|||
164152688|NCT01757275|592921403|FG001|Overall Study|Lost to Follow-up|2|||
164152689|NCT01757275|592921402|FG000|Overall Study|Adverse Event|3|||
164152690|NCT01757275|592921403|FG001|Overall Study|Adverse Event|3|||
164152691|NCT01757275|592921402|FG000|Overall Study|Withdrawal by Subject|2|||
164152692|NCT01757275|592921403|FG001|Overall Study|Withdrawal by Subject|4|||
164152693|NCT01757275|592921402|FG000|Overall Study|Not treated|3|||
164152694|NCT01757275|592921403|FG001|Overall Study|Not treated|4|||
164152695|NCT01821807|592921408|FG000|Overall Study|Lost to Follow-up|3|||
164152696|NCT01821807|592921409|FG001|Overall Study|Lost to Follow-up|1|||
164152697|NCT01401452|592921410|FG000|Overall Study|Adverse reaction|9|||
164152698|NCT01401452|592921410|FG000|Overall Study|Lost to Follow-up|12|||
164152699|NCT01401452|592921410|FG000|Overall Study|Lack of Efficacy|30|||
164152700|NCT01401452|592921410|FG000|Overall Study|Participant developed breast cancer|1|||
164152701|NCT01401452|592921410|FG000|Overall Study|Tx stopped due to financial reasons|1|||
164152702|NCT01401452|592921410|FG000|Overall Study|Tx stopped by psychiatrist|1|||
164152703|NCT01401452|592921410|FG000|Overall Study|No more visits within the 36 wk followup|4|||
164152704|NCT01401452|592921410|FG000|Overall Study|Subject did not come to follow up visits|2|||
164152705|NCT01401452|592921410|FG000|Overall Study|Subject didn't return for routine visits|1|||
164152706|NCT01401452|592921410|FG000|Overall Study|Subject moved to another city|1|||
164152707|NCT01401452|592921410|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
164152708|NCT01401452|592921410|FG000|Overall Study|Psoriatic arthritis|1|||
164152709|NCT01401452|592921410|FG000|Overall Study|Participant stopped Tx|2|||
164152710|NCT01401452|592921410|FG000|Overall Study|Discontinuation for personal reasons|1|||
164152711|NCT01401452|592921410|FG000|Overall Study|Treatment failure|1|||
164152712|NCT01401452|592921410|FG000|Overall Study|Unsatisfactory output|1|||
164152713|NCT01401452|592921410|FG000|Overall Study|Subject withdrew because of Tx success|1|||
164152714|NCT01401452|592921410|FG000|Overall Study|Subject chose to discontinue treatment|1|||
164152715|NCT01401452|592921410|FG000|Overall Study|Participant withdrew consent|1|||
164152716|NCT00550459|592921411|FG000|Overall Study|Adverse Event|0|||
164152717|NCT00550459|592921412|FG001|Overall Study|Adverse Event|2|||
164152718|NCT00550459|592921411|FG000|Overall Study|Withdrawal by Subject|1|||
164152719|NCT00550459|592921412|FG001|Overall Study|Withdrawal by Subject|1|||
164152720|NCT00584454|592921413|FG000|Overall Study|Adverse Event|1|||
164152721|NCT00584454|592921413|FG000|Overall Study|Relocation|1|||
164152722|NCT00584454|592921413|FG000|Overall Study|Clinical Hold|2|||
164152723|NCT02404805|592921414|FG000|Overall Study|Withdrawal by Subject|1|||
164152724|NCT02404805|592921415|FG001|Overall Study|Withdrawal by Subject|0|||
164152725|NCT02404805|592921416|FG002|Overall Study|Withdrawal by Subject|0|||
164152726|NCT02404805|592921417|FG003|Overall Study|Withdrawal by Subject|0|||
164152727|NCT02404805|592921418|FG004|Overall Study|Withdrawal by Subject|0|||
164152728|NCT02404805|592921419|FG005|Overall Study|Withdrawal by Subject|0|||
164152729|NCT01742897|592921420|FG000|Overall Study|Adverse Event|3|||
164152730|NCT01742897|592921420|FG000|Overall Study|Withdrawal by Subject|1|||
164152731|NCT01742897|592921420|FG000|Overall Study|Other|1|||
164152732|NCT01459783|592921422|FG000|Baseline to 6 Months|Death|1|||
164152733|NCT01459783|592921423|FG001|Baseline to 6 Months|Death|0|||
164152734|NCT01459783|592921422|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
164152735|NCT01459783|592921423|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
164152736|NCT01459783|592921422|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
164152737|NCT01459783|592921423|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
164152738|NCT01459783|592921422|FG000|6 Months to 12 Months|Death|0|||
164152739|NCT01459783|592921423|FG001|6 Months to 12 Months|Death|1|||
164152740|NCT01459783|592921422|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
164152741|NCT01459783|592921423|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
164152742|NCT01459783|592921422|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
164152743|NCT01459783|592921423|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
164152744|NCT01459783|592921422|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
164152745|NCT01459783|592921423|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
164152746|NCT04211831|592921424|FG000|Overall Study|Withdrawal by Subject|4|||
164152747|NCT04211831|592921425|FG001|Overall Study|Withdrawal by Subject|1|||
164152748|NCT04211831|592921426|FG002|Overall Study|Withdrawal by Subject|1|||
164152749|NCT04211831|592921424|FG000|Overall Study|Protocol Violation|0|||
164152750|NCT04211831|592921425|FG001|Overall Study|Protocol Violation|0|||
164152751|NCT04211831|592921426|FG002|Overall Study|Protocol Violation|1|||
164152752|NCT04211831|592921424|FG000|Overall Study|Adverse Event|0|||
164152753|NCT04211831|592921425|FG001|Overall Study|Adverse Event|1|||
164152754|NCT04211831|592921426|FG002|Overall Study|Adverse Event|0|||
164152755|NCT04211831|592921424|FG000|Overall Study|Lack of Efficacy|0|||
164152756|NCT04211831|592921425|FG001|Overall Study|Lack of Efficacy|0|||
164152757|NCT04211831|592921426|FG002|Overall Study|Lack of Efficacy|1|||
164152758|NCT04211831|592921424|FG000|Overall Study|Lost to Follow-up|0|||
164152759|NCT04211831|592921425|FG001|Overall Study|Lost to Follow-up|0|||
164152760|NCT04211831|592921426|FG002|Overall Study|Lost to Follow-up|2|||
164152761|NCT04211831|592921424|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
164152762|NCT04211831|592921425|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
164152763|NCT04211831|592921426|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
164152764|NCT04211831|592921424|FG000|Overall Study|Other|0|||
164152765|NCT04211831|592921425|FG001|Overall Study|Other|1|||
164152766|NCT04211831|592921426|FG002|Overall Study|Other|0|||
164152767|NCT00967330|592921427|FG000|Overall Study|Protocol Violation|3|||
164152768|NCT00967330|592921428|FG001|Overall Study|Protocol Violation|4|||
164152769|NCT00967330|592921427|FG000|Overall Study|Regular|10|||
164152770|NCT00967330|592921428|FG001|Overall Study|Regular|3|||
164152771|NCT00967330|592921427|FG000|Overall Study|Withdrawal by Subject|6|||
164152772|NCT00967330|592921428|FG001|Overall Study|Withdrawal by Subject|0|||
164152773|NCT00967330|592921427|FG000|Overall Study|Lost to Follow-up|1|||
164152774|NCT00967330|592921428|FG001|Overall Study|Lost to Follow-up|1|||
164152775|NCT00967330|592921427|FG000|Overall Study|Death|102|||
164152776|NCT00967330|592921428|FG001|Overall Study|Death|51|||
164152777|NCT00967330|592921427|FG000|Overall Study|Severe protocol deviation|0|||
164152778|NCT00967330|592921428|FG001|Overall Study|Severe protocol deviation|1|||
164152779|NCT04563754|592923292|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
164152780|NCT04563754|592923293|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
164152781|NCT04563754|592923294|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
164152782|NCT04563754|592923292|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
164152783|NCT04563754|592923293|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
164152784|NCT04563754|592923294|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
164152785|NCT04563754|592923292|FG000|Follow up|Lost to Follow-up|61|||
164152786|NCT04563754|592923293|FG001|Follow up|Lost to Follow-up|23|||
164152787|NCT04563754|592923294|FG002|Follow up|Lost to Follow-up|5|||
164152788|NCT04563754|592923292|FG000|Follow up|Death|0|||
164152789|NCT04563754|592923293|FG001|Follow up|Death|2|||
164152790|NCT04563754|592923294|FG002|Follow up|Death|0|||
164152791|NCT04563754|592923292|FG000|Follow up|Ongoing|0|||
164152792|NCT04563754|592923293|FG001|Follow up|Ongoing|28|||
164152793|NCT04563754|592923294|FG002|Follow up|Ongoing|0|||
164152794|NCT00070564|592923295|FG000|Overall Study|Progression|2|||
164152795|NCT00070564|592923296|FG001|Overall Study|Progression|4|||
164152796|NCT00070564|592923297|FG002|Overall Study|Progression|7|||
164152797|NCT00070564|592923298|FG003|Overall Study|Progression|7|||
164152798|NCT00070564|592923299|FG004|Overall Study|Progression|1|||
164152799|NCT00070564|592923300|FG005|Overall Study|Progression|0|||
164152800|NCT00070564|592923295|FG000|Overall Study|Delinquent|1|||
164152801|NCT00070564|592923296|FG001|Overall Study|Delinquent|4|||
164152802|NCT00070564|592923297|FG002|Overall Study|Delinquent|2|||
164152803|NCT00070564|592923298|FG003|Overall Study|Delinquent|0|||
164152804|NCT00070564|592923299|FG004|Overall Study|Delinquent|0|||
164152805|NCT00070564|592923300|FG005|Overall Study|Delinquent|0|||
164152806|NCT00070564|592923295|FG000|Overall Study|Adverse Event|150|||
164152807|NCT00070564|592923296|FG001|Overall Study|Adverse Event|142|||
164152808|NCT00070564|592923297|FG002|Overall Study|Adverse Event|120|||
164152809|NCT00070564|592923298|FG003|Overall Study|Adverse Event|108|||
164152810|NCT00070564|592923299|FG004|Overall Study|Adverse Event|63|||
164152811|NCT00070564|592923300|FG005|Overall Study|Adverse Event|36|||
164152812|NCT00070564|592923295|FG000|Overall Study|Death|4|||
164152813|NCT00070564|592923296|FG001|Overall Study|Death|1|||
164152814|NCT00070564|592923297|FG002|Overall Study|Death|5|||
164152815|NCT00070564|592923298|FG003|Overall Study|Death|3|||
164152816|NCT00070564|592923299|FG004|Overall Study|Death|0|||
164152817|NCT00070564|592923300|FG005|Overall Study|Death|1|||
164152818|NCT00070564|592923295|FG000|Overall Study|Other, not protocol specified|17|||
164152819|NCT00070564|592923296|FG001|Overall Study|Other, not protocol specified|15|||
164152820|NCT00070564|592923297|FG002|Overall Study|Other, not protocol specified|14|||
164152821|NCT00070564|592923298|FG003|Overall Study|Other, not protocol specified|19|||
164152822|NCT00070564|592923299|FG004|Overall Study|Other, not protocol specified|6|||
164152823|NCT00070564|592923300|FG005|Overall Study|Other, not protocol specified|7|||
164152824|NCT00070564|592923295|FG000|Overall Study|Withdrawal by Subject|26|||
164152825|NCT00070564|592923296|FG001|Overall Study|Withdrawal by Subject|37|||
164152826|NCT00070564|592923297|FG002|Overall Study|Withdrawal by Subject|23|||
164152827|NCT00070564|592923298|FG003|Overall Study|Withdrawal by Subject|30|||
164152828|NCT00070564|592923299|FG004|Overall Study|Withdrawal by Subject|8|||
164152829|NCT00070564|592923300|FG005|Overall Study|Withdrawal by Subject|8|||
164152830|NCT00070564|592923295|FG000|Overall Study|Not reported|0|||
164152831|NCT00070564|592923296|FG001|Overall Study|Not reported|0|||
164152832|NCT00070564|592923297|FG002|Overall Study|Not reported|0|||
164152833|NCT00070564|592923298|FG003|Overall Study|Not reported|0|||
164152834|NCT00070564|592923299|FG004|Overall Study|Not reported|1|||
164152835|NCT00070564|592923300|FG005|Overall Study|Not reported|0|||
164152836|NCT04796961|592923301|FG000|Overall Study|Lost to Follow-up|10|||
164152837|NCT04796961|592923301|FG000|Overall Study|Withdrawal by Subject|3|||
164152838|NCT04796961|592923301|FG000|Overall Study|Left Organization|10|||
164152839|NCT02325973|592923302|FG000|Overall Study|Death|5|||
164152840|NCT02325973|592923302|FG000|Overall Study|Withdrawal by subject or investigator|16|||
164152841|NCT01490086|592923306|FG000|Overall Study|Consent withdrawn|4|||
164152842|NCT01490086|592923307|FG001|Overall Study|Consent withdrawn|4|||
164152843|NCT01490086|592923308|FG002|Overall Study|Consent withdrawn|3|||
164152844|NCT01490086|592923309|FG003|Overall Study|Consent withdrawn|0|||
164152845|NCT01490086|592923310|FG004|Overall Study|Consent withdrawn|1|||
164152846|NCT01490086|592923306|FG000|Overall Study|Non-compliance|0|||
164152847|NCT01490086|592923307|FG001|Overall Study|Non-compliance|1|||
164152848|NCT01490086|592923308|FG002|Overall Study|Non-compliance|0|||
164152849|NCT01490086|592923309|FG003|Overall Study|Non-compliance|0|||
164152850|NCT01490086|592923310|FG004|Overall Study|Non-compliance|0|||
164152851|NCT01490086|592923306|FG000|Overall Study|Abnormal laboratory findings|1|||
164152852|NCT01490086|592923307|FG001|Overall Study|Abnormal laboratory findings|0|||
164152853|NCT01490086|592923308|FG002|Overall Study|Abnormal laboratory findings|0|||
164152854|NCT01490086|592923309|FG003|Overall Study|Abnormal laboratory findings|0|||
164152855|NCT01490086|592923310|FG004|Overall Study|Abnormal laboratory findings|0|||
164152856|NCT01490086|592923306|FG000|Overall Study|Lost to Follow-up|0|||
164152857|NCT01490086|592923307|FG001|Overall Study|Lost to Follow-up|0|||
164152858|NCT01490086|592923308|FG002|Overall Study|Lost to Follow-up|0|||
164152859|NCT01490086|592923309|FG003|Overall Study|Lost to Follow-up|0|||
164152860|NCT01490086|592923310|FG004|Overall Study|Lost to Follow-up|1|||
164152861|NCT01490086|592923306|FG000|Overall Study|Physician Decision|3|||
164152862|NCT01490086|592923307|FG001|Overall Study|Physician Decision|4|||
164152863|NCT01490086|592923308|FG002|Overall Study|Physician Decision|2|||
164152864|NCT01490086|592923309|FG003|Overall Study|Physician Decision|3|||
164152865|NCT01490086|592923310|FG004|Overall Study|Physician Decision|1|||
164152866|NCT01490086|592923306|FG000|Overall Study|Adverse Event|0|||
164152867|NCT01490086|592923307|FG001|Overall Study|Adverse Event|0|||
164152868|NCT01490086|592923308|FG002|Overall Study|Adverse Event|1|||
164152869|NCT01490086|592923309|FG003|Overall Study|Adverse Event|2|||
164152870|NCT01490086|592923310|FG004|Overall Study|Adverse Event|0|||
164152871|NCT01490086|592923306|FG000|Overall Study|Lack of Efficacy|0|||
164152872|NCT01490086|592923307|FG001|Overall Study|Lack of Efficacy|3|||
164152873|NCT01490086|592923308|FG002|Overall Study|Lack of Efficacy|1|||
164152874|NCT01490086|592923309|FG003|Overall Study|Lack of Efficacy|0|||
164152875|NCT01490086|592923310|FG004|Overall Study|Lack of Efficacy|8|||
164152876|NCT01490086|592923306|FG000|Overall Study|Worsening of symptoms|0|||
164152877|NCT01490086|592923307|FG001|Overall Study|Worsening of symptoms|1|||
164152878|NCT01490086|592923308|FG002|Overall Study|Worsening of symptoms|0|||
164152879|NCT01490086|592923309|FG003|Overall Study|Worsening of symptoms|1|||
164152880|NCT01490086|592923310|FG004|Overall Study|Worsening of symptoms|0|||
164152881|NCT01490086|592923306|FG000|Overall Study|Subject uncontrollable and abusive|0|||
164152882|NCT01490086|592923307|FG001|Overall Study|Subject uncontrollable and abusive|1|||
164152883|NCT01490086|592923308|FG002|Overall Study|Subject uncontrollable and abusive|0|||
164152884|NCT01490086|592923309|FG003|Overall Study|Subject uncontrollable and abusive|0|||
164152885|NCT01490086|592923310|FG004|Overall Study|Subject uncontrollable and abusive|0|||
164152886|NCT01490086|592923306|FG000|Overall Study|Subject left hospital|0|||
164152887|NCT01490086|592923307|FG001|Overall Study|Subject left hospital|1|||
164152888|NCT01490086|592923308|FG002|Overall Study|Subject left hospital|0|||
164152889|NCT01490086|592923309|FG003|Overall Study|Subject left hospital|1|||
164152890|NCT01490086|592923310|FG004|Overall Study|Subject left hospital|0|||
164152891|NCT00679211|592923313|FG000|Overall Study|Progressive disease|82|||
164152892|NCT00679211|592923313|FG000|Overall Study|Adverse Event|7|||
164152893|NCT00679211|592923313|FG000|Overall Study|Withdrawal by Subject|2|||
164152894|NCT00679211|592923313|FG000|Overall Study|Physician Decision|5|||
164152895|NCT00679211|592923313|FG000|Overall Study|Refused to undergo protocol procedures|1|||
164152896|NCT00679211|592923313|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
164152897|NCT00679211|592923313|FG000|Overall Study|Other|1|||
164152898|NCT01922037|592923314|FG000|Overall Study|Withdrawal by Subject|2|||
164152899|NCT01922037|592923315|FG001|Overall Study|Withdrawal by Subject|44|||
164152900|NCT01922037|592923314|FG000|Overall Study|Adverse Event|1|||
164152901|NCT01922037|592923315|FG001|Overall Study|Adverse Event|7|||
164152902|NCT01922037|592923314|FG000|Overall Study|Death|0|||
164152903|NCT01922037|592923315|FG001|Overall Study|Death|5|||
164152904|NCT01922037|592923314|FG000|Overall Study|Pregnancy|0|||
164152905|NCT01922037|592923315|FG001|Overall Study|Pregnancy|2|||
164152906|NCT01922037|592923314|FG000|Overall Study|Participant non-compliance|4|||
164152907|NCT01922037|592923315|FG001|Overall Study|Participant non-compliance|46|||
164152908|NCT01922037|592923314|FG000|Overall Study|Investigator/Sponsor decision|1|||
164152909|NCT01922037|592923315|FG001|Overall Study|Investigator/Sponsor decision|4|||
164152910|NCT01922037|592923314|FG000|Overall Study|Other unspecified|2|||
164152911|NCT01922037|592923315|FG001|Overall Study|Other unspecified|66|||
164152912|NCT00931528|592923316|FG000|Overall Study|Protocol Violation|9|||
164152913|NCT00931528|592923317|FG001|Overall Study|Protocol Violation|12|||
164152914|NCT00931528|592923316|FG000|Overall Study|Withdrawal by Subject|4|||
164152915|NCT00931528|592923317|FG001|Overall Study|Withdrawal by Subject|12|||
164152916|NCT00931528|592923316|FG000|Overall Study|Lost to Follow-up|6|||
164152917|NCT00931528|592923317|FG001|Overall Study|Lost to Follow-up|13|||
164152918|NCT00931528|592923316|FG000|Overall Study|Assessment outside of Time Frame|22|||
164152919|NCT00931528|592923317|FG001|Overall Study|Assessment outside of Time Frame|23|||
164152920|NCT01470248|592923318|FG000|Overall Study|Withdrawal by Subject|1|||
164152921|NCT05842967|592923321|FG000|Period 1: SSA|Adverse Event|1|||
164152922|NCT05842967|592923322|FG001|Period 1: SSA|Adverse Event|1|||
164152923|NCT05842967|592923323|FG002|Period 1: SSA|Adverse Event|0|||
164152924|NCT05842967|592923324|FG003|Period 1: SSA|Adverse Event|0|||
164152925|NCT05842967|592923321|FG000|Period 1: SSA|Death|1|||
164152926|NCT05842967|592923322|FG001|Period 1: SSA|Death|0|||
164152927|NCT05842967|592923323|FG002|Period 1: SSA|Death|0|||
164152928|NCT05842967|592923324|FG003|Period 1: SSA|Death|0|||
164152929|NCT05842967|592923321|FG000|Period 1: SSA|Lost to Follow-up|16|||
164152930|NCT05842967|592923322|FG001|Period 1: SSA|Lost to Follow-up|4|||
164152931|NCT05842967|592923323|FG002|Period 1: SSA|Lost to Follow-up|0|||
164152932|NCT05842967|592923324|FG003|Period 1: SSA|Lost to Follow-up|0|||
164152933|NCT05842967|592923321|FG000|Period 1: SSA|Physician Decision|1|||
164152934|NCT05842967|592923322|FG001|Period 1: SSA|Physician Decision|0|||
164152935|NCT05842967|592923323|FG002|Period 1: SSA|Physician Decision|0|||
164152936|NCT05842967|592923324|FG003|Period 1: SSA|Physician Decision|0|||
164152937|NCT05842967|592923321|FG000|Period 1: SSA|Withdrawal by Subject|2|||
164152938|NCT05842967|592923322|FG001|Period 1: SSA|Withdrawal by Subject|2|||
164152939|NCT05842967|592923323|FG002|Period 1: SSA|Withdrawal by Subject|0|||
164152940|NCT05842967|592923324|FG003|Period 1: SSA|Withdrawal by Subject|0|||
164152941|NCT05842967|592923321|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
164152942|NCT05842967|592923322|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
164152943|NCT05842967|592923323|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
164152944|NCT05842967|592923324|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
164152945|NCT05842967|592923321|FG000|Period 2: SSB|Adverse Event|0|||
164152946|NCT05842967|592923322|FG001|Period 2: SSB|Adverse Event|0|||
164152947|NCT05842967|592923323|FG002|Period 2: SSB|Adverse Event|2|||
164152948|NCT05842967|592923324|FG003|Period 2: SSB|Adverse Event|0|||
164152949|NCT05842967|592923321|FG000|Period 2: SSB|Lost to Follow-up|0|||
164152950|NCT05842967|592923322|FG001|Period 2: SSB|Lost to Follow-up|0|||
164152951|NCT05842967|592923323|FG002|Period 2: SSB|Lost to Follow-up|4|||
164152952|NCT05842967|592923324|FG003|Period 2: SSB|Lost to Follow-up|3|||
164152953|NCT05842967|592923321|FG000|Period 2: SSB|Withdrawal by Subject|0|||
164152954|NCT05842967|592923322|FG001|Period 2: SSB|Withdrawal by Subject|0|||
164152955|NCT05842967|592923323|FG002|Period 2: SSB|Withdrawal by Subject|1|||
164152956|NCT05842967|592923324|FG003|Period 2: SSB|Withdrawal by Subject|0|||
164152957|NCT05842967|592923321|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
164152958|NCT05842967|592923322|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
164152959|NCT05842967|592923323|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
164152960|NCT05842967|592923324|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
164152961|NCT05842967|592923321|FG000|Period 2: SSB|Protocol Violation|0|||
164152962|NCT05842967|592923322|FG001|Period 2: SSB|Protocol Violation|0|||
164152963|NCT05842967|592923323|FG002|Period 2: SSB|Protocol Violation|0|||
164152964|NCT05842967|592923324|FG003|Period 2: SSB|Protocol Violation|1|||
164152965|NCT02572570|592923330|FG000|Overall Study|Study Terminated|27|||
164152966|NCT00611923|592923331|FG000|Overall Study|Withdrawal by Subject|2|||
164152967|NCT00611923|592923332|FG001|Overall Study|Withdrawal by Subject|2|||
164152968|NCT02302833|592923346|FG000|Overall Study|Lost to Follow-up|3|||
164152969|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
164152970|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
164153263|NCT00262028|592923424|FG000|Overall Study|Protocol Violation|0|||
164152971|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152972|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152973|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152974|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
164152975|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
164152976|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
164152977|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
164152978|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
164152979|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
164152980|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
164152981|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
164152982|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
164152983|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
164152984|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
164152985|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
164152986|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
164152987|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
164152988|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
164152989|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
164152990|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
164152991|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
164152992|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
164152993|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
164152994|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
164152995|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
164152996|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
164152997|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
164152998|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
164152999|NCT04429503|592923347|FG000|Main Study (Up to Wk 96)|Death|9|||
164153000|NCT04429503|592923348|FG001|Main Study (Up to Wk 96)|Death|18|||
164153001|NCT04429503|592923349|FG002|Main Study (Up to Wk 96)|Death|5|||
164153002|NCT04429503|592923350|FG003|Main Study (Up to Wk 96)|Death|0|||
164153003|NCT04429503|592923351|FG004|Main Study (Up to Wk 96)|Death|0|||
164153004|NCT04429503|592923352|FG005|Main Study (Up to Wk 96)|Death|0|||
164153005|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153006|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153007|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153008|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
164153009|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153010|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
164153011|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
164153012|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
164153013|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
164153014|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
164153015|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
164153016|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
164153017|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153018|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153019|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153020|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
164153021|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
164153022|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
164153023|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
164153024|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
164153025|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
164153026|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
164153027|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
164153028|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
164153029|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
164153030|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
164153031|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
164153032|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
164153033|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
164153034|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
164153035|NCT04429503|592923347|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
164153036|NCT04429503|592923348|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
164153037|NCT04429503|592923349|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
164153038|NCT04429503|592923350|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
164153039|NCT04429503|592923351|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
164153040|NCT04429503|592923352|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
164153041|NCT05516108|592923353|FG000|Overall Study|Time Commitment|3|||
164153042|NCT05516108|592923354|FG001|Overall Study|Time Commitment|1|||
164153043|NCT05516108|592923353|FG000|Overall Study|Reason Unknown|2|||
164153044|NCT05516108|592923354|FG001|Overall Study|Reason Unknown|4|||
164153045|NCT03664232|592923355|FG000|Overall Study|Withdrawal by Subject|0|||
164153046|NCT03664232|592923356|FG001|Overall Study|Withdrawal by Subject|1|||
164153047|NCT03664232|592923357|FG002|Overall Study|Withdrawal by Subject|0|||
164153048|NCT03664232|592923358|FG003|Overall Study|Withdrawal by Subject|1|||
164153049|NCT03664232|592923355|FG000|Overall Study|Adverse Event|0|||
164153050|NCT03664232|592923356|FG001|Overall Study|Adverse Event|0|||
164153051|NCT03664232|592923357|FG002|Overall Study|Adverse Event|1|||
164153052|NCT03664232|592923358|FG003|Overall Study|Adverse Event|0|||
164153053|NCT03664232|592923355|FG000|Overall Study|Other-Non-compliance with study drug|0|||
164153054|NCT03664232|592923356|FG001|Overall Study|Other-Non-compliance with study drug|1|||
164153055|NCT03664232|592923357|FG002|Overall Study|Other-Non-compliance with study drug|0|||
164153056|NCT03664232|592923358|FG003|Overall Study|Other-Non-compliance with study drug|2|||
164153057|NCT03664232|592923355|FG000|Overall Study|Other-Unspecified|0|||
164153058|NCT03664232|592923356|FG001|Overall Study|Other-Unspecified|3|||
164153059|NCT03664232|592923357|FG002|Overall Study|Other-Unspecified|0|||
164153060|NCT03664232|592923358|FG003|Overall Study|Other-Unspecified|1|||
164153061|NCT03664232|592923355|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
164153062|NCT03664232|592923356|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
164153063|NCT03664232|592923357|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
164153064|NCT03664232|592923358|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
164153065|NCT02717507|592923359|FG000|Overall Study|Lost to Follow-up|5|||
164153066|NCT02717507|592923360|FG001|Overall Study|Lost to Follow-up|8|||
164153067|NCT02717507|592923359|FG000|Overall Study|Pregnancy|1|||
164153068|NCT02717507|592923360|FG001|Overall Study|Pregnancy|1|||
164153069|NCT02717507|592923359|FG000|Overall Study|Protocol Violation|2|||
164153070|NCT02717507|592923360|FG001|Overall Study|Protocol Violation|2|||
164153071|NCT02717507|592923359|FG000|Overall Study|Withdrawal by Subject|20|||
164153072|NCT02717507|592923360|FG001|Overall Study|Withdrawal by Subject|20|||
164153073|NCT02717507|592923359|FG000|Overall Study|Relapse|1|||
164153074|NCT02717507|592923360|FG001|Overall Study|Relapse|1|||
164153075|NCT02717507|592923359|FG000|Overall Study|Cardiac Event|2|||
164153076|NCT02717507|592923360|FG001|Overall Study|Cardiac Event|6|||
164153077|NCT05017246|592923361|FG000|Overall Study|Withdrawal by Subject|5|||
164153078|NCT05017246|592923362|FG001|Overall Study|Withdrawal by Subject|3|||
164153079|NCT05017246|592923361|FG000|Overall Study|Determined to be ineligible|0|||
164153080|NCT05017246|592923362|FG001|Overall Study|Determined to be ineligible|1|||
164153081|NCT05017246|592923361|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
164153082|NCT05017246|592923362|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
164153083|NCT05017246|592923361|FG000|Overall Study|Technical failure|1|||
164153084|NCT05017246|592923362|FG001|Overall Study|Technical failure|3|||
164153085|NCT00970593|592923363|FG000|Overall Study|Adverse Event|1|||
164153086|NCT00970593|592923364|FG001|Overall Study|Adverse Event|1|||
164153087|NCT00970593|592923365|FG002|Overall Study|Adverse Event|0|||
164153088|NCT00970593|592923366|FG003|Overall Study|Adverse Event|0|||
164153089|NCT00970593|592923367|FG004|Overall Study|Adverse Event|0|||
164153090|NCT00970593|592923368|FG005|Overall Study|Adverse Event|0|||
164153091|NCT00970593|592923369|FG006|Overall Study|Adverse Event|0|||
164153092|NCT00970593|592923363|FG000|Overall Study|Discontinuation of study by sponsor|0|||
164153093|NCT00970593|592923364|FG001|Overall Study|Discontinuation of study by sponsor|0|||
164153094|NCT00970593|592923365|FG002|Overall Study|Discontinuation of study by sponsor|5|||
164153095|NCT00970593|592923366|FG003|Overall Study|Discontinuation of study by sponsor|0|||
164153096|NCT00970593|592923367|FG004|Overall Study|Discontinuation of study by sponsor|0|||
164153097|NCT00970593|592923368|FG005|Overall Study|Discontinuation of study by sponsor|0|||
164153098|NCT00970593|592923369|FG006|Overall Study|Discontinuation of study by sponsor|2|||
164153099|NCT00970593|592923363|FG000|Overall Study|Withdrawal by Subject|0|||
164153100|NCT00970593|592923364|FG001|Overall Study|Withdrawal by Subject|0|||
164153101|NCT00970593|592923365|FG002|Overall Study|Withdrawal by Subject|1|||
164153102|NCT00970593|592923366|FG003|Overall Study|Withdrawal by Subject|0|||
164153103|NCT00970593|592923367|FG004|Overall Study|Withdrawal by Subject|0|||
164153104|NCT00970593|592923368|FG005|Overall Study|Withdrawal by Subject|0|||
164153105|NCT00970593|592923369|FG006|Overall Study|Withdrawal by Subject|0|||
164153106|NCT02203357|592923370|FG000|Overall Study|Lost to Follow-up|58|||
164153107|NCT02203357|592923371|FG001|Overall Study|Lost to Follow-up|66|||
164153108|NCT02203357|592923372|FG002|Overall Study|Lost to Follow-up|70|||
164153109|NCT02288312|592923381|FG000|Overall Study|Pregnancy|1|||
164153110|NCT02288312|592923382|FG001|Overall Study|Pregnancy|0|||
164153111|NCT02288312|592923383|FG002|Overall Study|Pregnancy|0|||
164153112|NCT02002221|592923384|FG000|Overall Study|Adverse Event|2|||
164153113|NCT02002221|592923385|FG001|Overall Study|Adverse Event|1|||
164153114|NCT02002221|592923384|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
164153115|NCT02002221|592923385|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
164153116|NCT02002221|592923384|FG000|Overall Study|Patient withdrew consent|0|||
164153117|NCT02002221|592923385|FG001|Overall Study|Patient withdrew consent|1|||
164153118|NCT01068860|592923386|FG000|Overall Study|Withdrawal by Subject|0|||
164153119|NCT01068860|592923387|FG001|Overall Study|Withdrawal by Subject|0|||
164153120|NCT01068860|592923388|FG002|Overall Study|Withdrawal by Subject|0|||
164153121|NCT01068860|592923389|FG003|Overall Study|Withdrawal by Subject|0|||
164153122|NCT01068860|592923390|FG004|Overall Study|Withdrawal by Subject|0|||
164153123|NCT01068860|592923391|FG005|Overall Study|Withdrawal by Subject|2|||
164153124|NCT01068860|592923392|FG006|Overall Study|Withdrawal by Subject|0|||
164153125|NCT01068860|592923393|FG007|Overall Study|Withdrawal by Subject|0|||
164153126|NCT01068860|592923394|FG008|Overall Study|Withdrawal by Subject|0|||
164153127|NCT01068860|592923395|FG009|Overall Study|Withdrawal by Subject|3|||
164153128|NCT01068860|592923386|FG000|Overall Study|Administrative problems; misrandomized|0|||
164153129|NCT01068860|592923387|FG001|Overall Study|Administrative problems; misrandomized|0|||
164153130|NCT01068860|592923388|FG002|Overall Study|Administrative problems; misrandomized|0|||
164153131|NCT01068860|592923389|FG003|Overall Study|Administrative problems; misrandomized|1|||
164153132|NCT01068860|592923390|FG004|Overall Study|Administrative problems; misrandomized|0|||
164153133|NCT01068860|592923391|FG005|Overall Study|Administrative problems; misrandomized|0|||
164153134|NCT01068860|592923392|FG006|Overall Study|Administrative problems; misrandomized|0|||
164153135|NCT01068860|592923393|FG007|Overall Study|Administrative problems; misrandomized|0|||
164153136|NCT01068860|592923394|FG008|Overall Study|Administrative problems; misrandomized|0|||
164153137|NCT01068860|592923395|FG009|Overall Study|Administrative problems; misrandomized|1|||
164153138|NCT01068860|592923386|FG000|Overall Study|Lost to Follow-up|0|||
164153139|NCT01068860|592923387|FG001|Overall Study|Lost to Follow-up|1|||
164153140|NCT01068860|592923388|FG002|Overall Study|Lost to Follow-up|0|||
164153141|NCT01068860|592923389|FG003|Overall Study|Lost to Follow-up|0|||
164153142|NCT01068860|592923390|FG004|Overall Study|Lost to Follow-up|0|||
164153143|NCT01068860|592923391|FG005|Overall Study|Lost to Follow-up|0|||
164153144|NCT01068860|592923392|FG006|Overall Study|Lost to Follow-up|0|||
164153145|NCT01068860|592923393|FG007|Overall Study|Lost to Follow-up|0|||
164153146|NCT01068860|592923394|FG008|Overall Study|Lost to Follow-up|0|||
164153147|NCT01068860|592923395|FG009|Overall Study|Lost to Follow-up|0|||
164153148|NCT02568072|592923396|FG000|Overall Study|Unavailable for appointment|23|||
164153149|NCT02568072|592923396|FG000|Overall Study|Unable to contact|3|||
164153150|NCT02568072|592923396|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
164153151|NCT02568072|592923396|FG000|Overall Study|Withdrawal by Subject|1|||
164153152|NCT02568072|592923396|FG000|Overall Study|Sustained injury, marathon not run|24|||
164153153|NCT05263908|592923400|FG000|Overall Study|No informed consent for publication of study results|397|||
164153154|NCT05263908|592923400|FG000|Overall Study|CRF not collected|1|||
164153155|NCT02714218|592923401|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164153156|NCT02714218|592923402|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
164153157|NCT02714218|592923403|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
164153158|NCT02714218|592923401|FG000|Pre-Treatment Period|Other reasons|0|||
164153159|NCT02714218|592923402|FG001|Pre-Treatment Period|Other reasons|1|||
164153160|NCT02714218|592923403|FG002|Pre-Treatment Period|Other reasons|0|||
164153161|NCT02714218|592923401|FG000|Treatment Period|Disease Progression|55|||
164153162|NCT02714218|592923402|FG001|Treatment Period|Disease Progression|52|||
164153163|NCT02714218|592923403|FG002|Treatment Period|Disease Progression|14|||
164153164|NCT02714218|592923401|FG000|Treatment Period|Study drug toxicity|46|||
164153165|NCT02714218|592923402|FG001|Treatment Period|Study drug toxicity|70|||
164153166|NCT02714218|592923403|FG002|Treatment Period|Study drug toxicity|6|||
164153167|NCT02714218|592923401|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
164153168|NCT02714218|592923402|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
164153169|NCT02714218|592923403|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
164153170|NCT02714218|592923401|FG000|Treatment Period|Request to discontinue treatment|1|||
164153171|NCT02714218|592923402|FG001|Treatment Period|Request to discontinue treatment|4|||
164153172|NCT02714218|592923403|FG002|Treatment Period|Request to discontinue treatment|1|||
164153173|NCT02714218|592923401|FG000|Treatment Period|Participant withdrew consent|2|||
164153174|NCT02714218|592923402|FG001|Treatment Period|Participant withdrew consent|2|||
164153175|NCT02714218|592923403|FG002|Treatment Period|Participant withdrew consent|0|||
164153176|NCT02714218|592923401|FG000|Treatment Period|Maximum clinical benefit|4|||
164153177|NCT02714218|592923402|FG001|Treatment Period|Maximum clinical benefit|2|||
164153178|NCT02714218|592923403|FG002|Treatment Period|Maximum clinical benefit|0|||
164153179|NCT02714218|592923401|FG000|Treatment Period|Administrative reason by sponsor|2|||
164153180|NCT02714218|592923402|FG001|Treatment Period|Administrative reason by sponsor|1|||
164153181|NCT02714218|592923403|FG002|Treatment Period|Administrative reason by sponsor|0|||
164153182|NCT02714218|592923401|FG000|Treatment Period|Other reasons|6|||
164153183|NCT02714218|592923402|FG001|Treatment Period|Other reasons|6|||
164153184|NCT02714218|592923403|FG002|Treatment Period|Other reasons|0|||
164153185|NCT02714218|592923401|FG000|Treatment Period|Completed treatment as per protocol|36|||
164153186|NCT02714218|592923402|FG001|Treatment Period|Completed treatment as per protocol|27|||
164153187|NCT02714218|592923403|FG002|Treatment Period|Completed treatment as per protocol|3|||
164153188|NCT02714218|592923401|FG000|Treatment Period|Not reported|9|||
164153189|NCT02714218|592923402|FG001|Treatment Period|Not reported|6|||
164153190|NCT02714218|592923403|FG002|Treatment Period|Not reported|0|||
164153191|NCT03743051|592923404|FG000|Overall Study|Adverse Event|5|||
164153192|NCT03743051|592923405|FG001|Overall Study|Adverse Event|9|||
164153193|NCT03743051|592923404|FG000|Overall Study|Death|27|||
164153194|NCT03743051|592923405|FG001|Overall Study|Death|26|||
164153195|NCT03743051|592923404|FG000|Overall Study|Lost to Follow-up|4|||
164153196|NCT03743051|592923405|FG001|Overall Study|Lost to Follow-up|8|||
164153197|NCT03743051|592923404|FG000|Overall Study|Withdrawal by Subject|32|||
164153198|NCT03743051|592923405|FG001|Overall Study|Withdrawal by Subject|19|||
164153199|NCT03743051|592923404|FG000|Overall Study|Physician Decision|10|||
164153200|NCT03743051|592923405|FG001|Overall Study|Physician Decision|15|||
164153201|NCT03743051|592923404|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
164153202|NCT03743051|592923405|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
164153203|NCT00840749|592923408|FG000|Overall Study|Death|1|||
164153204|NCT00840749|592923409|FG001|Overall Study|Death|2|||
164153205|NCT00840749|592923408|FG000|Overall Study|not treated on study arm|11|||
164153206|NCT00840749|592923409|FG001|Overall Study|not treated on study arm|11|||
164153207|NCT00840749|592923408|FG000|Overall Study|study closed|19|||
164153208|NCT00840749|592923409|FG001|Overall Study|study closed|14|||
164153209|NCT02550561|592923410|FG000|Overall Study|Lost to Follow-up|5|||
164153210|NCT02550561|592923410|FG000|Overall Study|Withdrawal by Subject|1|||
164153211|NCT03411863|592923415|FG000|Overall Study|Withdrawal by Subject|3|||
164153212|NCT03411863|592923416|FG001|Overall Study|Withdrawal by Subject|1|||
164153213|NCT03411863|592923415|FG000|Overall Study|Physician Decision|0|||
164153214|NCT03411863|592923416|FG001|Overall Study|Physician Decision|1|||
164153215|NCT02766335|592923417|FG000|Initial Registration|Adverse Event|6|||
164153216|NCT02766335|592923418|FG001|Initial Registration|Adverse Event|3|||
164153217|NCT02766335|592923419|FG002|Initial Registration|Adverse Event|0|||
164153218|NCT02766335|592923417|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
164153219|NCT02766335|592923418|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
164153220|NCT02766335|592923419|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
164153221|NCT02766335|592923417|FG000|Initial Registration|Progression/relapse|49|||
164153222|NCT02766335|592923418|FG001|Initial Registration|Progression/relapse|15|||
164153223|NCT02766335|592923419|FG002|Initial Registration|Progression/relapse|0|||
164153224|NCT02766335|592923417|FG000|Initial Registration|Death|1|||
164153225|NCT02766335|592923418|FG001|Initial Registration|Death|3|||
164153226|NCT02766335|592923419|FG002|Initial Registration|Death|0|||
164153227|NCT02766335|592923417|FG000|Initial Registration|not protocol specified|1|||
164153228|NCT02766335|592923418|FG001|Initial Registration|not protocol specified|9|||
164153229|NCT02766335|592923419|FG002|Initial Registration|not protocol specified|0|||
164153230|NCT02766335|592923417|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
164153231|NCT02766335|592923418|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
164153232|NCT02766335|592923419|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
164153233|NCT02766335|592923417|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
164153234|NCT02766335|592923418|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
164153235|NCT02766335|592923419|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
164153236|NCT00262028|592923424|FG000|Overall Study|Withdrawal by Subject|6|||
164153237|NCT00262028|592923425|FG001|Overall Study|Withdrawal by Subject|3|||
164153238|NCT00262028|592923426|FG002|Overall Study|Withdrawal by Subject|6|||
164153239|NCT00262028|592923427|FG003|Overall Study|Withdrawal by Subject|5|||
164153240|NCT00262028|592923428|FG004|Overall Study|Withdrawal by Subject|2|||
164153241|NCT00262028|592923429|FG005|Overall Study|Withdrawal by Subject|3|||
164153242|NCT00262028|592923430|FG006|Overall Study|Withdrawal by Subject|5|||
164153243|NCT00262028|592923431|FG007|Overall Study|Withdrawal by Subject|7|||
164153244|NCT00262028|592923432|FG008|Overall Study|Withdrawal by Subject|2|||
164153245|NCT00262028|592923424|FG000|Overall Study|Lost to Follow-up|7|||
164153246|NCT00262028|592923425|FG001|Overall Study|Lost to Follow-up|7|||
164153247|NCT00262028|592923426|FG002|Overall Study|Lost to Follow-up|5|||
164153248|NCT00262028|592923427|FG003|Overall Study|Lost to Follow-up|5|||
164153249|NCT00262028|592923428|FG004|Overall Study|Lost to Follow-up|4|||
164153250|NCT00262028|592923429|FG005|Overall Study|Lost to Follow-up|3|||
164153251|NCT00262028|592923430|FG006|Overall Study|Lost to Follow-up|3|||
164153252|NCT00262028|592923431|FG007|Overall Study|Lost to Follow-up|5|||
164153253|NCT00262028|592923432|FG008|Overall Study|Lost to Follow-up|6|||
164153254|NCT00262028|592923424|FG000|Overall Study|Administrative Reason|11|||
164153255|NCT00262028|592923425|FG001|Overall Study|Administrative Reason|14|||
164153256|NCT00262028|592923426|FG002|Overall Study|Administrative Reason|9|||
164153257|NCT00262028|592923427|FG003|Overall Study|Administrative Reason|12|||
164153258|NCT00262028|592923428|FG004|Overall Study|Administrative Reason|6|||
164153259|NCT00262028|592923429|FG005|Overall Study|Administrative Reason|7|||
164153260|NCT00262028|592923430|FG006|Overall Study|Administrative Reason|4|||
164153261|NCT00262028|592923431|FG007|Overall Study|Administrative Reason|6|||
164153262|NCT00262028|592923432|FG008|Overall Study|Administrative Reason|10|||
164153264|NCT00262028|592923425|FG001|Overall Study|Protocol Violation|0|||
164153265|NCT00262028|592923426|FG002|Overall Study|Protocol Violation|0|||
164153266|NCT00262028|592923427|FG003|Overall Study|Protocol Violation|1|||
164153267|NCT00262028|592923428|FG004|Overall Study|Protocol Violation|0|||
164153268|NCT00262028|592923429|FG005|Overall Study|Protocol Violation|0|||
164153269|NCT00262028|592923430|FG006|Overall Study|Protocol Violation|0|||
164153270|NCT00262028|592923431|FG007|Overall Study|Protocol Violation|0|||
164153271|NCT00262028|592923432|FG008|Overall Study|Protocol Violation|0|||
164153272|NCT00262028|592923424|FG000|Overall Study|Unable to classify|0|||
164153273|NCT00262028|592923425|FG001|Overall Study|Unable to classify|3|||
164153274|NCT00262028|592923426|FG002|Overall Study|Unable to classify|0|||
164153275|NCT00262028|592923427|FG003|Overall Study|Unable to classify|0|||
164153276|NCT00262028|592923428|FG004|Overall Study|Unable to classify|0|||
164153277|NCT00262028|592923429|FG005|Overall Study|Unable to classify|0|||
164153278|NCT00262028|592923430|FG006|Overall Study|Unable to classify|0|||
164153279|NCT00262028|592923431|FG007|Overall Study|Unable to classify|0|||
164153280|NCT00262028|592923432|FG008|Overall Study|Unable to classify|1|||
164153281|NCT03164551|592923433|FG000|Overall Study|Imaging discontinued prior completion|8|||
164153282|NCT03164551|592923434|FG001|Overall Study|Imaging discontinued prior completion|0|||
164153283|NCT03164551|592923433|FG000|Overall Study|Participant was non-compliant|1|||
164153284|NCT03164551|592923434|FG001|Overall Study|Participant was non-compliant|0|||
164153285|NCT03164551|592923433|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
164153286|NCT03164551|592923434|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
164153287|NCT03164551|592923433|FG000|Overall Study|Other|8|||
164153288|NCT03164551|592923434|FG001|Overall Study|Other|2|||
164153289|NCT01515423|592923435|FG000|Open Label Phase|Adverse Event|57|||
164153290|NCT01515423|592923436|FG001|Open Label Phase|Adverse Event|0|||
164153291|NCT01515423|592923437|FG002|Open Label Phase|Adverse Event|0|||
164153292|NCT01515423|592923435|FG000|Open Label Phase|Death|2|||
164153293|NCT01515423|592923436|FG001|Open Label Phase|Death|0|||
164153294|NCT01515423|592923437|FG002|Open Label Phase|Death|0|||
164153295|NCT01515423|592923435|FG000|Open Label Phase|Lack of Efficacy|117|||
164153296|NCT01515423|592923436|FG001|Open Label Phase|Lack of Efficacy|0|||
164153297|NCT01515423|592923437|FG002|Open Label Phase|Lack of Efficacy|0|||
164153298|NCT01515423|592923435|FG000|Open Label Phase|Lost to Follow-up|21|||
164153299|NCT01515423|592923436|FG001|Open Label Phase|Lost to Follow-up|0|||
164153300|NCT01515423|592923437|FG002|Open Label Phase|Lost to Follow-up|0|||
164153301|NCT01515423|592923435|FG000|Open Label Phase|Withdrawal by Subject|118|||
164153302|NCT01515423|592923436|FG001|Open Label Phase|Withdrawal by Subject|0|||
164153303|NCT01515423|592923437|FG002|Open Label Phase|Withdrawal by Subject|0|||
164153304|NCT01515423|592923435|FG000|Open Label Phase|excluded from DB Phase|70|||
164153305|NCT01515423|592923436|FG001|Open Label Phase|excluded from DB Phase|0|||
164153306|NCT01515423|592923437|FG002|Open Label Phase|excluded from DB Phase|0|||
164153307|NCT01515423|592923435|FG000|Open Label Phase|Other|28|||
164153308|NCT01515423|592923436|FG001|Open Label Phase|Other|0|||
164153309|NCT01515423|592923437|FG002|Open Label Phase|Other|0|||
164153310|NCT01515423|592923435|FG000|DOUBLE BLIND|Adverse Event|0|||
164153311|NCT01515423|592923436|FG001|DOUBLE BLIND|Adverse Event|15|||
164153312|NCT01515423|592923437|FG002|DOUBLE BLIND|Adverse Event|13|||
164153313|NCT01515423|592923435|FG000|DOUBLE BLIND|Death|0|||
164153314|NCT01515423|592923436|FG001|DOUBLE BLIND|Death|1|||
164153315|NCT01515423|592923437|FG002|DOUBLE BLIND|Death|2|||
164153316|NCT01515423|592923435|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
164153317|NCT01515423|592923436|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
164153318|NCT01515423|592923437|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
164153319|NCT01515423|592923435|FG000|DOUBLE BLIND|Pregnancy|0|||
164153320|NCT01515423|592923436|FG001|DOUBLE BLIND|Pregnancy|2|||
164153321|NCT01515423|592923437|FG002|DOUBLE BLIND|Pregnancy|0|||
164153322|NCT01515423|592923435|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
164153323|NCT01515423|592923436|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
164153324|NCT01515423|592923437|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
164153325|NCT01515423|592923435|FG000|DOUBLE BLIND|Other|0|||
164153326|NCT01515423|592923436|FG001|DOUBLE BLIND|Other|6|||
164153327|NCT01515423|592923437|FG002|DOUBLE BLIND|Other|12|||
164153328|NCT01515423|592923435|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
164153329|NCT01515423|592923436|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
164153330|NCT01515423|592923437|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
164153331|NCT01422213|592923442|FG000|Overall Study|Adverse Event|8|||
164153332|NCT01422213|592923443|FG001|Overall Study|Adverse Event|7|||
164153333|NCT01422213|592923444|FG002|Overall Study|Adverse Event|11|||
164153334|NCT01422213|592923442|FG000|Overall Study|Lack of Efficacy|10|||
164153335|NCT01422213|592923443|FG001|Overall Study|Lack of Efficacy|2|||
164153336|NCT01422213|592923444|FG002|Overall Study|Lack of Efficacy|2|||
164153337|NCT01422213|592923442|FG000|Overall Study|Non-compliance with study drug|0|||
164153338|NCT01422213|592923443|FG001|Overall Study|Non-compliance with study drug|1|||
164153339|NCT01422213|592923444|FG002|Overall Study|Non-compliance with study drug|0|||
164153340|NCT01422213|592923442|FG000|Overall Study|Protocol Violation|0|||
164153341|NCT01422213|592923443|FG001|Overall Study|Protocol Violation|2|||
164153342|NCT01422213|592923444|FG002|Overall Study|Protocol Violation|4|||
164153343|NCT01422213|592923442|FG000|Overall Study|Withdrawal of Consent|7|||
164153344|NCT01422213|592923443|FG001|Overall Study|Withdrawal of Consent|3|||
164153345|NCT01422213|592923444|FG002|Overall Study|Withdrawal of Consent|5|||
164153346|NCT01422213|592923442|FG000|Overall Study|Lost to Follow-up|3|||
164153347|NCT01422213|592923443|FG001|Overall Study|Lost to Follow-up|3|||
164153348|NCT01422213|592923444|FG002|Overall Study|Lost to Follow-up|5|||
164153349|NCT01422213|592923442|FG000|Overall Study|Administrative or Other Reason(s)|5|||
164153350|NCT01422213|592923443|FG001|Overall Study|Administrative or Other Reason(s)|4|||
164153351|NCT01422213|592923444|FG002|Overall Study|Administrative or Other Reason(s)|2|||
164153352|NCT00476190|592923456|FG000|Overall Study|Ineligible|1|||
164153353|NCT00476190|592923457|FG001|Overall Study|Ineligible|1|||
164153354|NCT00476190|592923456|FG000|Overall Study|Induction Death|2|||
164153355|NCT00476190|592923457|FG001|Overall Study|Induction Death|0|||
164153356|NCT00476190|592923456|FG000|Overall Study|Induction Failure|2|||
164153357|NCT00476190|592923457|FG001|Overall Study|Induction Failure|4|||
164153358|NCT00476190|592923456|FG000|Overall Study|Lost to Follow-up|1|||
164153359|NCT00476190|592923457|FG001|Overall Study|Lost to Follow-up|0|||
164153360|NCT00476190|592923456|FG000|Overall Study|Relapse/Progression|5|||
164153361|NCT00476190|592923457|FG001|Overall Study|Relapse/Progression|2|||
164153362|NCT00476190|592923456|FG000|Overall Study|Remission Death|0|||
164153363|NCT00476190|592923457|FG001|Overall Study|Remission Death|1|||
164153364|NCT00476190|592923456|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
164153365|NCT00476190|592923457|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
164153366|NCT00476190|592923456|FG000|Overall Study|Withdrawal by Subject|6|||
164153367|NCT00476190|592923457|FG001|Overall Study|Withdrawal by Subject|2|||
164153368|NCT00476190|592923456|FG000|Overall Study|Other|9|||
164153369|NCT00476190|592923457|FG001|Overall Study|Other|10|||
164153370|NCT04782076|592923458|FG000|Overall Study|Family Emergency|1|||
164153371|NCT02189837|592923462|FG000|Overall Study|Withdrawal by Subject|2|||
164153372|NCT02189837|592923463|FG001|Overall Study|Withdrawal by Subject|1|||
164153373|NCT02189837|592923464|FG002|Overall Study|Withdrawal by Subject|3|||
164153374|NCT02189837|592923465|FG003|Overall Study|Withdrawal by Subject|1|||
164153375|NCT02189837|592923462|FG000|Overall Study|Sponsor Decision|0|||
164153376|NCT02189837|592923463|FG001|Overall Study|Sponsor Decision|0|||
164153377|NCT02189837|592923464|FG002|Overall Study|Sponsor Decision|0|||
164153378|NCT02189837|592923465|FG003|Overall Study|Sponsor Decision|1|||
164153379|NCT02201784|592923470|FG000|Overall Study|Failure to achieve adequate block|2|||
164153380|NCT02201784|592923471|FG001|Overall Study|Failure to achieve adequate block|0|||
164153381|NCT00258960|592923472|FG000|Overall Study|Death|2|||
164153382|NCT00258960|592923472|FG000|Overall Study|Disease Progression|7|||
164153383|NCT00258960|592923472|FG000|Overall Study|Adverse Event|4|||
164153384|NCT00258960|592923472|FG000|Overall Study|Physician Decision|1|||
164153385|NCT00258960|592923472|FG000|Overall Study|Withdrawal by Subject|1|||
164153386|NCT00258960|592923472|FG000|Overall Study|Mistake|2|||
164153387|NCT00473590|592923473|FG000|Overall Study|Adverse Event|3|||
164153388|NCT00473590|592923474|FG001|Overall Study|Adverse Event|3|||
164153389|NCT00473590|592923473|FG000|Overall Study|Death|4|||
164153390|NCT00473590|592923474|FG001|Overall Study|Death|2|||
164153391|NCT00473590|592923473|FG000|Overall Study|Progression not resulting in death|24|||
164153392|NCT00473590|592923474|FG001|Overall Study|Progression not resulting in death|20|||
164153393|NCT00473590|592923473|FG000|Overall Study|Non-protocol-specified therapy|7|||
164153394|NCT00473590|592923474|FG001|Overall Study|Non-protocol-specified therapy|5|||
164153395|NCT00473590|592923473|FG000|Overall Study|Physician Decision|2|||
164153396|NCT00473590|592923474|FG001|Overall Study|Physician Decision|4|||
164153397|NCT00473590|592923473|FG000|Overall Study|Withdrawal by Subject|5|||
164153398|NCT00473590|592923474|FG001|Overall Study|Withdrawal by Subject|3|||
164153399|NCT00473590|592923473|FG000|Overall Study|Other|0|||
164153400|NCT00473590|592923474|FG001|Overall Study|Other|1|||
164153401|NCT04199104|592925463|FG000|Overall Study|Death|148|||
164153402|NCT04199104|592925464|FG001|Overall Study|Death|134|||
164153403|NCT04199104|592925463|FG000|Overall Study|Lost to Follow-up|1|||
164153404|NCT04199104|592925464|FG001|Overall Study|Lost to Follow-up|1|||
164153405|NCT04199104|592925463|FG000|Overall Study|Withdrawal by Subject|4|||
164153406|NCT04199104|592925464|FG001|Overall Study|Withdrawal by Subject|4|||
164153407|NCT04199104|592925463|FG000|Overall Study|Participants Ongoing|103|||
164153408|NCT04199104|592925464|FG001|Overall Study|Participants Ongoing|116|||
164153409|NCT04023396|592925465|FG000|Overall Study|Adverse Event|16|||
164153410|NCT04023396|592925465|FG000|Overall Study|Death|1|||
164153411|NCT04023396|592925465|FG000|Overall Study|Lost to Follow-up|1|||
164153412|NCT04023396|592925465|FG000|Overall Study|Withdrawal by Subject|14|||
164153413|NCT04023396|592925465|FG000|Overall Study|Pregnancy|4|||
164153414|NCT04023396|592925465|FG000|Overall Study|Lack of Efficacy|3|||
164153415|NCT04023396|592925465|FG000|Overall Study|Physician Decision|4|||
164153416|NCT04023396|592925465|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
164153417|NCT04075825|592925470|FG000|Overall Study|Withdrawal by Subject|6|||
164153418|NCT04075825|592925471|FG001|Overall Study|Withdrawal by Subject|8|||
164153419|NCT04075825|592925470|FG000|Overall Study|Physician Decision|3|||
164153420|NCT04075825|592925471|FG001|Overall Study|Physician Decision|1|||
164153421|NCT04075825|592925470|FG000|Overall Study|Lost to Follow-up|5|||
164153422|NCT04075825|592925471|FG001|Overall Study|Lost to Follow-up|1|||
164153423|NCT04075825|592925470|FG000|Overall Study|Participation in New Clinical Trial|1|||
164153424|NCT04075825|592925471|FG001|Overall Study|Participation in New Clinical Trial|1|||
164153425|NCT04075825|592925470|FG000|Overall Study|Reason Not Specified|2|||
164153426|NCT04075825|592925471|FG001|Overall Study|Reason Not Specified|2|||
164153427|NCT01168232|592925472|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
164153428|NCT01168232|592925472|FG000|Overall Study|Ineligible- Wrong cell type|6|||
164153429|NCT01168232|592925472|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
164153430|NCT03879135|592925479|FG000|Overall Study|Physician Decision|0|||
164153431|NCT03879135|592925480|FG001|Overall Study|Physician Decision|0|||
164153432|NCT03879135|592925481|FG002|Overall Study|Physician Decision|0|||
164153433|NCT03879135|592925482|FG003|Overall Study|Physician Decision|1|||
164153434|NCT03879135|592925483|FG004|Overall Study|Physician Decision|0|||
164153435|NCT03879135|592925484|FG005|Overall Study|Physician Decision|0|||
164153436|NCT03879135|592925479|FG000|Overall Study|Withdrawal by Subject|0|||
164153437|NCT03879135|592925480|FG001|Overall Study|Withdrawal by Subject|0|||
164153438|NCT03879135|592925481|FG002|Overall Study|Withdrawal by Subject|0|||
164153439|NCT03879135|592925482|FG003|Overall Study|Withdrawal by Subject|0|||
164153440|NCT03879135|592925483|FG004|Overall Study|Withdrawal by Subject|0|||
164153441|NCT03879135|592925484|FG005|Overall Study|Withdrawal by Subject|1|||
164153442|NCT03879135|592925479|FG000|Overall Study|Site Closed by Sponsor|0|||
164153443|NCT03879135|592925480|FG001|Overall Study|Site Closed by Sponsor|0|||
164153444|NCT03879135|592925481|FG002|Overall Study|Site Closed by Sponsor|0|||
164153445|NCT03879135|592925482|FG003|Overall Study|Site Closed by Sponsor|1|||
164153446|NCT03879135|592925483|FG004|Overall Study|Site Closed by Sponsor|1|||
164153447|NCT03879135|592925484|FG005|Overall Study|Site Closed by Sponsor|0|||
164153448|NCT05201794|592925485|FG000|Overall Study|Withdrawal by Subject|13|||
164153449|NCT05201794|592925486|FG001|Overall Study|Withdrawal by Subject|12|||
164153450|NCT05201794|592925487|FG002|Overall Study|Withdrawal by Subject|14|||
164153451|NCT05201794|592925488|FG003|Overall Study|Withdrawal by Subject|0|||
164153452|NCT05201794|592925485|FG000|Overall Study|Adverse Event|5|||
164153453|NCT05201794|592925486|FG001|Overall Study|Adverse Event|5|||
164153454|NCT05201794|592925487|FG002|Overall Study|Adverse Event|4|||
164153455|NCT05201794|592925488|FG003|Overall Study|Adverse Event|0|||
164153456|NCT05201794|592925485|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
164153457|NCT05201794|592925486|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
164153458|NCT05201794|592925487|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
164153459|NCT05201794|592925488|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
164153460|NCT05201794|592925485|FG000|Overall Study|Non-Compliance With Study Drug|2|||
164153461|NCT05201794|592925486|FG001|Overall Study|Non-Compliance With Study Drug|3|||
164153462|NCT05201794|592925487|FG002|Overall Study|Non-Compliance With Study Drug|3|||
164153463|NCT05201794|592925488|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164153464|NCT05201794|592925485|FG000|Overall Study|Physician Decision|1|||
164153465|NCT05201794|592925486|FG001|Overall Study|Physician Decision|3|||
164153466|NCT05201794|592925487|FG002|Overall Study|Physician Decision|2|||
164153467|NCT05201794|592925488|FG003|Overall Study|Physician Decision|0|||
164153468|NCT05201794|592925485|FG000|Overall Study|Lost to Follow-up|2|||
164153469|NCT05201794|592925486|FG001|Overall Study|Lost to Follow-up|2|||
164153470|NCT05201794|592925487|FG002|Overall Study|Lost to Follow-up|0|||
164153471|NCT05201794|592925488|FG003|Overall Study|Lost to Follow-up|0|||
164153472|NCT05201794|592925485|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
164153473|NCT05201794|592925486|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
164153474|NCT05201794|592925487|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
164153475|NCT05201794|592925488|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
164153476|NCT05201794|592925485|FG000|Overall Study|Protocol Violation|2|||
164153477|NCT05201794|592925486|FG001|Overall Study|Protocol Violation|0|||
164153478|NCT05201794|592925487|FG002|Overall Study|Protocol Violation|1|||
164153479|NCT05201794|592925488|FG003|Overall Study|Protocol Violation|0|||
164153480|NCT05201794|592925485|FG000|Overall Study|Death|1|||
164153481|NCT05201794|592925486|FG001|Overall Study|Death|0|||
164153482|NCT05201794|592925487|FG002|Overall Study|Death|0|||
164153483|NCT05201794|592925488|FG003|Overall Study|Death|0|||
164153484|NCT05201794|592925485|FG000|Overall Study|Site Terminated By Sponsor|0|||
164153485|NCT05201794|592925486|FG001|Overall Study|Site Terminated By Sponsor|1|||
164153486|NCT05201794|592925487|FG002|Overall Study|Site Terminated By Sponsor|0|||
164153487|NCT05201794|592925488|FG003|Overall Study|Site Terminated By Sponsor|0|||
164153488|NCT05201794|592925485|FG000|Overall Study|Other|3|||
164153489|NCT05201794|592925486|FG001|Overall Study|Other|3|||
164153490|NCT05201794|592925487|FG002|Overall Study|Other|3|||
164153491|NCT05201794|592925488|FG003|Overall Study|Other|0|||
164153492|NCT05201794|592925485|FG000|Overall Study|Randomized But Not Treated|1|||
164153493|NCT05201794|592925486|FG001|Overall Study|Randomized But Not Treated|2|||
164153494|NCT05201794|592925487|FG002|Overall Study|Randomized But Not Treated|1|||
164153495|NCT05201794|592925488|FG003|Overall Study|Randomized But Not Treated|0|||
164153496|NCT03428958|592925489|FG000|Overall Study|Adverse Event|0|||
164153497|NCT03428958|592925490|FG001|Overall Study|Adverse Event|0|||
164153498|NCT03428958|592925491|FG002|Overall Study|Adverse Event|0|||
164153499|NCT03428958|592925492|FG003|Overall Study|Adverse Event|1|||
164153500|NCT03428958|592925493|FG004|Overall Study|Adverse Event|0|||
164153501|NCT03428958|592925494|FG005|Overall Study|Adverse Event|2|||
164153502|NCT03428958|592925495|FG006|Overall Study|Adverse Event|1|||
164153503|NCT03428958|592925496|FG007|Overall Study|Adverse Event|0|||
164153504|NCT03428958|592925497|FG008|Overall Study|Adverse Event|0|||
164153505|NCT03428958|592925498|FG009|Overall Study|Adverse Event|0|||
164153506|NCT03428958|592925499|FG010|Overall Study|Adverse Event|0|||
164153507|NCT03428958|592925500|FG011|Overall Study|Adverse Event|0|||
164153508|NCT03428958|592925501|FG012|Overall Study|Adverse Event|0|||
164153509|NCT03428958|592925502|FG013|Overall Study|Adverse Event|0|||
164153510|NCT03428958|592925503|FG014|Overall Study|Adverse Event|0|||
164153511|NCT03428958|592925504|FG015|Overall Study|Adverse Event|0|||
164153512|NCT03428958|592925505|FG016|Overall Study|Adverse Event|0|||
164153513|NCT03428958|592925489|FG000|Overall Study|Clinical Progression|2|||
164153514|NCT03428958|592925490|FG001|Overall Study|Clinical Progression|3|||
164153515|NCT03428958|592925491|FG002|Overall Study|Clinical Progression|2|||
164153516|NCT03428958|592925492|FG003|Overall Study|Clinical Progression|1|||
164153517|NCT03428958|592925493|FG004|Overall Study|Clinical Progression|0|||
164153518|NCT03428958|592925494|FG005|Overall Study|Clinical Progression|2|||
164153519|NCT03428958|592925495|FG006|Overall Study|Clinical Progression|0|||
164153520|NCT03428958|592925496|FG007|Overall Study|Clinical Progression|0|||
164153521|NCT03428958|592925497|FG008|Overall Study|Clinical Progression|0|||
164153522|NCT03428958|592925498|FG009|Overall Study|Clinical Progression|0|||
164153523|NCT03428958|592925499|FG010|Overall Study|Clinical Progression|0|||
164153524|NCT03428958|592925500|FG011|Overall Study|Clinical Progression|0|||
164153525|NCT03428958|592925501|FG012|Overall Study|Clinical Progression|0|||
164153526|NCT03428958|592925502|FG013|Overall Study|Clinical Progression|0|||
164153527|NCT03428958|592925503|FG014|Overall Study|Clinical Progression|0|||
164153528|NCT03428958|592925504|FG015|Overall Study|Clinical Progression|0|||
164153529|NCT03428958|592925505|FG016|Overall Study|Clinical Progression|0|||
164153530|NCT03428958|592925489|FG000|Overall Study|Progression per RECIST|6|||
164153531|NCT03428958|592925490|FG001|Overall Study|Progression per RECIST|6|||
164153532|NCT03428958|592925491|FG002|Overall Study|Progression per RECIST|7|||
164153533|NCT03428958|592925492|FG003|Overall Study|Progression per RECIST|4|||
164153534|NCT03428958|592925493|FG004|Overall Study|Progression per RECIST|0|||
164153535|NCT03428958|592925494|FG005|Overall Study|Progression per RECIST|7|||
164153536|NCT03428958|592925495|FG006|Overall Study|Progression per RECIST|8|||
164153537|NCT03428958|592925496|FG007|Overall Study|Progression per RECIST|0|||
164153538|NCT03428958|592925497|FG008|Overall Study|Progression per RECIST|0|||
164153539|NCT03428958|592925498|FG009|Overall Study|Progression per RECIST|0|||
164153540|NCT03428958|592925499|FG010|Overall Study|Progression per RECIST|0|||
164153541|NCT03428958|592925500|FG011|Overall Study|Progression per RECIST|0|||
164153542|NCT03428958|592925501|FG012|Overall Study|Progression per RECIST|1|||
164153543|NCT03428958|592925502|FG013|Overall Study|Progression per RECIST|0|||
164153544|NCT03428958|592925503|FG014|Overall Study|Progression per RECIST|0|||
164153545|NCT03428958|592925504|FG015|Overall Study|Progression per RECIST|0|||
164153546|NCT03428958|592925505|FG016|Overall Study|Progression per RECIST|0|||
164153547|NCT03428958|592925489|FG000|Overall Study|Death|2|||
164153548|NCT03428958|592925490|FG001|Overall Study|Death|2|||
164153549|NCT03428958|592925491|FG002|Overall Study|Death|0|||
164153550|NCT03428958|592925492|FG003|Overall Study|Death|0|||
164153551|NCT03428958|592925493|FG004|Overall Study|Death|0|||
164153552|NCT03428958|592925494|FG005|Overall Study|Death|7|||
164153553|NCT03428958|592925495|FG006|Overall Study|Death|9|||
164153554|NCT03428958|592925496|FG007|Overall Study|Death|6|||
164153555|NCT03428958|592925497|FG008|Overall Study|Death|0|||
164153556|NCT03428958|592925498|FG009|Overall Study|Death|0|||
164153557|NCT03428958|592925499|FG010|Overall Study|Death|3|||
164153558|NCT03428958|592925500|FG011|Overall Study|Death|0|||
164153559|NCT03428958|592925501|FG012|Overall Study|Death|4|||
164153560|NCT03428958|592925502|FG013|Overall Study|Death|0|||
164153561|NCT03428958|592925503|FG014|Overall Study|Death|0|||
164153562|NCT03428958|592925504|FG015|Overall Study|Death|0|||
164153563|NCT03428958|592925505|FG016|Overall Study|Death|0|||
164153564|NCT03428958|592925489|FG000|Overall Study|Lost to Follow-up|0|||
164153565|NCT03428958|592925490|FG001|Overall Study|Lost to Follow-up|0|||
164153566|NCT03428958|592925491|FG002|Overall Study|Lost to Follow-up|0|||
164153567|NCT03428958|592925492|FG003|Overall Study|Lost to Follow-up|0|||
164153568|NCT03428958|592925493|FG004|Overall Study|Lost to Follow-up|0|||
164153569|NCT03428958|592925494|FG005|Overall Study|Lost to Follow-up|1|||
164153570|NCT03428958|592925495|FG006|Overall Study|Lost to Follow-up|1|||
164153571|NCT03428958|592925496|FG007|Overall Study|Lost to Follow-up|0|||
164153572|NCT03428958|592925497|FG008|Overall Study|Lost to Follow-up|0|||
164153573|NCT03428958|592925498|FG009|Overall Study|Lost to Follow-up|0|||
164153574|NCT03428958|592925499|FG010|Overall Study|Lost to Follow-up|0|||
164153575|NCT03428958|592925500|FG011|Overall Study|Lost to Follow-up|0|||
164153576|NCT03428958|592925501|FG012|Overall Study|Lost to Follow-up|0|||
164153577|NCT03428958|592925502|FG013|Overall Study|Lost to Follow-up|0|||
164153578|NCT03428958|592925503|FG014|Overall Study|Lost to Follow-up|0|||
164153579|NCT03428958|592925504|FG015|Overall Study|Lost to Follow-up|0|||
164153580|NCT03428958|592925505|FG016|Overall Study|Lost to Follow-up|0|||
164153581|NCT03428958|592925489|FG000|Overall Study|Physician/Sponsor Decision|1|||
164153582|NCT03428958|592925490|FG001|Overall Study|Physician/Sponsor Decision|0|||
164153583|NCT03428958|592925491|FG002|Overall Study|Physician/Sponsor Decision|1|||
164153584|NCT03428958|592925492|FG003|Overall Study|Physician/Sponsor Decision|0|||
164153585|NCT03428958|592925493|FG004|Overall Study|Physician/Sponsor Decision|0|||
164153586|NCT03428958|592925494|FG005|Overall Study|Physician/Sponsor Decision|2|||
164153587|NCT03428958|592925495|FG006|Overall Study|Physician/Sponsor Decision|2|||
164153588|NCT03428958|592925496|FG007|Overall Study|Physician/Sponsor Decision|2|||
164153589|NCT03428958|592925497|FG008|Overall Study|Physician/Sponsor Decision|0|||
164153590|NCT03428958|592925498|FG009|Overall Study|Physician/Sponsor Decision|0|||
164153591|NCT03428958|592925499|FG010|Overall Study|Physician/Sponsor Decision|2|||
164153592|NCT03428958|592925500|FG011|Overall Study|Physician/Sponsor Decision|0|||
164153593|NCT03428958|592925501|FG012|Overall Study|Physician/Sponsor Decision|4|||
164153594|NCT03428958|592925502|FG013|Overall Study|Physician/Sponsor Decision|0|||
164153595|NCT03428958|592925503|FG014|Overall Study|Physician/Sponsor Decision|0|||
164153596|NCT03428958|592925504|FG015|Overall Study|Physician/Sponsor Decision|0|||
164153597|NCT03428958|592925505|FG016|Overall Study|Physician/Sponsor Decision|0|||
164153598|NCT03428958|592925489|FG000|Overall Study|Withdrawal by Subject|0|||
164153599|NCT03428958|592925490|FG001|Overall Study|Withdrawal by Subject|0|||
164153600|NCT03428958|592925491|FG002|Overall Study|Withdrawal by Subject|2|||
164153601|NCT03428958|592925492|FG003|Overall Study|Withdrawal by Subject|0|||
164153602|NCT03428958|592925493|FG004|Overall Study|Withdrawal by Subject|0|||
164153603|NCT03428958|592925494|FG005|Overall Study|Withdrawal by Subject|2|||
164153604|NCT03428958|592925495|FG006|Overall Study|Withdrawal by Subject|4|||
164153605|NCT03428958|592925496|FG007|Overall Study|Withdrawal by Subject|1|||
164153606|NCT03428958|592925497|FG008|Overall Study|Withdrawal by Subject|0|||
164153607|NCT03428958|592925498|FG009|Overall Study|Withdrawal by Subject|0|||
164153608|NCT03428958|592925499|FG010|Overall Study|Withdrawal by Subject|0|||
164153609|NCT03428958|592925500|FG011|Overall Study|Withdrawal by Subject|0|||
164153610|NCT03428958|592925501|FG012|Overall Study|Withdrawal by Subject|0|||
164153611|NCT03428958|592925502|FG013|Overall Study|Withdrawal by Subject|0|||
164153612|NCT03428958|592925503|FG014|Overall Study|Withdrawal by Subject|0|||
164153613|NCT03428958|592925504|FG015|Overall Study|Withdrawal by Subject|0|||
164153614|NCT03428958|592925505|FG016|Overall Study|Withdrawal by Subject|0|||
164153615|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
164153616|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
164153617|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
164153618|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
164153619|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164153620|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164153621|NCT03874117|592925506|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
164153622|NCT03874117|592925507|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
164153623|NCT03874117|592925506|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164153624|NCT03874117|592925507|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164153625|NCT04510090|592925508|FG000|FE-HS|Withdrawal by Subject|0|||
164153626|NCT04510090|592925509|FG001|FE-HS|Withdrawal by Subject|0|||
164153627|NCT04510090|592925510|FG002|FE-HS|Withdrawal by Subject|0|||
164153628|NCT04510090|592925511|FG003|FE-HS|Withdrawal by Subject|0|||
164153629|NCT04510090|592925512|FG004|FE-HS|Withdrawal by Subject|1|||
164153630|NCT04510090|592925513|FG005|FE-HS|Withdrawal by Subject|0|||
164153631|NCT04510090|592925514|FG006|FE-HS|Withdrawal by Subject|0|||
164153632|NCT04510090|592925515|FG007|FE-HS|Withdrawal by Subject|0|||
164153633|NCT01127256|592925516|FG000|Overall Study|Adverse Event|13|||
164153634|NCT01127256|592925517|FG001|Overall Study|Adverse Event|13|||
164153635|NCT01127256|592925516|FG000|Overall Study|Lack of Efficacy|4|||
164153636|NCT01127256|592925517|FG001|Overall Study|Lack of Efficacy|0|||
164153637|NCT01127256|592925516|FG000|Overall Study|Lost to Follow-up|16|||
164153638|NCT01127256|592925517|FG001|Overall Study|Lost to Follow-up|17|||
164153639|NCT01127256|592925516|FG000|Overall Study|Withdrawal by Subject|5|||
164153640|NCT01127256|592925517|FG001|Overall Study|Withdrawal by Subject|9|||
164153641|NCT01127256|592925516|FG000|Overall Study|Protocol Violation|1|||
164153642|NCT01127256|592925517|FG001|Overall Study|Protocol Violation|0|||
164153643|NCT03657797|592925520|FG000|Overall Study|Lost to Follow-up|0|||
164153644|NCT03657797|592925521|FG001|Overall Study|Lost to Follow-up|1|||
164153645|NCT03657797|592925522|FG002|Overall Study|Lost to Follow-up|1|||
164153646|NCT03657797|592925523|FG003|Overall Study|Lost to Follow-up|0|||
164153647|NCT03657797|592925520|FG000|Overall Study|Physician Decision|0|||
164153648|NCT03657797|592925521|FG001|Overall Study|Physician Decision|1|||
164153649|NCT03657797|592925522|FG002|Overall Study|Physician Decision|0|||
164153650|NCT03657797|592925523|FG003|Overall Study|Physician Decision|0|||
164153651|NCT03657797|592925520|FG000|Overall Study|Withdrawal by Subject|0|||
164153652|NCT03657797|592925521|FG001|Overall Study|Withdrawal by Subject|1|||
164153653|NCT03657797|592925522|FG002|Overall Study|Withdrawal by Subject|2|||
164153654|NCT03657797|592925523|FG003|Overall Study|Withdrawal by Subject|0|||
164153655|NCT03657797|592925520|FG000|Overall Study|Adverse Event|0|||
164153656|NCT03657797|592925521|FG001|Overall Study|Adverse Event|0|||
164153657|NCT03657797|592925522|FG002|Overall Study|Adverse Event|2|||
164153658|NCT03657797|592925523|FG003|Overall Study|Adverse Event|0|||
164153659|NCT00711243|592925524|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
164153660|NCT00711243|592925525|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
164153661|NCT00711243|592925526|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
164153662|NCT00711243|592925527|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
164153663|NCT00711243|592925528|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
164153664|NCT00711243|592925529|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
164153665|NCT00711243|592925524|FG000|Reached First Response/4 Cycles|Death|0|||
164153666|NCT00711243|592925525|FG001|Reached First Response/4 Cycles|Death|0|||
164153667|NCT00711243|592925526|FG002|Reached First Response/4 Cycles|Death|0|||
164153668|NCT00711243|592925527|FG003|Reached First Response/4 Cycles|Death|0|||
164153669|NCT00711243|592925528|FG004|Reached First Response/4 Cycles|Death|0|||
164153670|NCT00711243|592925529|FG005|Reached First Response/4 Cycles|Death|2|||
164153671|NCT00711243|592925524|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
164153672|NCT00711243|592925525|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
164153673|NCT00711243|592925526|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
164153674|NCT00711243|592925527|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
164153675|NCT00711243|592925528|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
164153676|NCT00711243|592925529|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
164153677|NCT00711243|592925524|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
164153678|NCT00711243|592925525|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
164153679|NCT00711243|592925526|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
164153680|NCT00711243|592925527|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
164153681|NCT00711243|592925528|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
164153682|NCT00711243|592925529|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
164153683|NCT00711243|592925524|FG000|Treated Cycle 5 After First Response|Death|0|||
164153684|NCT00711243|592925525|FG001|Treated Cycle 5 After First Response|Death|0|||
164153685|NCT00711243|592925526|FG002|Treated Cycle 5 After First Response|Death|0|||
164153686|NCT00711243|592925527|FG003|Treated Cycle 5 After First Response|Death|0|||
164153687|NCT00711243|592925528|FG004|Treated Cycle 5 After First Response|Death|0|||
164153688|NCT00711243|592925529|FG005|Treated Cycle 5 After First Response|Death|2|||
164153689|NCT00711243|592925524|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153690|NCT00711243|592925525|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153691|NCT00711243|592925526|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153692|NCT00711243|592925527|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153693|NCT00711243|592925528|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
164153694|NCT00711243|592925529|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
164153695|NCT00711243|592925524|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153696|NCT00711243|592925525|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153697|NCT00711243|592925526|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153698|NCT00711243|592925527|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153699|NCT00711243|592925528|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
164153700|NCT00711243|592925529|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
164153701|NCT01402570|592925532|FG000|Overall Study|Adverse Event|1|||
164153702|NCT03642262|592925533|FG000|Period 1|Withdrawal by Subject|1|||
164153703|NCT03642262|592925534|FG001|Period 1|Withdrawal by Subject|1|||
164153704|NCT03642262|592925533|FG000|Period 1|Adverse Event|0|||
164153705|NCT03642262|592925534|FG001|Period 1|Adverse Event|1|||
164153706|NCT02019472|592925535|FG000|Overall Study|Adverse Event|14|||
164153707|NCT02019472|592925536|FG001|Overall Study|Adverse Event|23|||
164153708|NCT02019472|592925537|FG002|Overall Study|Adverse Event|17|||
164153709|NCT02019472|592925535|FG000|Overall Study|Death|0|||
164153710|NCT02019472|592925536|FG001|Overall Study|Death|1|||
164153711|NCT02019472|592925537|FG002|Overall Study|Death|1|||
164153712|NCT02019472|592925535|FG000|Overall Study|Lack of Efficacy|7|||
164153713|NCT02019472|592925536|FG001|Overall Study|Lack of Efficacy|4|||
164153714|NCT02019472|592925537|FG002|Overall Study|Lack of Efficacy|4|||
164153715|NCT02019472|592925535|FG000|Overall Study|Lost to Follow-up|0|||
164153716|NCT02019472|592925536|FG001|Overall Study|Lost to Follow-up|2|||
164153717|NCT02019472|592925537|FG002|Overall Study|Lost to Follow-up|1|||
164153718|NCT02019472|592925535|FG000|Overall Study|Physician Decision|1|||
164153719|NCT02019472|592925536|FG001|Overall Study|Physician Decision|2|||
164153720|NCT02019472|592925537|FG002|Overall Study|Physician Decision|0|||
164153721|NCT02019472|592925535|FG000|Overall Study|Pregnancy|1|||
164153722|NCT02019472|592925536|FG001|Overall Study|Pregnancy|2|||
164153723|NCT02019472|592925537|FG002|Overall Study|Pregnancy|2|||
164153724|NCT02019472|592925535|FG000|Overall Study|Withdrawal by Subject|11|||
164153725|NCT02019472|592925536|FG001|Overall Study|Withdrawal by Subject|10|||
164153726|NCT02019472|592925537|FG002|Overall Study|Withdrawal by Subject|11|||
164153727|NCT02019472|592925535|FG000|Overall Study|Other|3|||
164153728|NCT02019472|592925536|FG001|Overall Study|Other|8|||
164153729|NCT02019472|592925537|FG002|Overall Study|Other|6|||
164153730|NCT00513695|592925540|FG000|Overall Study|Discontinued therapy|2|||
164153731|NCT00513695|592925540|FG000|Overall Study|Progression prior to surgery|3|||
164153732|NCT02157935|592925541|FG000|Overall Study|Withdrawal by Subject|25|||
164153733|NCT02157935|592925542|FG001|Overall Study|Withdrawal by Subject|39|||
164153734|NCT02157935|592925541|FG000|Overall Study|Screen failure|1|||
164153735|NCT02157935|592925542|FG001|Overall Study|Screen failure|2|||
164153736|NCT02157935|592925541|FG000|Overall Study|Protocol Violation|1|||
164153737|NCT02157935|592925542|FG001|Overall Study|Protocol Violation|0|||
164153738|NCT02157935|592925541|FG000|Overall Study|Progressive disease|0|||
164153739|NCT02157935|592925542|FG001|Overall Study|Progressive disease|2|||
164153740|NCT02157935|592925541|FG000|Overall Study|Other|5|||
164153741|NCT02157935|592925542|FG001|Overall Study|Other|12|||
164153742|NCT02157935|592925541|FG000|Overall Study|Lack of Efficacy|0|||
164153743|NCT02157935|592925542|FG001|Overall Study|Lack of Efficacy|1|||
164153744|NCT02157935|592925541|FG000|Overall Study|Death|4|||
164153745|NCT02157935|592925542|FG001|Overall Study|Death|4|||
164153746|NCT02157935|592925541|FG000|Overall Study|Adverse Event|3|||
164153747|NCT02157935|592925542|FG001|Overall Study|Adverse Event|5|||
164153748|NCT01417156|592925543|FG000|Overall Study|Adverse Event|12|||
164153749|NCT01417156|592925543|FG000|Overall Study|Protocol Violation|2|||
164153750|NCT03192488|592925544|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
164153751|NCT03192488|592925545|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
164153752|NCT03192488|592925546|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
164153753|NCT03192488|592925547|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
164153754|NCT03192488|592925548|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
164153755|NCT03192488|592925549|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
164153756|NCT03192488|592925544|FG000|Third Intervention (d1)|Adverse Event|0|||
164153757|NCT03192488|592925545|FG001|Third Intervention (d1)|Adverse Event|0|||
164153758|NCT03192488|592925546|FG002|Third Intervention (d1)|Adverse Event|0|||
164153759|NCT03192488|592925547|FG003|Third Intervention (d1)|Adverse Event|0|||
164153760|NCT03192488|592925548|FG004|Third Intervention (d1)|Adverse Event|1|||
164153761|NCT03192488|592925549|FG005|Third Intervention (d1)|Adverse Event|0|||
164153762|NCT04565145|592925551|FG000|Overall Study|Withdrawal by Subject|1|||
164153763|NCT04565145|592925552|FG001|Overall Study|Withdrawal by Subject|1|||
164153764|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
164153765|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
164153766|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
164153767|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
164153768|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
164153769|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
164153770|NCT02547428|592925553|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
164153771|NCT02547428|592925554|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
164153772|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
164153773|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
164153774|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
164153775|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
164153776|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
164153777|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
164153778|NCT02547428|592925553|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
164153779|NCT02547428|592925554|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
164153780|NCT00742209|592925567|FG000|Overall Study|Adverse Event|11|||
164153781|NCT00742209|592925568|FG001|Overall Study|Adverse Event|4|||
164153782|NCT00742209|592925569|FG002|Overall Study|Adverse Event|17|||
164153783|NCT00742209|592925570|FG003|Overall Study|Adverse Event|16|||
164153784|NCT00742209|592925571|FG004|Overall Study|Adverse Event|13|||
164153785|NCT00742209|592925567|FG000|Overall Study|Participant Withdrew Consent|8|||
164153786|NCT00742209|592925568|FG001|Overall Study|Participant Withdrew Consent|4|||
164153787|NCT00742209|592925569|FG002|Overall Study|Participant Withdrew Consent|14|||
164153788|NCT00742209|592925570|FG003|Overall Study|Participant Withdrew Consent|7|||
164153789|NCT00742209|592925571|FG004|Overall Study|Participant Withdrew Consent|4|||
164153790|NCT00742209|592925567|FG000|Overall Study|Protocol Violation|6|||
164153791|NCT00742209|592925568|FG001|Overall Study|Protocol Violation|5|||
164153792|NCT00742209|592925569|FG002|Overall Study|Protocol Violation|4|||
164153793|NCT00742209|592925570|FG003|Overall Study|Protocol Violation|5|||
164153794|NCT00742209|592925571|FG004|Overall Study|Protocol Violation|3|||
164153795|NCT00742209|592925567|FG000|Overall Study|Lost to Follow-up|3|||
164153796|NCT00742209|592925568|FG001|Overall Study|Lost to Follow-up|4|||
164153797|NCT00742209|592925569|FG002|Overall Study|Lost to Follow-up|5|||
164153798|NCT00742209|592925570|FG003|Overall Study|Lost to Follow-up|5|||
164153799|NCT00742209|592925571|FG004|Overall Study|Lost to Follow-up|3|||
164153800|NCT00742209|592925567|FG000|Overall Study|Lack of Efficacy|6|||
164153801|NCT00742209|592925568|FG001|Overall Study|Lack of Efficacy|1|||
164153802|NCT00742209|592925569|FG002|Overall Study|Lack of Efficacy|1|||
164153803|NCT00742209|592925570|FG003|Overall Study|Lack of Efficacy|3|||
164153804|NCT00742209|592925571|FG004|Overall Study|Lack of Efficacy|1|||
164153805|NCT00742209|592925567|FG000|Overall Study|Investigator Discretion|0|||
164153806|NCT00742209|592925568|FG001|Overall Study|Investigator Discretion|0|||
164153807|NCT00742209|592925569|FG002|Overall Study|Investigator Discretion|5|||
164153808|NCT00742209|592925570|FG003|Overall Study|Investigator Discretion|1|||
164153809|NCT00742209|592925571|FG004|Overall Study|Investigator Discretion|1|||
164153810|NCT02003209|592925572|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
164153811|NCT02003209|592925573|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
164153812|NCT00485264|592925576|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
164153813|NCT00485264|592925577|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
164153814|NCT00485264|592925578|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
164153815|NCT00485264|592925579|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
164153816|NCT00485264|592925580|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
164153817|NCT00485264|592925581|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
164153818|NCT00485264|592925576|FG000|Overall Study|Death|1|||
164153819|NCT00485264|592925577|FG001|Overall Study|Death|0|||
164153820|NCT00485264|592925578|FG002|Overall Study|Death|0|||
164153821|NCT00485264|592925579|FG003|Overall Study|Death|0|||
164153822|NCT00485264|592925580|FG004|Overall Study|Death|1|||
164153823|NCT00485264|592925581|FG005|Overall Study|Death|0|||
164153824|NCT00485264|592925576|FG000|Overall Study|Adverse Event|1|||
164153825|NCT00485264|592925577|FG001|Overall Study|Adverse Event|0|||
164153826|NCT00485264|592925578|FG002|Overall Study|Adverse Event|2|||
164153827|NCT00485264|592925579|FG003|Overall Study|Adverse Event|3|||
164153828|NCT00485264|592925580|FG004|Overall Study|Adverse Event|1|||
164153829|NCT00485264|592925581|FG005|Overall Study|Adverse Event|3|||
164153830|NCT00485264|592925576|FG000|Overall Study|Pregnancy|4|||
164153831|NCT00485264|592925577|FG001|Overall Study|Pregnancy|0|||
164153832|NCT00485264|592925578|FG002|Overall Study|Pregnancy|0|||
164153833|NCT00485264|592925579|FG003|Overall Study|Pregnancy|0|||
164153834|NCT00485264|592925580|FG004|Overall Study|Pregnancy|0|||
164153835|NCT00485264|592925581|FG005|Overall Study|Pregnancy|0|||
164153836|NCT00485264|592925576|FG000|Overall Study|Disallowed Medication|0|||
164153837|NCT00485264|592925577|FG001|Overall Study|Disallowed Medication|0|||
164153838|NCT00485264|592925578|FG002|Overall Study|Disallowed Medication|0|||
164153839|NCT00485264|592925579|FG003|Overall Study|Disallowed Medication|0|||
164153840|NCT00485264|592925580|FG004|Overall Study|Disallowed Medication|0|||
164153841|NCT00485264|592925581|FG005|Overall Study|Disallowed Medication|1|||
164153842|NCT00485264|592925576|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
164153843|NCT00485264|592925577|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
164153844|NCT00485264|592925578|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
164153845|NCT00485264|592925579|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
164153846|NCT00485264|592925580|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
164153847|NCT00485264|592925581|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
164153848|NCT00485264|592925576|FG000|Overall Study|Lack of Efficacy|0|||
164153849|NCT00485264|592925577|FG001|Overall Study|Lack of Efficacy|1|||
164153850|NCT00485264|592925578|FG002|Overall Study|Lack of Efficacy|0|||
164153851|NCT00485264|592925579|FG003|Overall Study|Lack of Efficacy|0|||
164153852|NCT00485264|592925580|FG004|Overall Study|Lack of Efficacy|0|||
164153853|NCT00485264|592925581|FG005|Overall Study|Lack of Efficacy|0|||
164153854|NCT00485264|592925576|FG000|Overall Study|Guardian Consent Withdrawn|1|||
164153855|NCT00485264|592925577|FG001|Overall Study|Guardian Consent Withdrawn|0|||
164153856|NCT00485264|592925578|FG002|Overall Study|Guardian Consent Withdrawn|0|||
164153857|NCT00485264|592925579|FG003|Overall Study|Guardian Consent Withdrawn|0|||
164153858|NCT00485264|592925580|FG004|Overall Study|Guardian Consent Withdrawn|1|||
164153859|NCT00485264|592925581|FG005|Overall Study|Guardian Consent Withdrawn|0|||
164153860|NCT00485264|592925576|FG000|Overall Study|Physician Decision|0|||
164153861|NCT00485264|592925577|FG001|Overall Study|Physician Decision|2|||
164153862|NCT00485264|592925578|FG002|Overall Study|Physician Decision|0|||
164153863|NCT00485264|592925579|FG003|Overall Study|Physician Decision|0|||
164153864|NCT00485264|592925580|FG004|Overall Study|Physician Decision|0|||
164153865|NCT00485264|592925581|FG005|Overall Study|Physician Decision|0|||
164153866|NCT00485264|592925576|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153867|NCT00485264|592925577|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153868|NCT00485264|592925578|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
164153869|NCT00485264|592925579|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153870|NCT00485264|592925580|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153871|NCT00485264|592925581|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
164153872|NCT00485264|592925576|FG000|Overall Study|Not Able to Attend Clinic|5|||
164153873|NCT00485264|592925577|FG001|Overall Study|Not Able to Attend Clinic|0|||
164153874|NCT00485264|592925578|FG002|Overall Study|Not Able to Attend Clinic|0|||
164153875|NCT00485264|592925579|FG003|Overall Study|Not Able to Attend Clinic|1|||
164153876|NCT00485264|592925580|FG004|Overall Study|Not Able to Attend Clinic|1|||
164153877|NCT00485264|592925581|FG005|Overall Study|Not Able to Attend Clinic|2|||
164153878|NCT00485264|592925576|FG000|Overall Study|Non-Compliant|17|||
164153879|NCT00485264|592925577|FG001|Overall Study|Non-Compliant|2|||
164153880|NCT00485264|592925578|FG002|Overall Study|Non-Compliant|1|||
164153881|NCT00485264|592925579|FG003|Overall Study|Non-Compliant|0|||
164153882|NCT00485264|592925580|FG004|Overall Study|Non-Compliant|1|||
164153883|NCT00485264|592925581|FG005|Overall Study|Non-Compliant|0|||
164153884|NCT00485264|592925576|FG000|Overall Study|Lost to Follow-up|2|||
164153885|NCT00485264|592925577|FG001|Overall Study|Lost to Follow-up|1|||
164153886|NCT00485264|592925578|FG002|Overall Study|Lost to Follow-up|1|||
164153887|NCT00485264|592925579|FG003|Overall Study|Lost to Follow-up|0|||
164153888|NCT00485264|592925580|FG004|Overall Study|Lost to Follow-up|0|||
164153889|NCT00485264|592925581|FG005|Overall Study|Lost to Follow-up|1|||
164153890|NCT00485264|592925576|FG000|Overall Study|Other Reason|3|||
164153891|NCT00485264|592925577|FG001|Overall Study|Other Reason|0|||
164153892|NCT00485264|592925578|FG002|Overall Study|Other Reason|0|||
164153893|NCT00485264|592925579|FG003|Overall Study|Other Reason|0|||
164153894|NCT00485264|592925580|FG004|Overall Study|Other Reason|0|||
164153895|NCT00485264|592925581|FG005|Overall Study|Other Reason|0|||
164153896|NCT01514461|592925582|FG000|Overall Study|Adverse Event|2|||
164153897|NCT01514461|592925583|FG001|Overall Study|Adverse Event|1|||
164153898|NCT01514461|592925584|FG002|Overall Study|Adverse Event|3|||
164153899|NCT01514461|592925582|FG000|Overall Study|Physician Decision|1|||
164153900|NCT01514461|592925583|FG001|Overall Study|Physician Decision|1|||
164153901|NCT01514461|592925584|FG002|Overall Study|Physician Decision|0|||
164153902|NCT01514461|592925582|FG000|Overall Study|Patient/guardian decision|1|||
164153903|NCT01514461|592925583|FG001|Overall Study|Patient/guardian decision|1|||
164153904|NCT01514461|592925584|FG002|Overall Study|Patient/guardian decision|1|||
164153905|NCT01514461|592925582|FG000|Overall Study|Death|1|||
164153906|NCT01514461|592925583|FG001|Overall Study|Death|0|||
164153907|NCT01514461|592925584|FG002|Overall Study|Death|0|||
164153908|NCT02548832|592925585|FG000|Overall Study|Lost to Follow-up|2|||
164153909|NCT02548832|592925586|FG001|Overall Study|Lost to Follow-up|2|||
164153910|NCT02548832|592925587|FG002|Overall Study|Lost to Follow-up|2|||
164153911|NCT03565900|592925588|FG000|Overall Study|Disposition Unknown|4|||
164153912|NCT03565900|592925589|FG001|Overall Study|Disposition Unknown|1|||
164153913|NCT03565900|592925588|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164153914|NCT03565900|592925589|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
164153915|NCT03565900|592925588|FG000|Overall Study|Withdrawal by Subject|4|||
164153916|NCT03565900|592925589|FG001|Overall Study|Withdrawal by Subject|5|||
164153917|NCT03565900|592925588|FG000|Overall Study|Randomized By Mistake|0|||
164153918|NCT03565900|592925589|FG001|Overall Study|Randomized By Mistake|2|||
164153919|NCT03565900|592925588|FG000|Overall Study|Physician Decision|7|||
164153920|NCT03565900|592925589|FG001|Overall Study|Physician Decision|11|||
164153921|NCT03565900|592925588|FG000|Overall Study|Death|9|||
164153922|NCT03565900|592925589|FG001|Overall Study|Death|7|||
164153923|NCT01037218|592925590|FG000|Overall Study|Adverse Event|4|||
164153924|NCT01037218|592925591|FG001|Overall Study|Adverse Event|2|||
164153925|NCT01037218|592925592|FG002|Overall Study|Adverse Event|2|||
164153926|NCT01037218|592925593|FG003|Overall Study|Adverse Event|1|||
164153927|NCT01037218|592925590|FG000|Overall Study|Lack of Efficacy|0|||
164153928|NCT01037218|592925591|FG001|Overall Study|Lack of Efficacy|2|||
164153929|NCT01037218|592925592|FG002|Overall Study|Lack of Efficacy|1|||
164153930|NCT01037218|592925593|FG003|Overall Study|Lack of Efficacy|5|||
164153931|NCT01037218|592925590|FG000|Overall Study|Lost to Follow-up|3|||
164153932|NCT01037218|592925591|FG001|Overall Study|Lost to Follow-up|5|||
164153933|NCT01037218|592925592|FG002|Overall Study|Lost to Follow-up|4|||
164153934|NCT01037218|592925593|FG003|Overall Study|Lost to Follow-up|2|||
164153935|NCT01037218|592925590|FG000|Overall Study|Withdrawal by Subject|6|||
164153936|NCT01037218|592925591|FG001|Overall Study|Withdrawal by Subject|7|||
164153937|NCT01037218|592925592|FG002|Overall Study|Withdrawal by Subject|7|||
164153938|NCT01037218|592925593|FG003|Overall Study|Withdrawal by Subject|4|||
164153939|NCT01037218|592925590|FG000|Overall Study|Partner Withdrew Consent|0|||
164153940|NCT01037218|592925591|FG001|Overall Study|Partner Withdrew Consent|3|||
164153941|NCT01037218|592925592|FG002|Overall Study|Partner Withdrew Consent|2|||
164153942|NCT01037218|592925593|FG003|Overall Study|Partner Withdrew Consent|1|||
164153943|NCT01037218|592925590|FG000|Overall Study|Protocol Violation|0|||
164153944|NCT01037218|592925591|FG001|Overall Study|Protocol Violation|0|||
164153945|NCT01037218|592925592|FG002|Overall Study|Protocol Violation|2|||
164153946|NCT01037218|592925593|FG003|Overall Study|Protocol Violation|2|||
164153947|NCT01037218|592925590|FG000|Overall Study|Various|3|||
164153948|NCT01037218|592925591|FG001|Overall Study|Various|2|||
164153949|NCT01037218|592925592|FG002|Overall Study|Various|3|||
164153950|NCT01037218|592925593|FG003|Overall Study|Various|1|||
164153951|NCT00513240|592925594|FG000|Overall Study|Did not have intended surgery|3|||
164153952|NCT00513240|592925595|FG001|Overall Study|Did not have intended surgery|0|||
164153953|NCT00513240|592925594|FG000|Overall Study|Death|3|||
164153954|NCT00513240|592925595|FG001|Overall Study|Death|3|||
164153955|NCT00513240|592925594|FG000|Overall Study|Withdrawal by Subject|7|||
164153956|NCT00513240|592925595|FG001|Overall Study|Withdrawal by Subject|4|||
164153957|NCT01113892|592925601|FG000|Overall Study|Lost to Follow-up|2|||
164153958|NCT01113892|592925602|FG001|Overall Study|Lost to Follow-up|2|||
164153959|NCT01113892|592925601|FG000|Overall Study|Withdrawal by Subject|1|||
164153960|NCT01113892|592925602|FG001|Overall Study|Withdrawal by Subject|1|||
164153961|NCT01113892|592925601|FG000|Overall Study|Death|2|||
164153962|NCT01113892|592925602|FG001|Overall Study|Death|4|||
164153963|NCT01113892|592925601|FG000|Overall Study|Graft no longer evaluable|9|||
164153964|NCT01113892|592925602|FG001|Overall Study|Graft no longer evaluable|9|||
164153965|NCT00789854|592925603|FG000|Overall Study|Adverse Event|28|||
164153966|NCT00789854|592925604|FG001|Overall Study|Adverse Event|23|||
164153967|NCT00789854|592925605|FG002|Overall Study|Adverse Event|18|||
164153968|NCT00789854|592925603|FG000|Overall Study|Lost to Follow-up|1|||
164153969|NCT00789854|592925604|FG001|Overall Study|Lost to Follow-up|1|||
164153970|NCT00789854|592925605|FG002|Overall Study|Lost to Follow-up|4|||
164153971|NCT00789854|592925603|FG000|Overall Study|Withdrawal by Subject|9|||
164153972|NCT00789854|592925604|FG001|Overall Study|Withdrawal by Subject|6|||
164153973|NCT00789854|592925605|FG002|Overall Study|Withdrawal by Subject|17|||
164153974|NCT00789854|592925603|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164153975|NCT00789854|592925604|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
164153976|NCT00789854|592925605|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
164153977|NCT00789854|592925603|FG000|Overall Study|Severe non-compliance to the protocol|3|||
164153978|NCT00789854|592925604|FG001|Overall Study|Severe non-compliance to the protocol|0|||
164153979|NCT00789854|592925605|FG002|Overall Study|Severe non-compliance to the protocol|0|||
164153980|NCT00789854|592925603|FG000|Overall Study|Safety reasons|0|||
164153981|NCT00789854|592925604|FG001|Overall Study|Safety reasons|0|||
164153982|NCT00789854|592925605|FG002|Overall Study|Safety reasons|2|||
164153983|NCT00789854|592925603|FG000|Overall Study|Other|6|||
164153984|NCT00789854|592925604|FG001|Overall Study|Other|0|||
164153985|NCT00789854|592925605|FG002|Overall Study|Other|5|||
164153986|NCT03473925|592925606|FG000|Overall Study|Death|48|||
164153987|NCT03473925|592925607|FG001|Overall Study|Death|44|||
164153988|NCT03473925|592925606|FG000|Overall Study|Sponsor Decision|2|||
164153989|NCT03473925|592925607|FG001|Overall Study|Sponsor Decision|7|||
164153990|NCT03473925|592925606|FG000|Overall Study|Withdrawal by Subject|1|||
164153991|NCT03473925|592925607|FG001|Overall Study|Withdrawal by Subject|3|||
164153992|NCT03473925|592925606|FG000|Overall Study|Not Treated|1|||
164153993|NCT03473925|592925607|FG001|Overall Study|Not Treated|1|||
164153994|NCT02756611|592925609|FG000|Overall Study|Death|70|||
164153995|NCT02756611|592925609|FG000|Overall Study|Withdrawal by Subject|2|||
164153996|NCT02756611|592925609|FG000|Overall Study|Lost to Follow-up|3|||
164153997|NCT02756611|592925609|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
164153998|NCT02756611|592925609|FG000|Overall Study|Other|10|||
164153999|NCT03125798|592925610|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
164154000|NCT03125798|592925611|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
164154001|NCT03125798|592925610|FG000|Overall Study|Conversion to thoracotomy|7|||
164154002|NCT03125798|592925611|FG001|Overall Study|Conversion to thoracotomy|7|||
164154003|NCT01949662|592925614|FG000|Overall Study|Death|9|||
164154004|NCT01949662|592925615|FG001|Overall Study|Death|7|||
164154005|NCT01949662|592925614|FG000|Overall Study|Discharged before an agitation event|8|||
164154006|NCT01949662|592925615|FG001|Overall Study|Discharged before an agitation event|3|||
164154007|NCT01949662|592925614|FG000|Overall Study|Dropped out|1|||
164154008|NCT01949662|592925615|FG001|Overall Study|Dropped out|3|||
164154009|NCT01949662|592925614|FG000|Overall Study|Ineligible|0|||
164154010|NCT01949662|592925615|FG001|Overall Study|Ineligible|1|||
164154011|NCT02291237|592925616|FG000|Overall Study|Study Terminated by Sponsor|72|||
164154012|NCT02291237|592925617|FG001|Overall Study|Study Terminated by Sponsor|67|||
164154013|NCT02291237|592925616|FG000|Overall Study|Adverse Event|1|||
164154014|NCT02291237|592925617|FG001|Overall Study|Adverse Event|3|||
164154015|NCT02291237|592925616|FG000|Overall Study|Investigator's Discretion|0|||
164154016|NCT02291237|592925617|FG001|Overall Study|Investigator's Discretion|3|||
164154017|NCT02291237|592925616|FG000|Overall Study|Withdrew Consent|11|||
164154018|NCT02291237|592925617|FG001|Overall Study|Withdrew Consent|11|||
164154019|NCT02291237|592925616|FG000|Overall Study|Lost to Follow-up|0|||
164154020|NCT02291237|592925617|FG001|Overall Study|Lost to Follow-up|2|||
164154021|NCT02291237|592925616|FG000|Overall Study|Subject Required Prohibited Medication|2|||
164154022|NCT02291237|592925617|FG001|Overall Study|Subject Required Prohibited Medication|0|||
164154023|NCT00456300|592925620|FG000|Overall Study|Adverse Event|1|||
164154024|NCT00456300|592925621|FG001|Overall Study|Adverse Event|0|||
164154025|NCT02586155|592925635|FG000|Overall Study|Adverse Event|2|||
164154026|NCT02586155|592925636|FG001|Overall Study|Adverse Event|3|||
164154027|NCT02586155|592925635|FG000|Overall Study|Withdrawal by Subject|31|||
164154028|NCT02586155|592925636|FG001|Overall Study|Withdrawal by Subject|24|||
164154029|NCT02586155|592925635|FG000|Overall Study|Lost to Follow-up|7|||
164154030|NCT02586155|592925636|FG001|Overall Study|Lost to Follow-up|13|||
164154031|NCT02586155|592925635|FG000|Overall Study|Death|61|||
164154032|NCT02586155|592925636|FG001|Overall Study|Death|72|||
164154033|NCT02586155|592925635|FG000|Overall Study|Other reasons|26|||
164154034|NCT02586155|592925636|FG001|Overall Study|Other reasons|15|||
164154035|NCT01522456|592925637|FG000|Overall Study|Adverse Event|2|||
164154036|NCT01522456|592925637|FG000|Overall Study|Lost to Follow-up|2|||
164154037|NCT01522456|592925637|FG000|Overall Study|Withdrawal by Subject|2|||
164154038|NCT01522456|592925637|FG000|Overall Study|Pregnancy|1|||
164154039|NCT01522456|592925637|FG000|Overall Study|Tolerability Assessment|1|||
164154040|NCT02072980|592925638|FG000|Period 2, Second Wear|Adverse Event|0|||
164154041|NCT02072980|592925639|FG001|Period 2, Second Wear|Adverse Event|1|||
164154042|NCT00916383|592925640|FG000|Overall Study|Adverse Event|1|||
164154043|NCT00916383|592925640|FG000|Overall Study|Death|1|||
164154044|NCT00916383|592925640|FG000|Overall Study|Protocol Violation|1|||
164154045|NCT02899962|592925641|FG000|Open-label Phase|Adverse Event|2|||
164154046|NCT02899962|592925642|FG001|Open-label Phase|Adverse Event|0|||
164154047|NCT02899962|592925643|FG002|Open-label Phase|Adverse Event|0|||
164154048|NCT02899962|592925641|FG000|Open-label Phase|Lost to Follow-up|9|||
164154049|NCT02899962|592925642|FG001|Open-label Phase|Lost to Follow-up|0|||
164154050|NCT02899962|592925643|FG002|Open-label Phase|Lost to Follow-up|0|||
164154051|NCT02899962|592925641|FG000|Open-label Phase|Other reasons|9|||
164154052|NCT02899962|592925642|FG001|Open-label Phase|Other reasons|0|||
164154053|NCT02899962|592925643|FG002|Open-label Phase|Other reasons|0|||
164154054|NCT02899962|592925641|FG000|Open-label Phase|Withdrawal by Subject|7|||
164154055|NCT02899962|592925642|FG001|Open-label Phase|Withdrawal by Subject|0|||
164154056|NCT02899962|592925643|FG002|Open-label Phase|Withdrawal by Subject|0|||
164154057|NCT02899962|592925641|FG000|Maintenance Phase|Adverse Event|0|||
164154058|NCT02899962|592925642|FG001|Maintenance Phase|Adverse Event|2|||
164154059|NCT02899962|592925643|FG002|Maintenance Phase|Adverse Event|1|||
164154060|NCT02899962|592925641|FG000|Maintenance Phase|Death|0|||
164154061|NCT02899962|592925642|FG001|Maintenance Phase|Death|0|||
164154062|NCT02899962|592925643|FG002|Maintenance Phase|Death|1|||
164154063|NCT02899962|592925641|FG000|Maintenance Phase|Lack of Efficacy|0|||
164154064|NCT02899962|592925642|FG001|Maintenance Phase|Lack of Efficacy|20|||
164154065|NCT02899962|592925643|FG002|Maintenance Phase|Lack of Efficacy|16|||
164154066|NCT02899962|592925641|FG000|Maintenance Phase|Lost to Follow-up|0|||
164154067|NCT02899962|592925642|FG001|Maintenance Phase|Lost to Follow-up|12|||
164154068|NCT02899962|592925643|FG002|Maintenance Phase|Lost to Follow-up|14|||
164154069|NCT02899962|592925641|FG000|Maintenance Phase|Other reasons|0|||
164154070|NCT02899962|592925642|FG001|Maintenance Phase|Other reasons|9|||
164154071|NCT02899962|592925643|FG002|Maintenance Phase|Other reasons|13|||
164154072|NCT02899962|592925641|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
164154073|NCT02899962|592925642|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
164154074|NCT02899962|592925643|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
164154075|NCT02899962|592925641|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
164154076|NCT02899962|592925642|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
164154077|NCT02899962|592925643|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
164154078|NCT02899962|592925641|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164154079|NCT02899962|592925642|FG001|Maintenance Phase|Withdrawal by Subject|30|||
164154080|NCT02899962|592925643|FG002|Maintenance Phase|Withdrawal by Subject|36|||
164154081|NCT02601014|592925646|FG000|Overall Study|Adverse Event|3|||
164154082|NCT02601014|592925647|FG001|Overall Study|Adverse Event|3|||
164154083|NCT02601014|592925646|FG000|Overall Study|Death|3|||
164154084|NCT02601014|592925647|FG001|Overall Study|Death|1|||
164154085|NCT02601014|592925646|FG000|Overall Study|Disease progression|4|||
164154086|NCT02601014|592925647|FG001|Overall Study|Disease progression|8|||
164154087|NCT02623725|592925649|FG000|Overall Study|Non compliance with protocol|9|||
164154088|NCT02623725|592925650|FG001|Overall Study|Non compliance with protocol|3|||
164154089|NCT02623725|592925649|FG000|Overall Study|Serious adverse event|0|||
164154090|NCT02623725|592925650|FG001|Overall Study|Serious adverse event|2|||
164154091|NCT02623725|592925649|FG000|Overall Study|Withdrawal by Subject|7|||
164154092|NCT02623725|592925650|FG001|Overall Study|Withdrawal by Subject|1|||
164154093|NCT03918629|592925651|FG000|Overall Study|Adverse Event|19|||
164154094|NCT03918629|592925652|FG001|Overall Study|Adverse Event|20|||
164154095|NCT03918629|592925651|FG000|Overall Study|Death|14|||
164154096|NCT03918629|592925652|FG001|Overall Study|Death|7|||
164154097|NCT03918629|592925651|FG000|Overall Study|Lost to Follow-up|36|||
164154098|NCT03918629|592925652|FG001|Overall Study|Lost to Follow-up|28|||
164154099|NCT03918629|592925651|FG000|Overall Study|Physician Decision|1|||
164154100|NCT03918629|592925652|FG001|Overall Study|Physician Decision|0|||
164154101|NCT03918629|592925651|FG000|Overall Study|Protocol Violation|7|||
164154102|NCT03918629|592925652|FG001|Overall Study|Protocol Violation|4|||
164154103|NCT03918629|592925651|FG000|Overall Study|Withdrawal by Subject|47|||
164154104|NCT03918629|592925652|FG001|Overall Study|Withdrawal by Subject|47|||
164154105|NCT03918629|592925651|FG000|Overall Study|Other|7|||
164154106|NCT03918629|592925652|FG001|Overall Study|Other|11|||
164154107|NCT03918629|592925651|FG000|Overall Study|Randomized but not vaccinated|2|||
164154108|NCT03918629|592925652|FG001|Overall Study|Randomized but not vaccinated|1|||
164154109|NCT01891864|592925654|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
164154110|NCT01891864|592925655|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
164154111|NCT01891864|592925656|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154112|NCT01891864|592925657|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154113|NCT01891864|592925658|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154114|NCT01891864|592925659|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
164154115|NCT01891864|592925654|FG000|Treatment Period 1|Physician Decision|0|||
164154116|NCT01891864|592925655|FG001|Treatment Period 1|Physician Decision|1|||
164154117|NCT01891864|592925656|FG002|Treatment Period 1|Physician Decision|0|||
164154118|NCT01891864|592925657|FG003|Treatment Period 1|Physician Decision|0|||
164154119|NCT01891864|592925658|FG004|Treatment Period 1|Physician Decision|0|||
164154120|NCT01891864|592925659|FG005|Treatment Period 1|Physician Decision|0|||
164154121|NCT01891864|592925654|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154122|NCT01891864|592925655|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
164154123|NCT01891864|592925656|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154124|NCT01891864|592925657|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154125|NCT01891864|592925658|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154126|NCT01891864|592925659|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
164154127|NCT01891864|592925654|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
164154128|NCT01891864|592925655|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
164154129|NCT01891864|592925656|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154130|NCT01891864|592925657|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154131|NCT01891864|592925658|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154132|NCT01891864|592925659|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
164154133|NCT01891864|592925654|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164154134|NCT01891864|592925655|FG001|Treatment Period 1|Withdrawal by Subject|5|||
164154135|NCT01891864|592925656|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164154136|NCT01891864|592925657|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164154137|NCT01891864|592925658|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164154138|NCT01891864|592925659|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164154139|NCT01891864|592925654|FG000|Treatment Period 1|Lost to Follow-up|1|||
164154140|NCT01891864|592925655|FG001|Treatment Period 1|Lost to Follow-up|0|||
164154141|NCT01891864|592925656|FG002|Treatment Period 1|Lost to Follow-up|0|||
164154142|NCT01891864|592925657|FG003|Treatment Period 1|Lost to Follow-up|0|||
164154143|NCT01891864|592925658|FG004|Treatment Period 1|Lost to Follow-up|0|||
164154144|NCT01891864|592925659|FG005|Treatment Period 1|Lost to Follow-up|0|||
164154145|NCT01891864|592925654|FG000|Treatment Period 2|Protocol Violation|0|||
164154146|NCT01891864|592925655|FG001|Treatment Period 2|Protocol Violation|0|||
164154147|NCT01891864|592925656|FG002|Treatment Period 2|Protocol Violation|0|||
164154148|NCT01891864|592925657|FG003|Treatment Period 2|Protocol Violation|1|||
164154149|NCT01891864|592925658|FG004|Treatment Period 2|Protocol Violation|0|||
164154150|NCT01891864|592925659|FG005|Treatment Period 2|Protocol Violation|0|||
164154151|NCT01891864|592925654|FG000|Treatment Period 2|Physician Decision|0|||
164154152|NCT01891864|592925655|FG001|Treatment Period 2|Physician Decision|0|||
164154153|NCT01891864|592925656|FG002|Treatment Period 2|Physician Decision|1|||
164154154|NCT01891864|592925657|FG003|Treatment Period 2|Physician Decision|0|||
164154155|NCT01891864|592925658|FG004|Treatment Period 2|Physician Decision|0|||
164154156|NCT01891864|592925659|FG005|Treatment Period 2|Physician Decision|0|||
164154157|NCT01891864|592925654|FG000|Treatment Period 2|Site Termination|0|||
164154158|NCT01891864|592925655|FG001|Treatment Period 2|Site Termination|0|||
164154159|NCT01891864|592925656|FG002|Treatment Period 2|Site Termination|1|||
164154160|NCT01891864|592925657|FG003|Treatment Period 2|Site Termination|2|||
164154161|NCT01891864|592925658|FG004|Treatment Period 2|Site Termination|0|||
164154162|NCT01891864|592925659|FG005|Treatment Period 2|Site Termination|0|||
164154163|NCT01891864|592925654|FG000|Treatment Period 2|Lack of Efficacy|0|||
164154164|NCT01891864|592925655|FG001|Treatment Period 2|Lack of Efficacy|0|||
164154165|NCT01891864|592925656|FG002|Treatment Period 2|Lack of Efficacy|1|||
164154166|NCT01891864|592925657|FG003|Treatment Period 2|Lack of Efficacy|0|||
164154167|NCT01891864|592925658|FG004|Treatment Period 2|Lack of Efficacy|1|||
164154168|NCT01891864|592925659|FG005|Treatment Period 2|Lack of Efficacy|0|||
164154169|NCT01891864|592925654|FG000|Treatment Period 2|Adverse Event|0|||
164154170|NCT01891864|592925655|FG001|Treatment Period 2|Adverse Event|0|||
164154171|NCT01891864|592925656|FG002|Treatment Period 2|Adverse Event|1|||
164154172|NCT01891864|592925657|FG003|Treatment Period 2|Adverse Event|2|||
164154173|NCT01891864|592925658|FG004|Treatment Period 2|Adverse Event|0|||
164154174|NCT01891864|592925659|FG005|Treatment Period 2|Adverse Event|4|||
164154175|NCT01891864|592925654|FG000|Treatment Period 2|Termination of Site|0|||
164154176|NCT01891864|592925655|FG001|Treatment Period 2|Termination of Site|0|||
164154177|NCT01891864|592925656|FG002|Treatment Period 2|Termination of Site|0|||
164154178|NCT01891864|592925657|FG003|Treatment Period 2|Termination of Site|0|||
164154179|NCT01891864|592925658|FG004|Treatment Period 2|Termination of Site|2|||
164154180|NCT01891864|592925659|FG005|Treatment Period 2|Termination of Site|0|||
164154181|NCT01891864|592925654|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164154182|NCT01891864|592925655|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164154183|NCT01891864|592925656|FG002|Treatment Period 2|Withdrawal by Subject|3|||
164154184|NCT01891864|592925657|FG003|Treatment Period 2|Withdrawal by Subject|4|||
164154185|NCT01891864|592925658|FG004|Treatment Period 2|Withdrawal by Subject|1|||
164154186|NCT01891864|592925659|FG005|Treatment Period 2|Withdrawal by Subject|1|||
164154187|NCT01891864|592925654|FG000|Extension Period|Lack of Efficacy|0|||
164154188|NCT01891864|592925655|FG001|Extension Period|Lack of Efficacy|0|||
164154189|NCT01891864|592925656|FG002|Extension Period|Lack of Efficacy|0|||
164154190|NCT01891864|592925657|FG003|Extension Period|Lack of Efficacy|1|||
164154191|NCT01891864|592925658|FG004|Extension Period|Lack of Efficacy|1|||
164154192|NCT01891864|592925659|FG005|Extension Period|Lack of Efficacy|0|||
164154193|NCT01891864|592925654|FG000|Extension Period|Pregnancy|0|||
164154194|NCT01891864|592925655|FG001|Extension Period|Pregnancy|0|||
164154195|NCT01891864|592925656|FG002|Extension Period|Pregnancy|1|||
164154196|NCT01891864|592925657|FG003|Extension Period|Pregnancy|0|||
164154197|NCT01891864|592925658|FG004|Extension Period|Pregnancy|0|||
164154198|NCT01891864|592925659|FG005|Extension Period|Pregnancy|0|||
164154199|NCT01891864|592925654|FG000|Extension Period|Adverse Event|0|||
164154200|NCT01891864|592925655|FG001|Extension Period|Adverse Event|0|||
164154201|NCT01891864|592925656|FG002|Extension Period|Adverse Event|4|||
164154202|NCT01891864|592925657|FG003|Extension Period|Adverse Event|2|||
164154203|NCT01891864|592925658|FG004|Extension Period|Adverse Event|2|||
164154204|NCT01891864|592925659|FG005|Extension Period|Adverse Event|0|||
164154205|NCT01891864|592925654|FG000|Extension Period|Withdrawal by Subject|0|||
164154206|NCT01891864|592925655|FG001|Extension Period|Withdrawal by Subject|0|||
164154207|NCT01891864|592925656|FG002|Extension Period|Withdrawal by Subject|1|||
164154208|NCT01891864|592925657|FG003|Extension Period|Withdrawal by Subject|2|||
164154209|NCT01891864|592925658|FG004|Extension Period|Withdrawal by Subject|4|||
164154210|NCT01891864|592925659|FG005|Extension Period|Withdrawal by Subject|0|||
164154211|NCT01891864|592925654|FG000|Extension Period|Lost to Follow-up|0|||
164154212|NCT01891864|592925655|FG001|Extension Period|Lost to Follow-up|0|||
164154213|NCT01891864|592925656|FG002|Extension Period|Lost to Follow-up|2|||
164154214|NCT01891864|592925657|FG003|Extension Period|Lost to Follow-up|0|||
164154215|NCT01891864|592925658|FG004|Extension Period|Lost to Follow-up|0|||
164154216|NCT01891864|592925659|FG005|Extension Period|Lost to Follow-up|0|||
164154217|NCT02698163|592925660|FG000|Overall Study|Lost to Follow-up|0|||
164154218|NCT02698163|592925661|FG001|Overall Study|Lost to Follow-up|1|||
164154219|NCT01133067|592925662|FG000|Overall Study|Death|136|||
164154220|NCT01133067|592925662|FG000|Overall Study|Lost to Follow-up|3|||
164154221|NCT00349973|592925663|FG000|Overall Study|Adverse Event|3|||
164154222|NCT00349973|592925664|FG001|Overall Study|Adverse Event|3|||
164154223|NCT00349973|592925663|FG000|Overall Study|Withdrawal by Subject|1|||
164154224|NCT00349973|592925664|FG001|Overall Study|Withdrawal by Subject|0|||
164154225|NCT04021914|592928102|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
164154226|NCT00803790|592928106|FG000|Period 1|Adverse Event|0|||
164154227|NCT00803790|592928107|FG001|Period 1|Adverse Event|1|||
164154228|NCT00803790|592928108|FG002|Period 1|Adverse Event|0|||
164154229|NCT00803790|592928109|FG003|Period 1|Adverse Event|0|||
164154230|NCT00803790|592928106|FG000|Period 1|Lost to Follow-up|1|||
164154231|NCT00803790|592928107|FG001|Period 1|Lost to Follow-up|2|||
164154232|NCT00803790|592928108|FG002|Period 1|Lost to Follow-up|0|||
164154233|NCT00803790|592928109|FG003|Period 1|Lost to Follow-up|0|||
164154234|NCT00803790|592928106|FG000|Period 1|Withdrawal by Subject|8|||
164154235|NCT00803790|592928107|FG001|Period 1|Withdrawal by Subject|6|||
164154236|NCT00803790|592928108|FG002|Period 1|Withdrawal by Subject|0|||
164154237|NCT00803790|592928109|FG003|Period 1|Withdrawal by Subject|0|||
164154238|NCT00803790|592928106|FG000|Period 1|positive drug screen or personal reasons|0|||
164154239|NCT00803790|592928107|FG001|Period 1|positive drug screen or personal reasons|3|||
164154240|NCT00803790|592928108|FG002|Period 1|positive drug screen or personal reasons|0|||
164154241|NCT00803790|592928109|FG003|Period 1|positive drug screen or personal reasons|4|||
164154242|NCT00803790|592928106|FG000|Period 1|Protocol Violation|0|||
164154243|NCT00803790|592928107|FG001|Period 1|Protocol Violation|0|||
164154244|NCT00803790|592928108|FG002|Period 1|Protocol Violation|1|||
164154245|NCT00803790|592928109|FG003|Period 1|Protocol Violation|0|||
164154246|NCT00803790|592928106|FG000|Period 2|Adverse Event|0|||
164154247|NCT00803790|592928107|FG001|Period 2|Adverse Event|0|||
164154248|NCT00803790|592928108|FG002|Period 2|Adverse Event|1|||
164154249|NCT00803790|592928109|FG003|Period 2|Adverse Event|1|||
164154250|NCT00803790|592928106|FG000|Period 2|Withdrawal by Subject|1|||
164154251|NCT00803790|592928107|FG001|Period 2|Withdrawal by Subject|0|||
164154252|NCT00803790|592928108|FG002|Period 2|Withdrawal by Subject|0|||
164154253|NCT00803790|592928109|FG003|Period 2|Withdrawal by Subject|0|||
164154254|NCT00803790|592928106|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
164154255|NCT00803790|592928107|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
164154256|NCT00803790|592928108|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
164154257|NCT00803790|592928109|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
164154258|NCT04581824|592928111|FG000|Overall Study|Lost to Follow-up|1|||
164154259|NCT04581824|592928112|FG001|Overall Study|Lost to Follow-up|0|||
164154260|NCT04581824|592928111|FG000|Overall Study|Withdrawal by Subject|2|||
164154261|NCT04581824|592928112|FG001|Overall Study|Withdrawal by Subject|7|||
164154262|NCT04581824|592928111|FG000|Overall Study|Study terminated by sponsor|37|||
164154263|NCT04581824|592928112|FG001|Overall Study|Study terminated by sponsor|23|||
164154264|NCT05012098|592928113|FG000|Overall Study|Disease progression|5|||
164154265|NCT05012098|592928114|FG001|Overall Study|Disease progression|2|||
164154266|NCT05012098|592928113|FG000|Overall Study|Adverse Event|1|||
164154267|NCT05012098|592928114|FG001|Overall Study|Adverse Event|0|||
164154268|NCT05012098|592928113|FG000|Overall Study|Withdrawal by Subject|1|||
164154269|NCT05012098|592928114|FG001|Overall Study|Withdrawal by Subject|0|||
164154270|NCT05012098|592928113|FG000|Overall Study|Discontinuation per protocol|1|||
164154271|NCT05012098|592928114|FG001|Overall Study|Discontinuation per protocol|0|||
164154272|NCT05573464|592928115|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
164154273|NCT05573464|592928116|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
164154274|NCT05573464|592928115|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
164154275|NCT05573464|592928116|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
164154276|NCT05573464|592928115|FG000|12-week Treatment Period|Protocol Violation|3|||
164154277|NCT05573464|592928116|FG001|12-week Treatment Period|Protocol Violation|1|||
164154278|NCT05573464|592928115|FG000|12-week Treatment Period|Physician Decision|1|||
164154279|NCT05573464|592928116|FG001|12-week Treatment Period|Physician Decision|2|||
164154280|NCT05573464|592928115|FG000|12-week Treatment Period|Lost to Follow-up|2|||
164154281|NCT05573464|592928116|FG001|12-week Treatment Period|Lost to Follow-up|0|||
164154282|NCT05573464|592928115|FG000|12-week Treatment Period|Adverse Event|20|||
164154283|NCT05573464|592928116|FG001|12-week Treatment Period|Adverse Event|9|||
164154284|NCT05573464|592928115|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
164154285|NCT05573464|592928116|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
164154286|NCT05573464|592928115|FG000|12-week Treatment Period|Randomised, not treated|0|||
164154287|NCT05573464|592928116|FG001|12-week Treatment Period|Randomised, not treated|1|||
164154288|NCT05573464|592928115|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
164154289|NCT05573464|592928116|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
164154290|NCT05573464|592928115|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
164154291|NCT05573464|592928116|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
164154292|NCT05573464|592928115|FG000|52-week Treatment Period|Protocol Violation|1|||
164154293|NCT05573464|592928116|FG001|52-week Treatment Period|Protocol Violation|1|||
164154294|NCT05573464|592928115|FG000|52-week Treatment Period|Physician Decision|2|||
164154295|NCT05573464|592928116|FG001|52-week Treatment Period|Physician Decision|2|||
164154296|NCT05573464|592928115|FG000|52-week Treatment Period|Lost to Follow-up|1|||
164154297|NCT05573464|592928116|FG001|52-week Treatment Period|Lost to Follow-up|1|||
164154298|NCT05573464|592928115|FG000|52-week Treatment Period|Adverse Event|11|||
164154299|NCT05573464|592928116|FG001|52-week Treatment Period|Adverse Event|8|||
164154300|NCT05573464|592928115|FG000|52-week Treatment Period|Death|1|||
164154301|NCT05573464|592928116|FG001|52-week Treatment Period|Death|1|||
164154302|NCT05734157|592928117|FG000|Overall Study|Death|3|||
164154303|NCT05734157|592928117|FG000|Overall Study|Withdrawal by Subject|2|||
164154304|NCT05734157|592928117|FG000|Overall Study|Lost to Follow-up|1|||
164154305|NCT05734157|592928117|FG000|Overall Study|Telephone call|3|||
164154306|NCT04815083|592928118|FG000|Overall Study|Physician Decision|1|||
164154307|NCT04815083|592928118|FG000|Overall Study|Study pause|2|||
164154308|NCT04815083|592928118|FG000|Overall Study|Screening failure|4|||
164154309|NCT06025721|592928119|FG000|Overall Study|Physician Decision|1|||
164154310|NCT06025721|592928119|FG000|Overall Study|Protocol Violation|1|||
164154311|NCT06025721|592928119|FG000|Overall Study|Incarceration|1|||
164154312|NCT01749826|592928120|FG000|Overall Study|Study Terminated|20|||
164154313|NCT01749826|592928121|FG001|Overall Study|Study Terminated|0|||
164154314|NCT01730053|592928124|FG000|Overall Study|Participant moved|0|||
164154315|NCT01730053|592928125|FG001|Overall Study|Participant moved|0|||
164154316|NCT01730053|592928126|FG002|Overall Study|Participant moved|1|||
164154317|NCT01730053|592928127|FG003|Overall Study|Participant moved|0|||
164154318|NCT01730053|592928128|FG004|Overall Study|Participant moved|0|||
164154319|NCT01730053|592928129|FG005|Overall Study|Participant moved|0|||
164154320|NCT01730053|592928124|FG000|Overall Study|Physician Decision|0|||
164154321|NCT01730053|592928125|FG001|Overall Study|Physician Decision|0|||
164154322|NCT01730053|592928126|FG002|Overall Study|Physician Decision|0|||
164154323|NCT01730053|592928127|FG003|Overall Study|Physician Decision|1|||
164154324|NCT01730053|592928128|FG004|Overall Study|Physician Decision|0|||
164154325|NCT01730053|592928129|FG005|Overall Study|Physician Decision|0|||
164154326|NCT01730053|592928124|FG000|Overall Study|Adverse Event|2|||
164154327|NCT01730053|592928125|FG001|Overall Study|Adverse Event|6|||
164154328|NCT01730053|592928126|FG002|Overall Study|Adverse Event|3|||
164154329|NCT01730053|592928127|FG003|Overall Study|Adverse Event|3|||
164154330|NCT01730053|592928128|FG004|Overall Study|Adverse Event|2|||
164154331|NCT01730053|592928129|FG005|Overall Study|Adverse Event|2|||
164154332|NCT01730053|592928124|FG000|Overall Study|Poor compliance to protocol|1|||
164154333|NCT01730053|592928125|FG001|Overall Study|Poor compliance to protocol|2|||
164154334|NCT01730053|592928126|FG002|Overall Study|Poor compliance to protocol|2|||
164154335|NCT01730053|592928127|FG003|Overall Study|Poor compliance to protocol|0|||
164154336|NCT01730053|592928128|FG004|Overall Study|Poor compliance to protocol|0|||
164154337|NCT01730053|592928129|FG005|Overall Study|Poor compliance to protocol|2|||
164154338|NCT01730053|592928124|FG000|Overall Study|Other than specified|2|||
164154339|NCT01730053|592928125|FG001|Overall Study|Other than specified|6|||
164154340|NCT01730053|592928126|FG002|Overall Study|Other than specified|5|||
164154341|NCT01730053|592928127|FG003|Overall Study|Other than specified|4|||
164154342|NCT01730053|592928128|FG004|Overall Study|Other than specified|7|||
164154343|NCT01730053|592928129|FG005|Overall Study|Other than specified|9|||
164154344|NCT02068508|592928130|FG000|Overall Study|Case report forms uncollected|27|||
164154345|NCT02068508|592928130|FG000|Overall Study|Patient did not visit the study site|1|||
164154346|NCT02068508|592928130|FG000|Overall Study|Protocol Violation|4|||
164154347|NCT00813150|592928131|FG000|Treatment Period|Adverse Event|16|||
164154348|NCT00813150|592928132|FG001|Treatment Period|Adverse Event|15|||
164154349|NCT00813150|592928131|FG000|Treatment Period|Death|2|||
164154350|NCT00813150|592928132|FG001|Treatment Period|Death|0|||
164154351|NCT00813150|592928131|FG000|Treatment Period|Progressive disease|1|||
164154352|NCT00813150|592928132|FG001|Treatment Period|Progressive disease|0|||
164154353|NCT00813150|592928131|FG000|Treatment Period|Complete response|0|||
164154354|NCT00813150|592928132|FG001|Treatment Period|Complete response|1|||
164154355|NCT00813150|592928131|FG000|Treatment Period|Stable disease|1|||
164154356|NCT00813150|592928132|FG001|Treatment Period|Stable disease|2|||
164154357|NCT00813150|592928131|FG000|Treatment Period|Protocol Violation|3|||
164154358|NCT00813150|592928132|FG001|Treatment Period|Protocol Violation|4|||
164154359|NCT00813150|592928131|FG000|Treatment Period|Withdrawal by Subject|5|||
164154360|NCT00813150|592928132|FG001|Treatment Period|Withdrawal by Subject|3|||
164154361|NCT00813150|592928131|FG000|Treatment Period|Non compliance|0|||
164154362|NCT00813150|592928132|FG001|Treatment Period|Non compliance|1|||
164154363|NCT00813150|592928131|FG000|Treatment Period|Reason not specified|3|||
164154364|NCT00813150|592928132|FG001|Treatment Period|Reason not specified|4|||
164154365|NCT00813150|592928131|FG000|Treatment Period|Data not available|1|||
164154366|NCT00813150|592928132|FG001|Treatment Period|Data not available|2|||
164154367|NCT00813150|592928131|FG000|Long Term Follow-up|Death|0|||
164154368|NCT00813150|592928132|FG001|Long Term Follow-up|Death|4|||
164154369|NCT00813150|592928131|FG000|Long Term Follow-up|Other|0|||
164154370|NCT00813150|592928132|FG001|Long Term Follow-up|Other|3|||
164154371|NCT00813150|592928131|FG000|Long Term Follow-up|Lost to Follow-up|2|||
164154372|NCT00813150|592928132|FG001|Long Term Follow-up|Lost to Follow-up|0|||
164154373|NCT00813150|592928131|FG000|Long Term Follow-up|Progression/Relapse|22|||
164154374|NCT00813150|592928132|FG001|Long Term Follow-up|Progression/Relapse|24|||
164154375|NCT05085834|592928133|FG000|Overall Study|Lost to Follow-up|9|||
164154376|NCT05085834|592928134|FG001|Overall Study|Lost to Follow-up|2|||
164154377|NCT05085834|592928133|FG000|Overall Study|Adverse Event|6|||
164154378|NCT05085834|592928134|FG001|Overall Study|Adverse Event|0|||
164154379|NCT05085834|592928133|FG000|Overall Study|Death|1|||
164154380|NCT05085834|592928134|FG001|Overall Study|Death|0|||
164154381|NCT05085834|592928133|FG000|Overall Study|Inability to swallow the pill|0|||
164154382|NCT05085834|592928134|FG001|Overall Study|Inability to swallow the pill|1|||
164154383|NCT01823328|592928139|FG000|Overall Study|Withdrawal by Subject|8|||
164154384|NCT01823328|592928140|FG001|Overall Study|Withdrawal by Subject|6|||
164154385|NCT01662635|592928141|FG000|Overall Study|scarce samples for evaluation|30|||
164154386|NCT01217112|592928142|FG000|Overall Study|Adverse Event|0|||
164154387|NCT01217112|592928143|FG001|Overall Study|Adverse Event|2|||
164154388|NCT01217112|592928144|FG002|Overall Study|Adverse Event|0|||
164154389|NCT01217112|592928145|FG003|Overall Study|Adverse Event|2|||
164154390|NCT01217112|592928146|FG004|Overall Study|Adverse Event|0|||
164154391|NCT01217112|592928142|FG000|Overall Study|Withdrawal by Subject|0|||
164154392|NCT01217112|592928143|FG001|Overall Study|Withdrawal by Subject|0|||
164154393|NCT01217112|592928144|FG002|Overall Study|Withdrawal by Subject|1|||
164154394|NCT01217112|592928145|FG003|Overall Study|Withdrawal by Subject|0|||
164154395|NCT01217112|592928146|FG004|Overall Study|Withdrawal by Subject|0|||
164154396|NCT01217112|592928142|FG000|Overall Study|Physician Decision|0|||
164154397|NCT01217112|592928143|FG001|Overall Study|Physician Decision|0|||
164154398|NCT01217112|592928144|FG002|Overall Study|Physician Decision|0|||
164154399|NCT01217112|592928145|FG003|Overall Study|Physician Decision|0|||
164154400|NCT01217112|592928146|FG004|Overall Study|Physician Decision|1|||
164154401|NCT01401361|592928147|FG000|Overall Study|Withdrawal by Subject|16|||
164154402|NCT01401361|592928147|FG000|Overall Study|Lack of Efficacy|6|||
164154403|NCT01401361|592928147|FG000|Overall Study|Physician Decision|1|||
164154404|NCT01401361|592928147|FG000|Overall Study|Lost to Follow-up|3|||
164154405|NCT01401361|592928147|FG000|Overall Study|Subject/family decision post procedure|2|||
164154406|NCT00595920|592928150|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
164154407|NCT00351468|592928151|FG000|Overall Study|Adverse Event|42|||
164154408|NCT00351468|592928151|FG000|Overall Study|Withdrawal by Subject|39|||
164154409|NCT00351468|592928151|FG000|Overall Study|Various -follow up w clinical team|39|||
164154410|NCT00351468|592928151|FG000|Overall Study|Lack of Efficacy|32|||
164154411|NCT00351468|592928151|FG000|Overall Study|Non-compliance|8|||
164154412|NCT00351468|592928151|FG000|Overall Study|Lost to Follow-up|4|||
164154413|NCT00351468|592928151|FG000|Overall Study|Protocol Violation|3|||
164154414|NCT03588910|592928152|FG000|Overall Study|Withdrawal by Subject|1|||
164154415|NCT03588910|592928153|FG001|Overall Study|Withdrawal by Subject|0|||
164154416|NCT03588910|592928152|FG000|Overall Study|Allergy|2|||
164154417|NCT03588910|592928153|FG001|Overall Study|Allergy|0|||
164154418|NCT03588910|592928152|FG000|Overall Study|Protocol Violation|0|||
164154419|NCT03588910|592928153|FG001|Overall Study|Protocol Violation|3|||
164154420|NCT03588910|592928152|FG000|Overall Study|Did not complete Day 1 Survey|5|||
164154421|NCT03588910|592928153|FG001|Overall Study|Did not complete Day 1 Survey|10|||
164154422|NCT03588910|592928152|FG000|Overall Study|Did not complete Day 7 Survey|5|||
164154423|NCT03588910|592928153|FG001|Overall Study|Did not complete Day 7 Survey|2|||
164154424|NCT03096314|592928154|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
164154425|NCT03096314|592928155|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
164154426|NCT00471822|592928156|FG000|Overall Study|Protocol Violation|2|||
164154427|NCT03318861|592928157|FG000|Overall Study|Death|2|||
164154428|NCT03318861|592928158|FG001|Overall Study|Death|3|||
164154429|NCT03318861|592928159|FG002|Overall Study|Death|3|||
164154430|NCT03318861|592928160|FG003|Overall Study|Death|2|||
164154431|NCT03318861|592928161|FG004|Overall Study|Death|2|||
164154432|NCT03318861|592928157|FG000|Overall Study|Enrolled But Never Treated|0|||
164154433|NCT03318861|592928158|FG001|Overall Study|Enrolled But Never Treated|1|||
164154434|NCT03318861|592928159|FG002|Overall Study|Enrolled But Never Treated|0|||
164154435|NCT03318861|592928160|FG003|Overall Study|Enrolled But Never Treated|1|||
164154436|NCT03318861|592928161|FG004|Overall Study|Enrolled But Never Treated|1|||
164154437|NCT03318861|592928157|FG000|Overall Study|Informed Consent Withdraw|0|||
164154438|NCT03318861|592928158|FG001|Overall Study|Informed Consent Withdraw|0|||
164154439|NCT03318861|592928159|FG002|Overall Study|Informed Consent Withdraw|0|||
164154440|NCT03318861|592928160|FG003|Overall Study|Informed Consent Withdraw|1|||
164154441|NCT03318861|592928161|FG004|Overall Study|Informed Consent Withdraw|0|||
164154442|NCT03318861|592928157|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
164154443|NCT03318861|592928158|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154444|NCT03318861|592928159|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154445|NCT03318861|592928160|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154446|NCT03318861|592928161|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
164154447|NCT01892501|592928162|FG000|Overall Study|Protocol Violation|2|||
164154448|NCT01892501|592928162|FG000|Overall Study|Puncture not carried out|9|||
164154449|NCT01892501|592928162|FG000|Overall Study|Radiological monitoring not carried out|5|||
164154450|NCT01892501|592928162|FG000|Overall Study|Non-contributory histological result|12|||
164154451|NCT04335123|592928165|FG000|Overall Study|Withdrawal by Subject|2|||
164154452|NCT04335123|592928166|FG001|Overall Study|Withdrawal by Subject|0|||
164154453|NCT04335123|592928165|FG000|Overall Study|Physician Decision|2|||
164154454|NCT04335123|592928166|FG001|Overall Study|Physician Decision|0|||
164154455|NCT01254643|592928167|FG000|Overall Study|Withdrawal by Subject|1|||
164154456|NCT03359850|592928173|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
164154457|NCT03359850|592928174|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
164154458|NCT03359850|592928173|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
164154459|NCT03359850|592928174|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
164154460|NCT03359850|592928173|FG000|Extension Phase (Up to 28 Months)|Death|2|||
164154461|NCT03359850|592928174|FG001|Extension Phase (Up to 28 Months)|Death|4|||
164154462|NCT03359850|592928173|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
164154463|NCT03359850|592928174|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
164154464|NCT03359850|592928173|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
164154465|NCT03359850|592928174|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
164154466|NCT03817125|592928192|FG000|Overall Study|Adverse Event|1|||
164154467|NCT03817125|592928193|FG001|Overall Study|Adverse Event|0|||
164154468|NCT03817125|592928192|FG000|Overall Study|Physician Decision|0|||
164154469|NCT03817125|592928193|FG001|Overall Study|Physician Decision|1|||
164154470|NCT03817125|592928192|FG000|Overall Study|Lack of Efficacy|1|||
164154471|NCT03817125|592928193|FG001|Overall Study|Lack of Efficacy|5|||
164154472|NCT00942084|592928194|FG000|Overall Study|Death|2|||
164154473|NCT01062425|592928195|FG000|Overall Study|Protocol Violation|3|||
164154474|NCT01062425|592928196|FG001|Overall Study|Protocol Violation|6|||
164154475|NCT01433471|592928199|FG000|Overall Study|Withdrawal by Subject|0|||
164154476|NCT01433471|592928200|FG001|Overall Study|Withdrawal by Subject|1|||
164154477|NCT00395629|592928203|FG000|Core Study|Adverse Event|0|||
164154478|NCT00395629|592928204|FG001|Core Study|Adverse Event|3|||
164154479|NCT00395629|592928205|FG002|Core Study|Adverse Event|4|||
164154480|NCT00395629|592928203|FG000|Core Study|Abnormal laboratory value(s)|0|||
164154481|NCT00395629|592928204|FG001|Core Study|Abnormal laboratory value(s)|0|||
164154482|NCT00395629|592928205|FG002|Core Study|Abnormal laboratory value(s)|1|||
164154483|NCT00395629|592928203|FG000|Core Study|Protocol Violation|1|||
164154484|NCT00395629|592928204|FG001|Core Study|Protocol Violation|0|||
164154485|NCT00395629|592928205|FG002|Core Study|Protocol Violation|0|||
164154486|NCT00395629|592928203|FG000|Core Study|Withdrawal by Subject|0|||
164154487|NCT00395629|592928204|FG001|Core Study|Withdrawal by Subject|1|||
164154488|NCT00395629|592928205|FG002|Core Study|Withdrawal by Subject|1|||
164154489|NCT00395629|592928203|FG000|Core Study|Lost to Follow-up|0|||
164154490|NCT00395629|592928204|FG001|Core Study|Lost to Follow-up|0|||
164154491|NCT00395629|592928205|FG002|Core Study|Lost to Follow-up|1|||
164154492|NCT00395629|592928203|FG000|Extension Study|Adverse Event|0|||
164154493|NCT00395629|592928204|FG001|Extension Study|Adverse Event|0|||
164154494|NCT00395629|592928205|FG002|Extension Study|Adverse Event|2|||
164154495|NCT00395629|592928203|FG000|Extension Study|Administrative problems|0|||
164154496|NCT00395629|592928204|FG001|Extension Study|Administrative problems|0|||
164154497|NCT00395629|592928205|FG002|Extension Study|Administrative problems|1|||
164154498|NCT03428152|592928206|FG000|Overall Study|Physician Decision|4|||
164154499|NCT03428152|592928207|FG001|Overall Study|Physician Decision|2|||
164154500|NCT03428152|592928206|FG000|Overall Study|Protocol Violation|3|||
164154501|NCT03428152|592928207|FG001|Overall Study|Protocol Violation|5|||
164154502|NCT03428152|592928206|FG000|Overall Study|Lack of Efficacy|0|||
164154503|NCT03428152|592928207|FG001|Overall Study|Lack of Efficacy|4|||
164154504|NCT01686373|592928208|FG000|Overall Study|Lost to Follow-up|3|||
164154505|NCT01686373|592928209|FG001|Overall Study|Lost to Follow-up|0|||
164154506|NCT01686373|592928208|FG000|Overall Study|Withdrawal by Subject|0|||
164154507|NCT01686373|592928209|FG001|Overall Study|Withdrawal by Subject|1|||
164154508|NCT01686373|592928208|FG000|Overall Study|Adverse Event|0|||
164154509|NCT01686373|592928209|FG001|Overall Study|Adverse Event|1|||
164154510|NCT00191477|592928213|FG000|Overall Study|Tumor Recurrence|49|||
164154511|NCT00191477|592928214|FG001|Overall Study|Tumor Recurrence|48|||
164154512|NCT00191477|592928213|FG000|Overall Study|Death, Study Disease|1|||
164154513|NCT00191477|592928214|FG001|Overall Study|Death, Study Disease|1|||
164154514|NCT00191477|592928213|FG000|Overall Study|Death, Other Cause|3|||
164154515|NCT00191477|592928214|FG001|Overall Study|Death, Other Cause|6|||
164154516|NCT00191477|592928213|FG000|Overall Study|Lost to Follow-up|23|||
164154517|NCT00191477|592928214|FG001|Overall Study|Lost to Follow-up|21|||
164154518|NCT00191477|592928213|FG000|Overall Study|Protocol Violation|1|||
164154519|NCT00191477|592928214|FG001|Overall Study|Protocol Violation|1|||
164154520|NCT00191477|592928213|FG000|Overall Study|Treatment Change|2|||
164154521|NCT00191477|592928214|FG001|Overall Study|Treatment Change|0|||
164154522|NCT00191477|592928213|FG000|Overall Study|Withdrawal by Subject|2|||
164154523|NCT00191477|592928214|FG001|Overall Study|Withdrawal by Subject|0|||
164154524|NCT00191477|592928213|FG000|Overall Study|Other|2|||
164154525|NCT00191477|592928214|FG001|Overall Study|Other|0|||
164154526|NCT00191477|592928213|FG000|Overall Study|Not Eligible|41|||
164154527|NCT00191477|592928214|FG001|Overall Study|Not Eligible|38|||
164154528|NCT00191477|592928213|FG000|Overall Study|Pathological Specimen Lost|1|||
164154529|NCT00191477|592928214|FG001|Overall Study|Pathological Specimen Lost|0|||
164154530|NCT00191477|592928213|FG000|Overall Study|Discontinued Prior to Instillation|13|||
164154531|NCT00191477|592928214|FG001|Overall Study|Discontinued Prior to Instillation|14|||
164154532|NCT06481709|592928215|FG000|Overall Study|Withdrawal by Subject|0|||
164154533|NCT06481709|592928216|FG001|Overall Study|Withdrawal by Subject|0|||
164154534|NCT06481709|592928217|FG002|Overall Study|Withdrawal by Subject|2|||
164154535|NCT06481709|592928218|FG003|Overall Study|Withdrawal by Subject|0|||
164154536|NCT01108718|592928220|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
164154537|NCT01108718|592928221|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
164154538|NCT02857816|592928224|FG000|Overall Study|Screen Failure|33|||
164154539|NCT02857816|592928224|FG000|Overall Study|Withdrawal by Subject|4|||
164154540|NCT02857816|592928224|FG000|Overall Study|Lost to Follow-up|1|||
164154541|NCT00729937|592928225|FG000|Overall Study|Lost to Follow-up|49|||
164154542|NCT00729937|592928226|FG001|Overall Study|Lost to Follow-up|58|||
164154543|NCT00729937|592928227|FG002|Overall Study|Lost to Follow-up|18|||
164154544|NCT00729937|592928228|FG003|Overall Study|Lost to Follow-up|33|||
164154545|NCT00729937|592928229|FG004|Overall Study|Lost to Follow-up|18|||
164154546|NCT00729937|592928230|FG005|Overall Study|Lost to Follow-up|23|||
164154547|NCT00729937|592928225|FG000|Overall Study|Physician Decision|7|||
164154548|NCT00729937|592928226|FG001|Overall Study|Physician Decision|16|||
164154549|NCT00729937|592928227|FG002|Overall Study|Physician Decision|2|||
164154550|NCT00729937|592928228|FG003|Overall Study|Physician Decision|0|||
164154551|NCT00729937|592928229|FG004|Overall Study|Physician Decision|5|||
164154552|NCT00729937|592928230|FG005|Overall Study|Physician Decision|8|||
164154553|NCT00729937|592928225|FG000|Overall Study|Death|1|||
164154554|NCT00729937|592928226|FG001|Overall Study|Death|0|||
164154555|NCT00729937|592928227|FG002|Overall Study|Death|1|||
164154556|NCT00729937|592928228|FG003|Overall Study|Death|0|||
164154557|NCT00729937|592928229|FG004|Overall Study|Death|0|||
164154558|NCT00729937|592928230|FG005|Overall Study|Death|1|||
164154559|NCT00729937|592928225|FG000|Overall Study|Withdrawal by Subject|3|||
164154560|NCT00729937|592928226|FG001|Overall Study|Withdrawal by Subject|5|||
164154561|NCT00729937|592928227|FG002|Overall Study|Withdrawal by Subject|6|||
164154562|NCT00729937|592928228|FG003|Overall Study|Withdrawal by Subject|0|||
164154563|NCT00729937|592928229|FG004|Overall Study|Withdrawal by Subject|4|||
164154564|NCT00729937|592928230|FG005|Overall Study|Withdrawal by Subject|2|||
164154565|NCT00729937|592928225|FG000|Overall Study|Randomized but not treated|12|||
164154566|NCT00729937|592928226|FG001|Overall Study|Randomized but not treated|6|||
164154567|NCT00729937|592928227|FG002|Overall Study|Randomized but not treated|1|||
164154568|NCT00729937|592928228|FG003|Overall Study|Randomized but not treated|0|||
164154569|NCT00729937|592928229|FG004|Overall Study|Randomized but not treated|1|||
164154570|NCT00729937|592928230|FG005|Overall Study|Randomized but not treated|3|||
164154571|NCT00729937|592928225|FG000|Overall Study|Did not meet eligibility criteria|2|||
164154572|NCT00729937|592928226|FG001|Overall Study|Did not meet eligibility criteria|1|||
164154573|NCT00729937|592928227|FG002|Overall Study|Did not meet eligibility criteria|0|||
164154574|NCT00729937|592928228|FG003|Overall Study|Did not meet eligibility criteria|0|||
164154575|NCT00729937|592928229|FG004|Overall Study|Did not meet eligibility criteria|0|||
164154576|NCT00729937|592928230|FG005|Overall Study|Did not meet eligibility criteria|0|||
164154577|NCT00729937|592928225|FG000|Overall Study|Incarcerated|0|||
164154578|NCT00729937|592928226|FG001|Overall Study|Incarcerated|2|||
164154579|NCT00729937|592928227|FG002|Overall Study|Incarcerated|1|||
164154580|NCT00729937|592928228|FG003|Overall Study|Incarcerated|1|||
164154581|NCT00729937|592928229|FG004|Overall Study|Incarcerated|0|||
164154582|NCT00729937|592928230|FG005|Overall Study|Incarcerated|0|||
164154583|NCT02198963|592928234|FG000|Overall Study|Adverse Event|1|||
164154584|NCT02198963|592928234|FG000|Overall Study|Withdrawal by Subject|6|||
164154585|NCT00281957|592928235|FG000|Overall Study|Adverse Event|7|||
164154586|NCT00281957|592928236|FG001|Overall Study|Adverse Event|2|||
164154587|NCT00281957|592928235|FG000|Overall Study|Death|1|||
164154588|NCT00281957|592928236|FG001|Overall Study|Death|0|||
164154589|NCT00281957|592928235|FG000|Overall Study|Progression/relapse|47|||
164154590|NCT00281957|592928236|FG001|Overall Study|Progression/relapse|35|||
164154591|NCT00281957|592928235|FG000|Overall Study|Not protocol specified|8|||
164154592|NCT00281957|592928236|FG001|Overall Study|Not protocol specified|1|||
164154593|NCT00281957|592928235|FG000|Overall Study|Not eligible|1|||
164154594|NCT00281957|592928236|FG001|Overall Study|Not eligible|2|||
164154595|NCT00281957|592928235|FG000|Overall Study|Did not start treatment|3|||
164154596|NCT00281957|592928236|FG001|Overall Study|Did not start treatment|1|||
164154597|NCT00281957|592928235|FG000|Overall Study|Refusal unrelated to adverse events|0|||
164154598|NCT00281957|592928236|FG001|Overall Study|Refusal unrelated to adverse events|1|||
164154599|NCT03281876|592928244|FG000|Overall Study|Adverse Event|4|||
164154600|NCT03281876|592928245|FG001|Overall Study|Adverse Event|15|||
164154601|NCT03281876|592928244|FG000|Overall Study|Lost to Follow-up|1|||
164154602|NCT03281876|592928245|FG001|Overall Study|Lost to Follow-up|4|||
164154603|NCT03281876|592928244|FG000|Overall Study|Withdrawal by Subject|11|||
164154604|NCT03281876|592928245|FG001|Overall Study|Withdrawal by Subject|15|||
164154605|NCT03281876|592928244|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164154606|NCT03281876|592928245|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164154607|NCT03281876|592928244|FG000|Overall Study|OTHER|5|||
164154608|NCT03281876|592928245|FG001|Overall Study|OTHER|5|||
164154609|NCT02208089|592928246|FG000|Overall Study|Withdrawal by Subject|1|||
164154610|NCT02208089|592928247|FG001|Overall Study|Withdrawal by Subject|0|||
164154611|NCT02208089|592928246|FG000|Overall Study|Lost to Follow-up|6|||
164154612|NCT02208089|592928247|FG001|Overall Study|Lost to Follow-up|0|||
164154613|NCT02443740|592928248|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154614|NCT02443740|592928249|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154615|NCT02443740|592928250|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154616|NCT02443740|592928251|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154617|NCT02443740|592928252|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154618|NCT02443740|592928253|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
164154619|NCT02443740|592928254|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154620|NCT02443740|592928255|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154621|NCT02443740|592928256|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154622|NCT02443740|592928257|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154623|NCT02443740|592928258|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
164154624|NCT02443740|592928248|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
164154625|NCT02443740|592928249|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154626|NCT02443740|592928250|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154627|NCT02443740|592928251|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154628|NCT02443740|592928252|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154629|NCT02443740|592928253|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154630|NCT02443740|592928254|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
164154631|NCT02443740|592928255|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154632|NCT02443740|592928256|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154633|NCT02443740|592928257|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154634|NCT02443740|592928258|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
164154635|NCT02443740|592928248|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154636|NCT02443740|592928249|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154637|NCT02443740|592928250|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154638|NCT02443740|592928251|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154639|NCT02443740|592928252|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154640|NCT02443740|592928253|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
164154641|NCT02443740|592928254|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154642|NCT02443740|592928255|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154643|NCT02443740|592928256|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154644|NCT02443740|592928257|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154645|NCT02443740|592928258|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
164154646|NCT01478373|592928259|FG000|Treatment Phase|Protocol Violation|1|||
164154647|NCT01478373|592928259|FG000|Survival Phase|Adverse Event|8|||
164154648|NCT01478373|592928259|FG000|Survival Phase|Protocol Violation|1|||
164154649|NCT01478373|592928259|FG000|Survival Phase|crossover to another study|2|||
164154650|NCT01478373|592928259|FG000|Survival Phase|Progressive Disease|27|||
164154651|NCT00683657|592928261|FG000|Overall Study|Adverse Event|0|||
164154652|NCT00683657|592928262|FG001|Overall Study|Adverse Event|1|||
164154653|NCT00683657|592928261|FG000|Overall Study|Subject Withdrew Consent|1|||
164154654|NCT00683657|592928262|FG001|Overall Study|Subject Withdrew Consent|0|||
164154655|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
164154656|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154657|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154658|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154659|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
164154660|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
164154661|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154662|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154663|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154664|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
164154665|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
164154666|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154667|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154668|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154669|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
164154670|NCT01074944|592928263|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
164154671|NCT01074944|592928264|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154672|NCT01074944|592928265|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154673|NCT01074944|592928266|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154674|NCT01074944|592928267|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
164154675|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
164154676|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
164154677|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
164154678|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
164154679|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
164154680|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
164154681|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
164154682|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
164154683|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
164154684|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
164154685|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164154686|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
164154687|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
164154688|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164154689|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
164154690|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154691|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
164154692|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154693|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154694|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
164154695|NCT01074944|592928263|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
164154696|NCT01074944|592928264|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
164154697|NCT01074944|592928265|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
164154698|NCT01074944|592928266|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
164154699|NCT01074944|592928267|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
164154700|NCT01074944|592928263|FG000|Long Term Treatment|Adverse Event|0|||
164154701|NCT01074944|592928264|FG001|Long Term Treatment|Adverse Event|0|||
164154702|NCT01074944|592928265|FG002|Long Term Treatment|Adverse Event|0|||
164154703|NCT01074944|592928266|FG003|Long Term Treatment|Adverse Event|3|||
164154704|NCT01074944|592928267|FG004|Long Term Treatment|Adverse Event|0|||
164154705|NCT01074944|592928263|FG000|Long Term Treatment|Lost to Follow-up|0|||
164154706|NCT01074944|592928264|FG001|Long Term Treatment|Lost to Follow-up|0|||
164154707|NCT01074944|592928265|FG002|Long Term Treatment|Lost to Follow-up|0|||
164154708|NCT01074944|592928266|FG003|Long Term Treatment|Lost to Follow-up|2|||
164154709|NCT01074944|592928267|FG004|Long Term Treatment|Lost to Follow-up|0|||
164154710|NCT01074944|592928263|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154711|NCT01074944|592928264|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154712|NCT01074944|592928265|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154713|NCT01074944|592928266|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
164154714|NCT01074944|592928267|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
164154715|NCT01074944|592928263|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154716|NCT01074944|592928264|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154717|NCT01074944|592928265|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154718|NCT01074944|592928266|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
164154719|NCT01074944|592928267|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
164154720|NCT01074944|592928263|FG000|Long Term Treatment|Withdrawal by Subject|0|||
164154721|NCT01074944|592928264|FG001|Long Term Treatment|Withdrawal by Subject|0|||
164154722|NCT01074944|592928265|FG002|Long Term Treatment|Withdrawal by Subject|0|||
164154723|NCT01074944|592928266|FG003|Long Term Treatment|Withdrawal by Subject|2|||
164154724|NCT01074944|592928267|FG004|Long Term Treatment|Withdrawal by Subject|0|||
164154725|NCT01074944|592928263|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154726|NCT01074944|592928264|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154727|NCT01074944|592928265|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154728|NCT01074944|592928266|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
164154729|NCT01074944|592928267|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
164154730|NCT01074944|592928263|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154731|NCT01074944|592928264|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154732|NCT01074944|592928265|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154733|NCT01074944|592928266|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
164154734|NCT01074944|592928267|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
164154735|NCT03200717|592928271|FG000|Overall Study|Progressive disease|24|||
164154736|NCT03200717|592928272|FG001|Overall Study|Progressive disease|5|||
164154737|NCT03200717|592928271|FG000|Overall Study|Adverse Event|11|||
164154738|NCT03200717|592928272|FG001|Overall Study|Adverse Event|8|||
164154739|NCT03200717|592928271|FG000|Overall Study|Physician Decision|3|||
164154740|NCT03200717|592928272|FG001|Overall Study|Physician Decision|2|||
164154741|NCT03200717|592928271|FG000|Overall Study|Death|2|||
164154742|NCT03200717|592928272|FG001|Overall Study|Death|0|||
164154743|NCT03200717|592928271|FG000|Overall Study|Subject/Guardian Decision|1|||
164154744|NCT03200717|592928272|FG001|Overall Study|Subject/Guardian Decision|0|||
164154745|NCT05373108|592928275|FG000|Overall Study|Withdrawal by Subject|2|||
164154746|NCT02892331|592928277|FG000|Overall Study|Withdrawal by Subject|0|||
164154747|NCT02892331|592928278|FG001|Overall Study|Withdrawal by Subject|1|||
164154748|NCT02892331|592928279|FG002|Overall Study|Withdrawal by Subject|1|||
164154749|NCT02892331|592928277|FG000|Overall Study|Sick family member|0|||
164154750|NCT02892331|592928278|FG001|Overall Study|Sick family member|0|||
164154751|NCT02892331|592928279|FG002|Overall Study|Sick family member|1|||
164154752|NCT02892331|592928277|FG000|Overall Study|Corona virus pandemic|1|||
164154753|NCT02892331|592928278|FG001|Overall Study|Corona virus pandemic|0|||
164154754|NCT02892331|592928279|FG002|Overall Study|Corona virus pandemic|1|||
164154755|NCT02892331|592928277|FG000|Overall Study|Lost to Follow-up|1|||
164154756|NCT02892331|592928278|FG001|Overall Study|Lost to Follow-up|0|||
164154757|NCT02892331|592928279|FG002|Overall Study|Lost to Follow-up|1|||
164154758|NCT02892331|592928277|FG000|Overall Study|Blood pressure was too elevated|0|||
164154759|NCT02892331|592928278|FG001|Overall Study|Blood pressure was too elevated|1|||
164154760|NCT02892331|592928279|FG002|Overall Study|Blood pressure was too elevated|0|||
164154761|NCT02892331|592928277|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
164154762|NCT02892331|592928278|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
164154763|NCT02892331|592928279|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
164154764|NCT00752128|592928280|FG000|Overall Study|Withdrawal by Subject|4|||
164154765|NCT04135937|592928281|FG000|Overall Study|Lost to Follow-up|2|||
164154766|NCT04135937|592928281|FG000|Overall Study|Withdrawal by Subject|1|||
164154767|NCT05620082|592928282|FG000|Overall Study|Discharged before study end|1|||
164154768|NCT05620082|592928283|FG001|Overall Study|Discharged before study end|4|||
164154769|NCT05620082|592928284|FG002|Overall Study|Discharged before study end|0|||
164154770|NCT05620082|592928282|FG000|Overall Study|Moved to a different ward|1|||
164154771|NCT05620082|592928283|FG001|Overall Study|Moved to a different ward|0|||
164154772|NCT05620082|592928284|FG002|Overall Study|Moved to a different ward|0|||
164154773|NCT05620082|592928282|FG000|Overall Study|Feeling too unwell|1|||
164154774|NCT05620082|592928283|FG001|Overall Study|Feeling too unwell|0|||
164154775|NCT05620082|592928284|FG002|Overall Study|Feeling too unwell|0|||
164154776|NCT00625820|592928285|FG000|Overall Study|Withdrawal by Subject|1|||
164154777|NCT02141438|592930365|FG000|Overall Study|Death|1308|||
164154778|NCT02141438|592930365|FG000|Overall Study|Lost to Follow-up|84|||
164154779|NCT02141438|592930365|FG000|Overall Study|Withdrawal by Subject|52|||
164154780|NCT02141438|592930365|FG000|Overall Study|Physician Decision|1|||
164154781|NCT02141438|592930365|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
164154782|NCT02546986|592930368|FG000|Treatment Period|Progressive Disease|20|||
164154783|NCT02546986|592930369|FG001|Treatment Period|Progressive Disease|22|||
164154784|NCT02546986|592930368|FG000|Treatment Period|Adverse Event|14|||
164154785|NCT02546986|592930369|FG001|Treatment Period|Adverse Event|6|||
164154786|NCT02546986|592930368|FG000|Treatment Period|Symptomatic Deterioration|4|||
164154787|NCT02546986|592930369|FG001|Treatment Period|Symptomatic Deterioration|3|||
164154788|NCT02546986|592930368|FG000|Treatment Period|Death|3|||
164154789|NCT02546986|592930369|FG001|Treatment Period|Death|4|||
164154790|NCT02546986|592930368|FG000|Treatment Period|Physician Decision|1|||
164154791|NCT02546986|592930369|FG001|Treatment Period|Physician Decision|2|||
164154792|NCT02546986|592930368|FG000|Treatment Period|Protocol Violation|1|||
164154793|NCT02546986|592930369|FG001|Treatment Period|Protocol Violation|0|||
164154794|NCT02546986|592930368|FG000|Treatment Period|Withdrawal by Subject|1|||
164154795|NCT02546986|592930369|FG001|Treatment Period|Withdrawal by Subject|1|||
164154796|NCT02546986|592930368|FG000|Treatment Period|Non-compliance with Study Drug|0|||
164154797|NCT02546986|592930369|FG001|Treatment Period|Non-compliance with Study Drug|1|||
164154798|NCT02546986|592930368|FG000|Treatment Period|Study Terminated by Sponsor|0|||
164154799|NCT02546986|592930369|FG001|Treatment Period|Study Terminated by Sponsor|1|||
164154800|NCT02546986|592930368|FG000|Treatment Period|Miscellaneous|7|||
164154801|NCT02546986|592930369|FG001|Treatment Period|Miscellaneous|9|||
164154802|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Missing Status|3|||
164154803|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Missing Status|5|||
164154804|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Death|18|||
164154805|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Death|12|||
164154806|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Alive|13|||
164154807|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Alive|16|||
164154808|NCT02546986|592930368|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
164154809|NCT02546986|592930369|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
164154810|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
164154811|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
164154812|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
164154813|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
164154814|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
164154815|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
164154816|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
164154817|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
164154818|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
164154819|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
164154820|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
164154821|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
164154822|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
164154823|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
164154824|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
164154825|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
164154826|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
164154827|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
164154828|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
164154829|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
164154830|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
164154831|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
164154832|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
164154833|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
164154834|NCT02513160|592930370|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
164154835|NCT02513160|592930371|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
164154836|NCT02513160|592930372|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
164154837|NCT02513160|592930373|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
164154838|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
164154839|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
164154840|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
164154841|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
164154842|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
164154843|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
164154844|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
164154845|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
164154846|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
164154847|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
164154848|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
164154849|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
164154850|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
164154851|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
164154852|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
164154853|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
164154854|NCT02513160|592930370|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
164154855|NCT02513160|592930371|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
164154856|NCT02513160|592930372|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
164154857|NCT02513160|592930373|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
164154858|NCT00437021|592930374|FG000|Overall Study|Adverse Event|0|||
164154859|NCT00437021|592930375|FG001|Overall Study|Adverse Event|0|||
164154860|NCT00437021|592930376|FG002|Overall Study|Adverse Event|0|||
164154861|NCT00437021|592930377|FG003|Overall Study|Adverse Event|0|||
164154862|NCT00437021|592930378|FG004|Overall Study|Adverse Event|0|||
164154863|NCT00437021|592930379|FG005|Overall Study|Adverse Event|0|||
164154864|NCT00437021|592930380|FG006|Overall Study|Adverse Event|1|||
164154865|NCT00437021|592930381|FG007|Overall Study|Adverse Event|0|||
164154866|NCT00437021|592930382|FG008|Overall Study|Adverse Event|0|||
164154867|NCT00437021|592930383|FG009|Overall Study|Adverse Event|0|||
164154868|NCT00437021|592930384|FG010|Overall Study|Adverse Event|0|||
164154869|NCT00437021|592930385|FG011|Overall Study|Adverse Event|0|||
164154870|NCT00437021|592930374|FG000|Overall Study|Lost to Follow-up|0|||
164154871|NCT00437021|592930375|FG001|Overall Study|Lost to Follow-up|3|||
164154872|NCT00437021|592930376|FG002|Overall Study|Lost to Follow-up|0|||
164154873|NCT00437021|592930377|FG003|Overall Study|Lost to Follow-up|0|||
164154874|NCT00437021|592930378|FG004|Overall Study|Lost to Follow-up|0|||
164154875|NCT00437021|592930379|FG005|Overall Study|Lost to Follow-up|2|||
164154876|NCT00437021|592930380|FG006|Overall Study|Lost to Follow-up|0|||
164154877|NCT00437021|592930381|FG007|Overall Study|Lost to Follow-up|1|||
164154878|NCT00437021|592930382|FG008|Overall Study|Lost to Follow-up|0|||
164154879|NCT00437021|592930383|FG009|Overall Study|Lost to Follow-up|0|||
164154880|NCT00437021|592930384|FG010|Overall Study|Lost to Follow-up|0|||
164154881|NCT00437021|592930385|FG011|Overall Study|Lost to Follow-up|0|||
164154882|NCT00437021|592930374|FG000|Overall Study|Withdrawal by Subject|2|||
164154883|NCT00437021|592930375|FG001|Overall Study|Withdrawal by Subject|1|||
164154884|NCT00437021|592930376|FG002|Overall Study|Withdrawal by Subject|0|||
164154885|NCT00437021|592930377|FG003|Overall Study|Withdrawal by Subject|0|||
164154886|NCT00437021|592930378|FG004|Overall Study|Withdrawal by Subject|0|||
164154887|NCT00437021|592930379|FG005|Overall Study|Withdrawal by Subject|0|||
164154888|NCT00437021|592930380|FG006|Overall Study|Withdrawal by Subject|0|||
164154889|NCT00437021|592930381|FG007|Overall Study|Withdrawal by Subject|0|||
164154890|NCT00437021|592930382|FG008|Overall Study|Withdrawal by Subject|0|||
164154891|NCT00437021|592930383|FG009|Overall Study|Withdrawal by Subject|0|||
164154892|NCT00437021|592930384|FG010|Overall Study|Withdrawal by Subject|0|||
164154893|NCT00437021|592930385|FG011|Overall Study|Withdrawal by Subject|0|||
164154894|NCT04162847|592930386|FG000|Overall Study|Withdrawal by Subject|7|||
164154895|NCT04162847|592930387|FG001|Overall Study|Withdrawal by Subject|1|||
164154896|NCT03985800|592930388|FG000|Overall Study|Death|1|||
164154897|NCT03985800|592930389|FG001|Overall Study|Death|2|||
164154898|NCT03985800|592930388|FG000|Overall Study|Withdrawal by Subject|3|||
164154899|NCT03985800|592930389|FG001|Overall Study|Withdrawal by Subject|6|||
164154900|NCT03985800|592930388|FG000|Overall Study|Protocol Violation|2|||
164154901|NCT03985800|592930389|FG001|Overall Study|Protocol Violation|0|||
164154902|NCT05258773|592930390|FG000|Overall Study|Screen Failure|1|||
164154903|NCT05258773|592930391|FG001|Overall Study|Screen Failure|1|||
164154904|NCT05258773|592930390|FG000|Overall Study|Adverse Event|1|||
164154905|NCT05258773|592930391|FG001|Overall Study|Adverse Event|0|||
164154906|NCT05258773|592930390|FG000|Overall Study|Withdrawal by Subject|0|||
164154907|NCT05258773|592930391|FG001|Overall Study|Withdrawal by Subject|1|||
164154908|NCT03018288|592930392|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
164154909|NCT03018288|592930393|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
164154910|NCT03018288|592930394|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
164154911|NCT03018288|592930395|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
164154912|NCT03018288|592930392|FG000|Overall Study|Participant withdrew consent.|0|||
164154913|NCT03018288|592930393|FG001|Overall Study|Participant withdrew consent.|0|||
164154914|NCT03018288|592930394|FG002|Overall Study|Participant withdrew consent.|1|||
164154915|NCT03018288|592930395|FG003|Overall Study|Participant withdrew consent.|0|||
164154916|NCT03018288|592930392|FG000|Overall Study|Switched to alternative treatment.|0|||
164154917|NCT03018288|592930393|FG001|Overall Study|Switched to alternative treatment.|0|||
164154918|NCT03018288|592930394|FG002|Overall Study|Switched to alternative treatment.|1|||
164154919|NCT03018288|592930395|FG003|Overall Study|Switched to alternative treatment.|0|||
164154920|NCT03018288|592930392|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
164154921|NCT03018288|592930393|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
164154922|NCT03018288|592930394|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
164154923|NCT03018288|592930395|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
164154924|NCT03018288|592930392|FG000|Overall Study|Screen failures|0|||
164154925|NCT03018288|592930393|FG001|Overall Study|Screen failures|0|||
164154926|NCT03018288|592930394|FG002|Overall Study|Screen failures|0|||
164154927|NCT03018288|592930395|FG003|Overall Study|Screen failures|51|||
164154928|NCT03018288|592930392|FG000|Overall Study|Chose treatment outside of UNC|0|||
164154929|NCT03018288|592930393|FG001|Overall Study|Chose treatment outside of UNC|0|||
164154930|NCT03018288|592930394|FG002|Overall Study|Chose treatment outside of UNC|0|||
164154931|NCT03018288|592930395|FG003|Overall Study|Chose treatment outside of UNC|1|||
164154932|NCT03018288|592930392|FG000|Overall Study|Unable to comply with protocol requirements|1|||
164154933|NCT03018288|592930393|FG001|Overall Study|Unable to comply with protocol requirements|1|||
164154934|NCT03018288|592930394|FG002|Overall Study|Unable to comply with protocol requirements|0|||
164154935|NCT03018288|592930395|FG003|Overall Study|Unable to comply with protocol requirements|1|||
164154936|NCT03018288|592930392|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
164154937|NCT03018288|592930393|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
164154938|NCT03018288|592930394|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
164154939|NCT03018288|592930395|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
164154940|NCT03018288|592930392|FG000|Overall Study|Physician Decision|0|||
164154941|NCT03018288|592930393|FG001|Overall Study|Physician Decision|0|||
164154942|NCT03018288|592930394|FG002|Overall Study|Physician Decision|0|||
164154943|NCT03018288|592930395|FG003|Overall Study|Physician Decision|1|||
164154944|NCT04173507|592930398|FG000|Overall Study|On Treatment|3|||
164154945|NCT04173507|592930398|FG000|Overall Study|Adverse Event|3|||
164154946|NCT04173507|592930398|FG000|Overall Study|Progression/Relapse|34|||
164154947|NCT04173507|592930398|FG000|Overall Study|Death|2|||
164154948|NCT02832687|592930399|FG000|Overall Study|Adverse Event|0|||
164154949|NCT02832687|592930400|FG001|Overall Study|Adverse Event|2|||
164154950|NCT04231825|592930401|FG000|Overall Study|Protocol Violation|3|||
164154951|NCT04231825|592930402|FG001|Overall Study|Protocol Violation|3|||
164154952|NCT04231825|592930401|FG000|Overall Study|Lost to Follow-up|0|||
164154953|NCT04231825|592930402|FG001|Overall Study|Lost to Follow-up|1|||
164154954|NCT02844933|592930403|FG000|Overall Study|Discontinued due to premature termination of study|3|||
164154955|NCT02844933|592930404|FG001|Overall Study|Discontinued due to premature termination of study|2|||
164154956|NCT01479465|592930405|FG000|Overall Study|Disease Progression|9|||
164154957|NCT01479465|592930406|FG001|Overall Study|Disease Progression|61|||
164154958|NCT01479465|592930407|FG002|Overall Study|Disease Progression|65|||
164154959|NCT01479465|592930408|FG003|Overall Study|Disease Progression|70|||
164154960|NCT01479465|592930405|FG000|Overall Study|Study Discontinued by Sponsor|0|||
164154961|NCT01479465|592930406|FG001|Overall Study|Study Discontinued by Sponsor|7|||
164154962|NCT01479465|592930407|FG002|Overall Study|Study Discontinued by Sponsor|5|||
164154963|NCT01479465|592930408|FG003|Overall Study|Study Discontinued by Sponsor|3|||
164154964|NCT01479465|592930405|FG000|Overall Study|Adverse Event|0|||
164154965|NCT01479465|592930406|FG001|Overall Study|Adverse Event|3|||
164154966|NCT01479465|592930407|FG002|Overall Study|Adverse Event|6|||
164154967|NCT01479465|592930408|FG003|Overall Study|Adverse Event|4|||
164154968|NCT01479465|592930405|FG000|Overall Study|Investigator Discretion|1|||
164154969|NCT01479465|592930406|FG001|Overall Study|Investigator Discretion|4|||
164154970|NCT01479465|592930407|FG002|Overall Study|Investigator Discretion|2|||
164154971|NCT01479465|592930408|FG003|Overall Study|Investigator Discretion|4|||
164154972|NCT01479465|592930405|FG000|Overall Study|Subject Request|1|||
164154973|NCT01479465|592930406|FG001|Overall Study|Subject Request|3|||
164154974|NCT01479465|592930407|FG002|Overall Study|Subject Request|4|||
164154975|NCT01479465|592930408|FG003|Overall Study|Subject Request|2|||
164154976|NCT01479465|592930405|FG000|Overall Study|Subject Withdrew Consent|0|||
164154977|NCT01479465|592930406|FG001|Overall Study|Subject Withdrew Consent|5|||
164154978|NCT01479465|592930407|FG002|Overall Study|Subject Withdrew Consent|2|||
164154979|NCT01479465|592930408|FG003|Overall Study|Subject Withdrew Consent|1|||
164154980|NCT01479465|592930405|FG000|Overall Study|Protocol Violation|0|||
164154981|NCT01479465|592930406|FG001|Overall Study|Protocol Violation|1|||
164154982|NCT01479465|592930407|FG002|Overall Study|Protocol Violation|1|||
164154983|NCT01479465|592930408|FG003|Overall Study|Protocol Violation|0|||
164154984|NCT01479465|592930405|FG000|Overall Study|Death|0|||
164154985|NCT01479465|592930406|FG001|Overall Study|Death|0|||
164154986|NCT01479465|592930407|FG002|Overall Study|Death|0|||
164154987|NCT01479465|592930408|FG003|Overall Study|Death|1|||
164154988|NCT01479465|592930405|FG000|Overall Study|Lost to Follow-up|0|||
164154989|NCT01479465|592930406|FG001|Overall Study|Lost to Follow-up|0|||
164154990|NCT01479465|592930407|FG002|Overall Study|Lost to Follow-up|1|||
164154991|NCT01479465|592930408|FG003|Overall Study|Lost to Follow-up|0|||
164154992|NCT01439802|592930410|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
164154993|NCT01439802|592930410|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
164154994|NCT02392481|592930414|FG000|Overall Study|Adverse Event|0|||
164154995|NCT02392481|592930415|FG001|Overall Study|Adverse Event|0|||
164154996|NCT02392481|592930416|FG002|Overall Study|Adverse Event|1|||
164154997|NCT02392481|592930417|FG003|Overall Study|Adverse Event|2|||
164154998|NCT02392481|592930414|FG000|Overall Study|Withdrawal by Subject|0|||
164154999|NCT02392481|592930415|FG001|Overall Study|Withdrawal by Subject|0|||
164155000|NCT02392481|592930416|FG002|Overall Study|Withdrawal by Subject|1|||
164155001|NCT02392481|592930417|FG003|Overall Study|Withdrawal by Subject|0|||
164155002|NCT02502149|592930418|FG000|Intermediate|Discontinued prematurely|1|||
164155003|NCT02502149|592930419|FG001|Intermediate|Discontinued prematurely|0|||
164155004|NCT02502149|592930420|FG002|Intermediate|Discontinued prematurely|0|||
164155005|NCT02502149|592930421|FG003|Intermediate|Discontinued prematurely|0|||
164155006|NCT02502149|592930422|FG004|Intermediate|Discontinued prematurely|0|||
164155007|NCT04067050|592930423|FG000|One Month|Lost to Follow-up|4|||
164155008|NCT04067050|592930424|FG001|One Month|Lost to Follow-up|0|||
164155009|NCT04067050|592930423|FG000|Two Month|Lost to Follow-up|1|||
164155010|NCT04067050|592930424|FG001|Two Month|Lost to Follow-up|0|||
164155011|NCT04067050|592930423|FG000|Two Month|Adverse Event|1|||
164155012|NCT04067050|592930424|FG001|Two Month|Adverse Event|0|||
164155013|NCT02088177|592930432|FG000|Overall Study|Lost to Follow-up|3|||
164155014|NCT01234350|592930433|FG000|Overall Study|Adverse Event|277|||
164155015|NCT01234350|592930434|FG001|Overall Study|Adverse Event|92|||
164155016|NCT01234350|592930433|FG000|Overall Study|Withdrawal by Subject|61|||
164155017|NCT01234350|592930434|FG001|Overall Study|Withdrawal by Subject|36|||
164155018|NCT01234350|592930433|FG000|Overall Study|Lost to Follow-up|115|||
164155019|NCT01234350|592930434|FG001|Overall Study|Lost to Follow-up|47|||
164155020|NCT01234350|592930433|FG000|Overall Study|Covers a diverse set of reasons|234|||
164155021|NCT01234350|592930434|FG001|Overall Study|Covers a diverse set of reasons|92|||
164155022|NCT00289848|592930435|FG000|Overall Study|Adverse Event|6|||
164155023|NCT00289848|592930436|FG001|Overall Study|Adverse Event|4|||
164155024|NCT00289848|592930435|FG000|Overall Study|Death|1|||
164155025|NCT00289848|592930436|FG001|Overall Study|Death|0|||
164155026|NCT00289848|592930435|FG000|Overall Study|Lack of Efficacy|20|||
164155027|NCT00289848|592930436|FG001|Overall Study|Lack of Efficacy|24|||
164155028|NCT00289848|592930435|FG000|Overall Study|Lost to Follow-up|3|||
164155029|NCT00289848|592930436|FG001|Overall Study|Lost to Follow-up|1|||
164155030|NCT00289848|592930435|FG000|Overall Study|Protocol Violation|5|||
164155031|NCT00289848|592930436|FG001|Overall Study|Protocol Violation|2|||
164155032|NCT00289848|592930435|FG000|Overall Study|Withdrawal by Subject|5|||
164155033|NCT00289848|592930436|FG001|Overall Study|Withdrawal by Subject|11|||
164155034|NCT00289848|592930435|FG000|Overall Study|Patient Moved|6|||
164155035|NCT00289848|592930436|FG001|Overall Study|Patient Moved|2|||
164155036|NCT00289848|592930435|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
164155037|NCT00289848|592930436|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
164155038|NCT01836471|592930445|FG000|Overall Study|Pregnancy|1|||
164155039|NCT01836471|592930446|FG001|Overall Study|Pregnancy|0|||
164155040|NCT01836471|592930447|FG002|Overall Study|Pregnancy|0|||
164155041|NCT01836471|592930448|FG003|Overall Study|Pregnancy|0|||
164155042|NCT01836471|592930449|FG004|Overall Study|Pregnancy|0|||
164155043|NCT01836471|592930445|FG000|Overall Study|Withdrawal by Subject|3|||
164155044|NCT01836471|592930446|FG001|Overall Study|Withdrawal by Subject|4|||
164155045|NCT01836471|592930447|FG002|Overall Study|Withdrawal by Subject|1|||
164155046|NCT01836471|592930448|FG003|Overall Study|Withdrawal by Subject|0|||
164155047|NCT01836471|592930449|FG004|Overall Study|Withdrawal by Subject|2|||
164155048|NCT01836471|592930445|FG000|Overall Study|Physician Decision|0|||
164155049|NCT01836471|592930446|FG001|Overall Study|Physician Decision|1|||
164155050|NCT01836471|592930447|FG002|Overall Study|Physician Decision|0|||
164155051|NCT01836471|592930448|FG003|Overall Study|Physician Decision|0|||
164155052|NCT01836471|592930449|FG004|Overall Study|Physician Decision|0|||
164155053|NCT01836471|592930445|FG000|Overall Study|Lost to Follow-up|0|||
164155054|NCT01836471|592930446|FG001|Overall Study|Lost to Follow-up|0|||
164155055|NCT01836471|592930447|FG002|Overall Study|Lost to Follow-up|0|||
164155056|NCT01836471|592930448|FG003|Overall Study|Lost to Follow-up|1|||
164155057|NCT01836471|592930449|FG004|Overall Study|Lost to Follow-up|1|||
164155058|NCT01836471|592930445|FG000|Overall Study|Adverse Event|6|||
164155059|NCT01836471|592930446|FG001|Overall Study|Adverse Event|3|||
164155060|NCT01836471|592930447|FG002|Overall Study|Adverse Event|1|||
164155061|NCT01836471|592930448|FG003|Overall Study|Adverse Event|1|||
164155062|NCT01836471|592930449|FG004|Overall Study|Adverse Event|2|||
164155063|NCT01836471|592930445|FG000|Overall Study|Non compliance with tx|1|||
164155064|NCT01836471|592930446|FG001|Overall Study|Non compliance with tx|1|||
164155065|NCT01836471|592930447|FG002|Overall Study|Non compliance with tx|0|||
164155066|NCT01836471|592930448|FG003|Overall Study|Non compliance with tx|0|||
164155067|NCT01836471|592930449|FG004|Overall Study|Non compliance with tx|0|||
164155068|NCT02570308|592930452|FG000|Overall Study|Death|1|||
164155069|NCT02570308|592930453|FG001|Overall Study|Death|5|||
164155070|NCT02570308|592930454|FG002|Overall Study|Death|4|||
164155071|NCT02570308|592930455|FG003|Overall Study|Death|4|||
164155072|NCT02570308|592930456|FG004|Overall Study|Death|69|||
164155073|NCT02570308|592930452|FG000|Overall Study|Lost to Follow-up|0|||
164155074|NCT02570308|592930453|FG001|Overall Study|Lost to Follow-up|0|||
164155075|NCT02570308|592930454|FG002|Overall Study|Lost to Follow-up|0|||
164155076|NCT02570308|592930455|FG003|Overall Study|Lost to Follow-up|0|||
164155077|NCT02570308|592930456|FG004|Overall Study|Lost to Follow-up|2|||
164155078|NCT02570308|592930452|FG000|Overall Study|Withdrawal by Subject|0|||
164155079|NCT02570308|592930453|FG001|Overall Study|Withdrawal by Subject|0|||
164155080|NCT02570308|592930454|FG002|Overall Study|Withdrawal by Subject|0|||
164155081|NCT02570308|592930455|FG003|Overall Study|Withdrawal by Subject|0|||
164155082|NCT02570308|592930456|FG004|Overall Study|Withdrawal by Subject|1|||
164155083|NCT02570308|592930452|FG000|Overall Study|Other|0|||
164155084|NCT02570308|592930453|FG001|Overall Study|Other|0|||
164155085|NCT02570308|592930454|FG002|Overall Study|Other|0|||
164155086|NCT02570308|592930455|FG003|Overall Study|Other|0|||
164155087|NCT02570308|592930456|FG004|Overall Study|Other|2|||
164155088|NCT01960413|592930457|FG000|Overall Study|Withdrawal by Subject|1|||
164155089|NCT01960413|592930458|FG001|Overall Study|Withdrawal by Subject|1|||
164155090|NCT01960413|592930457|FG000|Overall Study|Physician Decision|1|||
164155091|NCT01960413|592930458|FG001|Overall Study|Physician Decision|0|||
164155092|NCT01960413|592930457|FG000|Overall Study|Lost to Follow-up|2|||
164155093|NCT01960413|592930458|FG001|Overall Study|Lost to Follow-up|0|||
164155094|NCT02285361|592930459|FG000|Overall Study|Protocol Violation|43|||
164155095|NCT02285361|592930459|FG000|Overall Study|Lost to Follow-up|5|||
164155096|NCT02285361|592930459|FG000|Overall Study|Not taken GIOTRIF|2|||
164155097|NCT02285361|592930459|FG000|Overall Study|Consented prior to the contract date|1|||
164155098|NCT01283464|592930460|FG000|Overall Study|Lost to Follow-up|0|||
164155099|NCT01283464|592930461|FG001|Overall Study|Lost to Follow-up|1|||
164155100|NCT01283464|592930460|FG000|Overall Study|Withdrawal by Subject|1|||
164155101|NCT01283464|592930461|FG001|Overall Study|Withdrawal by Subject|0|||
164155102|NCT01283464|592930460|FG000|Overall Study|Physician Decision|1|||
164155103|NCT01283464|592930461|FG001|Overall Study|Physician Decision|0|||
164155104|NCT03051100|592930462|FG000|Overall Study|Withdrawal by Subject|1|||
164155105|NCT03051100|592930463|FG001|Overall Study|Withdrawal by Subject|0|||
164155106|NCT02626026|592930464|FG000|Overall Study|Randomized but Never Treated|0|||
164155107|NCT02626026|592930465|FG001|Overall Study|Randomized but Never Treated|0|||
164155108|NCT02626026|592930466|FG002|Overall Study|Randomized but Never Treated|0|||
164155109|NCT02626026|592930467|FG003|Overall Study|Randomized but Never Treated|0|||
164155110|NCT02626026|592930468|FG004|Overall Study|Randomized but Never Treated|1|||
164155111|NCT02626026|592930469|FG005|Overall Study|Randomized but Never Treated|0|||
164155112|NCT01778855|592930470|FG000|Overall Study|Death|0|||
164155113|NCT01778855|592930471|FG001|Overall Study|Death|1|||
164155114|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
164155115|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
164155116|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
164155117|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
164155118|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
164155119|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
164155120|NCT02059135|592930472|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
164155121|NCT02059135|592930473|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
164155122|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
164155123|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
164155124|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
164155125|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
164155126|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
164155127|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
164155128|NCT02059135|592930472|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
164155129|NCT02059135|592930473|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
164155130|NCT05921903|592930474|FG000|Overall Study|Unsolicited non-SAE|0|||
164155131|NCT05921903|592930475|FG001|Overall Study|Unsolicited non-SAE|1|||
164155132|NCT05921903|592930476|FG002|Overall Study|Unsolicited non-SAE|0|||
164155133|NCT05921903|592930474|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
164155134|NCT05921903|592930475|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
164155135|NCT05921903|592930476|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
164155136|NCT05921903|592930474|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
164155137|NCT05921903|592930475|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
164155138|NCT05921903|592930476|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
164155139|NCT03305848|592930477|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
164155140|NCT03305848|592930477|FG000|Overall Study|Physician Decision|2|||
164155141|NCT05366010|592930479|FG000|Overall Study|Withdrawal by Subject|1|||
164155142|NCT05366010|592930479|FG000|Overall Study|Protocol Violation|1|||
164155143|NCT05366010|592930479|FG000|Overall Study|Lost to Follow-up|2|||
164155144|NCT05366010|592930479|FG000|Overall Study|Screen Failure|2|||
164155145|NCT02224157|592930480|FG000|Overall Study|Severe non-compliance to protocol|2|||
164155146|NCT02224157|592930481|FG001|Overall Study|Severe non-compliance to protocol|2|||
164155147|NCT02224157|592930480|FG000|Overall Study|Other|13|||
164155148|NCT02224157|592930481|FG001|Overall Study|Other|10|||
164155149|NCT02224157|592930480|FG000|Overall Study|Subject decision|58|||
164155150|NCT02224157|592930481|FG001|Overall Study|Subject decision|50|||
164155151|NCT02224157|592930480|FG000|Overall Study|Prematurely closed site|4|||
164155152|NCT02224157|592930481|FG001|Overall Study|Prematurely closed site|2|||
164155153|NCT02224157|592930480|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
164155154|NCT02224157|592930481|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
164155155|NCT02224157|592930480|FG000|Overall Study|Lost to Follow-up|27|||
164155156|NCT02224157|592930481|FG001|Overall Study|Lost to Follow-up|35|||
164155157|NCT02224157|592930480|FG000|Overall Study|Death|1|||
164155158|NCT02224157|592930481|FG001|Overall Study|Death|1|||
164155159|NCT02224157|592930480|FG000|Overall Study|Adverse Event|1|||
164155160|NCT02224157|592930481|FG001|Overall Study|Adverse Event|3|||
164155161|NCT05906628|592930482|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
164155162|NCT05906628|592930483|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
164155163|NCT05906628|592930482|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
164155164|NCT05906628|592930483|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
164155165|NCT05906628|592930482|FG000|16-Week DBVC Period|Protocol Violation|4|||
164155166|NCT05906628|592930483|FG001|16-Week DBVC Period|Protocol Violation|2|||
164155167|NCT05906628|592930482|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
164155168|NCT05906628|592930483|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
164155169|NCT05906628|592930482|FG000|16-Week OLE Period|Death|1|||
164155170|NCT05906628|592930483|FG001|16-Week OLE Period|Death|0|||
164155171|NCT05906628|592930482|FG000|16-Week OLE Period|Lost to Follow-up|1|||
164155172|NCT05906628|592930483|FG001|16-Week OLE Period|Lost to Follow-up|1|||
164155173|NCT05906628|592930482|FG000|16-Week OLE Period|Protocol Violation|0|||
164155174|NCT05906628|592930483|FG001|16-Week OLE Period|Protocol Violation|1|||
164155175|NCT05906628|592930482|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
164155176|NCT05906628|592930483|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
164155177|NCT02301169|592930484|FG000|Overall Study|Adverse Event|1|||
164155178|NCT02301169|592930485|FG001|Overall Study|Adverse Event|0|||
164155179|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
164155180|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
164155181|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
164155182|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
164155183|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
164155184|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
164155185|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
164155186|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
164155187|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
164155188|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
164155189|NCT03762265|592930486|FG000|BT Period: Weeks 1 to 37|Other|0|||
164155190|NCT03762265|592930487|FG001|BT Period: Weeks 1 to 37|Other|1|||
164155191|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
164155192|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
164155193|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
164155194|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
164155195|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
164155196|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
164155197|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
164155198|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
164155199|NCT03762265|592930486|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
164155200|NCT03762265|592930487|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
164155201|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
164155202|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
164155203|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
164155204|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
164155205|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
164155206|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
164155207|NCT03762265|592930486|FG000|LTE Period: Weeks 61 to 109|Other|1|||
164155208|NCT03762265|592930487|FG001|LTE Period: Weeks 61 to 109|Other|0|||
164155209|NCT00765102|592930488|FG000|Overall Study|Progressive disease|18|||
164155210|NCT00765102|592930488|FG000|Overall Study|Adverse Event|6|||
164155211|NCT00765102|592930488|FG000|Overall Study|Physician Decision|4|||
164155212|NCT00765102|592930488|FG000|Overall Study|Withdrawal by Subject|2|||
164155213|NCT00765102|592930488|FG000|Overall Study|Protocol Violation|1|||
164155214|NCT02289729|592930491|FG000|Overall Study|Lack of Efficacy|3|||
164155215|NCT02289729|592930491|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
164155216|NCT02289729|592930491|FG000|Overall Study|Withdrawal by Subject|1|||
164155217|NCT02289729|592930491|FG000|Overall Study|Death|1|||
164155218|NCT00470470|592930492|FG000|Overall Study|Adverse Event|2|||
164155219|NCT00470470|592930492|FG000|Overall Study|Death|2|||
164155220|NCT00470470|592930492|FG000|Overall Study|Not treated|1|||
164155221|NCT02046603|592930493|FG000|Overall Study|Other|11|||
164155222|NCT02046603|592930494|FG001|Overall Study|Other|66|||
164155223|NCT02046603|592930493|FG000|Overall Study|Protocol Violation|0|||
164155224|NCT02046603|592930494|FG001|Overall Study|Protocol Violation|1|||
164155225|NCT02046603|592930493|FG000|Overall Study|Participant/legal guardian decision|1|||
164155226|NCT02046603|592930494|FG001|Overall Study|Participant/legal guardian decision|3|||
164155227|NCT02046603|592930493|FG000|Overall Study|Physician Decision|2|||
164155228|NCT02046603|592930494|FG001|Overall Study|Physician Decision|1|||
164155229|NCT02046603|592930493|FG000|Overall Study|Lost to Follow-up|1|||
164155230|NCT02046603|592930494|FG001|Overall Study|Lost to Follow-up|2|||
164155231|NCT02046603|592930493|FG000|Overall Study|Death|0|||
164155232|NCT02046603|592930494|FG001|Overall Study|Death|1|||
164155233|NCT02046603|592930493|FG000|Overall Study|Adverse Event|0|||
164155234|NCT02046603|592930494|FG001|Overall Study|Adverse Event|1|||
164155235|NCT02461160|592930495|FG000|Overall Study|Lost to Follow-up|0|||
164155236|NCT02461160|592930496|FG001|Overall Study|Lost to Follow-up|0|||
164155237|NCT02461160|592930497|FG002|Overall Study|Lost to Follow-up|0|||
164155238|NCT02461160|592930498|FG003|Overall Study|Lost to Follow-up|0|||
164155239|NCT02461160|592930499|FG004|Overall Study|Lost to Follow-up|0|||
164155240|NCT02461160|592930500|FG005|Overall Study|Lost to Follow-up|0|||
164155241|NCT02461160|592930501|FG006|Overall Study|Lost to Follow-up|0|||
164155242|NCT02461160|592930502|FG007|Overall Study|Lost to Follow-up|1|||
164155243|NCT02461160|592930503|FG008|Overall Study|Lost to Follow-up|0|||
164155244|NCT02461160|592930504|FG009|Overall Study|Lost to Follow-up|0|||
164155245|NCT02461160|592930505|FG010|Overall Study|Lost to Follow-up|0|||
164155246|NCT02461160|592930506|FG011|Overall Study|Lost to Follow-up|0|||
164155247|NCT02461160|592930507|FG012|Overall Study|Lost to Follow-up|0|||
164155248|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
164155249|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
164155250|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Physician Decision|2|||
164155251|NCT00193050|592930508|FG000|Neoadjuvant Treatment|Adverse Event|2|||
164155252|NCT00193050|592930508|FG000|Adjuvant|Physician Decision|5|||
164155253|NCT00193050|592930508|FG000|Adjuvant|Intercurrent Hospitalization|3|||
164155254|NCT00193050|592930508|FG000|Adjuvant|Lack of Efficacy|2|||
164155255|NCT02431364|592930509|FG000|Overall Study|Adverse Event|0|||
164155256|NCT02431364|592930510|FG001|Overall Study|Adverse Event|1|||
164155257|NCT02431364|592930511|FG002|Overall Study|Adverse Event|0|||
164155258|NCT02431364|592930512|FG003|Overall Study|Adverse Event|0|||
164155259|NCT02431364|592930513|FG004|Overall Study|Adverse Event|0|||
164155260|NCT02431364|592930509|FG000|Overall Study|Randomized but never treated|0|||
164155261|NCT02431364|592930510|FG001|Overall Study|Randomized but never treated|0|||
164155262|NCT02431364|592930511|FG002|Overall Study|Randomized but never treated|0|||
164155263|NCT02431364|592930512|FG003|Overall Study|Randomized but never treated|1|||
164155264|NCT02431364|592930513|FG004|Overall Study|Randomized but never treated|0|||
164155265|NCT00061932|592930514|FG000|Overall Study|Withdrawal by Subject|13|||
164155266|NCT00061932|592930515|FG001|Overall Study|Withdrawal by Subject|4|||
164155267|NCT03367819|592930516|FG000|Overall Study|Adverse Event|4|||
164155268|NCT03367819|592930517|FG001|Overall Study|Adverse Event|4|||
164155269|NCT03367819|592930516|FG000|Overall Study|Progressive Disease|15|||
164155270|NCT03367819|592930517|FG001|Overall Study|Progressive Disease|13|||
164155271|NCT03367819|592930516|FG000|Overall Study|Withdrawal by Subject|1|||
164155272|NCT03367819|592930517|FG001|Overall Study|Withdrawal by Subject|0|||
164155273|NCT03367819|592930516|FG000|Overall Study|Other|4|||
164155274|NCT03367819|592930517|FG001|Overall Study|Other|2|||
164155275|NCT00445146|592930520|FG000|Overall Study|Withdrew Consent|29|||
164155276|NCT00445146|592930520|FG000|Overall Study|Lack of Efficacy|28|||
164155277|NCT00445146|592930520|FG000|Overall Study|Investigator's Discretion|22|||
164155278|NCT00445146|592930520|FG000|Overall Study|Adverse Event|13|||
164155279|NCT00445146|592930520|FG000|Overall Study|Lost to Follow-up|13|||
164155280|NCT00445146|592930520|FG000|Overall Study|Death|9|||
164155281|NCT00445146|592930520|FG000|Overall Study|Protocol Violation|4|||
164155282|NCT00445146|592930520|FG000|Overall Study|Pregnancy|1|||
164155283|NCT02456740|592930521|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
164155284|NCT02456740|592930522|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
164155285|NCT02456740|592930523|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
164155286|NCT02456740|592930524|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155287|NCT02456740|592930525|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155288|NCT02456740|592930526|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155289|NCT02456740|592930527|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155290|NCT02456740|592930528|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155291|NCT02456740|592930529|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
164155292|NCT02456740|592930521|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
164155293|NCT02456740|592930522|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
164155294|NCT02456740|592930523|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
164155295|NCT02456740|592930524|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155296|NCT02456740|592930525|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155297|NCT02456740|592930526|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155298|NCT02456740|592930527|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155299|NCT02456740|592930528|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155300|NCT02456740|592930529|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
164155301|NCT02456740|592930521|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
164155302|NCT02456740|592930522|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
164155303|NCT02456740|592930523|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
164155446|NCT02445248|592932284|FG000|Overall Study|Lost to Follow-up|1|||
164155304|NCT02456740|592930524|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155305|NCT02456740|592930525|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155306|NCT02456740|592930526|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155307|NCT02456740|592930527|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155308|NCT02456740|592930528|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155309|NCT02456740|592930529|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
164155310|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155311|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155312|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155313|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
164155314|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
164155315|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155316|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155317|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
164155318|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
164155319|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164155320|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164155321|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
164155322|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
164155323|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
164155324|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
164155325|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
164155326|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
164155327|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
164155328|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155329|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155330|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155331|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155332|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155333|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155334|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155335|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
164155336|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
164155337|NCT02456740|592930521|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164155338|NCT02456740|592930522|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164155339|NCT02456740|592930523|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
164155340|NCT02456740|592930524|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
164155341|NCT02456740|592930525|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
164155342|NCT02456740|592930526|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
164155343|NCT02456740|592930527|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
164155344|NCT02456740|592930528|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
164155345|NCT02456740|592930529|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
164155346|NCT04720105|592930533|FG000|Overall Study|Lack of Efficacy|1|||
164155347|NCT04720105|592930533|FG000|Overall Study|Lost to Follow-up|1|||
164155348|NCT04720105|592930533|FG000|Overall Study|Withdrawal by Subject|3|||
164155349|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
164155350|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
164155351|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
164155352|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
164155353|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
164155354|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
164155355|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
164155356|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
164155357|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
164155358|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Other|1|||
164155359|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Other|0|||
164155360|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Other|4|||
164155361|NCT02654054|592930538|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164155362|NCT02654054|592930539|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
164155363|NCT02654054|592930540|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
164155364|NCT04871776|592930541|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
164155365|NCT04871776|592930542|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
164155366|NCT04871776|592930543|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
164155367|NCT04871776|592930541|FG000|Overall Study|Did not meet eligibility criteria|1|||
164155368|NCT04871776|592930542|FG001|Overall Study|Did not meet eligibility criteria|1|||
164155369|NCT04871776|592930543|FG002|Overall Study|Did not meet eligibility criteria|1|||
164155370|NCT02844543|592932247|FG000|Overall Study|Withdrawal by Subject|4|||
164155371|NCT02844543|592932247|FG000|Overall Study|Did not meet eligibility criteria|1|||
164155372|NCT03349060|592932248|FG000|Overall Study|Adverse Event|9|||
164155373|NCT03349060|592932249|FG001|Overall Study|Adverse Event|9|||
164155374|NCT03349060|592932250|FG002|Overall Study|Adverse Event|7|||
164155375|NCT03349060|592932248|FG000|Overall Study|Lack of Efficacy|1|||
164155376|NCT03349060|592932249|FG001|Overall Study|Lack of Efficacy|0|||
164155377|NCT03349060|592932250|FG002|Overall Study|Lack of Efficacy|2|||
164155378|NCT03349060|592932248|FG000|Overall Study|Lost to Follow-up|2|||
164155379|NCT03349060|592932249|FG001|Overall Study|Lost to Follow-up|1|||
164155380|NCT03349060|592932250|FG002|Overall Study|Lost to Follow-up|1|||
164155381|NCT03349060|592932248|FG000|Overall Study|Protocol Violation|2|||
164155382|NCT03349060|592932249|FG001|Overall Study|Protocol Violation|2|||
164155383|NCT03349060|592932250|FG002|Overall Study|Protocol Violation|1|||
164155384|NCT03349060|592932248|FG000|Overall Study|Withdrawal by Subject|5|||
164155385|NCT03349060|592932249|FG001|Overall Study|Withdrawal by Subject|3|||
164155386|NCT03349060|592932250|FG002|Overall Study|Withdrawal by Subject|4|||
164155387|NCT03349060|592932248|FG000|Overall Study|Medication error,no linked adverse event|0|||
164155388|NCT03349060|592932249|FG001|Overall Study|Medication error,no linked adverse event|0|||
164155389|NCT03349060|592932250|FG002|Overall Study|Medication error,no linked adverse event|1|||
164155390|NCT03349060|592932248|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
164155391|NCT03349060|592932249|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
164155392|NCT03349060|592932250|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
164155393|NCT03349060|592932248|FG000|Overall Study|Other|2|||
164155394|NCT03349060|592932249|FG001|Overall Study|Other|1|||
164155395|NCT03349060|592932250|FG002|Overall Study|Other|0|||
164155396|NCT02861586|592932251|FG000|Overall Study|Withdrawal by Subject|1|||
164155397|NCT02861586|592932252|FG001|Overall Study|Withdrawal by Subject|2|||
164155398|NCT02861586|592932253|FG002|Overall Study|Withdrawal by Subject|0|||
164155399|NCT02861586|592932254|FG003|Overall Study|Withdrawal by Subject|0|||
164155400|NCT02861586|592932255|FG004|Overall Study|Withdrawal by Subject|0|||
164155401|NCT02861586|592932256|FG005|Overall Study|Withdrawal by Subject|1|||
164155402|NCT02861586|592932257|FG006|Overall Study|Withdrawal by Subject|1|||
164155403|NCT02861586|592932258|FG007|Overall Study|Withdrawal by Subject|0|||
164155404|NCT02861586|592932251|FG000|Overall Study|Lost to Follow-up|3|||
164155405|NCT02861586|592932252|FG001|Overall Study|Lost to Follow-up|1|||
164155406|NCT02861586|592932253|FG002|Overall Study|Lost to Follow-up|1|||
164155407|NCT02861586|592932254|FG003|Overall Study|Lost to Follow-up|0|||
164155408|NCT02861586|592932255|FG004|Overall Study|Lost to Follow-up|0|||
164155409|NCT02861586|592932256|FG005|Overall Study|Lost to Follow-up|3|||
164155410|NCT02861586|592932257|FG006|Overall Study|Lost to Follow-up|0|||
164155411|NCT02861586|592932258|FG007|Overall Study|Lost to Follow-up|0|||
164155412|NCT02861586|592932251|FG000|Overall Study|Adverse Event|0|||
164155413|NCT02861586|592932252|FG001|Overall Study|Adverse Event|0|||
164155414|NCT02861586|592932253|FG002|Overall Study|Adverse Event|0|||
164155415|NCT02861586|592932254|FG003|Overall Study|Adverse Event|0|||
164155416|NCT02861586|592932255|FG004|Overall Study|Adverse Event|0|||
164155417|NCT02861586|592932256|FG005|Overall Study|Adverse Event|1|||
164155418|NCT02861586|592932257|FG006|Overall Study|Adverse Event|0|||
164155419|NCT02861586|592932258|FG007|Overall Study|Adverse Event|0|||
164155420|NCT04710576|592932259|FG000|Overall Study|Participants still in the study|73|||
164155421|NCT04710576|592932260|FG001|Overall Study|Participants still in the study|70|||
164155422|NCT04710576|592932261|FG002|Overall Study|Participants still in the study|60|||
164155423|NCT04710576|592932259|FG000|Overall Study|Death|2|||
164155424|NCT04710576|592932260|FG001|Overall Study|Death|7|||
164155425|NCT04710576|592932261|FG002|Overall Study|Death|12|||
164155426|NCT04710576|592932259|FG000|Overall Study|Withdrawal by Subject|4|||
164155427|NCT04710576|592932260|FG001|Overall Study|Withdrawal by Subject|3|||
164155428|NCT04710576|592932261|FG002|Overall Study|Withdrawal by Subject|7|||
164155429|NCT04710576|592932259|FG000|Overall Study|Sponsor decision|1|||
164155430|NCT04710576|592932260|FG001|Overall Study|Sponsor decision|0|||
164155431|NCT04710576|592932261|FG002|Overall Study|Sponsor decision|0|||
164155432|NCT04796909|592932262|FG000|Overall Study|Withdrawal by Subject|1|||
164155433|NCT04796909|592932263|FG001|Overall Study|Withdrawal by Subject|1|||
164155434|NCT00075816|592932278|FG000|Overall Study|Did not undergo transplantation|14|||
164155435|NCT00075816|592932279|FG001|Overall Study|Did not undergo transplantation|11|||
164155436|NCT02445248|592932284|FG000|Overall Study|Death|45|||
164155437|NCT02445248|592932285|FG001|Overall Study|Death|12|||
164155438|NCT02445248|592932284|FG000|Overall Study|Progressive disease|13|||
164155439|NCT02445248|592932285|FG001|Overall Study|Progressive disease|1|||
164155440|NCT02445248|592932284|FG000|Overall Study|Subject decision|8|||
164155441|NCT02445248|592932285|FG001|Overall Study|Subject decision|0|||
164155442|NCT02445248|592932284|FG000|Overall Study|Physician Decision|5|||
164155443|NCT02445248|592932285|FG001|Overall Study|Physician Decision|0|||
164155444|NCT02445248|592932284|FG000|Overall Study|Adverse Event|1|||
164155445|NCT02445248|592932285|FG001|Overall Study|Adverse Event|0|||
164155447|NCT02445248|592932285|FG001|Overall Study|Lost to Follow-up|0|||
164155448|NCT01120184|592932286|FG000|Overall Study|Adverse Event|0|||
164155449|NCT01120184|592932287|FG001|Overall Study|Adverse Event|1|||
164155450|NCT01120184|592932288|FG002|Overall Study|Adverse Event|0|||
164155451|NCT01120184|592932286|FG000|Overall Study|Lost to Follow-up|13|||
164155452|NCT01120184|592932287|FG001|Overall Study|Lost to Follow-up|13|||
164155453|NCT01120184|592932288|FG002|Overall Study|Lost to Follow-up|11|||
164155454|NCT01120184|592932286|FG000|Overall Study|Physician Decision|9|||
164155455|NCT01120184|592932287|FG001|Overall Study|Physician Decision|1|||
164155456|NCT01120184|592932288|FG002|Overall Study|Physician Decision|3|||
164155457|NCT01120184|592932286|FG000|Overall Study|Reason not Specified|8|||
164155458|NCT01120184|592932287|FG001|Overall Study|Reason not Specified|3|||
164155459|NCT01120184|592932288|FG002|Overall Study|Reason not Specified|12|||
164155460|NCT01120184|592932286|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
164155461|NCT01120184|592932287|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
164155462|NCT01120184|592932288|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
164155463|NCT01120184|592932286|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
164155464|NCT01120184|592932287|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
164155465|NCT01120184|592932288|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
164155466|NCT01120184|592932286|FG000|Overall Study|Death|170|||
164155467|NCT01120184|592932287|FG001|Overall Study|Death|176|||
164155468|NCT01120184|592932288|FG002|Overall Study|Death|169|||
164155469|NCT02596971|592932291|FG000|Overall Study|Death|5|||
164155470|NCT02596971|592932292|FG001|Overall Study|Death|1|||
164155471|NCT02596971|592932293|FG002|Overall Study|Death|5|||
164155472|NCT02596971|592932291|FG000|Overall Study|Withdrawal by Subject|5|||
164155473|NCT02596971|592932292|FG001|Overall Study|Withdrawal by Subject|1|||
164155474|NCT02596971|592932293|FG002|Overall Study|Withdrawal by Subject|4|||
164155475|NCT00824772|592932294|FG000|Overall Study|Withdrawal by Subject|8|||
164155476|NCT00683618|592932295|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
164155477|NCT00683618|592932296|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
164155478|NCT00683618|592932297|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
164155479|NCT00683618|592932295|FG000|Randomised Treatment Period|Protocol Violation|0|||
164155480|NCT00683618|592932296|FG001|Randomised Treatment Period|Protocol Violation|1|||
164155481|NCT00683618|592932297|FG002|Randomised Treatment Period|Protocol Violation|0|||
164155482|NCT00683618|592932295|FG000|Randomised Treatment Period|Adverse Event|2|||
164155483|NCT00683618|592932296|FG001|Randomised Treatment Period|Adverse Event|0|||
164155484|NCT00683618|592932297|FG002|Randomised Treatment Period|Adverse Event|2|||
164155485|NCT00683618|592932295|FG000|Randomised Treatment Period|Reason not provided|0|||
164155486|NCT00683618|592932296|FG001|Randomised Treatment Period|Reason not provided|0|||
164155487|NCT00683618|592932297|FG002|Randomised Treatment Period|Reason not provided|2|||
164155488|NCT00683618|592932295|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
164155489|NCT00683618|592932296|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164155490|NCT00683618|592932297|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
164155491|NCT00683618|592932295|FG000|Extension Treatment Period|Adverse Event|1|||
164155492|NCT00683618|592932296|FG001|Extension Treatment Period|Adverse Event|0|||
164155493|NCT00683618|592932297|FG002|Extension Treatment Period|Adverse Event|0|||
164155494|NCT00683618|592932295|FG000|Extension Treatment Period|Protocol Violation|1|||
164155495|NCT00683618|592932296|FG001|Extension Treatment Period|Protocol Violation|0|||
164155496|NCT00683618|592932297|FG002|Extension Treatment Period|Protocol Violation|0|||
164155497|NCT04570670|592932298|FG000|Overall Study|Withdrawal by Subject|1|||
164155498|NCT04570670|592932299|FG001|Overall Study|Withdrawal by Subject|0|||
164155499|NCT00318474|592932301|FG000|Overall Study|Adverse Event|1|||
164155500|NCT00318474|592932302|FG001|Overall Study|Adverse Event|1|||
164155501|NCT00318474|592932301|FG000|Overall Study|Lost to Follow-up|0|||
164155502|NCT00318474|592932302|FG001|Overall Study|Lost to Follow-up|1|||
164155503|NCT00318474|592932301|FG000|Overall Study|Pregnancy|0|||
164155504|NCT00318474|592932302|FG001|Overall Study|Pregnancy|2|||
164155505|NCT00318474|592932301|FG000|Overall Study|Protocol Violation|1|||
164155506|NCT00318474|592932302|FG001|Overall Study|Protocol Violation|0|||
164155507|NCT00318474|592932301|FG000|Overall Study|Withdrawal by Subject|3|||
164155508|NCT00318474|592932302|FG001|Overall Study|Withdrawal by Subject|2|||
164155509|NCT00318474|592932301|FG000|Overall Study|Fall in GFR|3|||
164155510|NCT00318474|592932302|FG001|Overall Study|Fall in GFR|3|||
164155511|NCT00318474|592932301|FG000|Overall Study|Post-therapy hyperflycemia|0|||
164155512|NCT00318474|592932302|FG001|Overall Study|Post-therapy hyperflycemia|1|||
164155513|NCT00318474|592932301|FG000|Overall Study|Trial terminated|10|||
164155514|NCT00318474|592932302|FG001|Overall Study|Trial terminated|7|||
164155515|NCT02383017|592932303|FG000|Overall Study|Injury Sustained Outside Study|1|||
164155516|NCT02383017|592932304|FG001|Overall Study|Injury Sustained Outside Study|0|||
164155517|NCT02383017|592932303|FG000|Overall Study|Compliance|3|||
164155518|NCT02383017|592932304|FG001|Overall Study|Compliance|2|||
164155519|NCT02383017|592932303|FG000|Overall Study|Found to be Hypogonadal|1|||
164155520|NCT02383017|592932304|FG001|Overall Study|Found to be Hypogonadal|0|||
164155521|NCT04341363|592932309|FG000|Overall Study|Adverse Event|1|||
164155522|NCT04341363|592932309|FG000|Overall Study|Withdrawal by Subject|1|||
164155523|NCT00063934|592932310|FG000|Overall Study|Ineligible|1|||
164155524|NCT02069015|592932311|FG000|Overall Study|Lost to Follow-up|39|||
164155525|NCT02069015|592932312|FG001|Overall Study|Lost to Follow-up|32|||
164155526|NCT02069015|592932311|FG000|Overall Study|Withdrawal by Subject|1|||
164155527|NCT02069015|592932312|FG001|Overall Study|Withdrawal by Subject|1|||
164155528|NCT00923013|592932320|FG000|Overall Study|Refused further treatment|0|||
164155529|NCT00923013|592932321|FG001|Overall Study|Refused further treatment|1|||
164155530|NCT00923013|592932322|FG002|Overall Study|Refused further treatment|2|||
164155531|NCT00923013|592932323|FG003|Overall Study|Refused further treatment|0|||
164155532|NCT00923013|592932324|FG004|Overall Study|Refused further treatment|0|||
164155533|NCT00923013|592932325|FG005|Overall Study|Refused further treatment|0|||
164155534|NCT00923013|592932320|FG000|Overall Study|Switched to alternative treatment|0|||
164155535|NCT00923013|592932321|FG001|Overall Study|Switched to alternative treatment|1|||
164155536|NCT00923013|592932322|FG002|Overall Study|Switched to alternative treatment|0|||
164155537|NCT00923013|592932323|FG003|Overall Study|Switched to alternative treatment|0|||
164155538|NCT00923013|592932324|FG004|Overall Study|Switched to alternative treatment|0|||
164155539|NCT00923013|592932325|FG005|Overall Study|Switched to alternative treatment|0|||
164155540|NCT00923013|592932320|FG000|Overall Study|Death on study|2|||
164155541|NCT00923013|592932321|FG001|Overall Study|Death on study|2|||
164155542|NCT00923013|592932322|FG002|Overall Study|Death on study|0|||
164155543|NCT00923013|592932323|FG003|Overall Study|Death on study|1|||
164155544|NCT00923013|592932324|FG004|Overall Study|Death on study|0|||
164155545|NCT00923013|592932325|FG005|Overall Study|Death on study|0|||
164155546|NCT01060072|592932328|FG000|Overall Study|Adverse Event|1|||
164155547|NCT01060072|592932329|FG001|Overall Study|Adverse Event|1|||
164155548|NCT01060072|592932328|FG000|Overall Study|Physician Decision|0|||
164155549|NCT01060072|592932329|FG001|Overall Study|Physician Decision|2|||
164155550|NCT01060072|592932328|FG000|Overall Study|Protocol Violation|0|||
164155551|NCT01060072|592932329|FG001|Overall Study|Protocol Violation|1|||
164155552|NCT01060072|592932328|FG000|Overall Study|Acute cholecystitis|1|||
164155553|NCT01060072|592932329|FG001|Overall Study|Acute cholecystitis|0|||
164155554|NCT01060072|592932328|FG000|Overall Study|Excluded Medications|0|||
164155555|NCT01060072|592932329|FG001|Overall Study|Excluded Medications|1|||
164155556|NCT01149863|592932342|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
164155557|NCT03326193|592932344|FG000|Overall Study|Sponsor decision|35|||
164155558|NCT00822692|592932347|FG000|Overall Study|Lost to Follow-up|17|||
164155559|NCT00822692|592932348|FG001|Overall Study|Lost to Follow-up|25|||
164155560|NCT02452476|592932350|FG000|Overall Study|Death|4|||
164155561|NCT02452476|592932351|FG001|Overall Study|Death|7|||
164155562|NCT02452476|592932350|FG000|Overall Study|Lost to Follow-up|1|||
164155563|NCT02452476|592932351|FG001|Overall Study|Lost to Follow-up|1|||
164155564|NCT02452476|592932350|FG000|Overall Study|Physician Decision|1|||
164155565|NCT02452476|592932351|FG001|Overall Study|Physician Decision|1|||
164155566|NCT02452476|592932350|FG000|Overall Study|Not treated|5|||
164155567|NCT02452476|592932351|FG001|Overall Study|Not treated|1|||
164155568|NCT02348112|592932352|FG000|Overall Study|Withdrawal by Subject|32|||
164155569|NCT02348112|592932353|FG001|Overall Study|Withdrawal by Subject|29|||
164155570|NCT02348112|592932352|FG000|Overall Study|Lost to Follow-up|24|||
164155571|NCT02348112|592932353|FG001|Overall Study|Lost to Follow-up|20|||
164155572|NCT02348112|592932352|FG000|Overall Study|Physician Decision|17|||
164155573|NCT02348112|592932353|FG001|Overall Study|Physician Decision|15|||
164155574|NCT02348112|592932352|FG000|Overall Study|Site closed due to PI leaving|0|||
164155575|NCT02348112|592932353|FG001|Overall Study|Site closed due to PI leaving|30|||
164155576|NCT02348112|592932352|FG000|Overall Study|Sponsor withdrawal|0|||
164155577|NCT02348112|592932353|FG001|Overall Study|Sponsor withdrawal|7|||
164155578|NCT02348112|592932352|FG000|Overall Study|Death|0|||
164155579|NCT02348112|592932353|FG001|Overall Study|Death|1|||
164155580|NCT01408043|592932354|FG000|Overall Study|unable to collect cells|1|||
164155581|NCT00946920|592932356|FG000|Overall Study|Withdrawal by Subject|28|||
164155582|NCT00946920|592932357|FG001|Overall Study|Withdrawal by Subject|15|||
164155583|NCT00946920|592932356|FG000|Overall Study|Lost to Follow-up|2|||
164155584|NCT00946920|592932357|FG001|Overall Study|Lost to Follow-up|2|||
164155585|NCT00946920|592932356|FG000|Overall Study|Physician Decision|5|||
164155586|NCT00946920|592932357|FG001|Overall Study|Physician Decision|2|||
164155587|NCT00946920|592932356|FG000|Overall Study|Adverse Event|41|||
164155588|NCT00946920|592932357|FG001|Overall Study|Adverse Event|14|||
164155589|NCT00946920|592932356|FG000|Overall Study|Protocol Violation|16|||
164155590|NCT00946920|592932357|FG001|Overall Study|Protocol Violation|8|||
164155591|NCT00946920|592932356|FG000|Overall Study|Miscellaneous reasons|18|||
164155592|NCT00946920|592932357|FG001|Overall Study|Miscellaneous reasons|3|||
164155593|NCT01168427|592932358|FG000|Overall Study|Patient exited prior to implant|1|||
164155594|NCT00640315|592932359|FG000|Overall Study|Withdrawal by Subject|0|||
164155595|NCT00640315|592932360|FG001|Overall Study|Withdrawal by Subject|1|||
164155596|NCT00397514|592932361|FG000|Overall Study|Withdrawal by Subject|1|||
164155597|NCT00397514|592932361|FG000|Overall Study|Pacing wire malfunction|1|||
164155598|NCT00397514|592932361|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
164155599|NCT00397514|592932361|FG000|Overall Study|early extubation|2|||
164155600|NCT00397514|592932361|FG000|Overall Study|poor echocardiographic windows|1|||
164155601|NCT01530464|592932362|FG000|Washout (24h)|Withdrawal by Subject|1|||
164155602|NCT01530464|592932363|FG001|Washout (24h)|Withdrawal by Subject|0|||
164155603|NCT01530464|592932362|FG000|Washout (24h)|Withdrawal by Subject|0|||
164155604|NCT01530464|592932363|FG001|Washout (24h)|Withdrawal by Subject|1|||
164155605|NCT01709500|592932364|FG000|Overall Study|Randomized but not treated|0|||
164155606|NCT01709500|592932365|FG001|Overall Study|Randomized but not treated|1|||
164155607|NCT01709500|592932364|FG000|Overall Study|Adverse Event|5|||
164155608|NCT01709500|592932365|FG001|Overall Study|Adverse Event|1|||
164155609|NCT01709500|592932364|FG000|Overall Study|Poor compliance to protocol|2|||
164155610|NCT01709500|592932365|FG001|Overall Study|Poor compliance to protocol|1|||
164155611|NCT01709500|592932364|FG000|Overall Study|Other|3|||
164155612|NCT01709500|592932365|FG001|Overall Study|Other|1|||
164155613|NCT01709500|592932364|FG000|Overall Study|Related to IMP administration|1|||
164155614|NCT01709500|592932365|FG001|Overall Study|Related to IMP administration|0|||
164155615|NCT01709500|592932364|FG000|Overall Study|Treatment ongoing|156|||
164155616|NCT01709500|592932365|FG001|Overall Study|Treatment ongoing|78|||
164155617|NCT02107131|592932366|FG000|Overall Study|Lost to Follow-up|4|||
164155618|NCT02107131|592932367|FG001|Overall Study|Lost to Follow-up|4|||
164155619|NCT02107131|592932366|FG000|Overall Study|Physician Decision|1|||
164155620|NCT02107131|592932367|FG001|Overall Study|Physician Decision|0|||
164155621|NCT02107131|592932366|FG000|Overall Study|Withdrawal by Subject|2|||
164155622|NCT02107131|592932367|FG001|Overall Study|Withdrawal by Subject|0|||
164155623|NCT02107131|592932366|FG000|Overall Study|mental instability|1|||
164155624|NCT02107131|592932367|FG001|Overall Study|mental instability|0|||
164155625|NCT02107131|592932366|FG000|Overall Study|Death|0|||
164155626|NCT02107131|592932367|FG001|Overall Study|Death|1|||
164155627|NCT02107131|592932366|FG000|Overall Study|Protocol Violation|0|||
164155628|NCT02107131|592932367|FG001|Overall Study|Protocol Violation|4|||
164155629|NCT02286713|592932368|FG000|One Week Follow-Up|Death|1|||
164155630|NCT02286713|592932369|FG001|One Week Follow-Up|Death|0|||
164155631|NCT02286713|592932368|FG000|One Week Follow-Up|Lost to Follow-up|17|||
164155632|NCT02286713|592932369|FG001|One Week Follow-Up|Lost to Follow-up|21|||
164155633|NCT02286713|592932368|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
164155634|NCT02286713|592932369|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
164155635|NCT02286713|592932368|FG000|Three Month Follow-Up|Death|1|||
164155636|NCT02286713|592932369|FG001|Three Month Follow-Up|Death|1|||
164155637|NCT02286713|592932368|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
164155638|NCT02286713|592932369|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
164155639|NCT02286713|592932368|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
164155640|NCT02286713|592932369|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
164155641|NCT02286713|592932368|FG000|Six Month Follow-Up|Death|2|||
164155642|NCT02286713|592932369|FG001|Six Month Follow-Up|Death|0|||
164155643|NCT02286713|592932368|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
164155644|NCT02286713|592932369|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
164155645|NCT04314037|592932370|FG000|Treatment Period 2|Adverse Event|1|||
164155646|NCT04314037|592932371|FG001|Treatment Period 2|Adverse Event|0|||
164155647|NCT04314037|592932370|FG000|Treatment Period 3|Protocol Violation|1|||
164155648|NCT04314037|592932371|FG001|Treatment Period 3|Protocol Violation|0|||
164155649|NCT04314037|592932370|FG000|Treatment Period 3|Adverse Event|0|||
164155650|NCT04314037|592932371|FG001|Treatment Period 3|Adverse Event|1|||
164155651|NCT00856492|592932374|FG000|Overall Study|Ineligible or withdrew consent|1|||
164155652|NCT00856492|592932375|FG001|Overall Study|Ineligible or withdrew consent|1|||
164155653|NCT00856492|592932376|FG002|Overall Study|Ineligible or withdrew consent|2|||
164155654|NCT06389487|592932377|FG000|Overall Study|Lost to Follow-up|9|||
164155655|NCT06389487|592932378|FG001|Overall Study|Lost to Follow-up|5|||
164155656|NCT06389487|592932379|FG002|Overall Study|Lost to Follow-up|13|||
164155657|NCT06389487|592932377|FG000|Overall Study|Protocol Violation|0|||
164155658|NCT06389487|592932378|FG001|Overall Study|Protocol Violation|0|||
164155659|NCT06389487|592932379|FG002|Overall Study|Protocol Violation|2|||
164155660|NCT06389487|592932377|FG000|Overall Study|Withdrawal by Subject|2|||
164155661|NCT06389487|592932378|FG001|Overall Study|Withdrawal by Subject|2|||
164155662|NCT06389487|592932379|FG002|Overall Study|Withdrawal by Subject|1|||
164155663|NCT06389487|592932377|FG000|Overall Study|Other|1|||
164155664|NCT06389487|592932378|FG001|Overall Study|Other|0|||
164155665|NCT06389487|592932379|FG002|Overall Study|Other|1|||
164155666|NCT00955409|592933993|FG000|Overall Study|Lack of Efficacy|1|||
164155667|NCT00955409|592933994|FG001|Overall Study|Lack of Efficacy|0|||
164155668|NCT00955409|592933995|FG002|Overall Study|Lack of Efficacy|0|||
164155669|NCT00955409|592933996|FG003|Overall Study|Lack of Efficacy|0|||
164155670|NCT00955409|592933997|FG004|Overall Study|Lack of Efficacy|0|||
164155671|NCT00955409|592933998|FG005|Overall Study|Lack of Efficacy|0|||
164155672|NCT00955409|592933999|FG006|Overall Study|Lack of Efficacy|0|||
164155673|NCT00955409|592934000|FG007|Overall Study|Lack of Efficacy|0|||
164155674|NCT00955409|592934001|FG008|Overall Study|Lack of Efficacy|0|||
164155675|NCT00955409|592934002|FG009|Overall Study|Lack of Efficacy|0|||
164155676|NCT00955409|592933993|FG000|Overall Study|Withdrawal by Subject|1|||
164155677|NCT00955409|592933994|FG001|Overall Study|Withdrawal by Subject|0|||
164155678|NCT00955409|592933995|FG002|Overall Study|Withdrawal by Subject|5|||
164155679|NCT00955409|592933996|FG003|Overall Study|Withdrawal by Subject|2|||
164155680|NCT00955409|592933997|FG004|Overall Study|Withdrawal by Subject|0|||
164155681|NCT00955409|592933998|FG005|Overall Study|Withdrawal by Subject|0|||
164155682|NCT00955409|592933999|FG006|Overall Study|Withdrawal by Subject|2|||
164155683|NCT00955409|592934000|FG007|Overall Study|Withdrawal by Subject|0|||
164155684|NCT00955409|592934001|FG008|Overall Study|Withdrawal by Subject|1|||
164155685|NCT00955409|592934002|FG009|Overall Study|Withdrawal by Subject|0|||
164155686|NCT00955409|592933993|FG000|Overall Study|Caregiver Request|2|||
164155687|NCT00955409|592933994|FG001|Overall Study|Caregiver Request|0|||
164155688|NCT00955409|592933995|FG002|Overall Study|Caregiver Request|6|||
164155689|NCT00955409|592933996|FG003|Overall Study|Caregiver Request|5|||
164155690|NCT00955409|592933997|FG004|Overall Study|Caregiver Request|0|||
164155691|NCT00955409|592933998|FG005|Overall Study|Caregiver Request|2|||
164155692|NCT00955409|592933999|FG006|Overall Study|Caregiver Request|3|||
164155693|NCT00955409|592934000|FG007|Overall Study|Caregiver Request|1|||
164155694|NCT00955409|592934001|FG008|Overall Study|Caregiver Request|3|||
164155695|NCT00955409|592934002|FG009|Overall Study|Caregiver Request|0|||
164155696|NCT00955409|592933993|FG000|Overall Study|Investigator Request|0|||
164155697|NCT00955409|592933994|FG001|Overall Study|Investigator Request|0|||
164155698|NCT00955409|592933995|FG002|Overall Study|Investigator Request|1|||
164155699|NCT00955409|592933996|FG003|Overall Study|Investigator Request|0|||
164155700|NCT00955409|592933997|FG004|Overall Study|Investigator Request|0|||
164155701|NCT00955409|592933998|FG005|Overall Study|Investigator Request|0|||
164155702|NCT00955409|592933999|FG006|Overall Study|Investigator Request|0|||
164155703|NCT00955409|592934000|FG007|Overall Study|Investigator Request|0|||
164155704|NCT00955409|592934001|FG008|Overall Study|Investigator Request|0|||
164155705|NCT00955409|592934002|FG009|Overall Study|Investigator Request|0|||
164155706|NCT00955409|592933993|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
164155707|NCT00955409|592933994|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164155708|NCT00955409|592933995|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
164155709|NCT00955409|592933996|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
164155710|NCT00955409|592933997|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
164155711|NCT00955409|592933998|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
164155712|NCT00955409|592933999|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
164155713|NCT00955409|592934000|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
164155714|NCT00955409|592934001|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
164155715|NCT00955409|592934002|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
164155716|NCT00955409|592933993|FG000|Overall Study|Lost to Follow-up|0|||
164155717|NCT00955409|592933994|FG001|Overall Study|Lost to Follow-up|0|||
164155718|NCT00955409|592933995|FG002|Overall Study|Lost to Follow-up|1|||
164155719|NCT00955409|592933996|FG003|Overall Study|Lost to Follow-up|0|||
164155720|NCT00955409|592933997|FG004|Overall Study|Lost to Follow-up|0|||
164155721|NCT00955409|592933998|FG005|Overall Study|Lost to Follow-up|0|||
164155722|NCT00955409|592933999|FG006|Overall Study|Lost to Follow-up|1|||
164155723|NCT00955409|592934000|FG007|Overall Study|Lost to Follow-up|0|||
164155724|NCT00955409|592934001|FG008|Overall Study|Lost to Follow-up|0|||
164155725|NCT00955409|592934002|FG009|Overall Study|Lost to Follow-up|0|||
164155726|NCT00955409|592933993|FG000|Overall Study|Failed to Return|2|||
164155727|NCT00955409|592933994|FG001|Overall Study|Failed to Return|0|||
164155728|NCT00955409|592933995|FG002|Overall Study|Failed to Return|0|||
164155729|NCT00955409|592933996|FG003|Overall Study|Failed to Return|0|||
164155730|NCT00955409|592933997|FG004|Overall Study|Failed to Return|0|||
164155731|NCT00955409|592933998|FG005|Overall Study|Failed to Return|0|||
164155732|NCT00955409|592933999|FG006|Overall Study|Failed to Return|0|||
164155733|NCT00955409|592934000|FG007|Overall Study|Failed to Return|2|||
164155734|NCT00955409|592934001|FG008|Overall Study|Failed to Return|0|||
164155735|NCT00955409|592934002|FG009|Overall Study|Failed to Return|0|||
164155736|NCT00955409|592933993|FG000|Overall Study|Adverse Event (AE)|2|||
164155737|NCT00955409|592933994|FG001|Overall Study|Adverse Event (AE)|0|||
164155738|NCT00955409|592933995|FG002|Overall Study|Adverse Event (AE)|0|||
164155739|NCT00955409|592933996|FG003|Overall Study|Adverse Event (AE)|0|||
164155740|NCT00955409|592933997|FG004|Overall Study|Adverse Event (AE)|0|||
164155741|NCT00955409|592933998|FG005|Overall Study|Adverse Event (AE)|1|||
164155742|NCT00955409|592933999|FG006|Overall Study|Adverse Event (AE)|2|||
164155743|NCT00955409|592934000|FG007|Overall Study|Adverse Event (AE)|0|||
164155744|NCT00955409|592934001|FG008|Overall Study|Adverse Event (AE)|2|||
164155745|NCT00955409|592934002|FG009|Overall Study|Adverse Event (AE)|0|||
164155746|NCT00955409|592933993|FG000|Overall Study|Reason not Specified|2|||
164155747|NCT00955409|592933994|FG001|Overall Study|Reason not Specified|1|||
164155748|NCT00955409|592933995|FG002|Overall Study|Reason not Specified|13|||
164155749|NCT00955409|592933996|FG003|Overall Study|Reason not Specified|1|||
164155750|NCT00955409|592933997|FG004|Overall Study|Reason not Specified|2|||
164155751|NCT00955409|592933998|FG005|Overall Study|Reason not Specified|0|||
164155752|NCT00955409|592933999|FG006|Overall Study|Reason not Specified|16|||
164155753|NCT00955409|592934000|FG007|Overall Study|Reason not Specified|0|||
164155754|NCT00955409|592934001|FG008|Overall Study|Reason not Specified|8|||
164155755|NCT00955409|592934002|FG009|Overall Study|Reason not Specified|1|||
164155756|NCT00485732|592934003|FG000|Overall Study|Protocol Violation|1|||
164155757|NCT00485732|592934004|FG001|Overall Study|Protocol Violation|3|||
164155758|NCT00485732|592934003|FG000|Overall Study|Withdrawal by Subject|5|||
164155759|NCT00485732|592934004|FG001|Overall Study|Withdrawal by Subject|4|||
164155760|NCT00485732|592934003|FG000|Overall Study|Lost to Follow-up|2|||
164155761|NCT00485732|592934004|FG001|Overall Study|Lost to Follow-up|2|||
164155762|NCT05423093|592934006|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
164155763|NCT05423093|592934006|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
164155764|NCT05423093|592934006|FG000|Attended Intervention Session|Lost to Follow-up|3|||
164155765|NCT05423093|592934006|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
164155766|NCT05423093|592934006|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
164155767|NCT03593525|592934007|FG000|Overall Study|Withdrawal by Subject|1|||
164155768|NCT03593525|592934008|FG001|Overall Study|Withdrawal by Subject|0|||
164155769|NCT03593525|592934007|FG000|Overall Study|Lost to Follow-up|7|||
164155770|NCT03593525|592934008|FG001|Overall Study|Lost to Follow-up|5|||
164155771|NCT00210210|592934011|FG000|Overall Study|Withdrawal by Subject|3|||
164155772|NCT00210210|592934012|FG001|Overall Study|Withdrawal by Subject|2|||
164155773|NCT00210210|592934011|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
164155774|NCT00210210|592934012|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
164155775|NCT01002989|592934015|FG000|Overall Study|exclusion criteria, no consent|5|||
164155776|NCT02954601|592934016|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
164155777|NCT02954601|592934017|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
164155778|NCT02954601|592934018|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
164155779|NCT02954601|592934019|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
164155780|NCT00917852|592934023|FG000|Overall Study|Death|6|||
164155781|NCT00471081|592934024|FG000|Active Phase|Protocol Violation|1|||
164155782|NCT00471081|592934025|FG001|Active Phase|Protocol Violation|1|||
164155783|NCT00471081|592934024|FG000|Active Phase|Withdrawal by Subject|0|||
164155784|NCT00471081|592934025|FG001|Active Phase|Withdrawal by Subject|3|||
164155785|NCT00471081|592934024|FG000|Active Phase|Lost to Follow-up|0|||
164155786|NCT00471081|592934025|FG001|Active Phase|Lost to Follow-up|1|||
164155787|NCT00471081|592934024|FG000|Active Phase|Lost health plan/insurance|1|||
164155788|NCT00471081|592934025|FG001|Active Phase|Lost health plan/insurance|8|||
164155789|NCT00471081|592934024|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
164155790|NCT00471081|592934025|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
164155791|NCT00471081|592934024|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
164155792|NCT00471081|592934025|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
164155793|NCT00471081|592934024|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
164155794|NCT00471081|592934025|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
164155795|NCT02393950|592934030|FG000|Overall Study|Adverse Event|1|||
164155796|NCT02393950|592934031|FG001|Overall Study|Adverse Event|0|||
164155797|NCT02393950|592934030|FG000|Overall Study|Withdrawal by Subject|0|||
164155798|NCT02393950|592934031|FG001|Overall Study|Withdrawal by Subject|1|||
164155799|NCT05486091|592934032|FG000|Overall Study|Withdrawal by Subject|1|||
164155800|NCT05486091|592934032|FG000|Overall Study|Lost to Follow-up|2|||
164155801|NCT03871543|592934047|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
164155802|NCT03871543|592934047|FG000|Period 1|Investigator Error|1|||
164155803|NCT03871543|592934047|FG000|Period 1|Protocol Violation|2|||
164155804|NCT03871543|592934047|FG000|Period 1|COVID-19 Related|1|||
164155805|NCT03871543|592934047|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
164155806|NCT03871543|592934047|FG000|Period 1|Withdrawal by Subject|10|||
164155807|NCT03871543|592934047|FG000|Period 2|Adverse Event|1|||
164155808|NCT03871543|592934047|FG000|Period 2|Withdrawal by Subject|1|||
164155809|NCT01894919|592934048|FG000|Overall Study|Withdrawal by Subject|1|||
164155810|NCT01894919|592934049|FG001|Overall Study|Withdrawal by Subject|0|||
164155811|NCT01894919|592934050|FG002|Overall Study|Withdrawal by Subject|0|||
164155812|NCT01894919|592934051|FG003|Overall Study|Withdrawal by Subject|0|||
164155813|NCT01894919|592934052|FG004|Overall Study|Withdrawal by Subject|1|||
164155814|NCT01894919|592934053|FG005|Overall Study|Withdrawal by Subject|0|||
164155815|NCT01894919|592934054|FG006|Overall Study|Withdrawal by Subject|0|||
164155816|NCT01894919|592934055|FG007|Overall Study|Withdrawal by Subject|0|||
164155817|NCT01894919|592934056|FG008|Overall Study|Withdrawal by Subject|0|||
164155818|NCT01894919|592934057|FG009|Overall Study|Withdrawal by Subject|1|||
164155819|NCT01894919|592934058|FG010|Overall Study|Withdrawal by Subject|1|||
164155820|NCT01894919|592934059|FG011|Overall Study|Withdrawal by Subject|0|||
164155821|NCT01894919|592934060|FG012|Overall Study|Withdrawal by Subject|0|||
164155822|NCT01894919|592934048|FG000|Overall Study|Adverse Event|0|||
164155823|NCT01894919|592934049|FG001|Overall Study|Adverse Event|0|||
164155824|NCT01894919|592934050|FG002|Overall Study|Adverse Event|0|||
164155825|NCT01894919|592934051|FG003|Overall Study|Adverse Event|0|||
164155826|NCT01894919|592934052|FG004|Overall Study|Adverse Event|0|||
164155827|NCT01894919|592934053|FG005|Overall Study|Adverse Event|0|||
164155828|NCT01894919|592934054|FG006|Overall Study|Adverse Event|0|||
164155829|NCT01894919|592934055|FG007|Overall Study|Adverse Event|0|||
164155830|NCT01894919|592934056|FG008|Overall Study|Adverse Event|0|||
164155831|NCT01894919|592934057|FG009|Overall Study|Adverse Event|0|||
164155832|NCT01894919|592934058|FG010|Overall Study|Adverse Event|1|||
164155833|NCT01894919|592934059|FG011|Overall Study|Adverse Event|0|||
164155834|NCT01894919|592934060|FG012|Overall Study|Adverse Event|0|||
164155835|NCT01894919|592934048|FG000|Overall Study|Other-Unspecified|1|||
164155836|NCT01894919|592934049|FG001|Overall Study|Other-Unspecified|0|||
164155837|NCT01894919|592934050|FG002|Overall Study|Other-Unspecified|0|||
164155838|NCT01894919|592934051|FG003|Overall Study|Other-Unspecified|0|||
164155839|NCT01894919|592934052|FG004|Overall Study|Other-Unspecified|0|||
164155840|NCT01894919|592934053|FG005|Overall Study|Other-Unspecified|0|||
164155841|NCT01894919|592934054|FG006|Overall Study|Other-Unspecified|0|||
164155842|NCT01894919|592934055|FG007|Overall Study|Other-Unspecified|0|||
164155843|NCT01894919|592934056|FG008|Overall Study|Other-Unspecified|0|||
164155844|NCT01894919|592934057|FG009|Overall Study|Other-Unspecified|0|||
164155845|NCT01894919|592934058|FG010|Overall Study|Other-Unspecified|0|||
164155846|NCT01894919|592934059|FG011|Overall Study|Other-Unspecified|0|||
164155847|NCT01894919|592934060|FG012|Overall Study|Other-Unspecified|0|||
164155848|NCT01894919|592934048|FG000|Overall Study|Lost to Follow-up|0|||
164155849|NCT01894919|592934049|FG001|Overall Study|Lost to Follow-up|0|||
164155850|NCT01894919|592934050|FG002|Overall Study|Lost to Follow-up|0|||
164155851|NCT01894919|592934051|FG003|Overall Study|Lost to Follow-up|0|||
164155852|NCT01894919|592934052|FG004|Overall Study|Lost to Follow-up|2|||
164155853|NCT01894919|592934053|FG005|Overall Study|Lost to Follow-up|0|||
164155854|NCT01894919|592934054|FG006|Overall Study|Lost to Follow-up|0|||
164155855|NCT01894919|592934055|FG007|Overall Study|Lost to Follow-up|0|||
164155856|NCT01894919|592934056|FG008|Overall Study|Lost to Follow-up|0|||
164155857|NCT01894919|592934057|FG009|Overall Study|Lost to Follow-up|0|||
164155858|NCT01894919|592934058|FG010|Overall Study|Lost to Follow-up|0|||
164155859|NCT01894919|592934059|FG011|Overall Study|Lost to Follow-up|0|||
164155860|NCT01894919|592934060|FG012|Overall Study|Lost to Follow-up|0|||
164155861|NCT03711188|592934063|FG000|Overall Study|Disease progression|11|||
164155862|NCT03711188|592934063|FG000|Overall Study|Adverse Event|1|||
164155863|NCT03534687|592934064|FG000|Overall Study|Lost to Follow-up|7|||
164155864|NCT03534687|592934065|FG001|Overall Study|Lost to Follow-up|2|||
164155865|NCT00314340|592934067|FG000|Overall Study|lost interest|1|||
164155866|NCT00957801|592934068|FG000|Overall Study|Withdrawal by Subject|0|||
164155867|NCT00957801|592934069|FG001|Overall Study|Withdrawal by Subject|0|||
164155868|NCT00957801|592934070|FG002|Overall Study|Withdrawal by Subject|0|||
164155869|NCT00957801|592934071|FG003|Overall Study|Withdrawal by Subject|1|||
164155870|NCT03776357|592934075|FG000|Overall Study|Lost to Follow-up|3|||
164155871|NCT01286467|592934076|FG000|Overall Study|Death|1|||
164155872|NCT01286467|592934077|FG001|Overall Study|Death|1|||
164155873|NCT01286467|592934078|FG002|Overall Study|Death|1|||
164155874|NCT01286467|592934079|FG003|Overall Study|Death|0|||
164155875|NCT01286467|592934076|FG000|Overall Study|Lost to Follow-up|0|||
164155876|NCT01286467|592934077|FG001|Overall Study|Lost to Follow-up|0|||
164155877|NCT01286467|592934078|FG002|Overall Study|Lost to Follow-up|0|||
164155878|NCT01286467|592934079|FG003|Overall Study|Lost to Follow-up|1|||
164155879|NCT01286467|592934076|FG000|Overall Study|Withdrawal by Subject|0|||
164155880|NCT01286467|592934077|FG001|Overall Study|Withdrawal by Subject|0|||
164155881|NCT01286467|592934078|FG002|Overall Study|Withdrawal by Subject|1|||
164155882|NCT01286467|592934079|FG003|Overall Study|Withdrawal by Subject|0|||
164155883|NCT01286467|592934076|FG000|Overall Study|Physician Decision|0|||
164155884|NCT01286467|592934077|FG001|Overall Study|Physician Decision|0|||
164155885|NCT01286467|592934078|FG002|Overall Study|Physician Decision|0|||
164155886|NCT01286467|592934079|FG003|Overall Study|Physician Decision|1|||
164155887|NCT01286467|592934076|FG000|Overall Study|Disease progression|3|||
164155888|NCT01286467|592934077|FG001|Overall Study|Disease progression|2|||
164155889|NCT01286467|592934078|FG002|Overall Study|Disease progression|2|||
164155890|NCT01286467|592934079|FG003|Overall Study|Disease progression|3|||
164155891|NCT01286467|592934076|FG000|Overall Study|Adverse Event|0|||
164155892|NCT01286467|592934077|FG001|Overall Study|Adverse Event|1|||
164155893|NCT01286467|592934078|FG002|Overall Study|Adverse Event|2|||
164155894|NCT01286467|592934079|FG003|Overall Study|Adverse Event|3|||
164155895|NCT01286467|592934076|FG000|Overall Study|Study drug stop longer than 14 days|0|||
164155896|NCT01286467|592934077|FG001|Overall Study|Study drug stop longer than 14 days|0|||
164155897|NCT01286467|592934078|FG002|Overall Study|Study drug stop longer than 14 days|1|||
164155898|NCT01286467|592934079|FG003|Overall Study|Study drug stop longer than 14 days|0|||
164155899|NCT03335475|592934080|FG000|Overall Study|Did not wear accelerometer|4|||
164155900|NCT03335475|592934081|FG001|Overall Study|Did not wear accelerometer|0|||
164155901|NCT03335475|592934080|FG000|Overall Study|Withdrawal by Subject|0|||
164155902|NCT03335475|592934081|FG001|Overall Study|Withdrawal by Subject|1|||
164155903|NCT04886596|592934082|FG000|Overall Study|Adverse Event|442|||
164155904|NCT04886596|592934083|FG001|Overall Study|Adverse Event|441|||
164155905|NCT04886596|592934082|FG000|Overall Study|Lost to Follow-up|448|||
164155906|NCT04886596|592934083|FG001|Overall Study|Lost to Follow-up|465|||
164155907|NCT04886596|592934082|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
164155908|NCT04886596|592934083|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
164155909|NCT04886596|592934082|FG000|Overall Study|Migrated/moved from the study area|201|||
164155910|NCT04886596|592934083|FG001|Overall Study|Migrated/moved from the study area|184|||
164155911|NCT04886596|592934082|FG000|Overall Study|Other|298|||
164155912|NCT04886596|592934083|FG001|Overall Study|Other|326|||
164155913|NCT02211209|592934084|FG000|Overall Study|Investigator judgment|0|||
164155914|NCT02211209|592934085|FG001|Overall Study|Investigator judgment|1|||
164155915|NCT02211209|592934084|FG000|Overall Study|Voluntary withdrawal|1|||
164155916|NCT02211209|592934085|FG001|Overall Study|Voluntary withdrawal|4|||
164155917|NCT02211209|592934084|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
164155918|NCT02211209|592934085|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
164155919|NCT02211209|592934084|FG000|Overall Study|Reason Not Specified|1|||
164155920|NCT02211209|592934085|FG001|Overall Study|Reason Not Specified|0|||
164155921|NCT03751098|592934091|FG000|Overall Study|Withdrawal by Subject|0|||
164155922|NCT03751098|592934092|FG001|Overall Study|Withdrawal by Subject|1|||
164155923|NCT02964247|592934094|FG000|Overall Study|Lost to Follow-up|2|||
164155924|NCT02964247|592934095|FG001|Overall Study|Lost to Follow-up|0|||
164155925|NCT02964247|592934094|FG000|Overall Study|Withdrawal by Subject|1|||
164155926|NCT02964247|592934095|FG001|Overall Study|Withdrawal by Subject|2|||
164155927|NCT06018129|592934096|FG000|Overall Study|Death|1|||
164155928|NCT06018129|592934097|FG001|Overall Study|Death|1|||
164155929|NCT06018129|592934098|FG002|Overall Study|Death|2|||
164155930|NCT06018129|592934096|FG000|Overall Study|Sponsor Decision|2|||
164155931|NCT06018129|592934097|FG001|Overall Study|Sponsor Decision|2|||
164155932|NCT06018129|592934098|FG002|Overall Study|Sponsor Decision|1|||
164155933|NCT03832686|592934099|FG000|Overall Study|Lost to Follow-up|6|||
164155934|NCT03832686|592934100|FG001|Overall Study|Lost to Follow-up|9|||
164155935|NCT03832686|592934099|FG000|Overall Study|Discontinued Intervention|5|||
164155936|NCT03832686|592934100|FG001|Overall Study|Discontinued Intervention|4|||
164155937|NCT02208362|592934101|FG000|Overall Study|Participant did not complete treatment|0|||
164155938|NCT02208362|592934102|FG001|Overall Study|Participant did not complete treatment|1|||
164155939|NCT02208362|592934103|FG002|Overall Study|Participant did not complete treatment|0|||
164155940|NCT02208362|592934104|FG003|Overall Study|Participant did not complete treatment|0|||
164155941|NCT02208362|592934105|FG004|Overall Study|Participant did not complete treatment|0|||
164155942|NCT02208362|592934106|FG005|Overall Study|Participant did not complete treatment|0|||
164155943|NCT02208362|592934107|FG006|Overall Study|Participant did not complete treatment|1|||
164155944|NCT02208362|592934108|FG007|Overall Study|Participant did not complete treatment|1|||
164155945|NCT02208362|592934109|FG008|Overall Study|Participant did not complete treatment|2|||
164155946|NCT02208362|592934110|FG009|Overall Study|Participant did not complete treatment|0|||
164155947|NCT02208362|592934111|FG010|Overall Study|Participant did not complete treatment|1|||
164155948|NCT02208362|592934112|FG011|Overall Study|Participant did not complete treatment|0|||
164155949|NCT02208362|592934101|FG000|Overall Study|Participant received disallowed treatment|0|||
164155950|NCT02208362|592934102|FG001|Overall Study|Participant received disallowed treatment|0|||
164155951|NCT02208362|592934103|FG002|Overall Study|Participant received disallowed treatment|0|||
164155952|NCT02208362|592934104|FG003|Overall Study|Participant received disallowed treatment|0|||
164155953|NCT02208362|592934105|FG004|Overall Study|Participant received disallowed treatment|0|||
164155954|NCT02208362|592934106|FG005|Overall Study|Participant received disallowed treatment|0|||
164155955|NCT02208362|592934107|FG006|Overall Study|Participant received disallowed treatment|0|||
164155956|NCT02208362|592934108|FG007|Overall Study|Participant received disallowed treatment|0|||
164155957|NCT02208362|592934109|FG008|Overall Study|Participant received disallowed treatment|1|||
164155958|NCT02208362|592934110|FG009|Overall Study|Participant received disallowed treatment|0|||
164155959|NCT02208362|592934111|FG010|Overall Study|Participant received disallowed treatment|0|||
164155960|NCT02208362|592934112|FG011|Overall Study|Participant received disallowed treatment|0|||
164155961|NCT02235454|592934115|FG000|Overall Study|Withdrawal by Subject|2|||
164155962|NCT03323398|592934116|FG000|Overall Study|Other than Specified|0|||
164155963|NCT03323398|592934117|FG001|Overall Study|Other than Specified|1|||
164155964|NCT03323398|592934118|FG002|Overall Study|Other than Specified|2|||
164155965|NCT03323398|592934119|FG003|Overall Study|Other than Specified|0|||
164155966|NCT03323398|592934120|FG004|Overall Study|Other than Specified|0|||
164155967|NCT03323398|592934121|FG005|Overall Study|Other than Specified|0|||
164155968|NCT03323398|592934122|FG006|Overall Study|Other than Specified|1|||
164155969|NCT03323398|592934123|FG007|Overall Study|Other than Specified|0|||
164155970|NCT03323398|592934124|FG008|Overall Study|Other than Specified|2|||
164155971|NCT03323398|592934116|FG000|Overall Study|Lost to Follow-up|1|||
164155972|NCT03323398|592934117|FG001|Overall Study|Lost to Follow-up|2|||
164155973|NCT03323398|592934118|FG002|Overall Study|Lost to Follow-up|1|||
164155974|NCT03323398|592934119|FG003|Overall Study|Lost to Follow-up|0|||
164155975|NCT03323398|592934120|FG004|Overall Study|Lost to Follow-up|0|||
164155976|NCT03323398|592934121|FG005|Overall Study|Lost to Follow-up|0|||
164155977|NCT03323398|592934122|FG006|Overall Study|Lost to Follow-up|0|||
164155978|NCT03323398|592934123|FG007|Overall Study|Lost to Follow-up|0|||
164155979|NCT03323398|592934124|FG008|Overall Study|Lost to Follow-up|0|||
164155980|NCT03323398|592934116|FG000|Overall Study|Death|4|||
164155981|NCT03323398|592934117|FG001|Overall Study|Death|6|||
164155982|NCT03323398|592934118|FG002|Overall Study|Death|2|||
164155983|NCT03323398|592934119|FG003|Overall Study|Death|2|||
164155984|NCT03323398|592934120|FG004|Overall Study|Death|1|||
164155985|NCT03323398|592934121|FG005|Overall Study|Death|2|||
164155986|NCT03323398|592934122|FG006|Overall Study|Death|0|||
164155987|NCT03323398|592934123|FG007|Overall Study|Death|0|||
164155988|NCT03323398|592934124|FG008|Overall Study|Death|6|||
164155989|NCT03323398|592934116|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
164155990|NCT03323398|592934117|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
164155991|NCT03323398|592934118|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
164155992|NCT03323398|592934119|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
164155993|NCT03323398|592934120|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
164155994|NCT03323398|592934121|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
164155995|NCT03323398|592934122|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
164155996|NCT03323398|592934123|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
164155997|NCT03323398|592934124|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
164155998|NCT03323398|592934116|FG000|Overall Study|Withdrawal by Subject|2|||
164155999|NCT03323398|592934117|FG001|Overall Study|Withdrawal by Subject|1|||
164156000|NCT03323398|592934118|FG002|Overall Study|Withdrawal by Subject|3|||
164156001|NCT03323398|592934119|FG003|Overall Study|Withdrawal by Subject|0|||
164156002|NCT03323398|592934120|FG004|Overall Study|Withdrawal by Subject|0|||
164156003|NCT03323398|592934121|FG005|Overall Study|Withdrawal by Subject|1|||
164156004|NCT03323398|592934122|FG006|Overall Study|Withdrawal by Subject|0|||
164156005|NCT03323398|592934123|FG007|Overall Study|Withdrawal by Subject|0|||
164156006|NCT03323398|592934124|FG008|Overall Study|Withdrawal by Subject|0|||
164156007|NCT03323398|592934116|FG000|Overall Study|Participant was Put on Hospice|0|||
164156008|NCT03323398|592934117|FG001|Overall Study|Participant was Put on Hospice|0|||
164156009|NCT03323398|592934118|FG002|Overall Study|Participant was Put on Hospice|0|||
164156010|NCT03323398|592934119|FG003|Overall Study|Participant was Put on Hospice|0|||
164156011|NCT03323398|592934120|FG004|Overall Study|Participant was Put on Hospice|0|||
164156012|NCT03323398|592934121|FG005|Overall Study|Participant was Put on Hospice|0|||
164156013|NCT03323398|592934122|FG006|Overall Study|Participant was Put on Hospice|1|||
164156014|NCT03323398|592934123|FG007|Overall Study|Participant was Put on Hospice|0|||
164156015|NCT03323398|592934124|FG008|Overall Study|Participant was Put on Hospice|0|||
164156016|NCT03323398|592934116|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
164156017|NCT03323398|592934117|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
164156018|NCT03323398|592934118|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
164156019|NCT03323398|592934119|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
164156020|NCT03323398|592934120|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
164156021|NCT03323398|592934121|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
164156022|NCT03323398|592934122|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
164156023|NCT03323398|592934123|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
164156024|NCT03323398|592934124|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
164156025|NCT03641469|592934125|FG000|Overall Study|Ineligible|2|||
164156026|NCT03641469|592934125|FG000|Overall Study|Withdrawal by Subject|5|||
164156027|NCT03641469|592934125|FG000|Overall Study|Physician Decision|1|||
164156028|NCT03641469|592934125|FG000|Overall Study|Protocol Violation|1|||
164156029|NCT03641469|592934125|FG000|Overall Study|Lost to Follow-up|2|||
164156030|NCT05479435|592934126|FG000|Overall Study|Withdrawal by Subject|1|||
164156031|NCT05479435|592934127|FG001|Overall Study|Withdrawal by Subject|0|||
164156032|NCT05479435|592934128|FG002|Overall Study|Withdrawal by Subject|0|||
164156033|NCT05479435|592934126|FG000|Overall Study|Covid 19|0|||
164156034|NCT05479435|592934127|FG001|Overall Study|Covid 19|0|||
164156035|NCT05479435|592934128|FG002|Overall Study|Covid 19|2|||
164156036|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
164156037|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
164156038|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
164156039|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
164156040|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
164156041|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
164156042|NCT00955617|592934130|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
164156043|NCT00955617|592934131|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
164156044|NCT00858273|592934132|FG000|Overall Study|Protocol Violation|3|||
164156045|NCT00858273|592934133|FG001|Overall Study|Protocol Violation|5|||
164156046|NCT00982657|592934134|FG000|Overall Study|Death|1|||
164156047|NCT00982657|592934135|FG001|Overall Study|Death|0|||
164156048|NCT00982657|592934136|FG002|Overall Study|Death|1|||
164156049|NCT00982657|592934137|FG003|Overall Study|Death|1|||
164156050|NCT00982657|592934134|FG000|Overall Study|Withdrawal by Subject|0|||
164156051|NCT00982657|592934135|FG001|Overall Study|Withdrawal by Subject|0|||
164156052|NCT00982657|592934136|FG002|Overall Study|Withdrawal by Subject|1|||
164156053|NCT00982657|592934137|FG003|Overall Study|Withdrawal by Subject|3|||
164156054|NCT00982657|592934134|FG000|Overall Study|Other|0|||
164156055|NCT00982657|592934135|FG001|Overall Study|Other|0|||
164156056|NCT00982657|592934136|FG002|Overall Study|Other|0|||
164156057|NCT00982657|592934137|FG003|Overall Study|Other|4|||
164156058|NCT00982657|592934134|FG000|Overall Study|On going at date of cut-off|0|||
164156059|NCT00982657|592934135|FG001|Overall Study|On going at date of cut-off|0|||
164156060|NCT00982657|592934136|FG002|Overall Study|On going at date of cut-off|0|||
164156061|NCT00982657|592934137|FG003|Overall Study|On going at date of cut-off|1|||
164156062|NCT02764762|592935517|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
164156063|NCT02764762|592935517|FG000|Overall Study|Lost to Follow-up|4|||
164156064|NCT02764762|592935517|FG000|Overall Study|Voluntary Withdrawal|8|||
164156065|NCT02764762|592935517|FG000|Overall Study|Site Termination|1|||
164156066|NCT02764762|592935517|FG000|Overall Study|Lack of Efficacy|16|||
164156067|NCT02764762|592935517|FG000|Overall Study|Reason not Specified|1|||
164156068|NCT00370552|592935518|FG000|Overall Study|Adverse Event|2|||
164156069|NCT00370552|592935519|FG001|Overall Study|Adverse Event|2|||
164156070|NCT00370552|592935520|FG002|Overall Study|Adverse Event|2|||
164156071|NCT00370552|592935518|FG000|Overall Study|Disease progression|23|||
164156072|NCT00370552|592935519|FG001|Overall Study|Disease progression|23|||
164156073|NCT00370552|592935520|FG002|Overall Study|Disease progression|15|||
164156074|NCT00370552|592935518|FG000|Overall Study|Maximum clinical benefit|3|||
164156075|NCT00370552|592935519|FG001|Overall Study|Maximum clinical benefit|5|||
164156076|NCT00370552|592935520|FG002|Overall Study|Maximum clinical benefit|5|||
164156077|NCT00370552|592935518|FG000|Overall Study|Poor or noncompliance|0|||
164156078|NCT00370552|592935519|FG001|Overall Study|Poor or noncompliance|0|||
164156079|NCT00370552|592935520|FG002|Overall Study|Poor or noncompliance|1|||
164156080|NCT00370552|592935518|FG000|Overall Study|Study drug toxicity|11|||
164156081|NCT00370552|592935519|FG001|Overall Study|Study drug toxicity|8|||
164156082|NCT00370552|592935520|FG002|Overall Study|Study drug toxicity|6|||
164156083|NCT00370552|592935518|FG000|Overall Study|Withdrawal by Subject|2|||
164156084|NCT00370552|592935519|FG001|Overall Study|Withdrawal by Subject|0|||
164156085|NCT00370552|592935520|FG002|Overall Study|Withdrawal by Subject|1|||
164156086|NCT00370552|592935518|FG000|Overall Study|Still on treatment|1|||
164156087|NCT00370552|592935519|FG001|Overall Study|Still on treatment|3|||
164156088|NCT00370552|592935520|FG002|Overall Study|Still on treatment|2|||
164156089|NCT00370552|592935518|FG000|Overall Study|Never treated|1|||
164156090|NCT00370552|592935519|FG001|Overall Study|Never treated|0|||
164156091|NCT00370552|592935520|FG002|Overall Study|Never treated|0|||
164156092|NCT00370552|592935518|FG000|Overall Study|Physician Decision|1|||
164156093|NCT00370552|592935519|FG001|Overall Study|Physician Decision|1|||
164156094|NCT00370552|592935520|FG002|Overall Study|Physician Decision|0|||
164156095|NCT00370552|592935518|FG000|Overall Study|Investigator decision|2|||
164156096|NCT00370552|592935519|FG001|Overall Study|Investigator decision|1|||
164156097|NCT00370552|592935520|FG002|Overall Study|Investigator decision|0|||
164156098|NCT00370552|592935518|FG000|Overall Study|High risk of allergic reaction|0|||
164156099|NCT00370552|592935519|FG001|Overall Study|High risk of allergic reaction|1|||
164156100|NCT00370552|592935520|FG002|Overall Study|High risk of allergic reaction|0|||
164156101|NCT00370552|592935518|FG000|Overall Study|Planned radiation for palliation|0|||
164156102|NCT00370552|592935519|FG001|Overall Study|Planned radiation for palliation|1|||
164156103|NCT00370552|592935520|FG002|Overall Study|Planned radiation for palliation|0|||
164156104|NCT03499067|592935521|FG000|First Intervention|Physician Decision|2|||
164156105|NCT03499067|592935522|FG001|First Intervention|Physician Decision|1|||
164156106|NCT03499067|592935521|FG000|First Intervention|Withdrawal by Subject|3|||
164156107|NCT03499067|592935522|FG001|First Intervention|Withdrawal by Subject|6|||
164156108|NCT02342678|592935523|FG000|Overall Study|Lost to Follow-up|0|||
164156109|NCT02342678|592935524|FG001|Overall Study|Lost to Follow-up|1|||
164156110|NCT02342678|592935523|FG000|Overall Study|Too busy to complete study|0|||
164156111|NCT02342678|592935524|FG001|Overall Study|Too busy to complete study|2|||
164156112|NCT02342678|592935523|FG000|Overall Study|Family illness/emergency|0|||
164156113|NCT02342678|592935524|FG001|Overall Study|Family illness/emergency|1|||
164156114|NCT02342678|592935523|FG000|Overall Study|Illness/medical reason|1|||
164156115|NCT02342678|592935524|FG001|Overall Study|Illness/medical reason|1|||
164156116|NCT03876743|592935528|FG000|Overall Study|Lost to Follow-up|6|||
164156117|NCT03876743|592935529|FG001|Overall Study|Lost to Follow-up|4|||
164156118|NCT03876743|592935530|FG002|Overall Study|Lost to Follow-up|4|||
164156119|NCT03876743|592935531|FG003|Overall Study|Lost to Follow-up|7|||
164156120|NCT03889418|592935532|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
164156121|NCT03889418|592935533|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156122|NCT03889418|592935534|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156123|NCT03889418|592935535|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156124|NCT03889418|592935536|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156125|NCT03889418|592935537|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156126|NCT03889418|592935538|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156127|NCT03889418|592935539|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156128|NCT03889418|592935540|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156129|NCT03889418|592935541|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
164156130|NCT03889418|592935532|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156131|NCT03889418|592935533|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
164156132|NCT03889418|592935534|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
164156274|NCT04740918|592935599|FG001|Overall Study|Death|6|||
164156133|NCT03889418|592935535|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156134|NCT03889418|592935536|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156135|NCT03889418|592935537|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156136|NCT03889418|592935538|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156137|NCT03889418|592935539|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156138|NCT03889418|592935540|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156139|NCT03889418|592935541|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
164156140|NCT03889418|592935532|FG000|October-December 2019 (Month 7-9)|Death|0|||
164156141|NCT03889418|592935533|FG001|October-December 2019 (Month 7-9)|Death|0|||
164156142|NCT03889418|592935534|FG002|October-December 2019 (Month 7-9)|Death|0|||
164156143|NCT03889418|592935535|FG003|October-December 2019 (Month 7-9)|Death|0|||
164156144|NCT03889418|592935536|FG004|October-December 2019 (Month 7-9)|Death|0|||
164156145|NCT03889418|592935537|FG005|October-December 2019 (Month 7-9)|Death|0|||
164156146|NCT03889418|592935538|FG006|October-December 2019 (Month 7-9)|Death|0|||
164156147|NCT03889418|592935539|FG007|October-December 2019 (Month 7-9)|Death|0|||
164156148|NCT03889418|592935540|FG008|October-December 2019 (Month 7-9)|Death|1|||
164156149|NCT03889418|592935541|FG009|October-December 2019 (Month 7-9)|Death|0|||
164156150|NCT03889418|592935532|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156151|NCT03889418|592935533|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156152|NCT03889418|592935534|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156153|NCT03889418|592935535|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
164156154|NCT03889418|592935536|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156155|NCT03889418|592935537|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156156|NCT03889418|592935538|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156157|NCT03889418|592935539|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
164156158|NCT03889418|592935540|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156159|NCT03889418|592935541|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
164156160|NCT03889418|592935532|FG000|April - June 2020 (Month 13-15)|Death|0|||
164156161|NCT03889418|592935533|FG001|April - June 2020 (Month 13-15)|Death|1|||
164156162|NCT03889418|592935534|FG002|April - June 2020 (Month 13-15)|Death|0|||
164156163|NCT03889418|592935535|FG003|April - June 2020 (Month 13-15)|Death|0|||
164156164|NCT03889418|592935536|FG004|April - June 2020 (Month 13-15)|Death|0|||
164156165|NCT03889418|592935537|FG005|April - June 2020 (Month 13-15)|Death|0|||
164156166|NCT03889418|592935538|FG006|April - June 2020 (Month 13-15)|Death|0|||
164156167|NCT03889418|592935539|FG007|April - June 2020 (Month 13-15)|Death|0|||
164156168|NCT03889418|592935540|FG008|April - June 2020 (Month 13-15)|Death|0|||
164156169|NCT03889418|592935541|FG009|April - June 2020 (Month 13-15)|Death|0|||
164156170|NCT03889418|592935532|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156171|NCT03889418|592935533|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156172|NCT03889418|592935534|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156173|NCT03889418|592935535|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
164156174|NCT03889418|592935536|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156175|NCT03889418|592935537|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156176|NCT03889418|592935538|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156177|NCT03889418|592935539|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156178|NCT03889418|592935540|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156179|NCT03889418|592935541|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
164156180|NCT03889418|592935532|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
164156181|NCT03889418|592935533|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156182|NCT03889418|592935534|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
164156183|NCT03889418|592935535|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
164156184|NCT03889418|592935536|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156185|NCT03889418|592935537|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156186|NCT03889418|592935538|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156187|NCT03889418|592935539|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
164156188|NCT03889418|592935540|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156189|NCT03889418|592935541|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
164156190|NCT03889418|592935532|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156191|NCT03889418|592935533|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
164156192|NCT03889418|592935534|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
164156193|NCT03889418|592935535|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
164156194|NCT03889418|592935536|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156195|NCT03889418|592935537|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156196|NCT03889418|592935538|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156197|NCT03889418|592935539|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
164156198|NCT03889418|592935540|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
164156199|NCT03889418|592935541|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
164156200|NCT00837148|592935546|FG000|Overall Study|Adverse Event|1|||
164156201|NCT00837148|592935546|FG000|Overall Study|Death|1|||
164156202|NCT00931411|592935549|FG000|First Intervention - 42 Days|Adverse Event|2|||
164156203|NCT00931411|592935550|FG001|First Intervention - 42 Days|Adverse Event|3|||
164156204|NCT00931411|592935549|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
164156205|NCT00931411|592935550|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
164156206|NCT00931411|592935549|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
164156207|NCT00931411|592935550|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
164156208|NCT01827111|592935551|FG000|Overall Study|Disease Progression|1|||
164156209|NCT03181633|592935554|FG000|Overall Study|Withdrawal by Subject|1|||
164156210|NCT03181633|592935554|FG000|Overall Study|Missing follow-up visit|1|||
164156211|NCT04383327|592935561|FG000|Overall Study|Lost to Follow-up|112|||
164156212|NCT04383327|592935562|FG001|Overall Study|Lost to Follow-up|14|||
164156213|NCT04383327|592935563|FG002|Overall Study|Lost to Follow-up|78|||
164156214|NCT04383327|592935564|FG003|Overall Study|Lost to Follow-up|13|||
164156215|NCT04383327|592935565|FG004|Overall Study|Lost to Follow-up|110|||
164156216|NCT04383327|592935566|FG005|Overall Study|Lost to Follow-up|13|||
164156217|NCT04383327|592935567|FG006|Overall Study|Lost to Follow-up|74|||
164156218|NCT04383327|592935568|FG007|Overall Study|Lost to Follow-up|13|||
164156219|NCT04383327|592935569|FG008|Overall Study|Lost to Follow-up|78|||
164156220|NCT04383327|592935570|FG009|Overall Study|Lost to Follow-up|10|||
164156221|NCT04383327|592935571|FG010|Overall Study|Lost to Follow-up|160|||
164156222|NCT04383327|592935572|FG011|Overall Study|Lost to Follow-up|13|||
164156223|NCT04837196|592935573|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
164156224|NCT04837196|592935574|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
164156225|NCT04837196|592935575|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
164156226|NCT04837196|592935576|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
164156227|NCT04837196|592935577|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
164156228|NCT04837196|592935573|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
164156229|NCT04837196|592935574|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
164156230|NCT04837196|592935575|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
164156231|NCT04837196|592935576|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
164156232|NCT04837196|592935577|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
164156233|NCT04837196|592935573|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156234|NCT04837196|592935574|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
164156235|NCT04837196|592935575|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156236|NCT04837196|592935576|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156237|NCT04837196|592935577|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
164156238|NCT04837196|592935573|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156239|NCT04837196|592935574|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156240|NCT04837196|592935575|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
164156241|NCT04837196|592935576|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156242|NCT04837196|592935577|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
164156243|NCT04837196|592935573|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156244|NCT04837196|592935574|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156245|NCT04837196|592935575|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
164156246|NCT04837196|592935576|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156247|NCT04837196|592935577|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
164156248|NCT00991887|592935578|FG000|Overall Study|Lost to Follow-up|2|||
164156249|NCT00991887|592935579|FG001|Overall Study|Lost to Follow-up|1|||
164156250|NCT01306305|592935580|FG000|Overall Study|Lost to Follow-up|1|||
164156251|NCT01306305|592935581|FG001|Overall Study|Lost to Follow-up|0|||
164156252|NCT01306305|592935580|FG000|Overall Study|Withdrew consent|1|||
164156253|NCT01306305|592935581|FG001|Overall Study|Withdrew consent|0|||
164156254|NCT04030299|592935582|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
164156255|NCT04030299|592935582|FG000|Overall Study|Withdrawal by Subject|3|||
164156256|NCT01964976|592935583|FG000|Overall Study|Protocol Violation|31|||
164156257|NCT00699998|592935584|FG000|Overall Study|Withdrawal by Subject|194|||
164156258|NCT00699998|592935585|FG001|Overall Study|Withdrawal by Subject|83|||
164156259|NCT00699998|592935586|FG002|Overall Study|Withdrawal by Subject|202|||
164156260|NCT00699998|592935587|FG003|Overall Study|Withdrawal by Subject|80|||
164156261|NCT00699998|592935584|FG000|Overall Study|Physician Decision|3|||
164156262|NCT00699998|592935585|FG001|Overall Study|Physician Decision|2|||
164156263|NCT00699998|592935586|FG002|Overall Study|Physician Decision|1|||
164156264|NCT00699998|592935587|FG003|Overall Study|Physician Decision|1|||
164156265|NCT00699998|592935584|FG000|Overall Study|Lost to Follow-up|2|||
164156266|NCT00699998|592935585|FG001|Overall Study|Lost to Follow-up|1|||
164156267|NCT00699998|592935586|FG002|Overall Study|Lost to Follow-up|3|||
164156268|NCT00699998|592935587|FG003|Overall Study|Lost to Follow-up|1|||
164156269|NCT04616612|592935594|FG000|Overall Study|Lost to Follow-up|6|||
164156270|NCT04616612|592935595|FG001|Overall Study|Lost to Follow-up|3|||
164156271|NCT04740918|592935598|FG000|Overall Study|Study Terminated by Sponsor|41|||
164156272|NCT04740918|592935599|FG001|Overall Study|Study Terminated by Sponsor|32|||
164156273|NCT04740918|592935598|FG000|Overall Study|Death|3|||
164156275|NCT04740918|592935598|FG000|Overall Study|Withdrawal by Subject|5|||
164156276|NCT04740918|592935599|FG001|Overall Study|Withdrawal by Subject|4|||
164156277|NCT04740918|592935598|FG000|Overall Study|Lost to Follow-up|1|||
164156278|NCT04740918|592935599|FG001|Overall Study|Lost to Follow-up|3|||
164156279|NCT04740918|592935598|FG000|Overall Study|Progressive disease|0|||
164156280|NCT04740918|592935599|FG001|Overall Study|Progressive disease|1|||
164156281|NCT01256879|592935602|FG000|Overall Study|Withdrawal by Subject|1|||
164156282|NCT00725920|592935603|FG000|Overall Study|Lack of Efficacy|3|||
164156283|NCT00725920|592935604|FG001|Overall Study|Lack of Efficacy|6|||
164156284|NCT01288079|592935605|FG000|Overall Study|Withdrawal by Subject|2|||
164156285|NCT01288079|592935606|FG001|Overall Study|Withdrawal by Subject|4|||
164156286|NCT01288079|592935607|FG002|Overall Study|Withdrawal by Subject|1|||
164156287|NCT01288079|592935608|FG003|Overall Study|Withdrawal by Subject|0|||
164156288|NCT01288079|592935605|FG000|Overall Study|Adverse Event|2|||
164156289|NCT01288079|592935606|FG001|Overall Study|Adverse Event|1|||
164156290|NCT01288079|592935607|FG002|Overall Study|Adverse Event|2|||
164156291|NCT01288079|592935608|FG003|Overall Study|Adverse Event|3|||
164156292|NCT01288079|592935605|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
164156293|NCT01288079|592935606|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
164156294|NCT01288079|592935607|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
164156295|NCT01288079|592935608|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
164156296|NCT01288079|592935605|FG000|Overall Study|Condition under Investigation Worsened|0|||
164156297|NCT01288079|592935606|FG001|Overall Study|Condition under Investigation Worsened|0|||
164156298|NCT01288079|592935607|FG002|Overall Study|Condition under Investigation Worsened|0|||
164156299|NCT01288079|592935608|FG003|Overall Study|Condition under Investigation Worsened|1|||
164156300|NCT01288079|592935605|FG000|Overall Study|Lack of Efficacy|2|||
164156301|NCT01288079|592935606|FG001|Overall Study|Lack of Efficacy|2|||
164156302|NCT01288079|592935607|FG002|Overall Study|Lack of Efficacy|0|||
164156303|NCT01288079|592935608|FG003|Overall Study|Lack of Efficacy|2|||
164156304|NCT01288079|592935605|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
164156305|NCT01288079|592935606|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
164156306|NCT01288079|592935607|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
164156307|NCT01288079|592935608|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
164156308|NCT01288079|592935605|FG000|Overall Study|Lost to Follow-up|1|||
164156309|NCT01288079|592935606|FG001|Overall Study|Lost to Follow-up|1|||
164156310|NCT01288079|592935607|FG002|Overall Study|Lost to Follow-up|1|||
164156311|NCT01288079|592935608|FG003|Overall Study|Lost to Follow-up|0|||
164156312|NCT01288079|592935605|FG000|Overall Study|Other or Study Termination|11|||
164156313|NCT01288079|592935606|FG001|Overall Study|Other or Study Termination|15|||
164156314|NCT01288079|592935607|FG002|Overall Study|Other or Study Termination|14|||
164156315|NCT01288079|592935608|FG003|Overall Study|Other or Study Termination|8|||
164156316|NCT03170544|592935609|FG000|Part 1|Lost to Follow-up|1|||
164156317|NCT03170544|592935610|FG001|Part 1|Lost to Follow-up|0|||
164156318|NCT03170544|592935611|FG002|Part 1|Lost to Follow-up|0|||
164156319|NCT03170544|592935612|FG003|Part 1|Lost to Follow-up|0|||
164156320|NCT03170544|592935613|FG004|Part 1|Lost to Follow-up|0|||
164156321|NCT03170544|592935614|FG005|Part 1|Lost to Follow-up|0|||
164156322|NCT03170544|592935615|FG006|Part 1|Lost to Follow-up|0|||
164156323|NCT03170544|592935616|FG007|Part 1|Lost to Follow-up|0|||
164156324|NCT03170544|592935617|FG008|Part 1|Lost to Follow-up|0|||
164156325|NCT03170544|592935618|FG009|Part 1|Lost to Follow-up|0|||
164156326|NCT03170544|592935619|FG010|Part 1|Lost to Follow-up|0|||
164156327|NCT03170544|592935620|FG011|Part 1|Lost to Follow-up|0|||
164156328|NCT03170544|592935609|FG000|Part 1|Not treated|0|||
164156329|NCT03170544|592935610|FG001|Part 1|Not treated|0|||
164156330|NCT03170544|592935611|FG002|Part 1|Not treated|0|||
164156331|NCT03170544|592935612|FG003|Part 1|Not treated|1|||
164156332|NCT03170544|592935613|FG004|Part 1|Not treated|0|||
164156333|NCT03170544|592935614|FG005|Part 1|Not treated|0|||
164156334|NCT03170544|592935615|FG006|Part 1|Not treated|0|||
164156335|NCT03170544|592935616|FG007|Part 1|Not treated|0|||
164156336|NCT03170544|592935617|FG008|Part 1|Not treated|0|||
164156337|NCT03170544|592935618|FG009|Part 1|Not treated|0|||
164156338|NCT03170544|592935619|FG010|Part 1|Not treated|0|||
164156339|NCT03170544|592935620|FG011|Part 1|Not treated|0|||
164156340|NCT02387840|592935621|FG000|Overall Study|Death|0|||
164156341|NCT02387840|592935622|FG001|Overall Study|Death|0|||
164156342|NCT02387840|592935623|FG002|Overall Study|Death|0|||
164156343|NCT02387840|592935624|FG003|Overall Study|Death|0|||
164156344|NCT02387840|592935625|FG004|Overall Study|Death|0|||
164156345|NCT02387840|592935626|FG005|Overall Study|Death|1|||
164156346|NCT01213966|592935627|FG000|Overall Study|Protocol Violation|1|||
164156347|NCT01213966|592935628|FG001|Overall Study|Protocol Violation|0|||
164156348|NCT01213966|592935629|FG002|Overall Study|Protocol Violation|3|||
164156349|NCT01213966|592935630|FG003|Overall Study|Protocol Violation|1|||
164156350|NCT00420420|592935646|FG000|Overall Study|Adverse Event|5|||
164156351|NCT00420420|592935647|FG001|Overall Study|Adverse Event|3|||
164156352|NCT00420420|592935646|FG000|Overall Study|Protocol Violation|1|||
164156353|NCT00420420|592935647|FG001|Overall Study|Protocol Violation|1|||
164156354|NCT00420420|592935646|FG000|Overall Study|Withdrawal by Subject|1|||
164156355|NCT00420420|592935647|FG001|Overall Study|Withdrawal by Subject|0|||
164156356|NCT00420420|592935646|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
164156357|NCT00420420|592935647|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
164156358|NCT00273182|592935648|FG000|Overall Study|Death|450|||
164156359|NCT00273182|592935648|FG000|Overall Study|Lost to Follow-up|88|||
164156360|NCT00273182|592935648|FG000|Overall Study|Withdrawal by Subject|257|||
164156361|NCT00273182|592935648|FG000|Overall Study|Device/System Explant|154|||
164156362|NCT00273182|592935648|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
164156363|NCT00359424|592935649|FG000|Overall Study|Death|99|||
164156364|NCT00359424|592935650|FG001|Overall Study|Death|58|||
164156365|NCT00359424|592935649|FG000|Overall Study|Lost to Follow-up|19|||
164156366|NCT00359424|592935650|FG001|Overall Study|Lost to Follow-up|7|||
164156367|NCT00359424|592935649|FG000|Overall Study|Withdrawal by Subject|10|||
164156368|NCT00359424|592935650|FG001|Overall Study|Withdrawal by Subject|2|||
164156369|NCT00359424|592935649|FG000|Overall Study|follow up not conducted|2|||
164156370|NCT00359424|592935650|FG001|Overall Study|follow up not conducted|0|||
164156371|NCT01609790|592935654|FG000|Overall Study|Protocol Violation|1|||
164156372|NCT01609790|592935655|FG001|Overall Study|Protocol Violation|7|||
164156373|NCT01609790|592935656|FG002|Overall Study|Protocol Violation|8|||
164156374|NCT03760744|592937928|FG000|Overall Study|Lost to Follow-up|3|||
164156375|NCT03760744|592937929|FG001|Overall Study|Lost to Follow-up|0|||
164156376|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Adverse Event|7|||
164156377|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
164156378|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Non-compliance|3|||
164156379|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Other|17|||
164156380|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Physician Decision|2|||
164156381|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Pregnancy|1|||
164156382|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
164156383|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
164156384|NCT05207865|592937930|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
164156385|NCT05207865|592937930|FG000|Follow-up Phase|Lost to Follow-up|1|||
164156386|NCT05207865|592937930|FG000|Follow-up Phase|Non-compliance|1|||
164156387|NCT05207865|592937930|FG000|Follow-up Phase|Not reported|2|||
164156388|NCT05207865|592937930|FG000|Follow-up Phase|Not collected|11|||
164156389|NCT00739882|592937931|FG000|Double-blind Period|Adverse Event|1|||
164156390|NCT00739882|592937932|FG001|Double-blind Period|Adverse Event|2|||
164156391|NCT00739882|592937931|FG000|Double-blind Period|Protocol Violation|1|||
164156392|NCT00739882|592937932|FG001|Double-blind Period|Protocol Violation|0|||
164156393|NCT00739882|592937931|FG000|Double-blind Period|Lack of Efficacy|1|||
164156394|NCT00739882|592937932|FG001|Double-blind Period|Lack of Efficacy|1|||
164156395|NCT00739882|592937931|FG000|Double-blind Period|Other|16|||
164156396|NCT00739882|592937932|FG001|Double-blind Period|Other|8|||
164156397|NCT00739882|592937931|FG000|Open-label Period|Adverse Event|1|||
164156398|NCT00739882|592937932|FG001|Open-label Period|Adverse Event|0|||
164156399|NCT00739882|592937931|FG000|Open-label Period|Other|9|||
164156400|NCT00739882|592937932|FG001|Open-label Period|Other|5|||
164156401|NCT03055338|592937935|FG000|Overall Study|Lost to Follow-up|9|||
164156402|NCT03055338|592937936|FG001|Overall Study|Lost to Follow-up|2|||
164156403|NCT03055338|592937937|FG002|Overall Study|Lost to Follow-up|3|||
164156404|NCT03055338|592937935|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
164156405|NCT03055338|592937936|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
164156406|NCT03055338|592937937|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
164156407|NCT03055338|592937935|FG000|Overall Study|Physician Decision|0|||
164156408|NCT03055338|592937936|FG001|Overall Study|Physician Decision|0|||
164156409|NCT03055338|592937937|FG002|Overall Study|Physician Decision|2|||
164156410|NCT03055338|592937935|FG000|Overall Study|Withdrawal by Subject|9|||
164156411|NCT03055338|592937936|FG001|Overall Study|Withdrawal by Subject|8|||
164156412|NCT03055338|592937937|FG002|Overall Study|Withdrawal by Subject|7|||
164156413|NCT00975611|592937938|FG000|Overall Study|Screen Fail|16|||
164156414|NCT00975611|592937938|FG000|Overall Study|Physician Decision|1|||
164156415|NCT03058705|592937939|FG000|Overall Study|Withdrawal by Subject|2|||
164156416|NCT03058705|592937939|FG000|Overall Study|Physician Decision|2|||
164156417|NCT01880554|592937940|FG000|Overall Study|Protocol Violation|14|||
164156418|NCT01880554|592937940|FG000|Overall Study|Simon's design requirements|2|||
164156419|NCT01415518|592937941|FG000|Overall Study|Withdrawal by Subject|2|||
164156420|NCT01415518|592937942|FG001|Overall Study|Withdrawal by Subject|12|||
164156421|NCT01415518|592937941|FG000|Overall Study|Protocol Violation|6|||
164156422|NCT01415518|592937942|FG001|Overall Study|Protocol Violation|8|||
164156423|NCT01415518|592937941|FG000|Overall Study|Lost to Follow-up|3|||
164156424|NCT01415518|592937942|FG001|Overall Study|Lost to Follow-up|5|||
164156425|NCT01415518|592937941|FG000|Overall Study|Adverse Event|3|||
164156426|NCT01415518|592937942|FG001|Overall Study|Adverse Event|4|||
164156427|NCT01415518|592937941|FG000|Overall Study|Death|1|||
164156428|NCT01415518|592937942|FG001|Overall Study|Death|1|||
164156429|NCT01415518|592937941|FG000|Overall Study|Condition under Investigation Worsened|1|||
164156430|NCT01415518|592937942|FG001|Overall Study|Condition under Investigation Worsened|1|||
164156431|NCT01102257|592937950|FG000|Overall Study|Adverse Event|1|||
164156432|NCT01102257|592937951|FG001|Overall Study|Adverse Event|0|||
164156433|NCT01102257|592937950|FG000|Overall Study|Adverse Event|1|||
164156434|NCT01102257|592937951|FG001|Overall Study|Adverse Event|0|||
164156435|NCT03752970|592937952|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
164156436|NCT03752970|592937953|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
164156437|NCT03752970|592937954|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
164156438|NCT03752970|592937952|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
164156439|NCT03752970|592937953|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
164156440|NCT03752970|592937954|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
164156441|NCT03752970|592937952|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
164156442|NCT03752970|592937953|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
164156443|NCT03752970|592937954|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
164156444|NCT03752970|592937952|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
164156445|NCT03752970|592937953|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
164156446|NCT03752970|592937954|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
164156447|NCT03752970|592937952|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
164156448|NCT03752970|592937953|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
164156449|NCT03752970|592937954|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
164156450|NCT03976362|592937955|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
164156451|NCT03976362|592937956|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164156452|NCT03976362|592937957|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164156453|NCT03976362|592937955|FG000|Induction Phase|Death|62|||
164156454|NCT03976362|592937956|FG001|Induction Phase|Death|0|||
164156455|NCT03976362|592937957|FG002|Induction Phase|Death|0|||
164156456|NCT03976362|592937955|FG000|Maintenance Phase|Participants Ongoing|0|||
164156457|NCT03976362|592937956|FG001|Maintenance Phase|Participants Ongoing|106|||
164156458|NCT03976362|592937957|FG002|Maintenance Phase|Participants Ongoing|103|||
164156459|NCT03976362|592937955|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164156460|NCT03976362|592937956|FG001|Maintenance Phase|Withdrawal by Subject|4|||
164156461|NCT03976362|592937957|FG002|Maintenance Phase|Withdrawal by Subject|4|||
164156462|NCT03976362|592937955|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
164156463|NCT03976362|592937956|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
164156464|NCT03976362|592937957|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
164156465|NCT03976362|592937955|FG000|Maintenance Phase|Death|0|||
164156466|NCT03976362|592937956|FG001|Maintenance Phase|Death|186|||
164156467|NCT03976362|592937957|FG002|Maintenance Phase|Death|187|||
164156468|NCT04767282|592937958|FG000|Overall Study|Refused or did not begin surveys|6|||
164156469|NCT04767282|592937959|FG001|Overall Study|Refused or did not begin surveys|2|||
164156470|NCT04767282|592937960|FG002|Overall Study|Refused or did not begin surveys|2|||
164156471|NCT04767282|592937958|FG000|Overall Study|Duplicate household previously enrolled|2|||
164156472|NCT04767282|592937959|FG001|Overall Study|Duplicate household previously enrolled|0|||
164156473|NCT04767282|592937960|FG002|Overall Study|Duplicate household previously enrolled|8|||
164156474|NCT04767282|592937958|FG000|Overall Study|Unable to confirm legal guardian|0|||
164156475|NCT04767282|592937959|FG001|Overall Study|Unable to confirm legal guardian|2|||
164156476|NCT04767282|592937960|FG002|Overall Study|Unable to confirm legal guardian|8|||
164156477|NCT04767282|592937958|FG000|Overall Study|Withdrawal by Subject|0|||
164156478|NCT04767282|592937959|FG001|Overall Study|Withdrawal by Subject|0|||
164156479|NCT04767282|592937960|FG002|Overall Study|Withdrawal by Subject|6|||
164156480|NCT04767282|592937958|FG000|Overall Study|Survey comprehension challenges|4|||
164156481|NCT04767282|592937959|FG001|Overall Study|Survey comprehension challenges|0|||
164156482|NCT04767282|592937960|FG002|Overall Study|Survey comprehension challenges|0|||
164156483|NCT01467713|592937962|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
164156484|NCT01467713|592937963|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
164156485|NCT01467713|592937964|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
164156486|NCT01467713|592937965|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
164156487|NCT01467713|592937962|FG000|Overall Study|Major Protocol Deviation|2|||
164156488|NCT01467713|592937963|FG001|Overall Study|Major Protocol Deviation|4|||
164156489|NCT01467713|592937964|FG002|Overall Study|Major Protocol Deviation|4|||
164156490|NCT01467713|592937965|FG003|Overall Study|Major Protocol Deviation|1|||
164156491|NCT01467713|592937962|FG000|Overall Study|Lost to Follow-up|9|||
164156492|NCT01467713|592937963|FG001|Overall Study|Lost to Follow-up|12|||
164156493|NCT01467713|592937964|FG002|Overall Study|Lost to Follow-up|6|||
164156494|NCT01467713|592937965|FG003|Overall Study|Lost to Follow-up|9|||
164156495|NCT01467713|592937962|FG000|Overall Study|Voluntary Withdrawal|18|||
164156496|NCT01467713|592937963|FG001|Overall Study|Voluntary Withdrawal|14|||
164156497|NCT01467713|592937964|FG002|Overall Study|Voluntary Withdrawal|21|||
164156498|NCT01467713|592937965|FG003|Overall Study|Voluntary Withdrawal|20|||
164156499|NCT01467713|592937962|FG000|Overall Study|Study Termination|23|||
164156500|NCT01467713|592937963|FG001|Overall Study|Study Termination|33|||
164156501|NCT01467713|592937964|FG002|Overall Study|Study Termination|28|||
164156502|NCT01467713|592937965|FG003|Overall Study|Study Termination|29|||
164156503|NCT01467713|592937962|FG000|Overall Study|Pregnancy|0|||
164156504|NCT01467713|592937963|FG001|Overall Study|Pregnancy|1|||
164156505|NCT01467713|592937964|FG002|Overall Study|Pregnancy|1|||
164156506|NCT01467713|592937965|FG003|Overall Study|Pregnancy|3|||
164156507|NCT01467713|592937962|FG000|Overall Study|Relapse|35|||
164156508|NCT01467713|592937963|FG001|Overall Study|Relapse|25|||
164156509|NCT01467713|592937964|FG002|Overall Study|Relapse|28|||
164156510|NCT01467713|592937965|FG003|Overall Study|Relapse|35|||
164156511|NCT01467713|592937962|FG000|Overall Study|Reason not Specified|6|||
164156512|NCT01467713|592937963|FG001|Overall Study|Reason not Specified|11|||
164156513|NCT01467713|592937964|FG002|Overall Study|Reason not Specified|8|||
164156514|NCT01467713|592937965|FG003|Overall Study|Reason not Specified|7|||
164156515|NCT04846569|592937966|FG000|Overall Study|Withdrawal by Subject|3|||
164156516|NCT04846569|592937967|FG001|Overall Study|Withdrawal by Subject|1|||
164156517|NCT02525783|592937968|FG000|Overall Study|Lost to Follow-up|10|||
164156518|NCT02512302|592937969|FG000|Period 1|Adverse Event|0|||
164156519|NCT02512302|592937970|FG001|Period 1|Adverse Event|1|||
164156520|NCT02512302|592937971|FG002|Period 1|Adverse Event|0|||
164156521|NCT02512302|592937972|FG003|Period 1|Adverse Event|0|||
164156522|NCT02512302|592937973|FG004|Period 1|Adverse Event|0|||
164156523|NCT02512302|592937974|FG005|Period 1|Adverse Event|0|||
164156524|NCT02512302|592937975|FG006|Period 1|Adverse Event|0|||
164156525|NCT02512302|592937976|FG007|Period 1|Adverse Event|0|||
164156526|NCT02512302|592937977|FG008|Period 1|Adverse Event|0|||
164156527|NCT02512302|592937978|FG009|Period 1|Adverse Event|0|||
164156528|NCT02512302|592937969|FG000|Period 2|Adverse Event|0|||
164156529|NCT02512302|592937970|FG001|Period 2|Adverse Event|0|||
164156530|NCT02512302|592937971|FG002|Period 2|Adverse Event|0|||
164156531|NCT02512302|592937972|FG003|Period 2|Adverse Event|0|||
164156532|NCT02512302|592937973|FG004|Period 2|Adverse Event|0|||
164156533|NCT02512302|592937974|FG005|Period 2|Adverse Event|0|||
164156534|NCT02512302|592937975|FG006|Period 2|Adverse Event|0|||
164156535|NCT02512302|592937976|FG007|Period 2|Adverse Event|0|||
164156536|NCT02512302|592937977|FG008|Period 2|Adverse Event|0|||
164156537|NCT02512302|592937978|FG009|Period 2|Adverse Event|1|||
164156538|NCT02512302|592937969|FG000|Period 3|Lost to Follow-up|0|||
164156539|NCT02512302|592937970|FG001|Period 3|Lost to Follow-up|0|||
164156540|NCT02512302|592937971|FG002|Period 3|Lost to Follow-up|1|||
164156541|NCT02512302|592937972|FG003|Period 3|Lost to Follow-up|0|||
164156542|NCT02512302|592937973|FG004|Period 3|Lost to Follow-up|0|||
164156543|NCT02512302|592937974|FG005|Period 3|Lost to Follow-up|0|||
164156544|NCT02512302|592937975|FG006|Period 3|Lost to Follow-up|0|||
164156545|NCT02512302|592937976|FG007|Period 3|Lost to Follow-up|0|||
164156546|NCT02512302|592937977|FG008|Period 3|Lost to Follow-up|0|||
164156547|NCT02512302|592937978|FG009|Period 3|Lost to Follow-up|0|||
164156548|NCT02512302|592937969|FG000|Period 4|Adverse Event|0|||
164156549|NCT02512302|592937970|FG001|Period 4|Adverse Event|0|||
164156550|NCT02512302|592937971|FG002|Period 4|Adverse Event|0|||
164156551|NCT02512302|592937972|FG003|Period 4|Adverse Event|0|||
164156552|NCT02512302|592937973|FG004|Period 4|Adverse Event|0|||
164156553|NCT02512302|592937974|FG005|Period 4|Adverse Event|0|||
164156554|NCT02512302|592937975|FG006|Period 4|Adverse Event|1|||
164156555|NCT02512302|592937976|FG007|Period 4|Adverse Event|0|||
164156556|NCT02512302|592937977|FG008|Period 4|Adverse Event|0|||
164156557|NCT02512302|592937978|FG009|Period 4|Adverse Event|0|||
164156558|NCT01735916|592937989|FG000|Overall Study|Subject not eligible to be randomized|11|||
164156559|NCT01735916|592937990|FG001|Overall Study|Subject not eligible to be randomized|0|||
164156560|NCT01735916|592937991|FG002|Overall Study|Subject not eligible to be randomized|0|||
164156561|NCT01735916|592937989|FG000|Overall Study|Early termination of study by sponsor|4|||
164156562|NCT01735916|592937990|FG001|Overall Study|Early termination of study by sponsor|19|||
164156563|NCT01735916|592937991|FG002|Overall Study|Early termination of study by sponsor|7|||
164156564|NCT01735916|592937989|FG000|Overall Study|Withdrawal by Subject|3|||
164156565|NCT01735916|592937990|FG001|Overall Study|Withdrawal by Subject|0|||
164156566|NCT01735916|592937991|FG002|Overall Study|Withdrawal by Subject|0|||
164156567|NCT05177484|592937997|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
164156568|NCT05177484|592937998|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
164156569|NCT05177484|592937997|FG000|Overall Study|Inadvertently withdrawn|3|||
164156570|NCT05177484|592937998|FG001|Overall Study|Inadvertently withdrawn|1|||
164156571|NCT05177484|592937997|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
164156572|NCT05177484|592937998|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
164156573|NCT01379768|592937999|FG000|Overall Study|Adverse Event|1|||
164156574|NCT01379768|592938000|FG001|Overall Study|Adverse Event|1|||
164156575|NCT01379768|592938001|FG002|Overall Study|Adverse Event|0|||
164156576|NCT01379768|592937999|FG000|Overall Study|Lost to Follow-up|2|||
164156577|NCT01379768|592938000|FG001|Overall Study|Lost to Follow-up|0|||
164156578|NCT01379768|592938001|FG002|Overall Study|Lost to Follow-up|0|||
164156579|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
164156580|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
164156581|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
164156582|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
164156583|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
164156584|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156585|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156586|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156587|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156588|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156589|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156590|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156591|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156592|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156593|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
164156594|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
164156595|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
164156596|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
164156597|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
164156598|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
164156599|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156600|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156601|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156602|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156603|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156604|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156605|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156606|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156607|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156608|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
164156609|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
164156610|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
164156611|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
164156612|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
164156613|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
164156614|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156615|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156616|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156617|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156618|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156619|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156620|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156621|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156622|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156623|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
164156624|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
164156625|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
164156626|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
164156627|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
164156628|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
164156629|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156630|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156631|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156632|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156633|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156634|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156635|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156636|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156637|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156638|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
164156639|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
164156640|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156641|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
164156642|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
164156643|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
164156644|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156645|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156646|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156647|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156648|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156649|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156650|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156651|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156652|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156653|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
164156654|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156655|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156656|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156657|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
164156658|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156659|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156660|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156661|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156662|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156663|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156664|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156665|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156666|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156667|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156668|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
164156669|NCT03334435|592938006|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156670|NCT03334435|592938007|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
164156671|NCT03334435|592938008|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
164156672|NCT03334435|592938009|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
164156673|NCT03334435|592938010|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
164156674|NCT03334435|592938011|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156675|NCT03334435|592938012|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156676|NCT03334435|592938013|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156677|NCT03334435|592938014|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156678|NCT03334435|592938015|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156679|NCT03334435|592938016|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156680|NCT03334435|592938017|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156681|NCT03334435|592938018|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156682|NCT03334435|592938019|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156683|NCT03334435|592938020|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
164156684|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156685|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156686|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156687|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156688|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
164156689|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
164156690|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
164156691|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
164156692|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
164156693|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
164156694|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
164156695|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
164156696|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
164156697|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
164156698|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
164156699|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156700|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156701|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156702|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156703|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
164156906|NCT00460603|592938029|FG004|Phase 1|Withdrawal by Subject|3|||
164156704|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
164156705|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
164156706|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
164156707|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
164156708|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
164156709|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
164156710|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
164156711|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
164156712|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
164156713|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
164156714|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156715|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156716|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156717|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156718|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156719|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
164156720|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
164156721|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
164156722|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
164156723|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
164156724|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
164156725|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
164156726|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
164156727|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
164156728|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
164156729|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156730|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156731|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156732|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156733|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
164156734|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
164156735|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
164156736|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
164156737|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
164156738|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
164156739|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
164156740|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
164156741|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
164156742|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
164156743|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
164156744|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156745|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156746|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156747|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156748|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156749|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156750|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
164156751|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
164156752|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
164156753|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
164156754|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
164156755|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
164156756|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
164156757|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
164156758|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
164156759|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156760|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156761|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156762|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156763|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156764|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156765|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156766|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156767|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156768|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156769|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156770|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
164156771|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156772|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
164156773|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
164156774|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156775|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156776|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156777|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156778|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156779|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
164156780|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156781|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156782|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156783|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156784|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156785|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156786|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156787|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
164156788|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
164156789|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156790|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156791|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156792|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156793|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156794|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156795|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156796|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156797|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156798|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
164156799|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156800|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
164156801|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156802|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156803|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
164156804|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156805|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156806|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156807|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156808|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156809|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156810|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156811|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156812|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156813|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156814|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
164156815|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156816|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
164156817|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
164156818|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
164156819|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156820|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156821|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156822|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156823|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156824|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
164156825|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156826|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156827|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156828|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156907|NCT00460603|592938030|FG005|Phase 1|Withdrawal by Subject|0|||
164156829|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
164156830|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156831|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156832|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
164156833|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
164156834|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156835|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156836|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156837|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156838|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156839|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156840|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156841|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156842|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156843|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156844|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156845|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
164156846|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
164156847|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156848|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
164156849|NCT03334435|592938006|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156850|NCT03334435|592938007|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156851|NCT03334435|592938008|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156852|NCT03334435|592938009|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156853|NCT03334435|592938010|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156854|NCT03334435|592938011|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156855|NCT03334435|592938012|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156856|NCT03334435|592938013|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156857|NCT03334435|592938014|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156858|NCT03334435|592938015|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156859|NCT03334435|592938016|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156860|NCT03334435|592938017|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
164156861|NCT03334435|592938018|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
164156862|NCT03334435|592938019|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
164156863|NCT03334435|592938020|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
164156864|NCT03922321|592938021|FG000|Overall Study|Participant Moved|1|||
164156865|NCT03922321|592938021|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
164156866|NCT00460603|592938025|FG000|Phase 1|Death|1|||
164156867|NCT00460603|592938026|FG001|Phase 1|Death|0|||
164156868|NCT00460603|592938027|FG002|Phase 1|Death|0|||
164156869|NCT00460603|592938028|FG003|Phase 1|Death|2|||
164156870|NCT00460603|592938029|FG004|Phase 1|Death|0|||
164156871|NCT00460603|592938030|FG005|Phase 1|Death|0|||
164156872|NCT00460603|592938031|FG006|Phase 1|Death|0|||
164156873|NCT00460603|592938032|FG007|Phase 1|Death|0|||
164156874|NCT00460603|592938033|FG008|Phase 1|Death|1|||
164156875|NCT00460603|592938034|FG009|Phase 1|Death|0|||
164156876|NCT00460603|592938035|FG010|Phase 1|Death|0|||
164156877|NCT00460603|592938036|FG011|Phase 1|Death|0|||
164156878|NCT00460603|592938025|FG000|Phase 1|Adverse Event|3|||
164156879|NCT00460603|592938026|FG001|Phase 1|Adverse Event|1|||
164156880|NCT00460603|592938027|FG002|Phase 1|Adverse Event|1|||
164156881|NCT00460603|592938028|FG003|Phase 1|Adverse Event|2|||
164156882|NCT00460603|592938029|FG004|Phase 1|Adverse Event|0|||
164156883|NCT00460603|592938030|FG005|Phase 1|Adverse Event|0|||
164156884|NCT00460603|592938031|FG006|Phase 1|Adverse Event|3|||
164156885|NCT00460603|592938032|FG007|Phase 1|Adverse Event|0|||
164156886|NCT00460603|592938033|FG008|Phase 1|Adverse Event|4|||
164156887|NCT00460603|592938034|FG009|Phase 1|Adverse Event|0|||
164156888|NCT00460603|592938035|FG010|Phase 1|Adverse Event|0|||
164156889|NCT00460603|592938036|FG011|Phase 1|Adverse Event|0|||
164156890|NCT00460603|592938025|FG000|Phase 1|Lack of Efficacy|1|||
164156891|NCT00460603|592938026|FG001|Phase 1|Lack of Efficacy|0|||
164156892|NCT00460603|592938027|FG002|Phase 1|Lack of Efficacy|1|||
164156893|NCT00460603|592938028|FG003|Phase 1|Lack of Efficacy|2|||
164156894|NCT00460603|592938029|FG004|Phase 1|Lack of Efficacy|2|||
164156895|NCT00460603|592938030|FG005|Phase 1|Lack of Efficacy|2|||
164156896|NCT00460603|592938031|FG006|Phase 1|Lack of Efficacy|2|||
164156897|NCT00460603|592938032|FG007|Phase 1|Lack of Efficacy|2|||
164156898|NCT00460603|592938033|FG008|Phase 1|Lack of Efficacy|11|||
164156899|NCT00460603|592938034|FG009|Phase 1|Lack of Efficacy|0|||
164156900|NCT00460603|592938035|FG010|Phase 1|Lack of Efficacy|0|||
164156901|NCT00460603|592938036|FG011|Phase 1|Lack of Efficacy|0|||
164156902|NCT00460603|592938025|FG000|Phase 1|Withdrawal by Subject|1|||
164156903|NCT00460603|592938026|FG001|Phase 1|Withdrawal by Subject|2|||
164156904|NCT00460603|592938027|FG002|Phase 1|Withdrawal by Subject|1|||
164156905|NCT00460603|592938028|FG003|Phase 1|Withdrawal by Subject|1|||
164156908|NCT00460603|592938031|FG006|Phase 1|Withdrawal by Subject|1|||
164156909|NCT00460603|592938032|FG007|Phase 1|Withdrawal by Subject|0|||
164156910|NCT00460603|592938033|FG008|Phase 1|Withdrawal by Subject|2|||
164156911|NCT00460603|592938034|FG009|Phase 1|Withdrawal by Subject|0|||
164156912|NCT00460603|592938035|FG010|Phase 1|Withdrawal by Subject|0|||
164156913|NCT00460603|592938036|FG011|Phase 1|Withdrawal by Subject|0|||
164156914|NCT00460603|592938025|FG000|Phase 1|Other|0|||
164156915|NCT00460603|592938026|FG001|Phase 1|Other|3|||
164156916|NCT00460603|592938027|FG002|Phase 1|Other|1|||
164156917|NCT00460603|592938028|FG003|Phase 1|Other|1|||
164156918|NCT00460603|592938029|FG004|Phase 1|Other|1|||
164156919|NCT00460603|592938030|FG005|Phase 1|Other|2|||
164156920|NCT00460603|592938031|FG006|Phase 1|Other|0|||
164156921|NCT00460603|592938032|FG007|Phase 1|Other|1|||
164156922|NCT00460603|592938033|FG008|Phase 1|Other|0|||
164156923|NCT00460603|592938034|FG009|Phase 1|Other|0|||
164156924|NCT00460603|592938035|FG010|Phase 1|Other|0|||
164156925|NCT00460603|592938036|FG011|Phase 1|Other|0|||
164156926|NCT00460603|592938025|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156927|NCT00460603|592938026|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156928|NCT00460603|592938027|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156929|NCT00460603|592938028|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156930|NCT00460603|592938029|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156931|NCT00460603|592938030|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156932|NCT00460603|592938031|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156933|NCT00460603|592938032|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156934|NCT00460603|592938033|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156935|NCT00460603|592938034|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
164156936|NCT00460603|592938035|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156937|NCT00460603|592938036|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
164156938|NCT00460603|592938025|FG000|Phase 2|Adverse Event|0|||
164156939|NCT00460603|592938026|FG001|Phase 2|Adverse Event|0|||
164156940|NCT00460603|592938027|FG002|Phase 2|Adverse Event|0|||
164156941|NCT00460603|592938028|FG003|Phase 2|Adverse Event|0|||
164156942|NCT00460603|592938029|FG004|Phase 2|Adverse Event|0|||
164156943|NCT00460603|592938030|FG005|Phase 2|Adverse Event|0|||
164156944|NCT00460603|592938031|FG006|Phase 2|Adverse Event|0|||
164156945|NCT00460603|592938032|FG007|Phase 2|Adverse Event|0|||
164156946|NCT00460603|592938033|FG008|Phase 2|Adverse Event|0|||
164156947|NCT00460603|592938034|FG009|Phase 2|Adverse Event|12|||
164156948|NCT00460603|592938035|FG010|Phase 2|Adverse Event|9|||
164156949|NCT00460603|592938036|FG011|Phase 2|Adverse Event|10|||
164156950|NCT00460603|592938025|FG000|Phase 2|Death|0|||
164156951|NCT00460603|592938026|FG001|Phase 2|Death|0|||
164156952|NCT00460603|592938027|FG002|Phase 2|Death|0|||
164156953|NCT00460603|592938028|FG003|Phase 2|Death|0|||
164156954|NCT00460603|592938029|FG004|Phase 2|Death|0|||
164156955|NCT00460603|592938030|FG005|Phase 2|Death|0|||
164156956|NCT00460603|592938031|FG006|Phase 2|Death|0|||
164156957|NCT00460603|592938032|FG007|Phase 2|Death|0|||
164156958|NCT00460603|592938033|FG008|Phase 2|Death|0|||
164156959|NCT00460603|592938034|FG009|Phase 2|Death|4|||
164156960|NCT00460603|592938035|FG010|Phase 2|Death|2|||
164156961|NCT00460603|592938036|FG011|Phase 2|Death|2|||
164156962|NCT00460603|592938025|FG000|Phase 2|Protocol Violation|0|||
164156963|NCT00460603|592938026|FG001|Phase 2|Protocol Violation|0|||
164156964|NCT00460603|592938027|FG002|Phase 2|Protocol Violation|0|||
164156965|NCT00460603|592938028|FG003|Phase 2|Protocol Violation|0|||
164156966|NCT00460603|592938029|FG004|Phase 2|Protocol Violation|0|||
164156967|NCT00460603|592938030|FG005|Phase 2|Protocol Violation|0|||
164156968|NCT00460603|592938031|FG006|Phase 2|Protocol Violation|0|||
164156969|NCT00460603|592938032|FG007|Phase 2|Protocol Violation|0|||
164156970|NCT00460603|592938033|FG008|Phase 2|Protocol Violation|0|||
164156971|NCT00460603|592938034|FG009|Phase 2|Protocol Violation|1|||
164156972|NCT00460603|592938035|FG010|Phase 2|Protocol Violation|1|||
164156973|NCT00460603|592938036|FG011|Phase 2|Protocol Violation|0|||
164156974|NCT00460603|592938025|FG000|Phase 2|Lost to Follow-up|0|||
164156975|NCT00460603|592938026|FG001|Phase 2|Lost to Follow-up|0|||
164156976|NCT00460603|592938027|FG002|Phase 2|Lost to Follow-up|0|||
164156977|NCT00460603|592938028|FG003|Phase 2|Lost to Follow-up|0|||
164156978|NCT00460603|592938029|FG004|Phase 2|Lost to Follow-up|0|||
164156979|NCT00460603|592938030|FG005|Phase 2|Lost to Follow-up|0|||
164156980|NCT00460603|592938031|FG006|Phase 2|Lost to Follow-up|0|||
164156981|NCT00460603|592938032|FG007|Phase 2|Lost to Follow-up|0|||
164156982|NCT00460603|592938033|FG008|Phase 2|Lost to Follow-up|0|||
164156983|NCT00460603|592938034|FG009|Phase 2|Lost to Follow-up|1|||
164156984|NCT00460603|592938035|FG010|Phase 2|Lost to Follow-up|0|||
164156985|NCT00460603|592938036|FG011|Phase 2|Lost to Follow-up|0|||
164156986|NCT00460603|592938025|FG000|Phase 2|Other|0|||
164156987|NCT00460603|592938026|FG001|Phase 2|Other|0|||
164156988|NCT00460603|592938027|FG002|Phase 2|Other|0|||
164156989|NCT00460603|592938028|FG003|Phase 2|Other|0|||
164156990|NCT00460603|592938029|FG004|Phase 2|Other|0|||
164156991|NCT00460603|592938030|FG005|Phase 2|Other|0|||
164156992|NCT00460603|592938031|FG006|Phase 2|Other|0|||
164156993|NCT00460603|592938032|FG007|Phase 2|Other|0|||
164156994|NCT00460603|592938033|FG008|Phase 2|Other|0|||
164156995|NCT00460603|592938034|FG009|Phase 2|Other|6|||
164156996|NCT00460603|592938035|FG010|Phase 2|Other|16|||
164156997|NCT00460603|592938036|FG011|Phase 2|Other|7|||
164156998|NCT00460603|592938025|FG000|Phase 2|Objective Progression or Relapse|0|||
164156999|NCT00460603|592938026|FG001|Phase 2|Objective Progression or Relapse|0|||
164157000|NCT00460603|592938027|FG002|Phase 2|Objective Progression or Relapse|0|||
164157001|NCT00460603|592938028|FG003|Phase 2|Objective Progression or Relapse|0|||
164157002|NCT00460603|592938029|FG004|Phase 2|Objective Progression or Relapse|0|||
164157003|NCT00460603|592938030|FG005|Phase 2|Objective Progression or Relapse|0|||
164157004|NCT00460603|592938031|FG006|Phase 2|Objective Progression or Relapse|0|||
164157005|NCT00460603|592938032|FG007|Phase 2|Objective Progression or Relapse|0|||
164157006|NCT00460603|592938033|FG008|Phase 2|Objective Progression or Relapse|0|||
164157007|NCT00460603|592938034|FG009|Phase 2|Objective Progression or Relapse|9|||
164157008|NCT00460603|592938035|FG010|Phase 2|Objective Progression or Relapse|10|||
164157009|NCT00460603|592938036|FG011|Phase 2|Objective Progression or Relapse|17|||
164157010|NCT00460603|592938025|FG000|Phase 2|Global Deterioration of Health Status|0|||
164157011|NCT00460603|592938026|FG001|Phase 2|Global Deterioration of Health Status|0|||
164157012|NCT00460603|592938027|FG002|Phase 2|Global Deterioration of Health Status|0|||
164157013|NCT00460603|592938028|FG003|Phase 2|Global Deterioration of Health Status|0|||
164157014|NCT00460603|592938029|FG004|Phase 2|Global Deterioration of Health Status|0|||
164157015|NCT00460603|592938030|FG005|Phase 2|Global Deterioration of Health Status|0|||
164157016|NCT00460603|592938031|FG006|Phase 2|Global Deterioration of Health Status|0|||
164157017|NCT00460603|592938032|FG007|Phase 2|Global Deterioration of Health Status|0|||
164157018|NCT00460603|592938033|FG008|Phase 2|Global Deterioration of Health Status|0|||
164157019|NCT00460603|592938034|FG009|Phase 2|Global Deterioration of Health Status|0|||
164157020|NCT00460603|592938035|FG010|Phase 2|Global Deterioration of Health Status|1|||
164157021|NCT00460603|592938036|FG011|Phase 2|Global Deterioration of Health Status|0|||
164157022|NCT00460603|592938025|FG000|Phase 2|Withdrawal by Subject|0|||
164157023|NCT00460603|592938026|FG001|Phase 2|Withdrawal by Subject|0|||
164157024|NCT00460603|592938027|FG002|Phase 2|Withdrawal by Subject|0|||
164157025|NCT00460603|592938028|FG003|Phase 2|Withdrawal by Subject|0|||
164157026|NCT00460603|592938029|FG004|Phase 2|Withdrawal by Subject|0|||
164157027|NCT00460603|592938030|FG005|Phase 2|Withdrawal by Subject|0|||
164157028|NCT00460603|592938031|FG006|Phase 2|Withdrawal by Subject|0|||
164157029|NCT00460603|592938032|FG007|Phase 2|Withdrawal by Subject|0|||
164157030|NCT00460603|592938033|FG008|Phase 2|Withdrawal by Subject|0|||
164157031|NCT00460603|592938034|FG009|Phase 2|Withdrawal by Subject|5|||
164157032|NCT00460603|592938035|FG010|Phase 2|Withdrawal by Subject|4|||
164157033|NCT00460603|592938036|FG011|Phase 2|Withdrawal by Subject|5|||
164157034|NCT00460603|592938025|FG000|Phase 2|Randomized, but not treated|0|||
164157035|NCT00460603|592938026|FG001|Phase 2|Randomized, but not treated|0|||
164157036|NCT00460603|592938027|FG002|Phase 2|Randomized, but not treated|0|||
164157037|NCT00460603|592938028|FG003|Phase 2|Randomized, but not treated|0|||
164157038|NCT00460603|592938029|FG004|Phase 2|Randomized, but not treated|0|||
164157039|NCT00460603|592938030|FG005|Phase 2|Randomized, but not treated|0|||
164157040|NCT00460603|592938031|FG006|Phase 2|Randomized, but not treated|0|||
164157041|NCT00460603|592938032|FG007|Phase 2|Randomized, but not treated|0|||
164157042|NCT00460603|592938033|FG008|Phase 2|Randomized, but not treated|0|||
164157043|NCT00460603|592938034|FG009|Phase 2|Randomized, but not treated|3|||
164157044|NCT00460603|592938035|FG010|Phase 2|Randomized, but not treated|0|||
164157045|NCT00460603|592938036|FG011|Phase 2|Randomized, but not treated|0|||
164157046|NCT01651117|592938040|FG000|Overall Study|Death|2|||
164157047|NCT01651117|592938041|FG001|Overall Study|Death|3|||
164157048|NCT01651117|592938042|FG002|Overall Study|Death|2|||
164157049|NCT01651117|592938043|FG003|Overall Study|Death|2|||
164157050|NCT02075203|592938045|FG000|Overall Study|Withdrawal by Subject|1|||
164157051|NCT02075203|592938046|FG001|Overall Study|Withdrawal by Subject|0|||
164157052|NCT02075203|592938047|FG002|Overall Study|Withdrawal by Subject|1|||
164157053|NCT02075203|592938045|FG000|Overall Study|Adverse Event|1|||
164157054|NCT02075203|592938046|FG001|Overall Study|Adverse Event|0|||
164157055|NCT02075203|592938047|FG002|Overall Study|Adverse Event|0|||
164157056|NCT02075203|592938045|FG000|Overall Study|participant refused to use contraception|1|||
164157057|NCT02075203|592938046|FG001|Overall Study|participant refused to use contraception|0|||
164157058|NCT02075203|592938047|FG002|Overall Study|participant refused to use contraception|0|||
164157059|NCT00350207|592938048|FG000|Overall Study|Adverse Event|5|||
164157060|NCT00350207|592938049|FG001|Overall Study|Adverse Event|2|||
164157061|NCT00350207|592938050|FG002|Overall Study|Adverse Event|2|||
164157062|NCT00350207|592938048|FG000|Overall Study|Lack of Efficacy|1|||
164157063|NCT00350207|592938049|FG001|Overall Study|Lack of Efficacy|0|||
164157064|NCT00350207|592938050|FG002|Overall Study|Lack of Efficacy|2|||
164157065|NCT00350207|592938048|FG000|Overall Study|Lost to Follow-up|1|||
164157066|NCT00350207|592938049|FG001|Overall Study|Lost to Follow-up|0|||
164157067|NCT00350207|592938050|FG002|Overall Study|Lost to Follow-up|1|||
164157068|NCT00350207|592938048|FG000|Overall Study|Withdrawal by Subject|0|||
164157069|NCT00350207|592938049|FG001|Overall Study|Withdrawal by Subject|1|||
164157070|NCT00350207|592938050|FG002|Overall Study|Withdrawal by Subject|1|||
164157071|NCT00350207|592938048|FG000|Overall Study|Other|1|||
164157072|NCT00350207|592938049|FG001|Overall Study|Other|3|||
164157073|NCT00350207|592938050|FG002|Overall Study|Other|1|||
164157074|NCT03802825|592938051|FG000|Overall Study|Lost to follow-up for intervention|12|||
164157075|NCT03802825|592938052|FG001|Overall Study|Lost to follow-up for intervention|3|||
164157076|NCT03802825|592938051|FG000|Overall Study|Received only 1 component of intervention|0|||
164157077|NCT03802825|592938052|FG001|Overall Study|Received only 1 component of intervention|13|||
164157078|NCT00568451|592938055|FG000|Overall Study|Disease Progression|0|||
164157079|NCT00568451|592938056|FG001|Overall Study|Disease Progression|0|||
164157080|NCT00568451|592938057|FG002|Overall Study|Disease Progression|2|||
164157081|NCT00568451|592938058|FG003|Overall Study|Disease Progression|7|||
164157082|NCT02996968|592938060|FG000|Overall Study|Withdrawal by Subject|1|||
164157083|NCT02996968|592938061|FG001|Overall Study|Withdrawal by Subject|0|||
164157084|NCT01293695|592938062|FG000|Overall Study|Withdrawal by Subject|7|||
164157085|NCT01293695|592938063|FG001|Overall Study|Withdrawal by Subject|1|||
164157086|NCT01293695|592938062|FG000|Overall Study|Lost to Follow-up|8|||
164157087|NCT01293695|592938063|FG001|Overall Study|Lost to Follow-up|6|||
164157088|NCT00791778|592938065|FG000|Double-blind Treatment|Adverse Event|49|||
164157089|NCT00791778|592938066|FG001|Double-blind Treatment|Adverse Event|9|||
164157090|NCT00791778|592938065|FG000|Double-blind Treatment|Physician Decision|6|||
164157091|NCT00791778|592938066|FG001|Double-blind Treatment|Physician Decision|26|||
164157092|NCT00791778|592938065|FG000|Double-blind Treatment|Protocol Violation|0|||
164157093|NCT00791778|592938066|FG001|Double-blind Treatment|Protocol Violation|4|||
164157094|NCT00791778|592938065|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
164157095|NCT00791778|592938066|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
164157096|NCT00791778|592938065|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
164157097|NCT00791778|592938066|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
164157098|NCT00791778|592938065|FG000|Follow-up|Withdrawal by Subject|3|||
164157099|NCT00791778|592938066|FG001|Follow-up|Withdrawal by Subject|0|||
164157100|NCT00791778|592938065|FG000|Follow-up|Lost to Follow-up|2|||
164157101|NCT00791778|592938066|FG001|Follow-up|Lost to Follow-up|1|||
164157102|NCT03313180|592938067|FG000|Overall Study|Adverse Event|120|||
164157103|NCT03313180|592938067|FG000|Overall Study|Lost to Follow-up|3|||
164157104|NCT03313180|592938067|FG000|Overall Study|Withdrawal by Subject|39|||
164157105|NCT03313180|592938067|FG000|Overall Study|Other than listed above|15|||
164157106|NCT03313180|592938067|FG000|Overall Study|Covid-19 related|2|||
164157107|NCT01058642|592938069|FG000|Treatment Period 1|Adverse Event|0|||
164157108|NCT01058642|592938070|FG001|Treatment Period 1|Adverse Event|1|||
164157109|NCT01058642|592938071|FG002|Treatment Period 1|Adverse Event|1|||
164157110|NCT01058642|592938072|FG003|Treatment Period 1|Adverse Event|0|||
164157111|NCT01058642|592938069|FG000|Treatment Period 1|Physician Decision|0|||
164157112|NCT01058642|592938070|FG001|Treatment Period 1|Physician Decision|0|||
164157113|NCT01058642|592938071|FG002|Treatment Period 1|Physician Decision|1|||
164157114|NCT01058642|592938072|FG003|Treatment Period 1|Physician Decision|0|||
164157115|NCT01058642|592938069|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164157116|NCT01058642|592938070|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164157117|NCT01058642|592938071|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164157118|NCT01058642|592938072|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164157119|NCT01058642|592938069|FG000|Treatment Period 1|Lack of Efficacy|0|||
164157120|NCT01058642|592938070|FG001|Treatment Period 1|Lack of Efficacy|0|||
164157121|NCT01058642|592938071|FG002|Treatment Period 1|Lack of Efficacy|0|||
164157122|NCT01058642|592938072|FG003|Treatment Period 1|Lack of Efficacy|1|||
164157123|NCT01058642|592938069|FG000|Treatment Period 1|Protocol Violation|0|||
164157124|NCT01058642|592938070|FG001|Treatment Period 1|Protocol Violation|0|||
164157125|NCT01058642|592938071|FG002|Treatment Period 1|Protocol Violation|0|||
164157126|NCT01058642|592938072|FG003|Treatment Period 1|Protocol Violation|1|||
164157127|NCT01058642|592938069|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
164157128|NCT01058642|592938070|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
164157129|NCT01058642|592938071|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
164157130|NCT01058642|592938072|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
164157131|NCT01704495|592938073|FG000|Subjects Randomized|Other Reason|3|||
164157132|NCT01704495|592938074|FG001|Subjects Randomized|Other Reason|2|||
164157133|NCT01704495|592938075|FG002|Subjects Randomized|Other Reason|3|||
164157134|NCT01704495|592938076|FG003|Subjects Randomized|Other Reason|2|||
164157135|NCT01704495|592938073|FG000|Subjects Randomized|Discontinuation criteria met|4|||
164157136|NCT01704495|592938074|FG001|Subjects Randomized|Discontinuation criteria met|2|||
164157137|NCT01704495|592938075|FG002|Subjects Randomized|Discontinuation criteria met|2|||
164157138|NCT01704495|592938076|FG003|Subjects Randomized|Discontinuation criteria met|0|||
164157139|NCT01704495|592938073|FG000|Subjects Randomized|Adverse Event|8|||
164157140|NCT01704495|592938074|FG001|Subjects Randomized|Adverse Event|2|||
164157141|NCT01704495|592938075|FG002|Subjects Randomized|Adverse Event|0|||
164157142|NCT01704495|592938076|FG003|Subjects Randomized|Adverse Event|7|||
164157143|NCT01704495|592938073|FG000|Subjects Randomized|Withdrawal by Subject|5|||
164157144|NCT01704495|592938074|FG001|Subjects Randomized|Withdrawal by Subject|5|||
164157145|NCT01704495|592938075|FG002|Subjects Randomized|Withdrawal by Subject|5|||
164157146|NCT01704495|592938076|FG003|Subjects Randomized|Withdrawal by Subject|5|||
164157147|NCT01704495|592938073|FG000|Subjects Randomized|Protocol Violation|1|||
164157148|NCT01704495|592938074|FG001|Subjects Randomized|Protocol Violation|1|||
164157149|NCT01704495|592938075|FG002|Subjects Randomized|Protocol Violation|2|||
164157150|NCT01704495|592938076|FG003|Subjects Randomized|Protocol Violation|0|||
164157151|NCT01704495|592938073|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
164157152|NCT01704495|592938074|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
164157153|NCT01704495|592938075|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
164157154|NCT01704495|592938076|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
164157155|NCT01704495|592938073|FG000|Optional Safety Extension|Adverse Event|0|||
164157156|NCT01704495|592938074|FG001|Optional Safety Extension|Adverse Event|4|||
164157157|NCT01704495|592938075|FG002|Optional Safety Extension|Adverse Event|0|||
164157158|NCT01704495|592938076|FG003|Optional Safety Extension|Adverse Event|1|||
164157159|NCT01704495|592938073|FG000|Optional Safety Extension|Other reason|27|||
164157160|NCT01704495|592938074|FG001|Optional Safety Extension|Other reason|29|||
164157161|NCT01704495|592938075|FG002|Optional Safety Extension|Other reason|30|||
164157162|NCT01704495|592938076|FG003|Optional Safety Extension|Other reason|28|||
164157163|NCT01704495|592938073|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
164157164|NCT01704495|592938074|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
164157165|NCT01704495|592938075|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
164157166|NCT01704495|592938076|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
164157167|NCT01256450|592938077|FG000|Open-label Titration|Adverse Event|39|||
164157168|NCT01256450|592938078|FG001|Open-label Titration|Adverse Event|0|||
164157169|NCT01256450|592938079|FG002|Open-label Titration|Adverse Event|0|||
164157170|NCT01256450|592938077|FG000|Open-label Titration|Lost to Follow-up|7|||
164157171|NCT01256450|592938078|FG001|Open-label Titration|Lost to Follow-up|0|||
164157172|NCT01256450|592938079|FG002|Open-label Titration|Lost to Follow-up|0|||
164157173|NCT01256450|592938077|FG000|Open-label Titration|Lack of analgesic effect|30|||
164157174|NCT01256450|592938078|FG001|Open-label Titration|Lack of analgesic effect|0|||
164157175|NCT01256450|592938079|FG002|Open-label Titration|Lack of analgesic effect|0|||
164157176|NCT01256450|592938077|FG000|Open-label Titration|Non-compliance|9|||
164157177|NCT01256450|592938078|FG001|Open-label Titration|Non-compliance|0|||
164157178|NCT01256450|592938079|FG002|Open-label Titration|Non-compliance|0|||
164157179|NCT01256450|592938077|FG000|Open-label Titration|Screen failure|1|||
164157180|NCT01256450|592938078|FG001|Open-label Titration|Screen failure|0|||
164157181|NCT01256450|592938079|FG002|Open-label Titration|Screen failure|0|||
164157182|NCT01256450|592938077|FG000|Open-label Titration|Other|13|||
164157183|NCT01256450|592938078|FG001|Open-label Titration|Other|0|||
164157184|NCT01256450|592938079|FG002|Open-label Titration|Other|0|||
164157185|NCT01256450|592938077|FG000|Double-blind Treatment|Adverse Event|0|||
164157186|NCT01256450|592938078|FG001|Double-blind Treatment|Adverse Event|8|||
164157187|NCT01256450|592938079|FG002|Double-blind Treatment|Adverse Event|6|||
164157188|NCT01256450|592938077|FG000|Double-blind Treatment|Lost to Follow-up|0|||
164157189|NCT01256450|592938078|FG001|Double-blind Treatment|Lost to Follow-up|1|||
164157190|NCT01256450|592938079|FG002|Double-blind Treatment|Lost to Follow-up|7|||
164157191|NCT01256450|592938077|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
164157192|NCT01256450|592938078|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
164157193|NCT01256450|592938079|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
164157194|NCT01256450|592938077|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
164157195|NCT01256450|592938078|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
164157196|NCT01256450|592938079|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
164157197|NCT01256450|592938077|FG000|Double-blind Treatment|Non-compliance|0|||
164157198|NCT01256450|592938078|FG001|Double-blind Treatment|Non-compliance|5|||
164157199|NCT01256450|592938079|FG002|Double-blind Treatment|Non-compliance|4|||
164157200|NCT01256450|592938077|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
164157201|NCT01256450|592938078|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
164157202|NCT01256450|592938079|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
164157203|NCT01256450|592938077|FG000|Double-blind Treatment|Other|0|||
164157204|NCT01256450|592938078|FG001|Double-blind Treatment|Other|9|||
164157205|NCT01256450|592938079|FG002|Double-blind Treatment|Other|12|||
164157206|NCT00891020|592938080|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
164157207|NCT00891020|592938081|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
164157208|NCT00891020|592938082|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
164157209|NCT00891020|592938080|FG000|24 Week Treatment Period|Death|0|||
164157210|NCT00891020|592938081|FG001|24 Week Treatment Period|Death|2|||
164157211|NCT00891020|592938082|FG002|24 Week Treatment Period|Death|0|||
164157212|NCT00891020|592938080|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
164157213|NCT00891020|592938081|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
164157214|NCT00891020|592938082|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
164157215|NCT00891020|592938080|FG000|24 Week Treatment Period|Failure to return|4|||
164157216|NCT00891020|592938081|FG001|24 Week Treatment Period|Failure to return|5|||
164157217|NCT00891020|592938082|FG002|24 Week Treatment Period|Failure to return|5|||
164157218|NCT00891020|592938080|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
164157219|NCT00891020|592938081|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
164157220|NCT00891020|592938082|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
164157221|NCT00891020|592938080|FG000|24 Week Treatment Period|Other protocol violation|1|||
164157222|NCT00891020|592938081|FG001|24 Week Treatment Period|Other protocol violation|1|||
164157223|NCT00891020|592938082|FG002|24 Week Treatment Period|Other protocol violation|2|||
164157224|NCT00891020|592938080|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
164157225|NCT00891020|592938081|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
164157226|NCT00891020|592938082|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
164157227|NCT00891020|592938080|FG000|24 Week Treatment Period|Withdrew consent|6|||
164157228|NCT00891020|592938081|FG001|24 Week Treatment Period|Withdrew consent|3|||
164157229|NCT00891020|592938082|FG002|24 Week Treatment Period|Withdrew consent|15|||
164157230|NCT00891020|592938080|FG000|24 Week Treatment Period|Administrative/Other|5|||
164157231|NCT00891020|592938081|FG001|24 Week Treatment Period|Administrative/Other|6|||
164157232|NCT00891020|592938082|FG002|24 Week Treatment Period|Administrative/Other|1|||
164157233|NCT00891020|592938080|FG000|Long-term Extension Period|Adverse Event|1|||
164157234|NCT00891020|592938081|FG001|Long-term Extension Period|Adverse Event|11|||
164157235|NCT00891020|592938082|FG002|Long-term Extension Period|Adverse Event|10|||
164157236|NCT00891020|592938080|FG000|Long-term Extension Period|Death|0|||
164157237|NCT00891020|592938081|FG001|Long-term Extension Period|Death|0|||
164157238|NCT00891020|592938082|FG002|Long-term Extension Period|Death|1|||
164157239|NCT00891020|592938080|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
164157240|NCT00891020|592938081|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
164157241|NCT00891020|592938082|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
164157242|NCT00891020|592938080|FG000|Long-term Extension Period|Protocol Violation|0|||
164157243|NCT00891020|592938081|FG001|Long-term Extension Period|Protocol Violation|1|||
164157244|NCT00891020|592938082|FG002|Long-term Extension Period|Protocol Violation|1|||
164157245|NCT00891020|592938080|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
164157246|NCT00891020|592938081|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
164157247|NCT00891020|592938082|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
164157248|NCT00891020|592938080|FG000|Long-term Extension Period|Failure to return|0|||
164157249|NCT00891020|592938081|FG001|Long-term Extension Period|Failure to return|2|||
164157250|NCT00891020|592938082|FG002|Long-term Extension Period|Failure to return|3|||
164157251|NCT00891020|592938080|FG000|Long-term Extension Period|Administrative|1|||
164157252|NCT00891020|592938081|FG001|Long-term Extension Period|Administrative|2|||
164157253|NCT00891020|592938082|FG002|Long-term Extension Period|Administrative|2|||
164157254|NCT04177095|592938090|FG000|Overall Study|Withdrawal by Subject|3|||
164157255|NCT04177095|592938090|FG000|Overall Study|Screen Failure|3|||
164157256|NCT04177095|592938090|FG000|Overall Study|Problems with the Trugraf assay|1|||
164157257|NCT02275819|592938091|FG000|Overall Study|Adverse Event|0|||
164157258|NCT02275819|592938092|FG001|Overall Study|Adverse Event|1|||
164157259|NCT01346059|592938093|FG000|Overall Study|Withdrawal by Subject|1|||
164157260|NCT01346059|592938094|FG001|Overall Study|Withdrawal by Subject|0|||
164157261|NCT02556775|592938095|FG000|Overall Study|Withdrawal by Subject|1|||
164157262|NCT02556775|592938096|FG001|Overall Study|Withdrawal by Subject|0|||
164157263|NCT02556775|592938097|FG002|Overall Study|Withdrawal by Subject|1|||
164157264|NCT02556775|592938098|FG003|Overall Study|Withdrawal by Subject|0|||
164157265|NCT02556775|592938095|FG000|Overall Study|Lost to Follow-up|1|||
164157266|NCT02556775|592938096|FG001|Overall Study|Lost to Follow-up|0|||
164157267|NCT02556775|592938097|FG002|Overall Study|Lost to Follow-up|0|||
164157268|NCT02556775|592938098|FG003|Overall Study|Lost to Follow-up|0|||
164157269|NCT00777296|592938099|FG000|Overall Study|Adverse Event|0|||
164157270|NCT00777296|592938100|FG001|Overall Study|Adverse Event|1|||
164157271|NCT00777296|592938101|FG002|Overall Study|Adverse Event|0|||
164157272|NCT00777296|592938102|FG003|Overall Study|Adverse Event|1|||
164157273|NCT00777296|592938099|FG000|Overall Study|Withdrawal by Subject|1|||
164157274|NCT00777296|592938100|FG001|Overall Study|Withdrawal by Subject|0|||
164157275|NCT00777296|592938101|FG002|Overall Study|Withdrawal by Subject|0|||
164157276|NCT00777296|592938102|FG003|Overall Study|Withdrawal by Subject|0|||
164157277|NCT00777296|592938099|FG000|Overall Study|CRF form not completed|0|||
164157278|NCT00777296|592938100|FG001|Overall Study|CRF form not completed|0|||
164157279|NCT00777296|592938101|FG002|Overall Study|CRF form not completed|2|||
164157280|NCT00777296|592938102|FG003|Overall Study|CRF form not completed|0|||
164157281|NCT00658723|592938103|FG000|Overall Study|Lost to Follow-up|0|||
164157282|NCT00658723|592938104|FG001|Overall Study|Lost to Follow-up|2|||
164157283|NCT00658723|592938105|FG002|Overall Study|Lost to Follow-up|2|||
164157284|NCT00658723|592938103|FG000|Overall Study|Death|2|||
164157285|NCT00658723|592938104|FG001|Overall Study|Death|1|||
164157286|NCT00658723|592938105|FG002|Overall Study|Death|4|||
164157287|NCT00658723|592938103|FG000|Overall Study|Scheduling Issue|1|||
164157288|NCT00658723|592938104|FG001|Overall Study|Scheduling Issue|1|||
164157289|NCT00658723|592938105|FG002|Overall Study|Scheduling Issue|0|||
164157290|NCT00658723|592938103|FG000|Overall Study|Withdrawal by Subject|1|||
164157291|NCT00658723|592938104|FG001|Overall Study|Withdrawal by Subject|0|||
164157292|NCT00658723|592938105|FG002|Overall Study|Withdrawal by Subject|1|||
164157293|NCT00092118|592938106|FG000|Overall Study|Adverse Event|35|||
164157294|NCT00092118|592938107|FG001|Overall Study|Adverse Event|32|||
164157295|NCT00092118|592938106|FG000|Overall Study|Lack of Efficacy|12|||
164157296|NCT00092118|592938107|FG001|Overall Study|Lack of Efficacy|14|||
164157297|NCT00092118|592938106|FG000|Overall Study|Lost to Follow-up|4|||
164157298|NCT00092118|592938107|FG001|Overall Study|Lost to Follow-up|3|||
164157299|NCT00092118|592938106|FG000|Overall Study|Protocol Violation|23|||
164157300|NCT00092118|592938107|FG001|Overall Study|Protocol Violation|25|||
164157301|NCT00092118|592938106|FG000|Overall Study|Withdrawal by Subject|4|||
164157302|NCT00092118|592938107|FG001|Overall Study|Withdrawal by Subject|10|||
164157303|NCT00092118|592938106|FG000|Overall Study|Other|6|||
164157304|NCT00092118|592938107|FG001|Overall Study|Other|5|||
164157305|NCT01139125|592938108|FG000|Overall Study|Withdrawal by Subject|1|||
164157306|NCT01592786|592938109|FG000|Overall Study|Adverse Event|60|||
164157307|NCT01592786|592938109|FG000|Overall Study|Lack of Efficacy|19|||
164157308|NCT01592786|592938109|FG000|Overall Study|Protocol Violation|14|||
164157309|NCT01592786|592938109|FG000|Overall Study|Withdrawal by Subject|23|||
164157310|NCT01592786|592938109|FG000|Overall Study|Lost to Follow-up|19|||
164157311|NCT01592786|592938109|FG000|Overall Study|Other|3|||
164157312|NCT02025725|592938110|FG000|Overall Study|Adverse Event|5|||
164157313|NCT02025725|592938111|FG001|Overall Study|Adverse Event|0|||
164157314|NCT02025725|592938110|FG000|Overall Study|Lost to Follow-up|2|||
164157315|NCT02025725|592938111|FG001|Overall Study|Lost to Follow-up|0|||
164157316|NCT02025725|592938110|FG000|Overall Study|Protocol Violation|1|||
164157317|NCT02025725|592938111|FG001|Overall Study|Protocol Violation|1|||
164157318|NCT02025725|592938110|FG000|Overall Study|Withdrawal by Subject|3|||
164157319|NCT02025725|592938111|FG001|Overall Study|Withdrawal by Subject|2|||
164157320|NCT02025725|592938110|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
164157321|NCT02025725|592938111|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
164157322|NCT00235755|592938113|FG000|4-Week Titration Phase|Adverse Event|6|||
164157323|NCT00235755|592938114|FG001|4-Week Titration Phase|Adverse Event|14|||
164157324|NCT00235755|592938115|FG002|4-Week Titration Phase|Adverse Event|20|||
164157325|NCT00235755|592938113|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
164157326|NCT00235755|592938114|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
164157327|NCT00235755|592938115|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
164157328|NCT00235755|592938113|FG000|4-Week Titration Phase|Protocol Violation|2|||
164157329|NCT00235755|592938114|FG001|4-Week Titration Phase|Protocol Violation|2|||
164157330|NCT00235755|592938115|FG002|4-Week Titration Phase|Protocol Violation|1|||
164157331|NCT00235755|592938113|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
164157332|NCT00235755|592938114|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
164157333|NCT00235755|592938115|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
164157334|NCT00235755|592938113|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
164157335|NCT00235755|592938114|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
164157336|NCT00235755|592938115|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
164157337|NCT00235755|592938113|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
164157338|NCT00235755|592938114|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
164157339|NCT00235755|592938115|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
164157340|NCT00235755|592938113|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
164157341|NCT00235755|592938114|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
164157342|NCT00235755|592938115|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
164157343|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Adverse Event|8|||
164157344|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Adverse Event|12|||
164157345|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Adverse Event|26|||
164157346|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
164157347|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
164157348|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
164157349|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
164157350|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
164157351|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
164157352|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
164157353|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
164157354|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
164157355|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
164157356|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
164157357|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
164157358|NCT00235755|592938113|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
164157359|NCT00235755|592938114|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
164157360|NCT00235755|592938115|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
164157361|NCT01532934|592938120|FG000|Overall Study|Lost to Follow-up|11|||
164157362|NCT01532934|592938121|FG001|Overall Study|Lost to Follow-up|11|||
164157363|NCT01532934|592938120|FG000|Overall Study|In controlled environment|3|||
164157364|NCT01532934|592938121|FG001|Overall Study|In controlled environment|2|||
164157365|NCT00468819|592938122|FG000|Overall Study|Withdrawal by Subject|4|||
164157366|NCT00468819|592938123|FG001|Overall Study|Withdrawal by Subject|0|||
164157367|NCT00468819|592938124|FG002|Overall Study|Withdrawal by Subject|1|||
164157368|NCT00468819|592938122|FG000|Overall Study|Lost to Follow-up|0|||
164157369|NCT00468819|592938123|FG001|Overall Study|Lost to Follow-up|0|||
164157370|NCT00468819|592938124|FG002|Overall Study|Lost to Follow-up|1|||
164157371|NCT00468819|592938122|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
164157372|NCT00468819|592938123|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
164157373|NCT00468819|592938124|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
164157374|NCT02723344|592938125|FG000|Overall Study|Lost to Follow-up|0|||
164157375|NCT02723344|592938126|FG001|Overall Study|Lost to Follow-up|4|||
164157376|NCT03759392|592938128|FG000|Overall Study|Adverse Event|12|||
164157377|NCT03759392|592938129|FG001|Overall Study|Adverse Event|4|||
164157378|NCT03759392|592938128|FG000|Overall Study|Death|2|||
164157379|NCT03759392|592938129|FG001|Overall Study|Death|1|||
164157380|NCT03759392|592938128|FG000|Overall Study|Withdrawal by Subject|2|||
164157381|NCT03759392|592938129|FG001|Overall Study|Withdrawal by Subject|0|||
164157382|NCT03759392|592938128|FG000|Overall Study|Protocol Violation|2|||
164157383|NCT03759392|592938129|FG001|Overall Study|Protocol Violation|0|||
164157384|NCT03759392|592938128|FG000|Overall Study|Physician Decision|0|||
164157385|NCT03759392|592938129|FG001|Overall Study|Physician Decision|1|||
164157386|NCT03759392|592938128|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
164157387|NCT03759392|592938129|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
164157388|NCT03759392|592938128|FG000|Overall Study|No longer able to take medicines|1|||
164157389|NCT03759392|592938129|FG001|Overall Study|No longer able to take medicines|0|||
164157390|NCT03759392|592938128|FG000|Overall Study|Stopped taking study drug|1|||
164157391|NCT03759392|592938129|FG001|Overall Study|Stopped taking study drug|0|||
164157392|NCT04762160|592938130|FG000|Overall Study|Study terminated early due to business reasons|5|||
164157393|NCT05364931|592940098|FG000|Overall Study|Adverse Event|0|||
164157394|NCT05364931|592940099|FG001|Overall Study|Adverse Event|2|||
164157395|NCT05364931|592940100|FG002|Overall Study|Adverse Event|1|||
164157396|NCT05364931|592940101|FG003|Overall Study|Adverse Event|0|||
164157397|NCT05364931|592940098|FG000|Overall Study|Lost to Follow-up|1|||
164157398|NCT05364931|592940099|FG001|Overall Study|Lost to Follow-up|0|||
164157399|NCT05364931|592940100|FG002|Overall Study|Lost to Follow-up|0|||
164157400|NCT05364931|592940101|FG003|Overall Study|Lost to Follow-up|0|||
164157401|NCT05364931|592940098|FG000|Overall Study|Withdrawal by Subject|1|||
164157402|NCT05364931|592940099|FG001|Overall Study|Withdrawal by Subject|1|||
164157403|NCT05364931|592940100|FG002|Overall Study|Withdrawal by Subject|3|||
164157404|NCT05364931|592940101|FG003|Overall Study|Withdrawal by Subject|2|||
164157405|NCT05364931|592940098|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
164157406|NCT05364931|592940099|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
164157407|NCT05364931|592940100|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
164157408|NCT05364931|592940101|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
164157409|NCT05364931|592940098|FG000|Overall Study|Discontinued|1|||
164157410|NCT05364931|592940099|FG001|Overall Study|Discontinued|0|||
164157411|NCT05364931|592940100|FG002|Overall Study|Discontinued|0|||
164157412|NCT05364931|592940101|FG003|Overall Study|Discontinued|0|||
164157413|NCT01100086|592940104|FG000|Period 1|Withdrawal by Subject|1|||
164157414|NCT01100086|592940105|FG001|Period 1|Withdrawal by Subject|0|||
164157415|NCT01611935|592940108|FG000|Overall Study|Family Declined Participation|1|||
164157416|NCT01611935|592940109|FG001|Overall Study|Family Declined Participation|0|||
164157417|NCT04168112|592940110|FG000|Overall Study|Lost to Follow-up|1|||
164157418|NCT04168112|592940111|FG001|Overall Study|Lost to Follow-up|0|||
164157419|NCT04168112|592940110|FG000|Overall Study|Withdrawal by Subject|1|||
164157420|NCT04168112|592940111|FG001|Overall Study|Withdrawal by Subject|0|||
164157421|NCT02275546|592940114|FG000|Treatment Period 2|Withdrawal by Subject|2|||
164157422|NCT02275546|592940115|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164157423|NCT02275546|592940114|FG000|Treatment Period 2|Protocol Violation|0|||
164157424|NCT02275546|592940115|FG001|Treatment Period 2|Protocol Violation|1|||
164157425|NCT04227197|592940121|FG000|Randomization|Protocol Violation|1|||
164157426|NCT04227197|592940122|FG001|Randomization|Protocol Violation|0|||
164157427|NCT04227197|592940121|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
164157428|NCT04227197|592940122|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
164157429|NCT04227197|592940121|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
164157430|NCT04227197|592940122|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
164157431|NCT04227197|592940121|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
164157432|NCT04227197|592940122|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
164157433|NCT04227197|592940121|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
164157434|NCT04227197|592940122|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
164157435|NCT04227197|592940121|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
164157436|NCT04227197|592940122|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
164157437|NCT04227197|592940121|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
164157438|NCT04227197|592940122|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
164157439|NCT00570141|592940127|FG000|Overall Study|Adverse Event|1|||
164157440|NCT00570141|592940127|FG000|Overall Study|Missed visits|1|||
164157441|NCT00570141|592940127|FG000|Overall Study|Lost to Follow-up|1|||
164157442|NCT02549859|592940132|FG000|Long-term 60 Hz DBS|Study Closed|1|||
164157443|NCT01209949|592940140|FG000|Overall Study|Lost to Follow-up|3|||
164157444|NCT00729612|592940141|FG000|Overall Study|Non evaluable for response|10|||
164157445|NCT00708552|592940142|FG000|Overall Study|Adverse Event|10|||
164157446|NCT00708552|592940143|FG001|Overall Study|Adverse Event|3|||
164157447|NCT00708552|592940144|FG002|Overall Study|Adverse Event|4|||
164157448|NCT00708552|592940145|FG003|Overall Study|Adverse Event|6|||
164157449|NCT00708552|592940142|FG000|Overall Study|Lack of Efficacy|0|||
164157450|NCT00708552|592940143|FG001|Overall Study|Lack of Efficacy|4|||
164157451|NCT00708552|592940144|FG002|Overall Study|Lack of Efficacy|1|||
164157452|NCT00708552|592940145|FG003|Overall Study|Lack of Efficacy|0|||
164157453|NCT00708552|592940142|FG000|Overall Study|Protocol Violation|0|||
164157454|NCT00708552|592940143|FG001|Overall Study|Protocol Violation|0|||
164157455|NCT00708552|592940144|FG002|Overall Study|Protocol Violation|2|||
164157456|NCT00708552|592940145|FG003|Overall Study|Protocol Violation|4|||
164157457|NCT00708552|592940142|FG000|Overall Study|Lost to Follow-up|4|||
164157458|NCT00708552|592940143|FG001|Overall Study|Lost to Follow-up|2|||
164157459|NCT00708552|592940144|FG002|Overall Study|Lost to Follow-up|0|||
164157460|NCT00708552|592940145|FG003|Overall Study|Lost to Follow-up|1|||
164157461|NCT00708552|592940142|FG000|Overall Study|Physician Decision|1|||
164157462|NCT00708552|592940143|FG001|Overall Study|Physician Decision|2|||
164157463|NCT00708552|592940144|FG002|Overall Study|Physician Decision|0|||
164157464|NCT00708552|592940145|FG003|Overall Study|Physician Decision|0|||
164157465|NCT00708552|592940142|FG000|Overall Study|Withdrawal by Subject|12|||
164157466|NCT00708552|592940143|FG001|Overall Study|Withdrawal by Subject|7|||
164157467|NCT00708552|592940144|FG002|Overall Study|Withdrawal by Subject|8|||
164157468|NCT00708552|592940145|FG003|Overall Study|Withdrawal by Subject|10|||
164157469|NCT02309411|592940146|FG000|Overall Study|Physician Decision|1|||
164157470|NCT02309411|592940147|FG001|Overall Study|Physician Decision|0|||
164157471|NCT02309411|592940148|FG002|Overall Study|Physician Decision|0|||
164157472|NCT02309411|592940146|FG000|Overall Study|Withdrawal by Subject|1|||
164157473|NCT02309411|592940147|FG001|Overall Study|Withdrawal by Subject|1|||
164157474|NCT02309411|592940148|FG002|Overall Study|Withdrawal by Subject|0|||
164157475|NCT00495391|592940150|FG000|Overall Study|Lack of Efficacy|34|||
164157476|NCT00495391|592940151|FG001|Overall Study|Lack of Efficacy|18|||
164157477|NCT00495391|592940150|FG000|Overall Study|Withdrawal by Subject|2|||
164157478|NCT00495391|592940151|FG001|Overall Study|Withdrawal by Subject|3|||
164157479|NCT03214224|592940152|FG000|Overall Study|Protocol Violation|1|||
164157480|NCT03214224|592940152|FG000|Overall Study|Withdrawal by Subject|2|||
164157481|NCT03214224|592940152|FG000|Overall Study|Practice controls or therapists|6|||
164157482|NCT02712320|592940161|FG000|Overall Study|Lost to Follow-up|1|||
164157483|NCT02712320|592940161|FG000|Overall Study|Withdrawal by Subject|1|||
164157484|NCT02712320|592940161|FG000|Overall Study|Transferred to another facility|1|||
164157485|NCT02712320|592940161|FG000|Overall Study|Treating with the prohibited medications|2|||
164157486|NCT05266053|592940162|FG000|Overall Study|Withdrawal by Subject|8|||
164157487|NCT05266053|592940163|FG001|Overall Study|Withdrawal by Subject|4|||
164157488|NCT05344560|592940164|FG000|Period 1|Subject out of visit window|1|||
164157489|NCT05344560|592940165|FG001|Period 1|Subject out of visit window|1|||
164157490|NCT05344560|592940164|FG000|Period 2|Covid-19 Related|1|||
164157491|NCT05344560|592940165|FG001|Period 2|Covid-19 Related|0|||
164157492|NCT05344560|592940164|FG000|Period 2|Adverse Event|1|||
164157493|NCT05344560|592940165|FG001|Period 2|Adverse Event|0|||
164157494|NCT05344560|592940164|FG000|Period 2|Subject out of visit window|1|||
164157495|NCT05344560|592940165|FG001|Period 2|Subject out of visit window|1|||
164157496|NCT05344560|592940164|FG000|Period 3|Subject out of visit window|1|||
164157497|NCT05344560|592940165|FG001|Period 3|Subject out of visit window|0|||
164157498|NCT01051960|592940170|FG000|Overall Study|Adverse Event|1|||
164157499|NCT00391768|592940174|FG000|Overall Study|Withdrawal by Subject|0|||
164157500|NCT00391768|592940175|FG001|Overall Study|Withdrawal by Subject|0|||
164157501|NCT00391768|592940176|FG002|Overall Study|Withdrawal by Subject|1|||
164157502|NCT00391768|592940177|FG003|Overall Study|Withdrawal by Subject|0|||
164157503|NCT00391768|592940178|FG004|Overall Study|Withdrawal by Subject|0|||
164157504|NCT00391768|592940179|FG005|Overall Study|Withdrawal by Subject|1|||
164157505|NCT00391768|592940180|FG006|Overall Study|Withdrawal by Subject|1|||
164157506|NCT00391768|592940174|FG000|Overall Study|Lost to Follow-up|0|||
164157507|NCT00391768|592940175|FG001|Overall Study|Lost to Follow-up|0|||
164157508|NCT00391768|592940176|FG002|Overall Study|Lost to Follow-up|0|||
164157509|NCT00391768|592940177|FG003|Overall Study|Lost to Follow-up|1|||
164157510|NCT00391768|592940178|FG004|Overall Study|Lost to Follow-up|2|||
164157511|NCT00391768|592940179|FG005|Overall Study|Lost to Follow-up|2|||
164157512|NCT00391768|592940180|FG006|Overall Study|Lost to Follow-up|3|||
164157513|NCT01082328|592940183|FG000|Overall Study|Adverse Event|1|||
164157514|NCT00031590|592940184|FG000|Overall Study|Adverse Event|1|||
164157515|NCT00031590|592940184|FG000|Overall Study|Withdrawal by parents|2|||
164157516|NCT05506046|592940185|FG000|Overall Study|Lost to Follow-up|89|||
164157517|NCT05506046|592940186|FG001|Overall Study|Lost to Follow-up|101|||
164157518|NCT05506046|592940187|FG002|Overall Study|Lost to Follow-up|102|||
164157519|NCT05506046|592940188|FG003|Overall Study|Lost to Follow-up|99|||
164157520|NCT00444535|592940191|FG000|Overall Study|Withdrawal by Subject|5|||
164157521|NCT00444535|592940191|FG000|Overall Study|Physician Decision|5|||
164157522|NCT00444535|592940191|FG000|Overall Study|progressive disease|1|||
164157523|NCT00444535|592940191|FG000|Overall Study|Adverse Event|2|||
164157524|NCT01568892|592940192|FG000|Open-label Phase|Adverse Event|2|||
164157525|NCT01568892|592940193|FG001|Open-label Phase|Adverse Event|0|||
164157526|NCT01568892|592940192|FG000|Open-label Phase|Lack of Efficacy|4|||
164157527|NCT01568892|592940193|FG001|Open-label Phase|Lack of Efficacy|2|||
164157528|NCT01568892|592940192|FG000|Open-label Phase|Lost to Follow-up|0|||
164157529|NCT01568892|592940193|FG001|Open-label Phase|Lost to Follow-up|1|||
164157530|NCT01697748|592940204|FG000|Overall Study|ineligible skin incision|1|||
164157531|NCT01697748|592940205|FG001|Overall Study|ineligible skin incision|2|||
164157532|NCT01697748|592940204|FG000|Overall Study|ineligible uterine incision|4|||
164157533|NCT01697748|592940205|FG001|Overall Study|ineligible uterine incision|1|||
164157534|NCT01697748|592940204|FG000|Overall Study|Lost to Follow-up|53|||
164157535|NCT01697748|592940205|FG001|Overall Study|Lost to Follow-up|65|||
164157536|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
164157537|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
164157538|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
164157539|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
164157540|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
164157541|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
164157542|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
164157543|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
164157544|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
164157545|NCT02375971|592940209|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
164157546|NCT02375971|592940210|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
164157547|NCT02375971|592940211|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
164157548|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
164157549|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
164157550|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
164157551|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
164157552|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
164157553|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
164157554|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
164157555|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
164157556|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
164157557|NCT02375971|592940209|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
164157558|NCT02375971|592940210|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
164157559|NCT02375971|592940211|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
164157560|NCT02172664|592940217|FG000|Overall Study|Lost to Follow-up|4|||
164157561|NCT02172664|592940218|FG001|Overall Study|Lost to Follow-up|4|||
164157562|NCT02172664|592940217|FG000|Overall Study|Death|1|||
164157563|NCT02172664|592940218|FG001|Overall Study|Death|1|||
164157564|NCT02172664|592940217|FG000|Overall Study|Moved out of area|1|||
164157565|NCT02172664|592940218|FG001|Overall Study|Moved out of area|1|||
164157566|NCT01909934|592940219|FG000|Overall Study|Withdrawal by Subject|3|||
164157567|NCT01909934|592940219|FG000|Overall Study|Lost to Follow-up|1|||
164157568|NCT01909934|592940219|FG000|Overall Study|Death|25|||
164157569|NCT01909934|592940219|FG000|Overall Study|Withdrawal of Informed Consent|1|||
164157570|NCT01909934|592940219|FG000|Overall Study|Reason Not Specified|1|||
164157571|NCT03810092|592940220|FG000|Overall Study|no ground support|17|||
164157572|NCT03810092|592940220|FG000|Overall Study|ADL not done at J0|16|||
164157573|NCT03810092|592940220|FG000|Overall Study|No hemoglobin measure at J5|27|||
164157574|NCT00806403|592940221|FG000|Overall Study|Death|4|||
164157575|NCT00806403|592940222|FG001|Overall Study|Death|3|||
164157576|NCT01320293|592940225|FG000|Overall Study|Lack of Efficacy|1|||
164157577|NCT01320293|592940225|FG000|Overall Study|Adverse Event|1|||
164157578|NCT01787292|592940228|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
164157579|NCT01787292|592940229|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
164157580|NCT01787292|592940228|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
164157581|NCT01787292|592940229|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
164157582|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
164157583|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157584|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157585|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157586|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157587|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
164157588|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
164157589|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
164157590|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
164157591|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
164157592|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
164157593|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
164157594|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
164157595|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
164157596|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157597|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
164157598|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157599|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157600|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157601|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
164157602|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
164157603|NCT01147068|592940230|FG000|Subjects That Received 2nd Dose|Other|0|||
164157604|NCT01147068|592940231|FG001|Subjects That Received 2nd Dose|Other|3|||
164157605|NCT01147068|592940232|FG002|Subjects That Received 2nd Dose|Other|3|||
164157606|NCT01147068|592940233|FG003|Subjects That Received 2nd Dose|Other|0|||
164157607|NCT01147068|592940234|FG004|Subjects That Received 2nd Dose|Other|1|||
164157608|NCT01147068|592940235|FG005|Subjects That Received 2nd Dose|Other|0|||
164157609|NCT01147068|592940236|FG006|Subjects That Received 2nd Dose|Other|0|||
164157610|NCT01147068|592940230|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
164157611|NCT01147068|592940231|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157612|NCT01147068|592940232|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157613|NCT01147068|592940233|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157614|NCT01147068|592940234|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
164157615|NCT01147068|592940235|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
164157616|NCT01147068|592940236|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
164157617|NCT01147068|592940230|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157618|NCT01147068|592940231|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157619|NCT01147068|592940232|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157620|NCT01147068|592940233|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
164157621|NCT01147068|592940234|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157622|NCT01147068|592940235|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157623|NCT01147068|592940236|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
164157624|NCT01147068|592940230|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157625|NCT01147068|592940231|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
164157626|NCT01147068|592940232|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157627|NCT01147068|592940233|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157628|NCT01147068|592940234|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157629|NCT01147068|592940235|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157630|NCT01147068|592940236|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
164157631|NCT02962648|592940238|FG000|Overall Study|Withdrawal by Subject|3|||
164157632|NCT02962648|592940238|FG000|Overall Study|Lost to Follow-up|3|||
164157633|NCT02962648|592940238|FG000|Overall Study|Physician Decision|1|||
164157634|NCT02962648|592940238|FG000|Overall Study|Subject had problems with transportation|2|||
164157635|NCT01597778|592940240|FG000|Overall Study|Death|7|||
164157636|NCT01597778|592940241|FG001|Overall Study|Death|10|||
164157637|NCT01597778|592940240|FG000|Overall Study|Withdrawal by Subject|3|||
164157638|NCT01597778|592940241|FG001|Overall Study|Withdrawal by Subject|4|||
164157639|NCT01597778|592940240|FG000|Overall Study|Adverse Event|1|||
164157640|NCT01597778|592940241|FG001|Overall Study|Adverse Event|1|||
164157641|NCT01597778|592940240|FG000|Overall Study|Protocol Violation|1|||
164157642|NCT01597778|592940241|FG001|Overall Study|Protocol Violation|11|||
164157643|NCT01597778|592940240|FG000|Overall Study|Transplanted off protocol|2|||
164157644|NCT01597778|592940241|FG001|Overall Study|Transplanted off protocol|3|||
164157645|NCT03267212|592940242|FG000|First Intervention|Lost to Follow-up|0|||
164157646|NCT03267212|592940243|FG001|First Intervention|Lost to Follow-up|2|||
164157647|NCT03267212|592940242|FG000|First Intervention|Withdrawal by Subject|1|||
164157648|NCT03267212|592940243|FG001|First Intervention|Withdrawal by Subject|1|||
164157649|NCT03267212|592940242|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
164157650|NCT03267212|592940243|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
164157651|NCT05691712|592940244|FG000|Overall Study|Adverse Event|0|||
164157652|NCT05691712|592940245|FG001|Overall Study|Adverse Event|1|||
164157653|NCT05691712|592940246|FG002|Overall Study|Adverse Event|2|||
164157654|NCT05691712|592940247|FG003|Overall Study|Adverse Event|1|||
164157655|NCT05691712|592940244|FG000|Overall Study|Withdrawal by Subject|2|||
164157656|NCT05691712|592940245|FG001|Overall Study|Withdrawal by Subject|3|||
164157657|NCT05691712|592940246|FG002|Overall Study|Withdrawal by Subject|3|||
164157658|NCT05691712|592940247|FG003|Overall Study|Withdrawal by Subject|1|||
164157659|NCT05691712|592940244|FG000|Overall Study|Death|1|||
164157660|NCT05691712|592940245|FG001|Overall Study|Death|0|||
164157661|NCT05691712|592940246|FG002|Overall Study|Death|0|||
164157662|NCT05691712|592940247|FG003|Overall Study|Death|0|||
164157663|NCT05691712|592940244|FG000|Overall Study|Pregnancy|0|||
164157664|NCT05691712|592940245|FG001|Overall Study|Pregnancy|1|||
164157665|NCT05691712|592940246|FG002|Overall Study|Pregnancy|0|||
164157666|NCT05691712|592940247|FG003|Overall Study|Pregnancy|0|||
164157667|NCT05691712|592940244|FG000|Overall Study|Assigned Treatment by Mistake|1|||
164157668|NCT05691712|592940245|FG001|Overall Study|Assigned Treatment by Mistake|0|||
164157669|NCT05691712|592940246|FG002|Overall Study|Assigned Treatment by Mistake|0|||
164157670|NCT05691712|592940247|FG003|Overall Study|Assigned Treatment by Mistake|1|||
164157671|NCT05303194|592940248|FG000|Overall Study|Lost to Follow-up|1|||
164157672|NCT05303194|592940249|FG001|Overall Study|Lost to Follow-up|1|||
164157673|NCT05303194|592940248|FG000|Overall Study|Withdrawal by Subject|0|||
164157674|NCT05303194|592940249|FG001|Overall Study|Withdrawal by Subject|1|||
164157675|NCT00226499|592940259|FG000|Overall Study|Adverse Event|10|||
164157676|NCT00226499|592940260|FG001|Overall Study|Adverse Event|6|||
164157677|NCT00226499|592940261|FG002|Overall Study|Adverse Event|3|||
164157678|NCT00226499|592940259|FG000|Overall Study|Others|1064|||
164157679|NCT00226499|592940260|FG001|Overall Study|Others|1066|||
164157680|NCT00226499|592940261|FG002|Overall Study|Others|356|||
164157681|NCT02524847|592940262|FG000|Overall Study|Adverse Event|4|||
164157682|NCT02524847|592940262|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
164157683|NCT02524847|592940262|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
164157684|NCT02524847|592940262|FG000|Overall Study|Death|1|||
164157685|NCT02524847|592940262|FG000|Overall Study|Reason not Specified|1|||
164157686|NCT04352101|592940263|FG000|Overall Study|Physician Decision|2|||
164157687|NCT04352101|592940264|FG001|Overall Study|Physician Decision|1|||
164157688|NCT05795153|592941807|FG000|Overall Study|Adverse Event|2|||
164157689|NCT05795153|592941807|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
164157690|NCT05795153|592941807|FG000|Overall Study|Lost to Follow-up|1|||
164157691|NCT05795153|592941807|FG000|Overall Study|Subject decision|2|||
164157692|NCT03668119|592941808|FG000|Pre-treatment|Disease Progression|1|||
164157693|NCT03668119|592941809|FG001|Pre-treatment|Disease Progression|0|||
164157694|NCT03668119|592941808|FG000|Treatment|Disease Progression|76|||
164157695|NCT03668119|592941809|FG001|Treatment|Disease Progression|57|||
164157696|NCT03668119|592941808|FG000|Treatment|Study drug toxicity|19|||
164157697|NCT03668119|592941809|FG001|Treatment|Study drug toxicity|1|||
164157698|NCT03668119|592941808|FG000|Treatment|Death|3|||
164157699|NCT03668119|592941809|FG001|Treatment|Death|0|||
164157700|NCT03668119|592941808|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
164157701|NCT03668119|592941809|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
164157702|NCT03668119|592941808|FG000|Treatment|Withdrawal by Subject|1|||
164157703|NCT03668119|592941809|FG001|Treatment|Withdrawal by Subject|1|||
164157704|NCT03668119|592941808|FG000|Treatment|Participant request to discontinue study treatment|3|||
164157705|NCT03668119|592941809|FG001|Treatment|Participant request to discontinue study treatment|1|||
164157706|NCT03668119|592941808|FG000|Treatment|Maximum Clinical Benefit|0|||
164157707|NCT03668119|592941809|FG001|Treatment|Maximum Clinical Benefit|1|||
164157708|NCT03668119|592941808|FG000|Treatment|Participants completed treatment|27|||
164157709|NCT03668119|592941809|FG001|Treatment|Participants completed treatment|11|||
164157710|NCT03668119|592941808|FG000|Treatment|Other reasons|2|||
164157711|NCT03668119|592941809|FG001|Treatment|Other reasons|1|||
164157712|NCT03769168|592941810|FG000|Overall Study|Adverse Event|0|||
164157713|NCT03769168|592941811|FG001|Overall Study|Adverse Event|1|||
164157714|NCT03769168|592941810|FG000|Overall Study|Lack of Efficacy|2|||
164157715|NCT03769168|592941811|FG001|Overall Study|Lack of Efficacy|4|||
164157716|NCT03769168|592941810|FG000|Overall Study|Post study access to treatment|3|||
164157717|NCT03769168|592941811|FG001|Overall Study|Post study access to treatment|11|||
164157718|NCT03769168|592941810|FG000|Overall Study|Physician Decision|1|||
164157719|NCT03769168|592941811|FG001|Overall Study|Physician Decision|4|||
164157720|NCT03769168|592941810|FG000|Overall Study|Subject Decision|2|||
164157721|NCT03769168|592941811|FG001|Overall Study|Subject Decision|4|||
164157722|NCT03769168|592941810|FG000|Overall Study|Guardian decision|1|||
164157723|NCT03769168|592941811|FG001|Overall Study|Guardian decision|0|||
164157724|NCT05142722|592941812|FG000|Overall Study|Lost to Follow-up|16|||
164157725|NCT05142722|592941813|FG001|Overall Study|Lost to Follow-up|38|||
164157726|NCT05142722|592941812|FG000|Overall Study|Withdrawal by Subject|20|||
164157727|NCT05142722|592941813|FG001|Overall Study|Withdrawal by Subject|27|||
164157728|NCT05142722|592941812|FG000|Overall Study|Death|11|||
164157729|NCT05142722|592941813|FG001|Overall Study|Death|17|||
164157730|NCT05142722|592941812|FG000|Overall Study|Physician Decision|0|||
164157731|NCT05142722|592941813|FG001|Overall Study|Physician Decision|1|||
164157732|NCT05142722|592941812|FG000|Overall Study|Participant Moved Away|0|||
164157733|NCT05142722|592941813|FG001|Overall Study|Participant Moved Away|2|||
164157734|NCT05142722|592941812|FG000|Overall Study|Adverse Event|2|||
164157735|NCT05142722|592941813|FG001|Overall Study|Adverse Event|1|||
164157736|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
164157737|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157738|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
164157739|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157740|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
164157741|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157742|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157743|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
164157744|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157745|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157746|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
164157747|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157748|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157749|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
164157750|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157751|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
164157752|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157753|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157754|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
164157755|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157756|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157757|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
164157758|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
164157759|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
164157760|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157761|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157762|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157763|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157764|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157765|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
164157766|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157767|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
164157768|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157769|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157770|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
164157771|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157772|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157773|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157774|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
164157775|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157776|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157777|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157778|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
164157779|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157780|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157781|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
164157782|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
164157783|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
164157784|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
164157785|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
164157786|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157787|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157788|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157789|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157790|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157791|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
164157792|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157793|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
164157794|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157795|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157796|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157797|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157798|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157799|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
164157800|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157801|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157802|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157803|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157804|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
164157805|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157806|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157807|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
164157808|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157809|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157810|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157811|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157812|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157813|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
164157814|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157815|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
164157816|NCT03896503|592941816|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157817|NCT03896503|592941817|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157818|NCT03896503|592941818|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157819|NCT03896503|592941819|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157820|NCT03896503|592941820|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157821|NCT03896503|592941821|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
164157822|NCT03896503|592941822|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
164157823|NCT03896503|592941823|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
164157824|NCT05400655|592941824|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
164157825|NCT05400655|592941825|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
164157826|NCT05400655|592941826|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
164157827|NCT05400655|592941827|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
164157828|NCT05400655|592941828|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
164157829|NCT05400655|592941829|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
164157830|NCT05400655|592941830|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
164157831|NCT05400655|592941831|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
164157832|NCT05400655|592941832|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
164157833|NCT05400655|592941833|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
164157834|NCT05400655|592941834|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
164157835|NCT05400655|592941835|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
164157836|NCT05400655|592941836|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
164157837|NCT05400655|592941837|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
164157838|NCT05400655|592941838|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
164157839|NCT05400655|592941839|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
164157840|NCT05400655|592941840|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
164157841|NCT05400655|592941841|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
164157842|NCT05400655|592941842|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
164157843|NCT05400655|592941843|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
164157844|NCT05400655|592941844|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
164157845|NCT05400655|592941845|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
164157846|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157847|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157848|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157849|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157850|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157851|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157852|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157853|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157854|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157855|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157856|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157857|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157858|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
164157859|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157860|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157861|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157862|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
164157863|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157864|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
164157865|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
164157866|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157867|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
164157868|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157869|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157870|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157871|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157872|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157873|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157874|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157875|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157876|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157877|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157878|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157879|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157880|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157881|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
164157882|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157883|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157884|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
164157885|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157886|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
164157887|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157888|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157889|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
164157890|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157891|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157892|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157893|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157894|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157895|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157896|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157897|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157898|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157899|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157900|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157901|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157902|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157903|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157904|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157905|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157906|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
164157907|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
164157908|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
164157909|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
164157910|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
164157911|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
164157912|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157913|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157914|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157915|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157916|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157917|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157918|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157919|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157920|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157921|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157922|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157923|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157924|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157925|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157926|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157927|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157928|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157929|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
164157930|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
164157931|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157932|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164157933|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
164158292|NCT03817853|592941915|FG002|Follow-up Phase|Death|1|||
164157934|NCT05400655|592941824|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157935|NCT05400655|592941825|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157936|NCT05400655|592941826|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157937|NCT05400655|592941827|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157938|NCT05400655|592941828|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157939|NCT05400655|592941829|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157940|NCT05400655|592941830|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157941|NCT05400655|592941831|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157942|NCT05400655|592941832|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157943|NCT05400655|592941833|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157944|NCT05400655|592941834|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157945|NCT05400655|592941835|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157946|NCT05400655|592941836|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157947|NCT05400655|592941837|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157948|NCT05400655|592941838|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157949|NCT05400655|592941839|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157950|NCT05400655|592941840|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
164157951|NCT05400655|592941841|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
164157952|NCT05400655|592941842|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
164157953|NCT05400655|592941843|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
164157954|NCT05400655|592941844|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
164157955|NCT05400655|592941845|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
164157956|NCT01068678|592941854|FG000|Overall Study|Lack of Efficacy|3|||
164157957|NCT01068678|592941855|FG001|Overall Study|Lack of Efficacy|2|||
164157958|NCT01068678|592941854|FG000|Overall Study|Protocol Violation|5|||
164157959|NCT01068678|592941855|FG001|Overall Study|Protocol Violation|1|||
164157960|NCT01068678|592941854|FG000|Overall Study|Withdrawal criteria|12|||
164157961|NCT01068678|592941855|FG001|Overall Study|Withdrawal criteria|6|||
164157962|NCT01068678|592941854|FG000|Overall Study|Unclassified|18|||
164157963|NCT01068678|592941855|FG001|Overall Study|Unclassified|15|||
164157964|NCT05161481|592941856|FG000|Overall Study|Withdrawal of consent|0|||
164157965|NCT05161481|592941857|FG001|Overall Study|Withdrawal of consent|1|||
164157966|NCT05161481|592941858|FG002|Overall Study|Withdrawal of consent|1|||
164157967|NCT05161481|592941856|FG000|Overall Study|Study terminated by sponsor|3|||
164157968|NCT05161481|592941857|FG001|Overall Study|Study terminated by sponsor|3|||
164157969|NCT05161481|592941858|FG002|Overall Study|Study terminated by sponsor|2|||
164157970|NCT05161481|592941856|FG000|Overall Study|Adverse Event|3|||
164157971|NCT05161481|592941857|FG001|Overall Study|Adverse Event|0|||
164157972|NCT05161481|592941858|FG002|Overall Study|Adverse Event|6|||
164157973|NCT05161481|592941856|FG000|Overall Study|Randomised in error and was not treated|1|||
164157974|NCT05161481|592941857|FG001|Overall Study|Randomised in error and was not treated|0|||
164157975|NCT05161481|592941858|FG002|Overall Study|Randomised in error and was not treated|0|||
164157976|NCT05161481|592941856|FG000|Overall Study|Subject decision|0|||
164157977|NCT05161481|592941857|FG001|Overall Study|Subject decision|0|||
164157978|NCT05161481|592941858|FG002|Overall Study|Subject decision|1|||
164157979|NCT03827291|592941859|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
164157980|NCT03827291|592941860|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
164157981|NCT04795466|592941861|FG000|Overall Study|Adverse Event|3|||
164157982|NCT04795466|592941862|FG001|Overall Study|Adverse Event|1|||
164157983|NCT04795466|592941861|FG000|Overall Study|Physician Decision|1|||
164157984|NCT04795466|592941862|FG001|Overall Study|Physician Decision|0|||
164157985|NCT04795466|592941861|FG000|Overall Study|Withdrawal by Subject|2|||
164157986|NCT04795466|592941862|FG001|Overall Study|Withdrawal by Subject|1|||
164157987|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
164157988|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
164157989|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
164157990|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
164157991|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
164157992|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
164157993|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
164157994|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
164157995|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
164157996|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
164157997|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
164157998|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
164157999|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164158000|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164158001|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
164158002|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
164158003|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
164158004|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
164158005|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
164158006|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
164158007|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
164158008|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
164158009|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
164158010|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
164158011|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
164158012|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
164158013|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
164158014|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
164158015|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
164158016|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
164158017|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
164158018|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
164158019|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
164158020|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
164158021|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
164158022|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
164158023|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
164158024|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
164158025|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
164158026|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
164158027|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
164158028|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
164158029|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
164158030|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
164158031|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
164158032|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
164158033|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
164158034|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
164158035|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
164158036|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
164158037|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
164158038|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
164158039|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Site closed|0|||
164158040|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Site closed|0|||
164158041|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Site closed|1|||
164158042|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Site closed|0|||
164158043|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
164158044|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
164158045|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
164158046|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
164158047|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
164158048|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
164158049|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
164158050|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
164158051|NCT00838903|592941865|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
164158052|NCT00838903|592941866|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
164158053|NCT00838903|592941867|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
164158054|NCT00838903|592941868|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
164158055|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
164158056|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
164158057|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
164158058|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
164158059|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
164158060|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
164158061|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
164158062|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
164158063|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
164158064|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
164158065|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
164158066|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
164158067|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
164158068|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
164158069|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
164158070|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
164158071|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
164158072|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
164158073|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
164158074|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
164158075|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158076|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158077|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158078|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
164158079|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
164158080|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
164158081|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
164158082|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
164158083|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
164158084|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
164158085|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
164158086|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
164158087|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
164158088|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
164158089|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
164158090|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
164158091|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
164158092|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
164158093|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
164158094|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
164158095|NCT00838903|592941865|FG000|Follow-up Period (8 Weeks)|Missing|1|||
164158096|NCT00838903|592941866|FG001|Follow-up Period (8 Weeks)|Missing|2|||
164158097|NCT00838903|592941867|FG002|Follow-up Period (8 Weeks)|Missing|1|||
164158098|NCT00838903|592941868|FG003|Follow-up Period (8 Weeks)|Missing|1|||
164158099|NCT00536939|592941869|FG000|Overall Study|Withdrawal by Subject|1|||
164158100|NCT00536939|592941870|FG001|Overall Study|Withdrawal by Subject|0|||
164158101|NCT00536939|592941869|FG000|Overall Study|Other Complicating Disease|1|||
164158102|NCT00536939|592941870|FG001|Overall Study|Other Complicating Disease|0|||
164158103|NCT04225715|592941871|FG000|Overall Study|Reason not Specified|1|||
164158104|NCT04225715|592941872|FG001|Overall Study|Reason not Specified|0|||
164158105|NCT04225715|592941873|FG002|Overall Study|Reason not Specified|0|||
164158106|NCT04225715|592941874|FG003|Overall Study|Reason not Specified|0|||
164158107|NCT04225715|592941875|FG004|Overall Study|Reason not Specified|0|||
164158108|NCT04225715|592941876|FG005|Overall Study|Reason not Specified|0|||
164158109|NCT04225715|592941877|FG006|Overall Study|Reason not Specified|0|||
164158110|NCT04225715|592941878|FG007|Overall Study|Reason not Specified|0|||
164158111|NCT04225715|592941879|FG008|Overall Study|Reason not Specified|0|||
164158112|NCT04225715|592941871|FG000|Overall Study|Protocol Violation|1|||
164158113|NCT04225715|592941872|FG001|Overall Study|Protocol Violation|0|||
164158114|NCT04225715|592941873|FG002|Overall Study|Protocol Violation|0|||
164158115|NCT04225715|592941874|FG003|Overall Study|Protocol Violation|0|||
164158116|NCT04225715|592941875|FG004|Overall Study|Protocol Violation|0|||
164158117|NCT04225715|592941876|FG005|Overall Study|Protocol Violation|9|||
164158118|NCT04225715|592941877|FG006|Overall Study|Protocol Violation|0|||
164158119|NCT04225715|592941878|FG007|Overall Study|Protocol Violation|0|||
164158120|NCT04225715|592941879|FG008|Overall Study|Protocol Violation|0|||
164158121|NCT04225715|592941871|FG000|Overall Study|Withdrawal by Subject|4|||
164158122|NCT04225715|592941872|FG001|Overall Study|Withdrawal by Subject|1|||
164158123|NCT04225715|592941873|FG002|Overall Study|Withdrawal by Subject|1|||
164158124|NCT04225715|592941874|FG003|Overall Study|Withdrawal by Subject|0|||
164158125|NCT04225715|592941875|FG004|Overall Study|Withdrawal by Subject|3|||
164158126|NCT04225715|592941876|FG005|Overall Study|Withdrawal by Subject|1|||
164158127|NCT04225715|592941877|FG006|Overall Study|Withdrawal by Subject|1|||
164158128|NCT04225715|592941878|FG007|Overall Study|Withdrawal by Subject|1|||
164158129|NCT04225715|592941879|FG008|Overall Study|Withdrawal by Subject|0|||
164158130|NCT04225715|592941871|FG000|Overall Study|Adverse Event|0|||
164158131|NCT04225715|592941872|FG001|Overall Study|Adverse Event|0|||
164158132|NCT04225715|592941873|FG002|Overall Study|Adverse Event|0|||
164158133|NCT04225715|592941874|FG003|Overall Study|Adverse Event|0|||
164158134|NCT04225715|592941875|FG004|Overall Study|Adverse Event|0|||
164158135|NCT04225715|592941876|FG005|Overall Study|Adverse Event|0|||
164158136|NCT04225715|592941877|FG006|Overall Study|Adverse Event|0|||
164158137|NCT04225715|592941878|FG007|Overall Study|Adverse Event|0|||
164158138|NCT04225715|592941879|FG008|Overall Study|Adverse Event|1|||
164158139|NCT04225715|592941871|FG000|Overall Study|Arm Terminated By Sponsor|0|||
164158140|NCT04225715|592941872|FG001|Overall Study|Arm Terminated By Sponsor|0|||
164158141|NCT04225715|592941873|FG002|Overall Study|Arm Terminated By Sponsor|0|||
164158142|NCT04225715|592941874|FG003|Overall Study|Arm Terminated By Sponsor|0|||
164158143|NCT04225715|592941875|FG004|Overall Study|Arm Terminated By Sponsor|0|||
164158144|NCT04225715|592941876|FG005|Overall Study|Arm Terminated By Sponsor|0|||
164158145|NCT04225715|592941877|FG006|Overall Study|Arm Terminated By Sponsor|0|||
164158146|NCT04225715|592941878|FG007|Overall Study|Arm Terminated By Sponsor|17|||
164158147|NCT04225715|592941879|FG008|Overall Study|Arm Terminated By Sponsor|18|||
164158148|NCT01894841|592941880|FG000|Overall Study|Withdrawal by Subject|9|||
164158149|NCT01894841|592941881|FG001|Overall Study|Withdrawal by Subject|4|||
164158150|NCT01894841|592941880|FG000|Overall Study|Withdrawn by investigator|2|||
164158151|NCT01894841|592941881|FG001|Overall Study|Withdrawn by investigator|2|||
164158152|NCT01894841|592941880|FG000|Overall Study|Lost to Follow-up|7|||
164158153|NCT01894841|592941881|FG001|Overall Study|Lost to Follow-up|3|||
164158154|NCT02955355|592941882|FG000|Overall Study|Adverse Event|4|||
164158155|NCT02955355|592941882|FG000|Overall Study|Death|1|||
164158156|NCT02955355|592941882|FG000|Overall Study|Physician Decision|21|||
164158157|NCT02955355|592941882|FG000|Overall Study|Site Terminated by Sponsor|35|||
164158158|NCT02955355|592941882|FG000|Overall Study|Withdrawal by Subject|19|||
164158159|NCT02955355|592941882|FG000|Overall Study|Reason Not Specified|5|||
164158160|NCT02612623|592941883|FG000|Overall Study|Withdrawal by Subject|0|||
164158161|NCT02612623|592941884|FG001|Overall Study|Withdrawal by Subject|1|||
164158162|NCT02612623|592941885|FG002|Overall Study|Withdrawal by Subject|0|||
164158163|NCT02612623|592941886|FG003|Overall Study|Withdrawal by Subject|0|||
164158164|NCT02612623|592941883|FG000|Overall Study|Adverse Event|1|||
164158165|NCT02612623|592941884|FG001|Overall Study|Adverse Event|0|||
164158166|NCT02612623|592941885|FG002|Overall Study|Adverse Event|1|||
164158167|NCT02612623|592941886|FG003|Overall Study|Adverse Event|0|||
164158168|NCT04878432|592941890|FG000|Overall Study|Adverse Event|1|||
164158169|NCT04878432|592941890|FG000|Overall Study|Death|2|||
164158170|NCT04878432|592941890|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
164158171|NCT04878432|592941890|FG000|Overall Study|Withdrawal by Subject|6|||
164158172|NCT04878432|592941890|FG000|Overall Study|Progressive Disease|7|||
164158173|NCT04878432|592941890|FG000|Overall Study|New Therapy for Study Indication|7|||
164158174|NCT04878432|592941890|FG000|Overall Study|Physician Decision|11|||
164158175|NCT03971071|592941891|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158176|NCT03971071|592941892|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
164158177|NCT03971071|592941893|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158178|NCT03971071|592941894|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158179|NCT03971071|592941895|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
164158180|NCT03971071|592941891|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
164158181|NCT03971071|592941892|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
164158182|NCT03971071|592941893|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
164158183|NCT03971071|592941894|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164158184|NCT03971071|592941895|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
164158185|NCT03971071|592941891|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
164158186|NCT03971071|592941892|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
164158187|NCT03971071|592941893|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
164158188|NCT03971071|592941894|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
164158189|NCT03971071|592941895|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
164158190|NCT03971071|592941891|FG000|Open-label Treatment Period|Sponsor decision|0|||
164158191|NCT03971071|592941892|FG001|Open-label Treatment Period|Sponsor decision|0|||
164158192|NCT03971071|592941893|FG002|Open-label Treatment Period|Sponsor decision|0|||
164158193|NCT03971071|592941894|FG003|Open-label Treatment Period|Sponsor decision|0|||
164158194|NCT03971071|592941895|FG004|Open-label Treatment Period|Sponsor decision|1|||
164158195|NCT03971071|592941891|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
164158196|NCT03971071|592941892|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
164158197|NCT03971071|592941893|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
164158198|NCT03971071|592941894|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
164158199|NCT03971071|592941895|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
164158200|NCT03971071|592941891|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
164158201|NCT03971071|592941892|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
164158202|NCT03971071|592941893|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
164158203|NCT03971071|592941894|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
164158204|NCT03971071|592941895|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
164158205|NCT00360282|592941897|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
164158206|NCT00360282|592941898|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
164158207|NCT00360282|592941899|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
164158208|NCT00360282|592941900|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
164158209|NCT00360282|592941897|FG000|Second Intervention|Adverse Event|0|||
164158210|NCT00360282|592941898|FG001|Second Intervention|Adverse Event|1|||
164158211|NCT00360282|592941899|FG002|Second Intervention|Adverse Event|0|||
164158212|NCT00360282|592941900|FG003|Second Intervention|Adverse Event|0|||
164158213|NCT00925704|592941901|FG000|First Intervention|Withdrew consent|0|||
164158214|NCT00925704|592941902|FG001|First Intervention|Withdrew consent|0|||
164158215|NCT00925704|592941903|FG002|First Intervention|Withdrew consent|0|||
164158216|NCT00925704|592941904|FG003|First Intervention|Withdrew consent|1|||
164158217|NCT00925704|592941905|FG004|First Intervention|Withdrew consent|1|||
164158218|NCT00925704|592941906|FG005|First Intervention|Withdrew consent|0|||
164158219|NCT00925704|592941901|FG000|Second Intervention|Withdrawal by Subject|1|||
164158220|NCT00925704|592941902|FG001|Second Intervention|Withdrawal by Subject|0|||
164158221|NCT00925704|592941903|FG002|Second Intervention|Withdrawal by Subject|0|||
164158222|NCT00925704|592941904|FG003|Second Intervention|Withdrawal by Subject|0|||
164158223|NCT00925704|592941905|FG004|Second Intervention|Withdrawal by Subject|1|||
164158224|NCT00925704|592941906|FG005|Second Intervention|Withdrawal by Subject|0|||
164158225|NCT00925704|592941901|FG000|Third Intervention|Withdrew consent|0|||
164158226|NCT00925704|592941902|FG001|Third Intervention|Withdrew consent|0|||
164158227|NCT00925704|592941903|FG002|Third Intervention|Withdrew consent|0|||
164158228|NCT00925704|592941904|FG003|Third Intervention|Withdrew consent|0|||
164158229|NCT00925704|592941905|FG004|Third Intervention|Withdrew consent|0|||
164158230|NCT00925704|592941906|FG005|Third Intervention|Withdrew consent|1|||
164158231|NCT04537078|592941909|FG000|Overall Study|Protocol Violation|3|||
164158232|NCT04537078|592941910|FG001|Overall Study|Protocol Violation|2|||
164158233|NCT04537078|592941909|FG000|Overall Study|Lost to Follow-up|1|||
164158234|NCT04537078|592941910|FG001|Overall Study|Lost to Follow-up|0|||
164158235|NCT04537078|592941909|FG000|Overall Study|Withdrawal by Subject|0|||
164158236|NCT04537078|592941910|FG001|Overall Study|Withdrawal by Subject|1|||
164158237|NCT03207815|592941911|FG000|Overall Study|Protocol Violation|3|||
164158238|NCT03207815|592941912|FG001|Overall Study|Protocol Violation|1|||
164158239|NCT03207815|592941911|FG000|Overall Study|Adverse Event|1|||
164158240|NCT03207815|592941912|FG001|Overall Study|Adverse Event|2|||
164158241|NCT03207815|592941911|FG000|Overall Study|Lost to Follow-up|1|||
164158242|NCT03207815|592941912|FG001|Overall Study|Lost to Follow-up|2|||
164158243|NCT03207815|592941911|FG000|Overall Study|Investigator's Discretion|1|||
164158244|NCT03207815|592941912|FG001|Overall Study|Investigator's Discretion|1|||
164158245|NCT03207815|592941911|FG000|Overall Study|Lack of Efficacy|0|||
164158246|NCT03207815|592941912|FG001|Overall Study|Lack of Efficacy|1|||
164158247|NCT03207815|592941911|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
164158248|NCT03207815|592941912|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
164158249|NCT03207815|592941911|FG000|Overall Study|Withdrew Consent|1|||
164158250|NCT03207815|592941912|FG001|Overall Study|Withdrew Consent|0|||
164158251|NCT03817853|592941913|FG000|Induction Phase|Adverse Event|5|||
164158252|NCT03817853|592941914|FG001|Induction Phase|Adverse Event|0|||
164158253|NCT03817853|592941915|FG002|Induction Phase|Adverse Event|0|||
164158254|NCT03817853|592941913|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
164158255|NCT03817853|592941914|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
164158256|NCT03817853|592941915|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
164158257|NCT03817853|592941913|FG000|Induction Phase|Physician Decision|2|||
164158258|NCT03817853|592941914|FG001|Induction Phase|Physician Decision|0|||
164158259|NCT03817853|592941915|FG002|Induction Phase|Physician Decision|0|||
164158260|NCT03817853|592941913|FG000|Induction Phase|Progressive Disease|6|||
164158261|NCT03817853|592941914|FG001|Induction Phase|Progressive Disease|0|||
164158262|NCT03817853|592941915|FG002|Induction Phase|Progressive Disease|0|||
164158263|NCT03817853|592941913|FG000|Induction Phase|Withdrawal by Subject|4|||
164158264|NCT03817853|592941914|FG001|Induction Phase|Withdrawal by Subject|0|||
164158265|NCT03817853|592941915|FG002|Induction Phase|Withdrawal by Subject|0|||
164158266|NCT03817853|592941913|FG000|Maintenance Phase|Adverse Event|0|||
164158267|NCT03817853|592941914|FG001|Maintenance Phase|Adverse Event|8|||
164158268|NCT03817853|592941915|FG002|Maintenance Phase|Adverse Event|0|||
164158269|NCT03817853|592941913|FG000|Maintenance Phase|Death|0|||
164158270|NCT03817853|592941914|FG001|Maintenance Phase|Death|5|||
164158271|NCT03817853|592941915|FG002|Maintenance Phase|Death|0|||
164158272|NCT03817853|592941913|FG000|Maintenance Phase|Progressive Disease|0|||
164158273|NCT03817853|592941914|FG001|Maintenance Phase|Progressive Disease|7|||
164158274|NCT03817853|592941915|FG002|Maintenance Phase|Progressive Disease|0|||
164158275|NCT03817853|592941913|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164158276|NCT03817853|592941914|FG001|Maintenance Phase|Withdrawal by Subject|2|||
164158277|NCT03817853|592941915|FG002|Maintenance Phase|Withdrawal by Subject|0|||
164158278|NCT03817853|592941913|FG000|Maintenance Phase|Physician Decision|0|||
164158279|NCT03817853|592941914|FG001|Maintenance Phase|Physician Decision|1|||
164158280|NCT03817853|592941915|FG002|Maintenance Phase|Physician Decision|0|||
164158281|NCT03817853|592941913|FG000|Maintenance Phase|Various reasons|0|||
164158282|NCT03817853|592941914|FG001|Maintenance Phase|Various reasons|4|||
164158283|NCT03817853|592941915|FG002|Maintenance Phase|Various reasons|0|||
164158284|NCT03817853|592941913|FG000|Maintenance Phase|Protocol Deviation|0|||
164158285|NCT03817853|592941914|FG001|Maintenance Phase|Protocol Deviation|1|||
164158286|NCT03817853|592941915|FG002|Maintenance Phase|Protocol Deviation|0|||
164158287|NCT03817853|592941913|FG000|Follow-up Phase|Adverse Event|0|||
164158288|NCT03817853|592941914|FG001|Follow-up Phase|Adverse Event|0|||
164158289|NCT03817853|592941915|FG002|Follow-up Phase|Adverse Event|2|||
164158290|NCT03817853|592941913|FG000|Follow-up Phase|Death|0|||
164158291|NCT03817853|592941914|FG001|Follow-up Phase|Death|0|||
164158293|NCT03817853|592941913|FG000|Follow-up Phase|Progressive Disease|0|||
164158294|NCT03817853|592941914|FG001|Follow-up Phase|Progressive Disease|0|||
164158295|NCT03817853|592941915|FG002|Follow-up Phase|Progressive Disease|3|||
164158296|NCT03817853|592941913|FG000|Follow-up Phase|Withdrawal by Subject|0|||
164158297|NCT03817853|592941914|FG001|Follow-up Phase|Withdrawal by Subject|0|||
164158298|NCT03817853|592941915|FG002|Follow-up Phase|Withdrawal by Subject|1|||
164158299|NCT01620138|592941916|FG000|Overall Study|Withdrawal by Subject|3|||
164158300|NCT01620138|592941917|FG001|Overall Study|Withdrawal by Subject|0|||
164158301|NCT01620138|592941916|FG000|Overall Study|Lack of Efficacy|1|||
164158302|NCT01620138|592941917|FG001|Overall Study|Lack of Efficacy|0|||
164158303|NCT01620138|592941916|FG000|Overall Study|Adverse Event|2|||
164158304|NCT01620138|592941917|FG001|Overall Study|Adverse Event|0|||
164158305|NCT05005507|592941920|FG000|Overall Study|Premature termination of study|1|||
164158306|NCT03866512|592941922|FG000|Overall Study|Lost to Follow-up|1|||
164158307|NCT03866512|592941923|FG001|Overall Study|Lost to Follow-up|2|||
164158308|NCT03866512|592941924|FG002|Overall Study|Lost to Follow-up|1|||
164158309|NCT03866512|592941922|FG000|Overall Study|Cannulation issues|0|||
164158310|NCT03866512|592941923|FG001|Overall Study|Cannulation issues|1|||
164158311|NCT03866512|592941924|FG002|Overall Study|Cannulation issues|2|||
164158312|NCT00320710|592941925|FG000|Overall Study|Disease progression|24|||
164158313|NCT00320710|592941926|FG001|Overall Study|Disease progression|19|||
164158314|NCT00320710|592941927|FG002|Overall Study|Disease progression|2|||
164158315|NCT00320710|592941925|FG000|Overall Study|Death|10|||
164158316|NCT00320710|592941926|FG001|Overall Study|Death|7|||
164158317|NCT00320710|592941927|FG002|Overall Study|Death|1|||
164158318|NCT00320710|592941925|FG000|Overall Study|Administrative problems|1|||
164158319|NCT00320710|592941926|FG001|Overall Study|Administrative problems|2|||
164158320|NCT00320710|592941927|FG002|Overall Study|Administrative problems|0|||
164158321|NCT00320710|592941925|FG000|Overall Study|Withdrawal by Subject|20|||
164158322|NCT00320710|592941926|FG001|Overall Study|Withdrawal by Subject|26|||
164158323|NCT00320710|592941927|FG002|Overall Study|Withdrawal by Subject|1|||
164158324|NCT00320710|592941925|FG000|Overall Study|Protocol Violation|6|||
164158325|NCT00320710|592941926|FG001|Overall Study|Protocol Violation|5|||
164158326|NCT00320710|592941927|FG002|Overall Study|Protocol Violation|0|||
164158327|NCT00320710|592941925|FG000|Overall Study|Abnormal test procedure result(s)|2|||
164158328|NCT00320710|592941926|FG001|Overall Study|Abnormal test procedure result(s)|0|||
164158329|NCT00320710|592941927|FG002|Overall Study|Abnormal test procedure result(s)|0|||
164158330|NCT00320710|592941925|FG000|Overall Study|Abnormal laboratory value(s)|12|||
164158331|NCT00320710|592941926|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164158332|NCT00320710|592941927|FG002|Overall Study|Abnormal laboratory value(s)|0|||
164158333|NCT00320710|592941925|FG000|Overall Study|Adverse Event|18|||
164158334|NCT00320710|592941926|FG001|Overall Study|Adverse Event|14|||
164158335|NCT00320710|592941927|FG002|Overall Study|Adverse Event|1|||
164158336|NCT00320710|592941925|FG000|Overall Study|Lost to Follow-up|1|||
164158337|NCT00320710|592941926|FG001|Overall Study|Lost to Follow-up|0|||
164158338|NCT00320710|592941927|FG002|Overall Study|Lost to Follow-up|0|||
164158339|NCT00997373|592941933|FG000|Overall Study|Withdrawal by Subject|5|||
164158340|NCT00997373|592941934|FG001|Overall Study|Withdrawal by Subject|0|||
164158341|NCT00997373|592941933|FG000|Overall Study|wrong tumor type|4|||
164158342|NCT00997373|592941934|FG001|Overall Study|wrong tumor type|0|||
164158343|NCT00997373|592941933|FG000|Overall Study|could not have hysterectomy|6|||
164158344|NCT00997373|592941934|FG001|Overall Study|could not have hysterectomy|0|||
164158345|NCT04578457|592941935|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
164158346|NCT04578457|592941935|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
164158347|NCT04578457|592941935|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
164158348|NCT04578457|592941935|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
164158349|NCT00832455|592941936|FG000|Overall Study|Adverse Event|13|||
164158350|NCT00832455|592941936|FG000|Overall Study|Lost to Follow-up|26|||
164158351|NCT00832455|592941936|FG000|Overall Study|Protocol Violation|4|||
164158352|NCT00832455|592941936|FG000|Overall Study|Withdrawal by Subject|17|||
164158353|NCT00832455|592941936|FG000|Overall Study|Screening Failure|2|||
164158354|NCT00832455|592941936|FG000|Overall Study|Stopped Medication|4|||
164158355|NCT00832455|592941936|FG000|Overall Study|Parent misunderstood study|1|||
164158356|NCT00832455|592941936|FG000|Overall Study|Parent dissatisfied|1|||
164158357|NCT00832455|592941936|FG000|Overall Study|No improvement|3|||
164158358|NCT00832455|592941936|FG000|Overall Study|Patient moved|1|||
164158359|NCT02841995|592941944|FG000|Overall Study|Disease progression|5|||
164158360|NCT02841995|592941945|FG001|Overall Study|Disease progression|11|||
164158361|NCT02841995|592941946|FG002|Overall Study|Disease progression|8|||
164158362|NCT02841995|592941944|FG000|Overall Study|Withdrawal by Subject|2|||
164158363|NCT02841995|592941945|FG001|Overall Study|Withdrawal by Subject|4|||
164158364|NCT02841995|592941946|FG002|Overall Study|Withdrawal by Subject|4|||
164158365|NCT02841995|592941944|FG000|Overall Study|Adverse Event|2|||
164158366|NCT02841995|592941945|FG001|Overall Study|Adverse Event|0|||
164158367|NCT02841995|592941946|FG002|Overall Study|Adverse Event|1|||
164158368|NCT02841995|592941944|FG000|Overall Study|Investigator decision|2|||
164158369|NCT02841995|592941945|FG001|Overall Study|Investigator decision|0|||
164158370|NCT02841995|592941946|FG002|Overall Study|Investigator decision|1|||
164158371|NCT02841995|592941944|FG000|Overall Study|Death|0|||
164158372|NCT02841995|592941945|FG001|Overall Study|Death|0|||
164158373|NCT02841995|592941946|FG002|Overall Study|Death|2|||
164158374|NCT02841995|592941944|FG000|Overall Study|Noncompliance to protocol|1|||
164158375|NCT02841995|592941945|FG001|Overall Study|Noncompliance to protocol|0|||
164158376|NCT02841995|592941946|FG002|Overall Study|Noncompliance to protocol|0|||
164158377|NCT02841995|592941944|FG000|Overall Study|Sponsor decision|1|||
164158378|NCT02841995|592941945|FG001|Overall Study|Sponsor decision|0|||
164158379|NCT02841995|592941946|FG002|Overall Study|Sponsor decision|0|||
164158380|NCT02841995|592941944|FG000|Overall Study|Other|4|||
164158381|NCT02841995|592941945|FG001|Overall Study|Other|1|||
164158382|NCT02841995|592941946|FG002|Overall Study|Other|5|||
164158383|NCT02755103|592941948|FG000|Overall Study|Lost to Follow-up|17|||
164158384|NCT02755103|592941949|FG001|Overall Study|Lost to Follow-up|15|||
164158385|NCT02755103|592941948|FG000|Overall Study|Death|0|||
164158386|NCT02755103|592941949|FG001|Overall Study|Death|1|||
164158387|NCT02755103|592941948|FG000|Overall Study|Physician Decision|0|||
164158388|NCT02755103|592941949|FG001|Overall Study|Physician Decision|1|||
164158389|NCT02755103|592941948|FG000|Overall Study|Pregnancy|0|||
164158390|NCT02755103|592941949|FG001|Overall Study|Pregnancy|1|||
164158391|NCT02755103|592941948|FG000|Overall Study|Withdrawal by Subject|3|||
164158392|NCT02755103|592941949|FG001|Overall Study|Withdrawal by Subject|0|||
164158393|NCT00739661|592941957|FG000|Overall Study|Adverse Event|2|||
164158394|NCT00739661|592941958|FG001|Overall Study|Adverse Event|0|||
164158395|NCT00739661|592941957|FG000|Overall Study|Physician decision to withdraw patient|1|||
164158396|NCT00739661|592941958|FG001|Overall Study|Physician decision to withdraw patient|0|||
164158397|NCT00739661|592941957|FG000|Overall Study|Patient decision to withdraw|9|||
164158398|NCT00739661|592941958|FG001|Overall Study|Patient decision to withdraw|4|||
164158399|NCT00739661|592941957|FG000|Overall Study|Disease progression, radiographic|33|||
164158400|NCT00739661|592941958|FG001|Overall Study|Disease progression, radiographic|37|||
164158401|NCT00739661|592941957|FG000|Overall Study|Reason for discontinuation not available|1|||
164158402|NCT00739661|592941958|FG001|Overall Study|Reason for discontinuation not available|1|||
164158403|NCT03839628|592941961|FG000|Overall Study|Withdrawal by Subject|1|||
164158404|NCT01289678|592941962|FG000|Overall Study|Physician Decision|6|||
164158405|NCT03539302|592941965|FG000|Overall Study|Spontaneous cardio version|0|||
164158406|NCT03539302|592941966|FG001|Overall Study|Spontaneous cardio version|0|||
164158407|NCT03539302|592941967|FG002|Overall Study|Spontaneous cardio version|0|||
164158408|NCT03539302|592941968|FG003|Overall Study|Spontaneous cardio version|0|||
164158409|NCT03539302|592941969|FG004|Overall Study|Spontaneous cardio version|0|||
164158410|NCT03539302|592941970|FG005|Overall Study|Spontaneous cardio version|1|||
164158411|NCT03539302|592941971|FG006|Overall Study|Spontaneous cardio version|1|||
164158412|NCT04564092|592941973|FG000|Overall Study|Withdrawal by Subject|1|||
164158413|NCT02362360|592941979|FG000|Period 1|Lack of Efficacy|1|||
164158414|NCT02362360|592941980|FG001|Period 1|Lack of Efficacy|0|||
164158415|NCT02362360|592941979|FG000|Period 1|Withdrawal by Subject|2|||
164158416|NCT02362360|592941980|FG001|Period 1|Withdrawal by Subject|1|||
164158417|NCT04146012|592941981|FG000|Overall Study|Study Terminated|30|||
164158418|NCT04146012|592941982|FG001|Overall Study|Study Terminated|15|||
164158419|NCT03817190|592941983|FG000|Overall Study|Early Termination|13|||
164158420|NCT03817190|592941984|FG001|Overall Study|Early Termination|20|||
164158421|NCT03817190|592941983|FG000|Overall Study|Adverse Event|10|||
164158422|NCT03817190|592941984|FG001|Overall Study|Adverse Event|17|||
164158423|NCT03817190|592941983|FG000|Overall Study|Withdrawal by Subject|12|||
164158424|NCT03817190|592941984|FG001|Overall Study|Withdrawal by Subject|8|||
164158425|NCT03817190|592941983|FG000|Overall Study|Lost to Follow-up|11|||
164158426|NCT03817190|592941984|FG001|Overall Study|Lost to Follow-up|7|||
164158427|NCT03817190|592941983|FG000|Overall Study|Lack of Efficacy|7|||
164158428|NCT03817190|592941984|FG001|Overall Study|Lack of Efficacy|5|||
164158429|NCT03817190|592941983|FG000|Overall Study|Investigator Decision|5|||
164158430|NCT03817190|592941984|FG001|Overall Study|Investigator Decision|1|||
164158431|NCT03817190|592941983|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
164158432|NCT03817190|592941984|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
164158433|NCT03817190|592941983|FG000|Overall Study|Lack of Contact|1|||
164158434|NCT03817190|592941984|FG001|Overall Study|Lack of Contact|0|||
164158435|NCT03817190|592941983|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
164158436|NCT03817190|592941984|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
164158437|NCT01546025|592941985|FG000|Overall Study|Lost to Follow-up|0|||
164158438|NCT01546025|592941986|FG001|Overall Study|Lost to Follow-up|1|||
164158439|NCT00868530|592941987|FG000|Overall Study|Adverse Event|3|||
164158440|NCT00868530|592941987|FG000|Overall Study|Lost to Follow-up|1|||
164158441|NCT04955691|592943714|FG000|Period 2|Discontinued intervention|1|||
164158442|NCT04955691|592943715|FG001|Period 2|Discontinued intervention|2|||
164158443|NCT05336227|592943716|FG000|Overall Study|Adverse Event|1|||
164158444|NCT05336227|592943717|FG001|Overall Study|Adverse Event|0|||
164158445|NCT05336227|592943716|FG000|Overall Study|Lost to Follow-up|2|||
164158446|NCT05336227|592943717|FG001|Overall Study|Lost to Follow-up|0|||
164158447|NCT05336227|592943716|FG000|Overall Study|Withdrawal by Subject|1|||
164158448|NCT05336227|592943717|FG001|Overall Study|Withdrawal by Subject|0|||
164158449|NCT05086744|592943718|FG000|Part A|Adverse Event|0|||
164158450|NCT05086744|592943719|FG001|Part A|Adverse Event|1|||
164158451|NCT05086744|592943718|FG000|Part A|Lack of Efficacy|3|||
164158452|NCT05086744|592943719|FG001|Part A|Lack of Efficacy|0|||
164158453|NCT05086744|592943718|FG000|Part A|Protocol deviation|1|||
164158454|NCT05086744|592943719|FG001|Part A|Protocol deviation|0|||
164158455|NCT05086744|592943718|FG000|Part A|Subject decision|1|||
164158456|NCT05086744|592943719|FG001|Part A|Subject decision|0|||
164158457|NCT05086744|592943718|FG000|Part B|Adverse Event|0|||
164158458|NCT05086744|592943719|FG001|Part B|Adverse Event|1|||
164158459|NCT05086744|592943718|FG000|Part B|Lack of Efficacy|0|||
164158460|NCT05086744|592943719|FG001|Part B|Lack of Efficacy|1|||
164158461|NCT05086744|592943718|FG000|Part B|Study terminated by sponsor|1|||
164158462|NCT05086744|592943719|FG001|Part B|Study terminated by sponsor|6|||
164158463|NCT04050462|592943720|FG000|Overall Study|Withdrawal by Subject|1|||
164158464|NCT04050462|592943721|FG001|Overall Study|Withdrawal by Subject|0|||
164158465|NCT04050462|592943722|FG002|Overall Study|Withdrawal by Subject|0|||
164158466|NCT05151744|592943725|FG000|Overall Study|Adverse Event|6|||
164158467|NCT05151744|592943726|FG001|Overall Study|Adverse Event|2|||
164158468|NCT05151744|592943725|FG000|Overall Study|Death|1|||
164158469|NCT05151744|592943726|FG001|Overall Study|Death|2|||
164158470|NCT05151744|592943725|FG000|Overall Study|Lack of Efficacy|1|||
164158471|NCT05151744|592943726|FG001|Overall Study|Lack of Efficacy|1|||
164158472|NCT05151744|592943725|FG000|Overall Study|Lost to Follow-up|2|||
164158473|NCT05151744|592943726|FG001|Overall Study|Lost to Follow-up|2|||
164158474|NCT05151744|592943725|FG000|Overall Study|Need for Rescue Treatment|0|||
164158475|NCT05151744|592943726|FG001|Overall Study|Need for Rescue Treatment|1|||
164158476|NCT05151744|592943725|FG000|Overall Study|Non-compliance with Study Drug|0|||
164158477|NCT05151744|592943726|FG001|Overall Study|Non-compliance with Study Drug|1|||
164158478|NCT05151744|592943725|FG000|Overall Study|Reason not Specified|10|||
164158479|NCT05151744|592943726|FG001|Overall Study|Reason not Specified|0|||
164158480|NCT05151744|592943725|FG000|Overall Study|Physician Decision|2|||
164158481|NCT05151744|592943726|FG001|Overall Study|Physician Decision|1|||
164158482|NCT05151744|592943725|FG000|Overall Study|Protocol Violation|1|||
164158483|NCT05151744|592943726|FG001|Overall Study|Protocol Violation|0|||
164158484|NCT05151744|592943725|FG000|Overall Study|Withdrawal by Subject|6|||
164158485|NCT05151744|592943726|FG001|Overall Study|Withdrawal by Subject|3|||
164158486|NCT04053868|592943727|FG000|Overall Study|Withdrawal by Subject|1|||
164158487|NCT04053868|592943728|FG001|Overall Study|Withdrawal by Subject|0|||
164158488|NCT05731700|592943729|FG000|Overall Study|Death|1|||
164158489|NCT01682226|592943732|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
164158490|NCT01682226|592943732|FG000|Overall Study|Participants did not receive treatment|2|||
164158491|NCT01682226|592943732|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
164158492|NCT03771898|592943741|FG000|Overall Study|Adverse Event|1|||
164158493|NCT03771898|592943742|FG001|Overall Study|Adverse Event|0|||
164158494|NCT03771898|592943743|FG002|Overall Study|Adverse Event|0|||
164158495|NCT03771898|592943744|FG003|Overall Study|Adverse Event|0|||
164158496|NCT03771898|592943745|FG004|Overall Study|Adverse Event|0|||
164158497|NCT03771898|592943741|FG000|Overall Study|Lost to Follow-up|1|||
164158498|NCT03771898|592943742|FG001|Overall Study|Lost to Follow-up|1|||
164158499|NCT03771898|592943743|FG002|Overall Study|Lost to Follow-up|1|||
164158500|NCT03771898|592943744|FG003|Overall Study|Lost to Follow-up|0|||
164158501|NCT03771898|592943745|FG004|Overall Study|Lost to Follow-up|0|||
164158502|NCT03771898|592943741|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164158503|NCT03771898|592943742|FG001|Overall Study|Withdrawal by parent/guardian|1|||
164158504|NCT03771898|592943743|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164158505|NCT03771898|592943744|FG003|Overall Study|Withdrawal by parent/guardian|0|||
164158506|NCT03771898|592943745|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164158507|NCT03771898|592943741|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158508|NCT03771898|592943742|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158509|NCT03771898|592943743|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158510|NCT03771898|592943744|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
164158511|NCT03771898|592943745|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
164158512|NCT03123120|592943746|FG000|Overall Study|Lost to Follow-up|0|||
164158513|NCT03123120|592943747|FG001|Overall Study|Lost to Follow-up|1|||
164158514|NCT03123120|592943746|FG000|Overall Study|Withdrawal by Subject|0|||
164158515|NCT03123120|592943747|FG001|Overall Study|Withdrawal by Subject|1|||
164158516|NCT03135548|592943751|FG000|Overall Study|Lost to Follow-up|3|||
164158517|NCT03135548|592943752|FG001|Overall Study|Lost to Follow-up|0|||
164158518|NCT03135548|592943753|FG002|Overall Study|Lost to Follow-up|0|||
164158519|NCT03135548|592943751|FG000|Overall Study|Withdrawal by Subject|2|||
164158520|NCT03135548|592943752|FG001|Overall Study|Withdrawal by Subject|2|||
164158521|NCT03135548|592943753|FG002|Overall Study|Withdrawal by Subject|1|||
164158522|NCT03135548|592943751|FG000|Overall Study|Other than listed|0|||
164158523|NCT03135548|592943752|FG001|Overall Study|Other than listed|2|||
164158524|NCT03135548|592943753|FG002|Overall Study|Other than listed|2|||
164158525|NCT02632175|592943754|FG000|Overall Study|Withdrawal by Subject|6|||
164158526|NCT02632175|592943754|FG000|Overall Study|Lost to Follow-up|1|||
164158527|NCT02632175|592943754|FG000|Overall Study|Lack of Efficacy|18|||
164158528|NCT02632175|592943754|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
164158529|NCT02632175|592943754|FG000|Overall Study|Subject noncompliance|3|||
164158530|NCT02632175|592943754|FG000|Overall Study|other|2|||
164158531|NCT02088554|592943755|FG000|Overall Study|Exited before procedure|130|||
164158532|NCT02088554|592943755|FG000|Overall Study|Attempted but not implanted|31|||
164158533|NCT02088554|592943755|FG000|Overall Study|Implant not attempted|19|||
164158534|NCT02088554|592943755|FG000|Overall Study|Pending next visit|532|||
164158535|NCT02088554|592943755|FG000|Overall Study|Death|170|||
164158536|NCT02088554|592943755|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
164158537|NCT02088554|592943755|FG000|Overall Study|Lost to Follow-up|23|||
164158538|NCT02088554|592943755|FG000|Overall Study|Explanted|32|||
164158539|NCT02088554|592943755|FG000|Overall Study|Any other reason not covered by previous categories|11|||
164158540|NCT04623216|592943756|FG000|Overall Study|Death|5|||
164158541|NCT04623216|592943757|FG001|Overall Study|Death|2|||
164158542|NCT04623216|592943758|FG002|Overall Study|Death|0|||
164158543|NCT04623216|592943759|FG003|Overall Study|Death|0|||
164158544|NCT04623216|592943756|FG000|Overall Study|Terminated by Sponsor|3|||
164158545|NCT04623216|592943757|FG001|Overall Study|Terminated by Sponsor|2|||
164158546|NCT04623216|592943758|FG002|Overall Study|Terminated by Sponsor|2|||
164158547|NCT04623216|592943759|FG003|Overall Study|Terminated by Sponsor|0|||
164158548|NCT04623216|592943756|FG000|Overall Study|Physician Decision|1|||
164158549|NCT04623216|592943757|FG001|Overall Study|Physician Decision|0|||
164158550|NCT04623216|592943758|FG002|Overall Study|Physician Decision|0|||
164158551|NCT04623216|592943759|FG003|Overall Study|Physician Decision|0|||
164158552|NCT03521154|592943762|FG000|Overall Study|Ongoing study at data cut-off|111|||
164158553|NCT03521154|592943763|FG001|Overall Study|Ongoing study at data cut-off|52|||
164158554|NCT05468164|592943764|FG000|Treatment Period 4|Adverse Event|0|||
164158555|NCT05468164|592943765|FG001|Treatment Period 4|Adverse Event|0|||
164158556|NCT05468164|592943766|FG002|Treatment Period 4|Adverse Event|0|||
164158557|NCT05468164|592943767|FG003|Treatment Period 4|Adverse Event|1|||
164158558|NCT04632927|592943768|FG000|Overall Study|Adverse Event|0|||
164158559|NCT04632927|592943769|FG001|Overall Study|Adverse Event|1|||
164158560|NCT04632927|592943768|FG000|Overall Study|Lack of Efficacy|0|||
164158561|NCT04632927|592943769|FG001|Overall Study|Lack of Efficacy|4|||
164158562|NCT04632927|592943768|FG000|Overall Study|Loss of efficacy|0|||
164158563|NCT04632927|592943769|FG001|Overall Study|Loss of efficacy|1|||
164158564|NCT04632927|592943768|FG000|Overall Study|Non-compliance with study drug|0|||
164158565|NCT04632927|592943769|FG001|Overall Study|Non-compliance with study drug|1|||
164158566|NCT04632927|592943768|FG000|Overall Study|Physician Decision|0|||
164158567|NCT04632927|592943769|FG001|Overall Study|Physician Decision|1|||
164158568|NCT04632927|592943768|FG000|Overall Study|Subject decision|0|||
164158569|NCT04632927|592943769|FG001|Overall Study|Subject decision|1|||
164158570|NCT04632927|592943768|FG000|Overall Study|Withdrawal by Subject|0|||
164158571|NCT04632927|592943769|FG001|Overall Study|Withdrawal by Subject|1|||
164158572|NCT03168711|592943777|FG000|Overall Study|Adverse Event|2|||
164158573|NCT03168711|592943778|FG001|Overall Study|Adverse Event|0|||
164158574|NCT03168711|592943777|FG000|Overall Study|Withdrawal by Subject|0|||
164158575|NCT03168711|592943778|FG001|Overall Study|Withdrawal by Subject|1|||
164158576|NCT03168711|592943777|FG000|Overall Study|Death|0|||
164158577|NCT03168711|592943778|FG001|Overall Study|Death|1|||
164158578|NCT01671007|592943780|FG000|Overall Study|Other reasons than listed|166|||
164158579|NCT01671007|592943781|FG001|Overall Study|Other reasons than listed|373|||
164158580|NCT01671007|592943782|FG002|Overall Study|Other reasons than listed|197|||
164158581|NCT01671007|592943783|FG003|Overall Study|Other reasons than listed|228|||
164158582|NCT01671007|592943784|FG004|Overall Study|Other reasons than listed|14|||
164158583|NCT01671007|592943785|FG005|Overall Study|Other reasons than listed|71|||
164158584|NCT01671007|592943786|FG006|Overall Study|Other reasons than listed|17|||
164158585|NCT01671007|592943787|FG007|Overall Study|Other reasons than listed|66|||
164158586|NCT01671007|592943788|FG008|Overall Study|Other reasons than listed|0|||
164158587|NCT01671007|592943780|FG000|Overall Study|Withdrawal by Subject|36|||
164158588|NCT01671007|592943781|FG001|Overall Study|Withdrawal by Subject|59|||
164158589|NCT01671007|592943782|FG002|Overall Study|Withdrawal by Subject|53|||
164158590|NCT01671007|592943783|FG003|Overall Study|Withdrawal by Subject|58|||
164158591|NCT01671007|592943784|FG004|Overall Study|Withdrawal by Subject|4|||
164158592|NCT01671007|592943785|FG005|Overall Study|Withdrawal by Subject|15|||
164158593|NCT01671007|592943786|FG006|Overall Study|Withdrawal by Subject|1|||
164158594|NCT01671007|592943787|FG007|Overall Study|Withdrawal by Subject|19|||
164158595|NCT01671007|592943788|FG008|Overall Study|Withdrawal by Subject|0|||
164158596|NCT01671007|592943780|FG000|Overall Study|Lost to Follow-up|93|||
164158597|NCT01671007|592943781|FG001|Overall Study|Lost to Follow-up|142|||
164158598|NCT01671007|592943782|FG002|Overall Study|Lost to Follow-up|91|||
164158599|NCT01671007|592943783|FG003|Overall Study|Lost to Follow-up|63|||
164158600|NCT01671007|592943784|FG004|Overall Study|Lost to Follow-up|7|||
164158601|NCT01671007|592943785|FG005|Overall Study|Lost to Follow-up|20|||
164158602|NCT01671007|592943786|FG006|Overall Study|Lost to Follow-up|2|||
164158603|NCT01671007|592943787|FG007|Overall Study|Lost to Follow-up|28|||
164158604|NCT01671007|592943788|FG008|Overall Study|Lost to Follow-up|0|||
164158605|NCT01671007|592943780|FG000|Overall Study|No end of study case report form|3|||
164158606|NCT01671007|592943781|FG001|Overall Study|No end of study case report form|1|||
164158607|NCT01671007|592943782|FG002|Overall Study|No end of study case report form|0|||
164158608|NCT01671007|592943783|FG003|Overall Study|No end of study case report form|2|||
164158609|NCT01671007|592943784|FG004|Overall Study|No end of study case report form|0|||
164158610|NCT01671007|592943785|FG005|Overall Study|No end of study case report form|0|||
164158611|NCT01671007|592943786|FG006|Overall Study|No end of study case report form|0|||
164158612|NCT01671007|592943787|FG007|Overall Study|No end of study case report form|0|||
164158613|NCT01671007|592943788|FG008|Overall Study|No end of study case report form|0|||
164158614|NCT01671007|592943780|FG000|Overall Study|Not eligible|23|||
164158615|NCT01671007|592943781|FG001|Overall Study|Not eligible|76|||
164158616|NCT01671007|592943782|FG002|Overall Study|Not eligible|25|||
164158617|NCT01671007|592943783|FG003|Overall Study|Not eligible|17|||
164158618|NCT01671007|592943784|FG004|Overall Study|Not eligible|0|||
164158619|NCT01671007|592943785|FG005|Overall Study|Not eligible|6|||
164158620|NCT01671007|592943786|FG006|Overall Study|Not eligible|1|||
164158621|NCT01671007|592943787|FG007|Overall Study|Not eligible|19|||
164158622|NCT01671007|592943788|FG008|Overall Study|Not eligible|0|||
164158623|NCT03877068|592943789|FG000|Overall Study|Physician Decision|9|||
164158624|NCT03877068|592943790|FG001|Overall Study|Physician Decision|3|||
164158625|NCT00449865|592943791|FG000|Overall Study|Withdrawal by Subject|110|||
164158626|NCT00449865|592943792|FG001|Overall Study|Withdrawal by Subject|110|||
164158627|NCT00449865|592943791|FG000|Overall Study|Lost to Follow-up|36|||
164158628|NCT00449865|592943792|FG001|Overall Study|Lost to Follow-up|37|||
164158629|NCT00449865|592943791|FG000|Overall Study|Physician Decision|13|||
164158630|NCT00449865|592943792|FG001|Overall Study|Physician Decision|12|||
164158631|NCT00449865|592943791|FG000|Overall Study|Death|31|||
164158632|NCT00449865|592943792|FG001|Overall Study|Death|40|||
164158633|NCT00449865|592943791|FG000|Overall Study|Protocol Violation|8|||
164158634|NCT00449865|592943792|FG001|Overall Study|Protocol Violation|7|||
164158635|NCT00449865|592943791|FG000|Overall Study|Study was stopped|324|||
164158636|NCT00449865|592943792|FG001|Overall Study|Study was stopped|328|||
164158637|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
164158638|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
164158639|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
164158640|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
164158641|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
164158642|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
164158643|NCT00406367|592943793|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
164158644|NCT00406367|592943794|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
164158645|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
164158646|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
164158647|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
164158648|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
164158649|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
164158650|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
164158651|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
164158652|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
164158653|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
164158654|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
164158655|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
164158656|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
164158657|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
164158658|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
164158659|NCT00406367|592943793|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
164158660|NCT00406367|592943794|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
164158661|NCT03922308|592943795|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
164158662|NCT03922308|592943796|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
164158663|NCT03922308|592943797|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
164158664|NCT03922308|592943795|FG000|Overall Study|Lost to Follow-up|1|||
164158665|NCT03922308|592943796|FG001|Overall Study|Lost to Follow-up|0|||
164158666|NCT03922308|592943797|FG002|Overall Study|Lost to Follow-up|0|||
164158667|NCT03922308|592943795|FG000|Overall Study|Reason not Specified|0|||
164158668|NCT03922308|592943796|FG001|Overall Study|Reason not Specified|2|||
164158669|NCT03922308|592943797|FG002|Overall Study|Reason not Specified|1|||
164158670|NCT03252535|592943798|FG000|Overall Study|Withdrawal by Subject|1|||
164158671|NCT03252535|592943799|FG001|Overall Study|Withdrawal by Subject|0|||
164158672|NCT03252535|592943800|FG002|Overall Study|Withdrawal by Subject|0|||
164158673|NCT03252535|592943798|FG000|Overall Study|Physician Decision|0|||
164158674|NCT03252535|592943799|FG001|Overall Study|Physician Decision|1|||
164158675|NCT03252535|592943800|FG002|Overall Study|Physician Decision|0|||
164158676|NCT03252535|592943798|FG000|Overall Study|Met discontinuation criteria|0|||
164158677|NCT03252535|592943799|FG001|Overall Study|Met discontinuation criteria|1|||
164158678|NCT03252535|592943800|FG002|Overall Study|Met discontinuation criteria|0|||
164158679|NCT02588612|592943801|FG000|Overall Study|Physician Decision|1|||
164158680|NCT02588612|592943801|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
164158681|NCT02588612|592943801|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
164158682|NCT02588612|592943801|FG000|Overall Study|Death prior to T-cell infusion|1|||
164158683|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
164158684|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158685|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158686|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158687|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
164158688|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
164158689|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
164158690|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
164158691|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
164158692|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
164158693|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
164158694|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
164158695|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
164158696|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158697|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158698|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158699|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
164158700|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158701|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158702|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158703|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
164158704|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158705|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158706|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158707|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
164158708|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
164158709|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
164158710|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
164158711|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
164158712|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
164158713|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
164158714|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
164158715|NCT00506415|592943802|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
164158716|NCT00506415|592943803|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158717|NCT00506415|592943804|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158718|NCT00506415|592943805|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158719|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
164158720|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
164158721|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
164158722|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
164158723|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
164158724|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
164158725|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
164158726|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
164158727|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
164158728|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
164158729|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
164158730|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
164158731|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
164158732|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
164158733|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
164158734|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
164158735|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
164158736|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
164158737|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
164158738|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
164158739|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
164158740|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
164158741|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
164158742|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
164158743|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
164158744|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
164158745|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
164158746|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
164158747|NCT00506415|592943802|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
164158748|NCT00506415|592943803|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
164158749|NCT00506415|592943804|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
164158750|NCT00506415|592943805|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
164158751|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
164158752|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
164158753|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
164158754|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
164158755|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158756|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158757|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
164158758|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
164158759|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158760|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158761|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
164158762|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
164158763|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158764|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158765|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
164158766|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
164158767|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158768|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158769|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
164158770|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
164158771|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158772|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158773|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
164158774|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
164158775|NCT00506415|592943802|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
164158776|NCT00506415|592943803|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
164158777|NCT00506415|592943804|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
164158778|NCT00506415|592943805|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
164158779|NCT03809663|592943806|FG000|Overall Study|Decision by sponsor|24|||
164158780|NCT03809663|592943807|FG001|Overall Study|Decision by sponsor|18|||
164158781|NCT03809663|592943808|FG002|Overall Study|Decision by sponsor|20|||
164158782|NCT03809663|592943809|FG003|Overall Study|Decision by sponsor|20|||
164158783|NCT03809663|592943810|FG004|Overall Study|Decision by sponsor|0|||
164158784|NCT03809663|592943811|FG005|Overall Study|Decision by sponsor|0|||
164158785|NCT03809663|592943806|FG000|Overall Study|Withdrawal by Subject|26|||
164158786|NCT03809663|592943807|FG001|Overall Study|Withdrawal by Subject|22|||
164158787|NCT03809663|592943808|FG002|Overall Study|Withdrawal by Subject|27|||
164158788|NCT03809663|592943809|FG003|Overall Study|Withdrawal by Subject|26|||
164158789|NCT03809663|592943810|FG004|Overall Study|Withdrawal by Subject|0|||
164158790|NCT03809663|592943811|FG005|Overall Study|Withdrawal by Subject|0|||
164158791|NCT03809663|592943806|FG000|Overall Study|Lost to Follow-up|1|||
164158792|NCT03809663|592943807|FG001|Overall Study|Lost to Follow-up|4|||
164158793|NCT03809663|592943808|FG002|Overall Study|Lost to Follow-up|1|||
164158794|NCT03809663|592943809|FG003|Overall Study|Lost to Follow-up|1|||
164158795|NCT03809663|592943810|FG004|Overall Study|Lost to Follow-up|0|||
164158796|NCT03809663|592943811|FG005|Overall Study|Lost to Follow-up|0|||
164158797|NCT03376789|592943812|FG000|Overall Study|Withdrawal by Subject|3|||
164158798|NCT03376789|592943813|FG001|Overall Study|Withdrawal by Subject|5|||
164158799|NCT03376789|592943812|FG000|Overall Study|Protocol Violation|0|||
164158800|NCT03376789|592943813|FG001|Overall Study|Protocol Violation|1|||
164158801|NCT03376789|592943812|FG000|Overall Study|Adverse Event|0|||
164158802|NCT03376789|592943813|FG001|Overall Study|Adverse Event|1|||
164158803|NCT03376789|592943812|FG000|Overall Study|Lost to Follow-up|1|||
164158804|NCT03376789|592943813|FG001|Overall Study|Lost to Follow-up|1|||
164158805|NCT03376789|592943812|FG000|Overall Study|Per sponsor due to noncompliance|1|||
164158806|NCT03376789|592943813|FG001|Overall Study|Per sponsor due to noncompliance|0|||
164158807|NCT03376789|592943812|FG000|Overall Study|Subject off study medication|0|||
164158808|NCT03376789|592943813|FG001|Overall Study|Subject off study medication|1|||
164158809|NCT01703260|592943814|FG000|Overall Study|Adverse Event|1|||
164158810|NCT01703260|592943815|FG001|Overall Study|Adverse Event|2|||
164158811|NCT01703260|592943816|FG002|Overall Study|Adverse Event|2|||
164158812|NCT01703260|592943814|FG000|Overall Study|Lost to Follow-up|1|||
164158813|NCT01703260|592943815|FG001|Overall Study|Lost to Follow-up|0|||
164158814|NCT01703260|592943816|FG002|Overall Study|Lost to Follow-up|0|||
164158815|NCT01703260|592943814|FG000|Overall Study|Withdrawal by Subject|0|||
164158816|NCT01703260|592943815|FG001|Overall Study|Withdrawal by Subject|0|||
164158817|NCT01703260|592943816|FG002|Overall Study|Withdrawal by Subject|1|||
164158818|NCT01703260|592943814|FG000|Overall Study|Study Termination|1|||
164158819|NCT01703260|592943815|FG001|Overall Study|Study Termination|2|||
164158820|NCT01703260|592943816|FG002|Overall Study|Study Termination|0|||
164158821|NCT02042014|592943817|FG000|Overall Study|Adverse Event|1|||
164158822|NCT02042014|592943817|FG000|Overall Study|Physician Decision|7|||
164158823|NCT02792062|592943821|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
164158824|NCT02792062|592943822|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158825|NCT02792062|592943823|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158826|NCT02792062|592943824|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158827|NCT02792062|592943825|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158828|NCT02792062|592943826|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
164158829|NCT02883062|592943829|FG000|Overall Study|Withdrawal by Subject|6|||
164158830|NCT02883062|592943830|FG001|Overall Study|Withdrawal by Subject|0|||
164158831|NCT04578535|592943831|FG000|Overall Study|Lost to Follow-up|1|||
164158832|NCT04578535|592943832|FG001|Overall Study|Lost to Follow-up|0|||
164158833|NCT04578535|592943833|FG002|Overall Study|Lost to Follow-up|0|||
164158834|NCT04578535|592943834|FG003|Overall Study|Lost to Follow-up|1|||
164158835|NCT04578535|592943835|FG004|Overall Study|Lost to Follow-up|0|||
164158836|NCT04578535|592943836|FG005|Overall Study|Lost to Follow-up|2|||
164158837|NCT04578535|592943831|FG000|Overall Study|Pregnancy|1|||
164158838|NCT04578535|592943832|FG001|Overall Study|Pregnancy|0|||
164158839|NCT04578535|592943833|FG002|Overall Study|Pregnancy|0|||
164158840|NCT04578535|592943834|FG003|Overall Study|Pregnancy|0|||
164158841|NCT04578535|592943835|FG004|Overall Study|Pregnancy|0|||
164158842|NCT04578535|592943836|FG005|Overall Study|Pregnancy|0|||
164158843|NCT04578535|592943831|FG000|Overall Study|Withdrawal by Subject|0|||
164158844|NCT04578535|592943832|FG001|Overall Study|Withdrawal by Subject|0|||
164158845|NCT04578535|592943833|FG002|Overall Study|Withdrawal by Subject|0|||
164158846|NCT04578535|592943834|FG003|Overall Study|Withdrawal by Subject|1|||
164158847|NCT04578535|592943835|FG004|Overall Study|Withdrawal by Subject|1|||
164158848|NCT04578535|592943836|FG005|Overall Study|Withdrawal by Subject|5|||
164158849|NCT04578535|592943831|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
164158850|NCT04578535|592943832|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
164158851|NCT04578535|592943833|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
164158852|NCT04578535|592943834|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
164158853|NCT04578535|592943835|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
164158854|NCT04578535|592943836|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
164158855|NCT00380874|592943837|FG000|Overall Study|Adverse Event|7|||
164158856|NCT00380874|592943838|FG001|Overall Study|Adverse Event|7|||
164158857|NCT00380874|592943837|FG000|Overall Study|Death|1|||
164158858|NCT00380874|592943838|FG001|Overall Study|Death|0|||
164158859|NCT00380874|592943837|FG000|Overall Study|Withdrawal by Subject|2|||
164158860|NCT00380874|592943838|FG001|Overall Study|Withdrawal by Subject|1|||
164158861|NCT00380874|592943837|FG000|Overall Study|Not related to study drug|3|||
164158862|NCT00380874|592943838|FG001|Overall Study|Not related to study drug|2|||
164158863|NCT03380429|592943839|FG000|Overall Study|Physician Decision|0|||
164158864|NCT03380429|592943840|FG001|Overall Study|Physician Decision|1|||
164158865|NCT03380429|592943841|FG002|Overall Study|Physician Decision|0|||
164158866|NCT03380429|592943842|FG003|Overall Study|Physician Decision|1|||
164158867|NCT03380429|592943843|FG004|Overall Study|Physician Decision|1|||
164158868|NCT03380429|592943839|FG000|Overall Study|Withdrawal by Subject|3|||
164158869|NCT03380429|592943840|FG001|Overall Study|Withdrawal by Subject|3|||
164158870|NCT03380429|592943841|FG002|Overall Study|Withdrawal by Subject|5|||
164158871|NCT03380429|592943842|FG003|Overall Study|Withdrawal by Subject|2|||
164158872|NCT03380429|592943843|FG004|Overall Study|Withdrawal by Subject|1|||
164158873|NCT03380429|592943839|FG000|Overall Study|Lost to Follow-up|0|||
164158874|NCT03380429|592943840|FG001|Overall Study|Lost to Follow-up|2|||
164158875|NCT03380429|592943841|FG002|Overall Study|Lost to Follow-up|4|||
164158876|NCT03380429|592943842|FG003|Overall Study|Lost to Follow-up|3|||
164158877|NCT03380429|592943843|FG004|Overall Study|Lost to Follow-up|1|||
164158878|NCT03380429|592943839|FG000|Overall Study|Protocol Violation|1|||
164158879|NCT03380429|592943840|FG001|Overall Study|Protocol Violation|0|||
164158880|NCT03380429|592943841|FG002|Overall Study|Protocol Violation|1|||
164158881|NCT03380429|592943842|FG003|Overall Study|Protocol Violation|0|||
164158882|NCT03380429|592943843|FG004|Overall Study|Protocol Violation|1|||
164158883|NCT03380429|592943839|FG000|Overall Study|Lack of Efficacy|0|||
164158884|NCT03380429|592943840|FG001|Overall Study|Lack of Efficacy|0|||
164158885|NCT03380429|592943841|FG002|Overall Study|Lack of Efficacy|0|||
164158886|NCT03380429|592943842|FG003|Overall Study|Lack of Efficacy|2|||
164158887|NCT03380429|592943843|FG004|Overall Study|Lack of Efficacy|1|||
164158888|NCT03380429|592943839|FG000|Overall Study|Adverse Event|1|||
164158889|NCT03380429|592943840|FG001|Overall Study|Adverse Event|1|||
164158890|NCT03380429|592943841|FG002|Overall Study|Adverse Event|1|||
164158891|NCT03380429|592943842|FG003|Overall Study|Adverse Event|2|||
164158892|NCT03380429|592943843|FG004|Overall Study|Adverse Event|0|||
164158893|NCT01707290|592943848|FG000|Overall Study|Adverse event (AE)|1|||
164158894|NCT01707290|592943849|FG001|Overall Study|Adverse event (AE)|0|||
164158895|NCT01707290|592943848|FG000|Overall Study|Physician Decision|1|||
164158896|NCT01707290|592943849|FG001|Overall Study|Physician Decision|0|||
164158897|NCT01707290|592943848|FG000|Overall Study|Lost to Follow-up|3|||
164158898|NCT01707290|592943849|FG001|Overall Study|Lost to Follow-up|0|||
164158899|NCT01707290|592943848|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
164158900|NCT01707290|592943849|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
164158901|NCT01707290|592943848|FG000|Overall Study|Commercial drug available|60|||
164158902|NCT01707290|592943849|FG001|Overall Study|Commercial drug available|1|||
164158903|NCT01707290|592943848|FG000|Overall Study|Other unspecified|17|||
164158904|NCT01707290|592943849|FG001|Overall Study|Other unspecified|0|||
164158905|NCT02314026|592943850|FG000|Overall Study|Protocol Violation|28|||
164158906|NCT01139775|592943851|FG000|Overall Study|Adverse Event|0|||
164158907|NCT01139775|592943852|FG001|Overall Study|Adverse Event|6|||
164158908|NCT01139775|592943853|FG002|Overall Study|Adverse Event|2|||
164158909|NCT01139775|592943851|FG000|Overall Study|Protocol Violation|0|||
164158910|NCT01139775|592943852|FG001|Overall Study|Protocol Violation|5|||
164158911|NCT01139775|592943853|FG002|Overall Study|Protocol Violation|0|||
164158912|NCT01139775|592943851|FG000|Overall Study|Withdrawal by Subject|1|||
164158913|NCT01139775|592943852|FG001|Overall Study|Withdrawal by Subject|0|||
164158914|NCT01139775|592943853|FG002|Overall Study|Withdrawal by Subject|2|||
164158915|NCT01139775|592943851|FG000|Overall Study|Physician Decision|0|||
164158916|NCT01139775|592943852|FG001|Overall Study|Physician Decision|2|||
164158917|NCT01139775|592943853|FG002|Overall Study|Physician Decision|2|||
164158918|NCT01882985|592943856|FG000|Overall Study|Lost to Follow-up|1|||
164158919|NCT01882985|592943856|FG000|Overall Study|Withdrawal by Subject|1|||
164158920|NCT03193853|592943863|FG000|Overall Study|Death|6|||
164158921|NCT04129125|592943864|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
164158922|NCT04129125|592943864|FG000|Overall Study|Study device was not used|3|||
164158923|NCT00740636|592943871|FG000|Overall Study|Adverse Event|0|||
164158924|NCT00740636|592943872|FG001|Overall Study|Adverse Event|2|||
164158925|NCT00740636|592943871|FG000|Overall Study|Patient Ineligible|0|||
164158926|NCT00740636|592943872|FG001|Overall Study|Patient Ineligible|1|||
164158927|NCT00740636|592943871|FG000|Overall Study|Patient Not Treated|0|||
164158928|NCT00740636|592943872|FG001|Overall Study|Patient Not Treated|1|||
164158929|NCT00740636|592943871|FG000|Overall Study|Progressive Disease|1|||
164158930|NCT00740636|592943872|FG001|Overall Study|Progressive Disease|0|||
164158931|NCT00740636|592943871|FG000|Overall Study|Death|1|||
164158932|NCT00740636|592943872|FG001|Overall Study|Death|0|||
164158933|NCT02174627|592943877|FG000|Overall Study|Missing|0|||
164158934|NCT02174627|592943878|FG001|Overall Study|Missing|1|||
164158935|NCT02174627|592943877|FG000|Overall Study|Incorrect enrolment before randomization|0|||
164158936|NCT02174627|592943878|FG001|Overall Study|Incorrect enrolment before randomization|1|||
164158937|NCT02174627|592943877|FG000|Overall Study|Participant decision|84|||
164158938|NCT02174627|592943878|FG001|Overall Study|Participant decision|128|||
164158939|NCT02166333|592943879|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
164158940|NCT02166333|592943880|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
164158941|NCT02166333|592943881|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
164158942|NCT02166333|592943882|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
164158943|NCT02166333|592943883|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
164158944|NCT02166333|592943884|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
164158945|NCT02166333|592943879|FG000|Stage 1|Death|4|||
164158946|NCT02166333|592943880|FG001|Stage 1|Death|0|||
164158947|NCT02166333|592943881|FG002|Stage 1|Death|2|||
164158948|NCT02166333|592943882|FG003|Stage 1|Death|0|||
164158949|NCT02166333|592943883|FG004|Stage 1|Death|3|||
164158950|NCT02166333|592943884|FG005|Stage 1|Death|2|||
164158951|NCT02166333|592943879|FG000|Stage 1|Lost to Follow-up|12|||
164158952|NCT02166333|592943880|FG001|Stage 1|Lost to Follow-up|0|||
164158953|NCT02166333|592943881|FG002|Stage 1|Lost to Follow-up|6|||
164158954|NCT02166333|592943882|FG003|Stage 1|Lost to Follow-up|0|||
164158955|NCT02166333|592943883|FG004|Stage 1|Lost to Follow-up|3|||
164158956|NCT02166333|592943884|FG005|Stage 1|Lost to Follow-up|3|||
164158957|NCT02166333|592943879|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
164158958|NCT02166333|592943880|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
164158959|NCT02166333|592943881|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
164159267|NCT02632409|592946228|FG001|Treatment Period|Death|0|||
164158960|NCT02166333|592943882|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
164158961|NCT02166333|592943883|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
164158962|NCT02166333|592943884|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
164158963|NCT02166333|592943879|FG000|Stage 2|Death|4|||
164158964|NCT02166333|592943880|FG001|Stage 2|Death|2|||
164158965|NCT02166333|592943881|FG002|Stage 2|Death|1|||
164158966|NCT02166333|592943882|FG003|Stage 2|Death|0|||
164158967|NCT02166333|592943883|FG004|Stage 2|Death|0|||
164158968|NCT02166333|592943884|FG005|Stage 2|Death|1|||
164158969|NCT02166333|592943879|FG000|Stage 2|Lost to Follow-up|23|||
164158970|NCT02166333|592943880|FG001|Stage 2|Lost to Follow-up|4|||
164158971|NCT02166333|592943881|FG002|Stage 2|Lost to Follow-up|11|||
164158972|NCT02166333|592943882|FG003|Stage 2|Lost to Follow-up|9|||
164158973|NCT02166333|592943883|FG004|Stage 2|Lost to Follow-up|3|||
164158974|NCT02166333|592943884|FG005|Stage 2|Lost to Follow-up|6|||
164158975|NCT02269098|592943885|FG000|Overall Study|Lost to Follow-up|14|||
164158976|NCT02269098|592943886|FG001|Overall Study|Lost to Follow-up|9|||
164158977|NCT00503698|592943887|FG000|Overall Study|Protocol Violation|5|||
164158978|NCT00503698|592943888|FG001|Overall Study|Protocol Violation|6|||
164158979|NCT00503698|592943887|FG000|Overall Study|Adverse Event|52|||
164158980|NCT00503698|592943888|FG001|Overall Study|Adverse Event|41|||
164158981|NCT00503698|592943887|FG000|Overall Study|Death|1|||
164158982|NCT00503698|592943888|FG001|Overall Study|Death|0|||
164158983|NCT00503698|592943887|FG000|Overall Study|Lack of Efficacy|3|||
164158984|NCT00503698|592943888|FG001|Overall Study|Lack of Efficacy|4|||
164158985|NCT00503698|592943887|FG000|Overall Study|Trial terminated|216|||
164158986|NCT00503698|592943888|FG001|Overall Study|Trial terminated|253|||
164158987|NCT00503698|592943887|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
164158988|NCT00503698|592943888|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
164158989|NCT00503698|592943887|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
164158990|NCT00503698|592943888|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
164158991|NCT00503698|592943887|FG000|Overall Study|Any condition in exclusion criteria|4|||
164158992|NCT00503698|592943888|FG001|Overall Study|Any condition in exclusion criteria|6|||
164158993|NCT00503698|592943887|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
164158994|NCT00503698|592943888|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
164158995|NCT00503698|592943887|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
164158996|NCT00503698|592943888|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
164158997|NCT00503698|592943887|FG000|Overall Study|Critically ill|2|||
164158998|NCT00503698|592943888|FG001|Overall Study|Critically ill|0|||
164158999|NCT00503698|592943887|FG000|Overall Study|Unclassified|48|||
164159000|NCT00503698|592943888|FG001|Overall Study|Unclassified|32|||
164159001|NCT00503698|592943887|FG000|Overall Study|Not exposed to trial drug|11|||
164159002|NCT00503698|592943888|FG001|Overall Study|Not exposed to trial drug|6|||
164159003|NCT00682786|592943893|FG000|Overall Study|Withdrawal by Subject|2|||
164159004|NCT00682786|592943894|FG001|Overall Study|Withdrawal by Subject|2|||
164159005|NCT00682786|592943893|FG000|Overall Study|Did not receive irinotecan|0|||
164159006|NCT00682786|592943894|FG001|Overall Study|Did not receive irinotecan|1|||
164159007|NCT03644342|592943895|FG000|Overall Study|Adverse Event|2|||
164159008|NCT03644342|592943896|FG001|Overall Study|Adverse Event|0|||
164159009|NCT03644342|592943895|FG000|Overall Study|Protocol Violation|0|||
164159010|NCT03644342|592943896|FG001|Overall Study|Protocol Violation|1|||
164159011|NCT02462603|592943899|FG000|Overall Study|Investigator Decision|1|||
164159012|NCT02462603|592943899|FG000|Overall Study|Non-Compliance|1|||
164159013|NCT02462603|592943899|FG000|Overall Study|Withdrawal by Subject|2|||
164159014|NCT01831635|592943900|FG000|Overall Study|Withdrawal by Subject|0|||
164159015|NCT01831635|592943901|FG001|Overall Study|Withdrawal by Subject|2|||
164159016|NCT01831635|592943902|FG002|Overall Study|Withdrawal by Subject|0|||
164159017|NCT01991743|592943905|FG000|Overall Study|external cephalic version not performed|0|||
164159018|NCT01991743|592943906|FG001|Overall Study|external cephalic version not performed|0|||
164159019|NCT01991743|592943907|FG002|Overall Study|external cephalic version not performed|1|||
164159020|NCT01991743|592943908|FG003|Overall Study|external cephalic version not performed|0|||
164159021|NCT05271370|592946128|FG000|Overall Study|Study early termination|8|||
164159022|NCT05271370|592946129|FG001|Overall Study|Study early termination|16|||
164159023|NCT05271370|592946130|FG002|Overall Study|Study early termination|29|||
164159024|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
164159025|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
164159026|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
164159027|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
164159028|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
164159029|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
164159030|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Death|0|||
164159031|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Death|0|||
164159032|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Death|0|||
164159033|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Death|0|||
164159034|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Death|0|||
164159035|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Death|2|||
164159036|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159037|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159038|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159039|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159040|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
164159041|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
164159042|NCT04066244|592946142|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159043|NCT04066244|592946143|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159044|NCT04066244|592946144|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159045|NCT04066244|592946145|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159046|NCT04066244|592946146|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
164159047|NCT04066244|592946147|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
164159048|NCT00866281|592946148|FG000|Overall Study|Adverse Event|1|||
164159049|NCT00866281|592946149|FG001|Overall Study|Adverse Event|0|||
164159050|NCT00866281|592946148|FG000|Overall Study|Withdrawal by participants|3|||
164159051|NCT00866281|592946149|FG001|Overall Study|Withdrawal by participants|0|||
164159052|NCT00866281|592946148|FG000|Overall Study|Disease progression|3|||
164159053|NCT00866281|592946149|FG001|Overall Study|Disease progression|11|||
164159054|NCT00866281|592946148|FG000|Overall Study|New cancer therapy|0|||
164159055|NCT00866281|592946149|FG001|Overall Study|New cancer therapy|4|||
164159056|NCT00529087|592946152|FG000|Overall Study|Adverse Event|10|||
164159057|NCT00529087|592946153|FG001|Overall Study|Adverse Event|13|||
164159058|NCT00529087|592946154|FG002|Overall Study|Adverse Event|4|||
164159059|NCT00529087|592946152|FG000|Overall Study|Lost to Follow-up|6|||
164159060|NCT00529087|592946153|FG001|Overall Study|Lost to Follow-up|4|||
164159061|NCT00529087|592946154|FG002|Overall Study|Lost to Follow-up|1|||
164159062|NCT00529087|592946152|FG000|Overall Study|Protocol Violation|8|||
164159063|NCT00529087|592946153|FG001|Overall Study|Protocol Violation|7|||
164159064|NCT00529087|592946154|FG002|Overall Study|Protocol Violation|6|||
164159065|NCT00529087|592946152|FG000|Overall Study|Withdrawal by Subject|3|||
164159066|NCT00529087|592946153|FG001|Overall Study|Withdrawal by Subject|3|||
164159067|NCT00529087|592946154|FG002|Overall Study|Withdrawal by Subject|3|||
164159068|NCT00529087|592946152|FG000|Overall Study|Protocol deviation|1|||
164159069|NCT00529087|592946153|FG001|Overall Study|Protocol deviation|1|||
164159070|NCT00529087|592946154|FG002|Overall Study|Protocol deviation|2|||
164159071|NCT02283268|592946157|FG000|Overall Study|Withdrawal by Subject|1|||
164159072|NCT00333983|592946158|FG000|Overall Study|Lost to Follow-up|2|||
164159073|NCT00333983|592946159|FG001|Overall Study|Lost to Follow-up|1|||
164159074|NCT00333983|592946160|FG002|Overall Study|Lost to Follow-up|0|||
164159075|NCT00333983|592946158|FG000|Overall Study|Adverse Event|1|||
164159076|NCT00333983|592946159|FG001|Overall Study|Adverse Event|1|||
164159077|NCT00333983|592946160|FG002|Overall Study|Adverse Event|1|||
164159078|NCT00333983|592946158|FG000|Overall Study|Withdrawal by Subject|0|||
164159079|NCT00333983|592946159|FG001|Overall Study|Withdrawal by Subject|3|||
164159080|NCT00333983|592946160|FG002|Overall Study|Withdrawal by Subject|1|||
164159081|NCT03656068|592946161|FG000|Overall Study|Withdrawal by Subject|4|||
164159082|NCT03656068|592946161|FG000|Overall Study|Adverse Event|1|||
164159083|NCT01436370|592946162|FG000|Overall Study|Lost to Follow-up|0|||
164159084|NCT01436370|592946163|FG001|Overall Study|Lost to Follow-up|0|||
164159085|NCT01436370|592946164|FG002|Overall Study|Lost to Follow-up|0|||
164159086|NCT01436370|592946165|FG003|Overall Study|Lost to Follow-up|0|||
164159087|NCT01436370|592946166|FG004|Overall Study|Lost to Follow-up|1|||
164159088|NCT01436370|592946167|FG005|Overall Study|Lost to Follow-up|0|||
164159089|NCT01436370|592946168|FG006|Overall Study|Lost to Follow-up|0|||
164159090|NCT01436370|592946169|FG007|Overall Study|Lost to Follow-up|0|||
164159091|NCT02770170|592946170|FG000|Overall Study|Withdrawal by Subject|0|||
164159092|NCT02770170|592946171|FG001|Overall Study|Withdrawal by Subject|0|||
164159093|NCT02770170|592946172|FG002|Overall Study|Withdrawal by Subject|0|||
164159094|NCT02770170|592946173|FG003|Overall Study|Withdrawal by Subject|2|||
164159095|NCT02770170|592946170|FG000|Overall Study|due to pregnancy|1|||
164159096|NCT02770170|592946171|FG001|Overall Study|due to pregnancy|0|||
164159097|NCT02770170|592946172|FG002|Overall Study|due to pregnancy|0|||
164159098|NCT02770170|592946173|FG003|Overall Study|due to pregnancy|0|||
164159099|NCT02770170|592946170|FG000|Overall Study|Lack of Efficacy|2|||
164159100|NCT02770170|592946171|FG001|Overall Study|Lack of Efficacy|0|||
164159101|NCT02770170|592946172|FG002|Overall Study|Lack of Efficacy|0|||
164159102|NCT02770170|592946173|FG003|Overall Study|Lack of Efficacy|1|||
164159103|NCT02770170|592946170|FG000|Overall Study|Adverse Event|4|||
164159104|NCT02770170|592946171|FG001|Overall Study|Adverse Event|3|||
164159105|NCT02770170|592946172|FG002|Overall Study|Adverse Event|5|||
164159106|NCT02770170|592946173|FG003|Overall Study|Adverse Event|3|||
164159107|NCT02770170|592946170|FG000|Overall Study|due to disease worsening|0|||
164159108|NCT02770170|592946171|FG001|Overall Study|due to disease worsening|0|||
164159109|NCT02770170|592946172|FG002|Overall Study|due to disease worsening|0|||
164159110|NCT02770170|592946173|FG003|Overall Study|due to disease worsening|1|||
164159111|NCT03270657|592946174|FG000|Overall Study|Withdrawal by Subject|1|||
164159112|NCT00162981|592946175|FG000|Overall Study|Adverse Event|2|||
164159113|NCT00162981|592946176|FG001|Overall Study|Adverse Event|5|||
164159114|NCT00162981|592946175|FG000|Overall Study|Withdrawal by Subject|1|||
164159115|NCT00162981|592946176|FG001|Overall Study|Withdrawal by Subject|1|||
164159116|NCT00162981|592946175|FG000|Overall Study|Physician Decision|1|||
164159117|NCT00162981|592946176|FG001|Overall Study|Physician Decision|0|||
164159118|NCT00171210|592946177|FG000|Overall Study|Adverse Event|16|||
164159119|NCT00171210|592946178|FG001|Overall Study|Adverse Event|27|||
164159120|NCT00171210|592946177|FG000|Overall Study|Abnormal laboratory value(s)|6|||
164159121|NCT00171210|592946178|FG001|Overall Study|Abnormal laboratory value(s)|3|||
164159122|NCT00171210|592946177|FG000|Overall Study|Abnormal test procedure result(s)|0|||
164159123|NCT00171210|592946178|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164159124|NCT00171210|592946177|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
164159125|NCT00171210|592946178|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
164159126|NCT00171210|592946177|FG000|Overall Study|Protocol Violation|0|||
164159127|NCT00171210|592946178|FG001|Overall Study|Protocol Violation|2|||
164159128|NCT00171210|592946177|FG000|Overall Study|Withdrawal by Subject|32|||
164159129|NCT00171210|592946178|FG001|Overall Study|Withdrawal by Subject|30|||
164159130|NCT00171210|592946177|FG000|Overall Study|Lost to Follow-up|1|||
164159131|NCT00171210|592946178|FG001|Overall Study|Lost to Follow-up|0|||
164159132|NCT00171210|592946177|FG000|Overall Study|Administrative problems|1|||
164159133|NCT00171210|592946178|FG001|Overall Study|Administrative problems|1|||
164159134|NCT00171210|592946177|FG000|Overall Study|Death|2|||
164159135|NCT00171210|592946178|FG001|Overall Study|Death|3|||
164159136|NCT00171210|592946177|FG000|Overall Study|Stopped at end of core|0|||
164159137|NCT00171210|592946178|FG001|Overall Study|Stopped at end of core|32|||
164159138|NCT00171210|592946177|FG000|Overall Study|Stopped at end of extension 1|0|||
164159139|NCT00171210|592946178|FG001|Overall Study|Stopped at end of extension 1|1|||
164159140|NCT03187301|592946181|FG000|Titration Period|Adverse Event|0|||
164159141|NCT03187301|592946182|FG001|Titration Period|Adverse Event|0|||
164159142|NCT03187301|592946183|FG002|Titration Period|Adverse Event|0|||
164159143|NCT03187301|592946184|FG003|Titration Period|Adverse Event|0|||
164159144|NCT03187301|592946185|FG004|Titration Period|Adverse Event|0|||
164159145|NCT03187301|592946186|FG005|Titration Period|Adverse Event|0|||
164159146|NCT03187301|592946187|FG006|Titration Period|Adverse Event|5|||
164159147|NCT03187301|592946181|FG000|Titration Period|Withdrawal by Subject|0|||
164159148|NCT03187301|592946182|FG001|Titration Period|Withdrawal by Subject|0|||
164159149|NCT03187301|592946183|FG002|Titration Period|Withdrawal by Subject|0|||
164159150|NCT03187301|592946184|FG003|Titration Period|Withdrawal by Subject|0|||
164159151|NCT03187301|592946185|FG004|Titration Period|Withdrawal by Subject|0|||
164159152|NCT03187301|592946186|FG005|Titration Period|Withdrawal by Subject|0|||
164159153|NCT03187301|592946187|FG006|Titration Period|Withdrawal by Subject|1|||
164159154|NCT03187301|592946181|FG000|Titration Period|Exclusion Criteria Met|0|||
164159155|NCT03187301|592946182|FG001|Titration Period|Exclusion Criteria Met|0|||
164159156|NCT03187301|592946183|FG002|Titration Period|Exclusion Criteria Met|0|||
164159157|NCT03187301|592946184|FG003|Titration Period|Exclusion Criteria Met|0|||
164159158|NCT03187301|592946185|FG004|Titration Period|Exclusion Criteria Met|0|||
164159159|NCT03187301|592946186|FG005|Titration Period|Exclusion Criteria Met|0|||
164159160|NCT03187301|592946187|FG006|Titration Period|Exclusion Criteria Met|1|||
164159161|NCT03187301|592946181|FG000|Pre-Intervention|Withdrawal by Subject|1|||
164159162|NCT03187301|592946182|FG001|Pre-Intervention|Withdrawal by Subject|0|||
164159163|NCT03187301|592946183|FG002|Pre-Intervention|Withdrawal by Subject|0|||
164159164|NCT03187301|592946184|FG003|Pre-Intervention|Withdrawal by Subject|0|||
164159165|NCT03187301|592946185|FG004|Pre-Intervention|Withdrawal by Subject|0|||
164159166|NCT03187301|592946186|FG005|Pre-Intervention|Withdrawal by Subject|0|||
164159167|NCT03187301|592946187|FG006|Pre-Intervention|Withdrawal by Subject|0|||
164159168|NCT01966120|592946193|FG000|Overall Study|Withdrawal by Subject|0|||
164159169|NCT01966120|592946194|FG001|Overall Study|Withdrawal by Subject|5|||
164159170|NCT01966120|592946193|FG000|Overall Study|Lost to Follow-up|1|||
164159171|NCT01966120|592946194|FG001|Overall Study|Lost to Follow-up|1|||
164159172|NCT00461630|592946195|FG000|Overall Study|Death|798|||
164159173|NCT00461630|592946196|FG001|Overall Study|Death|732|||
164159174|NCT00461630|592946195|FG000|Overall Study|Lost to Follow-up|108|||
164159175|NCT00461630|592946196|FG001|Overall Study|Lost to Follow-up|95|||
164159176|NCT03309943|592946200|FG000|Overall Study|Withdrawal by Subject|0|||
164159177|NCT03309943|592946201|FG001|Overall Study|Withdrawal by Subject|1|||
164159178|NCT03309943|592946200|FG000|Overall Study|Inappropriate behavior towards staff|0|||
164159179|NCT03309943|592946201|FG001|Overall Study|Inappropriate behavior towards staff|1|||
164159180|NCT03123393|592946202|FG000|Overall Study|Study Terminated by Sponsor|6|||
164159181|NCT03123393|592946203|FG001|Overall Study|Study Terminated by Sponsor|9|||
164159182|NCT03123393|592946202|FG000|Overall Study|Withdrawal by Subject|2|||
164159183|NCT03123393|592946203|FG001|Overall Study|Withdrawal by Subject|1|||
164159184|NCT03123393|592946202|FG000|Overall Study|Reason not Specified|13|||
164159185|NCT03123393|592946203|FG001|Overall Study|Reason not Specified|13|||
164159186|NCT01609296|592946205|FG000|Overall Study|Death|253|||
164159187|NCT01609296|592946205|FG000|Overall Study|Withdrawal by Subject|151|||
164159188|NCT01609296|592946205|FG000|Overall Study|Lost to Follow-up|21|||
164159189|NCT01609296|592946205|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
164159190|NCT01609296|592946205|FG000|Overall Study|missed visit but known to be alive|28|||
164159191|NCT02230904|592946208|FG000|Overall Study|Safety follow up could not take place|0|||
164159192|NCT02230904|592946209|FG001|Overall Study|Safety follow up could not take place|1|||
164159193|NCT01464333|592946213|FG000|Overall Study|Adverse Event|34|||
164159194|NCT01464333|592946213|FG000|Overall Study|Lack of Efficacy|72|||
164159195|NCT01464333|592946213|FG000|Overall Study|Withdrawal by Subject|11|||
164159196|NCT01464333|592946213|FG000|Overall Study|Other|4|||
164159197|NCT01464333|592946213|FG000|Overall Study|No Hospital Visit|42|||
164159198|NCT05047211|592946217|FG000|Overall Study|Lost to Follow-up|8|||
164159199|NCT05047211|592946218|FG001|Overall Study|Lost to Follow-up|5|||
164159200|NCT00561392|592946219|FG000|Overall Study|Adverse Event|38|||
164159201|NCT00561392|592946219|FG000|Overall Study|Lack of Efficacy|2|||
164159202|NCT00561392|592946219|FG000|Overall Study|Protocol Violation|1|||
164159203|NCT00561392|592946219|FG000|Overall Study|Withdrawal by Subject|8|||
164159204|NCT00561392|592946219|FG000|Overall Study|Administrative problems|4|||
164159205|NCT03321968|592946220|FG000|Overall Study|Withdrawal by Subject|1|||
164159206|NCT03321968|592946221|FG001|Overall Study|Withdrawal by Subject|2|||
164159207|NCT03321968|592946222|FG002|Overall Study|Withdrawal by Subject|1|||
164159208|NCT03321968|592946220|FG000|Overall Study|Lost to Follow-up|2|||
164159209|NCT03321968|592946221|FG001|Overall Study|Lost to Follow-up|0|||
164159210|NCT03321968|592946222|FG002|Overall Study|Lost to Follow-up|1|||
164159211|NCT03321968|592946220|FG000|Overall Study|Other than specified|0|||
164159212|NCT03321968|592946221|FG001|Overall Study|Other than specified|0|||
164159213|NCT03321968|592946222|FG002|Overall Study|Other than specified|1|||
164159214|NCT03822468|592946223|FG000|Treatment Period|Progressive disease|98|||
164159215|NCT03822468|592946224|FG001|Treatment Period|Progressive disease|94|||
164159216|NCT03822468|592946223|FG000|Treatment Period|Adverse Event|21|||
164159217|NCT03822468|592946224|FG001|Treatment Period|Adverse Event|24|||
164159218|NCT03822468|592946223|FG000|Treatment Period|Withdrawal by Subject|9|||
164159219|NCT03822468|592946224|FG001|Treatment Period|Withdrawal by Subject|5|||
164159220|NCT03822468|592946223|FG000|Treatment Period|Physician Decision|9|||
164159221|NCT03822468|592946224|FG001|Treatment Period|Physician Decision|7|||
164159222|NCT03822468|592946223|FG000|Treatment Period|Protocol Violation|2|||
164159223|NCT03822468|592946224|FG001|Treatment Period|Protocol Violation|1|||
164159224|NCT03822468|592946223|FG000|Treatment Period|Death|2|||
164159225|NCT03822468|592946224|FG001|Treatment Period|Death|3|||
164159226|NCT03822468|592946223|FG000|Treatment Period|Lost to Follow-up|1|||
164159227|NCT03822468|592946224|FG001|Treatment Period|Lost to Follow-up|1|||
164159228|NCT03822468|592946223|FG000|Treatment Period|Sponsor decision|46|||
164159229|NCT03822468|592946224|FG001|Treatment Period|Sponsor decision|53|||
164159230|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
164159231|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
164159232|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
164159233|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
164159234|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Death|1|||
164159235|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Death|0|||
164159236|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164159237|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
164159238|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
164159239|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
164159240|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
164159241|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
164159242|NCT03822468|592946223|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
164159243|NCT03822468|592946224|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
164159244|NCT02198664|592946225|FG000|Overall Study|Adverse Event|2|||
164159245|NCT02198664|592946226|FG001|Overall Study|Adverse Event|0|||
164159246|NCT02198664|592946225|FG000|Overall Study|Withdrawal by Subject|11|||
164159247|NCT02198664|592946226|FG001|Overall Study|Withdrawal by Subject|8|||
164159248|NCT02198664|592946225|FG000|Overall Study|Failure to tolerate|2|||
164159249|NCT02198664|592946226|FG001|Overall Study|Failure to tolerate|0|||
164159250|NCT02198664|592946225|FG000|Overall Study|Not stated|1|||
164159251|NCT02198664|592946226|FG001|Overall Study|Not stated|0|||
164159252|NCT02632409|592946227|FG000|Randomized|AE unrelated to study Drug|0|||
164159253|NCT02632409|592946228|FG001|Randomized|AE unrelated to study Drug|1|||
164159254|NCT02632409|592946227|FG000|Randomized|Participant withdrew consent|2|||
164159255|NCT02632409|592946228|FG001|Randomized|Participant withdrew consent|1|||
164159256|NCT02632409|592946227|FG000|Randomized|No Longer meets study criteria|5|||
164159257|NCT02632409|592946228|FG001|Randomized|No Longer meets study criteria|0|||
164159258|NCT02632409|592946227|FG000|Randomized|other reasons|1|||
164159259|NCT02632409|592946228|FG001|Randomized|other reasons|0|||
164159260|NCT02632409|592946227|FG000|Treatment Period|Ongoing Treatment|20|||
164159261|NCT02632409|592946228|FG001|Treatment Period|Ongoing Treatment|21|||
164159262|NCT02632409|592946227|FG000|Treatment Period|Disease Recurrence|147|||
164159263|NCT02632409|592946228|FG001|Treatment Period|Disease Recurrence|90|||
164159264|NCT02632409|592946227|FG000|Treatment Period|Study Drug Toxicity|8|||
164159265|NCT02632409|592946228|FG001|Treatment Period|Study Drug Toxicity|49|||
164159266|NCT02632409|592946227|FG000|Treatment Period|Death|1|||
164159268|NCT02632409|592946227|FG000|Treatment Period|AE unrelated to study drug|15|||
164159269|NCT02632409|592946228|FG001|Treatment Period|AE unrelated to study drug|16|||
164159270|NCT02632409|592946227|FG000|Treatment Period|Request to discontinue treatment|4|||
164159271|NCT02632409|592946228|FG001|Treatment Period|Request to discontinue treatment|19|||
164159272|NCT02632409|592946227|FG000|Treatment Period|Participant withdrew consent|7|||
164159273|NCT02632409|592946228|FG001|Treatment Period|Participant withdrew consent|5|||
164159274|NCT02632409|592946227|FG000|Treatment Period|Lost to Follow-up|0|||
164159275|NCT02632409|592946228|FG001|Treatment Period|Lost to Follow-up|1|||
164159276|NCT02632409|592946227|FG000|Treatment Period|Maximum clinical benefit|1|||
164159277|NCT02632409|592946228|FG001|Treatment Period|Maximum clinical benefit|0|||
164159278|NCT02632409|592946227|FG000|Treatment Period|No longer meets study criteria|3|||
164159279|NCT02632409|592946228|FG001|Treatment Period|No longer meets study criteria|0|||
164159280|NCT02632409|592946227|FG000|Treatment Period|Administrative Reason by sponsor|0|||
164159281|NCT02632409|592946228|FG001|Treatment Period|Administrative Reason by sponsor|1|||
164159282|NCT02632409|592946227|FG000|Treatment Period|Other Reasons|10|||
164159283|NCT02632409|592946228|FG001|Treatment Period|Other Reasons|6|||
164159284|NCT04426006|592946229|FG000|Inclusion|Protocol Violation|1|||
164159285|NCT04426006|592946229|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
164159286|NCT04426006|592946229|FG000|Inclusion|Blood sample at inclusion not done|1|||
164159287|NCT04426006|592946229|FG000|3 Months|Lost to Follow-up|17|||
164159288|NCT04426006|592946229|FG000|12 Months|Lost to Follow-up|38|||
164159289|NCT01262872|592946232|FG000|Step 2|Death|0|||
164159290|NCT01262872|592946233|FG001|Step 2|Death|0|||
164159291|NCT01262872|592946234|FG002|Step 2|Death|0|||
164159292|NCT01262872|592946235|FG003|Step 2|Death|1|||
164159293|NCT01262872|592946236|FG004|Step 2|Death|0|||
164159294|NCT01262872|592946237|FG005|Step 2|Death|2|||
164159295|NCT01262872|592946238|FG006|Step 2|Death|2|||
164159296|NCT01262872|592946239|FG007|Step 2|Death|1|||
164159297|NCT01262872|592946232|FG000|Step 2|Protocol Violation|0|||
164159298|NCT01262872|592946233|FG001|Step 2|Protocol Violation|0|||
164159299|NCT01262872|592946234|FG002|Step 2|Protocol Violation|1|||
164159300|NCT01262872|592946235|FG003|Step 2|Protocol Violation|0|||
164159301|NCT01262872|592946236|FG004|Step 2|Protocol Violation|0|||
164159302|NCT01262872|592946237|FG005|Step 2|Protocol Violation|0|||
164159303|NCT01262872|592946238|FG006|Step 2|Protocol Violation|3|||
164159304|NCT01262872|592946239|FG007|Step 2|Protocol Violation|1|||
164159305|NCT01262872|592946232|FG000|Step 2|Withdrawal by Subject|0|||
164159306|NCT01262872|592946233|FG001|Step 2|Withdrawal by Subject|0|||
164159307|NCT01262872|592946234|FG002|Step 2|Withdrawal by Subject|4|||
164159308|NCT01262872|592946235|FG003|Step 2|Withdrawal by Subject|6|||
164159309|NCT01262872|592946236|FG004|Step 2|Withdrawal by Subject|3|||
164159310|NCT01262872|592946237|FG005|Step 2|Withdrawal by Subject|1|||
164159311|NCT01262872|592946238|FG006|Step 2|Withdrawal by Subject|2|||
164159312|NCT01262872|592946239|FG007|Step 2|Withdrawal by Subject|1|||
164159313|NCT01262872|592946232|FG000|Step 2|Migrated/moved from study area|0|||
164159314|NCT01262872|592946233|FG001|Step 2|Migrated/moved from study area|0|||
164159315|NCT01262872|592946234|FG002|Step 2|Migrated/moved from study area|4|||
164159316|NCT01262872|592946235|FG003|Step 2|Migrated/moved from study area|3|||
164159317|NCT01262872|592946236|FG004|Step 2|Migrated/moved from study area|2|||
164159318|NCT01262872|592946237|FG005|Step 2|Migrated/moved from study area|6|||
164159319|NCT01262872|592946238|FG006|Step 2|Migrated/moved from study area|2|||
164159320|NCT01262872|592946239|FG007|Step 2|Migrated/moved from study area|3|||
164159321|NCT01000155|592946242|FG000|Overall Study|Withdrawal by Subject|1|||
164159322|NCT01000155|592946242|FG000|Overall Study|Adverse Event|1|||
164159323|NCT00720213|592946245|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
164159324|NCT00720213|592946246|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
164159325|NCT00720213|592946247|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
164159326|NCT01198470|592946248|FG000|Overall Study|Adverse Event|2|||
164159327|NCT01924689|592946252|FG000|Overall Study|Death|0|||
164159328|NCT01924689|592946253|FG001|Overall Study|Death|1|||
164159329|NCT01924689|592946254|FG002|Overall Study|Death|0|||
164159330|NCT01924689|592946255|FG003|Overall Study|Death|1|||
164159331|NCT01924689|592946256|FG004|Overall Study|Death|0|||
164159332|NCT01924689|592946257|FG005|Overall Study|Death|0|||
164159333|NCT01924689|592946252|FG000|Overall Study|Disease progression|0|||
164159334|NCT01924689|592946253|FG001|Overall Study|Disease progression|0|||
164159335|NCT01924689|592946254|FG002|Overall Study|Disease progression|2|||
164159336|NCT01924689|592946255|FG003|Overall Study|Disease progression|0|||
164159337|NCT01924689|592946256|FG004|Overall Study|Disease progression|3|||
164159338|NCT01924689|592946257|FG005|Overall Study|Disease progression|2|||
164159339|NCT01924689|592946252|FG000|Overall Study|New therapy or study|3|||
164159340|NCT01924689|592946253|FG001|Overall Study|New therapy or study|2|||
164159341|NCT01924689|592946254|FG002|Overall Study|New therapy or study|1|||
164159342|NCT01924689|592946255|FG003|Overall Study|New therapy or study|4|||
164159343|NCT01924689|592946256|FG004|Overall Study|New therapy or study|2|||
164159344|NCT01924689|592946257|FG005|Overall Study|New therapy or study|0|||
164159345|NCT01924689|592946252|FG000|Overall Study|Withdrawal of consent|0|||
164159346|NCT01924689|592946253|FG001|Overall Study|Withdrawal of consent|0|||
164159347|NCT01924689|592946254|FG002|Overall Study|Withdrawal of consent|1|||
164159348|NCT01924689|592946255|FG003|Overall Study|Withdrawal of consent|1|||
164159349|NCT01924689|592946256|FG004|Overall Study|Withdrawal of consent|0|||
164159350|NCT01924689|592946257|FG005|Overall Study|Withdrawal of consent|0|||
164159351|NCT01924689|592946252|FG000|Overall Study|Other|0|||
164159352|NCT01924689|592946253|FG001|Overall Study|Other|0|||
164159353|NCT01924689|592946254|FG002|Overall Study|Other|0|||
164159354|NCT01924689|592946255|FG003|Overall Study|Other|0|||
164159355|NCT01924689|592946256|FG004|Overall Study|Other|1|||
164159356|NCT01924689|592946257|FG005|Overall Study|Other|0|||
164159357|NCT05271175|592946258|FG000|One Week Follow up|Lost to Follow-up|10|||
164159358|NCT05271175|592946259|FG001|One Week Follow up|Lost to Follow-up|7|||
164159359|NCT05271175|592946260|FG002|One Week Follow up|Lost to Follow-up|5|||
164159360|NCT05271175|592946258|FG000|One Month Follow up|Lost to Follow-up|12|||
164159361|NCT05271175|592946259|FG001|One Month Follow up|Lost to Follow-up|7|||
164159362|NCT05271175|592946260|FG002|One Month Follow up|Lost to Follow-up|9|||
164159363|NCT05271175|592946258|FG000|Six Months Follow up|Lost to Follow-up|8|||
164159364|NCT05271175|592946259|FG001|Six Months Follow up|Lost to Follow-up|2|||
164159365|NCT05271175|592946260|FG002|Six Months Follow up|Lost to Follow-up|2|||
164159366|NCT02492867|592946261|FG000|Overall Study|Alternate therapy|1|||
164159367|NCT02492867|592946261|FG000|Overall Study|Withdrawal by Subject|2|||
164159368|NCT02492867|592946261|FG000|Overall Study|Disease progression after treatment started|1|||
164159369|NCT02492867|592946261|FG000|Overall Study|Death|1|||
164159370|NCT03296527|592946262|FG000|Overall Study|Adverse Event|15|||
164159371|NCT03296527|592946263|FG001|Overall Study|Adverse Event|33|||
164159372|NCT03296527|592946262|FG000|Overall Study|Protocol Deviation|4|||
164159373|NCT03296527|592946263|FG001|Overall Study|Protocol Deviation|0|||
164159374|NCT03296527|592946262|FG000|Overall Study|Participant withdrew consent|3|||
164159375|NCT03296527|592946263|FG001|Overall Study|Participant withdrew consent|1|||
164159376|NCT03296527|592946262|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
164159377|NCT03296527|592946263|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
164159378|NCT03296527|592946262|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
164159379|NCT03296527|592946263|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
164159380|NCT03296527|592946262|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
164159381|NCT03296527|592946263|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
164159382|NCT03296527|592946262|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
164159383|NCT03296527|592946263|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
164159384|NCT03296527|592946262|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
164159385|NCT03296527|592946263|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
164159386|NCT01597973|592946264|FG000|Overall Study|Found ineligible before study medication started|4|||
164159387|NCT01597973|592946265|FG001|Overall Study|Found ineligible before study medication started|2|||
164159388|NCT01597973|592946264|FG000|Overall Study|Eligible pathogen not confirmed|14|||
164159389|NCT01597973|592946265|FG001|Overall Study|Eligible pathogen not confirmed|15|||
164159390|NCT01597973|592946264|FG000|Overall Study|LAR not authorized to consent|0|||
164159391|NCT01597973|592946265|FG001|Overall Study|LAR not authorized to consent|1|||
164159392|NCT01597973|592946264|FG000|Overall Study|Ineligible due to early seizures|1|||
164159393|NCT01597973|592946265|FG001|Overall Study|Ineligible due to early seizures|0|||
164159394|NCT01597973|592946264|FG000|Overall Study|Ineligible due to non-target infection|1|||
164159395|NCT01597973|592946265|FG001|Overall Study|Ineligible due to non-target infection|1|||
164159396|NCT01326845|592946266|FG000|Overall Study|Administrative Problems|5|||
164159397|NCT01326845|592946267|FG001|Overall Study|Administrative Problems|2|||
164159398|NCT01326845|592946266|FG000|Overall Study|Adverse Event|1|||
164159399|NCT01326845|592946267|FG001|Overall Study|Adverse Event|0|||
164159400|NCT01326845|592946266|FG000|Overall Study|Misisng|1|||
164159401|NCT01326845|592946267|FG001|Overall Study|Misisng|3|||
164159402|NCT01662492|592946272|FG000|Overall Study|Other miscellaneous reasons.|1|||
164159403|NCT01662492|592946273|FG001|Overall Study|Other miscellaneous reasons.|0|||
164159404|NCT01662492|592946274|FG002|Overall Study|Other miscellaneous reasons.|1|||
164159405|NCT01662492|592946272|FG000|Overall Study|Withdrawal by Subject|0|||
164159406|NCT01662492|592946273|FG001|Overall Study|Withdrawal by Subject|0|||
164159407|NCT01662492|592946274|FG002|Overall Study|Withdrawal by Subject|1|||
164159408|NCT01662492|592946272|FG000|Overall Study|Protocol Violation|1|||
164159409|NCT01662492|592946273|FG001|Overall Study|Protocol Violation|0|||
164159410|NCT01662492|592946274|FG002|Overall Study|Protocol Violation|0|||
164159411|NCT01662492|592946272|FG000|Overall Study|Lost to Follow-up|0|||
164159412|NCT01662492|592946273|FG001|Overall Study|Lost to Follow-up|0|||
164159413|NCT01662492|592946274|FG002|Overall Study|Lost to Follow-up|2|||
164159414|NCT01662492|592946272|FG000|Overall Study|Lack of Efficacy|1|||
164159415|NCT01662492|592946273|FG001|Overall Study|Lack of Efficacy|1|||
164159416|NCT01662492|592946274|FG002|Overall Study|Lack of Efficacy|2|||
164159417|NCT01591096|592946275|FG000|Overall Study|Adverse Event|1|||
164159418|NCT03655405|592946276|FG000|Overall Study|Death after initial data collection|4|||
164159419|NCT03655405|592946277|FG001|Overall Study|Death after initial data collection|2|||
164159420|NCT03655405|592946276|FG000|Overall Study|Died before initial data collection|1|||
164159421|NCT03655405|592946277|FG001|Overall Study|Died before initial data collection|2|||
164159422|NCT03655405|592946276|FG000|Overall Study|Protocol Violation|0|||
164159423|NCT03655405|592946277|FG001|Overall Study|Protocol Violation|1|||
164159424|NCT02859337|592946278|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
164159425|NCT02859337|592946279|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
164159426|NCT02859337|592946280|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
164159427|NCT02859337|592946278|FG000|Overall Study|Withdrawal by Subject|3|||
164159428|NCT02859337|592946279|FG001|Overall Study|Withdrawal by Subject|1|||
164159429|NCT02859337|592946280|FG002|Overall Study|Withdrawal by Subject|0|||
164159430|NCT02859337|592946278|FG000|Overall Study|Lost to Follow-up|1|||
164159431|NCT02859337|592946279|FG001|Overall Study|Lost to Follow-up|0|||
164159432|NCT02859337|592946280|FG002|Overall Study|Lost to Follow-up|0|||
164159433|NCT00833105|592947610|FG000|Overall Study|Withdrawal by Subject|1|||
164159434|NCT00833105|592947610|FG000|Overall Study|Adverse Event|2|||
164159435|NCT02898597|592947611|FG000|Overall Study|Protocol Violation|4|||
164159436|NCT02898597|592947612|FG001|Overall Study|Protocol Violation|2|||
164159437|NCT02898597|592947611|FG000|Overall Study|Lost to Follow-up|0|||
164159438|NCT02898597|592947612|FG001|Overall Study|Lost to Follow-up|9|||
164159439|NCT02898597|592947611|FG000|Overall Study|Death|0|||
164159440|NCT02898597|592947612|FG001|Overall Study|Death|1|||
164159441|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
164159442|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
164159443|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
164159444|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
164159445|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
164159446|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
164159447|NCT01081769|592947618|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
164159448|NCT01081769|592947619|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
164159449|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Adverse Event|14|||
164159450|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Adverse Event|11|||
164159451|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Death|1|||
164159452|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Death|1|||
164159453|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
164159454|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
164159455|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
164159456|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
164159457|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Pregnancy|1|||
164159458|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Pregnancy|0|||
164159459|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
164159460|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
164159461|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
164159462|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
164159463|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Other|0|||
164159464|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Other|1|||
164159465|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Ineligibility|3|||
164159466|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Ineligibility|4|||
164159467|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
164159468|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
164159469|NCT01081769|592947618|FG000|CORE Intent-To-Treat|Patient Moved|2|||
164159470|NCT01081769|592947619|FG001|CORE Intent-To-Treat|Patient Moved|2|||
164159471|NCT01681212|592947620|FG000|Overall Study|No longer met study criteria|5|||
164159472|NCT01681212|592947620|FG000|Overall Study|Administrative reason by sponsor|1|||
164159473|NCT01464424|592947621|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
164159474|NCT01464424|592947622|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
164159475|NCT02282813|592947625|FG000|Overall Study|Withdrawal by Subject|4|||
164159476|NCT02282813|592947626|FG001|Overall Study|Withdrawal by Subject|5|||
164159477|NCT02282813|592947627|FG002|Overall Study|Withdrawal by Subject|0|||
164159478|NCT02282813|592947625|FG000|Overall Study|Adverse Event|3|||
164159479|NCT02282813|592947626|FG001|Overall Study|Adverse Event|10|||
164159480|NCT02282813|592947627|FG002|Overall Study|Adverse Event|1|||
164159481|NCT02282813|592947625|FG000|Overall Study|Subject non-compliance|1|||
164159482|NCT02282813|592947626|FG001|Overall Study|Subject non-compliance|4|||
164159483|NCT02282813|592947627|FG002|Overall Study|Subject non-compliance|0|||
164159484|NCT02282813|592947625|FG000|Overall Study|Physician Decision|0|||
164159485|NCT02282813|592947626|FG001|Overall Study|Physician Decision|3|||
164159486|NCT02282813|592947627|FG002|Overall Study|Physician Decision|1|||
164159487|NCT02282813|592947625|FG000|Overall Study|Lost to Follow-up|2|||
164159488|NCT02282813|592947626|FG001|Overall Study|Lost to Follow-up|0|||
164159489|NCT02282813|592947627|FG002|Overall Study|Lost to Follow-up|1|||
164159490|NCT02282813|592947625|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
164159491|NCT02282813|592947626|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
164159492|NCT02282813|592947627|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
164159493|NCT02282813|592947625|FG000|Overall Study|Lack of Efficacy|1|||
164159494|NCT02282813|592947626|FG001|Overall Study|Lack of Efficacy|0|||
164159495|NCT02282813|592947627|FG002|Overall Study|Lack of Efficacy|0|||
164159496|NCT02282813|592947625|FG000|Overall Study|Administrative reasons|0|||
164159497|NCT02282813|592947626|FG001|Overall Study|Administrative reasons|1|||
164159498|NCT02282813|592947627|FG002|Overall Study|Administrative reasons|0|||
164159499|NCT00529308|592947628|FG000|Overall Study|Withdrawal by Subject|1|||
164159500|NCT00529308|592947629|FG001|Overall Study|Withdrawal by Subject|1|||
164159501|NCT06509438|592947630|FG000|Overall Study|Adverse Event|1|||
164159502|NCT06509438|592947630|FG000|Overall Study|Lost to Follow-up|3|||
164159503|NCT03331796|592947631|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
164159504|NCT03331796|592947632|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
164159505|NCT03331796|592947633|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
164159506|NCT03331796|592947631|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
164159507|NCT03331796|592947632|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
164159508|NCT03331796|592947633|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
164159509|NCT03331796|592947631|FG000|Extended Follow-up|Adverse Event|1|||
164159510|NCT03331796|592947632|FG001|Extended Follow-up|Adverse Event|0|||
164159511|NCT03331796|592947633|FG002|Extended Follow-up|Adverse Event|1|||
164159512|NCT03331796|592947631|FG000|Extended Follow-up|Lost to Follow-up|0|||
164159513|NCT03331796|592947632|FG001|Extended Follow-up|Lost to Follow-up|0|||
164159514|NCT03331796|592947633|FG002|Extended Follow-up|Lost to Follow-up|1|||
164159515|NCT03331796|592947631|FG000|Extended Follow-up|Withdrawal by Subject|1|||
164159516|NCT03331796|592947632|FG001|Extended Follow-up|Withdrawal by Subject|0|||
164159517|NCT03331796|592947633|FG002|Extended Follow-up|Withdrawal by Subject|0|||
164159518|NCT03331796|592947631|FG000|Extended Follow-up|Termination of Funding|0|||
164159519|NCT03331796|592947632|FG001|Extended Follow-up|Termination of Funding|1|||
164159520|NCT03331796|592947633|FG002|Extended Follow-up|Termination of Funding|0|||
164159521|NCT01808066|592947636|FG000|Overall Study|Withdrawal by Subject|15|||
164159522|NCT02949973|592947641|FG000|Overall Study|Physician Decision|1|||
164159523|NCT01420068|592947642|FG000|Overall Study|Administrative problems|1|||
164159524|NCT01420068|592947643|FG001|Overall Study|Administrative problems|3|||
164159525|NCT01420068|592947642|FG000|Overall Study|Withdrawal by Subject|1|||
164159526|NCT01420068|592947643|FG001|Overall Study|Withdrawal by Subject|2|||
164159527|NCT01252095|592947644|FG000|Overall Study|Disease progression|1|||
164159528|NCT01252095|592947645|FG001|Overall Study|Disease progression|0|||
164159529|NCT00365794|592947646|FG000|Overall Study|Withdrawal by Subject|2|||
164159530|NCT00586703|592947647|FG000|Overall Study|Death|12|||
164159531|NCT04760626|592947648|FG000|Overall Study|Withdrawal by Subject|24|||
164159532|NCT04760626|592947649|FG001|Overall Study|Withdrawal by Subject|20|||
164159533|NCT04760626|592947648|FG000|Overall Study|Lost to Follow-up|14|||
164159534|NCT04760626|592947649|FG001|Overall Study|Lost to Follow-up|19|||
164159535|NCT04760626|592947648|FG000|Overall Study|Physician Decision|3|||
164159536|NCT04760626|592947649|FG001|Overall Study|Physician Decision|5|||
164159537|NCT04760626|592947648|FG000|Overall Study|Death|3|||
164159538|NCT04760626|592947649|FG001|Overall Study|Death|6|||
164159539|NCT04760626|592947648|FG000|Overall Study|Site closure|1|||
164159540|NCT04760626|592947649|FG001|Overall Study|Site closure|0|||
164159541|NCT00745901|592947652|FG000|Overall Study|Adverse Event|3|||
164159542|NCT00745901|592947653|FG001|Overall Study|Adverse Event|4|||
164159543|NCT00745901|592947652|FG000|Overall Study|Protocol Violation|0|||
164159544|NCT00745901|592947653|FG001|Overall Study|Protocol Violation|1|||
164159545|NCT00745901|592947652|FG000|Overall Study|Withdrawal by Subject|1|||
164159546|NCT00745901|592947653|FG001|Overall Study|Withdrawal by Subject|0|||
164159547|NCT00745901|592947652|FG000|Overall Study|Lost to Follow-up|7|||
164159548|NCT00745901|592947653|FG001|Overall Study|Lost to Follow-up|4|||
164159549|NCT00745901|592947652|FG000|Overall Study|Pregnancy|2|||
164159550|NCT00745901|592947653|FG001|Overall Study|Pregnancy|4|||
164159551|NCT00745901|592947652|FG000|Overall Study|Lack of compliance|2|||
164159552|NCT00745901|592947653|FG001|Overall Study|Lack of compliance|2|||
164159553|NCT00745901|592947652|FG000|Overall Study|Patient's next menses did not start with|1|||
164159554|NCT00745901|592947653|FG001|Overall Study|Patient's next menses did not start with|0|||
164159555|NCT00745901|592947652|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
164159556|NCT00745901|592947653|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
164159557|NCT00745901|592947652|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
164159558|NCT00745901|592947653|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
164159559|NCT00745901|592947652|FG000|Overall Study|Patient didn't take any study medication|7|||
164159560|NCT00745901|592947653|FG001|Overall Study|Patient didn't take any study medication|3|||
164159561|NCT02554682|592947655|FG000|Overall Study|Lost to Follow-up|11|||
164159562|NCT02554682|592947656|FG001|Overall Study|Lost to Follow-up|9|||
164159563|NCT02554682|592947657|FG002|Overall Study|Lost to Follow-up|4|||
164159564|NCT02554682|592947658|FG003|Overall Study|Lost to Follow-up|3|||
164159565|NCT02554682|592947659|FG004|Overall Study|Lost to Follow-up|2|||
164159566|NCT02554682|592947660|FG005|Overall Study|Lost to Follow-up|1|||
164159567|NCT02554682|592947661|FG006|Overall Study|Lost to Follow-up|6|||
164159568|NCT02554682|592947662|FG007|Overall Study|Lost to Follow-up|6|||
164159569|NCT02554682|592947663|FG008|Overall Study|Lost to Follow-up|2|||
164159570|NCT02554682|592947664|FG009|Overall Study|Lost to Follow-up|2|||
164159571|NCT02554682|592947655|FG000|Overall Study|Withdrawal by Subject|2|||
164159572|NCT02554682|592947656|FG001|Overall Study|Withdrawal by Subject|1|||
164159573|NCT02554682|592947657|FG002|Overall Study|Withdrawal by Subject|0|||
164159574|NCT02554682|592947658|FG003|Overall Study|Withdrawal by Subject|0|||
164159575|NCT02554682|592947659|FG004|Overall Study|Withdrawal by Subject|0|||
164159576|NCT02554682|592947660|FG005|Overall Study|Withdrawal by Subject|0|||
164159577|NCT02554682|592947661|FG006|Overall Study|Withdrawal by Subject|0|||
164159578|NCT02554682|592947662|FG007|Overall Study|Withdrawal by Subject|0|||
164159579|NCT02554682|592947663|FG008|Overall Study|Withdrawal by Subject|0|||
164159580|NCT02554682|592947664|FG009|Overall Study|Withdrawal by Subject|0|||
164159581|NCT02554682|592947655|FG000|Overall Study|Physician Decision|2|||
164159582|NCT02554682|592947656|FG001|Overall Study|Physician Decision|2|||
164159583|NCT02554682|592947657|FG002|Overall Study|Physician Decision|0|||
164159584|NCT02554682|592947658|FG003|Overall Study|Physician Decision|0|||
164159585|NCT02554682|592947659|FG004|Overall Study|Physician Decision|0|||
164159586|NCT02554682|592947660|FG005|Overall Study|Physician Decision|0|||
164159587|NCT02554682|592947661|FG006|Overall Study|Physician Decision|0|||
164159588|NCT02554682|592947662|FG007|Overall Study|Physician Decision|0|||
164159589|NCT02554682|592947663|FG008|Overall Study|Physician Decision|0|||
164159590|NCT02554682|592947664|FG009|Overall Study|Physician Decision|0|||
164159591|NCT00884117|592947667|FG000|Overall Study|Adverse Event|2|||
164159592|NCT00884117|592947667|FG000|Overall Study|Withdrawal by Subject|89|||
164159593|NCT00884117|592947667|FG000|Overall Study|Death|3|||
164159594|NCT00884117|592947667|FG000|Overall Study|Lost to Follow-up|143|||
164159595|NCT00884117|592947667|FG000|Overall Study|Other|12|||
164159596|NCT01753310|592947668|FG000|Overall Study|Entered into open label extension study|25|||
164159597|NCT01753310|592947669|FG001|Overall Study|Entered into open label extension study|22|||
164159598|NCT01753310|592947668|FG000|Overall Study|Adverse Event|1|||
164159599|NCT01753310|592947669|FG001|Overall Study|Adverse Event|0|||
164159600|NCT01753310|592947668|FG000|Overall Study|Lost to Follow-up|2|||
164159601|NCT01753310|592947669|FG001|Overall Study|Lost to Follow-up|0|||
164159602|NCT01753310|592947668|FG000|Overall Study|Subject decision|2|||
164159603|NCT01753310|592947669|FG001|Overall Study|Subject decision|2|||
164159604|NCT01753310|592947668|FG000|Overall Study|Sponsor decision|1|||
164159605|NCT01753310|592947669|FG001|Overall Study|Sponsor decision|0|||
164159606|NCT01753310|592947668|FG000|Overall Study|Withdrawal by Subject|1|||
164159607|NCT01753310|592947669|FG001|Overall Study|Withdrawal by Subject|0|||
164159608|NCT02946463|592947670|FG000|Primary Evaluation Period|Physician Decision|0|||
164159609|NCT02946463|592947671|FG001|Primary Evaluation Period|Physician Decision|1|||
164159610|NCT02946463|592947672|FG002|Primary Evaluation Period|Physician Decision|0|||
164159611|NCT02946463|592947673|FG003|Primary Evaluation Period|Physician Decision|0|||
164159612|NCT02946463|592947670|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
164159613|NCT02946463|592947671|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
164159614|NCT02946463|592947672|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
164159615|NCT02946463|592947673|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
164159616|NCT02946463|592947670|FG000|Extension Period|Death|4|||
164159617|NCT02946463|592947671|FG001|Extension Period|Death|4|||
164159618|NCT02946463|592947672|FG002|Extension Period|Death|0|||
164159619|NCT02946463|592947673|FG003|Extension Period|Death|0|||
164159620|NCT02946463|592947670|FG000|Extension Period|Withdrawal by Subject|4|||
164159621|NCT02946463|592947671|FG001|Extension Period|Withdrawal by Subject|3|||
164159622|NCT02946463|592947672|FG002|Extension Period|Withdrawal by Subject|0|||
164159623|NCT02946463|592947673|FG003|Extension Period|Withdrawal by Subject|0|||
164159624|NCT02946463|592947670|FG000|Extension Period|Other than specified|2|||
164159625|NCT02946463|592947671|FG001|Extension Period|Other than specified|3|||
164159626|NCT02946463|592947672|FG002|Extension Period|Other than specified|2|||
164159627|NCT02946463|592947673|FG003|Extension Period|Other than specified|0|||
164159628|NCT02946463|592947670|FG000|Extension Period|Physician Decision|1|||
164159629|NCT02946463|592947671|FG001|Extension Period|Physician Decision|4|||
164159630|NCT02946463|592947672|FG002|Extension Period|Physician Decision|0|||
164159631|NCT02946463|592947673|FG003|Extension Period|Physician Decision|0|||
164159632|NCT02946463|592947670|FG000|Extension Period|Pregnancy|3|||
164159633|NCT02946463|592947671|FG001|Extension Period|Pregnancy|1|||
164159634|NCT02946463|592947672|FG002|Extension Period|Pregnancy|0|||
164159635|NCT02946463|592947673|FG003|Extension Period|Pregnancy|0|||
164159636|NCT02946463|592947670|FG000|Extension Period|Adverse Event|1|||
164159637|NCT02946463|592947671|FG001|Extension Period|Adverse Event|2|||
164159638|NCT02946463|592947672|FG002|Extension Period|Adverse Event|0|||
164159639|NCT02946463|592947673|FG003|Extension Period|Adverse Event|0|||
164159640|NCT02946463|592947670|FG000|Extension Period|Lost to Follow-up|1|||
164159641|NCT02946463|592947671|FG001|Extension Period|Lost to Follow-up|0|||
164159642|NCT02946463|592947672|FG002|Extension Period|Lost to Follow-up|0|||
164159643|NCT02946463|592947673|FG003|Extension Period|Lost to Follow-up|0|||
164159644|NCT02022202|592947674|FG000|Overall Study|Withdrawal by Subject|2|||
164159645|NCT02022202|592947674|FG000|Overall Study|Disease Progression|3|||
164159646|NCT02022202|592947674|FG000|Overall Study|Desire go to immediately to surgery|3|||
164159647|NCT05581641|592947676|FG000|Overall Study|Withdrawal by Subject|0|||
164159648|NCT05581641|592947677|FG001|Overall Study|Withdrawal by Subject|1|||
164159649|NCT05581641|592947678|FG002|Overall Study|Withdrawal by Subject|3|||
164159650|NCT05581641|592947679|FG003|Overall Study|Withdrawal by Subject|1|||
164159651|NCT05581641|592947676|FG000|Overall Study|Lost to Follow-up|0|||
164159652|NCT05581641|592947677|FG001|Overall Study|Lost to Follow-up|1|||
164159653|NCT05581641|592947678|FG002|Overall Study|Lost to Follow-up|0|||
164159654|NCT05581641|592947679|FG003|Overall Study|Lost to Follow-up|1|||
164159655|NCT05581641|592947676|FG000|Overall Study|Protocol Violation|1|||
164159656|NCT05581641|592947677|FG001|Overall Study|Protocol Violation|0|||
164159657|NCT05581641|592947678|FG002|Overall Study|Protocol Violation|0|||
164159658|NCT05581641|592947679|FG003|Overall Study|Protocol Violation|0|||
164159659|NCT05581641|592947676|FG000|Overall Study|Other|1|||
164159660|NCT05581641|592947677|FG001|Overall Study|Other|0|||
164159661|NCT05581641|592947678|FG002|Overall Study|Other|2|||
164159662|NCT05581641|592947679|FG003|Overall Study|Other|1|||
164159663|NCT04390763|592947680|FG000|Safety run-in Part|Adverse Event|4|||
164159664|NCT04390763|592947681|FG001|Safety run-in Part|Adverse Event|0|||
164159665|NCT04390763|592947682|FG002|Safety run-in Part|Adverse Event|0|||
164159666|NCT04390763|592947683|FG003|Safety run-in Part|Adverse Event|0|||
164159667|NCT04390763|592947680|FG000|Safety run-in Part|Physician Decision|1|||
164159668|NCT04390763|592947681|FG001|Safety run-in Part|Physician Decision|0|||
164159669|NCT04390763|592947682|FG002|Safety run-in Part|Physician Decision|0|||
164159670|NCT04390763|592947683|FG003|Safety run-in Part|Physician Decision|0|||
164159671|NCT04390763|592947680|FG000|Safety run-in Part|Progressive Disease|6|||
164159672|NCT04390763|592947681|FG001|Safety run-in Part|Progressive Disease|0|||
164159673|NCT04390763|592947682|FG002|Safety run-in Part|Progressive Disease|0|||
164159674|NCT04390763|592947683|FG003|Safety run-in Part|Progressive Disease|0|||
164159675|NCT04390763|592947680|FG000|Randomized Part|Adverse Event|0|||
164159676|NCT04390763|592947681|FG001|Randomized Part|Adverse Event|11|||
164159677|NCT04390763|592947682|FG002|Randomized Part|Adverse Event|5|||
164159678|NCT04390763|592947683|FG003|Randomized Part|Adverse Event|5|||
164159679|NCT04390763|592947680|FG000|Randomized Part|Death|0|||
164159680|NCT04390763|592947681|FG001|Randomized Part|Death|3|||
164159681|NCT04390763|592947682|FG002|Randomized Part|Death|4|||
164159682|NCT04390763|592947683|FG003|Randomized Part|Death|2|||
164159683|NCT04390763|592947680|FG000|Randomized Part|Physician Decision|0|||
164159684|NCT04390763|592947681|FG001|Randomized Part|Physician Decision|2|||
164159685|NCT04390763|592947682|FG002|Randomized Part|Physician Decision|2|||
164159686|NCT04390763|592947683|FG003|Randomized Part|Physician Decision|9|||
164159687|NCT04390763|592947680|FG000|Randomized Part|Progressive Disease|0|||
164159688|NCT04390763|592947681|FG001|Randomized Part|Progressive Disease|24|||
164159689|NCT04390763|592947682|FG002|Randomized Part|Progressive Disease|31|||
164159690|NCT04390763|592947683|FG003|Randomized Part|Progressive Disease|23|||
164159691|NCT04390763|592947680|FG000|Randomized Part|Study terminated by sponsor|0|||
164159692|NCT04390763|592947681|FG001|Randomized Part|Study terminated by sponsor|1|||
164159693|NCT04390763|592947682|FG002|Randomized Part|Study terminated by sponsor|0|||
164159694|NCT04390763|592947683|FG003|Randomized Part|Study terminated by sponsor|0|||
164159695|NCT04390763|592947680|FG000|Randomized Part|Participant Decision|0|||
164159696|NCT04390763|592947681|FG001|Randomized Part|Participant Decision|5|||
164159697|NCT04390763|592947682|FG002|Randomized Part|Participant Decision|7|||
164159698|NCT04390763|592947683|FG003|Randomized Part|Participant Decision|6|||
164159699|NCT04390763|592947680|FG000|Randomized Part|Not treated|0|||
164159700|NCT04390763|592947681|FG001|Randomized Part|Not treated|4|||
164159701|NCT04390763|592947682|FG002|Randomized Part|Not treated|2|||
164159702|NCT04390763|592947683|FG003|Randomized Part|Not treated|7|||
164159703|NCT01786993|592947684|FG000|Overall Study|Death|6|||
164159704|NCT01786993|592947685|FG001|Overall Study|Death|7|||
164159705|NCT01786993|592947684|FG000|Overall Study|Withdrawal by Subject|3|||
164159706|NCT01786993|592947685|FG001|Overall Study|Withdrawal by Subject|2|||
164159707|NCT01786993|592947684|FG000|Overall Study|Lost to Follow-up|0|||
164159708|NCT01786993|592947685|FG001|Overall Study|Lost to Follow-up|1|||
164159709|NCT01786993|592947684|FG000|Overall Study|Subject Non-Compliance|1|||
164159710|NCT01786993|592947685|FG001|Overall Study|Subject Non-Compliance|0|||
164159711|NCT01786993|592947684|FG000|Overall Study|System Explant|1|||
164159712|NCT01786993|592947685|FG001|Overall Study|System Explant|0|||
164159713|NCT01786993|592947684|FG000|Overall Study|Hospice Admission|1|||
164159714|NCT01786993|592947685|FG001|Overall Study|Hospice Admission|0|||
164159715|NCT00450437|592947686|FG000|Overall Study|Withdrawal by Subject|10|||
164159716|NCT00450437|592947687|FG001|Overall Study|Withdrawal by Subject|2|||
164159717|NCT00450437|592947688|FG002|Overall Study|Withdrawal by Subject|0|||
164159718|NCT00450437|592947689|FG003|Overall Study|Withdrawal by Subject|1|||
164159719|NCT00450437|592947686|FG000|Overall Study|Lost to Follow-up|31|||
164159720|NCT00450437|592947687|FG001|Overall Study|Lost to Follow-up|12|||
164159721|NCT00450437|592947688|FG002|Overall Study|Lost to Follow-up|19|||
164159722|NCT00450437|592947689|FG003|Overall Study|Lost to Follow-up|9|||
164159723|NCT00450437|592947686|FG000|Overall Study|Protocol Violation|0|||
164159724|NCT00450437|592947687|FG001|Overall Study|Protocol Violation|1|||
164159725|NCT00450437|592947688|FG002|Overall Study|Protocol Violation|0|||
164159726|NCT00450437|592947689|FG003|Overall Study|Protocol Violation|1|||
164159727|NCT00450437|592947686|FG000|Overall Study|Inappropriate enrollment|4|||
164159728|NCT00450437|592947687|FG001|Overall Study|Inappropriate enrollment|1|||
164159729|NCT00450437|592947688|FG002|Overall Study|Inappropriate enrollment|3|||
164159730|NCT00450437|592947689|FG003|Overall Study|Inappropriate enrollment|0|||
164159731|NCT00450437|592947686|FG000|Overall Study|Administrative reason|0|||
164159732|NCT00450437|592947687|FG001|Overall Study|Administrative reason|0|||
164159733|NCT00450437|592947688|FG002|Overall Study|Administrative reason|1|||
164159734|NCT00450437|592947689|FG003|Overall Study|Administrative reason|0|||
164159735|NCT00450437|592947686|FG000|Overall Study|Unable to Classify|1|||
164159736|NCT00450437|592947687|FG001|Overall Study|Unable to Classify|0|||
164159737|NCT00450437|592947688|FG002|Overall Study|Unable to Classify|1|||
164159738|NCT00450437|592947689|FG003|Overall Study|Unable to Classify|0|||
164159739|NCT01890122|592947690|FG000|Overall Study|Adverse Event|1|||
164159740|NCT01890122|592947691|FG001|Overall Study|Adverse Event|1|||
164159741|NCT01890122|592947692|FG002|Overall Study|Adverse Event|1|||
164159742|NCT01890122|592947693|FG003|Overall Study|Adverse Event|2|||
164159743|NCT01890122|592947690|FG000|Overall Study|Major Protocol Deviation|3|||
164159744|NCT01890122|592947691|FG001|Overall Study|Major Protocol Deviation|1|||
164159745|NCT01890122|592947692|FG002|Overall Study|Major Protocol Deviation|0|||
164159746|NCT01890122|592947693|FG003|Overall Study|Major Protocol Deviation|1|||
164159747|NCT01890122|592947690|FG000|Overall Study|Lost to Follow-up|0|||
164159748|NCT01890122|592947691|FG001|Overall Study|Lost to Follow-up|1|||
164159749|NCT01890122|592947692|FG002|Overall Study|Lost to Follow-up|2|||
164159750|NCT01890122|592947693|FG003|Overall Study|Lost to Follow-up|2|||
164159751|NCT01890122|592947690|FG000|Overall Study|Voluntary Withdrawal|8|||
164159752|NCT01890122|592947691|FG001|Overall Study|Voluntary Withdrawal|8|||
164159753|NCT01890122|592947692|FG002|Overall Study|Voluntary Withdrawal|2|||
164159754|NCT01890122|592947693|FG003|Overall Study|Voluntary Withdrawal|11|||
164159755|NCT01890122|592947690|FG000|Overall Study|Lack of Efficacy|14|||
164159756|NCT01890122|592947691|FG001|Overall Study|Lack of Efficacy|24|||
164159757|NCT01890122|592947692|FG002|Overall Study|Lack of Efficacy|7|||
164159758|NCT01890122|592947693|FG003|Overall Study|Lack of Efficacy|41|||
164159759|NCT01890122|592947690|FG000|Overall Study|Reason not Specified|0|||
164159760|NCT01890122|592947691|FG001|Overall Study|Reason not Specified|1|||
164159761|NCT01890122|592947692|FG002|Overall Study|Reason not Specified|1|||
164159762|NCT01890122|592947693|FG003|Overall Study|Reason not Specified|2|||
164159763|NCT01890122|592947690|FG000|Overall Study|Randomized but not Treated|1|||
164159764|NCT01890122|592947691|FG001|Overall Study|Randomized but not Treated|1|||
164159765|NCT01890122|592947692|FG002|Overall Study|Randomized but not Treated|0|||
164159766|NCT01890122|592947693|FG003|Overall Study|Randomized but not Treated|0|||
164159767|NCT04025879|592947694|FG000|Randomization|Participant withdrew consent|0|||
164159768|NCT04025879|592947695|FG001|Randomization|Participant withdrew consent|1|||
164159769|NCT04025879|592947694|FG000|Randomization|Participant no longer met study criteria|1|||
164159770|NCT04025879|592947695|FG001|Randomization|Participant no longer met study criteria|1|||
164159771|NCT04025879|592947694|FG000|Treatment|Ongoing treatment|10|||
164159772|NCT04025879|592947695|FG001|Treatment|Ongoing treatment|8|||
164159773|NCT04025879|592947694|FG000|Treatment|Disease progression/recurrence|36|||
164159774|NCT04025879|592947695|FG001|Treatment|Disease progression/recurrence|72|||
164159775|NCT04025879|592947694|FG000|Treatment|Study drug toxicity|36|||
164159776|NCT04025879|592947695|FG001|Treatment|Study drug toxicity|13|||
164159777|NCT04025879|592947694|FG000|Treatment|Death|2|||
164159778|NCT04025879|592947695|FG001|Treatment|Death|0|||
164159779|NCT04025879|592947694|FG000|Treatment|Adverse event unrelated to study drug|21|||
164159780|NCT04025879|592947695|FG001|Treatment|Adverse event unrelated to study drug|14|||
164159781|NCT04025879|592947694|FG000|Treatment|Participant request to discontinue study treatment|16|||
164159782|NCT04025879|592947695|FG001|Treatment|Participant request to discontinue study treatment|8|||
164159783|NCT04025879|592947694|FG000|Treatment|Participant withdrew consent|1|||
164159784|NCT04025879|592947695|FG001|Treatment|Participant withdrew consent|3|||
164159785|NCT04025879|592947694|FG000|Treatment|Participant no longer meets study criteria|3|||
164159786|NCT04025879|592947695|FG001|Treatment|Participant no longer meets study criteria|2|||
164159787|NCT04025879|592947694|FG000|Treatment|Lost to Follow-up|1|||
164159788|NCT04025879|592947695|FG001|Treatment|Lost to Follow-up|0|||
164159789|NCT04025879|592947694|FG000|Treatment|Other reasons|15|||
164159790|NCT04025879|592947695|FG001|Treatment|Other reasons|17|||
164159791|NCT04025879|592947694|FG000|Treatment|Administrative reason by sponsor|0|||
164159792|NCT04025879|592947695|FG001|Treatment|Administrative reason by sponsor|1|||
164159793|NCT04025879|592947694|FG000|Treatment|Not reported|2|||
164159794|NCT04025879|592947695|FG001|Treatment|Not reported|0|||
164159795|NCT01565889|592947700|FG000|Part A|Withdrawal by Subject|1|||
164159796|NCT01565889|592947701|FG001|Part A|Withdrawal by Subject|0|||
164159797|NCT01565889|592947702|FG002|Part A|Withdrawal by Subject|0|||
164159798|NCT01565889|592947703|FG003|Part A|Withdrawal by Subject|0|||
164159799|NCT01565889|592947704|FG004|Part A|Withdrawal by Subject|0|||
164159800|NCT01565889|592947705|FG005|Part A|Withdrawal by Subject|0|||
164159801|NCT01565889|592947700|FG000|Part B|Withdrawal by Subject|0|||
164159802|NCT01565889|592947701|FG001|Part B|Withdrawal by Subject|0|||
164159803|NCT01565889|592947702|FG002|Part B|Withdrawal by Subject|0|||
164159804|NCT01565889|592947703|FG003|Part B|Withdrawal by Subject|0|||
164159805|NCT01565889|592947704|FG004|Part B|Withdrawal by Subject|0|||
164159806|NCT01565889|592947705|FG005|Part B|Withdrawal by Subject|1|||
164159807|NCT01565889|592947700|FG000|Part B|Lack of Efficacy|0|||
164159808|NCT01565889|592947701|FG001|Part B|Lack of Efficacy|0|||
164159809|NCT01565889|592947702|FG002|Part B|Lack of Efficacy|0|||
164159810|NCT01565889|592947703|FG003|Part B|Lack of Efficacy|0|||
164159811|NCT01565889|592947704|FG004|Part B|Lack of Efficacy|0|||
164159812|NCT01565889|592947705|FG005|Part B|Lack of Efficacy|2|||
164159813|NCT01565889|592947700|FG000|Part B|Lost to Follow-up|0|||
164159814|NCT01565889|592947701|FG001|Part B|Lost to Follow-up|0|||
164159815|NCT01565889|592947702|FG002|Part B|Lost to Follow-up|0|||
164159816|NCT01565889|592947703|FG003|Part B|Lost to Follow-up|0|||
164159817|NCT01565889|592947704|FG004|Part B|Lost to Follow-up|0|||
164159818|NCT01565889|592947705|FG005|Part B|Lost to Follow-up|1|||
164159819|NCT00122382|592947706|FG000|Double-Blind Study|Adverse Event|9|||
164159820|NCT00122382|592947707|FG001|Double-Blind Study|Adverse Event|11|||
164159821|NCT00122382|592947708|FG002|Double-Blind Study|Adverse Event|0|||
164159822|NCT00122382|592947706|FG000|Double-Blind Study|Death|2|||
164159823|NCT00122382|592947707|FG001|Double-Blind Study|Death|2|||
164159824|NCT00122382|592947708|FG002|Double-Blind Study|Death|0|||
164159825|NCT00122382|592947706|FG000|Double-Blind Study|Lack of Efficacy|0|||
164159826|NCT00122382|592947707|FG001|Double-Blind Study|Lack of Efficacy|8|||
164159827|NCT00122382|592947708|FG002|Double-Blind Study|Lack of Efficacy|0|||
164159828|NCT00122382|592947706|FG000|Double-Blind Study|Lost to Follow-up|2|||
164159829|NCT00122382|592947707|FG001|Double-Blind Study|Lost to Follow-up|1|||
164159830|NCT00122382|592947708|FG002|Double-Blind Study|Lost to Follow-up|0|||
164159831|NCT00122382|592947706|FG000|Double-Blind Study|Pregnancy|2|||
164159832|NCT00122382|592947707|FG001|Double-Blind Study|Pregnancy|0|||
164159833|NCT00122382|592947708|FG002|Double-Blind Study|Pregnancy|0|||
164159834|NCT00122382|592947706|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
164159835|NCT00122382|592947707|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
164159836|NCT00122382|592947708|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
164159837|NCT00122382|592947706|FG000|Double-Blind Study|Withdrawal of Consent|7|||
164159838|NCT00122382|592947707|FG001|Double-Blind Study|Withdrawal of Consent|3|||
164159839|NCT00122382|592947708|FG002|Double-Blind Study|Withdrawal of Consent|0|||
164159840|NCT00122382|592947706|FG000|Double-Blind Study|Protocol Violation|1|||
164159841|NCT00122382|592947707|FG001|Double-Blind Study|Protocol Violation|0|||
164159842|NCT00122382|592947708|FG002|Double-Blind Study|Protocol Violation|0|||
164159843|NCT00122382|592947706|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
164159844|NCT00122382|592947707|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
164159845|NCT00122382|592947708|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
164159846|NCT00122382|592947706|FG000|Double-Blind Study|Randomized but not treated|0|||
164159847|NCT00122382|592947707|FG001|Double-Blind Study|Randomized but not treated|2|||
164159848|NCT00122382|592947708|FG002|Double-Blind Study|Randomized but not treated|0|||
164159849|NCT00122382|592947706|FG000|Open-Label Study|Adverse Event|0|||
164159850|NCT00122382|592947707|FG001|Open-Label Study|Adverse Event|0|||
164159851|NCT00122382|592947708|FG002|Open-Label Study|Adverse Event|11|||
164159852|NCT00122382|592947706|FG000|Open-Label Study|Death|0|||
164159853|NCT00122382|592947707|FG001|Open-Label Study|Death|0|||
164159854|NCT00122382|592947708|FG002|Open-Label Study|Death|2|||
164159855|NCT00122382|592947706|FG000|Open-Label Study|Lack of Efficacy|0|||
164159856|NCT00122382|592947707|FG001|Open-Label Study|Lack of Efficacy|0|||
164159857|NCT00122382|592947708|FG002|Open-Label Study|Lack of Efficacy|3|||
164159858|NCT00122382|592947706|FG000|Open-Label Study|Lost to Follow-up|0|||
164159859|NCT00122382|592947707|FG001|Open-Label Study|Lost to Follow-up|0|||
164159860|NCT00122382|592947708|FG002|Open-Label Study|Lost to Follow-up|3|||
164159861|NCT00122382|592947706|FG000|Open-Label Study|Pregnancy|0|||
164159862|NCT00122382|592947707|FG001|Open-Label Study|Pregnancy|0|||
164159863|NCT00122382|592947708|FG002|Open-Label Study|Pregnancy|2|||
164159864|NCT00122382|592947706|FG000|Open-Label Study|Poor/Non-Compliance|0|||
164159865|NCT00122382|592947707|FG001|Open-Label Study|Poor/Non-Compliance|0|||
164159866|NCT00122382|592947708|FG002|Open-Label Study|Poor/Non-Compliance|1|||
164159867|NCT00122382|592947706|FG000|Open-Label Study|Withdrawal of Consent|0|||
164159868|NCT00122382|592947707|FG001|Open-Label Study|Withdrawal of Consent|0|||
164159869|NCT00122382|592947708|FG002|Open-Label Study|Withdrawal of Consent|4|||
164159870|NCT02040805|592947709|FG000|Overall Study|Lost to Follow-up|14|||
164159871|NCT02040805|592947710|FG001|Overall Study|Lost to Follow-up|9|||
164159872|NCT02040805|592947709|FG000|Overall Study|Withdrawal by Subject|28|||
164159873|NCT02040805|592947710|FG001|Overall Study|Withdrawal by Subject|41|||
164159874|NCT00908544|592947711|FG000|Overall Study|Withdrawal by Subject|2|||
164159875|NCT00908544|592947712|FG001|Overall Study|Withdrawal by Subject|4|||
164159876|NCT00908544|592947711|FG000|Overall Study|Lack of Efficacy|0|||
164159877|NCT00908544|592947712|FG001|Overall Study|Lack of Efficacy|1|||
164159878|NCT00908544|592947711|FG000|Overall Study|Pregnancy|1|||
164159879|NCT00908544|592947712|FG001|Overall Study|Pregnancy|0|||
164159880|NCT00908544|592947711|FG000|Overall Study|Relocation abroad|1|||
164159881|NCT00908544|592947712|FG001|Overall Study|Relocation abroad|1|||
164159882|NCT00908544|592947711|FG000|Overall Study|Unable to visit sutdy center|1|||
164159883|NCT00908544|592947712|FG001|Overall Study|Unable to visit sutdy center|0|||
164159884|NCT00071110|592947715|FG000|Overall Study|Protocol Violation|0|||
164159885|NCT00071110|592947716|FG001|Overall Study|Protocol Violation|4|||
164159886|NCT03859427|592947724|FG000|Overall Study|Withdrawal by Subject|4|||
164159887|NCT03859427|592947725|FG001|Overall Study|Withdrawal by Subject|7|||
164159888|NCT03859427|592947724|FG000|Overall Study|Decision by sponsor|0|||
164159889|NCT03859427|592947725|FG001|Overall Study|Decision by sponsor|3|||
164159890|NCT03859427|592947724|FG000|Overall Study|Lost to Follow-up|3|||
164159891|NCT03859427|592947725|FG001|Overall Study|Lost to Follow-up|2|||
164159892|NCT03859427|592947724|FG000|Overall Study|Death|22|||
164159893|NCT03859427|592947725|FG001|Overall Study|Death|25|||
164159894|NCT00722137|592947729|FG000|Overall Study|Overt Disease Progression|5|||
164159895|NCT00722137|592947730|FG001|Overall Study|Overt Disease Progression|4|||
164159896|NCT00722137|592947729|FG000|Overall Study|Adverse Event|17|||
164159897|NCT00722137|592947730|FG001|Overall Study|Adverse Event|21|||
164159898|NCT00722137|592947729|FG000|Overall Study|Death|12|||
164159899|NCT00722137|592947730|FG001|Overall Study|Death|7|||
164159900|NCT00722137|592947729|FG000|Overall Study|Withdrawal by Subject|6|||
164159901|NCT00722137|592947730|FG001|Overall Study|Withdrawal by Subject|9|||
164159902|NCT00722137|592947729|FG000|Overall Study|Other Reason Unknown|3|||
164159903|NCT00722137|592947730|FG001|Overall Study|Other Reason Unknown|4|||
164159904|NCT00722137|592947729|FG000|Overall Study|Randomized But Not Treated|2|||
164159905|NCT00722137|592947730|FG001|Overall Study|Randomized But Not Treated|3|||
164159906|NCT00848718|592947731|FG000|Overall Study|Adverse Event|2|||
164159907|NCT00848718|592947732|FG001|Overall Study|Adverse Event|2|||
164159908|NCT00848718|592947733|FG002|Overall Study|Adverse Event|1|||
164159909|NCT00848718|592947734|FG003|Overall Study|Adverse Event|1|||
164159910|NCT00848718|592947735|FG004|Overall Study|Adverse Event|1|||
164159911|NCT00848718|592947736|FG005|Overall Study|Adverse Event|0|||
164159912|NCT00848718|592947737|FG006|Overall Study|Adverse Event|0|||
164159913|NCT00848718|592947738|FG007|Overall Study|Adverse Event|1|||
164159914|NCT00848718|592947739|FG008|Overall Study|Adverse Event|1|||
164159915|NCT00848718|592947740|FG009|Overall Study|Adverse Event|0|||
164159916|NCT00848718|592947741|FG010|Overall Study|Adverse Event|0|||
164159917|NCT00848718|592947742|FG011|Overall Study|Adverse Event|0|||
164159918|NCT00848718|592947743|FG012|Overall Study|Adverse Event|2|||
164159919|NCT00848718|592947731|FG000|Overall Study|Lack of Efficacy|0|||
164159920|NCT00848718|592947732|FG001|Overall Study|Lack of Efficacy|0|||
164159921|NCT00848718|592947733|FG002|Overall Study|Lack of Efficacy|1|||
164159922|NCT00848718|592947734|FG003|Overall Study|Lack of Efficacy|0|||
164159923|NCT00848718|592947735|FG004|Overall Study|Lack of Efficacy|0|||
164159924|NCT00848718|592947736|FG005|Overall Study|Lack of Efficacy|0|||
164159925|NCT00848718|592947737|FG006|Overall Study|Lack of Efficacy|1|||
164159926|NCT00848718|592947738|FG007|Overall Study|Lack of Efficacy|0|||
164159927|NCT00848718|592947739|FG008|Overall Study|Lack of Efficacy|0|||
164159928|NCT00848718|592947740|FG009|Overall Study|Lack of Efficacy|0|||
164159929|NCT00848718|592947741|FG010|Overall Study|Lack of Efficacy|0|||
164159930|NCT00848718|592947742|FG011|Overall Study|Lack of Efficacy|0|||
164159931|NCT00848718|592947743|FG012|Overall Study|Lack of Efficacy|0|||
164159932|NCT00848718|592947731|FG000|Overall Study|Physician Decision|0|||
164159933|NCT00848718|592947732|FG001|Overall Study|Physician Decision|1|||
164159934|NCT00848718|592947733|FG002|Overall Study|Physician Decision|0|||
164159935|NCT00848718|592947734|FG003|Overall Study|Physician Decision|0|||
164159936|NCT00848718|592947735|FG004|Overall Study|Physician Decision|1|||
164159937|NCT00848718|592947736|FG005|Overall Study|Physician Decision|1|||
164159938|NCT00848718|592947737|FG006|Overall Study|Physician Decision|0|||
164159939|NCT00848718|592947738|FG007|Overall Study|Physician Decision|0|||
164159940|NCT00848718|592947739|FG008|Overall Study|Physician Decision|1|||
164159941|NCT00848718|592947740|FG009|Overall Study|Physician Decision|2|||
164159942|NCT00848718|592947741|FG010|Overall Study|Physician Decision|0|||
164159943|NCT00848718|592947742|FG011|Overall Study|Physician Decision|0|||
164159944|NCT00848718|592947743|FG012|Overall Study|Physician Decision|1|||
164159945|NCT00848718|592947731|FG000|Overall Study|Progressive disease before treatment|1|||
164159946|NCT00848718|592947732|FG001|Overall Study|Progressive disease before treatment|5|||
164159947|NCT00848718|592947733|FG002|Overall Study|Progressive disease before treatment|1|||
164159948|NCT00848718|592947734|FG003|Overall Study|Progressive disease before treatment|3|||
164159949|NCT00848718|592947735|FG004|Overall Study|Progressive disease before treatment|4|||
164159950|NCT00848718|592947736|FG005|Overall Study|Progressive disease before treatment|4|||
164159951|NCT00848718|592947737|FG006|Overall Study|Progressive disease before treatment|2|||
164159952|NCT00848718|592947738|FG007|Overall Study|Progressive disease before treatment|1|||
164159953|NCT00848718|592947739|FG008|Overall Study|Progressive disease before treatment|2|||
164159954|NCT00848718|592947740|FG009|Overall Study|Progressive disease before treatment|7|||
164159955|NCT00848718|592947741|FG010|Overall Study|Progressive disease before treatment|3|||
164159956|NCT00848718|592947742|FG011|Overall Study|Progressive disease before treatment|6|||
164159957|NCT00848718|592947743|FG012|Overall Study|Progressive disease before treatment|2|||
164159958|NCT00848718|592947731|FG000|Overall Study|Protocol Violation|0|||
164159959|NCT00848718|592947732|FG001|Overall Study|Protocol Violation|1|||
164159960|NCT00848718|592947733|FG002|Overall Study|Protocol Violation|0|||
164159961|NCT00848718|592947734|FG003|Overall Study|Protocol Violation|0|||
164159962|NCT00848718|592947735|FG004|Overall Study|Protocol Violation|0|||
164159963|NCT00848718|592947736|FG005|Overall Study|Protocol Violation|0|||
164159964|NCT00848718|592947737|FG006|Overall Study|Protocol Violation|0|||
164159965|NCT00848718|592947738|FG007|Overall Study|Protocol Violation|1|||
164159966|NCT00848718|592947739|FG008|Overall Study|Protocol Violation|0|||
164159967|NCT00848718|592947740|FG009|Overall Study|Protocol Violation|0|||
164159968|NCT00848718|592947741|FG010|Overall Study|Protocol Violation|0|||
164159969|NCT00848718|592947742|FG011|Overall Study|Protocol Violation|0|||
164159970|NCT00848718|592947743|FG012|Overall Study|Protocol Violation|1|||
164159971|NCT00848718|592947731|FG000|Overall Study|Withdrawal by Subject|1|||
164159972|NCT00848718|592947732|FG001|Overall Study|Withdrawal by Subject|0|||
164159973|NCT00848718|592947733|FG002|Overall Study|Withdrawal by Subject|0|||
164159974|NCT00848718|592947734|FG003|Overall Study|Withdrawal by Subject|1|||
164159975|NCT00848718|592947735|FG004|Overall Study|Withdrawal by Subject|0|||
164159976|NCT00848718|592947736|FG005|Overall Study|Withdrawal by Subject|0|||
164159977|NCT00848718|592947737|FG006|Overall Study|Withdrawal by Subject|0|||
164159978|NCT00848718|592947738|FG007|Overall Study|Withdrawal by Subject|0|||
164159979|NCT00848718|592947739|FG008|Overall Study|Withdrawal by Subject|0|||
164159980|NCT00848718|592947740|FG009|Overall Study|Withdrawal by Subject|0|||
164159981|NCT00848718|592947741|FG010|Overall Study|Withdrawal by Subject|1|||
164159982|NCT00848718|592947742|FG011|Overall Study|Withdrawal by Subject|0|||
164159983|NCT00848718|592947743|FG012|Overall Study|Withdrawal by Subject|0|||
164159984|NCT00848718|592947731|FG000|Overall Study|Progressive disease during treatment|3|||
164159985|NCT00848718|592947732|FG001|Overall Study|Progressive disease during treatment|0|||
164159986|NCT00848718|592947733|FG002|Overall Study|Progressive disease during treatment|3|||
164159987|NCT00848718|592947734|FG003|Overall Study|Progressive disease during treatment|0|||
164159988|NCT00848718|592947735|FG004|Overall Study|Progressive disease during treatment|0|||
164159989|NCT00848718|592947736|FG005|Overall Study|Progressive disease during treatment|0|||
164159990|NCT00848718|592947737|FG006|Overall Study|Progressive disease during treatment|0|||
164159991|NCT00848718|592947738|FG007|Overall Study|Progressive disease during treatment|2|||
164159992|NCT00848718|592947739|FG008|Overall Study|Progressive disease during treatment|0|||
164159993|NCT00848718|592947740|FG009|Overall Study|Progressive disease during treatment|0|||
164159994|NCT00848718|592947741|FG010|Overall Study|Progressive disease during treatment|0|||
164159995|NCT00848718|592947742|FG011|Overall Study|Progressive disease during treatment|0|||
164159996|NCT00848718|592947743|FG012|Overall Study|Progressive disease during treatment|2|||
164159997|NCT02389829|592947744|FG000|Overall Study|Lost to Follow-up|0|||
164159998|NCT02389829|592947745|FG001|Overall Study|Lost to Follow-up|1|||
164159999|NCT04031846|592947746|FG000|Overall Study|Lost to Follow-up|4|||
164160000|NCT04031846|592947747|FG001|Overall Study|Lost to Follow-up|4|||
164160001|NCT04031846|592947746|FG000|Overall Study|Physician Decision|0|||
164160002|NCT04031846|592947747|FG001|Overall Study|Physician Decision|1|||
164160003|NCT04031846|592947746|FG000|Overall Study|Protocol Violation|1|||
164160004|NCT04031846|592947747|FG001|Overall Study|Protocol Violation|1|||
164160005|NCT04031846|592947746|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
164160006|NCT04031846|592947747|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
164160007|NCT00571727|592947748|FG000|Overall Study|Did not enter in this study|1|||
164160008|NCT00571727|592947748|FG000|Overall Study|Non-compliance|4|||
164160009|NCT00571727|592947748|FG000|Overall Study|Lost to Follow-up|30|||
164160010|NCT00571727|592947748|FG000|Overall Study|Poor growth|1|||
164160011|NCT00571727|592947748|FG000|Overall Study|Parent/patient decision|2|||
164160012|NCT00571727|592947748|FG000|Overall Study|Participant transferred to commercial drug|14|||
164160013|NCT00571727|592947748|FG000|Overall Study|Unable to provide study drug|6|||
164160014|NCT00571727|592947748|FG000|Overall Study|On-treatment at end of study|8|||
164160015|NCT01622673|592947749|FG000|Treatment Period 1|Withdrawal by Subject|0|||
164160016|NCT01622673|592947750|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164160017|NCT01622673|592947751|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164160018|NCT01622673|592947752|FG003|Treatment Period 1|Withdrawal by Subject|1|||
164160019|NCT01622673|592947753|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164160020|NCT01622673|592947754|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164160021|NCT01622673|592947749|FG000|Treatment Period 1|Protocol Violation|0|||
164160022|NCT01622673|592947750|FG001|Treatment Period 1|Protocol Violation|1|||
164160023|NCT01622673|592947751|FG002|Treatment Period 1|Protocol Violation|0|||
164160024|NCT01622673|592947752|FG003|Treatment Period 1|Protocol Violation|0|||
164160025|NCT01622673|592947753|FG004|Treatment Period 1|Protocol Violation|0|||
164160026|NCT01622673|592947754|FG005|Treatment Period 1|Protocol Violation|0|||
164160027|NCT01622673|592947749|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164160028|NCT01622673|592947750|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164160029|NCT01622673|592947751|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164160030|NCT01622673|592947752|FG003|Treatment Period 2|Withdrawal by Subject|1|||
164160031|NCT01622673|592947753|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164160032|NCT01622673|592947754|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164160033|NCT01622673|592947749|FG000|Treatment Period 3|Protocol Violation|0|||
164160034|NCT01622673|592947750|FG001|Treatment Period 3|Protocol Violation|1|||
164160035|NCT01622673|592947751|FG002|Treatment Period 3|Protocol Violation|0|||
164160036|NCT01622673|592947752|FG003|Treatment Period 3|Protocol Violation|0|||
164160037|NCT01622673|592947753|FG004|Treatment Period 3|Protocol Violation|0|||
164160038|NCT01622673|592947754|FG005|Treatment Period 3|Protocol Violation|0|||
164160039|NCT01295671|592949051|FG000|Overall Study|Lost to Follow-up|4|||
164160040|NCT01295671|592949052|FG001|Overall Study|Lost to Follow-up|6|||
164160041|NCT01295671|592949053|FG002|Overall Study|Lost to Follow-up|3|||
164160042|NCT01295671|592949051|FG000|Overall Study|Withdrawal by Subject|3|||
164160043|NCT01295671|592949052|FG001|Overall Study|Withdrawal by Subject|1|||
164160044|NCT01295671|592949053|FG002|Overall Study|Withdrawal by Subject|0|||
164160045|NCT02395848|592949056|FG000|Overall Study|Lost to Follow-up|2|||
164160046|NCT02276560|592949057|FG000|Overall Study|Adverse Event|1|||
164160047|NCT02276560|592949058|FG001|Overall Study|Adverse Event|0|||
164160048|NCT02276560|592949059|FG002|Overall Study|Adverse Event|0|||
164160049|NCT02366637|592949061|FG000|First Intervention Period|Adverse Event|0|||
164160050|NCT02366637|592949062|FG001|First Intervention Period|Adverse Event|1|||
164160051|NCT02366637|592949061|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
164160052|NCT02366637|592949062|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
164160053|NCT02366637|592949061|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
164160054|NCT02366637|592949062|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
164160055|NCT01609010|592949065|FG000|Overall Study|Stable disease (SD)|22|||
164160056|NCT01609010|592949066|FG001|Overall Study|Stable disease (SD)|16|||
164160057|NCT01609010|592949065|FG000|Overall Study|Progressive disease (PD)|8|||
164160058|NCT01609010|592949066|FG001|Overall Study|Progressive disease (PD)|10|||
164160059|NCT01609010|592949065|FG000|Overall Study|Adverse Event|3|||
164160060|NCT01609010|592949066|FG001|Overall Study|Adverse Event|6|||
164160061|NCT01609010|592949065|FG000|Overall Study|Withdrawal by Subject|2|||
164160062|NCT01609010|592949066|FG001|Overall Study|Withdrawal by Subject|2|||
164160063|NCT01609010|592949065|FG000|Overall Study|Other|2|||
164160064|NCT01609010|592949066|FG001|Overall Study|Other|0|||
164160065|NCT01609010|592949065|FG000|Overall Study|Other malignancy|1|||
164160066|NCT01609010|592949066|FG001|Overall Study|Other malignancy|0|||
164160067|NCT01609010|592949065|FG000|Overall Study|Pathology review|2|||
164160068|NCT01609010|592949066|FG001|Overall Study|Pathology review|1|||
164160069|NCT01609010|592949065|FG000|Overall Study|Protocol Violation|1|||
164160070|NCT01609010|592949066|FG001|Overall Study|Protocol Violation|1|||
164160071|NCT01609010|592949065|FG000|Overall Study|New cancer|1|||
164160072|NCT01609010|592949066|FG001|Overall Study|New cancer|0|||
164160073|NCT01609010|592949065|FG000|Overall Study|Lost to Follow-up|1|||
164160074|NCT01609010|592949066|FG001|Overall Study|Lost to Follow-up|1|||
164160075|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
164160076|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
164160077|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
164160078|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
164160079|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
164160080|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
164160081|NCT01134107|592949068|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
164160082|NCT01134107|592949069|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
164160083|NCT01134107|592949068|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
164160084|NCT01134107|592949069|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
164160085|NCT01134107|592949068|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
164160086|NCT01134107|592949069|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
164160087|NCT01134107|592949068|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
164160088|NCT01134107|592949069|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
164160089|NCT04541589|592949079|FG000|Treatment Period|Adverse Event|8|||
164160090|NCT04541589|592949080|FG001|Treatment Period|Adverse Event|2|||
164160091|NCT04541589|592949079|FG000|Treatment Period|Physician Decision|3|||
164160092|NCT04541589|592949080|FG001|Treatment Period|Physician Decision|1|||
164160093|NCT04541589|592949079|FG000|Treatment Period|Subject decision|7|||
164160094|NCT04541589|592949080|FG001|Treatment Period|Subject decision|4|||
164160095|NCT04541589|592949079|FG000|Treatment Period|Withdrawal by Subject|1|||
164160096|NCT04541589|592949080|FG001|Treatment Period|Withdrawal by Subject|0|||
164160097|NCT04541589|592949079|FG000|Safety Follow-up Period|Adverse Event|2|||
164160098|NCT04541589|592949080|FG001|Safety Follow-up Period|Adverse Event|1|||
164160099|NCT04541589|592949079|FG000|Safety Follow-up Period|Physician Decision|1|||
164160100|NCT04541589|592949080|FG001|Safety Follow-up Period|Physician Decision|0|||
164160101|NCT04541589|592949079|FG000|Safety Follow-up Period|Subject decision|5|||
164160102|NCT04541589|592949080|FG001|Safety Follow-up Period|Subject decision|3|||
164160103|NCT04541589|592949079|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
164160104|NCT04541589|592949080|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
164160105|NCT03581123|592949083|FG000|2-month Follow-up|Withdrawal by Subject|5|||
164160106|NCT03581123|592949084|FG001|2-month Follow-up|Withdrawal by Subject|4|||
164160107|NCT03581123|592949085|FG002|2-month Follow-up|Withdrawal by Subject|6|||
164160108|NCT03581123|592949086|FG003|2-month Follow-up|Withdrawal by Subject|4|||
164160109|NCT03581123|592949083|FG000|2-month Follow-up|Lost to Follow-up|8|||
164160110|NCT03581123|592949084|FG001|2-month Follow-up|Lost to Follow-up|1|||
164160111|NCT03581123|592949085|FG002|2-month Follow-up|Lost to Follow-up|2|||
164160112|NCT03581123|592949086|FG003|2-month Follow-up|Lost to Follow-up|2|||
164160113|NCT03581123|592949083|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
164160114|NCT03581123|592949084|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
164160115|NCT03581123|592949085|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
164160116|NCT03581123|592949086|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
164160117|NCT03581123|592949083|FG000|6-Month Follow-up|Lost to Follow-up|3|||
164160118|NCT03581123|592949084|FG001|6-Month Follow-up|Lost to Follow-up|3|||
164160119|NCT03581123|592949085|FG002|6-Month Follow-up|Lost to Follow-up|1|||
164160120|NCT03581123|592949086|FG003|6-Month Follow-up|Lost to Follow-up|1|||
164160121|NCT03581123|592949083|FG000|12-Month Follow-up|Lost to Follow-up|4|||
164160122|NCT03581123|592949084|FG001|12-Month Follow-up|Lost to Follow-up|3|||
164160123|NCT03581123|592949085|FG002|12-Month Follow-up|Lost to Follow-up|4|||
164160124|NCT03581123|592949086|FG003|12-Month Follow-up|Lost to Follow-up|5|||
164160125|NCT04195685|592949087|FG000|Overall Study|Withdrawal by Subject|6|||
164160126|NCT04195685|592949088|FG001|Overall Study|Withdrawal by Subject|2|||
164160127|NCT04195685|592949087|FG000|Overall Study|Lost to Follow-up|1|||
164160128|NCT04195685|592949088|FG001|Overall Study|Lost to Follow-up|4|||
164160129|NCT00455403|592949095|FG000|Overall Study|Lost to Follow-up|2|||
164160130|NCT00455403|592949096|FG001|Overall Study|Lost to Follow-up|1|||
164160131|NCT00455403|592949095|FG000|Overall Study|Withdrawal by Subject|1|||
164160132|NCT00455403|592949096|FG001|Overall Study|Withdrawal by Subject|3|||
164160133|NCT00455403|592949095|FG000|Overall Study|Protocol Violation|0|||
164160134|NCT00455403|592949096|FG001|Overall Study|Protocol Violation|2|||
164160135|NCT04509076|592949097|FG000|Overall Study|Withdrawal by Subject|1|||
164160136|NCT04509076|592949098|FG001|Overall Study|Withdrawal by Subject|2|||
164160137|NCT04509076|592949097|FG000|Overall Study|Lost to Follow-up|1|||
164160138|NCT04509076|592949098|FG001|Overall Study|Lost to Follow-up|2|||
164160139|NCT00558701|592949102|FG000|Overall Study|Protocol Deviations|1|||
164160140|NCT00558701|592949103|FG001|Overall Study|Protocol Deviations|4|||
164160141|NCT00427648|592949104|FG000|Overall Study|Protocol Violation|1|||
164160142|NCT00427648|592949105|FG001|Overall Study|Protocol Violation|2|||
164160143|NCT00427648|592949104|FG000|Overall Study|Adverse Event|0|||
164160144|NCT00427648|592949105|FG001|Overall Study|Adverse Event|1|||
164160145|NCT01532518|592949106|FG000|Overall Study|Withdrawal by Subject|0|||
164160146|NCT01532518|592949107|FG001|Overall Study|Withdrawal by Subject|0|||
164160147|NCT01532518|592949108|FG002|Overall Study|Withdrawal by Subject|1|||
164160148|NCT03591874|592949113|FG000|Overall Study|Adverse Event|4|||
164160149|NCT03591874|592949114|FG001|Overall Study|Adverse Event|0|||
164160150|NCT03591874|592949113|FG000|Overall Study|Withdrawal by Subject|2|||
164160151|NCT03591874|592949114|FG001|Overall Study|Withdrawal by Subject|1|||
164160152|NCT03591874|592949113|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
164160153|NCT03591874|592949114|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
164160154|NCT03591874|592949113|FG000|Overall Study|On Study at Time of Study Termination|12|||
164160155|NCT03591874|592949114|FG001|Overall Study|On Study at Time of Study Termination|6|||
164160156|NCT02259010|592949115|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
164160157|NCT03194542|592949116|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
164160158|NCT03194542|592949117|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
164160159|NCT03194542|592949118|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
164160160|NCT03194542|592949119|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
164160161|NCT03194542|592949116|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
164160162|NCT03194542|592949117|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
164160163|NCT03194542|592949118|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
164160164|NCT03194542|592949119|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
164160165|NCT03194542|592949116|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
164160166|NCT03194542|592949117|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
164160167|NCT03194542|592949118|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
164160168|NCT03194542|592949119|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
164160169|NCT03194542|592949116|FG000|Overall Study|Loss of Response|4|||
164160170|NCT03194542|592949117|FG001|Overall Study|Loss of Response|2|||
164160171|NCT03194542|592949118|FG002|Overall Study|Loss of Response|3|||
164160172|NCT03194542|592949119|FG003|Overall Study|Loss of Response|4|||
164160173|NCT03194542|592949116|FG000|Overall Study|Physician Decision|0|||
164160174|NCT03194542|592949117|FG001|Overall Study|Physician Decision|1|||
164160175|NCT03194542|592949118|FG002|Overall Study|Physician Decision|0|||
164160176|NCT03194542|592949119|FG003|Overall Study|Physician Decision|0|||
164160177|NCT03194542|592949116|FG000|Overall Study|Lack of Efficacy|2|||
164160178|NCT03194542|592949117|FG001|Overall Study|Lack of Efficacy|2|||
164160179|NCT03194542|592949118|FG002|Overall Study|Lack of Efficacy|2|||
164160180|NCT03194542|592949119|FG003|Overall Study|Lack of Efficacy|6|||
164160181|NCT03194542|592949116|FG000|Overall Study|Withdrawal by Subject|2|||
164160182|NCT03194542|592949117|FG001|Overall Study|Withdrawal by Subject|1|||
164160183|NCT03194542|592949118|FG002|Overall Study|Withdrawal by Subject|5|||
164160184|NCT03194542|592949119|FG003|Overall Study|Withdrawal by Subject|4|||
164160185|NCT03194542|592949116|FG000|Overall Study|Progressive Disease|1|||
164160186|NCT03194542|592949117|FG001|Overall Study|Progressive Disease|0|||
164160187|NCT03194542|592949118|FG002|Overall Study|Progressive Disease|1|||
164160188|NCT03194542|592949119|FG003|Overall Study|Progressive Disease|1|||
164160189|NCT03194542|592949116|FG000|Overall Study|Adverse Event|1|||
164160190|NCT03194542|592949117|FG001|Overall Study|Adverse Event|2|||
164160191|NCT03194542|592949118|FG002|Overall Study|Adverse Event|0|||
164160192|NCT03194542|592949119|FG003|Overall Study|Adverse Event|5|||
164160193|NCT03194542|592949116|FG000|Overall Study|Death|1|||
164160194|NCT03194542|592949117|FG001|Overall Study|Death|2|||
164160195|NCT03194542|592949118|FG002|Overall Study|Death|0|||
164160196|NCT03194542|592949119|FG003|Overall Study|Death|5|||
164160197|NCT03194542|592949116|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
164160198|NCT03194542|592949117|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
164160199|NCT03194542|592949118|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
164160200|NCT03194542|592949119|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
164160201|NCT02640664|592949122|FG000|Epoch 1|Withdrawal of informed consent|1|||
164160202|NCT02640664|592949123|FG001|Epoch 1|Withdrawal of informed consent|0|||
164160203|NCT02640664|592949124|FG002|Epoch 1|Withdrawal of informed consent|0|||
164160204|NCT02640664|592949122|FG000|Epoch 1|Death|0|||
164160205|NCT02640664|592949123|FG001|Epoch 1|Death|0|||
164160206|NCT02640664|592949124|FG002|Epoch 1|Death|1|||
164160207|NCT02640664|592949122|FG000|Epoch 2|Withdrawal of informed consent|3|||
164160208|NCT02640664|592949123|FG001|Epoch 2|Withdrawal of informed consent|4|||
164160209|NCT02640664|592949124|FG002|Epoch 2|Withdrawal of informed consent|2|||
164160210|NCT02640664|592949122|FG000|Epoch 2|Subject/guardian decision|0|||
164160211|NCT02640664|592949123|FG001|Epoch 2|Subject/guardian decision|2|||
164160212|NCT02640664|592949124|FG002|Epoch 2|Subject/guardian decision|2|||
164160213|NCT02640664|592949122|FG000|Epoch 2|Lost to Follow-up|3|||
164160214|NCT02640664|592949123|FG001|Epoch 2|Lost to Follow-up|4|||
164160215|NCT02640664|592949124|FG002|Epoch 2|Lost to Follow-up|1|||
164160216|NCT02640664|592949122|FG000|Epoch 2|Death|0|||
164160217|NCT02640664|592949123|FG001|Epoch 2|Death|0|||
164160218|NCT02640664|592949124|FG002|Epoch 2|Death|1|||
164160219|NCT05514873|592949125|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
164160220|NCT05514873|592949125|FG000|Main Treatment Period|Adverse Event|2|||
164160221|NCT05514873|592949125|FG000|Extension Treatment Period|Lost to Follow-up|3|||
164160222|NCT02729025|592949129|FG000|Overall Study|Sponsor Decision|0|||
164160223|NCT02729025|592949130|FG001|Overall Study|Sponsor Decision|1|||
164160224|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
164160225|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
164160226|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
164160227|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
164160228|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
164160229|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
164160230|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
164160231|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
164160232|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
164160233|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
164160234|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
164160235|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
164160236|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
164160237|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
164160238|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
164160239|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
164160240|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
164160241|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
164160242|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
164160243|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
164160244|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
164160245|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
164160246|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
164160247|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
164160248|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
164160249|NCT03525678|592949134|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
164160250|NCT03525678|592949135|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
164160251|NCT03525678|592949136|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
164160252|NCT03525678|592949137|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
164160253|NCT03525678|592949138|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
164160254|NCT05343000|592950838|FG000|Overall Study|Physician Decision|2|||
164160255|NCT04432831|592950839|FG000|Overall Study|Withdrawal by Subject|24|||
164160256|NCT04432831|592950840|FG001|Overall Study|Withdrawal by Subject|28|||
164160257|NCT04432831|592950841|FG002|Overall Study|Withdrawal by Subject|21|||
164160258|NCT04432831|592950839|FG000|Overall Study|Death|23|||
164160259|NCT04432831|592950840|FG001|Overall Study|Death|23|||
164160260|NCT04432831|592950841|FG002|Overall Study|Death|17|||
164160261|NCT04432831|592950839|FG000|Overall Study|Lost to Follow-up|15|||
164160262|NCT04432831|592950840|FG001|Overall Study|Lost to Follow-up|15|||
164160263|NCT04432831|592950841|FG002|Overall Study|Lost to Follow-up|12|||
164160264|NCT04432831|592950839|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
164160265|NCT04432831|592950840|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
164160266|NCT04432831|592950841|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
164160267|NCT04432831|592950839|FG000|Overall Study|Reason Not Specified|7|||
164160268|NCT04432831|592950840|FG001|Overall Study|Reason Not Specified|11|||
164160269|NCT04432831|592950841|FG002|Overall Study|Reason Not Specified|9|||
164160270|NCT04432831|592950839|FG000|Overall Study|Adverse Event|7|||
164160271|NCT04432831|592950840|FG001|Overall Study|Adverse Event|7|||
164160272|NCT04432831|592950841|FG002|Overall Study|Adverse Event|7|||
164160273|NCT04432831|592950839|FG000|Overall Study|Physician Decision|1|||
164160274|NCT04432831|592950840|FG001|Overall Study|Physician Decision|3|||
164160275|NCT04432831|592950841|FG002|Overall Study|Physician Decision|6|||
164160276|NCT04432831|592950839|FG000|Overall Study|Protocol Violation|1|||
164160277|NCT04432831|592950840|FG001|Overall Study|Protocol Violation|0|||
164160278|NCT04432831|592950841|FG002|Overall Study|Protocol Violation|2|||
164160279|NCT04432831|592950839|FG000|Overall Study|Pregnancy|0|||
164160280|NCT04432831|592950840|FG001|Overall Study|Pregnancy|1|||
164160281|NCT04432831|592950841|FG002|Overall Study|Pregnancy|0|||
164160282|NCT04432831|592950839|FG000|Overall Study|Lack of Efficacy|0|||
164160283|NCT04432831|592950840|FG001|Overall Study|Lack of Efficacy|0|||
164160284|NCT04432831|592950841|FG002|Overall Study|Lack of Efficacy|2|||
164160285|NCT03782792|592950842|FG000|Overall Study|Patient left the country|0|||
164160286|NCT03782792|592950843|FG001|Overall Study|Patient left the country|1|||
164160287|NCT03782792|592950842|FG000|Overall Study|Withdrawal by Subject|1|||
164160288|NCT03782792|592950843|FG001|Overall Study|Withdrawal by Subject|2|||
164160289|NCT00617890|592950844|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
164160290|NCT00617890|592950845|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
164160291|NCT00617890|592950846|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
164160292|NCT00617890|592950847|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
164160293|NCT00617890|592950844|FG000|Overall Study|Lack of Efficacy|23|||
164160294|NCT00617890|592950845|FG001|Overall Study|Lack of Efficacy|26|||
164160295|NCT00617890|592950846|FG002|Overall Study|Lack of Efficacy|30|||
164160296|NCT00617890|592950847|FG003|Overall Study|Lack of Efficacy|97|||
164160297|NCT00617890|592950844|FG000|Overall Study|Lost to Follow-up|0|||
164160298|NCT00617890|592950845|FG001|Overall Study|Lost to Follow-up|0|||
164160299|NCT00617890|592950846|FG002|Overall Study|Lost to Follow-up|1|||
164160300|NCT00617890|592950847|FG003|Overall Study|Lost to Follow-up|2|||
164160301|NCT00617890|592950844|FG000|Overall Study|Withdrawal by Subject|4|||
164160302|NCT00617890|592950845|FG001|Overall Study|Withdrawal by Subject|1|||
164160303|NCT00617890|592950846|FG002|Overall Study|Withdrawal by Subject|0|||
164160304|NCT00617890|592950847|FG003|Overall Study|Withdrawal by Subject|2|||
164160305|NCT00617890|592950844|FG000|Overall Study|Protocol Violation|2|||
164160306|NCT00617890|592950845|FG001|Overall Study|Protocol Violation|1|||
164160307|NCT00617890|592950846|FG002|Overall Study|Protocol Violation|0|||
164160308|NCT00617890|592950847|FG003|Overall Study|Protocol Violation|0|||
164160309|NCT00617890|592950844|FG000|Overall Study|Adverse Event|1|||
164160310|NCT00617890|592950845|FG001|Overall Study|Adverse Event|0|||
164160311|NCT00617890|592950846|FG002|Overall Study|Adverse Event|3|||
164160312|NCT00617890|592950847|FG003|Overall Study|Adverse Event|8|||
164160313|NCT00617890|592950844|FG000|Overall Study|Not treated|1|||
164160314|NCT00617890|592950845|FG001|Overall Study|Not treated|0|||
164160315|NCT00617890|592950846|FG002|Overall Study|Not treated|1|||
164160316|NCT00617890|592950847|FG003|Overall Study|Not treated|1|||
164160317|NCT00154284|592950851|FG000|Overall Study|Adverse Event|6|||
164160318|NCT00154284|592950852|FG001|Overall Study|Adverse Event|9|||
164160319|NCT00154284|592950851|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164160320|NCT00154284|592950852|FG001|Overall Study|Abnormal laboratory value(s)|1|||
164160321|NCT00154284|592950851|FG000|Overall Study|Lack of Efficacy|1|||
164160322|NCT00154284|592950852|FG001|Overall Study|Lack of Efficacy|2|||
164160323|NCT00154284|592950851|FG000|Overall Study|Protocol Violation|0|||
164160324|NCT00154284|592950852|FG001|Overall Study|Protocol Violation|1|||
164160325|NCT02058537|592950861|FG000|Overall Study|Withdrawal by Subject|1|||
164160326|NCT01780038|592950864|FG000|Overall Study|Lost to Follow-up|4|||
164160327|NCT01780038|592950865|FG001|Overall Study|Lost to Follow-up|1|||
164160328|NCT01085630|592950866|FG000|Overall Study|Insufficient data|1|||
164160329|NCT01085630|592950867|FG001|Overall Study|Insufficient data|0|||
164160330|NCT01085630|592950866|FG000|Overall Study|Ineligible|3|||
164160331|NCT01085630|592950867|FG001|Overall Study|Ineligible|0|||
164160332|NCT02609607|592950873|FG000|Overall Study|Lost to Follow-up|0|||
164160333|NCT02609607|592950874|FG001|Overall Study|Lost to Follow-up|1|||
164160334|NCT03691207|592950880|FG000|Overall Study|Death|41|||
164160335|NCT03691207|592950881|FG001|Overall Study|Death|26|||
164160336|NCT03691207|592950880|FG000|Overall Study|Lost to Follow-up|1|||
164160337|NCT03691207|592950881|FG001|Overall Study|Lost to Follow-up|1|||
164160338|NCT03691207|592950880|FG000|Overall Study|Withdrawal by Subject|2|||
164160339|NCT03691207|592950881|FG001|Overall Study|Withdrawal by Subject|8|||
164160340|NCT03691207|592950880|FG000|Overall Study|Sponsor decision|1|||
164160341|NCT03691207|592950881|FG001|Overall Study|Sponsor decision|7|||
164160342|NCT00651261|592950882|FG000|Overall Study|Adverse Event|32|||
164160343|NCT00651261|592950883|FG001|Overall Study|Adverse Event|22|||
164160344|NCT00651261|592950882|FG000|Overall Study|Death|18|||
164160345|NCT00651261|592950883|FG001|Overall Study|Death|18|||
164160346|NCT00651261|592950882|FG000|Overall Study|Withdrawal by Subject|22|||
164160347|NCT00651261|592950883|FG001|Overall Study|Withdrawal by Subject|40|||
164160348|NCT00651261|592950882|FG000|Overall Study|Induction failure|24|||
164160349|NCT00651261|592950883|FG001|Overall Study|Induction failure|35|||
164160350|NCT00651261|592950882|FG000|Overall Study|Disease progression|58|||
164160351|NCT00651261|592950883|FG001|Overall Study|Disease progression|58|||
164160352|NCT00651261|592950882|FG000|Overall Study|Alternative therapy|109|||
164160353|NCT00651261|592950883|FG001|Overall Study|Alternative therapy|107|||
164160354|NCT00651261|592950882|FG000|Overall Study|Other disease or participant decisions|23|||
164160355|NCT00651261|592950883|FG001|Overall Study|Other disease or participant decisions|23|||
164160356|NCT00651261|592950882|FG000|Overall Study|Never treated|5|||
164160357|NCT00651261|592950883|FG001|Overall Study|Never treated|3|||
164160358|NCT02027545|592950884|FG000|Overall Study|Failed to sign HIPAA|0|||
164160359|NCT02027545|592950885|FG001|Overall Study|Failed to sign HIPAA|2|||
164160360|NCT02027545|592950884|FG000|Overall Study|Failed to attend study visit|2|||
164160361|NCT02027545|592950885|FG001|Overall Study|Failed to attend study visit|0|||
164160362|NCT02027545|592950884|FG000|Overall Study|Protocol Violation|1|||
164160363|NCT02027545|592950885|FG001|Overall Study|Protocol Violation|0|||
164160364|NCT03351608|592950886|FG000|Overall Study|Lost to Follow-up|0|||
164160365|NCT03351608|592950887|FG001|Overall Study|Lost to Follow-up|1|||
164160366|NCT03351608|592950888|FG002|Overall Study|Lost to Follow-up|1|||
164160367|NCT03351608|592950889|FG003|Overall Study|Lost to Follow-up|1|||
164160368|NCT03351608|592950890|FG004|Overall Study|Lost to Follow-up|1|||
164160369|NCT03351608|592950886|FG000|Overall Study|Physician Decision|1|||
164160370|NCT03351608|592950887|FG001|Overall Study|Physician Decision|0|||
164160371|NCT03351608|592950888|FG002|Overall Study|Physician Decision|0|||
164160372|NCT03351608|592950889|FG003|Overall Study|Physician Decision|2|||
164160373|NCT03351608|592950890|FG004|Overall Study|Physician Decision|1|||
164160374|NCT03351608|592950886|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
164160375|NCT03351608|592950887|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
164160376|NCT03351608|592950888|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
164160377|NCT03351608|592950889|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
164160378|NCT03351608|592950890|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
164160379|NCT03351608|592950886|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164160380|NCT03351608|592950887|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164160381|NCT03351608|592950888|FG002|Overall Study|Withdrawal by parent/guardian|1|||
164160382|NCT03351608|592950889|FG003|Overall Study|Withdrawal by parent/guardian|1|||
164160383|NCT03351608|592950890|FG004|Overall Study|Withdrawal by parent/guardian|0|||
164160384|NCT03351608|592950886|FG000|Overall Study|Other|0|||
164160385|NCT03351608|592950887|FG001|Overall Study|Other|1|||
164160386|NCT03351608|592950888|FG002|Overall Study|Other|1|||
164160387|NCT03351608|592950889|FG003|Overall Study|Other|3|||
164160388|NCT03351608|592950890|FG004|Overall Study|Other|0|||
164160389|NCT02877004|592950891|FG000|Overall Study|Pregnancy|0|||
164160390|NCT02877004|592950892|FG001|Overall Study|Pregnancy|0|||
164160391|NCT02877004|592950893|FG002|Overall Study|Pregnancy|1|||
164160392|NCT02727478|592950894|FG000|Overall Study|Withdrawal by Subject|8|||
164160393|NCT02727478|592950895|FG001|Overall Study|Withdrawal by Subject|10|||
164160394|NCT02633293|592950896|FG000|Overall Study|Death|56|||
164160395|NCT02633293|592950896|FG000|Overall Study|Progressive Disease|12|||
164160396|NCT02633293|592950896|FG000|Overall Study|Adverse Event|29|||
164160397|NCT02633293|592950896|FG000|Overall Study|Withdrawal by Subject|41|||
164160398|NCT02633293|592950896|FG000|Overall Study|Protocol Violation|1|||
164160399|NCT02633293|592950896|FG000|Overall Study|Lost to Follow-up|1|||
164160400|NCT02633293|592950896|FG000|Overall Study|Study Terminated by Sponsor|24|||
164160401|NCT02633293|592950896|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
164160402|NCT02633293|592950896|FG000|Overall Study|Lung Transplant|5|||
164160403|NCT02633293|592950896|FG000|Overall Study|Lack of Efficacy|2|||
164160404|NCT02633293|592950896|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
164160405|NCT01343043|592950897|FG000|Overall Study|Disease progression before treatment|1|||
164160406|NCT01343043|592950898|FG001|Overall Study|Disease progression before treatment|0|||
164160407|NCT01343043|592950899|FG002|Overall Study|Disease progression before treatment|0|||
164160408|NCT01343043|592950900|FG003|Overall Study|Disease progression before treatment|0|||
164160409|NCT01343043|592950897|FG000|Overall Study|Withdrawal by Subject|1|||
164160410|NCT01343043|592950898|FG001|Overall Study|Withdrawal by Subject|0|||
164160411|NCT01343043|592950899|FG002|Overall Study|Withdrawal by Subject|0|||
164160412|NCT01343043|592950900|FG003|Overall Study|Withdrawal by Subject|0|||
164160413|NCT01343043|592950897|FG000|Overall Study|Death|1|||
164160414|NCT01343043|592950898|FG001|Overall Study|Death|1|||
164160415|NCT01343043|592950899|FG002|Overall Study|Death|0|||
164160416|NCT01343043|592950900|FG003|Overall Study|Death|1|||
164160417|NCT00502242|592950909|FG000|Overall Study|Lack of Efficacy|1|||
164160418|NCT00502242|592950910|FG001|Overall Study|Lack of Efficacy|11|||
164160419|NCT00502242|592950909|FG000|Overall Study|Adverse Event|31|||
164160420|NCT00502242|592950910|FG001|Overall Study|Adverse Event|20|||
164160421|NCT00502242|592950909|FG000|Overall Study|Physician Decision|2|||
164160422|NCT00502242|592950910|FG001|Overall Study|Physician Decision|3|||
164160423|NCT00502242|592950909|FG000|Overall Study|Other - Unspecified|8|||
164160424|NCT00502242|592950910|FG001|Overall Study|Other - Unspecified|14|||
164160425|NCT00502242|592950909|FG000|Overall Study|Protocol Violation|3|||
164160426|NCT00502242|592950910|FG001|Overall Study|Protocol Violation|1|||
164160427|NCT00502242|592950909|FG000|Overall Study|Withdrawal by Subject|6|||
164160428|NCT00502242|592950910|FG001|Overall Study|Withdrawal by Subject|7|||
164160429|NCT00778817|592950911|FG000|Overall Study|Adverse Event|2|||
164160430|NCT00778817|592950911|FG000|Overall Study|Withdrawal by Subject|2|||
164160431|NCT02509507|592950912|FG000|Overall Study|Death|21|||
164160432|NCT02509507|592950913|FG001|Overall Study|Death|3|||
164160433|NCT02509507|592950914|FG002|Overall Study|Death|22|||
164160434|NCT02509507|592950915|FG003|Overall Study|Death|14|||
164160435|NCT02509507|592950916|FG004|Overall Study|Death|8|||
164160436|NCT02509507|592950917|FG005|Overall Study|Death|12|||
164160437|NCT02509507|592950918|FG006|Overall Study|Death|5|||
164160438|NCT02509507|592950919|FG007|Overall Study|Death|4|||
164160439|NCT02509507|592950920|FG008|Overall Study|Death|8|||
164160440|NCT02509507|592950912|FG000|Overall Study|Lost to Follow-up|0|||
164160441|NCT02509507|592950913|FG001|Overall Study|Lost to Follow-up|1|||
164160442|NCT02509507|592950914|FG002|Overall Study|Lost to Follow-up|0|||
164160443|NCT02509507|592950915|FG003|Overall Study|Lost to Follow-up|0|||
164160444|NCT02509507|592950916|FG004|Overall Study|Lost to Follow-up|0|||
164160445|NCT02509507|592950917|FG005|Overall Study|Lost to Follow-up|2|||
164160446|NCT02509507|592950918|FG006|Overall Study|Lost to Follow-up|0|||
164160447|NCT02509507|592950919|FG007|Overall Study|Lost to Follow-up|0|||
164160448|NCT02509507|592950920|FG008|Overall Study|Lost to Follow-up|0|||
164160449|NCT02509507|592950912|FG000|Overall Study|Withdrawal by Subject|2|||
164160450|NCT02509507|592950913|FG001|Overall Study|Withdrawal by Subject|0|||
164160451|NCT02509507|592950914|FG002|Overall Study|Withdrawal by Subject|1|||
164160452|NCT02509507|592950915|FG003|Overall Study|Withdrawal by Subject|4|||
164160453|NCT02509507|592950916|FG004|Overall Study|Withdrawal by Subject|1|||
164160454|NCT02509507|592950917|FG005|Overall Study|Withdrawal by Subject|3|||
164160455|NCT02509507|592950918|FG006|Overall Study|Withdrawal by Subject|4|||
164160456|NCT02509507|592950919|FG007|Overall Study|Withdrawal by Subject|0|||
164160457|NCT02509507|592950920|FG008|Overall Study|Withdrawal by Subject|1|||
164160458|NCT02356588|592950921|FG000|Overall Study|Lack of Efficacy|4|||
164160459|NCT02356588|592950922|FG001|Overall Study|Lack of Efficacy|10|||
164160460|NCT02356588|592950921|FG000|Overall Study|Adverse Event|0|||
164160461|NCT02356588|592950922|FG001|Overall Study|Adverse Event|2|||
164160462|NCT02356588|592950921|FG000|Overall Study|Withdrawal by Subject|1|||
164160463|NCT02356588|592950922|FG001|Overall Study|Withdrawal by Subject|0|||
164160464|NCT02356588|592950921|FG000|Overall Study|Protocol Violation|0|||
164160465|NCT02356588|592950922|FG001|Overall Study|Protocol Violation|1|||
164160466|NCT01418378|592950923|FG000|Overall Study|Death|1|||
164160467|NCT01418378|592950924|FG001|Overall Study|Death|2|||
164160468|NCT01418378|592950923|FG000|Overall Study|Physician Decision|0|||
164160469|NCT01418378|592950924|FG001|Overall Study|Physician Decision|1|||
164160470|NCT01418378|592950923|FG000|Overall Study|ligament imbalance|0|||
164160471|NCT01418378|592950924|FG001|Overall Study|ligament imbalance|1|||
164160472|NCT01418378|592950923|FG000|Overall Study|developed chronic myopathy|0|||
164160473|NCT01418378|592950924|FG001|Overall Study|developed chronic myopathy|1|||
164160474|NCT01812109|592950929|FG000|Overall Study|research personnel delay|16|||
164160475|NCT01812109|592950929|FG000|Overall Study|NIRS Unattainable|17|||
164160476|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
164160477|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
164160478|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Death|0|||
164160479|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Death|1|||
164160480|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
164160481|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
164160482|NCT00442897|592950930|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
164160483|NCT00442897|592950931|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
164160484|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
164160485|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
164160486|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
164160487|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
164160488|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
164160489|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
164160490|NCT00442897|592950930|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
164160787|NCT04157348|592952984|FG001|Open-label Extension Period|Death|1|||
164160491|NCT00442897|592950931|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
164160492|NCT03448419|592950932|FG000|Overall Study|Adverse Event|10|||
164160493|NCT03448419|592950933|FG001|Overall Study|Adverse Event|9|||
164160494|NCT03448419|592950932|FG000|Overall Study|Lost to Follow-up|0|||
164160495|NCT03448419|592950933|FG001|Overall Study|Lost to Follow-up|2|||
164160496|NCT03448419|592950932|FG000|Overall Study|Withdrawal by Subject|3|||
164160497|NCT03448419|592950933|FG001|Overall Study|Withdrawal by Subject|1|||
164160498|NCT03448419|592950932|FG000|Overall Study|Not treated|0|||
164160499|NCT03448419|592950933|FG001|Overall Study|Not treated|1|||
164160500|NCT03448419|592950932|FG000|Overall Study|Patient did not attend all visits|0|||
164160501|NCT03448419|592950933|FG001|Overall Study|Patient did not attend all visits|2|||
164160502|NCT03448419|592950932|FG000|Overall Study|Withdrawn by Sponsor|0|||
164160503|NCT03448419|592950933|FG001|Overall Study|Withdrawn by Sponsor|1|||
164160504|NCT04548193|592950944|FG000|Overall Study|Lost to Follow-up|0|||
164160505|NCT04548193|592950945|FG001|Overall Study|Lost to Follow-up|1|||
164160506|NCT04548193|592950944|FG000|Overall Study|Death|0|||
164160507|NCT04548193|592950945|FG001|Overall Study|Death|1|||
164160508|NCT04548193|592950944|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
164160509|NCT04548193|592950945|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
164160510|NCT04548193|592950944|FG000|Overall Study|Withdrawal by Subject|2|||
164160511|NCT04548193|592950945|FG001|Overall Study|Withdrawal by Subject|2|||
164160512|NCT00630825|592950946|FG000|Overall Study|Adverse Event|4|||
164160513|NCT00630825|592950947|FG001|Overall Study|Adverse Event|4|||
164160514|NCT00630825|592950948|FG002|Overall Study|Adverse Event|3|||
164160515|NCT00630825|592950949|FG003|Overall Study|Adverse Event|1|||
164160516|NCT00630825|592950946|FG000|Overall Study|Entry Criteria Not Met|1|||
164160517|NCT00630825|592950947|FG001|Overall Study|Entry Criteria Not Met|0|||
164160518|NCT00630825|592950948|FG002|Overall Study|Entry Criteria Not Met|2|||
164160519|NCT00630825|592950949|FG003|Overall Study|Entry Criteria Not Met|1|||
164160520|NCT00630825|592950946|FG000|Overall Study|Lost to Follow-up|1|||
164160521|NCT00630825|592950947|FG001|Overall Study|Lost to Follow-up|1|||
164160522|NCT00630825|592950948|FG002|Overall Study|Lost to Follow-up|1|||
164160523|NCT00630825|592950949|FG003|Overall Study|Lost to Follow-up|1|||
164160524|NCT00630825|592950946|FG000|Overall Study|Physician Decision|1|||
164160525|NCT00630825|592950947|FG001|Overall Study|Physician Decision|0|||
164160526|NCT00630825|592950948|FG002|Overall Study|Physician Decision|0|||
164160527|NCT00630825|592950949|FG003|Overall Study|Physician Decision|0|||
164160528|NCT00630825|592950946|FG000|Overall Study|Withdrawal by Subject|2|||
164160529|NCT00630825|592950947|FG001|Overall Study|Withdrawal by Subject|2|||
164160530|NCT00630825|592950948|FG002|Overall Study|Withdrawal by Subject|2|||
164160531|NCT00630825|592950949|FG003|Overall Study|Withdrawal by Subject|3|||
164160532|NCT04610346|592950950|FG000|Overall Study|Withdrawal by Subject|1|||
164160533|NCT04610346|592950951|FG001|Overall Study|Withdrawal by Subject|1|||
164160534|NCT04610346|592950950|FG000|Overall Study|did not complete shelter onboarding|2|||
164160535|NCT04610346|592950951|FG001|Overall Study|did not complete shelter onboarding|1|||
164160536|NCT00931255|592950952|FG000|Overall Study|Follow up biopsy not done|2|||
164160537|NCT00931255|592950953|FG001|Overall Study|Follow up biopsy not done|3|||
164160538|NCT02019264|592950956|FG000|Overall Study|Not treated|6|||
164160539|NCT02019264|592950957|FG001|Overall Study|Not treated|4|||
164160540|NCT02019264|592950956|FG000|Overall Study|Lost to Follow-up|50|||
164160541|NCT02019264|592950957|FG001|Overall Study|Lost to Follow-up|47|||
164160542|NCT02019264|592950956|FG000|Overall Study|Withdrawal by Subject|142|||
164160543|NCT02019264|592950957|FG001|Overall Study|Withdrawal by Subject|117|||
164160544|NCT02019264|592950956|FG000|Overall Study|Administrative reason|36|||
164160545|NCT02019264|592950957|FG001|Overall Study|Administrative reason|28|||
164160546|NCT02019264|592950956|FG000|Overall Study|Missing|14|||
164160547|NCT02019264|592950957|FG001|Overall Study|Missing|11|||
164160548|NCT02187198|592950958|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
164160549|NCT02187198|592950959|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
164160550|NCT02187198|592950958|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
164160551|NCT02187198|592950959|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
164160552|NCT00546377|592950960|FG000|Overall Study|Deemed ineligible|1|||
164160553|NCT00546377|592950960|FG000|Overall Study|Adverse Event|6|||
164160554|NCT01575834|592950961|FG000|Overall Study|Withdrawal by Subject|352|||
164160555|NCT01575834|592950962|FG001|Overall Study|Withdrawal by Subject|390|||
164160556|NCT01575834|592950961|FG000|Overall Study|Death|81|||
164160557|NCT01575834|592950962|FG001|Overall Study|Death|74|||
164160558|NCT01575834|592950961|FG000|Overall Study|Other|70|||
164160559|NCT01575834|592950962|FG001|Overall Study|Other|70|||
164160560|NCT01575834|592950961|FG000|Overall Study|Adverse Event|63|||
164160561|NCT01575834|592950962|FG001|Overall Study|Adverse Event|61|||
164160562|NCT01575834|592950961|FG000|Overall Study|Lost to Follow-up|55|||
164160563|NCT01575834|592950962|FG001|Overall Study|Lost to Follow-up|68|||
164160564|NCT01575834|592950961|FG000|Overall Study|Noncompliance|52|||
164160565|NCT01575834|592950962|FG001|Overall Study|Noncompliance|27|||
164160566|NCT01575834|592950961|FG000|Overall Study|Administrative decision|15|||
164160567|NCT01575834|592950962|FG001|Overall Study|Administrative decision|33|||
164160568|NCT01575834|592950961|FG000|Overall Study|Ineligibility Determined|5|||
164160569|NCT01575834|592950962|FG001|Overall Study|Ineligibility Determined|8|||
164160570|NCT01575834|592950961|FG000|Overall Study|Protocol Deviation|4|||
164160571|NCT01575834|592950962|FG001|Overall Study|Protocol Deviation|3|||
164160572|NCT01575834|592950961|FG000|Overall Study|Requirement for Alternative Therapy|2|||
164160573|NCT01575834|592950962|FG001|Overall Study|Requirement for Alternative Therapy|4|||
164160574|NCT00488644|592950964|FG000|Overall Study|Not Eligible|1|||
164160575|NCT00488644|592950964|FG000|Overall Study|Not Evaluable|1|||
164160576|NCT01956773|592950971|FG000|Overall Study|Lost to Follow-up|628|||
164160577|NCT01956773|592950972|FG001|Overall Study|Lost to Follow-up|1|||
164160578|NCT01383174|592950973|FG000|3 Month Assessment|Death|0|||
164160579|NCT01383174|592950974|FG001|3 Month Assessment|Death|1|||
164160580|NCT01383174|592950973|FG000|3 Month Assessment|Lost to Follow-up|2|||
164160581|NCT01383174|592950974|FG001|3 Month Assessment|Lost to Follow-up|0|||
164160582|NCT01383174|592950973|FG000|3 Month Assessment|Refused to complete|4|||
164160583|NCT01383174|592950974|FG001|3 Month Assessment|Refused to complete|0|||
164160584|NCT01383174|592950973|FG000|6 Month Assessment|Lost to Follow-up|1|||
164160585|NCT01383174|592950974|FG001|6 Month Assessment|Lost to Follow-up|1|||
164160586|NCT01383174|592950973|FG000|6 Month Assessment|Refused to complete|4|||
164160587|NCT01383174|592950974|FG001|6 Month Assessment|Refused to complete|0|||
164160588|NCT01153815|592950977|FG000|Overall Study|Adverse Event|3|||
164160589|NCT01153815|592950978|FG001|Overall Study|Adverse Event|1|||
164160590|NCT01153815|592950977|FG000|Overall Study|Withdrawal by Subject|6|||
164160591|NCT01153815|592950978|FG001|Overall Study|Withdrawal by Subject|4|||
164160592|NCT02169271|592950979|FG000|Overall Study|Protocol Violation|1|||
164160593|NCT02169271|592950980|FG001|Overall Study|Protocol Violation|2|||
164160594|NCT04926831|592950981|FG000|Overall Study|Withdrawal by Subject|2|||
164160595|NCT04926831|592950981|FG000|Overall Study|Adverse Event|2|||
164160596|NCT00564850|592950982|FG000|Overall Study|Protocol Violation|2|||
164160597|NCT00030901|592950985|FG000|Initial Registration|Ineligible|167|||
164160598|NCT00030901|592950986|FG001|Initial Registration|Ineligible|0|||
164160599|NCT00030901|592950987|FG002|Initial Registration|Ineligible|0|||
164160600|NCT00030901|592950985|FG000|Randomization|Adverse Event|0|||
164160601|NCT00030901|592950986|FG001|Randomization|Adverse Event|11|||
164160602|NCT00030901|592950987|FG002|Randomization|Adverse Event|7|||
164160603|NCT00030901|592950985|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
164160604|NCT00030901|592950986|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
164160605|NCT00030901|592950987|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
164160606|NCT00030901|592950985|FG000|Randomization|Progression/Relapse|0|||
164160607|NCT00030901|592950986|FG001|Randomization|Progression/Relapse|22|||
164160608|NCT00030901|592950987|FG002|Randomization|Progression/Relapse|21|||
164160609|NCT00030901|592950985|FG000|Randomization|Death|0|||
164160610|NCT00030901|592950986|FG001|Randomization|Death|1|||
164160611|NCT00030901|592950987|FG002|Randomization|Death|3|||
164160612|NCT00030901|592950985|FG000|Randomization|Other|0|||
164160613|NCT00030901|592950986|FG001|Randomization|Other|36|||
164160614|NCT00030901|592950987|FG002|Randomization|Other|33|||
164160615|NCT00030901|592950985|FG000|Randomization|Ineligible|0|||
164160616|NCT00030901|592950986|FG001|Randomization|Ineligible|15|||
164160617|NCT00030901|592950987|FG002|Randomization|Ineligible|14|||
164160618|NCT01806051|592950990|FG000|Overall Study|Withdrawal by Subject|6|||
164160619|NCT02576847|592950991|FG000|Overall Study|Adverse Event|27|||
164160620|NCT02576847|592950991|FG000|Overall Study|Lost to Follow-up|22|||
164160621|NCT02576847|592950991|FG000|Overall Study|Physician Decision|1|||
164160622|NCT02576847|592950991|FG000|Overall Study|Pregnancy|1|||
164160623|NCT02576847|592950991|FG000|Overall Study|Protocol Violation|3|||
164160624|NCT02576847|592950991|FG000|Overall Study|Withdrawal by Subject|78|||
164160625|NCT02576847|592950991|FG000|Overall Study|Other|5|||
164160626|NCT01205776|592950992|FG000|Overall Study|Lost to Follow-up|53|||
164160627|NCT01205776|592950993|FG001|Overall Study|Lost to Follow-up|61|||
164160628|NCT01205776|592950992|FG000|Overall Study|Withdrawal by Subject|11|||
164160629|NCT01205776|592950993|FG001|Overall Study|Withdrawal by Subject|34|||
164160630|NCT02418182|592950994|FG000|Overall Study|Unable to re-consent|18|||
164160631|NCT02418182|592950995|FG001|Overall Study|Unable to re-consent|15|||
164160632|NCT02418182|592950994|FG000|Overall Study|Lost to Follow-up|0|||
164160633|NCT02418182|592950995|FG001|Overall Study|Lost to Follow-up|2|||
164160634|NCT02431676|592950996|FG000|Overall Study|no lab obtained|0|||
164160635|NCT02431676|592950997|FG001|Overall Study|no lab obtained|1|||
164160636|NCT02431676|592950998|FG002|Overall Study|no lab obtained|2|||
164160637|NCT00298272|592952922|FG000|Double-blind Phase|Adverse Event|2|||
164160638|NCT00298272|592952923|FG001|Double-blind Phase|Adverse Event|0|||
164160639|NCT00298272|592952922|FG000|Double-blind Phase|Failure to Return|2|||
164160640|NCT00298272|592952923|FG001|Double-blind Phase|Failure to Return|0|||
164160641|NCT00298272|592952922|FG000|Double-blind Phase|Protocol Violation|2|||
164160642|NCT00298272|592952923|FG001|Double-blind Phase|Protocol Violation|0|||
164160643|NCT00298272|592952922|FG000|Double-blind Phase|Withdrawal by Subject|2|||
164160644|NCT00298272|592952923|FG001|Double-blind Phase|Withdrawal by Subject|0|||
164160645|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Adverse Event|1|||
164160646|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Adverse Event|2|||
164160647|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
164160648|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
164160649|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Failure to Return|1|||
164160650|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Failure to Return|0|||
164160651|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
164160652|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
164160653|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
164160654|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
164160655|NCT00298272|592952922|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
164160656|NCT00298272|592952923|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
164160657|NCT00298272|592952922|FG000|Safety Follow-up Phase|Failure to Return|1|||
164160658|NCT00298272|592952923|FG001|Safety Follow-up Phase|Failure to Return|1|||
164160659|NCT00298272|592952922|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
164160660|NCT00298272|592952923|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
164160661|NCT00298272|592952922|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
164160662|NCT00298272|592952923|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
164160663|NCT05253573|592952924|FG000|Overall Study|Death|1|||
164160664|NCT05253573|592952925|FG001|Overall Study|Death|0|||
164160665|NCT01344824|592952926|FG000|Overall Study|Adverse Event|15|||
164160666|NCT01344824|592952926|FG000|Overall Study|Withdrawal by Subject|6|||
164160667|NCT01344824|592952926|FG000|Overall Study|Other complicating disease|1|||
164160668|NCT01344824|592952926|FG000|Overall Study|Progression|15|||
164160669|NCT00566020|592952927|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
164160670|NCT00566020|592952928|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
164160671|NCT00566020|592952927|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
164160672|NCT00566020|592952928|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
164160673|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
164160674|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
164160675|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
164160676|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
164160677|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
164160678|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
164160679|NCT00566020|592952927|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
164160680|NCT00566020|592952928|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
164160681|NCT01754129|592952929|FG000|Overall Study|Death|13|||
164160682|NCT01754129|592952929|FG000|Overall Study|Duodopa discontinuation|9|||
164160683|NCT01754129|592952929|FG000|Overall Study|Lost to Follow-up|7|||
164160684|NCT01754129|592952929|FG000|Overall Study|Withdrew consent|1|||
164160685|NCT01754129|592952929|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
164160686|NCT02126579|592952930|FG000|Overall Study|disease progression|0|||
164160687|NCT02126579|592952931|FG001|Overall Study|disease progression|0|||
164160688|NCT02126579|592952932|FG002|Overall Study|disease progression|0|||
164160689|NCT02126579|592952933|FG003|Overall Study|disease progression|1|||
164160690|NCT02126579|592952934|FG004|Overall Study|disease progression|0|||
164160691|NCT02126579|592952935|FG005|Overall Study|disease progression|0|||
164160692|NCT02126579|592952936|FG006|Overall Study|disease progression|1|||
164160693|NCT04630002|592952937|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
164160694|NCT04630002|592952938|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160695|NCT04630002|592952939|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160696|NCT04630002|592952937|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
164160697|NCT04630002|592952938|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160698|NCT04630002|592952939|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160699|NCT04630002|592952937|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
164160700|NCT04630002|592952938|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160701|NCT04630002|592952939|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160702|NCT04630002|592952937|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160703|NCT04630002|592952938|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
164160704|NCT04630002|592952939|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
164160705|NCT04630002|592952937|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160706|NCT04630002|592952938|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
164160707|NCT04630002|592952939|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
164160708|NCT04630002|592952937|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160709|NCT04630002|592952938|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
164160710|NCT04630002|592952939|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
164160711|NCT04630002|592952937|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
164160712|NCT04630002|592952938|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
164160713|NCT04630002|592952939|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
164161076|NCT03483961|592954922|FG001|Overall Study|Adverse Event|0|||
164160714|NCT04630002|592952937|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
164160715|NCT04630002|592952938|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
164160716|NCT04630002|592952939|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
164160717|NCT04498182|592952941|FG000|Overall Study|Adverse Event|2|||
164160718|NCT04498182|592952942|FG001|Overall Study|Adverse Event|3|||
164160719|NCT04498182|592952943|FG002|Overall Study|Adverse Event|2|||
164160720|NCT04498182|592952941|FG000|Overall Study|Withdrawal of Consent|3|||
164160721|NCT04498182|592952942|FG001|Overall Study|Withdrawal of Consent|4|||
164160722|NCT04498182|592952943|FG002|Overall Study|Withdrawal of Consent|3|||
164160723|NCT04498182|592952941|FG000|Overall Study|Non-Compliant|1|||
164160724|NCT04498182|592952942|FG001|Overall Study|Non-Compliant|0|||
164160725|NCT04498182|592952943|FG002|Overall Study|Non-Compliant|1|||
164160726|NCT04498182|592952941|FG000|Overall Study|Lost to Follow-up|0|||
164160727|NCT04498182|592952942|FG001|Overall Study|Lost to Follow-up|0|||
164160728|NCT04498182|592952943|FG002|Overall Study|Lost to Follow-up|1|||
164160729|NCT04498182|592952941|FG000|Overall Study|Investigator Decision|0|||
164160730|NCT04498182|592952942|FG001|Overall Study|Investigator Decision|0|||
164160731|NCT04498182|592952943|FG002|Overall Study|Investigator Decision|1|||
164160732|NCT04498182|592952941|FG000|Overall Study|Protocol Violation|1|||
164160733|NCT04498182|592952942|FG001|Overall Study|Protocol Violation|0|||
164160734|NCT04498182|592952943|FG002|Overall Study|Protocol Violation|2|||
164160735|NCT02182843|592952944|FG000|Overall Study|Withdrawal by Subject|7|||
164160736|NCT02182843|592952944|FG000|Overall Study|Lost to Follow-up|2|||
164160737|NCT02182843|592952944|FG000|Overall Study|Adverse Event|1|||
164160738|NCT00288626|592952956|FG000|Overall Study|Death|3|||
164160739|NCT00288626|592952956|FG000|Overall Study|Withdrawal by Subject|4|||
164160740|NCT01372618|592952957|FG000|Overall Study|PI Died. Study Terminated|9|||
164160741|NCT00558467|592952958|FG000|Overall Study|Adverse Event|1|||
164160742|NCT00558467|592952959|FG001|Overall Study|Adverse Event|2|||
164160743|NCT00558467|592952958|FG000|Overall Study|Lack of Efficacy|0|||
164160744|NCT00558467|592952959|FG001|Overall Study|Lack of Efficacy|1|||
164160745|NCT00558467|592952958|FG000|Overall Study|Patient moving out of state|0|||
164160746|NCT00558467|592952959|FG001|Overall Study|Patient moving out of state|1|||
164160747|NCT01684423|592952962|FG000|Overall Study|Withdrawal by Subject|0|||
164160748|NCT01684423|592952963|FG001|Overall Study|Withdrawal by Subject|0|||
164160749|NCT01684423|592952964|FG002|Overall Study|Withdrawal by Subject|1|||
164160750|NCT01684423|592952965|FG003|Overall Study|Withdrawal by Subject|0|||
164160751|NCT01684423|592952966|FG004|Overall Study|Withdrawal by Subject|0|||
164160752|NCT01741688|592952967|FG000|Overall Study|Lack of insurance coverage|2|||
164160753|NCT01741688|592952967|FG000|Overall Study|Withdrawal by Subject|1|||
164160754|NCT03850496|592952972|FG000|Overall Study|Withdrawal by Subject|1|||
164160755|NCT03850496|592952973|FG001|Overall Study|Withdrawal by Subject|0|||
164160756|NCT03850496|592952974|FG002|Overall Study|Withdrawal by Subject|0|||
164160757|NCT03850496|592952972|FG000|Overall Study|Lost to Follow-up|0|||
164160758|NCT03850496|592952973|FG001|Overall Study|Lost to Follow-up|1|||
164160759|NCT03850496|592952974|FG002|Overall Study|Lost to Follow-up|4|||
164160760|NCT00869999|592952977|FG000|Overall Study|Withdrawal by Subject|1|||
164160761|NCT00869999|592952977|FG000|Overall Study|removed prior to starting therapy|1|||
164160762|NCT03674112|592952981|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
164160763|NCT03674112|592952982|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
164160764|NCT03674112|592952981|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
164160765|NCT03674112|592952982|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
164160766|NCT03674112|592952981|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
164160767|NCT03674112|592952982|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
164160768|NCT03674112|592952981|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
164160769|NCT03674112|592952982|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
164160770|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
164160771|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
164160772|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
164160773|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
164160774|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Death|2|||
164160775|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Death|0|||
164160776|NCT03674112|592952981|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
164160777|NCT03674112|592952982|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
164160778|NCT04157348|592952983|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
164160779|NCT04157348|592952984|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
164160780|NCT04157348|592952983|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164160781|NCT04157348|592952984|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
164160782|NCT04157348|592952983|FG000|Double-blind Treatment Period|Adverse Event|0|||
164160783|NCT04157348|592952984|FG001|Double-blind Treatment Period|Adverse Event|1|||
164160784|NCT04157348|592952983|FG000|Open-label Extension Period|Adverse Event|1|||
164160785|NCT04157348|592952984|FG001|Open-label Extension Period|Adverse Event|1|||
164160786|NCT04157348|592952983|FG000|Open-label Extension Period|Death|0|||
164160788|NCT04157348|592952983|FG000|Open-label Extension Period|Lack of Efficacy|2|||
164160789|NCT04157348|592952984|FG001|Open-label Extension Period|Lack of Efficacy|2|||
164160790|NCT04157348|592952983|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
164160791|NCT04157348|592952984|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
164160792|NCT04157348|592952983|FG000|Open-label Extension Period|Ongoing|60|||
164160793|NCT04157348|592952984|FG001|Open-label Extension Period|Ongoing|57|||
164160794|NCT04157348|592952983|FG000|Open-label Extension Period|other reasons|1|||
164160795|NCT04157348|592952984|FG001|Open-label Extension Period|other reasons|1|||
164160796|NCT02220764|592952987|FG000|Overall Study|Lost to Follow-up|3|||
164160797|NCT02220764|592952988|FG001|Overall Study|Lost to Follow-up|1|||
164160798|NCT02220764|592952987|FG000|Overall Study|Death|1|||
164160799|NCT02220764|592952988|FG001|Overall Study|Death|0|||
164160800|NCT03020992|592952989|FG000|Overall Study|Adverse Event|5|||
164160801|NCT03020992|592952989|FG000|Overall Study|Withdrawal by Subject|1|||
164160802|NCT05000164|592952990|FG000|Overall Study|Adverse Event|1|||
164160803|NCT05000164|592952990|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164160804|NCT05000164|592952990|FG000|Overall Study|Lens Discomfort|3|||
164160805|NCT05000164|592952990|FG000|Overall Study|Withdrew Consent during Study|2|||
164160806|NCT05000164|592952990|FG000|Overall Study|Subject Withdrawn by PI|2|||
164160807|NCT05000164|592952990|FG000|Overall Study|Other Fractured Test Article|1|||
164160808|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
164160809|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
164160810|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
164160811|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
164160812|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Pregnancy|0|||
164160813|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Pregnancy|1|||
164160814|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
164160815|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
164160816|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
164160817|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
164160818|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
164160819|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
164160820|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Other|3|||
164160821|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Other|0|||
164160822|NCT01006122|592952991|FG000|First Double-blind Intervention Period|Adverse Event|0|||
164160823|NCT01006122|592952992|FG001|First Double-blind Intervention Period|Adverse Event|4|||
164160824|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
164160825|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
164160826|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
164160827|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
164160828|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
164160829|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
164160830|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
164160831|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
164160832|NCT01006122|592952991|FG000|Second Double-blind Intervention Period|Death|0|||
164160833|NCT01006122|592952992|FG001|Second Double-blind Intervention Period|Death|1|||
164160834|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
164160835|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
164160836|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
164160837|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
164160838|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
164160839|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
164160840|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
164160841|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
164160842|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
164160843|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
164160844|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
164160845|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
164160846|NCT03493854|592952993|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
164160847|NCT03493854|592952994|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
164160848|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
164160849|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
164160850|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
164160851|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
164160852|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
164160853|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
164160854|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
164160855|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
164160856|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
164160857|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
164160858|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
164160859|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
164160860|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
164160861|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
164160862|NCT03493854|592952993|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
164160863|NCT03493854|592952994|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
164160864|NCT03493854|592952993|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
164160865|NCT03493854|592952994|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
164160866|NCT03493854|592952993|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
164160867|NCT03493854|592952994|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
164160868|NCT03493854|592952993|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
164160869|NCT03493854|592952994|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
164160870|NCT00410813|592952997|FG000|Overall Study|Adverse Event|6|||
164160871|NCT00410813|592952998|FG001|Overall Study|Adverse Event|11|||
164160872|NCT00410813|592952997|FG000|Overall Study|Progression|32|||
164160873|NCT00410813|592952998|FG001|Overall Study|Progression|21|||
164160874|NCT00410813|592952997|FG000|Overall Study|Not protocol specified|3|||
164160875|NCT00410813|592952998|FG001|Overall Study|Not protocol specified|4|||
164160876|NCT00410813|592952997|FG000|Overall Study|Ineligible|2|||
164160877|NCT00410813|592952998|FG001|Overall Study|Ineligible|4|||
164160878|NCT00410813|592952997|FG000|Overall Study|Death|0|||
164160879|NCT00410813|592952998|FG001|Overall Study|Death|2|||
164160880|NCT04526288|592953002|FG000|Overall Study|Disease Progression|1|||
164160881|NCT04526288|592953003|FG001|Overall Study|Disease Progression|0|||
164160882|NCT02097745|592953004|FG000|Overall Study|Adverse Event|25|||
164160883|NCT02097745|592953004|FG000|Overall Study|Death|16|||
164160884|NCT02097745|592953004|FG000|Overall Study|Failure to Return|14|||
164160885|NCT02097745|592953004|FG000|Overall Study|Administrative/Other|27|||
164160886|NCT02097745|592953004|FG000|Overall Study|Reason Not Specified|96|||
164160887|NCT02748356|592953005|FG000|Overall Study|Withdrawal by Subject|1|||
164160888|NCT00425750|592953006|FG000|Overall Study|Death|1|||
164160889|NCT00425750|592953006|FG000|Overall Study|Withdrawal by Subject|3|||
164160890|NCT00425750|592953006|FG000|Overall Study|Adverse Event|3|||
164160891|NCT00425750|592953006|FG000|Overall Study|Progression of disease|18|||
164160892|NCT00996125|592953007|FG000|Overall Study|Adverse Event|0|||
164160893|NCT00996125|592953008|FG001|Overall Study|Adverse Event|2|||
164160894|NCT00996125|592953007|FG000|Overall Study|Lost to Follow-up|1|||
164160895|NCT00996125|592953008|FG001|Overall Study|Lost to Follow-up|6|||
164160896|NCT00996125|592953007|FG000|Overall Study|Withdrawal by Subject|4|||
164160897|NCT00996125|592953008|FG001|Overall Study|Withdrawal by Subject|3|||
164160898|NCT00952068|592953010|FG000|Overall Study|Adverse Event|3|||
164160899|NCT00952068|592953010|FG000|Overall Study|Withdrawal by Subject|4|||
164160900|NCT04331067|592953011|FG000|Overall Study|Adverse Event|1|||
164160901|NCT04331067|592953012|FG001|Overall Study|Adverse Event|3|||
164160902|NCT04331067|592953013|FG002|Overall Study|Adverse Event|1|||
164160903|NCT04331067|592953011|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
164160904|NCT04331067|592953012|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
164160905|NCT04331067|592953013|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
164160906|NCT05236764|592953014|FG000|Overall Study|In follow up (ongoing)|1|||
164160907|NCT05236764|592953014|FG000|Overall Study|Taken off study - secondary graft failure|1|||
164160908|NCT05236764|592953014|FG000|Overall Study|Death|1|||
164160909|NCT02062450|592953020|FG000|Overall Study|No follow-up visit|124|||
164160910|NCT01796392|592953024|FG000|Overall Study|Withdrawal by Subject|2|||
164160911|NCT01796392|592953025|FG001|Overall Study|Withdrawal by Subject|0|||
164160912|NCT01796392|592953024|FG000|Overall Study|Death|5|||
164160913|NCT01796392|592953025|FG001|Overall Study|Death|1|||
164160914|NCT01796392|592953024|FG000|Overall Study|Excluded for medical reasons|1|||
164160915|NCT01796392|592953025|FG001|Overall Study|Excluded for medical reasons|2|||
164160916|NCT01796392|592953024|FG000|Overall Study|Lost to Follow-up|1|||
164160917|NCT01796392|592953025|FG001|Overall Study|Lost to Follow-up|0|||
164160918|NCT03482635|592953026|FG000|Overall Study|Lack of Efficacy|0|||
164160919|NCT03482635|592953027|FG001|Overall Study|Lack of Efficacy|0|||
164160920|NCT03482635|592953028|FG002|Overall Study|Lack of Efficacy|1|||
164160921|NCT03482635|592953029|FG003|Overall Study|Lack of Efficacy|3|||
164160922|NCT03482635|592953026|FG000|Overall Study|Adverse Event|2|||
164160923|NCT03482635|592953027|FG001|Overall Study|Adverse Event|2|||
164160924|NCT03482635|592953028|FG002|Overall Study|Adverse Event|0|||
164160925|NCT03482635|592953029|FG003|Overall Study|Adverse Event|3|||
164160926|NCT03482635|592953026|FG000|Overall Study|Withdrawal by Subject|2|||
164160927|NCT03482635|592953027|FG001|Overall Study|Withdrawal by Subject|1|||
164160928|NCT03482635|592953028|FG002|Overall Study|Withdrawal by Subject|0|||
164160929|NCT03482635|592953029|FG003|Overall Study|Withdrawal by Subject|1|||
164160930|NCT03482635|592953026|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
164160931|NCT03482635|592953027|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
164160932|NCT03482635|592953028|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
164160933|NCT03482635|592953029|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
164160934|NCT03482635|592953026|FG000|Overall Study|Not treated|0|||
164160935|NCT03482635|592953027|FG001|Overall Study|Not treated|0|||
164160936|NCT03482635|592953028|FG002|Overall Study|Not treated|0|||
164160937|NCT03482635|592953029|FG003|Overall Study|Not treated|1|||
164160938|NCT00979654|592953030|FG000|Overall Study|Lost to Follow-up|1|||
164160939|NCT00979654|592953030|FG000|Overall Study|Withdrawal by Subject|22|||
164160940|NCT00979654|592953030|FG000|Overall Study|Death|1|||
164160941|NCT00979654|592953030|FG000|Overall Study|Lack of Efficacy|6|||
164160942|NCT00979654|592953030|FG000|Overall Study|Adverse Event|1|||
164160943|NCT00979654|592953030|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
164160944|NCT00979654|592953030|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
164160945|NCT00979654|592953030|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
164160946|NCT00979654|592953030|FG000|Overall Study|Serious Adverse Event|1|||
164160947|NCT00979654|592953030|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
164160948|NCT01804946|592953031|FG000|Overall Study|Protocol Violation|1|||
164160949|NCT01804946|592953032|FG001|Overall Study|Protocol Violation|0|||
164160950|NCT01804946|592953031|FG000|Overall Study|Adverse Event|0|||
164160951|NCT01804946|592953032|FG001|Overall Study|Adverse Event|1|||
164160952|NCT01804946|592953031|FG000|Overall Study|Insufficient data available|0|||
164160953|NCT01804946|592953032|FG001|Overall Study|Insufficient data available|1|||
164160954|NCT01804946|592953031|FG000|Overall Study|Do not meet inclusion criteria|1|||
164160955|NCT01804946|592953032|FG001|Overall Study|Do not meet inclusion criteria|2|||
164160956|NCT01129557|592953034|FG000|Overall Study|Adverse Event|1|||
164160957|NCT01129557|592953035|FG001|Overall Study|Adverse Event|2|||
164160958|NCT01129557|592953036|FG002|Overall Study|Adverse Event|2|||
164160959|NCT01129557|592953034|FG000|Overall Study|Novartis terminated study early|3|||
164160960|NCT01129557|592953035|FG001|Overall Study|Novartis terminated study early|3|||
164160961|NCT01129557|592953036|FG002|Overall Study|Novartis terminated study early|2|||
164160962|NCT01486446|592953037|FG000|Overall Study|Adverse Event|1|||
164160963|NCT01486446|592953038|FG001|Overall Study|Adverse Event|0|||
164160964|NCT01445730|592953039|FG000|Overall Study|Adverse Event|1|||
164160965|NCT01445730|592953039|FG000|Overall Study|For the advice of a dentist|1|||
164160966|NCT01445730|592953039|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
164160967|NCT01367886|592953044|FG000|Overall Study|Lost to Follow-up|4|||
164160968|NCT01367886|592953044|FG000|Overall Study|Lack of Efficacy|2|||
164160969|NCT01367886|592953044|FG000|Overall Study|Death|1|||
164160970|NCT01167140|592953049|FG000|Overall Study|Withdrawal by Subject|1|||
164160971|NCT00985504|592953050|FG000|Acute Treatment Period|Adverse Event|3|||
164160972|NCT00985504|592953051|FG001|Acute Treatment Period|Adverse Event|4|||
164160973|NCT00985504|592953050|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
164160974|NCT00985504|592953051|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
164160975|NCT00985504|592953050|FG000|Acute Treatment Period|Protocol Violation|2|||
164160976|NCT00985504|592953051|FG001|Acute Treatment Period|Protocol Violation|0|||
164160977|NCT00985504|592953050|FG000|Acute Treatment Period|Sponsor Decision|0|||
164160978|NCT00985504|592953051|FG001|Acute Treatment Period|Sponsor Decision|1|||
164160979|NCT00985504|592953050|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
164160980|NCT00985504|592953051|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
164160981|NCT00985504|592953050|FG000|Optimization Period|Adverse Event|7|||
164160982|NCT00985504|592953051|FG001|Optimization Period|Adverse Event|9|||
164160983|NCT00985504|592953050|FG000|Optimization Period|Death|0|||
164160984|NCT00985504|592953051|FG001|Optimization Period|Death|1|||
164160985|NCT00985504|592953050|FG000|Optimization Period|Lack of Efficacy|5|||
164160986|NCT00985504|592953051|FG001|Optimization Period|Lack of Efficacy|3|||
164160987|NCT00985504|592953050|FG000|Optimization Period|Lost to Follow-up|0|||
164160988|NCT00985504|592953051|FG001|Optimization Period|Lost to Follow-up|1|||
164160989|NCT00985504|592953050|FG000|Optimization Period|Physician Decision|1|||
164160990|NCT00985504|592953051|FG001|Optimization Period|Physician Decision|0|||
164160991|NCT00985504|592953050|FG000|Optimization Period|Protocol Violation|3|||
164160992|NCT00985504|592953051|FG001|Optimization Period|Protocol Violation|1|||
164160993|NCT00985504|592953050|FG000|Optimization Period|Withdrawal by Subject|10|||
164160994|NCT00985504|592953051|FG001|Optimization Period|Withdrawal by Subject|8|||
164160995|NCT03805412|592953052|FG000|Overall Study|Lost to Follow-up|0|||
164160996|NCT03805412|592953053|FG001|Overall Study|Lost to Follow-up|1|||
164160997|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
164160998|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
164160999|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
164161000|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
164161001|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
164161002|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
164161003|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
164161004|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
164161077|NCT03483961|592954923|FG002|Overall Study|Adverse Event|1|||
164161005|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
164161006|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
164161007|NCT03711786|592953056|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
164161008|NCT03711786|592953057|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
164161009|NCT00669669|592953062|FG000|Overall Study|To late to start treatment|1|||
164161010|NCT04390113|592953063|FG000|Overall Study|Not Treated|0|||
164161011|NCT04390113|592953064|FG001|Overall Study|Not Treated|1|||
164161012|NCT04390113|592953063|FG000|Overall Study|Adverse Event|1|||
164161013|NCT04390113|592953064|FG001|Overall Study|Adverse Event|0|||
164161014|NCT04390113|592953063|FG000|Overall Study|Death|2|||
164161015|NCT04390113|592953064|FG001|Overall Study|Death|1|||
164161016|NCT04390113|592953063|FG000|Overall Study|Physician Decision|1|||
164161017|NCT04390113|592953064|FG001|Overall Study|Physician Decision|3|||
164161018|NCT04390113|592953063|FG000|Overall Study|Study Terminated by Sponsor|5|||
164161019|NCT04390113|592953064|FG001|Overall Study|Study Terminated by Sponsor|3|||
164161020|NCT04390113|592953063|FG000|Overall Study|Withdrawal by Subject|10|||
164161021|NCT04390113|592953064|FG001|Overall Study|Withdrawal by Subject|5|||
164161022|NCT04390113|592953063|FG000|Overall Study|Other|1|||
164161023|NCT04390113|592953064|FG001|Overall Study|Other|0|||
164161024|NCT04390113|592953063|FG000|Overall Study|Missing|0|||
164161025|NCT04390113|592953064|FG001|Overall Study|Missing|1|||
164161026|NCT01611883|592953065|FG000|Overall Study|Adverse Event|1|||
164161027|NCT01611883|592953066|FG001|Overall Study|Adverse Event|1|||
164161028|NCT03379727|592953068|FG000|Overall Study|Lack of Efficacy|73|||
164161029|NCT03379727|592953068|FG000|Overall Study|Adverse Event|32|||
164161030|NCT03379727|592953068|FG000|Overall Study|Death|18|||
164161031|NCT03379727|592953068|FG000|Overall Study|Patient/guardian decision|17|||
164161032|NCT03379727|592953068|FG000|Overall Study|Physician Decision|104|||
164161033|NCT03379727|592953068|FG000|Overall Study|Protocol Violation|4|||
164161034|NCT03379727|592953068|FG000|Overall Study|Lost to Follow-up|1|||
164161035|NCT00734994|592953074|FG000|Overall Study|Withdrawal by Subject|1|||
164161036|NCT03100903|592954911|FG000|Overall Study|Withdrawal by Subject|0|||
164161037|NCT03100903|592954912|FG001|Overall Study|Withdrawal by Subject|0|||
164161038|NCT03100903|592954913|FG002|Overall Study|Withdrawal by Subject|1|||
164161039|NCT04659993|592954914|FG000|Overall Study|Withdrawal by Subject|2|||
164161040|NCT04659993|592954914|FG000|Overall Study|Lost to Follow-up|2|||
164161041|NCT01540487|592954917|FG000|Overall Study|Protocol Violation|1|||
164161042|NCT01540487|592954918|FG001|Overall Study|Protocol Violation|0|||
164161043|NCT03503370|592954919|FG000|Overall Study|Death|3|||
164161044|NCT03503370|592954920|FG001|Overall Study|Death|1|||
164161045|NCT03483961|592954921|FG000|Overall Study|Lost to Follow-up|7|||
164161046|NCT03483961|592954922|FG001|Overall Study|Lost to Follow-up|6|||
164161047|NCT03483961|592954923|FG002|Overall Study|Lost to Follow-up|6|||
164161048|NCT03483961|592954924|FG003|Overall Study|Lost to Follow-up|6|||
164161049|NCT03483961|592954925|FG004|Overall Study|Lost to Follow-up|6|||
164161050|NCT03483961|592954926|FG005|Overall Study|Lost to Follow-up|4|||
164161051|NCT03483961|592954927|FG006|Overall Study|Lost to Follow-up|4|||
164161052|NCT03483961|592954928|FG007|Overall Study|Lost to Follow-up|11|||
164161053|NCT03483961|592954929|FG008|Overall Study|Lost to Follow-up|1|||
164161054|NCT03483961|592954930|FG009|Overall Study|Lost to Follow-up|0|||
164161055|NCT03483961|592954921|FG000|Overall Study|Withdrawal by Subject|3|||
164161056|NCT03483961|592954922|FG001|Overall Study|Withdrawal by Subject|4|||
164161057|NCT03483961|592954923|FG002|Overall Study|Withdrawal by Subject|5|||
164161058|NCT03483961|592954924|FG003|Overall Study|Withdrawal by Subject|3|||
164161059|NCT03483961|592954925|FG004|Overall Study|Withdrawal by Subject|4|||
164161060|NCT03483961|592954926|FG005|Overall Study|Withdrawal by Subject|2|||
164161061|NCT03483961|592954927|FG006|Overall Study|Withdrawal by Subject|1|||
164161062|NCT03483961|592954928|FG007|Overall Study|Withdrawal by Subject|2|||
164161063|NCT03483961|592954929|FG008|Overall Study|Withdrawal by Subject|1|||
164161064|NCT03483961|592954930|FG009|Overall Study|Withdrawal by Subject|0|||
164161065|NCT03483961|592954921|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
164161066|NCT03483961|592954922|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161067|NCT03483961|592954923|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161068|NCT03483961|592954924|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161069|NCT03483961|592954925|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161070|NCT03483961|592954926|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161071|NCT03483961|592954927|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161072|NCT03483961|592954928|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161073|NCT03483961|592954929|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161074|NCT03483961|592954930|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
164161075|NCT03483961|592954921|FG000|Overall Study|Adverse Event|0|||
164161078|NCT03483961|592954924|FG003|Overall Study|Adverse Event|0|||
164161079|NCT03483961|592954925|FG004|Overall Study|Adverse Event|0|||
164161080|NCT03483961|592954926|FG005|Overall Study|Adverse Event|0|||
164161081|NCT03483961|592954927|FG006|Overall Study|Adverse Event|0|||
164161082|NCT03483961|592954928|FG007|Overall Study|Adverse Event|0|||
164161083|NCT03483961|592954929|FG008|Overall Study|Adverse Event|0|||
164161084|NCT03483961|592954930|FG009|Overall Study|Adverse Event|0|||
164161085|NCT00457002|592954931|FG000|Overall Study|Death|40|||
164161086|NCT00457002|592954932|FG001|Overall Study|Death|47|||
164161087|NCT00457002|592954931|FG000|Overall Study|Adverse Event|284|||
164161088|NCT00457002|592954932|FG001|Overall Study|Adverse Event|260|||
164161089|NCT00457002|592954931|FG000|Overall Study|Withdrawal by Subject|299|||
164161090|NCT00457002|592954932|FG001|Overall Study|Withdrawal by Subject|271|||
164161091|NCT00457002|592954931|FG000|Overall Study|Lost to Follow-up|72|||
164161092|NCT00457002|592954932|FG001|Overall Study|Lost to Follow-up|71|||
164161093|NCT00457002|592954931|FG000|Overall Study|Poor/Non-compliance|46|||
164161094|NCT00457002|592954932|FG001|Overall Study|Poor/Non-compliance|33|||
164161095|NCT00457002|592954931|FG000|Overall Study|No longer met criteria|41|||
164161096|NCT00457002|592954932|FG001|Overall Study|No longer met criteria|37|||
164161097|NCT00457002|592954931|FG000|Overall Study|Administrative reason by Sponsor|1|||
164161098|NCT00457002|592954932|FG001|Overall Study|Administrative reason by Sponsor|0|||
164161099|NCT00457002|592954931|FG000|Overall Study|non-specified|29|||
164161100|NCT00457002|592954932|FG001|Overall Study|non-specified|38|||
164161101|NCT00457002|592954931|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
164161102|NCT00457002|592954932|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
164161103|NCT01623310|592954933|FG000|Overall Study|Adverse Event|21|||
164161104|NCT01623310|592954933|FG000|Overall Study|Lost to Follow-up|18|||
164161105|NCT01623310|592954933|FG000|Overall Study|Lack of Efficacy|6|||
164161106|NCT01623310|592954933|FG000|Overall Study|Protocol Violation|6|||
164161107|NCT01623310|592954933|FG000|Overall Study|Withdrawal by Subject|25|||
164161108|NCT01623310|592954933|FG000|Overall Study|Became potentially child-bearing|1|||
164161109|NCT01623310|592954933|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
164161110|NCT01623310|592954933|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
164161111|NCT00326716|592954934|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
164161112|NCT00326716|592954935|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
164161113|NCT00326716|592954936|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
164161114|NCT00326716|592954937|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
164161115|NCT00684411|592954938|FG000|Overall Study|New Primary Cancer|1|||
164161116|NCT00684411|592954938|FG000|Overall Study|Disease Progression|10|||
164161117|NCT00684411|592954938|FG000|Overall Study|Adverse Event|1|||
164161118|NCT00734162|592954939|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
164161119|NCT00734162|592954940|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
164161120|NCT00734162|592954941|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
164161121|NCT00734162|592954942|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
164161122|NCT00734162|592954939|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
164161123|NCT00734162|592954940|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
164161124|NCT00734162|592954941|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
164161125|NCT00734162|592954942|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
164161126|NCT00734162|592954939|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
164161127|NCT00734162|592954940|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
164161128|NCT00734162|592954941|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
164161129|NCT00734162|592954942|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
164161130|NCT00734162|592954939|FG000|Open-Label Phase|Withdrew Consent|1|||
164161131|NCT00734162|592954940|FG001|Open-Label Phase|Withdrew Consent|0|||
164161132|NCT00734162|592954941|FG002|Open-Label Phase|Withdrew Consent|1|||
164161133|NCT00734162|592954942|FG003|Open-Label Phase|Withdrew Consent|1|||
164161134|NCT00734162|592954939|FG000|Open-Label Phase|Lost to Follow-up|1|||
164161135|NCT00734162|592954940|FG001|Open-Label Phase|Lost to Follow-up|2|||
164161136|NCT00734162|592954941|FG002|Open-Label Phase|Lost to Follow-up|0|||
164161137|NCT00734162|592954942|FG003|Open-Label Phase|Lost to Follow-up|1|||
164161138|NCT00734162|592954939|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164161139|NCT00734162|592954940|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164161140|NCT00734162|592954941|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
164161141|NCT00734162|592954942|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
164161142|NCT04134767|592954943|FG000|Overall Study|Death|0|||
164161143|NCT04134767|592954944|FG001|Overall Study|Death|1|||
164161144|NCT04134767|592954943|FG000|Overall Study|Removed for harassing staff|0|||
164161145|NCT04134767|592954944|FG001|Overall Study|Removed for harassing staff|1|||
164161146|NCT04134767|592954943|FG000|Overall Study|Lost to Follow-up|44|||
164161147|NCT04134767|592954944|FG001|Overall Study|Lost to Follow-up|40|||
164161148|NCT05483686|592954948|FG000|Overall Study|Lost to Follow-up|5|||
164161149|NCT05483686|592954949|FG001|Overall Study|Lost to Follow-up|7|||
164161150|NCT05780983|592954950|FG000|Overall Study|Withdrawal by Subject|1|||
164161151|NCT06028438|592954954|FG000|Overall Study|Adverse Event|3|||
164161152|NCT06028438|592954955|FG001|Overall Study|Adverse Event|9|||
164161153|NCT06028438|592954954|FG000|Overall Study|Lack of Efficacy|1|||
164161154|NCT06028438|592954955|FG001|Overall Study|Lack of Efficacy|1|||
164161155|NCT06028438|592954954|FG000|Overall Study|Lost to Follow-up|1|||
164161156|NCT06028438|592954955|FG001|Overall Study|Lost to Follow-up|0|||
164161157|NCT06028438|592954954|FG000|Overall Study|Withdrawal by Subject|1|||
164161158|NCT06028438|592954955|FG001|Overall Study|Withdrawal by Subject|0|||
164161159|NCT06028438|592954954|FG000|Overall Study|Other|3|||
164161160|NCT06028438|592954955|FG001|Overall Study|Other|3|||
164161161|NCT01017874|592954957|FG000|Overall Study|Withdrawal by Subject|23|||
164161162|NCT01017874|592954958|FG001|Overall Study|Withdrawal by Subject|20|||
164161163|NCT01017874|592954957|FG000|Overall Study|Sponsor decision|3|||
164161164|NCT01017874|592954958|FG001|Overall Study|Sponsor decision|1|||
164161165|NCT01017874|592954957|FG000|Overall Study|Lost to Follow-up|3|||
164161166|NCT01017874|592954958|FG001|Overall Study|Lost to Follow-up|2|||
164161167|NCT01017874|592954957|FG000|Overall Study|Physician Decision|1|||
164161168|NCT01017874|592954958|FG001|Overall Study|Physician Decision|3|||
164161169|NCT00808210|592954959|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
164161170|NCT00808210|592954960|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
164161171|NCT00808210|592954959|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
164161172|NCT00808210|592954960|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
164161173|NCT00808210|592954959|FG000|Double-Blind TX Period|Adverse Event|0|||
164161174|NCT00808210|592954960|FG001|Double-Blind TX Period|Adverse Event|1|||
164161175|NCT00808210|592954959|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
164161176|NCT00808210|592954960|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
164161177|NCT00808210|592954959|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
164161178|NCT00808210|592954960|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
164161179|NCT00808210|592954959|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
164161180|NCT00808210|592954960|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
164161181|NCT02044302|592954961|FG000|Overall Study|study terminated|2|||
164161182|NCT02044302|592954962|FG001|Overall Study|study terminated|0|||
164161183|NCT03150719|592954964|FG000|Overall Study|Adverse Event|0|||
164161184|NCT03150719|592954965|FG001|Overall Study|Adverse Event|1|||
164161185|NCT03150719|592954964|FG000|Overall Study|Death|0|||
164161186|NCT03150719|592954965|FG001|Overall Study|Death|1|||
164161187|NCT03150719|592954964|FG000|Overall Study|Other|1|||
164161188|NCT03150719|592954965|FG001|Overall Study|Other|0|||
164161189|NCT01790984|592954966|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
164161190|NCT01790984|592954967|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
164161191|NCT01790984|592954968|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
164161192|NCT01790984|592954969|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
164161193|NCT01346696|592954971|FG000|Overall Study|Death|1|||
164161194|NCT01051791|592954973|FG000|Overall Study|Failed screening|3|||
164161195|NCT01051791|592954973|FG000|Overall Study|Withdrawal by Subject|1|||
164161196|NCT01954056|592954980|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
164161197|NCT01954056|592954981|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
164161198|NCT02155283|592955000|FG000|Overall Study|Lost to Follow-up|3|||
164161199|NCT02155283|592955000|FG000|Overall Study|Withdrawal by Subject|1|||
164161200|NCT02155283|592955000|FG000|Overall Study|Protocol Violation|3|||
164161201|NCT02268916|592955020|FG000|Overall Study|Lost to Follow-up|1|||
164161202|NCT02268916|592955021|FG001|Overall Study|Lost to Follow-up|1|||
164161203|NCT02268916|592955020|FG000|Overall Study|Withdrawal by Subject|6|||
164161204|NCT02268916|592955021|FG001|Overall Study|Withdrawal by Subject|5|||
164161205|NCT02268916|592955020|FG000|Overall Study|Participant did not have diabetes|1|||
164161206|NCT02268916|592955021|FG001|Overall Study|Participant did not have diabetes|0|||
164161207|NCT02268916|592955020|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
164161208|NCT02268916|592955021|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
164161209|NCT00594165|592955026|FG000|Overall Study|Major protocol violation|1|||
164161210|NCT00594165|592955026|FG000|Overall Study|Lack of Efficacy|12|||
164161211|NCT00594165|592955026|FG000|Overall Study|Adverse Event|52|||
164161212|NCT00594165|592955026|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
164161213|NCT00594165|592955026|FG000|Overall Study|Subject withdrew consent|27|||
164161214|NCT00594165|592955026|FG000|Overall Study|Study ended per sponsor|102|||
164161215|NCT00594165|592955026|FG000|Overall Study|Lost to Follow-up|4|||
164161216|NCT00594165|592955026|FG000|Overall Study|Other: PI discretion|5|||
164161217|NCT00594165|592955026|FG000|Overall Study|Other: Subject moving|3|||
164161218|NCT00594165|592955026|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
164161219|NCT00594165|592955026|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
164161220|NCT00594165|592955026|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
164161221|NCT00594165|592955026|FG000|Overall Study|Other: Site terminated participation|2|||
164161222|NCT04830969|592955027|FG000|Overall Study|Withdrawal by Subject|6|||
164161223|NCT04830969|592955028|FG001|Overall Study|Withdrawal by Subject|2|||
164161224|NCT04830969|592955027|FG000|Overall Study|Protocol Violation|3|||
164161225|NCT04830969|592955028|FG001|Overall Study|Protocol Violation|9|||
164161226|NCT04830969|592955027|FG000|Overall Study|Lost to Follow-up|4|||
164161227|NCT04830969|592955028|FG001|Overall Study|Lost to Follow-up|4|||
164161228|NCT04639219|592955031|FG000|Overall Study|Withdrawal by Subject|8|||
164161229|NCT04639219|592955031|FG000|Overall Study|Lost to Follow-up|6|||
164161230|NCT04639219|592955031|FG000|Overall Study|Death|55|||
164161231|NCT02712554|592955034|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
164161232|NCT02712554|592955035|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
164161233|NCT02712554|592955034|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
164161234|NCT02712554|592955035|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
164161235|NCT02712554|592955034|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
164161236|NCT02712554|592955035|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
164161237|NCT02712554|592955034|FG000|Part B: Qualification Phase|Adverse Event|0|||
164161238|NCT02712554|592955035|FG001|Part B: Qualification Phase|Adverse Event|1|||
164161239|NCT02712554|592955034|FG000|Part B: Treatment Phase|Adverse Event|0|||
164161240|NCT02712554|592955035|FG001|Part B: Treatment Phase|Adverse Event|1|||
164161241|NCT02712554|592955034|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
164161242|NCT02712554|592955035|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
164161243|NCT02712554|592955034|FG000|Part B: Treatment Phase|Other|0|||
164161244|NCT02712554|592955035|FG001|Part B: Treatment Phase|Other|1|||
164161245|NCT02503540|592955036|FG000|Overall Study|Death|2|||
164161246|NCT02503540|592955036|FG000|Overall Study|Withdrawal by Subject|1|||
164161247|NCT01205269|592955039|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161248|NCT01205269|592955040|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161249|NCT01205269|592955041|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161250|NCT01205269|592955042|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
164161251|NCT01205269|592955043|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161252|NCT01205269|592955044|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
164161253|NCT03830333|592955046|FG000|Overall Study|Death|0|||
164161254|NCT03830333|592955047|FG001|Overall Study|Death|1|||
164161255|NCT03830333|592955046|FG000|Overall Study|Withdrawal by Subject|5|||
164161256|NCT03830333|592955047|FG001|Overall Study|Withdrawal by Subject|1|||
164161257|NCT03830333|592955046|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
164161258|NCT03830333|592955047|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
164161259|NCT00987337|592955048|FG000|Overall Study|Adverse Event|10|||
164161260|NCT00987337|592955049|FG001|Overall Study|Adverse Event|9|||
164161261|NCT00987337|592955050|FG002|Overall Study|Adverse Event|8|||
164161262|NCT00987337|592955048|FG000|Overall Study|Insufficient Virologic Response|10|||
164161263|NCT00987337|592955049|FG001|Overall Study|Insufficient Virologic Response|7|||
164161264|NCT00987337|592955050|FG002|Overall Study|Insufficient Virologic Response|12|||
164161265|NCT00987337|592955048|FG000|Overall Study|Virologic Breakthrough|2|||
164161266|NCT00987337|592955049|FG001|Overall Study|Virologic Breakthrough|2|||
164161267|NCT00987337|592955050|FG002|Overall Study|Virologic Breakthrough|8|||
164161268|NCT00987337|592955048|FG000|Overall Study|Lost to Follow-up|10|||
164161269|NCT00987337|592955049|FG001|Overall Study|Lost to Follow-up|6|||
164161270|NCT00987337|592955050|FG002|Overall Study|Lost to Follow-up|2|||
164161271|NCT00987337|592955048|FG000|Overall Study|Withdrawal by Subject|6|||
164161272|NCT00987337|592955049|FG001|Overall Study|Withdrawal by Subject|9|||
164161273|NCT00987337|592955050|FG002|Overall Study|Withdrawal by Subject|9|||
164161274|NCT00987337|592955048|FG000|Overall Study|Other|0|||
164161275|NCT00987337|592955049|FG001|Overall Study|Other|2|||
164161276|NCT00987337|592955050|FG002|Overall Study|Other|5|||
164161277|NCT00987337|592955048|FG000|Overall Study|Protocol Violation|1|||
164161278|NCT00987337|592955049|FG001|Overall Study|Protocol Violation|0|||
164161279|NCT00987337|592955050|FG002|Overall Study|Protocol Violation|2|||
164161280|NCT00987337|592955048|FG000|Overall Study|Participant Relapsed|18|||
164161281|NCT00987337|592955049|FG001|Overall Study|Participant Relapsed|20|||
164161282|NCT00987337|592955050|FG002|Overall Study|Participant Relapsed|5|||
164161283|NCT02747108|592955054|FG000|Overall Study|Death|2|||
164161284|NCT02747108|592955055|FG001|Overall Study|Death|2|||
164161285|NCT02747108|592955054|FG000|Overall Study|Withdrawal by Subject|1|||
164161286|NCT02747108|592955055|FG001|Overall Study|Withdrawal by Subject|0|||
164161287|NCT02747108|592955054|FG000|Overall Study|Protocol Violation|2|||
164161288|NCT02747108|592955055|FG001|Overall Study|Protocol Violation|0|||
164161289|NCT03103152|592955056|FG000|Overall Study|Physician Decision|5|||
164161290|NCT03103152|592955057|FG001|Overall Study|Physician Decision|2|||
164161291|NCT03103152|592955058|FG002|Overall Study|Physician Decision|6|||
164161292|NCT03103152|592955059|FG003|Overall Study|Physician Decision|3|||
164161293|NCT03103152|592955060|FG004|Overall Study|Physician Decision|3|||
164161294|NCT03103152|592955061|FG005|Overall Study|Physician Decision|1|||
164161295|NCT03103152|592955056|FG000|Overall Study|Protocol Violation|2|||
164161296|NCT03103152|592955057|FG001|Overall Study|Protocol Violation|2|||
164161297|NCT03103152|592955058|FG002|Overall Study|Protocol Violation|1|||
164161298|NCT03103152|592955059|FG003|Overall Study|Protocol Violation|2|||
164161299|NCT03103152|592955060|FG004|Overall Study|Protocol Violation|1|||
164161300|NCT03103152|592955061|FG005|Overall Study|Protocol Violation|1|||
164161301|NCT03103152|592955056|FG000|Overall Study|Inter-current illness|0|||
164161302|NCT03103152|592955057|FG001|Overall Study|Inter-current illness|0|||
164161303|NCT03103152|592955058|FG002|Overall Study|Inter-current illness|1|||
164161304|NCT03103152|592955059|FG003|Overall Study|Inter-current illness|0|||
164161305|NCT03103152|592955060|FG004|Overall Study|Inter-current illness|0|||
164161306|NCT03103152|592955061|FG005|Overall Study|Inter-current illness|0|||
164161307|NCT03103152|592955056|FG000|Overall Study|Death|0|||
164161308|NCT03103152|592955057|FG001|Overall Study|Death|1|||
164161309|NCT03103152|592955058|FG002|Overall Study|Death|0|||
164161310|NCT03103152|592955059|FG003|Overall Study|Death|0|||
164161311|NCT03103152|592955060|FG004|Overall Study|Death|0|||
164161312|NCT03103152|592955061|FG005|Overall Study|Death|0|||
164161313|NCT03103152|592955056|FG000|Overall Study|Adverse Event|0|||
164161314|NCT03103152|592955057|FG001|Overall Study|Adverse Event|0|||
164161315|NCT03103152|592955058|FG002|Overall Study|Adverse Event|1|||
164161316|NCT03103152|592955059|FG003|Overall Study|Adverse Event|0|||
164161317|NCT03103152|592955060|FG004|Overall Study|Adverse Event|0|||
164161318|NCT03103152|592955061|FG005|Overall Study|Adverse Event|1|||
164161319|NCT03103152|592955056|FG000|Overall Study|Withdrawal by Subject|1|||
164161320|NCT03103152|592955057|FG001|Overall Study|Withdrawal by Subject|0|||
164161321|NCT03103152|592955058|FG002|Overall Study|Withdrawal by Subject|1|||
164161322|NCT03103152|592955059|FG003|Overall Study|Withdrawal by Subject|1|||
164161323|NCT03103152|592955060|FG004|Overall Study|Withdrawal by Subject|1|||
164161324|NCT03103152|592955061|FG005|Overall Study|Withdrawal by Subject|1|||
164161325|NCT03103152|592955056|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
164161326|NCT03103152|592955057|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
164161327|NCT03103152|592955058|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
164161328|NCT03103152|592955059|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
164161329|NCT03103152|592955060|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
164161330|NCT03103152|592955061|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
164161331|NCT03103152|592955056|FG000|Overall Study|Unacceptable side effects|0|||
164161332|NCT03103152|592955057|FG001|Overall Study|Unacceptable side effects|0|||
164161333|NCT03103152|592955058|FG002|Overall Study|Unacceptable side effects|0|||
164161334|NCT03103152|592955059|FG003|Overall Study|Unacceptable side effects|0|||
164161335|NCT03103152|592955060|FG004|Overall Study|Unacceptable side effects|0|||
164161336|NCT03103152|592955061|FG005|Overall Study|Unacceptable side effects|1|||
164161337|NCT03103152|592955056|FG000|Overall Study|Lost to Follow-up|0|||
164161338|NCT03103152|592955057|FG001|Overall Study|Lost to Follow-up|1|||
164161339|NCT03103152|592955058|FG002|Overall Study|Lost to Follow-up|0|||
164161340|NCT03103152|592955059|FG003|Overall Study|Lost to Follow-up|1|||
164161341|NCT03103152|592955060|FG004|Overall Study|Lost to Follow-up|0|||
164161342|NCT03103152|592955061|FG005|Overall Study|Lost to Follow-up|1|||
164161343|NCT03103152|592955056|FG000|Overall Study|Testicular pain|0|||
164161344|NCT03103152|592955057|FG001|Overall Study|Testicular pain|0|||
164161345|NCT03103152|592955058|FG002|Overall Study|Testicular pain|0|||
164161346|NCT03103152|592955059|FG003|Overall Study|Testicular pain|1|||
164161347|NCT03103152|592955060|FG004|Overall Study|Testicular pain|0|||
164161348|NCT03103152|592955061|FG005|Overall Study|Testicular pain|0|||
164161349|NCT05966584|592955062|FG000|Overall Study|Lost to Follow-up|1|||
164161350|NCT06360588|592956907|FG000|Overall Study|Adverse Event|3|||
164161351|NCT06360588|592956907|FG000|Overall Study|Death|2|||
164161352|NCT06360588|592956907|FG000|Overall Study|Disease Progression|14|||
164161353|NCT06360588|592956907|FG000|Overall Study|Withdrawal by Subject|1|||
164161354|NCT06360588|592956907|FG000|Overall Study|Lack of Efficacy|1|||
164161355|NCT06360588|592956907|FG000|Overall Study|Ineligible|1|||
164161356|NCT04010240|592956908|FG000|Overall Study|IHC not performed|2299|||
164161357|NCT01481766|592956909|FG000|4 months|Lost to Follow-up|3|||
164161358|NCT01481766|592956910|FG001|4 months|Lost to Follow-up|2|||
164161359|NCT01481766|592956911|FG002|4 months|Lost to Follow-up|1|||
164161360|NCT01481766|592956912|FG003|4 months|Lost to Follow-up|5|||
164161361|NCT01481766|592956909|FG000|12 months|Lost to Follow-up|7|||
164161362|NCT01481766|592956910|FG001|12 months|Lost to Follow-up|8|||
164161363|NCT01481766|592956911|FG002|12 months|Lost to Follow-up|5|||
164161364|NCT01481766|592956912|FG003|12 months|Lost to Follow-up|3|||
164161365|NCT00347958|592956913|FG000|Overall Study|Adverse Event|1|||
164161366|NCT00347958|592956913|FG000|Overall Study|Protocol Violation|2|||
164161367|NCT00347958|592956913|FG000|Overall Study|Withdrawal by Subject|1|||
164161368|NCT00754234|592956914|FG000|Overall Study|Withdrawal by Subject|3|||
164161369|NCT00570687|592956915|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161370|NCT00570687|592956916|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161371|NCT00570687|592956917|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161372|NCT00570687|592956918|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161373|NCT00570687|592956919|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161374|NCT00570687|592956920|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161375|NCT00570687|592956921|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
164161376|NCT00570687|592956922|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161377|NCT00570687|592956923|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
164161378|NCT00570687|592956924|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
164161379|NCT00570687|592956915|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161380|NCT00570687|592956916|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161381|NCT00570687|592956917|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161382|NCT00570687|592956918|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161383|NCT00570687|592956919|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161384|NCT00570687|592956920|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161385|NCT00570687|592956921|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161386|NCT00570687|592956922|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161387|NCT00570687|592956923|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
164161388|NCT00570687|592956924|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161389|NCT00570687|592956915|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161390|NCT00570687|592956916|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161391|NCT00570687|592956917|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161392|NCT00570687|592956918|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161393|NCT00570687|592956919|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161394|NCT00570687|592956920|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161395|NCT00570687|592956921|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
164161396|NCT00570687|592956922|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161397|NCT00570687|592956923|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161398|NCT00570687|592956924|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
164161399|NCT03263936|592956925|FG000|Overall Study|Adverse Event|0|||
164161400|NCT03263936|592956926|FG001|Overall Study|Adverse Event|1|||
164161401|NCT03263936|592956927|FG002|Overall Study|Adverse Event|0|||
164161402|NCT03263936|592956925|FG000|Overall Study|Death|0|||
164161403|NCT03263936|592956926|FG001|Overall Study|Death|1|||
164161404|NCT03263936|592956927|FG002|Overall Study|Death|0|||
164161405|NCT04545489|592956929|FG000|Overall Study|Withdrawal by Subject|12|||
164161406|NCT04545489|592956930|FG001|Overall Study|Withdrawal by Subject|4|||
164161407|NCT04545489|592956929|FG000|Overall Study|Lost to Follow-up|17|||
164161408|NCT04545489|592956930|FG001|Overall Study|Lost to Follow-up|18|||
164161409|NCT04545489|592956929|FG000|Overall Study|12month BP not collected|4|||
164161410|NCT04545489|592956930|FG001|Overall Study|12month BP not collected|4|||
164161411|NCT00652626|592956931|FG000|Initial Treatment Phase|Adverse Event|0|||
164161412|NCT00652626|592956932|FG001|Initial Treatment Phase|Adverse Event|0|||
164161413|NCT00652626|592956933|FG002|Initial Treatment Phase|Adverse Event|0|||
164161414|NCT00652626|592956934|FG003|Initial Treatment Phase|Adverse Event|0|||
164161415|NCT00652626|592956935|FG004|Initial Treatment Phase|Adverse Event|1|||
164161416|NCT00652626|592956936|FG005|Initial Treatment Phase|Adverse Event|0|||
164161417|NCT00652626|592956937|FG006|Initial Treatment Phase|Adverse Event|0|||
164161418|NCT00652626|592956931|FG000|Initial Treatment Phase|Protocol Violation|0|||
164161419|NCT00652626|592956932|FG001|Initial Treatment Phase|Protocol Violation|0|||
164161420|NCT00652626|592956933|FG002|Initial Treatment Phase|Protocol Violation|0|||
164161421|NCT00652626|592956934|FG003|Initial Treatment Phase|Protocol Violation|1|||
164161422|NCT00652626|592956935|FG004|Initial Treatment Phase|Protocol Violation|0|||
164161423|NCT00652626|592956936|FG005|Initial Treatment Phase|Protocol Violation|0|||
164161424|NCT00652626|592956937|FG006|Initial Treatment Phase|Protocol Violation|0|||
164161425|NCT00652626|592956931|FG000|Initial Treatment Phase|Physician Decision|0|||
164161426|NCT00652626|592956932|FG001|Initial Treatment Phase|Physician Decision|0|||
164161427|NCT00652626|592956933|FG002|Initial Treatment Phase|Physician Decision|0|||
164161428|NCT00652626|592956934|FG003|Initial Treatment Phase|Physician Decision|0|||
164161429|NCT00652626|592956935|FG004|Initial Treatment Phase|Physician Decision|1|||
164161430|NCT00652626|592956936|FG005|Initial Treatment Phase|Physician Decision|0|||
164161431|NCT00652626|592956937|FG006|Initial Treatment Phase|Physician Decision|0|||
164161432|NCT00652626|592956931|FG000|Initial Treatment Phase|Sponsor Request|0|||
164161433|NCT00652626|592956932|FG001|Initial Treatment Phase|Sponsor Request|0|||
164161434|NCT00652626|592956933|FG002|Initial Treatment Phase|Sponsor Request|1|||
164161435|NCT00652626|592956934|FG003|Initial Treatment Phase|Sponsor Request|0|||
164161436|NCT00652626|592956935|FG004|Initial Treatment Phase|Sponsor Request|0|||
164161437|NCT00652626|592956936|FG005|Initial Treatment Phase|Sponsor Request|0|||
164161438|NCT00652626|592956937|FG006|Initial Treatment Phase|Sponsor Request|0|||
164161439|NCT00652626|592956931|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
164161440|NCT00652626|592956932|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
164161441|NCT00652626|592956933|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
164161442|NCT00652626|592956934|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
164161443|NCT00652626|592956935|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
164161444|NCT00652626|592956936|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
164161445|NCT00652626|592956937|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
164161446|NCT00652626|592956931|FG000|Extension Phase|Withdrawal by Subject|0|||
164161447|NCT00652626|592956932|FG001|Extension Phase|Withdrawal by Subject|0|||
164161448|NCT00652626|592956933|FG002|Extension Phase|Withdrawal by Subject|0|||
164161449|NCT00652626|592956934|FG003|Extension Phase|Withdrawal by Subject|0|||
164161450|NCT00652626|592956935|FG004|Extension Phase|Withdrawal by Subject|0|||
164161451|NCT00652626|592956936|FG005|Extension Phase|Withdrawal by Subject|2|||
164161452|NCT00652626|592956937|FG006|Extension Phase|Withdrawal by Subject|0|||
164161453|NCT00652626|592956931|FG000|Extension Phase|Adverse Event|0|||
164161454|NCT00652626|592956932|FG001|Extension Phase|Adverse Event|0|||
164161455|NCT00652626|592956933|FG002|Extension Phase|Adverse Event|0|||
164161456|NCT00652626|592956934|FG003|Extension Phase|Adverse Event|0|||
164161457|NCT00652626|592956935|FG004|Extension Phase|Adverse Event|0|||
164161458|NCT00652626|592956936|FG005|Extension Phase|Adverse Event|2|||
164161459|NCT00652626|592956937|FG006|Extension Phase|Adverse Event|1|||
164161460|NCT00652626|592956931|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161461|NCT00652626|592956932|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161462|NCT00652626|592956933|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161463|NCT00652626|592956934|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161464|NCT00652626|592956935|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161465|NCT00652626|592956936|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
164161466|NCT00652626|592956937|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
164161467|NCT00652626|592956931|FG000|Extension Phase|Physician Decision|0|||
164161468|NCT00652626|592956932|FG001|Extension Phase|Physician Decision|0|||
164161469|NCT00652626|592956933|FG002|Extension Phase|Physician Decision|0|||
164161470|NCT00652626|592956934|FG003|Extension Phase|Physician Decision|0|||
164161471|NCT00652626|592956935|FG004|Extension Phase|Physician Decision|0|||
164161472|NCT00652626|592956936|FG005|Extension Phase|Physician Decision|1|||
164161473|NCT00652626|592956937|FG006|Extension Phase|Physician Decision|1|||
164161474|NCT00652626|592956931|FG000|Extension Phase|Death|0|||
164161475|NCT00652626|592956932|FG001|Extension Phase|Death|0|||
164161476|NCT00652626|592956933|FG002|Extension Phase|Death|0|||
164161477|NCT00652626|592956934|FG003|Extension Phase|Death|0|||
164161478|NCT00652626|592956935|FG004|Extension Phase|Death|0|||
164161479|NCT00652626|592956936|FG005|Extension Phase|Death|1|||
164161480|NCT00652626|592956937|FG006|Extension Phase|Death|1|||
164161481|NCT04003636|592956938|FG000|Overall Study|Death|409|||
164161482|NCT04003636|592956939|FG001|Overall Study|Death|443|||
164161483|NCT04003636|592956938|FG000|Overall Study|Lost to Follow-up|0|||
164161484|NCT04003636|592956939|FG001|Overall Study|Lost to Follow-up|1|||
164161485|NCT04003636|592956938|FG000|Overall Study|Withdrawal by Subject|5|||
164161486|NCT04003636|592956939|FG001|Overall Study|Withdrawal by Subject|2|||
164161487|NCT04003636|592956938|FG000|Overall Study|Participant On-going|119|||
164161488|NCT04003636|592956939|FG001|Overall Study|Participant On-going|90|||
164161489|NCT00454246|592956940|FG000|Overall Study|Adverse Event|2|||
164161490|NCT00454246|592956941|FG001|Overall Study|Adverse Event|2|||
164161491|NCT00454246|592956942|FG002|Overall Study|Adverse Event|0|||
164161492|NCT00454246|592956940|FG000|Overall Study|Violation of selection criteria at entry|6|||
164161493|NCT00454246|592956941|FG001|Overall Study|Violation of selection criteria at entry|0|||
164161494|NCT00454246|592956942|FG002|Overall Study|Violation of selection criteria at entry|0|||
164161495|NCT00454246|592956940|FG000|Overall Study|Protocol Violation|1|||
164161496|NCT00454246|592956941|FG001|Overall Study|Protocol Violation|0|||
164161497|NCT00454246|592956942|FG002|Overall Study|Protocol Violation|0|||
164161498|NCT00454246|592956940|FG000|Overall Study|Refused Treatment|1|||
164161499|NCT00454246|592956941|FG001|Overall Study|Refused Treatment|1|||
164161500|NCT00454246|592956942|FG002|Overall Study|Refused Treatment|0|||
164161501|NCT00454246|592956940|FG000|Overall Study|Failure to return|1|||
164161502|NCT00454246|592956941|FG001|Overall Study|Failure to return|0|||
164161503|NCT00454246|592956942|FG002|Overall Study|Failure to return|0|||
164161504|NCT00454246|592956940|FG000|Overall Study|Early termination of study|62|||
164161505|NCT00454246|592956941|FG001|Overall Study|Early termination of study|26|||
164161506|NCT00454246|592956942|FG002|Overall Study|Early termination of study|9|||
164161507|NCT00356603|592956943|FG000|Overall Study|Other|6|||
164161508|NCT00356603|592956944|FG001|Overall Study|Other|3|||
164161509|NCT05326529|592956945|FG000|Overall Study|Lack of Efficacy|0|||
164161510|NCT05326529|592956946|FG001|Overall Study|Lack of Efficacy|1|||
164161511|NCT05326529|592956947|FG002|Overall Study|Lack of Efficacy|0|||
164161512|NCT05326529|592956945|FG000|Overall Study|Physician Decision|0|||
164161513|NCT05326529|592956946|FG001|Overall Study|Physician Decision|0|||
164161514|NCT05326529|592956947|FG002|Overall Study|Physician Decision|2|||
164161515|NCT01262287|592956949|FG000|Overall Study|Lost to Follow-up|2|||
164161516|NCT01262287|592956950|FG001|Overall Study|Lost to Follow-up|1|||
164161517|NCT00932373|592956951|FG000|Overall Study|Progressive disease|3|||
164161518|NCT00932373|592956952|FG001|Overall Study|Progressive disease|1|||
164161519|NCT00932373|592956953|FG002|Overall Study|Progressive disease|0|||
164161520|NCT00932373|592956954|FG003|Overall Study|Progressive disease|0|||
164161521|NCT00932373|592956955|FG004|Overall Study|Progressive disease|10|||
164161522|NCT00932373|592956956|FG005|Overall Study|Progressive disease|1|||
164161523|NCT00932373|592956957|FG006|Overall Study|Progressive disease|0|||
164161524|NCT00932373|592956958|FG007|Overall Study|Progressive disease|2|||
164161525|NCT00932373|592956959|FG008|Overall Study|Progressive disease|1|||
164161526|NCT00932373|592956960|FG009|Overall Study|Progressive disease|9|||
164161527|NCT00932373|592956961|FG010|Overall Study|Progressive disease|2|||
164161528|NCT00932373|592956951|FG000|Overall Study|Adverse Event|0|||
164161529|NCT00932373|592956952|FG001|Overall Study|Adverse Event|0|||
164161530|NCT00932373|592956953|FG002|Overall Study|Adverse Event|0|||
164161531|NCT00932373|592956954|FG003|Overall Study|Adverse Event|0|||
164161532|NCT00932373|592956955|FG004|Overall Study|Adverse Event|2|||
164161533|NCT00932373|592956956|FG005|Overall Study|Adverse Event|1|||
164161534|NCT00932373|592956957|FG006|Overall Study|Adverse Event|0|||
164161535|NCT00932373|592956958|FG007|Overall Study|Adverse Event|1|||
164161536|NCT00932373|592956959|FG008|Overall Study|Adverse Event|0|||
164161537|NCT00932373|592956960|FG009|Overall Study|Adverse Event|2|||
164161538|NCT00932373|592956961|FG010|Overall Study|Adverse Event|1|||
164161539|NCT00932373|592956951|FG000|Overall Study|Physician Decision|0|||
164161540|NCT00932373|592956952|FG001|Overall Study|Physician Decision|0|||
164161541|NCT00932373|592956953|FG002|Overall Study|Physician Decision|1|||
164161542|NCT00932373|592956954|FG003|Overall Study|Physician Decision|0|||
164161543|NCT00932373|592956955|FG004|Overall Study|Physician Decision|2|||
164161544|NCT00932373|592956956|FG005|Overall Study|Physician Decision|0|||
164161545|NCT00932373|592956957|FG006|Overall Study|Physician Decision|0|||
164161546|NCT00932373|592956958|FG007|Overall Study|Physician Decision|0|||
164161547|NCT00932373|592956959|FG008|Overall Study|Physician Decision|0|||
164161548|NCT00932373|592956960|FG009|Overall Study|Physician Decision|1|||
164161549|NCT00932373|592956961|FG010|Overall Study|Physician Decision|0|||
164161550|NCT00932373|592956951|FG000|Overall Study|Dose limiting toxicity|0|||
164161551|NCT00932373|592956952|FG001|Overall Study|Dose limiting toxicity|0|||
164161552|NCT00932373|592956953|FG002|Overall Study|Dose limiting toxicity|0|||
164161553|NCT00932373|592956954|FG003|Overall Study|Dose limiting toxicity|0|||
164161554|NCT00932373|592956955|FG004|Overall Study|Dose limiting toxicity|0|||
164161555|NCT00932373|592956956|FG005|Overall Study|Dose limiting toxicity|1|||
164161556|NCT00932373|592956957|FG006|Overall Study|Dose limiting toxicity|0|||
164161557|NCT00932373|592956958|FG007|Overall Study|Dose limiting toxicity|0|||
164161558|NCT00932373|592956959|FG008|Overall Study|Dose limiting toxicity|0|||
164161559|NCT00932373|592956960|FG009|Overall Study|Dose limiting toxicity|0|||
164161560|NCT00932373|592956961|FG010|Overall Study|Dose limiting toxicity|0|||
164161561|NCT00932373|592956951|FG000|Overall Study|Withdrawal by Subject|0|||
164161562|NCT00932373|592956952|FG001|Overall Study|Withdrawal by Subject|0|||
164161563|NCT00932373|592956953|FG002|Overall Study|Withdrawal by Subject|0|||
164161564|NCT00932373|592956954|FG003|Overall Study|Withdrawal by Subject|0|||
164161565|NCT00932373|592956955|FG004|Overall Study|Withdrawal by Subject|0|||
164161566|NCT00932373|592956956|FG005|Overall Study|Withdrawal by Subject|0|||
164161567|NCT00932373|592956957|FG006|Overall Study|Withdrawal by Subject|0|||
164161568|NCT00932373|592956958|FG007|Overall Study|Withdrawal by Subject|0|||
164161569|NCT00932373|592956959|FG008|Overall Study|Withdrawal by Subject|1|||
164161570|NCT00932373|592956960|FG009|Overall Study|Withdrawal by Subject|0|||
164161571|NCT00932373|592956961|FG010|Overall Study|Withdrawal by Subject|0|||
164161572|NCT00932373|592956951|FG000|Overall Study|Clinical progression|0|||
164161573|NCT00932373|592956952|FG001|Overall Study|Clinical progression|0|||
164161574|NCT00932373|592956953|FG002|Overall Study|Clinical progression|0|||
164161575|NCT00932373|592956954|FG003|Overall Study|Clinical progression|0|||
164161576|NCT00932373|592956955|FG004|Overall Study|Clinical progression|0|||
164161577|NCT00932373|592956956|FG005|Overall Study|Clinical progression|0|||
164161578|NCT00932373|592956957|FG006|Overall Study|Clinical progression|1|||
164161579|NCT00932373|592956958|FG007|Overall Study|Clinical progression|0|||
164161580|NCT00932373|592956959|FG008|Overall Study|Clinical progression|0|||
164161581|NCT00932373|592956960|FG009|Overall Study|Clinical progression|0|||
164161582|NCT00932373|592956961|FG010|Overall Study|Clinical progression|0|||
164161583|NCT00932373|592956951|FG000|Overall Study|Lack of Efficacy|0|||
164161584|NCT00932373|592956952|FG001|Overall Study|Lack of Efficacy|0|||
164161585|NCT00932373|592956953|FG002|Overall Study|Lack of Efficacy|0|||
164161586|NCT00932373|592956954|FG003|Overall Study|Lack of Efficacy|0|||
164161587|NCT00932373|592956955|FG004|Overall Study|Lack of Efficacy|0|||
164161588|NCT00932373|592956956|FG005|Overall Study|Lack of Efficacy|0|||
164161589|NCT00932373|592956957|FG006|Overall Study|Lack of Efficacy|0|||
164161590|NCT00932373|592956958|FG007|Overall Study|Lack of Efficacy|0|||
164161591|NCT00932373|592956959|FG008|Overall Study|Lack of Efficacy|0|||
164161592|NCT00932373|592956960|FG009|Overall Study|Lack of Efficacy|1|||
164161593|NCT00932373|592956961|FG010|Overall Study|Lack of Efficacy|0|||
164161594|NCT02492984|592956964|FG000|Overall Study|Adverse Event|1|||
164161595|NCT02492984|592956965|FG001|Overall Study|Adverse Event|0|||
164161596|NCT02492984|592956964|FG000|Overall Study|Protocol Violation|1|||
164161597|NCT02492984|592956965|FG001|Overall Study|Protocol Violation|0|||
164161598|NCT02492984|592956964|FG000|Overall Study|Withdrawal by Subject|1|||
164161599|NCT02492984|592956965|FG001|Overall Study|Withdrawal by Subject|0|||
164161600|NCT01841762|592956966|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
164161601|NCT01841762|592956966|FG000|Treatment Period|Adverse Event|16|||
164161602|NCT01841762|592956966|FG000|Treatment Period|Death|1|||
164161603|NCT01841762|592956966|FG000|Treatment Period|Withdrawal by Subject|7|||
164161604|NCT01841762|592956966|FG000|Treatment Period|Lost to Follow-up|1|||
164161605|NCT01841762|592956966|FG000|Treatment Period|Physician Decision|2|||
164161606|NCT01841762|592956966|FG000|Treatment Period|Other, including non-compliance|5|||
164161607|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
164161608|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
164161609|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
164161610|NCT01841762|592956966|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
164161611|NCT06152224|592956971|FG000|Overall Study|Withdrawal by Subject|1|||
164161612|NCT06152224|592956972|FG001|Overall Study|Withdrawal by Subject|0|||
164161613|NCT06152224|592956971|FG000|Overall Study|Lost to Follow-up|0|||
164161614|NCT06152224|592956972|FG001|Overall Study|Lost to Follow-up|1|||
164161615|NCT06152224|592956971|FG000|Overall Study|On Follow Up|18|||
164161616|NCT06152224|592956972|FG001|Overall Study|On Follow Up|18|||
164161617|NCT05625802|592956973|FG000|Overall Study|Lost to Follow-up|1|||
164161618|NCT05625802|592956974|FG001|Overall Study|Lost to Follow-up|0|||
164161619|NCT01164579|592956975|FG000|Overall Study|Lack of Efficacy|0|||
164161620|NCT01164579|592956976|FG001|Overall Study|Lack of Efficacy|0|||
164161621|NCT01164579|592956977|FG002|Overall Study|Lack of Efficacy|6|||
164161622|NCT01164579|592956975|FG000|Overall Study|Lost to Follow-up|1|||
164161623|NCT01164579|592956976|FG001|Overall Study|Lost to Follow-up|1|||
164161624|NCT01164579|592956977|FG002|Overall Study|Lost to Follow-up|0|||
164161625|NCT01164579|592956975|FG000|Overall Study|Withdrawal by Subject|2|||
164161626|NCT01164579|592956976|FG001|Overall Study|Withdrawal by Subject|5|||
164161627|NCT01164579|592956977|FG002|Overall Study|Withdrawal by Subject|3|||
164161628|NCT01164579|592956975|FG000|Overall Study|Protocol Violation|0|||
164161629|NCT01164579|592956976|FG001|Overall Study|Protocol Violation|1|||
164161630|NCT01164579|592956977|FG002|Overall Study|Protocol Violation|2|||
164161631|NCT01164579|592956975|FG000|Overall Study|Adverse Event|4|||
164161632|NCT01164579|592956976|FG001|Overall Study|Adverse Event|2|||
164161633|NCT01164579|592956977|FG002|Overall Study|Adverse Event|5|||
164161634|NCT01164579|592956975|FG000|Overall Study|Reason not specified|1|||
164161635|NCT01164579|592956976|FG001|Overall Study|Reason not specified|0|||
164161636|NCT01164579|592956977|FG002|Overall Study|Reason not specified|0|||
164161637|NCT01163851|592956981|FG000|Overall Study|Site Closure|0|||
164161638|NCT01163851|592956982|FG001|Overall Study|Site Closure|1|||
164161639|NCT01163851|592956981|FG000|Overall Study|Enrolled but not treated|1|||
164161640|NCT01163851|592956982|FG001|Overall Study|Enrolled but not treated|0|||
164161641|NCT00789373|592956983|FG000|Induction|Adverse Event|64|||
164161642|NCT00789373|592956984|FG001|Induction|Adverse Event|0|||
164161643|NCT00789373|592956985|FG002|Induction|Adverse Event|0|||
164161644|NCT00789373|592956983|FG000|Induction|Death Due to study disease|24|||
164161645|NCT00789373|592956984|FG001|Induction|Death Due to study disease|0|||
164161646|NCT00789373|592956985|FG002|Induction|Death Due to study disease|0|||
164161647|NCT00789373|592956983|FG000|Induction|Death due to adverse event|19|||
164161648|NCT00789373|592956984|FG001|Induction|Death due to adverse event|0|||
164161649|NCT00789373|592956985|FG002|Induction|Death due to adverse event|0|||
164161650|NCT00789373|592956983|FG000|Induction|Death due to toxicity|11|||
164161651|NCT00789373|592956984|FG001|Induction|Death due to toxicity|0|||
164161652|NCT00789373|592956985|FG002|Induction|Death due to toxicity|0|||
164161653|NCT00789373|592956983|FG000|Induction|Death due to procedure|1|||
164161654|NCT00789373|592956984|FG001|Induction|Death due to procedure|0|||
164161655|NCT00789373|592956985|FG002|Induction|Death due to procedure|0|||
164161656|NCT00789373|592956983|FG000|Induction|Investigator decision|7|||
164161657|NCT00789373|592956984|FG001|Induction|Investigator decision|0|||
164161658|NCT00789373|592956985|FG002|Induction|Investigator decision|0|||
164161659|NCT00789373|592956983|FG000|Induction|Protocol entry criteria not met|9|||
164161660|NCT00789373|592956984|FG001|Induction|Protocol entry criteria not met|0|||
164161661|NCT00789373|592956985|FG002|Induction|Protocol entry criteria not met|0|||
164161662|NCT00789373|592956983|FG000|Induction|Lost to Follow-up|6|||
164161663|NCT00789373|592956984|FG001|Induction|Lost to Follow-up|0|||
164161664|NCT00789373|592956985|FG002|Induction|Lost to Follow-up|0|||
164161665|NCT00789373|592956983|FG000|Induction|Protocol Violation|1|||
164161666|NCT00789373|592956984|FG001|Induction|Protocol Violation|0|||
164161667|NCT00789373|592956985|FG002|Induction|Protocol Violation|0|||
164161668|NCT00789373|592956983|FG000|Induction|Progressive Disease|220|||
164161669|NCT00789373|592956984|FG001|Induction|Progressive Disease|0|||
164161670|NCT00789373|592956985|FG002|Induction|Progressive Disease|0|||
164161671|NCT00789373|592956983|FG000|Induction|Withdrawal by Subject|37|||
164161672|NCT00789373|592956984|FG001|Induction|Withdrawal by Subject|0|||
164161673|NCT00789373|592956985|FG002|Induction|Withdrawal by Subject|0|||
164161674|NCT00789373|592956983|FG000|Maintenance|Adverse Event|0|||
164161675|NCT00789373|592956984|FG001|Maintenance|Adverse Event|65|||
164161676|NCT00789373|592956985|FG002|Maintenance|Adverse Event|12|||
164161677|NCT00789373|592956983|FG000|Maintenance|Death due to study disease|0|||
164161678|NCT00789373|592956984|FG001|Maintenance|Death due to study disease|3|||
164161679|NCT00789373|592956985|FG002|Maintenance|Death due to study disease|1|||
164161680|NCT00789373|592956983|FG000|Maintenance|Death due to adverse event|0|||
164161681|NCT00789373|592956984|FG001|Maintenance|Death due to adverse event|4|||
164161682|NCT00789373|592956985|FG002|Maintenance|Death due to adverse event|1|||
164161683|NCT00789373|592956983|FG000|Maintenance|Death due to toxicity|0|||
164161684|NCT00789373|592956984|FG001|Maintenance|Death due to toxicity|1|||
164161685|NCT00789373|592956985|FG002|Maintenance|Death due to toxicity|2|||
164161686|NCT00789373|592956983|FG000|Maintenance|Investigator Decision|0|||
164161687|NCT00789373|592956984|FG001|Maintenance|Investigator Decision|4|||
164161688|NCT00789373|592956985|FG002|Maintenance|Investigator Decision|2|||
164161689|NCT00789373|592956983|FG000|Maintenance|Protocol entry criteria not met|0|||
164161690|NCT00789373|592956984|FG001|Maintenance|Protocol entry criteria not met|2|||
164161691|NCT00789373|592956985|FG002|Maintenance|Protocol entry criteria not met|0|||
164161692|NCT00789373|592956983|FG000|Maintenance|Lost to Follow-up|0|||
164161693|NCT00789373|592956984|FG001|Maintenance|Lost to Follow-up|2|||
164161694|NCT00789373|592956985|FG002|Maintenance|Lost to Follow-up|0|||
164161695|NCT00789373|592956983|FG000|Maintenance|Progressive Disease|0|||
164161696|NCT00789373|592956984|FG001|Maintenance|Progressive Disease|253|||
164161697|NCT00789373|592956985|FG002|Maintenance|Progressive Disease|152|||
164161698|NCT00789373|592956983|FG000|Maintenance|Withdrawal by Subject|0|||
164161699|NCT00789373|592956984|FG001|Maintenance|Withdrawal by Subject|21|||
164161700|NCT00789373|592956985|FG002|Maintenance|Withdrawal by Subject|8|||
164161701|NCT00789373|592956983|FG000|Maintenance|Sponsor Decision|0|||
164161702|NCT00789373|592956984|FG001|Maintenance|Sponsor Decision|0|||
164161703|NCT00789373|592956985|FG002|Maintenance|Sponsor Decision|2|||
164161704|NCT00789373|592956983|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
164161705|NCT00789373|592956984|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
164161706|NCT00789373|592956985|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
164161707|NCT04938180|592956986|FG000|Overall Study|Adverse Event|1|||
164161708|NCT01964222|592956987|FG000|Overall Study|Lost to Follow-up|7|||
164161709|NCT01964222|592956988|FG001|Overall Study|Lost to Follow-up|5|||
164161710|NCT01964222|592956987|FG000|Overall Study|Withdrawal by Subject|6|||
164161711|NCT01964222|592956988|FG001|Overall Study|Withdrawal by Subject|6|||
164161712|NCT01964222|592956987|FG000|Overall Study|Screening Failure|2|||
164161713|NCT01964222|592956988|FG001|Overall Study|Screening Failure|0|||
164161714|NCT01019694|592956993|FG000|Overall Study|Adverse Event|12|||
164161715|NCT01019694|592956994|FG001|Overall Study|Adverse Event|16|||
164161716|NCT01019694|592956995|FG002|Overall Study|Adverse Event|19|||
164161717|NCT01019694|592956993|FG000|Overall Study|Protocol Violation|2|||
164161718|NCT01019694|592956994|FG001|Overall Study|Protocol Violation|6|||
164161719|NCT01019694|592956995|FG002|Overall Study|Protocol Violation|4|||
164161720|NCT01019694|592956993|FG000|Overall Study|Lost to Follow-up|5|||
164161721|NCT01019694|592956994|FG001|Overall Study|Lost to Follow-up|3|||
164161722|NCT01019694|592956995|FG002|Overall Study|Lost to Follow-up|3|||
164161723|NCT01019694|592956993|FG000|Overall Study|Withdrawal by Subject|4|||
164161724|NCT01019694|592956994|FG001|Overall Study|Withdrawal by Subject|6|||
164161725|NCT01019694|592956995|FG002|Overall Study|Withdrawal by Subject|12|||
164161726|NCT01019694|592956993|FG000|Overall Study|Not treated|0|||
164161727|NCT01019694|592956994|FG001|Overall Study|Not treated|2|||
164161728|NCT01019694|592956995|FG002|Overall Study|Not treated|3|||
164161729|NCT01019694|592956993|FG000|Overall Study|Other reason (not specified)|1|||
164161730|NCT01019694|592956994|FG001|Overall Study|Other reason (not specified)|5|||
164161731|NCT01019694|592956995|FG002|Overall Study|Other reason (not specified)|6|||
164161732|NCT00441129|592957001|FG000|Overall Study|Withdrawal by Subject|6|||
164161733|NCT00441129|592957002|FG001|Overall Study|Withdrawal by Subject|14|||
164161734|NCT00463047|592957003|FG000|Titration Period 1|Adverse Event|10|||
164161735|NCT00463047|592957004|FG001|Titration Period 1|Adverse Event|8|||
164161736|NCT00463047|592957003|FG000|Titration Period 1|Lack of Efficacy|10|||
164161737|NCT00463047|592957004|FG001|Titration Period 1|Lack of Efficacy|4|||
164161738|NCT00463047|592957003|FG000|Titration Period 1|Lost to Follow-up|2|||
164161739|NCT00463047|592957004|FG001|Titration Period 1|Lost to Follow-up|0|||
164161740|NCT00463047|592957003|FG000|Titration Period 1|Non-compliance with study medication|3|||
164161741|NCT00463047|592957004|FG001|Titration Period 1|Non-compliance with study medication|5|||
164161742|NCT00463047|592957003|FG000|Titration Period 1|Protocol Violation|5|||
164161743|NCT00463047|592957004|FG001|Titration Period 1|Protocol Violation|5|||
164161744|NCT00463047|592957003|FG000|Titration Period 1|Withdrawal by Subject|3|||
164161745|NCT00463047|592957004|FG001|Titration Period 1|Withdrawal by Subject|5|||
164161746|NCT00463047|592957003|FG000|Titration Period 1|Non-compliance procedures|4|||
164161747|NCT00463047|592957004|FG001|Titration Period 1|Non-compliance procedures|10|||
164161748|NCT00463047|592957003|FG000|Titration Period 1|Other|0|||
164161749|NCT00463047|592957004|FG001|Titration Period 1|Other|2|||
164161750|NCT00463047|592957003|FG000|Titration Period 2|Adverse Event|9|||
164161751|NCT00463047|592957004|FG001|Titration Period 2|Adverse Event|9|||
164161752|NCT00463047|592957003|FG000|Titration Period 2|Lack of Efficacy|6|||
164161753|NCT00463047|592957004|FG001|Titration Period 2|Lack of Efficacy|4|||
164161754|NCT00463047|592957003|FG000|Titration Period 2|Withdrawal by Subject|1|||
164161755|NCT00463047|592957004|FG001|Titration Period 2|Withdrawal by Subject|0|||
164161756|NCT00463047|592957003|FG000|Titration Period 2|Protocol Violation|2|||
164161757|NCT00463047|592957004|FG001|Titration Period 2|Protocol Violation|3|||
164161758|NCT00463047|592957003|FG000|Titration Period 2|Lost to Follow-up|1|||
164161992|NCT01637922|592958842|FG000|Overall Study|Lost to Follow-up|2|||
164161759|NCT00463047|592957004|FG001|Titration Period 2|Lost to Follow-up|2|||
164161760|NCT00463047|592957003|FG000|Titration Period 2|Non-compliance study medication|4|||
164161761|NCT00463047|592957004|FG001|Titration Period 2|Non-compliance study medication|2|||
164161762|NCT00463047|592957003|FG000|Titration Period 2|Non-compliance procedures|4|||
164161763|NCT00463047|592957004|FG001|Titration Period 2|Non-compliance procedures|1|||
164161764|NCT00463047|592957003|FG000|Titration Period 2|Other|3|||
164161765|NCT00463047|592957004|FG001|Titration Period 2|Other|2|||
164161766|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
164161767|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
164161768|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
164161769|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
164161770|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
164161771|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
164161772|NCT00463047|592957003|FG000|Double-Blind Treatment Period 1|Other|1|||
164161773|NCT00463047|592957004|FG001|Double-Blind Treatment Period 1|Other|0|||
164161774|NCT00463047|592957003|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
164161775|NCT00463047|592957004|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
164161776|NCT00463047|592957003|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
164161777|NCT00463047|592957004|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
164161778|NCT00463047|592957003|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
164161779|NCT00463047|592957004|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
164161780|NCT04278417|592957017|FG000|Overall Study|Withdrawal by Subject|20|||
164161781|NCT04278417|592957018|FG001|Overall Study|Withdrawal by Subject|20|||
164161782|NCT04278417|592957017|FG000|Overall Study|Progressive disease|0|||
164161783|NCT04278417|592957018|FG001|Overall Study|Progressive disease|2|||
164161784|NCT04278417|592957017|FG000|Overall Study|Physician Decision|4|||
164161785|NCT04278417|592957018|FG001|Overall Study|Physician Decision|6|||
164161786|NCT04278417|592957017|FG000|Overall Study|Lost to Follow-up|11|||
164161787|NCT04278417|592957018|FG001|Overall Study|Lost to Follow-up|13|||
164161788|NCT04278417|592957017|FG000|Overall Study|Death|8|||
164161789|NCT04278417|592957018|FG001|Overall Study|Death|9|||
164161790|NCT04278417|592957017|FG000|Overall Study|Adverse Event|3|||
164161791|NCT04278417|592957018|FG001|Overall Study|Adverse Event|5|||
164161792|NCT01732458|592957020|FG000|Overall Study|Lost to Follow-up|0|||
164161793|NCT01732458|592957021|FG001|Overall Study|Lost to Follow-up|2|||
164161794|NCT01732458|592957022|FG002|Overall Study|Lost to Follow-up|0|||
164161795|NCT01732458|592957023|FG003|Overall Study|Lost to Follow-up|0|||
164161796|NCT01732458|592957020|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164161797|NCT01732458|592957021|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164161798|NCT01732458|592957022|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164161799|NCT01732458|592957023|FG003|Overall Study|Non-Compliance With Study Drug|0|||
164161800|NCT01732458|592957020|FG000|Overall Study|Physician Decision|1|||
164161801|NCT01732458|592957021|FG001|Overall Study|Physician Decision|2|||
164161802|NCT01732458|592957022|FG002|Overall Study|Physician Decision|2|||
164161803|NCT01732458|592957023|FG003|Overall Study|Physician Decision|0|||
164161804|NCT01732458|592957020|FG000|Overall Study|Protocol Violation|2|||
164161805|NCT01732458|592957021|FG001|Overall Study|Protocol Violation|0|||
164161806|NCT01732458|592957022|FG002|Overall Study|Protocol Violation|0|||
164161807|NCT01732458|592957023|FG003|Overall Study|Protocol Violation|2|||
164161808|NCT01732458|592957020|FG000|Overall Study|Screen Failure|0|||
164161809|NCT01732458|592957021|FG001|Overall Study|Screen Failure|1|||
164161810|NCT01732458|592957022|FG002|Overall Study|Screen Failure|0|||
164161811|NCT01732458|592957023|FG003|Overall Study|Screen Failure|0|||
164161812|NCT05870371|592957024|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
164161813|NCT05870371|592957025|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
164161814|NCT02203721|592957026|FG000|Overall Study|Lost to Follow-up|1|||
164161815|NCT02203721|592957027|FG001|Overall Study|Lost to Follow-up|0|||
164161816|NCT02203721|592957026|FG000|Overall Study|Death|0|||
164161817|NCT02203721|592957027|FG001|Overall Study|Death|2|||
164161818|NCT02203721|592957026|FG000|Overall Study|Illness|0|||
164161819|NCT02203721|592957027|FG001|Overall Study|Illness|1|||
164161820|NCT00703157|592957028|FG000|Overall Study|Lost to Follow-up|0|||
164161821|NCT00703157|592957029|FG001|Overall Study|Lost to Follow-up|1|||
164161822|NCT00703157|592957028|FG000|Overall Study|source data permanently lost/ other|4|||
164161823|NCT00703157|592957029|FG001|Overall Study|source data permanently lost/ other|1|||
164161824|NCT00347009|592957030|FG000|Overall Study|Death|1|||
164161825|NCT00347009|592957030|FG000|Overall Study|Adverse Event|6|||
164161826|NCT00347009|592957030|FG000|Overall Study|Withdrawal by Subject|3|||
164161827|NCT00347009|592957030|FG000|Overall Study|Physician Decision|5|||
164161828|NCT00347009|592957030|FG000|Overall Study|Lost to Follow-up|4|||
164161829|NCT00347009|592957030|FG000|Overall Study|Protocol Violation|2|||
164161830|NCT00347009|592957030|FG000|Overall Study|Adverse Laboratory Experience|1|||
164161831|NCT00347009|592957030|FG000|Overall Study|Insufficient Viral Suppression|3|||
164161832|NCT00347009|592957030|FG000|Overall Study|Increased ALT/HBV DNA|1|||
164161833|NCT00347009|592957030|FG000|Overall Study|Serious Adverse Event|1|||
164161834|NCT04495751|592957031|FG000|Overall Study|Withdrawal by Subject|1|||
164161835|NCT04495751|592957032|FG001|Overall Study|Withdrawal by Subject|0|||
164161836|NCT04495751|592957031|FG000|Overall Study|Lost to Follow-up|1|||
164161837|NCT04495751|592957032|FG001|Overall Study|Lost to Follow-up|0|||
164161838|NCT00708461|592957033|FG000|Overall Study|Lost to Follow-up|18|||
164161839|NCT00708461|592957034|FG001|Overall Study|Lost to Follow-up|11|||
164161840|NCT00708461|592957033|FG000|Overall Study|Withdrawal by Subject|8|||
164161841|NCT00708461|592957034|FG001|Overall Study|Withdrawal by Subject|9|||
164161842|NCT00708461|592957033|FG000|Overall Study|left workforce|115|||
164161843|NCT00708461|592957034|FG001|Overall Study|left workforce|180|||
164161844|NCT02907177|592957035|FG000|Overall Study|Death|0|||
164161845|NCT02907177|592957036|FG001|Overall Study|Death|1|||
164161846|NCT02907177|592957035|FG000|Overall Study|Physician Decision|3|||
164161847|NCT02907177|592957036|FG001|Overall Study|Physician Decision|3|||
164161848|NCT02907177|592957035|FG000|Overall Study|Withdrawal by Subject|15|||
164161849|NCT02907177|592957036|FG001|Overall Study|Withdrawal by Subject|7|||
164161850|NCT02907177|592957035|FG000|Overall Study|Sponsor's Decision|50|||
164161851|NCT02907177|592957036|FG001|Overall Study|Sponsor's Decision|57|||
164161852|NCT02968173|592957037|FG000|Overall Study|Withdrawal by Subject|1|||
164161853|NCT04681066|592957038|FG000|Overall Study|Lost to Follow-up|3|||
164161854|NCT04681066|592957039|FG001|Overall Study|Lost to Follow-up|1|||
164161855|NCT04681066|592957040|FG002|Overall Study|Lost to Follow-up|2|||
164161856|NCT04681066|592957041|FG003|Overall Study|Lost to Follow-up|1|||
164161857|NCT04681066|592957038|FG000|Overall Study|Withdrawal by Subject|2|||
164161858|NCT04681066|592957039|FG001|Overall Study|Withdrawal by Subject|1|||
164161859|NCT04681066|592957040|FG002|Overall Study|Withdrawal by Subject|0|||
164161860|NCT04681066|592957041|FG003|Overall Study|Withdrawal by Subject|3|||
164161861|NCT04681066|592957038|FG000|Overall Study|Death|0|||
164161862|NCT04681066|592957039|FG001|Overall Study|Death|1|||
164161863|NCT04681066|592957040|FG002|Overall Study|Death|0|||
164161864|NCT04681066|592957041|FG003|Overall Study|Death|0|||
164161865|NCT04495829|592957045|FG000|Overall Study|Lost to Follow-up|2|||
164161866|NCT04495829|592957045|FG000|Overall Study|Inclusion criterion not met|3|||
164161867|NCT00314327|592957052|FG000|Overall Study|Withdrawal by Subject|1|||
164161868|NCT01207687|592957053|FG000|Overall Study|Adverse Event|1|||
164161869|NCT01207687|592957053|FG000|Overall Study|Withdrawal by Subject|1|||
164161870|NCT03474965|592957054|FG000|Overall Study|Pregnancy|1|||
164161871|NCT03474965|592957055|FG001|Overall Study|Pregnancy|0|||
164161872|NCT03474965|592957056|FG002|Overall Study|Pregnancy|0|||
164161873|NCT03474965|592957057|FG003|Overall Study|Pregnancy|0|||
164161874|NCT03474965|592957054|FG000|Overall Study|Lost to Follow-up|0|||
164161875|NCT03474965|592957055|FG001|Overall Study|Lost to Follow-up|0|||
164161876|NCT03474965|592957056|FG002|Overall Study|Lost to Follow-up|1|||
164161877|NCT03474965|592957057|FG003|Overall Study|Lost to Follow-up|0|||
164161878|NCT03474965|592957054|FG000|Overall Study|Death|1|||
164161879|NCT03474965|592957055|FG001|Overall Study|Death|0|||
164161880|NCT03474965|592957056|FG002|Overall Study|Death|0|||
164161881|NCT03474965|592957057|FG003|Overall Study|Death|0|||
164161882|NCT03474965|592957054|FG000|Overall Study|Adverse Event|1|||
164161883|NCT03474965|592957055|FG001|Overall Study|Adverse Event|0|||
164161884|NCT03474965|592957056|FG002|Overall Study|Adverse Event|0|||
164161885|NCT03474965|592957057|FG003|Overall Study|Adverse Event|1|||
164161886|NCT03474965|592957054|FG000|Overall Study|Physician Decision|3|||
164161887|NCT03474965|592957055|FG001|Overall Study|Physician Decision|1|||
164161888|NCT03474965|592957056|FG002|Overall Study|Physician Decision|2|||
164161889|NCT03474965|592957057|FG003|Overall Study|Physician Decision|0|||
164161890|NCT03474965|592957054|FG000|Overall Study|Participant Decision|7|||
164161891|NCT03474965|592957055|FG001|Overall Study|Participant Decision|0|||
164161892|NCT03474965|592957056|FG002|Overall Study|Participant Decision|1|||
164161893|NCT03474965|592957057|FG003|Overall Study|Participant Decision|0|||
164161894|NCT03474965|592957054|FG000|Overall Study|Guardian Decision|4|||
164161895|NCT03474965|592957055|FG001|Overall Study|Guardian Decision|2|||
164161896|NCT03474965|592957056|FG002|Overall Study|Guardian Decision|7|||
164161897|NCT03474965|592957057|FG003|Overall Study|Guardian Decision|2|||
164161898|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
164161899|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
164161900|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
164161901|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
164161902|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
164161903|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
164161904|NCT03868930|592958821|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
164161905|NCT03868930|592958822|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
164161906|NCT03868930|592958821|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
164161907|NCT03868930|592958822|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
164161908|NCT02151851|592958827|FG000|Overall Study|Lack of Efficacy|67|||
164161909|NCT02151851|592958828|FG001|Overall Study|Lack of Efficacy|94|||
164161910|NCT02151851|592958827|FG000|Overall Study|Protocol Violation|0|||
164161911|NCT02151851|592958828|FG001|Overall Study|Protocol Violation|1|||
164161912|NCT02151851|592958827|FG000|Overall Study|Withdrawal by Subject|2|||
164161913|NCT02151851|592958828|FG001|Overall Study|Withdrawal by Subject|5|||
164161914|NCT02151851|592958827|FG000|Overall Study|Medical impairment|1|||
164161915|NCT02151851|592958828|FG001|Overall Study|Medical impairment|0|||
164161916|NCT02151851|592958827|FG000|Overall Study|Low compliance to study visits|0|||
164161917|NCT02151851|592958828|FG001|Overall Study|Low compliance to study visits|1|||
164161918|NCT02151851|592958827|FG000|Overall Study|Subject entered into study in error|0|||
164161919|NCT02151851|592958828|FG001|Overall Study|Subject entered into study in error|1|||
164161920|NCT02151851|592958827|FG000|Overall Study|Adverse Event|6|||
164161921|NCT02151851|592958828|FG001|Overall Study|Adverse Event|28|||
164161922|NCT02159053|592958829|FG000|Overall Study|Death|2|||
164161923|NCT02159053|592958830|FG001|Overall Study|Death|0|||
164161924|NCT02159053|592958831|FG002|Overall Study|Death|1|||
164161925|NCT02159053|592958829|FG000|Overall Study|Physician Decision|0|||
164161926|NCT02159053|592958830|FG001|Overall Study|Physician Decision|1|||
164161927|NCT02159053|592958831|FG002|Overall Study|Physician Decision|1|||
164161928|NCT02159053|592958829|FG000|Overall Study|Lack of Efficacy|3|||
164161929|NCT02159053|592958830|FG001|Overall Study|Lack of Efficacy|4|||
164161930|NCT02159053|592958831|FG002|Overall Study|Lack of Efficacy|7|||
164161931|NCT02159053|592958829|FG000|Overall Study|Adverse Event|7|||
164161932|NCT02159053|592958830|FG001|Overall Study|Adverse Event|6|||
164161933|NCT02159053|592958831|FG002|Overall Study|Adverse Event|5|||
164161934|NCT02159053|592958829|FG000|Overall Study|Participants/guardian decision|8|||
164161935|NCT02159053|592958830|FG001|Overall Study|Participants/guardian decision|10|||
164161936|NCT02159053|592958831|FG002|Overall Study|Participants/guardian decision|6|||
164161937|NCT02640950|592958832|FG000|Overall Study|Adverse Event|1|||
164161938|NCT02640950|592958832|FG000|Overall Study|Withdrawal by Subject|1|||
164161939|NCT03048747|592958833|FG000|Overall Study|Adverse Event|2|||
164161940|NCT03048747|592958833|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
164161941|NCT03048747|592958833|FG000|Overall Study|Physician Decision|1|||
164161942|NCT00915018|592958836|FG000|Overall Study|Death|75|||
164161943|NCT00915018|592958837|FG001|Overall Study|Death|70|||
164161944|NCT00915018|592958836|FG000|Overall Study|Lost to Follow-up|10|||
164161945|NCT00915018|592958837|FG001|Overall Study|Lost to Follow-up|5|||
164161946|NCT00915018|592958836|FG000|Overall Study|Withdrawal by Subject|38|||
164161947|NCT00915018|592958837|FG001|Overall Study|Withdrawal by Subject|27|||
164161948|NCT00915018|592958836|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
164161949|NCT00915018|592958837|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
164161950|NCT02582242|592958838|FG000|Overall Study|Adverse Event|4|||
164161951|NCT02582242|592958839|FG001|Overall Study|Adverse Event|3|||
164161952|NCT02582242|592958838|FG000|Overall Study|Protocol Violation|3|||
164161953|NCT02582242|592958839|FG001|Overall Study|Protocol Violation|1|||
164161954|NCT02582242|592958838|FG000|Overall Study|Lost to Follow-up|0|||
164161955|NCT02582242|592958839|FG001|Overall Study|Lost to Follow-up|1|||
164161956|NCT02582242|592958838|FG000|Overall Study|Withdrawal by Subject|11|||
164161957|NCT02582242|592958839|FG001|Overall Study|Withdrawal by Subject|11|||
164161958|NCT02582242|592958838|FG000|Overall Study|Unclassified|2|||
164161959|NCT02582242|592958839|FG001|Overall Study|Unclassified|1|||
164161960|NCT00300885|592958840|FG000|Treatment|Adverse Event|134|||
164161961|NCT00300885|592958841|FG001|Treatment|Adverse Event|82|||
164161962|NCT00300885|592958840|FG000|Treatment|Death|20|||
164161963|NCT00300885|592958841|FG001|Treatment|Death|7|||
164161964|NCT00300885|592958840|FG000|Treatment|Lack of Efficacy|1|||
164161965|NCT00300885|592958841|FG001|Treatment|Lack of Efficacy|1|||
164161966|NCT00300885|592958840|FG000|Treatment|Lost to Follow-up|3|||
164161967|NCT00300885|592958841|FG001|Treatment|Lost to Follow-up|2|||
164161968|NCT00300885|592958840|FG000|Treatment|Physician Decision|4|||
164161969|NCT00300885|592958841|FG001|Treatment|Physician Decision|5|||
164161970|NCT00300885|592958840|FG000|Treatment|Protocol Violation|11|||
164161971|NCT00300885|592958841|FG001|Treatment|Protocol Violation|11|||
164161972|NCT00300885|592958840|FG000|Treatment|Withdrawal by Subject|26|||
164161973|NCT00300885|592958841|FG001|Treatment|Withdrawal by Subject|23|||
164161974|NCT00300885|592958840|FG000|Treatment|Disease progression|171|||
164161975|NCT00300885|592958841|FG001|Treatment|Disease progression|238|||
164161976|NCT00300885|592958840|FG000|Treatment|Random code broken (subject died)|0|||
164161977|NCT00300885|592958841|FG001|Treatment|Random code broken (subject died)|1|||
164161978|NCT00300885|592958840|FG000|Treatment|Non-compliant with study medication|3|||
164161979|NCT00300885|592958841|FG001|Treatment|Non-compliant with study medication|4|||
164161980|NCT00300885|592958840|FG000|Follow-up|Death|141|||
164161981|NCT00300885|592958841|FG001|Follow-up|Death|163|||
164161982|NCT00300885|592958840|FG000|Follow-up|Lost to Follow-up|11|||
164161983|NCT00300885|592958841|FG001|Follow-up|Lost to Follow-up|7|||
164161984|NCT00300885|592958840|FG000|Follow-up|Withdrawal by Subject|26|||
164161985|NCT00300885|592958841|FG001|Follow-up|Withdrawal by Subject|25|||
164161986|NCT01637922|592958842|FG000|Overall Study|Adverse Event|0|||
164161987|NCT01637922|592958843|FG001|Overall Study|Adverse Event|1|||
164161988|NCT01637922|592958842|FG000|Overall Study|Protocol Violation|0|||
164161989|NCT01637922|592958843|FG001|Overall Study|Protocol Violation|1|||
164161990|NCT01637922|592958842|FG000|Overall Study|Withdrawal by Subject|0|||
164161991|NCT01637922|592958843|FG001|Overall Study|Withdrawal by Subject|3|||
164161993|NCT01637922|592958843|FG001|Overall Study|Lost to Follow-up|0|||
164161994|NCT00638404|592958844|FG000|Overall Study|Physician Decision|8|||
164161995|NCT00638404|592958845|FG001|Overall Study|Physician Decision|0|||
164161996|NCT02101736|592958846|FG000|Overall Study|Protocol Violation|3|||
164161997|NCT02101736|592958847|FG001|Overall Study|Protocol Violation|0|||
164161998|NCT02101736|592958846|FG000|Overall Study|Withdrawal by Subject|1|||
164161999|NCT02101736|592958847|FG001|Overall Study|Withdrawal by Subject|1|||
164162000|NCT02282631|592958848|FG000|Overall Study|Lost to Follow-up|2|||
164162001|NCT02282631|592958849|FG001|Overall Study|Lost to Follow-up|0|||
164162002|NCT00459290|592958850|FG000|Overall Study|Adverse Event|3|||
164162003|NCT00459290|592958850|FG000|Overall Study|Ineligible|2|||
164162004|NCT00687271|592958851|FG000|Overall Study|Adverse Event|1|||
164162005|NCT00687271|592958852|FG001|Overall Study|Adverse Event|3|||
164162006|NCT00687271|592958853|FG002|Overall Study|Adverse Event|1|||
164162007|NCT00687271|592958854|FG003|Overall Study|Adverse Event|0|||
164162008|NCT00687271|592958851|FG000|Overall Study|Lost to Follow-up|0|||
164162009|NCT00687271|592958852|FG001|Overall Study|Lost to Follow-up|1|||
164162010|NCT00687271|592958853|FG002|Overall Study|Lost to Follow-up|0|||
164162011|NCT00687271|592958854|FG003|Overall Study|Lost to Follow-up|0|||
164162012|NCT00687271|592958851|FG000|Overall Study|Protocol Violation|2|||
164162013|NCT00687271|592958852|FG001|Overall Study|Protocol Violation|1|||
164162014|NCT00687271|592958853|FG002|Overall Study|Protocol Violation|1|||
164162015|NCT00687271|592958854|FG003|Overall Study|Protocol Violation|0|||
164162016|NCT00687271|592958851|FG000|Overall Study|Withdrawal by Subject|0|||
164162017|NCT00687271|592958852|FG001|Overall Study|Withdrawal by Subject|1|||
164162018|NCT00687271|592958853|FG002|Overall Study|Withdrawal by Subject|3|||
164162019|NCT00687271|592958854|FG003|Overall Study|Withdrawal by Subject|0|||
164162020|NCT02453334|592958855|FG000|Overall Study|Death|15|||
164162021|NCT02453334|592958856|FG001|Overall Study|Death|13|||
164162022|NCT02453334|592958855|FG000|Overall Study|Adverse Event|2|||
164162023|NCT02453334|592958856|FG001|Overall Study|Adverse Event|1|||
164162024|NCT02453334|592958855|FG000|Overall Study|Lost to Follow-up|5|||
164162025|NCT02453334|592958856|FG001|Overall Study|Lost to Follow-up|9|||
164162026|NCT02453334|592958855|FG000|Overall Study|Physician Decision|1|||
164162027|NCT02453334|592958856|FG001|Overall Study|Physician Decision|0|||
164162028|NCT02453334|592958855|FG000|Overall Study|Withdrawal by Subject|17|||
164162029|NCT02453334|592958856|FG001|Overall Study|Withdrawal by Subject|13|||
164162030|NCT02453334|592958855|FG000|Overall Study|Other reason|1|||
164162031|NCT02453334|592958856|FG001|Overall Study|Other reason|4|||
164162032|NCT02693106|592958861|FG000|Overall Study|No time|3|||
164162033|NCT03981900|592958862|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
164162034|NCT03981900|592958862|FG000|Overall Study|Adverse Event|5|||
164162035|NCT03981900|592958862|FG000|Overall Study|Protocol Violation|1|||
164162036|NCT03981900|592958862|FG000|Overall Study|Withdrawal by Subject|7|||
164162037|NCT03981900|592958862|FG000|Overall Study|Lost to Follow-up|46|||
164162038|NCT03981900|592958862|FG000|Overall Study|Decision of the researcher|3|||
164162039|NCT03981900|592958862|FG000|Overall Study|Death|3|||
164162040|NCT03981900|592958862|FG000|Overall Study|Other|5|||
164162041|NCT04090060|592958875|FG000|Overall Study|Lost to Follow-up|76|||
164162042|NCT04090060|592958876|FG001|Overall Study|Lost to Follow-up|77|||
164162043|NCT03337113|592958883|FG000|Overall Study|Adverse Event|1|||
164162044|NCT03337113|592958884|FG001|Overall Study|Adverse Event|1|||
164162045|NCT03337113|592958885|FG002|Overall Study|Adverse Event|0|||
164162046|NCT03337113|592958886|FG003|Overall Study|Adverse Event|1|||
164162047|NCT03337113|592958883|FG000|Overall Study|Physician Decision|0|||
164162048|NCT03337113|592958884|FG001|Overall Study|Physician Decision|2|||
164162049|NCT03337113|592958885|FG002|Overall Study|Physician Decision|0|||
164162050|NCT03337113|592958886|FG003|Overall Study|Physician Decision|1|||
164162051|NCT03337113|592958883|FG000|Overall Study|Withdrawal by Subject|0|||
164162052|NCT03337113|592958884|FG001|Overall Study|Withdrawal by Subject|0|||
164162053|NCT03337113|592958885|FG002|Overall Study|Withdrawal by Subject|1|||
164162054|NCT03337113|592958886|FG003|Overall Study|Withdrawal by Subject|0|||
164162055|NCT00507455|592958892|FG000|Overall Study|Adverse Event|3|||
164162056|NCT00507455|592958893|FG001|Overall Study|Adverse Event|3|||
164162057|NCT00507455|592958894|FG002|Overall Study|Adverse Event|6|||
164162058|NCT00507455|592958892|FG000|Overall Study|Withdrawal by Subject|2|||
164162059|NCT00507455|592958893|FG001|Overall Study|Withdrawal by Subject|1|||
164162060|NCT00507455|592958894|FG002|Overall Study|Withdrawal by Subject|2|||
164162061|NCT00507455|592958892|FG000|Overall Study|Protocol Violation|4|||
164162062|NCT00507455|592958893|FG001|Overall Study|Protocol Violation|1|||
164162063|NCT00507455|592958894|FG002|Overall Study|Protocol Violation|1|||
164162064|NCT00507455|592958892|FG000|Overall Study|Lost to Follow-up|2|||
164162065|NCT00507455|592958893|FG001|Overall Study|Lost to Follow-up|0|||
164162066|NCT00507455|592958894|FG002|Overall Study|Lost to Follow-up|2|||
164162067|NCT00507455|592958892|FG000|Overall Study|Lack of Efficacy|0|||
164162068|NCT00507455|592958893|FG001|Overall Study|Lack of Efficacy|1|||
164162069|NCT00507455|592958894|FG002|Overall Study|Lack of Efficacy|0|||
164162070|NCT00507455|592958892|FG000|Overall Study|Other - miscellaneous reason|1|||
164162071|NCT00507455|592958893|FG001|Overall Study|Other - miscellaneous reason|0|||
164162146|NCT02527434|592958932|FG001|Overall Study|Site closure|0|||
164162072|NCT00507455|592958894|FG002|Overall Study|Other - miscellaneous reason|1|||
164162073|NCT02176655|592958895|FG000|Overall Study|Subjects did not treat|6|||
164162074|NCT01372995|592958896|FG000|Overall Study|Spouse withdrew participant from study|0|||
164162075|NCT01372995|592958897|FG001|Overall Study|Spouse withdrew participant from study|1|||
164162076|NCT01372995|592958898|FG002|Overall Study|Spouse withdrew participant from study|0|||
164162077|NCT01372995|592958896|FG000|Overall Study|Physician Decision|0|||
164162078|NCT01372995|592958897|FG001|Overall Study|Physician Decision|0|||
164162079|NCT01372995|592958898|FG002|Overall Study|Physician Decision|1|||
164162080|NCT06110494|592958904|FG000|Overall Study|Protocol Violation|2|||
164162081|NCT06110494|592958905|FG001|Overall Study|Protocol Violation|0|||
164162082|NCT06110494|592958906|FG002|Overall Study|Protocol Violation|1|||
164162083|NCT06110494|592958904|FG000|Overall Study|Dixon's test for outlier analysis|1|||
164162084|NCT06110494|592958905|FG001|Overall Study|Dixon's test for outlier analysis|1|||
164162085|NCT06110494|592958906|FG002|Overall Study|Dixon's test for outlier analysis|0|||
164162086|NCT00105079|592958907|FG000|Overall Study|Adverse Event|5|||
164162087|NCT00105079|592958908|FG001|Overall Study|Adverse Event|12|||
164162088|NCT00105079|592958907|FG000|Overall Study|Death|3|||
164162089|NCT00105079|592958908|FG001|Overall Study|Death|1|||
164162090|NCT00105079|592958907|FG000|Overall Study|Lost to Follow-up|12|||
164162091|NCT00105079|592958908|FG001|Overall Study|Lost to Follow-up|12|||
164162092|NCT00105079|592958907|FG000|Overall Study|Lack of Efficacy|9|||
164162093|NCT00105079|592958908|FG001|Overall Study|Lack of Efficacy|3|||
164162094|NCT00105079|592958907|FG000|Overall Study|Refused treatment|6|||
164162095|NCT00105079|592958908|FG001|Overall Study|Refused treatment|4|||
164162096|NCT00105079|592958907|FG000|Overall Study|Violation of selection criteria at entry|0|||
164162097|NCT00105079|592958908|FG001|Overall Study|Violation of selection criteria at entry|2|||
164162098|NCT00105079|592958907|FG000|Overall Study|Protocol Violation|1|||
164162099|NCT00105079|592958908|FG001|Overall Study|Protocol Violation|0|||
164162100|NCT00105079|592958907|FG000|Overall Study|Other|3|||
164162101|NCT00105079|592958908|FG001|Overall Study|Other|1|||
164162102|NCT01464593|592958909|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
164162103|NCT01737710|592958919|FG000|Overall Study|Lost to Follow-up|0|||
164162104|NCT01737710|592958920|FG001|Overall Study|Lost to Follow-up|2|||
164162105|NCT01737710|592958921|FG002|Overall Study|Lost to Follow-up|2|||
164162106|NCT01737710|592958922|FG003|Overall Study|Lost to Follow-up|0|||
164162107|NCT01737710|592958923|FG004|Overall Study|Lost to Follow-up|0|||
164162108|NCT01737710|592958919|FG000|Overall Study|Withdrawal by Subject|1|||
164162109|NCT01737710|592958920|FG001|Overall Study|Withdrawal by Subject|1|||
164162110|NCT01737710|592958921|FG002|Overall Study|Withdrawal by Subject|1|||
164162111|NCT01737710|592958922|FG003|Overall Study|Withdrawal by Subject|0|||
164162112|NCT01737710|592958923|FG004|Overall Study|Withdrawal by Subject|0|||
164162113|NCT01737710|592958919|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
164162114|NCT01737710|592958920|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
164162115|NCT01737710|592958921|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
164162116|NCT01737710|592958922|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
164162117|NCT01737710|592958923|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
164162118|NCT00921557|592958928|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
164162119|NCT00921557|592958929|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
164162120|NCT00921557|592958930|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
164162121|NCT00921557|592958928|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
164162122|NCT00921557|592958929|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
164162123|NCT00921557|592958930|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
164162124|NCT00921557|592958928|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
164162125|NCT00921557|592958929|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
164162126|NCT00921557|592958930|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
164162127|NCT00921557|592958928|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
164162128|NCT00921557|592958929|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
164162129|NCT00921557|592958930|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
164162130|NCT00921557|592958928|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
164162131|NCT00921557|592958929|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
164162132|NCT00921557|592958930|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
164162133|NCT02527434|592958931|FG000|Overall Study|Lost to Follow-up|2|||
164162134|NCT02527434|592958932|FG001|Overall Study|Lost to Follow-up|2|||
164162135|NCT02527434|592958933|FG002|Overall Study|Lost to Follow-up|0|||
164162136|NCT02527434|592958931|FG000|Overall Study|Death|19|||
164162137|NCT02527434|592958932|FG001|Overall Study|Death|6|||
164162138|NCT02527434|592958933|FG002|Overall Study|Death|17|||
164162139|NCT02527434|592958931|FG000|Overall Study|Withdrawal by Subject|5|||
164162140|NCT02527434|592958932|FG001|Overall Study|Withdrawal by Subject|3|||
164162141|NCT02527434|592958933|FG002|Overall Study|Withdrawal by Subject|3|||
164162142|NCT02527434|592958931|FG000|Overall Study|Reason Not Specified|1|||
164162143|NCT02527434|592958932|FG001|Overall Study|Reason Not Specified|0|||
164162144|NCT02527434|592958933|FG002|Overall Study|Reason Not Specified|0|||
164162145|NCT02527434|592958931|FG000|Overall Study|Site closure|1|||
164162147|NCT02527434|592958933|FG002|Overall Study|Site closure|0|||
164162148|NCT02589639|592958947|FG000|Overall Study|Lost to Follow-up|1|||
164162149|NCT02589639|592958948|FG001|Overall Study|Lost to Follow-up|0|||
164162150|NCT02589639|592958949|FG002|Overall Study|Lost to Follow-up|0|||
164162151|NCT02589639|592958947|FG000|Overall Study|Protocol Violation|1|||
164162152|NCT02589639|592958948|FG001|Overall Study|Protocol Violation|0|||
164162153|NCT02589639|592958949|FG002|Overall Study|Protocol Violation|0|||
164162154|NCT02589639|592958947|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
164162155|NCT02589639|592958948|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
164162156|NCT02589639|592958949|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
164162157|NCT02589639|592958947|FG000|Overall Study|Adverse Event|4|||
164162158|NCT02589639|592958948|FG001|Overall Study|Adverse Event|5|||
164162159|NCT02589639|592958949|FG002|Overall Study|Adverse Event|3|||
164162160|NCT02589639|592958947|FG000|Overall Study|Other reason than specified above|1|||
164162161|NCT02589639|592958948|FG001|Overall Study|Other reason than specified above|2|||
164162162|NCT02589639|592958949|FG002|Overall Study|Other reason than specified above|1|||
164162163|NCT02589639|592958947|FG000|Overall Study|Not Treated|0|||
164162164|NCT02589639|592958948|FG001|Overall Study|Not Treated|3|||
164162165|NCT02589639|592958949|FG002|Overall Study|Not Treated|0|||
164162166|NCT01276756|592958952|FG000|Overall Study|Lost to Follow-up|2|||
164162167|NCT01276756|592958953|FG001|Overall Study|Lost to Follow-up|0|||
164162168|NCT01276756|592958952|FG000|Overall Study|Adverse Event|3|||
164162169|NCT01276756|592958953|FG001|Overall Study|Adverse Event|2|||
164162170|NCT05868577|592958954|FG000|Overall Study|Lost to Follow-up|5|||
164162171|NCT05868577|592958955|FG001|Overall Study|Lost to Follow-up|5|||
164162172|NCT02522884|592958958|FG000|Overall Study|Withdrawal by Subject|6|||
164162173|NCT02522884|592958958|FG000|Overall Study|Death|3|||
164162174|NCT02522884|592958958|FG000|Overall Study|Missed 12-month Follow-up|9|||
164162175|NCT03289754|592958959|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
164162176|NCT04873934|592958960|FG000|Overall Study|Adverse Event|0|||
164162177|NCT04873934|592958961|FG001|Overall Study|Adverse Event|1|||
164162178|NCT04873934|592958960|FG000|Overall Study|Death|0|||
164162179|NCT04873934|592958961|FG001|Overall Study|Death|2|||
164162180|NCT04873934|592958960|FG000|Overall Study|Lost to Follow-up|13|||
164162181|NCT04873934|592958961|FG001|Overall Study|Lost to Follow-up|9|||
164162182|NCT04873934|592958960|FG000|Overall Study|Physician Decision|1|||
164162183|NCT04873934|592958961|FG001|Overall Study|Physician Decision|1|||
164162184|NCT04873934|592958960|FG000|Overall Study|Protocol deviation|2|||
164162185|NCT04873934|592958961|FG001|Overall Study|Protocol deviation|1|||
164162186|NCT04873934|592958960|FG000|Overall Study|Subject decision|1|||
164162187|NCT04873934|592958961|FG001|Overall Study|Subject decision|8|||
164162188|NCT04873934|592958960|FG000|Overall Study|Withdrew consent|0|||
164162189|NCT04873934|592958961|FG001|Overall Study|Withdrew consent|4|||
164162190|NCT04873934|592958960|FG000|Overall Study|Missing|1|||
164162191|NCT04873934|592958961|FG001|Overall Study|Missing|0|||
164162192|NCT03584854|592958963|FG000|Overall Study|Primary outcome not measured|1|||
164162193|NCT03584854|592958964|FG001|Overall Study|Primary outcome not measured|2|||
164162194|NCT02630251|592958965|FG000|Overall Study|Physician Decision|0|||
164162195|NCT02630251|592958966|FG001|Overall Study|Physician Decision|0|||
164162196|NCT02630251|592958967|FG002|Overall Study|Physician Decision|1|||
164162197|NCT02630251|592958968|FG003|Overall Study|Physician Decision|0|||
164162198|NCT02134015|592958969|FG000|Overall Study|Protocol Violation|0|||
164162199|NCT02134015|592958970|FG001|Overall Study|Protocol Violation|1|||
164162200|NCT02134015|592958969|FG000|Overall Study|Death|2|||
164162201|NCT02134015|592958970|FG001|Overall Study|Death|1|||
164162202|NCT02134015|592958969|FG000|Overall Study|Reason not provided|1|||
164162203|NCT02134015|592958970|FG001|Overall Study|Reason not provided|2|||
164162204|NCT02134015|592958969|FG000|Overall Study|Clinical progression|14|||
164162205|NCT02134015|592958970|FG001|Overall Study|Clinical progression|7|||
164162206|NCT02134015|592958969|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
164162207|NCT02134015|592958970|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
164162208|NCT02134015|592958969|FG000|Overall Study|Study terminated by sponsor|2|||
164162209|NCT02134015|592958970|FG001|Overall Study|Study terminated by sponsor|3|||
164162210|NCT02134015|592958969|FG000|Overall Study|Adverse Event|9|||
164162211|NCT02134015|592958970|FG001|Overall Study|Adverse Event|10|||
164162212|NCT02134015|592958969|FG000|Overall Study|Withdrawal by Subject|3|||
164162213|NCT02134015|592958970|FG001|Overall Study|Withdrawal by Subject|7|||
164162214|NCT01777282|592958973|FG000|Overall Study|Persistent Hyperglycemia|0|||
164162215|NCT01777282|592958974|FG001|Overall Study|Persistent Hyperglycemia|0|||
164162216|NCT01777282|592958975|FG002|Overall Study|Persistent Hyperglycemia|1|||
164162217|NCT01777282|592958976|FG003|Overall Study|Persistent Hyperglycemia|0|||
164162218|NCT01777282|592958977|FG004|Overall Study|Persistent Hyperglycemia|0|||
164162219|NCT01777282|592958973|FG000|Overall Study|New Antidiabetic Medication|0|||
164162220|NCT01777282|592958974|FG001|Overall Study|New Antidiabetic Medication|0|||
164162221|NCT01777282|592958975|FG002|Overall Study|New Antidiabetic Medication|1|||
164162222|NCT01777282|592958976|FG003|Overall Study|New Antidiabetic Medication|0|||
164162223|NCT01777282|592958977|FG004|Overall Study|New Antidiabetic Medication|0|||
164162224|NCT01777282|592958973|FG000|Overall Study|Adverse Event|4|||
164162225|NCT01777282|592958974|FG001|Overall Study|Adverse Event|4|||
164162226|NCT01777282|592958975|FG002|Overall Study|Adverse Event|2|||
164162227|NCT01777282|592958976|FG003|Overall Study|Adverse Event|1|||
164162228|NCT01777282|592958977|FG004|Overall Study|Adverse Event|3|||
164162229|NCT01777282|592958973|FG000|Overall Study|Withdrawal by Subject|4|||
164162230|NCT01777282|592958974|FG001|Overall Study|Withdrawal by Subject|0|||
164162231|NCT01777282|592958975|FG002|Overall Study|Withdrawal by Subject|0|||
164162232|NCT01777282|592958976|FG003|Overall Study|Withdrawal by Subject|1|||
164162233|NCT01777282|592958977|FG004|Overall Study|Withdrawal by Subject|2|||
164162234|NCT01777282|592958973|FG000|Overall Study|Protocol Violation|2|||
164162235|NCT01777282|592958974|FG001|Overall Study|Protocol Violation|0|||
164162236|NCT01777282|592958975|FG002|Overall Study|Protocol Violation|1|||
164162237|NCT01777282|592958976|FG003|Overall Study|Protocol Violation|0|||
164162238|NCT01777282|592958977|FG004|Overall Study|Protocol Violation|2|||
164162239|NCT01777282|592958973|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
164162240|NCT01777282|592958974|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
164162241|NCT01777282|592958975|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
164162242|NCT01777282|592958976|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
164162243|NCT01777282|592958977|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
164162244|NCT04015518|592958978|FG000|Overall Study|Adverse Event|6|||
164162245|NCT04015518|592958979|FG001|Overall Study|Adverse Event|1|||
164162246|NCT04015518|592958980|FG002|Overall Study|Adverse Event|1|||
164162247|NCT04015518|592958981|FG003|Overall Study|Adverse Event|3|||
164162248|NCT04015518|592958982|FG004|Overall Study|Adverse Event|3|||
164162249|NCT04015518|592958978|FG000|Overall Study|Lack of Efficacy|1|||
164162250|NCT04015518|592958979|FG001|Overall Study|Lack of Efficacy|0|||
164162251|NCT04015518|592958980|FG002|Overall Study|Lack of Efficacy|1|||
164162252|NCT04015518|592958981|FG003|Overall Study|Lack of Efficacy|0|||
164162253|NCT04015518|592958982|FG004|Overall Study|Lack of Efficacy|4|||
164162254|NCT04015518|592958978|FG000|Overall Study|Lost to Follow-up|0|||
164162255|NCT04015518|592958979|FG001|Overall Study|Lost to Follow-up|0|||
164162256|NCT04015518|592958980|FG002|Overall Study|Lost to Follow-up|0|||
164162257|NCT04015518|592958981|FG003|Overall Study|Lost to Follow-up|0|||
164162258|NCT04015518|592958982|FG004|Overall Study|Lost to Follow-up|1|||
164162259|NCT04015518|592958978|FG000|Overall Study|Withdrawal by Subject|0|||
164162260|NCT04015518|592958979|FG001|Overall Study|Withdrawal by Subject|1|||
164162261|NCT04015518|592958980|FG002|Overall Study|Withdrawal by Subject|0|||
164162262|NCT04015518|592958981|FG003|Overall Study|Withdrawal by Subject|1|||
164162263|NCT04015518|592958982|FG004|Overall Study|Withdrawal by Subject|1|||
164162264|NCT04015518|592958978|FG000|Overall Study|Patient did not come for consecutive visits|0|||
164162265|NCT04015518|592958979|FG001|Overall Study|Patient did not come for consecutive visits|1|||
164162266|NCT04015518|592958980|FG002|Overall Study|Patient did not come for consecutive visits|0|||
164162267|NCT04015518|592958981|FG003|Overall Study|Patient did not come for consecutive visits|0|||
164162268|NCT04015518|592958982|FG004|Overall Study|Patient did not come for consecutive visits|0|||
164162269|NCT04015518|592958978|FG000|Overall Study|not willing to travel due to Covid-19|0|||
164162270|NCT04015518|592958979|FG001|Overall Study|not willing to travel due to Covid-19|0|||
164162271|NCT04015518|592958980|FG002|Overall Study|not willing to travel due to Covid-19|1|||
164162272|NCT04015518|592958981|FG003|Overall Study|not willing to travel due to Covid-19|0|||
164162273|NCT04015518|592958982|FG004|Overall Study|not willing to travel due to Covid-19|0|||
164162274|NCT04015518|592958978|FG000|Overall Study|Patient wants to discontinue treatment|0|||
164162275|NCT04015518|592958979|FG001|Overall Study|Patient wants to discontinue treatment|0|||
164162276|NCT04015518|592958980|FG002|Overall Study|Patient wants to discontinue treatment|0|||
164162277|NCT04015518|592958981|FG003|Overall Study|Patient wants to discontinue treatment|1|||
164162278|NCT04015518|592958982|FG004|Overall Study|Patient wants to discontinue treatment|0|||
164162279|NCT04015518|592958978|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
164162280|NCT04015518|592958979|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
164162281|NCT04015518|592958980|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
164162282|NCT04015518|592958981|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
164162283|NCT04015518|592958982|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
164162284|NCT04015518|592958978|FG000|Overall Study|Pregnancy|0|||
164162285|NCT04015518|592958979|FG001|Overall Study|Pregnancy|0|||
164162286|NCT04015518|592958980|FG002|Overall Study|Pregnancy|0|||
164162287|NCT04015518|592958981|FG003|Overall Study|Pregnancy|0|||
164162288|NCT04015518|592958982|FG004|Overall Study|Pregnancy|1|||
164162289|NCT04015518|592958978|FG000|Overall Study|Personal reasons|1|||
164162290|NCT04015518|592958979|FG001|Overall Study|Personal reasons|0|||
164162291|NCT04015518|592958980|FG002|Overall Study|Personal reasons|0|||
164162292|NCT04015518|592958981|FG003|Overall Study|Personal reasons|0|||
164162293|NCT04015518|592958982|FG004|Overall Study|Personal reasons|1|||
164162294|NCT04015518|592958978|FG000|Overall Study|Withdrew consent|1|||
164162295|NCT04015518|592958979|FG001|Overall Study|Withdrew consent|0|||
164162296|NCT04015518|592958980|FG002|Overall Study|Withdrew consent|0|||
164162297|NCT04015518|592958981|FG003|Overall Study|Withdrew consent|0|||
164162298|NCT04015518|592958982|FG004|Overall Study|Withdrew consent|0|||
164162299|NCT04015518|592958978|FG000|Overall Study|Prostate carcinoma|1|||
164162300|NCT04015518|592958979|FG001|Overall Study|Prostate carcinoma|0|||
164162301|NCT04015518|592958980|FG002|Overall Study|Prostate carcinoma|0|||
164162302|NCT04015518|592958981|FG003|Overall Study|Prostate carcinoma|0|||
164162303|NCT04015518|592958982|FG004|Overall Study|Prostate carcinoma|0|||
164162304|NCT04015518|592958978|FG000|Overall Study|Could not keep appointments due to work|1|||
164162305|NCT04015518|592958979|FG001|Overall Study|Could not keep appointments due to work|0|||
164162306|NCT04015518|592958980|FG002|Overall Study|Could not keep appointments due to work|0|||
164162307|NCT04015518|592958981|FG003|Overall Study|Could not keep appointments due to work|0|||
164162308|NCT04015518|592958982|FG004|Overall Study|Could not keep appointments due to work|0|||
164162309|NCT02186873|592960432|FG000|Overall Study|Adverse Event|1|||
164162310|NCT02186873|592960433|FG001|Overall Study|Adverse Event|3|||
164162311|NCT02186873|592960432|FG000|Overall Study|Lack of Efficacy|0|||
164162312|NCT02186873|592960433|FG001|Overall Study|Lack of Efficacy|1|||
164162313|NCT02186873|592960432|FG000|Overall Study|Lost to Follow-up|1|||
164162314|NCT02186873|592960433|FG001|Overall Study|Lost to Follow-up|2|||
164162315|NCT02186873|592960432|FG000|Overall Study|Withdrawal by Subject|7|||
164162316|NCT02186873|592960433|FG001|Overall Study|Withdrawal by Subject|2|||
164162317|NCT03694002|592960434|FG000|Overall Study|Progression|4|||
164162318|NCT03694002|592960435|FG001|Overall Study|Progression|2|||
164162319|NCT03694002|592960434|FG000|Overall Study|Adverse Event|2|||
164162320|NCT03694002|592960435|FG001|Overall Study|Adverse Event|0|||
164162321|NCT03694002|592960434|FG000|Overall Study|Other not protocol specified|1|||
164162322|NCT03694002|592960435|FG001|Overall Study|Other not protocol specified|0|||
164162323|NCT03694002|592960434|FG000|Overall Study|Ineligible|0|||
164162324|NCT03694002|592960435|FG001|Overall Study|Ineligible|1|||
164162325|NCT03694002|592960434|FG000|Overall Study|Withdrew consent before starting treatment|0|||
164162326|NCT03694002|592960435|FG001|Overall Study|Withdrew consent before starting treatment|3|||
164162327|NCT01760655|592960436|FG000|Overall Study|Death|18|||
164162328|NCT01760655|592960436|FG000|Overall Study|Physician Decision|1|||
164162329|NCT01568034|592960438|FG000|Overall Study|Withdrawal by Subject|1|||
164162330|NCT01568034|592960439|FG001|Overall Study|Withdrawal by Subject|0|||
164162331|NCT01568034|592960440|FG002|Overall Study|Withdrawal by Subject|0|||
164162332|NCT01568034|592960441|FG003|Overall Study|Withdrawal by Subject|0|||
164162333|NCT01068730|592960442|FG000|Period 3|Personal reason|1|||
164162334|NCT01068730|592960443|FG001|Period 3|Personal reason|0|||
164162335|NCT01068730|592960444|FG002|Period 3|Personal reason|0|||
164162336|NCT01068730|592960445|FG003|Period 3|Personal reason|0|||
164162337|NCT01068730|592960442|FG000|Period 4|Family emergency|0|||
164162338|NCT01068730|592960443|FG001|Period 4|Family emergency|1|||
164162339|NCT01068730|592960444|FG002|Period 4|Family emergency|0|||
164162340|NCT01068730|592960445|FG003|Period 4|Family emergency|0|||
164162341|NCT01515865|592960449|FG000|Part A (Open-label)|Other|3|||
164162342|NCT01515865|592960450|FG001|Part A (Open-label)|Other|0|||
164162343|NCT01515865|592960451|FG002|Part A (Open-label)|Other|0|||
164162344|NCT01515865|592960449|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
164162345|NCT01515865|592960450|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
164162346|NCT01515865|592960451|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
164162347|NCT01515865|592960449|FG000|Part B (Open-label)|Other|1|||
164162348|NCT01515865|592960450|FG001|Part B (Open-label)|Other|0|||
164162349|NCT01515865|592960451|FG002|Part B (Open-label)|Other|0|||
164162350|NCT02510664|592960454|FG000|Overall Study|Transferred Care|9|||
164162351|NCT02510664|592960455|FG001|Overall Study|Transferred Care|9|||
164162352|NCT02510664|592960456|FG002|Overall Study|Transferred Care|0|||
164162353|NCT02510664|592960454|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
164162354|NCT02510664|592960455|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
164162355|NCT02510664|592960456|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
164162356|NCT02510664|592960454|FG000|Overall Study|Time Constraints|1|||
164162357|NCT02510664|592960455|FG001|Overall Study|Time Constraints|1|||
164162358|NCT02510664|592960456|FG002|Overall Study|Time Constraints|0|||
164162359|NCT01297517|592960462|FG000|Overall Study|Adverse Event|21|||
164162360|NCT01297517|592960463|FG001|Overall Study|Adverse Event|7|||
164162361|NCT01297517|592960464|FG002|Overall Study|Adverse Event|16|||
164162362|NCT01297517|592960462|FG000|Overall Study|Lost to Follow-up|1|||
164162363|NCT01297517|592960463|FG001|Overall Study|Lost to Follow-up|0|||
164162364|NCT01297517|592960464|FG002|Overall Study|Lost to Follow-up|1|||
164162365|NCT01297517|592960462|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
164162366|NCT01297517|592960463|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
164162367|NCT01297517|592960464|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
164162368|NCT01297517|592960462|FG000|Overall Study|Noncompliance|1|||
164162369|NCT01297517|592960463|FG001|Overall Study|Noncompliance|0|||
164162370|NCT01297517|592960464|FG002|Overall Study|Noncompliance|0|||
164162371|NCT01297517|592960462|FG000|Overall Study|Protocol Violation|1|||
164162372|NCT01297517|592960463|FG001|Overall Study|Protocol Violation|1|||
164162373|NCT01297517|592960464|FG002|Overall Study|Protocol Violation|1|||
164162374|NCT01297517|592960462|FG000|Overall Study|Inadequate Control of IOP|1|||
164162375|NCT01297517|592960463|FG001|Overall Study|Inadequate Control of IOP|1|||
164162376|NCT01297517|592960464|FG002|Overall Study|Inadequate Control of IOP|2|||
164162377|NCT02914613|592960465|FG000|Overall Study|Withdrawal by Subject|1|||
164162378|NCT02914613|592960466|FG001|Overall Study|Withdrawal by Subject|2|||
164162379|NCT02914613|592960465|FG000|Overall Study|Adverse Event|1|||
164162380|NCT02914613|592960466|FG001|Overall Study|Adverse Event|0|||
164162381|NCT00423332|592960467|FG000|Overall Study|Adverse Event|6|||
164162382|NCT00423332|592960468|FG001|Overall Study|Adverse Event|2|||
164162383|NCT00423332|592960467|FG000|Overall Study|Withdrawal by Subject|1|||
164162384|NCT00423332|592960468|FG001|Overall Study|Withdrawal by Subject|0|||
164162385|NCT00423332|592960467|FG000|Overall Study|Condition under investigation worsened|1|||
164162386|NCT00423332|592960468|FG001|Overall Study|Condition under investigation worsened|1|||
164162387|NCT00423332|592960467|FG000|Overall Study|Progressive at Week 6|0|||
164162388|NCT00423332|592960468|FG001|Overall Study|Progressive at Week 6|1|||
164162389|NCT00423332|592960467|FG000|Overall Study|Unblinded before 12 weeks|1|||
164162390|NCT00423332|592960468|FG001|Overall Study|Unblinded before 12 weeks|3|||
164162391|NCT02035202|592960469|FG000|Overall Study|Lost to Follow-up|8|||
164162392|NCT02035202|592960470|FG001|Overall Study|Lost to Follow-up|16|||
164162393|NCT02035202|592960471|FG002|Overall Study|Lost to Follow-up|2|||
164162394|NCT00402688|592960473|FG000|Overall Study|Adverse Event|12|||
164162395|NCT00402688|592960474|FG001|Overall Study|Adverse Event|9|||
164162396|NCT00402688|592960475|FG002|Overall Study|Adverse Event|3|||
164162397|NCT00402688|592960473|FG000|Overall Study|Withdrawal by Subject|3|||
164162398|NCT00402688|592960474|FG001|Overall Study|Withdrawal by Subject|1|||
164162399|NCT00402688|592960475|FG002|Overall Study|Withdrawal by Subject|1|||
164162400|NCT00402688|592960473|FG000|Overall Study|Physician Decision|0|||
164162401|NCT00402688|592960474|FG001|Overall Study|Physician Decision|0|||
164162402|NCT00402688|592960475|FG002|Overall Study|Physician Decision|1|||
164162403|NCT00402688|592960473|FG000|Overall Study|Lack of Efficacy|4|||
164162404|NCT00402688|592960474|FG001|Overall Study|Lack of Efficacy|4|||
164162405|NCT00402688|592960475|FG002|Overall Study|Lack of Efficacy|5|||
164162406|NCT00402688|592960473|FG000|Overall Study|Protocol Violation|1|||
164162407|NCT00402688|592960474|FG001|Overall Study|Protocol Violation|1|||
164162408|NCT00402688|592960475|FG002|Overall Study|Protocol Violation|1|||
164162409|NCT00402688|592960473|FG000|Overall Study|Lost to Follow-up|1|||
164162410|NCT00402688|592960474|FG001|Overall Study|Lost to Follow-up|0|||
164162411|NCT00402688|592960475|FG002|Overall Study|Lost to Follow-up|2|||
164162412|NCT00402688|592960473|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
164162413|NCT00402688|592960474|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
164162414|NCT00402688|592960475|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
164162415|NCT00402688|592960473|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
164162416|NCT00402688|592960474|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
164162417|NCT00402688|592960475|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
164162418|NCT00402688|592960473|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
164162419|NCT00402688|592960474|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
164162420|NCT00402688|592960475|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
164162421|NCT00758485|592960476|FG000|Overall Study|Lost to Follow-up|0|||
164162422|NCT00758485|592960477|FG001|Overall Study|Lost to Follow-up|1|||
164162423|NCT00758485|592960476|FG000|Overall Study|Not Treated|1|||
164162424|NCT00758485|592960477|FG001|Overall Study|Not Treated|2|||
164162425|NCT01136356|592960478|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
164162426|NCT01136356|592960479|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
164162427|NCT01136356|592960478|FG000|First 18-day Withdrawal|Physician Decision|1|||
164162428|NCT01136356|592960479|FG001|First 18-day Withdrawal|Physician Decision|0|||
164162429|NCT01136356|592960478|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
164162430|NCT01136356|592960479|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
164162431|NCT00656292|592960480|FG000|Overall Study|Withdrawal by Subject|2|||
164162432|NCT00656292|592960481|FG001|Overall Study|Withdrawal by Subject|3|||
164162433|NCT00656292|592960480|FG000|Overall Study|Screen failure|1|||
164162434|NCT00656292|592960481|FG001|Overall Study|Screen failure|2|||
164162435|NCT03259425|592960482|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
164162436|NCT04157296|592960483|FG000|Overall Study|Withdrawal by Subject|0|||
164162437|NCT04157296|592960484|FG001|Overall Study|Withdrawal by Subject|1|||
164162438|NCT04157296|592960483|FG000|Overall Study|Did not obtain second fMRI.|0|||
164162439|NCT04157296|592960484|FG001|Overall Study|Did not obtain second fMRI.|1|||
164162440|NCT04157296|592960483|FG000|Overall Study|MRI failed/no second fMRI|0|||
164162441|NCT04157296|592960484|FG001|Overall Study|MRI failed/no second fMRI|1|||
164162442|NCT02088905|592960487|FG000|Overall Study|Withdrawal by Subject|5|||
164162443|NCT02088905|592960488|FG001|Overall Study|Withdrawal by Subject|1|||
164162444|NCT02649439|592960494|FG000|Overall Study|Switched to alternative treatment|6|||
164162445|NCT02649439|592960495|FG001|Overall Study|Switched to alternative treatment|4|||
164162446|NCT02649439|592960494|FG000|Overall Study|Patient decision|1|||
164162447|NCT02649439|592960495|FG001|Overall Study|Patient decision|0|||
164162448|NCT02649439|592960494|FG000|Overall Study|Patient going out of country|1|||
164162449|NCT02649439|592960495|FG001|Overall Study|Patient going out of country|0|||
164162450|NCT02649439|592960494|FG000|Overall Study|To start finasteride|1|||
164162451|NCT02649439|592960495|FG001|Overall Study|To start finasteride|0|||
164162452|NCT02649439|592960494|FG000|Overall Study|Physician Decision|1|||
164162453|NCT02649439|592960495|FG001|Overall Study|Physician Decision|0|||
164162454|NCT02649439|592960494|FG000|Overall Study|Disease progression on study|12|||
164162455|NCT02649439|592960495|FG001|Overall Study|Disease progression on study|13|||
164162456|NCT02649439|592960494|FG000|Overall Study|Refused further treatment|1|||
164162457|NCT02649439|592960495|FG001|Overall Study|Refused further treatment|0|||
164162458|NCT02649439|592960494|FG000|Overall Study|Refused further follow up|2|||
164162459|NCT02649439|592960495|FG001|Overall Study|Refused further follow up|7|||
164162460|NCT02649439|592960494|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
164162461|NCT02649439|592960495|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
164162462|NCT02649439|592960494|FG000|Overall Study|No treatment, per protocol|1|||
164162463|NCT02649439|592960495|FG001|Overall Study|No treatment, per protocol|0|||
164162464|NCT02649439|592960494|FG000|Overall Study|PSA DT makes ineligible|0|||
164162465|NCT02649439|592960495|FG001|Overall Study|PSA DT makes ineligible|1|||
164162466|NCT02649439|592960494|FG000|Overall Study|Rising PSA No Mets|0|||
164162467|NCT02649439|592960495|FG001|Overall Study|Rising PSA No Mets|1|||
164162468|NCT02649439|592960494|FG000|Overall Study|Rising PSA|0|||
164162469|NCT02649439|592960495|FG001|Overall Study|Rising PSA|1|||
164162470|NCT02649439|592960494|FG000|Overall Study|Signed follow up protocol|0|||
164162471|NCT02649439|592960495|FG001|Overall Study|Signed follow up protocol|1|||
164162472|NCT02097238|592960498|FG000|Overall Study|Death|1|||
164162473|NCT02097238|592960498|FG000|Overall Study|Physician Decision|1|||
164162474|NCT02097238|592960498|FG000|Overall Study|Progressive Disease|17|||
164162475|NCT01282372|592960506|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
164162476|NCT01282372|592960506|FG000|Overall Study|Lost to Follow-up|23|||
164162477|NCT01282372|592960506|FG000|Overall Study|Withdrawal by Subject|11|||
164162478|NCT01282372|592960506|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
164162479|NCT01282372|592960506|FG000|Overall Study|Death|1|||
164162480|NCT01282372|592960506|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
164162481|NCT01282372|592960506|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
164162482|NCT01282372|592960506|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
164162483|NCT01282372|592960506|FG000|Overall Study|Adverse Event|12|||
164162484|NCT02993250|592960508|FG000|Overall Study|Lost to Follow-up|0|||
164162485|NCT02993250|592960509|FG001|Overall Study|Lost to Follow-up|1|||
164162486|NCT02861807|592960511|FG000|Overall Study|Lost to Follow-up|7|||
164162487|NCT02861807|592960512|FG001|Overall Study|Lost to Follow-up|6|||
164162488|NCT02861807|592960511|FG000|Overall Study|Withdrawal by Subject|5|||
164162489|NCT02861807|592960512|FG001|Overall Study|Withdrawal by Subject|8|||
164162490|NCT00568061|592960517|FG000|Overall Study|Inclusion / exclusion criteria|5|||
164162491|NCT00568061|592960518|FG001|Overall Study|Inclusion / exclusion criteria|1|||
164162492|NCT00568061|592960517|FG000|Overall Study|Adverse Event|0|||
164162493|NCT00568061|592960518|FG001|Overall Study|Adverse Event|1|||
164162494|NCT05027451|592960519|FG000|Overall Study|Lost to Follow-up|1|||
164162495|NCT05027451|592960520|FG001|Overall Study|Lost to Follow-up|1|||
164162496|NCT00356148|592960521|FG000|Overall Study|Reoperation within 30 days|2|||
164162497|NCT00356148|592960522|FG001|Overall Study|Reoperation within 30 days|1|||
164162498|NCT02693002|592960524|FG000|Overall Study|Withdrawal by Subject|1|||
164162499|NCT02693002|592960525|FG001|Overall Study|Withdrawal by Subject|0|||
164162500|NCT00812981|592960526|FG000|Overall Study|Other|0|||
164162501|NCT00812981|592960527|FG001|Overall Study|Other|1|||
164162502|NCT04666259|592960529|FG000|Treatment Phase|Physician Decision|9|||
164162503|NCT04666259|592960530|FG001|Treatment Phase|Physician Decision|3|||
164162504|NCT04666259|592960531|FG002|Treatment Phase|Physician Decision|3|||
164162505|NCT04666259|592960529|FG000|Treatment Phase|Adverse Event|3|||
164162506|NCT04666259|592960530|FG001|Treatment Phase|Adverse Event|1|||
164162507|NCT04666259|592960531|FG002|Treatment Phase|Adverse Event|0|||
164162508|NCT04666259|592960529|FG000|Treatment Phase|Subject decision|1|||
164162509|NCT04666259|592960530|FG001|Treatment Phase|Subject decision|2|||
164162510|NCT04666259|592960531|FG002|Treatment Phase|Subject decision|0|||
164162511|NCT04666259|592960529|FG000|Treatment Phase|Progressive disease|0|||
164162512|NCT04666259|592960530|FG001|Treatment Phase|Progressive disease|1|||
164162513|NCT04666259|592960531|FG002|Treatment Phase|Progressive disease|0|||
164162514|NCT04666259|592960529|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
164162515|NCT04666259|592960530|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
164162516|NCT04666259|592960531|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
164162517|NCT04666259|592960529|FG000|Safety Follow-up Phase|Physician Decision|2|||
164162518|NCT04666259|592960530|FG001|Safety Follow-up Phase|Physician Decision|0|||
164162519|NCT04666259|592960531|FG002|Safety Follow-up Phase|Physician Decision|0|||
164162520|NCT04666259|592960529|FG000|Safety Follow-up Phase|Subject decision|1|||
164162521|NCT04666259|592960530|FG001|Safety Follow-up Phase|Subject decision|0|||
164162522|NCT04666259|592960531|FG002|Safety Follow-up Phase|Subject decision|0|||
164162523|NCT04666259|592960529|FG000|Safety Follow-up Phase|Death|0|||
164162524|NCT04666259|592960530|FG001|Safety Follow-up Phase|Death|1|||
164162525|NCT04666259|592960531|FG002|Safety Follow-up Phase|Death|0|||
164162526|NCT02737930|592960532|FG000|Overall Study|Withdrawal by Subject|0|||
164162527|NCT02737930|592960533|FG001|Overall Study|Withdrawal by Subject|1|||
164162528|NCT04178122|592960534|FG000|Overall Study|Withdrawal by Subject|1|||
164162529|NCT04178122|592960535|FG001|Overall Study|Withdrawal by Subject|1|||
164162530|NCT04178122|592960534|FG000|Overall Study|Death|2|||
164162531|NCT04178122|592960535|FG001|Overall Study|Death|0|||
164162532|NCT04178122|592960534|FG000|Overall Study|Did not complete testing|3|||
164162533|NCT04178122|592960535|FG001|Overall Study|Did not complete testing|13|||
164162534|NCT03124407|592960536|FG000|Overall Study|Lost to Follow-up|1|||
164162535|NCT03124407|592960537|FG001|Overall Study|Lost to Follow-up|0|||
164162536|NCT03124407|592960538|FG002|Overall Study|Lost to Follow-up|0|||
164162537|NCT03124407|592960539|FG003|Overall Study|Lost to Follow-up|0|||
164162538|NCT03124407|592960536|FG000|Overall Study|Adverse Event|0|||
164162539|NCT03124407|592960537|FG001|Overall Study|Adverse Event|0|||
164162540|NCT03124407|592960538|FG002|Overall Study|Adverse Event|1|||
164162541|NCT03124407|592960539|FG003|Overall Study|Adverse Event|0|||
164162542|NCT05343364|592960540|FG000|Overall Study|Miscellaneous|0|||
164162543|NCT05343364|592960541|FG001|Overall Study|Miscellaneous|1|||
164162544|NCT01791894|592960542|FG000|Overall Study|Adverse Event|1|||
164162545|NCT00984542|592960545|FG000|Overall Study|disease progression|19|||
164162546|NCT00984542|592960545|FG000|Overall Study|toxicity|7|||
164162547|NCT00984542|592960545|FG000|Overall Study|Death|7|||
164162548|NCT00984542|592960545|FG000|Overall Study|complicating disease|3|||
164162549|NCT00984542|592960545|FG000|Overall Study|Withdrawal by Subject|3|||
164162550|NCT00984542|592960545|FG000|Overall Study|clinical deterioration|2|||
164162551|NCT01422889|592960546|FG000|Overall Study|No Data Entered for Study Stent|9|||
164162552|NCT01757184|592960547|FG000|Double-blind Period|Adverse Event|1|||
164162553|NCT01757184|592960548|FG001|Double-blind Period|Adverse Event|0|||
164162554|NCT01757184|592960549|FG002|Double-blind Period|Adverse Event|0|||
164162555|NCT01757184|592960550|FG003|Double-blind Period|Adverse Event|0|||
164162556|NCT01757184|592960547|FG000|Open-label Period|Lost to Follow-up|0|||
164162557|NCT01757184|592960548|FG001|Open-label Period|Lost to Follow-up|0|||
164162558|NCT01757184|592960549|FG002|Open-label Period|Lost to Follow-up|2|||
164162559|NCT01757184|592960550|FG003|Open-label Period|Lost to Follow-up|0|||
164162560|NCT01757184|592960547|FG000|Open-label Period|Withdrawal by Subject|0|||
164162561|NCT01757184|592960548|FG001|Open-label Period|Withdrawal by Subject|0|||
164162562|NCT01757184|592960549|FG002|Open-label Period|Withdrawal by Subject|1|||
164162563|NCT01757184|592960550|FG003|Open-label Period|Withdrawal by Subject|1|||
164162564|NCT01757184|592960547|FG000|Open-label Period|Discontinued by Sponsor|0|||
164162565|NCT01757184|592960548|FG001|Open-label Period|Discontinued by Sponsor|0|||
164162566|NCT01757184|592960549|FG002|Open-label Period|Discontinued by Sponsor|1|||
164162567|NCT01757184|592960550|FG003|Open-label Period|Discontinued by Sponsor|2|||
164162568|NCT04468347|592960553|FG000|Overall Study|Withdrawal by Subject|0|||
164162569|NCT04468347|592960554|FG001|Overall Study|Withdrawal by Subject|1|||
164162570|NCT04468347|592960555|FG002|Overall Study|Withdrawal by Subject|3|||
164162571|NCT04468347|592960556|FG003|Overall Study|Withdrawal by Subject|3|||
164162572|NCT04468347|592960553|FG000|Overall Study|Lost to Follow-up|0|||
164162573|NCT04468347|592960554|FG001|Overall Study|Lost to Follow-up|0|||
164162574|NCT04468347|592960555|FG002|Overall Study|Lost to Follow-up|1|||
164162575|NCT04468347|592960556|FG003|Overall Study|Lost to Follow-up|1|||
164162576|NCT04468347|592960553|FG000|Overall Study|Physician Decision|1|||
164162577|NCT04468347|592960554|FG001|Overall Study|Physician Decision|0|||
164162578|NCT04468347|592960555|FG002|Overall Study|Physician Decision|2|||
164162579|NCT04468347|592960556|FG003|Overall Study|Physician Decision|0|||
164162580|NCT04468347|592960553|FG000|Overall Study|Protocol Violation|1|||
164162581|NCT04468347|592960554|FG001|Overall Study|Protocol Violation|0|||
164162582|NCT04468347|592960555|FG002|Overall Study|Protocol Violation|0|||
164162583|NCT04468347|592960556|FG003|Overall Study|Protocol Violation|0|||
164162584|NCT00994461|592960557|FG000|Overall Study|Adverse Event|2|||
164162585|NCT00994461|592960558|FG001|Overall Study|Adverse Event|1|||
164162586|NCT00994461|592960559|FG002|Overall Study|Adverse Event|0|||
164162587|NCT04339062|592960560|FG000|Overall Study|Death|0|||
164162588|NCT04339062|592960561|FG001|Overall Study|Death|1|||
164162589|NCT04586244|592960562|FG000|Overall Study|Lost to Follow-up|1|||
164162590|NCT04586244|592960563|FG001|Overall Study|Lost to Follow-up|0|||
164162591|NCT04586244|592960564|FG002|Overall Study|Lost to Follow-up|0|||
164162592|NCT04586244|592960565|FG003|Overall Study|Lost to Follow-up|1|||
164162593|NCT04586244|592960566|FG004|Overall Study|Lost to Follow-up|0|||
164162594|NCT04586244|592960562|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162595|NCT04586244|592960563|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
164162596|NCT04586244|592960564|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162597|NCT04586244|592960565|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162598|NCT04586244|592960566|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
164162599|NCT02505217|592960567|FG000|Overall Study|Withdrawal by Subject|1|||
164162600|NCT02505217|592960568|FG001|Overall Study|Withdrawal by Subject|2|||
164162601|NCT00153179|592960574|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
164162602|NCT00153179|592960575|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
164162603|NCT00153179|592960576|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
164162604|NCT00153179|592960577|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
164162605|NCT03517540|592960578|FG000|Overall Study|Protocol Violation|2|||
164162606|NCT03517540|592960579|FG001|Overall Study|Protocol Violation|0|||
164162607|NCT03517540|592960580|FG002|Overall Study|Protocol Violation|0|||
164162608|NCT03517540|592960581|FG003|Overall Study|Protocol Violation|1|||
164162609|NCT03517540|592960578|FG000|Overall Study|Adverse Event|9|||
164162610|NCT03517540|592960579|FG001|Overall Study|Adverse Event|3|||
164162611|NCT03517540|592960580|FG002|Overall Study|Adverse Event|8|||
164162612|NCT03517540|592960581|FG003|Overall Study|Adverse Event|1|||
164162613|NCT03517540|592960578|FG000|Overall Study|Withdrawal by Subject|3|||
164162614|NCT03517540|592960579|FG001|Overall Study|Withdrawal by Subject|4|||
164162615|NCT03517540|592960580|FG002|Overall Study|Withdrawal by Subject|1|||
164162616|NCT03517540|592960581|FG003|Overall Study|Withdrawal by Subject|3|||
164162617|NCT00615550|592960586|FG000|Overall Study|Lost to Follow-up|6|||
164162618|NCT00615550|592960587|FG001|Overall Study|Lost to Follow-up|1|||
164162619|NCT01408303|592960588|FG000|Overall Study|Adverse Event|3|||
164162620|NCT01408303|592960589|FG001|Overall Study|Adverse Event|7|||
164162621|NCT01408303|592960590|FG002|Overall Study|Adverse Event|2|||
164162622|NCT01408303|592960588|FG000|Overall Study|Lost to Follow-up|0|||
164162623|NCT01408303|592960589|FG001|Overall Study|Lost to Follow-up|1|||
164162624|NCT01408303|592960590|FG002|Overall Study|Lost to Follow-up|2|||
164162625|NCT01408303|592960588|FG000|Overall Study|Withdrawal by Subject|2|||
164162626|NCT01408303|592960589|FG001|Overall Study|Withdrawal by Subject|3|||
164162627|NCT01408303|592960590|FG002|Overall Study|Withdrawal by Subject|1|||
164162628|NCT01408303|592960588|FG000|Overall Study|Protocol Violation|0|||
164162629|NCT01408303|592960589|FG001|Overall Study|Protocol Violation|1|||
164162630|NCT01408303|592960590|FG002|Overall Study|Protocol Violation|0|||
164162631|NCT01408303|592960588|FG000|Overall Study|Noncompliance|1|||
164162632|NCT01408303|592960589|FG001|Overall Study|Noncompliance|0|||
164162633|NCT01408303|592960590|FG002|Overall Study|Noncompliance|1|||
164162634|NCT01801865|592960591|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
164162635|NCT01801865|592960591|FG000|Overall Study|Physician Decision|7|||
164162636|NCT02644668|592960592|FG000|Overall Study|Adverse Event|2|||
164162637|NCT02644668|592960593|FG001|Overall Study|Adverse Event|0|||
164162638|NCT02644668|592960594|FG002|Overall Study|Adverse Event|1|||
164162639|NCT02644668|592960592|FG000|Overall Study|Protocol Violation|0|||
164162640|NCT02644668|592960593|FG001|Overall Study|Protocol Violation|0|||
164162641|NCT02644668|592960594|FG002|Overall Study|Protocol Violation|1|||
164162642|NCT02644668|592960592|FG000|Overall Study|Withdrawal by Subject|0|||
164162643|NCT02644668|592960593|FG001|Overall Study|Withdrawal by Subject|0|||
164162644|NCT02644668|592960594|FG002|Overall Study|Withdrawal by Subject|1|||
164162645|NCT01500382|592960597|FG000|Washout Period|Study site went out of business|0|||
164162646|NCT01500382|592960598|FG001|Washout Period|Study site went out of business|0|||
164162647|NCT01500382|592960599|FG002|Washout Period|Study site went out of business|1|||
164162648|NCT01500382|592960600|FG003|Washout Period|Study site went out of business|0|||
164162649|NCT05763875|592960601|FG000|Overall Study|Subject decision|5|||
164162650|NCT05763875|592960602|FG001|Overall Study|Subject decision|2|||
164162651|NCT05763875|592960603|FG002|Overall Study|Subject decision|1|||
164162652|NCT05763875|592960601|FG000|Overall Study|Lost to Follow-up|4|||
164162653|NCT05763875|592960602|FG001|Overall Study|Lost to Follow-up|1|||
164162654|NCT05763875|592960603|FG002|Overall Study|Lost to Follow-up|2|||
164162655|NCT05763875|592960601|FG000|Overall Study|Adverse Event|1|||
164162656|NCT05763875|592960602|FG001|Overall Study|Adverse Event|0|||
164162657|NCT05763875|592960603|FG002|Overall Study|Adverse Event|0|||
164162658|NCT00068393|592962252|FG000|Overall Study|Adverse Event|2|||
164162659|NCT00068393|592962252|FG000|Overall Study|Death|3|||
164162660|NCT00068393|592962252|FG000|Overall Study|Withdrawal by Subject|3|||
164162661|NCT00068393|592962252|FG000|Overall Study|Alternative treatment|1|||
164162662|NCT00068393|592962252|FG000|Overall Study|Quality of life worsening|1|||
164162663|NCT01399047|592962253|FG000|Overall Study|Withdrawal by Subject|0|||
164162664|NCT01399047|592962254|FG001|Overall Study|Withdrawal by Subject|1|||
164162665|NCT03300505|592962260|FG000|Overall Study|Death|0|||
164162666|NCT03300505|592962261|FG001|Overall Study|Death|1|||
164162667|NCT03300505|592962262|FG002|Overall Study|Death|0|||
164162668|NCT03300505|592962260|FG000|Overall Study|Withdrawal by Subject|0|||
164162669|NCT03300505|592962261|FG001|Overall Study|Withdrawal by Subject|1|||
164162670|NCT03300505|592962262|FG002|Overall Study|Withdrawal by Subject|1|||
164162671|NCT03300505|592962260|FG000|Overall Study|Sponsor Termination|0|||
164162672|NCT03300505|592962261|FG001|Overall Study|Sponsor Termination|1|||
164162673|NCT03300505|592962262|FG002|Overall Study|Sponsor Termination|0|||
164162674|NCT03300505|592962260|FG000|Overall Study|Adverse Event|0|||
164162675|NCT03300505|592962261|FG001|Overall Study|Adverse Event|0|||
164162676|NCT03300505|592962262|FG002|Overall Study|Adverse Event|2|||
164162677|NCT01108341|592962265|FG000|Overall Study|Death|2|||
164162678|NCT01108341|592962265|FG000|Overall Study|Withdrawal by Subject|1|||
164162679|NCT01108341|592962265|FG000|Overall Study|Lost to Follow-up|1|||
164162680|NCT01108341|592962265|FG000|Overall Study|Other|1|||
164162681|NCT00769067|592962269|FG000|Overall Study|Death|89|||
164162682|NCT00769067|592962270|FG001|Overall Study|Death|86|||
164162683|NCT00769067|592962269|FG000|Overall Study|Lost to Follow-up|3|||
164162684|NCT00769067|592962270|FG001|Overall Study|Lost to Follow-up|1|||
164162685|NCT00769067|592962269|FG000|Overall Study|Study terminated by sponsor|1|||
164162686|NCT00769067|592962270|FG001|Overall Study|Study terminated by sponsor|3|||
164162687|NCT00769067|592962269|FG000|Overall Study|Other|1|||
164162688|NCT00769067|592962270|FG001|Overall Study|Other|3|||
164162689|NCT00769067|592962269|FG000|Overall Study|Withdrawal by Subject|0|||
164162690|NCT00769067|592962270|FG001|Overall Study|Withdrawal by Subject|1|||
164162691|NCT04981470|592962273|FG000|Overall Study|Device failure in all 4 patients|4|||
164162692|NCT04402138|592962274|FG000|Overall Study|Progressive Disease|2|||
164162693|NCT04402138|592962274|FG000|Overall Study|Adverse Event|1|||
164162694|NCT03056638|592962277|FG000|Overall Study|Death|1|||
164162695|NCT03056638|592962278|FG001|Overall Study|Death|0|||
164162696|NCT00784238|592962279|FG000|Overall Study|Adverse Event|14|||
164162697|NCT00784238|592962279|FG000|Overall Study|Death|2|||
164162698|NCT00784238|592962279|FG000|Overall Study|Lack of Efficacy|33|||
164162699|NCT00784238|592962279|FG000|Overall Study|Lost to Follow-up|29|||
164162700|NCT00784238|592962279|FG000|Overall Study|Pregnancy|1|||
164162701|NCT00784238|592962279|FG000|Overall Study|Withdrawal by Subject|26|||
164162702|NCT00784238|592962279|FG000|Overall Study|Other|14|||
164162703|NCT02530125|592962280|FG000|Completed Treatment|Early termination of study|1|||
164162704|NCT02530125|592962280|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
164162705|NCT00468481|592962282|FG000|Overall Study|Adverse Event|13|||
164162706|NCT00468481|592962283|FG001|Overall Study|Adverse Event|3|||
164162707|NCT00468481|592962282|FG000|Overall Study|Lost to Follow-up|25|||
164162708|NCT00468481|592962283|FG001|Overall Study|Lost to Follow-up|8|||
164162709|NCT00468481|592962282|FG000|Overall Study|Pregnancy|2|||
164162710|NCT00468481|592962283|FG001|Overall Study|Pregnancy|0|||
164162711|NCT00468481|592962282|FG000|Overall Study|Protocol Violation|18|||
164162712|NCT00468481|592962283|FG001|Overall Study|Protocol Violation|8|||
164162713|NCT00468481|592962282|FG000|Overall Study|Withdrawal by Subject|12|||
164162714|NCT00468481|592962283|FG001|Overall Study|Withdrawal by Subject|3|||
164162715|NCT00468481|592962282|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
164162716|NCT00468481|592962283|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
164162717|NCT00468481|592962282|FG000|Overall Study|Prohibited Medication|1|||
164162718|NCT00468481|592962283|FG001|Overall Study|Prohibited Medication|1|||
164162719|NCT00468481|592962282|FG000|Overall Study|Egg Donor|1|||
164162720|NCT00468481|592962283|FG001|Overall Study|Egg Donor|0|||
164162721|NCT00468481|592962282|FG000|Overall Study|Moved out of area|4|||
164162722|NCT00468481|592962283|FG001|Overall Study|Moved out of area|1|||
164162723|NCT00468481|592962282|FG000|Overall Study|Non-Compliance|5|||
164162724|NCT00468481|592962283|FG001|Overall Study|Non-Compliance|0|||
164162725|NCT00468481|592962282|FG000|Overall Study|Other|6|||
164162726|NCT00468481|592962283|FG001|Overall Study|Other|0|||
164162727|NCT00078767|592962284|FG000|Overall Study|Withdrawal by Subject|1|||
164162728|NCT00078767|592962285|FG001|Overall Study|Withdrawal by Subject|1|||
164162729|NCT00728468|592962286|FG000|Overall Study|Enrolled but not treated|1|||
164162730|NCT00728468|592962286|FG000|Overall Study|Death|1|||
164162731|NCT00728468|592962286|FG000|Overall Study|Protocol Violation|4|||
164162732|NCT00728468|592962286|FG000|Overall Study|Objective progression or relapse|9|||
164162733|NCT00728468|592962286|FG000|Overall Study|Study terminated by sponsor|1|||
164162734|NCT00596687|592962287|FG000|Overall Study|< 24 hours of insulin treatment|8|||
164162735|NCT00596687|592962288|FG001|Overall Study|< 24 hours of insulin treatment|6|||
164162736|NCT00596687|592962287|FG000|Overall Study|continuous insulin infusion during TPN|2|||
164162737|NCT00596687|592962288|FG001|Overall Study|continuous insulin infusion during TPN|1|||
164162738|NCT00596687|592962287|FG000|Overall Study|Withdrawal by Subject|3|||
164162739|NCT00596687|592962288|FG001|Overall Study|Withdrawal by Subject|1|||
164162740|NCT00596687|592962287|FG000|Overall Study|cancelled surgery|1|||
164162741|NCT00596687|592962288|FG001|Overall Study|cancelled surgery|1|||
164162742|NCT06098339|592962289|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
164162743|NCT06098339|592962290|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
164162744|NCT06098339|592962289|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
164162745|NCT06098339|592962290|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
164162746|NCT03831113|592962291|FG000|Overall Study|Withdrawal by Subject|0|||
164162747|NCT03831113|592962292|FG001|Overall Study|Withdrawal by Subject|2|||
164162748|NCT03831113|592962291|FG000|Overall Study|Protocol Violation|0|||
164162749|NCT03831113|592962292|FG001|Overall Study|Protocol Violation|9|||
164162750|NCT03508726|592962293|FG000|Overall Study|Withdrawal by Subject|0|||
164162751|NCT03508726|592962294|FG001|Overall Study|Withdrawal by Subject|1|||
164162752|NCT02498444|592962295|FG000|Overall Study|Withdrawal by Subject|3|||
164162753|NCT02498444|592962296|FG001|Overall Study|Withdrawal by Subject|0|||
164162754|NCT02498444|592962295|FG000|Overall Study|Physician Decision|1|||
164162755|NCT02498444|592962296|FG001|Overall Study|Physician Decision|0|||
164162756|NCT05656534|592962299|FG000|Overall Study|Withdrawal by Subject|1|||
164162757|NCT05656534|592962300|FG001|Overall Study|Withdrawal by Subject|1|||
164162758|NCT05656534|592962301|FG002|Overall Study|Withdrawal by Subject|0|||
164162759|NCT05656534|592962302|FG003|Overall Study|Withdrawal by Subject|0|||
164162760|NCT05656534|592962299|FG000|Overall Study|Physician Decision|1|||
164162761|NCT05656534|592962300|FG001|Overall Study|Physician Decision|1|||
164162762|NCT05656534|592962301|FG002|Overall Study|Physician Decision|0|||
164162763|NCT05656534|592962302|FG003|Overall Study|Physician Decision|0|||
164162764|NCT00302328|592962310|FG000|Overall Study|Physician Decision|0|||
164162765|NCT00302328|592962311|FG001|Overall Study|Physician Decision|1|||
164162766|NCT00302328|592962312|FG002|Overall Study|Physician Decision|0|||
164162767|NCT00386360|592962317|FG000|Overall Study|Adverse Event|4|||
164162768|NCT00386360|592962318|FG001|Overall Study|Adverse Event|2|||
164162769|NCT00386360|592962317|FG000|Overall Study|Physician Decision|2|||
164162770|NCT00386360|592962318|FG001|Overall Study|Physician Decision|2|||
164162771|NCT00386360|592962317|FG000|Overall Study|Lost to Follow-up|0|||
164162772|NCT00386360|592962318|FG001|Overall Study|Lost to Follow-up|2|||
164162773|NCT00386360|592962317|FG000|Overall Study|Protocol Violation|0|||
164162774|NCT00386360|592962318|FG001|Overall Study|Protocol Violation|3|||
164162775|NCT00386360|592962317|FG000|Overall Study|Withdrawal by Subject|3|||
164162776|NCT00386360|592962318|FG001|Overall Study|Withdrawal by Subject|6|||
164162777|NCT00386360|592962317|FG000|Overall Study|Did not take any study medication|0|||
164162778|NCT00386360|592962318|FG001|Overall Study|Did not take any study medication|2|||
164162779|NCT02490371|592962321|FG000|Overall Study|Lost to Follow-up|1|||
164162780|NCT02490371|592962322|FG001|Overall Study|Lost to Follow-up|1|||
164162781|NCT01718535|592962323|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
164162782|NCT01718535|592962324|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
164162783|NCT01718535|592962325|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
164162784|NCT01718535|592962326|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
164162785|NCT01718535|592962327|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
164162786|NCT01718535|592962328|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
164162787|NCT01718535|592962329|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
164162788|NCT01718535|592962330|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
164162789|NCT01718535|592962331|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
164162790|NCT01718535|592962332|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
164162791|NCT02476578|592962335|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
164162792|NCT02476578|592962336|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
164162793|NCT02476578|592962335|FG000|Overall Study|Lost to Follow-up|6|||
164162794|NCT02476578|592962336|FG001|Overall Study|Lost to Follow-up|13|||
164162795|NCT01073605|592962337|FG000|Overall Study|Ongoing at Cutoff Date|1|||
164162796|NCT01073605|592962338|FG001|Overall Study|Ongoing at Cutoff Date|1|||
164162797|NCT01073605|592962339|FG002|Overall Study|Ongoing at Cutoff Date|0|||
164162798|NCT01073605|592962337|FG000|Overall Study|Adverse Event|2|||
164162799|NCT01073605|592962338|FG001|Overall Study|Adverse Event|1|||
164162800|NCT01073605|592962339|FG002|Overall Study|Adverse Event|0|||
164162801|NCT01073605|592962337|FG000|Overall Study|Lost to Follow-up|3|||
164162802|NCT01073605|592962338|FG001|Overall Study|Lost to Follow-up|4|||
164162803|NCT01073605|592962339|FG002|Overall Study|Lost to Follow-up|9|||
164162804|NCT01073605|592962337|FG000|Overall Study|Other|25|||
164162805|NCT01073605|592962338|FG001|Overall Study|Other|21|||
164162806|NCT01073605|592962339|FG002|Overall Study|Other|29|||
164162807|NCT01073605|592962337|FG000|Overall Study|Withdrawal by Subject|31|||
164162808|NCT01073605|592962338|FG001|Overall Study|Withdrawal by Subject|39|||
164162809|NCT01073605|592962339|FG002|Overall Study|Withdrawal by Subject|22|||
164162810|NCT01073605|592962337|FG000|Overall Study|Randomized But Not Treated|0|||
164162811|NCT01073605|592962338|FG001|Overall Study|Randomized But Not Treated|1|||
164162812|NCT01073605|592962339|FG002|Overall Study|Randomized But Not Treated|1|||
164162813|NCT03018080|592962340|FG000|Overall Study|Death|12|||
164162814|NCT03018080|592962341|FG001|Overall Study|Death|19|||
164162815|NCT03491462|592962342|FG000|Overall Study|Lost to Follow-up|2|||
164162816|NCT03491462|592962343|FG001|Overall Study|Lost to Follow-up|0|||
164162817|NCT03491462|592962342|FG000|Overall Study|Adverse Event|11|||
164162818|NCT03491462|592962343|FG001|Overall Study|Adverse Event|1|||
164162819|NCT03491462|592962342|FG000|Overall Study|Physician Decision|3|||
164162820|NCT03491462|592962343|FG001|Overall Study|Physician Decision|0|||
164162821|NCT03491462|592962342|FG000|Overall Study|Withdrawal by Subject|22|||
164162822|NCT03491462|592962343|FG001|Overall Study|Withdrawal by Subject|15|||
164162823|NCT00740792|592962344|FG000|Overall Study|Adverse Event|3|||
164162824|NCT00740792|592962345|FG001|Overall Study|Adverse Event|1|||
164162825|NCT00740792|592962346|FG002|Overall Study|Adverse Event|1|||
164162826|NCT00740792|592962347|FG003|Overall Study|Adverse Event|3|||
164162827|NCT00740792|592962344|FG000|Overall Study|Lack of Efficacy|1|||
164162828|NCT00740792|592962345|FG001|Overall Study|Lack of Efficacy|1|||
164162829|NCT00740792|592962346|FG002|Overall Study|Lack of Efficacy|0|||
164162830|NCT00740792|592962347|FG003|Overall Study|Lack of Efficacy|3|||
164162831|NCT00740792|592962344|FG000|Overall Study|Lost to Follow-up|2|||
164162832|NCT00740792|592962345|FG001|Overall Study|Lost to Follow-up|1|||
164162833|NCT00740792|592962346|FG002|Overall Study|Lost to Follow-up|0|||
164162834|NCT00740792|592962347|FG003|Overall Study|Lost to Follow-up|0|||
164162835|NCT00740792|592962344|FG000|Overall Study|Protocol Violation|0|||
164162836|NCT00740792|592962345|FG001|Overall Study|Protocol Violation|1|||
164162837|NCT00740792|592962346|FG002|Overall Study|Protocol Violation|0|||
164162838|NCT00740792|592962347|FG003|Overall Study|Protocol Violation|2|||
164162839|NCT00740792|592962344|FG000|Overall Study|Withdrawal by Subject|1|||
164162840|NCT00740792|592962345|FG001|Overall Study|Withdrawal by Subject|1|||
164162841|NCT00740792|592962346|FG002|Overall Study|Withdrawal by Subject|0|||
164162842|NCT00740792|592962347|FG003|Overall Study|Withdrawal by Subject|0|||
164162843|NCT00740792|592962344|FG000|Overall Study|administrative|3|||
164162844|NCT00740792|592962345|FG001|Overall Study|administrative|3|||
164162845|NCT00740792|592962346|FG002|Overall Study|administrative|8|||
164162846|NCT00740792|592962347|FG003|Overall Study|administrative|2|||
164162847|NCT00026494|592962350|FG000|Overall Study|Withdrawal by Subject|1|||
164162848|NCT00026494|592962351|FG001|Overall Study|Withdrawal by Subject|0|||
164162849|NCT00026494|592962352|FG002|Overall Study|Withdrawal by Subject|1|||
164162850|NCT00026494|592962353|FG003|Overall Study|Withdrawal by Subject|0|||
164162851|NCT00026494|592962350|FG000|Overall Study|Patient non-compliance|1|||
164162852|NCT00026494|592962351|FG001|Overall Study|Patient non-compliance|0|||
164162853|NCT00026494|592962352|FG002|Overall Study|Patient non-compliance|0|||
164162854|NCT00026494|592962353|FG003|Overall Study|Patient non-compliance|0|||
164162855|NCT00026494|592962350|FG000|Overall Study|Patient not treated|0|||
164162856|NCT00026494|592962351|FG001|Overall Study|Patient not treated|0|||
164162857|NCT00026494|592962352|FG002|Overall Study|Patient not treated|2|||
164162858|NCT00026494|592962353|FG003|Overall Study|Patient not treated|0|||
164162859|NCT00026494|592962350|FG000|Overall Study|Clinical progression|0|||
164162860|NCT00026494|592962351|FG001|Overall Study|Clinical progression|0|||
164162861|NCT00026494|592962352|FG002|Overall Study|Clinical progression|3|||
164162862|NCT00026494|592962353|FG003|Overall Study|Clinical progression|0|||
164162863|NCT01455597|592962354|FG000|Overall Study|Adverse Event|7|||
164162864|NCT01455597|592962355|FG001|Overall Study|Adverse Event|0|||
164162865|NCT01455597|592962356|FG002|Overall Study|Adverse Event|5|||
164162866|NCT01455597|592962357|FG003|Overall Study|Adverse Event|1|||
164162867|NCT01455597|592962354|FG000|Overall Study|Lack of Efficacy|0|||
164162868|NCT01455597|592962355|FG001|Overall Study|Lack of Efficacy|1|||
164162869|NCT01455597|592962356|FG002|Overall Study|Lack of Efficacy|2|||
164162870|NCT01455597|592962357|FG003|Overall Study|Lack of Efficacy|0|||
164162871|NCT01455597|592962354|FG000|Overall Study|Lost to Follow-up|3|||
164162872|NCT01455597|592962355|FG001|Overall Study|Lost to Follow-up|0|||
164162873|NCT01455597|592962356|FG002|Overall Study|Lost to Follow-up|2|||
164162874|NCT01455597|592962357|FG003|Overall Study|Lost to Follow-up|1|||
164162875|NCT01455597|592962354|FG000|Overall Study|Withdrew Consent|6|||
164162876|NCT01455597|592962355|FG001|Overall Study|Withdrew Consent|5|||
164162877|NCT01455597|592962356|FG002|Overall Study|Withdrew Consent|8|||
164162878|NCT01455597|592962357|FG003|Overall Study|Withdrew Consent|5|||
164162879|NCT01455597|592962354|FG000|Overall Study|Reason not Specified|1|||
164162880|NCT01455597|592962355|FG001|Overall Study|Reason not Specified|2|||
164162881|NCT01455597|592962356|FG002|Overall Study|Reason not Specified|3|||
164162882|NCT01455597|592962357|FG003|Overall Study|Reason not Specified|3|||
164162883|NCT03412734|592962361|FG000|Overall Study|Incorrect labeling of samples|2|||
164162884|NCT03412734|592962362|FG001|Overall Study|Incorrect labeling of samples|0|||
164162885|NCT03412734|592962361|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
164162886|NCT03412734|592962362|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
164162887|NCT03777436|592962363|FG000|Placebo-controlled Phase|Adverse Event|8|||
164162888|NCT03777436|592962364|FG001|Placebo-controlled Phase|Adverse Event|10|||
164162889|NCT03777436|592962365|FG002|Placebo-controlled Phase|Adverse Event|0|||
164162890|NCT03777436|592962363|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
164162891|NCT03777436|592962364|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
164162892|NCT03777436|592962365|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
164162893|NCT03777436|592962363|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
164162894|NCT03777436|592962364|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
164162895|NCT03777436|592962365|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
164162896|NCT03777436|592962363|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
164162897|NCT03777436|592962364|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
164162898|NCT03777436|592962365|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
164162899|NCT03777436|592962363|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
164162900|NCT03777436|592962364|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
164162901|NCT03777436|592962365|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
164162902|NCT03777436|592962363|FG000|Placebo-controlled Phase|Physician Decision|0|||
164162903|NCT03777436|592962364|FG001|Placebo-controlled Phase|Physician Decision|1|||
164162904|NCT03777436|592962365|FG002|Placebo-controlled Phase|Physician Decision|0|||
164162905|NCT03777436|592962363|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
164162906|NCT03777436|592962364|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
164162907|NCT03777436|592962365|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
164162908|NCT03777436|592962363|FG000|Apremilast Extension Phase|Adverse Event|0|||
164162909|NCT03777436|592962364|FG001|Apremilast Extension Phase|Adverse Event|0|||
164162910|NCT03777436|592962365|FG002|Apremilast Extension Phase|Adverse Event|6|||
164162911|NCT03777436|592962363|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
164162912|NCT03777436|592962364|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
164162913|NCT03777436|592962365|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
164162914|NCT03777436|592962363|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
164162915|NCT03777436|592962364|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
164162916|NCT03777436|592962365|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
164162917|NCT03777436|592962363|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
164162918|NCT03777436|592962364|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
164162919|NCT03777436|592962365|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
164162920|NCT03777436|592962363|FG000|Apremilast Extension Phase|Miscellaneous|0|||
164162921|NCT03777436|592962364|FG001|Apremilast Extension Phase|Miscellaneous|0|||
164162922|NCT03777436|592962365|FG002|Apremilast Extension Phase|Miscellaneous|1|||
164162923|NCT00685399|592962366|FG000|Treatment Period 1|Withdrawal by Subject|2|||
164162924|NCT00685399|592962367|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164162925|NCT00685399|592962368|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164162926|NCT00685399|592962369|FG003|Treatment Period 1|Withdrawal by Subject|0|||
164162927|NCT00685399|592962370|FG004|Treatment Period 1|Withdrawal by Subject|0|||
164162928|NCT00685399|592962371|FG005|Treatment Period 1|Withdrawal by Subject|0|||
164162929|NCT00685399|592962372|FG006|Treatment Period 1|Withdrawal by Subject|0|||
164162930|NCT00685399|592962373|FG007|Treatment Period 1|Withdrawal by Subject|0|||
164162931|NCT00685399|592962366|FG000|Treatment Period 1|Protocol Violation|1|||
164162932|NCT00685399|592962367|FG001|Treatment Period 1|Protocol Violation|0|||
164162933|NCT00685399|592962368|FG002|Treatment Period 1|Protocol Violation|0|||
164162934|NCT00685399|592962369|FG003|Treatment Period 1|Protocol Violation|0|||
164162935|NCT00685399|592962370|FG004|Treatment Period 1|Protocol Violation|0|||
164162936|NCT00685399|592962371|FG005|Treatment Period 1|Protocol Violation|0|||
164162937|NCT00685399|592962372|FG006|Treatment Period 1|Protocol Violation|0|||
164162938|NCT00685399|592962373|FG007|Treatment Period 1|Protocol Violation|0|||
164162939|NCT00685399|592962366|FG000|Treatment Period 1|Administrative|2|||
164162940|NCT00685399|592962367|FG001|Treatment Period 1|Administrative|0|||
164162941|NCT00685399|592962368|FG002|Treatment Period 1|Administrative|0|||
164162942|NCT00685399|592962369|FG003|Treatment Period 1|Administrative|0|||
164162943|NCT00685399|592962370|FG004|Treatment Period 1|Administrative|0|||
164162944|NCT00685399|592962371|FG005|Treatment Period 1|Administrative|0|||
164162945|NCT00685399|592962372|FG006|Treatment Period 1|Administrative|0|||
164162946|NCT00685399|592962373|FG007|Treatment Period 1|Administrative|0|||
164162947|NCT00685399|592962366|FG000|Treatment Period 1|Lack of Efficacy|1|||
164162948|NCT00685399|592962367|FG001|Treatment Period 1|Lack of Efficacy|0|||
164162949|NCT00685399|592962368|FG002|Treatment Period 1|Lack of Efficacy|0|||
164162950|NCT00685399|592962369|FG003|Treatment Period 1|Lack of Efficacy|0|||
164162951|NCT00685399|592962370|FG004|Treatment Period 1|Lack of Efficacy|0|||
164162952|NCT00685399|592962371|FG005|Treatment Period 1|Lack of Efficacy|0|||
164162953|NCT00685399|592962372|FG006|Treatment Period 1|Lack of Efficacy|0|||
164162954|NCT00685399|592962373|FG007|Treatment Period 1|Lack of Efficacy|0|||
164162955|NCT00685399|592962366|FG000|Treatment Period 2|Administrative Problems|0|||
164162956|NCT00685399|592962367|FG001|Treatment Period 2|Administrative Problems|2|||
164162957|NCT00685399|592962368|FG002|Treatment Period 2|Administrative Problems|1|||
164162958|NCT00685399|592962369|FG003|Treatment Period 2|Administrative Problems|0|||
164162959|NCT00685399|592962370|FG004|Treatment Period 2|Administrative Problems|0|||
164162960|NCT00685399|592962371|FG005|Treatment Period 2|Administrative Problems|0|||
164162961|NCT00685399|592962372|FG006|Treatment Period 2|Administrative Problems|0|||
164162962|NCT00685399|592962373|FG007|Treatment Period 2|Administrative Problems|0|||
164162963|NCT00685399|592962366|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164162964|NCT00685399|592962367|FG001|Treatment Period 2|Withdrawal by Subject|0|||
164162965|NCT00685399|592962368|FG002|Treatment Period 2|Withdrawal by Subject|0|||
164162966|NCT00685399|592962369|FG003|Treatment Period 2|Withdrawal by Subject|0|||
164162967|NCT00685399|592962370|FG004|Treatment Period 2|Withdrawal by Subject|0|||
164162968|NCT00685399|592962371|FG005|Treatment Period 2|Withdrawal by Subject|0|||
164162969|NCT00685399|592962372|FG006|Treatment Period 2|Withdrawal by Subject|0|||
164162970|NCT00685399|592962373|FG007|Treatment Period 2|Withdrawal by Subject|2|||
164162971|NCT00685399|592962366|FG000|Treatment Period 2|Adverse Event|0|||
164162972|NCT00685399|592962367|FG001|Treatment Period 2|Adverse Event|0|||
164162973|NCT00685399|592962368|FG002|Treatment Period 2|Adverse Event|0|||
164162974|NCT00685399|592962369|FG003|Treatment Period 2|Adverse Event|0|||
164162975|NCT00685399|592962370|FG004|Treatment Period 2|Adverse Event|0|||
164162976|NCT00685399|592962371|FG005|Treatment Period 2|Adverse Event|1|||
164162977|NCT00685399|592962372|FG006|Treatment Period 2|Adverse Event|0|||
164162978|NCT00685399|592962373|FG007|Treatment Period 2|Adverse Event|0|||
164162979|NCT00685399|592962366|FG000|Treatment Period 2|Lack of Efficacy|0|||
164162980|NCT00685399|592962367|FG001|Treatment Period 2|Lack of Efficacy|10|||
164162981|NCT00685399|592962368|FG002|Treatment Period 2|Lack of Efficacy|2|||
164162982|NCT00685399|592962369|FG003|Treatment Period 2|Lack of Efficacy|0|||
164162983|NCT00685399|592962370|FG004|Treatment Period 2|Lack of Efficacy|0|||
164162984|NCT00685399|592962371|FG005|Treatment Period 2|Lack of Efficacy|1|||
164162985|NCT00685399|592962372|FG006|Treatment Period 2|Lack of Efficacy|0|||
164162986|NCT00685399|592962373|FG007|Treatment Period 2|Lack of Efficacy|0|||
164162987|NCT00685399|592962366|FG000|Extension|Administrative Issues|0|||
164162988|NCT00685399|592962367|FG001|Extension|Administrative Issues|0|||
164162989|NCT00685399|592962368|FG002|Extension|Administrative Issues|0|||
164162990|NCT00685399|592962369|FG003|Extension|Administrative Issues|1|||
164162991|NCT00685399|592962370|FG004|Extension|Administrative Issues|0|||
164162992|NCT00685399|592962371|FG005|Extension|Administrative Issues|0|||
164162993|NCT00685399|592962372|FG006|Extension|Administrative Issues|0|||
164162994|NCT00685399|592962373|FG007|Extension|Administrative Issues|0|||
164162995|NCT00685399|592962366|FG000|Extension|Withdrawal by Subject|0|||
164162996|NCT00685399|592962367|FG001|Extension|Withdrawal by Subject|0|||
164162997|NCT00685399|592962368|FG002|Extension|Withdrawal by Subject|0|||
164162998|NCT00685399|592962369|FG003|Extension|Withdrawal by Subject|1|||
164162999|NCT00685399|592962370|FG004|Extension|Withdrawal by Subject|0|||
164163000|NCT00685399|592962371|FG005|Extension|Withdrawal by Subject|0|||
164163001|NCT00685399|592962372|FG006|Extension|Withdrawal by Subject|0|||
164163002|NCT00685399|592962373|FG007|Extension|Withdrawal by Subject|0|||
164163003|NCT00685399|592962366|FG000|Extension|Protocol Violation|0|||
164163004|NCT00685399|592962367|FG001|Extension|Protocol Violation|0|||
164163005|NCT00685399|592962368|FG002|Extension|Protocol Violation|0|||
164163006|NCT00685399|592962369|FG003|Extension|Protocol Violation|1|||
164163007|NCT00685399|592962370|FG004|Extension|Protocol Violation|0|||
164163008|NCT00685399|592962371|FG005|Extension|Protocol Violation|0|||
164163009|NCT00685399|592962372|FG006|Extension|Protocol Violation|0|||
164163010|NCT00685399|592962373|FG007|Extension|Protocol Violation|0|||
164163011|NCT00685399|592962366|FG000|Extension|Lack of Efficacy|0|||
164163012|NCT00685399|592962367|FG001|Extension|Lack of Efficacy|0|||
164163013|NCT00685399|592962368|FG002|Extension|Lack of Efficacy|0|||
164163014|NCT00685399|592962369|FG003|Extension|Lack of Efficacy|2|||
164163015|NCT00685399|592962370|FG004|Extension|Lack of Efficacy|0|||
164163016|NCT00685399|592962371|FG005|Extension|Lack of Efficacy|0|||
164163017|NCT00685399|592962372|FG006|Extension|Lack of Efficacy|0|||
164163018|NCT00685399|592962373|FG007|Extension|Lack of Efficacy|0|||
164163019|NCT00685399|592962366|FG000|Extension|Adverse Event|0|||
164163020|NCT00685399|592962367|FG001|Extension|Adverse Event|0|||
164163021|NCT00685399|592962368|FG002|Extension|Adverse Event|0|||
164163022|NCT00685399|592962369|FG003|Extension|Adverse Event|2|||
164163023|NCT00685399|592962370|FG004|Extension|Adverse Event|0|||
164163024|NCT00685399|592962371|FG005|Extension|Adverse Event|0|||
164163025|NCT00685399|592962372|FG006|Extension|Adverse Event|0|||
164163026|NCT00685399|592962373|FG007|Extension|Adverse Event|0|||
164163027|NCT03363776|592962374|FG000|Overall Study|Progressive disease|2|||
164163028|NCT03363776|592962375|FG001|Overall Study|Progressive disease|3|||
164163029|NCT03363776|592962376|FG002|Overall Study|Progressive disease|1|||
164163030|NCT03363776|592962374|FG000|Overall Study|Study drug toxicity|0|||
164163031|NCT03363776|592962375|FG001|Overall Study|Study drug toxicity|0|||
164163032|NCT03363776|592962376|FG002|Overall Study|Study drug toxicity|1|||
164163033|NCT03363776|592962374|FG000|Overall Study|Death|1|||
164163034|NCT03363776|592962375|FG001|Overall Study|Death|0|||
164163035|NCT03363776|592962376|FG002|Overall Study|Death|0|||
164163036|NCT01562782|592962377|FG000|Overall Study|Withdrawal by Subject|3|||
164163037|NCT01562782|592962378|FG001|Overall Study|Withdrawal by Subject|3|||
164163038|NCT01562782|592962377|FG000|Overall Study|screen failure|1|||
164163039|NCT01562782|592962378|FG001|Overall Study|screen failure|2|||
164163040|NCT01421225|592962383|FG000|Overall Study|Withdrawal by Subject|0|||
164163041|NCT01421225|592962384|FG001|Overall Study|Withdrawal by Subject|1|||
164163042|NCT02343939|592962400|FG000|Overall Study|Death|0|||
164163043|NCT02343939|592962401|FG001|Overall Study|Death|15|||
164163044|NCT02343939|592962402|FG002|Overall Study|Death|4|||
164163045|NCT02343939|592962403|FG003|Overall Study|Death|2|||
164163046|NCT02343939|592962404|FG004|Overall Study|Death|5|||
164163047|NCT02343939|592962405|FG005|Overall Study|Death|11|||
164163048|NCT02343939|592962406|FG006|Overall Study|Death|8|||
164163049|NCT02343939|592962407|FG007|Overall Study|Death|22|||
164163050|NCT02343939|592962408|FG008|Overall Study|Death|1|||
164163051|NCT02343939|592962400|FG000|Overall Study|Study terminated by sponsor|0|||
164163052|NCT02343939|592962401|FG001|Overall Study|Study terminated by sponsor|27|||
164163053|NCT02343939|592962402|FG002|Overall Study|Study terminated by sponsor|0|||
164163054|NCT02343939|592962403|FG003|Overall Study|Study terminated by sponsor|1|||
164163055|NCT02343939|592962404|FG004|Overall Study|Study terminated by sponsor|1|||
164163056|NCT02343939|592962405|FG005|Overall Study|Study terminated by sponsor|5|||
164163057|NCT02343939|592962406|FG006|Overall Study|Study terminated by sponsor|3|||
164163058|NCT02343939|592962407|FG007|Overall Study|Study terminated by sponsor|4|||
164163059|NCT02343939|592962408|FG008|Overall Study|Study terminated by sponsor|0|||
164163060|NCT02343939|592962400|FG000|Overall Study|Withdrew consent|3|||
164163061|NCT02343939|592962401|FG001|Overall Study|Withdrew consent|6|||
164163062|NCT02343939|592962402|FG002|Overall Study|Withdrew consent|1|||
164163063|NCT02343939|592962403|FG003|Overall Study|Withdrew consent|2|||
164163064|NCT02343939|592962404|FG004|Overall Study|Withdrew consent|2|||
164163065|NCT02343939|592962405|FG005|Overall Study|Withdrew consent|0|||
164163066|NCT02343939|592962406|FG006|Overall Study|Withdrew consent|0|||
164163067|NCT02343939|592962407|FG007|Overall Study|Withdrew consent|8|||
164163068|NCT02343939|592962408|FG008|Overall Study|Withdrew consent|6|||
164163069|NCT02343939|592962400|FG000|Overall Study|Treatment failure|0|||
164163070|NCT02343939|592962401|FG001|Overall Study|Treatment failure|0|||
164163071|NCT02343939|592962402|FG002|Overall Study|Treatment failure|0|||
164163072|NCT02343939|592962403|FG003|Overall Study|Treatment failure|0|||
164163073|NCT02343939|592962404|FG004|Overall Study|Treatment failure|0|||
164163074|NCT02343939|592962405|FG005|Overall Study|Treatment failure|0|||
164163075|NCT02343939|592962406|FG006|Overall Study|Treatment failure|2|||
164163076|NCT02343939|592962407|FG007|Overall Study|Treatment failure|1|||
164163077|NCT02343939|592962408|FG008|Overall Study|Treatment failure|0|||
164163078|NCT02343939|592962400|FG000|Overall Study|Investigator's discretion|0|||
164163079|NCT02343939|592962401|FG001|Overall Study|Investigator's discretion|0|||
164163080|NCT02343939|592962402|FG002|Overall Study|Investigator's discretion|0|||
164163081|NCT02343939|592962403|FG003|Overall Study|Investigator's discretion|1|||
164163082|NCT02343939|592962404|FG004|Overall Study|Investigator's discretion|0|||
164163083|NCT02343939|592962405|FG005|Overall Study|Investigator's discretion|0|||
164163084|NCT02343939|592962406|FG006|Overall Study|Investigator's discretion|1|||
164163085|NCT02343939|592962407|FG007|Overall Study|Investigator's discretion|0|||
164163086|NCT02343939|592962408|FG008|Overall Study|Investigator's discretion|0|||
164163087|NCT02343939|592962400|FG000|Overall Study|Adverse Event|0|||
164163088|NCT02343939|592962401|FG001|Overall Study|Adverse Event|0|||
164163089|NCT02343939|592962402|FG002|Overall Study|Adverse Event|0|||
164163090|NCT02343939|592962403|FG003|Overall Study|Adverse Event|0|||
164163091|NCT02343939|592962404|FG004|Overall Study|Adverse Event|0|||
164163092|NCT02343939|592962405|FG005|Overall Study|Adverse Event|1|||
164163093|NCT02343939|592962406|FG006|Overall Study|Adverse Event|0|||
164163094|NCT02343939|592962407|FG007|Overall Study|Adverse Event|0|||
164163095|NCT02343939|592962408|FG008|Overall Study|Adverse Event|0|||
164163096|NCT02343939|592962400|FG000|Overall Study|Never Treated With ENTO|0|||
164163097|NCT02343939|592962401|FG001|Overall Study|Never Treated With ENTO|0|||
164163098|NCT02343939|592962402|FG002|Overall Study|Never Treated With ENTO|0|||
164163099|NCT02343939|592962403|FG003|Overall Study|Never Treated With ENTO|0|||
164163100|NCT02343939|592962404|FG004|Overall Study|Never Treated With ENTO|0|||
164163101|NCT02343939|592962405|FG005|Overall Study|Never Treated With ENTO|0|||
164163102|NCT02343939|592962406|FG006|Overall Study|Never Treated With ENTO|1|||
164163103|NCT02343939|592962407|FG007|Overall Study|Never Treated With ENTO|2|||
164163104|NCT02343939|592962408|FG008|Overall Study|Never Treated With ENTO|0|||
164163105|NCT02064816|592962409|FG000|Overall Study|Adverse Event|3|||
164163106|NCT02064816|592962410|FG001|Overall Study|Adverse Event|2|||
164163107|NCT02064816|592962409|FG000|Overall Study|Withdrawal by Subject|2|||
164163108|NCT02064816|592962410|FG001|Overall Study|Withdrawal by Subject|1|||
164163109|NCT02064816|592962409|FG000|Overall Study|Lost to Follow-up|2|||
164163110|NCT02064816|592962410|FG001|Overall Study|Lost to Follow-up|1|||
164163111|NCT02064816|592962409|FG000|Overall Study|Therapeutic failure|0|||
164163112|NCT02064816|592962410|FG001|Overall Study|Therapeutic failure|1|||
164163113|NCT02064816|592962409|FG000|Overall Study|Other|1|||
164163114|NCT02064816|592962410|FG001|Overall Study|Other|3|||
164163115|NCT05107492|592962411|FG000|Overall Study|Lost to Follow-up|1|||
164163116|NCT05107492|592962412|FG001|Overall Study|Lost to Follow-up|0|||
164163117|NCT03896022|592962413|FG000|Overall Study|Withdrawal by Subject|1|||
164163118|NCT03896022|592962414|FG001|Overall Study|Withdrawal by Subject|0|||
164163119|NCT03896022|592962415|FG002|Overall Study|Withdrawal by Subject|0|||
164163120|NCT03896022|592962413|FG000|Overall Study|Did not have procedure|3|||
164163121|NCT03896022|592962414|FG001|Overall Study|Did not have procedure|0|||
164163122|NCT03896022|592962415|FG002|Overall Study|Did not have procedure|0|||
164163123|NCT02741076|592962416|FG000|Overall Study|Adverse Event|0|||
164163124|NCT02741076|592962417|FG001|Overall Study|Adverse Event|1|||
164163125|NCT02741076|592962418|FG002|Overall Study|Adverse Event|1|||
164163126|NCT02741076|592962419|FG003|Overall Study|Adverse Event|0|||
164163127|NCT02741076|592962416|FG000|Overall Study|Lack of Efficacy|1|||
164163128|NCT02741076|592962417|FG001|Overall Study|Lack of Efficacy|0|||
164163129|NCT02741076|592962418|FG002|Overall Study|Lack of Efficacy|0|||
164163130|NCT02741076|592962419|FG003|Overall Study|Lack of Efficacy|0|||
164163131|NCT02741076|592962416|FG000|Overall Study|Withdrawal by Subject|0|||
164163132|NCT02741076|592962417|FG001|Overall Study|Withdrawal by Subject|1|||
164163133|NCT02741076|592962418|FG002|Overall Study|Withdrawal by Subject|0|||
164163134|NCT02741076|592962419|FG003|Overall Study|Withdrawal by Subject|0|||
164163135|NCT02741076|592962416|FG000|Overall Study|Sponsor Request|2|||
164163136|NCT02741076|592962417|FG001|Overall Study|Sponsor Request|3|||
164163137|NCT02741076|592962418|FG002|Overall Study|Sponsor Request|0|||
164163138|NCT02741076|592962419|FG003|Overall Study|Sponsor Request|1|||
164163139|NCT02741076|592962416|FG000|Overall Study|No additional information available|0|||
164163140|NCT02741076|592962417|FG001|Overall Study|No additional information available|0|||
164163141|NCT02741076|592962418|FG002|Overall Study|No additional information available|1|||
164163142|NCT02741076|592962419|FG003|Overall Study|No additional information available|1|||
164163143|NCT01779440|592962420|FG000|Overall Study|Withdrawal by Subject|3|||
164163144|NCT01779440|592962421|FG001|Overall Study|Withdrawal by Subject|5|||
164163145|NCT00550745|592962426|FG000|Overall Study|Death|20|||
164163146|NCT00550745|592962427|FG001|Overall Study|Death|16|||
164163147|NCT00550745|592962426|FG000|Overall Study|Lost to Follow-up|45|||
164163148|NCT00550745|592962427|FG001|Overall Study|Lost to Follow-up|30|||
164163149|NCT00550745|592962426|FG000|Overall Study|Physician Decision|0|||
164163150|NCT00550745|592962427|FG001|Overall Study|Physician Decision|2|||
164163151|NCT00550745|592962426|FG000|Overall Study|Protocol Violation|4|||
164163152|NCT00550745|592962427|FG001|Overall Study|Protocol Violation|2|||
164163153|NCT00550745|592962426|FG000|Overall Study|Withdrawal by Subject|17|||
164163154|NCT00550745|592962427|FG001|Overall Study|Withdrawal by Subject|10|||
164163155|NCT00550745|592962426|FG000|Overall Study|Screen failure|1|||
164163156|NCT00550745|592962427|FG001|Overall Study|Screen failure|0|||
164163157|NCT00764660|592962428|FG000|Overall Study|Adverse Event|6|||
164163158|NCT00764660|592962429|FG001|Overall Study|Adverse Event|3|||
164163159|NCT00764660|592962428|FG000|Overall Study|Lost to Follow-up|3|||
164163160|NCT00764660|592962429|FG001|Overall Study|Lost to Follow-up|4|||
164163161|NCT00764660|592962428|FG000|Overall Study|Withdrawal by Subject|7|||
164163162|NCT00764660|592962429|FG001|Overall Study|Withdrawal by Subject|3|||
164163163|NCT00764660|592962428|FG000|Overall Study|Noncompliance With Protocol|5|||
164163164|NCT00764660|592962429|FG001|Overall Study|Noncompliance With Protocol|1|||
164163165|NCT00764660|592962428|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
164163166|NCT00764660|592962429|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
164163167|NCT01131455|592962430|FG000|Overall Study|Death of PI|6|||
164163168|NCT01131455|592962431|FG001|Overall Study|Death of PI|4|||
164163169|NCT01131455|592962432|FG002|Overall Study|Death of PI|0|||
164163170|NCT05119595|592963645|FG000|Overall Study|Death|1|||
164163171|NCT05119595|592963645|FG000|Overall Study|Lost to Follow-up|7|||
164163172|NCT01806961|592963646|FG000|Overall Study|sponsor decision|16|||
164163173|NCT00839800|592963649|FG000|Overall Study|Adverse Event|8|||
164163174|NCT00839800|592963650|FG001|Overall Study|Adverse Event|12|||
164163175|NCT00839800|592963649|FG000|Overall Study|Lost to Follow-up|31|||
164163176|NCT00839800|592963650|FG001|Overall Study|Lost to Follow-up|26|||
164163177|NCT00839800|592963649|FG000|Overall Study|Withdrawal by Subject|28|||
164163178|NCT00839800|592963650|FG001|Overall Study|Withdrawal by Subject|34|||
164163179|NCT00839800|592963649|FG000|Overall Study|Incorrect Enrolment|3|||
164163180|NCT00839800|592963650|FG001|Overall Study|Incorrect Enrolment|3|||
164163181|NCT00839800|592963649|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
164163182|NCT00839800|592963650|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
164163183|NCT00839800|592963649|FG000|Overall Study|Safety Reasons|2|||
164163184|NCT00839800|592963650|FG001|Overall Study|Safety Reasons|1|||
164163185|NCT00839800|592963649|FG000|Overall Study|Other|8|||
164163186|NCT00839800|592963650|FG001|Overall Study|Other|14|||
164163187|NCT00839800|592963649|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
164163188|NCT00839800|592963650|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
164163189|NCT00912743|592963659|FG000|Overall Study|Adverse Event|3|||
164163190|NCT00912743|592963660|FG001|Overall Study|Adverse Event|1|||
164163191|NCT00912743|592963659|FG000|Overall Study|Lack of Efficacy|9|||
164163192|NCT00912743|592963660|FG001|Overall Study|Lack of Efficacy|18|||
164163193|NCT00912743|592963659|FG000|Overall Study|Toxicity|0|||
164163194|NCT00912743|592963660|FG001|Overall Study|Toxicity|1|||
164163195|NCT00912743|592963659|FG000|Overall Study|End of treatment form was not collected|1|||
164163196|NCT00912743|592963660|FG001|Overall Study|End of treatment form was not collected|0|||
164163197|NCT00179660|592963670|FG000|Overall Study|Adverse Event|7|||
164163198|NCT00179660|592963670|FG000|Overall Study|Lack of therapeutic effect|28|||
164163199|NCT00179660|592963670|FG000|Overall Study|Withdrawal by Subject|2|||
164163200|NCT00179660|592963670|FG000|Overall Study|Lost to Follow-up|1|||
164163201|NCT00179660|592963670|FG000|Overall Study|Death|3|||
164163202|NCT00179660|592963670|FG000|Overall Study|Other - Unspecified|9|||
164163203|NCT04478695|592963671|FG000|Overall Study|Death|1|||
164163204|NCT04478695|592963672|FG001|Overall Study|Death|0|||
164163205|NCT00644917|592963673|FG000|Overall Study|Withdrawal by Subject|2|||
164163206|NCT00178685|592963674|FG000|Overall Study|Death|3|||
164163207|NCT00178685|592963675|FG001|Overall Study|Death|3|||
164163208|NCT00178685|592963676|FG002|Overall Study|Death|6|||
164163209|NCT00178685|592963674|FG000|Overall Study|Lost to Follow-up|100|||
164163210|NCT00178685|592963675|FG001|Overall Study|Lost to Follow-up|187|||
164163211|NCT00178685|592963676|FG002|Overall Study|Lost to Follow-up|183|||
164163212|NCT00178685|592963674|FG000|Overall Study|Withdrawal by Subject|8|||
164163213|NCT00178685|592963675|FG001|Overall Study|Withdrawal by Subject|14|||
164163214|NCT00178685|592963676|FG002|Overall Study|Withdrawal by Subject|7|||
164163215|NCT00927862|592963677|FG000|Overall Study|Missing data needed for endpt analyses|27|||
164163216|NCT00927862|592963678|FG001|Overall Study|Missing data needed for endpt analyses|45|||
164163217|NCT00820248|592963679|FG000|Overall Study|No treated|4|||
164163218|NCT00820248|592963680|FG001|Overall Study|No treated|1|||
164163219|NCT01057810|592963694|FG000|Overall Study|Disease progression|156|||
164163220|NCT01057810|592963695|FG001|Overall Study|Disease progression|197|||
164163221|NCT01057810|592963694|FG000|Overall Study|Study drug toxicity|5|||
164163222|NCT01057810|592963695|FG001|Overall Study|Study drug toxicity|114|||
164163223|NCT01057810|592963694|FG000|Overall Study|Adverse event unrelated to study drug|13|||
164163224|NCT01057810|592963695|FG001|Overall Study|Adverse event unrelated to study drug|29|||
164163225|NCT01057810|592963694|FG000|Overall Study|Withdrawal by Subject|10|||
164163226|NCT01057810|592963695|FG001|Overall Study|Withdrawal by Subject|25|||
164163227|NCT01057810|592963694|FG000|Overall Study|Death|2|||
164163228|NCT01057810|592963695|FG001|Overall Study|Death|12|||
164163229|NCT01057810|592963694|FG000|Overall Study|Maximum clinical benefit|5|||
164163230|NCT01057810|592963695|FG001|Overall Study|Maximum clinical benefit|5|||
164163231|NCT01057810|592963694|FG000|Overall Study|Poor/non-compliance|0|||
164163232|NCT01057810|592963695|FG001|Overall Study|Poor/non-compliance|1|||
164163233|NCT01057810|592963694|FG000|Overall Study|No longer met study criteria|0|||
164163234|NCT01057810|592963695|FG001|Overall Study|No longer met study criteria|1|||
164163235|NCT01057810|592963694|FG000|Overall Study|Other|7|||
164163236|NCT01057810|592963695|FG001|Overall Study|Other|14|||
164163237|NCT00267969|592963696|FG000|Controlled Period|Adverse Event|6|||
164163238|NCT00267969|592963697|FG001|Controlled Period|Adverse Event|0|||
164163239|NCT00267969|592963698|FG002|Controlled Period|Adverse Event|2|||
164163240|NCT00267969|592963699|FG003|Controlled Period|Adverse Event|0|||
164163241|NCT00267969|592963700|FG004|Controlled Period|Adverse Event|0|||
164163242|NCT00267969|592963701|FG005|Controlled Period|Adverse Event|0|||
164163243|NCT00267969|592963702|FG006|Controlled Period|Adverse Event|0|||
164163244|NCT00267969|592963696|FG000|Controlled Period|Lack of Efficacy|3|||
164163245|NCT00267969|592963697|FG001|Controlled Period|Lack of Efficacy|0|||
164163246|NCT00267969|592963698|FG002|Controlled Period|Lack of Efficacy|1|||
164163247|NCT00267969|592963699|FG003|Controlled Period|Lack of Efficacy|0|||
164163248|NCT00267969|592963700|FG004|Controlled Period|Lack of Efficacy|0|||
164163249|NCT00267969|592963701|FG005|Controlled Period|Lack of Efficacy|0|||
164163250|NCT00267969|592963702|FG006|Controlled Period|Lack of Efficacy|0|||
164163251|NCT00267969|592963696|FG000|Controlled Period|Lost to Follow-up|1|||
164163252|NCT00267969|592963697|FG001|Controlled Period|Lost to Follow-up|0|||
164163253|NCT00267969|592963698|FG002|Controlled Period|Lost to Follow-up|1|||
164163254|NCT00267969|592963699|FG003|Controlled Period|Lost to Follow-up|0|||
164163255|NCT00267969|592963700|FG004|Controlled Period|Lost to Follow-up|0|||
164163256|NCT00267969|592963701|FG005|Controlled Period|Lost to Follow-up|0|||
164163257|NCT00267969|592963702|FG006|Controlled Period|Lost to Follow-up|0|||
164163258|NCT00267969|592963696|FG000|Controlled Period|Randomized but not treated|0|||
164163259|NCT00267969|592963697|FG001|Controlled Period|Randomized but not treated|0|||
164163260|NCT00267969|592963698|FG002|Controlled Period|Randomized but not treated|1|||
164163261|NCT00267969|592963699|FG003|Controlled Period|Randomized but not treated|0|||
164163262|NCT00267969|592963700|FG004|Controlled Period|Randomized but not treated|0|||
164163263|NCT00267969|592963701|FG005|Controlled Period|Randomized but not treated|0|||
164163264|NCT00267969|592963702|FG006|Controlled Period|Randomized but not treated|0|||
164163265|NCT00267969|592963696|FG000|Controlled Period|Other|2|||
164163266|NCT00267969|592963697|FG001|Controlled Period|Other|1|||
164163267|NCT00267969|592963698|FG002|Controlled Period|Other|6|||
164163268|NCT00267969|592963699|FG003|Controlled Period|Other|0|||
164163269|NCT00267969|592963700|FG004|Controlled Period|Other|0|||
164163270|NCT00267969|592963701|FG005|Controlled Period|Other|0|||
164163271|NCT00267969|592963702|FG006|Controlled Period|Other|0|||
164163272|NCT00267969|592963696|FG000|After Controlled Period|Adverse Event|0|||
164163273|NCT00267969|592963697|FG001|After Controlled Period|Adverse Event|0|||
164163274|NCT00267969|592963698|FG002|After Controlled Period|Adverse Event|0|||
164163275|NCT00267969|592963699|FG003|After Controlled Period|Adverse Event|7|||
164163276|NCT00267969|592963700|FG004|After Controlled Period|Adverse Event|8|||
164163277|NCT00267969|592963701|FG005|After Controlled Period|Adverse Event|23|||
164163278|NCT00267969|592963702|FG006|After Controlled Period|Adverse Event|21|||
164163279|NCT00267969|592963696|FG000|After Controlled Period|Death|0|||
164163280|NCT00267969|592963697|FG001|After Controlled Period|Death|0|||
164163281|NCT00267969|592963698|FG002|After Controlled Period|Death|0|||
164163282|NCT00267969|592963699|FG003|After Controlled Period|Death|1|||
164163283|NCT00267969|592963700|FG004|After Controlled Period|Death|2|||
164163284|NCT00267969|592963701|FG005|After Controlled Period|Death|0|||
164163285|NCT00267969|592963702|FG006|After Controlled Period|Death|1|||
164163286|NCT00267969|592963696|FG000|After Controlled Period|Lack of Efficacy|0|||
164163287|NCT00267969|592963697|FG001|After Controlled Period|Lack of Efficacy|0|||
164163288|NCT00267969|592963698|FG002|After Controlled Period|Lack of Efficacy|0|||
164163289|NCT00267969|592963699|FG003|After Controlled Period|Lack of Efficacy|10|||
164163290|NCT00267969|592963700|FG004|After Controlled Period|Lack of Efficacy|6|||
164163291|NCT00267969|592963701|FG005|After Controlled Period|Lack of Efficacy|28|||
164163292|NCT00267969|592963702|FG006|After Controlled Period|Lack of Efficacy|15|||
164163293|NCT00267969|592963696|FG000|After Controlled Period|Lost to Follow-up|0|||
164163294|NCT00267969|592963697|FG001|After Controlled Period|Lost to Follow-up|0|||
164163295|NCT00267969|592963698|FG002|After Controlled Period|Lost to Follow-up|0|||
164163296|NCT00267969|592963699|FG003|After Controlled Period|Lost to Follow-up|5|||
164163297|NCT00267969|592963700|FG004|After Controlled Period|Lost to Follow-up|8|||
164163298|NCT00267969|592963701|FG005|After Controlled Period|Lost to Follow-up|9|||
164163299|NCT00267969|592963702|FG006|After Controlled Period|Lost to Follow-up|10|||
164163300|NCT00267969|592963696|FG000|After Controlled Period|Other|0|||
164163301|NCT00267969|592963697|FG001|After Controlled Period|Other|0|||
164163302|NCT00267969|592963698|FG002|After Controlled Period|Other|0|||
164163303|NCT00267969|592963699|FG003|After Controlled Period|Other|13|||
164163304|NCT00267969|592963700|FG004|After Controlled Period|Other|11|||
164163305|NCT00267969|592963701|FG005|After Controlled Period|Other|22|||
164163306|NCT00267969|592963702|FG006|After Controlled Period|Other|25|||
164163307|NCT00862823|592963703|FG000|First Intervention|Withdrawal by Subject|1|||
164163308|NCT00862823|592963704|FG001|First Intervention|Withdrawal by Subject|1|||
164163309|NCT00887315|592963705|FG000|Overall Study|Study termination|7|||
164163310|NCT00887315|592963706|FG001|Overall Study|Study termination|4|||
164163311|NCT00619892|592963711|FG000|Overall Study|Adverse Event|3|||
164163312|NCT00619892|592963712|FG001|Overall Study|Adverse Event|0|||
164163313|NCT00619892|592963711|FG000|Overall Study|Lost to Follow-up|0|||
164163314|NCT00619892|592963712|FG001|Overall Study|Lost to Follow-up|1|||
164163315|NCT00619892|592963711|FG000|Overall Study|Intercurrent illness|0|||
164163316|NCT00619892|592963712|FG001|Overall Study|Intercurrent illness|1|||
164163317|NCT00857896|592963718|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
164163318|NCT02308540|592963719|FG000|Overall Study|Lost to Follow-up|0|||
164163319|NCT02308540|592963720|FG001|Overall Study|Lost to Follow-up|0|||
164163320|NCT02308540|592963721|FG002|Overall Study|Lost to Follow-up|0|||
164163321|NCT02308540|592963722|FG003|Overall Study|Lost to Follow-up|0|||
164163322|NCT02308540|592963723|FG004|Overall Study|Lost to Follow-up|0|||
164163323|NCT02308540|592963724|FG005|Overall Study|Lost to Follow-up|1|||
164163324|NCT01091662|592963725|FG000|Overall Study|Adverse Event|1|||
164163325|NCT01091662|592963726|FG001|Overall Study|Adverse Event|9|||
164163326|NCT01091662|592963725|FG000|Overall Study|Physician Decision|1|||
164163327|NCT01091662|592963726|FG001|Overall Study|Physician Decision|1|||
164163328|NCT01091662|592963725|FG000|Overall Study|Withdrawal by Subject|7|||
164163329|NCT01091662|592963726|FG001|Overall Study|Withdrawal by Subject|6|||
164163330|NCT01091662|592963725|FG000|Overall Study|met exit criteria|7|||
164163331|NCT01091662|592963726|FG001|Overall Study|met exit criteria|13|||
164163332|NCT01091662|592963725|FG000|Overall Study|met exclusion criteria|1|||
164163333|NCT01091662|592963726|FG001|Overall Study|met exclusion criteria|0|||
164163334|NCT01091662|592963725|FG000|Overall Study|Lost to Follow-up|0|||
164163335|NCT01091662|592963726|FG001|Overall Study|Lost to Follow-up|1|||
164163336|NCT01091662|592963725|FG000|Overall Study|Pregnancy|0|||
164163337|NCT01091662|592963726|FG001|Overall Study|Pregnancy|1|||
164163338|NCT01091662|592963725|FG000|Overall Study|Protocol Violation|0|||
164163339|NCT01091662|592963726|FG001|Overall Study|Protocol Violation|2|||
164163340|NCT01091662|592963725|FG000|Overall Study|unable to swallow capsule|0|||
164163341|NCT01091662|592963726|FG001|Overall Study|unable to swallow capsule|1|||
164163342|NCT04109391|592963727|FG000|Overall Study|Adverse Event|2|||
164163343|NCT04109391|592963728|FG001|Overall Study|Adverse Event|2|||
164163344|NCT04109391|592963729|FG002|Overall Study|Adverse Event|0|||
164163345|NCT04109391|592963727|FG000|Overall Study|Withdrawal by Subject|2|||
164163346|NCT04109391|592963728|FG001|Overall Study|Withdrawal by Subject|0|||
164163347|NCT04109391|592963729|FG002|Overall Study|Withdrawal by Subject|0|||
164163348|NCT04109391|592963727|FG000|Overall Study|Pregnancy|1|||
164163349|NCT04109391|592963728|FG001|Overall Study|Pregnancy|0|||
164163350|NCT04109391|592963729|FG002|Overall Study|Pregnancy|0|||
164163351|NCT04109391|592963727|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
164163352|NCT04109391|592963728|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
164163353|NCT04109391|592963729|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
164163354|NCT04109391|592963727|FG000|Overall Study|Lost to Follow-up|0|||
164163355|NCT04109391|592963728|FG001|Overall Study|Lost to Follow-up|0|||
164163356|NCT04109391|592963729|FG002|Overall Study|Lost to Follow-up|1|||
164163357|NCT04109391|592963727|FG000|Overall Study|Lack of Efficacy|2|||
164163358|NCT04109391|592963728|FG001|Overall Study|Lack of Efficacy|2|||
164163359|NCT04109391|592963729|FG002|Overall Study|Lack of Efficacy|3|||
164163360|NCT02285166|592963730|FG000|Overall Study|Case Report Forms Uncollected|564|||
164163361|NCT02285166|592963730|FG000|Overall Study|Protocol Deviation|402|||
164163362|NCT00443079|592963731|FG000|Overall Study|Lost to Follow-up|0|||
164163363|NCT00443079|592963732|FG001|Overall Study|Lost to Follow-up|1|||
164163364|NCT01106911|592963733|FG000|Overall Study|Physician Decision|2|||
164163365|NCT01106911|592963733|FG000|Overall Study|deemed ineligible after screening|3|||
164163366|NCT05708976|592963743|FG000|Overall Study|Withdrawal by Subject|0|||
164163367|NCT05708976|592963744|FG001|Overall Study|Withdrawal by Subject|1|||
164163368|NCT02684097|592963745|FG000|Overall Study|Lack of Efficacy|13|||
164163369|NCT02684097|592963746|FG001|Overall Study|Lack of Efficacy|6|||
164163370|NCT03218826|592963747|FG000|Overall Study|Non-compliance with protocol|1|||
164163371|NCT03218826|592963748|FG001|Overall Study|Non-compliance with protocol|0|||
164163372|NCT03218826|592963749|FG002|Overall Study|Non-compliance with protocol|2|||
164163373|NCT03218826|592963750|FG003|Overall Study|Non-compliance with protocol|1|||
164163374|NCT03218826|592963751|FG004|Overall Study|Non-compliance with protocol|1|||
164163375|NCT02858583|592963754|FG000|Overall Study|Declined consent|1|||
164163376|NCT02858583|592963755|FG001|Overall Study|Declined consent|1|||
164163377|NCT03564119|592963762|FG000|Overall Study|Adverse Event|4|||
164163378|NCT03564119|592963763|FG001|Overall Study|Adverse Event|0|||
164163379|NCT03564119|592963762|FG000|Overall Study|Lost to Follow-up|1|||
164163380|NCT03564119|592963763|FG001|Overall Study|Lost to Follow-up|4|||
164163381|NCT03564119|592963762|FG000|Overall Study|Protocol Violation|1|||
164163382|NCT03564119|592963763|FG001|Overall Study|Protocol Violation|0|||
164163383|NCT03564119|592963762|FG000|Overall Study|Withdrawal by Subject|9|||
164163384|NCT03564119|592963763|FG001|Overall Study|Withdrawal by Subject|4|||
164163385|NCT03564119|592963762|FG000|Overall Study|Other Than Specified|0|||
164163386|NCT03564119|592963763|FG001|Overall Study|Other Than Specified|1|||
164163387|NCT00634036|592963764|FG000|Overall Study|Lost to Follow-up|1|||
164163388|NCT00634036|592963765|FG001|Overall Study|Lost to Follow-up|1|||
164163389|NCT00634036|592963764|FG000|Overall Study|Withdrawal by Subject|1|||
164163390|NCT00634036|592963765|FG001|Overall Study|Withdrawal by Subject|1|||
164163391|NCT00961350|592963766|FG000|Overall Study|Adverse Event|18|||
164163392|NCT00961350|592963767|FG001|Overall Study|Adverse Event|33|||
164163393|NCT00961350|592963766|FG000|Overall Study|Withdrawal by Subject|10|||
164163394|NCT00961350|592963767|FG001|Overall Study|Withdrawal by Subject|10|||
164163395|NCT00961350|592963766|FG000|Overall Study|Lost to Follow-up|3|||
164163396|NCT00961350|592963767|FG001|Overall Study|Lost to Follow-up|3|||
164163397|NCT00961350|592963766|FG000|Overall Study|Misc|16|||
164163398|NCT00961350|592963767|FG001|Overall Study|Misc|21|||
164163399|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
164163400|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
164163401|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
164163402|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
164163403|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
164163404|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
164163405|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
164163406|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
164163407|NCT03867201|592963768|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
164163408|NCT03867201|592963769|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
164163409|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Adverse Event|5|||
164163410|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Adverse Event|11|||
164163411|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
164163412|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
164163413|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Physician Decision|6|||
164163414|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Physician Decision|3|||
164163415|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Pregnancy|2|||
164163416|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Pregnancy|2|||
164163417|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
164163418|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
164163419|NCT03867201|592963768|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
164163420|NCT03867201|592963769|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
164163421|NCT03867201|592963768|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
164163422|NCT03867201|592963769|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
164163423|NCT03867201|592963768|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
164163424|NCT03867201|592963769|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
164163425|NCT01190410|592964982|FG000|Overall Study|Adverse Event|0|||
164163426|NCT01190410|592964983|FG001|Overall Study|Adverse Event|3|||
164163427|NCT01190410|592964982|FG000|Overall Study|Lack of Efficacy|0|||
164163428|NCT01190410|592964983|FG001|Overall Study|Lack of Efficacy|2|||
164163429|NCT01190410|592964982|FG000|Overall Study|Withdrawal by Subject|0|||
164163430|NCT01190410|592964983|FG001|Overall Study|Withdrawal by Subject|2|||
164163431|NCT01190410|592964982|FG000|Overall Study|Administrative decision|1|||
164163432|NCT01190410|592964983|FG001|Overall Study|Administrative decision|0|||
164163433|NCT01190410|592964982|FG000|Overall Study|PI discretion|0|||
164163434|NCT01190410|592964983|FG001|Overall Study|PI discretion|2|||
164163435|NCT01283334|592964987|FG000|Overall Study|Withdrawal by Subject|1|||
164163436|NCT01283334|592964987|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
164163437|NCT01283334|592964987|FG000|Overall Study|Adverse Event|4|||
164163438|NCT01283334|592964987|FG000|Overall Study|Physician Decision|1|||
164163439|NCT03467217|592964988|FG000|Overall Study|Trial stopped early|5|||
164163440|NCT03467217|592964989|FG001|Overall Study|Trial stopped early|2|||
164163441|NCT03467217|592964988|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
164163442|NCT03467217|592964989|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
164163443|NCT03467217|592964988|FG000|Overall Study|Lost to Follow-up|0|||
164163444|NCT03467217|592964989|FG001|Overall Study|Lost to Follow-up|2|||
164163445|NCT04390503|592964990|FG000|Overall Study|Physician Decision|2|||
164163446|NCT04390503|592964991|FG001|Overall Study|Physician Decision|1|||
164163447|NCT04390503|592964990|FG000|Overall Study|Adverse Event|1|||
164163448|NCT04390503|592964991|FG001|Overall Study|Adverse Event|0|||
164163449|NCT03656692|592964995|FG000|Overall Study|Worsening of disease activity|2|||
164163450|NCT03656692|592964995|FG000|Overall Study|Physician Decision|1|||
164163451|NCT03233529|592964999|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
164163452|NCT03233529|592964999|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
164163453|NCT03260244|592965000|FG000|Overall Study|Death|19|||
164163454|NCT03260244|592965000|FG000|Overall Study|Lost to Follow-up|60|||
164163455|NCT03260244|592965000|FG000|Overall Study|Withdrawal by Subject|48|||
164163456|NCT03260244|592965000|FG000|Overall Study|Procedure Not Performed|21|||
164163457|NCT03260244|592965000|FG000|Overall Study|Enrollment Criteria Not Met|31|||
164163458|NCT03260244|592965000|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
164163459|NCT03260244|592965000|FG000|Overall Study|Subject Noncompliance|6|||
164163460|NCT03260244|592965000|FG000|Overall Study|No inducible Arrhythmia|2|||
164163461|NCT03260244|592965000|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
164163462|NCT03260244|592965000|FG000|Overall Study|Screen Failure|2|||
164163463|NCT03260244|592965000|FG000|Overall Study|Treated Off Label|69|||
164163464|NCT03260244|592965000|FG000|Overall Study|No Radiofrequency Ablation|14|||
164163465|NCT01177293|592965001|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
164163466|NCT01177293|592965002|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
164163467|NCT00594100|592965003|FG000|Procedure|Technical Failure|9|||
164163468|NCT00594100|592965003|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
164163469|NCT00594100|592965003|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
164163470|NCT00594100|592965003|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
164163471|NCT02448537|592965004|FG000|Overall Study|Withdrawal by Subject|1|||
164163472|NCT02448537|592965005|FG001|Overall Study|Withdrawal by Subject|1|||
164163473|NCT02448537|592965006|FG002|Overall Study|Withdrawal by Subject|1|||
164163474|NCT03528369|592965007|FG000|Overall Study|Withdrawal by Subject|2|||
164163475|NCT03528369|592965008|FG001|Overall Study|Withdrawal by Subject|0|||
164163476|NCT03528369|592965009|FG002|Overall Study|Withdrawal by Subject|0|||
164163477|NCT03528369|592965007|FG000|Overall Study|Lost to Follow-up|1|||
164163478|NCT03528369|592965008|FG001|Overall Study|Lost to Follow-up|0|||
164163479|NCT03528369|592965009|FG002|Overall Study|Lost to Follow-up|0|||
164163480|NCT03528369|592965007|FG000|Overall Study|Adverse Event|0|||
164163481|NCT03528369|592965008|FG001|Overall Study|Adverse Event|1|||
164163482|NCT03528369|592965009|FG002|Overall Study|Adverse Event|0|||
164163483|NCT04725812|592965010|FG000|Overall Study|Withdrawal by Subject|1|||
164163484|NCT02801617|592965014|FG000|Overall Study|Protocol Violation|2|||
164163485|NCT02801617|592965015|FG001|Overall Study|Protocol Violation|6|||
164163486|NCT04747886|592965016|FG000|Overall Study|Withdrawal by Subject|1|||
164163487|NCT04747886|592965017|FG001|Overall Study|Withdrawal by Subject|4|||
164163488|NCT02237196|592965018|FG000|Overall Study|Adverse Event|0|||
164163489|NCT02237196|592965019|FG001|Overall Study|Adverse Event|1|||
164163490|NCT02237196|592965020|FG002|Overall Study|Adverse Event|1|||
164163491|NCT02237196|592965021|FG003|Overall Study|Adverse Event|0|||
164163492|NCT02237196|592965018|FG000|Overall Study|Lost to Follow-up|4|||
164163493|NCT02237196|592965019|FG001|Overall Study|Lost to Follow-up|2|||
164163494|NCT02237196|592965020|FG002|Overall Study|Lost to Follow-up|4|||
164163495|NCT02237196|592965021|FG003|Overall Study|Lost to Follow-up|6|||
164163496|NCT02237196|592965018|FG000|Overall Study|Physician Decision|2|||
164163497|NCT02237196|592965019|FG001|Overall Study|Physician Decision|0|||
164163498|NCT02237196|592965020|FG002|Overall Study|Physician Decision|0|||
164163499|NCT02237196|592965021|FG003|Overall Study|Physician Decision|1|||
164163500|NCT02237196|592965018|FG000|Overall Study|Pregnancy|0|||
164163501|NCT02237196|592965019|FG001|Overall Study|Pregnancy|0|||
164163502|NCT02237196|592965020|FG002|Overall Study|Pregnancy|1|||
164163503|NCT02237196|592965021|FG003|Overall Study|Pregnancy|1|||
164163504|NCT02237196|592965018|FG000|Overall Study|Withdrawal by Subject|1|||
164163505|NCT02237196|592965019|FG001|Overall Study|Withdrawal by Subject|1|||
164163506|NCT02237196|592965020|FG002|Overall Study|Withdrawal by Subject|4|||
164163507|NCT02237196|592965021|FG003|Overall Study|Withdrawal by Subject|1|||
164163508|NCT02237196|592965018|FG000|Overall Study|Site Error|1|||
164163509|NCT02237196|592965019|FG001|Overall Study|Site Error|2|||
164163510|NCT02237196|592965020|FG002|Overall Study|Site Error|0|||
164163511|NCT02237196|592965021|FG003|Overall Study|Site Error|2|||
164163512|NCT01814696|592965023|FG000|Overall Study|Withdrawal by Subject|1|||
164163513|NCT01814696|592965024|FG001|Overall Study|Withdrawal by Subject|0|||
164163514|NCT01814696|592965023|FG000|Overall Study|Randomized to wrong group|1|||
164163515|NCT01814696|592965024|FG001|Overall Study|Randomized to wrong group|0|||
164163516|NCT05310071|592965026|FG000|Overall Study|Death|0|||
164163517|NCT05310071|592965027|FG001|Overall Study|Death|3|||
164163518|NCT05310071|592965026|FG000|Overall Study|Adverse Event|4|||
164163519|NCT05310071|592965027|FG001|Overall Study|Adverse Event|31|||
164163520|NCT05310071|592965026|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
164163521|NCT05310071|592965027|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
164163522|NCT05310071|592965026|FG000|Overall Study|Protocol Deviation|2|||
164163523|NCT05310071|592965027|FG001|Overall Study|Protocol Deviation|0|||
164163524|NCT05310071|592965026|FG000|Overall Study|Randomized by Mistake|0|||
164163525|NCT05310071|592965027|FG001|Overall Study|Randomized by Mistake|1|||
164163526|NCT05310071|592965026|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
164163527|NCT05310071|592965027|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
164163528|NCT05310071|592965026|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
164163529|NCT05310071|592965027|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
164163530|NCT05310071|592965026|FG000|Overall Study|Site Terminated by Sponsor|0|||
164163531|NCT05310071|592965027|FG001|Overall Study|Site Terminated by Sponsor|2|||
164163532|NCT05310071|592965026|FG000|Overall Study|Study Terminated by Sponsor|282|||
164163533|NCT05310071|592965027|FG001|Overall Study|Study Terminated by Sponsor|559|||
164163534|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
164163535|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
164163536|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
164163537|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
164163538|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
164163539|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
164163540|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
164163541|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
164163542|NCT05310071|592965026|FG000|Overall Study|Withdrawal by Participant - Other|25|||
164163543|NCT05310071|592965027|FG001|Overall Study|Withdrawal by Participant - Other|30|||
164163544|NCT05310071|592965026|FG000|Overall Study|Lost to Follow-up|2|||
164163545|NCT05310071|592965027|FG001|Overall Study|Lost to Follow-up|4|||
164163546|NCT05310071|592965026|FG000|Overall Study|Reason Not Specified|1|||
164163547|NCT05310071|592965027|FG001|Overall Study|Reason Not Specified|3|||
164163548|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
164163549|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163550|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163551|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163552|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163553|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
164163554|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
164163555|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
164163556|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163557|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163558|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163559|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
164163560|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
164163561|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
164163562|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163563|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163564|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163565|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163566|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
164163567|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
164163568|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163569|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163570|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163571|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163572|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
164163573|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
164163574|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163575|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163576|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163577|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
164163578|NCT02105987|592965028|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163579|NCT02105987|592965029|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
164163580|NCT02105987|592965030|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163581|NCT02105987|592965031|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163582|NCT02105987|592965032|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163583|NCT02105987|592965033|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
164163584|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163585|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163586|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
164163587|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
164163588|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163589|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
164163590|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163591|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163592|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
164163593|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
164163594|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163595|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
164163596|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163597|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163598|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
164163599|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
164163600|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163601|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
164163602|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163603|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163604|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
164163605|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
164163606|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163607|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
164163608|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163609|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163610|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
164163611|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163612|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163613|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
164163614|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163615|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163616|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163617|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
164163618|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163619|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
164163620|NCT02105987|592965028|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163621|NCT02105987|592965029|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163622|NCT02105987|592965030|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
164163623|NCT02105987|592965031|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163624|NCT02105987|592965032|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163625|NCT02105987|592965033|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
164163626|NCT02105987|592965028|FG000|Continuation Phase|Protocol Violation|0|||
164163627|NCT02105987|592965029|FG001|Continuation Phase|Protocol Violation|0|||
164163628|NCT02105987|592965030|FG002|Continuation Phase|Protocol Violation|0|||
164163629|NCT02105987|592965031|FG003|Continuation Phase|Protocol Violation|0|||
164163630|NCT02105987|592965032|FG004|Continuation Phase|Protocol Violation|1|||
164163631|NCT02105987|592965033|FG005|Continuation Phase|Protocol Violation|0|||
164163632|NCT02418949|592965034|FG000|Overall Study|Withdrawal by Subject|1|||
164163633|NCT02418949|592965035|FG001|Overall Study|Withdrawal by Subject|0|||
164163634|NCT02418949|592965036|FG002|Overall Study|Withdrawal by Subject|1|||
164163635|NCT02418949|592965037|FG003|Overall Study|Withdrawal by Subject|1|||
164163636|NCT02418949|592965034|FG000|Overall Study|Lost to Follow-up|1|||
164163637|NCT02418949|592965035|FG001|Overall Study|Lost to Follow-up|0|||
164163638|NCT02418949|592965036|FG002|Overall Study|Lost to Follow-up|1|||
164163639|NCT02418949|592965037|FG003|Overall Study|Lost to Follow-up|0|||
164163640|NCT02418949|592965034|FG000|Overall Study|Physician Decision|1|||
164163641|NCT02418949|592965035|FG001|Overall Study|Physician Decision|1|||
164163642|NCT02418949|592965036|FG002|Overall Study|Physician Decision|1|||
164163643|NCT02418949|592965037|FG003|Overall Study|Physician Decision|0|||
164163644|NCT00396656|592965038|FG000|First Treatment Period|Withdrawal by Subject|0|||
164163645|NCT00396656|592965039|FG001|First Treatment Period|Withdrawal by Subject|2|||
164163646|NCT00396656|592965038|FG000|Second Treatment Period|Adverse Event|0|||
164163647|NCT00396656|592965039|FG001|Second Treatment Period|Adverse Event|1|||
164163648|NCT01303172|592965041|FG000|Overall Study|Physician Decision|9|||
164163649|NCT01303172|592965042|FG001|Overall Study|Physician Decision|6|||
164163650|NCT01303172|592965041|FG000|Overall Study|Adverse Event|5|||
164163651|NCT01303172|592965042|FG001|Overall Study|Adverse Event|2|||
164163652|NCT01303172|592965041|FG000|Overall Study|Withdrawal by Subject|4|||
164163653|NCT01303172|592965042|FG001|Overall Study|Withdrawal by Subject|2|||
164163654|NCT01303172|592965041|FG000|Overall Study|Death|20|||
164163655|NCT01303172|592965042|FG001|Overall Study|Death|7|||
164163656|NCT01303172|592965041|FG000|Overall Study|Lack of Efficacy|25|||
164163657|NCT01303172|592965042|FG001|Overall Study|Lack of Efficacy|17|||
164163658|NCT00462709|592965043|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
164163659|NCT00462709|592965043|FG000|Overall Study|Lost to Follow-up|10|||
164163660|NCT00462709|592965043|FG000|Overall Study|Withdrawal by Subject|8|||
164163661|NCT00462709|592965043|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
164163662|NCT00462709|592965043|FG000|Overall Study|Death|2|||
164163663|NCT00462709|592965043|FG000|Overall Study|Logistical reasons|2|||
164163664|NCT00462709|592965043|FG000|Overall Study|Physician Decision|1|||
164163665|NCT00462709|592965043|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
164163666|NCT02099110|592965048|FG000|Overall Study|Protocol Violation|2|||
164163667|NCT02099110|592965049|FG001|Overall Study|Protocol Violation|1|||
164163668|NCT02099110|592965050|FG002|Overall Study|Protocol Violation|0|||
164163669|NCT02099110|592965051|FG003|Overall Study|Protocol Violation|3|||
164163670|NCT02099110|592965052|FG004|Overall Study|Protocol Violation|1|||
164163671|NCT02099110|592965048|FG000|Overall Study|Participant moved|1|||
164163672|NCT02099110|592965049|FG001|Overall Study|Participant moved|1|||
164163673|NCT02099110|592965050|FG002|Overall Study|Participant moved|1|||
164163674|NCT02099110|592965051|FG003|Overall Study|Participant moved|0|||
164163675|NCT02099110|592965052|FG004|Overall Study|Participant moved|2|||
164163676|NCT02099110|592965048|FG000|Overall Study|Withdrawal by Subject|7|||
164163677|NCT02099110|592965049|FG001|Overall Study|Withdrawal by Subject|11|||
164163678|NCT02099110|592965050|FG002|Overall Study|Withdrawal by Subject|13|||
164163679|NCT02099110|592965051|FG003|Overall Study|Withdrawal by Subject|9|||
164163680|NCT02099110|592965052|FG004|Overall Study|Withdrawal by Subject|13|||
164163681|NCT02099110|592965048|FG000|Overall Study|Adverse Event|3|||
164163682|NCT02099110|592965049|FG001|Overall Study|Adverse Event|5|||
164163683|NCT02099110|592965050|FG002|Overall Study|Adverse Event|2|||
164163684|NCT02099110|592965051|FG003|Overall Study|Adverse Event|3|||
164163685|NCT02099110|592965052|FG004|Overall Study|Adverse Event|2|||
164163686|NCT02099110|592965048|FG000|Overall Study|Lost to Follow-up|6|||
164163687|NCT02099110|592965049|FG001|Overall Study|Lost to Follow-up|12|||
164163688|NCT02099110|592965050|FG002|Overall Study|Lost to Follow-up|11|||
164163689|NCT02099110|592965051|FG003|Overall Study|Lost to Follow-up|5|||
164163690|NCT02099110|592965052|FG004|Overall Study|Lost to Follow-up|6|||
164163691|NCT02099110|592965048|FG000|Overall Study|Death|0|||
164163692|NCT02099110|592965049|FG001|Overall Study|Death|1|||
164163693|NCT02099110|592965050|FG002|Overall Study|Death|0|||
164163694|NCT02099110|592965051|FG003|Overall Study|Death|0|||
164163695|NCT02099110|592965052|FG004|Overall Study|Death|0|||
164163696|NCT02099110|592965048|FG000|Overall Study|Screen failure|0|||
164163697|NCT02099110|592965049|FG001|Overall Study|Screen failure|0|||
164163698|NCT02099110|592965050|FG002|Overall Study|Screen failure|0|||
164163699|NCT02099110|592965051|FG003|Overall Study|Screen failure|0|||
164163700|NCT02099110|592965052|FG004|Overall Study|Screen failure|1|||
164163701|NCT02099110|592965048|FG000|Overall Study|Non-compliance with study drug|2|||
164163702|NCT02099110|592965049|FG001|Overall Study|Non-compliance with study drug|0|||
164163703|NCT02099110|592965050|FG002|Overall Study|Non-compliance with study drug|0|||
164163704|NCT02099110|592965051|FG003|Overall Study|Non-compliance with study drug|0|||
164163705|NCT02099110|592965052|FG004|Overall Study|Non-compliance with study drug|1|||
164163706|NCT02099110|592965048|FG000|Overall Study|Physician Decision|3|||
164163707|NCT02099110|592965049|FG001|Overall Study|Physician Decision|0|||
164163708|NCT02099110|592965050|FG002|Overall Study|Physician Decision|1|||
164163709|NCT02099110|592965051|FG003|Overall Study|Physician Decision|2|||
164163710|NCT02099110|592965052|FG004|Overall Study|Physician Decision|1|||
164163711|NCT03515811|592965059|FG000|Overall Study|Lost to Follow-up|2|||
164163712|NCT03515811|592965060|FG001|Overall Study|Lost to Follow-up|1|||
164163713|NCT03515811|592965059|FG000|Overall Study|Protocol Violation|1|||
164163714|NCT03515811|592965060|FG001|Overall Study|Protocol Violation|1|||
164163715|NCT03515811|592965059|FG000|Overall Study|Death|1|||
164163716|NCT03515811|592965060|FG001|Overall Study|Death|1|||
164163717|NCT03515811|592965059|FG000|Overall Study|Withdrawal by Subject|0|||
164163718|NCT03515811|592965060|FG001|Overall Study|Withdrawal by Subject|2|||
164163719|NCT03515811|592965059|FG000|Overall Study|Technical Problems|1|||
164163720|NCT03515811|592965060|FG001|Overall Study|Technical Problems|0|||
164163721|NCT03515811|592965059|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
164163722|NCT03515811|592965060|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
164163723|NCT03515811|592965059|FG000|Overall Study|COVID-19|0|||
164163724|NCT03515811|592965060|FG001|Overall Study|COVID-19|1|||
164163725|NCT00237458|592965061|FG000|Overall Study|Lack of Efficacy|1|||
164163726|NCT00237458|592965061|FG000|Overall Study|Adverse Event|1|||
164163727|NCT00237458|592965061|FG000|Overall Study|Withdrawal by Subject|1|||
164163728|NCT04657198|592965062|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
164163729|NCT04657198|592965063|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
164163730|NCT04657198|592965064|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
164163731|NCT02977572|592965065|FG000|Overall Study|Exclusion criterion|2|||
164163732|NCT02977572|592965066|FG001|Overall Study|Exclusion criterion|2|||
164163733|NCT01166438|592965069|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
164163734|NCT01166438|592965070|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
164163735|NCT01166438|592965069|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
164163736|NCT01166438|592965070|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
164163737|NCT01166438|592965069|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
164163738|NCT01166438|592965070|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
164163739|NCT01166438|592965069|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
164163740|NCT01166438|592965070|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
164163741|NCT01166438|592965069|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
164163742|NCT01166438|592965070|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
164163743|NCT01166438|592965069|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
164163744|NCT01166438|592965070|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
164163745|NCT01075256|592965071|FG000|Overall Study|Withdrawal by Subject|1|||
164163746|NCT01075256|592965072|FG001|Overall Study|Withdrawal by Subject|0|||
164163747|NCT01075256|592965073|FG002|Overall Study|Withdrawal by Subject|0|||
164163748|NCT03502070|592965074|FG000|Overall Study|Withdrawal by Subject|1|||
164163749|NCT03502070|592965074|FG000|Overall Study|Screen Failure|1|||
164163750|NCT01197534|592965079|FG000|Overall Study|Not reported|16|||
164163751|NCT01197534|592965080|FG001|Overall Study|Not reported|10|||
164163752|NCT01197534|592965081|FG002|Overall Study|Not reported|16|||
164163753|NCT01197534|592965079|FG000|Overall Study|Enrolment in long term extension|57|||
164163754|NCT01197534|592965080|FG001|Overall Study|Enrolment in long term extension|66|||
164163755|NCT01197534|592965081|FG002|Overall Study|Enrolment in long term extension|119|||
164163756|NCT01197534|592965079|FG000|Overall Study|Severe non-compliance to protocol|3|||
164163757|NCT01197534|592965080|FG001|Overall Study|Severe non-compliance to protocol|4|||
164163758|NCT01197534|592965081|FG002|Overall Study|Severe non-compliance to protocol|1|||
164163759|NCT01197534|592965079|FG000|Overall Study|Lack of therapeutic response|9|||
164163760|NCT01197534|592965080|FG001|Overall Study|Lack of therapeutic response|4|||
164163761|NCT01197534|592965081|FG002|Overall Study|Lack of therapeutic response|9|||
164163762|NCT01197534|592965079|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
164163763|NCT01197534|592965080|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
164163764|NCT01197534|592965081|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
164163765|NCT01197534|592965079|FG000|Overall Study|Lost to Follow-up|1|||
164163766|NCT01197534|592965080|FG001|Overall Study|Lost to Follow-up|4|||
164163767|NCT01197534|592965081|FG002|Overall Study|Lost to Follow-up|2|||
164163768|NCT01197534|592965079|FG000|Overall Study|Adverse Event|35|||
164163769|NCT01197534|592965080|FG001|Overall Study|Adverse Event|36|||
164163770|NCT01197534|592965081|FG002|Overall Study|Adverse Event|24|||
164163771|NCT02593097|592965090|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
164163772|NCT02593097|592965091|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
164163773|NCT02593097|592965090|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
164163774|NCT02593097|592965091|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
164163775|NCT02593097|592965090|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
164163776|NCT02593097|592965091|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
164163777|NCT02593097|592965090|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
164163778|NCT02593097|592965091|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
164163779|NCT02593097|592965090|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
164163780|NCT02593097|592965091|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
164163781|NCT03759587|592965092|FG000|Overall Study|Adverse Event|5|||
164163782|NCT03759587|592965092|FG000|Overall Study|Progressive Disease|10|||
164163783|NCT03759587|592965092|FG000|Overall Study|Site Terminated by Sponsor|3|||
164163784|NCT03759587|592965092|FG000|Overall Study|Withdrawal by Subject|1|||
164163785|NCT00591565|592965095|FG000|Overall Study|lost follow up, withdrawn|5|||
164163786|NCT00454363|592965096|FG000|Overall Study|Adverse Event|1|||
164163787|NCT00454363|592965097|FG001|Overall Study|Adverse Event|2|||
164163788|NCT00454363|592965096|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
164163789|NCT00454363|592965097|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
164163790|NCT01554527|592965099|FG000|Overall Study|Withdrawal by Subject|1|||
164163791|NCT01554527|592965100|FG001|Overall Study|Withdrawal by Subject|0|||
164163792|NCT01554527|592965101|FG002|Overall Study|Withdrawal by Subject|3|||
164163793|NCT01554527|592965099|FG000|Overall Study|Lost to Follow-up|0|||
164163794|NCT01554527|592965100|FG001|Overall Study|Lost to Follow-up|0|||
164163795|NCT01554527|592965101|FG002|Overall Study|Lost to Follow-up|4|||
164163796|NCT01554527|592965099|FG000|Overall Study|Physician Decision|0|||
164163797|NCT01554527|592965100|FG001|Overall Study|Physician Decision|0|||
164163798|NCT01554527|592965101|FG002|Overall Study|Physician Decision|1|||
164163799|NCT01863667|592965108|FG000|Overall Study|Adverse Event|1|||
164163800|NCT01863667|592965109|FG001|Overall Study|Adverse Event|0|||
164163801|NCT01863667|592965108|FG000|Overall Study|Study terminated by Sponsor|30|||
164163802|NCT01863667|592965109|FG001|Overall Study|Study terminated by Sponsor|30|||
164163803|NCT01863667|592965108|FG000|Overall Study|Withdrawal by Subject|2|||
164163804|NCT01863667|592965109|FG001|Overall Study|Withdrawal by Subject|2|||
164163805|NCT01537042|592965112|FG000|Overall Study|Adverse Event|0|||
164163806|NCT01537042|592965113|FG001|Overall Study|Adverse Event|2|||
164163807|NCT01537042|592965112|FG000|Overall Study|Lack of Efficacy|0|||
164163808|NCT01537042|592965113|FG001|Overall Study|Lack of Efficacy|1|||
164163809|NCT01537042|592965112|FG000|Overall Study|Protocol Violation|0|||
164163810|NCT01537042|592965113|FG001|Overall Study|Protocol Violation|1|||
164163811|NCT01537042|592965112|FG000|Overall Study|Other|0|||
164163812|NCT01537042|592965113|FG001|Overall Study|Other|1|||
164163813|NCT00315458|592965116|FG000|Overall Study|Administrative|0|||
164163814|NCT00315458|592965117|FG001|Overall Study|Administrative|3|||
164163815|NCT00315458|592965118|FG002|Overall Study|Administrative|8|||
164163816|NCT00315458|592965119|FG003|Overall Study|Administrative|21|||
164163817|NCT00315458|592965116|FG000|Overall Study|Adverse Event|2|||
164163818|NCT00315458|592965117|FG001|Overall Study|Adverse Event|4|||
164163819|NCT00315458|592965118|FG002|Overall Study|Adverse Event|23|||
164163820|NCT00315458|592965119|FG003|Overall Study|Adverse Event|3|||
164163821|NCT00315458|592965116|FG000|Overall Study|Lost to Follow-up|1|||
164163822|NCT00315458|592965117|FG001|Overall Study|Lost to Follow-up|2|||
164163823|NCT00315458|592965118|FG002|Overall Study|Lost to Follow-up|0|||
164163824|NCT00315458|592965119|FG003|Overall Study|Lost to Follow-up|2|||
164163825|NCT00315458|592965116|FG000|Overall Study|Withdrawal by Subject|0|||
164163826|NCT00315458|592965117|FG001|Overall Study|Withdrawal by Subject|3|||
164163827|NCT00315458|592965118|FG002|Overall Study|Withdrawal by Subject|0|||
164163828|NCT00315458|592965119|FG003|Overall Study|Withdrawal by Subject|2|||
164163829|NCT00315458|592965116|FG000|Overall Study|Lack of Efficacy|0|||
164163830|NCT00315458|592965117|FG001|Overall Study|Lack of Efficacy|0|||
164163831|NCT00315458|592965118|FG002|Overall Study|Lack of Efficacy|20|||
164163832|NCT00315458|592965119|FG003|Overall Study|Lack of Efficacy|1|||
164163833|NCT00315458|592965116|FG000|Overall Study|Did not qualify|0|||
164163834|NCT00315458|592965117|FG001|Overall Study|Did not qualify|0|||
164163835|NCT00315458|592965118|FG002|Overall Study|Did not qualify|1|||
164163836|NCT00315458|592965119|FG003|Overall Study|Did not qualify|0|||
164163837|NCT00086619|592965122|FG000|Overall Study|Withdrawal by Subject|6|||
164163838|NCT00086619|592965123|FG001|Overall Study|Withdrawal by Subject|6|||
164163839|NCT00086619|592965122|FG000|Overall Study|Adverse Event|8|||
164163840|NCT00086619|592965123|FG001|Overall Study|Adverse Event|10|||
164163841|NCT00086619|592965122|FG000|Overall Study|Protocol Violation|1|||
164163842|NCT00086619|592965123|FG001|Overall Study|Protocol Violation|1|||
164163843|NCT00489918|592965124|FG000|Overall Study|Withdrawal by Subject|2|||
164163844|NCT00489918|592965125|FG001|Overall Study|Withdrawal by Subject|1|||
164163845|NCT00489918|592965126|FG002|Overall Study|Withdrawal by Subject|1|||
164163846|NCT00489918|592965127|FG003|Overall Study|Withdrawal by Subject|0|||
164163847|NCT00489918|592965128|FG004|Overall Study|Withdrawal by Subject|1|||
164163848|NCT00489918|592965124|FG000|Overall Study|Adverse Event|0|||
164163849|NCT00489918|592965125|FG001|Overall Study|Adverse Event|1|||
164163850|NCT00489918|592965126|FG002|Overall Study|Adverse Event|1|||
164163851|NCT00489918|592965127|FG003|Overall Study|Adverse Event|0|||
164163852|NCT00489918|592965128|FG004|Overall Study|Adverse Event|0|||
164163853|NCT00489918|592965124|FG000|Overall Study|Lost to Follow-up|0|||
164163854|NCT00489918|592965125|FG001|Overall Study|Lost to Follow-up|0|||
164163855|NCT00489918|592965126|FG002|Overall Study|Lost to Follow-up|1|||
164163856|NCT00489918|592965127|FG003|Overall Study|Lost to Follow-up|1|||
164163857|NCT00489918|592965128|FG004|Overall Study|Lost to Follow-up|0|||
164163858|NCT00489918|592965124|FG000|Overall Study|Physician Decision|0|||
164163859|NCT00489918|592965125|FG001|Overall Study|Physician Decision|0|||
164163860|NCT00489918|592965126|FG002|Overall Study|Physician Decision|1|||
164163861|NCT00489918|592965127|FG003|Overall Study|Physician Decision|0|||
164163862|NCT00489918|592965128|FG004|Overall Study|Physician Decision|0|||
164163863|NCT02748213|592965129|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
164163864|NCT02748213|592965130|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
164163865|NCT02748213|592965129|FG000|Overall Study|Abnormal Laboratory Test|1|||
164163866|NCT02748213|592965130|FG001|Overall Study|Abnormal Laboratory Test|0|||
164163867|NCT02748213|592965129|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
164163868|NCT02748213|592965130|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
164163869|NCT02748213|592965129|FG000|Overall Study|Death|5|||
164163870|NCT02748213|592965130|FG001|Overall Study|Death|3|||
164163871|NCT02748213|592965129|FG000|Overall Study|Insufficient Therapeutic Response|56|||
164163872|NCT02748213|592965130|FG001|Overall Study|Insufficient Therapeutic Response|57|||
164163873|NCT02748213|592965129|FG000|Overall Study|Violation of Selection Criteria|2|||
164163874|NCT02748213|592965130|FG001|Overall Study|Violation of Selection Criteria|0|||
164163875|NCT02748213|592965129|FG000|Overall Study|Protocol Violation|6|||
164163876|NCT02748213|592965130|FG001|Overall Study|Protocol Violation|4|||
164163877|NCT02748213|592965129|FG000|Overall Study|Refused Treatment*|6|||
164163878|NCT02748213|592965130|FG001|Overall Study|Refused Treatment*|6|||
164163879|NCT02748213|592965129|FG000|Overall Study|Failure to Return|1|||
164163880|NCT02748213|592965130|FG001|Overall Study|Failure to Return|0|||
164163881|NCT02748213|592965129|FG000|Overall Study|Other|30|||
164163882|NCT02748213|592965130|FG001|Overall Study|Other|29|||
164163883|NCT03232931|592966597|FG000|Overall Study|Physician Decision|1|||
164163884|NCT03232931|592966598|FG001|Overall Study|Physician Decision|1|||
164163885|NCT03232931|592966597|FG000|Overall Study|Withdrawal by Subject|6|||
164163886|NCT03232931|592966598|FG001|Overall Study|Withdrawal by Subject|0|||
164163887|NCT03232931|592966597|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
164163888|NCT03232931|592966598|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
164163889|NCT03232931|592966597|FG000|Overall Study|Parent did not record voice|1|||
164163890|NCT03232931|592966598|FG001|Overall Study|Parent did not record voice|2|||
164163891|NCT03232931|592966597|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
164163892|NCT03232931|592966598|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
164163893|NCT01270464|592966602|FG000|Overall Study|Protocol Violation|4|||
164163894|NCT01270464|592966603|FG001|Overall Study|Protocol Violation|3|||
164163895|NCT01270464|592966604|FG002|Overall Study|Protocol Violation|2|||
164163896|NCT01270464|592966602|FG000|Overall Study|Lack of Efficacy|2|||
164163897|NCT01270464|592966603|FG001|Overall Study|Lack of Efficacy|3|||
164163898|NCT01270464|592966604|FG002|Overall Study|Lack of Efficacy|1|||
164163899|NCT01270464|592966602|FG000|Overall Study|Adverse Event|9|||
164163900|NCT01270464|592966603|FG001|Overall Study|Adverse Event|1|||
164163901|NCT01270464|592966604|FG002|Overall Study|Adverse Event|7|||
164163902|NCT01270464|592966602|FG000|Overall Study|Withdrawal by Subject|2|||
164163903|NCT01270464|592966603|FG001|Overall Study|Withdrawal by Subject|1|||
164163904|NCT01270464|592966604|FG002|Overall Study|Withdrawal by Subject|4|||
164163905|NCT01270464|592966602|FG000|Overall Study|Lost to Follow-up|2|||
164163906|NCT01270464|592966603|FG001|Overall Study|Lost to Follow-up|3|||
164163907|NCT01270464|592966604|FG002|Overall Study|Lost to Follow-up|1|||
164163908|NCT01270464|592966602|FG000|Overall Study|Other|1|||
164163909|NCT01270464|592966603|FG001|Overall Study|Other|1|||
164163910|NCT01270464|592966604|FG002|Overall Study|Other|3|||
164163911|NCT01750697|592966606|FG000|Overall Study|Transferred Back to Local Hospital|1|||
164163912|NCT01750697|592966606|FG000|Overall Study|Physician and Family Decision|1|||
164163913|NCT01750697|592966606|FG000|Overall Study|Transferred to Adult Services|5|||
164163914|NCT01750697|592966606|FG000|Overall Study|Physician Decision|1|||
164163915|NCT01750697|592966606|FG000|Overall Study|Withdrawal by Subject|1|||
164163916|NCT00384839|592966620|FG000|Overall Study|Adverse Event|4|||
164163917|NCT00384839|592966620|FG000|Overall Study|Investigator Request|1|||
164163918|NCT00384839|592966620|FG000|Overall Study|Patient Request|1|||
164163919|NCT00384839|592966620|FG000|Overall Study|Ineligible|2|||
164163920|NCT02049814|592966623|FG000|Overall Study|Reason not Specified|4|||
164163921|NCT02049814|592966624|FG001|Overall Study|Reason not Specified|3|||
164163922|NCT02049814|592966623|FG000|Overall Study|Pregnancy|1|||
164163923|NCT02049814|592966624|FG001|Overall Study|Pregnancy|0|||
164163924|NCT02049814|592966623|FG000|Overall Study|Lost to Follow-up|2|||
164163925|NCT02049814|592966624|FG001|Overall Study|Lost to Follow-up|3|||
164163926|NCT02049814|592966623|FG000|Overall Study|Serious Protocol Violation|5|||
164163927|NCT02049814|592966624|FG001|Overall Study|Serious Protocol Violation|7|||
164163928|NCT02049814|592966623|FG000|Overall Study|Study Termination|0|||
164163929|NCT02049814|592966624|FG001|Overall Study|Study Termination|1|||
164163930|NCT02049814|592966623|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
164163931|NCT02049814|592966624|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
164163932|NCT02049814|592966623|FG000|Overall Study|Voluntary withdrawal|9|||
164163933|NCT02049814|592966624|FG001|Overall Study|Voluntary withdrawal|8|||
164163934|NCT02714595|592966627|FG000|Overall Study|Lost to Follow-up|1|||
164163935|NCT02714595|592966628|FG001|Overall Study|Lost to Follow-up|0|||
164163936|NCT02714595|592966627|FG000|Overall Study|Withdrawal by Subject|1|||
164163937|NCT02714595|592966628|FG001|Overall Study|Withdrawal by Subject|2|||
164163938|NCT02714595|592966627|FG000|Overall Study|Lack of Efficacy|0|||
164163939|NCT02714595|592966628|FG001|Overall Study|Lack of Efficacy|1|||
164163940|NCT02714595|592966627|FG000|Overall Study|Death|30|||
164163941|NCT02714595|592966628|FG001|Overall Study|Death|9|||
164163942|NCT02714595|592966627|FG000|Overall Study|Other-Miscellaneous|0|||
164163943|NCT02714595|592966628|FG001|Overall Study|Other-Miscellaneous|1|||
164163944|NCT00713258|592966629|FG000|Overall Study|Adverse Event|2|||
164163945|NCT00713258|592966630|FG001|Overall Study|Adverse Event|4|||
164163946|NCT00713258|592966629|FG000|Overall Study|Non-Compliance|2|||
164163947|NCT00713258|592966630|FG001|Overall Study|Non-Compliance|1|||
164163948|NCT00713258|592966629|FG000|Overall Study|Other|1|||
164163949|NCT00713258|592966630|FG001|Overall Study|Other|1|||
164163950|NCT01322490|592966631|FG000|Treatment Period|Adverse Event|12|||
164163951|NCT01322490|592966632|FG001|Treatment Period|Adverse Event|18|||
164163952|NCT01322490|592966633|FG002|Treatment Period|Adverse Event|15|||
164163953|NCT01322490|592966631|FG000|Treatment Period|Death|5|||
164163954|NCT01322490|592966632|FG001|Treatment Period|Death|7|||
164163955|NCT01322490|592966633|FG002|Treatment Period|Death|3|||
164163956|NCT01322490|592966631|FG000|Treatment Period|Lack of Efficacy|89|||
164163957|NCT01322490|592966632|FG001|Treatment Period|Lack of Efficacy|100|||
164163958|NCT01322490|592966633|FG002|Treatment Period|Lack of Efficacy|112|||
164163959|NCT01322490|592966631|FG000|Treatment Period|Physician Decision|0|||
164163960|NCT01322490|592966632|FG001|Treatment Period|Physician Decision|2|||
164163961|NCT01322490|592966633|FG002|Treatment Period|Physician Decision|1|||
164163962|NCT01322490|592966631|FG000|Treatment Period|Protocol Violation|7|||
164163963|NCT01322490|592966632|FG001|Treatment Period|Protocol Violation|5|||
164163964|NCT01322490|592966633|FG002|Treatment Period|Protocol Violation|4|||
164163965|NCT01322490|592966631|FG000|Treatment Period|Withdrawal by Subject|14|||
164163966|NCT01322490|592966632|FG001|Treatment Period|Withdrawal by Subject|16|||
164163967|NCT01322490|592966633|FG002|Treatment Period|Withdrawal by Subject|11|||
164163968|NCT01322490|592966631|FG000|Treatment Period|Non-compliance with study drug|0|||
164163969|NCT01322490|592966632|FG001|Treatment Period|Non-compliance with study drug|0|||
164163970|NCT01322490|592966633|FG002|Treatment Period|Non-compliance with study drug|1|||
164163971|NCT01322490|592966631|FG000|Treatment Period|Other per report|2|||
164163972|NCT01322490|592966632|FG001|Treatment Period|Other per report|2|||
164163973|NCT01322490|592966633|FG002|Treatment Period|Other per report|1|||
164163974|NCT01322490|592966631|FG000|Treatment Period|Randomized but Not Treated|3|||
164163975|NCT01322490|592966632|FG001|Treatment Period|Randomized but Not Treated|3|||
164163976|NCT01322490|592966633|FG002|Treatment Period|Randomized but Not Treated|5|||
164163977|NCT01322490|592966631|FG000|Long Term Follow-up Period|Death|235|||
164163978|NCT01322490|592966632|FG001|Long Term Follow-up Period|Death|239|||
164163979|NCT01322490|592966633|FG002|Long Term Follow-up Period|Death|236|||
164163980|NCT01322490|592966631|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
164163981|NCT01322490|592966632|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
164163982|NCT01322490|592966633|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
164163983|NCT01322490|592966631|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
164163984|NCT01322490|592966632|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
164163985|NCT01322490|592966633|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
164163986|NCT01322490|592966631|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
164163987|NCT01322490|592966632|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
164163988|NCT01322490|592966633|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
164163989|NCT01322490|592966631|FG000|Long Term Follow-up Period|Other per report|3|||
164163990|NCT01322490|592966632|FG001|Long Term Follow-up Period|Other per report|2|||
164163991|NCT01322490|592966633|FG002|Long Term Follow-up Period|Other per report|2|||
164163992|NCT01322490|592966631|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
164163993|NCT01322490|592966632|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
164163994|NCT01322490|592966633|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
164163995|NCT02257489|592966636|FG000|Overall Study|Withdrawal by Subject|0|||
164163996|NCT02257489|592966637|FG001|Overall Study|Withdrawal by Subject|0|||
164163997|NCT02257489|592966638|FG002|Overall Study|Withdrawal by Subject|0|||
164163998|NCT02257489|592966639|FG003|Overall Study|Withdrawal by Subject|1|||
164163999|NCT02257489|592966640|FG004|Overall Study|Withdrawal by Subject|0|||
164164000|NCT02257489|592966641|FG005|Overall Study|Withdrawal by Subject|0|||
164164001|NCT02257489|592966642|FG006|Overall Study|Withdrawal by Subject|0|||
164164002|NCT02257489|592966643|FG007|Overall Study|Withdrawal by Subject|0|||
164164003|NCT02257489|592966644|FG008|Overall Study|Withdrawal by Subject|0|||
164164004|NCT04606394|592966645|FG000|Overall Study|Withdrawal by Subject|3|||
164164005|NCT04606394|592966645|FG000|Overall Study|Exclusion criteria screen failure|12|||
164164006|NCT01431716|592966646|FG000|Overall Study|Withdrawal of consent|1|||
164164007|NCT02484456|592966649|FG000|Washout Period|Withdrawal by Subject|0|||
164164008|NCT02484456|592966650|FG001|Washout Period|Withdrawal by Subject|1|||
164164009|NCT02484456|592966649|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
164164010|NCT02484456|592966650|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
164164011|NCT02484456|592966649|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
164164012|NCT02484456|592966650|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
164164013|NCT02484456|592966649|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
164164014|NCT02484456|592966650|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
164164015|NCT00708214|592966651|FG000|Overall Study|Other Adverse Event|3|||
164164016|NCT00708214|592966652|FG001|Overall Study|Other Adverse Event|6|||
164164017|NCT00708214|592966653|FG002|Overall Study|Other Adverse Event|2|||
164164018|NCT00708214|592966651|FG000|Overall Study|Other|0|||
164164019|NCT00708214|592966652|FG001|Overall Study|Other|1|||
164164020|NCT00708214|592966653|FG002|Overall Study|Other|1|||
164164021|NCT00708214|592966651|FG000|Overall Study|Progressive Disease|4|||
164164022|NCT00708214|592966652|FG001|Overall Study|Progressive Disease|6|||
164164023|NCT00708214|592966653|FG002|Overall Study|Progressive Disease|5|||
164164024|NCT02199795|592966654|FG000|Overall Study|no longer met inclusion criteria|1|||
164164025|NCT02199795|592966655|FG001|Overall Study|no longer met inclusion criteria|0|||
164164026|NCT02199795|592966654|FG000|Overall Study|withdrew due to shoulder pain|1|||
164164027|NCT02199795|592966655|FG001|Overall Study|withdrew due to shoulder pain|0|||
164164028|NCT01908829|592966659|FG000|Overall Study|Adverse Event|13|||
164164029|NCT01908829|592966660|FG001|Overall Study|Adverse Event|11|||
164164030|NCT01908829|592966661|FG002|Overall Study|Adverse Event|13|||
164164031|NCT01908829|592966659|FG000|Overall Study|Lost to Follow-up|4|||
164164032|NCT01908829|592966660|FG001|Overall Study|Lost to Follow-up|2|||
164164033|NCT01908829|592966661|FG002|Overall Study|Lost to Follow-up|1|||
164164034|NCT01908829|592966659|FG000|Overall Study|Randomized no double-blind drug received|1|||
164164035|NCT01908829|592966660|FG001|Overall Study|Randomized no double-blind drug received|0|||
164164036|NCT01908829|592966661|FG002|Overall Study|Randomized no double-blind drug received|1|||
164164037|NCT01908829|592966659|FG000|Overall Study|Discontinued (no EoT page)|2|||
164164038|NCT01908829|592966660|FG001|Overall Study|Discontinued (no EoT page)|0|||
164164039|NCT01908829|592966661|FG002|Overall Study|Discontinued (no EoT page)|0|||
164164040|NCT01908829|592966659|FG000|Overall Study|Miscellaneous|0|||
164164041|NCT01908829|592966660|FG001|Overall Study|Miscellaneous|2|||
164164042|NCT01908829|592966661|FG002|Overall Study|Miscellaneous|0|||
164164043|NCT01908829|592966659|FG000|Overall Study|Protocol Violation|2|||
164164044|NCT01908829|592966660|FG001|Overall Study|Protocol Violation|2|||
164164045|NCT01908829|592966661|FG002|Overall Study|Protocol Violation|0|||
164164046|NCT01908829|592966659|FG000|Overall Study|Lack of Efficacy|1|||
164164047|NCT01908829|592966660|FG001|Overall Study|Lack of Efficacy|3|||
164164048|NCT01908829|592966661|FG002|Overall Study|Lack of Efficacy|2|||
164164049|NCT01908829|592966659|FG000|Overall Study|Withdrawal by Subject|26|||
164164050|NCT01908829|592966660|FG001|Overall Study|Withdrawal by Subject|29|||
164164051|NCT01908829|592966661|FG002|Overall Study|Withdrawal by Subject|22|||
164164052|NCT01339923|592966662|FG000|Overall Study|Adverse Event|1|||
164164053|NCT01339923|592966663|FG001|Overall Study|Adverse Event|1|||
164164054|NCT01339923|592966664|FG002|Overall Study|Adverse Event|1|||
164164055|NCT01339923|592966665|FG003|Overall Study|Adverse Event|0|||
164164056|NCT01339923|592966666|FG004|Overall Study|Adverse Event|0|||
164164057|NCT01339923|592966667|FG005|Overall Study|Adverse Event|0|||
164164058|NCT01339923|592966668|FG006|Overall Study|Adverse Event|1|||
164164059|NCT01339923|592966662|FG000|Overall Study|Inappropriate Enrollment|1|||
164164060|NCT01339923|592966663|FG001|Overall Study|Inappropriate Enrollment|0|||
164164061|NCT01339923|592966664|FG002|Overall Study|Inappropriate Enrollment|0|||
164164062|NCT01339923|592966665|FG003|Overall Study|Inappropriate Enrollment|0|||
164164063|NCT01339923|592966666|FG004|Overall Study|Inappropriate Enrollment|0|||
164164064|NCT01339923|592966667|FG005|Overall Study|Inappropriate Enrollment|1|||
164164065|NCT01339923|592966668|FG006|Overall Study|Inappropriate Enrollment|0|||
164164066|NCT01339923|592966662|FG000|Overall Study|Lost to Follow-up|4|||
164164067|NCT01339923|592966663|FG001|Overall Study|Lost to Follow-up|4|||
164164068|NCT01339923|592966664|FG002|Overall Study|Lost to Follow-up|0|||
164164069|NCT01339923|592966665|FG003|Overall Study|Lost to Follow-up|3|||
164164070|NCT01339923|592966666|FG004|Overall Study|Lost to Follow-up|1|||
164164071|NCT01339923|592966667|FG005|Overall Study|Lost to Follow-up|1|||
164164072|NCT01339923|592966668|FG006|Overall Study|Lost to Follow-up|5|||
164164073|NCT01339923|592966662|FG000|Overall Study|Protocol Violation|0|||
164164074|NCT01339923|592966663|FG001|Overall Study|Protocol Violation|0|||
164164075|NCT01339923|592966664|FG002|Overall Study|Protocol Violation|0|||
164164076|NCT01339923|592966665|FG003|Overall Study|Protocol Violation|0|||
164164077|NCT01339923|592966666|FG004|Overall Study|Protocol Violation|0|||
164164078|NCT01339923|592966667|FG005|Overall Study|Protocol Violation|3|||
164164079|NCT01339923|592966668|FG006|Overall Study|Protocol Violation|1|||
164164080|NCT01339923|592966662|FG000|Overall Study|Unable to Classify|1|||
164164081|NCT01339923|592966663|FG001|Overall Study|Unable to Classify|0|||
164164082|NCT01339923|592966664|FG002|Overall Study|Unable to Classify|1|||
164164083|NCT01339923|592966665|FG003|Overall Study|Unable to Classify|0|||
164164084|NCT01339923|592966666|FG004|Overall Study|Unable to Classify|0|||
164164085|NCT01339923|592966667|FG005|Overall Study|Unable to Classify|1|||
164164086|NCT01339923|592966668|FG006|Overall Study|Unable to Classify|5|||
164164087|NCT01339923|592966662|FG000|Overall Study|Withdrawal by Subject|7|||
164164088|NCT01339923|592966663|FG001|Overall Study|Withdrawal by Subject|11|||
164164089|NCT01339923|592966664|FG002|Overall Study|Withdrawal by Subject|6|||
164164090|NCT01339923|592966665|FG003|Overall Study|Withdrawal by Subject|1|||
164164091|NCT01339923|592966666|FG004|Overall Study|Withdrawal by Subject|4|||
164164092|NCT01339923|592966667|FG005|Overall Study|Withdrawal by Subject|3|||
164164093|NCT01339923|592966668|FG006|Overall Study|Withdrawal by Subject|2|||
164164094|NCT00828568|592966680|FG000|Randomized|Withdrawal by Subject|1|||
164164095|NCT00828568|592966681|FG001|Randomized|Withdrawal by Subject|0|||
164164096|NCT00828568|592966682|FG002|Randomized|Withdrawal by Subject|2|||
164164097|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
164164098|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
164164099|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
164164100|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
164164101|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
164164102|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
164164103|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
164164104|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
164164105|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
164164106|NCT00828568|592966680|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
164164107|NCT00828568|592966681|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
164164108|NCT00828568|592966682|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
164164109|NCT02091089|592966684|FG000|Overall Study|Lost to Follow-up|2|||
164164110|NCT00460811|592966685|FG000|Overall Study|Adverse Event|4|||
164164111|NCT00460811|592966686|FG001|Overall Study|Adverse Event|6|||
164164112|NCT00460811|592966687|FG002|Overall Study|Adverse Event|3|||
164164113|NCT00460811|592966688|FG003|Overall Study|Adverse Event|10|||
164164114|NCT00460811|592966689|FG004|Overall Study|Adverse Event|2|||
164164115|NCT00460811|592966685|FG000|Overall Study|Noncompliance|1|||
164164116|NCT00460811|592966686|FG001|Overall Study|Noncompliance|0|||
164164117|NCT00460811|592966687|FG002|Overall Study|Noncompliance|0|||
164164118|NCT00460811|592966688|FG003|Overall Study|Noncompliance|2|||
164164119|NCT00460811|592966689|FG004|Overall Study|Noncompliance|1|||
164164120|NCT00460811|592966685|FG000|Overall Study|Withdrawal by Subject|7|||
164164121|NCT00460811|592966686|FG001|Overall Study|Withdrawal by Subject|7|||
164164122|NCT00460811|592966687|FG002|Overall Study|Withdrawal by Subject|6|||
164164123|NCT00460811|592966688|FG003|Overall Study|Withdrawal by Subject|3|||
164164124|NCT00460811|592966689|FG004|Overall Study|Withdrawal by Subject|11|||
164164125|NCT00460811|592966685|FG000|Overall Study|Physician Decision|1|||
164164126|NCT00460811|592966686|FG001|Overall Study|Physician Decision|0|||
164164127|NCT00460811|592966687|FG002|Overall Study|Physician Decision|0|||
164164128|NCT00460811|592966688|FG003|Overall Study|Physician Decision|0|||
164164129|NCT00460811|592966689|FG004|Overall Study|Physician Decision|0|||
164164130|NCT00460811|592966685|FG000|Overall Study|Lost to Follow-up|3|||
164164131|NCT00460811|592966686|FG001|Overall Study|Lost to Follow-up|2|||
164164132|NCT00460811|592966687|FG002|Overall Study|Lost to Follow-up|5|||
164164133|NCT00460811|592966688|FG003|Overall Study|Lost to Follow-up|3|||
164164134|NCT00460811|592966689|FG004|Overall Study|Lost to Follow-up|6|||
164164135|NCT02821754|592966690|FG000|Overall Study|Procedure not required prior to amendment change|13|||
164164136|NCT02821754|592966691|FG001|Overall Study|Procedure not required prior to amendment change|11|||
164164137|NCT02821754|592966692|FG002|Overall Study|Procedure not required prior to amendment change|0|||
164164138|NCT02821754|592966690|FG000|Overall Study|Participant's Clinical status|2|||
164164139|NCT02821754|592966691|FG001|Overall Study|Participant's Clinical status|0|||
164164140|NCT02821754|592966692|FG002|Overall Study|Participant's Clinical status|0|||
164164141|NCT02821754|592966690|FG000|Overall Study|Participant removed for noncompliance|1|||
164164142|NCT02821754|592966691|FG001|Overall Study|Participant removed for noncompliance|0|||
164164143|NCT02821754|592966692|FG002|Overall Study|Participant removed for noncompliance|0|||
164164144|NCT02821754|592966690|FG000|Overall Study|Drug not available.|0|||
164164145|NCT02821754|592966691|FG001|Overall Study|Drug not available.|0|||
164164146|NCT02821754|592966692|FG002|Overall Study|Drug not available.|1|||
164164147|NCT02821754|592966690|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
164164148|NCT02821754|592966691|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
164164149|NCT02821754|592966692|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
164164150|NCT00364923|592966697|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
164164151|NCT00364923|592966697|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
164164152|NCT00766636|592966701|FG000|Overall Study|Withdrawal by Subject|1|||
164164153|NCT00766636|592966702|FG001|Overall Study|Withdrawal by Subject|1|||
164164154|NCT00766636|592966701|FG000|Overall Study|Incomplete Treatment|0|||
164164155|NCT00766636|592966702|FG001|Overall Study|Incomplete Treatment|1|||
164164156|NCT00766636|592966701|FG000|Overall Study|Adverse Event|1|||
164164157|NCT00766636|592966702|FG001|Overall Study|Adverse Event|0|||
164164158|NCT00766636|592966701|FG000|Overall Study|Disease Progression|1|||
164164159|NCT00766636|592966702|FG001|Overall Study|Disease Progression|0|||
164164160|NCT01355575|592966703|FG000|Overall Study|Withdrawal by Subject|2|||
164164161|NCT02477332|592966706|FG000|Overall Study|Adverse Event|0|||
164164162|NCT02477332|592966707|FG001|Overall Study|Adverse Event|1|||
164164163|NCT02477332|592966708|FG002|Overall Study|Adverse Event|1|||
164164164|NCT02477332|592966709|FG003|Overall Study|Adverse Event|2|||
164164165|NCT02477332|592966710|FG004|Overall Study|Adverse Event|1|||
164164166|NCT02477332|592966711|FG005|Overall Study|Adverse Event|2|||
164164167|NCT02477332|592966706|FG000|Overall Study|Lack of Efficacy|1|||
164164168|NCT02477332|592966707|FG001|Overall Study|Lack of Efficacy|2|||
164164169|NCT02477332|592966708|FG002|Overall Study|Lack of Efficacy|1|||
164164170|NCT02477332|592966709|FG003|Overall Study|Lack of Efficacy|2|||
164164171|NCT02477332|592966710|FG004|Overall Study|Lack of Efficacy|1|||
164164172|NCT02477332|592966711|FG005|Overall Study|Lack of Efficacy|1|||
164164173|NCT02477332|592966706|FG000|Overall Study|Non-compliance with study treatment|0|||
164164174|NCT02477332|592966707|FG001|Overall Study|Non-compliance with study treatment|1|||
164164175|NCT02477332|592966708|FG002|Overall Study|Non-compliance with study treatment|2|||
164164176|NCT02477332|592966709|FG003|Overall Study|Non-compliance with study treatment|0|||
164164177|NCT02477332|592966710|FG004|Overall Study|Non-compliance with study treatment|0|||
164164178|NCT02477332|592966711|FG005|Overall Study|Non-compliance with study treatment|0|||
164164179|NCT02477332|592966706|FG000|Overall Study|Pregnancy|0|||
164164180|NCT02477332|592966707|FG001|Overall Study|Pregnancy|0|||
164164181|NCT02477332|592966708|FG002|Overall Study|Pregnancy|0|||
164164182|NCT02477332|592966709|FG003|Overall Study|Pregnancy|1|||
164164183|NCT02477332|592966710|FG004|Overall Study|Pregnancy|0|||
164164184|NCT02477332|592966711|FG005|Overall Study|Pregnancy|0|||
164164185|NCT02477332|592966706|FG000|Overall Study|Protocol Violation|2|||
164164186|NCT02477332|592966707|FG001|Overall Study|Protocol Violation|0|||
164164187|NCT02477332|592966708|FG002|Overall Study|Protocol Violation|3|||
164164188|NCT02477332|592966709|FG003|Overall Study|Protocol Violation|3|||
164164189|NCT02477332|592966710|FG004|Overall Study|Protocol Violation|1|||
164164190|NCT02477332|592966711|FG005|Overall Study|Protocol Violation|1|||
164164191|NCT02477332|592966706|FG000|Overall Study|Technical problems|0|||
164164192|NCT02477332|592966707|FG001|Overall Study|Technical problems|0|||
164164193|NCT02477332|592966708|FG002|Overall Study|Technical problems|1|||
164164194|NCT02477332|592966709|FG003|Overall Study|Technical problems|0|||
164164195|NCT02477332|592966710|FG004|Overall Study|Technical problems|0|||
164164196|NCT02477332|592966711|FG005|Overall Study|Technical problems|0|||
164164197|NCT02477332|592966706|FG000|Overall Study|Lost to Follow-up|0|||
164164198|NCT02477332|592966707|FG001|Overall Study|Lost to Follow-up|0|||
164164199|NCT02477332|592966708|FG002|Overall Study|Lost to Follow-up|2|||
164164200|NCT02477332|592966709|FG003|Overall Study|Lost to Follow-up|0|||
164164201|NCT02477332|592966710|FG004|Overall Study|Lost to Follow-up|0|||
164164202|NCT02477332|592966711|FG005|Overall Study|Lost to Follow-up|0|||
164164203|NCT02477332|592966706|FG000|Overall Study|Physician Decision|0|||
164164204|NCT02477332|592966707|FG001|Overall Study|Physician Decision|0|||
164164205|NCT02477332|592966708|FG002|Overall Study|Physician Decision|1|||
164164206|NCT02477332|592966709|FG003|Overall Study|Physician Decision|3|||
164164207|NCT02477332|592966710|FG004|Overall Study|Physician Decision|0|||
164164208|NCT02477332|592966711|FG005|Overall Study|Physician Decision|1|||
164164209|NCT02477332|592966706|FG000|Overall Study|Withdrawal by Subject|0|||
164164210|NCT02477332|592966707|FG001|Overall Study|Withdrawal by Subject|3|||
164164211|NCT02477332|592966708|FG002|Overall Study|Withdrawal by Subject|1|||
164164212|NCT02477332|592966709|FG003|Overall Study|Withdrawal by Subject|2|||
164164213|NCT02477332|592966710|FG004|Overall Study|Withdrawal by Subject|1|||
164164214|NCT02477332|592966711|FG005|Overall Study|Withdrawal by Subject|0|||
164164215|NCT03627546|592966720|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
164164216|NCT03627546|592966721|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
164164217|NCT03627546|592966722|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
164164218|NCT03627546|592966720|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
164164219|NCT03627546|592966721|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
164164220|NCT03627546|592966722|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
164164221|NCT02837731|592966724|FG000|Allocation|Admitted to General Floor|3|||
164164222|NCT02837731|592966725|FG001|Allocation|Admitted to General Floor|4|||
164164223|NCT02837731|592966724|FG000|Allocation|Immediate surgery/withdrew|2|||
164164224|NCT02837731|592966725|FG001|Allocation|Immediate surgery/withdrew|0|||
164164225|NCT02837731|592966724|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
164164226|NCT02837731|592966725|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
164164227|NCT02837731|592966724|FG000|Allocation|Withdrawal by Subject|2|||
164164228|NCT02837731|592966725|FG001|Allocation|Withdrawal by Subject|0|||
164164229|NCT02837731|592966724|FG000|Allocation|Device not available|1|||
164164230|NCT02837731|592966725|FG001|Allocation|Device not available|0|||
164164231|NCT02837731|592966724|FG000|Allocation|Protocol not implemented|7|||
164164232|NCT02837731|592966725|FG001|Allocation|Protocol not implemented|0|||
164164233|NCT02837731|592966724|FG000|Allocation|Moribund/Do not resuscitate|2|||
164164234|NCT02837731|592966725|FG001|Allocation|Moribund/Do not resuscitate|0|||
164164235|NCT02837731|592966724|FG000|Allocation|Did not meet sepsis criteria|1|||
164164236|NCT02837731|592966725|FG001|Allocation|Did not meet sepsis criteria|2|||
164164237|NCT02837731|592966724|FG000|Allocation|Known aortic abnormalities|0|||
164164238|NCT02837731|592966725|FG001|Allocation|Known aortic abnormalities|1|||
164164239|NCT02965573|592966726|FG000|Overall Study|Lack of Efficacy|1|||
164164240|NCT02965573|592966727|FG001|Overall Study|Lack of Efficacy|0|||
164164241|NCT00523848|592966729|FG000|Overall Study|Adverse Event|11|||
164164242|NCT00523848|592966729|FG000|Overall Study|Withdrawal by Subject|2|||
164164243|NCT00523848|592966729|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
164164244|NCT00523848|592966729|FG000|Overall Study|Disease Progression|5|||
164164245|NCT00523848|592966729|FG000|Overall Study|Other, unspecified|4|||
164164246|NCT01209520|592966733|FG000|Overall Study|Withdrawal by Subject|3|||
164164247|NCT03291431|592966735|FG000|Overall Study|Protocol Violation|2|||
164164248|NCT03291431|592966736|FG001|Overall Study|Protocol Violation|1|||
164164249|NCT03291431|592966735|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
164164250|NCT03291431|592966736|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
164164251|NCT03291431|592966735|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
164164252|NCT03291431|592966736|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
164164253|NCT06868654|592966737|FG000|Overall Study|Death|4|||
164164254|NCT06868654|592966738|FG001|Overall Study|Death|14|||
164164255|NCT06868654|592966737|FG000|Overall Study|Lost to Follow-up|0|||
164164256|NCT06868654|592966738|FG001|Overall Study|Lost to Follow-up|1|||
164164257|NCT06868654|592966737|FG000|Overall Study|Withdrawal by Subject|5|||
164164258|NCT06868654|592966738|FG001|Overall Study|Withdrawal by Subject|3|||
164164259|NCT06868654|592966737|FG000|Overall Study|Physician Decision|0|||
164164260|NCT06868654|592966738|FG001|Overall Study|Physician Decision|1|||
164164261|NCT06868654|592966737|FG000|Overall Study|Ongoing|23|||
164164262|NCT06868654|592966738|FG001|Overall Study|Ongoing|21|||
164164263|NCT04925557|592968496|FG000|Overall Study|Study closed|5|||
164164264|NCT04925557|592968497|FG001|Overall Study|Study closed|3|||
164164265|NCT01736397|592968498|FG000|Overall Study|Lack of Efficacy|1|||
164164266|NCT01736397|592968499|FG001|Overall Study|Lack of Efficacy|11|||
164164267|NCT01736397|592968498|FG000|Overall Study|Withdrawal by Subject|6|||
164164268|NCT01736397|592968499|FG001|Overall Study|Withdrawal by Subject|5|||
164164269|NCT01736397|592968498|FG000|Overall Study|Lost to Follow-up|0|||
164164270|NCT01736397|592968499|FG001|Overall Study|Lost to Follow-up|1|||
164164271|NCT01736397|592968498|FG000|Overall Study|Adverse Event|6|||
164164272|NCT01736397|592968499|FG001|Overall Study|Adverse Event|3|||
164164273|NCT01736397|592968498|FG000|Overall Study|Not stated|1|||
164164274|NCT01736397|592968499|FG001|Overall Study|Not stated|4|||
164164275|NCT00076752|592968500|FG000|Overall Study|Death|2|||
164164276|NCT00076752|592968500|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
164164277|NCT01288937|592968501|FG000|Overall Study|Adverse Event|1|||
164164278|NCT01288937|592968502|FG001|Overall Study|Adverse Event|0|||
164164279|NCT02875613|592968506|FG000|Overall Study|Withdrawal by Subject|1|||
164164280|NCT02875613|592968506|FG000|Overall Study|Screen Failure|1|||
164164281|NCT00892151|592968507|FG000|Overall Study|Protocol Violation|1|||
164164282|NCT04075682|592968508|FG000|Overall Study|Lost to Follow-up|5|||
164164283|NCT04075682|592968509|FG001|Overall Study|Lost to Follow-up|5|||
164164284|NCT04075682|592968510|FG002|Overall Study|Lost to Follow-up|2|||
164164285|NCT04075682|592968511|FG003|Overall Study|Lost to Follow-up|2|||
164164286|NCT04075682|592968508|FG000|Overall Study|Withdrawal by Subject|1|||
164164287|NCT04075682|592968509|FG001|Overall Study|Withdrawal by Subject|0|||
164164288|NCT04075682|592968510|FG002|Overall Study|Withdrawal by Subject|1|||
164164289|NCT04075682|592968511|FG003|Overall Study|Withdrawal by Subject|0|||
164164290|NCT04075682|592968508|FG000|Overall Study|Protocol Violation|0|||
164164291|NCT04075682|592968509|FG001|Overall Study|Protocol Violation|1|||
164164292|NCT04075682|592968510|FG002|Overall Study|Protocol Violation|1|||
164164293|NCT04075682|592968511|FG003|Overall Study|Protocol Violation|0|||
164164294|NCT04075682|592968508|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
164164295|NCT04075682|592968509|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
164164296|NCT04075682|592968510|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
164164297|NCT04075682|592968511|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
164164298|NCT04075682|592968508|FG000|Overall Study|Lost study phone the first day of study participation|0|||
164164299|NCT04075682|592968509|FG001|Overall Study|Lost study phone the first day of study participation|1|||
164164300|NCT04075682|592968510|FG002|Overall Study|Lost study phone the first day of study participation|0|||
164164301|NCT04075682|592968511|FG003|Overall Study|Lost study phone the first day of study participation|0|||
164164302|NCT01222520|592968512|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
164164303|NCT01222520|592968513|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
164164304|NCT01222520|592968512|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
164164305|NCT01222520|592968513|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
164164306|NCT01222520|592968512|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
164164307|NCT01222520|592968513|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
164164308|NCT01222520|592968512|FG000|Double-blind Period|Adverse Event|0|||
164164309|NCT01222520|592968513|FG001|Double-blind Period|Adverse Event|1|||
164164310|NCT01222520|592968512|FG000|Double-blind Period|Lack of Efficacy|0|||
164164311|NCT01222520|592968513|FG001|Double-blind Period|Lack of Efficacy|1|||
164164312|NCT01222520|592968512|FG000|Double-blind Period|Study medication stolen|1|||
164164313|NCT01222520|592968513|FG001|Double-blind Period|Study medication stolen|0|||
164164314|NCT01896128|592968514|FG000|Overall Study|Withdrawal by Subject|3|||
164164315|NCT01896128|592968515|FG001|Overall Study|Withdrawal by Subject|3|||
164164316|NCT00954941|592968516|FG000|Overall Study|Received treatment at home|1|||
164164317|NCT00954941|592968517|FG001|Overall Study|Received treatment at home|0|||
164164318|NCT00954941|592968516|FG000|Overall Study|Withdrawal by Subject|1|||
164164319|NCT00954941|592968517|FG001|Overall Study|Withdrawal by Subject|0|||
164164320|NCT00954941|592968516|FG000|Overall Study|Insurance Denial|2|||
164164321|NCT00954941|592968517|FG001|Overall Study|Insurance Denial|2|||
164164322|NCT00954941|592968516|FG000|Overall Study|Physician Decision|2|||
164164323|NCT00954941|592968517|FG001|Overall Study|Physician Decision|2|||
164164324|NCT00954941|592968516|FG000|Overall Study|Ineligible|2|||
164164325|NCT00954941|592968517|FG001|Overall Study|Ineligible|2|||
164164326|NCT00954941|592968516|FG000|Overall Study|Adverse Event|0|||
164164327|NCT00954941|592968517|FG001|Overall Study|Adverse Event|1|||
164164328|NCT01996254|592968518|FG000|Overall Study|Change in Eligibility|0|||
164164329|NCT01996254|592968519|FG001|Overall Study|Change in Eligibility|2|||
164164330|NCT01996254|592968520|FG002|Overall Study|Change in Eligibility|0|||
164164331|NCT01996254|592968518|FG000|Overall Study|Withdrawal by Subject|0|||
164164332|NCT01996254|592968519|FG001|Overall Study|Withdrawal by Subject|3|||
164164333|NCT01996254|592968520|FG002|Overall Study|Withdrawal by Subject|4|||
164164334|NCT01996254|592968518|FG000|Overall Study|Lost to Follow-up|1|||
164164335|NCT01996254|592968519|FG001|Overall Study|Lost to Follow-up|0|||
164164336|NCT01996254|592968520|FG002|Overall Study|Lost to Follow-up|4|||
164164337|NCT03423173|592968521|FG000|Overall Study|Randomized but not vaccinated|1|||
164164338|NCT03423173|592968522|FG001|Overall Study|Randomized but not vaccinated|0|||
164164339|NCT03423173|592968523|FG002|Overall Study|Randomized but not vaccinated|2|||
164164340|NCT03423173|592968524|FG003|Overall Study|Randomized but not vaccinated|1|||
164164341|NCT03423173|592968521|FG000|Overall Study|Adverse Event|1|||
164164342|NCT03423173|592968522|FG001|Overall Study|Adverse Event|1|||
164164343|NCT03423173|592968523|FG002|Overall Study|Adverse Event|1|||
164164344|NCT03423173|592968524|FG003|Overall Study|Adverse Event|1|||
164164345|NCT03423173|592968521|FG000|Overall Study|Lost to Follow-up|10|||
164164346|NCT03423173|592968522|FG001|Overall Study|Lost to Follow-up|19|||
164164347|NCT03423173|592968523|FG002|Overall Study|Lost to Follow-up|17|||
164164348|NCT03423173|592968524|FG003|Overall Study|Lost to Follow-up|22|||
164164349|NCT03423173|592968521|FG000|Overall Study|Withdrawal of consent|4|||
164164350|NCT03423173|592968522|FG001|Overall Study|Withdrawal of consent|10|||
164164351|NCT03423173|592968523|FG002|Overall Study|Withdrawal of consent|4|||
164164352|NCT03423173|592968524|FG003|Overall Study|Withdrawal of consent|5|||
164164353|NCT03423173|592968521|FG000|Overall Study|Death|1|||
164164354|NCT03423173|592968522|FG001|Overall Study|Death|0|||
164164355|NCT03423173|592968523|FG002|Overall Study|Death|0|||
164164356|NCT03423173|592968524|FG003|Overall Study|Death|0|||
164164357|NCT03423173|592968521|FG000|Overall Study|Reason not Specified|2|||
164164358|NCT03423173|592968522|FG001|Overall Study|Reason not Specified|5|||
164164359|NCT03423173|592968523|FG002|Overall Study|Reason not Specified|3|||
164164360|NCT03423173|592968524|FG003|Overall Study|Reason not Specified|1|||
164164361|NCT02920008|592968525|FG000|Overall Study|Death|117|||
164164362|NCT02920008|592968526|FG001|Overall Study|Death|127|||
164164363|NCT02920008|592968525|FG000|Overall Study|Withdrawal by Subject|3|||
164164364|NCT02920008|592968526|FG001|Overall Study|Withdrawal by Subject|6|||
164164365|NCT02920008|592968525|FG000|Overall Study|Lost to Follow-up|0|||
164164366|NCT02920008|592968526|FG001|Overall Study|Lost to Follow-up|1|||
164164367|NCT02411396|592968528|FG000|Overall Study|Lost to Follow-up|31|||
164164368|NCT02411396|592968528|FG000|Overall Study|Death|10|||
164164369|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
164164370|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
164164371|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
164164372|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
164164373|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
164164374|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
164164375|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
164164376|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
164164377|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
164164378|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
164164379|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
164164380|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
164164381|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
164164382|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
164164383|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164384|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164385|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164386|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
164164387|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
164164388|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
164164389|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
164164390|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
164164391|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
164164392|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
164164393|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
164164394|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
164164395|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
164164396|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
164164397|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
164164398|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
164164399|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
164164400|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
164164401|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164402|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164403|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164404|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
164164405|NCT02016105|592968535|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
164164406|NCT02016105|592968536|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
164164407|NCT02016105|592968537|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164408|NCT02016105|592968538|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164409|NCT02016105|592968539|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164410|NCT02016105|592968540|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
164164411|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164412|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164413|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164414|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164415|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
164164416|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
164164417|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
164164418|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
164164419|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
164164420|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
164164421|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
164164422|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
164164423|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
164164424|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
164164425|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
164164426|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
164164427|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
164164428|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
164164429|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Death|0|||
164164430|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Death|0|||
164164431|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Death|0|||
164164432|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Death|0|||
164164433|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Death|0|||
164164434|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Death|1|||
164164435|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
164164436|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
164164437|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
164164438|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
164164439|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
164164440|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
164164441|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
164164442|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
164164443|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
164164444|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
164164445|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
164164446|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
164164447|NCT02016105|592968535|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164448|NCT02016105|592968536|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164449|NCT02016105|592968537|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
164164450|NCT02016105|592968538|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164451|NCT02016105|592968539|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
164164452|NCT02016105|592968540|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
164164453|NCT02016105|592968535|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
164164454|NCT02016105|592968536|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
164164455|NCT02016105|592968537|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
164164456|NCT02016105|592968538|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
164164457|NCT02016105|592968539|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
164164458|NCT02016105|592968540|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
164164459|NCT02016105|592968535|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
164164460|NCT02016105|592968536|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
164164461|NCT02016105|592968537|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
164164462|NCT02016105|592968538|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
164164463|NCT02016105|592968539|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
164164464|NCT02016105|592968540|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
164164465|NCT02016105|592968535|FG000|EXTENSION PERIOD|Adverse Event|0|||
164164466|NCT02016105|592968536|FG001|EXTENSION PERIOD|Adverse Event|0|||
164164467|NCT02016105|592968537|FG002|EXTENSION PERIOD|Adverse Event|2|||
164164468|NCT02016105|592968538|FG003|EXTENSION PERIOD|Adverse Event|0|||
164164469|NCT02016105|592968539|FG004|EXTENSION PERIOD|Adverse Event|1|||
164164470|NCT02016105|592968540|FG005|EXTENSION PERIOD|Adverse Event|0|||
164164471|NCT02016105|592968535|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
164164472|NCT02016105|592968536|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
164164473|NCT02016105|592968537|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164474|NCT02016105|592968538|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164475|NCT02016105|592968539|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164476|NCT02016105|592968540|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
164164477|NCT02016105|592968535|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164478|NCT02016105|592968536|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164479|NCT02016105|592968537|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164480|NCT02016105|592968538|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164481|NCT02016105|592968539|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
164164482|NCT02016105|592968540|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
164164483|NCT02016105|592968535|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
164164484|NCT02016105|592968536|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
164164485|NCT02016105|592968537|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
164164486|NCT02016105|592968538|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
164164487|NCT02016105|592968539|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
164164488|NCT02016105|592968540|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
164164489|NCT00090493|592968541|FG000|Overall Study|Physician Decision|2|||
164164490|NCT02071706|592968542|FG000|Overall Study|Adverse Event|1|||
164164491|NCT02071706|592968542|FG000|Overall Study|Withdrawal by Subject|2|||
164164492|NCT02865499|592968545|FG000|Baseline|Adverse Event|1|||
164164493|NCT02865499|592968545|FG000|Baseline|Withdrawal by Subject|1|||
164164494|NCT02247440|592968546|FG000|Overall Study|Withdrawal by Subject|1|||
164164495|NCT02247440|592968546|FG000|Overall Study|Lack of Efficacy|3|||
164164496|NCT02792192|592968547|FG000|Overall Study|Death|1|||
164164497|NCT02792192|592968548|FG001|Overall Study|Death|0|||
164164498|NCT02792192|592968549|FG002|Overall Study|Death|0|||
164164499|NCT02792192|592968550|FG003|Overall Study|Death|0|||
164164500|NCT02792192|592968547|FG000|Overall Study|Informed Consent Withdrawn|4|||
164164501|NCT02792192|592968548|FG001|Overall Study|Informed Consent Withdrawn|0|||
164164502|NCT02792192|592968549|FG002|Overall Study|Informed Consent Withdrawn|0|||
164164503|NCT02792192|592968550|FG003|Overall Study|Informed Consent Withdrawn|0|||
164164504|NCT02792192|592968547|FG000|Overall Study|Physician Decision|1|||
164164505|NCT02792192|592968548|FG001|Overall Study|Physician Decision|0|||
164164506|NCT02792192|592968549|FG002|Overall Study|Physician Decision|0|||
164164507|NCT02792192|592968550|FG003|Overall Study|Physician Decision|0|||
164164508|NCT02792192|592968547|FG000|Overall Study|Progressive Disease|0|||
164164509|NCT02792192|592968548|FG001|Overall Study|Progressive Disease|1|||
164164510|NCT02792192|592968549|FG002|Overall Study|Progressive Disease|0|||
164164511|NCT02792192|592968550|FG003|Overall Study|Progressive Disease|0|||
164164512|NCT02792192|592968547|FG000|Overall Study|Study Terminated By Sponsor|6|||
164164513|NCT02792192|592968548|FG001|Overall Study|Study Terminated By Sponsor|10|||
164164514|NCT02792192|592968549|FG002|Overall Study|Study Terminated By Sponsor|0|||
164164515|NCT02792192|592968550|FG003|Overall Study|Study Terminated By Sponsor|0|||
164164516|NCT02320058|592968551|FG000|Overall Study|Death|25|||
164164517|NCT02320058|592968552|FG001|Overall Study|Death|10|||
164164518|NCT02320058|592968551|FG000|Overall Study|Lost to Follow-up|4|||
164164519|NCT02320058|592968552|FG001|Overall Study|Lost to Follow-up|0|||
164164520|NCT02320058|592968551|FG000|Overall Study|Other reasons|4|||
164164521|NCT02320058|592968552|FG001|Overall Study|Other reasons|1|||
164164522|NCT02320058|592968551|FG000|Overall Study|Withdrawal by Subject|8|||
164164523|NCT02320058|592968552|FG001|Overall Study|Withdrawal by Subject|2|||
164164524|NCT02320058|592968551|FG000|Overall Study|Not reported|1|||
164164525|NCT02320058|592968552|FG001|Overall Study|Not reported|0|||
164164526|NCT00729157|592968553|FG000|Overall Study|Withdrawal by Subject|1|||
164164527|NCT00661609|592968554|FG000|Overall Study|Adverse Event|4|||
164164528|NCT00661609|592968554|FG000|Overall Study|Death|20|||
164164529|NCT00661609|592968554|FG000|Overall Study|Withdrawal by Subject|2|||
164164530|NCT00661609|592968554|FG000|Overall Study|PI Decision|1|||
164164531|NCT00661609|592968554|FG000|Overall Study|Survival follow up stage discontinued|11|||
164164532|NCT00661609|592968554|FG000|Overall Study|Disease progression|3|||
164164533|NCT03521115|592968556|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
164164534|NCT03521115|592968557|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
164164535|NCT03521115|592968556|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
164164536|NCT03521115|592968557|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
164164537|NCT01430403|592968560|FG000|Overall Study|Lost to Follow-up|5|||
164164538|NCT01430403|592968561|FG001|Overall Study|Lost to Follow-up|5|||
164164539|NCT01430403|592968562|FG002|Overall Study|Lost to Follow-up|3|||
164164540|NCT01430403|592968560|FG000|Overall Study|Physician Decision|1|||
164164541|NCT01430403|592968561|FG001|Overall Study|Physician Decision|0|||
164164542|NCT01430403|592968562|FG002|Overall Study|Physician Decision|0|||
164164543|NCT01430403|592968560|FG000|Overall Study|Protocol Violation|2|||
164164544|NCT01430403|592968561|FG001|Overall Study|Protocol Violation|3|||
164164545|NCT01430403|592968562|FG002|Overall Study|Protocol Violation|2|||
164164546|NCT01430403|592968560|FG000|Overall Study|Withdrawal by Subject|9|||
164164547|NCT01430403|592968561|FG001|Overall Study|Withdrawal by Subject|1|||
164164548|NCT01430403|592968562|FG002|Overall Study|Withdrawal by Subject|3|||
164164549|NCT02677922|592968565|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
164164550|NCT02677922|592968566|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
164164551|NCT02677922|592968567|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
164164552|NCT02677922|592968568|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
164164553|NCT02677922|592968569|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
164164554|NCT02677922|592968570|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
164164555|NCT02677922|592968565|FG000|Treatment Period|Adverse Event|0|||
164164556|NCT02677922|592968566|FG001|Treatment Period|Adverse Event|0|||
164164557|NCT02677922|592968567|FG002|Treatment Period|Adverse Event|1|||
164164558|NCT02677922|592968568|FG003|Treatment Period|Adverse Event|3|||
164164559|NCT02677922|592968569|FG004|Treatment Period|Adverse Event|5|||
164164560|NCT02677922|592968570|FG005|Treatment Period|Adverse Event|2|||
164164561|NCT02677922|592968565|FG000|Treatment Period|Progressive Disease|1|||
164164562|NCT02677922|592968566|FG001|Treatment Period|Progressive Disease|1|||
164164563|NCT02677922|592968567|FG002|Treatment Period|Progressive Disease|0|||
164164564|NCT02677922|592968568|FG003|Treatment Period|Progressive Disease|0|||
164164565|NCT02677922|592968569|FG004|Treatment Period|Progressive Disease|8|||
164164566|NCT02677922|592968570|FG005|Treatment Period|Progressive Disease|7|||
164164567|NCT02677922|592968565|FG000|Treatment Period|Lack of Efficacy|0|||
164164568|NCT02677922|592968566|FG001|Treatment Period|Lack of Efficacy|0|||
164164569|NCT02677922|592968567|FG002|Treatment Period|Lack of Efficacy|0|||
164164570|NCT02677922|592968568|FG003|Treatment Period|Lack of Efficacy|1|||
164164571|NCT02677922|592968569|FG004|Treatment Period|Lack of Efficacy|1|||
164164572|NCT02677922|592968570|FG005|Treatment Period|Lack of Efficacy|6|||
164164573|NCT02677922|592968565|FG000|Treatment Period|Withdrawal by Subject|0|||
164164574|NCT02677922|592968566|FG001|Treatment Period|Withdrawal by Subject|0|||
164164575|NCT02677922|592968567|FG002|Treatment Period|Withdrawal by Subject|1|||
164164576|NCT02677922|592968568|FG003|Treatment Period|Withdrawal by Subject|3|||
164164577|NCT02677922|592968569|FG004|Treatment Period|Withdrawal by Subject|5|||
164164578|NCT02677922|592968570|FG005|Treatment Period|Withdrawal by Subject|5|||
164164579|NCT02677922|592968565|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
164164580|NCT02677922|592968566|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
164164581|NCT02677922|592968567|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
164164582|NCT02677922|592968568|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
164164583|NCT02677922|592968569|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
164164584|NCT02677922|592968570|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
164164585|NCT02677922|592968565|FG000|Treatment Period|Disease Relapse|0|||
164164586|NCT02677922|592968566|FG001|Treatment Period|Disease Relapse|0|||
164164587|NCT02677922|592968567|FG002|Treatment Period|Disease Relapse|0|||
164164588|NCT02677922|592968568|FG003|Treatment Period|Disease Relapse|3|||
164164589|NCT02677922|592968569|FG004|Treatment Period|Disease Relapse|6|||
164164590|NCT02677922|592968570|FG005|Treatment Period|Disease Relapse|1|||
164164591|NCT02677922|592968565|FG000|Treatment Period|Allogeneic HSCT|1|||
164164592|NCT02677922|592968566|FG001|Treatment Period|Allogeneic HSCT|0|||
164164593|NCT02677922|592968567|FG002|Treatment Period|Allogeneic HSCT|0|||
164164594|NCT02677922|592968568|FG003|Treatment Period|Allogeneic HSCT|1|||
164164595|NCT02677922|592968569|FG004|Treatment Period|Allogeneic HSCT|4|||
164164596|NCT02677922|592968570|FG005|Treatment Period|Allogeneic HSCT|1|||
164164597|NCT02677922|592968565|FG000|Treatment Period|Other Reasons|0|||
164164598|NCT02677922|592968566|FG001|Treatment Period|Other Reasons|0|||
164164599|NCT02677922|592968567|FG002|Treatment Period|Other Reasons|0|||
164164600|NCT02677922|592968568|FG003|Treatment Period|Other Reasons|1|||
164164601|NCT02677922|592968569|FG004|Treatment Period|Other Reasons|3|||
164164602|NCT02677922|592968570|FG005|Treatment Period|Other Reasons|5|||
164164603|NCT02677922|592968565|FG000|Treatment Period|Death|0|||
164164604|NCT02677922|592968566|FG001|Treatment Period|Death|0|||
164164605|NCT02677922|592968567|FG002|Treatment Period|Death|0|||
164164606|NCT02677922|592968568|FG003|Treatment Period|Death|0|||
164164607|NCT02677922|592968569|FG004|Treatment Period|Death|12|||
164164608|NCT02677922|592968570|FG005|Treatment Period|Death|1|||
164164609|NCT02677922|592968565|FG000|Treatment Period|Non-compliance with Study Drug|0|||
164164610|NCT02677922|592968566|FG001|Treatment Period|Non-compliance with Study Drug|0|||
164164611|NCT02677922|592968567|FG002|Treatment Period|Non-compliance with Study Drug|0|||
164164612|NCT02677922|592968568|FG003|Treatment Period|Non-compliance with Study Drug|0|||
164164613|NCT02677922|592968569|FG004|Treatment Period|Non-compliance with Study Drug|1|||
164164614|NCT02677922|592968570|FG005|Treatment Period|Non-compliance with Study Drug|0|||
164164615|NCT02677922|592968565|FG000|Treatment Period|Physician Decision|0|||
164164616|NCT02677922|592968566|FG001|Treatment Period|Physician Decision|0|||
164164617|NCT02677922|592968567|FG002|Treatment Period|Physician Decision|0|||
164164618|NCT02677922|592968568|FG003|Treatment Period|Physician Decision|0|||
164164619|NCT02677922|592968569|FG004|Treatment Period|Physician Decision|0|||
164164620|NCT02677922|592968570|FG005|Treatment Period|Physician Decision|1|||
164164621|NCT02677922|592968565|FG000|Treatment Period|Symptomatic Deterioration|0|||
164164622|NCT02677922|592968566|FG001|Treatment Period|Symptomatic Deterioration|0|||
164164623|NCT02677922|592968567|FG002|Treatment Period|Symptomatic Deterioration|0|||
164164624|NCT02677922|592968568|FG003|Treatment Period|Symptomatic Deterioration|0|||
164164625|NCT02677922|592968569|FG004|Treatment Period|Symptomatic Deterioration|1|||
164164626|NCT02677922|592968570|FG005|Treatment Period|Symptomatic Deterioration|0|||
164164627|NCT00637000|592968575|FG000|Overall Study|Withdrawal by Subject|4|||
164164628|NCT00637000|592968576|FG001|Overall Study|Withdrawal by Subject|3|||
164164629|NCT00562302|592968579|FG000|Overall Study|Lost to Follow-up|3|||
164164630|NCT00562302|592968580|FG001|Overall Study|Lost to Follow-up|3|||
164164631|NCT00562302|592968579|FG000|Overall Study|Adverse Event|0|||
164164632|NCT00562302|592968580|FG001|Overall Study|Adverse Event|6|||
164164633|NCT00562302|592968579|FG000|Overall Study|Non-compliance|1|||
164164634|NCT00562302|592968580|FG001|Overall Study|Non-compliance|2|||
164164635|NCT00562302|592968579|FG000|Overall Study|Withdrawal by Subject|7|||
164164636|NCT00562302|592968580|FG001|Overall Study|Withdrawal by Subject|8|||
164164637|NCT00562302|592968579|FG000|Overall Study|Death|1|||
164164638|NCT00562302|592968580|FG001|Overall Study|Death|2|||
164164639|NCT00562302|592968579|FG000|Overall Study|Lung resection prior to study completion|7|||
164164640|NCT00562302|592968580|FG001|Overall Study|Lung resection prior to study completion|7|||
164164641|NCT00562302|592968579|FG000|Overall Study|Not stated|1|||
164164642|NCT00562302|592968580|FG001|Overall Study|Not stated|4|||
164164643|NCT03615144|592968581|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
164164644|NCT03615144|592968582|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
164164645|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
164164646|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
164164647|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
164164648|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
164164649|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164650|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164651|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164652|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164653|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164654|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164655|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
164164656|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
164164657|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164658|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
164164659|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
164164660|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164661|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164662|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164663|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164664|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164665|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164666|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
164164667|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
164164668|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
164164669|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
164164670|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
164164671|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164672|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164673|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164674|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164675|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164676|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164677|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
164164678|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
164164679|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
164164680|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
164164681|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
164164682|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164683|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164684|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164685|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164686|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164687|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164688|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
164164689|NCT04791319|592968583|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164690|NCT04791319|592968584|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164691|NCT04791319|592968585|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164692|NCT04791319|592968586|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
164164693|NCT04791319|592968587|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164694|NCT04791319|592968588|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164695|NCT04791319|592968589|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164696|NCT04791319|592968590|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164697|NCT04791319|592968591|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164698|NCT04791319|592968592|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164699|NCT04791319|592968593|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
164164700|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164701|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164702|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164703|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164704|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
164164705|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
164164706|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
164164707|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164708|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164709|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
164164710|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
164164711|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164712|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164713|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164714|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164715|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164716|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164717|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164718|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164719|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164720|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
164164721|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
164164790|NCT00014495|592968631|FG000|Overall Study|Death|0|||
164164722|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164723|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164724|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164725|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164726|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
164164727|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
164164728|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
164164729|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
164164730|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
164164731|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
164164732|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
164164733|NCT04791319|592968583|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164734|NCT04791319|592968584|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164735|NCT04791319|592968585|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164736|NCT04791319|592968586|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
164164737|NCT04791319|592968587|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
164164738|NCT04791319|592968588|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
164164739|NCT04791319|592968589|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
164164740|NCT04791319|592968590|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
164164741|NCT04791319|592968591|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
164164742|NCT04791319|592968592|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
164164743|NCT04791319|592968593|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
164164744|NCT01860040|592968596|FG000|Overall Study|Withdrawal by Subject|1|||
164164745|NCT01860040|592968597|FG001|Overall Study|Withdrawal by Subject|0|||
164164746|NCT01931995|592968598|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
164164747|NCT01931995|592968599|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
164164748|NCT01931995|592968598|FG000|First Intervention (1 Day)|Physician Decision|1|||
164164749|NCT01931995|592968599|FG001|First Intervention (1 Day)|Physician Decision|1|||
164164750|NCT01931995|592968598|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
164164751|NCT01931995|592968599|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
164164752|NCT00791661|592968600|FG000|7 Day Wash-out|Adverse Event|0|||
164164753|NCT00791661|592968601|FG001|7 Day Wash-out|Adverse Event|0|||
164164754|NCT00791661|592968602|FG002|7 Day Wash-out|Adverse Event|1|||
164164755|NCT00791661|592968600|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
164164756|NCT00791661|592968601|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
164164757|NCT00791661|592968602|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
164164758|NCT00679289|592968621|FG000|Overall Study|Progressive disease|4|||
164164759|NCT00679289|592968622|FG001|Overall Study|Progressive disease|5|||
164164760|NCT00679289|592968623|FG002|Overall Study|Progressive disease|18|||
164164761|NCT00679289|592968621|FG000|Overall Study|Withdrawal by Subject|0|||
164164762|NCT00679289|592968622|FG001|Overall Study|Withdrawal by Subject|1|||
164164763|NCT00679289|592968623|FG002|Overall Study|Withdrawal by Subject|1|||
164164764|NCT00679289|592968621|FG000|Overall Study|Adverse Event|0|||
164164765|NCT00679289|592968622|FG001|Overall Study|Adverse Event|0|||
164164766|NCT00679289|592968623|FG002|Overall Study|Adverse Event|3|||
164164767|NCT00679289|592968621|FG000|Overall Study|Physician Decision|1|||
164164768|NCT00679289|592968622|FG001|Overall Study|Physician Decision|0|||
164164769|NCT00679289|592968623|FG002|Overall Study|Physician Decision|1|||
164164770|NCT00937040|592968624|FG000|Overall Study|Adverse Event|5|||
164164771|NCT00937040|592968625|FG001|Overall Study|Adverse Event|8|||
164164772|NCT00937040|592968624|FG000|Overall Study|Lost to Follow-up|12|||
164164773|NCT00937040|592968625|FG001|Overall Study|Lost to Follow-up|12|||
164164774|NCT00937040|592968624|FG000|Overall Study|Protocol Violation|3|||
164164775|NCT00937040|592968625|FG001|Overall Study|Protocol Violation|0|||
164164776|NCT00937040|592968624|FG000|Overall Study|Withdrawal by Subject|13|||
164164777|NCT00937040|592968625|FG001|Overall Study|Withdrawal by Subject|7|||
164164778|NCT00937040|592968624|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
164164779|NCT00937040|592968625|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
164164780|NCT00937040|592968624|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
164164781|NCT00937040|592968625|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
164164782|NCT00183885|592968628|FG000|Overall Study|Adverse Event|11|||
164164783|NCT00183885|592968628|FG000|Overall Study|Death|1|||
164164784|NCT00183885|592968628|FG000|Overall Study|Lost to Follow-up|3|||
164164785|NCT00183885|592968628|FG000|Overall Study|Physician Decision|6|||
164164786|NCT00183885|592968628|FG000|Overall Study|Withdrawal by Subject|5|||
164164787|NCT00183885|592968628|FG000|Overall Study|Switched to alternative treatment|8|||
164164788|NCT00183885|592968628|FG000|Overall Study|Treatment delayed too long|4|||
164164789|NCT00183885|592968628|FG000|Overall Study|Developed second malignancy|1|||
164164791|NCT00014495|592968632|FG001|Overall Study|Death|0|||
164164792|NCT00014495|592968633|FG002|Overall Study|Death|1|||
164164793|NCT00014495|592968634|FG003|Overall Study|Death|0|||
164164794|NCT00014495|592968631|FG000|Overall Study|Clinical deterioration|0|||
164164795|NCT00014495|592968632|FG001|Overall Study|Clinical deterioration|0|||
164164796|NCT00014495|592968633|FG002|Overall Study|Clinical deterioration|0|||
164164797|NCT00014495|592968634|FG003|Overall Study|Clinical deterioration|1|||
164164798|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
164164799|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
164164800|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
164164801|NCT00403481|592968635|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
164164802|NCT00403481|592968635|FG000|Olm 40 mg|Adverse Event|2|||
164164803|NCT00403481|592968635|FG000|Olm 40 mg|Protocol Violation|1|||
164164804|NCT00403481|592968635|FG000|Olm 40 mg|Withdrawal by Subject|1|||
164164805|NCT00403481|592968635|FG000|Olm 40 mg|Other|1|||
164164806|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
164164807|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
164164808|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
164164809|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
164164810|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
164164811|NCT00403481|592968635|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
164164812|NCT02929589|592968637|FG000|Overall Study|Withdrawal by Subject|1|||
164164813|NCT02929589|592968638|FG001|Overall Study|Withdrawal by Subject|0|||
164164814|NCT02929589|592968639|FG002|Overall Study|Withdrawal by Subject|0|||
164164815|NCT02929589|592968640|FG003|Overall Study|Withdrawal by Subject|0|||
164164816|NCT02929589|592968637|FG000|Overall Study|Physician Decision|2|||
164164817|NCT02929589|592968638|FG001|Overall Study|Physician Decision|0|||
164164818|NCT02929589|592968639|FG002|Overall Study|Physician Decision|0|||
164164819|NCT02929589|592968640|FG003|Overall Study|Physician Decision|0|||
164164820|NCT00520533|592968647|FG000|Overall Study|Death|1|||
164164821|NCT00520533|592968647|FG000|Overall Study|Suspension of the study for safety reasons|1|||
164164822|NCT00520533|592968647|FG000|Overall Study|Withdrawal by Subject|1|||
164164823|NCT00520533|592968647|FG000|Overall Study|Physician Decision|1|||
164164824|NCT00697463|592968659|FG000|Overall Study|Withdrawal by Subject|1|||
164164825|NCT02568189|592968660|FG000|Overall Study|Protocol Violation|0|||
164164826|NCT02568189|592968661|FG001|Overall Study|Protocol Violation|0|||
164164827|NCT02568189|592968662|FG002|Overall Study|Protocol Violation|19|||
164164828|NCT02568189|592968663|FG003|Overall Study|Protocol Violation|18|||
164164829|NCT00603473|592968666|FG000|Overall Study|Adverse Event|4|||
164164830|NCT00603473|592968666|FG000|Overall Study|Lack of Efficacy|4|||
164164831|NCT00603473|592968666|FG000|Overall Study|Protocol Violation|1|||
164164832|NCT03850483|592968670|FG000|Treatment for Stage 1|Adverse Event|1|||
164164833|NCT03850483|592968671|FG001|Treatment for Stage 1|Adverse Event|1|||
164164834|NCT03850483|592968672|FG002|Treatment for Stage 1|Adverse Event|3|||
164164835|NCT03850483|592968673|FG003|Treatment for Stage 1|Adverse Event|0|||
164164836|NCT03850483|592968674|FG004|Treatment for Stage 1|Adverse Event|2|||
164164837|NCT03850483|592968675|FG005|Treatment for Stage 1|Adverse Event|0|||
164164838|NCT03850483|592968676|FG006|Treatment for Stage 1|Adverse Event|2|||
164164839|NCT03850483|592968677|FG007|Treatment for Stage 1|Adverse Event|2|||
164164840|NCT03850483|592968678|FG008|Treatment for Stage 1|Adverse Event|0|||
164164841|NCT03850483|592968679|FG009|Treatment for Stage 1|Adverse Event|0|||
164164842|NCT03850483|592968670|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
164164843|NCT03850483|592968671|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
164164844|NCT03850483|592968672|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
164164845|NCT03850483|592968673|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
164164846|NCT03850483|592968674|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
164164847|NCT03850483|592968675|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
164164848|NCT03850483|592968676|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
164164849|NCT03850483|592968677|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
164164850|NCT03850483|592968678|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
164164851|NCT03850483|592968679|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
164164852|NCT03850483|592968670|FG000|Treatment for Stage 1|Protocol Violation|1|||
164164853|NCT03850483|592968671|FG001|Treatment for Stage 1|Protocol Violation|0|||
164164854|NCT03850483|592968672|FG002|Treatment for Stage 1|Protocol Violation|0|||
164164855|NCT03850483|592968673|FG003|Treatment for Stage 1|Protocol Violation|0|||
164164856|NCT03850483|592968674|FG004|Treatment for Stage 1|Protocol Violation|0|||
164164857|NCT03850483|592968675|FG005|Treatment for Stage 1|Protocol Violation|0|||
164164858|NCT03850483|592968676|FG006|Treatment for Stage 1|Protocol Violation|1|||
164164859|NCT03850483|592968677|FG007|Treatment for Stage 1|Protocol Violation|0|||
164164860|NCT03850483|592968678|FG008|Treatment for Stage 1|Protocol Violation|0|||
164164861|NCT03850483|592968679|FG009|Treatment for Stage 1|Protocol Violation|0|||
164164862|NCT03850483|592968670|FG000|Treatment for Stage 1|Physician Decision|0|||
164164863|NCT03850483|592968671|FG001|Treatment for Stage 1|Physician Decision|0|||
164164864|NCT03850483|592968672|FG002|Treatment for Stage 1|Physician Decision|0|||
164164865|NCT03850483|592968673|FG003|Treatment for Stage 1|Physician Decision|0|||
164164866|NCT03850483|592968674|FG004|Treatment for Stage 1|Physician Decision|0|||
164164867|NCT03850483|592968675|FG005|Treatment for Stage 1|Physician Decision|1|||
164164868|NCT03850483|592968676|FG006|Treatment for Stage 1|Physician Decision|0|||
164164869|NCT03850483|592968677|FG007|Treatment for Stage 1|Physician Decision|0|||
164164870|NCT03850483|592968678|FG008|Treatment for Stage 1|Physician Decision|0|||
164164871|NCT03850483|592968679|FG009|Treatment for Stage 1|Physician Decision|0|||
164164872|NCT03850483|592968670|FG000|Treatment for Stage 1|Other|0|||
164164873|NCT03850483|592968671|FG001|Treatment for Stage 1|Other|0|||
164164874|NCT03850483|592968672|FG002|Treatment for Stage 1|Other|0|||
164164875|NCT03850483|592968673|FG003|Treatment for Stage 1|Other|0|||
164164876|NCT03850483|592968674|FG004|Treatment for Stage 1|Other|2|||
164164877|NCT03850483|592968675|FG005|Treatment for Stage 1|Other|1|||
164164878|NCT03850483|592968676|FG006|Treatment for Stage 1|Other|0|||
164164879|NCT03850483|592968677|FG007|Treatment for Stage 1|Other|0|||
164164880|NCT03850483|592968678|FG008|Treatment for Stage 1|Other|0|||
164164881|NCT03850483|592968679|FG009|Treatment for Stage 1|Other|0|||
164164882|NCT03850483|592968670|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164883|NCT03850483|592968671|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164884|NCT03850483|592968672|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
164164885|NCT03850483|592968673|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164886|NCT03850483|592968674|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164887|NCT03850483|592968675|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164888|NCT03850483|592968676|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164889|NCT03850483|592968677|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164890|NCT03850483|592968678|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164891|NCT03850483|592968679|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
164164892|NCT03850483|592968670|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164893|NCT03850483|592968671|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164894|NCT03850483|592968672|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164895|NCT03850483|592968673|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164896|NCT03850483|592968674|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164897|NCT03850483|592968675|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
164164898|NCT03850483|592968676|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164899|NCT03850483|592968677|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164900|NCT03850483|592968678|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164901|NCT03850483|592968679|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
164164902|NCT03850483|592968670|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
164164903|NCT03850483|592968671|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
164164904|NCT03850483|592968672|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
164164905|NCT03850483|592968673|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
164164906|NCT03850483|592968674|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
164164907|NCT03850483|592968675|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
164164908|NCT03850483|592968676|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
164164909|NCT03850483|592968677|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
164164910|NCT03850483|592968678|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
164164911|NCT03850483|592968679|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
164164912|NCT03850483|592968670|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
164164913|NCT03850483|592968671|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
164164914|NCT03850483|592968672|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
164164915|NCT03850483|592968673|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
164164916|NCT03850483|592968674|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
164164917|NCT03850483|592968675|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
164164918|NCT03850483|592968676|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
164164919|NCT03850483|592968677|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
164164920|NCT03850483|592968678|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
164164921|NCT03850483|592968679|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
164164922|NCT03850483|592968670|FG000|Treatment for Stage 1|Death|0|||
164164923|NCT03850483|592968671|FG001|Treatment for Stage 1|Death|0|||
164164924|NCT03850483|592968672|FG002|Treatment for Stage 1|Death|0|||
164164925|NCT03850483|592968673|FG003|Treatment for Stage 1|Death|0|||
164164926|NCT03850483|592968674|FG004|Treatment for Stage 1|Death|0|||
164164927|NCT03850483|592968675|FG005|Treatment for Stage 1|Death|1|||
164164928|NCT03850483|592968676|FG006|Treatment for Stage 1|Death|0|||
164164929|NCT03850483|592968677|FG007|Treatment for Stage 1|Death|0|||
164164930|NCT03850483|592968678|FG008|Treatment for Stage 1|Death|0|||
164164931|NCT03850483|592968679|FG009|Treatment for Stage 1|Death|0|||
164164932|NCT03850483|592968670|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
164164933|NCT03850483|592968671|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
164164934|NCT03850483|592968672|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
164164935|NCT03850483|592968673|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
164164936|NCT03850483|592968674|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
164164937|NCT03850483|592968675|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
164164938|NCT03850483|592968676|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
164164939|NCT03850483|592968677|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
164164940|NCT03850483|592968678|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
164164941|NCT03850483|592968679|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
164164942|NCT03850483|592968670|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
164164943|NCT03850483|592968671|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
164164944|NCT03850483|592968672|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
164164945|NCT03850483|592968673|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
164164946|NCT03850483|592968674|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
164164947|NCT03850483|592968675|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
164164948|NCT03850483|592968676|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
164164949|NCT03850483|592968677|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
164164950|NCT03850483|592968678|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
164164951|NCT03850483|592968679|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
164164952|NCT03850483|592968670|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164953|NCT03850483|592968671|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164954|NCT03850483|592968672|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164955|NCT03850483|592968673|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164956|NCT03850483|592968674|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164957|NCT03850483|592968675|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164958|NCT03850483|592968676|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
164164959|NCT03850483|592968677|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
164164960|NCT03850483|592968678|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164961|NCT03850483|592968679|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
164164962|NCT03850483|592968670|FG000|Follow-up for Stage 1|Physician Decision|0|||
164164963|NCT03850483|592968671|FG001|Follow-up for Stage 1|Physician Decision|0|||
164164964|NCT03850483|592968672|FG002|Follow-up for Stage 1|Physician Decision|0|||
164164965|NCT03850483|592968673|FG003|Follow-up for Stage 1|Physician Decision|0|||
164164966|NCT03850483|592968674|FG004|Follow-up for Stage 1|Physician Decision|1|||
164164967|NCT03850483|592968675|FG005|Follow-up for Stage 1|Physician Decision|0|||
164164968|NCT03850483|592968676|FG006|Follow-up for Stage 1|Physician Decision|1|||
164164969|NCT03850483|592968677|FG007|Follow-up for Stage 1|Physician Decision|0|||
164164970|NCT03850483|592968678|FG008|Follow-up for Stage 1|Physician Decision|0|||
164164971|NCT03850483|592968679|FG009|Follow-up for Stage 1|Physician Decision|0|||
164164972|NCT03850483|592968670|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
164164973|NCT03850483|592968671|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
164164974|NCT03850483|592968672|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
164164975|NCT03850483|592968673|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
164164976|NCT03850483|592968674|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
164164977|NCT03850483|592968675|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
164164978|NCT03850483|592968676|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
164164979|NCT03850483|592968677|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
164164980|NCT03850483|592968678|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
164164981|NCT03850483|592968679|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
164164982|NCT03850483|592968670|FG000|Follow-up for Stage 1|Adverse Event|0|||
164164983|NCT03850483|592968671|FG001|Follow-up for Stage 1|Adverse Event|0|||
164164984|NCT03850483|592968672|FG002|Follow-up for Stage 1|Adverse Event|1|||
164164985|NCT03850483|592968673|FG003|Follow-up for Stage 1|Adverse Event|0|||
164164986|NCT03850483|592968674|FG004|Follow-up for Stage 1|Adverse Event|0|||
164164987|NCT03850483|592968675|FG005|Follow-up for Stage 1|Adverse Event|1|||
164164988|NCT03850483|592968676|FG006|Follow-up for Stage 1|Adverse Event|0|||
164164989|NCT03850483|592968677|FG007|Follow-up for Stage 1|Adverse Event|0|||
164164990|NCT03850483|592968678|FG008|Follow-up for Stage 1|Adverse Event|0|||
164164991|NCT03850483|592968679|FG009|Follow-up for Stage 1|Adverse Event|0|||
164164992|NCT03850483|592968670|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164993|NCT03850483|592968671|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
164164994|NCT03850483|592968672|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164995|NCT03850483|592968673|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164996|NCT03850483|592968674|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
164164997|NCT03850483|592968675|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
164164998|NCT03850483|592968676|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164164999|NCT03850483|592968677|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164165000|NCT03850483|592968678|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164165001|NCT03850483|592968679|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
164165002|NCT03850483|592968670|FG000|Follow-up for Stage 1|Other|0|||
164165003|NCT03850483|592968671|FG001|Follow-up for Stage 1|Other|2|||
164165004|NCT03850483|592968672|FG002|Follow-up for Stage 1|Other|0|||
164165005|NCT03850483|592968673|FG003|Follow-up for Stage 1|Other|2|||
164165006|NCT03850483|592968674|FG004|Follow-up for Stage 1|Other|0|||
164165007|NCT03850483|592968675|FG005|Follow-up for Stage 1|Other|1|||
164165008|NCT03850483|592968676|FG006|Follow-up for Stage 1|Other|0|||
164165009|NCT03850483|592968677|FG007|Follow-up for Stage 1|Other|0|||
164165010|NCT03850483|592968678|FG008|Follow-up for Stage 1|Other|0|||
164165011|NCT03850483|592968679|FG009|Follow-up for Stage 1|Other|0|||
164165012|NCT03850483|592968670|FG000|Treatment for Stage 2|Adverse Event|0|||
164165013|NCT03850483|592968671|FG001|Treatment for Stage 2|Adverse Event|0|||
164165014|NCT03850483|592968672|FG002|Treatment for Stage 2|Adverse Event|0|||
164165015|NCT03850483|592968673|FG003|Treatment for Stage 2|Adverse Event|0|||
164165016|NCT03850483|592968674|FG004|Treatment for Stage 2|Adverse Event|0|||
164165017|NCT03850483|592968675|FG005|Treatment for Stage 2|Adverse Event|0|||
164165018|NCT03850483|592968676|FG006|Treatment for Stage 2|Adverse Event|0|||
164165019|NCT03850483|592968677|FG007|Treatment for Stage 2|Adverse Event|0|||
164165020|NCT03850483|592968678|FG008|Treatment for Stage 2|Adverse Event|0|||
164165021|NCT03850483|592968679|FG009|Treatment for Stage 2|Adverse Event|1|||
164165022|NCT03850483|592968670|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
164165023|NCT03850483|592968671|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
164165024|NCT03850483|592968672|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
164165025|NCT03850483|592968673|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
164165026|NCT03850483|592968674|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
164165027|NCT03850483|592968675|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
164165028|NCT03850483|592968676|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
164165029|NCT03850483|592968677|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
164165030|NCT03850483|592968678|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
164165031|NCT03850483|592968679|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
164165032|NCT03850483|592968670|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
164165033|NCT03850483|592968671|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
164165034|NCT03850483|592968672|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
164165035|NCT03850483|592968673|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
164165036|NCT03850483|592968674|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
164165037|NCT03850483|592968675|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
164165038|NCT03850483|592968676|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
164165039|NCT03850483|592968677|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
164165040|NCT03850483|592968678|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
164165041|NCT03850483|592968679|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
164165042|NCT03850483|592968670|FG000|Treatment for Stage 2|Physician Decision|0|||
164165043|NCT03850483|592968671|FG001|Treatment for Stage 2|Physician Decision|0|||
164165044|NCT03850483|592968672|FG002|Treatment for Stage 2|Physician Decision|0|||
164165045|NCT03850483|592968673|FG003|Treatment for Stage 2|Physician Decision|0|||
164165046|NCT03850483|592968674|FG004|Treatment for Stage 2|Physician Decision|0|||
164165047|NCT03850483|592968675|FG005|Treatment for Stage 2|Physician Decision|0|||
164165048|NCT03850483|592968676|FG006|Treatment for Stage 2|Physician Decision|0|||
164165049|NCT03850483|592968677|FG007|Treatment for Stage 2|Physician Decision|0|||
164165050|NCT03850483|592968678|FG008|Treatment for Stage 2|Physician Decision|0|||
164165051|NCT03850483|592968679|FG009|Treatment for Stage 2|Physician Decision|1|||
164165052|NCT03850483|592968670|FG000|Treatment for Stage 2|Protocol Violation|0|||
164165053|NCT03850483|592968671|FG001|Treatment for Stage 2|Protocol Violation|0|||
164165054|NCT03850483|592968672|FG002|Treatment for Stage 2|Protocol Violation|0|||
164165055|NCT03850483|592968673|FG003|Treatment for Stage 2|Protocol Violation|0|||
164165056|NCT03850483|592968674|FG004|Treatment for Stage 2|Protocol Violation|0|||
164165057|NCT03850483|592968675|FG005|Treatment for Stage 2|Protocol Violation|0|||
164165058|NCT03850483|592968676|FG006|Treatment for Stage 2|Protocol Violation|0|||
164165059|NCT03850483|592968677|FG007|Treatment for Stage 2|Protocol Violation|0|||
164165060|NCT03850483|592968678|FG008|Treatment for Stage 2|Protocol Violation|1|||
164165061|NCT03850483|592968679|FG009|Treatment for Stage 2|Protocol Violation|0|||
164165062|NCT03850483|592968670|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
164165063|NCT03850483|592968671|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
164165064|NCT03850483|592968672|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
164165065|NCT03850483|592968673|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
164165066|NCT03850483|592968674|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
164165067|NCT03850483|592968675|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
164165068|NCT03850483|592968676|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
164165069|NCT03850483|592968677|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
164165070|NCT03850483|592968678|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
164165071|NCT03850483|592968679|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
164165072|NCT03850483|592968670|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165073|NCT03850483|592968671|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165074|NCT03850483|592968672|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165075|NCT03850483|592968673|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165076|NCT03850483|592968674|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165077|NCT03850483|592968675|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165078|NCT03850483|592968676|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165079|NCT03850483|592968677|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165080|NCT03850483|592968678|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
164165081|NCT03850483|592968679|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
164165082|NCT03850483|592968670|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
164165083|NCT03850483|592968671|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
164165084|NCT03850483|592968672|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
164165085|NCT03850483|592968673|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
164165086|NCT03850483|592968674|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
164165087|NCT03850483|592968675|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
164165088|NCT03850483|592968676|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
164165089|NCT03850483|592968677|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
164165090|NCT03850483|592968678|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
164165091|NCT03850483|592968679|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
164165092|NCT03850483|592968670|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
164165093|NCT03850483|592968671|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
164165094|NCT03850483|592968672|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
164165095|NCT03850483|592968673|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
164165096|NCT03850483|592968674|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
164165097|NCT03850483|592968675|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
164165098|NCT03850483|592968676|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
164165099|NCT03850483|592968677|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
164165100|NCT03850483|592968678|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
164165101|NCT03850483|592968679|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
164165102|NCT03850483|592968670|FG000|Follow-up For Stage 2|Other|0|||
164165103|NCT03850483|592968671|FG001|Follow-up For Stage 2|Other|0|||
164165104|NCT03850483|592968672|FG002|Follow-up For Stage 2|Other|0|||
164165105|NCT03850483|592968673|FG003|Follow-up For Stage 2|Other|0|||
164165106|NCT03850483|592968674|FG004|Follow-up For Stage 2|Other|0|||
164165107|NCT03850483|592968675|FG005|Follow-up For Stage 2|Other|0|||
164165108|NCT03850483|592968676|FG006|Follow-up For Stage 2|Other|0|||
164165109|NCT03850483|592968677|FG007|Follow-up For Stage 2|Other|0|||
164165110|NCT03850483|592968678|FG008|Follow-up For Stage 2|Other|0|||
164165111|NCT03850483|592968679|FG009|Follow-up For Stage 2|Other|1|||
164165112|NCT03225105|592968680|FG000|Overall Study|Withdrawal by Subject|1|||
164165113|NCT03225105|592968681|FG001|Overall Study|Withdrawal by Subject|0|||
164165114|NCT03225105|592968682|FG002|Overall Study|Withdrawal by Subject|0|||
164165115|NCT03225105|592968683|FG003|Overall Study|Withdrawal by Subject|0|||
164165116|NCT03225105|592968680|FG000|Overall Study|Death|0|||
164165117|NCT03225105|592968681|FG001|Overall Study|Death|4|||
164165118|NCT03225105|592968682|FG002|Overall Study|Death|2|||
164165119|NCT03225105|592968683|FG003|Overall Study|Death|0|||
164165120|NCT03225105|592968680|FG000|Overall Study|Study termination per Sponsor Decision|2|||
164165121|NCT03225105|592968681|FG001|Overall Study|Study termination per Sponsor Decision|0|||
164165122|NCT03225105|592968682|FG002|Overall Study|Study termination per Sponsor Decision|3|||
164165123|NCT03225105|592968683|FG003|Overall Study|Study termination per Sponsor Decision|3|||
164165124|NCT05488470|592970454|FG000|Overall Study|Physician Decision|2|||
164165125|NCT05488470|592970454|FG000|Overall Study|Withdrawal by Subject|1|||
164165126|NCT05488470|592970454|FG000|Overall Study|Death|1|||
164165127|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
164165128|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
164165129|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
164165130|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
164165131|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Death|0|||
164165132|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Death|0|||
164165133|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Death|1|||
164165134|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Death|0|||
164165135|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
164165136|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
164165137|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
164165138|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
164165139|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
164165140|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
164165141|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
164165142|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
164165143|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
164165144|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
164165145|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
164165146|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
164165147|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
164165148|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
164165149|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
164165150|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
164165151|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
164165152|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
164165153|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
164165154|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
164165155|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
164165156|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
164165157|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
164165158|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
164165159|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
164165160|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
164165161|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164165162|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
164165163|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
164165164|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
164165165|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
164165166|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
164165167|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
164165168|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
164165169|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
164165170|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
164165171|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Other|8|||
164165172|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Other|14|||
164165173|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Other|8|||
164165174|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Other|23|||
164165175|NCT01106677|592970456|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
164165176|NCT01106677|592970457|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
164165177|NCT01106677|592970458|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
164165178|NCT01106677|592970459|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
164165179|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164165180|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
164165181|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
164165182|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
164165183|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Death|0|||
164165184|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Death|0|||
164165185|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Death|0|||
164165186|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Death|1|||
164165187|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
164165188|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
164165189|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
164165190|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
164165191|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
164165192|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164165193|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164165194|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
164165195|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164165196|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
164165197|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
164165198|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
164165199|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
164165200|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164165201|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164165202|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
164165203|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164165204|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
164165205|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
164165206|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
164165207|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
164165208|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
164165209|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
164165210|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
164165211|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164165212|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164165213|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
164165214|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
164165215|NCT01106677|592970456|FG000|Extension Period: Week 26 to Week 52|Other|6|||
164165216|NCT01106677|592970457|FG001|Extension Period: Week 26 to Week 52|Other|5|||
164165217|NCT01106677|592970458|FG002|Extension Period: Week 26 to Week 52|Other|8|||
164165218|NCT01106677|592970459|FG003|Extension Period: Week 26 to Week 52|Other|5|||
164165219|NCT00972816|592970460|FG000|Overall Study|Adverse Event|0|||
164165220|NCT00972816|592970461|FG001|Overall Study|Adverse Event|0|||
164165221|NCT00972816|592970462|FG002|Overall Study|Adverse Event|1|||
164165222|NCT00972816|592970463|FG003|Overall Study|Adverse Event|0|||
164165223|NCT00972816|592970464|FG004|Overall Study|Adverse Event|0|||
164165224|NCT00972816|592970465|FG005|Overall Study|Adverse Event|0|||
164165225|NCT00972816|592970466|FG006|Overall Study|Adverse Event|0|||
164165226|NCT00972816|592970467|FG007|Overall Study|Adverse Event|0|||
164165227|NCT00972816|592970460|FG000|Overall Study|Withdrawal by Subject|4|||
164165228|NCT00972816|592970461|FG001|Overall Study|Withdrawal by Subject|2|||
164165229|NCT00972816|592970462|FG002|Overall Study|Withdrawal by Subject|1|||
164165230|NCT00972816|592970463|FG003|Overall Study|Withdrawal by Subject|3|||
164165231|NCT00972816|592970464|FG004|Overall Study|Withdrawal by Subject|0|||
164165232|NCT00972816|592970465|FG005|Overall Study|Withdrawal by Subject|1|||
164165233|NCT00972816|592970466|FG006|Overall Study|Withdrawal by Subject|1|||
164165234|NCT00972816|592970467|FG007|Overall Study|Withdrawal by Subject|2|||
164165235|NCT00972816|592970460|FG000|Overall Study|Lost to Follow-up|11|||
164165236|NCT00972816|592970461|FG001|Overall Study|Lost to Follow-up|9|||
164165237|NCT00972816|592970462|FG002|Overall Study|Lost to Follow-up|7|||
164165238|NCT00972816|592970463|FG003|Overall Study|Lost to Follow-up|5|||
164165239|NCT00972816|592970464|FG004|Overall Study|Lost to Follow-up|11|||
164165240|NCT00972816|592970465|FG005|Overall Study|Lost to Follow-up|10|||
164165241|NCT00972816|592970466|FG006|Overall Study|Lost to Follow-up|7|||
164165242|NCT00972816|592970467|FG007|Overall Study|Lost to Follow-up|7|||
164165243|NCT00972816|592970460|FG000|Overall Study|Inappropriate enrolment|0|||
164165244|NCT00972816|592970461|FG001|Overall Study|Inappropriate enrolment|0|||
164165245|NCT00972816|592970462|FG002|Overall Study|Inappropriate enrolment|0|||
164165246|NCT00972816|592970463|FG003|Overall Study|Inappropriate enrolment|0|||
164165247|NCT00972816|592970464|FG004|Overall Study|Inappropriate enrolment|0|||
164165248|NCT00972816|592970465|FG005|Overall Study|Inappropriate enrolment|0|||
164165249|NCT00972816|592970466|FG006|Overall Study|Inappropriate enrolment|2|||
164165250|NCT00972816|592970467|FG007|Overall Study|Inappropriate enrolment|0|||
164165251|NCT00972816|592970460|FG000|Overall Study|Unable to classify|2|||
164165252|NCT00972816|592970461|FG001|Overall Study|Unable to classify|0|||
164165253|NCT00972816|592970462|FG002|Overall Study|Unable to classify|0|||
164165254|NCT00972816|592970463|FG003|Overall Study|Unable to classify|0|||
164165255|NCT00972816|592970464|FG004|Overall Study|Unable to classify|1|||
164165256|NCT00972816|592970465|FG005|Overall Study|Unable to classify|0|||
164165257|NCT00972816|592970466|FG006|Overall Study|Unable to classify|0|||
164165258|NCT00972816|592970467|FG007|Overall Study|Unable to classify|0|||
164165259|NCT03806933|592970468|FG000|Main Period|Physician Decision|0|||
164165260|NCT03806933|592970469|FG001|Main Period|Physician Decision|0|||
164165261|NCT03806933|592970470|FG002|Main Period|Physician Decision|0|||
164165262|NCT03806933|592970471|FG003|Main Period|Physician Decision|1|||
164165263|NCT03806933|592970468|FG000|Main Period|Pregnancy|0|||
164165264|NCT03806933|592970469|FG001|Main Period|Pregnancy|0|||
164165265|NCT03806933|592970470|FG002|Main Period|Pregnancy|1|||
164165266|NCT03806933|592970471|FG003|Main Period|Pregnancy|0|||
164165267|NCT03806933|592970468|FG000|Main Period|Withdrawal by Subject|2|||
164165268|NCT03806933|592970469|FG001|Main Period|Withdrawal by Subject|1|||
164165269|NCT03806933|592970470|FG002|Main Period|Withdrawal by Subject|1|||
164165270|NCT03806933|592970471|FG003|Main Period|Withdrawal by Subject|2|||
164165271|NCT03806933|592970468|FG000|Main Period|Lost to Follow-up|2|||
164165272|NCT03806933|592970469|FG001|Main Period|Lost to Follow-up|2|||
164165273|NCT03806933|592970470|FG002|Main Period|Lost to Follow-up|0|||
164165274|NCT03806933|592970471|FG003|Main Period|Lost to Follow-up|0|||
164165275|NCT03806933|592970468|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
164165276|NCT03806933|592970469|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
164165277|NCT03806933|592970470|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
164165278|NCT03806933|592970471|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
164165279|NCT05088603|592970472|FG000|Overall Study|Protocol Violation|6|||
164165280|NCT05088603|592970473|FG001|Overall Study|Protocol Violation|1|||
164165281|NCT01868438|592970474|FG000|First Intervention|Withdrawal by Subject|5|||
164165282|NCT01868438|592970475|FG001|First Intervention|Withdrawal by Subject|1|||
164165283|NCT01868438|592970474|FG000|First Intervention|Lost to Follow-up|2|||
164165284|NCT01868438|592970475|FG001|First Intervention|Lost to Follow-up|3|||
164165285|NCT01868438|592970474|FG000|First Intervention|Meeting the non-redosing criteria|0|||
164165286|NCT01868438|592970475|FG001|First Intervention|Meeting the non-redosing criteria|1|||
164165287|NCT01868438|592970474|FG000|Second Intervention|Adverse Event|3|||
164165288|NCT01868438|592970475|FG001|Second Intervention|Adverse Event|3|||
164165289|NCT00955955|592970477|FG000|Overall Study|Lost to Follow-up|2|||
164165290|NCT00955955|592970478|FG001|Overall Study|Lost to Follow-up|0|||
164165291|NCT00955955|592970479|FG002|Overall Study|Lost to Follow-up|0|||
164165292|NCT01053663|592970483|FG000|Overall Study|Death|2|||
164165293|NCT01053663|592970483|FG000|Overall Study|Lost to Follow-up|1|||
164165294|NCT01053663|592970483|FG000|Overall Study|Poor IV Access|1|||
164165295|NCT01053663|592970483|FG000|Overall Study|Transferred to Another Hospital|1|||
164165296|NCT01053663|592970483|FG000|Overall Study|Negative Influenza Diagnosis|1|||
164165297|NCT03533114|592970486|FG000|Overall|Adverse Event|16|||
164165298|NCT03533114|592970487|FG001|Overall|Adverse Event|11|||
164165299|NCT03533114|592970486|FG000|Overall|Consent Withdrawal by Participant|7|||
164165300|NCT03533114|592970487|FG001|Overall|Consent Withdrawal by Participant|6|||
164165301|NCT03533114|592970486|FG000|Overall|Lack of Efficacy|5|||
164165302|NCT03533114|592970487|FG001|Overall|Lack of Efficacy|3|||
164165303|NCT03533114|592970486|FG000|Overall|Lost to Follow-up|1|||
164165304|NCT03533114|592970487|FG001|Overall|Lost to Follow-up|1|||
164165305|NCT03533114|592970486|FG000|Overall|Physician Decision|0|||
164165306|NCT03533114|592970487|FG001|Overall|Physician Decision|2|||
164165307|NCT03533114|592970486|FG000|Overall|Protocol deviation|1|||
164165308|NCT03533114|592970487|FG001|Overall|Protocol deviation|1|||
164165309|NCT03533114|592970486|FG000|Overall|Failure to meet randomization criteria|1|||
164165310|NCT03533114|592970487|FG001|Overall|Failure to meet randomization criteria|2|||
164165311|NCT03533114|592970486|FG000|Overall|Non-Compliance with study drug|0|||
164165312|NCT03533114|592970487|FG001|Overall|Non-Compliance with study drug|1|||
164165313|NCT03533114|592970486|FG000|Overall|Other|0|||
164165314|NCT03533114|592970487|FG001|Overall|Other|1|||
164165315|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Adverse Event|11|||
164165316|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Adverse Event|8|||
164165317|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
164165318|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
164165319|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
164165320|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
164165321|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
164165322|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
164165323|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
164165324|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
164165325|NCT03533114|592970486|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
164165326|NCT03533114|592970487|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
164165327|NCT03533114|592970486|FG000|Stable Dose|Adverse Event|0|||
164165328|NCT03533114|592970487|FG001|Stable Dose|Adverse Event|2|||
164165329|NCT03533114|592970486|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
164165330|NCT03533114|592970487|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
164165331|NCT03533114|592970486|FG000|Stable Dose|Lack of Efficacy|1|||
164165332|NCT03533114|592970487|FG001|Stable Dose|Lack of Efficacy|0|||
164165333|NCT03533114|592970486|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
164165334|NCT03533114|592970487|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
164165335|NCT03533114|592970486|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
164165336|NCT03533114|592970487|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
164165337|NCT03533114|592970486|FG000|Open-Label Safety Extension|Adverse Event|3|||
164165338|NCT03533114|592970487|FG001|Open-Label Safety Extension|Adverse Event|0|||
164165339|NCT03533114|592970486|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
164165340|NCT03533114|592970487|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
164165341|NCT03533114|592970486|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
164165342|NCT03533114|592970487|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
164165343|NCT03533114|592970486|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
164165344|NCT03533114|592970487|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
164165345|NCT03533114|592970486|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
164165346|NCT03533114|592970487|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
164165347|NCT01862250|592970488|FG000|Overall Study|Adverse Event|4|||
164165348|NCT03852264|592970489|FG000|Third Research Visit|Lost to Follow-up|1|||
164165349|NCT03852264|592970490|FG001|Third Research Visit|Lost to Follow-up|0|||
164165350|NCT02244463|592970495|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
164165351|NCT02244463|592970496|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165352|NCT02244463|592970497|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165353|NCT02244463|592970498|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165354|NCT02244463|592970499|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165355|NCT02244463|592970500|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
164165356|NCT02244463|592970495|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
164165357|NCT02244463|592970496|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
164165358|NCT02244463|592970497|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
164165359|NCT02244463|592970498|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
164165360|NCT02244463|592970499|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
164165361|NCT02244463|592970500|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
164165362|NCT02244463|592970495|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165363|NCT02244463|592970496|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
164165364|NCT02244463|592970497|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165365|NCT02244463|592970498|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165366|NCT02244463|592970499|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165367|NCT02244463|592970500|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
164165368|NCT02244463|592970495|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165369|NCT02244463|592970496|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165370|NCT02244463|592970497|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
164165371|NCT02244463|592970498|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165372|NCT02244463|592970499|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165373|NCT02244463|592970500|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
164165374|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165375|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165376|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165377|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
164165378|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165379|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
164165380|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165381|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165382|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165383|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
164165384|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165385|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
164165386|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165387|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165388|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165389|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
164165390|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165391|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
164165392|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165393|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165394|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165395|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
164165396|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165397|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
164165398|NCT02244463|592970495|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165399|NCT02244463|592970496|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165400|NCT02244463|592970497|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165401|NCT02244463|592970498|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
164165402|NCT02244463|592970499|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165403|NCT02244463|592970500|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
164165404|NCT02244463|592970495|FG000|Period 5: Phase II|Disease Progression|0|||
164165405|NCT02244463|592970496|FG001|Period 5: Phase II|Disease Progression|0|||
164165406|NCT02244463|592970497|FG002|Period 5: Phase II|Disease Progression|0|||
164165407|NCT02244463|592970498|FG003|Period 5: Phase II|Disease Progression|0|||
164165408|NCT02244463|592970499|FG004|Period 5: Phase II|Disease Progression|10|||
164165409|NCT02244463|592970500|FG005|Period 5: Phase II|Disease Progression|11|||
164165410|NCT02244463|592970495|FG000|Period 5: Phase II|Physician Decision|0|||
164165411|NCT02244463|592970496|FG001|Period 5: Phase II|Physician Decision|0|||
164165412|NCT02244463|592970497|FG002|Period 5: Phase II|Physician Decision|0|||
164165413|NCT02244463|592970498|FG003|Period 5: Phase II|Physician Decision|0|||
164165414|NCT02244463|592970499|FG004|Period 5: Phase II|Physician Decision|3|||
164165415|NCT02244463|592970500|FG005|Period 5: Phase II|Physician Decision|2|||
164165416|NCT02244463|592970495|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
164165417|NCT02244463|592970496|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
164165418|NCT02244463|592970497|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
164165419|NCT02244463|592970498|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
164165420|NCT02244463|592970499|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
164165421|NCT02244463|592970500|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
164165422|NCT02244463|592970495|FG000|Period 5: Phase II|Intercurrent Illness|0|||
164165423|NCT02244463|592970496|FG001|Period 5: Phase II|Intercurrent Illness|0|||
164165424|NCT02244463|592970497|FG002|Period 5: Phase II|Intercurrent Illness|0|||
164165425|NCT02244463|592970498|FG003|Period 5: Phase II|Intercurrent Illness|0|||
164165426|NCT02244463|592970499|FG004|Period 5: Phase II|Intercurrent Illness|2|||
164165427|NCT02244463|592970500|FG005|Period 5: Phase II|Intercurrent Illness|0|||
164165428|NCT02244463|592970495|FG000|Period 5: Phase II|Adverse Event|0|||
164165429|NCT02244463|592970496|FG001|Period 5: Phase II|Adverse Event|0|||
164165430|NCT02244463|592970497|FG002|Period 5: Phase II|Adverse Event|0|||
164165431|NCT02244463|592970498|FG003|Period 5: Phase II|Adverse Event|0|||
164165432|NCT02244463|592970499|FG004|Period 5: Phase II|Adverse Event|0|||
164165433|NCT02244463|592970500|FG005|Period 5: Phase II|Adverse Event|2|||
164165434|NCT02244463|592970495|FG000|Period 5: Phase II|Still On treatment|0|||
164165435|NCT02244463|592970496|FG001|Period 5: Phase II|Still On treatment|0|||
164165436|NCT02244463|592970497|FG002|Period 5: Phase II|Still On treatment|0|||
164165437|NCT02244463|592970498|FG003|Period 5: Phase II|Still On treatment|0|||
164165438|NCT02244463|592970499|FG004|Period 5: Phase II|Still On treatment|0|||
164165439|NCT02244463|592970500|FG005|Period 5: Phase II|Still On treatment|3|||
164165440|NCT05481125|592970501|FG000|Overall Study|Adverse Event|1|||
164165441|NCT05481125|592970502|FG001|Overall Study|Adverse Event|0|||
164165442|NCT05481125|592970501|FG000|Overall Study|Lost to Follow-up|0|||
164165443|NCT05481125|592970502|FG001|Overall Study|Lost to Follow-up|1|||
164165444|NCT05481125|592970501|FG000|Overall Study|Withdrawal by Subject|0|||
164165445|NCT05481125|592970502|FG001|Overall Study|Withdrawal by Subject|1|||
164165446|NCT01769508|592970507|FG000|Overall Study|Death|3|||
164165447|NCT01769508|592970507|FG000|Overall Study|Withdrawal by Subject|1|||
164165448|NCT01769508|592970507|FG000|Overall Study|Adverse Event|1|||
164165449|NCT01769508|592970507|FG000|Overall Study|Lost to Follow-up|1|||
164165450|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
164165451|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
164165452|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
164165453|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
164165454|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
164165455|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
164165456|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
164165457|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
164165458|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
164165459|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
164165460|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
164165461|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
164165462|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
164165463|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
164165464|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
164165465|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
164165466|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
164165467|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
164165468|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
164165469|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
164165470|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
164165471|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
164165472|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
164165473|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
164165474|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
164165475|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
164165476|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
164165477|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
164165478|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
164165479|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
164165480|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
164165481|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
164165482|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
164165483|NCT00839527|592970510|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
164165484|NCT00839527|592970511|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
164165485|NCT00839527|592970512|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
164165486|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
164165487|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
164165488|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
164165489|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
164165490|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
164165491|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
164165492|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
164165493|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
164165494|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
164165495|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
164165496|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
164165497|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
164165498|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
164165499|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
164165500|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
164165501|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
164165502|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
164165503|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
164165504|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
164165505|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
164165506|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
164165796|NCT02477826|592970547|FG002|Treatment Period|Pregnancy|0|||
164165507|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
164165508|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
164165509|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
164165510|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
164165511|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
164165512|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
164165513|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
164165514|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
164165515|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
164165516|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
164165517|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
164165518|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
164165519|NCT00839527|592970510|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
164165520|NCT00839527|592970511|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
164165521|NCT00839527|592970512|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
164165522|NCT02295020|592970513|FG000|Overall Study|Adverse Event|0|||
164165523|NCT02295020|592970514|FG001|Overall Study|Adverse Event|1|||
164165524|NCT02295020|592970513|FG000|Overall Study|Withdrawal by Subject|3|||
164165525|NCT02295020|592970514|FG001|Overall Study|Withdrawal by Subject|2|||
164165526|NCT02751450|592970515|FG000|Overall Study|Adverse Event|1|||
164165527|NCT02751450|592970516|FG001|Overall Study|Adverse Event|0|||
164165528|NCT01290679|592970517|FG000|Overall Study|Adverse Event|2|||
164165529|NCT01290679|592970518|FG001|Overall Study|Adverse Event|0|||
164165530|NCT01290679|592970517|FG000|Overall Study|Lost to Follow-up|8|||
164165531|NCT01290679|592970518|FG001|Overall Study|Lost to Follow-up|10|||
164165532|NCT01290679|592970517|FG000|Overall Study|Protocol Violation|0|||
164165533|NCT01290679|592970518|FG001|Overall Study|Protocol Violation|1|||
164165534|NCT01290679|592970517|FG000|Overall Study|Withdrawal by Subject|6|||
164165535|NCT01290679|592970518|FG001|Overall Study|Withdrawal by Subject|5|||
164165536|NCT01290679|592970517|FG000|Overall Study|Subject Entered Another Trial|0|||
164165537|NCT01290679|592970518|FG001|Overall Study|Subject Entered Another Trial|5|||
164165538|NCT01855243|592970519|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
164165539|NCT01855243|592970520|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
164165540|NCT01855243|592970521|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
164165541|NCT02587598|592970524|FG000|Overall Study|Death|4|||
164165542|NCT02587598|592970525|FG001|Overall Study|Death|8|||
164165543|NCT02587598|592970526|FG002|Overall Study|Death|4|||
164165544|NCT02587598|592970527|FG003|Overall Study|Death|16|||
164165545|NCT02587598|592970528|FG004|Overall Study|Death|9|||
164165546|NCT02587598|592970529|FG005|Overall Study|Death|4|||
164165547|NCT02587598|592970530|FG006|Overall Study|Death|6|||
164165548|NCT02587598|592970531|FG007|Overall Study|Death|7|||
164165549|NCT02587598|592970532|FG008|Overall Study|Death|9|||
164165550|NCT02587598|592970533|FG009|Overall Study|Death|1|||
164165551|NCT02587598|592970534|FG010|Overall Study|Death|3|||
164165552|NCT02587598|592970524|FG000|Overall Study|Study Terminated by the Sponsor|0|||
164165553|NCT02587598|592970525|FG001|Overall Study|Study Terminated by the Sponsor|1|||
164165554|NCT02587598|592970526|FG002|Overall Study|Study Terminated by the Sponsor|0|||
164165555|NCT02587598|592970527|FG003|Overall Study|Study Terminated by the Sponsor|3|||
164165556|NCT02587598|592970528|FG004|Overall Study|Study Terminated by the Sponsor|0|||
164165557|NCT02587598|592970529|FG005|Overall Study|Study Terminated by the Sponsor|1|||
164165558|NCT02587598|592970530|FG006|Overall Study|Study Terminated by the Sponsor|0|||
164165559|NCT02587598|592970531|FG007|Overall Study|Study Terminated by the Sponsor|0|||
164165560|NCT02587598|592970532|FG008|Overall Study|Study Terminated by the Sponsor|0|||
164165561|NCT02587598|592970533|FG009|Overall Study|Study Terminated by the Sponsor|1|||
164165562|NCT02587598|592970534|FG010|Overall Study|Study Terminated by the Sponsor|6|||
164165563|NCT02587598|592970524|FG000|Overall Study|Reason for study withdrawal not specified|0|||
164165564|NCT02587598|592970525|FG001|Overall Study|Reason for study withdrawal not specified|1|||
164165565|NCT02587598|592970526|FG002|Overall Study|Reason for study withdrawal not specified|0|||
164165566|NCT02587598|592970527|FG003|Overall Study|Reason for study withdrawal not specified|0|||
164165567|NCT02587598|592970528|FG004|Overall Study|Reason for study withdrawal not specified|0|||
164165568|NCT02587598|592970529|FG005|Overall Study|Reason for study withdrawal not specified|0|||
164165569|NCT02587598|592970530|FG006|Overall Study|Reason for study withdrawal not specified|0|||
164165570|NCT02587598|592970531|FG007|Overall Study|Reason for study withdrawal not specified|0|||
164165571|NCT02587598|592970532|FG008|Overall Study|Reason for study withdrawal not specified|0|||
164165572|NCT02587598|592970533|FG009|Overall Study|Reason for study withdrawal not specified|0|||
164165573|NCT02587598|592970534|FG010|Overall Study|Reason for study withdrawal not specified|0|||
164165574|NCT02587598|592970524|FG000|Overall Study|Withdrawal by Subject|0|||
164165575|NCT02587598|592970525|FG001|Overall Study|Withdrawal by Subject|1|||
164165576|NCT02587598|592970526|FG002|Overall Study|Withdrawal by Subject|0|||
164165577|NCT02587598|592970527|FG003|Overall Study|Withdrawal by Subject|2|||
164165578|NCT02587598|592970528|FG004|Overall Study|Withdrawal by Subject|3|||
164165579|NCT02587598|592970529|FG005|Overall Study|Withdrawal by Subject|1|||
164165580|NCT02587598|592970530|FG006|Overall Study|Withdrawal by Subject|0|||
164165581|NCT02587598|592970531|FG007|Overall Study|Withdrawal by Subject|0|||
164165582|NCT02587598|592970532|FG008|Overall Study|Withdrawal by Subject|0|||
164165583|NCT02587598|592970533|FG009|Overall Study|Withdrawal by Subject|1|||
164165584|NCT02587598|592970534|FG010|Overall Study|Withdrawal by Subject|2|||
164165585|NCT02587598|592970524|FG000|Overall Study|Physician Decision|0|||
164165586|NCT02587598|592970525|FG001|Overall Study|Physician Decision|0|||
164165587|NCT02587598|592970526|FG002|Overall Study|Physician Decision|0|||
164165588|NCT02587598|592970527|FG003|Overall Study|Physician Decision|0|||
164165589|NCT02587598|592970528|FG004|Overall Study|Physician Decision|0|||
164165590|NCT02587598|592970529|FG005|Overall Study|Physician Decision|0|||
164165591|NCT02587598|592970530|FG006|Overall Study|Physician Decision|0|||
164165592|NCT02587598|592970531|FG007|Overall Study|Physician Decision|0|||
164165593|NCT02587598|592970532|FG008|Overall Study|Physician Decision|0|||
164165594|NCT02587598|592970533|FG009|Overall Study|Physician Decision|0|||
164165595|NCT02587598|592970534|FG010|Overall Study|Physician Decision|3|||
164165596|NCT01704651|592970541|FG000|Overall Study|Pre-op withdrawal by subject|1|||
164165597|NCT01704651|592970542|FG001|Overall Study|Pre-op withdrawal by subject|1|||
164165598|NCT01704651|592970541|FG000|Overall Study|Pre-op change in treatment plan|1|||
164165599|NCT01704651|592970542|FG001|Overall Study|Pre-op change in treatment plan|4|||
164165600|NCT01704651|592970541|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
164165601|NCT01704651|592970542|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
164165602|NCT01704651|592970541|FG000|Overall Study|Post-op did not have laparotomy|2|||
164165603|NCT01704651|592970542|FG001|Overall Study|Post-op did not have laparotomy|1|||
164165604|NCT02477826|592970545|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165605|NCT02477826|592970546|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
164165606|NCT02477826|592970547|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
164165607|NCT02477826|592970548|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
164165608|NCT02477826|592970549|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165609|NCT02477826|592970550|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165610|NCT02477826|592970551|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
164165611|NCT02477826|592970552|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
164165612|NCT02477826|592970553|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165613|NCT02477826|592970554|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
164165614|NCT02477826|592970545|FG000|Pre-Treatment|Other reasons|4|||
164165615|NCT02477826|592970546|FG001|Pre-Treatment|Other reasons|1|||
164165616|NCT02477826|592970547|FG002|Pre-Treatment|Other reasons|4|||
164165617|NCT02477826|592970548|FG003|Pre-Treatment|Other reasons|1|||
164165618|NCT02477826|592970549|FG004|Pre-Treatment|Other reasons|4|||
164165619|NCT02477826|592970550|FG005|Pre-Treatment|Other reasons|2|||
164165620|NCT02477826|592970551|FG006|Pre-Treatment|Other reasons|0|||
164165621|NCT02477826|592970552|FG007|Pre-Treatment|Other reasons|0|||
164165622|NCT02477826|592970553|FG008|Pre-Treatment|Other reasons|0|||
164165623|NCT02477826|592970554|FG009|Pre-Treatment|Other reasons|0|||
164165624|NCT02477826|592970545|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
164165625|NCT02477826|592970546|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
164165626|NCT02477826|592970547|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
164165627|NCT02477826|592970548|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
164165628|NCT02477826|592970549|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
164165629|NCT02477826|592970550|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
164165630|NCT02477826|592970551|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
164165631|NCT02477826|592970552|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
164165632|NCT02477826|592970553|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
164165633|NCT02477826|592970554|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
164165634|NCT02477826|592970545|FG000|Pre-Treatment|Subject withdrew consent|0|||
164165635|NCT02477826|592970546|FG001|Pre-Treatment|Subject withdrew consent|0|||
164165636|NCT02477826|592970547|FG002|Pre-Treatment|Subject withdrew consent|3|||
164165637|NCT02477826|592970548|FG003|Pre-Treatment|Subject withdrew consent|0|||
164165638|NCT02477826|592970549|FG004|Pre-Treatment|Subject withdrew consent|0|||
164165639|NCT02477826|592970550|FG005|Pre-Treatment|Subject withdrew consent|1|||
164165640|NCT02477826|592970551|FG006|Pre-Treatment|Subject withdrew consent|0|||
164165641|NCT02477826|592970552|FG007|Pre-Treatment|Subject withdrew consent|1|||
164165642|NCT02477826|592970553|FG008|Pre-Treatment|Subject withdrew consent|0|||
164165643|NCT02477826|592970554|FG009|Pre-Treatment|Subject withdrew consent|3|||
164165644|NCT02477826|592970545|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165645|NCT02477826|592970546|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
164165646|NCT02477826|592970547|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165647|NCT02477826|592970548|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165648|NCT02477826|592970549|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165649|NCT02477826|592970550|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165797|NCT02477826|592970548|FG003|Treatment Period|Pregnancy|0|||
164165650|NCT02477826|592970551|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165651|NCT02477826|592970552|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165652|NCT02477826|592970553|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
164165653|NCT02477826|592970554|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
164165654|NCT02477826|592970545|FG000|Pre-Treatment|Death|0|||
164165655|NCT02477826|592970546|FG001|Pre-Treatment|Death|0|||
164165656|NCT02477826|592970547|FG002|Pre-Treatment|Death|0|||
164165657|NCT02477826|592970548|FG003|Pre-Treatment|Death|0|||
164165658|NCT02477826|592970549|FG004|Pre-Treatment|Death|0|||
164165659|NCT02477826|592970550|FG005|Pre-Treatment|Death|0|||
164165660|NCT02477826|592970551|FG006|Pre-Treatment|Death|1|||
164165661|NCT02477826|592970552|FG007|Pre-Treatment|Death|0|||
164165662|NCT02477826|592970553|FG008|Pre-Treatment|Death|0|||
164165663|NCT02477826|592970554|FG009|Pre-Treatment|Death|0|||
164165664|NCT02477826|592970545|FG000|Treatment Period|Not reported|8|||
164165665|NCT02477826|592970546|FG001|Treatment Period|Not reported|6|||
164165666|NCT02477826|592970547|FG002|Treatment Period|Not reported|4|||
164165667|NCT02477826|592970548|FG003|Treatment Period|Not reported|4|||
164165668|NCT02477826|592970549|FG004|Treatment Period|Not reported|2|||
164165669|NCT02477826|592970550|FG005|Treatment Period|Not reported|1|||
164165670|NCT02477826|592970551|FG006|Treatment Period|Not reported|14|||
164165671|NCT02477826|592970552|FG007|Treatment Period|Not reported|8|||
164165672|NCT02477826|592970553|FG008|Treatment Period|Not reported|5|||
164165673|NCT02477826|592970554|FG009|Treatment Period|Not reported|2|||
164165674|NCT02477826|592970545|FG000|Treatment Period|Other reasons|5|||
164165675|NCT02477826|592970546|FG001|Treatment Period|Other reasons|6|||
164165676|NCT02477826|592970547|FG002|Treatment Period|Other reasons|12|||
164165677|NCT02477826|592970548|FG003|Treatment Period|Other reasons|7|||
164165678|NCT02477826|592970549|FG004|Treatment Period|Other reasons|5|||
164165679|NCT02477826|592970550|FG005|Treatment Period|Other reasons|1|||
164165680|NCT02477826|592970551|FG006|Treatment Period|Other reasons|8|||
164165681|NCT02477826|592970552|FG007|Treatment Period|Other reasons|8|||
164165682|NCT02477826|592970553|FG008|Treatment Period|Other reasons|21|||
164165683|NCT02477826|592970554|FG009|Treatment Period|Other reasons|1|||
164165684|NCT02477826|592970545|FG000|Treatment Period|Administrative reason by sponsor|0|||
164165685|NCT02477826|592970546|FG001|Treatment Period|Administrative reason by sponsor|3|||
164165686|NCT02477826|592970547|FG002|Treatment Period|Administrative reason by sponsor|0|||
164165687|NCT02477826|592970548|FG003|Treatment Period|Administrative reason by sponsor|0|||
164165688|NCT02477826|592970549|FG004|Treatment Period|Administrative reason by sponsor|0|||
164165689|NCT02477826|592970550|FG005|Treatment Period|Administrative reason by sponsor|0|||
164165690|NCT02477826|592970551|FG006|Treatment Period|Administrative reason by sponsor|0|||
164165691|NCT02477826|592970552|FG007|Treatment Period|Administrative reason by sponsor|0|||
164165692|NCT02477826|592970553|FG008|Treatment Period|Administrative reason by sponsor|0|||
164165693|NCT02477826|592970554|FG009|Treatment Period|Administrative reason by sponsor|0|||
164165694|NCT02477826|592970545|FG000|Treatment Period|Participant meet no longer study criteria|1|||
164165695|NCT02477826|592970546|FG001|Treatment Period|Participant meet no longer study criteria|1|||
164165696|NCT02477826|592970547|FG002|Treatment Period|Participant meet no longer study criteria|0|||
164165697|NCT02477826|592970548|FG003|Treatment Period|Participant meet no longer study criteria|0|||
164165698|NCT02477826|592970549|FG004|Treatment Period|Participant meet no longer study criteria|1|||
164165699|NCT02477826|592970550|FG005|Treatment Period|Participant meet no longer study criteria|1|||
164165700|NCT02477826|592970551|FG006|Treatment Period|Participant meet no longer study criteria|0|||
164165701|NCT02477826|592970552|FG007|Treatment Period|Participant meet no longer study criteria|1|||
164165702|NCT02477826|592970553|FG008|Treatment Period|Participant meet no longer study criteria|0|||
164165703|NCT02477826|592970554|FG009|Treatment Period|Participant meet no longer study criteria|0|||
164165704|NCT02477826|592970545|FG000|Treatment Period|Poor/Non Compliance|1|||
164165705|NCT02477826|592970546|FG001|Treatment Period|Poor/Non Compliance|0|||
164165706|NCT02477826|592970547|FG002|Treatment Period|Poor/Non Compliance|2|||
164165707|NCT02477826|592970548|FG003|Treatment Period|Poor/Non Compliance|0|||
164165708|NCT02477826|592970549|FG004|Treatment Period|Poor/Non Compliance|0|||
164165709|NCT02477826|592970550|FG005|Treatment Period|Poor/Non Compliance|1|||
164165710|NCT02477826|592970551|FG006|Treatment Period|Poor/Non Compliance|1|||
164165711|NCT02477826|592970552|FG007|Treatment Period|Poor/Non Compliance|0|||
164165712|NCT02477826|592970553|FG008|Treatment Period|Poor/Non Compliance|0|||
164165713|NCT02477826|592970554|FG009|Treatment Period|Poor/Non Compliance|1|||
164165714|NCT02477826|592970545|FG000|Treatment Period|Maximum Clinical Benefit|3|||
164165715|NCT02477826|592970546|FG001|Treatment Period|Maximum Clinical Benefit|3|||
164165716|NCT02477826|592970547|FG002|Treatment Period|Maximum Clinical Benefit|1|||
164165717|NCT02477826|592970548|FG003|Treatment Period|Maximum Clinical Benefit|1|||
164165718|NCT02477826|592970549|FG004|Treatment Period|Maximum Clinical Benefit|3|||
164165719|NCT02477826|592970550|FG005|Treatment Period|Maximum Clinical Benefit|0|||
164165720|NCT02477826|592970551|FG006|Treatment Period|Maximum Clinical Benefit|3|||
164165721|NCT02477826|592970552|FG007|Treatment Period|Maximum Clinical Benefit|2|||
164165722|NCT02477826|592970553|FG008|Treatment Period|Maximum Clinical Benefit|2|||
164165723|NCT02477826|592970554|FG009|Treatment Period|Maximum Clinical Benefit|2|||
164165724|NCT02477826|592970545|FG000|Treatment Period|Lost to Follow-up|0|||
164165725|NCT02477826|592970546|FG001|Treatment Period|Lost to Follow-up|0|||
164165726|NCT02477826|592970547|FG002|Treatment Period|Lost to Follow-up|1|||
164165727|NCT02477826|592970548|FG003|Treatment Period|Lost to Follow-up|1|||
164165728|NCT02477826|592970549|FG004|Treatment Period|Lost to Follow-up|0|||
164165729|NCT02477826|592970550|FG005|Treatment Period|Lost to Follow-up|0|||
164165730|NCT02477826|592970551|FG006|Treatment Period|Lost to Follow-up|2|||
164165731|NCT02477826|592970552|FG007|Treatment Period|Lost to Follow-up|2|||
164165732|NCT02477826|592970553|FG008|Treatment Period|Lost to Follow-up|0|||
164165733|NCT02477826|592970554|FG009|Treatment Period|Lost to Follow-up|0|||
164165734|NCT02477826|592970545|FG000|Treatment Period|Participant withdrew Consent|5|||
164165735|NCT02477826|592970546|FG001|Treatment Period|Participant withdrew Consent|5|||
164165736|NCT02477826|592970547|FG002|Treatment Period|Participant withdrew Consent|3|||
164165737|NCT02477826|592970548|FG003|Treatment Period|Participant withdrew Consent|3|||
164165738|NCT02477826|592970549|FG004|Treatment Period|Participant withdrew Consent|1|||
164165739|NCT02477826|592970550|FG005|Treatment Period|Participant withdrew Consent|3|||
164165740|NCT02477826|592970551|FG006|Treatment Period|Participant withdrew Consent|3|||
164165741|NCT02477826|592970552|FG007|Treatment Period|Participant withdrew Consent|3|||
164165742|NCT02477826|592970553|FG008|Treatment Period|Participant withdrew Consent|2|||
164165743|NCT02477826|592970554|FG009|Treatment Period|Participant withdrew Consent|3|||
164165744|NCT02477826|592970545|FG000|Treatment Period|Participant request to discontinue treatment|5|||
164165745|NCT02477826|592970546|FG001|Treatment Period|Participant request to discontinue treatment|3|||
164165746|NCT02477826|592970547|FG002|Treatment Period|Participant request to discontinue treatment|15|||
164165747|NCT02477826|592970548|FG003|Treatment Period|Participant request to discontinue treatment|5|||
164165748|NCT02477826|592970549|FG004|Treatment Period|Participant request to discontinue treatment|3|||
164165749|NCT02477826|592970550|FG005|Treatment Period|Participant request to discontinue treatment|6|||
164165750|NCT02477826|592970551|FG006|Treatment Period|Participant request to discontinue treatment|13|||
164165751|NCT02477826|592970552|FG007|Treatment Period|Participant request to discontinue treatment|15|||
164165752|NCT02477826|592970553|FG008|Treatment Period|Participant request to discontinue treatment|4|||
164165753|NCT02477826|592970554|FG009|Treatment Period|Participant request to discontinue treatment|18|||
164165754|NCT02477826|592970545|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
164165755|NCT02477826|592970546|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
164165756|NCT02477826|592970547|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
164165757|NCT02477826|592970548|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
164165758|NCT02477826|592970549|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
164165759|NCT02477826|592970550|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
164165760|NCT02477826|592970551|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
164165761|NCT02477826|592970552|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
164165762|NCT02477826|592970553|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
164165763|NCT02477826|592970554|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
164165764|NCT02477826|592970545|FG000|Treatment Period|Death|4|||
164165765|NCT02477826|592970546|FG001|Treatment Period|Death|7|||
164165766|NCT02477826|592970547|FG002|Treatment Period|Death|0|||
164165767|NCT02477826|592970548|FG003|Treatment Period|Death|0|||
164165768|NCT02477826|592970549|FG004|Treatment Period|Death|1|||
164165769|NCT02477826|592970550|FG005|Treatment Period|Death|2|||
164165770|NCT02477826|592970551|FG006|Treatment Period|Death|6|||
164165771|NCT02477826|592970552|FG007|Treatment Period|Death|5|||
164165772|NCT02477826|592970553|FG008|Treatment Period|Death|9|||
164165773|NCT02477826|592970554|FG009|Treatment Period|Death|0|||
164165774|NCT02477826|592970545|FG000|Treatment Period|Study Drug Toxicity|79|||
164165775|NCT02477826|592970546|FG001|Treatment Period|Study Drug Toxicity|51|||
164165776|NCT02477826|592970547|FG002|Treatment Period|Study Drug Toxicity|31|||
164165777|NCT02477826|592970548|FG003|Treatment Period|Study Drug Toxicity|39|||
164165778|NCT02477826|592970549|FG004|Treatment Period|Study Drug Toxicity|12|||
164165779|NCT02477826|592970550|FG005|Treatment Period|Study Drug Toxicity|25|||
164165780|NCT02477826|592970551|FG006|Treatment Period|Study Drug Toxicity|52|||
164165781|NCT02477826|592970552|FG007|Treatment Period|Study Drug Toxicity|30|||
164165782|NCT02477826|592970553|FG008|Treatment Period|Study Drug Toxicity|20|||
164165783|NCT02477826|592970554|FG009|Treatment Period|Study Drug Toxicity|9|||
164165784|NCT02477826|592970545|FG000|Treatment Period|Disease progression|212|||
164165785|NCT02477826|592970546|FG001|Treatment Period|Disease progression|240|||
164165786|NCT02477826|592970547|FG002|Treatment Period|Disease progression|202|||
164165787|NCT02477826|592970548|FG003|Treatment Period|Disease progression|93|||
164165788|NCT02477826|592970549|FG004|Treatment Period|Disease progression|113|||
164165789|NCT02477826|592970550|FG005|Treatment Period|Disease progression|96|||
164165790|NCT02477826|592970551|FG006|Treatment Period|Disease progression|208|||
164165791|NCT02477826|592970552|FG007|Treatment Period|Disease progression|195|||
164165792|NCT02477826|592970553|FG008|Treatment Period|Disease progression|59|||
164165793|NCT02477826|592970554|FG009|Treatment Period|Disease progression|46|||
164165794|NCT02477826|592970545|FG000|Treatment Period|Pregnancy|0|||
164165795|NCT02477826|592970546|FG001|Treatment Period|Pregnancy|0|||
164165798|NCT02477826|592970549|FG004|Treatment Period|Pregnancy|0|||
164165799|NCT02477826|592970550|FG005|Treatment Period|Pregnancy|0|||
164165800|NCT02477826|592970551|FG006|Treatment Period|Pregnancy|0|||
164165801|NCT02477826|592970552|FG007|Treatment Period|Pregnancy|0|||
164165802|NCT02477826|592970553|FG008|Treatment Period|Pregnancy|0|||
164165803|NCT02477826|592970554|FG009|Treatment Period|Pregnancy|1|||
164165804|NCT02477826|592970545|FG000|Treatment Period|Other|0|||
164165805|NCT02477826|592970546|FG001|Treatment Period|Other|0|||
164165806|NCT02477826|592970547|FG002|Treatment Period|Other|0|||
164165807|NCT02477826|592970548|FG003|Treatment Period|Other|0|||
164165808|NCT02477826|592970549|FG004|Treatment Period|Other|0|||
164165809|NCT02477826|592970550|FG005|Treatment Period|Other|0|||
164165810|NCT02477826|592970551|FG006|Treatment Period|Other|0|||
164165811|NCT02477826|592970552|FG007|Treatment Period|Other|0|||
164165812|NCT02477826|592970553|FG008|Treatment Period|Other|0|||
164165813|NCT02477826|592970554|FG009|Treatment Period|Other|1|||
164165814|NCT01218087|592970588|FG000|Overall Study|Death|2|||
164165815|NCT01218087|592970589|FG001|Overall Study|Death|1|||
164165816|NCT01218087|592970588|FG000|Overall Study|Withdrawal by Subject|5|||
164165817|NCT01218087|592970589|FG001|Overall Study|Withdrawal by Subject|0|||
164165818|NCT01218087|592970588|FG000|Overall Study|Transferred|8|||
164165819|NCT01218087|592970589|FG001|Overall Study|Transferred|5|||
164165820|NCT03170362|592970590|FG000|Overall Study|Death|2|||
164165821|NCT03170362|592970591|FG001|Overall Study|Death|2|||
164165822|NCT03170362|592970590|FG000|Overall Study|Withdrawal by Subject|23|||
164165823|NCT03170362|592970591|FG001|Overall Study|Withdrawal by Subject|22|||
164165824|NCT03170362|592970590|FG000|Overall Study|Lost to Follow-up|187|||
164165825|NCT03170362|592970591|FG001|Overall Study|Lost to Follow-up|167|||
164165826|NCT00552396|592970592|FG000|Overall Study|protocol withdrawal criteria|3|||
164165827|NCT00552396|592970593|FG001|Overall Study|protocol withdrawal criteria|3|||
164165828|NCT00552396|592970594|FG002|Overall Study|protocol withdrawal criteria|3|||
164165829|NCT00552396|592970595|FG003|Overall Study|protocol withdrawal criteria|6|||
164165830|NCT00552396|592970596|FG004|Overall Study|protocol withdrawal criteria|3|||
164165831|NCT00552396|592970597|FG005|Overall Study|protocol withdrawal criteria|3|||
164165832|NCT00552396|592970598|FG006|Overall Study|protocol withdrawal criteria|9|||
164165833|NCT03340454|592970601|FG000|Overall Study|Lost to Follow-up|0|||
164165834|NCT03340454|592970602|FG001|Overall Study|Lost to Follow-up|4|||
164165835|NCT01464164|592970604|FG000|Overall Study|Screen failure|0|||
164165836|NCT01464164|592970605|FG001|Overall Study|Screen failure|1|||
164165837|NCT01464164|592970606|FG002|Overall Study|Screen failure|2|||
164165838|NCT01464164|592970607|FG003|Overall Study|Screen failure|0|||
164165839|NCT01464164|592970608|FG004|Overall Study|Screen failure|0|||
164165840|NCT01464164|592970609|FG005|Overall Study|Screen failure|0|||
164165841|NCT01464164|592970610|FG006|Overall Study|Screen failure|0|||
164165842|NCT01464164|592970604|FG000|Overall Study|Physician Decision|0|||
164165843|NCT01464164|592970605|FG001|Overall Study|Physician Decision|1|||
164165844|NCT01464164|592970606|FG002|Overall Study|Physician Decision|0|||
164165845|NCT01464164|592970607|FG003|Overall Study|Physician Decision|0|||
164165846|NCT01464164|592970608|FG004|Overall Study|Physician Decision|0|||
164165847|NCT01464164|592970609|FG005|Overall Study|Physician Decision|0|||
164165848|NCT01464164|592970610|FG006|Overall Study|Physician Decision|2|||
164165849|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Death|1|||
164165850|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Death|0|||
164165851|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
164165852|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
164165853|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
164165854|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
164165855|NCT01972438|592970611|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
164165856|NCT01972438|592970612|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
164165857|NCT01972438|592970611|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
164165858|NCT01972438|592970612|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
164165859|NCT01972438|592970611|FG000|Months 6-12 Study Period|Death|1|||
164165860|NCT01972438|592970612|FG001|Months 6-12 Study Period|Death|0|||
164165861|NCT01972438|592970611|FG000|Months 6-12 Study Period|Early Study Closure|2|||
164165862|NCT01972438|592970612|FG001|Months 6-12 Study Period|Early Study Closure|2|||
164165863|NCT01972438|592970611|FG000|Post Month 12 Study Period|Early Study Closure|3|||
164165864|NCT01972438|592970612|FG001|Post Month 12 Study Period|Early Study Closure|4|||
164165865|NCT03307252|592970613|FG000|Part 2, Period 1|Treatment not received|0|||
164165866|NCT03307252|592970614|FG001|Part 2, Period 1|Treatment not received|0|||
164165867|NCT03307252|592970615|FG002|Part 2, Period 1|Treatment not received|0|||
164165868|NCT03307252|592970616|FG003|Part 2, Period 1|Treatment not received|0|||
164165869|NCT03307252|592970617|FG004|Part 2, Period 1|Treatment not received|0|||
164165870|NCT03307252|592970618|FG005|Part 2, Period 1|Treatment not received|1|||
164165871|NCT03307252|592970619|FG006|Part 2, Period 1|Treatment not received|0|||
164165872|NCT03307252|592970620|FG007|Part 2, Period 1|Treatment not received|0|||
164165873|NCT03307252|592970621|FG008|Part 2, Period 1|Treatment not received|0|||
164165874|NCT03307252|592970622|FG009|Part 2, Period 1|Treatment not received|0|||
164165875|NCT03307252|592970623|FG010|Part 2, Period 1|Treatment not received|0|||
164165876|NCT03307252|592970613|FG000|Part 2, Period 3|Other than listed|0|||
164165877|NCT03307252|592970614|FG001|Part 2, Period 3|Other than listed|0|||
164165878|NCT03307252|592970615|FG002|Part 2, Period 3|Other than listed|0|||
164165879|NCT03307252|592970616|FG003|Part 2, Period 3|Other than listed|0|||
164165880|NCT03307252|592970617|FG004|Part 2, Period 3|Other than listed|1|||
164165881|NCT03307252|592970618|FG005|Part 2, Period 3|Other than listed|0|||
164165882|NCT03307252|592970619|FG006|Part 2, Period 3|Other than listed|0|||
164165883|NCT03307252|592970620|FG007|Part 2, Period 3|Other than listed|0|||
164165884|NCT03307252|592970621|FG008|Part 2, Period 3|Other than listed|0|||
164165885|NCT03307252|592970622|FG009|Part 2, Period 3|Other than listed|0|||
164165886|NCT03307252|592970623|FG010|Part 2, Period 3|Other than listed|0|||
164165887|NCT03307252|592970613|FG000|Part 2, Period 4|Other than listed|0|||
164165888|NCT03307252|592970614|FG001|Part 2, Period 4|Other than listed|0|||
164165889|NCT03307252|592970615|FG002|Part 2, Period 4|Other than listed|0|||
164165890|NCT03307252|592970616|FG003|Part 2, Period 4|Other than listed|0|||
164165891|NCT03307252|592970617|FG004|Part 2, Period 4|Other than listed|0|||
164165892|NCT03307252|592970618|FG005|Part 2, Period 4|Other than listed|0|||
164165893|NCT03307252|592970619|FG006|Part 2, Period 4|Other than listed|1|||
164165894|NCT03307252|592970620|FG007|Part 2, Period 4|Other than listed|0|||
164165895|NCT03307252|592970621|FG008|Part 2, Period 4|Other than listed|0|||
164165896|NCT03307252|592970622|FG009|Part 2, Period 4|Other than listed|0|||
164165897|NCT03307252|592970623|FG010|Part 2, Period 4|Other than listed|0|||
164165898|NCT03307252|592970613|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165899|NCT03307252|592970614|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165900|NCT03307252|592970615|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165901|NCT03307252|592970616|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165902|NCT03307252|592970617|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165903|NCT03307252|592970618|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165904|NCT03307252|592970619|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165905|NCT03307252|592970620|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165906|NCT03307252|592970621|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165907|NCT03307252|592970622|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
164165908|NCT03307252|592970623|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
164165909|NCT01052480|592970624|FG000|Overall Study|Lost to Follow-up|3|||
164165910|NCT01052480|592970625|FG001|Overall Study|Lost to Follow-up|3|||
164165911|NCT01052480|592970624|FG000|Overall Study|Protocol Violation|1|||
164165912|NCT01052480|592970625|FG001|Overall Study|Protocol Violation|0|||
164165913|NCT01052480|592970624|FG000|Overall Study|Withdrawal by Subject|3|||
164165914|NCT01052480|592970625|FG001|Overall Study|Withdrawal by Subject|7|||
164165915|NCT01052480|592970624|FG000|Overall Study|Physician Decision|0|||
164165916|NCT01052480|592970625|FG001|Overall Study|Physician Decision|2|||
164165917|NCT01052480|592970624|FG000|Overall Study|Death|1|||
164165918|NCT01052480|592970625|FG001|Overall Study|Death|5|||
164165919|NCT00529373|592970626|FG000|Base Study|Adverse Event|525|||
164165920|NCT00529373|592970627|FG001|Base Study|Adverse Event|470|||
164165921|NCT00529373|592970626|FG000|Base Study|Lack of Efficacy|16|||
164165922|NCT00529373|592970627|FG001|Base Study|Lack of Efficacy|75|||
164165923|NCT00529373|592970626|FG000|Base Study|Lost to Follow-up|221|||
164165924|NCT00529373|592970627|FG001|Base Study|Lost to Follow-up|208|||
164165925|NCT00529373|592970626|FG000|Base Study|Other Protocol Specified Criteria|19|||
164165926|NCT00529373|592970627|FG001|Base Study|Other Protocol Specified Criteria|20|||
164165927|NCT00529373|592970626|FG000|Base Study|Physician Decision|60|||
164165928|NCT00529373|592970627|FG001|Base Study|Physician Decision|52|||
164165929|NCT00529373|592970626|FG000|Base Study|Protocol Violation|48|||
164165930|NCT00529373|592970627|FG001|Base Study|Protocol Violation|38|||
164165931|NCT00529373|592970626|FG000|Base Study|Withdrawal by Subject|1062|||
164165932|NCT00529373|592970627|FG001|Base Study|Withdrawal by Subject|967|||
164165933|NCT00529373|592970626|FG000|Base Study|Did not continue into Extension|1795|||
164165934|NCT00529373|592970627|FG001|Base Study|Did not continue into Extension|2238|||
164165935|NCT00529373|592970626|FG000|First Extension Study|Adverse Event|162|||
164165936|NCT00529373|592970627|FG001|First Extension Study|Adverse Event|142|||
164165937|NCT00529373|592970626|FG000|First Extension Study|Lack of Efficacy|65|||
164165938|NCT00529373|592970627|FG001|First Extension Study|Lack of Efficacy|427|||
164165939|NCT00529373|592970626|FG000|First Extension Study|Lost to Follow-up|41|||
164165940|NCT00529373|592970627|FG001|First Extension Study|Lost to Follow-up|37|||
164165941|NCT00529373|592970626|FG000|First Extension Study|Other|27|||
164165942|NCT00529373|592970627|FG001|First Extension Study|Other|47|||
164165943|NCT00529373|592970626|FG000|First Extension Study|Physician Decision|50|||
164165944|NCT00529373|592970627|FG001|First Extension Study|Physician Decision|45|||
164165945|NCT00529373|592970626|FG000|First Extension Study|Protocol Violation|16|||
164165946|NCT00529373|592970627|FG001|First Extension Study|Protocol Violation|13|||
164165947|NCT00529373|592970626|FG000|First Extension Study|Withdrawal by Subject|296|||
164166097|NCT03634033|592972597|FG005|Overall Study|Lost to Follow-up|1|||
164165948|NCT00529373|592970627|FG001|First Extension Study|Withdrawal by Subject|287|||
164165949|NCT00529373|592970626|FG000|First Extension Study|Disposition record non-existing|0|||
164165950|NCT00529373|592970627|FG001|First Extension Study|Disposition record non-existing|1|||
164165951|NCT00529373|592970626|FG000|First Extension Study|Discontinued after 5 years completion|208|||
164165952|NCT00529373|592970627|FG001|First Extension Study|Discontinued after 5 years completion|346|||
164165953|NCT00529373|592970626|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
164165954|NCT00529373|592970627|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
164165955|NCT00529373|592970626|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
164165956|NCT00529373|592970627|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
164165957|NCT00529373|592970626|FG000|Second Extension Study|Adverse Event|101|||
164165958|NCT00529373|592970627|FG001|Second Extension Study|Adverse Event|51|||
164165959|NCT00529373|592970626|FG000|Second Extension Study|Lack of Efficacy|7|||
164165960|NCT00529373|592970627|FG001|Second Extension Study|Lack of Efficacy|15|||
164165961|NCT00529373|592970626|FG000|Second Extension Study|Lost to Follow-up|18|||
164165962|NCT00529373|592970627|FG001|Second Extension Study|Lost to Follow-up|12|||
164165963|NCT00529373|592970626|FG000|Second Extension Study|Other|7|||
164165964|NCT00529373|592970627|FG001|Second Extension Study|Other|12|||
164165965|NCT00529373|592970626|FG000|Second Extension Study|Physician Decision|63|||
164165966|NCT00529373|592970627|FG001|Second Extension Study|Physician Decision|26|||
164165967|NCT00529373|592970626|FG000|Second Extension Study|Protocol Violation|2|||
164165968|NCT00529373|592970627|FG001|Second Extension Study|Protocol Violation|1|||
164165969|NCT00529373|592970626|FG000|Second Extension Study|Withdrawal by Subject|97|||
164165970|NCT00529373|592970627|FG001|Second Extension Study|Withdrawal by Subject|75|||
164165971|NCT00529373|592970626|FG000|Second Extension Study|Status Missing|5|||
164165972|NCT00529373|592970627|FG001|Second Extension Study|Status Missing|5|||
164165973|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
164165974|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
164165975|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
164165976|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
164165977|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
164165978|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
164165979|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
164165980|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
164165981|NCT01074268|592970628|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
164165982|NCT01074268|592970629|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
164165983|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
164165984|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
164165985|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
164165986|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
164165987|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
164165988|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
164165989|NCT01074268|592970628|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
164165990|NCT01074268|592970629|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
164165991|NCT01578239|592970630|FG000|Treatment Period|Progressive Disease|19|||
164165992|NCT01578239|592970631|FG001|Treatment Period|Progressive Disease|64|||
164165993|NCT01578239|592970630|FG000|Treatment Period|Physician Decision|17|||
164165994|NCT01578239|592970631|FG001|Treatment Period|Physician Decision|17|||
164165995|NCT01578239|592970630|FG000|Treatment Period|Adverse Event|13|||
164165996|NCT01578239|592970631|FG001|Treatment Period|Adverse Event|10|||
164165997|NCT01578239|592970630|FG000|Treatment Period|Non-compliance|2|||
164165998|NCT01578239|592970631|FG001|Treatment Period|Non-compliance|0|||
164165999|NCT01578239|592970630|FG000|Treatment Period|Withdrawal by Subject|10|||
164166000|NCT01578239|592970631|FG001|Treatment Period|Withdrawal by Subject|9|||
164166001|NCT01578239|592970630|FG000|Treatment Period|Other|6|||
164166002|NCT01578239|592970631|FG001|Treatment Period|Other|1|||
164166003|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Death|69|||
164166004|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Death|64|||
164166005|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
164166006|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
164166007|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
164166008|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
164166009|NCT01578239|592970630|FG000|Long-term Follow-Up Period|Other|2|||
164166010|NCT01578239|592970631|FG001|Long-term Follow-Up Period|Other|2|||
164166011|NCT02347813|592970636|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
164166012|NCT02347813|592970637|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
164166013|NCT02347813|592970636|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
164166014|NCT02347813|592970637|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
164166015|NCT01119859|592970640|FG000|Overall Study|Adverse Event|9|||
164166016|NCT01119859|592970641|FG001|Overall Study|Adverse Event|10|||
164166017|NCT01119859|592970640|FG000|Overall Study|Death|2|||
164166018|NCT01119859|592970641|FG001|Overall Study|Death|0|||
164166019|NCT01119859|592970640|FG000|Overall Study|Insufficient therapeutic response|7|||
164166020|NCT01119859|592970641|FG001|Overall Study|Insufficient therapeutic response|14|||
164166021|NCT01119859|592970640|FG000|Overall Study|Refused treatment|3|||
164166022|NCT01119859|592970641|FG001|Overall Study|Refused treatment|6|||
164166023|NCT01119859|592970640|FG000|Overall Study|Failure to return|3|||
164166024|NCT01119859|592970641|FG001|Overall Study|Failure to return|0|||
164166025|NCT01134939|592970642|FG000|Overall Study|Adverse Event|9|||
164166026|NCT01134939|592970643|FG001|Overall Study|Adverse Event|3|||
164166027|NCT01134939|592970644|FG002|Overall Study|Adverse Event|4|||
164166028|NCT01134939|592970645|FG003|Overall Study|Adverse Event|5|||
164166029|NCT01134939|592970646|FG004|Overall Study|Adverse Event|5|||
164166030|NCT01134939|592970647|FG005|Overall Study|Adverse Event|5|||
164166031|NCT01134939|592970648|FG006|Overall Study|Adverse Event|1|||
164166032|NCT01134939|592970649|FG007|Overall Study|Adverse Event|0|||
164166033|NCT01134939|592970642|FG000|Overall Study|Lack of Efficacy|2|||
164166034|NCT01134939|592970643|FG001|Overall Study|Lack of Efficacy|5|||
164166035|NCT01134939|592970644|FG002|Overall Study|Lack of Efficacy|1|||
164166036|NCT01134939|592970645|FG003|Overall Study|Lack of Efficacy|0|||
164166037|NCT01134939|592970646|FG004|Overall Study|Lack of Efficacy|3|||
164166038|NCT01134939|592970647|FG005|Overall Study|Lack of Efficacy|0|||
164166039|NCT01134939|592970648|FG006|Overall Study|Lack of Efficacy|1|||
164166040|NCT01134939|592970649|FG007|Overall Study|Lack of Efficacy|0|||
164166041|NCT01134939|592970642|FG000|Overall Study|Lost to Follow-up|2|||
164166042|NCT01134939|592970643|FG001|Overall Study|Lost to Follow-up|3|||
164166043|NCT01134939|592970644|FG002|Overall Study|Lost to Follow-up|0|||
164166044|NCT01134939|592970645|FG003|Overall Study|Lost to Follow-up|1|||
164166045|NCT01134939|592970646|FG004|Overall Study|Lost to Follow-up|2|||
164166046|NCT01134939|592970647|FG005|Overall Study|Lost to Follow-up|1|||
164166047|NCT01134939|592970648|FG006|Overall Study|Lost to Follow-up|0|||
164166048|NCT01134939|592970649|FG007|Overall Study|Lost to Follow-up|0|||
164166049|NCT01134939|592970642|FG000|Overall Study|Death|0|||
164166050|NCT01134939|592970643|FG001|Overall Study|Death|1|||
164166051|NCT01134939|592970644|FG002|Overall Study|Death|0|||
164166052|NCT01134939|592970645|FG003|Overall Study|Death|0|||
164166053|NCT01134939|592970646|FG004|Overall Study|Death|0|||
164166054|NCT01134939|592970647|FG005|Overall Study|Death|0|||
164166055|NCT01134939|592970648|FG006|Overall Study|Death|0|||
164166056|NCT01134939|592970649|FG007|Overall Study|Death|0|||
164166057|NCT01134939|592970642|FG000|Overall Study|Termination page not available|4|||
164166058|NCT01134939|592970643|FG001|Overall Study|Termination page not available|6|||
164166059|NCT01134939|592970644|FG002|Overall Study|Termination page not available|5|||
164166060|NCT01134939|592970645|FG003|Overall Study|Termination page not available|8|||
164166061|NCT01134939|592970646|FG004|Overall Study|Termination page not available|0|||
164166062|NCT01134939|592970647|FG005|Overall Study|Termination page not available|3|||
164166063|NCT01134939|592970648|FG006|Overall Study|Termination page not available|7|||
164166064|NCT01134939|592970649|FG007|Overall Study|Termination page not available|0|||
164166065|NCT02981082|592970653|FG000|Overall Study|Withdrawal by Subject|2|||
164166066|NCT02981082|592970654|FG001|Overall Study|Withdrawal by Subject|0|||
164166067|NCT02981082|592970653|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
164166068|NCT02981082|592970654|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
164166069|NCT02981082|592970653|FG000|Overall Study|Adverse Event|0|||
164166070|NCT02981082|592970654|FG001|Overall Study|Adverse Event|1|||
164166071|NCT03634033|592972592|FG000|Overall Study|Did not have a post-assessment|384|||
164166072|NCT03634033|592972593|FG001|Overall Study|Did not have a post-assessment|291|||
164166073|NCT03634033|592972594|FG002|Overall Study|Did not have a post-assessment|114|||
164166074|NCT03634033|592972595|FG003|Overall Study|Did not have a post-assessment|161|||
164166075|NCT03634033|592972596|FG004|Overall Study|Did not have a post-assessment|5|||
164166076|NCT03634033|592972597|FG005|Overall Study|Did not have a post-assessment|0|||
164166077|NCT03634033|592972598|FG006|Overall Study|Did not have a post-assessment|0|||
164166078|NCT03634033|592972592|FG000|Overall Study|Death|0|||
164166079|NCT03634033|592972593|FG001|Overall Study|Death|0|||
164166080|NCT03634033|592972594|FG002|Overall Study|Death|0|||
164166081|NCT03634033|592972595|FG003|Overall Study|Death|0|||
164166082|NCT03634033|592972596|FG004|Overall Study|Death|0|||
164166083|NCT03634033|592972597|FG005|Overall Study|Death|7|||
164166084|NCT03634033|592972598|FG006|Overall Study|Death|7|||
164166085|NCT03634033|592972592|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166086|NCT03634033|592972593|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166087|NCT03634033|592972594|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166088|NCT03634033|592972595|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166089|NCT03634033|592972596|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
164166090|NCT03634033|592972597|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
164166091|NCT03634033|592972598|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
164166092|NCT03634033|592972592|FG000|Overall Study|Lost to Follow-up|0|||
164166093|NCT03634033|592972593|FG001|Overall Study|Lost to Follow-up|0|||
164166094|NCT03634033|592972594|FG002|Overall Study|Lost to Follow-up|0|||
164166095|NCT03634033|592972595|FG003|Overall Study|Lost to Follow-up|0|||
164166096|NCT03634033|592972596|FG004|Overall Study|Lost to Follow-up|0|||
164166098|NCT03634033|592972598|FG006|Overall Study|Lost to Follow-up|2|||
164166099|NCT03634033|592972592|FG000|Overall Study|Withdrawal by Subject|0|||
164166100|NCT03634033|592972593|FG001|Overall Study|Withdrawal by Subject|0|||
164166101|NCT03634033|592972594|FG002|Overall Study|Withdrawal by Subject|0|||
164166102|NCT03634033|592972595|FG003|Overall Study|Withdrawal by Subject|0|||
164166103|NCT03634033|592972596|FG004|Overall Study|Withdrawal by Subject|0|||
164166104|NCT03634033|592972597|FG005|Overall Study|Withdrawal by Subject|0|||
164166105|NCT03634033|592972598|FG006|Overall Study|Withdrawal by Subject|1|||
164166106|NCT00956592|592972603|FG000|Overall Study|Protocol Violation|1|||
164166107|NCT00956592|592972604|FG001|Overall Study|Protocol Violation|3|||
164166108|NCT02162719|592972605|FG000|Overall Study|Death|41|||
164166109|NCT02162719|592972606|FG001|Overall Study|Death|46|||
164166110|NCT02162719|592972605|FG000|Overall Study|Lost to Follow-up|1|||
164166111|NCT02162719|592972606|FG001|Overall Study|Lost to Follow-up|3|||
164166112|NCT02162719|592972605|FG000|Overall Study|Disease Progression|2|||
164166113|NCT02162719|592972606|FG001|Overall Study|Disease Progression|1|||
164166114|NCT02162719|592972605|FG000|Overall Study|Withdrawal by Subject|8|||
164166115|NCT02162719|592972606|FG001|Overall Study|Withdrawal by Subject|2|||
164166116|NCT02162719|592972605|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
164166117|NCT02162719|592972606|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
164166118|NCT03555565|592972607|FG000|Overall Study|Case Report Forms Uncollected|2|||
164166119|NCT03555565|592972607|FG000|Overall Study|Protocol Deviation|13|||
164166120|NCT00723255|592972608|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
164166121|NCT00723255|592972608|FG000|Overall Study|Ineligible: Second primary|1|||
164166122|NCT00723255|592972608|FG000|Overall Study|Ineligible: Wrong Primary|2|||
164166123|NCT00614523|592972609|FG000|Overall Study|Adverse Event|4|||
164166124|NCT00614523|592972610|FG001|Overall Study|Adverse Event|20|||
164166125|NCT00614523|592972609|FG000|Overall Study|Death|5|||
164166126|NCT00614523|592972610|FG001|Overall Study|Death|8|||
164166127|NCT00614523|592972609|FG000|Overall Study|Lack of Efficacy|9|||
164166128|NCT00614523|592972610|FG001|Overall Study|Lack of Efficacy|11|||
164166129|NCT00614523|592972609|FG000|Overall Study|Lost to Follow-up|0|||
164166130|NCT00614523|592972610|FG001|Overall Study|Lost to Follow-up|1|||
164166131|NCT00614523|592972609|FG000|Overall Study|Protocol Violation|3|||
164166132|NCT00614523|592972610|FG001|Overall Study|Protocol Violation|2|||
164166133|NCT00614523|592972609|FG000|Overall Study|Withdrawal by Subject|12|||
164166134|NCT00614523|592972610|FG001|Overall Study|Withdrawal by Subject|22|||
164166135|NCT00614523|592972609|FG000|Overall Study|Other|6|||
164166136|NCT00614523|592972610|FG001|Overall Study|Other|11|||
164166137|NCT00614523|592972609|FG000|Overall Study|Ineligibility Determined|1|||
164166138|NCT00614523|592972610|FG001|Overall Study|Ineligibility Determined|2|||
164166139|NCT00614523|592972609|FG000|Overall Study|Disease Progression|0|||
164166140|NCT00614523|592972610|FG001|Overall Study|Disease Progression|8|||
164166141|NCT00614523|592972609|FG000|Overall Study|Administrative Decision|23|||
164166142|NCT00614523|592972610|FG001|Overall Study|Administrative Decision|46|||
164166143|NCT03854370|592972619|FG000|Overall Study|samples not collected|1|||
164166144|NCT03854370|592972620|FG001|Overall Study|samples not collected|1|||
164166145|NCT03854370|592972621|FG002|Overall Study|samples not collected|1|||
164166146|NCT03854370|592972622|FG003|Overall Study|samples not collected|1|||
164166147|NCT00452673|592972623|FG000|Dose Escalation Period|Disease Progression|6|||
164166148|NCT00452673|592972624|FG001|Dose Escalation Period|Disease Progression|6|||
164166149|NCT00452673|592972625|FG002|Dose Escalation Period|Disease Progression|2|||
164166150|NCT00452673|592972626|FG003|Dose Escalation Period|Disease Progression|6|||
164166151|NCT00452673|592972627|FG004|Dose Escalation Period|Disease Progression|0|||
164166152|NCT00452673|592972623|FG000|Dose Escalation Period|study drug toxicity|1|||
164166153|NCT00452673|592972624|FG001|Dose Escalation Period|study drug toxicity|3|||
164166154|NCT00452673|592972625|FG002|Dose Escalation Period|study drug toxicity|3|||
164166155|NCT00452673|592972626|FG003|Dose Escalation Period|study drug toxicity|1|||
164166156|NCT00452673|592972627|FG004|Dose Escalation Period|study drug toxicity|0|||
164166157|NCT00452673|592972623|FG000|Dose Escalation Period|Other|0|||
164166158|NCT00452673|592972624|FG001|Dose Escalation Period|Other|0|||
164166159|NCT00452673|592972625|FG002|Dose Escalation Period|Other|1|||
164166160|NCT00452673|592972626|FG003|Dose Escalation Period|Other|0|||
164166161|NCT00452673|592972627|FG004|Dose Escalation Period|Other|0|||
164166162|NCT00452673|592972623|FG000|Dose Escalation Period|Adverse Event|0|||
164166163|NCT00452673|592972624|FG001|Dose Escalation Period|Adverse Event|0|||
164166164|NCT00452673|592972625|FG002|Dose Escalation Period|Adverse Event|0|||
164166165|NCT00452673|592972626|FG003|Dose Escalation Period|Adverse Event|1|||
164166166|NCT00452673|592972627|FG004|Dose Escalation Period|Adverse Event|0|||
164166167|NCT00452673|592972623|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
164166168|NCT00452673|592972624|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
164166169|NCT00452673|592972625|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
164166170|NCT00452673|592972626|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
164166171|NCT00452673|592972627|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
164166172|NCT00452673|592972623|FG000|Dose Expansion Period|Disease Progression|0|||
164166173|NCT00452673|592972624|FG001|Dose Expansion Period|Disease Progression|0|||
164166174|NCT00452673|592972625|FG002|Dose Expansion Period|Disease Progression|0|||
164166175|NCT00452673|592972626|FG003|Dose Expansion Period|Disease Progression|0|||
164166176|NCT00452673|592972627|FG004|Dose Expansion Period|Disease Progression|19|||
164166177|NCT00452673|592972623|FG000|Dose Expansion Period|Other|0|||
164166178|NCT00452673|592972624|FG001|Dose Expansion Period|Other|0|||
164166179|NCT00452673|592972625|FG002|Dose Expansion Period|Other|0|||
164166180|NCT00452673|592972626|FG003|Dose Expansion Period|Other|0|||
164166181|NCT00452673|592972627|FG004|Dose Expansion Period|Other|2|||
164166182|NCT02656290|592972628|FG000|Overall Study|Lost to Follow-up|1|||
164166183|NCT02656290|592972628|FG000|Overall Study|Reintervention|3|||
164166184|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
164166185|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
164166186|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
164166187|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
164166188|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
164166189|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
164166190|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
164166191|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
164166192|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Death|0|||
164166193|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Death|1|||
164166194|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
164166195|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
164166196|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
164166197|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
164166198|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
164166199|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
164166200|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
164166201|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
164166202|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
164166203|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
164166204|NCT00394836|592972631|FG000|Teatment or Follow-up Phase|Non compliance|0|||
164166205|NCT00394836|592972632|FG001|Teatment or Follow-up Phase|Non compliance|1|||
164166206|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
164166207|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
164166208|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
164166209|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
164166210|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
164166211|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
164166212|NCT00394836|592972631|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
164166213|NCT00394836|592972632|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
164166214|NCT03692325|592972633|FG000|Overall Study|Adverse Event|2|||
164166215|NCT03692325|592972633|FG000|Overall Study|Progression/Recurrence|2|||
164166216|NCT02817516|592972634|FG000|Overall Study|Other|0|||
164166217|NCT02817516|592972635|FG001|Overall Study|Other|0|||
164166218|NCT02817516|592972636|FG002|Overall Study|Other|1|||
164166219|NCT02817516|592972637|FG003|Overall Study|Other|0|||
164166220|NCT00748189|592972638|FG000|Overall Study|Death|99|||
164166221|NCT00748189|592972639|FG001|Overall Study|Death|84|||
164166222|NCT00748189|592972638|FG000|Overall Study|Withdrawal by Subject|23|||
164166223|NCT00748189|592972639|FG001|Overall Study|Withdrawal by Subject|29|||
164166224|NCT00748189|592972638|FG000|Overall Study|Physician Decision|16|||
164166225|NCT00748189|592972639|FG001|Overall Study|Physician Decision|5|||
164166226|NCT00748189|592972638|FG000|Overall Study|Lost to Follow-up|8|||
164166227|NCT00748189|592972639|FG001|Overall Study|Lost to Follow-up|15|||
164166228|NCT00748189|592972638|FG000|Overall Study|Study terminated by Sponsor|70|||
164166229|NCT00748189|592972639|FG001|Overall Study|Study terminated by Sponsor|79|||
164166230|NCT04481191|592972646|FG000|Overall Study|Withdrawn by parent/guardian|15|||
164166231|NCT04481191|592972647|FG001|Overall Study|Withdrawn by parent/guardian|10|||
164166232|NCT00546117|592972652|FG000|Overall Study|Withdrawal by Subject|3|||
164166233|NCT00546117|592972653|FG001|Overall Study|Withdrawal by Subject|0|||
164166234|NCT00546117|592972652|FG000|Overall Study|Inability to schedule follow-up visit|1|||
164166235|NCT00546117|592972653|FG001|Overall Study|Inability to schedule follow-up visit|0|||
164166236|NCT00610155|592972657|FG000|Period 1|Withdrawal by Subject|0|||
164166237|NCT00610155|592972658|FG001|Period 1|Withdrawal by Subject|0|||
164166238|NCT00610155|592972659|FG002|Period 1|Withdrawal by Subject|1|||
164166239|NCT00610155|592972660|FG003|Period 1|Withdrawal by Subject|0|||
164166240|NCT00610155|592972661|FG004|Period 1|Withdrawal by Subject|0|||
164166241|NCT00610155|592972662|FG005|Period 1|Withdrawal by Subject|0|||
164166242|NCT00610155|592972657|FG000|Period 3|Adverse Event|1|||
164166243|NCT00610155|592972658|FG001|Period 3|Adverse Event|0|||
164166244|NCT00610155|592972659|FG002|Period 3|Adverse Event|0|||
164166245|NCT00610155|592972660|FG003|Period 3|Adverse Event|0|||
164166246|NCT00610155|592972661|FG004|Period 3|Adverse Event|0|||
164166247|NCT00610155|592972662|FG005|Period 3|Adverse Event|0|||
164166248|NCT01560234|592972663|FG000|Overall Study|Lost to Follow-up|3|||
164166249|NCT01560234|592972664|FG001|Overall Study|Lost to Follow-up|0|||
164166250|NCT01560234|592972665|FG002|Overall Study|Lost to Follow-up|1|||
164166251|NCT01560234|592972666|FG003|Overall Study|Lost to Follow-up|0|||
164166252|NCT01560234|592972667|FG004|Overall Study|Lost to Follow-up|0|||
164166253|NCT01560234|592972668|FG005|Overall Study|Lost to Follow-up|2|||
164166254|NCT01560234|592972669|FG006|Overall Study|Lost to Follow-up|0|||
164166255|NCT01560234|592972670|FG007|Overall Study|Lost to Follow-up|2|||
164166256|NCT02028767|592972671|FG000|Treatment Period 2|Non compliant with protocol|1|||
164166257|NCT02028767|592972672|FG001|Treatment Period 2|Non compliant with protocol|0|||
164166258|NCT02028767|592972671|FG000|Treatment Period 2|Reason other than those specified above|1|||
164166259|NCT02028767|592972672|FG001|Treatment Period 2|Reason other than those specified above|0|||
164166260|NCT01284348|592972673|FG000|Overall Study|Death|1|||
164166261|NCT01284348|592972674|FG001|Overall Study|Death|1|||
164166262|NCT01284348|592972673|FG000|Overall Study|Withdrew consent|0|||
164166263|NCT01284348|592972674|FG001|Overall Study|Withdrew consent|1|||
164166264|NCT01284348|592972673|FG000|Overall Study|Status not recorded|9|||
164166265|NCT01284348|592972674|FG001|Overall Study|Status not recorded|10|||
164166266|NCT00083759|592972680|FG000|Overall Study|Adverse Event|5|||
164166267|NCT00083759|592972681|FG001|Overall Study|Adverse Event|3|||
164166268|NCT00083759|592972680|FG000|Overall Study|Lost to Follow-up|1|||
164166269|NCT00083759|592972681|FG001|Overall Study|Lost to Follow-up|0|||
164166270|NCT00083759|592972680|FG000|Overall Study|Death|1|||
164166271|NCT00083759|592972681|FG001|Overall Study|Death|1|||
164166272|NCT00083759|592972680|FG000|Overall Study|Inadequate Therapeutic Response|32|||
164166273|NCT00083759|592972681|FG001|Overall Study|Inadequate Therapeutic Response|35|||
164166274|NCT00083759|592972680|FG000|Overall Study|Subject Withdrew Consent|2|||
164166275|NCT00083759|592972681|FG001|Overall Study|Subject Withdrew Consent|2|||
164166276|NCT00083759|592972680|FG000|Overall Study|Non-Compliance|1|||
164166277|NCT00083759|592972681|FG001|Overall Study|Non-Compliance|0|||
164166278|NCT00083759|592972680|FG000|Overall Study|Sponsor's Discretion|28|||
164166279|NCT00083759|592972681|FG001|Overall Study|Sponsor's Discretion|29|||
164166280|NCT00083759|592972680|FG000|Overall Study|Other|14|||
164166281|NCT00083759|592972681|FG001|Overall Study|Other|13|||
164166282|NCT02347774|592972682|FG000|Study Participation|Lost to Follow-up|3|||
164166283|NCT02347774|592972683|FG001|Study Participation|Lost to Follow-up|6|||
164166284|NCT02347774|592972684|FG002|Study Participation|Lost to Follow-up|2|||
164166285|NCT02347774|592972682|FG000|Study Participation|Withdrawal by Subject|8|||
164166286|NCT02347774|592972683|FG001|Study Participation|Withdrawal by Subject|9|||
164166287|NCT02347774|592972684|FG002|Study Participation|Withdrawal by Subject|15|||
164166288|NCT02347774|592972682|FG000|Study Participation|Adverse Event|1|||
164166289|NCT02347774|592972683|FG001|Study Participation|Adverse Event|4|||
164166290|NCT02347774|592972684|FG002|Study Participation|Adverse Event|6|||
164166291|NCT02347774|592972682|FG000|Study Participation|withdrew consent|1|||
164166292|NCT02347774|592972683|FG001|Study Participation|withdrew consent|1|||
164166293|NCT02347774|592972684|FG002|Study Participation|withdrew consent|1|||
164166294|NCT02347774|592972682|FG000|Study Participation|Met Prolonged QT criteria|1|||
164166295|NCT02347774|592972683|FG001|Study Participation|Met Prolonged QT criteria|0|||
164166296|NCT02347774|592972684|FG002|Study Participation|Met Prolonged QT criteria|0|||
164166297|NCT02347774|592972682|FG000|Study Participation|non-compliance with study drug|0|||
164166298|NCT02347774|592972683|FG001|Study Participation|non-compliance with study drug|1|||
164166299|NCT02347774|592972684|FG002|Study Participation|non-compliance with study drug|0|||
164166300|NCT02347774|592972682|FG000|Study Participation|incarceration|1|||
164166301|NCT02347774|592972683|FG001|Study Participation|incarceration|0|||
164166302|NCT02347774|592972684|FG002|Study Participation|incarceration|0|||
164166303|NCT02347774|592972682|FG000|Study Participation|randomized in error|0|||
164166304|NCT02347774|592972683|FG001|Study Participation|randomized in error|0|||
164166305|NCT02347774|592972684|FG002|Study Participation|randomized in error|1|||
164166306|NCT02347774|592972682|FG000|On Study Treatment|Adverse Event|9|||
164166307|NCT02347774|592972683|FG001|On Study Treatment|Adverse Event|15|||
164166308|NCT02347774|592972684|FG002|On Study Treatment|Adverse Event|19|||
164166309|NCT02347774|592972682|FG000|On Study Treatment|Lack of Efficacy|3|||
164166310|NCT02347774|592972683|FG001|On Study Treatment|Lack of Efficacy|0|||
164166311|NCT02347774|592972684|FG002|On Study Treatment|Lack of Efficacy|2|||
164166312|NCT02347774|592972682|FG000|On Study Treatment|non-complicance with study medication|0|||
164166313|NCT02347774|592972683|FG001|On Study Treatment|non-complicance with study medication|2|||
164166314|NCT02347774|592972684|FG002|On Study Treatment|non-complicance with study medication|0|||
164166315|NCT02347774|592972682|FG000|On Study Treatment|Protocol Violation|0|||
164166316|NCT02347774|592972683|FG001|On Study Treatment|Protocol Violation|0|||
164166317|NCT02347774|592972684|FG002|On Study Treatment|Protocol Violation|1|||
164166318|NCT02347774|592972682|FG000|On Study Treatment|withdrew consent|9|||
164166319|NCT02347774|592972683|FG001|On Study Treatment|withdrew consent|8|||
164166320|NCT02347774|592972684|FG002|On Study Treatment|withdrew consent|12|||
164166321|NCT02347774|592972682|FG000|On Study Treatment|Lost to Follow-up|2|||
164166322|NCT02347774|592972683|FG001|On Study Treatment|Lost to Follow-up|6|||
164166323|NCT02347774|592972684|FG002|On Study Treatment|Lost to Follow-up|1|||
164166324|NCT02347774|592972682|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
164166325|NCT02347774|592972683|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
164166326|NCT02347774|592972684|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
164166327|NCT02347774|592972682|FG000|On Study Treatment|ranomized in error|0|||
164166328|NCT02347774|592972683|FG001|On Study Treatment|ranomized in error|0|||
164166329|NCT02347774|592972684|FG002|On Study Treatment|ranomized in error|1|||
164166330|NCT04112043|592972686|FG000|Overall Study|Withdrawal by Subject|1|||
164166331|NCT04112043|592972687|FG001|Overall Study|Withdrawal by Subject|1|||
164166332|NCT04112043|592972688|FG002|Overall Study|Withdrawal by Subject|1|||
164166333|NCT04112043|592972686|FG000|Overall Study|Taking NR supplement|1|||
164166334|NCT04112043|592972687|FG001|Overall Study|Taking NR supplement|0|||
164166335|NCT04112043|592972688|FG002|Overall Study|Taking NR supplement|0|||
164166336|NCT04112043|592972686|FG000|Overall Study|Adverse Event|0|||
164166337|NCT04112043|592972687|FG001|Overall Study|Adverse Event|1|||
164166338|NCT04112043|592972688|FG002|Overall Study|Adverse Event|0|||
164166339|NCT05338502|592972695|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
164166340|NCT05338502|592972696|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
164166341|NCT05338502|592972697|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
164166342|NCT05338502|592972695|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
164166343|NCT05338502|592972696|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
164166344|NCT05338502|592972697|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
164166345|NCT01062113|592972705|FG000|Overall Study|Adverse Event|1|||
164166346|NCT01062113|592972706|FG001|Overall Study|Adverse Event|0|||
164166347|NCT01062113|592972707|FG002|Overall Study|Adverse Event|0|||
164166348|NCT01062113|592972705|FG000|Overall Study|Lack of Efficacy|38|||
164166349|NCT01062113|592972706|FG001|Overall Study|Lack of Efficacy|22|||
164166350|NCT01062113|592972707|FG002|Overall Study|Lack of Efficacy|31|||
164166351|NCT01062113|592972705|FG000|Overall Study|Withdrawal by Subject|1|||
164166352|NCT01062113|592972706|FG001|Overall Study|Withdrawal by Subject|0|||
164166353|NCT01062113|592972707|FG002|Overall Study|Withdrawal by Subject|0|||
164166354|NCT03499899|592972708|FG000|Overall Study|Adverse Event|2|||
164166355|NCT03499899|592972709|FG001|Overall Study|Adverse Event|3|||
164166356|NCT03499899|592972710|FG002|Overall Study|Adverse Event|3|||
164166357|NCT03499899|592972708|FG000|Overall Study|Death|0|||
164166358|NCT03499899|592972709|FG001|Overall Study|Death|0|||
164166359|NCT03499899|592972710|FG002|Overall Study|Death|1|||
164166360|NCT03499899|592972708|FG000|Overall Study|Physician Decision|3|||
164166361|NCT03499899|592972709|FG001|Overall Study|Physician Decision|6|||
164166362|NCT03499899|592972710|FG002|Overall Study|Physician Decision|6|||
164166363|NCT03499899|592972708|FG000|Overall Study|Progressive disease|15|||
164166364|NCT03499899|592972709|FG001|Overall Study|Progressive disease|23|||
164166365|NCT03499899|592972710|FG002|Overall Study|Progressive disease|23|||
164166366|NCT03499899|592972708|FG000|Overall Study|Patient decision|0|||
164166367|NCT03499899|592972709|FG001|Overall Study|Patient decision|1|||
164166368|NCT03499899|592972710|FG002|Overall Study|Patient decision|1|||
164166369|NCT03499899|592972708|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
164166370|NCT03499899|592972709|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
164166371|NCT03499899|592972710|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
164166372|NCT03655470|592972711|FG000|Overall Study|Lost to Follow-up|6|||
164166373|NCT03655470|592972712|FG001|Overall Study|Lost to Follow-up|7|||
164166374|NCT03063086|592972713|FG000|Overall Study|technical problems|1|||
164166375|NCT03063086|592972714|FG001|Overall Study|technical problems|0|||
164166376|NCT03063086|592972715|FG002|Overall Study|technical problems|0|||
164166377|NCT03063086|592972716|FG003|Overall Study|technical problems|0|||
164166378|NCT03063086|592972717|FG004|Overall Study|technical problems|0|||
164166379|NCT03063086|592972718|FG005|Overall Study|technical problems|0|||
164166380|NCT03063086|592972713|FG000|Overall Study|Adverse Event|1|||
164166381|NCT03063086|592972714|FG001|Overall Study|Adverse Event|1|||
164166382|NCT03063086|592972715|FG002|Overall Study|Adverse Event|1|||
164166383|NCT03063086|592972716|FG003|Overall Study|Adverse Event|1|||
164166384|NCT03063086|592972717|FG004|Overall Study|Adverse Event|0|||
164166385|NCT03063086|592972718|FG005|Overall Study|Adverse Event|0|||
164166386|NCT03063086|592972713|FG000|Overall Study|subject/guardian decision|1|||
164166387|NCT03063086|592972714|FG001|Overall Study|subject/guardian decision|0|||
164166388|NCT03063086|592972715|FG002|Overall Study|subject/guardian decision|0|||
164166389|NCT03063086|592972716|FG003|Overall Study|subject/guardian decision|0|||
164166390|NCT03063086|592972717|FG004|Overall Study|subject/guardian decision|0|||
164166391|NCT03063086|592972718|FG005|Overall Study|subject/guardian decision|0|||
164166392|NCT03063086|592972713|FG000|Overall Study|Non-compliance with study treatment|0|||
164166393|NCT03063086|592972714|FG001|Overall Study|Non-compliance with study treatment|0|||
164166394|NCT03063086|592972715|FG002|Overall Study|Non-compliance with study treatment|0|||
164166395|NCT03063086|592972716|FG003|Overall Study|Non-compliance with study treatment|1|||
164166396|NCT03063086|592972717|FG004|Overall Study|Non-compliance with study treatment|0|||
164166397|NCT03063086|592972718|FG005|Overall Study|Non-compliance with study treatment|1|||
164166398|NCT03063086|592972713|FG000|Overall Study|Physician Decision|0|||
164166399|NCT03063086|592972714|FG001|Overall Study|Physician Decision|0|||
164166400|NCT03063086|592972715|FG002|Overall Study|Physician Decision|0|||
164166401|NCT03063086|592972716|FG003|Overall Study|Physician Decision|1|||
164166402|NCT03063086|592972717|FG004|Overall Study|Physician Decision|0|||
164166403|NCT03063086|592972718|FG005|Overall Study|Physician Decision|0|||
164166404|NCT03702010|592972721|FG000|Follow-up (30days)|Lack of Efficacy|2|||
164166405|NCT03702010|592972722|FG001|Follow-up (30days)|Lack of Efficacy|2|||
164166406|NCT02549287|592972735|FG000|Overall Study|Lost to Follow-up|65|||
164166407|NCT02549287|592972736|FG001|Overall Study|Lost to Follow-up|26|||
164166408|NCT02549287|592972735|FG000|Overall Study|Withdrawal by Subject|15|||
164166409|NCT02549287|592972736|FG001|Overall Study|Withdrawal by Subject|6|||
164166410|NCT03793842|592972737|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
164166411|NCT03793842|592972738|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
164166412|NCT03793842|592972737|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
164166413|NCT03793842|592972738|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
164166414|NCT00427921|592972742|FG000|Overall Study|Adverse Event|26|||
164166415|NCT00427921|592972742|FG000|Overall Study|Withdrawal by Subject|4|||
164166416|NCT00427921|592972742|FG000|Overall Study|Lost to Follow-up|2|||
164166417|NCT00427921|592972742|FG000|Overall Study|Other reason not specified|10|||
164166418|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Hospitalization|1|||
164166419|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
164166420|NCT00427921|592972742|FG000|Overall Study|Adverse Event + No Response|1|||
164166421|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
164166422|NCT00427921|592972742|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
164166423|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Lost Response|1|||
164166424|NCT00427921|592972742|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
164166425|NCT00427921|592972742|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
164166426|NCT00765336|592972745|FG000|Overall Study|Protocol Violation|4|||
164166427|NCT00765336|592972746|FG001|Overall Study|Protocol Violation|2|||
164166428|NCT00765336|592972745|FG000|Overall Study|Withdrawal by Subject|6|||
164166429|NCT00765336|592972746|FG001|Overall Study|Withdrawal by Subject|4|||
164166430|NCT00765336|592972745|FG000|Overall Study|Lost to Follow-up|7|||
164166431|NCT00765336|592972746|FG001|Overall Study|Lost to Follow-up|9|||
164166432|NCT00765336|592972745|FG000|Overall Study|Adverse Event|2|||
164166433|NCT00765336|592972746|FG001|Overall Study|Adverse Event|1|||
164166434|NCT00733421|592972747|FG000|Overall Study|Withdrawal by Subject|1|||
164166435|NCT00733421|592972748|FG001|Overall Study|Withdrawal by Subject|1|||
164166436|NCT04185220|592972752|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
164166437|NCT04185220|592972753|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
164166438|NCT04185220|592972752|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
164166439|NCT04185220|592972753|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
164166440|NCT01029782|592972754|FG000|Overall Study|Lost to Follow-up|2|||
164166441|NCT01029782|592972755|FG001|Overall Study|Lost to Follow-up|2|||
164166442|NCT01029782|592972754|FG000|Overall Study|Diagnosis changed|1|||
164166443|NCT01029782|592972755|FG001|Overall Study|Diagnosis changed|1|||
164166444|NCT01029782|592972754|FG000|Overall Study|Adverse Event|0|||
164166445|NCT01029782|592972755|FG001|Overall Study|Adverse Event|1|||
164166446|NCT01029782|592972754|FG000|Overall Study|Physician Decision|0|||
164166447|NCT01029782|592972755|FG001|Overall Study|Physician Decision|1|||
164166448|NCT01029782|592972754|FG000|Overall Study|Protocol Violation|0|||
164166449|NCT01029782|592972755|FG001|Overall Study|Protocol Violation|2|||
164166450|NCT01029782|592972754|FG000|Overall Study|Withdrawal by Subject|0|||
164166451|NCT01029782|592972755|FG001|Overall Study|Withdrawal by Subject|1|||
164166452|NCT02195869|592972759|FG000|Overall Study|cGVHD Progression|5|||
164166453|NCT02195869|592972759|FG000|Overall Study|Malignancy Progression/relapse|2|||
164166454|NCT02195869|592972759|FG000|Overall Study|Adverse Event|15|||
164166455|NCT02195869|592972759|FG000|Overall Study|Withdrawal by Subject|7|||
164166456|NCT02195869|592972759|FG000|Overall Study|Physician Decision|4|||
164166457|NCT02195869|592972759|FG000|Overall Study|Study Terminated by Sponsor|7|||
164166458|NCT02195869|592972759|FG000|Overall Study|Noncompliance with study drug|2|||
164166459|NCT01314872|592972762|FG000|Treatment Period 1|Protocol Violation|2|||
164166460|NCT01314872|592972763|FG001|Treatment Period 1|Protocol Violation|1|||
164166461|NCT01314872|592972764|FG002|Treatment Period 1|Protocol Violation|1|||
164166462|NCT01314872|592972765|FG003|Treatment Period 1|Protocol Violation|0|||
164166463|NCT01314872|592972766|FG004|Treatment Period 1|Protocol Violation|1|||
164166464|NCT01314872|592972767|FG005|Treatment Period 1|Protocol Violation|0|||
164166465|NCT01314872|592972768|FG006|Treatment Period 1|Protocol Violation|0|||
164166466|NCT01314872|592972769|FG007|Treatment Period 1|Protocol Violation|0|||
164166467|NCT01314872|592972770|FG008|Treatment Period 1|Protocol Violation|0|||
164166468|NCT01314872|592972771|FG009|Treatment Period 1|Protocol Violation|1|||
164166469|NCT01314872|592972772|FG010|Treatment Period 1|Protocol Violation|1|||
164166470|NCT01314872|592972773|FG011|Treatment Period 1|Protocol Violation|0|||
164166471|NCT01314872|592972774|FG012|Treatment Period 1|Protocol Violation|0|||
164166472|NCT01314872|592972775|FG013|Treatment Period 1|Protocol Violation|0|||
164166473|NCT01314872|592972776|FG014|Treatment Period 1|Protocol Violation|0|||
164166474|NCT01314872|592972762|FG000|Treatment Period 1|Physician Decision|0|||
164166475|NCT01314872|592972763|FG001|Treatment Period 1|Physician Decision|1|||
164166476|NCT01314872|592972764|FG002|Treatment Period 1|Physician Decision|0|||
164166477|NCT01314872|592972765|FG003|Treatment Period 1|Physician Decision|1|||
164166478|NCT01314872|592972766|FG004|Treatment Period 1|Physician Decision|0|||
164166479|NCT01314872|592972767|FG005|Treatment Period 1|Physician Decision|0|||
164166480|NCT01314872|592972768|FG006|Treatment Period 1|Physician Decision|0|||
164166481|NCT01314872|592972769|FG007|Treatment Period 1|Physician Decision|0|||
164166482|NCT01314872|592972770|FG008|Treatment Period 1|Physician Decision|0|||
164166483|NCT01314872|592972771|FG009|Treatment Period 1|Physician Decision|1|||
164166484|NCT01314872|592972772|FG010|Treatment Period 1|Physician Decision|0|||
164166485|NCT01314872|592972773|FG011|Treatment Period 1|Physician Decision|0|||
164166486|NCT01314872|592972774|FG012|Treatment Period 1|Physician Decision|0|||
164166487|NCT01314872|592972775|FG013|Treatment Period 1|Physician Decision|0|||
164166488|NCT01314872|592972776|FG014|Treatment Period 1|Physician Decision|0|||
164166489|NCT01314872|592972762|FG000|Treatment Period 1|Lack of Efficacy|1|||
164166490|NCT01314872|592972763|FG001|Treatment Period 1|Lack of Efficacy|0|||
164166491|NCT01314872|592972764|FG002|Treatment Period 1|Lack of Efficacy|0|||
164166492|NCT01314872|592972765|FG003|Treatment Period 1|Lack of Efficacy|0|||
164166493|NCT01314872|592972766|FG004|Treatment Period 1|Lack of Efficacy|0|||
164166494|NCT01314872|592972767|FG005|Treatment Period 1|Lack of Efficacy|1|||
164166495|NCT01314872|592972768|FG006|Treatment Period 1|Lack of Efficacy|0|||
164166496|NCT01314872|592972769|FG007|Treatment Period 1|Lack of Efficacy|2|||
164166497|NCT01314872|592972770|FG008|Treatment Period 1|Lack of Efficacy|0|||
164166498|NCT01314872|592972771|FG009|Treatment Period 1|Lack of Efficacy|0|||
164166499|NCT01314872|592972772|FG010|Treatment Period 1|Lack of Efficacy|0|||
164166500|NCT01314872|592972773|FG011|Treatment Period 1|Lack of Efficacy|0|||
164166501|NCT01314872|592972774|FG012|Treatment Period 1|Lack of Efficacy|0|||
164166502|NCT01314872|592972775|FG013|Treatment Period 1|Lack of Efficacy|0|||
164166503|NCT01314872|592972776|FG014|Treatment Period 1|Lack of Efficacy|0|||
164166504|NCT01314872|592972762|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
164166505|NCT01314872|592972763|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
164166506|NCT01314872|592972764|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
164166507|NCT01314872|592972765|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
164166508|NCT01314872|592972766|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
164166509|NCT01314872|592972767|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
164166510|NCT01314872|592972768|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
164166511|NCT01314872|592972769|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
164166512|NCT01314872|592972770|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
164166513|NCT01314872|592972771|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
164166514|NCT01314872|592972772|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
164166515|NCT01314872|592972773|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
164166516|NCT01314872|592972774|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
164166517|NCT01314872|592972775|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
164166518|NCT01314872|592972776|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
164166519|NCT01314872|592972762|FG000|Treatment Period 1|Withdrawal by Subject|3|||
164166520|NCT01314872|592972763|FG001|Treatment Period 1|Withdrawal by Subject|1|||
164166521|NCT01314872|592972764|FG002|Treatment Period 1|Withdrawal by Subject|0|||
164166522|NCT01314872|592972765|FG003|Treatment Period 1|Withdrawal by Subject|2|||
164166523|NCT01314872|592972766|FG004|Treatment Period 1|Withdrawal by Subject|3|||
164166524|NCT01314872|592972767|FG005|Treatment Period 1|Withdrawal by Subject|1|||
164166525|NCT01314872|592972768|FG006|Treatment Period 1|Withdrawal by Subject|3|||
164166526|NCT01314872|592972769|FG007|Treatment Period 1|Withdrawal by Subject|2|||
164166527|NCT01314872|592972770|FG008|Treatment Period 1|Withdrawal by Subject|2|||
164166528|NCT01314872|592972771|FG009|Treatment Period 1|Withdrawal by Subject|2|||
164166529|NCT01314872|592972772|FG010|Treatment Period 1|Withdrawal by Subject|1|||
164166530|NCT01314872|592972773|FG011|Treatment Period 1|Withdrawal by Subject|0|||
164166531|NCT01314872|592972774|FG012|Treatment Period 1|Withdrawal by Subject|0|||
164166532|NCT01314872|592972775|FG013|Treatment Period 1|Withdrawal by Subject|0|||
164166533|NCT01314872|592972776|FG014|Treatment Period 1|Withdrawal by Subject|0|||
164166534|NCT01314872|592972762|FG000|Treatment Period 1|Lost to Follow-up|0|||
164166535|NCT01314872|592972763|FG001|Treatment Period 1|Lost to Follow-up|1|||
164166536|NCT01314872|592972764|FG002|Treatment Period 1|Lost to Follow-up|2|||
164166537|NCT01314872|592972765|FG003|Treatment Period 1|Lost to Follow-up|2|||
164166538|NCT01314872|592972766|FG004|Treatment Period 1|Lost to Follow-up|1|||
164166539|NCT01314872|592972767|FG005|Treatment Period 1|Lost to Follow-up|1|||
164166540|NCT01314872|592972768|FG006|Treatment Period 1|Lost to Follow-up|1|||
164166541|NCT01314872|592972769|FG007|Treatment Period 1|Lost to Follow-up|1|||
164166542|NCT01314872|592972770|FG008|Treatment Period 1|Lost to Follow-up|1|||
164166543|NCT01314872|592972771|FG009|Treatment Period 1|Lost to Follow-up|0|||
164166544|NCT01314872|592972772|FG010|Treatment Period 1|Lost to Follow-up|0|||
164166545|NCT01314872|592972773|FG011|Treatment Period 1|Lost to Follow-up|0|||
164166546|NCT01314872|592972774|FG012|Treatment Period 1|Lost to Follow-up|0|||
164166547|NCT01314872|592972775|FG013|Treatment Period 1|Lost to Follow-up|0|||
164166548|NCT01314872|592972776|FG014|Treatment Period 1|Lost to Follow-up|0|||
164166549|NCT01314872|592972762|FG000|Period 2|Protocol Violation|0|||
164166550|NCT01314872|592972763|FG001|Period 2|Protocol Violation|0|||
164166551|NCT01314872|592972764|FG002|Period 2|Protocol Violation|0|||
164166552|NCT01314872|592972765|FG003|Period 2|Protocol Violation|0|||
164166553|NCT01314872|592972766|FG004|Period 2|Protocol Violation|0|||
164166554|NCT01314872|592972767|FG005|Period 2|Protocol Violation|0|||
164166555|NCT01314872|592972768|FG006|Period 2|Protocol Violation|0|||
164166556|NCT01314872|592972769|FG007|Period 2|Protocol Violation|0|||
164166557|NCT01314872|592972770|FG008|Period 2|Protocol Violation|0|||
164166558|NCT01314872|592972771|FG009|Period 2|Protocol Violation|0|||
164166559|NCT01314872|592972772|FG010|Period 2|Protocol Violation|0|||
164166560|NCT01314872|592972773|FG011|Period 2|Protocol Violation|3|||
164166561|NCT01314872|592972774|FG012|Period 2|Protocol Violation|3|||
164166562|NCT01314872|592972775|FG013|Period 2|Protocol Violation|2|||
164166563|NCT01314872|592972776|FG014|Period 2|Protocol Violation|0|||
164166564|NCT01314872|592972762|FG000|Period 2|Non-compliance with study drug|0|||
164166565|NCT01314872|592972763|FG001|Period 2|Non-compliance with study drug|0|||
164166566|NCT01314872|592972764|FG002|Period 2|Non-compliance with study drug|0|||
164166567|NCT01314872|592972765|FG003|Period 2|Non-compliance with study drug|0|||
164166568|NCT01314872|592972766|FG004|Period 2|Non-compliance with study drug|0|||
164166569|NCT01314872|592972767|FG005|Period 2|Non-compliance with study drug|0|||
164166570|NCT01314872|592972768|FG006|Period 2|Non-compliance with study drug|0|||
164166571|NCT01314872|592972769|FG007|Period 2|Non-compliance with study drug|0|||
164166572|NCT01314872|592972770|FG008|Period 2|Non-compliance with study drug|0|||
164166573|NCT01314872|592972771|FG009|Period 2|Non-compliance with study drug|0|||
164166574|NCT01314872|592972772|FG010|Period 2|Non-compliance with study drug|0|||
164166575|NCT01314872|592972773|FG011|Period 2|Non-compliance with study drug|3|||
164166576|NCT01314872|592972774|FG012|Period 2|Non-compliance with study drug|3|||
164166577|NCT01314872|592972775|FG013|Period 2|Non-compliance with study drug|1|||
164166578|NCT01314872|592972776|FG014|Period 2|Non-compliance with study drug|2|||
164166579|NCT01314872|592972762|FG000|Period 2|Lack of Efficacy|0|||
164166580|NCT01314872|592972763|FG001|Period 2|Lack of Efficacy|0|||
164166581|NCT01314872|592972764|FG002|Period 2|Lack of Efficacy|0|||
164166582|NCT01314872|592972765|FG003|Period 2|Lack of Efficacy|0|||
164166583|NCT01314872|592972766|FG004|Period 2|Lack of Efficacy|0|||
164166584|NCT01314872|592972767|FG005|Period 2|Lack of Efficacy|0|||
164166585|NCT01314872|592972768|FG006|Period 2|Lack of Efficacy|0|||
164166586|NCT01314872|592972769|FG007|Period 2|Lack of Efficacy|0|||
164166587|NCT01314872|592972770|FG008|Period 2|Lack of Efficacy|0|||
164166588|NCT01314872|592972771|FG009|Period 2|Lack of Efficacy|0|||
164166589|NCT01314872|592972772|FG010|Period 2|Lack of Efficacy|0|||
164166590|NCT01314872|592972773|FG011|Period 2|Lack of Efficacy|7|||
164166591|NCT01314872|592972774|FG012|Period 2|Lack of Efficacy|12|||
164166592|NCT01314872|592972775|FG013|Period 2|Lack of Efficacy|9|||
164166593|NCT01314872|592972776|FG014|Period 2|Lack of Efficacy|2|||
164166594|NCT01314872|592972762|FG000|Period 2|Pregnancy|0|||
164166595|NCT01314872|592972763|FG001|Period 2|Pregnancy|0|||
164166596|NCT01314872|592972764|FG002|Period 2|Pregnancy|0|||
164166597|NCT01314872|592972765|FG003|Period 2|Pregnancy|0|||
164166598|NCT01314872|592972766|FG004|Period 2|Pregnancy|0|||
164166599|NCT01314872|592972767|FG005|Period 2|Pregnancy|0|||
164166600|NCT01314872|592972768|FG006|Period 2|Pregnancy|0|||
164166601|NCT01314872|592972769|FG007|Period 2|Pregnancy|0|||
164166602|NCT01314872|592972770|FG008|Period 2|Pregnancy|0|||
164166603|NCT01314872|592972771|FG009|Period 2|Pregnancy|0|||
164166604|NCT01314872|592972772|FG010|Period 2|Pregnancy|0|||
164166605|NCT01314872|592972773|FG011|Period 2|Pregnancy|0|||
164166606|NCT01314872|592972774|FG012|Period 2|Pregnancy|0|||
164166607|NCT01314872|592972775|FG013|Period 2|Pregnancy|0|||
164166608|NCT01314872|592972776|FG014|Period 2|Pregnancy|1|||
164166609|NCT01314872|592972762|FG000|Period 2|Study terminated by Sponsor|0|||
164166610|NCT01314872|592972763|FG001|Period 2|Study terminated by Sponsor|0|||
164166611|NCT01314872|592972764|FG002|Period 2|Study terminated by Sponsor|0|||
164166612|NCT01314872|592972765|FG003|Period 2|Study terminated by Sponsor|0|||
164166613|NCT01314872|592972766|FG004|Period 2|Study terminated by Sponsor|0|||
164166614|NCT01314872|592972767|FG005|Period 2|Study terminated by Sponsor|0|||
164166615|NCT01314872|592972768|FG006|Period 2|Study terminated by Sponsor|0|||
164166616|NCT01314872|592972769|FG007|Period 2|Study terminated by Sponsor|0|||
164166617|NCT01314872|592972770|FG008|Period 2|Study terminated by Sponsor|0|||
164166618|NCT01314872|592972771|FG009|Period 2|Study terminated by Sponsor|0|||
164166619|NCT01314872|592972772|FG010|Period 2|Study terminated by Sponsor|0|||
164166620|NCT01314872|592972773|FG011|Period 2|Study terminated by Sponsor|2|||
164166621|NCT01314872|592972774|FG012|Period 2|Study terminated by Sponsor|2|||
164166622|NCT01314872|592972775|FG013|Period 2|Study terminated by Sponsor|3|||
164166623|NCT01314872|592972776|FG014|Period 2|Study terminated by Sponsor|0|||
164166624|NCT01314872|592972762|FG000|Period 2|Adverse event, non-fatal|0|||
164166625|NCT01314872|592972763|FG001|Period 2|Adverse event, non-fatal|0|||
164166626|NCT01314872|592972764|FG002|Period 2|Adverse event, non-fatal|0|||
164166627|NCT01314872|592972765|FG003|Period 2|Adverse event, non-fatal|0|||
164166628|NCT01314872|592972766|FG004|Period 2|Adverse event, non-fatal|0|||
164166629|NCT01314872|592972767|FG005|Period 2|Adverse event, non-fatal|0|||
164166630|NCT01314872|592972768|FG006|Period 2|Adverse event, non-fatal|0|||
164166631|NCT01314872|592972769|FG007|Period 2|Adverse event, non-fatal|0|||
164166632|NCT01314872|592972770|FG008|Period 2|Adverse event, non-fatal|0|||
164166633|NCT01314872|592972771|FG009|Period 2|Adverse event, non-fatal|0|||
164166634|NCT01314872|592972772|FG010|Period 2|Adverse event, non-fatal|0|||
164166635|NCT01314872|592972773|FG011|Period 2|Adverse event, non-fatal|13|||
164166636|NCT01314872|592972774|FG012|Period 2|Adverse event, non-fatal|16|||
164166637|NCT01314872|592972775|FG013|Period 2|Adverse event, non-fatal|24|||
164166638|NCT01314872|592972776|FG014|Period 2|Adverse event, non-fatal|9|||
164166639|NCT01314872|592972762|FG000|Period 2|Withdrawal by Subject|0|||
164166640|NCT01314872|592972763|FG001|Period 2|Withdrawal by Subject|0|||
164166641|NCT01314872|592972764|FG002|Period 2|Withdrawal by Subject|0|||
164166642|NCT01314872|592972765|FG003|Period 2|Withdrawal by Subject|0|||
164166643|NCT01314872|592972766|FG004|Period 2|Withdrawal by Subject|0|||
164166644|NCT01314872|592972767|FG005|Period 2|Withdrawal by Subject|0|||
164166645|NCT01314872|592972768|FG006|Period 2|Withdrawal by Subject|0|||
164166646|NCT01314872|592972769|FG007|Period 2|Withdrawal by Subject|0|||
164166647|NCT01314872|592972770|FG008|Period 2|Withdrawal by Subject|0|||
164166648|NCT01314872|592972771|FG009|Period 2|Withdrawal by Subject|0|||
164166649|NCT01314872|592972772|FG010|Period 2|Withdrawal by Subject|0|||
164166650|NCT01314872|592972773|FG011|Period 2|Withdrawal by Subject|14|||
164166651|NCT01314872|592972774|FG012|Period 2|Withdrawal by Subject|17|||
164166652|NCT01314872|592972775|FG013|Period 2|Withdrawal by Subject|12|||
164166653|NCT01314872|592972776|FG014|Period 2|Withdrawal by Subject|4|||
164166654|NCT01314872|592972762|FG000|Period 2|Lost to Follow-up|0|||
164166655|NCT01314872|592972763|FG001|Period 2|Lost to Follow-up|0|||
164166656|NCT01314872|592972764|FG002|Period 2|Lost to Follow-up|0|||
164166657|NCT01314872|592972765|FG003|Period 2|Lost to Follow-up|0|||
164166658|NCT01314872|592972766|FG004|Period 2|Lost to Follow-up|0|||
164166659|NCT01314872|592972767|FG005|Period 2|Lost to Follow-up|0|||
164166660|NCT01314872|592972768|FG006|Period 2|Lost to Follow-up|0|||
164166661|NCT01314872|592972769|FG007|Period 2|Lost to Follow-up|0|||
164166662|NCT01314872|592972770|FG008|Period 2|Lost to Follow-up|0|||
164166663|NCT01314872|592972771|FG009|Period 2|Lost to Follow-up|0|||
164166664|NCT01314872|592972772|FG010|Period 2|Lost to Follow-up|0|||
164166665|NCT01314872|592972773|FG011|Period 2|Lost to Follow-up|6|||
164166666|NCT01314872|592972774|FG012|Period 2|Lost to Follow-up|7|||
164166667|NCT01314872|592972775|FG013|Period 2|Lost to Follow-up|2|||
164166668|NCT01314872|592972776|FG014|Period 2|Lost to Follow-up|6|||
164166669|NCT06366087|592974093|FG000|Overall Study|Withdrawal by Subject|0|||
164166670|NCT06366087|592974094|FG001|Overall Study|Withdrawal by Subject|1|||
164166671|NCT00199797|592974096|FG000|Overall Study|Progressive Disease|1|||
164166672|NCT00199797|592974096|FG000|Overall Study|Adverse Event|1|||
164166673|NCT00199797|592974096|FG000|Overall Study|Physician Decision|1|||
164166674|NCT03652636|592974099|FG000|Overall Study|Withdrawal by Subject|7|||
164166675|NCT00679029|592974106|FG000|Overall Study|Adverse Event|3|||
164166676|NCT00679029|592974106|FG000|Overall Study|Withdrawal by Subject|1|||
164166677|NCT00679029|592974106|FG000|Overall Study|Lost to Follow-up|1|||
164166678|NCT00504725|592974107|FG000|Overall Study|Protocol Violation|1|||
164166679|NCT00504725|592974108|FG001|Overall Study|Protocol Violation|0|||
164166680|NCT03937908|592974109|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
164166681|NCT03937908|592974110|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
164166682|NCT03875092|592974111|FG000|Overall Study|Adverse Event|2|||
164166683|NCT03875092|592974112|FG001|Overall Study|Adverse Event|5|||
164166684|NCT03875092|592974111|FG000|Overall Study|Death|44|||
164166685|NCT03875092|592974112|FG001|Overall Study|Death|51|||
164166686|NCT03875092|592974111|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
164166687|NCT03875092|592974112|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
164166688|NCT03205761|592974113|FG000|Overall Study|Withdrawal by Subject|1|||
164166689|NCT03205761|592974113|FG000|Overall Study|Progressive Disease|10|||
164166690|NCT00636194|592974114|FG000|Overall Study|Study related symptoms and complaints|1|||
164166691|NCT00636194|592974115|FG001|Overall Study|Study related symptoms and complaints|0|||
164166692|NCT00636194|592974114|FG000|Overall Study|Protocol Violation|2|||
164166693|NCT00636194|592974115|FG001|Overall Study|Protocol Violation|0|||
164166694|NCT04114357|592974117|FG000|Baseline-Randomization|Adverse Event|2|||
164166695|NCT04114357|592974118|FG001|Baseline-Randomization|Adverse Event|1|||
164166696|NCT04114357|592974117|FG000|Baseline-Randomization|Lost to Follow-up|1|||
164166697|NCT04114357|592974118|FG001|Baseline-Randomization|Lost to Follow-up|1|||
164166698|NCT04114357|592974117|FG000|Cross-over|Adverse Event|0|||
164166699|NCT04114357|592974118|FG001|Cross-over|Adverse Event|1|||
164166700|NCT02163226|592974119|FG000|Overall Study|Death|2|||
164166701|NCT02163226|592974120|FG001|Overall Study|Death|1|||
164166702|NCT02163226|592974119|FG000|Overall Study|Withdrawal by Subject|5|||
164166703|NCT02163226|592974120|FG001|Overall Study|Withdrawal by Subject|2|||
164166704|NCT02163226|592974119|FG000|Overall Study|Returned home, local radiotherapy|3|||
164166705|NCT02163226|592974120|FG001|Overall Study|Returned home, local radiotherapy|0|||
164166706|NCT02163226|592974119|FG000|Overall Study|Repeat imaging showed no disease|2|||
164166707|NCT02163226|592974120|FG001|Overall Study|Repeat imaging showed no disease|0|||
164166708|NCT02163226|592974119|FG000|Overall Study|Incomplete radiotherapy|3|||
164166709|NCT02163226|592974120|FG001|Overall Study|Incomplete radiotherapy|0|||
164166710|NCT02163226|592974119|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
164166711|NCT02163226|592974120|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
164166712|NCT02163226|592974119|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
164166713|NCT02163226|592974120|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
164166714|NCT02163226|592974119|FG000|Overall Study|ineligible|0|||
164166715|NCT02163226|592974120|FG001|Overall Study|ineligible|3|||
164166716|NCT05318092|592974126|FG000|Overall Study|Lost to Follow-up|3|||
164166717|NCT05318092|592974126|FG000|Overall Study|Withdrawal by Subject|1|||
164166718|NCT00160706|592974128|FG000|Overall Study|Adverse Event|53|||
164166719|NCT00160706|592974128|FG000|Overall Study|Adverse Event and Other Reason|105|||
164166720|NCT00160706|592974128|FG000|Overall Study|Protocol Violation|3|||
164166721|NCT00160706|592974128|FG000|Overall Study|Withdrawal by Subject|41|||
164166722|NCT00160706|592974128|FG000|Overall Study|Withdrawal by Subject and Other|12|||
164166723|NCT00160706|592974128|FG000|Overall Study|Physician Decision|10|||
164166724|NCT00160706|592974128|FG000|Overall Study|Physician Decision and Other|3|||
164166725|NCT00160706|592974128|FG000|Overall Study|Lost to Follow-up|4|||
164166726|NCT00160706|592974128|FG000|Overall Study|Lost to Follow-up and Other|1|||
164166727|NCT00160706|592974128|FG000|Overall Study|Lack of Efficacy|42|||
164166728|NCT00160706|592974128|FG000|Overall Study|Lack of Efficacy and Other|1|||
164166729|NCT00160706|592974128|FG000|Overall Study|Other Reason|11|||
164166730|NCT03214380|592974129|FG000|Lead-in|Adverse Event|3|||
164166731|NCT03214380|592974130|FG001|Lead-in|Adverse Event|0|||
164166732|NCT03214380|592974131|FG002|Lead-in|Adverse Event|0|||
164166733|NCT03214380|592974132|FG003|Lead-in|Adverse Event|1|||
164166734|NCT03214380|592974133|FG004|Lead-in|Adverse Event|0|||
164166735|NCT03214380|592974134|FG005|Lead-in|Adverse Event|0|||
164166736|NCT03214380|592974129|FG000|Lead-in|Lost to Follow-up|4|||
164166737|NCT03214380|592974130|FG001|Lead-in|Lost to Follow-up|0|||
164166738|NCT03214380|592974131|FG002|Lead-in|Lost to Follow-up|0|||
164166739|NCT03214380|592974132|FG003|Lead-in|Lost to Follow-up|1|||
164166740|NCT03214380|592974133|FG004|Lead-in|Lost to Follow-up|0|||
164166741|NCT03214380|592974134|FG005|Lead-in|Lost to Follow-up|0|||
164166742|NCT03214380|592974129|FG000|Lead-in|Eligibility Criteria|3|||
164166743|NCT03214380|592974130|FG001|Lead-in|Eligibility Criteria|0|||
164166744|NCT03214380|592974131|FG002|Lead-in|Eligibility Criteria|0|||
164166745|NCT03214380|592974132|FG003|Lead-in|Eligibility Criteria|0|||
164166746|NCT03214380|592974133|FG004|Lead-in|Eligibility Criteria|0|||
164166747|NCT03214380|592974134|FG005|Lead-in|Eligibility Criteria|0|||
164166748|NCT03214380|592974129|FG000|Lead-in|Physician Decision|6|||
164166749|NCT03214380|592974130|FG001|Lead-in|Physician Decision|0|||
164166750|NCT03214380|592974131|FG002|Lead-in|Physician Decision|0|||
164166751|NCT03214380|592974132|FG003|Lead-in|Physician Decision|0|||
164166752|NCT03214380|592974133|FG004|Lead-in|Physician Decision|0|||
164166753|NCT03214380|592974134|FG005|Lead-in|Physician Decision|0|||
164166754|NCT03214380|592974129|FG000|Lead-in|Protocol Deviation|7|||
164166755|NCT03214380|592974130|FG001|Lead-in|Protocol Deviation|0|||
164166756|NCT03214380|592974131|FG002|Lead-in|Protocol Deviation|0|||
164166757|NCT03214380|592974132|FG003|Lead-in|Protocol Deviation|3|||
164166758|NCT03214380|592974133|FG004|Lead-in|Protocol Deviation|0|||
164166759|NCT03214380|592974134|FG005|Lead-in|Protocol Deviation|0|||
164166760|NCT03214380|592974129|FG000|Lead-in|Withdrawal by Subject|41|||
164166761|NCT03214380|592974130|FG001|Lead-in|Withdrawal by Subject|0|||
164166762|NCT03214380|592974131|FG002|Lead-in|Withdrawal by Subject|0|||
164166763|NCT03214380|592974132|FG003|Lead-in|Withdrawal by Subject|14|||
164166764|NCT03214380|592974133|FG004|Lead-in|Withdrawal by Subject|0|||
164166765|NCT03214380|592974134|FG005|Lead-in|Withdrawal by Subject|0|||
164166766|NCT03214380|592974129|FG000|Lead-in|Family Emergency|1|||
164166767|NCT03214380|592974130|FG001|Lead-in|Family Emergency|0|||
164166768|NCT03214380|592974131|FG002|Lead-in|Family Emergency|0|||
164166769|NCT03214380|592974132|FG003|Lead-in|Family Emergency|0|||
164166770|NCT03214380|592974133|FG004|Lead-in|Family Emergency|0|||
164166771|NCT03214380|592974134|FG005|Lead-in|Family Emergency|0|||
164166772|NCT03214380|592974129|FG000|Lead-in|Natural Disaster|9|||
164166773|NCT03214380|592974130|FG001|Lead-in|Natural Disaster|0|||
164166774|NCT03214380|592974131|FG002|Lead-in|Natural Disaster|0|||
164166775|NCT03214380|592974132|FG003|Lead-in|Natural Disaster|0|||
164166776|NCT03214380|592974133|FG004|Lead-in|Natural Disaster|0|||
164166777|NCT03214380|592974134|FG005|Lead-in|Natural Disaster|0|||
164166778|NCT03214380|592974129|FG000|Lead-in|Non Compliance|1|||
164166779|NCT03214380|592974130|FG001|Lead-in|Non Compliance|0|||
164166780|NCT03214380|592974131|FG002|Lead-in|Non Compliance|0|||
164166781|NCT03214380|592974132|FG003|Lead-in|Non Compliance|0|||
164166782|NCT03214380|592974133|FG004|Lead-in|Non Compliance|0|||
164166783|NCT03214380|592974134|FG005|Lead-in|Non Compliance|0|||
164166784|NCT03214380|592974129|FG000|Lead-in|Participant Schedule|2|||
164166785|NCT03214380|592974130|FG001|Lead-in|Participant Schedule|0|||
164166786|NCT03214380|592974131|FG002|Lead-in|Participant Schedule|0|||
164166787|NCT03214380|592974132|FG003|Lead-in|Participant Schedule|0|||
164166788|NCT03214380|592974133|FG004|Lead-in|Participant Schedule|0|||
164166789|NCT03214380|592974134|FG005|Lead-in|Participant Schedule|0|||
164166790|NCT03214380|592974129|FG000|Treatment Period|Adverse Event|0|||
164166791|NCT03214380|592974130|FG001|Treatment Period|Adverse Event|1|||
164166792|NCT03214380|592974131|FG002|Treatment Period|Adverse Event|1|||
164166793|NCT03214380|592974132|FG003|Treatment Period|Adverse Event|0|||
164166794|NCT03214380|592974133|FG004|Treatment Period|Adverse Event|1|||
164166795|NCT03214380|592974134|FG005|Treatment Period|Adverse Event|0|||
164166796|NCT03214380|592974129|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
164166797|NCT03214380|592974130|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
164166798|NCT03214380|592974131|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
164166799|NCT03214380|592974132|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
164166800|NCT03214380|592974133|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
164166801|NCT03214380|592974134|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
164166802|NCT03214380|592974129|FG000|Treatment Period|Withdrawal by Subject|0|||
164166803|NCT03214380|592974130|FG001|Treatment Period|Withdrawal by Subject|10|||
164166804|NCT03214380|592974131|FG002|Treatment Period|Withdrawal by Subject|8|||
164166805|NCT03214380|592974132|FG003|Treatment Period|Withdrawal by Subject|0|||
164166806|NCT03214380|592974133|FG004|Treatment Period|Withdrawal by Subject|7|||
164166807|NCT03214380|592974134|FG005|Treatment Period|Withdrawal by Subject|11|||
164166808|NCT03214380|592974129|FG000|Treatment Period|Death|0|||
164166809|NCT03214380|592974130|FG001|Treatment Period|Death|1|||
164166810|NCT03214380|592974131|FG002|Treatment Period|Death|2|||
164166811|NCT03214380|592974132|FG003|Treatment Period|Death|0|||
164166812|NCT03214380|592974133|FG004|Treatment Period|Death|0|||
164166813|NCT03214380|592974134|FG005|Treatment Period|Death|0|||
164166814|NCT03214380|592974129|FG000|Treatment Period|Lost to Follow-up|0|||
164166815|NCT03214380|592974130|FG001|Treatment Period|Lost to Follow-up|6|||
164166816|NCT03214380|592974131|FG002|Treatment Period|Lost to Follow-up|3|||
164166817|NCT03214380|592974132|FG003|Treatment Period|Lost to Follow-up|0|||
164166818|NCT03214380|592974133|FG004|Treatment Period|Lost to Follow-up|0|||
164166819|NCT03214380|592974134|FG005|Treatment Period|Lost to Follow-up|0|||
164166820|NCT03214380|592974129|FG000|Treatment Period|Participant schedule|0|||
164166821|NCT03214380|592974130|FG001|Treatment Period|Participant schedule|0|||
164166822|NCT03214380|592974131|FG002|Treatment Period|Participant schedule|1|||
164166823|NCT03214380|592974132|FG003|Treatment Period|Participant schedule|0|||
164166824|NCT03214380|592974133|FG004|Treatment Period|Participant schedule|0|||
164166825|NCT03214380|592974134|FG005|Treatment Period|Participant schedule|0|||
164166826|NCT03214380|592974129|FG000|Treatment Period|Treatment Interruption|0|||
164166827|NCT03214380|592974130|FG001|Treatment Period|Treatment Interruption|0|||
164166828|NCT03214380|592974131|FG002|Treatment Period|Treatment Interruption|1|||
164166829|NCT03214380|592974132|FG003|Treatment Period|Treatment Interruption|0|||
164166830|NCT03214380|592974133|FG004|Treatment Period|Treatment Interruption|0|||
164166831|NCT03214380|592974134|FG005|Treatment Period|Treatment Interruption|0|||
164166832|NCT04984278|592974144|FG000|Period 1|Withdrawal by Subject|1|||
164166833|NCT04984278|592974145|FG001|Period 1|Withdrawal by Subject|0|||
164166834|NCT04984278|592974144|FG000|Period 1|Other|0|||
164166835|NCT04984278|592974145|FG001|Period 1|Other|1|||
164166836|NCT04984278|592974144|FG000|Period 2|Adverse Event|1|||
164166837|NCT04984278|592974145|FG001|Period 2|Adverse Event|0|||
164166838|NCT04984278|592974144|FG000|Period 2|Other|0|||
164166839|NCT04984278|592974145|FG001|Period 2|Other|1|||
164166840|NCT04292912|592974146|FG000|Overall Study|Physician Decision|1|||
164166841|NCT04292912|592974146|FG000|Overall Study|Protocol Violation|6|||
164166842|NCT00280397|592974147|FG000|Overall Study|Adverse Event|1|||
164166843|NCT03348930|592974152|FG000|Washout (1 Week)|Lost to Follow-up|1|||
164166844|NCT03348930|592974153|FG001|Washout (1 Week)|Lost to Follow-up|1|||
164166845|NCT01598090|592974154|FG000|Treatment Period|Poor/non-compliance|0|||
164166846|NCT01598090|592974155|FG001|Treatment Period|Poor/non-compliance|2|||
164166847|NCT01598090|592974156|FG002|Treatment Period|Poor/non-compliance|0|||
164166848|NCT01598090|592974154|FG000|Treatment Period|No longer meet study criteria|0|||
164166849|NCT01598090|592974155|FG001|Treatment Period|No longer meet study criteria|1|||
164166850|NCT01598090|592974156|FG002|Treatment Period|No longer meet study criteria|0|||
164166851|NCT01598090|592974154|FG000|Treatment Period|Lack of Efficacy|5|||
164166852|NCT01598090|592974155|FG001|Treatment Period|Lack of Efficacy|14|||
164166853|NCT01598090|592974156|FG002|Treatment Period|Lack of Efficacy|6|||
164166854|NCT01598090|592974154|FG000|Treatment Period|Adverse Event|2|||
164166855|NCT01598090|592974155|FG001|Treatment Period|Adverse Event|33|||
164166856|NCT01598090|592974156|FG002|Treatment Period|Adverse Event|17|||
164166857|NCT01598090|592974154|FG000|Treatment Period|Other reasons|0|||
164166858|NCT01598090|592974155|FG001|Treatment Period|Other reasons|4|||
164166859|NCT01598090|592974156|FG002|Treatment Period|Other reasons|1|||
164166860|NCT01598090|592974154|FG000|Treatment Period|Withdrawal by Subject|3|||
164166861|NCT01598090|592974155|FG001|Treatment Period|Withdrawal by Subject|13|||
164166862|NCT01598090|592974156|FG002|Treatment Period|Withdrawal by Subject|10|||
164166863|NCT01598090|592974154|FG000|Treatment Period|Lost to Follow-up|1|||
164166864|NCT01598090|592974155|FG001|Treatment Period|Lost to Follow-up|5|||
164166865|NCT01598090|592974156|FG002|Treatment Period|Lost to Follow-up|1|||
164166866|NCT01598090|592974154|FG000|Follow-up Period|Death|0|||
164166867|NCT01598090|592974155|FG001|Follow-up Period|Death|1|||
164166868|NCT01598090|592974156|FG002|Follow-up Period|Death|0|||
164166869|NCT01598090|592974154|FG000|Follow-up Period|No longer required per protocol|1|||
164166870|NCT01598090|592974155|FG001|Follow-up Period|No longer required per protocol|3|||
164166871|NCT01598090|592974156|FG002|Follow-up Period|No longer required per protocol|2|||
164166872|NCT01598090|592974154|FG000|Follow-up Period|Not reported|0|||
164166873|NCT01598090|592974155|FG001|Follow-up Period|Not reported|10|||
164166874|NCT01598090|592974156|FG002|Follow-up Period|Not reported|4|||
164166875|NCT01598090|592974154|FG000|Follow-up Period|Withdrawal by Subject|0|||
164166876|NCT01598090|592974155|FG001|Follow-up Period|Withdrawal by Subject|3|||
164166877|NCT01598090|592974156|FG002|Follow-up Period|Withdrawal by Subject|2|||
164166878|NCT01598090|592974154|FG000|Follow-up Period|Other reasons|2|||
164166879|NCT01598090|592974155|FG001|Follow-up Period|Other reasons|8|||
164166880|NCT01598090|592974156|FG002|Follow-up Period|Other reasons|8|||
164166881|NCT01598090|592974154|FG000|Follow-up Period|Lost to Follow-up|2|||
164166882|NCT01598090|592974155|FG001|Follow-up Period|Lost to Follow-up|10|||
164166883|NCT01598090|592974156|FG002|Follow-up Period|Lost to Follow-up|12|||
164166884|NCT00355147|592974159|FG000|Overall Study|Lost to Follow-up|10|||
164166885|NCT00355147|592974160|FG001|Overall Study|Lost to Follow-up|8|||
164166886|NCT00355147|592974159|FG000|Overall Study|Withdrawal by Subject|8|||
164166887|NCT00355147|592974160|FG001|Overall Study|Withdrawal by Subject|12|||
164166888|NCT03474731|592974166|FG000|Overall Study|Withdrawal by Subject|36|||
164166889|NCT03474731|592974167|FG001|Overall Study|Withdrawal by Subject|29|||
164166890|NCT03474731|592974168|FG002|Overall Study|Withdrawal by Subject|11|||
164166891|NCT03474731|592974169|FG003|Overall Study|Withdrawal by Subject|27|||
164166892|NCT03474731|592974166|FG000|Overall Study|COVID|0|||
164166893|NCT03474731|592974167|FG001|Overall Study|COVID|23|||
164166894|NCT03474731|592974168|FG002|Overall Study|COVID|0|||
164166895|NCT03474731|592974169|FG003|Overall Study|COVID|0|||
164166896|NCT03474731|592974166|FG000|Overall Study|Participant moved from area|1|||
164166897|NCT03474731|592974167|FG001|Overall Study|Participant moved from area|0|||
164166898|NCT03474731|592974168|FG002|Overall Study|Participant moved from area|0|||
164166899|NCT03474731|592974169|FG003|Overall Study|Participant moved from area|0|||
164166900|NCT03474731|592974166|FG000|Overall Study|Lost to Follow-up|11|||
164166901|NCT03474731|592974167|FG001|Overall Study|Lost to Follow-up|3|||
164166902|NCT03474731|592974168|FG002|Overall Study|Lost to Follow-up|18|||
164166903|NCT03474731|592974169|FG003|Overall Study|Lost to Follow-up|17|||
164166904|NCT03474731|592974166|FG000|Overall Study|Death|0|||
164166905|NCT03474731|592974167|FG001|Overall Study|Death|1|||
164166906|NCT03474731|592974168|FG002|Overall Study|Death|0|||
164166907|NCT03474731|592974169|FG003|Overall Study|Death|0|||
164166908|NCT03474731|592974166|FG000|Overall Study|Participant Removed|0|||
164166909|NCT03474731|592974167|FG001|Overall Study|Participant Removed|0|||
164166910|NCT03474731|592974168|FG002|Overall Study|Participant Removed|0|||
164166911|NCT03474731|592974169|FG003|Overall Study|Participant Removed|1|||
164166912|NCT00554515|592974170|FG000|Overall Study|Withdrawal by Subject|3|||
164166913|NCT00554515|592974170|FG000|Overall Study|Disease progression|52|||
164166914|NCT00554515|592974170|FG000|Overall Study|Physician Decision|18|||
164166915|NCT00554515|592974170|FG000|Overall Study|Withdrawal by Subject|11|||
164166916|NCT00554515|592974170|FG000|Overall Study|Adverse Event|9|||
164166917|NCT00554515|592974170|FG000|Overall Study|Death|2|||
164166918|NCT00554515|592974170|FG000|Overall Study|Achieved Stable Disease|7|||
164166919|NCT00554515|592974170|FG000|Overall Study|Other|1|||
164166920|NCT00554515|592974170|FG000|Overall Study|Misc|15|||
164166921|NCT04087720|592974175|FG000|Overall Study|Withdrawal by Subject|2|||
164166922|NCT04087720|592974175|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
164166923|NCT00900159|592974178|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
164166924|NCT00900159|592974179|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
164166925|NCT01377922|592974181|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
164166926|NCT01377922|592974182|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
164166927|NCT04615403|592974183|FG000|Overall Study|Death|1|||
164166928|NCT00665431|592974184|FG000|Overall Study|Adverse Event|16|||
164166929|NCT00665431|592974185|FG001|Overall Study|Adverse Event|22|||
164166930|NCT00665431|592974186|FG002|Overall Study|Adverse Event|6|||
164166931|NCT00665431|592974184|FG000|Overall Study|Withdrawal by Subject|17|||
164166932|NCT00665431|592974185|FG001|Overall Study|Withdrawal by Subject|25|||
164166933|NCT00665431|592974186|FG002|Overall Study|Withdrawal by Subject|15|||
164166934|NCT00665431|592974184|FG000|Overall Study|Lost to Follow-up|3|||
164166935|NCT00665431|592974185|FG001|Overall Study|Lost to Follow-up|3|||
164166936|NCT00665431|592974186|FG002|Overall Study|Lost to Follow-up|1|||
164166937|NCT00665431|592974184|FG000|Overall Study|Other|4|||
164166938|NCT00665431|592974185|FG001|Overall Study|Other|7|||
164166939|NCT00665431|592974186|FG002|Overall Study|Other|2|||
164166940|NCT01726270|592974189|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
164166941|NCT01726270|592974189|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
164166942|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
164166943|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
164166944|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
164166945|NCT01726270|592974189|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
164166946|NCT02157376|592974190|FG000|Overall Study|Death|10|||
164166947|NCT02157376|592974191|FG001|Overall Study|Death|4|||
164166948|NCT02157376|592974190|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164166949|NCT02157376|592974191|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
164166950|NCT02157376|592974190|FG000|Overall Study|Withdrawal by Subject|3|||
164166951|NCT02157376|592974191|FG001|Overall Study|Withdrawal by Subject|8|||
164166952|NCT02157376|592974190|FG000|Overall Study|Not treated|8|||
164166953|NCT02157376|592974191|FG001|Overall Study|Not treated|3|||
164166954|NCT02157376|592974190|FG000|Overall Study|Investigator's misjudgement|1|||
164166955|NCT02157376|592974191|FG001|Overall Study|Investigator's misjudgement|2|||
164166956|NCT02547220|592974192|FG000|Overall Study|Withdrawal by Subject|1|||
164166957|NCT02547220|592974193|FG001|Overall Study|Withdrawal by Subject|0|||
164166958|NCT02547220|592974192|FG000|Overall Study|Study terminated by sponsor|18|||
164166959|NCT02547220|592974193|FG001|Overall Study|Study terminated by sponsor|20|||
164166960|NCT03817229|592974194|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
164166961|NCT03817229|592974195|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
164166962|NCT03817229|592974196|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
164166963|NCT03817229|592974197|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
164166964|NCT03817229|592974194|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
164166965|NCT03817229|592974195|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
164166966|NCT03817229|592974196|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
164166967|NCT03817229|592974197|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
164166968|NCT03817229|592974194|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
164166969|NCT03817229|592974195|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
164166970|NCT03817229|592974196|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
164166971|NCT03817229|592974197|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
164166972|NCT03817229|592974194|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
164166973|NCT03817229|592974195|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
164166974|NCT03817229|592974196|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
164166975|NCT03817229|592974197|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
164166976|NCT03817229|592974194|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
164166977|NCT03817229|592974195|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
164166978|NCT03817229|592974196|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
164166979|NCT03817229|592974197|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
164166980|NCT03817229|592974194|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
164166981|NCT03817229|592974195|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
164166982|NCT03817229|592974196|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
164166983|NCT03817229|592974197|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
164166984|NCT03817229|592974194|FG000|Post-Intervention|Withdrawal by Subject|6|||
164166985|NCT03817229|592974195|FG001|Post-Intervention|Withdrawal by Subject|0|||
164166986|NCT03817229|592974196|FG002|Post-Intervention|Withdrawal by Subject|2|||
164166987|NCT03817229|592974197|FG003|Post-Intervention|Withdrawal by Subject|2|||
164166988|NCT03817229|592974194|FG000|Post-Intervention|Withdrawal by Study Team|3|||
164166989|NCT03817229|592974195|FG001|Post-Intervention|Withdrawal by Study Team|1|||
164166990|NCT03817229|592974196|FG002|Post-Intervention|Withdrawal by Study Team|1|||
164166991|NCT03817229|592974197|FG003|Post-Intervention|Withdrawal by Study Team|4|||
164166992|NCT03817229|592974194|FG000|Post-Intervention|Weaned from medication|3|||
164166993|NCT03817229|592974195|FG001|Post-Intervention|Weaned from medication|0|||
164166994|NCT03817229|592974196|FG002|Post-Intervention|Weaned from medication|2|||
164166995|NCT03817229|592974197|FG003|Post-Intervention|Weaned from medication|1|||
164166996|NCT03817229|592974194|FG000|Post-Intervention|Transferred care to another institution|1|||
164166997|NCT03817229|592974195|FG001|Post-Intervention|Transferred care to another institution|0|||
164166998|NCT03817229|592974196|FG002|Post-Intervention|Transferred care to another institution|0|||
164166999|NCT03817229|592974197|FG003|Post-Intervention|Transferred care to another institution|0|||
164167000|NCT03817229|592974194|FG000|Post-Intervention|Change in parental guardianship|0|||
164167001|NCT03817229|592974195|FG001|Post-Intervention|Change in parental guardianship|0|||
164167002|NCT03817229|592974196|FG002|Post-Intervention|Change in parental guardianship|1|||
164167003|NCT03817229|592974197|FG003|Post-Intervention|Change in parental guardianship|0|||
164167004|NCT03817229|592974194|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
164167005|NCT03817229|592974195|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
164167006|NCT03817229|592974196|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
164167007|NCT03817229|592974197|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
164167008|NCT03817229|592974194|FG000|Follow-up 1|Withdrawal by Subject|1|||
164167009|NCT03817229|592974195|FG001|Follow-up 1|Withdrawal by Subject|2|||
164167010|NCT03817229|592974196|FG002|Follow-up 1|Withdrawal by Subject|0|||
164167011|NCT03817229|592974197|FG003|Follow-up 1|Withdrawal by Subject|0|||
164167012|NCT03817229|592974194|FG000|Follow-up 1|Withdrawal by Study Team|3|||
164167013|NCT03817229|592974195|FG001|Follow-up 1|Withdrawal by Study Team|1|||
164167014|NCT03817229|592974196|FG002|Follow-up 1|Withdrawal by Study Team|0|||
164167015|NCT03817229|592974197|FG003|Follow-up 1|Withdrawal by Study Team|0|||
164167016|NCT03817229|592974194|FG000|Follow-up 1|Wean from medication|3|||
164167017|NCT03817229|592974195|FG001|Follow-up 1|Wean from medication|4|||
164167018|NCT03817229|592974196|FG002|Follow-up 1|Wean from medication|0|||
164167019|NCT03817229|592974197|FG003|Follow-up 1|Wean from medication|1|||
164167020|NCT03817229|592974194|FG000|Follow-up 1|Transferred care to another hospital|1|||
164167021|NCT03817229|592974195|FG001|Follow-up 1|Transferred care to another hospital|0|||
164167022|NCT03817229|592974196|FG002|Follow-up 1|Transferred care to another hospital|0|||
164167023|NCT03817229|592974197|FG003|Follow-up 1|Transferred care to another hospital|0|||
164167024|NCT03817229|592974194|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
164167025|NCT03817229|592974195|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
164167026|NCT03817229|592974196|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
164167027|NCT03817229|592974197|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
164167028|NCT03817229|592974194|FG000|Follow-up 2|Withdrawal by Subject|2|||
164167029|NCT03817229|592974195|FG001|Follow-up 2|Withdrawal by Subject|0|||
164167030|NCT03817229|592974196|FG002|Follow-up 2|Withdrawal by Subject|1|||
164167031|NCT03817229|592974197|FG003|Follow-up 2|Withdrawal by Subject|1|||
164167032|NCT03817229|592974194|FG000|Follow-up 2|Withdrawal by Study Team|2|||
164167033|NCT03817229|592974195|FG001|Follow-up 2|Withdrawal by Study Team|0|||
164167034|NCT03817229|592974196|FG002|Follow-up 2|Withdrawal by Study Team|1|||
164167035|NCT03817229|592974197|FG003|Follow-up 2|Withdrawal by Study Team|0|||
164167036|NCT03817229|592974194|FG000|Follow-up 2|Wean from medication|1|||
164167037|NCT03817229|592974195|FG001|Follow-up 2|Wean from medication|0|||
164167038|NCT03817229|592974196|FG002|Follow-up 2|Wean from medication|0|||
164167039|NCT03817229|592974197|FG003|Follow-up 2|Wean from medication|0|||
164167040|NCT03817229|592974194|FG000|Follow-up 2|Transferred care|0|||
164167041|NCT03817229|592974195|FG001|Follow-up 2|Transferred care|0|||
164167042|NCT03817229|592974196|FG002|Follow-up 2|Transferred care|1|||
164167043|NCT03817229|592974197|FG003|Follow-up 2|Transferred care|0|||
164167044|NCT02887183|592974199|FG000|Overall Study|Adverse Event|44|||
164167045|NCT02887183|592974199|FG000|Overall Study|Death|30|||
164167046|NCT02887183|592974199|FG000|Overall Study|Pregnancy|1|||
164167047|NCT02887183|592974199|FG000|Overall Study|Protocol Violation|6|||
164167048|NCT02887183|592974199|FG000|Overall Study|Technical Problems|2|||
164167049|NCT02887183|592974199|FG000|Overall Study|Lost to Follow-up|13|||
164167050|NCT02887183|592974199|FG000|Overall Study|Physician Decision|10|||
164167051|NCT02887183|592974199|FG000|Overall Study|Withdrawal by Subject|35|||
164167052|NCT02702388|592974205|FG000|Overall Study|Disease Progression|18|||
164167053|NCT02702388|592974206|FG001|Overall Study|Disease Progression|25|||
164167054|NCT02702388|592974205|FG000|Overall Study|Withdrawal by Subject|9|||
164167055|NCT02702388|592974206|FG001|Overall Study|Withdrawal by Subject|7|||
164167056|NCT02702388|592974205|FG000|Overall Study|Adverse Event|11|||
164167057|NCT02702388|592974206|FG001|Overall Study|Adverse Event|15|||
164167058|NCT02702388|592974205|FG000|Overall Study|Other|2|||
164167059|NCT02702388|592974206|FG001|Overall Study|Other|4|||
164167060|NCT02729051|592974207|FG000|Overall Study|Adverse Event|21|||
164167061|NCT02729051|592974208|FG001|Overall Study|Adverse Event|11|||
164167062|NCT02729051|592974207|FG000|Overall Study|Lack of Efficacy|1|||
164167063|NCT02729051|592974208|FG001|Overall Study|Lack of Efficacy|1|||
164167064|NCT02729051|592974207|FG000|Overall Study|Lost to Follow-up|1|||
164167065|NCT02729051|592974208|FG001|Overall Study|Lost to Follow-up|2|||
164167066|NCT02729051|592974207|FG000|Overall Study|Physician Decision|1|||
164167067|NCT02729051|592974208|FG001|Overall Study|Physician Decision|1|||
164167068|NCT02729051|592974207|FG000|Overall Study|Withdrawal by Subject|6|||
164167069|NCT02729051|592974208|FG001|Overall Study|Withdrawal by Subject|17|||
164167070|NCT01397786|592975648|FG000|Phase A|Lost to Follow-up|0|||
164167071|NCT01397786|592975649|FG001|Phase A|Lost to Follow-up|0|||
164167072|NCT01397786|592975650|FG002|Phase A|Lost to Follow-up|6|||
164167073|NCT01397786|592975648|FG000|Phase A|Adverse Event|0|||
164167074|NCT01397786|592975649|FG001|Phase A|Adverse Event|0|||
164167075|NCT01397786|592975650|FG002|Phase A|Adverse Event|8|||
164167076|NCT01397786|592975648|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
164167077|NCT01397786|592975649|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
164167078|NCT01397786|592975650|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
164167079|NCT01397786|592975648|FG000|Phase A|Physician Decision|0|||
164167080|NCT01397786|592975649|FG001|Phase A|Physician Decision|0|||
164167081|NCT01397786|592975650|FG002|Phase A|Physician Decision|1|||
164167082|NCT01397786|592975648|FG000|Phase A|Withdrawal by Subject|0|||
164167083|NCT01397786|592975649|FG001|Phase A|Withdrawal by Subject|0|||
164167084|NCT01397786|592975650|FG002|Phase A|Withdrawal by Subject|5|||
164167085|NCT01397786|592975648|FG000|Phase A|Lack of Efficacy|0|||
164167086|NCT01397786|592975649|FG001|Phase A|Lack of Efficacy|0|||
164167087|NCT01397786|592975650|FG002|Phase A|Lack of Efficacy|1|||
164167088|NCT01397786|592975648|FG000|Phase B|Lost to Follow-up|22|||
164167089|NCT01397786|592975649|FG001|Phase B|Lost to Follow-up|12|||
164167090|NCT01397786|592975650|FG002|Phase B|Lost to Follow-up|22|||
164167091|NCT01397786|592975648|FG000|Phase B|Adverse Event|109|||
164167092|NCT01397786|592975649|FG001|Phase B|Adverse Event|23|||
164167093|NCT01397786|592975650|FG002|Phase B|Adverse Event|27|||
164167094|NCT01397786|592975648|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
164167095|NCT01397786|592975649|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
164167096|NCT01397786|592975650|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
164167097|NCT01397786|592975648|FG000|Phase B|Physician Decision|9|||
164167098|NCT01397786|592975649|FG001|Phase B|Physician Decision|1|||
164167099|NCT01397786|592975650|FG002|Phase B|Physician Decision|3|||
164167100|NCT01397786|592975648|FG000|Phase B|Withdrawal by Subject|102|||
164167101|NCT01397786|592975649|FG001|Phase B|Withdrawal by Subject|45|||
164167102|NCT01397786|592975650|FG002|Phase B|Withdrawal by Subject|30|||
164167103|NCT01397786|592975648|FG000|Phase B|Protocol Deviation|1|||
164167104|NCT01397786|592975649|FG001|Phase B|Protocol Deviation|2|||
164167105|NCT01397786|592975650|FG002|Phase B|Protocol Deviation|4|||
164167106|NCT01397786|592975648|FG000|Phase B|Lack of Efficacy|22|||
164167107|NCT01397786|592975649|FG001|Phase B|Lack of Efficacy|7|||
164167108|NCT01397786|592975650|FG002|Phase B|Lack of Efficacy|14|||
164167109|NCT04250350|592975654|FG000|Overall Study|Withdrawal by Subject|13|||
164167110|NCT04250350|592975654|FG000|Overall Study|Lost to Follow-up|8|||
164167111|NCT04250350|592975654|FG000|Overall Study|Adverse Event|5|||
164167112|NCT04250350|592975654|FG000|Overall Study|Lack of Efficacy|4|||
164167113|NCT04250350|592975654|FG000|Overall Study|Physician Decision|1|||
164167114|NCT04250350|592975654|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
164167115|NCT00860249|592975655|FG000|Overall Study|trial was terminated prior to completion|21|||
164167116|NCT00860249|592975656|FG001|Overall Study|trial was terminated prior to completion|18|||
164167117|NCT00860249|592975657|FG002|Overall Study|trial was terminated prior to completion|21|||
164167118|NCT00743288|592975658|FG000|Overall Study|Adverse Event|1|||
164167119|NCT00743288|592975659|FG001|Overall Study|Adverse Event|1|||
164167120|NCT00743288|592975660|FG002|Overall Study|Adverse Event|2|||
164167121|NCT00743288|592975661|FG003|Overall Study|Adverse Event|2|||
164167122|NCT00743288|592975662|FG004|Overall Study|Adverse Event|1|||
164167123|NCT00743288|592975663|FG005|Overall Study|Adverse Event|1|||
164167124|NCT00743288|592975664|FG006|Overall Study|Adverse Event|2|||
164167125|NCT00743288|592975658|FG000|Overall Study|Withdrawal by Subject|0|||
164167126|NCT00743288|592975659|FG001|Overall Study|Withdrawal by Subject|0|||
164167127|NCT00743288|592975660|FG002|Overall Study|Withdrawal by Subject|1|||
164167128|NCT00743288|592975661|FG003|Overall Study|Withdrawal by Subject|0|||
164167129|NCT00743288|592975662|FG004|Overall Study|Withdrawal by Subject|0|||
164167130|NCT00743288|592975663|FG005|Overall Study|Withdrawal by Subject|1|||
164167131|NCT00743288|592975664|FG006|Overall Study|Withdrawal by Subject|1|||
164167132|NCT00743288|592975658|FG000|Overall Study|Progressive disease (PD)|2|||
164167133|NCT00743288|592975659|FG001|Overall Study|Progressive disease (PD)|0|||
164167134|NCT00743288|592975660|FG002|Overall Study|Progressive disease (PD)|1|||
164167135|NCT00743288|592975661|FG003|Overall Study|Progressive disease (PD)|4|||
164167136|NCT00743288|592975662|FG004|Overall Study|Progressive disease (PD)|5|||
164167137|NCT00743288|592975663|FG005|Overall Study|Progressive disease (PD)|3|||
164167138|NCT00743288|592975664|FG006|Overall Study|Progressive disease (PD)|6|||
164167139|NCT00743288|592975658|FG000|Overall Study|Worsening of condition (Not PD)|0|||
164167140|NCT00743288|592975659|FG001|Overall Study|Worsening of condition (Not PD)|2|||
164167141|NCT00743288|592975660|FG002|Overall Study|Worsening of condition (Not PD)|1|||
164167142|NCT00743288|592975661|FG003|Overall Study|Worsening of condition (Not PD)|1|||
164167143|NCT00743288|592975662|FG004|Overall Study|Worsening of condition (Not PD)|0|||
164167144|NCT00743288|592975663|FG005|Overall Study|Worsening of condition (Not PD)|0|||
164167145|NCT00743288|592975664|FG006|Overall Study|Worsening of condition (Not PD)|0|||
164167146|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
164167147|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
164167148|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
164167149|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
164167150|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
164167151|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
164167152|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164167153|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
164167154|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164167155|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
164167156|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164167157|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164167158|NCT02836236|592975668|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
164167159|NCT02836236|592975669|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164167160|NCT02836236|592975670|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164167161|NCT02836236|592975671|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
164167162|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164167163|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
164167164|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
164167165|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
164167166|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164167167|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
164167168|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
164167169|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
164167170|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Death|0|||
164167171|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Death|0|||
164167172|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Death|1|||
164167173|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Death|1|||
164167174|NCT02836236|592975668|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
164167175|NCT02836236|592975669|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
164167176|NCT02836236|592975670|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
164167177|NCT02836236|592975671|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
164167178|NCT00378508|592975672|FG000|Overall Study|Withdrawal by Subject|1|||
164167179|NCT00378508|592975673|FG001|Overall Study|Withdrawal by Subject|3|||
164167180|NCT00378508|592975672|FG000|Overall Study|Lost to Follow-up|1|||
164167181|NCT00378508|592975673|FG001|Overall Study|Lost to Follow-up|0|||
164167182|NCT01435018|592975674|FG000|Overall Study|Death|37|||
164167183|NCT01435018|592975675|FG001|Overall Study|Death|18|||
164167184|NCT01435018|592975676|FG002|Overall Study|Death|25|||
164167185|NCT01435018|592975674|FG000|Overall Study|Site is closing|4|||
164167186|NCT01435018|592975675|FG001|Overall Study|Site is closing|9|||
164167187|NCT01435018|592975676|FG002|Overall Study|Site is closing|7|||
164167188|NCT01435018|592975674|FG000|Overall Study|Withdrew consent|0|||
164167189|NCT01435018|592975675|FG001|Overall Study|Withdrew consent|3|||
164167190|NCT01435018|592975676|FG002|Overall Study|Withdrew consent|1|||
164167191|NCT01435018|592975674|FG000|Overall Study|Not willing to adhere to requirements|0|||
164167192|NCT01435018|592975675|FG001|Overall Study|Not willing to adhere to requirements|2|||
164167193|NCT01435018|592975676|FG002|Overall Study|Not willing to adhere to requirements|3|||
164167194|NCT01435018|592975674|FG000|Overall Study|Not able to get to clinic|2|||
164167195|NCT01435018|592975675|FG001|Overall Study|Not able to get to clinic|0|||
164167196|NCT01435018|592975676|FG002|Overall Study|Not able to get to clinic|2|||
164167197|NCT01435018|592975674|FG000|Overall Study|Severe debilitation, unable to continue|0|||
164167198|NCT01435018|592975675|FG001|Overall Study|Severe debilitation, unable to continue|0|||
164167199|NCT01435018|592975676|FG002|Overall Study|Severe debilitation, unable to continue|1|||
164167200|NCT01435018|592975674|FG000|Overall Study|Unable to contact participant/parent|1|||
164167201|NCT01435018|592975675|FG001|Overall Study|Unable to contact participant/parent|1|||
164167202|NCT01435018|592975676|FG002|Overall Study|Unable to contact participant/parent|1|||
164167203|NCT01435018|592975674|FG000|Overall Study|Enrollment Violation|0|||
164167204|NCT01435018|592975675|FG001|Overall Study|Enrollment Violation|1|||
164167205|NCT01435018|592975676|FG002|Overall Study|Enrollment Violation|0|||
164167206|NCT01435018|592975674|FG000|Overall Study|Never started chemotherapy|3|||
164167207|NCT01435018|592975675|FG001|Overall Study|Never started chemotherapy|0|||
164167208|NCT01435018|592975676|FG002|Overall Study|Never started chemotherapy|1|||
164167209|NCT00593684|592975677|FG000|Overall Study|Death|2|||
164167210|NCT00593684|592975678|FG001|Overall Study|Death|1|||
164167211|NCT03625466|592975679|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
164167212|NCT03625466|592975680|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
164167213|NCT03625466|592975681|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
164167214|NCT03625466|592975679|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167215|NCT03625466|592975680|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
164167216|NCT03625466|592975681|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167217|NCT03625466|592975679|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167218|NCT03625466|592975680|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
164167219|NCT03625466|592975681|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
164167220|NCT00809471|592975683|FG000|Overall Study|Protocol non-compliance|15|||
164167221|NCT00809471|592975684|FG001|Overall Study|Protocol non-compliance|15|||
164167222|NCT00809471|592975685|FG002|Overall Study|Protocol non-compliance|6|||
164167223|NCT00809471|592975683|FG000|Overall Study|Lost to Follow-up|4|||
164167224|NCT00809471|592975684|FG001|Overall Study|Lost to Follow-up|2|||
164167225|NCT00809471|592975685|FG002|Overall Study|Lost to Follow-up|9|||
164167226|NCT00809471|592975683|FG000|Overall Study|Adverse Event|0|||
164167227|NCT00809471|592975684|FG001|Overall Study|Adverse Event|2|||
164167228|NCT00809471|592975685|FG002|Overall Study|Adverse Event|2|||
164167229|NCT00809471|592975683|FG000|Overall Study|Requirement for restricted medication|1|||
164167230|NCT00809471|592975684|FG001|Overall Study|Requirement for restricted medication|1|||
164167231|NCT00809471|592975685|FG002|Overall Study|Requirement for restricted medication|0|||
164167232|NCT00831311|592975687|FG000|Overall Study|Definitive Contraindication|3|||
164167233|NCT00831311|592975688|FG001|Overall Study|Definitive Contraindication|3|||
164167234|NCT00831311|592975687|FG000|Overall Study|Lost to Follow-up|3|||
164167235|NCT00831311|592975688|FG001|Overall Study|Lost to Follow-up|0|||
164167236|NCT00831311|592975687|FG000|Overall Study|Physician Decision|0|||
164167237|NCT00831311|592975688|FG001|Overall Study|Physician Decision|1|||
164167238|NCT00831311|592975687|FG000|Overall Study|Withdrawal by Subject|6|||
164167239|NCT00831311|592975688|FG001|Overall Study|Withdrawal by Subject|4|||
164167240|NCT01608087|592975690|FG000|Overall Study|Lost to Follow-up|0|||
164167241|NCT01608087|592975691|FG001|Overall Study|Lost to Follow-up|1|||
164167242|NCT01608087|592975692|FG002|Overall Study|Lost to Follow-up|0|||
164167243|NCT01608087|592975690|FG000|Overall Study|Other Reason|0|||
164167244|NCT01608087|592975691|FG001|Overall Study|Other Reason|1|||
164167245|NCT01608087|592975692|FG002|Overall Study|Other Reason|0|||
164167246|NCT04696055|592975701|FG000|Overall Study|Adverse Event|10|||
164167247|NCT04696055|592975702|FG001|Overall Study|Adverse Event|2|||
164167248|NCT04696055|592975701|FG000|Overall Study|Death|4|||
164167249|NCT04696055|592975702|FG001|Overall Study|Death|0|||
164167250|NCT04696055|592975701|FG000|Overall Study|Other|7|||
164167251|NCT04696055|592975702|FG001|Overall Study|Other|2|||
164167252|NCT04696055|592975701|FG000|Overall Study|Physician Decision|3|||
164167253|NCT04696055|592975702|FG001|Overall Study|Physician Decision|0|||
164167254|NCT04696055|592975701|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
164167255|NCT04696055|592975702|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
164167256|NCT04696055|592975701|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
164167257|NCT04696055|592975702|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
164167258|NCT04696055|592975701|FG000|Overall Study|Subject Decision|1|||
164167259|NCT04696055|592975702|FG001|Overall Study|Subject Decision|2|||
164167260|NCT03969901|592975703|FG000|Overall Study|Withdrawal by parent/guardian|0|||
164167261|NCT03969901|592975704|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164167262|NCT03969901|592975705|FG002|Overall Study|Withdrawal by parent/guardian|0|||
164167263|NCT03969901|592975706|FG003|Overall Study|Withdrawal by parent/guardian|0|||
164167264|NCT03969901|592975707|FG004|Overall Study|Withdrawal by parent/guardian|1|||
164167265|NCT03969901|592975708|FG005|Overall Study|Withdrawal by parent/guardian|0|||
164167266|NCT03969901|592975709|FG006|Overall Study|Withdrawal by parent/guardian|0|||
164167267|NCT03969901|592975710|FG007|Overall Study|Withdrawal by parent/guardian|1|||
164167268|NCT03969901|592975711|FG008|Overall Study|Withdrawal by parent/guardian|1|||
164167269|NCT03969901|592975712|FG009|Overall Study|Withdrawal by parent/guardian|0|||
164167270|NCT00348595|592975713|FG000|Overall Study|Adverse Event|5|||
164167271|NCT00348595|592975714|FG001|Overall Study|Adverse Event|8|||
164167272|NCT01920958|592975715|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
164167273|NCT03192306|592975720|FG000|Overall Study|Did not treat cold sore during study|149|||
164167274|NCT03192306|592975721|FG001|Overall Study|Did not treat cold sore during study|143|||
164167275|NCT03192306|592975720|FG000|Overall Study|Withdrawal by Subject|1|||
164167276|NCT03192306|592975721|FG001|Overall Study|Withdrawal by Subject|1|||
164167277|NCT03192306|592975720|FG000|Overall Study|Lost to Follow-up|1|||
164167278|NCT03192306|592975721|FG001|Overall Study|Lost to Follow-up|0|||
164167279|NCT03192306|592975720|FG000|Overall Study|Protocol Violation|1|||
164167280|NCT03192306|592975721|FG001|Overall Study|Protocol Violation|1|||
164167281|NCT02589626|592975726|FG000|Overall Study|Other than the reason specified|1|||
164167282|NCT02589626|592975727|FG001|Overall Study|Other than the reason specified|0|||
164167283|NCT02589626|592975726|FG000|Overall Study|Withdrawal by Subject|1|||
164167284|NCT02589626|592975727|FG001|Overall Study|Withdrawal by Subject|1|||
164167285|NCT02589626|592975726|FG000|Overall Study|Adverse Event|1|||
164167286|NCT02589626|592975727|FG001|Overall Study|Adverse Event|1|||
164167287|NCT00379080|592975728|FG000|Overall Study|Withdrawal by Subject|0|||
164167288|NCT00379080|592975729|FG001|Overall Study|Withdrawal by Subject|4|||
164167289|NCT00379080|592975730|FG002|Overall Study|Withdrawal by Subject|0|||
164167290|NCT02780713|592975731|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167291|NCT02780713|592975732|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167292|NCT02780713|592975733|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
164167293|NCT02780713|592975734|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167294|NCT02780713|592975735|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
164167295|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
164167296|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
164167297|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
164167298|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
164167299|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
164167300|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
164167301|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
164167302|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
164167303|NCT01931475|592975736|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
164167304|NCT01931475|592975737|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
164167305|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
164167306|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
164167307|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
164167308|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
164167309|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
164167310|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
164167311|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
164167312|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
164167313|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
164167314|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
164167315|NCT01931475|592975736|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
164167316|NCT01931475|592975737|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
164167317|NCT01089608|592975740|FG000|Overall Study|Adverse Event|0|||
164167318|NCT01089608|592975741|FG001|Overall Study|Adverse Event|4|||
164167319|NCT01089608|592975740|FG000|Overall Study|Lost to Follow-up|0|||
164167320|NCT01089608|592975741|FG001|Overall Study|Lost to Follow-up|2|||
164167321|NCT01028014|592975745|FG000|Overall Study|Lost to Follow-up|1|||
164167322|NCT01028014|592975746|FG001|Overall Study|Lost to Follow-up|2|||
164167323|NCT01028014|592975747|FG002|Overall Study|Lost to Follow-up|0|||
164167324|NCT01028014|592975748|FG003|Overall Study|Lost to Follow-up|1|||
164167325|NCT01028014|592975749|FG004|Overall Study|Lost to Follow-up|1|||
164167326|NCT01028014|592975750|FG005|Overall Study|Lost to Follow-up|2|||
164167327|NCT01250873|592975751|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
164167328|NCT01250873|592975751|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
164167329|NCT01127451|592975752|FG000|Overall Study|Other|2|||
164167330|NCT01127451|592975753|FG001|Overall Study|Other|1|||
164167331|NCT01127451|592975752|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
164167332|NCT01127451|592975753|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
164167333|NCT01127451|592975752|FG000|Overall Study|Death|22|||
164167334|NCT01127451|592975753|FG001|Overall Study|Death|17|||
164167335|NCT01127451|592975752|FG000|Overall Study|Lost to Follow-up|3|||
164167336|NCT01127451|592975753|FG001|Overall Study|Lost to Follow-up|0|||
164167337|NCT01127451|592975752|FG000|Overall Study|Administrative Reason by Sponsor|2|||
164167338|NCT01127451|592975753|FG001|Overall Study|Administrative Reason by Sponsor|2|||
164167339|NCT00425061|592975754|FG000|Overall Study|Adverse Event|1|||
164167340|NCT00425061|592975755|FG001|Overall Study|Adverse Event|0|||
164167341|NCT00425061|592975756|FG002|Overall Study|Adverse Event|0|||
164167342|NCT00425061|592975757|FG003|Overall Study|Adverse Event|2|||
164167343|NCT00425061|592975758|FG004|Overall Study|Adverse Event|2|||
164167344|NCT00425061|592975759|FG005|Overall Study|Adverse Event|0|||
164167345|NCT00425061|592975760|FG006|Overall Study|Adverse Event|0|||
164167346|NCT00425061|592975754|FG000|Overall Study|Lost to Follow-up|0|||
164167347|NCT00425061|592975755|FG001|Overall Study|Lost to Follow-up|1|||
164167348|NCT00425061|592975756|FG002|Overall Study|Lost to Follow-up|0|||
164167349|NCT00425061|592975757|FG003|Overall Study|Lost to Follow-up|0|||
164167350|NCT00425061|592975758|FG004|Overall Study|Lost to Follow-up|0|||
164167351|NCT00425061|592975759|FG005|Overall Study|Lost to Follow-up|0|||
164167352|NCT00425061|592975760|FG006|Overall Study|Lost to Follow-up|0|||
164167353|NCT00425061|592975754|FG000|Overall Study|Protocol Violation|1|||
164167354|NCT00425061|592975755|FG001|Overall Study|Protocol Violation|0|||
164167355|NCT00425061|592975756|FG002|Overall Study|Protocol Violation|0|||
164167356|NCT00425061|592975757|FG003|Overall Study|Protocol Violation|0|||
164167357|NCT00425061|592975758|FG004|Overall Study|Protocol Violation|0|||
164167358|NCT00425061|592975759|FG005|Overall Study|Protocol Violation|0|||
164167359|NCT00425061|592975760|FG006|Overall Study|Protocol Violation|0|||
164167360|NCT00425061|592975754|FG000|Overall Study|Withdrawal by Subject|0|||
164167361|NCT00425061|592975755|FG001|Overall Study|Withdrawal by Subject|1|||
164167362|NCT00425061|592975756|FG002|Overall Study|Withdrawal by Subject|0|||
164167363|NCT00425061|592975757|FG003|Overall Study|Withdrawal by Subject|0|||
164167364|NCT00425061|592975758|FG004|Overall Study|Withdrawal by Subject|1|||
164167365|NCT00425061|592975759|FG005|Overall Study|Withdrawal by Subject|0|||
164167366|NCT00425061|592975760|FG006|Overall Study|Withdrawal by Subject|3|||
164167367|NCT00425061|592975754|FG000|Overall Study|Sponsor's request|0|||
164167368|NCT00425061|592975755|FG001|Overall Study|Sponsor's request|0|||
164167369|NCT00425061|592975756|FG002|Overall Study|Sponsor's request|0|||
164167370|NCT00425061|592975757|FG003|Overall Study|Sponsor's request|0|||
164167371|NCT00425061|592975758|FG004|Overall Study|Sponsor's request|19|||
164167372|NCT00425061|592975759|FG005|Overall Study|Sponsor's request|4|||
164167373|NCT00425061|592975760|FG006|Overall Study|Sponsor's request|15|||
164167374|NCT00425061|592975754|FG000|Overall Study|Physician Decision|0|||
164167375|NCT00425061|592975755|FG001|Overall Study|Physician Decision|0|||
164167376|NCT00425061|592975756|FG002|Overall Study|Physician Decision|0|||
164167377|NCT00425061|592975757|FG003|Overall Study|Physician Decision|0|||
164167378|NCT00425061|592975758|FG004|Overall Study|Physician Decision|1|||
164167379|NCT00425061|592975759|FG005|Overall Study|Physician Decision|0|||
164167380|NCT00425061|592975760|FG006|Overall Study|Physician Decision|0|||
164167381|NCT00425061|592975754|FG000|Overall Study|Other|0|||
164167382|NCT00425061|592975755|FG001|Overall Study|Other|0|||
164167383|NCT00425061|592975756|FG002|Overall Study|Other|0|||
164167384|NCT00425061|592975757|FG003|Overall Study|Other|0|||
164167385|NCT00425061|592975758|FG004|Overall Study|Other|3|||
164167386|NCT00425061|592975759|FG005|Overall Study|Other|0|||
164167387|NCT00425061|592975760|FG006|Overall Study|Other|1|||
164167388|NCT02111577|592975761|FG000|Overall Study|Protocol Violation|2|||
164167389|NCT02111577|592975762|FG001|Overall Study|Protocol Violation|0|||
164167468|NCT01031680|592975790|FG001|Overall Study|Incorrect Enrolment|2|||
164167390|NCT02111577|592975761|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
164167391|NCT02111577|592975762|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
164167392|NCT02111577|592975761|FG000|Overall Study|Failure to produce study treatment|6|||
164167393|NCT02111577|592975762|FG001|Overall Study|Failure to produce study treatment|0|||
164167394|NCT02111577|592975761|FG000|Overall Study|Death|518|||
164167395|NCT02111577|592975762|FG001|Overall Study|Death|254|||
164167396|NCT02111577|592975761|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
164167397|NCT02111577|592975762|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
164167398|NCT02111577|592975761|FG000|Overall Study|Adverse Event|1|||
164167399|NCT02111577|592975762|FG001|Overall Study|Adverse Event|1|||
164167400|NCT02111577|592975761|FG000|Overall Study|Withdrawal by Subject|51|||
164167401|NCT02111577|592975762|FG001|Overall Study|Withdrawal by Subject|23|||
164167402|NCT02111577|592975761|FG000|Overall Study|Disease progression|0|||
164167403|NCT02111577|592975762|FG001|Overall Study|Disease progression|1|||
164167404|NCT02111577|592975761|FG000|Overall Study|Lost to Follow-up|19|||
164167405|NCT02111577|592975762|FG001|Overall Study|Lost to Follow-up|10|||
164167406|NCT02429778|592975764|FG000|Overall Study|Lost to Follow-up|2|||
164167407|NCT02429778|592975765|FG001|Overall Study|Lost to Follow-up|0|||
164167408|NCT02429778|592975764|FG000|Overall Study|Withdrawal by Subject|5|||
164167409|NCT02429778|592975765|FG001|Overall Study|Withdrawal by Subject|0|||
164167410|NCT03557931|592975771|FG000|Overall Study|Adverse Event|4|||
164167411|NCT03557931|592975772|FG001|Overall Study|Adverse Event|6|||
164167412|NCT03557931|592975773|FG002|Overall Study|Adverse Event|1|||
164167413|NCT03557931|592975771|FG000|Overall Study|Lost to Follow-up|4|||
164167414|NCT03557931|592975772|FG001|Overall Study|Lost to Follow-up|4|||
164167415|NCT03557931|592975773|FG002|Overall Study|Lost to Follow-up|1|||
164167416|NCT03557931|592975771|FG000|Overall Study|Protocol Violation|1|||
164167417|NCT03557931|592975772|FG001|Overall Study|Protocol Violation|4|||
164167418|NCT03557931|592975773|FG002|Overall Study|Protocol Violation|1|||
164167419|NCT03557931|592975771|FG000|Overall Study|Withdrawal by Subject|14|||
164167420|NCT03557931|592975772|FG001|Overall Study|Withdrawal by Subject|0|||
164167421|NCT03557931|592975773|FG002|Overall Study|Withdrawal by Subject|7|||
164167422|NCT03557931|592975771|FG000|Overall Study|Miscellaneous|8|||
164167423|NCT03557931|592975772|FG001|Overall Study|Miscellaneous|5|||
164167424|NCT03557931|592975773|FG002|Overall Study|Miscellaneous|3|||
164167425|NCT02394340|592975774|FG000|Overall Study|Failed drug screen test|1|||
164167426|NCT02394340|592975774|FG000|Overall Study|Adverse Event|1|||
164167427|NCT00634803|592975775|FG000|Overall Study|Lost to Follow-up|6|||
164167428|NCT00634803|592975776|FG001|Overall Study|Lost to Follow-up|7|||
164167429|NCT00634803|592975777|FG002|Overall Study|Lost to Follow-up|7|||
164167430|NCT00886743|592975779|FG000|Overall Study|Adverse Event|3|||
164167431|NCT00886743|592975779|FG000|Overall Study|Other|1|||
164167432|NCT00478777|592975780|FG000|Overall Study|Adverse Event|29|||
164167433|NCT00478777|592975780|FG000|Overall Study|Lack of Efficacy|23|||
164167434|NCT00478777|592975780|FG000|Overall Study|Withdrawal by Subject|4|||
164167435|NCT00478777|592975780|FG000|Overall Study|Death|3|||
164167436|NCT00478777|592975780|FG000|Overall Study|Protocol Violation|3|||
164167437|NCT00478777|592975780|FG000|Overall Study|Lost to Follow-up|3|||
164167438|NCT00478777|592975780|FG000|Overall Study|Physician Decision|1|||
164167439|NCT00478777|592975780|FG000|Overall Study|Intolerance of therapy|1|||
164167440|NCT00478777|592975780|FG000|Overall Study|Lack of compliance|1|||
164167441|NCT00478777|592975780|FG000|Overall Study|Lymphocytes infusion|1|||
164167442|NCT00478777|592975780|FG000|Overall Study|End of therapy|2|||
164167443|NCT00478777|592975780|FG000|Overall Study|Not treated with lenalidomide|6|||
164167444|NCT01323387|592975783|FG000|Overall Study|Withdrawal by Subject|41|||
164167445|NCT01323387|592975783|FG000|Overall Study|Radiographic Data Unavailable|1|||
164167446|NCT01323387|592975783|FG000|Overall Study|Revision|14|||
164167447|NCT01323387|592975783|FG000|Overall Study|Protocol Violation|12|||
164167448|NCT01323387|592975783|FG000|Overall Study|Randomized but Never Treated|16|||
164167449|NCT04200651|592975786|FG000|Overall Study|Moved to another country during follow-up|2|||
164167450|NCT04200651|592975787|FG001|Overall Study|Moved to another country during follow-up|2|||
164167451|NCT04200651|592975786|FG000|Overall Study|Lost to Follow-up|1|||
164167452|NCT04200651|592975787|FG001|Overall Study|Lost to Follow-up|3|||
164167453|NCT01031680|592975789|FG000|Overall Study|Adverse Event|8|||
164167454|NCT01031680|592975790|FG001|Overall Study|Adverse Event|3|||
164167455|NCT01031680|592975789|FG000|Overall Study|Lost to Follow-up|2|||
164167456|NCT01031680|592975790|FG001|Overall Study|Lost to Follow-up|10|||
164167457|NCT01031680|592975789|FG000|Overall Study|Withdrawal by Subject|12|||
164167458|NCT01031680|592975790|FG001|Overall Study|Withdrawal by Subject|16|||
164167459|NCT01031680|592975789|FG000|Overall Study|Death|2|||
164167460|NCT01031680|592975790|FG001|Overall Study|Death|1|||
164167461|NCT01031680|592975789|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
164167462|NCT01031680|592975790|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
164167463|NCT01031680|592975789|FG000|Overall Study|Poor/Non-compliance|5|||
164167464|NCT01031680|592975790|FG001|Overall Study|Poor/Non-compliance|6|||
164167465|NCT01031680|592975789|FG000|Overall Study|Safety|1|||
164167466|NCT01031680|592975790|FG001|Overall Study|Safety|0|||
164167467|NCT01031680|592975789|FG000|Overall Study|Incorrect Enrolment|1|||
164167469|NCT01031680|592975789|FG000|Overall Study|Administrative Reason by Sponsor|0|||
164167470|NCT01031680|592975790|FG001|Overall Study|Administrative Reason by Sponsor|1|||
164167471|NCT01031680|592975789|FG000|Overall Study|Various|0|||
164167472|NCT01031680|592975790|FG001|Overall Study|Various|2|||
164167473|NCT00757042|592975794|FG000|Overall Study|Lost to Follow-up|0|||
164167474|NCT00757042|592975795|FG001|Overall Study|Lost to Follow-up|0|||
164167475|NCT00757042|592975796|FG002|Overall Study|Lost to Follow-up|0|||
164167476|NCT00757042|592975797|FG003|Overall Study|Lost to Follow-up|0|||
164167477|NCT00757042|592975798|FG004|Overall Study|Lost to Follow-up|0|||
164167478|NCT00757042|592975799|FG005|Overall Study|Lost to Follow-up|0|||
164167479|NCT00757042|592975800|FG006|Overall Study|Lost to Follow-up|0|||
164167480|NCT00757042|592975801|FG007|Overall Study|Lost to Follow-up|0|||
164167481|NCT00757042|592975802|FG008|Overall Study|Lost to Follow-up|1|||
164167482|NCT00757042|592975803|FG009|Overall Study|Lost to Follow-up|0|||
164167483|NCT00757042|592975804|FG010|Overall Study|Lost to Follow-up|0|||
164167484|NCT00757042|592975794|FG000|Overall Study|Ineligibility Determined|0|||
164167485|NCT00757042|592975795|FG001|Overall Study|Ineligibility Determined|0|||
164167486|NCT00757042|592975796|FG002|Overall Study|Ineligibility Determined|0|||
164167487|NCT00757042|592975797|FG003|Overall Study|Ineligibility Determined|0|||
164167488|NCT00757042|592975798|FG004|Overall Study|Ineligibility Determined|0|||
164167489|NCT00757042|592975799|FG005|Overall Study|Ineligibility Determined|0|||
164167490|NCT00757042|592975800|FG006|Overall Study|Ineligibility Determined|0|||
164167491|NCT00757042|592975801|FG007|Overall Study|Ineligibility Determined|0|||
164167492|NCT00757042|592975802|FG008|Overall Study|Ineligibility Determined|0|||
164167493|NCT00757042|592975803|FG009|Overall Study|Ineligibility Determined|0|||
164167494|NCT00757042|592975804|FG010|Overall Study|Ineligibility Determined|1|||
164167495|NCT00757042|592975794|FG000|Overall Study|Withdrawal by Subject|0|||
164167496|NCT00757042|592975795|FG001|Overall Study|Withdrawal by Subject|0|||
164167497|NCT00757042|592975796|FG002|Overall Study|Withdrawal by Subject|0|||
164167498|NCT00757042|592975797|FG003|Overall Study|Withdrawal by Subject|0|||
164167499|NCT00757042|592975798|FG004|Overall Study|Withdrawal by Subject|0|||
164167500|NCT00757042|592975799|FG005|Overall Study|Withdrawal by Subject|0|||
164167501|NCT00757042|592975800|FG006|Overall Study|Withdrawal by Subject|0|||
164167502|NCT00757042|592975801|FG007|Overall Study|Withdrawal by Subject|0|||
164167503|NCT00757042|592975802|FG008|Overall Study|Withdrawal by Subject|0|||
164167504|NCT00757042|592975803|FG009|Overall Study|Withdrawal by Subject|1|||
164167505|NCT00757042|592975804|FG010|Overall Study|Withdrawal by Subject|0|||
164167506|NCT03319732|592975805|FG000|Overall Study|Adverse Event|40|||
164167507|NCT03319732|592975805|FG000|Overall Study|Withdrawal by Subject|50|||
164167508|NCT03319732|592975805|FG000|Overall Study|MS relapse|10|||
164167509|NCT03319732|592975805|FG000|Overall Study|reason not specified|5|||
164167510|NCT02654977|592975807|FG000|Overall Study|Death|1|||
164167511|NCT02654977|592975807|FG000|Overall Study|Lost to Follow-up|1|||
164167512|NCT02654977|592975807|FG000|Overall Study|Adverse Event|1|||
164167513|NCT02654977|592975807|FG000|Overall Study|Withdrawal by Subject|1|||
164167514|NCT02654977|592975807|FG000|Overall Study|Lack of Efficacy|3|||
164167515|NCT01266291|592975808|FG000|Overall Study|Adverse Event|1|||
164167516|NCT00596817|592975811|FG000|Open-label Period|Adverse Event|0|||
164167517|NCT00596817|592975812|FG001|Open-label Period|Adverse Event|49|||
164167518|NCT00596817|592975811|FG000|Open-label Period|Lack of Efficacy|0|||
164167519|NCT00596817|592975812|FG001|Open-label Period|Lack of Efficacy|33|||
164167520|NCT00596817|592975811|FG000|Open-label Period|Other Reasons|0|||
164167521|NCT00596817|592975812|FG001|Open-label Period|Other Reasons|65|||
164167522|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
164167523|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
164167524|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
164167525|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
164167526|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
164167527|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
164167528|NCT00596817|592975811|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
164167529|NCT00596817|592975812|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
164167530|NCT00596817|592975811|FG000|Double-blind Period|Adverse Event|5|||
164167531|NCT00596817|592975812|FG001|Double-blind Period|Adverse Event|16|||
164167532|NCT00596817|592975811|FG000|Double-blind Period|Lack of Efficacy|52|||
164167533|NCT00596817|592975812|FG001|Double-blind Period|Lack of Efficacy|28|||
164167534|NCT00596817|592975811|FG000|Double-blind Period|Non-compliance With Study Product|3|||
164167535|NCT00596817|592975812|FG001|Double-blind Period|Non-compliance With Study Product|4|||
164167536|NCT00596817|592975811|FG000|Double-blind Period|Protocol Violation|11|||
164167537|NCT00596817|592975812|FG001|Double-blind Period|Protocol Violation|8|||
164167538|NCT00596817|592975811|FG000|Double-blind Period|Withdrawal of Consent|7|||
164167539|NCT00596817|592975812|FG001|Double-blind Period|Withdrawal of Consent|3|||
164167540|NCT00596817|592975811|FG000|Double-blind Period|Lost to Follow-up|0|||
164167541|NCT00596817|592975812|FG001|Double-blind Period|Lost to Follow-up|2|||
164167542|NCT00596817|592975811|FG000|Double-blind Period|Other Reasons|10|||
164167543|NCT00596817|592975812|FG001|Double-blind Period|Other Reasons|18|||
164167544|NCT00519428|592978088|FG000|Overall Study|Adverse Event|5|||
164167545|NCT00519428|592978089|FG001|Overall Study|Adverse Event|2|||
164167546|NCT00519428|592978090|FG002|Overall Study|Adverse Event|10|||
164167547|NCT00519428|592978088|FG000|Overall Study|Lost to Follow-up|7|||
164167548|NCT00519428|592978089|FG001|Overall Study|Lost to Follow-up|7|||
164167549|NCT00519428|592978090|FG002|Overall Study|Lost to Follow-up|6|||
164167550|NCT00519428|592978088|FG000|Overall Study|Withdrawal by Subject|8|||
164167551|NCT00519428|592978089|FG001|Overall Study|Withdrawal by Subject|3|||
164167552|NCT00519428|592978090|FG002|Overall Study|Withdrawal by Subject|7|||
164167553|NCT00519428|592978088|FG000|Overall Study|unstated|1|||
164167554|NCT00519428|592978089|FG001|Overall Study|unstated|3|||
164167555|NCT00519428|592978090|FG002|Overall Study|unstated|2|||
164167556|NCT00688701|592978092|FG000|Overall Study|Adverse Event|1|||
164167557|NCT00688701|592978093|FG001|Overall Study|Adverse Event|0|||
164167558|NCT00688701|592978094|FG002|Overall Study|Adverse Event|5|||
164167559|NCT00688701|592978095|FG003|Overall Study|Adverse Event|3|||
164167560|NCT00688701|592978092|FG000|Overall Study|Lack of Efficacy|0|||
164167561|NCT00688701|592978093|FG001|Overall Study|Lack of Efficacy|1|||
164167562|NCT00688701|592978094|FG002|Overall Study|Lack of Efficacy|0|||
164167563|NCT00688701|592978095|FG003|Overall Study|Lack of Efficacy|0|||
164167564|NCT00688701|592978092|FG000|Overall Study|Withdrawal by Subject|3|||
164167565|NCT00688701|592978093|FG001|Overall Study|Withdrawal by Subject|3|||
164167566|NCT00688701|592978094|FG002|Overall Study|Withdrawal by Subject|4|||
164167567|NCT00688701|592978095|FG003|Overall Study|Withdrawal by Subject|8|||
164167568|NCT00688701|592978092|FG000|Overall Study|Poor compliance to protocol|0|||
164167569|NCT00688701|592978093|FG001|Overall Study|Poor compliance to protocol|1|||
164167570|NCT00688701|592978094|FG002|Overall Study|Poor compliance to protocol|1|||
164167571|NCT00688701|592978095|FG003|Overall Study|Poor compliance to protocol|0|||
164167572|NCT03962790|592978100|FG000|Period 1|Adverse Event|0|||
164167573|NCT03962790|592978101|FG001|Period 1|Adverse Event|1|||
164167574|NCT03962790|592978100|FG000|Period 1|Failed to meet all eligibility criteria|1|||
164167575|NCT03962790|592978101|FG001|Period 1|Failed to meet all eligibility criteria|1|||
164167576|NCT03962790|592978100|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
164167577|NCT03962790|592978101|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
164167578|NCT03962790|592978100|FG000|Period 1|Withdrawal by Subject|1|||
164167579|NCT03962790|592978101|FG001|Period 1|Withdrawal by Subject|0|||
164167580|NCT00664859|592978117|FG000|Overall Study|Adverse Event|2|||
164167581|NCT00664859|592978118|FG001|Overall Study|Adverse Event|1|||
164167582|NCT00664859|592978119|FG002|Overall Study|Adverse Event|3|||
164167583|NCT00664859|592978117|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
164167584|NCT00664859|592978118|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
164167585|NCT00664859|592978119|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
164167586|NCT00664859|592978117|FG000|Overall Study|Noncompliance with protocol|1|||
164167587|NCT00664859|592978118|FG001|Overall Study|Noncompliance with protocol|0|||
164167588|NCT00664859|592978119|FG002|Overall Study|Noncompliance with protocol|4|||
164167589|NCT00664859|592978117|FG000|Overall Study|Laboratory abnormality|2|||
164167590|NCT00664859|592978118|FG001|Overall Study|Laboratory abnormality|1|||
164167591|NCT00664859|592978119|FG002|Overall Study|Laboratory abnormality|4|||
164167592|NCT00664859|592978117|FG000|Overall Study|Withdrawal by Subject|4|||
164167593|NCT00664859|592978118|FG001|Overall Study|Withdrawal by Subject|1|||
164167594|NCT00664859|592978119|FG002|Overall Study|Withdrawal by Subject|3|||
164167595|NCT00664859|592978117|FG000|Overall Study|Lost to Follow-up|2|||
164167596|NCT00664859|592978118|FG001|Overall Study|Lost to Follow-up|2|||
164167597|NCT00664859|592978119|FG002|Overall Study|Lost to Follow-up|1|||
164167598|NCT00664859|592978117|FG000|Overall Study|Other|0|||
164167599|NCT00664859|592978118|FG001|Overall Study|Other|1|||
164167600|NCT00664859|592978119|FG002|Overall Study|Other|2|||
164167601|NCT01943851|592978120|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167602|NCT01943851|592978121|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167603|NCT01943851|592978122|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167604|NCT01943851|592978123|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167605|NCT01943851|592978124|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167606|NCT01943851|592978125|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167607|NCT01943851|592978126|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167608|NCT01943851|592978127|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167609|NCT01943851|592978128|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
164167610|NCT01943851|592978129|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167611|NCT01943851|592978130|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167612|NCT01943851|592978131|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167613|NCT01943851|592978132|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167614|NCT01943851|592978133|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167615|NCT01943851|592978134|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167616|NCT01943851|592978135|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167617|NCT01943851|592978136|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167618|NCT01943851|592978137|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
164167619|NCT01943851|592978120|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167620|NCT01943851|592978121|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167621|NCT01943851|592978122|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167622|NCT01943851|592978123|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167623|NCT01943851|592978124|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
164167624|NCT01943851|592978125|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167625|NCT01943851|592978126|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167626|NCT01943851|592978127|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
164167627|NCT01943851|592978128|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167628|NCT01943851|592978129|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167629|NCT01943851|592978130|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167630|NCT01943851|592978131|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167631|NCT01943851|592978132|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167632|NCT01943851|592978133|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167633|NCT01943851|592978134|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167634|NCT01943851|592978135|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167635|NCT01943851|592978136|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167636|NCT01943851|592978137|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
164167637|NCT01943851|592978120|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167638|NCT01943851|592978121|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167639|NCT01943851|592978122|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167640|NCT01943851|592978123|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167641|NCT01943851|592978124|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167642|NCT01943851|592978125|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167643|NCT01943851|592978126|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167644|NCT01943851|592978127|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167645|NCT01943851|592978128|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167646|NCT01943851|592978129|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167647|NCT01943851|592978130|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167648|NCT01943851|592978131|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167649|NCT01943851|592978132|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167650|NCT01943851|592978133|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
164167651|NCT01943851|592978134|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167652|NCT01943851|592978135|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167653|NCT01943851|592978136|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167654|NCT01943851|592978137|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
164167655|NCT01943851|592978120|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167656|NCT01943851|592978121|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167657|NCT01943851|592978122|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167658|NCT01943851|592978123|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167659|NCT01943851|592978124|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167660|NCT01943851|592978125|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167661|NCT01943851|592978126|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167662|NCT01943851|592978127|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167663|NCT01943851|592978128|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167664|NCT01943851|592978129|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167665|NCT01943851|592978130|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167666|NCT01943851|592978131|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167667|NCT01943851|592978132|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167668|NCT01943851|592978133|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167669|NCT01943851|592978134|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167670|NCT01943851|592978135|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
164167671|NCT01943851|592978136|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167672|NCT01943851|592978137|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
164167673|NCT01943851|592978120|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167674|NCT01943851|592978121|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167675|NCT01943851|592978122|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167676|NCT01943851|592978123|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167677|NCT01943851|592978124|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167678|NCT01943851|592978125|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167679|NCT01943851|592978126|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167680|NCT01943851|592978127|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167681|NCT01943851|592978128|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167682|NCT01943851|592978129|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167683|NCT01943851|592978130|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167684|NCT01943851|592978131|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167685|NCT01943851|592978132|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167686|NCT01943851|592978133|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167687|NCT01943851|592978134|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
164167688|NCT01943851|592978135|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
164167689|NCT01943851|592978136|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
164167690|NCT01943851|592978137|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
164167691|NCT00401544|592978139|FG000|Overall Study|Adverse Event|5|||
164167692|NCT00401544|592978140|FG001|Overall Study|Adverse Event|1|||
164167693|NCT00401544|592978141|FG002|Overall Study|Adverse Event|1|||
164167694|NCT00401544|592978142|FG003|Overall Study|Adverse Event|1|||
164167695|NCT00401544|592978139|FG000|Overall Study|Death|3|||
164167696|NCT00401544|592978140|FG001|Overall Study|Death|6|||
164167697|NCT00401544|592978141|FG002|Overall Study|Death|2|||
164167698|NCT00401544|592978142|FG003|Overall Study|Death|5|||
164167699|NCT00401544|592978139|FG000|Overall Study|Lost to Follow-up|2|||
164167700|NCT00401544|592978140|FG001|Overall Study|Lost to Follow-up|0|||
164167701|NCT00401544|592978141|FG002|Overall Study|Lost to Follow-up|1|||
164167702|NCT00401544|592978142|FG003|Overall Study|Lost to Follow-up|1|||
164167703|NCT00401544|592978139|FG000|Overall Study|Withdrawal by Subject|7|||
164167704|NCT00401544|592978140|FG001|Overall Study|Withdrawal by Subject|6|||
164167705|NCT00401544|592978141|FG002|Overall Study|Withdrawal by Subject|6|||
164167706|NCT00401544|592978142|FG003|Overall Study|Withdrawal by Subject|5|||
164167707|NCT00401544|592978139|FG000|Overall Study|Physician Decision|1|||
164167708|NCT00401544|592978140|FG001|Overall Study|Physician Decision|3|||
164167709|NCT00401544|592978141|FG002|Overall Study|Physician Decision|0|||
164167710|NCT00401544|592978142|FG003|Overall Study|Physician Decision|0|||
164167711|NCT00401544|592978139|FG000|Overall Study|Ineligibility determined|0|||
164167712|NCT00401544|592978140|FG001|Overall Study|Ineligibility determined|1|||
164167713|NCT00401544|592978141|FG002|Overall Study|Ineligibility determined|0|||
164167714|NCT00401544|592978142|FG003|Overall Study|Ineligibility determined|2|||
164167715|NCT00401544|592978139|FG000|Overall Study|Disease progression|0|||
164167716|NCT00401544|592978140|FG001|Overall Study|Disease progression|1|||
164167717|NCT00401544|592978141|FG002|Overall Study|Disease progression|0|||
164167718|NCT00401544|592978142|FG003|Overall Study|Disease progression|0|||
164167719|NCT00401544|592978139|FG000|Overall Study|Other|0|||
164167720|NCT00401544|592978140|FG001|Overall Study|Other|0|||
164167721|NCT00401544|592978141|FG002|Overall Study|Other|2|||
164167722|NCT00401544|592978142|FG003|Overall Study|Other|2|||
164167723|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
164167724|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
164167725|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
164167726|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
164167727|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
164167728|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
164167729|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
164167730|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
164167731|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
164167732|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
164167733|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
164167734|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
164167735|NCT03645395|592978143|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
164167736|NCT03645395|592978144|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
164167737|NCT03645395|592978145|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
164167738|NCT03645395|592978146|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
164167739|NCT01289639|592978148|FG000|Overall Study|Lost to Follow-up|1|||
164167740|NCT01289639|592978149|FG001|Overall Study|Lost to Follow-up|0|||
164167741|NCT01289639|592978150|FG002|Overall Study|Lost to Follow-up|0|||
164167742|NCT02278939|592978153|FG000|Overall Study|lack of time|1|||
164167743|NCT02278939|592978154|FG001|Overall Study|lack of time|0|||
164167744|NCT02278939|592978153|FG000|Overall Study|Lost to Follow-up|1|||
164167745|NCT02278939|592978154|FG001|Overall Study|Lost to Follow-up|1|||
164167746|NCT02278939|592978153|FG000|Overall Study|death in family|1|||
164167747|NCT02278939|592978154|FG001|Overall Study|death in family|0|||
164167748|NCT02278939|592978153|FG000|Overall Study|family emergency unable to commit|2|||
164167749|NCT02278939|592978154|FG001|Overall Study|family emergency unable to commit|0|||
164167750|NCT02423343|592978160|FG000|Overall Study|Withdrawal by Subject|0|||
164167751|NCT02423343|592978161|FG001|Overall Study|Withdrawal by Subject|1|||
164167752|NCT02423343|592978162|FG002|Overall Study|Withdrawal by Subject|0|||
164167753|NCT02423343|592978163|FG003|Overall Study|Withdrawal by Subject|0|||
164167754|NCT02423343|592978164|FG004|Overall Study|Withdrawal by Subject|0|||
164167755|NCT02423343|592978165|FG005|Overall Study|Withdrawal by Subject|0|||
164167756|NCT02423343|592978160|FG000|Overall Study|Progressive Disease|0|||
164167757|NCT02423343|592978161|FG001|Overall Study|Progressive Disease|0|||
164167758|NCT02423343|592978162|FG002|Overall Study|Progressive Disease|0|||
164167759|NCT02423343|592978163|FG003|Overall Study|Progressive Disease|0|||
164167760|NCT02423343|592978164|FG004|Overall Study|Progressive Disease|2|||
164167761|NCT02423343|592978165|FG005|Overall Study|Progressive Disease|0|||
164167762|NCT02423343|592978160|FG000|Overall Study|Adverse Event|0|||
164167763|NCT02423343|592978161|FG001|Overall Study|Adverse Event|0|||
164167764|NCT02423343|592978162|FG002|Overall Study|Adverse Event|0|||
164167765|NCT02423343|592978163|FG003|Overall Study|Adverse Event|0|||
164167766|NCT02423343|592978164|FG004|Overall Study|Adverse Event|2|||
164167767|NCT02423343|592978165|FG005|Overall Study|Adverse Event|0|||
164167768|NCT02423343|592978160|FG000|Overall Study|Death|0|||
164167769|NCT02423343|592978161|FG001|Overall Study|Death|0|||
164167770|NCT02423343|592978162|FG002|Overall Study|Death|0|||
164167771|NCT02423343|592978163|FG003|Overall Study|Death|0|||
164167772|NCT02423343|592978164|FG004|Overall Study|Death|1|||
164167773|NCT02423343|592978165|FG005|Overall Study|Death|0|||
164167774|NCT04429555|592978170|FG000|Overall Study|Death|0|||
164167775|NCT04429555|592978171|FG001|Overall Study|Death|2|||
164167776|NCT04429555|592978170|FG000|Overall Study|Other|2|||
164167777|NCT04429555|592978171|FG001|Overall Study|Other|0|||
164167778|NCT00930774|592978172|FG000|Overall Study|Withdrawal by Subject|1|||
164167779|NCT00930774|592978173|FG001|Overall Study|Withdrawal by Subject|9|||
164167780|NCT00930774|592978174|FG002|Overall Study|Withdrawal by Subject|2|||
164167781|NCT00930774|592978175|FG003|Overall Study|Withdrawal by Subject|0|||
164167782|NCT00712881|592978176|FG000|Overall Study|Adverse Event|3|||
164167783|NCT00712881|592978177|FG001|Overall Study|Adverse Event|3|||
164167784|NCT00712881|592978176|FG000|Overall Study|Withdrawal by Subject|1|||
164167785|NCT00712881|592978177|FG001|Overall Study|Withdrawal by Subject|1|||
164167786|NCT00712881|592978176|FG000|Overall Study|Disease Progression|2|||
164167787|NCT00712881|592978177|FG001|Overall Study|Disease Progression|1|||
164167788|NCT00712881|592978176|FG000|Overall Study|Lost to Follow-up|1|||
164167789|NCT00712881|592978177|FG001|Overall Study|Lost to Follow-up|1|||
164167790|NCT00712881|592978176|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
164167791|NCT00712881|592978177|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
164167792|NCT00712881|592978176|FG000|Overall Study|Protocol Violation|1|||
164167793|NCT00712881|592978177|FG001|Overall Study|Protocol Violation|1|||
164167794|NCT00712881|592978176|FG000|Overall Study|Randomized but not treated|1|||
164167795|NCT00712881|592978177|FG001|Overall Study|Randomized but not treated|0|||
164167796|NCT03200704|592978178|FG000|Overall Study|Withdrawal by Subject|1|||
164167797|NCT01680861|592978179|FG000|Early Post-transplant Period|Protocol Violation|1|||
164167798|NCT01680861|592978180|FG001|Early Post-transplant Period|Protocol Violation|1|||
164167799|NCT04590586|592978188|FG000|Overall Study|Death|7|||
164167800|NCT04590586|592978189|FG001|Overall Study|Death|1|||
164167801|NCT04590586|592978190|FG002|Overall Study|Death|37|||
164167802|NCT04590586|592978191|FG003|Overall Study|Death|34|||
164167803|NCT04590586|592978192|FG004|Overall Study|Death|19|||
164167804|NCT04590586|592978193|FG005|Overall Study|Death|3|||
164167805|NCT04590586|592978188|FG000|Overall Study|Lost to Follow-up|3|||
164167806|NCT04590586|592978189|FG001|Overall Study|Lost to Follow-up|0|||
164167807|NCT04590586|592978190|FG002|Overall Study|Lost to Follow-up|11|||
164167808|NCT04590586|592978191|FG003|Overall Study|Lost to Follow-up|11|||
164167809|NCT04590586|592978192|FG004|Overall Study|Lost to Follow-up|6|||
164167810|NCT04590586|592978193|FG005|Overall Study|Lost to Follow-up|0|||
164167811|NCT04590586|592978188|FG000|Overall Study|Withdrawal by Subject|0|||
164167812|NCT04590586|592978189|FG001|Overall Study|Withdrawal by Subject|0|||
164167813|NCT04590586|592978190|FG002|Overall Study|Withdrawal by Subject|6|||
164167814|NCT04590586|592978191|FG003|Overall Study|Withdrawal by Subject|0|||
164167815|NCT04590586|592978192|FG004|Overall Study|Withdrawal by Subject|3|||
164167816|NCT04590586|592978193|FG005|Overall Study|Withdrawal by Subject|0|||
164167817|NCT04590586|592978188|FG000|Overall Study|Other|3|||
164167818|NCT04590586|592978189|FG001|Overall Study|Other|0|||
164167819|NCT04590586|592978190|FG002|Overall Study|Other|1|||
164167820|NCT04590586|592978191|FG003|Overall Study|Other|1|||
164167821|NCT04590586|592978192|FG004|Overall Study|Other|2|||
164167822|NCT04590586|592978193|FG005|Overall Study|Other|1|||
164167823|NCT01609543|592978194|FG000|Overall Study|Disease Progression|28|||
164167824|NCT01609543|592978194|FG000|Overall Study|Adverse Event|5|||
164167825|NCT01609543|592978194|FG000|Overall Study|Withdrawal by Subject|1|||
164167826|NCT01609543|592978194|FG000|Overall Study|Protocol Violation|1|||
164167827|NCT01609543|592978194|FG000|Overall Study|Death|7|||
164167828|NCT01893281|592978195|FG000|Overall Study|Adverse Event|1|||
164167829|NCT01893281|592978195|FG000|Overall Study|Protocol Violation|1|||
164167830|NCT01893281|592978195|FG000|Overall Study|Withdrawal by Subject|1|||
164167831|NCT01254318|592978196|FG000|Overall Study|Lost to Follow-up|5|||
164167832|NCT01254318|592978196|FG000|Overall Study|Death|47|||
164167833|NCT01137110|592978206|FG000|Overall Study|Protocol Violation|1|||
164167834|NCT01137110|592978207|FG001|Overall Study|Protocol Violation|0|||
164167835|NCT02828124|592978212|FG000|Overall Study|Disease Progression|1|||
164167836|NCT02828124|592978213|FG001|Overall Study|Disease Progression|2|||
164167837|NCT02828124|592978214|FG002|Overall Study|Disease Progression|1|||
164167838|NCT02828124|592978215|FG003|Overall Study|Disease Progression|4|||
164167839|NCT02828124|592978212|FG000|Overall Study|AE Unrelated to Study Drug|0|||
164167840|NCT02828124|592978213|FG001|Overall Study|AE Unrelated to Study Drug|0|||
164167841|NCT02828124|592978214|FG002|Overall Study|AE Unrelated to Study Drug|0|||
164167842|NCT02828124|592978215|FG003|Overall Study|AE Unrelated to Study Drug|1|||
164167843|NCT02828124|592978212|FG000|Overall Study|Subject Withdrew Consent|0|||
164167844|NCT02828124|592978213|FG001|Overall Study|Subject Withdrew Consent|0|||
164167845|NCT02828124|592978214|FG002|Overall Study|Subject Withdrew Consent|0|||
164167846|NCT02828124|592978215|FG003|Overall Study|Subject Withdrew Consent|1|||
164167847|NCT03990571|592978216|FG000|Overall Study|Withdrawal by Subject|1|||
164167848|NCT03990571|592978216|FG000|Overall Study|Insurance Issues|3|||
164167849|NCT03990571|592978216|FG000|Overall Study|Covid Restrictions|2|||
164167850|NCT03605862|592978217|FG000|Overall Study|Withdrawal by Subject|12|||
164167851|NCT03605862|592978218|FG001|Overall Study|Withdrawal by Subject|9|||
164167852|NCT03605862|592978217|FG000|Overall Study|Adverse Event|2|||
164167853|NCT03605862|592978218|FG001|Overall Study|Adverse Event|1|||
164167854|NCT03605862|592978217|FG000|Overall Study|Physician Decision|3|||
164167855|NCT03605862|592978218|FG001|Overall Study|Physician Decision|1|||
164167856|NCT03605862|592978217|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
164167857|NCT03605862|592978218|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
164167858|NCT00675428|592978221|FG000|Overall Study|Disease Progression|2|||
164167859|NCT00675428|592978222|FG001|Overall Study|Disease Progression|2|||
164167860|NCT00675428|592978221|FG000|Overall Study|No Disease Response After Cycle 6|0|||
164167861|NCT00675428|592978222|FG001|Overall Study|No Disease Response After Cycle 6|1|||
164167862|NCT00675428|592978221|FG000|Overall Study|Physician Decision|1|||
164167863|NCT00675428|592978222|FG001|Overall Study|Physician Decision|0|||
164167864|NCT04105218|592978223|FG000|Overall Study|Withdrawal by Subject|3|||
164167865|NCT04105218|592978224|FG001|Overall Study|Withdrawal by Subject|2|||
164167866|NCT04105218|592978223|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
164167867|NCT04105218|592978224|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
164167868|NCT04105218|592978223|FG000|Overall Study|Failed screening tests|2|||
164167869|NCT04105218|592978224|FG001|Overall Study|Failed screening tests|1|||
164167870|NCT02553499|592978227|FG000|Overall Study|Adverse Event|0|||
164167871|NCT02553499|592978228|FG001|Overall Study|Adverse Event|0|||
164167872|NCT02553499|592978229|FG002|Overall Study|Adverse Event|0|||
164167873|NCT02553499|592978230|FG003|Overall Study|Adverse Event|0|||
164167874|NCT02553499|592978231|FG004|Overall Study|Adverse Event|0|||
164167875|NCT02553499|592978232|FG005|Overall Study|Adverse Event|0|||
164167876|NCT02553499|592978233|FG006|Overall Study|Adverse Event|1|||
164167877|NCT02553499|592978234|FG007|Overall Study|Adverse Event|1|||
164167878|NCT02553499|592978235|FG008|Overall Study|Adverse Event|0|||
164167879|NCT02553499|592978236|FG009|Overall Study|Adverse Event|0|||
164167880|NCT02553499|592978237|FG010|Overall Study|Adverse Event|0|||
164167881|NCT02553499|592978238|FG011|Overall Study|Adverse Event|0|||
164167882|NCT02553499|592978239|FG012|Overall Study|Adverse Event|0|||
164167883|NCT02553499|592978240|FG013|Overall Study|Adverse Event|1|||
164167884|NCT02553499|592978227|FG000|Overall Study|Death|0|||
164167885|NCT02553499|592978228|FG001|Overall Study|Death|1|||
164167886|NCT02553499|592978229|FG002|Overall Study|Death|1|||
164167887|NCT02553499|592978230|FG003|Overall Study|Death|0|||
164167888|NCT02553499|592978231|FG004|Overall Study|Death|1|||
164167889|NCT02553499|592978232|FG005|Overall Study|Death|2|||
164167890|NCT02553499|592978233|FG006|Overall Study|Death|0|||
164167891|NCT02553499|592978234|FG007|Overall Study|Death|0|||
164167892|NCT02553499|592978235|FG008|Overall Study|Death|0|||
164167893|NCT02553499|592978236|FG009|Overall Study|Death|0|||
164167894|NCT02553499|592978237|FG010|Overall Study|Death|1|||
164167895|NCT02553499|592978238|FG011|Overall Study|Death|0|||
164167896|NCT02553499|592978239|FG012|Overall Study|Death|0|||
164167897|NCT02553499|592978240|FG013|Overall Study|Death|0|||
164167898|NCT02553499|592978227|FG000|Overall Study|Lost to Follow-up|0|||
164167899|NCT02553499|592978228|FG001|Overall Study|Lost to Follow-up|0|||
164167900|NCT02553499|592978229|FG002|Overall Study|Lost to Follow-up|0|||
164167901|NCT02553499|592978230|FG003|Overall Study|Lost to Follow-up|0|||
164167902|NCT02553499|592978231|FG004|Overall Study|Lost to Follow-up|0|||
164167903|NCT02553499|592978232|FG005|Overall Study|Lost to Follow-up|0|||
164167904|NCT02553499|592978233|FG006|Overall Study|Lost to Follow-up|1|||
164167905|NCT02553499|592978234|FG007|Overall Study|Lost to Follow-up|0|||
164167906|NCT02553499|592978235|FG008|Overall Study|Lost to Follow-up|0|||
164167907|NCT02553499|592978236|FG009|Overall Study|Lost to Follow-up|0|||
164167908|NCT02553499|592978237|FG010|Overall Study|Lost to Follow-up|0|||
164167909|NCT02553499|592978238|FG011|Overall Study|Lost to Follow-up|0|||
164167910|NCT02553499|592978239|FG012|Overall Study|Lost to Follow-up|0|||
164167911|NCT02553499|592978240|FG013|Overall Study|Lost to Follow-up|0|||
164167912|NCT02553499|592978227|FG000|Overall Study|Physician Decision|0|||
164167913|NCT02553499|592978228|FG001|Overall Study|Physician Decision|1|||
164167914|NCT02553499|592978229|FG002|Overall Study|Physician Decision|1|||
164167915|NCT02553499|592978230|FG003|Overall Study|Physician Decision|0|||
164167916|NCT02553499|592978231|FG004|Overall Study|Physician Decision|1|||
164167917|NCT02553499|592978232|FG005|Overall Study|Physician Decision|0|||
164167918|NCT02553499|592978233|FG006|Overall Study|Physician Decision|0|||
164167919|NCT02553499|592978234|FG007|Overall Study|Physician Decision|1|||
164167920|NCT02553499|592978235|FG008|Overall Study|Physician Decision|1|||
164167921|NCT02553499|592978236|FG009|Overall Study|Physician Decision|2|||
164167922|NCT02553499|592978237|FG010|Overall Study|Physician Decision|1|||
164167923|NCT02553499|592978238|FG011|Overall Study|Physician Decision|3|||
164167924|NCT02553499|592978239|FG012|Overall Study|Physician Decision|1|||
164167925|NCT02553499|592978240|FG013|Overall Study|Physician Decision|0|||
164167926|NCT02553499|592978227|FG000|Overall Study|Progressive Disease|0|||
164167927|NCT02553499|592978228|FG001|Overall Study|Progressive Disease|0|||
164167928|NCT02553499|592978229|FG002|Overall Study|Progressive Disease|0|||
164167929|NCT02553499|592978230|FG003|Overall Study|Progressive Disease|2|||
164167930|NCT02553499|592978231|FG004|Overall Study|Progressive Disease|1|||
164167931|NCT02553499|592978232|FG005|Overall Study|Progressive Disease|1|||
164167932|NCT02553499|592978233|FG006|Overall Study|Progressive Disease|1|||
164167933|NCT02553499|592978234|FG007|Overall Study|Progressive Disease|0|||
164167934|NCT02553499|592978235|FG008|Overall Study|Progressive Disease|0|||
164167935|NCT02553499|592978236|FG009|Overall Study|Progressive Disease|1|||
164167936|NCT02553499|592978237|FG010|Overall Study|Progressive Disease|0|||
164167937|NCT02553499|592978238|FG011|Overall Study|Progressive Disease|0|||
164167938|NCT02553499|592978239|FG012|Overall Study|Progressive Disease|2|||
164167939|NCT02553499|592978240|FG013|Overall Study|Progressive Disease|1|||
164167940|NCT02553499|592978227|FG000|Overall Study|Study Terminated by Sponsor|0|||
164167941|NCT02553499|592978228|FG001|Overall Study|Study Terminated by Sponsor|0|||
164167942|NCT02553499|592978229|FG002|Overall Study|Study Terminated by Sponsor|0|||
164167943|NCT02553499|592978230|FG003|Overall Study|Study Terminated by Sponsor|0|||
164167944|NCT02553499|592978231|FG004|Overall Study|Study Terminated by Sponsor|0|||
164167945|NCT02553499|592978232|FG005|Overall Study|Study Terminated by Sponsor|0|||
164167946|NCT02553499|592978233|FG006|Overall Study|Study Terminated by Sponsor|0|||
164167947|NCT02553499|592978234|FG007|Overall Study|Study Terminated by Sponsor|0|||
164167948|NCT02553499|592978235|FG008|Overall Study|Study Terminated by Sponsor|1|||
164167949|NCT02553499|592978236|FG009|Overall Study|Study Terminated by Sponsor|0|||
164167950|NCT02553499|592978237|FG010|Overall Study|Study Terminated by Sponsor|0|||
164167951|NCT02553499|592978238|FG011|Overall Study|Study Terminated by Sponsor|0|||
164167952|NCT02553499|592978239|FG012|Overall Study|Study Terminated by Sponsor|0|||
164167953|NCT02553499|592978240|FG013|Overall Study|Study Terminated by Sponsor|0|||
164167954|NCT02553499|592978227|FG000|Overall Study|Withdrawal by Subject|2|||
164167955|NCT02553499|592978228|FG001|Overall Study|Withdrawal by Subject|0|||
164167956|NCT02553499|592978229|FG002|Overall Study|Withdrawal by Subject|0|||
164167957|NCT02553499|592978230|FG003|Overall Study|Withdrawal by Subject|0|||
164167958|NCT02553499|592978231|FG004|Overall Study|Withdrawal by Subject|0|||
164167959|NCT02553499|592978232|FG005|Overall Study|Withdrawal by Subject|0|||
164167960|NCT02553499|592978233|FG006|Overall Study|Withdrawal by Subject|0|||
164167961|NCT02553499|592978234|FG007|Overall Study|Withdrawal by Subject|1|||
164167962|NCT02553499|592978235|FG008|Overall Study|Withdrawal by Subject|1|||
164167963|NCT02553499|592978236|FG009|Overall Study|Withdrawal by Subject|0|||
164167964|NCT02553499|592978237|FG010|Overall Study|Withdrawal by Subject|1|||
164167965|NCT02553499|592978238|FG011|Overall Study|Withdrawal by Subject|0|||
164167966|NCT02553499|592978239|FG012|Overall Study|Withdrawal by Subject|0|||
164167967|NCT02553499|592978240|FG013|Overall Study|Withdrawal by Subject|0|||
164167968|NCT01582178|592978241|FG000|Overall Study|Physician Decision|6|||
164167969|NCT01582178|592978242|FG001|Overall Study|Physician Decision|5|||
164167970|NCT00570063|592978243|FG000|Overall Study|Adverse Event|4|||
164167971|NCT00570063|592978244|FG001|Overall Study|Adverse Event|1|||
164167972|NCT00570063|592978243|FG000|Overall Study|Lack of Efficacy|0|||
164167973|NCT00570063|592978244|FG001|Overall Study|Lack of Efficacy|1|||
164167974|NCT00570063|592978243|FG000|Overall Study|Withdrawal by Subject|4|||
164167975|NCT00570063|592978244|FG001|Overall Study|Withdrawal by Subject|3|||
164167976|NCT00570063|592978243|FG000|Overall Study|Sponsor's Decision|7|||
164167977|NCT00570063|592978244|FG001|Overall Study|Sponsor's Decision|3|||
164167978|NCT00550043|592978248|FG000|Overall Study|Adverse Event|0|||
164167979|NCT00550043|592978249|FG001|Overall Study|Adverse Event|0|||
164167980|NCT00550043|592978250|FG002|Overall Study|Adverse Event|0|||
164167981|NCT00550043|592978251|FG003|Overall Study|Adverse Event|1|||
164167982|NCT00550043|592978252|FG004|Overall Study|Adverse Event|1|||
164167983|NCT00550043|592978248|FG000|Overall Study|Subject Withdrew Consent|0|||
164167984|NCT00550043|592978249|FG001|Overall Study|Subject Withdrew Consent|2|||
164167985|NCT00550043|592978250|FG002|Overall Study|Subject Withdrew Consent|1|||
164167986|NCT00550043|592978251|FG003|Overall Study|Subject Withdrew Consent|0|||
164167987|NCT00550043|592978252|FG004|Overall Study|Subject Withdrew Consent|0|||
164167988|NCT00550043|592978248|FG000|Overall Study|Other Reasons- Unspecified|0|||
164167989|NCT00550043|592978249|FG001|Overall Study|Other Reasons- Unspecified|1|||
164167990|NCT00550043|592978250|FG002|Overall Study|Other Reasons- Unspecified|0|||
164167991|NCT00550043|592978251|FG003|Overall Study|Other Reasons- Unspecified|1|||
164167992|NCT00550043|592978252|FG004|Overall Study|Other Reasons- Unspecified|0|||
164167993|NCT01186692|592978256|FG000|Overall Study|Not Catheterized|11|||
164167994|NCT01186692|592978256|FG000|Overall Study|Futher testing contraindicated implant|19|||
164167995|NCT01186692|592978256|FG000|Overall Study|Adverse Event|2|||
164167996|NCT00789698|592978257|FG000|Overall Study|Lack of Efficacy|10|||
164167997|NCT00789698|592978258|FG001|Overall Study|Lack of Efficacy|4|||
164167998|NCT00789698|592978259|FG002|Overall Study|Lack of Efficacy|5|||
164167999|NCT00789698|592978260|FG003|Overall Study|Lack of Efficacy|18|||
164168000|NCT00789698|592978257|FG000|Overall Study|Adverse Event|5|||
164168001|NCT00789698|592978258|FG001|Overall Study|Adverse Event|5|||
164168002|NCT00789698|592978259|FG002|Overall Study|Adverse Event|3|||
164168003|NCT00789698|592978260|FG003|Overall Study|Adverse Event|4|||
164168004|NCT00789698|592978257|FG000|Overall Study|Lost to Follow-up|5|||
164168005|NCT00789698|592978258|FG001|Overall Study|Lost to Follow-up|5|||
164168006|NCT00789698|592978259|FG002|Overall Study|Lost to Follow-up|2|||
164168007|NCT00789698|592978260|FG003|Overall Study|Lost to Follow-up|9|||
164168008|NCT00789698|592978257|FG000|Overall Study|Protocol Violation|6|||
164168009|NCT00789698|592978258|FG001|Overall Study|Protocol Violation|1|||
164168010|NCT00789698|592978259|FG002|Overall Study|Protocol Violation|2|||
164168011|NCT00789698|592978260|FG003|Overall Study|Protocol Violation|1|||
164168012|NCT00789698|592978257|FG000|Overall Study|Withdrawal by Subject|14|||
164168013|NCT00789698|592978258|FG001|Overall Study|Withdrawal by Subject|15|||
164168014|NCT00789698|592978259|FG002|Overall Study|Withdrawal by Subject|12|||
164168015|NCT00789698|592978260|FG003|Overall Study|Withdrawal by Subject|19|||
164168016|NCT00789698|592978257|FG000|Overall Study|Administrative|0|||
164168017|NCT00789698|592978258|FG001|Overall Study|Administrative|3|||
164168018|NCT00789698|592978259|FG002|Overall Study|Administrative|3|||
164168019|NCT00789698|592978260|FG003|Overall Study|Administrative|1|||
164168020|NCT01921101|592978261|FG000|Overall Study|Death|16|||
164168021|NCT01921101|592978262|FG001|Overall Study|Death|6|||
164168022|NCT01275755|592980618|FG000|Double-blind Treatment Period|Adverse Event|0|||
164168023|NCT01275755|592980619|FG001|Double-blind Treatment Period|Adverse Event|2|||
164168024|NCT01275755|592980618|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
164168025|NCT01275755|592980619|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
164168026|NCT01275755|592980618|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
164168027|NCT01275755|592980619|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164168028|NCT01275755|592980618|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
164168029|NCT01275755|592980619|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
164168030|NCT04420585|592980624|FG000|Overall Study|Adverse Event|1|||
164168031|NCT04420585|592980624|FG000|Overall Study|Never initiated medication|2|||
164168032|NCT03693612|592980627|FG000|Overall Study|Lost to Follow-up|0|||
164168033|NCT03693612|592980628|FG001|Overall Study|Lost to Follow-up|0|||
164168034|NCT03693612|592980629|FG002|Overall Study|Lost to Follow-up|0|||
164168035|NCT03693612|592980630|FG003|Overall Study|Lost to Follow-up|0|||
164168036|NCT03693612|592980631|FG004|Overall Study|Lost to Follow-up|1|||
164168037|NCT03693612|592980632|FG005|Overall Study|Lost to Follow-up|0|||
164168038|NCT03693612|592980633|FG006|Overall Study|Lost to Follow-up|0|||
164168039|NCT03693612|592980627|FG000|Overall Study|Withdrawal by Subject|0|||
164168040|NCT03693612|592980628|FG001|Overall Study|Withdrawal by Subject|0|||
164168041|NCT03693612|592980629|FG002|Overall Study|Withdrawal by Subject|1|||
164168042|NCT03693612|592980630|FG003|Overall Study|Withdrawal by Subject|0|||
164168043|NCT03693612|592980631|FG004|Overall Study|Withdrawal by Subject|2|||
164168044|NCT03693612|592980632|FG005|Overall Study|Withdrawal by Subject|0|||
164168045|NCT03693612|592980633|FG006|Overall Study|Withdrawal by Subject|0|||
164168046|NCT03693612|592980627|FG000|Overall Study|Study Terminated by Sponsor|0|||
164168047|NCT03693612|592980628|FG001|Overall Study|Study Terminated by Sponsor|1|||
164168048|NCT03693612|592980629|FG002|Overall Study|Study Terminated by Sponsor|0|||
164168049|NCT03693612|592980630|FG003|Overall Study|Study Terminated by Sponsor|0|||
164168050|NCT03693612|592980631|FG004|Overall Study|Study Terminated by Sponsor|3|||
164168051|NCT03693612|592980632|FG005|Overall Study|Study Terminated by Sponsor|0|||
164168052|NCT03693612|592980633|FG006|Overall Study|Study Terminated by Sponsor|0|||
164168053|NCT01669174|592980640|FG000|Overall Study|Subject withdrew consent|2|||
164168054|NCT01669174|592980641|FG001|Overall Study|Subject withdrew consent|2|||
164168055|NCT01669174|592980640|FG000|Overall Study|Lost to Follow-up|1|||
164168056|NCT01669174|592980641|FG001|Overall Study|Lost to Follow-up|0|||
164168057|NCT01669174|592980640|FG000|Overall Study|Adverse Event|2|||
164168058|NCT01669174|592980641|FG001|Overall Study|Adverse Event|2|||
164168059|NCT01669174|592980640|FG000|Overall Study|Administrative problems|1|||
164168060|NCT01669174|592980641|FG001|Overall Study|Administrative problems|2|||
164168061|NCT01953601|592980645|FG000|Part 1 (Base Study)|Adverse Event|24|||
164168062|NCT01953601|592980646|FG001|Part 1 (Base Study)|Adverse Event|37|||
164168063|NCT01953601|592980647|FG002|Part 1 (Base Study)|Adverse Event|15|||
164168064|NCT01953601|592980645|FG000|Part 1 (Base Study)|Death|2|||
164168065|NCT01953601|592980646|FG001|Part 1 (Base Study)|Death|0|||
164168066|NCT01953601|592980647|FG002|Part 1 (Base Study)|Death|3|||
164168067|NCT01953601|592980645|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
164168068|NCT01953601|592980646|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
164168069|NCT01953601|592980647|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
164168070|NCT01953601|592980645|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
164168071|NCT01953601|592980646|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
164168072|NCT01953601|592980647|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
164168073|NCT01953601|592980645|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
164168074|NCT01953601|592980646|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
164168075|NCT01953601|592980647|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
164168076|NCT01953601|592980645|FG000|Part 1 (Base Study)|Physician Decision|3|||
164168077|NCT01953601|592980646|FG001|Part 1 (Base Study)|Physician Decision|7|||
164168078|NCT01953601|592980647|FG002|Part 1 (Base Study)|Physician Decision|4|||
164168079|NCT01953601|592980645|FG000|Part 1 (Base Study)|Screen failure|1|||
164168080|NCT01953601|592980646|FG001|Part 1 (Base Study)|Screen failure|0|||
164168081|NCT01953601|592980647|FG002|Part 1 (Base Study)|Screen failure|1|||
164168082|NCT01953601|592980645|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
164168083|NCT01953601|592980646|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
164168084|NCT01953601|592980647|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
164168085|NCT01953601|592980645|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
164168086|NCT01953601|592980646|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
164168087|NCT01953601|592980647|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
164168088|NCT01953601|592980645|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
164168089|NCT01953601|592980646|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
164168090|NCT01953601|592980647|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
164168091|NCT01953601|592980645|FG000|Part 1 (Base Study)|Subject moved|2|||
164168092|NCT01953601|592980646|FG001|Part 1 (Base Study)|Subject moved|2|||
164168093|NCT01953601|592980647|FG002|Part 1 (Base Study)|Subject moved|1|||
164168094|NCT01953601|592980645|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
164168095|NCT01953601|592980646|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
164168096|NCT01953601|592980647|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
164168097|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Adverse Event|1|||
164168098|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Adverse Event|1|||
164168099|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Adverse Event|10|||
164168100|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Death|0|||
164168101|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Death|3|||
164168102|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Death|0|||
164168103|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
164168104|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
164168105|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
164168106|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
164168107|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
164168108|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
164168109|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Physician Decision|2|||
164168110|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Physician Decision|0|||
164168111|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Physician Decision|2|||
164168112|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
164168113|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
164168114|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
164168115|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
164168116|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
164168117|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
164168118|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
164168119|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
164168120|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
164168121|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Subject moved|0|||
164168122|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Subject moved|0|||
164168123|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Subject moved|1|||
164168124|NCT01953601|592980645|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
164168125|NCT01953601|592980646|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
164168126|NCT01953601|592980647|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
164168127|NCT01905553|592980654|FG000|Period 2|Adverse Event|1|||
164168128|NCT01905553|592980655|FG001|Period 2|Adverse Event|0|||
164168129|NCT04310397|592980656|FG000|Overall Study|Lack of Efficacy|3|||
164168130|NCT04310397|592980656|FG000|Overall Study|Withdrawal by Subject|1|||
164168131|NCT02703272|592980663|FG000|Overall Study|Death|4|||
164168132|NCT02703272|592980664|FG001|Overall Study|Death|9|||
164168133|NCT02703272|592980665|FG002|Overall Study|Death|19|||
164168134|NCT02703272|592980666|FG003|Overall Study|Death|10|||
164168135|NCT02703272|592980663|FG000|Overall Study|Withdrawal by Subject|0|||
164168136|NCT02703272|592980664|FG001|Overall Study|Withdrawal by Subject|0|||
164168137|NCT02703272|592980665|FG002|Overall Study|Withdrawal by Subject|4|||
164168138|NCT02703272|592980666|FG003|Overall Study|Withdrawal by Subject|2|||
164168139|NCT02703272|592980663|FG000|Overall Study|Study Terminated by Sponsor|6|||
164168140|NCT02703272|592980664|FG001|Overall Study|Study Terminated by Sponsor|1|||
164168141|NCT02703272|592980665|FG002|Overall Study|Study Terminated by Sponsor|12|||
164168142|NCT02703272|592980666|FG003|Overall Study|Study Terminated by Sponsor|4|||
164168143|NCT02703272|592980663|FG000|Overall Study|Other|1|||
164168144|NCT02703272|592980664|FG001|Overall Study|Other|0|||
164168145|NCT02703272|592980665|FG002|Overall Study|Other|0|||
164168146|NCT02703272|592980666|FG003|Overall Study|Other|0|||
164168147|NCT00623935|592980667|FG000|Overall Study|Death|1|||
164168148|NCT00623935|592980667|FG000|Overall Study|Patient Declined Transplant|1|||
164168149|NCT03315286|592980668|FG000|Overall Study|Lost to Follow-up|0|||
164168150|NCT03315286|592980669|FG001|Overall Study|Lost to Follow-up|3|||
164168151|NCT03315286|592980668|FG000|Overall Study|Withdrawal by Subject|1|||
164168152|NCT03315286|592980669|FG001|Overall Study|Withdrawal by Subject|0|||
164168153|NCT03315286|592980668|FG000|Overall Study|Protocol Violation|0|||
164168154|NCT03315286|592980669|FG001|Overall Study|Protocol Violation|1|||
164168155|NCT00747474|592980670|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168156|NCT00747474|592980671|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168157|NCT00747474|592980672|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168158|NCT00747474|592980673|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168159|NCT00747474|592980674|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168160|NCT00747474|592980675|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168161|NCT00747474|592980676|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168162|NCT00747474|592980677|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
164168163|NCT00747474|592980678|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168164|NCT00747474|592980679|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168165|NCT00747474|592980680|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168166|NCT00747474|592980681|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
164168167|NCT02829723|592980683|FG000|Overall Study|Adverse Event|0|||
164168168|NCT02829723|592980684|FG001|Overall Study|Adverse Event|0|||
164168169|NCT02829723|592980685|FG002|Overall Study|Adverse Event|1|||
164168170|NCT02829723|592980686|FG003|Overall Study|Adverse Event|1|||
164168171|NCT02829723|592980687|FG004|Overall Study|Adverse Event|0|||
164168172|NCT02829723|592980688|FG005|Overall Study|Adverse Event|0|||
164168173|NCT02829723|592980689|FG006|Overall Study|Adverse Event|0|||
164168174|NCT02829723|592980690|FG007|Overall Study|Adverse Event|1|||
164168175|NCT02829723|592980691|FG008|Overall Study|Adverse Event|0|||
164168176|NCT02829723|592980692|FG009|Overall Study|Adverse Event|0|||
164168177|NCT02829723|592980693|FG010|Overall Study|Adverse Event|0|||
164168178|NCT02829723|592980694|FG011|Overall Study|Adverse Event|0|||
164168179|NCT02829723|592980695|FG012|Overall Study|Adverse Event|0|||
164168180|NCT02829723|592980696|FG013|Overall Study|Adverse Event|0|||
164168181|NCT02829723|592980697|FG014|Overall Study|Adverse Event|1|||
164168182|NCT02829723|592980698|FG015|Overall Study|Adverse Event|1|||
164168183|NCT02829723|592980699|FG016|Overall Study|Adverse Event|1|||
164168184|NCT02829723|592980700|FG017|Overall Study|Adverse Event|2|||
164168185|NCT02829723|592980701|FG018|Overall Study|Adverse Event|1|||
164168186|NCT02829723|592980702|FG019|Overall Study|Adverse Event|1|||
164168187|NCT02829723|592980703|FG020|Overall Study|Adverse Event|3|||
164168188|NCT02829723|592980704|FG021|Overall Study|Adverse Event|0|||
164168189|NCT02829723|592980705|FG022|Overall Study|Adverse Event|0|||
164168190|NCT02829723|592980706|FG023|Overall Study|Adverse Event|1|||
164168191|NCT02829723|592980707|FG024|Overall Study|Adverse Event|1|||
164168192|NCT02829723|592980708|FG025|Overall Study|Adverse Event|3|||
164168193|NCT02829723|592980709|FG026|Overall Study|Adverse Event|5|||
164168194|NCT02829723|592980683|FG000|Overall Study|Death|1|||
164168195|NCT02829723|592980684|FG001|Overall Study|Death|0|||
164168196|NCT02829723|592980685|FG002|Overall Study|Death|1|||
164168197|NCT02829723|592980686|FG003|Overall Study|Death|1|||
164168198|NCT02829723|592980687|FG004|Overall Study|Death|0|||
164168199|NCT02829723|592980688|FG005|Overall Study|Death|0|||
164168200|NCT02829723|592980689|FG006|Overall Study|Death|2|||
164168201|NCT02829723|592980690|FG007|Overall Study|Death|0|||
164168202|NCT02829723|592980691|FG008|Overall Study|Death|1|||
164168203|NCT02829723|592980692|FG009|Overall Study|Death|0|||
164168204|NCT02829723|592980693|FG010|Overall Study|Death|0|||
164168205|NCT02829723|592980694|FG011|Overall Study|Death|0|||
164168206|NCT02829723|592980695|FG012|Overall Study|Death|2|||
164168207|NCT02829723|592980696|FG013|Overall Study|Death|1|||
164168208|NCT02829723|592980697|FG014|Overall Study|Death|0|||
164168209|NCT02829723|592980698|FG015|Overall Study|Death|0|||
164168210|NCT02829723|592980699|FG016|Overall Study|Death|0|||
164168211|NCT02829723|592980700|FG017|Overall Study|Death|0|||
164168212|NCT02829723|592980701|FG018|Overall Study|Death|0|||
164168213|NCT02829723|592980702|FG019|Overall Study|Death|0|||
164168214|NCT02829723|592980703|FG020|Overall Study|Death|0|||
164168215|NCT02829723|592980704|FG021|Overall Study|Death|2|||
164168216|NCT02829723|592980705|FG022|Overall Study|Death|0|||
164168217|NCT02829723|592980706|FG023|Overall Study|Death|0|||
164168218|NCT02829723|592980707|FG024|Overall Study|Death|0|||
164168219|NCT02829723|592980708|FG025|Overall Study|Death|1|||
164168220|NCT02829723|592980709|FG026|Overall Study|Death|2|||
164168221|NCT02829723|592980683|FG000|Overall Study|Physician Decision|0|||
164168222|NCT02829723|592980684|FG001|Overall Study|Physician Decision|0|||
164168223|NCT02829723|592980685|FG002|Overall Study|Physician Decision|0|||
164168224|NCT02829723|592980686|FG003|Overall Study|Physician Decision|0|||
164168225|NCT02829723|592980687|FG004|Overall Study|Physician Decision|0|||
164168226|NCT02829723|592980688|FG005|Overall Study|Physician Decision|0|||
164168227|NCT02829723|592980689|FG006|Overall Study|Physician Decision|0|||
164168228|NCT02829723|592980690|FG007|Overall Study|Physician Decision|0|||
164168229|NCT02829723|592980691|FG008|Overall Study|Physician Decision|0|||
164168230|NCT02829723|592980692|FG009|Overall Study|Physician Decision|1|||
164168231|NCT02829723|592980693|FG010|Overall Study|Physician Decision|1|||
164168232|NCT02829723|592980694|FG011|Overall Study|Physician Decision|0|||
164168233|NCT02829723|592980695|FG012|Overall Study|Physician Decision|0|||
164168234|NCT02829723|592980696|FG013|Overall Study|Physician Decision|1|||
164168235|NCT02829723|592980697|FG014|Overall Study|Physician Decision|0|||
164168236|NCT02829723|592980698|FG015|Overall Study|Physician Decision|0|||
164168237|NCT02829723|592980699|FG016|Overall Study|Physician Decision|2|||
164168238|NCT02829723|592980700|FG017|Overall Study|Physician Decision|0|||
164168239|NCT02829723|592980701|FG018|Overall Study|Physician Decision|0|||
164168240|NCT02829723|592980702|FG019|Overall Study|Physician Decision|0|||
164168241|NCT02829723|592980703|FG020|Overall Study|Physician Decision|0|||
164168242|NCT02829723|592980704|FG021|Overall Study|Physician Decision|0|||
164168243|NCT02829723|592980705|FG022|Overall Study|Physician Decision|1|||
164168244|NCT02829723|592980706|FG023|Overall Study|Physician Decision|1|||
164168245|NCT02829723|592980707|FG024|Overall Study|Physician Decision|1|||
164168246|NCT02829723|592980708|FG025|Overall Study|Physician Decision|1|||
164168247|NCT02829723|592980709|FG026|Overall Study|Physician Decision|3|||
164168248|NCT02829723|592980683|FG000|Overall Study|Progressive disease|4|||
164168249|NCT02829723|592980684|FG001|Overall Study|Progressive disease|6|||
164168250|NCT02829723|592980685|FG002|Overall Study|Progressive disease|3|||
164168251|NCT02829723|592980686|FG003|Overall Study|Progressive disease|3|||
164168252|NCT02829723|592980687|FG004|Overall Study|Progressive disease|3|||
164168253|NCT02829723|592980688|FG005|Overall Study|Progressive disease|5|||
164168254|NCT02829723|592980689|FG006|Overall Study|Progressive disease|4|||
164168255|NCT02829723|592980690|FG007|Overall Study|Progressive disease|6|||
164168256|NCT02829723|592980691|FG008|Overall Study|Progressive disease|8|||
164168257|NCT02829723|592980692|FG009|Overall Study|Progressive disease|4|||
164168258|NCT02829723|592980693|FG010|Overall Study|Progressive disease|9|||
164168259|NCT02829723|592980694|FG011|Overall Study|Progressive disease|0|||
164168260|NCT02829723|592980695|FG012|Overall Study|Progressive disease|3|||
164168261|NCT02829723|592980696|FG013|Overall Study|Progressive disease|4|||
164168262|NCT02829723|592980697|FG014|Overall Study|Progressive disease|2|||
164168263|NCT02829723|592980698|FG015|Overall Study|Progressive disease|4|||
164168264|NCT02829723|592980699|FG016|Overall Study|Progressive disease|5|||
164168265|NCT02829723|592980700|FG017|Overall Study|Progressive disease|3|||
164168266|NCT02829723|592980701|FG018|Overall Study|Progressive disease|4|||
164168267|NCT02829723|592980702|FG019|Overall Study|Progressive disease|4|||
164168268|NCT02829723|592980703|FG020|Overall Study|Progressive disease|7|||
164168269|NCT02829723|592980704|FG021|Overall Study|Progressive disease|6|||
164168270|NCT02829723|592980705|FG022|Overall Study|Progressive disease|3|||
164168271|NCT02829723|592980706|FG023|Overall Study|Progressive disease|3|||
164168272|NCT02829723|592980707|FG024|Overall Study|Progressive disease|3|||
164168273|NCT02829723|592980708|FG025|Overall Study|Progressive disease|16|||
164168274|NCT02829723|592980709|FG026|Overall Study|Progressive disease|10|||
164168275|NCT02829723|592980683|FG000|Overall Study|Subject/guardian decision|0|||
164168276|NCT02829723|592980684|FG001|Overall Study|Subject/guardian decision|1|||
164168277|NCT02829723|592980685|FG002|Overall Study|Subject/guardian decision|0|||
164168278|NCT02829723|592980686|FG003|Overall Study|Subject/guardian decision|1|||
164168279|NCT02829723|592980687|FG004|Overall Study|Subject/guardian decision|0|||
164168280|NCT02829723|592980688|FG005|Overall Study|Subject/guardian decision|0|||
164168281|NCT02829723|592980689|FG006|Overall Study|Subject/guardian decision|0|||
164168282|NCT02829723|592980690|FG007|Overall Study|Subject/guardian decision|1|||
164168283|NCT02829723|592980691|FG008|Overall Study|Subject/guardian decision|0|||
164168284|NCT02829723|592980692|FG009|Overall Study|Subject/guardian decision|0|||
164168285|NCT02829723|592980693|FG010|Overall Study|Subject/guardian decision|0|||
164168286|NCT02829723|592980694|FG011|Overall Study|Subject/guardian decision|0|||
164168287|NCT02829723|592980695|FG012|Overall Study|Subject/guardian decision|0|||
164168288|NCT02829723|592980696|FG013|Overall Study|Subject/guardian decision|0|||
164168289|NCT02829723|592980697|FG014|Overall Study|Subject/guardian decision|1|||
164168290|NCT02829723|592980698|FG015|Overall Study|Subject/guardian decision|0|||
164168291|NCT02829723|592980699|FG016|Overall Study|Subject/guardian decision|1|||
164168292|NCT02829723|592980700|FG017|Overall Study|Subject/guardian decision|0|||
164168293|NCT02829723|592980701|FG018|Overall Study|Subject/guardian decision|1|||
164168294|NCT02829723|592980702|FG019|Overall Study|Subject/guardian decision|0|||
164168295|NCT02829723|592980703|FG020|Overall Study|Subject/guardian decision|1|||
164168296|NCT02829723|592980704|FG021|Overall Study|Subject/guardian decision|0|||
164168297|NCT02829723|592980705|FG022|Overall Study|Subject/guardian decision|0|||
164168298|NCT02829723|592980706|FG023|Overall Study|Subject/guardian decision|1|||
164168299|NCT02829723|592980707|FG024|Overall Study|Subject/guardian decision|0|||
164168300|NCT02829723|592980708|FG025|Overall Study|Subject/guardian decision|1|||
164168301|NCT02829723|592980709|FG026|Overall Study|Subject/guardian decision|1|||
164168302|NCT02829723|592980683|FG000|Overall Study|Study terminated by sponsor|0|||
164168303|NCT02829723|592980684|FG001|Overall Study|Study terminated by sponsor|0|||
164168304|NCT02829723|592980685|FG002|Overall Study|Study terminated by sponsor|0|||
164168305|NCT02829723|592980686|FG003|Overall Study|Study terminated by sponsor|0|||
164168306|NCT02829723|592980687|FG004|Overall Study|Study terminated by sponsor|0|||
164168307|NCT02829723|592980688|FG005|Overall Study|Study terminated by sponsor|0|||
164168308|NCT02829723|592980689|FG006|Overall Study|Study terminated by sponsor|0|||
164168309|NCT02829723|592980690|FG007|Overall Study|Study terminated by sponsor|0|||
164168310|NCT02829723|592980691|FG008|Overall Study|Study terminated by sponsor|0|||
164168311|NCT02829723|592980692|FG009|Overall Study|Study terminated by sponsor|0|||
164168312|NCT02829723|592980693|FG010|Overall Study|Study terminated by sponsor|0|||
164168313|NCT02829723|592980694|FG011|Overall Study|Study terminated by sponsor|0|||
164168314|NCT02829723|592980695|FG012|Overall Study|Study terminated by sponsor|0|||
164168315|NCT02829723|592980696|FG013|Overall Study|Study terminated by sponsor|0|||
164168316|NCT02829723|592980697|FG014|Overall Study|Study terminated by sponsor|0|||
164168317|NCT02829723|592980698|FG015|Overall Study|Study terminated by sponsor|0|||
164168318|NCT02829723|592980699|FG016|Overall Study|Study terminated by sponsor|0|||
164168319|NCT02829723|592980700|FG017|Overall Study|Study terminated by sponsor|0|||
164168320|NCT02829723|592980701|FG018|Overall Study|Study terminated by sponsor|0|||
164168321|NCT02829723|592980702|FG019|Overall Study|Study terminated by sponsor|0|||
164168322|NCT02829723|592980703|FG020|Overall Study|Study terminated by sponsor|0|||
164168323|NCT02829723|592980704|FG021|Overall Study|Study terminated by sponsor|1|||
164168324|NCT02829723|592980705|FG022|Overall Study|Study terminated by sponsor|0|||
164168325|NCT02829723|592980706|FG023|Overall Study|Study terminated by sponsor|0|||
164168326|NCT02829723|592980707|FG024|Overall Study|Study terminated by sponsor|0|||
164168327|NCT02829723|592980708|FG025|Overall Study|Study terminated by sponsor|0|||
164168328|NCT02829723|592980709|FG026|Overall Study|Study terminated by sponsor|0|||
164168329|NCT02989649|592980710|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
164168330|NCT02989649|592980710|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
164168331|NCT02989649|592980710|FG000|Overall Study|Lost For Observation During Study|3|||
164168332|NCT02989649|592980710|FG000|Overall Study|Reason Not Specified|13|||
164168333|NCT00330343|592980711|FG000|Overall Study|Lost to Follow-up|5|||
164168334|NCT00256854|592980712|FG000|Overall Study|Withdrawal by Subject|2|||
164168335|NCT00256854|592980713|FG001|Overall Study|Withdrawal by Subject|3|||
164168336|NCT00256854|592980714|FG002|Overall Study|Withdrawal by Subject|0|||
164168337|NCT00256854|592980715|FG003|Overall Study|Withdrawal by Subject|0|||
164168338|NCT00256854|592980716|FG004|Overall Study|Withdrawal by Subject|0|||
164168339|NCT00256854|592980717|FG005|Overall Study|Withdrawal by Subject|0|||
164168340|NCT00256854|592980712|FG000|Overall Study|Lack of Efficacy|1|||
164168341|NCT00256854|592980713|FG001|Overall Study|Lack of Efficacy|0|||
164168342|NCT00256854|592980714|FG002|Overall Study|Lack of Efficacy|0|||
164168343|NCT00256854|592980715|FG003|Overall Study|Lack of Efficacy|0|||
164168344|NCT00256854|592980716|FG004|Overall Study|Lack of Efficacy|0|||
164168345|NCT00256854|592980717|FG005|Overall Study|Lack of Efficacy|0|||
164168346|NCT00256854|592980712|FG000|Overall Study|Protocol Violation|0|||
164168347|NCT00256854|592980713|FG001|Overall Study|Protocol Violation|1|||
164168348|NCT00256854|592980714|FG002|Overall Study|Protocol Violation|1|||
164168349|NCT00256854|592980715|FG003|Overall Study|Protocol Violation|1|||
164168350|NCT00256854|592980716|FG004|Overall Study|Protocol Violation|0|||
164168351|NCT00256854|592980717|FG005|Overall Study|Protocol Violation|0|||
164168352|NCT00256854|592980712|FG000|Overall Study|Adverse Event|0|||
164168353|NCT00256854|592980713|FG001|Overall Study|Adverse Event|0|||
164168354|NCT00256854|592980714|FG002|Overall Study|Adverse Event|2|||
164168355|NCT00256854|592980715|FG003|Overall Study|Adverse Event|2|||
164168356|NCT00256854|592980716|FG004|Overall Study|Adverse Event|0|||
164168357|NCT00256854|592980717|FG005|Overall Study|Adverse Event|1|||
164168358|NCT00256854|592980712|FG000|Overall Study|Not compliant with the study drug|0|||
164168359|NCT00256854|592980713|FG001|Overall Study|Not compliant with the study drug|0|||
164168360|NCT00256854|592980714|FG002|Overall Study|Not compliant with the study drug|0|||
164168361|NCT00256854|592980715|FG003|Overall Study|Not compliant with the study drug|0|||
164168362|NCT00256854|592980716|FG004|Overall Study|Not compliant with the study drug|1|||
164168363|NCT00256854|592980717|FG005|Overall Study|Not compliant with the study drug|0|||
164168364|NCT00281632|592980718|FG000|Overall Study|Adverse Event|7|||
164168365|NCT00281632|592980718|FG000|Overall Study|Withdrawal by Subject|2|||
164168366|NCT00281632|592980718|FG000|Overall Study|Disease Progression|22|||
164168367|NCT00281632|592980718|FG000|Overall Study|Death|1|||
164168368|NCT00281632|592980718|FG000|Overall Study|Physician Decision|1|||
164168369|NCT00281632|592980718|FG000|Overall Study|Ongoing|3|||
164168370|NCT06586788|592980720|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
164168371|NCT03514485|592980721|FG000|Overall Study|Lost to Follow-up|5|||
164168372|NCT03514485|592980722|FG001|Overall Study|Lost to Follow-up|3|||
164168373|NCT03514485|592980723|FG002|Overall Study|Lost to Follow-up|2|||
164168374|NCT03514485|592980724|FG003|Overall Study|Lost to Follow-up|0|||
164168375|NCT03514485|592980725|FG004|Overall Study|Lost to Follow-up|1|||
164168376|NCT03514485|592980726|FG005|Overall Study|Lost to Follow-up|4|||
164168377|NCT03514485|592980721|FG000|Overall Study|Withdrawal by Subject|0|||
164168378|NCT03514485|592980722|FG001|Overall Study|Withdrawal by Subject|1|||
164168379|NCT03514485|592980723|FG002|Overall Study|Withdrawal by Subject|3|||
164168380|NCT03514485|592980724|FG003|Overall Study|Withdrawal by Subject|1|||
164168381|NCT03514485|592980725|FG004|Overall Study|Withdrawal by Subject|2|||
164168382|NCT03514485|592980726|FG005|Overall Study|Withdrawal by Subject|1|||
164168383|NCT03075891|592980727|FG000|Overall Study|Withdrawal by Subject|3|||
164168384|NCT03075891|592980728|FG001|Overall Study|Withdrawal by Subject|6|||
164168385|NCT03075891|592980727|FG000|Overall Study|Lost to Follow-up|1|||
164168386|NCT03075891|592980728|FG001|Overall Study|Lost to Follow-up|0|||
164168387|NCT03075891|592980727|FG000|Overall Study|Pregnancy|3|||
164168388|NCT03075891|592980728|FG001|Overall Study|Pregnancy|1|||
164168389|NCT03075891|592980727|FG000|Overall Study|visits not performed (no time)|1|||
164168390|NCT03075891|592980728|FG001|Overall Study|visits not performed (no time)|0|||
164168391|NCT03075891|592980727|FG000|Overall Study|Drug abuse relapse issue|0|||
164168392|NCT03075891|592980728|FG001|Overall Study|Drug abuse relapse issue|1|||
164168393|NCT03075891|592980727|FG000|Overall Study|Participant requiring study withdrawal|0|||
164168394|NCT03075891|592980728|FG001|Overall Study|Participant requiring study withdrawal|1|||
164168395|NCT03075891|592980727|FG000|Overall Study|Adverse event, non-fatal|1|||
164168396|NCT03075891|592980728|FG001|Overall Study|Adverse event, non-fatal|4|||
164168397|NCT01878084|592980731|FG000|Overall Study|Physician Decision|2|||
164168398|NCT00582608|592980761|FG000|Overall Study|Not Treated|7|||
164168399|NCT00582608|592980761|FG000|Overall Study|Patient Ineligible|1|||
164168400|NCT00582608|592980761|FG000|Overall Study|Lack of accrual|4|||
164168401|NCT03482453|592980762|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168402|NCT03482453|592980763|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168403|NCT03482453|592980764|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168404|NCT03482453|592980765|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168405|NCT03482453|592980766|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168406|NCT03482453|592980767|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168407|NCT03482453|592980768|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168408|NCT03482453|592980769|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168409|NCT03482453|592980770|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168410|NCT03482453|592980771|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168411|NCT03482453|592980772|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
164168412|NCT03482453|592980773|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
164168413|NCT03478644|592980774|FG000|Phase 2|Withdrawal by Subject|2|||
164168414|NCT03478644|592980775|FG001|Phase 2|Withdrawal by Subject|1|||
164168415|NCT03478644|592980774|FG000|Phase 2|Lost to Follow-up|1|||
164168416|NCT03478644|592980775|FG001|Phase 2|Lost to Follow-up|0|||
164168417|NCT01870973|592980776|FG000|Overall Study|Lost to Follow-up|10|||
164168418|NCT01870973|592980777|FG001|Overall Study|Lost to Follow-up|3|||
164168419|NCT02504827|592980780|FG000|Overall Study|Could not produce sputum|1|||
164168420|NCT00686829|592980781|FG000|Overall Study|Adverse Event|5|||
164168421|NCT00686829|592980781|FG000|Overall Study|Lack of Efficacy|6|||
164168422|NCT00686829|592980781|FG000|Overall Study|Lost to Follow-up|4|||
164168423|NCT00686829|592980781|FG000|Overall Study|Withdrawal by Subject|14|||
164168424|NCT00686829|592980781|FG000|Overall Study|Protocol Violation|3|||
164168425|NCT00686829|592980781|FG000|Overall Study|Sponsor discontinued VCV|47|||
164168426|NCT00712543|592980782|FG000|Day 8-14|Lost to Follow-up|0|||
164168427|NCT00712543|592980783|FG001|Day 8-14|Lost to Follow-up|2|||
164168428|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
164168429|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
164168430|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
164168431|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
164168432|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
164168433|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
164168434|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
164168435|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
164168436|NCT04740827|592980784|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
164168437|NCT04740827|592980785|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
164168438|NCT04740827|592980784|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
164168439|NCT04740827|592980785|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
164168440|NCT00940823|592980786|FG000|Overall Study|Death|8|||
164168441|NCT00940823|592980787|FG001|Overall Study|Death|12|||
164168442|NCT00940823|592980786|FG000|Overall Study|Lost to Follow-up|27|||
164168443|NCT00940823|592980787|FG001|Overall Study|Lost to Follow-up|20|||
164168444|NCT00784550|592982669|FG000|Overall Study|Adverse Event|12|||
164168445|NCT00784550|592982670|FG001|Overall Study|Adverse Event|10|||
164168446|NCT00784550|592982669|FG000|Overall Study|Lack of Efficacy|0|||
164168447|NCT00784550|592982670|FG001|Overall Study|Lack of Efficacy|1|||
164168448|NCT00784550|592982669|FG000|Overall Study|Protocol Violation|10|||
164168449|NCT00784550|592982670|FG001|Overall Study|Protocol Violation|10|||
164168450|NCT00784550|592982669|FG000|Overall Study|Lost to Follow-up|8|||
164168451|NCT00784550|592982670|FG001|Overall Study|Lost to Follow-up|5|||
164168452|NCT00784550|592982669|FG000|Overall Study|Physician Decision|2|||
164168453|NCT00784550|592982670|FG001|Overall Study|Physician Decision|3|||
164168454|NCT00784550|592982669|FG000|Overall Study|Withdrawal by Subject|4|||
164168455|NCT00784550|592982670|FG001|Overall Study|Withdrawal by Subject|13|||
164168456|NCT00477750|592982672|FG000|Overall Study|Currently Receiving Treatment|11|||
164168457|NCT03558152|592982673|FG000|Overall Study|Adverse Event|0|||
164168458|NCT03558152|592982674|FG001|Overall Study|Adverse Event|0|||
164168459|NCT03558152|592982675|FG002|Overall Study|Adverse Event|1|||
164168460|NCT03558152|592982676|FG003|Overall Study|Adverse Event|1|||
164168461|NCT03558152|592982677|FG004|Overall Study|Adverse Event|2|||
164168462|NCT03558152|592982678|FG005|Overall Study|Adverse Event|1|||
164168463|NCT03558152|592982679|FG006|Overall Study|Adverse Event|1|||
164168464|NCT03558152|592982680|FG007|Overall Study|Adverse Event|0|||
164168465|NCT03558152|592982673|FG000|Overall Study|Death|0|||
164168466|NCT03558152|592982674|FG001|Overall Study|Death|0|||
164168467|NCT03558152|592982675|FG002|Overall Study|Death|0|||
164168468|NCT03558152|592982676|FG003|Overall Study|Death|0|||
164168469|NCT03558152|592982677|FG004|Overall Study|Death|1|||
164168470|NCT03558152|592982678|FG005|Overall Study|Death|0|||
164168471|NCT03558152|592982679|FG006|Overall Study|Death|0|||
164168472|NCT03558152|592982680|FG007|Overall Study|Death|0|||
164168473|NCT03558152|592982673|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
164168474|NCT03558152|592982674|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168475|NCT03558152|592982675|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168476|NCT03558152|592982676|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168477|NCT03558152|592982677|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168478|NCT03558152|592982678|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168479|NCT03558152|592982679|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168480|NCT03558152|592982680|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
164168481|NCT03558152|592982673|FG000|Overall Study|Miscalculation in mmcs|0|||
164168482|NCT03558152|592982674|FG001|Overall Study|Miscalculation in mmcs|0|||
164168483|NCT03558152|592982675|FG002|Overall Study|Miscalculation in mmcs|0|||
164168484|NCT03558152|592982676|FG003|Overall Study|Miscalculation in mmcs|0|||
164168485|NCT03558152|592982677|FG004|Overall Study|Miscalculation in mmcs|0|||
164168486|NCT03558152|592982678|FG005|Overall Study|Miscalculation in mmcs|0|||
164168487|NCT03558152|592982679|FG006|Overall Study|Miscalculation in mmcs|1|||
164168488|NCT03558152|592982680|FG007|Overall Study|Miscalculation in mmcs|0|||
164168489|NCT03558152|592982673|FG000|Overall Study|Mistake in calculation|0|||
164168490|NCT03558152|592982674|FG001|Overall Study|Mistake in calculation|0|||
164168491|NCT03558152|592982675|FG002|Overall Study|Mistake in calculation|0|||
164168492|NCT03558152|592982676|FG003|Overall Study|Mistake in calculation|1|||
164168493|NCT03558152|592982677|FG004|Overall Study|Mistake in calculation|0|||
164168494|NCT03558152|592982678|FG005|Overall Study|Mistake in calculation|0|||
164168495|NCT03558152|592982679|FG006|Overall Study|Mistake in calculation|0|||
164168496|NCT03558152|592982680|FG007|Overall Study|Mistake in calculation|0|||
164168497|NCT03558152|592982673|FG000|Overall Study|Mistake in evaluation of disease status|0|||
164168498|NCT03558152|592982674|FG001|Overall Study|Mistake in evaluation of disease status|0|||
164168499|NCT03558152|592982675|FG002|Overall Study|Mistake in evaluation of disease status|0|||
164168500|NCT03558152|592982676|FG003|Overall Study|Mistake in evaluation of disease status|0|||
164168501|NCT03558152|592982677|FG004|Overall Study|Mistake in evaluation of disease status|0|||
164168502|NCT03558152|592982678|FG005|Overall Study|Mistake in evaluation of disease status|0|||
164168503|NCT03558152|592982679|FG006|Overall Study|Mistake in evaluation of disease status|0|||
164168504|NCT03558152|592982680|FG007|Overall Study|Mistake in evaluation of disease status|1|||
164168505|NCT03558152|592982673|FG000|Overall Study|Physician Decision|0|||
164168506|NCT03558152|592982674|FG001|Overall Study|Physician Decision|0|||
164168507|NCT03558152|592982675|FG002|Overall Study|Physician Decision|0|||
164168508|NCT03558152|592982676|FG003|Overall Study|Physician Decision|0|||
164168509|NCT03558152|592982677|FG004|Overall Study|Physician Decision|0|||
164168510|NCT03558152|592982678|FG005|Overall Study|Physician Decision|0|||
164168511|NCT03558152|592982679|FG006|Overall Study|Physician Decision|1|||
164168512|NCT03558152|592982680|FG007|Overall Study|Physician Decision|0|||
164168513|NCT03558152|592982673|FG000|Overall Study|Withdrawal by Subject|2|||
164168514|NCT03558152|592982674|FG001|Overall Study|Withdrawal by Subject|3|||
164168515|NCT03558152|592982675|FG002|Overall Study|Withdrawal by Subject|2|||
164168516|NCT03558152|592982676|FG003|Overall Study|Withdrawal by Subject|1|||
164168517|NCT03558152|592982677|FG004|Overall Study|Withdrawal by Subject|1|||
164168518|NCT03558152|592982678|FG005|Overall Study|Withdrawal by Subject|1|||
164168519|NCT03558152|592982679|FG006|Overall Study|Withdrawal by Subject|3|||
164168520|NCT03558152|592982680|FG007|Overall Study|Withdrawal by Subject|2|||
164168521|NCT03558152|592982673|FG000|Overall Study|Lack of Efficacy|11|||
164168522|NCT03558152|592982674|FG001|Overall Study|Lack of Efficacy|11|||
164168523|NCT03558152|592982675|FG002|Overall Study|Lack of Efficacy|10|||
164168524|NCT03558152|592982676|FG003|Overall Study|Lack of Efficacy|11|||
164168525|NCT03558152|592982677|FG004|Overall Study|Lack of Efficacy|14|||
164168526|NCT03558152|592982678|FG005|Overall Study|Lack of Efficacy|12|||
164168527|NCT03558152|592982679|FG006|Overall Study|Lack of Efficacy|14|||
164168528|NCT03558152|592982680|FG007|Overall Study|Lack of Efficacy|13|||
164168529|NCT03558152|592982673|FG000|Overall Study|Protocol Violation|1|||
164168530|NCT03558152|592982674|FG001|Overall Study|Protocol Violation|1|||
164168531|NCT03558152|592982675|FG002|Overall Study|Protocol Violation|0|||
164168532|NCT03558152|592982676|FG003|Overall Study|Protocol Violation|1|||
164168533|NCT03558152|592982677|FG004|Overall Study|Protocol Violation|1|||
164168534|NCT03558152|592982678|FG005|Overall Study|Protocol Violation|0|||
164168535|NCT03558152|592982679|FG006|Overall Study|Protocol Violation|2|||
164168536|NCT03558152|592982680|FG007|Overall Study|Protocol Violation|0|||
164168537|NCT04166591|592982681|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
164168538|NCT04166591|592982682|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
164168539|NCT04166591|592982683|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168540|NCT04166591|592982684|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168541|NCT04166591|592982681|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
164168542|NCT04166591|592982682|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
164168543|NCT04166591|592982683|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168544|NCT04166591|592982684|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
164168545|NCT03960021|592982685|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
164168546|NCT00601172|592982686|FG000|Overall Study|Adverse Event|43|||
164168547|NCT00601172|592982687|FG001|Overall Study|Adverse Event|32|||
164168548|NCT00601172|592982686|FG000|Overall Study|Lack of Efficacy|11|||
164168549|NCT00601172|592982687|FG001|Overall Study|Lack of Efficacy|12|||
164168550|NCT00601172|592982686|FG000|Overall Study|Protocol Violation|2|||
164168551|NCT00601172|592982687|FG001|Overall Study|Protocol Violation|5|||
164168552|NCT00601172|592982686|FG000|Overall Study|Lost to Follow-up|4|||
164168553|NCT00601172|592982687|FG001|Overall Study|Lost to Follow-up|3|||
164168554|NCT00601172|592982686|FG000|Overall Study|Physician Decision|27|||
164168555|NCT00601172|592982687|FG001|Overall Study|Physician Decision|28|||
164168556|NCT00601172|592982686|FG000|Overall Study|Withdrawal by Subject|35|||
164168557|NCT00601172|592982687|FG001|Overall Study|Withdrawal by Subject|27|||
164168558|NCT00601172|592982686|FG000|Overall Study|Did not meet continuation criteria|19|||
164168559|NCT00601172|592982687|FG001|Overall Study|Did not meet continuation criteria|20|||
164168560|NCT04434469|592982688|FG000|Overall Study|Death|2|||
164168561|NCT04434469|592982689|FG001|Overall Study|Death|3|||
164168562|NCT04434469|592982690|FG002|Overall Study|Death|2|||
164168563|NCT04434469|592982691|FG003|Overall Study|Death|2|||
164168564|NCT04434469|592982692|FG004|Overall Study|Death|2|||
164168565|NCT04434469|592982693|FG005|Overall Study|Death|0|||
164168566|NCT04434469|592982688|FG000|Overall Study|Lost to Follow-up|0|||
164168567|NCT04434469|592982689|FG001|Overall Study|Lost to Follow-up|0|||
164168568|NCT04434469|592982690|FG002|Overall Study|Lost to Follow-up|0|||
164168569|NCT04434469|592982691|FG003|Overall Study|Lost to Follow-up|1|||
164168570|NCT04434469|592982692|FG004|Overall Study|Lost to Follow-up|1|||
164168571|NCT04434469|592982693|FG005|Overall Study|Lost to Follow-up|0|||
164168572|NCT04434469|592982688|FG000|Overall Study|Study terminated by sponsor|1|||
164168573|NCT04434469|592982689|FG001|Overall Study|Study terminated by sponsor|1|||
164168574|NCT04434469|592982690|FG002|Overall Study|Study terminated by sponsor|1|||
164168575|NCT04434469|592982691|FG003|Overall Study|Study terminated by sponsor|2|||
164168576|NCT04434469|592982692|FG004|Overall Study|Study terminated by sponsor|3|||
164168577|NCT04434469|592982693|FG005|Overall Study|Study terminated by sponsor|3|||
164168578|NCT04434469|592982688|FG000|Overall Study|Withdrawal by Subject|0|||
164168579|NCT04434469|592982689|FG001|Overall Study|Withdrawal by Subject|0|||
164168580|NCT04434469|592982690|FG002|Overall Study|Withdrawal by Subject|1|||
164168581|NCT04434469|592982691|FG003|Overall Study|Withdrawal by Subject|0|||
164168582|NCT04434469|592982692|FG004|Overall Study|Withdrawal by Subject|0|||
164168583|NCT04434469|592982693|FG005|Overall Study|Withdrawal by Subject|0|||
164168584|NCT01300338|592982695|FG000|Overall Study|Lost to Follow-up|5|||
164168585|NCT01300338|592982696|FG001|Overall Study|Lost to Follow-up|0|||
164168586|NCT02461524|592982697|FG000|Overall Study|Death|16|||
164168587|NCT02461524|592982697|FG000|Overall Study|Withdrawal by Subject|4|||
164168588|NCT02461524|592982697|FG000|Overall Study|Device Explanted|5|||
164168589|NCT02461524|592982697|FG000|Overall Study|Missed Visit|6|||
164168590|NCT00381238|592982701|FG000|Overall Study|Adverse Event|3|||
164168591|NCT00381238|592982701|FG000|Overall Study|Protocol Violation|1|||
164168592|NCT00381238|592982701|FG000|Overall Study|Withdrawal by Subject|4|||
164168593|NCT00381238|592982701|FG000|Overall Study|Lack of Efficacy|2|||
164168594|NCT00381238|592982701|FG000|Overall Study|Withdrew by physician|1|||
164168595|NCT00381238|592982701|FG000|Overall Study|Disease progression|1|||
164168596|NCT00843037|592982704|FG000|Overall Study|Lost to Follow-up|1|||
164168597|NCT03535194|592982705|FG000|Induction Period|Adverse Event|2|||
164168598|NCT03535194|592982706|FG001|Induction Period|Adverse Event|2|||
164168599|NCT03535194|592982707|FG002|Induction Period|Adverse Event|1|||
164168600|NCT03535194|592982708|FG003|Induction Period|Adverse Event|3|||
164168601|NCT03535194|592982709|FG004|Induction Period|Adverse Event|0|||
164168602|NCT03535194|592982705|FG000|Induction Period|Death|0|||
164168603|NCT03535194|592982706|FG001|Induction Period|Death|1|||
164168604|NCT03535194|592982707|FG002|Induction Period|Death|0|||
164168605|NCT03535194|592982708|FG003|Induction Period|Death|0|||
164168606|NCT03535194|592982709|FG004|Induction Period|Death|0|||
164168607|NCT03535194|592982705|FG000|Induction Period|Lack of Efficacy|1|||
164168608|NCT03535194|592982706|FG001|Induction Period|Lack of Efficacy|3|||
164168609|NCT03535194|592982707|FG002|Induction Period|Lack of Efficacy|2|||
164168610|NCT03535194|592982708|FG003|Induction Period|Lack of Efficacy|2|||
164168611|NCT03535194|592982709|FG004|Induction Period|Lack of Efficacy|0|||
164168612|NCT03535194|592982705|FG000|Induction Period|Lost to Follow-up|3|||
164168613|NCT03535194|592982706|FG001|Induction Period|Lost to Follow-up|5|||
164168614|NCT03535194|592982707|FG002|Induction Period|Lost to Follow-up|2|||
164168615|NCT03535194|592982708|FG003|Induction Period|Lost to Follow-up|3|||
164168616|NCT03535194|592982709|FG004|Induction Period|Lost to Follow-up|0|||
164168617|NCT03535194|592982705|FG000|Induction Period|Physician Decision|1|||
164168618|NCT03535194|592982706|FG001|Induction Period|Physician Decision|1|||
164168619|NCT03535194|592982707|FG002|Induction Period|Physician Decision|0|||
164168620|NCT03535194|592982708|FG003|Induction Period|Physician Decision|0|||
164168621|NCT03535194|592982709|FG004|Induction Period|Physician Decision|0|||
164168622|NCT03535194|592982705|FG000|Induction Period|Protocol Violation|1|||
164168623|NCT03535194|592982706|FG001|Induction Period|Protocol Violation|0|||
164168624|NCT03535194|592982707|FG002|Induction Period|Protocol Violation|0|||
164168625|NCT03535194|592982708|FG003|Induction Period|Protocol Violation|1|||
164168626|NCT03535194|592982709|FG004|Induction Period|Protocol Violation|0|||
164168627|NCT03535194|592982705|FG000|Induction Period|Screen Failure|0|||
164168628|NCT03535194|592982706|FG001|Induction Period|Screen Failure|1|||
164168629|NCT03535194|592982707|FG002|Induction Period|Screen Failure|0|||
164168630|NCT03535194|592982708|FG003|Induction Period|Screen Failure|0|||
164168631|NCT03535194|592982709|FG004|Induction Period|Screen Failure|0|||
164168632|NCT03535194|592982705|FG000|Induction Period|Withdrawal by Subject|3|||
164168633|NCT03535194|592982706|FG001|Induction Period|Withdrawal by Subject|4|||
164168634|NCT03535194|592982707|FG002|Induction Period|Withdrawal by Subject|3|||
164168635|NCT03535194|592982708|FG003|Induction Period|Withdrawal by Subject|2|||
164168636|NCT03535194|592982709|FG004|Induction Period|Withdrawal by Subject|0|||
164168637|NCT03535194|592982705|FG000|Maintenance Period|Adverse Event|6|||
164168638|NCT03535194|592982706|FG001|Maintenance Period|Adverse Event|5|||
164168639|NCT03535194|592982707|FG002|Maintenance Period|Adverse Event|1|||
164168640|NCT03535194|592982708|FG003|Maintenance Period|Adverse Event|11|||
164168641|NCT03535194|592982709|FG004|Maintenance Period|Adverse Event|4|||
164168642|NCT03535194|592982705|FG000|Maintenance Period|Lack of Efficacy|3|||
164168643|NCT03535194|592982706|FG001|Maintenance Period|Lack of Efficacy|2|||
164168644|NCT03535194|592982707|FG002|Maintenance Period|Lack of Efficacy|5|||
164168645|NCT03535194|592982708|FG003|Maintenance Period|Lack of Efficacy|9|||
164168646|NCT03535194|592982709|FG004|Maintenance Period|Lack of Efficacy|0|||
164168647|NCT03535194|592982705|FG000|Maintenance Period|Lost to Follow-up|4|||
164168648|NCT03535194|592982706|FG001|Maintenance Period|Lost to Follow-up|2|||
164168649|NCT03535194|592982707|FG002|Maintenance Period|Lost to Follow-up|1|||
164168650|NCT03535194|592982708|FG003|Maintenance Period|Lost to Follow-up|5|||
164168651|NCT03535194|592982709|FG004|Maintenance Period|Lost to Follow-up|2|||
164168652|NCT03535194|592982705|FG000|Maintenance Period|Other|1|||
164168653|NCT03535194|592982706|FG001|Maintenance Period|Other|2|||
164168654|NCT03535194|592982707|FG002|Maintenance Period|Other|0|||
164168655|NCT03535194|592982708|FG003|Maintenance Period|Other|0|||
164168656|NCT03535194|592982709|FG004|Maintenance Period|Other|0|||
164168657|NCT03535194|592982705|FG000|Maintenance Period|Physician Decision|1|||
164168658|NCT03535194|592982706|FG001|Maintenance Period|Physician Decision|2|||
164168659|NCT03535194|592982707|FG002|Maintenance Period|Physician Decision|0|||
164168660|NCT03535194|592982708|FG003|Maintenance Period|Physician Decision|2|||
164168661|NCT03535194|592982709|FG004|Maintenance Period|Physician Decision|0|||
164168662|NCT03535194|592982705|FG000|Maintenance Period|Pregnancy|0|||
164168663|NCT03535194|592982706|FG001|Maintenance Period|Pregnancy|0|||
164168664|NCT03535194|592982707|FG002|Maintenance Period|Pregnancy|0|||
164168665|NCT03535194|592982708|FG003|Maintenance Period|Pregnancy|2|||
164168666|NCT03535194|592982709|FG004|Maintenance Period|Pregnancy|0|||
164168667|NCT03535194|592982705|FG000|Maintenance Period|Protocol Violation|0|||
164168668|NCT03535194|592982706|FG001|Maintenance Period|Protocol Violation|1|||
164168669|NCT03535194|592982707|FG002|Maintenance Period|Protocol Violation|0|||
164168670|NCT03535194|592982708|FG003|Maintenance Period|Protocol Violation|0|||
164168671|NCT03535194|592982709|FG004|Maintenance Period|Protocol Violation|0|||
164168672|NCT03535194|592982705|FG000|Maintenance Period|Withdrawal by Subject|7|||
164168673|NCT03535194|592982706|FG001|Maintenance Period|Withdrawal by Subject|2|||
164168674|NCT03535194|592982707|FG002|Maintenance Period|Withdrawal by Subject|1|||
164168675|NCT03535194|592982708|FG003|Maintenance Period|Withdrawal by Subject|8|||
164168676|NCT03535194|592982709|FG004|Maintenance Period|Withdrawal by Subject|0|||
164168677|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Adverse Event|4|||
164168678|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Adverse Event|5|||
164168679|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Adverse Event|1|||
164168680|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Adverse Event|8|||
164168681|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Adverse Event|0|||
164168682|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
164168683|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
164168684|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
164168685|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
164168686|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
164168687|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
164168688|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
164168689|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
164168690|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
164168691|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
164168692|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Other|1|||
164168693|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Other|0|||
164168694|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Other|0|||
164168695|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Other|5|||
164168696|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Other|0|||
164168697|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Physician Decision|0|||
164168698|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Physician Decision|2|||
164168699|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Physician Decision|1|||
164168700|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Physician Decision|1|||
164168701|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Physician Decision|0|||
164168702|NCT03535194|592982705|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
164168703|NCT03535194|592982706|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
164168704|NCT03535194|592982707|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
164168705|NCT03535194|592982708|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
164168706|NCT03535194|592982709|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
164168707|NCT04411810|592982710|FG000|Overall Study|Screen failure|1|||
164168708|NCT04411810|592982710|FG000|Overall Study|Withdrawal by Subject|1|||
164168709|NCT02564900|592982711|FG000|Dose Escalation|Progressive disease per RECIST|2|||
164168710|NCT02564900|592982712|FG001|Dose Escalation|Progressive disease per RECIST|3|||
164168711|NCT02564900|592982713|FG002|Dose Escalation|Progressive disease per RECIST|3|||
164168712|NCT02564900|592982714|FG003|Dose Escalation|Progressive disease per RECIST|3|||
164168713|NCT02564900|592982715|FG004|Dose Escalation|Progressive disease per RECIST|3|||
164168714|NCT02564900|592982716|FG005|Dose Escalation|Progressive disease per RECIST|1|||
164168715|NCT02564900|592982717|FG006|Dose Escalation|Progressive disease per RECIST|0|||
164168716|NCT02564900|592982718|FG007|Dose Escalation|Progressive disease per RECIST|0|||
164168717|NCT02564900|592982719|FG008|Dose Escalation|Progressive disease per RECIST|0|||
164168718|NCT02564900|592982720|FG009|Dose Escalation|Progressive disease per RECIST|0|||
164168719|NCT02564900|592982721|FG010|Dose Escalation|Progressive disease per RECIST|0|||
164168720|NCT02564900|592982722|FG011|Dose Escalation|Progressive disease per RECIST|0|||
164168721|NCT02564900|592982723|FG012|Dose Escalation|Progressive disease per RECIST|0|||
164168722|NCT02564900|592982724|FG013|Dose Escalation|Progressive disease per RECIST|0|||
164168723|NCT02564900|592982725|FG014|Dose Escalation|Progressive disease per RECIST|0|||
164168724|NCT02564900|592982711|FG000|Dose Escalation|Ongoing|1|||
164168725|NCT02564900|592982712|FG001|Dose Escalation|Ongoing|0|||
164168726|NCT02564900|592982713|FG002|Dose Escalation|Ongoing|0|||
164168727|NCT02564900|592982714|FG003|Dose Escalation|Ongoing|2|||
164168728|NCT02564900|592982715|FG004|Dose Escalation|Ongoing|2|||
164168729|NCT02564900|592982716|FG005|Dose Escalation|Ongoing|2|||
164168730|NCT02564900|592982717|FG006|Dose Escalation|Ongoing|0|||
164168731|NCT02564900|592982718|FG007|Dose Escalation|Ongoing|0|||
164168732|NCT02564900|592982719|FG008|Dose Escalation|Ongoing|0|||
164168733|NCT02564900|592982720|FG009|Dose Escalation|Ongoing|0|||
164168734|NCT02564900|592982721|FG010|Dose Escalation|Ongoing|0|||
164168735|NCT02564900|592982722|FG011|Dose Escalation|Ongoing|0|||
164168736|NCT02564900|592982723|FG012|Dose Escalation|Ongoing|0|||
164168737|NCT02564900|592982724|FG013|Dose Escalation|Ongoing|0|||
164168738|NCT02564900|592982725|FG014|Dose Escalation|Ongoing|0|||
164168739|NCT02564900|592982711|FG000|Dose Escalation|Adverse Event|0|||
164168740|NCT02564900|592982712|FG001|Dose Escalation|Adverse Event|0|||
164168741|NCT02564900|592982713|FG002|Dose Escalation|Adverse Event|0|||
164168742|NCT02564900|592982714|FG003|Dose Escalation|Adverse Event|1|||
164168743|NCT02564900|592982715|FG004|Dose Escalation|Adverse Event|1|||
164168744|NCT02564900|592982716|FG005|Dose Escalation|Adverse Event|3|||
164168745|NCT02564900|592982717|FG006|Dose Escalation|Adverse Event|0|||
164168746|NCT02564900|592982718|FG007|Dose Escalation|Adverse Event|0|||
164168747|NCT02564900|592982719|FG008|Dose Escalation|Adverse Event|0|||
164168748|NCT02564900|592982720|FG009|Dose Escalation|Adverse Event|0|||
164168749|NCT02564900|592982721|FG010|Dose Escalation|Adverse Event|0|||
164168750|NCT02564900|592982722|FG011|Dose Escalation|Adverse Event|0|||
164168751|NCT02564900|592982723|FG012|Dose Escalation|Adverse Event|0|||
164168752|NCT02564900|592982724|FG013|Dose Escalation|Adverse Event|0|||
164168753|NCT02564900|592982725|FG014|Dose Escalation|Adverse Event|0|||
164168754|NCT02564900|592982711|FG000|Dose Expansion|Progressive disease per RECIST|0|||
164168755|NCT02564900|592982712|FG001|Dose Expansion|Progressive disease per RECIST|0|||
164168756|NCT02564900|592982713|FG002|Dose Expansion|Progressive disease per RECIST|0|||
164168757|NCT02564900|592982714|FG003|Dose Expansion|Progressive disease per RECIST|0|||
164168758|NCT02564900|592982715|FG004|Dose Expansion|Progressive disease per RECIST|0|||
164168759|NCT02564900|592982716|FG005|Dose Expansion|Progressive disease per RECIST|0|||
164168760|NCT02564900|592982717|FG006|Dose Expansion|Progressive disease per RECIST|19|||
164168761|NCT02564900|592982718|FG007|Dose Expansion|Progressive disease per RECIST|17|||
164168762|NCT02564900|592982719|FG008|Dose Expansion|Progressive disease per RECIST|8|||
164168763|NCT02564900|592982720|FG009|Dose Expansion|Progressive disease per RECIST|16|||
164168764|NCT02564900|592982721|FG010|Dose Expansion|Progressive disease per RECIST|13|||
164168765|NCT02564900|592982722|FG011|Dose Expansion|Progressive disease per RECIST|19|||
164168766|NCT02564900|592982723|FG012|Dose Expansion|Progressive disease per RECIST|10|||
164168767|NCT02564900|592982724|FG013|Dose Expansion|Progressive disease per RECIST|13|||
164168768|NCT02564900|592982725|FG014|Dose Expansion|Progressive disease per RECIST|11|||
164168769|NCT02564900|592982711|FG000|Dose Expansion|Clinical progression|0|||
164168770|NCT02564900|592982712|FG001|Dose Expansion|Clinical progression|0|||
164168771|NCT02564900|592982713|FG002|Dose Expansion|Clinical progression|0|||
164168772|NCT02564900|592982714|FG003|Dose Expansion|Clinical progression|0|||
164168773|NCT02564900|592982715|FG004|Dose Expansion|Clinical progression|0|||
164168774|NCT02564900|592982716|FG005|Dose Expansion|Clinical progression|0|||
164168775|NCT02564900|592982717|FG006|Dose Expansion|Clinical progression|5|||
164168776|NCT02564900|592982718|FG007|Dose Expansion|Clinical progression|12|||
164168777|NCT02564900|592982719|FG008|Dose Expansion|Clinical progression|0|||
164168778|NCT02564900|592982720|FG009|Dose Expansion|Clinical progression|3|||
164168779|NCT02564900|592982721|FG010|Dose Expansion|Clinical progression|2|||
164168780|NCT02564900|592982722|FG011|Dose Expansion|Clinical progression|0|||
164168781|NCT02564900|592982723|FG012|Dose Expansion|Clinical progression|1|||
164168782|NCT02564900|592982724|FG013|Dose Expansion|Clinical progression|3|||
164168783|NCT02564900|592982725|FG014|Dose Expansion|Clinical progression|1|||
164168784|NCT02564900|592982711|FG000|Dose Expansion|Adverse Event|0|||
164168785|NCT02564900|592982712|FG001|Dose Expansion|Adverse Event|0|||
164168786|NCT02564900|592982713|FG002|Dose Expansion|Adverse Event|0|||
164168787|NCT02564900|592982714|FG003|Dose Expansion|Adverse Event|0|||
164168788|NCT02564900|592982715|FG004|Dose Expansion|Adverse Event|0|||
164168789|NCT02564900|592982716|FG005|Dose Expansion|Adverse Event|0|||
164168790|NCT02564900|592982717|FG006|Dose Expansion|Adverse Event|9|||
164168791|NCT02564900|592982718|FG007|Dose Expansion|Adverse Event|22|||
164168792|NCT02564900|592982719|FG008|Dose Expansion|Adverse Event|0|||
164168793|NCT02564900|592982720|FG009|Dose Expansion|Adverse Event|11|||
164168794|NCT02564900|592982721|FG010|Dose Expansion|Adverse Event|0|||
164168795|NCT02564900|592982722|FG011|Dose Expansion|Adverse Event|5|||
164168796|NCT02564900|592982723|FG012|Dose Expansion|Adverse Event|2|||
164168797|NCT02564900|592982724|FG013|Dose Expansion|Adverse Event|2|||
164168798|NCT02564900|592982725|FG014|Dose Expansion|Adverse Event|1|||
164168799|NCT02564900|592982711|FG000|Dose Expansion|Ongoing|0|||
164168800|NCT02564900|592982712|FG001|Dose Expansion|Ongoing|0|||
164168801|NCT02564900|592982713|FG002|Dose Expansion|Ongoing|0|||
164168802|NCT02564900|592982714|FG003|Dose Expansion|Ongoing|0|||
164168803|NCT02564900|592982715|FG004|Dose Expansion|Ongoing|0|||
164168804|NCT02564900|592982716|FG005|Dose Expansion|Ongoing|0|||
164168805|NCT02564900|592982717|FG006|Dose Expansion|Ongoing|9|||
164168806|NCT02564900|592982718|FG007|Dose Expansion|Ongoing|10|||
164168807|NCT02564900|592982719|FG008|Dose Expansion|Ongoing|11|||
164168808|NCT02564900|592982720|FG009|Dose Expansion|Ongoing|3|||
164168809|NCT02564900|592982721|FG010|Dose Expansion|Ongoing|0|||
164168810|NCT02564900|592982722|FG011|Dose Expansion|Ongoing|0|||
164168811|NCT02564900|592982723|FG012|Dose Expansion|Ongoing|4|||
164168812|NCT02564900|592982724|FG013|Dose Expansion|Ongoing|0|||
164168813|NCT02564900|592982725|FG014|Dose Expansion|Ongoing|6|||
164168814|NCT02564900|592982711|FG000|Dose Expansion|Death|0|||
164168815|NCT02564900|592982712|FG001|Dose Expansion|Death|0|||
164168816|NCT02564900|592982713|FG002|Dose Expansion|Death|0|||
164168817|NCT02564900|592982714|FG003|Dose Expansion|Death|0|||
164168818|NCT02564900|592982715|FG004|Dose Expansion|Death|0|||
164168819|NCT02564900|592982716|FG005|Dose Expansion|Death|0|||
164168820|NCT02564900|592982717|FG006|Dose Expansion|Death|1|||
164168821|NCT02564900|592982718|FG007|Dose Expansion|Death|0|||
164168822|NCT02564900|592982719|FG008|Dose Expansion|Death|0|||
164168823|NCT02564900|592982720|FG009|Dose Expansion|Death|0|||
164168824|NCT02564900|592982721|FG010|Dose Expansion|Death|1|||
164168825|NCT02564900|592982722|FG011|Dose Expansion|Death|0|||
164168826|NCT02564900|592982723|FG012|Dose Expansion|Death|1|||
164168827|NCT02564900|592982724|FG013|Dose Expansion|Death|1|||
164168828|NCT02564900|592982725|FG014|Dose Expansion|Death|0|||
164168829|NCT02564900|592982711|FG000|Dose Expansion|Withdrawal by Subject|0|||
164168830|NCT02564900|592982712|FG001|Dose Expansion|Withdrawal by Subject|0|||
164168831|NCT02564900|592982713|FG002|Dose Expansion|Withdrawal by Subject|0|||
164168832|NCT02564900|592982714|FG003|Dose Expansion|Withdrawal by Subject|0|||
164168833|NCT02564900|592982715|FG004|Dose Expansion|Withdrawal by Subject|0|||
164168834|NCT02564900|592982716|FG005|Dose Expansion|Withdrawal by Subject|0|||
164168835|NCT02564900|592982717|FG006|Dose Expansion|Withdrawal by Subject|4|||
164168836|NCT02564900|592982718|FG007|Dose Expansion|Withdrawal by Subject|0|||
164168837|NCT02564900|592982719|FG008|Dose Expansion|Withdrawal by Subject|0|||
164168838|NCT02564900|592982720|FG009|Dose Expansion|Withdrawal by Subject|0|||
164168839|NCT02564900|592982721|FG010|Dose Expansion|Withdrawal by Subject|1|||
164168840|NCT02564900|592982722|FG011|Dose Expansion|Withdrawal by Subject|0|||
164168841|NCT02564900|592982723|FG012|Dose Expansion|Withdrawal by Subject|0|||
164168842|NCT02564900|592982724|FG013|Dose Expansion|Withdrawal by Subject|1|||
164168843|NCT02564900|592982725|FG014|Dose Expansion|Withdrawal by Subject|1|||
164168844|NCT02564900|592982711|FG000|Dose Expansion|Other|0|||
164168845|NCT02564900|592982712|FG001|Dose Expansion|Other|0|||
164168846|NCT02564900|592982713|FG002|Dose Expansion|Other|0|||
164168847|NCT02564900|592982714|FG003|Dose Expansion|Other|0|||
164168848|NCT02564900|592982715|FG004|Dose Expansion|Other|0|||
164168849|NCT02564900|592982716|FG005|Dose Expansion|Other|0|||
164168850|NCT02564900|592982717|FG006|Dose Expansion|Other|1|||
164168851|NCT02564900|592982718|FG007|Dose Expansion|Other|0|||
164168852|NCT02564900|592982719|FG008|Dose Expansion|Other|1|||
164168853|NCT02564900|592982720|FG009|Dose Expansion|Other|0|||
164168854|NCT02564900|592982721|FG010|Dose Expansion|Other|0|||
164168855|NCT02564900|592982722|FG011|Dose Expansion|Other|0|||
164168856|NCT02564900|592982723|FG012|Dose Expansion|Other|0|||
164168857|NCT02564900|592982724|FG013|Dose Expansion|Other|0|||
164168858|NCT02564900|592982725|FG014|Dose Expansion|Other|1|||
164168859|NCT02564900|592982711|FG000|Dose Expansion|Did not receive treatment|0|||
164168860|NCT02564900|592982712|FG001|Dose Expansion|Did not receive treatment|0|||
164168861|NCT02564900|592982713|FG002|Dose Expansion|Did not receive treatment|0|||
164168862|NCT02564900|592982714|FG003|Dose Expansion|Did not receive treatment|0|||
164168863|NCT02564900|592982715|FG004|Dose Expansion|Did not receive treatment|0|||
164168864|NCT02564900|592982716|FG005|Dose Expansion|Did not receive treatment|0|||
164168865|NCT02564900|592982717|FG006|Dose Expansion|Did not receive treatment|1|||
164168866|NCT02564900|592982718|FG007|Dose Expansion|Did not receive treatment|1|||
164168867|NCT02564900|592982719|FG008|Dose Expansion|Did not receive treatment|0|||
164168868|NCT02564900|592982720|FG009|Dose Expansion|Did not receive treatment|0|||
164168869|NCT02564900|592982721|FG010|Dose Expansion|Did not receive treatment|0|||
164168870|NCT02564900|592982722|FG011|Dose Expansion|Did not receive treatment|0|||
164168871|NCT02564900|592982723|FG012|Dose Expansion|Did not receive treatment|0|||
164168872|NCT02564900|592982724|FG013|Dose Expansion|Did not receive treatment|0|||
164168873|NCT02564900|592982725|FG014|Dose Expansion|Did not receive treatment|1|||
164168874|NCT03991299|592982729|FG000|Overall Study|Study closed, sponsor decision|3|||
164168875|NCT03991299|592982729|FG000|Overall Study|Withdrawal by Subject|1|||
164168876|NCT04304235|592982730|FG000|Overall Study|incomplete triage data|0|||
164168877|NCT04304235|592982731|FG001|Overall Study|incomplete triage data|69|||
164168878|NCT04304235|592982732|FG002|Overall Study|incomplete triage data|0|||
164168879|NCT04304235|592982733|FG003|Overall Study|incomplete triage data|0|||
164168880|NCT04304235|592982734|FG004|Overall Study|incomplete triage data|289|||
164168881|NCT04304235|592982735|FG005|Overall Study|incomplete triage data|123|||
164168882|NCT04304235|592982736|FG006|Overall Study|incomplete triage data|65|||
164168883|NCT04470544|592982737|FG000|Overall Study|Withdrawal by Subject|4|||
164168884|NCT04470544|592982738|FG001|Overall Study|Withdrawal by Subject|6|||
164168885|NCT02005692|592982739|FG000|Overall Study|Protocol Violation|1|||
164168886|NCT02005692|592982739|FG000|Overall Study|Withdrawal by Subject|1|||
164168887|NCT02005692|592982739|FG000|Overall Study|Discharged earlier than anticipated|5|||
164168888|NCT04967885|592982740|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
164168889|NCT04967885|592982741|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
164168890|NCT04967885|592982740|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
164168891|NCT04967885|592982741|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
164168892|NCT04967885|592982740|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
164168893|NCT04967885|592982741|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
164168894|NCT04967885|592982740|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
164168895|NCT04967885|592982741|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
164168896|NCT04967885|592982740|FG000|EMI-II Intervention|Lost to Follow-up|14|||
164168897|NCT04967885|592982741|FG001|EMI-II Intervention|Lost to Follow-up|10|||
164168898|NCT01011465|592982742|FG000|Overall Study|Withdrawal by Subject|2|||
164168899|NCT01011465|592982743|FG001|Overall Study|Withdrawal by Subject|1|||
164168900|NCT01011465|592982744|FG002|Overall Study|Withdrawal by Subject|0|||
164168901|NCT01011465|592982745|FG003|Overall Study|Withdrawal by Subject|0|||
164168902|NCT01011465|592982746|FG004|Overall Study|Withdrawal by Subject|1|||
164168903|NCT01011465|592982747|FG005|Overall Study|Withdrawal by Subject|0|||
164168904|NCT01011465|592982748|FG006|Overall Study|Withdrawal by Subject|1|||
164168905|NCT01011465|592982749|FG007|Overall Study|Withdrawal by Subject|0|||
164168906|NCT02042950|592982752|FG000|Overall Study|Progressive Disease|4|||
164168907|NCT00723008|592982753|FG000|Enrollment|Lost to Follow-up|1|||
164168908|NCT00723008|592982754|FG001|Enrollment|Lost to Follow-up|0|||
164168909|NCT00723008|592982753|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
164168910|NCT00723008|592982754|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
164168911|NCT00723008|592982753|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
164168912|NCT00723008|592982754|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
164168913|NCT00723008|592982753|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
164168914|NCT00723008|592982754|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
164168915|NCT00723008|592982753|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
164168916|NCT00723008|592982754|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
164168917|NCT00723008|592982753|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
164168918|NCT00723008|592982754|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
164168919|NCT05896527|592982755|FG000|Overall Study|Withdrawal by Subject|11|||
164168920|NCT05896527|592982756|FG001|Overall Study|Withdrawal by Subject|10|||
164168921|NCT05896527|592982757|FG002|Overall Study|Withdrawal by Subject|4|||
164168922|NCT05896527|592982758|FG003|Overall Study|Withdrawal by Subject|3|||
164168923|NCT05896527|592982759|FG004|Overall Study|Withdrawal by Subject|2|||
164168924|NCT05896527|592982755|FG000|Overall Study|Lost to Follow-up|0|||
164168925|NCT05896527|592982756|FG001|Overall Study|Lost to Follow-up|2|||
164168926|NCT05896527|592982757|FG002|Overall Study|Lost to Follow-up|2|||
164168927|NCT05896527|592982758|FG003|Overall Study|Lost to Follow-up|2|||
164168928|NCT05896527|592982759|FG004|Overall Study|Lost to Follow-up|1|||
164168929|NCT05896527|592982755|FG000|Overall Study|Significant protocol noncompliance|0|||
164168930|NCT05896527|592982756|FG001|Overall Study|Significant protocol noncompliance|1|||
164168931|NCT05896527|592982757|FG002|Overall Study|Significant protocol noncompliance|0|||
164168932|NCT05896527|592982758|FG003|Overall Study|Significant protocol noncompliance|0|||
164168933|NCT05896527|592982759|FG004|Overall Study|Significant protocol noncompliance|0|||
164168934|NCT05896527|592982755|FG000|Overall Study|Eligibility criteria not met|1|||
164168935|NCT05896527|592982756|FG001|Overall Study|Eligibility criteria not met|0|||
164168936|NCT05896527|592982757|FG002|Overall Study|Eligibility criteria not met|0|||
164168937|NCT05896527|592982758|FG003|Overall Study|Eligibility criteria not met|0|||
164168938|NCT05896527|592982759|FG004|Overall Study|Eligibility criteria not met|0|||
164168939|NCT05896527|592982755|FG000|Overall Study|Sponsor's decision|0|||
164168940|NCT05896527|592982756|FG001|Overall Study|Sponsor's decision|0|||
164168941|NCT05896527|592982757|FG002|Overall Study|Sponsor's decision|0|||
164168942|NCT05896527|592982758|FG003|Overall Study|Sponsor's decision|1|||
164168943|NCT05896527|592982759|FG004|Overall Study|Sponsor's decision|0|||
164168944|NCT05896527|592982755|FG000|Overall Study|Investigator's decision|0|||
164168945|NCT05896527|592982756|FG001|Overall Study|Investigator's decision|1|||
164168946|NCT05896527|592982757|FG002|Overall Study|Investigator's decision|0|||
164168947|NCT05896527|592982758|FG003|Overall Study|Investigator's decision|0|||
164168948|NCT05896527|592982759|FG004|Overall Study|Investigator's decision|0|||
164168949|NCT05896527|592982755|FG000|Overall Study|Pregnancy of his partner|0|||
164168950|NCT05896527|592982756|FG001|Overall Study|Pregnancy of his partner|0|||
164168951|NCT05896527|592982757|FG002|Overall Study|Pregnancy of his partner|0|||
164168952|NCT05896527|592982758|FG003|Overall Study|Pregnancy of his partner|1|||
164168953|NCT05896527|592982759|FG004|Overall Study|Pregnancy of his partner|0|||
164168954|NCT01279070|592982760|FG000|Overall Study|Withdrawal by Subject|2|||
164168955|NCT01279070|592982761|FG001|Overall Study|Withdrawal by Subject|3|||
164168956|NCT01279070|592982760|FG000|Overall Study|Acute exacerbation|3|||
164168957|NCT01279070|592982761|FG001|Overall Study|Acute exacerbation|1|||
164168958|NCT02217410|592982768|FG000|Overall Study|Graft Loss|0|||
164168959|NCT02217410|592982769|FG001|Overall Study|Graft Loss|0|||
164168960|NCT02217410|592982770|FG002|Overall Study|Graft Loss|2|||
164168961|NCT02217410|592982768|FG000|Overall Study|Withdrawal by Subject|0|||
164168962|NCT02217410|592982769|FG001|Overall Study|Withdrawal by Subject|0|||
164168963|NCT02217410|592982770|FG002|Overall Study|Withdrawal by Subject|2|||
164168964|NCT02217410|592982768|FG000|Overall Study|Lost to Follow-up|0|||
164168965|NCT02217410|592982769|FG001|Overall Study|Lost to Follow-up|0|||
164168966|NCT02217410|592982770|FG002|Overall Study|Lost to Follow-up|1|||
164168967|NCT02217410|592982768|FG000|Overall Study|Lack of Efficacy|0|||
164168968|NCT02217410|592982769|FG001|Overall Study|Lack of Efficacy|1|||
164168969|NCT02217410|592982770|FG002|Overall Study|Lack of Efficacy|0|||
164168970|NCT02217410|592982768|FG000|Overall Study|Physician Decision|1|||
164168971|NCT02217410|592982769|FG001|Overall Study|Physician Decision|3|||
164168972|NCT02217410|592982770|FG002|Overall Study|Physician Decision|0|||
164168973|NCT00626821|592982773|FG000|Overall Study|Adverse Event|44|||
164168974|NCT00626821|592982773|FG000|Overall Study|Protocol Violation|33|||
164168975|NCT00626821|592982773|FG000|Overall Study|Withdrawal by Subject|10|||
164168976|NCT00626821|592982773|FG000|Overall Study|Physician Decision|9|||
164168977|NCT00626821|592982773|FG000|Overall Study|Product dysfunction|21|||
164168978|NCT00626821|592982773|FG000|Overall Study|other/unknown reason|104|||
164168979|NCT01940887|592982774|FG000|Year 1|Protocol Violation|0|||
164168980|NCT01940887|592982775|FG001|Year 1|Protocol Violation|1|||
164168981|NCT01940887|592982774|FG000|Year 1|Physician Decision|7|||
164168982|NCT01940887|592982775|FG001|Year 1|Physician Decision|3|||
164168983|NCT01940887|592982774|FG000|Year 1|Death|5|||
164168984|NCT01940887|592982775|FG001|Year 1|Death|3|||
164168985|NCT01940887|592982774|FG000|Year 1|Adverse Event|7|||
164168986|NCT01940887|592982775|FG001|Year 1|Adverse Event|6|||
164168987|NCT01940887|592982774|FG000|Year 1|Withdrawal by Subject|18|||
164168988|NCT01940887|592982775|FG001|Year 1|Withdrawal by Subject|9|||
164168989|NCT01940887|592982774|FG000|Year 1|Lost to Follow-up|2|||
164168990|NCT01940887|592982775|FG001|Year 1|Lost to Follow-up|1|||
164168991|NCT01940887|592982774|FG000|Year 2|Physician Decision|8|||
164168992|NCT01940887|592982775|FG001|Year 2|Physician Decision|1|||
164168993|NCT01940887|592982774|FG000|Year 2|Death|0|||
164168994|NCT01940887|592982775|FG001|Year 2|Death|2|||
164168995|NCT01940887|592982774|FG000|Year 2|Sponsor Decision, early termination|192|||
164168996|NCT01940887|592982775|FG001|Year 2|Sponsor Decision, early termination|203|||
164168997|NCT01940887|592982774|FG000|Year 2|Adverse Event|8|||
164168998|NCT01940887|592982775|FG001|Year 2|Adverse Event|2|||
164168999|NCT01940887|592982774|FG000|Year 2|Withdrawal by Subject|8|||
164169000|NCT01940887|592982775|FG001|Year 2|Withdrawal by Subject|8|||
164169001|NCT01940887|592982774|FG000|Year 2|Lost to Follow-up|1|||
164169002|NCT01940887|592982775|FG001|Year 2|Lost to Follow-up|6|||
164169003|NCT01471340|592982779|FG000|Overall Study|Death|5|||
164169004|NCT01471340|592982780|FG001|Overall Study|Death|4|||
164169005|NCT01471340|592982779|FG000|Overall Study|Lost to Follow-up|0|||
164169006|NCT01471340|592982780|FG001|Overall Study|Lost to Follow-up|1|||
164169007|NCT01471340|592982779|FG000|Overall Study|Investigational site closure|0|||
164169008|NCT01471340|592982780|FG001|Overall Study|Investigational site closure|1|||
164169009|NCT01471340|592982779|FG000|Overall Study|Invalid informed consent|1|||
164169010|NCT01471340|592982780|FG001|Overall Study|Invalid informed consent|0|||
164169011|NCT02475265|592982781|FG000|Overall Study|Physician Decision|1|||
164169012|NCT02475265|592982781|FG000|Overall Study|Withdrawal by Subject|2|||
164169013|NCT02218736|592982785|FG000|Overall Study|Withdrawal by Subject|10|||
164169014|NCT02218736|592982786|FG001|Overall Study|Withdrawal by Subject|9|||
164169015|NCT02218736|592982785|FG000|Overall Study|Protocol Violation|2|||
164169016|NCT02218736|592982786|FG001|Overall Study|Protocol Violation|0|||
164169017|NCT03452488|592982787|FG000|Overall Study|Adverse Event|4|||
164169018|NCT03452488|592982788|FG001|Overall Study|Adverse Event|6|||
164169019|NCT03452488|592982789|FG002|Overall Study|Adverse Event|1|||
164169020|NCT03452488|592982787|FG000|Overall Study|Death|0|||
164169021|NCT03452488|592982788|FG001|Overall Study|Death|0|||
164169022|NCT03452488|592982789|FG002|Overall Study|Death|1|||
164169023|NCT03452488|592982787|FG000|Overall Study|Lost to Follow-up|1|||
164169024|NCT03452488|592982788|FG001|Overall Study|Lost to Follow-up|2|||
164169025|NCT03452488|592982789|FG002|Overall Study|Lost to Follow-up|0|||
164169026|NCT03452488|592982787|FG000|Overall Study|PI Decision|1|||
164169027|NCT03452488|592982788|FG001|Overall Study|PI Decision|0|||
164169028|NCT03452488|592982789|FG002|Overall Study|PI Decision|0|||
164169029|NCT03452488|592982787|FG000|Overall Study|Withdrew consent|4|||
164169030|NCT03452488|592982788|FG001|Overall Study|Withdrew consent|2|||
164169031|NCT03452488|592982789|FG002|Overall Study|Withdrew consent|2|||
164169032|NCT03452488|592982787|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
164169033|NCT03452488|592982788|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
164169034|NCT03452488|592982789|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
164169035|NCT03452488|592982787|FG000|Overall Study|Other|0|||
164169036|NCT03452488|592982788|FG001|Overall Study|Other|2|||
164169037|NCT03452488|592982789|FG002|Overall Study|Other|2|||
164169038|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
164169039|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
164169040|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
164169041|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
164169042|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
164169043|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
164169044|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
164169045|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
164169046|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
164169047|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
164169048|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Death|1|||
164169049|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Death|0|||
164169050|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
164169051|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
164169052|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
164169053|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
164169054|NCT01876784|592982792|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
164169055|NCT01876784|592982793|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
164169056|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
164169057|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
164169058|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Adverse Event|2|||
164169059|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Adverse Event|6|||
164169060|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
164169061|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
164169062|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Progressive disease|4|||
164169063|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Progressive disease|35|||
164169064|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
164169065|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
164169066|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
164169067|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
164169068|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Death|0|||
164169069|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Death|1|||
164169070|NCT01876784|592982792|FG000|Open-label Period (31 Months)|Other than specified above|9|||
164169071|NCT01876784|592982793|FG001|Open-label Period (31 Months)|Other than specified above|18|||
164169072|NCT03047720|592982794|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
164169073|NCT03047720|592982795|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
164169074|NCT01475851|592982796|FG000|Overall Study|Protocol defined stopping criteria|1|||
164169075|NCT01475851|592982797|FG001|Overall Study|Protocol defined stopping criteria|0|||
164169076|NCT04603482|592982798|FG000|Overall Study|Lost to Follow-up|15|||
164169077|NCT04603482|592982799|FG001|Overall Study|Lost to Follow-up|15|||
164169078|NCT04603482|592982800|FG002|Overall Study|Lost to Follow-up|15|||
164169079|NCT00732758|592982801|FG000|Overall Study|Lost to Follow-up|8|||
164169080|NCT00732758|592982802|FG001|Overall Study|Lost to Follow-up|16|||
164169081|NCT00373958|592982803|FG000|Infant Series|Withdrawal by Subject|13|||
164169082|NCT00373958|592982804|FG001|Infant Series|Withdrawal by Subject|15|||
164169083|NCT00373958|592982803|FG000|Infant Series|Failed to return|8|||
164169084|NCT00373958|592982804|FG001|Infant Series|Failed to return|13|||
164169085|NCT00373958|592982803|FG000|Infant Series|Lost to Follow-up|6|||
164169086|NCT00373958|592982804|FG001|Infant Series|Lost to Follow-up|5|||
164169087|NCT00373958|592982803|FG000|Infant Series|Protocol Violation|3|||
164169088|NCT00373958|592982804|FG001|Infant Series|Protocol Violation|7|||
164169089|NCT00373958|592982803|FG000|Infant Series|Lost Kaiser coverage|4|||
164169090|NCT00373958|592982804|FG001|Infant Series|Lost Kaiser coverage|0|||
164169091|NCT00373958|592982803|FG000|Infant Series|Child relocated|1|||
164169092|NCT00373958|592982804|FG001|Infant Series|Child relocated|0|||
164169093|NCT00373958|592982803|FG000|Infant Series|Consent was not received|1|||
164169094|NCT00373958|592982804|FG001|Infant Series|Consent was not received|0|||
164169095|NCT00373958|592982803|FG000|Infant Series|Adverse Event|3|||
164169096|NCT00373958|592982804|FG001|Infant Series|Adverse Event|1|||
164169097|NCT00373958|592982803|FG000|Infant Series|Physician Decision|1|||
164169098|NCT00373958|592982804|FG001|Infant Series|Physician Decision|1|||
164169099|NCT00373958|592982803|FG000|Toddler Dose|Lost to Follow-up|5|||
164169100|NCT00373958|592982804|FG001|Toddler Dose|Lost to Follow-up|8|||
164169101|NCT00373958|592982803|FG000|Toddler Dose|Withdrawal by Subject|2|||
164169102|NCT00373958|592982804|FG001|Toddler Dose|Withdrawal by Subject|2|||
164169103|NCT00373958|592982803|FG000|Toddler Dose|Failed to return|1|||
164169104|NCT00373958|592982804|FG001|Toddler Dose|Failed to return|2|||
164169105|NCT00373958|592982803|FG000|Toddler Dose|Protocol Violation|0|||
164169106|NCT00373958|592982804|FG001|Toddler Dose|Protocol Violation|1|||
164169107|NCT00373958|592982803|FG000|Toddler Dose|Withdrawn after infant series|22|||
164169108|NCT00373958|592982804|FG001|Toddler Dose|Withdrawn after infant series|25|||
164169109|NCT01552915|592982805|FG000|Overall Study|Adverse Event|3|||
164169110|NCT01552915|592982806|FG001|Overall Study|Adverse Event|14|||
164169111|NCT01552915|592982807|FG002|Overall Study|Adverse Event|3|||
164169112|NCT01552915|592982805|FG000|Overall Study|Lost to Follow-up|4|||
164169113|NCT01552915|592982806|FG001|Overall Study|Lost to Follow-up|6|||
164169114|NCT01552915|592982807|FG002|Overall Study|Lost to Follow-up|5|||
164169115|NCT01552915|592982805|FG000|Overall Study|Withdrawal by Subject|6|||
164169116|NCT01552915|592982806|FG001|Overall Study|Withdrawal by Subject|4|||
164169117|NCT01552915|592982807|FG002|Overall Study|Withdrawal by Subject|5|||
164169118|NCT01552915|592982805|FG000|Overall Study|Protocol Violation|0|||
164169119|NCT01552915|592982806|FG001|Overall Study|Protocol Violation|4|||
164169120|NCT01552915|592982807|FG002|Overall Study|Protocol Violation|4|||
164169121|NCT01552915|592982805|FG000|Overall Study|Lack of Efficacy|8|||
164169122|NCT01552915|592982806|FG001|Overall Study|Lack of Efficacy|1|||
164169123|NCT01552915|592982807|FG002|Overall Study|Lack of Efficacy|4|||
164169124|NCT01552915|592982805|FG000|Overall Study|Other|2|||
164169125|NCT01552915|592982806|FG001|Overall Study|Other|0|||
164169126|NCT01552915|592982807|FG002|Overall Study|Other|6|||
164169127|NCT00179673|592982810|FG000|Overall Study|Adverse Event|7|||
164169128|NCT00179673|592982810|FG000|Overall Study|Lack of Efficacy|15|||
164169129|NCT00179673|592982810|FG000|Overall Study|Withdrawal by Subject|3|||
164169130|NCT00179673|592982810|FG000|Overall Study|Death|4|||
164169131|NCT00179673|592982810|FG000|Overall Study|Other Observations and options|14|||
164169132|NCT00492648|592982811|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
164169133|NCT00492648|592982812|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
164169134|NCT02387957|592982813|FG000|Overall Study|The study was discontinued|21|||
164169135|NCT02387957|592982814|FG001|Overall Study|The study was discontinued|21|||
164169136|NCT02387957|592982815|FG002|Overall Study|The study was discontinued|20|||
164169137|NCT02887248|592982816|FG000|Overall Study|Withdrawal by Subject|1|||
164169138|NCT02887248|592982816|FG000|Overall Study|Adverse Event|1|||
164169139|NCT02887248|592982816|FG000|Overall Study|Progressive Disease|1|||
164169140|NCT02294396|592982817|FG000|Overall Study|Adverse Event|26|||
164169141|NCT02294396|592982818|FG001|Overall Study|Adverse Event|25|||
164169142|NCT02294396|592982819|FG002|Overall Study|Adverse Event|21|||
164169143|NCT02294396|592982820|FG003|Overall Study|Adverse Event|24|||
164169144|NCT02294396|592982817|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
164169145|NCT02294396|592982818|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
164169146|NCT02294396|592982819|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
164169147|NCT02294396|592982820|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
164169148|NCT02294396|592982817|FG000|Overall Study|Withdrawal by Subject|8|||
164169149|NCT02294396|592982818|FG001|Overall Study|Withdrawal by Subject|6|||
164169150|NCT02294396|592982819|FG002|Overall Study|Withdrawal by Subject|6|||
164169151|NCT02294396|592982820|FG003|Overall Study|Withdrawal by Subject|8|||
164169152|NCT02294396|592982817|FG000|Overall Study|Lost to Follow-up|0|||
164169153|NCT02294396|592982818|FG001|Overall Study|Lost to Follow-up|0|||
164169154|NCT02294396|592982819|FG002|Overall Study|Lost to Follow-up|1|||
164169155|NCT02294396|592982820|FG003|Overall Study|Lost to Follow-up|1|||
164169156|NCT02294396|592982817|FG000|Overall Study|Protocol Deviation|3|||
164169157|NCT02294396|592982818|FG001|Overall Study|Protocol Deviation|2|||
164169158|NCT02294396|592982819|FG002|Overall Study|Protocol Deviation|2|||
164169159|NCT02294396|592982820|FG003|Overall Study|Protocol Deviation|1|||
164169160|NCT02294396|592982817|FG000|Overall Study|Miscellaneous|2|||
164169161|NCT02294396|592982818|FG001|Overall Study|Miscellaneous|0|||
164169162|NCT02294396|592982819|FG002|Overall Study|Miscellaneous|5|||
164169163|NCT02294396|592982820|FG003|Overall Study|Miscellaneous|2|||
164169164|NCT02120833|592982821|FG000|Overall Study|Adverse Event|1|||
164169165|NCT02120833|592982822|FG001|Overall Study|Adverse Event|0|||
164169166|NCT02120833|592982821|FG000|Overall Study|Withdrawal by Subject|2|||
164169167|NCT02120833|592982822|FG001|Overall Study|Withdrawal by Subject|0|||
164169168|NCT02120833|592982821|FG000|Overall Study|Lost to Follow-up|1|||
164169169|NCT02120833|592982822|FG001|Overall Study|Lost to Follow-up|1|||
164169170|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
164169171|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
164169172|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
164169173|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
164169174|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
164169175|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164169176|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164169177|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
164169178|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
164169179|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
164169180|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164169181|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
164169182|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
164169183|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
164169184|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
164169185|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
164169186|NCT02438826|592982823|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
164169187|NCT02438826|592982824|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
164169188|NCT02438826|592982825|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
164169189|NCT02438826|592982826|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
164169190|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Adverse Event|11|||
164169191|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Adverse Event|6|||
164169192|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Adverse Event|0|||
164169193|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Adverse Event|0|||
164169194|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
164169195|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
164169196|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
164169197|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
164169198|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
164169199|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
164169200|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
164169201|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
164169202|NCT02438826|592982823|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
164169203|NCT02438826|592982824|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
164169204|NCT02438826|592982825|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
164169205|NCT02438826|592982826|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
164169206|NCT02438826|592982823|FG000|Post-Treatment Phase|Adverse Event|3|||
164169207|NCT02438826|592982824|FG001|Post-Treatment Phase|Adverse Event|0|||
164169208|NCT02438826|592982825|FG002|Post-Treatment Phase|Adverse Event|0|||
164169209|NCT02438826|592982826|FG003|Post-Treatment Phase|Adverse Event|0|||
164169210|NCT02438826|592982823|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
164169211|NCT02438826|592982824|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
164169212|NCT02438826|592982825|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
164169213|NCT02438826|592982826|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
164169214|NCT02438826|592982823|FG000|Post-Treatment Phase|Physician Decision|1|||
164169215|NCT02438826|592982824|FG001|Post-Treatment Phase|Physician Decision|0|||
164169216|NCT02438826|592982825|FG002|Post-Treatment Phase|Physician Decision|0|||
164169217|NCT02438826|592982826|FG003|Post-Treatment Phase|Physician Decision|0|||
164169218|NCT02438826|592982823|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
164169219|NCT02438826|592982824|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
164169220|NCT02438826|592982825|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
164169221|NCT02438826|592982826|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
164169222|NCT03613649|592982829|FG000|Second Treatment|Lost to Follow-up|0|||
164169223|NCT03613649|592982830|FG001|Second Treatment|Lost to Follow-up|0|||
164169224|NCT03613649|592982831|FG002|Second Treatment|Lost to Follow-up|1|||
164169225|NCT03613649|592982832|FG003|Second Treatment|Lost to Follow-up|0|||
164169226|NCT03613649|592982833|FG004|Second Treatment|Lost to Follow-up|0|||
164169227|NCT03613649|592982834|FG005|Second Treatment|Lost to Follow-up|0|||
164169228|NCT03613649|592982835|FG006|Second Treatment|Lost to Follow-up|0|||
164169229|NCT03613649|592982836|FG007|Second Treatment|Lost to Follow-up|0|||
164169230|NCT03613649|592982837|FG008|Second Treatment|Lost to Follow-up|0|||
164169231|NCT03613649|592982838|FG009|Second Treatment|Lost to Follow-up|0|||
164169232|NCT03613649|592982839|FG010|Second Treatment|Lost to Follow-up|0|||
164169233|NCT03613649|592982840|FG011|Second Treatment|Lost to Follow-up|0|||
164169234|NCT03613649|592982829|FG000|Second Treatment|Withdrawal by Subject|0|||
164169235|NCT03613649|592982830|FG001|Second Treatment|Withdrawal by Subject|0|||
164169236|NCT03613649|592982831|FG002|Second Treatment|Withdrawal by Subject|0|||
164169237|NCT03613649|592982832|FG003|Second Treatment|Withdrawal by Subject|0|||
164169238|NCT03613649|592982833|FG004|Second Treatment|Withdrawal by Subject|1|||
164169239|NCT03613649|592982834|FG005|Second Treatment|Withdrawal by Subject|0|||
164169240|NCT03613649|592982835|FG006|Second Treatment|Withdrawal by Subject|0|||
164169241|NCT03613649|592982836|FG007|Second Treatment|Withdrawal by Subject|0|||
164169242|NCT03613649|592982837|FG008|Second Treatment|Withdrawal by Subject|0|||
164169243|NCT03613649|592982838|FG009|Second Treatment|Withdrawal by Subject|0|||
164169244|NCT03613649|592982839|FG010|Second Treatment|Withdrawal by Subject|0|||
164169245|NCT03613649|592982840|FG011|Second Treatment|Withdrawal by Subject|0|||
164169246|NCT03613649|592982829|FG000|Third Treatment|Lost to Follow-up|0|||
164169247|NCT03613649|592982830|FG001|Third Treatment|Lost to Follow-up|0|||
164169248|NCT03613649|592982831|FG002|Third Treatment|Lost to Follow-up|0|||
164169249|NCT03613649|592982832|FG003|Third Treatment|Lost to Follow-up|0|||
164169250|NCT03613649|592982833|FG004|Third Treatment|Lost to Follow-up|1|||
164169251|NCT03613649|592982834|FG005|Third Treatment|Lost to Follow-up|0|||
164169252|NCT03613649|592982835|FG006|Third Treatment|Lost to Follow-up|0|||
164169253|NCT03613649|592982836|FG007|Third Treatment|Lost to Follow-up|0|||
164169254|NCT03613649|592982837|FG008|Third Treatment|Lost to Follow-up|0|||
164169255|NCT03613649|592982838|FG009|Third Treatment|Lost to Follow-up|0|||
164169256|NCT03613649|592982839|FG010|Third Treatment|Lost to Follow-up|0|||
164169257|NCT03613649|592982840|FG011|Third Treatment|Lost to Follow-up|1|||
164169258|NCT03613649|592982829|FG000|Third Treatment|Protocol Violation|0|||
164169259|NCT03613649|592982830|FG001|Third Treatment|Protocol Violation|0|||
164169260|NCT03613649|592982831|FG002|Third Treatment|Protocol Violation|0|||
164169261|NCT03613649|592982832|FG003|Third Treatment|Protocol Violation|0|||
164169262|NCT03613649|592982833|FG004|Third Treatment|Protocol Violation|0|||
164169263|NCT03613649|592982834|FG005|Third Treatment|Protocol Violation|0|||
164169264|NCT03613649|592982835|FG006|Third Treatment|Protocol Violation|1|||
164169265|NCT03613649|592982836|FG007|Third Treatment|Protocol Violation|0|||
164169266|NCT03613649|592982837|FG008|Third Treatment|Protocol Violation|0|||
164169267|NCT03613649|592982838|FG009|Third Treatment|Protocol Violation|0|||
164169268|NCT03613649|592982839|FG010|Third Treatment|Protocol Violation|0|||
164169269|NCT03613649|592982840|FG011|Third Treatment|Protocol Violation|1|||
164169270|NCT03613649|592982829|FG000|Fourth Treatment|Protocol Violation|1|||
164169271|NCT03613649|592982830|FG001|Fourth Treatment|Protocol Violation|0|||
164169272|NCT03613649|592982831|FG002|Fourth Treatment|Protocol Violation|0|||
164169273|NCT03613649|592982832|FG003|Fourth Treatment|Protocol Violation|0|||
164169274|NCT03613649|592982833|FG004|Fourth Treatment|Protocol Violation|1|||
164169275|NCT03613649|592982834|FG005|Fourth Treatment|Protocol Violation|0|||
164169276|NCT03613649|592982835|FG006|Fourth Treatment|Protocol Violation|0|||
164169277|NCT03613649|592982836|FG007|Fourth Treatment|Protocol Violation|0|||
164169278|NCT03613649|592982837|FG008|Fourth Treatment|Protocol Violation|0|||
164169279|NCT03613649|592982838|FG009|Fourth Treatment|Protocol Violation|0|||
164169280|NCT03613649|592982839|FG010|Fourth Treatment|Protocol Violation|0|||
164169281|NCT03613649|592982840|FG011|Fourth Treatment|Protocol Violation|0|||
164169282|NCT03613649|592982829|FG000|Fourth Treatment|Physician Decision|0|||
164169283|NCT03613649|592982830|FG001|Fourth Treatment|Physician Decision|0|||
164169284|NCT03613649|592982831|FG002|Fourth Treatment|Physician Decision|0|||
164169285|NCT03613649|592982832|FG003|Fourth Treatment|Physician Decision|0|||
164169286|NCT03613649|592982833|FG004|Fourth Treatment|Physician Decision|0|||
164169287|NCT03613649|592982834|FG005|Fourth Treatment|Physician Decision|0|||
164169288|NCT03613649|592982835|FG006|Fourth Treatment|Physician Decision|1|||
164169289|NCT03613649|592982836|FG007|Fourth Treatment|Physician Decision|0|||
164169290|NCT03613649|592982837|FG008|Fourth Treatment|Physician Decision|0|||
164169291|NCT03613649|592982838|FG009|Fourth Treatment|Physician Decision|0|||
164169292|NCT03613649|592982839|FG010|Fourth Treatment|Physician Decision|0|||
164169293|NCT03613649|592982840|FG011|Fourth Treatment|Physician Decision|0|||
164169294|NCT03429244|592982841|FG000|Overall Study|Withdrawal by Subject|2|||
164169295|NCT03429244|592982842|FG001|Overall Study|Withdrawal by Subject|1|||
164169296|NCT03429244|592982843|FG002|Overall Study|Withdrawal by Subject|1|||
164169297|NCT01500187|592982849|FG000|Overall Study|Lost to Follow-up|6|||
164169298|NCT01500187|592982850|FG001|Overall Study|Lost to Follow-up|0|||
164169299|NCT00750139|592982852|FG000|Overall Study|Adverse Event|1|||
164169300|NCT00750139|592982853|FG001|Overall Study|Adverse Event|2|||
164169301|NCT00750139|592982854|FG002|Overall Study|Adverse Event|0|||
164169302|NCT00750139|592982855|FG003|Overall Study|Adverse Event|1|||
164169303|NCT00750139|592982852|FG000|Overall Study|Lost to Follow-up|17|||
164169304|NCT00750139|592982853|FG001|Overall Study|Lost to Follow-up|12|||
164169305|NCT00750139|592982854|FG002|Overall Study|Lost to Follow-up|15|||
164169306|NCT00750139|592982855|FG003|Overall Study|Lost to Follow-up|6|||
164169307|NCT00750139|592982852|FG000|Overall Study|Withdrawal by Subject|3|||
164169308|NCT00750139|592982853|FG001|Overall Study|Withdrawal by Subject|2|||
164169309|NCT00750139|592982854|FG002|Overall Study|Withdrawal by Subject|6|||
164169310|NCT00750139|592982855|FG003|Overall Study|Withdrawal by Subject|2|||
164169311|NCT00750139|592982852|FG000|Overall Study|Physician Decision|1|||
164169312|NCT00750139|592982853|FG001|Overall Study|Physician Decision|1|||
164169313|NCT00750139|592982854|FG002|Overall Study|Physician Decision|0|||
164169314|NCT00750139|592982855|FG003|Overall Study|Physician Decision|0|||
164169315|NCT00750139|592982852|FG000|Overall Study|Non-compliance|1|||
164169316|NCT00750139|592982853|FG001|Overall Study|Non-compliance|0|||
164169317|NCT00750139|592982854|FG002|Overall Study|Non-compliance|1|||
164169318|NCT00750139|592982855|FG003|Overall Study|Non-compliance|3|||
164169319|NCT00750139|592982852|FG000|Overall Study|Termination by sponsor|4|||
164169320|NCT00750139|592982853|FG001|Overall Study|Termination by sponsor|0|||
164169321|NCT00750139|592982854|FG002|Overall Study|Termination by sponsor|0|||
164169322|NCT00750139|592982855|FG003|Overall Study|Termination by sponsor|1|||
164169323|NCT00750139|592982852|FG000|Overall Study|Non-specific|62|||
164169324|NCT00750139|592982853|FG001|Overall Study|Non-specific|42|||
164169325|NCT00750139|592982854|FG002|Overall Study|Non-specific|79|||
164169326|NCT00750139|592982855|FG003|Overall Study|Non-specific|33|||
164169327|NCT00586820|592982861|FG000|Overall Study|Unsuccessful PCI|1|||
164169328|NCT00586820|592982862|FG001|Overall Study|Unsuccessful PCI|0|||
164169329|NCT02073929|592982863|FG000|Overall Study|Lost to Follow-up|2|||
164169330|NCT02073929|592982864|FG001|Overall Study|Lost to Follow-up|1|||
164169331|NCT02073929|592982863|FG000|Overall Study|Adverse Event|2|||
164169332|NCT02073929|592982864|FG001|Overall Study|Adverse Event|1|||
164169333|NCT02073929|592982863|FG000|Overall Study|Withdrawal by Subject|0|||
164169334|NCT02073929|592982864|FG001|Overall Study|Withdrawal by Subject|1|||
164169335|NCT00430573|592982865|FG000|Overall Study|Withdrawal by Subject|5|||
164169336|NCT01483027|592982866|FG000|Overall Study|Administrative Reasons|2|||
164169337|NCT01483027|592982867|FG001|Overall Study|Administrative Reasons|1|||
164169338|NCT01483027|592982866|FG000|Overall Study|Withdrawal by Subject|21|||
164169339|NCT01483027|592982867|FG001|Overall Study|Withdrawal by Subject|32|||
164169340|NCT01483027|592982866|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
164169341|NCT01483027|592982867|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
164169342|NCT01483027|592982866|FG000|Overall Study|Lost to Follow-up|1|||
164169343|NCT01483027|592982867|FG001|Overall Study|Lost to Follow-up|1|||
164169344|NCT01483027|592982866|FG000|Overall Study|Adverse Event|0|||
164169345|NCT01483027|592982867|FG001|Overall Study|Adverse Event|1|||
164169346|NCT01483027|592982866|FG000|Overall Study|Withdrawal by Subject|0|||
164169347|NCT01483027|592982867|FG001|Overall Study|Withdrawal by Subject|1|||
164169348|NCT01936181|592984971|FG000|Randomised, Double-blind|Adverse Event|27|||
164169349|NCT01936181|592984972|FG001|Randomised, Double-blind|Adverse Event|21|||
164169350|NCT01936181|592984973|FG002|Randomised, Double-blind|Adverse Event|0|||
164169351|NCT01936181|592984974|FG003|Randomised, Double-blind|Adverse Event|0|||
164169352|NCT01936181|592984971|FG000|Randomised, Double-blind|Protocol Violation|1|||
164169353|NCT01936181|592984972|FG001|Randomised, Double-blind|Protocol Violation|5|||
164169354|NCT01936181|592984973|FG002|Randomised, Double-blind|Protocol Violation|0|||
164169355|NCT01936181|592984974|FG003|Randomised, Double-blind|Protocol Violation|0|||
164169356|NCT01936181|592984971|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
164169357|NCT01936181|592984972|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
164169358|NCT01936181|592984973|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
164169359|NCT01936181|592984974|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
164169360|NCT01936181|592984971|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
164169361|NCT01936181|592984972|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
164169362|NCT01936181|592984973|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
164169363|NCT01936181|592984974|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
164169364|NCT01936181|592984971|FG000|Randomised, Double-blind|Pregnancy|0|||
164169365|NCT01936181|592984972|FG001|Randomised, Double-blind|Pregnancy|1|||
164169366|NCT01936181|592984973|FG002|Randomised, Double-blind|Pregnancy|0|||
164169367|NCT01936181|592984974|FG003|Randomised, Double-blind|Pregnancy|0|||
164169368|NCT01936181|592984971|FG000|Randomised, Double-blind|Physician Decision|4|||
164169369|NCT01936181|592984972|FG001|Randomised, Double-blind|Physician Decision|4|||
164169370|NCT01936181|592984973|FG002|Randomised, Double-blind|Physician Decision|0|||
164169371|NCT01936181|592984974|FG003|Randomised, Double-blind|Physician Decision|0|||
164169372|NCT01936181|592984971|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
164169373|NCT01936181|592984972|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
164169374|NCT01936181|592984973|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
164169375|NCT01936181|592984974|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
164169376|NCT01936181|592984971|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
164169377|NCT01936181|592984972|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
164169378|NCT01936181|592984973|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
164169379|NCT01936181|592984974|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
164169380|NCT01936181|592984971|FG000|Transition-extension|Adverse Event|3|||
164169381|NCT01936181|592984972|FG001|Transition-extension|Adverse Event|0|||
164169382|NCT01936181|592984973|FG002|Transition-extension|Adverse Event|3|||
164169383|NCT01936181|592984974|FG003|Transition-extension|Adverse Event|1|||
164169384|NCT01936181|592984971|FG000|Transition-extension|Lost to Follow-up|3|||
164169385|NCT01936181|592984972|FG001|Transition-extension|Lost to Follow-up|0|||
164169386|NCT01936181|592984973|FG002|Transition-extension|Lost to Follow-up|1|||
164169387|NCT01936181|592984974|FG003|Transition-extension|Lost to Follow-up|2|||
164169388|NCT01936181|592984971|FG000|Transition-extension|Physician Decision|2|||
164169389|NCT01936181|592984972|FG001|Transition-extension|Physician Decision|0|||
164169390|NCT01936181|592984973|FG002|Transition-extension|Physician Decision|0|||
164169391|NCT01936181|592984974|FG003|Transition-extension|Physician Decision|1|||
164169392|NCT01936181|592984971|FG000|Transition-extension|Withdrawal by Subject|7|||
164169393|NCT01936181|592984972|FG001|Transition-extension|Withdrawal by Subject|0|||
164169394|NCT01936181|592984973|FG002|Transition-extension|Withdrawal by Subject|2|||
164169395|NCT01936181|592984974|FG003|Transition-extension|Withdrawal by Subject|1|||
164169396|NCT01346189|592984975|FG000|Overall Study|Withdrawal by Subject|7|||
164169397|NCT01346189|592984976|FG001|Overall Study|Withdrawal by Subject|5|||
164169398|NCT01346189|592984977|FG002|Overall Study|Withdrawal by Subject|3|||
164169399|NCT01346189|592984978|FG003|Overall Study|Withdrawal by Subject|5|||
164169400|NCT01346189|592984975|FG000|Overall Study|Physician Decision|4|||
164169401|NCT01346189|592984976|FG001|Overall Study|Physician Decision|0|||
164169402|NCT01346189|592984977|FG002|Overall Study|Physician Decision|0|||
164169403|NCT01346189|592984978|FG003|Overall Study|Physician Decision|0|||
164169404|NCT01346189|592984975|FG000|Overall Study|Moved|3|||
164169405|NCT01346189|592984976|FG001|Overall Study|Moved|0|||
164169406|NCT01346189|592984977|FG002|Overall Study|Moved|4|||
164169407|NCT01346189|592984978|FG003|Overall Study|Moved|0|||
164169408|NCT01346189|592984975|FG000|Overall Study|Other|2|||
164169409|NCT01346189|592984976|FG001|Overall Study|Other|4|||
164169410|NCT01346189|592984977|FG002|Overall Study|Other|7|||
164169411|NCT01346189|592984978|FG003|Overall Study|Other|3|||
164169412|NCT01346189|592984975|FG000|Overall Study|Death|0|||
164169413|NCT01346189|592984976|FG001|Overall Study|Death|3|||
164169414|NCT01346189|592984977|FG002|Overall Study|Death|0|||
164169415|NCT01346189|592984978|FG003|Overall Study|Death|0|||
164169416|NCT01346189|592984975|FG000|Overall Study|Non-health system primary care physician|0|||
164169417|NCT01346189|592984976|FG001|Overall Study|Non-health system primary care physician|5|||
164169418|NCT01346189|592984977|FG002|Overall Study|Non-health system primary care physician|0|||
164169419|NCT01346189|592984978|FG003|Overall Study|Non-health system primary care physician|0|||
164169420|NCT01346189|592984975|FG000|Overall Study|Travel|0|||
164169421|NCT01346189|592984976|FG001|Overall Study|Travel|0|||
164169422|NCT01346189|592984977|FG002|Overall Study|Travel|0|||
164169423|NCT01346189|592984978|FG003|Overall Study|Travel|3|||
164169424|NCT00900757|592984979|FG000|Overall Study|screen failure|19|||
164169425|NCT01014988|592984984|FG000|Overall Study|Adverse Event|20|||
164169426|NCT01014988|592984985|FG001|Overall Study|Adverse Event|0|||
164169427|NCT01014988|592984986|FG002|Overall Study|Adverse Event|1|||
164169428|NCT01014988|592984987|FG003|Overall Study|Adverse Event|0|||
164169429|NCT01014988|592984988|FG004|Overall Study|Adverse Event|1|||
164169430|NCT01014988|592984989|FG005|Overall Study|Adverse Event|3|||
164169431|NCT01014988|592984984|FG000|Overall Study|Lost to Follow-up|1|||
164169432|NCT01014988|592984985|FG001|Overall Study|Lost to Follow-up|0|||
164169433|NCT01014988|592984986|FG002|Overall Study|Lost to Follow-up|1|||
164169434|NCT01014988|592984987|FG003|Overall Study|Lost to Follow-up|0|||
164169435|NCT01014988|592984988|FG004|Overall Study|Lost to Follow-up|0|||
164169436|NCT01014988|592984989|FG005|Overall Study|Lost to Follow-up|0|||
164169437|NCT01014988|592984984|FG000|Overall Study|Physician Decision|1|||
164169438|NCT01014988|592984985|FG001|Overall Study|Physician Decision|0|||
164169439|NCT01014988|592984986|FG002|Overall Study|Physician Decision|0|||
164169440|NCT01014988|592984987|FG003|Overall Study|Physician Decision|0|||
164169441|NCT01014988|592984988|FG004|Overall Study|Physician Decision|0|||
164169442|NCT01014988|592984989|FG005|Overall Study|Physician Decision|0|||
164169443|NCT01014988|592984984|FG000|Overall Study|Withdrawal by Subject|1|||
164169444|NCT01014988|592984985|FG001|Overall Study|Withdrawal by Subject|0|||
164169445|NCT01014988|592984986|FG002|Overall Study|Withdrawal by Subject|0|||
164169446|NCT01014988|592984987|FG003|Overall Study|Withdrawal by Subject|0|||
164169447|NCT01014988|592984988|FG004|Overall Study|Withdrawal by Subject|0|||
164169448|NCT01014988|592984989|FG005|Overall Study|Withdrawal by Subject|0|||
164169449|NCT05835011|592984990|FG000|Overall Study|Study Terminated by the Sponsor|1|||
164169450|NCT05835011|592984990|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
164169451|NCT01683266|592984991|FG000|Overall Study|Adverse Event|5|||
164169452|NCT01683266|592984992|FG001|Overall Study|Adverse Event|4|||
164169453|NCT01683266|592984991|FG000|Overall Study|Lack of Efficacy|5|||
164169454|NCT01683266|592984992|FG001|Overall Study|Lack of Efficacy|2|||
164169455|NCT01683266|592984991|FG000|Overall Study|Protocol Violation|13|||
164169456|NCT01683266|592984992|FG001|Overall Study|Protocol Violation|6|||
164169457|NCT01683266|592984991|FG000|Overall Study|Personal Reason|17|||
164169458|NCT01683266|592984992|FG001|Overall Study|Personal Reason|25|||
164169679|NCT02738879|592985026|FG000|Overall Study|Screen Failure|1|||
164169459|NCT01683266|592984991|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
164169460|NCT01683266|592984992|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
164169461|NCT01683266|592984991|FG000|Overall Study|Lost to Follow-up|5|||
164169462|NCT01683266|592984992|FG001|Overall Study|Lost to Follow-up|0|||
164169463|NCT01683266|592984991|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
164169464|NCT01683266|592984992|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
164169465|NCT01683266|592984991|FG000|Overall Study|Nonserious Hypoglycemia|0|||
164169466|NCT01683266|592984992|FG001|Overall Study|Nonserious Hypoglycemia|3|||
164169467|NCT01683266|592984991|FG000|Overall Study|Perceived Lack of Efficacy|1|||
164169468|NCT01683266|592984992|FG001|Overall Study|Perceived Lack of Efficacy|1|||
164169469|NCT01683266|592984991|FG000|Overall Study|Possibly Hypoglycemia|1|||
164169470|NCT01683266|592984992|FG001|Overall Study|Possibly Hypoglycemia|0|||
164169471|NCT01683266|592984991|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
164169472|NCT01683266|592984992|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
164169473|NCT02222545|592984993|FG000|Overall Study|Adverse Event|1|||
164169474|NCT02222545|592984994|FG001|Overall Study|Adverse Event|0|||
164169475|NCT02222545|592984995|FG002|Overall Study|Adverse Event|2|||
164169476|NCT02222545|592984993|FG000|Overall Study|Death|0|||
164169477|NCT02222545|592984994|FG001|Overall Study|Death|0|||
164169478|NCT02222545|592984995|FG002|Overall Study|Death|9|||
164169479|NCT02222545|592984993|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
164169480|NCT02222545|592984994|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
164169481|NCT02222545|592984995|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
164169482|NCT02222545|592984993|FG000|Overall Study|Withdrawal by Subject|0|||
164169483|NCT02222545|592984994|FG001|Overall Study|Withdrawal by Subject|0|||
164169484|NCT02222545|592984995|FG002|Overall Study|Withdrawal by Subject|3|||
164169485|NCT02222545|592984993|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
164169486|NCT02222545|592984994|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
164169487|NCT02222545|592984995|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
164169488|NCT00090220|592984996|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
164169489|NCT00090220|592984997|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
164169490|NCT00090220|592984998|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169491|NCT00090220|592984999|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169492|NCT00090220|592985000|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169493|NCT00090220|592985001|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
164169494|NCT00090220|592984996|FG000|Base Study Vaccination Period|Adverse Event|6|||
164169495|NCT00090220|592984997|FG001|Base Study Vaccination Period|Adverse Event|1|||
164169496|NCT00090220|592984998|FG002|Base Study Vaccination Period|Adverse Event|0|||
164169497|NCT00090220|592984999|FG003|Base Study Vaccination Period|Adverse Event|0|||
164169498|NCT00090220|592985000|FG004|Base Study Vaccination Period|Adverse Event|0|||
164169499|NCT00090220|592985001|FG005|Base Study Vaccination Period|Adverse Event|0|||
164169500|NCT00090220|592984996|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
164169501|NCT00090220|592984997|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
164169502|NCT00090220|592984998|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
164169503|NCT00090220|592984999|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
164169504|NCT00090220|592985000|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
164169505|NCT00090220|592985001|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
164169506|NCT00090220|592984996|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
164169507|NCT00090220|592984997|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
164169508|NCT00090220|592984998|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169509|NCT00090220|592984999|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169510|NCT00090220|592985000|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169511|NCT00090220|592985001|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
164169512|NCT00090220|592984996|FG000|Base Study Vaccination Period|Patient Moved|6|||
164169513|NCT00090220|592984997|FG001|Base Study Vaccination Period|Patient Moved|2|||
164169514|NCT00090220|592984998|FG002|Base Study Vaccination Period|Patient Moved|0|||
164169515|NCT00090220|592984999|FG003|Base Study Vaccination Period|Patient Moved|0|||
164169516|NCT00090220|592985000|FG004|Base Study Vaccination Period|Patient Moved|0|||
164169517|NCT00090220|592985001|FG005|Base Study Vaccination Period|Patient Moved|0|||
164169518|NCT00090220|592984996|FG000|Base Study Vaccination Period|Other|4|||
164169519|NCT00090220|592984997|FG001|Base Study Vaccination Period|Other|4|||
164169520|NCT00090220|592984998|FG002|Base Study Vaccination Period|Other|0|||
164169521|NCT00090220|592984999|FG003|Base Study Vaccination Period|Other|0|||
164169522|NCT00090220|592985000|FG004|Base Study Vaccination Period|Other|0|||
164169523|NCT00090220|592985001|FG005|Base Study Vaccination Period|Other|0|||
164169524|NCT00090220|592984996|FG000|Base Study Follow-up Period|Adverse Event|6|||
164169525|NCT00090220|592984997|FG001|Base Study Follow-up Period|Adverse Event|1|||
164169526|NCT00090220|592984998|FG002|Base Study Follow-up Period|Adverse Event|0|||
164169527|NCT00090220|592984999|FG003|Base Study Follow-up Period|Adverse Event|0|||
164169528|NCT00090220|592985000|FG004|Base Study Follow-up Period|Adverse Event|0|||
164169529|NCT00090220|592985001|FG005|Base Study Follow-up Period|Adverse Event|0|||
164169530|NCT00090220|592984996|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
164169531|NCT00090220|592984997|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
164169532|NCT00090220|592984998|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
164169533|NCT00090220|592984999|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
164169534|NCT00090220|592985000|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
164169535|NCT00090220|592985001|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
164169536|NCT00090220|592984996|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
164169537|NCT00090220|592984997|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
164169538|NCT00090220|592984998|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169539|NCT00090220|592984999|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169540|NCT00090220|592985000|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169541|NCT00090220|592985001|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
164169542|NCT00090220|592984996|FG000|Base Study Follow-up Period|Patient Moved|20|||
164169543|NCT00090220|592984997|FG001|Base Study Follow-up Period|Patient Moved|28|||
164169544|NCT00090220|592984998|FG002|Base Study Follow-up Period|Patient Moved|0|||
164169545|NCT00090220|592984999|FG003|Base Study Follow-up Period|Patient Moved|0|||
164169546|NCT00090220|592985000|FG004|Base Study Follow-up Period|Patient Moved|0|||
164169547|NCT00090220|592985001|FG005|Base Study Follow-up Period|Patient Moved|0|||
164169548|NCT00090220|592984996|FG000|Base Study Follow-up Period|Other|19|||
164169549|NCT00090220|592984997|FG001|Base Study Follow-up Period|Other|21|||
164169550|NCT00090220|592984998|FG002|Base Study Follow-up Period|Other|0|||
164169551|NCT00090220|592984999|FG003|Base Study Follow-up Period|Other|0|||
164169552|NCT00090220|592985000|FG004|Base Study Follow-up Period|Other|0|||
164169553|NCT00090220|592985001|FG005|Base Study Follow-up Period|Other|0|||
164169554|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Adverse Event|0|||
164169555|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Adverse Event|0|||
164169556|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Adverse Event|4|||
164169557|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Adverse Event|0|||
164169558|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Adverse Event|0|||
164169559|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Adverse Event|0|||
164169560|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169561|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169562|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
164169563|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169564|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169565|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
164169566|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Moved|0|||
164169567|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Moved|0|||
164169568|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Moved|2|||
164169569|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Moved|1|||
164169570|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Moved|0|||
164169571|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Moved|0|||
164169572|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169573|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169574|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
164169575|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169576|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169577|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
164169578|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
164169579|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
164169580|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
164169581|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
164169582|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
164169583|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
164169584|NCT00090220|592984996|FG000|Extension 1 (EXT1)|Other reason|0|||
164169585|NCT00090220|592984997|FG001|Extension 1 (EXT1)|Other reason|0|||
164169586|NCT00090220|592984998|FG002|Extension 1 (EXT1)|Other reason|2|||
164169587|NCT00090220|592984999|FG003|Extension 1 (EXT1)|Other reason|0|||
164169588|NCT00090220|592985000|FG004|Extension 1 (EXT1)|Other reason|0|||
164169589|NCT00090220|592985001|FG005|Extension 1 (EXT1)|Other reason|0|||
164169590|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169591|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169592|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169593|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
164169594|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
164169595|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
164169596|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Death|0|||
164169597|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Death|0|||
164169598|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Death|0|||
164169599|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Death|0|||
164169600|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Death|1|||
164169601|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Death|1|||
164169602|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169603|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169604|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169605|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
164169606|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
164169607|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
164169608|NCT00090220|592984996|FG000|Long-term Follow-up (EXT2)|Other|0|||
164169609|NCT00090220|592984997|FG001|Long-term Follow-up (EXT2)|Other|0|||
164169610|NCT00090220|592984998|FG002|Long-term Follow-up (EXT2)|Other|0|||
164169611|NCT00090220|592984999|FG003|Long-term Follow-up (EXT2)|Other|0|||
164169612|NCT00090220|592985000|FG004|Long-term Follow-up (EXT2)|Other|1|||
164169613|NCT00090220|592985001|FG005|Long-term Follow-up (EXT2)|Other|0|||
164169614|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
164169615|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
164169616|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
164169617|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
164169618|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
164169619|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169620|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169621|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169622|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
164169623|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
164169624|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
164169625|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
164169626|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
164169627|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
164169628|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
164169629|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Death|0|||
164169630|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Death|0|||
164169631|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Death|1|||
164169632|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Death|2|||
164169633|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Death|7|||
164169634|NCT00941863|592985002|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
164169635|NCT00941863|592985003|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
164169636|NCT00941863|592985004|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
164169637|NCT00941863|592985005|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
164169638|NCT00941863|592985006|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
164169639|NCT00941863|592985002|FG000|Continued After PCD|Withdrawal by Subject|0|||
164169640|NCT00941863|592985003|FG001|Continued After PCD|Withdrawal by Subject|0|||
164169641|NCT00941863|592985004|FG002|Continued After PCD|Withdrawal by Subject|0|||
164169642|NCT00941863|592985005|FG003|Continued After PCD|Withdrawal by Subject|0|||
164169643|NCT00941863|592985006|FG004|Continued After PCD|Withdrawal by Subject|1|||
164169644|NCT00941863|592985002|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169645|NCT00941863|592985003|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169646|NCT00941863|592985004|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169647|NCT00941863|592985005|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
164169648|NCT00941863|592985006|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
164169649|NCT02651155|592985007|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
164169650|NCT02651155|592985008|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
164169651|NCT02651155|592985007|FG000|Overall Study|Voluntary Withdrawal|5|||
164169652|NCT02651155|592985008|FG001|Overall Study|Voluntary Withdrawal|0|||
164169653|NCT04016779|592985012|FG000|Overall Study|Adverse Event|9|||
164169654|NCT04016779|592985013|FG001|Overall Study|Adverse Event|17|||
164169655|NCT04016779|592985012|FG000|Overall Study|Lack of Efficacy|4|||
164169656|NCT04016779|592985013|FG001|Overall Study|Lack of Efficacy|1|||
164169657|NCT04016779|592985012|FG000|Overall Study|Lost to Follow-up|5|||
164169658|NCT04016779|592985013|FG001|Overall Study|Lost to Follow-up|14|||
164169659|NCT04016779|592985012|FG000|Overall Study|Physician Decision|1|||
164169660|NCT04016779|592985013|FG001|Overall Study|Physician Decision|3|||
164169661|NCT04016779|592985012|FG000|Overall Study|Withdrawal by Subject|6|||
164169662|NCT04016779|592985013|FG001|Overall Study|Withdrawal by Subject|8|||
164169663|NCT04016779|592985012|FG000|Overall Study|Non-compliance with Study Drug|2|||
164169664|NCT04016779|592985013|FG001|Overall Study|Non-compliance with Study Drug|3|||
164169665|NCT04016779|592985012|FG000|Overall Study|Other, Multiple categories|17|||
164169666|NCT04016779|592985013|FG001|Overall Study|Other, Multiple categories|17|||
164169667|NCT02738879|592985026|FG000|Overall Study|Adverse Event|1|||
164169668|NCT02738879|592985027|FG001|Overall Study|Adverse Event|1|||
164169669|NCT02738879|592985026|FG000|Overall Study|Death|0|||
164169670|NCT02738879|592985027|FG001|Overall Study|Death|2|||
164169671|NCT02738879|592985026|FG000|Overall Study|Lost to Follow-up|1|||
164169672|NCT02738879|592985027|FG001|Overall Study|Lost to Follow-up|5|||
164169673|NCT02738879|592985026|FG000|Overall Study|Protocol Violation|1|||
164169674|NCT02738879|592985027|FG001|Overall Study|Protocol Violation|3|||
164169675|NCT02738879|592985026|FG000|Overall Study|Physician Decision|3|||
164169676|NCT02738879|592985027|FG001|Overall Study|Physician Decision|4|||
164169677|NCT02738879|592985026|FG000|Overall Study|Pregnancy|0|||
164169678|NCT02738879|592985027|FG001|Overall Study|Pregnancy|1|||
164169680|NCT02738879|592985027|FG001|Overall Study|Screen Failure|2|||
164169681|NCT02738879|592985026|FG000|Overall Study|Site Discontinued Study Participation|1|||
164169682|NCT02738879|592985027|FG001|Overall Study|Site Discontinued Study Participation|0|||
164169683|NCT02738879|592985026|FG000|Overall Study|Withdrawal by Subject|5|||
164169684|NCT02738879|592985027|FG001|Overall Study|Withdrawal by Subject|7|||
164169685|NCT00890084|592985028|FG000|Overall Study|Adverse Event|16|||
164169686|NCT00890084|592985028|FG000|Overall Study|Lost to Follow-up|126|||
164169687|NCT04143594|592985033|FG000|Overall Study|Withdrew consent|3|||
164169688|NCT04143594|592985034|FG001|Overall Study|Withdrew consent|10|||
164169689|NCT04143594|592985035|FG002|Overall Study|Withdrew consent|3|||
164169690|NCT04143594|592985036|FG003|Overall Study|Withdrew consent|1|||
164169691|NCT04143594|592985033|FG000|Overall Study|Lost to Follow-up|3|||
164169692|NCT04143594|592985034|FG001|Overall Study|Lost to Follow-up|5|||
164169693|NCT04143594|592985035|FG002|Overall Study|Lost to Follow-up|11|||
164169694|NCT04143594|592985036|FG003|Overall Study|Lost to Follow-up|0|||
164169695|NCT04143594|592985033|FG000|Overall Study|Investigator's discretion|2|||
164169696|NCT04143594|592985034|FG001|Overall Study|Investigator's discretion|2|||
164169697|NCT04143594|592985035|FG002|Overall Study|Investigator's discretion|0|||
164169698|NCT04143594|592985036|FG003|Overall Study|Investigator's discretion|0|||
164169699|NCT04143594|592985033|FG000|Overall Study|Randomized but never treated|0|||
164169700|NCT04143594|592985034|FG001|Overall Study|Randomized but never treated|0|||
164169701|NCT04143594|592985035|FG002|Overall Study|Randomized but never treated|0|||
164169702|NCT04143594|592985036|FG003|Overall Study|Randomized but never treated|1|||
164169703|NCT04143594|592985033|FG000|Overall Study|Death|1|||
164169704|NCT04143594|592985034|FG001|Overall Study|Death|0|||
164169705|NCT04143594|592985035|FG002|Overall Study|Death|1|||
164169706|NCT04143594|592985036|FG003|Overall Study|Death|0|||
164169707|NCT04143594|592985033|FG000|Overall Study|Adverse Event|1|||
164169708|NCT04143594|592985034|FG001|Overall Study|Adverse Event|0|||
164169709|NCT04143594|592985035|FG002|Overall Study|Adverse Event|0|||
164169710|NCT04143594|592985036|FG003|Overall Study|Adverse Event|0|||
164169711|NCT04143594|592985033|FG000|Overall Study|Pregnancy|0|||
164169712|NCT04143594|592985034|FG001|Overall Study|Pregnancy|0|||
164169713|NCT04143594|592985035|FG002|Overall Study|Pregnancy|1|||
164169714|NCT04143594|592985036|FG003|Overall Study|Pregnancy|0|||
164169715|NCT04143594|592985033|FG000|Overall Study|Lack of Efficacy|1|||
164169716|NCT04143594|592985034|FG001|Overall Study|Lack of Efficacy|1|||
164169717|NCT04143594|592985035|FG002|Overall Study|Lack of Efficacy|0|||
164169718|NCT04143594|592985036|FG003|Overall Study|Lack of Efficacy|0|||
164169719|NCT01023256|592985039|FG000|Overall Study|Protocol Violation|2|||
164169720|NCT01023256|592985040|FG001|Overall Study|Protocol Violation|3|||
164169721|NCT01023256|592985041|FG002|Overall Study|Protocol Violation|0|||
164169722|NCT01023256|592985042|FG003|Overall Study|Protocol Violation|0|||
164169723|NCT01023256|592985039|FG000|Overall Study|Randomized but not treated|1|||
164169724|NCT01023256|592985040|FG001|Overall Study|Randomized but not treated|0|||
164169725|NCT01023256|592985041|FG002|Overall Study|Randomized but not treated|1|||
164169726|NCT01023256|592985042|FG003|Overall Study|Randomized but not treated|0|||
164169727|NCT01023256|592985039|FG000|Overall Study|Other|1|||
164169728|NCT01023256|592985040|FG001|Overall Study|Other|0|||
164169729|NCT01023256|592985041|FG002|Overall Study|Other|0|||
164169730|NCT01023256|592985042|FG003|Overall Study|Other|2|||
164169731|NCT01023256|592985039|FG000|Overall Study|Adverse Event|0|||
164169732|NCT01023256|592985040|FG001|Overall Study|Adverse Event|0|||
164169733|NCT01023256|592985041|FG002|Overall Study|Adverse Event|0|||
164169734|NCT01023256|592985042|FG003|Overall Study|Adverse Event|1|||
164169735|NCT01023256|592985039|FG000|Overall Study|Withdrawal by Subject|0|||
164169736|NCT01023256|592985040|FG001|Overall Study|Withdrawal by Subject|0|||
164169737|NCT01023256|592985041|FG002|Overall Study|Withdrawal by Subject|0|||
164169738|NCT01023256|592985042|FG003|Overall Study|Withdrawal by Subject|2|||
164169739|NCT03089697|592985043|FG000|Overall Study|Adverse Event|1|||
164169740|NCT03089697|592985044|FG001|Overall Study|Adverse Event|2|||
164169741|NCT03089697|592985043|FG000|Overall Study|Withdrawal by Subject|1|||
164169742|NCT03089697|592985044|FG001|Overall Study|Withdrawal by Subject|0|||
164169743|NCT00638443|592985045|FG000|First Intervention|Adverse Event|2|||
164169744|NCT00638443|592985046|FG001|First Intervention|Adverse Event|1|||
164169745|NCT01044290|592985047|FG000|Follow-up 1|Death|3|||
164169746|NCT01044290|592985048|FG001|Follow-up 1|Death|3|||
164169747|NCT01044290|592985049|FG002|Follow-up 1|Death|1|||
164169748|NCT01044290|592985047|FG000|Follow-up 1|Withdrawal by Subject|2|||
164169749|NCT01044290|592985048|FG001|Follow-up 1|Withdrawal by Subject|2|||
164169750|NCT01044290|592985049|FG002|Follow-up 1|Withdrawal by Subject|0|||
164169751|NCT01044290|592985047|FG000|Follow-Up 2|Death|0|||
164169752|NCT01044290|592985048|FG001|Follow-Up 2|Death|1|||
164169753|NCT01044290|592985049|FG002|Follow-Up 2|Death|1|||
164169754|NCT01044290|592985047|FG000|Follow-Up 2|Withdrawal by Subject|0|||
164169755|NCT01044290|592985048|FG001|Follow-Up 2|Withdrawal by Subject|1|||
164169756|NCT01044290|592985049|FG002|Follow-Up 2|Withdrawal by Subject|1|||
164169757|NCT01967706|592985052|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
164169758|NCT01967706|592985053|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
164169759|NCT01967706|592985054|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
164169760|NCT01967706|592985055|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
164169761|NCT01154088|592985056|FG000|Overall Study|Lost to Follow-up|4|||
164169762|NCT01154088|592985057|FG001|Overall Study|Lost to Follow-up|6|||
164169763|NCT01154088|592985058|FG002|Overall Study|Lost to Follow-up|7|||
164169764|NCT00282113|592985062|FG000|Overall Study|Removed at parents request|1|||
164169765|NCT00282113|592985063|FG001|Overall Study|Removed at parents request|0|||
164169766|NCT00282113|592985064|FG002|Overall Study|Removed at parents request|0|||
164169767|NCT03382834|592985065|FG000|Step 1|Lost to Follow-up|0|||
164169768|NCT03382834|592985066|FG001|Step 1|Lost to Follow-up|1|||
164169769|NCT03382834|592985065|FG000|Step 2|Death|1|||
164169770|NCT03382834|592985066|FG001|Step 2|Death|0|||
164169771|NCT03382834|592985065|FG000|Step 2|Lost to Follow-up|2|||
164169772|NCT03382834|592985066|FG001|Step 2|Lost to Follow-up|2|||
164169773|NCT03382834|592985065|FG000|Step 2|Site Terminated by Sponsor|1|||
164169774|NCT03382834|592985066|FG001|Step 2|Site Terminated by Sponsor|0|||
164169775|NCT02949843|592985067|FG000|Overall Study|Withdrawal by Subject|0|||
164169776|NCT02949843|592985068|FG001|Overall Study|Withdrawal by Subject|1|||
164169777|NCT02949843|592985069|FG002|Overall Study|Withdrawal by Subject|1|||
164169778|NCT02783729|592985073|FG000|Overall Study|Lack of Efficacy|1|||
164169779|NCT02783729|592985074|FG001|Overall Study|Lack of Efficacy|0|||
164169780|NCT02783729|592985075|FG002|Overall Study|Lack of Efficacy|0|||
164169781|NCT02783729|592985076|FG003|Overall Study|Lack of Efficacy|0|||
164169782|NCT02783729|592985073|FG000|Overall Study|Adverse Event|2|||
164169783|NCT02783729|592985074|FG001|Overall Study|Adverse Event|6|||
164169784|NCT02783729|592985075|FG002|Overall Study|Adverse Event|2|||
164169785|NCT02783729|592985076|FG003|Overall Study|Adverse Event|3|||
164169786|NCT02783729|592985073|FG000|Overall Study|Other|1|||
164169787|NCT02783729|592985074|FG001|Overall Study|Other|6|||
164169788|NCT02783729|592985075|FG002|Overall Study|Other|2|||
164169789|NCT02783729|592985076|FG003|Overall Study|Other|3|||
164169790|NCT02783729|592985073|FG000|Overall Study|Withdrawal by Subject|2|||
164169791|NCT02783729|592985074|FG001|Overall Study|Withdrawal by Subject|3|||
164169792|NCT02783729|592985075|FG002|Overall Study|Withdrawal by Subject|1|||
164169793|NCT02783729|592985076|FG003|Overall Study|Withdrawal by Subject|2|||
164169794|NCT02783729|592985073|FG000|Overall Study|Participant's choice|2|||
164169795|NCT02783729|592985074|FG001|Overall Study|Participant's choice|1|||
164169796|NCT02783729|592985075|FG002|Overall Study|Participant's choice|2|||
164169797|NCT02783729|592985076|FG003|Overall Study|Participant's choice|1|||
164169798|NCT02783729|592985073|FG000|Overall Study|Lost to Follow-up|2|||
164169799|NCT02783729|592985074|FG001|Overall Study|Lost to Follow-up|1|||
164169800|NCT02783729|592985075|FG002|Overall Study|Lost to Follow-up|1|||
164169801|NCT02783729|592985076|FG003|Overall Study|Lost to Follow-up|0|||
164169802|NCT02693171|592985078|FG000|Overall Study|Adverse Event|1|||
164169803|NCT02693171|592985078|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
164169804|NCT00319592|592985079|FG000|Overall Study|Protocol Violation|1|||
164169805|NCT00319592|592985080|FG001|Overall Study|Protocol Violation|0|||
164169806|NCT00319592|592985079|FG000|Overall Study|Physician Decision|0|||
164169807|NCT00319592|592985080|FG001|Overall Study|Physician Decision|1|||
164169808|NCT00658775|592985083|FG000|Overall Study|Adverse Event|4|||
164169809|NCT00658775|592985084|FG001|Overall Study|Adverse Event|6|||
164169810|NCT00658775|592985083|FG000|Overall Study|Lost to Follow-up|17|||
164169811|NCT00658775|592985084|FG001|Overall Study|Lost to Follow-up|18|||
164169812|NCT00658775|592985083|FG000|Overall Study|Withdrawal by Subject|6|||
164169813|NCT00658775|592985084|FG001|Overall Study|Withdrawal by Subject|4|||
164169814|NCT00658775|592985083|FG000|Overall Study|Withdrawal of consent|8|||
164169815|NCT00658775|592985084|FG001|Overall Study|Withdrawal of consent|7|||
164169816|NCT00658775|592985083|FG000|Overall Study|Other|7|||
164169817|NCT00658775|592985084|FG001|Overall Study|Other|8|||
164169818|NCT03085238|592985085|FG000|Overall Study|Adverse Event|2|||
164169819|NCT03085238|592985085|FG000|Overall Study|Death|2|||
164169820|NCT01992653|592985088|FG000|Overall Study|Death|0|||
164169821|NCT01992653|592985089|FG001|Overall Study|Death|0|||
164169822|NCT01992653|592985090|FG002|Overall Study|Death|1|||
164169823|NCT01992653|592985091|FG003|Overall Study|Death|0|||
164169824|NCT01992653|592985092|FG004|Overall Study|Death|1|||
164169825|NCT01992653|592985093|FG005|Overall Study|Death|0|||
164169826|NCT01992653|592985094|FG006|Overall Study|Death|4|||
164169827|NCT01992653|592985095|FG007|Overall Study|Death|2|||
164169828|NCT01992653|592985088|FG000|Overall Study|Lost to Follow-up|0|||
164169829|NCT01992653|592985089|FG001|Overall Study|Lost to Follow-up|0|||
164169830|NCT01992653|592985090|FG002|Overall Study|Lost to Follow-up|0|||
164169831|NCT01992653|592985091|FG003|Overall Study|Lost to Follow-up|0|||
164169832|NCT01992653|592985092|FG004|Overall Study|Lost to Follow-up|0|||
164169833|NCT01992653|592985093|FG005|Overall Study|Lost to Follow-up|0|||
164169834|NCT01992653|592985094|FG006|Overall Study|Lost to Follow-up|0|||
164169835|NCT01992653|592985095|FG007|Overall Study|Lost to Follow-up|1|||
164169836|NCT01992653|592985088|FG000|Overall Study|Study Completed|0|||
164169837|NCT01992653|592985089|FG001|Overall Study|Study Completed|0|||
164169838|NCT01992653|592985090|FG002|Overall Study|Study Completed|0|||
164169839|NCT01992653|592985091|FG003|Overall Study|Study Completed|0|||
164169840|NCT01992653|592985092|FG004|Overall Study|Study Completed|0|||
164169841|NCT01992653|592985093|FG005|Overall Study|Study Completed|0|||
164169842|NCT01992653|592985094|FG006|Overall Study|Study Completed|0|||
164169843|NCT01992653|592985095|FG007|Overall Study|Study Completed|1|||
164169844|NCT01992653|592985088|FG000|Overall Study|Disease Progression|0|||
164169845|NCT01992653|592985089|FG001|Overall Study|Disease Progression|0|||
164169846|NCT01992653|592985090|FG002|Overall Study|Disease Progression|0|||
164169847|NCT01992653|592985091|FG003|Overall Study|Disease Progression|0|||
164169848|NCT01992653|592985092|FG004|Overall Study|Disease Progression|0|||
164169849|NCT01992653|592985093|FG005|Overall Study|Disease Progression|0|||
164169850|NCT01992653|592985094|FG006|Overall Study|Disease Progression|4|||
164169851|NCT01992653|592985095|FG007|Overall Study|Disease Progression|0|||
164169852|NCT01435460|592985096|FG000|Overall Study|Adverse Event|2|||
164169853|NCT01435460|592985097|FG001|Overall Study|Adverse Event|1|||
164169854|NCT01435460|592985096|FG000|Overall Study|Lost to Follow-up|6|||
164169855|NCT01435460|592985097|FG001|Overall Study|Lost to Follow-up|1|||
164169856|NCT01435460|592985096|FG000|Overall Study|Withdrawal by Subject|1|||
164169857|NCT01435460|592985097|FG001|Overall Study|Withdrawal by Subject|3|||
164169858|NCT01435460|592985096|FG000|Overall Study|Protocol Violation|0|||
164169859|NCT01435460|592985097|FG001|Overall Study|Protocol Violation|1|||
164169860|NCT01435460|592985096|FG000|Overall Study|Did not meet eligibility criteria|2|||
164169861|NCT01435460|592985097|FG001|Overall Study|Did not meet eligibility criteria|0|||
164169862|NCT01706939|592985098|FG000|Pre Randomization|Screen Failure|1|||
164169863|NCT01706939|592985099|FG001|Pre Randomization|Screen Failure|0|||
164169864|NCT01706939|592985100|FG002|Pre Randomization|Screen Failure|0|||
164169865|NCT01706939|592985098|FG000|Pre Randomization|Ineligible for Randomization|1|||
164169866|NCT01706939|592985099|FG001|Pre Randomization|Ineligible for Randomization|0|||
164169867|NCT01706939|592985100|FG002|Pre Randomization|Ineligible for Randomization|0|||
164169868|NCT01706939|592985098|FG000|Pre Randomization|Withdrawal by Subject|1|||
164169869|NCT01706939|592985099|FG001|Pre Randomization|Withdrawal by Subject|0|||
164169870|NCT01706939|592985100|FG002|Pre Randomization|Withdrawal by Subject|0|||
164169871|NCT01706939|592985098|FG000|Randomization|Insufficient QoL survey compliance|0|||
164169872|NCT01706939|592985099|FG001|Randomization|Insufficient QoL survey compliance|1|||
164169873|NCT01706939|592985100|FG002|Randomization|Insufficient QoL survey compliance|1|||
164169874|NCT01706939|592985098|FG000|Randomization|Progression of disease|0|||
164169875|NCT01706939|592985099|FG001|Randomization|Progression of disease|2|||
164169876|NCT01706939|592985100|FG002|Randomization|Progression of disease|1|||
164169877|NCT01046903|592985101|FG000|Overall Study|Lost to Follow-up|16|||
164169878|NCT01046903|592985101|FG000|Overall Study|Adverse Event|4|||
164169879|NCT01046903|592985101|FG000|Overall Study|Withdrawal by Subject|3|||
164169880|NCT01046903|592985101|FG000|Overall Study|Other|5|||
164169881|NCT00977314|592985102|FG000|Overall Study|Withdrawal by Subject|1|||
164169882|NCT00977314|592985103|FG001|Overall Study|Withdrawal by Subject|0|||
164169883|NCT00977314|592985102|FG000|Overall Study|Physician Decision|1|||
164169884|NCT00977314|592985103|FG001|Overall Study|Physician Decision|0|||
164169885|NCT04463251|592985112|FG000|Overall Study|Death|1|||
164169886|NCT04463251|592985113|FG001|Overall Study|Death|0|||
164169887|NCT04463251|592985114|FG002|Overall Study|Death|1|||
164169888|NCT04463251|592985112|FG000|Overall Study|Adverse Event|0|||
164169889|NCT04463251|592985113|FG001|Overall Study|Adverse Event|1|||
164169890|NCT04463251|592985114|FG002|Overall Study|Adverse Event|0|||
164169891|NCT04463251|592985112|FG000|Overall Study|Lost to Follow-up|0|||
164169892|NCT04463251|592985113|FG001|Overall Study|Lost to Follow-up|1|||
164169893|NCT04463251|592985114|FG002|Overall Study|Lost to Follow-up|0|||
164169894|NCT04463251|592985112|FG000|Overall Study|Withdrawal by Subject|0|||
164169895|NCT04463251|592985113|FG001|Overall Study|Withdrawal by Subject|2|||
164169896|NCT04463251|592985114|FG002|Overall Study|Withdrawal by Subject|2|||
164169897|NCT05020665|592985115|FG000|Overall Study|Study terminated by Sponsor|5|||
164169898|NCT05020665|592985116|FG001|Overall Study|Study terminated by Sponsor|4|||
164169899|NCT05020665|592985115|FG000|Overall Study|Death|2|||
164169900|NCT05020665|592985116|FG001|Overall Study|Death|1|||
164169901|NCT05020665|592985115|FG000|Overall Study|Physician Decision|0|||
164169902|NCT05020665|592985116|FG001|Overall Study|Physician Decision|1|||
164169903|NCT05020665|592985115|FG000|Overall Study|Withdrawal by Subject|0|||
164169904|NCT05020665|592985116|FG001|Overall Study|Withdrawal by Subject|1|||
164169905|NCT05020665|592985115|FG000|Overall Study|Reason not specified|1|||
164169906|NCT05020665|592985116|FG001|Overall Study|Reason not specified|0|||
164169907|NCT01743560|592985121|FG000|Overall Study|Disease progression|26|||
164169908|NCT01743560|592985121|FG000|Overall Study|Adverse Event|8|||
164169909|NCT01743560|592985121|FG000|Overall Study|Death|3|||
164169910|NCT01743560|592985121|FG000|Overall Study|Withdrawal by Subject|2|||
164169911|NCT01743560|592985121|FG000|Overall Study|Protocol Violation|1|||
164169912|NCT01743560|592985121|FG000|Overall Study|>1 dose of study drug|3|||
164169913|NCT01732640|592985127|FG000|Overall Study|Adverse Event|0|||
164169914|NCT01732640|592985128|FG001|Overall Study|Adverse Event|1|||
164169915|NCT01732640|592985127|FG000|Overall Study|Death|0|||
164169916|NCT01732640|592985128|FG001|Overall Study|Death|1|||
164169917|NCT00877487|592985131|FG000|Open-label Treatment Phase|Adverse Event|1|||
164169918|NCT00877487|592985132|FG001|Open-label Treatment Phase|Adverse Event|0|||
164169919|NCT00877487|592985131|FG000|Open-label Treatment Phase|Protocol Violation|3|||
164169920|NCT00877487|592985132|FG001|Open-label Treatment Phase|Protocol Violation|0|||
164169921|NCT00877487|592985131|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
164169922|NCT00877487|592985132|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
164169923|NCT00877487|592985131|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
164169924|NCT00877487|592985132|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
164169925|NCT00877487|592985131|FG000|Open-label Treatment Phase|Out of country for business|1|||
164169926|NCT00877487|592985132|FG001|Open-label Treatment Phase|Out of country for business|0|||
164169927|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
164169928|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
164169929|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
164169930|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
164169931|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
164169932|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
164169933|NCT00877487|592985131|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
164169934|NCT00877487|592985132|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
164169935|NCT03070002|592985133|FG000|Follow up for 2 Years|Death|1|||
164169936|NCT03425396|592985145|FG000|Overall Study|Lost to Follow-up|2|||
164169937|NCT03425396|592985146|FG001|Overall Study|Lost to Follow-up|5|||
164169938|NCT03425396|592985147|FG002|Overall Study|Lost to Follow-up|2|||
164169939|NCT03425396|592985148|FG003|Overall Study|Lost to Follow-up|0|||
164169940|NCT03425396|592985149|FG004|Overall Study|Lost to Follow-up|0|||
164169941|NCT03425396|592985145|FG000|Overall Study|Withdrawal by Subject|0|||
164169942|NCT03425396|592985146|FG001|Overall Study|Withdrawal by Subject|1|||
164169943|NCT03425396|592985147|FG002|Overall Study|Withdrawal by Subject|0|||
164169944|NCT03425396|592985148|FG003|Overall Study|Withdrawal by Subject|1|||
164169945|NCT03425396|592985149|FG004|Overall Study|Withdrawal by Subject|0|||
164169946|NCT03425396|592985145|FG000|Overall Study|Other|0|||
164169947|NCT03425396|592985146|FG001|Overall Study|Other|1|||
164169948|NCT03425396|592985147|FG002|Overall Study|Other|1|||
164169949|NCT03425396|592985148|FG003|Overall Study|Other|0|||
164169950|NCT03425396|592985149|FG004|Overall Study|Other|1|||
164169951|NCT01082211|592985152|FG000|Overall Study|Protocol Violation|4|||
164169952|NCT01082211|592985152|FG000|Overall Study|No protocol treatment received|3|||
164169953|NCT04999163|592985153|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
164169954|NCT04999163|592985154|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
164169955|NCT04999163|592985153|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
164169956|NCT04999163|592985154|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
164169957|NCT04999163|592985153|FG000|Overall Study|Withdrawal by Subject|1|||
164169958|NCT04999163|592985154|FG001|Overall Study|Withdrawal by Subject|0|||
164169959|NCT05903924|592987323|FG000|Overall Study|Lost to Follow-up|1|||
164169960|NCT05903924|592987324|FG001|Overall Study|Lost to Follow-up|0|||
164169961|NCT05903924|592987325|FG002|Overall Study|Lost to Follow-up|0|||
164169962|NCT04338269|592987326|FG000|Overall Study|Death|86|||
164169963|NCT04338269|592987327|FG001|Overall Study|Death|89|||
164169964|NCT04338269|592987326|FG000|Overall Study|Lost to Follow-up|1|||
164169965|NCT04338269|592987327|FG001|Overall Study|Lost to Follow-up|2|||
164169966|NCT04338269|592987326|FG000|Overall Study|Physician Decision|1|||
164169967|NCT04338269|592987327|FG001|Overall Study|Physician Decision|0|||
164169968|NCT04338269|592987326|FG000|Overall Study|Withdrawal by Subject|14|||
164169969|NCT04338269|592987327|FG001|Overall Study|Withdrawal by Subject|11|||
164169970|NCT00174967|592987328|FG000|Overall Study|Adverse Event|1|||
164169971|NCT00174967|592987329|FG001|Overall Study|Adverse Event|2|||
164169972|NCT00174967|592987330|FG002|Overall Study|Adverse Event|2|||
164169973|NCT00174967|592987331|FG003|Overall Study|Adverse Event|1|||
164169974|NCT00174967|592987328|FG000|Overall Study|Gout Flare|0|||
164169975|NCT00174967|592987329|FG001|Overall Study|Gout Flare|0|||
164169976|NCT00174967|592987330|FG002|Overall Study|Gout Flare|0|||
164169977|NCT00174967|592987331|FG003|Overall Study|Gout Flare|1|||
164169978|NCT00174967|592987328|FG000|Overall Study|Other|0|||
164169979|NCT00174967|592987329|FG001|Overall Study|Other|1|||
164169980|NCT00174967|592987330|FG002|Overall Study|Other|0|||
164169981|NCT00174967|592987331|FG003|Overall Study|Other|0|||
164169982|NCT03030989|592987332|FG000|Overall Study|Fever|2|||
164169983|NCT03030989|592987333|FG001|Overall Study|Fever|2|||
164169984|NCT03030989|592987332|FG000|Overall Study|Rash|2|||
164169985|NCT03030989|592987333|FG001|Overall Study|Rash|1|||
164169986|NCT03030989|592987332|FG000|Overall Study|Fatigue/Overwhelmed|1|||
164169987|NCT03030989|592987333|FG001|Overall Study|Fatigue/Overwhelmed|5|||
164169988|NCT03030989|592987332|FG000|Overall Study|Positive Blood Cultures|2|||
164169989|NCT03030989|592987333|FG001|Overall Study|Positive Blood Cultures|1|||
164169990|NCT03030989|592987332|FG000|Overall Study|Line Removed|0|||
164169991|NCT03030989|592987333|FG001|Overall Study|Line Removed|2|||
164169992|NCT03030989|592987332|FG000|Overall Study|No longer interested|5|||
164169993|NCT03030989|592987333|FG001|Overall Study|No longer interested|3|||
164169994|NCT02730377|592987334|FG000|Overall Study|Other|5|||
164169995|NCT02730377|592987335|FG001|Overall Study|Other|4|||
164169996|NCT02730377|592987334|FG000|Overall Study|Death|1|||
164169997|NCT02730377|592987335|FG001|Overall Study|Death|8|||
164169998|NCT02730377|592987334|FG000|Overall Study|Inadequate glycaemic control|368|||
164169999|NCT02730377|592987335|FG001|Overall Study|Inadequate glycaemic control|473|||
164170000|NCT02730377|592987334|FG000|Overall Study|Adverse Event|79|||
164170001|NCT02730377|592987335|FG001|Overall Study|Adverse Event|41|||
164170002|NCT02730377|592987334|FG000|Overall Study|Protocol Violation|23|||
164170003|NCT02730377|592987335|FG001|Overall Study|Protocol Violation|30|||
164170004|NCT02730377|592987334|FG000|Overall Study|Lack of Efficacy|4|||
164170005|NCT02730377|592987335|FG001|Overall Study|Lack of Efficacy|13|||
164170006|NCT02730377|592987334|FG000|Overall Study|Pregnancy|0|||
164170007|NCT02730377|592987335|FG001|Overall Study|Pregnancy|1|||
164170008|NCT02730377|592987334|FG000|Overall Study|Withdrawal by Subject|45|||
164170009|NCT02730377|592987335|FG001|Overall Study|Withdrawal by Subject|42|||
164170010|NCT02730377|592987334|FG000|Overall Study|Lost to Follow-up|25|||
164170011|NCT02730377|592987335|FG001|Overall Study|Lost to Follow-up|21|||
164170012|NCT03917472|592987336|FG000|Overall Study|Physician Decision|4|||
164170013|NCT03917472|592987337|FG001|Overall Study|Physician Decision|0|||
164170014|NCT03917472|592987336|FG000|Overall Study|Adverse Event|3|||
164170015|NCT03917472|592987337|FG001|Overall Study|Adverse Event|1|||
164170016|NCT03917472|592987336|FG000|Overall Study|Death|7|||
164170017|NCT03917472|592987337|FG001|Overall Study|Death|5|||
164170018|NCT03917472|592987336|FG000|Overall Study|Withdrawal by Subject|11|||
164170019|NCT03917472|592987337|FG001|Overall Study|Withdrawal by Subject|4|||
164170020|NCT03917472|592987336|FG000|Overall Study|Lost to Follow-up|10|||
164170021|NCT03917472|592987337|FG001|Overall Study|Lost to Follow-up|5|||
164170022|NCT02706886|592987338|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
164170023|NCT02706886|592987339|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
164170024|NCT02706886|592987340|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
164170025|NCT02706886|592987341|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
164170026|NCT02706886|592987342|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
164170027|NCT02706886|592987343|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
164170028|NCT02706886|592987344|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
164170029|NCT02706886|592987345|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
164170030|NCT02706886|592987346|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
164170031|NCT01154296|592987347|FG000|Randomization and Intervention|Decided to decline|1|||
164170032|NCT01154296|592987348|FG001|Randomization and Intervention|Decided to decline|1|||
164170033|NCT01154296|592987347|FG000|Randomization and Intervention|Declined by staff|1|||
164170034|NCT01154296|592987348|FG001|Randomization and Intervention|Declined by staff|0|||
164170035|NCT01154296|592987347|FG000|Randomization and Intervention|Did not return|1|||
164170036|NCT01154296|592987348|FG001|Randomization and Intervention|Did not return|0|||
164170037|NCT01154296|592987347|FG000|Randomization and Intervention|Left before test|0|||
164170038|NCT01154296|592987348|FG001|Randomization and Intervention|Left before test|1|||
164170039|NCT01154296|592987347|FG000|Randomization and Intervention|Left clinic early|2|||
164170040|NCT01154296|592987348|FG001|Randomization and Intervention|Left clinic early|0|||
164170041|NCT01154296|592987347|FG000|6-month Follow-up|Lost contact|269|||
164170042|NCT01154296|592987348|FG001|6-month Follow-up|Lost contact|275|||
164170043|NCT01154296|592987347|FG000|6-month Follow-up|Incarcerated|37|||
164170044|NCT01154296|592987348|FG001|6-month Follow-up|Incarcerated|32|||
164170045|NCT01154296|592987347|FG000|6-month Follow-up|Withdrew consent|14|||
164170046|NCT01154296|592987348|FG001|6-month Follow-up|Withdrew consent|15|||
164170047|NCT01154296|592987347|FG000|6-month Follow-up|Death|3|||
164170048|NCT01154296|592987348|FG001|6-month Follow-up|Death|2|||
164170049|NCT01154296|592987347|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
164170050|NCT01154296|592987348|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
164170051|NCT02203851|592987349|FG000|Overall Study|Lost to Follow-up|4|||
164170052|NCT02203851|592987349|FG000|Overall Study|Withdrawal by Subject|6|||
164170053|NCT02203851|592987349|FG000|Overall Study|Other|1|||
164170054|NCT02086448|592987350|FG000|Overall Study|Withdrawal by Subject|1|||
164170055|NCT02086448|592987351|FG001|Overall Study|Withdrawal by Subject|0|||
164170056|NCT02086448|592987352|FG002|Overall Study|Withdrawal by Subject|0|||
164170057|NCT02086448|592987353|FG003|Overall Study|Withdrawal by Subject|2|||
164170058|NCT02031640|592987364|FG000|Screening Period|Adverse Event|1|||
164170059|NCT02031640|592987365|FG001|Screening Period|Adverse Event|0|||
164170060|NCT02031640|592987366|FG002|Screening Period|Adverse Event|0|||
164170061|NCT02031640|592987367|FG003|Screening Period|Adverse Event|0|||
164170062|NCT02031640|592987368|FG004|Screening Period|Adverse Event|0|||
164170063|NCT02031640|592987369|FG005|Screening Period|Adverse Event|0|||
164170064|NCT02031640|592987364|FG000|Screening Period|Withdrawal by Subject|29|||
164170065|NCT02031640|592987365|FG001|Screening Period|Withdrawal by Subject|0|||
164170066|NCT02031640|592987366|FG002|Screening Period|Withdrawal by Subject|0|||
164170067|NCT02031640|592987367|FG003|Screening Period|Withdrawal by Subject|0|||
164170068|NCT02031640|592987368|FG004|Screening Period|Withdrawal by Subject|0|||
164170069|NCT02031640|592987369|FG005|Screening Period|Withdrawal by Subject|0|||
164170070|NCT02031640|592987364|FG000|Screening Period|Inclusion criteria not met|312|||
164170071|NCT02031640|592987365|FG001|Screening Period|Inclusion criteria not met|0|||
164170072|NCT02031640|592987366|FG002|Screening Period|Inclusion criteria not met|0|||
164170073|NCT02031640|592987367|FG003|Screening Period|Inclusion criteria not met|0|||
164170074|NCT02031640|592987368|FG004|Screening Period|Inclusion criteria not met|0|||
164170075|NCT02031640|592987369|FG005|Screening Period|Inclusion criteria not met|0|||
164170076|NCT02031640|592987364|FG000|Screening Period|Exclusion criteria met|30|||
164170077|NCT02031640|592987365|FG001|Screening Period|Exclusion criteria met|0|||
164170078|NCT02031640|592987366|FG002|Screening Period|Exclusion criteria met|0|||
164170079|NCT02031640|592987367|FG003|Screening Period|Exclusion criteria met|0|||
164170080|NCT02031640|592987368|FG004|Screening Period|Exclusion criteria met|0|||
164170081|NCT02031640|592987369|FG005|Screening Period|Exclusion criteria met|0|||
164170082|NCT02031640|592987364|FG000|Screening Period|Lost to Follow-up|14|||
164170083|NCT02031640|592987365|FG001|Screening Period|Lost to Follow-up|0|||
164170084|NCT02031640|592987366|FG002|Screening Period|Lost to Follow-up|0|||
164170085|NCT02031640|592987367|FG003|Screening Period|Lost to Follow-up|0|||
164170086|NCT02031640|592987368|FG004|Screening Period|Lost to Follow-up|0|||
164170087|NCT02031640|592987369|FG005|Screening Period|Lost to Follow-up|0|||
164170088|NCT02031640|592987364|FG000|Screening Period|Enrollment closed|26|||
164170089|NCT02031640|592987365|FG001|Screening Period|Enrollment closed|0|||
164170090|NCT02031640|592987366|FG002|Screening Period|Enrollment closed|0|||
164170091|NCT02031640|592987367|FG003|Screening Period|Enrollment closed|0|||
164170092|NCT02031640|592987368|FG004|Screening Period|Enrollment closed|0|||
164170093|NCT02031640|592987369|FG005|Screening Period|Enrollment closed|0|||
164170094|NCT02031640|592987364|FG000|Run-In Period|Adverse Event|4|||
164170095|NCT02031640|592987365|FG001|Run-In Period|Adverse Event|0|||
164170096|NCT02031640|592987366|FG002|Run-In Period|Adverse Event|0|||
164170097|NCT02031640|592987367|FG003|Run-In Period|Adverse Event|0|||
164170098|NCT02031640|592987368|FG004|Run-In Period|Adverse Event|0|||
164170099|NCT02031640|592987369|FG005|Run-In Period|Adverse Event|0|||
164170100|NCT02031640|592987364|FG000|Run-In Period|Withdrawal by Subject|17|||
164170101|NCT02031640|592987365|FG001|Run-In Period|Withdrawal by Subject|0|||
164170102|NCT02031640|592987366|FG002|Run-In Period|Withdrawal by Subject|0|||
164170103|NCT02031640|592987367|FG003|Run-In Period|Withdrawal by Subject|0|||
164170104|NCT02031640|592987368|FG004|Run-In Period|Withdrawal by Subject|0|||
164170105|NCT02031640|592987369|FG005|Run-In Period|Withdrawal by Subject|0|||
164170106|NCT02031640|592987364|FG000|Run-In Period|Inclusion criteria not met|38|||
164170107|NCT02031640|592987365|FG001|Run-In Period|Inclusion criteria not met|0|||
164170108|NCT02031640|592987366|FG002|Run-In Period|Inclusion criteria not met|0|||
164170109|NCT02031640|592987367|FG003|Run-In Period|Inclusion criteria not met|0|||
164170110|NCT02031640|592987368|FG004|Run-In Period|Inclusion criteria not met|0|||
164170111|NCT02031640|592987369|FG005|Run-In Period|Inclusion criteria not met|0|||
164170112|NCT02031640|592987364|FG000|Run-In Period|Exclusion criteria met|8|||
164170113|NCT02031640|592987365|FG001|Run-In Period|Exclusion criteria met|0|||
164170114|NCT02031640|592987366|FG002|Run-In Period|Exclusion criteria met|0|||
164170115|NCT02031640|592987367|FG003|Run-In Period|Exclusion criteria met|0|||
164170116|NCT02031640|592987368|FG004|Run-In Period|Exclusion criteria met|0|||
164170117|NCT02031640|592987369|FG005|Run-In Period|Exclusion criteria met|0|||
164170118|NCT02031640|592987364|FG000|Run-In Period|Randomization criteria not met|85|||
164170119|NCT02031640|592987365|FG001|Run-In Period|Randomization criteria not met|0|||
164170120|NCT02031640|592987366|FG002|Run-In Period|Randomization criteria not met|0|||
164170121|NCT02031640|592987367|FG003|Run-In Period|Randomization criteria not met|0|||
164170122|NCT02031640|592987368|FG004|Run-In Period|Randomization criteria not met|0|||
164170123|NCT02031640|592987369|FG005|Run-In Period|Randomization criteria not met|0|||
164170124|NCT02031640|592987364|FG000|Run-In Period|Various administrative reasons|17|||
164170125|NCT02031640|592987365|FG001|Run-In Period|Various administrative reasons|0|||
164170126|NCT02031640|592987366|FG002|Run-In Period|Various administrative reasons|0|||
164170127|NCT02031640|592987367|FG003|Run-In Period|Various administrative reasons|0|||
164170128|NCT02031640|592987368|FG004|Run-In Period|Various administrative reasons|0|||
164170129|NCT02031640|592987369|FG005|Run-In Period|Various administrative reasons|0|||
164170130|NCT02031640|592987364|FG000|Double-blind Treatment Period|Protocol deviation|0|||
164170131|NCT02031640|592987365|FG001|Double-blind Treatment Period|Protocol deviation|2|||
164170132|NCT02031640|592987366|FG002|Double-blind Treatment Period|Protocol deviation|0|||
164170133|NCT02031640|592987367|FG003|Double-blind Treatment Period|Protocol deviation|1|||
164170134|NCT02031640|592987368|FG004|Double-blind Treatment Period|Protocol deviation|3|||
164170135|NCT02031640|592987369|FG005|Double-blind Treatment Period|Protocol deviation|1|||
164170136|NCT02031640|592987364|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
164170137|NCT02031640|592987365|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
164170138|NCT02031640|592987366|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
164170139|NCT02031640|592987367|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
164170140|NCT02031640|592987368|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
164170141|NCT02031640|592987369|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
164170142|NCT02031640|592987364|FG000|Double-blind Treatment Period|Non-compliance|0|||
164170143|NCT02031640|592987365|FG001|Double-blind Treatment Period|Non-compliance|1|||
164170144|NCT02031640|592987366|FG002|Double-blind Treatment Period|Non-compliance|0|||
164170145|NCT02031640|592987367|FG003|Double-blind Treatment Period|Non-compliance|1|||
164170146|NCT02031640|592987368|FG004|Double-blind Treatment Period|Non-compliance|1|||
164170147|NCT02031640|592987369|FG005|Double-blind Treatment Period|Non-compliance|0|||
164170148|NCT02031640|592987364|FG000|Double-blind Treatment Period|Adverse Event|0|||
164170149|NCT02031640|592987365|FG001|Double-blind Treatment Period|Adverse Event|0|||
164170150|NCT02031640|592987366|FG002|Double-blind Treatment Period|Adverse Event|0|||
164170151|NCT02031640|592987367|FG003|Double-blind Treatment Period|Adverse Event|2|||
164170152|NCT02031640|592987368|FG004|Double-blind Treatment Period|Adverse Event|0|||
164170153|NCT02031640|592987369|FG005|Double-blind Treatment Period|Adverse Event|0|||
164170154|NCT02031640|592987364|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
164170155|NCT02031640|592987365|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
164170156|NCT02031640|592987366|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
164170157|NCT02031640|592987367|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
164170158|NCT02031640|592987368|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
164170159|NCT02031640|592987369|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
164170160|NCT02031640|592987364|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
164170161|NCT02031640|592987365|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
164170162|NCT02031640|592987366|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
164170163|NCT02031640|592987367|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
164170164|NCT02031640|592987368|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
164170165|NCT02031640|592987369|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
164170166|NCT00654875|592987370|FG000|Overall Study|Adverse Event|5|||
164170167|NCT00654875|592987371|FG001|Overall Study|Adverse Event|5|||
164170168|NCT00654875|592987370|FG000|Overall Study|Withdrawal by Subject|4|||
164170169|NCT00654875|592987371|FG001|Overall Study|Withdrawal by Subject|4|||
164170170|NCT00654875|592987370|FG000|Overall Study|Protocol Violation|3|||
164170171|NCT00654875|592987371|FG001|Overall Study|Protocol Violation|3|||
164170172|NCT00654875|592987370|FG000|Overall Study|Lack of Efficacy|2|||
164170173|NCT00654875|592987371|FG001|Overall Study|Lack of Efficacy|2|||
164170174|NCT00654875|592987370|FG000|Overall Study|Lost to Follow-up|1|||
164170175|NCT00654875|592987371|FG001|Overall Study|Lost to Follow-up|3|||
164170176|NCT00654875|592987370|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
164170177|NCT00654875|592987371|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164170178|NCT00654875|592987370|FG000|Overall Study|Administrative Problems|1|||
164170179|NCT00654875|592987371|FG001|Overall Study|Administrative Problems|0|||
164170180|NCT01867710|592987373|FG000|Overall Study|Death|25|||
164170181|NCT01867710|592987374|FG001|Overall Study|Death|15|||
164170182|NCT01867710|592987375|FG002|Overall Study|Death|27|||
164170183|NCT01867710|592987376|FG003|Overall Study|Death|20|||
164170184|NCT01867710|592987373|FG000|Overall Study|Lost to Follow-up|3|||
164170185|NCT01867710|592987374|FG001|Overall Study|Lost to Follow-up|4|||
164170186|NCT01867710|592987375|FG002|Overall Study|Lost to Follow-up|3|||
164170187|NCT01867710|592987376|FG003|Overall Study|Lost to Follow-up|2|||
164170188|NCT01867710|592987373|FG000|Overall Study|Withdrawal of consent|2|||
164170189|NCT01867710|592987374|FG001|Overall Study|Withdrawal of consent|5|||
164170190|NCT01867710|592987375|FG002|Overall Study|Withdrawal of consent|1|||
164170191|NCT01867710|592987376|FG003|Overall Study|Withdrawal of consent|2|||
164170192|NCT01867710|592987373|FG000|Overall Study|Study Terminated by Sponsor|9|||
164170193|NCT01867710|592987374|FG001|Overall Study|Study Terminated by Sponsor|13|||
164170194|NCT01867710|592987375|FG002|Overall Study|Study Terminated by Sponsor|8|||
164170195|NCT01867710|592987376|FG003|Overall Study|Study Terminated by Sponsor|16|||
164170196|NCT01867710|592987373|FG000|Overall Study|Biochemical progression|0|||
164170197|NCT01867710|592987374|FG001|Overall Study|Biochemical progression|1|||
164170198|NCT01867710|592987375|FG002|Overall Study|Biochemical progression|0|||
164170199|NCT01867710|592987376|FG003|Overall Study|Biochemical progression|0|||
164170200|NCT01867710|592987373|FG000|Overall Study|Clinical progression|0|||
164170201|NCT01867710|592987374|FG001|Overall Study|Clinical progression|0|||
164170202|NCT01867710|592987375|FG002|Overall Study|Clinical progression|1|||
164170203|NCT01867710|592987376|FG003|Overall Study|Clinical progression|0|||
164170204|NCT01867710|592987373|FG000|Overall Study|Disease progression|1|||
164170205|NCT01867710|592987374|FG001|Overall Study|Disease progression|0|||
164170206|NCT01867710|592987375|FG002|Overall Study|Disease progression|0|||
164170207|NCT01867710|592987376|FG003|Overall Study|Disease progression|0|||
164170208|NCT01867710|592987373|FG000|Overall Study|Patient decision|0|||
164170209|NCT01867710|592987374|FG001|Overall Study|Patient decision|0|||
164170210|NCT01867710|592987375|FG002|Overall Study|Patient decision|0|||
164170211|NCT01867710|592987376|FG003|Overall Study|Patient decision|1|||
164170212|NCT01867710|592987373|FG000|Overall Study|Patient to follow subsequent treatment|0|||
164170213|NCT01867710|592987374|FG001|Overall Study|Patient to follow subsequent treatment|1|||
164170214|NCT01867710|592987375|FG002|Overall Study|Patient to follow subsequent treatment|0|||
164170215|NCT01867710|592987376|FG003|Overall Study|Patient to follow subsequent treatment|0|||
164170216|NCT01867710|592987373|FG000|Overall Study|Progressive disease|1|||
164170217|NCT01867710|592987374|FG001|Overall Study|Progressive disease|0|||
164170218|NCT01867710|592987375|FG002|Overall Study|Progressive disease|0|||
164170219|NCT01867710|592987376|FG003|Overall Study|Progressive disease|0|||
164170220|NCT01867710|592987373|FG000|Overall Study|Protocol Violation|0|||
164170221|NCT01867710|592987374|FG001|Overall Study|Protocol Violation|0|||
164170222|NCT01867710|592987375|FG002|Overall Study|Protocol Violation|0|||
164170223|NCT01867710|592987376|FG003|Overall Study|Protocol Violation|1|||
164170224|NCT01867710|592987373|FG000|Overall Study|PSA-progression|0|||
164170225|NCT01867710|592987374|FG001|Overall Study|PSA-progression|1|||
164170226|NCT01867710|592987375|FG002|Overall Study|PSA-progression|0|||
164170227|NCT01867710|592987376|FG003|Overall Study|PSA-progression|0|||
164170228|NCT01867710|592987373|FG000|Overall Study|Study medication no longer effective|0|||
164170229|NCT01867710|592987374|FG001|Overall Study|Study medication no longer effective|1|||
164170230|NCT01867710|592987375|FG002|Overall Study|Study medication no longer effective|0|||
164170231|NCT01867710|592987376|FG003|Overall Study|Study medication no longer effective|0|||
164170232|NCT05113979|592987377|FG000|Overall Study|Death|2|||
164170233|NCT05113979|592987377|FG000|Overall Study|Lost to Follow-up|1|||
164170234|NCT02048826|592987378|FG000|Overall Study|Withdrawal by Subject|1|||
164170235|NCT02048826|592987379|FG001|Overall Study|Withdrawal by Subject|0|||
164170236|NCT00976820|592987380|FG000|Overall Study|Lost to Follow-up|5|||
164170237|NCT00976820|592987381|FG001|Overall Study|Lost to Follow-up|16|||
164170238|NCT00976820|592987382|FG002|Overall Study|Lost to Follow-up|2|||
164170239|NCT00976820|592987383|FG003|Overall Study|Lost to Follow-up|3|||
164170240|NCT00976820|592987380|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
164170241|NCT00976820|592987381|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
164170242|NCT00976820|592987382|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
164170243|NCT00976820|592987383|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
164170244|NCT00976820|592987380|FG000|Overall Study|Withdrawal by Subject|2|||
164170245|NCT00976820|592987381|FG001|Overall Study|Withdrawal by Subject|4|||
164170246|NCT00976820|592987382|FG002|Overall Study|Withdrawal by Subject|1|||
164170247|NCT00976820|592987383|FG003|Overall Study|Withdrawal by Subject|4|||
164170248|NCT00526669|592987384|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
164170249|NCT00526669|592987385|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
164170250|NCT00526669|592987384|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
164170251|NCT00526669|592987385|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
164170252|NCT00526669|592987384|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
164170253|NCT00526669|592987385|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
164170254|NCT00526669|592987384|FG000|Combined Treatment Phase|Death|0|||
164170255|NCT00526669|592987385|FG001|Combined Treatment Phase|Death|2|||
164170256|NCT00968981|592987386|FG000|Overall Study|Adverse Event|2|||
164170257|NCT00968981|592987387|FG001|Overall Study|Adverse Event|0|||
164170258|NCT00968981|592987388|FG002|Overall Study|Adverse Event|0|||
164170259|NCT00968981|592987386|FG000|Overall Study|Disease Progression|14|||
164170260|NCT00968981|592987387|FG001|Overall Study|Disease Progression|16|||
164170261|NCT00968981|592987388|FG002|Overall Study|Disease Progression|13|||
164170262|NCT00968981|592987386|FG000|Overall Study|Lost to Follow-up|0|||
164170263|NCT00968981|592987387|FG001|Overall Study|Lost to Follow-up|0|||
164170264|NCT00968981|592987388|FG002|Overall Study|Lost to Follow-up|1|||
164170265|NCT00968981|592987386|FG000|Overall Study|Physician Decision|5|||
164170266|NCT00968981|592987387|FG001|Overall Study|Physician Decision|3|||
164170267|NCT00968981|592987388|FG002|Overall Study|Physician Decision|5|||
164170268|NCT00968981|592987386|FG000|Overall Study|Withdrawal by Subject|1|||
164170269|NCT00968981|592987387|FG001|Overall Study|Withdrawal by Subject|3|||
164170270|NCT00968981|592987388|FG002|Overall Study|Withdrawal by Subject|3|||
164170271|NCT01981954|592987399|FG000|Titration Period|Protocol Deviation|1|||
164170272|NCT01981954|592987399|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
164170273|NCT01489254|592987400|FG000|Double-blind Part|Adverse Event|7|||
164170274|NCT01489254|592987401|FG001|Double-blind Part|Adverse Event|2|||
164170275|NCT01489254|592987402|FG002|Double-blind Part|Adverse Event|2|||
164170276|NCT01489254|592987403|FG003|Double-blind Part|Adverse Event|0|||
164170277|NCT01489254|592987400|FG000|Double-blind Part|Pregnancy|1|||
164170278|NCT01489254|592987401|FG001|Double-blind Part|Pregnancy|3|||
164170279|NCT01489254|592987402|FG002|Double-blind Part|Pregnancy|0|||
164170280|NCT01489254|592987403|FG003|Double-blind Part|Pregnancy|0|||
164170281|NCT01489254|592987400|FG000|Double-blind Part|Withdrawal by Subject|12|||
164170282|NCT01489254|592987401|FG001|Double-blind Part|Withdrawal by Subject|20|||
164170283|NCT01489254|592987402|FG002|Double-blind Part|Withdrawal by Subject|1|||
164170284|NCT01489254|592987403|FG003|Double-blind Part|Withdrawal by Subject|0|||
164170285|NCT01489254|592987400|FG000|Double-blind Part|Lost to Follow-up|1|||
164170286|NCT01489254|592987401|FG001|Double-blind Part|Lost to Follow-up|2|||
164170287|NCT01489254|592987402|FG002|Double-blind Part|Lost to Follow-up|0|||
164170288|NCT01489254|592987403|FG003|Double-blind Part|Lost to Follow-up|0|||
164170289|NCT01489254|592987400|FG000|Double-blind Part|Other reasons for not completing study|4|||
164170290|NCT01489254|592987401|FG001|Double-blind Part|Other reasons for not completing study|6|||
164170291|NCT01489254|592987402|FG002|Double-blind Part|Other reasons for not completing study|0|||
164170292|NCT01489254|592987403|FG003|Double-blind Part|Other reasons for not completing study|0|||
164170293|NCT01489254|592987400|FG000|Open-label Extension Part|Adverse Event|0|||
164170294|NCT01489254|592987401|FG001|Open-label Extension Part|Adverse Event|0|||
164170295|NCT01489254|592987402|FG002|Open-label Extension Part|Adverse Event|0|||
164170296|NCT01489254|592987403|FG003|Open-label Extension Part|Adverse Event|10|||
164170725|NCT02147158|592987475|FG002|Treatment Course 1|Adverse Event|3|||
164170297|NCT01489254|592987400|FG000|Open-label Extension Part|Pregnancy|0|||
164170298|NCT01489254|592987401|FG001|Open-label Extension Part|Pregnancy|0|||
164170299|NCT01489254|592987402|FG002|Open-label Extension Part|Pregnancy|0|||
164170300|NCT01489254|592987403|FG003|Open-label Extension Part|Pregnancy|3|||
164170301|NCT01489254|592987400|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
164170302|NCT01489254|592987401|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
164170303|NCT01489254|592987402|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
164170304|NCT01489254|592987403|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
164170305|NCT01489254|592987400|FG000|Open-label Extension Part|Protocol Violation|0|||
164170306|NCT01489254|592987401|FG001|Open-label Extension Part|Protocol Violation|0|||
164170307|NCT01489254|592987402|FG002|Open-label Extension Part|Protocol Violation|0|||
164170308|NCT01489254|592987403|FG003|Open-label Extension Part|Protocol Violation|1|||
164170309|NCT01489254|592987400|FG000|Open-label Extension Part|Lost to Follow-up|0|||
164170310|NCT01489254|592987401|FG001|Open-label Extension Part|Lost to Follow-up|0|||
164170311|NCT01489254|592987402|FG002|Open-label Extension Part|Lost to Follow-up|0|||
164170312|NCT01489254|592987403|FG003|Open-label Extension Part|Lost to Follow-up|9|||
164170313|NCT01489254|592987400|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
164170314|NCT01489254|592987401|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
164170315|NCT01489254|592987402|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
164170316|NCT01489254|592987403|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
164170317|NCT01730534|592987404|FG000|Overall Study|Withdrawal by Subject|97|||
164170318|NCT01730534|592987405|FG001|Overall Study|Withdrawal by Subject|127|||
164170319|NCT01730534|592987404|FG000|Overall Study|Lost to Follow-up|12|||
164170320|NCT01730534|592987405|FG001|Overall Study|Lost to Follow-up|18|||
164170321|NCT02980341|592987406|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
164170322|NCT02980341|592987407|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
164170323|NCT02980341|592987408|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
164170324|NCT02980341|592987409|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
164170325|NCT02980341|592987410|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
164170326|NCT02980341|592987411|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170327|NCT02980341|592987412|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170328|NCT02980341|592987413|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170329|NCT02980341|592987414|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170330|NCT02980341|592987415|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170331|NCT02980341|592987416|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
164170332|NCT02980341|592987406|FG000|Dose Escalation|Clinical progression|0|||
164170333|NCT02980341|592987407|FG001|Dose Escalation|Clinical progression|0|||
164170334|NCT02980341|592987408|FG002|Dose Escalation|Clinical progression|2|||
164170335|NCT02980341|592987409|FG003|Dose Escalation|Clinical progression|1|||
164170336|NCT02980341|592987410|FG004|Dose Escalation|Clinical progression|0|||
164170337|NCT02980341|592987411|FG005|Dose Escalation|Clinical progression|0|||
164170338|NCT02980341|592987412|FG006|Dose Escalation|Clinical progression|0|||
164170339|NCT02980341|592987413|FG007|Dose Escalation|Clinical progression|0|||
164170340|NCT02980341|592987414|FG008|Dose Escalation|Clinical progression|0|||
164170341|NCT02980341|592987415|FG009|Dose Escalation|Clinical progression|0|||
164170342|NCT02980341|592987416|FG010|Dose Escalation|Clinical progression|0|||
164170343|NCT02980341|592987406|FG000|Dose Escalation|Adverse Event|0|||
164170344|NCT02980341|592987407|FG001|Dose Escalation|Adverse Event|0|||
164170345|NCT02980341|592987408|FG002|Dose Escalation|Adverse Event|1|||
164170346|NCT02980341|592987409|FG003|Dose Escalation|Adverse Event|2|||
164170347|NCT02980341|592987410|FG004|Dose Escalation|Adverse Event|2|||
164170348|NCT02980341|592987411|FG005|Dose Escalation|Adverse Event|0|||
164170349|NCT02980341|592987412|FG006|Dose Escalation|Adverse Event|0|||
164170350|NCT02980341|592987413|FG007|Dose Escalation|Adverse Event|0|||
164170351|NCT02980341|592987414|FG008|Dose Escalation|Adverse Event|0|||
164170352|NCT02980341|592987415|FG009|Dose Escalation|Adverse Event|0|||
164170353|NCT02980341|592987416|FG010|Dose Escalation|Adverse Event|0|||
164170354|NCT02980341|592987406|FG000|Dose Escalation|Withdrawal by Subject|0|||
164170355|NCT02980341|592987407|FG001|Dose Escalation|Withdrawal by Subject|0|||
164170356|NCT02980341|592987408|FG002|Dose Escalation|Withdrawal by Subject|1|||
164170357|NCT02980341|592987409|FG003|Dose Escalation|Withdrawal by Subject|0|||
164170358|NCT02980341|592987410|FG004|Dose Escalation|Withdrawal by Subject|0|||
164170359|NCT02980341|592987411|FG005|Dose Escalation|Withdrawal by Subject|0|||
164170360|NCT02980341|592987412|FG006|Dose Escalation|Withdrawal by Subject|0|||
164170361|NCT02980341|592987413|FG007|Dose Escalation|Withdrawal by Subject|0|||
164170362|NCT02980341|592987414|FG008|Dose Escalation|Withdrawal by Subject|0|||
164170363|NCT02980341|592987415|FG009|Dose Escalation|Withdrawal by Subject|0|||
164170364|NCT02980341|592987416|FG010|Dose Escalation|Withdrawal by Subject|0|||
164170365|NCT02980341|592987406|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170366|NCT02980341|592987407|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170367|NCT02980341|592987408|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170368|NCT02980341|592987409|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
164170369|NCT02980341|592987410|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170370|NCT02980341|592987411|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170371|NCT02980341|592987412|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170372|NCT02980341|592987413|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170373|NCT02980341|592987414|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170374|NCT02980341|592987415|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170375|NCT02980341|592987416|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
164170376|NCT02980341|592987406|FG000|Dose Escalation|Due to investigator's decision|0|||
164170377|NCT02980341|592987407|FG001|Dose Escalation|Due to investigator's decision|0|||
164170378|NCT02980341|592987408|FG002|Dose Escalation|Due to investigator's decision|0|||
164170379|NCT02980341|592987409|FG003|Dose Escalation|Due to investigator's decision|0|||
164170380|NCT02980341|592987410|FG004|Dose Escalation|Due to investigator's decision|1|||
164170381|NCT02980341|592987411|FG005|Dose Escalation|Due to investigator's decision|0|||
164170382|NCT02980341|592987412|FG006|Dose Escalation|Due to investigator's decision|0|||
164170383|NCT02980341|592987413|FG007|Dose Escalation|Due to investigator's decision|0|||
164170384|NCT02980341|592987414|FG008|Dose Escalation|Due to investigator's decision|0|||
164170385|NCT02980341|592987415|FG009|Dose Escalation|Due to investigator's decision|0|||
164170386|NCT02980341|592987416|FG010|Dose Escalation|Due to investigator's decision|0|||
164170387|NCT02980341|592987406|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170388|NCT02980341|592987407|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170389|NCT02980341|592987408|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170390|NCT02980341|592987409|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170391|NCT02980341|592987410|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170392|NCT02980341|592987411|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
164170393|NCT02980341|592987412|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
164170394|NCT02980341|592987413|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170395|NCT02980341|592987414|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170396|NCT02980341|592987415|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170397|NCT02980341|592987416|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
164170398|NCT02980341|592987406|FG000|Dose Finding|Adverse Event|0|||
164170399|NCT02980341|592987407|FG001|Dose Finding|Adverse Event|0|||
164170400|NCT02980341|592987408|FG002|Dose Finding|Adverse Event|0|||
164170401|NCT02980341|592987409|FG003|Dose Finding|Adverse Event|0|||
164170402|NCT02980341|592987410|FG004|Dose Finding|Adverse Event|0|||
164170403|NCT02980341|592987411|FG005|Dose Finding|Adverse Event|3|||
164170404|NCT02980341|592987412|FG006|Dose Finding|Adverse Event|0|||
164170405|NCT02980341|592987413|FG007|Dose Finding|Adverse Event|0|||
164170406|NCT02980341|592987414|FG008|Dose Finding|Adverse Event|0|||
164170407|NCT02980341|592987415|FG009|Dose Finding|Adverse Event|0|||
164170408|NCT02980341|592987416|FG010|Dose Finding|Adverse Event|0|||
164170409|NCT02980341|592987406|FG000|Dose Finding|Withdrawal by Subject|0|||
164170410|NCT02980341|592987407|FG001|Dose Finding|Withdrawal by Subject|0|||
164170411|NCT02980341|592987408|FG002|Dose Finding|Withdrawal by Subject|0|||
164170412|NCT02980341|592987409|FG003|Dose Finding|Withdrawal by Subject|0|||
164170413|NCT02980341|592987410|FG004|Dose Finding|Withdrawal by Subject|0|||
164170414|NCT02980341|592987411|FG005|Dose Finding|Withdrawal by Subject|1|||
164170415|NCT02980341|592987412|FG006|Dose Finding|Withdrawal by Subject|1|||
164170416|NCT02980341|592987413|FG007|Dose Finding|Withdrawal by Subject|0|||
164170417|NCT02980341|592987414|FG008|Dose Finding|Withdrawal by Subject|0|||
164170418|NCT02980341|592987415|FG009|Dose Finding|Withdrawal by Subject|0|||
164170419|NCT02980341|592987416|FG010|Dose Finding|Withdrawal by Subject|0|||
164170420|NCT02980341|592987406|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170421|NCT02980341|592987407|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170422|NCT02980341|592987408|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170423|NCT02980341|592987409|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170424|NCT02980341|592987410|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170425|NCT02980341|592987411|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170426|NCT02980341|592987412|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
164170427|NCT02980341|592987413|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
164170428|NCT02980341|592987414|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
164170429|NCT02980341|592987415|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
164170430|NCT02980341|592987416|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
164170431|NCT02980341|592987406|FG000|Dose Expansion|Clinical progression|0|||
164170432|NCT02980341|592987407|FG001|Dose Expansion|Clinical progression|0|||
164170433|NCT02980341|592987408|FG002|Dose Expansion|Clinical progression|0|||
164170434|NCT02980341|592987409|FG003|Dose Expansion|Clinical progression|0|||
164170435|NCT02980341|592987410|FG004|Dose Expansion|Clinical progression|0|||
164170436|NCT02980341|592987411|FG005|Dose Expansion|Clinical progression|0|||
164170437|NCT02980341|592987412|FG006|Dose Expansion|Clinical progression|0|||
164170438|NCT02980341|592987413|FG007|Dose Expansion|Clinical progression|4|||
164170439|NCT02980341|592987414|FG008|Dose Expansion|Clinical progression|3|||
164170440|NCT02980341|592987415|FG009|Dose Expansion|Clinical progression|1|||
164170441|NCT02980341|592987416|FG010|Dose Expansion|Clinical progression|4|||
164170442|NCT02980341|592987406|FG000|Dose Expansion|Adverse Event|0|||
164170443|NCT02980341|592987407|FG001|Dose Expansion|Adverse Event|0|||
164170444|NCT02980341|592987408|FG002|Dose Expansion|Adverse Event|0|||
164170445|NCT02980341|592987409|FG003|Dose Expansion|Adverse Event|0|||
164170446|NCT02980341|592987410|FG004|Dose Expansion|Adverse Event|0|||
164170447|NCT02980341|592987411|FG005|Dose Expansion|Adverse Event|0|||
164170448|NCT02980341|592987412|FG006|Dose Expansion|Adverse Event|0|||
164170449|NCT02980341|592987413|FG007|Dose Expansion|Adverse Event|3|||
164170450|NCT02980341|592987414|FG008|Dose Expansion|Adverse Event|0|||
164170451|NCT02980341|592987415|FG009|Dose Expansion|Adverse Event|1|||
164170452|NCT02980341|592987416|FG010|Dose Expansion|Adverse Event|3|||
164170453|NCT02980341|592987406|FG000|Dose Expansion|Death|0|||
164170454|NCT02980341|592987407|FG001|Dose Expansion|Death|0|||
164170455|NCT02980341|592987408|FG002|Dose Expansion|Death|0|||
164170456|NCT02980341|592987409|FG003|Dose Expansion|Death|0|||
164170457|NCT02980341|592987410|FG004|Dose Expansion|Death|0|||
164170458|NCT02980341|592987411|FG005|Dose Expansion|Death|0|||
164170459|NCT02980341|592987412|FG006|Dose Expansion|Death|0|||
164170460|NCT02980341|592987413|FG007|Dose Expansion|Death|0|||
164170461|NCT02980341|592987414|FG008|Dose Expansion|Death|2|||
164170462|NCT02980341|592987415|FG009|Dose Expansion|Death|1|||
164170463|NCT02980341|592987416|FG010|Dose Expansion|Death|0|||
164170464|NCT02980341|592987406|FG000|Dose Expansion|Withdrawal by Subject|0|||
164170465|NCT02980341|592987407|FG001|Dose Expansion|Withdrawal by Subject|0|||
164170466|NCT02980341|592987408|FG002|Dose Expansion|Withdrawal by Subject|0|||
164170467|NCT02980341|592987409|FG003|Dose Expansion|Withdrawal by Subject|0|||
164170468|NCT02980341|592987410|FG004|Dose Expansion|Withdrawal by Subject|0|||
164170469|NCT02980341|592987411|FG005|Dose Expansion|Withdrawal by Subject|0|||
164170470|NCT02980341|592987412|FG006|Dose Expansion|Withdrawal by Subject|0|||
164170471|NCT02980341|592987413|FG007|Dose Expansion|Withdrawal by Subject|2|||
164170472|NCT02980341|592987414|FG008|Dose Expansion|Withdrawal by Subject|0|||
164170473|NCT02980341|592987415|FG009|Dose Expansion|Withdrawal by Subject|1|||
164170474|NCT02980341|592987416|FG010|Dose Expansion|Withdrawal by Subject|0|||
164170475|NCT02980341|592987406|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170476|NCT02980341|592987407|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170477|NCT02980341|592987408|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170478|NCT02980341|592987409|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170479|NCT02980341|592987410|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170480|NCT02980341|592987411|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170481|NCT02980341|592987412|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170482|NCT02980341|592987413|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
164170483|NCT02980341|592987414|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170484|NCT02980341|592987415|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170485|NCT02980341|592987416|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
164170486|NCT02980341|592987406|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170487|NCT02980341|592987407|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170488|NCT02980341|592987408|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170489|NCT02980341|592987409|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170490|NCT02980341|592987410|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170491|NCT02980341|592987411|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170492|NCT02980341|592987412|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170493|NCT02980341|592987413|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170494|NCT02980341|592987414|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
164170495|NCT02980341|592987415|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170496|NCT02980341|592987416|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
164170497|NCT02980341|592987406|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170498|NCT02980341|592987407|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170499|NCT02980341|592987408|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170500|NCT02980341|592987409|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170501|NCT02980341|592987410|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170502|NCT02980341|592987411|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170503|NCT02980341|592987412|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170504|NCT02980341|592987413|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170505|NCT02980341|592987414|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
164170506|NCT02980341|592987415|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170507|NCT02980341|592987416|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
164170508|NCT02980341|592987406|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170509|NCT02980341|592987407|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170510|NCT02980341|592987408|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170511|NCT02980341|592987409|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170512|NCT02980341|592987410|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170513|NCT02980341|592987411|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170514|NCT02980341|592987412|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170515|NCT02980341|592987413|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170516|NCT02980341|592987414|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170517|NCT02980341|592987415|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
164170518|NCT02980341|592987416|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
164170519|NCT01647516|592987417|FG000|Induction Period (IP)|Physician Decision|2|||
164170520|NCT01647516|592987418|FG001|Induction Period (IP)|Physician Decision|0|||
164170521|NCT01647516|592987419|FG002|Induction Period (IP)|Physician Decision|0|||
164170522|NCT01647516|592987420|FG003|Induction Period (IP)|Physician Decision|0|||
164170523|NCT01647516|592987421|FG004|Induction Period (IP)|Physician Decision|0|||
164170524|NCT01647516|592987422|FG005|Induction Period (IP)|Physician Decision|0|||
164170525|NCT01647516|592987417|FG000|Induction Period (IP)|Adverse Event|1|||
164170526|NCT01647516|592987418|FG001|Induction Period (IP)|Adverse Event|2|||
164170527|NCT01647516|592987419|FG002|Induction Period (IP)|Adverse Event|0|||
164170528|NCT01647516|592987420|FG003|Induction Period (IP)|Adverse Event|0|||
164170529|NCT01647516|592987421|FG004|Induction Period (IP)|Adverse Event|0|||
164170530|NCT01647516|592987422|FG005|Induction Period (IP)|Adverse Event|0|||
164170531|NCT01647516|592987417|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
164170532|NCT01647516|592987418|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
164170533|NCT01647516|592987419|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
164170534|NCT01647516|592987420|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
164170535|NCT01647516|592987421|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
164170536|NCT01647516|592987422|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
164170537|NCT01647516|592987417|FG000|Induction Period (IP)|Participant Choice|0|||
164170538|NCT01647516|592987418|FG001|Induction Period (IP)|Participant Choice|0|||
164170539|NCT01647516|592987419|FG002|Induction Period (IP)|Participant Choice|1|||
164170540|NCT01647516|592987420|FG003|Induction Period (IP)|Participant Choice|0|||
164170541|NCT01647516|592987421|FG004|Induction Period (IP)|Participant Choice|0|||
164170542|NCT01647516|592987422|FG005|Induction Period (IP)|Participant Choice|0|||
164170543|NCT01647516|592987417|FG000|Induction Period (IP)|Lack of Efficacy|1|||
164170544|NCT01647516|592987418|FG001|Induction Period (IP)|Lack of Efficacy|0|||
164170545|NCT01647516|592987419|FG002|Induction Period (IP)|Lack of Efficacy|0|||
164170546|NCT01647516|592987420|FG003|Induction Period (IP)|Lack of Efficacy|0|||
164170547|NCT01647516|592987421|FG004|Induction Period (IP)|Lack of Efficacy|0|||
164170548|NCT01647516|592987422|FG005|Induction Period (IP)|Lack of Efficacy|0|||
164170549|NCT01647516|592987417|FG000|Induction Period (IP)|No study drug received|1|||
164170550|NCT01647516|592987418|FG001|Induction Period (IP)|No study drug received|1|||
164170551|NCT01647516|592987419|FG002|Induction Period (IP)|No study drug received|0|||
164170552|NCT01647516|592987420|FG003|Induction Period (IP)|No study drug received|0|||
164170553|NCT01647516|592987421|FG004|Induction Period (IP)|No study drug received|0|||
164170554|NCT01647516|592987422|FG005|Induction Period (IP)|No study drug received|0|||
164170555|NCT01647516|592987417|FG000|Maintenance Period (MP)|Adverse Event|2|||
164170556|NCT01647516|592987418|FG001|Maintenance Period (MP)|Adverse Event|1|||
164170557|NCT01647516|592987419|FG002|Maintenance Period (MP)|Adverse Event|0|||
164170558|NCT01647516|592987420|FG003|Maintenance Period (MP)|Adverse Event|0|||
164170559|NCT01647516|592987421|FG004|Maintenance Period (MP)|Adverse Event|0|||
164170560|NCT01647516|592987422|FG005|Maintenance Period (MP)|Adverse Event|0|||
164170561|NCT01647516|592987417|FG000|Maintenance Period (MP)|Non-compliance|1|||
164170562|NCT01647516|592987418|FG001|Maintenance Period (MP)|Non-compliance|0|||
164170563|NCT01647516|592987419|FG002|Maintenance Period (MP)|Non-compliance|0|||
164170564|NCT01647516|592987420|FG003|Maintenance Period (MP)|Non-compliance|0|||
164170565|NCT01647516|592987421|FG004|Maintenance Period (MP)|Non-compliance|0|||
164170566|NCT01647516|592987422|FG005|Maintenance Period (MP)|Non-compliance|0|||
164170567|NCT01647516|592987417|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170568|NCT01647516|592987418|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
164170569|NCT01647516|592987419|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
164170570|NCT01647516|592987420|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170571|NCT01647516|592987421|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170572|NCT01647516|592987422|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
164170573|NCT01647516|592987417|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
164170574|NCT01647516|592987418|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
164170575|NCT01647516|592987419|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
164170576|NCT01647516|592987420|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
164170577|NCT01647516|592987421|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
164170578|NCT01647516|592987422|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
164170579|NCT01647516|592987417|FG000|Open-Label Period|Adverse Event|0|||
164170580|NCT01647516|592987418|FG001|Open-Label Period|Adverse Event|0|||
164170581|NCT01647516|592987419|FG002|Open-Label Period|Adverse Event|0|||
164170582|NCT01647516|592987420|FG003|Open-Label Period|Adverse Event|5|||
164170583|NCT01647516|592987421|FG004|Open-Label Period|Adverse Event|6|||
164170584|NCT01647516|592987422|FG005|Open-Label Period|Adverse Event|3|||
164170585|NCT01647516|592987417|FG000|Open-Label Period|Pregnancy|0|||
164170586|NCT01647516|592987418|FG001|Open-Label Period|Pregnancy|0|||
164170587|NCT01647516|592987419|FG002|Open-Label Period|Pregnancy|0|||
164170588|NCT01647516|592987420|FG003|Open-Label Period|Pregnancy|0|||
164170589|NCT01647516|592987421|FG004|Open-Label Period|Pregnancy|0|||
164170590|NCT01647516|592987422|FG005|Open-Label Period|Pregnancy|1|||
164170591|NCT01647516|592987417|FG000|Open-Label Period|Non-compliance|0|||
164170592|NCT01647516|592987418|FG001|Open-Label Period|Non-compliance|0|||
164170593|NCT01647516|592987419|FG002|Open-Label Period|Non-compliance|0|||
164170594|NCT01647516|592987420|FG003|Open-Label Period|Non-compliance|1|||
164170595|NCT01647516|592987421|FG004|Open-Label Period|Non-compliance|0|||
164170596|NCT01647516|592987422|FG005|Open-Label Period|Non-compliance|1|||
164170597|NCT01647516|592987417|FG000|Open-Label Period|Physician Decision|0|||
164170598|NCT01647516|592987418|FG001|Open-Label Period|Physician Decision|0|||
164170599|NCT01647516|592987419|FG002|Open-Label Period|Physician Decision|0|||
164170600|NCT01647516|592987420|FG003|Open-Label Period|Physician Decision|1|||
164170601|NCT01647516|592987421|FG004|Open-Label Period|Physician Decision|1|||
164170602|NCT01647516|592987422|FG005|Open-Label Period|Physician Decision|0|||
164170603|NCT01647516|592987417|FG000|Open-Label Period|Withdrawal by Subject|0|||
164170604|NCT01647516|592987418|FG001|Open-Label Period|Withdrawal by Subject|0|||
164170605|NCT01647516|592987419|FG002|Open-Label Period|Withdrawal by Subject|0|||
164170606|NCT01647516|592987420|FG003|Open-Label Period|Withdrawal by Subject|9|||
164170607|NCT01647516|592987421|FG004|Open-Label Period|Withdrawal by Subject|11|||
164170608|NCT01647516|592987422|FG005|Open-Label Period|Withdrawal by Subject|6|||
164170609|NCT01647516|592987417|FG000|Open-Label Period|Lost to Follow-up|0|||
164170610|NCT01647516|592987418|FG001|Open-Label Period|Lost to Follow-up|0|||
164170611|NCT01647516|592987419|FG002|Open-Label Period|Lost to Follow-up|0|||
164170612|NCT01647516|592987420|FG003|Open-Label Period|Lost to Follow-up|1|||
164170613|NCT01647516|592987421|FG004|Open-Label Period|Lost to Follow-up|0|||
164170614|NCT01647516|592987422|FG005|Open-Label Period|Lost to Follow-up|1|||
164170615|NCT01647516|592987417|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
164170616|NCT01647516|592987418|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
164170617|NCT01647516|592987419|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
164170618|NCT01647516|592987420|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
164170619|NCT01647516|592987421|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
164170620|NCT01647516|592987422|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
164170621|NCT01647516|592987417|FG000|Open-Label Period|Lack of Efficacy|0|||
164170622|NCT01647516|592987418|FG001|Open-Label Period|Lack of Efficacy|0|||
164170623|NCT01647516|592987419|FG002|Open-Label Period|Lack of Efficacy|0|||
164170624|NCT01647516|592987420|FG003|Open-Label Period|Lack of Efficacy|7|||
164170625|NCT01647516|592987421|FG004|Open-Label Period|Lack of Efficacy|9|||
164170626|NCT01647516|592987422|FG005|Open-Label Period|Lack of Efficacy|10|||
164170627|NCT01647516|592987417|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
164170628|NCT01647516|592987418|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
164170629|NCT01647516|592987419|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
164170630|NCT01647516|592987420|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
164170631|NCT01647516|592987421|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
164170632|NCT01647516|592987422|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
164170633|NCT01647516|592987417|FG000|Open-Label Period|No completion / discontinuation visit|0|||
164170634|NCT01647516|592987418|FG001|Open-Label Period|No completion / discontinuation visit|0|||
164170635|NCT01647516|592987419|FG002|Open-Label Period|No completion / discontinuation visit|0|||
164170636|NCT01647516|592987420|FG003|Open-Label Period|No completion / discontinuation visit|0|||
164170637|NCT01647516|592987421|FG004|Open-Label Period|No completion / discontinuation visit|2|||
164170638|NCT01647516|592987422|FG005|Open-Label Period|No completion / discontinuation visit|1|||
164170639|NCT01676896|592987423|FG000|Overall Study|Withdrawal by Subject|12|||
164170640|NCT01676896|592987424|FG001|Overall Study|Withdrawal by Subject|7|||
164170641|NCT01676896|592987425|FG002|Overall Study|Withdrawal by Subject|19|||
164170642|NCT03614078|592987426|FG000|Overall Study|Withdrawal by Subject|2|||
164170643|NCT03614078|592987427|FG001|Overall Study|Withdrawal by Subject|2|||
164170644|NCT03614078|592987428|FG002|Overall Study|Withdrawal by Subject|3|||
164170645|NCT03614078|592987426|FG000|Overall Study|Participant Did Not Return for Visit|0|||
164170646|NCT03614078|592987427|FG001|Overall Study|Participant Did Not Return for Visit|1|||
164170647|NCT03614078|592987428|FG002|Overall Study|Participant Did Not Return for Visit|0|||
164170648|NCT03614078|592987426|FG000|Overall Study|High Neutrophils|0|||
164170649|NCT03614078|592987427|FG001|Overall Study|High Neutrophils|0|||
164170650|NCT03614078|592987428|FG002|Overall Study|High Neutrophils|2|||
164170651|NCT03614078|592987426|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
164170652|NCT03614078|592987427|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
164170653|NCT03614078|592987428|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
164170654|NCT03614078|592987426|FG000|Overall Study|Exacerbation of Psoriasis|0|||
164170655|NCT03614078|592987427|FG001|Overall Study|Exacerbation of Psoriasis|1|||
164170656|NCT03614078|592987428|FG002|Overall Study|Exacerbation of Psoriasis|0|||
164170657|NCT03614078|592987426|FG000|Overall Study|Adverse Event|0|||
164170658|NCT03614078|592987427|FG001|Overall Study|Adverse Event|2|||
164170659|NCT03614078|592987428|FG002|Overall Study|Adverse Event|0|||
164170660|NCT03614078|592987426|FG000|Overall Study|Dizziness and Rash|0|||
164170661|NCT03614078|592987427|FG001|Overall Study|Dizziness and Rash|1|||
164170662|NCT03614078|592987428|FG002|Overall Study|Dizziness and Rash|0|||
164170663|NCT04964544|592987431|FG000|Overall Study|Screen failure or other uncategorised|10|||
164170664|NCT04964544|592987431|FG000|Overall Study|Physician Decision|4|||
164170665|NCT04964544|592987431|FG000|Overall Study|Lost to Follow-up|9|||
164170666|NCT04964544|592987431|FG000|Overall Study|Withdrawal by Subject|18|||
164170667|NCT04964544|592987431|FG000|Overall Study|Death|1|||
164170668|NCT01613222|592987434|FG000|Overall Study|Physician Decision|1|||
164170669|NCT01613222|592987434|FG000|Overall Study|Unable to place arterial line|1|||
164170670|NCT01613222|592987434|FG000|Overall Study|Reused disposable sensors|10|||
164170671|NCT02691936|592987436|FG000|Overall Study|Withdrawal by Subject|2|||
164170672|NCT02691936|592987437|FG001|Overall Study|Withdrawal by Subject|5|||
164170673|NCT00749684|592987441|FG000|Overall Study|Death|1|||
164170674|NCT00749684|592987441|FG000|Overall Study|Adverse Event|27|||
164170675|NCT00749684|592987441|FG000|Overall Study|Participant's Wish|10|||
164170676|NCT00749684|592987441|FG000|Overall Study|Not Documented|1|||
164170677|NCT00749684|592987441|FG000|Overall Study|Progressive Desease|31|||
164170678|NCT00749684|592987441|FG000|Overall Study|Therapy according to protocol + AE|2|||
164170679|NCT00749684|592987441|FG000|Overall Study|AE+discontinuation on participants wish|1|||
164170680|NCT00749684|592987441|FG000|Overall Study|Missing|9|||
164170681|NCT01194531|592987442|FG000|Overall Study|Withdrawal by Subject|1|||
164170682|NCT01194531|592987443|FG001|Overall Study|Withdrawal by Subject|0|||
164170683|NCT01194531|592987442|FG000|Overall Study|Protocol Violation|4|||
164170684|NCT01194531|592987443|FG001|Overall Study|Protocol Violation|1|||
164170685|NCT01194531|592987442|FG000|Overall Study|Physician Decision|0|||
164170686|NCT01194531|592987443|FG001|Overall Study|Physician Decision|2|||
164170687|NCT01343277|592987446|FG000|Overall Study|Other|3|||
164170688|NCT01343277|592987447|FG001|Overall Study|Other|3|||
164170689|NCT01343277|592987446|FG000|Overall Study|Withdrawal by Subject|18|||
164170690|NCT01343277|592987447|FG001|Overall Study|Withdrawal by Subject|13|||
164170691|NCT01343277|592987446|FG000|Overall Study|Physician Decision|1|||
164170692|NCT01343277|592987447|FG001|Overall Study|Physician Decision|2|||
164170693|NCT01343277|592987446|FG000|Overall Study|Death|10|||
164170694|NCT01343277|592987447|FG001|Overall Study|Death|1|||
164170695|NCT01343277|592987446|FG000|Overall Study|Adverse Event|67|||
164170696|NCT01343277|592987447|FG001|Overall Study|Adverse Event|13|||
164170697|NCT01343277|592987446|FG000|Overall Study|Disease progression|270|||
164170698|NCT01343277|592987447|FG001|Overall Study|Disease progression|138|||
164170699|NCT01343277|592987446|FG000|Overall Study|Randomized not treated|6|||
164170700|NCT01343277|592987447|FG001|Overall Study|Randomized not treated|21|||
164170701|NCT01343277|592987446|FG000|Overall Study|Treatment ongoing|8|||
164170702|NCT01343277|592987447|FG001|Overall Study|Treatment ongoing|2|||
164170703|NCT01343277|592987446|FG000|Overall Study|Subsequent anticancer therapy|1|||
164170704|NCT01343277|592987447|FG001|Overall Study|Subsequent anticancer therapy|0|||
164170705|NCT01894100|592987450|FG000|Overall Study|Lost to Follow-up|0|||
164170706|NCT01894100|592987451|FG001|Overall Study|Lost to Follow-up|1|||
164170707|NCT01894100|592987450|FG000|Overall Study|Withdrawal by Subject|3|||
164170708|NCT01894100|592987451|FG001|Overall Study|Withdrawal by Subject|0|||
164170709|NCT00135512|592987454|FG000|Overall Study|Adverse Event|56|||
164170710|NCT00135512|592987454|FG000|Overall Study|Lack of Efficacy|25|||
164170711|NCT00135512|592987454|FG000|Overall Study|Other|42|||
164170712|NCT01094301|592987455|FG000|Trial Stage|Withdrawal by Subject|1|||
164170713|NCT01094301|592987455|FG000|Implant Stage|Adverse Event|1|||
164170714|NCT01094301|592987455|FG000|Implant Stage|Protocol Violation|1|||
164170715|NCT01094301|592987455|FG000|Implant Stage|Withdrawal by Subject|2|||
164170716|NCT01094301|592987455|FG000|Implant Stage|No return of pain|4|||
164170717|NCT04152837|592987465|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
164170718|NCT04152837|592987465|FG000|Maintenance Period|Adverse Event|1|||
164170719|NCT04152837|592987465|FG000|Maintenance Period|Withdrawal by Subject|1|||
164170720|NCT04152837|592987465|FG000|Maintenance Period|Sponsor Termination of Study|2|||
164170721|NCT04553471|592987472|FG000|Overall Study|Did not start treatment on protocol|3|||
164170722|NCT04553471|592987472|FG000|Overall Study|Death|1|||
164170723|NCT02147158|592987473|FG000|Treatment Course 1|Adverse Event|1|||
164170724|NCT02147158|592987474|FG001|Treatment Course 1|Adverse Event|4|||
164170726|NCT02147158|592987476|FG003|Treatment Course 1|Adverse Event|4|||
164170727|NCT02147158|592987477|FG004|Treatment Course 1|Adverse Event|1|||
164170728|NCT02147158|592987478|FG005|Treatment Course 1|Adverse Event|2|||
164170729|NCT02147158|592987473|FG000|Treatment Course 1|Lost to Follow-up|2|||
164170730|NCT02147158|592987474|FG001|Treatment Course 1|Lost to Follow-up|4|||
164170731|NCT02147158|592987475|FG002|Treatment Course 1|Lost to Follow-up|3|||
164170732|NCT02147158|592987476|FG003|Treatment Course 1|Lost to Follow-up|3|||
164170733|NCT02147158|592987477|FG004|Treatment Course 1|Lost to Follow-up|2|||
164170734|NCT02147158|592987478|FG005|Treatment Course 1|Lost to Follow-up|4|||
164170735|NCT02147158|592987473|FG000|Treatment Course 1|Protocol Violation|0|||
164170736|NCT02147158|592987474|FG001|Treatment Course 1|Protocol Violation|0|||
164170737|NCT02147158|592987475|FG002|Treatment Course 1|Protocol Violation|1|||
164170738|NCT02147158|592987476|FG003|Treatment Course 1|Protocol Violation|1|||
164170739|NCT02147158|592987477|FG004|Treatment Course 1|Protocol Violation|0|||
164170740|NCT02147158|592987478|FG005|Treatment Course 1|Protocol Violation|0|||
164170741|NCT02147158|592987473|FG000|Treatment Course 1|Withdrawal of Consent|1|||
164170742|NCT02147158|592987474|FG001|Treatment Course 1|Withdrawal of Consent|1|||
164170743|NCT02147158|592987475|FG002|Treatment Course 1|Withdrawal of Consent|1|||
164170744|NCT02147158|592987476|FG003|Treatment Course 1|Withdrawal of Consent|5|||
164170745|NCT02147158|592987477|FG004|Treatment Course 1|Withdrawal of Consent|3|||
164170746|NCT02147158|592987478|FG005|Treatment Course 1|Withdrawal of Consent|2|||
164170747|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Adverse Event|1|||
164170748|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Adverse Event|0|||
164170749|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Adverse Event|0|||
164170750|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Adverse Event|1|||
164170751|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Adverse Event|0|||
164170752|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Adverse Event|0|||
164170753|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
164170754|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
164170755|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
164170756|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
164170757|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
164170758|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
164170759|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
164170760|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
164170761|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
164170762|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
164170763|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
164170764|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
164170765|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
164170766|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
164170767|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
164170768|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
164170769|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
164170770|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
164170771|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170772|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170773|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
164170774|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170775|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
164170776|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
164170777|NCT02147158|592987473|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
164170778|NCT02147158|592987474|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
164170779|NCT02147158|592987475|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
164170780|NCT02147158|592987476|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
164170781|NCT02147158|592987477|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
164170782|NCT02147158|592987478|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
164170783|NCT02147158|592987473|FG000|Treatment Course 2|Adverse Event|0|||
164170784|NCT02147158|592987474|FG001|Treatment Course 2|Adverse Event|4|||
164170785|NCT02147158|592987475|FG002|Treatment Course 2|Adverse Event|2|||
164170786|NCT02147158|592987476|FG003|Treatment Course 2|Adverse Event|1|||
164170787|NCT02147158|592987477|FG004|Treatment Course 2|Adverse Event|0|||
164170788|NCT02147158|592987478|FG005|Treatment Course 2|Adverse Event|1|||
164170789|NCT02147158|592987473|FG000|Treatment Course 2|Withdrawal of Consent|0|||
164170790|NCT02147158|592987474|FG001|Treatment Course 2|Withdrawal of Consent|1|||
164170791|NCT02147158|592987475|FG002|Treatment Course 2|Withdrawal of Consent|2|||
164170792|NCT02147158|592987476|FG003|Treatment Course 2|Withdrawal of Consent|3|||
164170793|NCT02147158|592987477|FG004|Treatment Course 2|Withdrawal of Consent|0|||
164170794|NCT02147158|592987478|FG005|Treatment Course 2|Withdrawal of Consent|0|||
164170795|NCT02147158|592987473|FG000|Treatment Course 2|Lost to Follow-up|1|||
164170796|NCT02147158|592987474|FG001|Treatment Course 2|Lost to Follow-up|0|||
164170797|NCT02147158|592987475|FG002|Treatment Course 2|Lost to Follow-up|1|||
164170798|NCT02147158|592987476|FG003|Treatment Course 2|Lost to Follow-up|1|||
164170799|NCT02147158|592987477|FG004|Treatment Course 2|Lost to Follow-up|0|||
164170800|NCT02147158|592987478|FG005|Treatment Course 2|Lost to Follow-up|1|||
164170801|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170802|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
164170803|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
164170804|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170805|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170806|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
164170807|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
164170808|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
164170809|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
164170810|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
164170811|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
164170812|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
164170813|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
164170814|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
164170815|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
164170816|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
164170817|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
164170818|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
164170819|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
164170820|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
164170821|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
164170822|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
164170823|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
164170824|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
164170825|NCT02147158|592987473|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
164170826|NCT02147158|592987474|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
164170827|NCT02147158|592987475|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
164170828|NCT02147158|592987476|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
164170829|NCT02147158|592987477|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
164170830|NCT02147158|592987478|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
164170831|NCT01441765|592987479|FG000|Overall Study|Death|1|||
164170832|NCT01441765|592987480|FG001|Overall Study|Death|0|||
164170833|NCT04520997|592987481|FG000|Overall Study|Lost to Follow-up|1|||
164170834|NCT04520997|592987482|FG001|Overall Study|Lost to Follow-up|1|||
164170835|NCT04520997|592987481|FG000|Overall Study|Withdrawal by Subject|1|||
164170836|NCT04520997|592987482|FG001|Overall Study|Withdrawal by Subject|0|||
164170837|NCT04520997|592987481|FG000|Overall Study|Not Treated|0|||
164170838|NCT04520997|592987482|FG001|Overall Study|Not Treated|1|||
164170839|NCT03689374|592987483|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
164170840|NCT03689374|592987484|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
164170841|NCT03689374|592987485|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
164170842|NCT03689374|592987483|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
164170843|NCT03689374|592987484|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
164170844|NCT03689374|592987485|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
164170845|NCT03689374|592987483|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
164170846|NCT03689374|592987484|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
164170847|NCT03689374|592987485|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
164170848|NCT03689374|592987483|FG000|Treatment Period (Week 0 to 52)|Death|0|||
164170849|NCT03689374|592987484|FG001|Treatment Period (Week 0 to 52)|Death|11|||
164170850|NCT03689374|592987485|FG002|Treatment Period (Week 0 to 52)|Death|1|||
164170851|NCT05367973|592987486|FG000|Overall Study|Adverse Event|0|||
164170852|NCT05367973|592987487|FG001|Overall Study|Adverse Event|2|||
164170853|NCT00986921|592987488|FG000|Overall Study|Physician Decision|1|||
164170854|NCT00986921|592987489|FG001|Overall Study|Physician Decision|0|||
164170855|NCT00813813|592987490|FG000|Overall Study|Withdrawal by Subject|1|||
164170856|NCT00813813|592987491|FG001|Overall Study|Withdrawal by Subject|1|||
164170857|NCT00813813|592987490|FG000|Overall Study|Lost to Follow-up|2|||
164170858|NCT00813813|592987491|FG001|Overall Study|Lost to Follow-up|7|||
164170859|NCT00813813|592987490|FG000|Overall Study|Other|0|||
164170860|NCT00813813|592987491|FG001|Overall Study|Other|1|||
164170861|NCT01758731|592987492|FG000|Overall Study|Physician Decision|1|||
164170862|NCT04445714|592987493|FG000|Overall Study|Discontinuation of the study|14|||
164170863|NCT04445714|592987493|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
164170864|NCT04445714|592987493|FG000|Overall Study|Withdrawal of Informed Consent|8|||
164170865|NCT02396420|592987494|FG000|Overall Study|Death|1|||
164170866|NCT01273623|592987500|FG000|Overall Study|did not meet IVUS criteria|29|||
164170867|NCT04934189|592989092|FG000|Overall Study|Lost to Follow-up|4|||
164170868|NCT04934189|592989092|FG000|Overall Study|Withdrawal by Subject|17|||
164170869|NCT03320850|592989095|FG000|Overall Study|Lost to Follow-up|0|||
164170870|NCT03320850|592989096|FG001|Overall Study|Lost to Follow-up|0|||
164170871|NCT03320850|592989097|FG002|Overall Study|Lost to Follow-up|0|||
164170872|NCT03320850|592989098|FG003|Overall Study|Lost to Follow-up|0|||
164170873|NCT03320850|592989099|FG004|Overall Study|Lost to Follow-up|1|||
164170874|NCT03320850|592989100|FG005|Overall Study|Lost to Follow-up|2|||
164170875|NCT03320850|592989101|FG006|Overall Study|Lost to Follow-up|2|||
164170876|NCT03320850|592989102|FG007|Overall Study|Lost to Follow-up|0|||
164170877|NCT03320850|592989103|FG008|Overall Study|Lost to Follow-up|6|||
164170878|NCT03320850|592989104|FG009|Overall Study|Lost to Follow-up|4|||
164170879|NCT03320850|592989095|FG000|Overall Study|Withdrawal by Subject|0|||
164170880|NCT03320850|592989096|FG001|Overall Study|Withdrawal by Subject|0|||
164170881|NCT03320850|592989097|FG002|Overall Study|Withdrawal by Subject|0|||
164170882|NCT03320850|592989098|FG003|Overall Study|Withdrawal by Subject|0|||
164170883|NCT03320850|592989099|FG004|Overall Study|Withdrawal by Subject|1|||
164170884|NCT03320850|592989100|FG005|Overall Study|Withdrawal by Subject|2|||
164170885|NCT03320850|592989101|FG006|Overall Study|Withdrawal by Subject|4|||
164170886|NCT03320850|592989102|FG007|Overall Study|Withdrawal by Subject|5|||
164170887|NCT03320850|592989103|FG008|Overall Study|Withdrawal by Subject|2|||
164170888|NCT03320850|592989104|FG009|Overall Study|Withdrawal by Subject|1|||
164170889|NCT03320850|592989095|FG000|Overall Study|Lack of Efficacy|0|||
164170890|NCT03320850|592989096|FG001|Overall Study|Lack of Efficacy|0|||
164170891|NCT03320850|592989097|FG002|Overall Study|Lack of Efficacy|0|||
164170892|NCT03320850|592989098|FG003|Overall Study|Lack of Efficacy|1|||
164170893|NCT03320850|592989099|FG004|Overall Study|Lack of Efficacy|0|||
164170894|NCT03320850|592989100|FG005|Overall Study|Lack of Efficacy|1|||
164170895|NCT03320850|592989101|FG006|Overall Study|Lack of Efficacy|0|||
164170896|NCT03320850|592989102|FG007|Overall Study|Lack of Efficacy|2|||
164170897|NCT03320850|592989103|FG008|Overall Study|Lack of Efficacy|0|||
164170898|NCT03320850|592989104|FG009|Overall Study|Lack of Efficacy|3|||
164170899|NCT03320850|592989095|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
164170900|NCT03320850|592989096|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
164170901|NCT03320850|592989097|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
164170902|NCT03320850|592989098|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
164170903|NCT03320850|592989099|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
164170904|NCT03320850|592989100|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
164170905|NCT03320850|592989101|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
164170906|NCT03320850|592989102|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
164170907|NCT03320850|592989103|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
164170908|NCT03320850|592989104|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
164170909|NCT03320850|592989095|FG000|Overall Study|Adverse Event|0|||
164170910|NCT03320850|592989096|FG001|Overall Study|Adverse Event|0|||
164170911|NCT03320850|592989097|FG002|Overall Study|Adverse Event|0|||
164170912|NCT03320850|592989098|FG003|Overall Study|Adverse Event|0|||
164170913|NCT03320850|592989099|FG004|Overall Study|Adverse Event|0|||
164170914|NCT03320850|592989100|FG005|Overall Study|Adverse Event|2|||
164170915|NCT03320850|592989101|FG006|Overall Study|Adverse Event|1|||
164170916|NCT03320850|592989102|FG007|Overall Study|Adverse Event|0|||
164170917|NCT03320850|592989103|FG008|Overall Study|Adverse Event|2|||
164170918|NCT03320850|592989104|FG009|Overall Study|Adverse Event|0|||
164170919|NCT03320850|592989095|FG000|Overall Study|Reason Not Specified|0|||
164170920|NCT03320850|592989096|FG001|Overall Study|Reason Not Specified|0|||
164170921|NCT03320850|592989097|FG002|Overall Study|Reason Not Specified|0|||
164170922|NCT03320850|592989098|FG003|Overall Study|Reason Not Specified|0|||
164170923|NCT03320850|592989099|FG004|Overall Study|Reason Not Specified|0|||
164170924|NCT03320850|592989100|FG005|Overall Study|Reason Not Specified|1|||
164170925|NCT03320850|592989101|FG006|Overall Study|Reason Not Specified|0|||
164170926|NCT03320850|592989102|FG007|Overall Study|Reason Not Specified|0|||
164170927|NCT03320850|592989103|FG008|Overall Study|Reason Not Specified|0|||
164170928|NCT03320850|592989104|FG009|Overall Study|Reason Not Specified|1|||
164170929|NCT02002533|592989108|FG000|Overall Study|Withdrawal by Subject|6|||
164170930|NCT02002533|592989109|FG001|Overall Study|Withdrawal by Subject|13|||
164170931|NCT02002533|592989108|FG000|Overall Study|Protocol Violation|0|||
164170932|NCT02002533|592989109|FG001|Overall Study|Protocol Violation|1|||
164170933|NCT02002533|592989108|FG000|Overall Study|Adverse Event|0|||
164170934|NCT02002533|592989109|FG001|Overall Study|Adverse Event|3|||
164170935|NCT02002533|592989108|FG000|Overall Study|Lost to Follow-up|0|||
164170936|NCT02002533|592989109|FG001|Overall Study|Lost to Follow-up|1|||
164170937|NCT03408444|592989121|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
164170938|NCT03408444|592989122|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164170939|NCT03408444|592989123|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164170940|NCT03408444|592989124|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
164170941|NCT03408444|592989121|FG000|Overall Study|Lens Discomfort|0|||
164170942|NCT03408444|592989122|FG001|Overall Study|Lens Discomfort|1|||
164170943|NCT03408444|592989123|FG002|Overall Study|Lens Discomfort|0|||
164170944|NCT03408444|592989124|FG003|Overall Study|Lens Discomfort|0|||
164170945|NCT03408444|592989121|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
164170946|NCT03408444|592989122|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
164170947|NCT03408444|592989123|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
164171093|NCT01938430|592989154|FG004|Overall Study|Lack of Efficacy|0|||
164170948|NCT03408444|592989124|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
164170949|NCT03408444|592989121|FG000|Overall Study|Withdrawal by Subject|0|||
164170950|NCT03408444|592989122|FG001|Overall Study|Withdrawal by Subject|2|||
164170951|NCT03408444|592989123|FG002|Overall Study|Withdrawal by Subject|3|||
164170952|NCT03408444|592989124|FG003|Overall Study|Withdrawal by Subject|0|||
164170953|NCT03408444|592989121|FG000|Overall Study|Lost to Follow-up|0|||
164170954|NCT03408444|592989122|FG001|Overall Study|Lost to Follow-up|0|||
164170955|NCT03408444|592989123|FG002|Overall Study|Lost to Follow-up|1|||
164170956|NCT03408444|592989124|FG003|Overall Study|Lost to Follow-up|0|||
164170957|NCT03408444|592989121|FG000|Overall Study|Adverse Event|0|||
164170958|NCT03408444|592989122|FG001|Overall Study|Adverse Event|0|||
164170959|NCT03408444|592989123|FG002|Overall Study|Adverse Event|0|||
164170960|NCT03408444|592989124|FG003|Overall Study|Adverse Event|1|||
164170961|NCT03408444|592989121|FG000|Overall Study|Lens Handling Difficulties|0|||
164170962|NCT03408444|592989122|FG001|Overall Study|Lens Handling Difficulties|0|||
164170963|NCT03408444|592989123|FG002|Overall Study|Lens Handling Difficulties|1|||
164170964|NCT03408444|592989124|FG003|Overall Study|Lens Handling Difficulties|0|||
164170965|NCT03408444|592989121|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
164170966|NCT03408444|592989122|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
164170967|NCT03408444|592989123|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
164170968|NCT03408444|592989124|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
164170969|NCT00231114|592989125|FG000|Randomized|Withdrawal by Subject|6|||
164170970|NCT00231114|592989126|FG001|Randomized|Withdrawal by Subject|3|||
164170971|NCT00231114|592989125|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
164170972|NCT00231114|592989126|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
164170973|NCT00231114|592989125|FG000|Post-Treatment Period|Lost to Follow-up|6|||
164170974|NCT00231114|592989126|FG001|Post-Treatment Period|Lost to Follow-up|1|||
164170975|NCT00231114|592989125|FG000|Post-Treatment Period|Physician Decision|1|||
164170976|NCT00231114|592989126|FG001|Post-Treatment Period|Physician Decision|0|||
164170977|NCT00231114|592989125|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
164170978|NCT00231114|592989126|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
164170979|NCT01194999|592989130|FG000|Overall Study|Lost to Follow-up|17|||
164170980|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
164170981|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
164170982|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
164170983|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
164170984|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
164170985|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
164170986|NCT01895270|592989131|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
164170987|NCT01895270|592989132|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
164170988|NCT01895270|592989131|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
164170989|NCT01895270|592989132|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
164170990|NCT01895270|592989131|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
164170991|NCT01895270|592989132|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
164170992|NCT01895270|592989131|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
164170993|NCT01895270|592989132|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
164170994|NCT02091375|592989135|FG000|Overall Study|Adverse Event|8|||
164170995|NCT02091375|592989136|FG001|Overall Study|Adverse Event|1|||
164170996|NCT02091375|592989135|FG000|Overall Study|Lost to Follow-up|0|||
164170997|NCT02091375|592989136|FG001|Overall Study|Lost to Follow-up|1|||
164170998|NCT02091375|592989135|FG000|Overall Study|Withdrawal by Subject|0|||
164170999|NCT02091375|592989136|FG001|Overall Study|Withdrawal by Subject|1|||
164171000|NCT02091375|592989135|FG000|Overall Study|Withdrawn by the investigator|1|||
164171001|NCT02091375|592989136|FG001|Overall Study|Withdrawn by the investigator|0|||
164171002|NCT02682823|592989138|FG000|Overall Study|Withdrawal by Subject|0|||
164171003|NCT02682823|592989139|FG001|Overall Study|Withdrawal by Subject|0|||
164171004|NCT02682823|592989140|FG002|Overall Study|Withdrawal by Subject|1|||
164171005|NCT02682823|592989141|FG003|Overall Study|Withdrawal by Subject|0|||
164171006|NCT02682823|592989142|FG004|Overall Study|Withdrawal by Subject|1|||
164171007|NCT02682823|592989138|FG000|Overall Study|Protocol Deviation|0|||
164171008|NCT02682823|592989139|FG001|Overall Study|Protocol Deviation|1|||
164171009|NCT02682823|592989140|FG002|Overall Study|Protocol Deviation|0|||
164171010|NCT02682823|592989141|FG003|Overall Study|Protocol Deviation|0|||
164171011|NCT02682823|592989142|FG004|Overall Study|Protocol Deviation|0|||
164171012|NCT02682823|592989138|FG000|Overall Study|Adverse Event|0|||
164171013|NCT02682823|592989139|FG001|Overall Study|Adverse Event|0|||
164171014|NCT02682823|592989140|FG002|Overall Study|Adverse Event|0|||
164171015|NCT02682823|592989141|FG003|Overall Study|Adverse Event|1|||
164171016|NCT02682823|592989142|FG004|Overall Study|Adverse Event|0|||
164171017|NCT03781583|592989145|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
164171018|NCT03781583|592989146|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
164171019|NCT03781583|592989147|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
164171020|NCT03781583|592989148|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
164171021|NCT03781583|592989145|FG000|Overall Study|Technology did not work for that person in that environment|1|||
164171022|NCT03781583|592989146|FG001|Overall Study|Technology did not work for that person in that environment|0|||
164171023|NCT03781583|592989147|FG002|Overall Study|Technology did not work for that person in that environment|0|||
164171024|NCT03781583|592989148|FG003|Overall Study|Technology did not work for that person in that environment|0|||
164171025|NCT03781583|592989145|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
164171026|NCT03781583|592989146|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
164171027|NCT03781583|592989147|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
164171028|NCT03781583|592989148|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
164171029|NCT03781583|592989145|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
164171030|NCT03781583|592989146|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
164171031|NCT03781583|592989147|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
164171032|NCT03781583|592989148|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
164171033|NCT01938430|592989150|FG000|Overall Study|Randomized but Not Treated|0|||
164171034|NCT01938430|592989151|FG001|Overall Study|Randomized but Not Treated|0|||
164171035|NCT01938430|592989152|FG002|Overall Study|Randomized but Not Treated|0|||
164171036|NCT01938430|592989153|FG003|Overall Study|Randomized but Not Treated|0|||
164171037|NCT01938430|592989154|FG004|Overall Study|Randomized but Not Treated|0|||
164171038|NCT01938430|592989155|FG005|Overall Study|Randomized but Not Treated|0|||
164171039|NCT01938430|592989156|FG006|Overall Study|Randomized but Not Treated|0|||
164171040|NCT01938430|592989157|FG007|Overall Study|Randomized but Not Treated|0|||
164171041|NCT01938430|592989158|FG008|Overall Study|Randomized but Not Treated|0|||
164171042|NCT01938430|592989159|FG009|Overall Study|Randomized but Not Treated|0|||
164171043|NCT01938430|592989160|FG010|Overall Study|Randomized but Not Treated|1|||
164171044|NCT01938430|592989161|FG011|Overall Study|Randomized but Not Treated|0|||
164171045|NCT01938430|592989162|FG012|Overall Study|Randomized but Not Treated|0|||
164171046|NCT01938430|592989163|FG013|Overall Study|Randomized but Not Treated|1|||
164171047|NCT01938430|592989150|FG000|Overall Study|Adverse Event|0|||
164171048|NCT01938430|592989151|FG001|Overall Study|Adverse Event|0|||
164171049|NCT01938430|592989152|FG002|Overall Study|Adverse Event|0|||
164171050|NCT01938430|592989153|FG003|Overall Study|Adverse Event|0|||
164171051|NCT01938430|592989154|FG004|Overall Study|Adverse Event|0|||
164171052|NCT01938430|592989155|FG005|Overall Study|Adverse Event|0|||
164171053|NCT01938430|592989156|FG006|Overall Study|Adverse Event|1|||
164171054|NCT01938430|592989157|FG007|Overall Study|Adverse Event|0|||
164171055|NCT01938430|592989158|FG008|Overall Study|Adverse Event|0|||
164171056|NCT01938430|592989159|FG009|Overall Study|Adverse Event|0|||
164171057|NCT01938430|592989160|FG010|Overall Study|Adverse Event|0|||
164171058|NCT01938430|592989161|FG011|Overall Study|Adverse Event|0|||
164171059|NCT01938430|592989162|FG012|Overall Study|Adverse Event|0|||
164171060|NCT01938430|592989163|FG013|Overall Study|Adverse Event|0|||
164171061|NCT01938430|592989150|FG000|Overall Study|Death|1|||
164171062|NCT01938430|592989151|FG001|Overall Study|Death|2|||
164171063|NCT01938430|592989152|FG002|Overall Study|Death|2|||
164171064|NCT01938430|592989153|FG003|Overall Study|Death|1|||
164171065|NCT01938430|592989154|FG004|Overall Study|Death|0|||
164171066|NCT01938430|592989155|FG005|Overall Study|Death|0|||
164171067|NCT01938430|592989156|FG006|Overall Study|Death|1|||
164171068|NCT01938430|592989157|FG007|Overall Study|Death|1|||
164171069|NCT01938430|592989158|FG008|Overall Study|Death|2|||
164171070|NCT01938430|592989159|FG009|Overall Study|Death|3|||
164171071|NCT01938430|592989160|FG010|Overall Study|Death|0|||
164171072|NCT01938430|592989161|FG011|Overall Study|Death|0|||
164171073|NCT01938430|592989162|FG012|Overall Study|Death|0|||
164171074|NCT01938430|592989163|FG013|Overall Study|Death|0|||
164171075|NCT01938430|592989150|FG000|Overall Study|Investigator's Discretion|0|||
164171076|NCT01938430|592989151|FG001|Overall Study|Investigator's Discretion|0|||
164171077|NCT01938430|592989152|FG002|Overall Study|Investigator's Discretion|1|||
164171078|NCT01938430|592989153|FG003|Overall Study|Investigator's Discretion|0|||
164171079|NCT01938430|592989154|FG004|Overall Study|Investigator's Discretion|0|||
164171080|NCT01938430|592989155|FG005|Overall Study|Investigator's Discretion|0|||
164171081|NCT01938430|592989156|FG006|Overall Study|Investigator's Discretion|0|||
164171082|NCT01938430|592989157|FG007|Overall Study|Investigator's Discretion|0|||
164171083|NCT01938430|592989158|FG008|Overall Study|Investigator's Discretion|0|||
164171084|NCT01938430|592989159|FG009|Overall Study|Investigator's Discretion|0|||
164171085|NCT01938430|592989160|FG010|Overall Study|Investigator's Discretion|0|||
164171086|NCT01938430|592989161|FG011|Overall Study|Investigator's Discretion|0|||
164171087|NCT01938430|592989162|FG012|Overall Study|Investigator's Discretion|0|||
164171088|NCT01938430|592989163|FG013|Overall Study|Investigator's Discretion|0|||
164171089|NCT01938430|592989150|FG000|Overall Study|Lack of Efficacy|3|||
164171090|NCT01938430|592989151|FG001|Overall Study|Lack of Efficacy|1|||
164171091|NCT01938430|592989152|FG002|Overall Study|Lack of Efficacy|1|||
164171092|NCT01938430|592989153|FG003|Overall Study|Lack of Efficacy|1|||
164171094|NCT01938430|592989155|FG005|Overall Study|Lack of Efficacy|0|||
164171095|NCT01938430|592989156|FG006|Overall Study|Lack of Efficacy|0|||
164171096|NCT01938430|592989157|FG007|Overall Study|Lack of Efficacy|0|||
164171097|NCT01938430|592989158|FG008|Overall Study|Lack of Efficacy|1|||
164171098|NCT01938430|592989159|FG009|Overall Study|Lack of Efficacy|0|||
164171099|NCT01938430|592989160|FG010|Overall Study|Lack of Efficacy|2|||
164171100|NCT01938430|592989161|FG011|Overall Study|Lack of Efficacy|1|||
164171101|NCT01938430|592989162|FG012|Overall Study|Lack of Efficacy|0|||
164171102|NCT01938430|592989163|FG013|Overall Study|Lack of Efficacy|0|||
164171103|NCT01938430|592989150|FG000|Overall Study|Lost to Follow-up|0|||
164171104|NCT01938430|592989151|FG001|Overall Study|Lost to Follow-up|0|||
164171105|NCT01938430|592989152|FG002|Overall Study|Lost to Follow-up|1|||
164171106|NCT01938430|592989153|FG003|Overall Study|Lost to Follow-up|0|||
164171107|NCT01938430|592989154|FG004|Overall Study|Lost to Follow-up|0|||
164171108|NCT01938430|592989155|FG005|Overall Study|Lost to Follow-up|1|||
164171109|NCT01938430|592989156|FG006|Overall Study|Lost to Follow-up|0|||
164171110|NCT01938430|592989157|FG007|Overall Study|Lost to Follow-up|0|||
164171111|NCT01938430|592989158|FG008|Overall Study|Lost to Follow-up|0|||
164171112|NCT01938430|592989159|FG009|Overall Study|Lost to Follow-up|0|||
164171113|NCT01938430|592989160|FG010|Overall Study|Lost to Follow-up|0|||
164171114|NCT01938430|592989161|FG011|Overall Study|Lost to Follow-up|0|||
164171115|NCT01938430|592989162|FG012|Overall Study|Lost to Follow-up|0|||
164171116|NCT01938430|592989163|FG013|Overall Study|Lost to Follow-up|0|||
164171117|NCT01938430|592989150|FG000|Overall Study|Withdrew Consent|0|||
164171118|NCT01938430|592989151|FG001|Overall Study|Withdrew Consent|0|||
164171119|NCT01938430|592989152|FG002|Overall Study|Withdrew Consent|0|||
164171120|NCT01938430|592989153|FG003|Overall Study|Withdrew Consent|0|||
164171121|NCT01938430|592989154|FG004|Overall Study|Withdrew Consent|0|||
164171122|NCT01938430|592989155|FG005|Overall Study|Withdrew Consent|0|||
164171123|NCT01938430|592989156|FG006|Overall Study|Withdrew Consent|0|||
164171124|NCT01938430|592989157|FG007|Overall Study|Withdrew Consent|0|||
164171125|NCT01938430|592989158|FG008|Overall Study|Withdrew Consent|1|||
164171126|NCT01938430|592989159|FG009|Overall Study|Withdrew Consent|0|||
164171127|NCT01938430|592989160|FG010|Overall Study|Withdrew Consent|0|||
164171128|NCT01938430|592989161|FG011|Overall Study|Withdrew Consent|0|||
164171129|NCT01938430|592989162|FG012|Overall Study|Withdrew Consent|0|||
164171130|NCT01938430|592989163|FG013|Overall Study|Withdrew Consent|0|||
164171131|NCT00537316|592989165|FG000|Part 1|Adverse Event|7|||
164171132|NCT00537316|592989166|FG001|Part 1|Adverse Event|11|||
164171133|NCT00537316|592989167|FG002|Part 1|Adverse Event|8|||
164171134|NCT00537316|592989168|FG003|Part 1|Adverse Event|0|||
164171135|NCT00537316|592989169|FG004|Part 1|Adverse Event|0|||
164171136|NCT00537316|592989170|FG005|Part 1|Adverse Event|0|||
164171137|NCT00537316|592989171|FG006|Part 1|Adverse Event|0|||
164171138|NCT00537316|592989165|FG000|Part 1|Protocol defined clinical event|1|||
164171139|NCT00537316|592989166|FG001|Part 1|Protocol defined clinical event|0|||
164171140|NCT00537316|592989167|FG002|Part 1|Protocol defined clinical event|0|||
164171141|NCT00537316|592989168|FG003|Part 1|Protocol defined clinical event|0|||
164171142|NCT00537316|592989169|FG004|Part 1|Protocol defined clinical event|0|||
164171143|NCT00537316|592989170|FG005|Part 1|Protocol defined clinical event|0|||
164171144|NCT00537316|592989171|FG006|Part 1|Protocol defined clinical event|0|||
164171145|NCT00537316|592989165|FG000|Part 1|Lost to Follow-up|1|||
164171146|NCT00537316|592989166|FG001|Part 1|Lost to Follow-up|0|||
164171147|NCT00537316|592989167|FG002|Part 1|Lost to Follow-up|0|||
164171148|NCT00537316|592989168|FG003|Part 1|Lost to Follow-up|0|||
164171149|NCT00537316|592989169|FG004|Part 1|Lost to Follow-up|0|||
164171150|NCT00537316|592989170|FG005|Part 1|Lost to Follow-up|0|||
164171151|NCT00537316|592989171|FG006|Part 1|Lost to Follow-up|0|||
164171152|NCT00537316|592989165|FG000|Part 1|Withdrawal by Subject|3|||
164171153|NCT00537316|592989166|FG001|Part 1|Withdrawal by Subject|8|||
164171154|NCT00537316|592989167|FG002|Part 1|Withdrawal by Subject|4|||
164171155|NCT00537316|592989168|FG003|Part 1|Withdrawal by Subject|0|||
164171156|NCT00537316|592989169|FG004|Part 1|Withdrawal by Subject|0|||
164171157|NCT00537316|592989170|FG005|Part 1|Withdrawal by Subject|0|||
164171158|NCT00537316|592989171|FG006|Part 1|Withdrawal by Subject|0|||
164171159|NCT00537316|592989165|FG000|Part 1|Protocol Violation|1|||
164171160|NCT00537316|592989166|FG001|Part 1|Protocol Violation|5|||
164171161|NCT00537316|592989167|FG002|Part 1|Protocol Violation|1|||
164171162|NCT00537316|592989168|FG003|Part 1|Protocol Violation|0|||
164171163|NCT00537316|592989169|FG004|Part 1|Protocol Violation|0|||
164171164|NCT00537316|592989170|FG005|Part 1|Protocol Violation|0|||
164171165|NCT00537316|592989171|FG006|Part 1|Protocol Violation|0|||
164171166|NCT00537316|592989165|FG000|Part 1|Did not meet protocol eligibility|1|||
164171167|NCT00537316|592989166|FG001|Part 1|Did not meet protocol eligibility|3|||
164171168|NCT00537316|592989167|FG002|Part 1|Did not meet protocol eligibility|2|||
164171169|NCT00537316|592989168|FG003|Part 1|Did not meet protocol eligibility|0|||
164171170|NCT00537316|592989169|FG004|Part 1|Did not meet protocol eligibility|0|||
164171171|NCT00537316|592989170|FG005|Part 1|Did not meet protocol eligibility|0|||
164171172|NCT00537316|592989171|FG006|Part 1|Did not meet protocol eligibility|0|||
164171173|NCT00537316|592989165|FG000|Part 1|Administrative|0|||
164171174|NCT00537316|592989166|FG001|Part 1|Administrative|0|||
164171175|NCT00537316|592989167|FG002|Part 1|Administrative|2|||
164171176|NCT00537316|592989168|FG003|Part 1|Administrative|0|||
164171177|NCT00537316|592989169|FG004|Part 1|Administrative|0|||
164171178|NCT00537316|592989170|FG005|Part 1|Administrative|0|||
164171179|NCT00537316|592989171|FG006|Part 1|Administrative|0|||
164171180|NCT00537316|592989165|FG000|Part 2|Never entered follow-up|0|||
164171181|NCT00537316|592989166|FG001|Part 2|Never entered follow-up|0|||
164171182|NCT00537316|592989167|FG002|Part 2|Never entered follow-up|0|||
164171183|NCT00537316|592989168|FG003|Part 2|Never entered follow-up|0|||
164171184|NCT00537316|592989169|FG004|Part 2|Never entered follow-up|0|||
164171185|NCT00537316|592989170|FG005|Part 2|Never entered follow-up|0|||
164171186|NCT00537316|592989171|FG006|Part 2|Never entered follow-up|1|||
164171187|NCT00537316|592989165|FG000|Part 2|Adverse Event|4|||
164171188|NCT00537316|592989166|FG001|Part 2|Adverse Event|0|||
164171189|NCT00537316|592989167|FG002|Part 2|Adverse Event|2|||
164171190|NCT00537316|592989168|FG003|Part 2|Adverse Event|0|||
164171191|NCT00537316|592989169|FG004|Part 2|Adverse Event|0|||
164171192|NCT00537316|592989170|FG005|Part 2|Adverse Event|0|||
164171193|NCT00537316|592989171|FG006|Part 2|Adverse Event|0|||
164171194|NCT00537316|592989165|FG000|Part 2|Lost to Follow-up|1|||
164171195|NCT00537316|592989166|FG001|Part 2|Lost to Follow-up|0|||
164171196|NCT00537316|592989167|FG002|Part 2|Lost to Follow-up|2|||
164171197|NCT00537316|592989168|FG003|Part 2|Lost to Follow-up|0|||
164171198|NCT00537316|592989169|FG004|Part 2|Lost to Follow-up|0|||
164171199|NCT00537316|592989170|FG005|Part 2|Lost to Follow-up|0|||
164171200|NCT00537316|592989171|FG006|Part 2|Lost to Follow-up|0|||
164171201|NCT00537316|592989165|FG000|Part 2|Withdrawal by Subject|5|||
164171202|NCT00537316|592989166|FG001|Part 2|Withdrawal by Subject|1|||
164171203|NCT00537316|592989167|FG002|Part 2|Withdrawal by Subject|4|||
164171204|NCT00537316|592989168|FG003|Part 2|Withdrawal by Subject|0|||
164171205|NCT00537316|592989169|FG004|Part 2|Withdrawal by Subject|0|||
164171206|NCT00537316|592989170|FG005|Part 2|Withdrawal by Subject|0|||
164171207|NCT00537316|592989171|FG006|Part 2|Withdrawal by Subject|0|||
164171208|NCT00537316|592989165|FG000|Part 2|Administrative|16|||
164171209|NCT00537316|592989166|FG001|Part 2|Administrative|8|||
164171210|NCT00537316|592989167|FG002|Part 2|Administrative|24|||
164171211|NCT00537316|592989168|FG003|Part 2|Administrative|3|||
164171212|NCT00537316|592989169|FG004|Part 2|Administrative|1|||
164171213|NCT00537316|592989170|FG005|Part 2|Administrative|4|||
164171214|NCT00537316|592989171|FG006|Part 2|Administrative|1|||
164171215|NCT00782184|592989174|FG000|Overall Study|Adverse Event|1|||
164171216|NCT00782184|592989175|FG001|Overall Study|Adverse Event|2|||
164171217|NCT00782184|592989174|FG000|Overall Study|Protocol Violation|0|||
164171218|NCT00782184|592989175|FG001|Overall Study|Protocol Violation|1|||
164171219|NCT00782184|592989174|FG000|Overall Study|Withdrawal by Subject|3|||
164171220|NCT00782184|592989175|FG001|Overall Study|Withdrawal by Subject|2|||
164171221|NCT01438294|592989176|FG000|Overall Study|Lost to Follow-up|3|||
164171222|NCT01438294|592989177|FG001|Overall Study|Lost to Follow-up|7|||
164171223|NCT03696108|592989185|FG000|Overall Study|Physician Decision|1|||
164171224|NCT03696108|592989186|FG001|Overall Study|Physician Decision|0|||
164171225|NCT03696108|592989185|FG000|Overall Study|Withdrawal by Subject|3|||
164171226|NCT03696108|592989186|FG001|Overall Study|Withdrawal by Subject|6|||
164171227|NCT03505593|592989187|FG000|Overall Study|Withdrawal by Subject|1|||
164171228|NCT03505593|592989187|FG000|Overall Study|Died before procedure|1|||
164171229|NCT03505593|592989187|FG000|Overall Study|Anatomical abnormality|1|||
164171230|NCT03505593|592989187|FG000|Overall Study|Unable to pass through esophagus|1|||
164171231|NCT03505593|592989187|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
164171232|NCT02822573|592989189|FG000|Overall Study|Lost to Follow-up|5|||
164171233|NCT02822573|592989190|FG001|Overall Study|Lost to Follow-up|3|||
164171234|NCT02822573|592989189|FG000|Overall Study|Physician Decision|1|||
164171235|NCT02822573|592989190|FG001|Overall Study|Physician Decision|1|||
164171236|NCT02822573|592989189|FG000|Overall Study|Withdrawal by Subject|9|||
164171237|NCT02822573|592989190|FG001|Overall Study|Withdrawal by Subject|5|||
164171238|NCT02822573|592989189|FG000|Overall Study|Protocol Violation|6|||
164171239|NCT02822573|592989190|FG001|Overall Study|Protocol Violation|4|||
164171240|NCT02822573|592989189|FG000|Overall Study|Too sick or ill|2|||
164171241|NCT02822573|592989190|FG001|Overall Study|Too sick or ill|1|||
164171242|NCT02822573|592989189|FG000|Overall Study|Disease Progression|1|||
164171243|NCT02822573|592989190|FG001|Overall Study|Disease Progression|1|||
164171244|NCT02822573|592989189|FG000|Overall Study|No reason given|6|||
164171245|NCT02822573|592989190|FG001|Overall Study|No reason given|4|||
164171246|NCT03891862|592989191|FG000|Open-label Period|Adverse Event|2|||
164171247|NCT03891862|592989192|FG001|Open-label Period|Adverse Event|0|||
164171248|NCT03891862|592989193|FG002|Open-label Period|Adverse Event|0|||
164171249|NCT03891862|592989191|FG000|Open-label Period|Protocol Violation|5|||
164171250|NCT03891862|592989192|FG001|Open-label Period|Protocol Violation|0|||
164171251|NCT03891862|592989193|FG002|Open-label Period|Protocol Violation|0|||
164171252|NCT03891862|592989191|FG000|Open-label Period|Withdrawal by Subject|6|||
164171253|NCT03891862|592989192|FG001|Open-label Period|Withdrawal by Subject|0|||
164171254|NCT03891862|592989193|FG002|Open-label Period|Withdrawal by Subject|0|||
164171255|NCT03891862|592989191|FG000|Open-label Period|Death|1|||
164171256|NCT03891862|592989192|FG001|Open-label Period|Death|0|||
164171257|NCT03891862|592989193|FG002|Open-label Period|Death|0|||
164171258|NCT03891862|592989191|FG000|Open-label Period|Lost to Follow-up|2|||
164171259|NCT03891862|592989192|FG001|Open-label Period|Lost to Follow-up|0|||
164171260|NCT03891862|592989193|FG002|Open-label Period|Lost to Follow-up|0|||
164171261|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
164171262|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
164171263|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
164171264|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
164171265|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
164171266|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
164171267|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
164171268|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
164171269|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
164171270|NCT03891862|592989191|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
164171271|NCT03891862|592989192|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
164171272|NCT03891862|592989193|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
164171273|NCT01053962|592989194|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
164171274|NCT01053962|592989195|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
164171275|NCT01053962|592989196|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
164171276|NCT01053962|592989197|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
164171277|NCT01053962|592989198|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
164171278|NCT01053962|592989194|FG000|Pretreatment Period|Venipuncture Failure|0|||
164171279|NCT01053962|592989195|FG001|Pretreatment Period|Venipuncture Failure|0|||
164171280|NCT01053962|592989196|FG002|Pretreatment Period|Venipuncture Failure|1|||
164171281|NCT01053962|592989197|FG003|Pretreatment Period|Venipuncture Failure|0|||
164171282|NCT01053962|592989198|FG004|Pretreatment Period|Venipuncture Failure|0|||
164171283|NCT01053962|592989194|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171284|NCT01053962|592989195|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
164171285|NCT01053962|592989196|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171286|NCT01053962|592989197|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171287|NCT01053962|592989198|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
164171288|NCT01053962|592989194|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171289|NCT01053962|592989195|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171290|NCT01053962|592989196|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171291|NCT01053962|592989197|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
164171292|NCT01053962|592989198|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
164171293|NCT01053962|592989194|FG000|Treatment Period|Lack of Efficacy|0|||
164171294|NCT01053962|592989195|FG001|Treatment Period|Lack of Efficacy|0|||
164171295|NCT01053962|592989196|FG002|Treatment Period|Lack of Efficacy|0|||
164171296|NCT01053962|592989197|FG003|Treatment Period|Lack of Efficacy|0|||
164171297|NCT01053962|592989198|FG004|Treatment Period|Lack of Efficacy|1|||
164171298|NCT01053962|592989194|FG000|Treatment Period|Adverse Event|0|||
164171299|NCT01053962|592989195|FG001|Treatment Period|Adverse Event|0|||
164171300|NCT01053962|592989196|FG002|Treatment Period|Adverse Event|0|||
164171301|NCT01053962|592989197|FG003|Treatment Period|Adverse Event|0|||
164171302|NCT01053962|592989198|FG004|Treatment Period|Adverse Event|1|||
164171303|NCT01053962|592989194|FG000|Treatment Period|Withdrawal by Subject|0|||
164171304|NCT01053962|592989195|FG001|Treatment Period|Withdrawal by Subject|0|||
164171305|NCT01053962|592989196|FG002|Treatment Period|Withdrawal by Subject|0|||
164171306|NCT01053962|592989197|FG003|Treatment Period|Withdrawal by Subject|0|||
164171307|NCT01053962|592989198|FG004|Treatment Period|Withdrawal by Subject|1|||
164171308|NCT01053962|592989194|FG000|Treatment Period|Noncompliance with protocol|1|||
164171309|NCT01053962|592989195|FG001|Treatment Period|Noncompliance with protocol|0|||
164171310|NCT01053962|592989196|FG002|Treatment Period|Noncompliance with protocol|0|||
164171311|NCT01053962|592989197|FG003|Treatment Period|Noncompliance with protocol|0|||
164171312|NCT01053962|592989198|FG004|Treatment Period|Noncompliance with protocol|0|||
164171313|NCT02833844|592989199|FG000|Double-Blind Period|Withdrawal by Subject|2|||
164171314|NCT02833844|592989200|FG001|Double-Blind Period|Withdrawal by Subject|3|||
164171315|NCT02833844|592989199|FG000|Double-Blind Period|Protocol Violation|0|||
164171316|NCT02833844|592989200|FG001|Double-Blind Period|Protocol Violation|4|||
164171317|NCT02833844|592989199|FG000|Open-Label Period|Death|0|||
164171318|NCT02833844|592989200|FG001|Open-Label Period|Death|2|||
164171319|NCT02833844|592989199|FG000|Open-Label Period|Lost to Follow-up|1|||
164171320|NCT02833844|592989200|FG001|Open-Label Period|Lost to Follow-up|0|||
164171321|NCT02833844|592989199|FG000|Open-Label Period|Withdrawal by Subject|1|||
164171322|NCT02833844|592989200|FG001|Open-Label Period|Withdrawal by Subject|0|||
164171323|NCT00308087|592989201|FG000|Overall Study|Progressive Disease|19|||
164171324|NCT00308087|592989202|FG001|Overall Study|Progressive Disease|21|||
164171325|NCT00308087|592989201|FG000|Overall Study|Study Closure|11|||
164171326|NCT00308087|592989202|FG001|Overall Study|Study Closure|12|||
164171327|NCT00308087|592989201|FG000|Overall Study|Withdrawal by Subject|2|||
164171328|NCT00308087|592989202|FG001|Overall Study|Withdrawal by Subject|1|||
164171329|NCT00308087|592989201|FG000|Overall Study|Other|4|||
164171330|NCT00308087|592989202|FG001|Overall Study|Other|3|||
164171331|NCT01646021|592989204|FG000|Overall Study|Death|77|||
164171332|NCT01646021|592989205|FG001|Overall Study|Death|83|||
164171333|NCT01646021|592989204|FG000|Overall Study|Study Terminated by Sponsor|50|||
164171334|NCT01646021|592989205|FG001|Overall Study|Study Terminated by Sponsor|41|||
164171335|NCT01646021|592989204|FG000|Overall Study|Lost to Follow-up|2|||
164171336|NCT01646021|592989205|FG001|Overall Study|Lost to Follow-up|2|||
164171337|NCT01646021|592989204|FG000|Overall Study|Withdrawal by Subject|10|||
164171338|NCT01646021|592989205|FG001|Overall Study|Withdrawal by Subject|15|||
164171339|NCT02347891|592989206|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
164171340|NCT02347891|592989207|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
164171341|NCT02347891|592989206|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
164171342|NCT02347891|592989207|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
164171343|NCT05129137|592989208|FG000|Second Period|Adverse Event|1|||
164171344|NCT05129137|592989209|FG001|Second Period|Adverse Event|0|||
164171345|NCT05129137|592989210|FG002|Second Period|Adverse Event|0|||
164171346|NCT05129137|592989211|FG003|Second Period|Adverse Event|0|||
164171347|NCT05129137|592989208|FG000|Second Period|Protocol Violation|0|||
164171348|NCT05129137|592989209|FG001|Second Period|Protocol Violation|0|||
164171349|NCT05129137|592989210|FG002|Second Period|Protocol Violation|0|||
164171350|NCT05129137|592989211|FG003|Second Period|Protocol Violation|1|||
164171351|NCT05129137|592989208|FG000|Third Period|Protocol Violation|0|||
164171352|NCT05129137|592989209|FG001|Third Period|Protocol Violation|0|||
164171353|NCT05129137|592989210|FG002|Third Period|Protocol Violation|0|||
164171354|NCT05129137|592989211|FG003|Third Period|Protocol Violation|1|||
164171355|NCT05129137|592989208|FG000|Forth Period|Protocol Violation|0|||
164171356|NCT05129137|592989209|FG001|Forth Period|Protocol Violation|1|||
164171357|NCT05129137|592989210|FG002|Forth Period|Protocol Violation|0|||
164171358|NCT05129137|592989211|FG003|Forth Period|Protocol Violation|0|||
164171359|NCT05129137|592989208|FG000|Forth Period|Withdrawal by Subject|0|||
164171360|NCT05129137|592989209|FG001|Forth Period|Withdrawal by Subject|0|||
164171361|NCT05129137|592989210|FG002|Forth Period|Withdrawal by Subject|1|||
164171362|NCT05129137|592989211|FG003|Forth Period|Withdrawal by Subject|0|||
164171363|NCT00727844|592989213|FG000|Initial Randomization|Physician Decision|2|||
164171364|NCT00727844|592989214|FG001|Initial Randomization|Physician Decision|0|||
164171365|NCT00727844|592989215|FG002|Initial Randomization|Physician Decision|0|||
164171366|NCT00727844|592989216|FG003|Initial Randomization|Physician Decision|0|||
164171367|NCT04439214|592989217|FG000|Overall Study|Adverse Event|13|||
164171368|NCT04439214|592989217|FG000|Overall Study|Disease progression|16|||
164171369|NCT04439214|592989217|FG000|Overall Study|Death|1|||
164171370|NCT04439214|592989217|FG000|Overall Study|Withdrawal by Subject|2|||
164171371|NCT04439214|592989217|FG000|Overall Study|Declining health|1|||
164171372|NCT04439214|592989217|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
164171373|NCT04439214|592989217|FG000|Overall Study|Ineligible|5|||
164171374|NCT04013672|592989222|FG000|Overall Study|Withdrawal by Subject|3|||
164171375|NCT04013672|592989223|FG001|Overall Study|Withdrawal by Subject|0|||
164171376|NCT04013672|592989222|FG000|Overall Study|Death|1|||
164171377|NCT04013672|592989223|FG001|Overall Study|Death|0|||
164171378|NCT04013672|592989222|FG000|Overall Study|Physician Decision|5|||
164171379|NCT04013672|592989223|FG001|Overall Study|Physician Decision|0|||
164171380|NCT02847494|592989228|FG000|Overall Study|Lost to Follow-up|8|||
164171381|NCT02847494|592989229|FG001|Overall Study|Lost to Follow-up|5|||
164171382|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
164171383|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
164171384|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
164171385|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
164171386|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
164171387|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
164171388|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
164171389|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
164171390|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
164171391|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
164171392|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
164171393|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
164171394|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
164171395|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
164171396|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
164171397|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
164171398|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
164171399|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
164171400|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
164171401|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
164171402|NCT00556933|592989230|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
164171403|NCT00556933|592989231|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
164171404|NCT00556933|592989232|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
164171405|NCT00556933|592989233|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
164171406|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
164171407|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
164171408|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
164171409|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
164171410|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
164171411|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
164171412|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
164171413|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
164171414|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
164171415|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
164171416|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
164171417|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
164171418|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
164171419|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
164171420|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
164171421|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
164171422|NCT00556933|592989230|FG000|CNI Withdrawal vs. Minimization|Death|0|||
164171423|NCT00556933|592989231|FG001|CNI Withdrawal vs. Minimization|Death|0|||
164171424|NCT00556933|592989232|FG002|CNI Withdrawal vs. Minimization|Death|0|||
164171425|NCT00556933|592989233|FG003|CNI Withdrawal vs. Minimization|Death|1|||
164171426|NCT00767455|592989234|FG000|Overall Study|Investigator error|19|||
164171427|NCT00746564|592989235|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
164171428|NCT00022698|592989236|FG000|Overall Study|Adverse Event|5|||
164171429|NCT00022698|592989237|FG001|Overall Study|Adverse Event|9|||
164171430|NCT00022698|592989236|FG000|Overall Study|Death|0|||
164171431|NCT00022698|592989237|FG001|Overall Study|Death|2|||
164171432|NCT00022698|592989236|FG000|Overall Study|Failure to return|0|||
164171433|NCT00022698|592989237|FG001|Overall Study|Failure to return|1|||
164171434|NCT00022698|592989236|FG000|Overall Study|Refused treatment|0|||
164171435|NCT00022698|592989237|FG001|Overall Study|Refused treatment|2|||
164171436|NCT00022698|592989236|FG000|Overall Study|Insufficient therapeutic response|2|||
164171437|NCT00022698|592989237|FG001|Overall Study|Insufficient therapeutic response|14|||
164171438|NCT00022698|592989236|FG000|Overall Study|Administrative /other|1|||
164171439|NCT00022698|592989237|FG001|Overall Study|Administrative /other|7|||
164171440|NCT01827267|592989238|FG000|Overall Study|Did not receive study drug|1|||
164171441|NCT01827267|592989239|FG001|Overall Study|Did not receive study drug|1|||
164171442|NCT01827267|592989238|FG000|Overall Study|Physician Decision|1|||
164171443|NCT01827267|592989239|FG001|Overall Study|Physician Decision|0|||
164171444|NCT01827267|592989238|FG000|Overall Study|Disease Progression|1|||
164171445|NCT01827267|592989239|FG001|Overall Study|Disease Progression|1|||
164171446|NCT01827267|592989238|FG000|Overall Study|Sponsor Discontinued Study|2|||
164171447|NCT01827267|592989239|FG001|Overall Study|Sponsor Discontinued Study|8|||
164171448|NCT01827267|592989238|FG000|Overall Study|Still on study|0|||
164171449|NCT01827267|592989239|FG001|Overall Study|Still on study|2|||
164171450|NCT01684943|592989243|FG000|Overall Study|Inadequate Venous Access|3|||
164171451|NCT01684943|592989244|FG001|Overall Study|Inadequate Venous Access|0|||
164171452|NCT01684943|592989245|FG002|Overall Study|Inadequate Venous Access|0|||
164171453|NCT01684943|592989243|FG000|Overall Study|Principal Investigator Determination|1|||
164171454|NCT01684943|592989244|FG001|Overall Study|Principal Investigator Determination|0|||
164171455|NCT01684943|592989245|FG002|Overall Study|Principal Investigator Determination|0|||
164171456|NCT01684943|592989243|FG000|Overall Study|Excluded from Analysis|1|||
164171457|NCT01684943|592989244|FG001|Overall Study|Excluded from Analysis|1|||
164171458|NCT01684943|592989245|FG002|Overall Study|Excluded from Analysis|1|||
164171459|NCT01684943|592989243|FG000|Overall Study|Lost to Follow-up|3|||
164171460|NCT01684943|592989244|FG001|Overall Study|Lost to Follow-up|0|||
164171461|NCT01684943|592989245|FG002|Overall Study|Lost to Follow-up|0|||
164171462|NCT01684943|592989243|FG000|Overall Study|Planning Pregnancy|1|||
164171463|NCT01684943|592989244|FG001|Overall Study|Planning Pregnancy|0|||
164171464|NCT01684943|592989245|FG002|Overall Study|Planning Pregnancy|0|||
164171465|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
164171466|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
164171467|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
164171468|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171469|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171470|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171471|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
164171472|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171473|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
164171474|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
164171475|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171476|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171477|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171478|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
164171479|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
164171480|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
164171481|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171482|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171483|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171484|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171485|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
164171486|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171487|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
164171488|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171489|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171490|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171491|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171492|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
164171493|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
164171494|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171495|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
164171496|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171497|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171498|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171499|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
164171500|NCT03395184|592989246|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
164171501|NCT03395184|592989247|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
164171502|NCT03395184|592989248|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
164171503|NCT03395184|592989249|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
164171504|NCT03395184|592989250|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
164171505|NCT03395184|592989251|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
164171506|NCT03395184|592989252|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
164171507|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
164171508|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
164171509|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
164171510|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
164171511|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
164171512|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
164171513|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
164171514|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
164171515|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
164171516|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
164171517|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
164171518|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
164171519|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
164171520|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
164171521|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171522|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171523|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171524|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171525|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
164171526|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171527|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
164171528|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
164171529|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
164171530|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
164171531|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
164171532|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
164171533|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
164171534|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
164171535|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171536|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171537|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171538|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
164171539|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171540|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
164171541|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
164171542|NCT03395184|592989246|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
164171543|NCT03395184|592989247|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
164171544|NCT03395184|592989248|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
164171545|NCT03395184|592989249|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
164171546|NCT03395184|592989250|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
164171547|NCT03395184|592989251|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
164171548|NCT03395184|592989252|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
164171549|NCT02122887|592989261|FG000|Overall Study|Withdrawal by Subject|20|||
164171550|NCT02122887|592989262|FG001|Overall Study|Withdrawal by Subject|2|||
164171551|NCT05033262|592989263|FG000|Overall Study|Lost to Follow-up|1|||
164171552|NCT05033262|592989264|FG001|Overall Study|Lost to Follow-up|0|||
164171553|NCT05033262|592989265|FG002|Overall Study|Lost to Follow-up|0|||
164171554|NCT05033262|592989266|FG003|Overall Study|Lost to Follow-up|1|||
164171555|NCT01482065|592990763|FG000|Overall Study|Withdrawal by Subject|0|||
164171556|NCT01482065|592990764|FG001|Overall Study|Withdrawal by Subject|1|||
164171557|NCT04720911|592990765|FG000|Overall Study|Withdrawal by Subject|0|||
164171558|NCT04720911|592990766|FG001|Overall Study|Withdrawal by Subject|1|||
164171559|NCT04720911|592990767|FG002|Overall Study|Withdrawal by Subject|0|||
164171560|NCT04533412|592990768|FG000|Overall Study|Withdrawal by Subject|1|||
164171561|NCT04533412|592990769|FG001|Overall Study|Withdrawal by Subject|1|||
164171562|NCT04533412|592990768|FG000|Overall Study|Lost to Follow-up|1|||
164171563|NCT04533412|592990769|FG001|Overall Study|Lost to Follow-up|4|||
164171564|NCT03261674|592990770|FG000|Overall Study|Lost to Follow-up|6|||
164171565|NCT03261674|592990771|FG001|Overall Study|Lost to Follow-up|7|||
164171566|NCT03261674|592990770|FG000|Overall Study|Protocol Violation|1|||
164171567|NCT03261674|592990771|FG001|Overall Study|Protocol Violation|4|||
164171568|NCT03261674|592990770|FG000|Overall Study|Withdrawal by Subject|1|||
164171569|NCT03261674|592990771|FG001|Overall Study|Withdrawal by Subject|4|||
164171570|NCT03261674|592990770|FG000|Overall Study|Physician Decision|1|||
164171571|NCT03261674|592990771|FG001|Overall Study|Physician Decision|0|||
164171572|NCT02004886|592990772|FG000|Overall Study|Adverse Event|0|||
164171573|NCT02004886|592990773|FG001|Overall Study|Adverse Event|1|||
164171574|NCT02004886|592990774|FG002|Overall Study|Adverse Event|0|||
164171575|NCT02004886|592990775|FG003|Overall Study|Adverse Event|0|||
164171576|NCT02004886|592990772|FG000|Overall Study|Unable to attend future visits|1|||
164171577|NCT02004886|592990773|FG001|Overall Study|Unable to attend future visits|0|||
164171578|NCT02004886|592990774|FG002|Overall Study|Unable to attend future visits|0|||
164171579|NCT02004886|592990775|FG003|Overall Study|Unable to attend future visits|0|||
164171580|NCT01895608|592990777|FG000|Overall Study|change in health status|0|||
164171581|NCT01895608|592990778|FG001|Overall Study|change in health status|1|||
164171582|NCT01895608|592990779|FG002|Overall Study|change in health status|1|||
164171583|NCT01895608|592990780|FG003|Overall Study|change in health status|0|||
164171584|NCT01895608|592990777|FG000|Overall Study|Withdrawal by Subject|0|||
164171585|NCT01895608|592990778|FG001|Overall Study|Withdrawal by Subject|0|||
164171586|NCT01895608|592990779|FG002|Overall Study|Withdrawal by Subject|2|||
164171587|NCT01895608|592990780|FG003|Overall Study|Withdrawal by Subject|0|||
164171588|NCT02892422|592990782|FG000|Overall Study|Enrolled not treated|4|||
164171589|NCT02892422|592990782|FG000|Overall Study|Adverse Event|38|||
164171590|NCT02892422|592990782|FG000|Overall Study|Lack of Efficacy|32|||
164171591|NCT02892422|592990782|FG000|Overall Study|Non-compliance with study drug|11|||
164171592|NCT02892422|592990782|FG000|Overall Study|Protocol Violation|4|||
164171593|NCT02892422|592990782|FG000|Overall Study|Withdrawal by Subject|56|||
164171594|NCT02892422|592990782|FG000|Overall Study|Lost to Follow-up|5|||
164171595|NCT02892422|592990782|FG000|Overall Study|sponsor information 16159A results|21|||
164171596|NCT02892422|592990782|FG000|Overall Study|withdrawal of consent|13|||
164171597|NCT02892422|592990782|FG000|Overall Study|exclusion criteria met|3|||
164171598|NCT02892422|592990782|FG000|Overall Study|moving elsewhere|4|||
164171599|NCT02892422|592990782|FG000|Overall Study|non-compliance|10|||
164171600|NCT02892422|592990782|FG000|Overall Study|patient legally incapable|1|||
164171601|NCT02892422|592990782|FG000|Overall Study|patient decision|7|||
164171602|NCT02892422|592990782|FG000|Overall Study|Investigator decision|1|||
164171603|NCT04323306|592990783|FG000|Overall Study|Physician Decision|1|||
164171604|NCT04323306|592990784|FG001|Overall Study|Physician Decision|0|||
164171605|NCT04323306|592990785|FG002|Overall Study|Physician Decision|0|||
164171606|NCT04323306|592990786|FG003|Overall Study|Physician Decision|0|||
164171607|NCT04323306|592990787|FG004|Overall Study|Physician Decision|0|||
164171608|NCT04323306|592990788|FG005|Overall Study|Physician Decision|0|||
164171609|NCT04323306|592990789|FG006|Overall Study|Physician Decision|0|||
164171610|NCT04323306|592990790|FG007|Overall Study|Physician Decision|0|||
164171611|NCT04323306|592990791|FG008|Overall Study|Physician Decision|0|||
164171612|NCT04323306|592990783|FG000|Overall Study|Withdrawal by Subject|0|||
164171613|NCT04323306|592990784|FG001|Overall Study|Withdrawal by Subject|0|||
164171614|NCT04323306|592990785|FG002|Overall Study|Withdrawal by Subject|0|||
164171615|NCT04323306|592990786|FG003|Overall Study|Withdrawal by Subject|0|||
164171616|NCT04323306|592990787|FG004|Overall Study|Withdrawal by Subject|0|||
164171617|NCT04323306|592990788|FG005|Overall Study|Withdrawal by Subject|1|||
164171618|NCT04323306|592990789|FG006|Overall Study|Withdrawal by Subject|3|||
164171619|NCT04323306|592990790|FG007|Overall Study|Withdrawal by Subject|0|||
164171620|NCT04323306|592990791|FG008|Overall Study|Withdrawal by Subject|1|||
164171621|NCT00759785|592990792|FG000|Overall Study|Participant sample not evaluable|11|||
164171622|NCT00759785|592990793|FG001|Overall Study|Participant sample not evaluable|2|||
164171623|NCT00759785|592990792|FG000|Overall Study|Participant sample lost|0|||
164171624|NCT00759785|592990793|FG001|Overall Study|Participant sample lost|1|||
164171625|NCT00759785|592990792|FG000|Overall Study|Protocol Violation|1|||
164171626|NCT00759785|592990793|FG001|Overall Study|Protocol Violation|0|||
164171627|NCT00759785|592990792|FG000|Overall Study|Physician Decision|0|||
164171628|NCT00759785|592990793|FG001|Overall Study|Physician Decision|1|||
164171629|NCT00759785|592990792|FG000|Overall Study|Withdrawal by Subject|0|||
164171630|NCT00759785|592990793|FG001|Overall Study|Withdrawal by Subject|1|||
164171631|NCT00089778|592990794|FG000|Overall Study|Protocol Violation|0|||
164171632|NCT00089778|592990795|FG001|Overall Study|Protocol Violation|0|||
164171633|NCT00089778|592990796|FG002|Overall Study|Protocol Violation|1|||
164171634|NCT04712019|592990797|FG000|Overall Study|Withdrawal by Subject|2|||
164171635|NCT04712019|592990798|FG001|Overall Study|Withdrawal by Subject|2|||
164171636|NCT04712019|592990797|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
164171637|NCT04712019|592990798|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
164171638|NCT00725608|592990806|FG000|Overall Study|Lost to Follow-up|60|||
164171639|NCT00725608|592990806|FG000|Overall Study|Adverse Event|14|||
164171640|NCT00725608|592990806|FG000|Overall Study|Individual reasons|86|||
164171641|NCT00725608|592990806|FG000|Overall Study|Other|7|||
164171642|NCT00614120|592990810|FG000|Overall Study|Adverse Event|9|||
164171643|NCT00614120|592990811|FG001|Overall Study|Adverse Event|22|||
164171644|NCT00614120|592990812|FG002|Overall Study|Adverse Event|30|||
164171645|NCT00614120|592990813|FG003|Overall Study|Adverse Event|3|||
164171646|NCT00614120|592990810|FG000|Overall Study|Lack of Efficacy|3|||
164171647|NCT00614120|592990811|FG001|Overall Study|Lack of Efficacy|3|||
164171648|NCT00614120|592990812|FG002|Overall Study|Lack of Efficacy|2|||
164171649|NCT00614120|592990813|FG003|Overall Study|Lack of Efficacy|2|||
164171650|NCT00614120|592990810|FG000|Overall Study|Protocol Violation|2|||
164171651|NCT00614120|592990811|FG001|Overall Study|Protocol Violation|5|||
164171652|NCT00614120|592990812|FG002|Overall Study|Protocol Violation|3|||
164171653|NCT00614120|592990813|FG003|Overall Study|Protocol Violation|1|||
164171654|NCT00614120|592990810|FG000|Overall Study|Withdrawal criteria|1|||
164171655|NCT00614120|592990811|FG001|Overall Study|Withdrawal criteria|0|||
164171656|NCT00614120|592990812|FG002|Overall Study|Withdrawal criteria|0|||
164171657|NCT00614120|592990813|FG003|Overall Study|Withdrawal criteria|0|||
164171658|NCT00614120|592990810|FG000|Overall Study|Withdrawal by Subject|9|||
164171659|NCT00614120|592990811|FG001|Overall Study|Withdrawal by Subject|10|||
164171660|NCT00614120|592990812|FG002|Overall Study|Withdrawal by Subject|16|||
164171661|NCT00614120|592990813|FG003|Overall Study|Withdrawal by Subject|3|||
164171662|NCT00614120|592990810|FG000|Overall Study|Did not meet trial criteria|0|||
164171663|NCT00614120|592990811|FG001|Overall Study|Did not meet trial criteria|1|||
164171664|NCT00614120|592990812|FG002|Overall Study|Did not meet trial criteria|1|||
164171665|NCT00614120|592990813|FG003|Overall Study|Did not meet trial criteria|1|||
164171666|NCT00614120|592990810|FG000|Overall Study|hCG positive (not pregnant)|0|||
164171667|NCT00614120|592990811|FG001|Overall Study|hCG positive (not pregnant)|0|||
164171668|NCT00614120|592990812|FG002|Overall Study|hCG positive (not pregnant)|1|||
164171669|NCT00614120|592990813|FG003|Overall Study|hCG positive (not pregnant)|0|||
164171670|NCT00614120|592990810|FG000|Overall Study|Hypoglycaemia|0|||
164171671|NCT00614120|592990811|FG001|Overall Study|Hypoglycaemia|0|||
164171672|NCT00614120|592990812|FG002|Overall Study|Hypoglycaemia|0|||
164171673|NCT00614120|592990813|FG003|Overall Study|Hypoglycaemia|1|||
164171674|NCT00614120|592990810|FG000|Overall Study|Lack of trial product|3|||
164171675|NCT00614120|592990811|FG001|Overall Study|Lack of trial product|3|||
164171676|NCT00614120|592990812|FG002|Overall Study|Lack of trial product|2|||
164171677|NCT00614120|592990813|FG003|Overall Study|Lack of trial product|0|||
164171678|NCT00614120|592990810|FG000|Overall Study|Late syphilis, latent|1|||
164171679|NCT00614120|592990811|FG001|Overall Study|Late syphilis, latent|0|||
164171680|NCT00614120|592990812|FG002|Overall Study|Late syphilis, latent|0|||
164171681|NCT00614120|592990813|FG003|Overall Study|Late syphilis, latent|0|||
164171682|NCT00614120|592990810|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
164171683|NCT00614120|592990811|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
164171684|NCT00614120|592990812|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
164171685|NCT00614120|592990813|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
164171686|NCT00614120|592990810|FG000|Overall Study|Lost to Follow-up|1|||
164171687|NCT00614120|592990811|FG001|Overall Study|Lost to Follow-up|2|||
164171688|NCT00614120|592990812|FG002|Overall Study|Lost to Follow-up|3|||
164171689|NCT00614120|592990813|FG003|Overall Study|Lost to Follow-up|4|||
164171690|NCT01968707|592990814|FG000|Overall Study|Did not meet treatment day baseline|49|||
164171691|NCT01968707|592990815|FG001|Overall Study|Did not meet treatment day baseline|12|||
164171692|NCT01968707|592990816|FG002|Overall Study|Did not meet treatment day baseline|41|||
164171693|NCT01968707|592990817|FG003|Overall Study|Did not meet treatment day baseline|44|||
164171694|NCT01968707|592990818|FG004|Overall Study|Did not meet treatment day baseline|36|||
164171695|NCT01968707|592990819|FG005|Overall Study|Did not meet treatment day baseline|11|||
164171696|NCT01968707|592990820|FG006|Overall Study|Did not meet treatment day baseline|34|||
164171697|NCT01968707|592990821|FG007|Overall Study|Did not meet treatment day baseline|35|||
164171698|NCT01084668|592990822|FG000|Overall Study|Lack of Efficacy|5|||
164171699|NCT01084668|592990822|FG000|Overall Study|Withdrawal by Subject|2|||
164171700|NCT01084668|592990822|FG000|Overall Study|Pregnancy|1|||
164171701|NCT01084668|592990822|FG000|Overall Study|Non-compliance|1|||
164171702|NCT03729570|592990826|FG000|Overall Study|Lost to Follow-up|16|||
164171703|NCT03729570|592990827|FG001|Overall Study|Lost to Follow-up|20|||
164171704|NCT03729570|592990826|FG000|Overall Study|Seroconversion|5|||
164171705|NCT03729570|592990827|FG001|Overall Study|Seroconversion|0|||
164171706|NCT03729570|592990826|FG000|Overall Study|Moved out of the city|1|||
164171707|NCT03729570|592990827|FG001|Overall Study|Moved out of the city|0|||
164171708|NCT03729570|592990826|FG000|Overall Study|Time Conflict|1|||
164171709|NCT03729570|592990827|FG001|Overall Study|Time Conflict|0|||
164171710|NCT03729570|592990826|FG000|Overall Study|Time Commitment|2|||
164171711|NCT03729570|592990827|FG001|Overall Study|Time Commitment|0|||
164171712|NCT03729570|592990826|FG000|Overall Study|Bad Experience|0|||
164171713|NCT03729570|592990827|FG001|Overall Study|Bad Experience|1|||
164171714|NCT03729570|592990826|FG000|Overall Study|No reason provided|2|||
164171715|NCT03729570|592990827|FG001|Overall Study|No reason provided|1|||
164171716|NCT03729570|592990826|FG000|Overall Study|Family Conflict|0|||
164171717|NCT03729570|592990827|FG001|Overall Study|Family Conflict|1|||
164171718|NCT03729570|592990826|FG000|Overall Study|Did not want to continue taking medications|0|||
164171719|NCT03729570|592990827|FG001|Overall Study|Did not want to continue taking medications|1|||
164171720|NCT03729570|592990826|FG000|Overall Study|Found another PrEP provider|1|||
164171721|NCT03729570|592990827|FG001|Overall Study|Found another PrEP provider|0|||
164171722|NCT03729570|592990826|FG000|Overall Study|Did not enjoy being in the control group|0|||
164171723|NCT03729570|592990827|FG001|Overall Study|Did not enjoy being in the control group|1|||
164171724|NCT02474589|592990828|FG000|Overall Study|Adverse Event|6|||
164171725|NCT02474589|592990829|FG001|Overall Study|Adverse Event|2|||
164171726|NCT02474589|592990828|FG000|Overall Study|Lost to Follow-up|6|||
164171727|NCT02474589|592990829|FG001|Overall Study|Lost to Follow-up|1|||
164171728|NCT02474589|592990828|FG000|Overall Study|Protocol Violation|4|||
164171729|NCT02474589|592990829|FG001|Overall Study|Protocol Violation|1|||
164171730|NCT02474589|592990828|FG000|Overall Study|Withdrawal by Subject|4|||
164171731|NCT02474589|592990829|FG001|Overall Study|Withdrawal by Subject|0|||
164171732|NCT02474589|592990828|FG000|Overall Study|Inability to complete study procedures|5|||
164171733|NCT02474589|592990829|FG001|Overall Study|Inability to complete study procedures|1|||
164171734|NCT00459706|592990830|FG000|Overall Study|Adverse Event|19|||
164171735|NCT00459706|592990831|FG001|Overall Study|Adverse Event|13|||
164171736|NCT00459706|592990830|FG000|Overall Study|Withdrawal by Subject|1|||
164171737|NCT00459706|592990831|FG001|Overall Study|Withdrawal by Subject|6|||
164171738|NCT00459706|592990830|FG000|Overall Study|Physician Decision|2|||
164171739|NCT00459706|592990831|FG001|Overall Study|Physician Decision|0|||
164171740|NCT00459706|592990830|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
164171741|NCT00459706|592990831|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
164171742|NCT00459706|592990830|FG000|Overall Study|Protocol Violation|2|||
164171743|NCT00459706|592990831|FG001|Overall Study|Protocol Violation|1|||
164171744|NCT00459706|592990830|FG000|Overall Study|Failed to Return|1|||
164171745|NCT00459706|592990831|FG001|Overall Study|Failed to Return|0|||
164171746|NCT00459706|592990830|FG000|Overall Study|Other|0|||
164171747|NCT00459706|592990831|FG001|Overall Study|Other|1|||
164171748|NCT02447497|592990832|FG000|Overall Study|Did not meet treatment day baseline.|6|||
164171749|NCT02447497|592990833|FG001|Overall Study|Did not meet treatment day baseline.|5|||
164171750|NCT02447497|592990834|FG002|Overall Study|Did not meet treatment day baseline.|2|||
164171751|NCT02447497|592990835|FG003|Overall Study|Did not meet treatment day baseline.|2|||
164171752|NCT02447497|592990832|FG000|Overall Study|Dressing was compromised|0|||
164171753|NCT02447497|592990833|FG001|Overall Study|Dressing was compromised|1|||
164171754|NCT02447497|592990834|FG002|Overall Study|Dressing was compromised|0|||
164171755|NCT02447497|592990835|FG003|Overall Study|Dressing was compromised|0|||
164171756|NCT02017912|592990836|FG000|Overall Study|Withdrawal by Subject|2|||
164171757|NCT02017912|592990837|FG001|Overall Study|Withdrawal by Subject|1|||
164171758|NCT02017912|592990836|FG000|Overall Study|miscellaneous|1|||
164171759|NCT02017912|592990837|FG001|Overall Study|miscellaneous|1|||
164171760|NCT04569968|592990838|FG000|Overall Study|Lost to Follow-up|2|||
164171761|NCT04569968|592990839|FG001|Overall Study|Lost to Follow-up|5|||
164171762|NCT04569968|592990838|FG000|Overall Study|Story of head and/or neck surgery|2|||
164171763|NCT04569968|592990839|FG001|Overall Study|Story of head and/or neck surgery|2|||
164171764|NCT04569968|592990838|FG000|Overall Study|Time of stroke onset|8|||
164171765|NCT04569968|592990839|FG001|Overall Study|Time of stroke onset|7|||
164171766|NCT04569968|592990838|FG000|Overall Study|Type of strokr|12|||
164171767|NCT04569968|592990839|FG001|Overall Study|Type of strokr|8|||
164171768|NCT04569968|592990838|FG000|Overall Study|Cooperation|8|||
164171769|NCT04569968|592990839|FG001|Overall Study|Cooperation|8|||
164171770|NCT04569968|592990838|FG000|Overall Study|Age interval|17|||
164171771|NCT04569968|592990839|FG001|Overall Study|Age interval|6|||
164171772|NCT04569968|592990838|FG000|Overall Study|Denial of participation to the study|0|||
164171773|NCT04569968|592990839|FG001|Overall Study|Denial of participation to the study|3|||
164172293|NCT02083185|592993194|FG000|Overall Study|Death|2|||
164171774|NCT04569968|592990838|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
164171775|NCT04569968|592990839|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
164171776|NCT04569968|592990838|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
164171777|NCT04569968|592990839|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
164171778|NCT04569968|592990838|FG000|Overall Study|Quarantine|1|||
164171779|NCT04569968|592990839|FG001|Overall Study|Quarantine|0|||
164171780|NCT04569968|592990838|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
164171781|NCT04569968|592990839|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
164171782|NCT04569968|592990838|FG000|Overall Study|Repetitive stroke|8|||
164171783|NCT04569968|592990839|FG001|Overall Study|Repetitive stroke|0|||
164171784|NCT04569968|592990838|FG000|Overall Study|Insufficient mastication|1|||
164171785|NCT04569968|592990839|FG001|Overall Study|Insufficient mastication|0|||
164171786|NCT04569968|592990838|FG000|Overall Study|Infection|1|||
164171787|NCT04569968|592990839|FG001|Overall Study|Infection|0|||
164171788|NCT00985959|592990844|FG000|Overall Study|Adverse Event|0|||
164171789|NCT00985959|592990845|FG001|Overall Study|Adverse Event|0|||
164171790|NCT00985959|592990846|FG002|Overall Study|Adverse Event|19|||
164171791|NCT00985959|592990844|FG000|Overall Study|Withdrawal by Subject|0|||
164171792|NCT00985959|592990845|FG001|Overall Study|Withdrawal by Subject|0|||
164171793|NCT00985959|592990846|FG002|Overall Study|Withdrawal by Subject|8|||
164171794|NCT00985959|592990844|FG000|Overall Study|Progressive disease|1|||
164171795|NCT00985959|592990845|FG001|Overall Study|Progressive disease|2|||
164171796|NCT00985959|592990846|FG002|Overall Study|Progressive disease|8|||
164171797|NCT00985959|592990844|FG000|Overall Study|Unrecovered toxicity|0|||
164171798|NCT00985959|592990845|FG001|Overall Study|Unrecovered toxicity|0|||
164171799|NCT00985959|592990846|FG002|Overall Study|Unrecovered toxicity|7|||
164171800|NCT00985959|592990844|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
164171801|NCT00985959|592990845|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
164171802|NCT00985959|592990846|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
164171803|NCT00985959|592990844|FG000|Overall Study|Complete response observed over 2 cycles|0|||
164171804|NCT00985959|592990845|FG001|Overall Study|Complete response observed over 2 cycles|1|||
164171805|NCT00985959|592990846|FG002|Overall Study|Complete response observed over 2 cycles|4|||
164171806|NCT00985959|592990844|FG000|Overall Study|Other|0|||
164171807|NCT00985959|592990845|FG001|Overall Study|Other|0|||
164171808|NCT00985959|592990846|FG002|Overall Study|Other|11|||
164171809|NCT00979420|592990847|FG000|Overall Study|Adverse Event|1|||
164171810|NCT00979420|592990848|FG001|Overall Study|Adverse Event|0|||
164171811|NCT00979420|592990849|FG002|Overall Study|Adverse Event|0|||
164171812|NCT00979420|592990850|FG003|Overall Study|Adverse Event|0|||
164171813|NCT00979420|592990847|FG000|Overall Study|Lack of Efficacy|3|||
164171814|NCT00979420|592990848|FG001|Overall Study|Lack of Efficacy|0|||
164171815|NCT00979420|592990849|FG002|Overall Study|Lack of Efficacy|1|||
164171816|NCT00979420|592990850|FG003|Overall Study|Lack of Efficacy|1|||
164171817|NCT00979420|592990847|FG000|Overall Study|Other reasons not related to Viramune|3|||
164171818|NCT00979420|592990848|FG001|Overall Study|Other reasons not related to Viramune|0|||
164171819|NCT00979420|592990849|FG002|Overall Study|Other reasons not related to Viramune|0|||
164171820|NCT00979420|592990850|FG003|Overall Study|Other reasons not related to Viramune|1|||
164171821|NCT02107859|592990851|FG000|Overall Study|Withdrawal by Subject|14|||
164171822|NCT02107859|592990851|FG000|Overall Study|Adverse Event|3|||
164171823|NCT02107859|592990851|FG000|Overall Study|Study closure|41|||
164171824|NCT02107859|592990851|FG000|Overall Study|Other than specified|3|||
164171825|NCT02235077|592990852|FG000|Overall Study|Death|5|||
164171826|NCT02235077|592990853|FG001|Overall Study|Death|7|||
164171827|NCT02235077|592990852|FG000|Overall Study|Lost to Follow-up|5|||
164171828|NCT02235077|592990853|FG001|Overall Study|Lost to Follow-up|6|||
164171829|NCT02235077|592990852|FG000|Overall Study|Withdrawal by Subject|8|||
164171830|NCT02235077|592990853|FG001|Overall Study|Withdrawal by Subject|5|||
164171831|NCT02235077|592990852|FG000|Overall Study|Physician Decision|0|||
164171832|NCT02235077|592990853|FG001|Overall Study|Physician Decision|1|||
164171833|NCT02964208|592990854|FG000|Overall Study|Death|103|||
164171834|NCT02964208|592990854|FG000|Overall Study|Withdrawal by Subject|6|||
164171835|NCT02964208|592990854|FG000|Overall Study|Lost to Follow-up|6|||
164171836|NCT02964208|592990854|FG000|Overall Study|Unsuccessful Procedure|5|||
164171837|NCT02964208|592990854|FG000|Overall Study|Device Explant|1|||
164171838|NCT02964208|592990854|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
164171839|NCT03887442|592990860|FG000|Overall Study|Adverse Event|1|||
164171840|NCT03887442|592990861|FG001|Overall Study|Adverse Event|0|||
164171841|NCT00101166|592990864|FG000|Overall Study|progressive disease|10|||
164171842|NCT01868022|592990865|FG000|Overall Study|Withdrawal by Subject|0|||
164171843|NCT01868022|592990866|FG001|Overall Study|Withdrawal by Subject|0|||
164171844|NCT01868022|592990867|FG002|Overall Study|Withdrawal by Subject|1|||
164171845|NCT01868022|592990868|FG003|Overall Study|Withdrawal by Subject|1|||
164171846|NCT01868022|592990869|FG004|Overall Study|Withdrawal by Subject|0|||
164171847|NCT01868022|592990870|FG005|Overall Study|Withdrawal by Subject|0|||
164171848|NCT01868022|592990871|FG006|Overall Study|Withdrawal by Subject|0|||
164171849|NCT01868022|592990872|FG007|Overall Study|Withdrawal by Subject|1|||
164171850|NCT01868022|592990873|FG008|Overall Study|Withdrawal by Subject|0|||
164171851|NCT01868022|592990865|FG000|Overall Study|Adverse Event|0|||
164171852|NCT01868022|592990866|FG001|Overall Study|Adverse Event|0|||
164171853|NCT01868022|592990867|FG002|Overall Study|Adverse Event|0|||
164171854|NCT01868022|592990868|FG003|Overall Study|Adverse Event|0|||
164171855|NCT01868022|592990869|FG004|Overall Study|Adverse Event|2|||
164171856|NCT01868022|592990870|FG005|Overall Study|Adverse Event|0|||
164171857|NCT01868022|592990871|FG006|Overall Study|Adverse Event|0|||
164171858|NCT01868022|592990872|FG007|Overall Study|Adverse Event|2|||
164171859|NCT01868022|592990873|FG008|Overall Study|Adverse Event|2|||
164171860|NCT01868022|592990865|FG000|Overall Study|Physician Decision|0|||
164171861|NCT01868022|592990866|FG001|Overall Study|Physician Decision|0|||
164171862|NCT01868022|592990867|FG002|Overall Study|Physician Decision|0|||
164171863|NCT01868022|592990868|FG003|Overall Study|Physician Decision|0|||
164171864|NCT01868022|592990869|FG004|Overall Study|Physician Decision|0|||
164171865|NCT01868022|592990870|FG005|Overall Study|Physician Decision|1|||
164171866|NCT01868022|592990871|FG006|Overall Study|Physician Decision|0|||
164171867|NCT01868022|592990872|FG007|Overall Study|Physician Decision|2|||
164171868|NCT01868022|592990873|FG008|Overall Study|Physician Decision|0|||
164171869|NCT01868022|592990865|FG000|Overall Study|Study closed/terminated|0|||
164171870|NCT01868022|592990866|FG001|Overall Study|Study closed/terminated|0|||
164171871|NCT01868022|592990867|FG002|Overall Study|Study closed/terminated|0|||
164171872|NCT01868022|592990868|FG003|Overall Study|Study closed/terminated|0|||
164171873|NCT01868022|592990869|FG004|Overall Study|Study closed/terminated|0|||
164171874|NCT01868022|592990870|FG005|Overall Study|Study closed/terminated|0|||
164171875|NCT01868022|592990871|FG006|Overall Study|Study closed/terminated|0|||
164171876|NCT01868022|592990872|FG007|Overall Study|Study closed/terminated|1|||
164171877|NCT01868022|592990873|FG008|Overall Study|Study closed/terminated|0|||
164171878|NCT01868022|592990865|FG000|Overall Study|Ongoing|0|||
164171879|NCT01868022|592990866|FG001|Overall Study|Ongoing|0|||
164171880|NCT01868022|592990867|FG002|Overall Study|Ongoing|0|||
164171881|NCT01868022|592990868|FG003|Overall Study|Ongoing|0|||
164171882|NCT01868022|592990869|FG004|Overall Study|Ongoing|0|||
164171883|NCT01868022|592990870|FG005|Overall Study|Ongoing|0|||
164171884|NCT01868022|592990871|FG006|Overall Study|Ongoing|0|||
164171885|NCT01868022|592990872|FG007|Overall Study|Ongoing|3|||
164171886|NCT01868022|592990873|FG008|Overall Study|Ongoing|0|||
164171887|NCT01628198|592990874|FG000|Overall Study|Lost to Follow-up|7|||
164171888|NCT01628198|592990874|FG000|Overall Study|Withdrawal by Subject|10|||
164171889|NCT01628198|592990874|FG000|Overall Study|Screen failure|1|||
164171890|NCT03386994|592990875|FG000|Overall Study|Lung transplant|1|||
164171891|NCT03386994|592990875|FG000|Overall Study|Adverse Event|14|||
164171892|NCT03386994|592990875|FG000|Overall Study|Lost to Follow-up|4|||
164171893|NCT03386994|592990875|FG000|Overall Study|Withdrawal by Subject|3|||
164171894|NCT03386994|592990875|FG000|Overall Study|Death|16|||
164171895|NCT03226769|592990878|FG000|Overall Study|Withdrawal by Subject|0|||
164171896|NCT03226769|592990879|FG001|Overall Study|Withdrawal by Subject|1|||
164171897|NCT01516008|592990880|FG000|Overall Study|Adverse Event|0|||
164171898|NCT01516008|592990881|FG001|Overall Study|Adverse Event|2|||
164171899|NCT01516008|592990882|FG002|Overall Study|Adverse Event|7|||
164171900|NCT01516008|592990880|FG000|Overall Study|Lack of Efficacy|44|||
164171901|NCT01516008|592990881|FG001|Overall Study|Lack of Efficacy|14|||
164171902|NCT01516008|592990882|FG002|Overall Study|Lack of Efficacy|10|||
164171903|NCT01516008|592990880|FG000|Overall Study|Protocol Violation|1|||
164171904|NCT01516008|592990881|FG001|Overall Study|Protocol Violation|0|||
164171905|NCT01516008|592990882|FG002|Overall Study|Protocol Violation|0|||
164171906|NCT01516008|592990880|FG000|Overall Study|Reason not specified|0|||
164171907|NCT01516008|592990881|FG001|Overall Study|Reason not specified|0|||
164171908|NCT01516008|592990882|FG002|Overall Study|Reason not specified|1|||
164171909|NCT01217476|592990885|FG000|Overall Study|Adverse Event|6|||
164171910|NCT01217476|592990886|FG001|Overall Study|Adverse Event|1|||
164171911|NCT01217476|592990885|FG000|Overall Study|Physician Decision|0|||
164171912|NCT01217476|592990886|FG001|Overall Study|Physician Decision|1|||
164171913|NCT01217476|592990885|FG000|Overall Study|Withdrawal by Subject|3|||
164171914|NCT01217476|592990886|FG001|Overall Study|Withdrawal by Subject|3|||
164171915|NCT01217476|592990885|FG000|Overall Study|Surgery on the Target Limb|0|||
164171916|NCT01217476|592990886|FG001|Overall Study|Surgery on the Target Limb|2|||
164171917|NCT01217476|592990885|FG000|Overall Study|Protocol Deviation|1|||
164171918|NCT01217476|592990886|FG001|Overall Study|Protocol Deviation|0|||
164171919|NCT01217476|592990885|FG000|Overall Study|Other|2|||
164171920|NCT01217476|592990886|FG001|Overall Study|Other|0|||
164171921|NCT03033602|592990887|FG000|Overall Study|Withdrawal by Subject|11|||
164171922|NCT03033602|592990888|FG001|Overall Study|Withdrawal by Subject|21|||
164171923|NCT03033602|592990887|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
164171924|NCT03033602|592990888|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
164171925|NCT01493284|592990893|FG000|Overall Study|Death|29|||
164171926|NCT01493284|592990893|FG000|Overall Study|Withdrawal by Subject|32|||
164171927|NCT00325156|592990894|FG000|Overall Study|Protocol Violation|8|||
164171928|NCT00325156|592990894|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
164171929|NCT00325156|592990894|FG000|Overall Study|Migrated/moved from study area|12|||
164171930|NCT00325156|592990894|FG000|Overall Study|Adverse event, non-fatal|3|||
164171931|NCT00325156|592990894|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
164171932|NCT00325156|592990894|FG000|Overall Study|Other|1|||
164171933|NCT00325156|592990894|FG000|Overall Study|Withdrawal by Subject|31|||
164171934|NCT04064411|592990895|FG000|Overall Study|Adverse Event|29|||
164171935|NCT04064411|592990896|FG001|Overall Study|Adverse Event|19|||
164171936|NCT04064411|592990895|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
164171937|NCT04064411|592990896|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
164171938|NCT04064411|592990895|FG000|Overall Study|Protocol Deviation|0|||
164171939|NCT04064411|592990896|FG001|Overall Study|Protocol Deviation|2|||
164171940|NCT04064411|592990895|FG000|Overall Study|Withdrawal by Subject|25|||
164171941|NCT04064411|592990896|FG001|Overall Study|Withdrawal by Subject|29|||
164171942|NCT04064411|592990895|FG000|Overall Study|Lost to Follow-up|5|||
164171943|NCT04064411|592990896|FG001|Overall Study|Lost to Follow-up|2|||
164171944|NCT04064411|592990895|FG000|Overall Study|Other than Specified|4|||
164171945|NCT04064411|592990896|FG001|Overall Study|Other than Specified|1|||
164171946|NCT04064411|592990895|FG000|Overall Study|Death|1|||
164171947|NCT04064411|592990896|FG001|Overall Study|Death|0|||
164171948|NCT03512210|592990898|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
164171949|NCT03512210|592990898|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
164171950|NCT03512210|592990898|FG000|Step 2:Post-MINMON|Death|2|||
164171951|NCT03512210|592990898|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
164171952|NCT03512210|592990898|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
164171953|NCT01672710|592990899|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
164171954|NCT01672710|592990900|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
164171955|NCT01672710|592990899|FG000|3 Month Follow up|Lost to Follow-up|2|||
164171956|NCT01672710|592990900|FG001|3 Month Follow up|Lost to Follow-up|3|||
164171957|NCT01672710|592990899|FG000|3 Month Follow up|follow up due after termination date|4|||
164171958|NCT01672710|592990900|FG001|3 Month Follow up|follow up due after termination date|1|||
164171959|NCT03725761|592990901|FG000|Overall Study|still on study|1|||
164171960|NCT03197467|592993064|FG000|Overall Study|Withdrawal by Subject|1|||
164171961|NCT03666533|592993065|FG000|Overall Study|Lost to Follow-up|2|||
164171962|NCT03666533|592993066|FG001|Overall Study|Lost to Follow-up|2|||
164171963|NCT02017717|592993067|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171964|NCT02017717|592993068|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171965|NCT02017717|592993069|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171966|NCT02017717|592993070|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171967|NCT02017717|592993071|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171968|NCT02017717|592993072|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171969|NCT02017717|592993073|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171970|NCT02017717|592993074|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
164171971|NCT02017717|592993075|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
164171972|NCT02017717|592993067|FG000|Before Treatment Period|Participant request to stop therapy|0|||
164171973|NCT02017717|592993068|FG001|Before Treatment Period|Participant request to stop therapy|0|||
164171974|NCT02017717|592993069|FG002|Before Treatment Period|Participant request to stop therapy|0|||
164171975|NCT02017717|592993070|FG003|Before Treatment Period|Participant request to stop therapy|0|||
164171976|NCT02017717|592993071|FG004|Before Treatment Period|Participant request to stop therapy|0|||
164171977|NCT02017717|592993072|FG005|Before Treatment Period|Participant request to stop therapy|0|||
164171978|NCT02017717|592993073|FG006|Before Treatment Period|Participant request to stop therapy|0|||
164171979|NCT02017717|592993074|FG007|Before Treatment Period|Participant request to stop therapy|0|||
164171980|NCT02017717|592993075|FG008|Before Treatment Period|Participant request to stop therapy|5|||
164171981|NCT02017717|592993067|FG000|Before Treatment Period|Participant withdrew consent|0|||
164171982|NCT02017717|592993068|FG001|Before Treatment Period|Participant withdrew consent|0|||
164171983|NCT02017717|592993069|FG002|Before Treatment Period|Participant withdrew consent|0|||
164171984|NCT02017717|592993070|FG003|Before Treatment Period|Participant withdrew consent|0|||
164171985|NCT02017717|592993071|FG004|Before Treatment Period|Participant withdrew consent|0|||
164171986|NCT02017717|592993072|FG005|Before Treatment Period|Participant withdrew consent|0|||
164171987|NCT02017717|592993073|FG006|Before Treatment Period|Participant withdrew consent|2|||
164171988|NCT02017717|592993074|FG007|Before Treatment Period|Participant withdrew consent|0|||
164171989|NCT02017717|592993075|FG008|Before Treatment Period|Participant withdrew consent|11|||
164171990|NCT02017717|592993067|FG000|Before Treatment Period|Lost to Follow-up|0|||
164171991|NCT02017717|592993068|FG001|Before Treatment Period|Lost to Follow-up|0|||
164171992|NCT02017717|592993069|FG002|Before Treatment Period|Lost to Follow-up|0|||
164171993|NCT02017717|592993070|FG003|Before Treatment Period|Lost to Follow-up|0|||
164171994|NCT02017717|592993071|FG004|Before Treatment Period|Lost to Follow-up|0|||
164171995|NCT02017717|592993072|FG005|Before Treatment Period|Lost to Follow-up|0|||
164171996|NCT02017717|592993073|FG006|Before Treatment Period|Lost to Follow-up|0|||
164171997|NCT02017717|592993074|FG007|Before Treatment Period|Lost to Follow-up|0|||
164171998|NCT02017717|592993075|FG008|Before Treatment Period|Lost to Follow-up|1|||
164171999|NCT02017717|592993067|FG000|Before Treatment Period|Participant no longer met criteria|0|||
164172000|NCT02017717|592993068|FG001|Before Treatment Period|Participant no longer met criteria|0|||
164172001|NCT02017717|592993069|FG002|Before Treatment Period|Participant no longer met criteria|0|||
164172002|NCT02017717|592993070|FG003|Before Treatment Period|Participant no longer met criteria|0|||
164172003|NCT02017717|592993071|FG004|Before Treatment Period|Participant no longer met criteria|0|||
164172004|NCT02017717|592993072|FG005|Before Treatment Period|Participant no longer met criteria|1|||
164172005|NCT02017717|592993073|FG006|Before Treatment Period|Participant no longer met criteria|0|||
164172006|NCT02017717|592993074|FG007|Before Treatment Period|Participant no longer met criteria|1|||
164172007|NCT02017717|592993075|FG008|Before Treatment Period|Participant no longer met criteria|2|||
164172008|NCT02017717|592993067|FG000|Before Treatment Period|other reason|0|||
164172009|NCT02017717|592993068|FG001|Before Treatment Period|other reason|0|||
164172010|NCT02017717|592993069|FG002|Before Treatment Period|other reason|0|||
164172011|NCT02017717|592993070|FG003|Before Treatment Period|other reason|0|||
164172012|NCT02017717|592993071|FG004|Before Treatment Period|other reason|0|||
164172013|NCT02017717|592993072|FG005|Before Treatment Period|other reason|0|||
164172014|NCT02017717|592993073|FG006|Before Treatment Period|other reason|0|||
164172015|NCT02017717|592993074|FG007|Before Treatment Period|other reason|0|||
164172016|NCT02017717|592993075|FG008|Before Treatment Period|other reason|1|||
164172017|NCT02017717|592993067|FG000|Treatment Period|Disease progression|7|||
164172018|NCT02017717|592993068|FG001|Treatment Period|Disease progression|9|||
164172019|NCT02017717|592993069|FG002|Treatment Period|Disease progression|12|||
164172020|NCT02017717|592993070|FG003|Treatment Period|Disease progression|20|||
164172021|NCT02017717|592993071|FG004|Treatment Period|Disease progression|26|||
164172022|NCT02017717|592993072|FG005|Treatment Period|Disease progression|16|||
164172023|NCT02017717|592993073|FG006|Treatment Period|Disease progression|22|||
164172024|NCT02017717|592993074|FG007|Treatment Period|Disease progression|165|||
164172025|NCT02017717|592993075|FG008|Treatment Period|Disease progression|135|||
164172026|NCT02017717|592993067|FG000|Treatment Period|Study drug toxicity|3|||
164172027|NCT02017717|592993068|FG001|Treatment Period|Study drug toxicity|0|||
164172028|NCT02017717|592993069|FG002|Treatment Period|Study drug toxicity|1|||
164172029|NCT02017717|592993070|FG003|Treatment Period|Study drug toxicity|4|||
164172030|NCT02017717|592993071|FG004|Treatment Period|Study drug toxicity|4|||
164172031|NCT02017717|592993072|FG005|Treatment Period|Study drug toxicity|5|||
164172032|NCT02017717|592993073|FG006|Treatment Period|Study drug toxicity|3|||
164172033|NCT02017717|592993074|FG007|Treatment Period|Study drug toxicity|7|||
164172034|NCT02017717|592993075|FG008|Treatment Period|Study drug toxicity|11|||
164172035|NCT02017717|592993067|FG000|Treatment Period|Death|0|||
164172036|NCT02017717|592993068|FG001|Treatment Period|Death|0|||
164172037|NCT02017717|592993069|FG002|Treatment Period|Death|1|||
164172038|NCT02017717|592993070|FG003|Treatment Period|Death|0|||
164172039|NCT02017717|592993071|FG004|Treatment Period|Death|0|||
164172040|NCT02017717|592993072|FG005|Treatment Period|Death|2|||
164172041|NCT02017717|592993073|FG006|Treatment Period|Death|0|||
164172042|NCT02017717|592993074|FG007|Treatment Period|Death|0|||
164172043|NCT02017717|592993075|FG008|Treatment Period|Death|0|||
164172044|NCT02017717|592993067|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
164172045|NCT02017717|592993068|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
164172046|NCT02017717|592993069|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
164172047|NCT02017717|592993070|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
164172048|NCT02017717|592993071|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
164172049|NCT02017717|592993072|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
164172050|NCT02017717|592993073|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
164172051|NCT02017717|592993074|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
164172052|NCT02017717|592993075|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
164172053|NCT02017717|592993067|FG000|Treatment Period|Participant request to stop therapy|0|||
164172054|NCT02017717|592993068|FG001|Treatment Period|Participant request to stop therapy|0|||
164172055|NCT02017717|592993069|FG002|Treatment Period|Participant request to stop therapy|3|||
164172056|NCT02017717|592993070|FG003|Treatment Period|Participant request to stop therapy|6|||
164172057|NCT02017717|592993071|FG004|Treatment Period|Participant request to stop therapy|0|||
164172058|NCT02017717|592993072|FG005|Treatment Period|Participant request to stop therapy|2|||
164172059|NCT02017717|592993073|FG006|Treatment Period|Participant request to stop therapy|1|||
164172060|NCT02017717|592993074|FG007|Treatment Period|Participant request to stop therapy|4|||
164172061|NCT02017717|592993075|FG008|Treatment Period|Participant request to stop therapy|7|||
164172062|NCT02017717|592993067|FG000|Treatment Period|Participant withdrew consent|0|||
164172063|NCT02017717|592993068|FG001|Treatment Period|Participant withdrew consent|0|||
164172064|NCT02017717|592993069|FG002|Treatment Period|Participant withdrew consent|1|||
164172065|NCT02017717|592993070|FG003|Treatment Period|Participant withdrew consent|0|||
164172066|NCT02017717|592993071|FG004|Treatment Period|Participant withdrew consent|0|||
164172067|NCT02017717|592993072|FG005|Treatment Period|Participant withdrew consent|2|||
164172068|NCT02017717|592993073|FG006|Treatment Period|Participant withdrew consent|0|||
164172069|NCT02017717|592993074|FG007|Treatment Period|Participant withdrew consent|1|||
164172070|NCT02017717|592993075|FG008|Treatment Period|Participant withdrew consent|4|||
164172071|NCT02017717|592993067|FG000|Treatment Period|Participant no longer met criteria|0|||
164172072|NCT02017717|592993068|FG001|Treatment Period|Participant no longer met criteria|0|||
164172073|NCT02017717|592993069|FG002|Treatment Period|Participant no longer met criteria|0|||
164172074|NCT02017717|592993070|FG003|Treatment Period|Participant no longer met criteria|0|||
164172075|NCT02017717|592993071|FG004|Treatment Period|Participant no longer met criteria|0|||
164172076|NCT02017717|592993072|FG005|Treatment Period|Participant no longer met criteria|0|||
164172077|NCT02017717|592993073|FG006|Treatment Period|Participant no longer met criteria|0|||
164172078|NCT02017717|592993074|FG007|Treatment Period|Participant no longer met criteria|0|||
164172079|NCT02017717|592993075|FG008|Treatment Period|Participant no longer met criteria|1|||
164172080|NCT02017717|592993067|FG000|Treatment Period|Other reasons|0|||
164172081|NCT02017717|592993068|FG001|Treatment Period|Other reasons|0|||
164172082|NCT02017717|592993069|FG002|Treatment Period|Other reasons|0|||
164172083|NCT02017717|592993070|FG003|Treatment Period|Other reasons|1|||
164172084|NCT02017717|592993071|FG004|Treatment Period|Other reasons|0|||
164172085|NCT02017717|592993072|FG005|Treatment Period|Other reasons|1|||
164172086|NCT02017717|592993073|FG006|Treatment Period|Other reasons|1|||
164172087|NCT02017717|592993074|FG007|Treatment Period|Other reasons|1|||
164172088|NCT02017717|592993075|FG008|Treatment Period|Other reasons|1|||
164172089|NCT02017717|592993067|FG000|Treatment Period|Maximum clinical benefit|0|||
164172090|NCT02017717|592993068|FG001|Treatment Period|Maximum clinical benefit|0|||
164172091|NCT02017717|592993069|FG002|Treatment Period|Maximum clinical benefit|0|||
164172092|NCT02017717|592993070|FG003|Treatment Period|Maximum clinical benefit|0|||
164172093|NCT02017717|592993071|FG004|Treatment Period|Maximum clinical benefit|0|||
164172094|NCT02017717|592993072|FG005|Treatment Period|Maximum clinical benefit|0|||
164172095|NCT02017717|592993073|FG006|Treatment Period|Maximum clinical benefit|0|||
164172096|NCT02017717|592993074|FG007|Treatment Period|Maximum clinical benefit|0|||
164172097|NCT02017717|592993075|FG008|Treatment Period|Maximum clinical benefit|1|||
164172098|NCT02017717|592993067|FG000|Treatment Period|Not reported|0|||
164172099|NCT02017717|592993068|FG001|Treatment Period|Not reported|1|||
164172100|NCT02017717|592993069|FG002|Treatment Period|Not reported|0|||
164172101|NCT02017717|592993070|FG003|Treatment Period|Not reported|0|||
164172102|NCT02017717|592993071|FG004|Treatment Period|Not reported|0|||
164172103|NCT02017717|592993072|FG005|Treatment Period|Not reported|0|||
164172104|NCT02017717|592993073|FG006|Treatment Period|Not reported|0|||
164172105|NCT02017717|592993074|FG007|Treatment Period|Not reported|0|||
164172106|NCT02017717|592993075|FG008|Treatment Period|Not reported|0|||
164172107|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
164172108|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
164172109|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
164172110|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
164172111|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
164172112|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
164172113|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
164172114|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
164172115|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
164172116|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
164172117|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
164172118|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
164172119|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
164172120|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
164172121|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
164172122|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
164172123|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
164172124|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
164172125|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
164172126|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
164172127|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
164172128|NCT04488419|592993077|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
164172129|NCT04488419|592993078|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
164172130|NCT04488419|592993079|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
164172131|NCT04488419|592993077|FG000|Primary Analysis Population|Adverse Event|6|||
164172132|NCT04488419|592993078|FG001|Primary Analysis Population|Adverse Event|9|||
164172133|NCT04488419|592993079|FG002|Primary Analysis Population|Adverse Event|0|||
164172134|NCT04488419|592993077|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
164172135|NCT04488419|592993078|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
164172136|NCT04488419|592993079|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
164172137|NCT04488419|592993077|FG000|Primary Analysis Population|Protocol Violation|1|||
164172138|NCT04488419|592993078|FG001|Primary Analysis Population|Protocol Violation|1|||
164172139|NCT04488419|592993079|FG002|Primary Analysis Population|Protocol Violation|0|||
164172140|NCT04488419|592993077|FG000|Primary Analysis Population|Undetermined|7|||
164172141|NCT04488419|592993078|FG001|Primary Analysis Population|Undetermined|3|||
164172142|NCT04488419|592993079|FG002|Primary Analysis Population|Undetermined|0|||
164172143|NCT04488419|592993077|FG000|Primary Analysis Population|>1 Reason|2|||
164172144|NCT04488419|592993078|FG001|Primary Analysis Population|>1 Reason|4|||
164172145|NCT04488419|592993079|FG002|Primary Analysis Population|>1 Reason|0|||
164172146|NCT00970632|592993081|FG000|Overall Study|Adverse Event|2|||
164172147|NCT00970632|592993082|FG001|Overall Study|Adverse Event|2|||
164172148|NCT00970632|592993083|FG002|Overall Study|Adverse Event|1|||
164172149|NCT00970632|592993081|FG000|Overall Study|Lack of Efficacy|3|||
164172150|NCT00970632|592993082|FG001|Overall Study|Lack of Efficacy|0|||
164172151|NCT00970632|592993083|FG002|Overall Study|Lack of Efficacy|0|||
164172152|NCT00970632|592993081|FG000|Overall Study|Lost to Follow-up|3|||
164172153|NCT00970632|592993082|FG001|Overall Study|Lost to Follow-up|0|||
164172154|NCT00970632|592993083|FG002|Overall Study|Lost to Follow-up|2|||
164172155|NCT00970632|592993081|FG000|Overall Study|Protocol Violation|8|||
164172156|NCT00970632|592993082|FG001|Overall Study|Protocol Violation|5|||
164172157|NCT00970632|592993083|FG002|Overall Study|Protocol Violation|8|||
164172158|NCT00970632|592993081|FG000|Overall Study|Withdrawal by Subject|7|||
164172159|NCT00970632|592993082|FG001|Overall Study|Withdrawal by Subject|6|||
164172160|NCT00970632|592993083|FG002|Overall Study|Withdrawal by Subject|4|||
164172161|NCT00970632|592993081|FG000|Overall Study|Entry criteria not met|0|||
164172162|NCT00970632|592993082|FG001|Overall Study|Entry criteria not met|2|||
164172163|NCT00970632|592993083|FG002|Overall Study|Entry criteria not met|2|||
164172164|NCT00970632|592993081|FG000|Overall Study|Sponsor decision|1|||
164172165|NCT00970632|592993082|FG001|Overall Study|Sponsor decision|0|||
164172166|NCT00970632|592993083|FG002|Overall Study|Sponsor decision|1|||
164172167|NCT01286168|592993089|FG000|Overall Study|Withdrawal by Subject|1|||
164172168|NCT01286168|592993089|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
164172169|NCT02487771|592993090|FG000|Overall Study|Lost to Follow-up|2|||
164172170|NCT02487771|592993091|FG001|Overall Study|Lost to Follow-up|3|||
164172171|NCT02487771|592993090|FG000|Overall Study|Moved out of area|5|||
164172172|NCT02487771|592993091|FG001|Overall Study|Moved out of area|6|||
164172173|NCT02487771|592993090|FG000|Overall Study|Withdrawal by Subject|3|||
164172174|NCT02487771|592993091|FG001|Overall Study|Withdrawal by Subject|5|||
164172175|NCT01871402|592993092|FG000|Overall Study|Lost to Follow-up|1|||
164172176|NCT01871402|592993093|FG001|Overall Study|Lost to Follow-up|0|||
164172177|NCT01871402|592993092|FG000|Overall Study|Withdrawal by Subject|0|||
164172178|NCT01871402|592993093|FG001|Overall Study|Withdrawal by Subject|2|||
164172179|NCT01871402|592993092|FG000|Overall Study|Non-compliance|0|||
164172180|NCT01871402|592993093|FG001|Overall Study|Non-compliance|1|||
164172181|NCT04594941|592993094|FG000|Overall Study|Other|0|||
164172182|NCT04594941|592993095|FG001|Overall Study|Other|3|||
164172183|NCT04594941|592993096|FG002|Overall Study|Other|1|||
164172184|NCT04594941|592993097|FG003|Overall Study|Other|0|||
164172185|NCT04984681|592993098|FG000|Overall Study|Lost to Follow-up|3|||
164172186|NCT04984681|592993099|FG001|Overall Study|Lost to Follow-up|1|||
164172187|NCT04327661|592993100|FG000|Overall Study|Withdrawal by Subject|1|||
164172188|NCT04327661|592993101|FG001|Overall Study|Withdrawal by Subject|0|||
164172189|NCT04327661|592993102|FG002|Overall Study|Withdrawal by Subject|0|||
164172190|NCT02091960|592993103|FG000|Overall Study|Death|7|||
164172191|NCT02091960|592993103|FG000|Overall Study|Withdrawal by Subject|1|||
164172192|NCT02091960|592993103|FG000|Overall Study|Miscellaneous Reasons|37|||
164172193|NCT01942486|592993114|FG000|Overall Study|Lost to Follow-up|27|||
164172194|NCT03728426|592993115|FG000|Overall Study|Death|3|||
164172195|NCT02424630|592993118|FG000|Overall Study|No rotator cuff tear|1|||
164172196|NCT02424630|592993119|FG001|Overall Study|No rotator cuff tear|2|||
164172197|NCT02424630|592993118|FG000|Overall Study|Open procedure|0|||
164172198|NCT02424630|592993119|FG001|Overall Study|Open procedure|1|||
164172199|NCT02637895|592993120|FG000|Overall Study|Lost to Follow-up|4|||
164172200|NCT02637895|592993121|FG001|Overall Study|Lost to Follow-up|0|||
164172201|NCT02637895|592993120|FG000|Overall Study|Protocol Violation|0|||
164172202|NCT02637895|592993121|FG001|Overall Study|Protocol Violation|1|||
164172203|NCT02637895|592993120|FG000|Overall Study|Lack of Efficacy|1|||
164172204|NCT02637895|592993121|FG001|Overall Study|Lack of Efficacy|0|||
164172205|NCT02637895|592993120|FG000|Overall Study|Withdrawal by Subject|1|||
164172206|NCT02637895|592993121|FG001|Overall Study|Withdrawal by Subject|1|||
164172207|NCT02637895|592993120|FG000|Overall Study|Abnormal baseline lab|0|||
164172208|NCT02637895|592993121|FG001|Overall Study|Abnormal baseline lab|1|||
164172209|NCT01741792|592993124|FG000|Overall Study|Death|6|||
164172210|NCT01741792|592993125|FG001|Overall Study|Death|1|||
164172211|NCT01741792|592993126|FG002|Overall Study|Death|12|||
164172212|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
164172213|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
164172214|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
164172215|NCT01995175|592993127|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
164172216|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
164172217|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
164172218|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
164172219|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
164172220|NCT01995175|592993127|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
164172221|NCT00984061|592993128|FG000|Clarithromycin Alone|Protocol Violation|1|||
164172222|NCT05139303|592993129|FG000|Overall Study|Lost to Follow-up|3|||
164172223|NCT05139303|592993130|FG001|Overall Study|Lost to Follow-up|0|||
164172224|NCT05139303|592993129|FG000|Overall Study|Adverse Event|1|||
164172225|NCT05139303|592993130|FG001|Overall Study|Adverse Event|0|||
164172226|NCT02045862|592993131|FG000|Overall Study|Death|0|||
164172227|NCT02045862|592993132|FG001|Overall Study|Death|0|||
164172228|NCT02045862|592993133|FG002|Overall Study|Death|1|||
164172229|NCT02045862|592993131|FG000|Overall Study|Miscellaneous|5|||
164172230|NCT02045862|592993132|FG001|Overall Study|Miscellaneous|0|||
164172231|NCT02045862|592993133|FG002|Overall Study|Miscellaneous|8|||
164172232|NCT02045862|592993131|FG000|Overall Study|Withdrawal by Patient|18|||
164172233|NCT02045862|592993132|FG001|Overall Study|Withdrawal by Patient|27|||
164172234|NCT02045862|592993133|FG002|Overall Study|Withdrawal by Patient|57|||
164172235|NCT02045862|592993131|FG000|Overall Study|Protocol Violation|0|||
164172236|NCT02045862|592993132|FG001|Overall Study|Protocol Violation|0|||
164172237|NCT02045862|592993133|FG002|Overall Study|Protocol Violation|6|||
164172238|NCT02045862|592993131|FG000|Overall Study|Lack of Efficacy|8|||
164172239|NCT02045862|592993132|FG001|Overall Study|Lack of Efficacy|4|||
164172240|NCT02045862|592993133|FG002|Overall Study|Lack of Efficacy|13|||
164172241|NCT02045862|592993131|FG000|Overall Study|Randomized but not Received Study Drug|0|||
164172242|NCT02045862|592993132|FG001|Overall Study|Randomized but not Received Study Drug|2|||
164172243|NCT02045862|592993133|FG002|Overall Study|Randomized but not Received Study Drug|8|||
164172244|NCT02045862|592993131|FG000|Overall Study|Adverse Event|7|||
164172245|NCT02045862|592993132|FG001|Overall Study|Adverse Event|5|||
164172246|NCT02045862|592993133|FG002|Overall Study|Adverse Event|27|||
164172247|NCT02045862|592993131|FG000|Overall Study|Lost to Follow-up|1|||
164172248|NCT02045862|592993132|FG001|Overall Study|Lost to Follow-up|2|||
164172249|NCT02045862|592993133|FG002|Overall Study|Lost to Follow-up|6|||
164172250|NCT02353442|592993138|FG000|Overall Study|Withdrawal by Subject|3|||
164172251|NCT02353442|592993139|FG001|Overall Study|Withdrawal by Subject|4|||
164172252|NCT01075646|592993142|FG000|Overall Study|Lost to Follow-up|4|||
164172253|NCT01075646|592993143|FG001|Overall Study|Lost to Follow-up|3|||
164172254|NCT01075646|592993144|FG002|Overall Study|Lost to Follow-up|1|||
164172255|NCT01075646|592993145|FG003|Overall Study|Lost to Follow-up|2|||
164172256|NCT05239494|592993149|FG000|Overall Study|Lost to Follow-up|1|||
164172257|NCT02855359|592993150|FG000|Overall Study|Death|2|||
164172258|NCT02855359|592993151|FG001|Overall Study|Death|2|||
164172259|NCT02855359|592993152|FG002|Overall Study|Death|0|||
164172260|NCT02855359|592993153|FG003|Overall Study|Death|0|||
164172261|NCT02855359|592993150|FG000|Overall Study|Study Termination by Sponsor|9|||
164172262|NCT02855359|592993151|FG001|Overall Study|Study Termination by Sponsor|11|||
164172263|NCT02855359|592993152|FG002|Overall Study|Study Termination by Sponsor|0|||
164172264|NCT02855359|592993153|FG003|Overall Study|Study Termination by Sponsor|0|||
164172265|NCT03155178|592993154|FG000|Overall Study|Did not meet treatment day baseline|7|||
164172266|NCT03155178|592993155|FG001|Overall Study|Did not meet treatment day baseline|7|||
164172267|NCT03155178|592993156|FG002|Overall Study|Did not meet treatment day baseline|7|||
164172268|NCT03155178|592993157|FG003|Overall Study|Did not meet treatment day baseline|7|||
164172269|NCT02677038|592993163|FG000|Overall Study|Physician Decision|1|||
164172270|NCT02677038|592993163|FG000|Overall Study|Withdrawal by Subject|1|||
164172271|NCT02777970|592993167|FG000|Overall Study|Lost to Follow-up|0|||
164172272|NCT02777970|592993168|FG001|Overall Study|Lost to Follow-up|1|||
164172273|NCT02777970|592993169|FG002|Overall Study|Lost to Follow-up|0|||
164172274|NCT02777970|592993167|FG000|Overall Study|Protocol Violation|1|||
164172275|NCT02777970|592993168|FG001|Overall Study|Protocol Violation|0|||
164172276|NCT02777970|592993169|FG002|Overall Study|Protocol Violation|0|||
164172277|NCT02541669|592993177|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
164172278|NCT02541669|592993178|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
164172279|NCT02541669|592993179|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
164172280|NCT02541669|592993180|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
164172281|NCT02541669|592993181|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
164172282|NCT00834639|592993182|FG000|Second Intervention|Physician Decision|0|||
164172283|NCT00834639|592993183|FG001|Second Intervention|Physician Decision|2|||
164172284|NCT04739722|592993187|FG000|Overall Study|Lost to Follow-up|5301|||
164172285|NCT04739722|592993187|FG000|Overall Study|Withdrawal by Subject|42|||
164172286|NCT04739722|592993187|FG000|Overall Study|Non Average-risk|1157|||
164172287|NCT02083185|592993194|FG000|Overall Study|Lost to Follow-up|0|||
164172288|NCT02083185|592993195|FG001|Overall Study|Lost to Follow-up|3|||
164172289|NCT02083185|592993196|FG002|Overall Study|Lost to Follow-up|0|||
164172290|NCT02083185|592993194|FG000|Overall Study|Withdrawal by Subject|9|||
164172291|NCT02083185|592993195|FG001|Overall Study|Withdrawal by Subject|15|||
164172292|NCT02083185|592993196|FG002|Overall Study|Withdrawal by Subject|1|||
164172294|NCT02083185|592993195|FG001|Overall Study|Death|2|||
164172295|NCT02083185|592993196|FG002|Overall Study|Death|1|||
164172296|NCT02083185|592993194|FG000|Overall Study|Reason not Specified|9|||
164172297|NCT02083185|592993195|FG001|Overall Study|Reason not Specified|6|||
164172298|NCT02083185|592993196|FG002|Overall Study|Reason not Specified|5|||
164172299|NCT02083185|592993194|FG000|Overall Study|Study Terminated by Sponsor|0|||
164172300|NCT02083185|592993195|FG001|Overall Study|Study Terminated by Sponsor|1|||
164172301|NCT02083185|592993196|FG002|Overall Study|Study Terminated by Sponsor|0|||
164172302|NCT02083185|592993194|FG000|Overall Study|Did not Receive Study Drug|0|||
164172303|NCT02083185|592993195|FG001|Overall Study|Did not Receive Study Drug|2|||
164172304|NCT02083185|592993196|FG002|Overall Study|Did not Receive Study Drug|0|||
164172305|NCT01322035|592993197|FG000|Overall Study|Lost to Follow-up|8|||
164172306|NCT01322035|592993198|FG001|Overall Study|Lost to Follow-up|3|||
164172307|NCT00535847|592993199|FG000|Overall Study|Adverse Event|5|||
164172308|NCT00535847|592993200|FG001|Overall Study|Adverse Event|3|||
164172309|NCT00535847|592993201|FG002|Overall Study|Adverse Event|2|||
164172310|NCT00535847|592993199|FG000|Overall Study|Non compliance|1|||
164172311|NCT00535847|592993200|FG001|Overall Study|Non compliance|1|||
164172312|NCT00535847|592993201|FG002|Overall Study|Non compliance|0|||
164172313|NCT00535847|592993199|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
164172314|NCT00535847|592993200|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
164172315|NCT00535847|592993201|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
164172316|NCT01546168|592993202|FG000|Overall Study|Lost to Follow-up|1|||
164172317|NCT01546168|592993203|FG001|Overall Study|Lost to Follow-up|0|||
164172318|NCT01546168|592993202|FG000|Overall Study|Withdrawal by Subject|1|||
164172319|NCT01546168|592993203|FG001|Overall Study|Withdrawal by Subject|0|||
164172320|NCT01546168|592993202|FG000|Overall Study|ineligible after signing consent|2|||
164172321|NCT01546168|592993203|FG001|Overall Study|ineligible after signing consent|0|||
164172322|NCT02850016|592993204|FG000|Overall Study|Withdrawal by Subject|1|||
164172323|NCT02850016|592993205|FG001|Overall Study|Withdrawal by Subject|2|||
164172324|NCT01054196|592993213|FG000|Overall Study|Physician Decision|0|||
164172325|NCT01054196|592993214|FG001|Overall Study|Physician Decision|0|||
164172326|NCT01054196|592993215|FG002|Overall Study|Physician Decision|0|||
164172327|NCT01054196|592993216|FG003|Overall Study|Physician Decision|1|||
164172328|NCT01054196|592993217|FG004|Overall Study|Physician Decision|0|||
164172329|NCT01054196|592993218|FG005|Overall Study|Physician Decision|0|||
164172330|NCT01054196|592993219|FG006|Overall Study|Physician Decision|1|||
164172331|NCT00478699|592993226|FG000|Overall Study|Inclusion Error|1|||
164172332|NCT00478699|592993227|FG001|Overall Study|Inclusion Error|7|||
164172333|NCT00478699|592993226|FG000|Overall Study|Not receive study treatment|6|||
164172334|NCT00478699|592993227|FG001|Overall Study|Not receive study treatment|30|||
164172335|NCT01508130|592993228|FG000|Overall Study|Adverse Event|81|||
164172336|NCT01508130|592993229|FG001|Overall Study|Adverse Event|28|||
164172337|NCT01508130|592993228|FG000|Overall Study|Death|3|||
164172338|NCT01508130|592993229|FG001|Overall Study|Death|1|||
164172339|NCT01508130|592993228|FG000|Overall Study|Protocol Violation|2|||
164172340|NCT01508130|592993229|FG001|Overall Study|Protocol Violation|0|||
164172341|NCT01508130|592993228|FG000|Overall Study|Lost to Follow-up|25|||
164172342|NCT01508130|592993229|FG001|Overall Study|Lost to Follow-up|2|||
164172343|NCT01508130|592993228|FG000|Overall Study|Withdrawal by Subject|3|||
164172344|NCT01508130|592993229|FG001|Overall Study|Withdrawal by Subject|3|||
164172345|NCT01508130|592993228|FG000|Overall Study|Subject's substantial non-compliance|25|||
164172346|NCT01508130|592993229|FG001|Overall Study|Subject's substantial non-compliance|9|||
164172347|NCT01508130|592993228|FG000|Overall Study|Insufficient therapeutic response|74|||
164172348|NCT01508130|592993229|FG001|Overall Study|Insufficient therapeutic response|23|||
164172349|NCT01508130|592993228|FG000|Overall Study|Administrative|14|||
164172350|NCT01508130|592993229|FG001|Overall Study|Administrative|3|||
164172351|NCT01880086|592993235|FG000|Overall Study|Lost to Follow-up|1|||
164172352|NCT01880086|592993236|FG001|Overall Study|Lost to Follow-up|1|||
164172353|NCT02288091|592993240|FG000|Overall Study|Lost to Follow-up|1|||
164172354|NCT02288091|592993240|FG000|Overall Study|Screen fail|7|||
164172355|NCT03843632|592993246|FG000|Overall Study|Withdrawal by Subject|1|||
164172356|NCT03843632|592993247|FG001|Overall Study|Withdrawal by Subject|0|||
164172357|NCT03843632|592993248|FG002|Overall Study|Withdrawal by Subject|0|||
164172358|NCT03843632|592993249|FG003|Overall Study|Withdrawal by Subject|0|||
164172359|NCT01820572|592993250|FG000|Randomization|Not Treated|2|||
164172360|NCT01820572|592993251|FG001|Randomization|Not Treated|1|||
164172361|NCT01820572|592993250|FG000|Treatment Period|Adverse Event|12|||
164172362|NCT01820572|592993251|FG001|Treatment Period|Adverse Event|7|||
164172363|NCT01820572|592993250|FG000|Treatment Period|Death|3|||
164172364|NCT01820572|592993251|FG001|Treatment Period|Death|3|||
164172365|NCT01820572|592993250|FG000|Treatment Period|Lack of Efficacy|1|||
164172366|NCT01820572|592993251|FG001|Treatment Period|Lack of Efficacy|0|||
164172367|NCT01820572|592993250|FG000|Treatment Period|poor/non compliance|0|||
164172368|NCT01820572|592993251|FG001|Treatment Period|poor/non compliance|3|||
164172369|NCT01820572|592993250|FG000|Treatment Period|request to discontinue|6|||
164172370|NCT01820572|592993251|FG001|Treatment Period|request to discontinue|11|||
164172371|NCT01820572|592993250|FG000|Treatment Period|No longer meets study criteria|3|||
164172372|NCT01820572|592993251|FG001|Treatment Period|No longer meets study criteria|10|||
164172373|NCT01820572|592993250|FG000|Treatment Period|withdrew consent|1|||
164172374|NCT01820572|592993251|FG001|Treatment Period|withdrew consent|2|||
164172375|NCT00595517|592993252|FG000|Overall Study|Adverse Event|6|||
164172376|NCT00595517|592993252|FG000|Overall Study|Withdrawal by Subject|4|||
164172377|NCT00595517|592993252|FG000|Overall Study|Protocol Violation|2|||
164172378|NCT00595517|592993252|FG000|Overall Study|Recurrence of ulcer|5|||
164172379|NCT00595517|592993252|FG000|Overall Study|usage of prohibited treatment|1|||
164172380|NCT00595517|592993252|FG000|Overall Study|No intention to attend regularly|1|||
164172381|NCT03852628|592993255|FG000|Overall Study|Lost to Follow-up|7|||
164172382|NCT03852628|592993256|FG001|Overall Study|Lost to Follow-up|6|||
164172383|NCT03852628|592993255|FG000|Overall Study|Lack of Efficacy|6|||
164172384|NCT03852628|592993256|FG001|Overall Study|Lack of Efficacy|6|||
164172385|NCT01931956|592993257|FG000|Overall Study|Death|42|||
164172386|NCT01931956|592993258|FG001|Overall Study|Death|7|||
164172387|NCT01931956|592993259|FG002|Overall Study|Death|379|||
164172388|NCT01931956|592993260|FG003|Overall Study|Death|96|||
164172389|NCT01931956|592993257|FG000|Overall Study|Withdrawal by Subject|5|||
164172390|NCT01931956|592993258|FG001|Overall Study|Withdrawal by Subject|0|||
164172391|NCT01931956|592993259|FG002|Overall Study|Withdrawal by Subject|70|||
164172392|NCT01931956|592993260|FG003|Overall Study|Withdrawal by Subject|30|||
164172393|NCT01931956|592993257|FG000|Overall Study|Lost to Follow-up|2|||
164172394|NCT01931956|592993258|FG001|Overall Study|Lost to Follow-up|0|||
164172395|NCT01931956|592993259|FG002|Overall Study|Lost to Follow-up|11|||
164172396|NCT01931956|592993260|FG003|Overall Study|Lost to Follow-up|7|||
164172397|NCT01931956|592993257|FG000|Overall Study|Expected|2|||
164172398|NCT01931956|592993258|FG001|Overall Study|Expected|0|||
164172399|NCT01931956|592993259|FG002|Overall Study|Expected|6|||
164172400|NCT01931956|592993260|FG003|Overall Study|Expected|0|||
164172401|NCT01931956|592993257|FG000|Overall Study|Not due|0|||
164172402|NCT01931956|592993258|FG001|Overall Study|Not due|0|||
164172403|NCT01931956|592993259|FG002|Overall Study|Not due|21|||
164172404|NCT01931956|592993260|FG003|Overall Study|Not due|0|||
164172405|NCT02600845|592993270|FG000|Overall Study|Reason Not Specified|3|||
164172406|NCT02600845|592993270|FG000|Overall Study|Non-compliance with Study Procedures|10|||
164172407|NCT02600845|592993270|FG000|Overall Study|Consent Withdrawal|5|||
164172408|NCT00197002|592995423|FG000|Overall Study|Adverse Event|0|||
164172409|NCT00197002|592995424|FG001|Overall Study|Adverse Event|1|||
164172410|NCT00197002|592995425|FG002|Overall Study|Adverse Event|0|||
164172411|NCT00197002|592995423|FG000|Overall Study|Protocol Violation|1|||
164172412|NCT00197002|592995424|FG001|Overall Study|Protocol Violation|0|||
164172413|NCT00197002|592995425|FG002|Overall Study|Protocol Violation|2|||
164172414|NCT00197002|592995423|FG000|Overall Study|Withdrawal by Subject|9|||
164172415|NCT00197002|592995424|FG001|Overall Study|Withdrawal by Subject|5|||
164172416|NCT00197002|592995425|FG002|Overall Study|Withdrawal by Subject|7|||
164172417|NCT00197002|592995423|FG000|Overall Study|Migrated/moved from study area|3|||
164172418|NCT00197002|592995424|FG001|Overall Study|Migrated/moved from study area|5|||
164172419|NCT00197002|592995425|FG002|Overall Study|Migrated/moved from study area|1|||
164172420|NCT00197002|592995423|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
164172421|NCT00197002|592995424|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
164172422|NCT00197002|592995425|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
164172423|NCT00197002|592995423|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
164172424|NCT00197002|592995424|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
164172425|NCT00197002|592995425|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
164172426|NCT00197002|592995423|FG000|Overall Study|Others|3|||
164172427|NCT00197002|592995424|FG001|Overall Study|Others|1|||
164172428|NCT00197002|592995425|FG002|Overall Study|Others|1|||
164172429|NCT05072106|592995428|FG000|Overall Study|Progressive disease|3|||
164172430|NCT05072106|592995429|FG001|Overall Study|Progressive disease|3|||
164172431|NCT05072106|592995428|FG000|Overall Study|Compassionate use|3|||
164172432|NCT05072106|592995429|FG001|Overall Study|Compassionate use|1|||
164172433|NCT05072106|592995428|FG000|Overall Study|Withdrawal by Subject|1|||
164172434|NCT05072106|592995429|FG001|Overall Study|Withdrawal by Subject|0|||
164172435|NCT03839459|592995430|FG000|Overall Study|Withdrawal by Subject|2|||
164172436|NCT03839459|592995430|FG000|Overall Study|progression of disease|3|||
164172437|NCT05376241|592995431|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
164172438|NCT05376241|592995431|FG000|Overall Study|103 did not complete the survey|103|||
164172439|NCT05376241|592995431|FG000|Overall Study|17 failed 2 attention check questions|17|||
164172440|NCT01632150|592995432|FG000|Overall Study|Disease progression|27|||
164172441|NCT01632150|592995432|FG000|Overall Study|Study drug toxicity|1|||
164172442|NCT01632150|592995432|FG000|Overall Study|Unrelated adverse event|7|||
164172443|NCT01632150|592995432|FG000|Overall Study|Withdrawal by Subject|2|||
164172444|NCT01632150|592995432|FG000|Overall Study|Patient underwent autologous transplant|1|||
164172445|NCT01632150|592995432|FG000|Overall Study|Moved to compassionate program|2|||
164172446|NCT02879994|592995435|FG000|Overall Study|off treatment early|7|||
164172447|NCT02879994|592995435|FG000|Overall Study|Adverse Event|2|||
164172448|NCT02879994|592995435|FG000|Overall Study|Death|2|||
164172449|NCT02143791|592995436|FG000|Enrolled|Withdrawal by Subject|4|||
164172450|NCT02143791|592995436|FG000|Trial Stimulation|Lack of Efficacy|21|||
164172451|NCT02143791|592995436|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
164172452|NCT02143791|592995436|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
164172453|NCT02143791|592995436|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
164172454|NCT02143791|592995436|FG000|Any Programming (3-6 Months)|Missing Data|1|||
164172455|NCT02143791|592995436|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
164172456|NCT00507819|592995444|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
164172457|NCT00507819|592995445|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
164172458|NCT02691013|592995448|FG000|Overall Study|Withdrawal by Subject|3|||
164172459|NCT02691013|592995449|FG001|Overall Study|Withdrawal by Subject|0|||
164172460|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Adverse Event|6|||
164172461|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Adverse Event|14|||
164172462|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Death|3|||
164172463|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Death|1|||
164172464|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
164172465|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
164172466|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
164172467|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
164172468|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
164172469|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
164172470|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
164172471|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
164172472|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
164172473|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
164172474|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Physician Decision|2|||
164172475|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Physician Decision|4|||
164172476|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Pregnancy|2|||
164172477|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Pregnancy|1|||
164172478|NCT02275780|592995452|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
164172479|NCT02275780|592995453|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
164172480|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
164172481|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
164172482|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
164172483|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
164172484|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
164172485|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
164172486|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
164172487|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
164172488|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
164172489|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
164172490|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
164172491|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
164172492|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
164172493|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
164172494|NCT02275780|592995452|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
164172495|NCT02275780|592995453|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
164172496|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
164172497|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
164172498|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
164172499|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
164172500|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
164172501|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
164172502|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
164172503|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
164172504|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
164172505|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
164172506|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
164172507|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
164172508|NCT02275780|592995452|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
164172509|NCT02275780|592995453|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
164172510|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
164172511|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
164172512|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
164172513|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
164172514|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
164172515|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
164172516|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
164172517|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
164172518|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
164172519|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
164172520|NCT02275780|592995452|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
164172521|NCT02275780|592995453|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
164172522|NCT00631410|592995456|FG000|Overall Study|Adverse Event|1|||
164172523|NCT00631410|592995457|FG001|Overall Study|Adverse Event|3|||
164172524|NCT00631410|592995456|FG000|Overall Study|Objective Progression or Relapse|4|||
164172525|NCT00631410|592995457|FG001|Overall Study|Objective Progression or Relapse|3|||
164172526|NCT00631410|592995456|FG000|Overall Study|Surgery|1|||
164172527|NCT00631410|592995457|FG001|Overall Study|Surgery|0|||
164172528|NCT03419598|592995459|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
164172529|NCT00380081|592995462|FG000|Overall Study|Withdrawal by Subject|0|||
164172530|NCT00380081|592995463|FG001|Overall Study|Withdrawal by Subject|0|||
164172531|NCT00380081|592995464|FG002|Overall Study|Withdrawal by Subject|0|||
164172532|NCT00380081|592995465|FG003|Overall Study|Withdrawal by Subject|0|||
164172533|NCT00380081|592995466|FG004|Overall Study|Withdrawal by Subject|1|||
164172534|NCT00380081|592995467|FG005|Overall Study|Withdrawal by Subject|0|||
164172535|NCT00380081|592995462|FG000|Overall Study|Family Emergency|0|||
164172536|NCT00380081|592995463|FG001|Overall Study|Family Emergency|0|||
164172537|NCT00380081|592995464|FG002|Overall Study|Family Emergency|0|||
164172538|NCT00380081|592995465|FG003|Overall Study|Family Emergency|0|||
164172539|NCT00380081|592995466|FG004|Overall Study|Family Emergency|0|||
164172540|NCT00380081|592995467|FG005|Overall Study|Family Emergency|1|||
164172541|NCT02231879|592995468|FG000|Overall Study|Adverse Event|2|||
164172542|NCT02231879|592995469|FG001|Overall Study|Adverse Event|1|||
164172543|NCT02231879|592995468|FG000|Overall Study|Lack of Efficacy|0|||
164172544|NCT02231879|592995469|FG001|Overall Study|Lack of Efficacy|1|||
164172545|NCT00189306|592995470|FG000|Treatment Period|Withdrawal by Subject|2|||
164172546|NCT00189306|592995470|FG000|Treatment Period|Adverse Event|2|||
164172547|NCT00189306|592995470|FG000|Treatment Period|Protocol Violation|1|||
164172548|NCT00189306|592995470|FG000|Posttreatment Period|Death|1|||
164172549|NCT00189306|592995470|FG000|Posttreatment Period|Withdrawal by Subject|2|||
164172550|NCT00189306|592995470|FG000|Posttreatment Period|Noncompliance|1|||
164172551|NCT00189306|592995470|FG000|Posttreatment Period|Target lesion excised|1|||
164172552|NCT00189306|592995470|FG000|Posttreatment Period|Protocol Violation|1|||
164172553|NCT00189306|592995470|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
164172554|NCT00189306|592995470|FG000|Posttreatment Period|Local skin reaction/sign|1|||
164172555|NCT00189306|592995470|FG000|Long-Term Follow-up|Adverse Event|2|||
164172556|NCT00189306|592995470|FG000|Long-Term Follow-up|Death|4|||
164172557|NCT00189306|592995470|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
164172558|NCT00189306|592995470|FG000|Long-Term Follow-up|Intercurrent disease|2|||
164172559|NCT00189306|592995470|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
164172560|NCT00189306|592995470|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
164172561|NCT03640481|592995471|FG000|Overall Study|Death|14|||
164172562|NCT03640481|592995472|FG001|Overall Study|Death|14|||
164172563|NCT03640481|592995473|FG002|Overall Study|Death|0|||
164172564|NCT03640481|592995474|FG003|Overall Study|Death|0|||
164172565|NCT03640481|592995471|FG000|Overall Study|Lost to Follow-up|2|||
164172566|NCT03640481|592995472|FG001|Overall Study|Lost to Follow-up|0|||
164172567|NCT03640481|592995473|FG002|Overall Study|Lost to Follow-up|0|||
164172568|NCT03640481|592995474|FG003|Overall Study|Lost to Follow-up|0|||
164172569|NCT03640481|592995471|FG000|Overall Study|Site terminated by sponsor|1|||
164172570|NCT03640481|592995472|FG001|Overall Study|Site terminated by sponsor|3|||
164172571|NCT03640481|592995473|FG002|Overall Study|Site terminated by sponsor|0|||
164172572|NCT03640481|592995474|FG003|Overall Study|Site terminated by sponsor|0|||
164172573|NCT03640481|592995471|FG000|Overall Study|Study terminated by sponsor|29|||
164172574|NCT03640481|592995472|FG001|Overall Study|Study terminated by sponsor|42|||
164172575|NCT03640481|592995473|FG002|Overall Study|Study terminated by sponsor|1|||
164172576|NCT03640481|592995474|FG003|Overall Study|Study terminated by sponsor|0|||
164172577|NCT03640481|592995471|FG000|Overall Study|Withdrawal by Subject|5|||
164172578|NCT03640481|592995472|FG001|Overall Study|Withdrawal by Subject|4|||
164172579|NCT03640481|592995473|FG002|Overall Study|Withdrawal by Subject|0|||
164172580|NCT03640481|592995474|FG003|Overall Study|Withdrawal by Subject|1|||
164172581|NCT03640481|592995471|FG000|Overall Study|Other|26|||
164172582|NCT03640481|592995472|FG001|Overall Study|Other|12|||
164172583|NCT03640481|592995473|FG002|Overall Study|Other|1|||
164172584|NCT03640481|592995474|FG003|Overall Study|Other|0|||
164172585|NCT03640481|592995471|FG000|Overall Study|Randomized, but not treated|1|||
164172586|NCT03640481|592995472|FG001|Overall Study|Randomized, but not treated|3|||
164172587|NCT03640481|592995473|FG002|Overall Study|Randomized, but not treated|0|||
164172588|NCT03640481|592995474|FG003|Overall Study|Randomized, but not treated|0|||
164172589|NCT00070018|592995477|FG000|Overall Study|Adverse Event|2|||
164172590|NCT00070018|592995477|FG000|Overall Study|Lack of Efficacy|1|||
164172591|NCT00070018|592995477|FG000|Overall Study|Withdrawal by Subject|1|||
164172592|NCT02939716|592995478|FG000|Overall Study|scanner failure|0|||
164172593|NCT02939716|592995479|FG001|Overall Study|scanner failure|0|||
164172594|NCT02939716|592995480|FG002|Overall Study|scanner failure|0|||
164172595|NCT02939716|592995481|FG003|Overall Study|scanner failure|1|||
164172596|NCT02939716|592995482|FG004|Overall Study|scanner failure|1|||
164172597|NCT02939716|592995483|FG005|Overall Study|scanner failure|1|||
164172598|NCT00574249|592995486|FG000|Overall Study|Adverse Event|6|||
164172599|NCT00574249|592995487|FG001|Overall Study|Adverse Event|18|||
164172600|NCT00574249|592995486|FG000|Overall Study|Lack of Efficacy|5|||
164172601|NCT00574249|592995487|FG001|Overall Study|Lack of Efficacy|3|||
164172602|NCT00574249|592995486|FG000|Overall Study|Lost to Follow-up|4|||
164172603|NCT00574249|592995487|FG001|Overall Study|Lost to Follow-up|3|||
164172604|NCT00574249|592995486|FG000|Overall Study|Protocol Violation|5|||
164172605|NCT00574249|592995487|FG001|Overall Study|Protocol Violation|2|||
164172606|NCT00574249|592995486|FG000|Overall Study|History of carcinoma|1|||
164172607|NCT00574249|592995487|FG001|Overall Study|History of carcinoma|0|||
164172608|NCT00574249|592995486|FG000|Overall Study|Withdrawal by Subject|3|||
164172609|NCT00574249|592995487|FG001|Overall Study|Withdrawal by Subject|0|||
164172610|NCT00574249|592995486|FG000|Overall Study|Physician Decision|1|||
164172611|NCT00574249|592995487|FG001|Overall Study|Physician Decision|0|||
164172612|NCT00574249|592995486|FG000|Overall Study|Pregnancy|1|||
164172613|NCT00574249|592995487|FG001|Overall Study|Pregnancy|0|||
164172614|NCT00574249|592995486|FG000|Overall Study|Excluded by company|0|||
164172615|NCT00574249|592995487|FG001|Overall Study|Excluded by company|1|||
164172616|NCT00574249|592995486|FG000|Overall Study|PPD test taken twice|0|||
164172617|NCT00574249|592995487|FG001|Overall Study|PPD test taken twice|1|||
164172618|NCT03197870|592995488|FG000|Overall Study|Adverse Event|9|||
164172619|NCT03197870|592995489|FG001|Overall Study|Adverse Event|4|||
164172620|NCT03197870|592995490|FG002|Overall Study|Adverse Event|6|||
164172621|NCT03197870|592995488|FG000|Overall Study|Withdrawal by Subject|2|||
164172622|NCT03197870|592995489|FG001|Overall Study|Withdrawal by Subject|3|||
164172623|NCT03197870|592995490|FG002|Overall Study|Withdrawal by Subject|0|||
164172624|NCT03197870|592995488|FG000|Overall Study|Lost to Follow-up|2|||
164172625|NCT03197870|592995489|FG001|Overall Study|Lost to Follow-up|2|||
164172626|NCT03197870|592995490|FG002|Overall Study|Lost to Follow-up|0|||
164172627|NCT03197870|592995488|FG000|Overall Study|data not available|1|||
164172628|NCT03197870|592995489|FG001|Overall Study|data not available|1|||
164172629|NCT03197870|592995490|FG002|Overall Study|data not available|0|||
164172630|NCT01618019|592995492|FG000|Overall Study|Withdrawal by Subject|14|||
164172631|NCT01618019|592995493|FG001|Overall Study|Withdrawal by Subject|14|||
164172632|NCT01542034|592995494|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
164172633|NCT01542034|592995495|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
164172634|NCT01542034|592995494|FG000|Overall Study|Administrative decision|0|||
164172635|NCT01542034|592995495|FG001|Overall Study|Administrative decision|3|||
164172636|NCT01542034|592995494|FG000|Overall Study|Subject Noncompliance|1|||
164172637|NCT01542034|592995495|FG001|Overall Study|Subject Noncompliance|0|||
164172638|NCT01542034|592995494|FG000|Overall Study|Adverse Event|2|||
164172639|NCT01542034|592995495|FG001|Overall Study|Adverse Event|2|||
164172640|NCT01542034|592995494|FG000|Overall Study|Lost to Follow-up|7|||
164172641|NCT01542034|592995495|FG001|Overall Study|Lost to Follow-up|6|||
164172642|NCT02612610|592995496|FG000|Overall Study|Withdrawal by Subject|1|||
164172643|NCT02612610|592995497|FG001|Overall Study|Withdrawal by Subject|1|||
164172644|NCT02612610|592995498|FG002|Overall Study|Withdrawal by Subject|0|||
164172645|NCT02612610|592995499|FG003|Overall Study|Withdrawal by Subject|2|||
164172646|NCT02612610|592995496|FG000|Overall Study|Adverse Event|2|||
164172647|NCT02612610|592995497|FG001|Overall Study|Adverse Event|2|||
164172648|NCT02612610|592995498|FG002|Overall Study|Adverse Event|3|||
164172649|NCT02612610|592995499|FG003|Overall Study|Adverse Event|10|||
164172650|NCT02612610|592995496|FG000|Overall Study|Lost to Follow-up|0|||
164172651|NCT02612610|592995497|FG001|Overall Study|Lost to Follow-up|1|||
164172652|NCT02612610|592995498|FG002|Overall Study|Lost to Follow-up|0|||
164172653|NCT02612610|592995499|FG003|Overall Study|Lost to Follow-up|0|||
164172654|NCT02612610|592995496|FG000|Overall Study|Protocol Violation|0|||
164172655|NCT02612610|592995497|FG001|Overall Study|Protocol Violation|1|||
164172656|NCT02612610|592995498|FG002|Overall Study|Protocol Violation|1|||
164172657|NCT02612610|592995499|FG003|Overall Study|Protocol Violation|0|||
164172658|NCT02612610|592995496|FG000|Overall Study|Lack of Efficacy|1|||
164172659|NCT02612610|592995497|FG001|Overall Study|Lack of Efficacy|2|||
164172660|NCT02612610|592995498|FG002|Overall Study|Lack of Efficacy|0|||
164172661|NCT02612610|592995499|FG003|Overall Study|Lack of Efficacy|1|||
164172662|NCT02612610|592995496|FG000|Overall Study|Physician Decision|0|||
164172663|NCT02612610|592995497|FG001|Overall Study|Physician Decision|1|||
164172664|NCT02612610|592995498|FG002|Overall Study|Physician Decision|0|||
164172665|NCT02612610|592995499|FG003|Overall Study|Physician Decision|0|||
164172666|NCT02612610|592995496|FG000|Overall Study|Noncompliance|1|||
164172667|NCT02612610|592995497|FG001|Overall Study|Noncompliance|0|||
164172668|NCT02612610|592995498|FG002|Overall Study|Noncompliance|0|||
164172669|NCT02612610|592995499|FG003|Overall Study|Noncompliance|0|||
164172670|NCT02612610|592995496|FG000|Overall Study|Cough Improvement|0|||
164172671|NCT02612610|592995497|FG001|Overall Study|Cough Improvement|0|||
164172672|NCT02612610|592995498|FG002|Overall Study|Cough Improvement|1|||
164172673|NCT02612610|592995499|FG003|Overall Study|Cough Improvement|0|||
164172674|NCT01546571|592995502|FG000|Overall Study|Adverse Event|1|||
164172675|NCT01546571|592995503|FG001|Overall Study|Adverse Event|0|||
164172676|NCT01546571|592995504|FG002|Overall Study|Adverse Event|0|||
164172677|NCT01546571|592995505|FG003|Overall Study|Adverse Event|1|||
164172678|NCT01546571|592995506|FG004|Overall Study|Adverse Event|0|||
164172679|NCT01546571|592995502|FG000|Overall Study|assigned placebo in Part A|0|||
164172680|NCT01546571|592995503|FG001|Overall Study|assigned placebo in Part A|0|||
164172681|NCT01546571|592995504|FG002|Overall Study|assigned placebo in Part A|22|||
164172682|NCT01546571|592995505|FG003|Overall Study|assigned placebo in Part A|0|||
164172683|NCT01546571|592995506|FG004|Overall Study|assigned placebo in Part A|0|||
164172684|NCT01546571|592995502|FG000|Overall Study|Death|0|||
164172685|NCT01546571|592995503|FG001|Overall Study|Death|1|||
164172686|NCT01546571|592995504|FG002|Overall Study|Death|0|||
164172687|NCT01546571|592995505|FG003|Overall Study|Death|0|||
164172688|NCT01546571|592995506|FG004|Overall Study|Death|0|||
164172689|NCT01546571|592995502|FG000|Overall Study|Lost to Follow-up|0|||
164172690|NCT01546571|592995503|FG001|Overall Study|Lost to Follow-up|0|||
164172691|NCT01546571|592995504|FG002|Overall Study|Lost to Follow-up|2|||
164172692|NCT01546571|592995505|FG003|Overall Study|Lost to Follow-up|2|||
164172693|NCT01546571|592995506|FG004|Overall Study|Lost to Follow-up|3|||
164172694|NCT01546571|592995502|FG000|Overall Study|Pregnancy|0|||
164172695|NCT01546571|592995503|FG001|Overall Study|Pregnancy|0|||
164172696|NCT01546571|592995504|FG002|Overall Study|Pregnancy|0|||
164172697|NCT01546571|592995505|FG003|Overall Study|Pregnancy|1|||
164172698|NCT01546571|592995506|FG004|Overall Study|Pregnancy|0|||
164172699|NCT01546571|592995502|FG000|Overall Study|Disease Progression|20|||
164172700|NCT01546571|592995503|FG001|Overall Study|Disease Progression|18|||
164172701|NCT01546571|592995504|FG002|Overall Study|Disease Progression|15|||
164172702|NCT01546571|592995505|FG003|Overall Study|Disease Progression|73|||
164172703|NCT01546571|592995506|FG004|Overall Study|Disease Progression|37|||
164172704|NCT01546571|592995502|FG000|Overall Study|Withdrawal by Subject|1|||
164172705|NCT01546571|592995503|FG001|Overall Study|Withdrawal by Subject|2|||
164172706|NCT01546571|592995504|FG002|Overall Study|Withdrawal by Subject|4|||
164172707|NCT01546571|592995505|FG003|Overall Study|Withdrawal by Subject|9|||
164172708|NCT01546571|592995506|FG004|Overall Study|Withdrawal by Subject|2|||
164172709|NCT01546571|592995502|FG000|Overall Study|Intercurrent Illness|1|||
164172710|NCT01546571|592995503|FG001|Overall Study|Intercurrent Illness|2|||
164172711|NCT01546571|592995504|FG002|Overall Study|Intercurrent Illness|0|||
164172712|NCT01546571|592995505|FG003|Overall Study|Intercurrent Illness|0|||
164172713|NCT01546571|592995506|FG004|Overall Study|Intercurrent Illness|0|||
164172714|NCT01546571|592995502|FG000|Overall Study|Other Cancers|0|||
164172715|NCT01546571|592995503|FG001|Overall Study|Other Cancers|0|||
164172716|NCT01546571|592995504|FG002|Overall Study|Other Cancers|0|||
164172717|NCT01546571|592995505|FG003|Overall Study|Other Cancers|3|||
164172718|NCT01546571|592995506|FG004|Overall Study|Other Cancers|1|||
164172719|NCT01546571|592995502|FG000|Overall Study|Other|0|||
164172720|NCT01546571|592995503|FG001|Overall Study|Other|0|||
164172721|NCT01546571|592995504|FG002|Overall Study|Other|3|||
164172722|NCT01546571|592995505|FG003|Overall Study|Other|0|||
164172723|NCT01546571|592995506|FG004|Overall Study|Other|0|||
164172724|NCT00387010|592995509|FG000|Dose Titration Period|Adverse Event|12|||
164172725|NCT00387010|592995509|FG000|Dose Titration Period|Lack of Efficacy|5|||
164172726|NCT00387010|592995509|FG000|Dose Titration Period|Withdrawal by Subject|3|||
164172727|NCT00387010|592995509|FG000|Dose Titration Period|Protocol Violation|1|||
164172728|NCT00387010|592995509|FG000|Dose Titration Period|Lost to Follow-up|2|||
164172729|NCT00387010|592995509|FG000|Dose Titration Period|Noncompliance with study medication|8|||
164172730|NCT00387010|592995509|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
164172731|NCT00387010|592995509|FG000|Treatment Period|Adverse Event|4|||
164172732|NCT00387010|592995509|FG000|Treatment Period|Withdrawal by Subject|1|||
164172733|NCT00387010|592995509|FG000|Treatment Period|Noncompliance with study medication|2|||
164172734|NCT00387010|592995509|FG000|Treatment Period|Noncompliance with study procedures|3|||
164172735|NCT00387010|592995509|FG000|Treatment Period|Participant reported study drug stolen|1|||
164172736|NCT00430352|592995510|FG000|Overall Study|Disease progression|58|||
164172737|NCT00430352|592995510|FG000|Overall Study|Withdrawal by Subject|11|||
164172738|NCT00430352|592995510|FG000|Overall Study|Adverse Event|16|||
164172739|NCT00430352|592995510|FG000|Overall Study|Death|5|||
164172740|NCT00430352|592995510|FG000|Overall Study|Other|48|||
164172741|NCT03099694|592995511|FG000|Overall Study|Withdrawal by Subject|11|||
164172742|NCT03099694|592995512|FG001|Overall Study|Withdrawal by Subject|13|||
164172743|NCT03099694|592995511|FG000|Overall Study|Lost to Follow-up|9|||
164172744|NCT03099694|592995512|FG001|Overall Study|Lost to Follow-up|5|||
164172745|NCT04326439|592995513|FG000|Overall Study|Withdrawal by Subject|1|||
164172746|NCT04326439|592995514|FG001|Overall Study|Withdrawal by Subject|0|||
164172747|NCT04326439|592995513|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
164172748|NCT04326439|592995514|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
164172749|NCT04326439|592995513|FG000|Overall Study|Relapse after Induction 2|0|||
164172750|NCT04326439|592995514|FG001|Overall Study|Relapse after Induction 2|1|||
164172751|NCT04326439|592995513|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
164172752|NCT04326439|592995514|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
164172753|NCT01167881|592995516|FG000|Overall Study|Adverse Event|47|||
164172754|NCT01167881|592995517|FG001|Overall Study|Adverse Event|51|||
164172755|NCT01167881|592995516|FG000|Overall Study|Lack of Efficacy|4|||
164172756|NCT01167881|592995517|FG001|Overall Study|Lack of Efficacy|7|||
164172757|NCT01167881|592995516|FG000|Overall Study|Non compliant with protocol|9|||
164172758|NCT01167881|592995517|FG001|Overall Study|Non compliant with protocol|18|||
164172759|NCT01167881|592995516|FG000|Overall Study|Lost to Follow-up|19|||
164172760|NCT01167881|592995517|FG001|Overall Study|Lost to Follow-up|20|||
164172761|NCT01167881|592995516|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
164172762|NCT01167881|592995517|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
164172763|NCT01167881|592995516|FG000|Overall Study|Not treated|4|||
164172764|NCT01167881|592995517|FG001|Overall Study|Not treated|0|||
164172765|NCT01167881|592995516|FG000|Overall Study|Other not defined above|31|||
164172766|NCT01167881|592995517|FG001|Overall Study|Other not defined above|55|||
164172767|NCT00471718|592995520|FG000|Overall Study|Adverse Event|3|||
164172768|NCT00471718|592995520|FG000|Overall Study|other complicating disease|1|||
164172769|NCT00471718|592995520|FG000|Overall Study|disease progression|22|||
164172770|NCT00471718|592995520|FG000|Overall Study|Withdrawal by Subject|1|||
164172771|NCT01446237|592995521|FG000|Overall Study|Adverse Event|1|||
164172772|NCT01446237|592995521|FG000|Overall Study|Lost to Follow-up|2|||
164172773|NCT01446237|592995521|FG000|Overall Study|Withdrawal by Subject|7|||
164172774|NCT02294175|592995533|FG000|Overall Study|Withdrawal by Subject|1|||
164172775|NCT02294175|592995534|FG001|Overall Study|Withdrawal by Subject|2|||
164172776|NCT02294175|592995533|FG000|Overall Study|pt taking excluded medication|3|||
164172777|NCT02294175|592995534|FG001|Overall Study|pt taking excluded medication|1|||
164172778|NCT02294175|592995533|FG000|Overall Study|Protocol Violation|1|||
164172779|NCT02294175|592995534|FG001|Overall Study|Protocol Violation|0|||
164172780|NCT02294175|592995533|FG000|Overall Study|Lost to Follow-up|0|||
164172781|NCT02294175|592995534|FG001|Overall Study|Lost to Follow-up|1|||
164172782|NCT02294175|592995533|FG000|Overall Study|wound healed|0|||
164172783|NCT02294175|592995534|FG001|Overall Study|wound healed|2|||
164172784|NCT01901653|592995535|FG000|Overall Study|Death|2|||
164172785|NCT01901653|592995536|FG001|Overall Study|Death|1|||
164172786|NCT01901653|592995537|FG002|Overall Study|Death|8|||
164172787|NCT01901653|592995538|FG003|Overall Study|Death|3|||
164172788|NCT01901653|592995539|FG004|Overall Study|Death|2|||
164172789|NCT01901653|592995540|FG005|Overall Study|Death|2|||
164172790|NCT01901653|592995541|FG006|Overall Study|Death|6|||
164172791|NCT01901653|592995542|FG007|Overall Study|Death|9|||
164172792|NCT01901653|592995543|FG008|Overall Study|Death|1|||
164172793|NCT01901653|592995544|FG009|Overall Study|Death|16|||
164172794|NCT01901653|592995545|FG010|Overall Study|Death|2|||
164172795|NCT01901653|592995546|FG011|Overall Study|Death|15|||
164172796|NCT01901653|592995547|FG012|Overall Study|Death|4|||
164172797|NCT01901653|592995535|FG000|Overall Study|Lost to Follow-up|1|||
164172798|NCT01901653|592995536|FG001|Overall Study|Lost to Follow-up|0|||
164172799|NCT01901653|592995537|FG002|Overall Study|Lost to Follow-up|2|||
164172800|NCT01901653|592995538|FG003|Overall Study|Lost to Follow-up|0|||
164172801|NCT01901653|592995539|FG004|Overall Study|Lost to Follow-up|0|||
164172802|NCT01901653|592995540|FG005|Overall Study|Lost to Follow-up|1|||
164172803|NCT01901653|592995541|FG006|Overall Study|Lost to Follow-up|0|||
164172804|NCT01901653|592995542|FG007|Overall Study|Lost to Follow-up|1|||
164172805|NCT01901653|592995543|FG008|Overall Study|Lost to Follow-up|0|||
164172806|NCT01901653|592995544|FG009|Overall Study|Lost to Follow-up|0|||
164172807|NCT01901653|592995545|FG010|Overall Study|Lost to Follow-up|0|||
164172808|NCT01901653|592995546|FG011|Overall Study|Lost to Follow-up|0|||
164172809|NCT01901653|592995547|FG012|Overall Study|Lost to Follow-up|0|||
164172810|NCT01901653|592995535|FG000|Overall Study|Withdrawal by Subject|0|||
164172811|NCT01901653|592995536|FG001|Overall Study|Withdrawal by Subject|0|||
164172812|NCT01901653|592995537|FG002|Overall Study|Withdrawal by Subject|0|||
164172813|NCT01901653|592995538|FG003|Overall Study|Withdrawal by Subject|0|||
164172814|NCT01901653|592995539|FG004|Overall Study|Withdrawal by Subject|0|||
164172815|NCT01901653|592995540|FG005|Overall Study|Withdrawal by Subject|0|||
164172816|NCT01901653|592995541|FG006|Overall Study|Withdrawal by Subject|1|||
164172817|NCT01901653|592995542|FG007|Overall Study|Withdrawal by Subject|0|||
164172818|NCT01901653|592995543|FG008|Overall Study|Withdrawal by Subject|0|||
164172819|NCT01901653|592995544|FG009|Overall Study|Withdrawal by Subject|0|||
164172820|NCT01901653|592995545|FG010|Overall Study|Withdrawal by Subject|0|||
164172821|NCT01901653|592995546|FG011|Overall Study|Withdrawal by Subject|0|||
164172822|NCT01901653|592995547|FG012|Overall Study|Withdrawal by Subject|0|||
164172823|NCT01901653|592995535|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
164172824|NCT01901653|592995536|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
164172825|NCT01901653|592995537|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
164172826|NCT01901653|592995538|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
164172827|NCT01901653|592995539|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
164172828|NCT01901653|592995540|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
164172829|NCT01901653|592995541|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
164172830|NCT01901653|592995542|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
164172831|NCT01901653|592995543|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
164172832|NCT01901653|592995544|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
164172833|NCT01901653|592995545|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
164172834|NCT01901653|592995546|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
164172835|NCT01901653|592995547|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
164172836|NCT02548351|592995548|FG000|Overall Study|Withdrawal by Subject|149|||
164172837|NCT02548351|592995549|FG001|Overall Study|Withdrawal by Subject|154|||
164172838|NCT02548351|592995550|FG002|Overall Study|Withdrawal by Subject|152|||
164172839|NCT02548351|592995548|FG000|Overall Study|Death|11|||
164172840|NCT02548351|592995549|FG001|Overall Study|Death|15|||
164172841|NCT02548351|592995550|FG002|Overall Study|Death|12|||
164172842|NCT02548351|592995548|FG000|Overall Study|Adverse Event|22|||
164172843|NCT02548351|592995549|FG001|Overall Study|Adverse Event|56|||
164172844|NCT02548351|592995550|FG002|Overall Study|Adverse Event|36|||
164172845|NCT02548351|592995548|FG000|Overall Study|Study Terminated by Sponsor|549|||
164172846|NCT02548351|592995549|FG001|Overall Study|Study Terminated by Sponsor|509|||
164172847|NCT02548351|592995550|FG002|Overall Study|Study Terminated by Sponsor|528|||
164172848|NCT02548351|592995548|FG000|Overall Study|Site Closure|14|||
164172849|NCT02548351|592995549|FG001|Overall Study|Site Closure|5|||
164172850|NCT02548351|592995550|FG002|Overall Study|Site Closure|7|||
164172851|NCT02548351|592995548|FG000|Overall Study|Non-compliance with Study Drug|4|||
164172852|NCT02548351|592995549|FG001|Overall Study|Non-compliance with Study Drug|2|||
164172853|NCT02548351|592995550|FG002|Overall Study|Non-compliance with Study Drug|0|||
164172854|NCT02548351|592995548|FG000|Overall Study|Protocol Violation|2|||
164172855|NCT02548351|592995549|FG001|Overall Study|Protocol Violation|1|||
164172856|NCT02548351|592995550|FG002|Overall Study|Protocol Violation|2|||
164172857|NCT02548351|592995548|FG000|Overall Study|Physician Decision|11|||
164172858|NCT02548351|592995549|FG001|Overall Study|Physician Decision|18|||
164172859|NCT02548351|592995550|FG002|Overall Study|Physician Decision|11|||
164172860|NCT02548351|592995548|FG000|Overall Study|Lost to Follow-up|43|||
164172861|NCT02548351|592995549|FG001|Overall Study|Lost to Follow-up|50|||
164172862|NCT02548351|592995550|FG002|Overall Study|Lost to Follow-up|57|||
164172863|NCT02548351|592995548|FG000|Overall Study|Other|19|||
164172864|NCT02548351|592995549|FG001|Overall Study|Other|16|||
164172865|NCT02548351|592995550|FG002|Overall Study|Other|20|||
164172866|NCT02548351|592995548|FG000|Overall Study|Missing|1|||
164172867|NCT02548351|592995549|FG001|Overall Study|Missing|1|||
164172868|NCT02548351|592995550|FG002|Overall Study|Missing|0|||
164172869|NCT01668173|592995551|FG000|Overall Study|Adverse Event|3|||
164172870|NCT01668173|592995551|FG000|Overall Study|Trial suspension|4|||
164172871|NCT01295827|592995552|FG000|Overall Study|Adverse Event|1|||
164172872|NCT01295827|592995553|FG001|Overall Study|Adverse Event|2|||
164172873|NCT01295827|592995554|FG002|Overall Study|Adverse Event|2|||
164172874|NCT01295827|592995555|FG003|Overall Study|Adverse Event|1|||
164172875|NCT01295827|592995556|FG004|Overall Study|Adverse Event|1|||
164172876|NCT01295827|592995557|FG005|Overall Study|Adverse Event|4|||
164172877|NCT01295827|592995558|FG006|Overall Study|Adverse Event|15|||
164172878|NCT01295827|592995559|FG007|Overall Study|Adverse Event|49|||
164172879|NCT01295827|592995560|FG008|Overall Study|Adverse Event|22|||
164172880|NCT01295827|592995561|FG009|Overall Study|Adverse Event|7|||
164172881|NCT01295827|592995562|FG010|Overall Study|Adverse Event|50|||
164172882|NCT01295827|592995563|FG011|Overall Study|Adverse Event|21|||
164172883|NCT01295827|592995564|FG012|Overall Study|Adverse Event|0|||
164172884|NCT01295827|592995565|FG013|Overall Study|Adverse Event|0|||
164172885|NCT01295827|592995566|FG014|Overall Study|Adverse Event|0|||
164172886|NCT01295827|592995552|FG000|Overall Study|Lost to Follow-up|0|||
164172887|NCT01295827|592995553|FG001|Overall Study|Lost to Follow-up|0|||
164172888|NCT01295827|592995554|FG002|Overall Study|Lost to Follow-up|3|||
164172889|NCT01295827|592995555|FG003|Overall Study|Lost to Follow-up|0|||
164172890|NCT01295827|592995556|FG004|Overall Study|Lost to Follow-up|1|||
164172891|NCT01295827|592995557|FG005|Overall Study|Lost to Follow-up|0|||
164172892|NCT01295827|592995558|FG006|Overall Study|Lost to Follow-up|4|||
164172893|NCT01295827|592995559|FG007|Overall Study|Lost to Follow-up|8|||
164172894|NCT01295827|592995560|FG008|Overall Study|Lost to Follow-up|7|||
164172895|NCT01295827|592995561|FG009|Overall Study|Lost to Follow-up|4|||
164172896|NCT01295827|592995562|FG010|Overall Study|Lost to Follow-up|7|||
164172897|NCT01295827|592995563|FG011|Overall Study|Lost to Follow-up|3|||
164172898|NCT01295827|592995564|FG012|Overall Study|Lost to Follow-up|0|||
164172899|NCT01295827|592995565|FG013|Overall Study|Lost to Follow-up|0|||
164172900|NCT01295827|592995566|FG014|Overall Study|Lost to Follow-up|0|||
164172901|NCT01295827|592995552|FG000|Overall Study|Not Reported|0|||
164172902|NCT01295827|592995553|FG001|Overall Study|Not Reported|0|||
164172903|NCT01295827|592995554|FG002|Overall Study|Not Reported|0|||
164172904|NCT01295827|592995555|FG003|Overall Study|Not Reported|1|||
164172905|NCT01295827|592995556|FG004|Overall Study|Not Reported|0|||
164172906|NCT01295827|592995557|FG005|Overall Study|Not Reported|0|||
164172907|NCT01295827|592995558|FG006|Overall Study|Not Reported|24|||
164172908|NCT01295827|592995559|FG007|Overall Study|Not Reported|58|||
164172909|NCT01295827|592995560|FG008|Overall Study|Not Reported|41|||
164172910|NCT01295827|592995561|FG009|Overall Study|Not Reported|2|||
164172911|NCT01295827|592995562|FG010|Overall Study|Not Reported|23|||
164172912|NCT01295827|592995563|FG011|Overall Study|Not Reported|13|||
164172913|NCT01295827|592995564|FG012|Overall Study|Not Reported|0|||
164172914|NCT01295827|592995565|FG013|Overall Study|Not Reported|0|||
164172915|NCT01295827|592995566|FG014|Overall Study|Not Reported|0|||
164172916|NCT01295827|592995552|FG000|Overall Study|Progressive Disease|2|||
164172917|NCT01295827|592995553|FG001|Overall Study|Progressive Disease|1|||
164172918|NCT01295827|592995554|FG002|Overall Study|Progressive Disease|5|||
164172919|NCT01295827|592995555|FG003|Overall Study|Progressive Disease|2|||
164172920|NCT01295827|592995556|FG004|Overall Study|Progressive Disease|0|||
164172921|NCT01295827|592995557|FG005|Overall Study|Progressive Disease|1|||
164172922|NCT01295827|592995558|FG006|Overall Study|Progressive Disease|87|||
164172923|NCT01295827|592995559|FG007|Overall Study|Progressive Disease|144|||
164172924|NCT01295827|592995560|FG008|Overall Study|Progressive Disease|85|||
164172925|NCT01295827|592995561|FG009|Overall Study|Progressive Disease|40|||
164172926|NCT01295827|592995562|FG010|Overall Study|Progressive Disease|175|||
164172927|NCT01295827|592995563|FG011|Overall Study|Progressive Disease|136|||
164172928|NCT01295827|592995564|FG012|Overall Study|Progressive Disease|0|||
164172929|NCT01295827|592995565|FG013|Overall Study|Progressive Disease|0|||
164172930|NCT01295827|592995566|FG014|Overall Study|Progressive Disease|0|||
164172931|NCT01295827|592995552|FG000|Overall Study|Screen Failure|0|||
164172932|NCT01295827|592995553|FG001|Overall Study|Screen Failure|0|||
164172933|NCT01295827|592995554|FG002|Overall Study|Screen Failure|0|||
164172934|NCT01295827|592995555|FG003|Overall Study|Screen Failure|0|||
164172935|NCT01295827|592995556|FG004|Overall Study|Screen Failure|0|||
164172936|NCT01295827|592995557|FG005|Overall Study|Screen Failure|0|||
164172937|NCT01295827|592995558|FG006|Overall Study|Screen Failure|2|||
164172938|NCT01295827|592995559|FG007|Overall Study|Screen Failure|2|||
164172939|NCT01295827|592995560|FG008|Overall Study|Screen Failure|2|||
164172940|NCT01295827|592995561|FG009|Overall Study|Screen Failure|0|||
164172941|NCT01295827|592995562|FG010|Overall Study|Screen Failure|1|||
164172942|NCT01295827|592995563|FG011|Overall Study|Screen Failure|0|||
164172943|NCT01295827|592995564|FG012|Overall Study|Screen Failure|0|||
164172944|NCT01295827|592995565|FG013|Overall Study|Screen Failure|0|||
164172945|NCT01295827|592995566|FG014|Overall Study|Screen Failure|0|||
164172946|NCT01295827|592995552|FG000|Overall Study|Withdrawal by Subject|1|||
164172947|NCT01295827|592995553|FG001|Overall Study|Withdrawal by Subject|0|||
164172948|NCT01295827|592995554|FG002|Overall Study|Withdrawal by Subject|2|||
164172949|NCT01295827|592995555|FG003|Overall Study|Withdrawal by Subject|0|||
164172950|NCT01295827|592995556|FG004|Overall Study|Withdrawal by Subject|0|||
164172951|NCT01295827|592995557|FG005|Overall Study|Withdrawal by Subject|1|||
164172952|NCT01295827|592995558|FG006|Overall Study|Withdrawal by Subject|13|||
164172953|NCT01295827|592995559|FG007|Overall Study|Withdrawal by Subject|35|||
164172954|NCT01295827|592995560|FG008|Overall Study|Withdrawal by Subject|11|||
164172955|NCT01295827|592995561|FG009|Overall Study|Withdrawal by Subject|2|||
164172956|NCT01295827|592995562|FG010|Overall Study|Withdrawal by Subject|18|||
164172957|NCT01295827|592995563|FG011|Overall Study|Withdrawal by Subject|13|||
164172958|NCT01295827|592995564|FG012|Overall Study|Withdrawal by Subject|0|||
164172959|NCT01295827|592995565|FG013|Overall Study|Withdrawal by Subject|0|||
164172960|NCT01295827|592995566|FG014|Overall Study|Withdrawal by Subject|0|||
164172961|NCT01295827|592995552|FG000|Overall Study|Other|0|||
164172962|NCT01295827|592995553|FG001|Overall Study|Other|0|||
164172963|NCT01295827|592995554|FG002|Overall Study|Other|0|||
164172964|NCT01295827|592995555|FG003|Overall Study|Other|0|||
164172965|NCT01295827|592995556|FG004|Overall Study|Other|0|||
164172966|NCT01295827|592995557|FG005|Overall Study|Other|0|||
164172967|NCT01295827|592995558|FG006|Overall Study|Other|1|||
164172968|NCT01295827|592995559|FG007|Overall Study|Other|1|||
164172969|NCT01295827|592995560|FG008|Overall Study|Other|1|||
164172970|NCT01295827|592995561|FG009|Overall Study|Other|0|||
164172971|NCT01295827|592995562|FG010|Overall Study|Other|2|||
164172972|NCT01295827|592995563|FG011|Overall Study|Other|0|||
164172973|NCT01295827|592995564|FG012|Overall Study|Other|0|||
164172974|NCT01295827|592995565|FG013|Overall Study|Other|0|||
164172975|NCT01295827|592995566|FG014|Overall Study|Other|0|||
164172976|NCT02640677|592995567|FG000|Overall Study|Lost to Follow-up|1|||
164172977|NCT02640677|592995567|FG000|Overall Study|Withdrawal by Subject|1|||
164172978|NCT02805660|592995574|FG000|Overall Study|Death|5|||
164172979|NCT02805660|592995575|FG001|Overall Study|Death|2|||
164172980|NCT02805660|592995576|FG002|Overall Study|Death|9|||
164172981|NCT02805660|592995577|FG003|Overall Study|Death|5|||
164172982|NCT02805660|592995578|FG004|Overall Study|Death|0|||
164172983|NCT02805660|592995579|FG005|Overall Study|Death|14|||
164172984|NCT02805660|592995580|FG006|Overall Study|Death|12|||
164172985|NCT02805660|592995574|FG000|Overall Study|Lost to Follow-up|0|||
164172986|NCT02805660|592995575|FG001|Overall Study|Lost to Follow-up|1|||
164172987|NCT02805660|592995576|FG002|Overall Study|Lost to Follow-up|1|||
164172988|NCT02805660|592995577|FG003|Overall Study|Lost to Follow-up|2|||
164172989|NCT02805660|592995578|FG004|Overall Study|Lost to Follow-up|0|||
164172990|NCT02805660|592995579|FG005|Overall Study|Lost to Follow-up|0|||
164172991|NCT02805660|592995580|FG006|Overall Study|Lost to Follow-up|0|||
164172992|NCT02805660|592995574|FG000|Overall Study|Withdrawal by Subject|0|||
164172993|NCT02805660|592995575|FG001|Overall Study|Withdrawal by Subject|0|||
164172994|NCT02805660|592995576|FG002|Overall Study|Withdrawal by Subject|0|||
164172995|NCT02805660|592995577|FG003|Overall Study|Withdrawal by Subject|3|||
164172996|NCT02805660|592995578|FG004|Overall Study|Withdrawal by Subject|1|||
164172997|NCT02805660|592995579|FG005|Overall Study|Withdrawal by Subject|0|||
164172998|NCT02805660|592995580|FG006|Overall Study|Withdrawal by Subject|2|||
164172999|NCT02805660|592995574|FG000|Overall Study|Study terminated by Sponsor|0|||
164173000|NCT02805660|592995575|FG001|Overall Study|Study terminated by Sponsor|0|||
164173001|NCT02805660|592995576|FG002|Overall Study|Study terminated by Sponsor|1|||
164173002|NCT02805660|592995577|FG003|Overall Study|Study terminated by Sponsor|4|||
164173003|NCT02805660|592995578|FG004|Overall Study|Study terminated by Sponsor|2|||
164173004|NCT02805660|592995579|FG005|Overall Study|Study terminated by Sponsor|3|||
164173005|NCT02805660|592995580|FG006|Overall Study|Study terminated by Sponsor|1|||
164173006|NCT02805660|592995574|FG000|Overall Study|Miscellaneous|0|||
164173007|NCT02805660|592995575|FG001|Overall Study|Miscellaneous|1|||
164173008|NCT02805660|592995576|FG002|Overall Study|Miscellaneous|0|||
164173009|NCT02805660|592995577|FG003|Overall Study|Miscellaneous|4|||
164173010|NCT02805660|592995578|FG004|Overall Study|Miscellaneous|0|||
164173011|NCT02805660|592995579|FG005|Overall Study|Miscellaneous|6|||
164173012|NCT02805660|592995580|FG006|Overall Study|Miscellaneous|4|||
164173013|NCT02572076|592995581|FG000|Overall Study|Protocol Violation|1|||
164173014|NCT02778074|592995582|FG000|Overall Study|Lost to Follow-up|7|||
164173015|NCT02778074|592995583|FG001|Overall Study|Lost to Follow-up|10|||
164173016|NCT03489707|592995586|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
164173017|NCT03489707|592995587|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
164173018|NCT03489707|592995586|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
164173019|NCT03489707|592995587|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
164173020|NCT01817582|592995593|FG000|Overall Study|Withdrawal by Subject|0|||
164173021|NCT01817582|592995594|FG001|Overall Study|Withdrawal by Subject|1|||
164173022|NCT01817582|592995595|FG002|Overall Study|Withdrawal by Subject|0|||
164173023|NCT01817582|592995593|FG000|Overall Study|Participant revealed masked treatment|1|||
164173024|NCT01817582|592995594|FG001|Overall Study|Participant revealed masked treatment|0|||
164173025|NCT01817582|592995595|FG002|Overall Study|Participant revealed masked treatment|0|||
164173026|NCT01817582|592995593|FG000|Overall Study|Randomized but exclusion criteria met|1|||
164173027|NCT01817582|592995594|FG001|Overall Study|Randomized but exclusion criteria met|0|||
164173028|NCT01817582|592995595|FG002|Overall Study|Randomized but exclusion criteria met|0|||
164173029|NCT03053063|592995596|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
164173030|NCT03053063|592995597|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
164173031|NCT03053063|592995598|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
164173032|NCT03053063|592995599|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
164173033|NCT03053063|592995596|FG000|Randomized Phase|Withdrew consent|8|||
164173034|NCT03053063|592995597|FG001|Randomized Phase|Withdrew consent|11|||
164173035|NCT03053063|592995598|FG002|Randomized Phase|Withdrew consent|5|||
164173036|NCT03053063|592995599|FG003|Randomized Phase|Withdrew consent|0|||
164173037|NCT03053063|592995596|FG000|Randomized Phase|Investigator's Discretion|8|||
164173038|NCT03053063|592995597|FG001|Randomized Phase|Investigator's Discretion|6|||
164173039|NCT03053063|592995598|FG002|Randomized Phase|Investigator's Discretion|2|||
164173040|NCT03053063|592995599|FG003|Randomized Phase|Investigator's Discretion|0|||
164173041|NCT03053063|592995596|FG000|Randomized Phase|Lost to Follow-up|3|||
164173042|NCT03053063|592995597|FG001|Randomized Phase|Lost to Follow-up|5|||
164173043|NCT03053063|592995598|FG002|Randomized Phase|Lost to Follow-up|1|||
164173044|NCT03053063|592995599|FG003|Randomized Phase|Lost to Follow-up|0|||
164173045|NCT03053063|592995596|FG000|Randomized Phase|Adverse Event|0|||
164173046|NCT03053063|592995597|FG001|Randomized Phase|Adverse Event|1|||
164173047|NCT03053063|592995598|FG002|Randomized Phase|Adverse Event|0|||
164173048|NCT03053063|592995599|FG003|Randomized Phase|Adverse Event|0|||
164173049|NCT03053063|592995596|FG000|Randomized Phase|Randomized but Never Treated|1|||
164173050|NCT03053063|592995597|FG001|Randomized Phase|Randomized but Never Treated|3|||
164173051|NCT03053063|592995598|FG002|Randomized Phase|Randomized but Never Treated|2|||
164173052|NCT03053063|592995599|FG003|Randomized Phase|Randomized but Never Treated|0|||
164173053|NCT03053063|592995596|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
164173054|NCT03053063|592995597|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
164173055|NCT03053063|592995598|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
164173056|NCT03053063|592995599|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
164173057|NCT03053063|592995596|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
164173058|NCT03053063|592995597|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
164173059|NCT03053063|592995598|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
164173060|NCT03053063|592995599|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
164173061|NCT03053063|592995596|FG000|Open-Label Phase|Death|0|||
164173062|NCT03053063|592995597|FG001|Open-Label Phase|Death|0|||
164173063|NCT03053063|592995598|FG002|Open-Label Phase|Death|0|||
164173064|NCT03053063|592995599|FG003|Open-Label Phase|Death|2|||
164173065|NCT03053063|592995596|FG000|Open-Label Phase|Investigator's discretion|0|||
164173066|NCT03053063|592995597|FG001|Open-Label Phase|Investigator's discretion|0|||
164173067|NCT03053063|592995598|FG002|Open-Label Phase|Investigator's discretion|0|||
164173068|NCT03053063|592995599|FG003|Open-Label Phase|Investigator's discretion|2|||
164173069|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
164173070|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
164173071|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
164173072|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
164173073|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
164173074|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
164173075|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
164173076|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
164173077|NCT03963232|592995601|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
164173078|NCT03963232|592995602|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
164173079|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Adverse Event|1|||
164173080|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Adverse Event|2|||
164173081|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
164173082|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
164173083|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
164173084|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
164173085|NCT03963232|592995601|FG000|Open-Label Treatment Phase|Pregnancy|1|||
164173086|NCT03963232|592995602|FG001|Open-Label Treatment Phase|Pregnancy|0|||
164173087|NCT03963232|592995601|FG000|Follow-up Phase|Withdrawal by Subject|7|||
164173088|NCT03963232|592995602|FG001|Follow-up Phase|Withdrawal by Subject|5|||
164173089|NCT03963232|592995601|FG000|Follow-up Phase|Protocol Violation|0|||
164173090|NCT03963232|592995602|FG001|Follow-up Phase|Protocol Violation|2|||
164173091|NCT03963232|592995601|FG000|Follow-up Phase|Adverse Event|0|||
164173092|NCT03963232|592995602|FG001|Follow-up Phase|Adverse Event|1|||
164173093|NCT03963232|592995601|FG000|Follow-up Phase|Lost to Follow-up|0|||
164173094|NCT03963232|592995602|FG001|Follow-up Phase|Lost to Follow-up|1|||
164173095|NCT00356135|592995603|FG000|Overall Study|Protocol Violation|1|||
164173096|NCT00356135|592995604|FG001|Overall Study|Protocol Violation|0|||
164173097|NCT00356135|592995605|FG002|Overall Study|Protocol Violation|0|||
164173098|NCT00356135|592995603|FG000|Overall Study|Adverse Event|1|||
164173099|NCT00356135|592995604|FG001|Overall Study|Adverse Event|0|||
164173100|NCT00356135|592995605|FG002|Overall Study|Adverse Event|0|||
164173101|NCT00356135|592995603|FG000|Overall Study|Lost to Follow-up|0|||
164173102|NCT00356135|592995604|FG001|Overall Study|Lost to Follow-up|0|||
164173103|NCT00356135|592995605|FG002|Overall Study|Lost to Follow-up|1|||
164173104|NCT00356135|592995603|FG000|Overall Study|Physician Decision|1|||
164173105|NCT00356135|592995604|FG001|Overall Study|Physician Decision|1|||
164173106|NCT00356135|592995605|FG002|Overall Study|Physician Decision|1|||
164173107|NCT00356135|592995603|FG000|Overall Study|Subject non-compliance|1|||
164173108|NCT00356135|592995604|FG001|Overall Study|Subject non-compliance|1|||
164173109|NCT00356135|592995605|FG002|Overall Study|Subject non-compliance|3|||
164173110|NCT03617770|592995606|FG000|Overall Study|Lost to Follow-up|1|||
164173111|NCT03617770|592995607|FG001|Overall Study|Lost to Follow-up|0|||
164173112|NCT05270395|592995613|FG000|Overall Study|Lost to Follow-up|2|||
164173113|NCT05270395|592995614|FG001|Overall Study|Lost to Follow-up|2|||
164173114|NCT05270395|592995613|FG000|Overall Study|Death|1|||
164173115|NCT05270395|592995614|FG001|Overall Study|Death|2|||
164173116|NCT05270395|592995613|FG000|Overall Study|Study Team Withdrew|1|||
164173117|NCT05270395|592995614|FG001|Overall Study|Study Team Withdrew|0|||
164173118|NCT03055494|592997456|FG000|Overall Study|Lost to Follow-up|6|||
164173119|NCT03055494|592997457|FG001|Overall Study|Lost to Follow-up|0|||
164173120|NCT03055494|592997456|FG000|Overall Study|Physician Decision|2|||
164173121|NCT03055494|592997457|FG001|Overall Study|Physician Decision|0|||
164173122|NCT03055494|592997456|FG000|Overall Study|Withdrawal by Subject|1|||
164173123|NCT03055494|592997457|FG001|Overall Study|Withdrawal by Subject|0|||
164173124|NCT03055494|592997456|FG000|Overall Study|Adverse Event|0|||
164173125|NCT03055494|592997457|FG001|Overall Study|Adverse Event|1|||
164173126|NCT03055494|592997456|FG000|Overall Study|Non-compliance with study treatment|1|||
164173127|NCT03055494|592997457|FG001|Overall Study|Non-compliance with study treatment|0|||
164173128|NCT03569293|592997461|FG000|Overall Study|Adverse Event|4|||
164173129|NCT03569293|592997462|FG001|Overall Study|Adverse Event|1|||
164173130|NCT03569293|592997463|FG002|Overall Study|Adverse Event|5|||
164173131|NCT03569293|592997464|FG003|Overall Study|Adverse Event|1|||
164173132|NCT03569293|592997465|FG004|Overall Study|Adverse Event|0|||
164173133|NCT03569293|592997466|FG005|Overall Study|Adverse Event|0|||
164173134|NCT03569293|592997461|FG000|Overall Study|Withdrawal by Subject|16|||
164173135|NCT03569293|592997462|FG001|Overall Study|Withdrawal by Subject|2|||
164173136|NCT03569293|592997463|FG002|Overall Study|Withdrawal by Subject|4|||
164173137|NCT03569293|592997464|FG003|Overall Study|Withdrawal by Subject|1|||
164173138|NCT03569293|592997465|FG004|Overall Study|Withdrawal by Subject|0|||
164173139|NCT03569293|592997466|FG005|Overall Study|Withdrawal by Subject|0|||
164173140|NCT03569293|592997461|FG000|Overall Study|Lost to Follow-up|1|||
164173141|NCT03569293|592997462|FG001|Overall Study|Lost to Follow-up|3|||
164173142|NCT03569293|592997463|FG002|Overall Study|Lost to Follow-up|1|||
164173143|NCT03569293|592997464|FG003|Overall Study|Lost to Follow-up|1|||
164173144|NCT03569293|592997465|FG004|Overall Study|Lost to Follow-up|0|||
164173145|NCT03569293|592997466|FG005|Overall Study|Lost to Follow-up|0|||
164173146|NCT03569293|592997461|FG000|Overall Study|Other|8|||
164173147|NCT03569293|592997462|FG001|Overall Study|Other|2|||
164173148|NCT03569293|592997463|FG002|Overall Study|Other|1|||
164173149|NCT03569293|592997464|FG003|Overall Study|Other|1|||
164173150|NCT03569293|592997465|FG004|Overall Study|Other|0|||
164173151|NCT03569293|592997466|FG005|Overall Study|Other|0|||
164173152|NCT03569293|592997461|FG000|Overall Study|Ongoing at Time of Analysis|8|||
164173153|NCT03569293|592997462|FG001|Overall Study|Ongoing at Time of Analysis|1|||
164173154|NCT03569293|592997463|FG002|Overall Study|Ongoing at Time of Analysis|3|||
164173155|NCT03569293|592997464|FG003|Overall Study|Ongoing at Time of Analysis|0|||
164173156|NCT03569293|592997465|FG004|Overall Study|Ongoing at Time of Analysis|0|||
164173157|NCT03569293|592997466|FG005|Overall Study|Ongoing at Time of Analysis|0|||
164173158|NCT03036098|592997477|FG000|Pre-Treatment|Other Reasons|1|||
164173159|NCT03036098|592997478|FG001|Pre-Treatment|Other Reasons|2|||
164173160|NCT03036098|592997479|FG002|Pre-Treatment|Other Reasons|0|||
164173161|NCT03036098|592997480|FG003|Pre-Treatment|Other Reasons|5|||
164173162|NCT03036098|592997477|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
164173163|NCT03036098|592997478|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
164173164|NCT03036098|592997479|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
164173165|NCT03036098|592997480|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
164173166|NCT03036098|592997477|FG000|Pre-Treatment|Withdrawal by Subject|1|||
164173167|NCT03036098|592997478|FG001|Pre-Treatment|Withdrawal by Subject|14|||
164173168|NCT03036098|592997479|FG002|Pre-Treatment|Withdrawal by Subject|0|||
164173169|NCT03036098|592997480|FG003|Pre-Treatment|Withdrawal by Subject|5|||
164173170|NCT03036098|592997477|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
164173171|NCT03036098|592997478|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
164173172|NCT03036098|592997479|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
164173173|NCT03036098|592997480|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
164173174|NCT03036098|592997477|FG000|Treatment|Disease Progression|130|||
164173175|NCT03036098|592997478|FG001|Treatment|Disease Progression|77|||
164173176|NCT03036098|592997479|FG002|Treatment|Disease Progression|168|||
164173177|NCT03036098|592997480|FG003|Treatment|Disease Progression|50|||
164173178|NCT03036098|592997477|FG000|Treatment|Study Drug Toxicity|95|||
164173179|NCT03036098|592997478|FG001|Treatment|Study Drug Toxicity|45|||
164173180|NCT03036098|592997479|FG002|Treatment|Study Drug Toxicity|26|||
164173181|NCT03036098|592997480|FG003|Treatment|Study Drug Toxicity|22|||
164173182|NCT03036098|592997477|FG000|Treatment|Death|9|||
164173183|NCT03036098|592997478|FG001|Treatment|Death|3|||
164173184|NCT03036098|592997479|FG002|Treatment|Death|1|||
164173185|NCT03036098|592997480|FG003|Treatment|Death|2|||
164173186|NCT03036098|592997477|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
164173187|NCT03036098|592997478|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
164173188|NCT03036098|592997479|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
164173189|NCT03036098|592997480|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
164173190|NCT03036098|592997477|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
164173191|NCT03036098|592997478|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
164173192|NCT03036098|592997479|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
164173193|NCT03036098|592997480|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
164173194|NCT03036098|592997477|FG000|Treatment|Withdrawal by Subject|2|||
164173195|NCT03036098|592997478|FG001|Treatment|Withdrawal by Subject|9|||
164173196|NCT03036098|592997479|FG002|Treatment|Withdrawal by Subject|2|||
164173197|NCT03036098|592997480|FG003|Treatment|Withdrawal by Subject|4|||
164173198|NCT03036098|592997477|FG000|Treatment|Maximum Clinical Benefit|6|||
164173199|NCT03036098|592997478|FG001|Treatment|Maximum Clinical Benefit|1|||
164173200|NCT03036098|592997479|FG002|Treatment|Maximum Clinical Benefit|6|||
164173201|NCT03036098|592997480|FG003|Treatment|Maximum Clinical Benefit|10|||
164173202|NCT03036098|592997477|FG000|Treatment|Poor/Non Compliance|1|||
164173203|NCT03036098|592997478|FG001|Treatment|Poor/Non Compliance|2|||
164173204|NCT03036098|592997479|FG002|Treatment|Poor/Non Compliance|0|||
164173205|NCT03036098|592997480|FG003|Treatment|Poor/Non Compliance|1|||
164173206|NCT03036098|592997477|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
164173207|NCT03036098|592997478|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
164173208|NCT03036098|592997479|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
164173209|NCT03036098|592997480|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
164173210|NCT03036098|592997477|FG000|Treatment|Administrative Reason by Sponsor|1|||
164173211|NCT03036098|592997478|FG001|Treatment|Administrative Reason by Sponsor|0|||
164173212|NCT03036098|592997479|FG002|Treatment|Administrative Reason by Sponsor|2|||
164173213|NCT03036098|592997480|FG003|Treatment|Administrative Reason by Sponsor|1|||
164173214|NCT03036098|592997477|FG000|Treatment|Other Reasons|31|||
164173215|NCT03036098|592997478|FG001|Treatment|Other Reasons|5|||
164173216|NCT03036098|592997479|FG002|Treatment|Other Reasons|21|||
164173217|NCT03036098|592997480|FG003|Treatment|Other Reasons|8|||
164173218|NCT03036098|592997477|FG000|Treatment|Ongoing Treatment|0|||
164173219|NCT03036098|592997478|FG001|Treatment|Ongoing Treatment|0|||
164173220|NCT03036098|592997479|FG002|Treatment|Ongoing Treatment|23|||
164173221|NCT03036098|592997480|FG003|Treatment|Ongoing Treatment|0|||
164173222|NCT04240886|592997483|FG000|Treatment Phase|Death|4|||
164173223|NCT04240886|592997483|FG000|Treatment Phase|Discontinuation by Subject|1|||
164173224|NCT04240886|592997483|FG000|Treatment Phase|Adverse Event|5|||
164173225|NCT04240886|592997483|FG000|Follow-up Phase|Withdrawal by Subject|1|||
164173226|NCT04240886|592997483|FG000|Follow-up Phase|Discontinuation by Subject|1|||
164173227|NCT04240886|592997483|FG000|Follow-up Phase|Death|2|||
164173228|NCT02276053|592997484|FG000|Overall Study|Death|2|||
164173229|NCT02276053|592997484|FG000|Overall Study|Adverse Event|5|||
164173230|NCT02276053|592997484|FG000|Overall Study|Lack of Efficacy|2|||
164173231|NCT02276053|592997484|FG000|Overall Study|Withdrawal by Subject|1|||
164173232|NCT02276053|592997484|FG000|Overall Study|Patient does not meet selection criteria|3|||
164173233|NCT02276053|592997484|FG000|Overall Study|Patient needs to increase baseline AED|1|||
164173234|NCT04743804|592997487|FG000|Overall Study|Other|1|||
164173235|NCT04743804|592997488|FG001|Overall Study|Other|0|||
164173236|NCT04743804|592997487|FG000|Overall Study|Withdrawal by Subject|0|||
164173237|NCT04743804|592997488|FG001|Overall Study|Withdrawal by Subject|1|||
164173238|NCT04743804|592997487|FG000|Overall Study|Study Terminated by Sponsor|1|||
164173239|NCT04743804|592997488|FG001|Overall Study|Study Terminated by Sponsor|4|||
164173240|NCT04743804|592997487|FG000|Overall Study|Physician Decision|0|||
164173241|NCT04743804|592997488|FG001|Overall Study|Physician Decision|1|||
164173242|NCT04743804|592997487|FG000|Overall Study|Death|3|||
164173243|NCT04743804|592997488|FG001|Overall Study|Death|0|||
164173244|NCT02059434|592997489|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
164173245|NCT02059434|592997490|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
164173246|NCT02059434|592997491|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
164173247|NCT02059434|592997492|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
164173248|NCT02059434|592997493|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
164173249|NCT02059434|592997494|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
164173250|NCT02059434|592997495|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
164173251|NCT02059434|592997496|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
164173252|NCT02059434|592997497|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
164173253|NCT02059434|592997489|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
164173254|NCT02059434|592997490|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
164173255|NCT02059434|592997491|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
164173256|NCT02059434|592997492|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
164173257|NCT02059434|592997493|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
164173258|NCT02059434|592997494|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
164173259|NCT02059434|592997495|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
164173260|NCT02059434|592997496|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
164173261|NCT02059434|592997497|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
164173262|NCT02059434|592997489|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
164173263|NCT02059434|592997490|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
164173264|NCT02059434|592997491|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
164173265|NCT02059434|592997492|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
164173266|NCT02059434|592997493|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
164173267|NCT02059434|592997494|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
164173268|NCT02059434|592997495|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
164173269|NCT02059434|592997496|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
164173270|NCT02059434|592997497|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
164173271|NCT02059434|592997489|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
164173272|NCT02059434|592997490|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
164173273|NCT02059434|592997491|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
164173274|NCT02059434|592997492|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
164173275|NCT02059434|592997493|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
164173276|NCT02059434|592997494|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
164173277|NCT02059434|592997495|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
164173278|NCT02059434|592997496|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
164173279|NCT02059434|592997497|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
164173280|NCT02059434|592997489|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173281|NCT02059434|592997490|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173282|NCT02059434|592997491|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173283|NCT02059434|592997492|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173284|NCT02059434|592997493|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173285|NCT02059434|592997494|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173286|NCT02059434|592997495|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173287|NCT02059434|592997496|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
164173288|NCT02059434|592997497|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
164173289|NCT02928770|592997502|FG000|Overall Study|Withdrawal by Subject|2|||
164173290|NCT03201874|592997503|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
164173291|NCT03201874|592997504|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
164173292|NCT03201874|592997503|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
164173293|NCT03201874|592997504|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
164173294|NCT02515994|592997510|FG000|Overall Study|Protocol Violation|3|||
164173295|NCT02515994|592997511|FG001|Overall Study|Protocol Violation|5|||
164173296|NCT02515994|592997510|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
164173297|NCT02515994|592997511|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
164173298|NCT02515994|592997510|FG000|Overall Study|Adverse Event|3|||
164173299|NCT02515994|592997511|FG001|Overall Study|Adverse Event|1|||
164173300|NCT02515994|592997510|FG000|Overall Study|Withdrawal by Subject|2|||
164173301|NCT02515994|592997511|FG001|Overall Study|Withdrawal by Subject|0|||
164173302|NCT01424514|592997512|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
164173303|NCT01424514|592997513|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
164173304|NCT01424514|592997512|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
164173305|NCT01424514|592997513|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
164173306|NCT04598451|592997514|FG000|Overall Study|Adverse Event|3|||
164173307|NCT04598451|592997515|FG001|Overall Study|Adverse Event|2|||
164173308|NCT04598451|592997514|FG000|Overall Study|Withdrawal by Subject|3|||
164173309|NCT04598451|592997515|FG001|Overall Study|Withdrawal by Subject|7|||
164173310|NCT04598451|592997514|FG000|Overall Study|Lost to Follow-up|2|||
164173311|NCT04598451|592997515|FG001|Overall Study|Lost to Follow-up|0|||
164173312|NCT04598451|592997514|FG000|Overall Study|Physician Decision|4|||
164173313|NCT04598451|592997515|FG001|Overall Study|Physician Decision|1|||
164173314|NCT04598451|592997514|FG000|Overall Study|Requires Prohibited Medication|1|||
164173315|NCT04598451|592997515|FG001|Overall Study|Requires Prohibited Medication|0|||
164173316|NCT04598451|592997514|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
164173317|NCT04598451|592997515|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
164173318|NCT02653170|592997516|FG000|Overall Study|Withdrawal by Subject|3|||
164173319|NCT02653170|592997517|FG001|Overall Study|Withdrawal by Subject|8|||
164173320|NCT02653170|592997518|FG002|Overall Study|Withdrawal by Subject|3|||
164173321|NCT02653170|592997516|FG000|Overall Study|withdrawn by study team|2|||
164173322|NCT02653170|592997517|FG001|Overall Study|withdrawn by study team|4|||
164173323|NCT02653170|592997518|FG002|Overall Study|withdrawn by study team|5|||
164173324|NCT02653170|592997516|FG000|Overall Study|Lost to Follow-up|12|||
164173325|NCT02653170|592997517|FG001|Overall Study|Lost to Follow-up|4|||
164173326|NCT02653170|592997518|FG002|Overall Study|Lost to Follow-up|10|||
164173327|NCT02963558|592997519|FG000|Overall Study|Withdrawn by investigator|1|||
164173328|NCT02963558|592997520|FG001|Overall Study|Withdrawn by investigator|0|||
164173329|NCT02963558|592997519|FG000|Overall Study|Withdrawal by Subject|0|||
164173330|NCT02963558|592997520|FG001|Overall Study|Withdrawal by Subject|1|||
164173331|NCT04063657|592997524|FG000|Overall Study|Lost to Follow-up|1|||
164173332|NCT04063657|592997525|FG001|Overall Study|Lost to Follow-up|0|||
164173333|NCT01214252|592997526|FG000|Overall Study|Not eligible per protocol|82|||
164173334|NCT01371877|592997528|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
164173335|NCT01371877|592997529|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
164173336|NCT05932225|592997530|FG000|Overall Study|Lost to Follow-up|0|||
164173337|NCT05932225|592997531|FG001|Overall Study|Lost to Follow-up|1|||
164173338|NCT05932225|592997532|FG002|Overall Study|Lost to Follow-up|0|||
164173339|NCT05932225|592997530|FG000|Overall Study|Withdrawal by Subject|1|||
164173340|NCT05932225|592997531|FG001|Overall Study|Withdrawal by Subject|0|||
164173341|NCT05932225|592997532|FG002|Overall Study|Withdrawal by Subject|0|||
164173342|NCT05932225|592997530|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
164173343|NCT05932225|592997531|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
164173344|NCT05932225|592997532|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
164173345|NCT01473394|592997533|FG000|Overall Study|Adverse Event|13|||
164173346|NCT01473394|592997534|FG001|Overall Study|Adverse Event|16|||
164173347|NCT01473394|592997533|FG000|Overall Study|Insufficient Therapeutic Response|4|||
164173348|NCT01473394|592997534|FG001|Overall Study|Insufficient Therapeutic Response|1|||
164173349|NCT01473394|592997533|FG000|Overall Study|Protocol Violation|7|||
164173350|NCT01473394|592997534|FG001|Overall Study|Protocol Violation|5|||
164173351|NCT01473394|592997533|FG000|Overall Study|Withdrew Consent|12|||
164173352|NCT01473394|592997534|FG001|Overall Study|Withdrew Consent|10|||
164173353|NCT01473394|592997533|FG000|Overall Study|Lost to Follow-up|9|||
164173354|NCT01473394|592997534|FG001|Overall Study|Lost to Follow-up|11|||
164173355|NCT01877551|592997535|FG000|Overall Study|Physician Decision|0|||
164173356|NCT01877551|592997536|FG001|Overall Study|Physician Decision|1|||
164173514|NCT03802565|592997623|FG001|Overall Study|Lost to Follow-up|0|||
164173357|NCT00761280|592997537|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
164173358|NCT00761280|592997538|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
164173359|NCT00761280|592997537|FG000|Randomization to First Dose|Sponsor decision|1|||
164173360|NCT00761280|592997538|FG001|Randomization to First Dose|Sponsor decision|0|||
164173361|NCT00761280|592997537|FG000|Randomization to First Dose|Other|1|||
164173362|NCT00761280|592997538|FG001|Randomization to First Dose|Other|0|||
164173363|NCT00761280|592997537|FG000|First Dose to End of Study|End of trial|5|||
164173364|NCT00761280|592997538|FG001|First Dose to End of Study|End of trial|5|||
164173365|NCT00761280|592997537|FG000|First Dose to End of Study|Progressive disease|5|||
164173366|NCT00761280|592997538|FG001|First Dose to End of Study|Progressive disease|3|||
164173367|NCT00761280|592997537|FG000|First Dose to End of Study|Sponsor decision|1|||
164173368|NCT00761280|592997538|FG001|First Dose to End of Study|Sponsor decision|2|||
164173369|NCT00761280|592997537|FG000|First Dose to End of Study|Death|1|||
164173370|NCT00761280|592997538|FG001|First Dose to End of Study|Death|0|||
164173371|NCT00761280|592997537|FG000|First Dose to End of Study|Lost to Follow-up|0|||
164173372|NCT00761280|592997538|FG001|First Dose to End of Study|Lost to Follow-up|1|||
164173373|NCT03875482|592997539|FG000|Overall Study|Adverse Event|0|||
164173374|NCT03875482|592997540|FG001|Overall Study|Adverse Event|1|||
164173375|NCT03875482|592997539|FG000|Overall Study|Withdrew consent|5|||
164173376|NCT03875482|592997540|FG001|Overall Study|Withdrew consent|6|||
164173377|NCT03875482|592997539|FG000|Overall Study|Lost to Follow-up|8|||
164173378|NCT03875482|592997540|FG001|Overall Study|Lost to Follow-up|2|||
164173379|NCT03875482|592997539|FG000|Overall Study|Lack of Efficacy|0|||
164173380|NCT03875482|592997540|FG001|Overall Study|Lack of Efficacy|11|||
164173381|NCT04507256|592997541|FG000|Overall Study|Withdrawal by Subject|1|||
164173382|NCT04507256|592997542|FG001|Overall Study|Withdrawal by Subject|0|||
164173383|NCT04507256|592997543|FG002|Overall Study|Withdrawal by Subject|0|||
164173384|NCT04507256|592997544|FG003|Overall Study|Withdrawal by Subject|1|||
164173385|NCT04507256|592997545|FG004|Overall Study|Withdrawal by Subject|0|||
164173386|NCT04507256|592997546|FG005|Overall Study|Withdrawal by Subject|0|||
164173387|NCT02111785|592997547|FG000|Overall Study|Death|0|||
164173388|NCT02111785|592997548|FG001|Overall Study|Death|1|||
164173389|NCT02111785|592997549|FG002|Overall Study|Death|0|||
164173390|NCT02111785|592997550|FG003|Overall Study|Death|0|||
164173391|NCT02256982|592997552|FG000|Overall Study|Disease Progression|0|||
164173392|NCT02256982|592997553|FG001|Overall Study|Disease Progression|1|||
164173393|NCT01054300|592997558|FG000|Period 1|Adverse Event|1|||
164173394|NCT01054300|592997559|FG001|Period 1|Adverse Event|0|||
164173395|NCT01054300|592997560|FG002|Period 1|Adverse Event|0|||
164173396|NCT01054300|592997561|FG003|Period 1|Adverse Event|0|||
164173397|NCT01054300|592997558|FG000|Period 2|Withdrawal by Subject|0|||
164173398|NCT01054300|592997559|FG001|Period 2|Withdrawal by Subject|0|||
164173399|NCT01054300|592997560|FG002|Period 2|Withdrawal by Subject|1|||
164173400|NCT01054300|592997561|FG003|Period 2|Withdrawal by Subject|0|||
164173401|NCT01899742|592997564|FG000|Overall Study|Adverse Event|5|||
164173402|NCT01899742|592997565|FG001|Overall Study|Adverse Event|4|||
164173403|NCT01899742|592997564|FG000|Overall Study|Lack of Efficacy|1|||
164173404|NCT01899742|592997565|FG001|Overall Study|Lack of Efficacy|5|||
164173405|NCT01899742|592997564|FG000|Overall Study|Protocol Violation|2|||
164173406|NCT01899742|592997565|FG001|Overall Study|Protocol Violation|2|||
164173407|NCT01899742|592997564|FG000|Overall Study|Withdrawal by Subject|9|||
164173408|NCT01899742|592997565|FG001|Overall Study|Withdrawal by Subject|5|||
164173409|NCT00738881|592997569|FG000|Overall Study|Withdrawal by Subject|0|||
164173410|NCT00738881|592997570|FG001|Overall Study|Withdrawal by Subject|2|||
164173411|NCT02662764|592997571|FG000|Overall Study|Adverse Event|6|||
164173412|NCT02662764|592997571|FG000|Overall Study|Lack of Efficacy|8|||
164173413|NCT02662764|592997571|FG000|Overall Study|Protocol Violation|1|||
164173414|NCT02662764|592997571|FG000|Overall Study|Withdrawal by Subject|5|||
164173415|NCT02662764|592997571|FG000|Overall Study|Device failure|4|||
164173416|NCT02662764|592997571|FG000|Overall Study|Patient changed treatment|1|||
164173417|NCT02662764|592997571|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
164173418|NCT02035748|592997575|FG000|Overall Study|Adverse Event|5|||
164173419|NCT02035748|592997575|FG000|Overall Study|Death|3|||
164173420|NCT02035748|592997575|FG000|Overall Study|Lost to Follow-up|2|||
164173421|NCT02035748|592997575|FG000|Overall Study|Physician Decision|3|||
164173422|NCT02035748|592997575|FG000|Overall Study|Withdrawal by Subject|6|||
164173423|NCT02035748|592997575|FG000|Overall Study|Progressive Disease|1|||
164173424|NCT01740128|592997576|FG000|Overall Study|Pregnancy|0|||
164173425|NCT01740128|592997577|FG001|Overall Study|Pregnancy|1|||
164173426|NCT01740128|592997576|FG000|Overall Study|Protocol Violation|1|||
164173427|NCT01740128|592997577|FG001|Overall Study|Protocol Violation|2|||
164173428|NCT01740128|592997576|FG000|Overall Study|Lost to Follow-up|2|||
164173429|NCT01740128|592997577|FG001|Overall Study|Lost to Follow-up|2|||
164173430|NCT01740128|592997576|FG000|Overall Study|Withdrawal by Subject|1|||
164173431|NCT01740128|592997577|FG001|Overall Study|Withdrawal by Subject|0|||
164173432|NCT01740128|592997576|FG000|Overall Study|Insufficient protocol compliance|2|||
164173433|NCT01740128|592997577|FG001|Overall Study|Insufficient protocol compliance|2|||
164173434|NCT01041976|592997578|FG000|Overall Study|Withdrawal by Subject|3|||
164173515|NCT03802565|592997624|FG002|Overall Study|Lost to Follow-up|1|||
164173435|NCT01041976|592997579|FG001|Overall Study|Withdrawal by Subject|0|||
164173436|NCT01041976|592997578|FG000|Overall Study|Incarceration|2|||
164173437|NCT01041976|592997579|FG001|Overall Study|Incarceration|0|||
164173438|NCT01041976|592997578|FG000|Overall Study|Death|0|||
164173439|NCT01041976|592997579|FG001|Overall Study|Death|4|||
164173440|NCT02658734|592997580|FG000|Overall Study|Adverse Event|2|||
164173441|NCT02658734|592997580|FG000|Overall Study|Death|4|||
164173442|NCT02658734|592997580|FG000|Overall Study|Lost to Follow-up|7|||
164173443|NCT02658734|592997580|FG000|Overall Study|Withdrawal of Consent|16|||
164173444|NCT02658734|592997580|FG000|Overall Study|Disease Progression|28|||
164173445|NCT04240457|592997583|FG000|Overall Study|Lost to Follow-up|5|||
164173446|NCT04240457|592997584|FG001|Overall Study|Lost to Follow-up|1|||
164173447|NCT00976209|592997585|FG000|Treatment Period 1|Protocol Violation|1|||
164173448|NCT00976209|592997586|FG001|Treatment Period 1|Protocol Violation|0|||
164173449|NCT00976209|592997585|FG000|Treatment Period 1|Lost to Follow-up|2|||
164173450|NCT00976209|592997586|FG001|Treatment Period 1|Lost to Follow-up|0|||
164173451|NCT00976209|592997585|FG000|Treatment Period 1|Other|0|||
164173452|NCT00976209|592997586|FG001|Treatment Period 1|Other|1|||
164173453|NCT00976209|592997585|FG000|Wash-out Period|Adverse Event|1|||
164173454|NCT00976209|592997586|FG001|Wash-out Period|Adverse Event|2|||
164173455|NCT00976209|592997585|FG000|Wash-out Period|Lost to Follow-up|1|||
164173456|NCT00976209|592997586|FG001|Wash-out Period|Lost to Follow-up|0|||
164173457|NCT00976209|592997585|FG000|Wash-out Period|Protocol Violation|1|||
164173458|NCT00976209|592997586|FG001|Wash-out Period|Protocol Violation|0|||
164173459|NCT00976209|592997585|FG000|Wash-out Period|Other|1|||
164173460|NCT00976209|592997586|FG001|Wash-out Period|Other|0|||
164173461|NCT00976209|592997585|FG000|Treatment Period 2|Withdrawal by Subject|0|||
164173462|NCT00976209|592997586|FG001|Treatment Period 2|Withdrawal by Subject|1|||
164173463|NCT00976209|592997585|FG000|Treatment Period 2|Lost to Follow-up|0|||
164173464|NCT00976209|592997586|FG001|Treatment Period 2|Lost to Follow-up|1|||
164173465|NCT00844480|592997591|FG000|Overall Study|Withdrawal by Subject|2|||
164173466|NCT00844480|592997592|FG001|Overall Study|Withdrawal by Subject|3|||
164173467|NCT02858180|592997593|FG000|Overall Study|Lost to Follow-up|0|||
164173468|NCT02858180|592997594|FG001|Overall Study|Lost to Follow-up|2|||
164173469|NCT01252563|592997599|FG000|Overall Study|Contract Deviation|41|||
164173470|NCT01252563|592997599|FG000|Overall Study|Centralized Registration Deviation|30|||
164173471|NCT01252563|592997599|FG000|Overall Study|Lost to Follow-up|161|||
164173472|NCT01252563|592997599|FG000|Overall Study|No visit after first day of treatment|194|||
164173473|NCT01252563|592997599|FG000|Overall Study|No drug administration|6|||
164173474|NCT01866657|592997605|FG000|Overall Study|Surgery canceled|2|||
164173475|NCT01866657|592997606|FG001|Overall Study|Surgery canceled|0|||
164173476|NCT03403751|592997608|FG000|Overall Study|Death|5|||
164173477|NCT03403751|592997609|FG001|Overall Study|Death|6|||
164173478|NCT03403751|592997608|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
164173479|NCT03403751|592997609|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
164173480|NCT00520481|592997616|FG000|Overall Study|Adverse Event|4|||
164173481|NCT00520481|592997617|FG001|Overall Study|Adverse Event|1|||
164173482|NCT00520481|592997616|FG000|Overall Study|Withdrawal by Subject|3|||
164173483|NCT00520481|592997617|FG001|Overall Study|Withdrawal by Subject|0|||
164173484|NCT04442269|592997620|FG000|Overall Study|Adverse Event|1|||
164173485|NCT04442269|592997621|FG001|Overall Study|Adverse Event|0|||
164173486|NCT04442269|592997620|FG000|Overall Study|Death|0|||
164173487|NCT04442269|592997621|FG001|Overall Study|Death|1|||
164173488|NCT04442269|592997620|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
164173489|NCT04442269|592997621|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
164173490|NCT04442269|592997620|FG000|Overall Study|Lost to Follow-up|1|||
164173491|NCT04442269|592997621|FG001|Overall Study|Lost to Follow-up|0|||
164173492|NCT04442269|592997620|FG000|Overall Study|Withdrawal by Subject|3|||
164173493|NCT04442269|592997621|FG001|Overall Study|Withdrawal by Subject|2|||
164173494|NCT04442269|592997620|FG000|Overall Study|Protocol Deviation|0|||
164173495|NCT04442269|592997621|FG001|Overall Study|Protocol Deviation|1|||
164173496|NCT04442269|592997620|FG000|Overall Study|Travel Limitations|1|||
164173497|NCT04442269|592997621|FG001|Overall Study|Travel Limitations|1|||
164173498|NCT03802565|592997622|FG000|Overall Study|Adverse Event|0|||
164173499|NCT03802565|592997623|FG001|Overall Study|Adverse Event|1|||
164173500|NCT03802565|592997624|FG002|Overall Study|Adverse Event|2|||
164173501|NCT03802565|592997625|FG003|Overall Study|Adverse Event|1|||
164173502|NCT03802565|592997626|FG004|Overall Study|Adverse Event|1|||
164173503|NCT03802565|592997622|FG000|Overall Study|Withdrawal by Subject|2|||
164173504|NCT03802565|592997623|FG001|Overall Study|Withdrawal by Subject|2|||
164173505|NCT03802565|592997624|FG002|Overall Study|Withdrawal by Subject|2|||
164173506|NCT03802565|592997625|FG003|Overall Study|Withdrawal by Subject|0|||
164173507|NCT03802565|592997626|FG004|Overall Study|Withdrawal by Subject|1|||
164173508|NCT03802565|592997622|FG000|Overall Study|Protocol Violation|2|||
164173509|NCT03802565|592997623|FG001|Overall Study|Protocol Violation|1|||
164173510|NCT03802565|592997624|FG002|Overall Study|Protocol Violation|4|||
164173511|NCT03802565|592997625|FG003|Overall Study|Protocol Violation|5|||
164173512|NCT03802565|592997626|FG004|Overall Study|Protocol Violation|1|||
164173513|NCT03802565|592997622|FG000|Overall Study|Lost to Follow-up|0|||
164173516|NCT03802565|592997625|FG003|Overall Study|Lost to Follow-up|0|||
164173517|NCT03802565|592997626|FG004|Overall Study|Lost to Follow-up|0|||
164173518|NCT03802565|592997622|FG000|Overall Study|Subjects Related to Each Other|1|||
164173519|NCT03802565|592997623|FG001|Overall Study|Subjects Related to Each Other|0|||
164173520|NCT03802565|592997624|FG002|Overall Study|Subjects Related to Each Other|0|||
164173521|NCT03802565|592997625|FG003|Overall Study|Subjects Related to Each Other|2|||
164173522|NCT03802565|592997626|FG004|Overall Study|Subjects Related to Each Other|1|||
164173523|NCT03802565|592997622|FG000|Overall Study|Elevated Enzymes|0|||
164173524|NCT03802565|592997623|FG001|Overall Study|Elevated Enzymes|0|||
164173525|NCT03802565|592997624|FG002|Overall Study|Elevated Enzymes|0|||
164173526|NCT03802565|592997625|FG003|Overall Study|Elevated Enzymes|0|||
164173527|NCT03802565|592997626|FG004|Overall Study|Elevated Enzymes|2|||
164173528|NCT01004406|592999977|FG000|Overall Study|Withdrawal by Subject|2|||
164173529|NCT01004406|592999978|FG001|Overall Study|Withdrawal by Subject|0|||
164173530|NCT01004406|592999977|FG000|Overall Study|Lost to Follow-up|1|||
164173531|NCT01004406|592999978|FG001|Overall Study|Lost to Follow-up|0|||
164173532|NCT02907593|592999981|FG000|Overall Study|Withdrawal by Subject|0|||
164173533|NCT02907593|592999982|FG001|Overall Study|Withdrawal by Subject|0|||
164173534|NCT02907593|592999983|FG002|Overall Study|Withdrawal by Subject|1|||
164173535|NCT02907593|592999984|FG003|Overall Study|Withdrawal by Subject|0|||
164173536|NCT01944670|592999985|FG000|Overall Study|Lost to Follow-up|2|||
164173537|NCT05128773|592999986|FG000|Overall Study|Sponsor decision to terminate study|3|||
164173538|NCT04250714|592999987|FG000|Overall Study|Treatment - withdrawal by subject|14|||
164173539|NCT04250714|592999987|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
164173540|NCT04250714|592999987|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
164173541|NCT04250714|592999987|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
164173542|NCT04250714|592999987|FG000|Overall Study|Treatment - Death|1|||
164173543|NCT04250714|592999987|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
164173544|NCT04250714|592999987|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
164173545|NCT04250714|592999987|FG000|Overall Study|Attempt|2|||
164173546|NCT04250714|592999987|FG000|Overall Study|Intent|7|||
164173547|NCT02759055|592999990|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
164173548|NCT02759055|592999991|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
164173549|NCT00623597|592999992|FG000|Overall Study|Failed to return|1|||
164173550|NCT00623597|592999993|FG001|Overall Study|Failed to return|0|||
164173551|NCT04045132|592999997|FG000|Overall Study|Lost to Follow-up|3|||
164173552|NCT04045132|592999998|FG001|Overall Study|Lost to Follow-up|6|||
164173553|NCT00552032|592999999|FG000|Overall Study|Withdrawal by Subject|2|||
164173554|NCT00552032|593000000|FG001|Overall Study|Withdrawal by Subject|2|||
164173555|NCT00552032|592999999|FG000|Overall Study|Protocol Violation|7|||
164173556|NCT00552032|593000000|FG001|Overall Study|Protocol Violation|12|||
164173557|NCT00552032|592999999|FG000|Overall Study|Lost to Follow-up|8|||
164173558|NCT00552032|593000000|FG001|Overall Study|Lost to Follow-up|5|||
164173559|NCT03391232|593000001|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
164173560|NCT03391232|593000002|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
164173561|NCT03391232|593000001|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
164173562|NCT03391232|593000002|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
164173563|NCT00345878|593000003|FG000|Overall Study|Adverse Event|1|||
164173564|NCT00345878|593000004|FG001|Overall Study|Adverse Event|0|||
164173565|NCT00345878|593000003|FG000|Overall Study|Lost to Follow-up|2|||
164173566|NCT00345878|593000004|FG001|Overall Study|Lost to Follow-up|1|||
164173567|NCT00345878|593000003|FG000|Overall Study|Other|1|||
164173568|NCT00345878|593000004|FG001|Overall Study|Other|0|||
164173569|NCT02045732|593000005|FG000|Overall Study|At the discretion of the investigator|1|||
164173570|NCT02045732|593000006|FG001|Overall Study|At the discretion of the investigator|1|||
164173571|NCT04777201|593000010|FG000|Main Study|Withdrawal by Subject|19|||
164173572|NCT04777201|593000011|FG001|Main Study|Withdrawal by Subject|27|||
164173573|NCT04777201|593000012|FG002|Main Study|Withdrawal by Subject|0|||
164173574|NCT04777201|593000010|FG000|Main Study|Death|13|||
164173575|NCT04777201|593000011|FG001|Main Study|Death|27|||
164173576|NCT04777201|593000012|FG002|Main Study|Death|0|||
164173577|NCT04777201|593000010|FG000|Main Study|Subject missed the safety follow-up visit|9|||
164173578|NCT04777201|593000011|FG001|Main Study|Subject missed the safety follow-up visit|10|||
164173579|NCT04777201|593000012|FG002|Main Study|Subject missed the safety follow-up visit|0|||
164173580|NCT04777201|593000010|FG000|Main Study|Physician Decision|8|||
164173581|NCT04777201|593000011|FG001|Main Study|Physician Decision|10|||
164173582|NCT04777201|593000012|FG002|Main Study|Physician Decision|0|||
164173583|NCT04777201|593000010|FG000|Main Study|Adverse Event|8|||
164173584|NCT04777201|593000011|FG001|Main Study|Adverse Event|8|||
164173585|NCT04777201|593000012|FG002|Main Study|Adverse Event|0|||
164173586|NCT04777201|593000010|FG000|Main Study|Lost to Follow-up|9|||
164173587|NCT04777201|593000011|FG001|Main Study|Lost to Follow-up|4|||
164173588|NCT04777201|593000012|FG002|Main Study|Lost to Follow-up|0|||
164173589|NCT04777201|593000010|FG000|Main Study|Reason not specified|3|||
164173590|NCT04777201|593000011|FG001|Main Study|Reason not specified|3|||
164173591|NCT04777201|593000012|FG002|Main Study|Reason not specified|0|||
164173592|NCT04777201|593000010|FG000|Main Study|Lack of Efficacy|1|||
164173593|NCT04777201|593000011|FG001|Main Study|Lack of Efficacy|1|||
164173594|NCT04777201|593000012|FG002|Main Study|Lack of Efficacy|0|||
164173595|NCT04777201|593000010|FG000|Main Study|Protocol Violation|1|||
164173596|NCT04777201|593000011|FG001|Main Study|Protocol Violation|0|||
164173597|NCT04777201|593000012|FG002|Main Study|Protocol Violation|0|||
164173598|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
164173599|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
164173600|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
164173601|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
164173602|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
164173603|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
164173604|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
164173605|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
164173606|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
164173607|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
164173608|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
164173609|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
164173610|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
164173611|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
164173612|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
164173613|NCT04777201|593000010|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
164173614|NCT04777201|593000011|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
164173615|NCT04777201|593000012|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
164173616|NCT00177307|593000017|FG000|Overall Study|Withdrawal by Subject|1|||
164173617|NCT01282164|593000020|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
164173618|NCT01282164|593000021|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
164173619|NCT04521621|593000022|FG000|Overall Study|Death|17|||
164173620|NCT04521621|593000023|FG001|Overall Study|Death|8|||
164173621|NCT04521621|593000024|FG002|Overall Study|Death|8|||
164173622|NCT04521621|593000025|FG003|Overall Study|Death|5|||
164173623|NCT04521621|593000026|FG004|Overall Study|Death|2|||
164173624|NCT04521621|593000027|FG005|Overall Study|Death|7|||
164173625|NCT04521621|593000028|FG006|Overall Study|Death|0|||
164173626|NCT04521621|593000029|FG007|Overall Study|Death|0|||
164173627|NCT04521621|593000022|FG000|Overall Study|Study Terminated by Sponsor|4|||
164173628|NCT04521621|593000023|FG001|Overall Study|Study Terminated by Sponsor|6|||
164173629|NCT04521621|593000024|FG002|Overall Study|Study Terminated by Sponsor|8|||
164173630|NCT04521621|593000025|FG003|Overall Study|Study Terminated by Sponsor|0|||
164173631|NCT04521621|593000026|FG004|Overall Study|Study Terminated by Sponsor|1|||
164173632|NCT04521621|593000027|FG005|Overall Study|Study Terminated by Sponsor|7|||
164173633|NCT04521621|593000028|FG006|Overall Study|Study Terminated by Sponsor|0|||
164173634|NCT04521621|593000029|FG007|Overall Study|Study Terminated by Sponsor|0|||
164173635|NCT04521621|593000022|FG000|Overall Study|Withdrawal by Subject|0|||
164173636|NCT04521621|593000023|FG001|Overall Study|Withdrawal by Subject|0|||
164173637|NCT04521621|593000024|FG002|Overall Study|Withdrawal by Subject|1|||
164173638|NCT04521621|593000025|FG003|Overall Study|Withdrawal by Subject|1|||
164173639|NCT04521621|593000026|FG004|Overall Study|Withdrawal by Subject|0|||
164173640|NCT04521621|593000027|FG005|Overall Study|Withdrawal by Subject|0|||
164173641|NCT04521621|593000028|FG006|Overall Study|Withdrawal by Subject|0|||
164173642|NCT04521621|593000029|FG007|Overall Study|Withdrawal by Subject|0|||
164173643|NCT04521621|593000022|FG000|Overall Study|Allocated in error without study intervention|1|||
164173644|NCT04521621|593000023|FG001|Overall Study|Allocated in error without study intervention|0|||
164173645|NCT04521621|593000024|FG002|Overall Study|Allocated in error without study intervention|0|||
164173646|NCT04521621|593000025|FG003|Overall Study|Allocated in error without study intervention|0|||
164173647|NCT04521621|593000026|FG004|Overall Study|Allocated in error without study intervention|0|||
164173648|NCT04521621|593000027|FG005|Overall Study|Allocated in error without study intervention|0|||
164173649|NCT04521621|593000028|FG006|Overall Study|Allocated in error without study intervention|0|||
164173650|NCT04521621|593000029|FG007|Overall Study|Allocated in error without study intervention|0|||
164173651|NCT03671564|593000030|FG000|Overall Study|Progressive Disease|3|||
164173652|NCT03671564|593000031|FG001|Overall Study|Progressive Disease|5|||
164173653|NCT03671564|593000032|FG002|Overall Study|Progressive Disease|3|||
164173654|NCT03671564|593000030|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
164173655|NCT03671564|593000031|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
164173656|NCT03671564|593000032|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
164173657|NCT03671564|593000030|FG000|Overall Study|Withdrawal by Subject|1|||
164173658|NCT03671564|593000031|FG001|Overall Study|Withdrawal by Subject|1|||
164173659|NCT03671564|593000032|FG002|Overall Study|Withdrawal by Subject|0|||
164173660|NCT05845567|593000037|FG000|Overall Study|Withdrawal by Subject|1|||
164173661|NCT01104246|593000042|FG000|Overall Study|Withdrawal by Subject|1|||
164173662|NCT01104246|593000042|FG000|Overall Study|did not meet inclusion criteria|4|||
164173663|NCT05178641|593000045|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
164173664|NCT05178641|593000046|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
164173665|NCT05178641|593000045|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
164173666|NCT05178641|593000046|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
164173667|NCT01869699|593000047|FG000|Overall Study|Withdrawal by Subject|1|||
164173668|NCT01869699|593000048|FG001|Overall Study|Withdrawal by Subject|0|||
164173669|NCT01083186|593000050|FG000|Overall Study|Lost to Follow-up|48|||
164173670|NCT01083186|593000050|FG000|Overall Study|Consent Withdrawal|7|||
164173671|NCT01083186|593000050|FG000|Overall Study|Death|3|||
164173672|NCT01083186|593000050|FG000|Overall Study|Adverse Event|3|||
164173673|NCT01083186|593000050|FG000|Overall Study|Lack of Efficacy|2|||
164173674|NCT01083186|593000050|FG000|Overall Study|Hemodialysis Initiation|28|||
164173675|NCT01083186|593000050|FG000|Overall Study|Administrative Reasons|2|||
164173676|NCT01083186|593000050|FG000|Overall Study|Non-compliance to Study Treatment|1|||
164173677|NCT01867294|593000056|FG000|Overall Study|Withdrawal by Subject|1|||
164173678|NCT01867294|593000057|FG001|Overall Study|Withdrawal by Subject|1|||
164173679|NCT01867294|593000058|FG002|Overall Study|Withdrawal by Subject|0|||
164173680|NCT01867294|593000059|FG003|Overall Study|Withdrawal by Subject|0|||
164173681|NCT00978250|593000060|FG000|Overall Study|Late determination of ineligibility|0|||
164173682|NCT00978250|593000061|FG001|Overall Study|Late determination of ineligibility|1|||
164173683|NCT00978250|593000062|FG002|Overall Study|Late determination of ineligibility|0|||
164173684|NCT00978250|593000063|FG003|Overall Study|Late determination of ineligibility|1|||
164173685|NCT05174949|593000064|FG000|Overall Study|Physician Decision|1|||
164173686|NCT05174949|593000065|FG001|Overall Study|Physician Decision|2|||
164173687|NCT05174949|593000066|FG002|Overall Study|Physician Decision|0|||
164173688|NCT05174949|593000067|FG003|Overall Study|Physician Decision|1|||
164173689|NCT05174949|593000068|FG004|Overall Study|Physician Decision|0|||
164173690|NCT05174949|593000069|FG005|Overall Study|Physician Decision|0|||
164173691|NCT05174949|593000064|FG000|Overall Study|Withdrawal by Subject|0|||
164173692|NCT05174949|593000065|FG001|Overall Study|Withdrawal by Subject|1|||
164173693|NCT05174949|593000066|FG002|Overall Study|Withdrawal by Subject|0|||
164173694|NCT05174949|593000067|FG003|Overall Study|Withdrawal by Subject|0|||
164173695|NCT05174949|593000068|FG004|Overall Study|Withdrawal by Subject|0|||
164173696|NCT05174949|593000069|FG005|Overall Study|Withdrawal by Subject|0|||
164173697|NCT05174949|593000064|FG000|Overall Study|Lost to Follow-up|0|||
164173698|NCT05174949|593000065|FG001|Overall Study|Lost to Follow-up|0|||
164173699|NCT05174949|593000066|FG002|Overall Study|Lost to Follow-up|0|||
164173700|NCT05174949|593000067|FG003|Overall Study|Lost to Follow-up|1|||
164173701|NCT05174949|593000068|FG004|Overall Study|Lost to Follow-up|0|||
164173702|NCT05174949|593000069|FG005|Overall Study|Lost to Follow-up|0|||
164173703|NCT02029989|593000070|FG000|Overall Study|Withdrawal by Subject|1|||
164173704|NCT02029989|593000071|FG001|Overall Study|Withdrawal by Subject|0|||
164173705|NCT02029989|593000070|FG000|Overall Study|Withdrawal: Fear of needles|1|||
164173706|NCT02029989|593000071|FG001|Overall Study|Withdrawal: Fear of needles|0|||
164173707|NCT02029989|593000070|FG000|Overall Study|Change of location|2|||
164173708|NCT02029989|593000071|FG001|Overall Study|Change of location|3|||
164173709|NCT02029989|593000070|FG000|Overall Study|Physician Decision|2|||
164173710|NCT02029989|593000071|FG001|Overall Study|Physician Decision|0|||
164173711|NCT02029989|593000070|FG000|Overall Study|Lost to Follow-up|9|||
164173712|NCT02029989|593000071|FG001|Overall Study|Lost to Follow-up|7|||
164173713|NCT02029989|593000070|FG000|Overall Study|Death|0|||
164173714|NCT02029989|593000071|FG001|Overall Study|Death|1|||
164173715|NCT02029989|593000070|FG000|Overall Study|Protocol Violation|1|||
164173716|NCT02029989|593000071|FG001|Overall Study|Protocol Violation|0|||
164173717|NCT04351373|593000072|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
164173718|NCT01123941|593000078|FG000|Overall Study|Lost to Follow-up|2|||
164173719|NCT01123941|593000079|FG001|Overall Study|Lost to Follow-up|1|||
164173720|NCT05036668|593000080|FG000|Overall Study|lost to follow Up|0|||
164173721|NCT05036668|593000081|FG001|Overall Study|lost to follow Up|0|||
164173722|NCT05036668|593000082|FG002|Overall Study|lost to follow Up|1|||
164173723|NCT01537068|593000083|FG000|Overall Study|Lost to Follow-up|2|||
164173724|NCT01537068|593000084|FG001|Overall Study|Lost to Follow-up|1|||
164173725|NCT01537068|593000083|FG000|Overall Study|Adverse Event|0|||
164173726|NCT01537068|593000084|FG001|Overall Study|Adverse Event|1|||
164173727|NCT01537068|593000083|FG000|Overall Study|Withdrawal by Subject|1|||
164173728|NCT01537068|593000084|FG001|Overall Study|Withdrawal by Subject|1|||
164173729|NCT01537068|593000083|FG000|Overall Study|Lack of Efficacy|1|||
164173730|NCT01537068|593000084|FG001|Overall Study|Lack of Efficacy|0|||
164173731|NCT06011161|593000085|FG000|Overall Study|Withdrawal by Subject|2|||
164173732|NCT06011161|593000085|FG000|Overall Study|Lost to Follow-up|5|||
164173733|NCT02291601|593000086|FG000|Abdomen|Did not qualify|333|||
164173734|NCT02291601|593000087|FG001|Abdomen|Did not qualify|54|||
164173735|NCT02291601|593000088|FG002|Abdomen|Did not qualify|339|||
164173736|NCT02291601|593000086|FG000|Groin|Did not qualify|183|||
164173737|NCT02291601|593000087|FG001|Groin|Did not qualify|30|||
164173738|NCT02291601|593000088|FG002|Groin|Did not qualify|177|||
164173739|NCT04017832|593000096|FG000|Overall Study|Withdrawal by Subject|13|||
164173740|NCT04017832|593000097|FG001|Overall Study|Withdrawal by Subject|12|||
164173741|NCT04017832|593000098|FG002|Overall Study|Withdrawal by Subject|21|||
164173742|NCT04017832|593000099|FG003|Overall Study|Withdrawal by Subject|7|||
164173743|NCT04017832|593000096|FG000|Overall Study|Lost to Follow-up|0|||
164173744|NCT04017832|593000097|FG001|Overall Study|Lost to Follow-up|3|||
164173745|NCT04017832|593000098|FG002|Overall Study|Lost to Follow-up|3|||
164173746|NCT04017832|593000099|FG003|Overall Study|Lost to Follow-up|1|||
164173747|NCT04017832|593000096|FG000|Overall Study|Physician Decision|1|||
164173748|NCT04017832|593000097|FG001|Overall Study|Physician Decision|1|||
164173749|NCT04017832|593000098|FG002|Overall Study|Physician Decision|1|||
164173750|NCT04017832|593000099|FG003|Overall Study|Physician Decision|1|||
164173751|NCT04017832|593000096|FG000|Overall Study|Death|2|||
164173752|NCT04017832|593000097|FG001|Overall Study|Death|2|||
164173753|NCT04017832|593000098|FG002|Overall Study|Death|1|||
164173754|NCT04017832|593000099|FG003|Overall Study|Death|0|||
164173755|NCT01744184|593000103|FG000|Overall Study|Adverse Event|1|||
164173756|NCT01744184|593000104|FG001|Overall Study|Adverse Event|0|||
164173757|NCT01744184|593000103|FG000|Overall Study|Withdrawal by Subject|0|||
164173758|NCT01744184|593000104|FG001|Overall Study|Withdrawal by Subject|1|||
164173759|NCT00072280|593000105|FG000|Treatment|Found ineligible|1|||
164173760|NCT00072280|593000106|FG001|Treatment|Found ineligible|2|||
164173761|NCT00072280|593000105|FG000|Follow-up|Early termination of study|2|||
164173762|NCT00072280|593000106|FG001|Follow-up|Early termination of study|2|||
164173763|NCT02091986|593000107|FG000|Overall Study|7 rand in error 1 patient decision|2|||
164173764|NCT02091986|593000108|FG001|Overall Study|7 rand in error 1 patient decision|3|||
164173765|NCT02091986|593000109|FG002|Overall Study|7 rand in error 1 patient decision|3|||
164173766|NCT02091986|593000107|FG000|Overall Study|Lost to Follow-up|1|||
164173767|NCT02091986|593000108|FG001|Overall Study|Lost to Follow-up|0|||
164173768|NCT02091986|593000109|FG002|Overall Study|Lost to Follow-up|0|||
164173769|NCT02091986|593000107|FG000|Overall Study|Withdrawal by Subject|4|||
164173770|NCT02091986|593000108|FG001|Overall Study|Withdrawal by Subject|8|||
164173771|NCT02091986|593000109|FG002|Overall Study|Withdrawal by Subject|3|||
164173772|NCT02091986|593000107|FG000|Overall Study|Adverse Event|0|||
164173773|NCT02091986|593000108|FG001|Overall Study|Adverse Event|0|||
164173774|NCT02091986|593000109|FG002|Overall Study|Adverse Event|2|||
164173775|NCT02841280|593000110|FG000|Overall Study|Adverse Event|2|||
164173776|NCT02841280|593000111|FG001|Overall Study|Adverse Event|1|||
164173777|NCT02841280|593000110|FG000|Overall Study|Death|1|||
164173778|NCT02841280|593000111|FG001|Overall Study|Death|0|||
164173779|NCT02841280|593000110|FG000|Overall Study|Lost to Follow-up|2|||
164173780|NCT02841280|593000111|FG001|Overall Study|Lost to Follow-up|2|||
164173781|NCT02841280|593000110|FG000|Overall Study|Withdrawal by Subject|7|||
164173782|NCT02841280|593000111|FG001|Overall Study|Withdrawal by Subject|3|||
164173783|NCT02841280|593000110|FG000|Overall Study|Stop Point: BP above threshold|2|||
164173784|NCT02841280|593000111|FG001|Overall Study|Stop Point: BP above threshold|0|||
164173785|NCT00125242|593000112|FG000|Overall Study|did not qualify|7|||
164173786|NCT00125242|593000113|FG001|Overall Study|did not qualify|2|||
164173787|NCT01664949|593000114|FG000|Overall Study|Adverse Event|11|||
164173788|NCT01664949|593000115|FG001|Overall Study|Adverse Event|12|||
164173789|NCT01664949|593000114|FG000|Overall Study|Lack of Efficacy|1|||
164173790|NCT01664949|593000115|FG001|Overall Study|Lack of Efficacy|1|||
164173791|NCT01664949|593000114|FG000|Overall Study|Lost to Follow-up|1|||
164173792|NCT01664949|593000115|FG001|Overall Study|Lost to Follow-up|2|||
164173793|NCT01664949|593000114|FG000|Overall Study|Personal Reasons|3|||
164173794|NCT01664949|593000115|FG001|Overall Study|Personal Reasons|4|||
164173795|NCT01664949|593000114|FG000|Overall Study|Protocol Violation|5|||
164173796|NCT01664949|593000115|FG001|Overall Study|Protocol Violation|5|||
164173797|NCT01664949|593000114|FG000|Overall Study|Other Miscellaneous Reasons|3|||
164173798|NCT01664949|593000115|FG001|Overall Study|Other Miscellaneous Reasons|1|||
164173799|NCT02727777|593000122|FG000|Overall Study|Screen Failure|2|||
164173800|NCT02727777|593000123|FG001|Overall Study|Screen Failure|0|||
164173801|NCT02727777|593000124|FG002|Overall Study|Screen Failure|0|||
164173802|NCT02727777|593000122|FG000|Overall Study|Progressive disease|2|||
164173803|NCT02727777|593000123|FG001|Overall Study|Progressive disease|0|||
164173804|NCT02727777|593000124|FG002|Overall Study|Progressive disease|0|||
164173805|NCT03003494|593000125|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
164173806|NCT00957268|593000126|FG000|Overall Study|Voluntary Withdrawal|0|||
164173807|NCT00957268|593000127|FG001|Overall Study|Voluntary Withdrawal|0|||
164173808|NCT00957268|593000128|FG002|Overall Study|Voluntary Withdrawal|1|||
164173809|NCT00957268|593000129|FG003|Overall Study|Voluntary Withdrawal|0|||
164173810|NCT00957268|593000130|FG004|Overall Study|Voluntary Withdrawal|0|||
164173811|NCT01738503|593000132|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
164173812|NCT01738503|593000133|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173813|NCT01738503|593000134|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173814|NCT01738503|593000135|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173815|NCT01738503|593000136|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173816|NCT01738503|593000137|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173817|NCT01738503|593000138|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
164173818|NCT01738503|593000132|FG000|Treatment Period|Adverse Event|0|||
164173819|NCT01738503|593000133|FG001|Treatment Period|Adverse Event|1|||
164173820|NCT01738503|593000134|FG002|Treatment Period|Adverse Event|0|||
164173821|NCT01738503|593000135|FG003|Treatment Period|Adverse Event|1|||
164173822|NCT01738503|593000136|FG004|Treatment Period|Adverse Event|2|||
164173823|NCT01738503|593000137|FG005|Treatment Period|Adverse Event|2|||
164173824|NCT01738503|593000138|FG006|Treatment Period|Adverse Event|2|||
164173825|NCT01738503|593000132|FG000|Treatment Period|Lost to Follow-up|0|||
164173826|NCT01738503|593000133|FG001|Treatment Period|Lost to Follow-up|0|||
164173827|NCT01738503|593000134|FG002|Treatment Period|Lost to Follow-up|3|||
164173828|NCT01738503|593000135|FG003|Treatment Period|Lost to Follow-up|4|||
164173829|NCT01738503|593000136|FG004|Treatment Period|Lost to Follow-up|1|||
164173830|NCT01738503|593000137|FG005|Treatment Period|Lost to Follow-up|1|||
164173831|NCT01738503|593000138|FG006|Treatment Period|Lost to Follow-up|5|||
164173832|NCT01738503|593000132|FG000|Treatment Period|Withdrawal by Subject|0|||
164173833|NCT01738503|593000133|FG001|Treatment Period|Withdrawal by Subject|1|||
164173834|NCT01738503|593000134|FG002|Treatment Period|Withdrawal by Subject|0|||
164173835|NCT01738503|593000135|FG003|Treatment Period|Withdrawal by Subject|1|||
164173836|NCT01738503|593000136|FG004|Treatment Period|Withdrawal by Subject|1|||
164173837|NCT01738503|593000137|FG005|Treatment Period|Withdrawal by Subject|1|||
164173838|NCT01738503|593000138|FG006|Treatment Period|Withdrawal by Subject|1|||
164173839|NCT01738503|593000132|FG000|Treatment Period|Protocol Violation|0|||
164173840|NCT01738503|593000133|FG001|Treatment Period|Protocol Violation|3|||
164173841|NCT01738503|593000134|FG002|Treatment Period|Protocol Violation|1|||
164173842|NCT01738503|593000135|FG003|Treatment Period|Protocol Violation|0|||
164173843|NCT01738503|593000136|FG004|Treatment Period|Protocol Violation|4|||
164173844|NCT01738503|593000137|FG005|Treatment Period|Protocol Violation|2|||
164173845|NCT01738503|593000138|FG006|Treatment Period|Protocol Violation|0|||
164173846|NCT01738503|593000132|FG000|Treatment Period|Other|0|||
164173847|NCT01738503|593000133|FG001|Treatment Period|Other|0|||
164173848|NCT01738503|593000134|FG002|Treatment Period|Other|1|||
164173849|NCT01738503|593000135|FG003|Treatment Period|Other|0|||
164173850|NCT01738503|593000136|FG004|Treatment Period|Other|0|||
164173851|NCT01738503|593000137|FG005|Treatment Period|Other|0|||
164173852|NCT01738503|593000138|FG006|Treatment Period|Other|0|||
164173853|NCT01738503|593000132|FG000|PET Imaging Sub-study|Adverse Event|0|||
164173854|NCT01738503|593000133|FG001|PET Imaging Sub-study|Adverse Event|0|||
164173855|NCT01738503|593000134|FG002|PET Imaging Sub-study|Adverse Event|0|||
164173856|NCT01738503|593000135|FG003|PET Imaging Sub-study|Adverse Event|0|||
164173857|NCT01738503|593000136|FG004|PET Imaging Sub-study|Adverse Event|0|||
164173858|NCT01738503|593000137|FG005|PET Imaging Sub-study|Adverse Event|1|||
164173859|NCT01738503|593000138|FG006|PET Imaging Sub-study|Adverse Event|0|||
164173860|NCT01738503|593000132|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173861|NCT01738503|593000133|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173862|NCT01738503|593000134|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173863|NCT01738503|593000135|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173864|NCT01738503|593000136|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
164173865|NCT01738503|593000137|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
164173866|NCT01738503|593000138|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
164173867|NCT03005327|593000139|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
164173868|NCT03005327|593000140|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
164173869|NCT03005327|593000141|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
164173870|NCT03005327|593000142|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
164173871|NCT03005327|593000139|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164173872|NCT03005327|593000140|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
164173873|NCT03005327|593000141|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164173874|NCT03005327|593000142|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
164173875|NCT01340027|593000143|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
164173876|NCT01340027|593000144|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
164173877|NCT01340027|593000145|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
164173878|NCT01340027|593000146|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
164173879|NCT01340027|593000147|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
164173880|NCT01340027|593000148|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
164173881|NCT01340027|593000149|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
164173882|NCT01340027|593000150|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
164173883|NCT01340027|593000151|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
164173884|NCT01340027|593000152|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
164173885|NCT01340027|593000153|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
164173886|NCT01340027|593000154|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
164173887|NCT01340027|593000143|FG000|Overall Study|Adverse Event|0|||
164173888|NCT01340027|593000144|FG001|Overall Study|Adverse Event|1|||
164173889|NCT01340027|593000145|FG002|Overall Study|Adverse Event|2|||
164173890|NCT01340027|593000146|FG003|Overall Study|Adverse Event|0|||
164173891|NCT01340027|593000147|FG004|Overall Study|Adverse Event|1|||
164173892|NCT01340027|593000148|FG005|Overall Study|Adverse Event|2|||
164173893|NCT01340027|593000149|FG006|Overall Study|Adverse Event|2|||
164173894|NCT01340027|593000150|FG007|Overall Study|Adverse Event|1|||
164173895|NCT01340027|593000151|FG008|Overall Study|Adverse Event|4|||
164173896|NCT01340027|593000152|FG009|Overall Study|Adverse Event|1|||
164173897|NCT01340027|593000153|FG010|Overall Study|Adverse Event|1|||
164173898|NCT01340027|593000154|FG011|Overall Study|Adverse Event|3|||
164173899|NCT01340027|593000143|FG000|Overall Study|Lack of Efficacy|0|||
164173900|NCT01340027|593000144|FG001|Overall Study|Lack of Efficacy|0|||
164173901|NCT01340027|593000145|FG002|Overall Study|Lack of Efficacy|0|||
164173902|NCT01340027|593000146|FG003|Overall Study|Lack of Efficacy|0|||
164173903|NCT01340027|593000147|FG004|Overall Study|Lack of Efficacy|0|||
164173904|NCT01340027|593000148|FG005|Overall Study|Lack of Efficacy|0|||
164173905|NCT01340027|593000149|FG006|Overall Study|Lack of Efficacy|1|||
164173906|NCT01340027|593000150|FG007|Overall Study|Lack of Efficacy|1|||
164173907|NCT01340027|593000151|FG008|Overall Study|Lack of Efficacy|1|||
164173908|NCT01340027|593000152|FG009|Overall Study|Lack of Efficacy|0|||
164173909|NCT01340027|593000153|FG010|Overall Study|Lack of Efficacy|0|||
164173910|NCT01340027|593000154|FG011|Overall Study|Lack of Efficacy|0|||
164173911|NCT01340027|593000143|FG000|Overall Study|Lost to Follow-up|0|||
164173912|NCT01340027|593000144|FG001|Overall Study|Lost to Follow-up|1|||
164173913|NCT01340027|593000145|FG002|Overall Study|Lost to Follow-up|0|||
164173914|NCT01340027|593000146|FG003|Overall Study|Lost to Follow-up|0|||
164173915|NCT01340027|593000147|FG004|Overall Study|Lost to Follow-up|0|||
164173916|NCT01340027|593000148|FG005|Overall Study|Lost to Follow-up|0|||
164173917|NCT01340027|593000149|FG006|Overall Study|Lost to Follow-up|1|||
164173918|NCT01340027|593000150|FG007|Overall Study|Lost to Follow-up|0|||
164173919|NCT01340027|593000151|FG008|Overall Study|Lost to Follow-up|0|||
164173920|NCT01340027|593000152|FG009|Overall Study|Lost to Follow-up|1|||
164173921|NCT01340027|593000153|FG010|Overall Study|Lost to Follow-up|0|||
164173922|NCT01340027|593000154|FG011|Overall Study|Lost to Follow-up|0|||
164173923|NCT01340027|593000143|FG000|Overall Study|Protocol Violation|1|||
164173924|NCT01340027|593000144|FG001|Overall Study|Protocol Violation|2|||
164173925|NCT01340027|593000145|FG002|Overall Study|Protocol Violation|0|||
164173926|NCT01340027|593000146|FG003|Overall Study|Protocol Violation|0|||
164173927|NCT01340027|593000147|FG004|Overall Study|Protocol Violation|6|||
164173928|NCT01340027|593000148|FG005|Overall Study|Protocol Violation|0|||
164173929|NCT01340027|593000149|FG006|Overall Study|Protocol Violation|0|||
164173930|NCT01340027|593000150|FG007|Overall Study|Protocol Violation|1|||
164173931|NCT01340027|593000151|FG008|Overall Study|Protocol Violation|2|||
164173932|NCT01340027|593000152|FG009|Overall Study|Protocol Violation|2|||
164173933|NCT01340027|593000153|FG010|Overall Study|Protocol Violation|0|||
164173934|NCT01340027|593000154|FG011|Overall Study|Protocol Violation|0|||
164173935|NCT01340027|593000143|FG000|Overall Study|Withdrawal by Subject|4|||
164173936|NCT01340027|593000144|FG001|Overall Study|Withdrawal by Subject|3|||
164173937|NCT01340027|593000145|FG002|Overall Study|Withdrawal by Subject|1|||
164173938|NCT01340027|593000146|FG003|Overall Study|Withdrawal by Subject|3|||
164173939|NCT01340027|593000147|FG004|Overall Study|Withdrawal by Subject|3|||
164173940|NCT01340027|593000148|FG005|Overall Study|Withdrawal by Subject|2|||
164173941|NCT01340027|593000149|FG006|Overall Study|Withdrawal by Subject|3|||
164173942|NCT01340027|593000150|FG007|Overall Study|Withdrawal by Subject|4|||
164173943|NCT01340027|593000151|FG008|Overall Study|Withdrawal by Subject|1|||
164173944|NCT01340027|593000152|FG009|Overall Study|Withdrawal by Subject|2|||
164173945|NCT01340027|593000153|FG010|Overall Study|Withdrawal by Subject|0|||
164173946|NCT01340027|593000154|FG011|Overall Study|Withdrawal by Subject|1|||
164173947|NCT01340027|593000143|FG000|Overall Study|Miscellaneous|0|||
164173948|NCT01340027|593000144|FG001|Overall Study|Miscellaneous|0|||
164173949|NCT01340027|593000145|FG002|Overall Study|Miscellaneous|0|||
164173950|NCT01340027|593000146|FG003|Overall Study|Miscellaneous|1|||
164173951|NCT01340027|593000147|FG004|Overall Study|Miscellaneous|0|||
164173952|NCT01340027|593000148|FG005|Overall Study|Miscellaneous|0|||
164173953|NCT01340027|593000149|FG006|Overall Study|Miscellaneous|0|||
164173954|NCT01340027|593000150|FG007|Overall Study|Miscellaneous|0|||
164173955|NCT01340027|593000151|FG008|Overall Study|Miscellaneous|0|||
164173956|NCT01340027|593000152|FG009|Overall Study|Miscellaneous|0|||
164173957|NCT01340027|593000153|FG010|Overall Study|Miscellaneous|1|||
164173958|NCT01340027|593000154|FG011|Overall Study|Miscellaneous|0|||
164173959|NCT00833482|593000155|FG000|Days 11-20|Adverse Event|0|||
164173960|NCT00833482|593000156|FG001|Days 11-20|Adverse Event|2|||
164173961|NCT00833482|593000157|FG002|Days 11-20|Adverse Event|0|||
164173962|NCT00833482|593000158|FG003|Days 11-20|Adverse Event|0|||
164173963|NCT00833482|593000159|FG004|Days 11-20|Adverse Event|0|||
164173964|NCT00833482|593000160|FG005|Days 11-20|Adverse Event|0|||
164173965|NCT00833482|593000155|FG000|Days 11-20|Withdrawal by Subject|0|||
164173966|NCT00833482|593000156|FG001|Days 11-20|Withdrawal by Subject|1|||
164173967|NCT00833482|593000157|FG002|Days 11-20|Withdrawal by Subject|0|||
164173968|NCT00833482|593000158|FG003|Days 11-20|Withdrawal by Subject|0|||
164173969|NCT00833482|593000159|FG004|Days 11-20|Withdrawal by Subject|0|||
164173970|NCT00833482|593000160|FG005|Days 11-20|Withdrawal by Subject|0|||
164173971|NCT00833482|593000155|FG000|Days 21-30|Adverse Event|0|||
164173972|NCT00833482|593000156|FG001|Days 21-30|Adverse Event|0|||
164173973|NCT00833482|593000157|FG002|Days 21-30|Adverse Event|1|||
164173974|NCT00833482|593000158|FG003|Days 21-30|Adverse Event|0|||
164173975|NCT00833482|593000159|FG004|Days 21-30|Adverse Event|0|||
164173976|NCT00833482|593000160|FG005|Days 21-30|Adverse Event|0|||
164173977|NCT00833482|593000155|FG000|Days 21-30|Withdrawal by Subject|0|||
164173978|NCT00833482|593000156|FG001|Days 21-30|Withdrawal by Subject|0|||
164173979|NCT00833482|593000157|FG002|Days 21-30|Withdrawal by Subject|0|||
164173980|NCT00833482|593000158|FG003|Days 21-30|Withdrawal by Subject|0|||
164173981|NCT00833482|593000159|FG004|Days 21-30|Withdrawal by Subject|1|||
164173982|NCT00833482|593000160|FG005|Days 21-30|Withdrawal by Subject|0|||
164173983|NCT00915876|593000161|FG000|Overall Study|Adverse Event|0|||
164173984|NCT00915876|593000162|FG001|Overall Study|Adverse Event|1|||
164173985|NCT02496091|593000168|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
164173986|NCT02272842|593000169|FG000|Overall Study|Lost to Follow-up|8|||
164173987|NCT02272842|593000170|FG001|Overall Study|Lost to Follow-up|8|||
164173988|NCT02272842|593000169|FG000|Overall Study|Withdrawal by Subject|8|||
164173989|NCT02272842|593000170|FG001|Overall Study|Withdrawal by Subject|2|||
164173990|NCT01794793|593000172|FG000|Treatment Period|Withdrawal by Subject|24|||
164173991|NCT01794793|593000172|FG000|Treatment Period|Lack of Efficacy|22|||
164173992|NCT01794793|593000172|FG000|Treatment Period|Adverse Event|17|||
164173993|NCT01794793|593000172|FG000|Treatment Period|Physician Decision|14|||
164173994|NCT01794793|593000172|FG000|Treatment Period|Lost to Follow-up|7|||
164173995|NCT01794793|593000172|FG000|Treatment Period|Death|6|||
164173996|NCT01794793|593000172|FG000|Treatment Period|Protocol Violation|5|||
164173997|NCT01794793|593000172|FG000|Treatment Period|administrative problem|3|||
164173998|NCT01794793|593000172|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
164173999|NCT01794793|593000172|FG000|Post-treatment Follow-up|Adverse Event|8|||
164174000|NCT01794793|593000172|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
164174001|NCT01794793|593000172|FG000|Post-treatment Follow-up|administrative problem|5|||
164174002|NCT01794793|593000172|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
164174003|NCT01794793|593000172|FG000|Post-treatment Follow-up|Protocol Violation|3|||
164174004|NCT02234596|593000173|FG000|Overall Study|Participant not treated|2|||
164174005|NCT04852679|593000174|FG000|Main Intervention Period|Withdrawal by Subject|3|||
164174006|NCT04852679|593000174|FG000|Main Intervention Period|Adverse Event|1|||
164174007|NCT04852679|593000174|FG000|Main Intervention Period|Progressive Disease|16|||
164174008|NCT04852679|593000174|FG000|Main Intervention Period|Refused study visit|1|||
164174009|NCT04852679|593000174|FG000|Independent Injection Period|Missed study visit|1|||
164174010|NCT01632904|593001636|FG000|Overall Study|Adverse Event|4|||
164174011|NCT01632904|593001637|FG001|Overall Study|Adverse Event|1|||
164174012|NCT01632904|593001636|FG000|Overall Study|Physician Decision|0|||
164174013|NCT01632904|593001637|FG001|Overall Study|Physician Decision|1|||
164174014|NCT01632904|593001636|FG000|Overall Study|Subject decision|3|||
164174015|NCT01632904|593001637|FG001|Overall Study|Subject decision|2|||
164174016|NCT01632904|593001636|FG000|Overall Study|Disease Progression|0|||
164174017|NCT01632904|593001637|FG001|Overall Study|Disease Progression|1|||
164174018|NCT01632904|593001636|FG000|Overall Study|Reason for discontinuation not available|0|||
164174019|NCT01632904|593001637|FG001|Overall Study|Reason for discontinuation not available|1|||
164174020|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
164174021|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
164174022|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
164174023|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
164174024|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
164174025|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
164174026|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174027|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
164174028|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174029|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174030|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174031|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
164174032|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
164174033|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
164174034|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
164174035|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
164174036|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
164174037|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
164174038|NCT01752634|593001641|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
164174039|NCT01752634|593001642|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
164174040|NCT01752634|593001643|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
164174041|NCT01752634|593001644|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
164174042|NCT01752634|593001645|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
164174043|NCT01752634|593001646|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
164174044|NCT01752634|593001641|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
164174045|NCT01752634|593001642|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
164174046|NCT01752634|593001643|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
164174047|NCT01752634|593001644|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
164174048|NCT01752634|593001645|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
164174049|NCT01752634|593001646|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
164174050|NCT01752634|593001641|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
164174051|NCT01752634|593001642|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
164174052|NCT01752634|593001643|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
164174053|NCT01752634|593001644|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
164174054|NCT01752634|593001645|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
164174055|NCT01752634|593001646|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
164174056|NCT01752634|593001641|FG000|Week 24 to Week 260|Physician Decision|1|||
164174057|NCT01752634|593001642|FG001|Week 24 to Week 260|Physician Decision|2|||
164174058|NCT01752634|593001643|FG002|Week 24 to Week 260|Physician Decision|4|||
164174059|NCT01752634|593001644|FG003|Week 24 to Week 260|Physician Decision|2|||
164174060|NCT01752634|593001645|FG004|Week 24 to Week 260|Physician Decision|1|||
164174061|NCT01752634|593001646|FG005|Week 24 to Week 260|Physician Decision|0|||
164174062|NCT01752634|593001641|FG000|Week 24 to Week 260|Death|0|||
164174063|NCT01752634|593001642|FG001|Week 24 to Week 260|Death|1|||
164174064|NCT01752634|593001643|FG002|Week 24 to Week 260|Death|0|||
164174065|NCT01752634|593001644|FG003|Week 24 to Week 260|Death|0|||
164174066|NCT01752634|593001645|FG004|Week 24 to Week 260|Death|0|||
164174067|NCT01752634|593001646|FG005|Week 24 to Week 260|Death|0|||
164174068|NCT01752634|593001641|FG000|Week 24 to Week 260|Pregnancy|0|||
164174069|NCT01752634|593001642|FG001|Week 24 to Week 260|Pregnancy|0|||
164174070|NCT01752634|593001643|FG002|Week 24 to Week 260|Pregnancy|1|||
164174071|NCT01752634|593001644|FG003|Week 24 to Week 260|Pregnancy|0|||
164174072|NCT01752634|593001645|FG004|Week 24 to Week 260|Pregnancy|0|||
164174073|NCT01752634|593001646|FG005|Week 24 to Week 260|Pregnancy|0|||
164174074|NCT01752634|593001641|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174075|NCT01752634|593001642|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174076|NCT01752634|593001643|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
164174077|NCT01752634|593001644|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174078|NCT01752634|593001645|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174079|NCT01752634|593001646|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
164174080|NCT01752634|593001641|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
164174081|NCT01752634|593001642|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
164174082|NCT01752634|593001643|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
164174083|NCT01752634|593001644|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
164174084|NCT01752634|593001645|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
164174085|NCT01752634|593001646|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
164174086|NCT01752634|593001641|FG000|Week 24 to Week 260|Adverse Event|4|||
164174087|NCT01752634|593001642|FG001|Week 24 to Week 260|Adverse Event|8|||
164174088|NCT01752634|593001643|FG002|Week 24 to Week 260|Adverse Event|8|||
164174089|NCT01752634|593001644|FG003|Week 24 to Week 260|Adverse Event|4|||
164174090|NCT01752634|593001645|FG004|Week 24 to Week 260|Adverse Event|2|||
164174091|NCT01752634|593001646|FG005|Week 24 to Week 260|Adverse Event|0|||
164174092|NCT04697056|593001655|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
164174093|NCT04697056|593001656|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
164174094|NCT04542499|593001657|FG000|Overall Study|Adverse Event|23|||
164174095|NCT04542499|593001658|FG001|Overall Study|Adverse Event|43|||
164174096|NCT04542499|593001657|FG000|Overall Study|Lack of Efficacy|5|||
164174097|NCT04542499|593001658|FG001|Overall Study|Lack of Efficacy|2|||
164174098|NCT04542499|593001657|FG000|Overall Study|Lost to Follow-up|3|||
164174099|NCT04542499|593001658|FG001|Overall Study|Lost to Follow-up|4|||
164174100|NCT04542499|593001657|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
164174101|NCT04542499|593001658|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
164174102|NCT04542499|593001657|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
164174103|NCT04542499|593001658|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
164174104|NCT04542499|593001657|FG000|Overall Study|Non-Compliance with Study Drug|0|||
164174105|NCT04542499|593001658|FG001|Overall Study|Non-Compliance with Study Drug|2|||
164174106|NCT04542499|593001657|FG000|Overall Study|Physician Decision|0|||
164174107|NCT04542499|593001658|FG001|Overall Study|Physician Decision|1|||
164174108|NCT04542499|593001657|FG000|Overall Study|Site Terminated by Sponsor|3|||
164174109|NCT04542499|593001658|FG001|Overall Study|Site Terminated by Sponsor|5|||
164174110|NCT04542499|593001657|FG000|Overall Study|Withdrawal by Subject|12|||
164174111|NCT04542499|593001658|FG001|Overall Study|Withdrawal by Subject|33|||
164174112|NCT04542499|593001657|FG000|Overall Study|Other|2|||
164174113|NCT04542499|593001658|FG001|Overall Study|Other|2|||
164174114|NCT05906836|593001662|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
164174115|NCT05906836|593001662|FG000|Overall Study|Lost to Follow-up|1|||
164174116|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174117|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174118|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174119|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
164174120|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174121|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174122|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174123|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174124|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174125|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174126|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174127|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174128|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174129|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174130|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
164174131|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
164174132|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174133|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
164174134|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174135|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
164174136|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
164174137|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174138|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
164174139|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
164174140|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
164174141|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
164174142|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174143|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174144|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
164174145|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174146|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174147|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174148|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174149|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174150|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
164174151|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
164174152|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174153|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
164174154|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
164174155|NCT04035434|593001665|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174156|NCT04035434|593001666|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174157|NCT04035434|593001667|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174158|NCT04035434|593001668|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
164174159|NCT04035434|593001669|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174160|NCT04035434|593001670|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174161|NCT04035434|593001671|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174162|NCT04035434|593001672|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174163|NCT04035434|593001673|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174164|NCT04035434|593001674|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174165|NCT04035434|593001675|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174166|NCT04035434|593001676|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174167|NCT04035434|593001677|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
164174168|NCT04035434|593001665|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174169|NCT04035434|593001666|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174170|NCT04035434|593001667|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174171|NCT04035434|593001668|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174172|NCT04035434|593001669|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174173|NCT04035434|593001670|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
164174174|NCT04035434|593001671|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
164174175|NCT04035434|593001672|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174176|NCT04035434|593001673|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174177|NCT04035434|593001674|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174178|NCT04035434|593001675|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174179|NCT04035434|593001676|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174180|NCT04035434|593001677|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
164174181|NCT04035434|593001665|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174182|NCT04035434|593001666|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174183|NCT04035434|593001667|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174184|NCT04035434|593001668|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174185|NCT04035434|593001669|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174186|NCT04035434|593001670|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174187|NCT04035434|593001671|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
164174188|NCT04035434|593001672|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174189|NCT04035434|593001673|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174190|NCT04035434|593001674|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174191|NCT04035434|593001675|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174192|NCT04035434|593001676|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174193|NCT04035434|593001677|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
164174194|NCT04035434|593001665|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174195|NCT04035434|593001666|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174196|NCT04035434|593001667|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174197|NCT04035434|593001668|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174198|NCT04035434|593001669|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174199|NCT04035434|593001670|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
164174200|NCT04035434|593001671|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
164174201|NCT04035434|593001672|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174202|NCT04035434|593001673|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174203|NCT04035434|593001674|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174204|NCT04035434|593001675|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174205|NCT04035434|593001676|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174206|NCT04035434|593001677|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
164174207|NCT04488497|593001678|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
164174208|NCT04488497|593001679|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
164174209|NCT04488497|593001678|FG000|Intervention|Physician Decision|2|||
164174210|NCT04488497|593001679|FG001|Intervention|Physician Decision|1|||
164174211|NCT04488497|593001678|FG000|Intervention|Withdrawal by Subject|5|||
164174212|NCT04488497|593001679|FG001|Intervention|Withdrawal by Subject|6|||
164174213|NCT04488497|593001678|FG000|Intervention|Lost to Follow-up|2|||
164174214|NCT04488497|593001679|FG001|Intervention|Lost to Follow-up|0|||
164174215|NCT04488497|593001678|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
164174216|NCT04488497|593001679|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
164174217|NCT04488497|593001678|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
164174218|NCT04488497|593001679|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
164174219|NCT04322539|593001680|FG000|Overall Study|Adverse Event|2|||
164174220|NCT04322539|593001681|FG001|Overall Study|Adverse Event|0|||
164174221|NCT04322539|593001680|FG000|Overall Study|Death|411|||
164174222|NCT04322539|593001681|FG001|Overall Study|Death|203|||
164174223|NCT04322539|593001680|FG000|Overall Study|Lost to Follow-up|3|||
164174224|NCT04322539|593001681|FG001|Overall Study|Lost to Follow-up|1|||
164174225|NCT04322539|593001680|FG000|Overall Study|Withdrawal of consent|14|||
164174226|NCT04322539|593001681|FG001|Overall Study|Withdrawal of consent|8|||
164174227|NCT04322539|593001680|FG000|Overall Study|Radiological Disease Progression|6|||
164174228|NCT04322539|593001681|FG001|Overall Study|Radiological Disease Progression|0|||
164174229|NCT04322539|593001680|FG000|Overall Study|Sponsor Decision|19|||
164174230|NCT04322539|593001681|FG001|Overall Study|Sponsor Decision|14|||
164174231|NCT04322539|593001680|FG000|Overall Study|Other|6|||
164174232|NCT04322539|593001681|FG001|Overall Study|Other|4|||
164174233|NCT04161079|593001684|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
164174234|NCT01702532|593001685|FG000|Overall Study|Adverse Event|0|||
164174235|NCT01702532|593001686|FG001|Overall Study|Adverse Event|1|||
164174236|NCT03617861|593001687|FG000|Second Intervention (1 Day)|Adverse Event|0|||
164174237|NCT03617861|593001688|FG001|Second Intervention (1 Day)|Adverse Event|0|||
164174238|NCT03617861|593001689|FG002|Second Intervention (1 Day)|Adverse Event|1|||
164174239|NCT03617861|593001690|FG003|Second Intervention (1 Day)|Adverse Event|0|||
164174240|NCT01451164|593001691|FG000|Overall Study|Adverse Event|19|||
164174241|NCT01451164|593001692|FG001|Overall Study|Adverse Event|12|||
164174242|NCT01451164|593001693|FG002|Overall Study|Adverse Event|18|||
164174243|NCT01451164|593001694|FG003|Overall Study|Adverse Event|21|||
164174244|NCT01451164|593001691|FG000|Overall Study|Withdrawal Criteria|1|||
164174245|NCT01451164|593001692|FG001|Overall Study|Withdrawal Criteria|1|||
164174246|NCT01451164|593001693|FG002|Overall Study|Withdrawal Criteria|1|||
164174247|NCT01451164|593001694|FG003|Overall Study|Withdrawal Criteria|1|||
164174248|NCT01451164|593001691|FG000|Overall Study|Physician Decision|2|||
164174249|NCT01451164|593001692|FG001|Overall Study|Physician Decision|0|||
164174250|NCT01451164|593001693|FG002|Overall Study|Physician Decision|1|||
164174251|NCT01451164|593001694|FG003|Overall Study|Physician Decision|0|||
164174252|NCT01451164|593001691|FG000|Overall Study|Withdrawal by Subject|14|||
164174253|NCT01451164|593001692|FG001|Overall Study|Withdrawal by Subject|11|||
164174254|NCT01451164|593001693|FG002|Overall Study|Withdrawal by Subject|16|||
164174255|NCT01451164|593001694|FG003|Overall Study|Withdrawal by Subject|17|||
164174256|NCT01451164|593001691|FG000|Overall Study|Protocol Violation|0|||
164174257|NCT01451164|593001692|FG001|Overall Study|Protocol Violation|1|||
164174258|NCT01451164|593001693|FG002|Overall Study|Protocol Violation|0|||
164174259|NCT01451164|593001694|FG003|Overall Study|Protocol Violation|0|||
164174260|NCT01451164|593001691|FG000|Overall Study|Lack of Efficacy|7|||
164174261|NCT01451164|593001692|FG001|Overall Study|Lack of Efficacy|9|||
164174262|NCT01451164|593001693|FG002|Overall Study|Lack of Efficacy|9|||
164174263|NCT01451164|593001694|FG003|Overall Study|Lack of Efficacy|7|||
164174264|NCT00308750|593001697|FG000|Overall Study|Adverse Event|9|||
164174265|NCT00308750|593001698|FG001|Overall Study|Adverse Event|9|||
164174266|NCT00308750|593001699|FG002|Overall Study|Adverse Event|13|||
164174267|NCT00308750|593001697|FG000|Overall Study|Withdrawal by Subject|6|||
164174268|NCT00308750|593001698|FG001|Overall Study|Withdrawal by Subject|2|||
164174269|NCT00308750|593001699|FG002|Overall Study|Withdrawal by Subject|3|||
164174270|NCT00308750|593001697|FG000|Overall Study|Physician Decision|3|||
164174271|NCT00308750|593001698|FG001|Overall Study|Physician Decision|4|||
164174272|NCT00308750|593001699|FG002|Overall Study|Physician Decision|3|||
164174273|NCT00308750|593001697|FG000|Overall Study|Sponsor Decision|1|||
164174274|NCT00308750|593001698|FG001|Overall Study|Sponsor Decision|0|||
164174275|NCT00308750|593001699|FG002|Overall Study|Sponsor Decision|0|||
164174276|NCT00308750|593001697|FG000|Overall Study|Disease Progression|47|||
164174277|NCT00308750|593001698|FG001|Overall Study|Disease Progression|24|||
164174278|NCT00308750|593001699|FG002|Overall Study|Disease Progression|28|||
164174279|NCT00308750|593001697|FG000|Overall Study|Unrelated Complication|3|||
164174280|NCT00308750|593001698|FG001|Overall Study|Unrelated Complication|0|||
164174281|NCT00308750|593001699|FG002|Overall Study|Unrelated Complication|1|||
164174282|NCT00308750|593001697|FG000|Overall Study|Death|1|||
164174283|NCT00308750|593001698|FG001|Overall Study|Death|0|||
164174284|NCT00308750|593001699|FG002|Overall Study|Death|1|||
164174285|NCT00308750|593001697|FG000|Overall Study|Protocol Violation|1|||
164174286|NCT00308750|593001698|FG001|Overall Study|Protocol Violation|0|||
164174287|NCT00308750|593001699|FG002|Overall Study|Protocol Violation|0|||
164174288|NCT00308750|593001697|FG000|Overall Study|New Primary Disease Identified|1|||
164174289|NCT00308750|593001698|FG001|Overall Study|New Primary Disease Identified|1|||
164174290|NCT00308750|593001699|FG002|Overall Study|New Primary Disease Identified|0|||
164174291|NCT01358578|593001700|FG000|Induction Period|Adverse Event|2|||
164174292|NCT01358578|593001701|FG001|Induction Period|Adverse Event|4|||
164174293|NCT01358578|593001702|FG002|Induction Period|Adverse Event|2|||
164174294|NCT01358578|593001703|FG003|Induction Period|Adverse Event|6|||
164174295|NCT01358578|593001704|FG004|Induction Period|Adverse Event|0|||
164174296|NCT01358578|593001705|FG005|Induction Period|Adverse Event|0|||
164174297|NCT01358578|593001700|FG000|Induction Period|Lack of Efficacy|0|||
164174298|NCT01358578|593001701|FG001|Induction Period|Lack of Efficacy|0|||
164174299|NCT01358578|593001702|FG002|Induction Period|Lack of Efficacy|9|||
164174300|NCT01358578|593001703|FG003|Induction Period|Lack of Efficacy|1|||
164174301|NCT01358578|593001704|FG004|Induction Period|Lack of Efficacy|0|||
164174302|NCT01358578|593001705|FG005|Induction Period|Lack of Efficacy|0|||
164174303|NCT01358578|593001700|FG000|Induction Period|Lost to Follow-up|0|||
164174304|NCT01358578|593001701|FG001|Induction Period|Lost to Follow-up|0|||
164174305|NCT01358578|593001702|FG002|Induction Period|Lost to Follow-up|1|||
164174306|NCT01358578|593001703|FG003|Induction Period|Lost to Follow-up|4|||
164174307|NCT01358578|593001704|FG004|Induction Period|Lost to Follow-up|0|||
164174308|NCT01358578|593001705|FG005|Induction Period|Lost to Follow-up|0|||
164174309|NCT01358578|593001700|FG000|Induction Period|Physician Decision|2|||
164174310|NCT01358578|593001701|FG001|Induction Period|Physician Decision|1|||
164174311|NCT01358578|593001702|FG002|Induction Period|Physician Decision|2|||
164174312|NCT01358578|593001703|FG003|Induction Period|Physician Decision|0|||
164174313|NCT01358578|593001704|FG004|Induction Period|Physician Decision|0|||
164174314|NCT01358578|593001705|FG005|Induction Period|Physician Decision|0|||
164174315|NCT01358578|593001700|FG000|Induction Period|Protocol Deviation|3|||
164174316|NCT01358578|593001701|FG001|Induction Period|Protocol Deviation|5|||
164174317|NCT01358578|593001702|FG002|Induction Period|Protocol Deviation|0|||
164174318|NCT01358578|593001703|FG003|Induction Period|Protocol Deviation|3|||
164174319|NCT01358578|593001704|FG004|Induction Period|Protocol Deviation|0|||
164174320|NCT01358578|593001705|FG005|Induction Period|Protocol Deviation|0|||
164174321|NCT01358578|593001700|FG000|Induction Period|technical problems|0|||
164174322|NCT01358578|593001701|FG001|Induction Period|technical problems|0|||
164174323|NCT01358578|593001702|FG002|Induction Period|technical problems|1|||
164174324|NCT01358578|593001703|FG003|Induction Period|technical problems|1|||
164174325|NCT01358578|593001704|FG004|Induction Period|technical problems|0|||
164174326|NCT01358578|593001705|FG005|Induction Period|technical problems|0|||
164174327|NCT01358578|593001700|FG000|Induction Period|Withdrawal by Subject|5|||
164174328|NCT01358578|593001701|FG001|Induction Period|Withdrawal by Subject|5|||
164174329|NCT01358578|593001702|FG002|Induction Period|Withdrawal by Subject|10|||
164174330|NCT01358578|593001703|FG003|Induction Period|Withdrawal by Subject|6|||
164174331|NCT01358578|593001704|FG004|Induction Period|Withdrawal by Subject|0|||
164174332|NCT01358578|593001705|FG005|Induction Period|Withdrawal by Subject|0|||
164174333|NCT01358578|593001700|FG000|Maintenance Period|Adverse Event|2|||
164174334|NCT01358578|593001701|FG001|Maintenance Period|Adverse Event|7|||
164174335|NCT01358578|593001702|FG002|Maintenance Period|Adverse Event|0|||
164174336|NCT01358578|593001703|FG003|Maintenance Period|Adverse Event|6|||
164174337|NCT01358578|593001704|FG004|Maintenance Period|Adverse Event|4|||
164174338|NCT01358578|593001705|FG005|Maintenance Period|Adverse Event|3|||
164174339|NCT01358578|593001700|FG000|Maintenance Period|Lack of Efficacy|10|||
164174340|NCT01358578|593001701|FG001|Maintenance Period|Lack of Efficacy|2|||
164174341|NCT01358578|593001702|FG002|Maintenance Period|Lack of Efficacy|0|||
164174342|NCT01358578|593001703|FG003|Maintenance Period|Lack of Efficacy|11|||
164174343|NCT01358578|593001704|FG004|Maintenance Period|Lack of Efficacy|3|||
164174344|NCT01358578|593001705|FG005|Maintenance Period|Lack of Efficacy|0|||
164174345|NCT01358578|593001700|FG000|Maintenance Period|Lost to Follow-up|4|||
164174346|NCT01358578|593001701|FG001|Maintenance Period|Lost to Follow-up|0|||
164174347|NCT01358578|593001702|FG002|Maintenance Period|Lost to Follow-up|0|||
164174348|NCT01358578|593001703|FG003|Maintenance Period|Lost to Follow-up|5|||
164174349|NCT01358578|593001704|FG004|Maintenance Period|Lost to Follow-up|1|||
164174350|NCT01358578|593001705|FG005|Maintenance Period|Lost to Follow-up|1|||
164174351|NCT01358578|593001700|FG000|Maintenance Period|Non-compliance with study treatment|3|||
164174352|NCT01358578|593001701|FG001|Maintenance Period|Non-compliance with study treatment|1|||
164174353|NCT01358578|593001702|FG002|Maintenance Period|Non-compliance with study treatment|0|||
164174354|NCT01358578|593001703|FG003|Maintenance Period|Non-compliance with study treatment|2|||
164174355|NCT01358578|593001704|FG004|Maintenance Period|Non-compliance with study treatment|1|||
164174356|NCT01358578|593001705|FG005|Maintenance Period|Non-compliance with study treatment|2|||
164174357|NCT01358578|593001700|FG000|Maintenance Period|Physician Decision|0|||
164174358|NCT01358578|593001701|FG001|Maintenance Period|Physician Decision|1|||
164174359|NCT01358578|593001702|FG002|Maintenance Period|Physician Decision|0|||
164174360|NCT01358578|593001703|FG003|Maintenance Period|Physician Decision|1|||
164174361|NCT01358578|593001704|FG004|Maintenance Period|Physician Decision|0|||
164174362|NCT01358578|593001705|FG005|Maintenance Period|Physician Decision|0|||
164174363|NCT01358578|593001700|FG000|Maintenance Period|Pregnancy|1|||
164174364|NCT01358578|593001701|FG001|Maintenance Period|Pregnancy|0|||
164174365|NCT01358578|593001702|FG002|Maintenance Period|Pregnancy|0|||
164174366|NCT01358578|593001703|FG003|Maintenance Period|Pregnancy|0|||
164174367|NCT01358578|593001704|FG004|Maintenance Period|Pregnancy|0|||
164174368|NCT01358578|593001705|FG005|Maintenance Period|Pregnancy|0|||
164174369|NCT01358578|593001700|FG000|Maintenance Period|Protocol deviation|7|||
164174370|NCT01358578|593001701|FG001|Maintenance Period|Protocol deviation|4|||
164174371|NCT01358578|593001702|FG002|Maintenance Period|Protocol deviation|0|||
164174372|NCT01358578|593001703|FG003|Maintenance Period|Protocol deviation|2|||
164174373|NCT01358578|593001704|FG004|Maintenance Period|Protocol deviation|2|||
164174374|NCT01358578|593001705|FG005|Maintenance Period|Protocol deviation|2|||
164174375|NCT01358578|593001700|FG000|Maintenance Period|Withdrawal by Subject|12|||
164174376|NCT01358578|593001701|FG001|Maintenance Period|Withdrawal by Subject|7|||
164174377|NCT01358578|593001702|FG002|Maintenance Period|Withdrawal by Subject|2|||
164174378|NCT01358578|593001703|FG003|Maintenance Period|Withdrawal by Subject|15|||
164174379|NCT01358578|593001704|FG004|Maintenance Period|Withdrawal by Subject|6|||
164174380|NCT01358578|593001705|FG005|Maintenance Period|Withdrawal by Subject|3|||
164174381|NCT01358578|593001700|FG000|Follow-up Period|Adverse Event|1|||
164174382|NCT01358578|593001701|FG001|Follow-up Period|Adverse Event|1|||
164174383|NCT01358578|593001702|FG002|Follow-up Period|Adverse Event|0|||
164174384|NCT01358578|593001703|FG003|Follow-up Period|Adverse Event|0|||
164174385|NCT01358578|593001704|FG004|Follow-up Period|Adverse Event|0|||
164174386|NCT01358578|593001705|FG005|Follow-up Period|Adverse Event|0|||
164174387|NCT01358578|593001700|FG000|Follow-up Period|Lack of Efficacy|3|||
164174388|NCT01358578|593001701|FG001|Follow-up Period|Lack of Efficacy|0|||
164174389|NCT01358578|593001702|FG002|Follow-up Period|Lack of Efficacy|4|||
164174390|NCT01358578|593001703|FG003|Follow-up Period|Lack of Efficacy|1|||
164174391|NCT01358578|593001704|FG004|Follow-up Period|Lack of Efficacy|0|||
164174392|NCT01358578|593001705|FG005|Follow-up Period|Lack of Efficacy|0|||
164174393|NCT01358578|593001700|FG000|Follow-up Period|Lost to Follow-up|0|||
164174394|NCT01358578|593001701|FG001|Follow-up Period|Lost to Follow-up|1|||
164174395|NCT01358578|593001702|FG002|Follow-up Period|Lost to Follow-up|0|||
164174396|NCT01358578|593001703|FG003|Follow-up Period|Lost to Follow-up|4|||
164174397|NCT01358578|593001704|FG004|Follow-up Period|Lost to Follow-up|0|||
164174398|NCT01358578|593001705|FG005|Follow-up Period|Lost to Follow-up|0|||
164174399|NCT01358578|593001700|FG000|Follow-up Period|non- compliance with study treatment|1|||
164174400|NCT01358578|593001701|FG001|Follow-up Period|non- compliance with study treatment|0|||
164174401|NCT01358578|593001702|FG002|Follow-up Period|non- compliance with study treatment|0|||
164174402|NCT01358578|593001703|FG003|Follow-up Period|non- compliance with study treatment|0|||
164174403|NCT01358578|593001704|FG004|Follow-up Period|non- compliance with study treatment|0|||
164174404|NCT01358578|593001705|FG005|Follow-up Period|non- compliance with study treatment|0|||
164174405|NCT01358578|593001700|FG000|Follow-up Period|Pregnancy|1|||
164174406|NCT01358578|593001701|FG001|Follow-up Period|Pregnancy|0|||
164174407|NCT01358578|593001702|FG002|Follow-up Period|Pregnancy|0|||
164174408|NCT01358578|593001703|FG003|Follow-up Period|Pregnancy|0|||
164174409|NCT01358578|593001704|FG004|Follow-up Period|Pregnancy|0|||
164174410|NCT01358578|593001705|FG005|Follow-up Period|Pregnancy|0|||
164174411|NCT01358578|593001700|FG000|Follow-up Period|Withdrawal by Subject|3|||
164174412|NCT01358578|593001701|FG001|Follow-up Period|Withdrawal by Subject|3|||
164174413|NCT01358578|593001702|FG002|Follow-up Period|Withdrawal by Subject|1|||
164174414|NCT01358578|593001703|FG003|Follow-up Period|Withdrawal by Subject|12|||
164174415|NCT01358578|593001704|FG004|Follow-up Period|Withdrawal by Subject|0|||
164174416|NCT01358578|593001705|FG005|Follow-up Period|Withdrawal by Subject|0|||
164174417|NCT01358578|593001700|FG000|Follow-up Period|Physician Decision|1|||
164174418|NCT01358578|593001701|FG001|Follow-up Period|Physician Decision|1|||
164174419|NCT01358578|593001702|FG002|Follow-up Period|Physician Decision|0|||
164174420|NCT01358578|593001703|FG003|Follow-up Period|Physician Decision|2|||
164174421|NCT01358578|593001704|FG004|Follow-up Period|Physician Decision|0|||
164174422|NCT01358578|593001705|FG005|Follow-up Period|Physician Decision|0|||
164174423|NCT01643798|593001706|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
164174424|NCT01643798|593001707|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
164174425|NCT03605849|593001708|FG000|Overall Study|Adverse Event|20|||
164174426|NCT03605849|593001709|FG001|Overall Study|Adverse Event|21|||
164174427|NCT03605849|593001710|FG002|Overall Study|Adverse Event|29|||
164174428|NCT03605849|593001711|FG003|Overall Study|Adverse Event|11|||
164174429|NCT03605849|593001708|FG000|Overall Study|Lack of Efficacy|4|||
164174430|NCT03605849|593001709|FG001|Overall Study|Lack of Efficacy|7|||
164174431|NCT03605849|593001710|FG002|Overall Study|Lack of Efficacy|9|||
164174432|NCT03605849|593001711|FG003|Overall Study|Lack of Efficacy|2|||
164174433|NCT03605849|593001708|FG000|Overall Study|Lost to Follow-up|8|||
164174434|NCT03605849|593001709|FG001|Overall Study|Lost to Follow-up|8|||
164174435|NCT03605849|593001710|FG002|Overall Study|Lost to Follow-up|14|||
164174436|NCT03605849|593001711|FG003|Overall Study|Lost to Follow-up|11|||
164174437|NCT03605849|593001708|FG000|Overall Study|Non-compliance With IMP|6|||
164174438|NCT03605849|593001709|FG001|Overall Study|Non-compliance With IMP|5|||
164174439|NCT03605849|593001710|FG002|Overall Study|Non-compliance With IMP|2|||
164174440|NCT03605849|593001711|FG003|Overall Study|Non-compliance With IMP|1|||
164174441|NCT03605849|593001708|FG000|Overall Study|Protocol Deviation|1|||
164174442|NCT03605849|593001709|FG001|Overall Study|Protocol Deviation|2|||
164174443|NCT03605849|593001710|FG002|Overall Study|Protocol Deviation|1|||
164174444|NCT03605849|593001711|FG003|Overall Study|Protocol Deviation|3|||
164174445|NCT03605849|593001708|FG000|Overall Study|Withdrawal by Subject|33|||
164174446|NCT03605849|593001709|FG001|Overall Study|Withdrawal by Subject|28|||
164174447|NCT03605849|593001710|FG002|Overall Study|Withdrawal by Subject|30|||
164174448|NCT03605849|593001711|FG003|Overall Study|Withdrawal by Subject|28|||
164174449|NCT03605849|593001708|FG000|Overall Study|Site Terminated by Sponsor|0|||
164174450|NCT03605849|593001709|FG001|Overall Study|Site Terminated by Sponsor|0|||
164174451|NCT03605849|593001710|FG002|Overall Study|Site Terminated by Sponsor|0|||
164174452|NCT03605849|593001711|FG003|Overall Study|Site Terminated by Sponsor|1|||
164174453|NCT03605849|593001708|FG000|Overall Study|Physician Decision|2|||
164174454|NCT03605849|593001709|FG001|Overall Study|Physician Decision|1|||
164174455|NCT03605849|593001710|FG002|Overall Study|Physician Decision|2|||
164174456|NCT03605849|593001711|FG003|Overall Study|Physician Decision|1|||
164174457|NCT03605849|593001708|FG000|Overall Study|Enrolled, but not Treated|2|||
164174458|NCT03605849|593001709|FG001|Overall Study|Enrolled, but not Treated|2|||
164174459|NCT03605849|593001710|FG002|Overall Study|Enrolled, but not Treated|3|||
164174460|NCT03605849|593001711|FG003|Overall Study|Enrolled, but not Treated|2|||
164174461|NCT03605849|593001708|FG000|Overall Study|Other (COVID-19 Related)|0|||
164174462|NCT03605849|593001709|FG001|Overall Study|Other (COVID-19 Related)|1|||
164174463|NCT03605849|593001710|FG002|Overall Study|Other (COVID-19 Related)|1|||
164174464|NCT03605849|593001711|FG003|Overall Study|Other (COVID-19 Related)|0|||
164174465|NCT03605849|593001708|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
164174466|NCT03605849|593001709|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
164174467|NCT03605849|593001710|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
164174468|NCT03605849|593001711|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
164174469|NCT02659514|593001712|FG000|Overall Study|Adverse Event|3|||
164174470|NCT02659514|593001713|FG001|Overall Study|Adverse Event|12|||
164174471|NCT02659514|593001712|FG000|Overall Study|Disease Progression|23|||
164174472|NCT02659514|593001713|FG001|Overall Study|Disease Progression|13|||
164174473|NCT02659514|593001712|FG000|Overall Study|Withdrawal by Subject|0|||
164174474|NCT02659514|593001713|FG001|Overall Study|Withdrawal by Subject|4|||
164174475|NCT02659514|593001712|FG000|Overall Study|Lost to Follow-up|0|||
164174476|NCT02659514|593001713|FG001|Overall Study|Lost to Follow-up|1|||
164174477|NCT02659514|593001712|FG000|Overall Study|Death|6|||
164174478|NCT02659514|593001713|FG001|Overall Study|Death|1|||
164174479|NCT02659514|593001712|FG000|Overall Study|Reason Unspecified|0|||
164174480|NCT02659514|593001713|FG001|Overall Study|Reason Unspecified|3|||
164174481|NCT03409107|593001714|FG000|Overall Study|Withdrawal by Subject|4|||
164174482|NCT03409107|593001715|FG001|Overall Study|Withdrawal by Subject|2|||
164174483|NCT03409107|593001714|FG000|Overall Study|Physician Decision|1|||
164174484|NCT03409107|593001715|FG001|Overall Study|Physician Decision|0|||
164174485|NCT03409107|593001714|FG000|Overall Study|Lost to Follow-up|7|||
164174486|NCT03409107|593001715|FG001|Overall Study|Lost to Follow-up|2|||
164174487|NCT03409107|593001714|FG000|Overall Study|Adverse Event|5|||
164174488|NCT03409107|593001715|FG001|Overall Study|Adverse Event|3|||
164174489|NCT02062944|593001722|FG000|Overall Study|Lost to Follow-up|1|||
164174490|NCT02062944|593001722|FG000|Overall Study|New hemotological disorder identified|1|||
164174491|NCT02062944|593001722|FG000|Overall Study|Uncontrolled Hypertension|1|||
164174492|NCT02062944|593001722|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
164174493|NCT01482962|593001723|FG000|Overall Study|Progressive Disease|65|||
164174494|NCT01482962|593001724|FG001|Overall Study|Progressive Disease|53|||
164174495|NCT01482962|593001723|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
164174496|NCT01482962|593001724|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
164174497|NCT01482962|593001723|FG000|Overall Study|Adverse Event|18|||
164174498|NCT01482962|593001724|FG001|Overall Study|Adverse Event|22|||
164174499|NCT01482962|593001723|FG000|Overall Study|Withdrawal by Participant|8|||
164174500|NCT01482962|593001724|FG001|Overall Study|Withdrawal by Participant|13|||
164174501|NCT01482962|593001723|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
164174502|NCT01482962|593001724|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
164174503|NCT01482962|593001723|FG000|Overall Study|Other Reason|1|||
164174504|NCT01482962|593001724|FG001|Overall Study|Other Reason|5|||
164174505|NCT01482962|593001723|FG000|Overall Study|Study Terminated by Sponsor|5|||
164174506|NCT01482962|593001724|FG001|Overall Study|Study Terminated by Sponsor|2|||
164174507|NCT01482962|593001723|FG000|Overall Study|Did not Receive Study Drug|1|||
164174508|NCT01482962|593001724|FG001|Overall Study|Did not Receive Study Drug|6|||
164174509|NCT00278148|593001725|FG000|Phase II - Expansion Phase|Disease progression|0|||
164174510|NCT00278148|593001726|FG001|Phase II - Expansion Phase|Disease progression|0|||
164174511|NCT00278148|593001727|FG002|Phase II - Expansion Phase|Disease progression|4|||
164174512|NCT00278148|593001725|FG000|Phase II - Expansion Phase|Adverse Event|0|||
164174513|NCT00278148|593001726|FG001|Phase II - Expansion Phase|Adverse Event|0|||
164174514|NCT00278148|593001727|FG002|Phase II - Expansion Phase|Adverse Event|2|||
164174515|NCT02407457|593001728|FG000|1 Month|Death|3|||
164174516|NCT02407457|593001729|FG001|1 Month|Death|0|||
164174517|NCT02407457|593001728|FG000|1 Month|Lost to Follow-up|1|||
164174518|NCT02407457|593001729|FG001|1 Month|Lost to Follow-up|1|||
164174519|NCT02407457|593001728|FG000|1 Month|missed visit|2|||
164174520|NCT02407457|593001729|FG001|1 Month|missed visit|5|||
164174521|NCT02407457|593001728|FG000|6-Month|Death|2|||
164174522|NCT02407457|593001729|FG001|6-Month|Death|8|||
164174523|NCT02407457|593001728|FG000|6-Month|Lost to Follow-up|2|||
164174524|NCT02407457|593001729|FG001|6-Month|Lost to Follow-up|2|||
164174525|NCT02407457|593001728|FG000|6-Month|missed visit|16|||
164174526|NCT02407457|593001729|FG001|6-Month|missed visit|14|||
164174527|NCT02407457|593001728|FG000|6-Month|Open Repair|0|||
164174528|NCT02407457|593001729|FG001|6-Month|Open Repair|1|||
164174529|NCT02407457|593001728|FG000|1 Year|Death|6|||
164174530|NCT02407457|593001729|FG001|1 Year|Death|11|||
164174531|NCT02407457|593001728|FG000|1 Year|Lost to Follow-up|3|||
164174532|NCT02407457|593001729|FG001|1 Year|Lost to Follow-up|2|||
164174533|NCT02407457|593001728|FG000|1 Year|Missed Visit|24|||
164174534|NCT02407457|593001729|FG001|1 Year|Missed Visit|14|||
164174535|NCT02407457|593001728|FG000|1 Year|Open Repair|0|||
164174536|NCT02407457|593001729|FG001|1 Year|Open Repair|1|||
164174537|NCT02407457|593001728|FG000|2-year|Death|14|||
164174538|NCT02407457|593001729|FG001|2-year|Death|8|||
164174539|NCT02407457|593001728|FG000|2-year|Lost to Follow-up|7|||
164174540|NCT02407457|593001729|FG001|2-year|Lost to Follow-up|10|||
164174541|NCT02407457|593001728|FG000|2-year|Missed Visit|13|||
164174542|NCT02407457|593001729|FG001|2-year|Missed Visit|15|||
164174543|NCT02407457|593001728|FG000|2-year|Open Repair|0|||
164174544|NCT02407457|593001729|FG001|2-year|Open Repair|2|||
164174545|NCT02407457|593001728|FG000|3-year|Death|11|||
164174546|NCT02407457|593001729|FG001|3-year|Death|10|||
164174547|NCT02407457|593001728|FG000|3-year|Lost to Follow-up|9|||
164174548|NCT02407457|593001729|FG001|3-year|Lost to Follow-up|10|||
164174549|NCT02407457|593001728|FG000|3-year|Missed Visit|19|||
164174550|NCT02407457|593001729|FG001|3-year|Missed Visit|16|||
164174551|NCT02407457|593001728|FG000|4-year|Death|18|||
164174552|NCT02407457|593001729|FG001|4-year|Death|10|||
164174553|NCT02407457|593001728|FG000|4-year|Lost to Follow-up|10|||
164174554|NCT02407457|593001729|FG001|4-year|Lost to Follow-up|12|||
164174555|NCT02407457|593001728|FG000|4-year|Missed Visit|18|||
164174556|NCT02407457|593001729|FG001|4-year|Missed Visit|16|||
164174557|NCT02407457|593001728|FG000|5-year|Death|10|||
164174558|NCT02407457|593001729|FG001|5-year|Death|3|||
164174559|NCT02407457|593001728|FG000|5-year|Lost to Follow-up|22|||
164174560|NCT02407457|593001729|FG001|5-year|Lost to Follow-up|13|||
164174561|NCT02407457|593001728|FG000|5-year|Missed Visit|9|||
164174562|NCT02407457|593001729|FG001|5-year|Missed Visit|1|||
164174563|NCT01088243|593001731|FG000|Overall Study|Adverse Event|1|||
164174564|NCT01088243|593001732|FG001|Overall Study|Adverse Event|0|||
164174565|NCT05007041|593001752|FG000|Overall Study|Missing Diary Entries|0|||
164174566|NCT05007041|593001753|FG001|Overall Study|Missing Diary Entries|1|||
164174567|NCT04495816|593001754|FG000|Overall Study|Lost to Follow-up|10|||
164174568|NCT04495816|593001755|FG001|Overall Study|Lost to Follow-up|4|||
164174569|NCT04495816|593001754|FG000|Overall Study|Withdrawal by Subject|3|||
164174570|NCT04495816|593001755|FG001|Overall Study|Withdrawal by Subject|5|||
164174571|NCT01459718|593001757|FG000|Overall Study|Physician Decision|1|||
164174572|NCT01459718|593001757|FG000|Overall Study|Lost to Follow-up|1|||
164174573|NCT01459718|593001757|FG000|Overall Study|Adverse Event|1|||
164174574|NCT01258075|593001758|FG000|Overall Study|Adverse Event|8|||
164174575|NCT01258075|593001759|FG001|Overall Study|Adverse Event|3|||
164174576|NCT01258075|593001758|FG000|Overall Study|Lost to Follow-up|11|||
164174577|NCT01258075|593001759|FG001|Overall Study|Lost to Follow-up|6|||
164174578|NCT01258075|593001758|FG000|Overall Study|Withdrawal by Subject|10|||
164174579|NCT01258075|593001759|FG001|Overall Study|Withdrawal by Subject|7|||
164174580|NCT01258075|593001758|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
164174581|NCT01258075|593001759|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
164174582|NCT01258075|593001758|FG000|Overall Study|Other|12|||
164174583|NCT01258075|593001759|FG001|Overall Study|Other|5|||
164174584|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
164174585|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
164174586|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
164174587|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
164174588|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
164174589|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
164174590|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
164174591|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
164174592|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
164174593|NCT02951533|593001769|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
164174594|NCT02951533|593001770|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
164174595|NCT02951533|593001771|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
164174596|NCT02951533|593001769|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
164174597|NCT02951533|593001770|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
164174598|NCT02951533|593001771|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
164174599|NCT02951533|593001769|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
164174600|NCT02951533|593001770|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
164174601|NCT02951533|593001771|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
164174602|NCT02951533|593001769|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
164174603|NCT02951533|593001770|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
164174604|NCT02951533|593001771|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
164174605|NCT02951533|593001769|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
164174606|NCT02951533|593001770|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
164174607|NCT02951533|593001771|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
164174608|NCT02951533|593001769|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
164174609|NCT02951533|593001770|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
164174610|NCT02951533|593001771|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
164174611|NCT02951533|593001769|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
164174612|NCT02951533|593001770|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
164174613|NCT02951533|593001771|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
164174614|NCT02951533|593001769|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
164174615|NCT02951533|593001770|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
164174616|NCT02951533|593001771|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
164174617|NCT01597375|593001772|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
164174618|NCT01597375|593001773|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
164174619|NCT01597375|593001772|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
164174620|NCT01597375|593001773|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
164174621|NCT01597375|593001772|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
164174622|NCT01597375|593001773|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
164174623|NCT01597375|593001772|FG000|Washout (2 Weeks)|Adverse Event|1|||
164174624|NCT01597375|593001773|FG001|Washout (2 Weeks)|Adverse Event|0|||
164174625|NCT01597375|593001772|FG000|Second Intervention|Failed to react at both Aspirin|1|||
164174626|NCT01597375|593001773|FG001|Second Intervention|Failed to react at both Aspirin|1|||
164174627|NCT02375555|593001774|FG000|Induction Period|Adverse Event|7|||
164174628|NCT02375555|593001774|FG000|Induction Period|Withdrawal by Subject|2|||
164174629|NCT02375555|593001774|FG000|Induction Period|Other|1|||
164174630|NCT02375555|593001774|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
164174631|NCT02375555|593001774|FG000|Maintenance Period|Adverse Event|2|||
164174632|NCT02375555|593001774|FG000|Maintenance Period|Withdrawal by Subject|4|||
164174633|NCT02375555|593001774|FG000|Maintenance Period|Death|1|||
164174634|NCT02375555|593001774|FG000|Maintenance Period|Disease Progression|5|||
164174635|NCT02375555|593001774|FG000|Maintenance Period|Patient Non-compliance|1|||
164174636|NCT02375555|593001774|FG000|Maintenance Period|Still on maintenance|16|||
164174637|NCT01984892|593001780|FG000|Overall Study|Progressive disease|7|||
164174638|NCT04464720|593001781|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
164174639|NCT05723328|593001783|FG000|Overall Study|Investigator's Decision|5|||
164174640|NCT05723328|593001784|FG001|Overall Study|Investigator's Decision|2|||
164174641|NCT02000882|593003298|FG000|Overall Study|Adverse Event|3|||
164174642|NCT02000882|593003298|FG000|Overall Study|Physician Decision|2|||
164174643|NCT02000882|593003298|FG000|Overall Study|Withdrawal by Subject|1|||
164174644|NCT02417961|593003299|FG000|Overall Study|Adverse Event|1|||
164174645|NCT02417961|593003299|FG000|Overall Study|Lost to Follow-up|1|||
164174646|NCT02417961|593003299|FG000|Overall Study|Withdrawal by Subject|2|||
164174647|NCT01390428|593003300|FG000|Overall Study|Elective Surgery|0|||
164174648|NCT01390428|593003301|FG001|Overall Study|Elective Surgery|0|||
164174649|NCT01390428|593003302|FG002|Overall Study|Elective Surgery|0|||
164174650|NCT01390428|593003303|FG003|Overall Study|Elective Surgery|0|||
164174651|NCT01390428|593003304|FG004|Overall Study|Elective Surgery|1|||
164174652|NCT01390428|593003305|FG005|Overall Study|Elective Surgery|0|||
164174653|NCT01390428|593003300|FG000|Overall Study|Withdrawal by Subject|0|||
164174654|NCT01390428|593003301|FG001|Overall Study|Withdrawal by Subject|0|||
164174655|NCT01390428|593003302|FG002|Overall Study|Withdrawal by Subject|1|||
164174656|NCT01390428|593003303|FG003|Overall Study|Withdrawal by Subject|0|||
164174657|NCT01390428|593003304|FG004|Overall Study|Withdrawal by Subject|0|||
164174658|NCT01390428|593003305|FG005|Overall Study|Withdrawal by Subject|0|||
164174659|NCT05897827|593003306|FG000|Overall Study|Lost to Follow-up|33|||
164174660|NCT05897827|593003307|FG001|Overall Study|Lost to Follow-up|14|||
164174661|NCT05897827|593003306|FG000|Overall Study|Withdrawal by Subject|1|||
164174662|NCT05897827|593003307|FG001|Overall Study|Withdrawal by Subject|1|||
164174663|NCT03339726|593003308|FG000|Overall Study|Withdrawal by Subject|1|||
164174664|NCT03339726|593003309|FG001|Overall Study|Withdrawal by Subject|0|||
164174665|NCT03339726|593003310|FG002|Overall Study|Withdrawal by Subject|0|||
164174666|NCT03339726|593003308|FG000|Overall Study|Lost to Follow-up|0|||
164174667|NCT03339726|593003309|FG001|Overall Study|Lost to Follow-up|1|||
164174668|NCT03339726|593003310|FG002|Overall Study|Lost to Follow-up|0|||
164174669|NCT04599933|593003312|FG000|Overall Study|Adverse Event|4|||
164174670|NCT04599933|593003313|FG001|Overall Study|Adverse Event|1|||
164174671|NCT04599933|593003312|FG000|Overall Study|Withdrawal by Subject|4|||
164174672|NCT04599933|593003313|FG001|Overall Study|Withdrawal by Subject|2|||
164174673|NCT04599933|593003312|FG000|Overall Study|Lost to Follow-up|0|||
164174674|NCT04599933|593003313|FG001|Overall Study|Lost to Follow-up|1|||
164174675|NCT04599933|593003312|FG000|Overall Study|Physician Decision|0|||
164174676|NCT04599933|593003313|FG001|Overall Study|Physician Decision|1|||
164174677|NCT04599933|593003312|FG000|Overall Study|Screen Failure|1|||
164174678|NCT04599933|593003313|FG001|Overall Study|Screen Failure|2|||
164174679|NCT01911780|593003325|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
164174680|NCT01911780|593003326|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
164174681|NCT01911780|593003325|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
164174682|NCT01911780|593003326|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
164174683|NCT01911780|593003325|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
164174684|NCT01911780|593003326|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
164174685|NCT01911780|593003325|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
164174686|NCT01911780|593003326|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
164174687|NCT01911780|593003325|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
164174688|NCT01911780|593003326|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
164174689|NCT01911780|593003325|FG000|Extension Period (52 Weeks)|Personal reason|1|||
164174690|NCT01911780|593003326|FG001|Extension Period (52 Weeks)|Personal reason|1|||
164174691|NCT06303167|593003333|FG000|Overall Study|Ineligible|1|||
164174692|NCT06303167|593003333|FG000|Overall Study|Never start protocol therapy|2|||
164174693|NCT06303167|593003333|FG000|Overall Study|Disease progression|16|||
164174694|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Death|117|||
164174695|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Death|197|||
164174696|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
164174697|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
164174698|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
164174699|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
164174700|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
164174701|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
164174702|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
164174703|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
164174704|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
164174705|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
164174706|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
164174707|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
164174708|NCT02677896|593003334|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
164174709|NCT02677896|593003335|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
164174710|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
164174711|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
164174712|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
164174713|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
164174714|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
164174715|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
164174716|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
164174717|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
164174718|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
164174719|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
164174720|NCT02677896|593003334|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
164174721|NCT02677896|593003335|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
164174722|NCT00348790|593003341|FG000|Completed Treatment|Withdrawal by Subject|4|||
164174723|NCT00348790|593003341|FG000|Completed Treatment|Disease progression|14|||
164174724|NCT00348790|593003341|FG000|Completed Treatment|Adverse Event|4|||
164174725|NCT00348790|593003341|FG000|Completed Treatment|Required surgery|2|||
164174726|NCT00348790|593003341|FG000|Completed Treatment|Unable to travel to study site|1|||
164174727|NCT01185509|593003345|FG000|Overall Study|Progression/Relapse|9|||
164174728|NCT01185509|593003346|FG001|Overall Study|Progression/Relapse|15|||
164174729|NCT01185509|593003345|FG000|Overall Study|Physician Decision|2|||
164174730|NCT01185509|593003346|FG001|Overall Study|Physician Decision|2|||
164174731|NCT01185509|593003345|FG000|Overall Study|Withdrawal by Subject|0|||
164174732|NCT01185509|593003346|FG001|Overall Study|Withdrawal by Subject|1|||
164174733|NCT01185509|593003345|FG000|Overall Study|Death|0|||
164174734|NCT01185509|593003346|FG001|Overall Study|Death|1|||
164174735|NCT01185509|593003345|FG000|Overall Study|Intercurrent Illness|0|||
164174736|NCT01185509|593003346|FG001|Overall Study|Intercurrent Illness|1|||
164174737|NCT03687372|593003347|FG000|Overall Study|Lost to Follow-up|12|||
164174738|NCT03687372|593003348|FG001|Overall Study|Lost to Follow-up|21|||
164174739|NCT03687372|593003347|FG000|Overall Study|Withdrawal by Subject|4|||
164174740|NCT03687372|593003348|FG001|Overall Study|Withdrawal by Subject|17|||
164174741|NCT03687372|593003347|FG000|Overall Study|Investigator Decision|1|||
164174742|NCT03687372|593003348|FG001|Overall Study|Investigator Decision|1|||
164174743|NCT00655733|593003351|FG000|Overall Study|Lost to Follow-up|2|||
164174744|NCT00655733|593003352|FG001|Overall Study|Lost to Follow-up|2|||
164174745|NCT00655733|593003351|FG000|Overall Study|Adverse Event|2|||
164174746|NCT00655733|593003352|FG001|Overall Study|Adverse Event|2|||
164174747|NCT00655733|593003351|FG000|Overall Study|Withdrawal by Subject|3|||
164174748|NCT00655733|593003352|FG001|Overall Study|Withdrawal by Subject|3|||
164174749|NCT00655733|593003351|FG000|Overall Study|Physician Decision|0|||
164174750|NCT00655733|593003352|FG001|Overall Study|Physician Decision|1|||
164174751|NCT02370667|593003356|FG000|Overall Study|Lost to Follow-up|0|||
164174752|NCT02370667|593003357|FG001|Overall Study|Lost to Follow-up|1|||
164174753|NCT02370667|593003358|FG002|Overall Study|Lost to Follow-up|0|||
164174754|NCT03536949|593003359|FG000|Overall Study|Adverse Event|4|||
164174755|NCT03536949|593003360|FG001|Overall Study|Adverse Event|0|||
164174756|NCT03536949|593003359|FG000|Overall Study|Lost to Follow-up|2|||
164174757|NCT03536949|593003360|FG001|Overall Study|Lost to Follow-up|1|||
164174758|NCT03536949|593003359|FG000|Overall Study|Withdrawal by Subject|6|||
164174759|NCT03536949|593003360|FG001|Overall Study|Withdrawal by Subject|0|||
164174760|NCT03536949|593003359|FG000|Overall Study|Non-compliance|2|||
164174761|NCT03536949|593003360|FG001|Overall Study|Non-compliance|1|||
164174762|NCT00705718|593003361|FG000|Overall Study|Death|6|||
164174763|NCT00705718|593003362|FG001|Overall Study|Death|6|||
164174764|NCT00705718|593003361|FG000|Overall Study|Not due for Visit|0|||
164174765|NCT00705718|593003362|FG001|Overall Study|Not due for Visit|12|||
164174766|NCT00705718|593003361|FG000|Overall Study|Follow up not done|1|||
164174767|NCT00705718|593003362|FG001|Overall Study|Follow up not done|4|||
164174768|NCT02954653|593003363|FG000|Overall Study|Death|3|||
164174769|NCT02954653|593003364|FG001|Overall Study|Death|1|||
164174770|NCT02954653|593003365|FG002|Overall Study|Death|0|||
164174771|NCT02954653|593003366|FG003|Overall Study|Death|0|||
164174772|NCT02954653|593003367|FG004|Overall Study|Death|0|||
164174773|NCT02954653|593003368|FG005|Overall Study|Death|0|||
164174774|NCT02954653|593003369|FG006|Overall Study|Death|0|||
164174775|NCT02954653|593003370|FG007|Overall Study|Death|0|||
164174776|NCT02954653|593003371|FG008|Overall Study|Death|0|||
164174777|NCT02954653|593003363|FG000|Overall Study|Randomized but did not receive treatment|1|||
164174778|NCT02954653|593003364|FG001|Overall Study|Randomized but did not receive treatment|0|||
164174779|NCT02954653|593003365|FG002|Overall Study|Randomized but did not receive treatment|0|||
164174780|NCT02954653|593003366|FG003|Overall Study|Randomized but did not receive treatment|0|||
164174781|NCT02954653|593003367|FG004|Overall Study|Randomized but did not receive treatment|0|||
164174782|NCT02954653|593003368|FG005|Overall Study|Randomized but did not receive treatment|0|||
164174783|NCT02954653|593003369|FG006|Overall Study|Randomized but did not receive treatment|0|||
164174784|NCT02954653|593003370|FG007|Overall Study|Randomized but did not receive treatment|0|||
164174785|NCT02954653|593003371|FG008|Overall Study|Randomized but did not receive treatment|0|||
164174786|NCT02954653|593003363|FG000|Overall Study|Started another anti-cancer therapy|0|||
164174787|NCT02954653|593003364|FG001|Overall Study|Started another anti-cancer therapy|1|||
164174788|NCT02954653|593003365|FG002|Overall Study|Started another anti-cancer therapy|0|||
164174789|NCT02954653|593003366|FG003|Overall Study|Started another anti-cancer therapy|0|||
164174790|NCT02954653|593003367|FG004|Overall Study|Started another anti-cancer therapy|0|||
164174791|NCT02954653|593003368|FG005|Overall Study|Started another anti-cancer therapy|0|||
164174792|NCT02954653|593003369|FG006|Overall Study|Started another anti-cancer therapy|0|||
164174793|NCT02954653|593003370|FG007|Overall Study|Started another anti-cancer therapy|0|||
164174794|NCT02954653|593003371|FG008|Overall Study|Started another anti-cancer therapy|0|||
164174795|NCT02954653|593003363|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
164174796|NCT02954653|593003364|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
164174797|NCT02954653|593003365|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
164174798|NCT02954653|593003366|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
164174799|NCT02954653|593003367|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
164174800|NCT02954653|593003368|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
164174801|NCT02954653|593003369|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
164174802|NCT02954653|593003370|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
164174803|NCT02954653|593003371|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
164174804|NCT04329091|593003375|FG000|Overall Study|Physician Decision|5|||
164174805|NCT00423189|593003376|FG000|Overall Study|Death|0|||
164174806|NCT00423189|593003377|FG001|Overall Study|Death|1|||
164174807|NCT00423189|593003378|FG002|Overall Study|Death|0|||
164174808|NCT03787303|593003381|FG000|Overall Study|Death|1|||
164174809|NCT03787303|593003381|FG000|Overall Study|Premature Termination of Study|1|||
164174810|NCT01210495|593003388|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
164174811|NCT01210495|593003389|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
164174812|NCT01210495|593003390|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
164174813|NCT01210495|593003391|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
164174814|NCT01210495|593003388|FG000|Overall Study|Death|14|||
164174815|NCT01210495|593003389|FG001|Overall Study|Death|7|||
164174816|NCT01210495|593003390|FG002|Overall Study|Death|112|||
164174817|NCT01210495|593003391|FG003|Overall Study|Death|54|||
164174818|NCT01210495|593003388|FG000|Overall Study|Study Terminated by Sponsor|0|||
164174819|NCT01210495|593003389|FG001|Overall Study|Study Terminated by Sponsor|0|||
164174820|NCT01210495|593003390|FG002|Overall Study|Study Terminated by Sponsor|4|||
164174821|NCT01210495|593003391|FG003|Overall Study|Study Terminated by Sponsor|11|||
164174822|NCT01210495|593003388|FG000|Overall Study|Lost to Follow-up|0|||
164174823|NCT01210495|593003389|FG001|Overall Study|Lost to Follow-up|0|||
164174824|NCT01210495|593003390|FG002|Overall Study|Lost to Follow-up|1|||
164174825|NCT01210495|593003391|FG003|Overall Study|Lost to Follow-up|1|||
164174826|NCT01210495|593003388|FG000|Overall Study|Other unspecified|0|||
164174827|NCT01210495|593003389|FG001|Overall Study|Other unspecified|0|||
164174828|NCT01210495|593003390|FG002|Overall Study|Other unspecified|6|||
164174829|NCT01210495|593003391|FG003|Overall Study|Other unspecified|0|||
164174830|NCT01826370|593003396|FG000|Overall Study|Protocol Violation|6|||
164174831|NCT01826370|593003396|FG000|Overall Study|Lost to Follow-up|12|||
164174832|NCT01826370|593003396|FG000|Overall Study|Other reason not defined above|2|||
164174833|NCT04416737|593003397|FG000|Week 1 (First Injection)|Physician Decision|0|||
164174834|NCT04416737|593003398|FG001|Week 1 (First Injection)|Physician Decision|1|||
164174835|NCT03332628|593003399|FG000|Overall Study|Physician Decision|2|||
164174836|NCT02543892|593003407|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
164174837|NCT02543892|593003408|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
164174838|NCT02543892|593003409|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
164174839|NCT02543892|593003410|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
164174840|NCT02543892|593003411|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
164174841|NCT02543892|593003412|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
164174842|NCT02543892|593003413|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
164174843|NCT02543892|593003414|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
164174844|NCT02543892|593003407|FG000|Received Vaccination 2|Physician Decision|0|||
164174845|NCT02543892|593003408|FG001|Received Vaccination 2|Physician Decision|0|||
164174846|NCT02543892|593003409|FG002|Received Vaccination 2|Physician Decision|0|||
164174847|NCT02543892|593003410|FG003|Received Vaccination 2|Physician Decision|0|||
164174848|NCT02543892|593003411|FG004|Received Vaccination 2|Physician Decision|0|||
164174849|NCT02543892|593003412|FG005|Received Vaccination 2|Physician Decision|1|||
164174850|NCT02543892|593003413|FG006|Received Vaccination 2|Physician Decision|0|||
164174851|NCT02543892|593003414|FG007|Received Vaccination 2|Physician Decision|0|||
164174852|NCT02543892|593003407|FG000|Received Vaccination 2|Adverse Event|0|||
164174853|NCT02543892|593003408|FG001|Received Vaccination 2|Adverse Event|1|||
164174854|NCT02543892|593003409|FG002|Received Vaccination 2|Adverse Event|0|||
164174855|NCT02543892|593003410|FG003|Received Vaccination 2|Adverse Event|0|||
164174856|NCT02543892|593003411|FG004|Received Vaccination 2|Adverse Event|0|||
164174857|NCT02543892|593003412|FG005|Received Vaccination 2|Adverse Event|0|||
164174858|NCT02543892|593003413|FG006|Received Vaccination 2|Adverse Event|0|||
164174859|NCT02543892|593003414|FG007|Received Vaccination 2|Adverse Event|0|||
164174860|NCT02543892|593003407|FG000|Had Immunology Data|Withdrawal by Subject|0|||
164174861|NCT02543892|593003408|FG001|Had Immunology Data|Withdrawal by Subject|0|||
164174862|NCT02543892|593003409|FG002|Had Immunology Data|Withdrawal by Subject|0|||
164174863|NCT02543892|593003410|FG003|Had Immunology Data|Withdrawal by Subject|0|||
164174864|NCT02543892|593003411|FG004|Had Immunology Data|Withdrawal by Subject|0|||
164174865|NCT02543892|593003412|FG005|Had Immunology Data|Withdrawal by Subject|0|||
164174866|NCT02543892|593003413|FG006|Had Immunology Data|Withdrawal by Subject|1|||
164174867|NCT02543892|593003414|FG007|Had Immunology Data|Withdrawal by Subject|0|||
164174868|NCT01801280|593003415|FG000|Period 1|Withdrawal by Subject|0|||
164174869|NCT01801280|593003416|FG001|Period 1|Withdrawal by Subject|1|||
164174870|NCT01801280|593003417|FG002|Period 1|Withdrawal by Subject|0|||
164174871|NCT01801280|593003418|FG003|Period 1|Withdrawal by Subject|0|||
164174872|NCT01801280|593003415|FG000|Period 2|Withdrawal by Subject|1|||
164174873|NCT01801280|593003416|FG001|Period 2|Withdrawal by Subject|0|||
164174874|NCT01801280|593003417|FG002|Period 2|Withdrawal by Subject|0|||
164174875|NCT01801280|593003418|FG003|Period 2|Withdrawal by Subject|0|||
164174876|NCT01801280|593003415|FG000|Period 4|Protocol Violation|0|||
164174877|NCT01801280|593003416|FG001|Period 4|Protocol Violation|0|||
164174878|NCT01801280|593003417|FG002|Period 4|Protocol Violation|1|||
164174879|NCT01801280|593003418|FG003|Period 4|Protocol Violation|0|||
164174880|NCT04021121|593003421|FG000|Overall Study|Death|3|||
164174881|NCT04021121|593003422|FG001|Overall Study|Death|3|||
164174882|NCT04021121|593003423|FG002|Overall Study|Death|5|||
164174883|NCT04021121|593003424|FG003|Overall Study|Death|4|||
164174884|NCT04050124|593003430|FG000|Overall Study|Death|1|||
164174885|NCT04050124|593003431|FG001|Overall Study|Death|0|||
164174886|NCT05083923|593003436|FG000|Overall Study|Adverse Event|2|||
164174887|NCT05083923|593003437|FG001|Overall Study|Adverse Event|0|||
164174888|NCT05083923|593003436|FG000|Overall Study|Lack of Efficacy|1|||
164174889|NCT05083923|593003437|FG001|Overall Study|Lack of Efficacy|3|||
164174890|NCT05083923|593003436|FG000|Overall Study|Withdrawal by Subject|2|||
164174891|NCT05083923|593003437|FG001|Overall Study|Withdrawal by Subject|6|||
164174892|NCT05083923|593003436|FG000|Overall Study|Reason Not Specified|0|||
164174893|NCT05083923|593003437|FG001|Overall Study|Reason Not Specified|1|||
164174894|NCT01785849|593003448|FG000|Overall Study|Death|7|||
164174895|NCT01785849|593003449|FG001|Overall Study|Death|9|||
164174896|NCT01785849|593003448|FG000|Overall Study|Protocol Specified Criteria|29|||
164174897|NCT01785849|593003449|FG001|Overall Study|Protocol Specified Criteria|1|||
164174898|NCT01785849|593003448|FG000|Overall Study|Withdrawal by Subject|15|||
164174899|NCT01785849|593003449|FG001|Overall Study|Withdrawal by Subject|12|||
164174900|NCT01785849|593003448|FG000|Overall Study|Sponsor Decision|0|||
164174901|NCT01785849|593003449|FG001|Overall Study|Sponsor Decision|1|||
164174902|NCT01785849|593003448|FG000|Overall Study|Lost to Follow-up|10|||
164174903|NCT01785849|593003449|FG001|Overall Study|Lost to Follow-up|11|||
164174904|NCT00381043|593003450|FG000|Overall Study|Lost to Follow-up|8|||
164174905|NCT00381043|593003451|FG001|Overall Study|Lost to Follow-up|6|||
164174906|NCT00381043|593003450|FG000|Overall Study|Withdrawal by Subject|3|||
164174907|NCT00381043|593003451|FG001|Overall Study|Withdrawal by Subject|1|||
164174908|NCT00381043|593003450|FG000|Overall Study|wanted more care|0|||
164174909|NCT00381043|593003451|FG001|Overall Study|wanted more care|1|||
164174910|NCT00381043|593003450|FG000|Overall Study|incarcerated|1|||
164174911|NCT00381043|593003451|FG001|Overall Study|incarcerated|0|||
164174912|NCT02880865|593003454|FG000|Overall Study|Adverse Event|1|||
164174913|NCT02880865|593003455|FG001|Overall Study|Adverse Event|0|||
164174914|NCT02880865|593003454|FG000|Overall Study|Withdrawal by Subject|0|||
164174915|NCT02880865|593003455|FG001|Overall Study|Withdrawal by Subject|2|||
164174916|NCT02880865|593003454|FG000|Overall Study|Physician Decision|0|||
164174917|NCT02880865|593003455|FG001|Overall Study|Physician Decision|1|||
164174918|NCT03379753|593003456|FG000|Overall Study|Withdrawal by Subject|2|||
164174919|NCT03379753|593003457|FG001|Overall Study|Withdrawal by Subject|1|||
164174920|NCT03379753|593003456|FG000|Overall Study|not having correct procedure|1|||
164174921|NCT03379753|593003457|FG001|Overall Study|not having correct procedure|2|||
164174922|NCT03379753|593003456|FG000|Overall Study|No primary outcome|12|||
164174923|NCT03379753|593003457|FG001|Overall Study|No primary outcome|22|||
164174924|NCT05079750|593005167|FG000|Overall Study|Lost to Follow-up|0|||
164174925|NCT05079750|593005168|FG001|Overall Study|Lost to Follow-up|0|||
164174926|NCT05079750|593005169|FG002|Overall Study|Lost to Follow-up|1|||
164174927|NCT05091346|593005172|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
164174928|NCT05091346|593005173|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
164174929|NCT05091346|593005174|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
164174930|NCT05091346|593005175|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
164174931|NCT05091346|593005176|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
164174932|NCT05091346|593005172|FG000|Overall Study|Death|6|||
164174933|NCT05091346|593005173|FG001|Overall Study|Death|5|||
164174934|NCT05091346|593005174|FG002|Overall Study|Death|8|||
164174935|NCT05091346|593005175|FG003|Overall Study|Death|16|||
164174936|NCT05091346|593005176|FG004|Overall Study|Death|26|||
164174937|NCT05091346|593005172|FG000|Overall Study|Lost to Follow-up|0|||
164174938|NCT05091346|593005173|FG001|Overall Study|Lost to Follow-up|0|||
164174939|NCT05091346|593005174|FG002|Overall Study|Lost to Follow-up|0|||
164174940|NCT05091346|593005175|FG003|Overall Study|Lost to Follow-up|1|||
164174941|NCT05091346|593005176|FG004|Overall Study|Lost to Follow-up|0|||
164174942|NCT05091346|593005172|FG000|Overall Study|Withdrawal by Subject|0|||
164174943|NCT05091346|593005173|FG001|Overall Study|Withdrawal by Subject|1|||
164174944|NCT05091346|593005174|FG002|Overall Study|Withdrawal by Subject|2|||
164174945|NCT05091346|593005175|FG003|Overall Study|Withdrawal by Subject|2|||
164174946|NCT05091346|593005176|FG004|Overall Study|Withdrawal by Subject|1|||
164174947|NCT01573767|593005182|FG000|Overall Study|Adverse Event|0|||
164174948|NCT01573767|593005183|FG001|Overall Study|Adverse Event|1|||
164174949|NCT01573767|593005184|FG002|Overall Study|Adverse Event|0|||
164174950|NCT01573767|593005185|FG003|Overall Study|Adverse Event|1|||
164174951|NCT01573767|593005182|FG000|Overall Study|Lack of Efficacy|18|||
164174952|NCT01573767|593005183|FG001|Overall Study|Lack of Efficacy|15|||
164174953|NCT01573767|593005184|FG002|Overall Study|Lack of Efficacy|12|||
164174954|NCT01573767|593005185|FG003|Overall Study|Lack of Efficacy|17|||
164174955|NCT01573767|593005182|FG000|Overall Study|Protocol Violation|3|||
164174956|NCT01573767|593005183|FG001|Overall Study|Protocol Violation|1|||
164174957|NCT01573767|593005184|FG002|Overall Study|Protocol Violation|1|||
164174958|NCT01573767|593005185|FG003|Overall Study|Protocol Violation|3|||
164174959|NCT01573767|593005182|FG000|Overall Study|Lost to Follow-up|0|||
164174960|NCT01573767|593005183|FG001|Overall Study|Lost to Follow-up|1|||
164174961|NCT01573767|593005184|FG002|Overall Study|Lost to Follow-up|1|||
164174962|NCT01573767|593005185|FG003|Overall Study|Lost to Follow-up|1|||
164174963|NCT01573767|593005182|FG000|Overall Study|Physician Decision|1|||
164174964|NCT01573767|593005183|FG001|Overall Study|Physician Decision|2|||
164174965|NCT01573767|593005184|FG002|Overall Study|Physician Decision|0|||
164174966|NCT01573767|593005185|FG003|Overall Study|Physician Decision|2|||
164174967|NCT01573767|593005182|FG000|Overall Study|Withdrawal by Subject|0|||
164174968|NCT01573767|593005183|FG001|Overall Study|Withdrawal by Subject|1|||
164174969|NCT01573767|593005184|FG002|Overall Study|Withdrawal by Subject|0|||
164174970|NCT01573767|593005185|FG003|Overall Study|Withdrawal by Subject|0|||
164174971|NCT02339155|593005186|FG000|Overall Study|Adverse Event|0|||
164174972|NCT02339155|593005187|FG001|Overall Study|Adverse Event|6|||
164174973|NCT02339155|593005186|FG000|Overall Study|Death|1|||
164174974|NCT02339155|593005187|FG001|Overall Study|Death|1|||
164174975|NCT02339155|593005186|FG000|Overall Study|Lost to Follow-up|8|||
164174976|NCT02339155|593005187|FG001|Overall Study|Lost to Follow-up|9|||
164174977|NCT02339155|593005186|FG000|Overall Study|Physician Decision|2|||
164174978|NCT02339155|593005187|FG001|Overall Study|Physician Decision|1|||
164174979|NCT02339155|593005186|FG000|Overall Study|Withdrawal by Subject|4|||
164174980|NCT02339155|593005187|FG001|Overall Study|Withdrawal by Subject|4|||
164174981|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Adverse Event|0|||
164174982|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Adverse Event|1|||
164174983|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Adverse Event|0|||
164174984|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Adverse Event|0|||
164174985|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Adverse Event|0|||
164174986|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Adverse Event|0|||
164174987|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Death|0|||
164174988|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Death|0|||
164174989|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Death|1|||
164174990|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Death|0|||
164174991|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Death|0|||
164174992|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Death|0|||
164174993|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174994|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
164174995|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174996|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174997|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174998|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
164174999|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175000|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175001|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
164175002|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175003|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175004|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
164175005|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175006|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175007|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175008|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
164175009|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175010|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
164175011|NCT03226678|593005192|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
164175012|NCT03226678|593005193|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
164175013|NCT03226678|593005194|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175014|NCT03226678|593005195|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175089|NCT00878969|593005229|FG002|Overall Study|Pregnancy|0|||
164175015|NCT03226678|593005196|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175016|NCT03226678|593005197|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
164175017|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175018|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175019|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175020|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
164175021|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
164175022|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
164175023|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Death|0|||
164175024|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Death|0|||
164175025|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Death|0|||
164175026|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Death|0|||
164175027|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Death|0|||
164175028|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Death|1|||
164175029|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175030|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175031|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175032|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175033|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
164175034|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
164175035|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175036|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175037|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175038|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
164175039|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
164175040|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
164175041|NCT03226678|593005192|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175042|NCT03226678|593005193|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175043|NCT03226678|593005194|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175044|NCT03226678|593005195|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175045|NCT03226678|593005196|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
164175046|NCT03226678|593005197|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
164175047|NCT05014815|593005204|FG000|Overall Study|Death|63|||
164175048|NCT05014815|593005205|FG001|Overall Study|Death|70|||
164175049|NCT05014815|593005204|FG000|Overall Study|Withdrawal by Subject|10|||
164175050|NCT05014815|593005205|FG001|Overall Study|Withdrawal by Subject|10|||
164175051|NCT05014815|593005204|FG000|Overall Study|Lost to Follow-up|4|||
164175052|NCT05014815|593005205|FG001|Overall Study|Lost to Follow-up|2|||
164175053|NCT05014815|593005204|FG000|Overall Study|Physician Decision|2|||
164175054|NCT05014815|593005205|FG001|Overall Study|Physician Decision|4|||
164175055|NCT04247880|593005206|FG000|Overall Study|Lost to Follow-up|24|||
164175056|NCT04247880|593005207|FG001|Overall Study|Lost to Follow-up|17|||
164175057|NCT04247880|593005206|FG000|Overall Study|Withdrawal by Subject|3|||
164175058|NCT04247880|593005207|FG001|Overall Study|Withdrawal by Subject|0|||
164175059|NCT00916344|593005216|FG000|Overall Study|Death|2|||
164175060|NCT00916344|593005216|FG000|Overall Study|ICD upgrade|1|||
164175061|NCT00916344|593005216|FG000|Overall Study|Drop-out|5|||
164175062|NCT00108485|593005221|FG000|Overall Study|Withdrawal by Subject|3|||
164175063|NCT00108485|593005222|FG001|Overall Study|Withdrawal by Subject|0|||
164175064|NCT00108485|593005221|FG000|Overall Study|Lost to Follow-up|0|||
164175065|NCT00108485|593005222|FG001|Overall Study|Lost to Follow-up|2|||
164175066|NCT00878969|593005227|FG000|Overall Study|Physician Decision|5|||
164175067|NCT00878969|593005228|FG001|Overall Study|Physician Decision|3|||
164175068|NCT00878969|593005229|FG002|Overall Study|Physician Decision|2|||
164175069|NCT00878969|593005227|FG000|Overall Study|Withdrawal by Subject|1|||
164175070|NCT00878969|593005228|FG001|Overall Study|Withdrawal by Subject|6|||
164175071|NCT00878969|593005229|FG002|Overall Study|Withdrawal by Subject|3|||
164175072|NCT00878969|593005227|FG000|Overall Study|kidney transplant|2|||
164175073|NCT00878969|593005228|FG001|Overall Study|kidney transplant|3|||
164175074|NCT00878969|593005229|FG002|Overall Study|kidney transplant|2|||
164175075|NCT00878969|593005227|FG000|Overall Study|Adverse Event|3|||
164175076|NCT00878969|593005228|FG001|Overall Study|Adverse Event|1|||
164175077|NCT00878969|593005229|FG002|Overall Study|Adverse Event|2|||
164175078|NCT00878969|593005227|FG000|Overall Study|Lost to Follow-up|2|||
164175079|NCT00878969|593005228|FG001|Overall Study|Lost to Follow-up|1|||
164175080|NCT00878969|593005229|FG002|Overall Study|Lost to Follow-up|0|||
164175081|NCT00878969|593005227|FG000|Overall Study|Protocol Violation|2|||
164175082|NCT00878969|593005228|FG001|Overall Study|Protocol Violation|0|||
164175083|NCT00878969|593005229|FG002|Overall Study|Protocol Violation|0|||
164175084|NCT00878969|593005227|FG000|Overall Study|Death|0|||
164175085|NCT00878969|593005228|FG001|Overall Study|Death|0|||
164175086|NCT00878969|593005229|FG002|Overall Study|Death|2|||
164175087|NCT00878969|593005227|FG000|Overall Study|Pregnancy|0|||
164175088|NCT00878969|593005228|FG001|Overall Study|Pregnancy|1|||
164175090|NCT01701193|593005232|FG000|Overall Study|Withdrawal by Subject|2|||
164175091|NCT01701193|593005233|FG001|Overall Study|Withdrawal by Subject|2|||
164175092|NCT01701193|593005234|FG002|Overall Study|Withdrawal by Subject|1|||
164175093|NCT01701193|593005235|FG003|Overall Study|Withdrawal by Subject|2|||
164175094|NCT01701193|593005232|FG000|Overall Study|Adverse Event|1|||
164175095|NCT01701193|593005233|FG001|Overall Study|Adverse Event|0|||
164175096|NCT01701193|593005234|FG002|Overall Study|Adverse Event|0|||
164175097|NCT01701193|593005235|FG003|Overall Study|Adverse Event|0|||
164175098|NCT03054064|593005236|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
164175099|NCT03054064|593005236|FG000|Overall Study|Investigator Decision|2|||
164175100|NCT03054064|593005236|FG000|Overall Study|Bladder Issue|1|||
164175101|NCT03054064|593005236|FG000|Overall Study|High Blood Pressure|1|||
164175102|NCT03054064|593005236|FG000|Overall Study|Change in Status|1|||
164175103|NCT01384019|593005237|FG000|Overall Study|Withdrawal by Subject|3|||
164175104|NCT01384019|593005238|FG001|Overall Study|Withdrawal by Subject|0|||
164175105|NCT01384019|593005237|FG000|Overall Study|Death|1|||
164175106|NCT01384019|593005238|FG001|Overall Study|Death|0|||
164175107|NCT01384019|593005237|FG000|Overall Study|MRI refusal|6|||
164175108|NCT01384019|593005238|FG001|Overall Study|MRI refusal|6|||
164175109|NCT04489381|593005244|FG000|Overall Study|Lost to Follow-up|2|||
164175110|NCT04489381|593005245|FG001|Overall Study|Lost to Follow-up|3|||
164175111|NCT04489381|593005244|FG000|Overall Study|Withdrawal by Subject|1|||
164175112|NCT04489381|593005245|FG001|Overall Study|Withdrawal by Subject|0|||
164175113|NCT03199612|593005248|FG000|Overall Study|Adverse Event|1|||
164175114|NCT03199612|593005249|FG001|Overall Study|Adverse Event|0|||
164175115|NCT01199822|593005250|FG000|Overall Study|Investigator discontinued therapy|0|||
164175116|NCT01199822|593005251|FG001|Overall Study|Investigator discontinued therapy|1|||
164175117|NCT01199822|593005252|FG002|Overall Study|Investigator discontinued therapy|0|||
164175118|NCT01500213|593005253|FG000|Overall Study|Adverse Event|35|||
164175119|NCT01500213|593005254|FG001|Overall Study|Adverse Event|35|||
164175120|NCT01500213|593005253|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
164175121|NCT01500213|593005254|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
164175122|NCT01500213|593005253|FG000|Overall Study|Withdrawal by Subject|28|||
164175123|NCT01500213|593005254|FG001|Overall Study|Withdrawal by Subject|37|||
164175124|NCT01500213|593005253|FG000|Overall Study|Death|7|||
164175125|NCT01500213|593005254|FG001|Overall Study|Death|3|||
164175126|NCT01500213|593005253|FG000|Overall Study|Disease Progression|13|||
164175127|NCT01500213|593005254|FG001|Overall Study|Disease Progression|21|||
164175128|NCT01500213|593005253|FG000|Overall Study|Protocol Violation|19|||
164175129|NCT01500213|593005254|FG001|Overall Study|Protocol Violation|19|||
164175130|NCT01500213|593005253|FG000|Overall Study|Physician Decision|12|||
164175131|NCT01500213|593005254|FG001|Overall Study|Physician Decision|10|||
164175132|NCT01500213|593005253|FG000|Overall Study|Lack of Efficacy|9|||
164175133|NCT01500213|593005254|FG001|Overall Study|Lack of Efficacy|7|||
164175134|NCT01500213|593005253|FG000|Overall Study|Lost to Follow-up|3|||
164175135|NCT01500213|593005254|FG001|Overall Study|Lost to Follow-up|6|||
164175136|NCT01500213|593005253|FG000|Overall Study|Other Reasons|7|||
164175137|NCT01500213|593005254|FG001|Overall Study|Other Reasons|5|||
164175138|NCT04027075|593005255|FG000|Overall Study|Lost to Follow-up|41|||
164175139|NCT04027075|593005256|FG001|Overall Study|Lost to Follow-up|22|||
164175140|NCT01043705|593005258|FG000|Overall Study|Death|28|||
164175141|NCT01043705|593005259|FG001|Overall Study|Death|60|||
164175142|NCT01043705|593005260|FG002|Overall Study|Death|26|||
164175143|NCT01043705|593005258|FG000|Overall Study|Lost to Follow-up|27|||
164175144|NCT01043705|593005259|FG001|Overall Study|Lost to Follow-up|12|||
164175145|NCT01043705|593005260|FG002|Overall Study|Lost to Follow-up|0|||
164175146|NCT01043705|593005258|FG000|Overall Study|Multiple Reasons|4|||
164175147|NCT01043705|593005259|FG001|Overall Study|Multiple Reasons|7|||
164175148|NCT01043705|593005260|FG002|Overall Study|Multiple Reasons|0|||
164175149|NCT01043705|593005258|FG000|Overall Study|Protocol Violation|2|||
164175150|NCT01043705|593005259|FG001|Overall Study|Protocol Violation|1|||
164175151|NCT01043705|593005260|FG002|Overall Study|Protocol Violation|0|||
164175152|NCT01043705|593005258|FG000|Overall Study|Withdrawal by Subject|8|||
164175153|NCT01043705|593005259|FG001|Overall Study|Withdrawal by Subject|6|||
164175154|NCT01043705|593005260|FG002|Overall Study|Withdrawal by Subject|0|||
164175155|NCT01043705|593005258|FG000|Overall Study|Site Closure|8|||
164175156|NCT01043705|593005259|FG001|Overall Study|Site Closure|0|||
164175157|NCT01043705|593005260|FG002|Overall Study|Site Closure|0|||
164175158|NCT01043705|593005258|FG000|Overall Study|Subsequent Procedure|9|||
164175159|NCT01043705|593005259|FG001|Overall Study|Subsequent Procedure|24|||
164175160|NCT01043705|593005260|FG002|Overall Study|Subsequent Procedure|29|||
164175161|NCT01043705|593005258|FG000|Overall Study|Adverse Event|0|||
164175162|NCT01043705|593005259|FG001|Overall Study|Adverse Event|2|||
164175163|NCT01043705|593005260|FG002|Overall Study|Adverse Event|0|||
164175164|NCT01043705|593005258|FG000|Overall Study|Screen Fail|21|||
164175165|NCT01043705|593005259|FG001|Overall Study|Screen Fail|0|||
164175166|NCT01043705|593005260|FG002|Overall Study|Screen Fail|0|||
164175167|NCT01043705|593005258|FG000|Overall Study|Other|0|||
164175168|NCT01043705|593005259|FG001|Overall Study|Other|19|||
164175169|NCT01043705|593005260|FG002|Overall Study|Other|25|||
164175170|NCT02003963|593005264|FG000|Overall Study|Lost to Follow-up|2|||
164175171|NCT02003963|593005265|FG001|Overall Study|Lost to Follow-up|1|||
164175172|NCT01195844|593005266|FG000|Overall Study|Fecal sample not collected|40|||
164175173|NCT00176644|593005267|FG000|Overall Study|Withdrawal by Subject|1|||
164175174|NCT00581542|593005268|FG000|Overall Study|they met an exclusion criteria|2|||
164175175|NCT00581542|593005269|FG001|Overall Study|they met an exclusion criteria|2|||
164175176|NCT00581542|593005268|FG000|Overall Study|Lost to Follow-up|9|||
164175177|NCT00581542|593005269|FG001|Overall Study|Lost to Follow-up|21|||
164175178|NCT05020366|593005270|FG000|Overall Study|Lost to Follow-up|2|||
164175179|NCT05020366|593005271|FG001|Overall Study|Lost to Follow-up|0|||
164175180|NCT05020366|593005270|FG000|Overall Study|Withdrawal by Subject|2|||
164175181|NCT05020366|593005271|FG001|Overall Study|Withdrawal by Subject|0|||
164175182|NCT00195494|593005274|FG000|Year 1|Adverse Event|0|||
164175183|NCT00195494|593005275|FG001|Year 1|Adverse Event|0|||
164175184|NCT00195494|593005276|FG002|Year 1|Adverse Event|0|||
164175185|NCT00195494|593005277|FG003|Year 1|Adverse Event|0|||
164175186|NCT00195494|593005278|FG004|Year 1|Adverse Event|34|||
164175187|NCT00195494|593005279|FG005|Year 1|Adverse Event|27|||
164175188|NCT00195494|593005274|FG000|Year 1|System Toxicity|0|||
164175189|NCT00195494|593005275|FG001|Year 1|System Toxicity|0|||
164175190|NCT00195494|593005276|FG002|Year 1|System Toxicity|0|||
164175191|NCT00195494|593005277|FG003|Year 1|System Toxicity|0|||
164175192|NCT00195494|593005278|FG004|Year 1|System Toxicity|0|||
164175193|NCT00195494|593005279|FG005|Year 1|System Toxicity|1|||
164175194|NCT00195494|593005274|FG000|Year 1|Lack of Efficacy|0|||
164175195|NCT00195494|593005275|FG001|Year 1|Lack of Efficacy|0|||
164175196|NCT00195494|593005276|FG002|Year 1|Lack of Efficacy|0|||
164175197|NCT00195494|593005277|FG003|Year 1|Lack of Efficacy|0|||
164175198|NCT00195494|593005278|FG004|Year 1|Lack of Efficacy|24|||
164175199|NCT00195494|593005279|FG005|Year 1|Lack of Efficacy|9|||
164175200|NCT00195494|593005274|FG000|Year 1|Compliance|0|||
164175201|NCT00195494|593005275|FG001|Year 1|Compliance|0|||
164175202|NCT00195494|593005276|FG002|Year 1|Compliance|0|||
164175203|NCT00195494|593005277|FG003|Year 1|Compliance|0|||
164175204|NCT00195494|593005278|FG004|Year 1|Compliance|5|||
164175205|NCT00195494|593005279|FG005|Year 1|Compliance|1|||
164175206|NCT00195494|593005274|FG000|Year 1|Lost to Follow-up|0|||
164175207|NCT00195494|593005275|FG001|Year 1|Lost to Follow-up|0|||
164175208|NCT00195494|593005276|FG002|Year 1|Lost to Follow-up|0|||
164175209|NCT00195494|593005277|FG003|Year 1|Lost to Follow-up|0|||
164175210|NCT00195494|593005278|FG004|Year 1|Lost to Follow-up|1|||
164175211|NCT00195494|593005279|FG005|Year 1|Lost to Follow-up|0|||
164175212|NCT00195494|593005274|FG000|Year 1|Missed >4 consecutive doses|0|||
164175213|NCT00195494|593005275|FG001|Year 1|Missed >4 consecutive doses|0|||
164175214|NCT00195494|593005276|FG002|Year 1|Missed >4 consecutive doses|0|||
164175215|NCT00195494|593005277|FG003|Year 1|Missed >4 consecutive doses|0|||
164175216|NCT00195494|593005278|FG004|Year 1|Missed >4 consecutive doses|3|||
164175217|NCT00195494|593005279|FG005|Year 1|Missed >4 consecutive doses|2|||
164175218|NCT00195494|593005274|FG000|Year 1|Protocol deviation|0|||
164175219|NCT00195494|593005275|FG001|Year 1|Protocol deviation|0|||
164175220|NCT00195494|593005276|FG002|Year 1|Protocol deviation|0|||
164175221|NCT00195494|593005277|FG003|Year 1|Protocol deviation|0|||
164175222|NCT00195494|593005278|FG004|Year 1|Protocol deviation|2|||
164175223|NCT00195494|593005279|FG005|Year 1|Protocol deviation|3|||
164175224|NCT00195494|593005274|FG000|Year 1|Physician Decision|0|||
164175225|NCT00195494|593005275|FG001|Year 1|Physician Decision|0|||
164175226|NCT00195494|593005276|FG002|Year 1|Physician Decision|0|||
164175227|NCT00195494|593005277|FG003|Year 1|Physician Decision|0|||
164175228|NCT00195494|593005278|FG004|Year 1|Physician Decision|1|||
164175229|NCT00195494|593005279|FG005|Year 1|Physician Decision|0|||
164175230|NCT00195494|593005274|FG000|Year 1|Withdrawal by Subject|0|||
164175231|NCT00195494|593005275|FG001|Year 1|Withdrawal by Subject|0|||
164175232|NCT00195494|593005276|FG002|Year 1|Withdrawal by Subject|0|||
164175233|NCT00195494|593005277|FG003|Year 1|Withdrawal by Subject|0|||
164175234|NCT00195494|593005278|FG004|Year 1|Withdrawal by Subject|8|||
164175235|NCT00195494|593005279|FG005|Year 1|Withdrawal by Subject|9|||
164175236|NCT00195494|593005274|FG000|Year 1|Protocol Violation|0|||
164175237|NCT00195494|593005275|FG001|Year 1|Protocol Violation|0|||
164175238|NCT00195494|593005276|FG002|Year 1|Protocol Violation|0|||
164175239|NCT00195494|593005277|FG003|Year 1|Protocol Violation|0|||
164175240|NCT00195494|593005278|FG004|Year 1|Protocol Violation|1|||
164175241|NCT00195494|593005279|FG005|Year 1|Protocol Violation|1|||
164175242|NCT00195494|593005274|FG000|Year 2|Adverse Event|3|||
164175243|NCT00195494|593005275|FG001|Year 2|Adverse Event|7|||
164175244|NCT00195494|593005276|FG002|Year 2|Adverse Event|5|||
164175245|NCT00195494|593005277|FG003|Year 2|Adverse Event|9|||
164175246|NCT00195494|593005278|FG004|Year 2|Adverse Event|0|||
164175247|NCT00195494|593005279|FG005|Year 2|Adverse Event|0|||
164175248|NCT00195494|593005274|FG000|Year 2|Lack of Efficacy|0|||
164175249|NCT00195494|593005275|FG001|Year 2|Lack of Efficacy|1|||
164175250|NCT00195494|593005276|FG002|Year 2|Lack of Efficacy|7|||
164175251|NCT00195494|593005277|FG003|Year 2|Lack of Efficacy|7|||
164175252|NCT00195494|593005278|FG004|Year 2|Lack of Efficacy|0|||
164175253|NCT00195494|593005279|FG005|Year 2|Lack of Efficacy|0|||
164175254|NCT00195494|593005274|FG000|Year 2|Compliance|1|||
164175255|NCT00195494|593005275|FG001|Year 2|Compliance|0|||
164175256|NCT00195494|593005276|FG002|Year 2|Compliance|0|||
164175257|NCT00195494|593005277|FG003|Year 2|Compliance|2|||
164175258|NCT00195494|593005278|FG004|Year 2|Compliance|0|||
164175259|NCT00195494|593005279|FG005|Year 2|Compliance|0|||
164175260|NCT00195494|593005274|FG000|Year 2|Lost to Follow-up|0|||
164175261|NCT00195494|593005275|FG001|Year 2|Lost to Follow-up|0|||
164175262|NCT00195494|593005276|FG002|Year 2|Lost to Follow-up|1|||
164175263|NCT00195494|593005277|FG003|Year 2|Lost to Follow-up|1|||
164175264|NCT00195494|593005278|FG004|Year 2|Lost to Follow-up|0|||
164175265|NCT00195494|593005279|FG005|Year 2|Lost to Follow-up|0|||
164175266|NCT00195494|593005274|FG000|Year 2|Missed >4 consecutive doses|1|||
164175267|NCT00195494|593005275|FG001|Year 2|Missed >4 consecutive doses|1|||
164175268|NCT00195494|593005276|FG002|Year 2|Missed >4 consecutive doses|1|||
164175269|NCT00195494|593005277|FG003|Year 2|Missed >4 consecutive doses|0|||
164175270|NCT00195494|593005278|FG004|Year 2|Missed >4 consecutive doses|0|||
164175271|NCT00195494|593005279|FG005|Year 2|Missed >4 consecutive doses|0|||
164175272|NCT00195494|593005274|FG000|Year 2|Protocol deviation|0|||
164175273|NCT00195494|593005275|FG001|Year 2|Protocol deviation|1|||
164175274|NCT00195494|593005276|FG002|Year 2|Protocol deviation|0|||
164175275|NCT00195494|593005277|FG003|Year 2|Protocol deviation|0|||
164175276|NCT00195494|593005278|FG004|Year 2|Protocol deviation|0|||
164175277|NCT00195494|593005279|FG005|Year 2|Protocol deviation|0|||
164175278|NCT00195494|593005274|FG000|Year 2|Physician Decision|1|||
164175279|NCT00195494|593005275|FG001|Year 2|Physician Decision|1|||
164175280|NCT00195494|593005276|FG002|Year 2|Physician Decision|0|||
164175281|NCT00195494|593005277|FG003|Year 2|Physician Decision|0|||
164175282|NCT00195494|593005278|FG004|Year 2|Physician Decision|0|||
164175283|NCT00195494|593005279|FG005|Year 2|Physician Decision|0|||
164175284|NCT00195494|593005274|FG000|Year 2|Withdrawal by Subject|1|||
164175285|NCT00195494|593005275|FG001|Year 2|Withdrawal by Subject|5|||
164175286|NCT00195494|593005276|FG002|Year 2|Withdrawal by Subject|4|||
164175287|NCT00195494|593005277|FG003|Year 2|Withdrawal by Subject|3|||
164175288|NCT00195494|593005278|FG004|Year 2|Withdrawal by Subject|0|||
164175289|NCT00195494|593005279|FG005|Year 2|Withdrawal by Subject|0|||
164175290|NCT00195494|593005274|FG000|Year 2|System toxicity|0|||
164175291|NCT00195494|593005275|FG001|Year 2|System toxicity|0|||
164175292|NCT00195494|593005276|FG002|Year 2|System toxicity|0|||
164175293|NCT00195494|593005277|FG003|Year 2|System toxicity|1|||
164175294|NCT00195494|593005278|FG004|Year 2|System toxicity|0|||
164175295|NCT00195494|593005279|FG005|Year 2|System toxicity|0|||
164175296|NCT03045276|593005283|FG000|Intervention Phase|Withdrawal by Subject|7|||
164175297|NCT03045276|593005284|FG001|Intervention Phase|Withdrawal by Subject|2|||
164175298|NCT03045276|593005285|FG002|Intervention Phase|Withdrawal by Subject|3|||
164175299|NCT03045276|593005286|FG003|Intervention Phase|Withdrawal by Subject|7|||
164175300|NCT03045276|593005283|FG000|Intervention Phase|Developed exclusionary criteria|3|||
164175301|NCT03045276|593005284|FG001|Intervention Phase|Developed exclusionary criteria|3|||
164175302|NCT03045276|593005285|FG002|Intervention Phase|Developed exclusionary criteria|0|||
164175303|NCT03045276|593005286|FG003|Intervention Phase|Developed exclusionary criteria|0|||
164175304|NCT03045276|593005283|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
164175305|NCT03045276|593005284|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
164175306|NCT03045276|593005285|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
164175307|NCT03045276|593005286|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
164175308|NCT03045276|593005283|FG000|Follow-Up Phase|Lost to Follow-up|0|||
164175309|NCT03045276|593005284|FG001|Follow-Up Phase|Lost to Follow-up|1|||
164175310|NCT03045276|593005285|FG002|Follow-Up Phase|Lost to Follow-up|0|||
164175311|NCT03045276|593005286|FG003|Follow-Up Phase|Lost to Follow-up|1|||
164175312|NCT03045276|593005283|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
164175313|NCT03045276|593005284|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
164175314|NCT03045276|593005285|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
164175315|NCT03045276|593005286|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
164175316|NCT00347919|593005288|FG000|Overall Study|Lost to Follow-up|11|||
164175317|NCT00347919|593005289|FG001|Overall Study|Lost to Follow-up|13|||
164175318|NCT00347919|593005290|FG002|Overall Study|Lost to Follow-up|0|||
164175319|NCT00347919|593005288|FG000|Overall Study|Withdrawal by Subject|6|||
164175320|NCT00347919|593005289|FG001|Overall Study|Withdrawal by Subject|8|||
164175321|NCT00347919|593005290|FG002|Overall Study|Withdrawal by Subject|0|||
164175322|NCT00347919|593005288|FG000|Overall Study|Physician Decision|1|||
164175323|NCT00347919|593005289|FG001|Overall Study|Physician Decision|1|||
164175324|NCT00347919|593005290|FG002|Overall Study|Physician Decision|0|||
164175325|NCT00347919|593005288|FG000|Overall Study|Sponsor terminated study|15|||
164175326|NCT00347919|593005289|FG001|Overall Study|Sponsor terminated study|10|||
164175327|NCT00347919|593005290|FG002|Overall Study|Sponsor terminated study|16|||
164175328|NCT00347919|593005288|FG000|Overall Study|Death|35|||
164175329|NCT00347919|593005289|FG001|Overall Study|Death|42|||
164175330|NCT00347919|593005290|FG002|Overall Study|Death|19|||
164175331|NCT00347919|593005288|FG000|Overall Study|Par. Started Other Treatment|1|||
164175332|NCT00347919|593005289|FG001|Overall Study|Par. Started Other Treatment|1|||
164175333|NCT00347919|593005290|FG002|Overall Study|Par. Started Other Treatment|1|||
164175334|NCT00347919|593005288|FG000|Overall Study|Missing|2|||
164175335|NCT00347919|593005289|FG001|Overall Study|Missing|1|||
164175336|NCT00347919|593005290|FG002|Overall Study|Missing|2|||
164175337|NCT01190267|593005295|FG000|Overall Study|Adverse Event|10|||
164175338|NCT01190267|593005296|FG001|Overall Study|Adverse Event|0|||
164175339|NCT01190267|593005295|FG000|Overall Study|Treatment Failure|8|||
164175340|NCT01190267|593005296|FG001|Overall Study|Treatment Failure|2|||
164175341|NCT01190267|593005295|FG000|Overall Study|Lost to Follow-up|2|||
164175342|NCT01190267|593005296|FG001|Overall Study|Lost to Follow-up|0|||
164175343|NCT01190267|593005295|FG000|Overall Study|Withdrawal by Subject|13|||
164175344|NCT01190267|593005296|FG001|Overall Study|Withdrawal by Subject|1|||
164175345|NCT01190267|593005295|FG000|Overall Study|Protocol Violation|8|||
164175346|NCT01190267|593005296|FG001|Overall Study|Protocol Violation|1|||
164175347|NCT05513703|593005300|FG000|Overall Study|Death|4|||
164175348|NCT05513703|593005300|FG000|Overall Study|Study terminated by sponsor|5|||
164175349|NCT04450407|593005313|FG000|Overall Study|Withdrawal by Subject|10|||
164175350|NCT04450407|593005314|FG001|Overall Study|Withdrawal by Subject|1|||
164175351|NCT04450407|593005315|FG002|Overall Study|Withdrawal by Subject|4|||
164175352|NCT04450407|593005313|FG000|Overall Study|Adverse Event|0|||
164175353|NCT04450407|593005314|FG001|Overall Study|Adverse Event|0|||
164175354|NCT04450407|593005315|FG002|Overall Study|Adverse Event|1|||
164175355|NCT04450407|593005313|FG000|Overall Study|Lost to Follow-up|1|||
164175356|NCT04450407|593005314|FG001|Overall Study|Lost to Follow-up|0|||
164175357|NCT04450407|593005315|FG002|Overall Study|Lost to Follow-up|0|||
164175358|NCT04450407|593005313|FG000|Overall Study|Physician Decision|0|||
164175359|NCT04450407|593005314|FG001|Overall Study|Physician Decision|0|||
164175360|NCT04450407|593005315|FG002|Overall Study|Physician Decision|1|||
164175361|NCT04450407|593005313|FG000|Overall Study|Pregnancy|1|||
164175362|NCT04450407|593005314|FG001|Overall Study|Pregnancy|0|||
164175363|NCT04450407|593005315|FG002|Overall Study|Pregnancy|0|||
164175364|NCT04450407|593005313|FG000|Overall Study|Protocol Violation|2|||
164175365|NCT04450407|593005314|FG001|Overall Study|Protocol Violation|0|||
164175366|NCT04450407|593005315|FG002|Overall Study|Protocol Violation|0|||
164175367|NCT04450407|593005313|FG000|Overall Study|Investigational site terminated by sponsor|3|||
164175368|NCT04450407|593005314|FG001|Overall Study|Investigational site terminated by sponsor|0|||
164175369|NCT04450407|593005315|FG002|Overall Study|Investigational site terminated by sponsor|2|||
164175370|NCT04696354|593005318|FG000|Overall Study|Study termination|6|||
164175371|NCT04696354|593005319|FG001|Overall Study|Study termination|6|||
164175372|NCT00533702|593005321|FG000|Overall Study|Withdrawal by Subject|3|||
164175373|NCT00533702|593005322|FG001|Overall Study|Withdrawal by Subject|1|||
164175374|NCT00533702|593005321|FG000|Overall Study|Found ineligible after randomization|2|||
164175375|NCT00533702|593005322|FG001|Overall Study|Found ineligible after randomization|1|||
164175376|NCT01970475|593005325|FG000|Overall Study|Withdrawal by Subject|11|||
164175377|NCT01970475|593005326|FG001|Overall Study|Withdrawal by Subject|6|||
164175378|NCT01970475|593005325|FG000|Overall Study|Adverse Event|7|||
164175379|NCT01970475|593005326|FG001|Overall Study|Adverse Event|3|||
164175380|NCT01970475|593005325|FG000|Overall Study|Lost to Follow-up|2|||
164175381|NCT01970475|593005326|FG001|Overall Study|Lost to Follow-up|2|||
164175382|NCT01970475|593005325|FG000|Overall Study|Protocol Violation|1|||
164175383|NCT01970475|593005326|FG001|Overall Study|Protocol Violation|0|||
164175384|NCT04413552|593005331|FG000|Overall Study|Adverse Event|0|||
164175385|NCT04413552|593005332|FG001|Overall Study|Adverse Event|0|||
164175386|NCT04413552|593005333|FG002|Overall Study|Adverse Event|0|||
164175387|NCT04413552|593005334|FG003|Overall Study|Adverse Event|0|||
164175388|NCT04413552|593005335|FG004|Overall Study|Adverse Event|0|||
164175389|NCT04413552|593005336|FG005|Overall Study|Adverse Event|0|||
164175390|NCT04413552|593005337|FG006|Overall Study|Adverse Event|1|||
164175391|NCT04413552|593005338|FG007|Overall Study|Adverse Event|0|||
164175392|NCT04413552|593005339|FG008|Overall Study|Adverse Event|0|||
164175393|NCT04413552|593005340|FG009|Overall Study|Adverse Event|0|||
164175394|NCT01317797|593005341|FG000|Overall Study|Other|0|||
164175395|NCT01317797|593005342|FG001|Overall Study|Other|1|||
164175396|NCT01317797|593005343|FG002|Overall Study|Other|0|||
164175397|NCT01317797|593005341|FG000|Overall Study|Withdrawal of Patient|0|||
164175398|NCT01317797|593005342|FG001|Overall Study|Withdrawal of Patient|0|||
164175399|NCT01317797|593005343|FG002|Overall Study|Withdrawal of Patient|1|||
164175400|NCT03026530|593005344|FG000|Overall Study|Lost to Follow-up|19|||
164175401|NCT03026530|593005345|FG001|Overall Study|Lost to Follow-up|24|||
164175402|NCT03026530|593005344|FG000|Overall Study|Protocol Violation|2|||
164175403|NCT03026530|593005345|FG001|Overall Study|Protocol Violation|5|||
164175404|NCT03721835|593005347|FG000|Overall Study|Participant not able to return|1|||
164175405|NCT03721835|593005347|FG000|Overall Study|Lost to Follow-up|1|||
164175406|NCT03721835|593005347|FG000|Overall Study|Revision of the components of the study device|2|||
164175407|NCT03721835|593005347|FG000|Overall Study|Sponsor terminated study|6|||
164175408|NCT03721835|593005347|FG000|Overall Study|Death|1|||
164175409|NCT03721835|593005347|FG000|Overall Study|Sponsor decision|1|||
164175410|NCT03495154|593005348|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
164175411|NCT03495154|593005348|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
164175412|NCT03495154|593005348|FG000|Overall Study|Screen Failures During Surgery|6|||
164175413|NCT03495154|593005348|FG000|Overall Study|Death|2|||
164175414|NCT03495154|593005348|FG000|Overall Study|Lost to Follow-up|16|||
164175415|NCT03495154|593005348|FG000|Overall Study|Withdrawal by Subject|2|||
164175416|NCT03495154|593005348|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
164175417|NCT01294696|593005352|FG000|Overall Study|Screening failures|7|||
164175418|NCT01294696|593005352|FG000|Overall Study|Protocol Violation|8|||
164175419|NCT01294696|593005352|FG000|Overall Study|Missing BPI Response|7|||
164175420|NCT01294696|593005352|FG000|Overall Study|Site closure|52|||
164175421|NCT05741346|593006552|FG000|Overall Study|Withdrawn due to termination of study|28|||
164175422|NCT04439357|593006553|FG000|Overall Study|Disease Progression|4|||
164175423|NCT01668966|593006558|FG000|Overall Study|Withdrawal by Subject|1|||
164175424|NCT01668966|593006558|FG000|Overall Study|Death|1|||
164175425|NCT01668966|593006558|FG000|Overall Study|Not treated|2|||
164175426|NCT03602391|593006560|FG000|Overall Study|COVID-19|7|||
164175427|NCT03602391|593006561|FG001|Overall Study|COVID-19|6|||
164175428|NCT01527487|593006562|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
164175429|NCT01527487|593006563|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
164175430|NCT01527487|593006562|FG000|Overall Study|Disease Progression|4|||
164175431|NCT01527487|593006563|FG001|Overall Study|Disease Progression|1|||
164175432|NCT01527487|593006562|FG000|Overall Study|Adverse Event|1|||
164175433|NCT01527487|593006563|FG001|Overall Study|Adverse Event|1|||
164175434|NCT01527487|593006562|FG000|Overall Study|Death|0|||
164175435|NCT01527487|593006563|FG001|Overall Study|Death|1|||
164175436|NCT01892085|593006564|FG000|Overall Study|Death|4|||
164175437|NCT01892085|593006565|FG001|Overall Study|Death|1|||
164175438|NCT01892085|593006566|FG002|Overall Study|Death|3|||
164175439|NCT01892085|593006564|FG000|Overall Study|Withdrawal by Subject|2|||
164175440|NCT01892085|593006565|FG001|Overall Study|Withdrawal by Subject|0|||
164175441|NCT01892085|593006566|FG002|Overall Study|Withdrawal by Subject|2|||
164175442|NCT01472757|593006567|FG000|Overall Study|Withdrawal by Subject|1|||
164175443|NCT01472757|593006568|FG001|Overall Study|Withdrawal by Subject|2|||
164175444|NCT01472757|593006569|FG002|Overall Study|Withdrawal by Subject|2|||
164175445|NCT01472757|593006570|FG003|Overall Study|Withdrawal by Subject|0|||
164175446|NCT01472757|593006567|FG000|Overall Study|Asthma exacerbation|4|||
164175447|NCT01472757|593006568|FG001|Overall Study|Asthma exacerbation|1|||
164175448|NCT01472757|593006569|FG002|Overall Study|Asthma exacerbation|2|||
164175449|NCT01472757|593006570|FG003|Overall Study|Asthma exacerbation|1|||
164175450|NCT01472757|593006567|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
164175451|NCT01472757|593006568|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
164175452|NCT01472757|593006569|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
164175453|NCT01472757|593006570|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
164175454|NCT01472757|593006567|FG000|Overall Study|Protocol Violation|3|||
164175455|NCT01472757|593006568|FG001|Overall Study|Protocol Violation|2|||
164175456|NCT01472757|593006569|FG002|Overall Study|Protocol Violation|4|||
164175457|NCT01472757|593006570|FG003|Overall Study|Protocol Violation|4|||
164175458|NCT01472757|593006567|FG000|Overall Study|Other reasons|1|||
164175459|NCT01472757|593006568|FG001|Overall Study|Other reasons|0|||
164175460|NCT01472757|593006569|FG002|Overall Study|Other reasons|2|||
164175461|NCT01472757|593006570|FG003|Overall Study|Other reasons|2|||
164175462|NCT00597506|593006571|FG000|Overall Study|Subject is being followed for survival|1|||
164175463|NCT00081731|593006576|FG000|Overall Study|scientific integrity issue|8|||
164175464|NCT00081731|593006577|FG001|Overall Study|scientific integrity issue|8|||
164175465|NCT01629823|593006582|FG000|Trial Period|Missed visit|11|||
164175466|NCT01629823|593006583|FG001|Trial Period|Missed visit|9|||
164175467|NCT01629823|593006584|FG002|Trial Period|Missed visit|8|||
164175468|NCT01629823|593006582|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
164175469|NCT01629823|593006583|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
164175470|NCT01629823|593006584|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
164175471|NCT01629823|593006582|FG000|Trial Period|Pregnancy|1|||
164175472|NCT01629823|593006583|FG001|Trial Period|Pregnancy|0|||
164175473|NCT01629823|593006584|FG002|Trial Period|Pregnancy|0|||
164175474|NCT01629823|593006582|FG000|Trial Period|Adverse Event|0|||
164175475|NCT01629823|593006583|FG001|Trial Period|Adverse Event|1|||
164175476|NCT01629823|593006584|FG002|Trial Period|Adverse Event|0|||
164175477|NCT01629823|593006582|FG000|Trial Period|Out-of-window visit|0|||
164175478|NCT01629823|593006583|FG001|Trial Period|Out-of-window visit|2|||
164175479|NCT01629823|593006584|FG002|Trial Period|Out-of-window visit|0|||
164175480|NCT01629823|593006582|FG000|Trial Period|Failed to hold medication|0|||
164175481|NCT01629823|593006583|FG001|Trial Period|Failed to hold medication|0|||
164175482|NCT01629823|593006584|FG002|Trial Period|Failed to hold medication|1|||
164175483|NCT01629823|593006582|FG000|Washout Period|Safety|2|||
164175484|NCT01629823|593006583|FG001|Washout Period|Safety|5|||
164175485|NCT01629823|593006584|FG002|Washout Period|Safety|0|||
164175486|NCT01629823|593006582|FG000|Washout Period|Pregnancy|1|||
164175487|NCT01629823|593006583|FG001|Washout Period|Pregnancy|0|||
164175488|NCT01629823|593006584|FG002|Washout Period|Pregnancy|0|||
164175489|NCT01629823|593006582|FG000|Washout Period|Protocol Violation|0|||
164175490|NCT01629823|593006583|FG001|Washout Period|Protocol Violation|1|||
164175491|NCT01629823|593006584|FG002|Washout Period|Protocol Violation|0|||
164175492|NCT00785213|593006585|FG000|Quinine Sulfate Alone|Adverse Event|4|||
164175493|NCT00785213|593006585|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
164175494|NCT02386345|593006586|FG000|Overall Study|Not treated|14|||
164175495|NCT02386345|593006586|FG000|Overall Study|Lost to Follow-up|1|||
164175496|NCT02386345|593006586|FG000|Overall Study|Adverse Event|5|||
164175497|NCT02386345|593006586|FG000|Overall Study|Repeat Procedure|10|||
164175498|NCT02386345|593006586|FG000|Overall Study|Did not complete 12-month follow-up|72|||
164175499|NCT00526331|593006588|FG000|Overall Study|Sponsor Termination|55|||
164175500|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
164175501|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
164175502|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
164175503|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
164175504|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
164175505|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
164175506|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
164175507|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
164175508|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
164175509|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
164175510|NCT00455520|593006589|FG000|Open Label Tapentadol Extended Release|All other|33|||
164175511|NCT00455520|593006590|FG001|Open Label Tapentadol Extended Release|All other|0|||
164175512|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
164175513|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
164175514|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
164175515|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
164175516|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
164175517|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
164175518|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
164175519|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
164175520|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
164175521|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
164175522|NCT00455520|593006589|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
164175523|NCT00455520|593006590|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
164175524|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
164175525|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
164175526|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
164175527|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
164175528|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Death|1|||
164175529|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Death|1|||
164175530|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
164175531|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
164175532|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
164175533|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
164175534|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
164175535|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
164175536|NCT00033657|593006594|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
164175537|NCT00033657|593006595|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
164175538|NCT00033657|593006594|FG000|Surgical Resection|not complete resection|0|||
164175539|NCT00033657|593006595|FG001|Surgical Resection|not complete resection|3|||
164175540|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
164175541|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
164175542|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
164175543|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
164175544|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Death|2|||
164175545|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Death|1|||
164175546|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
164175547|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
164175548|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
164175549|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
164175550|NCT00033657|593006594|FG000|Adjuvant Chemotherapy|Other|0|||
164175551|NCT00033657|593006595|FG001|Adjuvant Chemotherapy|Other|2|||
164175552|NCT03448939|593006597|FG000|Overall Study|Adverse Event|5|||
164175553|NCT03448939|593006598|FG001|Overall Study|Adverse Event|1|||
164175554|NCT03448939|593006597|FG000|Overall Study|Lost to Follow-up|6|||
164175555|NCT03448939|593006598|FG001|Overall Study|Lost to Follow-up|6|||
164175556|NCT03448939|593006597|FG000|Overall Study|Pregnancy|1|||
164175557|NCT03448939|593006598|FG001|Overall Study|Pregnancy|1|||
164175558|NCT03448939|593006597|FG000|Overall Study|Withdrawal by Subject|9|||
164175559|NCT03448939|593006598|FG001|Overall Study|Withdrawal by Subject|3|||
164175560|NCT01259375|593006599|FG000|Overall Study|Adverse Event|1|||
164175561|NCT00986986|593006600|FG000|Overall Study|Lost to Follow-up|0|||
164175562|NCT00986986|593006601|FG001|Overall Study|Lost to Follow-up|1|||
164175563|NCT00628095|593006602|FG000|Overall Study|Adverse Event|5|||
164175564|NCT00628095|593006603|FG001|Overall Study|Adverse Event|3|||
164175565|NCT00628095|593006602|FG000|Overall Study|Lack of Efficacy|0|||
164175566|NCT00628095|593006603|FG001|Overall Study|Lack of Efficacy|3|||
164175567|NCT00628095|593006602|FG000|Overall Study|Withdrawal by Subject|2|||
164175568|NCT00628095|593006603|FG001|Overall Study|Withdrawal by Subject|0|||
164175569|NCT00628095|593006602|FG000|Overall Study|Other|0|||
164175570|NCT00628095|593006603|FG001|Overall Study|Other|1|||
164175571|NCT03235115|593006606|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175572|NCT03235115|593006607|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175573|NCT03235115|593006608|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175574|NCT03235115|593006609|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175575|NCT03235115|593006610|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
164175576|NCT03235115|593006611|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
164175577|NCT00503997|593006615|FG000|Overall Study|disease progression|1|||
164175578|NCT00503997|593006615|FG000|Overall Study|Adverse Event|5|||
164175579|NCT00503997|593006615|FG000|Overall Study|Death|1|||
164175580|NCT00503997|593006615|FG000|Overall Study|Withdrawal by Subject|1|||
164175581|NCT03973918|593006617|FG000|Overall Study|Adverse Event|0|||
164175582|NCT03973918|593006618|FG001|Overall Study|Adverse Event|0|||
164175583|NCT03973918|593006619|FG002|Overall Study|Adverse Event|0|||
164175584|NCT03973918|593006620|FG003|Overall Study|Adverse Event|1|||
164175585|NCT03973918|593006617|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
164175586|NCT03973918|593006618|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
164175587|NCT03973918|593006619|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
164175588|NCT03973918|593006620|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
164175589|NCT00955968|593006628|FG000|Overall Study|Death|2|||
164175590|NCT00955968|593006629|FG001|Overall Study|Death|4|||
164175591|NCT00955968|593006628|FG000|Overall Study|Withdrawal by Subject|35|||
164175592|NCT00955968|593006629|FG001|Overall Study|Withdrawal by Subject|31|||
164175593|NCT00955968|593006628|FG000|Overall Study|Lost to Follow-up|45|||
164175594|NCT00955968|593006629|FG001|Overall Study|Lost to Follow-up|39|||
164175595|NCT00955968|593006628|FG000|Overall Study|Site closed|55|||
164175596|NCT00955968|593006629|FG001|Overall Study|Site closed|52|||
164175597|NCT02484651|593006638|FG000|Overall Study|Patients' data files were corrupted.|1|||
164175598|NCT02484651|593006639|FG001|Overall Study|Patients' data files were corrupted.|1|||
164175599|NCT02484651|593006638|FG000|Overall Study|BIS monitoring failed.|1|||
164175600|NCT02484651|593006639|FG001|Overall Study|BIS monitoring failed.|1|||
164175601|NCT02484651|593006638|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
164175602|NCT02484651|593006639|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
164175603|NCT04972968|593006640|FG000|Overall Study|Adverse Event|3|||
164175604|NCT04972968|593006641|FG001|Overall Study|Adverse Event|1|||
164175605|NCT04972968|593006642|FG002|Overall Study|Adverse Event|1|||
164175606|NCT04972968|593006643|FG003|Overall Study|Adverse Event|7|||
164175607|NCT04972968|593006640|FG000|Overall Study|Lack of Efficacy|2|||
164175608|NCT04972968|593006641|FG001|Overall Study|Lack of Efficacy|1|||
164175609|NCT04972968|593006642|FG002|Overall Study|Lack of Efficacy|0|||
164175610|NCT04972968|593006643|FG003|Overall Study|Lack of Efficacy|0|||
164175611|NCT04972968|593006640|FG000|Overall Study|Withdrawal by Subject|7|||
164175612|NCT04972968|593006641|FG001|Overall Study|Withdrawal by Subject|4|||
164175613|NCT04972968|593006642|FG002|Overall Study|Withdrawal by Subject|3|||
164175614|NCT04972968|593006643|FG003|Overall Study|Withdrawal by Subject|2|||
164175615|NCT04972968|593006640|FG000|Overall Study|Study Terminated by Sponsor|25|||
164175616|NCT04972968|593006641|FG001|Overall Study|Study Terminated by Sponsor|28|||
164175617|NCT04972968|593006642|FG002|Overall Study|Study Terminated by Sponsor|32|||
164175618|NCT04972968|593006643|FG003|Overall Study|Study Terminated by Sponsor|27|||
164175619|NCT04972968|593006640|FG000|Overall Study|Other|1|||
164175620|NCT04972968|593006641|FG001|Overall Study|Other|0|||
164175621|NCT04972968|593006642|FG002|Overall Study|Other|1|||
164175622|NCT04972968|593006643|FG003|Overall Study|Other|1|||
164175623|NCT00150800|593006644|FG000|Overall Study|Adverse Event|89|||
164175624|NCT00150800|593006644|FG000|Overall Study|Death|18|||
164175625|NCT00150800|593006644|FG000|Overall Study|Lack of Efficacy|166|||
164175626|NCT00150800|593006644|FG000|Overall Study|Lost to Follow-up|58|||
164175627|NCT00150800|593006644|FG000|Overall Study|Subject's choice|90|||
164175628|NCT00150800|593006644|FG000|Overall Study|No compliance|18|||
164175629|NCT00150800|593006644|FG000|Overall Study|IP misshandling|1|||
164175630|NCT00150800|593006644|FG000|Overall Study|Site closure|24|||
164175631|NCT00150800|593006644|FG000|Overall Study|Protocol non-adherence|2|||
164175632|NCT00150800|593006644|FG000|Overall Study|Nobody to accompany patient|1|||
164175633|NCT00150800|593006644|FG000|Overall Study|Distance too long for patient|1|||
164175634|NCT00150800|593006644|FG000|Overall Study|Neurosurgery|2|||
164175635|NCT00150800|593006644|FG000|Overall Study|BRV monotherapy|1|||
164175636|NCT00150800|593006644|FG000|Overall Study|Visit refusal|3|||
164175637|NCT00150800|593006644|FG000|Overall Study|Sponsor's request|2|||
164175638|NCT00150800|593006644|FG000|Overall Study|Generalized Epilepsy|1|||
164175639|NCT00150800|593006644|FG000|Overall Study|Moved from area/country|8|||
164175640|NCT00150800|593006644|FG000|Overall Study|PI retiring|2|||
164175641|NCT00150800|593006644|FG000|Overall Study|PI leaving site|2|||
164175642|NCT00150800|593006644|FG000|Overall Study|Patient insurance|1|||
164175643|NCT00150800|593006644|FG000|Overall Study|Surgical intervention|4|||
164175644|NCT00150800|593006644|FG000|Overall Study|Pregnancy planned|1|||
164175645|NCT00150800|593006644|FG000|Overall Study|PI discontinuation request|1|||
164175646|NCT01698879|593006645|FG000|Overall Study|Withdrawal by Subject|1|||
164175647|NCT01698879|593006646|FG001|Overall Study|Withdrawal by Subject|0|||
164175648|NCT01698879|593006647|FG002|Overall Study|Withdrawal by Subject|0|||
164175649|NCT03649178|593006648|FG000|Overall Study|Adverse Event|1|||
164175650|NCT03649178|593006649|FG001|Overall Study|Adverse Event|2|||
164175651|NCT03649178|593006648|FG000|Overall Study|Withdrawal by Subject|0|||
164175652|NCT03649178|593006649|FG001|Overall Study|Withdrawal by Subject|2|||
164175653|NCT03649178|593006648|FG000|Overall Study|COVID regulation required halt in protocol|1|||
164175654|NCT03649178|593006649|FG001|Overall Study|COVID regulation required halt in protocol|0|||
164175655|NCT03619902|593006651|FG000|Overall Study|Termination of Study by Investigator|1|||
164175656|NCT03619902|593006651|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
164175657|NCT00794040|593006655|FG000|Overall Study|Withdrawal by Subject|3|||
164175658|NCT00794040|593006656|FG001|Overall Study|Withdrawal by Subject|4|||
164175659|NCT00794040|593006655|FG000|Overall Study|Physician Decision|0|||
164175660|NCT00794040|593006656|FG001|Overall Study|Physician Decision|1|||
164175661|NCT04687072|593006657|FG000|Overall Study|Adverse Event|2|||
164175662|NCT04687072|593006658|FG001|Overall Study|Adverse Event|0|||
164175663|NCT04687072|593006657|FG000|Overall Study|Death|1|||
164175664|NCT04687072|593006658|FG001|Overall Study|Death|0|||
164175665|NCT04687072|593006657|FG000|Overall Study|Lack of Efficacy|2|||
164175666|NCT04687072|593006658|FG001|Overall Study|Lack of Efficacy|1|||
164175667|NCT04687072|593006657|FG000|Overall Study|Physician Decision|1|||
164175668|NCT04687072|593006658|FG001|Overall Study|Physician Decision|0|||
164175669|NCT04687072|593006657|FG000|Overall Study|Pregnancy|1|||
164175670|NCT04687072|593006658|FG001|Overall Study|Pregnancy|0|||
164175671|NCT04687072|593006657|FG000|Overall Study|Requires Prohibited Medication|2|||
164175672|NCT04687072|593006658|FG001|Overall Study|Requires Prohibited Medication|0|||
164175673|NCT04687072|593006657|FG000|Overall Study|Withdrawal of Consent|11|||
164175674|NCT04687072|593006658|FG001|Overall Study|Withdrawal of Consent|6|||
164175675|NCT04687072|593006657|FG000|Overall Study|Miscellaneous|4|||
164175676|NCT04687072|593006658|FG001|Overall Study|Miscellaneous|1|||
164175677|NCT01263782|593006659|FG000|Overall Study|Death|0|||
164175678|NCT01263782|593006660|FG001|Overall Study|Death|0|||
164175679|NCT01263782|593006661|FG002|Overall Study|Death|1|||
164175680|NCT01263782|593006662|FG003|Overall Study|Death|0|||
164175681|NCT01263782|593006659|FG000|Overall Study|Progressive disease|0|||
164175682|NCT01263782|593006660|FG001|Overall Study|Progressive disease|0|||
164175683|NCT01263782|593006661|FG002|Overall Study|Progressive disease|0|||
164175684|NCT01263782|593006662|FG003|Overall Study|Progressive disease|1|||
164175685|NCT01263782|593006659|FG000|Overall Study|Too early|0|||
164175686|NCT01263782|593006660|FG001|Overall Study|Too early|0|||
164175687|NCT01263782|593006661|FG002|Overall Study|Too early|1|||
164175688|NCT01263782|593006662|FG003|Overall Study|Too early|0|||
164175689|NCT01263782|593006659|FG000|Overall Study|Inevaluable|0|||
164175690|NCT01263782|593006660|FG001|Overall Study|Inevaluable|0|||
164175691|NCT01263782|593006661|FG002|Overall Study|Inevaluable|1|||
164175692|NCT01263782|593006662|FG003|Overall Study|Inevaluable|0|||
164175693|NCT04545567|593006664|FG000|Overall Study|tested positive for SARS-co-V2|1|||
164175694|NCT04545567|593006665|FG001|Overall Study|tested positive for SARS-co-V2|1|||
164175695|NCT04545567|593006664|FG000|Overall Study|Withdrawal by Subject|0|||
164175696|NCT04545567|593006665|FG001|Overall Study|Withdrawal by Subject|1|||
164175697|NCT03626363|593006671|FG000|Overall Study|Protocol Violation|4|||
164175698|NCT03626363|593006672|FG001|Overall Study|Protocol Violation|0|||
164175699|NCT03626363|593006671|FG000|Overall Study|Lost to Follow-up|5|||
164175700|NCT03626363|593006672|FG001|Overall Study|Lost to Follow-up|7|||
164175701|NCT00965341|593006673|FG000|Overall Study|Withdrew consent|1|||
164175702|NCT00965341|593006674|FG001|Overall Study|Withdrew consent|5|||
164175703|NCT00965341|593006673|FG000|Overall Study|Lost to Follow-up|1|||
164175704|NCT00965341|593006674|FG001|Overall Study|Lost to Follow-up|0|||
164175705|NCT00965341|593006673|FG000|Overall Study|Transportation issues|4|||
164175706|NCT00965341|593006674|FG001|Overall Study|Transportation issues|3|||
164175707|NCT01077739|593006675|FG000|Overall Study|Premature withdrawal|1|||
164175708|NCT01077739|593006676|FG001|Overall Study|Premature withdrawal|3|||
164175709|NCT01077739|593006675|FG000|Overall Study|Withdrawal by Subject|1|||
164175710|NCT01077739|593006676|FG001|Overall Study|Withdrawal by Subject|0|||
164175711|NCT01077739|593006675|FG000|Overall Study|Death|0|||
164175712|NCT01077739|593006676|FG001|Overall Study|Death|3|||
164175713|NCT01077739|593006675|FG000|Overall Study|Unacceptable toxicity|1|||
164175714|NCT01077739|593006676|FG001|Overall Study|Unacceptable toxicity|2|||
164175715|NCT01077739|593006675|FG000|Overall Study|Other|2|||
164175716|NCT01077739|593006676|FG001|Overall Study|Other|2|||
164175717|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
164175718|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
164175719|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
164175720|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
164175721|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
164175722|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
164175723|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
164175724|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
164175725|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
164175726|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
164175727|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
164175728|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
164175729|NCT00960986|593006677|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
164175730|NCT00960986|593006678|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
164175731|NCT00960986|593006679|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
164175732|NCT00960986|593006680|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
164175733|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
164175734|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
164175735|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
164175736|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
164175737|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Death|0|||
164175738|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Death|0|||
164175739|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Death|1|||
164175740|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Death|0|||
164175741|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
164175742|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
164175743|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
164175744|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
164175745|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
164175746|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
164175747|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
164175748|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
164175749|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
164175750|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
164175751|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
164175752|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
164175753|NCT00960986|593006677|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
164175754|NCT00960986|593006678|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
164175755|NCT00960986|593006679|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
164175756|NCT00960986|593006680|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
164175757|NCT00877071|593006681|FG000|Overall Study|disease progression|2|||
164175758|NCT01556997|593008051|FG000|Overall Study|Adverse Event|10|||
164175759|NCT01556997|593008052|FG001|Overall Study|Adverse Event|12|||
164175760|NCT01556997|593008053|FG002|Overall Study|Adverse Event|12|||
164175761|NCT01556997|593008051|FG000|Overall Study|Lost to Follow-up|6|||
164175762|NCT01556997|593008052|FG001|Overall Study|Lost to Follow-up|6|||
164175763|NCT01556997|593008053|FG002|Overall Study|Lost to Follow-up|4|||
164175764|NCT01556997|593008051|FG000|Overall Study|Physician Decision|1|||
164175765|NCT01556997|593008052|FG001|Overall Study|Physician Decision|1|||
164175766|NCT01556997|593008053|FG002|Overall Study|Physician Decision|1|||
164175767|NCT01556997|593008051|FG000|Overall Study|Withdrawal by Subject|7|||
164175768|NCT01556997|593008052|FG001|Overall Study|Withdrawal by Subject|6|||
164175769|NCT01556997|593008053|FG002|Overall Study|Withdrawal by Subject|8|||
164175770|NCT01556997|593008051|FG000|Overall Study|Other|2|||
164175771|NCT01556997|593008052|FG001|Overall Study|Other|3|||
164175772|NCT01556997|593008053|FG002|Overall Study|Other|7|||
164175773|NCT05459558|593008054|FG000|Overall Study|Adverse Event|1|||
164175774|NCT05459558|593008055|FG001|Overall Study|Adverse Event|0|||
164175775|NCT05459558|593008056|FG002|Overall Study|Adverse Event|0|||
164175776|NCT05459558|593008054|FG000|Overall Study|Scheduling issue|0|||
164175777|NCT05459558|593008055|FG001|Overall Study|Scheduling issue|1|||
164175778|NCT05459558|593008056|FG002|Overall Study|Scheduling issue|3|||
164175779|NCT05459558|593008054|FG000|Overall Study|Withdrawal by Subject|0|||
164175780|NCT05459558|593008055|FG001|Overall Study|Withdrawal by Subject|0|||
164175781|NCT05459558|593008056|FG002|Overall Study|Withdrawal by Subject|2|||
164175782|NCT00250458|593008069|FG000|Overall Study|Lost to Follow-up|4|||
164175783|NCT00250458|593008070|FG001|Overall Study|Lost to Follow-up|2|||
164175784|NCT00250458|593008069|FG000|Overall Study|Protocol Violation|0|||
164175785|NCT00250458|593008070|FG001|Overall Study|Protocol Violation|1|||
164175786|NCT00250458|593008069|FG000|Overall Study|Withdrawal by Subject|4|||
164175787|NCT00250458|593008070|FG001|Overall Study|Withdrawal by Subject|2|||
164175788|NCT00250458|593008069|FG000|Overall Study|Lack of Migraine Attack|20|||
164175789|NCT00250458|593008070|FG001|Overall Study|Lack of Migraine Attack|9|||
164175790|NCT00250458|593008069|FG000|Overall Study|Qualifying migraine but did not treat|3|||
164175791|NCT00250458|593008070|FG001|Overall Study|Qualifying migraine but did not treat|3|||
164175792|NCT00250458|593008069|FG000|Overall Study|Other|1|||
164175793|NCT00250458|593008070|FG001|Overall Study|Other|0|||
164175794|NCT00741091|593008071|FG000|Overall Study|Death|13|||
164175795|NCT00741091|593008071|FG000|Overall Study|Lost to Follow-up|16|||
164175796|NCT00741091|593008071|FG000|Overall Study|Withdrawal by Subject|6|||
164175797|NCT00741091|593008071|FG000|Overall Study|Missed Visit|22|||
164175798|NCT00525902|593008075|FG000|Overall Study|Lack of Efficacy|1|||
164175799|NCT00480493|593008076|FG000|Overall Study|moved|2|||
164175800|NCT00480493|593008077|FG001|Overall Study|moved|7|||
164175801|NCT03747302|593008078|FG000|Overall Study|Withdrawal by Subject|1|||
164175802|NCT03747302|593008079|FG001|Overall Study|Withdrawal by Subject|2|||
164175803|NCT03769675|593008082|FG000|Overall Study|Lost to Follow-up|1|||
164175804|NCT02844907|593008083|FG000|With Dexamethasone|No IV access|1|||
164175805|NCT00738062|593008084|FG000|Open Label Treatment|Lack of Efficacy|5|||
164175806|NCT00738062|593008085|FG001|Open Label Treatment|Lack of Efficacy|0|||
164175807|NCT00738062|593008086|FG002|Open Label Treatment|Lack of Efficacy|0|||
164175808|NCT00738062|593008084|FG000|Open Label Treatment|Adverse Event|11|||
164175809|NCT00738062|593008085|FG001|Open Label Treatment|Adverse Event|0|||
164175810|NCT00738062|593008086|FG002|Open Label Treatment|Adverse Event|0|||
164175811|NCT00738062|593008084|FG000|Open Label Treatment|Protocol Violation|2|||
164175812|NCT00738062|593008085|FG001|Open Label Treatment|Protocol Violation|0|||
164175813|NCT00738062|593008086|FG002|Open Label Treatment|Protocol Violation|0|||
164175814|NCT00738062|593008084|FG000|Open Label Treatment|Withdrawal by Subject|9|||
164175815|NCT00738062|593008085|FG001|Open Label Treatment|Withdrawal by Subject|0|||
164175816|NCT00738062|593008086|FG002|Open Label Treatment|Withdrawal by Subject|0|||
164175817|NCT00738062|593008084|FG000|Open Label Treatment|Investigator Decision|1|||
164175818|NCT00738062|593008085|FG001|Open Label Treatment|Investigator Decision|0|||
164175819|NCT00738062|593008086|FG002|Open Label Treatment|Investigator Decision|0|||
164175820|NCT00738062|593008084|FG000|Open-Label Extension|Adverse Event|5|||
164175821|NCT00738062|593008085|FG001|Open-Label Extension|Adverse Event|0|||
164175822|NCT00738062|593008086|FG002|Open-Label Extension|Adverse Event|0|||
164175823|NCT00738062|593008084|FG000|Open-Label Extension|Physician Decision|1|||
164175824|NCT00738062|593008085|FG001|Open-Label Extension|Physician Decision|0|||
164175825|NCT00738062|593008086|FG002|Open-Label Extension|Physician Decision|0|||
164175826|NCT00738062|593008084|FG000|Open-Label Extension|Lack of Efficacy|2|||
164175827|NCT00738062|593008085|FG001|Open-Label Extension|Lack of Efficacy|0|||
164175828|NCT00738062|593008086|FG002|Open-Label Extension|Lack of Efficacy|0|||
164175829|NCT00738062|593008084|FG000|Open-Label Extension|Withdrawal by Subject|6|||
164175830|NCT00738062|593008085|FG001|Open-Label Extension|Withdrawal by Subject|0|||
164175831|NCT00738062|593008086|FG002|Open-Label Extension|Withdrawal by Subject|0|||
164175832|NCT00738062|593008084|FG000|Open-Label Extension|Protocol Violation|1|||
164175833|NCT00738062|593008085|FG001|Open-Label Extension|Protocol Violation|0|||
164175834|NCT00738062|593008086|FG002|Open-Label Extension|Protocol Violation|0|||
164175835|NCT00738062|593008084|FG000|Open-Label Extension|Study Terminated|2|||
164175836|NCT00738062|593008085|FG001|Open-Label Extension|Study Terminated|0|||
164175837|NCT00738062|593008086|FG002|Open-Label Extension|Study Terminated|0|||
164175838|NCT02945254|593008087|FG000|Overall Study|Lost to Follow-up|1|||
164175839|NCT02945254|593008088|FG001|Overall Study|Lost to Follow-up|0|||
164175840|NCT02945254|593008087|FG000|Overall Study|Withdrawal by Subject|1|||
164175841|NCT02945254|593008088|FG001|Overall Study|Withdrawal by Subject|0|||
164175842|NCT00783224|593008089|FG000|Overall Study|Adverse Event|0|||
164175843|NCT00783224|593008090|FG001|Overall Study|Adverse Event|0|||
164175844|NCT00783224|593008091|FG002|Overall Study|Adverse Event|1|||
164175845|NCT00783224|593008092|FG003|Overall Study|Adverse Event|0|||
164175846|NCT00783224|593008089|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
164175847|NCT00783224|593008090|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
164175848|NCT00783224|593008091|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
164175849|NCT00783224|593008092|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
164175850|NCT00783224|593008089|FG000|Overall Study|Inappropriate as a study subject|0|||
164175851|NCT00783224|593008090|FG001|Overall Study|Inappropriate as a study subject|0|||
164175852|NCT00783224|593008091|FG002|Overall Study|Inappropriate as a study subject|0|||
164175853|NCT00783224|593008092|FG003|Overall Study|Inappropriate as a study subject|1|||
164175854|NCT01711619|593008093|FG000|Overall Study|Early study termination|10|||
164175855|NCT01711619|593008094|FG001|Overall Study|Early study termination|14|||
164175856|NCT01711619|593008093|FG000|Overall Study|Withdrawal by Subject|3|||
164175857|NCT01711619|593008094|FG001|Overall Study|Withdrawal by Subject|7|||
164175858|NCT01711619|593008093|FG000|Overall Study|Protocol Violation|2|||
164175859|NCT01711619|593008094|FG001|Overall Study|Protocol Violation|3|||
164175860|NCT01711619|593008093|FG000|Overall Study|Adverse Event|2|||
164175861|NCT01711619|593008094|FG001|Overall Study|Adverse Event|0|||
164175862|NCT01711619|593008093|FG000|Overall Study|Lost to Follow-up|1|||
164175863|NCT01711619|593008094|FG001|Overall Study|Lost to Follow-up|0|||
164175864|NCT03422159|593008095|FG000|Overall Study|Exclusion due to terminal disease|2|||
164175865|NCT03422159|593008096|FG001|Overall Study|Exclusion due to terminal disease|1|||
164175866|NCT04631107|593008097|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
164175867|NCT04631107|593008097|FG000|Second Intervention (1 Night)|Adverse Event|1|||
164175868|NCT04631107|593008097|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
164175869|NCT04631107|593008097|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
164175870|NCT04601103|593008098|FG000|Overall Study|Needed crown & cleaning|0|||
164175871|NCT04601103|593008099|FG001|Overall Study|Needed crown & cleaning|0|||
164175872|NCT04601103|593008100|FG002|Overall Study|Needed crown & cleaning|1|||
164175873|NCT04601103|593008098|FG000|Overall Study|study was terminated|18|||
164175874|NCT04601103|593008099|FG001|Overall Study|study was terminated|18|||
164175875|NCT04601103|593008100|FG002|Overall Study|study was terminated|16|||
164175876|NCT01068626|593008101|FG000|Overall Study|Adverse Event|3|||
164175877|NCT01068626|593008102|FG001|Overall Study|Adverse Event|0|||
164175878|NCT01068626|593008101|FG000|Overall Study|Withdrawal by Subject|0|||
164175879|NCT01068626|593008102|FG001|Overall Study|Withdrawal by Subject|2|||
164175880|NCT03932331|593008104|FG000|Overall Study|Death|0|||
164175881|NCT03932331|593008105|FG001|Overall Study|Death|7|||
164175882|NCT03932331|593008106|FG002|Overall Study|Death|2|||
164175883|NCT03932331|593008104|FG000|Overall Study|Withdrawal by Subject|0|||
164175884|NCT03932331|593008105|FG001|Overall Study|Withdrawal by Subject|3|||
164175885|NCT03932331|593008106|FG002|Overall Study|Withdrawal by Subject|0|||
164175886|NCT03932331|593008104|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
164175887|NCT03932331|593008105|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
164175888|NCT03932331|593008106|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
164175889|NCT03932331|593008104|FG000|Overall Study|Progressive disease|3|||
164175890|NCT03932331|593008105|FG001|Overall Study|Progressive disease|0|||
164175891|NCT03932331|593008106|FG002|Overall Study|Progressive disease|0|||
164175892|NCT03932331|593008104|FG000|Overall Study|Lung infection|1|||
164175893|NCT03932331|593008105|FG001|Overall Study|Lung infection|0|||
164175894|NCT03932331|593008106|FG002|Overall Study|Lung infection|0|||
164175895|NCT03932331|593008104|FG000|Overall Study|Other|0|||
164175896|NCT03932331|593008105|FG001|Overall Study|Other|0|||
164175897|NCT03932331|593008106|FG002|Overall Study|Other|58|||
164175898|NCT01032239|593008107|FG000|Overall Study|Lost to Follow-up|3|||
164175899|NCT01032239|593008108|FG001|Overall Study|Lost to Follow-up|2|||
164175900|NCT01032239|593008107|FG000|Overall Study|Withdrawal by Subject|2|||
164175901|NCT01032239|593008108|FG001|Overall Study|Withdrawal by Subject|3|||
164175902|NCT01032239|593008107|FG000|Overall Study|Death|1|||
164175903|NCT01032239|593008108|FG001|Overall Study|Death|0|||
164175904|NCT01032239|593008107|FG000|Overall Study|Protocol Violation|1|||
164175905|NCT01032239|593008108|FG001|Overall Study|Protocol Violation|0|||
164175906|NCT01940900|593008109|FG000|Overall Study|Physician Decision|4|||
164175907|NCT01940900|593008110|FG001|Overall Study|Physician Decision|0|||
164175908|NCT01940900|593008109|FG000|Overall Study|Adverse Event|10|||
164175909|NCT01940900|593008110|FG001|Overall Study|Adverse Event|15|||
164175910|NCT01940900|593008109|FG000|Overall Study|Withdrawal by Subject|11|||
164175911|NCT01940900|593008110|FG001|Overall Study|Withdrawal by Subject|15|||
164175912|NCT01940900|593008109|FG000|Overall Study|Lost to Follow-up|1|||
164175913|NCT01940900|593008110|FG001|Overall Study|Lost to Follow-up|0|||
164175914|NCT01940900|593008109|FG000|Overall Study|Sponsor Decision|1|||
164175915|NCT01940900|593008110|FG001|Overall Study|Sponsor Decision|0|||
164175916|NCT01940900|593008109|FG000|Overall Study|subject non-compliance|1|||
164175917|NCT01940900|593008110|FG001|Overall Study|subject non-compliance|1|||
164175918|NCT01940900|593008109|FG000|Overall Study|other|1|||
164175919|NCT01940900|593008110|FG001|Overall Study|other|0|||
164175920|NCT00204477|593008113|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
164175921|NCT00204477|593008114|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
164175922|NCT00204477|593008113|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
164175923|NCT00204477|593008114|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
164175924|NCT04713592|593008115|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
164175925|NCT04713592|593008116|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
164175926|NCT04713592|593008117|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
164175927|NCT04713592|593008118|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
164175928|NCT04713592|593008115|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
164175929|NCT04713592|593008116|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
164175930|NCT04713592|593008117|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
164175931|NCT04713592|593008118|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
164175932|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
164175933|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
164175934|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
164175935|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
164175936|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164175937|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164175938|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
164175939|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
164175940|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
164175941|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
164175942|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
164175943|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
164175944|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164175945|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164175946|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164175947|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164175948|NCT04713592|593008115|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
164175949|NCT04713592|593008116|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
164175950|NCT04713592|593008117|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
164175951|NCT04713592|593008118|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
164175952|NCT02225366|593008121|FG000|Overall Study|Lack of Efficacy|1|||
164175953|NCT02225366|593008122|FG001|Overall Study|Lack of Efficacy|0|||
164175954|NCT03782298|593008127|FG000|Overall Study|Protocol Deviation|4|||
164175955|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
164175956|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
164175957|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
164175958|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
164175959|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
164175960|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
164175961|NCT00742508|593008128|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
164175962|NCT00742508|593008129|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
164175963|NCT00742508|593008128|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
164175964|NCT00742508|593008129|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
164175965|NCT02431806|593008130|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
164175966|NCT02431806|593008131|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
164175967|NCT02431806|593008132|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
164175968|NCT02431806|593008133|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
164175969|NCT02431806|593008130|FG000|Double-blind Treatment Period|Adverse Event|4|||
164175970|NCT02431806|593008131|FG001|Double-blind Treatment Period|Adverse Event|7|||
164175971|NCT02431806|593008132|FG002|Double-blind Treatment Period|Adverse Event|11|||
164175972|NCT02431806|593008133|FG003|Double-blind Treatment Period|Adverse Event|7|||
164175973|NCT02431806|593008130|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
164175974|NCT02431806|593008131|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164175975|NCT02431806|593008132|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
164175976|NCT02431806|593008133|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
164175977|NCT02431806|593008130|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
164175978|NCT02431806|593008131|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
164175979|NCT02431806|593008132|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
164175980|NCT02431806|593008133|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
164175981|NCT02431806|593008130|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
164175982|NCT02431806|593008131|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
164175983|NCT02431806|593008132|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
164175984|NCT02431806|593008133|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
164175985|NCT02431806|593008130|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
164175986|NCT02431806|593008131|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
164175987|NCT02431806|593008132|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
164175988|NCT02431806|593008133|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
164175989|NCT02431806|593008130|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
164175990|NCT02431806|593008131|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
164175991|NCT02431806|593008132|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
164175992|NCT02431806|593008133|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
164175993|NCT01382225|593008134|FG000|Overall Study|Adverse Event|3|||
164175994|NCT01382225|593008135|FG001|Overall Study|Adverse Event|2|||
164175995|NCT01382225|593008134|FG000|Overall Study|Protocol Violation|2|||
164175996|NCT01382225|593008135|FG001|Overall Study|Protocol Violation|1|||
164175997|NCT01382225|593008134|FG000|Overall Study|Subject Withdrew Consent|5|||
164175998|NCT01382225|593008135|FG001|Overall Study|Subject Withdrew Consent|2|||
164175999|NCT01382225|593008134|FG000|Overall Study|Other|4|||
164176000|NCT01382225|593008135|FG001|Overall Study|Other|2|||
164176001|NCT01797081|593008138|FG000|Overall Study|Adverse Event|1|||
164176002|NCT01797081|593008139|FG001|Overall Study|Adverse Event|0|||
164176003|NCT01797081|593008140|FG002|Overall Study|Adverse Event|1|||
164176004|NCT01797081|593008141|FG003|Overall Study|Adverse Event|0|||
164176005|NCT01797081|593008138|FG000|Overall Study|Pregnancy|1|||
164176006|NCT01797081|593008139|FG001|Overall Study|Pregnancy|0|||
164176007|NCT01797081|593008140|FG002|Overall Study|Pregnancy|0|||
164176008|NCT01797081|593008141|FG003|Overall Study|Pregnancy|0|||
164176009|NCT01797081|593008138|FG000|Overall Study|Personal Reasons|12|||
164176010|NCT01797081|593008139|FG001|Overall Study|Personal Reasons|4|||
164176011|NCT01797081|593008140|FG002|Overall Study|Personal Reasons|4|||
164176012|NCT01797081|593008141|FG003|Overall Study|Personal Reasons|8|||
164176013|NCT01797081|593008138|FG000|Overall Study|Protocol Violation|0|||
164176014|NCT01797081|593008139|FG001|Overall Study|Protocol Violation|0|||
164176015|NCT01797081|593008140|FG002|Overall Study|Protocol Violation|0|||
164176016|NCT01797081|593008141|FG003|Overall Study|Protocol Violation|1|||
164176017|NCT01793688|593008142|FG000|Overall Study|Protocol Violation|2|||
164176018|NCT01419080|593008143|FG000|Overall Study|Withdrawal by Subject|75|||
164176019|NCT01419080|593008143|FG000|Overall Study|Death|30|||
164176020|NCT01419080|593008143|FG000|Overall Study|Lost to Follow-up|23|||
164176021|NCT01419080|593008143|FG000|Overall Study|Too Ill|3|||
164176022|NCT05238025|593008144|FG000|Overall Study|Adverse Event|2|||
164176023|NCT05238025|593008145|FG001|Overall Study|Adverse Event|2|||
164176024|NCT05238025|593008144|FG000|Overall Study|Lost to Follow-up|334|||
164176025|NCT05238025|593008145|FG001|Overall Study|Lost to Follow-up|339|||
164176026|NCT05238025|593008144|FG000|Overall Study|Withdrawal by Subject|203|||
164176027|NCT05238025|593008145|FG001|Overall Study|Withdrawal by Subject|222|||
164176028|NCT05238025|593008144|FG000|Overall Study|Physician Decision|20|||
164176029|NCT05238025|593008145|FG001|Overall Study|Physician Decision|8|||
164176030|NCT05238025|593008144|FG000|Overall Study|Protocol Violation|6|||
164176031|NCT05238025|593008145|FG001|Overall Study|Protocol Violation|2|||
164176032|NCT05238025|593008144|FG000|Overall Study|Death|38|||
164176033|NCT05238025|593008145|FG001|Overall Study|Death|32|||
164176034|NCT05238025|593008144|FG000|Overall Study|Study terminated by Sponsor|6358|||
164176035|NCT05238025|593008145|FG001|Overall Study|Study terminated by Sponsor|6358|||
164176036|NCT05238025|593008144|FG000|Overall Study|Other Reason|669|||
164176037|NCT05238025|593008145|FG001|Overall Study|Other Reason|690|||
164176038|NCT03814720|593008148|FG000|Overall Study|Lost to Follow-up|0|||
164176039|NCT03814720|593008149|FG001|Overall Study|Lost to Follow-up|1|||
164176040|NCT03814720|593008150|FG002|Overall Study|Lost to Follow-up|0|||
164176041|NCT03814720|593008151|FG003|Overall Study|Lost to Follow-up|0|||
164176042|NCT03814720|593008152|FG004|Overall Study|Lost to Follow-up|0|||
164176043|NCT02135107|593008153|FG000|Treatment Period|Withdrawal by Subject|11|||
164176044|NCT02135107|593008154|FG001|Treatment Period|Withdrawal by Subject|0|||
164176045|NCT02135107|593008155|FG002|Treatment Period|Withdrawal by Subject|0|||
164176046|NCT02135107|593008156|FG003|Treatment Period|Withdrawal by Subject|0|||
164176047|NCT02135107|593008153|FG000|Treatment Period|Adverse Event|5|||
164176048|NCT02135107|593008154|FG001|Treatment Period|Adverse Event|2|||
164176049|NCT02135107|593008155|FG002|Treatment Period|Adverse Event|0|||
164176050|NCT02135107|593008156|FG003|Treatment Period|Adverse Event|0|||
164176051|NCT02135107|593008153|FG000|Treatment Period|Pregnancy|1|||
164176052|NCT02135107|593008154|FG001|Treatment Period|Pregnancy|0|||
164176053|NCT02135107|593008155|FG002|Treatment Period|Pregnancy|0|||
164176054|NCT02135107|593008156|FG003|Treatment Period|Pregnancy|0|||
164176055|NCT02135107|593008153|FG000|Treatment Period|Other|115|||
164176056|NCT02135107|593008154|FG001|Treatment Period|Other|24|||
164176057|NCT02135107|593008155|FG002|Treatment Period|Other|0|||
164176058|NCT02135107|593008156|FG003|Treatment Period|Other|0|||
164176059|NCT02135107|593008153|FG000|Maintenance Therapy Period|Adverse Event|0|||
164176060|NCT02135107|593008154|FG001|Maintenance Therapy Period|Adverse Event|0|||
164176061|NCT02135107|593008155|FG002|Maintenance Therapy Period|Adverse Event|3|||
164176062|NCT02135107|593008156|FG003|Maintenance Therapy Period|Adverse Event|7|||
164176063|NCT02135107|593008153|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
164176064|NCT02135107|593008154|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
164176065|NCT02135107|593008155|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
164176066|NCT02135107|593008156|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
164176067|NCT02135107|593008153|FG000|Maintenance Therapy Period|Pregnancy|0|||
164176068|NCT02135107|593008154|FG001|Maintenance Therapy Period|Pregnancy|0|||
164176069|NCT02135107|593008155|FG002|Maintenance Therapy Period|Pregnancy|0|||
164176070|NCT02135107|593008156|FG003|Maintenance Therapy Period|Pregnancy|1|||
164176071|NCT02135107|593008153|FG000|Maintenance Therapy Period|Other|0|||
164176072|NCT02135107|593008154|FG001|Maintenance Therapy Period|Other|0|||
164176073|NCT02135107|593008155|FG002|Maintenance Therapy Period|Other|7|||
164176074|NCT02135107|593008156|FG003|Maintenance Therapy Period|Other|8|||
164176075|NCT00474045|593008163|FG000|Overall Study|Adverse Event|18|||
164176076|NCT00474045|593008164|FG001|Overall Study|Adverse Event|8|||
164176077|NCT00474045|593008163|FG000|Overall Study|Unclassified|1|||
164176078|NCT00474045|593008164|FG001|Overall Study|Unclassified|3|||
164176079|NCT00474045|593008163|FG000|Overall Study|Lack of Efficacy|0|||
164176080|NCT00474045|593008164|FG001|Overall Study|Lack of Efficacy|9|||
164176081|NCT00474045|593008163|FG000|Overall Study|Lost to Follow-up|1|||
164176082|NCT00474045|593008164|FG001|Overall Study|Lost to Follow-up|1|||
164176083|NCT00474045|593008163|FG000|Overall Study|Protocol Violation|10|||
164176084|NCT00474045|593008164|FG001|Overall Study|Protocol Violation|12|||
164176085|NCT00474045|593008163|FG000|Overall Study|Withdrawal by Subject|16|||
164176086|NCT00474045|593008164|FG001|Overall Study|Withdrawal by Subject|18|||
164176087|NCT00474045|593008163|FG000|Overall Study|Withdrawal criteria|60|||
164176088|NCT00474045|593008164|FG001|Overall Study|Withdrawal criteria|50|||
164176089|NCT01095978|593008165|FG000|Overall Study|Did not take Klacid SR|2|||
164176090|NCT01095978|593008165|FG000|Overall Study|Adverse Event|1|||
164176091|NCT02009397|593008166|FG000|Overall Study|Protocol Violation|6|||
164176092|NCT02009397|593008166|FG000|Overall Study|Death|8|||
164176093|NCT02009397|593008166|FG000|Overall Study|Lost to Follow-up|6|||
164176094|NCT02278120|593008171|FG000|Treatment Period|Progressive disease|234|||
164176095|NCT02278120|593008172|FG001|Treatment Period|Progressive disease|260|||
164176096|NCT02278120|593008171|FG000|Treatment Period|Subject/guardian decision|23|||
164176097|NCT02278120|593008172|FG001|Treatment Period|Subject/guardian decision|20|||
164176098|NCT02278120|593008171|FG000|Treatment Period|Adverse Event|16|||
164176099|NCT02278120|593008172|FG001|Treatment Period|Adverse Event|14|||
164176100|NCT02278120|593008171|FG000|Treatment Period|Physician Decision|14|||
164176101|NCT02278120|593008172|FG001|Treatment Period|Physician Decision|27|||
164176102|NCT02278120|593008171|FG000|Treatment Period|Death|3|||
164176103|NCT02278120|593008172|FG001|Treatment Period|Death|3|||
164176104|NCT02278120|593008171|FG000|Treatment Period|Lost to Follow-up|2|||
164176105|NCT02278120|593008172|FG001|Treatment Period|Lost to Follow-up|0|||
164176106|NCT02278120|593008171|FG000|Treatment Period|Protocol deviation|0|||
164176107|NCT02278120|593008172|FG001|Treatment Period|Protocol deviation|2|||
164176108|NCT02278120|593008171|FG000|Treatment Period|Study terminated as per protocol|43|||
164176109|NCT02278120|593008172|FG001|Treatment Period|Study terminated as per protocol|11|||
164176110|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Death|0|||
164176111|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Death|1|||
164176112|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
164176113|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
164176114|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
164176115|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
164176116|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
164176117|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
164176118|NCT02278120|593008171|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164176119|NCT02278120|593008172|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
164176120|NCT00808639|593008176|FG000|Overall Study|Disease progression before surgery.|1|||
164176121|NCT01966068|593008177|FG000|Overall Study|Withdrawal by Subject|57|||
164176122|NCT01966068|593008177|FG000|Overall Study|Lost to Follow-up|81|||
164176123|NCT03197324|593008180|FG000|Overall Study|Adverse Event|0|||
164176124|NCT03197324|593008181|FG001|Overall Study|Adverse Event|1|||
164176125|NCT03589976|593008183|FG000|Overall Study|Death|5|||
164176126|NCT03589976|593008184|FG001|Overall Study|Death|1|||
164176127|NCT03589976|593008183|FG000|Overall Study|Adverse Event|5|||
164176128|NCT03589976|593008184|FG001|Overall Study|Adverse Event|1|||
164176129|NCT03589976|593008183|FG000|Overall Study|Withdrawal by Subject|4|||
164176130|NCT03589976|593008184|FG001|Overall Study|Withdrawal by Subject|1|||
164176131|NCT03589976|593008183|FG000|Overall Study|Lost to Follow-up|1|||
164176132|NCT03589976|593008184|FG001|Overall Study|Lost to Follow-up|0|||
164176133|NCT03589976|593008183|FG000|Overall Study|Other|4|||
164176134|NCT03589976|593008184|FG001|Overall Study|Other|3|||
164176135|NCT02089334|593008187|FG000|Overall Study|Withdrawal by Subject|0|||
164176136|NCT02089334|593008188|FG001|Overall Study|Withdrawal by Subject|0|||
164176137|NCT02089334|593008189|FG002|Overall Study|Withdrawal by Subject|0|||
164176138|NCT02089334|593008190|FG003|Overall Study|Withdrawal by Subject|2|||
164176139|NCT02089334|593008187|FG000|Overall Study|Adverse Event|0|||
164176140|NCT02089334|593008188|FG001|Overall Study|Adverse Event|0|||
164176141|NCT02089334|593008189|FG002|Overall Study|Adverse Event|0|||
164176142|NCT02089334|593008190|FG003|Overall Study|Adverse Event|2|||
164176143|NCT02089334|593008187|FG000|Overall Study|Progressive disease|0|||
164176144|NCT02089334|593008188|FG001|Overall Study|Progressive disease|0|||
164176145|NCT02089334|593008189|FG002|Overall Study|Progressive disease|0|||
164176146|NCT02089334|593008190|FG003|Overall Study|Progressive disease|2|||
164176147|NCT02089334|593008187|FG000|Overall Study|Physician Decision|0|||
164176148|NCT02089334|593008188|FG001|Overall Study|Physician Decision|0|||
164176149|NCT02089334|593008189|FG002|Overall Study|Physician Decision|1|||
164176150|NCT02089334|593008190|FG003|Overall Study|Physician Decision|1|||
164176151|NCT04778059|593008191|FG000|Overall Study|Death|2|||
164176152|NCT04778059|593008192|FG001|Overall Study|Death|2|||
164176153|NCT04778059|593008193|FG002|Overall Study|Death|1|||
164176154|NCT04778059|593008194|FG003|Overall Study|Death|1|||
164176155|NCT04778059|593008195|FG004|Overall Study|Death|1|||
164176156|NCT04778059|593008191|FG000|Overall Study|Lost to Follow-up|0|||
164176157|NCT04778059|593008192|FG001|Overall Study|Lost to Follow-up|0|||
164176158|NCT04778059|593008193|FG002|Overall Study|Lost to Follow-up|0|||
164176159|NCT04778059|593008194|FG003|Overall Study|Lost to Follow-up|0|||
164176160|NCT04778059|593008195|FG004|Overall Study|Lost to Follow-up|1|||
164176161|NCT04778059|593008191|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176162|NCT04778059|593008192|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176163|NCT04778059|593008193|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176164|NCT04778059|593008194|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
164176165|NCT04778059|593008195|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
164176166|NCT02832375|593008196|FG000|Overall Study|Lost to Follow-up|1|||
164176167|NCT02832375|593008197|FG001|Overall Study|Lost to Follow-up|0|||
164176168|NCT02832375|593008196|FG000|Overall Study|Withdrawal of Consent|1|||
164176169|NCT02832375|593008197|FG001|Overall Study|Withdrawal of Consent|0|||
164176170|NCT02100670|593008202|FG000|Overall Study|Adverse Event|10|||
164176171|NCT02100670|593008203|FG001|Overall Study|Adverse Event|3|||
164176172|NCT02100670|593008204|FG002|Overall Study|Adverse Event|3|||
164176173|NCT02100670|593008205|FG003|Overall Study|Adverse Event|0|||
164176174|NCT02100670|593008202|FG000|Overall Study|Lost to Follow-up|1|||
164176175|NCT02100670|593008203|FG001|Overall Study|Lost to Follow-up|0|||
164176176|NCT02100670|593008204|FG002|Overall Study|Lost to Follow-up|0|||
164176177|NCT02100670|593008205|FG003|Overall Study|Lost to Follow-up|0|||
164176178|NCT02100670|593008202|FG000|Overall Study|Protocol Violation|0|||
164176179|NCT02100670|593008203|FG001|Overall Study|Protocol Violation|1|||
164176180|NCT02100670|593008204|FG002|Overall Study|Protocol Violation|0|||
164176181|NCT02100670|593008205|FG003|Overall Study|Protocol Violation|1|||
164176182|NCT02100670|593008202|FG000|Overall Study|Withdrawal of Consent|0|||
164176183|NCT02100670|593008203|FG001|Overall Study|Withdrawal of Consent|1|||
164176184|NCT02100670|593008204|FG002|Overall Study|Withdrawal of Consent|1|||
164176185|NCT02100670|593008205|FG003|Overall Study|Withdrawal of Consent|0|||
164176186|NCT02100670|593008202|FG000|Overall Study|No swelling no pain|1|||
164176187|NCT02100670|593008203|FG001|Overall Study|No swelling no pain|0|||
164176188|NCT02100670|593008204|FG002|Overall Study|No swelling no pain|0|||
164176189|NCT02100670|593008205|FG003|Overall Study|No swelling no pain|0|||
164176190|NCT02100670|593008202|FG000|Overall Study|Poor Efficacy|0|||
164176191|NCT02100670|593008203|FG001|Overall Study|Poor Efficacy|1|||
164176192|NCT02100670|593008204|FG002|Overall Study|Poor Efficacy|0|||
164176193|NCT02100670|593008205|FG003|Overall Study|Poor Efficacy|0|||
164176194|NCT02100670|593008202|FG000|Overall Study|Physician Decision|0|||
164176195|NCT02100670|593008203|FG001|Overall Study|Physician Decision|1|||
164176196|NCT02100670|593008204|FG002|Overall Study|Physician Decision|0|||
164176197|NCT02100670|593008205|FG003|Overall Study|Physician Decision|0|||
164176198|NCT02100670|593008202|FG000|Overall Study|Withdrawal by Subject|1|||
164176199|NCT02100670|593008203|FG001|Overall Study|Withdrawal by Subject|0|||
164176200|NCT02100670|593008204|FG002|Overall Study|Withdrawal by Subject|0|||
164176201|NCT02100670|593008205|FG003|Overall Study|Withdrawal by Subject|0|||
164176202|NCT00549601|593009716|FG000|Randomized|Protocol Violation|0|||
164176203|NCT00549601|593009717|FG001|Randomized|Protocol Violation|0|||
164176204|NCT00549601|593009718|FG002|Randomized|Protocol Violation|1|||
164176205|NCT00549601|593009716|FG000|Randomized|Withdrawal by Subject|0|||
164176206|NCT00549601|593009717|FG001|Randomized|Withdrawal by Subject|1|||
164176207|NCT00549601|593009718|FG002|Randomized|Withdrawal by Subject|1|||
164176208|NCT00549601|593009716|FG000|Received Study Drug|Adverse Event|2|||
164176209|NCT00549601|593009717|FG001|Received Study Drug|Adverse Event|5|||
164176210|NCT00549601|593009718|FG002|Received Study Drug|Adverse Event|1|||
164176211|NCT00549601|593009716|FG000|Received Study Drug|Death|0|||
164176212|NCT00549601|593009717|FG001|Received Study Drug|Death|1|||
164176213|NCT00549601|593009718|FG002|Received Study Drug|Death|0|||
164176214|NCT00549601|593009716|FG000|Received Study Drug|Lost to Follow-up|0|||
164176215|NCT00549601|593009717|FG001|Received Study Drug|Lost to Follow-up|1|||
164176216|NCT00549601|593009718|FG002|Received Study Drug|Lost to Follow-up|1|||
164176217|NCT00549601|593009716|FG000|Received Study Drug|Protocol Violation|3|||
164176218|NCT00549601|593009717|FG001|Received Study Drug|Protocol Violation|4|||
164176219|NCT00549601|593009718|FG002|Received Study Drug|Protocol Violation|1|||
164176220|NCT00549601|593009716|FG000|Received Study Drug|Withdrawal by Subject|2|||
164176221|NCT00549601|593009717|FG001|Received Study Drug|Withdrawal by Subject|0|||
164176222|NCT00549601|593009718|FG002|Received Study Drug|Withdrawal by Subject|1|||
164176223|NCT02824562|593009719|FG000|Overall Study|Lost to Follow-up|3|||
164176224|NCT02824562|593009720|FG001|Overall Study|Lost to Follow-up|4|||
164176225|NCT02824562|593009719|FG000|Overall Study|Death|0|||
164176226|NCT02824562|593009720|FG001|Overall Study|Death|1|||
164176227|NCT00908596|593009724|FG000|Overall Study|Other reasons|46|||
164176228|NCT00908596|593009725|FG001|Overall Study|Other reasons|6|||
164176229|NCT00908596|593009726|FG002|Overall Study|Other reasons|2|||
164176230|NCT00908596|593009727|FG003|Overall Study|Other reasons|0|||
164176231|NCT00908596|593009724|FG000|Overall Study|Lost to Follow-up|0|||
164176232|NCT00908596|593009725|FG001|Overall Study|Lost to Follow-up|1|||
164176233|NCT00908596|593009726|FG002|Overall Study|Lost to Follow-up|12|||
164176234|NCT00908596|593009727|FG003|Overall Study|Lost to Follow-up|4|||
164176235|NCT00908596|593009724|FG000|Overall Study|Death|0|||
164176236|NCT00908596|593009725|FG001|Overall Study|Death|5|||
164176237|NCT00908596|593009726|FG002|Overall Study|Death|57|||
164176238|NCT00908596|593009727|FG003|Overall Study|Death|32|||
164176239|NCT00908596|593009724|FG000|Overall Study|Protocol Violation|1|||
164176240|NCT00908596|593009725|FG001|Overall Study|Protocol Violation|0|||
164176241|NCT00908596|593009726|FG002|Overall Study|Protocol Violation|0|||
164176242|NCT00908596|593009727|FG003|Overall Study|Protocol Violation|0|||
164176243|NCT00908596|593009724|FG000|Overall Study|Withdrawal by Subject|0|||
164176244|NCT00908596|593009725|FG001|Overall Study|Withdrawal by Subject|1|||
164176245|NCT00908596|593009726|FG002|Overall Study|Withdrawal by Subject|3|||
164176246|NCT00908596|593009727|FG003|Overall Study|Withdrawal by Subject|1|||
164176247|NCT00224406|593009728|FG000|Overall Study|Re-transplant|0|||
164176248|NCT00224406|593009729|FG001|Overall Study|Re-transplant|2|||
164176249|NCT00224406|593009728|FG000|Overall Study|Death|0|||
164176250|NCT00224406|593009729|FG001|Overall Study|Death|1|||
164176251|NCT00224406|593009728|FG000|Overall Study|Transplant cancelled|0|||
164176252|NCT00224406|593009729|FG001|Overall Study|Transplant cancelled|4|||
164176253|NCT00224406|593009728|FG000|Overall Study|Drug not delivered|2|||
164176254|NCT00224406|593009729|FG001|Overall Study|Drug not delivered|0|||
164176255|NCT00224406|593009728|FG000|Overall Study|Other|4|||
164176256|NCT00224406|593009729|FG001|Overall Study|Other|0|||
164176257|NCT00224406|593009728|FG000|Overall Study|Transplant cancelled|3|||
164176258|NCT00224406|593009729|FG001|Overall Study|Transplant cancelled|0|||
164176259|NCT01250171|593009734|FG000|Overall Study|Administrative reasons|1|||
164176260|NCT01250171|593009735|FG001|Overall Study|Administrative reasons|0|||
164176261|NCT01250171|593009736|FG002|Overall Study|Administrative reasons|0|||
164176262|NCT03427268|593009745|FG000|Overall Study|Progressive disease|25|||
164176263|NCT03427268|593009745|FG000|Overall Study|Never treated|2|||
164176264|NCT03427268|593009745|FG000|Overall Study|Compassionate use|1|||
164176265|NCT03427268|593009745|FG000|Overall Study|Withdrawal by Subject|1|||
164176266|NCT03427268|593009745|FG000|Overall Study|Adverse Event|3|||
164176267|NCT02638129|593009746|FG000|Overall Study|Study terminated|28|||
164176268|NCT02638129|593009747|FG001|Overall Study|Study terminated|30|||
164176269|NCT03117881|593009748|FG000|Baseline|Withdrawal by Subject|21|||
164176270|NCT03117881|593009749|FG001|Baseline|Withdrawal by Subject|10|||
164176271|NCT03117881|593009750|FG002|Baseline|Withdrawal by Subject|0|||
164176272|NCT03117881|593009748|FG000|Baseline|Lost to Follow-up|22|||
164176273|NCT03117881|593009749|FG001|Baseline|Lost to Follow-up|25|||
164176274|NCT03117881|593009750|FG002|Baseline|Lost to Follow-up|0|||
164176275|NCT03117881|593009748|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
164176276|NCT03117881|593009749|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
164176277|NCT03117881|593009750|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
164176278|NCT03117881|593009748|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
164176279|NCT03117881|593009749|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
164176280|NCT03117881|593009750|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
164176281|NCT03117881|593009748|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
164176282|NCT03117881|593009749|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
164176283|NCT03117881|593009750|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
164176284|NCT03117881|593009748|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
164176285|NCT03117881|593009749|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
164176286|NCT03117881|593009750|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
164176287|NCT03117881|593009748|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
164176288|NCT03117881|593009749|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
164176289|NCT03117881|593009750|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
164176290|NCT03117881|593009748|FG000|6-Month Follow-Up|Did not complete test|53|||
164176291|NCT03117881|593009749|FG001|6-Month Follow-Up|Did not complete test|25|||
164176292|NCT03117881|593009750|FG002|6-Month Follow-Up|Did not complete test|7|||
164176293|NCT03117881|593009748|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
164176294|NCT03117881|593009749|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
164176295|NCT03117881|593009750|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
164176296|NCT03117881|593009748|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
164176297|NCT03117881|593009749|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
164176298|NCT03117881|593009750|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
164176299|NCT03117881|593009748|FG000|12-Month Follow-Up|Did not complete test|40|||
164176300|NCT03117881|593009749|FG001|12-Month Follow-Up|Did not complete test|0|||
164176301|NCT03117881|593009750|FG002|12-Month Follow-Up|Did not complete test|0|||
164176302|NCT02309723|593009753|FG000|Overall Study|Withdrawal by Subject|24|||
164176303|NCT02309723|593009754|FG001|Overall Study|Withdrawal by Subject|23|||
164176304|NCT02309723|593009755|FG002|Overall Study|Withdrawal by Subject|24|||
164176305|NCT02560623|593009756|FG000|Overall Study|Unable to swallow sponge|0|||
164176306|NCT02560623|593009757|FG001|Overall Study|Unable to swallow sponge|1|||
164176307|NCT02560623|593009758|FG002|Overall Study|Unable to swallow sponge|0|||
164176308|NCT02560623|593009759|FG003|Overall Study|Unable to swallow sponge|0|||
164176309|NCT02560623|593009756|FG000|Overall Study|Intervention prior to sponge administration|0|||
164176310|NCT02560623|593009757|FG001|Overall Study|Intervention prior to sponge administration|1|||
164176311|NCT02560623|593009758|FG002|Overall Study|Intervention prior to sponge administration|0|||
164176312|NCT02560623|593009759|FG003|Overall Study|Intervention prior to sponge administration|0|||
164176313|NCT01349322|593009760|FG000|Overall Study|Protocol Violation|45|||
164176314|NCT01349322|593009761|FG001|Overall Study|Protocol Violation|47|||
164176315|NCT01565668|593009765|FG000|Overall Study|Death|2|||
164176316|NCT01565668|593009766|FG001|Overall Study|Death|1|||
164176317|NCT01565668|593009765|FG000|Overall Study|Lack of Efficacy|4|||
164176318|NCT01565668|593009766|FG001|Overall Study|Lack of Efficacy|2|||
164176319|NCT01565668|593009765|FG000|Overall Study|Participant went on Hospice Care|1|||
164176320|NCT01565668|593009766|FG001|Overall Study|Participant went on Hospice Care|0|||
164176321|NCT01565668|593009765|FG000|Overall Study|Adverse Event|6|||
164176322|NCT01565668|593009766|FG001|Overall Study|Adverse Event|1|||
164176323|NCT01565668|593009765|FG000|Overall Study|Randomized, but never received drug|0|||
164176324|NCT01565668|593009766|FG001|Overall Study|Randomized, but never received drug|2|||
164176325|NCT01565668|593009765|FG000|Overall Study|Progressive disease|13|||
164176326|NCT01565668|593009766|FG001|Overall Study|Progressive disease|14|||
164176327|NCT01565668|593009765|FG000|Overall Study|Withdrawal by Subject|1|||
164176328|NCT01565668|593009766|FG001|Overall Study|Withdrawal by Subject|3|||
164176329|NCT01565668|593009765|FG000|Overall Study|HSCT Transplant|11|||
164176330|NCT01565668|593009766|FG001|Overall Study|HSCT Transplant|15|||
164176331|NCT01097421|593009767|FG000|Overall Study|Adverse Event|8|||
164176332|NCT01097421|593009767|FG000|Overall Study|Protocol Violation|2|||
164176333|NCT01097421|593009767|FG000|Overall Study|Lost to Follow-up|1|||
164176334|NCT01097421|593009767|FG000|Overall Study|Withdrawal by Subject|3|||
164176335|NCT06137703|593009770|FG000|Overall Study|Other|0|||
164176336|NCT06137703|593009771|FG001|Overall Study|Other|1|||
164176337|NCT06137703|593009772|FG002|Overall Study|Other|0|||
164176338|NCT06137703|593009773|FG003|Overall Study|Other|0|||
164176339|NCT06137703|593009770|FG000|Overall Study|Adverse Event|0|||
164176340|NCT06137703|593009771|FG001|Overall Study|Adverse Event|0|||
164176341|NCT06137703|593009772|FG002|Overall Study|Adverse Event|1|||
164176342|NCT06137703|593009773|FG003|Overall Study|Adverse Event|0|||
164176343|NCT01801358|593009774|FG000|Overall Study|Adverse Event|0|||
164176344|NCT01801358|593009775|FG001|Overall Study|Adverse Event|2|||
164176345|NCT01801358|593009776|FG002|Overall Study|Adverse Event|1|||
164176346|NCT01801358|593009777|FG003|Overall Study|Adverse Event|0|||
164176347|NCT01801358|593009778|FG004|Overall Study|Adverse Event|0|||
164176348|NCT01801358|593009779|FG005|Overall Study|Adverse Event|1|||
164176349|NCT01801358|593009774|FG000|Overall Study|Physician Decision|0|||
164176350|NCT01801358|593009775|FG001|Overall Study|Physician Decision|0|||
164176351|NCT01801358|593009776|FG002|Overall Study|Physician Decision|1|||
164176352|NCT01801358|593009777|FG003|Overall Study|Physician Decision|0|||
164176353|NCT01801358|593009778|FG004|Overall Study|Physician Decision|0|||
164176354|NCT01801358|593009779|FG005|Overall Study|Physician Decision|0|||
164176355|NCT01801358|593009774|FG000|Overall Study|Progressive Disease|6|||
164176356|NCT01801358|593009775|FG001|Overall Study|Progressive Disease|4|||
164176357|NCT01801358|593009776|FG002|Overall Study|Progressive Disease|4|||
164176358|NCT01801358|593009777|FG003|Overall Study|Progressive Disease|5|||
164176359|NCT01801358|593009778|FG004|Overall Study|Progressive Disease|6|||
164176360|NCT01801358|593009779|FG005|Overall Study|Progressive Disease|5|||
164176361|NCT01801358|593009774|FG000|Overall Study|Withdrawal by Subject|0|||
164176362|NCT01801358|593009775|FG001|Overall Study|Withdrawal by Subject|0|||
164176363|NCT01801358|593009776|FG002|Overall Study|Withdrawal by Subject|0|||
164176364|NCT01801358|593009777|FG003|Overall Study|Withdrawal by Subject|1|||
164176365|NCT01801358|593009778|FG004|Overall Study|Withdrawal by Subject|0|||
164176366|NCT01801358|593009779|FG005|Overall Study|Withdrawal by Subject|2|||
164176367|NCT04093492|593009782|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
164176368|NCT04093492|593009783|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
164176369|NCT04093492|593009784|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
164176370|NCT04093492|593009785|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
164176371|NCT04093492|593009782|FG000|25 Weeks Gestational Age (GA)|No response|5|||
164176372|NCT04093492|593009783|FG001|25 Weeks Gestational Age (GA)|No response|5|||
164176373|NCT04093492|593009784|FG002|25 Weeks Gestational Age (GA)|No response|5|||
164176374|NCT04093492|593009785|FG003|25 Weeks Gestational Age (GA)|No response|2|||
164176375|NCT04093492|593009782|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
164176376|NCT04093492|593009783|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
164176377|NCT04093492|593009784|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
164176378|NCT04093492|593009785|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
164176379|NCT04093492|593009782|FG000|30 Weeks GA|Delivered before assessment|1|||
164176380|NCT04093492|593009783|FG001|30 Weeks GA|Delivered before assessment|2|||
164176381|NCT04093492|593009784|FG002|30 Weeks GA|Delivered before assessment|0|||
164176382|NCT04093492|593009785|FG003|30 Weeks GA|Delivered before assessment|0|||
164176383|NCT04093492|593009782|FG000|30 Weeks GA|No response|7|||
164176384|NCT04093492|593009783|FG001|30 Weeks GA|No response|5|||
164176385|NCT04093492|593009784|FG002|30 Weeks GA|No response|5|||
164176386|NCT04093492|593009785|FG003|30 Weeks GA|No response|2|||
164176387|NCT04093492|593009782|FG000|30 Weeks GA|Lost to Follow-up|0|||
164176388|NCT04093492|593009783|FG001|30 Weeks GA|Lost to Follow-up|1|||
164176389|NCT04093492|593009784|FG002|30 Weeks GA|Lost to Follow-up|0|||
164176390|NCT04093492|593009785|FG003|30 Weeks GA|Lost to Follow-up|0|||
164176391|NCT04093492|593009782|FG000|34 Weeks GA|Delivered before assessment|6|||
164176392|NCT04093492|593009783|FG001|34 Weeks GA|Delivered before assessment|3|||
164176393|NCT04093492|593009784|FG002|34 Weeks GA|Delivered before assessment|0|||
164176394|NCT04093492|593009785|FG003|34 Weeks GA|Delivered before assessment|0|||
164176395|NCT04093492|593009782|FG000|34 Weeks GA|No response|0|||
164176396|NCT04093492|593009783|FG001|34 Weeks GA|No response|7|||
164176397|NCT04093492|593009784|FG002|34 Weeks GA|No response|5|||
164176398|NCT04093492|593009785|FG003|34 Weeks GA|No response|3|||
164176399|NCT04093492|593009782|FG000|34 Weeks GA|Lost to Follow-up|0|||
164176400|NCT04093492|593009783|FG001|34 Weeks GA|Lost to Follow-up|1|||
164176401|NCT04093492|593009784|FG002|34 Weeks GA|Lost to Follow-up|0|||
164176402|NCT04093492|593009785|FG003|34 Weeks GA|Lost to Follow-up|0|||
164176403|NCT03436199|593009792|FG000|Overall Study|Adverse Event|15|||
164176404|NCT03436199|593009793|FG001|Overall Study|Adverse Event|40|||
164176405|NCT03436199|593009794|FG002|Overall Study|Adverse Event|7|||
164176406|NCT03436199|593009792|FG000|Overall Study|Withdrawal by Subject|4|||
164176407|NCT03436199|593009793|FG001|Overall Study|Withdrawal by Subject|10|||
164176408|NCT03436199|593009794|FG002|Overall Study|Withdrawal by Subject|3|||
164176409|NCT03436199|593009792|FG000|Overall Study|Lost to Follow-up|1|||
164176410|NCT03436199|593009793|FG001|Overall Study|Lost to Follow-up|0|||
164176411|NCT03436199|593009794|FG002|Overall Study|Lost to Follow-up|2|||
164176412|NCT03436199|593009792|FG000|Overall Study|Protocol Violation|1|||
164176413|NCT03436199|593009793|FG001|Overall Study|Protocol Violation|1|||
164176414|NCT03436199|593009794|FG002|Overall Study|Protocol Violation|0|||
164176415|NCT03436199|593009792|FG000|Overall Study|Physician Decision|0|||
164176416|NCT03436199|593009793|FG001|Overall Study|Physician Decision|1|||
164176417|NCT03436199|593009794|FG002|Overall Study|Physician Decision|0|||
164176418|NCT03436199|593009792|FG000|Overall Study|Could not return to clinic|1|||
164176419|NCT03436199|593009793|FG001|Overall Study|Could not return to clinic|0|||
164176420|NCT03436199|593009794|FG002|Overall Study|Could not return to clinic|0|||
164176421|NCT03436199|593009792|FG000|Overall Study|Withdrawn per physician|0|||
164176422|NCT03436199|593009793|FG001|Overall Study|Withdrawn per physician|1|||
164176423|NCT03436199|593009794|FG002|Overall Study|Withdrawn per physician|0|||
164176424|NCT00087126|593009798|FG000|Overall Study|Ineligible - second primary|1|||
164176425|NCT00087126|593009798|FG000|Overall Study|Never treated|1|||
164176426|NCT01432275|593009799|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
164176427|NCT01432275|593009800|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
164176428|NCT01432275|593009799|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
164176429|NCT01432275|593009800|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
164176430|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
164176431|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
164176432|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
164176433|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
164176434|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
164176435|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
164176436|NCT01432275|593009799|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
164176437|NCT01432275|593009800|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
164176438|NCT01432275|593009799|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
164176439|NCT01432275|593009800|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
164176440|NCT01432275|593009799|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
164176441|NCT01432275|593009800|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
164176442|NCT01432275|593009799|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
164176443|NCT01432275|593009800|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
164176444|NCT01935128|593009807|FG000|Overall Study|Death|1|||
164176445|NCT01935128|593009807|FG000|Overall Study|Adverse Event|6|||
164176446|NCT00096993|593009808|FG000|Overall Study|Death|1|||
164176447|NCT00096993|593009809|FG001|Overall Study|Death|0|||
164176448|NCT00096993|593009808|FG000|Overall Study|Disease progression|56|||
164176449|NCT00096993|593009809|FG001|Overall Study|Disease progression|53|||
164176450|NCT00096993|593009808|FG000|Overall Study|Adverse Event|2|||
164176451|NCT00096993|593009809|FG001|Overall Study|Adverse Event|8|||
164176452|NCT00096993|593009808|FG000|Overall Study|Subject's decision|3|||
164176453|NCT00096993|593009809|FG001|Overall Study|Subject's decision|1|||
164176454|NCT00096993|593009808|FG000|Overall Study|Physician Decision|2|||
164176455|NCT00096993|593009809|FG001|Overall Study|Physician Decision|1|||
164176456|NCT00096993|593009808|FG000|Overall Study|Non-compliance|0|||
164176457|NCT00096993|593009809|FG001|Overall Study|Non-compliance|1|||
164176458|NCT00096993|593009808|FG000|Overall Study|Other unspecified|1|||
164176459|NCT00096993|593009809|FG001|Overall Study|Other unspecified|1|||
164176460|NCT01438814|593009815|FG000|Overall Study|Adverse Event|3|||
164176461|NCT01438814|593009816|FG001|Overall Study|Adverse Event|3|||
164176462|NCT01438814|593009815|FG000|Overall Study|Protocol Violation|1|||
164176463|NCT01438814|593009816|FG001|Overall Study|Protocol Violation|2|||
164176464|NCT01438814|593009815|FG000|Overall Study|Lost to Follow-up|4|||
164176465|NCT01438814|593009816|FG001|Overall Study|Lost to Follow-up|3|||
164176466|NCT01438814|593009815|FG000|Overall Study|Withdrawal by Subject|4|||
164176467|NCT01438814|593009816|FG001|Overall Study|Withdrawal by Subject|2|||
164176468|NCT01438814|593009815|FG000|Overall Study|Other|2|||
164176469|NCT01438814|593009816|FG001|Overall Study|Other|4|||
164176470|NCT01739764|593009817|FG000|Overall Study|Adverse Event|0|||
164176471|NCT01739764|593009818|FG001|Overall Study|Adverse Event|3|||
164176472|NCT01739764|593009819|FG002|Overall Study|Adverse Event|4|||
164176473|NCT01739764|593009817|FG000|Overall Study|Death|4|||
164176474|NCT01739764|593009818|FG001|Overall Study|Death|6|||
164176475|NCT01739764|593009819|FG002|Overall Study|Death|38|||
164176476|NCT01739764|593009817|FG000|Overall Study|Lost to Follow-up|0|||
164176477|NCT01739764|593009818|FG001|Overall Study|Lost to Follow-up|0|||
164176478|NCT01739764|593009819|FG002|Overall Study|Lost to Follow-up|5|||
164176479|NCT01739764|593009817|FG000|Overall Study|Non-Compliance|0|||
164176480|NCT01739764|593009818|FG001|Overall Study|Non-Compliance|0|||
164176481|NCT01739764|593009819|FG002|Overall Study|Non-Compliance|1|||
164176482|NCT01739764|593009817|FG000|Overall Study|Multiple Reasons|3|||
164176483|NCT01739764|593009818|FG001|Overall Study|Multiple Reasons|2|||
164176484|NCT01739764|593009819|FG002|Overall Study|Multiple Reasons|3|||
164176485|NCT01739764|593009817|FG000|Overall Study|Physician Decision|2|||
164176486|NCT01739764|593009818|FG001|Overall Study|Physician Decision|2|||
164176487|NCT01739764|593009819|FG002|Overall Study|Physician Decision|4|||
164176488|NCT01739764|593009817|FG000|Overall Study|Progressive Disease|3|||
164176489|NCT01739764|593009818|FG001|Overall Study|Progressive Disease|5|||
164176490|NCT01739764|593009819|FG002|Overall Study|Progressive Disease|16|||
164176491|NCT01739764|593009817|FG000|Overall Study|Protocol Violation|0|||
164176492|NCT01739764|593009818|FG001|Overall Study|Protocol Violation|0|||
164176493|NCT01739764|593009819|FG002|Overall Study|Protocol Violation|2|||
164176494|NCT01739764|593009817|FG000|Overall Study|Study Terminated by Sponsor|8|||
164176495|NCT01739764|593009818|FG001|Overall Study|Study Terminated by Sponsor|13|||
164176496|NCT01739764|593009819|FG002|Overall Study|Study Terminated by Sponsor|26|||
164176497|NCT01739764|593009817|FG000|Overall Study|Withdrawal by Subject|6|||
164176498|NCT01739764|593009818|FG001|Overall Study|Withdrawal by Subject|5|||
164176499|NCT01739764|593009819|FG002|Overall Study|Withdrawal by Subject|27|||
164176500|NCT00404924|593009820|FG000|Overall Study|Adverse Event|75|||
164176501|NCT00404924|593009821|FG001|Overall Study|Adverse Event|16|||
164176502|NCT00404924|593009820|FG000|Overall Study|Condition under investigation worsened|475|||
164176503|NCT00404924|593009821|FG001|Overall Study|Condition under investigation worsened|264|||
164176504|NCT00404924|593009820|FG000|Overall Study|Lost to Follow-up|1|||
164176505|NCT00404924|593009821|FG001|Overall Study|Lost to Follow-up|1|||
164176506|NCT00404924|593009820|FG000|Overall Study|Withdrawal by Subject|26|||
164176507|NCT00404924|593009821|FG001|Overall Study|Withdrawal by Subject|13|||
164176508|NCT00404924|593009820|FG000|Overall Study|Other|25|||
164176509|NCT00404924|593009821|FG001|Overall Study|Other|11|||
164176510|NCT00404924|593009820|FG000|Overall Study|Randomised but not received treatment|1|||
164176511|NCT00404924|593009821|FG001|Overall Study|Randomised but not received treatment|1|||
164176512|NCT00513357|593009826|FG000|Overall Study|did not receive allocated placebo|2|||
164176513|NCT00513357|593009827|FG001|Overall Study|did not receive allocated placebo|3|||
164176514|NCT00513357|593009826|FG000|Overall Study|Adverse Event|4|||
164176515|NCT00513357|593009827|FG001|Overall Study|Adverse Event|2|||
164176516|NCT00513357|593009826|FG000|Overall Study|Death|2|||
164176517|NCT00513357|593009827|FG001|Overall Study|Death|0|||
164176518|NCT00513357|593009826|FG000|Overall Study|Withdrawal by Subject|5|||
164176519|NCT00513357|593009827|FG001|Overall Study|Withdrawal by Subject|4|||
164176520|NCT00513357|593009826|FG000|Overall Study|Disease Progression|2|||
164176521|NCT00513357|593009827|FG001|Overall Study|Disease Progression|1|||
164176522|NCT01162122|593009828|FG000|Overall Study|Withdrawal by Subject|52|||
164176523|NCT01162122|593009829|FG001|Overall Study|Withdrawal by Subject|43|||
164176524|NCT01162122|593009828|FG000|Overall Study|Lost to Follow-up|73|||
164176525|NCT01162122|593009829|FG001|Overall Study|Lost to Follow-up|91|||
164176526|NCT01162122|593009828|FG000|Overall Study|Adverse Event|3|||
164176527|NCT01162122|593009829|FG001|Overall Study|Adverse Event|2|||
164176528|NCT01162122|593009828|FG000|Overall Study|Death|51|||
164176529|NCT01162122|593009829|FG001|Overall Study|Death|46|||
164176530|NCT01162122|593009828|FG000|Overall Study|Protocol Violation|2|||
164176531|NCT01162122|593009829|FG001|Overall Study|Protocol Violation|2|||
164176532|NCT01162122|593009828|FG000|Overall Study|Inappropriate enrollment|5|||
164176533|NCT01162122|593009829|FG001|Overall Study|Inappropriate enrollment|4|||
164176534|NCT01162122|593009828|FG000|Overall Study|Administrative reason|1|||
164176535|NCT01162122|593009829|FG001|Overall Study|Administrative reason|1|||
164176536|NCT01162122|593009828|FG000|Overall Study|Unable to classify|3|||
164176537|NCT01162122|593009829|FG001|Overall Study|Unable to classify|7|||
164176538|NCT01162122|593009828|FG000|Overall Study|Missing primary reason|1|||
164176539|NCT01162122|593009829|FG001|Overall Study|Missing primary reason|0|||
164176540|NCT02020512|593009830|FG000|Overall Study|Adverse Event|1|||
164176541|NCT02020512|593009830|FG000|Overall Study|Lost to Follow-up|3|||
164176542|NCT02020512|593009830|FG000|Overall Study|Protocol Violation|4|||
164176543|NCT00656851|593009836|FG000|Overall Study|Withdrawal by Subject|0|||
164176544|NCT00656851|593009837|FG001|Overall Study|Withdrawal by Subject|4|||
164176545|NCT00835679|593009838|FG000|Overall Study|Withdrawal by Subject|1|||
164176546|NCT00835679|593009839|FG001|Overall Study|Withdrawal by Subject|0|||
164176547|NCT00835679|593009840|FG002|Overall Study|Withdrawal by Subject|0|||
164176548|NCT00835679|593009841|FG003|Overall Study|Withdrawal by Subject|0|||
164176549|NCT05020899|593009842|FG000|8 Week Follow-up|Lost to Follow-up|3|||
164176550|NCT05020899|593009843|FG001|8 Week Follow-up|Lost to Follow-up|6|||
164176551|NCT05020899|593009842|FG000|12 Week Follow-up|Lost to Follow-up|1|||
164176552|NCT05020899|593009843|FG001|12 Week Follow-up|Lost to Follow-up|0|||
164176553|NCT05020899|593009842|FG000|12 Week Follow-up|Death|0|||
164176554|NCT05020899|593009843|FG001|12 Week Follow-up|Death|1|||
164176555|NCT00191282|593009848|FG000|Overall Study|Adverse Event|5|||
164176556|NCT00191282|593009849|FG001|Overall Study|Adverse Event|6|||
164176557|NCT00191282|593009848|FG000|Overall Study|Death|51|||
164176558|NCT00191282|593009849|FG001|Overall Study|Death|51|||
164176559|NCT00191282|593009848|FG000|Overall Study|Lack of Efficacy|11|||
164176560|NCT00191282|593009849|FG001|Overall Study|Lack of Efficacy|6|||
164176561|NCT00191282|593009848|FG000|Overall Study|Noncompliance|14|||
164176562|NCT00191282|593009849|FG001|Overall Study|Noncompliance|17|||
164176563|NCT00191282|593009848|FG000|Overall Study|Patient moved|11|||
164176564|NCT00191282|593009849|FG001|Overall Study|Patient moved|14|||
164176565|NCT00191282|593009848|FG000|Overall Study|Withdrawal by Subject|59|||
164176566|NCT00191282|593009849|FG001|Overall Study|Withdrawal by Subject|44|||
164176567|NCT00191282|593009848|FG000|Overall Study|Physician Decision|18|||
164176568|NCT00191282|593009849|FG001|Overall Study|Physician Decision|15|||
164176569|NCT00191282|593009848|FG000|Overall Study|Protocol entry criteria not met|14|||
164176570|NCT00191282|593009849|FG001|Overall Study|Protocol entry criteria not met|9|||
164176571|NCT00191282|593009848|FG000|Overall Study|Protocol Violation|9|||
164176572|NCT00191282|593009849|FG001|Overall Study|Protocol Violation|12|||
164176573|NCT00191282|593009848|FG000|Overall Study|Severity of outcome|2|||
164176574|NCT00191282|593009849|FG001|Overall Study|Severity of outcome|5|||
164176575|NCT00191282|593009848|FG000|Overall Study|Sponsor's decision|2|||
164176576|NCT00191282|593009849|FG001|Overall Study|Sponsor's decision|2|||
164176577|NCT00191282|593009848|FG000|Overall Study|Lost to Follow-up|24|||
164176578|NCT00191282|593009849|FG001|Overall Study|Lost to Follow-up|31|||
164176579|NCT00102531|593009850|FG000|Overall Study|Adverse Event|0|||
164176580|NCT00102531|593009851|FG001|Overall Study|Adverse Event|1|||
164176581|NCT00102531|593009850|FG000|Overall Study|Disease Progression|5|||
164176582|NCT00102531|593009851|FG001|Overall Study|Disease Progression|9|||
164176583|NCT00102531|593009850|FG000|Overall Study|Physician Decision|0|||
164176584|NCT00102531|593009851|FG001|Overall Study|Physician Decision|1|||
164176585|NCT04756154|593009858|FG000|Overall Study|Did not meet treatment day baseline|30|||
164176586|NCT04756154|593009859|FG001|Overall Study|Did not meet treatment day baseline|28|||
164176587|NCT04756154|593009860|FG002|Overall Study|Did not meet treatment day baseline|7|||
164176588|NCT04756154|593009858|FG000|Overall Study|Did not return for final sample collection|1|||
164176589|NCT04756154|593009859|FG001|Overall Study|Did not return for final sample collection|1|||
164176590|NCT04756154|593009860|FG002|Overall Study|Did not return for final sample collection|0|||
164176591|NCT01790828|593009861|FG000|Overall Study|Other|34|||
164176592|NCT00710684|593009862|FG000|Overall Study|Adverse Event|11|||
164176593|NCT00710684|593009863|FG001|Overall Study|Adverse Event|19|||
164176594|NCT00710684|593009864|FG002|Overall Study|Adverse Event|16|||
164176595|NCT00710684|593009862|FG000|Overall Study|Lack of Efficacy|4|||
164176596|NCT00710684|593009863|FG001|Overall Study|Lack of Efficacy|3|||
164176597|NCT00710684|593009864|FG002|Overall Study|Lack of Efficacy|5|||
164176598|NCT00710684|593009862|FG000|Overall Study|Protocol Violation|5|||
164176599|NCT00710684|593009863|FG001|Overall Study|Protocol Violation|5|||
164176600|NCT00710684|593009864|FG002|Overall Study|Protocol Violation|5|||
164176601|NCT00710684|593009862|FG000|Overall Study|Lost to Follow-up|4|||
164176602|NCT00710684|593009863|FG001|Overall Study|Lost to Follow-up|6|||
164176603|NCT00710684|593009864|FG002|Overall Study|Lost to Follow-up|7|||
164176604|NCT00710684|593009862|FG000|Overall Study|Physician Decision|0|||
164176605|NCT00710684|593009863|FG001|Overall Study|Physician Decision|2|||
164176606|NCT00710684|593009864|FG002|Overall Study|Physician Decision|4|||
164176607|NCT00710684|593009862|FG000|Overall Study|Withdrawal by Subject|24|||
164176608|NCT00710684|593009863|FG001|Overall Study|Withdrawal by Subject|18|||
164176609|NCT00710684|593009864|FG002|Overall Study|Withdrawal by Subject|11|||
164176610|NCT00710684|593009862|FG000|Overall Study|Missing|1|||
164176611|NCT00710684|593009863|FG001|Overall Study|Missing|0|||
164176612|NCT00710684|593009864|FG002|Overall Study|Missing|0|||
164176613|NCT00710684|593009862|FG000|Overall Study|Did not continue after week 24|25|||
164176614|NCT00710684|593009863|FG001|Overall Study|Did not continue after week 24|21|||
164176615|NCT00710684|593009864|FG002|Overall Study|Did not continue after week 24|16|||
164176616|NCT00514904|593009865|FG000|Overall Study|Withdrawal by Subject|3|||
164176617|NCT00514904|593009866|FG001|Overall Study|Withdrawal by Subject|2|||
164176618|NCT00514904|593009865|FG000|Overall Study|Lost to Follow-up|21|||
164176619|NCT00514904|593009866|FG001|Overall Study|Lost to Follow-up|3|||
164176620|NCT00084318|593009867|FG000|Overall Study|Withdrawal by Subject|5|||
164176621|NCT00084318|593009868|FG001|Overall Study|Withdrawal by Subject|2|||
164176622|NCT00084318|593009867|FG000|Overall Study|Protocol Violation|15|||
164176623|NCT00084318|593009868|FG001|Overall Study|Protocol Violation|11|||
164176624|NCT00084318|593009867|FG000|Overall Study|No protocol treatment|2|||
164176625|NCT00084318|593009868|FG001|Overall Study|No protocol treatment|0|||
164176626|NCT02921750|593012487|FG000|Overall Study|Adverse Event|1|||
164176627|NCT02921750|593012488|FG001|Overall Study|Adverse Event|2|||
164176628|NCT02921750|593012487|FG000|Overall Study|Withdrawal by Subject|1|||
164176629|NCT02921750|593012488|FG001|Overall Study|Withdrawal by Subject|1|||
164176630|NCT02921750|593012487|FG000|Overall Study|Lost to Follow-up|3|||
164176631|NCT02921750|593012488|FG001|Overall Study|Lost to Follow-up|3|||
164176632|NCT02921750|593012487|FG000|Overall Study|Wound healed|3|||
164176633|NCT02921750|593012488|FG001|Overall Study|Wound healed|3|||
164176634|NCT02921750|593012487|FG000|Overall Study|Serious Adverse Event|1|||
164176635|NCT02921750|593012488|FG001|Overall Study|Serious Adverse Event|2|||
164176636|NCT04676412|593012490|FG000|Overall Study|Death|28|||
164176637|NCT04676412|593012491|FG001|Overall Study|Death|31|||
164176638|NCT04676412|593012490|FG000|Overall Study|Lost to Follow-up|1|||
164176639|NCT04676412|593012491|FG001|Overall Study|Lost to Follow-up|2|||
164176640|NCT04676412|593012490|FG000|Overall Study|Sponsor Decision|20|||
164176641|NCT04676412|593012491|FG001|Overall Study|Sponsor Decision|23|||
164176642|NCT04676412|593012490|FG000|Overall Study|Withdrawal by Subject|0|||
164176643|NCT04676412|593012491|FG001|Overall Study|Withdrawal by Subject|2|||
164176644|NCT04550832|593012492|FG000|Overall Study|Adverse Event|0|||
164176645|NCT04550832|593012493|FG001|Overall Study|Adverse Event|0|||
164176646|NCT04550832|593012494|FG002|Overall Study|Adverse Event|2|||
164176647|NCT04550832|593012495|FG003|Overall Study|Adverse Event|0|||
164176648|NCT04550832|593012496|FG004|Overall Study|Adverse Event|1|||
164176649|NCT04823130|593012497|FG000|Overall Study|Withdrawal by Subject|2|||
164176650|NCT04823130|593012498|FG001|Overall Study|Withdrawal by Subject|3|||
164176651|NCT04823130|593012497|FG000|Overall Study|Failure to meet inclusion criteria|6|||
164176652|NCT04823130|593012498|FG001|Overall Study|Failure to meet inclusion criteria|4|||
164176653|NCT04823130|593012497|FG000|Overall Study|Other-unspecified|1|||
164176654|NCT04823130|593012498|FG001|Overall Study|Other-unspecified|0|||
164176655|NCT03315455|593012500|FG000|Overall Study|Ongoing in the Study|13|||
164176656|NCT03315455|593012501|FG001|Overall Study|Ongoing in the Study|24|||
164176657|NCT03315455|593012502|FG002|Overall Study|Ongoing in the Study|17|||
164176658|NCT03315455|593012503|FG003|Overall Study|Ongoing in the Study|15|||
164176659|NCT03315455|593012500|FG000|Overall Study|Withdrawal by Subject|0|||
164176660|NCT03315455|593012501|FG001|Overall Study|Withdrawal by Subject|1|||
164176661|NCT03315455|593012502|FG002|Overall Study|Withdrawal by Subject|0|||
164176662|NCT03315455|593012503|FG003|Overall Study|Withdrawal by Subject|0|||
164176663|NCT01458951|593012509|FG000|Overall Study|Other|1|||
164176664|NCT01458951|593012510|FG001|Overall Study|Other|0|||
164176665|NCT01458951|593012511|FG002|Overall Study|Other|0|||
164176666|NCT01458951|593012509|FG000|Overall Study|Protocol Violation|5|||
164176667|NCT01458951|593012510|FG001|Overall Study|Protocol Violation|1|||
164176668|NCT01458951|593012511|FG002|Overall Study|Protocol Violation|0|||
164176669|NCT01458951|593012509|FG000|Overall Study|Withdrawal by Subject|2|||
164176670|NCT01458951|593012510|FG001|Overall Study|Withdrawal by Subject|0|||
164176671|NCT01458951|593012511|FG002|Overall Study|Withdrawal by Subject|2|||
164176672|NCT01458951|593012509|FG000|Overall Study|Adverse Event|7|||
164176673|NCT01458951|593012510|FG001|Overall Study|Adverse Event|0|||
164176674|NCT01458951|593012511|FG002|Overall Study|Adverse Event|2|||
164176675|NCT01458951|593012509|FG000|Overall Study|Insufficient Clinical Response|17|||
164176676|NCT01458951|593012510|FG001|Overall Study|Insufficient Clinical Response|0|||
164176677|NCT01458951|593012511|FG002|Overall Study|Insufficient Clinical Response|11|||
164176678|NCT01846221|593012514|FG000|Overall Study|Catheter Failure|2|||
164176679|NCT01846221|593012515|FG001|Overall Study|Catheter Failure|0|||
164176680|NCT01846221|593012514|FG000|Overall Study|Age Exclusion|1|||
164176681|NCT01846221|593012515|FG001|Overall Study|Age Exclusion|0|||
164176682|NCT04392167|593012516|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
164176683|NCT03309696|593012517|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
164176684|NCT03309696|593012518|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
164176685|NCT03309696|593012519|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
164176686|NCT03309696|593012520|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
164176687|NCT02304380|593012522|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176688|NCT02304380|593012523|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176689|NCT02304380|593012524|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176690|NCT02304380|593012525|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
164176691|NCT02304380|593012526|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176692|NCT02304380|593012527|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
164176693|NCT01027897|593012528|FG000|Overall Study|Protocol Violation|1|||
164176694|NCT01027897|593012528|FG000|Overall Study|Withdrawal by Subject|1|||
164176695|NCT00328094|593012529|FG000|Overall Study|Physician Decision|3|||
164176696|NCT00328094|593012530|FG001|Overall Study|Physician Decision|3|||
164176697|NCT00577005|593012531|FG000|Overall Study|Lost to Follow-up|3|||
164176698|NCT00577005|593012532|FG001|Overall Study|Lost to Follow-up|2|||
164176699|NCT00577005|593012531|FG000|Overall Study|Withdrawal by Subject|2|||
164176700|NCT00577005|593012532|FG001|Overall Study|Withdrawal by Subject|1|||
164176701|NCT02667626|593012533|FG000|Overall Study|Withdrawal by Subject|0|||
164176702|NCT02667626|593012534|FG001|Overall Study|Withdrawal by Subject|1|||
164176703|NCT00473824|593012535|FG000|Overall Study|Virologic Breakthrough|1|||
164176704|NCT00473824|593012536|FG001|Overall Study|Virologic Breakthrough|0|||
164176705|NCT00473824|593012535|FG000|Overall Study|Adverse Event|1|||
164176706|NCT00473824|593012536|FG001|Overall Study|Adverse Event|0|||
164176707|NCT00473824|593012535|FG000|Overall Study|Death|1|||
164176708|NCT00473824|593012536|FG001|Overall Study|Death|0|||
164176709|NCT00473824|593012535|FG000|Overall Study|Lost to Follow-up|1|||
164176710|NCT00473824|593012536|FG001|Overall Study|Lost to Follow-up|0|||
164176711|NCT00473824|593012535|FG000|Overall Study|Withdrawal by physician|1|||
164176712|NCT00473824|593012536|FG001|Overall Study|Withdrawal by physician|0|||
164176713|NCT02539134|593012539|FG000|Overall Study|Lost to Follow-up|1|||
164176714|NCT02539134|593012540|FG001|Overall Study|Lost to Follow-up|0|||
164176715|NCT02539134|593012541|FG002|Overall Study|Lost to Follow-up|0|||
164176716|NCT02539134|593012542|FG003|Overall Study|Lost to Follow-up|0|||
164176717|NCT02539134|593012543|FG004|Overall Study|Lost to Follow-up|0|||
164176718|NCT02539134|593012544|FG005|Overall Study|Lost to Follow-up|0|||
164176719|NCT01143064|593012545|FG000|Overall Study|Death|109|||
164176720|NCT01143064|593012546|FG001|Overall Study|Death|91|||
164176721|NCT01143064|593012545|FG000|Overall Study|Adverse Event|0|||
164176722|NCT01143064|593012546|FG001|Overall Study|Adverse Event|1|||
164176723|NCT01143064|593012545|FG000|Overall Study|Withdrawal by Subject|7|||
164176724|NCT01143064|593012546|FG001|Overall Study|Withdrawal by Subject|5|||
164176725|NCT01143064|593012545|FG000|Overall Study|Lost to Follow-up|17|||
164176726|NCT01143064|593012546|FG001|Overall Study|Lost to Follow-up|14|||
164176727|NCT01143064|593012545|FG000|Overall Study|Physician Decision|0|||
164176728|NCT01143064|593012546|FG001|Overall Study|Physician Decision|4|||
164176729|NCT02453282|593012547|FG000|Overall Study|Death|275|||
164176730|NCT02453282|593012548|FG001|Overall Study|Death|277|||
164176731|NCT02453282|593012549|FG002|Overall Study|Death|296|||
164176732|NCT02453282|593012547|FG000|Overall Study|Lost to Follow-up|1|||
164176733|NCT02453282|593012548|FG001|Overall Study|Lost to Follow-up|0|||
164176734|NCT02453282|593012549|FG002|Overall Study|Lost to Follow-up|2|||
164176735|NCT02453282|593012547|FG000|Overall Study|Withdrawal by Subject|12|||
164176736|NCT02453282|593012548|FG001|Overall Study|Withdrawal by Subject|10|||
164176737|NCT02453282|593012549|FG002|Overall Study|Withdrawal by Subject|11|||
164176738|NCT02453282|593012547|FG000|Overall Study|Participants ongoing at data cut-off|85|||
164176739|NCT02453282|593012548|FG001|Overall Study|Participants ongoing at data cut-off|84|||
164176740|NCT02453282|593012549|FG002|Overall Study|Participants ongoing at data cut-off|62|||
164176741|NCT02453282|593012547|FG000|Overall Study|Other|1|||
164176742|NCT02453282|593012548|FG001|Overall Study|Other|1|||
164176743|NCT02453282|593012549|FG002|Overall Study|Other|1|||
164176744|NCT00985426|593012550|FG000|Overall Study|Adverse Event|0|||
164176745|NCT00985426|593012551|FG001|Overall Study|Adverse Event|1|||
164176746|NCT00985426|593012550|FG000|Overall Study|Subject Non-Compliance|3|||
164176747|NCT00985426|593012551|FG001|Overall Study|Subject Non-Compliance|3|||
164176748|NCT00985426|593012550|FG000|Overall Study|Withdrawal by Subject|12|||
164176749|NCT00985426|593012551|FG001|Overall Study|Withdrawal by Subject|16|||
164176750|NCT00985426|593012550|FG000|Overall Study|Lost to Follow-up|8|||
164176751|NCT00985426|593012551|FG001|Overall Study|Lost to Follow-up|10|||
164176752|NCT00985426|593012550|FG000|Overall Study|Death|7|||
164176753|NCT00985426|593012551|FG001|Overall Study|Death|3|||
164176754|NCT00985426|593012550|FG000|Overall Study|Protocol Violation|2|||
164176755|NCT00985426|593012551|FG001|Overall Study|Protocol Violation|0|||
164176756|NCT00985426|593012550|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
164176757|NCT00985426|593012551|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
164176758|NCT02327013|593012554|FG000|Overall Study|Adverse Event|4|||
164176759|NCT02327013|593012555|FG001|Overall Study|Adverse Event|4|||
164176760|NCT02327013|593012556|FG002|Overall Study|Adverse Event|3|||
164176761|NCT02327013|593012557|FG003|Overall Study|Adverse Event|0|||
164176762|NCT02327013|593012558|FG004|Overall Study|Adverse Event|1|||
164176763|NCT02327013|593012554|FG000|Overall Study|Lack of Efficacy|2|||
164176764|NCT02327013|593012555|FG001|Overall Study|Lack of Efficacy|0|||
164176765|NCT02327013|593012556|FG002|Overall Study|Lack of Efficacy|5|||
164176766|NCT02327013|593012557|FG003|Overall Study|Lack of Efficacy|0|||
164176767|NCT02327013|593012558|FG004|Overall Study|Lack of Efficacy|1|||
164176768|NCT02327013|593012554|FG000|Overall Study|Non-compliance with IMP|1|||
164176769|NCT02327013|593012555|FG001|Overall Study|Non-compliance with IMP|2|||
164176770|NCT02327013|593012556|FG002|Overall Study|Non-compliance with IMP|7|||
164176771|NCT02327013|593012557|FG003|Overall Study|Non-compliance with IMP|0|||
164176772|NCT02327013|593012558|FG004|Overall Study|Non-compliance with IMP|0|||
164176773|NCT02327013|593012554|FG000|Overall Study|Withdrawal of Consent|1|||
164176774|NCT02327013|593012555|FG001|Overall Study|Withdrawal of Consent|0|||
164176775|NCT02327013|593012556|FG002|Overall Study|Withdrawal of Consent|3|||
164176776|NCT02327013|593012557|FG003|Overall Study|Withdrawal of Consent|0|||
164176777|NCT02327013|593012558|FG004|Overall Study|Withdrawal of Consent|0|||
164176778|NCT02327013|593012554|FG000|Overall Study|Lost to Follow-up|2|||
164176779|NCT02327013|593012555|FG001|Overall Study|Lost to Follow-up|4|||
164176780|NCT02327013|593012556|FG002|Overall Study|Lost to Follow-up|5|||
164176781|NCT02327013|593012557|FG003|Overall Study|Lost to Follow-up|0|||
164176782|NCT02327013|593012558|FG004|Overall Study|Lost to Follow-up|0|||
164176783|NCT02327013|593012554|FG000|Overall Study|Administrative or other reason(s)|1|||
164176784|NCT02327013|593012555|FG001|Overall Study|Administrative or other reason(s)|5|||
164176785|NCT02327013|593012556|FG002|Overall Study|Administrative or other reason(s)|11|||
164176786|NCT02327013|593012557|FG003|Overall Study|Administrative or other reason(s)|1|||
164176787|NCT02327013|593012558|FG004|Overall Study|Administrative or other reason(s)|1|||
164176788|NCT02327013|593012554|FG000|Overall Study|Protocol Violation|0|||
164176789|NCT02327013|593012555|FG001|Overall Study|Protocol Violation|0|||
164176790|NCT02327013|593012556|FG002|Overall Study|Protocol Violation|3|||
164176791|NCT02327013|593012557|FG003|Overall Study|Protocol Violation|0|||
164176792|NCT02327013|593012558|FG004|Overall Study|Protocol Violation|1|||
164176793|NCT02327013|593012554|FG000|Overall Study|Withdrawal before treatment|2|||
164176794|NCT02327013|593012555|FG001|Overall Study|Withdrawal before treatment|1|||
164176795|NCT02327013|593012556|FG002|Overall Study|Withdrawal before treatment|5|||
164176796|NCT02327013|593012557|FG003|Overall Study|Withdrawal before treatment|0|||
164176797|NCT02327013|593012558|FG004|Overall Study|Withdrawal before treatment|0|||
164176798|NCT02380859|593012559|FG000|Overall Study|Withdrawal by Subject|2|||
164176799|NCT02380859|593012560|FG001|Overall Study|Withdrawal by Subject|0|||
164176800|NCT04076059|593012563|FG000|Double Blind Phase|Progressive disease|22|||
164176801|NCT04076059|593012564|FG001|Double Blind Phase|Progressive disease|26|||
164176802|NCT04076059|593012565|FG002|Double Blind Phase|Progressive disease|0|||
164176803|NCT04076059|593012563|FG000|Double Blind Phase|Withdrawal by Subject|4|||
164176804|NCT04076059|593012564|FG001|Double Blind Phase|Withdrawal by Subject|11|||
164176805|NCT04076059|593012565|FG002|Double Blind Phase|Withdrawal by Subject|0|||
164176806|NCT04076059|593012563|FG000|Double Blind Phase|Death|1|||
164176807|NCT04076059|593012564|FG001|Double Blind Phase|Death|1|||
164176808|NCT04076059|593012565|FG002|Double Blind Phase|Death|0|||
164176809|NCT04076059|593012563|FG000|Double Blind Phase|Lost to Follow-up|1|||
164176810|NCT04076059|593012564|FG001|Double Blind Phase|Lost to Follow-up|0|||
164176811|NCT04076059|593012565|FG002|Double Blind Phase|Lost to Follow-up|0|||
164176812|NCT04076059|593012563|FG000|Double Blind Phase|Adverse Event|5|||
164176813|NCT04076059|593012564|FG001|Double Blind Phase|Adverse Event|1|||
164176814|NCT04076059|593012565|FG002|Double Blind Phase|Adverse Event|0|||
164176815|NCT04076059|593012563|FG000|Double Blind Phase|Ongoing Participants|82|||
164176816|NCT04076059|593012564|FG001|Double Blind Phase|Ongoing Participants|18|||
164176817|NCT04076059|593012565|FG002|Double Blind Phase|Ongoing Participants|0|||
164176818|NCT04076059|593012563|FG000|Double Blind Phase|Miscellaneous|3|||
164176819|NCT04076059|593012564|FG001|Double Blind Phase|Miscellaneous|1|||
164176820|NCT04076059|593012565|FG002|Double Blind Phase|Miscellaneous|0|||
164176821|NCT04076059|593012563|FG000|Double Blind Phase|Protocol Deviation|1|||
164176822|NCT04076059|593012564|FG001|Double Blind Phase|Protocol Deviation|1|||
164176823|NCT04076059|593012565|FG002|Double Blind Phase|Protocol Deviation|0|||
164176824|NCT04076059|593012563|FG000|Double Blind Phase|Did not take study drug|1|||
164176825|NCT04076059|593012564|FG001|Double Blind Phase|Did not take study drug|1|||
164176826|NCT04076059|593012565|FG002|Double Blind Phase|Did not take study drug|0|||
164176827|NCT04076059|593012563|FG000|Open Label Phase|Progressive disease|0|||
164176828|NCT04076059|593012564|FG001|Open Label Phase|Progressive disease|0|||
164176829|NCT04076059|593012565|FG002|Open Label Phase|Progressive disease|7|||
164176830|NCT04076059|593012563|FG000|Open Label Phase|Withdrawal by Subject|0|||
164176831|NCT04076059|593012564|FG001|Open Label Phase|Withdrawal by Subject|0|||
164176832|NCT04076059|593012565|FG002|Open Label Phase|Withdrawal by Subject|3|||
164176833|NCT04076059|593012563|FG000|Open Label Phase|Death|0|||
164176834|NCT04076059|593012564|FG001|Open Label Phase|Death|0|||
164176835|NCT04076059|593012565|FG002|Open Label Phase|Death|2|||
164176836|NCT04076059|593012563|FG000|Open Label Phase|Ongoing Participants|0|||
164176837|NCT04076059|593012564|FG001|Open Label Phase|Ongoing Participants|0|||
164176838|NCT04076059|593012565|FG002|Open Label Phase|Ongoing Participants|11|||
164176839|NCT04186806|593012566|FG000|Period 1: 7 Days|Adverse Event|1|||
164176840|NCT04186806|593012567|FG001|Period 1: 7 Days|Adverse Event|0|||
164176841|NCT01661933|593012569|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
164176842|NCT01661933|593012569|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
164176843|NCT03385304|593012570|FG000|Overall Study|Death|19|||
164176844|NCT03385304|593012571|FG001|Overall Study|Death|7|||
164176845|NCT03385304|593012570|FG000|Overall Study|Lost to Follow-up|17|||
164176846|NCT03385304|593012571|FG001|Overall Study|Lost to Follow-up|14|||
164176847|NCT03385304|593012570|FG000|Overall Study|Withdrawal by Subject|3|||
164176848|NCT03385304|593012571|FG001|Overall Study|Withdrawal by Subject|2|||
164176849|NCT03385304|593012570|FG000|Overall Study|Incarceration|2|||
164176850|NCT03385304|593012571|FG001|Overall Study|Incarceration|3|||
164176851|NCT01120249|593012572|FG000|Overall Study|No protocol treatment received|21|||
164176852|NCT01120249|593012573|FG001|Overall Study|No protocol treatment received|15|||
164176853|NCT01120249|593012572|FG000|Overall Study|Disease recurrence|107|||
164176854|NCT01120249|593012573|FG001|Overall Study|Disease recurrence|57|||
164176855|NCT01120249|593012572|FG000|Overall Study|Death|1|||
164176856|NCT01120249|593012573|FG001|Overall Study|Death|0|||
164176857|NCT01120249|593012572|FG000|Overall Study|Adverse Event|40|||
164176858|NCT01120249|593012573|FG001|Overall Study|Adverse Event|276|||
164176859|NCT01120249|593012572|FG000|Overall Study|Participant refusal|34|||
164176860|NCT01120249|593012573|FG001|Overall Study|Participant refusal|42|||
164176861|NCT01120249|593012572|FG000|Overall Study|Other reasons, not protocol specified|29|||
164176862|NCT01120249|593012573|FG001|Overall Study|Other reasons, not protocol specified|22|||
164176863|NCT04258254|593012574|FG000|Overall Study|Withdrawal by Subject|0|||
164176864|NCT04258254|593012575|FG001|Overall Study|Withdrawal by Subject|1|||
164176865|NCT04258254|593012576|FG002|Overall Study|Withdrawal by Subject|0|||
164176866|NCT02720744|593012577|FG000|Overall Study|Protocol Violation|0|||
164176867|NCT02720744|593012578|FG001|Overall Study|Protocol Violation|2|||
164176868|NCT02720744|593012577|FG000|Overall Study|Pregnancy|2|||
164176869|NCT02720744|593012578|FG001|Overall Study|Pregnancy|0|||
164176870|NCT02720744|593012577|FG000|Overall Study|Lack of Efficacy|2|||
164176871|NCT02720744|593012578|FG001|Overall Study|Lack of Efficacy|8|||
164176872|NCT02720744|593012577|FG000|Overall Study|Adverse Event|21|||
164176873|NCT02720744|593012578|FG001|Overall Study|Adverse Event|3|||
164176874|NCT02720744|593012577|FG000|Overall Study|Withdrawal by Subject|11|||
164176875|NCT02720744|593012578|FG001|Overall Study|Withdrawal by Subject|11|||
164176876|NCT02720744|593012577|FG000|Overall Study|Lost to follow up|2|||
164176877|NCT02720744|593012578|FG001|Overall Study|Lost to follow up|0|||
164176878|NCT02720744|593012577|FG000|Overall Study|Non Compliance with Investigational Product|0|||
164176879|NCT02720744|593012578|FG001|Overall Study|Non Compliance with Investigational Product|1|||
164176880|NCT02720744|593012577|FG000|Overall Study|Excluded Concomitant Medication|0|||
164176881|NCT02720744|593012578|FG001|Overall Study|Excluded Concomitant Medication|1|||
164176882|NCT02255552|593012579|FG000|Overall Study|Participants enrolled into another study|0|||
164176883|NCT02255552|593012580|FG001|Overall Study|Participants enrolled into another study|11|||
164176884|NCT02255552|593012579|FG000|Overall Study|Withdrawal by Subject|1|||
164176885|NCT02255552|593012580|FG001|Overall Study|Withdrawal by Subject|4|||
164176886|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
164176887|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
164176888|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
164176889|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
164176890|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
164176891|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
164176892|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Other|0|||
164176893|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Other|0|||
164176894|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Other|1|||
164176895|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Other|0|||
164176896|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Other|0|||
164176897|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Other|0|||
164176898|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176899|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
164176900|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176901|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176902|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176903|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
164176904|NCT02122770|593012581|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
164176905|NCT02122770|593012582|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
164176906|NCT02122770|593012583|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
164176907|NCT02122770|593012584|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
164176908|NCT02122770|593012585|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
164176909|NCT02122770|593012586|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
164176910|NCT02122770|593012581|FG000|Part B: Standard of Care|Adverse Event|0|||
164176911|NCT02122770|593012582|FG001|Part B: Standard of Care|Adverse Event|0|||
164176912|NCT02122770|593012583|FG002|Part B: Standard of Care|Adverse Event|0|||
164176913|NCT02122770|593012584|FG003|Part B: Standard of Care|Adverse Event|0|||
164176914|NCT02122770|593012585|FG004|Part B: Standard of Care|Adverse Event|4|||
164176915|NCT02122770|593012586|FG005|Part B: Standard of Care|Adverse Event|1|||
164176916|NCT02122770|593012581|FG000|Part B: Standard of Care|Other|0|||
164176917|NCT02122770|593012582|FG001|Part B: Standard of Care|Other|0|||
164176918|NCT02122770|593012583|FG002|Part B: Standard of Care|Other|0|||
164176919|NCT02122770|593012584|FG003|Part B: Standard of Care|Other|0|||
164176920|NCT02122770|593012585|FG004|Part B: Standard of Care|Other|0|||
164176921|NCT02122770|593012586|FG005|Part B: Standard of Care|Other|2|||
164176922|NCT02122770|593012581|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
164176923|NCT02122770|593012582|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
164176924|NCT02122770|593012583|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
164176925|NCT02122770|593012584|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
164176926|NCT02122770|593012585|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
164176927|NCT02122770|593012586|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
164176928|NCT02122770|593012581|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176929|NCT02122770|593012582|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176930|NCT02122770|593012583|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176931|NCT02122770|593012584|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176932|NCT02122770|593012585|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
164176933|NCT02122770|593012586|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
164176934|NCT02122770|593012581|FG000|Part B: Standard of Care|Progressive Disease|0|||
164176935|NCT02122770|593012582|FG001|Part B: Standard of Care|Progressive Disease|0|||
164176936|NCT02122770|593012583|FG002|Part B: Standard of Care|Progressive Disease|0|||
164176937|NCT02122770|593012584|FG003|Part B: Standard of Care|Progressive Disease|0|||
164176938|NCT02122770|593012585|FG004|Part B: Standard of Care|Progressive Disease|10|||
164176939|NCT02122770|593012586|FG005|Part B: Standard of Care|Progressive Disease|8|||
164176940|NCT00558896|593012587|FG000|Overall Study|Adverse Event|1|||
164176941|NCT00558896|593012588|FG001|Overall Study|Adverse Event|1|||
164176942|NCT00558896|593012589|FG002|Overall Study|Adverse Event|1|||
164176943|NCT00558896|593012590|FG003|Overall Study|Adverse Event|3|||
164176944|NCT00558896|593012591|FG004|Overall Study|Adverse Event|4|||
164176945|NCT00558896|593012592|FG005|Overall Study|Adverse Event|10|||
164176946|NCT00558896|593012593|FG006|Overall Study|Adverse Event|3|||
164176947|NCT00558896|593012587|FG000|Overall Study|Death|3|||
164176948|NCT00558896|593012588|FG001|Overall Study|Death|0|||
164176949|NCT00558896|593012589|FG002|Overall Study|Death|2|||
164176950|NCT00558896|593012590|FG003|Overall Study|Death|3|||
164176951|NCT00558896|593012591|FG004|Overall Study|Death|2|||
164176952|NCT00558896|593012592|FG005|Overall Study|Death|2|||
164176953|NCT00558896|593012593|FG006|Overall Study|Death|6|||
164176954|NCT00558896|593012587|FG000|Overall Study|Withdrawal by Subject|2|||
164176955|NCT00558896|593012588|FG001|Overall Study|Withdrawal by Subject|1|||
164176956|NCT00558896|593012589|FG002|Overall Study|Withdrawal by Subject|1|||
164176957|NCT00558896|593012590|FG003|Overall Study|Withdrawal by Subject|1|||
164176958|NCT00558896|593012591|FG004|Overall Study|Withdrawal by Subject|1|||
164176959|NCT00558896|593012592|FG005|Overall Study|Withdrawal by Subject|5|||
164176960|NCT00558896|593012593|FG006|Overall Study|Withdrawal by Subject|5|||
164176961|NCT00558896|593012587|FG000|Overall Study|Alternative Treatment|2|||
164176962|NCT00558896|593012588|FG001|Overall Study|Alternative Treatment|2|||
164176963|NCT00558896|593012589|FG002|Overall Study|Alternative Treatment|0|||
164176964|NCT00558896|593012590|FG003|Overall Study|Alternative Treatment|2|||
164176965|NCT00558896|593012591|FG004|Overall Study|Alternative Treatment|6|||
164176966|NCT00558896|593012592|FG005|Overall Study|Alternative Treatment|7|||
164176967|NCT00558896|593012593|FG006|Overall Study|Alternative Treatment|1|||
164176968|NCT00558896|593012587|FG000|Overall Study|Physician discretion|3|||
164176969|NCT00558896|593012588|FG001|Overall Study|Physician discretion|2|||
164176970|NCT00558896|593012589|FG002|Overall Study|Physician discretion|1|||
164176971|NCT00558896|593012590|FG003|Overall Study|Physician discretion|2|||
164176972|NCT00558896|593012591|FG004|Overall Study|Physician discretion|1|||
164176973|NCT00558896|593012592|FG005|Overall Study|Physician discretion|3|||
164176974|NCT00558896|593012593|FG006|Overall Study|Physician discretion|3|||
164176975|NCT00558896|593012587|FG000|Overall Study|Continues on treatment|10|||
164176976|NCT00558896|593012588|FG001|Overall Study|Continues on treatment|1|||
164176977|NCT00558896|593012589|FG002|Overall Study|Continues on treatment|0|||
164176978|NCT00558896|593012590|FG003|Overall Study|Continues on treatment|1|||
164176979|NCT00558896|593012591|FG004|Overall Study|Continues on treatment|9|||
164176980|NCT00558896|593012592|FG005|Overall Study|Continues on treatment|25|||
164176981|NCT00558896|593012593|FG006|Overall Study|Continues on treatment|6|||
164176982|NCT00723190|593012596|FG000|Overall Study|Withdrawal by Subject|45|||
164176983|NCT00723190|593012596|FG000|Overall Study|Lost to Follow-up|37|||
164176984|NCT00723190|593012596|FG000|Overall Study|Adverse Event|18|||
164176985|NCT00723190|593012596|FG000|Overall Study|Lack of Efficacy|16|||
164176986|NCT00723190|593012596|FG000|Overall Study|Protocol Violation|15|||
164176987|NCT00723190|593012596|FG000|Overall Study|Other-Premature Discontinuation|9|||
164176988|NCT00723190|593012596|FG000|Overall Study|Other-Not included in safety population|2|||
164176989|NCT03181503|593012597|FG000|Overall Study|Adverse Event|2|||
164176990|NCT03181503|593012598|FG001|Overall Study|Adverse Event|2|||
164176991|NCT03181503|593012597|FG000|Overall Study|Protocol Violation|1|||
164176992|NCT03181503|593012598|FG001|Overall Study|Protocol Violation|0|||
164176993|NCT03181503|593012597|FG000|Overall Study|Withdrawal by Subject|3|||
164176994|NCT03181503|593012598|FG001|Overall Study|Withdrawal by Subject|0|||
164176995|NCT03181503|593012597|FG000|Overall Study|Lost to Follow-up|1|||
164176996|NCT03181503|593012598|FG001|Overall Study|Lost to Follow-up|1|||
164176997|NCT00767039|593012602|FG000|Overall Study|Death|5|||
164176998|NCT00767039|593012603|FG001|Overall Study|Death|2|||
164176999|NCT02505334|593012604|FG000|Main Treatment Period|Adverse Event|3|||
164177000|NCT02505334|593012605|FG001|Main Treatment Period|Adverse Event|3|||
164177001|NCT02505334|593012604|FG000|Main Treatment Period|Lack of Efficacy|7|||
164177002|NCT02505334|593012605|FG001|Main Treatment Period|Lack of Efficacy|17|||
164177003|NCT02505334|593012604|FG000|Main Treatment Period|Protocol Violation|0|||
164177004|NCT02505334|593012605|FG001|Main Treatment Period|Protocol Violation|1|||
164177005|NCT02505334|593012604|FG000|Main Treatment Period|Withdrawal by Subject|1|||
164177006|NCT02505334|593012605|FG001|Main Treatment Period|Withdrawal by Subject|8|||
164177007|NCT02505334|593012604|FG000|Main Treatment Period|Unclassified|4|||
164177008|NCT02505334|593012605|FG001|Main Treatment Period|Unclassified|10|||
164177009|NCT02505334|593012604|FG000|Extension Treatment Period|Adverse Event|5|||
164177010|NCT02505334|593012605|FG001|Extension Treatment Period|Adverse Event|0|||
164177011|NCT02505334|593012604|FG000|Extension Treatment Period|Lack of Efficacy|4|||
164177012|NCT02505334|593012605|FG001|Extension Treatment Period|Lack of Efficacy|0|||
164177013|NCT02505334|593012604|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
164177014|NCT02505334|593012605|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
164177015|NCT02505334|593012604|FG000|Extension Treatment Period|Unclassified|3|||
164177016|NCT02505334|593012605|FG001|Extension Treatment Period|Unclassified|0|||
164177017|NCT01549041|593012610|FG000|Overall Study|Lack of Efficacy|2|||
164177018|NCT01549041|593012611|FG001|Overall Study|Lack of Efficacy|4|||
164177019|NCT01549041|593012610|FG000|Overall Study|Adverse Event|0|||
164177020|NCT01549041|593012611|FG001|Overall Study|Adverse Event|4|||
164177021|NCT04472026|593012616|FG000|Overall Study|Lost to Follow-up|5|||
164177022|NCT01404208|593012617|FG000|Overall Study|Discontinued|3|||
164177023|NCT01404208|593012618|FG001|Overall Study|Discontinued|0|||
164177024|NCT02382796|593012619|FG000|Overall Study|Global deterioration of health status|1|||
164177025|NCT02382796|593012619|FG000|Overall Study|Objective progression or relapse|3|||
164177026|NCT02382796|593012619|FG000|Overall Study|Commercial dacomitinib became available|3|||
164177027|NCT03077659|593012620|FG000|Overall Study|Withdrawal by Subject|0|||
164177028|NCT03077659|593012621|FG001|Overall Study|Withdrawal by Subject|0|||
164177029|NCT03077659|593012622|FG002|Overall Study|Withdrawal by Subject|1|||
164177030|NCT02258542|593012629|FG000|Overall Study|eg. not made to the visit|7|||
164177031|NCT02258542|593012630|FG001|Overall Study|eg. not made to the visit|4|||
164177032|NCT02258542|593012631|FG002|Overall Study|eg. not made to the visit|0|||
164177033|NCT02258542|593012632|FG003|Overall Study|eg. not made to the visit|1|||
164177034|NCT02258542|593012629|FG000|Overall Study|study specific discount. criteria|1|||
164177035|NCT02258542|593012630|FG001|Overall Study|study specific discount. criteria|1|||
164177036|NCT02258542|593012631|FG002|Overall Study|study specific discount. criteria|0|||
164177037|NCT02258542|593012632|FG003|Overall Study|study specific discount. criteria|0|||
164177038|NCT02258542|593012629|FG000|Overall Study|Withdrawal by Subject|20|||
164177039|NCT02258542|593012630|FG001|Overall Study|Withdrawal by Subject|20|||
164177040|NCT02258542|593012631|FG002|Overall Study|Withdrawal by Subject|7|||
164177041|NCT02258542|593012632|FG003|Overall Study|Withdrawal by Subject|1|||
164177042|NCT02258542|593012629|FG000|Overall Study|Lost to Follow-up|5|||
164177043|NCT02258542|593012630|FG001|Overall Study|Lost to Follow-up|12|||
164177044|NCT02258542|593012631|FG002|Overall Study|Lost to Follow-up|1|||
164177045|NCT02258542|593012632|FG003|Overall Study|Lost to Follow-up|2|||
164177046|NCT02258542|593012629|FG000|Overall Study|Death|5|||
164177047|NCT02258542|593012630|FG001|Overall Study|Death|4|||
164177048|NCT02258542|593012631|FG002|Overall Study|Death|0|||
164177049|NCT02258542|593012632|FG003|Overall Study|Death|1|||
164177050|NCT02258542|593012629|FG000|Overall Study|Adverse Event|3|||
164177051|NCT02258542|593012630|FG001|Overall Study|Adverse Event|4|||
164177052|NCT02258542|593012631|FG002|Overall Study|Adverse Event|0|||
164177053|NCT02258542|593012632|FG003|Overall Study|Adverse Event|0|||
164177054|NCT02258542|593012629|FG000|Overall Study|Protocol Violation|1|||
164177055|NCT02258542|593012630|FG001|Overall Study|Protocol Violation|2|||
164177056|NCT02258542|593012631|FG002|Overall Study|Protocol Violation|0|||
164177057|NCT02258542|593012632|FG003|Overall Study|Protocol Violation|0|||
164177058|NCT02258542|593012629|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
164177059|NCT02258542|593012630|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
164177060|NCT02258542|593012631|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
164177061|NCT02258542|593012632|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
164177062|NCT04068688|593012633|FG000|Overall Study|Lost to Follow-up|1|||
164177063|NCT04068688|593012634|FG001|Overall Study|Lost to Follow-up|1|||
164177064|NCT04068688|593012635|FG002|Overall Study|Lost to Follow-up|0|||
164177065|NCT04068688|593012636|FG003|Overall Study|Lost to Follow-up|0|||
164177066|NCT04068688|593012637|FG004|Overall Study|Lost to Follow-up|5|||
164177067|NCT04068688|593012638|FG005|Overall Study|Lost to Follow-up|5|||
164177068|NCT04068688|593012639|FG006|Overall Study|Lost to Follow-up|0|||
164177069|NCT04068688|593012640|FG007|Overall Study|Lost to Follow-up|0|||
164177070|NCT04068688|593012641|FG008|Overall Study|Lost to Follow-up|1|||
164177071|NCT04068688|593012642|FG009|Overall Study|Lost to Follow-up|0|||
164177072|NCT04068688|593012633|FG000|Overall Study|Withdrawal by Subject|1|||
164177073|NCT04068688|593012634|FG001|Overall Study|Withdrawal by Subject|1|||
164177074|NCT04068688|593012635|FG002|Overall Study|Withdrawal by Subject|0|||
164177075|NCT04068688|593012636|FG003|Overall Study|Withdrawal by Subject|0|||
164177076|NCT04068688|593012637|FG004|Overall Study|Withdrawal by Subject|0|||
164177077|NCT04068688|593012638|FG005|Overall Study|Withdrawal by Subject|0|||
164177078|NCT04068688|593012639|FG006|Overall Study|Withdrawal by Subject|0|||
164177079|NCT04068688|593012640|FG007|Overall Study|Withdrawal by Subject|0|||
164177080|NCT04068688|593012641|FG008|Overall Study|Withdrawal by Subject|0|||
164177081|NCT04068688|593012642|FG009|Overall Study|Withdrawal by Subject|0|||
164177082|NCT04068688|593012633|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
164177083|NCT04068688|593012634|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
164177084|NCT04068688|593012635|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177085|NCT04068688|593012636|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177086|NCT04068688|593012637|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177087|NCT04068688|593012638|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177088|NCT04068688|593012639|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177089|NCT04068688|593012640|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177090|NCT04068688|593012641|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177091|NCT04068688|593012642|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
164177092|NCT04679051|593012643|FG000|Overall Study|felt tired after restricted time in bed|3|||
164177093|NCT04679051|593012644|FG001|Overall Study|felt tired after restricted time in bed|0|||
164177094|NCT04679051|593012643|FG000|Overall Study|discomfort with blood pressure cuff|2|||
164177095|NCT04679051|593012644|FG001|Overall Study|discomfort with blood pressure cuff|0|||
164177096|NCT04679051|593012643|FG000|Overall Study|scheduling conflict|1|||
164177097|NCT04679051|593012644|FG001|Overall Study|scheduling conflict|1|||
164177098|NCT04679051|593012643|FG000|Overall Study|Protocol Violation|0|||
164177099|NCT04679051|593012644|FG001|Overall Study|Protocol Violation|4|||
164177100|NCT02772276|593012645|FG000|Overall Study|Lost to Follow-up|0|||
164177101|NCT02772276|593012646|FG001|Overall Study|Lost to Follow-up|0|||
164177102|NCT02772276|593012647|FG002|Overall Study|Lost to Follow-up|0|||
164177103|NCT02772276|593012648|FG003|Overall Study|Lost to Follow-up|0|||
164177104|NCT02772276|593012649|FG004|Overall Study|Lost to Follow-up|0|||
164177105|NCT02772276|593012650|FG005|Overall Study|Lost to Follow-up|0|||
164177106|NCT02772276|593012651|FG006|Overall Study|Lost to Follow-up|1|||
164177107|NCT02772276|593012652|FG007|Overall Study|Lost to Follow-up|0|||
164177108|NCT02772276|593012653|FG008|Overall Study|Lost to Follow-up|0|||
164177109|NCT02772276|593012654|FG009|Overall Study|Lost to Follow-up|0|||
164177110|NCT02772276|593012655|FG010|Overall Study|Lost to Follow-up|0|||
164177111|NCT02772276|593012656|FG011|Overall Study|Lost to Follow-up|0|||
164177112|NCT02772276|593012657|FG012|Overall Study|Lost to Follow-up|0|||
164177113|NCT02772276|593012645|FG000|Overall Study|Withdrew consent|0|||
164177114|NCT02772276|593012646|FG001|Overall Study|Withdrew consent|0|||
164177115|NCT02772276|593012647|FG002|Overall Study|Withdrew consent|0|||
164177116|NCT02772276|593012648|FG003|Overall Study|Withdrew consent|0|||
164177117|NCT02772276|593012649|FG004|Overall Study|Withdrew consent|0|||
164177118|NCT02772276|593012650|FG005|Overall Study|Withdrew consent|0|||
164177119|NCT02772276|593012651|FG006|Overall Study|Withdrew consent|0|||
164177120|NCT02772276|593012652|FG007|Overall Study|Withdrew consent|1|||
164177121|NCT02772276|593012653|FG008|Overall Study|Withdrew consent|0|||
164177122|NCT02772276|593012654|FG009|Overall Study|Withdrew consent|0|||
164177123|NCT02772276|593012655|FG010|Overall Study|Withdrew consent|0|||
164177124|NCT02772276|593012656|FG011|Overall Study|Withdrew consent|0|||
164177125|NCT02772276|593012657|FG012|Overall Study|Withdrew consent|0|||
164177126|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
164177127|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
164177128|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
164177129|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
164177130|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
164177131|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
164177132|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
164177133|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
164177134|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
164177135|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
164177136|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177137|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177138|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
164177139|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177140|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
164177141|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177142|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177143|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
164177144|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177145|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
164177146|NCT00550862|593012658|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177147|NCT00550862|593012659|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
164177148|NCT00550862|593012660|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177149|NCT00550862|593012661|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177150|NCT00550862|593012662|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
164177151|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177152|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177153|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177154|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
164177155|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
164177156|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177157|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177158|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177159|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
164177160|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
164177161|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177162|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177163|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177164|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
164177165|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
164177166|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
164177167|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
164177168|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
164177169|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
164177170|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
164177171|NCT00550862|593012658|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177172|NCT00550862|593012659|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177173|NCT00550862|593012660|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177174|NCT00550862|593012661|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
164177175|NCT00550862|593012662|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
164177176|NCT02248974|593012663|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
164177177|NCT02248974|593012664|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
164177178|NCT02248974|593012663|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
164177179|NCT02248974|593012664|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
164177180|NCT02248974|593012663|FG000|1-Day Follow-Up|Enrolled in another study|1|||
164177181|NCT02248974|593012664|FG001|1-Day Follow-Up|Enrolled in another study|0|||
164177182|NCT02248974|593012663|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
164177183|NCT02248974|593012664|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
164177184|NCT02248974|593012663|FG000|1-Week Follow-Up|Enrolled in another study|1|||
164177185|NCT02248974|593012664|FG001|1-Week Follow-Up|Enrolled in another study|1|||
164177186|NCT02248974|593012663|FG000|1-Week Follow-Up|Transferred to another facility|1|||
164177187|NCT02248974|593012664|FG001|1-Week Follow-Up|Transferred to another facility|0|||
164177188|NCT02248974|593012663|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
164177189|NCT02248974|593012664|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
164177190|NCT02248974|593012663|FG000|1-Week Follow-Up|Death|1|||
164177191|NCT02248974|593012664|FG001|1-Week Follow-Up|Death|1|||
164177192|NCT02248974|593012663|FG000|1-Week Follow-Up|Excluded because of age|0|||
164177193|NCT02248974|593012664|FG001|1-Week Follow-Up|Excluded because of age|1|||
164177194|NCT02248974|593012663|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
164177195|NCT02248974|593012664|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
164177196|NCT02248974|593012663|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
164177197|NCT02248974|593012664|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
164177198|NCT02248974|593012663|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
164177199|NCT02248974|593012664|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
164177200|NCT02248974|593012663|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
164177201|NCT02248974|593012664|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
164177202|NCT02248974|593012663|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
164177203|NCT02248974|593012664|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
164177204|NCT03488225|593012665|FG000|Overall Study|Off Protocol Therapy|2|||
164177205|NCT03488225|593012665|FG000|Overall Study|Stem Cell Transplant|2|||
164177206|NCT00085098|593012668|FG000|Overall Study|Withdrawal by Subject|0|||
164177207|NCT00085098|593012669|FG001|Overall Study|Withdrawal by Subject|1|||
164177208|NCT00085098|593012668|FG000|Overall Study|Ineligible|1|||
164177209|NCT00085098|593012669|FG001|Overall Study|Ineligible|1|||
164177210|NCT01935700|593012670|FG000|Overall Study|Withdrawal by Subject|1|||
164177211|NCT01935700|593012671|FG001|Overall Study|Withdrawal by Subject|0|||
164177212|NCT01935700|593012670|FG000|Overall Study|Physician Decision|4|||
164177213|NCT01935700|593012671|FG001|Overall Study|Physician Decision|0|||
164177214|NCT01273155|593012674|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
164177215|NCT01273155|593012675|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
164177216|NCT01273155|593012676|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
164177217|NCT01273155|593012677|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
164177218|NCT01273155|593012678|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
164177219|NCT01273155|593012679|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
164177220|NCT01273155|593012680|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
164177221|NCT01273155|593012674|FG000|Overall Study|Change in liver function/no longer eval.|0|||
164177222|NCT01273155|593012675|FG001|Overall Study|Change in liver function/no longer eval.|1|||
164177223|NCT01273155|593012676|FG002|Overall Study|Change in liver function/no longer eval.|0|||
164177224|NCT01273155|593012677|FG003|Overall Study|Change in liver function/no longer eval.|0|||
164177225|NCT01273155|593012678|FG004|Overall Study|Change in liver function/no longer eval.|1|||
164177226|NCT01273155|593012679|FG005|Overall Study|Change in liver function/no longer eval.|0|||
164177227|NCT01273155|593012680|FG006|Overall Study|Change in liver function/no longer eval.|0|||
164177228|NCT01273155|593012674|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
164177229|NCT01273155|593012675|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
164177230|NCT01273155|593012676|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
164177231|NCT01273155|593012677|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
164177232|NCT01273155|593012678|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
164177233|NCT01273155|593012679|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
164177234|NCT01273155|593012680|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
164177235|NCT01273155|593012674|FG000|Overall Study|Died during Cycle 1|0|||
164177236|NCT01273155|593012675|FG001|Overall Study|Died during Cycle 1|0|||
164177237|NCT01273155|593012676|FG002|Overall Study|Died during Cycle 1|1|||
164177238|NCT01273155|593012677|FG003|Overall Study|Died during Cycle 1|1|||
164177239|NCT01273155|593012678|FG004|Overall Study|Died during Cycle 1|0|||
164177240|NCT01273155|593012679|FG005|Overall Study|Died during Cycle 1|2|||
164177241|NCT01273155|593012680|FG006|Overall Study|Died during Cycle 1|2|||
164177242|NCT01273155|593012674|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
164177243|NCT01273155|593012675|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
164177244|NCT01273155|593012676|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
164177245|NCT01273155|593012677|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
164177246|NCT01273155|593012678|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
164177247|NCT01273155|593012679|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
164177248|NCT01273155|593012680|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
164177249|NCT02419612|593012681|FG000|Short-term Treatment Period|Adverse Event|1|||
164177250|NCT02419612|593012682|FG001|Short-term Treatment Period|Adverse Event|1|||
164177251|NCT02419612|593012681|FG000|Short-term Treatment Period|Death|0|||
164177252|NCT02419612|593012682|FG001|Short-term Treatment Period|Death|2|||
164177253|NCT02419612|593012681|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
164177254|NCT02419612|593012682|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
164177255|NCT02419612|593012681|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
164177256|NCT02419612|593012682|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
164177257|NCT02419612|593012681|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
164177258|NCT02419612|593012682|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
164177259|NCT02419612|593012681|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
164177260|NCT02419612|593012682|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
164177261|NCT02419612|593012681|FG000|Short-term Treatment Period|Worsening of liver function|0|||
164177262|NCT02419612|593012682|FG001|Short-term Treatment Period|Worsening of liver function|1|||
164177263|NCT02419612|593012681|FG000|Short-term Treatment Period|Subject moved out of state|0|||
164177264|NCT02419612|593012682|FG001|Short-term Treatment Period|Subject moved out of state|1|||
164177265|NCT02419612|593012681|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
164177266|NCT02419612|593012682|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
164177267|NCT02419612|593012681|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
164177268|NCT02419612|593012682|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
164177269|NCT02419612|593012681|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
164177270|NCT02419612|593012682|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
164177271|NCT02419612|593012681|FG000|Long-term Treatment Period|Death|0|||
164177272|NCT02419612|593012682|FG001|Long-term Treatment Period|Death|1|||
164177273|NCT02419612|593012681|FG000|Long-term Treatment Period|Adverse Event|0|||
164177274|NCT02419612|593012682|FG001|Long-term Treatment Period|Adverse Event|5|||
164177275|NCT02419612|593012681|FG000|Long-term Treatment Period|Other|4|||
164177276|NCT02419612|593012682|FG001|Long-term Treatment Period|Other|4|||
164177277|NCT02419612|593012681|FG000|Long-term Treatment Period|Subject Decision|2|||
164177278|NCT02419612|593012682|FG001|Long-term Treatment Period|Subject Decision|4|||
164177279|NCT02419612|593012681|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
164177280|NCT02419612|593012682|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
164177281|NCT00078949|593013972|FG000|Overall Study|No treated|4|||
164177282|NCT00078949|593013973|FG001|Overall Study|No treated|5|||
164177283|NCT00078949|593013974|FG002|Overall Study|No treated|3|||
164177284|NCT00078949|593013975|FG003|Overall Study|No treated|3|||
164177285|NCT00396877|593013976|FG000|Overall Study|Lost to Follow-up|2|||
164177286|NCT00396877|593013977|FG001|Overall Study|Lost to Follow-up|1|||
164177287|NCT00396877|593013976|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
164177288|NCT00396877|593013977|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
164177289|NCT02584959|593013978|FG000|Period 1|Withdrawn from study|3|||
164177290|NCT02584959|593013979|FG001|Period 1|Withdrawn from study|4|||
164177291|NCT02584959|593013980|FG002|Period 1|Withdrawn from study|0|||
164177292|NCT02584959|593013978|FG000|Period 2|Withdrawn from study|6|||
164177293|NCT02584959|593013979|FG001|Period 2|Withdrawn from study|1|||
164177294|NCT02584959|593013980|FG002|Period 2|Withdrawn from study|2|||
164177295|NCT00422422|593013981|FG000|Overall Study|Lack of Efficacy|1|||
164177296|NCT00422422|593013981|FG000|Overall Study|Protocol Violation|1|||
164177297|NCT00422422|593013981|FG000|Overall Study|Withdrawal by Subject|2|||
164177298|NCT00422422|593013981|FG000|Overall Study|SAE, non-fatal|1|||
164177299|NCT00422422|593013981|FG000|Overall Study|AE, non-serious non-fatal|5|||
164177300|NCT00926536|593013983|FG000|Overall Study|Physician Decision|1|||
164177301|NCT00926536|593013984|FG001|Overall Study|Physician Decision|2|||
164177302|NCT00435487|593013985|FG000|Overall Study|Death|3|||
164177303|NCT00435487|593013986|FG001|Overall Study|Death|4|||
164177304|NCT00435487|593013985|FG000|Overall Study|Adverse Event|0|||
164177305|NCT00435487|593013986|FG001|Overall Study|Adverse Event|3|||
164177306|NCT00435487|593013985|FG000|Overall Study|Lost to Follow-up|2|||
164177307|NCT00435487|593013986|FG001|Overall Study|Lost to Follow-up|2|||
164177308|NCT00435487|593013985|FG000|Overall Study|Other|5|||
164177309|NCT00435487|593013986|FG001|Overall Study|Other|2|||
164177310|NCT00435487|593013985|FG000|Overall Study|Withdrawal by Subject|2|||
164177311|NCT00435487|593013986|FG001|Overall Study|Withdrawal by Subject|1|||
164177312|NCT00435487|593013985|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
164177313|NCT00435487|593013986|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
164177314|NCT00435487|593013985|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
164177315|NCT00435487|593013986|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
164177316|NCT03301844|593013988|FG000|Overall Study|suspected colon cancer|1|||
164177317|NCT03301844|593013989|FG001|Overall Study|suspected colon cancer|1|||
164177318|NCT05087966|593013990|FG000|Overall Study|Lost to Follow-up|1|||
164177319|NCT05087966|593013990|FG000|Overall Study|Withdrawal by Subject|5|||
164177320|NCT01267201|593013992|FG000|First Intervention Period|Withdrawal by Subject|1|||
164177321|NCT01267201|593013993|FG001|First Intervention Period|Withdrawal by Subject|0|||
164177322|NCT01267201|593013994|FG002|First Intervention Period|Withdrawal by Subject|0|||
164177323|NCT01267201|593013995|FG003|First Intervention Period|Withdrawal by Subject|0|||
164177324|NCT01267201|593013996|FG004|First Intervention Period|Withdrawal by Subject|0|||
164177325|NCT01267201|593013997|FG005|First Intervention Period|Withdrawal by Subject|0|||
164177326|NCT01267201|593013992|FG000|Second Intervention Period|Withdrawal by Subject|0|||
164177327|NCT01267201|593013993|FG001|Second Intervention Period|Withdrawal by Subject|1|||
164177328|NCT01267201|593013994|FG002|Second Intervention Period|Withdrawal by Subject|0|||
164177329|NCT01267201|593013995|FG003|Second Intervention Period|Withdrawal by Subject|0|||
164177330|NCT01267201|593013996|FG004|Second Intervention Period|Withdrawal by Subject|0|||
164177331|NCT01267201|593013997|FG005|Second Intervention Period|Withdrawal by Subject|0|||
164177332|NCT00501059|593013998|FG000|Overall Study|Protocol Violation|80|||
164177333|NCT00501059|593013999|FG001|Overall Study|Protocol Violation|69|||
164177334|NCT00501059|593013998|FG000|Overall Study|Death|140|||
164177335|NCT00501059|593013999|FG001|Overall Study|Death|137|||
164177336|NCT00501059|593013998|FG000|Overall Study|Other|236|||
164177337|NCT00501059|593013999|FG001|Overall Study|Other|239|||
164177338|NCT00501059|593013998|FG000|Overall Study|Missing end-of-study page|91|||
164177339|NCT00501059|593013999|FG001|Overall Study|Missing end-of-study page|92|||
164177340|NCT00501059|593013998|FG000|Overall Study|Clinical endpoint reached|110|||
164177341|NCT00501059|593013999|FG001|Overall Study|Clinical endpoint reached|123|||
164177342|NCT00501059|593013998|FG000|Overall Study|Insufficient therapeutic effect|4|||
164177343|NCT00501059|593013999|FG001|Overall Study|Insufficient therapeutic effect|5|||
164177344|NCT00501059|593013998|FG000|Overall Study|Consent withdrawn by subject|817|||
164177345|NCT00501059|593013999|FG001|Overall Study|Consent withdrawn by subject|873|||
164177346|NCT00501059|593013998|FG000|Overall Study|Non-compliant with study treatment|23|||
164177347|NCT00501059|593013999|FG001|Overall Study|Non-compliant with study treatment|16|||
164177348|NCT00501059|593013998|FG000|Overall Study|Reason not given|3|||
164177349|NCT00501059|593013999|FG001|Overall Study|Reason not given|1|||
164177350|NCT00501059|593013998|FG000|Overall Study|Adverse Event|129|||
164177351|NCT00501059|593013999|FG001|Overall Study|Adverse Event|122|||
164177352|NCT00501059|593013998|FG000|Overall Study|Lost to Follow-up|210|||
164177353|NCT00501059|593013999|FG001|Overall Study|Lost to Follow-up|198|||
164177354|NCT00501059|593013998|FG000|Overall Study|Not treated|25|||
164177355|NCT00501059|593013999|FG001|Overall Study|Not treated|17|||
164177356|NCT00483704|593014000|FG000|Randomization|Withdrawal by Subject|19|||
164177357|NCT00483704|593014001|FG001|Randomization|Withdrawal by Subject|28|||
164177358|NCT00483704|593014002|FG002|Randomization|Withdrawal by Subject|18|||
164177359|NCT00483704|593014000|FG000|Randomization|Protocol Violation|14|||
164177360|NCT00483704|593014001|FG001|Randomization|Protocol Violation|25|||
164177361|NCT00483704|593014002|FG002|Randomization|Protocol Violation|22|||
164177362|NCT00483704|593014000|FG000|Randomization|Lost to Follow-up|14|||
164177363|NCT00483704|593014001|FG001|Randomization|Lost to Follow-up|14|||
164177364|NCT00483704|593014002|FG002|Randomization|Lost to Follow-up|19|||
164177365|NCT00483704|593014000|FG000|Randomization|Pregnancy|1|||
164177366|NCT00483704|593014001|FG001|Randomization|Pregnancy|0|||
164177367|NCT00483704|593014002|FG002|Randomization|Pregnancy|0|||
164177368|NCT00483704|593014000|FG000|Randomization|Physician Decision|2|||
164177369|NCT00483704|593014001|FG001|Randomization|Physician Decision|4|||
164177370|NCT00483704|593014002|FG002|Randomization|Physician Decision|0|||
164177371|NCT00483704|593014000|FG000|Randomization|Progressive disease|0|||
164177372|NCT00483704|593014001|FG001|Randomization|Progressive disease|0|||
164177373|NCT00483704|593014002|FG002|Randomization|Progressive disease|1|||
164177374|NCT00483704|593014000|FG000|Randomization|Lack of qualifying migraines|21|||
164177375|NCT00483704|593014001|FG001|Randomization|Lack of qualifying migraines|25|||
164177376|NCT00483704|593014002|FG002|Randomization|Lack of qualifying migraines|31|||
164177377|NCT00483704|593014000|FG000|Treatment|Lack of qualifying migraines|101|||
164177378|NCT00483704|593014001|FG001|Treatment|Lack of qualifying migraines|99|||
164177379|NCT00483704|593014002|FG002|Treatment|Lack of qualifying migraines|116|||
164177380|NCT00483704|593014000|FG000|Treatment|Adverse Event|3|||
164177381|NCT00483704|593014001|FG001|Treatment|Adverse Event|5|||
164177382|NCT00483704|593014002|FG002|Treatment|Adverse Event|4|||
164177383|NCT00483704|593014000|FG000|Treatment|Withdrawal by Subject|16|||
164177384|NCT00483704|593014001|FG001|Treatment|Withdrawal by Subject|12|||
164177385|NCT00483704|593014002|FG002|Treatment|Withdrawal by Subject|21|||
164177386|NCT00483704|593014000|FG000|Treatment|Protocol Violation|6|||
164177387|NCT00483704|593014001|FG001|Treatment|Protocol Violation|3|||
164177388|NCT00483704|593014002|FG002|Treatment|Protocol Violation|5|||
164177389|NCT00483704|593014000|FG000|Treatment|Lost to Follow-up|2|||
164177390|NCT00483704|593014001|FG001|Treatment|Lost to Follow-up|7|||
164177391|NCT00483704|593014002|FG002|Treatment|Lost to Follow-up|5|||
164177392|NCT00483704|593014000|FG000|Treatment|Lack of Efficacy|1|||
164177393|NCT00483704|593014001|FG001|Treatment|Lack of Efficacy|1|||
164177394|NCT00483704|593014002|FG002|Treatment|Lack of Efficacy|1|||
164177395|NCT00483704|593014000|FG000|Treatment|Pregnancy|0|||
164177396|NCT00483704|593014001|FG001|Treatment|Pregnancy|1|||
164177397|NCT00483704|593014002|FG002|Treatment|Pregnancy|0|||
164177398|NCT00483704|593014000|FG000|Treatment|Physician Decision|0|||
164177399|NCT00483704|593014001|FG001|Treatment|Physician Decision|1|||
164177400|NCT00483704|593014002|FG002|Treatment|Physician Decision|4|||
164177401|NCT02968433|593014004|FG000|Overall Study|Withdrawal by Subject|1|||
164177402|NCT00875433|593014005|FG000|Overall Study|Progressive disease|41|||
164177403|NCT00875433|593014005|FG000|Overall Study|Other Adverse Event|14|||
164177404|NCT00875433|593014005|FG000|Overall Study|Withdrawal by Subject|2|||
164177405|NCT00875433|593014005|FG000|Overall Study|Other|3|||
164177406|NCT04272606|593014006|FG000|Overall Study|Protocol Violation|1|||
164177407|NCT04272606|593014007|FG001|Overall Study|Protocol Violation|1|||
164177408|NCT04272606|593014006|FG000|Overall Study|Physician Decision|0|||
164177409|NCT04272606|593014007|FG001|Overall Study|Physician Decision|1|||
164177410|NCT00725101|593014008|FG000|Overall Study|Death|3|||
164177411|NCT00725101|593014008|FG000|Overall Study|Lost to Follow-up|353|||
164177412|NCT00725101|593014008|FG000|Overall Study|Protocol Violation|1|||
164177413|NCT00725101|593014008|FG000|Overall Study|Withdrawal by Subject|127|||
164177414|NCT00725101|593014008|FG000|Overall Study|not specified/no reason given|11|||
164177415|NCT03912428|593014018|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
164177416|NCT03912428|593014019|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
164177417|NCT03912428|593014020|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
164177418|NCT03912428|593014021|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
164177419|NCT03912428|593014018|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
164177420|NCT03912428|593014019|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
164177421|NCT03912428|593014020|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
164177422|NCT03912428|593014021|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
164177423|NCT03912428|593014018|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
164177424|NCT03912428|593014019|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
164177425|NCT03912428|593014020|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
164177426|NCT03912428|593014021|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
164177427|NCT02537431|593014022|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
164177428|NCT03430895|593014033|FG000|Overall Study|Not Treated|2|||
164177429|NCT01037127|593014037|FG000|Overall Study|Lost to Follow-up|2|||
164177430|NCT01037127|593014038|FG001|Overall Study|Lost to Follow-up|4|||
164177431|NCT01037127|593014037|FG000|Overall Study|Physician Decision|1|||
164177432|NCT01037127|593014038|FG001|Overall Study|Physician Decision|0|||
164177433|NCT01037127|593014037|FG000|Overall Study|Study Closed Terminated|2|||
164177434|NCT01037127|593014038|FG001|Overall Study|Study Closed Terminated|17|||
164177435|NCT00954512|593014042|FG000|Overall Study|Withdrawal by Subject|0|||
164177436|NCT00954512|593014043|FG001|Overall Study|Withdrawal by Subject|0|||
164177437|NCT00954512|593014044|FG002|Overall Study|Withdrawal by Subject|0|||
164177438|NCT00954512|593014045|FG003|Overall Study|Withdrawal by Subject|0|||
164177439|NCT00954512|593014046|FG004|Overall Study|Withdrawal by Subject|0|||
164177440|NCT00954512|593014047|FG005|Overall Study|Withdrawal by Subject|1|||
164177441|NCT00954512|593014042|FG000|Overall Study|Adverse Event|0|||
164177442|NCT00954512|593014043|FG001|Overall Study|Adverse Event|0|||
164177443|NCT00954512|593014044|FG002|Overall Study|Adverse Event|0|||
164177444|NCT00954512|593014045|FG003|Overall Study|Adverse Event|0|||
164177445|NCT00954512|593014046|FG004|Overall Study|Adverse Event|1|||
164177446|NCT00954512|593014047|FG005|Overall Study|Adverse Event|2|||
164177447|NCT00954512|593014042|FG000|Overall Study|Physician Decision|0|||
164177448|NCT00954512|593014043|FG001|Overall Study|Physician Decision|1|||
164177449|NCT00954512|593014044|FG002|Overall Study|Physician Decision|0|||
164177450|NCT00954512|593014045|FG003|Overall Study|Physician Decision|1|||
164177451|NCT00954512|593014046|FG004|Overall Study|Physician Decision|0|||
164177452|NCT00954512|593014047|FG005|Overall Study|Physician Decision|0|||
164177453|NCT00954512|593014042|FG000|Overall Study|Symptomatic Deterioration|0|||
164177454|NCT00954512|593014043|FG001|Overall Study|Symptomatic Deterioration|1|||
164177455|NCT00954512|593014044|FG002|Overall Study|Symptomatic Deterioration|0|||
164177456|NCT00954512|593014045|FG003|Overall Study|Symptomatic Deterioration|0|||
164177457|NCT00954512|593014046|FG004|Overall Study|Symptomatic Deterioration|2|||
164177458|NCT00954512|593014047|FG005|Overall Study|Symptomatic Deterioration|0|||
164177459|NCT00954512|593014042|FG000|Overall Study|Progression of Disease|2|||
164177460|NCT00954512|593014043|FG001|Overall Study|Progression of Disease|1|||
164177461|NCT00954512|593014044|FG002|Overall Study|Progression of Disease|0|||
164177462|NCT00954512|593014045|FG003|Overall Study|Progression of Disease|1|||
164177463|NCT00954512|593014046|FG004|Overall Study|Progression of Disease|1|||
164177464|NCT00954512|593014047|FG005|Overall Study|Progression of Disease|1|||
164177465|NCT04814368|593014048|FG000|Overall Study|Study Terminated by Sponsor|0|||
164177466|NCT04814368|593014049|FG001|Overall Study|Study Terminated by Sponsor|3|||
164177467|NCT04814368|593014050|FG002|Overall Study|Study Terminated by Sponsor|0|||
164177468|NCT04814368|593014051|FG003|Overall Study|Study Terminated by Sponsor|2|||
164177469|NCT04814368|593014048|FG000|Overall Study|Subject Decision|1|||
164177470|NCT04814368|593014049|FG001|Overall Study|Subject Decision|2|||
164177471|NCT04814368|593014050|FG002|Overall Study|Subject Decision|0|||
164177472|NCT04814368|593014051|FG003|Overall Study|Subject Decision|0|||
164177473|NCT01173055|593014053|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
164177474|NCT01173055|593014054|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
164177475|NCT01173055|593014053|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
164177476|NCT01173055|593014054|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
164177477|NCT04325698|593014055|FG000|Overall Study|Study Terminated By Sponsor|1|||
164177478|NCT04325698|593014056|FG001|Overall Study|Study Terminated By Sponsor|1|||
164177479|NCT04325698|593014055|FG000|Overall Study|Withdrawal by Subject|0|||
164177480|NCT04325698|593014056|FG001|Overall Study|Withdrawal by Subject|2|||
164177481|NCT04253782|593014057|FG000|Overall Study|Death|2|||
164177482|NCT04253782|593014058|FG001|Overall Study|Death|0|||
164177483|NCT04216589|593014060|FG000|Overall Study|Withdrawal by Subject|2|||
164177484|NCT04216589|593014060|FG000|Overall Study|Protocol Violation|1|||
164177485|NCT04216589|593014060|FG000|Overall Study|Incarceration|1|||
164177486|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177487|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177488|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
164177489|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177490|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177491|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177492|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177493|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177494|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177495|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177496|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177497|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177498|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177499|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
164177500|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
164177501|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177502|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177503|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177504|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177505|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177506|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177507|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177508|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177509|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177510|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177511|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177512|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177513|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
164177514|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
164177515|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
164177516|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177517|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177518|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177519|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177520|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177521|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177522|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177523|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177524|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177525|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177526|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177527|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
164177528|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
164177529|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
164177530|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177531|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177532|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177533|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177534|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177535|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177536|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177537|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177538|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177539|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177540|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177541|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
164177542|NCT02326298|593014065|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177543|NCT02326298|593014066|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177544|NCT02326298|593014067|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
164177545|NCT02326298|593014068|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177546|NCT02326298|593014069|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177547|NCT02326298|593014070|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177548|NCT02326298|593014071|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177549|NCT02326298|593014072|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177550|NCT02326298|593014073|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177551|NCT02326298|593014074|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177552|NCT02326298|593014075|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177553|NCT02326298|593014076|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177554|NCT02326298|593014077|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177555|NCT02326298|593014078|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
164177556|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177557|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177558|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177559|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177560|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177561|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177562|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
164177563|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177564|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177565|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
164177566|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177567|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177568|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177569|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
164177570|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177571|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177572|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177573|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177574|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177575|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
164177576|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
164177577|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177578|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
164177579|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177580|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177581|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177582|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177583|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
164177584|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177585|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177586|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177587|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177588|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177589|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
164177590|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177591|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177592|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177593|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177594|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177595|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177596|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177597|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
164177598|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177599|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177600|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177601|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177602|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177603|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177604|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
164177605|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177606|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177607|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177608|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177609|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177610|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177611|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
164177612|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177613|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177614|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177615|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177616|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177617|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177618|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177619|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
164177620|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177621|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177622|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177623|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177624|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177625|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
164177626|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177627|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177628|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177629|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177630|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177631|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177632|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
164177633|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
164177634|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177635|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177636|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177637|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177638|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177639|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
164177640|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177641|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177642|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177643|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177644|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177645|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177646|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177647|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
164177648|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177649|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177650|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177651|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177652|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177653|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
164177654|NCT02326298|593014065|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177655|NCT02326298|593014066|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177656|NCT02326298|593014067|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177657|NCT02326298|593014068|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177658|NCT02326298|593014069|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177659|NCT02326298|593014070|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
164177660|NCT02326298|593014071|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177661|NCT02326298|593014072|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177662|NCT02326298|593014073|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177663|NCT02326298|593014074|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177664|NCT02326298|593014075|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177665|NCT02326298|593014076|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177666|NCT02326298|593014077|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177667|NCT02326298|593014078|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
164177668|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
164177669|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
164177670|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
164177671|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
164177672|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
164177673|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
164177674|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
164177675|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
164177676|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
164177677|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
164177678|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
164177679|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
164177680|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
164177681|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
164177682|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177683|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177684|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177685|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177686|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177687|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177688|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177689|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177690|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177691|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177692|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177693|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
164177694|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
164177695|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
164177696|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177697|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177698|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177699|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177700|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177701|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177702|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177703|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177704|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177705|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177706|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177707|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164177708|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
164177709|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
164177710|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177854|NCT05685732|593014101|FG000|Overall Study|Physician Decision|1|||
164177711|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177712|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177713|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177714|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177715|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177716|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177717|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177718|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177719|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177720|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177721|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177722|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
164177723|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
164177724|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177725|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177726|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177727|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177728|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177729|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177730|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177731|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177732|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177733|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177734|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
164177735|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
164177736|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
164177737|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
164177738|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177739|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177740|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177741|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177742|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177743|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177744|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177745|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177746|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177747|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177748|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
164177749|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
164177750|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
164177751|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
164177752|NCT02326298|593014065|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177753|NCT02326298|593014066|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177754|NCT02326298|593014067|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177755|NCT02326298|593014068|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177756|NCT02326298|593014069|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177757|NCT02326298|593014070|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177758|NCT02326298|593014071|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177759|NCT02326298|593014072|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177760|NCT02326298|593014073|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177761|NCT02326298|593014074|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177762|NCT02326298|593014075|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
164177763|NCT02326298|593014076|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
164177764|NCT02326298|593014077|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
164177765|NCT02326298|593014078|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
164177766|NCT02889835|593014081|FG000|Overall Study|Lost to Follow-up|13|||
164177767|NCT02889835|593014082|FG001|Overall Study|Lost to Follow-up|13|||
164177768|NCT02889835|593014083|FG002|Overall Study|Lost to Follow-up|13|||
164177769|NCT02889835|593014081|FG000|Overall Study|Withdrawal by Subject|2|||
164177770|NCT02889835|593014082|FG001|Overall Study|Withdrawal by Subject|2|||
164177771|NCT02889835|593014083|FG002|Overall Study|Withdrawal by Subject|2|||
164177772|NCT02889835|593014081|FG000|Overall Study|Protocol Violation|1|||
164177773|NCT02889835|593014082|FG001|Overall Study|Protocol Violation|1|||
164177774|NCT02889835|593014083|FG002|Overall Study|Protocol Violation|1|||
164177775|NCT02889835|593014081|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
164177776|NCT02889835|593014082|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
164177777|NCT02889835|593014083|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
164177778|NCT02889835|593014081|FG000|Overall Study|Death|1|||
164177779|NCT02889835|593014082|FG001|Overall Study|Death|1|||
164177780|NCT02889835|593014083|FG002|Overall Study|Death|1|||
164177781|NCT02342548|593014086|FG000|Overall Study|Adverse Event|12|||
164177782|NCT02342548|593014087|FG001|Overall Study|Adverse Event|17|||
164177783|NCT02342548|593014088|FG002|Overall Study|Adverse Event|13|||
164177784|NCT02342548|593014086|FG000|Overall Study|Lost to Follow-up|0|||
164177785|NCT02342548|593014087|FG001|Overall Study|Lost to Follow-up|1|||
164177786|NCT02342548|593014088|FG002|Overall Study|Lost to Follow-up|0|||
164177787|NCT02342548|593014086|FG000|Overall Study|Study terminated by sponsor|20|||
164177788|NCT02342548|593014087|FG001|Overall Study|Study terminated by sponsor|39|||
164177789|NCT02342548|593014088|FG002|Overall Study|Study terminated by sponsor|25|||
164177790|NCT02342548|593014086|FG000|Overall Study|Protocol Violation|0|||
164177791|NCT02342548|593014087|FG001|Overall Study|Protocol Violation|1|||
164177792|NCT02342548|593014088|FG002|Overall Study|Protocol Violation|0|||
164177793|NCT02342548|593014086|FG000|Overall Study|Withdrawal by Subject|1|||
164177794|NCT02342548|593014087|FG001|Overall Study|Withdrawal by Subject|3|||
164177795|NCT02342548|593014088|FG002|Overall Study|Withdrawal by Subject|4|||
164177796|NCT02342548|593014086|FG000|Overall Study|Other|1|||
164177797|NCT02342548|593014087|FG001|Overall Study|Other|1|||
164177798|NCT02342548|593014088|FG002|Overall Study|Other|1|||
164177799|NCT02987972|593014089|FG000|Overall Study|Adverse Event|1|||
164177800|NCT02987972|593014090|FG001|Overall Study|Adverse Event|1|||
164177801|NCT02987972|593014091|FG002|Overall Study|Adverse Event|0|||
164177802|NCT02987972|593014089|FG000|Overall Study|Death|1|||
164177803|NCT02987972|593014090|FG001|Overall Study|Death|0|||
164177804|NCT02987972|593014091|FG002|Overall Study|Death|0|||
164177805|NCT02987972|593014089|FG000|Overall Study|Lack of Efficacy|9|||
164177806|NCT02987972|593014090|FG001|Overall Study|Lack of Efficacy|12|||
164177807|NCT02987972|593014091|FG002|Overall Study|Lack of Efficacy|12|||
164177808|NCT02987972|593014089|FG000|Overall Study|Lost to Follow-up|7|||
164177809|NCT02987972|593014090|FG001|Overall Study|Lost to Follow-up|8|||
164177810|NCT02987972|593014091|FG002|Overall Study|Lost to Follow-up|4|||
164177811|NCT02987972|593014089|FG000|Overall Study|Physician Decision|1|||
164177812|NCT02987972|593014090|FG001|Overall Study|Physician Decision|6|||
164177813|NCT02987972|593014091|FG002|Overall Study|Physician Decision|0|||
164177814|NCT02987972|593014089|FG000|Overall Study|Protocol Violation|2|||
164177815|NCT02987972|593014090|FG001|Overall Study|Protocol Violation|1|||
164177816|NCT02987972|593014091|FG002|Overall Study|Protocol Violation|5|||
164177817|NCT02987972|593014089|FG000|Overall Study|Withdrawal by Subject|22|||
164177818|NCT02987972|593014090|FG001|Overall Study|Withdrawal by Subject|17|||
164177819|NCT02987972|593014091|FG002|Overall Study|Withdrawal by Subject|21|||
164177820|NCT01047332|593014094|FG000|Overall Study|SEMS Obstruction|11|||
164177821|NCT01047332|593014095|FG001|Overall Study|SEMS Obstruction|20|||
164177822|NCT01047332|593014094|FG000|Overall Study|Died Unobstructed|38|||
164177823|NCT01047332|593014095|FG001|Overall Study|Died Unobstructed|41|||
164177824|NCT01047332|593014094|FG000|Overall Study|Lost to Follow-up|8|||
164177825|NCT01047332|593014095|FG001|Overall Study|Lost to Follow-up|3|||
164177826|NCT03521817|593014096|FG000|Overall Study|Protocol Violation|0|||
164177827|NCT03521817|593014097|FG001|Overall Study|Protocol Violation|1|||
164177828|NCT00787917|593014098|FG000|Blinded Treatment|Adverse Event|1|||
164177829|NCT00787917|593014099|FG001|Blinded Treatment|Adverse Event|0|||
164177830|NCT00787917|593014098|FG000|Blinded Treatment|Lack of Efficacy|1|||
164177831|NCT00787917|593014099|FG001|Blinded Treatment|Lack of Efficacy|0|||
164177832|NCT00787917|593014098|FG000|Blinded Treatment|Administrative problems|3|||
164177833|NCT00787917|593014099|FG001|Blinded Treatment|Administrative problems|2|||
164177834|NCT00787917|593014098|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
164177835|NCT00787917|593014099|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
164177836|NCT00787917|593014098|FG000|Open Label|Administrative problems|3|||
164177837|NCT00787917|593014099|FG001|Open Label|Administrative problems|0|||
164177838|NCT05685732|593014101|FG000|Overall Study|Withdrawal by Subject|2|||
164177839|NCT05685732|593014102|FG001|Overall Study|Withdrawal by Subject|0|||
164177840|NCT05685732|593014103|FG002|Overall Study|Withdrawal by Subject|2|||
164177841|NCT05685732|593014104|FG003|Overall Study|Withdrawal by Subject|3|||
164177842|NCT05685732|593014101|FG000|Overall Study|Protocol Violation|1|||
164177843|NCT05685732|593014102|FG001|Overall Study|Protocol Violation|2|||
164177844|NCT05685732|593014103|FG002|Overall Study|Protocol Violation|4|||
164177845|NCT05685732|593014104|FG003|Overall Study|Protocol Violation|1|||
164177846|NCT05685732|593014101|FG000|Overall Study|Lost to Follow-up|5|||
164177847|NCT05685732|593014102|FG001|Overall Study|Lost to Follow-up|1|||
164177848|NCT05685732|593014103|FG002|Overall Study|Lost to Follow-up|3|||
164177849|NCT05685732|593014104|FG003|Overall Study|Lost to Follow-up|1|||
164177850|NCT05685732|593014101|FG000|Overall Study|Adverse Event|2|||
164177851|NCT05685732|593014102|FG001|Overall Study|Adverse Event|1|||
164177852|NCT05685732|593014103|FG002|Overall Study|Adverse Event|0|||
164177853|NCT05685732|593014104|FG003|Overall Study|Adverse Event|0|||
164177855|NCT05685732|593014102|FG001|Overall Study|Physician Decision|0|||
164177856|NCT05685732|593014103|FG002|Overall Study|Physician Decision|0|||
164177857|NCT05685732|593014104|FG003|Overall Study|Physician Decision|0|||
164177858|NCT02640404|593014105|FG000|Overall Study|Protocol Violation|1|||
164177859|NCT02640404|593014106|FG001|Overall Study|Protocol Violation|0|||
164177860|NCT02640404|593014105|FG000|Overall Study|Withdrawal by Subject|1|||
164177861|NCT02640404|593014106|FG001|Overall Study|Withdrawal by Subject|0|||
164177862|NCT00778102|593014107|FG000|Overall Study|Adverse Event|8|||
164177863|NCT00778102|593014108|FG001|Overall Study|Adverse Event|5|||
164177864|NCT00778102|593014107|FG000|Overall Study|Death|1|||
164177865|NCT00778102|593014108|FG001|Overall Study|Death|1|||
164177866|NCT00778102|593014107|FG000|Overall Study|Lost to Follow-up|1|||
164177867|NCT00778102|593014108|FG001|Overall Study|Lost to Follow-up|0|||
164177868|NCT00778102|593014107|FG000|Overall Study|Violation of Selection Criteria|1|||
164177869|NCT00778102|593014108|FG001|Overall Study|Violation of Selection Criteria|1|||
164177870|NCT00778102|593014107|FG000|Overall Study|Protocol Violation|0|||
164177871|NCT00778102|593014108|FG001|Overall Study|Protocol Violation|1|||
164177872|NCT00778102|593014107|FG000|Overall Study|Refused Treatment|2|||
164177873|NCT00778102|593014108|FG001|Overall Study|Refused Treatment|3|||
164177874|NCT00778102|593014107|FG000|Overall Study|Withdrawal by Subject|1|||
164177875|NCT00778102|593014108|FG001|Overall Study|Withdrawal by Subject|1|||
164177876|NCT00778102|593014107|FG000|Overall Study|Administrative Reason|7|||
164177877|NCT00778102|593014108|FG001|Overall Study|Administrative Reason|10|||
164177878|NCT05397171|593014109|FG000|Overall Study|Death|2|||
164177879|NCT05397171|593014110|FG001|Overall Study|Death|3|||
164177880|NCT05397171|593014111|FG002|Overall Study|Death|3|||
164177881|NCT05397171|593014109|FG000|Overall Study|Study Terminated By Sponsor|1|||
164177882|NCT05397171|593014110|FG001|Overall Study|Study Terminated By Sponsor|2|||
164177883|NCT05397171|593014111|FG002|Overall Study|Study Terminated By Sponsor|3|||
164177884|NCT05397171|593014109|FG000|Overall Study|Withdrawal by Subject|0|||
164177885|NCT05397171|593014110|FG001|Overall Study|Withdrawal by Subject|1|||
164177886|NCT05397171|593014111|FG002|Overall Study|Withdrawal by Subject|1|||
164177887|NCT01328548|593014112|FG000|Overall Study|Death|3|||
164177888|NCT01328548|593014113|FG001|Overall Study|Death|0|||
164177889|NCT01328548|593014112|FG000|Overall Study|Protocol Violation|1|||
164177890|NCT01328548|593014113|FG001|Overall Study|Protocol Violation|0|||
164177891|NCT01066793|593016445|FG000|Overall Study|Death|4|||
164177892|NCT01066793|593016446|FG001|Overall Study|Death|1|||
164177893|NCT01066793|593016447|FG002|Overall Study|Death|1|||
164177894|NCT01066793|593016448|FG003|Overall Study|Death|0|||
164177895|NCT01066793|593016449|FG004|Overall Study|Death|0|||
164177896|NCT01066793|593016450|FG005|Overall Study|Death|0|||
164177897|NCT01066793|593016445|FG000|Overall Study|Lack of Efficacy|2|||
164177898|NCT01066793|593016446|FG001|Overall Study|Lack of Efficacy|1|||
164177899|NCT01066793|593016447|FG002|Overall Study|Lack of Efficacy|0|||
164177900|NCT01066793|593016448|FG003|Overall Study|Lack of Efficacy|0|||
164177901|NCT01066793|593016449|FG004|Overall Study|Lack of Efficacy|0|||
164177902|NCT01066793|593016450|FG005|Overall Study|Lack of Efficacy|0|||
164177903|NCT01066793|593016445|FG000|Overall Study|Lost to Follow-up|180|||
164177904|NCT01066793|593016446|FG001|Overall Study|Lost to Follow-up|39|||
164177905|NCT01066793|593016447|FG002|Overall Study|Lost to Follow-up|82|||
164177906|NCT01066793|593016448|FG003|Overall Study|Lost to Follow-up|16|||
164177907|NCT01066793|593016449|FG004|Overall Study|Lost to Follow-up|0|||
164177908|NCT01066793|593016450|FG005|Overall Study|Lost to Follow-up|1|||
164177909|NCT01066793|593016445|FG000|Overall Study|Physician Decision|3|||
164177910|NCT01066793|593016446|FG001|Overall Study|Physician Decision|0|||
164177911|NCT01066793|593016447|FG002|Overall Study|Physician Decision|0|||
164177912|NCT01066793|593016448|FG003|Overall Study|Physician Decision|0|||
164177913|NCT01066793|593016449|FG004|Overall Study|Physician Decision|0|||
164177914|NCT01066793|593016450|FG005|Overall Study|Physician Decision|0|||
164177915|NCT01066793|593016445|FG000|Overall Study|Protocol Violation|3|||
164177916|NCT01066793|593016446|FG001|Overall Study|Protocol Violation|2|||
164177917|NCT01066793|593016447|FG002|Overall Study|Protocol Violation|2|||
164177918|NCT01066793|593016448|FG003|Overall Study|Protocol Violation|0|||
164177919|NCT01066793|593016449|FG004|Overall Study|Protocol Violation|0|||
164177920|NCT01066793|593016450|FG005|Overall Study|Protocol Violation|0|||
164177921|NCT01066793|593016445|FG000|Overall Study|Withdrawal by Subject|7|||
164177922|NCT01066793|593016446|FG001|Overall Study|Withdrawal by Subject|4|||
164177923|NCT01066793|593016447|FG002|Overall Study|Withdrawal by Subject|1|||
164177924|NCT01066793|593016448|FG003|Overall Study|Withdrawal by Subject|0|||
164177925|NCT01066793|593016449|FG004|Overall Study|Withdrawal by Subject|0|||
164177926|NCT01066793|593016450|FG005|Overall Study|Withdrawal by Subject|0|||
164177927|NCT01066793|593016445|FG000|Overall Study|Early Termination|3|||
164177928|NCT01066793|593016446|FG001|Overall Study|Early Termination|0|||
164177929|NCT01066793|593016447|FG002|Overall Study|Early Termination|0|||
164177930|NCT01066793|593016448|FG003|Overall Study|Early Termination|0|||
164177931|NCT01066793|593016449|FG004|Overall Study|Early Termination|0|||
164177932|NCT01066793|593016450|FG005|Overall Study|Early Termination|0|||
164177933|NCT01066793|593016445|FG000|Overall Study|Lab test not done|7|||
164177934|NCT01066793|593016446|FG001|Overall Study|Lab test not done|0|||
164177935|NCT01066793|593016447|FG002|Overall Study|Lab test not done|0|||
164177936|NCT01066793|593016448|FG003|Overall Study|Lab test not done|1|||
164177937|NCT01066793|593016449|FG004|Overall Study|Lab test not done|0|||
164177938|NCT01066793|593016450|FG005|Overall Study|Lab test not done|0|||
164177939|NCT01066793|593016445|FG000|Overall Study|Miscellaneous|4|||
164177940|NCT01066793|593016446|FG001|Overall Study|Miscellaneous|5|||
164177941|NCT01066793|593016447|FG002|Overall Study|Miscellaneous|6|||
164177942|NCT01066793|593016448|FG003|Overall Study|Miscellaneous|0|||
164177943|NCT01066793|593016449|FG004|Overall Study|Miscellaneous|0|||
164177944|NCT01066793|593016450|FG005|Overall Study|Miscellaneous|0|||
164177945|NCT01066793|593016445|FG000|Overall Study|Non-responders|104|||
164177946|NCT01066793|593016446|FG001|Overall Study|Non-responders|5|||
164177947|NCT01066793|593016447|FG002|Overall Study|Non-responders|11|||
164177948|NCT01066793|593016448|FG003|Overall Study|Non-responders|25|||
164177949|NCT01066793|593016449|FG004|Overall Study|Non-responders|0|||
164177950|NCT01066793|593016450|FG005|Overall Study|Non-responders|0|||
164177951|NCT01066793|593016445|FG000|Overall Study|Other|15|||
164177952|NCT01066793|593016446|FG001|Overall Study|Other|5|||
164177953|NCT01066793|593016447|FG002|Overall Study|Other|6|||
164177954|NCT01066793|593016448|FG003|Overall Study|Other|2|||
164177955|NCT01066793|593016449|FG004|Overall Study|Other|0|||
164177956|NCT01066793|593016450|FG005|Overall Study|Other|0|||
164177957|NCT01066793|593016445|FG000|Overall Study|Relapse|20|||
164177958|NCT01066793|593016446|FG001|Overall Study|Relapse|8|||
164177959|NCT01066793|593016447|FG002|Overall Study|Relapse|2|||
164177960|NCT01066793|593016448|FG003|Overall Study|Relapse|3|||
164177961|NCT01066793|593016449|FG004|Overall Study|Relapse|0|||
164177962|NCT01066793|593016450|FG005|Overall Study|Relapse|0|||
164177963|NCT01066793|593016445|FG000|Overall Study|Result Not Available|1|||
164177964|NCT01066793|593016446|FG001|Overall Study|Result Not Available|0|||
164177965|NCT01066793|593016447|FG002|Overall Study|Result Not Available|0|||
164177966|NCT01066793|593016448|FG003|Overall Study|Result Not Available|0|||
164177967|NCT01066793|593016449|FG004|Overall Study|Result Not Available|0|||
164177968|NCT01066793|593016450|FG005|Overall Study|Result Not Available|0|||
164177969|NCT01066793|593016445|FG000|Overall Study|Treatment Interrupted|1|||
164177970|NCT01066793|593016446|FG001|Overall Study|Treatment Interrupted|1|||
164177971|NCT01066793|593016447|FG002|Overall Study|Treatment Interrupted|0|||
164177972|NCT01066793|593016448|FG003|Overall Study|Treatment Interrupted|0|||
164177973|NCT01066793|593016449|FG004|Overall Study|Treatment Interrupted|0|||
164177974|NCT01066793|593016450|FG005|Overall Study|Treatment Interrupted|0|||
164177975|NCT01066793|593016445|FG000|Overall Study|Treatment Never Started|18|||
164177976|NCT01066793|593016446|FG001|Overall Study|Treatment Never Started|5|||
164177977|NCT01066793|593016447|FG002|Overall Study|Treatment Never Started|4|||
164177978|NCT01066793|593016448|FG003|Overall Study|Treatment Never Started|1|||
164177979|NCT01066793|593016449|FG004|Overall Study|Treatment Never Started|0|||
164177980|NCT01066793|593016450|FG005|Overall Study|Treatment Never Started|0|||
164177981|NCT01066793|593016445|FG000|Overall Study|Treatment Stopped|2|||
164177982|NCT01066793|593016446|FG001|Overall Study|Treatment Stopped|1|||
164177983|NCT01066793|593016447|FG002|Overall Study|Treatment Stopped|0|||
164177984|NCT01066793|593016448|FG003|Overall Study|Treatment Stopped|1|||
164177985|NCT01066793|593016449|FG004|Overall Study|Treatment Stopped|0|||
164177986|NCT01066793|593016450|FG005|Overall Study|Treatment Stopped|0|||
164177987|NCT04643964|593016452|FG000|Overall Study|Lost to Follow-up|55|||
164177988|NCT04643964|593016453|FG001|Overall Study|Lost to Follow-up|59|||
164177989|NCT04643964|593016454|FG002|Overall Study|Lost to Follow-up|54|||
164177990|NCT04643964|593016455|FG003|Overall Study|Lost to Follow-up|129|||
164177991|NCT04643964|593016456|FG004|Overall Study|Lost to Follow-up|48|||
164177992|NCT04643964|593016452|FG000|Overall Study|Failed attention check|1|||
164177993|NCT04643964|593016453|FG001|Overall Study|Failed attention check|8|||
164177994|NCT04643964|593016454|FG002|Overall Study|Failed attention check|2|||
164177995|NCT04643964|593016455|FG003|Overall Study|Failed attention check|14|||
164177996|NCT04643964|593016456|FG004|Overall Study|Failed attention check|11|||
164177997|NCT02607280|593016458|FG000|Overall Study|Adverse Event|4|||
164177998|NCT02607280|593016459|FG001|Overall Study|Adverse Event|0|||
164177999|NCT02607280|593016458|FG000|Overall Study|Decrease in CrCl <15|0|||
164178000|NCT02607280|593016459|FG001|Overall Study|Decrease in CrCl <15|1|||
164178001|NCT02368210|593016460|FG000|Overall Study|Withdrawal by Subject|1|||
164178002|NCT02368210|593016461|FG001|Overall Study|Withdrawal by Subject|0|||
164178003|NCT02368210|593016460|FG000|Overall Study|Adverse Event|0|||
164178004|NCT02368210|593016461|FG001|Overall Study|Adverse Event|1|||
164178005|NCT00590538|593016462|FG000|Overall Study|Study terminated before completed|2|||
164178006|NCT01125813|593016463|FG000|Overall Study|Death|1|||
164178007|NCT01125813|593016463|FG000|Overall Study|Withdrawal by Subject|1|||
164178008|NCT01125813|593016463|FG000|Overall Study|Screen Failures|4|||
164178009|NCT00766467|593016465|FG000|Overall Study|Withdrawal by Subject|7|||
164178010|NCT00766467|593016466|FG001|Overall Study|Withdrawal by Subject|2|||
164178011|NCT00766467|593016465|FG000|Overall Study|Adverse Event|1|||
164178012|NCT00766467|593016466|FG001|Overall Study|Adverse Event|1|||
164178013|NCT00766467|593016465|FG000|Overall Study|Protocol Violation|2|||
164178014|NCT00766467|593016466|FG001|Overall Study|Protocol Violation|4|||
164178015|NCT00766467|593016465|FG000|Overall Study|Tumor Progression on Study|0|||
164178016|NCT00766467|593016466|FG001|Overall Study|Tumor Progression on Study|1|||
164178017|NCT00766467|593016465|FG000|Overall Study|Physician Decision|1|||
164178018|NCT00766467|593016466|FG001|Overall Study|Physician Decision|0|||
164178019|NCT00980018|593016473|FG000|Overall Study|Adverse Event|8|||
164178020|NCT00980018|593016473|FG000|Overall Study|Patient withdrew consent|3|||
164178021|NCT00980018|593016473|FG000|Overall Study|Lost to Follow-up|1|||
164178022|NCT00551161|593016475|FG000|Overall Study|Withdrawal by Subject|1|||
164178023|NCT00934856|593016476|FG000|Feasibility Part|Progressive disease|4|||
164178024|NCT00934856|593016477|FG001|Feasibility Part|Progressive disease|4|||
164178025|NCT00934856|593016478|FG002|Feasibility Part|Progressive disease|2|||
164178026|NCT00934856|593016479|FG003|Feasibility Part|Progressive disease|3|||
164178027|NCT00934856|593016480|FG004|Feasibility Part|Progressive disease|0|||
164178028|NCT00934856|593016481|FG005|Feasibility Part|Progressive disease|0|||
164178029|NCT00934856|593016476|FG000|Feasibility Part|Physician Decision|0|||
164178030|NCT00934856|593016477|FG001|Feasibility Part|Physician Decision|0|||
164178031|NCT00934856|593016478|FG002|Feasibility Part|Physician Decision|1|||
164178032|NCT00934856|593016479|FG003|Feasibility Part|Physician Decision|0|||
164178033|NCT00934856|593016480|FG004|Feasibility Part|Physician Decision|0|||
164178034|NCT00934856|593016481|FG005|Feasibility Part|Physician Decision|0|||
164178035|NCT00934856|593016476|FG000|Feasibility Part|Adverse Event|1|||
164178036|NCT00934856|593016477|FG001|Feasibility Part|Adverse Event|1|||
164178037|NCT00934856|593016478|FG002|Feasibility Part|Adverse Event|0|||
164178038|NCT00934856|593016479|FG003|Feasibility Part|Adverse Event|1|||
164178039|NCT00934856|593016480|FG004|Feasibility Part|Adverse Event|0|||
164178040|NCT00934856|593016481|FG005|Feasibility Part|Adverse Event|2|||
164178041|NCT00934856|593016476|FG000|Feasibility Part|Withdrawal by Subject|0|||
164178042|NCT00934856|593016477|FG001|Feasibility Part|Withdrawal by Subject|0|||
164178043|NCT00934856|593016478|FG002|Feasibility Part|Withdrawal by Subject|0|||
164178044|NCT00934856|593016479|FG003|Feasibility Part|Withdrawal by Subject|1|||
164178045|NCT00934856|593016480|FG004|Feasibility Part|Withdrawal by Subject|0|||
164178046|NCT00934856|593016481|FG005|Feasibility Part|Withdrawal by Subject|1|||
164178047|NCT00934856|593016476|FG000|Extension Part|Adverse Event|0|||
164178048|NCT00934856|593016477|FG001|Extension Part|Adverse Event|0|||
164178049|NCT00934856|593016478|FG002|Extension Part|Adverse Event|0|||
164178050|NCT00934856|593016479|FG003|Extension Part|Adverse Event|1|||
164178051|NCT00934856|593016480|FG004|Extension Part|Adverse Event|4|||
164178052|NCT00934856|593016481|FG005|Extension Part|Adverse Event|4|||
164178053|NCT00934856|593016476|FG000|Extension Part|Progressive disease|0|||
164178054|NCT00934856|593016477|FG001|Extension Part|Progressive disease|0|||
164178055|NCT00934856|593016478|FG002|Extension Part|Progressive disease|0|||
164178056|NCT00934856|593016479|FG003|Extension Part|Progressive disease|1|||
164178057|NCT00934856|593016480|FG004|Extension Part|Progressive disease|0|||
164178058|NCT00934856|593016481|FG005|Extension Part|Progressive disease|0|||
164178059|NCT00934856|593016476|FG000|Extension Part|Non-compliance with drug|0|||
164178060|NCT00934856|593016477|FG001|Extension Part|Non-compliance with drug|0|||
164178061|NCT00934856|593016478|FG002|Extension Part|Non-compliance with drug|0|||
164178062|NCT00934856|593016479|FG003|Extension Part|Non-compliance with drug|0|||
164178063|NCT00934856|593016480|FG004|Extension Part|Non-compliance with drug|0|||
164178064|NCT00934856|593016481|FG005|Extension Part|Non-compliance with drug|1|||
164178065|NCT00772005|593016482|FG000|Overall Study|Adverse Event|9|||
164178066|NCT00772005|593016483|FG001|Overall Study|Adverse Event|14|||
164178067|NCT00772005|593016484|FG002|Overall Study|Adverse Event|10|||
164178068|NCT00772005|593016485|FG003|Overall Study|Adverse Event|13|||
164178069|NCT00772005|593016482|FG000|Overall Study|Lack of Efficacy|0|||
164178070|NCT00772005|593016483|FG001|Overall Study|Lack of Efficacy|1|||
164178071|NCT00772005|593016484|FG002|Overall Study|Lack of Efficacy|0|||
164178072|NCT00772005|593016485|FG003|Overall Study|Lack of Efficacy|0|||
164178073|NCT00772005|593016482|FG000|Overall Study|Withdrawal by Subject|3|||
164178074|NCT00772005|593016483|FG001|Overall Study|Withdrawal by Subject|7|||
164178075|NCT00772005|593016484|FG002|Overall Study|Withdrawal by Subject|10|||
164178076|NCT00772005|593016485|FG003|Overall Study|Withdrawal by Subject|2|||
164178077|NCT00772005|593016482|FG000|Overall Study|Protocol Violation|2|||
164178078|NCT00772005|593016483|FG001|Overall Study|Protocol Violation|4|||
164178079|NCT00772005|593016484|FG002|Overall Study|Protocol Violation|1|||
164178080|NCT00772005|593016485|FG003|Overall Study|Protocol Violation|6|||
164178081|NCT00772005|593016482|FG000|Overall Study|Lost to Follow-up|7|||
164178082|NCT00772005|593016483|FG001|Overall Study|Lost to Follow-up|3|||
164178083|NCT00772005|593016484|FG002|Overall Study|Lost to Follow-up|6|||
164178084|NCT00772005|593016485|FG003|Overall Study|Lost to Follow-up|3|||
164178085|NCT00772005|593016482|FG000|Overall Study|Non-compliance with study procedures|1|||
164178086|NCT00772005|593016483|FG001|Overall Study|Non-compliance with study procedures|1|||
164178087|NCT00772005|593016484|FG002|Overall Study|Non-compliance with study procedures|0|||
164178088|NCT00772005|593016485|FG003|Overall Study|Non-compliance with study procedures|1|||
164178089|NCT00772005|593016482|FG000|Overall Study|Non-compliance with drug administration|3|||
164178090|NCT00772005|593016483|FG001|Overall Study|Non-compliance with drug administration|0|||
164178383|NCT01709864|593018541|FG001|Overall Study|Physician Decision|1|||
164178091|NCT00772005|593016484|FG002|Overall Study|Non-compliance with drug administration|1|||
164178092|NCT00772005|593016485|FG003|Overall Study|Non-compliance with drug administration|1|||
164178093|NCT01256385|593016488|FG000|Overall Study|Physician Decision|1|||
164178094|NCT01256385|593016489|FG001|Overall Study|Physician Decision|1|||
164178095|NCT01256385|593016488|FG000|Overall Study|Withdrawal by Subject|2|||
164178096|NCT01256385|593016489|FG001|Overall Study|Withdrawal by Subject|2|||
164178097|NCT01440569|593016490|FG000|Main Study|Enrolled but not treated|1|||
164178098|NCT01440569|593016491|FG001|Main Study|Enrolled but not treated|0|||
164178099|NCT01440569|593016490|FG000|Main Study|Adverse Event|9|||
164178100|NCT01440569|593016491|FG001|Main Study|Adverse Event|0|||
164178101|NCT01440569|593016490|FG000|Main Study|Pregnancy|1|||
164178102|NCT01440569|593016491|FG001|Main Study|Pregnancy|0|||
164178103|NCT01440569|593016490|FG000|Main Study|Investigator's Discretion|1|||
164178104|NCT01440569|593016491|FG001|Main Study|Investigator's Discretion|1|||
164178105|NCT01440569|593016490|FG000|Main Study|Withdrew Consent|7|||
164178106|NCT01440569|593016491|FG001|Main Study|Withdrew Consent|1|||
164178107|NCT01440569|593016490|FG000|Main Study|Lost to Follow-up|13|||
164178108|NCT01440569|593016491|FG001|Main Study|Lost to Follow-up|2|||
164178109|NCT01440569|593016490|FG000|Main Study|Subject Non-Compliance|3|||
164178110|NCT01440569|593016491|FG001|Main Study|Subject Non-Compliance|0|||
164178111|NCT01440569|593016490|FG000|Main Study|Protocol Violation|1|||
164178112|NCT01440569|593016491|FG001|Main Study|Protocol Violation|0|||
164178113|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Adverse Event|3|||
164178114|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Adverse Event|0|||
164178115|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Pregnancy|1|||
164178116|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Pregnancy|0|||
164178117|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
164178118|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
164178119|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
164178120|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
164178121|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
164178122|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
164178123|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
164178124|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
164178125|NCT01440569|593016490|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
164178126|NCT01440569|593016491|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
164178127|NCT02273908|593016501|FG000|Overall Study|Adverse Event|16|||
164178128|NCT02273908|593016502|FG001|Overall Study|Adverse Event|0|||
164178129|NCT02273908|593016501|FG000|Overall Study|Lost to Follow-up|10|||
164178130|NCT02273908|593016502|FG001|Overall Study|Lost to Follow-up|1|||
164178131|NCT02273908|593016501|FG000|Overall Study|Did not meet entrance criteria|3|||
164178132|NCT02273908|593016502|FG001|Overall Study|Did not meet entrance criteria|2|||
164178133|NCT02273908|593016501|FG000|Overall Study|Withdrawal by Subject|4|||
164178134|NCT02273908|593016502|FG001|Overall Study|Withdrawal by Subject|2|||
164178135|NCT03887117|593016503|FG000|Overall Study|Discontinued prematurely|0|||
164178136|NCT03887117|593016504|FG001|Overall Study|Discontinued prematurely|1|||
164178137|NCT03887117|593016505|FG002|Overall Study|Discontinued prematurely|1|||
164178138|NCT03887117|593016506|FG003|Overall Study|Discontinued prematurely|2|||
164178139|NCT04908475|593016507|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
164178140|NCT04908475|593016508|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178141|NCT04908475|593016509|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178142|NCT04908475|593016510|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178143|NCT04908475|593016511|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178144|NCT04908475|593016512|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
164178145|NCT04908475|593016507|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
164178146|NCT04908475|593016508|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178147|NCT04908475|593016509|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178148|NCT04908475|593016510|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178149|NCT04908475|593016511|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178150|NCT04908475|593016512|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
164178151|NCT04908475|593016507|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
164178152|NCT04908475|593016508|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178153|NCT04908475|593016509|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178154|NCT04908475|593016510|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178155|NCT04908475|593016511|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178156|NCT04908475|593016512|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
164178157|NCT04908475|593016507|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164178158|NCT04908475|593016508|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
164178159|NCT04908475|593016509|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
164178160|NCT04908475|593016510|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
164178161|NCT04908475|593016511|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164178162|NCT04908475|593016512|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
164178163|NCT04908475|593016507|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
164178164|NCT04908475|593016508|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
164178165|NCT04908475|593016509|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
164178166|NCT04908475|593016510|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
164178167|NCT04908475|593016511|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
164178168|NCT04908475|593016512|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
164178169|NCT04908475|593016507|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
164178170|NCT04908475|593016508|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
164178171|NCT04908475|593016509|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
164178172|NCT04908475|593016510|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
164178173|NCT04908475|593016511|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
164178174|NCT04908475|593016512|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
164178175|NCT02124759|593016517|FG000|Overall Study|Withdrawal by Subject|3|||
164178176|NCT02124759|593016518|FG001|Overall Study|Withdrawal by Subject|1|||
164178177|NCT02124759|593016519|FG002|Overall Study|Withdrawal by Subject|1|||
164178178|NCT02124759|593016517|FG000|Overall Study|Screen Fail|2|||
164178179|NCT02124759|593016518|FG001|Overall Study|Screen Fail|2|||
164178180|NCT02124759|593016519|FG002|Overall Study|Screen Fail|3|||
164178181|NCT01294371|593016520|FG000|Overall Study|Adverse Event|1|||
164178182|NCT01294371|593016520|FG000|Overall Study|Withdrawal by Subject|12|||
164178183|NCT01294371|593016520|FG000|Overall Study|Lost to Follow-up|6|||
164178184|NCT01294371|593016520|FG000|Overall Study|Administrative Reason|1|||
164178185|NCT01294371|593016520|FG000|Overall Study|Other|14|||
164178186|NCT03325894|593016521|FG000|Overall Study|Adverse Event|2|||
164178187|NCT03325894|593016522|FG001|Overall Study|Adverse Event|3|||
164178188|NCT03325894|593016521|FG000|Overall Study|Protocol Violation|1|||
164178189|NCT03325894|593016522|FG001|Overall Study|Protocol Violation|2|||
164178190|NCT03325894|593016521|FG000|Overall Study|Withdrawal by Subject|10|||
164178191|NCT03325894|593016522|FG001|Overall Study|Withdrawal by Subject|6|||
164178192|NCT03325894|593016521|FG000|Overall Study|Lost to Follow-up|4|||
164178193|NCT03325894|593016522|FG001|Overall Study|Lost to Follow-up|9|||
164178194|NCT03325894|593016521|FG000|Overall Study|Lack of Efficacy|8|||
164178195|NCT03325894|593016522|FG001|Overall Study|Lack of Efficacy|14|||
164178196|NCT03325894|593016521|FG000|Overall Study|Study Terminated by Sponsor|38|||
164178197|NCT03325894|593016522|FG001|Overall Study|Study Terminated by Sponsor|43|||
164178198|NCT03325894|593016521|FG000|Overall Study|Other (Not received Treatment)|1|||
164178199|NCT03325894|593016522|FG001|Overall Study|Other (Not received Treatment)|0|||
164178200|NCT03482167|593016525|FG000|Allocated to Intervention|Physician Decision|1|||
164178201|NCT03482167|593016526|FG001|Allocated to Intervention|Physician Decision|2|||
164178202|NCT03482167|593016525|FG000|Received Intervention|Adverse Event|3|||
164178203|NCT03482167|593016526|FG001|Received Intervention|Adverse Event|1|||
164178204|NCT03482167|593016525|FG000|Received Intervention|Physician Decision|1|||
164178205|NCT03482167|593016526|FG001|Received Intervention|Physician Decision|1|||
164178206|NCT03482167|593016525|FG000|Received Intervention|Withdrawal by Subject|1|||
164178207|NCT03482167|593016526|FG001|Received Intervention|Withdrawal by Subject|0|||
164178208|NCT00622336|593016528|FG000|Treatment Phase|Progression of Disease|181|||
164178209|NCT00622336|593016528|FG000|Treatment Phase|Adverse Event|46|||
164178210|NCT00622336|593016528|FG000|Treatment Phase|Other|40|||
164178211|NCT00622336|593016528|FG000|Treatment Phase|Death|14|||
164178212|NCT00622336|593016528|FG000|Treatment Phase|Lack of therapeutic effect|13|||
164178213|NCT00622336|593016528|FG000|Treatment Phase|Withdrawal by Subject|13|||
164178214|NCT00622336|593016528|FG000|Treatment Phase|Lost to Follow-up|2|||
164178215|NCT00622336|593016528|FG000|Extension Phase|Adverse Event|2|||
164178216|NCT00622336|593016528|FG000|Extension Phase|Progressive Disease|6|||
164178217|NCT00622336|593016528|FG000|Extension Phase|Lack of therapeutic effect|2|||
164178218|NCT00622336|593016528|FG000|Extension Phase|Withdrawal by Subject|1|||
164178219|NCT00622336|593016528|FG000|Extension Phase|Lost to Follow-up|1|||
164178220|NCT00622336|593016528|FG000|Extension Phase|Other|9|||
164178221|NCT00819780|593016529|FG000|Overall Study|Did not receive study drug|3|||
164178222|NCT00819780|593016530|FG001|Overall Study|Did not receive study drug|4|||
164178223|NCT00819780|593016529|FG000|Overall Study|Still in treatment|25|||
164178224|NCT00819780|593016530|FG001|Overall Study|Still in treatment|17|||
164178225|NCT04148287|593016535|FG000|Overall Study|Death|2|||
164178226|NCT00106639|593016536|FG000|Overall Study|Adverse Event|3|||
164178227|NCT00106639|593016537|FG001|Overall Study|Adverse Event|4|||
164178228|NCT00106639|593016538|FG002|Overall Study|Adverse Event|1|||
164178229|NCT00106639|593016536|FG000|Overall Study|Protocol Violation|0|||
164178230|NCT00106639|593016537|FG001|Overall Study|Protocol Violation|1|||
164178231|NCT00106639|593016538|FG002|Overall Study|Protocol Violation|0|||
164178232|NCT00106639|593016536|FG000|Overall Study|Withdrawal by Subject|0|||
164178233|NCT00106639|593016537|FG001|Overall Study|Withdrawal by Subject|1|||
164178234|NCT00106639|593016538|FG002|Overall Study|Withdrawal by Subject|0|||
164178235|NCT00106639|593016536|FG000|Overall Study|Participant defaulted|0|||
164178236|NCT00106639|593016537|FG001|Overall Study|Participant defaulted|1|||
164178237|NCT00106639|593016538|FG002|Overall Study|Participant defaulted|1|||
164178238|NCT01645891|593016543|FG000|Overall Study|Adverse Event|6|||
164178239|NCT01645891|593016544|FG001|Overall Study|Adverse Event|10|||
164178240|NCT01645891|593016543|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
164178241|NCT01645891|593016544|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
164178242|NCT01645891|593016543|FG000|Overall Study|Withdrawal by Subject|3|||
164178243|NCT01645891|593016544|FG001|Overall Study|Withdrawal by Subject|3|||
164178244|NCT01645891|593016543|FG000|Overall Study|Protocol Violation|4|||
164178245|NCT01645891|593016544|FG001|Overall Study|Protocol Violation|0|||
164178246|NCT01645891|593016543|FG000|Overall Study|Lost to Follow-up|4|||
164178247|NCT01645891|593016544|FG001|Overall Study|Lost to Follow-up|1|||
164178248|NCT01645891|593016543|FG000|Overall Study|Death|0|||
164178249|NCT01645891|593016544|FG001|Overall Study|Death|2|||
164178250|NCT00138073|593016545|FG000|Overall Study|lack of resources|55|||
164178251|NCT02847182|593016546|FG000|Overall Study|Withdrawal by Subject|0|||
164178252|NCT02847182|593016547|FG001|Overall Study|Withdrawal by Subject|1|||
164178253|NCT00962091|593016548|FG000|Overall Study|Withdrawal by Subject|1|||
164178254|NCT00962091|593016549|FG001|Overall Study|Withdrawal by Subject|2|||
164178255|NCT00962091|593016550|FG002|Overall Study|Withdrawal by Subject|1|||
164178256|NCT00962091|593016551|FG003|Overall Study|Withdrawal by Subject|1|||
164178257|NCT00962091|593016552|FG004|Overall Study|Withdrawal by Subject|0|||
164178258|NCT00962091|593016553|FG005|Overall Study|Withdrawal by Subject|1|||
164178259|NCT00962091|593016554|FG006|Overall Study|Withdrawal by Subject|0|||
164178260|NCT00962091|593016548|FG000|Overall Study|Adverse Event|0|||
164178261|NCT00962091|593016549|FG001|Overall Study|Adverse Event|0|||
164178262|NCT00962091|593016550|FG002|Overall Study|Adverse Event|0|||
164178263|NCT00962091|593016551|FG003|Overall Study|Adverse Event|0|||
164178264|NCT00962091|593016552|FG004|Overall Study|Adverse Event|0|||
164178265|NCT00962091|593016553|FG005|Overall Study|Adverse Event|0|||
164178266|NCT00962091|593016554|FG006|Overall Study|Adverse Event|1|||
164178267|NCT01306045|593016557|FG000|Met General Eligibility Criteria|Screen failures|193|||
164178268|NCT01306045|593016558|FG001|Met General Eligibility Criteria|Screen failures|11|||
164178269|NCT01306045|593016559|FG002|Met General Eligibility Criteria|Screen failures|8|||
164178270|NCT05072964|593016560|FG000|Overall Study|Withdrawal by Subject|4|||
164178271|NCT05072964|593016560|FG000|Overall Study|Death|1|||
164178272|NCT02172040|593016563|FG000|Overall Study|Adverse Event|0|||
164178273|NCT02172040|593016564|FG001|Overall Study|Adverse Event|2|||
164178274|NCT02172040|593016565|FG002|Overall Study|Adverse Event|0|||
164178275|NCT02172040|593016566|FG003|Overall Study|Adverse Event|0|||
164178276|NCT02172040|593016563|FG000|Overall Study|Protocol Violation|0|||
164178277|NCT02172040|593016564|FG001|Overall Study|Protocol Violation|1|||
164178278|NCT02172040|593016565|FG002|Overall Study|Protocol Violation|0|||
164178279|NCT02172040|593016566|FG003|Overall Study|Protocol Violation|0|||
164178280|NCT02172040|593016563|FG000|Overall Study|Withdrawal by Subject|0|||
164178281|NCT02172040|593016564|FG001|Overall Study|Withdrawal by Subject|0|||
164178282|NCT02172040|593016565|FG002|Overall Study|Withdrawal by Subject|1|||
164178283|NCT02172040|593016566|FG003|Overall Study|Withdrawal by Subject|0|||
164178284|NCT02172040|593016563|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
164178285|NCT02172040|593016564|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
164178286|NCT02172040|593016565|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
164178287|NCT02172040|593016566|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
164178288|NCT02172040|593016563|FG000|Overall Study|Family emergency abroad|0|||
164178289|NCT02172040|593016564|FG001|Overall Study|Family emergency abroad|0|||
164178290|NCT02172040|593016565|FG002|Overall Study|Family emergency abroad|0|||
164178291|NCT02172040|593016566|FG003|Overall Study|Family emergency abroad|1|||
164178292|NCT04908202|593016572|FG000|Pre-Treatment Period|OTHER REASONS|3|||
164178293|NCT04908202|593016573|FG001|Pre-Treatment Period|OTHER REASONS|1|||
164178294|NCT04908202|593016574|FG002|Pre-Treatment Period|OTHER REASONS|0|||
164178295|NCT04908202|593016575|FG003|Pre-Treatment Period|OTHER REASONS|0|||
164178296|NCT04908202|593016572|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
164178297|NCT04908202|593016573|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178298|NCT04908202|593016574|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178299|NCT04908202|593016575|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178300|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
164178301|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
164178302|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
164178303|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
164178304|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
164178305|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
164178306|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
164178307|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
164178308|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164178309|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
164178310|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178311|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178312|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
164178313|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
164178314|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178315|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178316|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
164178317|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
164178318|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
164178319|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
164178320|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178321|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
164178322|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178323|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178324|NCT04908202|593016572|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
164178325|NCT04908202|593016573|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
164178326|NCT04908202|593016574|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
164178327|NCT04908202|593016575|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
164178328|NCT04908202|593016572|FG000|Active Treatment Period|OTHER REASONS|0|||
164178329|NCT04908202|593016573|FG001|Active Treatment Period|OTHER REASONS|0|||
164178330|NCT04908202|593016574|FG002|Active Treatment Period|OTHER REASONS|1|||
164178331|NCT04908202|593016575|FG003|Active Treatment Period|OTHER REASONS|3|||
164178332|NCT04908202|593016572|FG000|Active Treatment Period|Lack of Efficacy|0|||
164178333|NCT04908202|593016573|FG001|Active Treatment Period|Lack of Efficacy|0|||
164178334|NCT04908202|593016574|FG002|Active Treatment Period|Lack of Efficacy|4|||
164178335|NCT04908202|593016575|FG003|Active Treatment Period|Lack of Efficacy|5|||
164178336|NCT04908202|593016572|FG000|Active Treatment Period|Adverse Event|0|||
164178337|NCT04908202|593016573|FG001|Active Treatment Period|Adverse Event|0|||
164178338|NCT04908202|593016574|FG002|Active Treatment Period|Adverse Event|5|||
164178339|NCT04908202|593016575|FG003|Active Treatment Period|Adverse Event|8|||
164178340|NCT04908202|593016572|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178341|NCT04908202|593016573|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
164178342|NCT04908202|593016574|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164178343|NCT04908202|593016575|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
164178344|NCT04908202|593016572|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178345|NCT04908202|593016573|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
164178346|NCT04908202|593016574|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
164178347|NCT04908202|593016575|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
164178348|NCT04908202|593016572|FG000|Active Treatment Period|Lost to Follow-up|0|||
164178349|NCT04908202|593016573|FG001|Active Treatment Period|Lost to Follow-up|0|||
164178350|NCT04908202|593016574|FG002|Active Treatment Period|Lost to Follow-up|2|||
164178351|NCT04908202|593016575|FG003|Active Treatment Period|Lost to Follow-up|2|||
164178352|NCT04908202|593016572|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
164178353|NCT04908202|593016573|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
164178354|NCT04908202|593016574|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
164178355|NCT04908202|593016575|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
164178356|NCT04908202|593016572|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178357|NCT04908202|593016573|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
164178358|NCT04908202|593016574|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
164178359|NCT04908202|593016575|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
164178360|NCT04908202|593016572|FG000|Active Treatment Period|ONGOING Treatment|0|||
164178361|NCT04908202|593016573|FG001|Active Treatment Period|ONGOING Treatment|0|||
164178362|NCT04908202|593016574|FG002|Active Treatment Period|ONGOING Treatment|117|||
164178363|NCT04908202|593016575|FG003|Active Treatment Period|ONGOING Treatment|114|||
164178364|NCT04506905|593016578|FG000|Overall Study|Lost to Follow-up|1|||
164178365|NCT04506905|593016579|FG001|Overall Study|Lost to Follow-up|0|||
164178366|NCT04506905|593016580|FG002|Overall Study|Lost to Follow-up|0|||
164178367|NCT04506905|593016581|FG003|Overall Study|Lost to Follow-up|1|||
164178368|NCT04506905|593016582|FG004|Overall Study|Lost to Follow-up|0|||
164178369|NCT04506905|593016583|FG005|Overall Study|Lost to Follow-up|0|||
164178370|NCT04506905|593016584|FG006|Overall Study|Lost to Follow-up|0|||
164178371|NCT04506905|593016585|FG007|Overall Study|Lost to Follow-up|0|||
164178372|NCT04506905|593016586|FG008|Overall Study|Lost to Follow-up|0|||
164178373|NCT04506905|593016578|FG000|Overall Study|Withdrawal by Subject|0|||
164178374|NCT04506905|593016579|FG001|Overall Study|Withdrawal by Subject|0|||
164178375|NCT04506905|593016580|FG002|Overall Study|Withdrawal by Subject|0|||
164178376|NCT04506905|593016581|FG003|Overall Study|Withdrawal by Subject|2|||
164178377|NCT04506905|593016582|FG004|Overall Study|Withdrawal by Subject|0|||
164178378|NCT04506905|593016583|FG005|Overall Study|Withdrawal by Subject|0|||
164178379|NCT04506905|593016584|FG006|Overall Study|Withdrawal by Subject|0|||
164178380|NCT04506905|593016585|FG007|Overall Study|Withdrawal by Subject|0|||
164178381|NCT04506905|593016586|FG008|Overall Study|Withdrawal by Subject|0|||
164178382|NCT01709864|593018540|FG000|Overall Study|Physician Decision|0|||
164178384|NCT01709864|593018540|FG000|Overall Study|subject/guardian decision|5|||
164178385|NCT01709864|593018541|FG001|Overall Study|subject/guardian decision|6|||
164178386|NCT01709864|593018540|FG000|Overall Study|Lost to Follow-up|1|||
164178387|NCT01709864|593018541|FG001|Overall Study|Lost to Follow-up|0|||
164178388|NCT01709864|593018540|FG000|Overall Study|non-compliance with study treatment|1|||
164178389|NCT01709864|593018541|FG001|Overall Study|non-compliance with study treatment|1|||
164178390|NCT01709864|593018540|FG000|Overall Study|Adverse Event|0|||
164178391|NCT01709864|593018541|FG001|Overall Study|Adverse Event|2|||
164178392|NCT01709864|593018540|FG000|Overall Study|Death|0|||
164178393|NCT01709864|593018541|FG001|Overall Study|Death|1|||
164178394|NCT03774394|593018542|FG000|Overall Study|Withdrawal by Subject|2|||
164178395|NCT03774394|593018543|FG001|Overall Study|Withdrawal by Subject|0|||
164178396|NCT02697916|593018544|FG000|Overall Study|Death|357|||
164178397|NCT02697916|593018545|FG001|Overall Study|Death|315|||
164178398|NCT02697916|593018544|FG000|Overall Study|Withdrawal by Subject|221|||
164178399|NCT02697916|593018545|FG001|Overall Study|Withdrawal by Subject|393|||
164178400|NCT01313221|593018546|FG000|Overall Study|Protocol Violation|0|||
164178401|NCT01313221|593018547|FG001|Overall Study|Protocol Violation|1|||
164178402|NCT01313221|593018548|FG002|Overall Study|Protocol Violation|1|||
164178403|NCT01313221|593018546|FG000|Overall Study|Non-compliance|3|||
164178404|NCT01313221|593018547|FG001|Overall Study|Non-compliance|0|||
164178405|NCT01313221|593018548|FG002|Overall Study|Non-compliance|2|||
164178406|NCT01313221|593018546|FG000|Overall Study|Withdrawal by Subject|2|||
164178407|NCT01313221|593018547|FG001|Overall Study|Withdrawal by Subject|3|||
164178408|NCT01313221|593018548|FG002|Overall Study|Withdrawal by Subject|5|||
164178409|NCT01313221|593018546|FG000|Overall Study|Requirement for alternative therapy|0|||
164178410|NCT01313221|593018547|FG001|Overall Study|Requirement for alternative therapy|1|||
164178411|NCT01313221|593018548|FG002|Overall Study|Requirement for alternative therapy|1|||
164178412|NCT01313221|593018546|FG000|Overall Study|Lost to Follow-up|6|||
164178413|NCT01313221|593018547|FG001|Overall Study|Lost to Follow-up|3|||
164178414|NCT01313221|593018548|FG002|Overall Study|Lost to Follow-up|1|||
164178415|NCT01313221|593018546|FG000|Overall Study|Other|1|||
164178416|NCT01313221|593018547|FG001|Overall Study|Other|0|||
164178417|NCT01313221|593018548|FG002|Overall Study|Other|0|||
164178418|NCT01313221|593018546|FG000|Overall Study|Adverse Event|0|||
164178419|NCT01313221|593018547|FG001|Overall Study|Adverse Event|0|||
164178420|NCT01313221|593018548|FG002|Overall Study|Adverse Event|7|||
164178421|NCT01313221|593018546|FG000|Overall Study|Disease progression|0|||
164178422|NCT01313221|593018547|FG001|Overall Study|Disease progression|0|||
164178423|NCT01313221|593018548|FG002|Overall Study|Disease progression|2|||
164178424|NCT01313221|593018546|FG000|Overall Study|Physician Decision|0|||
164178425|NCT01313221|593018547|FG001|Overall Study|Physician Decision|0|||
164178426|NCT01313221|593018548|FG002|Overall Study|Physician Decision|2|||
164178427|NCT01313221|593018546|FG000|Overall Study|Pregnancy|0|||
164178428|NCT01313221|593018547|FG001|Overall Study|Pregnancy|0|||
164178429|NCT01313221|593018548|FG002|Overall Study|Pregnancy|2|||
164178430|NCT03246061|593018549|FG000|Overall Study|Still in follow-up|15|||
164178431|NCT03246061|593018550|FG001|Overall Study|Still in follow-up|21|||
164178432|NCT02864316|593018551|FG000|Overall Study|Progressive Disease|2|||
164178433|NCT02864316|593018552|FG001|Overall Study|Progressive Disease|1|||
164178434|NCT02864316|593018551|FG000|Overall Study|Adverse Event|0|||
164178435|NCT02864316|593018552|FG001|Overall Study|Adverse Event|1|||
164178436|NCT00290693|593018553|FG000|Overall Study|Withdrawal by Subject|2|||
164178437|NCT05625477|593018554|FG000|Overall Study|Lost to Follow-up|2|||
164178438|NCT05625477|593018555|FG001|Overall Study|Lost to Follow-up|2|||
164178439|NCT05625477|593018556|FG002|Overall Study|Lost to Follow-up|1|||
164178440|NCT05625477|593018557|FG003|Overall Study|Lost to Follow-up|1|||
164178441|NCT05625477|593018558|FG004|Overall Study|Lost to Follow-up|0|||
164178442|NCT05625477|593018554|FG000|Overall Study|Covid quarantine|1|||
164178443|NCT05625477|593018555|FG001|Overall Study|Covid quarantine|0|||
164178444|NCT05625477|593018556|FG002|Overall Study|Covid quarantine|0|||
164178445|NCT05625477|593018557|FG003|Overall Study|Covid quarantine|0|||
164178446|NCT05625477|593018558|FG004|Overall Study|Covid quarantine|0|||
164178447|NCT01092637|593018561|FG000|Overall Study|Death|47|||
164178448|NCT01092637|593018562|FG001|Overall Study|Death|49|||
164178449|NCT01716520|593018567|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
164178450|NCT01716520|593018568|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178451|NCT01716520|593018569|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178452|NCT01716520|593018570|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178453|NCT01716520|593018571|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178454|NCT01716520|593018572|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
164178455|NCT01716520|593018567|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178456|NCT01716520|593018568|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178457|NCT01716520|593018569|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
164178458|NCT01716520|593018570|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178459|NCT01716520|593018571|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178460|NCT01716520|593018572|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178750|NCT00115037|593018637|FG003|Phase1|Withdrawal by Subject|0|||
164178461|NCT01716520|593018567|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178462|NCT01716520|593018568|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
164178463|NCT01716520|593018569|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178464|NCT01716520|593018570|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178465|NCT01716520|593018571|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178466|NCT01716520|593018572|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
164178467|NCT01716520|593018567|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178468|NCT01716520|593018568|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
164178469|NCT01716520|593018569|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178470|NCT01716520|593018570|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178471|NCT01716520|593018571|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178472|NCT01716520|593018572|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
164178473|NCT01716520|593018567|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178474|NCT01716520|593018568|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178475|NCT01716520|593018569|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178476|NCT01716520|593018570|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178477|NCT01716520|593018571|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
164178478|NCT01716520|593018572|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
164178479|NCT01716520|593018567|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178480|NCT01716520|593018568|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178481|NCT01716520|593018569|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
164178482|NCT01716520|593018570|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178483|NCT01716520|593018571|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
164178484|NCT01716520|593018572|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
164178485|NCT01716520|593018567|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178486|NCT01716520|593018568|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178487|NCT01716520|593018569|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178488|NCT01716520|593018570|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178489|NCT01716520|593018571|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
164178490|NCT01716520|593018572|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
164178491|NCT01716520|593018567|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178492|NCT01716520|593018568|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178493|NCT01716520|593018569|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178494|NCT01716520|593018570|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178495|NCT01716520|593018571|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
164178496|NCT01716520|593018572|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
164178497|NCT01716520|593018567|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178498|NCT01716520|593018568|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178499|NCT01716520|593018569|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178500|NCT01716520|593018570|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
164178501|NCT01716520|593018571|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178502|NCT01716520|593018572|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
164178503|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
164178504|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
164178505|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
164178506|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
164178507|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
164178508|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
164178509|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
164178510|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178511|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178512|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178513|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178514|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
164178515|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178516|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178517|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178518|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178519|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
164178520|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
164178521|NCT01716520|593018567|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178522|NCT01716520|593018568|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
164178523|NCT01716520|593018569|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178524|NCT01716520|593018570|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178525|NCT01716520|593018571|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178526|NCT01716520|593018572|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
164178527|NCT01716520|593018567|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178528|NCT01716520|593018568|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178529|NCT01716520|593018569|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178530|NCT01716520|593018570|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178531|NCT01716520|593018571|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
164178532|NCT01716520|593018572|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
164178533|NCT01716520|593018567|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178534|NCT01716520|593018568|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178535|NCT01716520|593018569|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
164178536|NCT01716520|593018570|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178537|NCT01716520|593018571|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178538|NCT01716520|593018572|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
164178539|NCT05916131|593018575|FG000|Overall Study|Lost to Follow-up|0|||
164178540|NCT05916131|593018576|FG001|Overall Study|Lost to Follow-up|0|||
164178541|NCT05916131|593018577|FG002|Overall Study|Lost to Follow-up|1|||
164178542|NCT05916131|593018578|FG003|Overall Study|Lost to Follow-up|0|||
164178543|NCT03030118|593018579|FG000|Overall Study|Achieved SLE Diagnosis|11|||
164178544|NCT03030118|593018580|FG001|Overall Study|Achieved SLE Diagnosis|10|||
164178545|NCT03030118|593018579|FG000|Overall Study|Adverse Event|1|||
164178546|NCT03030118|593018580|FG001|Overall Study|Adverse Event|1|||
164178547|NCT03030118|593018579|FG000|Overall Study|Pregnancy|2|||
164178548|NCT03030118|593018580|FG001|Overall Study|Pregnancy|2|||
164178549|NCT03030118|593018579|FG000|Overall Study|Lost to Follow-up|5|||
164178550|NCT03030118|593018580|FG001|Overall Study|Lost to Follow-up|6|||
164178551|NCT03030118|593018579|FG000|Overall Study|Concomitant Medications|1|||
164178552|NCT03030118|593018580|FG001|Overall Study|Concomitant Medications|1|||
164178553|NCT03030118|593018579|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
164178554|NCT03030118|593018580|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
164178555|NCT03030118|593018579|FG000|Overall Study|Other|2|||
164178556|NCT03030118|593018580|FG001|Overall Study|Other|0|||
164178557|NCT03030118|593018579|FG000|Overall Study|Withdrawal by Subject|26|||
164178558|NCT03030118|593018580|FG001|Overall Study|Withdrawal by Subject|21|||
164178559|NCT03030118|593018579|FG000|Overall Study|Protocol Violation|1|||
164178560|NCT03030118|593018580|FG001|Overall Study|Protocol Violation|6|||
164178561|NCT01447446|593018581|FG000|Overall Study|Death|6|||
164178562|NCT01447446|593018582|FG001|Overall Study|Death|3|||
164178563|NCT01447446|593018583|FG002|Overall Study|Death|2|||
164178564|NCT01447446|593018584|FG003|Overall Study|Death|1|||
164178565|NCT01447446|593018585|FG004|Overall Study|Death|7|||
164178566|NCT01447446|593018586|FG005|Overall Study|Death|0|||
164178567|NCT01447446|593018581|FG000|Overall Study|Adverse Event|3|||
164178568|NCT01447446|593018582|FG001|Overall Study|Adverse Event|0|||
164178569|NCT01447446|593018583|FG002|Overall Study|Adverse Event|1|||
164178570|NCT01447446|593018584|FG003|Overall Study|Adverse Event|0|||
164178571|NCT01447446|593018585|FG004|Overall Study|Adverse Event|2|||
164178572|NCT01447446|593018586|FG005|Overall Study|Adverse Event|0|||
164178573|NCT01447446|593018581|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
164178574|NCT01447446|593018582|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
164178575|NCT01447446|593018583|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
164178576|NCT01447446|593018584|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
164178577|NCT01447446|593018585|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
164178578|NCT01447446|593018586|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
164178579|NCT01447446|593018581|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
164178580|NCT01447446|593018582|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
164178581|NCT01447446|593018583|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
164178582|NCT01447446|593018584|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
164178583|NCT01447446|593018585|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
164178584|NCT01447446|593018586|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
164178585|NCT01447446|593018581|FG000|Overall Study|Administrative/Other|34|||
164178586|NCT01447446|593018582|FG001|Overall Study|Administrative/Other|9|||
164178587|NCT01447446|593018583|FG002|Overall Study|Administrative/Other|10|||
164178588|NCT01447446|593018584|FG003|Overall Study|Administrative/Other|2|||
164178589|NCT01447446|593018585|FG004|Overall Study|Administrative/Other|33|||
164178590|NCT01447446|593018586|FG005|Overall Study|Administrative/Other|4|||
164178591|NCT01447446|593018581|FG000|Overall Study|SVR12 Assessment|13|||
164178592|NCT01447446|593018582|FG001|Overall Study|SVR12 Assessment|1|||
164178593|NCT01447446|593018583|FG002|Overall Study|SVR12 Assessment|2|||
164178594|NCT01447446|593018584|FG003|Overall Study|SVR12 Assessment|1|||
164178595|NCT01447446|593018585|FG004|Overall Study|SVR12 Assessment|5|||
164178596|NCT01447446|593018586|FG005|Overall Study|SVR12 Assessment|5|||
164178597|NCT01447446|593018581|FG000|Overall Study|New Treatment Started|8|||
164178598|NCT01447446|593018582|FG001|Overall Study|New Treatment Started|2|||
164178599|NCT01447446|593018583|FG002|Overall Study|New Treatment Started|1|||
164178600|NCT01447446|593018584|FG003|Overall Study|New Treatment Started|0|||
164178601|NCT01447446|593018585|FG004|Overall Study|New Treatment Started|2|||
164178602|NCT01447446|593018586|FG005|Overall Study|New Treatment Started|0|||
164178603|NCT01447446|593018581|FG000|Overall Study|Reason not Specified|1|||
164178604|NCT01447446|593018582|FG001|Overall Study|Reason not Specified|1|||
164178605|NCT01447446|593018583|FG002|Overall Study|Reason not Specified|1|||
164178606|NCT01447446|593018584|FG003|Overall Study|Reason not Specified|1|||
164178607|NCT01447446|593018585|FG004|Overall Study|Reason not Specified|1|||
164178608|NCT01447446|593018586|FG005|Overall Study|Reason not Specified|0|||
164178609|NCT02052596|593018587|FG000|Active Phase|Adverse Event|3|||
164178610|NCT02052596|593018588|FG001|Active Phase|Adverse Event|2|||
164178611|NCT02052596|593018587|FG000|Active Phase|Lost to Follow-up|8|||
164178612|NCT02052596|593018588|FG001|Active Phase|Lost to Follow-up|11|||
164178613|NCT02052596|593018587|FG000|Active Phase|Protocol Violation|1|||
164178614|NCT02052596|593018588|FG001|Active Phase|Protocol Violation|2|||
164178615|NCT02052596|593018587|FG000|Active Phase|Withdrawal by Subject|3|||
164178616|NCT02052596|593018588|FG001|Active Phase|Withdrawal by Subject|4|||
164178617|NCT02052596|593018587|FG000|Active Phase|Enrolled in error|1|||
164178618|NCT02052596|593018588|FG001|Active Phase|Enrolled in error|0|||
164178619|NCT02052596|593018587|FG000|Active Phase|Lost due to Crohn's disease|0|||
164178620|NCT02052596|593018588|FG001|Active Phase|Lost due to Crohn's disease|1|||
164178621|NCT02052596|593018587|FG000|Safety Phase|Adverse Event|6|||
164178622|NCT02052596|593018588|FG001|Safety Phase|Adverse Event|3|||
164178623|NCT02052596|593018587|FG000|Safety Phase|Lost to Follow-up|11|||
164178624|NCT02052596|593018588|FG001|Safety Phase|Lost to Follow-up|18|||
164178625|NCT02052596|593018587|FG000|Safety Phase|Protocol Violation|1|||
164178626|NCT02052596|593018588|FG001|Safety Phase|Protocol Violation|2|||
164178627|NCT02052596|593018587|FG000|Safety Phase|Withdrawal by Subject|8|||
164178628|NCT02052596|593018588|FG001|Safety Phase|Withdrawal by Subject|11|||
164178629|NCT02052596|593018587|FG000|Safety Phase|Enrolled in error|1|||
164178630|NCT02052596|593018588|FG001|Safety Phase|Enrolled in error|0|||
164178631|NCT02052596|593018587|FG000|Safety Phase|Lost due to Crohn's disease|0|||
164178632|NCT02052596|593018588|FG001|Safety Phase|Lost due to Crohn's disease|1|||
164178633|NCT04829331|593018591|FG000|Overall Study|Lost to Follow-up|1|||
164178634|NCT04829331|593018592|FG001|Overall Study|Lost to Follow-up|0|||
164178635|NCT05323994|593018593|FG000|Overall Study|Protocol Violation|1|||
164178636|NCT00454818|593018595|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
164178637|NCT00454818|593018596|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178638|NCT00454818|593018597|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178639|NCT00454818|593018598|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178640|NCT00454818|593018599|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
164178641|NCT00454818|593018595|FG000|Phase I: Open-label Dose-escalation|Death|0|||
164178642|NCT00454818|593018596|FG001|Phase I: Open-label Dose-escalation|Death|1|||
164178643|NCT00454818|593018597|FG002|Phase I: Open-label Dose-escalation|Death|0|||
164178644|NCT00454818|593018598|FG003|Phase I: Open-label Dose-escalation|Death|0|||
164178645|NCT00454818|593018599|FG004|Phase I: Open-label Dose-escalation|Death|0|||
164178646|NCT00454818|593018595|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
164178647|NCT00454818|593018596|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
164178648|NCT00454818|593018597|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
164178649|NCT00454818|593018598|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
164178650|NCT00454818|593018599|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
164178651|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
164178652|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
164178653|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
164178654|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
164178655|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
164178656|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Death|0|||
164178657|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Death|1|||
164178658|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Death|0|||
164178659|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Death|0|||
164178660|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Death|1|||
164178661|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
164178662|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
164178663|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
164178664|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
164178665|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
164178666|NCT00454818|593018595|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
164178667|NCT00454818|593018596|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
164178668|NCT00454818|593018597|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
164178669|NCT00454818|593018598|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
164178670|NCT00454818|593018599|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
164178671|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
164178672|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
164178751|NCT00115037|593018638|FG004|Phase1|Withdrawal by Subject|0|||
164178673|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
164178674|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
164178675|NCT00943670|593018605|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
164178676|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
164178677|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
164178678|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
164178679|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
164178680|NCT00943670|593018605|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
164178681|NCT02604550|593018606|FG000|Overall Study|Lost to Follow-up|7|||
164178682|NCT02604550|593018607|FG001|Overall Study|Lost to Follow-up|6|||
164178683|NCT02604550|593018606|FG000|Overall Study|Withdrawal by Subject|0|||
164178684|NCT02604550|593018607|FG001|Overall Study|Withdrawal by Subject|1|||
164178685|NCT02604550|593018606|FG000|Overall Study|Incomplete data using paper journal|18|||
164178686|NCT02604550|593018607|FG001|Overall Study|Incomplete data using paper journal|19|||
164178687|NCT00908076|593018608|FG000|Overall Study|Lack of Efficacy|1|||
164178688|NCT00908076|593018609|FG001|Overall Study|Lack of Efficacy|1|||
164178689|NCT04526574|593018610|FG000|Overall Study|Protocol Violation|3|||
164178690|NCT04526574|593018611|FG001|Overall Study|Protocol Violation|1|||
164178691|NCT04526574|593018610|FG000|Overall Study|Withdrawal by Subject|12|||
164178692|NCT04526574|593018611|FG001|Overall Study|Withdrawal by Subject|9|||
164178693|NCT04526574|593018610|FG000|Overall Study|Other|1|||
164178694|NCT04526574|593018611|FG001|Overall Study|Other|2|||
164178695|NCT04526574|593018610|FG000|Overall Study|Adverse Event|1|||
164178696|NCT04526574|593018611|FG001|Overall Study|Adverse Event|1|||
164178697|NCT04526574|593018610|FG000|Overall Study|Death|2|||
164178698|NCT04526574|593018611|FG001|Overall Study|Death|3|||
164178699|NCT04526574|593018610|FG000|Overall Study|Lost to Follow-up|9|||
164178700|NCT04526574|593018611|FG001|Overall Study|Lost to Follow-up|9|||
164178701|NCT04526574|593018610|FG000|Overall Study|No longer meets eligibility criteria|8|||
164178702|NCT04526574|593018611|FG001|Overall Study|No longer meets eligibility criteria|8|||
164178703|NCT01032070|593018612|FG000|Overall Study|Disease progression|13|||
164178704|NCT01032070|593018613|FG001|Overall Study|Disease progression|8|||
164178705|NCT01032070|593018612|FG000|Overall Study|Medical or ethical reasons|0|||
164178706|NCT01032070|593018613|FG001|Overall Study|Medical or ethical reasons|2|||
164178707|NCT01032070|593018612|FG000|Overall Study|Withdrawal by Subject|0|||
164178708|NCT01032070|593018613|FG001|Overall Study|Withdrawal by Subject|2|||
164178709|NCT02554318|593018614|FG000|Overall Study|Withdrawal by Subject|10|||
164178710|NCT02554318|593018615|FG001|Overall Study|Withdrawal by Subject|8|||
164178711|NCT02332239|593018618|FG000|Overall Study|Lost to Follow-up|4|||
164178712|NCT02332239|593018619|FG001|Overall Study|Lost to Follow-up|6|||
164178713|NCT00894790|593018620|FG000|Overall Study|Protocol Violation|0|||
164178714|NCT00894790|593018621|FG001|Overall Study|Protocol Violation|1|||
164178715|NCT00894790|593018620|FG000|Overall Study|Lost to Follow-up|0|||
164178716|NCT00894790|593018621|FG001|Overall Study|Lost to Follow-up|1|||
164178717|NCT00894790|593018620|FG000|Overall Study|Did not meet entrance criteria|1|||
164178718|NCT00894790|593018621|FG001|Overall Study|Did not meet entrance criteria|0|||
164178719|NCT01472965|593018622|FG000|Overall Study|Withdrawal by Subject|1|||
164178720|NCT01472965|593018623|FG001|Overall Study|Withdrawal by Subject|0|||
164178721|NCT00006305|593018624|FG000|Overall Study|Withdrawal by Subject|17|||
164178722|NCT00006305|593018625|FG001|Overall Study|Withdrawal by Subject|10|||
164178723|NCT00006305|593018626|FG002|Overall Study|Withdrawal by Subject|15|||
164178724|NCT00006305|593018627|FG003|Overall Study|Withdrawal by Subject|14|||
164178725|NCT00662558|593018628|FG000|Overall Study|Adverse Event|21|||
164178726|NCT00662558|593018629|FG001|Overall Study|Adverse Event|59|||
164178727|NCT00662558|593018628|FG000|Overall Study|Lack of Efficacy|4|||
164178728|NCT00662558|593018629|FG001|Overall Study|Lack of Efficacy|7|||
164178729|NCT00662558|593018628|FG000|Overall Study|Lost to Follow-up|13|||
164178730|NCT00662558|593018629|FG001|Overall Study|Lost to Follow-up|10|||
164178731|NCT00662558|593018628|FG000|Overall Study|Other|9|||
164178732|NCT00662558|593018629|FG001|Overall Study|Other|14|||
164178733|NCT00662558|593018628|FG000|Overall Study|Withdrawal by Subject|7|||
164178734|NCT00662558|593018629|FG001|Overall Study|Withdrawal by Subject|12|||
164178735|NCT00662558|593018628|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
164178736|NCT00662558|593018629|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
164178737|NCT00329641|593018630|FG000|Overall Study|Did not start treatment|1|||
164178738|NCT00329641|593018630|FG000|Overall Study|Not eligible|1|||
164178739|NCT00329641|593018630|FG000|Overall Study|Adverse Event|3|||
164178740|NCT00329641|593018630|FG000|Overall Study|Other reason, not protocol specified|1|||
164178741|NCT00115037|593018634|FG000|Phase1|Lost to Follow-up|16|||
164178742|NCT00115037|593018635|FG001|Phase1|Lost to Follow-up|23|||
164178743|NCT00115037|593018636|FG002|Phase1|Lost to Follow-up|0|||
164178744|NCT00115037|593018637|FG003|Phase1|Lost to Follow-up|0|||
164178745|NCT00115037|593018638|FG004|Phase1|Lost to Follow-up|0|||
164178746|NCT00115037|593018639|FG005|Phase1|Lost to Follow-up|0|||
164178747|NCT00115037|593018634|FG000|Phase1|Withdrawal by Subject|9|||
164178748|NCT00115037|593018635|FG001|Phase1|Withdrawal by Subject|4|||
164178749|NCT00115037|593018636|FG002|Phase1|Withdrawal by Subject|0|||
164178752|NCT00115037|593018639|FG005|Phase1|Withdrawal by Subject|0|||
164178753|NCT00115037|593018634|FG000|Phase2|Death|0|||
164178754|NCT00115037|593018635|FG001|Phase2|Death|0|||
164178755|NCT00115037|593018636|FG002|Phase2|Death|1|||
164178756|NCT00115037|593018637|FG003|Phase2|Death|0|||
164178757|NCT00115037|593018638|FG004|Phase2|Death|0|||
164178758|NCT00115037|593018639|FG005|Phase2|Death|1|||
164178759|NCT00115037|593018634|FG000|Phase2|Withdrawal by Subject|0|||
164178760|NCT00115037|593018635|FG001|Phase2|Withdrawal by Subject|0|||
164178761|NCT00115037|593018636|FG002|Phase2|Withdrawal by Subject|2|||
164178762|NCT00115037|593018637|FG003|Phase2|Withdrawal by Subject|1|||
164178763|NCT00115037|593018638|FG004|Phase2|Withdrawal by Subject|2|||
164178764|NCT00115037|593018639|FG005|Phase2|Withdrawal by Subject|1|||
164178765|NCT00115037|593018634|FG000|Phase2|Lost to Follow-up|0|||
164178766|NCT00115037|593018635|FG001|Phase2|Lost to Follow-up|0|||
164178767|NCT00115037|593018636|FG002|Phase2|Lost to Follow-up|12|||
164178768|NCT00115037|593018637|FG003|Phase2|Lost to Follow-up|14|||
164178769|NCT00115037|593018638|FG004|Phase2|Lost to Follow-up|4|||
164178770|NCT00115037|593018639|FG005|Phase2|Lost to Follow-up|10|||
164178771|NCT01398410|593018640|FG000|Overall Study|Adverse Event|12|||
164178772|NCT01398410|593018641|FG001|Overall Study|Adverse Event|16|||
164178773|NCT01398410|593018640|FG000|Overall Study|Participants Choice|8|||
164178774|NCT01398410|593018641|FG001|Overall Study|Participants Choice|11|||
164178775|NCT01398410|593018640|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
164178776|NCT01398410|593018641|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
164178777|NCT01398410|593018640|FG000|Overall Study|Other|36|||
164178778|NCT01398410|593018641|FG001|Overall Study|Other|29|||
164178779|NCT00334802|593018642|FG000|Overall Study|Progressive Disease|2|||
164178780|NCT00334802|593018643|FG001|Overall Study|Progressive Disease|24|||
164178781|NCT00334802|593018642|FG000|Overall Study|Toxicity|1|||
164178782|NCT00334802|593018643|FG001|Overall Study|Toxicity|5|||
164178783|NCT00334802|593018642|FG000|Overall Study|Lack of Efficacy|1|||
164178784|NCT00334802|593018643|FG001|Overall Study|Lack of Efficacy|3|||
164178785|NCT00334802|593018642|FG000|Overall Study|Patient Condition Aggrevated|1|||
164178786|NCT00334802|593018643|FG001|Overall Study|Patient Condition Aggrevated|0|||
164178787|NCT00334802|593018642|FG000|Overall Study|Physician Decision|1|||
164178788|NCT00334802|593018643|FG001|Overall Study|Physician Decision|0|||
164178789|NCT00334802|593018642|FG000|Overall Study|Withdrawal by Subject|0|||
164178790|NCT00334802|593018643|FG001|Overall Study|Withdrawal by Subject|4|||
164178791|NCT00334802|593018642|FG000|Overall Study|Adverse Event|0|||
164178792|NCT00334802|593018643|FG001|Overall Study|Adverse Event|3|||
164178793|NCT00334802|593018642|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
164178794|NCT00334802|593018643|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
164178795|NCT03515629|593018654|FG000|Overall Study|Death|0|||
164178796|NCT03515629|593018655|FG001|Overall Study|Death|1|||
164178797|NCT03515629|593018656|FG002|Overall Study|Death|1|||
164178798|NCT03515629|593018654|FG000|Overall Study|Progressive disease|0|||
164178799|NCT03515629|593018655|FG001|Overall Study|Progressive disease|1|||
164178800|NCT03515629|593018656|FG002|Overall Study|Progressive disease|0|||
164178801|NCT03329248|593018657|FG000|Overall Study|Progressive Disease|6|||
164178802|NCT01886781|593018658|FG000|Overall Study|Protocol Violation|5|||
164178803|NCT01886781|593018659|FG001|Overall Study|Protocol Violation|0|||
164178804|NCT01886781|593018658|FG000|Overall Study|Adverse Event|1|||
164178805|NCT01886781|593018659|FG001|Overall Study|Adverse Event|0|||
164178806|NCT01886781|593018658|FG000|Overall Study|Lost to Follow-up|5|||
164178807|NCT01886781|593018659|FG001|Overall Study|Lost to Follow-up|0|||
164178808|NCT01886781|593018658|FG000|Overall Study|Withdrawal by Subject|2|||
164178809|NCT01886781|593018659|FG001|Overall Study|Withdrawal by Subject|1|||
164178810|NCT01886781|593018658|FG000|Overall Study|Worsening of symptoms|1|||
164178811|NCT01886781|593018659|FG001|Overall Study|Worsening of symptoms|1|||
164178812|NCT00987402|593018660|FG000|Overall Study|Insufficient data entry|86|||
164178813|NCT00987402|593018661|FG001|Overall Study|Insufficient data entry|98|||
164178814|NCT03000530|593018665|FG000|Overall Study|Adverse Event|0|||
164178815|NCT03000530|593018666|FG001|Overall Study|Adverse Event|0|||
164178816|NCT03000530|593018667|FG002|Overall Study|Adverse Event|2|||
164178817|NCT03000530|593018665|FG000|Overall Study|Lost to Follow-up|0|||
164178818|NCT03000530|593018666|FG001|Overall Study|Lost to Follow-up|3|||
164178819|NCT03000530|593018667|FG002|Overall Study|Lost to Follow-up|1|||
164178820|NCT03000530|593018665|FG000|Overall Study|Withdrawal by Subject|0|||
164178821|NCT03000530|593018666|FG001|Overall Study|Withdrawal by Subject|2|||
164178822|NCT03000530|593018667|FG002|Overall Study|Withdrawal by Subject|1|||
164178823|NCT03597022|593018670|FG000|Overall Study|Premature termination of the study|7|||
164178824|NCT03597022|593018671|FG001|Overall Study|Premature termination of the study|7|||
164178825|NCT03597022|593018672|FG002|Overall Study|Premature termination of the study|8|||
164178826|NCT03597022|593018670|FG000|Overall Study|Serious adverse event|1|||
164178827|NCT03597022|593018671|FG001|Overall Study|Serious adverse event|1|||
164178828|NCT03597022|593018672|FG002|Overall Study|Serious adverse event|0|||
164178829|NCT01430624|593018673|FG000|Overall Study|Lost to Follow-up|23|||
164178830|NCT01430624|593018674|FG001|Overall Study|Lost to Follow-up|29|||
164178831|NCT01430624|593018675|FG002|Overall Study|Lost to Follow-up|27|||
164178832|NCT01430624|593018673|FG000|Overall Study|technical or eligibility|5|||
164178833|NCT01430624|593018674|FG001|Overall Study|technical or eligibility|5|||
164178834|NCT01430624|593018675|FG002|Overall Study|technical or eligibility|2|||
164178835|NCT01672294|593018680|FG000|Overall Study|Withdrawal by Subject|4|||
164178836|NCT01672294|593018681|FG001|Overall Study|Withdrawal by Subject|4|||
164178837|NCT01672294|593018682|FG002|Overall Study|Withdrawal by Subject|4|||
164178838|NCT01672294|593018683|FG003|Overall Study|Withdrawal by Subject|4|||
164178839|NCT01672294|593018680|FG000|Overall Study|Excluded by study|1|||
164178840|NCT01672294|593018681|FG001|Overall Study|Excluded by study|1|||
164178841|NCT01672294|593018682|FG002|Overall Study|Excluded by study|0|||
164178842|NCT01672294|593018683|FG003|Overall Study|Excluded by study|0|||
164178843|NCT01672294|593018680|FG000|Overall Study|Lost to Follow-up|1|||
164178844|NCT01672294|593018681|FG001|Overall Study|Lost to Follow-up|16|||
164178845|NCT01672294|593018682|FG002|Overall Study|Lost to Follow-up|7|||
164178846|NCT01672294|593018683|FG003|Overall Study|Lost to Follow-up|9|||
164178847|NCT03379792|593018684|FG000|Overall Study|Physician Decision|0|||
164178848|NCT03379792|593018685|FG001|Overall Study|Physician Decision|0|||
164178849|NCT03379792|593018686|FG002|Overall Study|Physician Decision|0|||
164178850|NCT03379792|593018687|FG003|Overall Study|Physician Decision|1|||
164178851|NCT03379792|593018688|FG004|Overall Study|Physician Decision|0|||
164178852|NCT03379792|593018689|FG005|Overall Study|Physician Decision|0|||
164178853|NCT03379792|593018684|FG000|Overall Study|Withdrawal by Subject|0|||
164178854|NCT03379792|593018685|FG001|Overall Study|Withdrawal by Subject|0|||
164178855|NCT03379792|593018686|FG002|Overall Study|Withdrawal by Subject|0|||
164178856|NCT03379792|593018687|FG003|Overall Study|Withdrawal by Subject|0|||
164178857|NCT03379792|593018688|FG004|Overall Study|Withdrawal by Subject|1|||
164178858|NCT03379792|593018689|FG005|Overall Study|Withdrawal by Subject|1|||
164178859|NCT00306787|593018690|FG000|Overall Study|Discontinued without taking study drug|208|||
164178860|NCT00306787|593018691|FG001|Overall Study|Discontinued without taking study drug|215|||
164178861|NCT00306787|593018690|FG000|Overall Study|Adverse Event|1|||
164178862|NCT00306787|593018691|FG001|Overall Study|Adverse Event|1|||
164178863|NCT00306787|593018690|FG000|Overall Study|Lack of Efficacy|1|||
164178864|NCT00306787|593018691|FG001|Overall Study|Lack of Efficacy|0|||
164178865|NCT00306787|593018690|FG000|Overall Study|Protocol Violation|8|||
164178866|NCT00306787|593018691|FG001|Overall Study|Protocol Violation|10|||
164178867|NCT00306787|593018690|FG000|Overall Study|Withdrawal by Subject|2|||
164178868|NCT00306787|593018691|FG001|Overall Study|Withdrawal by Subject|9|||
164178869|NCT00306787|593018690|FG000|Overall Study|Lost to Follow-up|9|||
164178870|NCT00306787|593018691|FG001|Overall Study|Lost to Follow-up|6|||
164178871|NCT00306787|593018690|FG000|Overall Study|Administrative problems|4|||
164178872|NCT00306787|593018691|FG001|Overall Study|Administrative problems|0|||
164178873|NCT00306787|593018690|FG000|Overall Study|Abnormal laboratory value(s)|1|||
164178874|NCT00306787|593018691|FG001|Overall Study|Abnormal laboratory value(s)|0|||
164178875|NCT00369161|593018697|FG000|Overall Study|Adverse Event|15|||
164178876|NCT00369161|593018698|FG001|Overall Study|Adverse Event|13|||
164178877|NCT00369161|593018697|FG000|Overall Study|Abnormal laboratory value|0|||
164178878|NCT00369161|593018698|FG001|Overall Study|Abnormal laboratory value|1|||
164178879|NCT00369161|593018697|FG000|Overall Study|Lack of Efficacy|3|||
164178880|NCT00369161|593018698|FG001|Overall Study|Lack of Efficacy|1|||
164178881|NCT00369161|593018697|FG000|Overall Study|Protocol Violation|0|||
164178882|NCT00369161|593018698|FG001|Overall Study|Protocol Violation|2|||
164178883|NCT00369161|593018697|FG000|Overall Study|Withdrawal by Subject|2|||
164178884|NCT00369161|593018698|FG001|Overall Study|Withdrawal by Subject|3|||
164178885|NCT00369161|593018697|FG000|Overall Study|Death|1|||
164178886|NCT00369161|593018698|FG001|Overall Study|Death|2|||
164178887|NCT00369161|593018697|FG000|Overall Study|Graft loss|4|||
164178888|NCT00369161|593018698|FG001|Overall Study|Graft loss|0|||
164178889|NCT00369161|593018697|FG000|Overall Study|Administrative Problem|2|||
164178890|NCT00369161|593018698|FG001|Overall Study|Administrative Problem|2|||
164178891|NCT01870297|593018701|FG000|Overall Study|Adverse Event|0|||
164178892|NCT01870297|593018702|FG001|Overall Study|Adverse Event|0|||
164178893|NCT01870297|593018703|FG002|Overall Study|Adverse Event|0|||
164178894|NCT01870297|593018704|FG003|Overall Study|Adverse Event|0|||
164178895|NCT01870297|593018705|FG004|Overall Study|Adverse Event|2|||
164178896|NCT01870297|593018706|FG005|Overall Study|Adverse Event|0|||
164178897|NCT01870297|593018707|FG006|Overall Study|Adverse Event|0|||
164178898|NCT01870297|593018701|FG000|Overall Study|Lost to Follow-up|0|||
164178899|NCT01870297|593018702|FG001|Overall Study|Lost to Follow-up|1|||
164178900|NCT01870297|593018703|FG002|Overall Study|Lost to Follow-up|1|||
164178901|NCT01870297|593018704|FG003|Overall Study|Lost to Follow-up|0|||
164178902|NCT01870297|593018705|FG004|Overall Study|Lost to Follow-up|0|||
164178903|NCT01870297|593018706|FG005|Overall Study|Lost to Follow-up|0|||
164178904|NCT01870297|593018707|FG006|Overall Study|Lost to Follow-up|0|||
164178905|NCT01870297|593018701|FG000|Overall Study|Withdrawal by Subject|0|||
164178906|NCT01870297|593018702|FG001|Overall Study|Withdrawal by Subject|0|||
164178907|NCT01870297|593018703|FG002|Overall Study|Withdrawal by Subject|0|||
164178908|NCT01870297|593018704|FG003|Overall Study|Withdrawal by Subject|0|||
164178909|NCT01870297|593018705|FG004|Overall Study|Withdrawal by Subject|1|||
164178910|NCT01870297|593018706|FG005|Overall Study|Withdrawal by Subject|1|||
164178911|NCT01870297|593018707|FG006|Overall Study|Withdrawal by Subject|1|||
164178912|NCT01870297|593018701|FG000|Overall Study|Sponsor Decision|0|||
164178913|NCT01870297|593018702|FG001|Overall Study|Sponsor Decision|6|||
164178914|NCT01870297|593018703|FG002|Overall Study|Sponsor Decision|0|||
164178915|NCT01870297|593018704|FG003|Overall Study|Sponsor Decision|0|||
164178916|NCT01870297|593018705|FG004|Overall Study|Sponsor Decision|0|||
164178917|NCT01870297|593018706|FG005|Overall Study|Sponsor Decision|0|||
164178918|NCT01870297|593018707|FG006|Overall Study|Sponsor Decision|1|||
164178919|NCT04249622|593018710|FG000|Overall Study|Withdrawal by Subject|1|||
164178920|NCT04249622|593018711|FG001|Overall Study|Withdrawal by Subject|1|||
164178921|NCT04249622|593018710|FG000|Overall Study|Alternative therapy|1|||
164178922|NCT04249622|593018711|FG001|Overall Study|Alternative therapy|0|||
164178923|NCT04249622|593018710|FG000|Overall Study|Discontinuation of pertuzumab|1|||
164178924|NCT04249622|593018711|FG001|Overall Study|Discontinuation of pertuzumab|0|||
164178925|NCT03689543|593018713|FG000|Overall Study|Adverse Event|0|||
164178926|NCT03689543|593018714|FG001|Overall Study|Adverse Event|0|||
164178927|NCT03689543|593018715|FG002|Overall Study|Adverse Event|1|||
164178928|NCT00586508|593018716|FG000|Overall Study|Progressive disease|52|||
164178929|NCT00586508|593018717|FG001|Overall Study|Progressive disease|8|||
164178930|NCT00586508|593018716|FG000|Overall Study|Death|0|||
164178931|NCT00586508|593018717|FG001|Overall Study|Death|1|||
164178932|NCT00586508|593018716|FG000|Overall Study|Adverse Event|12|||
164178933|NCT00586508|593018717|FG001|Overall Study|Adverse Event|4|||
164178934|NCT00586508|593018716|FG000|Overall Study|Withdrawal by Subject|4|||
164178935|NCT00586508|593018717|FG001|Overall Study|Withdrawal by Subject|0|||
164178936|NCT05619536|593018718|FG000|Overall Study|Withdrawal by Subject|0|||
164178937|NCT05619536|593018719|FG001|Overall Study|Withdrawal by Subject|1|||
164178938|NCT05619536|593018720|FG002|Overall Study|Withdrawal by Subject|0|||
164178939|NCT05619536|593018721|FG003|Overall Study|Withdrawal by Subject|1|||
164178940|NCT05619536|593018718|FG000|Overall Study|Lost to Follow-up|0|||
164178941|NCT05619536|593018719|FG001|Overall Study|Lost to Follow-up|1|||
164178942|NCT05619536|593018720|FG002|Overall Study|Lost to Follow-up|1|||
164178943|NCT05619536|593018721|FG003|Overall Study|Lost to Follow-up|0|||
164178944|NCT03301740|593018722|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
164178945|NCT03301740|593018723|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
164178946|NCT03301740|593018722|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
164178947|NCT03301740|593018723|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
164178948|NCT02345889|593018727|FG000|Overall Study|Inadequate Bowel Prep|17|||
164178949|NCT02345889|593018728|FG001|Overall Study|Inadequate Bowel Prep|16|||
164178950|NCT02345889|593018729|FG002|Overall Study|Inadequate Bowel Prep|18|||
164178951|NCT02345889|593018730|FG003|Overall Study|Inadequate Bowel Prep|14|||
164178952|NCT02345889|593018727|FG000|Overall Study|Polyposis identified during procedure|1|||
164178953|NCT02345889|593018728|FG001|Overall Study|Polyposis identified during procedure|1|||
164178954|NCT02345889|593018729|FG002|Overall Study|Polyposis identified during procedure|0|||
164178955|NCT02345889|593018730|FG003|Overall Study|Polyposis identified during procedure|1|||
164178956|NCT02345889|593018727|FG000|Overall Study|Recognized ineligible post-randomization|1|||
164178957|NCT02345889|593018728|FG001|Overall Study|Recognized ineligible post-randomization|0|||
164178958|NCT02345889|593018729|FG002|Overall Study|Recognized ineligible post-randomization|2|||
164178959|NCT02345889|593018730|FG003|Overall Study|Recognized ineligible post-randomization|1|||
164178960|NCT02345889|593018727|FG000|Overall Study|Ulcerative Colitis identified|1|||
164178961|NCT02345889|593018728|FG001|Overall Study|Ulcerative Colitis identified|0|||
164178962|NCT02345889|593018729|FG002|Overall Study|Ulcerative Colitis identified|0|||
164178963|NCT02345889|593018730|FG003|Overall Study|Ulcerative Colitis identified|0|||
164178964|NCT02345889|593018727|FG000|Overall Study|Cecum not intubated|1|||
164178965|NCT02345889|593018728|FG001|Overall Study|Cecum not intubated|0|||
164178966|NCT02345889|593018729|FG002|Overall Study|Cecum not intubated|0|||
164178967|NCT02345889|593018730|FG003|Overall Study|Cecum not intubated|0|||
164178968|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178969|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178970|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178971|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178972|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
164178973|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
164178974|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178975|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178976|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178977|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178978|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
164178979|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
164178980|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Adverse Event|0|||
164178981|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Adverse Event|0|||
164178982|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Adverse Event|0|||
164178983|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Adverse Event|0|||
164178984|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Adverse Event|0|||
164178985|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Adverse Event|2|||
164178986|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178987|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178988|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178989|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178990|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
164178991|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
164178992|NCT03191864|593018732|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178993|NCT03191864|593018733|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178994|NCT03191864|593018734|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178995|NCT03191864|593018735|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178996|NCT03191864|593018736|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
164178997|NCT03191864|593018737|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
164178998|NCT03191864|593018732|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164178999|NCT03191864|593018733|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164179000|NCT03191864|593018734|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
164179001|NCT03191864|593018735|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164179002|NCT03191864|593018736|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
164179003|NCT03191864|593018737|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
164179004|NCT03191864|593018732|FG000|Part 1 - Induction|Adverse Event|0|||
164179005|NCT03191864|593018733|FG001|Part 1 - Induction|Adverse Event|2|||
164179006|NCT03191864|593018734|FG002|Part 1 - Induction|Adverse Event|0|||
164179007|NCT03191864|593018735|FG003|Part 1 - Induction|Adverse Event|1|||
164179008|NCT03191864|593018736|FG004|Part 1 - Induction|Adverse Event|0|||
164179009|NCT03191864|593018737|FG005|Part 1 - Induction|Adverse Event|2|||
164179010|NCT03191864|593018732|FG000|Part 1 - Induction|Randomized but never dosed|0|||
164179011|NCT03191864|593018733|FG001|Part 1 - Induction|Randomized but never dosed|0|||
164179012|NCT03191864|593018734|FG002|Part 1 - Induction|Randomized but never dosed|1|||
164179013|NCT03191864|593018735|FG003|Part 1 - Induction|Randomized but never dosed|0|||
164179014|NCT03191864|593018736|FG004|Part 1 - Induction|Randomized but never dosed|0|||
164179015|NCT03191864|593018737|FG005|Part 1 - Induction|Randomized but never dosed|0|||
164179016|NCT03191864|593018732|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
164179017|NCT03191864|593018733|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
164179018|NCT03191864|593018734|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
164179019|NCT03191864|593018735|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
164179020|NCT03191864|593018736|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
164179021|NCT03191864|593018737|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
164179022|NCT03191864|593018732|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179023|NCT03191864|593018733|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179024|NCT03191864|593018734|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
164179025|NCT03191864|593018735|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179026|NCT03191864|593018736|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179027|NCT03191864|593018737|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
164179028|NCT03191864|593018732|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
164179029|NCT03191864|593018733|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179030|NCT03191864|593018734|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179031|NCT03191864|593018735|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179032|NCT03191864|593018736|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179033|NCT03191864|593018737|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
164179034|NCT03191864|593018732|FG000|Part 2 - Maintenance|Physician Decision|1|||
164179035|NCT03191864|593018733|FG001|Part 2 - Maintenance|Physician Decision|0|||
164179036|NCT03191864|593018734|FG002|Part 2 - Maintenance|Physician Decision|0|||
164179037|NCT03191864|593018735|FG003|Part 2 - Maintenance|Physician Decision|0|||
164179038|NCT03191864|593018736|FG004|Part 2 - Maintenance|Physician Decision|0|||
164179039|NCT03191864|593018737|FG005|Part 2 - Maintenance|Physician Decision|0|||
164179040|NCT03191864|593018732|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
164179041|NCT03191864|593018733|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
164179042|NCT03191864|593018734|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
164179043|NCT03191864|593018735|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
164179044|NCT03191864|593018736|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
164179045|NCT03191864|593018737|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
164179046|NCT03191864|593018732|FG000|Part 2 - Maintenance|Adverse Event|0|||
164179047|NCT03191864|593018733|FG001|Part 2 - Maintenance|Adverse Event|0|||
164179048|NCT03191864|593018734|FG002|Part 2 - Maintenance|Adverse Event|0|||
164179049|NCT03191864|593018735|FG003|Part 2 - Maintenance|Adverse Event|0|||
164179050|NCT03191864|593018736|FG004|Part 2 - Maintenance|Adverse Event|1|||
164179051|NCT03191864|593018737|FG005|Part 2 - Maintenance|Adverse Event|0|||
164179052|NCT03191864|593018732|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
164179053|NCT03191864|593018733|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179054|NCT03191864|593018734|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179055|NCT03191864|593018735|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179056|NCT03191864|593018736|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
164179057|NCT03191864|593018737|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
164179058|NCT03191864|593018732|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179059|NCT03191864|593018733|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179060|NCT03191864|593018734|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179061|NCT03191864|593018735|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179062|NCT03191864|593018736|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
164179063|NCT03191864|593018737|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
164179064|NCT02044874|593018740|FG000|Overall Study|Adverse Event|5|||
164179065|NCT02044874|593018741|FG001|Overall Study|Adverse Event|6|||
164179066|NCT02044874|593018742|FG002|Overall Study|Adverse Event|6|||
164179067|NCT02044874|593018740|FG000|Overall Study|Withdrawal by Subject|8|||
164179068|NCT02044874|593018741|FG001|Overall Study|Withdrawal by Subject|16|||
164179069|NCT02044874|593018742|FG002|Overall Study|Withdrawal by Subject|23|||
164179070|NCT02044874|593018740|FG000|Overall Study|Physician Decision|0|||
164179071|NCT02044874|593018741|FG001|Overall Study|Physician Decision|2|||
164179072|NCT02044874|593018742|FG002|Overall Study|Physician Decision|1|||
164179073|NCT02044874|593018740|FG000|Overall Study|Lost to Follow-up|10|||
164179074|NCT02044874|593018741|FG001|Overall Study|Lost to Follow-up|27|||
164179075|NCT02044874|593018742|FG002|Overall Study|Lost to Follow-up|21|||
164179076|NCT02044874|593018740|FG000|Overall Study|Sponsor Decision|0|||
164179077|NCT02044874|593018741|FG001|Overall Study|Sponsor Decision|1|||
164179078|NCT02044874|593018742|FG002|Overall Study|Sponsor Decision|1|||
164179079|NCT02044874|593018740|FG000|Overall Study|Other|7|||
164179080|NCT02044874|593018741|FG001|Overall Study|Other|3|||
164179081|NCT02044874|593018742|FG002|Overall Study|Other|8|||
164179082|NCT00415597|593018743|FG000|Enrollment|Withdrawal by Subject|1|||
164179083|NCT00415597|593018743|FG000|Enrollment|Protocol Violation|1|||
164179084|NCT00415597|593018743|FG000|Treatment|Adverse Event|110|||
164179085|NCT00415597|593018743|FG000|Treatment|Lack of Efficacy|39|||
164179086|NCT00415597|593018743|FG000|Treatment|Protocol Violation|67|||
164179087|NCT00415597|593018743|FG000|Treatment|Physician Decision|3|||
164179088|NCT00415597|593018743|FG000|Treatment|Withdrawal by Subject|51|||
164179089|NCT00415597|593018743|FG000|Treatment|Lost to Follow-up|28|||
164179090|NCT00415597|593018743|FG000|Treatment|Drug Screen|2|||
164179091|NCT00415597|593018743|FG000|Treatment|Administrative|3|||
164179092|NCT00415597|593018743|FG000|Treatment|Sponsor Decision|1|||
164179093|NCT00415597|593018743|FG000|Treatment|Multiple Reasons|1|||
164179094|NCT03976323|593018744|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
164179095|NCT03976323|593018745|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164179096|NCT03976323|593018746|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
164179097|NCT03976323|593018744|FG000|Induction Phase|Death|80|||
164179098|NCT03976323|593018745|FG001|Induction Phase|Death|0|||
164179099|NCT03976323|593018746|FG002|Induction Phase|Death|0|||
164179100|NCT03976323|593018744|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
164179101|NCT03976323|593018745|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
164179102|NCT03976323|593018746|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
164179103|NCT03976323|593018744|FG000|Maintenance Phase|Withdrawal by Subject|0|||
164179104|NCT03976323|593018745|FG001|Maintenance Phase|Withdrawal by Subject|9|||
164179105|NCT03976323|593018746|FG002|Maintenance Phase|Withdrawal by Subject|3|||
164179106|NCT03976323|593018744|FG000|Maintenance Phase|Physician Decision|0|||
164179107|NCT03976323|593018745|FG001|Maintenance Phase|Physician Decision|0|||
164179108|NCT03976323|593018746|FG002|Maintenance Phase|Physician Decision|1|||
164179109|NCT03976323|593018744|FG000|Maintenance Phase|Death|0|||
164179110|NCT03976323|593018745|FG001|Maintenance Phase|Death|228|||
164179111|NCT03976323|593018746|FG002|Maintenance Phase|Death|234|||
164179112|NCT02913105|593020441|FG000|Overall Study|Adverse Event|11|||
164179113|NCT02913105|593020442|FG001|Overall Study|Adverse Event|0|||
164179114|NCT02913105|593020443|FG002|Overall Study|Adverse Event|4|||
164179115|NCT02913105|593020441|FG000|Overall Study|Non-Compliance With Study Drug|0|||
164179116|NCT02913105|593020442|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164179117|NCT02913105|593020443|FG002|Overall Study|Non-Compliance With Study Drug|1|||
164179118|NCT02913105|593020441|FG000|Overall Study|Reason Not Specified|3|||
164179119|NCT02913105|593020442|FG001|Overall Study|Reason Not Specified|1|||
164179120|NCT02913105|593020443|FG002|Overall Study|Reason Not Specified|1|||
164179121|NCT02913105|593020441|FG000|Overall Study|Physician Decision|1|||
164179122|NCT02913105|593020442|FG001|Overall Study|Physician Decision|1|||
164179123|NCT02913105|593020443|FG002|Overall Study|Physician Decision|0|||
164179124|NCT02913105|593020441|FG000|Overall Study|Withdrawal by Subject|0|||
164179125|NCT02913105|593020442|FG001|Overall Study|Withdrawal by Subject|3|||
164179126|NCT02913105|593020443|FG002|Overall Study|Withdrawal by Subject|1|||
164179127|NCT02168777|593020444|FG000|Overall Study|Withdrawal by Subject|1|||
164179128|NCT02168777|593020445|FG001|Overall Study|Withdrawal by Subject|0|||
164179129|NCT02168777|593020446|FG002|Overall Study|Withdrawal by Subject|2|||
164179130|NCT02168777|593020444|FG000|Overall Study|Adverse Event|1|||
164179131|NCT02168777|593020445|FG001|Overall Study|Adverse Event|0|||
164179132|NCT02168777|593020446|FG002|Overall Study|Adverse Event|1|||
164179133|NCT02168777|593020444|FG000|Overall Study|Disease recurrence|0|||
164179134|NCT02168777|593020445|FG001|Overall Study|Disease recurrence|0|||
164179135|NCT02168777|593020446|FG002|Overall Study|Disease recurrence|1|||
164179136|NCT02168777|593020444|FG000|Overall Study|Radiological disease progression|0|||
164179137|NCT02168777|593020445|FG001|Overall Study|Radiological disease progression|5|||
164179138|NCT02168777|593020446|FG002|Overall Study|Radiological disease progression|5|||
164179139|NCT02168777|593020444|FG000|Overall Study|Clinical disease progression|0|||
164179140|NCT02168777|593020445|FG001|Overall Study|Clinical disease progression|1|||
164179141|NCT02168777|593020446|FG002|Overall Study|Clinical disease progression|2|||
164179142|NCT02168777|593020444|FG000|Overall Study|Other reason|0|||
164179143|NCT02168777|593020445|FG001|Overall Study|Other reason|1|||
164179144|NCT02168777|593020446|FG002|Overall Study|Other reason|0|||
164179145|NCT05243563|593020447|FG000|Overall Study|Withdrawal by Subject|1|||
164179146|NCT05243563|593020448|FG001|Overall Study|Withdrawal by Subject|0|||
164179147|NCT05243563|593020447|FG000|Overall Study|Physician Decision|1|||
164179148|NCT05243563|593020448|FG001|Overall Study|Physician Decision|0|||
164179149|NCT00441363|593020449|FG000|Overall Study|Adverse Event|4|||
164179150|NCT00441363|593020450|FG001|Overall Study|Adverse Event|2|||
164179151|NCT00441363|593020449|FG000|Overall Study|Withdrawal by Subject|3|||
164179152|NCT00441363|593020450|FG001|Overall Study|Withdrawal by Subject|4|||
164179153|NCT00441363|593020449|FG000|Overall Study|Physician Decision|6|||
164179154|NCT00441363|593020450|FG001|Overall Study|Physician Decision|7|||
164179155|NCT00441363|593020449|FG000|Overall Study|Lost to Follow-up|2|||
164179156|NCT00441363|593020450|FG001|Overall Study|Lost to Follow-up|2|||
164179157|NCT00441363|593020449|FG000|Overall Study|Other|2|||
164179158|NCT00441363|593020450|FG001|Overall Study|Other|0|||
164179159|NCT02437188|593020453|FG000|Overall Study|Randomized but did not receive surgery|4|||
164179160|NCT02437188|593020454|FG001|Overall Study|Randomized but did not receive surgery|8|||
164179161|NCT02437188|593020453|FG000|Overall Study|Adverse Event|0|||
164179162|NCT02437188|593020454|FG001|Overall Study|Adverse Event|1|||
164179163|NCT01663857|593020455|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
164179164|NCT01663857|593020456|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
164179165|NCT01663857|593020457|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
164179166|NCT01663857|593020458|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
164179167|NCT01663857|593020455|FG000|Overall Study|Lost to Follow-up|0|||
164179168|NCT01663857|593020456|FG001|Overall Study|Lost to Follow-up|0|||
164179169|NCT01663857|593020457|FG002|Overall Study|Lost to Follow-up|3|||
164179170|NCT01663857|593020458|FG003|Overall Study|Lost to Follow-up|1|||
164179171|NCT02578940|593020467|FG000|Overall Study|Screening failure|5|||
164179172|NCT02578940|593020467|FG000|Overall Study|Lost to Follow-up|1|||
164179173|NCT01911793|593020468|FG000|Overall Study|Physician Decision|1|||
164179174|NCT01911793|593020469|FG001|Overall Study|Physician Decision|5|||
164179175|NCT03334422|593020470|FG000|Overall Study|Adverse Event|1|||
164179176|NCT03334422|593020471|FG001|Overall Study|Adverse Event|3|||
164179177|NCT03334422|593020472|FG002|Overall Study|Adverse Event|2|||
164179178|NCT03334422|593020473|FG003|Overall Study|Adverse Event|2|||
164179179|NCT03334422|593020470|FG000|Overall Study|Lack of Efficacy|10|||
164179180|NCT03334422|593020471|FG001|Overall Study|Lack of Efficacy|2|||
164179181|NCT03334422|593020472|FG002|Overall Study|Lack of Efficacy|7|||
164179182|NCT03334422|593020473|FG003|Overall Study|Lack of Efficacy|3|||
164179183|NCT03334422|593020470|FG000|Overall Study|Withdrawal by Subject|8|||
164179184|NCT03334422|593020471|FG001|Overall Study|Withdrawal by Subject|3|||
164179185|NCT03334422|593020472|FG002|Overall Study|Withdrawal by Subject|1|||
164179186|NCT03334422|593020473|FG003|Overall Study|Withdrawal by Subject|0|||
164179187|NCT03334422|593020470|FG000|Overall Study|Lost to Follow-up|0|||
164179188|NCT03334422|593020471|FG001|Overall Study|Lost to Follow-up|0|||
164179189|NCT03334422|593020472|FG002|Overall Study|Lost to Follow-up|0|||
164179190|NCT03334422|593020473|FG003|Overall Study|Lost to Follow-up|1|||
164179191|NCT03334422|593020470|FG000|Overall Study|Inability to obtain laboratory samples|0|||
164179192|NCT03334422|593020471|FG001|Overall Study|Inability to obtain laboratory samples|1|||
164179193|NCT03334422|593020472|FG002|Overall Study|Inability to obtain laboratory samples|0|||
164179194|NCT03334422|593020473|FG003|Overall Study|Inability to obtain laboratory samples|0|||
164179195|NCT03334422|593020470|FG000|Overall Study|Pregnancy|0|||
164179196|NCT03334422|593020471|FG001|Overall Study|Pregnancy|1|||
164179197|NCT03334422|593020472|FG002|Overall Study|Pregnancy|0|||
164179198|NCT03334422|593020473|FG003|Overall Study|Pregnancy|0|||
164179199|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
164179200|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
164179201|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
164179202|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
164179203|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
164179204|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
164179205|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
164179206|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
164179207|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
164179208|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
164179209|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
164179210|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
164179211|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
164179212|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
164179213|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
164179214|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
164179215|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
164179216|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
164179217|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
164179218|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
164179219|NCT00994214|593020474|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
164179220|NCT00994214|593020475|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
164179221|NCT00994214|593020476|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
164179222|NCT00994214|593020477|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
164179223|NCT04710368|593020483|FG000|Overall Study|Withdrawal by Subject|9|||
164179224|NCT04710368|593020483|FG000|Overall Study|Lost to Follow-up|4|||
164179225|NCT04710368|593020483|FG000|Overall Study|Death|2|||
164179226|NCT04710368|593020483|FG000|Overall Study|Patient preference|11|||
164179227|NCT04710368|593020483|FG000|Overall Study|Treatment discontinuation|1|||
164179228|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
164179229|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
164179230|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
164179231|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
164179232|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
164179233|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
164179234|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
164179235|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
164179236|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
164179237|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
164179238|NCT01777139|593020486|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
164179239|NCT01777139|593020487|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
164179240|NCT01777139|593020486|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
164179241|NCT01777139|593020487|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
164179242|NCT01777139|593020486|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
164179243|NCT01777139|593020487|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
164179244|NCT03959488|593020488|FG000|Season 1|Other|6|||
164179245|NCT03959488|593020489|FG001|Season 1|Other|7|||
164179246|NCT03959488|593020490|FG002|Season 1|Other|0|||
164179247|NCT03959488|593020491|FG003|Season 1|Other|0|||
164179248|NCT03959488|593020492|FG004|Season 1|Other|0|||
164179249|NCT03959488|593020488|FG000|Season 1|Withdrawal by parent/guardian|43|||
164179250|NCT03959488|593020489|FG001|Season 1|Withdrawal by parent/guardian|28|||
164179251|NCT03959488|593020490|FG002|Season 1|Withdrawal by parent/guardian|0|||
164179252|NCT03959488|593020491|FG003|Season 1|Withdrawal by parent/guardian|0|||
164179253|NCT03959488|593020492|FG004|Season 1|Withdrawal by parent/guardian|0|||
164179254|NCT03959488|593020488|FG000|Season 1|Due to COVID-19 pandemic|2|||
164179255|NCT03959488|593020489|FG001|Season 1|Due to COVID-19 pandemic|3|||
164179256|NCT03959488|593020490|FG002|Season 1|Due to COVID-19 pandemic|0|||
164179257|NCT03959488|593020491|FG003|Season 1|Due to COVID-19 pandemic|0|||
164179258|NCT03959488|593020492|FG004|Season 1|Due to COVID-19 pandemic|0|||
164179259|NCT03959488|593020488|FG000|Season 1|Lost to Follow-up|17|||
164179260|NCT03959488|593020489|FG001|Season 1|Lost to Follow-up|7|||
164179261|NCT03959488|593020490|FG002|Season 1|Lost to Follow-up|0|||
164179262|NCT03959488|593020491|FG003|Season 1|Lost to Follow-up|0|||
164179263|NCT03959488|593020492|FG004|Season 1|Lost to Follow-up|0|||
164179264|NCT03959488|593020488|FG000|Season 1|Death|5|||
164179265|NCT03959488|593020489|FG001|Season 1|Death|1|||
164179266|NCT03959488|593020490|FG002|Season 1|Death|0|||
164179267|NCT03959488|593020491|FG003|Season 1|Death|0|||
164179268|NCT03959488|593020492|FG004|Season 1|Death|0|||
164179269|NCT03959488|593020488|FG000|Season 2|Other|0|||
164179270|NCT03959488|593020489|FG001|Season 2|Other|0|||
164179271|NCT03959488|593020490|FG002|Season 2|Other|2|||
164179272|NCT03959488|593020491|FG003|Season 2|Other|0|||
164179273|NCT03959488|593020492|FG004|Season 2|Other|0|||
164179274|NCT03959488|593020488|FG000|Season 2|Withdrawal by parent/guardian|0|||
164179275|NCT03959488|593020489|FG001|Season 2|Withdrawal by parent/guardian|0|||
164179276|NCT03959488|593020490|FG002|Season 2|Withdrawal by parent/guardian|3|||
164179277|NCT03959488|593020491|FG003|Season 2|Withdrawal by parent/guardian|1|||
164179278|NCT03959488|593020492|FG004|Season 2|Withdrawal by parent/guardian|1|||
164179279|NCT03959488|593020488|FG000|Season 2|Lost to Follow-up|0|||
164179280|NCT03959488|593020489|FG001|Season 2|Lost to Follow-up|0|||
164179281|NCT03959488|593020490|FG002|Season 2|Lost to Follow-up|1|||
164179282|NCT03959488|593020491|FG003|Season 2|Lost to Follow-up|0|||
164179283|NCT03959488|593020492|FG004|Season 2|Lost to Follow-up|1|||
164179284|NCT01887288|593020494|FG000|Overall Study|The study was terminated and the PI has|16|||
164179285|NCT02278367|593020497|FG000|Overall Study|Physician Decision|5|||
164179286|NCT02278367|593020498|FG001|Overall Study|Physician Decision|0|||
164179287|NCT02278367|593020497|FG000|Overall Study|Withdrawal by Subject|5|||
164179288|NCT02278367|593020498|FG001|Overall Study|Withdrawal by Subject|0|||
164179289|NCT02949908|593020499|FG000|Overall Study|Study termination|2|||
164179290|NCT04105010|593020500|FG000|Overall Study|Death|3|||
164179291|NCT04105010|593020501|FG001|Overall Study|Death|1|||
164179292|NCT04105010|593020502|FG002|Overall Study|Death|1|||
164179293|NCT04105010|593020503|FG003|Overall Study|Death|54|||
164179294|NCT04105010|593020500|FG000|Overall Study|Lost to Follow-up|0|||
164179295|NCT04105010|593020501|FG001|Overall Study|Lost to Follow-up|0|||
164179296|NCT04105010|593020502|FG002|Overall Study|Lost to Follow-up|0|||
164179297|NCT04105010|593020503|FG003|Overall Study|Lost to Follow-up|4|||
164179298|NCT04105010|593020500|FG000|Overall Study|Withdrawal by Subject|8|||
164179299|NCT04105010|593020501|FG001|Overall Study|Withdrawal by Subject|1|||
164179300|NCT04105010|593020502|FG002|Overall Study|Withdrawal by Subject|1|||
164179301|NCT04105010|593020503|FG003|Overall Study|Withdrawal by Subject|4|||
164179302|NCT04105010|593020500|FG000|Overall Study|Other reason|4|||
164179303|NCT04105010|593020501|FG001|Overall Study|Other reason|7|||
164179304|NCT04105010|593020502|FG002|Overall Study|Other reason|0|||
164179305|NCT04105010|593020503|FG003|Overall Study|Other reason|19|||
164179306|NCT01211483|593020504|FG000|Phase 1b|Death|6|||
164179307|NCT01211483|593020505|FG001|Phase 1b|Death|0|||
164179308|NCT01211483|593020506|FG002|Phase 1b|Death|0|||
164179309|NCT01211483|593020507|FG003|Phase 1b|Death|0|||
164179310|NCT01211483|593020504|FG000|Phase 1b|Withdrawal by Subject|1|||
164179311|NCT01211483|593020505|FG001|Phase 1b|Withdrawal by Subject|0|||
164179312|NCT01211483|593020506|FG002|Phase 1b|Withdrawal by Subject|0|||
164179313|NCT01211483|593020507|FG003|Phase 1b|Withdrawal by Subject|0|||
164179314|NCT01211483|593020504|FG000|Phase 2|Lost to Follow-up|0|||
164179315|NCT01211483|593020505|FG001|Phase 2|Lost to Follow-up|1|||
164179316|NCT01211483|593020506|FG002|Phase 2|Lost to Follow-up|1|||
164179317|NCT01211483|593020507|FG003|Phase 2|Lost to Follow-up|2|||
164179318|NCT01211483|593020504|FG000|Phase 2|Death|0|||
164179319|NCT01211483|593020505|FG001|Phase 2|Death|64|||
164179320|NCT01211483|593020506|FG002|Phase 2|Death|53|||
164179321|NCT01211483|593020507|FG003|Phase 2|Death|53|||
164179322|NCT01211483|593020504|FG000|Phase 2|Withdrawal by Subject|0|||
164179323|NCT01211483|593020505|FG001|Phase 2|Withdrawal by Subject|1|||
164179324|NCT01211483|593020506|FG002|Phase 2|Withdrawal by Subject|10|||
164179325|NCT01211483|593020507|FG003|Phase 2|Withdrawal by Subject|5|||
164179326|NCT01211483|593020504|FG000|Phase 2|Study terminated by Sponsor|0|||
164179327|NCT01211483|593020505|FG001|Phase 2|Study terminated by Sponsor|6|||
164179328|NCT01211483|593020506|FG002|Phase 2|Study terminated by Sponsor|8|||
164179329|NCT01211483|593020507|FG003|Phase 2|Study terminated by Sponsor|11|||
164179330|NCT01675154|593020508|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
164179331|NCT01675154|593020509|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
164179332|NCT01675154|593020510|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
164179333|NCT01675154|593020511|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
164179334|NCT02971800|593020514|FG000|Overall Study|Protocol Violation|1|||
164179335|NCT02971800|593020514|FG000|Overall Study|Withdrawal by Subject|1|||
164179336|NCT02971800|593020514|FG000|Overall Study|Exclusion criteria prior intervention|1|||
164179337|NCT02971800|593020514|FG000|Overall Study|Number evaluable participant already reached|4|||
164179338|NCT00616603|593020517|FG000|Overall Study|Physician Decision|2|||
164179339|NCT00616603|593020518|FG001|Overall Study|Physician Decision|0|||
164179340|NCT00616603|593020519|FG002|Overall Study|Physician Decision|2|||
164179341|NCT01285492|593020522|FG000|Overall Study|Adverse Event|11|||
164179342|NCT01285492|593020523|FG001|Overall Study|Adverse Event|0|||
164179343|NCT01285492|593020522|FG000|Overall Study|Protocol Violation|3|||
164179344|NCT01285492|593020523|FG001|Overall Study|Protocol Violation|0|||
164179345|NCT01285492|593020522|FG000|Overall Study|Withdrawal by Subject|2|||
164179346|NCT01285492|593020523|FG001|Overall Study|Withdrawal by Subject|1|||
164179347|NCT01285492|593020522|FG000|Overall Study|Death|1|||
164179348|NCT01285492|593020523|FG001|Overall Study|Death|0|||
164179349|NCT01121536|593020524|FG000|Overall Study|Adverse Event|63|||
164179350|NCT01121536|593020524|FG000|Overall Study|Lack of Efficacy|35|||
164179351|NCT01121536|593020524|FG000|Overall Study|Withdrawal by Subject|65|||
164179352|NCT01121536|593020524|FG000|Overall Study|Protocol Violation|20|||
164179353|NCT01121536|593020524|FG000|Overall Study|Noncompliance with study medication|12|||
164179354|NCT01121536|593020524|FG000|Overall Study|Noncompliance with study procedures|9|||
164179355|NCT01121536|593020524|FG000|Overall Study|Lost to Follow-up|39|||
164179356|NCT01121536|593020524|FG000|Overall Study|Other|118|||
164179357|NCT02649426|593020526|FG000|Overall Study|Follow-up on going|1|||
164179358|NCT02649426|593020527|FG001|Overall Study|Follow-up on going|26|||
164179359|NCT02649426|593020528|FG002|Overall Study|Follow-up on going|28|||
164179360|NCT02649426|593020529|FG003|Overall Study|Follow-up on going|31|||
164179361|NCT01593254|593020532|FG000|Overall Study|Disease progression|2|||
164179362|NCT01593254|593020533|FG001|Overall Study|Disease progression|7|||
164179363|NCT01593254|593020532|FG000|Overall Study|Study drug toxicity|6|||
164179364|NCT01593254|593020533|FG001|Overall Study|Study drug toxicity|20|||
164179365|NCT01593254|593020532|FG000|Overall Study|Death|3|||
164179366|NCT01593254|593020533|FG001|Overall Study|Death|3|||
164179367|NCT01593254|593020532|FG000|Overall Study|AE unrelated to study drug|0|||
164179368|NCT01593254|593020533|FG001|Overall Study|AE unrelated to study drug|1|||
164179369|NCT01593254|593020532|FG000|Overall Study|participant request to discontinue study treatment|1|||
164179370|NCT01593254|593020533|FG001|Overall Study|participant request to discontinue study treatment|3|||
164179371|NCT01593254|593020532|FG000|Overall Study|participant withdrew consent|0|||
164179372|NCT01593254|593020533|FG001|Overall Study|participant withdrew consent|9|||
164179373|NCT01593254|593020532|FG000|Overall Study|lost to follow up|1|||
164179374|NCT01593254|593020533|FG001|Overall Study|lost to follow up|6|||
164179375|NCT01593254|593020532|FG000|Overall Study|maximum clinical benefit|1|||
164179376|NCT01593254|593020533|FG001|Overall Study|maximum clinical benefit|2|||
164179377|NCT01593254|593020532|FG000|Overall Study|Poor/non compliance|1|||
164179378|NCT01593254|593020533|FG001|Overall Study|Poor/non compliance|1|||
164179379|NCT01593254|593020532|FG000|Overall Study|Pregnancy|0|||
164179380|NCT01593254|593020533|FG001|Overall Study|Pregnancy|3|||
164179381|NCT01593254|593020532|FG000|Overall Study|participant no longer meets study criteria|1|||
164179382|NCT01593254|593020533|FG001|Overall Study|participant no longer meets study criteria|1|||
164179383|NCT01593254|593020532|FG000|Overall Study|Admin reason by sponsor|7|||
164179384|NCT01593254|593020533|FG001|Overall Study|Admin reason by sponsor|3|||
164179385|NCT01593254|593020532|FG000|Overall Study|Imatinib treatment failure|2|||
164179386|NCT01593254|593020533|FG001|Overall Study|Imatinib treatment failure|0|||
164179387|NCT01593254|593020532|FG000|Overall Study|Other Reasons|61|||
164179388|NCT01593254|593020533|FG001|Overall Study|Other Reasons|115|||
164179389|NCT02079636|593020534|FG000|Overall Study|Death|2|||
164179390|NCT02079636|593020535|FG001|Overall Study|Death|1|||
164179391|NCT02079636|593020536|FG002|Overall Study|Death|0|||
164179392|NCT02079636|593020537|FG003|Overall Study|Death|5|||
164179393|NCT02079636|593020538|FG004|Overall Study|Death|1|||
164179394|NCT02079636|593020539|FG005|Overall Study|Death|2|||
164179395|NCT02079636|593020540|FG006|Overall Study|Death|1|||
164179396|NCT02079636|593020541|FG007|Overall Study|Death|0|||
164179397|NCT02079636|593020542|FG008|Overall Study|Death|0|||
164179398|NCT02079636|593020543|FG009|Overall Study|Death|0|||
164179399|NCT02079636|593020544|FG010|Overall Study|Death|0|||
164179400|NCT02079636|593020545|FG011|Overall Study|Death|1|||
164179401|NCT02079636|593020546|FG012|Overall Study|Death|1|||
164179402|NCT02079636|593020547|FG013|Overall Study|Death|0|||
164179403|NCT02079636|593020548|FG014|Overall Study|Death|2|||
164179404|NCT02079636|593020534|FG000|Overall Study|Adverse Event|1|||
164179405|NCT02079636|593020535|FG001|Overall Study|Adverse Event|1|||
164179406|NCT02079636|593020536|FG002|Overall Study|Adverse Event|0|||
164179407|NCT02079636|593020537|FG003|Overall Study|Adverse Event|1|||
164179408|NCT02079636|593020538|FG004|Overall Study|Adverse Event|1|||
164179409|NCT02079636|593020539|FG005|Overall Study|Adverse Event|2|||
164179410|NCT02079636|593020540|FG006|Overall Study|Adverse Event|0|||
164179411|NCT02079636|593020541|FG007|Overall Study|Adverse Event|0|||
164179412|NCT02079636|593020542|FG008|Overall Study|Adverse Event|0|||
164179413|NCT02079636|593020543|FG009|Overall Study|Adverse Event|0|||
164179414|NCT02079636|593020544|FG010|Overall Study|Adverse Event|0|||
164179415|NCT02079636|593020545|FG011|Overall Study|Adverse Event|0|||
164179416|NCT02079636|593020546|FG012|Overall Study|Adverse Event|0|||
164179417|NCT02079636|593020547|FG013|Overall Study|Adverse Event|0|||
164179418|NCT02079636|593020548|FG014|Overall Study|Adverse Event|0|||
164179419|NCT02079636|593020534|FG000|Overall Study|Progressive disease|0|||
164179420|NCT02079636|593020535|FG001|Overall Study|Progressive disease|0|||
164179421|NCT02079636|593020536|FG002|Overall Study|Progressive disease|0|||
164179422|NCT02079636|593020537|FG003|Overall Study|Progressive disease|2|||
164179423|NCT02079636|593020538|FG004|Overall Study|Progressive disease|0|||
164179424|NCT02079636|593020539|FG005|Overall Study|Progressive disease|0|||
164179425|NCT02079636|593020540|FG006|Overall Study|Progressive disease|0|||
164179426|NCT02079636|593020541|FG007|Overall Study|Progressive disease|0|||
164179427|NCT02079636|593020542|FG008|Overall Study|Progressive disease|0|||
164179428|NCT02079636|593020543|FG009|Overall Study|Progressive disease|0|||
164179429|NCT02079636|593020544|FG010|Overall Study|Progressive disease|0|||
164179430|NCT02079636|593020545|FG011|Overall Study|Progressive disease|0|||
164179431|NCT02079636|593020546|FG012|Overall Study|Progressive disease|1|||
164179432|NCT02079636|593020547|FG013|Overall Study|Progressive disease|0|||
164179433|NCT02079636|593020548|FG014|Overall Study|Progressive disease|0|||
164179434|NCT02079636|593020534|FG000|Overall Study|Withdrawal by Subject|0|||
164179435|NCT02079636|593020535|FG001|Overall Study|Withdrawal by Subject|0|||
164179515|NCT01592292|593020559|FG002|Overall Study|Follow-up loss|1|||
164179436|NCT02079636|593020536|FG002|Overall Study|Withdrawal by Subject|0|||
164179437|NCT02079636|593020537|FG003|Overall Study|Withdrawal by Subject|4|||
164179438|NCT02079636|593020538|FG004|Overall Study|Withdrawal by Subject|0|||
164179439|NCT02079636|593020539|FG005|Overall Study|Withdrawal by Subject|1|||
164179440|NCT02079636|593020540|FG006|Overall Study|Withdrawal by Subject|0|||
164179441|NCT02079636|593020541|FG007|Overall Study|Withdrawal by Subject|0|||
164179442|NCT02079636|593020542|FG008|Overall Study|Withdrawal by Subject|0|||
164179443|NCT02079636|593020543|FG009|Overall Study|Withdrawal by Subject|2|||
164179444|NCT02079636|593020544|FG010|Overall Study|Withdrawal by Subject|1|||
164179445|NCT02079636|593020545|FG011|Overall Study|Withdrawal by Subject|1|||
164179446|NCT02079636|593020546|FG012|Overall Study|Withdrawal by Subject|1|||
164179447|NCT02079636|593020547|FG013|Overall Study|Withdrawal by Subject|0|||
164179448|NCT02079636|593020548|FG014|Overall Study|Withdrawal by Subject|2|||
164179449|NCT02079636|593020534|FG000|Overall Study|Physician Decision|0|||
164179450|NCT02079636|593020535|FG001|Overall Study|Physician Decision|0|||
164179451|NCT02079636|593020536|FG002|Overall Study|Physician Decision|0|||
164179452|NCT02079636|593020537|FG003|Overall Study|Physician Decision|0|||
164179453|NCT02079636|593020538|FG004|Overall Study|Physician Decision|0|||
164179454|NCT02079636|593020539|FG005|Overall Study|Physician Decision|1|||
164179455|NCT02079636|593020540|FG006|Overall Study|Physician Decision|0|||
164179456|NCT02079636|593020541|FG007|Overall Study|Physician Decision|0|||
164179457|NCT02079636|593020542|FG008|Overall Study|Physician Decision|0|||
164179458|NCT02079636|593020543|FG009|Overall Study|Physician Decision|1|||
164179459|NCT02079636|593020544|FG010|Overall Study|Physician Decision|1|||
164179460|NCT02079636|593020545|FG011|Overall Study|Physician Decision|0|||
164179461|NCT02079636|593020546|FG012|Overall Study|Physician Decision|0|||
164179462|NCT02079636|593020547|FG013|Overall Study|Physician Decision|0|||
164179463|NCT02079636|593020548|FG014|Overall Study|Physician Decision|1|||
164179464|NCT02079636|593020534|FG000|Overall Study|Lost to Follow-up|0|||
164179465|NCT02079636|593020535|FG001|Overall Study|Lost to Follow-up|0|||
164179466|NCT02079636|593020536|FG002|Overall Study|Lost to Follow-up|0|||
164179467|NCT02079636|593020537|FG003|Overall Study|Lost to Follow-up|0|||
164179468|NCT02079636|593020538|FG004|Overall Study|Lost to Follow-up|0|||
164179469|NCT02079636|593020539|FG005|Overall Study|Lost to Follow-up|0|||
164179470|NCT02079636|593020540|FG006|Overall Study|Lost to Follow-up|0|||
164179471|NCT02079636|593020541|FG007|Overall Study|Lost to Follow-up|1|||
164179472|NCT02079636|593020542|FG008|Overall Study|Lost to Follow-up|0|||
164179473|NCT02079636|593020543|FG009|Overall Study|Lost to Follow-up|0|||
164179474|NCT02079636|593020544|FG010|Overall Study|Lost to Follow-up|0|||
164179475|NCT02079636|593020545|FG011|Overall Study|Lost to Follow-up|0|||
164179476|NCT02079636|593020546|FG012|Overall Study|Lost to Follow-up|0|||
164179477|NCT02079636|593020547|FG013|Overall Study|Lost to Follow-up|0|||
164179478|NCT02079636|593020548|FG014|Overall Study|Lost to Follow-up|0|||
164179479|NCT00561470|593020549|FG000|Overall Study|Adverse Event|74|||
164179480|NCT00561470|593020550|FG001|Overall Study|Adverse Event|163|||
164179481|NCT00561470|593020549|FG000|Overall Study|Disease progression|437|||
164179482|NCT00561470|593020550|FG001|Overall Study|Disease progression|305|||
164179483|NCT00561470|593020549|FG000|Overall Study|poor compliance to protocol|4|||
164179484|NCT00561470|593020550|FG001|Overall Study|poor compliance to protocol|4|||
164179485|NCT00561470|593020549|FG000|Overall Study|Lost to Follow-up|2|||
164179486|NCT00561470|593020550|FG001|Overall Study|Lost to Follow-up|0|||
164179487|NCT00561470|593020549|FG000|Overall Study|Physician Decision|21|||
164179488|NCT00561470|593020550|FG001|Overall Study|Physician Decision|20|||
164179489|NCT00561470|593020549|FG000|Overall Study|Consent Withdrawn|2|||
164179490|NCT00561470|593020550|FG001|Overall Study|Consent Withdrawn|6|||
164179491|NCT00561470|593020549|FG000|Overall Study|Subject request|43|||
164179492|NCT00561470|593020550|FG001|Overall Study|Subject request|77|||
164179493|NCT00561470|593020549|FG000|Overall Study|Metastatic surgery|10|||
164179494|NCT00561470|593020550|FG001|Overall Study|Metastatic surgery|12|||
164179495|NCT00561470|593020549|FG000|Overall Study|Unauthorized procedure|3|||
164179496|NCT00561470|593020550|FG001|Overall Study|Unauthorized procedure|1|||
164179497|NCT00561470|593020549|FG000|Overall Study|Randomized but not treated|5|||
164179498|NCT00561470|593020550|FG001|Overall Study|Randomized but not treated|5|||
164179499|NCT00561470|593020549|FG000|Overall Study|Missed visit window|1|||
164179500|NCT00561470|593020550|FG001|Overall Study|Missed visit window|4|||
164179501|NCT00561470|593020549|FG000|Overall Study|Planning surgery|1|||
164179502|NCT00561470|593020550|FG001|Overall Study|Planning surgery|1|||
164179503|NCT00561470|593020549|FG000|Overall Study|Ongoing Treatment|11|||
164179504|NCT00561470|593020550|FG001|Overall Study|Ongoing Treatment|14|||
164179505|NCT00637806|593020551|FG000|Double-blind Phase|Study Discontinued|2|||
164179506|NCT00637806|593020552|FG001|Double-blind Phase|Study Discontinued|0|||
164179507|NCT00637806|593020553|FG002|Double-blind Phase|Study Discontinued|1|||
164179508|NCT00637806|593020554|FG003|Double-blind Phase|Study Discontinued|0|||
164179509|NCT00637806|593020551|FG000|Extension Phase|Study Discontinued|0|||
164179510|NCT00637806|593020552|FG001|Extension Phase|Study Discontinued|0|||
164179511|NCT00637806|593020553|FG002|Extension Phase|Study Discontinued|0|||
164179512|NCT00637806|593020554|FG003|Extension Phase|Study Discontinued|1|||
164179513|NCT01592292|593020557|FG000|Overall Study|Follow-up loss|3|||
164179514|NCT01592292|593020558|FG001|Overall Study|Follow-up loss|3|||
164179516|NCT01592292|593020560|FG003|Overall Study|Follow-up loss|0|||
164179517|NCT01592292|593020557|FG000|Overall Study|Withdrew consent|2|||
164179518|NCT01592292|593020558|FG001|Overall Study|Withdrew consent|1|||
164179519|NCT01592292|593020559|FG002|Overall Study|Withdrew consent|0|||
164179520|NCT01592292|593020560|FG003|Overall Study|Withdrew consent|0|||
164179521|NCT01592292|593020557|FG000|Overall Study|Other|1|||
164179522|NCT01592292|593020558|FG001|Overall Study|Other|1|||
164179523|NCT01592292|593020559|FG002|Overall Study|Other|2|||
164179524|NCT01592292|593020560|FG003|Overall Study|Other|1|||
164179525|NCT02923245|593020562|FG000|Overall Study|ultrasound order was cancelled|2|||
164179526|NCT02923245|593020563|FG001|Overall Study|ultrasound order was cancelled|1|||
164179527|NCT02680834|593020564|FG000|Overall Study|Physician Decision|5|||
164179528|NCT02680834|593020565|FG001|Overall Study|Physician Decision|2|||
164179529|NCT02680834|593020564|FG000|Overall Study|Withdrawal by Subject|6|||
164179530|NCT02680834|593020565|FG001|Overall Study|Withdrawal by Subject|0|||
164179531|NCT02680834|593020564|FG000|Overall Study|Lost to Follow-up|0|||
164179532|NCT02680834|593020565|FG001|Overall Study|Lost to Follow-up|1|||
164179533|NCT01712334|593020569|FG000|Treatment Period 1|Randomized in Error|0|||
164179534|NCT01712334|593020570|FG001|Treatment Period 1|Randomized in Error|2|||
164179535|NCT00232596|593020571|FG000|6-Week Titration Phase|Adverse Event|6|||
164179536|NCT00232596|593020572|FG001|6-Week Titration Phase|Adverse Event|19|||
164179537|NCT00232596|593020571|FG000|6-Week Titration Phase|Failed to Return|2|||
164179538|NCT00232596|593020572|FG001|6-Week Titration Phase|Failed to Return|1|||
164179539|NCT00232596|593020571|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
164179540|NCT00232596|593020572|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
164179541|NCT00232596|593020571|FG000|6-Week Titration Phase|Protocol Violation|1|||
164179542|NCT00232596|593020572|FG001|6-Week Titration Phase|Protocol Violation|3|||
164179543|NCT00232596|593020571|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
164179544|NCT00232596|593020572|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
164179545|NCT00232596|593020571|FG000|6-Week Titration Phase|Other|3|||
164179546|NCT00232596|593020572|FG001|6-Week Titration Phase|Other|3|||
164179547|NCT00232596|593020571|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
164179548|NCT00232596|593020572|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
164179549|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Adverse Event|7|||
164179550|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Adverse Event|22|||
164179551|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
164179552|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
164179553|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
164179554|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
164179555|NCT00232596|593020571|FG000|12-Week Maintenance Phase|Other|1|||
164179556|NCT00232596|593020572|FG001|12-Week Maintenance Phase|Other|3|||
164179557|NCT02637713|593020573|FG000|Overall Study|Screen Failure|2|||
164179558|NCT04102865|593020576|FG000|Overall Study|Adverse Event|4|||
164179559|NCT04102865|593020577|FG001|Overall Study|Adverse Event|0|||
164179560|NCT04102865|593020576|FG000|Overall Study|Lost to Follow-up|1|||
164179561|NCT04102865|593020577|FG001|Overall Study|Lost to Follow-up|0|||
164179562|NCT04102865|593020576|FG000|Overall Study|Withdrawal by Subject|2|||
164179563|NCT04102865|593020577|FG001|Overall Study|Withdrawal by Subject|0|||
164179564|NCT01764997|593020582|FG000|Run-in Period|Adverse Event|15|||
164179565|NCT01764997|593020583|FG001|Run-in Period|Adverse Event|0|||
164179566|NCT01764997|593020584|FG002|Run-in Period|Adverse Event|0|||
164179567|NCT01764997|593020585|FG003|Run-in Period|Adverse Event|0|||
164179568|NCT01764997|593020586|FG004|Run-in Period|Adverse Event|0|||
164179569|NCT01764997|593020582|FG000|Run-in Period|Lack of Efficacy|5|||
164179570|NCT01764997|593020583|FG001|Run-in Period|Lack of Efficacy|0|||
164179571|NCT01764997|593020584|FG002|Run-in Period|Lack of Efficacy|0|||
164179572|NCT01764997|593020585|FG003|Run-in Period|Lack of Efficacy|0|||
164179573|NCT01764997|593020586|FG004|Run-in Period|Lack of Efficacy|0|||
164179574|NCT01764997|593020582|FG000|Run-in Period|Poor compliance to protocol|1|||
164179575|NCT01764997|593020583|FG001|Run-in Period|Poor compliance to protocol|0|||
164179576|NCT01764997|593020584|FG002|Run-in Period|Poor compliance to protocol|0|||
164179577|NCT01764997|593020585|FG003|Run-in Period|Poor compliance to protocol|0|||
164179578|NCT01764997|593020586|FG004|Run-in Period|Poor compliance to protocol|0|||
164179579|NCT01764997|593020582|FG000|Run-in Period|Other than specified above|17|||
164179580|NCT01764997|593020583|FG001|Run-in Period|Other than specified above|0|||
164179581|NCT01764997|593020584|FG002|Run-in Period|Other than specified above|0|||
164179582|NCT01764997|593020585|FG003|Run-in Period|Other than specified above|0|||
164179583|NCT01764997|593020586|FG004|Run-in Period|Other than specified above|0|||
164179584|NCT01764997|593020582|FG000|Study Drug Treatment Period|Adverse Event|0|||
164179585|NCT01764997|593020583|FG001|Study Drug Treatment Period|Adverse Event|1|||
164179586|NCT01764997|593020584|FG002|Study Drug Treatment Period|Adverse Event|0|||
164179587|NCT01764997|593020585|FG003|Study Drug Treatment Period|Adverse Event|0|||
164179588|NCT01764997|593020586|FG004|Study Drug Treatment Period|Adverse Event|24|||
164179589|NCT01764997|593020582|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
164179590|NCT01764997|593020583|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
164179591|NCT01764997|593020584|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
164179592|NCT01764997|593020585|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
164179593|NCT01764997|593020586|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
164179594|NCT01764997|593020582|FG000|Study Drug Treatment Period|Other than specified above|0|||
164179595|NCT01764997|593020583|FG001|Study Drug Treatment Period|Other than specified above|0|||
164179596|NCT01764997|593020584|FG002|Study Drug Treatment Period|Other than specified above|0|||
164179597|NCT01764997|593020585|FG003|Study Drug Treatment Period|Other than specified above|0|||
164179598|NCT01764997|593020586|FG004|Study Drug Treatment Period|Other than specified above|10|||
164179599|NCT02093390|593020589|FG000|Overall Study|Withdrawal by Subject|0|||
164179600|NCT02093390|593020590|FG001|Overall Study|Withdrawal by Subject|1|||
164179601|NCT00073983|593020591|FG000|Overall Study|not evaluable|1|||
164179602|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
164179603|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
164179604|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
164179605|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
164179606|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
164179607|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
164179608|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
164179609|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
164179610|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
164179611|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
164179612|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
164179613|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
164179614|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
164179615|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
164179616|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
164179617|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
164179618|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
164179619|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
164179620|NCT02294461|593020594|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
164179621|NCT02294461|593020595|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
164179622|NCT02294461|593020596|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
164179623|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
164179624|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
164179625|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
164179626|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
164179627|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
164179628|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
164179629|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
164179630|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
164179631|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
164179632|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
164179633|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
164179634|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
164179635|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
164179636|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
164179637|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
164179638|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
164179639|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
164179640|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
164179641|NCT02294461|593020594|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
164179642|NCT02294461|593020595|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
164179643|NCT02294461|593020596|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
164179644|NCT03800836|593020597|FG000|Overall Study|Other|2|||
164179645|NCT03800836|593020598|FG001|Overall Study|Other|1|||
164179646|NCT03800836|593020599|FG002|Overall Study|Other|0|||
164179647|NCT03800836|593020600|FG003|Overall Study|Other|2|||
164179648|NCT03800836|593020601|FG004|Overall Study|Other|0|||
164179649|NCT03800836|593020602|FG005|Overall Study|Other|1|||
164179650|NCT03800836|593020597|FG000|Overall Study|Lost to Follow-up|2|||
164179651|NCT03800836|593020598|FG001|Overall Study|Lost to Follow-up|0|||
164179652|NCT03800836|593020599|FG002|Overall Study|Lost to Follow-up|1|||
164179653|NCT03800836|593020600|FG003|Overall Study|Lost to Follow-up|1|||
164179654|NCT03800836|593020601|FG004|Overall Study|Lost to Follow-up|3|||
164179655|NCT03800836|593020602|FG005|Overall Study|Lost to Follow-up|0|||
164179656|NCT03800836|593020597|FG000|Overall Study|Withdrawal by Subject|1|||
164179657|NCT03800836|593020598|FG001|Overall Study|Withdrawal by Subject|0|||
164179658|NCT03800836|593020599|FG002|Overall Study|Withdrawal by Subject|0|||
164179659|NCT03800836|593020600|FG003|Overall Study|Withdrawal by Subject|0|||
164179660|NCT03800836|593020601|FG004|Overall Study|Withdrawal by Subject|0|||
164179661|NCT03800836|593020602|FG005|Overall Study|Withdrawal by Subject|0|||
164179662|NCT03800836|593020597|FG000|Overall Study|Physician Decision|31|||
164179663|NCT03800836|593020598|FG001|Overall Study|Physician Decision|3|||
164179664|NCT03800836|593020599|FG002|Overall Study|Physician Decision|6|||
164179665|NCT03800836|593020600|FG003|Overall Study|Physician Decision|4|||
164179666|NCT03800836|593020601|FG004|Overall Study|Physician Decision|4|||
164179667|NCT03800836|593020602|FG005|Overall Study|Physician Decision|5|||
164179668|NCT03800836|593020597|FG000|Overall Study|Death|34|||
164179669|NCT03800836|593020598|FG001|Overall Study|Death|16|||
164179670|NCT03800836|593020599|FG002|Overall Study|Death|5|||
164179671|NCT03800836|593020600|FG003|Overall Study|Death|5|||
164179672|NCT03800836|593020601|FG004|Overall Study|Death|10|||
164179673|NCT03800836|593020602|FG005|Overall Study|Death|0|||
164179674|NCT03800836|593020597|FG000|Overall Study|Symptomatic Deterioration|1|||
164179675|NCT03800836|593020598|FG001|Overall Study|Symptomatic Deterioration|0|||
164179676|NCT03800836|593020599|FG002|Overall Study|Symptomatic Deterioration|1|||
164179677|NCT03800836|593020600|FG003|Overall Study|Symptomatic Deterioration|0|||
164179678|NCT03800836|593020601|FG004|Overall Study|Symptomatic Deterioration|0|||
164179679|NCT03800836|593020602|FG005|Overall Study|Symptomatic Deterioration|0|||
164179680|NCT03341936|593023028|FG000|Overall Study|Ineligible|1|||
164179681|NCT03341936|593023028|FG000|Overall Study|Disease Progression|2|||
164179682|NCT03341936|593023028|FG000|Overall Study|Withdrew Consent|4|||
164179683|NCT03341936|593023028|FG000|Overall Study|Non-Compliance|1|||
164179684|NCT03341936|593023028|FG000|Overall Study|Physician Decision|1|||
164179685|NCT03341936|593023028|FG000|Overall Study|Withdrawal by Subject|1|||
164179686|NCT03341936|593023028|FG000|Overall Study|Other|1|||
164179687|NCT04849416|593023029|FG000|Overall Study|Ongoing Treatment|12|||
164179688|NCT04849416|593023030|FG001|Overall Study|Ongoing Treatment|5|||
164179689|NCT04849416|593023031|FG002|Overall Study|Ongoing Treatment|3|||
164179690|NCT04849416|593023029|FG000|Overall Study|On Post-Treatment Follow-up|8|||
164179691|NCT04849416|593023030|FG001|Overall Study|On Post-Treatment Follow-up|9|||
164179692|NCT04849416|593023031|FG002|Overall Study|On Post-Treatment Follow-up|10|||
164179693|NCT04849416|593023029|FG000|Overall Study|Withdrawal by Subject|0|||
164179694|NCT04849416|593023030|FG001|Overall Study|Withdrawal by Subject|0|||
164179695|NCT04849416|593023031|FG002|Overall Study|Withdrawal by Subject|1|||
164179696|NCT04849416|593023029|FG000|Overall Study|Lost to Follow-up|1|||
164179697|NCT04849416|593023030|FG001|Overall Study|Lost to Follow-up|0|||
164179698|NCT04849416|593023031|FG002|Overall Study|Lost to Follow-up|0|||
164179699|NCT04529850|593023032|FG000|Overall Study|Death|2|||
164179700|NCT04529850|593023032|FG000|Overall Study|Physician Decision|1|||
164179701|NCT04529850|593023032|FG000|Overall Study|Withdrawal by Subject|2|||
164179702|NCT00593606|593023033|FG000|Overall Study|Adverse Event|13|||
164179703|NCT00593606|593023033|FG000|Overall Study|Withdrawal by Subject|1|||
164179704|NCT00593606|593023033|FG000|Overall Study|Protocol Violation|3|||
164179705|NCT00593606|593023033|FG000|Overall Study|Lost to Follow-up|2|||
164179706|NCT00593606|593023033|FG000|Overall Study|Run-In Failure|5|||
164179707|NCT00593606|593023033|FG000|Overall Study|Screen Failure|3|||
164179708|NCT00869557|593023036|FG000|Randomized Phase|Lost to Follow-up|2|||
164179709|NCT00869557|593023037|FG001|Randomized Phase|Lost to Follow-up|1|||
164179710|NCT00869557|593023036|FG000|Randomized Phase|Investigator's Discretion|1|||
164179711|NCT00869557|593023037|FG001|Randomized Phase|Investigator's Discretion|0|||
164179712|NCT00869557|593023036|FG000|Randomized Phase|Withdrew Consent|0|||
164179713|NCT00869557|593023037|FG001|Randomized Phase|Withdrew Consent|1|||
164179714|NCT00869557|593023036|FG000|Extension Phase|Adverse Event|2|||
164179715|NCT00869557|593023037|FG001|Extension Phase|Adverse Event|2|||
164179716|NCT00869557|593023036|FG000|Extension Phase|Lack of Efficacy|1|||
164179717|NCT00869557|593023037|FG001|Extension Phase|Lack of Efficacy|0|||
164179718|NCT00869557|593023036|FG000|Extension Phase|Lost to Follow-up|3|||
164179719|NCT00869557|593023037|FG001|Extension Phase|Lost to Follow-up|1|||
164179720|NCT00869557|593023036|FG000|Extension Phase|Investigator's Discretion|2|||
164179721|NCT00869557|593023037|FG001|Extension Phase|Investigator's Discretion|0|||
164179722|NCT00869557|593023036|FG000|Extension Phase|Withdrew Consent|2|||
164179723|NCT00869557|593023037|FG001|Extension Phase|Withdrew Consent|0|||
164179724|NCT01472939|593023038|FG000|Overall Study|Adverse Event|3|||
164179725|NCT01472939|593023039|FG001|Overall Study|Adverse Event|7|||
164179726|NCT01472939|593023040|FG002|Overall Study|Adverse Event|7|||
164179727|NCT01472939|593023041|FG003|Overall Study|Adverse Event|14|||
164179728|NCT01472939|593023038|FG000|Overall Study|Lack of Efficacy|1|||
164179729|NCT01472939|593023039|FG001|Overall Study|Lack of Efficacy|0|||
164179730|NCT01472939|593023040|FG002|Overall Study|Lack of Efficacy|0|||
164179731|NCT01472939|593023041|FG003|Overall Study|Lack of Efficacy|1|||
164179732|NCT01472939|593023038|FG000|Overall Study|Lost to Follow-up|3|||
164179733|NCT01472939|593023039|FG001|Overall Study|Lost to Follow-up|0|||
164179734|NCT01472939|593023040|FG002|Overall Study|Lost to Follow-up|2|||
164179735|NCT01472939|593023041|FG003|Overall Study|Lost to Follow-up|0|||
164179736|NCT01472939|593023038|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
164179737|NCT01472939|593023039|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
164179738|NCT01472939|593023040|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
164179739|NCT01472939|593023041|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
164179740|NCT01472939|593023038|FG000|Overall Study|Prohibited Medication|0|||
164179741|NCT01472939|593023039|FG001|Overall Study|Prohibited Medication|1|||
164179742|NCT01472939|593023040|FG002|Overall Study|Prohibited Medication|0|||
164179743|NCT01472939|593023041|FG003|Overall Study|Prohibited Medication|0|||
164179744|NCT01472939|593023038|FG000|Overall Study|Withdrawal By PI|1|||
164179745|NCT01472939|593023039|FG001|Overall Study|Withdrawal By PI|0|||
164179746|NCT01472939|593023040|FG002|Overall Study|Withdrawal By PI|0|||
164179747|NCT01472939|593023041|FG003|Overall Study|Withdrawal By PI|0|||
164179748|NCT01472939|593023038|FG000|Overall Study|Protocol Violation|3|||
164179749|NCT01472939|593023039|FG001|Overall Study|Protocol Violation|3|||
164179750|NCT01472939|593023040|FG002|Overall Study|Protocol Violation|0|||
164179751|NCT01472939|593023041|FG003|Overall Study|Protocol Violation|1|||
164179752|NCT01472939|593023038|FG000|Overall Study|Withdrawal by Subject|9|||
164179753|NCT01472939|593023039|FG001|Overall Study|Withdrawal by Subject|3|||
164179754|NCT01472939|593023040|FG002|Overall Study|Withdrawal by Subject|1|||
164179755|NCT01472939|593023041|FG003|Overall Study|Withdrawal by Subject|4|||
164179756|NCT00114738|593023042|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
164179757|NCT00114738|593023043|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
164179758|NCT00114738|593023044|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
164179759|NCT00114738|593023042|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
164179760|NCT00114738|593023043|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
164179761|NCT00114738|593023044|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
164179762|NCT00114738|593023042|FG000|Screening for Randomization|Neuropathy|17|||
164179763|NCT00114738|593023043|FG001|Screening for Randomization|Neuropathy|0|||
164179764|NCT00114738|593023044|FG002|Screening for Randomization|Neuropathy|0|||
164179765|NCT00114738|593023042|FG000|Screening for Randomization|Progressive disease|2|||
164179766|NCT00114738|593023043|FG001|Screening for Randomization|Progressive disease|0|||
164179767|NCT00114738|593023044|FG002|Screening for Randomization|Progressive disease|0|||
164179768|NCT00114738|593023042|FG000|Screening for Randomization|CNS Hemorrhage|1|||
164179769|NCT00114738|593023043|FG001|Screening for Randomization|CNS Hemorrhage|0|||
164179770|NCT00114738|593023044|FG002|Screening for Randomization|CNS Hemorrhage|0|||
164179771|NCT00114738|593023042|FG000|Screening for Randomization|Other|1|||
164179772|NCT00114738|593023043|FG001|Screening for Randomization|Other|0|||
164179773|NCT00114738|593023044|FG002|Screening for Randomization|Other|0|||
164179774|NCT05940077|593023045|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
164179775|NCT01492101|593023046|FG000|Overall Study|Death|323|||
164179776|NCT01492101|593023047|FG001|Overall Study|Death|322|||
164179777|NCT01492101|593023046|FG000|Overall Study|Withdrawal by Subject|14|||
164179778|NCT01492101|593023047|FG001|Overall Study|Withdrawal by Subject|18|||
164179779|NCT01492101|593023046|FG000|Overall Study|Lost to Follow-up|0|||
164179780|NCT01492101|593023047|FG001|Overall Study|Lost to Follow-up|2|||
164179781|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
164179782|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179783|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179784|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179785|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
164179786|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
164179787|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179788|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179789|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179790|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
164179791|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
164179792|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179793|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179794|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179795|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
164179796|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
164179797|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179798|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179799|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179800|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
164179801|NCT01004432|593023048|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
164179802|NCT01004432|593023049|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179803|NCT01004432|593023050|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179804|NCT01004432|593023051|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179805|NCT01004432|593023052|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
164179806|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
164179807|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
164179808|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
164179955|NCT03114657|593023095|FG000|Overall Study|Death|4|||
164179809|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
164179810|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
164179811|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
164179812|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
164179813|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
164179814|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
164179815|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
164179816|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
164179817|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
164179818|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
164179819|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
164179820|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
164179821|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179822|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179823|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179824|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
164179825|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
164179826|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
164179827|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
164179828|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
164179829|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
164179830|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
164179831|NCT01004432|593023048|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
164179832|NCT01004432|593023049|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
164179833|NCT01004432|593023050|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
164179834|NCT01004432|593023051|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
164179835|NCT01004432|593023052|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
164179836|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179837|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179838|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179839|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
164179840|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
164179841|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179842|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179843|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179844|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
164179845|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
164179846|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179847|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179848|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179849|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
164179850|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
164179851|NCT01004432|593023048|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179852|NCT01004432|593023049|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179853|NCT01004432|593023050|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179854|NCT01004432|593023051|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
164179855|NCT01004432|593023052|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
164179856|NCT01149421|593023054|FG000|Overall Study|Adverse Event|22|||
164179857|NCT01149421|593023055|FG001|Overall Study|Adverse Event|6|||
164179858|NCT01149421|593023056|FG002|Overall Study|Adverse Event|11|||
164179859|NCT01149421|593023054|FG000|Overall Study|Withdrawal by Subject|20|||
164179860|NCT01149421|593023055|FG001|Overall Study|Withdrawal by Subject|12|||
164179861|NCT01149421|593023056|FG002|Overall Study|Withdrawal by Subject|13|||
164179862|NCT01149421|593023054|FG000|Overall Study|Sponsor Decision|0|||
164179863|NCT01149421|593023055|FG001|Overall Study|Sponsor Decision|1|||
164179864|NCT01149421|593023056|FG002|Overall Study|Sponsor Decision|1|||
164179865|NCT01149421|593023054|FG000|Overall Study|Lost to Follow-up|2|||
164179866|NCT01149421|593023055|FG001|Overall Study|Lost to Follow-up|4|||
164179867|NCT01149421|593023056|FG002|Overall Study|Lost to Follow-up|5|||
164179868|NCT01149421|593023054|FG000|Overall Study|Physician Decision|5|||
164179869|NCT01149421|593023055|FG001|Overall Study|Physician Decision|3|||
164179870|NCT01149421|593023056|FG002|Overall Study|Physician Decision|6|||
164179871|NCT01149421|593023054|FG000|Overall Study|Entry Criteria Not Met|1|||
164179872|NCT01149421|593023055|FG001|Overall Study|Entry Criteria Not Met|1|||
164179873|NCT01149421|593023056|FG002|Overall Study|Entry Criteria Not Met|2|||
164179874|NCT01149421|593023054|FG000|Overall Study|Protocol Violation|2|||
164179875|NCT01149421|593023055|FG001|Overall Study|Protocol Violation|2|||
164179876|NCT01149421|593023056|FG002|Overall Study|Protocol Violation|6|||
164179877|NCT03738800|593023059|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
164179878|NCT03738800|593023060|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
164179879|NCT03738800|593023061|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
164179880|NCT03738800|593023059|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
164179881|NCT03738800|593023060|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
164179882|NCT03738800|593023061|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
164179883|NCT03738800|593023059|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
164179884|NCT03738800|593023060|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
164179885|NCT03738800|593023061|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
164179886|NCT02719353|593023062|FG000|First Intervention|Physician Decision|0|||
164179887|NCT02719353|593023063|FG001|First Intervention|Physician Decision|1|||
164179888|NCT02223819|593023067|FG000|Overall Study|Lost to Follow-up|2|||
164179889|NCT01917344|593023069|FG000|Overall Study|Withdrawal by Subject|1|||
164179890|NCT03435224|593023070|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
164179891|NCT00367484|593023071|FG000|Overall Study|Adverse Event|7|||
164179892|NCT00367484|593023071|FG000|Overall Study|Withdrew informed consent|5|||
164179893|NCT00367484|593023071|FG000|Overall Study|Travel to USA|1|||
164179894|NCT00367484|593023071|FG000|Overall Study|Lost to Follow-up|1|||
164179895|NCT00367484|593023071|FG000|Overall Study|Protocol Violation|1|||
164179896|NCT00367484|593023071|FG000|Overall Study|The choice of the patient|1|||
164179897|NCT00367484|593023071|FG000|Overall Study|Lack of Efficacy|1|||
164179898|NCT00412217|593023072|FG000|Overall Study|Insufficient Data Available|8|||
164179899|NCT00412217|593023073|FG001|Overall Study|Insufficient Data Available|3|||
164179900|NCT00412217|593023072|FG000|Overall Study|Death|5|||
164179901|NCT00412217|593023073|FG001|Overall Study|Death|4|||
164179902|NCT00412217|593023072|FG000|Overall Study|Disease Progression|2|||
164179903|NCT00412217|593023073|FG001|Overall Study|Disease Progression|3|||
164179904|NCT00412217|593023072|FG000|Overall Study|Investigator Decision|1|||
164179905|NCT00412217|593023073|FG001|Overall Study|Investigator Decision|0|||
164179906|NCT00412217|593023072|FG000|Overall Study|Withdrawal by Subject|2|||
164179907|NCT00412217|593023073|FG001|Overall Study|Withdrawal by Subject|0|||
164179908|NCT00412217|593023072|FG000|Overall Study|Lost to Follow-up|1|||
164179909|NCT00412217|593023073|FG001|Overall Study|Lost to Follow-up|4|||
164179910|NCT00412217|593023072|FG000|Overall Study|Study Terminated by Sponsor|26|||
164179911|NCT00412217|593023073|FG001|Overall Study|Study Terminated by Sponsor|33|||
164179912|NCT00412217|593023072|FG000|Overall Study|Other|1|||
164179913|NCT00412217|593023073|FG001|Overall Study|Other|1|||
164179914|NCT01777295|593023074|FG000|Overall Study|Withdrawal by Subject|2|||
164179915|NCT01777295|593023075|FG001|Overall Study|Withdrawal by Subject|2|||
164179916|NCT01777295|593023074|FG000|Overall Study|Pregnancy|0|||
164179917|NCT01777295|593023075|FG001|Overall Study|Pregnancy|1|||
164179918|NCT01777295|593023074|FG000|Overall Study|Personal problem|1|||
164179919|NCT01777295|593023075|FG001|Overall Study|Personal problem|0|||
164179920|NCT01777295|593023074|FG000|Overall Study|Investigator call for AEs check|1|||
164179921|NCT01777295|593023075|FG001|Overall Study|Investigator call for AEs check|0|||
164179922|NCT02609724|593023076|FG000|Overall Study|Death|2|||
164179923|NCT02609724|593023077|FG001|Overall Study|Death|0|||
164179924|NCT02609724|593023078|FG002|Overall Study|Death|1|||
164179925|NCT02609724|593023076|FG000|Overall Study|Withdrawal by Subject|1|||
164179926|NCT02609724|593023077|FG001|Overall Study|Withdrawal by Subject|2|||
164179927|NCT02609724|593023078|FG002|Overall Study|Withdrawal by Subject|3|||
164179928|NCT02609724|593023076|FG000|Overall Study|Illness|2|||
164179929|NCT02609724|593023077|FG001|Overall Study|Illness|1|||
164179930|NCT02609724|593023078|FG002|Overall Study|Illness|0|||
164179931|NCT04007107|593023083|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
164179932|NCT04007107|593023084|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
164179933|NCT04007107|593023085|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
164179934|NCT04007107|593023086|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
164179935|NCT00426660|593023092|FG000|Overall Study|Death|14|||
164179936|NCT00426660|593023092|FG000|Overall Study|Adverse Event|23|||
164179937|NCT00426660|593023092|FG000|Overall Study|Insufficient Clinical Response|22|||
164179938|NCT00426660|593023092|FG000|Overall Study|Lost to Follow-up|15|||
164179939|NCT00426660|593023092|FG000|Overall Study|Other|23|||
164179940|NCT00426660|593023092|FG000|Overall Study|Withdrawal by Subject|18|||
164179941|NCT00426660|593023092|FG000|Overall Study|Protocol Violation|1|||
164179942|NCT00426660|593023092|FG000|Overall Study|Enrolled Not Treated|15|||
164179943|NCT00980174|593023093|FG000|Overall Study|Withdrawal by Subject|1|||
164179944|NCT00980174|593023094|FG001|Overall Study|Withdrawal by Subject|4|||
164179945|NCT00980174|593023093|FG000|Overall Study|Adverse Event|0|||
164179946|NCT00980174|593023094|FG001|Overall Study|Adverse Event|3|||
164179947|NCT00980174|593023093|FG000|Overall Study|Ineligibility determined|2|||
164179948|NCT00980174|593023094|FG001|Overall Study|Ineligibility determined|1|||
164179949|NCT00980174|593023093|FG000|Overall Study|Death|1|||
164179950|NCT00980174|593023094|FG001|Overall Study|Death|1|||
164179951|NCT00980174|593023093|FG000|Overall Study|Other|0|||
164179952|NCT00980174|593023094|FG001|Overall Study|Other|1|||
164179953|NCT03114657|593023095|FG000|Overall Study|Adverse Event|9|||
164179954|NCT03114657|593023096|FG001|Overall Study|Adverse Event|6|||
164179956|NCT03114657|593023096|FG001|Overall Study|Death|0|||
164179957|NCT03114657|593023095|FG000|Overall Study|Multiple Reasons|1|||
164179958|NCT03114657|593023096|FG001|Overall Study|Multiple Reasons|2|||
164179959|NCT03114657|593023095|FG000|Overall Study|Physician Decision|2|||
164179960|NCT03114657|593023096|FG001|Overall Study|Physician Decision|2|||
164179961|NCT03114657|593023095|FG000|Overall Study|Study Terminated By Sponsor|355|||
164179962|NCT03114657|593023096|FG001|Overall Study|Study Terminated By Sponsor|374|||
164179963|NCT03114657|593023095|FG000|Overall Study|Symptomatic Deterioration|0|||
164179964|NCT03114657|593023096|FG001|Overall Study|Symptomatic Deterioration|1|||
164179965|NCT03114657|593023095|FG000|Overall Study|Withdrawal by Subject|28|||
164179966|NCT03114657|593023096|FG001|Overall Study|Withdrawal by Subject|22|||
164179967|NCT01546038|593023097|FG000|Overall Study|Death|15|||
164179968|NCT01546038|593023098|FG001|Overall Study|Death|6|||
164179969|NCT01546038|593023099|FG002|Overall Study|Death|4|||
164179970|NCT01546038|593023100|FG003|Overall Study|Death|2|||
164179971|NCT01546038|593023101|FG004|Overall Study|Death|9|||
164179972|NCT01546038|593023102|FG005|Overall Study|Death|3|||
164179973|NCT01546038|593023103|FG006|Overall Study|Death|46|||
164179974|NCT01546038|593023104|FG007|Overall Study|Death|76|||
164179975|NCT01546038|593023105|FG008|Overall Study|Death|39|||
164179976|NCT01546038|593023097|FG000|Overall Study|Lost to Follow-up|0|||
164179977|NCT01546038|593023098|FG001|Overall Study|Lost to Follow-up|0|||
164179978|NCT01546038|593023099|FG002|Overall Study|Lost to Follow-up|0|||
164179979|NCT01546038|593023100|FG003|Overall Study|Lost to Follow-up|0|||
164179980|NCT01546038|593023101|FG004|Overall Study|Lost to Follow-up|1|||
164179981|NCT01546038|593023102|FG005|Overall Study|Lost to Follow-up|0|||
164179982|NCT01546038|593023103|FG006|Overall Study|Lost to Follow-up|2|||
164179983|NCT01546038|593023104|FG007|Overall Study|Lost to Follow-up|1|||
164179984|NCT01546038|593023105|FG008|Overall Study|Lost to Follow-up|0|||
164179985|NCT01546038|593023097|FG000|Overall Study|Withdrawal by Subject|1|||
164179986|NCT01546038|593023098|FG001|Overall Study|Withdrawal by Subject|0|||
164179987|NCT01546038|593023099|FG002|Overall Study|Withdrawal by Subject|0|||
164179988|NCT01546038|593023100|FG003|Overall Study|Withdrawal by Subject|1|||
164179989|NCT01546038|593023101|FG004|Overall Study|Withdrawal by Subject|0|||
164179990|NCT01546038|593023102|FG005|Overall Study|Withdrawal by Subject|1|||
164179991|NCT01546038|593023103|FG006|Overall Study|Withdrawal by Subject|3|||
164179992|NCT01546038|593023104|FG007|Overall Study|Withdrawal by Subject|3|||
164179993|NCT01546038|593023105|FG008|Overall Study|Withdrawal by Subject|1|||
164179994|NCT01546038|593023097|FG000|Overall Study|: Randomized, not treated|0|||
164179995|NCT01546038|593023098|FG001|Overall Study|: Randomized, not treated|0|||
164179996|NCT01546038|593023099|FG002|Overall Study|: Randomized, not treated|0|||
164179997|NCT01546038|593023100|FG003|Overall Study|: Randomized, not treated|0|||
164179998|NCT01546038|593023101|FG004|Overall Study|: Randomized, not treated|0|||
164179999|NCT01546038|593023102|FG005|Overall Study|: Randomized, not treated|0|||
164180000|NCT01546038|593023103|FG006|Overall Study|: Randomized, not treated|2|||
164180001|NCT01546038|593023104|FG007|Overall Study|: Randomized, not treated|4|||
164180002|NCT01546038|593023105|FG008|Overall Study|: Randomized, not treated|3|||
164180003|NCT04245202|593023106|FG000|Overall Study|Lack of Efficacy|10|||
164180004|NCT04245202|593023107|FG001|Overall Study|Lack of Efficacy|1|||
164180005|NCT02470403|593023108|FG000|Overall Study|Adverse Event|1|||
164180006|NCT02470403|593023109|FG001|Overall Study|Adverse Event|0|||
164180007|NCT02470403|593023110|FG002|Overall Study|Adverse Event|0|||
164180008|NCT02470403|593023111|FG003|Overall Study|Adverse Event|0|||
164180009|NCT02470403|593023112|FG004|Overall Study|Adverse Event|0|||
164180010|NCT02470403|593023108|FG000|Overall Study|Lost to Follow-up|0|||
164180011|NCT02470403|593023109|FG001|Overall Study|Lost to Follow-up|1|||
164180012|NCT02470403|593023110|FG002|Overall Study|Lost to Follow-up|0|||
164180013|NCT02470403|593023111|FG003|Overall Study|Lost to Follow-up|0|||
164180014|NCT02470403|593023112|FG004|Overall Study|Lost to Follow-up|0|||
164180015|NCT02470403|593023108|FG000|Overall Study|Subject/guardian decision|1|||
164180016|NCT02470403|593023109|FG001|Overall Study|Subject/guardian decision|0|||
164180017|NCT02470403|593023110|FG002|Overall Study|Subject/guardian decision|0|||
164180018|NCT02470403|593023111|FG003|Overall Study|Subject/guardian decision|4|||
164180019|NCT02470403|593023112|FG004|Overall Study|Subject/guardian decision|0|||
164180020|NCT02631070|593023113|FG000|Overall Study|Withdrawal by Subject|35|||
164180021|NCT02631070|593023114|FG001|Overall Study|Withdrawal by Subject|13|||
164180022|NCT02631070|593023113|FG000|Overall Study|Death|45|||
164180023|NCT02631070|593023114|FG001|Overall Study|Death|24|||
164180024|NCT02631070|593023113|FG000|Overall Study|Lost to Follow-up|5|||
164180025|NCT02631070|593023114|FG001|Overall Study|Lost to Follow-up|1|||
164180026|NCT02631070|593023113|FG000|Overall Study|Transition to rollover protocol|52|||
164180027|NCT02631070|593023114|FG001|Overall Study|Transition to rollover protocol|21|||
164180028|NCT02631070|593023113|FG000|Overall Study|Other reasons|12|||
164180029|NCT02631070|593023114|FG001|Overall Study|Other reasons|5|||
164180030|NCT01522235|593023117|FG000|Overall Study|Physician Decision|1|||
164180031|NCT01522235|593023118|FG001|Overall Study|Physician Decision|1|||
164180032|NCT00312572|593023119|FG000|Overall Study|Adverse Event|10|||
164180033|NCT00312572|593023120|FG001|Overall Study|Adverse Event|16|||
164180034|NCT00312572|593023119|FG000|Overall Study|Lost to Follow-up|1|||
164180035|NCT00312572|593023120|FG001|Overall Study|Lost to Follow-up|1|||
164180036|NCT00312572|593023119|FG000|Overall Study|Administrative|4|||
164180037|NCT00312572|593023120|FG001|Overall Study|Administrative|2|||
164180038|NCT00312572|593023119|FG000|Overall Study|Lack of Efficacy|1|||
164180039|NCT00312572|593023120|FG001|Overall Study|Lack of Efficacy|2|||
164180040|NCT05385224|593023121|FG000|Overall Study|Unable to swallow capsule|2|||
164180041|NCT05385224|593023121|FG000|Overall Study|Withdrawal by Subject|2|||
164180042|NCT05385224|593023121|FG000|Overall Study|Did not meet study criteria|1|||
164180043|NCT04521114|593023124|FG000|Overall Study|Lost to Follow-up|1|||
164180044|NCT04521114|593023125|FG001|Overall Study|Lost to Follow-up|2|||
164180045|NCT04521114|593023126|FG002|Overall Study|Lost to Follow-up|0|||
164180046|NCT04521114|593023124|FG000|Overall Study|Withdrawal by Subject|1|||
164180047|NCT04521114|593023125|FG001|Overall Study|Withdrawal by Subject|2|||
164180048|NCT04521114|593023126|FG002|Overall Study|Withdrawal by Subject|2|||
164180049|NCT04521114|593023124|FG000|Overall Study|Adverse Event|1|||
164180050|NCT04521114|593023125|FG001|Overall Study|Adverse Event|0|||
164180051|NCT04521114|593023126|FG002|Overall Study|Adverse Event|0|||
164180052|NCT04521114|593023124|FG000|Overall Study|Sponsor Wish|1|||
164180053|NCT04521114|593023125|FG001|Overall Study|Sponsor Wish|0|||
164180054|NCT04521114|593023126|FG002|Overall Study|Sponsor Wish|0|||
164180055|NCT04521114|593023124|FG000|Overall Study|Withdrawal of Consent|2|||
164180056|NCT04521114|593023125|FG001|Overall Study|Withdrawal of Consent|2|||
164180057|NCT04521114|593023126|FG002|Overall Study|Withdrawal of Consent|0|||
164180058|NCT01362517|593023127|FG000|Overall Study|Protocol Violation|1|||
164180059|NCT01362517|593023127|FG000|Overall Study|Lost to Follow-up|1|||
164180060|NCT01133288|593023130|FG000|Eligibility Assessment|met exclusion criteria|5|||
164180061|NCT01133288|593023130|FG000|Intervention Allocation|study terminated|2|||
164180062|NCT02614131|593023131|FG000|Overall Study|Withdrawal by Subject|1|||
164180063|NCT02614131|593023132|FG001|Overall Study|Withdrawal by Subject|0|||
164180064|NCT02614131|593023133|FG002|Overall Study|Withdrawal by Subject|0|||
164180065|NCT02614131|593023134|FG003|Overall Study|Withdrawal by Subject|0|||
164180066|NCT02614131|593023135|FG004|Overall Study|Withdrawal by Subject|0|||
164180067|NCT02614131|593023136|FG005|Overall Study|Withdrawal by Subject|0|||
164180068|NCT02614131|593023137|FG006|Overall Study|Withdrawal by Subject|0|||
164180069|NCT02614131|593023131|FG000|Overall Study|Adverse Event|0|||
164180070|NCT02614131|593023132|FG001|Overall Study|Adverse Event|0|||
164180071|NCT02614131|593023133|FG002|Overall Study|Adverse Event|0|||
164180072|NCT02614131|593023134|FG003|Overall Study|Adverse Event|0|||
164180073|NCT02614131|593023135|FG004|Overall Study|Adverse Event|0|||
164180074|NCT02614131|593023136|FG005|Overall Study|Adverse Event|0|||
164180075|NCT02614131|593023137|FG006|Overall Study|Adverse Event|1|||
164180076|NCT01832818|593023138|FG000|Overall Study|Lost to Follow-up|6|||
164180077|NCT03209518|593023139|FG000|Overall Study|Case Report Forms Uncollected|1|||
164180078|NCT03209518|593023139|FG000|Overall Study|Protocol Deviation|1|||
164180079|NCT00568334|593023144|FG000|Overall Study|Withdrawal by Subject|0|||
164180080|NCT00568334|593023145|FG001|Overall Study|Withdrawal by Subject|1|||
164180081|NCT00568334|593023144|FG000|Overall Study|Lost to Follow-up|1|||
164180082|NCT00568334|593023145|FG001|Overall Study|Lost to Follow-up|0|||
164180083|NCT01897571|593023146|FG000|Overall Study|Lost to Follow-up|3|||
164180084|NCT01897571|593023147|FG001|Overall Study|Lost to Follow-up|0|||
164180085|NCT01897571|593023148|FG002|Overall Study|Lost to Follow-up|0|||
164180086|NCT01897571|593023149|FG003|Overall Study|Lost to Follow-up|0|||
164180087|NCT01897571|593023150|FG004|Overall Study|Lost to Follow-up|2|||
164180088|NCT01897571|593023151|FG005|Overall Study|Lost to Follow-up|0|||
164180089|NCT01897571|593023152|FG006|Overall Study|Lost to Follow-up|0|||
164180090|NCT01897571|593023153|FG007|Overall Study|Lost to Follow-up|0|||
164180091|NCT01897571|593023154|FG008|Overall Study|Lost to Follow-up|1|||
164180092|NCT01897571|593023155|FG009|Overall Study|Lost to Follow-up|2|||
164180093|NCT01897571|593023156|FG010|Overall Study|Lost to Follow-up|4|||
164180094|NCT01897571|593023146|FG000|Overall Study|Withdrawal by Subject|0|||
164180095|NCT01897571|593023147|FG001|Overall Study|Withdrawal by Subject|0|||
164180096|NCT01897571|593023148|FG002|Overall Study|Withdrawal by Subject|0|||
164180097|NCT01897571|593023149|FG003|Overall Study|Withdrawal by Subject|0|||
164180098|NCT01897571|593023150|FG004|Overall Study|Withdrawal by Subject|0|||
164180099|NCT01897571|593023151|FG005|Overall Study|Withdrawal by Subject|0|||
164180100|NCT01897571|593023152|FG006|Overall Study|Withdrawal by Subject|0|||
164180101|NCT01897571|593023153|FG007|Overall Study|Withdrawal by Subject|1|||
164180102|NCT01897571|593023154|FG008|Overall Study|Withdrawal by Subject|4|||
164180103|NCT01897571|593023155|FG009|Overall Study|Withdrawal by Subject|3|||
164180104|NCT01897571|593023156|FG010|Overall Study|Withdrawal by Subject|1|||
164180105|NCT01897571|593023146|FG000|Overall Study|Other|1|||
164180106|NCT01897571|593023147|FG001|Overall Study|Other|0|||
164180107|NCT01897571|593023148|FG002|Overall Study|Other|0|||
164180108|NCT01897571|593023149|FG003|Overall Study|Other|3|||
164180109|NCT01897571|593023150|FG004|Overall Study|Other|3|||
164180110|NCT01897571|593023151|FG005|Overall Study|Other|4|||
164180111|NCT01897571|593023152|FG006|Overall Study|Other|7|||
164180112|NCT01897571|593023153|FG007|Overall Study|Other|0|||
164180113|NCT01897571|593023154|FG008|Overall Study|Other|0|||
164180114|NCT01897571|593023155|FG009|Overall Study|Other|0|||
164180115|NCT01897571|593023156|FG010|Overall Study|Other|0|||
164180116|NCT01897571|593023146|FG000|Overall Study|Enrolled in rollover study|0|||
164180117|NCT01897571|593023147|FG001|Overall Study|Enrolled in rollover study|0|||
164180118|NCT01897571|593023148|FG002|Overall Study|Enrolled in rollover study|0|||
164180119|NCT01897571|593023149|FG003|Overall Study|Enrolled in rollover study|0|||
164180120|NCT01897571|593023150|FG004|Overall Study|Enrolled in rollover study|0|||
164180121|NCT01897571|593023151|FG005|Overall Study|Enrolled in rollover study|0|||
164180122|NCT01897571|593023152|FG006|Overall Study|Enrolled in rollover study|0|||
164180123|NCT01897571|593023153|FG007|Overall Study|Enrolled in rollover study|9|||
164180124|NCT01897571|593023154|FG008|Overall Study|Enrolled in rollover study|7|||
164180125|NCT01897571|593023155|FG009|Overall Study|Enrolled in rollover study|9|||
164180126|NCT01897571|593023156|FG010|Overall Study|Enrolled in rollover study|1|||
164180127|NCT01897571|593023146|FG000|Overall Study|Death|2|||
164180128|NCT01897571|593023147|FG001|Overall Study|Death|2|||
164180129|NCT01897571|593023148|FG002|Overall Study|Death|3|||
164180130|NCT01897571|593023149|FG003|Overall Study|Death|6|||
164180131|NCT01897571|593023150|FG004|Overall Study|Death|7|||
164180132|NCT01897571|593023151|FG005|Overall Study|Death|9|||
164180133|NCT01897571|593023152|FG006|Overall Study|Death|5|||
164180134|NCT01897571|593023153|FG007|Overall Study|Death|22|||
164180135|NCT01897571|593023154|FG008|Overall Study|Death|23|||
164180136|NCT01897571|593023155|FG009|Overall Study|Death|129|||
164180137|NCT01897571|593023156|FG010|Overall Study|Death|59|||
164180138|NCT00401960|593023157|FG000|Overall Study|Lost to Follow-up|3|||
164180139|NCT00401960|593023158|FG001|Overall Study|Lost to Follow-up|0|||
164180140|NCT00401960|593023157|FG000|Overall Study|Death|2|||
164180141|NCT00401960|593023158|FG001|Overall Study|Death|0|||
164180142|NCT01606202|593023159|FG000|Overall Study|Adverse Event|5|||
164180143|NCT01606202|593023160|FG001|Overall Study|Adverse Event|0|||
164180144|NCT01606202|593023159|FG000|Overall Study|Withdrawal by Subject|2|||
164180145|NCT01606202|593023160|FG001|Overall Study|Withdrawal by Subject|1|||
164180146|NCT01606202|593023159|FG000|Overall Study|Personal problems|0|||
164180147|NCT01606202|593023160|FG001|Overall Study|Personal problems|1|||
164180148|NCT01606202|593023159|FG000|Overall Study|Problems with administration|0|||
164180149|NCT01606202|593023160|FG001|Overall Study|Problems with administration|1|||
164180150|NCT03217968|593023163|FG000|Overall Study|Withdrawal by Subject|4|||
164180151|NCT03217968|593023163|FG000|Overall Study|Lost to Follow-up|1|||
164180152|NCT03217968|593023163|FG000|Overall Study|Protocol Violation|6|||
164180153|NCT00337779|593023164|FG000|Overall Study|Withdrawal by Subject|10|||
164180154|NCT00337779|593023165|FG001|Overall Study|Withdrawal by Subject|12|||
164180155|NCT00337779|593023164|FG000|Overall Study|Sponsor decision|1|||
164180156|NCT00337779|593023165|FG001|Overall Study|Sponsor decision|1|||
164180157|NCT00337779|593023164|FG000|Overall Study|Physician Decision|3|||
164180158|NCT00337779|593023165|FG001|Overall Study|Physician Decision|6|||
164180159|NCT00337779|593023164|FG000|Overall Study|Protocol Violation|1|||
164180160|NCT00337779|593023165|FG001|Overall Study|Protocol Violation|1|||
164180161|NCT00337779|593023164|FG000|Overall Study|Lost to Follow-up|6|||
164180162|NCT00337779|593023165|FG001|Overall Study|Lost to Follow-up|5|||
164180163|NCT00337779|593023164|FG000|Overall Study|Adverse Event|28|||
164180164|NCT00337779|593023165|FG001|Overall Study|Adverse Event|51|||
164180165|NCT00337779|593023164|FG000|Overall Study|Pregnancy|3|||
164180166|NCT00337779|593023165|FG001|Overall Study|Pregnancy|2|||
164180167|NCT00337779|593023164|FG000|Overall Study|Death|0|||
164180168|NCT00337779|593023165|FG001|Overall Study|Death|1|||
164180169|NCT03008278|593023166|FG000|Overall Study|Progressive Disease|0|||
164180170|NCT03008278|593023167|FG001|Overall Study|Progressive Disease|0|||
164180171|NCT03008278|593023168|FG002|Overall Study|Progressive Disease|32|||
164180172|NCT03008278|593023166|FG000|Overall Study|Adverse Event|0|||
164180173|NCT03008278|593023167|FG001|Overall Study|Adverse Event|0|||
164180174|NCT03008278|593023168|FG002|Overall Study|Adverse Event|4|||
164180175|NCT03008278|593023166|FG000|Overall Study|Withdrawal by Subject|0|||
164180176|NCT03008278|593023167|FG001|Overall Study|Withdrawal by Subject|0|||
164180177|NCT03008278|593023168|FG002|Overall Study|Withdrawal by Subject|3|||
164180178|NCT03008278|593023166|FG000|Overall Study|Physician Decision|0|||
164180179|NCT03008278|593023167|FG001|Overall Study|Physician Decision|2|||
164180180|NCT03008278|593023168|FG002|Overall Study|Physician Decision|0|||
164180181|NCT01074255|593023169|FG000|Overall Study|Did not receive EMEND|2|||
164180182|NCT01389258|593023170|FG000|Overall Study|Lost to Follow-up|5|||
164180183|NCT03313310|593023171|FG000|Phase 2|Lost to Follow-up|4|||
164180184|NCT03313310|593023172|FG001|Phase 2|Lost to Follow-up|0|||
164180185|NCT03313310|593023171|FG000|Phase 3|Lost to Follow-up|0|||
164180186|NCT03313310|593023172|FG001|Phase 3|Lost to Follow-up|1|||
164180187|NCT00932451|593023183|FG000|Overall Study|Withdrawal by Subject|69|||
164180188|NCT00932451|593023183|FG000|Overall Study|Lost to Follow-up|22|||
164180189|NCT00932451|593023183|FG000|Overall Study|Death|726|||
164180190|NCT00932451|593023183|FG000|Overall Study|Other reasons|5|||
164180191|NCT03627416|593023184|FG000|Overall Study|Adverse Event|0|||
164180192|NCT03627416|593023185|FG001|Overall Study|Adverse Event|1|||
164180193|NCT01096589|593023188|FG000|Overall Study|Adverse Event|2|||
164180194|NCT01096589|593023189|FG001|Overall Study|Adverse Event|1|||
164180195|NCT01096589|593023190|FG002|Overall Study|Adverse Event|2|||
164180196|NCT01096589|593023191|FG003|Overall Study|Adverse Event|1|||
164180197|NCT01096589|593023188|FG000|Overall Study|Withdrawal by Subject|2|||
164180198|NCT01096589|593023189|FG001|Overall Study|Withdrawal by Subject|1|||
164180199|NCT01096589|593023190|FG002|Overall Study|Withdrawal by Subject|1|||
164180200|NCT01096589|593023191|FG003|Overall Study|Withdrawal by Subject|1|||
164180201|NCT01096589|593023188|FG000|Overall Study|Compliance with protocol|0|||
164180202|NCT01096589|593023189|FG001|Overall Study|Compliance with protocol|0|||
164180203|NCT01096589|593023190|FG002|Overall Study|Compliance with protocol|1|||
164180204|NCT01096589|593023191|FG003|Overall Study|Compliance with protocol|0|||
164180205|NCT01096589|593023188|FG000|Overall Study|found treatment exhausting|0|||
164180206|NCT01096589|593023189|FG001|Overall Study|found treatment exhausting|0|||
164180207|NCT01096589|593023190|FG002|Overall Study|found treatment exhausting|0|||
164180208|NCT01096589|593023191|FG003|Overall Study|found treatment exhausting|1|||
164180209|NCT02520427|593023192|FG000|Overall Study|Decision by sponsor|0|||
164180210|NCT02520427|593023193|FG001|Overall Study|Decision by sponsor|0|||
164180211|NCT02520427|593023194|FG002|Overall Study|Decision by sponsor|0|||
164180212|NCT02520427|593023195|FG003|Overall Study|Decision by sponsor|0|||
164180213|NCT02520427|593023196|FG004|Overall Study|Decision by sponsor|0|||
164180214|NCT02520427|593023197|FG005|Overall Study|Decision by sponsor|0|||
164180215|NCT02520427|593023198|FG006|Overall Study|Decision by sponsor|0|||
164180216|NCT02520427|593023199|FG007|Overall Study|Decision by sponsor|0|||
164180217|NCT02520427|593023200|FG008|Overall Study|Decision by sponsor|1|||
164180218|NCT02520427|593023201|FG009|Overall Study|Decision by sponsor|1|||
164180219|NCT02520427|593023202|FG010|Overall Study|Decision by sponsor|0|||
164180220|NCT02520427|593023203|FG011|Overall Study|Decision by sponsor|0|||
164180221|NCT02520427|593023204|FG012|Overall Study|Decision by sponsor|0|||
164180222|NCT02520427|593023205|FG013|Overall Study|Decision by sponsor|0|||
164180223|NCT02520427|593023206|FG014|Overall Study|Decision by sponsor|0|||
164180224|NCT02520427|593023207|FG015|Overall Study|Decision by sponsor|0|||
164180225|NCT02520427|593023208|FG016|Overall Study|Decision by sponsor|0|||
164180226|NCT02520427|593023209|FG017|Overall Study|Decision by sponsor|0|||
164180227|NCT02520427|593023210|FG018|Overall Study|Decision by sponsor|0|||
164180228|NCT02520427|593023211|FG019|Overall Study|Decision by sponsor|0|||
164180229|NCT02520427|593023212|FG020|Overall Study|Decision by sponsor|0|||
164180230|NCT02520427|593023213|FG021|Overall Study|Decision by sponsor|0|||
164180231|NCT02520427|593023214|FG022|Overall Study|Decision by sponsor|0|||
164180232|NCT02520427|593023215|FG023|Overall Study|Decision by sponsor|0|||
164180233|NCT02520427|593023216|FG024|Overall Study|Decision by sponsor|0|||
164180234|NCT02520427|593023217|FG025|Overall Study|Decision by sponsor|0|||
164180235|NCT02520427|593023192|FG000|Overall Study|Withdrawal by Subject|0|||
164180236|NCT02520427|593023193|FG001|Overall Study|Withdrawal by Subject|0|||
164180237|NCT02520427|593023194|FG002|Overall Study|Withdrawal by Subject|1|||
164180238|NCT02520427|593023195|FG003|Overall Study|Withdrawal by Subject|0|||
164180239|NCT02520427|593023196|FG004|Overall Study|Withdrawal by Subject|0|||
164180240|NCT02520427|593023197|FG005|Overall Study|Withdrawal by Subject|0|||
164180241|NCT02520427|593023198|FG006|Overall Study|Withdrawal by Subject|0|||
164180242|NCT02520427|593023199|FG007|Overall Study|Withdrawal by Subject|0|||
164180243|NCT02520427|593023200|FG008|Overall Study|Withdrawal by Subject|0|||
164180244|NCT02520427|593023201|FG009|Overall Study|Withdrawal by Subject|0|||
164180245|NCT02520427|593023202|FG010|Overall Study|Withdrawal by Subject|0|||
164180246|NCT02520427|593023203|FG011|Overall Study|Withdrawal by Subject|0|||
164180247|NCT02520427|593023204|FG012|Overall Study|Withdrawal by Subject|1|||
164180248|NCT02520427|593023205|FG013|Overall Study|Withdrawal by Subject|1|||
164180249|NCT02520427|593023206|FG014|Overall Study|Withdrawal by Subject|1|||
164180250|NCT02520427|593023207|FG015|Overall Study|Withdrawal by Subject|0|||
164180251|NCT02520427|593023208|FG016|Overall Study|Withdrawal by Subject|1|||
164180252|NCT02520427|593023209|FG017|Overall Study|Withdrawal by Subject|0|||
164180253|NCT02520427|593023210|FG018|Overall Study|Withdrawal by Subject|0|||
164180254|NCT02520427|593023211|FG019|Overall Study|Withdrawal by Subject|3|||
164180255|NCT02520427|593023212|FG020|Overall Study|Withdrawal by Subject|2|||
164180256|NCT02520427|593023213|FG021|Overall Study|Withdrawal by Subject|0|||
164180257|NCT02520427|593023214|FG022|Overall Study|Withdrawal by Subject|0|||
164180258|NCT02520427|593023215|FG023|Overall Study|Withdrawal by Subject|0|||
164180259|NCT02520427|593023216|FG024|Overall Study|Withdrawal by Subject|0|||
164180260|NCT02520427|593023217|FG025|Overall Study|Withdrawal by Subject|0|||
164180261|NCT02520427|593023192|FG000|Overall Study|Death|1|||
164180262|NCT02520427|593023193|FG001|Overall Study|Death|0|||
164180263|NCT02520427|593023194|FG002|Overall Study|Death|0|||
164180264|NCT02520427|593023195|FG003|Overall Study|Death|0|||
164180265|NCT02520427|593023196|FG004|Overall Study|Death|0|||
164180266|NCT02520427|593023197|FG005|Overall Study|Death|0|||
164180267|NCT02520427|593023198|FG006|Overall Study|Death|0|||
164180268|NCT02520427|593023199|FG007|Overall Study|Death|0|||
164180269|NCT02520427|593023200|FG008|Overall Study|Death|0|||
164180270|NCT02520427|593023201|FG009|Overall Study|Death|0|||
164180271|NCT02520427|593023202|FG010|Overall Study|Death|0|||
164180272|NCT02520427|593023203|FG011|Overall Study|Death|0|||
164180273|NCT02520427|593023204|FG012|Overall Study|Death|0|||
164180274|NCT02520427|593023205|FG013|Overall Study|Death|0|||
164180275|NCT02520427|593023206|FG014|Overall Study|Death|0|||
164180276|NCT02520427|593023207|FG015|Overall Study|Death|0|||
164180277|NCT02520427|593023208|FG016|Overall Study|Death|2|||
164180278|NCT02520427|593023209|FG017|Overall Study|Death|1|||
164180279|NCT02520427|593023210|FG018|Overall Study|Death|3|||
164180280|NCT02520427|593023211|FG019|Overall Study|Death|2|||
164180281|NCT02520427|593023212|FG020|Overall Study|Death|0|||
164180282|NCT02520427|593023213|FG021|Overall Study|Death|0|||
164180283|NCT02520427|593023214|FG022|Overall Study|Death|1|||
164180284|NCT02520427|593023215|FG023|Overall Study|Death|0|||
164180285|NCT02520427|593023216|FG024|Overall Study|Death|1|||
164180286|NCT02520427|593023217|FG025|Overall Study|Death|0|||
164180287|NCT00793624|593023218|FG000|Overall Study|Adverse Event|18|||
164180288|NCT00793624|593023219|FG001|Overall Study|Adverse Event|16|||
164180289|NCT00793624|593023220|FG002|Overall Study|Adverse Event|15|||
164180290|NCT00793624|593023221|FG003|Overall Study|Adverse Event|20|||
164180291|NCT00793624|593023218|FG000|Overall Study|Lost to Follow-up|2|||
164180292|NCT00793624|593023219|FG001|Overall Study|Lost to Follow-up|2|||
164180293|NCT00793624|593023220|FG002|Overall Study|Lost to Follow-up|4|||
164180294|NCT00793624|593023221|FG003|Overall Study|Lost to Follow-up|0|||
164180295|NCT00793624|593023218|FG000|Overall Study|Withdrawal by Subject|20|||
164180296|NCT00793624|593023219|FG001|Overall Study|Withdrawal by Subject|9|||
164180297|NCT00793624|593023220|FG002|Overall Study|Withdrawal by Subject|11|||
164180298|NCT00793624|593023221|FG003|Overall Study|Withdrawal by Subject|14|||
164180299|NCT00793624|593023218|FG000|Overall Study|Lack of Efficacy|9|||
164180300|NCT00793624|593023219|FG001|Overall Study|Lack of Efficacy|2|||
164180301|NCT00793624|593023220|FG002|Overall Study|Lack of Efficacy|1|||
164180302|NCT00793624|593023221|FG003|Overall Study|Lack of Efficacy|3|||
164180303|NCT00793624|593023218|FG000|Overall Study|Non compliance with protocol|2|||
164180304|NCT00793624|593023219|FG001|Overall Study|Non compliance with protocol|3|||
164180305|NCT00793624|593023220|FG002|Overall Study|Non compliance with protocol|2|||
164180306|NCT00793624|593023221|FG003|Overall Study|Non compliance with protocol|3|||
164180307|NCT00793624|593023218|FG000|Overall Study|Other reason not described above|6|||
164180308|NCT00793624|593023219|FG001|Overall Study|Other reason not described above|4|||
164180309|NCT00793624|593023220|FG002|Overall Study|Other reason not described above|6|||
164180310|NCT00793624|593023221|FG003|Overall Study|Other reason not described above|3|||
164180311|NCT00157248|593023222|FG000|Overall Study|Adverse Event|36|||
164180312|NCT00157248|593023223|FG001|Overall Study|Adverse Event|25|||
164180313|NCT00157248|593023224|FG002|Overall Study|Adverse Event|13|||
164180314|NCT00157248|593023225|FG003|Overall Study|Adverse Event|33|||
164180315|NCT00157248|593023222|FG000|Overall Study|Protocol Violation|4|||
164180316|NCT00157248|593023223|FG001|Overall Study|Protocol Violation|0|||
164180317|NCT00157248|593023224|FG002|Overall Study|Protocol Violation|2|||
164180318|NCT00157248|593023225|FG003|Overall Study|Protocol Violation|2|||
164180319|NCT00157248|593023222|FG000|Overall Study|Lost to Follow-up|0|||
164180320|NCT00157248|593023223|FG001|Overall Study|Lost to Follow-up|1|||
164180321|NCT00157248|593023224|FG002|Overall Study|Lost to Follow-up|0|||
164180322|NCT00157248|593023225|FG003|Overall Study|Lost to Follow-up|0|||
164180323|NCT00157248|593023222|FG000|Overall Study|Withdrawal by Subject|1|||
164180324|NCT00157248|593023223|FG001|Overall Study|Withdrawal by Subject|4|||
164180325|NCT00157248|593023224|FG002|Overall Study|Withdrawal by Subject|3|||
164180326|NCT00157248|593023225|FG003|Overall Study|Withdrawal by Subject|3|||
164180327|NCT00157248|593023222|FG000|Overall Study|site closures, subject moving|7|||
164180328|NCT00157248|593023223|FG001|Overall Study|site closures, subject moving|7|||
164180329|NCT00157248|593023224|FG002|Overall Study|site closures, subject moving|3|||
164180330|NCT00157248|593023225|FG003|Overall Study|site closures, subject moving|9|||
164180331|NCT03467763|593023226|FG000|Overall Study|Lost to Follow-up|1|||
164180332|NCT03467763|593023226|FG000|Overall Study|Protocol Violation|2|||
164180333|NCT02073565|593023227|FG000|Cohort A|Withdrawal by Subject|1|||
164180334|NCT02073565|593023228|FG001|Cohort A|Withdrawal by Subject|0|||
164180335|NCT02073565|593023227|FG000|Cohort B|Withdrawal by Subject|1|||
164180336|NCT02073565|593023228|FG001|Cohort B|Withdrawal by Subject|2|||
164180337|NCT02073565|593023227|FG000|Cohort C|Withdrawal by Subject|0|||
164180338|NCT02073565|593023228|FG001|Cohort C|Withdrawal by Subject|2|||
164180339|NCT02073565|593023227|FG000|Cohort C|Lost to Follow-up|0|||
164180340|NCT02073565|593023228|FG001|Cohort C|Lost to Follow-up|2|||
164180341|NCT02227368|593025204|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
164180342|NCT02227368|593025205|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
164180343|NCT02227368|593025204|FG000|Overall Study|Lost to Follow-up|1|||
164180344|NCT02227368|593025205|FG001|Overall Study|Lost to Follow-up|0|||
164180345|NCT02227368|593025204|FG000|Overall Study|Adverse Event|1|||
164180346|NCT02227368|593025205|FG001|Overall Study|Adverse Event|0|||
164180347|NCT03046056|593025207|FG000|Overall Study|Non-responder at Week 10|6|||
164180348|NCT03046056|593025208|FG001|Overall Study|Non-responder at Week 10|6|||
164180349|NCT03046056|593025209|FG002|Overall Study|Non-responder at Week 10|4|||
164180350|NCT03046056|593025207|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
164180351|NCT03046056|593025208|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
164180352|NCT03046056|593025209|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
164180353|NCT03046056|593025207|FG000|Overall Study|Adverse Event|1|||
164180354|NCT03046056|593025208|FG001|Overall Study|Adverse Event|5|||
164180355|NCT03046056|593025209|FG002|Overall Study|Adverse Event|0|||
164180356|NCT03046056|593025207|FG000|Overall Study|Non-compliance With Study Drug|0|||
164180357|NCT03046056|593025208|FG001|Overall Study|Non-compliance With Study Drug|0|||
164180358|NCT03046056|593025209|FG002|Overall Study|Non-compliance With Study Drug|2|||
164180359|NCT03046056|593025207|FG000|Overall Study|Protocol Violation|1|||
164180360|NCT03046056|593025208|FG001|Overall Study|Protocol Violation|1|||
164180361|NCT03046056|593025209|FG002|Overall Study|Protocol Violation|0|||
164180362|NCT03046056|593025207|FG000|Overall Study|Investigator's Discretion|0|||
164180363|NCT03046056|593025208|FG001|Overall Study|Investigator's Discretion|1|||
164180364|NCT03046056|593025209|FG002|Overall Study|Investigator's Discretion|0|||
164180365|NCT03046056|593025207|FG000|Overall Study|Withdrew Consent|1|||
164180366|NCT03046056|593025208|FG001|Overall Study|Withdrew Consent|0|||
164180367|NCT03046056|593025209|FG002|Overall Study|Withdrew Consent|0|||
164180368|NCT03089853|593025210|FG000|Overall Study|Lost to Follow-up|2|||
164180369|NCT03089853|593025211|FG001|Overall Study|Lost to Follow-up|1|||
164180370|NCT01172808|593025212|FG000|Overall Study|Adverse Event|8|||
164180371|NCT01172808|593025213|FG001|Overall Study|Adverse Event|4|||
164180372|NCT01172808|593025214|FG002|Overall Study|Adverse Event|8|||
164180373|NCT01172808|593025215|FG003|Overall Study|Adverse Event|3|||
164180374|NCT01172808|593025212|FG000|Overall Study|Lack of Efficacy|1|||
164180375|NCT01172808|593025213|FG001|Overall Study|Lack of Efficacy|0|||
164180376|NCT01172808|593025214|FG002|Overall Study|Lack of Efficacy|0|||
164180377|NCT01172808|593025215|FG003|Overall Study|Lack of Efficacy|0|||
164180378|NCT01172808|593025212|FG000|Overall Study|Protocol Violation|2|||
164180379|NCT01172808|593025213|FG001|Overall Study|Protocol Violation|2|||
164180380|NCT01172808|593025214|FG002|Overall Study|Protocol Violation|2|||
164180381|NCT01172808|593025215|FG003|Overall Study|Protocol Violation|0|||
164180382|NCT01172808|593025212|FG000|Overall Study|Lost to Follow-up|0|||
164180383|NCT01172808|593025213|FG001|Overall Study|Lost to Follow-up|1|||
164180384|NCT01172808|593025214|FG002|Overall Study|Lost to Follow-up|1|||
164180385|NCT01172808|593025215|FG003|Overall Study|Lost to Follow-up|3|||
164180386|NCT01172808|593025212|FG000|Overall Study|Withdrawal by Subject|4|||
164180387|NCT01172808|593025213|FG001|Overall Study|Withdrawal by Subject|1|||
164180388|NCT01172808|593025214|FG002|Overall Study|Withdrawal by Subject|3|||
164180389|NCT01172808|593025215|FG003|Overall Study|Withdrawal by Subject|2|||
164180390|NCT01172808|593025212|FG000|Overall Study|Other|6|||
164180391|NCT01172808|593025213|FG001|Overall Study|Other|5|||
164180392|NCT01172808|593025214|FG002|Overall Study|Other|9|||
164180393|NCT01172808|593025215|FG003|Overall Study|Other|7|||
164180394|NCT03539484|593025223|FG000|Overall Study|Death|1|||
164180395|NCT03539484|593025224|FG001|Overall Study|Death|0|||
164180396|NCT03539484|593025225|FG002|Overall Study|Death|0|||
164180397|NCT03539484|593025226|FG003|Overall Study|Death|2|||
164180398|NCT03539484|593025227|FG004|Overall Study|Death|8|||
164180399|NCT03539484|593025228|FG005|Overall Study|Death|3|||
164180400|NCT03539484|593025229|FG006|Overall Study|Death|0|||
164180401|NCT03539484|593025223|FG000|Overall Study|Lost to Follow-up|0|||
164180402|NCT03539484|593025224|FG001|Overall Study|Lost to Follow-up|1|||
164180403|NCT03539484|593025225|FG002|Overall Study|Lost to Follow-up|0|||
164180404|NCT03539484|593025226|FG003|Overall Study|Lost to Follow-up|0|||
164180405|NCT03539484|593025227|FG004|Overall Study|Lost to Follow-up|1|||
164180406|NCT03539484|593025228|FG005|Overall Study|Lost to Follow-up|0|||
164180407|NCT03539484|593025229|FG006|Overall Study|Lost to Follow-up|0|||
164180408|NCT03539484|593025223|FG000|Overall Study|Withdrawal by Subject|0|||
164180409|NCT03539484|593025224|FG001|Overall Study|Withdrawal by Subject|0|||
164180410|NCT03539484|593025225|FG002|Overall Study|Withdrawal by Subject|0|||
164180411|NCT03539484|593025226|FG003|Overall Study|Withdrawal by Subject|0|||
164180412|NCT03539484|593025227|FG004|Overall Study|Withdrawal by Subject|2|||
164180413|NCT03539484|593025228|FG005|Overall Study|Withdrawal by Subject|0|||
164180414|NCT03539484|593025229|FG006|Overall Study|Withdrawal by Subject|1|||
164180415|NCT03539484|593025223|FG000|Overall Study|Study Terminated by Sponsor|0|||
164180416|NCT03539484|593025224|FG001|Overall Study|Study Terminated by Sponsor|0|||
164180417|NCT03539484|593025225|FG002|Overall Study|Study Terminated by Sponsor|1|||
164180418|NCT03539484|593025226|FG003|Overall Study|Study Terminated by Sponsor|1|||
164180419|NCT03539484|593025227|FG004|Overall Study|Study Terminated by Sponsor|2|||
164180420|NCT03539484|593025228|FG005|Overall Study|Study Terminated by Sponsor|2|||
164180421|NCT03539484|593025229|FG006|Overall Study|Study Terminated by Sponsor|1|||
164180422|NCT02131636|593025233|FG000|Overall Study|Personal Reasons|4|||
164180423|NCT02131636|593025234|FG001|Overall Study|Personal Reasons|4|||
164180424|NCT02131636|593025233|FG000|Overall Study|Lost to Follow-up|4|||
164180425|NCT02131636|593025234|FG001|Overall Study|Lost to Follow-up|0|||
164180426|NCT02131636|593025233|FG000|Overall Study|Adverse Event|4|||
164180427|NCT02131636|593025234|FG001|Overall Study|Adverse Event|1|||
164180428|NCT02173379|593025235|FG000|Overall Study|Lost to Follow-up|89|||
164180429|NCT02173379|593025236|FG001|Overall Study|Lost to Follow-up|81|||
164180430|NCT02173379|593025235|FG000|Overall Study|Withdrawal by Subject|24|||
164180431|NCT02173379|593025236|FG001|Overall Study|Withdrawal by Subject|29|||
164180432|NCT02173379|593025235|FG000|Overall Study|Physician Decision|8|||
164180433|NCT02173379|593025236|FG001|Overall Study|Physician Decision|8|||
164180434|NCT02173379|593025235|FG000|Overall Study|Death|75|||
164180435|NCT02173379|593025236|FG001|Overall Study|Death|72|||
164180436|NCT02173379|593025235|FG000|Overall Study|Other Reason|1|||
164180437|NCT02173379|593025236|FG001|Overall Study|Other Reason|0|||
164180438|NCT06226649|593025237|FG000|Overall Study|Withdrawal by Subject|4|||
164180439|NCT06226649|593025238|FG001|Overall Study|Withdrawal by Subject|1|||
164180440|NCT00981058|593025250|FG000|Overall Study|Progressive Disease|38|||
164180441|NCT00981058|593025251|FG001|Overall Study|Progressive Disease|31|||
164180442|NCT00981058|593025250|FG000|Overall Study|Lost to Follow-up|3|||
164180443|NCT00981058|593025251|FG001|Overall Study|Lost to Follow-up|2|||
164180444|NCT00981058|593025250|FG000|Overall Study|Physician Decision|4|||
164180445|NCT00981058|593025251|FG001|Overall Study|Physician Decision|5|||
164180446|NCT00981058|593025250|FG000|Overall Study|Randomization Error|0|||
164180447|NCT00981058|593025251|FG001|Overall Study|Randomization Error|1|||
164180448|NCT00981058|593025250|FG000|Overall Study|Withdrawal by Subject|24|||
164180449|NCT00981058|593025251|FG001|Overall Study|Withdrawal by Subject|22|||
164180450|NCT02667587|593025252|FG000|Pre-Treatment|Not reported|1|||
164180451|NCT02667587|593025253|FG001|Pre-Treatment|Not reported|0|||
164180452|NCT02667587|593025252|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
164180453|NCT02667587|593025253|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
164180454|NCT02667587|593025252|FG000|Pre-Treatment|Participant withdrew consent|0|||
164180455|NCT02667587|593025253|FG001|Pre-Treatment|Participant withdrew consent|1|||
164180456|NCT02667587|593025252|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
164180457|NCT02667587|593025253|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
164180458|NCT02667587|593025252|FG000|End of Treatment|Disease Progression|193|||
164180459|NCT02667587|593025253|FG001|End of Treatment|Disease Progression|226|||
164180460|NCT02667587|593025252|FG000|End of Treatment|Study Drug Toxicity|75|||
164180461|NCT02667587|593025253|FG001|End of Treatment|Study Drug Toxicity|19|||
164180462|NCT02667587|593025252|FG000|End of Treatment|Death|2|||
164180463|NCT02667587|593025253|FG001|End of Treatment|Death|1|||
164180464|NCT02667587|593025252|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
164180465|NCT02667587|593025253|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
164180466|NCT02667587|593025252|FG000|End of Treatment|participant request to discontinue treatment|33|||
164180467|NCT02667587|593025253|FG001|End of Treatment|participant request to discontinue treatment|35|||
164180468|NCT02667587|593025252|FG000|End of Treatment|participant withdrew consent|5|||
164180469|NCT02667587|593025253|FG001|End of Treatment|participant withdrew consent|6|||
164180470|NCT02667587|593025252|FG000|End of Treatment|Lost to Follow-up|1|||
164180471|NCT02667587|593025253|FG001|End of Treatment|Lost to Follow-up|2|||
164180472|NCT02667587|593025252|FG000|End of Treatment|maximum clinical benefit|4|||
164180473|NCT02667587|593025253|FG001|End of Treatment|maximum clinical benefit|4|||
164180474|NCT02667587|593025252|FG000|End of Treatment|poor or non compliant|0|||
164180475|NCT02667587|593025253|FG001|End of Treatment|poor or non compliant|1|||
164180476|NCT02667587|593025252|FG000|End of Treatment|participant no longer meets study criteria|1|||
164180477|NCT02667587|593025253|FG001|End of Treatment|participant no longer meets study criteria|1|||
164180478|NCT02667587|593025252|FG000|End of Treatment|administrative reason by sponsor|1|||
164180479|NCT02667587|593025253|FG001|End of Treatment|administrative reason by sponsor|29|||
164180480|NCT02667587|593025252|FG000|End of Treatment|other reasonse|21|||
164180481|NCT02667587|593025253|FG001|End of Treatment|other reasonse|10|||
164180482|NCT02542293|593025254|FG000|Overall Study|Death|367|||
164180483|NCT02542293|593025255|FG001|Overall Study|Death|377|||
164180484|NCT02542293|593025254|FG000|Overall Study|Withdrawal by Subject|8|||
164180485|NCT02542293|593025255|FG001|Overall Study|Withdrawal by Subject|19|||
164180486|NCT02305446|593025259|FG000|Overall Study|Adverse Event|1|||
164180487|NCT01636947|593025260|FG000|Overall Study|Not Treated|2|||
164180488|NCT01636947|593025261|FG001|Overall Study|Not Treated|2|||
164180489|NCT01636947|593025260|FG000|Overall Study|Lost to Follow-up|4|||
164180490|NCT01636947|593025261|FG001|Overall Study|Lost to Follow-up|0|||
164180491|NCT01636947|593025260|FG000|Overall Study|Protocol Violation|1|||
164180492|NCT01636947|593025261|FG001|Overall Study|Protocol Violation|1|||
164180493|NCT01636947|593025260|FG000|Overall Study|Withdrawal by Subject|3|||
164180494|NCT01636947|593025261|FG001|Overall Study|Withdrawal by Subject|3|||
164180495|NCT01636947|593025260|FG000|Overall Study|Adverse Event|1|||
164180496|NCT01636947|593025261|FG001|Overall Study|Adverse Event|1|||
164180497|NCT01636947|593025260|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
164180498|NCT01636947|593025261|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
164180499|NCT02696434|593025267|FG000|Overall Study|Adverse Event|3|||
164180500|NCT02696434|593025268|FG001|Overall Study|Adverse Event|1|||
164180501|NCT02696434|593025267|FG000|Overall Study|Lost to Follow-up|5|||
164180502|NCT02696434|593025268|FG001|Overall Study|Lost to Follow-up|4|||
164180503|NCT02696434|593025267|FG000|Overall Study|Withdrawal by Subject|14|||
164180504|NCT02696434|593025268|FG001|Overall Study|Withdrawal by Subject|12|||
164180505|NCT02696434|593025267|FG000|Overall Study|Physician Decision|0|||
164180506|NCT02696434|593025268|FG001|Overall Study|Physician Decision|1|||
164180507|NCT00316914|593025273|FG000|Overall Study|Withdrawal by Subject|5|||
164180508|NCT00316914|593025274|FG001|Overall Study|Withdrawal by Subject|3|||
164180509|NCT00316914|593025273|FG000|Overall Study|Adverse Event|8|||
164180510|NCT00316914|593025274|FG001|Overall Study|Adverse Event|7|||
164180511|NCT00316914|593025273|FG000|Overall Study|Other Problems|6|||
164180512|NCT00316914|593025274|FG001|Overall Study|Other Problems|11|||
164180513|NCT00316914|593025273|FG000|Overall Study|Missing end of treatment documentation|14|||
164180514|NCT00316914|593025274|FG001|Overall Study|Missing end of treatment documentation|15|||
164180515|NCT00717275|593025279|FG000|Overall Study|Premature study termination.|3|||
164180516|NCT00424021|593025281|FG000|NCT00046319 Study Period|Adverse Event|1|||
164180517|NCT00424021|593025282|FG001|NCT00046319 Study Period|Adverse Event|0|||
164180518|NCT00424021|593025283|FG002|NCT00046319 Study Period|Adverse Event|1|||
164180519|NCT00424021|593025284|FG003|NCT00046319 Study Period|Adverse Event|1|||
164180520|NCT00424021|593025281|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
164180521|NCT00424021|593025282|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
164180522|NCT00424021|593025283|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
164180523|NCT00424021|593025284|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
164180524|NCT00424021|593025281|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
164180525|NCT00424021|593025282|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
164180526|NCT00424021|593025283|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
164180527|NCT00424021|593025284|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
164180528|NCT00424021|593025281|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
164180529|NCT00424021|593025282|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
164180530|NCT00424021|593025283|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
164180531|NCT00424021|593025284|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
164180532|NCT00424021|593025281|FG000|AMB-220-E Study Period|Adverse Event|1|||
164180533|NCT00424021|593025282|FG001|AMB-220-E Study Period|Adverse Event|1|||
164180534|NCT00424021|593025283|FG002|AMB-220-E Study Period|Adverse Event|3|||
164180535|NCT00424021|593025284|FG003|AMB-220-E Study Period|Adverse Event|7|||
164180536|NCT00424021|593025281|FG000|AMB-220-E Study Period|Death|0|||
164180537|NCT00424021|593025282|FG001|AMB-220-E Study Period|Death|0|||
164180538|NCT00424021|593025283|FG002|AMB-220-E Study Period|Death|1|||
164180539|NCT00424021|593025284|FG003|AMB-220-E Study Period|Death|1|||
164180540|NCT00424021|593025281|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
164180541|NCT00424021|593025282|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
164180542|NCT00424021|593025283|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
164180543|NCT00424021|593025284|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
164180544|NCT00424021|593025281|FG000|AMB-220-E Study Period|Physician Decision|0|||
164180545|NCT00424021|593025282|FG001|AMB-220-E Study Period|Physician Decision|0|||
164180546|NCT00424021|593025283|FG002|AMB-220-E Study Period|Physician Decision|0|||
164180547|NCT00424021|593025284|FG003|AMB-220-E Study Period|Physician Decision|1|||
164180548|NCT03769194|593025285|FG000|Overall Study|Withdrawal by Subject|0|||
164180549|NCT03769194|593025286|FG001|Overall Study|Withdrawal by Subject|7|||
164180550|NCT03769194|593025287|FG002|Overall Study|Withdrawal by Subject|4|||
164180551|NCT03769194|593025288|FG003|Overall Study|Withdrawal by Subject|1|||
164180552|NCT03769194|593025285|FG000|Overall Study|moved from study area|0|||
164180553|NCT03769194|593025286|FG001|Overall Study|moved from study area|2|||
164180554|NCT03769194|593025287|FG002|Overall Study|moved from study area|1|||
164180555|NCT03769194|593025288|FG003|Overall Study|moved from study area|1|||
164180556|NCT03769194|593025285|FG000|Overall Study|Lost to Follow-up|3|||
164180557|NCT03769194|593025286|FG001|Overall Study|Lost to Follow-up|6|||
164180558|NCT03769194|593025287|FG002|Overall Study|Lost to Follow-up|3|||
164180559|NCT03769194|593025288|FG003|Overall Study|Lost to Follow-up|6|||
164180560|NCT03769194|593025285|FG000|Overall Study|other|1|||
164180561|NCT03769194|593025286|FG001|Overall Study|other|3|||
164180562|NCT03769194|593025287|FG002|Overall Study|other|0|||
164180563|NCT03769194|593025288|FG003|Overall Study|other|1|||
164180564|NCT01797094|593025294|FG000|Overall Study|Adverse Event|1|||
164180565|NCT01797094|593025295|FG001|Overall Study|Adverse Event|1|||
164180566|NCT01797094|593025294|FG000|Overall Study|Personal Reasons|4|||
164180567|NCT01797094|593025295|FG001|Overall Study|Personal Reasons|0|||
164180568|NCT01797094|593025294|FG000|Overall Study|Protocol Violation|0|||
164180569|NCT01797094|593025295|FG001|Overall Study|Protocol Violation|1|||
164180570|NCT01797094|593025294|FG000|Overall Study|Other Miscellaneous Reasons|1|||
164180571|NCT01797094|593025295|FG001|Overall Study|Other Miscellaneous Reasons|0|||
164180572|NCT03677934|593025305|FG000|Overall Study|Adverse Event|1|||
164180573|NCT03677934|593025306|FG001|Overall Study|Adverse Event|1|||
164180574|NCT03677934|593025305|FG000|Overall Study|Death|8|||
164180575|NCT03677934|593025306|FG001|Overall Study|Death|4|||
164180576|NCT03677934|593025305|FG000|Overall Study|Lost to Follow-up|3|||
164180577|NCT03677934|593025306|FG001|Overall Study|Lost to Follow-up|0|||
164180578|NCT03677934|593025305|FG000|Overall Study|Non-Compliance With Study Drug|1|||
164180579|NCT03677934|593025306|FG001|Overall Study|Non-Compliance With Study Drug|0|||
164180580|NCT03677934|593025305|FG000|Overall Study|Physician Decision|0|||
164180581|NCT03677934|593025306|FG001|Overall Study|Physician Decision|1|||
164180582|NCT03677934|593025305|FG000|Overall Study|Withdrawal by Subject|1|||
164180583|NCT03677934|593025306|FG001|Overall Study|Withdrawal by Subject|7|||
164180584|NCT04769739|593025307|FG000|Overall Study|Colorectal cancer obstruction|2|||
164180585|NCT04769739|593025308|FG001|Overall Study|Colorectal cancer obstruction|0|||
164180586|NCT04769739|593025309|FG002|Overall Study|Colorectal cancer obstruction|0|||
164180587|NCT04769739|593025310|FG003|Overall Study|Colorectal cancer obstruction|0|||
164180588|NCT04769739|593025307|FG000|Overall Study|Failed cecal intubation|1|||
164180589|NCT04769739|593025308|FG001|Overall Study|Failed cecal intubation|0|||
164180590|NCT04769739|593025309|FG002|Overall Study|Failed cecal intubation|0|||
164180591|NCT04769739|593025310|FG003|Overall Study|Failed cecal intubation|1|||
164180592|NCT04769739|593025307|FG000|Overall Study|Poor bowel preparation|0|||
164180593|NCT04769739|593025308|FG001|Overall Study|Poor bowel preparation|0|||
164180594|NCT04769739|593025309|FG002|Overall Study|Poor bowel preparation|0|||
164180595|NCT04769739|593025310|FG003|Overall Study|Poor bowel preparation|1|||
164180596|NCT04395274|593025330|FG000|Overall Study|Lost to Follow-up|20|||
164180597|NCT04395274|593025331|FG001|Overall Study|Lost to Follow-up|11|||
164180598|NCT04395274|593025330|FG000|Overall Study|Withdrawal by Subject|13|||
164180599|NCT04395274|593025331|FG001|Overall Study|Withdrawal by Subject|10|||
164180600|NCT04395274|593025330|FG000|Overall Study|Moved Abroad|0|||
164180601|NCT04395274|593025331|FG001|Overall Study|Moved Abroad|1|||
164180602|NCT02028169|593025332|FG000|Overall Study|Lost to Follow-up|21|||
164180603|NCT02028169|593025332|FG000|Overall Study|Lack of Efficacy|2|||
164180604|NCT02028169|593025332|FG000|Overall Study|Withdrawal by Subject|2|||
164180605|NCT02028169|593025332|FG000|Overall Study|Adverse Event|1|||
164180606|NCT02028169|593025332|FG000|Overall Study|Cessation of Drug|1|||
164180607|NCT02028169|593025332|FG000|Overall Study|Concomitant Medication Usage|1|||
164180608|NCT01876979|593025335|FG000|Overall Study|Physician Decision|2|||
164180609|NCT01876979|593025336|FG001|Overall Study|Physician Decision|3|||
164180610|NCT02240069|593025337|FG000|Overall Study|Withdrawal by Subject|5|||
164180611|NCT02240069|593025338|FG001|Overall Study|Withdrawal by Subject|5|||
164180612|NCT02240069|593025339|FG002|Overall Study|Withdrawal by Subject|2|||
164180613|NCT00948506|593025340|FG000|Overall Study|Withdrawal by Subject|3|||
164180614|NCT00948506|593025341|FG001|Overall Study|Withdrawal by Subject|1|||
164180615|NCT03233204|593025343|FG000|Overall Study|Adverse Event|1|||
164180616|NCT03233204|593025343|FG000|Overall Study|Death|1|||
164180617|NCT03233204|593025343|FG000|Overall Study|Withdrawal by Subject|1|||
164180618|NCT03233204|593025343|FG000|Overall Study|Progressive Disease|3|||
164180619|NCT02407054|593025346|FG000|Overall Study|Adverse Event|1|||
164180620|NCT02407054|593025347|FG001|Overall Study|Adverse Event|4|||
164180621|NCT02407054|593025348|FG002|Overall Study|Adverse Event|1|||
164180622|NCT02407054|593025346|FG000|Overall Study|Non-compliance with Study|0|||
164180623|NCT02407054|593025347|FG001|Overall Study|Non-compliance with Study|2|||
164180624|NCT02407054|593025348|FG002|Overall Study|Non-compliance with Study|1|||
164180625|NCT02407054|593025346|FG000|Overall Study|Physician Decision|1|||
164180626|NCT02407054|593025347|FG001|Overall Study|Physician Decision|3|||
164180627|NCT02407054|593025348|FG002|Overall Study|Physician Decision|3|||
164180628|NCT02407054|593025346|FG000|Overall Study|Withdrawal by Subject|5|||
164180629|NCT02407054|593025347|FG001|Overall Study|Withdrawal by Subject|9|||
164180630|NCT02407054|593025348|FG002|Overall Study|Withdrawal by Subject|2|||
164180631|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
164180632|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180633|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180634|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180635|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
164180636|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
164180637|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
164180638|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180639|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180640|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180641|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
164180642|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180643|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180644|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180645|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180646|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180647|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180648|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
164180649|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180650|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180651|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180652|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
164180653|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
164180654|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
164180655|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
164180656|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
164180657|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
164180658|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
164180659|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
164180660|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
164180661|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
164180662|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
164180663|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
164180664|NCT00932698|593025349|FG000|Part 1 (Dose Escalation)|Other|0|||
164180665|NCT00932698|593025350|FG001|Part 1 (Dose Escalation)|Other|0|||
164180666|NCT00932698|593025351|FG002|Part 1 (Dose Escalation)|Other|1|||
164180667|NCT00932698|593025352|FG003|Part 1 (Dose Escalation)|Other|0|||
164180668|NCT00932698|593025353|FG004|Part 1 (Dose Escalation)|Other|0|||
164180669|NCT00932698|593025354|FG005|Part 1 (Dose Escalation)|Other|0|||
164180670|NCT00932698|593025355|FG006|Part 1 (Dose Escalation)|Other|1|||
164180671|NCT00932698|593025356|FG007|Part 1 (Dose Escalation)|Other|0|||
164180672|NCT00932698|593025357|FG008|Part 1 (Dose Escalation)|Other|0|||
164180673|NCT00932698|593025358|FG009|Part 1 (Dose Escalation)|Other|0|||
164180674|NCT00932698|593025359|FG010|Part 1 (Dose Escalation)|Other|0|||
164180675|NCT00932698|593025349|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180676|NCT00932698|593025350|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180677|NCT00932698|593025351|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180678|NCT00932698|593025352|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180679|NCT00932698|593025353|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180680|NCT00932698|593025354|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180681|NCT00932698|593025355|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
164180682|NCT00932698|593025356|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
164180683|NCT00932698|593025357|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
164180684|NCT00932698|593025358|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
164180685|NCT00932698|593025359|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
164180686|NCT00932698|593025349|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180687|NCT00932698|593025350|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180688|NCT00932698|593025351|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180689|NCT00932698|593025352|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180690|NCT00932698|593025353|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180691|NCT00932698|593025354|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180692|NCT00932698|593025355|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180693|NCT00932698|593025356|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
164180694|NCT00932698|593025357|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
164180695|NCT00932698|593025358|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
164180696|NCT00932698|593025359|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
164180697|NCT00932698|593025349|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
164180698|NCT00932698|593025350|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
164180699|NCT00932698|593025351|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
164180700|NCT00932698|593025352|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
164180701|NCT00932698|593025353|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
164180702|NCT00932698|593025354|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
164180703|NCT00932698|593025355|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
164180704|NCT00932698|593025356|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
164180705|NCT00932698|593025357|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
164180706|NCT00932698|593025358|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
164180707|NCT00932698|593025359|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
164180708|NCT00642954|593026698|FG000|Overall Study|Progressive Disease|3|||
164180709|NCT00642954|593026699|FG001|Overall Study|Progressive Disease|3|||
164180710|NCT00642954|593026700|FG002|Overall Study|Progressive Disease|3|||
164180711|NCT00642954|593026701|FG003|Overall Study|Progressive Disease|3|||
164180712|NCT00642954|593026702|FG004|Overall Study|Progressive Disease|9|||
164180713|NCT00642954|593026698|FG000|Overall Study|Withdrawal by Subject|0|||
164180714|NCT00642954|593026699|FG001|Overall Study|Withdrawal by Subject|0|||
164180715|NCT00642954|593026700|FG002|Overall Study|Withdrawal by Subject|0|||
164180716|NCT00642954|593026701|FG003|Overall Study|Withdrawal by Subject|0|||
164180717|NCT00642954|593026702|FG004|Overall Study|Withdrawal by Subject|1|||
164180718|NCT00642954|593026698|FG000|Overall Study|Adverse Event|1|||
164180719|NCT00642954|593026699|FG001|Overall Study|Adverse Event|1|||
164180720|NCT00642954|593026700|FG002|Overall Study|Adverse Event|0|||
164180721|NCT00642954|593026701|FG003|Overall Study|Adverse Event|0|||
164180722|NCT00642954|593026702|FG004|Overall Study|Adverse Event|6|||
164180723|NCT01317004|593026703|FG000|Overall Study|Withdrawal by Subject|1|||
164180724|NCT01317004|593026704|FG001|Overall Study|Withdrawal by Subject|4|||
164180725|NCT01317004|593026703|FG000|Overall Study|Protocol Violation|0|||
164180726|NCT01317004|593026704|FG001|Overall Study|Protocol Violation|2|||
164180727|NCT01317004|593026703|FG000|Overall Study|Adverse Event|3|||
164180728|NCT01317004|593026704|FG001|Overall Study|Adverse Event|3|||
164180729|NCT01890759|593026707|FG000|Overall Study|Protocol Violation|0|||
164180730|NCT01890759|593026708|FG001|Overall Study|Protocol Violation|2|||
164180731|NCT01890759|593026707|FG000|Overall Study|Lost to Follow-up|0|||
164180732|NCT01890759|593026708|FG001|Overall Study|Lost to Follow-up|2|||
164180733|NCT01890759|593026707|FG000|Overall Study|Withdrawal by Subject|2|||
164180734|NCT01890759|593026708|FG001|Overall Study|Withdrawal by Subject|8|||
164180735|NCT01344759|593026709|FG000|Overall Study|Patients failed to reach sedation level|0|||
164180736|NCT01344759|593026710|FG001|Overall Study|Patients failed to reach sedation level|2|||
164180737|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
164180738|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
164180739|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
164180740|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
164180741|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
164180742|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
164180743|NCT04114656|593026713|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
164180744|NCT04114656|593026714|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
164180745|NCT04114656|593026713|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
164180746|NCT04114656|593026714|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
164180747|NCT00703326|593026715|FG000|Overall Study|Lost to Follow-up|47|||
164180748|NCT00703326|593026716|FG001|Overall Study|Lost to Follow-up|18|||
164180749|NCT00703326|593026715|FG000|Overall Study|Withdrawal by Subject|54|||
164180750|NCT00703326|593026716|FG001|Overall Study|Withdrawal by Subject|20|||
164180751|NCT00703326|593026715|FG000|Overall Study|Adverse Event|1|||
164180752|NCT00703326|593026716|FG001|Overall Study|Adverse Event|0|||
164180753|NCT02661061|593026718|FG000|Overall Study|Lack of Efficacy|1|||
164180754|NCT02661061|593026719|FG001|Overall Study|Lack of Efficacy|1|||
164180755|NCT02661061|593026718|FG000|Overall Study|Withdrawal by Subject|1|||
164180756|NCT02661061|593026719|FG001|Overall Study|Withdrawal by Subject|1|||
164180757|NCT01393106|593026720|FG000|Overall Study|Adverse Event|3|||
164180758|NCT01393106|593026720|FG000|Overall Study|Withdrawal by Subject|1|||
164180759|NCT01393106|593026720|FG000|Overall Study|Lack of Efficacy|1|||
164180760|NCT02732015|593026721|FG000|Overall Study|Lost to Follow-up|0|||
164180761|NCT02732015|593026722|FG001|Overall Study|Lost to Follow-up|1|||
164180762|NCT03052920|593026723|FG000|Overall Study|Withdrawal by Subject|1|||
164180763|NCT01980628|593026724|FG000|Overall Study|Adverse Event|12|||
164180764|NCT01980628|593026724|FG000|Overall Study|Physician Decision|5|||
164180765|NCT01980628|593026724|FG000|Overall Study|Withdrawal by Subject|4|||
164180766|NCT01980628|593026724|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
164180767|NCT05437640|593026725|FG000|Washout (1 Week)|Adverse Event|1|||
164180768|NCT05437640|593026726|FG001|Washout (1 Week)|Adverse Event|0|||
164180769|NCT02474355|593026727|FG000|Overall Study|Other|43|||
164180770|NCT02474355|593026727|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
164180771|NCT02474355|593026727|FG000|Overall Study|Lost to Follow-up|98|||
164180772|NCT02474355|593026727|FG000|Overall Study|Withdrawal by Subject|124|||
164180773|NCT02474355|593026727|FG000|Overall Study|Death|1361|||
164180774|NCT03015194|593026729|FG000|Overall Study|Death|10|||
164180775|NCT03015194|593026729|FG000|Overall Study|Withdrawal by Subject|2|||
164180776|NCT01937715|593026733|FG000|Overall Study|Death|0|||
164180777|NCT01937715|593026734|FG001|Overall Study|Death|0|||
164180778|NCT01937715|593026735|FG002|Overall Study|Death|0|||
164180779|NCT01937715|593026736|FG003|Overall Study|Death|1|||
164180780|NCT01937715|593026737|FG004|Overall Study|Death|0|||
164180781|NCT01937715|593026733|FG000|Overall Study|Withdrawal by Subject|0|||
164180782|NCT01937715|593026734|FG001|Overall Study|Withdrawal by Subject|1|||
164180783|NCT01937715|593026735|FG002|Overall Study|Withdrawal by Subject|0|||
164180784|NCT01937715|593026736|FG003|Overall Study|Withdrawal by Subject|0|||
164180785|NCT01937715|593026737|FG004|Overall Study|Withdrawal by Subject|2|||
164180786|NCT01937715|593026733|FG000|Overall Study|Other|0|||
164180787|NCT01937715|593026734|FG001|Overall Study|Other|0|||
164180788|NCT01937715|593026735|FG002|Overall Study|Other|0|||
164180789|NCT01937715|593026736|FG003|Overall Study|Other|3|||
164180790|NCT01937715|593026737|FG004|Overall Study|Other|0|||
164180791|NCT01698268|593026740|FG000|Overall Study|Physician Decision|2|||
164180792|NCT01698268|593026741|FG001|Overall Study|Physician Decision|1|||
164180793|NCT00433017|593026742|FG000|Overall Study|Adverse Event|5|||
164180794|NCT00433017|593026743|FG001|Overall Study|Adverse Event|3|||
164180795|NCT00433017|593026742|FG000|Overall Study|Withdrawal by Subject|4|||
164180796|NCT00433017|593026743|FG001|Overall Study|Withdrawal by Subject|5|||
164180797|NCT00433017|593026742|FG000|Overall Study|Lost to Follow-up|3|||
164180798|NCT00433017|593026743|FG001|Overall Study|Lost to Follow-up|4|||
164180799|NCT00433017|593026742|FG000|Overall Study|Administrative problems|80|||
164180800|NCT00433017|593026743|FG001|Overall Study|Administrative problems|86|||
164180801|NCT00433017|593026742|FG000|Overall Study|Protocol Violation|1|||
164180802|NCT00433017|593026743|FG001|Overall Study|Protocol Violation|0|||
164180803|NCT00433017|593026742|FG000|Overall Study|Death|2|||
164180804|NCT00433017|593026743|FG001|Overall Study|Death|2|||
164180805|NCT00433017|593026742|FG000|Overall Study|Subject no longer requires study drug|1|||
164180806|NCT00433017|593026743|FG001|Overall Study|Subject no longer requires study drug|1|||
164180807|NCT00153816|593026744|FG000|Overall Study|Death|6|||
164180808|NCT00153816|593026745|FG001|Overall Study|Death|5|||
164180809|NCT00153816|593026746|FG002|Overall Study|Death|4|||
164180810|NCT00153816|593026747|FG003|Overall Study|Death|6|||
164180811|NCT00153816|593026748|FG004|Overall Study|Death|0|||
164180812|NCT00153816|593026749|FG005|Overall Study|Death|2|||
164180813|NCT00153816|593026744|FG000|Overall Study|Lost to Follow-up|7|||
164180814|NCT00153816|593026745|FG001|Overall Study|Lost to Follow-up|8|||
164180815|NCT00153816|593026746|FG002|Overall Study|Lost to Follow-up|5|||
164180816|NCT00153816|593026747|FG003|Overall Study|Lost to Follow-up|8|||
164180817|NCT00153816|593026748|FG004|Overall Study|Lost to Follow-up|7|||
164180818|NCT00153816|593026749|FG005|Overall Study|Lost to Follow-up|9|||
164180819|NCT00153816|593026744|FG000|Overall Study|Withdrawal by Subject|9|||
164180820|NCT00153816|593026745|FG001|Overall Study|Withdrawal by Subject|9|||
164180821|NCT00153816|593026746|FG002|Overall Study|Withdrawal by Subject|9|||
164180822|NCT00153816|593026747|FG003|Overall Study|Withdrawal by Subject|4|||
164180823|NCT00153816|593026748|FG004|Overall Study|Withdrawal by Subject|1|||
164180824|NCT00153816|593026749|FG005|Overall Study|Withdrawal by Subject|5|||
164180825|NCT00153816|593026744|FG000|Overall Study|Follow-up exam not done|8|||
164180826|NCT00153816|593026745|FG001|Overall Study|Follow-up exam not done|7|||
164180827|NCT00153816|593026746|FG002|Overall Study|Follow-up exam not done|11|||
164180828|NCT00153816|593026747|FG003|Overall Study|Follow-up exam not done|10|||
164180829|NCT00153816|593026748|FG004|Overall Study|Follow-up exam not done|8|||
164180830|NCT00153816|593026749|FG005|Overall Study|Follow-up exam not done|9|||
164180831|NCT00153816|593026744|FG000|Overall Study|Follow-up exam done, histology missing|2|||
164180832|NCT00153816|593026745|FG001|Overall Study|Follow-up exam done, histology missing|3|||
164180833|NCT00153816|593026746|FG002|Overall Study|Follow-up exam done, histology missing|3|||
164180834|NCT00153816|593026747|FG003|Overall Study|Follow-up exam done, histology missing|3|||
164180835|NCT00153816|593026748|FG004|Overall Study|Follow-up exam done, histology missing|1|||
164180836|NCT00153816|593026749|FG005|Overall Study|Follow-up exam done, histology missing|2|||
164180837|NCT02263729|593026750|FG000|Overall Study|Lost to Follow-up|1|||
164180838|NCT02263729|593026751|FG001|Overall Study|Lost to Follow-up|1|||
164180839|NCT04591015|593026752|FG000|Overall Study|Death|6|||
164180840|NCT04591015|593026753|FG001|Overall Study|Death|4|||
164180841|NCT04591015|593026752|FG000|Overall Study|Withdrawal by Subject|6|||
164180842|NCT04591015|593026753|FG001|Overall Study|Withdrawal by Subject|3|||
164180843|NCT04591015|593026752|FG000|Overall Study|Lost to Follow-up|16|||
164180844|NCT04591015|593026753|FG001|Overall Study|Lost to Follow-up|11|||
164180845|NCT02509078|593026754|FG000|Overall Study|Protocol Violation|1|||
164180846|NCT02509078|593026755|FG001|Overall Study|Protocol Violation|1|||
164180847|NCT03594955|593026759|FG000|Overall Study|Adverse Event|1|||
164180848|NCT03594955|593026759|FG000|Overall Study|Progressive disease|5|||
164180849|NCT03594955|593026759|FG000|Overall Study|Sponsor's decision|1|||
164180850|NCT00631163|593026768|FG000|Number of Participants in Year 1|Adverse Event|12|||
164180851|NCT00631163|593026768|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
164180852|NCT00631163|593026768|FG000|Number of Participants in Year 1|Death|6|||
164180853|NCT00631163|593026768|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
164180854|NCT00631163|593026768|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
164180855|NCT00631163|593026768|FG000|Number of Participants in Year 1|Administrative problems|6|||
164180856|NCT00631163|593026768|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
164180857|NCT00631163|593026768|FG000|Number of Participants in Year 2|Adverse Event|1|||
164180858|NCT00631163|593026768|FG000|Number of Participants in Year 2|Protocol Violation|1|||
164180859|NCT00631163|593026768|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
164180860|NCT02290925|593026770|FG000|First Period of Three Months|Lost to Follow-up|2|||
164180861|NCT02290925|593026771|FG001|First Period of Three Months|Lost to Follow-up|1|||
164180862|NCT02290925|593026770|FG000|First Period of Three Months|Death|1|||
164180863|NCT02290925|593026771|FG001|First Period of Three Months|Death|0|||
164180864|NCT02290925|593026770|FG000|First Period of Three Months|Insulin Started|1|||
164180865|NCT02290925|593026771|FG001|First Period of Three Months|Insulin Started|1|||
164180866|NCT02290925|593026770|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
164180867|NCT02290925|593026771|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
164180868|NCT02290925|593026770|FG000|Second Period of 3 Months|insulin started|0|||
164180869|NCT02290925|593026771|FG001|Second Period of 3 Months|insulin started|1|||
164180870|NCT00388297|593026779|FG000|Overall Study|Lost to Follow-up|16|||
164180871|NCT00388297|593026780|FG001|Overall Study|Lost to Follow-up|12|||
164180872|NCT00388297|593026781|FG002|Overall Study|Lost to Follow-up|11|||
164180873|NCT00388297|593026782|FG003|Overall Study|Lost to Follow-up|8|||
164180874|NCT00427999|593026788|FG000|Overall Study|Adverse Event|6|||
164180875|NCT00427999|593026788|FG000|Overall Study|Abnormal laboratory values|1|||
164180876|NCT00427999|593026788|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
164180877|NCT00427999|593026788|FG000|Overall Study|Protocol Violation|2|||
164180878|NCT00427999|593026788|FG000|Overall Study|Withdrawal by Subject|9|||
164180879|NCT00427999|593026788|FG000|Overall Study|Death|1|||
164180880|NCT02284568|593026789|FG000|Overall Study|Adverse Event|2|||
164180881|NCT02284568|593026790|FG001|Overall Study|Adverse Event|9|||
164180882|NCT02284568|593026791|FG002|Overall Study|Adverse Event|4|||
164180883|NCT02284568|593026789|FG000|Overall Study|Withdrawal by Subject|22|||
164180884|NCT02284568|593026790|FG001|Overall Study|Withdrawal by Subject|21|||
164180885|NCT02284568|593026791|FG002|Overall Study|Withdrawal by Subject|1|||
164180886|NCT02284568|593026789|FG000|Overall Study|Noncompliance with study drug admin|1|||
164180887|NCT02284568|593026790|FG001|Overall Study|Noncompliance with study drug admin|2|||
164180888|NCT02284568|593026791|FG002|Overall Study|Noncompliance with study drug admin|0|||
164180889|NCT02284568|593026789|FG000|Overall Study|Noncompliance|1|||
164180890|NCT02284568|593026790|FG001|Overall Study|Noncompliance|0|||
164180891|NCT02284568|593026791|FG002|Overall Study|Noncompliance|0|||
164180892|NCT02284568|593026789|FG000|Overall Study|Protocol Violation|0|||
164180893|NCT02284568|593026790|FG001|Overall Study|Protocol Violation|1|||
164180894|NCT02284568|593026791|FG002|Overall Study|Protocol Violation|0|||
164180895|NCT02284568|593026789|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
164180896|NCT02284568|593026790|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
164180897|NCT02284568|593026791|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
164180898|NCT02284568|593026789|FG000|Overall Study|Lost to Follow-up|0|||
164180899|NCT02284568|593026790|FG001|Overall Study|Lost to Follow-up|3|||
164180900|NCT02284568|593026791|FG002|Overall Study|Lost to Follow-up|0|||
164180901|NCT02284568|593026789|FG000|Overall Study|Lack of Efficacy|4|||
164180902|NCT02284568|593026790|FG001|Overall Study|Lack of Efficacy|7|||
164180903|NCT02284568|593026791|FG002|Overall Study|Lack of Efficacy|0|||
164180904|NCT02284568|593026789|FG000|Overall Study|Other|1|||
164180905|NCT02284568|593026790|FG001|Overall Study|Other|2|||
164180906|NCT02284568|593026791|FG002|Overall Study|Other|0|||
164180907|NCT02284568|593026789|FG000|Overall Study|Withdrew before taking study drug|0|||
164180908|NCT02284568|593026790|FG001|Overall Study|Withdrew before taking study drug|1|||
164180909|NCT02284568|593026791|FG002|Overall Study|Withdrew before taking study drug|0|||
164180910|NCT00460265|593026792|FG000|Overall Study|Lost to Follow-up|14|||
164180911|NCT00460265|593026793|FG001|Overall Study|Lost to Follow-up|15|||
164180912|NCT00460265|593026792|FG000|Overall Study|Physician Decision|1|||
164180913|NCT00460265|593026793|FG001|Overall Study|Physician Decision|2|||
164180914|NCT00460265|593026792|FG000|Overall Study|Withdrawal by Subject|10|||
164180915|NCT00460265|593026793|FG001|Overall Study|Withdrawal by Subject|25|||
164180916|NCT00460265|593026792|FG000|Overall Study|Ongoing|60|||
164180917|NCT00460265|593026793|FG001|Overall Study|Ongoing|47|||
164180918|NCT03570554|593026796|FG000|Overall Study|Non-compliance with study drug|0|||
164180919|NCT03570554|593026797|FG001|Overall Study|Non-compliance with study drug|0|||
164180920|NCT03570554|593026798|FG002|Overall Study|Non-compliance with study drug|1|||
164180921|NCT03570554|593026799|FG003|Overall Study|Non-compliance with study drug|0|||
164180922|NCT03570554|593026796|FG000|Overall Study|Adverse Event|0|||
164180923|NCT03570554|593026797|FG001|Overall Study|Adverse Event|0|||
164180924|NCT03570554|593026798|FG002|Overall Study|Adverse Event|0|||
164180925|NCT03570554|593026799|FG003|Overall Study|Adverse Event|1|||
164180926|NCT02956057|593026811|FG000|Overall Study|Discontinued intervention|14|||
164180927|NCT02956057|593026812|FG001|Overall Study|Discontinued intervention|10|||
164180928|NCT02956057|593026813|FG002|Overall Study|Discontinued intervention|7|||
164180929|NCT02956057|593026814|FG003|Overall Study|Discontinued intervention|14|||
164180930|NCT02956057|593026815|FG004|Overall Study|Discontinued intervention|4|||
164180931|NCT02956057|593026816|FG005|Overall Study|Discontinued intervention|17|||
164180932|NCT02956057|593026811|FG000|Overall Study|Lost to Follow-up|0|||
164180933|NCT02956057|593026812|FG001|Overall Study|Lost to Follow-up|2|||
164180934|NCT02956057|593026813|FG002|Overall Study|Lost to Follow-up|1|||
164180935|NCT02956057|593026814|FG003|Overall Study|Lost to Follow-up|1|||
164180936|NCT02956057|593026815|FG004|Overall Study|Lost to Follow-up|1|||
164180937|NCT02956057|593026816|FG005|Overall Study|Lost to Follow-up|0|||
164180938|NCT01420679|593026821|FG000|Overall Study|Disease Progression|3|||
164180939|NCT01420679|593026822|FG001|Overall Study|Disease Progression|2|||
164180940|NCT01420679|593026821|FG000|Overall Study|Adverse Event|4|||
164180941|NCT01420679|593026822|FG001|Overall Study|Adverse Event|0|||
164180942|NCT01420679|593026821|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
164180943|NCT01420679|593026822|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
164180944|NCT01420679|593026821|FG000|Overall Study|Patient Decision|1|||
164180945|NCT01420679|593026822|FG001|Overall Study|Patient Decision|0|||
164180946|NCT01420679|593026821|FG000|Overall Study|Investigator Decision|1|||
164180947|NCT01420679|593026822|FG001|Overall Study|Investigator Decision|2|||
164180948|NCT01420679|593026821|FG000|Overall Study|Sponsor Decision|3|||
164180949|NCT01420679|593026822|FG001|Overall Study|Sponsor Decision|3|||
164180950|NCT01420679|593026821|FG000|Overall Study|Other|1|||
164180951|NCT01420679|593026822|FG001|Overall Study|Other|0|||
164180952|NCT03956615|593026823|FG000|Overall Study|No multiple myeloma confirmed|2|||
164180953|NCT03956615|593026823|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
164180954|NCT03956615|593026823|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
164180955|NCT03956615|593026823|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
164180956|NCT01069419|593026824|FG000|Overall Study|Adverse Event|233|||
164180957|NCT01069419|593026824|FG000|Overall Study|Lack of Efficacy|332|||
164180958|NCT01069419|593026824|FG000|Overall Study|Lost to Follow-up|49|||
164180959|NCT01069419|593026824|FG000|Overall Study|Remission of disease|11|||
164180960|NCT01069419|593026824|FG000|Overall Study|Withdrawal by Subject|34|||
164180961|NCT01069419|593026824|FG000|Overall Study|Other Reason|43|||
164180962|NCT01069419|593026824|FG000|Overall Study|Missing termination information|13|||
164180963|NCT00236899|593026827|FG000|Overall Study|Adverse Event (Study Related)|1|||
164180964|NCT00236899|593026828|FG001|Overall Study|Adverse Event (Study Related)|1|||
164180965|NCT00236899|593026829|FG002|Overall Study|Adverse Event (Study Related)|2|||
164180966|NCT00236899|593026830|FG003|Overall Study|Adverse Event (Study Related)|1|||
164180967|NCT00236899|593026827|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
164180968|NCT00236899|593026828|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
164180969|NCT00236899|593026829|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
164180970|NCT00236899|593026830|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
164180971|NCT00236899|593026827|FG000|Overall Study|Death (Study Disease)|1|||
164180972|NCT00236899|593026828|FG001|Overall Study|Death (Study Disease)|4|||
164180973|NCT00236899|593026829|FG002|Overall Study|Death (Study Disease)|0|||
164180974|NCT00236899|593026830|FG003|Overall Study|Death (Study Disease)|0|||
164180975|NCT00236899|593026827|FG000|Overall Study|Death (Not Study Related)|2|||
164180976|NCT00236899|593026828|FG001|Overall Study|Death (Not Study Related)|0|||
164180977|NCT00236899|593026829|FG002|Overall Study|Death (Not Study Related)|0|||
164180978|NCT00236899|593026830|FG003|Overall Study|Death (Not Study Related)|0|||
164180979|NCT00236899|593026827|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
164180980|NCT00236899|593026828|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
164180981|NCT00236899|593026829|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
164180982|NCT00236899|593026830|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
164180983|NCT00236899|593026827|FG000|Overall Study|Lost to Follow-up|0|||
164180984|NCT00236899|593026828|FG001|Overall Study|Lost to Follow-up|1|||
164180985|NCT00236899|593026829|FG002|Overall Study|Lost to Follow-up|0|||
164180986|NCT00236899|593026830|FG003|Overall Study|Lost to Follow-up|0|||
164180987|NCT00236899|593026827|FG000|Overall Study|Entry Criteria Exclusion|0|||
164180988|NCT00236899|593026828|FG001|Overall Study|Entry Criteria Exclusion|1|||
164180989|NCT00236899|593026829|FG002|Overall Study|Entry Criteria Exclusion|1|||
164180990|NCT00236899|593026830|FG003|Overall Study|Entry Criteria Exclusion|0|||
164180991|NCT00236899|593026827|FG000|Overall Study|Protocol Violation|1|||
164180992|NCT00236899|593026828|FG001|Overall Study|Protocol Violation|0|||
164180993|NCT00236899|593026829|FG002|Overall Study|Protocol Violation|0|||
164180994|NCT00236899|593026830|FG003|Overall Study|Protocol Violation|0|||
164180995|NCT00236899|593026827|FG000|Overall Study|Withdrawal by Subject|6|||
164180996|NCT00236899|593026828|FG001|Overall Study|Withdrawal by Subject|4|||
164180997|NCT00236899|593026829|FG002|Overall Study|Withdrawal by Subject|5|||
164180998|NCT00236899|593026830|FG003|Overall Study|Withdrawal by Subject|2|||
164180999|NCT00236899|593026827|FG000|Overall Study|Physician Decision|7|||
164181000|NCT00236899|593026828|FG001|Overall Study|Physician Decision|8|||
164181001|NCT00236899|593026829|FG002|Overall Study|Physician Decision|7|||
164181002|NCT00236899|593026830|FG003|Overall Study|Physician Decision|6|||
164181003|NCT00236899|593026827|FG000|Overall Study|Satisfactory Response|2|||
164181004|NCT00236899|593026828|FG001|Overall Study|Satisfactory Response|0|||
164181005|NCT00236899|593026829|FG002|Overall Study|Satisfactory Response|0|||
164181006|NCT00236899|593026830|FG003|Overall Study|Satisfactory Response|1|||
164181007|NCT00236899|593026827|FG000|Overall Study|Lack of Efficacy|18|||
164181008|NCT00236899|593026828|FG001|Overall Study|Lack of Efficacy|18|||
164181009|NCT00236899|593026829|FG002|Overall Study|Lack of Efficacy|25|||
164181010|NCT00236899|593026830|FG003|Overall Study|Lack of Efficacy|23|||
164181011|NCT02565706|593026831|FG000|Overall Study|Withdrawal by Subject|5|||
164181012|NCT02565706|593026832|FG001|Overall Study|Withdrawal by Subject|7|||
164181013|NCT02565706|593026833|FG002|Overall Study|Withdrawal by Subject|7|||
164181014|NCT02565706|593026834|FG003|Overall Study|Withdrawal by Subject|11|||
164181015|NCT02565706|593026831|FG000|Overall Study|Lost to Follow-up|72|||
164181016|NCT02565706|593026832|FG001|Overall Study|Lost to Follow-up|75|||
164181017|NCT02565706|593026833|FG002|Overall Study|Lost to Follow-up|82|||
164181018|NCT02565706|593026834|FG003|Overall Study|Lost to Follow-up|74|||
164181019|NCT01281956|593026837|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
164181020|NCT01281956|593026838|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
164181021|NCT01904903|593026839|FG000|Overall Study|Withdrawal by Subject|1|||
164181022|NCT01634659|593026841|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
164181023|NCT01634659|593026842|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
164181024|NCT01634659|593026841|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
164181025|NCT01634659|593026842|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
164181026|NCT00335959|593026843|FG000|Overall Study|Adverse Event|2|||
164181027|NCT00335959|593026843|FG000|Overall Study|Ineligible|1|||
164181028|NCT01447927|593026846|FG000|Overall Study|Adverse Event|4|||
164181029|NCT01447927|593026847|FG001|Overall Study|Adverse Event|3|||
164181030|NCT01447927|593026846|FG000|Overall Study|Withdrawal by Subject|1|||
164181031|NCT01447927|593026847|FG001|Overall Study|Withdrawal by Subject|0|||
164181032|NCT02190721|593028774|FG000|Overall Study|Patient was out of the city|0|||
164181033|NCT02190721|593028775|FG001|Overall Study|Patient was out of the city|1|||
164181034|NCT02190721|593028776|FG002|Overall Study|Patient was out of the city|0|||
164181035|NCT01760447|593028777|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
164181036|NCT01760447|593028778|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
164181037|NCT01760447|593028779|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
164181038|NCT01760447|593028780|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
164181039|NCT01760447|593028777|FG000|Weeks 0-20|Withdrawal by Subject|2|||
164181040|NCT01760447|593028778|FG001|Weeks 0-20|Withdrawal by Subject|0|||
164181041|NCT01760447|593028779|FG002|Weeks 0-20|Withdrawal by Subject|1|||
164181042|NCT01760447|593028780|FG003|Weeks 0-20|Withdrawal by Subject|0|||
164181043|NCT01760447|593028777|FG000|Weeks 0-20|Lost to Follow-up|1|||
164181044|NCT01760447|593028778|FG001|Weeks 0-20|Lost to Follow-up|0|||
164181045|NCT01760447|593028779|FG002|Weeks 0-20|Lost to Follow-up|1|||
164181046|NCT01760447|593028780|FG003|Weeks 0-20|Lost to Follow-up|1|||
164181047|NCT01760447|593028777|FG000|Weeks 0-20|Randomized but not treated|0|||
164181048|NCT01760447|593028778|FG001|Weeks 0-20|Randomized but not treated|0|||
164181049|NCT01760447|593028779|FG002|Weeks 0-20|Randomized but not treated|2|||
164181050|NCT01760447|593028780|FG003|Weeks 0-20|Randomized but not treated|0|||
164181051|NCT01760447|593028777|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
164181052|NCT01760447|593028778|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
164181053|NCT01760447|593028779|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
164181054|NCT01760447|593028780|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
164181055|NCT01760447|593028777|FG000|Weeks 20-54|Withdrawal by Subject|2|||
164181056|NCT01760447|593028778|FG001|Weeks 20-54|Withdrawal by Subject|1|||
164181057|NCT01760447|593028779|FG002|Weeks 20-54|Withdrawal by Subject|1|||
164181058|NCT01760447|593028780|FG003|Weeks 20-54|Withdrawal by Subject|2|||
164181059|NCT01760447|593028777|FG000|Weeks 20-54|Lost to Follow-up|0|||
164181060|NCT01760447|593028778|FG001|Weeks 20-54|Lost to Follow-up|0|||
164181061|NCT01760447|593028779|FG002|Weeks 20-54|Lost to Follow-up|1|||
164181062|NCT01760447|593028780|FG003|Weeks 20-54|Lost to Follow-up|2|||
164181063|NCT01214668|593028781|FG000|Overall Study|Adverse Event|0|||
164181064|NCT01214668|593028782|FG001|Overall Study|Adverse Event|1|||
164181065|NCT01214668|593028783|FG002|Overall Study|Adverse Event|0|||
164181066|NCT01214668|593028784|FG003|Overall Study|Adverse Event|2|||
164181067|NCT01214668|593028785|FG004|Overall Study|Adverse Event|1|||
164181068|NCT01214668|593028786|FG005|Overall Study|Adverse Event|1|||
164181069|NCT01214668|593028781|FG000|Overall Study|Death|0|||
164181070|NCT01214668|593028782|FG001|Overall Study|Death|0|||
164181071|NCT01214668|593028783|FG002|Overall Study|Death|1|||
164181072|NCT01214668|593028784|FG003|Overall Study|Death|0|||
164181073|NCT01214668|593028785|FG004|Overall Study|Death|0|||
164181074|NCT01214668|593028786|FG005|Overall Study|Death|0|||
164181075|NCT01214668|593028781|FG000|Overall Study|Progressive Disease|4|||
164181076|NCT01214668|593028782|FG001|Overall Study|Progressive Disease|2|||
164181077|NCT01214668|593028783|FG002|Overall Study|Progressive Disease|5|||
164181078|NCT01214668|593028784|FG003|Overall Study|Progressive Disease|4|||
164181079|NCT01214668|593028785|FG004|Overall Study|Progressive Disease|4|||
164181080|NCT01214668|593028786|FG005|Overall Study|Progressive Disease|5|||
164181081|NCT01214668|593028781|FG000|Overall Study|Withdrawal by Subject|0|||
164181082|NCT01214668|593028782|FG001|Overall Study|Withdrawal by Subject|0|||
164181083|NCT01214668|593028783|FG002|Overall Study|Withdrawal by Subject|0|||
164181084|NCT01214668|593028784|FG003|Overall Study|Withdrawal by Subject|0|||
164181085|NCT01214668|593028785|FG004|Overall Study|Withdrawal by Subject|1|||
164181086|NCT01214668|593028786|FG005|Overall Study|Withdrawal by Subject|0|||
164181087|NCT02907619|593028787|FG000|Overall Study|Study terminated by sponsor|18|||
164181088|NCT02907619|593028788|FG001|Overall Study|Study terminated by sponsor|18|||
164181089|NCT02907619|593028789|FG002|Overall Study|Study terminated by sponsor|19|||
164181090|NCT02907619|593028787|FG000|Overall Study|Death|0|||
164181091|NCT02907619|593028788|FG001|Overall Study|Death|0|||
164181092|NCT02907619|593028789|FG002|Overall Study|Death|1|||
164181093|NCT02907619|593028787|FG000|Overall Study|Withdrawal by Subject|1|||
164181094|NCT02907619|593028788|FG001|Overall Study|Withdrawal by Subject|1|||
164181095|NCT02907619|593028789|FG002|Overall Study|Withdrawal by Subject|0|||
164181096|NCT02907619|593028787|FG000|Overall Study|Other|0|||
164181097|NCT02907619|593028788|FG001|Overall Study|Other|1|||
164181098|NCT02907619|593028789|FG002|Overall Study|Other|0|||
164181099|NCT03326518|593028790|FG000|Overall Study|Protocol Violation|1|||
164181100|NCT03326518|593028791|FG001|Overall Study|Protocol Violation|0|||
164181101|NCT03326518|593028792|FG002|Overall Study|Protocol Violation|0|||
164181102|NCT03326518|593028790|FG000|Overall Study|Withdrawal by Subject|1|||
164181103|NCT03326518|593028791|FG001|Overall Study|Withdrawal by Subject|0|||
164181104|NCT03326518|593028792|FG002|Overall Study|Withdrawal by Subject|0|||
164181105|NCT03326518|593028790|FG000|Overall Study|Lost to Follow-up|1|||
164181106|NCT03326518|593028791|FG001|Overall Study|Lost to Follow-up|0|||
164181107|NCT03326518|593028792|FG002|Overall Study|Lost to Follow-up|1|||
164181108|NCT06439095|593028793|FG000|Overall Study|Lost to Follow-up|2|||
164181109|NCT03484403|593028795|FG000|Overall Study|Withdrawal by Subject|6|||
164181110|NCT03484403|593028796|FG001|Overall Study|Withdrawal by Subject|4|||
164181111|NCT01937884|593028797|FG000|Overall Study|Withdrawal by Subject|1|||
164181112|NCT01937884|593028798|FG001|Overall Study|Withdrawal by Subject|0|||
164181113|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
164181114|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
164181115|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
164181116|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
164181117|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
164181118|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
164181119|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
164181120|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
164181121|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
164181122|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
164181123|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
164181124|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
164181125|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Death|0|||
164181126|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Death|0|||
164181127|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Death|1|||
164181128|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Death|0|||
164181129|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
164181130|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
164181131|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
164181132|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
164181133|NCT01179737|593028803|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
164181134|NCT01179737|593028804|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
164181135|NCT01179737|593028805|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
164181136|NCT01179737|593028806|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
164181137|NCT01179737|593028803|FG000|Extension|The study was terminated|3|||
164181138|NCT01179737|593028804|FG001|Extension|The study was terminated|0|||
164181139|NCT01179737|593028805|FG002|Extension|The study was terminated|0|||
164181140|NCT01179737|593028806|FG003|Extension|The study was terminated|0|||
164181141|NCT01254721|593028807|FG000|Overall Study|Lost to Follow-up|0|||
164181142|NCT01254721|593028808|FG001|Overall Study|Lost to Follow-up|4|||
164181143|NCT01254721|593028807|FG000|Overall Study|Lack of Efficacy|4|||
164181144|NCT01254721|593028808|FG001|Overall Study|Lack of Efficacy|2|||
164181145|NCT01254721|593028807|FG000|Overall Study|Death|0|||
164181146|NCT01254721|593028808|FG001|Overall Study|Death|1|||
164181147|NCT01254721|593028807|FG000|Overall Study|technical problum|1|||
164181148|NCT01254721|593028808|FG001|Overall Study|technical problum|0|||
164181149|NCT01254721|593028807|FG000|Overall Study|Adverse Event|2|||
164181150|NCT01254721|593028808|FG001|Overall Study|Adverse Event|3|||
164181151|NCT01254721|593028807|FG000|Overall Study|Withdrawal by Subject|8|||
164181152|NCT01254721|593028808|FG001|Overall Study|Withdrawal by Subject|11|||
164181153|NCT01254721|593028807|FG000|Overall Study|Wrongly randomization|0|||
164181154|NCT01254721|593028808|FG001|Overall Study|Wrongly randomization|1|||
164181155|NCT01955109|593028809|FG000|Overall Study|Adverse Event|2|||
164181156|NCT01955109|593028810|FG001|Overall Study|Adverse Event|0|||
164181157|NCT01955109|593028809|FG000|Overall Study|Participant unwilling to continue|35|||
164181158|NCT01955109|593028810|FG001|Overall Study|Participant unwilling to continue|7|||
164181159|NCT01955109|593028809|FG000|Overall Study|Physician Decision|2|||
164181160|NCT01955109|593028810|FG001|Overall Study|Physician Decision|0|||
164181161|NCT01955109|593028809|FG000|Overall Study|Lost to Follow-up|3|||
164181162|NCT01955109|593028810|FG001|Overall Study|Lost to Follow-up|1|||
164181163|NCT01955109|593028809|FG000|Overall Study|Non-compliance|3|||
164181164|NCT01955109|593028810|FG001|Overall Study|Non-compliance|1|||
164181165|NCT00904839|593028811|FG000|Overall Study|Adverse Event|0|||
164181166|NCT00904839|593028812|FG001|Overall Study|Adverse Event|5|||
164181167|NCT00904839|593028813|FG002|Overall Study|Adverse Event|4|||
164181168|NCT00904839|593028811|FG000|Overall Study|Protocol Violation|0|||
164181169|NCT00904839|593028812|FG001|Overall Study|Protocol Violation|1|||
164181170|NCT00904839|593028813|FG002|Overall Study|Protocol Violation|1|||
164181171|NCT00904839|593028811|FG000|Overall Study|Lost to Follow-up|0|||
164181172|NCT00904839|593028812|FG001|Overall Study|Lost to Follow-up|1|||
164181173|NCT00904839|593028813|FG002|Overall Study|Lost to Follow-up|2|||
164181174|NCT00904839|593028811|FG000|Overall Study|Withdrawal by Subject|0|||
164181175|NCT00904839|593028812|FG001|Overall Study|Withdrawal by Subject|2|||
164181176|NCT00904839|593028813|FG002|Overall Study|Withdrawal by Subject|0|||
164181177|NCT00904839|593028811|FG000|Overall Study|Not treated|1|||
164181178|NCT00904839|593028812|FG001|Overall Study|Not treated|0|||
164181179|NCT00904839|593028813|FG002|Overall Study|Not treated|1|||
164181180|NCT00904839|593028811|FG000|Overall Study|Other than above|0|||
164181181|NCT00904839|593028812|FG001|Overall Study|Other than above|9|||
164181182|NCT00904839|593028813|FG002|Overall Study|Other than above|7|||
164181183|NCT01853696|593028816|FG000|Overall Study|Withdrawal by Subject|1|||
164181184|NCT01853696|593028817|FG001|Overall Study|Withdrawal by Subject|1|||
164181185|NCT01853696|593028816|FG000|Overall Study|Lost to Follow-up|5|||
164181186|NCT01853696|593028817|FG001|Overall Study|Lost to Follow-up|4|||
164181187|NCT01167634|593028818|FG000|Overall Study|Lost to Follow-up|1|||
164181188|NCT01167634|593028819|FG001|Overall Study|Lost to Follow-up|3|||
164181189|NCT01167634|593028820|FG002|Overall Study|Lost to Follow-up|3|||
164181190|NCT01167634|593028821|FG003|Overall Study|Lost to Follow-up|4|||
164181191|NCT01167634|593028818|FG000|Overall Study|Withdrawal by Subject|1|||
164181192|NCT01167634|593028819|FG001|Overall Study|Withdrawal by Subject|1|||
164181193|NCT01167634|593028820|FG002|Overall Study|Withdrawal by Subject|0|||
164181194|NCT01167634|593028821|FG003|Overall Study|Withdrawal by Subject|0|||
164181195|NCT00553358|593028822|FG000|Overall Study|Randomized but did not receive treatment|3|||
164181196|NCT00553358|593028823|FG001|Overall Study|Randomized but did not receive treatment|3|||
164181197|NCT00553358|593028824|FG002|Overall Study|Randomized but did not receive treatment|1|||
164181198|NCT00553358|593028822|FG000|Overall Study|Lost to Follow-up|22|||
164181199|NCT00553358|593028823|FG001|Overall Study|Lost to Follow-up|26|||
164181200|NCT00553358|593028824|FG002|Overall Study|Lost to Follow-up|18|||
164181201|NCT00553358|593028822|FG000|Overall Study|Withdrew completely|23|||
164181202|NCT00553358|593028823|FG001|Overall Study|Withdrew completely|33|||
164181203|NCT00553358|593028824|FG002|Overall Study|Withdrew completely|34|||
164181204|NCT00553358|593028822|FG000|Overall Study|Died during clinical follow-up|25|||
164181205|NCT00553358|593028823|FG001|Overall Study|Died during clinical follow-up|29|||
164181206|NCT00553358|593028824|FG002|Overall Study|Died during clinical follow-up|32|||
164181207|NCT00553358|593028822|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
164181208|NCT00553358|593028823|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
164181209|NCT00553358|593028824|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
164181210|NCT00553358|593028822|FG000|Overall Study|Died after clinical follow-up ended|1|||
164181211|NCT00553358|593028823|FG001|Overall Study|Died after clinical follow-up ended|2|||
164181212|NCT00553358|593028824|FG002|Overall Study|Died after clinical follow-up ended|0|||
164181213|NCT00553358|593028822|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
164181214|NCT00553358|593028823|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
164181215|NCT00553358|593028824|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
164181216|NCT02854605|593028829|FG000|Overall Study|Adverse Event|1|||
164181217|NCT02854605|593028830|FG001|Overall Study|Adverse Event|5|||
164181218|NCT02854605|593028831|FG002|Overall Study|Adverse Event|2|||
164181219|NCT02854605|593028829|FG000|Overall Study|Lost to Follow-up|0|||
164181220|NCT02854605|593028830|FG001|Overall Study|Lost to Follow-up|2|||
164181221|NCT02854605|593028831|FG002|Overall Study|Lost to Follow-up|0|||
164181222|NCT02854605|593028829|FG000|Overall Study|Withdrew Consent|1|||
164181223|NCT02854605|593028830|FG001|Overall Study|Withdrew Consent|0|||
164181224|NCT02854605|593028831|FG002|Overall Study|Withdrew Consent|1|||
164181225|NCT02854605|593028829|FG000|Overall Study|Investigator's Discretion|1|||
164181226|NCT02854605|593028830|FG001|Overall Study|Investigator's Discretion|0|||
164181227|NCT02854605|593028831|FG002|Overall Study|Investigator's Discretion|0|||
164181228|NCT02854605|593028829|FG000|Overall Study|Protocol Violation|0|||
164181229|NCT02854605|593028830|FG001|Overall Study|Protocol Violation|0|||
164181230|NCT02854605|593028831|FG002|Overall Study|Protocol Violation|1|||
164181231|NCT03003000|593028832|FG000|Overall Study|Adverse Event|1|||
164181232|NCT03003000|593028833|FG001|Overall Study|Adverse Event|2|||
164181233|NCT03003000|593028834|FG002|Overall Study|Adverse Event|3|||
164181234|NCT03003000|593028832|FG000|Overall Study|Lack of Efficacy|1|||
164181235|NCT03003000|593028833|FG001|Overall Study|Lack of Efficacy|0|||
164181236|NCT03003000|593028834|FG002|Overall Study|Lack of Efficacy|0|||
164181237|NCT03003000|593028832|FG000|Overall Study|Non-compliant with protocol|0|||
164181238|NCT03003000|593028833|FG001|Overall Study|Non-compliant with protocol|1|||
164181239|NCT03003000|593028834|FG002|Overall Study|Non-compliant with protocol|1|||
164181240|NCT03003000|593028832|FG000|Overall Study|Refused to continue medication|2|||
164181241|NCT03003000|593028833|FG001|Overall Study|Refused to continue medication|0|||
164181242|NCT03003000|593028834|FG002|Overall Study|Refused to continue medication|0|||
164181243|NCT03003000|593028832|FG000|Overall Study|Other than listed|1|||
164181244|NCT03003000|593028833|FG001|Overall Study|Other than listed|1|||
164181245|NCT03003000|593028834|FG002|Overall Study|Other than listed|1|||
164181246|NCT04933617|593028835|FG000|Dose Escalation|Early closure of study|0|||
164181247|NCT04933617|593028836|FG001|Dose Escalation|Early closure of study|3|||
164181248|NCT04933617|593028837|FG002|Dose Escalation|Early closure of study|0|||
164181249|NCT04933617|593028838|FG003|Dose Escalation|Early closure of study|0|||
164181250|NCT04933617|593028839|FG004|Dose Escalation|Early closure of study|0|||
164181251|NCT05268016|593028840|FG000|Overall Study|Unacceptable toxicity or AE|2|||
164181252|NCT05268016|593028841|FG001|Overall Study|Unacceptable toxicity or AE|2|||
164181253|NCT05268016|593028842|FG002|Overall Study|Unacceptable toxicity or AE|4|||
164181254|NCT05268016|593028843|FG003|Overall Study|Unacceptable toxicity or AE|3|||
164181255|NCT05268016|593028844|FG004|Overall Study|Unacceptable toxicity or AE|1|||
164181256|NCT05268016|593028840|FG000|Overall Study|Withdrawal by Subject|1|||
164181257|NCT05268016|593028841|FG001|Overall Study|Withdrawal by Subject|3|||
164181258|NCT05268016|593028842|FG002|Overall Study|Withdrawal by Subject|2|||
164181259|NCT05268016|593028843|FG003|Overall Study|Withdrawal by Subject|2|||
164181260|NCT05268016|593028844|FG004|Overall Study|Withdrawal by Subject|1|||
164181261|NCT05268016|593028840|FG000|Overall Study|Lost to Follow-up|4|||
164181262|NCT05268016|593028841|FG001|Overall Study|Lost to Follow-up|7|||
164181263|NCT05268016|593028842|FG002|Overall Study|Lost to Follow-up|1|||
164181264|NCT05268016|593028843|FG003|Overall Study|Lost to Follow-up|3|||
164181265|NCT05268016|593028844|FG004|Overall Study|Lost to Follow-up|5|||
164181345|NCT01260584|593028870|FG002|Period 1|Protocol Violation|1|||
164181266|NCT05268016|593028840|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
164181267|NCT05268016|593028841|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
164181268|NCT05268016|593028842|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
164181269|NCT05268016|593028843|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
164181270|NCT05268016|593028844|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
164181271|NCT05268016|593028840|FG000|Overall Study|Lack of Efficacy|0|||
164181272|NCT05268016|593028841|FG001|Overall Study|Lack of Efficacy|0|||
164181273|NCT05268016|593028842|FG002|Overall Study|Lack of Efficacy|0|||
164181274|NCT05268016|593028843|FG003|Overall Study|Lack of Efficacy|0|||
164181275|NCT05268016|593028844|FG004|Overall Study|Lack of Efficacy|4|||
164181276|NCT05268016|593028840|FG000|Overall Study|Physician Decision|0|||
164181277|NCT05268016|593028841|FG001|Overall Study|Physician Decision|0|||
164181278|NCT05268016|593028842|FG002|Overall Study|Physician Decision|0|||
164181279|NCT05268016|593028843|FG003|Overall Study|Physician Decision|1|||
164181280|NCT05268016|593028844|FG004|Overall Study|Physician Decision|0|||
164181281|NCT05268016|593028840|FG000|Overall Study|Other|1|||
164181282|NCT05268016|593028841|FG001|Overall Study|Other|0|||
164181283|NCT05268016|593028842|FG002|Overall Study|Other|1|||
164181284|NCT05268016|593028843|FG003|Overall Study|Other|2|||
164181285|NCT05268016|593028844|FG004|Overall Study|Other|0|||
164181286|NCT02191046|593028845|FG000|Overall Study|low compliance|5|||
164181287|NCT02191046|593028846|FG001|Overall Study|low compliance|1|||
164181288|NCT01964716|593028847|FG000|Overall Study|Withdrawal by Subject|2|||
164181289|NCT01964716|593028848|FG001|Overall Study|Withdrawal by Subject|3|||
164181290|NCT01964716|593028847|FG000|Overall Study|Lost to Follow-up|1|||
164181291|NCT01964716|593028848|FG001|Overall Study|Lost to Follow-up|2|||
164181292|NCT01964716|593028847|FG000|Overall Study|No longer met eligibility criteria|1|||
164181293|NCT01964716|593028848|FG001|Overall Study|No longer met eligibility criteria|1|||
164181294|NCT01964716|593028847|FG000|Overall Study|Death|1|||
164181295|NCT01964716|593028848|FG001|Overall Study|Death|0|||
164181296|NCT02147067|593028849|FG000|Overall Study|Withdrawal by Subject|2|||
164181297|NCT02147067|593028850|FG001|Overall Study|Withdrawal by Subject|2|||
164181298|NCT00791492|593028851|FG000|Overall Study|Withdrawal by Subject|1|||
164181299|NCT00791492|593028852|FG001|Overall Study|Withdrawal by Subject|2|||
164181300|NCT00791492|593028851|FG000|Overall Study|Liver transplantation|5|||
164181301|NCT00791492|593028852|FG001|Overall Study|Liver transplantation|1|||
164181302|NCT00090987|593028853|FG000|Overall Study|Adverse Event|5|||
164181303|NCT00090987|593028853|FG000|Overall Study|Lack of Efficacy|7|||
164181304|NCT00090987|593028853|FG000|Overall Study|Withdrawal by Subject|3|||
164181305|NCT00090987|593028853|FG000|Overall Study|alternative therapy|1|||
164181306|NCT00090987|593028853|FG000|Overall Study|Non-compliance|4|||
164181307|NCT00090987|593028853|FG000|Overall Study|Incarcerated|1|||
164181308|NCT00990665|593028858|FG000|Overall Study|Unsuccessful Implant|8|||
164181309|NCT00990665|593028858|FG000|Overall Study|Death|29|||
164181310|NCT00990665|593028858|FG000|Overall Study|Heart Transplant|1|||
164181311|NCT00990665|593028858|FG000|Overall Study|Withdrawal by Subject|6|||
164181312|NCT00990665|593028858|FG000|Overall Study|Lost to Follow-up|1|||
164181313|NCT00990665|593028858|FG000|Overall Study|System Explant|3|||
164181314|NCT00270231|593028859|FG000|First Intervention|Lost to Follow-up|1|||
164181315|NCT00270231|593028860|FG001|First Intervention|Lost to Follow-up|1|||
164181316|NCT00270231|593028859|FG000|Washout Period|Lost to Follow-up|1|||
164181317|NCT00270231|593028860|FG001|Washout Period|Lost to Follow-up|0|||
164181318|NCT00270231|593028859|FG000|Second Intervention|Lost to Follow-up|0|||
164181319|NCT00270231|593028860|FG001|Second Intervention|Lost to Follow-up|1|||
164181320|NCT02603562|593028861|FG000|Overall Study|Lost to Follow-up|1|||
164181321|NCT00574795|593028863|FG000|Infant Series|Withdrawal by Subject|2|||
164181322|NCT00574795|593028863|FG000|Infant Series|Protocol Violation|2|||
164181323|NCT00574795|593028863|FG000|Infant Series|Adverse Event|1|||
164181324|NCT00574795|593028863|FG000|After Infant Series|Withdrawal by Subject|1|||
164181325|NCT00574795|593028863|FG000|After Infant Series|Adverse Event|2|||
164181326|NCT00574795|593028863|FG000|Toddler Dose|Withdrawal by Subject|1|||
164181327|NCT00314132|593028864|FG000|Overall Study|Lost to Follow-up|3|||
164181328|NCT00314132|593028865|FG001|Overall Study|Lost to Follow-up|13|||
164181329|NCT00314132|593028864|FG000|Overall Study|Withdrawal by Subject|3|||
164181330|NCT00314132|593028865|FG001|Overall Study|Withdrawal by Subject|5|||
164181331|NCT00314132|593028864|FG000|Overall Study|Adverse Event|1|||
164181332|NCT00314132|593028865|FG001|Overall Study|Adverse Event|0|||
164181333|NCT00314132|593028864|FG000|Overall Study|Physician Decision|1|||
164181334|NCT00314132|593028865|FG001|Overall Study|Physician Decision|0|||
164181335|NCT00957905|593028866|FG000|Part B|Not Treated|0|||
164181336|NCT00957905|593028867|FG001|Part B|Not Treated|1|||
164181337|NCT00957905|593028866|FG000|Part B|Physician Decision|0|||
164181338|NCT00957905|593028867|FG001|Part B|Physician Decision|1|||
164181339|NCT00957905|593028866|FG000|Part B|Death|0|||
164181340|NCT00957905|593028867|FG001|Part B|Death|1|||
164181341|NCT00957905|593028866|FG000|Part B|Protocol Violation|0|||
164181342|NCT00957905|593028867|FG001|Part B|Protocol Violation|1|||
164181343|NCT01260584|593028868|FG000|Period 1|Protocol Violation|0|||
164181344|NCT01260584|593028869|FG001|Period 1|Protocol Violation|0|||
164181346|NCT01260584|593028871|FG003|Period 1|Protocol Violation|1|||
164181347|NCT01260584|593028868|FG000|Period 1|Adverse Event|0|||
164181348|NCT01260584|593028869|FG001|Period 1|Adverse Event|0|||
164181349|NCT01260584|593028870|FG002|Period 1|Adverse Event|1|||
164181350|NCT01260584|593028871|FG003|Period 1|Adverse Event|0|||
164181351|NCT01260584|593028868|FG000|Period 2|Protocol Violation|0|||
164181352|NCT01260584|593028869|FG001|Period 2|Protocol Violation|2|||
164181353|NCT01260584|593028870|FG002|Period 2|Protocol Violation|3|||
164181354|NCT01260584|593028871|FG003|Period 2|Protocol Violation|1|||
164181355|NCT01260584|593028868|FG000|Period 2|Adverse Event|1|||
164181356|NCT01260584|593028869|FG001|Period 2|Adverse Event|0|||
164181357|NCT01260584|593028870|FG002|Period 2|Adverse Event|2|||
164181358|NCT01260584|593028871|FG003|Period 2|Adverse Event|0|||
164181359|NCT01260584|593028868|FG000|Period 2|Withdrawal by Subject|0|||
164181360|NCT01260584|593028869|FG001|Period 2|Withdrawal by Subject|1|||
164181361|NCT01260584|593028870|FG002|Period 2|Withdrawal by Subject|0|||
164181362|NCT01260584|593028871|FG003|Period 2|Withdrawal by Subject|0|||
164181363|NCT03434249|593028872|FG000|Overall Study|Adverse Event|1|||
164181364|NCT03434249|593028873|FG001|Overall Study|Adverse Event|0|||
164181365|NCT03434249|593028872|FG000|Overall Study|Lost to Follow-up|0|||
164181366|NCT03434249|593028873|FG001|Overall Study|Lost to Follow-up|1|||
164181367|NCT03434249|593028872|FG000|Overall Study|Non-compliance of family|2|||
164181368|NCT03434249|593028873|FG001|Overall Study|Non-compliance of family|1|||
164181369|NCT03434249|593028872|FG000|Overall Study|Difficulties in completing daily diary|2|||
164181370|NCT03434249|593028873|FG001|Overall Study|Difficulties in completing daily diary|1|||
164181371|NCT02918552|593028874|FG000|Overall Study|Failed Pharmacokinetics|1|||
164181372|NCT02918552|593028875|FG001|Overall Study|Failed Pharmacokinetics|0|||
164181373|NCT02918552|593028874|FG000|Overall Study|Withdrawal by Subject|0|||
164181374|NCT02918552|593028875|FG001|Overall Study|Withdrawal by Subject|1|||
164181375|NCT02918552|593028874|FG000|Overall Study|Lost to Follow-up|0|||
164181376|NCT02918552|593028875|FG001|Overall Study|Lost to Follow-up|1|||
164181377|NCT01001598|593028876|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
164181378|NCT01001598|593028876|FG000|Overall Study|Adverse Event|1|||
164181379|NCT01969084|593028881|FG000|Overall Study|Adverse Event|0|||
164181380|NCT01969084|593028882|FG001|Overall Study|Adverse Event|1|||
164181381|NCT02920177|593028883|FG000|Overall Study|Withdrawal by Subject|1|||
164181382|NCT02920177|593028884|FG001|Overall Study|Withdrawal by Subject|1|||
164181383|NCT02920177|593028883|FG000|Overall Study|Physician Decision|1|||
164181384|NCT02920177|593028884|FG001|Overall Study|Physician Decision|0|||
164181385|NCT02920177|593028883|FG000|Overall Study|Lost to Follow-up|0|||
164181386|NCT02920177|593028884|FG001|Overall Study|Lost to Follow-up|1|||
164181387|NCT03164265|593028885|FG000|Overall Study|Physician Decision|3|||
164181388|NCT04907227|593028886|FG000|Overall Study|Death|12|||
164181389|NCT04907227|593028887|FG001|Overall Study|Death|8|||
164181390|NCT04907227|593028886|FG000|Overall Study|Withdrawal by Subject|2|||
164181391|NCT04907227|593028887|FG001|Overall Study|Withdrawal by Subject|2|||
164181392|NCT04907227|593028886|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
164181393|NCT04907227|593028887|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
164181394|NCT04907227|593028886|FG000|Overall Study|Sponsor Decision|25|||
164181395|NCT04907227|593028887|FG001|Overall Study|Sponsor Decision|30|||
164181396|NCT04907227|593028886|FG000|Overall Study|Physician Decision|1|||
164181397|NCT04907227|593028887|FG001|Overall Study|Physician Decision|0|||
164181398|NCT00824382|593028888|FG000|Overall Study|Adverse Event|4|||
164181399|NCT00824382|593028889|FG001|Overall Study|Adverse Event|1|||
164181400|NCT00824382|593028890|FG002|Overall Study|Adverse Event|1|||
164181401|NCT00824382|593028891|FG003|Overall Study|Adverse Event|4|||
164181402|NCT00824382|593028888|FG000|Overall Study|Protocol Violation|1|||
164181403|NCT00824382|593028889|FG001|Overall Study|Protocol Violation|0|||
164181404|NCT00824382|593028890|FG002|Overall Study|Protocol Violation|0|||
164181405|NCT00824382|593028891|FG003|Overall Study|Protocol Violation|1|||
164181406|NCT00824382|593028888|FG000|Overall Study|Investigator's decision|0|||
164181407|NCT00824382|593028889|FG001|Overall Study|Investigator's decision|1|||
164181408|NCT00824382|593028890|FG002|Overall Study|Investigator's decision|2|||
164181409|NCT00824382|593028891|FG003|Overall Study|Investigator's decision|0|||
164181410|NCT03673345|593028892|FG000|Overall Study|Lost to Follow-up|1|||
164181411|NCT03673345|593028893|FG001|Overall Study|Lost to Follow-up|0|||
164181412|NCT03673345|593028894|FG002|Overall Study|Lost to Follow-up|3|||
164181413|NCT03673345|593028895|FG003|Overall Study|Lost to Follow-up|3|||
164181414|NCT03673345|593028896|FG004|Overall Study|Lost to Follow-up|2|||
164181415|NCT03673345|593028897|FG005|Overall Study|Lost to Follow-up|1|||
164181416|NCT03673345|593028898|FG006|Overall Study|Lost to Follow-up|0|||
164181417|NCT03673345|593028899|FG007|Overall Study|Lost to Follow-up|0|||
164181418|NCT03673345|593028892|FG000|Overall Study|Withdrawal by Subject|1|||
164181419|NCT03673345|593028893|FG001|Overall Study|Withdrawal by Subject|0|||
164181420|NCT03673345|593028894|FG002|Overall Study|Withdrawal by Subject|4|||
164181421|NCT03673345|593028895|FG003|Overall Study|Withdrawal by Subject|2|||
164181422|NCT03673345|593028896|FG004|Overall Study|Withdrawal by Subject|0|||
164181423|NCT03673345|593028897|FG005|Overall Study|Withdrawal by Subject|0|||
164181424|NCT03673345|593028898|FG006|Overall Study|Withdrawal by Subject|0|||
164181425|NCT03673345|593028899|FG007|Overall Study|Withdrawal by Subject|0|||
164181426|NCT03673345|593028892|FG000|Overall Study|Physician Decision|0|||
164181427|NCT03673345|593028893|FG001|Overall Study|Physician Decision|0|||
164181428|NCT03673345|593028894|FG002|Overall Study|Physician Decision|2|||
164181429|NCT03673345|593028895|FG003|Overall Study|Physician Decision|0|||
164181430|NCT03673345|593028896|FG004|Overall Study|Physician Decision|0|||
164181431|NCT03673345|593028897|FG005|Overall Study|Physician Decision|0|||
164181432|NCT03673345|593028898|FG006|Overall Study|Physician Decision|0|||
164181433|NCT03673345|593028899|FG007|Overall Study|Physician Decision|0|||
164181434|NCT01362244|593028900|FG000|Overall Study|Adverse Event|3|||
164181435|NCT01362244|593028901|FG001|Overall Study|Adverse Event|5|||
164181436|NCT01362244|593028900|FG000|Overall Study|Lack of Efficacy|5|||
164181437|NCT01362244|593028901|FG001|Overall Study|Lack of Efficacy|11|||
164181438|NCT01362244|593028900|FG000|Overall Study|Lost to Follow-up|0|||
164181439|NCT01362244|593028901|FG001|Overall Study|Lost to Follow-up|2|||
164181440|NCT01362244|593028900|FG000|Overall Study|Protocol Violation|5|||
164181441|NCT01362244|593028901|FG001|Overall Study|Protocol Violation|1|||
164181442|NCT01362244|593028900|FG000|Overall Study|Withdrawal by Subject|2|||
164181443|NCT01362244|593028901|FG001|Overall Study|Withdrawal by Subject|1|||
164181444|NCT01362244|593028900|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
164181445|NCT01362244|593028901|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
164181446|NCT01362244|593028900|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
164181447|NCT01362244|593028901|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
164181448|NCT01253174|593028902|FG000|Period 1|Randomized but not treated|0|||
164181449|NCT01253174|593028903|FG001|Period 1|Randomized but not treated|1|||
164181450|NCT01253174|593028904|FG002|Period 1|Randomized but not treated|1|||
164181451|NCT01253174|593028905|FG003|Period 1|Randomized but not treated|0|||
164181452|NCT01253174|593028906|FG004|Period 1|Randomized but not treated|1|||
164181453|NCT01253174|593028907|FG005|Period 1|Randomized but not treated|0|||
164181454|NCT01253174|593028902|FG000|Period 2|Adverse Event|0|||
164181455|NCT01253174|593028903|FG001|Period 2|Adverse Event|0|||
164181456|NCT01253174|593028904|FG002|Period 2|Adverse Event|1|||
164181457|NCT01253174|593028905|FG003|Period 2|Adverse Event|0|||
164181458|NCT01253174|593028906|FG004|Period 2|Adverse Event|0|||
164181459|NCT01253174|593028907|FG005|Period 2|Adverse Event|0|||
164181460|NCT01253174|593028902|FG000|Period 3|Withdrawal by Subject|0|||
164181461|NCT01253174|593028903|FG001|Period 3|Withdrawal by Subject|1|||
164181462|NCT01253174|593028904|FG002|Period 3|Withdrawal by Subject|0|||
164181463|NCT01253174|593028905|FG003|Period 3|Withdrawal by Subject|0|||
164181464|NCT01253174|593028906|FG004|Period 3|Withdrawal by Subject|1|||
164181465|NCT01253174|593028907|FG005|Period 3|Withdrawal by Subject|0|||
164181466|NCT01253174|593028902|FG000|Period 3|Pregnancy|0|||
164181467|NCT01253174|593028903|FG001|Period 3|Pregnancy|0|||
164181468|NCT01253174|593028904|FG002|Period 3|Pregnancy|1|||
164181469|NCT01253174|593028905|FG003|Period 3|Pregnancy|0|||
164181470|NCT01253174|593028906|FG004|Period 3|Pregnancy|0|||
164181471|NCT01253174|593028907|FG005|Period 3|Pregnancy|0|||
164181472|NCT02267135|593028908|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
164181473|NCT02267135|593028909|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
164181474|NCT02267135|593028908|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
164181475|NCT02267135|593028909|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
164181476|NCT02267135|593028908|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
164181477|NCT02267135|593028909|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
164181478|NCT02267135|593028908|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
164181479|NCT02267135|593028909|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
164181480|NCT02267135|593028908|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
164181481|NCT02267135|593028909|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
164181482|NCT03806231|593028910|FG000|Overall Study|Physician Decision|1|||
164181483|NCT03806231|593028911|FG001|Overall Study|Physician Decision|0|||
164181484|NCT03806231|593028910|FG000|Overall Study|Withdrawal by Subject|1|||
164181485|NCT03806231|593028911|FG001|Overall Study|Withdrawal by Subject|0|||
164181486|NCT02919267|593028912|FG000|Overall Study|Protocol Violation|0|||
164181487|NCT02919267|593028913|FG001|Overall Study|Protocol Violation|3|||
164181488|NCT02919267|593028914|FG002|Overall Study|Protocol Violation|3|||
164181489|NCT02919267|593028915|FG003|Overall Study|Protocol Violation|4|||
164181490|NCT04608344|593028916|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
164181491|NCT04608344|593028917|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
164181492|NCT04608344|593028916|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
164181493|NCT04608344|593028917|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
164181494|NCT00467961|593028918|FG000|Overall Study|Technical Failures|5|||
164181495|NCT00467961|593028918|FG000|Overall Study|Disease Progression|2|||
164181496|NCT02908074|593028920|FG000|Overall Study|sponsor/ICON decision|0|||
164181497|NCT02908074|593028921|FG001|Overall Study|sponsor/ICON decision|0|||
164181498|NCT02908074|593028922|FG002|Overall Study|sponsor/ICON decision|1|||
164181499|NCT02908074|593028923|FG003|Overall Study|sponsor/ICON decision|0|||
164181500|NCT02908074|593028924|FG004|Overall Study|sponsor/ICON decision|0|||
164181501|NCT02908074|593028925|FG005|Overall Study|sponsor/ICON decision|0|||
164181502|NCT02908074|593028920|FG000|Overall Study|Protocol Violation|0|||
164181503|NCT02908074|593028921|FG001|Overall Study|Protocol Violation|1|||
164181504|NCT02908074|593028922|FG002|Overall Study|Protocol Violation|0|||
164181505|NCT02908074|593028923|FG003|Overall Study|Protocol Violation|0|||
164181506|NCT02908074|593028924|FG004|Overall Study|Protocol Violation|0|||
164181507|NCT02908074|593028925|FG005|Overall Study|Protocol Violation|0|||
164181508|NCT02908074|593028920|FG000|Overall Study|Adverse Event|5|||
164181509|NCT02908074|593028921|FG001|Overall Study|Adverse Event|2|||
164181510|NCT02908074|593028922|FG002|Overall Study|Adverse Event|0|||
164181511|NCT02908074|593028923|FG003|Overall Study|Adverse Event|0|||
164181512|NCT02908074|593028924|FG004|Overall Study|Adverse Event|1|||
164181513|NCT02908074|593028925|FG005|Overall Study|Adverse Event|0|||
164181514|NCT02908074|593028920|FG000|Overall Study|AESI|1|||
164181515|NCT02908074|593028921|FG001|Overall Study|AESI|0|||
164181516|NCT02908074|593028922|FG002|Overall Study|AESI|1|||
164181517|NCT02908074|593028923|FG003|Overall Study|AESI|0|||
164181518|NCT02908074|593028924|FG004|Overall Study|AESI|1|||
164181519|NCT02908074|593028925|FG005|Overall Study|AESI|0|||
164181520|NCT02908074|593028920|FG000|Overall Study|Discontinuation criteria per protocol|0|||
164181521|NCT02908074|593028921|FG001|Overall Study|Discontinuation criteria per protocol|0|||
164181522|NCT02908074|593028922|FG002|Overall Study|Discontinuation criteria per protocol|1|||
164181523|NCT02908074|593028923|FG003|Overall Study|Discontinuation criteria per protocol|0|||
164181524|NCT02908074|593028924|FG004|Overall Study|Discontinuation criteria per protocol|0|||
164181525|NCT02908074|593028925|FG005|Overall Study|Discontinuation criteria per protocol|1|||
164181526|NCT02908074|593028920|FG000|Overall Study|Withdrawal by Subject|3|||
164181527|NCT02908074|593028921|FG001|Overall Study|Withdrawal by Subject|2|||
164181528|NCT02908074|593028922|FG002|Overall Study|Withdrawal by Subject|2|||
164181529|NCT02908074|593028923|FG003|Overall Study|Withdrawal by Subject|2|||
164181530|NCT02908074|593028924|FG004|Overall Study|Withdrawal by Subject|2|||
164181531|NCT02908074|593028925|FG005|Overall Study|Withdrawal by Subject|2|||
164181532|NCT02908074|593028920|FG000|Overall Study|Lost to Follow-up|0|||
164181533|NCT02908074|593028921|FG001|Overall Study|Lost to Follow-up|1|||
164181534|NCT02908074|593028922|FG002|Overall Study|Lost to Follow-up|1|||
164181535|NCT02908074|593028923|FG003|Overall Study|Lost to Follow-up|1|||
164181536|NCT02908074|593028924|FG004|Overall Study|Lost to Follow-up|0|||
164181537|NCT02908074|593028925|FG005|Overall Study|Lost to Follow-up|1|||
164181538|NCT02429310|593028927|FG000|Overall Study|Lost to Follow-up|1|||
164181539|NCT02429310|593028928|FG001|Overall Study|Lost to Follow-up|2|||
164181540|NCT02429310|593028927|FG000|Overall Study|Protocol Violation|1|||
164181541|NCT02429310|593028928|FG001|Overall Study|Protocol Violation|1|||
164181542|NCT00394433|593028929|FG000|Overall Study|Adverse Event|2|||
164181543|NCT00394433|593028929|FG000|Overall Study|Alternative Therapy|1|||
164181544|NCT03646305|593028930|FG000|Overall Study|Lost to Follow-up|4|||
164181545|NCT03646305|593028931|FG001|Overall Study|Lost to Follow-up|2|||
164181546|NCT03646305|593028932|FG002|Overall Study|Lost to Follow-up|2|||
164181547|NCT03646305|593028933|FG003|Overall Study|Lost to Follow-up|1|||
164181548|NCT03646305|593028930|FG000|Overall Study|Withdrawal by Subject|1|||
164181549|NCT03646305|593028931|FG001|Overall Study|Withdrawal by Subject|0|||
164181550|NCT03646305|593028932|FG002|Overall Study|Withdrawal by Subject|0|||
164181551|NCT03646305|593028933|FG003|Overall Study|Withdrawal by Subject|1|||
164181552|NCT01554176|593028934|FG000|Treatment Phase|Protocol Violation|1|||
164181553|NCT01554176|593028935|FG001|Treatment Phase|Protocol Violation|2|||
164181554|NCT01554176|593028936|FG002|Treatment Phase|Protocol Violation|0|||
164181555|NCT01554176|593028937|FG003|Treatment Phase|Protocol Violation|0|||
164181556|NCT01554176|593028938|FG004|Treatment Phase|Protocol Violation|0|||
164181557|NCT01554176|593028934|FG000|Treatment Phase|Physician Decision|1|||
164181558|NCT01554176|593028935|FG001|Treatment Phase|Physician Decision|1|||
164181559|NCT01554176|593028936|FG002|Treatment Phase|Physician Decision|0|||
164181560|NCT01554176|593028937|FG003|Treatment Phase|Physician Decision|0|||
164181561|NCT01554176|593028938|FG004|Treatment Phase|Physician Decision|0|||
164181562|NCT01554176|593028934|FG000|Treatment Phase|Lack of Efficacy|0|||
164181563|NCT01554176|593028935|FG001|Treatment Phase|Lack of Efficacy|1|||
164181564|NCT01554176|593028936|FG002|Treatment Phase|Lack of Efficacy|0|||
164181565|NCT01554176|593028937|FG003|Treatment Phase|Lack of Efficacy|0|||
164181566|NCT01554176|593028938|FG004|Treatment Phase|Lack of Efficacy|0|||
164181567|NCT01554176|593028934|FG000|Treatment Phase|Adverse event, non-fatal|1|||
164181568|NCT01554176|593028935|FG001|Treatment Phase|Adverse event, non-fatal|1|||
164181569|NCT01554176|593028936|FG002|Treatment Phase|Adverse event, non-fatal|0|||
164181570|NCT01554176|593028937|FG003|Treatment Phase|Adverse event, non-fatal|0|||
164181571|NCT01554176|593028938|FG004|Treatment Phase|Adverse event, non-fatal|0|||
164181572|NCT01554176|593028934|FG000|Treatment Phase|Non-compliance with study drug|1|||
164181573|NCT01554176|593028935|FG001|Treatment Phase|Non-compliance with study drug|0|||
164181574|NCT01554176|593028936|FG002|Treatment Phase|Non-compliance with study drug|0|||
164181575|NCT01554176|593028937|FG003|Treatment Phase|Non-compliance with study drug|0|||
164181576|NCT01554176|593028938|FG004|Treatment Phase|Non-compliance with study drug|0|||
164181577|NCT01554176|593028934|FG000|Treatment Phase|Withdrawal by Subject|1|||
164181578|NCT01554176|593028935|FG001|Treatment Phase|Withdrawal by Subject|0|||
164181579|NCT01554176|593028936|FG002|Treatment Phase|Withdrawal by Subject|0|||
164181580|NCT01554176|593028937|FG003|Treatment Phase|Withdrawal by Subject|0|||
164181581|NCT01554176|593028938|FG004|Treatment Phase|Withdrawal by Subject|0|||
164181582|NCT01554176|593028934|FG000|Treatment Phase|Lost to Follow-up|3|||
164181583|NCT01554176|593028935|FG001|Treatment Phase|Lost to Follow-up|0|||
164181584|NCT01554176|593028936|FG002|Treatment Phase|Lost to Follow-up|0|||
164181585|NCT01554176|593028937|FG003|Treatment Phase|Lost to Follow-up|0|||
164181586|NCT01554176|593028938|FG004|Treatment Phase|Lost to Follow-up|0|||
164181587|NCT01554176|593028934|FG000|Run-out Phase|Protocol Violation|0|||
164181588|NCT01554176|593028935|FG001|Run-out Phase|Protocol Violation|0|||
164181589|NCT01554176|593028936|FG002|Run-out Phase|Protocol Violation|0|||
164181590|NCT01554176|593028937|FG003|Run-out Phase|Protocol Violation|1|||
164181591|NCT01554176|593028938|FG004|Run-out Phase|Protocol Violation|0|||
164181592|NCT02678000|593028939|FG000|PART 2|Adverse Event|0|||
164181593|NCT02678000|593028940|FG001|PART 2|Adverse Event|0|||
164181594|NCT02678000|593028941|FG002|PART 2|Adverse Event|2|||
164181595|NCT02678000|593028942|FG003|PART 2|Adverse Event|1|||
164181596|NCT02678000|593028943|FG004|PART 2|Adverse Event|0|||
164181597|NCT02678000|593028939|FG000|PART 2|Withdrawal by Subject|0|||
164181598|NCT02678000|593028940|FG001|PART 2|Withdrawal by Subject|0|||
164181599|NCT02678000|593028941|FG002|PART 2|Withdrawal by Subject|1|||
164181600|NCT02678000|593028942|FG003|PART 2|Withdrawal by Subject|0|||
164181601|NCT02678000|593028943|FG004|PART 2|Withdrawal by Subject|0|||
164181602|NCT00004088|593030693|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
164181603|NCT00004088|593030693|FG000|Overall Study|Withdrawal by Subject|1|||
164181604|NCT00004088|593030693|FG000|Overall Study|Protocol Violation|3|||
164181605|NCT00004088|593030693|FG000|Overall Study|Physician Decision|1|||
164181606|NCT03004924|593030694|FG000|Overall Study|Adverse Event|6|||
164181607|NCT03004924|593030695|FG001|Overall Study|Adverse Event|5|||
164181608|NCT03004924|593030696|FG002|Overall Study|Adverse Event|10|||
164181609|NCT03004924|593030694|FG000|Overall Study|Protocol Violation|4|||
164181610|NCT03004924|593030695|FG001|Overall Study|Protocol Violation|0|||
164181611|NCT03004924|593030696|FG002|Overall Study|Protocol Violation|1|||
164181612|NCT03004924|593030694|FG000|Overall Study|Withdrawal by Subject|5|||
164181613|NCT03004924|593030695|FG001|Overall Study|Withdrawal by Subject|3|||
164181614|NCT03004924|593030696|FG002|Overall Study|Withdrawal by Subject|5|||
164181615|NCT03004924|593030694|FG000|Overall Study|Lost to Follow-up|6|||
164181616|NCT03004924|593030695|FG001|Overall Study|Lost to Follow-up|1|||
164181617|NCT03004924|593030696|FG002|Overall Study|Lost to Follow-up|4|||
164181618|NCT03004924|593030694|FG000|Overall Study|Lack of Efficacy|2|||
164181619|NCT03004924|593030695|FG001|Overall Study|Lack of Efficacy|4|||
164181620|NCT03004924|593030696|FG002|Overall Study|Lack of Efficacy|2|||
164181621|NCT03004924|593030694|FG000|Overall Study|Physician Decision|1|||
164181622|NCT03004924|593030695|FG001|Overall Study|Physician Decision|0|||
164181623|NCT03004924|593030696|FG002|Overall Study|Physician Decision|1|||
164181624|NCT03004924|593030694|FG000|Overall Study|Withdrawal by parent/guardian|1|||
164181625|NCT03004924|593030695|FG001|Overall Study|Withdrawal by parent/guardian|0|||
164181626|NCT03004924|593030696|FG002|Overall Study|Withdrawal by parent/guardian|2|||
164181627|NCT03004924|593030694|FG000|Overall Study|Screen Failure|1|||
164181628|NCT03004924|593030695|FG001|Overall Study|Screen Failure|0|||
164181629|NCT03004924|593030696|FG002|Overall Study|Screen Failure|0|||
164181630|NCT03004924|593030694|FG000|Overall Study|Pregnancy|0|||
164181631|NCT03004924|593030695|FG001|Overall Study|Pregnancy|1|||
164181632|NCT03004924|593030696|FG002|Overall Study|Pregnancy|0|||
164181633|NCT03004924|593030694|FG000|Overall Study|Terminated by Sponsor|0|||
164181634|NCT03004924|593030695|FG001|Overall Study|Terminated by Sponsor|0|||
164181635|NCT03004924|593030696|FG002|Overall Study|Terminated by Sponsor|1|||
164181636|NCT03004924|593030694|FG000|Overall Study|Missed Study Visit|0|||
164181637|NCT03004924|593030695|FG001|Overall Study|Missed Study Visit|0|||
164181638|NCT03004924|593030696|FG002|Overall Study|Missed Study Visit|2|||
164181639|NCT03004924|593030694|FG000|Overall Study|HSV1 Positive|1|||
164181640|NCT03004924|593030695|FG001|Overall Study|HSV1 Positive|0|||
164181641|NCT03004924|593030696|FG002|Overall Study|HSV1 Positive|0|||
164181642|NCT00089635|593030702|FG000|Overall Study|Adverse Event|2|||
164181643|NCT00089635|593030702|FG000|Overall Study|Death|17|||
164181644|NCT00089635|593030702|FG000|Overall Study|Disease Progression|12|||
164181645|NCT00089635|593030702|FG000|Overall Study|Lost to Follow-up|3|||
164181646|NCT00089635|593030702|FG000|Overall Study|Withdrawal by Subject|6|||
164181647|NCT00089635|593030702|FG000|Overall Study|Ineligibility determined|1|||
164181648|NCT00089635|593030702|FG000|Overall Study|Other|2|||
164181649|NCT02943785|593030703|FG000|Overall Study|Adverse Event|112|||
164181650|NCT02943785|593030704|FG001|Overall Study|Adverse Event|97|||
164181651|NCT02943785|593030703|FG000|Overall Study|Withdrawal by Subject|63|||
164181652|NCT02943785|593030704|FG001|Overall Study|Withdrawal by Subject|126|||
164181653|NCT02943785|593030703|FG000|Overall Study|Physician Decision|23|||
164181654|NCT02943785|593030704|FG001|Overall Study|Physician Decision|47|||
164181655|NCT02943785|593030703|FG000|Overall Study|Death|46|||
164181656|NCT02943785|593030704|FG001|Overall Study|Death|46|||
164181657|NCT02943785|593030703|FG000|Overall Study|Lost to Follow-up|1|||
164181658|NCT02943785|593030704|FG001|Overall Study|Lost to Follow-up|0|||
164181659|NCT02943785|593030703|FG000|Overall Study|Other|16|||
164181660|NCT02943785|593030704|FG001|Overall Study|Other|19|||
164181661|NCT02943785|593030703|FG000|Overall Study|Did not receive any study medication|21|||
164181662|NCT02943785|593030704|FG001|Overall Study|Did not receive any study medication|28|||
164181663|NCT02603107|593030705|FG000|Randomized Phase|Withdrew consent|8|||
164181664|NCT02603107|593030706|FG001|Randomized Phase|Withdrew consent|15|||
164181665|NCT02603107|593030705|FG000|Randomized Phase|Lost to Follow-up|1|||
164181666|NCT02603107|593030706|FG001|Randomized Phase|Lost to Follow-up|3|||
164181667|NCT02603107|593030705|FG000|Randomized Phase|Adverse Event|2|||
164181668|NCT02603107|593030706|FG001|Randomized Phase|Adverse Event|0|||
164181669|NCT02603107|593030705|FG000|Randomized Phase|Death|1|||
164181670|NCT02603107|593030706|FG001|Randomized Phase|Death|1|||
164181671|NCT02603107|593030705|FG000|Randomized Phase|Non-compliance with study drug|1|||
164181672|NCT02603107|593030706|FG001|Randomized Phase|Non-compliance with study drug|1|||
164181673|NCT02603107|593030705|FG000|Randomized Phase|Investigator's discretion|0|||
164181674|NCT02603107|593030706|FG001|Randomized Phase|Investigator's discretion|1|||
164181675|NCT02603107|593030705|FG000|Randomized Phase|Lack of Efficacy|1|||
164181676|NCT02603107|593030706|FG001|Randomized Phase|Lack of Efficacy|0|||
164181677|NCT02603107|593030705|FG000|Randomized Phase|Protocol Violation|1|||
164181678|NCT02603107|593030706|FG001|Randomized Phase|Protocol Violation|0|||
164181679|NCT02603107|593030705|FG000|Optional Extension Phase|Lost to Follow-up|3|||
164181680|NCT02603107|593030706|FG001|Optional Extension Phase|Lost to Follow-up|3|||
164181681|NCT02603107|593030705|FG000|Optional Extension Phase|Withdrew consent|3|||
164181682|NCT02603107|593030706|FG001|Optional Extension Phase|Withdrew consent|2|||
164181683|NCT02603107|593030705|FG000|Optional Extension Phase|Investigator's discretion|2|||
164181684|NCT02603107|593030706|FG001|Optional Extension Phase|Investigator's discretion|2|||
164181685|NCT02603107|593030705|FG000|Optional Extension Phase|Pregnancy|0|||
164181686|NCT02603107|593030706|FG001|Optional Extension Phase|Pregnancy|3|||
164181687|NCT02603107|593030705|FG000|Optional Extension Phase|Adverse Event|0|||
164181688|NCT02603107|593030706|FG001|Optional Extension Phase|Adverse Event|2|||
164181689|NCT02603107|593030705|FG000|Optional Extension Phase|Not treated in extension phase|0|||
164181690|NCT02603107|593030706|FG001|Optional Extension Phase|Not treated in extension phase|1|||
164181691|NCT02603107|593030705|FG000|Optional Extension Phase|Protocol Violation|1|||
164181692|NCT02603107|593030706|FG001|Optional Extension Phase|Protocol Violation|0|||
164181693|NCT00821015|593030707|FG000|Overall Study|Lost to Follow-up|12|||
164181694|NCT03170609|593030710|FG000|Overall Study|Death|0|||
164181695|NCT03170609|593030711|FG001|Overall Study|Death|0|||
164181696|NCT03170609|593030712|FG002|Overall Study|Death|1|||
164181697|NCT03170609|593030713|FG003|Overall Study|Death|0|||
164181698|NCT03170609|593030714|FG004|Overall Study|Death|0|||
164181699|NCT03170609|593030715|FG005|Overall Study|Death|0|||
164181700|NCT03170609|593030716|FG006|Overall Study|Death|0|||
164181701|NCT03170609|593030710|FG000|Overall Study|Withdrawal by Subject|1|||
164181702|NCT03170609|593030711|FG001|Overall Study|Withdrawal by Subject|2|||
164181703|NCT03170609|593030712|FG002|Overall Study|Withdrawal by Subject|0|||
164181704|NCT03170609|593030713|FG003|Overall Study|Withdrawal by Subject|0|||
164181705|NCT03170609|593030714|FG004|Overall Study|Withdrawal by Subject|0|||
164181706|NCT03170609|593030715|FG005|Overall Study|Withdrawal by Subject|0|||
164181707|NCT03170609|593030716|FG006|Overall Study|Withdrawal by Subject|1|||
164181708|NCT03170609|593030710|FG000|Overall Study|Lost to Follow-up|1|||
164181709|NCT03170609|593030711|FG001|Overall Study|Lost to Follow-up|0|||
164181710|NCT03170609|593030712|FG002|Overall Study|Lost to Follow-up|5|||
164181711|NCT03170609|593030713|FG003|Overall Study|Lost to Follow-up|2|||
164181712|NCT03170609|593030714|FG004|Overall Study|Lost to Follow-up|1|||
164181713|NCT03170609|593030715|FG005|Overall Study|Lost to Follow-up|1|||
164181714|NCT03170609|593030716|FG006|Overall Study|Lost to Follow-up|0|||
164181715|NCT03170609|593030710|FG000|Overall Study|Other|1|||
164181716|NCT03170609|593030711|FG001|Overall Study|Other|0|||
164181717|NCT03170609|593030712|FG002|Overall Study|Other|0|||
164181718|NCT03170609|593030713|FG003|Overall Study|Other|0|||
164181719|NCT03170609|593030714|FG004|Overall Study|Other|0|||
164181720|NCT03170609|593030715|FG005|Overall Study|Other|1|||
164181721|NCT03170609|593030716|FG006|Overall Study|Other|0|||
164181722|NCT01887678|593030722|FG000|Overall Study|Adverse Event|4|||
164181723|NCT01887678|593030723|FG001|Overall Study|Adverse Event|6|||
164181724|NCT01887678|593030722|FG000|Overall Study|Exceeded rescue medication dosage|4|||
164181725|NCT01887678|593030723|FG001|Overall Study|Exceeded rescue medication dosage|5|||
164181726|NCT01887678|593030722|FG000|Overall Study|Withdrawal of consent|3|||
164181727|NCT01887678|593030723|FG001|Overall Study|Withdrawal of consent|4|||
164181728|NCT01887678|593030722|FG000|Overall Study|Lost to Follow-up|4|||
164181729|NCT01887678|593030723|FG001|Overall Study|Lost to Follow-up|2|||
164181730|NCT01887678|593030722|FG000|Overall Study|Deterioration of clinical condition|0|||
164181731|NCT01887678|593030723|FG001|Overall Study|Deterioration of clinical condition|4|||
164181732|NCT01887678|593030722|FG000|Overall Study|Lack of Efficacy|1|||
164181733|NCT01887678|593030723|FG001|Overall Study|Lack of Efficacy|2|||
164181734|NCT01887678|593030722|FG000|Overall Study|Non-compliance|0|||
164181735|NCT01887678|593030723|FG001|Overall Study|Non-compliance|3|||
164181736|NCT01887678|593030722|FG000|Overall Study|Specified|1|||
164181737|NCT01887678|593030723|FG001|Overall Study|Specified|2|||
164181738|NCT03013985|593030725|FG000|Overall Study|Protocol Violation|2|||
164181739|NCT03013985|593030726|FG001|Overall Study|Protocol Violation|2|||
164181740|NCT03013985|593030725|FG000|Overall Study|Withdrawal by Subject|14|||
164181741|NCT03013985|593030726|FG001|Overall Study|Withdrawal by Subject|17|||
164181742|NCT01370616|593030729|FG000|Overall Study|Adverse Event|11|||
164181743|NCT01370616|593030730|FG001|Overall Study|Adverse Event|16|||
164181744|NCT01370616|593030729|FG000|Overall Study|Death|1|||
164181745|NCT01370616|593030730|FG001|Overall Study|Death|0|||
164181746|NCT01370616|593030729|FG000|Overall Study|Lack of Efficacy|6|||
164181747|NCT01370616|593030730|FG001|Overall Study|Lack of Efficacy|2|||
164181748|NCT01370616|593030729|FG000|Overall Study|Lost to Follow-up|0|||
164181749|NCT01370616|593030730|FG001|Overall Study|Lost to Follow-up|3|||
164181750|NCT01370616|593030729|FG000|Overall Study|Physician Decision|6|||
164181751|NCT01370616|593030730|FG001|Overall Study|Physician Decision|6|||
164181752|NCT01370616|593030729|FG000|Overall Study|Progressive Disease|0|||
164181753|NCT01370616|593030730|FG001|Overall Study|Progressive Disease|1|||
164181754|NCT01370616|593030729|FG000|Overall Study|Recovery|1|||
164181755|NCT01370616|593030730|FG001|Overall Study|Recovery|0|||
164181756|NCT01370616|593030729|FG000|Overall Study|Technical Problems|3|||
164181757|NCT01370616|593030730|FG001|Overall Study|Technical Problems|5|||
164181758|NCT01370616|593030729|FG000|Overall Study|Withdrawal by Subject|34|||
164181759|NCT01370616|593030730|FG001|Overall Study|Withdrawal by Subject|34|||
164181760|NCT00076999|593030735|FG000|Overall Study|Adverse Event|2|||
164181761|NCT00076999|593030736|FG001|Overall Study|Adverse Event|8|||
164181762|NCT00076999|593030737|FG002|Overall Study|Adverse Event|6|||
164181763|NCT00076999|593030738|FG003|Overall Study|Adverse Event|0|||
164181764|NCT00076999|593030739|FG004|Overall Study|Adverse Event|2|||
164181765|NCT00076999|593030735|FG000|Overall Study|Protocol Violation|0|||
164181766|NCT00076999|593030736|FG001|Overall Study|Protocol Violation|3|||
164181767|NCT00076999|593030737|FG002|Overall Study|Protocol Violation|4|||
164181768|NCT00076999|593030738|FG003|Overall Study|Protocol Violation|0|||
164181769|NCT00076999|593030739|FG004|Overall Study|Protocol Violation|9|||
164181770|NCT00076999|593030735|FG000|Overall Study|Lost to Follow-up|2|||
164181771|NCT00076999|593030736|FG001|Overall Study|Lost to Follow-up|1|||
164181772|NCT00076999|593030737|FG002|Overall Study|Lost to Follow-up|0|||
164181773|NCT00076999|593030738|FG003|Overall Study|Lost to Follow-up|0|||
164181774|NCT00076999|593030739|FG004|Overall Study|Lost to Follow-up|0|||
164181775|NCT00076999|593030735|FG000|Overall Study|Withdrawal by Subject|0|||
164181776|NCT00076999|593030736|FG001|Overall Study|Withdrawal by Subject|4|||
164181777|NCT00076999|593030737|FG002|Overall Study|Withdrawal by Subject|3|||
164181778|NCT00076999|593030738|FG003|Overall Study|Withdrawal by Subject|0|||
164181779|NCT00076999|593030739|FG004|Overall Study|Withdrawal by Subject|1|||
164181780|NCT00076999|593030735|FG000|Overall Study|Other reason (not specified)|8|||
164181781|NCT00076999|593030736|FG001|Overall Study|Other reason (not specified)|8|||
164181782|NCT00076999|593030737|FG002|Overall Study|Other reason (not specified)|4|||
164181783|NCT00076999|593030738|FG003|Overall Study|Other reason (not specified)|1|||
164181784|NCT00076999|593030739|FG004|Overall Study|Other reason (not specified)|13|||
164181785|NCT00803205|593030740|FG000|Overall Study|Adverse Event|7|||
164181786|NCT00803205|593030741|FG001|Overall Study|Adverse Event|2|||
164181787|NCT00803205|593030740|FG000|Overall Study|Lost to Follow-up|1|||
164181788|NCT00803205|593030741|FG001|Overall Study|Lost to Follow-up|0|||
164181789|NCT00803205|593030740|FG000|Overall Study|Withdrawal by Subject|9|||
164181790|NCT00803205|593030741|FG001|Overall Study|Withdrawal by Subject|9|||
164181791|NCT00803205|593030740|FG000|Overall Study|Physician Decision|1|||
164181792|NCT00803205|593030741|FG001|Overall Study|Physician Decision|0|||
164181793|NCT00803205|593030740|FG000|Overall Study|Protocol Violation|1|||
164181794|NCT00803205|593030741|FG001|Overall Study|Protocol Violation|1|||
164181795|NCT00803205|593030740|FG000|Overall Study|Medical Monitor Decision|1|||
164181796|NCT00803205|593030741|FG001|Overall Study|Medical Monitor Decision|0|||
164181797|NCT00803205|593030740|FG000|Overall Study|Acquired a Lung Infection|0|||
164181798|NCT00803205|593030741|FG001|Overall Study|Acquired a Lung Infection|1|||
164181799|NCT00803205|593030740|FG000|Overall Study|Sponsor Decision|0|||
164181800|NCT00803205|593030741|FG001|Overall Study|Sponsor Decision|1|||
164181801|NCT01217385|593030743|FG000|Overall Study|Withdrawal by Subject|3|||
164181802|NCT01217385|593030743|FG000|Overall Study|DOSI not performed/not eval|12|||
164181803|NCT01217385|593030743|FG000|Overall Study|Central Path not Available|1|||
164181804|NCT01217385|593030743|FG000|Overall Study|Normal Breast TOI not available|10|||
164181805|NCT01534208|593030745|FG000|Overall Study|Lost to Follow-up|19|||
164181806|NCT01534208|593030746|FG001|Overall Study|Lost to Follow-up|14|||
164181807|NCT01534208|593030745|FG000|Overall Study|Withdrawal by Subject|6|||
164181808|NCT01534208|593030746|FG001|Overall Study|Withdrawal by Subject|20|||
164181809|NCT01534208|593030745|FG000|Overall Study|Adverse Event|15|||
164181810|NCT01534208|593030746|FG001|Overall Study|Adverse Event|8|||
164181811|NCT01534208|593030745|FG000|Overall Study|Physician Decision|2|||
164181812|NCT01534208|593030746|FG001|Overall Study|Physician Decision|0|||
164181813|NCT01534208|593030745|FG000|Overall Study|Lack of Efficacy|0|||
164181814|NCT01534208|593030746|FG001|Overall Study|Lack of Efficacy|3|||
164181815|NCT01534208|593030745|FG000|Overall Study|Protocol Violation|2|||
164181816|NCT01534208|593030746|FG001|Overall Study|Protocol Violation|2|||
164181817|NCT01534208|593030745|FG000|Overall Study|Sponsor decision|4|||
164181818|NCT01534208|593030746|FG001|Overall Study|Sponsor decision|1|||
164181819|NCT01534208|593030745|FG000|Overall Study|Subject relocation|2|||
164181820|NCT01534208|593030746|FG001|Overall Study|Subject relocation|0|||
164181821|NCT01534208|593030745|FG000|Overall Study|Lab assessment|2|||
164181822|NCT01534208|593030746|FG001|Overall Study|Lab assessment|1|||
164181823|NCT01534208|593030745|FG000|Overall Study|Eligibility error|3|||
164181824|NCT01534208|593030746|FG001|Overall Study|Eligibility error|0|||
164181825|NCT01534208|593030745|FG000|Overall Study|PCP decision|1|||
164181826|NCT01534208|593030746|FG001|Overall Study|PCP decision|0|||
164181827|NCT01534208|593030745|FG000|Overall Study|Needed prohibited meds|1|||
164181828|NCT01534208|593030746|FG001|Overall Study|Needed prohibited meds|0|||
164181829|NCT02117713|593030757|FG000|Week 48|Adverse Event|4|||
164181830|NCT02117713|593030757|FG000|Week 48|Withdrawal by caregiver|2|||
164181831|NCT02117713|593030757|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
164181832|NCT02117713|593030757|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
164181833|NCT02117713|593030757|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
164181834|NCT02117713|593030757|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
164181835|NCT00672841|593030758|FG000|Overall Study|Comfort care|1|||
164181836|NCT00672841|593030759|FG001|Overall Study|Comfort care|4|||
164181837|NCT00672841|593030758|FG000|Overall Study|icteric specimens|0|||
164181838|NCT00672841|593030759|FG001|Overall Study|icteric specimens|3|||
164181839|NCT00672841|593030758|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
164181840|NCT00672841|593030759|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
164181841|NCT00672841|593030758|FG000|Overall Study|Adverse Event|0|||
164181842|NCT00672841|593030759|FG001|Overall Study|Adverse Event|3|||
164181843|NCT00672841|593030758|FG000|Overall Study|Pregnancy|0|||
164181844|NCT00672841|593030759|FG001|Overall Study|Pregnancy|1|||
164181845|NCT02638259|593030760|FG000|Treatment Period 1|Adverse Event|1|||
164181846|NCT02638259|593030761|FG001|Treatment Period 1|Adverse Event|5|||
164181847|NCT02638259|593030760|FG000|Treatment Period 1|Death|0|||
164181848|NCT02638259|593030761|FG001|Treatment Period 1|Death|1|||
164181849|NCT02638259|593030760|FG000|Treatment Period 1|Lack of Efficacy|0|||
164181850|NCT02638259|593030761|FG001|Treatment Period 1|Lack of Efficacy|1|||
164181851|NCT02638259|593030760|FG000|Treatment Period 1|Protocol Violation|0|||
164181852|NCT02638259|593030761|FG001|Treatment Period 1|Protocol Violation|3|||
164181853|NCT02638259|593030760|FG000|Treatment Period 1|Withdrawal by Subject|4|||
164181854|NCT02638259|593030761|FG001|Treatment Period 1|Withdrawal by Subject|6|||
164181855|NCT02638259|593030760|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
164181856|NCT02638259|593030761|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
164181857|NCT02638259|593030760|FG000|Treatment Period 2|Adverse Event|5|||
164181858|NCT02638259|593030761|FG001|Treatment Period 2|Adverse Event|4|||
164181859|NCT02638259|593030760|FG000|Treatment Period 2|Withdrawal by Subject|1|||
164181860|NCT02638259|593030761|FG001|Treatment Period 2|Withdrawal by Subject|7|||
164181861|NCT04299048|593030762|FG000|Overall Study|Death|1|||
164181862|NCT04299048|593030762|FG000|Overall Study|Global deterioration of health status|2|||
164181863|NCT04299048|593030762|FG000|Overall Study|Enrolled and not treated|1|||
164181864|NCT03578146|593030764|FG000|Overall Study|Did Not Receive Treatment|1|||
164181865|NCT03578146|593030765|FG001|Overall Study|Did Not Receive Treatment|0|||
164181866|NCT03578146|593030766|FG002|Overall Study|Did Not Receive Treatment|0|||
164181867|NCT03578146|593030767|FG003|Overall Study|Did Not Receive Treatment|0|||
164181868|NCT03578146|593030768|FG004|Overall Study|Did Not Receive Treatment|0|||
164181869|NCT03578146|593030769|FG005|Overall Study|Did Not Receive Treatment|2|||
164181870|NCT03578146|593030764|FG000|Overall Study|Lost to Follow-up|0|||
164181871|NCT03578146|593030765|FG001|Overall Study|Lost to Follow-up|1|||
164181872|NCT03578146|593030766|FG002|Overall Study|Lost to Follow-up|1|||
164181873|NCT03578146|593030767|FG003|Overall Study|Lost to Follow-up|0|||
164181874|NCT03578146|593030768|FG004|Overall Study|Lost to Follow-up|0|||
164181875|NCT03578146|593030769|FG005|Overall Study|Lost to Follow-up|1|||
164181876|NCT01094782|593030770|FG000|Overall Study|Withdrawal by Subject|5|||
164181877|NCT01094782|593030771|FG001|Overall Study|Withdrawal by Subject|5|||
164181878|NCT01094782|593030772|FG002|Overall Study|Withdrawal by Subject|1|||
164181879|NCT01094782|593030773|FG003|Overall Study|Withdrawal by Subject|5|||
164181880|NCT01094782|593030774|FG004|Overall Study|Withdrawal by Subject|5|||
164181881|NCT01094782|593030775|FG005|Overall Study|Withdrawal by Subject|0|||
164181882|NCT01094782|593030770|FG000|Overall Study|Lost to Follow-up|1|||
164181883|NCT01094782|593030771|FG001|Overall Study|Lost to Follow-up|0|||
164181884|NCT01094782|593030772|FG002|Overall Study|Lost to Follow-up|0|||
164181885|NCT01094782|593030773|FG003|Overall Study|Lost to Follow-up|2|||
164181886|NCT01094782|593030774|FG004|Overall Study|Lost to Follow-up|1|||
164181887|NCT01094782|593030775|FG005|Overall Study|Lost to Follow-up|4|||
164181888|NCT01094782|593030770|FG000|Overall Study|Positive Drug Screen|2|||
164181889|NCT01094782|593030771|FG001|Overall Study|Positive Drug Screen|2|||
164181890|NCT01094782|593030772|FG002|Overall Study|Positive Drug Screen|1|||
164181891|NCT01094782|593030773|FG003|Overall Study|Positive Drug Screen|1|||
164181892|NCT01094782|593030774|FG004|Overall Study|Positive Drug Screen|3|||
164181893|NCT01094782|593030775|FG005|Overall Study|Positive Drug Screen|2|||
164181894|NCT01094782|593030770|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
164182126|NCT03041467|593032491|FG001|Overall Study|Lost to Follow-up|8|||
164181895|NCT01094782|593030771|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
164181896|NCT01094782|593030772|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
164181897|NCT01094782|593030773|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
164181898|NCT01094782|593030774|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
164181899|NCT01094782|593030775|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
164181900|NCT01094782|593030770|FG000|Overall Study|Unable to Complete Questionnaires|0|||
164181901|NCT01094782|593030771|FG001|Overall Study|Unable to Complete Questionnaires|1|||
164181902|NCT01094782|593030772|FG002|Overall Study|Unable to Complete Questionnaires|0|||
164181903|NCT01094782|593030773|FG003|Overall Study|Unable to Complete Questionnaires|0|||
164181904|NCT01094782|593030774|FG004|Overall Study|Unable to Complete Questionnaires|0|||
164181905|NCT01094782|593030775|FG005|Overall Study|Unable to Complete Questionnaires|0|||
164181906|NCT01094782|593030770|FG000|Overall Study|Healthy Subject Had Pain|0|||
164181907|NCT01094782|593030771|FG001|Overall Study|Healthy Subject Had Pain|1|||
164181908|NCT01094782|593030772|FG002|Overall Study|Healthy Subject Had Pain|0|||
164181909|NCT01094782|593030773|FG003|Overall Study|Healthy Subject Had Pain|0|||
164181910|NCT01094782|593030774|FG004|Overall Study|Healthy Subject Had Pain|0|||
164181911|NCT01094782|593030775|FG005|Overall Study|Healthy Subject Had Pain|0|||
164181912|NCT01094782|593030770|FG000|Overall Study|Hypertension|0|||
164181913|NCT01094782|593030771|FG001|Overall Study|Hypertension|0|||
164181914|NCT01094782|593030772|FG002|Overall Study|Hypertension|1|||
164181915|NCT01094782|593030773|FG003|Overall Study|Hypertension|0|||
164181916|NCT01094782|593030774|FG004|Overall Study|Hypertension|0|||
164181917|NCT01094782|593030775|FG005|Overall Study|Hypertension|0|||
164181918|NCT01094782|593030770|FG000|Overall Study|Wrong Pain Condition|0|||
164181919|NCT01094782|593030771|FG001|Overall Study|Wrong Pain Condition|0|||
164181920|NCT01094782|593030772|FG002|Overall Study|Wrong Pain Condition|0|||
164181921|NCT01094782|593030773|FG003|Overall Study|Wrong Pain Condition|2|||
164181922|NCT01094782|593030774|FG004|Overall Study|Wrong Pain Condition|1|||
164181923|NCT01094782|593030775|FG005|Overall Study|Wrong Pain Condition|1|||
164181924|NCT01094782|593030770|FG000|Overall Study|Recent Interventional Injection|0|||
164181925|NCT01094782|593030771|FG001|Overall Study|Recent Interventional Injection|0|||
164181926|NCT01094782|593030772|FG002|Overall Study|Recent Interventional Injection|0|||
164181927|NCT01094782|593030773|FG003|Overall Study|Recent Interventional Injection|0|||
164181928|NCT01094782|593030774|FG004|Overall Study|Recent Interventional Injection|0|||
164181929|NCT01094782|593030775|FG005|Overall Study|Recent Interventional Injection|1|||
164181930|NCT01094782|593030770|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181931|NCT01094782|593030771|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181932|NCT01094782|593030772|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181933|NCT01094782|593030773|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181934|NCT01094782|593030774|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
164181935|NCT01094782|593030775|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
164181936|NCT01094782|593030770|FG000|Overall Study|Noncompliance With Study Schedule|0|||
164181937|NCT01094782|593030771|FG001|Overall Study|Noncompliance With Study Schedule|0|||
164181938|NCT01094782|593030772|FG002|Overall Study|Noncompliance With Study Schedule|0|||
164181939|NCT01094782|593030773|FG003|Overall Study|Noncompliance With Study Schedule|1|||
164181940|NCT01094782|593030774|FG004|Overall Study|Noncompliance With Study Schedule|0|||
164181941|NCT01094782|593030775|FG005|Overall Study|Noncompliance With Study Schedule|0|||
164181942|NCT00634049|593030776|FG000|Overall Study|Never received study drug|1|||
164181943|NCT00634049|593030776|FG000|Overall Study|Died prior to receiving study drug|1|||
164181944|NCT00634049|593030776|FG000|Overall Study|Screening failure|1|||
164181945|NCT01717391|593030777|FG000|Overall Study|Withdrawal by Subject|5|||
164181946|NCT01717391|593030777|FG000|Overall Study|Physician Decision|1|||
164181947|NCT01717391|593030777|FG000|Overall Study|FLT technical failure|3|||
164181948|NCT00045734|593030797|FG000|Overall Study|Protocol Violation|1|||
164181949|NCT02069093|593030798|FG000|Overall Study|Disease progression|14|||
164181950|NCT02069093|593030798|FG000|Overall Study|New cancer therapy|1|||
164181951|NCT02069093|593030798|FG000|Overall Study|Death|1|||
164181952|NCT02069093|593030798|FG000|Overall Study|Administrative problems|1|||
164181953|NCT02069093|593030798|FG000|Overall Study|Withdrawal by Subject|2|||
164181954|NCT02069093|593030798|FG000|Overall Study|Abnormal laboratory values|1|||
164181955|NCT02069093|593030798|FG000|Overall Study|Adverse Event|10|||
164181956|NCT00474786|593030801|FG000|Overall Study|Not Meeting Study Criteria|0|||
164181957|NCT00474786|593030802|FG001|Overall Study|Not Meeting Study Criteria|1|||
164181958|NCT00474786|593030801|FG000|Overall Study|Investigator Request|2|||
164181959|NCT00474786|593030802|FG001|Overall Study|Investigator Request|1|||
164181960|NCT00474786|593030801|FG000|Overall Study|Death|189|||
164181961|NCT00474786|593030802|FG001|Overall Study|Death|170|||
164181962|NCT00474786|593030801|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
164181963|NCT00474786|593030802|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
164181964|NCT00474786|593030801|FG000|Overall Study|Lost to Follow-up|4|||
164181965|NCT00474786|593030802|FG001|Overall Study|Lost to Follow-up|7|||
164181966|NCT00474786|593030801|FG000|Overall Study|Protocol Violation|2|||
164181967|NCT00474786|593030802|FG001|Overall Study|Protocol Violation|0|||
164181968|NCT00474786|593030801|FG000|Overall Study|Withdrawal by Subject|15|||
164181969|NCT00474786|593030802|FG001|Overall Study|Withdrawal by Subject|15|||
164181970|NCT00474786|593030801|FG000|Overall Study|Other|5|||
164181971|NCT00474786|593030802|FG001|Overall Study|Other|0|||
164181972|NCT02892513|593030803|FG000|Overall Study|Withdrawal by Subject|0|||
164181973|NCT02892513|593030804|FG001|Overall Study|Withdrawal by Subject|1|||
164181974|NCT00900731|593030805|FG000|Overall Study|Adverse Event|31|||
164181975|NCT00900731|593030806|FG001|Overall Study|Adverse Event|27|||
164181976|NCT00900731|593030805|FG000|Overall Study|Withdrawal by Subject|8|||
164181977|NCT00900731|593030806|FG001|Overall Study|Withdrawal by Subject|7|||
164181978|NCT00900731|593030805|FG000|Overall Study|Protocol Deviation|8|||
164181979|NCT00900731|593030806|FG001|Overall Study|Protocol Deviation|11|||
164181980|NCT00900731|593030805|FG000|Overall Study|Administrative Problems|5|||
164181981|NCT00900731|593030806|FG001|Overall Study|Administrative Problems|4|||
164181982|NCT00900731|593030805|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
164181983|NCT00900731|593030806|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
164181984|NCT00900731|593030805|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
164181985|NCT00900731|593030806|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
164181986|NCT00900731|593030805|FG000|Overall Study|Lost to Follow-up|2|||
164181987|NCT00900731|593030806|FG001|Overall Study|Lost to Follow-up|3|||
164181988|NCT00900731|593030805|FG000|Overall Study|Lack of Efficacy|1|||
164181989|NCT00900731|593030806|FG001|Overall Study|Lack of Efficacy|3|||
164181990|NCT00900731|593030805|FG000|Overall Study|Death|0|||
164181991|NCT00900731|593030806|FG001|Overall Study|Death|2|||
164181992|NCT00131365|593030807|FG000|Overall Study|Withdrawal by Subject|1|||
164181993|NCT00131365|593030807|FG000|Overall Study|Alternative treatment|3|||
164181994|NCT05249127|593030808|FG000|Overall Study|Protocol Violation|13|||
164181995|NCT05249127|593030808|FG000|Overall Study|Physician Decision|4|||
164181996|NCT05249127|593030808|FG000|Overall Study|Withdrawal by Subject|2|||
164181997|NCT05249127|593030808|FG000|Overall Study|Participant Non-compliance|1|||
164181998|NCT03053427|593030811|FG000|Overall Study|Adverse Event|4|||
164181999|NCT03053427|593030812|FG001|Overall Study|Adverse Event|4|||
164182000|NCT03053427|593030811|FG000|Overall Study|Lack of Efficacy|1|||
164182001|NCT03053427|593030812|FG001|Overall Study|Lack of Efficacy|3|||
164182002|NCT03053427|593030811|FG000|Overall Study|Lost to Follow-up|2|||
164182003|NCT03053427|593030812|FG001|Overall Study|Lost to Follow-up|2|||
164182004|NCT03053427|593030811|FG000|Overall Study|Worsening of the target disease|0|||
164182005|NCT03053427|593030812|FG001|Overall Study|Worsening of the target disease|1|||
164182006|NCT03053427|593030811|FG000|Overall Study|Protocol Deviation|3|||
164182007|NCT03053427|593030812|FG001|Overall Study|Protocol Deviation|3|||
164182008|NCT03053427|593030811|FG000|Overall Study|Withdrawal by Subject|3|||
164182009|NCT03053427|593030812|FG001|Overall Study|Withdrawal by Subject|2|||
164182010|NCT03053427|593030811|FG000|Overall Study|Miscellaneous|0|||
164182011|NCT03053427|593030812|FG001|Overall Study|Miscellaneous|1|||
164182012|NCT02607306|593030817|FG000|Overall Study|Adverse Event|8|||
164182013|NCT02607306|593030818|FG001|Overall Study|Adverse Event|6|||
164182014|NCT02607306|593030819|FG002|Overall Study|Adverse Event|6|||
164182015|NCT02607306|593030817|FG000|Overall Study|Unclassified|1|||
164182016|NCT02607306|593030818|FG001|Overall Study|Unclassified|4|||
164182017|NCT02607306|593030819|FG002|Overall Study|Unclassified|0|||
164182018|NCT02607306|593030817|FG000|Overall Study|Withdrawal by Subject|8|||
164182019|NCT02607306|593030818|FG001|Overall Study|Withdrawal by Subject|10|||
164182020|NCT02607306|593030819|FG002|Overall Study|Withdrawal by Subject|2|||
164182021|NCT02607306|593030817|FG000|Overall Study|Lack of Efficacy|0|||
164182022|NCT02607306|593030818|FG001|Overall Study|Lack of Efficacy|1|||
164182023|NCT02607306|593030819|FG002|Overall Study|Lack of Efficacy|1|||
164182024|NCT02607306|593030817|FG000|Overall Study|Protocol Violation|4|||
164182025|NCT02607306|593030818|FG001|Overall Study|Protocol Violation|2|||
164182026|NCT02607306|593030819|FG002|Overall Study|Protocol Violation|1|||
164182027|NCT01324570|593030820|FG000|Overall Study|Adverse Event|4|||
164182028|NCT01324570|593030821|FG001|Overall Study|Adverse Event|7|||
164182029|NCT01324570|593030820|FG000|Overall Study|Withdrawal by Subject|0|||
164182030|NCT01324570|593030821|FG001|Overall Study|Withdrawal by Subject|3|||
164182031|NCT01324570|593030820|FG000|Overall Study|Lack of Efficacy|0|||
164182032|NCT01324570|593030821|FG001|Overall Study|Lack of Efficacy|1|||
164182033|NCT01324570|593030820|FG000|Overall Study|Confirmed or suspected diversion|0|||
164182034|NCT01324570|593030821|FG001|Overall Study|Confirmed or suspected diversion|1|||
164182035|NCT01324570|593030820|FG000|Overall Study|Administrative|0|||
164182036|NCT01324570|593030821|FG001|Overall Study|Administrative|2|||
164182037|NCT02360475|593030822|FG000|Overall Study|Lost to Follow-up|4|||
164182038|NCT02360475|593030823|FG001|Overall Study|Lost to Follow-up|12|||
164182039|NCT02360475|593030824|FG002|Overall Study|Lost to Follow-up|6|||
164182040|NCT02360475|593030825|FG003|Overall Study|Lost to Follow-up|4|||
164182041|NCT02360475|593030822|FG000|Overall Study|Withdrawal by Subject|0|||
164182042|NCT02360475|593030823|FG001|Overall Study|Withdrawal by Subject|1|||
164182043|NCT02360475|593030824|FG002|Overall Study|Withdrawal by Subject|2|||
164182044|NCT02360475|593030825|FG003|Overall Study|Withdrawal by Subject|0|||
164182045|NCT02360475|593030822|FG000|Overall Study|Migrated/moved from study area|0|||
164182046|NCT02360475|593030823|FG001|Overall Study|Migrated/moved from study area|0|||
164182047|NCT02360475|593030824|FG002|Overall Study|Migrated/moved from study area|0|||
164182048|NCT02360475|593030825|FG003|Overall Study|Migrated/moved from study area|1|||
164182049|NCT02510820|593032469|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
164182050|NCT02510820|593032470|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
164182051|NCT02510820|593032469|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
164182052|NCT02510820|593032470|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
164182053|NCT01859949|593032471|FG000|Overall Study|Family Matters|0|||
164182054|NCT01859949|593032472|FG001|Overall Study|Family Matters|1|||
164182055|NCT01859949|593032471|FG000|Overall Study|Physician Decision|2|||
164182056|NCT01859949|593032472|FG001|Overall Study|Physician Decision|4|||
164182057|NCT01859949|593032471|FG000|Overall Study|Withdrawal by Subject|11|||
164182058|NCT01859949|593032472|FG001|Overall Study|Withdrawal by Subject|10|||
164182059|NCT01859949|593032471|FG000|Overall Study|Protocol Violation|1|||
164182060|NCT01859949|593032472|FG001|Overall Study|Protocol Violation|1|||
164182061|NCT01859949|593032471|FG000|Overall Study|Adverse Event|0|||
164182062|NCT01859949|593032472|FG001|Overall Study|Adverse Event|1|||
164182063|NCT01153009|593032473|FG000|Overall Study|Adverse Event|4|||
164182064|NCT01153009|593032474|FG001|Overall Study|Adverse Event|14|||
164182065|NCT01153009|593032475|FG002|Overall Study|Adverse Event|14|||
164182066|NCT01153009|593032476|FG003|Overall Study|Adverse Event|10|||
164182067|NCT01153009|593032473|FG000|Overall Study|Lack of Efficacy|9|||
164182068|NCT01153009|593032474|FG001|Overall Study|Lack of Efficacy|0|||
164182069|NCT01153009|593032475|FG002|Overall Study|Lack of Efficacy|2|||
164182070|NCT01153009|593032476|FG003|Overall Study|Lack of Efficacy|1|||
164182071|NCT01153009|593032473|FG000|Overall Study|Noncompliance with Study Medication|1|||
164182072|NCT01153009|593032474|FG001|Overall Study|Noncompliance with Study Medication|3|||
164182073|NCT01153009|593032475|FG002|Overall Study|Noncompliance with Study Medication|4|||
164182074|NCT01153009|593032476|FG003|Overall Study|Noncompliance with Study Medication|1|||
164182075|NCT01153009|593032473|FG000|Overall Study|Protocol Deviations|4|||
164182076|NCT01153009|593032474|FG001|Overall Study|Protocol Deviations|3|||
164182077|NCT01153009|593032475|FG002|Overall Study|Protocol Deviations|3|||
164182078|NCT01153009|593032476|FG003|Overall Study|Protocol Deviations|2|||
164182079|NCT01153009|593032473|FG000|Overall Study|Withdrawal of Consent|5|||
164182080|NCT01153009|593032474|FG001|Overall Study|Withdrawal of Consent|5|||
164182081|NCT01153009|593032475|FG002|Overall Study|Withdrawal of Consent|4|||
164182082|NCT01153009|593032476|FG003|Overall Study|Withdrawal of Consent|6|||
164182083|NCT01153009|593032473|FG000|Overall Study|Lost to Follow-up|8|||
164182084|NCT01153009|593032474|FG001|Overall Study|Lost to Follow-up|8|||
164182085|NCT01153009|593032475|FG002|Overall Study|Lost to Follow-up|11|||
164182086|NCT01153009|593032476|FG003|Overall Study|Lost to Follow-up|15|||
164182087|NCT01153009|593032473|FG000|Overall Study|Other|1|||
164182088|NCT01153009|593032474|FG001|Overall Study|Other|1|||
164182089|NCT01153009|593032475|FG002|Overall Study|Other|3|||
164182090|NCT01153009|593032476|FG003|Overall Study|Other|2|||
164182091|NCT03307837|593032481|FG000|Overall Study|Withdrawal by Subject|0|||
164182092|NCT03307837|593032482|FG001|Overall Study|Withdrawal by Subject|0|||
164182093|NCT03307837|593032483|FG002|Overall Study|Withdrawal by Subject|1|||
164182094|NCT03307837|593032484|FG003|Overall Study|Withdrawal by Subject|0|||
164182095|NCT03307837|593032485|FG004|Overall Study|Withdrawal by Subject|0|||
164182096|NCT03307837|593032486|FG005|Overall Study|Withdrawal by Subject|1|||
164182097|NCT03307837|593032481|FG000|Overall Study|Lost to Follow-up|1|||
164182098|NCT03307837|593032482|FG001|Overall Study|Lost to Follow-up|1|||
164182099|NCT03307837|593032483|FG002|Overall Study|Lost to Follow-up|0|||
164182100|NCT03307837|593032484|FG003|Overall Study|Lost to Follow-up|0|||
164182101|NCT03307837|593032485|FG004|Overall Study|Lost to Follow-up|0|||
164182102|NCT03307837|593032486|FG005|Overall Study|Lost to Follow-up|1|||
164182103|NCT01744483|593032487|FG000|Overall Study|Death|9|||
164182104|NCT01744483|593032488|FG001|Overall Study|Death|4|||
164182105|NCT01744483|593032489|FG002|Overall Study|Death|11|||
164182106|NCT01744483|593032487|FG000|Overall Study|Lost to Follow-up|8|||
164182107|NCT01744483|593032488|FG001|Overall Study|Lost to Follow-up|9|||
164182108|NCT01744483|593032489|FG002|Overall Study|Lost to Follow-up|11|||
164182109|NCT01744483|593032487|FG000|Overall Study|Protocol Violation|1|||
164182110|NCT01744483|593032488|FG001|Overall Study|Protocol Violation|2|||
164182111|NCT01744483|593032489|FG002|Overall Study|Protocol Violation|1|||
164182112|NCT01744483|593032487|FG000|Overall Study|Withdrawal by Subject|4|||
164182113|NCT01744483|593032488|FG001|Overall Study|Withdrawal by Subject|6|||
164182114|NCT01744483|593032489|FG002|Overall Study|Withdrawal by Subject|2|||
164182115|NCT01744483|593032487|FG000|Overall Study|No ICU Admit|5|||
164182116|NCT01744483|593032488|FG001|Overall Study|No ICU Admit|1|||
164182117|NCT01744483|593032489|FG002|Overall Study|No ICU Admit|2|||
164182118|NCT01744483|593032487|FG000|Overall Study|Routed to OSH|2|||
164182119|NCT01744483|593032488|FG001|Overall Study|Routed to OSH|0|||
164182120|NCT01744483|593032489|FG002|Overall Study|Routed to OSH|1|||
164182121|NCT03041467|593032490|FG000|Overall Study|Death|46|||
164182122|NCT03041467|593032491|FG001|Overall Study|Death|39|||
164182123|NCT03041467|593032490|FG000|Overall Study|Withdrawal by Subject|36|||
164182124|NCT03041467|593032491|FG001|Overall Study|Withdrawal by Subject|37|||
164182125|NCT03041467|593032490|FG000|Overall Study|Lost to Follow-up|6|||
164182127|NCT03041467|593032490|FG000|Overall Study|Declined consent for study extension|21|||
164182128|NCT03041467|593032491|FG001|Overall Study|Declined consent for study extension|33|||
164182129|NCT03041467|593032490|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
164182130|NCT03041467|593032491|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
164182131|NCT02469168|593032496|FG000|Overall Study|Trial closed|1|||
164182132|NCT02469168|593032497|FG001|Overall Study|Trial closed|0|||
164182133|NCT00298363|593032498|FG000|Overall Study|Lost to Follow-up|0|||
164182134|NCT00298363|593032499|FG001|Overall Study|Lost to Follow-up|0|||
164182135|NCT00298363|593032500|FG002|Overall Study|Lost to Follow-up|1|||
164182136|NCT00298363|593032498|FG000|Overall Study|Physician Decision|4|||
164182137|NCT00298363|593032499|FG001|Overall Study|Physician Decision|1|||
164182138|NCT00298363|593032500|FG002|Overall Study|Physician Decision|0|||
164182139|NCT00298363|593032498|FG000|Overall Study|Protocol Violation|1|||
164182140|NCT00298363|593032499|FG001|Overall Study|Protocol Violation|1|||
164182141|NCT00298363|593032500|FG002|Overall Study|Protocol Violation|0|||
164182142|NCT00298363|593032498|FG000|Overall Study|Withdrawal by Subject|5|||
164182143|NCT00298363|593032499|FG001|Overall Study|Withdrawal by Subject|1|||
164182144|NCT00298363|593032500|FG002|Overall Study|Withdrawal by Subject|3|||
164182145|NCT00298363|593032498|FG000|Overall Study|Adverse Event|5|||
164182146|NCT00298363|593032499|FG001|Overall Study|Adverse Event|2|||
164182147|NCT00298363|593032500|FG002|Overall Study|Adverse Event|2|||
164182148|NCT00298363|593032498|FG000|Overall Study|Lack of Efficacy|2|||
164182149|NCT00298363|593032499|FG001|Overall Study|Lack of Efficacy|3|||
164182150|NCT00298363|593032500|FG002|Overall Study|Lack of Efficacy|0|||
164182151|NCT00135356|593032501|FG000|Overall Study|Adverse Event|6|||
164182152|NCT00135356|593032502|FG001|Overall Study|Adverse Event|2|||
164182153|NCT00135356|593032501|FG000|Overall Study|Lack of Efficacy|2|||
164182154|NCT00135356|593032502|FG001|Overall Study|Lack of Efficacy|0|||
164182155|NCT00135356|593032501|FG000|Overall Study|Lost to Follow-up|3|||
164182156|NCT00135356|593032502|FG001|Overall Study|Lost to Follow-up|1|||
164182157|NCT00135356|593032501|FG000|Overall Study|Surgery for abdominal fat|1|||
164182158|NCT00135356|593032502|FG001|Overall Study|Surgery for abdominal fat|0|||
164182159|NCT00135356|593032501|FG000|Overall Study|Change in antiviral regimen|0|||
164182160|NCT00135356|593032502|FG001|Overall Study|Change in antiviral regimen|1|||
164182161|NCT00135356|593032501|FG000|Overall Study|Poor/noncompliance|1|||
164182162|NCT00135356|593032502|FG001|Overall Study|Poor/noncompliance|1|||
164182163|NCT00135356|593032501|FG000|Overall Study|No longer meets study criteria|2|||
164182164|NCT00135356|593032502|FG001|Overall Study|No longer meets study criteria|0|||
164182165|NCT00135356|593032501|FG000|Overall Study|Withdrawal by Subject|2|||
164182166|NCT00135356|593032502|FG001|Overall Study|Withdrawal by Subject|4|||
164182167|NCT01533688|593032503|FG000|Overall Study|Withdrawal by Subject|5|||
164182168|NCT01533688|593032504|FG001|Overall Study|Withdrawal by Subject|4|||
164182169|NCT01533688|593032505|FG002|Overall Study|Withdrawal by Subject|3|||
164182170|NCT01533688|593032503|FG000|Overall Study|Medically unstable|1|||
164182171|NCT01533688|593032504|FG001|Overall Study|Medically unstable|3|||
164182172|NCT01533688|593032505|FG002|Overall Study|Medically unstable|3|||
164182173|NCT01533688|593032503|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
164182174|NCT01533688|593032504|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
164182175|NCT01533688|593032505|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
164182176|NCT01306214|593032507|FG000|Overall Study|Death|0|||
164182177|NCT01306214|593032508|FG001|Overall Study|Death|0|||
164182178|NCT01306214|593032509|FG002|Overall Study|Death|1|||
164182179|NCT01306214|593032507|FG000|Overall Study|Lost to Follow-up|3|||
164182180|NCT01306214|593032508|FG001|Overall Study|Lost to Follow-up|5|||
164182181|NCT01306214|593032509|FG002|Overall Study|Lost to Follow-up|4|||
164182182|NCT01306214|593032507|FG000|Overall Study|Withdrawal by Subject|24|||
164182183|NCT01306214|593032508|FG001|Overall Study|Withdrawal by Subject|22|||
164182184|NCT01306214|593032509|FG002|Overall Study|Withdrawal by Subject|16|||
164182185|NCT01306214|593032507|FG000|Overall Study|Not treated|1|||
164182186|NCT01306214|593032508|FG001|Overall Study|Not treated|1|||
164182187|NCT01306214|593032509|FG002|Overall Study|Not treated|1|||
164182188|NCT02686814|593032510|FG000|Overall Study|Physician Decision|14|||
164182189|NCT02686814|593032510|FG000|Overall Study|Withdrawal by Subject|4|||
164182190|NCT02686814|593032510|FG000|Overall Study|Death|1|||
164182191|NCT02065518|593032511|FG000|Overall Study|Lost to Follow-up|3|||
164182192|NCT02065518|593032512|FG001|Overall Study|Lost to Follow-up|4|||
164182193|NCT02065518|593032513|FG002|Overall Study|Lost to Follow-up|0|||
164182194|NCT02065518|593032514|FG003|Overall Study|Lost to Follow-up|3|||
164182195|NCT02065518|593032511|FG000|Overall Study|Withdrawal by Subject|3|||
164182196|NCT02065518|593032512|FG001|Overall Study|Withdrawal by Subject|4|||
164182197|NCT02065518|593032513|FG002|Overall Study|Withdrawal by Subject|9|||
164182198|NCT02065518|593032514|FG003|Overall Study|Withdrawal by Subject|2|||
164182199|NCT01090050|593032516|FG000|Overall Study|Lost to Follow-up|0|||
164182200|NCT01090050|593032517|FG001|Overall Study|Lost to Follow-up|1|||
164182201|NCT01090050|593032516|FG000|Overall Study|Lack of Efficacy|1|||
164182202|NCT01090050|593032517|FG001|Overall Study|Lack of Efficacy|5|||
164182203|NCT01090050|593032516|FG000|Overall Study|Physician Decision|0|||
164182204|NCT01090050|593032517|FG001|Overall Study|Physician Decision|1|||
164182205|NCT03624569|593032519|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
164182206|NCT03624569|593032520|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
164182207|NCT03624569|593032519|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
164182208|NCT03624569|593032520|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
164182209|NCT01464619|593032559|FG000|Overall Study|Lost to Follow-up|3|||
164182210|NCT01464619|593032560|FG001|Overall Study|Lost to Follow-up|4|||
164182211|NCT03411902|593032561|FG000|Overall Study|Lost to Follow-up|3|||
164182212|NCT03411902|593032562|FG001|Overall Study|Lost to Follow-up|0|||
164182213|NCT01693185|593032565|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
164182214|NCT01693185|593032566|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
164182215|NCT00419159|593032567|FG000|Overall Study|Adverse Event|7|||
164182216|NCT00419159|593032568|FG001|Overall Study|Adverse Event|15|||
164182217|NCT00419159|593032567|FG000|Overall Study|Abnormal laboratory value(s)|0|||
164182218|NCT00419159|593032568|FG001|Overall Study|Abnormal laboratory value(s)|2|||
164182219|NCT00419159|593032567|FG000|Overall Study|Subject's no longer requires study drug|0|||
164182220|NCT00419159|593032568|FG001|Overall Study|Subject's no longer requires study drug|1|||
164182221|NCT00419159|593032567|FG000|Overall Study|Protocol Violation|1|||
164182222|NCT00419159|593032568|FG001|Overall Study|Protocol Violation|0|||
164182223|NCT00419159|593032567|FG000|Overall Study|Withdrawal by Subject|10|||
164182224|NCT00419159|593032568|FG001|Overall Study|Withdrawal by Subject|3|||
164182225|NCT00419159|593032567|FG000|Overall Study|Lost to Follow-up|0|||
164182226|NCT00419159|593032568|FG001|Overall Study|Lost to Follow-up|1|||
164182227|NCT00419159|593032567|FG000|Overall Study|Death|2|||
164182228|NCT00419159|593032568|FG001|Overall Study|Death|2|||
164182229|NCT00419159|593032567|FG000|Overall Study|Disease progression|79|||
164182230|NCT00419159|593032568|FG001|Overall Study|Disease progression|76|||
164182231|NCT01017601|593032569|FG000|Overall Study|Disease Progression|12|||
164182232|NCT01017601|593032570|FG001|Overall Study|Disease Progression|12|||
164182233|NCT01017601|593032569|FG000|Overall Study|Withdrawal by Subject|0|||
164182234|NCT01017601|593032570|FG001|Overall Study|Withdrawal by Subject|1|||
164182235|NCT01857102|593032572|FG000|Period 1|No longer meets Eligibility Criteria|0|||
164182236|NCT01857102|593032573|FG001|Period 1|No longer meets Eligibility Criteria|2|||
164182237|NCT01857102|593032572|FG000|Period 1|Lost to Follow-up|0|||
164182238|NCT01857102|593032573|FG001|Period 1|Lost to Follow-up|3|||
164182239|NCT01857102|593032572|FG000|Period 1|Unsatisfactory Lens Fit|1|||
164182240|NCT01857102|593032573|FG001|Period 1|Unsatisfactory Lens Fit|0|||
164182241|NCT01857102|593032572|FG000|Period 1|Unsatisfactory Visual Response|1|||
164182242|NCT01857102|593032573|FG001|Period 1|Unsatisfactory Visual Response|0|||
164182243|NCT01857102|593032572|FG000|Period 1|Physician Decision|1|||
164182244|NCT01857102|593032573|FG001|Period 1|Physician Decision|0|||
164182245|NCT01857102|593032572|FG000|Period 2|Lens Discomfort|1|||
164182246|NCT01857102|593032573|FG001|Period 2|Lens Discomfort|0|||
164182247|NCT01857102|593032572|FG000|Period 2|Unsatisfactory Lens Fit|1|||
164182248|NCT01857102|593032573|FG001|Period 2|Unsatisfactory Lens Fit|0|||
164182249|NCT02735096|593032578|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
164182250|NCT01080391|593032589|FG000|Overall Study|Randomized but not treated|7|||
164182251|NCT01080391|593032590|FG001|Overall Study|Randomized but not treated|4|||
164182252|NCT02083653|593032598|FG000|Overall Study|Randomized but not Treated|0|||
164182253|NCT02083653|593032599|FG001|Overall Study|Randomized but not Treated|2|||
164182254|NCT02083653|593032600|FG002|Overall Study|Randomized but not Treated|7|||
164182255|NCT02083653|593032598|FG000|Overall Study|Adverse Event|12|||
164182256|NCT02083653|593032599|FG001|Overall Study|Adverse Event|5|||
164182257|NCT02083653|593032600|FG002|Overall Study|Adverse Event|4|||
164182258|NCT02083653|593032598|FG000|Overall Study|Lost to Follow-up|1|||
164182259|NCT02083653|593032599|FG001|Overall Study|Lost to Follow-up|0|||
164182260|NCT02083653|593032600|FG002|Overall Study|Lost to Follow-up|0|||
164182261|NCT02083653|593032598|FG000|Overall Study|Death|2|||
164182262|NCT02083653|593032599|FG001|Overall Study|Death|2|||
164182263|NCT02083653|593032600|FG002|Overall Study|Death|2|||
164182264|NCT02083653|593032598|FG000|Overall Study|Progressive Disease|65|||
164182265|NCT02083653|593032599|FG001|Overall Study|Progressive Disease|73|||
164182266|NCT02083653|593032600|FG002|Overall Study|Progressive Disease|63|||
164182267|NCT02083653|593032598|FG000|Overall Study|Withdrawal by Subject|2|||
164182268|NCT02083653|593032599|FG001|Overall Study|Withdrawal by Subject|1|||
164182269|NCT02083653|593032600|FG002|Overall Study|Withdrawal by Subject|2|||
164182270|NCT02083653|593032598|FG000|Overall Study|Other Events|0|||
164182271|NCT02083653|593032599|FG001|Overall Study|Other Events|2|||
164182272|NCT02083653|593032600|FG002|Overall Study|Other Events|2|||
164182273|NCT02083653|593032598|FG000|Overall Study|Reason Missing|0|||
164182274|NCT02083653|593032599|FG001|Overall Study|Reason Missing|0|||
164182275|NCT02083653|593032600|FG002|Overall Study|Reason Missing|4|||
164182276|NCT02073656|593032601|FG000|Primary Study|Lost to Follow-up|6|||
164182277|NCT02073656|593032601|FG000|Primary Study|Death|1|||
164182278|NCT02073656|593032601|FG000|Primary Study|Withdrew Consent|1|||
164182279|NCT02536781|593032605|FG000|Overall Study|Lost to Follow-up|2|||
164182280|NCT02536781|593032606|FG001|Overall Study|Lost to Follow-up|0|||
164182281|NCT03423147|593032607|FG000|Overall Study|Lost to Follow-up|5|||
164182282|NCT03423147|593032608|FG001|Overall Study|Lost to Follow-up|8|||
164182283|NCT03423147|593032607|FG000|Overall Study|Withdrawal by Subject|1|||
164182284|NCT03423147|593032608|FG001|Overall Study|Withdrawal by Subject|0|||
164182285|NCT03423147|593032607|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
164182286|NCT03423147|593032608|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
164182287|NCT03423147|593032607|FG000|Overall Study|Age < 18|1|||
164182288|NCT03423147|593032608|FG001|Overall Study|Age < 18|0|||
164182289|NCT03423147|593032607|FG000|Overall Study|No Trial of Labor|0|||
164182290|NCT03423147|593032608|FG001|Overall Study|No Trial of Labor|1|||
164182291|NCT01048099|593032609|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
164182292|NCT01048099|593032609|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
164182293|NCT01731470|593032611|FG000|Overall Study|Withdrawal by Subject|1|||
164182294|NCT01731470|593032611|FG000|Overall Study|Did not meet study criteria|1|||
164182295|NCT02450552|593032615|FG000|Overall Study|Withdrawal by Subject|4|||
164182296|NCT02450552|593032616|FG001|Overall Study|Withdrawal by Subject|0|||
164182297|NCT02450552|593032617|FG002|Overall Study|Withdrawal by Subject|4|||
164182298|NCT02450552|593032615|FG000|Overall Study|Physician Decision|1|||
164182299|NCT02450552|593032616|FG001|Overall Study|Physician Decision|0|||
164182300|NCT02450552|593032617|FG002|Overall Study|Physician Decision|1|||
164182301|NCT01524783|593032618|FG000|Blinded Period|Adverse Event|64|||
164182302|NCT01524783|593032619|FG001|Blinded Period|Adverse Event|7|||
164182303|NCT01524783|593032620|FG002|Blinded Period|Adverse Event|0|||
164182304|NCT01524783|593032618|FG000|Blinded Period|Disease Progression|89|||
164182305|NCT01524783|593032619|FG001|Blinded Period|Disease Progression|75|||
164182306|NCT01524783|593032620|FG002|Blinded Period|Disease Progression|0|||
164182307|NCT01524783|593032618|FG000|Blinded Period|Withdrawal by Subject|19|||
164182308|NCT01524783|593032619|FG001|Blinded Period|Withdrawal by Subject|6|||
164182309|NCT01524783|593032620|FG002|Blinded Period|Withdrawal by Subject|0|||
164182310|NCT01524783|593032618|FG000|Blinded Period|Protocol deviation|2|||
164182311|NCT01524783|593032619|FG001|Blinded Period|Protocol deviation|1|||
164182312|NCT01524783|593032620|FG002|Blinded Period|Protocol deviation|0|||
164182313|NCT01524783|593032618|FG000|Blinded Period|Death|5|||
164182314|NCT01524783|593032619|FG001|Blinded Period|Death|2|||
164182315|NCT01524783|593032620|FG002|Blinded Period|Death|0|||
164182316|NCT01524783|593032618|FG000|Open-label Period|Disease progression|13|||
164182317|NCT01524783|593032619|FG001|Open-label Period|Disease progression|0|||
164182318|NCT01524783|593032620|FG002|Open-label Period|Disease progression|2|||
164182319|NCT01524783|593032618|FG000|Open-label Period|Administrative problems|5|||
164182320|NCT01524783|593032619|FG001|Open-label Period|Administrative problems|0|||
164182321|NCT01524783|593032620|FG002|Open-label Period|Administrative problems|2|||
164182322|NCT01524783|593032618|FG000|Open-label Period|Adverse Event|5|||
164182323|NCT01524783|593032619|FG001|Open-label Period|Adverse Event|0|||
164182324|NCT01524783|593032620|FG002|Open-label Period|Adverse Event|1|||
164182325|NCT01524783|593032618|FG000|Open-label Period|Withdrawal by Subject|2|||
164182326|NCT01524783|593032619|FG001|Open-label Period|Withdrawal by Subject|0|||
164182327|NCT01524783|593032620|FG002|Open-label Period|Withdrawal by Subject|1|||
164182328|NCT01524783|593032618|FG000|Open-label Period|Protocol deviation|1|||
164182329|NCT01524783|593032619|FG001|Open-label Period|Protocol deviation|0|||
164182330|NCT01524783|593032620|FG002|Open-label Period|Protocol deviation|0|||
164182331|NCT01625689|593032621|FG000|Overall Study|Migration|2|||
164182332|NCT01625689|593032622|FG001|Overall Study|Migration|1|||
164182333|NCT03723070|593032627|FG000|Overall Study|Lost to Follow-up|2|||
164182334|NCT03723070|593032627|FG000|Overall Study|Physician Decision|1|||
164182335|NCT03723070|593032627|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
164182336|NCT02208050|593032628|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
164182337|NCT02208050|593032629|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
164182338|NCT00721279|593032633|FG000|Overall Study|Lack of Efficacy|6|||
164182339|NCT00721279|593032634|FG001|Overall Study|Lack of Efficacy|3|||
164182340|NCT00721279|593032633|FG000|Overall Study|Tolerability insufficient|5|||
164182341|NCT00721279|593032634|FG001|Overall Study|Tolerability insufficient|2|||
164182342|NCT00721279|593032633|FG000|Overall Study|Withdrawal by Subject|13|||
164182343|NCT00721279|593032634|FG001|Overall Study|Withdrawal by Subject|3|||
164182344|NCT00721279|593032633|FG000|Overall Study|Other|12|||
164182345|NCT00721279|593032634|FG001|Overall Study|Other|16|||
164182346|NCT05153148|593032635|FG000|Overall Study|Adverse Event|1|||
164182347|NCT05153148|593032636|FG001|Overall Study|Adverse Event|0|||
164182348|NCT05153148|593032637|FG002|Overall Study|Adverse Event|3|||
164182349|NCT05153148|593032638|FG003|Overall Study|Adverse Event|5|||
164182350|NCT05153148|593032635|FG000|Overall Study|Lost to Follow-up|1|||
164182351|NCT05153148|593032636|FG001|Overall Study|Lost to Follow-up|1|||
164182352|NCT05153148|593032637|FG002|Overall Study|Lost to Follow-up|2|||
164182353|NCT05153148|593032638|FG003|Overall Study|Lost to Follow-up|0|||
164182354|NCT05153148|593032635|FG000|Overall Study|Withdrawal by Subject|6|||
164182355|NCT05153148|593032636|FG001|Overall Study|Withdrawal by Subject|8|||
164182356|NCT05153148|593032637|FG002|Overall Study|Withdrawal by Subject|6|||
164182357|NCT05153148|593032638|FG003|Overall Study|Withdrawal by Subject|8|||
164182358|NCT05153148|593032635|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164182359|NCT05153148|593032636|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164182360|NCT05153148|593032637|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
164182361|NCT05153148|593032638|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
164182362|NCT05153148|593032635|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
164182363|NCT05153148|593032636|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
164182364|NCT05153148|593032637|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
164182365|NCT05153148|593032638|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
164182366|NCT05153148|593032635|FG000|Overall Study|Reason not Specified|1|||
164182367|NCT05153148|593032636|FG001|Overall Study|Reason not Specified|1|||
164182368|NCT05153148|593032637|FG002|Overall Study|Reason not Specified|1|||
164182369|NCT05153148|593032638|FG003|Overall Study|Reason not Specified|1|||
164182370|NCT01732471|593032639|FG000|Overall Study|Withdrawal by Subject|1|||
164182371|NCT04494425|593034190|FG000|Overall Study|Death|160|||
164182372|NCT04494425|593034191|FG001|Overall Study|Death|166|||
164182373|NCT04494425|593034190|FG000|Overall Study|Withdrawal by Subject|10|||
164182374|NCT04494425|593034191|FG001|Overall Study|Withdrawal by Subject|40|||
164182375|NCT04494425|593034190|FG000|Overall Study|Other|1|||
164182376|NCT04494425|593034191|FG001|Overall Study|Other|1|||
164182377|NCT04494425|593034190|FG000|Overall Study|Ongoing at the time of PCD|265|||
164182378|NCT04494425|593034191|FG001|Overall Study|Ongoing at the time of PCD|223|||
164182379|NCT01270321|593034193|FG000|Overall Study|Death|3|||
164182380|NCT01270321|593034194|FG001|Overall Study|Death|1|||
164182381|NCT01270321|593034195|FG002|Overall Study|Death|4|||
164182382|NCT01270321|593034193|FG000|Overall Study|Adverse Event|7|||
164182383|NCT01270321|593034194|FG001|Overall Study|Adverse Event|9|||
164182384|NCT01270321|593034195|FG002|Overall Study|Adverse Event|5|||
164182385|NCT04003623|593034199|FG000|Overall Study|Withdrawal by Subject|1|||
164182386|NCT04003623|593034200|FG001|Overall Study|Withdrawal by Subject|0|||
164182387|NCT01190189|593034204|FG000|Overall Study|Lost to Follow-up|4|||
164182388|NCT01190189|593034204|FG000|Overall Study|Withdrawal by Subject|1|||
164182389|NCT01190189|593034204|FG000|Overall Study|Migrated/moved from study area|1|||
164182390|NCT00762034|593034208|FG000|Induction Period|Protocol Violation|1|||
164182391|NCT00762034|593034209|FG001|Induction Period|Protocol Violation|2|||
164182392|NCT00762034|593034208|FG000|Induction Period|Entry Criterion Not Met|12|||
164182393|NCT00762034|593034209|FG001|Induction Period|Entry Criterion Not Met|11|||
164182394|NCT00762034|593034208|FG000|Induction Period|Adverse Event|27|||
164182395|NCT00762034|593034209|FG001|Induction Period|Adverse Event|38|||
164182396|NCT00762034|593034208|FG000|Induction Period|Lost to Follow-up|1|||
164182397|NCT00762034|593034209|FG001|Induction Period|Lost to Follow-up|1|||
164182398|NCT00762034|593034208|FG000|Induction Period|Progressive Disease|73|||
164182399|NCT00762034|593034209|FG001|Induction Period|Progressive Disease|55|||
164182400|NCT00762034|593034208|FG000|Induction Period|Physician Decision|21|||
164182401|NCT00762034|593034209|FG001|Induction Period|Physician Decision|20|||
164182402|NCT00762034|593034208|FG000|Induction Period|Withdrawal by Subject|15|||
164182403|NCT00762034|593034209|FG001|Induction Period|Withdrawal by Subject|19|||
164182404|NCT00762034|593034208|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
164182405|NCT00762034|593034209|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
164182406|NCT00762034|593034208|FG000|Induction Period|Deaths Due to Study Disease|9|||
164182407|NCT00762034|593034209|FG001|Induction Period|Deaths Due to Study Disease|9|||
164182408|NCT00762034|593034208|FG000|Maintenance Period|Protocol Violation|1|||
164182409|NCT00762034|593034209|FG001|Maintenance Period|Protocol Violation|3|||
164182410|NCT00762034|593034208|FG000|Maintenance Period|Entry Criterion Not Met|0|||
164182411|NCT00762034|593034209|FG001|Maintenance Period|Entry Criterion Not Met|2|||
164182412|NCT00762034|593034208|FG000|Maintenance Period|Adverse Event|42|||
164182413|NCT00762034|593034209|FG001|Maintenance Period|Adverse Event|26|||
164182414|NCT00762034|593034208|FG000|Maintenance Period|Progressive Disease|186|||
164182415|NCT00762034|593034209|FG001|Maintenance Period|Progressive Disease|224|||
164182416|NCT00762034|593034208|FG000|Maintenance Period|Physician Decision|25|||
164182417|NCT00762034|593034209|FG001|Maintenance Period|Physician Decision|20|||
164182418|NCT00762034|593034208|FG000|Maintenance Period|Withdrawal by Subject|34|||
164182419|NCT00762034|593034209|FG001|Maintenance Period|Withdrawal by Subject|14|||
164182420|NCT00762034|593034208|FG000|Maintenance Period|Death not due to study disease|2|||
164182421|NCT00762034|593034209|FG001|Maintenance Period|Death not due to study disease|5|||
164182422|NCT00762034|593034208|FG000|Maintenance Period|Death due to study disease|3|||
164182423|NCT00762034|593034209|FG001|Maintenance Period|Death due to study disease|3|||
164182424|NCT00762034|593034208|FG000|Maintenance Period|Other|1|||
164182425|NCT00762034|593034209|FG001|Maintenance Period|Other|1|||
164182426|NCT00734656|593034210|FG000|Lab Session 1|Withdrawal by Subject|2|||
164182427|NCT00734656|593034211|FG001|Lab Session 1|Withdrawal by Subject|0|||
164182428|NCT00734656|593034212|FG002|Lab Session 1|Withdrawal by Subject|0|||
164182429|NCT00734656|593034213|FG003|Lab Session 1|Withdrawal by Subject|0|||
164182430|NCT00734656|593034210|FG000|Washout 1|Withdrawal by Subject|1|||
164182431|NCT00734656|593034211|FG001|Washout 1|Withdrawal by Subject|5|||
164182432|NCT00734656|593034212|FG002|Washout 1|Withdrawal by Subject|2|||
164182433|NCT00734656|593034213|FG003|Washout 1|Withdrawal by Subject|3|||
164182434|NCT00734656|593034210|FG000|Lab Session 2|Withdrawal by Subject|1|||
164182435|NCT00734656|593034211|FG001|Lab Session 2|Withdrawal by Subject|0|||
164182436|NCT00734656|593034212|FG002|Lab Session 2|Withdrawal by Subject|0|||
164182437|NCT00734656|593034213|FG003|Lab Session 2|Withdrawal by Subject|1|||
164182438|NCT00734656|593034210|FG000|Washout 2|Withdrawal by Subject|1|||
164182439|NCT00734656|593034211|FG001|Washout 2|Withdrawal by Subject|1|||
164182440|NCT00734656|593034212|FG002|Washout 2|Withdrawal by Subject|1|||
164182441|NCT00734656|593034213|FG003|Washout 2|Withdrawal by Subject|0|||
164182442|NCT00734656|593034210|FG000|Washout 3|Withdrawal by Subject|1|||
164182443|NCT00734656|593034211|FG001|Washout 3|Withdrawal by Subject|0|||
164182444|NCT00734656|593034212|FG002|Washout 3|Withdrawal by Subject|0|||
164182445|NCT00734656|593034213|FG003|Washout 3|Withdrawal by Subject|1|||
164182446|NCT00734656|593034210|FG000|Lab Session 4|Withdrawal by Subject|0|||
164182447|NCT00734656|593034211|FG001|Lab Session 4|Withdrawal by Subject|0|||
164182448|NCT00734656|593034212|FG002|Lab Session 4|Withdrawal by Subject|0|||
164182449|NCT00734656|593034213|FG003|Lab Session 4|Withdrawal by Subject|1|||
164182450|NCT03214679|593034216|FG000|Overall Study|Lost to Follow-up|12|||
164182451|NCT03214679|593034217|FG001|Overall Study|Lost to Follow-up|14|||
164182452|NCT03214679|593034216|FG000|Overall Study|not eligible|2|||
164182453|NCT03214679|593034217|FG001|Overall Study|not eligible|0|||
164182454|NCT01754766|593034225|FG000|Overall Study|Personal reasons|1|||
164182455|NCT01754766|593034226|FG001|Overall Study|Personal reasons|1|||
164182456|NCT01754766|593034227|FG002|Overall Study|Personal reasons|0|||
164182457|NCT01709409|593034230|FG000|Overall Study|Protocol Violation|1|||
164182458|NCT01709409|593034231|FG001|Overall Study|Protocol Violation|0|||
164182459|NCT02412878|593034232|FG000|Overall Study|Withdrawal by Subject|19|||
164182460|NCT02412878|593034233|FG001|Overall Study|Withdrawal by Subject|10|||
164182461|NCT02412878|593034232|FG000|Overall Study|Lost to Follow-up|2|||
164182462|NCT02412878|593034233|FG001|Overall Study|Lost to Follow-up|3|||
164182463|NCT04571385|593034234|FG000|Overall Study|Participant non-compliance|1|||
164182464|NCT04571385|593034235|FG001|Overall Study|Participant non-compliance|0|||
164182465|NCT04571385|593034236|FG002|Overall Study|Participant non-compliance|0|||
164182466|NCT04571385|593034234|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
164182467|NCT04571385|593034235|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
164182468|NCT04571385|593034236|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
164182469|NCT04571385|593034234|FG000|Overall Study|Screen failure|0|||
164182470|NCT04571385|593034235|FG001|Overall Study|Screen failure|0|||
164182471|NCT04571385|593034236|FG002|Overall Study|Screen failure|1|||
164182472|NCT04676152|593034237|FG000|Overall Study|screen fail|9|||
164182473|NCT01928199|593034240|FG000|Overall Study|Lost to Follow-up|2|||
164182474|NCT01928199|593034241|FG001|Overall Study|Lost to Follow-up|1|||
164182475|NCT01928199|593034240|FG000|Overall Study|Withdrawal by Subject|3|||
164182476|NCT01928199|593034241|FG001|Overall Study|Withdrawal by Subject|5|||
164182477|NCT00571103|593034243|FG000|Overall Study|Withdrawal by Subject|1|||
164182478|NCT00571103|593034243|FG000|Overall Study|Lost to Follow-up|1|||
164182479|NCT02368886|593034244|FG000|Overall Study|Cancel|1|||
164182480|NCT02368886|593034245|FG001|Overall Study|Cancel|1|||
164182481|NCT02368886|593034246|FG002|Overall Study|Cancel|1|||
164182482|NCT02368886|593034247|FG003|Overall Study|Cancel|3|||
164182483|NCT02368886|593034244|FG000|Overall Study|Ineligible|0|||
164182484|NCT02368886|593034245|FG001|Overall Study|Ineligible|0|||
164182485|NCT02368886|593034246|FG002|Overall Study|Ineligible|0|||
164182486|NCT02368886|593034247|FG003|Overall Study|Ineligible|1|||
164182487|NCT04278924|593034249|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
164182488|NCT04278924|593034250|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
164182489|NCT04278924|593034251|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182490|NCT04278924|593034252|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
164182491|NCT04278924|593034253|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182492|NCT04278924|593034254|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182493|NCT04278924|593034255|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
164182494|NCT04278924|593034249|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182495|NCT04278924|593034250|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
164182496|NCT04278924|593034251|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182497|NCT04278924|593034252|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182498|NCT04278924|593034253|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182499|NCT04278924|593034254|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182500|NCT04278924|593034255|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
164182501|NCT04767529|593034256|FG000|Overall Study|Adverse Event|0|||
164182502|NCT04767529|593034257|FG001|Overall Study|Adverse Event|4|||
164182503|NCT04767529|593034258|FG002|Overall Study|Adverse Event|3|||
164182504|NCT04767529|593034256|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
164182505|NCT04767529|593034257|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
164182506|NCT04767529|593034258|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
164182507|NCT04767529|593034256|FG000|Overall Study|Required use of a prohibited medication|0|||
164182508|NCT04767529|593034257|FG001|Overall Study|Required use of a prohibited medication|1|||
164182509|NCT04767529|593034258|FG002|Overall Study|Required use of a prohibited medication|0|||
164182510|NCT04767529|593034256|FG000|Overall Study|Withdrawal by Subject|7|||
164182511|NCT04767529|593034257|FG001|Overall Study|Withdrawal by Subject|5|||
164182512|NCT04767529|593034258|FG002|Overall Study|Withdrawal by Subject|4|||
164182513|NCT04767529|593034256|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
164182514|NCT04767529|593034257|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
164182515|NCT04767529|593034258|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
164182516|NCT04767529|593034256|FG000|Overall Study|Lost to Follow-up|0|||
164182517|NCT04767529|593034257|FG001|Overall Study|Lost to Follow-up|2|||
164182518|NCT04767529|593034258|FG002|Overall Study|Lost to Follow-up|3|||
164182519|NCT04847232|593034259|FG000|Overall Study|Death|123|||
164182520|NCT04847232|593034260|FG001|Overall Study|Death|115|||
164182521|NCT04847232|593034259|FG000|Overall Study|Lost to Follow-up|3|||
164182522|NCT04847232|593034260|FG001|Overall Study|Lost to Follow-up|10|||
164182523|NCT04847232|593034259|FG000|Overall Study|Withdrawal by Subject|73|||
164182524|NCT04847232|593034260|FG001|Overall Study|Withdrawal by Subject|101|||
164182525|NCT04847232|593034259|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
164182526|NCT04847232|593034260|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
164182527|NCT02476916|593034261|FG000|Core Period|Adverse Event|2|||
164182528|NCT02476916|593034262|FG001|Core Period|Adverse Event|2|||
164182529|NCT02476916|593034261|FG000|Core Period|Investigator decision|1|||
164182530|NCT02476916|593034262|FG001|Core Period|Investigator decision|1|||
164182531|NCT02476916|593034261|FG000|Core Period|Withdrawal by Subject|3|||
164182532|NCT02476916|593034262|FG001|Core Period|Withdrawal by Subject|0|||
164182533|NCT02476916|593034261|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
164182534|NCT02476916|593034262|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
164182535|NCT02476916|593034261|FG000|Extension Period|On Treatment|12|||
164182536|NCT02476916|593034262|FG001|Extension Period|On Treatment|17|||
164182537|NCT06010732|593034263|FG000|Crossover Period 1|Protocol Violation|0|||
164182538|NCT06010732|593034264|FG001|Crossover Period 1|Protocol Violation|0|||
164182539|NCT06010732|593034265|FG002|Crossover Period 1|Protocol Violation|1|||
164182540|NCT06010732|593034266|FG003|Crossover Period 1|Protocol Violation|0|||
164182541|NCT06010732|593034267|FG004|Crossover Period 1|Protocol Violation|1|||
164182542|NCT06010732|593034268|FG005|Crossover Period 1|Protocol Violation|0|||
164182543|NCT06010732|593034263|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182544|NCT06010732|593034264|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
164182545|NCT06010732|593034265|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182546|NCT06010732|593034266|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182547|NCT06010732|593034267|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182548|NCT06010732|593034268|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
164182549|NCT06010732|593034263|FG000|Crossover Period 2|Adverse Event|0|||
164182550|NCT06010732|593034264|FG001|Crossover Period 2|Adverse Event|1|||
164182551|NCT06010732|593034265|FG002|Crossover Period 2|Adverse Event|0|||
164182552|NCT06010732|593034266|FG003|Crossover Period 2|Adverse Event|0|||
164182553|NCT06010732|593034267|FG004|Crossover Period 2|Adverse Event|0|||
164182554|NCT06010732|593034268|FG005|Crossover Period 2|Adverse Event|0|||
164182555|NCT06010732|593034263|FG000|Crossover Period 2|broken denture|0|||
164182556|NCT06010732|593034264|FG001|Crossover Period 2|broken denture|0|||
164182557|NCT06010732|593034265|FG002|Crossover Period 2|broken denture|1|||
164182558|NCT06010732|593034266|FG003|Crossover Period 2|broken denture|0|||
164182559|NCT06010732|593034267|FG004|Crossover Period 2|broken denture|0|||
164182560|NCT06010732|593034268|FG005|Crossover Period 2|broken denture|0|||
164182561|NCT00253370|593034270|FG000|Overall Study|Adverse Event|18|||
164182562|NCT00253370|593034270|FG000|Overall Study|Disease progression|13|||
164182563|NCT00253370|593034270|FG000|Overall Study|Death|2|||
164182564|NCT00253370|593034270|FG000|Overall Study|Withdrawal by Subject|6|||
164182565|NCT00253370|593034270|FG000|Overall Study|Non-protocol therapy|1|||
164182566|NCT00253370|593034270|FG000|Overall Study|Physician Decision|1|||
164182567|NCT00253370|593034270|FG000|Overall Study|Protocol Violation|1|||
164182568|NCT00253370|593034270|FG000|Overall Study|Abdominal pain due to disease|1|||
164182569|NCT03699540|593034271|FG000|Overall Study|Lost to Follow-up|1|||
164182570|NCT02697591|593034272|FG000|Overall Study|Lost to Follow-up|0|||
164182571|NCT02697591|593034273|FG001|Overall Study|Lost to Follow-up|0|||
164182572|NCT02697591|593034274|FG002|Overall Study|Lost to Follow-up|0|||
164182573|NCT02697591|593034275|FG003|Overall Study|Lost to Follow-up|0|||
164182574|NCT02697591|593034276|FG004|Overall Study|Lost to Follow-up|0|||
164182575|NCT02697591|593034277|FG005|Overall Study|Lost to Follow-up|1|||
164182576|NCT02697591|593034278|FG006|Overall Study|Lost to Follow-up|1|||
164182577|NCT02697591|593034279|FG007|Overall Study|Lost to Follow-up|0|||
164182578|NCT02697591|593034280|FG008|Overall Study|Lost to Follow-up|0|||
164182579|NCT02697591|593034281|FG009|Overall Study|Lost to Follow-up|1|||
164182580|NCT02697591|593034272|FG000|Overall Study|Withdrawal by Subject|1|||
164182581|NCT02697591|593034273|FG001|Overall Study|Withdrawal by Subject|1|||
164182582|NCT02697591|593034274|FG002|Overall Study|Withdrawal by Subject|2|||
164182583|NCT02697591|593034275|FG003|Overall Study|Withdrawal by Subject|1|||
164182584|NCT02697591|593034276|FG004|Overall Study|Withdrawal by Subject|7|||
164182585|NCT02697591|593034277|FG005|Overall Study|Withdrawal by Subject|6|||
164182586|NCT02697591|593034278|FG006|Overall Study|Withdrawal by Subject|9|||
164182587|NCT02697591|593034279|FG007|Overall Study|Withdrawal by Subject|1|||
164182588|NCT02697591|593034280|FG008|Overall Study|Withdrawal by Subject|6|||
164182589|NCT02697591|593034281|FG009|Overall Study|Withdrawal by Subject|10|||
164182590|NCT02697591|593034272|FG000|Overall Study|Physician Decision|1|||
164182591|NCT02697591|593034273|FG001|Overall Study|Physician Decision|0|||
164182592|NCT02697591|593034274|FG002|Overall Study|Physician Decision|0|||
164182593|NCT02697591|593034275|FG003|Overall Study|Physician Decision|0|||
164182594|NCT02697591|593034276|FG004|Overall Study|Physician Decision|1|||
164182595|NCT02697591|593034277|FG005|Overall Study|Physician Decision|2|||
164182596|NCT02697591|593034278|FG006|Overall Study|Physician Decision|0|||
164182597|NCT02697591|593034279|FG007|Overall Study|Physician Decision|0|||
164182598|NCT02697591|593034280|FG008|Overall Study|Physician Decision|1|||
164182599|NCT02697591|593034281|FG009|Overall Study|Physician Decision|1|||
164182600|NCT02697591|593034272|FG000|Overall Study|Death|2|||
164182601|NCT02697591|593034273|FG001|Overall Study|Death|3|||
164182602|NCT02697591|593034274|FG002|Overall Study|Death|1|||
164182603|NCT02697591|593034275|FG003|Overall Study|Death|1|||
164182604|NCT02697591|593034276|FG004|Overall Study|Death|4|||
164182605|NCT02697591|593034277|FG005|Overall Study|Death|5|||
164182606|NCT02697591|593034278|FG006|Overall Study|Death|3|||
164182607|NCT02697591|593034279|FG007|Overall Study|Death|1|||
164182608|NCT02697591|593034280|FG008|Overall Study|Death|1|||
164182609|NCT02697591|593034281|FG009|Overall Study|Death|5|||
164182610|NCT02697591|593034272|FG000|Overall Study|Reason not Specified|0|||
164182611|NCT02697591|593034273|FG001|Overall Study|Reason not Specified|0|||
164182612|NCT02697591|593034274|FG002|Overall Study|Reason not Specified|0|||
164182613|NCT02697591|593034275|FG003|Overall Study|Reason not Specified|1|||
164182614|NCT02697591|593034276|FG004|Overall Study|Reason not Specified|1|||
164182615|NCT02697591|593034277|FG005|Overall Study|Reason not Specified|2|||
164182616|NCT02697591|593034278|FG006|Overall Study|Reason not Specified|3|||
164182617|NCT02697591|593034279|FG007|Overall Study|Reason not Specified|1|||
164182618|NCT02697591|593034280|FG008|Overall Study|Reason not Specified|1|||
164182619|NCT02697591|593034281|FG009|Overall Study|Reason not Specified|3|||
164182620|NCT02636699|593034282|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
164182621|NCT02636699|593034283|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
164182622|NCT02636699|593034284|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
164182623|NCT02636699|593034282|FG000|Screening Period|Withdrawal by Subject|0|||
164182624|NCT02636699|593034283|FG001|Screening Period|Withdrawal by Subject|0|||
164182625|NCT02636699|593034284|FG002|Screening Period|Withdrawal by Subject|23|||
164182626|NCT02636699|593034282|FG000|Screening Period|Adverse Event|0|||
164182627|NCT02636699|593034283|FG001|Screening Period|Adverse Event|0|||
164182628|NCT02636699|593034284|FG002|Screening Period|Adverse Event|1|||
164182629|NCT02636699|593034282|FG000|Screening Period|Other not specified|0|||
164182630|NCT02636699|593034283|FG001|Screening Period|Other not specified|0|||
164182631|NCT02636699|593034284|FG002|Screening Period|Other not specified|3|||
164182632|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
164182633|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
164182634|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
164182635|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
164182636|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
164182637|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
164182638|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
164182639|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
164182640|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
164182641|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
164182642|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
164182643|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
164182644|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
164182645|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
164182646|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
164182647|NCT02636699|593034282|FG000|Treatment and Follow-up Periods|Other|3|||
164182648|NCT02636699|593034283|FG001|Treatment and Follow-up Periods|Other|1|||
164182649|NCT02636699|593034284|FG002|Treatment and Follow-up Periods|Other|0|||
164182650|NCT00624832|593034285|FG000|Overall Study|Adverse Event|0|||
164182651|NCT00624832|593034286|FG001|Overall Study|Adverse Event|1|||
164182652|NCT00624832|593034287|FG002|Overall Study|Adverse Event|0|||
164182653|NCT00624832|593034288|FG003|Overall Study|Adverse Event|1|||
164182654|NCT00624832|593034285|FG000|Overall Study|Abnormal Laboratory Value|2|||
164182655|NCT00624832|593034286|FG001|Overall Study|Abnormal Laboratory Value|0|||
164182656|NCT00624832|593034287|FG002|Overall Study|Abnormal Laboratory Value|0|||
164182657|NCT00624832|593034288|FG003|Overall Study|Abnormal Laboratory Value|0|||
164182658|NCT01939223|593034289|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
164182659|NCT01939223|593034290|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
164182660|NCT01939223|593034289|FG000|Overall Study|Disease recurrence (radiological)|1|||
164182661|NCT01939223|593034290|FG001|Overall Study|Disease recurrence (radiological)|3|||
164182662|NCT01939223|593034289|FG000|Overall Study|Study stopped by Sponsor|5|||
164182663|NCT01939223|593034290|FG001|Overall Study|Study stopped by Sponsor|7|||
164182664|NCT01939223|593034289|FG000|Overall Study|Withdrawal by Subject|6|||
164182665|NCT01939223|593034290|FG001|Overall Study|Withdrawal by Subject|0|||
164182666|NCT04379700|593034291|FG000|Overall Study|Withdrawal by Subject|10|||
164182667|NCT04379700|593034291|FG000|Overall Study|Screen Fail|4|||
164182668|NCT04379700|593034291|FG000|Overall Study|Lost to Follow-up|3|||
164182669|NCT02258334|593034293|FG000|Overall Study|Adverse Event|1|||
164182670|NCT02258334|593034294|FG001|Overall Study|Adverse Event|0|||
164182671|NCT02258334|593034295|FG002|Overall Study|Adverse Event|0|||
164182672|NCT02258334|593034296|FG003|Overall Study|Adverse Event|0|||
164182673|NCT03564795|593034303|FG000|Overall Study|Withdrawal by Subject|3|||
164182674|NCT03564795|593034303|FG000|Overall Study|Lost to Follow-up|6|||
164182675|NCT03564795|593034303|FG000|Overall Study|Physician Decision|2|||
164182676|NCT05079230|593034304|FG000|Overall Study|Study Terminated by Sponsor|101|||
164182677|NCT05079230|593034305|FG001|Overall Study|Study Terminated by Sponsor|102|||
164182678|NCT05079230|593034304|FG000|Overall Study|Death|72|||
164182679|NCT05079230|593034305|FG001|Overall Study|Death|66|||
164182680|NCT05079230|593034304|FG000|Overall Study|Withdrew Consent|16|||
164182681|NCT05079230|593034305|FG001|Overall Study|Withdrew Consent|18|||
164182682|NCT05079230|593034304|FG000|Overall Study|Lost to Follow-up|0|||
164182683|NCT05079230|593034305|FG001|Overall Study|Lost to Follow-up|3|||
164182684|NCT00564395|593034310|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
164182685|NCT00564395|593034311|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
164182686|NCT00564395|593034310|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
164182687|NCT00564395|593034311|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
164182688|NCT02054910|593034313|FG000|Overall Study|Lost to Follow-up|4|||
164182689|NCT02054910|593034314|FG001|Overall Study|Lost to Follow-up|1|||
164182690|NCT00477607|593034319|FG000|Overall Study|Lost to Follow-up|7|||
164182691|NCT00477607|593034320|FG001|Overall Study|Lost to Follow-up|7|||
164182692|NCT00432276|593034321|FG000|Overall Study|Hyperglycemic Rescue|44|||
164182693|NCT00432276|593034322|FG001|Overall Study|Hyperglycemic Rescue|87|||
164182694|NCT00432276|593034321|FG000|Overall Study|Adverse Event|13|||
164182695|NCT00432276|593034322|FG001|Overall Study|Adverse Event|16|||
164182696|NCT00432276|593034321|FG000|Overall Study|Protocol Violation|25|||
164182697|NCT00432276|593034322|FG001|Overall Study|Protocol Violation|20|||
164182698|NCT00432276|593034321|FG000|Overall Study|Lost to Follow-up|6|||
164182699|NCT00432276|593034322|FG001|Overall Study|Lost to Follow-up|2|||
164182700|NCT00432276|593034321|FG000|Overall Study|Withdrawal by Subject|25|||
164182701|NCT00432276|593034322|FG001|Overall Study|Withdrawal by Subject|20|||
164182702|NCT00432276|593034321|FG000|Overall Study|Physician Decision|6|||
164182703|NCT00432276|593034322|FG001|Overall Study|Physician Decision|8|||
164182704|NCT00432276|593034321|FG000|Overall Study|Other|2|||
164182705|NCT00432276|593034322|FG001|Overall Study|Other|3|||
164182706|NCT00594386|593034323|FG000|Overall Study|Major protocol violation|2|||
164182707|NCT00594386|593034323|FG000|Overall Study|Lack of Efficacy|12|||
164182708|NCT00594386|593034323|FG000|Overall Study|Adverse Event|68|||
164182709|NCT00594386|593034323|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
164182710|NCT00594386|593034323|FG000|Overall Study|Subject withdrew consent|35|||
164182711|NCT00594386|593034323|FG000|Overall Study|Study ended per sponsor|115|||
164182712|NCT00594386|593034323|FG000|Overall Study|Lost to Follow-up|6|||
164182713|NCT00594386|593034323|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
164182714|NCT00594386|593034323|FG000|Overall Study|Other: Subject moved to Seattle|1|||
164182715|NCT00594386|593034323|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
164182716|NCT00594386|593034323|FG000|Overall Study|Other: Study terminated per investigator|2|||
164182717|NCT00594386|593034323|FG000|Overall Study|Other: Sponsor closure of study|1|||
164182718|NCT00594386|593034323|FG000|Overall Study|Other: Site terminated participation|1|||
164182719|NCT00594386|593034323|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
164182720|NCT00594386|593034323|FG000|Overall Study|Other: Loss of drivers license|1|||
164182721|NCT01210144|593034324|FG000|Overall Study|Lack of ovarian response|1|||
164182722|NCT01210144|593034325|FG001|Overall Study|Lack of ovarian response|0|||
164182723|NCT01210144|593034324|FG000|Overall Study|No fertilization|1|||
164182724|NCT01210144|593034325|FG001|Overall Study|No fertilization|0|||
164182725|NCT01210144|593034324|FG000|Overall Study|No transfer|1|||
164182726|NCT01210144|593034325|FG001|Overall Study|No transfer|0|||
164182727|NCT00207727|593034333|FG000|Overall Study|Withdrawal by Subject|0|||
164182728|NCT00207727|593034334|FG001|Overall Study|Withdrawal by Subject|0|||
164182729|NCT00207727|593034335|FG002|Overall Study|Withdrawal by Subject|0|||
164182730|NCT00207727|593034336|FG003|Overall Study|Withdrawal by Subject|0|||
164182731|NCT00207727|593034337|FG004|Overall Study|Withdrawal by Subject|1|||
164182732|NCT00207727|593034333|FG000|Overall Study|Lost to Follow-up|0|||
164182733|NCT00207727|593034334|FG001|Overall Study|Lost to Follow-up|1|||
164182734|NCT00207727|593034335|FG002|Overall Study|Lost to Follow-up|0|||
164182735|NCT00207727|593034336|FG003|Overall Study|Lost to Follow-up|0|||
164182736|NCT00207727|593034337|FG004|Overall Study|Lost to Follow-up|0|||
164182737|NCT00207727|593034333|FG000|Overall Study|Other|38|||
164182738|NCT00207727|593034334|FG001|Overall Study|Other|41|||
164182739|NCT00207727|593034335|FG002|Overall Study|Other|41|||
164182740|NCT00207727|593034336|FG003|Overall Study|Other|37|||
164182741|NCT00207727|593034337|FG004|Overall Study|Other|33|||
164182742|NCT03759366|593034338|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
164182743|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
164182744|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
164182745|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
164182746|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
164182747|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
164182748|NCT03759366|593034338|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
164182749|NCT00539032|593034339|FG000|Overall Study|Withdrawal by Subject|2|||
164182750|NCT00539032|593034340|FG001|Overall Study|Withdrawal by Subject|1|||
164182751|NCT00505661|593034346|FG000|Overall Study|Not Eligible|4|||
164182752|NCT03611582|593034349|FG000|Overall Study|Adverse Event|26|||
164182753|NCT03611582|593034350|FG001|Overall Study|Adverse Event|6|||
164182754|NCT03611582|593034349|FG000|Overall Study|Protocol Violation|0|||
164182755|NCT03611582|593034350|FG001|Overall Study|Protocol Violation|1|||
164182756|NCT03611582|593034349|FG000|Overall Study|Pregnancy|1|||
164182757|NCT03611582|593034350|FG001|Overall Study|Pregnancy|2|||
164182758|NCT03611582|593034349|FG000|Overall Study|Lack of Efficacy|0|||
164182759|NCT03611582|593034350|FG001|Overall Study|Lack of Efficacy|1|||
164182760|NCT03611582|593034349|FG000|Overall Study|At the discretion of the investigator|1|||
164182761|NCT03611582|593034350|FG001|Overall Study|At the discretion of the investigator|0|||
164182762|NCT03611582|593034349|FG000|Overall Study|Safety concern as judged by the investigator|1|||
164182763|NCT03611582|593034350|FG001|Overall Study|Safety concern as judged by the investigator|2|||
164182764|NCT03611582|593034349|FG000|Overall Study|Withdrawal by Subject|4|||
164182765|NCT03611582|593034350|FG001|Overall Study|Withdrawal by Subject|3|||
164182766|NCT03611582|593034349|FG000|Overall Study|Lost to Follow-up|18|||
164182767|NCT03611582|593034350|FG001|Overall Study|Lost to Follow-up|7|||
164182768|NCT03611582|593034349|FG000|Overall Study|other|17|||
164182769|NCT03611582|593034350|FG001|Overall Study|other|16|||
164182770|NCT01573754|593034351|FG000|Overall Study|Noncompliance or remission not achieved|3|||
164182771|NCT01573754|593034352|FG001|Overall Study|Noncompliance or remission not achieved|15|||
164182772|NCT00463840|593034354|FG000|Overall Study|Disease progression|7|||
164182773|NCT00463840|593034354|FG000|Overall Study|Withdrawal by Subject|2|||
164182774|NCT00463840|593034354|FG000|Overall Study|Adverse Event|3|||
164182775|NCT04438499|593034355|FG000|Overall Study|Lack of Efficacy|3|||
164182776|NCT04228965|593036752|FG000|Overall Study|Lost to Follow-up|26|||
164182777|NCT04228965|593036753|FG001|Overall Study|Lost to Follow-up|11|||
164182778|NCT04228965|593036752|FG000|Overall Study|Withdrawal by Subject|18|||
164182779|NCT04228965|593036753|FG001|Overall Study|Withdrawal by Subject|5|||
164182780|NCT01026818|593036760|FG000|Screening Period|Entry Criteria Not Met|105|||
164182781|NCT01026818|593036761|FG001|Screening Period|Entry Criteria Not Met|0|||
164182782|NCT01026818|593036762|FG002|Screening Period|Entry Criteria Not Met|0|||
164182783|NCT01026818|593036763|FG003|Screening Period|Entry Criteria Not Met|0|||
164182784|NCT01026818|593036760|FG000|Screening Period|Withdrawal by Subject|49|||
164182785|NCT01026818|593036761|FG001|Screening Period|Withdrawal by Subject|0|||
164182786|NCT01026818|593036762|FG002|Screening Period|Withdrawal by Subject|0|||
164182787|NCT01026818|593036763|FG003|Screening Period|Withdrawal by Subject|0|||
164182788|NCT01026818|593036760|FG000|Screening Period|Protocol Deviation|3|||
164182789|NCT01026818|593036761|FG001|Screening Period|Protocol Deviation|0|||
164182790|NCT01026818|593036762|FG002|Screening Period|Protocol Deviation|0|||
164182791|NCT01026818|593036763|FG003|Screening Period|Protocol Deviation|0|||
164182792|NCT01026818|593036760|FG000|Screening Period|Adverse Event|2|||
164182793|NCT01026818|593036761|FG001|Screening Period|Adverse Event|0|||
164182794|NCT01026818|593036762|FG002|Screening Period|Adverse Event|0|||
164182795|NCT01026818|593036763|FG003|Screening Period|Adverse Event|0|||
164182796|NCT01026818|593036760|FG000|Screening Period|Physician Decision|1|||
164182797|NCT01026818|593036761|FG001|Screening Period|Physician Decision|0|||
164182798|NCT01026818|593036762|FG002|Screening Period|Physician Decision|0|||
164182799|NCT01026818|593036763|FG003|Screening Period|Physician Decision|0|||
164182800|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
164182801|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
164182802|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
164182803|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
164182804|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
164182805|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
164182806|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
164182807|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
164182808|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
164182809|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
164182810|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
164182811|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
164182878|NCT01641471|593036764|FG000|Overall Study|Lost to Follow-up|2|||
164182812|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
164182813|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
164182814|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
164182815|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
164182816|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
164182817|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
164182818|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
164182819|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
164182820|NCT01026818|593036760|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
164182821|NCT01026818|593036761|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
164182822|NCT01026818|593036762|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
164182823|NCT01026818|593036763|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
164182824|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
164182825|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
164182826|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
164182827|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
164182828|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
164182829|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
164182830|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
164182831|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
164182832|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
164182833|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
164182834|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
164182835|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
164182836|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
164182837|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
164182838|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
164182839|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
164182840|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
164182841|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
164182842|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
164182843|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
164182844|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
164182845|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
164182846|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
164182847|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
164182848|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
164182849|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
164182850|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
164182851|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
164182852|NCT01026818|593036760|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
164182853|NCT01026818|593036761|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
164182854|NCT01026818|593036762|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
164182855|NCT01026818|593036763|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
164182856|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
164182857|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
164182858|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
164182859|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
164182860|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
164182861|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
164182862|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
164182863|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
164182864|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
164182865|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
164182866|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
164182867|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
164182868|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
164182869|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
164182870|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
164182871|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
164182872|NCT01026818|593036760|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
164182873|NCT01026818|593036761|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
164182874|NCT01026818|593036762|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
164182875|NCT01026818|593036763|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
164182876|NCT01641471|593036764|FG000|Overall Study|Withdrawal by Subject|19|||
164182877|NCT01641471|593036765|FG001|Overall Study|Withdrawal by Subject|19|||
164182879|NCT01641471|593036765|FG001|Overall Study|Lost to Follow-up|4|||
164182880|NCT01641471|593036764|FG000|Overall Study|Protocol Violation|2|||
164182881|NCT01641471|593036765|FG001|Overall Study|Protocol Violation|4|||
164182882|NCT04575584|593036766|FG000|Overall Study|Death|6|||
164182883|NCT04575584|593036767|FG001|Overall Study|Death|4|||
164182884|NCT04575584|593036768|FG002|Overall Study|Death|6|||
164182885|NCT04575584|593036769|FG003|Overall Study|Death|2|||
164182886|NCT04575584|593036770|FG004|Overall Study|Death|0|||
164182887|NCT04575584|593036771|FG005|Overall Study|Death|0|||
164182888|NCT04575584|593036766|FG000|Overall Study|Lost to Follow-up|1|||
164182889|NCT04575584|593036767|FG001|Overall Study|Lost to Follow-up|1|||
164182890|NCT04575584|593036768|FG002|Overall Study|Lost to Follow-up|1|||
164182891|NCT04575584|593036769|FG003|Overall Study|Lost to Follow-up|1|||
164182892|NCT04575584|593036770|FG004|Overall Study|Lost to Follow-up|0|||
164182893|NCT04575584|593036771|FG005|Overall Study|Lost to Follow-up|0|||
164182894|NCT04575584|593036766|FG000|Overall Study|Physician Decision|0|||
164182895|NCT04575584|593036767|FG001|Overall Study|Physician Decision|1|||
164182896|NCT04575584|593036768|FG002|Overall Study|Physician Decision|1|||
164182897|NCT04575584|593036769|FG003|Overall Study|Physician Decision|1|||
164182898|NCT04575584|593036770|FG004|Overall Study|Physician Decision|0|||
164182899|NCT04575584|593036771|FG005|Overall Study|Physician Decision|0|||
164182900|NCT04575584|593036766|FG000|Overall Study|Withdrawal by Subject|7|||
164182901|NCT04575584|593036767|FG001|Overall Study|Withdrawal by Subject|9|||
164182902|NCT04575584|593036768|FG002|Overall Study|Withdrawal by Subject|5|||
164182903|NCT04575584|593036769|FG003|Overall Study|Withdrawal by Subject|3|||
164182904|NCT04575584|593036770|FG004|Overall Study|Withdrawal by Subject|0|||
164182905|NCT04575584|593036771|FG005|Overall Study|Withdrawal by Subject|0|||
164182906|NCT04575584|593036766|FG000|Overall Study|Not recorded|0|||
164182907|NCT04575584|593036767|FG001|Overall Study|Not recorded|0|||
164182908|NCT04575584|593036768|FG002|Overall Study|Not recorded|0|||
164182909|NCT04575584|593036769|FG003|Overall Study|Not recorded|1|||
164182910|NCT04575584|593036770|FG004|Overall Study|Not recorded|0|||
164182911|NCT04575584|593036771|FG005|Overall Study|Not recorded|0|||
164182912|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
164182913|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
164182914|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
164182915|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
164182916|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
164182917|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
164182918|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
164182919|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
164182920|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
164182921|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
164182922|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
164182923|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
164182924|NCT02634801|593036772|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
164182925|NCT02634801|593036773|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
164182926|NCT02634801|593036774|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
164182927|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
164182928|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
164182929|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
164182930|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
164182931|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
164182932|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
164182933|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
164182934|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
164182935|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
164182936|NCT02634801|593036772|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
164182937|NCT02634801|593036773|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
164182938|NCT02634801|593036774|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
164182939|NCT02634801|593036772|FG000|Follow-up Period|Lost to Follow-up|3|||
164182940|NCT02634801|593036773|FG001|Follow-up Period|Lost to Follow-up|1|||
164182941|NCT02634801|593036774|FG002|Follow-up Period|Lost to Follow-up|2|||
164182942|NCT02634801|593036772|FG000|Follow-up Period|Physician Decision|0|||
164182943|NCT02634801|593036773|FG001|Follow-up Period|Physician Decision|0|||
164182944|NCT02634801|593036774|FG002|Follow-up Period|Physician Decision|1|||
164182945|NCT02634801|593036772|FG000|Follow-up Period|Withdrawal by Subject|1|||
164182946|NCT02634801|593036773|FG001|Follow-up Period|Withdrawal by Subject|2|||
164182947|NCT02634801|593036774|FG002|Follow-up Period|Withdrawal by Subject|5|||
164182948|NCT02634801|593036772|FG000|Follow-up Period|Adverse Event|1|||
164182949|NCT02634801|593036773|FG001|Follow-up Period|Adverse Event|5|||
164182950|NCT02634801|593036774|FG002|Follow-up Period|Adverse Event|0|||
164182951|NCT00199849|593036777|FG000|Overall Study|Unrelated illness or complication|0|||
164182952|NCT00199849|593036778|FG001|Overall Study|Unrelated illness or complication|1|||
164182953|NCT00199849|593036779|FG002|Overall Study|Unrelated illness or complication|0|||
164182954|NCT00199849|593036777|FG000|Overall Study|Progressive disease requiring intervention|0|||
164182955|NCT00199849|593036778|FG001|Overall Study|Progressive disease requiring intervention|0|||
164182956|NCT00199849|593036779|FG002|Overall Study|Progressive disease requiring intervention|1|||
164182957|NCT00199849|593036777|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
164182958|NCT00199849|593036778|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
164182959|NCT00199849|593036779|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
164182960|NCT01548768|593036780|FG000|Overall Study|Withdrawal by Subject|0|||
164182961|NCT01548768|593036781|FG001|Overall Study|Withdrawal by Subject|2|||
164182962|NCT01548768|593036782|FG002|Overall Study|Withdrawal by Subject|1|||
164182963|NCT01548768|593036783|FG003|Overall Study|Withdrawal by Subject|0|||
164182964|NCT01548768|593036780|FG000|Overall Study|Physician Decision|1|||
164182965|NCT01548768|593036781|FG001|Overall Study|Physician Decision|0|||
164182966|NCT01548768|593036782|FG002|Overall Study|Physician Decision|0|||
164182967|NCT01548768|593036783|FG003|Overall Study|Physician Decision|0|||
164182968|NCT01548768|593036780|FG000|Overall Study|Adverse Event|0|||
164182969|NCT01548768|593036781|FG001|Overall Study|Adverse Event|0|||
164182970|NCT01548768|593036782|FG002|Overall Study|Adverse Event|0|||
164182971|NCT01548768|593036783|FG003|Overall Study|Adverse Event|1|||
164182972|NCT01548768|593036780|FG000|Overall Study|Non-Compliance|0|||
164182973|NCT01548768|593036781|FG001|Overall Study|Non-Compliance|0|||
164182974|NCT01548768|593036782|FG002|Overall Study|Non-Compliance|0|||
164182975|NCT01548768|593036783|FG003|Overall Study|Non-Compliance|3|||
164182976|NCT03300050|593036784|FG000|Overall Study|Lost to Follow-up|2|||
164182977|NCT03300050|593036785|FG001|Overall Study|Lost to Follow-up|1|||
164182978|NCT03300050|593036786|FG002|Overall Study|Lost to Follow-up|0|||
164182979|NCT03300050|593036787|FG003|Overall Study|Lost to Follow-up|0|||
164182980|NCT03300050|593036788|FG004|Overall Study|Lost to Follow-up|1|||
164182981|NCT03300050|593036784|FG000|Overall Study|Withdrawal by Subject|1|||
164182982|NCT03300050|593036785|FG001|Overall Study|Withdrawal by Subject|1|||
164182983|NCT03300050|593036786|FG002|Overall Study|Withdrawal by Subject|1|||
164182984|NCT03300050|593036787|FG003|Overall Study|Withdrawal by Subject|0|||
164182985|NCT03300050|593036788|FG004|Overall Study|Withdrawal by Subject|0|||
164182986|NCT03300050|593036784|FG000|Overall Study|Death|0|||
164182987|NCT03300050|593036785|FG001|Overall Study|Death|0|||
164182988|NCT03300050|593036786|FG002|Overall Study|Death|1|||
164182989|NCT03300050|593036787|FG003|Overall Study|Death|0|||
164182990|NCT03300050|593036788|FG004|Overall Study|Death|0|||
164182991|NCT03300050|593036784|FG000|Overall Study|Not Eligible at Randomization|0|||
164182992|NCT03300050|593036785|FG001|Overall Study|Not Eligible at Randomization|0|||
164182993|NCT03300050|593036786|FG002|Overall Study|Not Eligible at Randomization|1|||
164182994|NCT03300050|593036787|FG003|Overall Study|Not Eligible at Randomization|1|||
164182995|NCT03300050|593036788|FG004|Overall Study|Not Eligible at Randomization|0|||
164182996|NCT02499263|593036789|FG000|Overall Study|Lost to Follow-up|9|||
164182997|NCT02499263|593036789|FG000|Overall Study|Participant's withdrawal of consent|4|||
164182998|NCT02499263|593036789|FG000|Overall Study|Lack of Efficacy|22|||
164182999|NCT02499263|593036789|FG000|Overall Study|investigator's judgment|12|||
164183000|NCT02499263|593036789|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
164183001|NCT02499263|593036789|FG000|Overall Study|Participant's decision|3|||
164183002|NCT02499263|593036789|FG000|Overall Study|Pregnancy|1|||
164183003|NCT01375374|593036790|FG000|Overall Study|Adverse Event|1|||
164183004|NCT01908582|593036791|FG000|Period 2|Physician Decision|1|||
164183005|NCT01908582|593036791|FG000|Period 2|Withdrawal by Subject|1|||
164183006|NCT00424593|593036792|FG000|Acute Double-Blind Period|Adverse Event|16|||
164183007|NCT00424593|593036793|FG001|Acute Double-Blind Period|Adverse Event|7|||
164183008|NCT00424593|593036792|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
164183009|NCT00424593|593036793|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
164183010|NCT00424593|593036792|FG000|Acute Double-Blind Period|Protocol Violation|2|||
164183011|NCT00424593|593036793|FG001|Acute Double-Blind Period|Protocol Violation|2|||
164183012|NCT00424593|593036792|FG000|Acute Double-Blind Period|Physician Decision|1|||
164183013|NCT00424593|593036793|FG001|Acute Double-Blind Period|Physician Decision|2|||
164183014|NCT00424593|593036792|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
164183015|NCT00424593|593036793|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
164183016|NCT00424593|593036792|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
164183017|NCT00424593|593036793|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
164183018|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
164183019|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
164183020|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Adverse Event|18|||
164183021|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Adverse Event|0|||
164183022|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
164183023|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
164183024|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
164183025|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
164183026|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
164183027|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
164183028|NCT00424593|593036792|FG000|Dose-Blind Extension Period|Physician Decision|3|||
164183029|NCT00424593|593036793|FG001|Dose-Blind Extension Period|Physician Decision|0|||
164183030|NCT01108237|593036794|FG000|Overall Study|No alignment data|2|||
164183031|NCT01108237|593036795|FG001|Overall Study|No alignment data|15|||
164183032|NCT01108237|593036794|FG000|Overall Study|Did not meet criteria for analysis|7|||
164183033|NCT01108237|593036795|FG001|Overall Study|Did not meet criteria for analysis|0|||
164183034|NCT02178358|593036798|FG000|Overall Study|Withdrawal by Subject|0|||
164183035|NCT02178358|593036799|FG001|Overall Study|Withdrawal by Subject|2|||
164183036|NCT02178358|593036800|FG002|Overall Study|Withdrawal by Subject|2|||
164183037|NCT02178358|593036798|FG000|Overall Study|Lost to Follow-up|1|||
164183038|NCT02178358|593036799|FG001|Overall Study|Lost to Follow-up|0|||
164183039|NCT02178358|593036800|FG002|Overall Study|Lost to Follow-up|0|||
164183040|NCT01066663|593036801|FG000|Overall Study|Adverse Event|0|||
164183041|NCT01066663|593036802|FG001|Overall Study|Adverse Event|0|||
164183042|NCT01066663|593036803|FG002|Overall Study|Adverse Event|1|||
164183043|NCT02232061|593036804|FG000|Overall Study|Administrative problems|1|||
164183044|NCT02232061|593036804|FG000|Overall Study|Withdrawal by Subject|1|||
164183045|NCT03297021|593036806|FG000|Overall Study|Incomplete/illegible data sheet|4|||
164183046|NCT03297021|593036807|FG001|Overall Study|Incomplete/illegible data sheet|2|||
164183047|NCT03297021|593036808|FG002|Overall Study|Incomplete/illegible data sheet|3|||
164183048|NCT03297021|593036806|FG000|Overall Study|Missing Post-Op Data|1|||
164183049|NCT03297021|593036807|FG001|Overall Study|Missing Post-Op Data|2|||
164183050|NCT03297021|593036808|FG002|Overall Study|Missing Post-Op Data|1|||
164183051|NCT02784288|593036810|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
164183052|NCT02734862|593036811|FG000|Part A|Death|3|||
164183053|NCT02734862|593036812|FG001|Part A|Death|4|||
164183054|NCT02734862|593036813|FG002|Part A|Death|6|||
164183055|NCT02734862|593036811|FG000|Part A|Lost to Follow-up|2|||
164183056|NCT02734862|593036812|FG001|Part A|Lost to Follow-up|1|||
164183057|NCT02734862|593036813|FG002|Part A|Lost to Follow-up|1|||
164183058|NCT02734862|593036811|FG000|Part A|Withdrawal by Subject|1|||
164183059|NCT02734862|593036812|FG001|Part A|Withdrawal by Subject|1|||
164183060|NCT02734862|593036813|FG002|Part A|Withdrawal by Subject|2|||
164183061|NCT02734862|593036811|FG000|Part A|Physician Decision|2|||
164183062|NCT02734862|593036812|FG001|Part A|Physician Decision|0|||
164183063|NCT02734862|593036813|FG002|Part A|Physician Decision|1|||
164183064|NCT02734862|593036811|FG000|Part A|Adverse Event|2|||
164183065|NCT02734862|593036812|FG001|Part A|Adverse Event|0|||
164183066|NCT02734862|593036813|FG002|Part A|Adverse Event|1|||
164183067|NCT02734862|593036811|FG000|Part A|Noncompliance|1|||
164183068|NCT02734862|593036812|FG001|Part A|Noncompliance|1|||
164183069|NCT02734862|593036813|FG002|Part A|Noncompliance|0|||
164183070|NCT02734862|593036811|FG000|Part A|Other|1|||
164183071|NCT02734862|593036812|FG001|Part A|Other|1|||
164183072|NCT02734862|593036813|FG002|Part A|Other|3|||
164183073|NCT02734862|593036811|FG000|Part B|Death|8|||
164183074|NCT02734862|593036812|FG001|Part B|Death|3|||
164183075|NCT02734862|593036813|FG002|Part B|Death|5|||
164183076|NCT02734862|593036811|FG000|Part B|Lost to Follow-up|2|||
164183077|NCT02734862|593036812|FG001|Part B|Lost to Follow-up|2|||
164183078|NCT02734862|593036813|FG002|Part B|Lost to Follow-up|0|||
164183079|NCT02734862|593036811|FG000|Part B|Withdrawal by Subject|3|||
164183080|NCT02734862|593036812|FG001|Part B|Withdrawal by Subject|1|||
164183081|NCT02734862|593036813|FG002|Part B|Withdrawal by Subject|0|||
164183082|NCT02734862|593036811|FG000|Part B|Other|0|||
164183083|NCT02734862|593036812|FG001|Part B|Other|1|||
164183084|NCT02734862|593036813|FG002|Part B|Other|0|||
164183085|NCT02757625|593036814|FG000|Overall Study|Investigator's discretion|0|||
164183086|NCT02757625|593036815|FG001|Overall Study|Investigator's discretion|0|||
164183087|NCT02757625|593036816|FG002|Overall Study|Investigator's discretion|1|||
164183088|NCT02757625|593036817|FG003|Overall Study|Investigator's discretion|0|||
164183089|NCT02757625|593036814|FG000|Overall Study|Adverse Event|0|||
164183090|NCT02757625|593036815|FG001|Overall Study|Adverse Event|0|||
164183091|NCT02757625|593036816|FG002|Overall Study|Adverse Event|1|||
164183092|NCT02757625|593036817|FG003|Overall Study|Adverse Event|0|||
164183093|NCT00564278|593036818|FG000|Overall Study|Lost to Follow-up|35|||
164183094|NCT00564278|593036819|FG001|Overall Study|Lost to Follow-up|33|||
164183095|NCT00564278|593036818|FG000|Overall Study|Physician Decision|1|||
164183096|NCT00564278|593036819|FG001|Overall Study|Physician Decision|2|||
164183097|NCT00564278|593036818|FG000|Overall Study|Withdrawal by Subject|11|||
164183098|NCT00564278|593036819|FG001|Overall Study|Withdrawal by Subject|7|||
164183099|NCT00645671|593036820|FG000|Overall Study|Protocol Violation|1|||
164183100|NCT00645671|593036821|FG001|Overall Study|Protocol Violation|0|||
164183101|NCT00645671|593036820|FG000|Overall Study|Withdrawal by Subject|0|||
164183102|NCT00645671|593036821|FG001|Overall Study|Withdrawal by Subject|4|||
164183103|NCT00645671|593036820|FG000|Overall Study|Adverse Event|0|||
164183104|NCT00645671|593036821|FG001|Overall Study|Adverse Event|1|||
164183105|NCT00645671|593036820|FG000|Overall Study|Physician Decision|0|||
164183106|NCT00645671|593036821|FG001|Overall Study|Physician Decision|1|||
164183107|NCT00560703|593036822|FG000|Overall Study|Adverse Event|0|||
164183108|NCT00560703|593036823|FG001|Overall Study|Adverse Event|2|||
164183109|NCT00560703|593036822|FG000|Overall Study|Protocol Violation|0|||
164183110|NCT00560703|593036823|FG001|Overall Study|Protocol Violation|2|||
164183111|NCT00560703|593036822|FG000|Overall Study|Withdrawal by Subject|0|||
164183112|NCT00560703|593036823|FG001|Overall Study|Withdrawal by Subject|1|||
164183113|NCT00560703|593036822|FG000|Overall Study|non-compliance|0|||
164183114|NCT00560703|593036823|FG001|Overall Study|non-compliance|1|||
164183115|NCT02095197|593036824|FG000|Overall Study|Lost to Follow-up|0|||
164183116|NCT02095197|593036825|FG001|Overall Study|Lost to Follow-up|3|||
164183117|NCT00493311|593036826|FG000|Overall Study|Need for rescue medication|2|||
164183118|NCT00493311|593036827|FG001|Overall Study|Need for rescue medication|2|||
164183119|NCT02779075|593036828|FG000|Overall Study|Withdrawal by Subject|1|||
164183120|NCT02779075|593036829|FG001|Overall Study|Withdrawal by Subject|3|||
164183121|NCT02779075|593036828|FG000|Overall Study|IV lost during 2nd study|1|||
164183122|NCT02779075|593036829|FG001|Overall Study|IV lost during 2nd study|0|||
164183123|NCT00790556|593036830|FG000|Treatment Period 1|Physician Decision|1|||
164183124|NCT00790556|593036831|FG001|Treatment Period 1|Physician Decision|0|||
164183125|NCT00790556|593036830|FG000|Treatment Period 1|Withdrawal by Subject|1|||
164183126|NCT00790556|593036831|FG001|Treatment Period 1|Withdrawal by Subject|0|||
164183127|NCT03077607|593036832|FG000|Period 1 (15 Days)|Adverse Event|1|||
164183128|NCT03077607|593036833|FG001|Period 1 (15 Days)|Adverse Event|0|||
164183129|NCT03077607|593036832|FG000|Period 1 (15 Days)|Death|1|||
164183130|NCT03077607|593036833|FG001|Period 1 (15 Days)|Death|0|||
164183131|NCT03077607|593036832|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
164183132|NCT03077607|593036833|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
164183133|NCT03077607|593036832|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
164183134|NCT03077607|593036833|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
164183135|NCT05600036|593036835|FG000|Overall Study|Adverse Event|0|||
164183136|NCT05600036|593036836|FG001|Overall Study|Adverse Event|2|||
164183137|NCT05600036|593036837|FG002|Overall Study|Adverse Event|1|||
164183138|NCT05600036|593036838|FG003|Overall Study|Adverse Event|0|||
164183139|NCT05600036|593036839|FG004|Overall Study|Adverse Event|1|||
164183140|NCT05600036|593036840|FG005|Overall Study|Adverse Event|0|||
164183141|NCT05600036|593036835|FG000|Overall Study|Lost to Follow-up|0|||
164183142|NCT05600036|593036836|FG001|Overall Study|Lost to Follow-up|2|||
164183143|NCT05600036|593036837|FG002|Overall Study|Lost to Follow-up|1|||
164183144|NCT05600036|593036838|FG003|Overall Study|Lost to Follow-up|1|||
164183145|NCT05600036|593036839|FG004|Overall Study|Lost to Follow-up|0|||
164183146|NCT05600036|593036840|FG005|Overall Study|Lost to Follow-up|0|||
164183147|NCT05600036|593036835|FG000|Overall Study|Protocol Violation|0|||
164183148|NCT05600036|593036836|FG001|Overall Study|Protocol Violation|0|||
164183149|NCT05600036|593036837|FG002|Overall Study|Protocol Violation|2|||
164183150|NCT05600036|593036838|FG003|Overall Study|Protocol Violation|0|||
164183151|NCT05600036|593036839|FG004|Overall Study|Protocol Violation|0|||
164183152|NCT05600036|593036840|FG005|Overall Study|Protocol Violation|0|||
164183153|NCT05600036|593036835|FG000|Overall Study|Withdrawal by Subject|0|||
164183154|NCT05600036|593036836|FG001|Overall Study|Withdrawal by Subject|1|||
164183155|NCT05600036|593036837|FG002|Overall Study|Withdrawal by Subject|2|||
164183156|NCT05600036|593036838|FG003|Overall Study|Withdrawal by Subject|0|||
164183157|NCT05600036|593036839|FG004|Overall Study|Withdrawal by Subject|3|||
164183158|NCT05600036|593036840|FG005|Overall Study|Withdrawal by Subject|5|||
164183159|NCT05600036|593036835|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183160|NCT05600036|593036836|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183161|NCT05600036|593036837|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183162|NCT05600036|593036838|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
164183163|NCT05600036|593036839|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183164|NCT05600036|593036840|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
164183165|NCT05600036|593036835|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183166|NCT05600036|593036836|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
164183167|NCT05600036|593036837|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183168|NCT05600036|593036838|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183169|NCT05600036|593036839|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183170|NCT05600036|593036840|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
164183171|NCT05600036|593036835|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183172|NCT05600036|593036836|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183173|NCT05600036|593036837|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183174|NCT05600036|593036838|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
164183175|NCT05600036|593036839|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183176|NCT05600036|593036840|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
164183177|NCT04401202|593036841|FG000|Overall Study|Lost to Follow-up|2|||
164183178|NCT04401202|593036842|FG001|Overall Study|Lost to Follow-up|2|||
164183179|NCT04401202|593036841|FG000|Overall Study|Adverse Event|0|||
164183180|NCT04401202|593036842|FG001|Overall Study|Adverse Event|1|||
164183181|NCT04401202|593036841|FG000|Overall Study|Hospitalized|4|||
164183182|NCT04401202|593036842|FG001|Overall Study|Hospitalized|1|||
164183183|NCT02714036|593036843|FG000|Overall Study|Adverse Event|9|||
164183184|NCT02714036|593036844|FG001|Overall Study|Adverse Event|2|||
164183185|NCT02714036|593036843|FG000|Overall Study|Withdrawal by Subject|3|||
164183186|NCT02714036|593036844|FG001|Overall Study|Withdrawal by Subject|2|||
164183187|NCT05697627|593036848|FG000|Overall Study|Adverse Event|1|||
164183188|NCT04122625|593036849|FG000|Part A (up to 2.92 Years)|Death|2|||
164183189|NCT04122625|593036850|FG001|Part A (up to 2.92 Years)|Death|4|||
164183190|NCT04122625|593036851|FG002|Part A (up to 2.92 Years)|Death|0|||
164183191|NCT04122625|593036852|FG003|Part A (up to 2.92 Years)|Death|0|||
164183192|NCT04122625|593036853|FG004|Part A (up to 2.92 Years)|Death|0|||
164183193|NCT04122625|593036854|FG005|Part A (up to 2.92 Years)|Death|0|||
164183194|NCT04122625|593036849|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
164183195|NCT04122625|593036850|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
164183196|NCT04122625|593036851|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
164183197|NCT04122625|593036852|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
164183198|NCT04122625|593036853|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
164183199|NCT04122625|593036854|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
164183200|NCT04122625|593036849|FG000|Part B (up to 2.33 Years)|Death|0|||
164183201|NCT04122625|593036850|FG001|Part B (up to 2.33 Years)|Death|0|||
164183202|NCT04122625|593036851|FG002|Part B (up to 2.33 Years)|Death|5|||
164183203|NCT04122625|593036852|FG003|Part B (up to 2.33 Years)|Death|7|||
164183204|NCT04122625|593036853|FG004|Part B (up to 2.33 Years)|Death|6|||
164183205|NCT04122625|593036854|FG005|Part B (up to 2.33 Years)|Death|7|||
164183206|NCT04348500|593036855|FG000|Overall Study|Death|2|||
164183207|NCT04348500|593036856|FG001|Overall Study|Death|2|||
164183208|NCT04348500|593036855|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
164183209|NCT04348500|593036856|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
164183210|NCT02722746|593036857|FG000|Overall Study|Withdrawal by Subject|0|||
164183211|NCT02722746|593036858|FG001|Overall Study|Withdrawal by Subject|1|||
164183212|NCT02722746|593036859|FG002|Overall Study|Withdrawal by Subject|0|||
164183213|NCT02722746|593036857|FG000|Overall Study|Protocol Violation|8|||
164183214|NCT02722746|593036858|FG001|Overall Study|Protocol Violation|4|||
164183215|NCT02722746|593036859|FG002|Overall Study|Protocol Violation|6|||
164183216|NCT04165135|593036872|FG000|Overall Study|Protocol Violation|10|||
164183217|NCT04165135|593036872|FG000|Overall Study|Participants withdrawal of consent|5|||
164183218|NCT00530790|593036873|FG000|Overall Study|Adverse Event|2|||
164183219|NCT00530790|593036873|FG000|Overall Study|Withdrawal by Subject|2|||
164183220|NCT00530790|593036873|FG000|Overall Study|Physician Decision|1|||
164183221|NCT01618916|593036878|FG000|Overall Study|Adverse Event|1|||
164183222|NCT01618916|593036879|FG001|Overall Study|Adverse Event|0|||
164183223|NCT01618916|593036880|FG002|Overall Study|Adverse Event|0|||
164183224|NCT01618916|593036881|FG003|Overall Study|Adverse Event|0|||
164183225|NCT01618916|593036882|FG004|Overall Study|Adverse Event|0|||
164183226|NCT01618916|593036883|FG005|Overall Study|Adverse Event|0|||
164183227|NCT01618916|593036878|FG000|Overall Study|Withdrawal by Subject|0|||
164183228|NCT01618916|593036879|FG001|Overall Study|Withdrawal by Subject|1|||
164183229|NCT01618916|593036880|FG002|Overall Study|Withdrawal by Subject|1|||
164183230|NCT01618916|593036881|FG003|Overall Study|Withdrawal by Subject|0|||
164183231|NCT01618916|593036882|FG004|Overall Study|Withdrawal by Subject|1|||
164183232|NCT01618916|593036883|FG005|Overall Study|Withdrawal by Subject|0|||
164183233|NCT01618916|593036878|FG000|Overall Study|Lost to Follow-up|1|||
164183234|NCT01618916|593036879|FG001|Overall Study|Lost to Follow-up|0|||
164183235|NCT01618916|593036880|FG002|Overall Study|Lost to Follow-up|0|||
164183236|NCT01618916|593036881|FG003|Overall Study|Lost to Follow-up|2|||
164183237|NCT01618916|593036882|FG004|Overall Study|Lost to Follow-up|0|||
164183238|NCT01618916|593036883|FG005|Overall Study|Lost to Follow-up|0|||
164183239|NCT00438256|593036884|FG000|Overall Study|Ineligible for Resection|2|||
164183240|NCT00438256|593036885|FG001|Overall Study|Ineligible for Resection|1|||
164183241|NCT00438256|593036886|FG002|Overall Study|Ineligible for Resection|1|||
164183242|NCT00438256|593036887|FG003|Overall Study|Ineligible for Resection|7|||
164183243|NCT00438256|593036884|FG000|Overall Study|Excluded final Diagnosis|0|||
164183244|NCT00438256|593036885|FG001|Overall Study|Excluded final Diagnosis|0|||
164183245|NCT00438256|593036886|FG002|Overall Study|Excluded final Diagnosis|0|||
164183246|NCT00438256|593036887|FG003|Overall Study|Excluded final Diagnosis|2|||
164183247|NCT00849290|593036896|FG000|Overall Study|Adverse Event|3|||
164183248|NCT00849290|593036896|FG000|Overall Study|Death|14|||
164183249|NCT00849290|593036896|FG000|Overall Study|Withdrawal by Subject|11|||
164183250|NCT00849290|593036896|FG000|Overall Study|Lost to Follow-up|2|||
164183251|NCT00849290|593036896|FG000|Overall Study|Protocol Violation|5|||
164183252|NCT00849290|593036896|FG000|Overall Study|Disease Progression|20|||
164183253|NCT00938587|593036897|FG000|Overall Study|Adverse Event|2|||
164183254|NCT00938587|593036898|FG001|Overall Study|Adverse Event|0|||
164183255|NCT00938587|593036899|FG002|Overall Study|Adverse Event|0|||
164183256|NCT00938587|593036900|FG003|Overall Study|Adverse Event|2|||
164183257|NCT00938587|593036897|FG000|Overall Study|Did not meet entrance criteria|0|||
164183409|NCT00582426|593038925|FG001|Overall Study|Adverse Event|2|||
164183258|NCT00938587|593036898|FG001|Overall Study|Did not meet entrance criteria|0|||
164183259|NCT00938587|593036899|FG002|Overall Study|Did not meet entrance criteria|1|||
164183260|NCT00938587|593036900|FG003|Overall Study|Did not meet entrance criteria|0|||
164183261|NCT00938587|593036897|FG000|Overall Study|Withdrawal by Subject|1|||
164183262|NCT00938587|593036898|FG001|Overall Study|Withdrawal by Subject|1|||
164183263|NCT00938587|593036899|FG002|Overall Study|Withdrawal by Subject|0|||
164183264|NCT00938587|593036900|FG003|Overall Study|Withdrawal by Subject|0|||
164183265|NCT02819440|593036905|FG000|Overall Study|Adverse Event|3|||
164183266|NCT02819440|593036906|FG001|Overall Study|Adverse Event|1|||
164183267|NCT02819440|593036905|FG000|Overall Study|Lost to Follow-up|1|||
164183268|NCT02819440|593036906|FG001|Overall Study|Lost to Follow-up|3|||
164183269|NCT02819440|593036905|FG000|Overall Study|Withdrawal by Subject|9|||
164183270|NCT02819440|593036906|FG001|Overall Study|Withdrawal by Subject|8|||
164183271|NCT02334384|593036914|FG000|Overall Study|Lost to Follow-up|1|||
164183272|NCT02334384|593036915|FG001|Overall Study|Lost to Follow-up|1|||
164183273|NCT00055497|593036916|FG000|Overall Study|Adverse Event|1|||
164183274|NCT00055497|593036917|FG001|Overall Study|Adverse Event|1|||
164183275|NCT00055497|593036918|FG002|Overall Study|Adverse Event|1|||
164183276|NCT00055497|593036919|FG003|Overall Study|Adverse Event|28|||
164183277|NCT00055497|593036916|FG000|Overall Study|Withdrawal by Subject|3|||
164183278|NCT00055497|593036917|FG001|Overall Study|Withdrawal by Subject|1|||
164183279|NCT00055497|593036918|FG002|Overall Study|Withdrawal by Subject|1|||
164183280|NCT00055497|593036919|FG003|Overall Study|Withdrawal by Subject|15|||
164183281|NCT00055497|593036916|FG000|Overall Study|Lost to Follow-up|0|||
164183282|NCT00055497|593036917|FG001|Overall Study|Lost to Follow-up|1|||
164183283|NCT00055497|593036918|FG002|Overall Study|Lost to Follow-up|0|||
164183284|NCT00055497|593036919|FG003|Overall Study|Lost to Follow-up|5|||
164183285|NCT00055497|593036916|FG000|Overall Study|Protocol Violation|0|||
164183286|NCT00055497|593036917|FG001|Overall Study|Protocol Violation|0|||
164183287|NCT00055497|593036918|FG002|Overall Study|Protocol Violation|0|||
164183288|NCT00055497|593036919|FG003|Overall Study|Protocol Violation|3|||
164183289|NCT00055497|593036916|FG000|Overall Study|Lack of Efficacy|1|||
164183290|NCT00055497|593036917|FG001|Overall Study|Lack of Efficacy|0|||
164183291|NCT00055497|593036918|FG002|Overall Study|Lack of Efficacy|0|||
164183292|NCT00055497|593036919|FG003|Overall Study|Lack of Efficacy|27|||
164183293|NCT00055497|593036916|FG000|Overall Study|Administrative Reasons|0|||
164183294|NCT00055497|593036917|FG001|Overall Study|Administrative Reasons|0|||
164183295|NCT00055497|593036918|FG002|Overall Study|Administrative Reasons|0|||
164183296|NCT00055497|593036919|FG003|Overall Study|Administrative Reasons|1|||
164183297|NCT00055497|593036916|FG000|Overall Study|Other|0|||
164183298|NCT00055497|593036917|FG001|Overall Study|Other|0|||
164183299|NCT00055497|593036918|FG002|Overall Study|Other|0|||
164183300|NCT00055497|593036919|FG003|Overall Study|Other|11|||
164183301|NCT00048165|593036920|FG000|Completed 6 Months Study|Administration/Other|8|||
164183302|NCT00048165|593036921|FG001|Completed 6 Months Study|Administration/Other|8|||
164183303|NCT00048165|593036920|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
164183304|NCT00048165|593036921|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
164183305|NCT00048165|593036920|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
164183306|NCT00048165|593036921|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
164183307|NCT00048165|593036920|FG000|Completed 6 Months Study|Death|12|||
164183308|NCT00048165|593036921|FG001|Completed 6 Months Study|Death|6|||
164183309|NCT00048165|593036920|FG000|Completed 6 Months Study|Insufficient therapy|1|||
164183310|NCT00048165|593036921|FG001|Completed 6 Months Study|Insufficient therapy|4|||
164183311|NCT00048165|593036920|FG000|Completed 6 Months Study|Other violation|4|||
164183312|NCT00048165|593036921|FG001|Completed 6 Months Study|Other violation|6|||
164183313|NCT00048165|593036920|FG000|Completed 6 Months Study|Refused treatment|5|||
164183314|NCT00048165|593036921|FG001|Completed 6 Months Study|Refused treatment|5|||
164183315|NCT00048165|593036920|FG000|Completed 6 Months Study|Violation criteria|0|||
164183316|NCT00048165|593036921|FG001|Completed 6 Months Study|Violation criteria|2|||
164183317|NCT00048165|593036920|FG000|Completed 6 Months Study|Did not receive study drug|6|||
164183318|NCT00048165|593036921|FG001|Completed 6 Months Study|Did not receive study drug|6|||
164183319|NCT00048165|593036920|FG000|Completed 12 Months Study|Administration/Other|0|||
164183320|NCT00048165|593036921|FG001|Completed 12 Months Study|Administration/Other|2|||
164183321|NCT00048165|593036920|FG000|Completed 12 Months Study|Death|2|||
164183322|NCT00048165|593036921|FG001|Completed 12 Months Study|Death|1|||
164183323|NCT00048165|593036920|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
164183324|NCT00048165|593036921|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
164183325|NCT00731731|593036922|FG000|Overall Study|Protocol Violation|0|||
164183326|NCT00731731|593036923|FG001|Overall Study|Protocol Violation|0|||
164183327|NCT00731731|593036924|FG002|Overall Study|Protocol Violation|1|||
164183328|NCT00731731|593036922|FG000|Overall Study|Cancel prior to treatment|0|||
164183329|NCT00731731|593036923|FG001|Overall Study|Cancel prior to treatment|0|||
164183330|NCT00731731|593036924|FG002|Overall Study|Cancel prior to treatment|2|||
164183331|NCT01084538|593036925|FG000|Overall Study|Drug not available|30|||
164183332|NCT01084538|593036925|FG000|Overall Study|Adverse Event|9|||
164183333|NCT01084538|593036925|FG000|Overall Study|Kidney transplant|6|||
164183334|NCT01084538|593036925|FG000|Overall Study|Serious Adverse Event|3|||
164183335|NCT01084538|593036925|FG000|Overall Study|Lack of effectiveness|2|||
164183336|NCT01084538|593036925|FG000|Overall Study|Patient noncompliance|2|||
164183337|NCT01084538|593036925|FG000|Overall Study|Hyperphosphatemia|2|||
164183338|NCT01084538|593036925|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
164183339|NCT01084538|593036925|FG000|Overall Study|Change of residence|2|||
164183340|NCT01084538|593036925|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
164183341|NCT01084538|593036925|FG000|Overall Study|Reason unknown|8|||
164183342|NCT03742258|593036926|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
164183343|NCT03742258|593036927|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
164183344|NCT03742258|593036928|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
164183345|NCT03742258|593036926|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
164183346|NCT03742258|593036927|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
164183347|NCT03742258|593036928|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
164183348|NCT03742258|593036926|FG000|Survival Follow-Up|Still in Follow-up|0|||
164183349|NCT03742258|593036927|FG001|Survival Follow-Up|Still in Follow-up|0|||
164183350|NCT03742258|593036928|FG002|Survival Follow-Up|Still in Follow-up|2|||
164183351|NCT01687283|593038900|FG000|Overall Study|Adverse Event|11|||
164183352|NCT01687283|593038901|FG001|Overall Study|Adverse Event|4|||
164183353|NCT01687283|593038900|FG000|Overall Study|Lack of Efficacy|3|||
164183354|NCT01687283|593038901|FG001|Overall Study|Lack of Efficacy|1|||
164183355|NCT01687283|593038900|FG000|Overall Study|Protocol Violation|1|||
164183356|NCT01687283|593038901|FG001|Overall Study|Protocol Violation|3|||
164183357|NCT01687283|593038900|FG000|Overall Study|protocol defined stopping criteria|8|||
164183358|NCT01687283|593038901|FG001|Overall Study|protocol defined stopping criteria|10|||
164183359|NCT01687283|593038900|FG000|Overall Study|Lost to Follow-up|1|||
164183360|NCT01687283|593038901|FG001|Overall Study|Lost to Follow-up|1|||
164183361|NCT01687283|593038900|FG000|Overall Study|Investigator discretion|2|||
164183362|NCT01687283|593038901|FG001|Overall Study|Investigator discretion|0|||
164183363|NCT01687283|593038900|FG000|Overall Study|Withdrawal by Subject|9|||
164183364|NCT01687283|593038901|FG001|Overall Study|Withdrawal by Subject|8|||
164183365|NCT02442206|593038902|FG000|Period 1|Adverse Event|1|||
164183366|NCT02442206|593038903|FG001|Period 1|Adverse Event|1|||
164183367|NCT02442206|593038902|FG000|Period 1|withdrew consent|0|||
164183368|NCT02442206|593038903|FG001|Period 1|withdrew consent|1|||
164183369|NCT02442206|593038902|FG000|Period 1|COPD exacerbation|0|||
164183370|NCT02442206|593038903|FG001|Period 1|COPD exacerbation|1|||
164183371|NCT02442206|593038902|FG000|Period 2|Adverse Event|1|||
164183372|NCT02442206|593038903|FG001|Period 2|Adverse Event|0|||
164183373|NCT00497146|593038904|FG000|Treatment Period|Adverse Event|6|||
164183374|NCT00497146|593038905|FG001|Treatment Period|Adverse Event|2|||
164183375|NCT00497146|593038904|FG000|Treatment Period|Withdrawal by Subject|5|||
164183376|NCT00497146|593038905|FG001|Treatment Period|Withdrawal by Subject|9|||
164183377|NCT00497146|593038904|FG000|Treatment Period|Lost to Follow-up|1|||
164183378|NCT00497146|593038905|FG001|Treatment Period|Lost to Follow-up|3|||
164183379|NCT00497146|593038904|FG000|Treatment Period|Required dialysis|4|||
164183380|NCT00497146|593038905|FG001|Treatment Period|Required dialysis|1|||
164183381|NCT00497146|593038904|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
164183382|NCT00497146|593038905|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
164183383|NCT00497146|593038904|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
164183384|NCT00497146|593038905|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
164183385|NCT00497146|593038904|FG000|Treatment Period|Other Reason|2|||
164183386|NCT00497146|593038905|FG001|Treatment Period|Other Reason|3|||
164183387|NCT00497146|593038904|FG000|Long-term Follow-up Period|Adverse Event|2|||
164183388|NCT00497146|593038905|FG001|Long-term Follow-up Period|Adverse Event|2|||
164183389|NCT00497146|593038904|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
164183390|NCT00497146|593038905|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
164183391|NCT00497146|593038904|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
164183392|NCT00497146|593038905|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
164183393|NCT00497146|593038904|FG000|Long-term Follow-up Period|Other|0|||
164183394|NCT00497146|593038905|FG001|Long-term Follow-up Period|Other|1|||
164183395|NCT01471444|593038906|FG000|Overall Study|Physician Decision|3|||
164183396|NCT01471444|593038907|FG001|Overall Study|Physician Decision|2|||
164183397|NCT01471444|593038906|FG000|Overall Study|Withdrawal by Subject|0|||
164183398|NCT01471444|593038907|FG001|Overall Study|Withdrawal by Subject|1|||
164183399|NCT03915626|593038908|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
164183400|NCT02107313|593038911|FG000|Overall Study|One participant did not do the FED cohor|0|||
164183401|NCT02107313|593038912|FG001|Overall Study|One participant did not do the FED cohor|1|||
164183402|NCT01031004|593038915|FG000|Overall Study|Protocol Violation|0|||
164183403|NCT01031004|593038916|FG001|Overall Study|Protocol Violation|1|||
164183404|NCT01031004|593038915|FG000|Overall Study|Lost to Follow-up|1|||
164183405|NCT01031004|593038916|FG001|Overall Study|Lost to Follow-up|0|||
164183406|NCT00582426|593038924|FG000|Overall Study|Lost to Follow-up|0|||
164183407|NCT00582426|593038925|FG001|Overall Study|Lost to Follow-up|2|||
164183408|NCT00582426|593038924|FG000|Overall Study|Adverse Event|4|||
164183410|NCT00582426|593038924|FG000|Overall Study|Protocol Violation|6|||
164183411|NCT00582426|593038925|FG001|Overall Study|Protocol Violation|2|||
164183412|NCT00582426|593038924|FG000|Overall Study|Death|4|||
164183413|NCT00582426|593038925|FG001|Overall Study|Death|3|||
164183414|NCT00582426|593038924|FG000|Overall Study|Withdrawal by Subject|3|||
164183415|NCT00582426|593038925|FG001|Overall Study|Withdrawal by Subject|2|||
164183416|NCT00582426|593038924|FG000|Overall Study|Disease Progression|2|||
164183417|NCT00582426|593038925|FG001|Overall Study|Disease Progression|2|||
164183418|NCT00582426|593038924|FG000|Overall Study|Use of illicit drugs|1|||
164183419|NCT00582426|593038925|FG001|Overall Study|Use of illicit drugs|0|||
164183420|NCT00662311|593038928|FG000|Overall Study|Respiratory Infection|1|||
164183421|NCT00662311|593038929|FG001|Overall Study|Respiratory Infection|0|||
164183422|NCT00662311|593038930|FG002|Overall Study|Respiratory Infection|0|||
164183423|NCT02164318|593038931|FG000|Overall Study|Withdrawal by Subject|0|||
164183424|NCT02164318|593038932|FG001|Overall Study|Withdrawal by Subject|1|||
164183425|NCT02164318|593038933|FG002|Overall Study|Withdrawal by Subject|0|||
164183426|NCT02164318|593038934|FG003|Overall Study|Withdrawal by Subject|1|||
164183427|NCT04727528|593038935|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
164183428|NCT04727528|593038936|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
164183429|NCT04727528|593038935|FG000|Open-label Period|Randomized who did not receive treatment|1|||
164183430|NCT04727528|593038936|FG001|Open-label Period|Randomized who did not receive treatment|0|||
164183431|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Adverse Event|0|||
164183432|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Adverse Event|1|||
164183433|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Death|0|||
164183434|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Death|1|||
164183435|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
164183436|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
164183437|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
164183438|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
164183439|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Physician Decision|0|||
164183440|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Physician Decision|1|||
164183441|NCT04727528|593038935|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
164183442|NCT04727528|593038936|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
164183443|NCT02335346|593038940|FG000|Overall Study|Adverse Event|11|||
164183444|NCT02335346|593038940|FG000|Overall Study|Withdrawal by Subject|1|||
164183445|NCT01964989|593038941|FG000|Overall Study|Protocol Violation|3|||
164183446|NCT01964989|593038942|FG001|Overall Study|Protocol Violation|4|||
164183447|NCT01964989|593038941|FG000|Overall Study|Administrative Reason|103|||
164183448|NCT01964989|593038942|FG001|Overall Study|Administrative Reason|95|||
164183449|NCT01964989|593038941|FG000|Overall Study|Adverse Event|0|||
164183450|NCT01964989|593038942|FG001|Overall Study|Adverse Event|1|||
164183451|NCT01964989|593038941|FG000|Overall Study|Death|1|||
164183452|NCT01964989|593038942|FG001|Overall Study|Death|3|||
164183453|NCT01964989|593038941|FG000|Overall Study|Withdrawal by Subject|156|||
164183454|NCT01964989|593038942|FG001|Overall Study|Withdrawal by Subject|160|||
164183455|NCT01964989|593038941|FG000|Overall Study|Lost to Follow-up|254|||
164183456|NCT01964989|593038942|FG001|Overall Study|Lost to Follow-up|232|||
164183457|NCT01964989|593038941|FG000|Overall Study|Other|267|||
164183458|NCT01964989|593038942|FG001|Overall Study|Other|252|||
164183459|NCT02769312|593038943|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
164183460|NCT02769312|593038944|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
164183461|NCT02769312|593038943|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
164183462|NCT02769312|593038944|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
164183463|NCT02769312|593038943|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
164183464|NCT02769312|593038944|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
164183465|NCT02769312|593038943|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
164183466|NCT02769312|593038944|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
164183467|NCT02769312|593038943|FG000|Follow-up|Lost to Follow-up|1|||
164183468|NCT02769312|593038944|FG001|Follow-up|Lost to Follow-up|1|||
164183469|NCT01148459|593038947|FG000|Overall Study|Serious Adverse Event|5|||
164183470|NCT01148459|593038948|FG001|Overall Study|Serious Adverse Event|4|||
164183471|NCT01148459|593038947|FG000|Overall Study|Withdrawal by Subject|1|||
164183472|NCT01148459|593038948|FG001|Overall Study|Withdrawal by Subject|0|||
164183473|NCT01148459|593038947|FG000|Overall Study|Migrated/moved from study area|3|||
164183474|NCT01148459|593038948|FG001|Overall Study|Migrated/moved from study area|6|||
164183475|NCT01148459|593038947|FG000|Overall Study|Lost to Follow-up|2|||
164183476|NCT01148459|593038948|FG001|Overall Study|Lost to Follow-up|0|||
164183477|NCT01148459|593038947|FG000|Overall Study|Refusal|1|||
164183478|NCT01148459|593038948|FG001|Overall Study|Refusal|0|||
164183479|NCT01148459|593038947|FG000|Overall Study|Failure to comply with study procedures|0|||
164183480|NCT01148459|593038948|FG001|Overall Study|Failure to comply with study procedures|1|||
164183481|NCT02496039|593038949|FG000|Overall Study|Adverse Event|3|||
164183482|NCT02496039|593038949|FG000|Overall Study|Protocol Violation|1|||
164183483|NCT01038752|593038950|FG000|Overall Study|Tumor Progression|2|||
164183484|NCT01038752|593038951|FG001|Overall Study|Tumor Progression|2|||
164183485|NCT01038752|593038950|FG000|Overall Study|Lost to Follow-up|3|||
164183486|NCT01038752|593038951|FG001|Overall Study|Lost to Follow-up|3|||
164183487|NCT02700698|593038952|FG000|Overall Study|Withdrawal by Subject|1|||
164183488|NCT02700698|593038953|FG001|Overall Study|Withdrawal by Subject|0|||
164183489|NCT00703118|593038954|FG000|Overall Study|Adverse Event|1|||
164183490|NCT00703118|593038955|FG001|Overall Study|Adverse Event|2|||
164183491|NCT00703118|593038956|FG002|Overall Study|Adverse Event|2|||
164183492|NCT00703118|593038954|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
164183493|NCT00703118|593038955|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
164183494|NCT00703118|593038956|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
164183495|NCT00703118|593038954|FG000|Overall Study|Lost to Follow-up|6|||
164183496|NCT00703118|593038955|FG001|Overall Study|Lost to Follow-up|4|||
164183497|NCT00703118|593038956|FG002|Overall Study|Lost to Follow-up|4|||
164183498|NCT00703118|593038954|FG000|Overall Study|Withdrawal by Subject|8|||
164183499|NCT00703118|593038955|FG001|Overall Study|Withdrawal by Subject|7|||
164183500|NCT00703118|593038956|FG002|Overall Study|Withdrawal by Subject|13|||
164183501|NCT00703118|593038954|FG000|Overall Study|Other|0|||
164183502|NCT00703118|593038955|FG001|Overall Study|Other|0|||
164183503|NCT00703118|593038956|FG002|Overall Study|Other|1|||
164183504|NCT05053035|593038959|FG000|Overall Study|Withdrawal by Subject|1|||
164183505|NCT05053035|593038960|FG001|Overall Study|Withdrawal by Subject|0|||
164183506|NCT02005627|593038964|FG000|Overall Study|Lost to Follow-up|1|||
164183507|NCT02005627|593038965|FG001|Overall Study|Lost to Follow-up|2|||
164183508|NCT02005627|593038964|FG000|Overall Study|Withdrawal by Subject|1|||
164183509|NCT02005627|593038965|FG001|Overall Study|Withdrawal by Subject|2|||
164183510|NCT03760458|593038966|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
164183511|NCT03760458|593038967|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
164183512|NCT03760458|593038968|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
164183513|NCT03760458|593038969|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
164183514|NCT03760458|593038970|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
164183515|NCT00750919|593038971|FG000|Overall Study|Adverse Event|9|||
164183516|NCT00750919|593038971|FG000|Overall Study|Withdrawal by Subject|1|||
164183517|NCT00750919|593038971|FG000|Overall Study|Lack of Efficacy|8|||
164183518|NCT00750919|593038971|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
164183519|NCT00750919|593038971|FG000|Overall Study|Other|36|||
164183520|NCT00048997|593038976|FG000|Overall Study|Protocol Violation|7|||
164183521|NCT00048997|593038977|FG001|Overall Study|Protocol Violation|2|||
164183522|NCT00048997|593038976|FG000|Overall Study|Withdrawal by Subject|6|||
164183523|NCT00048997|593038977|FG001|Overall Study|Withdrawal by Subject|1|||
164183524|NCT00002525|593038984|FG000|Overall Study|Adverse Event|36|||
164183525|NCT00002525|593038985|FG001|Overall Study|Adverse Event|0|||
164183526|NCT00002525|593038984|FG000|Overall Study|Death|5|||
164183527|NCT00002525|593038985|FG001|Overall Study|Death|0|||
164183528|NCT00002525|593038984|FG000|Overall Study|Withdrawal by Subject|11|||
164183529|NCT00002525|593038985|FG001|Overall Study|Withdrawal by Subject|0|||
164183530|NCT00002525|593038984|FG000|Overall Study|Start non-protocol therapy|1|||
164183531|NCT00002525|593038985|FG001|Overall Study|Start non-protocol therapy|0|||
164183532|NCT00002525|593038984|FG000|Overall Study|Other complicating disease|1|||
164183533|NCT00002525|593038985|FG001|Overall Study|Other complicating disease|0|||
164183534|NCT00002525|593038984|FG000|Overall Study|Duke's A, B1, D disease|92|||
164183535|NCT00002525|593038985|FG001|Overall Study|Duke's A, B1, D disease|0|||
164183536|NCT00002525|593038984|FG000|Overall Study|Error|6|||
164183537|NCT00002525|593038985|FG001|Overall Study|Error|0|||
164183538|NCT00002525|593038984|FG000|Overall Study|Other|26|||
164183539|NCT00002525|593038985|FG001|Overall Study|Other|0|||
164183540|NCT00002525|593038984|FG000|Overall Study|Never start protocol therapy|8|||
164183541|NCT00002525|593038985|FG001|Overall Study|Never start protocol therapy|0|||
164183542|NCT03304184|593038986|FG000|Overall Study|Withdrawal by Subject|1|||
164183543|NCT03304184|593038987|FG001|Overall Study|Withdrawal by Subject|2|||
164183544|NCT04527978|593038991|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
164183545|NCT04527978|593038992|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
164183546|NCT02112877|593038994|FG000|Overall Study|Withdrawal by Subject|1|||
164183547|NCT02112877|593038995|FG001|Overall Study|Withdrawal by Subject|7|||
164183548|NCT02112877|593038994|FG000|Overall Study|Visit Missed|1|||
164183549|NCT02112877|593038995|FG001|Overall Study|Visit Missed|6|||
164183550|NCT01490697|593039006|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
164183551|NCT01490697|593039007|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
164183552|NCT00090584|593039008|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
164183553|NCT00090584|593039009|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
164183554|NCT00090584|593039008|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
164183555|NCT00090584|593039009|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
164183556|NCT00379808|593039010|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
164183557|NCT00379808|593039011|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
164183558|NCT01578499|593039012|FG000|Overall Study|Reason not Specified|0|||
164183559|NCT01578499|593039013|FG001|Overall Study|Reason not Specified|1|||
164183560|NCT01578499|593039012|FG000|Overall Study|Lost to Follow-up|2|||
164183561|NCT01578499|593039013|FG001|Overall Study|Lost to Follow-up|1|||
164183562|NCT01578499|593039012|FG000|Overall Study|Withdrawal by Subject|10|||
164183563|NCT01578499|593039013|FG001|Overall Study|Withdrawal by Subject|16|||
164183564|NCT01578499|593039012|FG000|Overall Study|Death|20|||
164183565|NCT01578499|593039013|FG001|Overall Study|Death|25|||
164183566|NCT01578499|593039012|FG000|Overall Study|Died and End of Study Page not Completed|2|||
164183567|NCT01578499|593039013|FG001|Overall Study|Died and End of Study Page not Completed|0|||
164183568|NCT00508157|593039014|FG000|Overall Study|Adverse Event|0|||
164183569|NCT00508157|593039015|FG001|Overall Study|Adverse Event|1|||
164183570|NCT00508157|593039014|FG000|Overall Study|Subject Withdrew Consent|1|||
164183571|NCT00508157|593039015|FG001|Overall Study|Subject Withdrew Consent|0|||
164183572|NCT00508157|593039014|FG000|Overall Study|Lost to Follow-up|1|||
164183573|NCT00508157|593039015|FG001|Overall Study|Lost to Follow-up|0|||
164183574|NCT00508157|593039014|FG000|Overall Study|Subject no longer met study criteria|0|||
164183575|NCT00508157|593039015|FG001|Overall Study|Subject no longer met study criteria|1|||
164183576|NCT00508157|593039014|FG000|Overall Study|Other known cause|0|||
164183577|NCT00508157|593039015|FG001|Overall Study|Other known cause|1|||
164183578|NCT01987232|593039016|FG000|Overall Study|Ongoing in Study|0|||
164183579|NCT01987232|593039017|FG001|Overall Study|Ongoing in Study|0|||
164183580|NCT01987232|593039018|FG002|Overall Study|Ongoing in Study|0|||
164183581|NCT01987232|593039019|FG003|Overall Study|Ongoing in Study|1|||
164183582|NCT01987232|593039020|FG004|Overall Study|Ongoing in Study|0|||
164183583|NCT01952080|593039022|FG000|Overall Study|Withdrawal by Subject|0|||
164183584|NCT01952080|593039023|FG001|Overall Study|Withdrawal by Subject|0|||
164183585|NCT01952080|593039024|FG002|Overall Study|Withdrawal by Subject|0|||
164183586|NCT01952080|593039025|FG003|Overall Study|Withdrawal by Subject|1|||
164183587|NCT01952080|593039022|FG000|Overall Study|Protocol Non-compliance|0|||
164183588|NCT01952080|593039023|FG001|Overall Study|Protocol Non-compliance|1|||
164183589|NCT01952080|593039024|FG002|Overall Study|Protocol Non-compliance|0|||
164183590|NCT01952080|593039025|FG003|Overall Study|Protocol Non-compliance|0|||
164183591|NCT01333956|593039036|FG000|Overall Study|Lost to Follow-up|1|||
164183592|NCT01333956|593039037|FG001|Overall Study|Lost to Follow-up|2|||
164183593|NCT01333956|593039038|FG002|Overall Study|Lost to Follow-up|0|||
164183594|NCT01333956|593039039|FG003|Overall Study|Lost to Follow-up|1|||
164183595|NCT01333956|593039036|FG000|Overall Study|Unable to complete study procedure|1|||
164183596|NCT01333956|593039037|FG001|Overall Study|Unable to complete study procedure|0|||
164183597|NCT01333956|593039038|FG002|Overall Study|Unable to complete study procedure|0|||
164183598|NCT01333956|593039039|FG003|Overall Study|Unable to complete study procedure|1|||
164183599|NCT01333956|593039036|FG000|Overall Study|Withdrawal by Subject|0|||
164183600|NCT01333956|593039037|FG001|Overall Study|Withdrawal by Subject|2|||
164183601|NCT01333956|593039038|FG002|Overall Study|Withdrawal by Subject|1|||
164183602|NCT01333956|593039039|FG003|Overall Study|Withdrawal by Subject|0|||
164183603|NCT02134353|593039040|FG000|Overall Study|Adverse Event|10|||
164183604|NCT02134353|593039041|FG001|Overall Study|Adverse Event|6|||
164183605|NCT02134353|593039040|FG000|Overall Study|Lost to Follow-up|1|||
164183606|NCT02134353|593039041|FG001|Overall Study|Lost to Follow-up|1|||
164183607|NCT02134353|593039040|FG000|Overall Study|Lack of Efficacy|2|||
164183608|NCT02134353|593039041|FG001|Overall Study|Lack of Efficacy|1|||
164183609|NCT02134353|593039040|FG000|Overall Study|Withdrawal by Subject|12|||
164183610|NCT02134353|593039041|FG001|Overall Study|Withdrawal by Subject|13|||
164183611|NCT02134353|593039040|FG000|Overall Study|Death|0|||
164183612|NCT02134353|593039041|FG001|Overall Study|Death|1|||
164183613|NCT02134353|593039040|FG000|Overall Study|Pregnancy|0|||
164183614|NCT02134353|593039041|FG001|Overall Study|Pregnancy|1|||
164183615|NCT02134353|593039040|FG000|Overall Study|Relocation|1|||
164183616|NCT02134353|593039041|FG001|Overall Study|Relocation|0|||
164183617|NCT02134353|593039040|FG000|Overall Study|Other - Patient's Choice|0|||
164183618|NCT02134353|593039041|FG001|Overall Study|Other - Patient's Choice|1|||
164183619|NCT00655681|593039044|FG000|Overall Study|Lost to Follow-up|1|||
164183620|NCT00655681|593039045|FG001|Overall Study|Lost to Follow-up|1|||
164183621|NCT01783821|593039049|FG000|Overall Study|Screen Failure|1|||
164183622|NCT01783821|593039050|FG001|Overall Study|Screen Failure|1|||
164183623|NCT01653327|593039057|FG000|Overall Study|Withdrawal by Subject|1|||
164183624|NCT00422292|593039058|FG000|Overall Study|Serious adverse events|1|||
164183625|NCT00422292|593039059|FG001|Overall Study|Serious adverse events|4|||
164183626|NCT00422292|593039060|FG002|Overall Study|Serious adverse events|0|||
164183627|NCT00422292|593039061|FG003|Overall Study|Serious adverse events|0|||
164183628|NCT00422292|593039058|FG000|Overall Study|Adverse Event|1|||
164183629|NCT00422292|593039059|FG001|Overall Study|Adverse Event|0|||
164183630|NCT00422292|593039060|FG002|Overall Study|Adverse Event|1|||
164183631|NCT00422292|593039061|FG003|Overall Study|Adverse Event|0|||
164183632|NCT00422292|593039058|FG000|Overall Study|Protocol Violation|4|||
164183633|NCT00422292|593039059|FG001|Overall Study|Protocol Violation|25|||
164183634|NCT00422292|593039060|FG002|Overall Study|Protocol Violation|8|||
164183635|NCT00422292|593039061|FG003|Overall Study|Protocol Violation|5|||
164183636|NCT00422292|593039058|FG000|Overall Study|Lost to Follow-up|6|||
164183637|NCT00422292|593039059|FG001|Overall Study|Lost to Follow-up|12|||
164183638|NCT00422292|593039060|FG002|Overall Study|Lost to Follow-up|6|||
164183639|NCT00422292|593039061|FG003|Overall Study|Lost to Follow-up|6|||
164183640|NCT00422292|593039058|FG000|Overall Study|Withdrawal by Subject|6|||
164183641|NCT00422292|593039059|FG001|Overall Study|Withdrawal by Subject|25|||
164183642|NCT00422292|593039060|FG002|Overall Study|Withdrawal by Subject|7|||
164183643|NCT00422292|593039061|FG003|Overall Study|Withdrawal by Subject|13|||
164183644|NCT02440854|593039062|FG000|Overall Study|Relocation of patient|1|||
164183645|NCT02440854|593039062|FG000|Overall Study|Death|6|||
164183646|NCT02440854|593039062|FG000|Overall Study|Lost to Follow-up|10|||
164183647|NCT02440854|593039062|FG000|Overall Study|Afatinib discontinuation|46|||
164183648|NCT02440854|593039062|FG000|Overall Study|stopped study at earlier timepoint|14|||
164183649|NCT02440854|593039062|FG000|Overall Study|Study medication not received|1|||
164183650|NCT02440854|593039062|FG000|Overall Study|Violation of inclusion criteria|2|||
164183651|NCT02243046|593039063|FG000|Overall Study|Lost to Follow-up|1|||
164183652|NCT02243046|593039064|FG001|Overall Study|Lost to Follow-up|1|||
164183653|NCT02243046|593039065|FG002|Overall Study|Lost to Follow-up|4|||
164183654|NCT02669082|593039066|FG000|Overall Study|Adverse Event|1|||
164183655|NCT04918355|593039067|FG000|Overall Study|no qualifying health encounter|497|||
164183656|NCT04918355|593039068|FG001|Overall Study|no qualifying health encounter|192|||
164183657|NCT04918355|593039069|FG002|Overall Study|no qualifying health encounter|438|||
164183658|NCT04918355|593039070|FG003|Overall Study|no qualifying health encounter|424|||
164183659|NCT04683939|593039074|FG000|Overall Study|Study termination by the sponsor|0|||
164183660|NCT04683939|593039075|FG001|Overall Study|Study termination by the sponsor|1|||
164183661|NCT04683939|593039076|FG002|Overall Study|Study termination by the sponsor|2|||
164183662|NCT04683939|593039077|FG003|Overall Study|Study termination by the sponsor|2|||
164183663|NCT04683939|593039074|FG000|Overall Study|Death|1|||
164183664|NCT04683939|593039075|FG001|Overall Study|Death|1|||
164183665|NCT04683939|593039076|FG002|Overall Study|Death|2|||
164183666|NCT04683939|593039077|FG003|Overall Study|Death|1|||
164183667|NCT04683939|593039074|FG000|Overall Study|Withdrawal by Subject|1|||
164183668|NCT04683939|593039075|FG001|Overall Study|Withdrawal by Subject|0|||
164183669|NCT04683939|593039076|FG002|Overall Study|Withdrawal by Subject|0|||
164183670|NCT04683939|593039077|FG003|Overall Study|Withdrawal by Subject|0|||
164183671|NCT04683939|593039074|FG000|Overall Study|Physician Decision|1|||
164183672|NCT04683939|593039075|FG001|Overall Study|Physician Decision|0|||
164183673|NCT04683939|593039076|FG002|Overall Study|Physician Decision|0|||
164183674|NCT04683939|593039077|FG003|Overall Study|Physician Decision|0|||
164183675|NCT04683939|593039074|FG000|Overall Study|Lost to Follow-up|0|||
164183676|NCT04683939|593039075|FG001|Overall Study|Lost to Follow-up|1|||
164183677|NCT04683939|593039076|FG002|Overall Study|Lost to Follow-up|0|||
164183678|NCT04683939|593039077|FG003|Overall Study|Lost to Follow-up|0|||
164183679|NCT04852276|593039078|FG000|Overall Study|Death|2|||
164183680|NCT04852276|593039079|FG001|Overall Study|Death|0|||
164183681|NCT04852276|593039078|FG000|Overall Study|Lost to Follow-up|15|||
164183682|NCT04852276|593039079|FG001|Overall Study|Lost to Follow-up|9|||
164183683|NCT04852276|593039078|FG000|Overall Study|Withdrawal by Subject|26|||
164183684|NCT04852276|593039079|FG001|Overall Study|Withdrawal by Subject|6|||
164183685|NCT00385827|593040491|FG000|Part 1|Adverse Event|1|||
164183686|NCT00385827|593040492|FG001|Part 1|Adverse Event|0|||
164183687|NCT00385827|593040493|FG002|Part 1|Adverse Event|0|||
164183688|NCT00385827|593040491|FG000|Part 1|Death|2|||
164183689|NCT00385827|593040492|FG001|Part 1|Death|0|||
164183690|NCT00385827|593040493|FG002|Part 1|Death|0|||
164183691|NCT00385827|593040491|FG000|Part 1|Lack of Efficacy|5|||
164183692|NCT00385827|593040492|FG001|Part 1|Lack of Efficacy|0|||
164183693|NCT00385827|593040493|FG002|Part 1|Lack of Efficacy|0|||
164183694|NCT00385827|593040491|FG000|Part 1|Other|1|||
164183695|NCT00385827|593040492|FG001|Part 1|Other|0|||
164183696|NCT00385827|593040493|FG002|Part 1|Other|0|||
164183697|NCT00385827|593040491|FG000|Part 2|Adverse Event|0|||
164183698|NCT00385827|593040492|FG001|Part 2|Adverse Event|6|||
164183699|NCT00385827|593040493|FG002|Part 2|Adverse Event|10|||
164183700|NCT00385827|593040491|FG000|Part 2|Death|0|||
164183701|NCT00385827|593040492|FG001|Part 2|Death|0|||
164183702|NCT00385827|593040493|FG002|Part 2|Death|2|||
164183703|NCT00385827|593040491|FG000|Part 2|Lack of Efficacy|0|||
164183704|NCT00385827|593040492|FG001|Part 2|Lack of Efficacy|14|||
164183705|NCT00385827|593040493|FG002|Part 2|Lack of Efficacy|13|||
164183706|NCT00385827|593040491|FG000|Part 2|Randomized but not treated|0|||
164183707|NCT00385827|593040492|FG001|Part 2|Randomized but not treated|2|||
164183708|NCT00385827|593040493|FG002|Part 2|Randomized but not treated|2|||
164183709|NCT00385827|593040491|FG000|Part 2|Other|0|||
164183710|NCT00385827|593040492|FG001|Part 2|Other|11|||
164183711|NCT00385827|593040493|FG002|Part 2|Other|21|||
164183712|NCT00410072|593040494|FG000|Day 1 to Week 48|Adverse Event|1|||
164183713|NCT00410072|593040495|FG001|Day 1 to Week 48|Adverse Event|2|||
164183714|NCT00410072|593040494|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
164183715|NCT00410072|593040495|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
164183716|NCT00410072|593040494|FG000|Day 1 to Week 48|Other|0|||
164183717|NCT00410072|593040495|FG001|Day 1 to Week 48|Other|1|||
164183718|NCT00410072|593040494|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
164183719|NCT00410072|593040495|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
164183720|NCT00410072|593040494|FG000|Day 1 to Week 48|Pregnancy|0|||
164183721|NCT00410072|593040495|FG001|Day 1 to Week 48|Pregnancy|2|||
164183722|NCT00410072|593040494|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
164183723|NCT00410072|593040495|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
164183724|NCT00410072|593040494|FG000|After Week 48 to Week 96|Adverse Event|1|||
164183725|NCT00410072|593040495|FG001|After Week 48 to Week 96|Adverse Event|2|||
164183726|NCT00410072|593040494|FG000|After Week 48 to Week 96|Death|0|||
164183727|NCT00410072|593040495|FG001|After Week 48 to Week 96|Death|1|||
164183728|NCT00410072|593040494|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
164183729|NCT00410072|593040495|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
164183730|NCT00410072|593040494|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
164183731|NCT00410072|593040495|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
164183732|NCT00410072|593040494|FG000|After Week 48 to Week 96|Other|2|||
164183733|NCT00410072|593040495|FG001|After Week 48 to Week 96|Other|0|||
164183734|NCT00410072|593040494|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
164183735|NCT00410072|593040495|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
164183736|NCT00410072|593040494|FG000|After Week 48 to Week 96|Pregnancy|0|||
164183737|NCT00410072|593040495|FG001|After Week 48 to Week 96|Pregnancy|2|||
164183738|NCT00410072|593040494|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
164183739|NCT00410072|593040495|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
164183740|NCT01421147|593040496|FG000|Treatment Period|Adverse Event|2|||
164183741|NCT01421147|593040497|FG001|Treatment Period|Adverse Event|3|||
164183742|NCT01421147|593040496|FG000|Treatment Period|Lost to Follow-up|2|||
164183743|NCT01421147|593040497|FG001|Treatment Period|Lost to Follow-up|1|||
164183744|NCT01421147|593040496|FG000|Treatment Period|Physician Decision|2|||
164183745|NCT01421147|593040497|FG001|Treatment Period|Physician Decision|2|||
164183746|NCT01421147|593040496|FG000|Treatment Period|Withdrawal by Subject|10|||
164183747|NCT01421147|593040497|FG001|Treatment Period|Withdrawal by Subject|5|||
164183748|NCT01421147|593040496|FG000|Extension Period|Adverse Event|0|||
164183749|NCT01421147|593040497|FG001|Extension Period|Adverse Event|2|||
164183750|NCT01421147|593040496|FG000|Extension Period|Death|0|||
164183751|NCT01421147|593040497|FG001|Extension Period|Death|1|||
164183752|NCT01421147|593040496|FG000|Extension Period|Lost to Follow-up|2|||
164183753|NCT01421147|593040497|FG001|Extension Period|Lost to Follow-up|5|||
164183754|NCT01421147|593040496|FG000|Extension Period|Physician Decision|1|||
164183755|NCT01421147|593040497|FG001|Extension Period|Physician Decision|0|||
164183756|NCT01421147|593040496|FG000|Extension Period|Withdrawal by Subject|5|||
164183757|NCT01421147|593040497|FG001|Extension Period|Withdrawal by Subject|3|||
164183758|NCT00904917|593040500|FG000|Overall Study|Lost to Follow-up|2|||
164183759|NCT00904917|593040501|FG001|Overall Study|Lost to Follow-up|2|||
164183760|NCT00904917|593040502|FG002|Overall Study|Lost to Follow-up|2|||
164183761|NCT00904917|593040503|FG003|Overall Study|Lost to Follow-up|2|||
164183762|NCT05025332|593040504|FG000|Screening|Screen failure|12|||
164183763|NCT05025332|593040504|FG000|Treatment & Follow Up|Protocol Violation|1|||
164183764|NCT05025332|593040504|FG000|Treatment & Follow Up|Adverse Event|4|||
164183765|NCT01299896|593040505|FG000|Overall Study|Withdrawal by Subject|1|||
164183766|NCT01299896|593040506|FG001|Overall Study|Withdrawal by Subject|7|||
164183767|NCT01299896|593040505|FG000|Overall Study|Lost to Follow-up|0|||
164183768|NCT01299896|593040506|FG001|Overall Study|Lost to Follow-up|11|||
164183769|NCT01467271|593040507|FG000|Overall Study|Death|84|||
164183770|NCT01467271|593040507|FG000|Overall Study|Lost to Follow-up|83|||
164183771|NCT01467271|593040507|FG000|Overall Study|Retraction of patient's consent|21|||
164183772|NCT01467271|593040507|FG000|Overall Study|Other reason|14|||
164183773|NCT01411319|593040512|FG000|Overall Study|Lost to Follow-up|1|||
164183774|NCT02815267|593040513|FG000|Double-Blind Phase|Adverse Event|0|||
164183775|NCT02815267|593040514|FG001|Double-Blind Phase|Adverse Event|3|||
164183776|NCT02815267|593040513|FG000|Double-Blind Phase|Lost to Follow-up|17|||
164183777|NCT02815267|593040514|FG001|Double-Blind Phase|Lost to Follow-up|9|||
164183778|NCT02815267|593040513|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
164183779|NCT02815267|593040514|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
164183780|NCT02815267|593040513|FG000|Double-Blind Phase|Protocol Violation|3|||
164183781|NCT02815267|593040514|FG001|Double-Blind Phase|Protocol Violation|2|||
164183782|NCT02815267|593040513|FG000|Double-Blind Phase|Site withdrawal|1|||
164183783|NCT02815267|593040514|FG001|Double-Blind Phase|Site withdrawal|6|||
164183784|NCT02815267|593040513|FG000|Double-Blind Phase|Received a disallowed medication|1|||
164183785|NCT02815267|593040514|FG001|Double-Blind Phase|Received a disallowed medication|1|||
164183786|NCT02815267|593040513|FG000|Open-Label Phase|Adverse Event|1|||
164183787|NCT02815267|593040514|FG001|Open-Label Phase|Adverse Event|1|||
164183788|NCT02815267|593040513|FG000|Open-Label Phase|Lost to Follow-up|23|||
164183789|NCT02815267|593040514|FG001|Open-Label Phase|Lost to Follow-up|9|||
164183790|NCT02815267|593040513|FG000|Open-Label Phase|Withdrawal by Subject|24|||
164183791|NCT02815267|593040514|FG001|Open-Label Phase|Withdrawal by Subject|13|||
164183792|NCT02815267|593040513|FG000|Open-Label Phase|Protocol Violation|0|||
164183793|NCT02815267|593040514|FG001|Open-Label Phase|Protocol Violation|1|||
164183794|NCT02815267|593040513|FG000|Open-Label Phase|Administrative|21|||
164183795|NCT02815267|593040514|FG001|Open-Label Phase|Administrative|12|||
164183796|NCT02815267|593040513|FG000|Open-Label Phase|Other|2|||
164183797|NCT02815267|593040514|FG001|Open-Label Phase|Other|5|||
164183798|NCT04126317|593040528|FG000|Overall Study|Adverse Event|0|||
164183799|NCT04126317|593040529|FG001|Overall Study|Adverse Event|1|||
164183800|NCT04126317|593040528|FG000|Overall Study|Withdrawal by Subject|4|||
164183801|NCT04126317|593040529|FG001|Overall Study|Withdrawal by Subject|1|||
164183802|NCT00660595|593040532|FG000|Overall Study|Lost to Follow-up|0|||
164183803|NCT00660595|593040533|FG001|Overall Study|Lost to Follow-up|1|||
164183804|NCT00660595|593040532|FG000|Overall Study|Did not consent to participate in study|12|||
164183805|NCT00660595|593040533|FG001|Overall Study|Did not consent to participate in study|8|||
164183806|NCT00660595|593040532|FG000|Overall Study|Participant left hospital|1|||
164183807|NCT00660595|593040533|FG001|Overall Study|Participant left hospital|0|||
164183808|NCT00660595|593040532|FG000|Overall Study|Non Specified reasons|5|||
164183809|NCT00660595|593040533|FG001|Overall Study|Non Specified reasons|0|||
164183810|NCT00948922|593040536|FG000|Overall Study|Did not start study treatment|2|||
164183811|NCT00948922|593040537|FG001|Overall Study|Did not start study treatment|5|||
164183812|NCT00948922|593040538|FG002|Overall Study|Did not start study treatment|0|||
164183813|NCT00948922|593040536|FG000|Overall Study|Withdrawal by Subject|0|||
164183814|NCT00948922|593040537|FG001|Overall Study|Withdrawal by Subject|2|||
164183815|NCT00948922|593040538|FG002|Overall Study|Withdrawal by Subject|1|||
164183816|NCT00948922|593040536|FG000|Overall Study|Death|3|||
164183817|NCT00948922|593040537|FG001|Overall Study|Death|0|||
164183818|NCT00948922|593040538|FG002|Overall Study|Death|0|||
164183819|NCT00948922|593040536|FG000|Overall Study|Disease progression|0|||
164183820|NCT00948922|593040537|FG001|Overall Study|Disease progression|1|||
164183821|NCT00948922|593040538|FG002|Overall Study|Disease progression|0|||
164183822|NCT00948922|593040536|FG000|Overall Study|Insurance issues|1|||
164183823|NCT00948922|593040537|FG001|Overall Study|Insurance issues|0|||
164183824|NCT00948922|593040538|FG002|Overall Study|Insurance issues|0|||
164183825|NCT00948922|593040536|FG000|Overall Study|Transplant eligibility issues|2|||
164183826|NCT00948922|593040537|FG001|Overall Study|Transplant eligibility issues|3|||
164183827|NCT00948922|593040538|FG002|Overall Study|Transplant eligibility issues|0|||
164183828|NCT00948922|593040536|FG000|Overall Study|Not evaluable at time of analysis|0|||
164183829|NCT00948922|593040537|FG001|Overall Study|Not evaluable at time of analysis|3|||
164183830|NCT00948922|593040538|FG002|Overall Study|Not evaluable at time of analysis|0|||
164183831|NCT04854057|593040539|FG000|Overall Study|Adverse Event|0|||
164183832|NCT04854057|593040540|FG001|Overall Study|Adverse Event|1|||
164183833|NCT02131233|593040541|FG000|Overall Study|Not Treated|2|||
164183834|NCT02131233|593040542|FG001|Overall Study|Not Treated|3|||
164183835|NCT02131233|593040541|FG000|Overall Study|Adverse Event|7|||
164183836|NCT02131233|593040542|FG001|Overall Study|Adverse Event|6|||
164183837|NCT02131233|593040541|FG000|Overall Study|Death|0|||
164183838|NCT02131233|593040542|FG001|Overall Study|Death|1|||
164183839|NCT02131233|593040541|FG000|Overall Study|Lack of Efficacy|6|||
164183840|NCT02131233|593040542|FG001|Overall Study|Lack of Efficacy|3|||
164183841|NCT02131233|593040541|FG000|Overall Study|Lost to Follow-up|14|||
164183842|NCT02131233|593040542|FG001|Overall Study|Lost to Follow-up|13|||
164183843|NCT02131233|593040541|FG000|Overall Study|Non-Compliance With Study Drug|8|||
164183844|NCT02131233|593040542|FG001|Overall Study|Non-Compliance With Study Drug|5|||
164183845|NCT02131233|593040541|FG000|Overall Study|Physician Decision|7|||
164183846|NCT02131233|593040542|FG001|Overall Study|Physician Decision|0|||
164183847|NCT02131233|593040541|FG000|Overall Study|Pregnancy|4|||
164183848|NCT02131233|593040542|FG001|Overall Study|Pregnancy|0|||
164183849|NCT02131233|593040541|FG000|Overall Study|Withdrawal by Subject|18|||
164183850|NCT02131233|593040542|FG001|Overall Study|Withdrawal by Subject|11|||
164183851|NCT05114564|593040544|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
164183852|NCT05114564|593040545|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
164183853|NCT05114564|593040544|FG000|First Intervention|Adverse Event|0|||
164183854|NCT05114564|593040545|FG001|First Intervention|Adverse Event|1|||
164183855|NCT00255840|593040546|FG000|Overall Study|Lost to Follow-up|10|||
164183856|NCT00255840|593040547|FG001|Overall Study|Lost to Follow-up|14|||
164183857|NCT00255840|593040546|FG000|Overall Study|Discontinued intervention|53|||
164183858|NCT00255840|593040547|FG001|Overall Study|Discontinued intervention|56|||
164183859|NCT01005901|593040552|FG000|Overall Study|Withdrawal by Subject|38|||
164183860|NCT01005901|593040553|FG001|Overall Study|Withdrawal by Subject|14|||
164183861|NCT01005901|593040552|FG000|Overall Study|Adverse Event|30|||
164183862|NCT01005901|593040553|FG001|Overall Study|Adverse Event|16|||
164183863|NCT01005901|593040552|FG000|Overall Study|Administrative problems|21|||
164183864|NCT01005901|593040553|FG001|Overall Study|Administrative problems|13|||
164183865|NCT01005901|593040552|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
164183866|NCT01005901|593040553|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
164183867|NCT01005901|593040552|FG000|Overall Study|Protocol Violation|4|||
164183868|NCT01005901|593040553|FG001|Overall Study|Protocol Violation|3|||
164183869|NCT01005901|593040552|FG000|Overall Study|Death|2|||
164183870|NCT01005901|593040553|FG001|Overall Study|Death|3|||
164183871|NCT01005901|593040552|FG000|Overall Study|Lost to Follow-up|1|||
164183872|NCT01005901|593040553|FG001|Overall Study|Lost to Follow-up|2|||
164183873|NCT01005901|593040552|FG000|Overall Study|Patient's inability to use the device|1|||
164183874|NCT01005901|593040553|FG001|Overall Study|Patient's inability to use the device|1|||
164183875|NCT01005901|593040552|FG000|Overall Study|No longer requires study drug|0|||
164183876|NCT01005901|593040553|FG001|Overall Study|No longer requires study drug|1|||
164183877|NCT00715520|593040558|FG000|Overall Study|Screen failure|8|||
164183878|NCT00715520|593040559|FG001|Overall Study|Screen failure|1|||
164183879|NCT00715520|593040560|FG002|Overall Study|Screen failure|1|||
164183880|NCT00715520|593040558|FG000|Overall Study|Withdrawal by Subject|2|||
164183881|NCT00715520|593040559|FG001|Overall Study|Withdrawal by Subject|0|||
164183882|NCT00715520|593040560|FG002|Overall Study|Withdrawal by Subject|1|||
164183883|NCT01006590|593040561|FG000|Overall Study|Adverse Event|2|||
164183884|NCT01006590|593040562|FG001|Overall Study|Adverse Event|3|||
164183885|NCT01006590|593040561|FG000|Overall Study|Death|1|||
164183886|NCT01006590|593040562|FG001|Overall Study|Death|1|||
164183887|NCT01006590|593040561|FG000|Overall Study|Lost to Follow-up|1|||
164183888|NCT01006590|593040562|FG001|Overall Study|Lost to Follow-up|1|||
164183889|NCT01006590|593040561|FG000|Overall Study|Protocol Violation|1|||
164183890|NCT01006590|593040562|FG001|Overall Study|Protocol Violation|0|||
164183891|NCT01006590|593040561|FG000|Overall Study|Withdrawal by Subject|4|||
164183892|NCT01006590|593040562|FG001|Overall Study|Withdrawal by Subject|2|||
164183893|NCT01006590|593040561|FG000|Overall Study|Study specific discontinuation criteria|16|||
164183894|NCT01006590|593040562|FG001|Overall Study|Study specific discontinuation criteria|23|||
164183895|NCT01006590|593040561|FG000|Overall Study|Other|3|||
164183896|NCT01006590|593040562|FG001|Overall Study|Other|2|||
164183897|NCT03332095|593040563|FG000|Overall Study|Lost to Follow-up|1|||
164183898|NCT03332095|593040564|FG001|Overall Study|Lost to Follow-up|0|||
164183899|NCT03332095|593040563|FG000|Overall Study|Pregnancy|0|||
164183900|NCT03332095|593040564|FG001|Overall Study|Pregnancy|1|||
164183901|NCT04942210|593040568|FG000|Overall Study|Adverse Event|0|||
164183902|NCT04942210|593040569|FG001|Overall Study|Adverse Event|1|||
164183903|NCT04942210|593040568|FG000|Overall Study|Protocol Deviation|4|||
164183904|NCT04942210|593040569|FG001|Overall Study|Protocol Deviation|1|||
164183905|NCT04942210|593040568|FG000|Overall Study|Withdrawal by Subject|5|||
164183906|NCT04942210|593040569|FG001|Overall Study|Withdrawal by Subject|2|||
164183907|NCT04942210|593040568|FG000|Overall Study|Lost to Follow-up|16|||
164183908|NCT04942210|593040569|FG001|Overall Study|Lost to Follow-up|7|||
164183909|NCT04942210|593040568|FG000|Overall Study|Ongoing at the time of DBL date|60|||
164183910|NCT04942210|593040569|FG001|Overall Study|Ongoing at the time of DBL date|25|||
164183911|NCT04942210|593040568|FG000|Overall Study|Randomized but did not receive vaccination|3|||
164183912|NCT04942210|593040569|FG001|Overall Study|Randomized but did not receive vaccination|0|||
164183913|NCT03420222|593040570|FG000|Overall Study|Withdrawal by Subject|5|||
164183914|NCT03420222|593040571|FG001|Overall Study|Withdrawal by Subject|0|||
164183915|NCT03420222|593040570|FG000|Overall Study|Physician Decision|0|||
164183916|NCT03420222|593040571|FG001|Overall Study|Physician Decision|1|||
164183917|NCT02651688|593040572|FG000|Overall Study|Non-compliance|0|||
164183918|NCT02651688|593040573|FG001|Overall Study|Non-compliance|0|||
164183919|NCT02651688|593040574|FG002|Overall Study|Non-compliance|1|||
164183920|NCT02651688|593040572|FG000|Overall Study|Principal Investigator (PI) decision|0|||
164183921|NCT02651688|593040573|FG001|Overall Study|Principal Investigator (PI) decision|2|||
164183922|NCT02651688|593040574|FG002|Overall Study|Principal Investigator (PI) decision|0|||
164183923|NCT02651688|593040572|FG000|Overall Study|Lost to Follow-up|1|||
164183924|NCT02651688|593040573|FG001|Overall Study|Lost to Follow-up|3|||
164183925|NCT02651688|593040574|FG002|Overall Study|Lost to Follow-up|0|||
164183926|NCT02651688|593040572|FG000|Overall Study|Withdrawal by Subject|1|||
164183927|NCT02651688|593040573|FG001|Overall Study|Withdrawal by Subject|0|||
164183928|NCT02651688|593040574|FG002|Overall Study|Withdrawal by Subject|2|||
164183929|NCT00187278|593040579|FG000|Overall Study|Protocol Violation|10|||
164183930|NCT00187278|593040580|FG001|Overall Study|Protocol Violation|13|||
164183931|NCT01380691|593040585|FG000|Washout (7 Days)|Protocol Violation|0|||
164183932|NCT01380691|593040586|FG001|Washout (7 Days)|Protocol Violation|0|||
164183933|NCT01380691|593040587|FG002|Washout (7 Days)|Protocol Violation|0|||
164183934|NCT01380691|593040588|FG003|Washout (7 Days)|Protocol Violation|1|||
164183935|NCT01380691|593040585|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
164183936|NCT01380691|593040586|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
164183937|NCT01380691|593040587|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
164183938|NCT01380691|593040588|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
164183939|NCT00460746|593040593|FG000|Overall Study|Adverse Event|1|||
164183940|NCT00460746|593040593|FG000|Overall Study|Lost to Follow-up|1|||
164183941|NCT02791438|593040596|FG000|Treatment Period|Adverse Event|1|||
164183942|NCT02791438|593040597|FG001|Treatment Period|Adverse Event|0|||
164183943|NCT02791438|593040596|FG000|Treatment Period|Withdrawal by Subject|0|||
164183944|NCT02791438|593040597|FG001|Treatment Period|Withdrawal by Subject|1|||
164183945|NCT02791438|593040596|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
164183946|NCT02791438|593040597|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
164183947|NCT01603394|593040598|FG000|Overall Study|Adverse Event|1|||
164183948|NCT00862459|593040599|FG000|Overall Study|Lost to Follow-up|1|||
164183949|NCT00862459|593040600|FG001|Overall Study|Lost to Follow-up|2|||
164183950|NCT00862459|593040601|FG002|Overall Study|Lost to Follow-up|2|||
164183951|NCT00862459|593040599|FG000|Overall Study|Protocol Violation|1|||
164183952|NCT00862459|593040600|FG001|Overall Study|Protocol Violation|0|||
164183953|NCT00862459|593040601|FG002|Overall Study|Protocol Violation|0|||
164183954|NCT00862459|593040599|FG000|Overall Study|Withdrawal by Subject|1|||
164183955|NCT00862459|593040600|FG001|Overall Study|Withdrawal by Subject|1|||
164183956|NCT00862459|593040601|FG002|Overall Study|Withdrawal by Subject|3|||
164183957|NCT00862459|593040599|FG000|Overall Study|Adverse Event|0|||
164183958|NCT00862459|593040600|FG001|Overall Study|Adverse Event|1|||
164183959|NCT00862459|593040601|FG002|Overall Study|Adverse Event|0|||
164183960|NCT00862459|593040599|FG000|Overall Study|Personal reasons|1|||
164183961|NCT00862459|593040600|FG001|Overall Study|Personal reasons|0|||
164183962|NCT00862459|593040601|FG002|Overall Study|Personal reasons|0|||
164183963|NCT00862459|593040599|FG000|Overall Study|Operation|1|||
164183964|NCT00862459|593040600|FG001|Overall Study|Operation|1|||
164183965|NCT00862459|593040601|FG002|Overall Study|Operation|0|||
164183966|NCT00862459|593040599|FG000|Overall Study|Intravenous (IV) site problems|1|||
164183967|NCT00862459|593040600|FG001|Overall Study|Intravenous (IV) site problems|0|||
164183968|NCT00862459|593040601|FG002|Overall Study|Intravenous (IV) site problems|1|||
164183969|NCT00862459|593040599|FG000|Overall Study|Unable to hold still for imaging|0|||
164183970|NCT00862459|593040600|FG001|Overall Study|Unable to hold still for imaging|1|||
164183971|NCT00862459|593040601|FG002|Overall Study|Unable to hold still for imaging|0|||
164183972|NCT00862459|593040599|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
164183973|NCT00862459|593040600|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
164183974|NCT00862459|593040601|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
164183975|NCT00862459|593040599|FG000|Overall Study|Administrative problems|0|||
164183976|NCT00862459|593040600|FG001|Overall Study|Administrative problems|1|||
164183977|NCT00862459|593040601|FG002|Overall Study|Administrative problems|0|||
164183978|NCT03426436|593040602|FG000|Overall Study|Incorrect lead placement|12|||
164183979|NCT03426436|593040602|FG000|Overall Study|Withdrawal by Subject|2|||
164183980|NCT03426436|593040602|FG000|Overall Study|Consent issue|1|||
164183981|NCT03426436|593040602|FG000|Overall Study|ECGs not saved|4|||
164183982|NCT03168919|593040603|FG000|Overall Study|Withdrawal by Subject|2|||
164183983|NCT01085136|593040604|FG000|Part A|Other Adverse event|223|||
164183984|NCT01085136|593040605|FG001|Part A|Other Adverse event|0|||
164183985|NCT01085136|593040606|FG002|Part A|Other Adverse event|0|||
164183986|NCT01085136|593040604|FG000|Part A|Protocol Violation|3|||
164183987|NCT01085136|593040605|FG001|Part A|Protocol Violation|0|||
164183988|NCT01085136|593040606|FG002|Part A|Protocol Violation|0|||
164183989|NCT01085136|593040604|FG000|Part A|Lost to Follow-up|3|||
164183990|NCT01085136|593040605|FG001|Part A|Lost to Follow-up|0|||
164183991|NCT01085136|593040606|FG002|Part A|Lost to Follow-up|0|||
164183992|NCT01085136|593040604|FG000|Part A|Refusal to continue trial medication|64|||
164183993|NCT01085136|593040605|FG001|Part A|Refusal to continue trial medication|0|||
164183994|NCT01085136|593040606|FG002|Part A|Refusal to continue trial medication|0|||
164183995|NCT01085136|593040604|FG000|Part A|Other reason not defined above|30|||
164183996|NCT01085136|593040605|FG001|Part A|Other reason not defined above|0|||
164183997|NCT01085136|593040606|FG002|Part A|Other reason not defined above|0|||
164183998|NCT01085136|593040604|FG000|Part B|Other AE|0|||
164183999|NCT01085136|593040605|FG001|Part B|Other AE|29|||
164184000|NCT01085136|593040606|FG002|Part B|Other AE|8|||
164184001|NCT01085136|593040604|FG000|Part B|Refusal to continue trial medication|0|||
164184002|NCT01085136|593040605|FG001|Part B|Refusal to continue trial medication|12|||
164184003|NCT01085136|593040606|FG002|Part B|Refusal to continue trial medication|7|||
164184004|NCT01085136|593040604|FG000|Part B|Not treated|0|||
164184005|NCT01085136|593040605|FG001|Part B|Not treated|4|||
164184006|NCT01085136|593040606|FG002|Part B|Not treated|8|||
164184007|NCT01085136|593040604|FG000|Part B|Other reason not defined above|0|||
164184008|NCT01085136|593040605|FG001|Part B|Other reason not defined above|6|||
164184009|NCT01085136|593040606|FG002|Part B|Other reason not defined above|3|||
164184010|NCT02655419|593040607|FG000|Overall Study|Enrolled but not treated|1|||
164184011|NCT02655419|593040608|FG001|Overall Study|Enrolled but not treated|5|||
164184012|NCT02655419|593040607|FG000|Overall Study|Withdrawal by Subject|4|||
164184013|NCT02655419|593040608|FG001|Overall Study|Withdrawal by Subject|1|||
164184014|NCT02655419|593040607|FG000|Overall Study|Other|0|||
164184015|NCT02655419|593040608|FG001|Overall Study|Other|1|||
164184016|NCT04226495|593040612|FG000|Overall Study|Withdrawal by Subject|3|||
164184017|NCT04226495|593040613|FG001|Overall Study|Withdrawal by Subject|3|||
164184018|NCT04226495|593040612|FG000|Overall Study|PI discretion|3|||
164184019|NCT04226495|593040613|FG001|Overall Study|PI discretion|4|||
164184020|NCT02333383|593040615|FG000|Overall Study|Adalimumab discontinuation|21|||
164184021|NCT02333383|593040615|FG000|Overall Study|Lost to Follow-up|15|||
164184022|NCT02333383|593040615|FG000|Overall Study|Withdrawal by Subject|3|||
164184023|NCT02333383|593040615|FG000|Overall Study|Transfer to another hospital|2|||
164184024|NCT04459598|593040616|FG000|Overall Study|Adverse Event|1|||
164184025|NCT04459598|593040617|FG001|Overall Study|Adverse Event|1|||
164184026|NCT00866333|593040618|FG000|Overall Study|Withdrawal of consent|0|||
164184027|NCT00866333|593040619|FG001|Overall Study|Withdrawal of consent|1|||
164184028|NCT00866333|593040620|FG002|Overall Study|Withdrawal of consent|2|||
164184029|NCT00866333|593040618|FG000|Overall Study|Reason not Specified|3|||
164184030|NCT00866333|593040619|FG001|Overall Study|Reason not Specified|1|||
164184031|NCT00866333|593040620|FG002|Overall Study|Reason not Specified|1|||
164184032|NCT00866333|593040618|FG000|Overall Study|Study Terminated by Sponsor|2|||
164184033|NCT00866333|593040619|FG001|Overall Study|Study Terminated by Sponsor|5|||
164184034|NCT00866333|593040620|FG002|Overall Study|Study Terminated by Sponsor|9|||
164184035|NCT01854879|593040621|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
164184036|NCT01854879|593040621|FG000|Overall Study|screen fail|3|||
164184037|NCT01854879|593040621|FG000|Overall Study|incomplete data set|1|||
164184038|NCT04985942|593042126|FG000|Overall Study|Adverse Event|14|||
164184039|NCT04985942|593042127|FG001|Overall Study|Adverse Event|2|||
164184040|NCT04985942|593042126|FG000|Overall Study|Lack of Efficacy|0|||
164184041|NCT04985942|593042127|FG001|Overall Study|Lack of Efficacy|3|||
164184042|NCT04985942|593042126|FG000|Overall Study|Lost to Follow-up|1|||
164184043|NCT04985942|593042127|FG001|Overall Study|Lost to Follow-up|1|||
164184044|NCT04985942|593042126|FG000|Overall Study|Protocol Violation|1|||
164184045|NCT04985942|593042127|FG001|Overall Study|Protocol Violation|1|||
164184046|NCT04985942|593042126|FG000|Overall Study|Withdrawal by Subject|5|||
164184047|NCT04985942|593042127|FG001|Overall Study|Withdrawal by Subject|4|||
164184048|NCT00171158|593042128|FG000|Core Study|Death|27|||
164184049|NCT00171158|593042128|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
164184050|NCT00171158|593042128|FG000|Core Study|Protocol Violation|4|||
164184051|NCT00171158|593042128|FG000|Core Study|Administrative problems|1|||
164184052|NCT00171158|593042128|FG000|Core Study|Adverse event, non-fatal|21|||
164184053|NCT00171158|593042128|FG000|Core Study|Consent withdrawn by subject|6|||
164184054|NCT00171158|593042128|FG000|Core Study|No longer required drug (BMT)|14|||
164184055|NCT00171158|593042128|FG000|Core Study|Abnormal Laboratory Values|2|||
164184056|NCT00171158|593042128|FG000|Core Study|Lost to Follow-up|1|||
164184057|NCT00171158|593042128|FG000|E2 Extension|Other|7|||
164184058|NCT02757352|593042129|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
164184059|NCT02757352|593042130|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184060|NCT02757352|593042131|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
164184061|NCT02757352|593042132|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184062|NCT02757352|593042133|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184063|NCT02757352|593042134|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184064|NCT02757352|593042135|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184065|NCT02757352|593042136|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184066|NCT02757352|593042137|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184067|NCT02757352|593042138|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
164184068|NCT02757352|593042129|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184069|NCT02757352|593042130|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184070|NCT02757352|593042131|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
164184071|NCT02757352|593042132|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184072|NCT02757352|593042133|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184073|NCT02757352|593042134|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184074|NCT02757352|593042135|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184075|NCT02757352|593042136|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184076|NCT02757352|593042137|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184077|NCT02757352|593042138|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
164184078|NCT02757352|593042129|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
164184079|NCT02757352|593042130|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
164184080|NCT02757352|593042131|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
164184081|NCT02757352|593042132|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184082|NCT02757352|593042133|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184083|NCT02757352|593042134|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184084|NCT02757352|593042135|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184085|NCT02757352|593042136|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184086|NCT02757352|593042137|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184087|NCT02757352|593042138|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
164184088|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184089|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
164184090|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184091|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184092|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184093|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184094|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184095|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184096|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184233|NCT04750278|593042139|FG000|Overall Study|Non-compliance|0|||
164184097|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
164184098|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184099|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164184100|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184101|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184102|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184103|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184104|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184105|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184106|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184107|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184108|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184109|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184110|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
164184111|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184112|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184113|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184114|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184115|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184116|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184117|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184118|NCT02757352|593042129|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
164184119|NCT02757352|593042130|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
164184120|NCT02757352|593042131|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
164184121|NCT02757352|593042132|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184122|NCT02757352|593042133|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184123|NCT02757352|593042134|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184124|NCT02757352|593042135|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184125|NCT02757352|593042136|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184126|NCT02757352|593042137|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184127|NCT02757352|593042138|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
164184128|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184129|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184130|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184131|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
164184132|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184133|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
164184134|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184135|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184136|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184137|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
164184138|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184139|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184140|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184141|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
164184142|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
164184143|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
164184144|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184145|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184146|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184147|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
164184148|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184149|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184150|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184151|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184152|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
164184153|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184154|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184155|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184156|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184157|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
164184158|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184159|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184160|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184161|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184162|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184163|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
164184164|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184165|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184166|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184167|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
164184168|NCT02757352|593042129|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184169|NCT02757352|593042130|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184170|NCT02757352|593042131|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184171|NCT02757352|593042132|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
164184172|NCT02757352|593042133|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184173|NCT02757352|593042134|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
164184174|NCT02757352|593042135|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184175|NCT02757352|593042136|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184176|NCT02757352|593042137|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184177|NCT02757352|593042138|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
164184178|NCT02757352|593042129|FG000|Follow-Up Period|Adverse Event|0|||
164184179|NCT02757352|593042130|FG001|Follow-Up Period|Adverse Event|0|||
164184180|NCT02757352|593042131|FG002|Follow-Up Period|Adverse Event|0|||
164184181|NCT02757352|593042132|FG003|Follow-Up Period|Adverse Event|0|||
164184182|NCT02757352|593042133|FG004|Follow-Up Period|Adverse Event|0|||
164184183|NCT02757352|593042134|FG005|Follow-Up Period|Adverse Event|0|||
164184184|NCT02757352|593042135|FG006|Follow-Up Period|Adverse Event|1|||
164184185|NCT02757352|593042136|FG007|Follow-Up Period|Adverse Event|0|||
164184186|NCT02757352|593042137|FG008|Follow-Up Period|Adverse Event|2|||
164184187|NCT02757352|593042138|FG009|Follow-Up Period|Adverse Event|0|||
164184188|NCT02757352|593042129|FG000|Follow-Up Period|Lost to Follow-up|0|||
164184189|NCT02757352|593042130|FG001|Follow-Up Period|Lost to Follow-up|0|||
164184190|NCT02757352|593042131|FG002|Follow-Up Period|Lost to Follow-up|0|||
164184191|NCT02757352|593042132|FG003|Follow-Up Period|Lost to Follow-up|0|||
164184192|NCT02757352|593042133|FG004|Follow-Up Period|Lost to Follow-up|0|||
164184193|NCT02757352|593042134|FG005|Follow-Up Period|Lost to Follow-up|0|||
164184194|NCT02757352|593042135|FG006|Follow-Up Period|Lost to Follow-up|0|||
164184195|NCT02757352|593042136|FG007|Follow-Up Period|Lost to Follow-up|0|||
164184196|NCT02757352|593042137|FG008|Follow-Up Period|Lost to Follow-up|1|||
164184197|NCT02757352|593042138|FG009|Follow-Up Period|Lost to Follow-up|0|||
164184198|NCT02757352|593042129|FG000|Follow-Up Period|Lack of Efficacy|0|||
164184199|NCT02757352|593042130|FG001|Follow-Up Period|Lack of Efficacy|0|||
164184200|NCT02757352|593042131|FG002|Follow-Up Period|Lack of Efficacy|0|||
164184201|NCT02757352|593042132|FG003|Follow-Up Period|Lack of Efficacy|0|||
164184202|NCT02757352|593042133|FG004|Follow-Up Period|Lack of Efficacy|0|||
164184203|NCT02757352|593042134|FG005|Follow-Up Period|Lack of Efficacy|0|||
164184204|NCT02757352|593042135|FG006|Follow-Up Period|Lack of Efficacy|0|||
164184205|NCT02757352|593042136|FG007|Follow-Up Period|Lack of Efficacy|0|||
164184206|NCT02757352|593042137|FG008|Follow-Up Period|Lack of Efficacy|1|||
164184207|NCT02757352|593042138|FG009|Follow-Up Period|Lack of Efficacy|1|||
164184208|NCT02757352|593042129|FG000|Follow-Up Period|Withdrawal by Subject|0|||
164184209|NCT02757352|593042130|FG001|Follow-Up Period|Withdrawal by Subject|0|||
164184210|NCT02757352|593042131|FG002|Follow-Up Period|Withdrawal by Subject|0|||
164184211|NCT02757352|593042132|FG003|Follow-Up Period|Withdrawal by Subject|0|||
164184212|NCT02757352|593042133|FG004|Follow-Up Period|Withdrawal by Subject|0|||
164184213|NCT02757352|593042134|FG005|Follow-Up Period|Withdrawal by Subject|0|||
164184214|NCT02757352|593042135|FG006|Follow-Up Period|Withdrawal by Subject|0|||
164184215|NCT02757352|593042136|FG007|Follow-Up Period|Withdrawal by Subject|1|||
164184216|NCT02757352|593042137|FG008|Follow-Up Period|Withdrawal by Subject|6|||
164184217|NCT02757352|593042138|FG009|Follow-Up Period|Withdrawal by Subject|2|||
164184218|NCT04750278|593042139|FG000|Overall Study|Death|9|||
164184219|NCT04750278|593042140|FG001|Overall Study|Death|10|||
164184220|NCT04750278|593042141|FG002|Overall Study|Death|10|||
164184221|NCT04750278|593042139|FG000|Overall Study|Withdrawal by Subject|4|||
164184222|NCT04750278|593042140|FG001|Overall Study|Withdrawal by Subject|1|||
164184223|NCT04750278|593042141|FG002|Overall Study|Withdrawal by Subject|2|||
164184224|NCT04750278|593042139|FG000|Overall Study|Lost to Follow-up|1|||
164184225|NCT04750278|593042140|FG001|Overall Study|Lost to Follow-up|1|||
164184226|NCT04750278|593042141|FG002|Overall Study|Lost to Follow-up|1|||
164184227|NCT04750278|593042139|FG000|Overall Study|Pregnancy|1|||
164184228|NCT04750278|593042140|FG001|Overall Study|Pregnancy|0|||
164184229|NCT04750278|593042141|FG002|Overall Study|Pregnancy|0|||
164184230|NCT04750278|593042139|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
164184231|NCT04750278|593042140|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
164184232|NCT04750278|593042141|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
164184234|NCT04750278|593042140|FG001|Overall Study|Non-compliance|0|||
164184235|NCT04750278|593042141|FG002|Overall Study|Non-compliance|1|||
164184236|NCT04750278|593042139|FG000|Overall Study|Transfer to Outside Facility|0|||
164184237|NCT04750278|593042140|FG001|Overall Study|Transfer to Outside Facility|2|||
164184238|NCT04750278|593042141|FG002|Overall Study|Transfer to Outside Facility|1|||
164184239|NCT04750278|593042139|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
164184240|NCT04750278|593042140|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
164184241|NCT04750278|593042141|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
164184242|NCT04750278|593042139|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
164184243|NCT04750278|593042140|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
164184244|NCT04750278|593042141|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
164184245|NCT01212159|593042142|FG000|Overall Study|Withdrawal by Subject|12|||
164184246|NCT01212159|593042143|FG001|Overall Study|Withdrawal by Subject|12|||
164184247|NCT02776670|593042184|FG000|Overall Study|Adverse Event|0|||
164184248|NCT02776670|593042185|FG001|Overall Study|Adverse Event|2|||
164184249|NCT02776670|593042184|FG000|Overall Study|Protocol Violation|0|||
164184250|NCT02776670|593042185|FG001|Overall Study|Protocol Violation|2|||
164184251|NCT02776670|593042184|FG000|Overall Study|Withdrawal by Subject|0|||
164184252|NCT02776670|593042185|FG001|Overall Study|Withdrawal by Subject|1|||
164184253|NCT02776670|593042184|FG000|Overall Study|Other - Reason not given|0|||
164184254|NCT02776670|593042185|FG001|Overall Study|Other - Reason not given|1|||
164184255|NCT00957424|593042190|FG000|Overall Study|Lost to Follow-up|19|||
164184256|NCT00957424|593042190|FG000|Overall Study|Protocol Violation|3|||
164184257|NCT00957424|593042190|FG000|Overall Study|Withdrawal by Subject|1|||
164184258|NCT01280682|593042195|FG000|Overall Study|Lost to Follow-up|0|||
164184259|NCT01280682|593042196|FG001|Overall Study|Lost to Follow-up|6|||
164184260|NCT01280682|593042195|FG000|Overall Study|Withdrawal by Subject|0|||
164184261|NCT01280682|593042196|FG001|Overall Study|Withdrawal by Subject|7|||
164184262|NCT00431067|593042199|FG000|Overall Study|Other Adverse Event|9|||
164184263|NCT00431067|593042199|FG000|Overall Study|Progressive disease|30|||
164184264|NCT00431067|593042199|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
164184265|NCT03913104|593042211|FG000|Overall Study|Lost to Follow-up|20|||
164184266|NCT03913104|593042211|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
164184267|NCT03913104|593042211|FG000|Overall Study|Withdrawal by Subject|2|||
164184268|NCT01119846|593042212|FG000|Overall Study|Adverse Event|1|||
164184269|NCT01119846|593042213|FG001|Overall Study|Adverse Event|0|||
164184270|NCT01119846|593042214|FG002|Overall Study|Adverse Event|6|||
164184271|NCT01119846|593042212|FG000|Overall Study|Physician Decision|1|||
164184272|NCT01119846|593042213|FG001|Overall Study|Physician Decision|0|||
164184273|NCT01119846|593042214|FG002|Overall Study|Physician Decision|0|||
164184274|NCT01119846|593042212|FG000|Overall Study|Protocol Violation|0|||
164184275|NCT01119846|593042213|FG001|Overall Study|Protocol Violation|0|||
164184276|NCT01119846|593042214|FG002|Overall Study|Protocol Violation|1|||
164184277|NCT01119846|593042212|FG000|Overall Study|Withdrawal by Subject|0|||
164184278|NCT01119846|593042213|FG001|Overall Study|Withdrawal by Subject|0|||
164184279|NCT01119846|593042214|FG002|Overall Study|Withdrawal by Subject|4|||
164184280|NCT01404949|593042215|FG000|Overall Study|Not Treated|1|||
164184281|NCT02007278|593042216|FG000|Overall Study|Failure to comply with an eligibility|0|||
164184282|NCT02007278|593042217|FG001|Overall Study|Failure to comply with an eligibility|1|||
164184283|NCT02007278|593042216|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
164184284|NCT02007278|593042217|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
164184285|NCT02007278|593042216|FG000|Overall Study|Incorrect medication administration|1|||
164184286|NCT02007278|593042217|FG001|Overall Study|Incorrect medication administration|0|||
164184287|NCT02007278|593042216|FG000|Overall Study|Mis-randomization|1|||
164184288|NCT02007278|593042217|FG001|Overall Study|Mis-randomization|1|||
164184289|NCT01429441|593042218|FG000|Overall Study|Adverse Event|5|||
164184290|NCT01429441|593042219|FG001|Overall Study|Adverse Event|1|||
164184291|NCT01429441|593042218|FG000|Overall Study|Death|0|||
164184292|NCT01429441|593042219|FG001|Overall Study|Death|2|||
164184293|NCT01429441|593042218|FG000|Overall Study|Lost to Follow-up|5|||
164184294|NCT01429441|593042219|FG001|Overall Study|Lost to Follow-up|2|||
164184295|NCT01429441|593042218|FG000|Overall Study|Physician Decision|1|||
164184296|NCT01429441|593042219|FG001|Overall Study|Physician Decision|0|||
164184297|NCT01429441|593042218|FG000|Overall Study|Withdrawal by Subject|27|||
164184298|NCT01429441|593042219|FG001|Overall Study|Withdrawal by Subject|18|||
164184299|NCT02279745|593042220|FG000|Overall Study|Adverse Event|7|||
164184300|NCT02279745|593042220|FG000|Overall Study|Death|6|||
164184301|NCT02279745|593042220|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
164184302|NCT02279745|593042220|FG000|Overall Study|Withdrawal by Subject|2|||
164184303|NCT02279745|593042220|FG000|Overall Study|Pregnancy|1|||
164184304|NCT02279745|593042220|FG000|Overall Study|Study Non-compliance|1|||
164184305|NCT02279745|593042220|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
164184306|NCT01606748|593042222|FG000|Overall Study|Adverse Event|1|||
164184307|NCT01606748|593042223|FG001|Overall Study|Adverse Event|0|||
164184308|NCT01606748|593042222|FG000|Overall Study|Progressive Disease|1|||
164184309|NCT01606748|593042223|FG001|Overall Study|Progressive Disease|0|||
164184310|NCT01606748|593042222|FG000|Overall Study|Withdrawal by Subject|1|||
164184311|NCT01606748|593042223|FG001|Overall Study|Withdrawal by Subject|0|||
164184312|NCT01706575|593042225|FG000|Overall Study|Participant Withdrew Consent|4|||
164184313|NCT01706575|593042225|FG000|Overall Study|Lost to Follow-up|2|||
164184314|NCT01706575|593042225|FG000|Overall Study|Started but not Treated|6|||
164184315|NCT03469999|593042228|FG000|Overall Study|Lost to Follow-up|2|||
164184316|NCT03084315|593042229|FG000|Overall Study|Lost to Follow-up|8|||
164184317|NCT03084315|593042230|FG001|Overall Study|Lost to Follow-up|7|||
164184318|NCT03084315|593042229|FG000|Overall Study|Withdrawal by Subject|2|||
164184319|NCT03084315|593042230|FG001|Overall Study|Withdrawal by Subject|2|||
164184320|NCT02155322|593042234|FG000|Overall Study|Adverse Event|1|||
164184321|NCT02155322|593042234|FG000|Overall Study|Physician Decision|1|||
164184322|NCT02155322|593042234|FG000|Overall Study|Relapse/Recurrence|8|||
164184323|NCT02155322|593042234|FG000|Overall Study|Withdrawal by Subject|4|||
164184324|NCT04424914|593042235|FG000|Overall Study|Other|0|||
164184325|NCT04424914|593042236|FG001|Overall Study|Other|0|||
164184326|NCT04424914|593042237|FG002|Overall Study|Other|28|||
164184327|NCT04424914|593042235|FG000|Overall Study|Withdrawal by Subject|3|||
164184328|NCT04424914|593042236|FG001|Overall Study|Withdrawal by Subject|0|||
164184329|NCT04424914|593042237|FG002|Overall Study|Withdrawal by Subject|0|||
164184330|NCT04424914|593042235|FG000|Overall Study|Study terminated by sponsor|23|||
164184331|NCT04424914|593042236|FG001|Overall Study|Study terminated by sponsor|7|||
164184332|NCT04424914|593042237|FG002|Overall Study|Study terminated by sponsor|0|||
164184333|NCT04424914|593042235|FG000|Overall Study|Lost to Follow-up|0|||
164184334|NCT04424914|593042236|FG001|Overall Study|Lost to Follow-up|0|||
164184335|NCT04424914|593042237|FG002|Overall Study|Lost to Follow-up|1|||
164184336|NCT04424914|593042235|FG000|Overall Study|Death|3|||
164184337|NCT04424914|593042236|FG001|Overall Study|Death|1|||
164184338|NCT04424914|593042237|FG002|Overall Study|Death|0|||
164184339|NCT01215435|593042243|FG000|Overall Study|Adverse Event|1|||
164184340|NCT01215435|593042244|FG001|Overall Study|Adverse Event|0|||
164184341|NCT01215435|593042243|FG000|Overall Study|Protocol Violation|2|||
164184342|NCT01215435|593042244|FG001|Overall Study|Protocol Violation|0|||
164184343|NCT01215435|593042243|FG000|Overall Study|Withdrawal Criteria|8|||
164184344|NCT01215435|593042244|FG001|Overall Study|Withdrawal Criteria|11|||
164184345|NCT01215435|593042243|FG000|Overall Study|Lost to Follow-up|3|||
164184346|NCT01215435|593042244|FG001|Overall Study|Lost to Follow-up|0|||
164184347|NCT01215435|593042243|FG000|Overall Study|Unclassified|5|||
164184348|NCT01215435|593042244|FG001|Overall Study|Unclassified|5|||
164184349|NCT00394771|593042245|FG000|Overall Study|Did not meet protocol requirements|1|||
164184350|NCT00394771|593042246|FG001|Overall Study|Did not meet protocol requirements|0|||
164184351|NCT00394771|593042247|FG002|Overall Study|Did not meet protocol requirements|2|||
164184352|NCT00394771|593042248|FG003|Overall Study|Did not meet protocol requirements|0|||
164184353|NCT00394771|593042245|FG000|Overall Study|Protocol Violation|2|||
164184354|NCT00394771|593042246|FG001|Overall Study|Protocol Violation|4|||
164184355|NCT00394771|593042247|FG002|Overall Study|Protocol Violation|9|||
164184356|NCT00394771|593042248|FG003|Overall Study|Protocol Violation|7|||
164184357|NCT00394771|593042245|FG000|Overall Study|Withdrawal by Subject|10|||
164184358|NCT00394771|593042246|FG001|Overall Study|Withdrawal by Subject|6|||
164184359|NCT00394771|593042247|FG002|Overall Study|Withdrawal by Subject|8|||
164184360|NCT00394771|593042248|FG003|Overall Study|Withdrawal by Subject|12|||
164184361|NCT00394771|593042245|FG000|Overall Study|Adverse Event|10|||
164184362|NCT00394771|593042246|FG001|Overall Study|Adverse Event|5|||
164184363|NCT00394771|593042247|FG002|Overall Study|Adverse Event|12|||
164184364|NCT00394771|593042248|FG003|Overall Study|Adverse Event|8|||
164184365|NCT00394771|593042245|FG000|Overall Study|Participant pregnant|0|||
164184366|NCT00394771|593042246|FG001|Overall Study|Participant pregnant|1|||
164184367|NCT00394771|593042247|FG002|Overall Study|Participant pregnant|2|||
164184368|NCT00394771|593042248|FG003|Overall Study|Participant pregnant|2|||
164184369|NCT00394771|593042245|FG000|Overall Study|Lost to Follow-up|15|||
164184370|NCT00394771|593042246|FG001|Overall Study|Lost to Follow-up|15|||
164184371|NCT00394771|593042247|FG002|Overall Study|Lost to Follow-up|13|||
164184372|NCT00394771|593042248|FG003|Overall Study|Lost to Follow-up|10|||
164184373|NCT00394771|593042245|FG000|Overall Study|Other|3|||
164184374|NCT00394771|593042246|FG001|Overall Study|Other|3|||
164184375|NCT00394771|593042247|FG002|Overall Study|Other|1|||
164184376|NCT00394771|593042248|FG003|Overall Study|Other|0|||
164184377|NCT03383692|593042249|FG000|Overall Study|Progressive disease as per RECIST|3|||
164184378|NCT03383692|593042250|FG001|Overall Study|Progressive disease as per RECIST|3|||
164184379|NCT03383692|593042249|FG000|Overall Study|Clinical progression|0|||
164184380|NCT03383692|593042250|FG001|Overall Study|Clinical progression|1|||
164184381|NCT03383692|593042249|FG000|Overall Study|Adverse Event|3|||
164184382|NCT03383692|593042250|FG001|Overall Study|Adverse Event|0|||
164184383|NCT02906033|593042254|FG000|Baseline|Protocol Violation|37|||
164184384|NCT02906033|593042255|FG001|Baseline|Protocol Violation|33|||
164184385|NCT02906033|593042254|FG000|Follow-up|Lost to Follow-up|46|||
164184386|NCT02906033|593042255|FG001|Follow-up|Lost to Follow-up|62|||
164184387|NCT00358956|593042256|FG000|Overall Study|Adverse Event|3|||
164184388|NCT00358956|593042256|FG000|Overall Study|condition under investigation worsened|4|||
164184389|NCT00358956|593042256|FG000|Overall Study|Withdrawal by Subject|1|||
164184390|NCT03417024|593042259|FG000|Overall Study|Study Termination prior to follow-up|11|||
164184391|NCT03417024|593042259|FG000|Overall Study|Physician Decision|2|||
164184392|NCT02195427|593042260|FG000|Overall Study|Did not consent to study extension|13|||
164184393|NCT02195427|593042261|FG001|Overall Study|Did not consent to study extension|9|||
164184394|NCT02195427|593042260|FG000|Overall Study|Withdrawal by Subject|4|||
164184395|NCT02195427|593042261|FG001|Overall Study|Withdrawal by Subject|2|||
164184396|NCT02195427|593042260|FG000|Overall Study|Lost to Follow-up|0|||
164184397|NCT02195427|593042261|FG001|Overall Study|Lost to Follow-up|1|||
164184398|NCT02195427|593042260|FG000|Overall Study|Protocol Violation|7|||
164184399|NCT02195427|593042261|FG001|Overall Study|Protocol Violation|14|||
164184400|NCT02195427|593042260|FG000|Overall Study|Conditional re-treatment at W52|2|||
164184401|NCT02195427|593042261|FG001|Overall Study|Conditional re-treatment at W52|1|||
164184402|NCT00386425|593042262|FG000|Overall Study|Physician Decision|3|||
164184403|NCT00386425|593042263|FG001|Overall Study|Physician Decision|0|||
164184404|NCT00386425|593042264|FG002|Overall Study|Physician Decision|0|||
164184405|NCT00386425|593042262|FG000|Overall Study|Withdrawal by Subject|0|||
164184406|NCT00386425|593042263|FG001|Overall Study|Withdrawal by Subject|1|||
164184407|NCT00386425|593042264|FG002|Overall Study|Withdrawal by Subject|0|||
164184408|NCT03782974|593042267|FG000|Overall Study|Withdrawal by Subject|7|||
164184409|NCT03782974|593042268|FG001|Overall Study|Withdrawal by Subject|7|||
164184410|NCT03782974|593042267|FG000|Overall Study|Pregnancy|1|||
164184411|NCT03782974|593042268|FG001|Overall Study|Pregnancy|0|||
164184412|NCT04607980|593042274|FG000|Overall Study|Adverse Event|3|||
164184413|NCT04607980|593042275|FG001|Overall Study|Adverse Event|4|||
164184414|NCT04607980|593042274|FG000|Overall Study|Death|0|||
164184415|NCT04607980|593042275|FG001|Overall Study|Death|1|||
164184416|NCT04607980|593042274|FG000|Overall Study|Withdrawal by Subject|2|||
164184417|NCT04607980|593042275|FG001|Overall Study|Withdrawal by Subject|5|||
164184418|NCT04607980|593042274|FG000|Overall Study|Lost to Follow-up|4|||
164184419|NCT04607980|593042275|FG001|Overall Study|Lost to Follow-up|8|||
164184420|NCT04607980|593042274|FG000|Overall Study|Protocol Violation|0|||
164184421|NCT04607980|593042275|FG001|Overall Study|Protocol Violation|3|||
164184422|NCT04607980|593042274|FG000|Overall Study|Other|3|||
164184423|NCT04607980|593042275|FG001|Overall Study|Other|0|||
164184424|NCT00448812|593042276|FG000|Year 2|Missed visit but remained in study|4|||
164184425|NCT00448812|593042277|FG001|Year 2|Missed visit but remained in study|1|||
164184426|NCT00448812|593042276|FG000|Year 3|Withdrawal by Subject|1|||
164184427|NCT00448812|593042277|FG001|Year 3|Withdrawal by Subject|3|||
164184428|NCT00448812|593042276|FG000|Year 3|Lost to Follow-up|1|||
164184429|NCT00448812|593042277|FG001|Year 3|Lost to Follow-up|0|||
164184430|NCT00448812|593042276|FG000|Year 3|Missed visit but remained in study|2|||
164184431|NCT00448812|593042277|FG001|Year 3|Missed visit but remained in study|0|||
164184432|NCT00448812|593042276|FG000|Year 5|Missed visit but remained in study|1|||
164184433|NCT00448812|593042277|FG001|Year 5|Missed visit but remained in study|0|||
164184434|NCT02012959|593042278|FG000|Treatment Phase A|Adverse Event|2|||
164184435|NCT02012959|593042279|FG001|Treatment Phase A|Adverse Event|0|||
164184436|NCT02012959|593042280|FG002|Treatment Phase A|Adverse Event|0|||
164184437|NCT02012959|593042281|FG003|Treatment Phase A|Adverse Event|0|||
164184438|NCT02012959|593042282|FG004|Treatment Phase A|Adverse Event|0|||
164184439|NCT01128400|593043756|FG000|Overall Study|Lost to Follow-up|1|||
164184440|NCT01128400|593043757|FG001|Overall Study|Lost to Follow-up|0|||
164184441|NCT01128400|593043758|FG002|Overall Study|Lost to Follow-up|1|||
164184442|NCT01128400|593043756|FG000|Overall Study|Screening failure|1|||
164184443|NCT01128400|593043757|FG001|Overall Study|Screening failure|0|||
164184444|NCT01128400|593043758|FG002|Overall Study|Screening failure|0|||
164184445|NCT01128400|593043756|FG000|Overall Study|were not invited to participate on taste|0|||
164184446|NCT01128400|593043757|FG001|Overall Study|were not invited to participate on taste|0|||
164184447|NCT01128400|593043758|FG002|Overall Study|were not invited to participate on taste|15|||
164184448|NCT01128400|593043756|FG000|Overall Study|Excluded due to sinus problems|0|||
164184449|NCT01128400|593043757|FG001|Overall Study|Excluded due to sinus problems|1|||
164184450|NCT01128400|593043758|FG002|Overall Study|Excluded due to sinus problems|0|||
164184451|NCT03782571|593043764|FG000|Period 1|Withdrawal by Subject|1|||
164184452|NCT03782571|593043765|FG001|Period 1|Withdrawal by Subject|0|||
164184453|NCT03782571|593043766|FG002|Period 1|Withdrawal by Subject|0|||
164184454|NCT03782571|593043767|FG003|Period 1|Withdrawal by Subject|0|||
164184455|NCT03782571|593043764|FG000|Period 3|Subject Unable to Attend V5|1|||
164184456|NCT03782571|593043765|FG001|Period 3|Subject Unable to Attend V5|0|||
164184457|NCT03782571|593043766|FG002|Period 3|Subject Unable to Attend V5|0|||
164184458|NCT03782571|593043767|FG003|Period 3|Subject Unable to Attend V5|0|||
164184459|NCT03782571|593043764|FG000|Period 3|Adverse Event|1|||
164184460|NCT03782571|593043765|FG001|Period 3|Adverse Event|0|||
164184461|NCT03782571|593043766|FG002|Period 3|Adverse Event|0|||
164184462|NCT03782571|593043767|FG003|Period 3|Adverse Event|0|||
164184463|NCT03504189|593043768|FG000|Overall Study|Withdrawal by Subject|1|||
164184464|NCT03504189|593043768|FG000|Overall Study|Screening Failure|1|||
164184465|NCT03504189|593043768|FG000|Overall Study|Device Failure|2|||
164184466|NCT02626000|593043785|FG000|Overall Study|Decision by Sponsor|1|||
164184467|NCT02626000|593043785|FG000|Overall Study|Death|29|||
164184468|NCT01796301|593043786|FG000|Overall Study|Withdrawal by Subject|15|||
164184469|NCT01796301|593043787|FG001|Overall Study|Withdrawal by Subject|15|||
164184470|NCT01796301|593043786|FG000|Overall Study|Lost to Follow-up|3|||
164184471|NCT01796301|593043787|FG001|Overall Study|Lost to Follow-up|3|||
164184472|NCT01796301|593043786|FG000|Overall Study|Death|0|||
164184473|NCT01796301|593043787|FG001|Overall Study|Death|1|||
164184474|NCT01796301|593043786|FG000|Overall Study|Decision by Sponsor|0|||
164184475|NCT01796301|593043787|FG001|Overall Study|Decision by Sponsor|1|||
164184476|NCT02570750|593043796|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
164184477|NCT02570750|593043797|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
164184478|NCT02570750|593043796|FG000|Overall Study|Protocol deviation|4|||
164184479|NCT02570750|593043797|FG001|Overall Study|Protocol deviation|2|||
164184480|NCT02570750|593043796|FG000|Overall Study|Withdrawal by Subject|5|||
164184481|NCT02570750|593043797|FG001|Overall Study|Withdrawal by Subject|0|||
164184482|NCT02570750|593043796|FG000|Overall Study|Lost to Follow-up|2|||
164184483|NCT02570750|593043797|FG001|Overall Study|Lost to Follow-up|2|||
164184484|NCT02570750|593043796|FG000|Overall Study|Adverse Event|2|||
164184485|NCT02570750|593043797|FG001|Overall Study|Adverse Event|1|||
164184486|NCT01884545|593043798|FG000|Overall Study|Lost to Follow-up|6|||
164184487|NCT01884545|593043799|FG001|Overall Study|Lost to Follow-up|4|||
164184488|NCT01884545|593043800|FG002|Overall Study|Lost to Follow-up|9|||
164184489|NCT01884545|593043801|FG003|Overall Study|Lost to Follow-up|4|||
164184490|NCT01884545|593043798|FG000|Overall Study|Patient withdrawn|7|||
164184491|NCT01884545|593043799|FG001|Overall Study|Patient withdrawn|12|||
164184492|NCT01884545|593043800|FG002|Overall Study|Patient withdrawn|5|||
164184493|NCT01884545|593043801|FG003|Overall Study|Patient withdrawn|5|||
164184494|NCT01884545|593043798|FG000|Overall Study|Non-adherence|0|||
164184495|NCT01884545|593043799|FG001|Overall Study|Non-adherence|2|||
164184496|NCT01884545|593043800|FG002|Overall Study|Non-adherence|0|||
164184497|NCT01884545|593043801|FG003|Overall Study|Non-adherence|0|||
164184498|NCT01410240|593043802|FG000|Overall Study|Physician Decision|0|||
164184499|NCT01410240|593043803|FG001|Overall Study|Physician Decision|0|||
164184500|NCT01410240|593043804|FG002|Overall Study|Physician Decision|1|||
164184501|NCT01410240|593043802|FG000|Overall Study|Missed week 6 assessments|1|||
164184502|NCT01410240|593043803|FG001|Overall Study|Missed week 6 assessments|1|||
164184503|NCT01410240|593043804|FG002|Overall Study|Missed week 6 assessments|1|||
164184504|NCT00496587|593043805|FG000|Overall Study|Adverse Event|2|||
164184505|NCT00496587|593043805|FG000|Overall Study|Progressive Disease|24|||
164184506|NCT00496587|593043805|FG000|Overall Study|Withdrawal by Subject|2|||
164184507|NCT00496587|593043805|FG000|Overall Study|Death|1|||
164184508|NCT00496587|593043805|FG000|Overall Study|Complications unrelated|2|||
164184509|NCT00592592|593043810|FG000|Overall Study|Patient found ineligible upon chart review|1|||
164184510|NCT01134263|593043811|FG000|Overall Study|Serious adverse event|2|||
164184511|NCT01134263|593043812|FG001|Overall Study|Serious adverse event|1|||
164184512|NCT01134263|593043813|FG002|Overall Study|Serious adverse event|1|||
164184513|NCT01134263|593043814|FG003|Overall Study|Serious adverse event|1|||
164184514|NCT01134263|593043815|FG004|Overall Study|Serious adverse event|1|||
164184515|NCT01134263|593043811|FG000|Overall Study|Other adverse event|1|||
164184516|NCT01134263|593043812|FG001|Overall Study|Other adverse event|2|||
164184517|NCT01134263|593043813|FG002|Overall Study|Other adverse event|5|||
164184518|NCT01134263|593043814|FG003|Overall Study|Other adverse event|3|||
164184519|NCT01134263|593043815|FG004|Overall Study|Other adverse event|0|||
164184520|NCT01134263|593043811|FG000|Overall Study|Protocol Violation|8|||
164184521|NCT01134263|593043812|FG001|Overall Study|Protocol Violation|7|||
164184522|NCT01134263|593043813|FG002|Overall Study|Protocol Violation|2|||
164184523|NCT01134263|593043814|FG003|Overall Study|Protocol Violation|4|||
164184524|NCT01134263|593043815|FG004|Overall Study|Protocol Violation|2|||
164184525|NCT01134263|593043811|FG000|Overall Study|Lost to Follow-up|4|||
164184526|NCT01134263|593043812|FG001|Overall Study|Lost to Follow-up|3|||
164184527|NCT01134263|593043813|FG002|Overall Study|Lost to Follow-up|5|||
164184528|NCT01134263|593043814|FG003|Overall Study|Lost to Follow-up|3|||
164184529|NCT01134263|593043815|FG004|Overall Study|Lost to Follow-up|1|||
164184530|NCT01134263|593043811|FG000|Overall Study|Withdrawal by Subject|8|||
164184531|NCT01134263|593043812|FG001|Overall Study|Withdrawal by Subject|6|||
164184532|NCT01134263|593043813|FG002|Overall Study|Withdrawal by Subject|16|||
164184533|NCT01134263|593043814|FG003|Overall Study|Withdrawal by Subject|7|||
164184534|NCT01134263|593043815|FG004|Overall Study|Withdrawal by Subject|5|||
164184535|NCT01134263|593043811|FG000|Overall Study|Enrolled, but not treated|1|||
164184536|NCT01134263|593043812|FG001|Overall Study|Enrolled, but not treated|1|||
164184537|NCT01134263|593043813|FG002|Overall Study|Enrolled, but not treated|0|||
164184538|NCT01134263|593043814|FG003|Overall Study|Enrolled, but not treated|1|||
164184539|NCT01134263|593043815|FG004|Overall Study|Enrolled, but not treated|0|||
164184540|NCT01557517|593043816|FG000|Overall Study|Death|1|||
164184541|NCT01557517|593043817|FG001|Overall Study|Death|0|||
164184542|NCT01557517|593043816|FG000|Overall Study|Refused further treatment|0|||
164184543|NCT01557517|593043817|FG001|Overall Study|Refused further treatment|2|||
164184544|NCT01557517|593043816|FG000|Overall Study|Adverse Event|0|||
164184545|NCT01557517|593043817|FG001|Overall Study|Adverse Event|2|||
164184546|NCT01557517|593043816|FG000|Overall Study|Pt declined before treatment started|1|||
164184547|NCT01557517|593043817|FG001|Overall Study|Pt declined before treatment started|0|||
164184548|NCT00162097|593043818|FG000|Overall Study|Participant no longer met study criteria|0|||
164184549|NCT00162097|593043819|FG001|Overall Study|Participant no longer met study criteria|0|||
164184550|NCT00162097|593043820|FG002|Overall Study|Participant no longer met study criteria|0|||
164184551|NCT00162097|593043821|FG003|Overall Study|Participant no longer met study criteria|1|||
164184552|NCT01204918|593043822|FG000|Overall Study|Withdrawal by Subject|4|||
164184553|NCT01204918|593043823|FG001|Overall Study|Withdrawal by Subject|10|||
164184554|NCT01204918|593043824|FG002|Overall Study|Withdrawal by Subject|5|||
164184555|NCT00770913|593043825|FG000|Overall Study|Adverse Event|1|||
164184556|NCT00770913|593043826|FG001|Overall Study|Adverse Event|3|||
164184557|NCT00770913|593043827|FG002|Overall Study|Adverse Event|6|||
164184558|NCT00770913|593043825|FG000|Overall Study|Refusal to continue participation|6|||
164184559|NCT00770913|593043826|FG001|Overall Study|Refusal to continue participation|4|||
164184560|NCT00770913|593043827|FG002|Overall Study|Refusal to continue participation|5|||
164184561|NCT00770913|593043825|FG000|Overall Study|Physician Decision|0|||
164184562|NCT00770913|593043826|FG001|Overall Study|Physician Decision|1|||
164184563|NCT00770913|593043827|FG002|Overall Study|Physician Decision|1|||
164184564|NCT00770913|593043825|FG000|Overall Study|Protocol Violation|3|||
164184565|NCT00770913|593043826|FG001|Overall Study|Protocol Violation|0|||
164184566|NCT00770913|593043827|FG002|Overall Study|Protocol Violation|1|||
164184567|NCT00770913|593043825|FG000|Overall Study|Incorrect drug was allocated|1|||
164184568|NCT00770913|593043826|FG001|Overall Study|Incorrect drug was allocated|0|||
164184569|NCT00770913|593043827|FG002|Overall Study|Incorrect drug was allocated|0|||
164184570|NCT00269477|593043831|FG000|Overall Study|Protocol Violation|5|||
164184571|NCT00269477|593043832|FG001|Overall Study|Protocol Violation|5|||
164184572|NCT00269477|593043833|FG002|Overall Study|Protocol Violation|1|||
164184573|NCT00269477|593043834|FG003|Overall Study|Protocol Violation|0|||
164184574|NCT00269477|593043831|FG000|Overall Study|Missed post-vaccination blood draw|0|||
164184575|NCT00269477|593043832|FG001|Overall Study|Missed post-vaccination blood draw|1|||
164184576|NCT00269477|593043833|FG002|Overall Study|Missed post-vaccination blood draw|0|||
164184577|NCT00269477|593043834|FG003|Overall Study|Missed post-vaccination blood draw|0|||
164184578|NCT00548249|593043835|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
164184579|NCT00548249|593043836|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
164184580|NCT00548249|593043837|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
164184581|NCT00548249|593043838|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
164184582|NCT00548249|593043839|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
164184583|NCT00548249|593043835|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
164184584|NCT00548249|593043836|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
164184585|NCT00548249|593043837|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
164184586|NCT00548249|593043838|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
164184587|NCT00548249|593043839|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
164184588|NCT00548249|593043835|FG000|Overall Study|Protocol Violation|1|||
164184589|NCT00548249|593043836|FG001|Overall Study|Protocol Violation|1|||
164184590|NCT00548249|593043837|FG002|Overall Study|Protocol Violation|4|||
164184591|NCT00548249|593043838|FG003|Overall Study|Protocol Violation|0|||
164184592|NCT00548249|593043839|FG004|Overall Study|Protocol Violation|3|||
164184593|NCT00548249|593043835|FG000|Overall Study|Miscellaneous|2|||
164184594|NCT00548249|593043836|FG001|Overall Study|Miscellaneous|3|||
164184595|NCT00548249|593043837|FG002|Overall Study|Miscellaneous|2|||
164184596|NCT00548249|593043838|FG003|Overall Study|Miscellaneous|0|||
164184597|NCT00548249|593043839|FG004|Overall Study|Miscellaneous|2|||
164184598|NCT00548249|593043835|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
164184599|NCT00548249|593043836|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
164184600|NCT00548249|593043837|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
164184601|NCT00548249|593043838|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
164184602|NCT00548249|593043839|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
164184603|NCT00548249|593043835|FG000|Overall Study|Adverse Event|2|||
164184604|NCT00548249|593043836|FG001|Overall Study|Adverse Event|2|||
164184605|NCT00548249|593043837|FG002|Overall Study|Adverse Event|0|||
164184606|NCT00548249|593043838|FG003|Overall Study|Adverse Event|1|||
164184607|NCT00548249|593043839|FG004|Overall Study|Adverse Event|1|||
164184608|NCT00548249|593043835|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
164184609|NCT00548249|593043836|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
164184610|NCT00548249|593043837|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
164184611|NCT00548249|593043838|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
164184612|NCT00548249|593043839|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
164184613|NCT00548249|593043835|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
164184614|NCT00548249|593043836|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
164184615|NCT00548249|593043837|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
164184616|NCT00548249|593043838|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
164184617|NCT00548249|593043839|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
164184618|NCT00548249|593043835|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184619|NCT00548249|593043836|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184620|NCT00548249|593043837|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184621|NCT00548249|593043838|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
164184622|NCT00548249|593043839|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
164184623|NCT00548249|593043835|FG000|Overall Study|Prolonged hospitalization|0|||
164184624|NCT00548249|593043836|FG001|Overall Study|Prolonged hospitalization|0|||
164184625|NCT00548249|593043837|FG002|Overall Study|Prolonged hospitalization|2|||
164184626|NCT00548249|593043838|FG003|Overall Study|Prolonged hospitalization|1|||
164184627|NCT00548249|593043839|FG004|Overall Study|Prolonged hospitalization|0|||
164184628|NCT00548249|593043835|FG000|Overall Study|Withdrawal by Subject|2|||
164184629|NCT00548249|593043836|FG001|Overall Study|Withdrawal by Subject|0|||
164184630|NCT00548249|593043837|FG002|Overall Study|Withdrawal by Subject|0|||
164184631|NCT00548249|593043838|FG003|Overall Study|Withdrawal by Subject|0|||
164184632|NCT00548249|593043839|FG004|Overall Study|Withdrawal by Subject|0|||
164184633|NCT00548249|593043835|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
164184634|NCT00548249|593043836|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
164184635|NCT00548249|593043837|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
164184636|NCT00548249|593043838|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
164184637|NCT00548249|593043839|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
164184638|NCT00548249|593043835|FG000|Overall Study|Sponsor's request|0|||
164184639|NCT00548249|593043836|FG001|Overall Study|Sponsor's request|0|||
164184640|NCT00548249|593043837|FG002|Overall Study|Sponsor's request|0|||
164184641|NCT00548249|593043838|FG003|Overall Study|Sponsor's request|1|||
164184642|NCT00548249|593043839|FG004|Overall Study|Sponsor's request|0|||
164184643|NCT02347072|593043840|FG000|Overall Study|Adverse Event|2|||
164184644|NCT02347072|593043840|FG000|Overall Study|Withdrawal by Subject|6|||
164184645|NCT02347072|593043840|FG000|Overall Study|Physician Decision|1|||
164184646|NCT02347072|593043840|FG000|Overall Study|Lost to Follow-up|2|||
164184647|NCT02347072|593043840|FG000|Overall Study|Protocol Violation|1|||
164184648|NCT02347072|593043840|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
164184649|NCT01134393|593043843|FG000|Overall Study|Adverse Event|18|||
164184650|NCT01134393|593043843|FG000|Overall Study|Lack of Efficacy|2|||
164184651|NCT01134393|593043843|FG000|Overall Study|Protocol Violation|12|||
164184652|NCT01134393|593043843|FG000|Overall Study|Lost to Follow-up|3|||
164184653|NCT01134393|593043843|FG000|Overall Study|Withdrawal by Subject|11|||
164184654|NCT01134393|593043843|FG000|Overall Study|Other|6|||
164184655|NCT00080483|593043844|FG000|Overall Study|Lost to Follow-up|1|||
164184656|NCT00080483|593043845|FG001|Overall Study|Lost to Follow-up|1|||
164184657|NCT00080483|593043844|FG000|Overall Study|Physician Decision|1|||
164184658|NCT00080483|593043845|FG001|Overall Study|Physician Decision|1|||
164184659|NCT02886884|593043851|FG000|Follow-up|Withdrawal by Subject|0|||
164184660|NCT02886884|593043852|FG001|Follow-up|Withdrawal by Subject|0|||
164184661|NCT02886884|593043853|FG002|Follow-up|Withdrawal by Subject|0|||
164184662|NCT02886884|593043854|FG003|Follow-up|Withdrawal by Subject|1|||
164184663|NCT00625183|593043855|FG000|Overall Study|Disease Progression|1|||
164184664|NCT02670382|593043856|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
164184665|NCT02670382|593043857|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
164184666|NCT03244618|593043858|FG000|Overall Study|Lost to Follow-up|3|||
164184667|NCT03244618|593043859|FG001|Overall Study|Lost to Follow-up|4|||
164184668|NCT03244618|593043858|FG000|Overall Study|Protocol Violation|4|||
164184669|NCT03244618|593043859|FG001|Overall Study|Protocol Violation|3|||
164184670|NCT03244618|593043858|FG000|Overall Study|Withdrawal by Subject|0|||
164184671|NCT03244618|593043859|FG001|Overall Study|Withdrawal by Subject|2|||
164184672|NCT01810783|593043861|FG000|Overall Study|Adverse Event|32|||
164184673|NCT01810783|593043861|FG000|Overall Study|Withdrawal by Subject|22|||
164184674|NCT01810783|593043861|FG000|Overall Study|Lack of Efficacy|12|||
164184675|NCT01810783|593043861|FG000|Overall Study|Lost to Follow-up|10|||
164184676|NCT01810783|593043861|FG000|Overall Study|Protocol Violation|5|||
164184677|NCT01810783|593043861|FG000|Overall Study|Non-compliance with IMP|4|||
164184678|NCT01810783|593043861|FG000|Overall Study|Adminstrative or other reason(s)|23|||
164184679|NCT01810783|593043861|FG000|Overall Study|Enrolled, not treated|1|||
164184680|NCT04776018|593043863|FG000|Overall Study|Death|0|||
164184681|NCT04776018|593043864|FG001|Overall Study|Death|1|||
164184682|NCT04776018|593043865|FG002|Overall Study|Death|4|||
164184683|NCT04776018|593043866|FG003|Overall Study|Death|1|||
164184684|NCT04776018|593043867|FG004|Overall Study|Death|4|||
164184685|NCT04776018|593043868|FG005|Overall Study|Death|0|||
164184686|NCT04776018|593043869|FG006|Overall Study|Death|0|||
164184687|NCT04776018|593043863|FG000|Overall Study|Study terminated by sponsor|2|||
164184688|NCT04776018|593043864|FG001|Overall Study|Study terminated by sponsor|1|||
164184689|NCT04776018|593043865|FG002|Overall Study|Study terminated by sponsor|4|||
164184690|NCT04776018|593043866|FG003|Overall Study|Study terminated by sponsor|0|||
164184691|NCT04776018|593043867|FG004|Overall Study|Study terminated by sponsor|3|||
164184692|NCT04776018|593043868|FG005|Overall Study|Study terminated by sponsor|0|||
164184693|NCT04776018|593043869|FG006|Overall Study|Study terminated by sponsor|0|||
164184694|NCT04776018|593043863|FG000|Overall Study|Withdrawal by Subject|1|||
164184695|NCT04776018|593043864|FG001|Overall Study|Withdrawal by Subject|0|||
164184696|NCT04776018|593043865|FG002|Overall Study|Withdrawal by Subject|0|||
164184697|NCT04776018|593043866|FG003|Overall Study|Withdrawal by Subject|2|||
164184698|NCT04776018|593043867|FG004|Overall Study|Withdrawal by Subject|1|||
164184699|NCT04776018|593043868|FG005|Overall Study|Withdrawal by Subject|0|||
164184700|NCT04776018|593043869|FG006|Overall Study|Withdrawal by Subject|0|||
164184701|NCT04776018|593043863|FG000|Overall Study|Other|0|||
164184702|NCT04776018|593043864|FG001|Overall Study|Other|1|||
164184703|NCT04776018|593043865|FG002|Overall Study|Other|1|||
164184704|NCT04776018|593043866|FG003|Overall Study|Other|0|||
164184705|NCT04776018|593043867|FG004|Overall Study|Other|0|||
164184706|NCT04776018|593043868|FG005|Overall Study|Other|0|||
164184707|NCT04776018|593043869|FG006|Overall Study|Other|0|||
164184708|NCT04776018|593043863|FG000|Overall Study|Lost to Follow-up|0|||
164184709|NCT04776018|593043864|FG001|Overall Study|Lost to Follow-up|0|||
164184710|NCT04776018|593043865|FG002|Overall Study|Lost to Follow-up|1|||
164184711|NCT04776018|593043866|FG003|Overall Study|Lost to Follow-up|0|||
164184712|NCT04776018|593043867|FG004|Overall Study|Lost to Follow-up|0|||
164184713|NCT04776018|593043868|FG005|Overall Study|Lost to Follow-up|0|||
164184714|NCT04776018|593043869|FG006|Overall Study|Lost to Follow-up|0|||
164184715|NCT00793546|593043870|FG000|Overall Study|Death|3|||
164184716|NCT00793546|593043871|FG001|Overall Study|Death|0|||
164184717|NCT00793546|593043870|FG000|Overall Study|Lost to Follow-up|1|||
164184718|NCT00793546|593043871|FG001|Overall Study|Lost to Follow-up|0|||
164184719|NCT00793546|593043870|FG000|Overall Study|Withdrawal by Subject|1|||
164184720|NCT00793546|593043871|FG001|Overall Study|Withdrawal by Subject|1|||
164184721|NCT00793546|593043870|FG000|Overall Study|Study Terminated by Sponsor|8|||
164184722|NCT00793546|593043871|FG001|Overall Study|Study Terminated by Sponsor|27|||
164184723|NCT00793546|593043870|FG000|Overall Study|Other|1|||
164184724|NCT00793546|593043871|FG001|Overall Study|Other|0|||
164184725|NCT00435019|593043873|FG000|Overall Study|Adverse Event|1|||
164184726|NCT00435019|593043874|FG001|Overall Study|Adverse Event|0|||
164184727|NCT00435019|593043873|FG000|Overall Study|Lack of Efficacy|1|||
164184728|NCT00435019|593043874|FG001|Overall Study|Lack of Efficacy|2|||
164184729|NCT00435019|593043873|FG000|Overall Study|Protocol Violation|3|||
164184730|NCT00435019|593043874|FG001|Overall Study|Protocol Violation|1|||
164184731|NCT00435019|593043873|FG000|Overall Study|Personal reasons for withdrawal|8|||
164184732|NCT00435019|593043874|FG001|Overall Study|Personal reasons for withdrawal|7|||
164184733|NCT04503668|593043875|FG000|Overall Study|Incomplete data|4|||
164184734|NCT04503668|593043876|FG001|Overall Study|Incomplete data|3|||
164184735|NCT04503668|593043875|FG000|Overall Study|Withdrawal by Subject|1|||
164184736|NCT04503668|593043876|FG001|Overall Study|Withdrawal by Subject|1|||
164184737|NCT04503668|593043875|FG000|Overall Study|Adverse Event|2|||
164184738|NCT04503668|593043876|FG001|Overall Study|Adverse Event|0|||
164184739|NCT02306694|593043877|FG000|Overall Study|Withdrawal by Subject|3|||
164184740|NCT02306694|593043877|FG000|Overall Study|Lost to Follow-up|1|||
164184741|NCT01907217|593043880|FG000|Overall Study|Withdrawal by Subject|0|||
164184742|NCT01907217|593043881|FG001|Overall Study|Withdrawal by Subject|2|||
164184743|NCT00742027|593043882|FG000|Overall Study|Disease Progression|76|||
164184744|NCT00742027|593043882|FG000|Overall Study|New Cancer Therapy|19|||
164184745|NCT00742027|593043882|FG000|Overall Study|Withdrawal by Subject|18|||
164184746|NCT00742027|593043882|FG000|Overall Study|Death|7|||
164184747|NCT00742027|593043882|FG000|Overall Study|Lost to Follow-up|4|||
164184748|NCT00742027|593043882|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
164184749|NCT00742027|593043882|FG000|Overall Study|Missing|2|||
164184750|NCT00742027|593043882|FG000|Overall Study|Administrative Problems|1|||
164184751|NCT01180049|593043883|FG000|Overall Study|Other|9|||
164184752|NCT01180049|593043884|FG001|Overall Study|Other|7|||
164184753|NCT01180049|593043883|FG000|Overall Study|Lost to Follow-up|8|||
164184754|NCT01180049|593043884|FG001|Overall Study|Lost to Follow-up|6|||
164184755|NCT01180049|593043883|FG000|Overall Study|Death|36|||
164184756|NCT01180049|593043884|FG001|Overall Study|Death|35|||
164184757|NCT01764659|593043885|FG000|Overall Study|Death|1|||
164184758|NCT01764659|593043885|FG000|Overall Study|Physician Decision|1|||
164184759|NCT01210352|593043886|FG000|Overall Study|Adverse Event|0|||
164184760|NCT01210352|593043887|FG001|Overall Study|Adverse Event|0|||
164184761|NCT01210352|593043888|FG002|Overall Study|Adverse Event|0|||
164184762|NCT01210352|593043889|FG003|Overall Study|Adverse Event|0|||
164184763|NCT01210352|593043890|FG004|Overall Study|Adverse Event|0|||
164184764|NCT01210352|593043891|FG005|Overall Study|Adverse Event|0|||
164184765|NCT01210352|593043892|FG006|Overall Study|Adverse Event|0|||
164184766|NCT01210352|593043893|FG007|Overall Study|Adverse Event|2|||
164184767|NCT01210352|593043894|FG008|Overall Study|Adverse Event|1|||
164184768|NCT01210352|593043886|FG000|Overall Study|Lack of Efficacy|0|||
164184769|NCT01210352|593043887|FG001|Overall Study|Lack of Efficacy|0|||
164184770|NCT01210352|593043888|FG002|Overall Study|Lack of Efficacy|0|||
164184771|NCT01210352|593043889|FG003|Overall Study|Lack of Efficacy|0|||
164184772|NCT01210352|593043890|FG004|Overall Study|Lack of Efficacy|0|||
164184773|NCT01210352|593043891|FG005|Overall Study|Lack of Efficacy|0|||
164184774|NCT01210352|593043892|FG006|Overall Study|Lack of Efficacy|1|||
164184775|NCT01210352|593043893|FG007|Overall Study|Lack of Efficacy|0|||
164184776|NCT01210352|593043894|FG008|Overall Study|Lack of Efficacy|0|||
164184777|NCT01210352|593043886|FG000|Overall Study|Physician Decision|0|||
164184778|NCT01210352|593043887|FG001|Overall Study|Physician Decision|0|||
164184779|NCT01210352|593043888|FG002|Overall Study|Physician Decision|0|||
164184780|NCT01210352|593043889|FG003|Overall Study|Physician Decision|0|||
164184781|NCT01210352|593043890|FG004|Overall Study|Physician Decision|0|||
164184782|NCT01210352|593043891|FG005|Overall Study|Physician Decision|0|||
164184783|NCT01210352|593043892|FG006|Overall Study|Physician Decision|0|||
164184784|NCT01210352|593043893|FG007|Overall Study|Physician Decision|1|||
164184785|NCT01210352|593043894|FG008|Overall Study|Physician Decision|2|||
164184786|NCT01210352|593043886|FG000|Overall Study|Withdrawal by Subject|0|||
164184787|NCT01210352|593043887|FG001|Overall Study|Withdrawal by Subject|0|||
164184788|NCT01210352|593043888|FG002|Overall Study|Withdrawal by Subject|1|||
164184789|NCT01210352|593043889|FG003|Overall Study|Withdrawal by Subject|0|||
164184790|NCT01210352|593043890|FG004|Overall Study|Withdrawal by Subject|0|||
164184791|NCT01210352|593043891|FG005|Overall Study|Withdrawal by Subject|0|||
164184792|NCT01210352|593043892|FG006|Overall Study|Withdrawal by Subject|1|||
164184793|NCT01210352|593043893|FG007|Overall Study|Withdrawal by Subject|0|||
164184794|NCT01210352|593043894|FG008|Overall Study|Withdrawal by Subject|1|||
164184795|NCT01210352|593043886|FG000|Overall Study|Patient Discharged Early|0|||
164184796|NCT01210352|593043887|FG001|Overall Study|Patient Discharged Early|0|||
164184797|NCT01210352|593043888|FG002|Overall Study|Patient Discharged Early|1|||
164184798|NCT01210352|593043889|FG003|Overall Study|Patient Discharged Early|0|||
164184799|NCT01210352|593043890|FG004|Overall Study|Patient Discharged Early|0|||
164184800|NCT01210352|593043891|FG005|Overall Study|Patient Discharged Early|0|||
164184801|NCT01210352|593043892|FG006|Overall Study|Patient Discharged Early|0|||
164184802|NCT01210352|593043893|FG007|Overall Study|Patient Discharged Early|0|||
164184803|NCT01210352|593043894|FG008|Overall Study|Patient Discharged Early|0|||
164184804|NCT03396822|593045386|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
164184805|NCT03396822|593045386|FG000|Overall Study|Physician Decision|1|||
164184806|NCT03630705|593045389|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
164184807|NCT03630705|593045390|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
164184808|NCT03630705|593045391|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
164184809|NCT03630705|593045392|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
164184810|NCT03630705|593045389|FG000|Overall Study|Lost to Follow-up|1|||
164184811|NCT03630705|593045390|FG001|Overall Study|Lost to Follow-up|2|||
164184812|NCT03630705|593045391|FG002|Overall Study|Lost to Follow-up|0|||
164184813|NCT03630705|593045392|FG003|Overall Study|Lost to Follow-up|0|||
164184814|NCT03488563|593045393|FG000|Overall Study|Lost to Follow-up|7|||
164184815|NCT03488563|593045394|FG001|Overall Study|Lost to Follow-up|6|||
164184816|NCT03488563|593045395|FG002|Overall Study|Lost to Follow-up|7|||
164184817|NCT03488563|593045393|FG000|Overall Study|Withdrawal by Subject|8|||
164184818|NCT03488563|593045394|FG001|Overall Study|Withdrawal by Subject|7|||
164184819|NCT03488563|593045395|FG002|Overall Study|Withdrawal by Subject|7|||
164184820|NCT03488563|593045393|FG000|Overall Study|Physician Decision|0|||
164184821|NCT03488563|593045394|FG001|Overall Study|Physician Decision|0|||
164184822|NCT03488563|593045395|FG002|Overall Study|Physician Decision|1|||
164184823|NCT03488563|593045393|FG000|Overall Study|Protocol Violation|3|||
164184824|NCT03488563|593045394|FG001|Overall Study|Protocol Violation|2|||
164184825|NCT03488563|593045395|FG002|Overall Study|Protocol Violation|6|||
164184826|NCT03488563|593045393|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
164184827|NCT03488563|593045394|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
164184828|NCT03488563|593045395|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
164184829|NCT03488563|593045393|FG000|Overall Study|Use of prohibited medication|2|||
164184830|NCT03488563|593045394|FG001|Overall Study|Use of prohibited medication|0|||
164184831|NCT03488563|593045395|FG002|Overall Study|Use of prohibited medication|0|||
164184832|NCT03488563|593045393|FG000|Overall Study|Adverse Event|1|||
164184833|NCT03488563|593045394|FG001|Overall Study|Adverse Event|0|||
164184834|NCT03488563|593045395|FG002|Overall Study|Adverse Event|1|||
164184835|NCT03488563|593045393|FG000|Overall Study|Subject returned for ET visit|0|||
164184836|NCT03488563|593045394|FG001|Overall Study|Subject returned for ET visit|1|||
164184837|NCT03488563|593045395|FG002|Overall Study|Subject returned for ET visit|0|||
164184838|NCT03488563|593045393|FG000|Overall Study|Sponsor's decision|0|||
164184839|NCT03488563|593045394|FG001|Overall Study|Sponsor's decision|0|||
164184840|NCT03488563|593045395|FG002|Overall Study|Sponsor's decision|1|||
164184841|NCT00339833|593045399|FG000|Overall Study|Withdrawal by Subject|1|||
164184842|NCT00339833|593045400|FG001|Overall Study|Withdrawal by Subject|2|||
164184843|NCT00339833|593045399|FG000|Overall Study|toothache|0|||
164184844|NCT00339833|593045400|FG001|Overall Study|toothache|1|||
164184845|NCT00339833|593045399|FG000|Overall Study|indigestion|0|||
164184846|NCT00339833|593045400|FG001|Overall Study|indigestion|1|||
164184847|NCT00339833|593045399|FG000|Overall Study|Chest pain|0|||
164184848|NCT00339833|593045400|FG001|Overall Study|Chest pain|1|||
164184849|NCT00339833|593045399|FG000|Overall Study|minor infection|0|||
164184850|NCT00339833|593045400|FG001|Overall Study|minor infection|1|||
164184851|NCT00339833|593045399|FG000|Overall Study|Poor venous access|2|||
164184852|NCT00339833|593045400|FG001|Overall Study|Poor venous access|2|||
164184853|NCT00339833|593045399|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
164184854|NCT00339833|593045400|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
164184855|NCT00339833|593045399|FG000|Overall Study|Error in data records|1|||
164184856|NCT00339833|593045400|FG001|Overall Study|Error in data records|0|||
164184857|NCT00217581|593045401|FG000|Overall Study|Withdrawal by Subject|1|||
164184858|NCT02829047|593045402|FG000|Overall Study|Withdrawal by Subject|1|||
164184859|NCT00329745|593045403|FG000|Overall Study|Protocol Violation|1|||
164184860|NCT00329745|593045404|FG001|Overall Study|Protocol Violation|0|||
164184861|NCT00329745|593045403|FG000|Overall Study|Withdrawal by Subject|0|||
164184862|NCT00329745|593045404|FG001|Overall Study|Withdrawal by Subject|1|||
164184863|NCT00329745|593045403|FG000|Overall Study|Lost to Follow-up|86|||
164184864|NCT00329745|593045404|FG001|Overall Study|Lost to Follow-up|101|||
164184865|NCT01597492|593045405|FG000|Overall Study|Withdrawal by Subject|1|||
164184866|NCT01597492|593045406|FG001|Overall Study|Withdrawal by Subject|2|||
164184867|NCT01597492|593045405|FG000|Overall Study|Adverse Event|3|||
164184868|NCT01597492|593045406|FG001|Overall Study|Adverse Event|0|||
164184869|NCT01597492|593045405|FG000|Overall Study|Lost to Follow-up|0|||
164184870|NCT01597492|593045406|FG001|Overall Study|Lost to Follow-up|2|||
164184871|NCT01597492|593045405|FG000|Overall Study|Other Reason|2|||
164184872|NCT01597492|593045406|FG001|Overall Study|Other Reason|0|||
164184873|NCT03146741|593045407|FG000|Overall Study|Txp with non-HCV+ heart|4|||
164184874|NCT03146741|593045407|FG000|Overall Study|Listeted for MOT|2|||
164184875|NCT03146741|593045407|FG000|Overall Study|Physician Decision|2|||
164184876|NCT03146741|593045407|FG000|Overall Study|Awaiting txp|2|||
164184877|NCT03224624|593045408|FG000|Overall Study|Lost to Follow-up|9|||
164184878|NCT03224624|593045409|FG001|Overall Study|Lost to Follow-up|4|||
164184879|NCT03224624|593045408|FG000|Overall Study|Death|1|||
164184880|NCT03224624|593045409|FG001|Overall Study|Death|0|||
164184881|NCT01424241|593045410|FG000|Overall Study|Withdrawal by Subject|1|||
164184882|NCT01424241|593045410|FG000|Overall Study|Time constraints|2|||
164184883|NCT00482170|593045414|FG000|Overall Study|Adverse Event|5|||
164184884|NCT00482170|593045415|FG001|Overall Study|Adverse Event|14|||
164184885|NCT00482170|593045414|FG000|Overall Study|Withdrawal by Subject|6|||
164184886|NCT00482170|593045415|FG001|Overall Study|Withdrawal by Subject|1|||
164184887|NCT00482170|593045414|FG000|Overall Study|Protocol Violation|2|||
164184888|NCT00482170|593045415|FG001|Overall Study|Protocol Violation|3|||
164184889|NCT00482170|593045414|FG000|Overall Study|Lost to Follow-up|2|||
164184890|NCT00482170|593045415|FG001|Overall Study|Lost to Follow-up|0|||
164184891|NCT00482170|593045414|FG000|Overall Study|Unspecified reason|0|||
164184892|NCT00482170|593045415|FG001|Overall Study|Unspecified reason|2|||
164184893|NCT03230838|593045420|FG000|Overall Study|Withdrawal by Subject|3|||
164184894|NCT03230838|593045421|FG001|Overall Study|Withdrawal by Subject|0|||
164184895|NCT03230838|593045420|FG000|Overall Study|Temperature excursion|1|||
164184896|NCT03230838|593045421|FG001|Overall Study|Temperature excursion|0|||
164184897|NCT00575510|593045424|FG000|Overall Study|Lost to Follow-up|4|||
164184898|NCT00575510|593045425|FG001|Overall Study|Lost to Follow-up|6|||
164184899|NCT00575510|593045426|FG002|Overall Study|Lost to Follow-up|9|||
164184900|NCT00575510|593045424|FG000|Overall Study|Withdrawal by Subject|1|||
164184901|NCT00575510|593045425|FG001|Overall Study|Withdrawal by Subject|0|||
164184902|NCT00575510|593045426|FG002|Overall Study|Withdrawal by Subject|0|||
164184903|NCT00575510|593045424|FG000|Overall Study|Clinic Called Patient|7|||
164184904|NCT00575510|593045425|FG001|Overall Study|Clinic Called Patient|7|||
164184905|NCT00575510|593045426|FG002|Overall Study|Clinic Called Patient|7|||
164184906|NCT00575510|593045424|FG000|Overall Study|Pregnancy|0|||
164184907|NCT00575510|593045425|FG001|Overall Study|Pregnancy|0|||
164184908|NCT00575510|593045426|FG002|Overall Study|Pregnancy|1|||
164184909|NCT02697734|593045429|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
164184910|NCT02697734|593045430|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
164184911|NCT02697734|593045429|FG000|Core Phase - up to Week 48|Adverse Event|1|||
164184912|NCT02697734|593045430|FG001|Core Phase - up to Week 48|Adverse Event|2|||
164184913|NCT02697734|593045429|FG000|Core Phase - up to Week 48|Physician Decision|1|||
164184914|NCT02697734|593045430|FG001|Core Phase - up to Week 48|Physician Decision|0|||
164184915|NCT02697734|593045429|FG000|Optional Extension Phase|Adverse Event|5|||
164184916|NCT02697734|593045430|FG001|Optional Extension Phase|Adverse Event|1|||
164184917|NCT02697734|593045429|FG000|Optional Extension Phase|Physician Decision|0|||
164184918|NCT02697734|593045430|FG001|Optional Extension Phase|Physician Decision|1|||
164184919|NCT02324699|593045431|FG000|Overall Study|study terminated|1|||
164184920|NCT03970200|593045432|FG000|Overall Study|Death|2|||
164184921|NCT03970200|593045433|FG001|Overall Study|Death|2|||
164184922|NCT03970200|593045434|FG002|Overall Study|Death|1|||
164184923|NCT03970200|593045432|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
164184924|NCT03970200|593045433|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
164184925|NCT03970200|593045434|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
164184926|NCT01607346|593045435|FG000|Overall Study|Adverse Event|3|||
164184927|NCT01098162|593045436|FG000|Overall Study|Adverse Event|37|||
164184928|NCT01098162|593045436|FG000|Overall Study|Lack of Efficacy|4|||
164184929|NCT01098162|593045436|FG000|Overall Study|Wish of Patient|7|||
164184930|NCT01098162|593045436|FG000|Overall Study|Lost to Follow-up|9|||
164184931|NCT01098162|593045436|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
164184932|NCT01098162|593045436|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
164184933|NCT01098162|593045436|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
164184934|NCT01098162|593045436|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
164184935|NCT01098162|593045436|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
164184936|NCT01098162|593045436|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
164184937|NCT01098162|593045436|FG000|Overall Study|Other Reason|1|||
164184938|NCT01098162|593045436|FG000|Overall Study|Reason Unknown|26|||
164184939|NCT01605825|593045437|FG000|Overall Study|Adverse Event|4|||
164184940|NCT01605825|593045438|FG001|Overall Study|Adverse Event|2|||
164184941|NCT01605825|593045437|FG000|Overall Study|Withdrawal by Subject|0|||
164184942|NCT01605825|593045438|FG001|Overall Study|Withdrawal by Subject|1|||
164184943|NCT01605825|593045437|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
164184944|NCT01605825|593045438|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
164184945|NCT01605825|593045437|FG000|Overall Study|Non-Compliance with Protocol|3|||
164184946|NCT01605825|593045438|FG001|Overall Study|Non-Compliance with Protocol|0|||
164184947|NCT00380718|593045441|FG000|Overall Study|Adverse Event|1|||
164184948|NCT00380718|593045441|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
164184949|NCT04318132|593045447|FG000|Overall Study|Protocol Violation|0|||
164184950|NCT04318132|593045448|FG001|Overall Study|Protocol Violation|0|||
164184951|NCT04318132|593045449|FG002|Overall Study|Protocol Violation|3|||
164184952|NCT04318132|593045450|FG003|Overall Study|Protocol Violation|0|||
164184953|NCT01863732|593045451|FG000|Overall Study|Adverse Event|2|||
164184954|NCT01863732|593045452|FG001|Overall Study|Adverse Event|0|||
164184955|NCT01863732|593045453|FG002|Overall Study|Adverse Event|3|||
164184956|NCT01863732|593045454|FG003|Overall Study|Adverse Event|3|||
164184957|NCT01863732|593045451|FG000|Overall Study|Lack of Efficacy|1|||
164184958|NCT01863732|593045452|FG001|Overall Study|Lack of Efficacy|0|||
164184959|NCT01863732|593045453|FG002|Overall Study|Lack of Efficacy|2|||
164184960|NCT01863732|593045454|FG003|Overall Study|Lack of Efficacy|1|||
164184961|NCT01863732|593045451|FG000|Overall Study|Lost to Follow-up|2|||
164184962|NCT01863732|593045452|FG001|Overall Study|Lost to Follow-up|2|||
164184963|NCT01863732|593045453|FG002|Overall Study|Lost to Follow-up|1|||
164184964|NCT01863732|593045454|FG003|Overall Study|Lost to Follow-up|1|||
164184965|NCT01863732|593045451|FG000|Overall Study|Physician Decision|1|||
164184966|NCT01863732|593045452|FG001|Overall Study|Physician Decision|0|||
164184967|NCT01863732|593045453|FG002|Overall Study|Physician Decision|1|||
164184968|NCT01863732|593045454|FG003|Overall Study|Physician Decision|0|||
164184969|NCT01863732|593045451|FG000|Overall Study|Pregnancy|0|||
164184970|NCT01863732|593045452|FG001|Overall Study|Pregnancy|0|||
164184971|NCT01863732|593045453|FG002|Overall Study|Pregnancy|0|||
164184972|NCT01863732|593045454|FG003|Overall Study|Pregnancy|1|||
164184973|NCT01863732|593045451|FG000|Overall Study|Technical problems|0|||
164184974|NCT01863732|593045452|FG001|Overall Study|Technical problems|1|||
164184975|NCT01863732|593045453|FG002|Overall Study|Technical problems|1|||
164184976|NCT01863732|593045454|FG003|Overall Study|Technical problems|0|||
164184977|NCT01863732|593045451|FG000|Overall Study|Subject/guardian decision|6|||
164184978|NCT01863732|593045452|FG001|Overall Study|Subject/guardian decision|9|||
164184979|NCT01863732|593045453|FG002|Overall Study|Subject/guardian decision|3|||
164184980|NCT01863732|593045454|FG003|Overall Study|Subject/guardian decision|1|||
164184981|NCT01863732|593045451|FG000|Overall Study|Death|1|||
164184982|NCT01863732|593045452|FG001|Overall Study|Death|0|||
164184983|NCT01863732|593045453|FG002|Overall Study|Death|0|||
164184984|NCT01863732|593045454|FG003|Overall Study|Death|1|||
164184985|NCT00840034|593045458|FG000|Acute Treatment Phase|Adverse Event|6|||
164184986|NCT00840034|593045459|FG001|Acute Treatment Phase|Adverse Event|8|||
164184987|NCT00840034|593045458|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
164184988|NCT00840034|593045459|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
164184989|NCT00840034|593045458|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
164184990|NCT00840034|593045459|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
164184991|NCT00840034|593045458|FG000|Acute Treatment Phase|Physician Decision|0|||
164184992|NCT00840034|593045459|FG001|Acute Treatment Phase|Physician Decision|1|||
164184993|NCT00840034|593045458|FG000|Acute Treatment Phase|Protocol Violation|2|||
164184994|NCT00840034|593045459|FG001|Acute Treatment Phase|Protocol Violation|4|||
164184995|NCT00840034|593045458|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
164184996|NCT00840034|593045459|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
164184997|NCT00840034|593045458|FG000|Taper Phase|Adverse Event|1|||
164184998|NCT00840034|593045459|FG001|Taper Phase|Adverse Event|0|||
164184999|NCT00840034|593045458|FG000|Taper Phase|Lost to Follow-up|1|||
164185000|NCT00840034|593045459|FG001|Taper Phase|Lost to Follow-up|1|||
164185001|NCT00840034|593045458|FG000|Taper Phase|Withdrawal by Subject|1|||
164185002|NCT00840034|593045459|FG001|Taper Phase|Withdrawal by Subject|1|||
164185003|NCT02839876|593045466|FG000|Overall Study|Protocol Violation|10|||
164185004|NCT02839876|593045467|FG001|Overall Study|Protocol Violation|11|||
164185005|NCT01156051|593045469|FG000|Overall Study|Lost to Follow-up|1|||
164185006|NCT01156051|593045470|FG001|Overall Study|Lost to Follow-up|0|||
164185007|NCT01156051|593045469|FG000|Overall Study|patient not compliant with protocol|0|||
164185008|NCT01156051|593045470|FG001|Overall Study|patient not compliant with protocol|1|||
164185009|NCT03816007|593045471|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
164185010|NCT03816007|593045472|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
164185011|NCT03816007|593045471|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
164185012|NCT03816007|593045472|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
164185013|NCT03816007|593045471|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
164185014|NCT03816007|593045472|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
164185015|NCT03628716|593045473|FG000|Overall Study|Adverse Event|1|||
164185016|NCT03628716|593045474|FG001|Overall Study|Adverse Event|1|||
164185017|NCT03628716|593045473|FG000|Overall Study|Death|1|||
164185018|NCT03628716|593045474|FG001|Overall Study|Death|0|||
164185019|NCT03628716|593045473|FG000|Overall Study|Lack of Efficacy|15|||
164185020|NCT03628716|593045474|FG001|Overall Study|Lack of Efficacy|20|||
164185021|NCT03628716|593045473|FG000|Overall Study|Withdrawal by Subject|1|||
164185022|NCT03628716|593045474|FG001|Overall Study|Withdrawal by Subject|2|||
164185023|NCT03628716|593045473|FG000|Overall Study|Study Terminated by Sponsor|1|||
164185024|NCT03628716|593045474|FG001|Overall Study|Study Terminated by Sponsor|0|||
164185025|NCT00856843|593045475|FG000|Overall Study|Withdrawal by Subject|1|||
164185026|NCT00856843|593045476|FG001|Overall Study|Withdrawal by Subject|5|||
164185027|NCT00856843|593045475|FG000|Overall Study|Lack of Efficacy|1|||
164185028|NCT00856843|593045476|FG001|Overall Study|Lack of Efficacy|0|||
164185029|NCT02179749|593045477|FG000|Overall Study|Adverse Event|0|||
164185030|NCT02179749|593045478|FG001|Overall Study|Adverse Event|0|||
164185031|NCT02179749|593045479|FG002|Overall Study|Adverse Event|1|||
164185032|NCT02179749|593045477|FG000|Overall Study|Withdrawal by Subject|0|||
164185033|NCT02179749|593045478|FG001|Overall Study|Withdrawal by Subject|0|||
164185034|NCT02179749|593045479|FG002|Overall Study|Withdrawal by Subject|1|||
164185035|NCT00094536|593045480|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
164185036|NCT00094536|593045480|FG000|Treatment and Follow-up|Adverse Event|4|||
164185037|NCT00094536|593045480|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
164185038|NCT00094536|593045480|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
164185039|NCT00094536|593045480|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
164185040|NCT00094536|593045480|FG000|Treatment and Follow-up|Subject non-compliance|9|||
164185041|NCT00094536|593045480|FG000|Treatment and Follow-up|Unable to attend visits|1|||
164185042|NCT02620384|593045481|FG000|Overall Study|Adverse Event|2|||
164185043|NCT02620384|593045482|FG001|Overall Study|Adverse Event|1|||
164185044|NCT02620384|593045481|FG000|Overall Study|Discharged prior to 2nd dose|2|||
164185045|NCT02620384|593045482|FG001|Overall Study|Discharged prior to 2nd dose|5|||
164185046|NCT02620384|593045481|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
164185047|NCT02620384|593045482|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
164185048|NCT00628927|593045487|FG000|Overall Study|Problems performing blood draw|6|||
164185049|NCT00628927|593045488|FG001|Overall Study|Problems performing blood draw|0|||
164185050|NCT00628927|593045487|FG000|Overall Study|Lost to Follow-up|1|||
164185051|NCT00628927|593045488|FG001|Overall Study|Lost to Follow-up|0|||
164185052|NCT00628927|593045487|FG000|Overall Study|Equipment failure|1|||
164185053|NCT00628927|593045488|FG001|Overall Study|Equipment failure|0|||
164185054|NCT01298141|593045492|FG000|Overall Study|Adverse Event|3|||
164185055|NCT01298141|593045492|FG000|Overall Study|Refusal of Required Study Procedures|1|||
164185056|NCT01298141|593045492|FG000|Overall Study|Withdrawal by Subject|6|||
164185057|NCT01298141|593045492|FG000|Overall Study|Termination of Study by the Investigator|5|||
164185058|NCT01298141|593045492|FG000|Overall Study|Other|5|||
164185059|NCT01298141|593045492|FG000|Overall Study|Lost to Follow-up|1|||
164185060|NCT01298141|593045492|FG000|Overall Study|Death|6|||
164185061|NCT01298141|593045492|FG000|Overall Study|Not treated|4|||
164185062|NCT03338569|593045493|FG000|Overall Study|Physician Decision|8|||
164185063|NCT03338569|593045494|FG001|Overall Study|Physician Decision|3|||
164185064|NCT03338569|593045493|FG000|Overall Study|Withdrawal by Subject|0|||
164185065|NCT03338569|593045494|FG001|Overall Study|Withdrawal by Subject|1|||
164185066|NCT03338569|593045493|FG000|Overall Study|Lost to Follow-up|0|||
164185067|NCT03338569|593045494|FG001|Overall Study|Lost to Follow-up|1|||
164185068|NCT00350779|593045495|FG000|Overall Study|Adverse Event|4|||
164185069|NCT00350779|593045496|FG001|Overall Study|Adverse Event|2|||
164185070|NCT00350779|593045495|FG000|Overall Study|Lack of Efficacy|0|||
164185071|NCT00350779|593045496|FG001|Overall Study|Lack of Efficacy|4|||
164185072|NCT00350779|593045495|FG000|Overall Study|Lost to Follow-up|2|||
164185073|NCT00350779|593045496|FG001|Overall Study|Lost to Follow-up|0|||
164185074|NCT00350779|593045495|FG000|Overall Study|Physician Decision|2|||
164185075|NCT00350779|593045496|FG001|Overall Study|Physician Decision|4|||
164185076|NCT00350779|593045495|FG000|Overall Study|Protocol Violation|3|||
164185077|NCT00350779|593045496|FG001|Overall Study|Protocol Violation|1|||
164185078|NCT00350779|593045495|FG000|Overall Study|Withdrawal by Subject|9|||
164185079|NCT00350779|593045496|FG001|Overall Study|Withdrawal by Subject|8|||
164185080|NCT00350779|593045495|FG000|Overall Study|Patient Moved|2|||
164185081|NCT00350779|593045496|FG001|Overall Study|Patient Moved|1|||
164185082|NCT00350779|593045495|FG000|Overall Study|Non-compliance with study procedures|0|||
164185083|NCT00350779|593045496|FG001|Overall Study|Non-compliance with study procedures|1|||
164185084|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
164185085|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185086|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185087|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185088|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185089|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185090|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185091|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185092|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
164185093|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185094|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
164185095|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
164185096|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
164185097|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185098|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
164185099|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
164185100|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185101|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
164185102|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
164185103|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
164185104|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
164185105|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
164185106|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
164185107|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
164185108|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
164185109|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
164185110|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
164185111|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
164185112|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
164185113|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
164185114|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
164185115|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
164185116|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
164185117|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
164185118|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
164185119|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
164185120|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185121|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185122|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185123|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
164185124|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185125|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
164185126|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185127|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185128|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
164185129|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
164185130|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185131|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
164185132|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185133|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185134|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
164185135|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185136|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185137|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
164185138|NCT00528372|593045497|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
164185139|NCT00528372|593045498|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185140|NCT00528372|593045499|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185141|NCT00528372|593045500|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
164185142|NCT00528372|593045501|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185143|NCT00528372|593045502|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185144|NCT00528372|593045503|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185145|NCT00528372|593045504|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
164185146|NCT00528372|593045505|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
164185147|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
164185148|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
164185149|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
164185150|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
164185151|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
164185152|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
164185153|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
164185154|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
164185155|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
164185156|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
164185157|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
164185158|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
164185159|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
164185160|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
164185161|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
164185162|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
164185163|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
164185164|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
164185165|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
164185166|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
164185167|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
164185168|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
164185169|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
164185170|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
164185171|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
164185172|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
164185173|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
164185174|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
164185175|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
164185176|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
164185177|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
164185178|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
164185179|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
164185180|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
164185181|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
164185182|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
164185183|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185184|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185185|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185186|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185187|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185188|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185189|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
164185190|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185191|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
164185192|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185193|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185194|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185195|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185196|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
164185197|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
164185198|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185199|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185200|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
164185201|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185202|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
164185203|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185204|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185205|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185206|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185207|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
164185208|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
164185209|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
164185210|NCT00528372|593045497|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
164185211|NCT00528372|593045498|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
164185212|NCT00528372|593045499|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
164185213|NCT00528372|593045500|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
164185214|NCT00528372|593045501|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
164185215|NCT00528372|593045502|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
164185216|NCT00528372|593045503|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
164185217|NCT00528372|593045504|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
164185218|NCT00528372|593045505|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
164185219|NCT01289574|593045508|FG000|Overall Study|Lack of Efficacy|4|||
164185220|NCT01289574|593045509|FG001|Overall Study|Lack of Efficacy|0|||
164185221|NCT01289574|593045510|FG002|Overall Study|Lack of Efficacy|1|||
164185222|NCT01289574|593045508|FG000|Overall Study|Lost to Follow-up|2|||
164185223|NCT01289574|593045509|FG001|Overall Study|Lost to Follow-up|0|||
164185224|NCT01289574|593045510|FG002|Overall Study|Lost to Follow-up|1|||
164185225|NCT01289574|593045508|FG000|Overall Study|Withdrawal by Subject|1|||
164185226|NCT01289574|593045509|FG001|Overall Study|Withdrawal by Subject|1|||
164185227|NCT01289574|593045510|FG002|Overall Study|Withdrawal by Subject|1|||
164185228|NCT01289574|593045508|FG000|Overall Study|Adverse Event|0|||
164185229|NCT01289574|593045509|FG001|Overall Study|Adverse Event|1|||
164185230|NCT01289574|593045510|FG002|Overall Study|Adverse Event|0|||
164185231|NCT01289574|593045508|FG000|Overall Study|Subject wanted alternate treatment|0|||
164185232|NCT01289574|593045509|FG001|Overall Study|Subject wanted alternate treatment|1|||
164185233|NCT01289574|593045510|FG002|Overall Study|Subject wanted alternate treatment|0|||
164185234|NCT00262002|593045511|FG000|Overall Study|Adverse Event|2|||
164185235|NCT00262002|593045512|FG001|Overall Study|Adverse Event|1|||
164185236|NCT00262002|593045513|FG002|Overall Study|Adverse Event|0|||
164185237|NCT00262002|593045514|FG003|Overall Study|Adverse Event|0|||
164185238|NCT00262002|593045515|FG004|Overall Study|Adverse Event|0|||
164185239|NCT00262002|593045516|FG005|Overall Study|Adverse Event|1|||
164185240|NCT00262002|593045517|FG006|Overall Study|Adverse Event|0|||
164185241|NCT00262002|593045511|FG000|Overall Study|Withdrawal by Subject|4|||
164185242|NCT00262002|593045512|FG001|Overall Study|Withdrawal by Subject|2|||
164185243|NCT00262002|593045513|FG002|Overall Study|Withdrawal by Subject|0|||
164185244|NCT00262002|593045514|FG003|Overall Study|Withdrawal by Subject|1|||
164185245|NCT00262002|593045515|FG004|Overall Study|Withdrawal by Subject|2|||
164185246|NCT00262002|593045516|FG005|Overall Study|Withdrawal by Subject|2|||
164185247|NCT00262002|593045517|FG006|Overall Study|Withdrawal by Subject|2|||
164185248|NCT00262002|593045511|FG000|Overall Study|Lost to Follow-up|2|||
164185249|NCT00262002|593045512|FG001|Overall Study|Lost to Follow-up|0|||
164185250|NCT00262002|593045513|FG002|Overall Study|Lost to Follow-up|0|||
164185251|NCT00262002|593045514|FG003|Overall Study|Lost to Follow-up|2|||
164185252|NCT00262002|593045515|FG004|Overall Study|Lost to Follow-up|0|||
164185253|NCT00262002|593045516|FG005|Overall Study|Lost to Follow-up|1|||
164185254|NCT00262002|593045517|FG006|Overall Study|Lost to Follow-up|0|||
164185255|NCT00262002|593045511|FG000|Overall Study|Inapropriate enrollment|0|||
164185256|NCT00262002|593045512|FG001|Overall Study|Inapropriate enrollment|1|||
164185257|NCT00262002|593045513|FG002|Overall Study|Inapropriate enrollment|0|||
164185258|NCT00262002|593045514|FG003|Overall Study|Inapropriate enrollment|0|||
164185259|NCT00262002|593045515|FG004|Overall Study|Inapropriate enrollment|0|||
164185260|NCT00262002|593045516|FG005|Overall Study|Inapropriate enrollment|0|||
164185261|NCT00262002|593045517|FG006|Overall Study|Inapropriate enrollment|0|||
164185262|NCT00262002|593045511|FG000|Overall Study|Protocol Violation|3|||
164185263|NCT00262002|593045512|FG001|Overall Study|Protocol Violation|2|||
164185264|NCT00262002|593045513|FG002|Overall Study|Protocol Violation|0|||
164185265|NCT00262002|593045514|FG003|Overall Study|Protocol Violation|2|||
164185266|NCT00262002|593045515|FG004|Overall Study|Protocol Violation|5|||
164185267|NCT00262002|593045516|FG005|Overall Study|Protocol Violation|3|||
164185268|NCT00262002|593045517|FG006|Overall Study|Protocol Violation|2|||
164185269|NCT00262002|593045511|FG000|Overall Study|Unable to classify|0|||
164185270|NCT00262002|593045512|FG001|Overall Study|Unable to classify|0|||
164185271|NCT00262002|593045513|FG002|Overall Study|Unable to classify|0|||
164185272|NCT00262002|593045514|FG003|Overall Study|Unable to classify|0|||
164185273|NCT00262002|593045515|FG004|Overall Study|Unable to classify|0|||
164185274|NCT00262002|593045516|FG005|Overall Study|Unable to classify|0|||
164185275|NCT00262002|593045517|FG006|Overall Study|Unable to classify|2|||
164185276|NCT02526160|593047428|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
164185277|NCT02526160|593047429|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
164185278|NCT02526160|593047428|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
164185279|NCT02526160|593047429|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
164185280|NCT02526160|593047428|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
164185281|NCT02526160|593047429|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
164185282|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Death|0|||
164185283|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Death|1|||
164185284|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
164185285|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
164185286|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
164185287|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
164185288|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
164185289|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
164185290|NCT02526160|593047428|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
164185291|NCT02526160|593047429|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
164185292|NCT04227405|593047430|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
164185293|NCT04227405|593047431|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
164185294|NCT04227405|593047430|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
164185295|NCT04227405|593047431|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
164185296|NCT04227405|593047430|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
164185297|NCT04227405|593047431|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
164185298|NCT03536663|593047432|FG000|Endexo|Protocol Violation|1|||
164185299|NCT01775787|593047433|FG000|First 7-10 Days|Adverse Event|0|||
164185300|NCT01775787|593047434|FG001|First 7-10 Days|Adverse Event|1|||
164185301|NCT01775787|593047433|FG000|First 7-10 Days|family emergency|0|||
164185302|NCT01775787|593047434|FG001|First 7-10 Days|family emergency|1|||
164185303|NCT01775787|593047433|FG000|First 7-10 Days|time commitment|0|||
164185304|NCT01775787|593047434|FG001|First 7-10 Days|time commitment|2|||
164185305|NCT01775787|593047433|FG000|First 7-10 Days|concerns with using IV|1|||
164185306|NCT01775787|593047434|FG001|First 7-10 Days|concerns with using IV|2|||
164185307|NCT01775787|593047433|FG000|Second 7-10 Days|time commitment|0|||
164185308|NCT01775787|593047434|FG001|Second 7-10 Days|time commitment|1|||
164185309|NCT01775787|593047433|FG000|Second 7-10 Days|concerns with using IV|0|||
164185310|NCT01775787|593047434|FG001|Second 7-10 Days|concerns with using IV|1|||
164185311|NCT01502956|593047435|FG000|Overall Study|Death|0|||
164185312|NCT01502956|593047436|FG001|Overall Study|Death|2|||
164185313|NCT01502956|593047435|FG000|Overall Study|Lost to Follow-up|14|||
164185314|NCT01502956|593047436|FG001|Overall Study|Lost to Follow-up|11|||
164185315|NCT01502956|593047435|FG000|Overall Study|Physician Decision|2|||
164185316|NCT01502956|593047436|FG001|Overall Study|Physician Decision|3|||
164185317|NCT01502956|593047435|FG000|Overall Study|Withdrawal by Subject|8|||
164185318|NCT01502956|593047436|FG001|Overall Study|Withdrawal by Subject|10|||
164185319|NCT01616758|593047437|FG000|Overall Study|Adverse Event|1|||
164185320|NCT01616758|593047437|FG000|Overall Study|Withdrawal by Subject|2|||
164185321|NCT01616758|593047437|FG000|Overall Study|Disease progression|18|||
164185322|NCT01616758|593047437|FG000|Overall Study|Study termination by Sponsor|1|||
164185323|NCT04076319|593047442|FG000|Overall Study|Withdrawal by Subject|2|||
164185324|NCT04076319|593047443|FG001|Overall Study|Withdrawal by Subject|0|||
164185325|NCT04076319|593047442|FG000|Overall Study|Death|1|||
164185326|NCT04076319|593047443|FG001|Overall Study|Death|0|||
164185327|NCT01054222|593047444|FG000|Overall Study|Lack of Efficacy|1|||
164185328|NCT01054222|593047444|FG000|Overall Study|Lost to Follow-up|4|||
164185329|NCT01054222|593047444|FG000|Overall Study|Withdrawal by Subject|6|||
164185330|NCT03252145|593047448|FG000|Overall Study|Withdrawal by Subject|1|||
164185331|NCT03252145|593047449|FG001|Overall Study|Withdrawal by Subject|0|||
164185332|NCT03252145|593047448|FG000|Overall Study|Complicating Disease|1|||
164185333|NCT03252145|593047449|FG001|Overall Study|Complicating Disease|2|||
164185334|NCT01763827|593047453|FG000|Overall Study|Withdrawal by Subject|1|||
164185335|NCT01763827|593047454|FG001|Overall Study|Withdrawal by Subject|0|||
164185336|NCT01763827|593047455|FG002|Overall Study|Withdrawal by Subject|0|||
164185337|NCT01763827|593047456|FG003|Overall Study|Withdrawal by Subject|0|||
164185338|NCT01763827|593047457|FG004|Overall Study|Withdrawal by Subject|2|||
164185339|NCT01763827|593047458|FG005|Overall Study|Withdrawal by Subject|0|||
164185340|NCT01763827|593047453|FG000|Overall Study|Decision by sponsor|2|||
164185341|NCT01763827|593047454|FG001|Overall Study|Decision by sponsor|0|||
164185342|NCT01763827|593047455|FG002|Overall Study|Decision by sponsor|3|||
164185343|NCT01763827|593047456|FG003|Overall Study|Decision by sponsor|0|||
164185344|NCT01763827|593047457|FG004|Overall Study|Decision by sponsor|2|||
164185345|NCT01763827|593047458|FG005|Overall Study|Decision by sponsor|1|||
164185346|NCT01763827|593047453|FG000|Overall Study|Lost to Follow-up|0|||
164185347|NCT01763827|593047454|FG001|Overall Study|Lost to Follow-up|1|||
164185348|NCT01763827|593047455|FG002|Overall Study|Lost to Follow-up|1|||
164185349|NCT01763827|593047456|FG003|Overall Study|Lost to Follow-up|1|||
164185350|NCT01763827|593047457|FG004|Overall Study|Lost to Follow-up|2|||
164185351|NCT01763827|593047458|FG005|Overall Study|Lost to Follow-up|1|||
164185352|NCT00667563|593047461|FG000|Overall Study|Protocol Violation|24|||
164185353|NCT03130959|593047464|FG000|Overall Study|Disease progression|19|||
164185354|NCT03130959|593047465|FG001|Overall Study|Disease progression|7|||
164185355|NCT03130959|593047466|FG002|Overall Study|Disease progression|12|||
164185356|NCT03130959|593047467|FG003|Overall Study|Disease progression|7|||
164185357|NCT03130959|593047468|FG004|Overall Study|Disease progression|12|||
164185358|NCT03130959|593047469|FG005|Overall Study|Disease progression|3|||
164185359|NCT03130959|593047470|FG006|Overall Study|Disease progression|6|||
164185360|NCT03130959|593047471|FG007|Overall Study|Disease progression|3|||
164185361|NCT03130959|593047472|FG008|Overall Study|Disease progression|15|||
164185362|NCT03130959|593047473|FG009|Overall Study|Disease progression|8|||
164185363|NCT03130959|593047464|FG000|Overall Study|Study drug toxicity|2|||
164185364|NCT03130959|593047465|FG001|Overall Study|Study drug toxicity|2|||
164185365|NCT03130959|593047466|FG002|Overall Study|Study drug toxicity|1|||
164185366|NCT03130959|593047467|FG003|Overall Study|Study drug toxicity|2|||
164185367|NCT03130959|593047468|FG004|Overall Study|Study drug toxicity|1|||
164185368|NCT03130959|593047469|FG005|Overall Study|Study drug toxicity|1|||
164185369|NCT03130959|593047470|FG006|Overall Study|Study drug toxicity|3|||
164185370|NCT03130959|593047471|FG007|Overall Study|Study drug toxicity|0|||
164185371|NCT03130959|593047472|FG008|Overall Study|Study drug toxicity|3|||
164185372|NCT03130959|593047473|FG009|Overall Study|Study drug toxicity|3|||
164185373|NCT03130959|593047464|FG000|Overall Study|Other reasons|0|||
164185374|NCT03130959|593047465|FG001|Overall Study|Other reasons|0|||
164185375|NCT03130959|593047466|FG002|Overall Study|Other reasons|0|||
164185376|NCT03130959|593047467|FG003|Overall Study|Other reasons|0|||
164185377|NCT03130959|593047468|FG004|Overall Study|Other reasons|0|||
164185378|NCT03130959|593047469|FG005|Overall Study|Other reasons|1|||
164185379|NCT03130959|593047470|FG006|Overall Study|Other reasons|1|||
164185380|NCT03130959|593047471|FG007|Overall Study|Other reasons|0|||
164185381|NCT03130959|593047472|FG008|Overall Study|Other reasons|0|||
164185382|NCT03130959|593047473|FG009|Overall Study|Other reasons|0|||
164185383|NCT03130959|593047464|FG000|Overall Study|Subject request to discontinue therapy|0|||
164185384|NCT03130959|593047465|FG001|Overall Study|Subject request to discontinue therapy|0|||
164185385|NCT03130959|593047466|FG002|Overall Study|Subject request to discontinue therapy|1|||
164185386|NCT03130959|593047467|FG003|Overall Study|Subject request to discontinue therapy|1|||
164185387|NCT03130959|593047468|FG004|Overall Study|Subject request to discontinue therapy|0|||
164185388|NCT03130959|593047469|FG005|Overall Study|Subject request to discontinue therapy|0|||
164185389|NCT03130959|593047470|FG006|Overall Study|Subject request to discontinue therapy|1|||
164185390|NCT03130959|593047471|FG007|Overall Study|Subject request to discontinue therapy|1|||
164185391|NCT03130959|593047472|FG008|Overall Study|Subject request to discontinue therapy|0|||
164185392|NCT03130959|593047473|FG009|Overall Study|Subject request to discontinue therapy|0|||
164185393|NCT03130959|593047464|FG000|Overall Study|Not reported|0|||
164185394|NCT03130959|593047465|FG001|Overall Study|Not reported|0|||
164185395|NCT03130959|593047466|FG002|Overall Study|Not reported|0|||
164185396|NCT03130959|593047467|FG003|Overall Study|Not reported|1|||
164185397|NCT03130959|593047468|FG004|Overall Study|Not reported|0|||
164185398|NCT03130959|593047469|FG005|Overall Study|Not reported|1|||
164185399|NCT03130959|593047470|FG006|Overall Study|Not reported|0|||
164185400|NCT03130959|593047471|FG007|Overall Study|Not reported|0|||
164185401|NCT03130959|593047472|FG008|Overall Study|Not reported|0|||
164185402|NCT03130959|593047473|FG009|Overall Study|Not reported|1|||
164185403|NCT03130959|593047464|FG000|Overall Study|Adverse Event unrelated to drug|0|||
164185404|NCT03130959|593047465|FG001|Overall Study|Adverse Event unrelated to drug|0|||
164185405|NCT03130959|593047466|FG002|Overall Study|Adverse Event unrelated to drug|1|||
164185406|NCT03130959|593047467|FG003|Overall Study|Adverse Event unrelated to drug|1|||
164185407|NCT03130959|593047468|FG004|Overall Study|Adverse Event unrelated to drug|1|||
164185408|NCT03130959|593047469|FG005|Overall Study|Adverse Event unrelated to drug|0|||
164185409|NCT03130959|593047470|FG006|Overall Study|Adverse Event unrelated to drug|1|||
164185410|NCT03130959|593047471|FG007|Overall Study|Adverse Event unrelated to drug|0|||
164185411|NCT03130959|593047472|FG008|Overall Study|Adverse Event unrelated to drug|1|||
164185412|NCT03130959|593047473|FG009|Overall Study|Adverse Event unrelated to drug|1|||
164185413|NCT03130959|593047464|FG000|Overall Study|Participant withdrew consent|0|||
164185414|NCT03130959|593047465|FG001|Overall Study|Participant withdrew consent|1|||
164185415|NCT03130959|593047466|FG002|Overall Study|Participant withdrew consent|0|||
164185416|NCT03130959|593047467|FG003|Overall Study|Participant withdrew consent|2|||
164185417|NCT03130959|593047468|FG004|Overall Study|Participant withdrew consent|1|||
164185418|NCT03130959|593047469|FG005|Overall Study|Participant withdrew consent|0|||
164185419|NCT03130959|593047470|FG006|Overall Study|Participant withdrew consent|0|||
164185420|NCT03130959|593047471|FG007|Overall Study|Participant withdrew consent|0|||
164185421|NCT03130959|593047472|FG008|Overall Study|Participant withdrew consent|0|||
164185422|NCT03130959|593047473|FG009|Overall Study|Participant withdrew consent|2|||
164185423|NCT03130959|593047464|FG000|Overall Study|Administrative reason by sponsor|1|||
164185424|NCT03130959|593047465|FG001|Overall Study|Administrative reason by sponsor|0|||
164185425|NCT03130959|593047466|FG002|Overall Study|Administrative reason by sponsor|1|||
164185426|NCT03130959|593047467|FG003|Overall Study|Administrative reason by sponsor|0|||
164185427|NCT03130959|593047468|FG004|Overall Study|Administrative reason by sponsor|0|||
164185428|NCT03130959|593047469|FG005|Overall Study|Administrative reason by sponsor|0|||
164185429|NCT03130959|593047470|FG006|Overall Study|Administrative reason by sponsor|0|||
164185430|NCT03130959|593047471|FG007|Overall Study|Administrative reason by sponsor|0|||
164185431|NCT03130959|593047472|FG008|Overall Study|Administrative reason by sponsor|0|||
164185432|NCT03130959|593047473|FG009|Overall Study|Administrative reason by sponsor|0|||
164185433|NCT03130959|593047464|FG000|Overall Study|Lost to Follow-up|1|||
164185434|NCT03130959|593047465|FG001|Overall Study|Lost to Follow-up|0|||
164185435|NCT03130959|593047466|FG002|Overall Study|Lost to Follow-up|0|||
164185436|NCT03130959|593047467|FG003|Overall Study|Lost to Follow-up|0|||
164185437|NCT03130959|593047468|FG004|Overall Study|Lost to Follow-up|0|||
164185438|NCT03130959|593047469|FG005|Overall Study|Lost to Follow-up|0|||
164185439|NCT03130959|593047470|FG006|Overall Study|Lost to Follow-up|0|||
164185440|NCT03130959|593047471|FG007|Overall Study|Lost to Follow-up|0|||
164185441|NCT03130959|593047472|FG008|Overall Study|Lost to Follow-up|0|||
164185442|NCT03130959|593047473|FG009|Overall Study|Lost to Follow-up|0|||
164185443|NCT02384538|593047488|FG000|Overall Study|Adverse Event|1|||
164185444|NCT02384538|593047489|FG001|Overall Study|Adverse Event|4|||
164185445|NCT02384538|593047488|FG000|Overall Study|Lack of Efficacy|4|||
164185446|NCT02384538|593047489|FG001|Overall Study|Lack of Efficacy|4|||
164185447|NCT02384538|593047488|FG000|Overall Study|Withdrew Consent|0|||
164185448|NCT02384538|593047489|FG001|Overall Study|Withdrew Consent|4|||
164185449|NCT02384538|593047488|FG000|Overall Study|Other|1|||
164185450|NCT02384538|593047489|FG001|Overall Study|Other|3|||
164185451|NCT04446429|593047492|FG000|Overall Study|Lost to Follow-up|6|||
164185452|NCT04446429|593047493|FG001|Overall Study|Lost to Follow-up|0|||
164185453|NCT05205005|593047494|FG000|Overall Study|Withdrawal by Subject|1|||
164185454|NCT05205005|593047495|FG001|Overall Study|Withdrawal by Subject|0|||
164185455|NCT05205005|593047494|FG000|Overall Study|Adverse Event|1|||
164185456|NCT05205005|593047495|FG001|Overall Study|Adverse Event|0|||
164185457|NCT02187029|593047496|FG000|Overall Study|Adverse Event|0|||
164185458|NCT02187029|593047497|FG001|Overall Study|Adverse Event|1|||
164185459|NCT02187029|593047498|FG002|Overall Study|Adverse Event|1|||
164185460|NCT02187029|593047499|FG003|Overall Study|Adverse Event|0|||
164185461|NCT02187029|593047496|FG000|Overall Study|Study Terminated by Sponsor|0|||
164185462|NCT02187029|593047497|FG001|Overall Study|Study Terminated by Sponsor|0|||
164185463|NCT02187029|593047498|FG002|Overall Study|Study Terminated by Sponsor|10|||
164185464|NCT02187029|593047499|FG003|Overall Study|Study Terminated by Sponsor|3|||
164185465|NCT02187029|593047496|FG000|Overall Study|Withdrawal by Subject|1|||
164185466|NCT02187029|593047497|FG001|Overall Study|Withdrawal by Subject|0|||
164185467|NCT02187029|593047498|FG002|Overall Study|Withdrawal by Subject|0|||
164185468|NCT02187029|593047499|FG003|Overall Study|Withdrawal by Subject|0|||
164185469|NCT03042910|593047500|FG000|Overall Study|Adverse Event|1|||
164185470|NCT03042910|593047500|FG000|Overall Study|Disease Progression|2|||
164185471|NCT03042910|593047500|FG000|Overall Study|Withdrawal by Subject|3|||
164185472|NCT03042910|593047500|FG000|Overall Study|Enrolled but not treated|1|||
164185473|NCT02985021|593047501|FG000|Overall Study|Inability to comply with study procedures|1|||
164185474|NCT02187861|593047502|FG000|Overall Study|Adverse Event|2|||
164185475|NCT02187861|593047503|FG001|Overall Study|Adverse Event|1|||
164185476|NCT02187861|593047504|FG002|Overall Study|Adverse Event|2|||
164185477|NCT02187861|593047505|FG003|Overall Study|Adverse Event|1|||
164185478|NCT02187861|593047502|FG000|Overall Study|Death|0|||
164185479|NCT02187861|593047503|FG001|Overall Study|Death|3|||
164185480|NCT02187861|593047504|FG002|Overall Study|Death|1|||
164185481|NCT02187861|593047505|FG003|Overall Study|Death|2|||
164185482|NCT02187861|593047502|FG000|Overall Study|Physician Decision|0|||
164185483|NCT02187861|593047503|FG001|Overall Study|Physician Decision|1|||
164185484|NCT02187861|593047504|FG002|Overall Study|Physician Decision|0|||
164185485|NCT02187861|593047505|FG003|Overall Study|Physician Decision|3|||
164185486|NCT02187861|593047502|FG000|Overall Study|Progressive Disease|4|||
164185487|NCT02187861|593047503|FG001|Overall Study|Progressive Disease|42|||
164185488|NCT02187861|593047504|FG002|Overall Study|Progressive Disease|19|||
164185489|NCT02187861|593047505|FG003|Overall Study|Progressive Disease|22|||
164185490|NCT02187861|593047502|FG000|Overall Study|Withdrawal by Subject|0|||
164185491|NCT02187861|593047503|FG001|Overall Study|Withdrawal by Subject|0|||
164185492|NCT02187861|593047504|FG002|Overall Study|Withdrawal by Subject|3|||
164185493|NCT02187861|593047505|FG003|Overall Study|Withdrawal by Subject|3|||
164185494|NCT02187861|593047502|FG000|Overall Study|Other|0|||
164185495|NCT02187861|593047503|FG001|Overall Study|Other|1|||
164185496|NCT02187861|593047504|FG002|Overall Study|Other|7|||
164185497|NCT02187861|593047505|FG003|Overall Study|Other|1|||
164185498|NCT01491841|593047507|FG000|Overall Study|Screen Failure|10|||
164185499|NCT01491841|593047507|FG000|Overall Study|Withdrawal by Subject|1|||
164185500|NCT01301079|593047508|FG000|Overall Study|Lost to Follow-up|2|||
164185501|NCT01301079|593047509|FG001|Overall Study|Lost to Follow-up|2|||
164185502|NCT04105842|593047510|FG000|Overall Study|Withdrawal by Subject|2|||
164185503|NCT00313586|593047511|FG000|Overall Study|Disease progression|14|||
164185504|NCT00313586|593047512|FG001|Overall Study|Disease progression|19|||
164185505|NCT00313586|593047513|FG002|Overall Study|Disease progression|10|||
164185506|NCT00313586|593047514|FG003|Overall Study|Disease progression|3|||
164185507|NCT00313586|593047511|FG000|Overall Study|Adverse Event|12|||
164185508|NCT00313586|593047512|FG001|Overall Study|Adverse Event|18|||
164185509|NCT00313586|593047513|FG002|Overall Study|Adverse Event|3|||
164185510|NCT00313586|593047514|FG003|Overall Study|Adverse Event|10|||
164185511|NCT00313586|593047511|FG000|Overall Study|Death|11|||
164185512|NCT00313586|593047512|FG001|Overall Study|Death|8|||
164185513|NCT00313586|593047513|FG002|Overall Study|Death|1|||
164185514|NCT00313586|593047514|FG003|Overall Study|Death|7|||
164185515|NCT00313586|593047511|FG000|Overall Study|Withdrawal by Subject|13|||
164185516|NCT00313586|593047512|FG001|Overall Study|Withdrawal by Subject|6|||
164185517|NCT00313586|593047513|FG002|Overall Study|Withdrawal by Subject|6|||
164185518|NCT00313586|593047514|FG003|Overall Study|Withdrawal by Subject|2|||
164185519|NCT00313586|593047511|FG000|Overall Study|Alternative therapy|3|||
164185520|NCT00313586|593047512|FG001|Overall Study|Alternative therapy|6|||
164185521|NCT00313586|593047513|FG002|Overall Study|Alternative therapy|2|||
164185522|NCT00313586|593047514|FG003|Overall Study|Alternative therapy|0|||
164185523|NCT00313586|593047511|FG000|Overall Study|Other complicating disease|2|||
164185524|NCT00313586|593047512|FG001|Overall Study|Other complicating disease|2|||
164185525|NCT00313586|593047513|FG002|Overall Study|Other complicating disease|0|||
164185526|NCT00313586|593047514|FG003|Overall Study|Other complicating disease|0|||
164185527|NCT00313586|593047511|FG000|Overall Study|Did not achieve HI-major/better response|10|||
164185528|NCT00313586|593047512|FG001|Overall Study|Did not achieve HI-major/better response|7|||
164185529|NCT00313586|593047513|FG002|Overall Study|Did not achieve HI-major/better response|2|||
164185530|NCT00313586|593047514|FG003|Overall Study|Did not achieve HI-major/better response|1|||
164185531|NCT00313586|593047511|FG000|Overall Study|Physician Decision|2|||
164185532|NCT00313586|593047512|FG001|Overall Study|Physician Decision|1|||
164185533|NCT00313586|593047513|FG002|Overall Study|Physician Decision|0|||
164185534|NCT00313586|593047514|FG003|Overall Study|Physician Decision|0|||
164185535|NCT00313586|593047511|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
164185536|NCT00313586|593047512|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
164185537|NCT00313586|593047513|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
164185538|NCT00313586|593047514|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
164185539|NCT00313586|593047511|FG000|Overall Study|Lost insurance|0|||
164185540|NCT00313586|593047512|FG001|Overall Study|Lost insurance|1|||
164185541|NCT00313586|593047513|FG002|Overall Study|Lost insurance|0|||
164185542|NCT00313586|593047514|FG003|Overall Study|Lost insurance|0|||
164185543|NCT00313586|593047511|FG000|Overall Study|Moved|0|||
164185544|NCT00313586|593047512|FG001|Overall Study|Moved|1|||
164185545|NCT00313586|593047513|FG002|Overall Study|Moved|0|||
164185546|NCT00313586|593047514|FG003|Overall Study|Moved|0|||
164185547|NCT00313586|593047511|FG000|Overall Study|Death before starting treatment|1|||
164185548|NCT00313586|593047512|FG001|Overall Study|Death before starting treatment|0|||
164185549|NCT00313586|593047513|FG002|Overall Study|Death before starting treatment|0|||
164185550|NCT00313586|593047514|FG003|Overall Study|Death before starting treatment|0|||
164185551|NCT00264290|593047515|FG000|Intervention (8 Weeks)|Adverse Event|1|||
164185552|NCT00264290|593047516|FG001|Intervention (8 Weeks)|Adverse Event|0|||
164185553|NCT04472494|593047517|FG000|Pre-treatment|Other reasons|2|||
164185554|NCT04472494|593047518|FG001|Pre-treatment|Other reasons|0|||
164185555|NCT04472494|593047517|FG000|Treatment|Death|5|||
164185556|NCT04472494|593047518|FG001|Treatment|Death|2|||
164185557|NCT04472494|593047517|FG000|Treatment|Hospital discharge|1|||
164185558|NCT04472494|593047518|FG001|Treatment|Hospital discharge|1|||
164185559|NCT00707980|593047519|FG000|Overall Study|Adverse Event|49|||
164185560|NCT00707980|593047519|FG000|Overall Study|Lack of Efficacy|35|||
164185561|NCT00707980|593047519|FG000|Overall Study|Non-Compliance with Study Drug|28|||
164185562|NCT00707980|593047519|FG000|Overall Study|Protocol Deviations|19|||
164185563|NCT00707980|593047519|FG000|Overall Study|Withdrawal of Consent|81|||
164185564|NCT00707980|593047519|FG000|Overall Study|Lost to Follow-up|59|||
164185565|NCT00707980|593047519|FG000|Overall Study|Other|39|||
164185566|NCT01909973|593047523|FG000|Overall Study|Lost to Follow-up|1|||
164185567|NCT01909973|593047524|FG001|Overall Study|Lost to Follow-up|0|||
164185568|NCT01152996|593047525|FG000|Overall Study|Withdrawal by Subject|142|||
164185569|NCT01152996|593047525|FG000|Overall Study|Adverse Event|115|||
164185570|NCT01152996|593047525|FG000|Overall Study|Lost to Follow-up|112|||
164185571|NCT01152996|593047525|FG000|Overall Study|Lack of Efficacy|68|||
164185572|NCT01152996|593047525|FG000|Overall Study|Noncompliance|41|||
164185573|NCT01152996|593047525|FG000|Overall Study|Other|36|||
164185574|NCT01152996|593047525|FG000|Overall Study|Protocol Violation|22|||
164185575|NCT01152996|593047525|FG000|Overall Study|Elevated liver enzymes|1|||
164185576|NCT01535443|593047529|FG000|Overall Study|Physician Decision|3|||
164185577|NCT00760487|593047531|FG000|Overall Study|Unilateral implantation|3|||
164185578|NCT02260817|593047532|FG000|Overall Study|Lost to Follow-up|0|||
164185579|NCT02260817|593047533|FG001|Overall Study|Lost to Follow-up|14|||
164185580|NCT02260817|593047532|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
164185581|NCT02260817|593047533|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
164185582|NCT02260817|593047532|FG000|Overall Study|Observation, no biopsy|0|||
164185583|NCT02260817|593047533|FG001|Overall Study|Observation, no biopsy|1|||
164185584|NCT02260817|593047532|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
164185585|NCT02260817|593047533|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
164185586|NCT02260817|593047532|FG000|Overall Study|Protocol Violation|0|||
164185587|NCT02260817|593047533|FG001|Overall Study|Protocol Violation|14|||
164185588|NCT03299101|593047534|FG000|Overall Study|Lost to Follow-up|1|||
164185589|NCT03299101|593047534|FG000|Overall Study|Withdrawal by Subject|5|||
164185590|NCT03299101|593047534|FG000|Overall Study|Surgery was changed|3|||
164185591|NCT03299101|593047534|FG000|Overall Study|Not enough time to complete prehab|1|||
164185592|NCT03585712|593047538|FG000|Treatment Period 1|Protocol Violation|1|||
164185593|NCT03585712|593047539|FG001|Treatment Period 1|Protocol Violation|0|||
164185594|NCT03585712|593047540|FG002|Treatment Period 1|Protocol Violation|0|||
164185595|NCT03585712|593047538|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
164185596|NCT03585712|593047539|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
164185597|NCT03585712|593047540|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
164185598|NCT03585712|593047538|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
164185599|NCT03585712|593047539|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
164185600|NCT03585712|593047540|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
164185601|NCT03585712|593047538|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
164185602|NCT03585712|593047539|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
164185603|NCT03585712|593047540|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
164185604|NCT00621517|593047542|FG000|Overall Study|Lost to Follow-up|3|||
164185605|NCT00621517|593047543|FG001|Overall Study|Lost to Follow-up|3|||
164185606|NCT00621517|593047542|FG000|Overall Study|Withdrawal by Subject|3|||
164185607|NCT00621517|593047543|FG001|Overall Study|Withdrawal by Subject|4|||
164185608|NCT00621517|593047542|FG000|Overall Study|Adverse Event|1|||
164185609|NCT00621517|593047543|FG001|Overall Study|Adverse Event|0|||
164185610|NCT02071082|593047544|FG000|Overall Study|Enrolled and Never Treated|1|||
164185611|NCT02071082|593047545|FG001|Overall Study|Enrolled and Never Treated|1|||
164185612|NCT02071082|593047544|FG000|Overall Study|Adverse Event|0|||
164185613|NCT02071082|593047545|FG001|Overall Study|Adverse Event|1|||
164185614|NCT02071082|593047544|FG000|Overall Study|Withdrew Consent|0|||
164185615|NCT02071082|593047545|FG001|Overall Study|Withdrew Consent|4|||
164185616|NCT02071082|593047544|FG000|Overall Study|Lost to Follow-up|1|||
164185617|NCT02071082|593047545|FG001|Overall Study|Lost to Follow-up|1|||
164185618|NCT02101359|593047546|FG000|Overall Study|Not included|23|||
164185619|NCT02101359|593047547|FG001|Overall Study|Not included|13|||
164185620|NCT02101359|593047546|FG000|Overall Study|Withdrawal by Subject|5|||
164185621|NCT02101359|593047547|FG001|Overall Study|Withdrawal by Subject|4|||
164185622|NCT02101359|593047546|FG000|Overall Study|Lost to Follow-up|1|||
164185623|NCT02101359|593047547|FG001|Overall Study|Lost to Follow-up|0|||
164185624|NCT02101359|593047546|FG000|Overall Study|Protocol Violation|0|||
164185625|NCT02101359|593047547|FG001|Overall Study|Protocol Violation|2|||
164185626|NCT00494221|593047548|FG000|Overall Study|Death|15|||
164185627|NCT00494221|593047549|FG001|Overall Study|Death|9|||
164185628|NCT00494221|593047550|FG002|Overall Study|Death|14|||
164185629|NCT00494221|593047548|FG000|Overall Study|Withdrawal by Subject|1|||
164185630|NCT00494221|593047549|FG001|Overall Study|Withdrawal by Subject|2|||
164185631|NCT00494221|593047550|FG002|Overall Study|Withdrawal by Subject|0|||
164185632|NCT01900431|593047551|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
164185633|NCT01900431|593047552|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
164185634|NCT01900431|593047553|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
164185635|NCT01900431|593047551|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
164185636|NCT01900431|593047552|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
164185637|NCT01900431|593047553|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
164185638|NCT01900431|593047551|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
164185639|NCT01900431|593047552|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
164185640|NCT01900431|593047553|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
164185641|NCT01900431|593047551|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
164185642|NCT01900431|593047552|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
164185643|NCT01900431|593047553|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
164185644|NCT01900431|593047551|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
164185645|NCT01900431|593047552|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
164185646|NCT01900431|593047553|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
164185647|NCT01900431|593047551|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
164185648|NCT01900431|593047552|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
164185649|NCT01900431|593047553|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
164185650|NCT01900431|593047551|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
164185651|NCT01900431|593047552|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
164185652|NCT01900431|593047553|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
164185653|NCT01900431|593047551|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
164185654|NCT01900431|593047552|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
164185655|NCT01900431|593047553|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
164185656|NCT01900431|593047551|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
164185657|NCT01900431|593047552|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
164185658|NCT01900431|593047553|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
164185659|NCT01841567|593047557|FG000|Overall Study|Adverse Event|3|||
164185660|NCT03172364|593047558|FG000|Overall Study|Adverse Event|1|||
164185661|NCT03172364|593047559|FG001|Overall Study|Adverse Event|1|||
164185662|NCT03172364|593047558|FG000|Overall Study|Protocol Violation|1|||
164185663|NCT03172364|593047559|FG001|Overall Study|Protocol Violation|0|||
164185664|NCT00630747|593047560|FG000|Overall Study|Death|1|||
164185665|NCT00630747|593047560|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
164185666|NCT00630747|593047560|FG000|Overall Study|Returned to country of origin|1|||
164185667|NCT02732327|593047561|FG000|Overall Study|Protocol Violation|0|||
164185668|NCT02732327|593047562|FG001|Overall Study|Protocol Violation|1|||
164185669|NCT00603382|593047565|FG000|Overall Study|Adverse Event|0|||
164185670|NCT00603382|593047566|FG001|Overall Study|Adverse Event|1|||
164185671|NCT00603382|593047567|FG002|Overall Study|Adverse Event|1|||
164185672|NCT00603382|593047568|FG003|Overall Study|Adverse Event|2|||
164185673|NCT00603382|593047569|FG004|Overall Study|Adverse Event|1|||
164185674|NCT00603382|593047570|FG005|Overall Study|Adverse Event|2|||
164185675|NCT00603382|593047565|FG000|Overall Study|Lack of Efficacy|14|||
164185676|NCT00603382|593047566|FG001|Overall Study|Lack of Efficacy|9|||
164185677|NCT00603382|593047567|FG002|Overall Study|Lack of Efficacy|3|||
164185678|NCT00603382|593047568|FG003|Overall Study|Lack of Efficacy|6|||
164185679|NCT00603382|593047569|FG004|Overall Study|Lack of Efficacy|6|||
164185680|NCT00603382|593047570|FG005|Overall Study|Lack of Efficacy|11|||
164185681|NCT00603382|593047565|FG000|Overall Study|Protocol Violation|1|||
164185682|NCT00603382|593047566|FG001|Overall Study|Protocol Violation|0|||
164185683|NCT00603382|593047567|FG002|Overall Study|Protocol Violation|1|||
164185684|NCT00603382|593047568|FG003|Overall Study|Protocol Violation|2|||
164185685|NCT00603382|593047569|FG004|Overall Study|Protocol Violation|1|||
164185686|NCT00603382|593047570|FG005|Overall Study|Protocol Violation|0|||
164185687|NCT00603382|593047565|FG000|Overall Study|Lost to Follow-up|0|||
164185688|NCT00603382|593047566|FG001|Overall Study|Lost to Follow-up|1|||
164185689|NCT00603382|593047567|FG002|Overall Study|Lost to Follow-up|1|||
164185690|NCT00603382|593047568|FG003|Overall Study|Lost to Follow-up|1|||
164185691|NCT00603382|593047569|FG004|Overall Study|Lost to Follow-up|0|||
164185692|NCT00603382|593047570|FG005|Overall Study|Lost to Follow-up|1|||
164185693|NCT00603382|593047565|FG000|Overall Study|Physician Decision|0|||
164185694|NCT00603382|593047566|FG001|Overall Study|Physician Decision|0|||
164185695|NCT00603382|593047567|FG002|Overall Study|Physician Decision|2|||
164185696|NCT00603382|593047568|FG003|Overall Study|Physician Decision|0|||
164185697|NCT00603382|593047569|FG004|Overall Study|Physician Decision|1|||
164185698|NCT00603382|593047570|FG005|Overall Study|Physician Decision|3|||
164185699|NCT00603382|593047565|FG000|Overall Study|Withdrawal by Subject|3|||
164185700|NCT00603382|593047566|FG001|Overall Study|Withdrawal by Subject|3|||
164185701|NCT00603382|593047567|FG002|Overall Study|Withdrawal by Subject|1|||
164185702|NCT00603382|593047568|FG003|Overall Study|Withdrawal by Subject|1|||
164185703|NCT00603382|593047569|FG004|Overall Study|Withdrawal by Subject|0|||
164185704|NCT00603382|593047570|FG005|Overall Study|Withdrawal by Subject|1|||
164185705|NCT00583102|593047571|FG000|Overall Study|Adverse Event|3|||
164185706|NCT01078298|593047572|FG000|Overall Study|Lost to Follow-up|12|||
164185707|NCT01078298|593047573|FG001|Overall Study|Lost to Follow-up|13|||
164185708|NCT01078298|593047572|FG000|Overall Study|Withdrawal by Subject|31|||
164185709|NCT01078298|593047573|FG001|Overall Study|Withdrawal by Subject|33|||
164185710|NCT01078298|593047572|FG000|Overall Study|Protocol Violation|6|||
164185711|NCT01078298|593047573|FG001|Overall Study|Protocol Violation|6|||
164185712|NCT01078298|593047572|FG000|Overall Study|Adverse Event|6|||
164185713|NCT01078298|593047573|FG001|Overall Study|Adverse Event|5|||
164185714|NCT01078298|593047572|FG000|Overall Study|Death|2|||
164185715|NCT01078298|593047573|FG001|Overall Study|Death|0|||
164185716|NCT01078298|593047572|FG000|Overall Study|Did not meet entrance criteria|0|||
164185717|NCT01078298|593047573|FG001|Overall Study|Did not meet entrance criteria|1|||
164185718|NCT01078298|593047572|FG000|Overall Study|Other|24|||
164185719|NCT01078298|593047573|FG001|Overall Study|Other|32|||
164185720|NCT02432144|593047575|FG000|Overall Study|Participant Non-Compliance|1|||
164185721|NCT00958412|593047578|FG000|Overall Study|Study prematurely terminated|18|||
164185722|NCT02552888|593047579|FG000|Overall Study|Lost to Follow-up|1|||
164185723|NCT02552888|593047580|FG001|Overall Study|Lost to Follow-up|1|||
164185724|NCT00398216|593049334|FG000|Overall Study|Adverse Event|4|||
164185725|NCT00398216|593049335|FG001|Overall Study|Adverse Event|2|||
164185726|NCT00398216|593049336|FG002|Overall Study|Adverse Event|5|||
164185727|NCT00398216|593049337|FG003|Overall Study|Adverse Event|7|||
164185728|NCT00398216|593049338|FG004|Overall Study|Adverse Event|2|||
164185729|NCT00398216|593049334|FG000|Overall Study|Protocol Violation|2|||
164185730|NCT00398216|593049335|FG001|Overall Study|Protocol Violation|4|||
164185731|NCT00398216|593049336|FG002|Overall Study|Protocol Violation|5|||
164185732|NCT00398216|593049337|FG003|Overall Study|Protocol Violation|7|||
164185733|NCT00398216|593049338|FG004|Overall Study|Protocol Violation|5|||
164185734|NCT00398216|593049334|FG000|Overall Study|Lost to Follow-up|1|||
164185735|NCT00398216|593049335|FG001|Overall Study|Lost to Follow-up|6|||
164185736|NCT00398216|593049336|FG002|Overall Study|Lost to Follow-up|4|||
164185737|NCT00398216|593049337|FG003|Overall Study|Lost to Follow-up|4|||
164185738|NCT00398216|593049338|FG004|Overall Study|Lost to Follow-up|1|||
164185739|NCT00398216|593049334|FG000|Overall Study|Death|0|||
164185740|NCT00398216|593049335|FG001|Overall Study|Death|3|||
164185741|NCT00398216|593049336|FG002|Overall Study|Death|0|||
164185742|NCT00398216|593049337|FG003|Overall Study|Death|0|||
164185743|NCT00398216|593049338|FG004|Overall Study|Death|0|||
164185744|NCT00398216|593049334|FG000|Overall Study|Withdrawal by Subject|1|||
164185745|NCT00398216|593049335|FG001|Overall Study|Withdrawal by Subject|0|||
164185746|NCT00398216|593049336|FG002|Overall Study|Withdrawal by Subject|3|||
164185747|NCT00398216|593049337|FG003|Overall Study|Withdrawal by Subject|1|||
164185748|NCT00398216|593049338|FG004|Overall Study|Withdrawal by Subject|2|||
164185749|NCT00398216|593049334|FG000|Overall Study|administrative reasons|3|||
164185750|NCT00398216|593049335|FG001|Overall Study|administrative reasons|4|||
164185751|NCT00398216|593049336|FG002|Overall Study|administrative reasons|4|||
164185752|NCT00398216|593049337|FG003|Overall Study|administrative reasons|3|||
164185753|NCT00398216|593049338|FG004|Overall Study|administrative reasons|3|||
164185754|NCT00398216|593049334|FG000|Overall Study|entrance criteria|0|||
164185755|NCT00398216|593049335|FG001|Overall Study|entrance criteria|0|||
164185756|NCT00398216|593049336|FG002|Overall Study|entrance criteria|0|||
164185757|NCT00398216|593049337|FG003|Overall Study|entrance criteria|0|||
164185758|NCT00398216|593049338|FG004|Overall Study|entrance criteria|2|||
164185759|NCT01048944|593049339|FG000|Overall Study|Protocol Violation|8|||
164185760|NCT01048944|593049340|FG001|Overall Study|Protocol Violation|10|||
164185761|NCT01048944|593049341|FG002|Overall Study|Protocol Violation|10|||
164185762|NCT01048944|593049342|FG003|Overall Study|Protocol Violation|2|||
164185763|NCT01962948|593049343|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
164185764|NCT01962948|593049344|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
164185765|NCT01962948|593049345|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
164185766|NCT01962948|593049346|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
164185767|NCT00376532|593049347|FG000|Overall Study|Lack sufficient blood sample|6|||
164185768|NCT00376532|593049348|FG001|Overall Study|Lack sufficient blood sample|6|||
164185769|NCT01133704|593049349|FG000|Overall Study|Death|44|||
164185770|NCT01133704|593049350|FG001|Overall Study|Death|26|||
164185771|NCT01133704|593049349|FG000|Overall Study|Patient refused to continue|4|||
164185772|NCT01133704|593049350|FG001|Overall Study|Patient refused to continue|0|||
164185773|NCT01133704|593049349|FG000|Overall Study|Study Closure|1|||
164185774|NCT01133704|593049350|FG001|Overall Study|Study Closure|0|||
164185775|NCT02207400|593049351|FG000|Overall Study|Adverse Event|1|||
164185776|NCT02207400|593049352|FG001|Overall Study|Adverse Event|1|||
164185777|NCT02207400|593049351|FG000|Overall Study|Lost to Follow-up|6|||
164185778|NCT02207400|593049352|FG001|Overall Study|Lost to Follow-up|7|||
164185779|NCT02207400|593049351|FG000|Overall Study|Protocol Violation|1|||
164185780|NCT02207400|593049352|FG001|Overall Study|Protocol Violation|1|||
164185781|NCT02207400|593049351|FG000|Overall Study|Withdrawal by Subject|8|||
164185782|NCT02207400|593049352|FG001|Overall Study|Withdrawal by Subject|4|||
164185783|NCT02207400|593049351|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
164185784|NCT02207400|593049352|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
164185785|NCT02849704|593049353|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
164185786|NCT02849704|593049354|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
164185787|NCT02849704|593049353|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
164185788|NCT02849704|593049354|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
164185789|NCT02849704|593049353|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
164185790|NCT02849704|593049354|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
164185791|NCT03519919|593049358|FG000|Overall Study|Withdrawal by Subject|1|||
164185792|NCT03519919|593049358|FG000|Overall Study|Lack of Efficacy|1|||
164185793|NCT03519919|593049358|FG000|Overall Study|Screen Failure|1|||
164185794|NCT03076996|593049359|FG000|Overall Study|Withdrawal by Subject|2|||
164185795|NCT03076996|593049359|FG000|Overall Study|Lost to Follow-up|3|||
164185796|NCT03076996|593049359|FG000|Overall Study|Literacy precluded participation|1|||
164185797|NCT00587795|593049364|FG000|Overall Study|Withdrawal by Subject|1|||
164185798|NCT00587795|593049365|FG001|Overall Study|Withdrawal by Subject|0|||
164185799|NCT02144077|593049366|FG000|Overall Study|Withdrawal by Subject|3|||
164185800|NCT02144077|593049367|FG001|Overall Study|Withdrawal by Subject|3|||
164185801|NCT02144077|593049366|FG000|Overall Study|Adverse Event|2|||
164185802|NCT02144077|593049367|FG001|Overall Study|Adverse Event|3|||
164185803|NCT02144077|593049366|FG000|Overall Study|Lost to Follow-up|2|||
164185804|NCT02144077|593049367|FG001|Overall Study|Lost to Follow-up|2|||
164185805|NCT02144077|593049366|FG000|Overall Study|Protocol Violation|1|||
164185806|NCT02144077|593049367|FG001|Overall Study|Protocol Violation|2|||
164185807|NCT02144077|593049366|FG000|Overall Study|Death|0|||
164185808|NCT02144077|593049367|FG001|Overall Study|Death|1|||
164185809|NCT02144077|593049366|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
164185810|NCT02144077|593049367|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
164185811|NCT01869777|593049368|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
164185812|NCT01951573|593049369|FG000|Washout Period|Adverse Event|0|||
164185813|NCT01951573|593049370|FG001|Washout Period|Adverse Event|1|||
164185814|NCT04399889|593049371|FG000|Overall Study|Death|5|||
164185815|NCT04399889|593049372|FG001|Overall Study|Death|1|||
164185816|NCT04399889|593049373|FG002|Overall Study|Death|1|||
164185817|NCT00943592|593049374|FG000|Overall Study|Death|3|||
164185818|NCT00460239|593049375|FG000|Overall Study|Physician Decision|0|||
164185819|NCT00460239|593049376|FG001|Overall Study|Physician Decision|1|||
164185820|NCT00460239|593049377|FG002|Overall Study|Physician Decision|0|||
164185821|NCT00460239|593049378|FG003|Overall Study|Physician Decision|0|||
164185822|NCT00460239|593049379|FG004|Overall Study|Physician Decision|0|||
164185823|NCT00460239|593049380|FG005|Overall Study|Physician Decision|2|||
164185824|NCT00460239|593049381|FG006|Overall Study|Physician Decision|0|||
164185825|NCT00460239|593049382|FG007|Overall Study|Physician Decision|0|||
164185826|NCT00460239|593049383|FG008|Overall Study|Physician Decision|0|||
164185827|NCT00460239|593049375|FG000|Overall Study|Withdrawal by Subject|0|||
164185828|NCT00460239|593049376|FG001|Overall Study|Withdrawal by Subject|0|||
164185829|NCT00460239|593049377|FG002|Overall Study|Withdrawal by Subject|0|||
164185830|NCT00460239|593049378|FG003|Overall Study|Withdrawal by Subject|0|||
164185831|NCT00460239|593049379|FG004|Overall Study|Withdrawal by Subject|0|||
164185832|NCT00460239|593049380|FG005|Overall Study|Withdrawal by Subject|1|||
164185833|NCT00460239|593049381|FG006|Overall Study|Withdrawal by Subject|0|||
164185834|NCT00460239|593049382|FG007|Overall Study|Withdrawal by Subject|0|||
164185835|NCT00460239|593049383|FG008|Overall Study|Withdrawal by Subject|0|||
164185836|NCT02438280|593049391|FG000|Overall Study|Physician Decision|1|||
164185837|NCT02438280|593049392|FG001|Overall Study|Physician Decision|0|||
164185838|NCT04217317|593049393|FG000|Overall Study|Lack of Efficacy|4|||
164185839|NCT04217317|593049393|FG000|Overall Study|Physician Decision|1|||
164185840|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
164185841|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
164185842|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
164185843|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
164185844|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
164185845|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
164185846|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
164185847|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
164185848|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
164185849|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
164185850|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
164185851|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
164185852|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
164185853|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
164185854|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
164185855|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
164185856|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
164185857|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
164185858|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
164185859|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
164185860|NCT02087943|593049394|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185861|NCT02087943|593049395|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
164185862|NCT02087943|593049396|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185863|NCT02087943|593049397|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185864|NCT02087943|593049398|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
164185865|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
164185866|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
164185867|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
164185868|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
164185869|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
164185870|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
164185871|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
164185872|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
164185873|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
164185874|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
164185875|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185876|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185877|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
164185878|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185879|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
164185880|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185881|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185882|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185883|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
164185884|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
164185885|NCT02087943|593049394|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
164185886|NCT02087943|593049395|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
164185887|NCT02087943|593049396|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
164185888|NCT02087943|593049397|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
164185889|NCT02087943|593049398|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
164185890|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
164185891|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
164185892|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
164185893|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
164185894|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
164185895|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
164185896|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
164185897|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185898|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185899|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185900|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185901|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
164185902|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
164185903|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
164185904|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185905|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185906|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185907|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
164185908|NCT01690299|593049399|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
164185909|NCT01690299|593049400|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
164185910|NCT01690299|593049401|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
164185911|NCT01690299|593049402|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
164185912|NCT01690299|593049403|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
164185913|NCT01690299|593049404|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
164185914|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
164185915|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
164185916|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
164185917|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
164185918|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
164185919|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
164185920|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
164185921|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
164185922|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
164185923|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
164185924|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
164185925|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
164185926|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185927|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185928|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185929|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
164185930|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
164185931|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
164185932|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
164185933|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
164185934|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
164185935|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
164185936|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
164185937|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
164185938|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
164185939|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
164185940|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
164185941|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
164185942|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
164185943|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
164185944|NCT01690299|593049399|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185945|NCT01690299|593049400|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185946|NCT01690299|593049401|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185947|NCT01690299|593049402|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185948|NCT01690299|593049403|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
164185949|NCT01690299|593049404|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
164185950|NCT01882803|593049409|FG000|Overall Study|Disease Progression|1|||
164185951|NCT01882803|593049409|FG000|Overall Study|Withdrawal by Subject|9|||
164185952|NCT01882803|593049409|FG000|Overall Study|Death|68|||
164185953|NCT01882803|593049409|FG000|Overall Study|Physician Decision|3|||
164185954|NCT01882803|593049409|FG000|Overall Study|Lost to Follow-up|3|||
164185955|NCT01882803|593049409|FG000|Overall Study|Follow-up Completed|39|||
164185956|NCT01882803|593049409|FG000|Overall Study|Study Terminated by the Sponsor|6|||
164185957|NCT02869893|593049410|FG000|Overall Study|participant aversion to IV|5|||
164185958|NCT02869893|593049410|FG000|Overall Study|participant fear of MRI scanner|2|||
164185959|NCT01563913|593049411|FG000|Overall Study|Physician Decision|1|||
164185960|NCT01563913|593049412|FG001|Overall Study|Physician Decision|0|||
164185961|NCT01563913|593049411|FG000|Overall Study|Spouse Passed Away|1|||
164185962|NCT01563913|593049412|FG001|Overall Study|Spouse Passed Away|0|||
164185963|NCT03066778|593049413|FG000|Overall Study|Death|195|||
164185964|NCT03066778|593049414|FG001|Overall Study|Death|205|||
164185965|NCT03066778|593049413|FG000|Overall Study|Withdrawal by Subject|5|||
164185966|NCT03066778|593049414|FG001|Overall Study|Withdrawal by Subject|7|||
164185967|NCT00551525|593049415|FG000|Overall Study|Protocol Violation|5|||
164185968|NCT05259917|593049421|FG000|Overall Study|Protocol Violation|0|||
164185969|NCT05259917|593049422|FG001|Overall Study|Protocol Violation|0|||
164185970|NCT05259917|593049423|FG002|Overall Study|Protocol Violation|1|||
164185971|NCT05259917|593049424|FG003|Overall Study|Protocol Violation|0|||
164185972|NCT05259917|593049425|FG004|Overall Study|Protocol Violation|0|||
164185973|NCT05259917|593049426|FG005|Overall Study|Protocol Violation|0|||
164185974|NCT05259917|593049421|FG000|Overall Study|Lost to Follow-up|0|||
164185975|NCT05259917|593049422|FG001|Overall Study|Lost to Follow-up|0|||
164185976|NCT05259917|593049423|FG002|Overall Study|Lost to Follow-up|1|||
164185977|NCT05259917|593049424|FG003|Overall Study|Lost to Follow-up|0|||
164185978|NCT05259917|593049425|FG004|Overall Study|Lost to Follow-up|0|||
164185979|NCT05259917|593049426|FG005|Overall Study|Lost to Follow-up|1|||
164185980|NCT05259917|593049421|FG000|Overall Study|Physician Decision|0|||
164185981|NCT05259917|593049422|FG001|Overall Study|Physician Decision|1|||
164185982|NCT05259917|593049423|FG002|Overall Study|Physician Decision|0|||
164185983|NCT05259917|593049424|FG003|Overall Study|Physician Decision|0|||
164185984|NCT05259917|593049425|FG004|Overall Study|Physician Decision|0|||
164185985|NCT05259917|593049426|FG005|Overall Study|Physician Decision|0|||
164185986|NCT05259917|593049421|FG000|Overall Study|Withdrawal by Subject|0|||
164185987|NCT05259917|593049422|FG001|Overall Study|Withdrawal by Subject|1|||
164185988|NCT05259917|593049423|FG002|Overall Study|Withdrawal by Subject|0|||
164185989|NCT05259917|593049424|FG003|Overall Study|Withdrawal by Subject|0|||
164185990|NCT05259917|593049425|FG004|Overall Study|Withdrawal by Subject|1|||
164185991|NCT05259917|593049426|FG005|Overall Study|Withdrawal by Subject|1|||
164185992|NCT05259917|593049421|FG000|Overall Study|Trial Termination by Sponsor|7|||
164185993|NCT05259917|593049422|FG001|Overall Study|Trial Termination by Sponsor|2|||
164185994|NCT05259917|593049423|FG002|Overall Study|Trial Termination by Sponsor|3|||
164185995|NCT05259917|593049424|FG003|Overall Study|Trial Termination by Sponsor|5|||
164185996|NCT05259917|593049425|FG004|Overall Study|Trial Termination by Sponsor|11|||
164185997|NCT05259917|593049426|FG005|Overall Study|Trial Termination by Sponsor|4|||
164185998|NCT05259917|593049421|FG000|Overall Study|Other|1|||
164185999|NCT05259917|593049422|FG001|Overall Study|Other|0|||
164186000|NCT05259917|593049423|FG002|Overall Study|Other|2|||
164186001|NCT05259917|593049424|FG003|Overall Study|Other|0|||
164186002|NCT05259917|593049425|FG004|Overall Study|Other|0|||
164186003|NCT05259917|593049426|FG005|Overall Study|Other|0|||
164186004|NCT00303472|593049427|FG000|Treatment Period|Adverse Event|0|||
164186005|NCT00303472|593049428|FG001|Treatment Period|Adverse Event|0|||
164186006|NCT00303472|593049429|FG002|Treatment Period|Adverse Event|0|||
164186007|NCT00303472|593049430|FG003|Treatment Period|Adverse Event|0|||
164186008|NCT00303472|593049431|FG004|Treatment Period|Adverse Event|1|||
164186009|NCT00303472|593049432|FG005|Treatment Period|Adverse Event|0|||
164186010|NCT00303472|593049433|FG006|Treatment Period|Adverse Event|0|||
164186011|NCT00303472|593049427|FG000|Treatment Period|Death|0|||
164186012|NCT00303472|593049428|FG001|Treatment Period|Death|0|||
164186013|NCT00303472|593049429|FG002|Treatment Period|Death|0|||
164186014|NCT00303472|593049430|FG003|Treatment Period|Death|1|||
164186015|NCT00303472|593049431|FG004|Treatment Period|Death|0|||
164186016|NCT00303472|593049432|FG005|Treatment Period|Death|0|||
164186017|NCT00303472|593049433|FG006|Treatment Period|Death|1|||
164186018|NCT00303472|593049427|FG000|Treatment Period|Withdrawal by Subject|0|||
164186019|NCT00303472|593049428|FG001|Treatment Period|Withdrawal by Subject|0|||
164186020|NCT00303472|593049429|FG002|Treatment Period|Withdrawal by Subject|0|||
164186021|NCT00303472|593049430|FG003|Treatment Period|Withdrawal by Subject|1|||
164186022|NCT00303472|593049431|FG004|Treatment Period|Withdrawal by Subject|0|||
164186023|NCT00303472|593049432|FG005|Treatment Period|Withdrawal by Subject|1|||
164186024|NCT00303472|593049433|FG006|Treatment Period|Withdrawal by Subject|0|||
164186025|NCT00303472|593049427|FG000|Treatment Period|Other|0|||
164186026|NCT00303472|593049428|FG001|Treatment Period|Other|0|||
164186027|NCT00303472|593049429|FG002|Treatment Period|Other|0|||
164186028|NCT00303472|593049430|FG003|Treatment Period|Other|0|||
164186029|NCT00303472|593049431|FG004|Treatment Period|Other|1|||
164186030|NCT00303472|593049432|FG005|Treatment Period|Other|0|||
164186031|NCT00303472|593049433|FG006|Treatment Period|Other|1|||
164186032|NCT00303472|593049427|FG000|Treatment Period|Disease Progression (to AML)|0|||
164186033|NCT00303472|593049428|FG001|Treatment Period|Disease Progression (to AML)|0|||
164186034|NCT00303472|593049429|FG002|Treatment Period|Disease Progression (to AML)|0|||
164186035|NCT00303472|593049430|FG003|Treatment Period|Disease Progression (to AML)|0|||
164186036|NCT00303472|593049431|FG004|Treatment Period|Disease Progression (to AML)|1|||
164186037|NCT00303472|593049432|FG005|Treatment Period|Disease Progression (to AML)|0|||
164186038|NCT00303472|593049433|FG006|Treatment Period|Disease Progression (to AML)|0|||
164186039|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Adverse Event|1|||
164186040|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Adverse Event|0|||
164186041|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Adverse Event|1|||
164186042|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Adverse Event|0|||
164186043|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Adverse Event|0|||
164186044|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Adverse Event|0|||
164186045|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Adverse Event|0|||
164186046|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Death|2|||
164186047|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Death|0|||
164186048|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Death|1|||
164186049|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Death|0|||
164186050|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Death|0|||
164186051|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Death|0|||
164186052|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Death|0|||
164186053|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186054|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186055|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186056|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
164186057|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186058|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186059|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
164186060|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Physician Decision|0|||
164186061|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Physician Decision|4|||
164186062|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Physician Decision|2|||
164186063|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Physician Decision|3|||
164186064|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Physician Decision|2|||
164186065|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Physician Decision|0|||
164186066|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Physician Decision|0|||
164186067|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
164186068|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
164186069|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
164186070|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
164186071|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
164186072|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
164186073|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
164186074|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Other|0|||
164186075|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Other|2|||
164186076|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Other|4|||
164186077|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Other|2|||
164186078|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Other|1|||
164186079|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Other|0|||
164186080|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Other|0|||
164186081|NCT00303472|593049427|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
164186082|NCT00303472|593049428|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186083|NCT00303472|593049429|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186084|NCT00303472|593049430|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186085|NCT00303472|593049431|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186086|NCT00303472|593049432|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
164186087|NCT00303472|593049433|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
164186088|NCT03517449|593049441|FG000|Overall Study|Death|184|||
164186089|NCT03517449|593049442|FG001|Overall Study|Death|236|||
164186090|NCT03517449|593049441|FG000|Overall Study|Lost to Follow-up|0|||
164186091|NCT03517449|593049442|FG001|Overall Study|Lost to Follow-up|2|||
164186092|NCT03517449|593049441|FG000|Overall Study|Withdrawal by Subject|7|||
164186093|NCT03517449|593049442|FG001|Overall Study|Withdrawal by Subject|26|||
164186094|NCT03517449|593049441|FG000|Overall Study|Participants Ongoing|220|||
164186095|NCT03517449|593049442|FG001|Overall Study|Participants Ongoing|152|||
164186096|NCT01808222|593049445|FG000|Overall Study|mpMR scan was not performed|1|||
164186097|NCT02912455|593049447|FG000|Overall Study|Withdrawal by Subject|0|||
164186098|NCT02912455|593049448|FG001|Overall Study|Withdrawal by Subject|1|||
164186099|NCT02912455|593049447|FG000|Overall Study|Lack of Efficacy|0|||
164186100|NCT02912455|593049448|FG001|Overall Study|Lack of Efficacy|1|||
164186101|NCT02912455|593049447|FG000|Overall Study|Lost to Follow-up|2|||
164186102|NCT02912455|593049448|FG001|Overall Study|Lost to Follow-up|1|||
164186103|NCT00073008|593049449|FG000|Overall Study|Missing|6|||
164186104|NCT00073008|593049450|FG001|Overall Study|Missing|6|||
164186105|NCT00073008|593049449|FG000|Overall Study|Withdrawal by Subject|2|||
164186106|NCT00073008|593049450|FG001|Overall Study|Withdrawal by Subject|2|||
164186107|NCT00073008|593049449|FG000|Overall Study|Lost to Follow-up|1|||
164186108|NCT00073008|593049450|FG001|Overall Study|Lost to Follow-up|3|||
164186109|NCT00073008|593049449|FG000|Overall Study|Death|46|||
164186110|NCT00073008|593049450|FG001|Overall Study|Death|47|||
164186111|NCT00073008|593049449|FG000|Overall Study|"Other selected on Case Report Form"|7|||
164186112|NCT00073008|593049450|FG001|Overall Study|"Other selected on Case Report Form"|5|||
164186113|NCT01778751|593049460|FG000|Overall Study|Lost to Follow-up|1|||
164186114|NCT01778751|593049461|FG001|Overall Study|Lost to Follow-up|0|||
164186115|NCT01778751|593049460|FG000|Overall Study|Withdrawal by Subject|0|||
164186116|NCT01778751|593049461|FG001|Overall Study|Withdrawal by Subject|2|||
164186117|NCT01778751|593049460|FG000|Overall Study|Transfered care|1|||
164186118|NCT01778751|593049461|FG001|Overall Study|Transfered care|0|||
164186119|NCT03337048|593049462|FG000|Overall Study|Withdrawal by Subject|2|||
164186120|NCT03337048|593049463|FG001|Overall Study|Withdrawal by Subject|0|||
164186121|NCT03337048|593049464|FG002|Overall Study|Withdrawal by Subject|0|||
164186122|NCT02669667|593049465|FG000|Overall Study|Lost to Follow-up|0|||
164186123|NCT02669667|593049466|FG001|Overall Study|Lost to Follow-up|0|||
164186124|NCT02669667|593049467|FG002|Overall Study|Lost to Follow-up|0|||
164186125|NCT02669667|593049468|FG003|Overall Study|Lost to Follow-up|0|||
164186126|NCT02669667|593049469|FG004|Overall Study|Lost to Follow-up|0|||
164186127|NCT02669667|593049470|FG005|Overall Study|Lost to Follow-up|1|||
164186128|NCT02669667|593049471|FG006|Overall Study|Lost to Follow-up|0|||
164186129|NCT00636961|593049479|FG000|Period 1|Administrative problems|1|||
164186130|NCT00636961|593049480|FG001|Period 1|Administrative problems|1|||
164186131|NCT00636961|593049479|FG000|Period 2|Adverse Event|1|||
164186132|NCT00636961|593049480|FG001|Period 2|Adverse Event|0|||
164186133|NCT01428115|593049484|FG000|Overall Study|Lack of Efficacy|3|||
164186134|NCT01428115|593049484|FG000|Overall Study|Lost to Follow-up|10|||
164186135|NCT01428115|593049484|FG000|Overall Study|Pregnancy|1|||
164186136|NCT01428115|593049484|FG000|Overall Study|Protocol Violation|3|||
164186137|NCT01428115|593049484|FG000|Overall Study|Withdrawal by Subject|4|||
164186138|NCT02774005|593049485|FG000|Overall Study|Adverse Event|8|||
164186139|NCT02774005|593049485|FG000|Overall Study|Withdrawal by Subject|23|||
164186140|NCT02774005|593049485|FG000|Overall Study|Lost to Follow-up|7|||
164186141|NCT02774005|593049485|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
164186142|NCT02774005|593049485|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
164186143|NCT02774005|593049485|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
164186144|NCT02774005|593049485|FG000|Overall Study|Death|1|||
164186145|NCT02774005|593049485|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
164186146|NCT02774005|593049485|FG000|Overall Study|Lack of compliance with study medication|4|||
164186147|NCT02774005|593049485|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
164186148|NCT02774005|593049485|FG000|Overall Study|another study|1|||
164186149|NCT02774005|593049485|FG000|Overall Study|cardiologist imposed travel restriction|1|||
164186150|NCT01790516|593049486|FG000|Overall Study|Physician Decision|1|||
164186151|NCT01790516|593049487|FG001|Overall Study|Physician Decision|0|||
164186152|NCT01402986|593049488|FG000|Overall Study|Withdrawal by Subject|7|||
164186153|NCT01402986|593049489|FG001|Overall Study|Withdrawal by Subject|10|||
164186154|NCT01402986|593049490|FG002|Overall Study|Withdrawal by Subject|7|||
164186155|NCT01402986|593049491|FG003|Overall Study|Withdrawal by Subject|13|||
164186156|NCT01402986|593049488|FG000|Overall Study|Death|0|||
164186157|NCT01402986|593049489|FG001|Overall Study|Death|0|||
164186158|NCT01402986|593049490|FG002|Overall Study|Death|0|||
164186159|NCT01402986|593049491|FG003|Overall Study|Death|2|||
164186160|NCT01402986|593049488|FG000|Overall Study|Lost to Follow-up|0|||
164186161|NCT01402986|593049489|FG001|Overall Study|Lost to Follow-up|0|||
164186162|NCT01402986|593049490|FG002|Overall Study|Lost to Follow-up|0|||
164186163|NCT01402986|593049491|FG003|Overall Study|Lost to Follow-up|1|||
164186164|NCT01402986|593049488|FG000|Overall Study|Other|2|||
164186165|NCT01402986|593049489|FG001|Overall Study|Other|5|||
164186166|NCT01402986|593049490|FG002|Overall Study|Other|1|||
164186167|NCT01402986|593049491|FG003|Overall Study|Other|6|||
164186168|NCT01085084|593049492|FG000|Overall Study|Withdrawal by Subject|1|||
164186169|NCT01085084|593049493|FG001|Overall Study|Withdrawal by Subject|0|||
164186170|NCT01085084|593049494|FG002|Overall Study|Withdrawal by Subject|0|||
164186171|NCT01085084|593049492|FG000|Overall Study|Lost to Follow-up|2|||
164186172|NCT01085084|593049493|FG001|Overall Study|Lost to Follow-up|1|||
164186173|NCT01085084|593049494|FG002|Overall Study|Lost to Follow-up|1|||
164186174|NCT01085084|593049492|FG000|Overall Study|Adverse Event|4|||
164186175|NCT01085084|593049493|FG001|Overall Study|Adverse Event|3|||
164186176|NCT01085084|593049494|FG002|Overall Study|Adverse Event|6|||
164186177|NCT01085084|593049492|FG000|Overall Study|Treatment Failure|0|||
164186178|NCT01085084|593049493|FG001|Overall Study|Treatment Failure|1|||
164186179|NCT01085084|593049494|FG002|Overall Study|Treatment Failure|2|||
164186180|NCT02749799|593049495|FG000|Overall Study|Adverse Event|2|||
164186181|NCT02749799|593049495|FG000|Overall Study|Lost to Follow-up|4|||
164186182|NCT02749799|593049495|FG000|Overall Study|Protocol Violation|1|||
164186183|NCT02749799|593049495|FG000|Overall Study|Withdrawal by Subject|1|||
164186184|NCT03749109|593049496|FG000|Overall Study|Adverse Event|2|||
164186185|NCT03749109|593049497|FG001|Overall Study|Adverse Event|0|||
164186186|NCT02070978|593049498|FG000|Overall Study|Adverse Event|6|||
164186187|NCT02070978|593049499|FG001|Overall Study|Adverse Event|2|||
164186188|NCT02070978|593049500|FG002|Overall Study|Adverse Event|0|||
164186189|NCT02070978|593049498|FG000|Overall Study|Lost to Follow-up|1|||
164186190|NCT02070978|593049499|FG001|Overall Study|Lost to Follow-up|3|||
164186191|NCT02070978|593049500|FG002|Overall Study|Lost to Follow-up|4|||
164186192|NCT02070978|593049498|FG000|Overall Study|Withdrawal by Subject|3|||
164186193|NCT02070978|593049499|FG001|Overall Study|Withdrawal by Subject|5|||
164186194|NCT02070978|593049500|FG002|Overall Study|Withdrawal by Subject|3|||
164186195|NCT02070978|593049498|FG000|Overall Study|Protocol Violation|1|||
164186196|NCT02070978|593049499|FG001|Overall Study|Protocol Violation|0|||
164186197|NCT02070978|593049500|FG002|Overall Study|Protocol Violation|3|||
164186198|NCT02070978|593049498|FG000|Overall Study|Lack of Efficacy|0|||
164186199|NCT02070978|593049499|FG001|Overall Study|Lack of Efficacy|1|||
164186200|NCT02070978|593049500|FG002|Overall Study|Lack of Efficacy|0|||
164186201|NCT02070978|593049498|FG000|Overall Study|Death|0|||
164186202|NCT02070978|593049499|FG001|Overall Study|Death|0|||
164186203|NCT02070978|593049500|FG002|Overall Study|Death|2|||
164186204|NCT02070978|593049498|FG000|Overall Study|Un-specified|3|||
164186205|NCT02070978|593049499|FG001|Overall Study|Un-specified|2|||
164186206|NCT02070978|593049500|FG002|Overall Study|Un-specified|2|||
164186207|NCT02070978|593049498|FG000|Overall Study|Terminated by Sponsor|33|||
164186208|NCT02070978|593049499|FG001|Overall Study|Terminated by Sponsor|40|||
164186209|NCT02070978|593049500|FG002|Overall Study|Terminated by Sponsor|39|||
164186210|NCT03178851|593049501|FG000|Overall Study|Death|48|||
164186211|NCT03178851|593049502|FG001|Overall Study|Death|2|||
164186212|NCT03178851|593049503|FG002|Overall Study|Death|25|||
164186213|NCT03178851|593049501|FG000|Overall Study|Withdrawal by Subject|8|||
164186214|NCT03178851|593049502|FG001|Overall Study|Withdrawal by Subject|0|||
164186215|NCT03178851|593049503|FG002|Overall Study|Withdrawal by Subject|0|||
164186216|NCT03178851|593049501|FG000|Overall Study|Lost to Follow-up|5|||
164186217|NCT03178851|593049502|FG001|Overall Study|Lost to Follow-up|2|||
164186218|NCT03178851|593049503|FG002|Overall Study|Lost to Follow-up|0|||
164186219|NCT03178851|593049501|FG000|Overall Study|Adverse Event|0|||
164186220|NCT03178851|593049502|FG001|Overall Study|Adverse Event|0|||
164186221|NCT03178851|593049503|FG002|Overall Study|Adverse Event|1|||
164186222|NCT03178851|593049501|FG000|Overall Study|Study Termination by Sponsor|31|||
164186223|NCT03178851|593049502|FG001|Overall Study|Study Termination by Sponsor|7|||
164186224|NCT03178851|593049503|FG002|Overall Study|Study Termination by Sponsor|26|||
164186225|NCT03951753|593049504|FG000|Overall Study|Adverse Event|1|||
164186226|NCT03951753|593049505|FG001|Overall Study|Adverse Event|0|||
164186227|NCT03951753|593049506|FG002|Overall Study|Adverse Event|3|||
164186228|NCT03951753|593049504|FG000|Overall Study|Withdrawal by Subject|3|||
164186229|NCT03951753|593049505|FG001|Overall Study|Withdrawal by Subject|1|||
164186230|NCT03951753|593049506|FG002|Overall Study|Withdrawal by Subject|0|||
164186231|NCT03951753|593049504|FG000|Overall Study|Lost to Follow-up|0|||
164186232|NCT03951753|593049505|FG001|Overall Study|Lost to Follow-up|0|||
164186233|NCT03951753|593049506|FG002|Overall Study|Lost to Follow-up|1|||
164186234|NCT01905592|593049509|FG000|Overall Study|Disease Progression|51|||
164186235|NCT01905592|593049510|FG001|Overall Study|Disease Progression|110|||
164186236|NCT01905592|593049509|FG000|Overall Study|Toxicity|1|||
164186237|NCT01905592|593049510|FG001|Overall Study|Toxicity|16|||
164186238|NCT01905592|593049509|FG000|Overall Study|Physician Decision|0|||
164186239|NCT01905592|593049510|FG001|Overall Study|Physician Decision|2|||
164186240|NCT01905592|593049509|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
164186241|NCT01905592|593049510|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
164186242|NCT01905592|593049509|FG000|Overall Study|Protocol Violation|0|||
164186243|NCT01905592|593049510|FG001|Overall Study|Protocol Violation|1|||
164186244|NCT01905592|593049509|FG000|Overall Study|Sponsor's decision|1|||
164186245|NCT01905592|593049510|FG001|Overall Study|Sponsor's decision|1|||
164186246|NCT01905592|593049509|FG000|Overall Study|Not treated|7|||
164186247|NCT01905592|593049510|FG001|Overall Study|Not treated|3|||
164186248|NCT01905592|593049509|FG000|Overall Study|Withdrawal by Subject|10|||
164186249|NCT01905592|593049510|FG001|Overall Study|Withdrawal by Subject|2|||
164186250|NCT02669043|593049511|FG000|Overall Study|Didn't meet I/E criteria|4|||
164186251|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
164186252|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186253|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186254|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
164186255|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
164186256|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
164186257|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
164186258|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186259|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186260|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186261|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186262|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186263|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186264|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
164186265|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186266|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
164186267|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186268|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
164186269|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186270|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186271|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
164186272|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186273|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186274|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186275|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186276|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186277|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186278|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
164186279|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
164186280|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186281|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186282|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186283|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186284|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186285|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186286|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186287|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186288|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186289|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186290|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186291|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186292|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
164186293|NCT01483599|593049513|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
164186294|NCT01483599|593049514|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
164186295|NCT01483599|593049515|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
164186296|NCT01483599|593049516|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
164186297|NCT01483599|593049517|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
164186298|NCT01483599|593049518|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
164186299|NCT01483599|593049519|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
164186300|NCT01483599|593049520|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
164186301|NCT01483599|593049521|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
164186302|NCT01483599|593049522|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
164186303|NCT01483599|593049523|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
164186304|NCT01483599|593049524|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
164186305|NCT01483599|593049525|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
164186306|NCT01483599|593049526|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
164186307|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
164186308|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
164186309|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
164186310|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
164186311|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
164186312|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
164186313|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
164186314|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
164186315|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
164186316|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
164186317|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
164186318|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
164186319|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
164186320|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
164186321|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186322|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186323|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186324|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186325|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186326|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186327|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186328|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186329|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186330|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186331|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186332|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
164186333|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186334|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
164186335|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186336|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186337|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186338|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186339|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186340|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186341|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186342|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186343|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
164186344|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186345|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186346|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
164186347|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
164186348|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
164186349|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186350|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186351|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186352|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186353|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186354|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186355|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186356|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186357|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
164186358|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186359|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
164186360|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186361|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
164186362|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
164186363|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186364|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186365|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186366|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186367|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186368|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186369|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186370|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186371|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
164186372|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186373|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186374|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
164186375|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
164186376|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
164186377|NCT01483599|593049513|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
164186378|NCT01483599|593049514|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
164186379|NCT01483599|593049515|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
164186380|NCT01483599|593049516|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
164186381|NCT01483599|593049517|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
164186382|NCT01483599|593049518|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
164186383|NCT01483599|593049519|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
164186384|NCT01483599|593049520|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
164186385|NCT01483599|593049521|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
164186386|NCT01483599|593049522|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
164186387|NCT01483599|593049523|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
164186388|NCT01483599|593049524|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
164186467|NCT04304508|593052260|FG001|Overall Study|Other|6|||
164186389|NCT01483599|593049525|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
164186390|NCT01483599|593049526|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
164186391|NCT02109445|593049527|FG000|Overall Study|Symptomatic deterioration|2|||
164186392|NCT02109445|593049527|FG000|Overall Study|Adverse Event|1|||
164186393|NCT00966355|593049532|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
164186394|NCT00966355|593049533|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
164186395|NCT00966355|593049534|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
164186396|NCT00966355|593049532|FG000|Overall Study|newly diagnosed advanced HCC|11|||
164186397|NCT00966355|593049533|FG001|Overall Study|newly diagnosed advanced HCC|12|||
164186398|NCT00966355|593049534|FG002|Overall Study|newly diagnosed advanced HCC|10|||
164186399|NCT00966355|593049532|FG000|Overall Study|Lost to Follow-up|5|||
164186400|NCT00966355|593049533|FG001|Overall Study|Lost to Follow-up|4|||
164186401|NCT00966355|593049534|FG002|Overall Study|Lost to Follow-up|3|||
164186402|NCT00401193|593052243|FG000|Overall Study|Adverse Event|1|||
164186403|NCT00401193|593052244|FG001|Overall Study|Adverse Event|3|||
164186404|NCT00401193|593052245|FG002|Overall Study|Adverse Event|1|||
164186405|NCT00401193|593052243|FG000|Overall Study|Protocol Violation|3|||
164186406|NCT00401193|593052244|FG001|Overall Study|Protocol Violation|1|||
164186407|NCT00401193|593052245|FG002|Overall Study|Protocol Violation|1|||
164186408|NCT00401193|593052243|FG000|Overall Study|Lost to Follow-up|6|||
164186409|NCT00401193|593052244|FG001|Overall Study|Lost to Follow-up|5|||
164186410|NCT00401193|593052245|FG002|Overall Study|Lost to Follow-up|1|||
164186411|NCT00401193|593052243|FG000|Overall Study|Withdrawal by Subject|2|||
164186412|NCT00401193|593052244|FG001|Overall Study|Withdrawal by Subject|0|||
164186413|NCT00401193|593052245|FG002|Overall Study|Withdrawal by Subject|1|||
164186414|NCT00401193|593052243|FG000|Overall Study|Other Event|3|||
164186415|NCT00401193|593052244|FG001|Overall Study|Other Event|2|||
164186416|NCT00401193|593052245|FG002|Overall Study|Other Event|2|||
164186417|NCT01844817|593052246|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
164186418|NCT01844817|593052247|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
164186419|NCT01844817|593052246|FG000|Treatment|Progressive Disease|27|||
164186420|NCT01844817|593052247|FG001|Treatment|Progressive Disease|36|||
164186421|NCT01844817|593052246|FG000|Treatment|Adverse Event|17|||
164186422|NCT01844817|593052247|FG001|Treatment|Adverse Event|9|||
164186423|NCT01844817|593052246|FG000|Treatment|Withdrawal by Subject|10|||
164186424|NCT01844817|593052247|FG001|Treatment|Withdrawal by Subject|6|||
164186425|NCT01844817|593052246|FG000|Treatment|Death|10|||
164186426|NCT01844817|593052247|FG001|Treatment|Death|8|||
164186427|NCT01844817|593052246|FG000|Treatment|Lost to Follow-up|0|||
164186428|NCT01844817|593052247|FG001|Treatment|Lost to Follow-up|1|||
164186429|NCT01844817|593052246|FG000|Treatment|Other|0|||
164186430|NCT01844817|593052247|FG001|Treatment|Other|3|||
164186431|NCT02447328|593052250|FG000|Overall Study|Withdrawal by Subject|1|||
164186432|NCT00314808|593052258|FG000|Overall Study|Disease Progression without AE|4|||
164186433|NCT00314808|593052258|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
164186434|NCT04304508|593052259|FG000|Overall Study|Subject Decision|29|||
164186435|NCT04304508|593052260|FG001|Overall Study|Subject Decision|39|||
164186436|NCT04304508|593052261|FG002|Overall Study|Subject Decision|37|||
164186437|NCT04304508|593052262|FG003|Overall Study|Subject Decision|48|||
164186438|NCT04304508|593052259|FG000|Overall Study|Death|6|||
164186439|NCT04304508|593052260|FG001|Overall Study|Death|1|||
164186440|NCT04304508|593052261|FG002|Overall Study|Death|8|||
164186441|NCT04304508|593052262|FG003|Overall Study|Death|5|||
164186442|NCT04304508|593052259|FG000|Overall Study|Non-compliance With Study Drug|3|||
164186443|NCT04304508|593052260|FG001|Overall Study|Non-compliance With Study Drug|1|||
164186444|NCT04304508|593052261|FG002|Overall Study|Non-compliance With Study Drug|2|||
164186445|NCT04304508|593052262|FG003|Overall Study|Non-compliance With Study Drug|0|||
164186446|NCT04304508|593052259|FG000|Overall Study|Switching To Other Therapy|1|||
164186447|NCT04304508|593052260|FG001|Overall Study|Switching To Other Therapy|1|||
164186448|NCT04304508|593052261|FG002|Overall Study|Switching To Other Therapy|1|||
164186449|NCT04304508|593052262|FG003|Overall Study|Switching To Other Therapy|2|||
164186450|NCT04304508|593052259|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
164186451|NCT04304508|593052260|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
164186452|NCT04304508|593052261|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
164186453|NCT04304508|593052262|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
164186454|NCT04304508|593052259|FG000|Overall Study|Withdrawal by Subject|7|||
164186455|NCT04304508|593052260|FG001|Overall Study|Withdrawal by Subject|5|||
164186456|NCT04304508|593052261|FG002|Overall Study|Withdrawal by Subject|11|||
164186457|NCT04304508|593052262|FG003|Overall Study|Withdrawal by Subject|6|||
164186458|NCT04304508|593052259|FG000|Overall Study|Logistical Difficulties|2|||
164186459|NCT04304508|593052260|FG001|Overall Study|Logistical Difficulties|2|||
164186460|NCT04304508|593052261|FG002|Overall Study|Logistical Difficulties|3|||
164186461|NCT04304508|593052262|FG003|Overall Study|Logistical Difficulties|2|||
164186462|NCT04304508|593052259|FG000|Overall Study|Missing Information|1|||
164186463|NCT04304508|593052260|FG001|Overall Study|Missing Information|2|||
164186464|NCT04304508|593052261|FG002|Overall Study|Missing Information|1|||
164186465|NCT04304508|593052262|FG003|Overall Study|Missing Information|3|||
164186466|NCT04304508|593052259|FG000|Overall Study|Other|7|||
164186468|NCT04304508|593052261|FG002|Overall Study|Other|5|||
164186469|NCT04304508|593052262|FG003|Overall Study|Other|4|||
164186470|NCT04304508|593052259|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
164186471|NCT04304508|593052260|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
164186472|NCT04304508|593052261|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
164186473|NCT04304508|593052262|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
164186474|NCT04304508|593052259|FG000|Overall Study|Physician Decision|3|||
164186475|NCT04304508|593052260|FG001|Overall Study|Physician Decision|4|||
164186476|NCT04304508|593052261|FG002|Overall Study|Physician Decision|9|||
164186477|NCT04304508|593052262|FG003|Overall Study|Physician Decision|7|||
164186478|NCT04304508|593052259|FG000|Overall Study|Study drug never administered|10|||
164186479|NCT04304508|593052260|FG001|Overall Study|Study drug never administered|4|||
164186480|NCT04304508|593052261|FG002|Overall Study|Study drug never administered|4|||
164186481|NCT04304508|593052262|FG003|Overall Study|Study drug never administered|4|||
164186482|NCT04304508|593052259|FG000|Overall Study|Adverse Event|49|||
164186483|NCT04304508|593052260|FG001|Overall Study|Adverse Event|50|||
164186484|NCT04304508|593052261|FG002|Overall Study|Adverse Event|51|||
164186485|NCT04304508|593052262|FG003|Overall Study|Adverse Event|56|||
164186486|NCT04304508|593052259|FG000|Overall Study|Lost to Follow-up|1|||
164186487|NCT04304508|593052260|FG001|Overall Study|Lost to Follow-up|5|||
164186488|NCT04304508|593052261|FG002|Overall Study|Lost to Follow-up|2|||
164186489|NCT04304508|593052262|FG003|Overall Study|Lost to Follow-up|3|||
164186490|NCT02113007|593052269|FG000|Overall Study|Progressive disease|2|||
164186491|NCT00885378|593052270|FG000|Overall Study|Lack of Efficacy|2|||
164186492|NCT00885378|593052271|FG001|Overall Study|Lack of Efficacy|2|||
164186493|NCT00885378|593052270|FG000|Overall Study|Withdrawal by Subject|1|||
164186494|NCT00885378|593052271|FG001|Overall Study|Withdrawal by Subject|2|||
164186495|NCT00885378|593052270|FG000|Overall Study|Lost to Follow-up|1|||
164186496|NCT00885378|593052271|FG001|Overall Study|Lost to Follow-up|2|||
164186497|NCT00885378|593052270|FG000|Overall Study|Poor/Noncompliance|2|||
164186498|NCT00885378|593052271|FG001|Overall Study|Poor/Noncompliance|2|||
164186499|NCT00885378|593052270|FG000|Overall Study|Protocol Violation|2|||
164186500|NCT00885378|593052271|FG001|Overall Study|Protocol Violation|0|||
164186501|NCT02579382|593052272|FG000|Main Study Phase|Lost to Follow-up|0|||
164186502|NCT02579382|593052273|FG001|Main Study Phase|Lost to Follow-up|0|||
164186503|NCT02579382|593052274|FG002|Main Study Phase|Lost to Follow-up|2|||
164186504|NCT02579382|593052275|FG003|Main Study Phase|Lost to Follow-up|0|||
164186505|NCT02579382|593052272|FG000|Main Study Phase|Withdrew Consent|0|||
164186506|NCT02579382|593052273|FG001|Main Study Phase|Withdrew Consent|0|||
164186507|NCT02579382|593052274|FG002|Main Study Phase|Withdrew Consent|0|||
164186508|NCT02579382|593052275|FG003|Main Study Phase|Withdrew Consent|2|||
164186509|NCT02579382|593052272|FG000|Main Study Phase|Lack of Efficacy|0|||
164186510|NCT02579382|593052273|FG001|Main Study Phase|Lack of Efficacy|0|||
164186511|NCT02579382|593052274|FG002|Main Study Phase|Lack of Efficacy|0|||
164186512|NCT02579382|593052275|FG003|Main Study Phase|Lack of Efficacy|1|||
164186513|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
164186514|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
164186515|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
164186516|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
164186517|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
164186518|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
164186519|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
164186520|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
164186521|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
164186522|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
164186523|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
164186524|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
164186525|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
164186526|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
164186527|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
164186528|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
164186529|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
164186530|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
164186531|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
164186532|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
164186533|NCT02579382|593052272|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
164186534|NCT02579382|593052273|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
164186535|NCT02579382|593052274|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
164186536|NCT02579382|593052275|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
164186537|NCT03091738|593052276|FG000|Overall Study|Adverse Event|1|||
164186538|NCT03091738|593052276|FG000|Overall Study|Lost to Follow-up|1|||
164186539|NCT01826981|593052277|FG000|Overall Study|Lack of Efficacy|0|||
164186540|NCT01826981|593052278|FG001|Overall Study|Lack of Efficacy|1|||
164186541|NCT01826981|593052279|FG002|Overall Study|Lack of Efficacy|0|||
164186542|NCT01826981|593052280|FG003|Overall Study|Lack of Efficacy|0|||
164186543|NCT01826981|593052281|FG004|Overall Study|Lack of Efficacy|5|||
164186544|NCT01826981|593052282|FG005|Overall Study|Lack of Efficacy|0|||
164186545|NCT01826981|593052283|FG006|Overall Study|Lack of Efficacy|0|||
164186546|NCT01826981|593052284|FG007|Overall Study|Lack of Efficacy|8|||
164186547|NCT01826981|593052285|FG008|Overall Study|Lack of Efficacy|7|||
164186548|NCT01826981|593052286|FG009|Overall Study|Lack of Efficacy|0|||
164186549|NCT01826981|593052287|FG010|Overall Study|Lack of Efficacy|1|||
164186550|NCT01826981|593052288|FG011|Overall Study|Lack of Efficacy|0|||
164186551|NCT01826981|593052289|FG012|Overall Study|Lack of Efficacy|0|||
164186552|NCT01826981|593052290|FG013|Overall Study|Lack of Efficacy|3|||
164186553|NCT01826981|593052291|FG014|Overall Study|Lack of Efficacy|0|||
164186554|NCT01826981|593052277|FG000|Overall Study|Lost to Follow-up|0|||
164186555|NCT01826981|593052278|FG001|Overall Study|Lost to Follow-up|0|||
164186556|NCT01826981|593052279|FG002|Overall Study|Lost to Follow-up|0|||
164186557|NCT01826981|593052280|FG003|Overall Study|Lost to Follow-up|0|||
164186558|NCT01826981|593052281|FG004|Overall Study|Lost to Follow-up|1|||
164186559|NCT01826981|593052282|FG005|Overall Study|Lost to Follow-up|1|||
164186560|NCT01826981|593052283|FG006|Overall Study|Lost to Follow-up|0|||
164186561|NCT01826981|593052284|FG007|Overall Study|Lost to Follow-up|1|||
164186562|NCT01826981|593052285|FG008|Overall Study|Lost to Follow-up|0|||
164186563|NCT01826981|593052286|FG009|Overall Study|Lost to Follow-up|1|||
164186564|NCT01826981|593052287|FG010|Overall Study|Lost to Follow-up|1|||
164186565|NCT01826981|593052288|FG011|Overall Study|Lost to Follow-up|1|||
164186566|NCT01826981|593052289|FG012|Overall Study|Lost to Follow-up|1|||
164186567|NCT01826981|593052290|FG013|Overall Study|Lost to Follow-up|0|||
164186568|NCT01826981|593052291|FG014|Overall Study|Lost to Follow-up|0|||
164186569|NCT01826981|593052277|FG000|Overall Study|Withdrew Consent|0|||
164186570|NCT01826981|593052278|FG001|Overall Study|Withdrew Consent|0|||
164186571|NCT01826981|593052279|FG002|Overall Study|Withdrew Consent|0|||
164186572|NCT01826981|593052280|FG003|Overall Study|Withdrew Consent|0|||
164186573|NCT01826981|593052281|FG004|Overall Study|Withdrew Consent|0|||
164186574|NCT01826981|593052282|FG005|Overall Study|Withdrew Consent|0|||
164186575|NCT01826981|593052283|FG006|Overall Study|Withdrew Consent|1|||
164186576|NCT01826981|593052284|FG007|Overall Study|Withdrew Consent|1|||
164186577|NCT01826981|593052285|FG008|Overall Study|Withdrew Consent|0|||
164186578|NCT01826981|593052286|FG009|Overall Study|Withdrew Consent|0|||
164186579|NCT01826981|593052287|FG010|Overall Study|Withdrew Consent|0|||
164186580|NCT01826981|593052288|FG011|Overall Study|Withdrew Consent|1|||
164186581|NCT01826981|593052289|FG012|Overall Study|Withdrew Consent|0|||
164186582|NCT01826981|593052290|FG013|Overall Study|Withdrew Consent|1|||
164186583|NCT01826981|593052291|FG014|Overall Study|Withdrew Consent|0|||
164186584|NCT01826981|593052277|FG000|Overall Study|Adverse Event|0|||
164186585|NCT01826981|593052278|FG001|Overall Study|Adverse Event|0|||
164186586|NCT01826981|593052279|FG002|Overall Study|Adverse Event|0|||
164186587|NCT01826981|593052280|FG003|Overall Study|Adverse Event|0|||
164186588|NCT01826981|593052281|FG004|Overall Study|Adverse Event|1|||
164186589|NCT01826981|593052282|FG005|Overall Study|Adverse Event|0|||
164186590|NCT01826981|593052283|FG006|Overall Study|Adverse Event|0|||
164186591|NCT01826981|593052284|FG007|Overall Study|Adverse Event|0|||
164186592|NCT01826981|593052285|FG008|Overall Study|Adverse Event|0|||
164186593|NCT01826981|593052286|FG009|Overall Study|Adverse Event|0|||
164186594|NCT01826981|593052287|FG010|Overall Study|Adverse Event|0|||
164186595|NCT01826981|593052288|FG011|Overall Study|Adverse Event|0|||
164186596|NCT01826981|593052289|FG012|Overall Study|Adverse Event|0|||
164186597|NCT01826981|593052290|FG013|Overall Study|Adverse Event|0|||
164186598|NCT01826981|593052291|FG014|Overall Study|Adverse Event|0|||
164186599|NCT01826981|593052277|FG000|Overall Study|Upper G-I Haemorrhage|0|||
164186600|NCT01826981|593052278|FG001|Overall Study|Upper G-I Haemorrhage|0|||
164186601|NCT01826981|593052279|FG002|Overall Study|Upper G-I Haemorrhage|0|||
164186602|NCT01826981|593052280|FG003|Overall Study|Upper G-I Haemorrhage|0|||
164186603|NCT01826981|593052281|FG004|Overall Study|Upper G-I Haemorrhage|0|||
164186604|NCT01826981|593052282|FG005|Overall Study|Upper G-I Haemorrhage|0|||
164186605|NCT01826981|593052283|FG006|Overall Study|Upper G-I Haemorrhage|0|||
164186606|NCT01826981|593052284|FG007|Overall Study|Upper G-I Haemorrhage|0|||
164186607|NCT01826981|593052285|FG008|Overall Study|Upper G-I Haemorrhage|0|||
164186608|NCT01826981|593052286|FG009|Overall Study|Upper G-I Haemorrhage|0|||
164186609|NCT01826981|593052287|FG010|Overall Study|Upper G-I Haemorrhage|0|||
164186610|NCT01826981|593052288|FG011|Overall Study|Upper G-I Haemorrhage|0|||
164186611|NCT01826981|593052289|FG012|Overall Study|Upper G-I Haemorrhage|0|||
164186612|NCT01826981|593052290|FG013|Overall Study|Upper G-I Haemorrhage|1|||
164186613|NCT01826981|593052291|FG014|Overall Study|Upper G-I Haemorrhage|0|||
164186614|NCT01826981|593052277|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186615|NCT01826981|593052278|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186616|NCT01826981|593052279|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186617|NCT01826981|593052280|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186618|NCT01826981|593052281|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186619|NCT01826981|593052282|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186620|NCT01826981|593052283|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186621|NCT01826981|593052284|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
164186622|NCT01826981|593052285|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186623|NCT01826981|593052286|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186624|NCT01826981|593052287|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186625|NCT01826981|593052288|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186626|NCT01826981|593052289|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186627|NCT01826981|593052290|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186628|NCT01826981|593052291|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
164186629|NCT02213380|593052294|FG000|Underwent Randomization|Withdrawal by Subject|2|||
164186630|NCT02213380|593052295|FG001|Underwent Randomization|Withdrawal by Subject|0|||
164186631|NCT02213380|593052294|FG000|Underwent Randomization|Not treated|3|||
164186632|NCT02213380|593052295|FG001|Underwent Randomization|Not treated|3|||
164186633|NCT02213380|593052294|FG000|Per-protocol Analysis|Protocol Violation|32|||
164186634|NCT02213380|593052295|FG001|Per-protocol Analysis|Protocol Violation|36|||
164186635|NCT03746405|593052296|FG000|Overall Study|Withdrawal by Subject|3|||
164186636|NCT03746405|593052297|FG001|Overall Study|Withdrawal by Subject|0|||
164186637|NCT03746405|593052296|FG000|Overall Study|technical difficulties|0|||
164186638|NCT03746405|593052297|FG001|Overall Study|technical difficulties|2|||
164186639|NCT03479008|593052298|FG000|Overall Study|Withdrawal by Subject|3|||
164186640|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
164186641|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
164186642|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
164186643|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
164186644|NCT00412932|593052299|FG000|Olmesartan (Olm) 20 mg|Other|1|||
164186645|NCT00412932|593052299|FG000|Olmesartan 40 mg|Adverse Event|4|||
164186646|NCT00412932|593052299|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
164186647|NCT00412932|593052299|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
164186648|NCT00412932|593052299|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
164186649|NCT00412932|593052299|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
164186650|NCT00412932|593052299|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
164186651|NCT00412932|593052299|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
164186652|NCT02753816|593052300|FG000|Overall Study|Protocol Violation|0|||
164186653|NCT02753816|593052301|FG001|Overall Study|Protocol Violation|1|||
164186654|NCT02753816|593052302|FG002|Overall Study|Protocol Violation|0|||
164186655|NCT01473940|593052303|FG000|Induction Therapy|Death|0|||
164186656|NCT01473940|593052304|FG001|Induction Therapy|Death|0|||
164186657|NCT01473940|593052305|FG002|Induction Therapy|Death|1|||
164186658|NCT01473940|593052306|FG003|Induction Therapy|Death|1|||
164186659|NCT01473940|593052303|FG000|Induction Therapy|Progressive Disease|0|||
164186660|NCT01473940|593052304|FG001|Induction Therapy|Progressive Disease|1|||
164186661|NCT01473940|593052305|FG002|Induction Therapy|Progressive Disease|1|||
164186662|NCT01473940|593052306|FG003|Induction Therapy|Progressive Disease|0|||
164186663|NCT01473940|593052303|FG000|Maintenance Therapy|Progressive Disease|1|||
164186664|NCT01473940|593052304|FG001|Maintenance Therapy|Progressive Disease|2|||
164186665|NCT01473940|593052305|FG002|Maintenance Therapy|Progressive Disease|1|||
164186666|NCT01473940|593052306|FG003|Maintenance Therapy|Progressive Disease|4|||
164186667|NCT02630563|593052309|FG000|Overall Study|Administrative|1|||
164186668|NCT00929994|593052310|FG000|Overall Study|Withdrawal by Subject|1|||
164186669|NCT00929994|593052310|FG000|Overall Study|medical issue unrelated to intervention|4|||
164186670|NCT00929994|593052310|FG000|Overall Study|employment|1|||
164186671|NCT02061813|593052312|FG000|Overall Study|Withdrawal by Subject|1|||
164186672|NCT02061813|593052312|FG000|Overall Study|Protocol Violation|2|||
164186673|NCT01705080|593052313|FG000|Overall Study|Missed visit|10|||
164186674|NCT01705080|593052314|FG001|Overall Study|Missed visit|4|||
164186675|NCT01705080|593052315|FG002|Overall Study|Missed visit|1|||
164186676|NCT01705080|593052313|FG000|Overall Study|Death|4|||
164186677|NCT01705080|593052314|FG001|Overall Study|Death|4|||
164186678|NCT01705080|593052315|FG002|Overall Study|Death|6|||
164186679|NCT01705080|593052313|FG000|Overall Study|Withdrawal by Subject|61|||
164186680|NCT01705080|593052314|FG001|Overall Study|Withdrawal by Subject|44|||
164186681|NCT01705080|593052315|FG002|Overall Study|Withdrawal by Subject|9|||
164186682|NCT01704755|593052317|FG000|Overall Study|Adverse Event|4|||
164186683|NCT01704755|593052318|FG001|Overall Study|Adverse Event|1|||
164186684|NCT01704755|593052317|FG000|Overall Study|Lost to Follow-up|3|||
164186685|NCT01704755|593052318|FG001|Overall Study|Lost to Follow-up|4|||
164186686|NCT01704755|593052317|FG000|Overall Study|Withdrew consent|1|||
164186687|NCT01704755|593052318|FG001|Overall Study|Withdrew consent|1|||
164186688|NCT01704755|593052317|FG000|Overall Study|Other (not specified)|3|||
164186689|NCT01704755|593052318|FG001|Overall Study|Other (not specified)|1|||
164186690|NCT01704755|593052317|FG000|Overall Study|Withdrew consent and personal issues|1|||
164186691|NCT01704755|593052318|FG001|Overall Study|Withdrew consent and personal issues|0|||
164186692|NCT02256917|593052325|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
164186693|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
164186694|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
164186695|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
164186696|NCT02256917|593052325|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
164186697|NCT02933528|593052326|FG000|Overall Study|Lost to Follow-up|2|||
164186698|NCT02982863|593052327|FG000|Overall Study|Not eligible patients|809|||
164186699|NCT02982863|593052328|FG001|Overall Study|Not eligible patients|4261|||
164186700|NCT02982863|593052329|FG002|Overall Study|Not eligible patients|1852|||
164186701|NCT02982863|593052330|FG003|Overall Study|Not eligible patients|1400|||
164186702|NCT02982863|593052331|FG004|Overall Study|Not eligible patients|492|||
164186703|NCT01753115|593052332|FG000|Overall Study|Lost to Follow-up|3|||
164186704|NCT01753115|593052333|FG001|Overall Study|Lost to Follow-up|6|||
164186705|NCT01753115|593052334|FG002|Overall Study|Lost to Follow-up|8|||
164186706|NCT01753115|593052332|FG000|Overall Study|Withdrawal by Subject|6|||
164186707|NCT01753115|593052333|FG001|Overall Study|Withdrawal by Subject|5|||
164186708|NCT01753115|593052334|FG002|Overall Study|Withdrawal by Subject|6|||
164186709|NCT01753115|593052332|FG000|Overall Study|Subject non-compliant|3|||
164186710|NCT01753115|593052333|FG001|Overall Study|Subject non-compliant|3|||
164186711|NCT01753115|593052334|FG002|Overall Study|Subject non-compliant|0|||
164186712|NCT01753115|593052332|FG000|Overall Study|Used excluded drug|0|||
164186713|NCT01753115|593052333|FG001|Overall Study|Used excluded drug|1|||
164186714|NCT01753115|593052334|FG002|Overall Study|Used excluded drug|0|||
164186715|NCT04313400|593052338|FG000|Overall Study|Withdrawal by Subject|0|||
164186716|NCT04313400|593052339|FG001|Overall Study|Withdrawal by Subject|0|||
164186717|NCT04313400|593052340|FG002|Overall Study|Withdrawal by Subject|0|||
164186718|NCT04313400|593052341|FG003|Overall Study|Withdrawal by Subject|0|||
164186719|NCT04313400|593052342|FG004|Overall Study|Withdrawal by Subject|0|||
164186720|NCT04313400|593052343|FG005|Overall Study|Withdrawal by Subject|4|||
164186721|NCT04313400|593052344|FG006|Overall Study|Withdrawal by Subject|1|||
164186722|NCT04313400|593052338|FG000|Overall Study|Adverse Event|0|||
164186723|NCT04313400|593052339|FG001|Overall Study|Adverse Event|0|||
164186724|NCT04313400|593052340|FG002|Overall Study|Adverse Event|0|||
164186725|NCT04313400|593052341|FG003|Overall Study|Adverse Event|0|||
164186726|NCT04313400|593052342|FG004|Overall Study|Adverse Event|0|||
164186727|NCT04313400|593052343|FG005|Overall Study|Adverse Event|1|||
164186728|NCT04313400|593052344|FG006|Overall Study|Adverse Event|0|||
164186729|NCT04313400|593052338|FG000|Overall Study|Lost to Follow-up|0|||
164186730|NCT04313400|593052339|FG001|Overall Study|Lost to Follow-up|0|||
164186731|NCT04313400|593052340|FG002|Overall Study|Lost to Follow-up|0|||
164186732|NCT04313400|593052341|FG003|Overall Study|Lost to Follow-up|0|||
164186733|NCT04313400|593052342|FG004|Overall Study|Lost to Follow-up|0|||
164186734|NCT04313400|593052343|FG005|Overall Study|Lost to Follow-up|1|||
164186735|NCT04313400|593052344|FG006|Overall Study|Lost to Follow-up|0|||
164186736|NCT02091414|593052345|FG000|Overall Study|Withdrawal by Subject|2|||
164186737|NCT02091414|593052345|FG000|Overall Study|Death|2|||
164186738|NCT02521792|593052349|FG000|Overall Study|Study Terminated|6|||
164186739|NCT01188668|593052350|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
164186740|NCT01188668|593052350|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
164186741|NCT01188668|593052350|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
164186742|NCT00902746|593052351|FG000|Overall Study|Protocol Violation|7|||
164186743|NCT00902746|593052351|FG000|Overall Study|Withdrawal by Subject|16|||
164186744|NCT00902746|593052351|FG000|Overall Study|Adverse Event|8|||
164186745|NCT00902746|593052351|FG000|Overall Study|Lost to Follow-up|3|||
164186746|NCT00902746|593052351|FG000|Overall Study|Physician Decision|2|||
164186747|NCT02081001|593052352|FG000|Overall Study|Adverse Event|0|||
164186748|NCT02081001|593052353|FG001|Overall Study|Adverse Event|0|||
164186749|NCT02081001|593052354|FG002|Overall Study|Adverse Event|0|||
164186750|NCT02081001|593052355|FG003|Overall Study|Adverse Event|0|||
164186751|NCT02081001|593052356|FG004|Overall Study|Adverse Event|1|||
164186752|NCT02081001|593052357|FG005|Overall Study|Adverse Event|0|||
164186753|NCT02081001|593052358|FG006|Overall Study|Adverse Event|0|||
164186754|NCT02081001|593052359|FG007|Overall Study|Adverse Event|0|||
164186755|NCT02081001|593052360|FG008|Overall Study|Adverse Event|0|||
164186756|NCT02081001|593052361|FG009|Overall Study|Adverse Event|0|||
164186757|NCT02081001|593052362|FG010|Overall Study|Adverse Event|0|||
164186758|NCT02081001|593052363|FG011|Overall Study|Adverse Event|0|||
164186759|NCT02937636|593052368|FG000|Overall Study|Other (Not specified)|3|||
164186760|NCT02937636|593052369|FG001|Overall Study|Other (Not specified)|2|||
164186761|NCT00359294|593052370|FG000|Overall Study|Progressive disease|1|||
164186762|NCT00359294|593052371|FG001|Overall Study|Progressive disease|1|||
164186763|NCT00359294|593052372|FG002|Overall Study|Progressive disease|2|||
164186764|NCT00359294|593052373|FG003|Overall Study|Progressive disease|3|||
164186765|NCT00359294|593052374|FG004|Overall Study|Progressive disease|2|||
164186766|NCT00359294|593052370|FG000|Overall Study|Withdrawal by Subject|0|||
164186767|NCT00359294|593052371|FG001|Overall Study|Withdrawal by Subject|0|||
164186768|NCT00359294|593052372|FG002|Overall Study|Withdrawal by Subject|0|||
164186769|NCT00359294|593052373|FG003|Overall Study|Withdrawal by Subject|0|||
164186770|NCT00359294|593052374|FG004|Overall Study|Withdrawal by Subject|1|||
164186771|NCT00359294|593052370|FG000|Overall Study|Not treated|0|||
164186772|NCT00359294|593052371|FG001|Overall Study|Not treated|0|||
164186773|NCT00359294|593052372|FG002|Overall Study|Not treated|0|||
164186774|NCT00359294|593052373|FG003|Overall Study|Not treated|1|||
164186775|NCT00359294|593052374|FG004|Overall Study|Not treated|0|||
164186776|NCT00359294|593052370|FG000|Overall Study|Physician Decision|0|||
164186777|NCT00359294|593052371|FG001|Overall Study|Physician Decision|0|||
164186778|NCT00359294|593052372|FG002|Overall Study|Physician Decision|1|||
164186779|NCT00359294|593052373|FG003|Overall Study|Physician Decision|0|||
164186780|NCT00359294|593052374|FG004|Overall Study|Physician Decision|0|||
164186781|NCT04208412|593052375|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
164186782|NCT04208412|593052376|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
164186783|NCT04208412|593052375|FG000|Overall Study|Withdrawal by Subject|1|||
164186784|NCT04208412|593052376|FG001|Overall Study|Withdrawal by Subject|0|||
164186785|NCT04208412|593052375|FG000|Overall Study|Lost to Follow-up|0|||
164186786|NCT04208412|593052376|FG001|Overall Study|Lost to Follow-up|1|||
164186787|NCT02588092|593052379|FG000|Overall Study|Death|4|||
164186788|NCT02588092|593052380|FG001|Overall Study|Death|3|||
164186789|NCT02588092|593052381|FG002|Overall Study|Death|3|||
164186790|NCT02588092|593052382|FG003|Overall Study|Death|3|||
164186791|NCT02588092|593052383|FG004|Overall Study|Death|2|||
164186792|NCT02588092|593052384|FG005|Overall Study|Death|2|||
164186793|NCT02588092|593052385|FG006|Overall Study|Death|2|||
164186794|NCT02588092|593052386|FG007|Overall Study|Death|1|||
164186795|NCT02588092|593052387|FG008|Overall Study|Death|5|||
164186796|NCT02588092|593052388|FG009|Overall Study|Death|2|||
164186797|NCT02588092|593052379|FG000|Overall Study|Withdrawal by Subject|0|||
164186798|NCT02588092|593052380|FG001|Overall Study|Withdrawal by Subject|0|||
164186799|NCT02588092|593052381|FG002|Overall Study|Withdrawal by Subject|0|||
164186800|NCT02588092|593052382|FG003|Overall Study|Withdrawal by Subject|0|||
164186801|NCT02588092|593052383|FG004|Overall Study|Withdrawal by Subject|0|||
164186802|NCT02588092|593052384|FG005|Overall Study|Withdrawal by Subject|1|||
164186803|NCT02588092|593052385|FG006|Overall Study|Withdrawal by Subject|1|||
164186804|NCT02588092|593052386|FG007|Overall Study|Withdrawal by Subject|2|||
164186805|NCT02588092|593052387|FG008|Overall Study|Withdrawal by Subject|0|||
164186806|NCT02588092|593052388|FG009|Overall Study|Withdrawal by Subject|0|||
164186807|NCT02588092|593052379|FG000|Overall Study|Started Another Treatment|0|||
164186808|NCT02588092|593052380|FG001|Overall Study|Started Another Treatment|0|||
164186809|NCT02588092|593052381|FG002|Overall Study|Started Another Treatment|0|||
164186810|NCT02588092|593052382|FG003|Overall Study|Started Another Treatment|0|||
164186811|NCT02588092|593052383|FG004|Overall Study|Started Another Treatment|1|||
164186812|NCT02588092|593052384|FG005|Overall Study|Started Another Treatment|0|||
164186813|NCT02588092|593052385|FG006|Overall Study|Started Another Treatment|0|||
164186814|NCT02588092|593052386|FG007|Overall Study|Started Another Treatment|1|||
164186815|NCT02588092|593052387|FG008|Overall Study|Started Another Treatment|0|||
164186816|NCT02588092|593052388|FG009|Overall Study|Started Another Treatment|0|||
164186817|NCT02588092|593052379|FG000|Overall Study|Sponsor Decision|0|||
164186818|NCT02588092|593052380|FG001|Overall Study|Sponsor Decision|0|||
164186819|NCT02588092|593052381|FG002|Overall Study|Sponsor Decision|0|||
164186820|NCT02588092|593052382|FG003|Overall Study|Sponsor Decision|0|||
164186821|NCT02588092|593052383|FG004|Overall Study|Sponsor Decision|0|||
164186822|NCT02588092|593052384|FG005|Overall Study|Sponsor Decision|0|||
164186823|NCT02588092|593052385|FG006|Overall Study|Sponsor Decision|0|||
164186824|NCT02588092|593052386|FG007|Overall Study|Sponsor Decision|0|||
164186825|NCT02588092|593052387|FG008|Overall Study|Sponsor Decision|1|||
164186826|NCT02588092|593052388|FG009|Overall Study|Sponsor Decision|1|||
164186827|NCT01348100|593052389|FG000|Overall Study|Subject Withdrew Consent|0|||
164186828|NCT01348100|593052390|FG001|Overall Study|Subject Withdrew Consent|0|||
164186829|NCT01348100|593052391|FG002|Overall Study|Subject Withdrew Consent|2|||
164186830|NCT01348100|593052392|FG003|Overall Study|Subject Withdrew Consent|0|||
164186831|NCT01348100|593052393|FG004|Overall Study|Subject Withdrew Consent|1|||
164186832|NCT01348100|593052394|FG005|Overall Study|Subject Withdrew Consent|0|||
164186833|NCT01348100|593052395|FG006|Overall Study|Subject Withdrew Consent|1|||
164186834|NCT01348100|593052389|FG000|Overall Study|Protocol Deviation|0|||
164186835|NCT01348100|593052390|FG001|Overall Study|Protocol Deviation|0|||
164186836|NCT01348100|593052391|FG002|Overall Study|Protocol Deviation|0|||
164186837|NCT01348100|593052392|FG003|Overall Study|Protocol Deviation|1|||
164186838|NCT01348100|593052393|FG004|Overall Study|Protocol Deviation|0|||
164186839|NCT01348100|593052394|FG005|Overall Study|Protocol Deviation|0|||
164186840|NCT01348100|593052395|FG006|Overall Study|Protocol Deviation|0|||
164186841|NCT01348100|593052389|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186842|NCT01348100|593052390|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186843|NCT01348100|593052391|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186844|NCT01348100|593052392|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186845|NCT01348100|593052393|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186846|NCT01348100|593052394|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
164186847|NCT01348100|593052395|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
164186848|NCT01348100|593052389|FG000|Overall Study|Lost to Follow-up|0|||
164186849|NCT01348100|593052390|FG001|Overall Study|Lost to Follow-up|0|||
164186850|NCT01348100|593052391|FG002|Overall Study|Lost to Follow-up|0|||
164186851|NCT01348100|593052392|FG003|Overall Study|Lost to Follow-up|0|||
164186852|NCT01348100|593052393|FG004|Overall Study|Lost to Follow-up|0|||
164186853|NCT01348100|593052394|FG005|Overall Study|Lost to Follow-up|0|||
164186854|NCT01348100|593052395|FG006|Overall Study|Lost to Follow-up|1|||
164186855|NCT01348100|593052389|FG000|Overall Study|Administrative Problems|0|||
164186856|NCT01348100|593052390|FG001|Overall Study|Administrative Problems|0|||
164186857|NCT01348100|593052391|FG002|Overall Study|Administrative Problems|0|||
164186858|NCT01348100|593052392|FG003|Overall Study|Administrative Problems|0|||
164186859|NCT01348100|593052393|FG004|Overall Study|Administrative Problems|0|||
164186860|NCT01348100|593052394|FG005|Overall Study|Administrative Problems|1|||
164186861|NCT01348100|593052395|FG006|Overall Study|Administrative Problems|1|||
164186862|NCT03882957|593052396|FG000|Overall Study|Did not complete all three arms|1|||
164186863|NCT03762681|593052401|FG000|Part 1|Withdrawal by Subject|0|||
164186864|NCT03762681|593052402|FG001|Part 1|Withdrawal by Subject|0|||
164186865|NCT03762681|593052403|FG002|Part 1|Withdrawal by Subject|0|||
164186866|NCT03762681|593052404|FG003|Part 1|Withdrawal by Subject|1|||
164186867|NCT03762681|593052405|FG004|Part 1|Withdrawal by Subject|0|||
164186868|NCT03762681|593052406|FG005|Part 1|Withdrawal by Subject|0|||
164186869|NCT03762681|593052407|FG006|Part 1|Withdrawal by Subject|0|||
164186870|NCT03762681|593052408|FG007|Part 1|Withdrawal by Subject|0|||
164186871|NCT03762681|593052401|FG000|Part 2a|Pandemic Travel Restrictions|0|||
164186872|NCT03762681|593052402|FG001|Part 2a|Pandemic Travel Restrictions|0|||
164186873|NCT03762681|593052403|FG002|Part 2a|Pandemic Travel Restrictions|0|||
164186874|NCT03762681|593052404|FG003|Part 2a|Pandemic Travel Restrictions|0|||
164186875|NCT03762681|593052405|FG004|Part 2a|Pandemic Travel Restrictions|0|||
164186876|NCT03762681|593052406|FG005|Part 2a|Pandemic Travel Restrictions|0|||
164186877|NCT03762681|593052407|FG006|Part 2a|Pandemic Travel Restrictions|0|||
164186878|NCT03762681|593052408|FG007|Part 2a|Pandemic Travel Restrictions|1|||
164186879|NCT03148067|593052409|FG000|Overall Study|Lost to Follow-up|3|||
164186880|NCT03148067|593052409|FG000|Overall Study|Death|1|||
164186881|NCT00435188|593052411|FG000|Overall Study|Death|1|||
164186882|NCT00435188|593052412|FG001|Overall Study|Death|6|||
164186883|NCT00435188|593052411|FG000|Overall Study|Withdrawal by Subject|16|||
164186884|NCT00435188|593052412|FG001|Overall Study|Withdrawal by Subject|11|||
164186885|NCT00435188|593052411|FG000|Overall Study|Lost to Follow-up|5|||
164186886|NCT00435188|593052412|FG001|Overall Study|Lost to Follow-up|6|||
164186887|NCT01915771|593052413|FG000|Day 1|Withdrawal by Subject|1|||
164186888|NCT01915771|593052413|FG000|Day 15|Withdrawal by Subject|1|||
164186889|NCT00334295|593052415|FG000|Overall Study|Patients received fewer than 3 injection|5|||
164186890|NCT03755518|593052422|FG000|Overall Study|Lack of Efficacy|10|||
164186891|NCT03755518|593052422|FG000|Overall Study|Adverse Event|7|||
164186892|NCT03755518|593052422|FG000|Overall Study|Study Terminated by Sponsor|5|||
164186893|NCT03755518|593052422|FG000|Overall Study|Death|1|||
164186894|NCT03755518|593052422|FG000|Overall Study|Withdrawal by Subject|3|||
164186895|NCT03755518|593052422|FG000|Overall Study|Progressive Disease|4|||
164186896|NCT03755518|593052422|FG000|Overall Study|Bone Marrow Transplant|4|||
164186897|NCT03755518|593052422|FG000|Overall Study|Physicians Decision|1|||
164186898|NCT03755518|593052422|FG000|Overall Study|Relapse|1|||
164186899|NCT03755518|593052422|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
164186900|NCT03755518|593052422|FG000|Overall Study|Withdrawal by PI|1|||
164186901|NCT01714609|593052423|FG000|Overall Study|Protocol Violation|1|||
164186902|NCT01714609|593052424|FG001|Overall Study|Protocol Violation|0|||
164186903|NCT03403621|593052425|FG000|Overall Study|Withdrawal by Subject|2|||
164186904|NCT03403621|593052426|FG001|Overall Study|Withdrawal by Subject|2|||
164186905|NCT00395642|593052428|FG000|Overall Study|Death|4|||
164186906|NCT00395642|593052428|FG000|Overall Study|Lost to Follow-up|1|||
164186907|NCT00395642|593052428|FG000|Overall Study|Physician Decision|7|||
164186908|NCT00395642|593052428|FG000|Overall Study|Withdrawal by Subject|1|||
164186909|NCT00659776|593052432|FG000|Overall Study|Withdrawal by Subject|12|||
164186910|NCT00659776|593052433|FG001|Overall Study|Withdrawal by Subject|2|||
164186911|NCT00659776|593052434|FG002|Overall Study|Withdrawal by Subject|0|||
164186912|NCT01738191|593052437|FG000|Overall Study|Withdrawal by Subject|4|||
164186913|NCT01738191|593052438|FG001|Overall Study|Withdrawal by Subject|1|||
164186914|NCT02483572|593052439|FG000|Overall Study|Withdrawal by Subject|1|||
164186915|NCT02483572|593052440|FG001|Overall Study|Withdrawal by Subject|0|||
164186916|NCT02483572|593052439|FG000|Overall Study|Lost to Follow-up|1|||
164186917|NCT02483572|593052440|FG001|Overall Study|Lost to Follow-up|0|||
164186918|NCT02483572|593052439|FG000|Overall Study|Physician Decision|0|||
164186919|NCT02483572|593052440|FG001|Overall Study|Physician Decision|1|||
164186920|NCT04811664|593052441|FG000|Overall Study|Lost to Follow-up|78|||
164186921|NCT04811664|593052442|FG001|Overall Study|Lost to Follow-up|125|||
164186922|NCT04811664|593052443|FG002|Overall Study|Lost to Follow-up|46|||
164186923|NCT04811664|593052441|FG000|Overall Study|Withdrawal by Subject|39|||
164186924|NCT04811664|593052442|FG001|Overall Study|Withdrawal by Subject|76|||
164186925|NCT04811664|593052443|FG002|Overall Study|Withdrawal by Subject|12|||
164186926|NCT04811664|593052441|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
164186927|NCT04811664|593052442|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
164186928|NCT04811664|593052443|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
164186929|NCT04811664|593052441|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
164186930|NCT04811664|593052442|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
164186931|NCT04811664|593052443|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
164186932|NCT04811664|593052441|FG000|Overall Study|Protocol Violation|0|||
164186933|NCT04811664|593052442|FG001|Overall Study|Protocol Violation|5|||
164186934|NCT04811664|593052443|FG002|Overall Study|Protocol Violation|11|||
164186935|NCT04811664|593052441|FG000|Overall Study|Study Terminated by Sponsor|4|||
164186936|NCT04811664|593052442|FG001|Overall Study|Study Terminated by Sponsor|3|||
164186937|NCT04811664|593052443|FG002|Overall Study|Study Terminated by Sponsor|34|||
164186938|NCT04811664|593052441|FG000|Overall Study|Early Study Closure|3|||
164186939|NCT04811664|593052442|FG001|Overall Study|Early Study Closure|7|||
164186940|NCT04811664|593052443|FG002|Overall Study|Early Study Closure|79|||
164186941|NCT04811664|593052441|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
164186942|NCT04811664|593052442|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
164186943|NCT04811664|593052443|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
164186944|NCT02717442|593052444|FG000|Overall Study|Study Terminated by Sponsor|31|||
164186945|NCT02717442|593052445|FG001|Overall Study|Study Terminated by Sponsor|29|||
164186946|NCT02717442|593052444|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
164186947|NCT02717442|593052445|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
164186948|NCT02717442|593052444|FG000|Overall Study|Other - Not Specified|2|||
164186949|NCT02717442|593052445|FG001|Overall Study|Other - Not Specified|0|||
164186950|NCT00723697|593052447|FG000|Overall Study|Physician questionnaires not received|2|||
164186951|NCT00723697|593052447|FG000|Overall Study|Missing Informed Consent Form|10|||
164186952|NCT00723697|593052447|FG000|Overall Study|Other exclusion criteria applied|6|||
164186953|NCT03275389|593052448|FG000|Overall Study|Lost to Follow-up|10|||
164186954|NCT03275389|593052449|FG001|Overall Study|Lost to Follow-up|10|||
164186955|NCT03275389|593052450|FG002|Overall Study|Lost to Follow-up|19|||
164186956|NCT03275389|593052451|FG003|Overall Study|Lost to Follow-up|12|||
164186957|NCT03275389|593052452|FG004|Overall Study|Lost to Follow-up|11|||
164186958|NCT03275389|593052453|FG005|Overall Study|Lost to Follow-up|12|||
164186959|NCT03275389|593052454|FG006|Overall Study|Lost to Follow-up|21|||
164186960|NCT03275389|593052455|FG007|Overall Study|Lost to Follow-up|15|||
164186961|NCT03275389|593052456|FG008|Overall Study|Lost to Follow-up|12|||
164186962|NCT03275389|593052457|FG009|Overall Study|Lost to Follow-up|14|||
164186963|NCT03275389|593052448|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186964|NCT03275389|593052449|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186965|NCT03275389|593052450|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186966|NCT03275389|593052451|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186967|NCT03275389|593052452|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186968|NCT03275389|593052453|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
164186969|NCT03275389|593052454|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186970|NCT03275389|593052455|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186971|NCT03275389|593052456|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
164186972|NCT03275389|593052457|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
164186973|NCT03275389|593052448|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
164186974|NCT03275389|593052449|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164186975|NCT03275389|593052450|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
164186976|NCT03275389|593052451|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
164186977|NCT03275389|593052452|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186978|NCT03275389|593052453|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186979|NCT03275389|593052454|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186980|NCT03275389|593052455|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
164186981|NCT03275389|593052456|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164186982|NCT03275389|593052457|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
164186983|NCT03275389|593052448|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186984|NCT03275389|593052449|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
164186985|NCT03275389|593052450|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186986|NCT03275389|593052451|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
164186987|NCT03275389|593052452|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186988|NCT03275389|593052453|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186989|NCT03275389|593052454|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
164186990|NCT03275389|593052455|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186991|NCT03275389|593052456|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186992|NCT03275389|593052457|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
164186993|NCT03275389|593052448|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186994|NCT03275389|593052449|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186995|NCT03275389|593052450|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
164186996|NCT03275389|593052451|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186997|NCT03275389|593052452|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186998|NCT03275389|593052453|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164186999|NCT03275389|593052454|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164187000|NCT03275389|593052455|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164187001|NCT03275389|593052456|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
164187002|NCT03275389|593052457|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
164187003|NCT03275389|593052448|FG000|Overall Study|Other|0|||
164187004|NCT03275389|593052449|FG001|Overall Study|Other|4|||
164187005|NCT03275389|593052450|FG002|Overall Study|Other|3|||
164187006|NCT03275389|593052451|FG003|Overall Study|Other|2|||
164187007|NCT03275389|593052452|FG004|Overall Study|Other|2|||
164187008|NCT03275389|593052453|FG005|Overall Study|Other|2|||
164187009|NCT03275389|593052454|FG006|Overall Study|Other|0|||
164187010|NCT03275389|593052455|FG007|Overall Study|Other|0|||
164187011|NCT03275389|593052456|FG008|Overall Study|Other|1|||
164187012|NCT03275389|593052457|FG009|Overall Study|Other|0|||
164187013|NCT00978341|593052462|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
164187014|NCT00978341|593052463|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
164187015|NCT03035916|593052464|FG000|Overall Study|Puncture failed|0|||
164187016|NCT03035916|593052465|FG001|Overall Study|Puncture failed|2|||
164187017|NCT03035916|593052466|FG002|Overall Study|Puncture failed|0|||
164187018|NCT03885999|593052467|FG000|Overall Study|Adverse Event|1|||
164187019|NCT01451554|593052468|FG000|Overall Study|Withdrawal by Subject|14|||
164187020|NCT01451554|593052469|FG001|Overall Study|Withdrawal by Subject|9|||
164187021|NCT02452554|593052470|FG000|Overall Study|Death|2|||
164187022|NCT02452554|593052471|FG001|Overall Study|Death|1|||
164187023|NCT02452554|593052472|FG002|Overall Study|Death|0|||
164187024|NCT02452554|593052473|FG003|Overall Study|Death|0|||
164187025|NCT02452554|593052474|FG004|Overall Study|Death|0|||
164187026|NCT02452554|593052475|FG005|Overall Study|Death|0|||
164187027|NCT02452554|593052470|FG000|Overall Study|Lack of Efficacy|13|||
164187028|NCT02452554|593052471|FG001|Overall Study|Lack of Efficacy|14|||
164187029|NCT02452554|593052472|FG002|Overall Study|Lack of Efficacy|9|||
164187030|NCT02452554|593052473|FG003|Overall Study|Lack of Efficacy|1|||
164187031|NCT02452554|593052474|FG004|Overall Study|Lack of Efficacy|5|||
164187032|NCT02452554|593052475|FG005|Overall Study|Lack of Efficacy|8|||
164187033|NCT02452554|593052470|FG000|Overall Study|Physician Decision|0|||
164187034|NCT02452554|593052471|FG001|Overall Study|Physician Decision|1|||
164187035|NCT02452554|593052472|FG002|Overall Study|Physician Decision|0|||
164187036|NCT02452554|593052473|FG003|Overall Study|Physician Decision|0|||
164187037|NCT02452554|593052474|FG004|Overall Study|Physician Decision|0|||
164187038|NCT02452554|593052475|FG005|Overall Study|Physician Decision|0|||
164187039|NCT02452554|593052470|FG000|Overall Study|Withdrawal by Subject|1|||
164187040|NCT02452554|593052471|FG001|Overall Study|Withdrawal by Subject|0|||
164187041|NCT02452554|593052472|FG002|Overall Study|Withdrawal by Subject|2|||
164187042|NCT02452554|593052473|FG003|Overall Study|Withdrawal by Subject|0|||
164187043|NCT02452554|593052474|FG004|Overall Study|Withdrawal by Subject|0|||
164187044|NCT02452554|593052475|FG005|Overall Study|Withdrawal by Subject|1|||
164187045|NCT02452554|593052470|FG000|Overall Study|Ineligible|0|||
164187046|NCT02452554|593052471|FG001|Overall Study|Ineligible|1|||
164187047|NCT02452554|593052472|FG002|Overall Study|Ineligible|0|||
164187048|NCT02452554|593052473|FG003|Overall Study|Ineligible|0|||
164187049|NCT02452554|593052474|FG004|Overall Study|Ineligible|0|||
164187050|NCT02452554|593052475|FG005|Overall Study|Ineligible|0|||
164187051|NCT02452554|593052470|FG000|Overall Study|Never Received Treatment|1|||
164187052|NCT02452554|593052471|FG001|Overall Study|Never Received Treatment|0|||
164187053|NCT02452554|593052472|FG002|Overall Study|Never Received Treatment|0|||
164187054|NCT02452554|593052473|FG003|Overall Study|Never Received Treatment|0|||
164187055|NCT02452554|593052474|FG004|Overall Study|Never Received Treatment|0|||
164187056|NCT02452554|593052475|FG005|Overall Study|Never Received Treatment|0|||
164187057|NCT04378569|593054361|FG000|Overall Study|Adverse Event|0|||
164187058|NCT04378569|593054362|FG001|Overall Study|Adverse Event|0|||
164187059|NCT04378569|593054363|FG002|Overall Study|Adverse Event|2|||
164187060|NCT04378569|593054364|FG003|Overall Study|Adverse Event|0|||
164187061|NCT04378569|593054365|FG004|Overall Study|Adverse Event|3|||
164187062|NCT04378569|593054366|FG005|Overall Study|Adverse Event|3|||
164187063|NCT04378569|593054361|FG000|Overall Study|Lost to Follow-up|0|||
164187064|NCT04378569|593054362|FG001|Overall Study|Lost to Follow-up|3|||
164187065|NCT04378569|593054363|FG002|Overall Study|Lost to Follow-up|1|||
164187066|NCT04378569|593054364|FG003|Overall Study|Lost to Follow-up|0|||
164187067|NCT04378569|593054365|FG004|Overall Study|Lost to Follow-up|1|||
164187068|NCT04378569|593054366|FG005|Overall Study|Lost to Follow-up|1|||
164187069|NCT04378569|593054361|FG000|Overall Study|Protocol Violation|0|||
164187070|NCT04378569|593054362|FG001|Overall Study|Protocol Violation|0|||
164187071|NCT04378569|593054363|FG002|Overall Study|Protocol Violation|0|||
164187072|NCT04378569|593054364|FG003|Overall Study|Protocol Violation|0|||
164187073|NCT04378569|593054365|FG004|Overall Study|Protocol Violation|0|||
164187074|NCT04378569|593054366|FG005|Overall Study|Protocol Violation|1|||
164187075|NCT04378569|593054361|FG000|Overall Study|Withdrawal by Subject|0|||
164187076|NCT04378569|593054362|FG001|Overall Study|Withdrawal by Subject|6|||
164187077|NCT04378569|593054363|FG002|Overall Study|Withdrawal by Subject|7|||
164187078|NCT04378569|593054364|FG003|Overall Study|Withdrawal by Subject|4|||
164187079|NCT04378569|593054365|FG004|Overall Study|Withdrawal by Subject|5|||
164187080|NCT04378569|593054366|FG005|Overall Study|Withdrawal by Subject|4|||
164187081|NCT04378569|593054361|FG000|Overall Study|Lack of response|0|||
164187082|NCT04378569|593054362|FG001|Overall Study|Lack of response|0|||
164187083|NCT04378569|593054363|FG002|Overall Study|Lack of response|1|||
164187084|NCT04378569|593054364|FG003|Overall Study|Lack of response|0|||
164187085|NCT04378569|593054365|FG004|Overall Study|Lack of response|1|||
164187086|NCT04378569|593054366|FG005|Overall Study|Lack of response|1|||
164187087|NCT03638466|593054370|FG000|Overall Study|Early Termination|0|||
164187088|NCT03638466|593054371|FG001|Overall Study|Early Termination|1|||
164187089|NCT02576977|593054372|FG000|Overall Study|Adverse Event|13|||
164187090|NCT02576977|593054373|FG001|Overall Study|Adverse Event|2|||
164187091|NCT02576977|593054372|FG000|Overall Study|Death|73|||
164187092|NCT02576977|593054373|FG001|Overall Study|Death|60|||
164187093|NCT02576977|593054372|FG000|Overall Study|Screen failure|1|||
164187094|NCT02576977|593054373|FG001|Overall Study|Screen failure|0|||
164187095|NCT02576977|593054372|FG000|Overall Study|Study Terminated at Selected Sites|27|||
164187096|NCT02576977|593054373|FG001|Overall Study|Study Terminated at Selected Sites|50|||
164187097|NCT02576977|593054372|FG000|Overall Study|Withdrawal by Subject|11|||
164187098|NCT02576977|593054373|FG001|Overall Study|Withdrawal by Subject|11|||
164187099|NCT02576977|593054372|FG000|Overall Study|Final Disposition Unknown|0|||
164187100|NCT02576977|593054373|FG001|Overall Study|Final Disposition Unknown|1|||
164187101|NCT02576977|593054372|FG000|Overall Study|Lost to Follow-up|1|||
164187102|NCT02576977|593054373|FG001|Overall Study|Lost to Follow-up|0|||
164187103|NCT02576977|593054372|FG000|Overall Study|Progressive Disease|0|||
164187104|NCT02576977|593054373|FG001|Overall Study|Progressive Disease|1|||
164187105|NCT04530838|593054374|FG000|Overall Study|Other|2|||
164187106|NCT04530838|593054375|FG001|Overall Study|Other|1|||
164187107|NCT04530838|593054376|FG002|Overall Study|Other|0|||
164187108|NCT04530838|593054374|FG000|Overall Study|Physician Decision|0|||
164187109|NCT04530838|593054375|FG001|Overall Study|Physician Decision|0|||
164187110|NCT04530838|593054376|FG002|Overall Study|Physician Decision|1|||
164187111|NCT04530838|593054374|FG000|Overall Study|Death|0|||
164187112|NCT04530838|593054375|FG001|Overall Study|Death|0|||
164187113|NCT04530838|593054376|FG002|Overall Study|Death|1|||
164187114|NCT04530838|593054374|FG000|Overall Study|Adverse Event|0|||
164187115|NCT04530838|593054375|FG001|Overall Study|Adverse Event|1|||
164187116|NCT04530838|593054376|FG002|Overall Study|Adverse Event|0|||
164187117|NCT04530838|593054374|FG000|Overall Study|No longer meets eligibility criteria|1|||
164187118|NCT04530838|593054375|FG001|Overall Study|No longer meets eligibility criteria|0|||
164187119|NCT04530838|593054376|FG002|Overall Study|No longer meets eligibility criteria|2|||
164187120|NCT04530838|593054374|FG000|Overall Study|Withdrawal by parent/guardian|5|||
164187121|NCT04530838|593054375|FG001|Overall Study|Withdrawal by parent/guardian|2|||
164187122|NCT04530838|593054376|FG002|Overall Study|Withdrawal by parent/guardian|2|||
164187123|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
164187124|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
164187125|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
164187126|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
164187127|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
164187128|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
164187129|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
164187130|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
164187131|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
164187132|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
164187133|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
164187134|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
164187135|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
164187136|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
164187137|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
164187138|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
164187139|NCT02362425|593054381|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
164187140|NCT02362425|593054382|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
164187141|NCT02362425|593054383|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
164187142|NCT02362425|593054384|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
164187143|NCT02362425|593054381|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
164187144|NCT02362425|593054382|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
164187145|NCT02362425|593054383|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
164187146|NCT02362425|593054384|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
164187147|NCT02362425|593054381|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
164187148|NCT02362425|593054382|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
164187149|NCT02362425|593054383|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
164187150|NCT02362425|593054384|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
164187151|NCT02362425|593054381|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
164187152|NCT02362425|593054382|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
164187153|NCT02362425|593054383|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
164187154|NCT02362425|593054384|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
164187155|NCT02155309|593054386|FG000|Overall Study|Protocol Violation|0|||
164187156|NCT02155309|593054387|FG001|Overall Study|Protocol Violation|0|||
164187157|NCT02155309|593054388|FG002|Overall Study|Protocol Violation|1|||
164187158|NCT02688764|593054392|FG000|Overall Study|Adverse Event|3|||
164187159|NCT02688764|593054393|FG001|Overall Study|Adverse Event|3|||
164187160|NCT02688764|593054392|FG000|Overall Study|AE/Kidney transplant|1|||
164187161|NCT02688764|593054393|FG001|Overall Study|AE/Kidney transplant|0|||
164187162|NCT02688764|593054392|FG000|Overall Study|AE/Lack of efficacy|1|||
164187163|NCT02688764|593054393|FG001|Overall Study|AE/Lack of efficacy|0|||
164187164|NCT02688764|593054392|FG000|Overall Study|AE/Non-compl.|1|||
164187165|NCT02688764|593054393|FG001|Overall Study|AE/Non-compl.|0|||
164187166|NCT02688764|593054392|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
164187167|NCT02688764|593054393|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
164187168|NCT02688764|593054392|FG000|Overall Study|AE/Other|0|||
164187169|NCT02688764|593054393|FG001|Overall Study|AE/Other|1|||
164187170|NCT02688764|593054392|FG000|Overall Study|AE/Physician decision|1|||
164187171|NCT02688764|593054393|FG001|Overall Study|AE/Physician decision|0|||
164187172|NCT02688764|593054392|FG000|Overall Study|AE/Withd. parent|3|||
164187173|NCT02688764|593054393|FG001|Overall Study|AE/Withd. parent|0|||
164187174|NCT02688764|593054392|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
164187175|NCT02688764|593054393|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
164187176|NCT02688764|593054392|FG000|Overall Study|AE/Withd. subject|1|||
164187177|NCT02688764|593054393|FG001|Overall Study|AE/Withd. subject|0|||
164187178|NCT02688764|593054392|FG000|Overall Study|Kidney transplant|10|||
164187179|NCT02688764|593054393|FG001|Overall Study|Kidney transplant|4|||
164187180|NCT02688764|593054392|FG000|Overall Study|Lack of Efficacy|3|||
164187181|NCT02688764|593054393|FG001|Overall Study|Lack of Efficacy|2|||
164187182|NCT02688764|593054392|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
164187183|NCT02688764|593054393|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
164187184|NCT02688764|593054392|FG000|Overall Study|Non-compliance with study drug|4|||
164187185|NCT02688764|593054393|FG001|Overall Study|Non-compliance with study drug|0|||
164187186|NCT02688764|593054392|FG000|Overall Study|Non-compl./Physician decision|2|||
164187187|NCT02688764|593054393|FG001|Overall Study|Non-compl./Physician decision|0|||
164187188|NCT02688764|593054392|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
164187189|NCT02688764|593054393|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
164187190|NCT02688764|593054392|FG000|Overall Study|Non-compl./Withd. subject|0|||
164187191|NCT02688764|593054393|FG001|Overall Study|Non-compl./Withd. subject|2|||
164187192|NCT02688764|593054392|FG000|Overall Study|Phosphorus level outside safe range|0|||
164187193|NCT02688764|593054393|FG001|Overall Study|Phosphorus level outside safe range|1|||
164187194|NCT02688764|593054392|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
164187195|NCT02688764|593054393|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
164187196|NCT02688764|593054392|FG000|Overall Study|Study drug taste/Withd. parent|1|||
164187197|NCT02688764|593054393|FG001|Overall Study|Study drug taste/Withd. parent|0|||
164187198|NCT02688764|593054392|FG000|Overall Study|Subject moving out|2|||
164187199|NCT02688764|593054393|FG001|Overall Study|Subject moving out|0|||
164187200|NCT02688764|593054392|FG000|Overall Study|Subject taken off dialysis|1|||
164187201|NCT02688764|593054393|FG001|Overall Study|Subject taken off dialysis|0|||
164187202|NCT02688764|593054392|FG000|Overall Study|Withdrawal by parent|3|||
164187203|NCT02688764|593054393|FG001|Overall Study|Withdrawal by parent|0|||
164187204|NCT03026283|593054394|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
164187205|NCT03026283|593054395|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
164187206|NCT03026283|593054396|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
164187207|NCT03026283|593054397|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
164187208|NCT03026283|593054398|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
164187209|NCT03026283|593054399|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
164187210|NCT03026283|593054400|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
164187211|NCT03026283|593054401|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
164187212|NCT03026283|593054394|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
164187213|NCT03026283|593054395|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
164187214|NCT03026283|593054396|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
164187215|NCT03026283|593054397|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
164187216|NCT03026283|593054398|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
164187217|NCT03026283|593054399|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
164187218|NCT03026283|593054400|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
164187219|NCT03026283|593054401|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
164187220|NCT03026283|593054394|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187221|NCT03026283|593054395|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
164187222|NCT03026283|593054396|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187223|NCT03026283|593054397|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187224|NCT03026283|593054398|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187225|NCT03026283|593054399|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187226|NCT03026283|593054400|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187227|NCT03026283|593054401|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
164187228|NCT03026283|593054394|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187229|NCT03026283|593054395|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187230|NCT03026283|593054396|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
164187231|NCT03026283|593054397|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187232|NCT03026283|593054398|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187233|NCT03026283|593054399|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187234|NCT03026283|593054400|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187235|NCT03026283|593054401|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
164187236|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187237|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187238|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187239|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
164187240|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
164187241|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187242|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187243|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
164187244|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187245|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187246|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187247|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
164187248|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
164187249|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
164187250|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187251|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
164187252|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187253|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187254|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187255|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
164187256|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187257|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
164187258|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187259|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
164187260|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187261|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187262|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187263|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
164187264|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187265|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187266|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187267|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
164187268|NCT03026283|593054394|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187269|NCT03026283|593054395|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187270|NCT03026283|593054396|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187271|NCT03026283|593054397|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187272|NCT03026283|593054398|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
164187273|NCT03026283|593054399|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
164187274|NCT03026283|593054400|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187275|NCT03026283|593054401|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
164187276|NCT02501161|593054402|FG000|Overall Study|Adverse Event|2|||
164187277|NCT02501161|593054403|FG001|Overall Study|Adverse Event|6|||
164187278|NCT02501161|593054402|FG000|Overall Study|Lost to Follow-up|7|||
164187279|NCT02501161|593054403|FG001|Overall Study|Lost to Follow-up|4|||
164187280|NCT02501161|593054402|FG000|Overall Study|Withdrawal by Subject|10|||
164187281|NCT02501161|593054403|FG001|Overall Study|Withdrawal by Subject|15|||
164187282|NCT02501161|593054402|FG000|Overall Study|Other|3|||
164187283|NCT02501161|593054403|FG001|Overall Study|Other|0|||
164187284|NCT00824655|593054404|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
164187285|NCT00824655|593054405|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
164187286|NCT00824655|593054404|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
164187287|NCT00824655|593054405|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
164187288|NCT04336475|593054406|FG000|Overall Study|pain|1|||
164187289|NCT04336475|593054407|FG001|Overall Study|pain|0|||
164187290|NCT04336475|593054406|FG000|Overall Study|upper respiratory infection|1|||
164187291|NCT04336475|593054407|FG001|Overall Study|upper respiratory infection|0|||
164187292|NCT04336475|593054406|FG000|Overall Study|Lost to Follow-up|0|||
164187293|NCT04336475|593054407|FG001|Overall Study|Lost to Follow-up|2|||
164187294|NCT02906579|593054422|FG000|Overall Study|Adverse Event|1|||
164187295|NCT02906579|593054422|FG000|Overall Study|Physician Decision|1|||
164187296|NCT02030119|593054423|FG000|Overall Study|Withdrawal by Subject|3|||
164187297|NCT02030119|593054424|FG001|Overall Study|Withdrawal by Subject|1|||
164187298|NCT02030119|593054425|FG002|Overall Study|Withdrawal by Subject|5|||
164187299|NCT02030119|593054426|FG003|Overall Study|Withdrawal by Subject|3|||
164187300|NCT02030119|593054423|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
164187301|NCT02030119|593054424|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
164187302|NCT02030119|593054425|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
164187303|NCT02030119|593054426|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
164187304|NCT00759655|593054427|FG000|Overall Study|Termination of the study by sponsor|1|||
164187305|NCT00905567|593054441|FG000|Washout|Withdrawal by Subject|0|||
164187306|NCT00905567|593054442|FG001|Washout|Withdrawal by Subject|1|||
164187307|NCT00621257|593054450|FG000|Overall Study|Lost to Follow-up|4|||
164187308|NCT00621257|593054451|FG001|Overall Study|Lost to Follow-up|0|||
164187309|NCT00621257|593054452|FG002|Overall Study|Lost to Follow-up|2|||
164187310|NCT00621257|593054453|FG003|Overall Study|Lost to Follow-up|4|||
164187311|NCT00621257|593054454|FG004|Overall Study|Lost to Follow-up|7|||
164187312|NCT00621257|593054450|FG000|Overall Study|Adverse Event|0|||
164187313|NCT00621257|593054451|FG001|Overall Study|Adverse Event|1|||
164187314|NCT00621257|593054452|FG002|Overall Study|Adverse Event|1|||
164187315|NCT00621257|593054453|FG003|Overall Study|Adverse Event|0|||
164187316|NCT00621257|593054454|FG004|Overall Study|Adverse Event|0|||
164187317|NCT00621257|593054450|FG000|Overall Study|Physician Decision|0|||
164187318|NCT00621257|593054451|FG001|Overall Study|Physician Decision|2|||
164187319|NCT00621257|593054452|FG002|Overall Study|Physician Decision|0|||
164187320|NCT00621257|593054453|FG003|Overall Study|Physician Decision|1|||
164187321|NCT00621257|593054454|FG004|Overall Study|Physician Decision|1|||
164187322|NCT00621257|593054450|FG000|Overall Study|Withdrawal by Subject|0|||
164187323|NCT00621257|593054451|FG001|Overall Study|Withdrawal by Subject|0|||
164187324|NCT00621257|593054452|FG002|Overall Study|Withdrawal by Subject|0|||
164187325|NCT00621257|593054453|FG003|Overall Study|Withdrawal by Subject|1|||
164187326|NCT00621257|593054454|FG004|Overall Study|Withdrawal by Subject|1|||
164187327|NCT00184002|593054455|FG000|Overall Study|Adverse Event|9|||
164187328|NCT00184002|593054455|FG000|Overall Study|Death|3|||
164187329|NCT00184002|593054455|FG000|Overall Study|Physician Decision|1|||
164187330|NCT00184002|593054455|FG000|Overall Study|Withdrawal by Subject|4|||
164187331|NCT02075008|593054465|FG000|Overall Study|Technical problems|1|||
164187332|NCT02075008|593054465|FG000|Overall Study|Pregnancy|1|||
164187333|NCT02075008|593054465|FG000|Overall Study|Physician Decision|1|||
164187334|NCT02075008|593054465|FG000|Overall Study|Lost to Follow-up|1|||
164187335|NCT02075008|593054465|FG000|Overall Study|Lack of Efficacy|1|||
164187336|NCT02075008|593054465|FG000|Overall Study|Death|1|||
164187337|NCT02075008|593054465|FG000|Overall Study|Adverse Event|5|||
164187338|NCT02075008|593054465|FG000|Overall Study|Withdrawal by Subject|6|||
164187339|NCT02075008|593054465|FG000|Overall Study|Study terminated by Sponsor|159|||
164187340|NCT02821416|593054466|FG000|Overall Study|Adverse Event|0|||
164187341|NCT02821416|593054467|FG001|Overall Study|Adverse Event|1|||
164187342|NCT02821416|593054466|FG000|Overall Study|Withdrawal by Subject|2|||
164187343|NCT02821416|593054467|FG001|Overall Study|Withdrawal by Subject|0|||
164187344|NCT02821416|593054466|FG000|Overall Study|Lost to Follow-up|1|||
164187345|NCT02821416|593054467|FG001|Overall Study|Lost to Follow-up|0|||
164187346|NCT01763203|593054470|FG000|Overall Study|Death|4|||
164187347|NCT01763203|593054471|FG001|Overall Study|Death|7|||
164187348|NCT01763203|593054470|FG000|Overall Study|Lost to Follow-up|12|||
164187349|NCT01763203|593054471|FG001|Overall Study|Lost to Follow-up|12|||
164187350|NCT01763203|593054470|FG000|Overall Study|Withdrawal by Subject|8|||
164187351|NCT01763203|593054471|FG001|Overall Study|Withdrawal by Subject|12|||
164187352|NCT01763203|593054470|FG000|Overall Study|Moved out of study region|7|||
164187353|NCT01763203|593054471|FG001|Overall Study|Moved out of study region|10|||
164187354|NCT01763203|593054470|FG000|Overall Study|Physician Decision|2|||
164187355|NCT01763203|593054471|FG001|Overall Study|Physician Decision|1|||
164187356|NCT02756819|593054472|FG000|Overall Study|Lost for observation|23|||
164187357|NCT02756819|593054472|FG000|Overall Study|Patient's unwillingness|16|||
164187358|NCT02756819|593054472|FG000|Overall Study|Insufficient efficacy|2|||
164187359|NCT02756819|593054472|FG000|Overall Study|Adverse Event|2|||
164187360|NCT02756819|593054472|FG000|Overall Study|Reason not Specified|9|||
164187361|NCT01639703|593054475|FG000|Overall Study|Withdrawal by Subject|5|||
164187362|NCT01639703|593054475|FG000|Overall Study|Other reason|7|||
164187363|NCT00878800|593054477|FG000|Overall Study|Adverse Event|0|||
164187364|NCT00878800|593054478|FG001|Overall Study|Adverse Event|0|||
164187365|NCT00878800|593054479|FG002|Overall Study|Adverse Event|2|||
164187366|NCT00878800|593054480|FG003|Overall Study|Adverse Event|0|||
164187367|NCT00878800|593054481|FG004|Overall Study|Adverse Event|1|||
164187368|NCT00878800|593054477|FG000|Overall Study|Progressive disease|1|||
164187369|NCT00878800|593054478|FG001|Overall Study|Progressive disease|5|||
164187370|NCT00878800|593054479|FG002|Overall Study|Progressive disease|6|||
164187371|NCT00878800|593054480|FG003|Overall Study|Progressive disease|5|||
164187372|NCT00878800|593054481|FG004|Overall Study|Progressive disease|13|||
164187373|NCT00878800|593054477|FG000|Overall Study|Withdrew consent|1|||
164187374|NCT00878800|593054478|FG001|Overall Study|Withdrew consent|1|||
164187375|NCT00878800|593054479|FG002|Overall Study|Withdrew consent|0|||
164187376|NCT00878800|593054480|FG003|Overall Study|Withdrew consent|1|||
164187377|NCT00878800|593054481|FG004|Overall Study|Withdrew consent|1|||
164187378|NCT00878800|593054477|FG000|Overall Study|Death|0|||
164187379|NCT00878800|593054478|FG001|Overall Study|Death|0|||
164187380|NCT00878800|593054479|FG002|Overall Study|Death|1|||
164187381|NCT00878800|593054480|FG003|Overall Study|Death|0|||
164187382|NCT00878800|593054481|FG004|Overall Study|Death|0|||
164187383|NCT00878800|593054477|FG000|Overall Study|Other|1|||
164187384|NCT00878800|593054478|FG001|Overall Study|Other|1|||
164187385|NCT00878800|593054479|FG002|Overall Study|Other|0|||
164187386|NCT00878800|593054480|FG003|Overall Study|Other|0|||
164187387|NCT00878800|593054481|FG004|Overall Study|Other|1|||
164187388|NCT02457195|593054487|FG000|Overall Study|Adverse Event|3|||
164187389|NCT02457195|593054487|FG000|Overall Study|Protocol Violation|2|||
164187390|NCT02457195|593054487|FG000|Overall Study|Withdrawal by Subject|4|||
164187391|NCT05980013|593054489|FG000|Overall Study|Withdrawal by Subject|0|||
164187392|NCT05980013|593054490|FG001|Overall Study|Withdrawal by Subject|1|||
164187393|NCT05980013|593054489|FG000|Overall Study|Device Error|0|||
164187394|NCT05980013|593054490|FG001|Overall Study|Device Error|1|||
164187395|NCT03739710|593054491|FG000|Overall Study|Screen Failed|81|||
164187396|NCT04892446|593054494|FG000|Overall Study|Death|4|||
164187397|NCT04892446|593054495|FG001|Overall Study|Death|4|||
164187398|NCT04892446|593054496|FG002|Overall Study|Death|0|||
164187399|NCT04892446|593054494|FG000|Overall Study|Withdrew consent|3|||
164187400|NCT04892446|593054495|FG001|Overall Study|Withdrew consent|0|||
164187401|NCT04892446|593054496|FG002|Overall Study|Withdrew consent|1|||
164187402|NCT04892446|593054494|FG000|Overall Study|Investigator's discretion|1|||
164187403|NCT04892446|593054495|FG001|Overall Study|Investigator's discretion|1|||
164187404|NCT04892446|593054496|FG002|Overall Study|Investigator's discretion|0|||
164187405|NCT04892446|593054494|FG000|Overall Study|Study terminated by sponsor|0|||
164187406|NCT04892446|593054495|FG001|Overall Study|Study terminated by sponsor|0|||
164187407|NCT04892446|593054496|FG002|Overall Study|Study terminated by sponsor|2|||
164187408|NCT02328937|593054499|FG000|Period 1|Lost to Follow-up|0|||
164187409|NCT02328937|593054500|FG001|Period 1|Lost to Follow-up|0|||
164187410|NCT02328937|593054501|FG002|Period 1|Lost to Follow-up|0|||
164187411|NCT02328937|593054502|FG003|Period 1|Lost to Follow-up|1|||
164187412|NCT02328937|593054503|FG004|Period 1|Lost to Follow-up|0|||
164187413|NCT02328937|593054504|FG005|Period 1|Lost to Follow-up|0|||
164187414|NCT02328937|593054499|FG000|Period 2|Adverse Event|0|||
164187415|NCT02328937|593054500|FG001|Period 2|Adverse Event|0|||
164187416|NCT02328937|593054501|FG002|Period 2|Adverse Event|1|||
164187417|NCT02328937|593054502|FG003|Period 2|Adverse Event|0|||
164187418|NCT02328937|593054503|FG004|Period 2|Adverse Event|0|||
164187419|NCT02328937|593054504|FG005|Period 2|Adverse Event|0|||
164187420|NCT00435461|593054511|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
164187421|NCT00435461|593054512|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
164187422|NCT00435461|593054513|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
164187423|NCT00435461|593054511|FG000|Overall Study|Protocol Violation|6|||
164187424|NCT00435461|593054512|FG001|Overall Study|Protocol Violation|9|||
164187425|NCT00435461|593054513|FG002|Overall Study|Protocol Violation|10|||
164187426|NCT00435461|593054511|FG000|Overall Study|Participant randomized(inadequate score)|1|||
164187427|NCT00435461|593054512|FG001|Overall Study|Participant randomized(inadequate score)|0|||
164187428|NCT00435461|593054513|FG002|Overall Study|Participant randomized(inadequate score)|0|||
164187429|NCT00435461|593054511|FG000|Overall Study|Compliance less than 80 percent|1|||
164187430|NCT00435461|593054512|FG001|Overall Study|Compliance less than 80 percent|0|||
164187431|NCT00435461|593054513|FG002|Overall Study|Compliance less than 80 percent|0|||
164187432|NCT00435461|593054511|FG000|Overall Study|In error, two study medications switched|1|||
164187433|NCT00435461|593054512|FG001|Overall Study|In error, two study medications switched|0|||
164187434|NCT00435461|593054513|FG002|Overall Study|In error, two study medications switched|0|||
164187435|NCT00435461|593054511|FG000|Overall Study|Lack of Efficacy|2|||
164187436|NCT00435461|593054512|FG001|Overall Study|Lack of Efficacy|1|||
164187437|NCT00435461|593054513|FG002|Overall Study|Lack of Efficacy|0|||
164187438|NCT00435461|593054511|FG000|Overall Study|Withdrawal by Subject|1|||
164187439|NCT00435461|593054512|FG001|Overall Study|Withdrawal by Subject|0|||
164187440|NCT00435461|593054513|FG002|Overall Study|Withdrawal by Subject|2|||
164187441|NCT00435461|593054511|FG000|Overall Study|Randomized in error|1|||
164187442|NCT00435461|593054512|FG001|Overall Study|Randomized in error|0|||
164187443|NCT00435461|593054513|FG002|Overall Study|Randomized in error|0|||
164187444|NCT00435461|593054511|FG000|Overall Study|Participant could not tolerate symptoms|0|||
164187445|NCT00435461|593054512|FG001|Overall Study|Participant could not tolerate symptoms|0|||
164187446|NCT00435461|593054513|FG002|Overall Study|Participant could not tolerate symptoms|1|||
164187447|NCT00435461|593054511|FG000|Overall Study|Participant could not swallow capsule|0|||
164187448|NCT00435461|593054512|FG001|Overall Study|Participant could not swallow capsule|0|||
164187449|NCT00435461|593054513|FG002|Overall Study|Participant could not swallow capsule|1|||
164187450|NCT00435461|593054511|FG000|Overall Study|Pregnancy|2|||
164187451|NCT00435461|593054512|FG001|Overall Study|Pregnancy|0|||
164187452|NCT00435461|593054513|FG002|Overall Study|Pregnancy|0|||
164187453|NCT00435461|593054511|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
164187454|NCT00435461|593054512|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
164187455|NCT00435461|593054513|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
164187456|NCT00435461|593054511|FG000|Overall Study|Participant ended study one day early|1|||
164187457|NCT00435461|593054512|FG001|Overall Study|Participant ended study one day early|0|||
164187458|NCT00435461|593054513|FG002|Overall Study|Participant ended study one day early|0|||
164187459|NCT00435461|593054511|FG000|Overall Study|Noncompliance with study requirements|1|||
164187460|NCT00435461|593054512|FG001|Overall Study|Noncompliance with study requirements|1|||
164187461|NCT00435461|593054513|FG002|Overall Study|Noncompliance with study requirements|1|||
164187462|NCT00435461|593054511|FG000|Overall Study|Adverse Event|1|||
164187463|NCT00435461|593054512|FG001|Overall Study|Adverse Event|2|||
164187464|NCT00435461|593054513|FG002|Overall Study|Adverse Event|6|||
164187465|NCT00435461|593054511|FG000|Overall Study|Non-Compliance of diary|2|||
164187466|NCT00435461|593054512|FG001|Overall Study|Non-Compliance of diary|0|||
164187467|NCT00435461|593054513|FG002|Overall Study|Non-Compliance of diary|1|||
164187468|NCT00435461|593054511|FG000|Overall Study|Lost to Follow-up|1|||
164187469|NCT00435461|593054512|FG001|Overall Study|Lost to Follow-up|1|||
164187470|NCT00435461|593054513|FG002|Overall Study|Lost to Follow-up|2|||
164187471|NCT04676724|593054516|FG000|Overall Study|Adverse Event|2|||
164187472|NCT04676724|593054517|FG001|Overall Study|Adverse Event|0|||
164187473|NCT04676724|593054516|FG000|Overall Study|Lost to Follow-up|1|||
164187474|NCT04676724|593054517|FG001|Overall Study|Lost to Follow-up|0|||
164187475|NCT04676724|593054516|FG000|Overall Study|Physician Decision|0|||
164187476|NCT04676724|593054517|FG001|Overall Study|Physician Decision|1|||
164187477|NCT04676724|593054516|FG000|Overall Study|Withdrawal by Subject|3|||
164187478|NCT04676724|593054517|FG001|Overall Study|Withdrawal by Subject|2|||
164187479|NCT02782377|593054520|FG000|Overall Study|Physician Decision|5|||
164187480|NCT00237692|593054521|FG000|Overall Study|Lost to Follow-up|9|||
164187481|NCT00237692|593054522|FG001|Overall Study|Lost to Follow-up|3|||
164187482|NCT00237692|593054523|FG002|Overall Study|Lost to Follow-up|5|||
164187483|NCT00237692|593054524|FG003|Overall Study|Lost to Follow-up|3|||
164187484|NCT00237692|593054521|FG000|Overall Study|Death|1|||
164187485|NCT00237692|593054522|FG001|Overall Study|Death|2|||
164187486|NCT00237692|593054523|FG002|Overall Study|Death|2|||
164187487|NCT00237692|593054524|FG003|Overall Study|Death|3|||
164187488|NCT00237692|593054521|FG000|Overall Study|Excluded - did not meet criteria|4|||
164187489|NCT00237692|593054522|FG001|Overall Study|Excluded - did not meet criteria|3|||
164187490|NCT00237692|593054523|FG002|Overall Study|Excluded - did not meet criteria|5|||
164187491|NCT00237692|593054524|FG003|Overall Study|Excluded - did not meet criteria|9|||
164187492|NCT00237692|593054521|FG000|Overall Study|Withdrawal by Subject|4|||
164187493|NCT00237692|593054522|FG001|Overall Study|Withdrawal by Subject|6|||
164187494|NCT00237692|593054523|FG002|Overall Study|Withdrawal by Subject|10|||
164187495|NCT00237692|593054524|FG003|Overall Study|Withdrawal by Subject|4|||
164187496|NCT00685360|593054525|FG000|Overall Study|Lost to Follow-up|0|||
164187497|NCT00685360|593054526|FG001|Overall Study|Lost to Follow-up|1|||
164187498|NCT00685360|593054527|FG002|Overall Study|Lost to Follow-up|2|||
164187499|NCT00685360|593054525|FG000|Overall Study|Adverse Event|4|||
164187500|NCT00685360|593054526|FG001|Overall Study|Adverse Event|6|||
164187501|NCT00685360|593054527|FG002|Overall Study|Adverse Event|4|||
164187502|NCT00685360|593054525|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
164187503|NCT00685360|593054526|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
164187504|NCT00685360|593054527|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
164187505|NCT00685360|593054525|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
164187506|NCT00685360|593054526|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
164187507|NCT00685360|593054527|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
164187508|NCT00685360|593054525|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
164187509|NCT00685360|593054526|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
164187510|NCT00685360|593054527|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
164187511|NCT00685360|593054525|FG000|Overall Study|Protocol Deviation|0|||
164187512|NCT00685360|593054526|FG001|Overall Study|Protocol Deviation|1|||
164187513|NCT00685360|593054527|FG002|Overall Study|Protocol Deviation|1|||
164187514|NCT00803712|593056562|FG000|Overall Study|Noncompliance|3|||
164187515|NCT00803712|593056563|FG001|Overall Study|Noncompliance|0|||
164187516|NCT00803712|593056562|FG000|Overall Study|Adverse Event|5|||
164187517|NCT00803712|593056563|FG001|Overall Study|Adverse Event|0|||
164187518|NCT00803712|593056562|FG000|Overall Study|Death|8|||
164187519|NCT00803712|593056563|FG001|Overall Study|Death|7|||
164187520|NCT00803712|593056562|FG000|Overall Study|Lost to Follow-up|3|||
164187521|NCT00803712|593056563|FG001|Overall Study|Lost to Follow-up|1|||
164187522|NCT00803712|593056562|FG000|Overall Study|Withdrawal by Subject|2|||
164187523|NCT00803712|593056563|FG001|Overall Study|Withdrawal by Subject|4|||
164187524|NCT00803712|593056562|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
164187525|NCT00803712|593056563|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
164187526|NCT00803712|593056562|FG000|Overall Study|Protocol criteria (other)|0|||
164187527|NCT00803712|593056563|FG001|Overall Study|Protocol criteria (other)|2|||
164187528|NCT00803712|593056562|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
164187529|NCT00803712|593056563|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
164187530|NCT00803712|593056562|FG000|Overall Study|Administrative decision|2|||
164187531|NCT00803712|593056563|FG001|Overall Study|Administrative decision|3|||
164187532|NCT00803712|593056562|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
164187533|NCT00803712|593056563|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
164187534|NCT02823470|593056564|FG000|Overall Study|Adverse Event|1|||
164187535|NCT02823470|593056565|FG001|Overall Study|Adverse Event|0|||
164187536|NCT02823470|593056564|FG000|Overall Study|Study terminated by sponsor|8|||
164187537|NCT02823470|593056565|FG001|Overall Study|Study terminated by sponsor|15|||
164187538|NCT01310127|593056567|FG000|Overall Study|Protocol Violation|1|||
164187539|NCT01310127|593056568|FG001|Overall Study|Protocol Violation|1|||
164187540|NCT01310127|593056567|FG000|Overall Study|advanced psc cataract outlier|1|||
164187541|NCT01310127|593056568|FG001|Overall Study|advanced psc cataract outlier|0|||
164187542|NCT01490840|593056569|FG000|Phase 1|Lost to Follow-up|1|||
164187543|NCT01490840|593056570|FG001|Phase 1|Lost to Follow-up|0|||
164187544|NCT01490840|593056569|FG000|Phase 1|Adverse Event|2|||
164187545|NCT01490840|593056570|FG001|Phase 1|Adverse Event|1|||
164187546|NCT01490840|593056569|FG000|Phase 1|Withdrawal by Subject|6|||
164187547|NCT01490840|593056570|FG001|Phase 1|Withdrawal by Subject|5|||
164187548|NCT01490840|593056569|FG000|Phase 1|Visit 6a omitted|1|||
164187549|NCT01490840|593056570|FG001|Phase 1|Visit 6a omitted|0|||
164187550|NCT01490840|593056569|FG000|Phase 2|Withdrawal by Subject|4|||
164187551|NCT01490840|593056570|FG001|Phase 2|Withdrawal by Subject|3|||
164187552|NCT01490840|593056569|FG000|Phase 2|Permanent interruption of fingolimod|0|||
164187553|NCT01490840|593056570|FG001|Phase 2|Permanent interruption of fingolimod|1|||
164187554|NCT01490840|593056569|FG000|Phase 2|Lost to Follow-up|1|||
164187555|NCT01490840|593056570|FG001|Phase 2|Lost to Follow-up|1|||
164187556|NCT01490840|593056569|FG000|Phase 2|Adverse Event|1|||
164187557|NCT01490840|593056570|FG001|Phase 2|Adverse Event|1|||
164187558|NCT01025284|593056574|FG000|Overall Study|Investigator Decision|0|||
164187559|NCT01025284|593056575|FG001|Overall Study|Investigator Decision|1|||
164187560|NCT01025284|593056576|FG002|Overall Study|Investigator Decision|0|||
164187561|NCT01025284|593056574|FG000|Overall Study|Withdrawal by Subject|0|||
164187562|NCT01025284|593056575|FG001|Overall Study|Withdrawal by Subject|1|||
164187563|NCT01025284|593056576|FG002|Overall Study|Withdrawal by Subject|0|||
164187564|NCT01465230|593056577|FG000|Overall Study|Withdrawal by Subject|2|||
164187565|NCT01738919|593056583|FG000|Overall Study|Lost to Follow-up|1|||
164187566|NCT01738919|593056584|FG001|Overall Study|Lost to Follow-up|0|||
164187567|NCT01738919|593056583|FG000|Overall Study|Immigrated|0|||
164187568|NCT01738919|593056584|FG001|Overall Study|Immigrated|1|||
164187569|NCT01738919|593056583|FG000|Overall Study|Withdrawal by Subject|0|||
164187570|NCT01738919|593056584|FG001|Overall Study|Withdrawal by Subject|1|||
164187571|NCT01738919|593056583|FG000|Overall Study|Not treated in accordance to guidelines|0|||
164187572|NCT01738919|593056584|FG001|Overall Study|Not treated in accordance to guidelines|1|||
164187573|NCT00547248|593056585|FG000|Overall Study|Protocol Violation|0|||
164187574|NCT00547248|593056586|FG001|Overall Study|Protocol Violation|0|||
164187575|NCT00547248|593056587|FG002|Overall Study|Protocol Violation|1|||
164187576|NCT00547248|593056588|FG003|Overall Study|Protocol Violation|1|||
164187577|NCT00547248|593056585|FG000|Overall Study|Migrated/moved from study area|0|||
164187578|NCT00547248|593056586|FG001|Overall Study|Migrated/moved from study area|0|||
164187579|NCT00547248|593056587|FG002|Overall Study|Migrated/moved from study area|2|||
164187580|NCT00547248|593056588|FG003|Overall Study|Migrated/moved from study area|0|||
164187581|NCT00547248|593056585|FG000|Overall Study|Withdrawal by Subject|0|||
164187582|NCT00547248|593056586|FG001|Overall Study|Withdrawal by Subject|0|||
164187583|NCT00547248|593056587|FG002|Overall Study|Withdrawal by Subject|7|||
164187584|NCT00547248|593056588|FG003|Overall Study|Withdrawal by Subject|1|||
164187585|NCT00534248|593056589|FG000|Overall Study|Adverse Event|19|||
164187586|NCT00534248|593056590|FG001|Overall Study|Adverse Event|29|||
164187587|NCT00534248|593056589|FG000|Overall Study|Lost to Follow-up|353|||
164187588|NCT00534248|593056590|FG001|Overall Study|Lost to Follow-up|375|||
164187589|NCT00534248|593056589|FG000|Overall Study|Other protocol specified criteria|13|||
164187590|NCT00534248|593056590|FG001|Overall Study|Other protocol specified criteria|3|||
164187591|NCT00534248|593056589|FG000|Overall Study|Physician Decision|10|||
164187592|NCT00534248|593056590|FG001|Overall Study|Physician Decision|7|||
164187593|NCT00534248|593056589|FG000|Overall Study|Protocol Violation|3|||
164187594|NCT00534248|593056590|FG001|Overall Study|Protocol Violation|4|||
164187595|NCT00534248|593056589|FG000|Overall Study|Withdrawal by Subject|263|||
164187596|NCT00534248|593056590|FG001|Overall Study|Withdrawal by Subject|255|||
164187597|NCT02849171|593056591|FG000|Overall Study|Withdrawal by Subject|1|||
164187598|NCT02849171|593056591|FG000|Overall Study|Not treated|1|||
164187599|NCT02532257|593056592|FG000|Overall Study|Adverse Event|2|||
164187600|NCT02532257|593056592|FG000|Overall Study|Physician Decision|4|||
164187601|NCT02532257|593056592|FG000|Overall Study|Withdrawal by Subject|3|||
164187602|NCT02532257|593056592|FG000|Overall Study|Progressive Disease|10|||
164187603|NCT02259400|593056593|FG000|Overall Study|Death|0|||
164187604|NCT02259400|593056594|FG001|Overall Study|Death|2|||
164187605|NCT03498313|593056598|FG000|Experimental Period 1|Adverse Event|1|||
164187606|NCT03498313|593056599|FG001|Experimental Period 1|Adverse Event|0|||
164187607|NCT03498313|593056600|FG002|Experimental Period 1|Adverse Event|0|||
164187608|NCT03498313|593056601|FG003|Experimental Period 1|Adverse Event|1|||
164187609|NCT03498313|593056602|FG004|Experimental Period 1|Adverse Event|0|||
164187610|NCT03498313|593056603|FG005|Experimental Period 1|Adverse Event|0|||
164187611|NCT03498313|593056598|FG000|Experimental Period 1|Withdrawal by Subject|0|||
164187612|NCT03498313|593056599|FG001|Experimental Period 1|Withdrawal by Subject|1|||
164187613|NCT03498313|593056600|FG002|Experimental Period 1|Withdrawal by Subject|0|||
164187614|NCT03498313|593056601|FG003|Experimental Period 1|Withdrawal by Subject|0|||
164187615|NCT03498313|593056602|FG004|Experimental Period 1|Withdrawal by Subject|0|||
164187616|NCT03498313|593056603|FG005|Experimental Period 1|Withdrawal by Subject|0|||
164187617|NCT03498313|593056598|FG000|Washout Period 1|Anovulation|1|||
164187618|NCT03498313|593056599|FG001|Washout Period 1|Anovulation|0|||
164187619|NCT03498313|593056600|FG002|Washout Period 1|Anovulation|0|||
164187620|NCT03498313|593056601|FG003|Washout Period 1|Anovulation|0|||
164187621|NCT03498313|593056602|FG004|Washout Period 1|Anovulation|0|||
164187622|NCT03498313|593056603|FG005|Washout Period 1|Anovulation|0|||
164187623|NCT03498313|593056598|FG000|Washout Period 1|Withdrawal by Subject|0|||
164187624|NCT03498313|593056599|FG001|Washout Period 1|Withdrawal by Subject|3|||
164187625|NCT03498313|593056600|FG002|Washout Period 1|Withdrawal by Subject|0|||
164187626|NCT03498313|593056601|FG003|Washout Period 1|Withdrawal by Subject|1|||
164187627|NCT03498313|593056602|FG004|Washout Period 1|Withdrawal by Subject|0|||
164187628|NCT03498313|593056603|FG005|Washout Period 1|Withdrawal by Subject|1|||
164187629|NCT03498313|593056598|FG000|Experimental Period 2|Adverse Event|0|||
164187630|NCT03498313|593056599|FG001|Experimental Period 2|Adverse Event|0|||
164187631|NCT03498313|593056600|FG002|Experimental Period 2|Adverse Event|0|||
164187632|NCT03498313|593056601|FG003|Experimental Period 2|Adverse Event|0|||
164187633|NCT03498313|593056602|FG004|Experimental Period 2|Adverse Event|1|||
164187634|NCT03498313|593056603|FG005|Experimental Period 2|Adverse Event|2|||
164187635|NCT03498313|593056598|FG000|Washout Period 2|Physician Decision|1|||
164187636|NCT03498313|593056599|FG001|Washout Period 2|Physician Decision|0|||
164187637|NCT03498313|593056600|FG002|Washout Period 2|Physician Decision|0|||
164187638|NCT03498313|593056601|FG003|Washout Period 2|Physician Decision|1|||
164187639|NCT03498313|593056602|FG004|Washout Period 2|Physician Decision|0|||
164187640|NCT03498313|593056603|FG005|Washout Period 2|Physician Decision|1|||
164187641|NCT03498313|593056598|FG000|Washout Period 2|Withdrawal by Subject|3|||
164187642|NCT03498313|593056599|FG001|Washout Period 2|Withdrawal by Subject|2|||
164187643|NCT03498313|593056600|FG002|Washout Period 2|Withdrawal by Subject|0|||
164187644|NCT03498313|593056601|FG003|Washout Period 2|Withdrawal by Subject|0|||
164187645|NCT03498313|593056602|FG004|Washout Period 2|Withdrawal by Subject|2|||
164187646|NCT03498313|593056603|FG005|Washout Period 2|Withdrawal by Subject|0|||
164187647|NCT03498313|593056598|FG000|Washout Period 2|Anovulation|0|||
164187648|NCT03498313|593056599|FG001|Washout Period 2|Anovulation|0|||
164187649|NCT03498313|593056600|FG002|Washout Period 2|Anovulation|0|||
164187650|NCT03498313|593056601|FG003|Washout Period 2|Anovulation|0|||
164187651|NCT03498313|593056602|FG004|Washout Period 2|Anovulation|0|||
164187652|NCT03498313|593056603|FG005|Washout Period 2|Anovulation|1|||
164187653|NCT02372383|593056604|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
164187654|NCT02372383|593056605|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
164187655|NCT02372383|593056606|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
164187656|NCT03084302|593056607|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
164187657|NCT03084302|593056607|FG000|Overall Study|No valid objective monitor data|6|||
164187658|NCT01255904|593056608|FG000|Overall Study|Physician Decision|1|||
164187659|NCT01255904|593056609|FG001|Overall Study|Physician Decision|4|||
164187660|NCT00305227|593056610|FG000|Overall Study|Lost to Follow-up|7|||
164187661|NCT00305227|593056611|FG001|Overall Study|Lost to Follow-up|6|||
164187662|NCT00694356|593056613|FG000|Overall Study|Adverse Event|1|||
164187663|NCT00694356|593056614|FG001|Overall Study|Adverse Event|0|||
164187664|NCT00694356|593056615|FG002|Overall Study|Adverse Event|0|||
164187665|NCT00694356|593056613|FG000|Overall Study|Progressive Disease|2|||
164187666|NCT00694356|593056614|FG001|Overall Study|Progressive Disease|6|||
164187667|NCT00694356|593056615|FG002|Overall Study|Progressive Disease|6|||
164187668|NCT00741598|593056620|FG000|Overall Study|Lost to Follow-up|3|||
164187669|NCT00741598|593056621|FG001|Overall Study|Lost to Follow-up|4|||
164187670|NCT00741598|593056620|FG000|Overall Study|Lack of Efficacy|1|||
164187671|NCT00741598|593056621|FG001|Overall Study|Lack of Efficacy|2|||
164187672|NCT00741598|593056620|FG000|Overall Study|Physician Decision|1|||
164187673|NCT00741598|593056621|FG001|Overall Study|Physician Decision|1|||
164187674|NCT00741598|593056620|FG000|Overall Study|Pregnancy|1|||
164187675|NCT00741598|593056621|FG001|Overall Study|Pregnancy|0|||
164187676|NCT00741598|593056620|FG000|Overall Study|Withdrawal by Subject|3|||
164187677|NCT00741598|593056621|FG001|Overall Study|Withdrawal by Subject|2|||
164187678|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
164187679|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
164187680|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
164187681|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
164187682|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
164187683|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
164187684|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
164187685|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
164187686|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
164187687|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
164187688|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
164187689|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
164187690|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
164187691|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
164187692|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
164187693|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
164187694|NCT01042392|593056622|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
164187695|NCT01042392|593056623|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
164187696|NCT01042392|593056624|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
164187697|NCT01042392|593056625|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
164187698|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
164187699|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
164187700|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
164187701|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
164187702|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
164187703|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
164187704|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
164187705|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
164187706|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
164187707|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
164187708|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
164187709|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
164187710|NCT01042392|593056622|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
164187711|NCT01042392|593056623|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
164187712|NCT01042392|593056624|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
164187713|NCT01042392|593056625|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
164187714|NCT03117361|593056626|FG000|Overall Study|Progressive disease|5|||
164187715|NCT03117361|593056626|FG000|Overall Study|Death|1|||
164187716|NCT03117361|593056626|FG000|Overall Study|Physician Decision|2|||
164187717|NCT03117361|593056626|FG000|Overall Study|On study treatment at the end of study|1|||
164187718|NCT03117361|593056626|FG000|Overall Study|Treatment-related adverse event|1|||
164187719|NCT03318003|593056627|FG000|Overall Study|Withdrawal by Subject|1|||
164187720|NCT03318003|593056628|FG001|Overall Study|Withdrawal by Subject|1|||
164187721|NCT03318003|593056627|FG000|Overall Study|fetal loss|0|||
164187722|NCT03318003|593056628|FG001|Overall Study|fetal loss|1|||
164187723|NCT02072941|593056629|FG000|Overall Study|Withdrawal by Subject|29|||
164187724|NCT02072941|593056630|FG001|Overall Study|Withdrawal by Subject|21|||
164187725|NCT02072941|593056629|FG000|Overall Study|Lost to Follow-up|4|||
164187726|NCT02072941|593056630|FG001|Overall Study|Lost to Follow-up|4|||
164187727|NCT02072941|593056629|FG000|Overall Study|Death|3|||
164187728|NCT02072941|593056630|FG001|Overall Study|Death|2|||
164187729|NCT02072941|593056629|FG000|Overall Study|Removed by Study Staff|2|||
164187730|NCT02072941|593056630|FG001|Overall Study|Removed by Study Staff|2|||
164187731|NCT01247350|593056633|FG000|Overall Study|Adverse Event|0|||
164187732|NCT01247350|593056634|FG001|Overall Study|Adverse Event|0|||
164187733|NCT01247350|593056635|FG002|Overall Study|Adverse Event|1|||
164187734|NCT01247350|593056636|FG003|Overall Study|Adverse Event|0|||
164187735|NCT01247350|593056637|FG004|Overall Study|Adverse Event|0|||
164187736|NCT01247350|593056633|FG000|Overall Study|Withdrawal by Subject|0|||
164187737|NCT01247350|593056634|FG001|Overall Study|Withdrawal by Subject|0|||
164187738|NCT01247350|593056635|FG002|Overall Study|Withdrawal by Subject|0|||
164187739|NCT01247350|593056636|FG003|Overall Study|Withdrawal by Subject|1|||
164187740|NCT01247350|593056637|FG004|Overall Study|Withdrawal by Subject|0|||
164187741|NCT01247350|593056633|FG000|Overall Study|Entry criteria not met|0|||
164187742|NCT01247350|593056634|FG001|Overall Study|Entry criteria not met|0|||
164187743|NCT01247350|593056635|FG002|Overall Study|Entry criteria not met|0|||
164187744|NCT01247350|593056636|FG003|Overall Study|Entry criteria not met|0|||
164187745|NCT01247350|593056637|FG004|Overall Study|Entry criteria not met|1|||
164187746|NCT00169104|593056638|FG000|Overall Study|Withdrawal by Subject|2|||
164187747|NCT00169104|593056639|FG001|Overall Study|Withdrawal by Subject|0|||
164187748|NCT00169104|593056638|FG000|Overall Study|Protocol Violation|0|||
164187749|NCT00169104|593056639|FG001|Overall Study|Protocol Violation|1|||
164187750|NCT00169104|593056638|FG000|Overall Study|Physician Decision|0|||
164187751|NCT00169104|593056639|FG001|Overall Study|Physician Decision|1|||
164187752|NCT00715299|593056645|FG000|Overall Study|Withdrawal by Subject|1|||
164187753|NCT00715299|593056645|FG000|Overall Study|Adverse Event|3|||
164187754|NCT00715299|593056645|FG000|Overall Study|failed the pre-screen exercise test|2|||
164187755|NCT02020889|593056646|FG000|Overall Study|Adverse Event|0|||
164187756|NCT02020889|593056647|FG001|Overall Study|Adverse Event|1|||
164187757|NCT02020889|593056646|FG000|Overall Study|Lack of Efficacy|1|||
164187758|NCT02020889|593056647|FG001|Overall Study|Lack of Efficacy|0|||
164187759|NCT02020889|593056646|FG000|Overall Study|Lost to Follow-up|1|||
164187760|NCT02020889|593056647|FG001|Overall Study|Lost to Follow-up|0|||
164187761|NCT02020889|593056646|FG000|Overall Study|Physician Decision|2|||
164187762|NCT02020889|593056647|FG001|Overall Study|Physician Decision|0|||
164187763|NCT02020889|593056646|FG000|Overall Study|Withdrawal by Subject|3|||
164187764|NCT02020889|593056647|FG001|Overall Study|Withdrawal by Subject|2|||
164187765|NCT01540981|593056648|FG000|Overall Study|Withdrawal by Subject|1|||
164187766|NCT01540981|593056649|FG001|Overall Study|Withdrawal by Subject|0|||
164187767|NCT00809094|593056650|FG000|Overall Study|Lost to Follow-up|0|||
164187768|NCT00809094|593056651|FG001|Overall Study|Lost to Follow-up|1|||
164187769|NCT00232557|593056652|FG000|Overall Study|Lost to Follow-up|3|||
164187770|NCT00232557|593056653|FG001|Overall Study|Lost to Follow-up|5|||
164187771|NCT02768792|593056658|FG000|Overall Study|Adverse Event|1|||
164187772|NCT04819438|593056659|FG000|Overall Study|Withdrawal by Subject|1|||
164187773|NCT04819438|593056660|FG001|Overall Study|Withdrawal by Subject|0|||
164187774|NCT04819438|593056659|FG000|Overall Study|Adverse Event|0|||
164187775|NCT04819438|593056660|FG001|Overall Study|Adverse Event|1|||
164187776|NCT04819438|593056659|FG000|Overall Study|Protocol Violation|0|||
164187777|NCT04819438|593056660|FG001|Overall Study|Protocol Violation|1|||
164187778|NCT04607135|593056662|FG000|Overall Study|Physician Decision|1|||
164187779|NCT04607135|593056662|FG000|Overall Study|Withdrawal by Subject|1|||
164187780|NCT04607135|593056662|FG000|Overall Study|Equipment not working|3|||
164187781|NCT03465709|593056663|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
164187782|NCT03465709|593056663|FG000|Overall Study|Withdrawal by Subject|3|||
164187783|NCT05359952|593056664|FG000|Overall Study|Lost to Follow-up|1|||
164187784|NCT05359952|593056665|FG001|Overall Study|Lost to Follow-up|0|||
164187785|NCT03836209|593056666|FG000|Overall Study|Adverse Event|5|||
164187786|NCT03836209|593056667|FG001|Overall Study|Adverse Event|2|||
164187787|NCT03836209|593056666|FG000|Overall Study|Death|4|||
164187788|NCT03836209|593056667|FG001|Overall Study|Death|1|||
164187789|NCT03836209|593056666|FG000|Overall Study|Lack of Efficacy|7|||
164187790|NCT03836209|593056667|FG001|Overall Study|Lack of Efficacy|10|||
164187791|NCT03836209|593056666|FG000|Overall Study|Physician Decision|7|||
164187792|NCT03836209|593056667|FG001|Overall Study|Physician Decision|11|||
164187793|NCT03836209|593056666|FG000|Overall Study|Protocol Violation|0|||
164187794|NCT03836209|593056667|FG001|Overall Study|Protocol Violation|3|||
164187795|NCT03836209|593056666|FG000|Overall Study|Withdrawal by Subject|2|||
164187796|NCT03836209|593056667|FG001|Overall Study|Withdrawal by Subject|10|||
164187797|NCT03836209|593056666|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
164187798|NCT03836209|593056667|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
164187799|NCT01768559|593056669|FG000|Overall Study|Randomized but not treated|0|||
164187800|NCT01768559|593056670|FG001|Overall Study|Randomized but not treated|0|||
164187801|NCT01768559|593056671|FG002|Overall Study|Randomized but not treated|1|||
164187802|NCT01768559|593056669|FG000|Overall Study|Adverse Event|15|||
164187803|NCT01768559|593056670|FG001|Overall Study|Adverse Event|2|||
164187804|NCT01768559|593056671|FG002|Overall Study|Adverse Event|5|||
164187805|NCT01768559|593056669|FG000|Overall Study|Lack of Efficacy|6|||
164187806|NCT01768559|593056670|FG001|Overall Study|Lack of Efficacy|4|||
164187807|NCT01768559|593056671|FG002|Overall Study|Lack of Efficacy|0|||
164187808|NCT01768559|593056669|FG000|Overall Study|Poor compliance to protocol|0|||
164187809|NCT01768559|593056670|FG001|Overall Study|Poor compliance to protocol|3|||
164187810|NCT01768559|593056671|FG002|Overall Study|Poor compliance to protocol|2|||
164187811|NCT01768559|593056669|FG000|Overall Study|Other than specified|9|||
164187812|NCT01768559|593056670|FG001|Overall Study|Other than specified|8|||
164187813|NCT01768559|593056671|FG002|Overall Study|Other than specified|5|||
164187814|NCT00398047|593056672|FG000|Overall Study|all patient progressed before completion|3|||
164187815|NCT01737879|593056673|FG000|Overall Study|Death|1|||
164187816|NCT01737879|593056673|FG000|Overall Study|Sponsor decision|40|||
164187817|NCT01386944|593056687|FG000|Overall Study|Adverse Event|26|||
164187818|NCT01386944|593056687|FG000|Overall Study|Lack of Efficacy|14|||
164187819|NCT01386944|593056687|FG000|Overall Study|Lost to Follow-up|8|||
164187820|NCT01386944|593056687|FG000|Overall Study|Unspecified reason|8|||
164187821|NCT00531947|593056691|FG000|Overall Study|Adverse Event|5|||
164187822|NCT00531947|593056692|FG001|Overall Study|Adverse Event|10|||
164187823|NCT00531947|593056691|FG000|Overall Study|Lost to Follow-up|12|||
164187824|NCT00531947|593056692|FG001|Overall Study|Lost to Follow-up|9|||
164187825|NCT00531947|593056691|FG000|Overall Study|Withdrawal by Subject|14|||
164187826|NCT00531947|593056692|FG001|Overall Study|Withdrawal by Subject|19|||
164187827|NCT00531947|593056691|FG000|Overall Study|Protocol Violation|2|||
164187828|NCT00531947|593056692|FG001|Overall Study|Protocol Violation|1|||
164187829|NCT00531947|593056691|FG000|Overall Study|Non-Compliance|4|||
164187830|NCT00531947|593056692|FG001|Overall Study|Non-Compliance|7|||
164187831|NCT00531947|593056691|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
164187832|NCT00531947|593056692|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
164187833|NCT02383355|593056693|FG000|Overall Study|Adverse Event|2|||
164187834|NCT02383355|593056694|FG001|Overall Study|Adverse Event|0|||
164187835|NCT00524680|593056695|FG000|Overall Study|progression|0|||
164187836|NCT00524680|593056696|FG001|Overall Study|progression|0|||
164187837|NCT00524680|593056697|FG002|Overall Study|progression|0|||
164187838|NCT00524680|593056698|FG003|Overall Study|progression|1|||
164187839|NCT00524680|593056695|FG000|Overall Study|Adverse Event|2|||
164187840|NCT00524680|593056696|FG001|Overall Study|Adverse Event|0|||
164187841|NCT00524680|593056697|FG002|Overall Study|Adverse Event|0|||
164187842|NCT00524680|593056698|FG003|Overall Study|Adverse Event|1|||
164187843|NCT00524680|593056695|FG000|Overall Study|Other|0|||
164187844|NCT00524680|593056696|FG001|Overall Study|Other|1|||
164187845|NCT00524680|593056697|FG002|Overall Study|Other|2|||
164187846|NCT00524680|593056698|FG003|Overall Study|Other|3|||
164187847|NCT00524680|593056695|FG000|Overall Study|Withdrawal by Subject|1|||
164187848|NCT00524680|593056696|FG001|Overall Study|Withdrawal by Subject|0|||
164187849|NCT00524680|593056697|FG002|Overall Study|Withdrawal by Subject|1|||
164187850|NCT00524680|593056698|FG003|Overall Study|Withdrawal by Subject|1|||
164187851|NCT01146561|593056701|FG000|Overall Study|Withdrawal by Subject|1|||
164187852|NCT01146561|593056701|FG000|Overall Study|Lost to Follow-up|1|||
164187853|NCT03092791|593056709|FG000|Overall Study|Lost to Follow-up|0|||
164187854|NCT03092791|593056710|FG001|Overall Study|Lost to Follow-up|0|||
164187855|NCT03092791|593056711|FG002|Overall Study|Lost to Follow-up|0|||
164187856|NCT03092791|593056712|FG003|Overall Study|Lost to Follow-up|0|||
164187857|NCT03092791|593056713|FG004|Overall Study|Lost to Follow-up|0|||
164187858|NCT03092791|593056714|FG005|Overall Study|Lost to Follow-up|0|||
164187859|NCT03092791|593056715|FG006|Overall Study|Lost to Follow-up|1|||
164187860|NCT03092791|593056716|FG007|Overall Study|Lost to Follow-up|0|||
164187861|NCT03092791|593056709|FG000|Overall Study|Withdrawal of Consent|0|||
164187862|NCT03092791|593056710|FG001|Overall Study|Withdrawal of Consent|0|||
164187863|NCT03092791|593056711|FG002|Overall Study|Withdrawal of Consent|0|||
164187864|NCT03092791|593056712|FG003|Overall Study|Withdrawal of Consent|0|||
164187865|NCT03092791|593056713|FG004|Overall Study|Withdrawal of Consent|4|||
164187866|NCT03092791|593056714|FG005|Overall Study|Withdrawal of Consent|12|||
164187867|NCT03092791|593056715|FG006|Overall Study|Withdrawal of Consent|6|||
164187868|NCT03092791|593056716|FG007|Overall Study|Withdrawal of Consent|4|||
164187869|NCT03092791|593056709|FG000|Overall Study|Study Termination|0|||
164187870|NCT03092791|593056710|FG001|Overall Study|Study Termination|0|||
164187871|NCT03092791|593056711|FG002|Overall Study|Study Termination|0|||
164187872|NCT03092791|593056712|FG003|Overall Study|Study Termination|0|||
164187873|NCT03092791|593056713|FG004|Overall Study|Study Termination|55|||
164187874|NCT03092791|593056714|FG005|Overall Study|Study Termination|46|||
164187875|NCT03092791|593056715|FG006|Overall Study|Study Termination|53|||
164187876|NCT03092791|593056716|FG007|Overall Study|Study Termination|55|||
164187877|NCT03092791|593056709|FG000|Overall Study|Death|0|||
164187878|NCT03092791|593056710|FG001|Overall Study|Death|0|||
164187879|NCT03092791|593056711|FG002|Overall Study|Death|0|||
164187880|NCT03092791|593056712|FG003|Overall Study|Death|0|||
164187881|NCT03092791|593056713|FG004|Overall Study|Death|0|||
164187882|NCT03092791|593056714|FG005|Overall Study|Death|1|||
164187883|NCT03092791|593056715|FG006|Overall Study|Death|0|||
164187884|NCT03092791|593056716|FG007|Overall Study|Death|1|||
164187885|NCT03092791|593056709|FG000|Overall Study|Reason Not Specified|0|||
164187886|NCT03092791|593056710|FG001|Overall Study|Reason Not Specified|0|||
164187887|NCT03092791|593056711|FG002|Overall Study|Reason Not Specified|0|||
164187888|NCT03092791|593056712|FG003|Overall Study|Reason Not Specified|0|||
164187889|NCT03092791|593056713|FG004|Overall Study|Reason Not Specified|1|||
164187890|NCT03092791|593056714|FG005|Overall Study|Reason Not Specified|1|||
164187891|NCT03092791|593056715|FG006|Overall Study|Reason Not Specified|0|||
164187892|NCT03092791|593056716|FG007|Overall Study|Reason Not Specified|0|||
164187893|NCT02182830|593056720|FG000|Overall Study|Not Treated|1|||
164187894|NCT02182830|593056721|FG001|Overall Study|Not Treated|1|||
164187895|NCT02182830|593056720|FG000|Overall Study|Trial stopped, reason missing|3|||
164187896|NCT02182830|593056721|FG001|Overall Study|Trial stopped, reason missing|3|||
164187897|NCT02182830|593056720|FG000|Overall Study|Consent withdrawn|8|||
164187898|NCT02182830|593056721|FG001|Overall Study|Consent withdrawn|8|||
164187899|NCT02182830|593056720|FG000|Overall Study|Lost to Follow-up|3|||
164187900|NCT02182830|593056721|FG001|Overall Study|Lost to Follow-up|3|||
164187901|NCT04399538|593056722|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
164187902|NCT04399538|593056723|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
164187903|NCT04399538|593056724|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
164187904|NCT04399538|593056725|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
164187905|NCT04399538|593056726|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
164187906|NCT04399538|593056722|FG000|Double-Blind Treatment|Adverse Event|0|||
164187907|NCT04399538|593056723|FG001|Double-Blind Treatment|Adverse Event|0|||
164187908|NCT04399538|593056724|FG002|Double-Blind Treatment|Adverse Event|0|||
164187909|NCT04399538|593056725|FG003|Double-Blind Treatment|Adverse Event|0|||
164187910|NCT04399538|593056726|FG004|Double-Blind Treatment|Adverse Event|1|||
164187911|NCT04399538|593056722|FG000|Follow-Up|Adverse Event|0|||
164187912|NCT04399538|593056723|FG001|Follow-Up|Adverse Event|0|||
164187913|NCT04399538|593056724|FG002|Follow-Up|Adverse Event|0|||
164187914|NCT04399538|593056725|FG003|Follow-Up|Adverse Event|0|||
164187915|NCT04399538|593056726|FG004|Follow-Up|Adverse Event|1|||
164187916|NCT04399538|593056722|FG000|Follow-Up|Withdrawal by Subject|0|||
164187917|NCT04399538|593056723|FG001|Follow-Up|Withdrawal by Subject|0|||
164187918|NCT04399538|593056724|FG002|Follow-Up|Withdrawal by Subject|0|||
164187919|NCT04399538|593056725|FG003|Follow-Up|Withdrawal by Subject|2|||
164187920|NCT04399538|593056726|FG004|Follow-Up|Withdrawal by Subject|0|||
164187921|NCT00586898|593056731|FG000|Overall Study|Adverse Event|1|||
164187922|NCT00586898|593056731|FG000|Overall Study|Patiemt Non-compliance|1|||
164187923|NCT00586898|593056731|FG000|Overall Study|Evaluable for Toxicity Only|5|||
164187924|NCT01588405|593056732|FG000|Overall Study|Adverse Event|1|||
164187925|NCT01588405|593056732|FG000|Overall Study|Clinical Worsening|1|||
164187926|NCT00893971|593056733|FG000|Overall Study|Physician Decision|3|||
164187927|NCT03268005|593056734|FG000|Overall Study|Death|2|||
164187928|NCT03268005|593056735|FG001|Overall Study|Death|1|||
164187929|NCT03268005|593056734|FG000|Overall Study|Lost to Follow-up|2|||
164187930|NCT03268005|593056735|FG001|Overall Study|Lost to Follow-up|2|||
164187931|NCT03268005|593056734|FG000|Overall Study|Withdrawal by Subject|11|||
164187932|NCT03268005|593056735|FG001|Overall Study|Withdrawal by Subject|11|||
164187933|NCT01926197|593056736|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
164187934|NCT01926197|593056737|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
164187935|NCT01926197|593056736|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
164187936|NCT01926197|593056737|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
164187937|NCT00492232|593056738|FG000|Placebo Run-in|Adverse Event|0|||
164187938|NCT00492232|593056739|FG001|Placebo Run-in|Adverse Event|2|||
164187939|NCT00492232|593056738|FG000|Placebo Run-in|Protocol Violation|0|||
164187940|NCT00492232|593056739|FG001|Placebo Run-in|Protocol Violation|3|||
164187941|NCT00492232|593056738|FG000|Placebo Run-in|Lost to Follow-up|0|||
164187942|NCT00492232|593056739|FG001|Placebo Run-in|Lost to Follow-up|3|||
164187943|NCT00492232|593056738|FG000|Placebo Run-in|Withdrawal by Subject|0|||
164187944|NCT00492232|593056739|FG001|Placebo Run-in|Withdrawal by Subject|8|||
164187945|NCT00492232|593056738|FG000|Placebo Run-in|Pregnancy|0|||
164187946|NCT00492232|593056739|FG001|Placebo Run-in|Pregnancy|1|||
164187947|NCT00492232|593056738|FG000|Placebo Run-in|Entrance criteria not met|0|||
164187948|NCT00492232|593056739|FG001|Placebo Run-in|Entrance criteria not met|45|||
164187949|NCT00492232|593056738|FG000|Placebo Run-in|Other|0|||
164187950|NCT00492232|593056739|FG001|Placebo Run-in|Other|6|||
164187951|NCT00492232|593056738|FG000|Placebo Run-in|Missing|0|||
164187952|NCT00492232|593056739|FG001|Placebo Run-in|Missing|2|||
164187953|NCT00492232|593056738|FG000|Double-Blind Treatment|Adverse Event|1|||
164187954|NCT00492232|593056739|FG001|Double-Blind Treatment|Adverse Event|2|||
164187955|NCT00492232|593056738|FG000|Double-Blind Treatment|Protocol Violation|3|||
164187956|NCT00492232|593056739|FG001|Double-Blind Treatment|Protocol Violation|7|||
164187957|NCT00492232|593056738|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
164187958|NCT00492232|593056739|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
164187959|NCT00492232|593056738|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
164187960|NCT00492232|593056739|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
164187961|NCT00492232|593056738|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
164187962|NCT00492232|593056739|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
164187963|NCT00492232|593056738|FG000|Double-Blind Treatment|Other|6|||
164187964|NCT00492232|593056739|FG001|Double-Blind Treatment|Other|5|||
164187965|NCT00492232|593056738|FG000|Double-Blind Treatment|Randomized not treated|1|||
164187966|NCT00492232|593056739|FG001|Double-Blind Treatment|Randomized not treated|0|||
164187967|NCT00492232|593056738|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
164187968|NCT00492232|593056739|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
164187969|NCT00980655|593056740|FG000|Overall Study|Adverse Event|13|||
164187970|NCT00980655|593056741|FG001|Overall Study|Adverse Event|31|||
164187971|NCT00980655|593056740|FG000|Overall Study|Death|0|||
164187972|NCT00980655|593056741|FG001|Overall Study|Death|7|||
164187973|NCT00980655|593056740|FG000|Overall Study|Protocol Violation|2|||
164187974|NCT00980655|593056741|FG001|Overall Study|Protocol Violation|7|||
164187975|NCT00980655|593056740|FG000|Overall Study|Withdrawal by Subject|0|||
164187976|NCT00980655|593056741|FG001|Overall Study|Withdrawal by Subject|4|||
164187977|NCT00980655|593056740|FG000|Overall Study|Lost to Follow-up|0|||
164187978|NCT00980655|593056741|FG001|Overall Study|Lost to Follow-up|1|||
164187979|NCT00980655|593056740|FG000|Overall Study|Parent/legal guardian request|1|||
164187980|NCT00980655|593056741|FG001|Overall Study|Parent/legal guardian request|0|||
164187981|NCT00980655|593056740|FG000|Overall Study|Other|0|||
164187982|NCT00980655|593056741|FG001|Overall Study|Other|1|||
164187983|NCT04162795|593056745|FG000|Overall Study|Other|16|||
164187984|NCT04162795|593056745|FG000|Overall Study|Screen failures|10|||
164187985|NCT01416155|593056746|FG000|Overall Study|Adverse Event|8|||
164187986|NCT01416155|593056746|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
164187987|NCT01416155|593056746|FG000|Overall Study|Withdrawal by Subject|33|||
164187988|NCT01416155|593056746|FG000|Overall Study|Investigator decision|8|||
164187989|NCT01416155|593056746|FG000|Overall Study|Other|7|||
164187990|NCT00829829|593056750|FG000|Overall Study|Protocol Violation|0|||
164187991|NCT00829829|593056751|FG001|Overall Study|Protocol Violation|3|||
164187992|NCT00829829|593056752|FG002|Overall Study|Protocol Violation|0|||
164187993|NCT00829829|593056750|FG000|Overall Study|Adverse Event|4|||
164187994|NCT00829829|593056751|FG001|Overall Study|Adverse Event|4|||
164187995|NCT00829829|593056752|FG002|Overall Study|Adverse Event|3|||
164187996|NCT00829829|593056750|FG000|Overall Study|Withdrawal by Subject|8|||
164187997|NCT00829829|593056751|FG001|Overall Study|Withdrawal by Subject|4|||
164187998|NCT00829829|593056752|FG002|Overall Study|Withdrawal by Subject|2|||
164187999|NCT00829829|593056750|FG000|Overall Study|Decision by the Sponsor|1|||
164188000|NCT00829829|593056751|FG001|Overall Study|Decision by the Sponsor|0|||
164188001|NCT00829829|593056752|FG002|Overall Study|Decision by the Sponsor|2|||
164188002|NCT00829829|593056750|FG000|Overall Study|Lost to Follow-up|7|||
164188003|NCT00829829|593056751|FG001|Overall Study|Lost to Follow-up|3|||
164188004|NCT00829829|593056752|FG002|Overall Study|Lost to Follow-up|3|||
164188005|NCT00829829|593056750|FG000|Overall Study|Other than specified above|2|||
164188006|NCT00829829|593056751|FG001|Overall Study|Other than specified above|2|||
164188007|NCT00829829|593056752|FG002|Overall Study|Other than specified above|1|||
164188008|NCT00382109|593056753|FG000|Overall Study|Adverse Event|3|||
164188009|NCT00382109|593056754|FG001|Overall Study|Adverse Event|0|||
164188010|NCT00382109|593056753|FG000|Overall Study|Physician Decision|6|||
164188011|NCT00382109|593056754|FG001|Overall Study|Physician Decision|1|||
164188012|NCT00382109|593056753|FG000|Overall Study|Withdrawal by Subject|1|||
164188013|NCT00382109|593056754|FG001|Overall Study|Withdrawal by Subject|0|||
164188014|NCT00382109|593056753|FG000|Overall Study|ineligible|2|||
164188015|NCT00382109|593056754|FG001|Overall Study|ineligible|0|||
164188016|NCT00382109|593056753|FG000|Overall Study|Other|0|||
164188017|NCT00382109|593056754|FG001|Overall Study|Other|2|||
164188018|NCT00382109|593056753|FG000|Overall Study|consent withdrawal|0|||
164188019|NCT00382109|593056754|FG001|Overall Study|consent withdrawal|1|||
164188020|NCT03251482|593058707|FG000|Overall Study|Withdrawal by Subject|0|||
164188021|NCT03251482|593058708|FG001|Overall Study|Withdrawal by Subject|1|||
164188022|NCT03251482|593058709|FG002|Overall Study|Withdrawal by Subject|0|||
164188023|NCT03251482|593058710|FG003|Overall Study|Withdrawal by Subject|0|||
164188024|NCT03251482|593058711|FG004|Overall Study|Withdrawal by Subject|0|||
164188025|NCT03859648|593058716|FG000|Overall Study|Lost to Follow-up|1|||
164188026|NCT03859648|593058716|FG000|Overall Study|Adverse Event|1|||
164188027|NCT01990573|593058722|FG000|Overall Study|Physician Decision|0|||
164188028|NCT01990573|593058723|FG001|Overall Study|Physician Decision|0|||
164188029|NCT01990573|593058724|FG002|Overall Study|Physician Decision|1|||
164188030|NCT03335813|593058735|FG000|Overall Study|Withdrawal by Subject|1|||
164188031|NCT00697593|593058743|FG000|Overall Study|Adverse Event|3|||
164188032|NCT00697593|593058743|FG000|Overall Study|Protocol Violation|1|||
164188033|NCT00697593|593058743|FG000|Overall Study|Lack of Efficacy|3|||
164188034|NCT00697593|593058743|FG000|Overall Study|Suspension of the study by sponsor|12|||
164188035|NCT05133323|593058748|FG000|Overall Study|Lack of Efficacy|0|||
164188036|NCT05133323|593058749|FG001|Overall Study|Lack of Efficacy|0|||
164188037|NCT05133323|593058750|FG002|Overall Study|Lack of Efficacy|1|||
164188038|NCT05133323|593058748|FG000|Overall Study|Withdrawal by Subject|2|||
164188039|NCT05133323|593058749|FG001|Overall Study|Withdrawal by Subject|1|||
164188040|NCT05133323|593058750|FG002|Overall Study|Withdrawal by Subject|0|||
164188041|NCT04152083|593058763|FG000|Overall Study|Lost to Follow-up|2|||
164188042|NCT04152083|593058764|FG001|Overall Study|Lost to Follow-up|1|||
164188043|NCT04152083|593058763|FG000|Overall Study|Adverse Event|1|||
164188044|NCT04152083|593058764|FG001|Overall Study|Adverse Event|0|||
164188045|NCT04152083|593058763|FG000|Overall Study|Randomized but not treated|3|||
164188046|NCT04152083|593058764|FG001|Overall Study|Randomized but not treated|2|||
164188047|NCT02087670|593058765|FG000|Overall Study|Withdrawal by Subject|3|||
164188048|NCT02087670|593058766|FG001|Overall Study|Withdrawal by Subject|2|||
164188049|NCT00411450|593058767|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
164188050|NCT03904420|593058768|FG000|Overall Study|Study terminated|2|||
164188051|NCT03904420|593058769|FG001|Overall Study|Study terminated|2|||
164188052|NCT00614874|593058770|FG000|Overall Study|Protocol Violation|1|||
164188053|NCT00614874|593058770|FG000|Overall Study|Withdrawal by Subject|1|||
164188054|NCT04435808|593058771|FG000|Overall Study|Study stopped by DSMB|0|||
164188055|NCT04435808|593058772|FG001|Overall Study|Study stopped by DSMB|1|||
164188056|NCT00807612|593058773|FG000|Overall Study|Death|8|||
164188057|NCT00807612|593058773|FG000|Overall Study|Study early termination|5|||
164188058|NCT00807612|593058773|FG000|Overall Study|Withdrawal by Subject|1|||
164188059|NCT00705341|593058774|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
164188060|NCT00705341|593058775|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
164188061|NCT00705341|593058776|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
164188062|NCT00705341|593058777|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
164188063|NCT00705341|593058774|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
164188064|NCT00705341|593058775|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
164188065|NCT00705341|593058776|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
164188066|NCT00705341|593058777|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
164188067|NCT04978337|593058784|FG000|Overall Study|Withdrawal by Subject|0|||
164188068|NCT04978337|593058785|FG001|Overall Study|Withdrawal by Subject|1|||
164188069|NCT01436227|593058789|FG000|Overall Study|Adverse Event|7|||
164188070|NCT01436227|593058789|FG000|Overall Study|Death|1|||
164188071|NCT01436227|593058789|FG000|Overall Study|Lack of Efficacy|1|||
164188072|NCT01436227|593058789|FG000|Overall Study|Lost to Follow-up|3|||
164188073|NCT01436227|593058789|FG000|Overall Study|Physician Decision|1|||
164188074|NCT01436227|593058789|FG000|Overall Study|Withdrawal by Subject|7|||
164188075|NCT01436227|593058789|FG000|Overall Study|Disease progression, relapse|6|||
164188076|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
164188077|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
164188078|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
164188079|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
164188080|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
164188081|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
164188082|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
164188083|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
164188084|NCT00972283|593058790|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
164188085|NCT00972283|593058791|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
164188086|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
164188087|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
164188088|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
164188089|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
164188090|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
164188091|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
164188092|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
164188093|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
164188094|NCT00972283|593058790|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
164188095|NCT00972283|593058791|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
164188096|NCT03124537|593058792|FG000|Overall Study|Lost to Follow-up|3|||
164188097|NCT03124537|593058793|FG001|Overall Study|Lost to Follow-up|5|||
164188098|NCT03124537|593058792|FG000|Overall Study|App Crash, Incomplete Data|7|||
164188099|NCT03124537|593058793|FG001|Overall Study|App Crash, Incomplete Data|8|||
164188100|NCT00830518|593058796|FG000|Overall Study|Progressive Disease|18|||
164188101|NCT00830518|593058797|FG001|Overall Study|Progressive Disease|8|||
164188102|NCT00830518|593058796|FG000|Overall Study|Symptomatic Deterioration|4|||
164188103|NCT00830518|593058797|FG001|Overall Study|Symptomatic Deterioration|1|||
164188104|NCT00830518|593058796|FG000|Overall Study|Adverse Event|14|||
164188105|NCT00830518|593058797|FG001|Overall Study|Adverse Event|1|||
164188106|NCT00830518|593058796|FG000|Overall Study|Withdrawal by Patient|2|||
164188107|NCT00830518|593058797|FG001|Overall Study|Withdrawal by Patient|0|||
164188108|NCT00830518|593058796|FG000|Overall Study|Reason not Specified|8|||
164188109|NCT00830518|593058797|FG001|Overall Study|Reason not Specified|1|||
164188110|NCT02756364|593058800|FG000|Overall Study|Site Terminated by Sponsor|24|||
164188111|NCT02756364|593058801|FG001|Overall Study|Site Terminated by Sponsor|30|||
164188112|NCT02756364|593058802|FG002|Overall Study|Site Terminated by Sponsor|21|||
164188113|NCT02756364|593058800|FG000|Overall Study|Death|20|||
164188114|NCT02756364|593058801|FG001|Overall Study|Death|15|||
164188115|NCT02756364|593058802|FG002|Overall Study|Death|18|||
164188116|NCT02756364|593058800|FG000|Overall Study|Withdrawal by Patient|2|||
164188117|NCT02756364|593058801|FG001|Overall Study|Withdrawal by Patient|1|||
164188118|NCT02756364|593058802|FG002|Overall Study|Withdrawal by Patient|8|||
164188119|NCT02756364|593058800|FG000|Overall Study|Lost to Follow-up|0|||
164188120|NCT02756364|593058801|FG001|Overall Study|Lost to Follow-up|1|||
164188121|NCT02756364|593058802|FG002|Overall Study|Lost to Follow-up|1|||
164188122|NCT02223364|593058803|FG000|Overall Study|Protocol Violation|3|||
164188123|NCT02223364|593058804|FG001|Overall Study|Protocol Violation|0|||
164188124|NCT02223364|593058805|FG002|Overall Study|Protocol Violation|3|||
164188125|NCT02223364|593058803|FG000|Overall Study|subject expired before surgery|1|||
164188126|NCT02223364|593058804|FG001|Overall Study|subject expired before surgery|0|||
164188127|NCT02223364|593058805|FG002|Overall Study|subject expired before surgery|0|||
164188128|NCT02223364|593058803|FG000|Overall Study|Physician Decision|1|||
164188129|NCT02223364|593058804|FG001|Overall Study|Physician Decision|0|||
164188130|NCT02223364|593058805|FG002|Overall Study|Physician Decision|0|||
164188131|NCT02984267|593058806|FG000|Overall Study|Protocol Violation|1|||
164188132|NCT02984267|593058807|FG001|Overall Study|Protocol Violation|0|||
164188133|NCT02984267|593058806|FG000|Overall Study|Withdrawal by Subject|0|||
164188134|NCT02984267|593058807|FG001|Overall Study|Withdrawal by Subject|1|||
164188135|NCT02685072|593058808|FG000|Treatment Period|Lost to Follow-up|12|||
164188136|NCT02685072|593058809|FG001|Treatment Period|Lost to Follow-up|6|||
164188137|NCT02685072|593058808|FG000|Treatment Period|Withdrawal by Subject|1|||
164188138|NCT02685072|593058809|FG001|Treatment Period|Withdrawal by Subject|3|||
164188139|NCT02685072|593058808|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
164188140|NCT02685072|593058809|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
164188141|NCT01994902|593058810|FG000|Test Period 1|Withdrawal by Subject|3|||
164188142|NCT01994902|593058811|FG001|Test Period 1|Withdrawal by Subject|0|||
164188143|NCT01994902|593058810|FG000|Test Period 1|device deficiency with adverse event|0|||
164188144|NCT01994902|593058811|FG001|Test Period 1|device deficiency with adverse event|1|||
164188145|NCT01994902|593058810|FG000|Test Period 1|Adverse Event|2|||
164188146|NCT01994902|593058811|FG001|Test Period 1|Adverse Event|1|||
164188147|NCT01994902|593058810|FG000|Test Period 1|Lack of Efficacy|0|||
164188148|NCT01994902|593058811|FG001|Test Period 1|Lack of Efficacy|1|||
164188149|NCT01994902|593058810|FG000|Test Period 1|bag too small|1|||
164188150|NCT01994902|593058811|FG001|Test Period 1|bag too small|0|||
164188151|NCT01994902|593058810|FG000|Test Period 2|Withdrawal by Subject|0|||
164188152|NCT01994902|593058811|FG001|Test Period 2|Withdrawal by Subject|2|||
164188153|NCT01994902|593058810|FG000|Test Period 2|Lack of Efficacy|0|||
164188154|NCT01994902|593058811|FG001|Test Period 2|Lack of Efficacy|1|||
164188155|NCT01994902|593058810|FG000|Test Period 2|Other|0|||
164188156|NCT01994902|593058811|FG001|Test Period 2|Other|3|||
164188157|NCT03597139|593058812|FG000|Overall Study|Adverse Event|3|||
164188158|NCT03597139|593058813|FG001|Overall Study|Adverse Event|0|||
164188159|NCT03597139|593058812|FG000|Overall Study|Protocol Non-compliance|1|||
164188160|NCT03597139|593058813|FG001|Overall Study|Protocol Non-compliance|0|||
164188161|NCT05052697|593058815|FG000|Substudy A|Lost to Follow-up|0|||
164188162|NCT05052697|593058816|FG001|Substudy A|Lost to Follow-up|0|||
164188163|NCT05052697|593058817|FG002|Substudy A|Lost to Follow-up|0|||
164188164|NCT05052697|593058818|FG003|Substudy A|Lost to Follow-up|0|||
164188165|NCT05052697|593058819|FG004|Substudy A|Lost to Follow-up|0|||
164188166|NCT05052697|593058820|FG005|Substudy A|Lost to Follow-up|1|||
164188167|NCT05052697|593058821|FG006|Substudy A|Lost to Follow-up|0|||
164188168|NCT05052697|593058822|FG007|Substudy A|Lost to Follow-up|0|||
164188169|NCT05052697|593058823|FG008|Substudy A|Lost to Follow-up|0|||
164188170|NCT05052697|593058824|FG009|Substudy A|Lost to Follow-up|0|||
164188171|NCT05052697|593058825|FG010|Substudy A|Lost to Follow-up|0|||
164188172|NCT05052697|593058826|FG011|Substudy A|Lost to Follow-up|0|||
164188173|NCT05052697|593058827|FG012|Substudy A|Lost to Follow-up|0|||
164188174|NCT05052697|593058828|FG013|Substudy A|Lost to Follow-up|0|||
164188175|NCT05052697|593058829|FG014|Substudy A|Lost to Follow-up|0|||
164188176|NCT05052697|593058830|FG015|Substudy A|Lost to Follow-up|2|||
164188177|NCT05052697|593058831|FG016|Substudy A|Lost to Follow-up|0|||
164188178|NCT05052697|593058832|FG017|Substudy A|Lost to Follow-up|0|||
164188179|NCT05052697|593058833|FG018|Substudy A|Lost to Follow-up|0|||
164188180|NCT05052697|593058834|FG019|Substudy A|Lost to Follow-up|0|||
164188181|NCT05052697|593058835|FG020|Substudy A|Lost to Follow-up|0|||
164188182|NCT05052697|593058836|FG021|Substudy A|Lost to Follow-up|0|||
164188183|NCT05052697|593058837|FG022|Substudy A|Lost to Follow-up|0|||
164188184|NCT05052697|593058838|FG023|Substudy A|Lost to Follow-up|0|||
164188185|NCT05052697|593058839|FG024|Substudy A|Lost to Follow-up|0|||
164188186|NCT05052697|593058840|FG025|Substudy A|Lost to Follow-up|0|||
164188187|NCT05052697|593058841|FG026|Substudy A|Lost to Follow-up|0|||
164188188|NCT05052697|593058842|FG027|Substudy A|Lost to Follow-up|0|||
164188189|NCT05052697|593058843|FG028|Substudy A|Lost to Follow-up|0|||
164188190|NCT05052697|593058844|FG029|Substudy A|Lost to Follow-up|0|||
164188191|NCT05052697|593058845|FG030|Substudy A|Lost to Follow-up|0|||
164188192|NCT05052697|593058846|FG031|Substudy A|Lost to Follow-up|0|||
164188193|NCT05052697|593058847|FG032|Substudy A|Lost to Follow-up|0|||
164188194|NCT05052697|593058848|FG033|Substudy A|Lost to Follow-up|0|||
164188195|NCT05052697|593058815|FG000|Substudy A|No longer met eligibility criteria|0|||
164188196|NCT05052697|593058816|FG001|Substudy A|No longer met eligibility criteria|0|||
164188197|NCT05052697|593058817|FG002|Substudy A|No longer met eligibility criteria|0|||
164188198|NCT05052697|593058818|FG003|Substudy A|No longer met eligibility criteria|0|||
164188199|NCT05052697|593058819|FG004|Substudy A|No longer met eligibility criteria|0|||
164188200|NCT05052697|593058820|FG005|Substudy A|No longer met eligibility criteria|0|||
164188201|NCT05052697|593058821|FG006|Substudy A|No longer met eligibility criteria|0|||
164188202|NCT05052697|593058822|FG007|Substudy A|No longer met eligibility criteria|0|||
164188203|NCT05052697|593058823|FG008|Substudy A|No longer met eligibility criteria|0|||
164188204|NCT05052697|593058824|FG009|Substudy A|No longer met eligibility criteria|0|||
164188205|NCT05052697|593058825|FG010|Substudy A|No longer met eligibility criteria|0|||
164188206|NCT05052697|593058826|FG011|Substudy A|No longer met eligibility criteria|0|||
164188207|NCT05052697|593058827|FG012|Substudy A|No longer met eligibility criteria|0|||
164188208|NCT05052697|593058828|FG013|Substudy A|No longer met eligibility criteria|1|||
164188209|NCT05052697|593058829|FG014|Substudy A|No longer met eligibility criteria|0|||
164188210|NCT05052697|593058830|FG015|Substudy A|No longer met eligibility criteria|0|||
164188211|NCT05052697|593058831|FG016|Substudy A|No longer met eligibility criteria|0|||
164188212|NCT05052697|593058832|FG017|Substudy A|No longer met eligibility criteria|0|||
164188213|NCT05052697|593058833|FG018|Substudy A|No longer met eligibility criteria|0|||
164188214|NCT05052697|593058834|FG019|Substudy A|No longer met eligibility criteria|0|||
164188215|NCT05052697|593058835|FG020|Substudy A|No longer met eligibility criteria|0|||
164188216|NCT05052697|593058836|FG021|Substudy A|No longer met eligibility criteria|0|||
164188217|NCT05052697|593058837|FG022|Substudy A|No longer met eligibility criteria|0|||
164188218|NCT05052697|593058838|FG023|Substudy A|No longer met eligibility criteria|0|||
164188219|NCT05052697|593058839|FG024|Substudy A|No longer met eligibility criteria|0|||
164188220|NCT05052697|593058840|FG025|Substudy A|No longer met eligibility criteria|0|||
164188221|NCT05052697|593058841|FG026|Substudy A|No longer met eligibility criteria|0|||
164188222|NCT05052697|593058842|FG027|Substudy A|No longer met eligibility criteria|0|||
164188223|NCT05052697|593058843|FG028|Substudy A|No longer met eligibility criteria|0|||
164188224|NCT05052697|593058844|FG029|Substudy A|No longer met eligibility criteria|0|||
164188225|NCT05052697|593058845|FG030|Substudy A|No longer met eligibility criteria|0|||
164188226|NCT05052697|593058846|FG031|Substudy A|No longer met eligibility criteria|0|||
164188227|NCT05052697|593058847|FG032|Substudy A|No longer met eligibility criteria|0|||
164188228|NCT05052697|593058848|FG033|Substudy A|No longer met eligibility criteria|0|||
164188229|NCT05052697|593058815|FG000|Substudy A|Not vaccinated|0|||
164188230|NCT05052697|593058816|FG001|Substudy A|Not vaccinated|0|||
164188231|NCT05052697|593058817|FG002|Substudy A|Not vaccinated|0|||
164188232|NCT05052697|593058818|FG003|Substudy A|Not vaccinated|1|||
164188233|NCT05052697|593058819|FG004|Substudy A|Not vaccinated|0|||
164188234|NCT05052697|593058820|FG005|Substudy A|Not vaccinated|0|||
164188235|NCT05052697|593058821|FG006|Substudy A|Not vaccinated|0|||
164188236|NCT05052697|593058822|FG007|Substudy A|Not vaccinated|0|||
164188237|NCT05052697|593058823|FG008|Substudy A|Not vaccinated|1|||
164188238|NCT05052697|593058824|FG009|Substudy A|Not vaccinated|0|||
164188239|NCT05052697|593058825|FG010|Substudy A|Not vaccinated|0|||
164188240|NCT05052697|593058826|FG011|Substudy A|Not vaccinated|0|||
164188241|NCT05052697|593058827|FG012|Substudy A|Not vaccinated|0|||
164188242|NCT05052697|593058828|FG013|Substudy A|Not vaccinated|0|||
164188243|NCT05052697|593058829|FG014|Substudy A|Not vaccinated|0|||
164188244|NCT05052697|593058830|FG015|Substudy A|Not vaccinated|0|||
164188245|NCT05052697|593058831|FG016|Substudy A|Not vaccinated|0|||
164188246|NCT05052697|593058832|FG017|Substudy A|Not vaccinated|0|||
164188247|NCT05052697|593058833|FG018|Substudy A|Not vaccinated|0|||
164188248|NCT05052697|593058834|FG019|Substudy A|Not vaccinated|0|||
164188249|NCT05052697|593058835|FG020|Substudy A|Not vaccinated|0|||
164188250|NCT05052697|593058836|FG021|Substudy A|Not vaccinated|0|||
164188251|NCT05052697|593058837|FG022|Substudy A|Not vaccinated|0|||
164188252|NCT05052697|593058838|FG023|Substudy A|Not vaccinated|0|||
164188253|NCT05052697|593058839|FG024|Substudy A|Not vaccinated|0|||
164188254|NCT05052697|593058840|FG025|Substudy A|Not vaccinated|0|||
164188255|NCT05052697|593058841|FG026|Substudy A|Not vaccinated|0|||
164188256|NCT05052697|593058842|FG027|Substudy A|Not vaccinated|0|||
164188257|NCT05052697|593058843|FG028|Substudy A|Not vaccinated|0|||
164188258|NCT05052697|593058844|FG029|Substudy A|Not vaccinated|0|||
164188259|NCT05052697|593058845|FG030|Substudy A|Not vaccinated|0|||
164188260|NCT05052697|593058846|FG031|Substudy A|Not vaccinated|0|||
164188261|NCT05052697|593058847|FG032|Substudy A|Not vaccinated|0|||
164188262|NCT05052697|593058848|FG033|Substudy A|Not vaccinated|0|||
164188263|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188264|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188265|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188266|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188267|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188268|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188269|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188270|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188271|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188272|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188273|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188274|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188275|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188276|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188277|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188278|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188279|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188280|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188281|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
164188282|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
164188283|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188560|NCT02427802|593058864|FG000|Overall Study|Death|0|||
164188284|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
164188285|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
164188286|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188287|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188288|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188289|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188290|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188291|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188292|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188293|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188294|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188295|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188296|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
164188297|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188298|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188299|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188300|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188301|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188302|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188303|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188304|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188305|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188306|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188307|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188308|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188309|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188310|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188311|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188312|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188313|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188314|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
164188315|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188316|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188317|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188318|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188319|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188320|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188321|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188322|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188323|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188324|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188325|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188326|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188327|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188328|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188329|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188330|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
164188331|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188332|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188333|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188334|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188335|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188336|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188337|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188338|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188339|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188340|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188341|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188342|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188343|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188344|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188345|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188346|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188347|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188348|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188349|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188350|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
164188351|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188352|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188353|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188354|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188355|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188356|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188357|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188358|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188359|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188360|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188361|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188362|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188363|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188364|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
164188365|NCT05052697|593058815|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188366|NCT05052697|593058816|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188367|NCT05052697|593058817|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188368|NCT05052697|593058818|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188369|NCT05052697|593058819|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188370|NCT05052697|593058820|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188371|NCT05052697|593058821|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188372|NCT05052697|593058822|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188373|NCT05052697|593058823|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188374|NCT05052697|593058824|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188375|NCT05052697|593058825|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188376|NCT05052697|593058826|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188377|NCT05052697|593058827|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188378|NCT05052697|593058828|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188379|NCT05052697|593058829|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188380|NCT05052697|593058830|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188381|NCT05052697|593058831|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188382|NCT05052697|593058832|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
164188383|NCT05052697|593058833|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188384|NCT05052697|593058834|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188385|NCT05052697|593058835|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188386|NCT05052697|593058836|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188387|NCT05052697|593058837|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188388|NCT05052697|593058838|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188389|NCT05052697|593058839|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188390|NCT05052697|593058840|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
164188391|NCT05052697|593058841|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188392|NCT05052697|593058842|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
164188393|NCT05052697|593058843|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188394|NCT05052697|593058844|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188395|NCT05052697|593058845|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188396|NCT05052697|593058846|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188397|NCT05052697|593058847|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188398|NCT05052697|593058848|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
164188399|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188400|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188401|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188402|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188403|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188404|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188405|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188406|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188407|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188408|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188409|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188410|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188411|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188412|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188413|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188414|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188415|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188416|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188417|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188418|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188419|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188420|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188561|NCT02427802|593058865|FG001|Overall Study|Death|4|||
164188421|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188422|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188423|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188424|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188425|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188426|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188427|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
164188428|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188429|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
164188430|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
164188431|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
164188432|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
164188433|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188434|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188435|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188436|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188437|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188438|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188439|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188440|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188441|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188442|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188443|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188444|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188445|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188446|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188447|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188448|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188449|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188450|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188451|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188452|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188453|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188454|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188455|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188456|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188457|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188458|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188459|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188460|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188461|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
164188462|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
164188463|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
164188464|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
164188465|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
164188466|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
164188467|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188468|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188469|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188470|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188471|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188472|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188473|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188474|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188475|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188476|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188477|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188478|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188479|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188480|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188481|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188482|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188483|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188484|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188485|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188486|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188487|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188488|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188489|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188490|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188491|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188492|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188493|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188494|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188495|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188496|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188497|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188498|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188499|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
164188500|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
164188501|NCT05052697|593058815|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188502|NCT05052697|593058816|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188503|NCT05052697|593058817|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188504|NCT05052697|593058818|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188505|NCT05052697|593058819|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188506|NCT05052697|593058820|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188507|NCT05052697|593058821|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188508|NCT05052697|593058822|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188509|NCT05052697|593058823|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188510|NCT05052697|593058824|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188511|NCT05052697|593058825|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188512|NCT05052697|593058826|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188513|NCT05052697|593058827|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188514|NCT05052697|593058828|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188515|NCT05052697|593058829|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188516|NCT05052697|593058830|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188517|NCT05052697|593058831|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188518|NCT05052697|593058832|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188519|NCT05052697|593058833|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188520|NCT05052697|593058834|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188521|NCT05052697|593058835|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188522|NCT05052697|593058836|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188523|NCT05052697|593058837|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188524|NCT05052697|593058838|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188525|NCT05052697|593058839|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188526|NCT05052697|593058840|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188527|NCT05052697|593058841|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188528|NCT05052697|593058842|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188529|NCT05052697|593058843|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
164188530|NCT05052697|593058844|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
164188531|NCT05052697|593058845|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
164188532|NCT05052697|593058846|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188533|NCT05052697|593058847|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188534|NCT05052697|593058848|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
164188535|NCT03796676|593058849|FG000|Overall Study|Adverse Event|2|||
164188536|NCT03796676|593058850|FG001|Overall Study|Adverse Event|1|||
164188537|NCT03796676|593058851|FG002|Overall Study|Adverse Event|2|||
164188538|NCT03796676|593058849|FG000|Overall Study|Lost to Follow-up|2|||
164188539|NCT03796676|593058850|FG001|Overall Study|Lost to Follow-up|1|||
164188540|NCT03796676|593058851|FG002|Overall Study|Lost to Follow-up|0|||
164188541|NCT03796676|593058849|FG000|Overall Study|Protocol Violation|0|||
164188542|NCT03796676|593058850|FG001|Overall Study|Protocol Violation|0|||
164188543|NCT03796676|593058851|FG002|Overall Study|Protocol Violation|1|||
164188544|NCT03796676|593058849|FG000|Overall Study|Withdrawal by Subject|1|||
164188545|NCT03796676|593058850|FG001|Overall Study|Withdrawal by Subject|1|||
164188546|NCT03796676|593058851|FG002|Overall Study|Withdrawal by Subject|0|||
164188547|NCT03796676|593058849|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
164188548|NCT03796676|593058850|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
164188549|NCT03796676|593058851|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
164188550|NCT01900899|593058854|FG000|Overall Study|Withdrawal by Subject|7|||
164188551|NCT01900899|593058855|FG001|Overall Study|Withdrawal by Subject|1|||
164188552|NCT01900899|593058854|FG000|Overall Study|Migrated from study area|2|||
164188553|NCT01900899|593058855|FG001|Overall Study|Migrated from study area|0|||
164188554|NCT02772809|593058856|FG000|Overall Study|not completed some tasks|6|||
164188555|NCT00534105|593058862|FG000|Overall Study|Lost to Follow-up|23|||
164188556|NCT00534105|593058863|FG001|Overall Study|Lost to Follow-up|39|||
164188557|NCT02427802|593058864|FG000|Overall Study|Adverse Event|11|||
164188558|NCT02427802|593058865|FG001|Overall Study|Adverse Event|3|||
164188559|NCT02427802|593058866|FG002|Overall Study|Adverse Event|7|||
164188562|NCT02427802|593058866|FG002|Overall Study|Death|1|||
164188563|NCT02427802|593058864|FG000|Overall Study|Lost to Follow-up|13|||
164188564|NCT02427802|593058865|FG001|Overall Study|Lost to Follow-up|8|||
164188565|NCT02427802|593058866|FG002|Overall Study|Lost to Follow-up|8|||
164188566|NCT02427802|593058864|FG000|Overall Study|Physician Decision|4|||
164188567|NCT02427802|593058865|FG001|Overall Study|Physician Decision|2|||
164188568|NCT02427802|593058866|FG002|Overall Study|Physician Decision|4|||
164188569|NCT02427802|593058864|FG000|Overall Study|Withdrawal by Subject|10|||
164188570|NCT02427802|593058865|FG001|Overall Study|Withdrawal by Subject|5|||
164188571|NCT02427802|593058866|FG002|Overall Study|Withdrawal by Subject|11|||
164188572|NCT02427802|593058864|FG000|Overall Study|Protocol Violation|3|||
164188573|NCT02427802|593058865|FG001|Overall Study|Protocol Violation|1|||
164188574|NCT02427802|593058866|FG002|Overall Study|Protocol Violation|1|||
164188575|NCT02427802|593058864|FG000|Overall Study|protocol specific treatment unrelated|18|||
164188576|NCT02427802|593058865|FG001|Overall Study|protocol specific treatment unrelated|11|||
164188577|NCT02427802|593058866|FG002|Overall Study|protocol specific treatment unrelated|11|||
164188578|NCT02226120|593058867|FG000|Overall Study|Adverse Event|60|||
164188579|NCT02226120|593058867|FG000|Overall Study|Death|172|||
164188580|NCT02226120|593058867|FG000|Overall Study|Study terminated by sponsor|1|||
164188581|NCT02226120|593058867|FG000|Overall Study|Technical problems|4|||
164188582|NCT02226120|593058867|FG000|Overall Study|Lost to Follow-up|13|||
164188583|NCT02226120|593058867|FG000|Overall Study|Physician Decision|21|||
164188584|NCT02226120|593058867|FG000|Overall Study|Withdrawal by parent/guardian|36|||
164188585|NCT02226120|593058867|FG000|Overall Study|Non-compliance with study drug|10|||
164188586|NCT02226120|593058867|FG000|Overall Study|Protocol deviation|1|||
164188587|NCT02226120|593058867|FG000|Overall Study|missing treatment disposition pages|2|||
164188588|NCT03034135|593058869|FG000|Overall Study|Withdrawal by Subject|2|||
164188589|NCT00467558|593058872|FG000|Overall Study|Lost to Follow-up|2|||
164188590|NCT00467558|593058873|FG001|Overall Study|Lost to Follow-up|0|||
164188591|NCT02636439|593058875|FG000|Overall Study|Adverse Event|2|||
164188592|NCT02636439|593058876|FG001|Overall Study|Adverse Event|2|||
164188593|NCT02636439|593058875|FG000|Overall Study|Lost to Follow-up|1|||
164188594|NCT02636439|593058876|FG001|Overall Study|Lost to Follow-up|0|||
164188595|NCT02636439|593058875|FG000|Overall Study|Non-compliance|1|||
164188596|NCT02636439|593058876|FG001|Overall Study|Non-compliance|1|||
164188597|NCT02636439|593058875|FG000|Overall Study|Personal reasons|2|||
164188598|NCT02636439|593058876|FG001|Overall Study|Personal reasons|0|||
164188599|NCT02494401|593058877|FG000|Overall Study|Lost to Follow-up|22|||
164188600|NCT02494401|593058878|FG001|Overall Study|Lost to Follow-up|25|||
164188601|NCT02494401|593058877|FG000|Overall Study|Withdrawal by Subject|3|||
164188602|NCT02494401|593058878|FG001|Overall Study|Withdrawal by Subject|2|||
164188603|NCT05188729|593058879|FG000|Overall Study|Withdrawal by Subject|0|||
164188604|NCT05188729|593058880|FG001|Overall Study|Withdrawal by Subject|0|||
164188605|NCT05188729|593058881|FG002|Overall Study|Withdrawal by Subject|0|||
164188606|NCT05188729|593058882|FG003|Overall Study|Withdrawal by Subject|0|||
164188607|NCT05188729|593058883|FG004|Overall Study|Withdrawal by Subject|0|||
164188608|NCT05188729|593058884|FG005|Overall Study|Withdrawal by Subject|0|||
164188609|NCT05188729|593058885|FG006|Overall Study|Withdrawal by Subject|0|||
164188610|NCT05188729|593058886|FG007|Overall Study|Withdrawal by Subject|0|||
164188611|NCT05188729|593058887|FG008|Overall Study|Withdrawal by Subject|0|||
164188612|NCT05188729|593058888|FG009|Overall Study|Withdrawal by Subject|1|||
164188613|NCT05188729|593058889|FG010|Overall Study|Withdrawal by Subject|0|||
164188614|NCT05188729|593058890|FG011|Overall Study|Withdrawal by Subject|0|||
164188615|NCT05188729|593058891|FG012|Overall Study|Withdrawal by Subject|0|||
164188616|NCT05188729|593058879|FG000|Overall Study|Lost to Follow-up|0|||
164188617|NCT05188729|593058880|FG001|Overall Study|Lost to Follow-up|0|||
164188618|NCT05188729|593058881|FG002|Overall Study|Lost to Follow-up|0|||
164188619|NCT05188729|593058882|FG003|Overall Study|Lost to Follow-up|0|||
164188620|NCT05188729|593058883|FG004|Overall Study|Lost to Follow-up|0|||
164188621|NCT05188729|593058884|FG005|Overall Study|Lost to Follow-up|0|||
164188622|NCT05188729|593058885|FG006|Overall Study|Lost to Follow-up|0|||
164188623|NCT05188729|593058886|FG007|Overall Study|Lost to Follow-up|0|||
164188624|NCT05188729|593058887|FG008|Overall Study|Lost to Follow-up|0|||
164188625|NCT05188729|593058888|FG009|Overall Study|Lost to Follow-up|0|||
164188626|NCT05188729|593058889|FG010|Overall Study|Lost to Follow-up|1|||
164188627|NCT05188729|593058890|FG011|Overall Study|Lost to Follow-up|1|||
164188628|NCT05188729|593058891|FG012|Overall Study|Lost to Follow-up|0|||
164188629|NCT00520767|593058893|FG000|Overall Study|Death|2|||
164301036|NCT03938259|593478408|FG001|Overall Study|unable to establish baseline for ventilation|1|||
164301037|NCT02435992|593478411|FG000|Overall Study|non compliance with protocol|2|||
164301038|NCT02435992|593478412|FG001|Overall Study|non compliance with protocol|0|||
164301039|NCT02435992|593478413|FG002|Overall Study|non compliance with protocol|1|||
164301040|NCT02435992|593478414|FG003|Overall Study|non compliance with protocol|0|||
164301041|NCT02435992|593478415|FG004|Overall Study|non compliance with protocol|0|||
164301042|NCT02435992|593478411|FG000|Overall Study|Adverse Event|11|||
164301043|NCT02435992|593478412|FG001|Overall Study|Adverse Event|6|||
164301044|NCT02435992|593478413|FG002|Overall Study|Adverse Event|12|||
164301045|NCT02435992|593478414|FG003|Overall Study|Adverse Event|0|||
164301082|NCT03879772|593478416|FG000|Overall Study|Withdrawal by Subject|0|||
164301083|NCT03879772|593478417|FG001|Overall Study|Withdrawal by Subject|1|||
164301084|NCT03879772|593478418|FG002|Overall Study|Withdrawal by Subject|3|||
164301085|NCT03879772|593478419|FG003|Overall Study|Withdrawal by Subject|1|||
164301086|NCT03879772|593478420|FG004|Overall Study|Withdrawal by Subject|1|||
164301087|NCT03879772|593478416|FG000|Overall Study|Protocol Violation|0|||
164301088|NCT03879772|593478417|FG001|Overall Study|Protocol Violation|0|||
164301089|NCT03879772|593478418|FG002|Overall Study|Protocol Violation|3|||
164301090|NCT03879772|593478419|FG003|Overall Study|Protocol Violation|1|||
164301091|NCT03879772|593478420|FG004|Overall Study|Protocol Violation|2|||
164301092|NCT03879772|593478416|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
164301093|NCT03879772|593478417|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
164301094|NCT03879772|593478418|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
164301095|NCT03879772|593478419|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
164301096|NCT03879772|593478420|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
164301097|NCT00389610|593478432|FG000|Overall Study|Disease Progression|0|||
164301098|NCT00389610|593478433|FG001|Overall Study|Disease Progression|19|||
164301099|NCT00389610|593478432|FG000|Overall Study|Death|0|||
164301100|NCT00389610|593478433|FG001|Overall Study|Death|1|||
164301101|NCT00389610|593478432|FG000|Overall Study|Physician Decision|0|||
164301102|NCT00389610|593478433|FG001|Overall Study|Physician Decision|1|||
164301103|NCT00389610|593478432|FG000|Overall Study|Withdrawal by Subject|0|||
164301104|NCT00389610|593478433|FG001|Overall Study|Withdrawal by Subject|1|||
164301105|NCT00887809|593478434|FG000|Overall Study|Patient Not Treated|3|||
164301106|NCT00887809|593478435|FG001|Overall Study|Patient Not Treated|0|||
164301107|NCT00887809|593478434|FG000|Overall Study|Death|1|||
164301108|NCT00887809|593478435|FG001|Overall Study|Death|0|||
164301109|NCT01210313|593478454|FG000|Overall Study|Withdrawal by Subject|3|||
164301110|NCT01210313|593478454|FG000|Overall Study|Adverse Event|2|||
164301111|NCT01210313|593478454|FG000|Overall Study|Distant recurrence|4|||
164301112|NCT01210313|593478454|FG000|Overall Study|Non-compliance|7|||
164301113|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
164301114|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
164301115|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
164301116|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
164301117|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
164301118|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
164301119|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
164301120|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
164301121|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
164301122|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
164301123|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
164301124|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
164301125|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
164301126|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
164301127|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
164301128|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
164301129|NCT03773978|593478459|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
164301130|NCT03773978|593478460|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
164301131|NCT03773978|593478459|FG000|DBW Period|Adverse Event|2|||
164301132|NCT03773978|593478460|FG001|DBW Period|Adverse Event|2|||
164301133|NCT03773978|593478459|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
164301134|NCT03773978|593478460|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
164301135|NCT03773978|593478459|FG000|DBW Period|Withdrawal by Subject|2|||
164301136|NCT03773978|593478460|FG001|DBW Period|Withdrawal by Subject|1|||
164301137|NCT03773978|593478459|FG000|DBW Period|Due to epidemic or pandemic|5|||
164301138|NCT03773978|593478460|FG001|DBW Period|Due to epidemic or pandemic|6|||
164301139|NCT03773978|593478459|FG000|DBW Period|Study team decision|1|||
164301140|NCT03773978|593478460|FG001|DBW Period|Study team decision|0|||
164301141|NCT03113487|593478461|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
164301142|NCT03777982|593478462|FG000|Overall Study|Physician Decision|0|||
164301143|NCT03777982|593478463|FG001|Overall Study|Physician Decision|1|||
164301144|NCT00870740|593478464|FG000|Overall Study|Adverse Event|2|||
164301145|NCT00870740|593478465|FG001|Overall Study|Adverse Event|1|||
164301146|NCT00870740|593478466|FG002|Overall Study|Adverse Event|3|||
164301147|NCT00870740|593478467|FG003|Overall Study|Adverse Event|2|||
164301148|NCT00870740|593478468|FG004|Overall Study|Adverse Event|1|||
164301149|NCT00870740|593478469|FG005|Overall Study|Adverse Event|6|||
164301150|NCT00870740|593478464|FG000|Overall Study|Consent Withdrawn|6|||
164301151|NCT00870740|593478465|FG001|Overall Study|Consent Withdrawn|3|||
164301152|NCT00870740|593478466|FG002|Overall Study|Consent Withdrawn|4|||
164301153|NCT00870740|593478467|FG003|Overall Study|Consent Withdrawn|6|||
164301154|NCT00870740|593478468|FG004|Overall Study|Consent Withdrawn|6|||
164301155|NCT00870740|593478469|FG005|Overall Study|Consent Withdrawn|5|||
164301156|NCT00870740|593478464|FG000|Overall Study|Investigator Decision|2|||
164301157|NCT00870740|593478465|FG001|Overall Study|Investigator Decision|0|||
164301158|NCT00870740|593478466|FG002|Overall Study|Investigator Decision|1|||
164301159|NCT00870740|593478467|FG003|Overall Study|Investigator Decision|0|||
164301160|NCT00870740|593478468|FG004|Overall Study|Investigator Decision|0|||
164301161|NCT00870740|593478469|FG005|Overall Study|Investigator Decision|0|||
164301162|NCT00870740|593478464|FG000|Overall Study|Subject Non-compliance|0|||
164301163|NCT00870740|593478465|FG001|Overall Study|Subject Non-compliance|0|||
164301164|NCT00870740|593478466|FG002|Overall Study|Subject Non-compliance|0|||
164301165|NCT00870740|593478467|FG003|Overall Study|Subject Non-compliance|0|||
164301166|NCT00870740|593478468|FG004|Overall Study|Subject Non-compliance|0|||
164301167|NCT00870740|593478469|FG005|Overall Study|Subject Non-compliance|1|||
164301168|NCT00870740|593478464|FG000|Overall Study|Death|0|||
164301169|NCT00870740|593478465|FG001|Overall Study|Death|0|||
164301170|NCT00870740|593478466|FG002|Overall Study|Death|0|||
164301171|NCT00870740|593478467|FG003|Overall Study|Death|0|||
164301172|NCT00870740|593478468|FG004|Overall Study|Death|1|||
164301173|NCT00870740|593478469|FG005|Overall Study|Death|0|||
164301174|NCT00870740|593478464|FG000|Overall Study|Other|2|||
164301175|NCT00870740|593478465|FG001|Overall Study|Other|5|||
164301176|NCT00870740|593478466|FG002|Overall Study|Other|2|||
164301177|NCT00870740|593478467|FG003|Overall Study|Other|4|||
164301178|NCT00870740|593478468|FG004|Overall Study|Other|3|||
164301179|NCT00870740|593478469|FG005|Overall Study|Other|5|||
164301180|NCT01502293|593478477|FG000|Overall Study|Progressive Disease|20|||
164301181|NCT01502293|593478478|FG001|Overall Study|Progressive Disease|12|||
164301182|NCT01502293|593478479|FG002|Overall Study|Progressive Disease|2|||
164301183|NCT01502293|593478477|FG000|Overall Study|Withdrawal by Subject|3|||
164301184|NCT01502293|593478478|FG001|Overall Study|Withdrawal by Subject|3|||
164301185|NCT01502293|593478479|FG002|Overall Study|Withdrawal by Subject|1|||
164301186|NCT01502293|593478477|FG000|Overall Study|Adverse Event|0|||
164301187|NCT01502293|593478478|FG001|Overall Study|Adverse Event|2|||
164301188|NCT01502293|593478479|FG002|Overall Study|Adverse Event|0|||
164301189|NCT01502293|593478477|FG000|Overall Study|Reason Not Specified|2|||
164301190|NCT01502293|593478478|FG001|Overall Study|Reason Not Specified|0|||
164301191|NCT01502293|593478479|FG002|Overall Study|Reason Not Specified|0|||
164301192|NCT01502293|593478477|FG000|Overall Study|Physician Decision|0|||
164301193|NCT01502293|593478478|FG001|Overall Study|Physician Decision|0|||
164301194|NCT01502293|593478479|FG002|Overall Study|Physician Decision|1|||
164301195|NCT03944577|593478484|FG000|Overall Study|Adverse Event|3|||
164301196|NCT00391586|593478485|FG000|Overall Study|Progressive disease|13|||
164301197|NCT00391586|593478485|FG000|Overall Study|Adverse Event|5|||
164301198|NCT00391586|593478485|FG000|Overall Study|Physician Decision|2|||
164301199|NCT00391586|593478485|FG000|Overall Study|Death|4|||
164301200|NCT03011099|593478486|FG000|Overall Study|Withdrawal by Subject|0|||
164301201|NCT03011099|593478487|FG001|Overall Study|Withdrawal by Subject|2|||
164301202|NCT03058146|593478488|FG000|Overall Study|Withdrawal by Subject|4|||
164301203|NCT03058146|593478489|FG001|Overall Study|Withdrawal by Subject|1|||
164301204|NCT03058146|593478488|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
164301205|NCT03058146|593478489|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
164301206|NCT03041181|593478490|FG000|Overall Study|Disease Progression|1|||
164301207|NCT03041181|593478491|FG001|Overall Study|Disease Progression|2|||
164301208|NCT02667119|593478492|FG000|Overall Study|Lost to Follow-up|3|||
164301209|NCT02667119|593478493|FG001|Overall Study|Lost to Follow-up|0|||
164301210|NCT00521079|593478496|FG000|Overall Study|Adverse Event|7|||
164301211|NCT00521079|593478497|FG001|Overall Study|Adverse Event|1|||
164301212|NCT00521079|593478496|FG000|Overall Study|Lost to Follow-up|2|||
164301213|NCT00521079|593478497|FG001|Overall Study|Lost to Follow-up|1|||
164301214|NCT00521079|593478496|FG000|Overall Study|Withdrawal by Subject|5|||
164301215|NCT00521079|593478497|FG001|Overall Study|Withdrawal by Subject|3|||
164301216|NCT04123470|593478500|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
164301217|NCT04123470|593478501|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
164301218|NCT04123470|593478500|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
164301219|NCT04123470|593478501|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
164301220|NCT04123470|593478500|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
164301221|NCT04123470|593478501|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
164301222|NCT04123470|593478500|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
164301223|NCT04123470|593478501|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
164301224|NCT03435211|593478502|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
164301225|NCT05972993|593478503|FG000|Overall Study|Lost to Follow-up|2|||
164301226|NCT05972993|593478504|FG001|Overall Study|Lost to Follow-up|0|||
164301227|NCT05972993|593478505|FG002|Overall Study|Lost to Follow-up|1|||
164301228|NCT05972993|593478506|FG003|Overall Study|Lost to Follow-up|0|||
164301229|NCT05972993|593478507|FG004|Overall Study|Lost to Follow-up|0|||
164301230|NCT05972993|593478508|FG005|Overall Study|Lost to Follow-up|0|||
164301231|NCT05972993|593478509|FG006|Overall Study|Lost to Follow-up|0|||
164301232|NCT05972993|593478510|FG007|Overall Study|Lost to Follow-up|2|||
164301233|NCT05972993|593478511|FG008|Overall Study|Lost to Follow-up|0|||
164301234|NCT03818256|593478513|FG000|Overall Study|Withdrawal by Subject|2|||
164301235|NCT03818256|593478514|FG001|Overall Study|Withdrawal by Subject|2|||
164301236|NCT03818256|593478513|FG000|Overall Study|Adverse Event|3|||
164301237|NCT03818256|593478514|FG001|Overall Study|Adverse Event|1|||
164301238|NCT03818256|593478513|FG000|Overall Study|Lost to Follow-up|0|||
164301239|NCT03818256|593478514|FG001|Overall Study|Lost to Follow-up|5|||
164301240|NCT03818256|593478513|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
164301241|NCT03818256|593478514|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
164301242|NCT03818256|593478513|FG000|Overall Study|Not reporting for scheduled visits|1|||
164301243|NCT03818256|593478514|FG001|Overall Study|Not reporting for scheduled visits|0|||
164301244|NCT03818256|593478513|FG000|Overall Study|Non-compliant with investigational product|1|||
164301245|NCT03818256|593478514|FG001|Overall Study|Non-compliant with investigational product|0|||
164301246|NCT02749422|593478515|FG000|Overall Study|Lost to Follow-up|0|||
164301247|NCT02749422|593478516|FG001|Overall Study|Lost to Follow-up|2|||
164301248|NCT02749422|593478515|FG000|Overall Study|Ineligible|0|||
164301249|NCT02749422|593478516|FG001|Overall Study|Ineligible|1|||
164301250|NCT00911170|593478517|FG000|Treatment Period|Randomized in error|1|||
164301251|NCT00911170|593478518|FG001|Treatment Period|Randomized in error|1|||
164301252|NCT00911170|593478517|FG000|Treatment Period|Ineligibility determined|1|||
164301253|NCT00911170|593478518|FG001|Treatment Period|Ineligibility determined|3|||
164301254|NCT00911170|593478517|FG000|Treatment Period|Protocol deviation|1|||
164301255|NCT00911170|593478518|FG001|Treatment Period|Protocol deviation|2|||
164301256|NCT00911170|593478517|FG000|Treatment Period|Adverse Event|9|||
164301257|NCT00911170|593478518|FG001|Treatment Period|Adverse Event|10|||
164301258|NCT00911170|593478517|FG000|Treatment Period|Withdrawal by Subject|4|||
164301259|NCT00911170|593478518|FG001|Treatment Period|Withdrawal by Subject|4|||
164301260|NCT00911170|593478517|FG000|Treatment Period|Disease progression|0|||
164301261|NCT00911170|593478518|FG001|Treatment Period|Disease progression|2|||
164301262|NCT00911170|593478517|FG000|Treatment Period|Physician Decision|5|||
164301263|NCT00911170|593478518|FG001|Treatment Period|Physician Decision|5|||
164301264|NCT00911170|593478517|FG000|Treatment Period|Lost to Follow-up|0|||
164301265|NCT00911170|593478518|FG001|Treatment Period|Lost to Follow-up|1|||
164301266|NCT00911170|593478517|FG000|Treatment Period|Death|6|||
164301267|NCT00911170|593478518|FG001|Treatment Period|Death|9|||
164301268|NCT00911170|593478517|FG000|Long Term Follow-Up|Continuing in study|274|||
164301269|NCT00911170|593478518|FG001|Long Term Follow-Up|Continuing in study|269|||
164301270|NCT00911170|593478517|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
164301271|NCT00911170|593478518|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
164301272|NCT00911170|593478517|FG000|Long Term Follow-Up|Physician Decision|5|||
164301273|NCT00911170|593478518|FG001|Long Term Follow-Up|Physician Decision|4|||
164301274|NCT00911170|593478517|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
164301275|NCT00911170|593478518|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
164301276|NCT00911170|593478517|FG000|Long Term Follow-Up|Death|116|||
164301277|NCT00911170|593478518|FG001|Long Term Follow-Up|Death|121|||
164301278|NCT02681523|593478519|FG000|Overall Study|Adverse Event|1|||
164301279|NCT02681523|593478519|FG000|Overall Study|Patient Non-compliance|1|||
164301280|NCT00554216|593480122|FG000|Overall Study|Lost to Follow-up|92|||
164301281|NCT00554216|593480123|FG001|Overall Study|Lost to Follow-up|31|||
164301282|NCT00554216|593480124|FG002|Overall Study|Lost to Follow-up|63|||
164301283|NCT00554216|593480122|FG000|Overall Study|Adverse Event|16|||
164301284|NCT00554216|593480123|FG001|Overall Study|Adverse Event|16|||
164301285|NCT00554216|593480124|FG002|Overall Study|Adverse Event|36|||
164301286|NCT00554216|593480122|FG000|Overall Study|Withdrawal by Subject|92|||
164301287|NCT00554216|593480123|FG001|Overall Study|Withdrawal by Subject|31|||
164301288|NCT00554216|593480124|FG002|Overall Study|Withdrawal by Subject|43|||
164301289|NCT00554216|593480122|FG000|Overall Study|Non compliance|10|||
164301290|NCT00554216|593480123|FG001|Overall Study|Non compliance|4|||
164301291|NCT00554216|593480124|FG002|Overall Study|Non compliance|5|||
164301292|NCT00554216|593480122|FG000|Overall Study|Pregnancy|2|||
164301293|NCT00554216|593480123|FG001|Overall Study|Pregnancy|1|||
164301294|NCT00554216|593480124|FG002|Overall Study|Pregnancy|14|||
164301295|NCT00554216|593480122|FG000|Overall Study|Restricted med|3|||
164301296|NCT00554216|593480123|FG001|Overall Study|Restricted med|1|||
164301297|NCT00554216|593480124|FG002|Overall Study|Restricted med|1|||
164301298|NCT00554216|593480122|FG000|Overall Study|Other|12|||
164301299|NCT00554216|593480123|FG001|Overall Study|Other|7|||
164301300|NCT00554216|593480124|FG002|Overall Study|Other|10|||
164301301|NCT00554216|593480122|FG000|Overall Study|Lack of Efficacy|15|||
164301302|NCT00554216|593480123|FG001|Overall Study|Lack of Efficacy|3|||
164301303|NCT00554216|593480124|FG002|Overall Study|Lack of Efficacy|0|||
164301304|NCT01347112|593480125|FG000|Overall Study|Withdrawal by Subject|1|||
164301305|NCT01347112|593480126|FG001|Overall Study|Withdrawal by Subject|7|||
164301306|NCT01347112|593480125|FG000|Overall Study|Lost to Follow-up|3|||
164301307|NCT01347112|593480126|FG001|Overall Study|Lost to Follow-up|5|||
164301308|NCT05462756|593480131|FG000|Treatment Period|Adverse Event|3|||
164301309|NCT05462756|593480132|FG001|Treatment Period|Adverse Event|0|||
164301310|NCT05462756|593480131|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
164301311|NCT05462756|593480132|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
164301312|NCT05462756|593480131|FG000|Treatment Period|Death|0|||
164301404|NCT00463567|593480149|FG004|Overall Study|Administrative problems|3|||
164301405|NCT00463567|593480150|FG005|Overall Study|Administrative problems|2|||
164301406|NCT00463567|593480151|FG006|Overall Study|Administrative problems|2|||
164301407|NCT00463567|593480145|FG000|Overall Study|Lack of Efficacy|4|||
164301408|NCT00463567|593480146|FG001|Overall Study|Lack of Efficacy|9|||
164301409|NCT00463567|593480147|FG002|Overall Study|Lack of Efficacy|9|||
164301410|NCT00463567|593480148|FG003|Overall Study|Lack of Efficacy|17|||
164301411|NCT00463567|593480149|FG004|Overall Study|Lack of Efficacy|1|||
164301412|NCT00463567|593480150|FG005|Overall Study|Lack of Efficacy|0|||
164301413|NCT00463567|593480151|FG006|Overall Study|Lack of Efficacy|1|||
164301414|NCT00463567|593480145|FG000|Overall Study|Abnormal lab value(s)|1|||
164301415|NCT00463567|593480146|FG001|Overall Study|Abnormal lab value(s)|1|||
164301416|NCT00463567|593480147|FG002|Overall Study|Abnormal lab value(s)|2|||
164301417|NCT00463567|593480148|FG003|Overall Study|Abnormal lab value(s)|1|||
164301418|NCT00463567|593480149|FG004|Overall Study|Abnormal lab value(s)|1|||
164301419|NCT00463567|593480150|FG005|Overall Study|Abnormal lab value(s)|0|||
164301420|NCT00463567|593480151|FG006|Overall Study|Abnormal lab value(s)|0|||
164301421|NCT00463567|593480145|FG000|Overall Study|Abnormal test procedure result(s)|1|||
164301422|NCT00463567|593480146|FG001|Overall Study|Abnormal test procedure result(s)|1|||
164301423|NCT00463567|593480147|FG002|Overall Study|Abnormal test procedure result(s)|6|||
164301424|NCT00463567|593480148|FG003|Overall Study|Abnormal test procedure result(s)|2|||
164301425|NCT00463567|593480149|FG004|Overall Study|Abnormal test procedure result(s)|0|||
164301426|NCT00463567|593480150|FG005|Overall Study|Abnormal test procedure result(s)|2|||
164301427|NCT00463567|593480151|FG006|Overall Study|Abnormal test procedure result(s)|0|||
164301428|NCT00463567|593480145|FG000|Overall Study|Death|1|||
164301429|NCT00463567|593480146|FG001|Overall Study|Death|0|||
164301430|NCT00463567|593480147|FG002|Overall Study|Death|2|||
164301431|NCT00463567|593480148|FG003|Overall Study|Death|0|||
164301432|NCT00463567|593480149|FG004|Overall Study|Death|0|||
164301433|NCT00463567|593480150|FG005|Overall Study|Death|0|||
164301434|NCT00463567|593480151|FG006|Overall Study|Death|0|||
164301435|NCT01432730|593480152|FG000|Period 1|Adverse Event|2|||
164301436|NCT01432730|593480153|FG001|Period 1|Adverse Event|0|||
164301437|NCT01432730|593480152|FG000|Period 2|Adverse Event|0|||
164301438|NCT01432730|593480153|FG001|Period 2|Adverse Event|4|||
164301439|NCT00641667|593480154|FG000|Overall Study|Withdrawal by Subject|1|||
164301440|NCT00641667|593480154|FG000|Overall Study|Adverse Event|1|||
164301441|NCT00641667|593480154|FG000|Overall Study|Physician Decision|1|||
164301442|NCT00641667|593480154|FG000|Overall Study|Worsening of underlying disease|3|||
164301443|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
164301444|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
164301445|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
164301446|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
164301447|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
164301448|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
164301449|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
164301450|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
164301451|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
164301452|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
164301453|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
164301454|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
164301455|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
164301456|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
164301457|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
164301458|NCT01235741|593480155|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
164301459|NCT01235741|593480156|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
164301460|NCT01235741|593480157|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
164301461|NCT01235741|593480155|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
164301462|NCT01235741|593480156|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
164301463|NCT01235741|593480157|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
164301464|NCT01235741|593480155|FG000|Randomized to Treatment|Adverse Event|0|||
164301465|NCT01235741|593480156|FG001|Randomized to Treatment|Adverse Event|1|||
164301466|NCT01235741|593480157|FG002|Randomized to Treatment|Adverse Event|1|||
164301467|NCT01235741|593480155|FG000|Randomized to Treatment|Sponsor terminated study|0|||
164301468|NCT01235741|593480156|FG001|Randomized to Treatment|Sponsor terminated study|35|||
164301469|NCT01235741|593480157|FG002|Randomized to Treatment|Sponsor terminated study|34|||
164301470|NCT01235741|593480155|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
164301471|NCT01235741|593480156|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
164301472|NCT01235741|593480157|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
164301473|NCT01235741|593480155|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
164301474|NCT01235741|593480156|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
164301475|NCT01235741|593480157|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
164301476|NCT01235741|593480155|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
164301477|NCT01235741|593480156|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
164301478|NCT01235741|593480157|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
164301479|NCT01705509|593480158|FG000|Inclusion CPET|Screen Failure|5|||
164301480|NCT01705509|593480158|FG000|Inclusion CPET|Withdrawal by Subject|2|||
164301481|NCT01705509|593480158|FG000|CPET w/ Ranexa|Screen Failure|2|||
164301482|NCT00904033|593480159|FG000|Overall Study|Withdrawal by Subject|1|||
164301483|NCT00904033|593480160|FG001|Overall Study|Withdrawal by Subject|1|||
164301484|NCT00904033|593480161|FG002|Overall Study|Withdrawal by Subject|0|||
164301485|NCT00904033|593480162|FG003|Overall Study|Withdrawal by Subject|0|||
164301486|NCT00904033|593480159|FG000|Overall Study|Physician Decision|0|||
164301487|NCT00904033|593480160|FG001|Overall Study|Physician Decision|0|||
164301488|NCT00904033|593480161|FG002|Overall Study|Physician Decision|1|||
164301489|NCT00904033|593480162|FG003|Overall Study|Physician Decision|0|||
164301490|NCT00904033|593480159|FG000|Overall Study|Unable to obtain final blood draw|0|||
164301491|NCT00904033|593480160|FG001|Overall Study|Unable to obtain final blood draw|0|||
164301492|NCT00904033|593480161|FG002|Overall Study|Unable to obtain final blood draw|0|||
164301493|NCT00904033|593480162|FG003|Overall Study|Unable to obtain final blood draw|2|||
164301494|NCT01774721|593480166|FG000|Overall Study|Death|133|||
164301495|NCT01774721|593480167|FG001|Overall Study|Death|152|||
164301496|NCT01774721|593480166|FG000|Overall Study|Withdrawal by Subject|20|||
164301497|NCT01774721|593480167|FG001|Overall Study|Withdrawal by Subject|14|||
164301498|NCT01774721|593480166|FG000|Overall Study|Lost to Follow-up|6|||
164301499|NCT01774721|593480167|FG001|Overall Study|Lost to Follow-up|7|||
164301500|NCT01774721|593480166|FG000|Overall Study|Did not meet eligibility criteria|0|||
164301501|NCT01774721|593480167|FG001|Overall Study|Did not meet eligibility criteria|3|||
164301502|NCT01774721|593480166|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
164301503|NCT01774721|593480167|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
164301504|NCT01774721|593480166|FG000|Overall Study|Study terminated by sponsor|5|||
164301505|NCT01774721|593480167|FG001|Overall Study|Study terminated by sponsor|0|||
164301506|NCT01774721|593480166|FG000|Overall Study|Disease progression|5|||
164301507|NCT01774721|593480167|FG001|Overall Study|Disease progression|0|||
164301508|NCT00118417|593480170|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
164301509|NCT00118417|593480171|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
164301510|NCT00118417|593480170|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
164301511|NCT00118417|593480171|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
164301512|NCT00118417|593480170|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
164301513|NCT00118417|593480171|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
164301514|NCT00118417|593480170|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
164301515|NCT00118417|593480171|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
164301516|NCT00118417|593480170|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
164301517|NCT00118417|593480171|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
164301518|NCT02978781|593480172|FG000|Part A|Adverse Event|1|||
164301519|NCT02978781|593480173|FG001|Part A|Adverse Event|1|||
164301520|NCT02978781|593480174|FG002|Part A|Adverse Event|0|||
164301521|NCT02978781|593480175|FG003|Part A|Adverse Event|0|||
164301522|NCT02978781|593480176|FG004|Part A|Adverse Event|0|||
164301523|NCT02978781|593480172|FG000|Part A|Withdrawal by Subject|0|||
164301524|NCT02978781|593480173|FG001|Part A|Withdrawal by Subject|1|||
164301525|NCT02978781|593480174|FG002|Part A|Withdrawal by Subject|0|||
164301526|NCT02978781|593480175|FG003|Part A|Withdrawal by Subject|0|||
164301527|NCT02978781|593480176|FG004|Part A|Withdrawal by Subject|0|||
164301528|NCT02978781|593480172|FG000|Part B|Withdrawal by Subject|0|||
164301529|NCT02978781|593480173|FG001|Part B|Withdrawal by Subject|0|||
164301530|NCT02978781|593480174|FG002|Part B|Withdrawal by Subject|0|||
164301531|NCT02978781|593480175|FG003|Part B|Withdrawal by Subject|1|||
164301532|NCT02978781|593480176|FG004|Part B|Withdrawal by Subject|0|||
164301533|NCT02978781|593480172|FG000|Part C|Adverse Event|0|||
164301534|NCT02978781|593480173|FG001|Part C|Adverse Event|0|||
164301535|NCT02978781|593480174|FG002|Part C|Adverse Event|0|||
164301536|NCT02978781|593480175|FG003|Part C|Adverse Event|0|||
164301537|NCT02978781|593480176|FG004|Part C|Adverse Event|2|||
164301538|NCT02978781|593480172|FG000|Part C|Withdrawal by Subject|0|||
164301539|NCT02978781|593480173|FG001|Part C|Withdrawal by Subject|0|||
164301540|NCT02978781|593480174|FG002|Part C|Withdrawal by Subject|0|||
164301541|NCT02978781|593480175|FG003|Part C|Withdrawal by Subject|0|||
164301542|NCT02978781|593480176|FG004|Part C|Withdrawal by Subject|1|||
164301543|NCT02978781|593480172|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301544|NCT02978781|593480173|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301545|NCT02978781|593480174|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301546|NCT02978781|593480175|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
164301547|NCT02978781|593480176|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
164301548|NCT01383356|593480177|FG000|Period 1|Adverse Event|5|||
164301549|NCT01383356|593480178|FG001|Period 1|Adverse Event|3|||
164301550|NCT01383356|593480177|FG000|Period 1|Non-compliance|3|||
164301551|NCT01383356|593480178|FG001|Period 1|Non-compliance|0|||
164301552|NCT01383356|593480177|FG000|Period 1|Out of Range Mid-study-Test|0|||
164301553|NCT01383356|593480178|FG001|Period 1|Out of Range Mid-study-Test|1|||
164301554|NCT01383356|593480177|FG000|Period 1|Personal|0|||
164301555|NCT01383356|593480178|FG001|Period 1|Personal|2|||
164301556|NCT02035267|593480179|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
164301557|NCT02035267|593480180|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
164301558|NCT02035267|593480181|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
164301559|NCT02035267|593480182|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
164301560|NCT02035267|593480179|FG000|Overall Study|Adverse Event|0|||
164301561|NCT02035267|593480180|FG001|Overall Study|Adverse Event|0|||
164301562|NCT02035267|593480181|FG002|Overall Study|Adverse Event|1|||
164301563|NCT02035267|593480182|FG003|Overall Study|Adverse Event|0|||
164301564|NCT02035267|593480179|FG000|Overall Study|Lost to Follow-up|0|||
164301565|NCT02035267|593480180|FG001|Overall Study|Lost to Follow-up|0|||
164301566|NCT02035267|593480181|FG002|Overall Study|Lost to Follow-up|0|||
164301567|NCT02035267|593480182|FG003|Overall Study|Lost to Follow-up|1|||
164301568|NCT02035267|593480179|FG000|Overall Study|Other unspecified|0|||
164301569|NCT02035267|593480180|FG001|Overall Study|Other unspecified|1|||
164301570|NCT02035267|593480181|FG002|Overall Study|Other unspecified|0|||
164301571|NCT02035267|593480182|FG003|Overall Study|Other unspecified|0|||
164301572|NCT02054104|593480184|FG000|Overall Study|Did not want to continue due to college classes|1|||
164301573|NCT02054104|593480185|FG001|Overall Study|Did not want to continue due to college classes|0|||
164301574|NCT02054104|593480184|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
164301575|NCT02054104|593480185|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
164301576|NCT02054104|593480184|FG000|Overall Study|No evidence of immunologic response|2|||
164301577|NCT02054104|593480185|FG001|Overall Study|No evidence of immunologic response|2|||
164301578|NCT02054104|593480184|FG000|Overall Study|Disease Progression On Study|4|||
164301579|NCT02054104|593480185|FG001|Overall Study|Disease Progression On Study|5|||
164301580|NCT02054104|593480184|FG000|Overall Study|Diagnosis of lymphoma|0|||
164301581|NCT02054104|593480185|FG001|Overall Study|Diagnosis of lymphoma|1|||
164301582|NCT02054104|593480184|FG000|Overall Study|Inconclusive response|0|||
164301583|NCT02054104|593480185|FG001|Overall Study|Inconclusive response|1|||
164301584|NCT00084136|593480188|FG000|PI Comparison|Death|10|||
164301585|NCT00084136|593480189|FG001|PI Comparison|Death|9|||
164301586|NCT00084136|593480190|FG002|PI Comparison|Death|0|||
164301587|NCT00084136|593480188|FG000|PI Comparison|Lost to Follow-up|11|||
164301588|NCT00084136|593480189|FG001|PI Comparison|Lost to Follow-up|8|||
164301589|NCT00084136|593480190|FG002|PI Comparison|Lost to Follow-up|0|||
164301590|NCT00084136|593480188|FG000|PI Comparison|Withdrawal by Subject|33|||
164301591|NCT00084136|593480189|FG001|PI Comparison|Withdrawal by Subject|30|||
164301592|NCT00084136|593480190|FG002|PI Comparison|Withdrawal by Subject|0|||
164301593|NCT00084136|593480188|FG000|PI Comparison|Clinic site closed|1|||
164301594|NCT00084136|593480189|FG001|PI Comparison|Clinic site closed|0|||
164301595|NCT00084136|593480190|FG002|PI Comparison|Clinic site closed|0|||
164301596|NCT00084136|593480188|FG000|NRTI Comparison|Death|20|||
164301597|NCT00084136|593480189|FG001|NRTI Comparison|Death|0|||
164301598|NCT00084136|593480190|FG002|NRTI Comparison|Death|18|||
164301599|NCT00084136|593480188|FG000|NRTI Comparison|Lost to Follow-up|14|||
164301600|NCT00084136|593480189|FG001|NRTI Comparison|Lost to Follow-up|0|||
164301601|NCT00084136|593480190|FG002|NRTI Comparison|Lost to Follow-up|12|||
164301602|NCT00084136|593480188|FG000|NRTI Comparison|Withdrawal by Subject|54|||
164301603|NCT00084136|593480189|FG001|NRTI Comparison|Withdrawal by Subject|0|||
164301604|NCT00084136|593480190|FG002|NRTI Comparison|Withdrawal by Subject|38|||
164301605|NCT00084136|593480188|FG000|NRTI Comparison|Clinic site closed|12|||
164301606|NCT00084136|593480189|FG001|NRTI Comparison|Clinic site closed|0|||
164301607|NCT00084136|593480190|FG002|NRTI Comparison|Clinic site closed|14|||
164301608|NCT00084136|593480188|FG000|NRTI Comparison|Not reason above|1|||
164301609|NCT00084136|593480189|FG001|NRTI Comparison|Not reason above|0|||
164301610|NCT00084136|593480190|FG002|NRTI Comparison|Not reason above|0|||
164301611|NCT00836693|593480196|FG000|Overall Study|Adverse Event|4|||
164301612|NCT00836693|593480197|FG001|Overall Study|Adverse Event|1|||
164301613|NCT00836693|593480196|FG000|Overall Study|Sponsor Decision|0|||
164301614|NCT00836693|593480197|FG001|Overall Study|Sponsor Decision|1|||
164301615|NCT00836693|593480196|FG000|Overall Study|Physician Decision|2|||
164301616|NCT00836693|593480197|FG001|Overall Study|Physician Decision|0|||
164301617|NCT00836693|593480196|FG000|Overall Study|Withdrawal by Subject|9|||
164301618|NCT00836693|593480197|FG001|Overall Study|Withdrawal by Subject|4|||
164301619|NCT00836693|593480196|FG000|Overall Study|Protocol Violation|1|||
164301620|NCT00836693|593480197|FG001|Overall Study|Protocol Violation|0|||
164301621|NCT00836693|593480196|FG000|Overall Study|Lost to Follow-up|1|||
164301622|NCT00836693|593480197|FG001|Overall Study|Lost to Follow-up|0|||
164301623|NCT02633306|593480200|FG000|Overall Study|Withdrawal by Subject|3|||
164301624|NCT01657019|593480201|FG000|Overall Study|Withdrawal by Subject|65|||
164301625|NCT01657019|593480201|FG000|Overall Study|Adverse Event|55|||
164301626|NCT01657019|593480201|FG000|Overall Study|Lost to Follow-up|48|||
164301627|NCT01657019|593480201|FG000|Overall Study|Protocol Violation|6|||
164301628|NCT01657019|593480201|FG000|Overall Study|Lack of Efficacy|3|||
164301629|NCT01657019|593480201|FG000|Overall Study|Other|58|||
164301630|NCT01213472|593480202|FG000|Overall Study|Recurrence/Progressive disease|25|||
164301631|NCT01213472|593480202|FG000|Overall Study|Withdrawal by Subject|1|||
164301632|NCT01213472|593480202|FG000|Overall Study|Physician Decision|1|||
164301633|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301634|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
164301635|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
164301636|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301637|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301638|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
164301639|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
164301640|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301641|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301642|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301643|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301644|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301645|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
164301646|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
164301647|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301648|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301649|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301650|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
164301651|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301652|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301653|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
164301654|NCT00129402|593480219|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301655|NCT00129402|593480220|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301656|NCT00129402|593480221|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
164301657|NCT00129402|593480222|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301658|NCT00129402|593480223|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
164301659|NCT00129402|593480224|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301660|NCT00129402|593480225|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
164301661|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301662|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301663|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
164301664|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301665|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301666|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301667|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
164301668|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301669|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301670|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
164301671|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301672|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301673|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
164301674|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
164301675|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301676|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301677|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
164301678|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301679|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301680|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301681|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
164301682|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301683|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301684|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
164301685|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301686|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301687|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
164301688|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
164301689|NCT00129402|593480219|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301690|NCT00129402|593480220|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301691|NCT00129402|593480221|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
164301692|NCT00129402|593480222|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301693|NCT00129402|593480223|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301694|NCT00129402|593480224|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
164301695|NCT00129402|593480225|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
164301696|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301697|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301698|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301699|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301700|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301701|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
164301702|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
164301703|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301704|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301705|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301706|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301707|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301708|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
164301709|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
164301710|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301711|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301712|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301713|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301714|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301715|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
164301716|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
164301717|NCT00129402|593480219|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301718|NCT00129402|593480220|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301719|NCT00129402|593480221|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301720|NCT00129402|593480222|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301721|NCT00129402|593480223|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301722|NCT00129402|593480224|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
164301723|NCT00129402|593480225|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
164301724|NCT02131259|593480226|FG000|Overall Study|Progressive disease|751|||
164301725|NCT02131259|593480226|FG000|Overall Study|Adverse Event|341|||
164301726|NCT02131259|593480226|FG000|Overall Study|Lost to Follow-up|7|||
164301727|NCT02131259|593480226|FG000|Overall Study|Relocation|32|||
164301728|NCT02131259|593480226|FG000|Overall Study|Other|63|||
164301729|NCT02131259|593480226|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
164301730|NCT02131259|593480226|FG000|Overall Study|Progressive disease/relocation|1|||
164301731|NCT02131259|593480226|FG000|Overall Study|Progressive disease/other|2|||
164301732|NCT02131259|593480226|FG000|Overall Study|AE/lost to follow-up|1|||
164301733|NCT02131259|593480226|FG000|Overall Study|AE/other|1|||
164301734|NCT02131259|593480226|FG000|Overall Study|Progressive disease/AE/other|1|||
164301735|NCT02131259|593480226|FG000|Overall Study|Missing|3|||
164301736|NCT01472289|593480231|FG000|Overall Study|Death|2|||
164301737|NCT00907335|593480232|FG000|Overall Study|Withdrawal by Subject|2|||
164301738|NCT00907335|593480233|FG001|Overall Study|Withdrawal by Subject|0|||
164301739|NCT00907335|593480232|FG000|Overall Study|Adverse Event|4|||
164301740|NCT00907335|593480233|FG001|Overall Study|Adverse Event|1|||
164301741|NCT00907335|593480232|FG000|Overall Study|Lost to Follow-up|2|||
164301742|NCT00907335|593480233|FG001|Overall Study|Lost to Follow-up|0|||
164301743|NCT03131570|593480234|FG000|Overall Study|Adverse Event|1|||
164301744|NCT03131570|593480235|FG001|Overall Study|Adverse Event|0|||
164301745|NCT04596267|593480236|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
164301746|NCT04596267|593480237|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
164301747|NCT04596267|593480236|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
164301748|NCT04596267|593480237|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
164301749|NCT00071058|593480238|FG000|Overall Study|brain tumor-removed from study|1|||
164301750|NCT04189952|593480242|FG000|Follow-up Period|Death|1|||
164301751|NCT04189952|593480242|FG000|Follow-up Period|Withdrawal by Subject|1|||
164301752|NCT01498068|593480243|FG000|Overall Study|Withdrawal by Subject|1|||
164301753|NCT01498068|593480244|FG001|Overall Study|Withdrawal by Subject|1|||
164301754|NCT00361296|593480248|FG000|Overall Study|Physician Decision|1|||
164301755|NCT00361296|593480248|FG000|Overall Study|Lack of Efficacy|2|||
164301756|NCT00198822|593480249|FG000|Overall Study|Lost to Follow-up|14|||
164301757|NCT00198822|593480250|FG001|Overall Study|Lost to Follow-up|20|||
164301758|NCT00198822|593480251|FG002|Overall Study|Lost to Follow-up|21|||
164301759|NCT00453206|593480255|FG000|Overall Study|Death|1|||
164301760|NCT04672239|593480258|FG000|Week 2 Survey|Failed survey check items|1|||
164301761|NCT04672239|593480259|FG001|Week 2 Survey|Failed survey check items|2|||
164301762|NCT04672239|593480260|FG002|Week 2 Survey|Failed survey check items|3|||
164301763|NCT04672239|593480258|FG000|Week 2 Survey|Partially completed survey|7|||
164301764|NCT04672239|593480259|FG001|Week 2 Survey|Partially completed survey|1|||
164301765|NCT04672239|593480260|FG002|Week 2 Survey|Partially completed survey|4|||
164301766|NCT04672239|593480258|FG000|Week 2 Survey|Withdrawal by Subject|0|||
164301767|NCT04672239|593480259|FG001|Week 2 Survey|Withdrawal by Subject|1|||
164301768|NCT04672239|593480260|FG002|Week 2 Survey|Withdrawal by Subject|0|||
164301769|NCT04672239|593480258|FG000|Week 2 Survey|Lost to Follow-up|3|||
164301770|NCT04672239|593480259|FG001|Week 2 Survey|Lost to Follow-up|2|||
164301771|NCT04672239|593480260|FG002|Week 2 Survey|Lost to Follow-up|5|||
164301772|NCT04672239|593480258|FG000|Week 6 Survey|Failed survey check items|2|||
164301773|NCT04672239|593480259|FG001|Week 6 Survey|Failed survey check items|2|||
164301774|NCT04672239|593480260|FG002|Week 6 Survey|Failed survey check items|2|||
164301775|NCT04672239|593480258|FG000|Week 6 Survey|Partially completed survey|3|||
164301776|NCT04672239|593480259|FG001|Week 6 Survey|Partially completed survey|3|||
164301777|NCT04672239|593480260|FG002|Week 6 Survey|Partially completed survey|2|||
164301778|NCT04672239|593480258|FG000|Week 6 Survey|Withdrawal by Subject|1|||
164301779|NCT04672239|593480259|FG001|Week 6 Survey|Withdrawal by Subject|1|||
164301780|NCT04672239|593480260|FG002|Week 6 Survey|Withdrawal by Subject|1|||
164301781|NCT04672239|593480258|FG000|Week 6 Survey|Withdrawn by PI|0|||
164301782|NCT04672239|593480259|FG001|Week 6 Survey|Withdrawn by PI|1|||
164301783|NCT04672239|593480260|FG002|Week 6 Survey|Withdrawn by PI|0|||
164301784|NCT04672239|593480258|FG000|Week 6 Survey|Lost to Follow-up|12|||
164301785|NCT04672239|593480259|FG001|Week 6 Survey|Lost to Follow-up|2|||
164301786|NCT04672239|593480260|FG002|Week 6 Survey|Lost to Follow-up|5|||
164301787|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
164301788|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
164301789|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
164301790|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
164301791|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
164301792|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
164301793|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
164301794|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
164301795|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
164301796|NCT04672239|593480258|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
164301797|NCT04672239|593480259|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
164301798|NCT04672239|593480260|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
164301799|NCT04672239|593480258|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
164301800|NCT04672239|593480259|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
164301801|NCT04672239|593480260|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
164301802|NCT04672239|593480258|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
164301803|NCT04672239|593480259|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
164301804|NCT04672239|593480260|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
164301805|NCT04672239|593480258|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
164301806|NCT04672239|593480259|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
164301807|NCT04672239|593480260|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
164301808|NCT03866577|593480263|FG000|Overall Study|Protocol Violation|0|||
164301809|NCT03866577|593480264|FG001|Overall Study|Protocol Violation|0|||
164301810|NCT03866577|593480265|FG002|Overall Study|Protocol Violation|0|||
164301811|NCT03866577|593480266|FG003|Overall Study|Protocol Violation|0|||
164301812|NCT03866577|593480267|FG004|Overall Study|Protocol Violation|0|||
164301813|NCT03866577|593480268|FG005|Overall Study|Protocol Violation|0|||
164301814|NCT03866577|593480269|FG006|Overall Study|Protocol Violation|0|||
164301815|NCT03866577|593480270|FG007|Overall Study|Protocol Violation|0|||
164301816|NCT03866577|593480271|FG008|Overall Study|Protocol Violation|0|||
164301817|NCT03866577|593480272|FG009|Overall Study|Protocol Violation|0|||
164301818|NCT03866577|593480273|FG010|Overall Study|Protocol Violation|0|||
164301819|NCT03866577|593480274|FG011|Overall Study|Protocol Violation|1|||
164301820|NCT03866577|593480275|FG012|Overall Study|Protocol Violation|0|||
164301821|NCT03866577|593480263|FG000|Overall Study|Withdrawal by Subject|0|||
164301822|NCT03866577|593480264|FG001|Overall Study|Withdrawal by Subject|0|||
164301823|NCT03866577|593480265|FG002|Overall Study|Withdrawal by Subject|0|||
164301824|NCT03866577|593480266|FG003|Overall Study|Withdrawal by Subject|0|||
164301825|NCT03866577|593480267|FG004|Overall Study|Withdrawal by Subject|0|||
164301826|NCT03866577|593480268|FG005|Overall Study|Withdrawal by Subject|0|||
164301827|NCT03866577|593480269|FG006|Overall Study|Withdrawal by Subject|0|||
164301828|NCT03866577|593480270|FG007|Overall Study|Withdrawal by Subject|0|||
164301829|NCT03866577|593480271|FG008|Overall Study|Withdrawal by Subject|1|||
164301830|NCT03866577|593480272|FG009|Overall Study|Withdrawal by Subject|1|||
164301831|NCT03866577|593480273|FG010|Overall Study|Withdrawal by Subject|0|||
164301832|NCT03866577|593480274|FG011|Overall Study|Withdrawal by Subject|0|||
164301833|NCT03866577|593480275|FG012|Overall Study|Withdrawal by Subject|0|||
164301834|NCT03866577|593480263|FG000|Overall Study|Not qualified for IVIg infusion|0|||
164301835|NCT03866577|593480264|FG001|Overall Study|Not qualified for IVIg infusion|0|||
164301836|NCT03866577|593480265|FG002|Overall Study|Not qualified for IVIg infusion|0|||
164301837|NCT03866577|593480266|FG003|Overall Study|Not qualified for IVIg infusion|0|||
164301838|NCT03866577|593480267|FG004|Overall Study|Not qualified for IVIg infusion|0|||
164301839|NCT03866577|593480268|FG005|Overall Study|Not qualified for IVIg infusion|0|||
164301840|NCT03866577|593480269|FG006|Overall Study|Not qualified for IVIg infusion|0|||
164301841|NCT03866577|593480270|FG007|Overall Study|Not qualified for IVIg infusion|0|||
164301842|NCT03866577|593480271|FG008|Overall Study|Not qualified for IVIg infusion|0|||
164301843|NCT03866577|593480272|FG009|Overall Study|Not qualified for IVIg infusion|1|||
164301844|NCT03866577|593480273|FG010|Overall Study|Not qualified for IVIg infusion|0|||
164301845|NCT03866577|593480274|FG011|Overall Study|Not qualified for IVIg infusion|0|||
164301846|NCT03866577|593480275|FG012|Overall Study|Not qualified for IVIg infusion|0|||
164301847|NCT04825678|593480276|FG000|Overall Study|Decision by Sponsor|2|||
164301848|NCT04825678|593480277|FG001|Overall Study|Decision by Sponsor|3|||
164301849|NCT04825678|593480276|FG000|Overall Study|Withdrawal of Consent From Study|7|||
164301850|NCT04825678|593480277|FG001|Overall Study|Withdrawal of Consent From Study|9|||
164301851|NCT04825678|593480276|FG000|Overall Study|Lost to Follow-up|3|||
164301852|NCT04825678|593480277|FG001|Overall Study|Lost to Follow-up|4|||
164301853|NCT04825678|593480276|FG000|Overall Study|Never Received Investigational Product|1|||
164301854|NCT04825678|593480277|FG001|Overall Study|Never Received Investigational Product|1|||
164301855|NCT01342211|593480278|FG000|Overall Study|Lost to Follow-up|0|||
164301856|NCT01342211|593480279|FG001|Overall Study|Lost to Follow-up|0|||
164301857|NCT01342211|593480280|FG002|Overall Study|Lost to Follow-up|0|||
164301858|NCT01342211|593480281|FG003|Overall Study|Lost to Follow-up|1|||
164301859|NCT01342211|593480282|FG004|Overall Study|Lost to Follow-up|0|||
164301860|NCT01342211|593480278|FG000|Overall Study|Adverse Event|0|||
164301861|NCT01342211|593480279|FG001|Overall Study|Adverse Event|0|||
164301862|NCT01342211|593480280|FG002|Overall Study|Adverse Event|0|||
164301863|NCT01342211|593480281|FG003|Overall Study|Adverse Event|0|||
164301864|NCT01342211|593480282|FG004|Overall Study|Adverse Event|1|||
164301865|NCT01342211|593480278|FG000|Overall Study|Withdrawal by Subject|0|||
164301866|NCT01342211|593480279|FG001|Overall Study|Withdrawal by Subject|0|||
164301867|NCT01342211|593480280|FG002|Overall Study|Withdrawal by Subject|0|||
164301868|NCT01342211|593480281|FG003|Overall Study|Withdrawal by Subject|1|||
164301869|NCT01342211|593480282|FG004|Overall Study|Withdrawal by Subject|0|||
164301870|NCT01342211|593480278|FG000|Overall Study|Randomized, but not Treated|0|||
164301871|NCT01342211|593480279|FG001|Overall Study|Randomized, but not Treated|2|||
164301872|NCT01342211|593480280|FG002|Overall Study|Randomized, but not Treated|0|||
164301873|NCT01342211|593480281|FG003|Overall Study|Randomized, but not Treated|0|||
164301874|NCT01342211|593480282|FG004|Overall Study|Randomized, but not Treated|1|||
164301875|NCT05430854|593480283|FG000|Overall Study|Trial terminated by Sponsor|39|||
164301876|NCT05430854|593480284|FG001|Overall Study|Trial terminated by Sponsor|50|||
164301877|NCT05430854|593480285|FG002|Overall Study|Trial terminated by Sponsor|46|||
164301878|NCT05430854|593480283|FG000|Overall Study|Withdrawal by Subject|0|||
164301879|NCT05430854|593480284|FG001|Overall Study|Withdrawal by Subject|3|||
164301880|NCT05430854|593480285|FG002|Overall Study|Withdrawal by Subject|0|||
164301881|NCT01824836|593480288|FG000|Overall Study|Adverse Event|48|||
164301882|NCT01824836|593480288|FG000|Overall Study|Withdrawal by Subject|63|||
164301883|NCT01824836|593480288|FG000|Overall Study|Other complicating disease|116|||
164301884|NCT01824836|593480288|FG000|Overall Study|Disease progression|5|||
164301885|NCT01824836|593480288|FG000|Overall Study|Alternative therapy|2|||
164301886|NCT01824836|593480288|FG000|Overall Study|Depression|1|||
164301887|NCT01824836|593480288|FG000|Overall Study|Non-compliance|3|||
164301888|NCT01824836|593480288|FG000|Overall Study|Patient regained ovarian function|3|||
164301889|NCT01824836|593480288|FG000|Overall Study|Lost to Follow-up|8|||
164301890|NCT01824836|593480288|FG000|Overall Study|Physician Decision|2|||
164301891|NCT01824836|593480288|FG000|Overall Study|Research office was closed|3|||
164301892|NCT01824836|593480288|FG000|Overall Study|Relocation|3|||
164301893|NCT01824836|593480288|FG000|Overall Study|Insurance-related issue|1|||
164301894|NCT01824836|593480288|FG000|Overall Study|Transportation issue|1|||
164301895|NCT01824836|593480288|FG000|Overall Study|Patient transferred care|1|||
164301896|NCT01824836|593480288|FG000|Overall Study|Unknown reasons|4|||
164301897|NCT01824836|593480288|FG000|Overall Study|Never started treatment|16|||
164301898|NCT03253393|593480289|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
164301899|NCT03253393|593480290|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
164301900|NCT03253393|593480291|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
164301901|NCT01987453|593482441|FG000|Overall Study|Death|0|||
164301902|NCT01987453|593482442|FG001|Overall Study|Death|0|||
164301903|NCT01987453|593482443|FG002|Overall Study|Death|1|||
164301904|NCT01987453|593482441|FG000|Overall Study|Lack of Efficacy|1|||
164301905|NCT01987453|593482442|FG001|Overall Study|Lack of Efficacy|12|||
164301906|NCT01987453|593482443|FG002|Overall Study|Lack of Efficacy|0|||
164301907|NCT05291520|593482446|FG000|Overall Study|Lost to Follow-up|0|||
164301908|NCT05291520|593482447|FG001|Overall Study|Lost to Follow-up|0|||
164301909|NCT05291520|593482448|FG002|Overall Study|Lost to Follow-up|1|||
164301910|NCT01354899|593482453|FG000|Overall Study|discharge from the hospital|2|||
164301911|NCT01354899|593482453|FG000|Overall Study|Protocol Violation|1|||
164301912|NCT01421719|593482458|FG000|Overall Study|Withdrawal by Subject|4|||
164301913|NCT01124006|593482459|FG000|Overall Study|Withdrawal by Subject|2|||
164301914|NCT01124006|593482460|FG001|Overall Study|Withdrawal by Subject|2|||
164301915|NCT01124006|593482461|FG002|Overall Study|Withdrawal by Subject|0|||
164301916|NCT01124006|593482459|FG000|Overall Study|Lost to Follow-up|1|||
164301917|NCT01124006|593482460|FG001|Overall Study|Lost to Follow-up|0|||
164301918|NCT01124006|593482461|FG002|Overall Study|Lost to Follow-up|1|||
164301919|NCT01124006|593482459|FG000|Overall Study|Other|0|||
164301920|NCT01124006|593482460|FG001|Overall Study|Other|0|||
164301921|NCT01124006|593482461|FG002|Overall Study|Other|1|||
164301922|NCT01357850|593482471|FG000|Overall Study|Lost to Follow-up|1|||
164301923|NCT01357850|593482472|FG001|Overall Study|Lost to Follow-up|0|||
164301924|NCT01357850|593482473|FG002|Overall Study|Lost to Follow-up|0|||
164301925|NCT01357850|593482474|FG003|Overall Study|Lost to Follow-up|0|||
164301926|NCT02736890|593482475|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
164301927|NCT02736890|593482476|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
164301928|NCT02736890|593482475|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
164301929|NCT02736890|593482476|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
164301930|NCT02351856|593482477|FG000|Overall Study|Adverse Event|2|||
164301931|NCT02351856|593482477|FG000|Overall Study|Physician Decision|5|||
164301932|NCT02351856|593482477|FG000|Overall Study|Study terminated by sponsor|1|||
164301933|NCT02904954|593482478|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
164301934|NCT02904954|593482479|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
164301935|NCT02904954|593482478|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
164301936|NCT02904954|593482479|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
164301937|NCT02904954|593482478|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
164301938|NCT02904954|593482479|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
164301939|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Recurrence|2|||
164301940|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Recurrence|0|||
164301941|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Adverse Event|2|||
164301942|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Adverse Event|6|||
164301943|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Participant wishes|12|||
164301944|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Participant wishes|7|||
164301945|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Physician Decision|2|||
164301946|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Physician Decision|1|||
164301947|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
164301948|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
164301949|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Death|0|||
164301950|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Death|1|||
164301951|NCT02904954|593482478|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
164301952|NCT02904954|593482479|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
164301953|NCT01198795|593482480|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
164301954|NCT01198795|593482480|FG000|Overall Study|Withdrawal by Subject|17|||
164301955|NCT01198795|593482480|FG000|Overall Study|Lost to Follow-up|15|||
164301956|NCT01198795|593482480|FG000|Overall Study|Adverse Event|9|||
164301957|NCT01198795|593482480|FG000|Overall Study|Lack of Efficacy|5|||
164301958|NCT01198795|593482480|FG000|Overall Study|Protocol Violation|2|||
164301959|NCT01198795|593482480|FG000|Overall Study|Other Reason|4|||
164301960|NCT00753506|593482481|FG000|Overall Study|Withdrawal by Subject|4|||
164301961|NCT00753506|593482482|FG001|Overall Study|Withdrawal by Subject|1|||
164301962|NCT00753506|593482481|FG000|Overall Study|Lost to Follow-up|2|||
164301963|NCT00753506|593482482|FG001|Overall Study|Lost to Follow-up|0|||
164301964|NCT00753506|593482481|FG000|Overall Study|Other reason|1|||
164301965|NCT00753506|593482482|FG001|Overall Study|Other reason|1|||
164301966|NCT03819114|593482483|FG000|Overall Study|Protocol Violation|0|||
164301967|NCT03819114|593482484|FG001|Overall Study|Protocol Violation|1|||
164301968|NCT03819114|593482485|FG002|Overall Study|Protocol Violation|1|||
164301969|NCT03819114|593482486|FG003|Overall Study|Protocol Violation|0|||
164301970|NCT03819114|593482483|FG000|Overall Study|Lost to Follow-up|0|||
164301971|NCT03819114|593482484|FG001|Overall Study|Lost to Follow-up|0|||
164301972|NCT03819114|593482485|FG002|Overall Study|Lost to Follow-up|1|||
164301973|NCT03819114|593482486|FG003|Overall Study|Lost to Follow-up|0|||
164301974|NCT04226742|593482487|FG000|Overall Study|Lost to Follow-up|16|||
164301975|NCT04226742|593482488|FG001|Overall Study|Lost to Follow-up|13|||
164301976|NCT04226742|593482487|FG000|Overall Study|Withdrawal by Subject|5|||
164301977|NCT04226742|593482488|FG001|Overall Study|Withdrawal by Subject|3|||
164301978|NCT01936870|593482495|FG000|Overall Study|No Visit After Treatment|176|||
164301979|NCT01936870|593482495|FG000|Overall Study|Protocol Violation|12|||
164301980|NCT01936870|593482495|FG000|Overall Study|No Drug Administration|1|||
164301981|NCT00248040|593482500|FG000|Overall Study|transplantectomy|2|||
164301982|NCT00248040|593482501|FG001|Overall Study|transplantectomy|1|||
164301983|NCT00248040|593482502|FG002|Overall Study|transplantectomy|3|||
164301984|NCT00248040|593482500|FG000|Overall Study|transplant cancelled post treat start|1|||
164301985|NCT00248040|593482501|FG001|Overall Study|transplant cancelled post treat start|0|||
164301986|NCT00248040|593482502|FG002|Overall Study|transplant cancelled post treat start|0|||
164301987|NCT00248040|593482500|FG000|Overall Study|Death|0|||
164301988|NCT00248040|593482501|FG001|Overall Study|Death|0|||
164302042|NCT02395471|593482509|FG000|Overall Study|Withdrawal by Subject|2|||
164302043|NCT02395471|593482510|FG001|Overall Study|Withdrawal by Subject|1|||
164302044|NCT02395471|593482509|FG000|Overall Study|Physician Decision|1|||
164302045|NCT02395471|593482510|FG001|Overall Study|Physician Decision|0|||
164302046|NCT02395471|593482509|FG000|Overall Study|Protocol Violation|0|||
164302047|NCT02395471|593482510|FG001|Overall Study|Protocol Violation|1|||
164302048|NCT02395471|593482509|FG000|Overall Study|Failure to swollow sponge twice|1|||
164302049|NCT02395471|593482510|FG001|Overall Study|Failure to swollow sponge twice|0|||
164302050|NCT02395471|593482509|FG000|Overall Study|Patient did not return for procedure|0|||
164302051|NCT02395471|593482510|FG001|Overall Study|Patient did not return for procedure|1|||
164302052|NCT02395471|593482509|FG000|Overall Study|Subject not eligible|1|||
164302053|NCT02395471|593482510|FG001|Overall Study|Subject not eligible|0|||
164302054|NCT03038880|593482516|FG000|Overall Study|Death|1|||
164302055|NCT03038880|593482517|FG001|Overall Study|Death|2|||
164302056|NCT03038880|593482518|FG002|Overall Study|Death|0|||
164302057|NCT03038880|593482516|FG000|Overall Study|Physician Decision|2|||
164302058|NCT03038880|593482517|FG001|Overall Study|Physician Decision|1|||
164302059|NCT03038880|593482518|FG002|Overall Study|Physician Decision|0|||
164302060|NCT03926611|593482523|FG000|Overall Study|Adverse Event|0|||
164302061|NCT03926611|593482524|FG001|Overall Study|Adverse Event|0|||
164302062|NCT03926611|593482525|FG002|Overall Study|Adverse Event|0|||
164302063|NCT03926611|593482526|FG003|Overall Study|Adverse Event|3|||
164302064|NCT03926611|593482527|FG004|Overall Study|Adverse Event|1|||
164302065|NCT03926611|593482528|FG005|Overall Study|Adverse Event|3|||
164302066|NCT03926611|593482529|FG006|Overall Study|Adverse Event|0|||
164302067|NCT03926611|593482523|FG000|Overall Study|Lack of Efficacy|1|||
164302068|NCT03926611|593482524|FG001|Overall Study|Lack of Efficacy|2|||
164302069|NCT03926611|593482525|FG002|Overall Study|Lack of Efficacy|0|||
164302070|NCT03926611|593482526|FG003|Overall Study|Lack of Efficacy|0|||
164302071|NCT03926611|593482527|FG004|Overall Study|Lack of Efficacy|1|||
164302072|NCT03926611|593482528|FG005|Overall Study|Lack of Efficacy|0|||
164302073|NCT03926611|593482529|FG006|Overall Study|Lack of Efficacy|1|||
164302074|NCT03926611|593482523|FG000|Overall Study|Physician Decision|0|||
164302075|NCT03926611|593482524|FG001|Overall Study|Physician Decision|0|||
164302076|NCT03926611|593482525|FG002|Overall Study|Physician Decision|0|||
164302077|NCT03926611|593482526|FG003|Overall Study|Physician Decision|0|||
164302078|NCT03926611|593482527|FG004|Overall Study|Physician Decision|0|||
164302079|NCT03926611|593482528|FG005|Overall Study|Physician Decision|1|||
164302080|NCT03926611|593482529|FG006|Overall Study|Physician Decision|0|||
164302081|NCT03926611|593482523|FG000|Overall Study|Protocol Violation|1|||
164302082|NCT03926611|593482524|FG001|Overall Study|Protocol Violation|0|||
164302083|NCT03926611|593482525|FG002|Overall Study|Protocol Violation|0|||
164302084|NCT03926611|593482526|FG003|Overall Study|Protocol Violation|1|||
164302085|NCT03926611|593482527|FG004|Overall Study|Protocol Violation|1|||
164302086|NCT03926611|593482528|FG005|Overall Study|Protocol Violation|1|||
164302087|NCT03926611|593482529|FG006|Overall Study|Protocol Violation|1|||
164302088|NCT03926611|593482523|FG000|Overall Study|Technical problems|0|||
164302089|NCT03926611|593482524|FG001|Overall Study|Technical problems|0|||
164302090|NCT03926611|593482525|FG002|Overall Study|Technical problems|0|||
164302091|NCT03926611|593482526|FG003|Overall Study|Technical problems|0|||
164302092|NCT03926611|593482527|FG004|Overall Study|Technical problems|0|||
164302093|NCT03926611|593482528|FG005|Overall Study|Technical problems|1|||
164302094|NCT03926611|593482529|FG006|Overall Study|Technical problems|0|||
164302095|NCT03926611|593482523|FG000|Overall Study|Withdrawal by Subject|1|||
164302096|NCT03926611|593482524|FG001|Overall Study|Withdrawal by Subject|1|||
164302097|NCT03926611|593482525|FG002|Overall Study|Withdrawal by Subject|1|||
164302098|NCT03926611|593482526|FG003|Overall Study|Withdrawal by Subject|0|||
164302099|NCT03926611|593482527|FG004|Overall Study|Withdrawal by Subject|0|||
164302100|NCT03926611|593482528|FG005|Overall Study|Withdrawal by Subject|1|||
164302101|NCT03926611|593482529|FG006|Overall Study|Withdrawal by Subject|3|||
164302102|NCT03926611|593482523|FG000|Overall Study|Covid-19 pandemic|0|||
164302103|NCT03926611|593482524|FG001|Overall Study|Covid-19 pandemic|0|||
164302104|NCT03926611|593482525|FG002|Overall Study|Covid-19 pandemic|1|||
164302105|NCT03926611|593482526|FG003|Overall Study|Covid-19 pandemic|0|||
164302106|NCT03926611|593482527|FG004|Overall Study|Covid-19 pandemic|1|||
164302107|NCT03926611|593482528|FG005|Overall Study|Covid-19 pandemic|2|||
164302108|NCT03926611|593482529|FG006|Overall Study|Covid-19 pandemic|0|||
164302109|NCT02612779|593482530|FG000|Overall Study|Administrative reason by sponsor|4|||
164302110|NCT02612779|593482531|FG001|Overall Study|Administrative reason by sponsor|1|||
164302111|NCT02612779|593482530|FG000|Overall Study|No longer meet study criteria|0|||
164302112|NCT02612779|593482531|FG001|Overall Study|No longer meet study criteria|1|||
164302113|NCT02612779|593482530|FG000|Overall Study|Disease progression|29|||
164302114|NCT02612779|593482531|FG001|Overall Study|Disease progression|2|||
164302115|NCT02612779|593482530|FG000|Overall Study|Study drug toxicity|10|||
164302116|NCT02612779|593482531|FG001|Overall Study|Study drug toxicity|1|||
164302117|NCT02612779|593482530|FG000|Overall Study|Death|1|||
164302118|NCT02612779|593482531|FG001|Overall Study|Death|0|||
164302119|NCT02612779|593482530|FG000|Overall Study|Adverse event unrelated to study drug|5|||
164302120|NCT02612779|593482531|FG001|Overall Study|Adverse event unrelated to study drug|0|||
164302121|NCT02612779|593482530|FG000|Overall Study|Participant withdrew consent|4|||
164302122|NCT02612779|593482531|FG001|Overall Study|Participant withdrew consent|0|||
164302123|NCT02612779|593482530|FG000|Overall Study|Lost to Follow-up|1|||
164302124|NCT02612779|593482531|FG001|Overall Study|Lost to Follow-up|0|||
164302125|NCT02612779|593482530|FG000|Overall Study|Maximum clinical benefit|10|||
164302126|NCT02612779|593482531|FG001|Overall Study|Maximum clinical benefit|1|||
164302127|NCT02612779|593482530|FG000|Overall Study|Other reasons|4|||
164302128|NCT02612779|593482531|FG001|Overall Study|Other reasons|0|||
164302129|NCT03041038|593482532|FG000|Overall Study|Withdrawal by Subject|4|||
164302130|NCT03041038|593482533|FG001|Overall Study|Withdrawal by Subject|0|||
164302131|NCT03041038|593482532|FG000|Overall Study|Lost to Follow-up|1|||
164302132|NCT03041038|593482533|FG001|Overall Study|Lost to Follow-up|1|||
164302133|NCT03041038|593482532|FG000|Overall Study|Protocol Violation|1|||
164302134|NCT03041038|593482533|FG001|Overall Study|Protocol Violation|1|||
164302135|NCT00763035|593482534|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
164302136|NCT00763035|593482535|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
164302137|NCT00763035|593482534|FG000|First Intervention|Adverse Event|0|||
164302138|NCT00763035|593482535|FG001|First Intervention|Adverse Event|1|||
164302139|NCT00763035|593482534|FG000|Second Intervention|Adverse Event|1|||
164302140|NCT00763035|593482535|FG001|Second Intervention|Adverse Event|0|||
164302141|NCT00763035|593482534|FG000|Second Intervention|Physician Decision|2|||
164302142|NCT00763035|593482535|FG001|Second Intervention|Physician Decision|0|||
164302143|NCT02796170|593482536|FG000|Overall Study|Lost to Follow-up|3|||
164302144|NCT02796170|593482537|FG001|Overall Study|Lost to Follow-up|0|||
164302145|NCT01527370|593482538|FG000|Overall Study|Withdrawal by Subject|4|||
164302146|NCT01527370|593482538|FG000|Overall Study|Physician Decision|1|||
164302147|NCT01527370|593482538|FG000|Overall Study|Death|1|||
164302148|NCT02177032|593482541|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
164302149|NCT02177032|593482542|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
164302150|NCT02177032|593482543|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
164302151|NCT02177032|593482544|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
164302152|NCT02177032|593482541|FG000|Overall Study|Lost to Follow-up|0|||
164302153|NCT02177032|593482542|FG001|Overall Study|Lost to Follow-up|2|||
164302154|NCT02177032|593482543|FG002|Overall Study|Lost to Follow-up|0|||
164302155|NCT02177032|593482544|FG003|Overall Study|Lost to Follow-up|0|||
164302156|NCT02177032|593482541|FG000|Overall Study|OTHER|2|||
164302157|NCT02177032|593482542|FG001|Overall Study|OTHER|0|||
164302158|NCT02177032|593482543|FG002|Overall Study|OTHER|1|||
164302159|NCT02177032|593482544|FG003|Overall Study|OTHER|0|||
164302160|NCT02177032|593482541|FG000|Overall Study|Withdrawal by Subject|1|||
164302161|NCT02177032|593482542|FG001|Overall Study|Withdrawal by Subject|0|||
164302162|NCT02177032|593482543|FG002|Overall Study|Withdrawal by Subject|1|||
164302163|NCT02177032|593482544|FG003|Overall Study|Withdrawal by Subject|0|||
164302164|NCT00930046|593482545|FG000|Overall Study|Wound catheter malfunctioned|1|||
164302165|NCT00930046|593482546|FG001|Overall Study|Wound catheter malfunctioned|2|||
164302166|NCT01598532|593482547|FG000|Overall Study|Lost to Follow-up|3|||
164302167|NCT01598532|593482547|FG000|Overall Study|Did not meet inclusion criteria|8|||
164302168|NCT00912808|593482548|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
164302169|NCT00912808|593482549|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
164302170|NCT00912808|593482548|FG000|Washout|Withdrawal by Subject|0|||
164302171|NCT00912808|593482549|FG001|Washout|Withdrawal by Subject|1|||
164302172|NCT00912808|593482548|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
164302173|NCT00912808|593482549|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
164302174|NCT00912808|593482548|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
164302175|NCT00912808|593482549|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
164302176|NCT00702221|593482550|FG000|Overall Study|Adverse Event|4|||
164302177|NCT00702221|593482551|FG001|Overall Study|Adverse Event|3|||
164302178|NCT02900378|593482552|FG000|Randomization (Visit 2)|Adverse Event|14|||
164302179|NCT02900378|593482553|FG001|Randomization (Visit 2)|Adverse Event|11|||
164302180|NCT02900378|593482552|FG000|Randomization (Visit 2)|Death|1|||
164302181|NCT02900378|593482553|FG001|Randomization (Visit 2)|Death|4|||
164302182|NCT02900378|593482552|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
164302183|NCT02900378|593482553|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
164302184|NCT02900378|593482552|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
164302185|NCT02900378|593482553|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
164302186|NCT02900378|593482552|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
164302187|NCT02900378|593482553|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
164302188|NCT02900378|593482552|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
164302189|NCT02900378|593482553|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
164302190|NCT02900378|593482552|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
164302191|NCT02900378|593482553|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
164302192|NCT01134055|593482556|FG000|Overall Study|Adverse Event|5|||
164302193|NCT01134055|593482557|FG001|Overall Study|Adverse Event|2|||
164302194|NCT01134055|593482558|FG002|Overall Study|Adverse Event|2|||
164302195|NCT01134055|593482559|FG003|Overall Study|Adverse Event|2|||
164302196|NCT01134055|593482560|FG004|Overall Study|Adverse Event|5|||
164302206|NCT01134055|593482556|FG000|Overall Study|Withdrawal by Subject|3|||
164302207|NCT01134055|593482557|FG001|Overall Study|Withdrawal by Subject|3|||
164302208|NCT01134055|593482558|FG002|Overall Study|Withdrawal by Subject|1|||
164302209|NCT01134055|593482559|FG003|Overall Study|Withdrawal by Subject|2|||
164302210|NCT01134055|593482560|FG004|Overall Study|Withdrawal by Subject|0|||
164302211|NCT01134055|593482561|FG005|Overall Study|Withdrawal by Subject|0|||
164302212|NCT01134055|593482562|FG006|Overall Study|Withdrawal by Subject|8|||
164302213|NCT01134055|593482556|FG000|Overall Study|Protocol Violation|0|||
164302214|NCT01134055|593482557|FG001|Overall Study|Protocol Violation|0|||
164302215|NCT01134055|593482558|FG002|Overall Study|Protocol Violation|0|||
164302216|NCT01134055|593482559|FG003|Overall Study|Protocol Violation|1|||
164302217|NCT01134055|593482560|FG004|Overall Study|Protocol Violation|1|||
164302218|NCT01134055|593482561|FG005|Overall Study|Protocol Violation|0|||
164302219|NCT01134055|593482562|FG006|Overall Study|Protocol Violation|0|||
164302220|NCT01134055|593482556|FG000|Overall Study|Physician Decision|0|||
164302221|NCT01134055|593482557|FG001|Overall Study|Physician Decision|0|||
164302222|NCT01134055|593482558|FG002|Overall Study|Physician Decision|0|||
164302223|NCT01134055|593482559|FG003|Overall Study|Physician Decision|0|||
164302224|NCT01134055|593482560|FG004|Overall Study|Physician Decision|0|||
164302225|NCT01134055|593482561|FG005|Overall Study|Physician Decision|0|||
164302226|NCT01134055|593482562|FG006|Overall Study|Physician Decision|1|||
164302227|NCT03345784|593482565|FG000|Overall Study|Withdrawal by Subject|2|||
164302228|NCT03345784|593482566|FG001|Overall Study|Withdrawal by Subject|1|||
164302229|NCT04798196|593482568|FG000|Overall Study|Lost to Follow-up|3|||
164302230|NCT04798196|593482569|FG001|Overall Study|Lost to Follow-up|1|||
164302231|NCT04798196|593482570|FG002|Overall Study|Lost to Follow-up|3|||
164302232|NCT01249261|593482578|FG000|Overall Study|Withdrawal by Subject|1|||
164302233|NCT01249261|593482579|FG001|Overall Study|Withdrawal by Subject|0|||
164302234|NCT01967940|593482586|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
164302235|NCT01967940|593482587|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
164302236|NCT01967940|593482588|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
164302237|NCT01967940|593482589|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
164302238|NCT01967940|593482586|FG000|Part 2|Adverse Event|0|||
164302239|NCT01967940|593482587|FG001|Part 2|Adverse Event|0|||
164302240|NCT01967940|593482588|FG002|Part 2|Adverse Event|0|||
164302241|NCT01967940|593482589|FG003|Part 2|Adverse Event|1|||
164302242|NCT01967940|593482586|FG000|Part 2|Unknown Reason|0|||
164302243|NCT01967940|593482587|FG001|Part 2|Unknown Reason|0|||
164302244|NCT01967940|593482588|FG002|Part 2|Unknown Reason|0|||
164302245|NCT01967940|593482589|FG003|Part 2|Unknown Reason|1|||
164302246|NCT01550003|593482590|FG000|Overall Study|Adverse Event|0|||
164302247|NCT01550003|593482591|FG001|Overall Study|Adverse Event|9|||
164302248|NCT01550003|593482592|FG002|Overall Study|Adverse Event|15|||
164302249|NCT01550003|593482590|FG000|Overall Study|Lack of Efficacy|4|||
164302250|NCT01550003|593482591|FG001|Overall Study|Lack of Efficacy|11|||
164302251|NCT01550003|593482592|FG002|Overall Study|Lack of Efficacy|15|||
164302252|NCT01550003|593482590|FG000|Overall Study|Protocol Violation|0|||
164302253|NCT01550003|593482591|FG001|Overall Study|Protocol Violation|3|||
164302254|NCT01550003|593482592|FG002|Overall Study|Protocol Violation|2|||
164302255|NCT01550003|593482590|FG000|Overall Study|Lost to Follow-up|1|||
164302256|NCT01550003|593482591|FG001|Overall Study|Lost to Follow-up|4|||
164302257|NCT01550003|593482592|FG002|Overall Study|Lost to Follow-up|8|||
164302258|NCT01550003|593482590|FG000|Overall Study|Consent withdrawn|2|||
164302259|NCT01550003|593482591|FG001|Overall Study|Consent withdrawn|11|||
164302260|NCT01550003|593482592|FG002|Overall Study|Consent withdrawn|23|||
164302261|NCT01550003|593482590|FG000|Overall Study|Missing|1|||
164302262|NCT01550003|593482591|FG001|Overall Study|Missing|0|||
164302263|NCT01550003|593482592|FG002|Overall Study|Missing|2|||
164302264|NCT01550003|593482590|FG000|Overall Study|Study closure as announced by sponsor|7|||
164302265|NCT01550003|593482591|FG001|Overall Study|Study closure as announced by sponsor|6|||
164302266|NCT01550003|593482592|FG002|Overall Study|Study closure as announced by sponsor|24|||
164302267|NCT01550003|593482590|FG000|Overall Study|Protocol Noncompliance|1|||
164302268|NCT01550003|593482591|FG001|Overall Study|Protocol Noncompliance|0|||
164302269|NCT01550003|593482592|FG002|Overall Study|Protocol Noncompliance|0|||
164302270|NCT01550003|593482590|FG000|Overall Study|Study closure|0|||
164302271|NCT01550003|593482591|FG001|Overall Study|Study closure|1|||
164302272|NCT01550003|593482592|FG002|Overall Study|Study closure|1|||
164302273|NCT01550003|593482590|FG000|Overall Study|Patient reached adulthood|0|||
164302274|NCT01550003|593482591|FG001|Overall Study|Patient reached adulthood|1|||
164302275|NCT01550003|593482592|FG002|Overall Study|Patient reached adulthood|0|||
164302276|NCT01550003|593482590|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
164302277|NCT01550003|593482591|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
164302278|NCT01550003|593482592|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
164302279|NCT01550003|593482590|FG000|Overall Study|Sponsor's order|0|||
164302280|NCT01550003|593482591|FG001|Overall Study|Sponsor's order|3|||
164302281|NCT01550003|593482592|FG002|Overall Study|Sponsor's order|3|||
164302282|NCT01550003|593482590|FG000|Overall Study|Sponsor's decision|1|||
164302283|NCT01550003|593482591|FG001|Overall Study|Sponsor's decision|5|||
164302284|NCT01550003|593482592|FG002|Overall Study|Sponsor's decision|4|||
164302285|NCT01550003|593482590|FG000|Overall Study|Subject mother passed away|0|||
164302286|NCT01550003|593482591|FG001|Overall Study|Subject mother passed away|1|||
164302287|NCT01550003|593482592|FG002|Overall Study|Subject mother passed away|0|||
164302288|NCT01550003|593482590|FG000|Overall Study|Discontinuation|0|||
164302289|NCT01550003|593482591|FG001|Overall Study|Discontinuation|1|||
164302290|NCT01550003|593482592|FG002|Overall Study|Discontinuation|0|||
164302291|NCT01550003|593482590|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
164302292|NCT01550003|593482591|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
164302293|NCT01550003|593482592|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
164302294|NCT01550003|593482590|FG000|Overall Study|Site closure|0|||
164302295|NCT01550003|593482591|FG001|Overall Study|Site closure|2|||
164302296|NCT01550003|593482592|FG002|Overall Study|Site closure|0|||
164302297|NCT01550003|593482590|FG000|Overall Study|Pregnancy|0|||
164302298|NCT01550003|593482591|FG001|Overall Study|Pregnancy|1|||
164302299|NCT01550003|593482592|FG002|Overall Study|Pregnancy|0|||
164302300|NCT01550003|593482590|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
164302301|NCT01550003|593482591|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
164302302|NCT01550003|593482592|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
164302303|NCT01550003|593482590|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
164302304|NCT01550003|593482591|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
164302305|NCT01550003|593482592|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
164302306|NCT01550003|593482590|FG000|Overall Study|Switching to adult rheumatologist|0|||
164302307|NCT01550003|593482591|FG001|Overall Study|Switching to adult rheumatologist|0|||
164302308|NCT01550003|593482592|FG002|Overall Study|Switching to adult rheumatologist|1|||
164302309|NCT01550003|593482590|FG000|Overall Study|Patient transition to adult care|0|||
164302310|NCT01550003|593482591|FG001|Overall Study|Patient transition to adult care|0|||
164302311|NCT01550003|593482592|FG002|Overall Study|Patient transition to adult care|1|||
164302312|NCT01550003|593482590|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
164302313|NCT01550003|593482591|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
164302314|NCT01550003|593482592|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
164302315|NCT01550003|593482590|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
164302316|NCT01550003|593482591|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
164302317|NCT01550003|593482592|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
164302318|NCT01550003|593482590|FG000|Overall Study|Per Sponsor request|1|||
164302319|NCT01550003|593482591|FG001|Overall Study|Per Sponsor request|0|||
164302320|NCT01550003|593482592|FG002|Overall Study|Per Sponsor request|1|||
164302321|NCT01550003|593482590|FG000|Overall Study|Patient not compliance|0|||
164302322|NCT01550003|593482591|FG001|Overall Study|Patient not compliance|0|||
164302323|NCT01550003|593482592|FG002|Overall Study|Patient not compliance|1|||
164302324|NCT01550003|593482590|FG000|Overall Study|Non-compliance|0|||
164302325|NCT01550003|593482591|FG001|Overall Study|Non-compliance|0|||
164302326|NCT01550003|593482592|FG002|Overall Study|Non-compliance|1|||
164302327|NCT01550003|593482590|FG000|Overall Study|Study closed|0|||
164302328|NCT01550003|593482591|FG001|Overall Study|Study closed|1|||
164302329|NCT01550003|593482592|FG002|Overall Study|Study closed|0|||
164302330|NCT01550003|593482590|FG000|Overall Study|Transitioned to adult rheumatology|0|||
164302331|NCT01550003|593482591|FG001|Overall Study|Transitioned to adult rheumatology|0|||
164302332|NCT01550003|593482592|FG002|Overall Study|Transitioned to adult rheumatology|1|||
164302333|NCT05567783|593482593|FG000|Overall Study|Death|2|||
164302334|NCT05567783|593482594|FG001|Overall Study|Death|3|||
164302335|NCT05567783|593482595|FG002|Overall Study|Death|0|||
164302336|NCT05567783|593482593|FG000|Overall Study|Lost to Follow-up|25|||
164302337|NCT05567783|593482594|FG001|Overall Study|Lost to Follow-up|19|||
164302338|NCT05567783|593482595|FG002|Overall Study|Lost to Follow-up|17|||
164302339|NCT05567783|593482593|FG000|Overall Study|Physician Decision|10|||
164302340|NCT05567783|593482594|FG001|Overall Study|Physician Decision|7|||
164302341|NCT05567783|593482595|FG002|Overall Study|Physician Decision|9|||
164302342|NCT05567783|593482593|FG000|Overall Study|Study Terminated by Sponsor|924|||
164302343|NCT05567783|593482594|FG001|Overall Study|Study Terminated by Sponsor|937|||
164302344|NCT05567783|593482595|FG002|Overall Study|Study Terminated by Sponsor|941|||
164302345|NCT05567783|593482593|FG000|Overall Study|Withdrawal by Subject|23|||
164302346|NCT05567783|593482594|FG001|Overall Study|Withdrawal by Subject|27|||
164302347|NCT05567783|593482595|FG002|Overall Study|Withdrawal by Subject|24|||
164302348|NCT05567783|593482593|FG000|Overall Study|Incarcerated|1|||
164302349|NCT05567783|593482594|FG001|Overall Study|Incarcerated|0|||
164302350|NCT05567783|593482595|FG002|Overall Study|Incarcerated|0|||
164302351|NCT05567783|593482593|FG000|Overall Study|Participant randomized in error|4|||
164302352|NCT05567783|593482594|FG001|Overall Study|Participant randomized in error|2|||
164302353|NCT05567783|593482595|FG002|Overall Study|Participant randomized in error|2|||
164302354|NCT03675126|593482598|FG000|Overall Study|Study Terminated by Sponsor|9|||
164302355|NCT03675126|593482598|FG000|Overall Study|Death|2|||
164302356|NCT03675126|593482598|FG000|Overall Study|Withdrawal by Subject|4|||
164302357|NCT00001959|593482599|FG000|Overall Study|newly diagnosed colon cancer|1|||
164302358|NCT00001959|593482599|FG000|Overall Study|disabling sedation|1|||
164302395|NCT02594124|593482619|FG006|Overall Study|Withdrawal by Subject|13|||
164302396|NCT02594124|593482620|FG007|Overall Study|Withdrawal by Subject|19|||
164302397|NCT02594124|593482621|FG008|Overall Study|Withdrawal by Subject|0|||
164302398|NCT02594124|593482613|FG000|Overall Study|Physician Decision|0|||
164302399|NCT02594124|593482614|FG001|Overall Study|Physician Decision|2|||
164302400|NCT02594124|593482615|FG002|Overall Study|Physician Decision|0|||
164302401|NCT02594124|593482616|FG003|Overall Study|Physician Decision|0|||
164302402|NCT02594124|593482617|FG004|Overall Study|Physician Decision|0|||
164302403|NCT02594124|593482618|FG005|Overall Study|Physician Decision|0|||
164302404|NCT02594124|593482619|FG006|Overall Study|Physician Decision|0|||
164302405|NCT02594124|593482620|FG007|Overall Study|Physician Decision|1|||
164302406|NCT02594124|593482621|FG008|Overall Study|Physician Decision|0|||
164302407|NCT02594124|593482613|FG000|Overall Study|Commercial drug|0|||
164302408|NCT02594124|593482614|FG001|Overall Study|Commercial drug|1|||
164302409|NCT02594124|593482615|FG002|Overall Study|Commercial drug|6|||
164302410|NCT02594124|593482616|FG003|Overall Study|Commercial drug|3|||
164302411|NCT02594124|593482617|FG004|Overall Study|Commercial drug|0|||
164302412|NCT02594124|593482618|FG005|Overall Study|Commercial drug|0|||
164302413|NCT02594124|593482619|FG006|Overall Study|Commercial drug|7|||
164302414|NCT02594124|593482620|FG007|Overall Study|Commercial drug|11|||
164302415|NCT02594124|593482621|FG008|Overall Study|Commercial drug|2|||
164302416|NCT02594124|593482613|FG000|Overall Study|Reason Not Specified|1|||
164302417|NCT02594124|593482614|FG001|Overall Study|Reason Not Specified|3|||
164302418|NCT02594124|593482615|FG002|Overall Study|Reason Not Specified|4|||
164302419|NCT02594124|593482616|FG003|Overall Study|Reason Not Specified|0|||
164302420|NCT02594124|593482617|FG004|Overall Study|Reason Not Specified|0|||
164302421|NCT02594124|593482618|FG005|Overall Study|Reason Not Specified|1|||
164302422|NCT02594124|593482619|FG006|Overall Study|Reason Not Specified|1|||
164302423|NCT02594124|593482620|FG007|Overall Study|Reason Not Specified|6|||
164302424|NCT02594124|593482621|FG008|Overall Study|Reason Not Specified|1|||
164302425|NCT05523089|593482622|FG000|Overall Study|Withdrawal by Subject|1|||
164302426|NCT05523089|593482623|FG001|Overall Study|Withdrawal by Subject|0|||
164302427|NCT05523089|593482624|FG002|Overall Study|Withdrawal by Subject|0|||
164302428|NCT05523089|593482622|FG000|Overall Study|Lost to Follow-up|1|||
164302429|NCT05523089|593482623|FG001|Overall Study|Lost to Follow-up|0|||
164302430|NCT05523089|593482624|FG002|Overall Study|Lost to Follow-up|0|||
164302431|NCT05530252|593482625|FG000|Overall Study|Lost to Follow-up|1|||
164302432|NCT05530252|593482626|FG001|Overall Study|Lost to Follow-up|1|||
164302433|NCT05530252|593482627|FG002|Overall Study|Lost to Follow-up|1|||
164302434|NCT01350999|593482628|FG000|Overall Study|Adverse Event|4|||
164302435|NCT01350999|593482629|FG001|Overall Study|Adverse Event|9|||
164302436|NCT01350999|593482630|FG002|Overall Study|Adverse Event|10|||
164302437|NCT01350999|593482628|FG000|Overall Study|Voluntary withdrawal|3|||
164302438|NCT01350999|593482629|FG001|Overall Study|Voluntary withdrawal|4|||
164302439|NCT01350999|593482630|FG002|Overall Study|Voluntary withdrawal|6|||
164302440|NCT01350999|593482628|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
164302441|NCT01350999|593482629|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
164302442|NCT01350999|593482630|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
164302443|NCT04040933|593484542|FG000|Overall Study|Protocol Violation|1|||
164302444|NCT04040933|593484542|FG000|Overall Study|Withdrawal by Subject|2|||
164302445|NCT02066181|593484543|FG000|Overall Study|Withdrawal by Subject|1|||
164302446|NCT02066181|593484544|FG001|Overall Study|Withdrawal by Subject|1|||
164302447|NCT02141295|593484548|FG000|Overall Study|Adverse Event|1|||
164302448|NCT02141295|593484549|FG001|Overall Study|Adverse Event|18|||
164302449|NCT02141295|593484550|FG002|Overall Study|Adverse Event|11|||
164302450|NCT02141295|593484548|FG000|Overall Study|Physician Decision|2|||
164302451|NCT02141295|593484549|FG001|Overall Study|Physician Decision|19|||
164302452|NCT02141295|593484550|FG002|Overall Study|Physician Decision|14|||
164302453|NCT02141295|593484548|FG000|Overall Study|Study terminated by sponsor|0|||
164302454|NCT02141295|593484549|FG001|Overall Study|Study terminated by sponsor|6|||
164302455|NCT02141295|593484550|FG002|Overall Study|Study terminated by sponsor|6|||
164302456|NCT02141295|593484548|FG000|Overall Study|Non-compliance|0|||
164302457|NCT02141295|593484549|FG001|Overall Study|Non-compliance|1|||
164302458|NCT02141295|593484550|FG002|Overall Study|Non-compliance|0|||
164302459|NCT02141295|593484548|FG000|Overall Study|Progressive disease|3|||
164302460|NCT02141295|593484549|FG001|Overall Study|Progressive disease|32|||
164302461|NCT02141295|593484550|FG002|Overall Study|Progressive disease|50|||
164302462|NCT02141295|593484548|FG000|Overall Study|Reason not specified|0|||
164302463|NCT02141295|593484549|FG001|Overall Study|Reason not specified|9|||
164302464|NCT02141295|593484550|FG002|Overall Study|Reason not specified|10|||
164302465|NCT02141295|593484548|FG000|Overall Study|Withdrawal by Subject|0|||
164302466|NCT02141295|593484549|FG001|Overall Study|Withdrawal by Subject|9|||
164302467|NCT02141295|593484550|FG002|Overall Study|Withdrawal by Subject|4|||
164302468|NCT02536976|593484551|FG000|Overall Study|Physician Decision|0|||
164302469|NCT02536976|593484552|FG001|Overall Study|Physician Decision|1|||
164302470|NCT01671319|593484555|FG000|Overall Study|Withdrawal by Subject|1|||
164302471|NCT02144610|593484556|FG000|Overall Study|Physician Decision|1|||
164302472|NCT02144610|593484557|FG001|Overall Study|Physician Decision|0|||
164302473|NCT02144610|593484556|FG000|Overall Study|Withdrawal by Subject|1|||
164302474|NCT02144610|593484557|FG001|Overall Study|Withdrawal by Subject|5|||
164302475|NCT02144610|593484556|FG000|Overall Study|Death|2|||
164302476|NCT02144610|593484557|FG001|Overall Study|Death|2|||
164302477|NCT02144610|593484556|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
164302478|NCT02144610|593484557|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
164302479|NCT02144610|593484556|FG000|Overall Study|Other|0|||
164302480|NCT02144610|593484557|FG001|Overall Study|Other|1|||
164302481|NCT00706238|593484563|FG000|Overall Study|Disease progression|4|||
164302482|NCT00706238|593484563|FG000|Overall Study|Other|1|||
164302483|NCT01193244|593484564|FG000|Overall Study|Withdrawal by Subject|79|||
164302484|NCT01193244|593484565|FG001|Overall Study|Withdrawal by Subject|97|||
164302485|NCT01193244|593484564|FG000|Overall Study|Other|303|||
164302486|NCT01193244|593484565|FG001|Overall Study|Other|278|||
164302487|NCT01193244|593484564|FG000|Overall Study|Lost to Follow-up|6|||
164302488|NCT01193244|593484565|FG001|Overall Study|Lost to Follow-up|15|||
164302489|NCT00628108|593484566|FG000|Overall Study|Adverse Event|0|||
164302490|NCT00628108|593484567|FG001|Overall Study|Adverse Event|3|||
164302491|NCT00628108|593484566|FG000|Overall Study|Withdrawal by Subject|1|||
164302492|NCT00628108|593484567|FG001|Overall Study|Withdrawal by Subject|0|||
164302493|NCT03848832|593484568|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
164302494|NCT03848832|593484569|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
164302495|NCT03848832|593484570|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
164302496|NCT03848832|593484568|FG000|Overall Study|Withdrawal by Subject|0|||
164302497|NCT03848832|593484569|FG001|Overall Study|Withdrawal by Subject|0|||
164302498|NCT03848832|593484570|FG002|Overall Study|Withdrawal by Subject|1|||
164302499|NCT03848832|593484568|FG000|Overall Study|Withdrawal (Covid-19)|0|||
164302500|NCT03848832|593484569|FG001|Overall Study|Withdrawal (Covid-19)|2|||
164302501|NCT03848832|593484570|FG002|Overall Study|Withdrawal (Covid-19)|0|||
164302502|NCT03848832|593484568|FG000|Overall Study|Physician Decision|2|||
164302503|NCT03848832|593484569|FG001|Overall Study|Physician Decision|1|||
164302504|NCT03848832|593484570|FG002|Overall Study|Physician Decision|3|||
164302505|NCT03848832|593484568|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
164302506|NCT03848832|593484569|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
164302507|NCT03848832|593484570|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
164302508|NCT03848832|593484568|FG000|Overall Study|Adverse Event|1|||
164302509|NCT03848832|593484569|FG001|Overall Study|Adverse Event|0|||
164302510|NCT03848832|593484570|FG002|Overall Study|Adverse Event|0|||
164302511|NCT00865566|593484571|FG000|Overall Study|Death|1|||
164302512|NCT00865566|593484572|FG001|Overall Study|Death|11|||
164302513|NCT00865566|593484571|FG000|Overall Study|Lost to Follow-up|314|||
164302514|NCT00865566|593484572|FG001|Overall Study|Lost to Follow-up|315|||
164302515|NCT00865566|593484571|FG000|Overall Study|Withdrawal by Subject|45|||
164302516|NCT00865566|593484572|FG001|Overall Study|Withdrawal by Subject|65|||
164302517|NCT00865566|593484571|FG000|Overall Study|Physician Decision|0|||
164302518|NCT00865566|593484572|FG001|Overall Study|Physician Decision|1|||
164302519|NCT00865566|593484571|FG000|Overall Study|Participant relocated|78|||
164302520|NCT00865566|593484572|FG001|Overall Study|Participant relocated|107|||
164302521|NCT00865566|593484571|FG000|Overall Study|Participant unable to adhere|27|||
164302522|NCT00865566|593484572|FG001|Overall Study|Participant unable to adhere|42|||
164302523|NCT00865566|593484571|FG000|Overall Study|Other; N=245 due to early study closure|154|||
164302524|NCT00865566|593484572|FG001|Overall Study|Other; N=245 due to early study closure|139|||
164302525|NCT00865566|593484571|FG000|Overall Study|HIV infection|5|||
164302526|NCT00865566|593484572|FG001|Overall Study|HIV infection|7|||
164302527|NCT01039376|593484573|FG000|Overall Study|Lost to Follow-up|5|||
164302528|NCT01039376|593484574|FG001|Overall Study|Lost to Follow-up|12|||
164302529|NCT01039376|593484573|FG000|Overall Study|Physician Decision|15|||
164302530|NCT01039376|593484574|FG001|Overall Study|Physician Decision|10|||
164302531|NCT01039376|593484573|FG000|Overall Study|Withdrawal by Subject|20|||
164302532|NCT01039376|593484574|FG001|Overall Study|Withdrawal by Subject|32|||
164302533|NCT01039376|593484573|FG000|Overall Study|Study terminated by Sponsor|90|||
164302534|NCT01039376|593484574|FG001|Overall Study|Study terminated by Sponsor|72|||
164302535|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
164302536|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
164302537|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Adverse Event|31|||
164302538|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Adverse Event|21|||
164302539|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
164302540|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
164302541|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
164302542|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
164302543|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
164302544|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
164302545|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
164302546|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
164302547|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Administrative problems|3|||
164302548|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Administrative problems|3|||
164302549|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Death|5|||
164302550|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Death|8|||
164302551|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Disease progression|139|||
164302552|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Disease progression|119|||
164302553|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
164302554|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
164302555|NCT00785785|593484575|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
164302556|NCT00785785|593484576|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
164302557|NCT00785785|593484575|FG000|Optional Extension Phase|Adverse Event|4|||
164302558|NCT00785785|593484576|FG001|Optional Extension Phase|Adverse Event|5|||
164302559|NCT00785785|593484575|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
164302560|NCT00785785|593484576|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
164302561|NCT00785785|593484575|FG000|Optional Extension Phase|Lost to Follow-up|1|||
164302562|NCT00785785|593484576|FG001|Optional Extension Phase|Lost to Follow-up|0|||
164302563|NCT00785785|593484575|FG000|Optional Extension Phase|Administrative problems|2|||
164302564|NCT00785785|593484576|FG001|Optional Extension Phase|Administrative problems|0|||
164302565|NCT00785785|593484575|FG000|Optional Extension Phase|Death|1|||
164302566|NCT00785785|593484576|FG001|Optional Extension Phase|Death|5|||
164302567|NCT00785785|593484575|FG000|Optional Extension Phase|Disease progression|22|||
164302568|NCT00785785|593484576|FG001|Optional Extension Phase|Disease progression|70|||
164302569|NCT00785785|593484575|FG000|Optional Extension Phase|Protocol deviation|0|||
164302570|NCT00785785|593484576|FG001|Optional Extension Phase|Protocol deviation|2|||
164302571|NCT00785785|593484575|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
164302572|NCT00785785|593484576|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
164302573|NCT02453321|593484577|FG000|Overall Study|Weakness|1|||
164302574|NCT02453321|593484578|FG001|Overall Study|Weakness|1|||
164302575|NCT02453321|593484579|FG002|Overall Study|Weakness|2|||
164302576|NCT02453321|593484577|FG000|Overall Study|Deep Venous Thrombosis|0|||
164302577|NCT02453321|593484578|FG001|Overall Study|Deep Venous Thrombosis|1|||
164302578|NCT02453321|593484579|FG002|Overall Study|Deep Venous Thrombosis|0|||
164302579|NCT03252925|593484580|FG000|Overall Study|Withdrawal by Subject|1|||
164302580|NCT03252925|593484581|FG001|Overall Study|Withdrawal by Subject|0|||
164302581|NCT03252925|593484580|FG000|Overall Study|Protocol Violation|6|||
164302582|NCT03252925|593484581|FG001|Overall Study|Protocol Violation|0|||
164302583|NCT03252925|593484580|FG000|Overall Study|Adverse Event|1|||
164302584|NCT03252925|593484581|FG001|Overall Study|Adverse Event|0|||
164302585|NCT03252925|593484580|FG000|Overall Study|Lost to Follow-up|6|||
164302586|NCT03252925|593484581|FG001|Overall Study|Lost to Follow-up|6|||
164302587|NCT01244893|593484582|FG000|Baseline|Protocol Violation|0|||
164302588|NCT01244893|593484583|FG001|Baseline|Protocol Violation|1|||
164302589|NCT01244893|593484582|FG000|1-Week Follow Up|Lost to Follow-up|1|||
164302590|NCT01244893|593484583|FG001|1-Week Follow Up|Lost to Follow-up|0|||
164302591|NCT00357552|593484584|FG000|Screening|Did not meet eligibility criteria|84|||
164302592|NCT00357552|593484584|FG000|Weeks 0 to 24|Death|1|||
164302593|NCT00357552|593484584|FG000|Weeks 24 to 104|Death|3|||
164302594|NCT00357552|593484584|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
164302595|NCT00521404|593484587|FG000|Overall Study|Adverse Event|13|||
164302596|NCT00521404|593484587|FG000|Overall Study|Disease Progression|33|||
164302597|NCT00521404|593484587|FG000|Overall Study|Investigator decision|5|||
164302598|NCT00521404|593484587|FG000|Overall Study|Withdrawal of consent|3|||
164302599|NCT00521404|593484587|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
164302600|NCT00521404|593484587|FG000|Overall Study|Other|7|||
164302601|NCT04555616|593484590|FG000|Overall Study|Death|1|||
164302602|NCT04555616|593484591|FG001|Overall Study|Death|0|||
164302603|NCT04555616|593484592|FG002|Overall Study|Death|1|||
164302604|NCT04555616|593484590|FG000|Overall Study|Withdrawal by Subject|2|||
164302605|NCT04555616|593484591|FG001|Overall Study|Withdrawal by Subject|1|||
164302606|NCT04555616|593484592|FG002|Overall Study|Withdrawal by Subject|0|||
164302607|NCT00882557|593484593|FG000|Overall Study|Withdrawal by Subject|1|||
164302608|NCT00882557|593484594|FG001|Overall Study|Withdrawal by Subject|0|||
164302609|NCT00882557|593484593|FG000|Overall Study|Trouble with Vein Access|1|||
164302610|NCT00882557|593484594|FG001|Overall Study|Trouble with Vein Access|0|||
164302611|NCT00882557|593484593|FG000|Overall Study|Randomized Not Treated|0|||
164302612|NCT00882557|593484594|FG001|Overall Study|Randomized Not Treated|1|||
164302613|NCT02282605|593484595|FG000|Overall Study|negative SA result on Day -1|3|||
164302614|NCT02282605|593484596|FG001|Overall Study|negative SA result on Day -1|0|||
164302615|NCT02282605|593484597|FG002|Overall Study|negative SA result on Day -1|0|||
164302616|NCT00711191|593484598|FG000|Overall Study|Adverse Event|1|||
164302617|NCT00711191|593484599|FG001|Overall Study|Adverse Event|1|||
164302618|NCT00711191|593484600|FG002|Overall Study|Adverse Event|2|||
164302619|NCT00711191|593484598|FG000|Overall Study|Objective progression or relapse|2|||
164302620|NCT00711191|593484599|FG001|Overall Study|Objective progression or relapse|3|||
164302621|NCT00711191|593484600|FG002|Overall Study|Objective progression or relapse|7|||
164302622|NCT00711191|593484598|FG000|Overall Study|Withdrawal by Subject|0|||
164302623|NCT00711191|593484599|FG001|Overall Study|Withdrawal by Subject|1|||
164302624|NCT00711191|593484600|FG002|Overall Study|Withdrawal by Subject|3|||
164302625|NCT02404025|593484601|FG000|Overall Study|Adverse Event|1|||
164302626|NCT02404025|593484601|FG000|Overall Study|Lack of Efficacy|3|||
164302627|NCT02230670|593484603|FG000|Overall Study|Adverse Event|1|||
164302628|NCT02230670|593484604|FG001|Overall Study|Adverse Event|2|||
164302629|NCT02230670|593484603|FG000|Overall Study|Withdrawal by Subject|2|||
164302630|NCT02230670|593484604|FG001|Overall Study|Withdrawal by Subject|2|||
164302631|NCT02230670|593484603|FG000|Overall Study|Physician Decision|0|||
164302632|NCT02230670|593484604|FG001|Overall Study|Physician Decision|1|||
164302633|NCT02230670|593484603|FG000|Overall Study|Protocol Violation|0|||
164302634|NCT02230670|593484604|FG001|Overall Study|Protocol Violation|1|||
164302635|NCT02230670|593484603|FG000|Overall Study|Progression to Child-Pugh C|1|||
164302636|NCT02230670|593484604|FG001|Overall Study|Progression to Child-Pugh C|2|||
164302637|NCT01907854|593484609|FG000|Overall Study|Protocol Violation|1|||
164302638|NCT01907854|593484610|FG001|Overall Study|Protocol Violation|1|||
164302639|NCT01907854|593484609|FG000|Overall Study|Withdrawal by Subject|9|||
164302640|NCT01907854|593484610|FG001|Overall Study|Withdrawal by Subject|7|||
164302641|NCT01907854|593484609|FG000|Overall Study|Lost to Follow-up|2|||
164302642|NCT01907854|593484610|FG001|Overall Study|Lost to Follow-up|2|||
164302643|NCT01907854|593484609|FG000|Overall Study|Unclassified|4|||
164302644|NCT01907854|593484610|FG001|Overall Study|Unclassified|3|||
164302645|NCT01744977|593484611|FG000|Overall Study|Withdrawal by Subject|1|||
164302646|NCT01744977|593484612|FG001|Overall Study|Withdrawal by Subject|2|||
164302647|NCT01744977|593484611|FG000|Overall Study|Death|2|||
164302648|NCT01744977|593484612|FG001|Overall Study|Death|3|||
164302649|NCT01744977|593484611|FG000|Overall Study|Lost to Follow-up|2|||
164302650|NCT01744977|593484612|FG001|Overall Study|Lost to Follow-up|0|||
164302651|NCT01744977|593484611|FG000|Overall Study|No longer meets inclusion|6|||
164302652|NCT01744977|593484612|FG001|Overall Study|No longer meets inclusion|0|||
164302653|NCT01750229|593484615|FG000|Randomized Crossover Phase|Adverse Event|1|||
164302654|NCT01750229|593484615|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
164302655|NCT01750229|593484615|FG000|Long-term Follow-up Phase|Adverse Event|2|||
164302656|NCT01750229|593484615|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
164302657|NCT03774576|593484616|FG000|Period 2|Adverse Event|1|||
164302658|NCT01746901|593484617|FG000|Naloxone Challenge Phase|Adverse Event|2|||
164302659|NCT01746901|593484618|FG001|Naloxone Challenge Phase|Adverse Event|0|||
164302660|NCT01746901|593484619|FG002|Naloxone Challenge Phase|Adverse Event|0|||
164302661|NCT01746901|593484620|FG003|Naloxone Challenge Phase|Adverse Event|0|||
164302662|NCT01746901|593484621|FG004|Naloxone Challenge Phase|Adverse Event|0|||
164302663|NCT01746901|593484622|FG005|Naloxone Challenge Phase|Adverse Event|0|||
164302664|NCT01746901|593484623|FG006|Naloxone Challenge Phase|Adverse Event|0|||
164302665|NCT01746901|593484624|FG007|Naloxone Challenge Phase|Adverse Event|0|||
164302666|NCT01746901|593484625|FG008|Naloxone Challenge Phase|Adverse Event|0|||
164302667|NCT01746901|593484617|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
164302668|NCT01746901|593484618|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302669|NCT01746901|593484619|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302670|NCT01746901|593484620|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302671|NCT01746901|593484621|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302672|NCT01746901|593484622|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302673|NCT01746901|593484623|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302674|NCT01746901|593484624|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302675|NCT01746901|593484625|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
164302676|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302677|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
164302678|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302679|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302680|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302681|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302682|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302683|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302684|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
164302685|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302686|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
164302687|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
164302688|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302689|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302690|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302691|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302692|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302693|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
164302694|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302695|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
164302903|NCT03815929|593484670|FG002|Overall Study|Physician Decision|0|||
164302696|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
164302697|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302698|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302699|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302700|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302701|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302702|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
164302703|NCT01746901|593484617|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302704|NCT01746901|593484618|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
164302705|NCT01746901|593484619|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
164302706|NCT01746901|593484620|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302707|NCT01746901|593484621|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302708|NCT01746901|593484622|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302709|NCT01746901|593484623|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302710|NCT01746901|593484624|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302711|NCT01746901|593484625|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
164302712|NCT01746901|593484617|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
164302713|NCT01746901|593484618|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
164302714|NCT01746901|593484619|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
164302715|NCT01746901|593484620|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
164302716|NCT01746901|593484621|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
164302717|NCT01746901|593484622|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
164302718|NCT01746901|593484623|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
164302719|NCT01746901|593484624|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
164302720|NCT01746901|593484625|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
164302721|NCT01746901|593484617|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302722|NCT01746901|593484618|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302723|NCT01746901|593484619|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302724|NCT01746901|593484620|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302725|NCT01746901|593484621|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302726|NCT01746901|593484622|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302727|NCT01746901|593484623|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302728|NCT01746901|593484624|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
164302729|NCT01746901|593484625|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
164302730|NCT01746901|593484617|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302731|NCT01746901|593484618|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302732|NCT01746901|593484619|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302733|NCT01746901|593484620|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302734|NCT01746901|593484621|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302735|NCT01746901|593484622|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
164302736|NCT01746901|593484623|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
164302737|NCT01746901|593484624|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302738|NCT01746901|593484625|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
164302739|NCT01746901|593484617|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302740|NCT01746901|593484618|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302741|NCT01746901|593484619|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302742|NCT01746901|593484620|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
164302743|NCT01746901|593484621|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302744|NCT01746901|593484622|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302745|NCT01746901|593484623|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302746|NCT01746901|593484624|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302747|NCT01746901|593484625|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
164302748|NCT01746901|593484617|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302749|NCT01746901|593484618|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302750|NCT01746901|593484619|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302751|NCT01746901|593484620|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302752|NCT01746901|593484621|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302753|NCT01746901|593484622|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
164302754|NCT01746901|593484623|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302755|NCT01746901|593484624|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
164302756|NCT01746901|593484625|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
164302757|NCT01746901|593484617|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302758|NCT01746901|593484618|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302759|NCT01746901|593484619|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302983|NCT02760498|593484677|FG004|Overall Study|Not treated|0|||
164302760|NCT01746901|593484620|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302761|NCT01746901|593484621|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302762|NCT01746901|593484622|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302763|NCT01746901|593484623|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
164302764|NCT01746901|593484624|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
164302765|NCT01746901|593484625|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
164302766|NCT03594110|593484626|FG000|Interventional Part|Participant concerned about study treatment|23|||
164302767|NCT03594110|593484627|FG001|Interventional Part|Participant concerned about study treatment|28|||
164302768|NCT03594110|593484626|FG000|Interventional Part|Doctor advice|38|||
164302769|NCT03594110|593484627|FG001|Interventional Part|Doctor advice|40|||
164302770|NCT03594110|593484626|FG000|Interventional Part|Participants' wish|89|||
164302771|NCT03594110|593484627|FG001|Interventional Part|Participants' wish|68|||
164302772|NCT03594110|593484626|FG000|Interventional Part|Adverse event-non-fatal events|119|||
164302773|NCT03594110|593484627|FG001|Interventional Part|Adverse event-non-fatal events|116|||
164302774|NCT03594110|593484626|FG000|Interventional Part|Study drug stopped, reason missing|336|||
164302775|NCT03594110|593484627|FG001|Interventional Part|Study drug stopped, reason missing|294|||
164302776|NCT03594110|593484626|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
164302777|NCT03594110|593484627|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
164302778|NCT03594110|593484626|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
164302779|NCT03594110|593484627|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
164302780|NCT03594110|593484626|FG000|Interventional Part|Contraindicated drug started|32|||
164302781|NCT03594110|593484627|FG001|Interventional Part|Contraindicated drug started|18|||
164302782|NCT03594110|593484626|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
164302783|NCT03594110|593484627|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
164302784|NCT03594110|593484626|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
164302785|NCT03594110|593484627|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
164302786|NCT03594110|593484626|FG000|Non-interventional Part|Withdrawal by Subject|3|||
164302787|NCT03594110|593484627|FG001|Non-interventional Part|Withdrawal by Subject|4|||
164302788|NCT03594110|593484626|FG000|Non-interventional Part|Lost to Follow-up|45|||
164302789|NCT03594110|593484627|FG001|Non-interventional Part|Lost to Follow-up|41|||
164302790|NCT02968004|593484628|FG000|Main Study Phase|Adverse Event|1|||
164302791|NCT02968004|593484629|FG001|Main Study Phase|Adverse Event|0|||
164302792|NCT02968004|593484628|FG000|Main Study Phase|Withdrawal by Subject|0|||
164302793|NCT02968004|593484629|FG001|Main Study Phase|Withdrawal by Subject|1|||
164302794|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
164302795|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
164302796|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
164302797|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
164302798|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
164302799|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
164302800|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
164302801|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
164302802|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
164302803|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
164302804|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
164302805|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
164302806|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
164302807|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
164302808|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
164302809|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
164302810|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
164302811|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
164302812|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
164302813|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
164302814|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
164302815|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
164302816|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
164302817|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
164302818|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
164302819|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
164302820|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
164302821|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
164302822|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
164302823|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
164302824|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
164302825|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
164302826|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
164302827|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
164302828|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
164302829|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
164302830|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
164302831|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
164302832|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
164302833|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
164302834|NCT02968004|593484628|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
164302835|NCT02968004|593484629|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
164302836|NCT00803569|593484631|FG000|Overall Study|Progressive Disease|3|||
164302837|NCT00803569|593484631|FG000|Overall Study|Noncompliance|1|||
164302838|NCT04298697|593484632|FG000|Overall Study|Lost to Follow-up|5|||
164302839|NCT04298697|593484633|FG001|Overall Study|Lost to Follow-up|5|||
164302840|NCT04298697|593484634|FG002|Overall Study|Lost to Follow-up|1|||
164302841|NCT04298697|593484635|FG003|Overall Study|Lost to Follow-up|0|||
164302842|NCT04298697|593484632|FG000|Overall Study|Withdrawal by Subject|0|||
164302843|NCT04298697|593484633|FG001|Overall Study|Withdrawal by Subject|3|||
164302844|NCT04298697|593484634|FG002|Overall Study|Withdrawal by Subject|2|||
164302845|NCT04298697|593484635|FG003|Overall Study|Withdrawal by Subject|3|||
164302846|NCT03995368|593484636|FG000|Overall Study|Lost to Follow-up|1|||
164302847|NCT03995368|593484637|FG001|Overall Study|Lost to Follow-up|4|||
164302848|NCT03995368|593484638|FG002|Overall Study|Lost to Follow-up|1|||
164302849|NCT03995368|593484636|FG000|Overall Study|Did not meet inclusion criteria|1|||
164302850|NCT03995368|593484637|FG001|Overall Study|Did not meet inclusion criteria|6|||
164302851|NCT03995368|593484638|FG002|Overall Study|Did not meet inclusion criteria|3|||
164302852|NCT03995368|593484636|FG000|Overall Study|Withdrawal by Subject|0|||
164302853|NCT03995368|593484637|FG001|Overall Study|Withdrawal by Subject|1|||
164302854|NCT03995368|593484638|FG002|Overall Study|Withdrawal by Subject|1|||
164302855|NCT03592186|593484639|FG000|Overall Study|Withdrawal by Subject|1|||
164302856|NCT03592186|593484640|FG001|Overall Study|Withdrawal by Subject|0|||
164302857|NCT03592186|593484639|FG000|Overall Study|Lost to Follow-up|16|||
164302858|NCT03592186|593484640|FG001|Overall Study|Lost to Follow-up|11|||
164302859|NCT02072668|593484644|FG000|Second Intervention|Lost to Follow-up|1|||
164302860|NCT02072668|593484645|FG001|Second Intervention|Lost to Follow-up|0|||
164302861|NCT01353898|593484646|FG000|Overall Study|Study site terminated|0|||
164302862|NCT01353898|593484647|FG001|Overall Study|Study site terminated|0|||
164302863|NCT01353898|593484648|FG002|Overall Study|Study site terminated|0|||
164302864|NCT01353898|593484649|FG003|Overall Study|Study site terminated|0|||
164302865|NCT01353898|593484650|FG004|Overall Study|Study site terminated|0|||
164302866|NCT01353898|593484651|FG005|Overall Study|Study site terminated|1|||
164302867|NCT01352793|593484653|FG000|Overall Study|Lost to Follow-up|289|||
164302868|NCT01352793|593484654|FG001|Overall Study|Lost to Follow-up|125|||
164302869|NCT01352793|593484653|FG000|Overall Study|Withdrawal by Subject|120|||
164302870|NCT01352793|593484654|FG001|Overall Study|Withdrawal by Subject|55|||
164302871|NCT01352793|593484653|FG000|Overall Study|Protocol Violation|44|||
164302872|NCT01352793|593484654|FG001|Overall Study|Protocol Violation|23|||
164302873|NCT01352793|593484653|FG000|Overall Study|Adverse Event|44|||
164302874|NCT01352793|593484654|FG001|Overall Study|Adverse Event|10|||
164302875|NCT01352793|593484653|FG000|Overall Study|Physician Decision|1|||
164302876|NCT01352793|593484654|FG001|Overall Study|Physician Decision|0|||
164302877|NCT01352793|593484653|FG000|Overall Study|Pregnancy|26|||
164302878|NCT01352793|593484654|FG001|Overall Study|Pregnancy|8|||
164302879|NCT01352793|593484653|FG000|Overall Study|Other|25|||
164302880|NCT01352793|593484654|FG001|Overall Study|Other|7|||
164302881|NCT01352793|593484653|FG000|Overall Study|Medication error|2|||
164302882|NCT01352793|593484654|FG001|Overall Study|Medication error|2|||
164302883|NCT01352793|593484653|FG000|Overall Study|Death|1|||
164302884|NCT01352793|593484654|FG001|Overall Study|Death|0|||
164302885|NCT01352793|593484653|FG000|Overall Study|Randomized but not vaccinated|8|||
164302886|NCT01352793|593484654|FG001|Overall Study|Randomized but not vaccinated|0|||
164302887|NCT01352793|593484653|FG000|Overall Study|No longer meets eligibility criteria|25|||
164302888|NCT01352793|593484654|FG001|Overall Study|No longer meets eligibility criteria|15|||
164302889|NCT04322526|593484657|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
164302890|NCT04322526|593484658|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
164302891|NCT04322526|593484657|FG000|Washout (1 Week)|Lost to Follow-up|1|||
164302892|NCT04322526|593484658|FG001|Washout (1 Week)|Lost to Follow-up|2|||
164302893|NCT00993967|593484659|FG000|Overall Study|Adverse Event|8|||
164302894|NCT00993967|593484659|FG000|Overall Study|Death|1|||
164302895|NCT00993967|593484659|FG000|Overall Study|Lost to Follow-up|14|||
164302896|NCT00993967|593484659|FG000|Overall Study|Withdrawal by Subject|36|||
164302897|NCT00993967|593484659|FG000|Overall Study|Protocol Violation|2|||
164302898|NCT03815929|593484668|FG000|Overall Study|Lost to Follow-up|2|||
164302899|NCT03815929|593484669|FG001|Overall Study|Lost to Follow-up|1|||
164302900|NCT03815929|593484670|FG002|Overall Study|Lost to Follow-up|0|||
164302901|NCT03815929|593484668|FG000|Overall Study|Physician Decision|2|||
164302902|NCT03815929|593484669|FG001|Overall Study|Physician Decision|2|||
164302904|NCT03815929|593484668|FG000|Overall Study|Withdrawal by Subject|0|||
164302905|NCT03815929|593484669|FG001|Overall Study|Withdrawal by Subject|0|||
164302906|NCT03815929|593484670|FG002|Overall Study|Withdrawal by Subject|1|||
164302907|NCT03313037|593484671|FG000|Overall Study|Protocol Violation|4|||
164302908|NCT03313037|593484672|FG001|Overall Study|Protocol Violation|1|||
164302909|NCT03313037|593484671|FG000|Overall Study|Other|1|||
164302910|NCT03313037|593484672|FG001|Overall Study|Other|1|||
164302911|NCT03313037|593484671|FG000|Overall Study|Withdrawal by Subject|4|||
164302912|NCT03313037|593484672|FG001|Overall Study|Withdrawal by Subject|3|||
164302913|NCT03313037|593484671|FG000|Overall Study|No longer meets eligibility criteria|1|||
164302914|NCT03313037|593484672|FG001|Overall Study|No longer meets eligibility criteria|7|||
164302915|NCT03313037|593484671|FG000|Overall Study|Lost to Follow-up|9|||
164302916|NCT03313037|593484672|FG001|Overall Study|Lost to Follow-up|8|||
164302917|NCT03313037|593484671|FG000|Overall Study|Randomized but not treated|1|||
164302918|NCT03313037|593484672|FG001|Overall Study|Randomized but not treated|0|||
164302919|NCT02760498|593484673|FG000|Overall Study|Adverse Event|3|||
164302920|NCT02760498|593484674|FG001|Overall Study|Adverse Event|3|||
164302921|NCT02760498|593484675|FG002|Overall Study|Adverse Event|1|||
164302922|NCT02760498|593484676|FG003|Overall Study|Adverse Event|1|||
164302923|NCT02760498|593484677|FG004|Overall Study|Adverse Event|0|||
164302924|NCT02760498|593484678|FG005|Overall Study|Adverse Event|6|||
164302925|NCT02760498|593484673|FG000|Overall Study|Death|7|||
164302926|NCT02760498|593484674|FG001|Overall Study|Death|5|||
164302927|NCT02760498|593484675|FG002|Overall Study|Death|5|||
164302928|NCT02760498|593484676|FG003|Overall Study|Death|7|||
164302929|NCT02760498|593484677|FG004|Overall Study|Death|0|||
164302930|NCT02760498|593484678|FG005|Overall Study|Death|23|||
164302931|NCT02760498|593484673|FG000|Overall Study|Lost to Follow-up|0|||
164302932|NCT02760498|593484674|FG001|Overall Study|Lost to Follow-up|0|||
164302933|NCT02760498|593484675|FG002|Overall Study|Lost to Follow-up|0|||
164302934|NCT02760498|593484676|FG003|Overall Study|Lost to Follow-up|0|||
164302935|NCT02760498|593484677|FG004|Overall Study|Lost to Follow-up|0|||
164302936|NCT02760498|593484678|FG005|Overall Study|Lost to Follow-up|3|||
164302937|NCT02760498|593484673|FG000|Overall Study|Non-compliance with study drug|0|||
164302938|NCT02760498|593484674|FG001|Overall Study|Non-compliance with study drug|2|||
164302939|NCT02760498|593484675|FG002|Overall Study|Non-compliance with study drug|0|||
164302940|NCT02760498|593484676|FG003|Overall Study|Non-compliance with study drug|0|||
164302941|NCT02760498|593484677|FG004|Overall Study|Non-compliance with study drug|0|||
164302942|NCT02760498|593484678|FG005|Overall Study|Non-compliance with study drug|0|||
164302943|NCT02760498|593484673|FG000|Overall Study|Participant decision|1|||
164302944|NCT02760498|593484674|FG001|Overall Study|Participant decision|4|||
164302945|NCT02760498|593484675|FG002|Overall Study|Participant decision|2|||
164302946|NCT02760498|593484676|FG003|Overall Study|Participant decision|2|||
164302947|NCT02760498|593484677|FG004|Overall Study|Participant decision|1|||
164302948|NCT02760498|593484678|FG005|Overall Study|Participant decision|6|||
164302949|NCT02760498|593484673|FG000|Overall Study|Sponsor decision|0|||
164302950|NCT02760498|593484674|FG001|Overall Study|Sponsor decision|0|||
164302951|NCT02760498|593484675|FG002|Overall Study|Sponsor decision|0|||
164302952|NCT02760498|593484676|FG003|Overall Study|Sponsor decision|3|||
164302953|NCT02760498|593484677|FG004|Overall Study|Sponsor decision|0|||
164302954|NCT02760498|593484678|FG005|Overall Study|Sponsor decision|0|||
164302955|NCT02760498|593484673|FG000|Overall Study|Physician Decision|3|||
164302956|NCT02760498|593484674|FG001|Overall Study|Physician Decision|4|||
164302957|NCT02760498|593484675|FG002|Overall Study|Physician Decision|1|||
164302958|NCT02760498|593484676|FG003|Overall Study|Physician Decision|4|||
164302959|NCT02760498|593484677|FG004|Overall Study|Physician Decision|0|||
164302960|NCT02760498|593484678|FG005|Overall Study|Physician Decision|2|||
164302961|NCT02760498|593484673|FG000|Overall Study|Disease progression|21|||
164302962|NCT02760498|593484674|FG001|Overall Study|Disease progression|19|||
164302963|NCT02760498|593484675|FG002|Overall Study|Disease progression|20|||
164302964|NCT02760498|593484676|FG003|Overall Study|Disease progression|18|||
164302965|NCT02760498|593484677|FG004|Overall Study|Disease progression|4|||
164302966|NCT02760498|593484678|FG005|Overall Study|Disease progression|55|||
164302967|NCT02760498|593484673|FG000|Overall Study|Withdrawal by Subject|4|||
164302968|NCT02760498|593484674|FG001|Overall Study|Withdrawal by Subject|7|||
164302969|NCT02760498|593484675|FG002|Overall Study|Withdrawal by Subject|5|||
164302970|NCT02760498|593484676|FG003|Overall Study|Withdrawal by Subject|1|||
164302971|NCT02760498|593484677|FG004|Overall Study|Withdrawal by Subject|0|||
164302972|NCT02760498|593484678|FG005|Overall Study|Withdrawal by Subject|6|||
164302973|NCT02760498|593484673|FG000|Overall Study|Other than specified|1|||
164302974|NCT02760498|593484674|FG001|Overall Study|Other than specified|6|||
164302975|NCT02760498|593484675|FG002|Overall Study|Other than specified|0|||
164302976|NCT02760498|593484676|FG003|Overall Study|Other than specified|3|||
164302977|NCT02760498|593484677|FG004|Overall Study|Other than specified|1|||
164302978|NCT02760498|593484678|FG005|Overall Study|Other than specified|0|||
164302979|NCT02760498|593484673|FG000|Overall Study|Not treated|0|||
164302980|NCT02760498|593484674|FG001|Overall Study|Not treated|0|||
164302981|NCT02760498|593484675|FG002|Overall Study|Not treated|0|||
164302982|NCT02760498|593484676|FG003|Overall Study|Not treated|0|||
164303022|NCT04323124|593484686|FG000|Overall Study|Coming from a red zone (COVID)|0|||
164303023|NCT04323124|593484687|FG001|Overall Study|Coming from a red zone (COVID)|0|||
164303024|NCT04323124|593484688|FG002|Overall Study|Coming from a red zone (COVID)|0|||
164303025|NCT04323124|593484689|FG003|Overall Study|Coming from a red zone (COVID)|0|||
164303026|NCT04323124|593484690|FG004|Overall Study|Coming from a red zone (COVID)|1|||
164303027|NCT04323124|593484691|FG005|Overall Study|Coming from a red zone (COVID)|1|||
164303028|NCT04323124|593484692|FG006|Overall Study|Coming from a red zone (COVID)|0|||
164303029|NCT04323124|593484693|FG007|Overall Study|Coming from a red zone (COVID)|0|||
164303030|NCT04323124|593484694|FG008|Overall Study|Coming from a red zone (COVID)|0|||
164303031|NCT04323124|593484695|FG009|Overall Study|Coming from a red zone (COVID)|0|||
164303032|NCT04323124|593484696|FG010|Overall Study|Coming from a red zone (COVID)|0|||
164303033|NCT04323124|593484697|FG011|Overall Study|Coming from a red zone (COVID)|0|||
164303034|NCT04323124|593484698|FG012|Overall Study|Coming from a red zone (COVID)|0|||
164303035|NCT04323124|593484699|FG013|Overall Study|Coming from a red zone (COVID)|0|||
164303036|NCT04323124|593484700|FG014|Overall Study|Coming from a red zone (COVID)|0|||
164303037|NCT04323124|593484686|FG000|Overall Study|No longer meets eligibility criteria|0|||
164303038|NCT04323124|593484687|FG001|Overall Study|No longer meets eligibility criteria|0|||
164303039|NCT04323124|593484688|FG002|Overall Study|No longer meets eligibility criteria|0|||
164303040|NCT04323124|593484689|FG003|Overall Study|No longer meets eligibility criteria|0|||
164303041|NCT04323124|593484690|FG004|Overall Study|No longer meets eligibility criteria|0|||
164303042|NCT04323124|593484691|FG005|Overall Study|No longer meets eligibility criteria|0|||
164303043|NCT04323124|593484692|FG006|Overall Study|No longer meets eligibility criteria|0|||
164303044|NCT04323124|593484693|FG007|Overall Study|No longer meets eligibility criteria|1|||
164303045|NCT04323124|593484694|FG008|Overall Study|No longer meets eligibility criteria|0|||
164303046|NCT04323124|593484695|FG009|Overall Study|No longer meets eligibility criteria|0|||
164303047|NCT04323124|593484696|FG010|Overall Study|No longer meets eligibility criteria|0|||
164303048|NCT04323124|593484697|FG011|Overall Study|No longer meets eligibility criteria|0|||
164303049|NCT04323124|593484698|FG012|Overall Study|No longer meets eligibility criteria|0|||
164303050|NCT04323124|593484699|FG013|Overall Study|No longer meets eligibility criteria|1|||
164303051|NCT04323124|593484700|FG014|Overall Study|No longer meets eligibility criteria|1|||
164303052|NCT04323124|593484686|FG000|Overall Study|Study terminated by sponsor|0|||
164303053|NCT04323124|593484687|FG001|Overall Study|Study terminated by sponsor|0|||
164303054|NCT04323124|593484688|FG002|Overall Study|Study terminated by sponsor|0|||
164303055|NCT04323124|593484689|FG003|Overall Study|Study terminated by sponsor|0|||
164303056|NCT04323124|593484690|FG004|Overall Study|Study terminated by sponsor|0|||
164303057|NCT04323124|593484691|FG005|Overall Study|Study terminated by sponsor|0|||
164303058|NCT04323124|593484692|FG006|Overall Study|Study terminated by sponsor|0|||
164303059|NCT04323124|593484693|FG007|Overall Study|Study terminated by sponsor|0|||
164303060|NCT04323124|593484694|FG008|Overall Study|Study terminated by sponsor|0|||
164303061|NCT04323124|593484695|FG009|Overall Study|Study terminated by sponsor|0|||
164303062|NCT04323124|593484696|FG010|Overall Study|Study terminated by sponsor|0|||
164303063|NCT04323124|593484697|FG011|Overall Study|Study terminated by sponsor|2|||
164303064|NCT04323124|593484698|FG012|Overall Study|Study terminated by sponsor|1|||
164303065|NCT04323124|593484699|FG013|Overall Study|Study terminated by sponsor|0|||
164303066|NCT04323124|593484700|FG014|Overall Study|Study terminated by sponsor|0|||
164303067|NCT04586205|593484701|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
164303068|NCT04586205|593484702|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
